,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
7142,GO:0031012,3.70250900001522e-26,1,91,240,extracellular matrix,CC,SERPINE2;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;COL8A1;CTGF;FBN1;ITGA6;SFRP1;MMP28;SLITRK6;ADAMTSL1;EFEMP1;COL5A2;NID1;COL7A1;BCAM;FBN2;COL5A1;TFPI2;SDC3;LAMB1;FLRT3;THBS2;SERPINE1;CRTAP;CSPG4;MAMDC2;MFAP5;TIMP2;ANGPTL4;BMP4;LAMB4;COL18A1;LGALS1;LTBP1;MMP19;TIMP1;EFEMP2;COL4A4;SMOC1;LAMC2;P3H2;NAV2;CCDC80;LTBP4;LAMA3;CLU;SLIT3;ANG;LAMA5;LAMB3;FBLN1;ADAMTS7;THSD4;GLG1;COL16A1;LTBP3;TGFBI;TGM2;CDH13;LMCD1;TGFBR3;CALR;CST3;CRIP2;SDC2;COL5A3;ANXA2;ADAMTS15;TGFB2;COL12A1;LRRN3;AGRN;TGFB1I1;COL17A1;ADAMTSL5;OLFML2A;POSTN;LGALS3;ECM2;COL4A1;EFNA5;SLITRK5;MATN3;DGCR6;CTSD;LAMB2
7915,GO:0032501,2.38461425349308e-23,1,623,4164,multicellular organismal process,BP,SERPINE2;ITGB6;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;APBB2;SYNE1;F2R;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;SLITRK6;PTGS1;ITGB4;EFEMP1;TENM4;IL20RB;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;COL7A1;NOS1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;MAGED1;MN1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;TFPI2;ROR1;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;TMEM204;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;DOCK5;MYLK;CSMD3;GJC2;THBS2;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;KRT14;CRTAP;TCF7L1;STON2;RNF165;ANXA5;VIM;NUPR1;CSPG4;TKFC;EVC;FAM210B;MFAP5;AMIGO2;STMN3;NTSR1;TIMP2;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;CBX5;VDR;PTPRM;BMP4;NEFM;ITM2C;NR1D1;SMARCA2;PTK6;SCN8A;TBC1D8;EIF2AK4;NETO1;MRC2;NEFL;HSF2BP;VAV3;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;SCN2A;LGALS1;GNG2;KCNMA1;ETV1;TP53;KRT13;PTPRS;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;LTBP1;MEF2D;KRT5;WNK1;DDX60;EFHC1;DLG4;SLC7A11;SEMA5A;ITGA2;ZCCHC11;PDGFA;MAP2;MMP19;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;COL4A4;GPNMB;TFDP2;SMOC1;DOCK4;CRIM1;CUL7;BTG1;ITGA3;SIK1;EMP1;PCDHAC2;HIVEP1;TPBG;ANO6;GPX1;LAMC2;GLI3;PAQR8;E2F7;DLG5;CNTN1;KITLG;NAV2;ERMAP;ASAP1;PLLP;PDPN;MTHFR;KRT15;MAGED2;CTSV;SEC14L1;SPG11;PLXNB1;EML2;KCNAB2;LRP1;FYN;XDH;TSHZ2;LTBP4;FUT10;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SPATA6;DOCK11;ESPN;SMARCA1;AHNAK2;UST;CLU;SERPING1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TNS2;EHD3;PPDPF;HMGA2;CAMK2D;ADGRG6;PHC2;ITGA1;MST1R;IL31RA;CCNI;PTPN14;PER1;PXN;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SLC38A2;ACACB;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;BBS2;ANK3;WFS1;MDFI;SPRY2;LAMB3;TTN;PRDM8;JARID2;PRR15;HPS4;FBLN1;MLH3;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;METRN;ROBO1;KCNJ5;IFT140;SPRY4;LRIG3;PRX;PHF2;TLR3;SNCA;ADAMTS7;MME;FZD7;GLG1;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;COL16A1;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;PDE4D;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;TRO;G6PD;MYOF;EPHB6;EDA2R;FZD8;CCDC136;SOX13;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CDH13;NFATC4;FOXN3;RAPH1;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;CALR;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;TCF4;BBS1;ANXA6;AKAP13;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;ZNF449;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;RNPEP;POGLUT1;CRIP2;VANGL2;ARHGEF2;NTNG1;SPRED3;KLHL12;SDC2;COL5A3;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;CES3;FNDC3A;HOXA1;METTL23;LEPR;STOX2;PGAP1;TSHZ1;IGFBP4;TTC8;TCF25;TCF12;NFAT5;PODXL;ZNF160;ABCC2;NAB2;MEGF8;NLGN4Y;ATXN1;HTR1B;STK36;SPA17;WDR19;TAF8;PRNP;CDH11;RET;ZFPM1;TGFB2;MAP2K5;ODF2;DLX2;OR2A4;COL12A1;SMG9;SCNN1A;AMOTL2;IFT122;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;LRRN3;ALDH7A1;ITM2A;CYP4V2;HERPUD2;SP100;ULK1;TEF;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;KIAA1109;HSPA5;BTN3A3;TH;CELF2;GOPC;SLC9A4;BOC;PIKFYVE;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;CCHCR1;CFAP54;ARHGEF19;ITPR2;IFT74;IFITM1;TACC2;OPHN1;TPGS1;LMF1;SH2B3;MYO9A;YAP1;CACNB1;GDNF;DNAH1;KLF5;TWIST2;KLHL3;ATRAID;SRR;HOXA3;UBA7;DIXDC1;AGPAT1;PPARG;CALCRL;KCNIP3;MEF2A;KLF7;ICK;SASH1;TGIF1;OBSL1;POSTN;UNK;LGALS3;PTPN3;ARL3;NYAP1;RARA;ECM2;COL4A1;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;SBF2;RASA1;ANKH;CREBRF;KRT10;HOXA2;FOS;KDM4A;CDK5RAP3;AGO4;CACNA2D3;SERPINB5;SCPEP1;MATN3;MED12;NPAS2;ABAT;MYH11;NIPBL;TTBK2;ADM2;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;PPP2R3A;CELSR1;LITAF;TUSC3;RXRA;SNTB1;DGCR6;ABCA5;TAOK3;DOCK1;DMPK;MOSPD3;LAMB2
2405,GO:0005578,1.20527640694422e-21,1,74,184,proteinaceous extracellular matrix,CC,MMP2;FN1;FLRT2;MMP9;CCBE1;COL8A1;CTGF;FBN1;ITGA6;SFRP1;MMP28;SLITRK6;ADAMTSL1;EFEMP1;COL5A2;NID1;COL7A1;FBN2;COL5A1;TFPI2;LAMB1;FLRT3;THBS2;CRTAP;MAMDC2;MFAP5;TIMP2;ANGPTL4;BMP4;LAMB4;COL18A1;LGALS1;LTBP1;MMP19;TIMP1;EFEMP2;COL4A4;SMOC1;LAMC2;P3H2;NAV2;CCDC80;LTBP4;LAMA3;SLIT3;ANG;LAMA5;LAMB3;FBLN1;ADAMTS7;THSD4;GLG1;COL16A1;TGFBI;TGFBR3;CALR;CST3;COL5A3;ANXA2;ADAMTS15;COL12A1;LRRN3;AGRN;COL17A1;ADAMTSL5;OLFML2A;POSTN;ECM2;COL4A1;EFNA5;SLITRK5;MATN3;DGCR6;LAMB2
7916,GO:0032502,1.31036986849299e-21,1,585,3885,developmental process,BP,SERPINE2;SULT1E1;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;MYH15;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;IGF2BP2;SDK1;TNIK;ANPEP;COL7A1;CLTCL1;NOS1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;MAGED1;MN1;MALL;MAP6;SULF2;COL5A1;UTRN;ROR1;AXL;DPYSL2;EGFR;TSC22D3;TMEM204;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;DOCK5;MYLK;SYNE3;CSMD3;GJC2;THBS2;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;KRT14;TCF7L1;S100A10;STON2;RNF165;VIM;NUPR1;CSPG4;EVC;FAM210B;MFAP5;AMIGO2;STMN3;TIMP2;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;VDR;PTPRM;BMP4;NEFM;ITM2C;NR1D1;SMARCA2;PTK6;SCN8A;CITED4;EIF2AK4;MRC2;NEFL;VAV3;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;SCN2A;LGALS1;MEST;ETV1;TP53;ARAP1;KRT13;MBNL2;PTPRS;WWTR1;PRICKLE1;DDIT3;LTBP1;MEF2D;KRT5;WNK1;EFHC1;DLG4;SLC7A11;SEMA5A;ITGA2;ZCCHC11;PDGFA;MAP2;MMP19;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;COL4A4;GPNMB;TFDP2;SMOC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;SIK1;EMP1;PCDHAC2;HIVEP1;TPBG;SNX1;ANO6;GPX1;LAMC2;GLI3;PAQR8;E2F7;DLG5;CNTN1;KITLG;NAV2;ASAP1;PLLP;PDPN;KRT15;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;FLNC;TSHZ2;LTBP4;ARHGAP18;ADIRF;FUT10;CLMN;UGT8;CPS1;LAMA3;CAV1;GLI2;ERCC6;RBFOX2;TRIB2;SPATA6;DOCK11;SMARCA1;AHNAK2;UST;CLU;SERPING1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TP53INP1;ARPIN;TNS2;PPDPF;HMGA2;CAMK2D;ADGRG6;PHC2;ITGA1;MST1R;IL31RA;PTPN14;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;SLC38A2;ACACB;PCLO;ANG;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;ANK3;WFS1;MDFI;SPRY2;LAMB3;TTN;PRDM8;JARID2;PRR15;HPS4;FBLN1;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;KLF13;S1PR5;PRKACB;AARS;CHEK2;METRN;ROBO1;WDFY2;IFT140;SPRY4;LRIG3;PRX;PHF2;TLR3;SNCA;FLOT2;ADAMTS7;MME;FZD7;GLG1;PAQR7;SH3TC2;PLXNA2;PTPRU;FGFR1;CBR1;IGF1R;LMNA;ALOX15B;DKK1;FSCN1;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;ASTN2;PDE4D;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;TRO;G6PD;MYOF;EPHB6;EDA2R;FZD8;CCDC136;SOX13;TRIOBP;DHTKD1;KDM4C;CDH13;NFATC4;FOXN3;RAPH1;SEPT6;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;CALR;MKLN1;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;AREG;IFNK;TCF4;AKAP13;SNX10;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;FGD4;POGLUT1;CRIP2;VANGL2;ARHGEF2;NTNG1;SPRED3;KLHL12;SDC2;COL5A3;NRK;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;FNDC3A;HOXA1;LEPR;STOX2;PGAP1;TSHZ1;IGFBP4;TTC8;TCF25;TCF12;PODXL;ZNF160;NAB2;MEGF8;NLGN4Y;ATXN1;IRF2BPL;STK36;WDR19;TAF8;PRNP;CDH11;RET;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;DLX2;COL12A1;SMG9;STAT2;AMOTL2;IFT122;LIG1;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;ITM2A;CDKN2A;SP100;ULK1;TEF;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;KIAA1109;HSPA5;TH;GOPC;SLC9A4;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;CCHCR1;CFAP54;ARHGEF19;IFT74;IFITM1;TACC2;OPHN1;TPGS1;SH2B3;MYO9A;YAP1;GDNF;DNAH1;KLF5;COL17A1;TWIST2;KLHL3;ATRAID;SRR;HOXA3;PRRC2B;DIXDC1;PPARG;INF2;CALCRL;MEF2A;KLF7;ICK;SASH1;TGIF1;OBSL1;POSTN;UNK;LGALS3;PTPN3;ARL3;NYAP1;RARA;ECM2;COL4A1;HOXC5;PBX2;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;PPP3CA;SBF2;RASA1;ANKH;KRT10;ETV4;HOXA2;FOS;DNPH1;KDM4A;CDK5RAP3;AGO4;FAM120B;SERPINB5;MATN3;MED12;NPAS2;ABAT;MYH11;NIPBL;TTBK2;ADM2;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;PPP2R3A;CELSR1;LITAF;RXRA;DGCR6;ABCA5;TAOK3;DOCK1;DMPK;MOSPD3;LAMB2
12387,GO:0048856,1.60672846417616e-19,1,545,3602,anatomical structure development,BP,SERPINE2;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;APBB2;SYNE1;F2R;MYH15;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;IGF2BP2;SDK1;TNIK;ANPEP;COL7A1;CLTCL1;NOS1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;MAGED1;MN1;MALL;MAP6;SULF2;COL5A1;UTRN;ROR1;AXL;DPYSL2;EGFR;TSC22D3;TMEM204;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;DOCK5;MYLK;SYNE3;CSMD3;GJC2;THBS2;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;KRT14;TCF7L1;S100A10;STON2;RNF165;VIM;NUPR1;CSPG4;EVC;FAM210B;MFAP5;AMIGO2;STMN3;TIMP2;TENM3;CXCL14;PAK1;ANGPTL4;VDR;PTPRM;BMP4;NEFM;ITM2C;NR1D1;SMARCA2;PTK6;SCN8A;EIF2AK4;NEFL;VAV3;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;SCN2A;LGALS1;MEST;ETV1;TP53;ARAP1;KRT13;PTPRS;WWTR1;PRICKLE1;DDIT3;LTBP1;MEF2D;KRT5;WNK1;EFHC1;DLG4;SLC7A11;SEMA5A;ITGA2;PDGFA;MAP2;MMP19;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;COL4A4;GPNMB;TFDP2;SMOC1;CRIM1;CUL7;BTG1;ITGA3;SIK1;EMP1;PCDHAC2;HIVEP1;TPBG;SNX1;ANO6;GPX1;LAMC2;GLI3;PAQR8;E2F7;DLG5;CNTN1;KITLG;NAV2;ASAP1;PLLP;PDPN;KRT15;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;FLNC;TSHZ2;LTBP4;ARHGAP18;FUT10;CLMN;UGT8;CPS1;LAMA3;CAV1;GLI2;RBFOX2;SPATA6;DOCK11;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;ARPIN;TNS2;PPDPF;HMGA2;CAMK2D;ADGRG6;PHC2;ITGA1;MST1R;IL31RA;PTPN14;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;SLC38A2;ACACB;PCLO;ANG;DUSP5;KIF17;PARVA;LAMA5;UNC5B;BBS2;ANK3;WFS1;MDFI;SPRY2;LAMB3;TTN;PRDM8;JARID2;PRR15;FBLN1;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;KLF13;S1PR5;PRKACB;AARS;METRN;ROBO1;IFT140;SPRY4;LRIG3;PRX;PHF2;TLR3;SNCA;FLOT2;ADAMTS7;MME;FZD7;GLG1;PAQR7;SH3TC2;PLXNA2;PTPRU;FGFR1;CBR1;IGF1R;LMNA;ALOX15B;DKK1;FSCN1;CTF1;SEC24D;SEMA4A;C5;TGFBI;SETX;ASTN2;PDE4D;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;TRO;G6PD;MYOF;EPHB6;EDA2R;FZD8;CCDC136;SOX13;TRIOBP;DHTKD1;KDM4C;CDH13;NFATC4;FOXN3;RAPH1;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;CALR;MKLN1;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;SNX10;CITED2;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;FGD4;POGLUT1;CRIP2;VANGL2;ARHGEF2;NTNG1;SPRED3;KLHL12;SDC2;COL5A3;NRK;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;GCNT1;PLAG1;PRKCA;SALL2;ZNF358;BCHE;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;FNDC3A;HOXA1;LEPR;STOX2;PGAP1;TSHZ1;IGFBP4;TTC8;TCF25;TCF12;PODXL;ZNF160;NAB2;MEGF8;NLGN4Y;ATXN1;STK36;WDR19;TAF8;CDH11;RET;ZFPM1;TGFB2;MAP2K5;ODF2;DLX2;COL12A1;SMG9;STAT2;AMOTL2;IFT122;LIG1;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ITM2A;SP100;ULK1;TEF;AGRN;NPHP3;VAV2;MAGI2;KIAA1109;HSPA5;TH;GOPC;SLC9A4;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;CCHCR1;ARHGEF19;IFT74;TACC2;OPHN1;TPGS1;SH2B3;MYO9A;YAP1;GDNF;DNAH1;KLF5;COL17A1;TWIST2;KLHL3;ATRAID;SRR;HOXA3;DIXDC1;PPARG;INF2;CALCRL;MEF2A;KLF7;ICK;SASH1;TGIF1;OBSL1;POSTN;UNK;LGALS3;PTPN3;ARL3;NYAP1;RARA;ECM2;COL4A1;HOXC5;PBX2;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;PPP3CA;SBF2;RASA1;ANKH;KRT10;HOXA2;FOS;DNPH1;KDM4A;CDK5RAP3;AGO4;SERPINB5;MATN3;MED12;NPAS2;ABAT;MYH11;NIPBL;TTBK2;ADM2;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;PPP2R3A;CELSR1;RXRA;DGCR6;TAOK3;DOCK1;DMPK;MOSPD3;LAMB2
3459,GO:0007275,1.10694983452525e-18,1,506,3295,multicellular organism development,BP,SERPINE2;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;APBB2;MYH15;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;SDK1;TNIK;ANPEP;COL7A1;NOS1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;MAGED1;MN1;MALL;MAP6;SULF2;COL5A1;UTRN;ROR1;AXL;DPYSL2;EGFR;TSC22D3;TMEM204;ITPK1;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;MYLK;CSMD3;GJC2;THBS2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;KRT14;TCF7L1;STON2;RNF165;VIM;NUPR1;CSPG4;EVC;FAM210B;MFAP5;AMIGO2;STMN3;TIMP2;TENM3;CXCL14;PAK1;ANGPTL4;VDR;PTPRM;BMP4;NEFM;ITM2C;NR1D1;SMARCA2;PTK6;SCN8A;EIF2AK4;NEFL;VAV3;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;SCN2A;LGALS1;ETV1;TP53;KRT13;PTPRS;WWTR1;PRICKLE1;DDIT3;LTBP1;MEF2D;KRT5;WNK1;EFHC1;DLG4;SLC7A11;SEMA5A;ITGA2;PDGFA;MAP2;MMP19;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;COL4A4;GPNMB;TFDP2;SMOC1;CRIM1;CUL7;BTG1;ITGA3;SIK1;EMP1;PCDHAC2;HIVEP1;TPBG;ANO6;GPX1;LAMC2;GLI3;PAQR8;E2F7;DLG5;CNTN1;KITLG;NAV2;ASAP1;PLLP;PDPN;KRT15;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;TSHZ2;LTBP4;FUT10;CLMN;UGT8;CPS1;LAMA3;CAV1;GLI2;RBFOX2;SPATA6;DOCK11;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TNS2;PPDPF;HMGA2;CAMK2D;ADGRG6;PHC2;ITGA1;MST1R;IL31RA;PTPN14;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;CAPRIN2;CREB3L2;ALDH3A2;SLC38A2;ACACB;PCLO;ANG;DUSP5;KIF17;PARVA;LAMA5;UNC5B;BBS2;ANK3;WFS1;MDFI;SPRY2;LAMB3;TTN;PRDM8;JARID2;PRR15;FBLN1;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;KLF13;S1PR5;PRKACB;AARS;METRN;ROBO1;IFT140;SPRY4;LRIG3;PRX;PHF2;TLR3;SNCA;ADAMTS7;MME;FZD7;GLG1;PAQR7;SH3TC2;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;CTF1;SEC24D;SEMA4A;C5;TGFBI;SETX;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;TRO;G6PD;EPHB6;EDA2R;FZD8;SOX13;TRIOBP;DHTKD1;KDM4C;CDH13;NFATC4;FOXN3;RAPH1;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;CALR;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;SNX10;CITED2;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;POGLUT1;CRIP2;VANGL2;ARHGEF2;NTNG1;SPRED3;KLHL12;SDC2;COL5A3;NRK;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;GCNT1;PLAG1;PRKCA;SALL2;ZNF358;BCHE;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;FNDC3A;HOXA1;LEPR;STOX2;PGAP1;TSHZ1;IGFBP4;TTC8;TCF25;TCF12;PODXL;ZNF160;NAB2;MEGF8;NLGN4Y;ATXN1;STK36;WDR19;TAF8;CDH11;RET;ZFPM1;TGFB2;MAP2K5;ODF2;DLX2;COL12A1;SMG9;AMOTL2;IFT122;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;LRRN3;ITM2A;SP100;ULK1;TEF;AGRN;NPHP3;VAV2;MAGI2;KIAA1109;HSPA5;TH;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;CCHCR1;ARHGEF19;IFT74;TACC2;OPHN1;TPGS1;SH2B3;YAP1;GDNF;KLF5;TWIST2;KLHL3;ATRAID;SRR;HOXA3;DIXDC1;PPARG;CALCRL;MEF2A;KLF7;ICK;SASH1;TGIF1;OBSL1;POSTN;UNK;LGALS3;PTPN3;ARL3;NYAP1;RARA;ECM2;COL4A1;HOXC5;PBX2;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;SBF2;RASA1;ANKH;KRT10;HOXA2;FOS;KDM4A;CDK5RAP3;AGO4;SERPINB5;MATN3;MED12;NPAS2;ABAT;MYH11;NIPBL;TTBK2;ADM2;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;PPP2R3A;CELSR1;RXRA;DGCR6;TAOK3;MOSPD3;LAMB2
12397,GO:0048869,3.31557209772311e-18,1,425,2674,cellular developmental process,BP,SERPINE2;SULT1E1;FLOT1;MMP2;KRT4;HTRA1;FN1;FLRT2;MMP9;TXNIP;ITGB5;COL8A1;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;APBB2;SYNE1;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;GSN;COL5A2;ETV5;IRS2;DUSP6;ZFP36L2;SDK1;TNIK;ANPEP;COL7A1;NOS1;GAS6;APCDD1;FBN2;SNAI2;MAP6;SULF2;COL5A1;ROR1;AXL;DPYSL2;EGFR;TMEM204;PEG10;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;DOCK5;SYNE3;CSMD3;GJC2;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;KRT14;TCF7L1;S100A10;STON2;RNF165;VIM;NUPR1;CSPG4;FAM210B;STMN3;TIMP2;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;VDR;PTPRM;BMP4;NEFM;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;MRC2;NEFL;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;LGALS1;ETV1;TP53;ARAP1;KRT13;PTPRS;WWTR1;PRICKLE1;DDIT3;MEF2D;KRT5;WNK1;DLG4;SLC7A11;SEMA5A;ITGA2;MAP2;MMP19;PPL;ADARB1;FLG;PHLDB1;HIP1;GPNMB;SMOC1;CCDC85B;CUL7;BTG1;ITGA3;SIK1;SNX1;GPX1;GLI3;PAQR8;E2F7;DLG5;CNTN1;KITLG;ASAP1;PDPN;KRT15;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;FLNC;LTBP4;ARHGAP18;ADIRF;CLMN;UGT8;CPS1;LAMA3;CAV1;GLI2;RBFOX2;TRIB2;SPATA6;DOCK11;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;ULK2;TP53INP1;ARPIN;PPDPF;HMGA2;CAMK2D;ADGRG6;ITGA1;MST1R;IL31RA;SPATA20;CCK;PIK3R1;SYT1;CAPRIN2;CREB3L2;CPT1A;ANG;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;ANK3;MDFI;SPRY2;LAMB3;TTN;PRDM8;JARID2;HPS4;FBLN1;TP73;CAT;CASP14;DLC1;KLF13;S1PR5;CHEK2;METRN;ROBO1;WDFY2;IFT140;PRX;TLR3;FLOT2;ADAMTS7;MME;FZD7;GLG1;PAQR7;SH3TC2;PLXNA2;PTPRU;FGFR1;CBR1;IGF1R;LMNA;ALOX15B;DKK1;CTF1;SEMA4A;LTBP3;RGS2;TGFBI;SETX;PDE4D;PSMB9;IL18;OBSCN;SULF1;PLA2R1;G6PD;MYOF;EPHB6;EDA2R;FZD8;CCDC136;SOX13;TRIOBP;DHTKD1;KDM4C;CDH13;NFATC4;FOXN3;RAPH1;SEPT6;TGFBR3;DLX3;FZD1;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;CALR;MKLN1;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;CST3;DLK2;MEIS2;AREG;IFNK;TCF4;AKAP13;SNX10;CITED2;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;FGD4;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;NFASC;CRTC1;NDRG1;PLAG1;PRKCA;MYBL1;BCHE;ANXA2;RGS14;RAB13;FNDC3A;LEPR;TCF12;PODXL;NAB2;MEGF8;WDR19;TAF8;CDH11;RET;ZFPM1;TGFB2;RBL2;ODF2;DLX2;COL12A1;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;ITM2A;CDKN2A;ULK1;AGRN;NPHP3;RHBDD1;MAGI2;KIAA1109;HSPA5;TH;GOPC;SLC9A4;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;CCHCR1;CFAP54;IFT74;IFITM1;OPHN1;TPGS1;SH2B3;MYO9A;YAP1;GDNF;DNAH1;KLF5;TWIST2;ATRAID;PRRC2B;DIXDC1;PPARG;MEF2A;KLF7;OBSL1;POSTN;UNK;LGALS3;ARL3;NYAP1;RARA;ECM2;COL4A1;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;PPP3CA;RASA1;KRT10;ETV4;FOS;DNPH1;KDM4A;CDK5RAP3;AGO4;FAM120B;MED12;MYH11;NIPBL;TTBK2;RHOBTB3;CELSR1;RXRA;ABCA5;DOCK1;DMPK;LAMB2
6728,GO:0030154,8.22995164623947e-18,1,404,2518,cell differentiation,BP,SERPINE2;SULT1E1;FLOT1;MMP2;KRT4;HTRA1;FN1;FLRT2;MMP9;TXNIP;ITGB5;COL8A1;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;APBB2;SYNE1;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;GSN;COL5A2;ETV5;IRS2;DUSP6;ZFP36L2;SDK1;TNIK;ANPEP;COL7A1;NOS1;GAS6;APCDD1;FBN2;SNAI2;MAP6;SULF2;COL5A1;ROR1;AXL;DPYSL2;EGFR;TMEM204;PEG10;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;DOCK5;CSMD3;GJC2;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;KRT14;TCF7L1;S100A10;STON2;RNF165;VIM;NUPR1;CSPG4;FAM210B;STMN3;TIMP2;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;VDR;PTPRM;BMP4;NEFM;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;MRC2;NEFL;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;LGALS1;ETV1;TP53;KRT13;PTPRS;WWTR1;PRICKLE1;DDIT3;MEF2D;KRT5;WNK1;DLG4;SLC7A11;SEMA5A;ITGA2;MAP2;MMP19;PPL;ADARB1;FLG;PHLDB1;HIP1;GPNMB;SMOC1;CCDC85B;CUL7;BTG1;ITGA3;SIK1;GPX1;GLI3;PAQR8;E2F7;DLG5;CNTN1;KITLG;ASAP1;PDPN;KRT15;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;FLNC;LTBP4;ADIRF;CLMN;UGT8;CPS1;LAMA3;CAV1;GLI2;RBFOX2;TRIB2;SPATA6;DOCK11;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;ULK2;TP53INP1;PPDPF;HMGA2;CAMK2D;ADGRG6;ITGA1;MST1R;IL31RA;SPATA20;CCK;PIK3R1;SYT1;CAPRIN2;CREB3L2;CPT1A;ANG;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;ANK3;MDFI;SPRY2;LAMB3;TTN;PRDM8;JARID2;HPS4;FBLN1;TP73;CAT;CASP14;KLF13;S1PR5;METRN;ROBO1;WDFY2;IFT140;PRX;TLR3;FLOT2;ADAMTS7;FZD7;GLG1;PAQR7;SH3TC2;PLXNA2;PTPRU;FGFR1;CBR1;IGF1R;LMNA;ALOX15B;DKK1;CTF1;SEMA4A;LTBP3;RGS2;TGFBI;SETX;PDE4D;PSMB9;IL18;OBSCN;SULF1;G6PD;MYOF;EPHB6;EDA2R;FZD8;CCDC136;SOX13;TRIOBP;DHTKD1;KDM4C;NFATC4;FOXN3;RAPH1;SEPT6;TGFBR3;DLX3;FZD1;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;CALR;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;CST3;DLK2;MEIS2;AREG;IFNK;TCF4;AKAP13;SNX10;CITED2;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;NFASC;CRTC1;NDRG1;PLAG1;PRKCA;MYBL1;BCHE;ANXA2;RGS14;RAB13;FNDC3A;LEPR;TCF12;PODXL;NAB2;MEGF8;TAF8;CDH11;RET;ZFPM1;TGFB2;RBL2;ODF2;DLX2;COL12A1;LEF1;THRA;SSBP3;FHL1;ZADH2;ITM2A;ULK1;AGRN;NPHP3;RHBDD1;MAGI2;KIAA1109;HSPA5;TH;GOPC;SLC9A4;BOC;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;CCHCR1;CFAP54;IFT74;IFITM1;OPHN1;TPGS1;SH2B3;MYO9A;YAP1;GDNF;DNAH1;KLF5;TWIST2;ATRAID;PRRC2B;DIXDC1;PPARG;MEF2A;KLF7;OBSL1;POSTN;UNK;LGALS3;ARL3;NYAP1;RARA;ECM2;COL4A1;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;RASA1;KRT10;ETV4;FOS;DNPH1;KDM4A;CDK5RAP3;AGO4;FAM120B;MED12;MYH11;NIPBL;CELSR1;RXRA;ABCA5;DOCK1;DMPK;LAMB2
6755,GO:0030198,2.96059842382463e-17,1,73,212,extracellular matrix organization,BP,ITGB6;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;ITGB5;COL8A1;CTGF;ADAM19;FBN1;ITGA6;APBB2;ITGB4;COL5A2;NID1;COL7A1;GAS6;FBN2;SULF2;COL5A1;LAMB1;THBS2;SERPINE1;SERPINH1;MFAP5;TIMP2;COL18A1;ITGA2;PDGFA;MMP19;TIMP1;EFEMP2;PHLDB1;COL4A4;ITGA3;LAMC2;ERO1B;PDPN;CCDC80;CTSV;LRP1;LAMA3;ITGA10;ITGA1;LAMA5;LAMB3;FBLN1;THSD4;COL16A1;FSCN1;TGFBI;SULF1;ENG;CST3;COL5A3;SOX9;ANXA2;TGFB2;COL12A1;AGRN;NPHP3;ITGB8;OLFML2A;POSTN;ECM2;COL4A1;SERPINB5;MATN3;MYH11;ADAM10;LAMB2
12332,GO:0048731,3.90599609178803e-17,1,455,2934,system development,BP,SERPINE2;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;TXNIP;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;CD109;CDKN2B;ZFP36L1;APBB2;MYH15;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;SDK1;TNIK;ANPEP;NOS1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;UTRN;ROR1;AXL;DPYSL2;EGFR;TSC22D3;TMEM204;ITPK1;LAMB1;FLRT3;TCHH;SPEG;SPTB;SLC8A1;NTM;MYLK;CSMD3;GJC2;THBS2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;KRT14;TCF7L1;STON2;RNF165;VIM;NUPR1;CSPG4;EVC;FAM210B;MFAP5;AMIGO2;STMN3;TIMP2;TENM3;CXCL14;PAK1;ANGPTL4;VDR;PTPRM;BMP4;NEFM;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;NEFL;VAV3;PDCD4;COL18A1;STAT1;BTBD2;SORL1;NEO1;SCN2A;LGALS1;ETV1;KRT13;PTPRS;WWTR1;PRICKLE1;DDIT3;LTBP1;MEF2D;KRT5;WNK1;EFHC1;DLG4;SLC7A11;SEMA5A;ITGA2;PDGFA;MAP2;MMP19;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;COL4A4;GPNMB;TFDP2;SMOC1;CRIM1;CUL7;BTG1;ITGA3;SIK1;PCDHAC2;TPBG;ANO6;GPX1;LAMC2;GLI3;E2F7;DLG5;CNTN1;KITLG;NAV2;ASAP1;PLLP;PDPN;KRT15;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;FUT10;CLMN;UGT8;CPS1;CAV1;GLI2;RBFOX2;DOCK11;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TNS2;PPDPF;HMGA2;CAMK2D;ADGRG6;ITGA1;IL31RA;PTPN14;CCK;PIK3R1;SYT1;SLC38A10;CAPRIN2;CREB3L2;ALDH3A2;SLC38A2;ACACB;PCLO;ANG;KIF17;PARVA;LAMA5;UNC5B;BBS2;ANK3;WFS1;MDFI;SPRY2;TTN;PRDM8;JARID2;TP73;CAT;CASP14;SHROOM4;DLC1;KLF13;S1PR5;PRKACB;AARS;METRN;ROBO1;IFT140;SPRY4;LRIG3;PRX;PHF2;TLR3;SNCA;ADAMTS7;MME;FZD7;GLG1;SH3TC2;PLXNA2;PTPRU;FGFR1;LMNA;ALOX15B;DKK1;CTF1;SEMA4A;C5;TGFBI;SETX;MYO3B;TGM2;PSMB9;IL18;SULF1;G6PD;FZD8;SOX13;TRIOBP;DHTKD1;KDM4C;CDH13;NFATC4;FOXN3;RAPH1;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;L3MBTL3;NAGLU;PBX1;ENG;FOXL1;BBS4;CALR;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;SNX10;CITED2;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;TRAK1;CD1D;FBXW8;SYNE2;HDAC11;POGLUT1;CRIP2;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;COL5A3;NRK;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;GCNT1;PLAG1;PRKCA;SALL2;ZNF358;BCHE;PRPS2;ANXA2;RGS14;RAB13;ETNK2;FNDC3A;HOXA1;LEPR;STOX2;PGAP1;TSHZ1;IGFBP4;TCF25;TCF12;PODXL;ZNF160;NAB2;MEGF8;NLGN4Y;ATXN1;STK36;WDR19;CDH11;RET;ZFPM1;TGFB2;MAP2K5;DLX2;COL12A1;SMG9;AMOTL2;IFT122;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;LRRN3;ITM2A;SP100;ULK1;AGRN;NPHP3;VAV2;MAGI2;HSPA5;TH;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;ARHGEF19;IFT74;TACC2;OPHN1;SH2B3;YAP1;GDNF;KLF5;KLHL3;ATRAID;SRR;HOXA3;DIXDC1;PPARG;CALCRL;MEF2A;KLF7;SASH1;OBSL1;POSTN;UNK;LGALS3;PTPN3;ARL3;NYAP1;RARA;ECM2;COL4A1;TAF1;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;SBF2;RASA1;ANKH;KRT10;FOS;KDM4A;CDK5RAP3;AGO4;SERPINB5;MATN3;MED12;NPAS2;ABAT;MYH11;NIPBL;TTBK2;ADM2;BSN;PCDHGB5;OXTR;RHOBTB3;CELSR1;RXRA;DGCR6;TAOK3;MOSPD3;LAMB2
4281,GO:0009653,4.14720822102501e-17,1,304,1695,anatomical structure morphogenesis,BP,SERPINE2;FLOT1;MMP2;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;ITGB5;COL8A1;CTGF;FBN1;SOX6;ITGA6;SFRP1;CD109;RHOBTB2;ZFP36L1;APBB2;F2R;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;COL5A2;ETV5;GJA5;PKD2;IRS2;DUSP6;IGF2BP2;SDK1;TNIK;ANPEP;COL7A1;CLTCL1;NOS1;FBN2;PDGFC;SNAI2;MAGED1;MAP6;SULF2;COL5A1;ROR1;AXL;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;DOCK5;MYLK;SYNE3;THBS2;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;S100A10;RNF165;CSPG4;TENM3;PAK1;ANGPTL4;VDR;PTPRM;BMP4;EIF2AK4;NEFL;VAV3;PDCD4;COL18A1;STAT1;NEO1;ETV1;ARAP1;KRT13;PTPRS;WWTR1;PRICKLE1;MEF2D;DLG4;SEMA5A;ITGA2;PDGFA;MAP2;MMP19;ADARB1;PHLDB1;GPNMB;CUL7;BTG1;ITGA3;SNX1;GPX1;GLI3;E2F7;DLG5;PDPN;CTSV;SPG11;PLXNB1;LRP1;FYN;XDH;ARHGAP18;UGT8;LAMA3;CAV1;GLI2;RBFOX2;AHNAK2;UST;CLU;PRKCZ;SLIT3;FBXW4;ULK2;ARPIN;HMGA2;ADGRG6;ITGA1;PTPN14;CCK;PIK3R1;SYT1;CAPRIN2;ANG;DUSP5;PARVA;LAMA5;UNC5B;BBS2;ANK3;MDFI;SPRY2;LAMB3;TTN;FBLN1;DLC1;PRKACB;METRN;ROBO1;IFT140;LRIG3;PRX;TLR3;FZD7;GLG1;PLXNA2;FGFR1;DKK1;FSCN1;SEMA4A;C5;TGFBI;ASTN2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;MYOF;FZD8;CCDC136;SOX13;TRIOBP;KDM4C;CDH13;NFATC4;FOXN3;RAPH1;TGFBR3;DLX3;FZD1;AMOTL1;NAGLU;PBX1;ENG;FOXL1;BBS4;CALR;MKLN1;ATM;EFNB3;MDM2;FAM20A;CST3;AREG;AKAP13;CITED2;NR2F2;PLXNA1;FHOD3;LMO4;TRAK1;FBXW8;FGD4;POGLUT1;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;SOX9;ISL1;BCL6;PRCP;NFASC;GCNT1;PLAG1;PRKCA;ZNF358;ANXA2;HOXA1;LEPR;TSHZ1;TTC8;PODXL;NAB2;MEGF8;WDR19;CDH11;RET;ZFPM1;TGFB2;MAP2K5;DLX2;COL12A1;STAT2;AMOTL2;IFT122;LIG1;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;SP100;ULK1;NPHP3;VAV2;MAGI2;HSPA5;TH;BOC;PIKFYVE;TGFB1I1;FLNB;SRPK2;SEMA4B;ITGB8;ARHGEF19;OPHN1;MYO9A;YAP1;GDNF;KLF5;KLHL3;HOXA3;PPARG;INF2;CALCRL;MEF2A;KLF7;SASH1;OBSL1;POSTN;UNK;NYAP1;RARA;ECM2;COL4A1;PBX2;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;PPP3CA;RASA1;AGO4;SERPINB5;MED12;MYH11;NIPBL;TTBK2;ADM2;RHOBTB3;CELSR1;RXRA;DGCR6;DOCK1;LAMB2
10279,GO:0043062,1.65183974272732e-16,1,77,241,extracellular structure organization,BP,ITGB6;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;ITGB5;COL8A1;CTGF;ADAM19;FBN1;ITGA6;APBB2;ITGB4;COL5A2;NID1;COL7A1;GAS6;FBN2;SULF2;COL5A1;LAMB1;THBS2;SERPINE1;SERPINH1;MFAP5;TIMP2;ABCA1;COL18A1;ITGA2;PDGFA;MMP19;TIMP1;ACSL3;EFEMP2;PHLDB1;COL4A4;ITGA3;LAMC2;ERO1B;PDPN;CCDC80;CTSV;LRP1;LAMA3;ITGA10;ITGA1;LAMA5;LAMB3;FBLN1;PRKACB;THSD4;COL16A1;FSCN1;TGFBI;SULF1;ENG;CST3;COL5A3;SOX9;ANXA2;TGFB2;COL12A1;AGRN;NPHP3;ITGB8;OLFML2A;POSTN;ECM2;COL4A1;SERPINB5;MATN3;MYH11;ADAM10;ABCA5;LAMB2
15734,GO:0072359,8.08978306161555e-16,1,152,676,circulatory system development,BP,MMP2;FN1;FLRT2;CCBE1;COL8A1;CTGF;ADAM19;FBN1;SOX6;SFRP1;ZFP36L1;FAT4;TGFBR2;TENM4;GJA5;PKD2;JPH2;DUSP6;ANPEP;SNAI2;COL5A1;EGFR;TMEM204;FLRT3;SLC8A1;MYLK;THBS2;ACTA2;SERPINE1;RNF213;CSPG4;PAK1;ANGPTL4;PTPRM;BMP4;VAV3;PDCD4;COL18A1;STAT1;PRICKLE1;DDIT3;LTBP1;MEF2D;SEMA5A;PDGFA;MMP19;GPNMB;TFDP2;CUL7;BTG1;ITGA3;SIK1;GPX1;GLI3;E2F7;PDPN;LRP1;XDH;CAV1;GLI2;HMGA2;ADGRG6;PTPN14;ACACB;ANG;PARVA;LAMA5;UNC5B;SPRY2;TTN;JARID2;TP73;DLC1;ROBO1;IFT140;TLR3;FZD7;FGFR1;LMNA;DKK1;SEMA4A;C5;TGFBI;IL18;SULF1;G6PD;FZD8;CDH13;NFATC4;TGFBR3;DLX3;FZD1;AMOTL1;ENG;FOXL1;BBS4;CALR;ATM;MDM2;AKAP13;CITED2;NR2F2;FHOD3;LMO4;FBXW8;POGLUT1;VANGL2;EGR1;SOX9;ISL1;PRCP;PRKCA;ANXA2;HOXA1;LEPR;TCF25;MEGF8;ZFPM1;TGFB2;MAP2K5;SMG9;AMOTL2;IFT122;LEF1;SP100;NPHP3;VAV2;TH;SRPK2;ITGB8;IFT74;YAP1;KLF5;HOXA3;PPARG;CALCRL;MEF2A;SASH1;OBSL1;RARA;COL4A1;FZD4;SLITRK5;ADGRA2;RASA1;MED12;MYH11;NIPBL;ADM2;OXTR;RXRA;MOSPD3
4332,GO:0009888,2.06010895639716e-15,1,225,1225,tissue development,BP,SERPINE2;FLOT1;MMP2;KRT4;FN1;MMP9;TXNIP;ITGB5;COL8A1;CTGF;SOX6;ITGA6;SFRP1;CD109;ZFP36L1;MYH15;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;DUSP6;COL7A1;GAS6;APCDD1;FBN2;SNAI2;MAGED1;SULF2;COL5A1;ROR1;EGFR;TSC22D3;ITPK1;LAMB1;FLRT3;TCHH;SLC8A1;MYLK;ACTA2;SERPINE1;SERPINH1;KRT14;VIM;NUPR1;EVC;PAK1;VDR;BMP4;PTK6;PDCD4;COL18A1;STAT1;MEST;KRT13;PTPRS;WWTR1;PRICKLE1;MEF2D;KRT5;SLC7A11;ITGA2;PDGFA;PPL;ADARB1;TIMP1;FLG;PHLDB1;GPNMB;CUL7;BTG1;ITGA3;SIK1;EMP1;ANO6;GPX1;LAMC2;GLI3;E2F7;DLG5;KITLG;PDPN;KRT15;CTSV;XDH;CPS1;LAMA3;CAV1;GLI2;FBXW4;HMGA2;IL31RA;CREB3L2;ALDH3A2;CPT1A;DUSP5;LAMA5;BBS2;SPRY2;LAMB3;TTN;JARID2;TP73;CAT;CASP14;DLC1;PRKACB;ROBO1;IFT140;FLOT2;ADAMTS7;FZD7;GLG1;PLXNA2;FGFR1;CBR1;LMNA;ALOX15B;DKK1;SEMA4A;TGFBI;ASTN2;PDE4D;TGM2;PSMB9;SULF1;G6PD;EDA2R;TRIOBP;NFATC4;TGFBR3;DLX3;FZD1;LRTOMT;PBX1;ENG;FOXL1;BBS4;CALR;ATM;MDM2;FAM20A;CST3;AREG;AKAP13;CITED2;NR2F2;PLXNA1;FHOD3;LMO4;MAF;FBXW8;POGLUT1;VANGL2;KLHL12;NRK;EGR1;SOX9;ENPP1;ISL1;GCNT1;SALL2;ZNF358;RAB13;FNDC3A;PODXL;NAB2;MEGF8;WDR19;RET;ZFPM1;TGFB2;DLX2;COL12A1;IFT122;GPR161;LEF1;THRA;SSBP3;NPHP3;MAGI2;KIAA1109;SLC9A4;TGFB1I1;FLNB;SEMA4B;ITGB8;ARHGEF19;IFT74;OPHN1;MYO9A;YAP1;GDNF;KLF5;COL17A1;KLHL3;ATRAID;HOXA3;PPARG;MEF2A;OBSL1;POSTN;LGALS3;RARA;COL4A1;FZD4;PPP3CA;ANKH;KRT10;FOS;DNPH1;SERPINB5;MED12;MYH11;PPP2R3A;CELSR1;RXRA;LAMB2
3375,GO:0007155,1.82552840749932e-14,1,164,792,cell adhesion,BP,SERPINE2;ITGB6;FLOT1;FN1;PCDH7;FLRT2;ITGB5;COL8A1;CTGF;FBN1;ITGA6;SFRP1;ZFP36L1;TLN2;FAT4;TGFBR2;ITGB4;TENM4;IL20RB;GSN;NID1;SDK1;COL7A1;BCAM;GAS6;SNAI2;COL5A1;UTRN;AXL;EGFR;LAMB1;FLRT3;NTM;CLCA2;DOCK5;THBS2;SERPINE1;S100A10;PSTPIP1;CTNNAL1;CNTNAP3;AMIGO2;TENM3;PAK1;PTPRM;BMP4;LAMB4;VAV3;COL18A1;NEO1;LGALS1;PTPRS;PYCARD;IL32;SLC7A11;SEMA5A;ITGA2;GPNMB;ITGA3;PCDHAC2;TPBG;LAMC2;GLI3;DLG5;CNTN1;KITLG;PDPN;SRPX;CCDC80;PLXNB1;FYN;LAMA3;FAT2;CAV1;GLI2;ITGA10;MAP3K14;NPHP4;PRKCZ;ITGA1;PXN;PIK3R1;PARVA;LAMA5;ANK3;LAMB3;TMEM8B;LMO7;FBLN1;DLC1;ROBO1;FLOT2;FRMD5;FZD7;PLXNA2;COL16A1;PTPRU;PAG1;TGFBI;TGM2;IL18;TRO;TRIOBP;CDH13;CD99L2;ITGBL1;ENG;CALR;MKLN1;NEGR1;EFNB3;ARF6;CITED2;PLXNA1;CD1D;COL5A3;SOX9;ITPKB;BCL6;PCDHGA11;NFASC;GCNT1;PRKCA;ANXA2;FNDC3A;CNTNAP3B;PODXL;NLGN4Y;PRNP;CDH11;RET;TGFB2;MAP2K5;COL12A1;LEF1;CDKN2A;IGFBP2;MAGI1;BOC;TGFB1I1;ITGB8;IFT74;COL17A1;POSTN;LGALS3;MIA3;RARA;ECM2;EFNA5;FZD4;ZBTB1;PDZD2;RASA1;ELMO2;ABAT;CERCAM;PCDHGB5;ADAM10;CELSR1;MPDZ;S100A11;DGCR6;DOCK1;LAMB2
6586,GO:0022610,2.33275964648153e-14,1,164,795,biological adhesion,BP,SERPINE2;ITGB6;FLOT1;FN1;PCDH7;FLRT2;ITGB5;COL8A1;CTGF;FBN1;ITGA6;SFRP1;ZFP36L1;TLN2;FAT4;TGFBR2;ITGB4;TENM4;IL20RB;GSN;NID1;SDK1;COL7A1;BCAM;GAS6;SNAI2;COL5A1;UTRN;AXL;EGFR;LAMB1;FLRT3;NTM;CLCA2;DOCK5;THBS2;SERPINE1;S100A10;PSTPIP1;CTNNAL1;CNTNAP3;AMIGO2;TENM3;PAK1;PTPRM;BMP4;LAMB4;VAV3;COL18A1;NEO1;LGALS1;PTPRS;PYCARD;IL32;SLC7A11;SEMA5A;ITGA2;GPNMB;ITGA3;PCDHAC2;TPBG;LAMC2;GLI3;DLG5;CNTN1;KITLG;PDPN;SRPX;CCDC80;PLXNB1;FYN;LAMA3;FAT2;CAV1;GLI2;ITGA10;MAP3K14;NPHP4;PRKCZ;ITGA1;PXN;PIK3R1;PARVA;LAMA5;ANK3;LAMB3;TMEM8B;LMO7;FBLN1;DLC1;ROBO1;FLOT2;FRMD5;FZD7;PLXNA2;COL16A1;PTPRU;PAG1;TGFBI;TGM2;IL18;TRO;TRIOBP;CDH13;CD99L2;ITGBL1;ENG;CALR;MKLN1;NEGR1;EFNB3;ARF6;CITED2;PLXNA1;CD1D;COL5A3;SOX9;ITPKB;BCL6;PCDHGA11;NFASC;GCNT1;PRKCA;ANXA2;FNDC3A;CNTNAP3B;PODXL;NLGN4Y;PRNP;CDH11;RET;TGFB2;MAP2K5;COL12A1;LEF1;CDKN2A;IGFBP2;MAGI1;BOC;TGFB1I1;ITGB8;IFT74;COL17A1;POSTN;LGALS3;MIA3;RARA;ECM2;EFNA5;FZD4;ZBTB1;PDZD2;RASA1;ELMO2;ABAT;CERCAM;PCDHGB5;ADAM10;CELSR1;MPDZ;S100A11;DGCR6;DOCK1;LAMB2
3496,GO:0007399,2.82479234989171e-14,1,262,1466,nervous system development,BP,SERPINE2;FLOT1;TRNP1;FN1;FLRT2;SOX6;MARVELD1;SFRP1;ZFP36L1;APBB2;DDIT4;FAT4;TGFBR2;SLITRK6;TENM4;GSN;ETV5;PKD2;IRS2;SDK1;TNIK;NOS1;GAS6;APCDD1;PDGFC;MALL;MAP6;SULF2;ROR1;AXL;DPYSL2;EGFR;ITPK1;LAMB1;FLRT3;SPTB;SLC8A1;NTM;CSMD3;GJC2;THBS2;DOK1;TCF7L1;RNF165;VIM;CSPG4;AMIGO2;STMN3;TIMP2;TENM3;PAK1;PTPRM;BMP4;NEFM;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;NEFL;BTBD2;SORL1;NEO1;SCN2A;LGALS1;ETV1;PTPRS;PRICKLE1;MEF2D;WNK1;EFHC1;DLG4;SLC7A11;SEMA5A;MAP2;ADARB1;ACSL3;PHGDH;CRIM1;CUL7;ITGA3;PCDHAC2;TPBG;GLI3;DLG5;CNTN1;NAV2;ASAP1;PLLP;CTSV;SPG11;PLXNB1;LRP1;FYN;FUT10;CLMN;UGT8;GLI2;RBFOX2;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;ULK2;CAMK2D;ADGRG6;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;ALDH3A2;SLC38A2;PCLO;KIF17;UNC5B;BBS2;ANK3;PRDM8;JARID2;TP73;SHROOM4;DLC1;S1PR5;PRKACB;AARS;METRN;ROBO1;IFT140;PRX;SNCA;FZD7;SH3TC2;PLXNA2;FGFR1;DKK1;CTF1;SEMA4A;SETX;SULF1;G6PD;FZD8;TRIOBP;KDM4C;NFATC4;RAPH1;FZD1;LRTOMT;NAGLU;PBX1;ENG;BBS4;CALR;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;CST3;AREG;TCF4;NR2F2;PLXNA1;LMO4;TRAK1;FBXW8;SYNE2;HDAC11;VANGL2;ARHGEF2;NTNG1;SDC2;NRK;SSH1;SOX9;IFT27;ISL1;BCL6;PCDHGA11;NFASC;CRTC1;NDRG1;PLAG1;PRKCA;SALL2;ZNF358;BCHE;RGS14;RAB13;HOXA1;PGAP1;TCF12;NAB2;MEGF8;NLGN4Y;ATXN1;STK36;WDR19;CDH11;RET;TGFB2;DLX2;SMG9;IFT122;GPR161;LEF1;THRA;SSBP3;LRRN3;ITM2A;ULK1;AGRN;NPHP3;MAGI2;HSPA5;TH;BOC;PIKFYVE;SEMA4B;TACC2;OPHN1;YAP1;GDNF;SRR;HOXA3;DIXDC1;PPARG;MEF2A;KLF7;OBSL1;POSTN;UNK;ARL3;NYAP1;RARA;ECM2;COL4A1;TAF1;EFNA5;FZD4;SLITRK5;ADGRA2;PPP3CA;SBF2;FOS;KDM4A;CDK5RAP3;MED12;NPAS2;ABAT;NIPBL;TTBK2;BSN;PCDHGB5;OXTR;CELSR1;TAOK3;LAMB2
10861,GO:0044420,6.20664991708916e-13,1,39,83,extracellular matrix component,CC,FN1;COL8A1;FBN1;ITGA6;COL5A2;NID1;COL7A1;FBN2;COL5A1;LAMB1;THBS2;MFAP5;LAMB4;COL18A1;LTBP1;TIMP1;EFEMP2;COL4A4;SMOC1;LAMC2;P3H2;CCDC80;LAMA3;ANG;LAMA5;LAMB3;FBLN1;THSD4;TGFBI;CST3;COL5A3;ANXA2;COL12A1;AGRN;COL17A1;ADAMTSL5;COL4A1;EFNA5;LAMB2
12217,GO:0048513,9.38350199394853e-13,1,330,2125,animal organ development,BP,SERPINE2;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FLRT2;MMP9;CCBE1;TXNIP;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;CD109;CDKN2B;ZFP36L1;MYH15;DDIT4;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;COL5A2;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;SDK1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;MAGED1;SULF2;COL5A1;UTRN;ROR1;AXL;DPYSL2;EGFR;TSC22D3;LAMB1;FLRT3;TCHH;SPEG;SLC8A1;MYLK;GJC2;ACTA2;SERPINE1;SERPINH1;KRT14;STON2;VIM;NUPR1;EVC;FAM210B;MFAP5;AMIGO2;TENM3;CXCL14;PAK1;VDR;PTPRM;BMP4;NEFL;PDCD4;COL18A1;STAT1;LGALS1;ETV1;KRT13;PTPRS;WWTR1;PRICKLE1;LTBP1;MEF2D;KRT5;EFHC1;SLC7A11;SEMA5A;ITGA2;PDGFA;MMP19;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;COL4A4;GPNMB;TFDP2;SMOC1;CUL7;ITGA3;SIK1;ANO6;GPX1;GLI3;E2F7;DLG5;CNTN1;KITLG;PDPN;KRT15;CTSV;PLXNB1;KCNAB2;LRP1;FYN;XDH;FUT10;CPS1;CAV1;GLI2;RBFOX2;DOCK11;SMARCA1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;TNS2;PPDPF;HMGA2;ADGRG6;IL31RA;PIK3R1;SYT1;SLC38A10;CREB3L2;SLC38A2;ACACB;ANG;PARVA;LAMA5;BBS2;WFS1;MDFI;SPRY2;TTN;JARID2;TP73;CAT;CASP14;SHROOM4;DLC1;KLF13;AARS;ROBO1;IFT140;SPRY4;LRIG3;PHF2;TLR3;ADAMTS7;MME;FZD7;GLG1;PLXNA2;PTPRU;FGFR1;LMNA;ALOX15B;DKK1;CTF1;SEMA4A;TGFBI;MYO3B;TGM2;PSMB9;IL18;SULF1;G6PD;FZD8;SOX13;TRIOBP;DHTKD1;NFATC4;FOXN3;TGFBR3;DLX3;FZD1;LRTOMT;L3MBTL3;NAGLU;PBX1;ENG;FOXL1;BBS4;CALR;ATM;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;AKAP13;SNX10;CITED2;NR2F2;PLXNA1;FHOD3;IFNE;LMO4;MAF;CD1D;FBXW8;SYNE2;POGLUT1;CRIP2;VANGL2;KLHL12;COL5A3;NRK;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;GCNT1;PLAG1;PRKCA;SALL2;PRPS2;ANXA2;RAB13;ETNK2;FNDC3A;HOXA1;LEPR;STOX2;PGAP1;TSHZ1;TCF25;TCF12;PODXL;ZNF160;NAB2;MEGF8;ATXN1;STK36;WDR19;RET;ZFPM1;TGFB2;MAP2K5;DLX2;SMG9;IFT122;LIPA;LEF1;THRA;SSBP3;FHL1;ITM2A;NPHP3;MAGI2;HSPA5;TH;TGFB1I1;RSAD2;FLNB;SEMA4B;ITGB8;ARHGEF19;IFT74;TACC2;OPHN1;SH2B3;YAP1;GDNF;KLF5;KLHL3;ATRAID;SRR;HOXA3;DIXDC1;PPARG;CALCRL;MEF2A;OBSL1;LGALS3;PTPN3;ARL3;RARA;COL4A1;TAF1;FZD4;SLITRK5;ZBTB1;PPP3CA;ANKH;KRT10;FOS;CDK5RAP3;AGO4;SERPINB5;MED12;ABAT;MYH11;NIPBL;TTBK2;OXTR;RHOBTB3;CELSR1;RXRA;DGCR6;MOSPD3;LAMB2
1253,GO:0003008,1.05232950104428e-12,1,158,804,system process,BP,SERPINE2;CCBE1;ITGB5;CTGF;F2R;TNNI2;SLITRK6;PTGS1;EFEMP1;TENM4;ANO1;GSN;GJA5;ANPEP;NOS1;GAS6;SNAI2;SULF2;UTRN;ROR1;EGFR;SLC8A1;DOCK5;MYLK;ACTA2;VIM;NTSR1;PAK1;VDR;BMP4;SCN8A;TBC1D8;EIF2AK4;NETO1;NEFL;COL18A1;STAT1;SCN2A;KCNMA1;WNK1;DLG4;ITGA2;NISCH;ADARB1;DOCK4;ITGA3;GPX1;NAV2;MTHFR;MAGED2;EML2;KCNAB2;FYN;CPS1;CAV1;RBFOX2;PLA2G6;ESPN;AHNAK2;SERPING1;PRKCZ;EHD3;CAMK2D;ITGA1;PXN;CCK;DYSF;BBS2;ANK3;WFS1;SPRY2;TTN;JARID2;SHROOM4;PRKACB;AARS;KCNJ5;PRX;MME;NIPSNAP1;FGFR1;LMNA;DKK1;RGS2;TGFBI;PDE4D;MYO3B;SULF1;G6PD;MYOF;TRIOBP;SLC24A1;LMCD1;LRTOMT;BBS4;MDM2;MEIS2;BBS1;ANXA6;AKAP13;GCLC;NR2F2;RNPEP;SOX9;PRCP;NFASC;CRTC1;PRKCA;BCHE;RGS14;HOXA1;METTL23;PGAP1;TTC8;NFAT5;NLGN4Y;ATXN1;HTR1B;WDR19;PRNP;TGFB2;OR2A4;SCNN1A;LEF1;THRA;ALDH7A1;CYP4V2;TH;CELF2;SLC9A4;REEP2;ITPR2;MYO9A;CACNB1;GDNF;KLHL3;PPARG;CALCRL;KCNIP3;MEF2A;OBSL1;POSTN;TSHZ3;FZD4;PPP3CA;FOS;KDM4A;CACNA2D3;SCPEP1;ABAT;MYH11;NIPBL;ADM2;OXTR;TUSC3;SNTB1;DMPK;LAMB2
12284,GO:0048646,5.55009455970209e-12,1,143,689,anatomical structure formation involved in morphogenesis,BP,FLOT1;MMP2;HTRA1;FN1;MMP9;CCBE1;ITGB5;COL8A1;CTGF;ITGA6;SFRP1;CD109;TGFBR2;ITGB4;TENM4;COL5A2;GJA5;DUSP6;SDK1;ANPEP;COL7A1;NOS1;FBN2;SNAI2;COL5A1;LAMB1;THBS2;RFX2;SERPINE1;RNF213;CSPG4;ANGPTL4;PTPRM;BMP4;VAV3;COL18A1;STAT1;PRICKLE1;SEMA5A;ITGA2;PDGFA;MMP19;PHLDB1;GPNMB;BTG1;ITGA3;GPX1;GLI3;E2F7;PDPN;UGT8;LAMA3;CAV1;GLI2;AHNAK2;HMGA2;ADGRG6;PTPN14;ANG;DUSP5;PARVA;LAMA5;UNC5B;SPRY2;LAMB3;TTN;DLC1;PRKACB;ROBO1;PRX;TLR3;FZD7;PLXNA2;FGFR1;DKK1;SEMA4A;C5;TGFBI;TGM2;IL18;OBSCN;SULF1;MYOF;FZD8;CCDC136;KDM4C;CDH13;NFATC4;TGFBR3;FZD1;AMOTL1;ENG;BBS4;ATM;FAM20A;AKAP13;CITED2;FHOD3;LMO4;POGLUT1;VANGL2;KLHL12;SOX9;ISL1;BCL6;PRCP;NFASC;PRKCA;ANXA2;HOXA1;LEPR;PODXL;RET;ZFPM1;TGFB2;MAP2K5;COL12A1;AMOTL2;IFT122;LEF1;SSBP3;SP100;NPHP3;VAV2;PIKFYVE;SRPK2;ITGB8;OPHN1;GDNF;KLF5;HOXA3;PPARG;CALCRL;MEF2A;SASH1;OBSL1;RARA;COL4A1;ADGRA2;MED12;MYH11;ADM2;CELSR1
10862,GO:0044421,1.14562176046311e-11,1,339,2508,extracellular region part,CC,SERPINE2;CPA4;ITGB6;TNFRSF6B;FLOT1;MMP2;PRSS23;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;GPRC5A;ITGB5;COL8A1;CTGF;FBN1;ITGA6;SFRP1;MMP28;CD109;NQO1;FAT4;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;EFEMP1;SLC7A8;ANO1;GSN;COL5A2;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;COL7A1;BCAM;CLTCL1;DNAJB4;GAS6;FBN2;PDGFC;SULF2;COL5A1;UTRN;ARHGAP23;TFPI2;AXL;DPYSL2;EGFR;SDC3;HSPA2;LAMB1;FLRT3;FKBP5;MYLK;SLC2A3;THBS2;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;CRTAP;S100A10;ANXA5;C1QTNF6;VIM;CSPG4;TKFC;MAMDC2;MFAP5;TOM1L2;TIMP2;PDLIM2;PLEC;CXCL14;ABCA1;ANGPTL4;BMP4;LAMB4;ITM2C;TP53I3;PCSK1;AHNAK;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;LTBP1;KRT5;IL32;SEC14L2;MUC19;ARMC9;SEMA5A;ZCCHC11;PDGFA;FRMD4B;MMP19;PPL;TIMP1;EFEMP2;PHGDH;COL4A4;SMOC1;CRIM1;ITGA3;ELFN2;ANO6;GPX1;LAMC2;CNTN1;KITLG;P3H2;NAV2;ECH1;PLLP;CTDSPL;ABHD14B;CCDC80;KRT15;CTSV;SPG11;ARHGEF12;XDH;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;IGFL1;PLA2G6;CLU;SERPING1;SNX29;PRKCZ;SLIT3;PARP4;PRDX5;ITGA1;SYTL1;METTL7A;PDIA4;CCK;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;LAMB3;CES2;TTN;APLP2;CRELD2;FBLN1;CAT;CASP14;PRKACB;AARS;METRN;LRIG3;STOM;BPHL;MAN1A1;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GLG1;JADE2;COL16A1;CBR1;ALOX15B;DKK1;FSCN1;CTF1;SEMA4A;LTBP3;C5;TGFBI;SETX;TGM2;PSMB9;IL18;SULF1;PLA2R1;G6PD;MYOF;ARSD;CDH13;MAGEF1;ITGBL1;LMCD1;TGFBR3;NAGLU;ENG;MTMR4;CALR;NEGR1;IDH2;ARF6;FAM20A;TMED10;CST3;DLK2;AREG;IFNK;ANXA6;PLXNA1;HEXA;IFNE;IGFL2;AKR7A2;HSPA12A;SYNE2;HDAC11;RNPEP;POGLUT1;CRIP2;CPNE8;SDC2;COL5A3;THNSL2;UCN2;ENPP1;PLD3;PRCP;NFASC;NDRG1;GCNT1;PRKCA;BCHE;PRPS2;ANXA2;TMC4;RAB13;CES3;ADAMTS15;MAN2B1;LANCL1;IGFBP4;ALDH9A1;MVB12B;GAL3ST4;PODXL;DECR1;MEGF8;UACA;IRF2BPL;RAB43;PRNP;CDH11;TGFB2;RBL2;DNASE1L1;COL12A1;SCNN1A;LIPA;LRRN3;ALDH7A1;ITM2A;EFR3A;OSBPL1A;AGRN;IGFBP2;HSPA5;REEP2;TGFB1I1;FLNB;SEMA4B;ITGB8;NAPRT;MON2;VPS13C;UGT1A6;COL17A1;CAPS;GALNT2;CAPG;ADAMTSL5;SNX9;OLFML2A;POSTN;LGALS3;ARL3;DNAJC3;RASSF9;ECM2;COL4A1;CCNY;PRKAG1;EFNA5;FZD4;SLITRK5;PEX1;KRT10;ACTR1B;PPCS;DNPH1;SERPINB5;SCPEP1;MATN3;ABAT;MYH11;NIPBL;VPS36;TTBK2;PCDHGB5;ADAM10;RHOBTB3;S100A11;MYO1C;DGCR6;ACAA2;CTSD;LAMB2
12585,GO:0050793,1.16455428453475e-11,1,268,1648,regulation of developmental process,BP,SERPINE2;SULT1E1;FLOT1;FN1;FLRT2;CCBE1;CTGF;FBN1;SOX6;INPP5D;SFRP1;CD109;RHOBTB2;ZFP36L1;FAT4;TGFBR2;SLITRK6;EFEMP1;TENM4;COL5A2;ETV5;JPH2;DUSP6;ZFP36L2;SDK1;TNIK;NOS1;GAS6;FBN2;SNAI2;MAGED1;SULF2;COL5A1;ROR1;AXL;DPYSL2;EGFR;TSC22D3;FLRT3;SLC8A1;DOCK5;SYNE3;CSMD3;GJC2;THBS2;SERPINE1;S100A10;VIM;NUPR1;FAM210B;AMIGO2;TIMP2;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;VDR;PTPRM;BMP4;ITM2C;NR1D1;PTK6;EIF2AK4;NEFL;PDCD4;STAT1;SORL1;LGALS1;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;DLG4;SEMA5A;PDGFA;MAP2;TIMP1;PHLDB1;GPNMB;SMOC1;CCDC85B;CUL7;BTG1;ITGA3;SIK1;TPBG;ANO6;GPX1;GLI3;DLG5;CNTN1;KITLG;ASAP1;PDPN;CTSV;PLXNB1;LRP1;FYN;XDH;LTBP4;ARHGAP18;ADIRF;LAMA3;CAV1;GLI2;RBFOX2;TRIB2;UST;PRKCZ;OAS2;ULK2;TP53INP1;ARPIN;HMGA2;PIK3R1;SYT1;CAPRIN2;ACACB;PARVA;LAMA5;BBS2;SPRY2;JARID2;FBLN1;TP73;DLC1;KLF13;S1PR5;PRKACB;METRN;ROBO1;WDFY2;TLR3;SNCA;FLOT2;ADAMTS7;FZD7;GLG1;PLXNA2;FGFR1;LMNA;ALOX15B;DKK1;SEMA4A;LTBP3;C5;SETX;PSMB9;IL18;SULF1;G6PD;SOX13;TRIOBP;KDM4C;NFATC4;TGFBR3;FZD1;PBX1;ENG;BBS4;CALR;MKLN1;NEGR1;EFNB3;IDH2;MDM2;ARF6;CST3;DLK2;MEIS2;AREG;TCF4;AKAP13;CITED2;PLXNA1;LMO4;MAF;TRAK1;FBXW8;FGD4;POGLUT1;VANGL2;ARHGEF2;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;CRTC1;PLAG1;PRKCA;ANXA2;RGS14;TCF12;NAB2;MEGF8;TAF8;RET;ZFPM1;TGFB2;MAP2K5;DLX2;STAT2;IFT122;GPR161;LEF1;THRA;SSBP3;CDC42EP5;LRRN3;ZADH2;CDKN2A;SP100;AGRN;NPHP3;MAGI2;KIAA1109;HSPA5;BOC;TGFB1I1;SEMA4B;ITGB8;ARHGEF19;IFITM1;YAP1;GDNF;KLF5;TWIST2;ATRAID;DIXDC1;PPARG;INF2;MEF2A;SASH1;OBSL1;POSTN;LGALS3;RARA;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;PPP3CA;RASA1;ANKH;FOS;KDM4A;CDK5RAP3;AGO4;MED12;NIPBL;TTBK2;ADM2;OXTR;RHOBTB3;CELSR1;RXRA;ABCA5;DOCK1;DMPK
6639,GO:0023052,2.51186177687628e-11,1,533,3920,signaling,BP,SERPINE2;ITGB6;SYT8;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;ZFP36L2;TNIK;ANPEP;SKP2;BCAM;CLTCL1;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;ROR1;AXL;DPYSL2;DOCK9;EGFR;TMEM204;PEG10;ITPK1;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;GJC2;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;PSTPIP1;CTNNAL1;TKFC;EVC;MAP3K6;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;ABCA1;NSG1;VDR;CHN2;PTPRM;SRGAP3;BMP4;TRIM38;ITM2C;PCSK1;NR1D1;PTK6;SCN8A;RIN2;XAF1;EIF2AK4;NETO1;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;STAT1;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;TP53;ARAP1;EXTL2;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;PLEKHG3;DDX60;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;CRIM1;CUL7;ITGA3;CHD3;SIK1;IFIT3;PCDHAC2;HIVEP1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;ERMAP;ASAP1;SYN1;PDPN;SRPX;SESN1;SEC14L1;SPG11;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;CAV1;SLC27A1;GLI2;RMI2;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;DOCK11;MAP3K14;SLC22A17;AHNAK2;CLU;DCBLD2;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TP53INP1;IQSEC2;GPR39;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;ITGA1;MST1R;SYTL1;KANK2;IL31RA;PER1;PXN;CCK;PIK3R1;SYT1;HHAT;CAPRIN2;CREB3L2;CPT1A;PCLO;DUSP5;LAMA5;UNC5B;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;LMO7;APLP2;FBLN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;CHEK2;BACE1;ROBO1;KCNJ5;IFT140;SPRY4;PRX;TLR3;SNCA;PDIA6;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;RGS2;C5;SETX;PDE4D;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;PDK3;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;ARHGEF17;SLC24A1;AFAP1L2;CDH13;NFATC4;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;FZD1;AMOTL1;NOTCH2NL;PBX1;ENG;FOXL1;BBS4;MTMR4;CALR;MKLN1;ATM;EFNB3;SRGAP1;APH1B;MDM2;ARF6;DLK2;AREG;IFNK;ANXA6;AKAP13;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;NEURL1B;ZMAT3;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;VANGL2;ARHGEF2;SPRED3;KLHL12;SDC2;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NCOR1;NDRG1;PRKCA;SALL2;BCHE;ANXA2;RGS14;RAB13;MPP7;SEPT5;LEPR;LANCL1;IGFBP4;DEPDC7;IFITM2;SAMD5;MVB12B;NFAT5;GAL3ST4;PAK6;MAP3K12;MEGF8;TSPAN5;NLGN4Y;UACA;HTR1B;STK36;RAB43;MAML2;WDR19;PRNP;RET;TGFB2;RBL2;MAP2K5;DLX2;OR2A4;STAT2;AMOTL2;IFT122;GPR161;LEF1;THRA;CDC42EP5;USP28;MAPK8IP3;C2CD4C;CDKN2A;SPPL2B;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;BTN3A3;TH;MAGI1;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;IFT74;IFITM1;OPHN1;TPGS1;SH2B3;MYO9A;YAP1;CACNB1;GDNF;RALGAPB;CAPS;DIXDC1;DERL3;MEIS3;PITPNC1;AGPAT1;PPARG;CALCRL;KCNIP3;MEF2A;GCSAM;SHISA9;ICK;SASH1;TBC1D16;ING4;POSTN;LGALS3;PTPN3;ARL3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;COL4A1;SV2A;CCNY;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;PPP3CA;PIK3C2B;RASA1;ARHGAP31;CREBRF;CTDSP2;FOS;CDK5RAP3;AGO4;CLEC2D;FAM120B;CACNA2D3;CAMK2N1;ELMO2;MED12;ABAT;UGGT2;TTBK2;ADM2;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;CELSR1;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;EDEM1;ACAA2;TAOK3;DOCK1;DMPK
15511,GO:0071944,2.57596026971295e-11,1,420,2895,cell periphery,CC,SERPINE2;ITGB6;SYT8;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;PCDH7;FLRT2;GPRC5A;ITGB5;CTGF;ADAM19;INPP5D;MARVELD1;ITGA6;SFRP1;CD109;RHOBTB2;SYNE1;F2R;TLN2;FAT4;TGFBR2;XPC;SLITRK6;ITGB4;TENM4;IL20RB;SLC7A8;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;BCAM;NOS1;DNAJB4;APCDD1;PDGFC;MAGED1;TCAF1;MALL;SULF2;UTRN;ROR1;AXL;DPYSL2;EGFR;TMEM204;SDC3;ITPK1;HSPA2;FLRT3;TCHH;SPTB;SLC8A1;NTM;CLCA2;DOCK5;MYLK;CSMD3;GJC2;SLC20A1;SLC2A3;SERPINE1;ATP10D;KRT14;S100A10;ANXA5;VIM;LPAR5;CSPG4;PSTPIP1;CTNNAL1;EVC;CNTNAP3;AMIGO2;ADD3;ASAP2;NTSR1;TENM3;PLEC;PAK1;ABCA1;NSG1;PTPRM;ITM2C;PTK6;AHNAK;SCN8A;ABTB1;NETO1;MRC2;VAV3;SORL1;NEO1;SCN2A;GNG2;KCNMA1;ARAP1;KIAA0319L;PTPRS;KRT5;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;PILRB;NISCH;PPL;FLG;PHLDB1;HIP1;GPNMB;DOCK4;CRIM1;ITGA3;EMP1;KLF9;PCDHAC2;SLC22A15;TPBG;ANO6;PLEK2;LAMC2;PAQR8;CDK14;DLG5;CNTN1;KITLG;TBC1D5;ERMAP;ASAP1;PDPN;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;EMP3;IFI6;FLNC;ARHGAP18;UGT8;FAT2;CAV1;SLC27A1;ITGA10;GLDC;SLC22A17;AHNAK2;CLU;DCBLD2;CXCR1;PRKCZ;SDR16C5;GPR39;KCNJ15;TNS2;EHD3;CAMK2D;ADGRG6;ITGA1;MST1R;SYTL1;IL31RA;ULBP1;ATP8B2;EHBP1;PXN;PIK3R1;SYT1;TMEM173;CAPRIN2;SLC38A2;CALHM2;PCLO;DYSF;KIF17;PARVA;UNC5B;BBS2;ANK3;PHKA2;SPRY2;TMEM8B;APLP2;CAT;PLCH2;SHROOM4;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;BACE1;ROBO1;KCNJ5;SPRY4;LRIG3;STOM;PRX;TLR3;SNCA;FLOT2;MME;PDIA6;VAMP1;FZD7;AIP;GLG1;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;ALOX15B;DKK1;MLEC;FSCN1;SEMA4A;RGS2;C5;TGFBI;ASTN2;PDE4D;TGM2;OBSCN;SULF1;PLA2R1;ESYT2;TRO;G6PD;MYOF;EPHB6;IL17RE;EDA2R;FZD8;TRIOBP;SLC24A1;AFAP1L2;CDH13;CD99L2;ITGBL1;RAPH1;SEPT6;TGFBR3;FZD1;AMOTL1;LRTOMT;ENG;BBS4;CALR;MKLN1;NEGR1;EFNB3;APH1B;MDM2;ARF6;TMED10;MANBA;BBS1;AKAP13;DGKQ;PLXNA1;ZMAT3;NRSN2;CD1D;LZTS1;SYNE2;HDAC11;RNPEP;CSMD2;PTPN1;KCNQ3;CRIP2;VANGL2;ARHGEF2;DNAL4;NTNG1;PLGRKT;SDC2;SYNC;SSH1;ENPP1;SLC27A6;SLC48A1;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;TMEM50B;PRKCA;ANXA2;RGS14;RAB13;MPP7;SEPT5;LEPR;LANCL1;IFITM2;MVB12B;TES;TTC8;KCTD7;MOSPD2;PODXL;ABCC2;MAP3K12;TSPAN5;NLGN4Y;XG;HTR1B;SPA17;SLC39A11;PRNP;CDH11;RET;OR2A4;SCNN1A;STAT2;AMOTL2;GPR161;FHL1;CDC42EP5;ITM2A;C2CD4C;EFR3A;SPPL2B;AGRN;IGFBP2;VAV2;MAGI2;HSPA5;BTN3A3;TH;GOPC;MAGI1;SLC9A4;BOC;REEP2;FLNB;CHIC2;SEMA4B;ITGB8;ITPR2;IFITM1;TACC2;CACNB1;COL17A1;ATRAID;SRR;CALCRL;KCNIP3;GCSAM;SNX9;SHISA9;PRR7;LGALS3;PTPN3;TSPAN18;DEF6;COG3;SV2A;ABCA2;CCNY;TMEM67;SENP7;TRIM16L;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;PPP3CA;PIK3C2B;RASA1;ANKH;LIMA1;STEAP2;KRT10;DNM1P46;SEPT9;CLEC2D;CACNA2D3;CAMK2N1;CERCAM;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;CELSR1;MPDZ;LITAF;TSPAN4;MYO1C;TUSC3;C2CD5;SNTB1;TAOK3;DMPK
12195,GO:0048468,3.28019430590242e-11,1,227,1294,cell development,BP,SERPINE2;FLOT1;FN1;FLRT2;FBN1;SOX6;SFRP1;APBB2;FAT4;TGFBR2;SLITRK6;TENM4;GSN;ETV5;IRS2;SDK1;TNIK;NOS1;SNAI2;MAP6;SULF2;ROR1;AXL;DPYSL2;EGFR;HSPA2;LAMB1;FLRT3;SPTB;SLC8A1;NTM;DOCK5;CSMD3;GJC2;RFX2;ACTA2;DOK1;SERPINH1;S100A10;RNF165;VIM;FAM210B;STMN3;TIMP2;TENM3;PAK1;PTPRM;BMP4;NEFM;ITM2C;SMARCA2;PTK6;EIF2AK4;NEFL;PDCD4;COL18A1;SORL1;NEO1;LGALS1;ETV1;PTPRS;WNK1;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;GPX1;GLI3;PAQR8;DLG5;CNTN1;KITLG;ASAP1;PDPN;SPG11;PLXNB1;LRP1;FYN;FLNC;CLMN;UGT8;GLI2;RBFOX2;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;ULK2;ADGRG6;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;ANG;PARVA;LAMA5;UNC5B;BBS2;ANK3;TTN;PRDM8;FBLN1;TP73;S1PR5;METRN;ROBO1;IFT140;PRX;FZD7;PAQR7;SH3TC2;PLXNA2;FGFR1;LMNA;DKK1;CTF1;SEMA4A;SETX;PDE4D;OBSCN;SULF1;G6PD;CCDC136;TRIOBP;KDM4C;NFATC4;RAPH1;TGFBR3;FZD1;LRTOMT;L3MBTL3;NAGLU;PBX1;ENG;BBS4;CALR;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;CST3;AREG;TCF4;AKAP13;PLXNA1;FHOD3;MAF;TRAK1;FBXW8;HDAC11;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;SOX9;IFT27;ISL1;BCL6;NFASC;CRTC1;NDRG1;PLAG1;PRKCA;ANXA2;RGS14;RAB13;FNDC3A;TCF12;PODXL;MEGF8;CDH11;RET;ZFPM1;TGFB2;ODF2;DLX2;LEF1;ULK1;AGRN;MAGI2;HSPA5;TH;GOPC;SLC9A4;BOC;FLNB;SEMA4B;IFT74;OPHN1;TPGS1;YAP1;GDNF;DNAH1;KLF5;DIXDC1;PPARG;MEF2A;KLF7;OBSL1;POSTN;UNK;ARL3;NYAP1;RARA;ECM2;EFNA5;FZD4;SLITRK5;ADGRA2;PPP3CA;KDM4A;CDK5RAP3;MED12;MYH11;NIPBL;DOCK1;LAMB2
2403,GO:0005576,5.58983030344953e-11,1,365,2783,extracellular region,CC,SERPINE2;CPA4;ITGB6;TNFRSF6B;FLOT1;MMP2;PRSS23;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;GPRC5A;ITGB5;COL8A1;CTGF;FBN1;ITGA6;SFRP1;MMP28;CD109;NQO1;F2R;FAT4;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;EFEMP1;SLC7A8;ANO1;GSN;COL5A2;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;COL7A1;BCAM;CLTCL1;DNAJB4;GAS6;FBN2;PDGFC;SULF2;COL5A1;UTRN;ARHGAP23;TFPI2;AXL;DPYSL2;EGFR;SDC3;HSPA2;LAMB1;FLRT3;NTM;FKBP5;CLCA2;MYLK;SLC2A3;THBS2;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;CRTAP;S100A10;ANXA5;C1QTNF6;VIM;CSPG4;TKFC;CNTNAP3;MAMDC2;MFAP5;TOM1L2;TIMP2;PDLIM2;PLEC;CXCL14;ABCA1;ANGPTL4;BMP4;LAMB4;ITM2C;TP53I3;PCSK1;AHNAK;NETO1;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;PYCARD;LTBP1;KRT5;IL32;SEC14L2;MUC19;ARMC9;SEMA5A;ZCCHC11;PDGFA;FRMD4B;MMP19;PPL;TIMP1;EFEMP2;PHGDH;COL4A4;SMOC1;CRIM1;ITGA3;ELFN2;ANO6;GPX1;LAMC2;CNTN1;KITLG;P3H2;NAV2;ECH1;PLLP;CTDSPL;ABHD14B;CCDC80;KRT15;MAGED2;CTSV;SPG11;PLXNB1;ARHGEF12;XDH;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;IGFL1;PLA2G6;SPATA6;XYLT1;CLU;SERPING1;SNX29;PRKCZ;SLIT3;PARP4;PRDX5;ITGA1;SYTL1;METTL7A;PDIA4;SPATA20;CCK;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;LAMB3;CES2;TTN;APLP2;CRELD2;FBLN1;CAT;CASP14;PRKACB;AARS;METRN;LRIG3;STOM;BPHL;MAN1A1;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GLG1;JADE2;COL16A1;FGFR1;CBR1;ALOX15B;DKK1;FSCN1;CTF1;SEMA4A;LTBP3;C5;TGFBI;SETX;TGM2;PSMB9;IL18;SULF1;PLA2R1;G6PD;MYOF;EPHB6;ARSD;IL17RE;C11ORF45;CDH13;MAGEF1;ITGBL1;LMCD1;TGFBR3;NOTCH2NL;NAGLU;ENG;MTMR4;CALR;NEGR1;IDH2;ARF6;FAM20A;TMED10;CST3;DLK2;AREG;IFNK;ANXA6;HSD17B11;PLXNA1;HEXA;IFNE;IGFL2;AKR7A2;HSPA12A;SYNE2;HDAC11;RNPEP;POGLUT1;CRIP2;CPNE8;NTNG1;SDC2;COL5A3;THNSL2;UCN2;ENPP1;C14ORF93;PLD3;PRCP;NFASC;NDRG1;GCNT1;PRKCA;BCHE;PRPS2;ANXA2;TMC4;RAB13;CES3;ADAMTS15;LEPR;MAN2B1;LANCL1;IGFBP4;ALDH9A1;MVB12B;GAL3ST4;PODXL;DECR1;IGIP;MEGF8;UACA;IRF2BPL;RAB43;PRNP;CDH11;TGFB2;RBL2;DNASE1L1;COL12A1;SCNN1A;LIPA;LRRN3;ALDH7A1;ITM2A;EFR3A;OSBPL1A;AGRN;IGFBP2;HSPA5;REEP2;TGFB1I1;FLNB;SEMA4B;ITGB8;NAPRT;MON2;VPS13C;UGT1A6;GDNF;COL17A1;CAPS;GALNT2;CAPG;ADAMTSL5;SNX9;OLFML2A;APOL6;POSTN;LGALS3;ARL3;DNAJC3;RASSF9;ECM2;COL4A1;CCNY;PRKAG1;EFNA5;FZD4;SLITRK5;PDZD2;PEX1;KRT10;ACTR1B;PPCS;DNPH1;SERPINB5;SCPEP1;MATN3;ABAT;MYH11;NIPBL;VPS36;TTBK2;ADM2;PCDHGB5;ADAM10;RHOBTB3;S100A11;MYO1C;DGCR6;ACAA2;CTSD;PINLYP;LAMB2
12870,GO:0051239,5.69525003651912e-11,1,284,1824,regulation of multicellular organismal process,BP,SERPINE2;FLOT1;FN1;FLRT2;MMP9;CCBE1;CTGF;FBN1;SOX6;INPP5D;SFRP1;CD109;ZFP36L1;F2R;FAT4;TGFBR2;TNNI2;SLITRK6;EFEMP1;TENM4;IL20RB;COL5A2;ETV5;GJA5;JPH2;DUSP6;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;NOS1;GAS6;FBN2;SNAI2;MAGED1;SULF2;COL5A1;UTRN;ROR1;AXL;DPYSL2;EGFR;TSC22D3;FLRT3;SLC8A1;DOCK5;CSMD3;GJC2;THBS2;SERPINE1;ANXA5;VIM;NUPR1;TKFC;FAM210B;AMIGO2;NTSR1;TIMP2;TENM3;PAK1;ABCA1;ANGPTL4;VDR;PTPRM;BMP4;ITM2C;PTK6;EIF2AK4;NEFL;PDCD4;STAT1;SORL1;LGALS1;PTPRS;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;WNK1;DDX60;DLG4;SEMA5A;ITGA2;PDGFA;MAP2;TIMP1;PHLDB1;GPNMB;SMOC1;DOCK4;CUL7;BTG1;ITGA3;TPBG;ANO6;GPX1;GLI3;DLG5;CNTN1;KITLG;ERMAP;ASAP1;PDPN;CTSV;SEC14L1;PLXNB1;LRP1;FYN;XDH;LAMA3;POLR3GL;CAV1;SLC27A1;GLI2;RNF135;RBFOX2;TRIB2;UST;CLU;SERPING1;PRKCZ;OAS2;ULK2;EHD3;HMGA2;CAMK2D;PER1;CCK;PIK3R1;SYT1;TMEM173;CAPRIN2;ACACB;LAMA5;BBS2;SPRY2;JARID2;TP73;KLF13;S1PR5;BTN3A1;PRKACB;METRN;ROBO1;KCNJ5;TLR3;SNCA;ADAMTS7;FZD7;GLG1;PLXNA2;FGFR1;LMNA;ALOX15B;DKK1;SEMA4A;RGS2;C5;SETX;PDE4D;PSMB9;IL18;SULF1;G6PD;SOX13;KDM4C;AFAP1L2;NFATC4;LMCD1;TGFBR3;FZD1;AMOTL1;PBX1;ENG;BBS4;MTMR4;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;CST3;MEIS2;AREG;TCF4;ANXA6;AKAP13;CITED2;NR2F2;PLXNA1;MAF;TRAK1;FBXW8;POGLUT1;VANGL2;ARHGEF2;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;CRTC1;PLAG1;PRKCA;ANXA2;RGS14;LEPR;TCF12;MEGF8;PRNP;RET;ZFPM1;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;THRA;LRRN3;SP100;AGRN;NPHP3;MAGI2;KIAA1109;HSPA5;BTN3A3;TH;CELF2;TGFB1I1;RSAD2;SEMA4B;ITGB8;ARHGEF19;ITPR2;IFITM1;YAP1;CACNB1;GDNF;TWIST2;ATRAID;UBA7;DIXDC1;AGPAT1;PPARG;CALCRL;KCNIP3;MEF2A;SASH1;OBSL1;POSTN;LGALS3;RARA;TSHZ3;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;ANKH;FOS;KDM4A;CDK5RAP3;AGO4;CACNA2D3;MED12;ABAT;NIPBL;ADM2;OXTR;CELSR1;LITAF;RXRA;DOCK1;DMPK
9046,GO:0035295,6.69876009651356e-11,1,133,653,tube development,BP,SERPINE2;MMP2;FN1;CCBE1;COL8A1;CTGF;ITGA6;SFRP1;ZFP36L1;FAT4;TGFBR2;ITGB4;ETV5;GJA5;PKD2;ANPEP;PDGFC;MAGED1;EGFR;ITPK1;MYLK;THBS2;SERPINE1;RNF213;CSPG4;PAK1;ANGPTL4;VDR;PTPRM;BMP4;PTK6;VAV3;COL18A1;STAT1;WWTR1;PRICKLE1;SEMA5A;PDGFA;MMP19;GPNMB;CUL7;BTG1;ITGA3;GPX1;GLI3;E2F7;DLG5;PDPN;LRP1;XDH;CPS1;CAV1;GLI2;HMGA2;ANG;PARVA;LAMA5;UNC5B;SPRY2;CAT;DLC1;PRKACB;ROBO1;IFT140;TLR3;PLXNA2;FGFR1;SEMA4A;C5;TGFBI;TGM2;IL18;SULF1;FZD8;CDH13;NFATC4;TGFBR3;FZD1;AMOTL1;PBX1;ENG;FOXL1;BBS4;AREG;CITED2;NR2F2;LMO4;VANGL2;SOX9;ISL1;PRCP;PRKCA;SALL2;ZNF358;ANXA2;HOXA1;LEPR;PODXL;MEGF8;WDR19;RET;TGFB2;MAP2K5;AMOTL2;IFT122;GPR161;LIPA;LEF1;THRA;SSBP3;SP100;NPHP3;VAV2;SRPK2;ITGB8;YAP1;GDNF;KLF5;KLHL3;HOXA3;PPARG;CALCRL;SASH1;RARA;COL4A1;FZD4;ADGRA2;RASA1;MED12;NIPBL;ADM2;OXTR;CELSR1
3374,GO:0007154,8.64603182020157e-11,1,532,3945,cell communication,BP,SERPINE2;ITGB6;SYT8;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;ZFP36L2;TNIK;ANPEP;SKP2;BCAM;CLTCL1;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;ROR1;AXL;DPYSL2;DOCK9;EGFR;TMEM204;PEG10;ITPK1;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;GJC2;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;PSTPIP1;CTNNAL1;TKFC;EVC;MAP3K6;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;ABCA1;NSG1;VDR;CHN2;PTPRM;SRGAP3;BMP4;TRIM38;ITM2C;PCSK1;NR1D1;PTK6;SCN8A;RIN2;XAF1;EIF2AK4;NETO1;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;STAT1;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;TP53;ARAP1;EXTL2;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;PLEKHG3;DDX60;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;CRIM1;CUL7;ITGA3;CHD3;SIK1;IFIT3;PCDHAC2;HIVEP1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;ERMAP;ASAP1;SYN1;PDPN;SRPX;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;CAV1;SLC27A1;GLI2;RMI2;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;DOCK11;MAP3K14;SLC22A17;AHNAK2;CLU;DCBLD2;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TP53INP1;IQSEC2;GPR39;TNS2;HMGA2;CAMK2D;ADGRG6;ITGA1;MST1R;SYTL1;KANK2;IL31RA;PER1;PXN;CCK;PIK3R1;SYT1;HHAT;CAPRIN2;CREB3L2;CPT1A;SLC38A2;PCLO;ANG;DUSP5;LAMA5;UNC5B;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;APLP2;FBLN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;CHEK2;BACE1;ROBO1;KCNJ5;IFT140;SPRY4;PRX;TLR3;SNCA;PDIA6;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;RGS2;C5;SETX;PDE4D;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;PDK3;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;ARHGEF17;SLC24A1;AFAP1L2;CDH13;NFATC4;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;FZD1;AMOTL1;NOTCH2NL;PBX1;ENG;FOXL1;BBS4;MTMR4;CALR;MKLN1;ATM;EFNB3;SRGAP1;APH1B;MDM2;ARF6;DLK2;AREG;IFNK;ANXA6;AKAP13;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;NEURL1B;ZMAT3;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;VANGL2;ARHGEF2;SPRED3;KLHL12;SDC2;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;PRCP;NFASC;CRTC1;NCOR1;NDRG1;PRKCA;SALL2;BCHE;ANXA2;RGS14;RAB13;MPP7;SEPT5;LEPR;LANCL1;IGFBP4;DEPDC7;IFITM2;SAMD5;MVB12B;NFAT5;GAL3ST4;PAK6;MAP3K12;MEGF8;TSPAN5;NLGN4Y;UACA;HTR1B;STK36;RAB43;MAML2;WDR19;PRNP;RET;TGFB2;RBL2;MAP2K5;DLX2;OR2A4;STAT2;AMOTL2;IFT122;GPR161;LEF1;THRA;CDC42EP5;USP28;MAPK8IP3;C2CD4C;CDKN2A;SPPL2B;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;BTN3A3;TH;MAGI1;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;IFT74;IFITM1;OPHN1;TPGS1;SH2B3;MYO9A;YAP1;CACNB1;GDNF;RALGAPB;CAPS;DIXDC1;DERL3;MEIS3;PITPNC1;AGPAT1;PPARG;CALCRL;KCNIP3;MEF2A;GCSAM;SHISA9;ICK;SASH1;ING4;POSTN;LGALS3;PTPN3;ARL3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;COL4A1;SV2A;CCNY;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;PPP3CA;PIK3C2B;RASA1;ARHGAP31;CREBRF;CTDSP2;FOS;CDK5RAP3;AGO4;CLEC2D;FAM120B;CAMK2N1;ELMO2;MED12;ABAT;UGGT2;TTBK2;ADM2;BSN;PCDHGB5;OXTR;ADAM10;RHOBTB3;CELSR1;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;EDEM1;ACAA2;TAOK3;DOCK1;DMPK
5509,GO:0016477,1.08756256374038e-10,1,163,884,cell migration,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;CTGF;INPP5D;ITGA6;SFRP1;MMP28;RHOBTB2;APBB2;F2R;DDIT4;TGFBR2;ASAP3;SLC7A8;PIK3C2G;IRS2;GAS6;APCDD1;PDGFC;SNAI2;TCAF1;COL5A1;AXL;EGFR;SDC3;LAMB1;FLRT3;SLC8A1;DOCK5;MYLK;SERPINE1;CSPG4;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;TNS1;PTK6;VAV3;COL18A1;SORL1;TP53;PYCARD;EFHC1;SLC7A11;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;BTG1;ITGA3;ANO6;GPX1;LAMC2;GLI3;DLG5;KITLG;PDPN;PLXNB1;LRP1;FYN;FUT10;LAMA3;FAT2;CAV1;RBFOX2;CXCR1;PRKCZ;TP53INP1;ARPIN;ITGA1;PXN;CCK;PIK3R1;ANG;PARVA;LAMA5;SPRY2;DLC1;ROBO1;FRMD5;GLG1;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;FSCN1;SEMA4A;C5;PDE4D;SULF1;CDH13;TGFBR3;AMOTL1;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;ELMO3;LMO4;SYNE2;VANGL2;ARHGEF2;SDC2;SSH1;LYST;SOX9;ISL1;PRCP;GCNT1;PRKCA;RAB13;MOSPD2;PODXL;PAK6;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;MAGI2;HSPA5;SEMA4B;IFITM1;OPHN1;GDNF;DIXDC1;PPARG;BEX4;GCSAM;SASH1;POSTN;UNK;LGALS3;MIA3;ADGRA2;PIK3C2B;ELMO2;NIPBL;TTBK2;ADAM10;RHOBTB3;CELSR1;MYO1C;DOCK1
6554,GO:0022008,1.15895457799982e-10,1,185,1015,neurogenesis,BP,SERPINE2;FLOT1;FN1;FLRT2;SOX6;SFRP1;APBB2;DDIT4;FAT4;SLITRK6;TENM4;GSN;ETV5;IRS2;SDK1;TNIK;NOS1;GAS6;APCDD1;MAP6;ROR1;AXL;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;NTM;CSMD3;GJC2;DOK1;TCF7L1;RNF165;VIM;CSPG4;STMN3;TIMP2;TENM3;PAK1;PTPRM;BMP4;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;BTBD2;SORL1;NEO1;LGALS1;ETV1;PTPRS;WNK1;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;SPG11;PLXNB1;LRP1;FYN;CLMN;UGT8;GLI2;RBFOX2;SMARCA1;AHNAK2;UST;CLU;NPHP4;PRKCZ;SLIT3;ULK2;ADGRG6;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;KIF17;UNC5B;ANK3;PRDM8;TP73;S1PR5;METRN;ROBO1;IFT140;PRX;FZD7;SH3TC2;PLXNA2;FGFR1;DKK1;CTF1;SEMA4A;SETX;FZD8;TRIOBP;KDM4C;NFATC4;RAPH1;FZD1;LRTOMT;NAGLU;PBX1;BBS4;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;AREG;TCF4;NR2F2;PLXNA1;LMO4;TRAK1;FBXW8;SYNE2;HDAC11;VANGL2;ARHGEF2;NTNG1;SDC2;NRK;SSH1;SOX9;IFT27;ISL1;BCL6;NFASC;CRTC1;NDRG1;PLAG1;PRKCA;BCHE;RGS14;RAB13;TCF12;NAB2;MEGF8;CDH11;RET;TGFB2;DLX2;LEF1;ULK1;AGRN;MAGI2;HSPA5;TH;BOC;SEMA4B;OPHN1;YAP1;GDNF;DIXDC1;PPARG;MEF2A;KLF7;OBSL1;POSTN;UNK;ARL3;NYAP1;RARA;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;KDM4A;CDK5RAP3;MED12;NIPBL;CELSR1;LAMB2
2210,GO:0005102,1.25920972938635e-10,1,153,881,signaling receptor binding,MF,SERPINE2;ITGB6;FLOT1;FN1;FLRT2;CTGF;FBN1;ITGA6;SFRP1;F2R;TGFBR2;ITGB4;EFEMP1;PKD2;PITPNM3;IRS2;GAS6;PDGFC;COL5A1;UTRN;EGFR;FLRT3;SERPINE1;TIMP2;TADA3;CXCL14;ABCA1;NSG1;VDR;BMP4;PTK6;NETO1;VAV3;STAT1;TP53;ARAP1;PYCARD;IL32;ARHGEF1;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;NISCH;TIMP1;HIP1;GPNMB;DOCK4;ITGA3;SNX1;KITLG;ECH1;ERMAP;PDPN;SEC14L1;PLXNB1;EML2;LRP1;FYN;ARHGEF12;LTBP4;LAMA3;CAV1;CLU;SLIT3;PRDX5;ITGA1;SYTL1;ULBP1;PTPN14;PXN;CCK;PIK3R1;SYT1;CAPRIN2;ANG;LAMA5;CAT;BTN3A1;FLOT2;FRMD5;FZD7;AIP;GLG1;COL16A1;FGFR1;PAG1;IGF1R;DKK1;CTF1;SEMA4A;C5;TGFBI;PDE4D;NCOA2;IL18;FZD8;KDM4C;NFATC4;TRAF1;TGFBR3;FZD1;ENG;CALR;EFNB3;MDM2;AREG;IFNK;BBS1;IFNE;IGFL2;TRAK1;PTPN1;THNSL2;UCN2;ENPP1;ISL1;NCOR1;PRKCA;LANCL1;IGFBP4;NLGN4Y;PRNP;TGFB2;LEF1;IGFBP2;VAV2;MAGI2;BTN3A3;GOPC;REEP2;TGFB1I1;SEMA4B;ITGB8;TACC2;OPHN1;GDNF;PPARG;LGALS3;RARA;ECM2;EFNA5;RASA1;ELMO2;EHHADH;MED12;ADM2;ADAM10;TSPAN4;MYO1C;RXRA;LAMB2
3386,GO:0007166,1.48443632631545e-10,1,282,1858,cell surface receptor signaling pathway,BP,SERPINE2;ITGB6;TNFRSF6B;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;INPP5D;ITGA6;SFRP1;CD109;CDKN2B;DDIT4;FAT4;TGFBR2;ITGB4;EFEMP1;IL20RB;IRS2;DUSP6;TNIK;GAS6;APCDD1;FBN2;PDGFC;SNAI2;SULF2;ROR1;AXL;EGFR;TMEM204;PEG10;FLRT3;SESN3;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;VIM;CSPG4;EVC;NTSR1;PAK1;ABCA1;BMP4;TRIM38;ITM2C;PTK6;XAF1;NETO1;TRIM5;VAV3;PDCD4;STAT1;NEO1;IFIT2;GNG2;TP53;ARAP1;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;MUC19;DLG4;ITGA2;PILRB;PDGFA;RBMS3;TIMP1;HIP1;CRIM1;ITGA3;IFIT3;ANO6;GPX1;GLI3;CDK14;DLG5;CNTN1;KITLG;ERMAP;SRPX;PLXNB1;LRP1;FYN;IFI6;XDH;LTBP4;CAV1;SLC27A1;GLI2;RBFOX2;PLA2G6;ITGA10;SEL1L;MAP3K14;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;CAMK2D;ADGRG6;ITGA1;MST1R;IL31RA;PXN;PIK3R1;HHAT;CAPRIN2;LAMA5;UNC5B;BBS2;MDFI;SPRY2;DAPK1;BTN3A1;PRKACB;ROBO1;IFT140;SPRY4;TLR3;SNCA;FZD7;AIP;GLG1;SH3TC2;PLXNA2;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;LMNA;IFI35;DKK1;FSCN1;CTF1;SEMA4A;C5;SETX;PDE4D;PSMB9;IL18;SULF1;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;AFAP1L2;CDH13;NFATC4;TRAF1;TGFBR3;FZD1;AMOTL1;NOTCH2NL;PBX1;ENG;FOXL1;BBS4;MTMR4;EFNB3;APH1B;DLK2;AREG;IFNK;DGKQ;CITED2;GCLC;PLXNA1;IFNE;NEURL1B;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;KLHL12;SDC2;SSH1;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRKCA;ANXA2;RGS14;LEPR;IGFBP4;IFITM2;MVB12B;MEGF8;TSPAN5;STK36;MAML2;WDR19;PRNP;RET;TGFB2;MAP2K5;DLX2;STAT2;AMOTL2;IFT122;GPR161;LEF1;SPPL2B;SP100;IGFBP2;NPHP3;VAV2;MAGI2;HSPA5;BTN3A3;MAGI1;BOC;TGFB1I1;RSAD2;SEMA4B;ITGB8;ARHGEF19;MDFIC;IFT74;IFITM1;YAP1;GDNF;DIXDC1;AGPAT1;PPARG;CALCRL;GCSAM;SHISA9;SASH1;POSTN;LGALS3;PTPN3;ARL3;TSPAN18;COL4A1;CCNY;EFNA5;FZD4;WIPF1;ADGRA2;PPP3CA;RASA1;CREBRF;FOS;AGO4;CLEC2D;ELMO2;MED12;ABAT;TTBK2;OXTR;ADAM10;CELSR1;TSPAN4;MYO1C;C2CD5;DOCK1;DMPK
2589,GO:0005886,1.82465691575055e-10,1,406,2824,plasma membrane,CC,SERPINE2;ITGB6;SYT8;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;PCDH7;FLRT2;GPRC5A;ITGB5;CTGF;ADAM19;INPP5D;MARVELD1;ITGA6;SFRP1;CD109;RHOBTB2;SYNE1;F2R;TLN2;FAT4;TGFBR2;XPC;SLITRK6;ITGB4;TENM4;IL20RB;SLC7A8;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;CYBRD1;SDK1;TNIK;ANPEP;PROM2;BCAM;NOS1;DNAJB4;APCDD1;PDGFC;MAGED1;TCAF1;MALL;SULF2;UTRN;ROR1;AXL;DPYSL2;EGFR;TMEM204;SDC3;ITPK1;HSPA2;FLRT3;TCHH;SPTB;SLC8A1;NTM;CLCA2;DOCK5;MYLK;CSMD3;GJC2;SLC20A1;SLC2A3;SERPINE1;ATP10D;S100A10;ANXA5;VIM;LPAR5;CSPG4;PSTPIP1;CTNNAL1;EVC;CNTNAP3;AMIGO2;ADD3;ASAP2;NTSR1;TENM3;PLEC;PAK1;ABCA1;NSG1;PTPRM;ITM2C;PTK6;AHNAK;SCN8A;ABTB1;NETO1;MRC2;VAV3;SORL1;NEO1;SCN2A;GNG2;KCNMA1;ARAP1;KIAA0319L;PTPRS;KRT5;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;PILRB;NISCH;PPL;FLG;HIP1;GPNMB;DOCK4;CRIM1;ITGA3;EMP1;KLF9;PCDHAC2;SLC22A15;TPBG;ANO6;PLEK2;PAQR8;CDK14;DLG5;CNTN1;KITLG;TBC1D5;ERMAP;ASAP1;PDPN;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;EMP3;IFI6;FLNC;ARHGAP18;UGT8;FAT2;CAV1;SLC27A1;ITGA10;GLDC;SLC22A17;AHNAK2;DCBLD2;CXCR1;PRKCZ;SDR16C5;GPR39;KCNJ15;TNS2;EHD3;CAMK2D;ADGRG6;ITGA1;MST1R;SYTL1;IL31RA;ULBP1;ATP8B2;EHBP1;PXN;PIK3R1;SYT1;TMEM173;CAPRIN2;SLC38A2;CALHM2;DYSF;KIF17;PARVA;UNC5B;BBS2;ANK3;PHKA2;SPRY2;TMEM8B;APLP2;CAT;PLCH2;SHROOM4;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;BACE1;ROBO1;KCNJ5;SPRY4;LRIG3;STOM;PRX;TLR3;SNCA;FLOT2;MME;PDIA6;VAMP1;FZD7;AIP;GLG1;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;ALOX15B;DKK1;MLEC;FSCN1;SEMA4A;RGS2;C5;TGFBI;PDE4D;TGM2;OBSCN;SULF1;PLA2R1;ESYT2;TRO;G6PD;MYOF;EPHB6;IL17RE;EDA2R;FZD8;SLC24A1;AFAP1L2;CDH13;CD99L2;ITGBL1;RAPH1;SEPT6;TGFBR3;FZD1;AMOTL1;LRTOMT;ENG;BBS4;CALR;NEGR1;EFNB3;APH1B;MDM2;ARF6;TMED10;MANBA;BBS1;DGKQ;PLXNA1;ZMAT3;NRSN2;CD1D;LZTS1;SYNE2;HDAC11;RNPEP;CSMD2;PTPN1;KCNQ3;VANGL2;ARHGEF2;DNAL4;NTNG1;PLGRKT;SDC2;SYNC;SSH1;ENPP1;SLC27A6;SLC48A1;PCDHGA11;PRCP;NFASC;CRTC1;NDRG1;TMEM50B;PRKCA;ANXA2;RGS14;RAB13;MPP7;SEPT5;LEPR;LANCL1;IFITM2;MVB12B;TES;TTC8;KCTD7;MOSPD2;PODXL;ABCC2;MAP3K12;TSPAN5;NLGN4Y;XG;HTR1B;SPA17;SLC39A11;PRNP;CDH11;RET;OR2A4;SCNN1A;STAT2;AMOTL2;GPR161;FHL1;CDC42EP5;ITM2A;C2CD4C;EFR3A;SPPL2B;AGRN;IGFBP2;VAV2;MAGI2;HSPA5;BTN3A3;TH;GOPC;MAGI1;SLC9A4;BOC;REEP2;FLNB;CHIC2;SEMA4B;ITGB8;ITPR2;IFITM1;TACC2;CACNB1;COL17A1;ATRAID;SRR;CALCRL;KCNIP3;GCSAM;SNX9;SHISA9;PRR7;LGALS3;PTPN3;TSPAN18;DEF6;COG3;SV2A;ABCA2;CCNY;TMEM67;SENP7;TRIM16L;EFNA5;FZD4;SLITRK5;ADGRA2;PPP3CA;PIK3C2B;RASA1;ANKH;LIMA1;STEAP2;KRT10;DNM1P46;CLEC2D;CACNA2D3;CAMK2N1;CERCAM;PCDHGB5;OXTR;ADAM10;RHOBTB3;CELSR1;MPDZ;LITAF;TSPAN4;MYO1C;TUSC3;C2CD5;SNTB1;TAOK3;DMPK
2529,GO:0005788,2.0605199106951e-10,0.999999999951131,52,185,endoplasmic reticulum lumen,CC,PRSS23;FN1;COL8A1;FBN1;ADAMTSL1;COL5A2;COL7A1;H6PD;GAS6;PDGFC;COL5A1;LAMB1;SERPINH1;CRTAP;BMP4;COL18A1;LGALS1;LTBP1;PDGFA;TIMP1;COL4A4;P3H2;PDIA4;WFS1;CES2;APLP2;BACE1;ADAMTS7;PDIA6;COL16A1;ARSD;CALR;CST3;POGLUT1;SDC2;COL5A3;BCHE;CES3;IGFBP4;COL12A1;HSPA5;COL17A1;GPX8;MIA3;DNAJC3;FKBP10;COL4A1;MATN3;UGGT2;CERCAM;ADAM10;LAMB2
9774,GO:0040011,2.50397291975978e-10,1,192,1101,locomotion,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;CTGF;INPP5D;ITGA6;SFRP1;MMP28;RHOBTB2;APBB2;F2R;DDIT4;TGFBR2;ITGB4;ASAP3;SLC7A8;PIK3C2G;IRS2;GAS6;APCDD1;PDGFC;SNAI2;TCAF1;COL5A1;AXL;DPYSL2;EGFR;SDC3;LAMB1;FLRT3;SPTB;SLC8A1;DOCK5;MYLK;SERPINE1;DOK1;RNF165;CSPG4;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;TNS1;PTK6;TRIM5;NEFL;VAV3;COL18A1;SORL1;NEO1;ETV1;TP53;PYCARD;EFHC1;SLC7A11;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;BTG1;ITGA3;ANO6;GPX1;LAMC2;GLI3;DLG5;KITLG;PDPN;PLXNB1;LRP1;FYN;ARHGAP18;FUT10;LAMA3;FAT2;CAV1;GLI2;RBFOX2;PLA2G6;CXCR1;NPHP4;PRKCZ;SLIT3;TP53INP1;ARPIN;ITGA1;PXN;CCK;PIK3R1;ANG;PARVA;LAMA5;UNC5B;BBS2;SPRY2;FBLN1;DLC1;ROBO1;SNCA;FRMD5;GLG1;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;FSCN1;SEMA4A;C5;PDE4D;SULF1;CDH13;TGFBR3;AMOTL1;ENG;BBS4;CALR;EFNB3;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;ELMO3;LMO4;SYNE2;VANGL2;ARHGEF2;PLGRKT;SDC2;SSH1;LYST;SOX9;ISL1;PRCP;NFASC;GCNT1;PRKCA;RAB13;MOSPD2;PODXL;PAK6;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;MAGI2;HSPA5;BOC;SEMA4B;CFAP54;IFITM1;OPHN1;TPGS1;GDNF;DNAH1;DIXDC1;PPARG;BEX4;GCSAM;KLF7;SASH1;POSTN;UNK;LGALS3;MIA3;EFNA5;FZD4;ADGRA2;PIK3C2B;ELMO2;NIPBL;TTBK2;ADAM10;RHOBTB3;CELSR1;MYO1C;DOCK1;LAMB2
2422,GO:0005604,2.61100572944346e-10,0.99999999995959,31,67,basement membrane,CC,FN1;COL8A1;FBN1;ITGA6;NID1;COL7A1;COL5A1;LAMB1;THBS2;LAMB4;COL18A1;TIMP1;EFEMP2;COL4A4;SMOC1;LAMC2;P3H2;CCDC80;LAMA3;ANG;LAMA5;LAMB3;FBLN1;TGFBI;CST3;ANXA2;AGRN;COL17A1;COL4A1;EFNA5;LAMB2
3257,GO:0006928,2.92377645705423e-10,1,218,1268,movement of cell or subcellular component,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;CTGF;INPP5D;ITGA6;SFRP1;MMP28;RHOBTB2;APBB2;F2R;MYH15;DDIT4;TGFBR2;TNNI2;ITGB4;ASAP3;SLC7A8;GJA5;PIK3C2G;IRS2;GAS6;APCDD1;PDGFC;SNAI2;TCAF1;COL5A1;AXL;DPYSL2;EGFR;SDC3;LAMB1;FLRT3;SPTB;SLC8A1;DOCK5;MYLK;SERPINE1;DOK1;RNF165;VIM;CSPG4;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;TNS1;PTK6;NEFL;VAV3;COL18A1;SORL1;NEO1;ETV1;TP53;ARAP1;PYCARD;EFHC1;SLC7A11;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;BTG1;ITGA3;WDR66;ANO6;GPX1;LAMC2;GLI3;DLG5;KITLG;PDPN;SPG11;PLXNB1;LRP1;FYN;ARHGAP18;FUT10;LAMA3;FAT2;CAV1;GLI2;RBFOX2;CXCR1;NPHP4;PRKCZ;SLIT3;TP53INP1;ARPIN;CAMK2D;ITGA1;PXN;CCK;PIK3R1;ANG;KIF17;PARVA;LAMA5;UNC5B;BBS2;SPRY2;TTN;FBLN1;DLC1;ROBO1;KCNJ5;IFT140;FRMD5;GLG1;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;FSCN1;SEMA4A;C5;PDE4D;MYO3B;SULF1;CDH13;TGFBR3;AMOTL1;ENG;BBS4;CALR;EFNB3;IDH2;SRGAP1;COPG2;MDM2;CITED2;NR2F2;PLXNA1;ELMO3;LMO4;TRAK1;SYNE2;VANGL2;ARHGEF2;DNAL4;SDC2;SSH1;LYST;SOX9;IFT27;ISL1;BCL6;PRCP;NFASC;GCNT1;PRKCA;RAB13;WDR63;IFT88;MOSPD2;PODXL;PAK6;MEGF8;STK36;SPA17;WDR19;RET;TGFB2;MAP2K5;AMOTL2;IFT122;LEF1;SP100;NPHP3;VAV2;MAGI2;HSPA5;BOC;SEMA4B;CFAP54;IFT74;IFITM1;OPHN1;TPGS1;MYO9A;GDNF;DNAH1;DIXDC1;PPARG;BEX4;GCSAM;KLF7;ICK;SASH1;POSTN;UNK;LGALS3;ARL3;MIA3;EFNA5;WIPF1;ADGRA2;PIK3C2B;ELMO2;MYH11;NIPBL;TTBK2;ADAM10;RHOBTB3;CELSR1;MYO1C;DOCK1;LAMB2
12398,GO:0048870,4.32889900064364e-10,1,171,957,cell motility,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;CTGF;INPP5D;ITGA6;SFRP1;MMP28;RHOBTB2;APBB2;F2R;DDIT4;TGFBR2;ITGB4;ASAP3;SLC7A8;PIK3C2G;IRS2;GAS6;APCDD1;PDGFC;SNAI2;TCAF1;COL5A1;AXL;EGFR;SDC3;LAMB1;FLRT3;SLC8A1;DOCK5;MYLK;SERPINE1;CSPG4;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;TNS1;PTK6;VAV3;COL18A1;SORL1;TP53;PYCARD;EFHC1;SLC7A11;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;BTG1;ITGA3;ANO6;GPX1;LAMC2;GLI3;DLG5;KITLG;PDPN;PLXNB1;LRP1;FYN;ARHGAP18;FUT10;LAMA3;FAT2;CAV1;RBFOX2;CXCR1;NPHP4;PRKCZ;TP53INP1;ARPIN;ITGA1;PXN;CCK;PIK3R1;ANG;PARVA;LAMA5;BBS2;SPRY2;FBLN1;DLC1;ROBO1;FRMD5;GLG1;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;FSCN1;SEMA4A;C5;PDE4D;SULF1;CDH13;TGFBR3;AMOTL1;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;ELMO3;LMO4;SYNE2;VANGL2;ARHGEF2;SDC2;SSH1;LYST;SOX9;ISL1;PRCP;GCNT1;PRKCA;RAB13;MOSPD2;PODXL;PAK6;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;MAGI2;HSPA5;SEMA4B;CFAP54;IFITM1;OPHN1;TPGS1;GDNF;DNAH1;DIXDC1;PPARG;BEX4;GCSAM;SASH1;POSTN;UNK;LGALS3;MIA3;ADGRA2;PIK3C2B;ELMO2;NIPBL;TTBK2;ADAM10;RHOBTB3;CELSR1;MYO1C;DOCK1
13100,GO:0051674,4.32889900064364e-10,1,171,957,localization of cell,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;CTGF;INPP5D;ITGA6;SFRP1;MMP28;RHOBTB2;APBB2;F2R;DDIT4;TGFBR2;ITGB4;ASAP3;SLC7A8;PIK3C2G;IRS2;GAS6;APCDD1;PDGFC;SNAI2;TCAF1;COL5A1;AXL;EGFR;SDC3;LAMB1;FLRT3;SLC8A1;DOCK5;MYLK;SERPINE1;CSPG4;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;TNS1;PTK6;VAV3;COL18A1;SORL1;TP53;PYCARD;EFHC1;SLC7A11;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;BTG1;ITGA3;ANO6;GPX1;LAMC2;GLI3;DLG5;KITLG;PDPN;PLXNB1;LRP1;FYN;ARHGAP18;FUT10;LAMA3;FAT2;CAV1;RBFOX2;CXCR1;NPHP4;PRKCZ;TP53INP1;ARPIN;ITGA1;PXN;CCK;PIK3R1;ANG;PARVA;LAMA5;BBS2;SPRY2;FBLN1;DLC1;ROBO1;FRMD5;GLG1;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;FSCN1;SEMA4A;C5;PDE4D;SULF1;CDH13;TGFBR3;AMOTL1;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;ELMO3;LMO4;SYNE2;VANGL2;ARHGEF2;SDC2;SSH1;LYST;SOX9;ISL1;PRCP;GCNT1;PRKCA;RAB13;MOSPD2;PODXL;PAK6;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;MAGI2;HSPA5;SEMA4B;CFAP54;IFITM1;OPHN1;TPGS1;GDNF;DNAH1;DIXDC1;PPARG;BEX4;GCSAM;SASH1;POSTN;UNK;LGALS3;MIA3;ADGRA2;PIK3C2B;ELMO2;NIPBL;TTBK2;ADAM10;RHOBTB3;CELSR1;MYO1C;DOCK1
19674,GO:2000026,5.36320693350659e-10,1,210,1269,regulation of multicellular organismal development,BP,SERPINE2;FLOT1;FN1;FLRT2;CCBE1;CTGF;FBN1;SOX6;INPP5D;SFRP1;CD109;ZFP36L1;FAT4;TGFBR2;SLITRK6;EFEMP1;TENM4;COL5A2;ETV5;JPH2;DUSP6;ZFP36L2;SDK1;TNIK;NOS1;GAS6;FBN2;SNAI2;MAGED1;SULF2;COL5A1;ROR1;AXL;DPYSL2;EGFR;TSC22D3;FLRT3;SLC8A1;CSMD3;GJC2;THBS2;SERPINE1;VIM;NUPR1;FAM210B;AMIGO2;TIMP2;TENM3;PAK1;ANGPTL4;VDR;PTPRM;BMP4;ITM2C;PTK6;EIF2AK4;NEFL;PDCD4;STAT1;SORL1;LGALS1;PTPRS;WWTR1;PRICKLE1;DDIT3;DLG4;SEMA5A;PDGFA;MAP2;TIMP1;PHLDB1;GPNMB;CUL7;BTG1;ITGA3;TPBG;ANO6;GPX1;GLI3;DLG5;CNTN1;KITLG;ASAP1;PDPN;CTSV;PLXNB1;LRP1;FYN;XDH;LAMA3;CAV1;GLI2;RBFOX2;UST;PRKCZ;OAS2;ULK2;HMGA2;PIK3R1;SYT1;CAPRIN2;ACACB;LAMA5;SPRY2;JARID2;TP73;KLF13;S1PR5;PRKACB;METRN;ROBO1;TLR3;SNCA;ADAMTS7;FZD7;GLG1;PLXNA2;FGFR1;ALOX15B;DKK1;SEMA4A;C5;SETX;PSMB9;IL18;SULF1;G6PD;SOX13;KDM4C;NFATC4;TGFBR3;FZD1;PBX1;ENG;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;MEIS2;TCF4;CITED2;PLXNA1;MAF;TRAK1;FBXW8;POGLUT1;VANGL2;ARHGEF2;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;CRTC1;PLAG1;PRKCA;RGS14;TCF12;MEGF8;RET;ZFPM1;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;LRRN3;SP100;AGRN;NPHP3;MAGI2;KIAA1109;HSPA5;TGFB1I1;SEMA4B;ITGB8;ARHGEF19;YAP1;GDNF;ATRAID;DIXDC1;PPARG;SASH1;OBSL1;LGALS3;RARA;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;ANKH;FOS;KDM4A;CDK5RAP3;AGO4;MED12;NIPBL;ADM2;OXTR;CELSR1;RXRA
3385,GO:0007165,7.89032813877276e-10,1,492,3658,signal transduction,BP,SERPINE2;ITGB6;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;FAT4;TGFBR2;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;ANO1;GSN;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;ZFP36L2;TNIK;ANPEP;SKP2;BCAM;CLTCL1;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;ROR1;AXL;DPYSL2;DOCK9;EGFR;TMEM204;PEG10;ITPK1;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;PSTPIP1;CTNNAL1;TKFC;EVC;MAP3K6;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;ABCA1;NSG1;VDR;CHN2;PTPRM;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;RIN2;XAF1;NETO1;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;STAT1;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;TP53;ARAP1;EXTL2;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;PLEKHG3;DDX60;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;RBMS3;MICAL1;NISCH;TIMP1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;CRIM1;CUL7;ITGA3;CHD3;SIK1;IFIT3;HIVEP1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;ERMAP;ASAP1;PDPN;SRPX;SESN1;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;CAV1;SLC27A1;GLI2;RMI2;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;DOCK11;MAP3K14;SLC22A17;CLU;DCBLD2;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TP53INP1;IQSEC2;GPR39;TNS2;CAMK2D;ADGRG6;ITGA1;MST1R;KANK2;IL31RA;PER1;PXN;CCK;PIK3R1;HHAT;CAPRIN2;CREB3L2;PCLO;DUSP5;LAMA5;UNC5B;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;APLP2;FBLN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;CHEK2;ROBO1;IFT140;SPRY4;TLR3;SNCA;PDIA6;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;RGS2;C5;SETX;PDE4D;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;PDK3;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;ARHGEF17;AFAP1L2;CDH13;NFATC4;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;FZD1;AMOTL1;NOTCH2NL;PBX1;ENG;FOXL1;BBS4;MTMR4;CALR;MKLN1;ATM;EFNB3;SRGAP1;APH1B;MDM2;ARF6;DLK2;AREG;IFNK;ANXA6;AKAP13;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;NEURL1B;ZMAT3;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;SPRED3;KLHL12;SDC2;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRCP;NCOR1;NDRG1;PRKCA;SALL2;ANXA2;RGS14;RAB13;MPP7;LEPR;LANCL1;IGFBP4;DEPDC7;IFITM2;SAMD5;MVB12B;NFAT5;PAK6;MAP3K12;MEGF8;TSPAN5;UACA;HTR1B;STK36;RAB43;MAML2;WDR19;PRNP;RET;TGFB2;RBL2;MAP2K5;DLX2;OR2A4;STAT2;AMOTL2;IFT122;GPR161;LEF1;THRA;CDC42EP5;USP28;MAPK8IP3;CDKN2A;SPPL2B;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;BTN3A3;MAGI1;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;IFT74;IFITM1;OPHN1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;CAPS;DIXDC1;DERL3;MEIS3;PITPNC1;AGPAT1;PPARG;CALCRL;KCNIP3;MEF2A;GCSAM;SHISA9;ICK;SASH1;ING4;POSTN;LGALS3;PTPN3;ARL3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;COL4A1;CCNY;PRKAG1;TAF1;SENP7;EFNA5;FZD4;WIPF1;ADGRA2;PPP3CA;PIK3C2B;RASA1;ARHGAP31;CREBRF;CTDSP2;FOS;CDK5RAP3;AGO4;CLEC2D;FAM120B;CAMK2N1;ELMO2;MED12;ABAT;UGGT2;TTBK2;ADM2;BSN;OXTR;ADAM10;RHOBTB3;CELSR1;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;EDEM1;ACAA2;TAOK3;DOCK1;DMPK
11261,GO:0045595,9.2044000970459e-10,1,192,1151,regulation of cell differentiation,BP,SERPINE2;SULT1E1;FLOT1;FN1;FLRT2;CTGF;FBN1;SOX6;INPP5D;SFRP1;CD109;ZFP36L1;FAT4;TGFBR2;EFEMP1;TENM4;COL5A2;ETV5;DUSP6;ZFP36L2;SDK1;TNIK;NOS1;GAS6;FBN2;SNAI2;COL5A1;AXL;DPYSL2;EGFR;DOCK5;CSMD3;GJC2;SERPINE1;S100A10;VIM;FAM210B;TIMP2;TENM3;CXCL14;PAK1;ABCA1;VDR;BMP4;ITM2C;NR1D1;PTK6;EIF2AK4;NEFL;PDCD4;STAT1;SORL1;LGALS1;PTPRS;WWTR1;PRICKLE1;DDIT3;DLG4;SEMA5A;MAP2;PHLDB1;SMOC1;CCDC85B;CUL7;BTG1;ITGA3;SIK1;GLI3;DLG5;CNTN1;KITLG;ASAP1;PDPN;CTSV;PLXNB1;LRP1;FYN;XDH;LTBP4;ADIRF;CAV1;GLI2;RBFOX2;TRIB2;UST;PRKCZ;ULK2;TP53INP1;PIK3R1;SYT1;CAPRIN2;SPRY2;FBLN1;TP73;KLF13;S1PR5;METRN;ROBO1;WDFY2;TLR3;FLOT2;ADAMTS7;FZD7;GLG1;PLXNA2;FGFR1;ALOX15B;DKK1;SEMA4A;LTBP3;SETX;PSMB9;IL18;G6PD;SOX13;TRIOBP;KDM4C;NFATC4;FZD1;PBX1;ENG;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;DLK2;MEIS2;AREG;TCF4;AKAP13;PLXNA1;LMO4;MAF;TRAK1;FBXW8;ARHGEF2;SDC2;SSH1;SOX9;ENPP1;ISL1;ITPKB;BCL6;CRTC1;PLAG1;PRKCA;RGS14;TCF12;MEGF8;TAF8;RET;ZFPM1;TGFB2;DLX2;LEF1;THRA;ZADH2;NPHP3;MAGI2;KIAA1109;HSPA5;BOC;TGFB1I1;SEMA4B;IFITM1;YAP1;GDNF;KLF5;TWIST2;ATRAID;DIXDC1;PPARG;MEF2A;OBSL1;POSTN;LGALS3;RARA;EFNA5;FZD4;ADGRA2;ZBTB1;PPP3CA;FOS;KDM4A;CDK5RAP3;AGO4;NIPBL;ABCA5;DOCK1;DMPK
2429,GO:0005615,1.02243068109757e-09,1,315,2398,extracellular space,CC,SERPINE2;CPA4;ITGB6;TNFRSF6B;FLOT1;MMP2;PRSS23;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;GPRC5A;ITGB5;COL8A1;CTGF;FBN1;SFRP1;CD109;NQO1;FAT4;XPC;SLITRK6;PTGS1;ITGB4;EFEMP1;SLC7A8;ANO1;GSN;COL5A2;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;COL7A1;BCAM;CLTCL1;DNAJB4;GAS6;PDGFC;SULF2;COL5A1;UTRN;ARHGAP23;AXL;DPYSL2;EGFR;HSPA2;LAMB1;FLRT3;FKBP5;MYLK;SLC2A3;THBS2;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;CRTAP;S100A10;ANXA5;C1QTNF6;VIM;CSPG4;TKFC;MFAP5;TOM1L2;TIMP2;PDLIM2;PLEC;CXCL14;ABCA1;ANGPTL4;BMP4;ITM2C;TP53I3;PCSK1;AHNAK;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;LTBP1;KRT5;IL32;SEC14L2;MUC19;ARMC9;SEMA5A;ZCCHC11;PDGFA;FRMD4B;MMP19;PPL;TIMP1;EFEMP2;PHGDH;CRIM1;ITGA3;ELFN2;ANO6;GPX1;LAMC2;CNTN1;KITLG;ECH1;PLLP;CTDSPL;ABHD14B;CCDC80;KRT15;CTSV;SPG11;ARHGEF12;XDH;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;IGFL1;PLA2G6;CLU;SERPING1;SNX29;PRKCZ;SLIT3;PARP4;PRDX5;ITGA1;SYTL1;METTL7A;PDIA4;CCK;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;CES2;TTN;APLP2;CRELD2;FBLN1;CAT;CASP14;PRKACB;AARS;METRN;LRIG3;STOM;BPHL;MAN1A1;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GLG1;JADE2;CBR1;ALOX15B;DKK1;FSCN1;CTF1;SEMA4A;LTBP3;C5;TGFBI;TGM2;PSMB9;IL18;SULF1;PLA2R1;G6PD;MYOF;ARSD;CDH13;MAGEF1;ITGBL1;LMCD1;TGFBR3;NAGLU;ENG;MTMR4;CALR;NEGR1;IDH2;ARF6;FAM20A;TMED10;CST3;DLK2;AREG;IFNK;ANXA6;PLXNA1;HEXA;IFNE;IGFL2;AKR7A2;HSPA12A;SYNE2;HDAC11;RNPEP;POGLUT1;CPNE8;COL5A3;THNSL2;UCN2;ENPP1;PLD3;PRCP;NFASC;NDRG1;GCNT1;PRKCA;BCHE;PRPS2;ANXA2;TMC4;RAB13;CES3;ADAMTS15;MAN2B1;LANCL1;IGFBP4;ALDH9A1;MVB12B;GAL3ST4;PODXL;DECR1;MEGF8;UACA;IRF2BPL;RAB43;PRNP;CDH11;TGFB2;RBL2;DNASE1L1;COL12A1;SCNN1A;LIPA;LRRN3;ALDH7A1;ITM2A;EFR3A;OSBPL1A;AGRN;IGFBP2;HSPA5;REEP2;FLNB;SEMA4B;ITGB8;NAPRT;MON2;VPS13C;UGT1A6;CAPS;GALNT2;CAPG;SNX9;POSTN;LGALS3;ARL3;DNAJC3;RASSF9;ECM2;COL4A1;CCNY;PRKAG1;FZD4;SLITRK5;PEX1;KRT10;ACTR1B;PPCS;DNPH1;SERPINB5;SCPEP1;ABAT;MYH11;NIPBL;VPS36;TTBK2;PCDHGB5;ADAM10;RHOBTB3;S100A11;MYO1C;ACAA2;CTSD;LAMB2
9885,GO:0042221,1.46222943363842e-09,1,377,2772,response to chemical,BP,TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;TXNIP;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;XPC;PTGS1;IL20RB;SLC7A8;ANO1;GSN;COL5A2;ETV5;PKD2;PIK3C2G;IRS2;DUSP6;CYBRD1;ZFP36L2;SDK1;SKP2;NOS1;DNAJB4;GAS6;FBN2;PDGFC;SNAI2;SULF2;AXL;DPYSL2;EGFR;TMEM204;PEG10;HSPA2;FLRT3;SPTB;SLC8A1;SESN3;GJC2;RFX2;SERPINE1;DOK1;SERPINH1;KRT14;S100A10;RNF165;ANXA5;VIM;NUPR1;FAM210B;NTSR1;TIMP2;TADA3;CXCL14;PAK1;ABCA1;VDR;PTPRM;BMP4;TRIM38;NR1D1;PTK6;XAF1;TRIM5;NEFL;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;NEO1;IFIT2;LGALS1;GNG2;KCNMA1;D2HGDH;ETV1;TP53;KRT13;EXTL2;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;SLC7A11;SEMA5A;ITGA2;ZCCHC11;PDGFA;MAP2;MMP19;TIMP1;ACSL3;GPNMB;BCKDHB;DOCK4;CUL7;BTG1;ITGA3;SIK1;IFIT3;KLF9;ANO6;GPX1;GLI3;PAQR8;PTGES;MTHFR;SESN1;CTSV;PLXNB1;LRP1;FYN;IFI6;XDH;LTBP4;ADIRF;CMBL;CPS1;CAV1;SLC27A1;GLI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;SEL1L;GLDC;MAP3K14;SLC35F3;CLU;CXCR1;PRKCZ;SLIT3;OAS2;TP53INP1;PARP4;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;PTPN14;PER1;PXN;CCK;PIK3R1;SYT1;TMEM173;CREB3L2;CPT1A;ACACB;ANG;PARVA;LAMA5;UNC5B;BBS2;HERPUD1;ANK3;WFS1;SPRY2;CES2;TTN;JARID2;TP73;CAT;DAPK1;PRKACB;CHEK2;ROBO1;SPRY4;TLR3;BPHL;SNCA;ADAMTS7;MME;PDIA6;FZD7;AIP;GLG1;PAQR7;PLXNA2;COL16A1;PTPRU;FGFR1;IGF1R;LMNA;IFI35;DKK1;FSCN1;CTF1;SEMA4A;C5;SETX;PDE4D;TMEM129;NCOA2;PSMB9;IL18;SULF1;PLA2R1;PDK3;G6PD;MYOF;TLE4;IL17RE;EDA2R;CHD6;CDH13;NFATC4;TRAF1;TGFBR3;FZD1;ENG;BBS4;MTMR4;CALR;EFNB3;MDM2;TMED10;CST3;MEIS2;AREG;IFNK;AKAP13;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;DNAJC4;AKR7A2;PTPN1;VANGL2;ARHGEF2;PLGRKT;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;ISL1;ITPKB;BCL6;PRCP;NFASC;STK16;NCOR1;NDRG1;GCNT1;PRKCA;PXMP2;BCHE;ANXA2;RAB13;CES3;LEPR;IFITM2;MOSPD2;RPL13A;ABCC2;MEGF8;HTR1B;RAB43;PRNP;RET;CARF;TGFB2;MAP2K5;OR2A4;STAT2;LEF1;THRA;TRIML2;HERPUD2;SPPL2B;SP100;TSPYL2;AGRN;IGFBP2;RHBDD1;MAGI2;HSPA5;CDK19;TH;BOC;TGFB1I1;RSAD2;FLNB;SEMA4B;ITPR2;UGT1A3;IFITM1;OPHN1;UGT1A6;YAP1;CACNB1;GDNF;NUB1;KLF5;GPX8;SRR;DERL3;AGPAT1;PPARG;CALCRL;MEF2A;KLF7;SASH1;TGIF1;POSTN;LGALS3;DNAJC3;RARA;COL4A1;ABCA2;TMEM67;TAF1;EFNA5;GSTZ1;FZD4;SLITRK5;ADGRA2;PPP3CA;CREBRF;CTDSP2;STEAP2;HP1BP3;FOS;CDK5RAP3;AGO4;ELMO2;MED12;ABAT;UGGT2;OXTR;ADAM10;PRDM5;LITAF;MYO1C;RXRA;C2CD5;EDEM1;ACAA2;NFKBIE;LAMB2
4364,GO:0009986,1.54418945162437e-09,1,80,372,cell surface,CC,SERPINE2;ITGB6;KRT4;ITGB5;ITGA6;SFRP1;CD109;F2R;TGFBR2;SLITRK6;ITGB4;ANPEP;PROM2;BCAM;PDGFC;SULF2;ROR1;AXL;EGFR;SDC3;HSPA2;ANXA5;CSPG4;NTSR1;TIMP2;ABCA1;TNS1;LGALS1;SLC7A11;ITGA2;PDGFA;ITGA3;TPBG;ANO6;ERMAP;SRPX;CTSV;CLU;DCBLD2;ITGA1;MST1R;IL31RA;PDIA4;ANK3;TMEM8B;BTN3A1;BACE1;ROBO1;KCNJ5;ADAMTS7;VAMP1;SULF1;PLA2R1;CDH13;TGFBR3;FZD1;ENG;CALR;AREG;CD1D;KCNQ3;SDC2;ENPP1;ANXA2;ADAMTS15;ABCC2;NLGN4Y;SPA17;PRNP;CDH11;HSPA5;BTN3A3;ITGB8;RARA;EFNA5;FZD4;ADGRA2;CLEC2D;BSN;ADAM10
12893,GO:0051270,1.79310026347495e-09,1,119,613,regulation of cellular component movement,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;ITGA6;SFRP1;MMP28;RHOBTB2;F2R;TGFBR2;GJA5;IRS2;GAS6;PDGFC;SNAI2;TCAF1;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;COL18A1;SORL1;TP53;ARAP1;PYCARD;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;DLG5;KITLG;PDPN;PLXNB1;LRP1;ARHGAP18;LAMA3;CAV1;TP53INP1;ARPIN;CAMK2D;PIK3R1;LAMA5;BBS2;SPRY2;FBLN1;DLC1;ROBO1;FRMD5;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;SEMA4A;C5;PDE4D;SULF1;CDH13;TGFBR3;AMOTL1;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;LMO4;SYNE2;ARHGEF2;SSH1;SOX9;BCL6;PRCP;PRKCA;MOSPD2;PODXL;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;MAGI2;HSPA5;SEMA4B;IFITM1;PPARG;BEX4;GCSAM;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;TTBK2;ADAM10;MYO1C;DOCK1
9850,GO:0042127,1.87066525781329e-09,1,168,1030,regulation of cell proliferation,BP,SERPINE2;TNFRSF6B;MMP2;KRT4;TRNP1;HTRA1;FN1;MMP9;TXNIP;CTGF;INPP5D;SFRP1;CD109;CDKN2B;ZFP36L1;F2R;TGFBR2;PTGS1;IL20RB;ETV5;PKD2;IRS2;SKP2;GAS6;PDGFC;SNAI2;MAGED1;SULF2;EGFR;LAMB1;SPEG;GJC2;NUPR1;TIMP2;PAK1;VDR;PTPRM;BMP4;TP53I11;NR1D1;SMARCA2;PTK6;TBC1D8;VAV3;PDCD4;COL18A1;STAT1;TP53;WWTR1;PYCARD;MEF2D;SEMA5A;ITGA2;PDGFA;ADARB1;TIMP1;GPNMB;BTG1;IFIT3;KLF9;GPX1;LAMC2;GLI3;PTGES;E2F7;DLG5;KITLG;P3H2;PDPN;SRPX;CTSV;PLXNB1;FYN;EMP3;XDH;CLMN;CAV1;GLI2;RBFOX2;PRKCZ;SLIT3;FBXW4;TP53INP1;TNS2;HMGA2;ITGA1;MST1R;KANK2;IL31RA;PTPN14;CCK;ANG;LAMA5;SPRY2;JARID2;FBLN1;TP73;DLC1;KLF13;ROBO1;FZD7;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;CTF1;LTBP3;TGM2;IL18;SULF1;KDM4C;CDH13;TGFBR3;PBX1;CALR;ATM;IDH2;MDM2;CST3;MEIS2;AREG;IFNK;NR2F2;CD1D;CRIP2;ARHGEF2;NRK;EGR1;SOX9;ISL1;BCL6;NDRG1;PLAG1;PRKCA;BCHE;ANXA2;TES;HTR1B;PRNP;TGFB2;MAP2K5;IFT122;LEF1;SSBP3;CDKN2A;IGFBP2;MAGI2;TGFB1I1;SRPK2;IFT74;IFITM1;YAP1;GDNF;KLF5;ATRAID;HOXA3;PPARG;BEX4;CALCRL;ING4;LGALS3;RARA;HP1BP3;SERPINB5;CAMK2N1;ADAM10;S100A11
6854,GO:0030334,4.40548021155471e-09,1,107,540,regulation of cell migration,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;ITGA6;SFRP1;MMP28;RHOBTB2;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;TCAF1;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;COL18A1;SORL1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;DLG5;KITLG;PDPN;PLXNB1;LRP1;LAMA3;TP53INP1;ARPIN;PIK3R1;LAMA5;SPRY2;DLC1;ROBO1;FRMD5;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;SEMA4A;C5;SULF1;CDH13;AMOTL1;ENG;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;LMO4;SYNE2;ARHGEF2;SSH1;SOX9;PRCP;PRKCA;MOSPD2;PODXL;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;MAGI2;HSPA5;SEMA4B;IFITM1;PPARG;BEX4;GCSAM;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;TTBK2;ADAM10;MYO1C;DOCK1
9009,GO:0035239,4.52905121842976e-09,1,110,538,tube morphogenesis,BP,MMP2;FN1;CCBE1;COL8A1;CTGF;SFRP1;ZFP36L1;FAT4;TGFBR2;ETV5;GJA5;PKD2;ANPEP;MAGED1;EGFR;MYLK;THBS2;SERPINE1;RNF213;CSPG4;PAK1;ANGPTL4;VDR;PTPRM;BMP4;VAV3;COL18A1;STAT1;PRICKLE1;SEMA5A;PDGFA;MMP19;GPNMB;CUL7;BTG1;GPX1;GLI3;E2F7;DLG5;LRP1;XDH;CAV1;GLI2;HMGA2;ANG;PARVA;LAMA5;UNC5B;SPRY2;DLC1;PRKACB;ROBO1;TLR3;FGFR1;SEMA4A;C5;TGFBI;TGM2;IL18;SULF1;FZD8;CDH13;NFATC4;TGFBR3;FZD1;AMOTL1;PBX1;ENG;BBS4;AREG;NR2F2;LMO4;VANGL2;SOX9;ISL1;PRCP;PRKCA;ANXA2;HOXA1;LEPR;PODXL;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;IFT122;LEF1;SP100;NPHP3;VAV2;SRPK2;ITGB8;YAP1;GDNF;KLF5;KLHL3;HOXA3;PPARG;CALCRL;SASH1;RARA;COL4A1;FZD4;ADGRA2;RASA1;MED12;NIPBL;ADM2;CELSR1
19730,GO:2000145,5.56689171612759e-09,1,111,572,regulation of cell motility,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;ITGA6;SFRP1;MMP28;RHOBTB2;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;TCAF1;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;COL18A1;SORL1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;DLG5;KITLG;PDPN;PLXNB1;LRP1;ARHGAP18;LAMA3;TP53INP1;ARPIN;PIK3R1;LAMA5;BBS2;SPRY2;FBLN1;DLC1;ROBO1;FRMD5;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;SEMA4A;C5;SULF1;CDH13;AMOTL1;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;LMO4;SYNE2;ARHGEF2;SSH1;SOX9;PRCP;PRKCA;MOSPD2;PODXL;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;MAGI2;HSPA5;SEMA4B;IFITM1;PPARG;BEX4;GCSAM;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;TTBK2;ADAM10;MYO1C;DOCK1
6662,GO:0030030,6.04316362842602e-09,1,181,1046,cell projection organization,BP,FLOT1;FN1;FLRT2;ITGA6;SFRP1;APBB2;FAT4;SLITRK6;GSN;IRS2;SDK1;TNIK;PROM2;MAP6;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;CEP126;MYLK;CSMD3;RFX2;DOK1;RNF165;VIM;STMN3;TENM3;PAK1;PTPRM;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;VAV3;NEO1;LGALS1;ETV1;ARAP1;CEP250;PTPRS;WWTR1;CNTRL;DLG4;SEMA5A;ITGA2;PDGFA;MAP2;ADARB1;CUL7;ITGA3;EVI5L;EMP1;SNX1;ANO6;PLEK2;GLI3;DLG5;CNTN1;ASAP1;PDPN;SPG11;PLXNB1;LRP1;FYN;EMP3;CLMN;UGT8;CAV1;GLI2;RBFOX2;SPATA6;DOCK11;ESPN;UST;NPHP4;PRKCZ;SLIT3;ULK2;ARPIN;EHD3;ITGA1;HAUS4;CCK;PIK3R1;SYT1;CAPRIN2;KIF17;PARVA;LAMA5;UNC5B;BBS2;ANK3;SPRY2;METRN;ROBO1;IFT140;PLXNA2;DZIP1L;FGFR1;IGF1R;FSCN1;SEMA4A;SETX;TRIOBP;CDH13;NFATC4;RAPH1;SEPT6;FZD1;BBS4;NEGR1;EFNB3;MDM2;ARF6;AREG;BBS1;SNX10;PLXNA1;TRAK1;FBXW8;SYNE2;FGD4;VANGL2;NTNG1;SDC2;NRK;SSH1;IFT27;ISL1;NFASC;CRTC1;PRKCA;RAB13;SEPT5;IFT88;TTC8;PODXL;MEGF8;STK36;WDR19;PRNP;CDH11;RET;ODF2;IFT122;CDC42EP5;ULK1;AGRN;NPHP3;VAV2;MAGI2;HSPA5;BOC;SEMA4B;CFAP54;IFT74;OPHN1;TPGS1;GDNF;DNAH1;KLF5;MEF2A;KLF7;ICK;OBSL1;POSTN;ARL3;NYAP1;ECM2;TMEM67;EFNA5;FZD4;SLITRK5;PPP3CA;LIMA1;SEPT9;TTBK2;RHOBTB3;LAMB2
15733,GO:0072358,7.71635801763526e-09,1,96,462,cardiovascular system development,BP,MMP2;FN1;CCBE1;COL8A1;CTGF;SFRP1;ZFP36L1;TGFBR2;GJA5;PKD2;ANPEP;COL5A1;TMEM204;MYLK;THBS2;ACTA2;SERPINE1;RNF213;CSPG4;ANGPTL4;PTPRM;BMP4;VAV3;PDCD4;COL18A1;STAT1;PRICKLE1;DDIT3;LTBP1;SEMA5A;PDGFA;MMP19;GPNMB;CUL7;BTG1;GPX1;GLI3;E2F7;PDPN;LRP1;XDH;CAV1;HMGA2;PTPN14;ANG;PARVA;LAMA5;UNC5B;SPRY2;ROBO1;TLR3;FGFR1;SEMA4A;C5;TGFBI;IL18;SULF1;FZD8;CDH13;NFATC4;TGFBR3;DLX3;AMOTL1;ENG;MDM2;NR2F2;FBXW8;POGLUT1;EGR1;ISL1;PRCP;PRKCA;ANXA2;HOXA1;LEPR;MEGF8;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;SRPK2;ITGB8;YAP1;KLF5;HOXA3;PPARG;CALCRL;SASH1;COL4A1;FZD4;SLITRK5;ADGRA2;RASA1;ADM2
12656,GO:0050896,9.97606878974183e-09,1,681,5515,response to stimulus,BP,SERPINE2;ITGB6;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;XPC;SLITRK6;PTGS1;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;SLC7A8;ANO1;GSN;COL5A2;ETV5;PKD2;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;CYBRD1;ZFP36L2;SDK1;HERC5;TNIK;ANPEP;SKP2;BCAM;CLTCL1;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;TFPI2;ROR1;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;TMEM204;PEG10;ITPK1;HSPA2;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;MYLK;GJC2;SLC20A1;SLC2A3;RFX2;ACTA2;SERPINE1;DOK1;SERPINH1;RNF213;KRT14;TCF7L1;S100A10;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;FAM210B;MAP3K6;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;D2HGDH;ETV1;TP53;ARAP1;KRT13;EXTL2;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;PLEKHG3;DDX60;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;PILRB;ZCCHC11;PDGFA;MAP2;MMP19;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;HIP1;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;IFIT3;KLF9;HIVEP1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;TBC1D5;ERMAP;ASAP1;PLLP;PDPN;MTHFR;SRPX;SESN1;CTSV;SEC14L1;PLXNB1;KCNAB2;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;CPS1;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;DOCK11;GLDC;MAP3K14;SLC22A17;SLC35F3;CLU;DCBLD2;SERPING1;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TP53INP1;PARP4;IQSEC2;GPR39;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;PRDX5;ITGA1;MST1R;KANK2;IL31RA;METTL7A;ULBP1;PTPN14;PER1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;SLC38A2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;PARVA;LAMA5;UNC5B;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;CES2;TTN;CIRBP;JARID2;APLP2;HPS4;FBLN1;MLH3;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;CHEK2;ROBO1;IFT140;SPRY4;STOM;TLR3;BPHL;SNCA;ADAMTS7;MME;PDIA6;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;CTF1;SEMA4A;RGS2;C5;TGFBI;SETX;PDE4D;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;PLA2R1;PDK3;G6PD;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;ARHGEF17;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;FZD1;AMOTL1;NOTCH2NL;PBX1;ENG;FOXL1;BBS4;MTMR4;CALR;MKLN1;ATM;EFNB3;SRGAP1;APH1B;MDM2;ARF6;TMED10;CST3;DLK2;MEIS2;MANBA;AREG;IFNK;BBS1;ANXA6;AKAP13;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;NEURL1B;DNAJC4;AKR7A2;ZMAT3;MSH5;CD1D;IFI44;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;PLGRKT;SPRED3;KLHL12;SDC2;THNSL2;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRCP;NFASC;STK16;CRTC1;NCOR1;NDRG1;GCNT1;PRKCA;SALL2;PXMP2;BCHE;ANXA2;RGS14;RAB13;PRIMPOL;CES3;HOXA1;MPP7;CXORF57;LEPR;MAN2B1;LANCL1;IGFBP4;DEPDC7;IFITM2;SAMD5;MVB12B;MOSPD2;TCF12;NFAT5;RPL13A;PAK6;ABCC2;MAP3K12;MEGF8;TSPAN5;UACA;HTR1B;STK36;RAB43;MAML2;WDR19;MUTYH;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;DNASE1L1;OR2A4;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;GPR161;LIPA;LEF1;THRA;CDC42EP5;USP28;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;CDKN2A;HERPUD2;SPPL2B;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;BTN3A3;CDK19;TH;MAGI1;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;NAPRT;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;IFT74;POLD4;IFITM1;OPHN1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;RALGAPB;NUB1;KLF5;COL17A1;GPX8;CAPS;SRR;UBA7;DIXDC1;DERL3;MEIS3;PITPNC1;AGPAT1;PPARG;CALCRL;TPST1;KCNIP3;MEF2A;GCSAM;KLF7;SHISA9;ICK;SASH1;TGIF1;ING4;APOL6;POSTN;PRR7;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;COL4A1;ABCA2;CCNY;POLH;TMEM67;PRKAG1;TAF1;SENP7;EFNA5;GSTZ1;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;PPP3CA;PIK3C2B;RASA1;ARHGAP31;CREBRF;CTDSP2;STEAP2;ACTR1B;HP1BP3;FOS;KDM4A;CDK5RAP3;AGO4;CLEC2D;FAM120B;FAM168A;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;NIPBL;UGGT2;TTBK2;ADM2;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;CELSR1;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;GBP3;EDEM1;ACAA2;TAOK3;NFKBIE;CTSD;DOCK1;DMPK;LAMB2
12315,GO:0048699,1.18782625614705e-08,1,167,944,generation of neurons,BP,SERPINE2;FLOT1;FN1;FLRT2;SFRP1;APBB2;DDIT4;FAT4;SLITRK6;TENM4;ETV5;IRS2;SDK1;TNIK;NOS1;GAS6;MAP6;AXL;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;NTM;CSMD3;GJC2;DOK1;TCF7L1;RNF165;VIM;STMN3;TIMP2;TENM3;PAK1;PTPRM;BMP4;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;SORL1;NEO1;LGALS1;ETV1;PTPRS;WNK1;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;SPG11;PLXNB1;LRP1;FYN;CLMN;UGT8;GLI2;RBFOX2;SMARCA1;UST;NPHP4;PRKCZ;SLIT3;ULK2;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;TP73;S1PR5;METRN;ROBO1;IFT140;FZD7;PLXNA2;FGFR1;DKK1;CTF1;SEMA4A;SETX;FZD8;TRIOBP;KDM4C;NFATC4;RAPH1;FZD1;LRTOMT;NAGLU;PBX1;BBS4;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;AREG;TCF4;NR2F2;PLXNA1;LMO4;TRAK1;FBXW8;VANGL2;ARHGEF2;NTNG1;SDC2;NRK;SSH1;SOX9;IFT27;ISL1;BCL6;NFASC;CRTC1;PLAG1;PRKCA;BCHE;RGS14;RAB13;TCF12;MEGF8;CDH11;RET;TGFB2;DLX2;LEF1;ULK1;AGRN;MAGI2;HSPA5;TH;BOC;SEMA4B;OPHN1;YAP1;GDNF;DIXDC1;PPARG;MEF2A;KLF7;OBSL1;POSTN;UNK;ARL3;NYAP1;RARA;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;KDM4A;CDK5RAP3;NIPBL;CELSR1;LAMB2
4560,GO:0010646,1.54423344340251e-08,1,327,2308,regulation of cell communication,BP,SERPINE2;FLOT1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;F2R;DDIT4;TGFBR2;EFEMP1;ASAP3;ANO1;GSN;GJA5;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;ROR1;AXL;EGFR;TMEM204;PEG10;FLRT3;SLC8A1;SESN3;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;CSPG4;TKFC;EVC;MAP3K6;STMN3;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;NSG1;CHN2;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;EIF2AK4;NETO1;TRIM5;VAV3;PDCD4;STAT1;SORL1;NEO1;LGALS1;TP53;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;WNK1;PLEKHG3;DDX60;ARHGEF1;DLG4;SEMA5A;ITGA2;PDGFA;RBMS3;NISCH;TIMP1;HIP1;GPNMB;TFDP2;ITGA3;CHD3;GPX1;GLI3;CDK14;DLG5;KITLG;ASAP1;SYN1;SRPX;SESN1;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;CAV1;GLI2;RMI2;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;NPHP4;PRKCZ;SLIT3;TP53INP1;IQSEC2;CAMK2D;ITGA1;MST1R;KANK2;IL31RA;PER1;PXN;CCK;PIK3R1;SYT1;CAPRIN2;CPT1A;DUSP5;UNC5B;HERPUD1;ANK3;WFS1;MDFI;SPRY2;FBLN1;TP73;CAT;DAPK1;DLC1;PRKACB;CHEK2;BACE1;ROBO1;IFT140;SPRY4;TLR3;SNCA;FZD7;AIP;GLG1;SH3TC2;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;DKK1;PRKAB2;CTF1;RGS2;C5;PDE4D;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;MYOF;EPHB6;EDA2R;FZD8;ARHGEF17;SLC24A1;AFAP1L2;CDH13;NFATC4;TRAF1;AKAP7;LMCD1;TGFBR3;FZD1;ENG;FOXL1;MTMR4;CALR;ATM;SRGAP1;MDM2;ARF6;DLK2;AREG;IFNK;AKAP13;DGKQ;CITED2;GCLC;IFNE;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;SPRED3;KLHL12;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;ITPKB;BCL6;PRCP;CRTC1;NCOR1;PRKCA;BCHE;RGS14;MPP7;SEPT5;IGFBP4;DEPDC7;SAMD5;MVB12B;NFAT5;PAK6;MAP3K12;MEGF8;TSPAN5;NLGN4Y;UACA;HTR1B;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;DLX2;STAT2;IFT122;GPR161;LEF1;THRA;MAPK8IP3;SPPL2B;SP100;TSPYL2;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;TGFB1I1;RSAD2;ARHGEF19;ITPR2;ARHGAP29;MDFIC;OPHN1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;DIXDC1;MEIS3;AGPAT1;PPARG;GCSAM;SHISA9;SASH1;POSTN;LGALS3;PTPN3;RARA;CCNY;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ADGRA2;PPP3CA;RASA1;ARHGAP31;CREBRF;CDK5RAP3;CAMK2N1;MED12;ABAT;ADM2;OXTR;LITAF;MYO1C;ACAA2;TAOK3;DMPK
3525,GO:0007507,1.65801605698822e-08,1,80,353,heart development,BP,FLRT2;ADAM19;FBN1;SOX6;ZFP36L1;FAT4;TGFBR2;TENM4;GJA5;PKD2;JPH2;DUSP6;SNAI2;COL5A1;EGFR;FLRT3;SLC8A1;PAK1;BMP4;PDCD4;PRICKLE1;LTBP1;MEF2D;TFDP2;ITGA3;SIK1;GLI3;GLI2;ADGRG6;ACACB;PARVA;TTN;JARID2;TP73;DLC1;ROBO1;IFT140;FZD7;FGFR1;LMNA;DKK1;G6PD;NFATC4;TGFBR3;FZD1;ENG;FOXL1;BBS4;CALR;ATM;MDM2;AKAP13;CITED2;FHOD3;LMO4;VANGL2;SOX9;ISL1;TCF25;MEGF8;ZFPM1;TGFB2;MAP2K5;SMG9;IFT122;NPHP3;TH;IFT74;YAP1;PPARG;CALCRL;MEF2A;OBSL1;RARA;MED12;MYH11;NIPBL;OXTR;RXRA;MOSPD3
717,GO:0001944,1.7903816832003e-08,1,94,456,vasculature development,BP,MMP2;FN1;CCBE1;COL8A1;CTGF;SFRP1;ZFP36L1;TGFBR2;GJA5;PKD2;ANPEP;COL5A1;TMEM204;MYLK;THBS2;ACTA2;SERPINE1;RNF213;CSPG4;ANGPTL4;PTPRM;BMP4;VAV3;PDCD4;COL18A1;STAT1;PRICKLE1;DDIT3;LTBP1;SEMA5A;PDGFA;MMP19;GPNMB;CUL7;BTG1;GPX1;GLI3;E2F7;PDPN;LRP1;XDH;CAV1;HMGA2;PTPN14;ANG;PARVA;LAMA5;UNC5B;SPRY2;ROBO1;TLR3;FGFR1;SEMA4A;C5;TGFBI;IL18;SULF1;FZD8;CDH13;NFATC4;TGFBR3;DLX3;AMOTL1;ENG;MDM2;NR2F2;FBXW8;EGR1;ISL1;PRCP;PRKCA;ANXA2;HOXA1;LEPR;MEGF8;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;SRPK2;ITGB8;YAP1;KLF5;HOXA3;PPARG;CALCRL;SASH1;COL4A1;FZD4;ADGRA2;RASA1;ADM2
6638,GO:0023051,1.82970930318581e-08,1,330,2339,regulation of signaling,BP,SERPINE2;FLOT1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;F2R;DDIT4;TGFBR2;EFEMP1;ASAP3;ANO1;GSN;GJA5;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;ROR1;AXL;EGFR;TMEM204;PEG10;FLRT3;SLC8A1;SESN3;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;CSPG4;TKFC;EVC;MAP3K6;STMN3;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;NSG1;CHN2;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;EIF2AK4;NETO1;TRIM5;VAV3;PDCD4;STAT1;SORL1;NEO1;LGALS1;TP53;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;WNK1;PLEKHG3;DDX60;ARHGEF1;DLG4;SEMA5A;ITGA2;PDGFA;RBMS3;NISCH;TIMP1;HIP1;GPNMB;TFDP2;ITGA3;CHD3;GPX1;GLI3;CDK14;DLG5;KITLG;ASAP1;SYN1;SRPX;SESN1;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;CAV1;GLI2;RMI2;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;NPHP4;PRKCZ;SLIT3;TP53INP1;IQSEC2;EHD3;CAMK2D;ITGA1;MST1R;KANK2;IL31RA;PER1;PXN;CCK;PIK3R1;SYT1;CAPRIN2;CPT1A;DUSP5;UNC5B;HERPUD1;WFS1;MDFI;SPRY2;LMO7;FBLN1;TP73;CAT;DAPK1;DLC1;PRKACB;CHEK2;BACE1;ROBO1;IFT140;SPRY4;TLR3;SNCA;FZD7;AIP;GLG1;SH3TC2;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;DKK1;PRKAB2;CTF1;RGS2;C5;PDE4D;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;MYOF;EPHB6;EDA2R;FZD8;ARHGEF17;SLC24A1;AFAP1L2;CDH13;NFATC4;TRAF1;AKAP7;LMCD1;TGFBR3;FZD1;ENG;FOXL1;MTMR4;CALR;ATM;SRGAP1;MDM2;ARF6;DLK2;AREG;IFNK;AKAP13;DGKQ;CITED2;GCLC;IFNE;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;SPRED3;KLHL12;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;ITPKB;BCL6;PRCP;CRTC1;NCOR1;PRKCA;BCHE;ANXA2;RGS14;MPP7;SEPT5;IGFBP4;DEPDC7;SAMD5;MVB12B;NFAT5;PAK6;MAP3K12;MEGF8;TSPAN5;NLGN4Y;UACA;HTR1B;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;DLX2;STAT2;IFT122;GPR161;LEF1;THRA;MAPK8IP3;SPPL2B;SP100;TSPYL2;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;TGFB1I1;RSAD2;ARHGEF19;ITPR2;ARHGAP29;MDFIC;OPHN1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;DIXDC1;MEIS3;AGPAT1;PPARG;GCSAM;SHISA9;SASH1;TBC1D16;POSTN;LGALS3;PTPN3;RARA;CCNY;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ADGRA2;PPP3CA;RASA1;ARHGAP31;CREBRF;CDK5RAP3;CAMK2N1;MED12;ABAT;ADM2;OXTR;LITAF;MYO1C;ACAA2;TAOK3;DMPK
14949,GO:0070887,2.10275927597027e-08,1,293,2112,cellular response to chemical stimulus,BP,TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;DDIT4;FAT4;TGFBR2;PTGS1;IL20RB;ANO1;GSN;COL5A2;ETV5;PKD2;IRS2;DUSP6;ZFP36L2;SKP2;NOS1;GAS6;FBN2;PDGFC;SNAI2;SULF2;AXL;EGFR;TMEM204;PEG10;HSPA2;FLRT3;SLC8A1;SESN3;RFX2;SERPINE1;RNF165;VIM;FAM210B;TADA3;CXCL14;PAK1;ABCA1;VDR;BMP4;TRIM38;NR1D1;PTK6;XAF1;TRIM5;VAV3;PDCD4;NR3C1;STAT1;NEO1;IFIT2;LGALS1;GNG2;TP53;KRT13;EXTL2;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;SEMA5A;ITGA2;ZCCHC11;MAP2;TIMP1;DOCK4;CUL7;ITGA3;SIK1;IFIT3;KLF9;ANO6;GPX1;PAQR8;SESN1;LRP1;FYN;IFI6;XDH;LTBP4;ADIRF;CMBL;CPS1;CAV1;SLC27A1;GLI2;RBFOX2;PLA2G6;GLDC;MAP3K14;CLU;CXCR1;PRKCZ;SLIT3;OAS2;TP53INP1;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;PTPN14;PER1;PXN;PIK3R1;SYT1;TMEM173;CREB3L2;CPT1A;PARVA;LAMA5;BBS2;HERPUD1;ANK3;WFS1;SPRY2;CES2;JARID2;CAT;DAPK1;PRKACB;CHEK2;ROBO1;SPRY4;TLR3;BPHL;SNCA;ADAMTS7;MME;PDIA6;FZD7;AIP;GLG1;PAQR7;COL16A1;FGFR1;IGF1R;LMNA;IFI35;DKK1;FSCN1;CTF1;C5;SETX;PDE4D;NCOA2;PSMB9;IL18;SULF1;PLA2R1;PDK3;G6PD;MYOF;TLE4;IL17RE;EDA2R;CHD6;NFATC4;TRAF1;TGFBR3;FZD1;ENG;BBS4;MTMR4;CALR;MDM2;CST3;IFNK;AKAP13;SNX10;CITED2;GCLC;NR2F2;IFNE;AKR7A2;PTPN1;ARHGEF2;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;NCOR1;NDRG1;PRKCA;PXMP2;BCHE;ANXA2;RAB13;CES3;LEPR;IFITM2;MOSPD2;RPL13A;ABCC2;MEGF8;HTR1B;RAB43;PRNP;RET;CARF;TGFB2;MAP2K5;STAT2;LEF1;THRA;SPPL2B;SP100;TSPYL2;AGRN;IGFBP2;RHBDD1;MAGI2;HSPA5;CDK19;TH;TGFB1I1;RSAD2;FLNB;ITPR2;UGT1A3;IFITM1;UGT1A6;YAP1;CACNB1;KLF5;GPX8;DERL3;AGPAT1;PPARG;CALCRL;MEF2A;SASH1;TGIF1;POSTN;LGALS3;DNAJC3;RARA;COL4A1;TAF1;EFNA5;GSTZ1;FZD4;ADGRA2;PPP3CA;CREBRF;CTDSP2;HP1BP3;FOS;CDK5RAP3;AGO4;ELMO2;MED12;UGGT2;OXTR;ADAM10;PRDM5;LITAF;MYO1C;RXRA;C2CD5;EDEM1;ACAA2
10892,GO:0044459,2.18125037166026e-08,1,227,1445,plasma membrane part,CC,SERPINE2;ITGB6;TNFRSF6B;FLOT1;FN1;PCDH7;FLRT2;GPRC5A;ITGB5;ITGA6;SYNE1;F2R;TGFBR2;SLITRK6;ITGB4;TENM4;SLC7A8;ANO1;GJA5;PKD2;CYBRD1;TNIK;ANPEP;PROM2;BCAM;NOS1;APCDD1;UTRN;ROR1;AXL;EGFR;ITPK1;HSPA2;FLRT3;SPTB;SLC8A1;CLCA2;MYLK;GJC2;SLC20A1;SLC2A3;S100A10;ANXA5;CSPG4;PSTPIP1;EVC;NTSR1;TENM3;PAK1;ABCA1;NSG1;PTPRM;PTK6;AHNAK;SCN8A;NETO1;MRC2;SORL1;NEO1;SCN2A;GNG2;KCNMA1;PTPRS;DLG4;SLC7A11;ITGA2;PILRB;HIP1;GPNMB;ITGA3;PCDHAC2;SLC22A15;TPBG;PLEK2;DLG5;TBC1D5;ERMAP;ASAP1;PDPN;CTSV;PLXNB1;KCNAB2;LRP1;FYN;CAV1;ITGA10;SLC22A17;AHNAK2;DCBLD2;PRKCZ;GPR39;KCNJ15;EHD3;ITGA1;MST1R;SYTL1;IL31RA;ULBP1;SYT1;SLC38A2;CALHM2;DYSF;KIF17;BBS2;ANK3;SPRY2;SHROOM4;DLC1;BTN3A1;BACE1;ROBO1;KCNJ5;SPRY4;STOM;PRX;TLR3;FLOT2;MME;VAMP1;NIPSNAP1;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;FSCN1;RGS2;C5;PDE4D;TGM2;PLA2R1;ESYT2;TRO;G6PD;MYOF;EPHB6;IL17RE;EDA2R;FZD8;SLC24A1;CDH13;SEPT6;TGFBR3;AMOTL1;ENG;BBS4;CALR;EFNB3;APH1B;ARF6;TMED10;BBS1;PLXNA1;CD1D;LZTS1;SYNE2;KCNQ3;VANGL2;ARHGEF2;NTNG1;PLGRKT;SSH1;ENPP1;PCDHGA11;PRKCA;ANXA2;RGS14;RAB13;MPP7;LEPR;TTC8;MOSPD2;PODXL;ABCC2;TSPAN5;NLGN4Y;XG;HTR1B;SPA17;PRNP;CDH11;RET;OR2A4;SCNN1A;AMOTL2;GPR161;IGFBP2;BTN3A3;TH;GOPC;SLC9A4;BOC;REEP2;ITGB8;CACNB1;COL17A1;CALCRL;KCNIP3;SNX9;SHISA9;PRR7;LGALS3;PTPN3;TSPAN18;ABCA2;TMEM67;EFNA5;FZD4;PPP3CA;RASA1;ANKH;LIMA1;STEAP2;DNM1P46;CLEC2D;CAMK2N1;PCDHGB5;OXTR;ADAM10;CELSR1;MPDZ;LITAF;TSPAN4;MYO1C;TUSC3;C2CD5;SNTB1
3742,GO:0008283,2.81449316177221e-08,1,200,1325,cell proliferation,BP,SERPINE2;TNFRSF6B;MMP2;KRT4;TRNP1;HTRA1;FN1;MMP9;TXNIP;COL8A1;CTGF;INPP5D;SFRP1;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;FAT4;TGFBR2;PTGS1;TENM4;IL20RB;ETV5;PKD2;IRS2;ZFP36L2;SKP2;GAS6;PDGFC;SNAI2;MAGED1;SULF2;EGFR;LAMB1;SPEG;GJC2;NUPR1;CSPG4;TIMP2;PAK1;VDR;PTPRM;BMP4;TP53I11;NR1D1;SMARCA2;PTK6;TBC1D8;VAV3;PDCD4;COL18A1;STAT1;GNG2;TP53;WWTR1;PYCARD;MEF2D;ARHGEF1;SEMA5A;ITGA2;PDGFA;ADARB1;TIMP1;GPNMB;BTG1;EMP1;IFIT3;KLF9;GPX1;LAMC2;GLI3;PTGES;E2F7;DLG5;KITLG;P3H2;PDPN;SRPX;CTSV;PLXNB1;LRP1;FYN;EMP3;XDH;CLMN;CAV1;GLI2;HLCS;RBFOX2;CLU;PRKCZ;SLIT3;SDR16C5;FBXW4;TP53INP1;TNS2;HMGA2;ITGA1;MST1R;KANK2;IL31RA;PTPN14;CCK;ANG;LAMA5;UHRF2;SPRY2;JARID2;FBLN1;TP73;DLC1;KLF13;BTN3A1;ROBO1;FBXL7;FZD7;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;FSCN1;CTF1;LTBP3;TGFBI;TGM2;IL18;SULF1;KDM4C;CDH13;TGFBR3;PBX1;CALR;ATM;IDH2;MDM2;CST3;MEIS2;AREG;IFNK;CITED2;NR2F2;IFNE;CD1D;FBXW8;CRIP2;ARHGEF2;NRK;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PLAG1;PRKCA;BCHE;ANXA2;IGFBP4;TES;NAB2;HTR1B;TAF8;PRNP;TGFB2;MAP2K5;IFT122;LIPA;LEF1;SSBP3;USP28;CDKN2A;IGFBP2;MAGI2;TGFB1I1;SRPK2;IFT74;IFITM1;TACC2;YAP1;GDNF;KLF5;ATRAID;HOXA3;DIXDC1;PPARG;BEX4;CALCRL;ING4;LGALS3;RARA;HP1BP3;DNPH1;CDK5RAP3;SERPINB5;CAMK2N1;ADAM10;S100A11;RXRA
4358,GO:0009966,2.82594826914553e-08,1,304,2136,regulation of signal transduction,BP,SERPINE2;FLOT1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;F2R;DDIT4;TGFBR2;EFEMP1;ASAP3;GSN;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;ROR1;AXL;EGFR;TMEM204;PEG10;FLRT3;SESN3;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;CSPG4;TKFC;EVC;MAP3K6;STMN3;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;CHN2;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;NETO1;TRIM5;VAV3;PDCD4;STAT1;SORL1;NEO1;LGALS1;TP53;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;WNK1;PLEKHG3;DDX60;ARHGEF1;DLG4;SEMA5A;PDGFA;RBMS3;TIMP1;HIP1;GPNMB;TFDP2;ITGA3;CHD3;GPX1;GLI3;CDK14;DLG5;KITLG;ASAP1;SRPX;SESN1;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;CAV1;GLI2;RMI2;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;NPHP4;PRKCZ;SLIT3;TP53INP1;IQSEC2;CAMK2D;ITGA1;MST1R;KANK2;IL31RA;PER1;PXN;CCK;PIK3R1;CAPRIN2;DUSP5;UNC5B;HERPUD1;WFS1;MDFI;SPRY2;FBLN1;TP73;CAT;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;IFT140;SPRY4;TLR3;SNCA;FZD7;AIP;GLG1;SH3TC2;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;DKK1;PRKAB2;CTF1;RGS2;C5;PDE4D;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;MYOF;EPHB6;EDA2R;FZD8;ARHGEF17;AFAP1L2;CDH13;NFATC4;TRAF1;AKAP7;LMCD1;TGFBR3;FZD1;ENG;FOXL1;MTMR4;CALR;ATM;SRGAP1;MDM2;ARF6;DLK2;AREG;IFNK;AKAP13;DGKQ;CITED2;GCLC;IFNE;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;SPRED3;KLHL12;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;ITPKB;BCL6;PRCP;NCOR1;PRKCA;RGS14;MPP7;IGFBP4;DEPDC7;SAMD5;MVB12B;NFAT5;PAK6;MAP3K12;MEGF8;TSPAN5;UACA;HTR1B;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;DLX2;STAT2;IFT122;GPR161;LEF1;THRA;MAPK8IP3;SPPL2B;SP100;TSPYL2;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;TGFB1I1;RSAD2;ARHGEF19;ARHGAP29;MDFIC;OPHN1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;DIXDC1;MEIS3;AGPAT1;PPARG;GCSAM;SHISA9;SASH1;POSTN;LGALS3;PTPN3;CCNY;PRKAG1;TAF1;FZD4;ADGRA2;RASA1;ARHGAP31;CREBRF;CDK5RAP3;CAMK2N1;MED12;ABAT;ADM2;LITAF;MYO1C;ACAA2;TAOK3;DMPK
17225,GO:0120036,3.31817346752771e-08,1,175,1025,plasma membrane bounded cell projection organization,BP,FLOT1;FN1;FLRT2;ITGA6;SFRP1;APBB2;FAT4;SLITRK6;GSN;IRS2;SDK1;TNIK;MAP6;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;CEP126;MYLK;CSMD3;RFX2;DOK1;RNF165;VIM;STMN3;TENM3;PAK1;PTPRM;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;VAV3;NEO1;LGALS1;ETV1;ARAP1;CEP250;PTPRS;WWTR1;CNTRL;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;EVI5L;EMP1;SNX1;ANO6;GLI3;DLG5;CNTN1;ASAP1;PDPN;SPG11;PLXNB1;LRP1;FYN;EMP3;CLMN;UGT8;CAV1;GLI2;RBFOX2;SPATA6;DOCK11;ESPN;UST;NPHP4;PRKCZ;SLIT3;ULK2;ARPIN;EHD3;ITGA1;HAUS4;CCK;PIK3R1;SYT1;CAPRIN2;KIF17;PARVA;LAMA5;UNC5B;BBS2;ANK3;METRN;ROBO1;IFT140;PLXNA2;DZIP1L;FGFR1;IGF1R;FSCN1;SEMA4A;SETX;TRIOBP;CDH13;NFATC4;RAPH1;SEPT6;FZD1;BBS4;NEGR1;EFNB3;MDM2;ARF6;AREG;BBS1;SNX10;PLXNA1;TRAK1;FBXW8;SYNE2;FGD4;VANGL2;NTNG1;SDC2;NRK;SSH1;IFT27;ISL1;NFASC;CRTC1;PRKCA;RAB13;SEPT5;IFT88;TTC8;PODXL;MEGF8;STK36;WDR19;PRNP;CDH11;RET;ODF2;IFT122;CDC42EP5;ULK1;AGRN;NPHP3;VAV2;MAGI2;HSPA5;BOC;SEMA4B;CFAP54;IFT74;OPHN1;TPGS1;GDNF;DNAH1;KLF5;MEF2A;KLF7;ICK;OBSL1;POSTN;ARL3;NYAP1;ECM2;TMEM67;EFNA5;FZD4;SLITRK5;PPP3CA;LIMA1;SEPT9;TTBK2;LAMB2
3744,GO:0008285,4.58236685589393e-08,1,88,471,negative regulation of cell proliferation,BP,SERPINE2;KRT4;INPP5D;SFRP1;CD109;CDKN2B;F2R;TGFBR2;IL20RB;PKD2;SNAI2;MAGED1;SPEG;NUPR1;TIMP2;PAK1;VDR;PTPRM;BMP4;TP53I11;SMARCA2;PDCD4;COL18A1;STAT1;TP53;ADARB1;GPNMB;BTG1;IFIT3;KLF9;GLI3;PTGES;E2F7;DLG5;P3H2;PDPN;SRPX;CTSV;PLXNB1;EMP3;XDH;CLMN;CAV1;SLIT3;TP53INP1;TNS2;ITGA1;KANK2;PTPN14;ANG;SPRY2;JARID2;FBLN1;TP73;DLC1;KLF13;ROBO1;PTPRU;LMNA;ALOX15B;SULF1;CDH13;TGFBR3;ATM;IDH2;IFNK;NR2F2;NRK;SOX9;ISL1;BCL6;NDRG1;BCHE;TES;PRNP;TGFB2;IFT122;CDKN2A;MAGI2;TGFB1I1;IFT74;IFITM1;ATRAID;PPARG;ING4;RARA;CAMK2N1;S100A11
13244,GO:0051960,4.62475537018362e-08,1,107,547,regulation of nervous system development,BP,SERPINE2;FN1;FLRT2;SFRP1;SLITRK6;TENM4;ETV5;SDK1;TNIK;NOS1;DPYSL2;FLRT3;CSMD3;GJC2;THBS2;VIM;AMIGO2;TIMP2;TENM3;PAK1;BMP4;ITM2C;PTK6;EIF2AK4;NEFL;SORL1;LGALS1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;ITGA3;TPBG;GLI3;DLG5;CNTN1;ASAP1;PLXNB1;LRP1;FYN;GLI2;UST;ULK2;SYT1;CAPRIN2;TP73;S1PR5;PRKACB;METRN;ROBO1;SNCA;PLXNA2;FGFR1;DKK1;SEMA4A;SETX;KDM4C;NFATC4;FZD1;PBX1;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;TCF4;PLXNA1;TRAK1;FBXW8;VANGL2;ARHGEF2;SDC2;SSH1;SOX9;ISL1;BCL6;CRTC1;PLAG1;RGS14;TCF12;MEGF8;RET;DLX2;IFT122;GPR161;LRRN3;AGRN;NPHP3;MAGI2;HSPA5;SEMA4B;YAP1;DIXDC1;PPARG;OBSL1;RARA;EFNA5;FZD4;SLITRK5;PPP3CA;KDM4A;CDK5RAP3;NIPBL;OXTR;CELSR1
505,GO:0001568,4.98530852106956e-08,1,90,436,blood vessel development,BP,MMP2;FN1;CCBE1;COL8A1;CTGF;SFRP1;ZFP36L1;TGFBR2;GJA5;PKD2;ANPEP;COL5A1;MYLK;THBS2;ACTA2;SERPINE1;RNF213;CSPG4;ANGPTL4;PTPRM;BMP4;VAV3;COL18A1;STAT1;PRICKLE1;DDIT3;LTBP1;SEMA5A;PDGFA;MMP19;GPNMB;CUL7;BTG1;GPX1;GLI3;E2F7;LRP1;XDH;CAV1;HMGA2;ANG;PARVA;LAMA5;UNC5B;SPRY2;ROBO1;TLR3;FGFR1;SEMA4A;C5;TGFBI;IL18;SULF1;FZD8;CDH13;NFATC4;TGFBR3;DLX3;AMOTL1;ENG;MDM2;NR2F2;FBXW8;EGR1;ISL1;PRCP;PRKCA;ANXA2;HOXA1;LEPR;MEGF8;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;SRPK2;ITGB8;YAP1;KLF5;HOXA3;PPARG;CALCRL;SASH1;COL4A1;FZD4;ADGRA2;RASA1;ADM2
9775,GO:0040012,5.48289345745082e-08,1,114,619,regulation of locomotion,BP,SERPINE2;FN1;FLRT2;MMP9;CCBE1;ITGA6;SFRP1;MMP28;RHOBTB2;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;TCAF1;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;PTPRM;SRGAP3;BMP4;TRIM5;COL18A1;SORL1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;NISCH;ADARB1;TIMP1;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;DLG5;KITLG;PDPN;PLXNB1;LRP1;ARHGAP18;LAMA3;TP53INP1;ARPIN;PIK3R1;LAMA5;BBS2;SPRY2;FBLN1;DLC1;ROBO1;SNCA;FRMD5;PLXNA2;PTPRU;FGFR1;IGF1R;LMNA;ALOX15B;SEMA4A;C5;SULF1;CDH13;AMOTL1;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;CITED2;NR2F2;PLXNA1;LMO4;SYNE2;ARHGEF2;SSH1;SOX9;PRCP;PRKCA;MOSPD2;PODXL;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;MAGI2;HSPA5;SEMA4B;IFITM1;PPARG;BEX4;GCSAM;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;TTBK2;ADAM10;MYO1C;DOCK1
12252,GO:0048583,5.60754533843031e-08,1,368,2704,regulation of response to stimulus,BP,SERPINE2;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;FBN1;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;F2R;DDIT4;TGFBR2;EFEMP1;ASAP3;IL20RB;ANO1;GSN;PKD2;JPH2;IRS2;DUSP6;HERC5;TNIK;SKP2;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;UTRN;ARHGAP23;ROR1;AXL;EGFR;TMEM204;PEG10;FLRT3;SESN3;MYLK;SLC20A1;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;CSPG4;TKFC;EVC;MAP3K6;STMN3;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;CHN2;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;EIF2AK4;NETO1;TRIM5;VAV3;PDCD4;STAT1;SORL1;NEO1;LGALS1;TP53;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;PLEKHG3;DDX60;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;RBMS3;TIMP1;HIP1;GPNMB;TFDP2;ITGA3;CHD3;ANO6;GPX1;GLI3;CDK14;DLG5;KITLG;ERMAP;ASAP1;PDPN;SRPX;SESN1;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;ADIRF;CAV1;GLI2;RMI2;RNF135;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;SERPING1;NPHP4;PRKCZ;SLIT3;TP53INP1;IQSEC2;HMGA2;CAMK2D;ITGA1;MST1R;KANK2;IL31RA;ULBP1;PER1;PXN;CCK;PIK3R1;SYT1;TMEM173;CAPRIN2;APOBEC3G;DUSP5;UNC5B;BBS2;HERPUD1;WFS1;MDFI;SPRY2;JARID2;FBLN1;TP73;CAT;DAPK1;DLC1;BTN3A1;PRKACB;CHEK2;ROBO1;IFT140;SPRY4;TLR3;SNCA;FZD7;AIP;GLG1;SH3TC2;PLXNA2;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;DKK1;PRKAB2;CTF1;SEMA4A;RGS2;C5;PDE4D;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;G6PD;MYOF;EPHB6;EDA2R;FZD8;ARHGEF17;AFAP1L2;CDH13;NFATC4;MAGEF1;TRAF1;AKAP7;LMCD1;TGFBR3;FZD1;ENG;FOXL1;BBS4;MTMR4;CALR;ATM;SRGAP1;MDM2;ARF6;DLK2;AREG;IFNK;AKAP13;DGKQ;CITED2;GCLC;PLXNA1;IFNE;CD1D;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;SPRED3;KLHL12;THNSL2;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;ITPKB;BCL6;PRCP;NCOR1;PRKCA;ANXA2;RGS14;MPP7;CXORF57;IGFBP4;DEPDC7;SAMD5;MVB12B;MOSPD2;NFAT5;PAK6;MAP3K12;MEGF8;TSPAN5;UACA;HTR1B;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;GGT7;DLX2;STAT2;IFT122;GPR161;LEF1;THRA;MAPK8IP3;CDKN2A;SPPL2B;SP100;TSPYL2;IGFBP2;NPHP3;VAV2;MAGI2;AGAP1;HSPA5;BTN3A3;CDK19;TGFB1I1;RSAD2;SEMA4B;ARHGEF19;ARHGAP29;MDFIC;VPS13C;IFITM1;OPHN1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;COL17A1;DIXDC1;DERL3;MEIS3;AGPAT1;PPARG;CALCRL;MEF2A;GCSAM;SHISA9;SASH1;POSTN;LGALS3;PTPN3;DNAJC3;RARA;CCNY;POLH;PRKAG1;TAF1;EFNA5;FZD4;WIPF1;ADGRA2;ZBTB1;PPP3CA;RASA1;ARHGAP31;CREBRF;FOS;CDK5RAP3;CLEC2D;FAM168A;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;ADM2;ADAM10;LITAF;MYO1C;C2CD5;EDEM1;ACAA2;TAOK3;DOCK1;DMPK
6749,GO:0030182,6.2741147365773e-08,1,151,852,neuron differentiation,BP,FLOT1;FN1;FLRT2;SFRP1;APBB2;DDIT4;FAT4;SLITRK6;TENM4;ETV5;IRS2;SDK1;TNIK;MAP6;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;NTM;CSMD3;DOK1;RNF165;VIM;STMN3;TIMP2;TENM3;PAK1;PTPRM;BMP4;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;NEO1;LGALS1;ETV1;PTPRS;WNK1;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;SPG11;PLXNB1;LRP1;FYN;CLMN;UGT8;GLI2;RBFOX2;SMARCA1;UST;NPHP4;PRKCZ;SLIT3;ULK2;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;TP73;S1PR5;METRN;ROBO1;IFT140;FZD7;PLXNA2;FGFR1;DKK1;CTF1;SEMA4A;SETX;FZD8;TRIOBP;KDM4C;NFATC4;RAPH1;FZD1;LRTOMT;NAGLU;PBX1;BBS4;CALR;NEGR1;EFNB3;MDM2;ARF6;AREG;TCF4;PLXNA1;LMO4;TRAK1;FBXW8;VANGL2;ARHGEF2;NTNG1;SDC2;NRK;SSH1;SOX9;IFT27;ISL1;BCL6;NFASC;CRTC1;PRKCA;RAB13;TCF12;MEGF8;CDH11;RET;TGFB2;DLX2;LEF1;ULK1;AGRN;MAGI2;HSPA5;TH;BOC;SEMA4B;OPHN1;GDNF;DIXDC1;MEF2A;KLF7;OBSL1;POSTN;UNK;ARL3;NYAP1;RARA;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;KDM4A;CDK5RAP3;LAMB2
12261,GO:0048598,8.72642985584223e-08,1,79,377,embryonic morphogenesis,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;FBN1;SFRP1;ZFP36L1;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;COL5A2;GJA5;PKD2;DUSP6;COL7A1;FBN2;COL5A1;LAMB1;FLRT3;BMP4;PRICKLE1;ITGA2;PHLDB1;ITGA3;GLI3;LAMA3;GLI2;FBXW4;HMGA2;DUSP5;LAMA5;MDFI;SPRY2;LAMB3;DLC1;PRKACB;IFT140;LRIG3;FZD7;FGFR1;DKK1;MYO3B;SULF1;TRIOBP;FZD1;NAGLU;PBX1;ENG;BBS4;LMO4;POGLUT1;VANGL2;SOX9;ZNF358;HOXA1;TSHZ1;MEGF8;WDR19;RET;TGFB2;MAP2K5;DLX2;COL12A1;IFT122;LEF1;NPHP3;TH;TGFB1I1;YAP1;GDNF;HOXA3;RARA;PBX2;MED12;NIPBL;CELSR1
12218,GO:0048514,1.05373495021e-07,1,79,376,blood vessel morphogenesis,BP,MMP2;FN1;CCBE1;COL8A1;CTGF;SFRP1;ZFP36L1;TGFBR2;GJA5;PKD2;ANPEP;MYLK;THBS2;SERPINE1;RNF213;CSPG4;ANGPTL4;PTPRM;BMP4;VAV3;COL18A1;STAT1;SEMA5A;PDGFA;MMP19;GPNMB;CUL7;BTG1;GPX1;E2F7;LRP1;XDH;CAV1;HMGA2;ANG;PARVA;LAMA5;UNC5B;SPRY2;ROBO1;TLR3;FGFR1;SEMA4A;C5;TGFBI;IL18;SULF1;FZD8;CDH13;NFATC4;TGFBR3;AMOTL1;ENG;NR2F2;ISL1;PRCP;PRKCA;ANXA2;HOXA1;LEPR;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;SRPK2;ITGB8;YAP1;KLF5;HOXA3;PPARG;CALCRL;SASH1;COL4A1;FZD4;ADGRA2;RASA1;ADM2
4257,GO:0009605,1.05892645796869e-07,1,198,1330,response to external stimulus,BP,SERPINE2;TNFRSF6B;HTRA1;FLRT2;TXNIP;ITGA6;SFRP1;MMP28;CD109;CDKN2B;NQO1;APBB2;F2R;DDIT4;TGFBR2;XPC;SLITRK6;IL20RB;ANO1;GSN;PKD2;PIK3C2G;IRS2;HERC5;SKP2;NOS1;GAS6;SNAI2;AXL;DPYSL2;EGFR;FLRT3;SPTB;SLC8A1;SESN3;ACTA2;SERPINE1;DOK1;RNF165;TKFC;IFI44L;NTSR1;CXCL14;ABCA1;VDR;APOBEC3C;PTPRM;BMP4;NR1D1;EIF2AK4;TRIM5;VAV3;PDCD4;STAT1;NEO1;IFIT2;ETV1;TP53;PTPRS;DDIT3;PYCARD;IFIT1;DDX60;SEMA5A;ITGA2;PDGFA;PPL;ADARB1;ACSL3;GPNMB;BCKDHB;DOCK4;SIK1;IFIT3;ANO6;GPX1;GLI3;PTGES;TBC1D5;PDPN;MTHFR;SESN1;CTSV;SEC14L1;PLXNB1;FYN;CPS1;CAV1;GLI2;HLCS;PLA2G6;MAP3K14;CLU;SERPING1;CXCR1;SLIT3;OAS2;ULK2;HMGA2;ITGA1;MST1R;KANK2;IL31RA;PER1;CCK;PIK3R1;TMEM173;SLC38A2;ACACB;APOBEC3G;PARVA;UNC5B;BBS2;TTN;CAT;ROBO1;TLR3;SNCA;PLXNA2;FGFR1;APOBEC3F;SEMA4A;C5;PDE4D;TGM2;IL18;G6PD;CDH13;ENG;BBS4;CALR;EFNB3;MDM2;CST3;MEIS2;IFNK;DGKQ;GCLC;PLXNA1;IFNE;CD1D;IFI44;MAP3K1;VANGL2;PLGRKT;SSH1;LYST;SOX9;UCN2;ISL1;BCL6;NFASC;CRTC1;PRKCA;BCHE;ANXA2;RAB13;IFITM2;MOSPD2;ABCC2;MEGF8;RET;TGFB2;STAT2;LEF1;ULK1;IGFBP2;HSPA5;CDK19;TH;BOC;RSAD2;SEMA4B;IFITM1;OPHN1;GDNF;SRR;PPARG;CALCRL;KLF7;SASH1;POSTN;LGALS3;DNAJC3;RARA;TAF1;EFNA5;WIPF1;ADGRA2;PIK3C2B;FOS;KDM4A;ELMO2;ABAT;ADAM10;LITAF;GBP3;LAMB2
12871,GO:0051240,1.30251415349259e-07,1,159,975,positive regulation of multicellular organismal process,BP,SERPINE2;FLOT1;FN1;FLRT2;MMP9;CCBE1;CTGF;SOX6;INPP5D;ZFP36L1;F2R;TGFBR2;SLITRK6;TENM4;IL20RB;ETV5;GJA5;NOS1;GAS6;FBN2;MAGED1;SULF2;AXL;EGFR;FLRT3;SLC8A1;DOCK5;GJC2;THBS2;SERPINE1;TKFC;FAM210B;AMIGO2;TIMP2;TENM3;PAK1;ANGPTL4;VDR;BMP4;PTK6;NEFL;STAT1;WWTR1;DDIT3;ZBTB20;PYCARD;DDX60;DLG4;SEMA5A;ITGA2;PDGFA;PHLDB1;CUL7;BTG1;ITGA3;TPBG;ANO6;GLI3;DLG5;CNTN1;KITLG;PDPN;SEC14L1;PLXNB1;LRP1;FYN;POLR3GL;CAV1;SLC27A1;GLI2;RNF135;CLU;PRKCZ;HMGA2;CAMK2D;PIK3R1;SYT1;TMEM173;CAPRIN2;ACACB;BBS2;TP73;METRN;ROBO1;TLR3;PLXNA2;FGFR1;ALOX15B;DKK1;RGS2;C5;SETX;PDE4D;IL18;SULF1;KDM4C;AFAP1L2;NFATC4;TGFBR3;FZD1;AMOTL1;ENG;BBS4;CALR;NEGR1;TCF4;CITED2;PLXNA1;TRAK1;FBXW8;ARHGEF2;EGR1;SOX9;ISL1;ITPKB;BCL6;CRTC1;PLAG1;PRKCA;ANXA2;RGS14;TCF12;MEGF8;RET;ZFPM1;TGFB2;DLX2;LEF1;LRRN3;AGRN;MAGI2;HSPA5;TGFB1I1;RSAD2;ITGB8;IFITM1;YAP1;GDNF;ATRAID;AGPAT1;PPARG;MEF2A;SASH1;OBSL1;POSTN;RARA;EFNA5;FZD4;SLITRK5;ADGRA2;ZBTB1;PPP3CA;FOS;KDM4A;ABAT;NIPBL;ADM2;OXTR;DOCK1
8214,GO:0032989,1.45136315059598e-07,1,137,745,cellular component morphogenesis,BP,FLOT1;FN1;FLRT2;SOX6;RHOBTB2;APBB2;SLITRK6;TENM4;IRS2;TNIK;MAP6;AXL;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;DOCK5;SYNE3;RFX2;DOK1;S100A10;RNF165;TENM3;PAK1;VDR;PTPRM;EIF2AK4;NEFL;COL18A1;NEO1;ETV1;ARAP1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;PHLDB1;CUL7;SNX1;GLI3;PDPN;SPG11;PLXNB1;FYN;ARHGAP18;UGT8;GLI2;RBFOX2;AHNAK2;UST;CLU;PRKCZ;SLIT3;ULK2;ARPIN;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;PARVA;LAMA5;UNC5B;ANK3;TTN;FBLN1;DLC1;METRN;ROBO1;PRX;FZD7;PLXNA2;DKK1;SEMA4A;OBSCN;CCDC136;TRIOBP;CDH13;NFATC4;RAPH1;CALR;MKLN1;EFNB3;AKAP13;PLXNA1;FHOD3;TRAK1;FBXW8;FGD4;VANGL2;ARHGEF2;NTNG1;SDC2;NRK;SSH1;ISL1;BCL6;NFASC;PRKCA;MEGF8;WDR19;CDH11;RET;ZFPM1;TGFB2;LIPA;LEF1;CDC42EP5;ULK1;BOC;PIKFYVE;FLNB;SEMA4B;OPHN1;YAP1;GDNF;MEF2A;KLF7;OBSL1;POSTN;UNK;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;WIPF1;PPP3CA;RASA1;AGO4;MYH11;TTBK2;RHOBTB3;DOCK1;LAMB2
1258,GO:0003013,1.60189868153442e-07,1,58,252,circulatory system process,BP,CTGF;F2R;TNNI2;PTGS1;GJA5;ANPEP;NOS1;GAS6;EGFR;SLC8A1;DOCK5;NTSR1;TBC1D8;STAT1;WNK1;NISCH;DOCK4;GPX1;NAV2;MTHFR;CPS1;CAV1;PLA2G6;SERPING1;EHD3;CAMK2D;ITGA1;BBS2;TTN;KCNJ5;MME;RGS2;PDE4D;MYOF;BBS4;MDM2;AKAP13;GCLC;NR2F2;RNPEP;PRCP;HTR1B;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;PPARG;KCNIP3;MEF2A;POSTN;CACNA2D3;SCPEP1;ABAT;ADM2;OXTR;DMPK
8197,GO:0032963,1.6254035555707e-07,0.999999963187152,25,73,collagen metabolic process,BP,MMP2;MMP9;COL8A1;CTGF;F2R;COL5A2;COL7A1;COL5A1;SERPINH1;VIM;BMP4;MRC2;COL18A1;ITGA2;MMP19;COL4A4;P3H2;TNS2;ENG;CST3;COL5A3;COL12A1;PPARG;COL4A1;CTSD
3588,GO:0008015,2.22505029348167e-07,1,57,250,blood circulation,BP,CTGF;F2R;TNNI2;PTGS1;GJA5;ANPEP;NOS1;GAS6;EGFR;SLC8A1;DOCK5;NTSR1;TBC1D8;STAT1;WNK1;NISCH;DOCK4;GPX1;NAV2;MTHFR;CPS1;CAV1;PLA2G6;SERPING1;EHD3;CAMK2D;ITGA1;BBS2;TTN;KCNJ5;MME;RGS2;PDE4D;MYOF;BBS4;MDM2;GCLC;NR2F2;RNPEP;PRCP;HTR1B;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;PPARG;KCNIP3;MEF2A;POSTN;CACNA2D3;SCPEP1;ABAT;ADM2;OXTR;DMPK
4853,GO:0014070,2.88839047635746e-07,1,108,630,response to organic cyclic compound,BP,FLOT1;TXNIP;CTGF;ITGA6;SFRP1;ZFP36L1;NQO1;DDIT4;TGFBR2;GSN;PKD2;DUSP6;ZFP36L2;SDK1;SKP2;SNAI2;EGFR;SLC8A1;FAM210B;TADA3;PAK1;ABCA1;VDR;BMP4;NR1D1;NEFL;NR3C1;STAT1;LGALS1;GNG2;TP53;IFIT1;ITGA2;ZCCHC11;MMP19;ACSL3;KLF9;PAQR8;PTGES;MTHFR;CTSV;CPS1;CAV1;GLI2;HLCS;RBFOX2;GLDC;CLU;SLIT3;KANK2;PER1;TMEM173;CPT1A;ACACB;CAT;PRKACB;CHEK2;TLR3;SNCA;PAQR7;PTPRU;PDE4D;IL18;G6PD;NFATC4;ENG;CALR;MDM2;CST3;AREG;IFNK;AKAP13;DGKQ;GCLC;NR2F2;IFNE;SSH1;EGR1;ISL1;NCOR1;BCHE;ABCC2;HTR1B;TGFB2;LEF1;THRA;IGFBP2;HSPA5;TH;TGFB1I1;ITPR2;YAP1;KLF5;SRR;PPARG;POSTN;RARA;ABCA2;TAF1;EFNA5;PPP3CA;CREBRF;FOS;AGO4;MED12;ABAT;OXTR;RXRA
10404,GO:0043269,2.89811108920886e-07,1,62,297,regulation of ion transport,BP,SERPINE2;MMP9;F2R;GJA5;PKD2;JPH2;IRS2;NOS1;TCAF1;UTRN;HSPA2;SLC8A1;MYLK;GJC2;NTSR1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;WNK1;DLG4;SIK1;ANO6;CNTN1;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;PER1;CCK;SYT1;ANK3;WFS1;DAPK1;KCNJ5;STOM;SNCA;FGFR1;PDE4D;PLA2R1;G6PD;KCNQ3;NCOR1;HTR1B;PRNP;FHL1;GOPC;CACNB1;GDNF;KCNIP3;SHISA9;LGALS3;PTPN3;SV2A;CACNA2D3;ABAT;KCNRG;DMPK
4378,GO:0010033,3.20558831398046e-07,1,292,2161,response to organic substance,BP,TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;TXNIP;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;CD109;CDKN2B;ZFP36L1;NQO1;F2R;DDIT4;FAT4;TGFBR2;IL20RB;ANO1;GSN;COL5A2;PKD2;IRS2;DUSP6;ZFP36L2;SDK1;SKP2;NOS1;DNAJB4;GAS6;FBN2;PDGFC;SNAI2;SULF2;AXL;EGFR;TMEM204;PEG10;HSPA2;FLRT3;SLC8A1;SESN3;RFX2;SERPINE1;SERPINH1;RNF165;ANXA5;VIM;FAM210B;NTSR1;TIMP2;TADA3;PAK1;ABCA1;VDR;BMP4;TRIM38;NR1D1;PTK6;XAF1;TRIM5;NEFL;PDCD4;NR3C1;MXRA5;STAT1;NEO1;IFIT2;LGALS1;GNG2;KCNMA1;TP53;KRT13;EXTL2;DDIT3;PYCARD;LTBP1;IL32;IFIT1;ITGA2;ZCCHC11;MAP2;MMP19;TIMP1;ACSL3;CUL7;BTG1;ITGA3;SIK1;IFIT3;KLF9;PAQR8;PTGES;MTHFR;SESN1;CTSV;LRP1;FYN;IFI6;XDH;LTBP4;CPS1;CAV1;SLC27A1;GLI2;PIAS3;HLCS;RBFOX2;PLA2G6;SEL1L;GLDC;MAP3K14;CLU;CXCR1;PRKCZ;SLIT3;OAS2;TP53INP1;CAMK2D;MST1R;KANK2;IL31RA;PTPN14;PER1;PXN;PIK3R1;TMEM173;CREB3L2;CPT1A;ACACB;ANG;LAMA5;BBS2;HERPUD1;WFS1;SPRY2;JARID2;TP73;CAT;DAPK1;PRKACB;CHEK2;ROBO1;SPRY4;TLR3;SNCA;ADAMTS7;MME;PDIA6;FZD7;AIP;GLG1;PAQR7;COL16A1;PTPRU;FGFR1;IGF1R;LMNA;IFI35;DKK1;FSCN1;CTF1;SETX;PDE4D;TMEM129;NCOA2;PSMB9;IL18;SULF1;PDK3;G6PD;MYOF;TLE4;IL17RE;EDA2R;CDH13;NFATC4;TRAF1;TGFBR3;FZD1;ENG;BBS4;MTMR4;CALR;MDM2;TMED10;CST3;MEIS2;AREG;IFNK;AKAP13;SNX10;DGKQ;CITED2;GCLC;NR2F2;IFNE;DNAJC4;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;BCL6;PRCP;STK16;NCOR1;GCNT1;PRKCA;BCHE;ANXA2;RAB13;LEPR;IFITM2;RPL13A;ABCC2;MEGF8;HTR1B;RAB43;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;THRA;TRIML2;HERPUD2;SPPL2B;SP100;TSPYL2;AGRN;IGFBP2;RHBDD1;MAGI2;HSPA5;CDK19;TH;TGFB1I1;RSAD2;FLNB;ITPR2;IFITM1;YAP1;CACNB1;NUB1;KLF5;SRR;DERL3;AGPAT1;PPARG;CALCRL;SASH1;TGIF1;POSTN;DNAJC3;RARA;COL4A1;ABCA2;TMEM67;TAF1;EFNA5;FZD4;ADGRA2;PPP3CA;CREBRF;CTDSP2;STEAP2;FOS;CDK5RAP3;AGO4;MED12;ABAT;UGGT2;OXTR;ADAM10;PRDM5;LITAF;MYO1C;RXRA;C2CD5;EDEM1
13802,GO:0060429,3.33099530463875e-07,1,134,811,epithelium development,BP,SERPINE2;KRT4;TXNIP;SFRP1;CD109;ZFP36L1;FAT4;TGFBR2;SLITRK6;ETV5;GJA5;PKD2;APCDD1;SNAI2;MAGED1;COL5A1;ROR1;EGFR;ITPK1;FLRT3;TCHH;ACTA2;SERPINE1;KRT14;VIM;PAK1;VDR;BMP4;PTK6;COL18A1;STAT1;KRT13;PTPRS;WWTR1;PRICKLE1;KRT5;SLC7A11;ITGA2;PDGFA;PPL;FLG;BTG1;GPX1;GLI3;E2F7;DLG5;PDPN;KRT15;CTSV;XDH;CPS1;CAV1;GLI2;IL31RA;CPT1A;LAMA5;SPRY2;CAT;CASP14;DLC1;PRKACB;ROBO1;IFT140;FZD7;PLXNA2;FGFR1;CBR1;ALOX15B;DKK1;ASTN2;PDE4D;TGM2;PSMB9;SULF1;TRIOBP;NFATC4;DLX3;FZD1;LRTOMT;PBX1;ENG;BBS4;ATM;CST3;AREG;CITED2;NR2F2;PLXNA1;LMO4;MAF;POGLUT1;VANGL2;SOX9;SALL2;ZNF358;RAB13;FNDC3A;PODXL;MEGF8;WDR19;RET;TGFB2;IFT122;GPR161;LEF1;THRA;SSBP3;NPHP3;MAGI2;KIAA1109;SLC9A4;TGFB1I1;FLNB;ARHGEF19;IFT74;OPHN1;MYO9A;YAP1;GDNF;KLF5;KLHL3;PPARG;LGALS3;RARA;COL4A1;FZD4;KRT10;DNPH1;SERPINB5;MED12;PPP2R3A;CELSR1;RXRA;LAMB2
2261,GO:0005178,3.47235277411489e-07,0.999999918075216,25,72,integrin binding,MF,ITGB6;FN1;CTGF;FBN1;ITGA6;COL5A1;UTRN;EGFR;TIMP2;ITGA2;NISCH;GPNMB;ITGA3;LTBP4;PXN;LAMA5;FRMD5;COL16A1;TGFBI;CALR;PRKCA;ECM2;ADAM10;TSPAN4;LAMB2
322,GO:0000902,3.69321644226746e-07,1,126,688,cell morphogenesis,BP,FLOT1;FN1;FLRT2;SOX6;RHOBTB2;APBB2;SLITRK6;TENM4;IRS2;TNIK;MAP6;AXL;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;DOCK5;SYNE3;DOK1;S100A10;RNF165;TENM3;PAK1;VDR;PTPRM;EIF2AK4;NEFL;COL18A1;NEO1;ETV1;ARAP1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;SNX1;GLI3;PDPN;SPG11;PLXNB1;FYN;ARHGAP18;UGT8;GLI2;RBFOX2;UST;CLU;PRKCZ;SLIT3;ULK2;ARPIN;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;PARVA;LAMA5;UNC5B;ANK3;FBLN1;DLC1;METRN;ROBO1;FZD7;PLXNA2;DKK1;SEMA4A;TRIOBP;CDH13;NFATC4;RAPH1;CALR;MKLN1;EFNB3;PLXNA1;TRAK1;FBXW8;FGD4;VANGL2;ARHGEF2;NTNG1;SDC2;NRK;SSH1;ISL1;BCL6;NFASC;PRKCA;MEGF8;WDR19;CDH11;RET;ZFPM1;TGFB2;LIPA;LEF1;CDC42EP5;ULK1;BOC;FLNB;SEMA4B;OPHN1;YAP1;GDNF;MEF2A;KLF7;OBSL1;POSTN;UNK;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;WIPF1;PPP3CA;RASA1;AGO4;TTBK2;RHOBTB3;DOCK1;LAMB2
2376,GO:0005509,3.9205980522494e-07,1,76,361,calcium ion binding,MF,SYT8;PCDH7;CCBE1;FBN1;FAT4;EFEMP1;GSN;PKD2;PITPNM3;NID1;GAS6;FBN2;SULF2;TCHH;SLC8A1;THBS2;S100A10;ANXA5;PADI3;LTBP1;EFHC1;EFEMP2;FLG;SMOC1;PCDHAC2;LPCAT2;LRP1;LTBP4;CPS1;FAT2;FKBP9;SLIT3;EHD3;SYTL1;SYT1;PCLO;DYSF;TTN;CRELD2;FBLN1;PLCH2;MAN1A1;SNCA;ALOX15B;LTBP3;ASTN2;SULF1;ESYT2;SLC24A1;CDH13;NOTCH2NL;CALR;DLK2;ANXA6;ENPP1;PCDHGA11;ANXA2;MEGF8;CDH11;RET;C2CD4C;AGRN;HSPA5;ITPR2;CAPS;SRR;KCNIP3;FKBP10;PPP3CA;MATN3;PCDHGB5;PPP2R3A;CELSR1;S100A11;C2CD5;EDEM1
4331,GO:0009887,4.18677061069979e-07,1,115,639,animal organ morphogenesis,BP,MMP2;HTRA1;FLRT2;COL8A1;CTGF;FBN1;ITGA6;SFRP1;FAT4;TGFBR2;SLITRK6;ITGB4;EFEMP1;COL5A2;ETV5;GJA5;PKD2;SDK1;FBN2;PDGFC;SNAI2;MAGED1;SULF2;COL5A1;ROR1;EGFR;LAMB1;MYLK;ACTA2;SERPINE1;SERPINH1;TENM3;VDR;PTPRM;BMP4;PDCD4;COL18A1;STAT1;KRT13;WWTR1;PRICKLE1;MEF2D;ITGA2;PDGFA;ADARB1;GLI3;DLG5;CAV1;GLI2;SLIT3;ADGRG6;PARVA;LAMA5;BBS2;MDFI;SPRY2;TTN;DLC1;IFT140;LRIG3;FZD7;GLG1;FGFR1;DKK1;MYO3B;TGM2;PSMB9;SULF1;TRIOBP;FOXN3;TGFBR3;DLX3;FZD1;NAGLU;PBX1;ENG;BBS4;MDM2;FAM20A;AREG;CITED2;PLXNA1;VANGL2;SOX9;ISL1;GCNT1;PLAG1;HOXA1;TSHZ1;NAB2;MEGF8;WDR19;ZFPM1;TGFB2;DLX2;IFT122;LEF1;THRA;FHL1;NPHP3;MAGI2;TH;ARHGEF19;YAP1;GDNF;KLHL3;HOXA3;RARA;FZD4;SERPINB5;MED12;NIPBL;CELSR1;RXRA;DGCR6
6729,GO:0030155,4.45024817368995e-07,1,82,421,regulation of cell adhesion,BP,SERPINE2;FLOT1;FN1;COL8A1;ITGA6;SFRP1;TGFBR2;IL20RB;GSN;NID1;SNAI2;UTRN;DOCK5;SERPINE1;S100A10;PAK1;BMP4;VAV3;LGALS1;PYCARD;SEMA5A;ITGA2;GPNMB;ITGA3;GLI3;DLG5;PDPN;CCDC80;PLXNB1;FYN;LAMA3;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;LAMA5;ANK3;LMO7;FBLN1;DLC1;FLOT2;FRMD5;FZD7;PLXNA2;COL16A1;PAG1;TGFBI;TGM2;IL18;TRIOBP;CDH13;CALR;EFNB3;CITED2;PLXNA1;CD1D;SOX9;ITPKB;BCL6;PRKCA;PODXL;PRNP;RET;TGFB2;MAP2K5;LEF1;CDKN2A;IGFBP2;IFT74;POSTN;LGALS3;MIA3;RARA;ECM2;EFNA5;FZD4;ZBTB1;RASA1;ABAT;ADAM10;DOCK1
479,GO:0001525,6.48196763558167e-07,1,67,321,angiogenesis,BP,MMP2;FN1;CCBE1;COL8A1;CTGF;SFRP1;TGFBR2;GJA5;ANPEP;THBS2;SERPINE1;RNF213;CSPG4;ANGPTL4;PTPRM;BMP4;VAV3;COL18A1;STAT1;SEMA5A;PDGFA;MMP19;GPNMB;BTG1;GPX1;E2F7;CAV1;HMGA2;ANG;PARVA;LAMA5;UNC5B;SPRY2;ROBO1;TLR3;FGFR1;SEMA4A;C5;TGFBI;IL18;SULF1;FZD8;CDH13;NFATC4;AMOTL1;ENG;ISL1;PRCP;PRKCA;ANXA2;LEPR;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;VAV2;SRPK2;ITGB8;KLF5;HOXA3;PPARG;CALCRL;SASH1;COL4A1;ADGRA2;ADM2
12772,GO:0051093,8.71768140890993e-07,0.999999687743207,101,561,negative regulation of developmental process,BP,FBN1;SOX6;INPP5D;SFRP1;ZFP36L1;TGFBR2;EFEMP1;COL5A2;ZFP36L2;GAS6;SNAI2;COL5A1;EGFR;TSC22D3;THBS2;SERPINE1;VIM;CXCL14;PAK1;ABCA1;PTPRM;BMP4;ITM2C;EIF2AK4;PDCD4;STAT1;SORL1;LGALS1;PTPRS;WWTR1;PRICKLE1;DDIT3;SEMA5A;TIMP1;CCDC85B;GLI3;ASAP1;LRP1;XDH;CAV1;GLI2;TRIB2;ULK2;TP53INP1;ARPIN;HMGA2;PIK3R1;BBS2;SPRY2;JARID2;FBLN1;TP73;KLF13;PRKACB;ROBO1;TLR3;ADAMTS7;FZD7;DKK1;SEMA4A;IL18;SULF1;G6PD;NFATC4;PBX1;CALR;EFNB3;IDH2;MDM2;ARF6;CST3;MEIS2;AREG;ARHGEF2;SOX9;ENPP1;ISL1;ITPKB;BCL6;ANXA2;ZFPM1;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;ZADH2;NPHP3;TGFB1I1;SEMA4B;YAP1;TWIST2;DIXDC1;PPARG;POSTN;RARA;EFNA5;PPP3CA;KDM4A;ABCA5
11262,GO:0045596,8.94665336465069e-07,0.99999969558446,80,419,negative regulation of cell differentiation,BP,FBN1;SOX6;INPP5D;SFRP1;ZFP36L1;EFEMP1;COL5A2;ZFP36L2;SNAI2;COL5A1;EGFR;VIM;CXCL14;PAK1;ABCA1;BMP4;ITM2C;EIF2AK4;PDCD4;STAT1;SORL1;LGALS1;PTPRS;WWTR1;PRICKLE1;DDIT3;SEMA5A;CCDC85B;GLI3;ASAP1;LRP1;XDH;CAV1;GLI2;TRIB2;ULK2;TP53INP1;PIK3R1;FBLN1;TP73;KLF13;TLR3;ADAMTS7;FZD7;DKK1;SEMA4A;IL18;G6PD;NFATC4;PBX1;CALR;EFNB3;IDH2;MDM2;ARF6;MEIS2;AREG;ARHGEF2;SOX9;ENPP1;ISL1;ITPKB;BCL6;ZFPM1;TGFB2;DLX2;ZADH2;NPHP3;TGFB1I1;SEMA4B;YAP1;TWIST2;DIXDC1;PPARG;POSTN;RARA;EFNA5;PPP3CA;KDM4A;ABCA5
7436,GO:0031581,9.27900599589617e-07,0.999999970175783,9,11,hemidesmosome assembly,BP,ITGA6;ITGB4;KRT14;PLEC;KRT5;LAMC2;LAMA3;LAMB3;COL17A1
12643,GO:0050877,1.13901000020564e-06,0.99999961294776,78,406,nervous system process,BP,SERPINE2;F2R;SLITRK6;EFEMP1;TENM4;ANO1;SNAI2;ROR1;EGFR;NTSR1;SCN8A;EIF2AK4;NETO1;NEFL;COL18A1;SCN2A;DLG4;ITGA2;ADARB1;ITGA3;GPX1;NAV2;EML2;KCNAB2;FYN;RBFOX2;PLA2G6;ESPN;AHNAK2;PRKCZ;CCK;BBS2;ANK3;WFS1;SPRY2;SHROOM4;AARS;PRX;MME;NIPSNAP1;FGFR1;DKK1;TGFBI;MYO3B;TRIOBP;SLC24A1;LRTOMT;BBS4;MEIS2;BBS1;NFASC;CRTC1;BCHE;RGS14;HOXA1;METTL23;PGAP1;TTC8;NLGN4Y;ATXN1;WDR19;PRNP;OR2A4;SCNN1A;LEF1;THRA;ALDH7A1;CYP4V2;TH;REEP2;MYO9A;TSHZ3;FZD4;FOS;NIPBL;OXTR;TUSC3;LAMB2
12292,GO:0048666,1.14250995482752e-06,0.999999572370776,126,705,neuron development,BP,FLOT1;FN1;FLRT2;SFRP1;APBB2;FAT4;SLITRK6;TENM4;IRS2;SDK1;TNIK;MAP6;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;NTM;CSMD3;DOK1;RNF165;VIM;STMN3;TENM3;PAK1;PTPRM;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;NEO1;LGALS1;ETV1;PTPRS;WNK1;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;SPG11;PLXNB1;LRP1;FYN;CLMN;UGT8;GLI2;RBFOX2;UST;NPHP4;PRKCZ;SLIT3;ULK2;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;IFT140;PLXNA2;FGFR1;CTF1;SEMA4A;SETX;TRIOBP;NFATC4;RAPH1;FZD1;LRTOMT;NAGLU;BBS4;NEGR1;EFNB3;MDM2;ARF6;AREG;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;NRK;SSH1;IFT27;ISL1;NFASC;CRTC1;PRKCA;RAB13;MEGF8;CDH11;RET;TGFB2;ULK1;AGRN;MAGI2;HSPA5;TH;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;UNK;ARL3;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;LAMB2
12773,GO:0051094,1.26458823860917e-06,0.999999519320526,136,822,positive regulation of developmental process,BP,SERPINE2;SULT1E1;FLOT1;FN1;FLRT2;CCBE1;CTGF;SOX6;INPP5D;SFRP1;ZFP36L1;TGFBR2;SLITRK6;TENM4;ETV5;GAS6;FBN2;SNAI2;MAGED1;AXL;FLRT3;SLC8A1;DOCK5;GJC2;THBS2;SERPINE1;S100A10;FAM210B;AMIGO2;TIMP2;TENM3;PAK1;ANGPTL4;VDR;BMP4;PTK6;NEFL;STAT1;WWTR1;DLG4;SEMA5A;PDGFA;PHLDB1;CUL7;BTG1;ITGA3;TPBG;ANO6;GLI3;DLG5;CNTN1;KITLG;PDPN;PLXNB1;FYN;ADIRF;GLI2;PRKCZ;HMGA2;SYT1;CAPRIN2;ACACB;BBS2;TP73;METRN;ROBO1;WDFY2;TLR3;PLXNA2;FGFR1;LMNA;ALOX15B;DKK1;LTBP3;C5;SETX;IL18;TRIOBP;KDM4C;TGFBR3;FZD1;ENG;BBS4;CALR;NEGR1;TCF4;CITED2;PLXNA1;TRAK1;FBXW8;ARHGEF2;EGR1;SOX9;ISL1;ITPKB;BCL6;CRTC1;PLAG1;PRKCA;RGS14;TCF12;MEGF8;RET;TGFB2;DLX2;LEF1;THRA;SSBP3;LRRN3;CDKN2A;AGRN;MAGI2;HSPA5;BOC;TGFB1I1;ITGB8;IFITM1;YAP1;GDNF;KLF5;ATRAID;PPARG;MEF2A;SASH1;OBSL1;RARA;EFNA5;FZD4;SLITRK5;ZBTB1;FOS;KDM4A;NIPBL;ADM2;OXTR;DOCK1
536,GO:0001655,1.34735097582916e-06,0.99999959628311,51,214,urogenital system development,BP,FBN1;ITGA6;SFRP1;FAT4;ITGB4;PKD2;NID1;MAGED1;SULF2;ACTA2;BMP4;STAT1;WWTR1;PDGFA;COL4A4;ITGA3;GLI3;DLG5;GLI2;TNS2;LAMA5;WFS1;TP73;CAT;IFT140;MME;FGFR1;ALOX15B;SULF1;PBX1;TMED10;VANGL2;EGR1;SOX9;GCNT1;PLAG1;PODXL;RET;TGFB2;NPHP3;MAGI2;YAP1;GDNF;KLHL3;ARL3;RARA;COL4A1;SERPINB5;NIPBL;RXRA;LAMB2
413,GO:0001101,1.40074364576417e-06,0.999999585506543,48,224,response to acid chemical,BP,MMP2;CTGF;SFRP1;NQO1;GSN;COL5A2;PKD2;PDGFC;EGFR;SESN3;ABCA1;PTK6;COL18A1;GNG2;TP53;KRT13;ITGA2;PTGES;MTHFR;SESN1;FYN;CPS1;HLCS;GLDC;CPT1A;CAT;FZD7;COL16A1;DKK1;SETX;PDK3;NFATC4;TGFBR3;GCLC;EGR1;SOX9;BCHE;ABCC2;RET;TRIML2;IGFBP2;TH;YAP1;PPARG;RARA;COL4A1;FZD4;RXRA
13120,GO:0051716,1.44706920905221e-06,0.999999174772477,577,4651,cellular response to stimulus,BP,SERPINE2;ITGB6;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;XPC;PTGS1;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;ANO1;GSN;COL5A2;ETV5;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;ZFP36L2;TNIK;ANPEP;SKP2;BCAM;CLTCL1;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;SULF2;ARHGAP23;TFPI2;ROR1;AXL;DPYSL2;DOCK9;EGFR;TMEM204;PEG10;ITPK1;HSPA2;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;MYLK;SLC20A1;RFX2;SERPINE1;DOK1;RNF213;TCF7L1;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;FAM210B;MAP3K6;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;ABCA1;NSG1;VDR;CHN2;PTPRM;SRGAP3;BMP4;TRIM38;ITM2C;NR1D1;PTK6;RIN2;XAF1;EIF2AK4;NETO1;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;STAT1;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;TP53;ARAP1;KRT13;EXTL2;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IL32;IFIT1;WNK1;PLEKHG3;DDX60;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;ZCCHC11;PDGFA;MAP2;RBMS3;MICAL1;NISCH;TIMP1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;CRIM1;CUL7;ITGA3;CHD3;SIK1;IFIT3;KLF9;HIVEP1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;ERMAP;ASAP1;PDPN;SRPX;SESN1;CTSV;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;LTBP4;ARHGAP18;ADIRF;CMBL;CPS1;CAV1;SLC27A1;GLI2;RMI2;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;DOCK11;GLDC;MAP3K14;SLC22A17;CLU;DCBLD2;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;FBXW4;ULK2;TP53INP1;PARP4;IQSEC2;GPR39;TNS2;HMGA2;CAMK2D;ADGRG6;PRDX5;ITGA1;MST1R;KANK2;IL31RA;PTPN14;PER1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;SLC38A2;PCLO;DUSP5;PARVA;LAMA5;UNC5B;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;CES2;TTN;JARID2;APLP2;FBLN1;MLH3;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;S1PR5;BTN3A1;PRKACB;CHEK2;ROBO1;IFT140;SPRY4;TLR3;BPHL;SNCA;ADAMTS7;MME;PDIA6;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;RGS2;C5;SETX;PDE4D;TMEM129;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;PLA2R1;PDK3;G6PD;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;ARHGEF17;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;FZD1;AMOTL1;NOTCH2NL;PBX1;ENG;FOXL1;BBS4;MTMR4;CALR;MKLN1;ATM;EFNB3;SRGAP1;APH1B;MDM2;ARF6;CST3;DLK2;AREG;IFNK;ANXA6;AKAP13;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;NEURL1B;AKR7A2;ZMAT3;MSH5;MAP3K1;FGD4;PTPN1;POGLUT1;VANGL2;ARHGEF2;SPRED3;KLHL12;SDC2;THNSL2;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRCP;STK16;NCOR1;NDRG1;PRKCA;SALL2;PXMP2;BCHE;ANXA2;RGS14;RAB13;PRIMPOL;CES3;MPP7;CXORF57;LEPR;LANCL1;IGFBP4;DEPDC7;IFITM2;SAMD5;MVB12B;MOSPD2;NFAT5;RPL13A;PAK6;ABCC2;MAP3K12;MEGF8;TSPAN5;UACA;HTR1B;STK36;RAB43;MAML2;WDR19;MUTYH;PRNP;RET;CARF;TGFB2;RBL2;MAP2K5;DLX2;OR2A4;STAT2;AMOTL2;IFT122;LIG1;GPR161;LEF1;THRA;CDC42EP5;USP28;MAPK8IP3;CDKN2A;SPPL2B;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;BTN3A3;CDK19;TH;MAGI1;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;IFT74;POLD4;IFITM1;OPHN1;SH2B3;UGT1A6;MYO9A;YAP1;CACNB1;GDNF;RALGAPB;KLF5;GPX8;CAPS;UBA7;DIXDC1;DERL3;MEIS3;PITPNC1;AGPAT1;PPARG;CALCRL;KCNIP3;MEF2A;GCSAM;SHISA9;ICK;SASH1;TGIF1;ING4;POSTN;LGALS3;PTPN3;ARL3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;COL4A1;CCNY;POLH;TMEM67;PRKAG1;TAF1;SENP7;EFNA5;GSTZ1;FZD4;WIPF1;ADGRA2;ZBTB1;PPP3CA;PIK3C2B;RASA1;ARHGAP31;CREBRF;CTDSP2;HP1BP3;FOS;CDK5RAP3;AGO4;CLEC2D;FAM120B;FAM168A;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;NIPBL;UGGT2;TTBK2;ADM2;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;CELSR1;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;EDEM1;ACAA2;TAOK3;DOCK1;DMPK;LAMB2
708,GO:0001934,1.54991906454006e-06,0.999999434298458,105,618,positive regulation of protein phosphorylation,BP,FLOT1;MMP9;CTGF;GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;PROM2;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;PTK6;TRIM5;TP53;PYCARD;WNK1;DLG4;PILRB;PDGFA;GPNMB;CNTN1;KITLG;FYN;XDH;CAV1;SLC27A1;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;SPRY2;TP73;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ISL1;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
2393,GO:0005539,1.55377430719011e-06,0.999999534673544,29,105,glycosaminoglycan binding,MF,SERPINE2;FN1;CTGF;FBN1;SFRP1;TGFBR2;COL5A1;THBS2;BMP4;EXTL2;PTPRS;SEMA5A;GPNMB;LAMC2;NAV2;CCDC80;LTBP4;ANG;APLP2;FGFR1;TGFBR3;ENG;COL5A3;ADAMTS15;PRNP;AGRN;ADAMTSL5;POSTN;ECM2
4507,GO:0010562,1.74183667081795e-06,0.999999351474376,116,697,positive regulation of phosphorus metabolic process,BP,FLOT1;MMP9;CTGF;ITGA6;GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;PROM2;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;CSPG4;MAP3K6;NTSR1;TIMP2;PAK1;BMP4;PTK6;TRIM5;VAV3;TP53;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;ACSL3;GPNMB;CNTN1;KITLG;FYN;XDH;CAV1;SLC27A1;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;SPRY2;TP73;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ISL1;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;GPR161;MAPK8IP3;VAV2;MAGI2;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
11457,GO:0045937,1.74183667081795e-06,0.999999351474376,116,697,positive regulation of phosphate metabolic process,BP,FLOT1;MMP9;CTGF;ITGA6;GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;PROM2;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;CSPG4;MAP3K6;NTSR1;TIMP2;PAK1;BMP4;PTK6;TRIM5;VAV3;TP53;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;ACSL3;GPNMB;CNTN1;KITLG;FYN;XDH;CAV1;SLC27A1;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;SPRY2;TP73;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ISL1;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;GPR161;MAPK8IP3;VAV2;MAGI2;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
15526,GO:0072001,2.23824419645299e-06,0.999999086186727,47,192,renal system development,BP,FBN1;ITGA6;SFRP1;FAT4;ITGB4;PKD2;NID1;MAGED1;SULF2;ACTA2;BMP4;STAT1;WWTR1;PDGFA;COL4A4;ITGA3;GLI3;DLG5;GLI2;TNS2;LAMA5;WFS1;TP73;CAT;IFT140;MME;FGFR1;SULF1;PBX1;TMED10;VANGL2;EGR1;SOX9;GCNT1;PODXL;RET;TGFB2;NPHP3;MAGI2;YAP1;GDNF;KLHL3;ARL3;RARA;COL4A1;NIPBL;LAMB2
3506,GO:0007417,2.456263794999e-06,0.999998831951016,105,583,central nervous system development,BP,SERPINE2;TRNP1;SOX6;SFRP1;DDIT4;FAT4;TGFBR2;TENM4;GSN;PKD2;IRS2;PDGFC;ROR1;AXL;DPYSL2;EGFR;LAMB1;SLC8A1;GJC2;VIM;AMIGO2;TIMP2;PAK1;BMP4;NEFL;PTPRS;EFHC1;SLC7A11;SEMA5A;MAP2;ADARB1;ACSL3;PHGDH;GLI3;DLG5;CNTN1;NAV2;LRP1;FYN;FUT10;UGT8;GLI2;RBFOX2;SMARCA1;CLU;SYT1;ALDH3A2;SLC38A2;BBS2;PRDM8;JARID2;TP73;SHROOM4;DLC1;AARS;ROBO1;PLXNA2;FGFR1;DKK1;G6PD;FZD1;NAGLU;ENG;BBS4;ATM;CST3;NR2F2;LMO4;SYNE2;HDAC11;SOX9;ISL1;PGAP1;ATXN1;STK36;CDH11;DLX2;SMG9;IFT122;LEF1;THRA;SSBP3;HSPA5;TH;TACC2;OPHN1;SRR;DIXDC1;PPARG;RARA;COL4A1;TAF1;FZD4;SLITRK5;ADGRA2;KDM4A;CDK5RAP3;MED12;NPAS2;ABAT;NIPBL;TTBK2;OXTR;CELSR1;LAMB2
2101,GO:0004871,3.30590379357099e-06,0.999998392510561,113,676,signal transducer activity,MF,TNFRSF6B;FLRT2;GPRC5A;SFRP1;RHOBTB2;F2R;TGFBR2;EFEMP1;IL20RB;PKD2;JPH2;IRS2;TNIK;BCAM;CLTCL1;ROR1;AXL;EGFR;FLRT3;SLC20A1;DOK1;LPAR5;CSPG4;MAP3K6;NTSR1;ABCA1;VDR;PTPRM;TRIM38;NR1D1;TRIM5;MRC2;NR3C1;STAT1;SORL1;LGALS1;GNG2;LTBP1;ITGA2;CRIM1;PAQR8;PLXNB1;FYN;LTBP4;MAP3K14;SLC22A17;CXCR1;GPR39;ADGRG6;MST1R;IL31RA;PIK3R1;UNC5B;PLCH2;S1PR5;ROBO1;TLR3;FZD7;AIP;PAQR7;PLXNA2;SP110;PTPRU;FGFR1;PAG1;IGF1R;DKK1;PLA2R1;EPHB6;IL17RE;EDA2R;FZD8;TGFBR3;FZD1;ENG;EFNB3;TMED10;AKAP13;DGKQ;NR2F2;PLXNA1;MAP3K1;NRK;RGS14;LEPR;LANCL1;MAP3K12;HTR1B;PRNP;RET;OR2A4;STAT2;GPR161;LEF1;THRA;MAGI2;ITPR2;IFITM1;SH2B3;PPARG;CALCRL;RARA;SENP7;EFNA5;FZD4;ADGRA2;CLEC2D;OXTR;RHOBTB3;CELSR1;LITAF;RXRA;TAOK3
9940,GO:0042327,3.52834047894515e-06,0.999998294023897,109,652,positive regulation of phosphorylation,BP,FLOT1;MMP9;CTGF;ITGA6;GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;PROM2;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;PTK6;TRIM5;VAV3;TP53;PYCARD;WNK1;DLG4;PILRB;PDGFA;GPNMB;CNTN1;KITLG;FYN;XDH;CAV1;SLC27A1;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;SPRY2;TP73;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ISL1;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;VAV2;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
4261,GO:0009611,3.88168441679596e-06,0.999998275297265,75,412,response to wounding,BP,SERPINE2;FN1;CTGF;CD109;ZFP36L1;F2R;TGFBR2;ITGB4;GSN;ZFP36L2;GAS6;PDGFC;SULF2;COL5A1;PHF21A;TFPI2;AXL;DOCK9;EGFR;ITPK1;FLRT3;MYLK;SERPINE1;ANXA5;PAK1;CBX5;NEFL;VAV3;LGALS1;GNG2;TP53;PTPRS;SLC7A11;ITGA2;PDGFA;MICAL1;TIMP1;ANO6;GPX1;GLI3;PLLP;PDPN;FYN;FUT10;CAV1;DOCK11;DCBLD2;SERPING1;EHD3;PIK3R1;DYSF;HPS4;FBLN1;PRKACB;FZD7;MYOF;CST3;DGKQ;VANGL2;ISL1;PRCP;PRKCA;ANXA2;ZFPM1;TGFB2;VAV2;ARHGEF19;ITPR2;SH2B3;POSTN;MIA3;ABAT;CELSR1;DOCK1;LAMB2
8545,GO:0033993,4.57572589154062e-06,0.999997620184575,97,584,response to lipid,BP,TNFRSF6B;TXNIP;CTGF;SFRP1;ZFP36L1;NQO1;F2R;DDIT4;TGFBR2;ZFP36L2;SKP2;NOS1;SNAI2;AXL;EGFR;SERPINE1;FAM210B;NTSR1;TADA3;PAK1;ABCA1;VDR;BMP4;NR1D1;PTK6;TRIM5;NEFL;PDCD4;NR3C1;GNG2;TP53;KRT13;PYCARD;ITGA2;KLF9;PAQR8;PTGES;CTSV;CPS1;CAV1;RBFOX2;GLDC;CLU;SLIT3;KANK2;PER1;CPT1A;CAT;SNCA;FZD7;PAQR7;PTPRU;DKK1;SETX;PDE4D;IL18;PDK3;NFATC4;TGFBR3;ENG;CALR;MDM2;CST3;AREG;AKAP13;NR2F2;SOX9;ISL1;PRKCA;BCHE;ABCC2;HTR1B;RET;TGFB2;LEF1;THRA;TRIML2;IGFBP2;CDK19;TH;TGFB1I1;YAP1;SRR;PPARG;SASH1;POSTN;RARA;ABCA2;TAF1;EFNA5;FZD4;CREBRF;FOS;MED12;OXTR;LITAF;RXRA
6592,GO:0022617,4.61732519608261e-06,0.999998932361978,20,57,extracellular matrix disassembly,BP,FLOT1;MMP2;HTRA1;FN1;MMP9;FBN1;NID1;FBN2;TIMP2;MMP19;TIMP1;LAMC2;PDPN;CTSV;LRP1;LAMA3;LAMB3;FSCN1;CST3;ADAM10
17219,GO:0120025,4.84281669605241e-06,0.999996996099053,195,1261,plasma membrane bounded cell projection,CC,FLOT1;FLRT2;ITGA6;NQO1;APBB2;TLN2;PTGS1;TENM4;ASAP3;GSN;PKD2;CYBRD1;PROM2;NOS1;MAP6;UTRN;ROR1;FLRT3;CEP126;SLC8A1;MYLK;GJC2;ACTA2;STON2;VIM;CSPG4;PSTPIP1;EVC;STMN3;NTSR1;TIMP2;TENM3;PAK1;NSG1;PTPRM;NEFM;NR1D1;PTK6;SCN8A;NEFL;STAT1;SCN2A;CEP250;PTPRS;TTLL11;CNTRL;EFHC1;DLG4;ITGA2;PDGFA;MAP2;FRMD4B;MICAL1;DOCK4;ITGA3;WDR66;SNX1;PLEK2;GLI3;DLG5;KITLG;ASAP1;SYN1;PDPN;CTSV;SPG11;KCNAB2;LRP1;FYN;CAV1;GLI2;PIAS3;SPATA6;ESPN;CLU;NPHP4;PRKCZ;ARPIN;EHD3;CAMK2D;ITGA1;SYTL1;IL31RA;PXN;CCK;SYT1;SLC38A2;ANG;DYSF;KIF17;BBS2;ANK3;WFS1;SPRY2;DLC1;PRKACB;BACE1;ROBO1;IFT140;SPRY4;SNCA;FLOT2;MME;VAMP1;DZIP1L;IGF1R;FSCN1;RGS2;SETX;MYO3B;EPHB6;TRIOBP;CDH13;RAPH1;SEPT6;AMOTL1;BBS4;MKLN1;ARF6;CST3;BBS1;TRAK1;LZTS1;SYNE2;FGD4;KCNQ3;ARHGEF2;DNAL4;SSH1;IFT27;NFASC;CRTC1;ANXA2;RGS14;RAB13;SEPT5;IFT88;TTC8;PODXL;ABCC2;MAP3K12;HTR1B;SPA17;WDR19;PRNP;RET;TGFB2;ODF2;SCNN1A;IFT122;GPR161;ULK1;NPHP3;MAGI2;TH;GOPC;BOC;TCTEX1D4;CFAP54;FHOD1;IFT74;OPHN1;TPGS1;DNAH1;KCNIP3;SNX9;SHISA9;ICK;PRR7;ARL3;DEF6;RARA;SV2A;TMEM67;TSHZ3;FZD4;WIPF1;ADGRA2;PPP3CA;RASA1;ARHGAP31;FOS;DNM1P46;SEPT9;CAMK2N1;ABAT;TTBK2;BSN;OXTR;MPDZ;ANKS6;S100A11;MYO1C;ORAI2;C2CD5
2380,GO:0005518,4.97566548071091e-06,0.999999083118379,16,41,collagen binding,MF,FN1;MMP9;CCBE1;NID1;SERPINH1;PAK1;MRC2;ITGA2;PDGFA;ITGA3;ITGA10;ADGRG6;ITGA1;TGFBI;COL5A3;ECM2
10282,GO:0043067,5.35598211113875e-06,0.999996763196047,161,1106,regulation of programmed cell death,BP,TNFRSF6B;MMP9;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;ZFP36L1;NQO1;APBB2;F2R;GSN;IRS2;DUSP6;TNIK;SKP2;GAS6;SNAI2;MAGED1;ROR1;AXL;EGFR;TSC22D3;TRIM2;SERPINE1;ANXA5;NUPR1;AMIGO2;NTSR1;PAK1;ANGPTL4;VDR;BMP4;ITM2C;TP53I3;HS1BP3;NEFL;VAV3;PDCD4;COL18A1;STAT1;IFIT2;LGALS1;KCNMA1;TP53;DDIT3;PYCARD;ARHGEF1;SEMA5A;MICAL1;TIMP1;HIP1;TFDP2;BTG1;SIK1;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;PDPN;SRPX;LRP1;FYN;ARHGEF12;IFI6;XDH;CAV1;GLI2;PLA2G6;MAP3K14;CLU;PRKCZ;TP53INP1;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;CCK;PIK3R1;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;DAPK1;DLC1;AARS;CHEK2;ROBO1;TLR3;SNCA;FGFR1;IGF1R;LMNA;DKK1;SETX;TGM2;OBSCN;G6PD;EPHB6;ARHGEF17;NFATC4;TRAF1;CALR;ATM;APH1B;MDM2;CST3;AKAP13;CITED2;GCLC;ZMAT3;MAP3K1;FGD4;PTPN1;ARHGEF2;NRK;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PRKCA;PAK6;MAP3K12;PRNP;RET;TGFB2;MAP2K5;LEF1;THRA;CDKN2A;SP100;VAV2;RHBDD1;HSPA5;CDK19;SRPK2;ARHGEF19;YAP1;GDNF;TWIST2;MEIS3;PPARG;RNF144B;ING4;LGALS3;DNAJC3;RARA;RASA1;AGO4;ACAA2;TAOK3
1257,GO:0003012,5.41414900541819e-06,0.999997721250236,50,223,muscle system process,BP,ITGB5;CTGF;F2R;TNNI2;GSN;GJA5;NOS1;SULF2;UTRN;SLC8A1;DOCK5;MYLK;ACTA2;VIM;PAK1;KCNMA1;ITGA2;DOCK4;CAV1;PLA2G6;EHD3;CAMK2D;ITGA1;PXN;DYSF;BBS2;TTN;JARID2;KCNJ5;LMNA;RGS2;PDE4D;SULF1;G6PD;MYOF;LMCD1;ANXA6;AKAP13;PRKCA;GDNF;CALCRL;MEF2A;OBSL1;PPP3CA;KDM4A;ABAT;MYH11;OXTR;SNTB1;DMPK
9647,GO:0038023,5.43836209052417e-06,0.99999738277949,72,384,signaling receptor activity,MF,TNFRSF6B;GPRC5A;SFRP1;F2R;TGFBR2;EFEMP1;IL20RB;BCAM;ROR1;AXL;EGFR;LPAR5;NTSR1;ABCA1;VDR;PTPRM;NR1D1;TRIM5;MRC2;NR3C1;SORL1;LTBP1;ITGA2;CRIM1;PAQR8;PLXNB1;LTBP4;SLC22A17;CXCR1;GPR39;ADGRG6;MST1R;IL31RA;UNC5B;S1PR5;ROBO1;TLR3;FZD7;PAQR7;PLXNA2;PTPRU;FGFR1;IGF1R;PLA2R1;EPHB6;IL17RE;EDA2R;FZD8;TGFBR3;FZD1;ENG;EFNB3;NR2F2;PLXNA1;LEPR;LANCL1;HTR1B;RET;OR2A4;GPR161;LEF1;THRA;PPARG;CALCRL;RARA;SENP7;FZD4;ADGRA2;CLEC2D;OXTR;CELSR1;RXRA
13588,GO:0060089,5.43836209052417e-06,0.99999738277949,72,384,molecular transducer activity,MF,TNFRSF6B;GPRC5A;SFRP1;F2R;TGFBR2;EFEMP1;IL20RB;BCAM;ROR1;AXL;EGFR;LPAR5;NTSR1;ABCA1;VDR;PTPRM;NR1D1;TRIM5;MRC2;NR3C1;SORL1;LTBP1;ITGA2;CRIM1;PAQR8;PLXNB1;LTBP4;SLC22A17;CXCR1;GPR39;ADGRG6;MST1R;IL31RA;UNC5B;S1PR5;ROBO1;TLR3;FZD7;PAQR7;PLXNA2;PTPRU;FGFR1;IGF1R;PLA2R1;EPHB6;IL17RE;EDA2R;FZD8;TGFBR3;FZD1;ENG;EFNB3;NR2F2;PLXNA1;LEPR;LANCL1;HTR1B;RET;OR2A4;GPR161;LEF1;THRA;PPARG;CALCRL;RARA;SENP7;FZD4;ADGRA2;CLEC2D;OXTR;CELSR1;RXRA
15146,GO:0071310,5.67335079109318e-06,0.999996247313312,247,1797,cellular response to organic substance,BP,TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;CD109;CDKN2B;ZFP36L1;DDIT4;FAT4;TGFBR2;IL20RB;ANO1;GSN;COL5A2;PKD2;IRS2;DUSP6;ZFP36L2;SKP2;NOS1;GAS6;FBN2;PDGFC;SNAI2;SULF2;AXL;EGFR;TMEM204;PEG10;HSPA2;FLRT3;SLC8A1;SESN3;RFX2;SERPINE1;RNF165;VIM;FAM210B;TADA3;PAK1;ABCA1;VDR;BMP4;TRIM38;NR1D1;PTK6;XAF1;TRIM5;PDCD4;NR3C1;STAT1;NEO1;IFIT2;LGALS1;GNG2;TP53;KRT13;EXTL2;DDIT3;PYCARD;LTBP1;IL32;IFIT1;ITGA2;ZCCHC11;MAP2;TIMP1;CUL7;ITGA3;SIK1;IFIT3;KLF9;PAQR8;SESN1;LRP1;FYN;IFI6;XDH;LTBP4;CPS1;CAV1;SLC27A1;GLI2;RBFOX2;PLA2G6;GLDC;MAP3K14;CLU;CXCR1;PRKCZ;SLIT3;OAS2;TP53INP1;CAMK2D;MST1R;KANK2;IL31RA;PTPN14;PER1;PXN;PIK3R1;TMEM173;CREB3L2;CPT1A;LAMA5;BBS2;HERPUD1;WFS1;SPRY2;JARID2;CAT;DAPK1;PRKACB;CHEK2;ROBO1;SPRY4;TLR3;SNCA;ADAMTS7;MME;PDIA6;FZD7;AIP;GLG1;PAQR7;COL16A1;FGFR1;IGF1R;LMNA;IFI35;DKK1;FSCN1;CTF1;SETX;PDE4D;NCOA2;PSMB9;IL18;SULF1;PDK3;MYOF;TLE4;IL17RE;EDA2R;NFATC4;TRAF1;TGFBR3;FZD1;ENG;BBS4;MTMR4;CALR;MDM2;IFNK;AKAP13;SNX10;CITED2;GCLC;NR2F2;IFNE;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;BCL6;PRCP;STK16;NCOR1;PRKCA;ANXA2;RAB13;LEPR;IFITM2;RPL13A;ABCC2;MEGF8;HTR1B;RAB43;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;THRA;SPPL2B;SP100;TSPYL2;AGRN;IGFBP2;RHBDD1;MAGI2;HSPA5;CDK19;TH;TGFB1I1;RSAD2;FLNB;ITPR2;IFITM1;YAP1;CACNB1;KLF5;DERL3;AGPAT1;PPARG;CALCRL;SASH1;TGIF1;POSTN;DNAJC3;RARA;COL4A1;TAF1;EFNA5;FZD4;ADGRA2;PPP3CA;CREBRF;CTDSP2;FOS;CDK5RAP3;AGO4;MED12;UGGT2;OXTR;PRDM5;LITAF;MYO1C;RXRA;C2CD5;EDEM1
11263,GO:0045597,5.74379785128214e-06,0.999996961518581,103,596,positive regulation of cell differentiation,BP,SERPINE2;SULT1E1;FLOT1;FN1;CTGF;SOX6;INPP5D;SFRP1;ZFP36L1;TGFBR2;TENM4;ETV5;GAS6;FBN2;SNAI2;AXL;DOCK5;GJC2;SERPINE1;S100A10;FAM210B;TIMP2;TENM3;PAK1;VDR;BMP4;PTK6;NEFL;STAT1;WWTR1;DLG4;SEMA5A;CUL7;BTG1;ITGA3;GLI3;DLG5;CNTN1;KITLG;PDPN;PLXNB1;FYN;ADIRF;GLI2;PRKCZ;SYT1;CAPRIN2;TP73;METRN;ROBO1;WDFY2;PLXNA2;FGFR1;ALOX15B;DKK1;LTBP3;SETX;IL18;TRIOBP;KDM4C;FZD1;ENG;CALR;NEGR1;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;SOX9;ISL1;ITPKB;BCL6;CRTC1;PLAG1;PRKCA;RGS14;TCF12;MEGF8;RET;TGFB2;DLX2;LEF1;THRA;MAGI2;HSPA5;BOC;TGFB1I1;IFITM1;GDNF;KLF5;ATRAID;PPARG;MEF2A;OBSL1;RARA;EFNA5;FZD4;ZBTB1;FOS;KDM4A;NIPBL;DOCK1
4757,GO:0010941,6.21658828537666e-06,0.999996200050539,170,1184,regulation of cell death,BP,TNFRSF6B;MMP9;PRODH;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;GSN;IRS2;DUSP6;TNIK;SKP2;GAS6;SNAI2;MAGED1;ROR1;AXL;EGFR;TSC22D3;TRIM2;SERPINE1;ANXA5;NUPR1;AMIGO2;NTSR1;PAK1;ANGPTL4;VDR;BMP4;ITM2C;TP53I3;HS1BP3;NEFL;VAV3;PDCD4;COL18A1;STAT1;SORL1;IFIT2;LGALS1;KCNMA1;TP53;DDIT3;PYCARD;ARHGEF1;SEMA5A;MICAL1;TIMP1;HIP1;GPNMB;TFDP2;BTG1;SIK1;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;PDPN;SRPX;LRP1;FYN;ARHGEF12;IFI6;XDH;CAV1;GLI2;PLA2G6;MAP3K14;CLU;PRKCZ;TP53INP1;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;CCK;PIK3R1;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;DAPK1;DLC1;AARS;CHEK2;ROBO1;TLR3;SNCA;FGFR1;IGF1R;LMNA;DKK1;SETX;TGM2;OBSCN;G6PD;EPHB6;ARHGEF17;NFATC4;TRAF1;FZD1;CALR;ATM;APH1B;MDM2;CST3;AKAP13;CITED2;GCLC;ZMAT3;MAP3K1;FGD4;PTPN1;ARHGEF2;NRK;SSH1;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PRKCA;PAK6;MAP3K12;PRNP;RET;TGFB2;MAP2K5;LEF1;THRA;CDKN2A;SP100;VAV2;RHBDD1;HSPA5;CDK19;SRPK2;ARHGEF19;YAP1;GDNF;TWIST2;MEIS3;PPARG;RNF144B;ING4;LGALS3;DNAJC3;RARA;RASA1;FOS;KDM4A;AGO4;NPAS2;ACAA2;TAOK3
9403,GO:0035987,6.23857067559961e-06,0.99999894851517,15,34,endodermal cell differentiation,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;COL5A2;DUSP6;COL7A1;COL5A1;LAMB1;LAMA3;HMGA2;LAMB3;DKK1;COL12A1
14145,GO:0061061,6.69285805298072e-06,0.999996731653015,75,379,muscle structure development,BP,FLOT1;SOX6;ZFP36L1;SYNE1;MYH15;TGFBR2;JPH2;NOS1;UTRN;TSC22D3;TMEM204;SPEG;SLC8A1;MYLK;RNF165;NUPR1;EVC;CXCL14;PAK1;BMP4;PDCD4;LGALS1;ETV1;PRICKLE1;DDIT3;MEF2D;ADARB1;BTG1;SIK1;GPX1;FLNC;CAV1;LAMA5;TTN;JARID2;TP73;FLOT2;FZD7;FGFR1;LMNA;DKK1;CTF1;IL18;OBSCN;G6PD;MYOF;NFATC4;TGFBR3;FZD1;ENG;CALR;AKAP13;NR2F2;FHOD3;VANGL2;EGR1;SOX9;ISL1;TCF12;ZFPM1;TGFB2;LEF1;THRA;FHL1;BOC;FLNB;KLF5;MEF2A;OBSL1;RARA;PPP3CA;FOS;MYH11;RXRA;DMPK
12895,GO:0051272,6.72976734808654e-06,0.999996860851458,64,329,positive regulation of cellular component movement,BP,FN1;MMP9;CCBE1;ITGA6;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;BMP4;COL18A1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;KITLG;PDPN;PIK3R1;SPRY2;FGFR1;IGF1R;SEMA4A;CDH13;AMOTL1;CALR;MDM2;SYNE2;ARHGEF2;SSH1;SOX9;BCL6;PRKCA;MOSPD2;PODXL;MEGF8;RET;TGFB2;LEF1;HSPA5;SEMA4B;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;ADAM10;MYO1C;DOCK1
3265,GO:0006939,6.76913797338278e-06,0.999998452506278,19,55,smooth muscle contraction,BP,F2R;SULF2;SLC8A1;DOCK5;MYLK;KCNMA1;ITGA2;DOCK4;CAV1;PLA2G6;BBS2;RGS2;PDE4D;SULF1;GDNF;CALCRL;ABAT;MYH11;OXTR
10227,GO:0042981,6.79654265416509e-06,0.999995884017494,159,1094,regulation of apoptotic process,BP,TNFRSF6B;MMP9;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;ZFP36L1;NQO1;APBB2;F2R;GSN;IRS2;DUSP6;TNIK;SKP2;GAS6;SNAI2;MAGED1;ROR1;AXL;EGFR;TSC22D3;TRIM2;SERPINE1;ANXA5;NUPR1;AMIGO2;NTSR1;PAK1;ANGPTL4;VDR;BMP4;ITM2C;TP53I3;HS1BP3;NEFL;VAV3;PDCD4;COL18A1;STAT1;IFIT2;LGALS1;KCNMA1;TP53;DDIT3;PYCARD;ARHGEF1;SEMA5A;MICAL1;TIMP1;HIP1;TFDP2;BTG1;SIK1;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;PDPN;SRPX;LRP1;FYN;ARHGEF12;IFI6;XDH;CAV1;GLI2;PLA2G6;MAP3K14;CLU;PRKCZ;TP53INP1;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;IL31RA;CCK;PIK3R1;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;DAPK1;DLC1;AARS;CHEK2;ROBO1;TLR3;SNCA;FGFR1;IGF1R;LMNA;DKK1;SETX;TGM2;OBSCN;G6PD;EPHB6;ARHGEF17;NFATC4;TRAF1;CALR;ATM;APH1B;MDM2;AKAP13;CITED2;GCLC;ZMAT3;MAP3K1;FGD4;PTPN1;ARHGEF2;NRK;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PRKCA;PAK6;MAP3K12;PRNP;RET;TGFB2;MAP2K5;LEF1;THRA;CDKN2A;SP100;VAV2;RHBDD1;HSPA5;CDK19;SRPK2;ARHGEF19;YAP1;GDNF;TWIST2;MEIS3;PPARG;RNF144B;ING4;LGALS3;DNAJC3;RARA;RASA1;AGO4;ACAA2;TAOK3
6855,GO:0030335,7.23012444482584e-06,0.999996656052711,62,315,positive regulation of cell migration,BP,FN1;MMP9;CCBE1;ITGA6;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;BMP4;COL18A1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;KITLG;PDPN;PIK3R1;SPRY2;FGFR1;IGF1R;SEMA4A;CDH13;AMOTL1;CALR;MDM2;SYNE2;ARHGEF2;SSH1;SOX9;PRKCA;MOSPD2;PODXL;RET;TGFB2;LEF1;HSPA5;SEMA4B;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;ADAM10;MYO1C;DOCK1
4360,GO:0009968,7.23052990478533e-06,0.999995738426526,136,885,negative regulation of signal transduction,BP,SERPINE2;HTRA1;FLRT2;MMP9;GPRC5A;FBN1;INPP5D;ITGA6;SFRP1;CD109;DDIT4;TGFBR2;PKD2;DUSP6;GAS6;APCDD1;FBN2;SNAI2;SULF2;ROR1;AXL;EGFR;PEG10;FLRT3;SESN3;SERPINE1;RNF213;TKFC;STMN3;TIMP2;BMP4;NR1D1;PTK6;PDCD4;STAT1;SORL1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;PDGFA;RBMS3;ITGA3;GPX1;GLI3;DLG5;SESN1;SEC14L1;LRP1;FYN;IFI6;XDH;CAV1;CLU;NPHP4;PRKCZ;SLIT3;ITGA1;MST1R;KANK2;PER1;DUSP5;UNC5B;HERPUD1;WFS1;MDFI;SPRY2;FBLN1;TP73;DAPK1;DLC1;PRKACB;ROBO1;SPRY4;TLR3;SNCA;GLG1;FGFR1;IGF1R;LMNA;DKK1;RGS2;PSMB9;SULF1;EPHB6;NFATC4;TGFBR3;FZD1;MTMR4;CALR;ATM;MDM2;DLK2;GCLC;PTPN1;ARHGEF2;KLHL12;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;RGS14;IGFBP4;MEGF8;HTR1B;PRNP;RET;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;IGFBP2;NPHP3;MAGI2;HSPA5;TGFB1I1;YAP1;GDNF;MEIS3;PPARG;LGALS3;PTPN3;ADGRA2;RASA1;CREBRF;CDK5RAP3;CAMK2N1;MED12;ACAA2;TAOK3
2423,GO:0005605,7.35027272470842e-06,0.999999329639482,11,17,basal lamina,CC,FN1;NID1;LAMB1;COL4A4;LAMC2;LAMA3;ANG;LAMA5;LAMB3;AGRN;LAMB2
6582,GO:0022603,7.39074831425571e-06,0.999995758097878,120,710,regulation of anatomical structure morphogenesis,BP,FLOT1;FN1;CCBE1;SFRP1;RHOBTB2;TGFBR2;TENM4;COL5A2;ETV5;DUSP6;TNIK;SNAI2;MAGED1;SULF2;COL5A1;ROR1;DPYSL2;DOCK5;SYNE3;THBS2;SERPINE1;S100A10;PAK1;ANGPTL4;VDR;PTPRM;BMP4;NEFL;STAT1;ARAP1;PTPRS;PRICKLE1;DLG4;SEMA5A;PDGFA;MAP2;PHLDB1;GPNMB;CUL7;BTG1;PDPN;PLXNB1;FYN;XDH;ARHGAP18;UST;ULK2;ARPIN;HMGA2;SYT1;CAPRIN2;PARVA;SPRY2;FBLN1;DLC1;METRN;ROBO1;TLR3;FZD7;PLXNA2;FGFR1;DKK1;SEMA4A;C5;PSMB9;SULF1;TRIOBP;NFATC4;FZD1;ENG;CALR;MKLN1;EFNB3;CST3;AKAP13;CITED2;PLXNA1;TRAK1;FBXW8;FGD4;POGLUT1;VANGL2;SDC2;SSH1;SOX9;ISL1;BCL6;PRKCA;MEGF8;RET;TGFB2;MAP2K5;STAT2;CDC42EP5;SP100;NPHP3;MAGI2;SEMA4B;ITGB8;ARHGEF19;GDNF;PPARG;INF2;SASH1;OBSL1;POSTN;EFNA5;FZD4;WIPF1;ADGRA2;PPP3CA;RASA1;AGO4;MED12;TTBK2;ADM2;RHOBTB3;CELSR1;RXRA;DOCK1
12691,GO:0050954,7.70604457964084e-06,0.999997947765564,22,72,sensory perception of mechanical stimulus,BP,SERPINE2;SLITRK6;SNAI2;ROR1;ITGA2;GPX1;NAV2;EML2;FYN;ESPN;WFS1;SPRY2;FGFR1;MYO3B;TRIOBP;LRTOMT;HOXA1;PGAP1;ALDH7A1;TH;FZD4;NIPBL
12615,GO:0050840,8.2426809050605e-06,0.999998653406509,14,33,extracellular matrix binding,MF,ITGA6;NID1;BCAM;LGALS1;ITGA2;SMOC1;ITGA3;ADGRG6;TGFBI;ANXA2;ADAMTS15;AGRN;OLFML2A;LGALS3
3262,GO:0006935,8.33293403364958e-06,0.999995871926149,68,358,chemotaxis,BP,FLRT2;MMP28;APBB2;PIK3C2G;IRS2;GAS6;DPYSL2;FLRT3;SPTB;SERPINE1;DOK1;RNF165;CXCL14;PTPRM;BMP4;VAV3;NEO1;ETV1;SEMA5A;ITGA2;PDGFA;GPNMB;DOCK4;ANO6;GLI3;PLXNB1;FYN;GLI2;PLA2G6;CXCR1;SLIT3;ITGA1;PIK3R1;PARVA;UNC5B;ROBO1;PLXNA2;FGFR1;SEMA4A;C5;PDE4D;CDH13;CALR;EFNB3;PLXNA1;VANGL2;PLGRKT;LYST;ISL1;NFASC;PRKCA;RAB13;MOSPD2;MEGF8;RET;TGFB2;LEF1;BOC;SEMA4B;OPHN1;GDNF;KLF7;LGALS3;EFNA5;ADGRA2;ELMO2;ADAM10;LAMB2
9942,GO:0042330,8.33293403364958e-06,0.999995871926149,68,358,taxis,BP,FLRT2;MMP28;APBB2;PIK3C2G;IRS2;GAS6;DPYSL2;FLRT3;SPTB;SERPINE1;DOK1;RNF165;CXCL14;PTPRM;BMP4;VAV3;NEO1;ETV1;SEMA5A;ITGA2;PDGFA;GPNMB;DOCK4;ANO6;GLI3;PLXNB1;FYN;GLI2;PLA2G6;CXCR1;SLIT3;ITGA1;PIK3R1;PARVA;UNC5B;ROBO1;PLXNA2;FGFR1;SEMA4A;C5;PDE4D;CDH13;CALR;EFNB3;PLXNA1;VANGL2;PLGRKT;LYST;ISL1;NFASC;PRKCA;RAB13;MOSPD2;MEGF8;RET;TGFB2;LEF1;BOC;SEMA4B;OPHN1;GDNF;KLF7;LGALS3;EFNA5;ADGRA2;ELMO2;ADAM10;LAMB2
462,GO:0001501,8.64535306716939e-06,0.999995835865666,63,307,skeletal system development,BP,MMP2;MMP9;CTGF;FBN1;SOX6;SFRP1;FAT4;TGFBR2;EFEMP1;COL5A2;GJA5;FBN2;PDGFC;SNAI2;SULF2;SERPINH1;EVC;VDR;BMP4;MEF2D;TIMP1;ANO6;GLI3;PLXNB1;GLI2;FBXW4;HMGA2;SLC38A10;CREB3L2;BBS2;MDFI;IFT140;ADAMTS7;GLG1;FGFR1;TGFBI;SULF1;FOXN3;PBX1;ENG;AKAP13;MAF;SOX9;ANXA2;HOXA1;IGFBP4;NAB2;MEGF8;WDR19;CDH11;ZFPM1;TGFB2;DLX2;COL12A1;THRA;ITGB8;HOXA3;POSTN;RARA;ANKH;MATN3;MED12;NIPBL
12854,GO:0051216,9.90972464336722e-06,0.999996709279614,29,105,cartilage development,BP,CTGF;SOX6;TGFBR2;EFEMP1;SNAI2;SULF2;SERPINH1;EVC;BMP4;MEF2D;TIMP1;GLI3;GLI2;FBXW4;HMGA2;CREB3L2;BBS2;ADAMTS7;GLG1;FGFR1;TGFBI;SULF1;MAF;SOX9;DLX2;THRA;ITGB8;HOXA3;RARA
11317,GO:0045664,1.03714230499005e-05,0.999994596587102,79,412,regulation of neuron differentiation,BP,FN1;SFRP1;ETV5;SDK1;TNIK;DPYSL2;CSMD3;VIM;TIMP2;TENM3;PAK1;BMP4;ITM2C;PTK6;EIF2AK4;NEFL;LGALS1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;PLXNB1;LRP1;FYN;GLI2;UST;ULK2;SYT1;CAPRIN2;TP73;S1PR5;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SEMA4A;SETX;KDM4C;NFATC4;FZD1;PBX1;CALR;NEGR1;EFNB3;MDM2;ARF6;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;SDC2;SSH1;SOX9;ISL1;BCL6;CRTC1;TCF12;MEGF8;RET;DLX2;MAGI2;HSPA5;SEMA4B;DIXDC1;OBSL1;RARA;EFNA5;FZD4;PPP3CA;KDM4A;CDK5RAP3
11375,GO:0045785,1.0496042955991e-05,0.999995358764765,49,238,positive regulation of cell adhesion,BP,FLOT1;FN1;COL8A1;ITGA6;SFRP1;TGFBR2;NID1;UTRN;DOCK5;S100A10;PAK1;VAV3;LGALS1;PYCARD;ITGA2;ITGA3;GLI3;PDPN;CCDC80;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;ANK3;FLOT2;FRMD5;COL16A1;TGM2;IL18;TRIOBP;CDH13;CALR;EFNB3;CITED2;CD1D;ITPKB;BCL6;PRKCA;PODXL;RET;TGFB2;IGFBP2;IFT74;RARA;ECM2;ZBTB1;DOCK1
13690,GO:0060284,1.06969166735992e-05,0.999994034157026,102,571,regulation of cell development,BP,SERPINE2;FN1;FLRT2;FBN1;SFRP1;TENM4;ETV5;SDK1;TNIK;NOS1;DPYSL2;DOCK5;CSMD3;GJC2;S100A10;VIM;TIMP2;TENM3;PAK1;BMP4;ITM2C;PTK6;EIF2AK4;NEFL;SORL1;LGALS1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;PDPN;PLXNB1;LRP1;FYN;GLI2;UST;ULK2;SYT1;CAPRIN2;FBLN1;TP73;S1PR5;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SEMA4A;SETX;G6PD;TRIOBP;KDM4C;NFATC4;FZD1;PBX1;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;TCF4;AKAP13;PLXNA1;TRAK1;FBXW8;ARHGEF2;SDC2;SSH1;SOX9;ISL1;BCL6;CRTC1;PLAG1;RGS14;TCF12;MEGF8;RET;DLX2;MAGI2;HSPA5;SEMA4B;YAP1;DIXDC1;PPARG;OBSL1;POSTN;RARA;EFNA5;FZD4;ADGRA2;PPP3CA;KDM4A;CDK5RAP3;NIPBL;DOCK1
12237,GO:0048545,1.07954722541731e-05,0.999995203124576,53,267,response to steroid hormone,BP,TXNIP;CTGF;SFRP1;ZFP36L1;DDIT4;TGFBR2;ZFP36L2;SKP2;EGFR;TADA3;PAK1;VDR;BMP4;NR1D1;NEFL;NR3C1;KLF9;PAQR8;CTSV;CPS1;CAV1;RBFOX2;SLIT3;KANK2;PER1;PAQR7;PTPRU;ENG;CALR;MDM2;AREG;AKAP13;NR2F2;ISL1;BCHE;ABCC2;HTR1B;TGFB2;LEF1;THRA;IGFBP2;TH;TGFB1I1;YAP1;PPARG;RARA;ABCA2;TAF1;CREBRF;FOS;MED12;OXTR;RXRA
19732,GO:2000147,1.1771888591017e-05,0.999994282420818,62,321,positive regulation of cell motility,BP,FN1;MMP9;CCBE1;ITGA6;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;BMP4;COL18A1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;KITLG;PDPN;PIK3R1;SPRY2;FGFR1;IGF1R;SEMA4A;CDH13;AMOTL1;CALR;MDM2;SYNE2;ARHGEF2;SSH1;SOX9;PRKCA;MOSPD2;PODXL;RET;TGFB2;LEF1;HSPA5;SEMA4B;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;ADAM10;MYO1C;DOCK1
3387,GO:0007167,1.19540741146825e-05,0.999993114292464,116,692,enzyme linked receptor protein signaling pathway,BP,MMP2;HTRA1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;SFRP1;CD109;CDKN2B;DDIT4;FAT4;TGFBR2;EFEMP1;IRS2;DUSP6;GAS6;FBN2;PDGFC;SULF2;ROR1;AXL;EGFR;TMEM204;PEG10;FLRT3;SESN3;DOK1;RNF165;VIM;CSPG4;PAK1;BMP4;PTK6;VAV3;PDCD4;NEO1;ARAP1;WWTR1;LTBP1;PILRB;PDGFA;HIP1;CRIM1;ITGA3;LRP1;FYN;XDH;LTBP4;CAV1;RBFOX2;PRKCZ;ITGA1;MST1R;IL31RA;PXN;PIK3R1;SPRY2;ROBO1;SPRY4;SNCA;GLG1;SH3TC2;PTPRU;FGFR1;PAG1;IGF1R;DKK1;CTF1;SETX;SULF1;MYOF;EPHB6;AFAP1L2;CDH13;TGFBR3;FZD1;ENG;MTMR4;EFNB3;APH1B;AREG;DGKQ;CITED2;PTPN1;SDC2;EGR1;SOX9;ENPP1;PRKCA;RGS14;IGFBP4;MVB12B;MEGF8;RET;TGFB2;LEF1;IGFBP2;VAV2;MAGI2;HSPA5;TGFB1I1;PTPN3;COL4A1;EFNA5;FZD4;ADGRA2;RASA1;FOS;ELMO2;MYO1C;C2CD5;DOCK1
3708,GO:0008219,1.20020705422251e-05,0.999991976634017,213,1567,cell death,BP,TNFRSF6B;KRT4;MMP9;PRODH;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;GSN;IRS2;DUSP6;TNIK;SKP2;TNS4;GAS6;SNAI2;MAGED1;ROR1;AXL;EGFR;TSC22D3;PEG10;TCHH;TRIM2;SERPINE1;KRT14;ANXA5;NUPR1;AMIGO2;NTSR1;PAK1;ANGPTL4;NSG1;VDR;BMP4;ITM2C;TP53I3;XAF1;HS1BP3;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;SORL1;IFIT2;SCN2A;LGALS1;KCNMA1;TP53;KRT13;DDIT3;PYCARD;MEF2D;KRT5;ARHGEF1;SEMA5A;MICAL1;NISCH;PPL;ADARB1;TIMP1;FLG;HIP1;GPNMB;TFDP2;BTG1;SIK1;EMP1;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;PDPN;SRPX;KRT15;CTSV;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;CAV1;GLI2;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;SLIT3;TP53INP1;PARP4;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;CCK;PIK3R1;TMEM173;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;CASP14;DAPK1;DLC1;AARS;CHEK2;ROBO1;TLR3;SNCA;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;SETX;TGM2;OBSCN;SULF1;G6PD;EPHB6;EDA2R;ARHGEF17;NFATC4;TRAF1;FZD1;CALR;ATM;APH1B;MDM2;ARF6;CST3;ANXA6;AKAP13;CITED2;GCLC;ELMO3;ZMAT3;MAP3K1;FGD4;PTPN1;ARHGEF2;NRK;SSH1;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PLAG1;PRKCA;PAK6;MAP3K12;UACA;PRNP;RET;TGFB2;MAP2K5;LEF1;THRA;USP28;CDKN2A;SP100;VAV2;RHBDD1;HSPA5;CDK19;MAGI1;SRPK2;ARHGEF19;YAP1;GDNF;TWIST2;MEIS3;PPARG;RNF144B;KCNIP3;MEF2A;ING4;LGALS3;DNAJC3;RARA;RASA1;KRT10;FOS;KDM4A;CDK5RAP3;AGO4;ELMO2;NPAS2;ACAA2;TAOK3;DOCK1;DMPK
4228,GO:0009410,1.23657500951954e-05,0.999995237029183,35,164,response to xenobiotic stimulus,BP,NQO1;DDIT4;PTGS1;SDK1;EGFR;SLC8A1;NR3C1;TP53;GPX1;CMBL;CPS1;CES2;PRKACB;CHEK2;BPHL;SNCA;AIP;MDM2;GCLC;AKR7A2;EGR1;BCHE;CES3;ABCC2;HTR1B;HSPA5;TH;UGT1A3;UGT1A6;SRR;PPARG;SLITRK5;PPP3CA;ABAT;OXTR
7591,GO:0031982,1.25426295741776e-05,0.999990883941097,372,3044,vesicle,CC,SERPINE2;ITGB6;SYT8;FLOT1;PRSS23;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;GPRC5A;ITGB5;COL8A1;FBN1;SFRP1;CD109;RHOBTB2;NQO1;F2R;FAT4;XPC;PTGS1;ITGB4;EFEMP1;SLC7A8;ANO1;GSN;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;COL7A1;BCAM;CLTCL1;NOS1;DNAJB4;GAS6;PDGFC;MALL;MAP6;COL5A1;UTRN;ARHGAP23;SAMD9L;AXL;DPYSL2;EGFR;HSPA2;LAMB1;FKBP5;MYLK;SLC2A3;THBS2;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;S100A10;STON2;ANXA5;VIM;CSPG4;TKFC;TOM1L2;TIMP2;PDLIM2;PLEC;ABCA1;NSG1;ITM2C;TP53I3;PCSK1;AHNAK;SCN8A;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;ARAP1;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;DDIT3;PYCARD;KRT5;SEC14L2;MUC19;DLG4;ARMC9;SEMA5A;ZCCHC11;PDGFA;NISCH;PPL;TIMP1;EFEMP2;PHGDH;HIP1;PACS1;GPNMB;CRIM1;ITGA3;SNX1;ANO6;GPX1;CNTN1;TBC1D5;ECH1;PLLP;SYN1;CTDSPL;PDPN;ABHD14B;KRT15;MAGED2;CTSV;SPG11;KCNAB2;LRP1;FYN;ARHGEF12;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;CAV1;SNX33;AHNAK2;CLU;SERPING1;CXCR1;SNX29;PRKCZ;ULK2;TP53INP1;PARP4;EHD3;CAMK2D;PRDX5;ITGA1;SYTL1;METTL7A;EHBP1;PDIA4;SYT1;TMEM173;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;TTN;APLP2;HPS4;FBLN1;CAT;CASP14;PRKACB;AARS;BACE1;WDFY2;LRIG3;STOM;TLR3;BPHL;MAN1A1;SNCA;FLOT2;ALDH1L2;MME;THSD4;PDIA6;VAMP1;FZD7;GLG1;JADE2;SH3TC2;FGFR1;CBR1;ALOX15B;DKK1;MLEC;FSCN1;SEC24D;LTBP3;C5;TGFBI;ASTN2;TGM2;PSMB9;IL18;PLA2R1;G6PD;MYOF;ARSD;CCDC136;CDH13;MAGEF1;SEPT6;TGFBR3;AMOTL1;NAGLU;LAPTM4A;MTMR4;CALR;NEGR1;ATM;IDH2;COPG2;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MANBA;AREG;ANXA6;DNAJC6;SNX10;DGKQ;PLXNA1;HEXA;NEURL1B;AKR7A2;NRSN2;TRAK1;CD1D;HSPA12A;SYNE2;HDAC11;RNPEP;PTPN1;POGLUT1;VANGL2;CPNE8;ARHGEF2;KLHL12;COL5A3;IFT27;SLC48A1;PLD3;PRCP;NFASC;STK16;NDRG1;PRKCA;TMEM175;PRPS2;ANXA2;TMC4;RAB13;CES3;FNDC3A;SEPT5;MAN2B1;LANCL1;ALDH9A1;MVB12B;MOSPD2;NMNAT2;GAL3ST4;PODXL;DECR1;MEGF8;UACA;RAB43;PRNP;CDH11;RET;TGFB2;RBL2;VPS39;DNASE1L1;OR2A4;COL12A1;SCNN1A;AMOTL2;GPR161;LIPA;ALDH7A1;ITM2A;C2CD4C;EFR3A;SPPL2B;OSBPL1A;ULK1;AGRN;IGFBP2;TMEM187;MAGI2;HSPA5;TH;GOPC;SNX7;PIKFYVE;EHBP1L1;REEP2;FLNB;CHIC2;UVRAG;TCTEX1D4;ITGB8;NAPRT;MON2;ITPR2;VPS13C;IFT74;UGT1A6;CAPS;GALNT2;CAPG;CALCRL;SNX9;TBC1D16;LGALS3;ARL3;DNAJC3;RASSF9;SV2A;ABCA2;CCNY;TMEM67;PRKAG1;FZD4;WIPF1;TMEM168;PIK3C2B;PEX1;STEAP2;KRT10;ACTR1B;PPCS;DNM1P46;DNPH1;SERPINB5;SCPEP1;ABAT;MYH11;NIPBL;VPS36;PCDHGB5;ADAM10;RHOBTB3;MPDZ;LITAF;TSPAN4;S100A11;MYO1C;C2CD5;ACAA2;ABCA5;CTSD;ZNRF1;LAMB2
632,GO:0001822,1.25939165309652e-05,0.999994674638584,43,182,kidney development,BP,FBN1;SFRP1;FAT4;PKD2;NID1;MAGED1;SULF2;ACTA2;BMP4;STAT1;WWTR1;PDGFA;COL4A4;ITGA3;GLI3;DLG5;GLI2;TNS2;LAMA5;WFS1;TP73;CAT;MME;FGFR1;SULF1;PBX1;TMED10;VANGL2;EGR1;SOX9;GCNT1;PODXL;RET;TGFB2;NPHP3;MAGI2;YAP1;GDNF;KLHL3;ARL3;RARA;NIPBL;LAMB2
706,GO:0001932,1.30286105087293e-05,0.999991841505144,143,934,regulation of protein phosphorylation,BP,FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;SFRP1;GADD45B;CD109;CDKN2B;F2R;DDIT4;TGFBR2;PKD2;DUSP6;HERC5;TNIK;PROM2;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;PDCD4;SORL1;TP53;WWTR1;PYCARD;WNK1;DLG4;PILRB;PDGFA;MICAL1;ADARB1;GPNMB;CNTN1;KITLG;CTDSPL;FYN;XDH;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;PER1;CCK;CAPRIN2;ANG;DUSP5;SPRY2;TTN;FBLN1;TP73;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;NR2F2;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;STAT2;MAPK8IP3;CDKN2A;TSPYL2;HSPA5;UVRAG;MDFIC;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CTDSP2;CDK5RAP3;CAMK2N1;TAOK3
323,GO:0000904,1.31497045562759e-05,0.999992840727613,91,482,cell morphogenesis involved in differentiation,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;TNIK;MAP6;AXL;DPYSL2;LAMB1;FLRT3;SPTB;DOCK5;DOK1;S100A10;RNF165;PAK1;PTPRM;NEFL;COL18A1;NEO1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;GLI3;PDPN;SPG11;PLXNB1;FYN;GLI2;RBFOX2;UST;SLIT3;ULK2;CCK;PIK3R1;CAPRIN2;PARVA;LAMA5;UNC5B;ANK3;FBLN1;METRN;ROBO1;FZD7;PLXNA2;DKK1;SEMA4A;TRIOBP;NFATC4;RAPH1;CALR;EFNB3;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ZFPM1;LEF1;ULK1;BOC;FLNB;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;UNK;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;DOCK1;LAMB2
564,GO:0001706,1.34240648894747e-05,0.999997306282319,16,41,endoderm formation,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;COL5A2;DUSP6;COL7A1;COL5A1;LAMB1;LAMA3;HMGA2;DUSP5;LAMB3;DKK1;COL12A1
7246,GO:0031224,1.3434497720158e-05,0.999990282065177,350,2754,intrinsic component of membrane,CC,ITGB6;SYT8;TNFRSF6B;FLOT1;PCDH7;FLRT2;GPRC5A;ITGB5;ADAM19;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;CD109;SYNE1;F2R;FAT4;TGFBR2;SLITRK6;ITGB4;TENM4;IL20RB;MARCH4;SLC7A8;ANO1;GJA5;PKD2;JPH2;SCARA3;CYBRD1;SDK1;ANPEP;PROM2;BCAM;NOS1;APCDD1;MALL;ROR1;AXL;EGFR;GALNT10;TMEM204;SDC3;HSPA2;FLRT3;SPTB;NYNRIN;SLC8A1;NTM;ORAI3;CLCA2;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;KIAA1549L;ATP10D;MBOAT2;LPAR5;FAM198B;CSPG4;EVC;CNTNAP3;FAM210B;AMIGO2;NTSR1;TENM3;ABCA1;LOC441081;NSG1;TMC7;PTPRM;TP53I11;ITM2C;SCN8A;NETO1;MRC2;SORL1;NEO1;SCN2A;KCNMA1;MEST;EXTL2;KIAA0319L;PTPRS;DLG4;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ACSL3;GPNMB;TMEM200A;CRIM1;ITGA3;EMP1;PCDHAC2;SLC22A15;ELFN2;TPBG;ANO6;PAQR8;PTGES;CNTN1;LPCAT2;KITLG;ERMAP;PLLP;SYN1;PDPN;PLXNB1;KCNAB2;LRP1;EMP3;IFI6;B3GAT3;FUT10;CLMN;UGT8;FAT2;CAV1;SLC27A1;ITGA10;SEL1L;SLC22A17;SLC35F3;OSBPL5;XYLT1;UST;DCBLD2;CXCR1;SDR16C5;GPR39;KCNJ15;CHST3;CAMK2D;ADGRG6;GOLGB1;ITGA1;MST1R;IL31RA;ULBP1;ATP8B2;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;ALDH3A2;CPT1A;SLC38A2;CALHM2;DYSF;UNC5B;HERPUD1;WFS1;TMEM139;TMEM8B;APLP2;ST6GAL2;S1PR5;BTN3A1;BACE1;ROBO1;KCNJ5;LRIG3;STOM;TLR3;MAN1A1;MME;FRMD5;VAMP1;FZD7;GLG1;PAQR7;PLXNA2;CYYR1;PTPRU;FGFR1;PAG1;IGF1R;ARMCX2;MLEC;SEMA4A;C5;GLT8D2;ASTN2;PDE4D;TMEM129;TGM2;PLA2R1;ESYT2;TRO;MYOF;EPHB6;IL17RE;EDA2R;FZD8;CCDC136;TMEM263;SLC24A1;CDH13;CD99L2;TGFBR3;FZD1;LRTOMT;LAPTM4A;ENG;CALR;NEGR1;EFNB3;APH1B;TMED10;DLK2;TMEM14C;AREG;PLXNA1;DNAJC4;NRSN2;CYP20A1;CD1D;SYNE2;CSMD2;NEMP2;KCNQ3;VANGL2;SMIM19;NTNG1;PLGRKT;SDC2;SLC25A35;ENPP1;SLC27A6;SLC48A1;PCDHGA11;PLD3;NFASC;G6PC3;GCNT1;TMEM50B;TMEM63C;PXMP2;TMEM175;TMC4;FNDC3A;TMEM94;RNF24;METTL23;LEPR;PGAP1;PLD5;IFITM2;MOSPD2;CNTNAP3B;GAL3ST4;PODXL;ABCC2;MEGF8;TSPAN5;NLGN4Y;XG;HTR1B;SLC39A11;PRNP;TMEM60;CDH11;RET;GGT7;DSEL;OR2A4;SCNN1A;GPR161;LRRN3;SFXN3;ITM2A;CYP4V2;HERPUD2;SPPL2B;AGRN;TMEM187;TMEM164;RHBDD1;KIAA1109;HSPA5;BTN3A3;NRM;SLC9A4;BOC;REEP2;FLNB;SEMA4B;ITGB8;ITPR2;UGT1A3;RHBDD2;IFITM1;LMF1;UGT1A6;MYO9A;CACNB1;ALG10;COL17A1;GPX8;ATRAID;GALNT2;DERL3;AGPAT1;RNF144B;CALCRL;TPST1;KCNIP3;TMEM212;SLC35E2B;CERS5;SHISA9;PRR7;MIA3;TSPAN18;SV2A;ABCA2;TMEM67;EFNA5;FZD4;MPPE1;SLITRK5;ADGRA2;NAT14;TMEM168;RASA1;ANKH;STEAP2;COX18;TMTC4;AIG1;CLEC2D;CACNA2D3;PCDHGB5;OXTR;ADAM10;CELSR1;TSPAN4;TUSC3;ORAI2;EDEM1;TMEM92;ABCA5;DMPK;MOSPD3
10237,GO:0042995,1.44604606059516e-05,0.999990313208666,199,1310,cell projection,CC,FLOT1;FLRT2;ITGA6;NQO1;APBB2;TLN2;PTGS1;TENM4;ASAP3;GSN;GJA5;PKD2;PITPNM3;CYBRD1;PROM2;NOS1;MAP6;UTRN;ROR1;FLRT3;CEP126;SLC8A1;MYLK;GJC2;ACTA2;STON2;VIM;CSPG4;PSTPIP1;EVC;STMN3;NTSR1;TIMP2;TENM3;PAK1;NSG1;PTPRM;NEFM;NR1D1;PTK6;SCN8A;NEFL;STAT1;SCN2A;CEP250;PTPRS;TTLL11;CNTRL;EFHC1;DLG4;ITGA2;PDGFA;MAP2;FRMD4B;MICAL1;DOCK4;ITGA3;WDR66;SNX1;PLEK2;GLI3;DLG5;KITLG;ASAP1;SYN1;PDPN;CTSV;SPG11;KCNAB2;LRP1;FYN;CAV1;GLI2;PIAS3;SPATA6;ESPN;CLU;NPHP4;PRKCZ;ARPIN;EHD3;CAMK2D;ITGA1;SYTL1;IL31RA;PXN;CCK;SYT1;SLC38A2;ANG;DYSF;KIF17;BBS2;ANK3;WFS1;SPRY2;DLC1;PRKACB;BACE1;ROBO1;IFT140;SPRY4;SNCA;FLOT2;MME;VAMP1;DZIP1L;IGF1R;FSCN1;RGS2;SETX;MYO3B;EPHB6;TRIOBP;CDH13;RAPH1;SEPT6;AMOTL1;BBS4;MKLN1;ARF6;CST3;BBS1;TRAK1;LZTS1;SYNE2;FGD4;KCNQ3;ARHGEF2;DNAL4;SSH1;IFT27;NFASC;CRTC1;ANXA2;RGS14;RAB13;SEPT5;IFT88;TTC8;PODXL;ABCC2;MAP3K12;HTR1B;SPA17;WDR19;PRNP;RET;TGFB2;ODF2;SCNN1A;IFT122;GPR161;ULK1;NPHP3;MAGI2;TH;GOPC;MAGI1;BOC;TCTEX1D4;CFAP54;FHOD1;IFT74;OPHN1;TPGS1;DNAH1;KCNIP3;SNX9;SHISA9;ICK;PRR7;ARL3;DEF6;RARA;SV2A;TMEM67;TSHZ3;FZD4;WIPF1;ADGRA2;PPP3CA;RASA1;ARHGAP31;FOS;DNM1P46;SEPT9;CAMK2N1;ABAT;TTBK2;BSN;OXTR;RHOBTB3;MPDZ;ANKS6;S100A11;MYO1C;ORAI2;C2CD5
4801,GO:0012501,1.48256785209448e-05,0.999990019841739,202,1480,programmed cell death,BP,TNFRSF6B;KRT4;MMP9;PRODH;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;GSN;IRS2;DUSP6;TNIK;SKP2;TNS4;GAS6;SNAI2;MAGED1;ROR1;AXL;EGFR;TSC22D3;PEG10;TCHH;TRIM2;SERPINE1;KRT14;ANXA5;NUPR1;AMIGO2;NTSR1;PAK1;ANGPTL4;NSG1;VDR;BMP4;ITM2C;TP53I3;XAF1;HS1BP3;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;IFIT2;SCN2A;LGALS1;KCNMA1;TP53;KRT13;DDIT3;PYCARD;MEF2D;KRT5;ARHGEF1;SEMA5A;MICAL1;NISCH;PPL;ADARB1;TIMP1;FLG;HIP1;TFDP2;BTG1;SIK1;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;PDPN;SRPX;KRT15;CTSV;LRP1;FYN;ARHGEF12;IFI6;XDH;CAV1;GLI2;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;SLIT3;TP53INP1;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;CCK;PIK3R1;TMEM173;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;CASP14;DAPK1;DLC1;AARS;CHEK2;ROBO1;TLR3;SNCA;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;SETX;TGM2;OBSCN;SULF1;G6PD;EPHB6;EDA2R;ARHGEF17;NFATC4;TRAF1;CALR;ATM;APH1B;MDM2;ARF6;CST3;ANXA6;AKAP13;CITED2;GCLC;ELMO3;ZMAT3;MAP3K1;FGD4;PTPN1;ARHGEF2;NRK;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PLAG1;PRKCA;PAK6;MAP3K12;UACA;PRNP;RET;TGFB2;MAP2K5;LEF1;THRA;USP28;CDKN2A;SP100;VAV2;RHBDD1;HSPA5;CDK19;SRPK2;ARHGEF19;YAP1;GDNF;TWIST2;MEIS3;PPARG;RNF144B;KCNIP3;MEF2A;ING4;LGALS3;DNAJC3;RARA;RASA1;KRT10;CDK5RAP3;AGO4;ELMO2;ACAA2;TAOK3;DOCK1;DMPK
12872,GO:0051241,1.48706192257614e-05,0.999991294756912,109,679,negative regulation of multicellular organismal process,BP,SERPINE2;FN1;FBN1;SOX6;INPP5D;SFRP1;ZFP36L1;F2R;TGFBR2;EFEMP1;IL20RB;COL5A2;GJA5;HERC5;GAS6;SNAI2;COL5A1;AXL;EGFR;TSC22D3;DOCK5;THBS2;SERPINE1;ANXA5;VIM;PAK1;PTPRM;BMP4;ITM2C;EIF2AK4;PDCD4;STAT1;SORL1;LGALS1;PTPRS;PRICKLE1;DDIT3;PYCARD;WNK1;SEMA5A;PDGFA;TIMP1;GPNMB;DOCK4;GLI3;ASAP1;LRP1;XDH;GLI2;RNF135;TRIB2;SERPING1;ULK2;PIK3R1;BBS2;SPRY2;JARID2;TP73;KLF13;PRKACB;ROBO1;TLR3;ADAMTS7;FZD7;FGFR1;LMNA;DKK1;SEMA4A;RGS2;PDE4D;SULF1;G6PD;NFATC4;PBX1;CALR;EFNB3;IDH2;MDM2;ARF6;CST3;MEIS2;AREG;NR2F2;ARHGEF2;SOX9;ISL1;ITPKB;BCL6;ANXA2;PRNP;ZFPM1;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;SP100;SEMA4B;TWIST2;UBA7;DIXDC1;PPARG;CALCRL;RARA;PPP3CA;KDM4A;ABAT;OXTR
7248,GO:0031226,1.49591611273975e-05,0.999991002754214,124,768,intrinsic component of plasma membrane,CC,ITGB6;TNFRSF6B;PCDH7;FLRT2;GPRC5A;ITGB5;ITGA6;F2R;TGFBR2;SLITRK6;ITGB4;TENM4;SLC7A8;GJA5;PKD2;PROM2;BCAM;APCDD1;ROR1;AXL;EGFR;FLRT3;SPTB;SLC8A1;CLCA2;SLC20A1;SLC2A3;CSPG4;NTSR1;TENM3;ABCA1;PTPRM;SCN8A;MRC2;SORL1;NEO1;SCN2A;KCNMA1;PTPRS;DLG4;SLC7A11;ITGA2;PILRB;GPNMB;ITGA3;PCDHAC2;SLC22A15;TPBG;PDPN;PLXNB1;KCNAB2;LRP1;CAV1;ITGA10;SLC22A17;DCBLD2;GPR39;KCNJ15;ITGA1;MST1R;ULBP1;SLC38A2;CALHM2;BACE1;ROBO1;KCNJ5;STOM;TLR3;MME;VAMP1;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;C5;TGM2;PLA2R1;ESYT2;TRO;EPHB6;IL17RE;EDA2R;SLC24A1;TGFBR3;ENG;EFNB3;APH1B;PLXNA1;CD1D;KCNQ3;NTNG1;PLGRKT;ENPP1;PCDHGA11;MOSPD2;PODXL;ABCC2;TSPAN5;NLGN4Y;XG;HTR1B;PRNP;RET;SCNN1A;BOC;REEP2;ITGB8;COL17A1;CALCRL;KCNIP3;SHISA9;TSPAN18;EFNA5;FZD4;RASA1;ANKH;STEAP2;CLEC2D;PCDHGB5;OXTR;CELSR1;TSPAN4;TUSC3
7057,GO:0030855,1.54682817376581e-05,0.999991755360161,76,436,epithelial cell differentiation,BP,KRT4;TXNIP;CD109;ZFP36L1;FAT4;SLITRK6;TCHH;ACTA2;SERPINE1;KRT14;VIM;VDR;BMP4;PTK6;COL18A1;STAT1;KRT13;PTPRS;WWTR1;KRT5;SLC7A11;ITGA2;PPL;FLG;BTG1;GPX1;E2F7;DLG5;PDPN;KRT15;CTSV;XDH;CPS1;CAV1;IL31RA;CPT1A;LAMA5;CASP14;FZD7;FGFR1;CBR1;ALOX15B;PDE4D;TRIOBP;DLX3;FZD1;LRTOMT;ENG;CST3;NR2F2;MAF;SOX9;RAB13;FNDC3A;PODXL;LEF1;THRA;MAGI2;KIAA1109;SLC9A4;TGFB1I1;FLNB;IFT74;OPHN1;MYO9A;YAP1;GDNF;KLF5;PPARG;LGALS3;RARA;COL4A1;KRT10;DNPH1;RXRA;LAMB2
17719,GO:1901681,1.5789209979775e-05,0.999994076167302,33,143,sulfur compound binding,MF,SERPINE2;FN1;CTGF;FBN1;SFRP1;COL5A1;THBS2;BMP4;PTPRS;SEMA5A;ITGA2;GPNMB;LAMC2;PTGES;NAV2;CCDC80;LRP1;HLCS;ACACB;ANG;APLP2;FGFR1;DHTKD1;TGFBR3;COL5A3;ENPP1;ADAMTS15;LANCL1;GAL3ST4;AGRN;ADAMTSL5;POSTN;ECM2
13246,GO:0051962,1.58494656288455e-05,0.999992120062184,65,327,positive regulation of nervous system development,BP,SERPINE2;FN1;FLRT2;SLITRK6;TENM4;ETV5;FLRT3;GJC2;THBS2;AMIGO2;TIMP2;TENM3;PAK1;BMP4;PTK6;NEFL;DLG4;SEMA5A;CUL7;ITGA3;TPBG;GLI3;DLG5;CNTN1;PLXNB1;FYN;GLI2;SYT1;CAPRIN2;TP73;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SETX;KDM4C;FZD1;NEGR1;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;BCL6;CRTC1;PLAG1;RGS14;TCF12;MEGF8;RET;DLX2;LRRN3;AGRN;MAGI2;HSPA5;PPARG;OBSL1;RARA;EFNA5;FZD4;SLITRK5;KDM4A;NIPBL;OXTR
3488,GO:0007369,1.63283236909867e-05,0.99999405852001,32,121,gastrulation,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;SFRP1;TGFBR2;ITGB4;TENM4;COL5A2;DUSP6;COL7A1;COL5A1;LAMB1;BMP4;ITGA2;PHLDB1;ITGA3;LAMA3;HMGA2;DUSP5;LAMB3;FZD7;FGFR1;DKK1;POGLUT1;VANGL2;MEGF8;MAP2K5;COL12A1;LEF1;NPHP3
15658,GO:0072215,1.63335985157946e-05,0.999998577658224,9,16,regulation of metanephros development,BP,FAT4;BMP4;STAT1;WWTR1;PDGFA;EGR1;RET;YAP1;GDNF
16756,GO:0098609,1.64053304214197e-05,0.999991185367954,78,436,cell-cell adhesion,BP,SERPINE2;FLOT1;PCDH7;ITGB5;ITGA6;ZFP36L1;FAT4;TGFBR2;TENM4;IL20RB;SDK1;GAS6;SNAI2;EGFR;LAMB1;FLRT3;AMIGO2;TENM3;PAK1;PTPRM;BMP4;LGALS1;PYCARD;SLC7A11;GPNMB;PCDHAC2;GLI3;DLG5;PDPN;FYN;FAT2;CAV1;GLI2;MAP3K14;NPHP4;PRKCZ;PIK3R1;PARVA;ANK3;ROBO1;FLOT2;PTPRU;PAG1;IL18;TRO;CDH13;NEGR1;EFNB3;CITED2;CD1D;SOX9;ITPKB;BCL6;PCDHGA11;NFASC;GCNT1;PRKCA;ANXA2;FNDC3A;PODXL;NLGN4Y;PRNP;CDH11;RET;TGFB2;MAP2K5;LEF1;IGFBP2;LGALS3;RARA;EFNA5;ZBTB1;ELMO2;ABAT;CERCAM;PCDHGB5;CELSR1;S100A11
3252,GO:0006915,1.71797926654227e-05,0.999988494925396,192,1389,apoptotic process,BP,TNFRSF6B;MMP9;PRODH;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;GSN;IRS2;DUSP6;TNIK;SKP2;TNS4;GAS6;SNAI2;MAGED1;ROR1;AXL;EGFR;TSC22D3;PEG10;TRIM2;SERPINE1;ANXA5;NUPR1;AMIGO2;NTSR1;PAK1;ANGPTL4;NSG1;VDR;BMP4;ITM2C;TP53I3;XAF1;HS1BP3;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;IFIT2;SCN2A;LGALS1;KCNMA1;TP53;DDIT3;PYCARD;MEF2D;ARHGEF1;SEMA5A;MICAL1;NISCH;ADARB1;TIMP1;HIP1;TFDP2;BTG1;SIK1;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;PDPN;SRPX;LRP1;FYN;ARHGEF12;IFI6;XDH;CAV1;GLI2;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;SLIT3;TP53INP1;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;CCK;PIK3R1;TMEM173;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;CASP14;DAPK1;DLC1;AARS;CHEK2;ROBO1;TLR3;SNCA;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;SETX;TGM2;OBSCN;SULF1;G6PD;EPHB6;EDA2R;ARHGEF17;NFATC4;TRAF1;CALR;ATM;APH1B;MDM2;ARF6;CST3;ANXA6;AKAP13;CITED2;GCLC;ELMO3;ZMAT3;MAP3K1;FGD4;PTPN1;ARHGEF2;NRK;EGR1;SOX9;ISL1;ITPKB;BCL6;NDRG1;PLAG1;PRKCA;PAK6;MAP3K12;UACA;PRNP;RET;TGFB2;MAP2K5;LEF1;THRA;USP28;CDKN2A;SP100;VAV2;RHBDD1;HSPA5;CDK19;SRPK2;ARHGEF19;YAP1;GDNF;TWIST2;MEIS3;PPARG;RNF144B;KCNIP3;MEF2A;ING4;LGALS3;DNAJC3;RARA;RASA1;CDK5RAP3;AGO4;ELMO2;ACAA2;TAOK3;DOCK1;DMPK
2108,GO:0004888,1.76460544588357e-05,0.9999913482986,61,323,transmembrane signaling receptor activity,MF,TNFRSF6B;GPRC5A;SFRP1;F2R;TGFBR2;EFEMP1;IL20RB;BCAM;ROR1;AXL;EGFR;LPAR5;NTSR1;ABCA1;PTPRM;MRC2;SORL1;LTBP1;ITGA2;CRIM1;PLXNB1;LTBP4;SLC22A17;CXCR1;GPR39;ADGRG6;MST1R;IL31RA;UNC5B;S1PR5;ROBO1;TLR3;FZD7;PLXNA2;PTPRU;FGFR1;IGF1R;PLA2R1;EPHB6;IL17RE;EDA2R;FZD8;TGFBR3;FZD1;ENG;EFNB3;PLXNA1;LEPR;LANCL1;HTR1B;RET;OR2A4;GPR161;PPARG;CALCRL;SENP7;FZD4;ADGRA2;CLEC2D;OXTR;CELSR1
12564,GO:0050767,1.81599102087409e-05,0.999989810343538,91,499,regulation of neurogenesis,BP,SERPINE2;FN1;FLRT2;SFRP1;TENM4;ETV5;SDK1;TNIK;NOS1;DPYSL2;CSMD3;GJC2;VIM;TIMP2;TENM3;PAK1;BMP4;ITM2C;PTK6;EIF2AK4;NEFL;SORL1;LGALS1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;PLXNB1;LRP1;FYN;GLI2;UST;ULK2;SYT1;CAPRIN2;TP73;S1PR5;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SEMA4A;SETX;KDM4C;NFATC4;FZD1;PBX1;CALR;NEGR1;EFNB3;IDH2;MDM2;ARF6;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;SDC2;SSH1;SOX9;ISL1;BCL6;CRTC1;PLAG1;RGS14;TCF12;MEGF8;RET;DLX2;MAGI2;HSPA5;SEMA4B;YAP1;DIXDC1;PPARG;OBSL1;RARA;EFNA5;FZD4;PPP3CA;KDM4A;CDK5RAP3;NIPBL
7434,GO:0031579,1.94586807239472e-05,0.999998060065374,9,19,membrane raft organization,BP,FLOT1;MARVELD1;GSN;MALL;S100A10;PLLP;CAV1;FLOT2;ANXA2
18151,GO:1902947,2.00467629108602e-05,1,5,5,regulation of tau-protein kinase activity,BP,SORL1;CLU;DKK1;EGR1;NAB2
7233,GO:0031175,2.008607196117e-05,0.999988100702563,113,645,neuron projection development,BP,FLOT1;FN1;FLRT2;SFRP1;APBB2;FAT4;SLITRK6;IRS2;SDK1;TNIK;MAP6;DPYSL2;EGFR;LAMB1;FLRT3;SPTB;CSMD3;DOK1;RNF165;VIM;STMN3;TENM3;PAK1;PTPRM;NEFM;ITM2C;PTK6;EIF2AK4;NEFL;NEO1;LGALS1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;ITGA3;GLI3;DLG5;CNTN1;ASAP1;SPG11;PLXNB1;LRP1;FYN;CLMN;UGT8;GLI2;RBFOX2;UST;PRKCZ;SLIT3;ULK2;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;PLXNA2;FGFR1;SEMA4A;SETX;TRIOBP;NFATC4;RAPH1;FZD1;BBS4;NEGR1;EFNB3;MDM2;ARF6;AREG;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;NRK;SSH1;IFT27;ISL1;NFASC;CRTC1;PRKCA;RAB13;MEGF8;CDH11;RET;ULK1;MAGI2;HSPA5;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;LAMB2
4562,GO:0010648,2.20958956079302e-05,0.999986057141191,140,934,negative regulation of cell communication,BP,SERPINE2;HTRA1;FLRT2;MMP9;GPRC5A;FBN1;INPP5D;ITGA6;SFRP1;CD109;DDIT4;TGFBR2;PKD2;DUSP6;GAS6;APCDD1;FBN2;SNAI2;SULF2;ROR1;AXL;EGFR;PEG10;FLRT3;SESN3;SERPINE1;RNF213;TKFC;STMN3;TIMP2;BMP4;NR1D1;PTK6;PDCD4;STAT1;SORL1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;PDGFA;RBMS3;ITGA3;GPX1;GLI3;DLG5;SESN1;SEC14L1;LRP1;FYN;IFI6;XDH;CAV1;PLA2G6;CLU;NPHP4;PRKCZ;SLIT3;ITGA1;MST1R;KANK2;PER1;DUSP5;UNC5B;HERPUD1;WFS1;MDFI;SPRY2;FBLN1;TP73;DAPK1;DLC1;PRKACB;ROBO1;SPRY4;TLR3;SNCA;GLG1;FGFR1;IGF1R;LMNA;DKK1;RGS2;PSMB9;SULF1;EPHB6;SLC24A1;NFATC4;TGFBR3;FZD1;MTMR4;CALR;ATM;MDM2;DLK2;GCLC;PTPN1;ARHGEF2;KLHL12;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;BCHE;RGS14;IGFBP4;MEGF8;HTR1B;PRNP;RET;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;IGFBP2;NPHP3;MAGI2;HSPA5;TGFB1I1;YAP1;GDNF;MEIS3;PPARG;LGALS3;PTPN3;ADGRA2;PPP3CA;RASA1;CREBRF;CDK5RAP3;CAMK2N1;MED12;ACAA2;TAOK3
12225,GO:0048523,2.25108181472509e-05,0.999983188542206,416,3279,negative regulation of cellular process,BP,SERPINE2;PHACTR3;TNFRSF6B;KRT4;HTRA1;FN1;FLRT2;MMP9;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;XPC;EFEMP1;IL20RB;GSN;COL5A2;PKD2;JPH2;IRS2;DUSP6;ZFP36L2;IGF2BP2;PROM2;COL7A1;NOS1;GAS6;APCDD1;FBN2;SNAI2;MAGED1;TCAF1;SULF2;COL5A1;PHF21A;TFPI2;ROR1;AXL;EGFR;TSC22D3;KLF8;PEG10;HSPA2;FLRT3;SPEG;SPTB;SLC8A1;SESN3;GJC2;ZNF608;SERPINE1;SERPINH1;RNF213;CRTAP;ANXA5;VIM;NUPR1;TKFC;AMIGO2;STMN3;TOM1L2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;ANGPTL4;CBX5;VDR;APOBEC3C;PTPRM;SRGAP3;BMP4;TP53I11;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;NEFL;PDCD4;NR3C1;COL18A1;STAT1;SORL1;LGALS1;TP53;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;LTBP1;ZC3H6;WNK1;DLG4;SEMA5A;ZCCHC11;PDGFA;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;GPNMB;TFDP2;CCDC85B;CRIM1;BTG1;ITGA3;SIK1;EVI5L;KLF12;IFIT3;KLF9;NFIX;ELFN2;HIVEP1;GPX1;GLI3;PTGES;E2F7;DLG5;KITLG;P3H2;ASAP1;CTDSPL;PDPN;SRPX;ZFP90;SESN1;CTSV;SEC14L1;PLXNB1;EML2;LRP1;FYN;EMP3;IFI6;XDH;TSHZ2;CLMN;CAV1;SLC27A1;GLI2;PIAS3;RBFOX2;PLA2G6;TRIB2;SNX33;MAP3K14;ESPN;ZNF318;TNRC18;CLU;DCBLD2;SERPING1;NPHP4;PRKCZ;SLIT3;SDR16C5;ULK2;TP53INP1;ARPIN;TNS2;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;PTPN14;PER1;PIK3R1;CAPRIN2;ACACB;APOBEC3G;ANG;DUSP5;UNC5B;UHRF2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;AARS;CHEK2;ROBO1;SPRY4;PAIP2B;PHF2;TLR3;FBXL7;SNCA;ADAMTS7;FRMD5;FZD7;GLG1;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;DKK1;PRKAB2;SEMA4A;RGS2;C5;TGFBI;SETX;PDE4D;NCOA2;PSMB9;IL18;SULF1;G6PD;TLE4;EPHB6;FZD8;TCEAL1;TRIOBP;KDM4C;SLC24A1;CDH13;NFATC4;MAGEF1;FOXN3;LMCD1;TGFBR3;FZD1;PBXIP1;PBX1;ENG;BBS4;MTMR4;CALR;ATM;EFNB3;IDH2;SRGAP1;MDM2;ARF6;CST3;DLK2;MEIS2;AREG;IFNK;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;CBX7;LMO4;MAF;LZTS1;PTPN1;ARHGEF2;KLHL12;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;NCOR1;NDRG1;PRKCA;SALL2;MYBL1;BCHE;ANXA2;RGS14;CXORF57;BAHCC1;LEPR;TSHZ1;IGFBP4;TES;TCF25;HMBOX1;RPL13A;PODXL;NAB2;MAP3K12;MEGF8;ATXN1;HTR1B;IRF2BPL;PRNP;RET;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;IFT122;GPR161;LEF1;THRA;FHL1;ZADH2;USP28;ITM2A;CDKN2A;SP100;ULK1;TSPYL2;IGFBP2;NPHP3;RHBDD1;MAGI2;HSPA5;GOPC;TGFB1I1;RSAD2;SEMA4B;ITPR2;MDFIC;VPS13C;IFT74;IFITM1;ZNF12;OPHN1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;DIXDC1;DERL3;MEIS3;PPARG;CAPG;RNF144B;PARP15;BEX4;KCNIP3;MEF2A;GCSAM;TGIF1;ING4;POSTN;UNK;LGALS3;PTPN3;MIA3;DNAJC3;RARA;HES2;TMEM67;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ADGRA2;ZBTB1;PPP3CA;RASA1;LIMA1;CREBRF;CTDSP2;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;TTBK2;KCNRG;ADAM10;PRDM5;S100A11;RXRA;ACAA2;ABCA5;TAOK3
792,GO:0002062,2.30213463524017e-05,0.999993935587127,20,60,chondrocyte differentiation,BP,CTGF;SOX6;TGFBR2;EFEMP1;SNAI2;SULF2;SERPINH1;BMP4;MEF2D;GLI3;GLI2;HMGA2;CREB3L2;ADAMTS7;GLG1;FGFR1;TGFBI;SULF1;MAF;SOX9
8953,GO:0035051,2.45280402876544e-05,0.999992263513783,25,83,cardiocyte differentiation,BP,SOX6;TENM4;EGFR;SLC8A1;PAK1;BMP4;PDCD4;PRICKLE1;SIK1;TTN;FZD7;LMNA;DKK1;G6PD;TGFBR3;CALR;AKAP13;FHOD3;ISL1;TGFB2;MEF2A;OBSL1;RARA;MYH11;RXRA
6641,GO:0023057,2.602975268292e-05,0.999983369797331,140,937,negative regulation of signaling,BP,SERPINE2;HTRA1;FLRT2;MMP9;GPRC5A;FBN1;INPP5D;ITGA6;SFRP1;CD109;DDIT4;TGFBR2;PKD2;DUSP6;GAS6;APCDD1;FBN2;SNAI2;SULF2;ROR1;AXL;EGFR;PEG10;FLRT3;SESN3;SERPINE1;RNF213;TKFC;STMN3;TIMP2;BMP4;NR1D1;PTK6;PDCD4;STAT1;SORL1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;PDGFA;RBMS3;ITGA3;GPX1;GLI3;DLG5;SESN1;SEC14L1;LRP1;FYN;IFI6;XDH;CAV1;PLA2G6;CLU;NPHP4;PRKCZ;SLIT3;ITGA1;MST1R;KANK2;PER1;DUSP5;UNC5B;HERPUD1;WFS1;MDFI;SPRY2;FBLN1;TP73;DAPK1;DLC1;PRKACB;ROBO1;SPRY4;TLR3;SNCA;GLG1;FGFR1;IGF1R;LMNA;DKK1;RGS2;PSMB9;SULF1;EPHB6;SLC24A1;NFATC4;TGFBR3;FZD1;MTMR4;CALR;ATM;MDM2;DLK2;GCLC;PTPN1;ARHGEF2;KLHL12;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;BCHE;RGS14;IGFBP4;MEGF8;HTR1B;PRNP;RET;TGFB2;MAP2K5;DLX2;IFT122;GPR161;LEF1;IGFBP2;NPHP3;MAGI2;HSPA5;TGFB1I1;YAP1;GDNF;MEIS3;PPARG;LGALS3;PTPN3;ADGRA2;PPP3CA;RASA1;CREBRF;CDK5RAP3;CAMK2N1;MED12;ACAA2;TAOK3
8907,GO:0034765,2.60670165070639e-05,0.999988470987604,45,211,regulation of ion transmembrane transport,BP,MMP9;F2R;GJA5;PKD2;JPH2;IRS2;NOS1;TCAF1;UTRN;HSPA2;SLC8A1;GJC2;NTSR1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;WNK1;DLG4;ANO6;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;ANK3;DAPK1;KCNJ5;STOM;SNCA;PDE4D;G6PD;KCNQ3;PRNP;FHL1;GOPC;CACNB1;KCNIP3;SHISA9;PTPN3;CACNA2D3;KCNRG
17227,GO:0120039,2.64684174102859e-05,0.999985325730349,84,441,plasma membrane bounded cell projection morphogenesis,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;TNIK;MAP6;DPYSL2;EGFR;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;EIF2AK4;NEFL;NEO1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;SNX1;GLI3;PDPN;SPG11;PLXNB1;FYN;UGT8;GLI2;RBFOX2;UST;PRKCZ;SLIT3;ULK2;ARPIN;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;NFATC4;RAPH1;EFNB3;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;NRK;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;LAMB2
3557,GO:0007600,2.71321209455267e-05,0.999988050449504,43,209,sensory perception,BP,SERPINE2;F2R;SLITRK6;EFEMP1;ANO1;SNAI2;ROR1;NTSR1;COL18A1;ITGA2;GPX1;NAV2;EML2;FYN;ESPN;CCK;BBS2;WFS1;SPRY2;MME;NIPSNAP1;FGFR1;TGFBI;MYO3B;TRIOBP;SLC24A1;LRTOMT;BBS4;BBS1;HOXA1;PGAP1;TTC8;OR2A4;SCNN1A;LEF1;ALDH7A1;CYP4V2;TH;REEP2;MYO9A;FZD4;NIPBL;LAMB2
3692,GO:0008201,2.75586546475729e-05,0.999991839697725,22,80,heparin binding,MF,SERPINE2;FN1;CTGF;FBN1;SFRP1;COL5A1;THBS2;BMP4;PTPRS;GPNMB;LAMC2;NAV2;CCDC80;ANG;APLP2;FGFR1;TGFBR3;COL5A3;ADAMTS15;ADAMTSL5;POSTN;ECM2
12389,GO:0048858,2.80087424639435e-05,0.999984444705717,84,442,cell projection morphogenesis,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;TNIK;MAP6;DPYSL2;EGFR;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;EIF2AK4;NEFL;NEO1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;SNX1;GLI3;PDPN;SPG11;PLXNB1;FYN;UGT8;GLI2;RBFOX2;UST;PRKCZ;SLIT3;ULK2;ARPIN;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;NFATC4;RAPH1;EFNB3;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;NRK;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;LAMB2
16208,GO:0090287,2.95294799695338e-05,0.99998753380933,39,172,regulation of cellular response to growth factor stimulus,BP,HTRA1;CCBE1;FBN1;SFRP1;CD109;CDKN2B;TGFBR2;DUSP6;FBN2;SULF2;TMEM204;PEG10;RNF165;BMP4;NEO1;LTBP1;ITGA3;XDH;LTBP4;CAV1;SPRY2;ROBO1;SPRY4;GLG1;FGFR1;DKK1;SULF1;MYOF;TGFBR3;FZD1;ENG;MTMR4;CITED2;PTPN1;HSPA5;TGFB1I1;FZD4;ADGRA2;MYO1C
8140,GO:0032879,3.00906788024969e-05,0.999978783994323,238,1689,regulation of localization,BP,SERPINE2;SYT8;FLOT1;FN1;FLRT2;MMP9;CCBE1;ITGA6;SFRP1;MMP28;RHOBTB2;ZFP36L1;F2R;TGFBR2;ANO1;GSN;GJA5;PKD2;JPH2;IRS2;PROM2;CLTCL1;NOS1;GAS6;PDGFC;SNAI2;TCAF1;UTRN;AXL;EGFR;HSPA2;LAMB1;SLC8A1;DOCK5;MYLK;GJC2;SERPINE1;STON2;NTSR1;CXCL14;PAK1;ABCA1;PTPRM;SRGAP3;BMP4;NR1D1;AHNAK;SCN8A;TBC1D8;NETO1;TRIM5;COL18A1;SORL1;SCN2A;KCNMA1;MEST;TP53;ARAP1;CEP250;DDIT3;PYCARD;WNK1;DLG4;SEMA5A;ITGA2;PDGFA;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;HIP1;GPNMB;TFDP2;DOCK4;ITGA3;SIK1;EVI5L;ANO6;LAMC2;GLI3;DLG5;CNTN1;KITLG;TBC1D5;SYN1;PDPN;PLXNB1;KCNAB2;LRP1;FYN;B3GAT3;ARHGAP18;LAMA3;CAV1;PLA2G6;SNX33;CLU;PRKCZ;OAS2;TP53INP1;KCNJ15;ARPIN;EHD3;CAMK2D;SYTL1;PTPN14;PER1;CCK;PIK3R1;SYT1;HHAT;TMEM173;CPT1A;ACACB;PCLO;ANG;LAMA5;BBS2;ANK3;WFS1;SPRY2;TTN;HPS4;FBLN1;TP73;DAPK1;DLC1;ROBO1;KCNJ5;STOM;SNCA;FRMD5;SH3TC2;PLXNA2;PTPRU;DZIP1L;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;SEMA4A;C5;ASTN2;PDE4D;SULF1;PLA2R1;G6PD;CDH13;TGFBR3;AMOTL1;LRTOMT;ENG;BBS4;CALR;IDH2;SRGAP1;MDM2;ARF6;DNAJC6;CITED2;NR2F2;PLXNA1;LMO4;SYNE2;PTPN1;KCNQ3;ARHGEF2;SSH1;SOX9;ENPP1;ISL1;BCL6;PRCP;NCOR1;PRKCA;ANXA2;RAB13;SEPT5;KCTD7;MOSPD2;PODXL;MEGF8;HTR1B;PRNP;RET;TGFB2;MAP2K5;AMOTL2;LEF1;FHL1;C2CD4C;SP100;MAGI2;HSPA5;GOPC;REEP2;RSAD2;UVRAG;SEMA4B;ITPR2;MDFIC;IFITM1;OPHN1;CACNB1;GDNF;DERL3;PPARG;BEX4;KCNIP3;GCSAM;SHISA9;SASH1;TBC1D16;POSTN;LGALS3;PTPN3;MIA3;SV2A;ABCA2;EFNA5;ADGRA2;PPP3CA;CDK5RAP3;CACNA2D3;ABAT;NIPBL;TTBK2;KCNRG;OXTR;ADAM10;MYO1C;C2CD5;EDEM1;ACAA2;DOCK1;DMPK
16186,GO:0090257,3.07580196240594e-05,0.999988745730286,30,119,regulation of muscle system process,BP,CTGF;F2R;TNNI2;GJA5;NOS1;UTRN;SLC8A1;DOCK5;PAK1;ITGA2;DOCK4;CAV1;EHD3;CAMK2D;JARID2;LMNA;RGS2;PDE4D;G6PD;LMCD1;MTMR4;ANXA6;AKAP13;PRKCA;CALCRL;MEF2A;PPP3CA;ABAT;OXTR;DMPK
9817,GO:0042060,3.38677528201677e-05,0.999982637036215,62,339,wound healing,BP,SERPINE2;FN1;CD109;F2R;TGFBR2;GSN;GAS6;PDGFC;COL5A1;PHF21A;TFPI2;AXL;DOCK9;EGFR;ITPK1;MYLK;SERPINE1;ANXA5;PAK1;CBX5;VAV3;GNG2;TP53;SLC7A11;ITGA2;PDGFA;MICAL1;TIMP1;ANO6;GPX1;GLI3;PDPN;FYN;FUT10;CAV1;DOCK11;DCBLD2;SERPING1;EHD3;PIK3R1;DYSF;HPS4;FBLN1;PRKACB;FZD7;MYOF;DGKQ;VANGL2;PRCP;PRKCA;ANXA2;ZFPM1;TGFB2;VAV2;ARHGEF19;ITPR2;SH2B3;POSTN;MIA3;ABAT;CELSR1;DOCK1
3706,GO:0008217,3.74826885042147e-05,0.999988614953785,22,82,regulation of blood pressure,BP,F2R;PTGS1;GJA5;ANPEP;NOS1;GAS6;NTSR1;WNK1;NISCH;NAV2;MME;PDE4D;BBS4;NR2F2;RNPEP;PRCP;PPARG;POSTN;SCPEP1;ABAT;ADM2;OXTR
12254,GO:0048585,3.88600217156217e-05,0.999974110708629,159,1101,negative regulation of response to stimulus,BP,SERPINE2;HTRA1;FLRT2;MMP9;GPRC5A;FBN1;INPP5D;ITGA6;SFRP1;MMP28;CD109;DDIT4;TGFBR2;IL20RB;PKD2;DUSP6;GAS6;APCDD1;FBN2;SNAI2;SULF2;ROR1;AXL;EGFR;PEG10;FLRT3;SESN3;SERPINE1;RNF213;TKFC;STMN3;TIMP2;BMP4;NR1D1;PTK6;PDCD4;STAT1;SORL1;PTPRS;WWTR1;PRICKLE1;DDIT3;PYCARD;LTBP1;IFIT1;SEMA5A;PDGFA;RBMS3;ITGA3;GPX1;GLI3;DLG5;SESN1;SEC14L1;LRP1;FYN;IFI6;XDH;CAV1;CLU;SERPING1;NPHP4;PRKCZ;SLIT3;HMGA2;ITGA1;MST1R;KANK2;PER1;CCK;DUSP5;UNC5B;BBS2;HERPUD1;WFS1;MDFI;SPRY2;FBLN1;TP73;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;SPRY4;TLR3;SNCA;GLG1;FGFR1;IGF1R;LMNA;DKK1;SEMA4A;RGS2;C5;PSMB9;SULF1;EPHB6;NFATC4;MAGEF1;TGFBR3;FZD1;BBS4;MTMR4;CALR;ATM;MDM2;DLK2;GCLC;PTPN1;ARHGEF2;KLHL12;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;ANXA2;RGS14;CXORF57;IGFBP4;MEGF8;HTR1B;PRNP;RET;TGFB2;MAP2K5;GGT7;DLX2;IFT122;GPR161;LEF1;IGFBP2;NPHP3;MAGI2;HSPA5;TGFB1I1;SEMA4B;VPS13C;YAP1;GDNF;DERL3;MEIS3;PPARG;CALCRL;LGALS3;PTPN3;DNAJC3;ADGRA2;PPP3CA;RASA1;CREBRF;CDK5RAP3;CAMK2N1;MED12;ABAT;ACAA2;TAOK3
2590,GO:0005887,3.93049280627003e-05,0.999975588599774,117,730,integral component of plasma membrane,CC,ITGB6;TNFRSF6B;PCDH7;FLRT2;GPRC5A;ITGB5;ITGA6;F2R;TGFBR2;SLITRK6;ITGB4;TENM4;SLC7A8;GJA5;PKD2;PROM2;BCAM;APCDD1;ROR1;AXL;EGFR;FLRT3;SLC8A1;CLCA2;SLC20A1;SLC2A3;CSPG4;NTSR1;TENM3;ABCA1;PTPRM;SCN8A;MRC2;SORL1;NEO1;SCN2A;KCNMA1;PTPRS;DLG4;SLC7A11;ITGA2;PILRB;GPNMB;ITGA3;PCDHAC2;SLC22A15;TPBG;PDPN;PLXNB1;KCNAB2;LRP1;CAV1;ITGA10;SLC22A17;DCBLD2;GPR39;KCNJ15;ITGA1;MST1R;SLC38A2;CALHM2;BACE1;ROBO1;KCNJ5;STOM;TLR3;MME;VAMP1;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;C5;PLA2R1;ESYT2;TRO;EPHB6;IL17RE;EDA2R;SLC24A1;TGFBR3;ENG;EFNB3;APH1B;PLXNA1;CD1D;KCNQ3;PLGRKT;ENPP1;PCDHGA11;MOSPD2;PODXL;ABCC2;TSPAN5;NLGN4Y;XG;HTR1B;RET;SCNN1A;BOC;REEP2;ITGB8;COL17A1;CALCRL;KCNIP3;SHISA9;TSPAN18;FZD4;ANKH;STEAP2;CLEC2D;PCDHGB5;OXTR;CELSR1;TSPAN4;TUSC3
15529,GO:0072006,4.02629140764243e-05,0.999986780919234,25,87,nephron development,BP,FAT4;PKD2;NID1;MAGED1;SULF2;ACTA2;BMP4;STAT1;WWTR1;COL4A4;ITGA3;GLI3;LAMA5;SULF1;PBX1;VANGL2;EGR1;SOX9;PODXL;RET;MAGI2;YAP1;GDNF;KLHL3;LAMB2
9967,GO:0042383,4.11950545432036e-05,0.999987238236743,23,77,sarcolemma,CC,FLOT1;NOS1;UTRN;SLC8A1;PLEC;AHNAK;SCN2A;FLNC;CAV1;AHNAK2;CAMK2D;SLC38A2;DYSF;ANK3;KCNJ5;PRX;OBSCN;SYNC;SLC27A6;ANXA2;CACNB1;PPP3CA;SNTB1
562,GO:0001704,4.15859267598161e-05,0.99998708110372,23,78,formation of primary germ layer,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;ITGB4;COL5A2;DUSP6;COL7A1;COL5A1;LAMB1;BMP4;ITGA2;ITGA3;LAMA3;HMGA2;DUSP5;LAMB3;FZD7;FGFR1;DKK1;COL12A1;LEF1
4308,GO:0009790,4.31913184840955e-05,0.999973448883133,111,665,embryo development,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;FBN1;SOX6;SFRP1;ZFP36L1;TGFBR2;SLITRK6;ITGB4;EFEMP1;TENM4;COL5A2;GJA5;PKD2;DUSP6;COL7A1;FBN2;PDGFC;SULF2;COL5A1;EGFR;ITPK1;LAMB1;FLRT3;BMP4;PRICKLE1;DLG4;ITGA2;PDGFA;PHLDB1;ITGA3;GLI3;E2F7;KITLG;LAMA3;GLI2;FBXW4;HMGA2;DUSP5;LAMA5;MDFI;SPRY2;LAMB3;DLC1;PRKACB;IFT140;LRIG3;FZD7;PLXNA2;FGFR1;DKK1;SEC24D;C5;MYO3B;SULF1;TRIOBP;KDM4C;FZD1;NAGLU;PBX1;ENG;BBS4;ATM;CITED2;NR2F2;LMO4;FBXW8;POGLUT1;VANGL2;KLHL12;NRK;SOX9;ISL1;SALL2;ZNF358;ETNK2;HOXA1;STOX2;PGAP1;TSHZ1;MEGF8;WDR19;TAF8;RET;ZFPM1;TGFB2;MAP2K5;DLX2;COL12A1;IFT122;GPR161;LEF1;SSBP3;NPHP3;TH;TGFB1I1;SH2B3;YAP1;GDNF;HOXA3;RARA;PBX2;MED12;NIPBL;ADAM10;PPP2R3A;CELSR1;RXRA
11487,GO:0045995,4.40325102971791e-05,0.999985787298995,24,85,regulation of embryonic development,BP,SFRP1;TENM4;COL5A2;DUSP6;COL5A1;BMP4;PHLDB1;LAMA3;LAMA5;PRKACB;FZD7;FGFR1;DKK1;SULF1;FZD1;POGLUT1;VANGL2;NRK;MAP2K5;GPR161;NPHP3;GDNF;NIPBL;CELSR1
3263,GO:0006936,4.41075382697767e-05,0.999981025888411,39,170,muscle contraction,BP,ITGB5;CTGF;F2R;TNNI2;GJA5;NOS1;SULF2;UTRN;SLC8A1;DOCK5;MYLK;ACTA2;VIM;KCNMA1;ITGA2;DOCK4;CAV1;PLA2G6;EHD3;CAMK2D;ITGA1;PXN;DYSF;BBS2;TTN;KCNJ5;RGS2;PDE4D;SULF1;MYOF;ANXA6;GDNF;CALCRL;OBSL1;ABAT;MYH11;OXTR;SNTB1;DMPK
3517,GO:0007492,5.16733271457652e-05,0.999986000584207,19,58,endoderm development,BP,MMP2;FN1;MMP9;ITGB5;COL8A1;ZFP36L1;COL5A2;DUSP6;COL7A1;COL5A1;LAMB1;BMP4;LAMA3;HMGA2;DUSP5;LAMB3;DKK1;COL12A1;MED12
12365,GO:0048812,5.25842319334881e-05,0.999970213345622,81,429,neuron projection morphogenesis,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;TNIK;MAP6;DPYSL2;EGFR;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;EIF2AK4;NEFL;NEO1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;GLI3;SPG11;PLXNB1;FYN;UGT8;GLI2;RBFOX2;UST;PRKCZ;SLIT3;ULK2;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;NFATC4;RAPH1;EFNB3;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;NRK;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;LAMB2
6938,GO:0030574,5.30279051571425e-05,0.999988497474302,15,40,collagen catabolic process,BP,MMP2;MMP9;COL8A1;COL5A2;COL7A1;COL5A1;MRC2;COL18A1;MMP19;COL4A4;CST3;COL5A3;COL12A1;COL4A1;CTSD
3547,GO:0007584,5.50252925574258e-05,0.999978471079176,31,143,response to nutrient,BP,SFRP1;CDKN2B;NQO1;TGFBR2;GSN;GAS6;SNAI2;EGFR;SLC8A1;ABCA1;VDR;STAT1;TP53;ITGA2;ACSL3;BCKDHB;MTHFR;FYN;HLCS;KANK2;CAT;MDM2;DGKQ;GCLC;SSH1;BCHE;IGFBP2;PPARG;POSTN;RARA;TAF1
7442,GO:0031589,5.63031863594808e-05,0.99997317633504,48,225,cell-substrate adhesion,BP,ITGB6;FN1;ITGB5;COL8A1;CTGF;ITGA6;SFRP1;ITGB4;NID1;BCAM;GAS6;UTRN;AXL;LAMB1;DOCK5;SERPINE1;S100A10;LGALS1;ITGA2;ITGA3;PDPN;CCDC80;ITGA10;PRKCZ;ITGA1;PXN;PIK3R1;PARVA;LAMA5;TMEM8B;FBLN1;DLC1;FZD7;COL16A1;TRIOBP;CDH13;CALR;MKLN1;COL5A3;BCL6;CDKN2A;COL17A1;POSTN;ECM2;EFNA5;FZD4;RASA1;DOCK1
14282,GO:0061448,5.75492951076642e-05,0.999976882087538,33,140,connective tissue development,BP,CTGF;SOX6;TGFBR2;EFEMP1;SNAI2;SULF2;COL5A1;ACTA2;SERPINH1;EVC;BMP4;MEF2D;TIMP1;GLI3;GLI2;FBXW4;HMGA2;CREB3L2;BBS2;ADAMTS7;GLG1;FGFR1;TGFBI;SULF1;BBS4;MAF;EGR1;SOX9;DLX2;THRA;ITGB8;HOXA3;RARA
9780,GO:0040017,5.93113678771281e-05,0.999968457918444,63,345,positive regulation of locomotion,BP,FN1;MMP9;CCBE1;ITGA6;F2R;TGFBR2;IRS2;GAS6;PDGFC;SNAI2;EGFR;LAMB1;SLC8A1;DOCK5;MYLK;SERPINE1;CXCL14;PAK1;BMP4;COL18A1;TP53;PYCARD;SEMA5A;ITGA2;PDGFA;GPNMB;DOCK4;ITGA3;ANO6;LAMC2;KITLG;PDPN;PIK3R1;SPRY2;FGFR1;IGF1R;SEMA4A;CDH13;AMOTL1;CALR;MDM2;SYNE2;ARHGEF2;SSH1;SOX9;PRKCA;MOSPD2;PODXL;MEGF8;RET;TGFB2;LEF1;HSPA5;SEMA4B;SASH1;POSTN;LGALS3;MIA3;ADGRA2;NIPBL;ADAM10;MYO1C;DOCK1
13509,GO:0055123,5.9430913984962e-05,0.999981028488618,23,79,digestive system development,BP,ITGA6;SFRP1;FAT4;TGFBR2;ITGB4;PDGFC;EGFR;BMP4;PTK6;GLI3;CPS1;GLI2;PPDPF;FOXL1;VANGL2;MEGF8;WDR19;RET;TGFB2;NPHP3;KLF5;NIPBL;OXTR
18153,GO:1902949,6.13693410859452e-05,1,4,4,positive regulation of tau-protein kinase activity,BP,CLU;DKK1;EGR1;NAB2
16267,GO:0090399,6.19370289899075e-05,0.99999602644912,7,11,replicative senescence,BP,SERPINE1;TP53;CHEK2;MME;PLA2R1;ATM;CDKN2A
12508,GO:0050680,6.7618677918514e-05,0.999977409456755,24,88,negative regulation of epithelial cell proliferation,BP,KRT4;SFRP1;CD109;CDKN2B;SNAI2;MAGED1;VDR;PTPRM;BMP4;STAT1;KLF9;CTSV;XDH;CAV1;ROBO1;SULF1;TGFBR3;NR2F2;SOX9;ISL1;TGFB2;IFT122;IFT74;PPARG
13866,GO:0060537,7.06314277935109e-05,0.999966024551909,48,224,muscle tissue development,BP,FLOT1;SOX6;MYH15;TGFBR2;TENM4;GJA5;PKD2;JPH2;TSC22D3;SLC8A1;MYLK;NUPR1;PAK1;BMP4;MEF2D;SIK1;GPX1;CAV1;TTN;JARID2;TP73;FZD7;FGFR1;LMNA;DKK1;G6PD;TGFBR3;ENG;CALR;AKAP13;NR2F2;FHOD3;POGLUT1;EGR1;SOX9;ISL1;ZFPM1;TGFB2;LEF1;FLNB;KLF5;MEF2A;OBSL1;RARA;PPP3CA;FOS;MYH11;RXRA
6678,GO:0030054,7.12894212903433e-05,0.999953137630632,137,872,cell junction,CC,ITGB6;FLOT1;FLRT2;ITGB5;ITGA6;TLN2;ITGB4;ASAP3;GSN;GJA5;PKD2;SDK1;TNS4;DNMBP;UTRN;EGFR;TMEM204;FLRT3;SLC8A1;CLCA2;GJC2;STON2;ANXA5;VIM;CSPG4;DDB2;ADD3;PLEC;PAK1;PTPRM;TNS1;AHNAK;NETO1;MRC2;SCN2A;PTPRS;DLG4;ITGA2;FRMD4B;PPL;ITGA3;DLG5;SYN1;PDPN;KCNAB2;LRP1;FLNC;FAT2;CAV1;NPHP4;PRKCZ;TNS2;EHD3;ITGA1;IL31RA;PXN;PIK3R1;SYT1;PCLO;PARVA;ANK3;LMO7;TP73;CAT;SHROOM4;DLC1;SPRY4;PRX;SNCA;FLOT2;MME;FRMD5;VAMP1;PTPRU;FSCN1;TGM2;TRIOBP;CDH13;CD99L2;FZD1;AMOTL1;ENG;CALR;ARF6;ANXA6;LZTS1;SYNE2;VANGL2;ARHGEF2;NFASC;NDRG1;ANXA2;RGS14;RAB13;MPP7;CEP68;TES;RPL13A;PODXL;PAK6;ABCC2;NLGN4Y;CDH11;AMOTL2;FHL1;MPRIP;AGRN;MAGI2;HSPA5;GOPC;MAGI1;PIKFYVE;TGFB1I1;FLNB;FHOD1;OPHN1;COL17A1;DIXDC1;SHISA9;OBSL1;PRR7;SV2A;HOXC5;EFNA5;FZD4;PDZD2;ARHGAP31;LIMA1;CAMK2N1;BSN;OXTR;ADAM10;MPDZ;TSPAN4;S100A11;SNTB1;ZNRF1
14178,GO:0061138,7.26586691420243e-05,0.999971008442378,32,130,morphogenesis of a branching epithelium,BP,SFRP1;FAT4;TGFBR2;ETV5;PKD2;SNAI2;MAGED1;PAK1;VDR;BMP4;PDGFA;GLI3;DLG5;GLI2;LAMA5;SPRY2;FGFR1;TGM2;SULF1;NFATC4;PBX1;ENG;AREG;PLXNA1;VANGL2;SOX9;LEF1;YAP1;GDNF;COL4A1;CELSR1;RXRA
5307,GO:0016021,7.72085066489254e-05,0.999941783972499,337,2689,integral component of membrane,CC,ITGB6;SYT8;TNFRSF6B;FLOT1;PCDH7;FLRT2;GPRC5A;ITGB5;ADAM19;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;SYNE1;F2R;FAT4;TGFBR2;SLITRK6;ITGB4;TENM4;IL20RB;MARCH4;SLC7A8;ANO1;GJA5;PKD2;JPH2;SCARA3;CYBRD1;SDK1;ANPEP;PROM2;BCAM;NOS1;APCDD1;MALL;ROR1;AXL;EGFR;GALNT10;TMEM204;SDC3;HSPA2;FLRT3;NYNRIN;SLC8A1;ORAI3;CLCA2;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;KIAA1549L;ATP10D;MBOAT2;LPAR5;FAM198B;CSPG4;EVC;CNTNAP3;FAM210B;AMIGO2;NTSR1;TENM3;ABCA1;LOC441081;NSG1;TMC7;PTPRM;TP53I11;ITM2C;SCN8A;NETO1;MRC2;SORL1;NEO1;SCN2A;KCNMA1;MEST;EXTL2;KIAA0319L;PTPRS;DLG4;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ACSL3;GPNMB;TMEM200A;CRIM1;ITGA3;EMP1;PCDHAC2;SLC22A15;ELFN2;TPBG;ANO6;PAQR8;PTGES;LPCAT2;KITLG;ERMAP;PLLP;PDPN;PLXNB1;KCNAB2;LRP1;EMP3;IFI6;B3GAT3;FUT10;CLMN;UGT8;FAT2;CAV1;SLC27A1;ITGA10;SEL1L;SLC22A17;SLC35F3;OSBPL5;XYLT1;UST;DCBLD2;CXCR1;SDR16C5;GPR39;KCNJ15;CHST3;CAMK2D;ADGRG6;GOLGB1;ITGA1;MST1R;IL31RA;ATP8B2;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;ALDH3A2;CPT1A;SLC38A2;CALHM2;DYSF;UNC5B;HERPUD1;WFS1;TMEM139;TMEM8B;APLP2;ST6GAL2;S1PR5;BTN3A1;BACE1;ROBO1;KCNJ5;LRIG3;STOM;TLR3;MAN1A1;MME;FRMD5;VAMP1;FZD7;GLG1;PAQR7;PLXNA2;CYYR1;PTPRU;FGFR1;PAG1;IGF1R;ARMCX2;MLEC;SEMA4A;C5;GLT8D2;ASTN2;PDE4D;TMEM129;PLA2R1;ESYT2;TRO;MYOF;EPHB6;IL17RE;EDA2R;FZD8;CCDC136;TMEM263;SLC24A1;CD99L2;TGFBR3;FZD1;LRTOMT;LAPTM4A;ENG;CALR;EFNB3;APH1B;TMED10;DLK2;TMEM14C;AREG;PLXNA1;DNAJC4;NRSN2;CYP20A1;CD1D;SYNE2;CSMD2;NEMP2;KCNQ3;VANGL2;SMIM19;PLGRKT;SDC2;SLC25A35;ENPP1;SLC27A6;SLC48A1;PCDHGA11;PLD3;NFASC;G6PC3;GCNT1;TMEM50B;TMEM63C;PXMP2;TMEM175;TMC4;FNDC3A;TMEM94;RNF24;METTL23;LEPR;PGAP1;PLD5;IFITM2;MOSPD2;CNTNAP3B;GAL3ST4;PODXL;ABCC2;MEGF8;TSPAN5;NLGN4Y;XG;HTR1B;SLC39A11;TMEM60;CDH11;RET;GGT7;DSEL;OR2A4;SCNN1A;GPR161;LRRN3;SFXN3;ITM2A;CYP4V2;HERPUD2;SPPL2B;AGRN;TMEM187;TMEM164;RHBDD1;KIAA1109;HSPA5;BTN3A3;NRM;SLC9A4;BOC;REEP2;FLNB;SEMA4B;ITGB8;ITPR2;UGT1A3;RHBDD2;IFITM1;LMF1;UGT1A6;MYO9A;CACNB1;ALG10;COL17A1;GPX8;ATRAID;GALNT2;DERL3;AGPAT1;RNF144B;CALCRL;TPST1;KCNIP3;TMEM212;SLC35E2B;CERS5;SHISA9;PRR7;MIA3;TSPAN18;SV2A;ABCA2;TMEM67;FZD4;MPPE1;SLITRK5;ADGRA2;NAT14;TMEM168;ANKH;STEAP2;COX18;TMTC4;AIG1;CLEC2D;CACNA2D3;PCDHGB5;OXTR;ADAM10;CELSR1;TSPAN4;TUSC3;ORAI2;EDEM1;TMEM92;ABCA5;DMPK;MOSPD3
8483,GO:0033674,7.91998275399115e-05,0.999955582733006,72,415,positive regulation of kinase activity,BP,GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;CSPG4;MAP3K6;PAK1;BMP4;VAV3;WNK1;DLG4;PILRB;PDGFA;KITLG;SLC27A1;ERCC6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;ANG;DUSP5;SPRY2;TP73;PRKACB;ROBO1;TLR3;SNCA;FGFR1;IGF1R;DKK1;C5;IL18;EPHB6;FZD8;AFAP1L2;FAM20A;AKAP13;DGKQ;LMO4;MAP3K1;PTPN1;VANGL2;NRK;EGR1;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;VAV2;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
2407,GO:0005581,7.94576310428305e-05,0.999983625903094,14,34,collagen trimer,CC,CCBE1;COL8A1;COL5A2;SCARA3;COL7A1;COL5A1;C1QTNF6;COL18A1;COL4A4;COL16A1;COL5A3;COL12A1;COL17A1;COL4A1
4470,GO:0010470,8.0787839965726e-05,0.999988666495145,10,22,regulation of gastrulation,BP,TENM4;COL5A2;DUSP6;COL5A1;PHLDB1;FZD7;FGFR1;DKK1;POGLUT1;MAP2K5
4758,GO:0010942,8.51688312848227e-05,0.999950711218259,79,496,positive regulation of cell death,BP,MMP9;PRODH;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;NQO1;APBB2;F2R;DDIT4;GSN;DUSP6;MAGED1;NUPR1;NTSR1;VDR;BMP4;ITM2C;VAV3;PDCD4;COL18A1;IFIT2;KCNMA1;TP53;DDIT3;PYCARD;ARHGEF1;HIP1;TFDP2;BTG1;SIK1;ANO6;SRPX;LRP1;FYN;ARHGEF12;XDH;CAV1;PLA2G6;CLU;TP53INP1;HMGA2;CAMK2D;ITGA1;CCK;TP73;DAPK1;DLC1;CHEK2;ROBO1;TLR3;SNCA;DKK1;TGM2;OBSCN;ARHGEF17;NFATC4;ATM;APH1B;AKAP13;ZMAT3;FGD4;ARHGEF2;SSH1;EGR1;BCL6;PRNP;RET;TGFB2;CDKN2A;VAV2;CDK19;SRPK2;ARHGEF19;PPARG;ING4;FOS
8215,GO:0032990,8.66745907117207e-05,0.999949132981204,84,460,cell part morphogenesis,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;TNIK;MAP6;DPYSL2;EGFR;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;EIF2AK4;NEFL;NEO1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;SNX1;GLI3;PDPN;SPG11;PLXNB1;FYN;UGT8;GLI2;RBFOX2;UST;PRKCZ;SLIT3;ULK2;ARPIN;ITGA1;CCK;PIK3R1;SYT1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;NFATC4;RAPH1;EFNB3;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;NRK;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;POSTN;NYAP1;ECM2;EFNA5;FZD4;SLITRK5;PPP3CA;LAMB2
595,GO:0001763,9.20206997123291e-05,0.999962124940403,33,137,morphogenesis of a branching structure,BP,SFRP1;FAT4;TGFBR2;ETV5;PKD2;SNAI2;MAGED1;PAK1;VDR;BMP4;PDGFA;GLI3;DLG5;GLI2;LAMA5;SPRY2;FGFR1;TGM2;SULF1;NFATC4;PBX1;ENG;AREG;PLXNA1;VANGL2;SOX9;DLX2;LEF1;YAP1;GDNF;COL4A1;CELSR1;RXRA
7323,GO:0031344,9.85114318506685e-05,0.999943018599141,78,436,regulation of cell projection organization,BP,FN1;SFRP1;SDK1;TNIK;PROM2;DPYSL2;CSMD3;VIM;TENM3;PAK1;ITM2C;PTK6;NEFL;LGALS1;ARAP1;PTPRS;DLG4;SEMA5A;ITGA2;MAP2;CUL7;ITGA3;EVI5L;PLEK2;DLG5;CNTN1;ASAP1;PDPN;PLXNB1;LRP1;FYN;CAV1;DOCK11;ESPN;UST;ULK2;ARPIN;SYT1;CAPRIN2;SPRY2;METRN;ROBO1;IFT140;PLXNA2;FGFR1;FSCN1;SEMA4A;SETX;NFATC4;FZD1;BBS4;NEGR1;EFNB3;MDM2;ARF6;PLXNA1;TRAK1;FBXW8;SYNE2;SDC2;SSH1;CRTC1;IFT88;PODXL;MEGF8;PRNP;RET;CDC42EP5;AGRN;MAGI2;HSPA5;SEMA4B;KLF5;OBSL1;EFNA5;FZD4;PPP3CA;SEPT9
7348,GO:0031401,0.000101403403675734,0.999934513021507,119,788,positive regulation of protein modification process,BP,FLOT1;MMP9;CTGF;GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;NUPR1;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;PTK6;TRIM5;TP53;PRICKLE1;PYCARD;WNK1;DLG4;PILRB;PDGFA;GPNMB;CNTN1;KITLG;FYN;XDH;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;MAP3K14;CLU;PRKCZ;SDR16C5;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;WFS1;SPRY2;JARID2;TP73;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ISL1;BCL6;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;MAGI2;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;CDK5RAP3;NIPBL;TAOK3
2938,GO:0006468,0.000103559833364695,0.999927231069963,187,1312,protein phosphorylation,BP,FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;EFEMP1;PKD2;IRS2;DUSP6;ZFP36L2;HERC5;TNIK;PROM2;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;FLRT3;SPEG;SPTB;MYLK;GJC2;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;NEFL;PDCD4;SORL1;TP53;WWTR1;CNTRL;PYCARD;WNK1;DLG4;PILRB;PDGFA;MICAL1;ADARB1;GPNMB;SIK1;CDK14;CNTN1;KITLG;CTDSPL;NEK9;FYN;XDH;ALPK1;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;ULK2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;CAPRIN2;ANG;DUSP5;CDK18;PHKA2;SPRY2;TTN;FBLN1;TP73;DAPK1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;MYO3B;PSMB9;IL18;OBSCN;PDK3;EPHB6;EDA2R;FZD8;AFAP1L2;TGFBR3;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;NR2F2;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;STK16;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;MAP2K5;STAT2;CDC42EP5;MAPK8IP3;CDKN2A;ULK1;TSPYL2;HSPA5;CDK19;SRPK2;UVRAG;MDFIC;GDNF;MEF2A;SNX9;ICK;SASH1;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;RASA1;CTDSP2;CDK5RAP3;CAMK2N1;TTBK2;ADM2;OXTR;ADAM10;TAOK3;DMPK
3452,GO:0007267,0.000106042344804447,0.999929523830802,137,910,cell-cell signaling,BP,SERPINE2;SYT8;FLOT1;CTGF;SFRP1;NQO1;F2R;ANO1;ETV5;GJA5;IRS2;TNIK;ANPEP;NOS1;APCDD1;SNAI2;SULF2;ROR1;EGFR;GJC2;RNF213;TCF7L1;NTSR1;CXCL14;NSG1;BMP4;PCSK1;NR1D1;EIF2AK4;NETO1;GNG2;WWTR1;PRICKLE1;DDIT3;WNK1;DLG4;SEMA5A;PDGFA;RBMS3;NISCH;ADARB1;GPNMB;ITGA3;PCDHAC2;GLI3;CDK14;SYN1;SPG11;LRP1;LTBP4;CAV1;GLI2;PLA2G6;NPHP4;PRKCZ;FBXW4;HMGA2;SYTL1;SYT1;CAPRIN2;CPT1A;PCLO;MDFI;BACE1;KCNJ5;SNCA;FZD7;PTPRU;FGFR1;DKK1;CTF1;PSMB9;IL18;SULF1;TLE4;FZD8;SLC24A1;NFATC4;FZD1;AMOTL1;FOXL1;EFNB3;AREG;KCNQ3;VANGL2;KLHL12;SSH1;EGR1;SOX9;ISL1;PCDHGA11;CRTC1;PRKCA;BCHE;RGS14;SEPT5;IGFBP4;GAL3ST4;NLGN4Y;HTR1B;PRNP;TGFB2;AMOTL2;LEF1;C2CD4C;IGFBP2;NPHP3;MAGI2;TH;TGFB1I1;ARHGEF19;ITPR2;MDFIC;OPHN1;TPGS1;YAP1;CACNB1;GDNF;DIXDC1;SHISA9;RARA;SV2A;CCNY;TSHZ3;EFNA5;FZD4;SLITRK5;PPP3CA;AGO4;MED12;ABAT;BSN;PCDHGB5;OXTR;ADAM10;CELSR1;DMPK
12293,GO:0048667,0.000106385763461883,0.999939602909247,73,383,cell morphogenesis involved in neuron differentiation,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;TNIK;MAP6;DPYSL2;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;NEFL;NEO1;ETV1;PTPRS;DLG4;SEMA5A;MAP2;ADARB1;CUL7;GLI3;SPG11;PLXNB1;FYN;GLI2;RBFOX2;UST;SLIT3;ULK2;CCK;PIK3R1;CAPRIN2;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;TRIOBP;NFATC4;RAPH1;EFNB3;PLXNA1;TRAK1;FBXW8;VANGL2;NTNG1;SDC2;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;MEF2A;KLF7;OBSL1;UNK;ECM2;EFNA5;SLITRK5;PPP3CA;LAMB2
16708,GO:0097755,0.000108766950941491,0.999978840282193,12,35,positive regulation of blood vessel diameter,BP,GJA5;NOS1;EGFR;DOCK5;DOCK4;GPX1;CPS1;PLA2G6;ITGA1;BBS2;RGS2;SCPEP1
10865,GO:0044425,0.000111206431231526,0.99991355003467,449,3686,membrane part,CC,SERPINE2;ITGB6;SYT8;TNFRSF6B;FLOT1;FN1;PCDH7;FLRT2;GPRC5A;ITGB5;ADAM19;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;CD109;SYNE1;F2R;FAT4;TGFBR2;SLITRK6;PTGS1;ITGB4;TENM4;IL20RB;MARCH4;SLC7A8;ANO1;GJA5;PKD2;JPH2;PIK3C2G;SCARA3;CYBRD1;SDK1;TNIK;ANPEP;PROM2;BCAM;CLTCL1;NOS1;APCDD1;MALL;UTRN;ROR1;AXL;EGFR;GALNT10;TMEM204;SDC3;ITPK1;HSPA2;FLRT3;SPTB;NYNRIN;SLC8A1;NTM;ORAI3;CLCA2;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;KIAA1549L;ATP10D;SERPINH1;S100A10;MBOAT2;ANXA5;LPAR5;FAM198B;CSPG4;PSTPIP1;EVC;CNTNAP3;FAM210B;AMIGO2;NTSR1;TENM3;PAK1;ABCA1;LOC441081;NSG1;TMC7;PTPRM;TP53I11;ITM2C;PTK6;AHNAK;SCN8A;NETO1;MRC2;SORL1;NEO1;SCN2A;GNG2;KCNMA1;MEST;EXTL2;KIAA0319L;PTPRS;DLG4;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ACSL3;HIP1;GPNMB;TMEM200A;CRIM1;ITGA3;EMP1;PCDHAC2;SLC22A15;ELFN2;TPBG;SNX1;ANO6;PLEK2;PAQR8;PTGES;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;ERMAP;ASAP1;ERO1B;PLLP;SYN1;PDPN;CTSV;PLXNB1;KCNAB2;LRP1;FYN;EMP3;IFI6;B3GAT3;FUT10;CLMN;UGT8;FAT2;CAV1;SLC27A1;ITGA10;SEL1L;SNX33;SLC22A17;SLC35F3;OSBPL5;XYLT1;AHNAK2;UST;DCBLD2;CXCR1;PRKCZ;SDR16C5;GPR39;KCNJ15;CHST3;EHD3;CAMK2D;ADGRG6;GOLGB1;ITGA1;MST1R;SYTL1;IL31RA;ULBP1;ATP8B2;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;ALDH3A2;CPT1A;SLC38A2;CALHM2;DYSF;KIF17;UNC5B;BBS2;HERPUD1;ANK3;WFS1;SPRY2;TMEM139;TMEM8B;APLP2;SHROOM4;ST6GAL2;DLC1;S1PR5;BTN3A1;BACE1;ROBO1;KCNJ5;SPRY4;LRIG3;STOM;PRX;TLR3;MAN1A1;SNCA;FLOT2;MME;FRMD5;PDIA6;VAMP1;FZD7;GLG1;PAQR7;NIPSNAP1;PLXNA2;CYYR1;PTPRU;FGFR1;PAG1;IGF1R;ARMCX2;ALOX15B;MLEC;FSCN1;SEC24D;SEMA4A;RGS2;C5;GLT8D2;ASTN2;PDE4D;TMEM129;TGM2;SULF1;PLA2R1;ESYT2;TRO;G6PD;MYOF;EPHB6;IL17RE;EDA2R;FZD8;CCDC136;TMEM263;SLC24A1;CDH13;CD99L2;SEPT6;TGFBR3;FZD1;AMOTL1;LRTOMT;LAPTM4A;ENG;BBS4;CALR;NEGR1;EFNB3;COPG2;APH1B;ARF6;TMED10;DLK2;TMEM14C;AREG;BBS1;SNX10;PLXNA1;DNAJC4;NRSN2;CYP20A1;CD1D;LZTS1;SYNE2;CSMD2;NEMP2;PTPN1;KCNQ3;VANGL2;ARHGEF2;SMIM19;NTNG1;PLGRKT;NDUFA4L2;KLHL12;SDC2;SLC25A35;SSH1;ENPP1;SLC27A6;SLC48A1;PCDHGA11;PLD3;NFASC;G6PC3;GCNT1;TMEM50B;PRKCA;TMEM63C;PXMP2;TMEM175;ANXA2;RGS14;TMC4;RAB13;FNDC3A;TMEM94;MPP7;RNF24;METTL23;LEPR;PGAP1;PLD5;IFITM2;MVB12B;TTC8;MOSPD2;CNTNAP3B;GAL3ST4;PODXL;ABCC2;MEGF8;TSPAN5;NLGN4Y;XG;HTR1B;SPA17;SLC39A11;PRNP;TMEM60;CDH11;RET;GGT7;VPS39;DSEL;OR2A4;SCNN1A;AMOTL2;GPR161;LRRN3;SFXN3;ITM2A;CYP4V2;HERPUD2;SPPL2B;ULK1;AGRN;IGFBP2;TMEM187;TMEM164;RHBDD1;KIAA1109;HSPA5;BTN3A3;NRM;TH;GOPC;SNX7;SLC9A4;BOC;PIKFYVE;REEP2;RSAD2;FLNB;UVRAG;SEMA4B;ITGB8;ITPR2;UGT1A3;VPS13C;RHBDD2;IFITM1;LMF1;UGT1A6;MYO9A;CACNB1;ALG10;COL17A1;GPX8;ATRAID;GALNT2;DERL3;AGPAT1;RNF144B;CALCRL;TPST1;KCNIP3;TMEM212;SLC35E2B;CERS5;SNX9;SHISA9;PRR7;LGALS3;PTPN3;MIA3;TSPAN18;DNAJC3;SV2A;ABCA2;TMEM67;EFNA5;FZD4;MPPE1;SLITRK5;ADGRA2;NAT14;PPP3CA;TMEM168;PIK3C2B;RASA1;ANKH;LIMA1;STEAP2;COX18;TMTC4;DNM1P46;AIG1;CLEC2D;CACNA2D3;CAMK2N1;VPS36;PCDHGB5;OXTR;ADAM10;CELSR1;MPDZ;LITAF;TSPAN4;MYO1C;TUSC3;ORAI2;C2CD5;SNTB1;EDEM1;TMEM92;ABCA5;CTSD;DMPK;MOSPD3
8220,GO:0033002,0.000111341882217458,0.999958030199335,27,116,muscle cell proliferation,BP,MMP2;MMP9;TGFBR2;TENM4;SKP2;EGFR;PAK1;BMP4;PDCD4;STAT1;TP53;MEF2D;ITGA2;ANG;JARID2;TP73;FGFR1;TGM2;IL18;CDH13;TGFBR3;MDM2;HTR1B;TGFB2;PPARG;CALCRL;RXRA
363,GO:0000982,0.000113628220887385,0.999942363702892,51,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SOX6;SNAI2;KLF8;NR1D1;NR3C1;ETV1;TP53;DDIT3;ZBTB20;MEF2D;GLI3;ZFP90;TSHZ2;GLI2;HMGA2;CREB3L2;TP73;KLF13;NFATC4;DLX3;PBX1;MEIS2;TCF4;EGR1;SOX9;ISL1;STK16;PLAG1;MYBL1;HLTF;TSHZ1;TCF12;NFAT5;CARF;ZFPM1;RBL2;LEF1;SSBP3;TEF;KLF5;MEIS3;KCNIP3;MEF2A;KLF7;TGIF1;HES2;TSHZ3;ETV4;FOS;PRDM5;LITAF
14518,GO:0070062,0.000118297241755681,0.999913156700323,244,2028,extracellular exosome,CC,ITGB6;FLOT1;PRSS23;HTRA1;FN1;PYGB;FLRT2;MMP9;GPRC5A;ITGB5;COL8A1;FBN1;SFRP1;NQO1;FAT4;XPC;PTGS1;ITGB4;EFEMP1;SLC7A8;ANO1;GSN;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;BCAM;CLTCL1;DNAJB4;GAS6;PDGFC;COL5A1;UTRN;ARHGAP23;AXL;DPYSL2;HSPA2;LAMB1;FKBP5;MYLK;SLC2A3;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;S100A10;ANXA5;VIM;CSPG4;TKFC;TOM1L2;TIMP2;PDLIM2;PLEC;ITM2C;TP53I3;AHNAK;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;KRT5;SEC14L2;MUC19;ARMC9;SEMA5A;ZCCHC11;PPL;TIMP1;EFEMP2;PHGDH;CRIM1;ITGA3;ANO6;GPX1;CNTN1;ECH1;PLLP;CTDSPL;ABHD14B;KRT15;CTSV;SPG11;ARHGEF12;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;CLU;SERPING1;SNX29;PRKCZ;PARP4;PRDX5;ITGA1;SYTL1;METTL7A;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;TTN;APLP2;FBLN1;CAT;CASP14;PRKACB;AARS;STOM;BPHL;MAN1A1;FLOT2;ALDH1L2;MME;THSD4;PDIA6;GLG1;JADE2;CBR1;ALOX15B;FSCN1;LTBP3;C5;TGFBI;TGM2;PSMB9;IL18;PLA2R1;G6PD;MYOF;ARSD;CDH13;MAGEF1;TGFBR3;NAGLU;CALR;NEGR1;IDH2;ARF6;FAM20A;TMED10;CST3;DLK2;ANXA6;PLXNA1;HEXA;AKR7A2;HSPA12A;SYNE2;HDAC11;RNPEP;POGLUT1;CPNE8;COL5A3;PLD3;PRCP;NFASC;NDRG1;PRKCA;PRPS2;ANXA2;TMC4;RAB13;CES3;MAN2B1;LANCL1;ALDH9A1;MVB12B;GAL3ST4;PODXL;DECR1;MEGF8;UACA;RAB43;PRNP;CDH11;RBL2;DNASE1L1;COL12A1;SCNN1A;LIPA;ALDH7A1;ITM2A;EFR3A;OSBPL1A;AGRN;IGFBP2;HSPA5;REEP2;FLNB;ITGB8;NAPRT;MON2;VPS13C;UGT1A6;CAPS;GALNT2;CAPG;SNX9;LGALS3;ARL3;DNAJC3;RASSF9;CCNY;PRKAG1;FZD4;PEX1;KRT10;ACTR1B;PPCS;DNPH1;SERPINB5;SCPEP1;ABAT;MYH11;NIPBL;VPS36;PCDHGB5;ADAM10;RHOBTB3;S100A11;MYO1C;ACAA2;CTSD;LAMB2
10021,GO:0042493,0.000118516424323225,0.999927508077453,92,602,response to drug,BP,TXNIP;SFRP1;NQO1;DDIT4;TGFBR2;XPC;GSN;DUSP6;SDK1;NOS1;GAS6;AXL;EGFR;SLC8A1;S100A10;NTSR1;TIMP2;ABCA1;PTPRM;NEFL;VAV3;NR3C1;COL18A1;STAT1;LGALS1;KCNMA1;TP53;SLC7A11;ITGA2;ITGA3;KLF9;GPX1;MTHFR;FYN;ADIRF;CPS1;CAV1;HLCS;SLC35F3;SLIT3;TP53INP1;PARP4;HMGA2;SYT1;CPT1A;ACACB;TP73;CAT;PRKACB;CHEK2;TLR3;SNCA;SETX;G6PD;FZD1;ENG;CALR;MDM2;CST3;AREG;DGKQ;GCLC;ARHGEF2;SSH1;EGR1;SOX9;BCHE;ABCC2;HTR1B;PRNP;RET;TGFB2;AGRN;IGFBP2;HSPA5;TH;ITPR2;YAP1;GDNF;SRR;PPARG;TGIF1;RARA;ABCA2;TAF1;EFNA5;FZD4;PPP3CA;FOS;ABAT;OXTR;NFKBIE
2268,GO:0005201,0.000118732305777182,0.999974508597504,14,34,extracellular matrix structural constituent,MF,FBN1;COL5A2;FBN2;COL5A1;TFPI2;LAMB1;MFAP5;EFEMP2;COL4A4;FBLN1;COL5A3;COL12A1;COL4A1;MATN3
9818,GO:0042063,0.000119831770539612,0.99994663670917,37,174,gliogenesis,BP,SERPINE2;SOX6;TENM4;GSN;ETV5;APCDD1;ROR1;EGFR;LAMB1;GJC2;VIM;CSPG4;GLI3;LRP1;AHNAK2;CLU;ADGRG6;PRDM8;TP73;METRN;PRX;SH3TC2;IDH2;AREG;SYNE2;HDAC11;SOX9;NDRG1;PLAG1;NAB2;TGFB2;DLX2;LEF1;PPARG;KDM4A;MED12;LAMB2
3561,GO:0007605,0.000119937079984145,0.999964203238968,19,68,sensory perception of sound,BP,SLITRK6;SNAI2;ROR1;GPX1;NAV2;EML2;ESPN;WFS1;SPRY2;FGFR1;MYO3B;TRIOBP;LRTOMT;HOXA1;PGAP1;ALDH7A1;TH;FZD4;NIPBL
10377,GO:0043230,0.000123524726154384,0.999909199465474,245,2037,extracellular organelle,CC,SERPINE2;ITGB6;FLOT1;PRSS23;HTRA1;FN1;PYGB;FLRT2;MMP9;GPRC5A;ITGB5;COL8A1;FBN1;SFRP1;NQO1;FAT4;XPC;PTGS1;ITGB4;EFEMP1;SLC7A8;ANO1;GSN;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;BCAM;CLTCL1;DNAJB4;GAS6;PDGFC;COL5A1;UTRN;ARHGAP23;AXL;DPYSL2;HSPA2;LAMB1;FKBP5;MYLK;SLC2A3;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;S100A10;ANXA5;VIM;CSPG4;TKFC;TOM1L2;TIMP2;PDLIM2;PLEC;ITM2C;TP53I3;AHNAK;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;KRT5;SEC14L2;MUC19;ARMC9;SEMA5A;ZCCHC11;PPL;TIMP1;EFEMP2;PHGDH;CRIM1;ITGA3;ANO6;GPX1;CNTN1;ECH1;PLLP;CTDSPL;ABHD14B;KRT15;CTSV;SPG11;ARHGEF12;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;CLU;SERPING1;SNX29;PRKCZ;PARP4;PRDX5;ITGA1;SYTL1;METTL7A;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;TTN;APLP2;FBLN1;CAT;CASP14;PRKACB;AARS;STOM;BPHL;MAN1A1;FLOT2;ALDH1L2;MME;THSD4;PDIA6;GLG1;JADE2;CBR1;ALOX15B;FSCN1;LTBP3;C5;TGFBI;TGM2;PSMB9;IL18;PLA2R1;G6PD;MYOF;ARSD;CDH13;MAGEF1;TGFBR3;NAGLU;CALR;NEGR1;IDH2;ARF6;FAM20A;TMED10;CST3;DLK2;ANXA6;PLXNA1;HEXA;AKR7A2;HSPA12A;SYNE2;HDAC11;RNPEP;POGLUT1;CPNE8;COL5A3;PLD3;PRCP;NFASC;NDRG1;PRKCA;PRPS2;ANXA2;TMC4;RAB13;CES3;MAN2B1;LANCL1;ALDH9A1;MVB12B;GAL3ST4;PODXL;DECR1;MEGF8;UACA;RAB43;PRNP;CDH11;RBL2;DNASE1L1;COL12A1;SCNN1A;LIPA;ALDH7A1;ITM2A;EFR3A;OSBPL1A;AGRN;IGFBP2;HSPA5;REEP2;FLNB;ITGB8;NAPRT;MON2;VPS13C;UGT1A6;CAPS;GALNT2;CAPG;SNX9;LGALS3;ARL3;DNAJC3;RASSF9;CCNY;PRKAG1;FZD4;PEX1;KRT10;ACTR1B;PPCS;DNPH1;SERPINB5;SCPEP1;ABAT;MYH11;NIPBL;VPS36;PCDHGB5;ADAM10;RHOBTB3;S100A11;MYO1C;ACAA2;CTSD;LAMB2
18438,GO:1903561,0.000123524726154384,0.999909199465474,245,2037,extracellular vesicle,CC,SERPINE2;ITGB6;FLOT1;PRSS23;HTRA1;FN1;PYGB;FLRT2;MMP9;GPRC5A;ITGB5;COL8A1;FBN1;SFRP1;NQO1;FAT4;XPC;PTGS1;ITGB4;EFEMP1;SLC7A8;ANO1;GSN;PKD2;CYBRD1;NID1;SDK1;TNIK;ANPEP;PROM2;BCAM;CLTCL1;DNAJB4;GAS6;PDGFC;COL5A1;UTRN;ARHGAP23;AXL;DPYSL2;HSPA2;LAMB1;FKBP5;MYLK;SLC2A3;ACTA2;SERPINE1;SERPINH1;ENDOD1;KRT14;S100A10;ANXA5;VIM;CSPG4;TKFC;TOM1L2;TIMP2;PDLIM2;PLEC;ITM2C;TP53I3;AHNAK;FCGBP;VAV3;MXRA5;COL18A1;SORL1;LGALS1;GNG2;KCNMA1;MEST;CPVL;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;KRT5;SEC14L2;MUC19;ARMC9;SEMA5A;ZCCHC11;PPL;TIMP1;EFEMP2;PHGDH;CRIM1;ITGA3;ANO6;GPX1;CNTN1;ECH1;PLLP;CTDSPL;ABHD14B;KRT15;CTSV;SPG11;ARHGEF12;B3GAT3;LTBP4;ADIRF;CMBL;LAMA3;FAT2;CLU;SERPING1;SNX29;PRKCZ;PARP4;PRDX5;ITGA1;SYTL1;METTL7A;ALDH3A2;PCLO;ANG;DYSF;LAMA5;CNTLN;TTN;APLP2;FBLN1;CAT;CASP14;PRKACB;AARS;STOM;BPHL;MAN1A1;FLOT2;ALDH1L2;MME;THSD4;PDIA6;GLG1;JADE2;CBR1;ALOX15B;FSCN1;LTBP3;C5;TGFBI;TGM2;PSMB9;IL18;PLA2R1;G6PD;MYOF;ARSD;CDH13;MAGEF1;TGFBR3;NAGLU;CALR;NEGR1;IDH2;ARF6;FAM20A;TMED10;CST3;DLK2;ANXA6;PLXNA1;HEXA;AKR7A2;HSPA12A;SYNE2;HDAC11;RNPEP;POGLUT1;CPNE8;COL5A3;PLD3;PRCP;NFASC;NDRG1;PRKCA;PRPS2;ANXA2;TMC4;RAB13;CES3;MAN2B1;LANCL1;ALDH9A1;MVB12B;GAL3ST4;PODXL;DECR1;MEGF8;UACA;RAB43;PRNP;CDH11;RBL2;DNASE1L1;COL12A1;SCNN1A;LIPA;ALDH7A1;ITM2A;EFR3A;OSBPL1A;AGRN;IGFBP2;HSPA5;REEP2;FLNB;ITGB8;NAPRT;MON2;VPS13C;UGT1A6;CAPS;GALNT2;CAPG;SNX9;LGALS3;ARL3;DNAJC3;RASSF9;CCNY;PRKAG1;FZD4;PEX1;KRT10;ACTR1B;PPCS;DNPH1;SERPINB5;SCPEP1;ABAT;MYH11;NIPBL;VPS36;PCDHGB5;ADAM10;RHOBTB3;S100A11;MYO1C;ACAA2;CTSD;LAMB2
7779,GO:0032330,0.000131879539843235,0.999977486540229,11,26,regulation of chondrocyte differentiation,BP,CTGF;SOX6;EFEMP1;SNAI2;BMP4;GLI3;GLI2;ADAMTS7;GLG1;MAF;SOX9
12247,GO:0048565,0.000142157394508917,0.999954343680053,21,72,digestive tract development,BP,ITGA6;SFRP1;FAT4;TGFBR2;ITGB4;PDGFC;EGFR;BMP4;PTK6;GLI3;CPS1;GLI2;FOXL1;VANGL2;MEGF8;RET;TGFB2;NPHP3;KLF5;NIPBL;OXTR
12046,GO:0048018,0.000143080110255181,0.999939997720363,31,169,receptor ligand activity,MF,FLRT2;CTGF;FBN1;EFEMP1;GAS6;PDGFC;FLRT3;CXCL14;BMP4;IL32;PDGFA;TIMP1;GPNMB;KITLG;CCK;DKK1;CTF1;SEMA4A;C5;IL18;AREG;IFNK;IFNE;THNSL2;UCN2;TGFB2;SEMA4B;GDNF;LGALS3;EFNA5;ADM2
12330,GO:0048729,0.000149203519988339,0.999911969125361,79,449,tissue morphogenesis,BP,SFRP1;FAT4;TGFBR2;ITGB4;ETV5;PKD2;SNAI2;MAGED1;COL5A1;ROR1;EGFR;FLRT3;MYLK;ACTA2;PAK1;VDR;BMP4;STAT1;PRICKLE1;ITGA2;PDGFA;ADARB1;ITGA3;GLI3;DLG5;PDPN;CTSV;GLI2;HMGA2;LAMA5;SPRY2;TTN;DLC1;PRKACB;FZD7;FGFR1;DKK1;ASTN2;TGM2;PSMB9;SULF1;NFATC4;TGFBR3;FZD1;PBX1;ENG;FOXL1;BBS4;MDM2;AREG;PLXNA1;LMO4;VANGL2;SOX9;ISL1;GCNT1;PODXL;MEGF8;RET;ZFPM1;TGFB2;IFT122;LEF1;NPHP3;MAGI2;TGFB1I1;ARHGEF19;OPHN1;MYO9A;YAP1;GDNF;KLHL3;RARA;COL4A1;FZD4;SERPINB5;MED12;CELSR1;RXRA
480,GO:0001527,0.000151142856882125,0.999993273834229,6,8,microfibril,CC,FBN1;FBN2;MFAP5;LTBP1;THSD4;ADAMTSL5
3757,GO:0008305,0.000151871511495812,0.999981185245658,9,17,integrin complex,CC,ITGB6;ITGB5;ITGA6;ITGB4;ITGA2;ITGA3;ITGA10;ITGA1;ITGB8
16766,GO:0098636,0.000151871511495812,0.999981185245658,9,17,protein complex involved in cell adhesion,CC,ITGB6;ITGB5;ITGA6;ITGB4;ITGA2;ITGA3;ITGA10;ITGA1;ITGB8
10564,GO:0043549,0.000153099587964456,0.999903725074716,100,641,regulation of kinase activity,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CDKN2B;F2R;TGFBR2;PKD2;IRS2;DUSP6;HERC5;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;FLRT3;CSPG4;MAP3K6;PAK1;BMP4;PTK6;VAV3;PDCD4;SORL1;WWTR1;PYCARD;WNK1;DLG4;PILRB;PDGFA;ADARB1;KITLG;CAV1;SLC27A1;ERCC6;TRIB2;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;PIK3R1;ANG;DUSP5;SPRY2;TTN;TP73;PRKACB;ROBO1;SPRY4;TLR3;SNCA;FGFR1;IGF1R;DKK1;RGS2;C5;IL18;EPHB6;FZD8;AFAP1L2;FAM20A;AKAP13;DGKQ;NR2F2;LMO4;MAP3K1;PTPN1;VANGL2;NRK;EGR1;RGS14;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;RBL2;MAP2K5;MAPK8IP3;CDKN2A;TSPYL2;VAV2;HSPA5;UVRAG;MDFIC;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CDK5RAP3;CAMK2N1;TAOK3
16780,GO:0098657,0.000159488119417368,0.999904239676383,83,502,import into cell,BP,SYT8;FLOT1;TGFBR2;GSN;SCARA3;PROM2;CLTCL1;NOS1;GAS6;AXL;DPYSL2;SLC8A1;SERPINE1;STON2;PSTPIP1;NTSR1;PAK1;ABCA1;RIN2;MRC2;VAV3;SORL1;PYCARD;DLG4;ITGA2;HIP1;SNX1;ANO6;TBC1D5;SRPX;SPG11;LRP1;FYN;CAV1;PLA2G6;SNX33;CLU;CXCR1;EHBP1;PIK3R1;SYT1;KCNJ5;SNCA;PDIA6;DKK1;TGM2;PLA2R1;ESYT2;CDH13;CALR;ARF6;DNAJC6;SNX10;ELMO3;NEURL1B;PTPN1;ENPP1;TMEM175;ANXA2;LEPR;NLGN4Y;HTR1B;PRNP;C2CD4C;VAV2;MAGI2;SNX7;SLC9A4;OPHN1;GDNF;PPARG;CALCRL;SNX9;LGALS3;RARA;WIPF1;PPP3CA;STEAP2;DNM1P46;ELMO2;RHOBTB3;MYO1C;DOCK1
8123,GO:0032835,0.00016092626893323,0.999965523855367,13,35,glomerulus development,BP,NID1;SULF2;ACTA2;BMP4;WWTR1;COL4A4;SULF1;VANGL2;EGR1;PODXL;RET;MAGI2;LAMB2
8904,GO:0034762,0.000162505410566973,0.999916155363805,51,267,regulation of transmembrane transport,BP,MMP9;F2R;GJA5;PKD2;JPH2;IRS2;CLTCL1;NOS1;TCAF1;UTRN;HSPA2;SLC8A1;GJC2;NTSR1;PAK1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;WNK1;DLG4;ANO6;KCNAB2;FYN;CAV1;PLA2G6;PRKCZ;KCNJ15;EHD3;CAMK2D;PIK3R1;ANK3;DAPK1;KCNJ5;STOM;SNCA;PDE4D;G6PD;KCNQ3;ENPP1;PRNP;FHL1;GOPC;CACNB1;KCNIP3;SHISA9;PTPN3;CACNA2D3;KCNRG;C2CD5
11411,GO:0045860,0.000163751527640981,0.999908613545785,64,372,positive regulation of protein kinase activity,BP,GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;GAS6;PDGFC;MAGED1;EGFR;CSPG4;MAP3K6;PAK1;BMP4;WNK1;DLG4;PILRB;PDGFA;KITLG;SLC27A1;ERCC6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;ANG;DUSP5;SPRY2;TP73;PRKACB;ROBO1;TLR3;SNCA;FGFR1;DKK1;C5;IL18;FZD8;AFAP1L2;FAM20A;AKAP13;DGKQ;MAP3K1;PTPN1;VANGL2;NRK;EGR1;PAK6;NAB2;MAP3K12;PRNP;TGFB2;MAP2K5;MAPK8IP3;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
15186,GO:0071363,0.000173957626651718,0.999897348353501,77,454,cellular response to growth factor stimulus,BP,HTRA1;FLRT2;CCBE1;ITGB5;CTGF;FBN1;SOX6;SFRP1;CD109;CDKN2B;ZFP36L1;DDIT4;FAT4;TGFBR2;DUSP6;ZFP36L2;NOS1;GAS6;FBN2;SNAI2;SULF2;EGFR;TMEM204;PEG10;FLRT3;RNF165;BMP4;PDCD4;NR3C1;NEO1;LTBP1;ITGA3;FYN;XDH;LTBP4;CPS1;CAV1;RBFOX2;PRKCZ;PXN;SPRY2;CAT;ROBO1;SPRY4;SNCA;ADAMTS7;GLG1;FGFR1;DKK1;SETX;SULF1;MYOF;TGFBR3;FZD1;ENG;MTMR4;MDM2;CITED2;GCLC;PTPN1;EGR1;SOX9;STK16;MEGF8;TGFB2;MAP2K5;LEF1;MAGI2;HSPA5;TH;TGFB1I1;TGIF1;POSTN;FZD4;ADGRA2;FOS;MYO1C
6679,GO:0030055,0.000175196376388547,0.999902870621714,62,362,cell-substrate junction,CC,ITGB6;FLOT1;FLRT2;ITGB5;ITGA6;TLN2;ITGB4;ASAP3;GSN;TNS4;EGFR;FLRT3;ANXA5;VIM;CSPG4;PLEC;PAK1;TNS1;AHNAK;MRC2;ITGA2;ITGA3;LRP1;FLNC;CAV1;TNS2;EHD3;ITGA1;PXN;PARVA;LMO7;CAT;DLC1;SPRY4;FLOT2;MME;TGM2;TRIOBP;CDH13;CD99L2;FZD1;ENG;CALR;ARF6;ANXA6;SYNE2;ARHGEF2;NFASC;TES;RPL13A;FHL1;MPRIP;HSPA5;TGFB1I1;FLNB;COL17A1;DIXDC1;ARHGAP31;LIMA1;ADAM10;TSPAN4;SNTB1
12221,GO:0048519,0.000184698944120151,0.999855369571754,442,3626,negative regulation of biological process,BP,SERPINE2;PHACTR3;TNFRSF6B;KRT4;HTRA1;FN1;FLRT2;MMP9;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;XPC;EFEMP1;IL20RB;GSN;COL5A2;GJA5;PKD2;JPH2;IRS2;DUSP6;ZFP36L2;IGF2BP2;HERC5;PROM2;COL7A1;NOS1;GAS6;APCDD1;FBN2;SNAI2;MAGED1;TCAF1;SULF2;COL5A1;PHF21A;TFPI2;ROR1;AXL;EGFR;TSC22D3;KLF8;PEG10;HSPA2;FLRT3;SPEG;SPTB;SLC8A1;DOCK5;SESN3;GJC2;THBS2;ZNF608;SERPINE1;SERPINH1;RNF213;CRTAP;ANXA5;VIM;NUPR1;TKFC;AMIGO2;STMN3;TOM1L2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;ANGPTL4;CBX5;VDR;APOBEC3C;PTPRM;SRGAP3;BMP4;TP53I11;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;TRIM5;NEFL;PDCD4;NR3C1;COL18A1;STAT1;SORL1;LGALS1;TP53;ARAP1;PTPRS;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;LTBP1;ZC3H6;IFIT1;WNK1;DLG4;SEMA5A;ZCCHC11;PDGFA;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;GPNMB;TFDP2;DOCK4;PNRC1;CCDC85B;CRIM1;BTG1;ITGA3;SIK1;EVI5L;KLF12;IFIT3;KLF9;NFIX;ELFN2;HIVEP1;GPX1;GLI3;PTGES;E2F7;DLG5;KITLG;P3H2;ASAP1;CTDSPL;PDPN;SRPX;ZFP90;SESN1;CTSV;SEC14L1;PLXNB1;EML2;LRP1;FYN;EMP3;IFI6;XDH;TSHZ2;CLMN;CAV1;SLC27A1;GLI2;PIAS3;RNF135;RBFOX2;PLA2G6;TRIB2;SNX33;MAP3K14;ESPN;ZNF318;TNRC18;CLU;DCBLD2;SERPING1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;ULK2;TP53INP1;ARPIN;TNS2;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;KANK2;IL31RA;PTPN14;PER1;CCK;PIK3R1;CAPRIN2;ACACB;APOBEC3G;ANG;DUSP5;UNC5B;UHRF2;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;AARS;CHEK2;ROBO1;SPRY4;PAIP2B;PHF2;TLR3;FBXL7;SNCA;FLOT2;ADAMTS7;FRMD5;FZD7;GLG1;PLXNA2;PTPRU;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;DKK1;PRKAB2;SEMA4A;RGS2;C5;TGFBI;SETX;ASTN2;PDE4D;NCOA2;PSMB9;IL18;SULF1;PLA2R1;G6PD;TLE4;EPHB6;FZD8;TCEAL1;TRIOBP;KDM4C;SLC24A1;CDH13;NFATC4;MAGEF1;FOXN3;LMCD1;TGFBR3;FZD1;PBXIP1;PBX1;ENG;BBS4;MTMR4;CALR;ATM;EFNB3;IDH2;SRGAP1;MDM2;ARF6;CST3;DLK2;MEIS2;AREG;IFNK;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;CBX7;LMO4;MAF;LZTS1;PTPN1;ARHGEF2;KLHL12;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;CRTC1;NCOR1;NDRG1;PLAG1;PRKCA;SALL2;MYBL1;BCHE;ANXA2;RGS14;CXORF57;BAHCC1;LEPR;TSHZ1;IGFBP4;IFITM2;TES;TCF25;HMBOX1;RPL13A;PODXL;NAB2;MAP3K12;MEGF8;ATXN1;HTR1B;IRF2BPL;PRNP;RET;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;SMG9;IFT122;GPR161;LEF1;THRA;FHL1;ZADH2;USP28;ITM2A;CDKN2A;SP100;ULK1;TSPYL2;IGFBP2;NPHP3;RHBDD1;MAGI2;HSPA5;GOPC;TGFB1I1;RSAD2;SRPK2;SEMA4B;ITGB8;ITPR2;MDFIC;VPS13C;IFT74;IFITM1;ZNF12;OPHN1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;UBA7;DIXDC1;DERL3;MEIS3;PPARG;CAPG;RNF144B;PARP15;BEX4;CALCRL;KCNIP3;MEF2A;GCSAM;TGIF1;ING4;POSTN;UNK;LGALS3;PTPN3;MIA3;DNAJC3;RARA;HES2;TMEM67;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ADGRA2;ZBTB1;PPP3CA;RASA1;LIMA1;CREBRF;CTDSP2;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;TTBK2;KCNRG;OXTR;ADAM10;PRDM5;S100A11;RXRA;ACAA2;ABCA5;TAOK3;NFKBIE
8361,GO:0033273,0.000185923963993032,0.999946437325121,17,63,response to vitamin,BP,SFRP1;GSN;GAS6;SNAI2;EGFR;VDR;TP53;ITGA2;MTHFR;HLCS;KANK2;CAT;MDM2;BCHE;PPARG;POSTN;RARA
9938,GO:0042325,0.000186661128517363,0.999871722661494,150,1035,regulation of phosphorylation,BP,FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;F2R;DDIT4;TGFBR2;PKD2;IRS2;DUSP6;HERC5;TNIK;PROM2;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;VAV3;PDCD4;SORL1;TP53;WWTR1;PYCARD;WNK1;DLG4;PILRB;PDGFA;MICAL1;ADARB1;GPNMB;CNTN1;KITLG;CTDSPL;FYN;XDH;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;CAPRIN2;ANG;DUSP5;SPRY2;TTN;FBLN1;TP73;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;NR2F2;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;MAPK8IP3;CDKN2A;TSPYL2;VAV2;HSPA5;UVRAG;MDFIC;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CTDSP2;CDK5RAP3;CAMK2N1;TAOK3
3239,GO:0006897,0.000187696975429238,0.999889255511745,76,455,endocytosis,BP,SYT8;FLOT1;TGFBR2;GSN;SCARA3;PROM2;CLTCL1;GAS6;AXL;DPYSL2;SERPINE1;STON2;PSTPIP1;PAK1;ABCA1;RIN2;MRC2;VAV3;SORL1;PYCARD;DLG4;ITGA2;HIP1;SNX1;ANO6;TBC1D5;SRPX;SPG11;LRP1;FYN;CAV1;PLA2G6;SNX33;CLU;CXCR1;EHBP1;PIK3R1;SYT1;SNCA;PDIA6;DKK1;TGM2;PLA2R1;ESYT2;CDH13;CALR;ARF6;DNAJC6;SNX10;ELMO3;NEURL1B;PTPN1;ENPP1;TMEM175;ANXA2;LEPR;NLGN4Y;HTR1B;C2CD4C;VAV2;MAGI2;SNX7;OPHN1;PPARG;CALCRL;SNX9;LGALS3;RARA;WIPF1;PPP3CA;STEAP2;DNM1P46;ELMO2;RHOBTB3;MYO1C;DOCK1
4769,GO:0010959,0.000193025735510402,0.999910495537256,38,187,regulation of metal ion transport,BP,SERPINE2;F2R;PKD2;JPH2;NOS1;UTRN;HSPA2;SLC8A1;MYLK;GJC2;NTSR1;AHNAK;NETO1;WNK1;SIK1;ANO6;CNTN1;KCNAB2;FYN;CAV1;PLA2G6;EHD3;CAMK2D;PER1;ANK3;WFS1;STOM;SNCA;PDE4D;G6PD;PRNP;FHL1;CACNB1;KCNIP3;LGALS3;PTPN3;KCNRG;DMPK
6587,GO:0022612,0.00019395665037677,0.999931715588552,23,86,gland morphogenesis,BP,SFRP1;TGFBR2;ETV5;SNAI2;SULF2;EGFR;VDR;BMP4;PDGFA;GLI3;CAV1;GLI2;LAMA5;FGFR1;TGM2;SULF1;AREG;PLXNA1;SOX9;PLAG1;TGFB2;SERPINB5;RXRA
7191,GO:0031091,0.000205125414318384,0.999946271961006,15,52,platelet alpha granule,CC,SERPINE2;FN1;PCDH7;CD109;GAS6;THBS2;SERPINE1;PDGFA;TIMP1;MAGED2;CLU;SERPING1;APLP2;SNCA;TGFB2
2605,GO:0005912,0.000208504789724895,0.999876958354985,75,448,adherens junction,CC,ITGB6;FLOT1;FLRT2;ITGB5;ITGA6;TLN2;ASAP3;GSN;TNS4;EGFR;TMEM204;FLRT3;ANXA5;VIM;CSPG4;PLEC;PAK1;PTPRM;TNS1;AHNAK;MRC2;ITGA2;FRMD4B;ITGA3;DLG5;LRP1;FLNC;FAT2;CAV1;TNS2;EHD3;ITGA1;PXN;PARVA;LMO7;CAT;SHROOM4;DLC1;SPRY4;FLOT2;MME;FRMD5;TGM2;TRIOBP;CDH13;CD99L2;FZD1;ENG;CALR;ARF6;ANXA6;SYNE2;ARHGEF2;NFASC;NDRG1;ANXA2;MPP7;TES;RPL13A;CDH11;FHL1;MPRIP;HSPA5;MAGI1;TGFB1I1;FLNB;DIXDC1;EFNA5;ARHGAP31;LIMA1;OXTR;ADAM10;TSPAN4;S100A11;SNTB1
5466,GO:0016405,0.000210302643521488,0.999979591978799,7,14,CoA-ligase activity,MF,SLC27A3;ACSL3;SLC27A1;ACSS1;ACSS2;SLC27A6;ACSF2
14927,GO:0070848,0.000215762509991946,0.999870805760602,79,471,response to growth factor,BP,HTRA1;FLRT2;CCBE1;ITGB5;CTGF;FBN1;SOX6;SFRP1;CD109;CDKN2B;ZFP36L1;DDIT4;FAT4;TGFBR2;DUSP6;ZFP36L2;NOS1;GAS6;FBN2;SNAI2;SULF2;EGFR;TMEM204;PEG10;FLRT3;RNF165;BMP4;PDCD4;NR3C1;MXRA5;NEO1;LTBP1;ITGA3;FYN;XDH;LTBP4;CPS1;CAV1;RBFOX2;PRKCZ;PXN;SPRY2;CAT;ROBO1;SPRY4;SNCA;ADAMTS7;GLG1;FGFR1;DKK1;SETX;SULF1;MYOF;TGFBR3;FZD1;ENG;MTMR4;MDM2;MEIS2;CITED2;GCLC;PTPN1;EGR1;SOX9;STK16;MEGF8;TGFB2;MAP2K5;LEF1;MAGI2;HSPA5;TH;TGFB1I1;TGIF1;POSTN;FZD4;ADGRA2;FOS;MYO1C
8989,GO:0035150,0.000215765094619793,0.999934134270848,18,69,regulation of tube size,BP,F2R;GJA5;NOS1;EGFR;SLC8A1;DOCK5;DOCK4;GPX1;CPS1;CAV1;PLA2G6;ITGA1;BBS2;RGS2;GCLC;HTR1B;SCPEP1;OXTR
12646,GO:0050880,0.000215765094619793,0.999934134270848,18,69,regulation of blood vessel size,BP,F2R;GJA5;NOS1;EGFR;SLC8A1;DOCK5;DOCK4;GPX1;CPS1;CAV1;PLA2G6;ITGA1;BBS2;RGS2;GCLC;HTR1B;SCPEP1;OXTR
6407,GO:0021675,0.000217239967828156,0.999944659178822,15,44,nerve development,BP,SERPINE2;SLITRK6;SULF2;RNF165;ADARB1;GLI3;NAV2;CTSV;AHNAK2;PRX;SULF1;ISL1;HOXA1;RET;HOXA3
4341,GO:0009897,0.000220486585829225,0.999918148241779,24,106,external side of plasma membrane,CC,SERPINE2;ITGB6;ITGA6;TGFBR2;ANPEP;BCAM;ANXA5;ABCA1;ITGA2;ITGA3;ERMAP;CTSV;ITGA1;IL31RA;BTN3A1;KCNJ5;CDH13;TGFBR3;ENG;CALR;SPA17;PRNP;BTN3A3;EFNA5
10701,GO:0044057,0.000230231486754742,0.999881863777375,48,250,regulation of system process,BP,CTGF;F2R;TNNI2;TENM4;GJA5;NOS1;GAS6;UTRN;EGFR;SLC8A1;DOCK5;NTSR1;PAK1;WNK1;ITGA2;DOCK4;CAV1;EHD3;CAMK2D;CCK;JARID2;KCNJ5;FGFR1;LMNA;RGS2;PDE4D;G6PD;LMCD1;MTMR4;MDM2;ANXA6;AKAP13;PRKCA;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;CALCRL;KCNIP3;MEF2A;TSHZ3;PPP3CA;CACNA2D3;ABAT;OXTR;DMPK
4288,GO:0009719,0.000232791562043088,0.999838171014838,155,1064,response to endogenous stimulus,BP,MMP2;HTRA1;FLRT2;TXNIP;ITGB5;CTGF;FBN1;SOX6;SFRP1;CD109;CDKN2B;ZFP36L1;NQO1;DDIT4;FAT4;TGFBR2;COL5A2;PKD2;IRS2;DUSP6;ZFP36L2;SKP2;NOS1;FBN2;PDGFC;SNAI2;SULF2;EGFR;PEG10;FLRT3;SLC8A1;SESN3;RNF165;FAM210B;TIMP2;TADA3;PAK1;ABCA1;VDR;BMP4;NR1D1;NEFL;PDCD4;NR3C1;MXRA5;STAT1;NEO1;GNG2;TP53;LTBP1;ITGA2;MMP19;TIMP1;BTG1;ITGA3;SIK1;KLF9;PAQR8;SESN1;CTSV;LRP1;FYN;LTBP4;CPS1;CAV1;SLC27A1;PIAS3;RBFOX2;PRKCZ;SLIT3;KANK2;PER1;PXN;PIK3R1;ANG;BBS2;SPRY2;CAT;PRKACB;CHEK2;SPRY4;SNCA;ADAMTS7;GLG1;PAQR7;COL16A1;PTPRU;FGFR1;IGF1R;DKK1;SETX;PDE4D;NCOA2;SULF1;CDH13;TGFBR3;FZD1;ENG;BBS4;MTMR4;CALR;MDM2;CST3;AREG;AKAP13;CITED2;GCLC;NR2F2;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;PRCP;STK16;GCNT1;BCHE;ANXA2;RAB13;LEPR;ABCC2;MEGF8;HTR1B;PRNP;TGFB2;LEF1;THRA;AGRN;IGFBP2;MAGI2;HSPA5;TH;TGFB1I1;ITPR2;YAP1;CACNB1;KLF5;PPARG;POSTN;RARA;COL4A1;ABCA2;TAF1;EFNA5;CREBRF;STEAP2;FOS;MED12;OXTR;MYO1C;RXRA;C2CD5
12224,GO:0048522,0.000232951042792148,0.99981712025416,433,3470,positive regulation of cellular process,BP,SERPINE2;SULT1E1;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;TXNIP;CTGF;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;SLITRK6;TENM4;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;ZFP36L2;TNIK;SKP2;PROM2;NOS1;GAS6;FBN2;PDGFC;SNAI2;MAGED1;SULF2;ROR1;AXL;EGFR;HSPA2;LAMB1;FLRT3;SLC8A1;DOCK5;SESN3;MYLK;GJC2;SLC20A1;THBS2;RFX2;SERPINE1;DOK1;S100A10;RNF165;VIM;NUPR1;CSPG4;DDB2;EVC;FAM210B;MAP3K6;AMIGO2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;NSG1;VDR;CHN2;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;TBC1D8;CITED4;EIF2AK4;NETO1;TRIM5;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;SORL1;NEO1;IFIT2;LGALS1;KCNMA1;ETV1;TP53;ARAP1;WWTR1;PRICKLE1;DDIT3;PYCARD;MEF2D;SEC14L2;WNK1;DDX60;ARHGEF1;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;RBMS3;TIMP1;ACSL3;PHLDB1;HIP1;GPNMB;TFDP2;DOCK4;CUL7;BTG1;ITGA3;SIK1;NFIX;TPBG;ANO6;GPX1;PLEK2;LAMC2;GLI3;E2F7;DLG5;CNTN1;KITLG;TBC1D5;ASAP1;PDPN;SRPX;ABHD14B;ZFP90;SESN1;PLXNB1;LRP1;FYN;ARHGEF12;XDH;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;PLA2G6;TRIB2;DOCK11;SNX33;MAP3K14;ESPN;SMARCA1;ZNF318;CLU;NPHP4;PRKCZ;SDR16C5;FBXW4;TP53INP1;ARPIN;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PER1;PXN;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;UNC5B;UHRF2;HERPUD1;ANK3;WFS1;SPRY2;TTN;CIRBP;JARID2;HPS4;FBLN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;CHEK2;METRN;ROBO1;WDFY2;PHF2;TLR3;SNCA;FLOT2;FZD7;PLXNA2;COL16A1;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;DKK1;FSCN1;CTF1;SEMA4A;LTBP3;RGS2;C5;SETX;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;EPHB6;EDA2R;FZD8;ARHGEF17;TRIOBP;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;LMCD1;TGFBR3;DLX3;FZD1;AMOTL1;PBX1;ENG;BBS4;CALR;NEGR1;ATM;EFNB3;APH1B;MDM2;ARF6;FAM20A;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;LMO4;ZMAT3;MAF;TRAK1;CD1D;FBXW8;SYNE2;MAP3K1;FGD4;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;PLGRKT;NRK;SSH1;EGR1;SOX9;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;NDRG1;PLAG1;PRKCA;SALL2;MYBL1;ANXA2;TRERF1;RGS14;HLTF;HOXA1;MPP7;METTL23;IGFBP4;MOSPD2;TCF12;HMBOX1;NFAT5;PODXL;PAK6;NAB2;MAP3K12;MEGF8;TSPAN5;HTR1B;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;OR2A4;GPR161;LEF1;THRA;SSBP3;CDC42EP5;LRRN3;MAPK8IP3;CDKN2A;SP100;ULK1;TEF;AGRN;IGFBP2;VAV2;RHBDD1;MAGI2;HSPA5;CDK19;BOC;TGFB1I1;RSAD2;SRPK2;UVRAG;SEMA4B;ARHGEF19;MDFIC;VPS13C;FHOD1;IFT74;IFITM1;SH2B3;YAP1;GDNF;NUB1;KLF5;ATRAID;HOXA3;DIXDC1;MEIS3;AGPAT1;PPARG;RNF144B;CALCRL;MEF2A;KLF7;SNX9;SASH1;OBSL1;ING4;POSTN;LGALS3;MIA3;DNAJC3;RARA;CCNY;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;FOS;SEPT9;DNPH1;KDM4A;CDK5RAP3;FAM168A;MED12;NPAS2;ABAT;NIPBL;OXTR;ADAM10;LITAF;MYO1C;RXRA;C2CD5;EDEM1;TAOK3;DOCK1
3553,GO:0007596,0.00024232950466608,0.999884395757505,39,210,blood coagulation,BP,SERPINE2;F2R;GAS6;PDGFC;PHF21A;TFPI2;AXL;DOCK9;ITPK1;SERPINE1;ANXA5;CBX5;VAV3;GNG2;SLC7A11;ITGA2;PDGFA;MICAL1;ANO6;PDPN;FYN;CAV1;DOCK11;SERPING1;EHD3;PIK3R1;HPS4;FBLN1;PRKACB;DGKQ;PRCP;PRKCA;ANXA2;ZFPM1;VAV2;ITPR2;SH2B3;ABAT;DOCK1
12287,GO:0048661,0.000244833731554868,0.999931608867689,16,55,positive regulation of smooth muscle cell proliferation,BP,MMP2;MMP9;TGFBR2;SKP2;EGFR;PAK1;BMP4;STAT1;MEF2D;ITGA2;TGM2;IL18;CDH13;MDM2;HTR1B;CALCRL
12220,GO:0048518,0.000250916087118852,0.999801616390673,476,3881,positive regulation of biological process,BP,SERPINE2;SULT1E1;FLOT1;MMP2;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;TXNIP;COL8A1;CTGF;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;SLITRK6;TENM4;IL20RB;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;IRS2;DUSP6;NID1;ZFP36L2;TNIK;SKP2;PROM2;CLTCL1;NOS1;GAS6;FBN2;PDGFC;SNAI2;MAGED1;TCAF1;SULF2;UTRN;ROR1;AXL;EGFR;HSPA2;LAMB1;FLRT3;SLC8A1;DOCK5;SESN3;MYLK;GJC2;SLC20A1;THBS2;RFX2;ACTA2;SERPINE1;DOK1;S100A10;RNF165;VIM;NUPR1;CSPG4;DDB2;TKFC;EVC;FAM210B;MAP3K6;AMIGO2;NTSR1;TIMP2;TADA3;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;VDR;CHN2;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;TBC1D8;CITED4;EIF2AK4;NETO1;TRIM5;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;SORL1;NEO1;IFIT2;LGALS1;KCNMA1;ETV1;TP53;ARAP1;CEP250;PTPRS;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;MEF2D;SEC14L2;IFIT1;WNK1;DDX60;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;RBMS3;ADARB1;TIMP1;ACSL3;PHLDB1;HIP1;GPNMB;TFDP2;DOCK4;CUL7;BTG1;ITGA3;SIK1;NFIX;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;E2F7;DLG5;CNTN1;KITLG;TBC1D5;ERMAP;ASAP1;PDPN;SRPX;ABHD14B;ZFP90;CCDC80;SESN1;SEC14L1;PLXNB1;LRP1;FYN;ARHGEF12;XDH;B3GAT3;ADIRF;POLR3GL;CAV1;SLC27A1;GLI2;PIAS3;RNF135;ERCC6;PLA2G6;TRIB2;DOCK11;SNX33;MAP3K14;ESPN;SMARCA1;ZNF318;CLU;SERPING1;NPHP4;PRKCZ;SDR16C5;FBXW4;TP53INP1;ARPIN;EHD3;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PER1;PXN;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;UNC5B;UHRF2;BBS2;HERPUD1;ANK3;WFS1;SPRY2;TTN;CIRBP;JARID2;HPS4;FBLN1;TP73;CAT;DAPK1;DLC1;KLF13;BTN3A1;PRKACB;CHEK2;METRN;ROBO1;WDFY2;STOM;PHF2;TLR3;SNCA;FLOT2;FRMD5;FZD7;PLXNA2;COL16A1;FGFR1;PAG1;IGF1R;LMNA;ALOX15B;DKK1;FSCN1;CTF1;SEMA4A;LTBP3;RGS2;C5;SETX;PDE4D;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;PLA2R1;G6PD;EPHB6;EDA2R;FZD8;ARHGEF17;TRIOBP;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;PBX1;ENG;BBS4;CALR;NEGR1;ATM;EFNB3;APH1B;MDM2;ARF6;FAM20A;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;IFNE;LMO4;ZMAT3;MAF;TRAK1;CD1D;FBXW8;SYNE2;MAP3K1;FGD4;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;PLGRKT;NRK;SSH1;EGR1;SOX9;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;NDRG1;PLAG1;PRKCA;SALL2;MYBL1;ANXA2;TRERF1;RGS14;HLTF;HOXA1;MPP7;METTL23;IGFBP4;MVB12B;KCTD7;MOSPD2;TCF12;HMBOX1;NFAT5;PODXL;PAK6;NAB2;MAP3K12;MEGF8;TSPAN5;HTR1B;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;OR2A4;GPR161;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;MAPK8IP3;CDKN2A;SP100;ULK1;TEF;AGRN;IGFBP2;VAV2;RHBDD1;MAGI2;HSPA5;BTN3A3;CDK19;BOC;TGFB1I1;RSAD2;SRPK2;UVRAG;SEMA4B;ITGB8;ARHGEF19;MDFIC;VPS13C;FHOD1;IFT74;IFITM1;SH2B3;YAP1;GDNF;NUB1;KLF5;ATRAID;HOXA3;DIXDC1;MEIS3;AGPAT1;PPARG;RNF144B;CALCRL;MEF2A;GCSAM;KLF7;SNX9;SASH1;OBSL1;ING4;POSTN;LGALS3;MIA3;DNAJC3;RARA;ECM2;CCNY;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;ADGRA2;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;FOS;SEPT9;DNPH1;KDM4A;CDK5RAP3;FAM168A;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;NIPBL;ADM2;OXTR;ADAM10;LITAF;MYO1C;RXRA;C2CD5;EDEM1;TAOK3;DOCK1
7581,GO:0031960,0.000256246295381012,0.999906049484206,23,102,response to corticosteroid,BP,CTGF;ZFP36L1;DDIT4;ZFP36L2;EGFR;NEFL;NR3C1;KLF9;CTSV;CPS1;SLIT3;PTPRU;ENG;AREG;AKAP13;ISL1;BCHE;ABCC2;HTR1B;IGFBP2;TH;CREBRF;FOS
14127,GO:0061037,0.000263132139149717,0.999973459360778,7,14,negative regulation of cartilage development,BP,EFEMP1;SNAI2;BMP4;GLI2;ADAMTS7;SOX9;RARA
1278,GO:0003073,0.00026386557435845,0.999937994519205,13,41,regulation of systemic arterial blood pressure,BP,F2R;GJA5;GAS6;NTSR1;WNK1;NAV2;MME;PDE4D;BBS4;NR2F2;PRCP;POSTN;OXTR
4290,GO:0009725,0.000275229399952878,0.999823566718799,100,649,response to hormone,BP,TXNIP;CTGF;FBN1;SFRP1;ZFP36L1;NQO1;DDIT4;TGFBR2;IRS2;ZFP36L2;SKP2;NOS1;EGFR;SESN3;FAM210B;TIMP2;TADA3;PAK1;VDR;BMP4;NR1D1;NEFL;NR3C1;STAT1;GNG2;ITGA2;MMP19;TIMP1;BTG1;ITGA3;SIK1;KLF9;PAQR8;CTSV;FYN;CPS1;CAV1;SLC27A1;PIAS3;RBFOX2;PRKCZ;SLIT3;KANK2;PER1;PXN;PIK3R1;ANG;BBS2;CAT;PRKACB;CHEK2;PAQR7;PTPRU;IGF1R;NCOA2;TGFBR3;ENG;BBS4;CALR;MDM2;CST3;AREG;AKAP13;GCLC;NR2F2;PTPN1;EGR1;UCN2;ENPP1;ISL1;PRCP;GCNT1;BCHE;ANXA2;RAB13;LEPR;ABCC2;HTR1B;TGFB2;LEF1;THRA;AGRN;IGFBP2;TH;TGFB1I1;YAP1;PPARG;POSTN;RARA;ABCA2;TAF1;EFNA5;CREBRF;STEAP2;FOS;MED12;OXTR;MYO1C;RXRA;C2CD5
18280,GO:1903224,0.00027529854285717,1,4,4,regulation of endodermal cell differentiation,BP,COL5A2;DUSP6;COL5A1;DKK1
487,GO:0001540,0.000277555427066529,0.999934087408327,13,42,amyloid-beta binding,MF,APBB2;ITM2C;SORL1;ITGA2;CLU;BACE1;APBB3;CST3;BCHE;PRNP;TGFB2;ITM2A;FZD4
2382,GO:0005520,0.000278658997328044,0.999966139483951,8,16,insulin-like growth factor binding,MF,HTRA1;CTGF;ITGA6;ITGB4;CRIM1;IGF1R;IGFBP4;IGFBP2
10797,GO:0044306,0.000280632382191181,0.999905847132032,20,79,neuron projection terminus,CC,ROR1;FLRT3;NTSR1;DLG4;ITGA2;MICAL1;SYN1;KCNAB2;CCK;SYT1;SNCA;MME;VAMP1;SEPT6;SEPT5;TH;OPHN1;KCNIP3;SV2A;BSN
12603,GO:0050817,0.000280818929204551,0.9998649396723,39,211,coagulation,BP,SERPINE2;F2R;GAS6;PDGFC;PHF21A;TFPI2;AXL;DOCK9;ITPK1;SERPINE1;ANXA5;CBX5;VAV3;GNG2;SLC7A11;ITGA2;PDGFA;MICAL1;ANO6;PDPN;FYN;CAV1;DOCK11;SERPING1;EHD3;PIK3R1;HPS4;FBLN1;PRKACB;DGKQ;PRCP;PRKCA;ANXA2;ZFPM1;VAV2;ITPR2;SH2B3;ABAT;DOCK1
19142,GO:1905208,0.000286249543968966,0.999972112405657,7,13,negative regulation of cardiocyte differentiation,BP,SOX6;EGFR;PAK1;PRICKLE1;FZD7;DKK1;G6PD
12253,GO:0048584,0.000287843009679965,0.999791692114387,192,1432,positive regulation of response to stimulus,BP,FLOT1;MMP2;MMP9;CCBE1;CTGF;INPP5D;SFRP1;GADD45B;CDKN2B;F2R;TGFBR2;ANO1;GSN;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;PDGFC;MAGED1;SULF2;ROR1;AXL;EGFR;MYLK;SLC20A1;SERPINE1;DOK1;RNF165;CSPG4;TKFC;EVC;MAP3K6;NTSR1;TIMP2;CXCL14;PAK1;CHN2;BMP4;TRIM38;ITM2C;NR1D1;PTK6;EIF2AK4;NETO1;TRIM5;VAV3;PDCD4;NEO1;LGALS1;TP53;ARAP1;PTPRS;DDIT3;PYCARD;WNK1;DDX60;MUC19;DLG4;SEMA5A;ITGA2;PDGFA;HIP1;GPNMB;TFDP2;ANO6;GPX1;DLG5;KITLG;ERMAP;PDPN;SRPX;SEC14L1;PLXNB1;FYN;XDH;CAV1;ERCC6;PLA2G6;MAP3K14;CLU;SERPING1;PRKCZ;TP53INP1;HMGA2;ITGA1;MST1R;IL31RA;PIK3R1;TMEM173;CAPRIN2;DUSP5;UNC5B;HERPUD1;SPRY2;TP73;CAT;BTN3A1;PRKACB;ROBO1;TLR3;SNCA;FZD7;FGFR1;PAG1;IGF1R;ALOX15B;DKK1;CTF1;C5;PDE4D;TGM2;PSMB9;IL18;SULF1;PLA2R1;EPHB6;EDA2R;FZD8;AFAP1L2;CDH13;NFATC4;LMCD1;TGFBR3;ENG;CALR;ATM;IFNK;AKAP13;CITED2;CD1D;MAP3K1;PTPN1;POGLUT1;VANGL2;NRK;SSH1;SOX9;ISL1;ITPKB;PRKCA;MPP7;IGFBP4;MOSPD2;MAP3K12;MEGF8;TSPAN5;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;CDKN2A;VAV2;BTN3A3;CDK19;TGFB1I1;RSAD2;MDFIC;SH2B3;YAP1;GDNF;DIXDC1;MEIS3;AGPAT1;GCSAM;SASH1;LGALS3;RARA;TAF1;FZD4;WIPF1;ZBTB1;PPP3CA;CREBRF;CDK5RAP3;FAM168A;ELMO2;NPAS2;ABAT;ADAM10;LITAF;MYO1C;C2CD5;EDEM1;TAOK3;DOCK1
13839,GO:0060485,0.000290177078597253,0.999868997941089,34,162,mesenchyme development,BP,SFRP1;ZFP36L1;TGFBR2;PKD2;SNAI2;ACTA2;BMP4;PDCD4;STAT1;WWTR1;PHLDB1;CUL7;DLG5;KITLG;PDPN;HMGA2;LAMA5;FGFR1;SEMA4A;TGFBR3;ENG;MDM2;CITED2;POGLUT1;KLHL12;SOX9;ISL1;RET;TGFB2;LEF1;TGFB1I1;SEMA4B;YAP1;GDNF
5221,GO:0015837,0.000293461811690251,0.999946372920681,10,29,amine transport,BP,NTSR1;CCK;SYT1;SNCA;HTR1B;TH;GDNF;SV2A;ABAT;OXTR
12457,GO:0050432,0.000300570896231567,0.999968975561086,7,14,catecholamine secretion,BP,NISCH;SYT1;SNCA;HTR1B;GDNF;ABAT;OXTR
10382,GO:0043236,0.000300883192860562,0.999954121525418,9,21,laminin binding,MF,ITGA6;NID1;BCAM;LGALS1;ITGA2;ITGA3;ADGRG6;AGRN;LGALS3
3306,GO:0007009,0.000304410675678101,0.999906285331117,18,60,plasma membrane organization,BP,FLOT1;FAT4;GSN;COL5A1;ANO6;ASAP1;CAV1;SNX33;AHNAK2;CLU;DYSF;ANK3;PRX;SH3TC2;MYOF;NDRG1;TGFB2;SNX9
3556,GO:0007599,0.000307234271076707,0.999851387955264,39,213,hemostasis,BP,SERPINE2;F2R;GAS6;PDGFC;PHF21A;TFPI2;AXL;DOCK9;ITPK1;SERPINE1;ANXA5;CBX5;VAV3;GNG2;SLC7A11;ITGA2;PDGFA;MICAL1;ANO6;PDPN;FYN;CAV1;DOCK11;SERPING1;EHD3;PIK3R1;HPS4;FBLN1;PRKACB;DGKQ;PRCP;PRKCA;ANXA2;ZFPM1;VAV2;ITPR2;SH2B3;ABAT;DOCK1
13249,GO:0051965,0.000311592700134471,0.999932677574521,12,33,positive regulation of synapse assembly,BP,FLRT2;SLITRK6;FLRT3;THBS2;AMIGO2;TPBG;DLG5;LRRN3;AGRN;EFNA5;SLITRK5;OXTR
11406,GO:0045843,0.000318128372795958,0.999935445712928,11,32,negative regulation of striated muscle tissue development,BP,SOX6;TGFBR2;TSC22D3;PAK1;BMP4;JARID2;TP73;FZD7;DKK1;G6PD;LEF1
11410,GO:0045859,0.000326611141194767,0.999794344377334,90,583,regulation of protein kinase activity,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CDKN2B;F2R;TGFBR2;PKD2;DUSP6;HERC5;TNIK;GAS6;PDGFC;MAGED1;EGFR;FLRT3;CSPG4;MAP3K6;PAK1;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;DLG4;PILRB;PDGFA;ADARB1;KITLG;CAV1;SLC27A1;ERCC6;TRIB2;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;ANG;DUSP5;SPRY2;TTN;TP73;PRKACB;ROBO1;SPRY4;TLR3;SNCA;FGFR1;IGF1R;DKK1;RGS2;C5;IL18;FZD8;AFAP1L2;FAM20A;AKAP13;DGKQ;NR2F2;MAP3K1;PTPN1;VANGL2;NRK;EGR1;RGS14;PAK6;NAB2;MAP3K12;PRNP;TGFB2;MAP2K5;MAPK8IP3;CDKN2A;TSPYL2;HSPA5;UVRAG;MDFIC;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CDK5RAP3;CAMK2N1;TAOK3
9047,GO:0035296,0.000326774282628354,0.999900485629425,17,65,regulation of tube diameter,BP,F2R;GJA5;NOS1;EGFR;SLC8A1;DOCK5;DOCK4;GPX1;CPS1;CAV1;PLA2G6;ITGA1;BBS2;RGS2;HTR1B;SCPEP1;OXTR
16703,GO:0097746,0.000326774282628354,0.999900485629425,17,65,regulation of blood vessel diameter,BP,F2R;GJA5;NOS1;EGFR;SLC8A1;DOCK5;DOCK4;GPX1;CPS1;CAV1;PLA2G6;ITGA1;BBS2;RGS2;HTR1B;SCPEP1;OXTR
2613,GO:0005925,0.00033099573794946,0.999813052196468,60,357,focal adhesion,CC,ITGB6;FLOT1;FLRT2;ITGB5;ITGA6;TLN2;ASAP3;GSN;TNS4;EGFR;FLRT3;ANXA5;VIM;CSPG4;PLEC;PAK1;TNS1;AHNAK;MRC2;ITGA2;ITGA3;LRP1;FLNC;CAV1;TNS2;EHD3;ITGA1;PXN;PARVA;LMO7;CAT;DLC1;SPRY4;FLOT2;MME;TGM2;TRIOBP;CDH13;CD99L2;FZD1;ENG;CALR;ARF6;ANXA6;SYNE2;ARHGEF2;NFASC;TES;RPL13A;FHL1;MPRIP;HSPA5;TGFB1I1;FLNB;DIXDC1;ARHGAP31;LIMA1;ADAM10;TSPAN4;SNTB1
4762,GO:0010951,0.000338733696421926,0.999860556978265,27,136,negative regulation of endopeptidase activity,BP,SERPINE2;TNFRSF6B;MMP9;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;SORL1;MICAL1;TIMP1;CRIM1;GPX1;IFI6;SERPING1;PRDX5;HERPUD1;APLP2;SNCA;C5;MDM2;CST3;MAP2K5;LEF1;SERPINB5
3510,GO:0007423,0.000339471432050947,0.999812028604391,57,306,sensory organ development,BP,COL8A1;FBN1;MYH15;FAT4;TGFBR2;SLITRK6;EFEMP1;COL5A2;SDK1;FBN2;COL5A1;ROR1;EGFR;VIM;TENM3;CXCL14;PTPRM;BMP4;KRT13;SLC7A11;SMOC1;GLI3;GLI2;NPHP4;SPRY2;IFT140;LRIG3;FGFR1;MYO3B;TRIOBP;LRTOMT;NAGLU;BBS4;CST3;MEIS2;MAF;VANGL2;SOX9;IFT27;SALL2;HOXA1;TSHZ1;WDR19;RET;TGFB2;DLX2;SMG9;IFT122;LEF1;TH;RARA;COL4A1;FZD4;NIPBL;CELSR1;RXRA;LAMB2
19943,GO:2000542,0.000339664279548122,1,4,4,negative regulation of gastrulation,BP,COL5A2;COL5A1;FZD7;DKK1
4367,GO:0009991,0.000341003788254228,0.99981110702021,56,337,response to extracellular stimulus,BP,ITGA6;SFRP1;CDKN2B;NQO1;TGFBR2;GSN;SKP2;GAS6;SNAI2;AXL;EGFR;SLC8A1;SESN3;ABCA1;VDR;EIF2AK4;STAT1;TP53;DDIT3;ITGA2;ACSL3;BCKDHB;TBC1D5;MTHFR;SESN1;CTSV;FYN;CPS1;HLCS;ULK2;KANK2;CCK;SLC38A2;ACACB;BBS2;CAT;G6PD;BBS4;MDM2;CST3;DGKQ;GCLC;SSH1;UCN2;BCHE;ULK1;IGFBP2;HSPA5;TH;PPARG;POSTN;RARA;TAF1;PIK3C2B;FOS;KDM4A
17725,GO:1901700,0.000344005172705123,0.999761392270878,143,1016,response to oxygen-containing compound,BP,TNFRSF6B;MMP2;MMP9;TXNIP;CTGF;FBN1;SFRP1;ZFP36L1;NQO1;F2R;DDIT4;TGFBR2;ANO1;GSN;COL5A2;PKD2;IRS2;SDK1;NOS1;GAS6;PDGFC;SNAI2;AXL;EGFR;SLC8A1;SESN3;SERPINE1;FAM210B;PAK1;ABCA1;VDR;NR1D1;PTK6;TRIM5;NEFL;PDCD4;NR3C1;COL18A1;STAT1;LGALS1;GNG2;KCNMA1;TP53;KRT13;PYCARD;ITGA2;MMP19;TIMP1;BTG1;KLF9;GPX1;PTGES;MTHFR;SESN1;CTSV;LRP1;FYN;CPS1;CAV1;SLC27A1;HLCS;ERCC6;PLA2G6;GLDC;CLU;PRKCZ;SLIT3;TP53INP1;PRDX5;KANK2;PER1;PXN;PIK3R1;CPT1A;CAT;DAPK1;PRKACB;CHEK2;SNCA;FZD7;COL16A1;IGF1R;DKK1;SETX;PDE4D;IL18;PDK3;G6PD;NFATC4;TGFBR3;CALR;MDM2;CST3;AREG;DGKQ;GCLC;NR2F2;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;ENPP1;GCNT1;PRKCA;PXMP2;BCHE;RAB13;ABCC2;HTR1B;PRNP;RET;TGFB2;TRIML2;AGRN;IGFBP2;HSPA5;CDK19;TH;ITPR2;YAP1;CACNB1;KLF5;SRR;PPARG;CALCRL;SASH1;POSTN;RARA;COL4A1;ABCA2;TAF1;EFNA5;FZD4;PPP3CA;FOS;ABAT;OXTR;LITAF;MYO1C;RXRA;C2CD5;EDEM1
2612,GO:0005924,0.000347813796525415,0.999803119771908,60,358,cell-substrate adherens junction,CC,ITGB6;FLOT1;FLRT2;ITGB5;ITGA6;TLN2;ASAP3;GSN;TNS4;EGFR;FLRT3;ANXA5;VIM;CSPG4;PLEC;PAK1;TNS1;AHNAK;MRC2;ITGA2;ITGA3;LRP1;FLNC;CAV1;TNS2;EHD3;ITGA1;PXN;PARVA;LMO7;CAT;DLC1;SPRY4;FLOT2;MME;TGM2;TRIOBP;CDH13;CD99L2;FZD1;ENG;CALR;ARF6;ANXA6;SYNE2;ARHGEF2;NFASC;TES;RPL13A;FHL1;MPRIP;HSPA5;TGFB1I1;FLNB;DIXDC1;ARHGAP31;LIMA1;ADAM10;TSPAN4;SNTB1
13768,GO:0060384,0.000355281938875682,0.999955135994579,8,16,innervation,BP,SERPINE2;SLITRK6;SULF2;RNF165;ADARB1;SULF1;ISL1;RET
3501,GO:0007409,0.000359069653520821,0.99979891726585,59,305,axonogenesis,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;DPYSL2;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;NEFL;NEO1;ETV1;PTPRS;SEMA5A;MAP2;ADARB1;GLI3;SPG11;PLXNB1;FYN;GLI2;UST;SLIT3;ULK2;CCK;PIK3R1;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;RAPH1;EFNB3;PLXNA1;TRAK1;VANGL2;NTNG1;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;KLF7;ECM2;EFNA5;SLITRK5;LAMB2
6927,GO:0030545,0.000363625896683916,0.999835730332889,32,185,receptor regulator activity,MF,FLRT2;CTGF;FBN1;EFEMP1;GAS6;PDGFC;FLRT3;CXCL14;BMP4;IL32;PDGFA;TIMP1;GPNMB;KITLG;CCK;DKK1;CTF1;SEMA4A;C5;IL18;AREG;IFNK;DGKQ;IFNE;THNSL2;UCN2;TGFB2;SEMA4B;GDNF;LGALS3;EFNA5;ADM2
10481,GO:0043405,0.000364308831178713,0.999809546408036,47,260,regulation of MAP kinase activity,BP,SFRP1;GADD45B;F2R;DUSP6;TNIK;PDGFC;MAGED1;EGFR;CSPG4;MAP3K6;PAK1;BMP4;PDCD4;SORL1;PDGFA;KITLG;CAV1;ERCC6;TRIB2;MAP3K14;ITGA1;MST1R;DUSP5;SPRY2;TP73;ROBO1;SPRY4;FGFR1;IGF1R;DKK1;RGS2;C5;FZD8;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;RGS14;MAP3K12;MAP2K5;MAPK8IP3;MDFIC;SASH1;FZD4;CDK5RAP3;TAOK3
4859,GO:0014706,0.000373127736627607,0.999810693537206,44,215,striated muscle tissue development,BP,FLOT1;SOX6;MYH15;TGFBR2;TENM4;GJA5;JPH2;TSC22D3;SLC8A1;NUPR1;PAK1;BMP4;MEF2D;SIK1;GPX1;CAV1;TTN;JARID2;TP73;FZD7;FGFR1;LMNA;DKK1;G6PD;TGFBR3;ENG;CALR;AKAP13;NR2F2;FHOD3;EGR1;ISL1;ZFPM1;TGFB2;LEF1;FLNB;KLF5;MEF2A;OBSL1;RARA;PPP3CA;FOS;MYH11;RXRA
11113,GO:0045178,0.000379542289028445,0.999909952705991,13,36,basal part of cell,CC,ITGA6;PKD2;EGFR;CLCA2;KRT14;ITGA2;PHLDB1;ITGA1;MST1R;ANK3;SHROOM4;PRCP;MYO1C
13068,GO:0051607,0.000385692713159836,0.999828784005228,31,161,defense response to virus,BP,HTRA1;DDIT4;HERC5;TKFC;IFI44L;APOBEC3C;EIF2AK4;TRIM5;STAT1;IFIT2;PYCARD;IFIT1;DDX60;ADARB1;IFIT3;SEC14L1;MAP3K14;OAS2;TMEM173;APOBEC3G;TLR3;APOBEC3F;IFNK;IFNE;LYST;IFITM2;STAT2;RSAD2;IFITM1;DNAJC3;GBP3
20243,GO:2001236,0.000386077117623536,0.999846553043508,25,118,regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;SFRP1;SNAI2;SERPINE1;BMP4;ITM2C;PYCARD;GPX1;SRPX;FYN;IFI6;CAV1;UNC5B;DAPK1;FGFR1;LMNA;TRAF1;GCLC;ARHGEF2;RET;MAP2K5;SP100;YAP1;GDNF;LGALS3
11264,GO:0045598,0.000398642075385746,0.999861906652619,20,81,regulation of fat cell differentiation,BP,SULT1E1;SFRP1;ZFP36L1;ZFP36L2;SNAI2;NR1D1;WWTR1;DDIT3;CCDC85B;ADIRF;TRIB2;WDFY2;DLK2;ENPP1;TAF8;ZFPM1;ZADH2;TGFB1I1;KLF5;PPARG
9771,GO:0040007,0.000401853765152691,0.999737776870944,103,650,growth,BP,SERPINE2;HTRA1;FN1;CTGF;SFRP1;ZFP36L1;APBB2;TGFBR2;SLITRK6;TENM4;GSN;DUSP6;GAS6;DPYSL2;EGFR;FLRT3;EVC;PAK1;BMP4;SMARCA2;PTK6;EIF2AK4;TP53;PTPRS;WWTR1;SEMA5A;ADARB1;CCDC85B;CRIM1;BTG1;GPX1;GLI3;SPG11;PLXNB1;LTBP4;GLI2;ERCC6;DCBLD2;PRKCZ;SLIT3;ULK2;TNS2;HMGA2;CAMK2D;SYT1;CAPRIN2;ACACB;BBS2;WFS1;SPRY2;JARID2;TMEM8B;TP73;ST6GAL2;FZD7;PLXNA2;FGFR1;ALOX15B;SEMA4A;PDE4D;G6PD;RAPH1;TGFBR3;BBS4;ATM;AREG;PLXNA1;ZMAT3;VANGL2;NRK;SOX9;ENPP1;BCL6;PLAG1;ETNK2;LEPR;IGFBP4;MEGF8;TAF8;TGFB2;MAP2K5;LEF1;FHL1;CDKN2A;ULK1;TSPYL2;AGRN;IGFBP2;MAGI2;KIAA1109;SEMA4B;YAP1;PPARG;ING4;POSTN;RARA;EFNA5;DNPH1;MED12;NIPBL;ADAM10;RXRA;LAMB2
4466,GO:0010466,0.000404335361586346,0.99983134879265,27,138,negative regulation of peptidase activity,BP,SERPINE2;TNFRSF6B;MMP9;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;SORL1;MICAL1;TIMP1;CRIM1;GPX1;IFI6;SERPING1;PRDX5;HERPUD1;APLP2;SNCA;C5;MDM2;CST3;MAP2K5;LEF1;SERPINB5
11319,GO:0045666,0.000420207764548554,0.999781534984904,46,233,positive regulation of neuron differentiation,BP,FN1;ETV5;TIMP2;TENM3;PAK1;BMP4;PTK6;NEFL;DLG4;SEMA5A;CUL7;ITGA3;DLG5;CNTN1;PLXNB1;FYN;GLI2;SYT1;CAPRIN2;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SETX;KDM4C;FZD1;NEGR1;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;BCL6;CRTC1;TCF12;MEGF8;RET;DLX2;MAGI2;HSPA5;OBSL1;RARA;EFNA5;FZD4;KDM4A
566,GO:0001708,0.000420859922271348,0.999905048962006,12,34,cell fate specification,BP,SOX6;TENM4;DUSP6;GLI3;GLI2;PPDPF;FZD7;FGFR1;DKK1;LMO4;SOX9;ISL1
12249,GO:0048568,0.000424934526342693,0.999771938140502,50,268,embryonic organ development,BP,FBN1;ZFP36L1;TGFBR2;SLITRK6;EFEMP1;GJA5;PKD2;FBN2;EGFR;BMP4;PDGFA;GLI3;E2F7;KITLG;GLI2;MDFI;SPRY2;IFT140;LRIG3;FGFR1;MYO3B;TRIOBP;NAGLU;PBX1;ENG;BBS4;CITED2;NR2F2;FBXW8;VANGL2;NRK;SOX9;HOXA1;TSHZ1;MEGF8;WDR19;ZFPM1;TGFB2;DLX2;IFT122;LEF1;NPHP3;TH;SH2B3;YAP1;HOXA3;RARA;MED12;NIPBL;CELSR1
18675,GO:1904062,0.000429788346902188,0.999803824567302,33,158,regulation of cation transmembrane transport,BP,MMP9;F2R;PKD2;JPH2;NOS1;UTRN;HSPA2;SLC8A1;GJC2;NTSR1;AHNAK;NETO1;DLG4;ANO6;KCNAB2;FYN;CAV1;PLA2G6;EHD3;CAMK2D;ANK3;DAPK1;STOM;SNCA;PDE4D;G6PD;PRNP;FHL1;CACNB1;KCNIP3;SHISA9;PTPN3;KCNRG
10105,GO:0042659,0.000434350005120134,0.999980694228949,5,7,regulation of cell fate specification,BP,DUSP6;FZD7;FGFR1;DKK1;LMO4
12274,GO:0048635,0.000435085573435011,0.999907507256711,11,33,negative regulation of muscle organ development,BP,SOX6;TGFBR2;TSC22D3;PAK1;BMP4;JARID2;TP73;FZD7;DKK1;G6PD;LEF1
15107,GO:0071229,0.000436691947988987,0.999812161893775,29,134,cellular response to acid chemical,BP,MMP2;SFRP1;COL5A2;PKD2;PDGFC;EGFR;SESN3;ABCA1;PTK6;GNG2;KRT13;SESN1;FYN;CPS1;CPT1A;FZD7;COL16A1;SETX;PDK3;NFATC4;GCLC;EGR1;SOX9;RET;YAP1;PPARG;RARA;COL4A1;FZD4
10396,GO:0043256,0.000445442464913446,0.999975367235996,6,8,laminin complex,CC,LAMB1;LAMC2;LAMA3;LAMA5;LAMB3;LAMB2
12336,GO:0048738,0.00044621733944654,0.999806471237184,30,126,cardiac muscle tissue development,BP,SOX6;TGFBR2;TENM4;GJA5;JPH2;SLC8A1;PAK1;BMP4;SIK1;TTN;JARID2;TP73;FZD7;FGFR1;LMNA;DKK1;G6PD;TGFBR3;ENG;CALR;AKAP13;FHOD3;ISL1;ZFPM1;TGFB2;MEF2A;OBSL1;RARA;MYH11;RXRA
7665,GO:0032105,0.000449279307897094,0.999975466385549,5,8,negative regulation of response to extracellular stimulus,BP,SNAI2;KANK2;CCK;BBS2;BBS4
7668,GO:0032108,0.000449279307897094,0.999975466385549,5,8,negative regulation of response to nutrient levels,BP,SNAI2;KANK2;CCK;BBS2;BBS4
4561,GO:0010647,0.00045327959018432,0.999677966584888,158,1143,positive regulation of cell communication,BP,SERPINE2;FLOT1;MMP9;CCBE1;CTGF;SFRP1;GADD45B;CDKN2B;F2R;ANO1;GSN;GJA5;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;PDGFC;MAGED1;SULF2;ROR1;AXL;EGFR;SLC20A1;DOK1;RNF165;CSPG4;EVC;MAP3K6;NTSR1;TIMP2;PAK1;NSG1;CHN2;BMP4;TRIM38;ITM2C;PTK6;EIF2AK4;NETO1;TRIM5;VAV3;PDCD4;NEO1;LGALS1;TP53;ARAP1;DDIT3;PYCARD;WNK1;DDX60;DLG4;SEMA5A;ITGA2;PDGFA;HIP1;GPNMB;TFDP2;GPX1;DLG5;KITLG;SRPX;PLXNB1;FYN;XDH;CAV1;ERCC6;PLA2G6;MAP3K14;PRKCZ;TP53INP1;ITGA1;MST1R;IL31RA;PIK3R1;SYT1;CAPRIN2;DUSP5;UNC5B;ANK3;SPRY2;TP73;CAT;ROBO1;TLR3;SNCA;FZD7;FGFR1;PAG1;IGF1R;ALOX15B;DKK1;CTF1;C5;TGM2;PSMB9;IL18;SULF1;PLA2R1;EPHB6;EDA2R;FZD8;SLC24A1;AFAP1L2;CDH13;NFATC4;LMCD1;TGFBR3;ENG;CALR;ATM;AKAP13;CITED2;MAP3K1;PTPN1;POGLUT1;VANGL2;NRK;SSH1;SOX9;ISL1;ITPKB;CRTC1;PRKCA;RGS14;MPP7;IGFBP4;MAP3K12;TSPAN5;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;TGFB1I1;RSAD2;MDFIC;SH2B3;YAP1;DIXDC1;MEIS3;AGPAT1;SASH1;TAF1;TSHZ3;FZD4;CREBRF;CDK5RAP3;ABAT;OXTR;LITAF;MYO1C;TAOK3
11370,GO:0045776,0.000461513714199263,0.999921482797573,9,24,negative regulation of blood pressure,BP,GJA5;NOS1;NTSR1;BBS4;RNPEP;PRCP;SCPEP1;ABAT;ADM2
12583,GO:0050790,0.000462079866308158,0.999657090758781,213,1608,regulation of catalytic activity,BP,SERPINE2;PHACTR3;TNFRSF6B;FN1;FLRT2;MMP9;GPRC5A;TXNIP;CTGF;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;NQO1;F2R;TGFBR2;ASAP3;GSN;PKD2;IRS2;DUSP6;HERC5;TNIK;PROM2;COL7A1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;MAGED1;ARHGAP23;TFPI2;ROR1;AXL;DOCK9;EGFR;HSPA2;FLRT3;SERPINE1;SERPINH1;S100A10;ANXA5;CSPG4;ALS2CL;MAP3K6;STMN3;ASAP2;TIMP2;PAK1;ANGPTL4;VDR;CHN2;SRGAP3;BMP4;PTK6;TBC1D8;RIN2;VAV3;PDCD4;SORL1;TP53;ARAP1;WWTR1;PYCARD;IFIT1;WNK1;ARHGEF1;DLG4;ITGA2;PILRB;PDGFA;MICAL1;ADARB1;TIMP1;HIP1;DOCK4;CRIM1;EVI5L;ELFN2;GPX1;KITLG;TBC1D5;ASAP1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;B3GAT3;ARHGAP18;CAV1;SLC27A1;ERCC6;TRIB2;DOCK11;MAP3K14;CLU;SERPING1;PRKCZ;OAS2;PARP4;CAMK2D;PRDX5;ITGA1;MST1R;CCK;PIK3R1;ACACB;ANG;DUSP5;HERPUD1;SPRY2;TTN;APLP2;FBLN1;TP73;DAPK1;DLC1;PRKACB;ROBO1;SPRY4;TLR3;SNCA;AIP;PLXNA2;FGFR1;IGF1R;DKK1;RGS2;C5;PSMB9;IL18;PLA2R1;EPHB6;FZD8;AFAP1L2;BBS4;SRGAP1;APH1B;MDM2;FAM20A;CST3;TBC1D19;AKAP13;DGKQ;NR2F2;PLXNA1;LMO4;MAP3K1;FGD4;PTPN1;VANGL2;DNAL4;NRK;EGR1;BCL6;ANXA2;RGS14;LEPR;DEPDC7;HMBOX1;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;RBL2;MAP2K5;LEF1;CDC42EP5;MAPK8IP3;CDKN2A;TSPYL2;AGRN;VAV2;MAGI2;AGAP1;HSPA5;GOPC;UVRAG;ARHGEF19;ARHGAP29;MDFIC;OPHN1;LMF1;MYO9A;GDNF;RALGAPB;PPARG;SNX9;SASH1;TBC1D16;ZYG11B;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;SBF2;RASA1;ARHGAP31;CDK5RAP3;SERPINB5;CAMK2N1;PPP2R3A;TAOK3;DOCK1;DMPK;PINLYP
17224,GO:0120035,0.000469894981687996,0.999715199701024,74,429,regulation of plasma membrane bounded cell projection organization,BP,FN1;SFRP1;SDK1;TNIK;DPYSL2;CSMD3;VIM;TENM3;PAK1;ITM2C;PTK6;NEFL;LGALS1;ARAP1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;ITGA3;EVI5L;DLG5;CNTN1;ASAP1;PDPN;PLXNB1;LRP1;FYN;CAV1;DOCK11;ESPN;UST;ULK2;ARPIN;SYT1;CAPRIN2;METRN;ROBO1;IFT140;PLXNA2;FGFR1;FSCN1;SEMA4A;SETX;NFATC4;FZD1;BBS4;NEGR1;EFNB3;MDM2;ARF6;PLXNA1;TRAK1;FBXW8;SYNE2;SDC2;SSH1;CRTC1;IFT88;PODXL;MEGF8;PRNP;RET;CDC42EP5;AGRN;MAGI2;HSPA5;SEMA4B;KLF5;OBSL1;EFNA5;FZD4;PPP3CA;SEPT9
14572,GO:0070161,0.000473407424170879,0.999710451058837,76,465,anchoring junction,CC,ITGB6;FLOT1;FLRT2;ITGB5;ITGA6;TLN2;ASAP3;GSN;TNS4;EGFR;TMEM204;FLRT3;ANXA5;VIM;CSPG4;PLEC;PAK1;PTPRM;TNS1;AHNAK;MRC2;ITGA2;FRMD4B;PPL;ITGA3;DLG5;LRP1;FLNC;FAT2;CAV1;TNS2;EHD3;ITGA1;PXN;PARVA;LMO7;CAT;SHROOM4;DLC1;SPRY4;FLOT2;MME;FRMD5;TGM2;TRIOBP;CDH13;CD99L2;FZD1;ENG;CALR;ARF6;ANXA6;SYNE2;ARHGEF2;NFASC;NDRG1;ANXA2;MPP7;TES;RPL13A;CDH11;FHL1;MPRIP;HSPA5;MAGI1;TGFB1I1;FLNB;DIXDC1;EFNA5;ARHGAP31;LIMA1;OXTR;ADAM10;TSPAN4;S100A11;SNTB1
17764,GO:1901862,0.000486072877407094,0.999895223333359,11,33,negative regulation of muscle tissue development,BP,SOX6;TGFBR2;TSC22D3;PAK1;BMP4;JARID2;TP73;FZD7;DKK1;G6PD;LEF1
2397,GO:0005544,0.000491421517961149,0.999893924665983,11,33,calcium-dependent phospholipid binding,MF,SYT8;ANXA5;SYTL1;SYT1;PCLO;DYSF;ESYT2;ANXA6;ANXA2;C2CD4C;C2CD5
5259,GO:0015909,0.000493120953607841,0.999884332932421,12,37,long-chain fatty acid transport,BP,IRS2;NTSR1;ACSL3;SLC27A1;PLA2G6;CPT1A;ACACB;PRKAB2;PLA2R1;SLC27A6;PPARG;CPT2
16604,GO:0097493,0.000493710719502294,1,6,6,structural molecule activity conferring elasticity,MF,FBN1;FBN2;AHNAK;TTN;OBSL1;COL4A1
7743,GO:0032270,0.000498792388493681,0.999648329533227,148,1080,positive regulation of cellular protein metabolic process,BP,FLOT1;FN1;MMP9;CCBE1;CTGF;GADD45B;F2R;TGFBR2;GSN;PKD2;DUSP6;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;TP53;PRICKLE1;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;RBMS3;HIP1;GPNMB;CNTN1;KITLG;LRP1;FYN;XDH;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;CLU;PRKCZ;SDR16C5;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;HERPUD1;WFS1;SPRY2;CIRBP;JARID2;FBLN1;TP73;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;MAGEF1;FZD1;ENG;ATM;MDM2;FAM20A;AREG;IFNK;AKAP13;DGKQ;GCLC;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;EGR1;SOX9;ISL1;BCL6;NCOR1;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;RHBDD1;MAGI2;HSPA5;MDFIC;NUB1;PPARG;RNF144B;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PPP3CA;CDK5RAP3;NIPBL;RXRA;EDEM1;TAOK3
14487,GO:0065009,0.000499952878642165,0.999615430915212,287,2240,regulation of molecular function,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;FN1;FLRT2;MMP9;GPRC5A;TXNIP;CTGF;FBN1;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;NQO1;F2R;TGFBR2;EFEMP1;ASAP3;GSN;PKD2;JPH2;IRS2;DUSP6;HERC5;TNIK;PROM2;COL7A1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;MAGED1;TCAF1;UTRN;ARHGAP23;TFPI2;ROR1;AXL;DOCK9;EGFR;HSPA2;FLRT3;SPTB;DOCK5;SERPINE1;SERPINH1;S100A10;ANXA5;CSPG4;ALS2CL;MAP3K6;STMN3;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ANGPTL4;VDR;CHN2;SRGAP3;BMP4;TRIM38;PTK6;AHNAK;TBC1D8;RIN2;EIF2AK4;NETO1;TRIM5;NEFL;VAV3;PDCD4;SORL1;IFIT2;TP53;ARAP1;WWTR1;DDIT3;PYCARD;IL32;IFIT1;WNK1;PLEKHG3;ARHGEF1;DLG4;ITGA2;PILRB;PDGFA;MICAL1;ADARB1;TIMP1;HIP1;GPNMB;DOCK4;CRIM1;SIK1;EVI5L;ELFN2;GPX1;KITLG;TBC1D5;ASAP1;ZFP90;SEC14L1;PLXNB1;KCNAB2;LRP1;FYN;ARHGEF12;IFI6;XDH;B3GAT3;ARHGAP18;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;TRIB2;DOCK11;MAP3K14;CLU;SERPING1;PRKCZ;OAS2;PARP4;IQSEC2;EHD3;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;CCK;PIK3R1;TMEM173;CAPRIN2;ACACB;ANG;DUSP5;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;APLP2;HPS4;FBLN1;TP73;CAT;DAPK1;DLC1;PRKACB;ROBO1;SPRY4;STOM;TLR3;SNCA;AIP;PLXNA2;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;PSMB9;IL18;OBSCN;PLA2R1;EPHB6;EDA2R;FZD8;ARHGEF17;AFAP1L2;NFATC4;TRAF1;TGFBR3;FZD1;BBS4;SRGAP1;APH1B;MDM2;FAM20A;CST3;TBC1D19;AREG;IFNK;AKAP13;DGKQ;NR2F2;PLXNA1;IFNE;LMO4;MAP3K1;FGD4;PTPN1;VANGL2;ARHGEF2;DNAL4;THNSL2;NRK;EGR1;UCN2;ISL1;BCL6;CRTC1;ANXA2;RGS14;LEPR;DEPDC7;KCTD7;HMBOX1;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;ZFPM1;TGFB2;RBL2;MAP2K5;LEF1;THRA;FHL1;CDC42EP5;MAPK8IP3;CDKN2A;SP100;TSPYL2;AGRN;VAV2;MAGI2;AGAP1;HSPA5;GOPC;UVRAG;ARHGEF19;ARHGAP29;MDFIC;OPHN1;LMF1;MYO9A;CACNB1;GDNF;RALGAPB;PPARG;KCNIP3;SNX9;SHISA9;SASH1;TBC1D16;ZYG11B;PTPN3;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PPP3CA;SBF2;RASA1;ARHGAP31;FOS;CDK5RAP3;SERPINB5;CAMK2N1;NIPBL;TTBK2;ADM2;KCNRG;PPP2R3A;TAOK3;NFKBIE;DOCK1;DMPK;PINLYP
12566,GO:0050769,0.000500987898033266,0.999720605176516,55,297,positive regulation of neurogenesis,BP,SERPINE2;FN1;TENM4;ETV5;GJC2;TIMP2;TENM3;PAK1;BMP4;PTK6;NEFL;DLG4;SEMA5A;CUL7;ITGA3;GLI3;DLG5;CNTN1;PLXNB1;FYN;GLI2;SYT1;CAPRIN2;TP73;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SETX;KDM4C;FZD1;NEGR1;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;BCL6;CRTC1;PLAG1;RGS14;TCF12;MEGF8;RET;DLX2;MAGI2;HSPA5;PPARG;OBSL1;RARA;EFNA5;FZD4;KDM4A;NIPBL
13236,GO:0051952,0.000502612683866872,0.999912352832606,9,25,regulation of amine transport,BP,NTSR1;CCK;SYT1;SNCA;HTR1B;GDNF;SV2A;ABAT;OXTR
12593,GO:0050804,0.000504703411037454,0.999757794712539,36,184,modulation of chemical synaptic transmission,BP,SERPINE2;FLOT1;F2R;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;NISCH;SYN1;PLA2G6;PRKCZ;SYT1;BACE1;SNCA;DKK1;SLC24A1;NFATC4;SSH1;CRTC1;BCHE;RGS14;SEPT5;NLGN4Y;HTR1B;PRNP;OPHN1;GDNF;SHISA9;RARA;TSHZ3;PPP3CA;ABAT;OXTR;DMPK
16994,GO:0099177,0.000504703411037454,0.999757794712539,36,184,regulation of trans-synaptic signaling,BP,SERPINE2;FLOT1;F2R;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;NISCH;SYN1;PLA2G6;PRKCZ;SYT1;BACE1;SNCA;DKK1;SLC24A1;NFATC4;SSH1;CRTC1;BCHE;RGS14;SEPT5;NLGN4Y;HTR1B;PRNP;OPHN1;GDNF;SHISA9;RARA;TSHZ3;PPP3CA;ABAT;OXTR;DMPK
597,GO:0001765,0.00050620246943062,0.999968040940248,5,9,membrane raft assembly,BP,FLOT1;S100A10;CAV1;FLOT2;ANXA2
11084,GO:0045121,0.000519195516479831,0.999742354874817,39,203,membrane raft,CC,FLOT1;INPP5D;MARVELD1;F2R;TGFBR2;PROM2;NOS1;MALL;EGFR;SERPINH1;S100A10;NTSR1;ABCA1;AHNAK;KCNMA1;CNTN1;PLLP;PDPN;FYN;CAV1;PRKCZ;ITGA1;UNC5B;DLC1;BACE1;STOM;FLOT2;PAG1;SULF1;MYOF;CDH13;ANXA2;PODXL;PRNP;RET;PIKFYVE;EFNA5;MYO1C;CTSD
10627,GO:0043679,0.000533632805373293,0.999829601587765,17,66,axon terminus,CC,ROR1;FLRT3;NTSR1;ITGA2;MICAL1;SYN1;KCNAB2;CCK;SYT1;SNCA;VAMP1;SEPT6;SEPT5;TH;OPHN1;KCNIP3;SV2A
11119,GO:0045185,0.000536765287552347,0.99979884007825,22,89,maintenance of protein location,BP,FBN1;SYNE1;TLN2;GSN;PKD2;FBN2;SYNE3;SORL1;LTBP1;CAV1;ANK3;MDFI;BBS4;SYNE2;TAF8;THRA;SP100;HSPA5;GOPC;FLNB;VPS13C;NFKBIE
2098,GO:0004866,0.000554822124399546,0.99981282185018,18,79,endopeptidase inhibitor activity,MF,SERPINE2;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;TIMP1;CRIM1;SERPING1;PRDX5;APLP2;SNCA;C5;CST3;LEF1;SERPINB5
6878,GO:0030414,0.000554822124399546,0.99981282185018,18,79,peptidase inhibitor activity,MF,SERPINE2;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;TIMP1;CRIM1;SERPING1;PRDX5;APLP2;SNCA;C5;CST3;LEF1;SERPINB5
16873,GO:0098857,0.000578692941242868,0.999711006233311,39,204,membrane microdomain,CC,FLOT1;INPP5D;MARVELD1;F2R;TGFBR2;PROM2;NOS1;MALL;EGFR;SERPINH1;S100A10;NTSR1;ABCA1;AHNAK;KCNMA1;CNTN1;PLLP;PDPN;FYN;CAV1;PRKCZ;ITGA1;UNC5B;DLC1;BACE1;STOM;FLOT2;PAG1;SULF1;MYOF;CDH13;ANXA2;PODXL;PRNP;RET;PIKFYVE;EFNA5;MYO1C;CTSD
12286,GO:0048660,0.000582094112066358,0.999790711364006,20,85,regulation of smooth muscle cell proliferation,BP,MMP2;MMP9;TGFBR2;SKP2;EGFR;PAK1;BMP4;PDCD4;STAT1;TP53;MEF2D;ITGA2;ANG;TGM2;IL18;CDH13;MDM2;HTR1B;PPARG;CALCRL
4463,GO:0010463,0.000582246388297447,0.999886999835539,10,26,mesenchymal cell proliferation,BP,FAT4;TGFBR2;IRS2;BMP4;STAT1;PDGFA;FBXW4;FGFR1;LMNA;SOX9
15604,GO:0072132,0.000588569643024998,0.999885604266255,10,26,mesenchyme morphogenesis,BP,TGFBR2;SNAI2;ACTA2;FGFR1;ENG;MDM2;SOX9;ISL1;TGFB2;LEF1
12458,GO:0050433,0.000597493424594506,0.999943651073367,6,12,regulation of catecholamine secretion,BP,SYT1;SNCA;HTR1B;GDNF;ABAT;OXTR
400,GO:0001077,0.000598501754329767,0.999717112437298,34,168,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR3C1;ETV1;DDIT3;MEF2D;GLI3;GLI2;HMGA2;CREB3L2;TP73;KLF13;DLX3;PBX1;MEIS2;TCF4;EGR1;SOX9;ISL1;STK16;PLAG1;MYBL1;HLTF;TCF12;NFAT5;CARF;LEF1;SSBP3;TEF;KLF5;MEIS3;MEF2A;KLF7;ETV4;FOS;LITAF
11314,GO:0045661,0.000600130491849791,0.999879341616487,10,29,regulation of myoblast differentiation,BP,ZFP36L1;CXCL14;BMP4;PRICKLE1;DDIT3;BTG1;FLOT2;IL18;SOX9;BOC
7838,GO:0032409,0.000600193915513438,0.999732246503621,30,139,regulation of transporter activity,BP,MMP9;PKD2;JPH2;NOS1;TCAF1;UTRN;HSPA2;NTSR1;AHNAK;NETO1;WNK1;DLG4;CAV1;PLA2G6;EHD3;CAMK2D;ANK3;DAPK1;STOM;SNCA;PDE4D;KCTD7;PRNP;FHL1;GOPC;CACNB1;PPARG;SHISA9;PTPN3;KCNRG
3528,GO:0007517,0.000608245919813365,0.999680386360615,45,225,muscle organ development,BP,FLOT1;SOX6;MYH15;TGFBR2;JPH2;UTRN;TSC22D3;SPEG;MYLK;NUPR1;EVC;PAK1;BMP4;ETV1;MEF2D;ADARB1;GPX1;CAV1;LAMA5;TTN;JARID2;TP73;FZD7;FGFR1;DKK1;CTF1;G6PD;TGFBR3;FZD1;ENG;NR2F2;VANGL2;EGR1;ISL1;TCF12;ZFPM1;TGFB2;LEF1;FHL1;FLNB;KLF5;MEF2A;PPP3CA;FOS;RXRA
4592,GO:0010712,0.000613190315700524,0.999903349325571,8,22,regulation of collagen metabolic process,BP,CTGF;F2R;VIM;BMP4;ITGA2;ENG;CST3;PPARG
12597,GO:0050808,0.000625749938233682,0.999691304616401,38,179,synapse organization,BP,FLRT2;F2R;SLITRK6;ETV5;SDK1;UTRN;FLRT3;THBS2;AMIGO2;DLG4;ITGA3;TPBG;DLG5;FYN;CAPRIN2;PCLO;ANK3;SNCA;IGF1R;DKK1;NFATC4;FZD1;SSH1;NFASC;NLGN4Y;PRNP;LRRN3;AGRN;MAGI2;CACNB1;GDNF;COL4A1;EFNA5;SLITRK5;BSN;OXTR;DMPK;LAMB2
13098,GO:0051668,0.000645435174607278,0.999766214129372,20,84,localization within membrane,BP,MARVELD1;GSN;ETV5;MALL;NSG1;NETO1;DLG4;HIP1;PLLP;KIF17;SEC24D;CDH13;SSH1;WDR19;IFT122;AGRN;MAGI2;REEP2;MIA3;DNM1P46
3270,GO:0006950,0.00064563547212099,0.999495169666539,321,2648,response to stress,BP,SERPINE2;ITGB6;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;MMP9;PRODH;TXNIP;CTGF;SFRP1;GADD45B;CD109;ZFP36L1;NQO1;F2R;DDIT4;TGFBR2;XPC;PTGS1;ITGB4;IL20RB;ANO1;GSN;ETV5;PKD2;SCARA3;DUSP6;ZFP36L2;HERC5;TNIK;NOS1;DNAJB4;GAS6;PDGFC;SNAI2;SULF2;COL5A1;PHF21A;TFPI2;AXL;DOCK9;EGFR;TSC22D3;ITPK1;HSPA2;FLRT3;SLC8A1;SESN3;MYLK;SERPINE1;SERPINH1;ANXA5;VIM;NUPR1;DDB2;PSTPIP1;TKFC;IFI44L;MAP3K6;PAK1;ABCA1;ANGPTL4;CBX5;APOBEC3C;TRIM38;NR1D1;PTK6;ABTB1;XAF1;EIF2AK4;TRIM5;NEFL;VAV3;PDCD4;COL18A1;STAT1;BTBD2;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;TP53;EXTL2;PTPRS;DDIT3;PYCARD;IL32;IFIT1;DDX60;MUC19;SLC7A11;ITGA2;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;TFDP2;CUL7;BTG1;IFIT3;ANO6;GPX1;GLI3;PTGES;E2F7;TBC1D5;PLLP;PDPN;MTHFR;SRPX;SESN1;CTSV;SEC14L1;FYN;IFI6;XDH;FUT10;CPS1;CAV1;SLC27A1;RMI2;RNF135;ERCC6;PLA2G6;SEL1L;DOCK11;MAP3K14;CLU;DCBLD2;SERPING1;PRKCZ;OAS2;ULK2;TP53INP1;PARP4;EHD3;HMGA2;CAMK2D;PRDX5;MST1R;IL31RA;ULBP1;PER1;PXN;PDIA4;CCK;PIK3R1;TMEM173;CREB3L2;SLC38A2;APOBEC3G;ANG;DYSF;HERPUD1;WFS1;CIRBP;HPS4;FBLN1;MLH3;TP73;CAT;CASP14;DAPK1;PRKACB;CHEK2;TLR3;SNCA;PDIA6;FZD7;IGF1R;APOBEC3F;LMNA;IFI35;DKK1;C5;SETX;TMEM129;TGM2;PSMB9;IL18;SPATA18;PLA2R1;PDK3;G6PD;MYOF;IL17RE;EDA2R;FZD8;AFAP1L2;CHD6;NFATC4;MAGEF1;FOXN3;TGFBR3;FZD1;CALR;ATM;MDM2;CST3;AREG;IFNK;DGKQ;CITED2;GCLC;IFNE;DNAJC4;ZMAT3;MSH5;CD1D;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;LYST;EGR1;UCN2;ISL1;BCL6;PRCP;NCOR1;NDRG1;PRKCA;PXMP2;ANXA2;RGS14;PRIMPOL;CXORF57;IGFBP4;IFITM2;RPL13A;PAK6;ABCC2;MAP3K12;RAB43;MUTYH;PRNP;RET;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;STAT2;LIG1;LIPA;THRA;CDC42EP5;USP28;MAPK8IP3;MSRB2;CDKN2A;HERPUD2;SP100;ULK1;TSPYL2;VAV2;RHBDD1;HSPA5;CDK19;TH;TGFB1I1;RSAD2;FLNB;SRPK2;UVRAG;NAPRT;ARHGEF19;ITPR2;MDFIC;VPS13C;POLD4;IFITM1;SH2B3;YAP1;HSP90AB4P;NUB1;GPX8;UBA7;DERL3;PPARG;CALCRL;TPST1;SASH1;ING4;POSTN;LGALS3;MIA3;DNAJC3;POLH;TMEM67;TAF1;FZD4;ZBTB1;PPP3CA;PIK3C2B;CREBRF;CTDSP2;HP1BP3;FOS;KDM4A;CDK5RAP3;FAM168A;NPAS2;ABAT;NIPBL;UGGT2;OXTR;CELSR1;MYO1C;GBP3;EDEM1;ACAA2;TAOK3;DOCK1;LAMB2
81,GO:0000165,0.000654355651102072,0.999577540502548,90,600,MAPK cascade,BP,FN1;CTGF;SFRP1;GADD45B;ZFP36L1;F2R;IRS2;DUSP6;ZFP36L2;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;SPTB;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;TRIM5;NEFL;PDCD4;SORL1;PYCARD;DLG4;PDGFA;GPNMB;KITLG;FYN;XDH;CAV1;ERCC6;TRIB2;MAP3K14;PRKCZ;CAMK2D;ITGA1;MST1R;IL31RA;PER1;DUSP5;SPRY2;FBLN1;TP73;ROBO1;SPRY4;TLR3;FZD7;FGFR1;IGF1R;DKK1;RGS2;C5;SETX;PSMB9;IL18;EPHB6;EDA2R;FZD8;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;SOX9;ITPKB;NCOR1;PRKCA;RGS14;IGFBP4;PAK6;MAP3K12;RET;TGFB2;MAP2K5;CDC42EP5;MAPK8IP3;MDFIC;GDNF;MEF2A;SASH1;FZD4;RASA1;CDK5RAP3;CAMK2N1;OXTR;TAOK3
4464,GO:0010464,0.000654784251545996,0.999884366916126,9,23,regulation of mesenchymal cell proliferation,BP,TGFBR2;IRS2;BMP4;STAT1;PDGFA;FBXW4;FGFR1;LMNA;SOX9
12285,GO:0048659,0.000665341308458689,0.999757753956081,20,86,smooth muscle cell proliferation,BP,MMP2;MMP9;TGFBR2;SKP2;EGFR;PAK1;BMP4;PDCD4;STAT1;TP53;MEF2D;ITGA2;ANG;TGM2;IL18;CDH13;MDM2;HTR1B;PPARG;CALCRL
598,GO:0001766,0.000666388297243525,0.99997595570601,4,6,membrane raft polarization,BP,MARVELD1;GSN;MALL;PLLP
7435,GO:0031580,0.000666388297243525,0.99997595570601,4,6,membrane raft distribution,BP,MARVELD1;GSN;MALL;PLLP
16209,GO:0090288,0.000671301498581196,0.999736882587274,23,96,negative regulation of cellular response to growth factor stimulus,BP,HTRA1;FBN1;SFRP1;CD109;TGFBR2;FBN2;SULF2;PEG10;LTBP1;XDH;CAV1;SPRY2;SPRY4;GLG1;DKK1;SULF1;TGFBR3;FZD1;MTMR4;PTPN1;HSPA5;TGFB1I1;ADGRA2
12283,GO:0048645,0.000677256417649928,0.999844815676633,11,36,animal organ formation,BP,TGFBR2;BMP4;GLI3;GLI2;FGFR1;DKK1;SULF1;CITED2;ISL1;GDNF;HOXA3
10893,GO:0044463,0.000679278811355666,0.999525867239298,134,891,cell projection part,CC,NQO1;APBB2;PTGS1;PKD2;CYBRD1;PROM2;NOS1;MAP6;UTRN;ROR1;FLRT3;CEP126;SLC8A1;GJC2;CSPG4;EVC;STMN3;NTSR1;TIMP2;PAK1;NSG1;NR1D1;SCN8A;NEFL;STAT1;SCN2A;CNTRL;EFHC1;DLG4;ITGA2;MAP2;MICAL1;ITGA3;WDR66;PLEK2;GLI3;DLG5;ASAP1;SYN1;PDPN;SPG11;KCNAB2;LRP1;FYN;GLI2;PIAS3;SPATA6;ESPN;CLU;NPHP4;PRKCZ;EHD3;SYTL1;CCK;SYT1;SLC38A2;ANG;KIF17;BBS2;ANK3;WFS1;SPRY2;DLC1;PRKACB;IFT140;SPRY4;SNCA;MME;VAMP1;DZIP1L;FSCN1;SETX;MYO3B;TRIOBP;SEPT6;BBS4;ARF6;BBS1;TRAK1;LZTS1;SYNE2;KCNQ3;ARHGEF2;SSH1;IFT27;NFASC;CRTC1;RGS14;SEPT5;IFT88;TTC8;PODXL;ABCC2;MAP3K12;HTR1B;SPA17;WDR19;PRNP;RET;ODF2;SCNN1A;IFT122;GPR161;NPHP3;MAGI2;TH;GOPC;BOC;TCTEX1D4;CFAP54;IFT74;OPHN1;TPGS1;DNAH1;KCNIP3;SHISA9;ICK;PRR7;ARL3;RARA;SV2A;TMEM67;TSHZ3;FZD4;PPP3CA;DNM1P46;SEPT9;CAMK2N1;TTBK2;BSN;MPDZ;MYO1C;ORAI2;C2CD5
17226,GO:0120038,0.000679278811355666,0.999525867239298,134,891,plasma membrane bounded cell projection part,CC,NQO1;APBB2;PTGS1;PKD2;CYBRD1;PROM2;NOS1;MAP6;UTRN;ROR1;FLRT3;CEP126;SLC8A1;GJC2;CSPG4;EVC;STMN3;NTSR1;TIMP2;PAK1;NSG1;NR1D1;SCN8A;NEFL;STAT1;SCN2A;CNTRL;EFHC1;DLG4;ITGA2;MAP2;MICAL1;ITGA3;WDR66;PLEK2;GLI3;DLG5;ASAP1;SYN1;PDPN;SPG11;KCNAB2;LRP1;FYN;GLI2;PIAS3;SPATA6;ESPN;CLU;NPHP4;PRKCZ;EHD3;SYTL1;CCK;SYT1;SLC38A2;ANG;KIF17;BBS2;ANK3;WFS1;SPRY2;DLC1;PRKACB;IFT140;SPRY4;SNCA;MME;VAMP1;DZIP1L;FSCN1;SETX;MYO3B;TRIOBP;SEPT6;BBS4;ARF6;BBS1;TRAK1;LZTS1;SYNE2;KCNQ3;ARHGEF2;SSH1;IFT27;NFASC;CRTC1;RGS14;SEPT5;IFT88;TTC8;PODXL;ABCC2;MAP3K12;HTR1B;SPA17;WDR19;PRNP;RET;ODF2;SCNN1A;IFT122;GPR161;NPHP3;MAGI2;TH;GOPC;BOC;TCTEX1D4;CFAP54;IFT74;OPHN1;TPGS1;DNAH1;KCNIP3;SHISA9;ICK;PRR7;ARL3;RARA;SV2A;TMEM67;TSHZ3;FZD4;PPP3CA;DNM1P46;SEPT9;CAMK2N1;TTBK2;BSN;MPDZ;MYO1C;ORAI2;C2CD5
12333,GO:0048732,0.000684555549021684,0.999616332100541,53,295,gland development,BP,SERPINE2;SFRP1;TGFBR2;ETV5;PKD2;IRS2;SNAI2;SULF2;EGFR;VDR;BMP4;ITGA2;PDGFA;GPX1;GLI3;E2F7;XDH;CPS1;CAV1;GLI2;OAS2;PPDPF;LAMA5;JARID2;ROBO1;PHF2;FGFR1;ALOX15B;TGM2;SULF1;TGFBR3;PBX1;ATM;ARF6;CST3;AREG;CITED2;PLXNA1;LMO4;SOX9;ISL1;PLAG1;TGFB2;LEF1;THRA;NPHP3;HOXA3;PTPN3;RARA;ZBTB1;SERPINB5;OXTR;RXRA
3380,GO:0007160,0.000730063314179655,0.999657282967473,33,149,cell-matrix adhesion,BP,ITGB6;FN1;ITGB5;CTGF;ITGA6;SFRP1;ITGB4;NID1;BCAM;UTRN;SERPINE1;S100A10;ITGA2;ITGA3;ITGA10;PRKCZ;ITGA1;PXN;PIK3R1;LAMA5;TMEM8B;DLC1;COL16A1;CDH13;MKLN1;COL5A3;BCL6;CDKN2A;COL17A1;POSTN;ECM2;EFNA5;RASA1
3564,GO:0007610,0.000731864263587479,0.999583759276944,55,311,behavior,BP,SERPINE2;SLITRK6;ETV5;SDK1;EGFR;NTSR1;EIF2AK4;NETO1;ETV1;TP53;DLG4;ADARB1;ITGA3;NAV2;SPG11;FYN;PLA2G6;ESPN;NPHP4;PRKCZ;CCK;CPT1A;BBS2;WFS1;SNCA;DKK1;NCOA2;NAGLU;BBS4;NEGR1;EFNB3;CST3;MEIS2;CRTC1;BCHE;RGS14;HOXA1;LEPR;NLGN4Y;ATXN1;HTR1B;PRNP;THRA;TH;TPGS1;GDNF;FZD4;SLITRK5;ANKH;CREBRF;FOS;ABAT;ADM2;OXTR;CELSR1
1304,GO:0003149,0.000734041063493813,0.999955093561971,5,8,membranous septum morphogenesis,BP,TGFBR2;BMP4;FZD1;VANGL2;TGFB2
7346,GO:0031399,0.000740983036227099,0.999459890409567,172,1257,regulation of protein modification process,BP,PHACTR3;FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;SFRP1;GADD45B;CD109;CDKN2B;F2R;DDIT4;TGFBR2;PKD2;DUSP6;HERC5;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;CRTAP;NUPR1;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;PDCD4;SORL1;TP53;WWTR1;PRICKLE1;PYCARD;WNK1;DLG4;PILRB;PDGFA;MICAL1;ADARB1;GPNMB;ELFN2;CNTN1;KITLG;CTDSPL;MTHFR;FYN;XDH;B3GAT3;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;SDR16C5;CAMK2D;ITGA1;MST1R;IL31RA;PER1;CCK;CAPRIN2;ANG;DUSP5;HERPUD1;WFS1;SPRY2;TTN;JARID2;FBLN1;TP73;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;IL18;G6PD;EPHB6;EDA2R;FZD8;KDM4C;AFAP1L2;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;GCLC;NR2F2;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;STAT2;MAPK8IP3;CDKN2A;TSPYL2;MAGI2;HSPA5;UVRAG;MDFIC;BEX4;SNX9;SASH1;ZYG11B;DNAJC3;CCNY;PRKAG1;TAF1;EFNA5;FZD4;CTDSP2;KDM4A;CDK5RAP3;CAMK2N1;NIPBL;PPP2R3A;TAOK3;DMPK
16731,GO:0098552,0.000747123470518807,0.999599954418808,45,260,side of membrane,CC,SERPINE2;ITGB6;ITGA6;TGFBR2;PKD2;ANPEP;BCAM;SPTB;ANXA5;NTSR1;ABCA1;PTK6;GNG2;DLG4;ITGA2;HIP1;ITGA3;ERMAP;CTSV;KCNAB2;FYN;ITGA1;IL31RA;SHROOM4;BTN3A1;KCNJ5;RGS2;ESYT2;G6PD;CDH13;TGFBR3;ENG;CALR;PTPN1;SPA17;PRNP;SPPL2B;BTN3A3;TH;SNX9;PTPN3;EFNA5;PPP3CA;RASA1;LITAF
11223,GO:0045444,0.000779092103427633,0.999649843824547,29,143,fat cell differentiation,BP,SULT1E1;ITGA6;SFRP1;ZFP36L1;ZFP36L2;SNAI2;NR1D1;WWTR1;DDIT3;CCDC85B;GPX1;ADIRF;TRIB2;HMGA2;BBS2;LAMB3;WDFY2;RGS2;BBS4;DLK2;ENPP1;TAF8;ZFPM1;ZADH2;TGFB1I1;KLF5;PPARG;FAM120B;NIPBL
8198,GO:0032964,0.000779608218186948,0.999853446644202,9,26,collagen biosynthetic process,BP,CTGF;F2R;COL5A1;SERPINH1;VIM;BMP4;ITGA2;ENG;PPARG
10486,GO:0043410,0.000779690162235269,0.99955183952368,56,332,positive regulation of MAPK cascade,BP,CTGF;GADD45B;F2R;DUSP6;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;TRIM5;PYCARD;PDGFA;GPNMB;KITLG;XDH;ERCC6;MAP3K14;PRKCZ;ITGA1;MST1R;DUSP5;SPRY2;TP73;ROBO1;TLR3;FZD7;FGFR1;IGF1R;DKK1;C5;EPHB6;EDA2R;FZD8;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;PRKCA;IGFBP4;MAP3K12;RET;TGFB2;MAP2K5;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
7485,GO:0031667,0.000782996154561224,0.999559215806946,52,315,response to nutrient levels,BP,SFRP1;CDKN2B;NQO1;TGFBR2;GSN;GAS6;SNAI2;EGFR;SLC8A1;SESN3;ABCA1;VDR;EIF2AK4;STAT1;TP53;DDIT3;ITGA2;ACSL3;BCKDHB;TBC1D5;MTHFR;SESN1;CTSV;FYN;CPS1;HLCS;ULK2;KANK2;CCK;SLC38A2;ACACB;BBS2;CAT;G6PD;BBS4;MDM2;CST3;DGKQ;GCLC;SSH1;UCN2;BCHE;ULK1;IGFBP2;HSPA5;TH;PPARG;POSTN;RARA;TAF1;PIK3C2B;KDM4A
6640,GO:0023056,0.000787873432971205,0.999432347791506,157,1149,positive regulation of signaling,BP,SERPINE2;FLOT1;MMP9;CCBE1;CTGF;SFRP1;GADD45B;CDKN2B;F2R;ANO1;GSN;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;PDGFC;MAGED1;SULF2;ROR1;AXL;EGFR;SLC20A1;DOK1;RNF165;CSPG4;EVC;MAP3K6;NTSR1;TIMP2;PAK1;NSG1;CHN2;BMP4;TRIM38;ITM2C;PTK6;EIF2AK4;NETO1;TRIM5;VAV3;PDCD4;NEO1;LGALS1;TP53;ARAP1;DDIT3;PYCARD;WNK1;DDX60;DLG4;SEMA5A;ITGA2;PDGFA;HIP1;GPNMB;TFDP2;GPX1;DLG5;KITLG;SRPX;PLXNB1;FYN;XDH;CAV1;ERCC6;PLA2G6;MAP3K14;PRKCZ;TP53INP1;ITGA1;MST1R;IL31RA;PIK3R1;SYT1;CAPRIN2;DUSP5;UNC5B;SPRY2;TP73;CAT;ROBO1;TLR3;SNCA;FZD7;FGFR1;PAG1;IGF1R;ALOX15B;DKK1;CTF1;C5;TGM2;PSMB9;IL18;SULF1;PLA2R1;EPHB6;EDA2R;FZD8;SLC24A1;AFAP1L2;CDH13;NFATC4;LMCD1;TGFBR3;ENG;CALR;ATM;AKAP13;CITED2;MAP3K1;PTPN1;POGLUT1;VANGL2;NRK;SSH1;SOX9;ISL1;ITPKB;CRTC1;PRKCA;ANXA2;RGS14;MPP7;IGFBP4;MAP3K12;TSPAN5;STK36;MAML2;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;TGFB1I1;RSAD2;MDFIC;SH2B3;YAP1;DIXDC1;MEIS3;AGPAT1;SASH1;TAF1;TSHZ3;FZD4;CREBRF;CDK5RAP3;ABAT;OXTR;LITAF;MYO1C;TAOK3
4600,GO:0010720,0.000789013970894228,0.999538281137545,60,340,positive regulation of cell development,BP,SERPINE2;FN1;TENM4;ETV5;DOCK5;GJC2;S100A10;TIMP2;TENM3;PAK1;BMP4;PTK6;NEFL;DLG4;SEMA5A;CUL7;ITGA3;GLI3;DLG5;CNTN1;PLXNB1;FYN;GLI2;SYT1;CAPRIN2;TP73;METRN;ROBO1;PLXNA2;FGFR1;DKK1;SETX;TRIOBP;KDM4C;FZD1;CALR;NEGR1;TCF4;PLXNA1;TRAK1;FBXW8;ARHGEF2;BCL6;CRTC1;PLAG1;RGS14;TCF12;MEGF8;RET;DLX2;MAGI2;HSPA5;PPARG;OBSL1;RARA;EFNA5;FZD4;KDM4A;NIPBL;DOCK1
16230,GO:0090314,0.000789780064427151,0.999870383384502,8,22,positive regulation of protein targeting to membrane,BP,TCAF1;PAK1;FYN;ANK3;STOM;PRNP;MYO1C;C2CD5
11007,GO:0044877,0.000802383254241266,0.999465763070552,101,662,protein-containing complex binding,MF,ITGB6;FN1;MMP9;CCBE1;CTGF;FBN1;ITGA6;SYNE1;TLN2;MYH15;GSN;IRS2;NID1;COL5A1;UTRN;EGFR;SPTB;SYNE3;SERPINH1;KRT14;CRTAP;VIM;DDB2;CTNNAL1;TIMP2;PAK1;CBX5;MRC2;SORL1;DLG4;ITGA2;PDGFA;NISCH;HIP1;GPNMB;ITGA3;SNX1;TBC1D5;MTHFR;LRP1;FYN;FLNC;LTBP4;RNF135;ERCC6;ITGA10;ESPN;SMARCA1;CLU;HMGA2;ADGRG6;ITGA1;PXN;PIK3R1;LAMA5;TTN;FBLN1;SHROOM4;SNCA;FRMD5;COL16A1;IGF1R;FSCN1;TGFBI;TRIOBP;CDH13;TGFBR3;ENG;CALR;ATM;MDM2;IFNK;IFNE;SYNE2;PTPN1;COL5A3;ENPP1;PRKCA;HMBOX1;MUTYH;PRNP;ULK1;HSPA5;CENPA;SAP30L;CAPG;SNX9;OBSL1;LGALS3;ECM2;WIPF1;LIMA1;PEX1;HP1BP3;MYH11;NIPBL;ADM2;ADAM10;TSPAN4;MYO1C;LAMB2
2524,GO:0005783,0.000817176244850009,0.99940307645933,170,1322,endoplasmic reticulum,CC,PRSS23;FN1;FLRT2;COL8A1;FBN1;PTGS1;ADAMTSL1;COL5A2;PKD2;JPH2;SCARA3;COL7A1;H6PD;NOS1;GAS6;PDGFC;SULF2;COL5A1;EGFR;LAMB1;FLRT3;SYNE3;ATP10D;SERPINH1;CRTAP;S100A10;MBOAT2;MAMDC2;NTSR1;ABCA1;NSG1;BMP4;HS1BP3;COL18A1;SORL1;IFIT2;LGALS1;MEST;TP53;EXTL2;PYCARD;LTBP1;DLG4;SLC7A11;SLC27A3;PDGFA;TIMP1;ACSL3;COL4A4;CPED1;TPBG;PTGES;LPCAT2;P3H2;ERO1B;SRPX;XDH;FUT10;LAMA3;CAV1;SLC27A1;SEL1L;OSBPL5;XYLT1;CLU;FKBP9;OAS2;SDR16C5;CAMK2D;METTL7A;ULBP1;ATP8B2;PDIA4;PIK3R1;HHAT;TMEM173;CREB3L2;ALDH3A2;HERPUD1;ANK3;WFS1;CES2;TMEM8B;APLP2;CRELD2;CAT;BACE1;STOM;TLR3;MAN1A1;SNCA;ADAMTS7;PDIA6;COL16A1;MLEC;SEC24D;TMEM129;TGM2;SULF1;ESYT2;ARSD;LRTOMT;CALR;COPG2;APH1B;FAM20A;TMED10;CST3;AREG;SNX10;CD1D;SYNE2;PTPN1;POGLUT1;SDC2;COL5A3;PLD3;G6PC3;TMEM50B;PRKCA;BCHE;CES3;PGAP1;IGFBP4;PRNP;DNASE1L1;COL12A1;CYP4V2;SPPL2B;ULK1;RHBDD1;HSPA5;TH;REEP2;RSAD2;UVRAG;ITPR2;UGT1A3;LMF1;UGT1A6;ALG10;COL17A1;GPX8;GALNT2;DERL3;AGPAT1;CALCRL;KCNIP3;CERS5;MIA3;DNAJC3;FKBP10;COL4A1;SV2A;TMEM67;MPPE1;PIK3C2B;PDZD2;FOS;CLEC2D;MATN3;UGGT2;CERCAM;KCNRG;ADAM10;TUSC3;EDEM1;DMPK;MOSPD3;LAMB2
3264,GO:0006937,0.000819852931086362,0.99970642146544,19,78,regulation of muscle contraction,BP,CTGF;F2R;TNNI2;GJA5;NOS1;SLC8A1;DOCK5;ITGA2;DOCK4;CAV1;EHD3;CAMK2D;RGS2;PDE4D;ANXA6;CALCRL;ABAT;OXTR;DMPK
15405,GO:0071709,0.000821137562287557,0.999871123437483,8,19,membrane assembly,BP,FLOT1;S100A10;CAV1;ANK3;FLOT2;ANXA2;NLGN4Y;MAGI2
15217,GO:0071407,0.000824669996866338,0.999498637519561,68,416,cellular response to organic cyclic compound,BP,FLOT1;ITGA6;SFRP1;ZFP36L1;DDIT4;PKD2;ZFP36L2;SKP2;SNAI2;EGFR;SLC8A1;FAM210B;TADA3;PAK1;ABCA1;VDR;BMP4;NR1D1;NR3C1;STAT1;LGALS1;GNG2;IFIT1;ITGA2;ZCCHC11;KLF9;PAQR8;CPS1;CAV1;GLI2;RBFOX2;CLU;KANK2;PER1;TMEM173;CHEK2;TLR3;SNCA;PAQR7;PDE4D;IL18;NFATC4;CALR;MDM2;AKAP13;GCLC;NR2F2;SSH1;EGR1;ISL1;NCOR1;ABCC2;LEF1;THRA;HSPA5;TGFB1I1;ITPR2;YAP1;KLF5;PPARG;RARA;TAF1;EFNA5;PPP3CA;CREBRF;AGO4;MED12;RXRA
12954,GO:0051384,0.000829152981533372,0.999690939404119,20,90,response to glucocorticoid,BP,ZFP36L1;DDIT4;ZFP36L2;EGFR;NEFL;NR3C1;KLF9;CTSV;CPS1;SLIT3;PTPRU;AREG;AKAP13;ISL1;BCHE;ABCC2;IGFBP2;TH;CREBRF;FOS
4381,GO:0010038,0.000835793272132138,0.999575849551136,38,215,response to metal ion,BP,MMP9;TXNIP;NQO1;GSN;PKD2;CYBRD1;EGFR;KRT14;KCNMA1;D2HGDH;TP53;WNK1;PTGES;CPS1;CAV1;CAMK2D;SYT1;ANK3;TTN;CAT;SNCA;G6PD;NFATC4;CALR;MDM2;GCLC;ITPKB;NDRG1;ABCC2;PRNP;CARF;IGFBP2;HSPA5;TH;MEF2A;PPP3CA;FOS;ABAT
7780,GO:0032331,0.000857701082357992,0.999913030241851,6,12,negative regulation of chondrocyte differentiation,BP,EFEMP1;SNAI2;BMP4;GLI2;ADAMTS7;SOX9
11448,GO:0045926,0.000887828694011148,0.999578590791927,32,168,negative regulation of growth,BP,SERPINE2;SFRP1;APBB2;TGFBR2;PAK1;BMP4;SMARCA2;PTK6;TP53;PTPRS;SEMA5A;CCDC85B;BTG1;DCBLD2;SLIT3;ULK2;CAPRIN2;BBS2;JARID2;TP73;ALOX15B;SEMA4A;G6PD;ENPP1;BCL6;TGFB2;FHL1;CDKN2A;TSPYL2;SEMA4B;PPARG;ING4
6626,GO:0023014,0.000891588332614788,0.999415023031368,92,617,signal transduction by protein phosphorylation,BP,FN1;CTGF;SFRP1;GADD45B;ZFP36L1;F2R;TGFBR2;IRS2;DUSP6;ZFP36L2;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;SPTB;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;TRIM5;NEFL;PDCD4;SORL1;PYCARD;WNK1;DLG4;PDGFA;GPNMB;KITLG;FYN;XDH;CAV1;ERCC6;TRIB2;MAP3K14;PRKCZ;CAMK2D;ITGA1;MST1R;IL31RA;PER1;DUSP5;SPRY2;FBLN1;TP73;ROBO1;SPRY4;TLR3;FZD7;FGFR1;IGF1R;DKK1;RGS2;C5;SETX;PSMB9;IL18;EPHB6;EDA2R;FZD8;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;SOX9;ITPKB;NCOR1;PRKCA;RGS14;IGFBP4;PAK6;MAP3K12;RET;TGFB2;MAP2K5;CDC42EP5;MAPK8IP3;MDFIC;GDNF;MEF2A;SASH1;FZD4;RASA1;CDK5RAP3;CAMK2N1;OXTR;TAOK3
3581,GO:0007631,0.000893979764778278,0.999789009499225,11,35,feeding behavior,BP,EIF2AK4;FYN;CCK;CPT1A;NEGR1;LEPR;HTR1B;TH;FOS;ADM2;OXTR
4851,GO:0014068,0.000896793687157292,0.999788259834002,11,35,positive regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;PDGFC;PDGFA;PLXNB1;FYN;UNC5B;CAT;FGFR1;IL18;SOX9;TGFB2
12166,GO:0048333,0.000900639561840257,0.999882696574846,7,15,mesodermal cell differentiation,BP,ITGB4;BMP4;ITGA2;ITGA3;HMGA2;FGFR1;DKK1
6249,GO:0019838,0.000912182056219397,0.999651472212073,21,86,growth factor binding,MF,HTRA1;CTGF;ITGA6;CD109;TGFBR2;ITGB4;COL5A1;EGFR;LTBP1;PDGFA;CRIM1;LTBP4;GLG1;FGFR1;IGF1R;LTBP3;TGFBR3;ENG;IGFBP4;IGFBP2;COL4A1
12928,GO:0051336,0.000915450695042044,0.999360278656731,127,893,regulation of hydrolase activity,BP,SERPINE2;PHACTR3;TNFRSF6B;FN1;MMP9;CTGF;ITGA6;SFRP1;CD109;F2R;ASAP3;GSN;PROM2;COL7A1;NOS1;DNAJB4;GAS6;DNMBP;ARHGAP23;TFPI2;DOCK9;EGFR;HSPA2;SERPINE1;SERPINH1;S100A10;ALS2CL;STMN3;ASAP2;TIMP2;ANGPTL4;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;SORL1;TP53;ARAP1;PYCARD;IFIT1;WNK1;ARHGEF1;ITGA2;MICAL1;TIMP1;HIP1;DOCK4;CRIM1;EVI5L;ELFN2;GPX1;TBC1D5;ASAP1;PLXNB1;LRP1;FYN;ARHGEF12;IFI6;XDH;B3GAT3;ARHGAP18;CAV1;DOCK11;SERPING1;PRKCZ;OAS2;CAMK2D;PRDX5;ITGA1;CCK;ANG;HERPUD1;SPRY2;APLP2;FBLN1;DAPK1;DLC1;ROBO1;SNCA;AIP;PLXNA2;FGFR1;RGS2;C5;PSMB9;PLA2R1;BBS4;SRGAP1;MDM2;CST3;TBC1D19;PLXNA1;FGD4;PTPN1;DNAL4;BCL6;RGS14;LEPR;DEPDC7;TGFB2;MAP2K5;LEF1;CDC42EP5;AGRN;VAV2;MAGI2;AGAP1;HSPA5;ARHGEF19;ARHGAP29;OPHN1;LMF1;MYO9A;RALGAPB;PPARG;SNX9;TBC1D16;EFNA5;SBF2;RASA1;ARHGAP31;CDK5RAP3;SERPINB5;PPP2R3A;DOCK1;DMPK
5533,GO:0016528,0.000918629442790931,0.999752975304824,13,40,sarcoplasm,CC,GSN;JPH2;NOS1;PLEC;P3H2;XDH;FLNC;CAMK2D;ANK3;CALR;SYNE2;ITPR2;DMPK
14125,GO:0061035,0.000935574303778507,0.999763006102036,12,37,regulation of cartilage development,BP,CTGF;SOX6;EFEMP1;SNAI2;BMP4;GLI3;GLI2;ADAMTS7;GLG1;MAF;SOX9;RARA
3451,GO:0007266,0.00097245939660013,0.999539964017825,32,148,Rho protein signal transduction,BP,FLOT1;RHOBTB2;F2R;DNMBP;CTNNAL1;PAK1;ABCA1;VAV3;ARAP1;PLEKHG3;ARHGEF1;ITGA3;PDPN;ARHGEF12;DLC1;ROBO1;OBSCN;ARHGEF17;CDH13;AKAP13;FGD4;VANGL2;ARHGEF2;BCL6;PAK6;CDC42EP5;VAV2;ARHGEF19;ARHGAP29;OPHN1;RHOBTB3;CELSR1
4835,GO:0014046,0.00097537608833611,0.999928339672231,5,9,dopamine secretion,BP,SYT1;SNCA;HTR1B;GDNF;ABAT
4843,GO:0014059,0.00097537608833611,0.999928339672231,5,9,regulation of dopamine secretion,BP,SYT1;SNCA;HTR1B;GDNF;ABAT
14176,GO:0061135,0.000977120575745035,0.999650753976461,18,84,endopeptidase regulator activity,MF,SERPINE2;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;TIMP1;CRIM1;SERPING1;PRDX5;APLP2;SNCA;C5;CST3;LEF1;SERPINB5
3502,GO:0007411,0.000998260576714967,0.99949984916952,37,170,axon guidance,BP,FLRT2;APBB2;IRS2;DPYSL2;FLRT3;SPTB;DOK1;RNF165;PTPRM;NEO1;ETV1;SEMA5A;GLI3;PLXNB1;FYN;GLI2;SLIT3;PIK3R1;UNC5B;ROBO1;PLXNA2;SEMA4A;EFNB3;PLXNA1;VANGL2;ISL1;NFASC;PRKCA;MEGF8;RET;BOC;SEMA4B;OPHN1;GDNF;KLF7;EFNA5;LAMB2
17559,GO:1901216,0.00101081673627889,0.999668555765532,16,64,positive regulation of neuron death,BP,NQO1;DDIT4;TP53;DDIT3;FYN;CLU;ITGA1;SNCA;DKK1;ATM;SSH1;EGR1;PRNP;TGFB2;SRPK2;FOS
13207,GO:0051899,0.00102346339302643,0.999697724016181,14,50,membrane depolarization,BP,GJA5;SLC8A1;NTSR1;SCN8A;SCN2A;IFI6;CAV1;PRKCZ;CAMK2D;CCK;ANK3;GCLC;FHL1;PTPN3
6572,GO:0022407,0.00102702303954308,0.99946262840375,40,229,regulation of cell-cell adhesion,BP,SERPINE2;FLOT1;ITGA6;TGFBR2;IL20RB;SNAI2;PAK1;BMP4;LGALS1;PYCARD;GPNMB;GLI3;DLG5;PDPN;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;ANK3;FLOT2;PAG1;IL18;EFNB3;CITED2;CD1D;ITPKB;BCL6;PRKCA;PODXL;PRNP;MAP2K5;LEF1;IGFBP2;LGALS3;RARA;EFNA5;ZBTB1;ABAT
7927,GO:0032526,0.00103447168666107,0.999645040079857,17,71,response to retinoic acid,BP,ABCA1;PTK6;TP53;KRT13;PTGES;FZD7;DKK1;SETX;SOX9;RET;TRIML2;IGFBP2;YAP1;PPARG;RARA;FZD4;RXRA
12506,GO:0050678,0.0010492214882918,0.999451985715134,40,217,regulation of epithelial cell proliferation,BP,KRT4;HTRA1;SFRP1;CD109;CDKN2B;ZFP36L1;SNAI2;MAGED1;SULF2;EGFR;LAMB1;VDR;PTPRM;BMP4;NR1D1;STAT1;SEMA5A;KLF9;GPX1;CTSV;XDH;CAV1;ANG;ROBO1;FZD7;FGFR1;SULF1;CDH13;TGFBR3;NR2F2;SOX9;ISL1;PRKCA;TGFB2;MAP2K5;IFT122;IFT74;YAP1;PPARG;SERPINB5
13949,GO:0060688,0.00105083254929309,0.99974528809602,11,36,regulation of morphogenesis of a branching structure,BP,SFRP1;ETV5;SNAI2;MAGED1;BMP4;PDGFA;FGFR1;SULF1;SOX9;GDNF;RXRA
9326,GO:0035850,0.0010573951422149,0.999774627897186,10,27,epithelial cell differentiation involved in kidney development,BP,FAT4;ACTA2;BMP4;STAT1;WWTR1;PODXL;MAGI2;YAP1;GDNF;LAMB2
6066,GO:0019220,0.00106494578693895,0.999221651523331,164,1188,regulation of phosphate metabolic process,BP,PHACTR3;FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;F2R;DDIT4;TGFBR2;PKD2;IRS2;DUSP6;HERC5;TNIK;PROM2;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;CSPG4;MAP3K6;NTSR1;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;VAV3;PDCD4;SORL1;TP53;WWTR1;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;MICAL1;ADARB1;ACSL3;GPNMB;ELFN2;CNTN1;KITLG;CTDSPL;FYN;XDH;B3GAT3;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;CAPRIN2;ANG;DUSP5;SPRY2;TTN;FBLN1;TP73;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;MTMR4;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;NR2F2;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;GPR161;MAPK8IP3;CDKN2A;TSPYL2;NPHP3;VAV2;MAGI2;HSPA5;UVRAG;MDFIC;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CTDSP2;CDK5RAP3;CAMK2N1;PPP2R3A;TAOK3;DMPK
1368,GO:0003254,0.00107339150729646,0.99978841894129,9,26,regulation of membrane depolarization,BP,GJA5;NTSR1;IFI6;CAMK2D;CCK;ANK3;GCLC;FHL1;PTPN3
5726,GO:0016878,0.00107436565158465,0.999843920526231,7,18,acid-thiol ligase activity,MF,SLC27A3;ACSL3;SLC27A1;ACSS1;ACSS2;SLC27A6;ACSF2
16837,GO:0098797,0.00107746083030748,0.999393041900621,50,282,plasma membrane protein complex,CC,ITGB6;FLOT1;ITGB5;ITGA6;TGFBR2;ITGB4;GJA5;NOS1;UTRN;EGFR;HSPA2;GJC2;EVC;SCN8A;NEO1;SCN2A;GNG2;KCNMA1;DLG4;ITGA2;HIP1;ITGA3;TBC1D5;KCNAB2;LRP1;ITGA10;ITGA1;KCNJ5;FLOT2;IGF1R;C5;PDE4D;FZD8;CDH13;TGFBR3;ENG;APH1B;TMED10;KCNQ3;PRKCA;MPP7;CDH11;RET;ITGB8;CACNB1;CALCRL;KCNIP3;SHISA9;ABCA2;SNTB1
16598,GO:0097485,0.00108211353991232,0.999454970682995,37,171,neuron projection guidance,BP,FLRT2;APBB2;IRS2;DPYSL2;FLRT3;SPTB;DOK1;RNF165;PTPRM;NEO1;ETV1;SEMA5A;GLI3;PLXNB1;FYN;GLI2;SLIT3;PIK3R1;UNC5B;ROBO1;PLXNA2;SEMA4A;EFNB3;PLXNA1;VANGL2;ISL1;NFASC;PRKCA;MEGF8;RET;BOC;SEMA4B;OPHN1;GDNF;KLF7;EFNA5;LAMB2
3508,GO:0007420,0.00110642645229139,0.999303442195974,75,444,brain development,BP,SERPINE2;TRNP1;SFRP1;DDIT4;FAT4;TGFBR2;IRS2;AXL;DPYSL2;EGFR;LAMB1;SLC8A1;GJC2;AMIGO2;PAK1;BMP4;NEFL;PTPRS;EFHC1;SLC7A11;SEMA5A;ACSL3;PHGDH;GLI3;DLG5;CNTN1;LRP1;FYN;FUT10;GLI2;RBFOX2;SMARCA1;SYT1;SLC38A2;BBS2;SHROOM4;DLC1;AARS;ROBO1;PLXNA2;FGFR1;DKK1;G6PD;FZD1;NAGLU;BBS4;ATM;CST3;NR2F2;SYNE2;ISL1;PGAP1;ATXN1;STK36;DLX2;SMG9;LEF1;THRA;SSBP3;HSPA5;TH;TACC2;OPHN1;SRR;DIXDC1;RARA;COL4A1;TAF1;FZD4;SLITRK5;CDK5RAP3;ABAT;NIPBL;TTBK2;OXTR
14175,GO:0061134,0.00110658680158074,0.999550945398224,22,111,peptidase regulator activity,MF,SERPINE2;FN1;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;PYCARD;TIMP1;CRIM1;CAV1;SERPING1;PRDX5;APLP2;FBLN1;SNCA;C5;CST3;LEF1;SERPINB5
10280,GO:0043065,0.00113634511801494,0.999292540909267,70,467,positive regulation of apoptotic process,BP,MMP9;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;NQO1;APBB2;F2R;GSN;DUSP6;MAGED1;NUPR1;NTSR1;VDR;BMP4;ITM2C;VAV3;PDCD4;COL18A1;IFIT2;KCNMA1;TP53;DDIT3;PYCARD;ARHGEF1;HIP1;TFDP2;BTG1;SIK1;ANO6;SRPX;ARHGEF12;XDH;CAV1;PLA2G6;TP53INP1;HMGA2;CAMK2D;ITGA1;CCK;TP73;DAPK1;DLC1;CHEK2;ROBO1;TLR3;SNCA;TGM2;OBSCN;ARHGEF17;NFATC4;ATM;APH1B;AKAP13;ZMAT3;FGD4;ARHGEF2;BCL6;PRNP;RET;TGFB2;CDKN2A;VAV2;CDK19;SRPK2;ARHGEF19;PPARG;ING4
12549,GO:0050730,0.00114059229530789,0.999479300008512,28,147,regulation of peptidyl-tyrosine phosphorylation,BP,GPRC5A;SFRP1;GAS6;PDGFC;EGFR;CSPG4;PTK6;TP53;DLG4;PDGFA;CNTN1;KITLG;FYN;CAV1;ERCC6;PRKCZ;IL31RA;CCK;CTF1;IL18;AFAP1L2;AREG;DGKQ;PTPN1;ARHGEF2;ISL1;PRNP;EFNA5
8679,GO:0034329,0.00115478012328976,0.999414642105613,37,177,cell junction assembly,BP,FLOT1;FN1;ITGA6;SFRP1;TLN2;ITGB4;GJA5;SNAI2;KRT14;S100A10;PLEC;TNS1;KRT5;ITGA2;LAMC2;DLG5;FLNC;UGT8;LAMA3;CAV1;NPHP4;LAMA5;LAMB3;DLC1;COL16A1;FSCN1;CDH13;NFASC;PRKCA;RAB13;MPP7;CDH11;OPHN1;MYO9A;COL17A1;EFNA5;MYO1C
10246,GO:0043005,0.00115756089467204,0.999201739986374,114,753,neuron projection,CC,FLRT2;NQO1;APBB2;PTGS1;TENM4;NOS1;MAP6;UTRN;ROR1;FLRT3;SLC8A1;GJC2;STON2;VIM;STMN3;NTSR1;TIMP2;TENM3;PAK1;NSG1;NEFM;NR1D1;SCN8A;NEFL;STAT1;SCN2A;PTPRS;DLG4;ITGA2;MAP2;MICAL1;DOCK4;ITGA3;ASAP1;SYN1;CTSV;SPG11;KCNAB2;LRP1;FYN;PIAS3;ESPN;CLU;NPHP4;PRKCZ;CAMK2D;ITGA1;IL31RA;CCK;SYT1;SLC38A2;ANG;KIF17;BBS2;ANK3;WFS1;BACE1;ROBO1;IFT140;SNCA;MME;VAMP1;IGF1R;FSCN1;RGS2;SETX;MYO3B;EPHB6;TRIOBP;CDH13;SEPT6;BBS4;CST3;TRAK1;LZTS1;KCNQ3;ARHGEF2;SSH1;NFASC;CRTC1;RGS14;RAB13;SEPT5;MAP3K12;HTR1B;WDR19;PRNP;RET;TGFB2;IFT122;ULK1;MAGI2;TH;GOPC;BOC;OPHN1;TPGS1;KCNIP3;SHISA9;PRR7;ARL3;RARA;SV2A;TSHZ3;FZD4;PPP3CA;FOS;DNM1P46;CAMK2N1;ABAT;BSN;MPDZ;MYO1C;ORAI2
4456,GO:0010453,0.0011654208672895,0.999868415341408,6,13,regulation of cell fate commitment,BP,DUSP6;BMP4;FZD7;FGFR1;DKK1;LMO4
13788,GO:0060411,0.00117662396469856,0.999650752018223,14,47,cardiac septum morphogenesis,BP,TGFBR2;GJA5;BMP4;PARVA;TGFBR3;FZD1;ENG;MDM2;CITED2;VANGL2;ISL1;ZFPM1;TGFB2;RARA
17487,GO:1900746,0.00120572924452335,0.999917092239706,5,8,regulation of vascular endothelial growth factor signaling pathway,BP,CCBE1;XDH;ROBO1;ADGRA2;MYO1C
18006,GO:1902547,0.00120572924452335,0.999917092239706,5,8,regulation of cellular response to vascular endothelial growth factor stimulus,BP,CCBE1;XDH;ROBO1;ADGRA2;MYO1C
11602,GO:0046328,0.00120919509610156,0.999458561934213,27,128,regulation of JNK cascade,BP,CTGF;SFRP1;GADD45B;TNIK;EGFR;MAP3K6;PAK1;PDCD4;PYCARD;ERCC6;PER1;TP73;TLR3;FZD7;IGF1R;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;NCOR1;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
12894,GO:0051271,0.0012105846044092,0.999375091348715,38,199,negative regulation of cellular component movement,BP,SFRP1;MMP28;TCAF1;SERPINE1;PTPRM;SRGAP3;SEMA5A;NISCH;ADARB1;TIMP1;DLG5;LRP1;TP53INP1;ARPIN;FBLN1;DLC1;ROBO1;FRMD5;PTPRU;ALOX15B;SEMA4A;C5;SULF1;TGFBR3;ENG;CALR;IDH2;SRGAP1;CITED2;NR2F2;MAP2K5;SP100;MAGI2;SEMA4B;IFITM1;PPARG;GCSAM;MIA3
17025,GO:0099537,0.00121221759796304,0.999304527568663,52,298,trans-synaptic signaling,BP,SERPINE2;SYT8;FLOT1;NQO1;F2R;ETV5;NOS1;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;NISCH;ADARB1;SYN1;SPG11;PLA2G6;PRKCZ;SYTL1;SYT1;PCLO;BACE1;SNCA;DKK1;SLC24A1;NFATC4;KCNQ3;SSH1;CRTC1;BCHE;RGS14;SEPT5;NLGN4Y;HTR1B;PRNP;C2CD4C;TH;OPHN1;TPGS1;CACNB1;GDNF;SHISA9;RARA;SV2A;TSHZ3;SLITRK5;PPP3CA;ABAT;BSN;OXTR;DMPK
11484,GO:0045992,0.00121301136112663,0.999793137592831,8,20,negative regulation of embryonic development,BP,COL5A2;COL5A1;BMP4;PRKACB;FZD7;DKK1;SULF1;GPR161
13250,GO:0051966,0.00122175904801232,0.999759958436488,9,24,regulation of synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;PLA2G6;SYT1;DKK1;HTR1B;OPHN1;TSHZ3;OXTR
15648,GO:0072202,0.0012238889784269,0.999831474904831,7,15,cell differentiation involved in metanephros development,BP,FAT4;BMP4;STAT1;WWTR1;YAP1;GDNF;LAMB2
13518,GO:0060008,0.00122512916245126,0.999866434962286,6,12,Sertoli cell differentiation,BP,CTSV;CST3;SOX9;RAB13;FNDC3A;RARA
10405,GO:0043270,0.00123213604639976,0.999465476094461,25,121,positive regulation of ion transport,BP,F2R;PKD2;JPH2;NOS1;TCAF1;HSPA2;MYLK;GJC2;NTSR1;WNK1;ANO6;CNTN1;CAV1;PLA2G6;EHD3;CCK;ANK3;WFS1;SNCA;PLA2R1;G6PD;FHL1;GDNF;LGALS3;ABAT
15209,GO:0071396,0.00123445690664448,0.999253865940635,62,382,cellular response to lipid,BP,SFRP1;ZFP36L1;DDIT4;ZFP36L2;SKP2;SNAI2;AXL;EGFR;SERPINE1;FAM210B;TADA3;PAK1;ABCA1;VDR;BMP4;NR1D1;PTK6;TRIM5;PDCD4;NR3C1;GNG2;KRT13;PYCARD;ITGA2;KLF9;PAQR8;CPS1;RBFOX2;CLU;KANK2;PER1;CPT1A;FZD7;PAQR7;SETX;PDE4D;IL18;PDK3;NFATC4;CALR;AKAP13;NR2F2;SOX9;ISL1;PRKCA;ABCC2;RET;LEF1;THRA;CDK19;TGFB1I1;YAP1;PPARG;SASH1;RARA;TAF1;EFNA5;FZD4;CREBRF;MED12;LITAF;RXRA
12929,GO:0051338,0.00124838384853538,0.999148607442302,105,731,regulation of transferase activity,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CDKN2B;F2R;TGFBR2;PKD2;IRS2;DUSP6;HERC5;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;FLRT3;CSPG4;MAP3K6;PAK1;BMP4;PTK6;VAV3;PDCD4;SORL1;TP53;WWTR1;PYCARD;WNK1;DLG4;PILRB;PDGFA;ADARB1;KITLG;CAV1;SLC27A1;ERCC6;TRIB2;MAP3K14;CLU;PRKCZ;PARP4;ITGA1;MST1R;PIK3R1;ANG;DUSP5;SPRY2;TTN;TP73;PRKACB;ROBO1;SPRY4;TLR3;SNCA;FGFR1;IGF1R;DKK1;RGS2;C5;IL18;EPHB6;FZD8;AFAP1L2;FAM20A;AKAP13;DGKQ;NR2F2;LMO4;MAP3K1;PTPN1;VANGL2;NRK;EGR1;RGS14;HMBOX1;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;RBL2;MAP2K5;MAPK8IP3;CDKN2A;TSPYL2;VAV2;HSPA5;UVRAG;MDFIC;PPARG;SNX9;SASH1;ZYG11B;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CDK5RAP3;CAMK2N1;TAOK3
11351,GO:0045740,0.00125770381735241,0.999661440928046,12,42,positive regulation of DNA replication,BP,PDGFC;EGFR;BMP4;PDGFA;E2F7;KITLG;GLI2;FGFR1;IGF1R;CALR;CST3;AREG
14320,GO:0061564,0.00126142159211937,0.999247004534076,60,330,axon development,BP,FLOT1;FN1;FLRT2;APBB2;SLITRK6;IRS2;DPYSL2;FLRT3;SPTB;DOK1;RNF165;PAK1;PTPRM;NEFM;NEFL;NEO1;ETV1;PTPRS;SEMA5A;MAP2;ADARB1;GLI3;SPG11;PLXNB1;FYN;GLI2;UST;SLIT3;ULK2;CCK;PIK3R1;UNC5B;ANK3;METRN;ROBO1;PLXNA2;SEMA4A;RAPH1;EFNB3;PLXNA1;TRAK1;VANGL2;NTNG1;SSH1;ISL1;NFASC;PRKCA;MEGF8;CDH11;RET;ULK1;BOC;SEMA4B;OPHN1;GDNF;KLF7;ECM2;EFNA5;SLITRK5;LAMB2
16028,GO:0086103,0.00128261309224941,0.99992635020919,5,7,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1;CAV1;RGS2;PDE4D;AKAP13
11130,GO:0045202,0.00128528453225024,0.999166135365841,83,510,synapse,CC,SERPINE2;SYT8;FLRT2;APBB2;SYNE1;F2R;TLN2;SDK1;NOS1;DNMBP;UTRN;ROR1;EGFR;FLRT3;SLC8A1;STON2;ADD3;NTSR1;NSG1;NR1D1;NETO1;KCNMA1;PTPRS;DLG4;ITGA2;MAP2;MICAL1;HIP1;ITGA3;DLG5;ASAP1;SYN1;MTHFR;SPG11;KCNAB2;FYN;PIAS3;NPHP4;SYTL1;IL31RA;CCK;SYT1;PCLO;LAMA5;ANK3;SNCA;MME;VAMP1;NIPSNAP1;SEPT6;DTNB;MDM2;DNAJC6;LZTS1;ARHGEF2;SYNC;CRTC1;RGS14;RAB13;SEPT5;NMNAT2;NLGN4Y;PRNP;C2CD4C;AGRN;MAGI2;TH;GOPC;OPHN1;KCNIP3;SHISA9;POSTN;PRR7;SV2A;PPP3CA;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ;SNTB1;ZNRF1;LAMB2
3509,GO:0007422,0.00128818051474729,0.999594463247688,15,51,peripheral nervous system development,BP,SCN8A;ETV1;UGT8;AHNAK2;ADGRG6;ALDH3A2;PRX;SH3TC2;ISL1;NFASC;NDRG1;NAB2;GDNF;MED12;LAMB2
16134,GO:0090183,0.00128831106779055,0.999677624144711,11,37,regulation of kidney development,BP,FAT4;MAGED1;BMP4;STAT1;WWTR1;PDGFA;EGR1;SOX9;RET;YAP1;GDNF
3543,GO:0007568,0.00129106655345912,0.999334127144286,37,210,aging,BP,CTGF;INPP5D;NQO1;TGFBR2;GSN;SERPINE1;KRT14;RNF165;TIMP2;PDCD4;TP53;TIMP1;CTSV;LRP1;SERPING1;HMGA2;CAT;CHEK2;SNCA;MME;LMNA;DKK1;PDE4D;PLA2R1;ENG;CALR;ATM;GCLC;BCL6;PRNP;CDKN2A;IGFBP2;TH;SRR;FOS;ABAT;LITAF
12829,GO:0051174,0.00129177578707343,0.999050100008459,165,1201,regulation of phosphorus metabolic process,BP,PHACTR3;FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;F2R;DDIT4;TGFBR2;PKD2;IRS2;DUSP6;HERC5;TNIK;PROM2;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;CSPG4;MAP3K6;NTSR1;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;VAV3;PDCD4;SORL1;TP53;WWTR1;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;MICAL1;ADARB1;ACSL3;GPNMB;ELFN2;CNTN1;KITLG;CTDSPL;FYN;XDH;B3GAT3;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;CAPRIN2;ANG;DUSP5;SPRY2;TTN;FBLN1;TP73;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;IL18;PDK3;EPHB6;EDA2R;FZD8;AFAP1L2;FZD1;ENG;MTMR4;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;NR2F2;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;GPR161;MAPK8IP3;CDKN2A;TSPYL2;NPHP3;VAV2;MAGI2;HSPA5;UVRAG;MDFIC;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;EFNA5;FZD4;CTDSP2;CDK5RAP3;CAMK2N1;PPP2R3A;TAOK3;DMPK
18003,GO:1902533,0.00129219949056391,0.999134597873101,95,656,positive regulation of intracellular signal transduction,BP,CTGF;GADD45B;F2R;PKD2;JPH2;IRS2;DUSP6;TNIK;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;SLC20A1;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;TRIM38;PTK6;TRIM5;PDCD4;LGALS1;TP53;DDIT3;PYCARD;DDX60;SEMA5A;PDGFA;HIP1;GPNMB;GPX1;DLG5;KITLG;PLXNB1;FYN;XDH;CAV1;ERCC6;PLA2G6;MAP3K14;PRKCZ;ITGA1;MST1R;IL31RA;PIK3R1;DUSP5;UNC5B;SPRY2;TP73;CAT;ROBO1;TLR3;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;TGM2;IL18;PLA2R1;EPHB6;EDA2R;FZD8;CDH13;LMCD1;ENG;CALR;ATM;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;SOX9;ISL1;ITPKB;PRKCA;IGFBP4;MAP3K12;RET;TGFB2;MAP2K5;MAPK8IP3;MDFIC;MEIS3;SASH1;FZD4;CDK5RAP3;LITAF;TAOK3
15275,GO:0071495,0.00130024688933463,0.999076351483148,132,907,cellular response to endogenous stimulus,BP,MMP2;HTRA1;FLRT2;ITGB5;CTGF;FBN1;SOX6;SFRP1;CD109;CDKN2B;ZFP36L1;DDIT4;FAT4;TGFBR2;COL5A2;PKD2;IRS2;DUSP6;ZFP36L2;SKP2;FBN2;PDGFC;SNAI2;SULF2;EGFR;PEG10;FLRT3;SLC8A1;SESN3;RNF165;FAM210B;TADA3;PAK1;VDR;BMP4;NR1D1;PDCD4;NR3C1;STAT1;NEO1;GNG2;TP53;LTBP1;ITGA2;ITGA3;SIK1;KLF9;PAQR8;SESN1;LRP1;FYN;LTBP4;CPS1;CAV1;SLC27A1;RBFOX2;PRKCZ;SLIT3;KANK2;PER1;PXN;PIK3R1;BBS2;SPRY2;PRKACB;CHEK2;SPRY4;SNCA;ADAMTS7;GLG1;PAQR7;COL16A1;FGFR1;IGF1R;DKK1;SETX;PDE4D;NCOA2;SULF1;TGFBR3;FZD1;ENG;BBS4;MTMR4;CALR;MDM2;AKAP13;CITED2;GCLC;NR2F2;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;UCN2;ENPP1;ISL1;PRCP;STK16;RAB13;LEPR;ABCC2;MEGF8;HTR1B;PRNP;TGFB2;LEF1;THRA;AGRN;IGFBP2;MAGI2;HSPA5;TH;TGFB1I1;ITPR2;YAP1;CACNB1;KLF5;PPARG;POSTN;RARA;COL4A1;TAF1;EFNA5;CREBRF;FOS;MED12;OXTR;MYO1C;RXRA;C2CD5
8578,GO:0034097,0.00130122189041861,0.999107868468752,106,806,response to cytokine,BP,TNFRSF6B;MMP2;FN1;FLRT2;MMP9;INPP5D;SFRP1;ZFP36L1;IL20RB;GSN;IRS2;ZFP36L2;GAS6;AXL;FLRT3;RFX2;VIM;TIMP2;TRIM38;XAF1;TRIM5;PDCD4;STAT1;IFIT2;TP53;PYCARD;IL32;IFIT1;TIMP1;IFIT3;PTGES;MTHFR;FYN;IFI6;CAV1;SLC27A1;GLDC;MAP3K14;CXCR1;SLIT3;OAS2;CAMK2D;MST1R;IL31RA;PTPN14;PIK3R1;TMEM173;LAMA5;BBS2;SPRY2;JARID2;DAPK1;ROBO1;TLR3;SNCA;ADAMTS7;MME;AIP;IFI35;FSCN1;CTF1;PSMB9;IL18;TLE4;IL17RE;EDA2R;TRAF1;BBS4;IFNK;SNX10;GCLC;IFNE;PTPN1;ARHGEF2;EGR1;SOX9;BCL6;PRKCA;ANXA2;LEPR;IFITM2;RPL13A;ABCC2;RAB43;MAP2K5;STAT2;LEF1;SPPL2B;SP100;HSPA5;RSAD2;FLNB;IFITM1;NUB1;KLF5;AGPAT1;PPARG;POSTN;RARA;FZD4;CREBRF;FOS;OXTR;ADAM10;PRDM5;MYO1C
16748,GO:0098589,0.00130366887292364,0.999316641556703,39,211,membrane region,CC,FLOT1;INPP5D;MARVELD1;F2R;TGFBR2;PROM2;NOS1;MALL;EGFR;SERPINH1;S100A10;NTSR1;ABCA1;AHNAK;KCNMA1;CNTN1;PLLP;PDPN;FYN;CAV1;PRKCZ;ITGA1;UNC5B;DLC1;BACE1;STOM;FLOT2;PAG1;SULF1;MYOF;CDH13;ANXA2;PODXL;PRNP;RET;PIKFYVE;EFNA5;MYO1C;CTSD
3382,GO:0007162,0.00131037803715634,0.99935580782994,33,168,negative regulation of cell adhesion,BP,SERPINE2;IL20RB;SNAI2;SERPINE1;BMP4;LGALS1;SEMA5A;GPNMB;GLI3;DLG5;PLXNB1;PIK3R1;FBLN1;DLC1;FZD7;PLXNA2;PAG1;TGFBI;CDH13;PLXNA1;BCL6;PODXL;PRNP;MAP2K5;CDKN2A;POSTN;LGALS3;MIA3;EFNA5;FZD4;RASA1;ABAT;ADAM10
1427,GO:0003401,0.00131293336876129,0.999742690027179,9,23,axis elongation,BP,SFRP1;BMP4;SPRY2;AREG;VANGL2;SOX9;MAGI2;YAP1;MED12
15308,GO:0071559,0.00131876739957184,0.99935221039004,33,165,response to transforming growth factor beta,BP,HTRA1;ITGB5;FBN1;SOX6;SFRP1;CD109;CDKN2B;ZFP36L1;TGFBR2;ZFP36L2;FBN2;PEG10;NR3C1;MXRA5;LTBP1;ITGA3;FYN;LTBP4;CAV1;PRKCZ;PXN;GLG1;TGFBR3;ENG;MTMR4;CITED2;SOX9;STK16;TGFB2;HSPA5;TGFB1I1;POSTN;FOS
8148,GO:0032890,0.0013300645668066,0.999729248257237,9,26,regulation of organic acid transport,BP,IRS2;NTSR1;PLA2G6;CCK;SNCA;PLA2R1;NCOR1;SV2A;ABAT
10707,GO:0044070,0.00134524862839848,0.999610484736944,13,47,regulation of anion transport,BP,IRS2;TCAF1;NTSR1;PLA2G6;CCK;SNCA;FGFR1;PLA2R1;NCOR1;PRNP;GOPC;SV2A;ABAT
15140,GO:0071295,0.00135179102292824,0.999765315797844,8,20,cellular response to vitamin,BP,SFRP1;GAS6;SNAI2;VDR;KANK2;MDM2;PPARG;POSTN
17024,GO:0099536,0.00135291334676559,0.999219466025177,52,299,synaptic signaling,BP,SERPINE2;SYT8;FLOT1;NQO1;F2R;ETV5;NOS1;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;NISCH;ADARB1;SYN1;SPG11;PLA2G6;PRKCZ;SYTL1;SYT1;PCLO;BACE1;SNCA;DKK1;SLC24A1;NFATC4;KCNQ3;SSH1;CRTC1;BCHE;RGS14;SEPT5;NLGN4Y;HTR1B;PRNP;C2CD4C;TH;OPHN1;TPGS1;CACNB1;GDNF;SHISA9;RARA;SV2A;TSHZ3;SLITRK5;PPP3CA;ABAT;BSN;OXTR;DMPK
3185,GO:0006811,0.00135433033169237,0.999049783624406,121,856,ion transport,BP,SERPINE2;MMP9;CTGF;F2R;SLC7A8;ANO1;GJA5;PKD2;PITPNM3;JPH2;IRS2;OSBPL10;NOS1;GAS6;TCAF1;UTRN;TSC22D3;HSPA2;SLC8A1;ORAI3;CLCA2;MYLK;GJC2;SLC20A1;SLC2A3;ATP10D;NTSR1;ABCA1;VDR;TMC7;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;WNK1;DLG4;SLC7A11;ACSL3;SIK1;SLC22A15;ANO6;CNTN1;PLLP;MAGED2;SEC14L1;KCNAB2;FYN;CAV1;SLC27A1;PLA2G6;SLC22A17;OSBPL5;KCNJ15;EHD3;CAMK2D;PER1;ATP8B2;CCK;SYT1;SLC38A10;CPT1A;SLC38A2;CALHM2;ACACB;ANK3;WFS1;DAPK1;KCNJ5;STOM;SNCA;FGFR1;PRKAB2;PDE4D;NCOA2;PLA2R1;G6PD;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;ENPP1;SLC27A6;NCOR1;TMEM63C;TMEM175;TMC4;ABCC2;HTR1B;SLC39A11;PRNP;SCNN1A;FHL1;SFXN3;GOPC;SLC9A4;ITPR2;CACNB1;GDNF;KLHL3;PITPNC1;PPARG;CALCRL;KCNIP3;SHISA9;LGALS3;PTPN3;SV2A;PPP3CA;ANKH;STEAP2;CACNA2D3;ABAT;KCNRG;TUSC3;RXRA;ORAI2;CPT2;NFKBIE;DMPK
18392,GO:1903463,0.00135929092324417,1,3,3,regulation of mitotic cell cycle DNA replication,BP,CHEK2;FGFR1;BCL6
8199,GO:0032965,0.00135939632988536,0.999790191612206,7,19,regulation of collagen biosynthetic process,BP,CTGF;F2R;VIM;BMP4;ITGA2;ENG;PPARG
10289,GO:0043086,0.00136754877560039,0.999119446252266,78,536,negative regulation of catalytic activity,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;TXNIP;SFRP1;GADD45B;CD109;CDKN2B;NQO1;IRS2;DUSP6;COL7A1;NOS1;GAS6;TFPI2;FLRT3;SERPINE1;SERPINH1;ANXA5;TIMP2;ANGPTL4;BMP4;PTK6;PDCD4;SORL1;TP53;WWTR1;PYCARD;IFIT1;WNK1;MICAL1;ADARB1;TIMP1;CRIM1;ELFN2;GPX1;IFI6;CAV1;TRIB2;SERPING1;PRKCZ;PRDX5;ACACB;DUSP5;HERPUD1;SPRY2;APLP2;TP73;SPRY4;SNCA;AIP;IGF1R;RGS2;C5;PLA2R1;BBS4;MDM2;CST3;NR2F2;PTPN1;ANXA2;RGS14;LEPR;PRNP;TGFB2;MAP2K5;LEF1;CDKN2A;PPARG;DNAJC3;CDK5RAP3;SERPINB5;CAMK2N1;TAOK3;PINLYP
6047,GO:0019199,0.00136767403152526,0.999568124003101,15,50,transmembrane receptor protein kinase activity,MF,TGFBR2;EFEMP1;ROR1;AXL;EGFR;LTBP1;CRIM1;LTBP4;MST1R;FGFR1;IGF1R;EPHB6;TGFBR3;EFNB3;RET
10283,GO:0043068,0.00137111010576237,0.999139290803835,70,470,positive regulation of programmed cell death,BP,MMP9;TXNIP;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;NQO1;APBB2;F2R;GSN;DUSP6;MAGED1;NUPR1;NTSR1;VDR;BMP4;ITM2C;VAV3;PDCD4;COL18A1;IFIT2;KCNMA1;TP53;DDIT3;PYCARD;ARHGEF1;HIP1;TFDP2;BTG1;SIK1;ANO6;SRPX;ARHGEF12;XDH;CAV1;PLA2G6;TP53INP1;HMGA2;CAMK2D;ITGA1;CCK;TP73;DAPK1;DLC1;CHEK2;ROBO1;TLR3;SNCA;TGM2;OBSCN;ARHGEF17;NFATC4;ATM;APH1B;AKAP13;ZMAT3;FGD4;ARHGEF2;BCL6;PRNP;RET;TGFB2;CDKN2A;VAV2;CDK19;SRPK2;ARHGEF19;PPARG;ING4
3389,GO:0007169,0.00137947523761711,0.999111426126814,79,500,transmembrane receptor protein tyrosine kinase signaling pathway,BP,MMP2;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;DDIT4;FAT4;EFEMP1;IRS2;DUSP6;PDGFC;SULF2;ROR1;AXL;EGFR;TMEM204;FLRT3;SESN3;DOK1;CSPG4;PAK1;PTK6;VAV3;ARAP1;PILRB;PDGFA;HIP1;CRIM1;LRP1;FYN;XDH;RBFOX2;PRKCZ;ITGA1;MST1R;IL31RA;PXN;PIK3R1;SPRY2;ROBO1;SPRY4;SNCA;SH3TC2;FGFR1;PAG1;IGF1R;SETX;SULF1;MYOF;EPHB6;AFAP1L2;CDH13;EFNB3;APH1B;AREG;DGKQ;PTPN1;SDC2;SOX9;ENPP1;PRKCA;RGS14;IGFBP4;MVB12B;RET;IGFBP2;VAV2;PTPN3;COL4A1;EFNA5;FZD4;ADGRA2;RASA1;ELMO2;MYO1C;C2CD5;DOCK1
12245,GO:0048562,0.0013919900008145,0.999314720699981,33,162,embryonic organ morphogenesis,BP,FBN1;TGFBR2;SLITRK6;EFEMP1;PKD2;FBN2;BMP4;GLI3;GLI2;MDFI;SPRY2;IFT140;LRIG3;FGFR1;MYO3B;TRIOBP;NAGLU;ENG;BBS4;VANGL2;SOX9;HOXA1;TSHZ1;MEGF8;WDR19;DLX2;NPHP3;TH;YAP1;HOXA3;MED12;NIPBL;CELSR1
14486,GO:0065008,0.00139243153040255,0.99890132472569,300,2382,regulation of biological quality,BP,SERPINE2;SYT8;SULT1E1;FLOT1;FN1;FLRT2;CTGF;FBN1;SOX6;INPP5D;SFRP1;RHOBTB2;ZFP36L1;NQO1;SYNE1;F2R;TLN2;SLITRK6;PTGS1;IL20RB;SLC7A8;ANO1;GSN;ETV5;GJA5;PKD2;JPH2;IRS2;CYBRD1;ZFP36L2;IGF2BP2;ANPEP;NOS1;GAS6;FBN2;PDGFC;MALL;PHF21A;TFPI2;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;ITPK1;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;SYNE3;THBS2;SERPINE1;ATP10D;CRTAP;ANXA5;VIM;FAM210B;AMIGO2;NTSR1;TADA3;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;BMP4;PCSK1;NR1D1;SCN8A;EIF2AK4;NETO1;NEFL;VAV3;STAT1;SORL1;NEO1;SCN2A;LGALS1;GNG2;KCNMA1;MEST;TP53;ARAP1;PTPRS;DDIT3;PYCARD;LTBP1;IFIT1;WNK1;DLG4;SLC7A11;SEMA5A;ITGA2;PDGFA;MICAL1;NISCH;FLG;HIP1;TFDP2;DOCK4;TEP1;TPBG;ANO6;GPX1;DLG5;KITLG;NAV2;ERO1B;SYN1;PDPN;PLXNB1;FYN;IFI6;XDH;LTBP4;ARHGAP18;CPS1;CAV1;SLC27A1;PIAS3;ERCC6;RBFOX2;PLA2G6;SEL1L;DOCK11;GLDC;SLC22A17;CLU;SERPING1;NPHP4;PRKCZ;OAS2;SDR16C5;ULK2;ARPIN;TNS2;EHD3;CAMK2D;PRDX5;ITGA1;SYTL1;KANK2;IL31RA;ATP8B2;PDIA4;CCK;PIK3R1;SYT1;CAPRIN2;CPT1A;ACACB;PCLO;ANG;PARVA;BBS2;HERPUD1;ANK3;WFS1;MDFI;CIRBP;HPS4;FBLN1;TP73;DLC1;KLF13;PRKACB;AARS;CHEK2;KCNJ5;SNCA;FLOT2;MME;PDIA6;PLXNA2;FGFR1;IGF1R;DKK1;SEMA4A;RGS2;PDE4D;TGM2;PSMB9;IL18;PDK3;G6PD;TRIOBP;SLC24A1;NFATC4;TGFBR3;LRTOMT;L3MBTL3;BBS4;CALR;MKLN1;ATM;MDM2;ARF6;FAM20A;BBS1;ANXA6;HSD17B11;DGKQ;GCLC;NR2F2;PLXNA1;FHOD3;SYNE2;RNPEP;FGD4;KCNQ3;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;CRTC1;PRKCA;TMEM175;BCHE;ANXA2;TRERF1;RGS14;SEPT5;LEPR;ALDH9A1;KCTD7;HMBOX1;ABCC2;MEGF8;HTR1B;TAF8;PRNP;RET;ZFPM1;SCNN1A;LIPA;THRA;FHL1;CDC42EP5;LRRN3;USP28;SFXN3;ALDH7A1;C2CD4C;SP100;AGRN;NPHP3;VAV2;HSPA5;TH;GOPC;SLC9A4;FLNB;UVRAG;SEMA4B;ITPR2;UGT1A3;VPS13C;POLD4;SH2B3;GDNF;KLHL3;PPARG;CAPG;SHISA9;POSTN;PTPN3;RARA;COG3;SV2A;ABCA2;TAF1;TSHZ3;EFNA5;FZD4;SLITRK5;WIPF1;DPYD;PPP3CA;RASA1;LIMA1;STEAP2;HP1BP3;DNM1P46;SCPEP1;ABAT;TTBK2;ADM2;OXTR;RHOBTB3;MYO1C;ACAA2;NFKBIE;DOCK1;DMPK
16313,GO:0090596,0.00139392282063018,0.999341556491132,30,140,sensory organ morphogenesis,BP,COL8A1;FBN1;SLITRK6;EFEMP1;COL5A2;SDK1;FBN2;COL5A1;TENM3;PTPRM;BMP4;KRT13;GLI3;GLI2;SPRY2;LRIG3;FGFR1;MYO3B;TRIOBP;NAGLU;BBS4;VANGL2;SOX9;HOXA1;TSHZ1;WDR19;IFT122;TH;NIPBL;CELSR1
1306,GO:0003151,0.00140339772029196,0.999594561417997,13,45,outflow tract morphogenesis,BP,TGFBR2;GJA5;BMP4;PARVA;TGFBR3;FZD1;ENG;CITED2;ISL1;ZFPM1;TGFB2;RARA;NIPBL
4371,GO:0010001,0.00141634419779812,0.999357664249895,27,130,glial cell differentiation,BP,SERPINE2;SOX6;TENM4;GSN;ROR1;EGFR;VIM;GLI3;LRP1;AHNAK2;CLU;ADGRG6;PRDM8;TP73;METRN;PRX;SH3TC2;HDAC11;SOX9;NDRG1;NAB2;DLX2;LEF1;PPARG;KDM4A;MED12;LAMB2
5258,GO:0015908,0.0014269373543809,0.999560124962424,14,52,fatty acid transport,BP,IRS2;NTSR1;ACSL3;SLC27A1;PLA2G6;CPT1A;ACACB;PRKAB2;PLA2R1;SLC27A6;NCOR1;ABCC2;PPARG;CPT2
7841,GO:0032412,0.00144747868831187,0.999344145543651,27,126,regulation of ion transmembrane transporter activity,BP,MMP9;PKD2;JPH2;NOS1;TCAF1;UTRN;HSPA2;NTSR1;AHNAK;NETO1;WNK1;DLG4;CAV1;PLA2G6;EHD3;CAMK2D;ANK3;DAPK1;STOM;PDE4D;PRNP;FHL1;GOPC;CACNB1;SHISA9;PTPN3;KCNRG
4594,GO:0010714,0.00145545465830561,0.999821844876995,6,14,positive regulation of collagen metabolic process,BP,CTGF;F2R;VIM;BMP4;ITGA2;ENG
8201,GO:0032967,0.00145545465830561,0.999821844876995,6,14,positive regulation of collagen biosynthetic process,BP,CTGF;F2R;VIM;BMP4;ITGA2;ENG
13460,GO:0055026,0.00145899845936773,0.999739216268593,8,21,negative regulation of cardiac muscle tissue development,BP,SOX6;TGFBR2;PAK1;JARID2;TP73;FZD7;DKK1;G6PD
537,GO:0001656,0.00150135038533315,0.999495756386485,16,57,metanephros development,BP,FBN1;FAT4;PKD2;BMP4;STAT1;WWTR1;PDGFA;GLI3;DLG5;EGR1;SOX9;RET;YAP1;GDNF;NIPBL;LAMB2
1303,GO:0003148,0.00150338271434125,0.999778412578515,7,16,outflow tract septum morphogenesis,BP,TGFBR2;BMP4;PARVA;ENG;ISL1;TGFB2;RARA
13096,GO:0051665,0.00151068765389554,0.999917564710057,4,7,membrane raft localization,BP,MARVELD1;GSN;MALL;PLLP
1252,GO:0003007,0.00151144818109163,0.999263935202484,32,148,heart morphogenesis,BP,FLRT2;FAT4;TGFBR2;GJA5;PKD2;SNAI2;COL5A1;BMP4;PDCD4;ADGRG6;PARVA;TTN;DLC1;DKK1;TGFBR3;FZD1;ENG;BBS4;MDM2;CITED2;VANGL2;SOX9;ISL1;MEGF8;ZFPM1;TGFB2;NPHP3;TH;YAP1;RARA;NIPBL;RXRA
3188,GO:0006814,0.00151288041244711,0.999324639330832,26,119,sodium ion transport,BP,SERPINE2;PKD2;NOS1;UTRN;SLC8A1;SLC20A1;SCN8A;NETO1;SCN2A;WNK1;SIK1;ANO6;CNTN1;MAGED2;CAMK2D;PER1;SLC38A10;SLC38A2;ANK3;STOM;SLC24A1;SCNN1A;SLC9A4;KLHL3;PTPN3;DMPK
3186,GO:0006812,0.00152984006434192,0.99899275026156,85,573,cation transport,BP,SERPINE2;MMP9;CTGF;F2R;SLC7A8;ANO1;GJA5;PKD2;JPH2;NOS1;GAS6;UTRN;HSPA2;SLC8A1;ORAI3;MYLK;GJC2;SLC20A1;ATP10D;NTSR1;VDR;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;WNK1;DLG4;SIK1;ANO6;CNTN1;MAGED2;SEC14L1;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;PER1;SYT1;SLC38A10;SLC38A2;CALHM2;ANK3;WFS1;DAPK1;KCNJ5;STOM;SNCA;PDE4D;G6PD;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;TMEM63C;TMEM175;ABCC2;HTR1B;SLC39A11;PRNP;SCNN1A;FHL1;SLC9A4;ITPR2;CACNB1;GDNF;KLHL3;CALCRL;KCNIP3;SHISA9;LGALS3;PTPN3;PPP3CA;STEAP2;CACNA2D3;ABAT;KCNRG;TUSC3;ORAI2;NFKBIE;DMPK
13732,GO:0060337,0.00153356049681847,0.999488702804172,15,68,type I interferon signaling pathway,BP,XAF1;STAT1;IFIT2;IFIT1;IFIT3;IFI6;OAS2;IFI35;PTPN1;EGR1;IFITM2;STAT2;SP100;RSAD2;IFITM1
15181,GO:0071357,0.00153356049681847,0.999488702804172,15,68,cellular response to type I interferon,BP,XAF1;STAT1;IFIT2;IFIT1;IFIT3;IFI6;OAS2;IFI35;PTPN1;EGR1;IFITM2;STAT2;SP100;RSAD2;IFITM1
6520,GO:0021915,0.00154796710490579,0.999296551573749,27,123,neural tube development,BP,SFRP1;ZFP36L1;PKD2;ITPK1;BMP4;PRICKLE1;GLI3;GLI2;DLC1;PRKACB;IFT140;PLXNA2;FZD1;BBS4;LMO4;VANGL2;SALL2;ZNF358;WDR19;TGFB2;IFT122;GPR161;SSBP3;NPHP3;RARA;MED12;CELSR1
12456,GO:0050431,0.00156254265368104,0.999774970622763,7,15,transforming growth factor beta binding,MF,CD109;TGFBR2;LTBP1;LTBP4;LTBP3;TGFBR3;ENG
12796,GO:0051128,0.0015951084589866,0.998765290219504,240,1801,regulation of cellular component organization,BP,SERPINE2;FLOT1;HTRA1;FN1;FLRT2;MMP9;CTGF;SFRP1;RHOBTB2;APBB2;SLITRK6;ASAP3;GSN;ETV5;SDK1;TNIK;PROM2;NOS1;GAS6;SNAI2;COL5A1;AXL;DPYSL2;EGFR;HSPA2;FLRT3;SPTB;DOCK5;SYNE3;CSMD3;THBS2;SERPINE1;S100A10;STON2;VIM;DDB2;AMIGO2;STMN3;TOM1L2;TADA3;TENM3;PAK1;ABCA1;BMP4;ITM2C;SMARCA2;PTK6;TBC1D8;NEFL;SORL1;LGALS1;TP53;ARAP1;CEP250;PTPRS;CUL9;PYCARD;DLG4;SEMA5A;ITGA2;PDGFA;MAP2;PHLDB1;HIP1;TFDP2;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;EVI5L;TPBG;ANO6;GPX1;PLEK2;DLG5;CNTN1;TBC1D5;ASAP1;PDPN;MTHFR;CTSV;PLXNB1;PDE4DIP;EML2;LRP1;FYN;LTBP4;ARHGAP18;CAV1;RMI2;PLA2G6;DOCK11;SNX33;ESPN;UST;CLU;DCBLD2;NPHP4;PRKCZ;SLIT3;SDR16C5;ULK2;ARPIN;EHD3;CAMK2D;KANK2;PXN;CCK;PIK3R1;SYT1;HHAT;CAPRIN2;PARVA;UHRF2;SPRY2;JARID2;HPS4;FBLN1;TP73;DLC1;METRN;ROBO1;IFT140;PHF2;SNCA;PLXNA2;COL16A1;FGFR1;IGF1R;LMNA;DKK1;FSCN1;SEMA4A;RGS2;SETX;G6PD;TRIOBP;KDM4C;CDH13;NFATC4;FZD1;BBS4;CALR;MKLN1;NEGR1;ATM;EFNB3;MDM2;ARF6;CST3;AKAP13;DNAJC6;PLXNA1;FHOD3;LMO4;TRAK1;FBXW8;SYNE2;FGD4;PTPN1;VANGL2;ARHGEF2;SDC2;SSH1;SOX9;ENPP1;ISL1;BCL6;CRTC1;ANXA2;MPP7;IGFBP4;IFT88;HMBOX1;RPL13A;PODXL;MEGF8;PRNP;RET;TGFB2;MAP2K5;OR2A4;STAT2;LEF1;THRA;FHL1;CDC42EP5;LRRN3;CDKN2A;ULK1;TSPYL2;AGRN;IGFBP2;MAGI2;KIAA1109;HSPA5;PIKFYVE;UVRAG;SEMA4B;ARHGEF19;VPS13C;FHOD1;OPHN1;KLF5;DIXDC1;PPARG;CAPG;INF2;SNX9;TBC1D16;OBSL1;POSTN;LGALS3;TMEM67;TAF1;EFNA5;FZD4;SLITRK5;WIPF1;PPP3CA;RASA1;LIMA1;CAPN6;SEPT9;DNPH1;KDM4A;KLHL22;AGO4;NIPBL;TTBK2;OXTR;ADAM10;RHOBTB3;CELSR1;MYO1C;C2CD5;ACAA2;DOCK1;DMPK
13443,GO:0055007,0.00160211114188399,0.999416824023504,18,66,cardiac muscle cell differentiation,BP,SOX6;SLC8A1;PAK1;BMP4;SIK1;TTN;FZD7;LMNA;DKK1;G6PD;CALR;AKAP13;FHOD3;MEF2A;OBSL1;RARA;MYH11;RXRA
7795,GO:0032355,0.0016084687005811,0.999416518174849,17,80,response to estradiol,BP,TXNIP;CTGF;SFRP1;NQO1;EGFR;FAM210B;ITGA2;CAT;CALR;CST3;AREG;NR2F2;IGFBP2;TH;POSTN;RARA;OXTR
15309,GO:0071560,0.00162481153489099,0.999199699286561,32,162,cellular response to transforming growth factor beta stimulus,BP,HTRA1;ITGB5;FBN1;SOX6;SFRP1;CD109;CDKN2B;ZFP36L1;TGFBR2;ZFP36L2;FBN2;PEG10;NR3C1;LTBP1;ITGA3;FYN;LTBP4;CAV1;PRKCZ;PXN;GLG1;TGFBR3;ENG;MTMR4;CITED2;SOX9;STK16;TGFB2;HSPA5;TGFB1I1;POSTN;FOS
9913,GO:0042277,0.00162483834618205,0.999204489287898,31,173,peptide binding,MF,APBB2;SLC7A8;ANPEP;ITM2C;SORL1;ITGA2;PTGES;CTSV;CLU;PIK3R1;ANG;BACE1;MME;IGF1R;APBB3;CALR;CST3;CD1D;RNPEP;BCHE;LANCL1;PRNP;TGFB2;ITM2A;PPARG;CALCRL;FZD4;PPP3CA;OXTR;RNPEPL1;RXRA
6661,GO:0030029,0.00162580143025855,0.998930886211706,85,514,actin filament-based process,BP,ITGB5;CTGF;SFRP1;RHOBTB2;TNNI2;ASAP3;GSN;GJA5;TNIK;SPTB;S100A10;VIM;PAK1;ARAP1;PYCARD;SEMA5A;PDGFA;MICAL1;NISCH;HIP1;PLEK2;LIMCH1;PDPN;CTSV;LRP1;ARHGAP18;CAV1;ESPN;NPHP4;PRKCZ;IQSEC2;ARPIN;CAMK2D;KANK2;PXN;PIK3R1;ANG;PARVA;TTN;SHROOM4;DLC1;KCNJ5;FRMD5;FSCN1;PDE4D;OBSCN;ARHGEF17;TRIOBP;AMOTL1;BBS4;CALR;MKLN1;ARF6;AKAP13;FHOD3;SYNE2;FGD4;PTPN1;VANGL2;ARHGEF2;SSH1;BCL6;RAB13;PAK6;OR2A4;AMOTL2;CDC42EP5;MSRB2;FLNB;ARHGEF19;FHOD1;OPHN1;DIXDC1;CAPG;INF2;MEF2A;OBSL1;EFNA5;WIPF1;RASA1;LIMA1;MYH11;RHOBTB3;CELSR1;MYO1C
4657,GO:0010810,0.00162621304769944,0.999223166312598,30,141,regulation of cell-substrate adhesion,BP,FN1;COL8A1;ITGA6;SFRP1;NID1;UTRN;DOCK5;SERPINE1;S100A10;LGALS1;ITGA3;PDPN;CCDC80;PRKCZ;PIK3R1;FBLN1;DLC1;FZD7;COL16A1;TRIOBP;CDH13;CALR;BCL6;CDKN2A;POSTN;ECM2;EFNA5;FZD4;RASA1;DOCK1
18001,GO:1902531,0.00165834256577339,0.998760489256401,177,1303,regulation of intracellular signal transduction,BP,SERPINE2;FLOT1;FN1;FLRT2;MMP9;CTGF;SFRP1;GADD45B;RHOBTB2;F2R;DDIT4;ASAP3;PKD2;JPH2;IRS2;DUSP6;TNIK;NOS1;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;ARHGAP23;ROR1;AXL;EGFR;FLRT3;SESN3;SLC20A1;CSPG4;TKFC;MAP3K6;STMN3;ASAP2;TIMP2;PAK1;ABCA1;CHN2;SRGAP3;BMP4;TRIM38;PTK6;TRIM5;VAV3;PDCD4;STAT1;SORL1;LGALS1;TP53;ARAP1;DDIT3;PYCARD;PLEKHG3;DDX60;ARHGEF1;SEMA5A;PDGFA;HIP1;GPNMB;ITGA3;CHD3;GPX1;DLG5;KITLG;ASAP1;SESN1;SEC14L1;PLXNB1;FYN;ARHGEF12;XDH;ARHGAP18;CAV1;RMI2;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;TP53INP1;IQSEC2;CAMK2D;ITGA1;MST1R;IL31RA;PER1;PIK3R1;DUSP5;UNC5B;HERPUD1;WFS1;SPRY2;FBLN1;TP73;CAT;DLC1;CHEK2;ROBO1;SPRY4;TLR3;FZD7;AIP;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;PDE4D;TGM2;IL18;OBSCN;PLA2R1;EPHB6;EDA2R;FZD8;ARHGEF17;CDH13;AKAP7;LMCD1;ENG;CALR;ATM;SRGAP1;MDM2;ARF6;IFNK;AKAP13;DGKQ;IFNE;MAP3K1;FGD4;PTPN1;VANGL2;ARHGEF2;NRK;SOX9;ISL1;ITPKB;BCL6;NCOR1;PRKCA;RGS14;IGFBP4;DEPDC7;NFAT5;PAK6;MAP3K12;UACA;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;VAV2;MAGI2;AGAP1;ARHGEF19;ARHGAP29;MDFIC;OPHN1;MYO9A;RALGAPB;MEIS3;SASH1;PRKAG1;TAF1;FZD4;RASA1;ARHGAP31;CDK5RAP3;CAMK2N1;LITAF;TAOK3
19731,GO:2000146,0.00167948834736642,0.99915034807181,34,177,negative regulation of cell motility,BP,SFRP1;MMP28;TCAF1;SERPINE1;PTPRM;SRGAP3;NISCH;ADARB1;TIMP1;DLG5;LRP1;TP53INP1;ARPIN;FBLN1;DLC1;ROBO1;FRMD5;PTPRU;ALOX15B;C5;SULF1;ENG;CALR;IDH2;SRGAP1;CITED2;NR2F2;MAP2K5;SP100;MAGI2;IFITM1;PPARG;GCSAM;MIA3
9166,GO:0035556,0.00168819114458936,0.998681981334411,257,1975,intracellular signal transduction,BP,SERPINE2;FLOT1;FN1;FLRT2;MMP9;PRODH;CTGF;INPP5D;SFRP1;GADD45B;RHOBTB2;ZFP36L1;APBB2;F2R;DDIT4;FAT4;ASAP3;GSN;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;ZFP36L2;TNIK;NOS1;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;ARHGAP23;ROR1;AXL;DOCK9;EGFR;FLRT3;SPTB;SLC8A1;DOCK5;SESN3;SLC20A1;DOK1;NUPR1;CSPG4;CTNNAL1;TKFC;MAP3K6;STMN3;ASAP2;TIMP2;PAK1;ABCA1;CHN2;SRGAP3;BMP4;TRIM38;PTK6;RIN2;TRIM5;NEFL;VAV3;PDCD4;STAT1;SORL1;SCN2A;LGALS1;GNG2;TP53;ARAP1;WWTR1;DDIT3;PYCARD;WNK1;PLEKHG3;DDX60;ARHGEF1;DLG4;SEMA5A;PDGFA;NISCH;HIP1;GPNMB;TFDP2;DOCK4;ITGA3;CHD3;SIK1;GPX1;PLEK2;E2F7;DLG5;KITLG;ASAP1;PDPN;SESN1;SEC14L1;PLXNB1;FYN;ARHGEF12;XDH;ARHGAP18;CAV1;RMI2;ERCC6;PLA2G6;TRIB2;DOCK11;MAP3K14;CLU;NPHP4;PRKCZ;TP53INP1;IQSEC2;TNS2;CAMK2D;ADGRG6;ITGA1;MST1R;IL31RA;PER1;PIK3R1;PCLO;DUSP5;UNC5B;HERPUD1;WFS1;SPRY2;TTN;FBLN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;CHEK2;ROBO1;SPRY4;TLR3;FZD7;AIP;FGFR1;PAG1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;TGM2;PSMB9;IL18;OBSCN;PLA2R1;EPHB6;EDA2R;FZD8;ARHGEF17;CDH13;NFATC4;AKAP7;LMCD1;TGFBR3;AMOTL1;ENG;CALR;ATM;SRGAP1;MDM2;ARF6;IFNK;AKAP13;DGKQ;IFNE;ZMAT3;MAP3K1;FGD4;PTPN1;VANGL2;ARHGEF2;NRK;SOX9;UCN2;IFT27;ISL1;ITPKB;BCL6;NCOR1;NDRG1;PRKCA;RGS14;RAB13;IGFBP4;DEPDC7;NFAT5;PAK6;MAP3K12;UACA;STK36;RAB43;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;AMOTL2;IFT122;CDC42EP5;USP28;MAPK8IP3;CDKN2A;SP100;VAV2;MAGI2;AGAP1;PIKFYVE;SRPK2;ARHGEF19;ITPR2;ARHGAP29;MDFIC;OPHN1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;CAPS;MEIS3;CALCRL;MEF2A;ICK;SASH1;ING4;ARL3;NYAP1;PRKAG1;TAF1;FZD4;PPP3CA;PIK3C2B;RASA1;ARHGAP31;CDK5RAP3;CAMK2N1;ADM2;OXTR;RHOBTB3;CELSR1;LITAF;TAOK3;DOCK1;DMPK
12938,GO:0051347,0.00169418439026073,0.998914283080618,74,483,positive regulation of transferase activity,BP,GADD45B;F2R;TGFBR2;PKD2;DUSP6;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;CSPG4;MAP3K6;PAK1;BMP4;VAV3;SORL1;WNK1;DLG4;PILRB;PDGFA;KITLG;SLC27A1;ERCC6;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;ANG;DUSP5;SPRY2;TP73;PRKACB;ROBO1;TLR3;SNCA;FGFR1;IGF1R;DKK1;C5;IL18;EPHB6;FZD8;AFAP1L2;FAM20A;AKAP13;DGKQ;LMO4;MAP3K1;PTPN1;VANGL2;NRK;EGR1;HMBOX1;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;MAPK8IP3;VAV2;HSPA5;MDFIC;SNX9;SASH1;CCNY;PRKAG1;EFNA5;FZD4;TAOK3
8124,GO:0032836,0.00169556683520568,0.999873493753908,5,8,glomerular basement membrane development,BP,NID1;SULF2;COL4A4;SULF1;LAMB2
3453,GO:0007268,0.00174957572218722,0.99898283965066,51,296,chemical synaptic transmission,BP,SERPINE2;SYT8;FLOT1;NQO1;F2R;ETV5;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;NISCH;ADARB1;SYN1;SPG11;PLA2G6;PRKCZ;SYTL1;SYT1;PCLO;BACE1;SNCA;DKK1;SLC24A1;NFATC4;KCNQ3;SSH1;CRTC1;BCHE;RGS14;SEPT5;NLGN4Y;HTR1B;PRNP;C2CD4C;TH;OPHN1;TPGS1;CACNB1;GDNF;SHISA9;RARA;SV2A;TSHZ3;SLITRK5;PPP3CA;ABAT;BSN;OXTR;DMPK
16907,GO:0098916,0.00174957572218722,0.99898283965066,51,296,anterograde trans-synaptic signaling,BP,SERPINE2;SYT8;FLOT1;NQO1;F2R;ETV5;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;NISCH;ADARB1;SYN1;SPG11;PLA2G6;PRKCZ;SYTL1;SYT1;PCLO;BACE1;SNCA;DKK1;SLC24A1;NFATC4;KCNQ3;SSH1;CRTC1;BCHE;RGS14;SEPT5;NLGN4Y;HTR1B;PRNP;C2CD4C;TH;OPHN1;TPGS1;CACNB1;GDNF;SHISA9;RARA;SV2A;TSHZ3;SLITRK5;PPP3CA;ABAT;BSN;OXTR;DMPK
16476,GO:0097205,0.00177070557504587,0.999782175343193,6,13,renal filtration,BP,F2R;GJA5;GAS6;SULF2;ITGA3;SULF1
12550,GO:0050731,0.00182133341053446,0.999250134557943,21,101,positive regulation of peptidyl-tyrosine phosphorylation,BP,GAS6;CSPG4;PTK6;TP53;DLG4;CNTN1;KITLG;FYN;ERCC6;IL31RA;CCK;CTF1;IL18;AFAP1L2;AREG;DGKQ;PTPN1;ARHGEF2;ISL1;PRNP;EFNA5
5574,GO:0016597,0.00182956904655641,0.999555322757354,10,34,amino acid binding,MF,NOS1;SESN3;SESN1;CPS1;GLDC;AARS;GCLC;THNSL2;TH;SRR
11287,GO:0045628,0.00184824287429908,0.999893224163988,4,7,regulation of T-helper 2 cell differentiation,BP,PRKCZ;IL18;BCL6;RARA
18253,GO:1903169,0.00185524431737669,0.999304164524147,18,75,regulation of calcium ion transmembrane transport,BP,F2R;PKD2;JPH2;NOS1;HSPA2;SLC8A1;GJC2;NTSR1;AHNAK;FYN;PLA2G6;EHD3;CAMK2D;SNCA;PDE4D;G6PD;PRNP;CACNB1
12604,GO:0050818,0.00189518763178911,0.999450459361752,12,49,regulation of coagulation,BP,SERPINE2;F2R;SERPINE1;ANXA5;PDGFA;ANO6;PDPN;CAV1;SERPING1;PRKCA;ANXA2;ABAT
13247,GO:0051963,0.00189589238793282,0.99943463771927,13,44,regulation of synapse assembly,BP,FLRT2;SLITRK6;FLRT3;THBS2;AMIGO2;TPBG;DLG5;SNCA;LRRN3;AGRN;EFNA5;SLITRK5;OXTR
13719,GO:0060322,0.00191323896518611,0.998756245931468,78,476,head development,BP,SERPINE2;MMP2;TRNP1;SFRP1;DDIT4;FAT4;TGFBR2;IRS2;AXL;DPYSL2;EGFR;LAMB1;FLRT3;SLC8A1;GJC2;AMIGO2;PAK1;BMP4;NEFL;PTPRS;EFHC1;SLC7A11;SEMA5A;ACSL3;PHGDH;GLI3;DLG5;CNTN1;LRP1;FYN;FUT10;GLI2;RBFOX2;SMARCA1;SYT1;SLC38A2;BBS2;SHROOM4;DLC1;AARS;ROBO1;PLXNA2;FGFR1;DKK1;G6PD;FZD1;NAGLU;BBS4;ATM;CST3;NR2F2;SYNE2;SOX9;ISL1;PGAP1;ATXN1;STK36;DLX2;SMG9;LEF1;THRA;SSBP3;HSPA5;TH;TACC2;OPHN1;SRR;DIXDC1;RARA;COL4A1;TAF1;FZD4;SLITRK5;CDK5RAP3;ABAT;NIPBL;TTBK2;OXTR
10482,GO:0043406,0.00191334426243139,0.999000835077964,36,197,positive regulation of MAP kinase activity,BP,GADD45B;F2R;DUSP6;TNIK;PDGFC;MAGED1;EGFR;CSPG4;MAP3K6;PAK1;BMP4;PDGFA;KITLG;ERCC6;MAP3K14;ITGA1;MST1R;DUSP5;TP73;ROBO1;FGFR1;DKK1;C5;FZD8;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;MAP3K12;MAP2K5;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
6623,GO:0022898,0.00191839412132788,0.999110791619663,27,129,regulation of transmembrane transporter activity,BP,MMP9;PKD2;JPH2;NOS1;TCAF1;UTRN;HSPA2;NTSR1;AHNAK;NETO1;WNK1;DLG4;CAV1;PLA2G6;EHD3;CAMK2D;ANK3;DAPK1;STOM;PDE4D;PRNP;FHL1;GOPC;CACNB1;SHISA9;PTPN3;KCNRG
10531,GO:0043506,0.00191850331916196,0.999303057709513,17,69,regulation of JUN kinase activity,BP,SFRP1;TNIK;MAP3K6;PAK1;PDCD4;ERCC6;TP73;DKK1;FZD8;PTPN1;VANGL2;NRK;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
8680,GO:0034330,0.00195114016490356,0.998939476459141,41,207,cell junction organization,BP,FLOT1;FN1;ITGA6;SFRP1;F2R;TLN2;ITGB4;GJA5;SDK1;SNAI2;KRT14;S100A10;PLEC;TNS1;KRT5;ITGA2;LAMC2;DLG5;FLNC;UGT8;LAMA3;CAV1;NPHP4;ANG;LAMA5;LAMB3;DLC1;COL16A1;FSCN1;CDH13;NFASC;PRKCA;RAB13;MPP7;CDH11;TGFB2;OPHN1;MYO9A;COL17A1;EFNA5;MYO1C
10583,GO:0043583,0.00197602066882846,0.999130312562543,24,111,ear development,BP,FAT4;SLITRK6;ROR1;CXCL14;BMP4;GLI3;GLI2;SPRY2;LRIG3;FGFR1;MYO3B;TRIOBP;LRTOMT;NAGLU;MAF;VANGL2;SOX9;IFT27;HOXA1;TSHZ1;WDR19;TGFB2;NIPBL;CELSR1
16148,GO:0090197,0.00198127678215878,0.999883254883959,4,7,positive regulation of chemokine secretion,BP,PYCARD;ALOX15B;C5;POSTN
10543,GO:0043523,0.00198470915045818,0.999086700243307,26,135,regulation of neuron apoptotic process,BP,NQO1;F2R;AXL;TRIM2;NEFL;TP53;DDIT3;GPX1;LRP1;FYN;ITGA1;UNC5B;WFS1;TP73;AARS;SNCA;G6PD;ATM;GCLC;ISL1;MAP3K12;PRNP;TGFB2;SRPK2;GDNF;RASA1
7661,GO:0032101,0.00200763687552978,0.998736879265917,66,440,regulation of response to external stimulus,BP,SERPINE2;HTRA1;MMP28;CD109;F2R;TGFBR2;IL20RB;HERC5;GAS6;SNAI2;EGFR;SERPINE1;TKFC;CXCL14;EIF2AK4;TRIM5;PDCD4;STAT1;PTPRS;PYCARD;IFIT1;DDX60;SEMA5A;ITGA2;PDGFA;ANO6;GPX1;PDPN;SEC14L1;CAV1;CLU;SERPING1;KANK2;PER1;CCK;TMEM173;APOBEC3G;BBS2;ROBO1;TLR3;SNCA;PLXNA2;FGFR1;APOBEC3F;SEMA4A;C5;TGM2;IL18;CDH13;BBS4;CALR;PLXNA1;ISL1;BCL6;PRKCA;ANXA2;MOSPD2;MEGF8;CDK19;SEMA4B;PPARG;CALCRL;SASH1;ADGRA2;ABAT;ADAM10
1459,GO:0003707,0.00203342568994485,0.999462412079935,11,36,steroid hormone receptor activity,MF,VDR;NR1D1;NR3C1;PAQR8;PAQR7;NR2F2;LEF1;THRA;PPARG;RARA;RXRA
761,GO:0002009,0.00203598761727319,0.998726967766204,65,396,morphogenesis of an epithelium,BP,SFRP1;FAT4;TGFBR2;ETV5;PKD2;SNAI2;MAGED1;COL5A1;ROR1;EGFR;FLRT3;PAK1;VDR;BMP4;STAT1;PRICKLE1;PDGFA;GLI3;DLG5;PDPN;CTSV;GLI2;LAMA5;SPRY2;DLC1;PRKACB;FZD7;FGFR1;DKK1;ASTN2;TGM2;PSMB9;SULF1;NFATC4;FZD1;PBX1;ENG;BBS4;AREG;PLXNA1;LMO4;VANGL2;SOX9;PODXL;MEGF8;RET;TGFB2;IFT122;LEF1;NPHP3;MAGI2;TGFB1I1;ARHGEF19;OPHN1;MYO9A;YAP1;GDNF;KLHL3;RARA;COL4A1;FZD4;SERPINB5;MED12;CELSR1;RXRA
11289,GO:0045630,0.00203995887217841,0.999955747505419,3,4,positive regulation of T-helper 2 cell differentiation,BP,PRKCZ;IL18;RARA
15673,GO:0072243,0.00205322304673186,0.999688902256652,7,15,metanephric nephron epithelium development,BP,FAT4;PKD2;STAT1;WWTR1;SOX9;YAP1;LAMB2
6833,GO:0030308,0.00206083573221352,0.999082437807669,24,123,negative regulation of cell growth,BP,SERPINE2;SFRP1;APBB2;PAK1;SMARCA2;TP53;PTPRS;SEMA5A;CCDC85B;BTG1;DCBLD2;SLIT3;ULK2;CAPRIN2;SEMA4A;G6PD;ENPP1;BCL6;TGFB2;FHL1;CDKN2A;TSPYL2;SEMA4B;PPARG
4262,GO:0009612,0.00206955316739886,0.999034128779298,27,131,response to mechanical stimulus,BP,SERPINE2;TXNIP;TGFBR2;XPC;SLITRK6;PKD2;EGFR;SLC8A1;STAT1;ETV1;ITGA2;PPL;FYN;GLI2;MAP3K14;SLC38A2;TTN;TLR3;ENG;MEIS2;GCLC;MAP3K1;SOX9;IGFBP2;PPARG;POSTN;FOS
13333,GO:0052547,0.00207287540004052,0.998836445744279,43,286,regulation of peptidase activity,BP,SERPINE2;TNFRSF6B;FN1;MMP9;CTGF;CD109;F2R;GSN;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;SORL1;PYCARD;MICAL1;TIMP1;HIP1;CRIM1;GPX1;FYN;IFI6;XDH;CAV1;SERPING1;PRDX5;CCK;HERPUD1;APLP2;FBLN1;DAPK1;DLC1;ROBO1;SNCA;C5;PSMB9;MDM2;CST3;MAP2K5;LEF1;PPARG;SERPINB5
12614,GO:0050839,0.00211187094959334,0.99869562324975,61,388,cell adhesion molecule binding,MF,ITGB6;FN1;GPRC5A;CTGF;FBN1;ITGA6;TENM4;COL5A1;UTRN;DOCK9;EGFR;CTNNAL1;TIMP2;TENM3;PLEC;PTPRM;AHNAK;STAT1;ITGA2;NISCH;PPL;GPNMB;ITGA3;SNX1;ASAP1;LTBP4;ARHGAP18;PXN;PARVA;LAMA5;ANK3;FRMD5;COL16A1;FSCN1;TGFBI;ESYT2;CDH13;CALR;CD1D;PTPN1;NDRG1;PRKCA;ANXA2;MPP7;TES;PAK6;NLGN4Y;CDH11;MPRIP;HSPA5;FLNB;CAPG;SNX9;POSTN;ECM2;LIMA1;SEPT9;ADAM10;TSPAN4;S100A11;LAMB2
13880,GO:0060560,0.00212059844948327,0.998929541682091,33,156,developmental growth involved in morphogenesis,BP,FN1;SFRP1;TGFBR2;DPYSL2;FLRT3;PAK1;BMP4;EIF2AK4;PTPRS;SEMA5A;SPG11;PLXNB1;PRKCZ;SLIT3;ULK2;SYT1;SPRY2;PLXNA2;SEMA4A;RAPH1;AREG;PLXNA1;VANGL2;SOX9;MEGF8;ULK1;MAGI2;SEMA4B;YAP1;POSTN;EFNA5;MED12;LAMB2
12346,GO:0048754,0.00212647819965208,0.999062361480558,24,106,branching morphogenesis of an epithelial tube,BP,FAT4;TGFBR2;ETV5;PKD2;MAGED1;PAK1;VDR;BMP4;GLI3;DLG5;GLI2;LAMA5;SPRY2;NFATC4;PBX1;ENG;AREG;VANGL2;SOX9;LEF1;YAP1;GDNF;COL4A1;CELSR1
4359,GO:0009967,0.00214748148831719,0.998429696831866,143,1059,positive regulation of signal transduction,BP,FLOT1;MMP9;CCBE1;CTGF;SFRP1;GADD45B;CDKN2B;F2R;GSN;PKD2;JPH2;IRS2;DUSP6;TNIK;SKP2;NOS1;GAS6;PDGFC;MAGED1;SULF2;ROR1;AXL;EGFR;SLC20A1;DOK1;RNF165;CSPG4;EVC;MAP3K6;NTSR1;TIMP2;PAK1;CHN2;BMP4;TRIM38;ITM2C;PTK6;NETO1;TRIM5;VAV3;PDCD4;NEO1;LGALS1;TP53;ARAP1;DDIT3;PYCARD;WNK1;DDX60;DLG4;SEMA5A;PDGFA;HIP1;GPNMB;TFDP2;GPX1;DLG5;KITLG;SRPX;PLXNB1;FYN;XDH;CAV1;ERCC6;PLA2G6;MAP3K14;PRKCZ;TP53INP1;ITGA1;MST1R;IL31RA;PIK3R1;CAPRIN2;DUSP5;UNC5B;SPRY2;TP73;CAT;ROBO1;TLR3;FZD7;FGFR1;PAG1;IGF1R;ALOX15B;DKK1;CTF1;C5;TGM2;PSMB9;IL18;SULF1;PLA2R1;EPHB6;EDA2R;FZD8;AFAP1L2;CDH13;NFATC4;LMCD1;TGFBR3;ENG;CALR;ATM;AKAP13;CITED2;MAP3K1;PTPN1;POGLUT1;VANGL2;NRK;SSH1;SOX9;ISL1;ITPKB;PRKCA;MPP7;IGFBP4;MAP3K12;TSPAN5;STK36;MAML2;RET;TGFB2;MAP2K5;MAPK8IP3;TGFB1I1;RSAD2;MDFIC;SH2B3;YAP1;DIXDC1;MEIS3;AGPAT1;SASH1;TAF1;FZD4;CREBRF;CDK5RAP3;ABAT;LITAF;MYO1C;TAOK3
4840,GO:0014052,0.00215829078888284,1,3,3,regulation of gamma-aminobutyric acid secretion,BP,NTSR1;SV2A;ABAT
3743,GO:0008284,0.00218094008797576,0.998565659407315,79,538,positive regulation of cell proliferation,BP,MMP2;HTRA1;FN1;MMP9;CTGF;SFRP1;F2R;TGFBR2;ETV5;IRS2;SKP2;GAS6;PDGFC;EGFR;LAMB1;GJC2;PAK1;BMP4;TBC1D8;VAV3;COL18A1;STAT1;WWTR1;PYCARD;MEF2D;SEMA5A;ITGA2;PDGFA;TIMP1;LAMC2;GLI3;KITLG;GLI2;PRKCZ;FBXW4;HMGA2;MST1R;IL31RA;CCK;ANG;FZD7;FGFR1;IGF1R;CTF1;LTBP3;TGM2;IL18;KDM4C;CDH13;TGFBR3;PBX1;CALR;MDM2;CST3;MEIS2;AREG;CD1D;CRIP2;EGR1;SOX9;ISL1;BCL6;PLAG1;PRKCA;ANXA2;HTR1B;TGFB2;MAP2K5;LEF1;SSBP3;IGFBP2;SRPK2;YAP1;GDNF;KLF5;HOXA3;CALCRL;RARA;ADAM10
12505,GO:0050673,0.00218158330284856,0.99877081146539,44,255,epithelial cell proliferation,BP,KRT4;HTRA1;COL8A1;SFRP1;CD109;CDKN2B;ZFP36L1;SNAI2;MAGED1;SULF2;EGFR;LAMB1;VDR;PTPRM;BMP4;NR1D1;STAT1;SEMA5A;KLF9;GPX1;CTSV;XDH;CAV1;SDR16C5;ANG;ROBO1;FZD7;FGFR1;SULF1;CDH13;TGFBR3;AREG;NR2F2;SOX9;ISL1;PRKCA;IGFBP4;TGFB2;MAP2K5;IFT122;IFT74;YAP1;PPARG;SERPINB5
4781,GO:0010975,0.00219148081456997,0.998679283918268,56,318,regulation of neuron projection development,BP,FN1;SFRP1;SDK1;TNIK;DPYSL2;CSMD3;VIM;TENM3;PAK1;ITM2C;PTK6;NEFL;LGALS1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;ITGA3;DLG5;CNTN1;ASAP1;PLXNB1;LRP1;FYN;UST;ULK2;SYT1;CAPRIN2;METRN;ROBO1;PLXNA2;FGFR1;SEMA4A;SETX;NFATC4;FZD1;NEGR1;EFNB3;MDM2;ARF6;PLXNA1;TRAK1;FBXW8;SDC2;SSH1;CRTC1;MEGF8;RET;MAGI2;HSPA5;SEMA4B;OBSL1;EFNA5;FZD4;PPP3CA
14110,GO:0061005,0.00221185926021388,0.999415461732379,11,34,cell differentiation involved in kidney development,BP,FAT4;ACTA2;BMP4;STAT1;WWTR1;GLI3;PODXL;MAGI2;YAP1;GDNF;LAMB2
16874,GO:0098858,0.00221556382456257,0.998980349090752,26,121,actin-based cell projection,CC,ITGA6;PROM2;UTRN;ACTA2;PDGFA;DOCK4;ITGA3;KITLG;PDPN;CTSV;ESPN;SYTL1;BBS2;FSCN1;MYO3B;TRIOBP;RAPH1;ARF6;SYNE2;FGD4;NFASC;PODXL;DEF6;ADGRA2;OXTR;MYO1C
4533,GO:0010611,0.00222072703290536,0.999409237969689,11,35,regulation of cardiac muscle hypertrophy,BP,PAK1;CAMK2D;JARID2;LMNA;RGS2;G6PD;LMCD1;AKAP13;PRKCA;MEF2A;PPP3CA
20259,GO:2001257,0.00223229260030495,0.999121782925142,19,80,regulation of cation channel activity,BP,MMP9;PKD2;JPH2;NOS1;NTSR1;AHNAK;NETO1;DLG4;CAV1;PLA2G6;EHD3;CAMK2D;ANK3;DAPK1;STOM;PDE4D;CACNB1;SHISA9;KCNRG
16082,GO:0090092,0.00224071944874742,0.99893043407334,28,139,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;FBN1;SFRP1;CD109;CDKN2B;TGFBR2;FBN2;PEG10;RNF165;BMP4;NEO1;WWTR1;LTBP1;ITGA3;LTBP4;CAV1;GLG1;DKK1;SULF1;TGFBR3;FZD1;ENG;MTMR4;CITED2;TGFB2;MAGI2;HSPA5;TGFB1I1
9843,GO:0042110,0.00224666854279511,0.998728905514663,44,269,T cell activation,BP,ZFP36L1;TGFBR2;IL20RB;GSN;ZFP36L2;PAK1;BMP4;EIF2AK4;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;BTN3A1;FLOT2;FZD7;PAG1;SEMA4A;IL18;FZD8;SOX13;EFNB3;IFNK;IFNE;CD1D;EGR1;ITPKB;BCL6;LEPR;PRNP;ZFPM1;LEF1;IGFBP2;RSAD2;LGALS3;RARA;ZBTB1;PPP3CA
10007,GO:0042471,0.00225225626672334,0.999232276423292,15,58,ear morphogenesis,BP,SLITRK6;GLI2;SPRY2;LRIG3;FGFR1;MYO3B;TRIOBP;NAGLU;VANGL2;SOX9;HOXA1;TSHZ1;WDR19;NIPBL;CELSR1
4563,GO:0010649,0.0022665860227908,0.99979654023131,5,9,regulation of cell communication by electrical coupling,BP,SLC8A1;CAV1;CAMK2D;ANK3;PDE4D
7488,GO:0031670,0.00226993308109096,0.999334958905568,12,45,cellular response to nutrient,BP,SFRP1;CDKN2B;GAS6;SNAI2;VDR;FYN;KANK2;MDM2;SSH1;PPARG;POSTN;TAF1
10714,GO:0044092,0.00230671816957993,0.998396924686792,103,748,negative regulation of molecular function,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;TXNIP;SFRP1;GADD45B;CD109;CDKN2B;NQO1;PKD2;IRS2;DUSP6;COL7A1;NOS1;GAS6;TFPI2;FLRT3;SERPINE1;SERPINH1;ANXA5;TIMP2;ANGPTL4;BMP4;PTK6;EIF2AK4;PDCD4;SORL1;IFIT2;TP53;WWTR1;DDIT3;PYCARD;IFIT1;WNK1;MICAL1;ADARB1;TIMP1;CRIM1;SIK1;ELFN2;GPX1;ZFP90;IFI6;CAV1;TRIB2;SERPING1;PRKCZ;HMGA2;CAMK2D;PRDX5;ACACB;DUSP5;HERPUD1;ANK3;WFS1;MDFI;SPRY2;APLP2;TP73;CAT;SPRY4;SNCA;AIP;IGF1R;DKK1;RGS2;C5;PLA2R1;NFATC4;BBS4;MDM2;CST3;NR2F2;PTPN1;ISL1;ANXA2;RGS14;LEPR;PRNP;ZFPM1;TGFB2;MAP2K5;LEF1;THRA;CDKN2A;SP100;HSPA5;GOPC;PPARG;DNAJC3;TAF1;PPP3CA;CDK5RAP3;SERPINB5;CAMK2N1;TTBK2;KCNRG;TAOK3;NFKBIE;PINLYP
4939,GO:0014909,0.00230963402015436,0.999289482242321,13,46,smooth muscle cell migration,BP,DOCK5;SERPINE1;PAK1;SORL1;ITGA2;PDGFA;DOCK4;LRP1;PARVA;MDM2;PLXNA1;SSH1;POSTN
1340,GO:0003203,0.00233970240399805,0.999616307292523,7,17,endocardial cushion morphogenesis,BP,TGFBR2;SNAI2;ENG;MDM2;SOX9;ISL1;TGFB2
626,GO:0001816,0.00241713284327854,0.998465484902476,66,450,cytokine production,BP,ITGB6;FLOT1;FN1;CCBE1;INPP5D;F2R;IL20RB;IGF2BP2;HERC5;GAS6;SNAI2;SULF2;AXL;SERPINE1;TKFC;ABCA1;PDCD4;STAT1;PTPRS;DDIT3;ZBTB20;PYCARD;DDX60;GPNMB;ERMAP;SEC14L1;POLR3GL;RNF135;TRIB2;CLU;PRKCZ;IL31RA;PER1;PIK3R1;TMEM173;BTN3A1;TLR3;FGFR1;ALOX15B;LTBP3;C5;PDE4D;IL18;SULF1;PLA2R1;AFAP1L2;NFATC4;MAF;ARHGEF2;EGR1;ISL1;BCL6;NFAT5;PRNP;ZFPM1;TGFB2;MAP2K5;LIPA;LEF1;BTN3A3;RSAD2;UBA7;AGPAT1;POSTN;RARA;LITAF
5618,GO:0016684,0.00244673707310549,0.999477938337388,8,31,oxidoreductase activity, acting on peroxide as acceptor,MF,PTGS1;SESN3;GPX1;SESN1;PRDX5;CAT;GPX8;GSTZ1
12874,GO:0051247,0.00244768657496865,0.998188409033945,151,1147,positive regulation of protein metabolic process,BP,FLOT1;FN1;MMP9;CCBE1;CTGF;GADD45B;F2R;TGFBR2;GSN;PKD2;DUSP6;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;SORL1;TP53;PRICKLE1;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;RBMS3;HIP1;GPNMB;SNX1;CNTN1;KITLG;LRP1;FYN;XDH;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;CLU;PRKCZ;SDR16C5;ITGA1;MST1R;IL31RA;CCK;CAPRIN2;ANG;DUSP5;HERPUD1;WFS1;SPRY2;CIRBP;JARID2;FBLN1;TP73;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;MAGEF1;FZD1;ENG;ATM;MDM2;FAM20A;AREG;IFNK;AKAP13;DGKQ;GCLC;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;EGR1;SOX9;ISL1;BCL6;NCOR1;PRKCA;ANXA2;IGFBP4;PAK6;NAB2;MAP3K12;PRNP;RET;ZFPM1;TGFB2;MAP2K5;MAPK8IP3;RHBDD1;MAGI2;HSPA5;MDFIC;NUB1;PPARG;RNF144B;SNX9;SASH1;DNAJC3;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PPP3CA;CDK5RAP3;NIPBL;RXRA;EDEM1;TAOK3
3900,GO:0008544,0.00245248632291119,0.998604920098923,44,272,epidermis development,BP,KRT4;TXNIP;CTGF;CD109;ZFP36L1;SLITRK6;COL7A1;APCDD1;EGFR;TCHH;KRT14;VDR;BMP4;KRT13;KRT5;PDGFA;PPL;FLG;EMP1;LAMC2;KRT15;CTSV;LAMA3;ALDH3A2;LAMA5;LAMB3;CASP14;FLOT2;FGFR1;ALOX15B;DKK1;EDA2R;TRIOBP;LRTOMT;VANGL2;SOX9;NAB2;TGFB2;FLNB;IFT74;YAP1;COL17A1;KRT10;CELSR1
5229,GO:0015850,0.00248328308135532,0.998928677139418,22,103,organic hydroxy compound transport,BP,NOS1;ABCA1;NISCH;LRP1;CAV1;OSBPL5;CLU;SYT1;SNCA;NCOA2;ANXA2;PGAP1;ABCC2;HTR1B;OSBPL1A;GDNF;PPARG;ABCA2;ABAT;OXTR;RXRA;ABCA5
10281,GO:0043066,0.00248912382933269,0.998323511210588,86,613,negative regulation of apoptotic process,BP,TNFRSF6B;MMP9;ITGA6;SFRP1;NQO1;APBB2;F2R;IRS2;GAS6;SNAI2;ROR1;AXL;EGFR;TSC22D3;SERPINE1;ANXA5;AMIGO2;NTSR1;ANGPTL4;BMP4;NEFL;PDCD4;TP53;SEMA5A;MICAL1;TIMP1;IFIT3;GPX1;GLI3;KITLG;PDPN;LRP1;FYN;IFI6;CAV1;GLI2;CLU;PRKCZ;HMGA2;PRDX5;MST1R;IL31RA;PIK3R1;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;DAPK1;AARS;SNCA;FGFR1;IGF1R;LMNA;DKK1;SETX;EPHB6;MDM2;CITED2;GCLC;PTPN1;ARHGEF2;SOX9;ISL1;ITPKB;BCL6;PRKCA;MAP3K12;PRNP;RET;MAP2K5;LEF1;RHBDD1;HSPA5;YAP1;GDNF;TWIST2;MEIS3;RNF144B;LGALS3;DNAJC3;RARA;RASA1;AGO4;ACAA2
15490,GO:0071900,0.00250659859807172,0.998444298379066,60,391,regulation of protein serine/threonine kinase activity,BP,SFRP1;GADD45B;CDKN2B;F2R;PKD2;DUSP6;HERC5;TNIK;PDGFC;MAGED1;EGFR;CSPG4;MAP3K6;PAK1;BMP4;PDCD4;SORL1;PYCARD;WNK1;PDGFA;KITLG;CAV1;SLC27A1;ERCC6;TRIB2;MAP3K14;ITGA1;MST1R;DUSP5;SPRY2;TP73;ROBO1;SPRY4;TLR3;SNCA;FGFR1;IGF1R;DKK1;RGS2;C5;FZD8;FAM20A;AKAP13;NR2F2;MAP3K1;PTPN1;VANGL2;NRK;RGS14;MAP3K12;MAP2K5;MAPK8IP3;CDKN2A;UVRAG;MDFIC;SASH1;CCNY;FZD4;CDK5RAP3;TAOK3
15094,GO:0071214,0.00251154547112235,0.998624977305267,39,229,cellular response to abiotic stimulus,BP,SFRP1;ZFP36L1;XPC;PKD2;SNAI2;EGFR;MYLK;DDB2;EIF2AK4;SCN2A;TP53;ITGA2;ADIRF;MAP3K14;TP53INP1;HMGA2;PIK3R1;SLC38A2;TP73;CHEK2;TLR3;MME;NFATC4;ENG;ATM;MDM2;GCLC;MAP3K1;ARHGEF2;EGR1;SOX9;USP28;RHBDD1;HSPA5;YAP1;POLH;TAF1;ZBTB1;NIPBL
17156,GO:0104004,0.00251154547112235,0.998624977305267,39,229,cellular response to environmental stimulus,BP,SFRP1;ZFP36L1;XPC;PKD2;SNAI2;EGFR;MYLK;DDB2;EIF2AK4;SCN2A;TP53;ITGA2;ADIRF;MAP3K14;TP53INP1;HMGA2;PIK3R1;SLC38A2;TP73;CHEK2;TLR3;MME;NFATC4;ENG;ATM;MDM2;GCLC;MAP3K1;ARHGEF2;EGR1;SOX9;USP28;RHBDD1;HSPA5;YAP1;POLH;TAF1;ZBTB1;NIPBL
16229,GO:0090313,0.00251931022655999,0.999477853589968,8,26,regulation of protein targeting to membrane,BP,TCAF1;PAK1;FYN;ANK3;STOM;PRNP;MYO1C;C2CD5
8466,GO:0033627,0.00252188877932785,0.999306747211659,11,38,cell adhesion mediated by integrin,BP,ITGB6;FBN1;ITGA6;SNAI2;SERPINE1;ITGA2;COL16A1;PODXL;RET;TGFB2;IFT74
5225,GO:0015844,0.00253099459153313,0.999484813235855,8,24,monoamine transport,BP,NOS1;NISCH;SYT1;SNCA;HTR1B;GDNF;ABAT;OXTR
20246,GO:2001239,0.00253157399029346,0.999401685004585,9,33,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,SNAI2;SRPX;FYN;IFI6;UNC5B;FGFR1;RET;MAP2K5;GDNF
10472,GO:0043394,0.0025380968632657,0.99944916080378,9,23,proteoglycan binding,MF,NID1;COL5A1;PTPRS;SEMA5A;ITGA2;GPNMB;LRP1;COL5A3;AGRN
12076,GO:0048103,0.00255934090070577,0.99958357678285,7,16,somatic stem cell division,BP,ZFP36L2;FZD7;FGFR1;VANGL2;ARHGEF2;TGFB2;LEF1
14824,GO:0070613,0.00255962024721823,0.999190436395254,13,51,regulation of protein processing,BP,SERPINE2;CCBE1;GSN;SERPINE1;CLU;SERPING1;PRKACB;GLG1;C5;MDM2;PLGRKT;PRNP;RHBDD1
6345,GO:0021532,0.00259161852285392,0.999410081819675,9,27,neural tube patterning,BP,BMP4;GLI3;GLI2;PRKACB;IFT140;WDR19;IFT122;GPR161;SSBP3
18414,GO:1903524,0.00259228156158404,0.999392110401093,9,31,positive regulation of blood circulation,BP,CTGF;F2R;GJA5;EGFR;CAV1;RGS2;PDE4D;TGFB2;OXTR
14086,GO:0060971,0.00259340108195233,1,3,3,embryonic heart tube left/right pattern formation,BP,CITED2;MEGF8;IFT122
4642,GO:0010769,0.00263472920134859,0.998574966875099,38,197,regulation of cell morphogenesis involved in differentiation,BP,FN1;TNIK;DPYSL2;DOCK5;S100A10;PAK1;NEFL;PTPRS;SEMA5A;MAP2;CUL7;PDPN;PLXNB1;UST;ULK2;CAPRIN2;FBLN1;METRN;ROBO1;PLXNA2;SEMA4A;TRIOBP;NFATC4;CALR;EFNB3;PLXNA1;TRAK1;FBXW8;SDC2;SSH1;MEGF8;RET;SEMA4B;OBSL1;POSTN;EFNA5;PPP3CA;DOCK1
10715,GO:0044093,0.00264542213797923,0.99801011219438,168,1256,positive regulation of molecular function,BP,FLOT1;FN1;MMP9;CTGF;ITGA6;SFRP1;GADD45B;F2R;TGFBR2;ASAP3;GSN;PKD2;JPH2;DUSP6;TNIK;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;MAGED1;TCAF1;ARHGAP23;ROR1;AXL;DOCK9;EGFR;HSPA2;S100A10;CSPG4;ALS2CL;MAP3K6;ASAP2;NTSR1;TIMP2;PAK1;VDR;CHN2;SRGAP3;BMP4;TRIM38;TBC1D8;RIN2;TRIM5;VAV3;SORL1;ARAP1;DDIT3;PYCARD;WNK1;ARHGEF1;DLG4;ITGA2;PILRB;PDGFA;HIP1;DOCK4;EVI5L;KITLG;TBC1D5;ASAP1;PLXNB1;LRP1;FYN;ARHGEF12;XDH;B3GAT3;ARHGAP18;CAV1;SLC27A1;ERCC6;DOCK11;MAP3K14;CLU;PRKCZ;EHD3;HMGA2;ITGA1;MST1R;CCK;TMEM173;CAPRIN2;ANG;DUSP5;HERPUD1;ANK3;SPRY2;FBLN1;TP73;CAT;DAPK1;DLC1;PRKACB;ROBO1;TLR3;SNCA;FGFR1;IGF1R;DKK1;RGS2;C5;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;TRAF1;FZD1;SRGAP1;APH1B;FAM20A;TBC1D19;AKAP13;DGKQ;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;DNAL4;NRK;EGR1;ISL1;CRTC1;ANXA2;RGS14;DEPDC7;KCTD7;HMBOX1;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;MAP2K5;CDC42EP5;MAPK8IP3;AGRN;VAV2;MAGI2;AGAP1;HSPA5;ARHGEF19;ARHGAP29;MDFIC;OPHN1;LMF1;MYO9A;GDNF;RALGAPB;PPARG;SNX9;SASH1;TBC1D16;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PPP3CA;RASA1;ARHGAP31;NIPBL;TAOK3;DOCK1
12964,GO:0051402,0.00266541151967816,0.998685381678676,29,158,neuron apoptotic process,BP,NQO1;F2R;AXL;TRIM2;NEFL;SCN2A;TP53;DDIT3;ADARB1;GPX1;LRP1;FYN;ITGA1;UNC5B;WFS1;TP73;AARS;SNCA;G6PD;ATM;GCLC;ISL1;MAP3K12;PRNP;TGFB2;HSPA5;SRPK2;GDNF;RASA1
9281,GO:0035743,0.00266988551688991,0.999809342699451,4,8,CD4-positive, alpha-beta T cell cytokine production,BP,PRKCZ;IL31RA;IL18;RSAD2
4848,GO:0014065,0.00267309158759485,0.99892499122359,19,84,phosphatidylinositol 3-kinase signaling,BP,SERPINE2;ZFP36L1;F2R;PIK3C2G;PDGFC;EGFR;PDGFA;PLXNB1;FYN;PIK3R1;UNC5B;CAT;FGFR1;IGF1R;IL18;SOX9;TGFB2;NYAP1;PIK3C2B
3436,GO:0007229,0.00268715897789236,0.999033803598574,16,60,integrin-mediated signaling pathway,BP,ITGB6;ITGB5;CTGF;ITGA6;ITGB4;VAV3;ITGA2;TIMP1;ITGA3;ITGA10;ITGA1;LAMA5;COL16A1;ITGB8;ADAM10;DOCK1
16059,GO:0090066,0.00269263412784476,0.998371757399192,54,326,regulation of anatomical structure size,BP,FN1;F2R;GSN;GJA5;NOS1;DPYSL2;EGFR;SPTB;SLC8A1;DOCK5;PAK1;NEFL;VAV3;KCNMA1;PTPRS;PYCARD;SEMA5A;DOCK4;ANO6;GPX1;ARHGAP18;CPS1;CAV1;PLA2G6;ULK2;ARPIN;ITGA1;KANK2;BBS2;PLXNA2;SEMA4A;RGS2;TRIOBP;BBS4;ARF6;GCLC;PLXNA1;FHOD3;SSH1;MEGF8;HTR1B;RET;CDC42EP5;VAV2;SEMA4B;CAPG;EFNA5;WIPF1;RASA1;LIMA1;HP1BP3;SCPEP1;OXTR;MYO1C
13582,GO:0060081,0.00270423622662606,0.999825815044916,4,7,membrane hyperpolarization,BP,PRKCZ;KCNQ3;CRTC1;KCTD7
7052,GO:0030850,0.00273063950095715,0.999248785620279,11,36,prostate gland development,BP,SFRP1;BMP4;GLI3;GLI2;ALOX15B;SULF1;SOX9;PLAG1;RARA;SERPINB5;RXRA
14028,GO:0060831,0.00276877031683673,0.999626041500251,6,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,GLI3;GLI2;PRKACB;WDR19;IFT122;GPR161
12634,GO:0050865,0.00278999002080229,0.998358456797382,48,308,regulation of cell activation,BP,SERPINE2;CTGF;INPP5D;SFRP1;ZFP36L1;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;GAS6;AXL;PAK1;BMP4;VAV3;LGALS1;PYCARD;PDGFA;GPNMB;GLI3;DLG5;PDPN;FYN;CAV1;GLI2;MAP3K14;PRKCZ;IL31RA;PIK3R1;SNCA;FLOT2;PAG1;IL18;SOX13;ATM;EFNB3;GCLC;LMO4;CD1D;ITPKB;BCL6;PRKCA;PRNP;IGFBP2;LGALS3;RARA;ZBTB1;ABAT
6574,GO:0022409,0.00283748821785389,0.998653942498669,26,141,positive regulation of cell-cell adhesion,BP,FLOT1;ITGA6;TGFBR2;PAK1;LGALS1;PYCARD;GLI3;PDPN;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;ANK3;FLOT2;IL18;EFNB3;CITED2;CD1D;ITPKB;BCL6;PODXL;IGFBP2;RARA;ZBTB1
12596,GO:0050807,0.00284094113328398,0.998790409467947,21,95,regulation of synapse organization,BP,FLRT2;SLITRK6;ETV5;FLRT3;THBS2;AMIGO2;TPBG;DLG5;FYN;CAPRIN2;SNCA;DKK1;NFATC4;SSH1;PRNP;LRRN3;AGRN;EFNA5;SLITRK5;OXTR;DMPK
788,GO:0002053,0.00284576578370005,0.999505757154309,7,18,positive regulation of mesenchymal cell proliferation,BP,TGFBR2;IRS2;STAT1;PDGFA;FBXW4;FGFR1;SOX9
11315,GO:0045662,0.00286877113345894,0.999584349810343,6,15,negative regulation of myoblast differentiation,BP,CXCL14;BMP4;PRICKLE1;DDIT3;IL18;SOX9
11414,GO:0045869,0.00286928902631257,0.999790837112022,4,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C;HMGA2;APOBEC3G;APOBEC3F
6517,GO:0021904,0.00287290204024388,0.999500154577938,7,18,dorsal/ventral neural tube patterning,BP,BMP4;GLI3;GLI2;PRKACB;WDR19;IFT122;GPR161
1251,GO:0003006,0.00287682858489626,0.998170257202937,65,411,developmental process involved in reproduction,BP,SERPINE2;HTRA1;SFRP1;ZFP36L1;ETV5;PKD2;AXL;EGFR;HSPA2;RFX2;NUPR1;VDR;BMP4;SMARCA2;MMP19;CUL7;GLI3;PAQR8;E2F7;KITLG;CTSV;GLI2;SLIT3;ANG;BBS2;MDFI;TLR3;PAQR7;ALOX15B;SULF1;CCDC136;DLX3;PBX1;BBS4;ATM;CST3;AREG;CITED2;NR2F2;FBXW8;NRK;SOX9;PLAG1;RAB13;ETNK2;FNDC3A;STOX2;IRF2BPL;WDR19;TGFB2;ODF2;LEF1;RHBDD1;GOPC;ITGB8;TPGS1;DNAH1;PPARG;RARA;FZD4;AGO4;SERPINB5;NIPBL;RHOBTB3;RXRA
3247,GO:0006909,0.00289251410682773,0.998585053014815,28,151,phagocytosis,BP,GSN;GAS6;AXL;PAK1;ABCA1;VAV3;PYCARD;ITGA2;ANO6;SRPX;SPG11;LRP1;FYN;PLA2G6;PIK3R1;PDIA6;TGM2;CALR;ELMO3;TMEM175;LEPR;VAV2;PPARG;RARA;WIPF1;ELMO2;MYO1C;DOCK1
11604,GO:0046330,0.0028985960551296,0.998791678755841,20,91,positive regulation of JNK cascade,BP,CTGF;GADD45B;TNIK;MAP3K6;PAK1;PYCARD;ERCC6;TLR3;FZD7;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
6856,GO:0030336,0.00290071795956052,0.998511028790001,32,167,negative regulation of cell migration,BP,SFRP1;MMP28;TCAF1;SERPINE1;PTPRM;SRGAP3;NISCH;ADARB1;TIMP1;DLG5;LRP1;TP53INP1;ARPIN;DLC1;ROBO1;PTPRU;ALOX15B;C5;SULF1;ENG;CALR;IDH2;SRGAP1;CITED2;NR2F2;MAP2K5;SP100;MAGI2;IFITM1;PPARG;GCSAM;MIA3
13156,GO:0051790,0.00290459012940096,0.999928316140491,3,4,short-chain fatty acid biosynthetic process,BP,ACSS1;ACSS2;THNSL2
3540,GO:0007565,0.00290464411194322,0.998671114654098,24,122,female pregnancy,BP,MMP2;MMP9;TGFBR2;VDR;ITGA2;TIMP1;ITGA3;MAGED2;CTSV;PLA2G6;SLC38A2;FBLN1;COL16A1;TRO;CALR;CST3;NR2F2;STOX2;ABCC2;IGFBP2;RARA;FOS;OXTR;RXRA
6579,GO:0022417,0.00294154404219395,0.999768223174236,4,9,protein maturation by protein folding,BP,ERO1B;WFS1;AIP;CALR
2294,GO:0005261,0.00294429667508018,0.998686616295853,23,106,cation channel activity,MF,ANO1;PKD2;JPH2;GAS6;ORAI3;SCN8A;SCN2A;KCNMA1;ANO6;KCNAB2;KCNJ15;CALHM2;KCNJ5;SLC24A1;KCNQ3;TMEM63C;TMEM175;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3;ORAI2
13875,GO:0060548,0.00295057801009416,0.997964671710006,94,683,negative regulation of cell death,BP,TNFRSF6B;MMP9;CTGF;ITGA6;SFRP1;NQO1;APBB2;F2R;IRS2;GAS6;SNAI2;ROR1;AXL;EGFR;TSC22D3;SERPINE1;ANXA5;AMIGO2;NTSR1;ANGPTL4;BMP4;NEFL;PDCD4;SORL1;TP53;SEMA5A;MICAL1;TIMP1;GPNMB;IFIT3;GPX1;GLI3;KITLG;PDPN;LRP1;FYN;IFI6;CAV1;GLI2;CLU;PRKCZ;HMGA2;PRDX5;MST1R;KANK2;IL31RA;PIK3R1;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;DAPK1;AARS;SNCA;FGFR1;IGF1R;LMNA;DKK1;SETX;EPHB6;FZD1;MDM2;CST3;CITED2;GCLC;PTPN1;ARHGEF2;SOX9;ISL1;ITPKB;BCL6;PRKCA;MAP3K12;PRNP;RET;MAP2K5;LEF1;RHBDD1;HSPA5;YAP1;GDNF;TWIST2;MEIS3;RNF144B;LGALS3;DNAJC3;RARA;RASA1;KDM4A;AGO4;NPAS2;ACAA2
15773,GO:0072497,0.00295638229391854,0.999837096278559,4,6,mesenchymal stem cell differentiation,BP,SOX6;LTBP3;FZD1;SOX9
18412,GO:1903522,0.00296082431391297,0.998600196152129,26,128,regulation of blood circulation,BP,CTGF;F2R;GJA5;NOS1;EGFR;SLC8A1;DOCK5;DOCK4;CAV1;EHD3;CAMK2D;KCNJ5;RGS2;PDE4D;MDM2;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;KCNIP3;MEF2A;CACNA2D3;OXTR;DMPK
13229,GO:0051937,0.00296315641408927,0.999464131846187,7,20,catecholamine transport,BP,NISCH;SYT1;SNCA;HTR1B;GDNF;ABAT;OXTR
10284,GO:0043069,0.00296560091515708,0.997983768063433,87,626,negative regulation of programmed cell death,BP,TNFRSF6B;MMP9;ITGA6;SFRP1;NQO1;APBB2;F2R;IRS2;GAS6;SNAI2;ROR1;AXL;EGFR;TSC22D3;SERPINE1;ANXA5;AMIGO2;NTSR1;ANGPTL4;BMP4;NEFL;PDCD4;TP53;SEMA5A;MICAL1;TIMP1;IFIT3;GPX1;GLI3;KITLG;PDPN;LRP1;FYN;IFI6;CAV1;GLI2;CLU;PRKCZ;HMGA2;PRDX5;MST1R;KANK2;IL31RA;PIK3R1;UNC5B;HERPUD1;WFS1;SPRY2;TP73;CAT;DAPK1;AARS;SNCA;FGFR1;IGF1R;LMNA;DKK1;SETX;EPHB6;MDM2;CITED2;GCLC;PTPN1;ARHGEF2;SOX9;ISL1;ITPKB;BCL6;PRKCA;MAP3K12;PRNP;RET;MAP2K5;LEF1;RHBDD1;HSPA5;YAP1;GDNF;TWIST2;MEIS3;RNF144B;LGALS3;DNAJC3;RARA;RASA1;AGO4;ACAA2
12374,GO:0048839,0.00297530488773979,0.998727960198838,21,95,inner ear development,BP,FAT4;SLITRK6;ROR1;CXCL14;BMP4;GLI3;GLI2;SPRY2;LRIG3;FGFR1;MYO3B;TRIOBP;LRTOMT;NAGLU;MAF;VANGL2;SOX9;IFT27;HOXA1;TGFB2;CELSR1
19258,GO:1905515,0.00297596192666276,0.999091835671648,12,47,non-motile cilium assembly,BP,CEP126;CEP250;BBS2;IFT140;BBS4;BBS1;VANGL2;TTC8;IFT122;NPHP3;IFT74;SEPT9
4876,GO:0014743,0.00302897714248008,0.999154831616346,11,36,regulation of muscle hypertrophy,BP,PAK1;CAMK2D;JARID2;LMNA;RGS2;G6PD;LMCD1;AKAP13;PRKCA;MEF2A;PPP3CA
5928,GO:0018212,0.0030513061283537,0.998297479975312,40,231,peptidyl-tyrosine modification,BP,GPRC5A;SFRP1;EFEMP1;GAS6;PDGFC;ROR1;AXL;EGFR;CSPG4;PTK6;TP53;CNTRL;DLG4;PDGFA;CNTN1;KITLG;FYN;CAV1;ERCC6;PRKCZ;MST1R;IL31RA;CCK;TTN;FGFR1;IGF1R;CTF1;IL18;AFAP1L2;AREG;DGKQ;PTPN1;ARHGEF2;ISL1;STK16;PRNP;RET;MAP2K5;TPST1;EFNA5
4940,GO:0014910,0.00306141810203291,0.999082155252644,12,41,regulation of smooth muscle cell migration,BP,DOCK5;SERPINE1;PAK1;SORL1;ITGA2;PDGFA;DOCK4;LRP1;MDM2;PLXNA1;SSH1;POSTN
10937,GO:0044706,0.00307720784530367,0.998534486694184,26,136,multi-multicellular organism process,BP,SERPINE2;MMP2;MMP9;TGFBR2;VDR;ITGA2;TIMP1;ITGA3;MAGED2;CTSV;PLA2G6;SLC38A2;FBLN1;COL16A1;TRO;CALR;CST3;NR2F2;NRK;STOX2;ABCC2;IGFBP2;RARA;FOS;OXTR;RXRA
10484,GO:0043408,0.00308352413790689,0.997990009127819,71,472,regulation of MAPK cascade,BP,FN1;CTGF;SFRP1;GADD45B;F2R;DUSP6;TNIK;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;CSPG4;MAP3K6;TIMP2;PAK1;BMP4;TRIM5;PDCD4;SORL1;PYCARD;PDGFA;GPNMB;KITLG;XDH;CAV1;ERCC6;TRIB2;MAP3K14;PRKCZ;ITGA1;MST1R;PER1;DUSP5;SPRY2;FBLN1;TP73;ROBO1;SPRY4;TLR3;FZD7;FGFR1;IGF1R;DKK1;RGS2;C5;EPHB6;EDA2R;FZD8;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;NCOR1;PRKCA;RGS14;IGFBP4;PAK6;MAP3K12;RET;TGFB2;MAP2K5;MAPK8IP3;MDFIC;SASH1;FZD4;CDK5RAP3;CAMK2N1;TAOK3
3266,GO:0006940,0.00309597979985755,0.999258483953337,9,30,regulation of smooth muscle contraction,BP,F2R;DOCK5;ITGA2;DOCK4;CAV1;RGS2;CALCRL;ABAT;OXTR
6288,GO:0019904,0.00315546244353987,0.997868317849051,84,561,protein domain specific binding,MF,FN1;ADAM19;INPP5D;GJA5;PKD2;IRS2;TCEAL4;HSPA2;VIM;STMN3;TADA3;NEFL;TP53;CEP250;DDIT3;PYCARD;DLG4;MICAL1;ACSL3;TFDP2;DOCK4;CRIM1;ITGA3;GPX1;FYN;ESPN;TCEAL3;PRKCZ;HMGA2;CNTLN;TCEAL8;DLC1;ROBO1;SNCA;FZD7;AIP;PAG1;WBP1;NCOA2;TGM2;FZD8;TCEAL1;AFAP1L2;TGFBR3;FZD1;MDM2;DNAJC6;CITED2;ELMO3;TRAK1;SDC2;NFASC;MPP7;CEP68;LANCL1;TCF12;ABCC2;SCNN1A;LEF1;THRA;SP100;HSPA5;TH;UVRAG;ARHGAP29;FHOD1;SRR;HOXA3;DIXDC1;PPARG;CAPG;SHISA9;RARA;FZD4;WIPF1;ARHGAP31;ELMO2;MED12;NIPBL;ADAM10;LITAF;RXRA;SNTB1;DOCK1
4558,GO:0010644,0.00315611828011836,0.999431164816986,7,19,cell communication by electrical coupling,BP,GJA5;SLC8A1;GJC2;CAV1;CAMK2D;ANK3;PDE4D
4263,GO:0009615,0.00316219031374247,0.998284219054741,36,223,response to virus,BP,HTRA1;DDIT4;HERC5;ACTA2;TKFC;IFI44L;APOBEC3C;EIF2AK4;TRIM5;STAT1;IFIT2;PYCARD;IFIT1;DDX60;ADARB1;IFIT3;SEC14L1;MAP3K14;CLU;OAS2;HMGA2;MST1R;TMEM173;APOBEC3G;TLR3;APOBEC3F;IFNK;IFNE;IFI44;LYST;IFITM2;STAT2;RSAD2;IFITM1;DNAJC3;GBP3
20061,GO:2000741,0.00316356793201582,1,3,3,positive regulation of mesenchymal stem cell differentiation,BP,SOX6;LTBP3;SOX9
15818,GO:0072562,0.00317437573958158,0.999142227278309,10,40,blood microparticle,CC,FN1;GSN;HSPA2;ANXA5;ANGPTL4;CLU;SERPING1;STOM;ENG;BCHE
8203,GO:0032970,0.00318993296700917,0.998140573875912,46,264,regulation of actin filament-based process,BP,CTGF;SFRP1;RHOBTB2;ASAP3;GSN;GJA5;SPTB;S100A10;PAK1;ARAP1;PYCARD;SEMA5A;PDGFA;PDPN;CTSV;LRP1;ARHGAP18;CAV1;ARPIN;CAMK2D;KANK2;PXN;PIK3R1;DLC1;FSCN1;PDE4D;TRIOBP;BBS4;ARF6;AKAP13;FHOD3;VANGL2;SSH1;OR2A4;CDC42EP5;ARHGEF19;FHOD1;DIXDC1;CAPG;EFNA5;WIPF1;RASA1;LIMA1;RHOBTB3;CELSR1;MYO1C
18320,GO:1903317,0.003215789557733,0.998951670108019,13,52,regulation of protein maturation,BP,SERPINE2;CCBE1;GSN;SERPINE1;CLU;SERPING1;PRKACB;GLG1;C5;MDM2;PLGRKT;PRNP;RHBDD1
20244,GO:2001237,0.00324139548358987,0.998783606127286,16,73,negative regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;SNAI2;SERPINE1;BMP4;GPX1;FYN;IFI6;UNC5B;DAPK1;LMNA;GCLC;ARHGEF2;MAP2K5;YAP1;GDNF;LGALS3
10713,GO:0044091,0.00326237287504487,0.999306727910989,8,24,membrane biogenesis,BP,FLOT1;S100A10;CAV1;ANK3;FLOT2;ANXA2;NLGN4Y;MAGI2
8294,GO:0033141,0.00326449450573947,0.999915895646673,3,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,IFNK;IFNE;RET
11050,GO:0045071,0.00326845658248983,0.999041780188525,11,46,negative regulation of viral genome replication,BP,APOBEC3C;EIF2AK4;IFIT1;OAS2;HMGA2;APOBEC3G;APOBEC3F;IFITM2;RSAD2;SRPK2;IFITM1
9036,GO:0035272,0.00328113634583823,0.999065161525608,11,38,exocrine system development,BP,SNAI2;EGFR;PDGFA;PPDPF;LAMA5;FGFR1;TGM2;CST3;PLXNA1;SOX9;TGFB2
12595,GO:0050806,0.00333734494337792,0.998627620773843,19,85,positive regulation of synaptic transmission,BP,SERPINE2;FLOT1;EGFR;NTSR1;NSG1;EIF2AK4;NETO1;DLG4;PRKCZ;SYT1;SNCA;SLC24A1;SSH1;CRTC1;RGS14;PRNP;TSHZ3;ABAT;OXTR
15562,GO:0072073,0.00334295932016596,0.998561515413344,21,91,kidney epithelium development,BP,SFRP1;FAT4;PKD2;MAGED1;BMP4;STAT1;WWTR1;GLI3;LAMA5;CAT;FGFR1;PBX1;SOX9;PODXL;RET;MAGI2;YAP1;GDNF;KLHL3;RARA;LAMB2
12658,GO:0050900,0.00335504401316642,0.998157996010825,37,225,leukocyte migration,BP,FN1;MMP9;INPP5D;ITGA6;MMP28;SLC7A8;GAS6;SDC3;SERPINE1;CXCL14;VAV3;TP53;PYCARD;SLC7A11;ITGA2;ITGA3;ANO6;KITLG;FYN;CAV1;CXCR1;ITGA1;PIK3R1;GLG1;C5;PDE4D;CALR;SDC2;LYST;GCNT1;MOSPD2;RET;TGFB2;GCSAM;LGALS3;MIA3;ADAM10
12592,GO:0050803,0.00335741040029501,0.998513211359315,22,103,regulation of synapse structure or activity,BP,FLRT2;SLITRK6;ETV5;FLRT3;THBS2;AMIGO2;TPBG;DLG5;FYN;CAPRIN2;SNCA;DKK1;NFATC4;SSH1;PRNP;LRRN3;AGRN;EFNA5;SLITRK5;DNM1P46;OXTR;DMPK
12349,GO:0048762,0.0033583485506478,0.998367770048003,27,138,mesenchymal cell differentiation,BP,SFRP1;TGFBR2;SNAI2;BMP4;PDCD4;STAT1;WWTR1;PHLDB1;CUL7;DLG5;KITLG;PDPN;HMGA2;LAMA5;FGFR1;SEMA4A;TGFBR3;ENG;KLHL12;SOX9;ISL1;RET;TGFB2;LEF1;TGFB1I1;SEMA4B;GDNF
16636,GO:0097546,0.00337180621055725,0.999272336350059,8,25,ciliary base,CC,CEP126;GLI3;GLI2;NPHP4;PRKACB;IFT122;NPHP3;ICK
10288,GO:0043085,0.00340581700122793,0.997484623555754,139,1022,positive regulation of catalytic activity,BP,FN1;CTGF;ITGA6;SFRP1;GADD45B;F2R;TGFBR2;ASAP3;GSN;PKD2;DUSP6;TNIK;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;MAGED1;ARHGAP23;ROR1;AXL;DOCK9;EGFR;HSPA2;S100A10;CSPG4;ALS2CL;MAP3K6;ASAP2;TIMP2;PAK1;VDR;CHN2;SRGAP3;BMP4;TBC1D8;RIN2;VAV3;SORL1;ARAP1;PYCARD;WNK1;ARHGEF1;DLG4;ITGA2;PILRB;PDGFA;HIP1;DOCK4;EVI5L;KITLG;TBC1D5;ASAP1;PLXNB1;FYN;ARHGEF12;XDH;B3GAT3;ARHGAP18;CAV1;SLC27A1;ERCC6;DOCK11;MAP3K14;CLU;PRKCZ;ITGA1;MST1R;CCK;ANG;DUSP5;SPRY2;FBLN1;TP73;DAPK1;DLC1;PRKACB;ROBO1;TLR3;SNCA;FGFR1;IGF1R;DKK1;RGS2;C5;IL18;EPHB6;FZD8;AFAP1L2;SRGAP1;APH1B;FAM20A;TBC1D19;AKAP13;DGKQ;LMO4;MAP3K1;PTPN1;VANGL2;DNAL4;NRK;EGR1;RGS14;DEPDC7;HMBOX1;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;CDC42EP5;MAPK8IP3;AGRN;VAV2;MAGI2;AGAP1;HSPA5;ARHGEF19;ARHGAP29;MDFIC;OPHN1;LMF1;MYO9A;GDNF;RALGAPB;PPARG;SNX9;SASH1;TBC1D16;CCNY;PRKAG1;EFNA5;FZD4;RASA1;ARHGAP31;TAOK3;DOCK1
16587,GO:0097458,0.00341102592452431,0.997496401815024,134,936,neuron part,CC,SYT8;FLRT2;NQO1;APBB2;PTGS1;TENM4;NOS1;MAP6;UTRN;ROR1;FLRT3;SLC8A1;GJC2;STON2;VIM;STMN3;ADD3;NTSR1;TIMP2;TENM3;PAK1;NSG1;NEFM;NR1D1;SMARCA2;SCN8A;NETO1;NEFL;STAT1;SCN2A;PTPRS;PYCARD;EFHC1;DLG4;ITGA2;MAP2;MICAL1;HIP1;DOCK4;ITGA3;GPX1;DLG5;ASAP1;SYN1;CTSV;SPG11;KCNAB2;LRP1;FYN;PIAS3;ESPN;CLU;NPHP4;PRKCZ;CAMK2D;ITGA1;SYTL1;IL31RA;CCK;SYT1;SLC38A2;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;WFS1;BACE1;ROBO1;IFT140;SNCA;MME;VAMP1;IGF1R;FSCN1;RGS2;SETX;ASTN2;MYO3B;EPHB6;TRIOBP;CDH13;SEPT6;BBS4;CST3;DNAJC6;NRSN2;TRAK1;LZTS1;KCNQ3;ARHGEF2;SSH1;NFASC;CRTC1;RGS14;RAB13;SEPT5;MAP3K12;NLGN4Y;HTR1B;WDR19;PRNP;RET;TGFB2;IFT122;C2CD4C;ULK1;MAGI2;TH;GOPC;BOC;OPHN1;TPGS1;SRR;KCNIP3;SHISA9;PRR7;ARL3;RARA;SV2A;TSHZ3;FZD4;PPP3CA;FOS;DNM1P46;CAMK2N1;ABAT;BSN;ADAM10;MPDZ;MYO1C;ORAI2;ZNRF1
4300,GO:0009755,0.00345593992118159,0.998244502785674,30,158,hormone-mediated signaling pathway,BP,SFRP1;SKP2;TADA3;PAK1;VDR;BMP4;NR1D1;NR3C1;PAQR8;SLC27A1;RBFOX2;KANK2;PER1;PAQR7;CALR;AKAP13;NR2F2;UCN2;ISL1;PRCP;LEF1;THRA;TGFB1I1;YAP1;PPARG;RARA;TAF1;CREBRF;MED12;RXRA
13334,GO:0052548,0.00345855431536088,0.998042541948548,40,268,regulation of endopeptidase activity,BP,SERPINE2;TNFRSF6B;MMP9;CTGF;CD109;F2R;GSN;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;SORL1;PYCARD;MICAL1;TIMP1;HIP1;CRIM1;GPX1;FYN;IFI6;XDH;SERPING1;PRDX5;CCK;HERPUD1;APLP2;DAPK1;DLC1;ROBO1;SNCA;C5;PSMB9;MDM2;CST3;MAP2K5;LEF1;PPARG;SERPINB5
20058,GO:2000738,0.00345943332073205,0.999628605054981,5,10,positive regulation of stem cell differentiation,BP,SOX6;BMP4;LTBP3;SOX9;TGFB2
1263,GO:0003018,0.00349073175835845,0.998591408052725,18,84,vascular process in circulatory system,BP,F2R;GJA5;NOS1;EGFR;SLC8A1;DOCK5;DOCK4;GPX1;CPS1;CAV1;PLA2G6;ITGA1;BBS2;RGS2;GCLC;HTR1B;SCPEP1;OXTR
12582,GO:0050789,0.00349371098245811,0.997114501991019,849,7495,regulation of biological process,BP,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;TSC22D1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;CLTCL1;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;TMEM204;KLF8;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;SLC8A1;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;CCNG2;THBS2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;DOK1;SERPINH1;RNF213;CRTAP;TCF7L1;S100A10;STON2;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;FAM210B;MAP3K6;AMIGO2;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;ZNF862;TADA3;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;BMP4;TRIM38;TP53I11;ITM2C;TP53I3;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;ETV1;TP53;ARAP1;CEP250;EXTL2;MBNL2;PTPRS;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;ZCCHC11;PDGFA;MAP2;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;PHLDB1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;EVI5L;ZNF18;TTC28;KLF12;IFIT3;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;TBC1D5;P3H2;ERMAP;ASAP1;ERO1B;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;CCDC80;SESN1;CTSV;SEC14L1;PLXNB1;PDE4DIP;EML2;KCNAB2;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;CLMN;LAMA3;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SLC2A4RG;DOCK11;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;AHNAK2;UST;CLU;DCBLD2;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;CCNI;ULBP1;HAUS4;PTPN14;PER1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DUSP5;PARVA;LAMA5;UNC5B;UHRF2;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;FBLN1;ZKSCAN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;METRN;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;PAIP2B;STOM;PRX;PHF2;TLR3;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;FRMD5;PDIA6;GATAD1;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;DZIP1L;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;ASTN2;PDE4D;APBB3;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;BRD3;PLA2R1;PDK3;G6PD;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;NOTCH2NL;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;AREG;IFNK;ZNF107;TCF4;ANXA6;AKAP13;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;IFNE;NEURL1B;CBX7;LMO4;ZNF449;ZMAT3;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;SYNE2;HDAC11;RCBTB1;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;ARHGEF2;PLGRKT;SPRED3;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;NDRG1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;CES3;HLTF;HOXA1;MPP7;CXORF57;SEPT5;BAHCC1;METTL23;LEPR;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;IFITM2;SAMD5;MVB12B;TES;KCTD7;TCF25;MOSPD2;TCF12;CABLES2;HMBOX1;NFAT5;RPL13A;PODXL;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;HTR1B;IRF2BPL;STK36;RAB43;MAML2;WDR19;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;DLX2;ZNF550;OR2A4;SMG9;STAT2;AMOTL2;IFT122;ZNF701;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;USP28;ITM2A;MAPK8IP3;MSRB2;C2CD4C;CDKN2A;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;TH;CELF2;GOPC;MAGI1;BOC;PIKFYVE;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;VPS13C;FHOD1;IFT74;SAP30L;IFITM1;ZNF12;OPHN1;LMF1;SH2B3;MYO9A;YAP1;CACNB1;GDNF;RALGAPB;NUB1;KLF5;COL17A1;TWIST2;CAPS;ATRAID;YEATS2;HOXA3;UBA7;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;KCNIP3;MEF2A;MLLT6;GCSAM;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;FZD4;SLITRK5;ZNF883;WIPF1;ADGRA2;ZBTB1;NAT14;PPP3CA;PIK3C2B;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;CAPN6;FOS;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;CLEC2D;FAM120B;FAM168A;CACNA2D3;SERPINB5;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;PPP2R3A;CELSR1;ZNF471;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;CPT2;EDEM1;ACAA2;ABCA5;TAOK3;NFKBIE;ZNF484;DOCK1;DMPK
6752,GO:0030193,0.00350452839196904,0.998962795125814,11,46,regulation of blood coagulation,BP,SERPINE2;F2R;SERPINE1;PDGFA;ANO6;PDPN;CAV1;SERPING1;PRKCA;ANXA2;ABAT
17327,GO:1900046,0.00350452839196904,0.998962795125814,11,46,regulation of hemostasis,BP,SERPINE2;F2R;SERPINE1;PDGFA;ANO6;PDPN;CAV1;SERPING1;PRKCA;ANXA2;ABAT
9776,GO:0040013,0.00353321885506612,0.998046106497281,38,211,negative regulation of locomotion,BP,SFRP1;MMP28;TCAF1;SERPINE1;PTPRM;SRGAP3;TRIM5;SEMA5A;NISCH;ADARB1;TIMP1;DLG5;LRP1;TP53INP1;ARPIN;FBLN1;DLC1;ROBO1;FRMD5;PTPRU;ALOX15B;SEMA4A;C5;SULF1;ENG;CALR;IDH2;SRGAP1;CITED2;NR2F2;MAP2K5;SP100;MAGI2;SEMA4B;IFITM1;PPARG;GCSAM;MIA3
3390,GO:0007171,0.00356482590590604,0.999751252404989,4,7,activation of transmembrane receptor protein tyrosine kinase activity,BP,PDGFC;PILRB;DGKQ;EFNA5
12586,GO:0050794,0.00357169813844959,0.99703802128143,812,7104,regulation of cellular process,BP,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;CLTCL1;NOS1;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;SULF2;COL5A1;PHF21A;ARHGAP23;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;TMEM204;KLF8;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;SLC8A1;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;CCNG2;THBS2;RFX2;TRIM2;ZNF608;SERPINE1;DOK1;SERPINH1;RNF213;CRTAP;TCF7L1;S100A10;STON2;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;FAM210B;MAP3K6;AMIGO2;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;ZNF862;TADA3;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;BMP4;TRIM38;TP53I11;ITM2C;TP53I3;NR1D1;SMARCA2;PTK6;AHNAK;TBC1D8;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;ETV1;TP53;ARAP1;CEP250;EXTL2;MBNL2;PTPRS;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SEMA5A;ITGA2;PILRB;ZCCHC11;PDGFA;MAP2;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;PHLDB1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;EVI5L;ZNF18;TTC28;KLF12;IFIT3;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;TPBG;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;TBC1D5;P3H2;ERMAP;ASAP1;ERO1B;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;SESN1;CTSV;SEC14L1;PLXNB1;PDE4DIP;EML2;KCNAB2;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;CLMN;LAMA3;CAV1;SLC27A1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SLC2A4RG;DOCK11;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;AHNAK2;UST;CLU;DCBLD2;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;ARPIN;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;CCNI;HAUS4;PTPN14;PER1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DUSP5;PARVA;LAMA5;UNC5B;UHRF2;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;APLP2;HPS4;FBLN1;ZKSCAN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;METRN;BACE1;ROBO1;WDFY2;IFT140;SPRY4;PAIP2B;PRX;PHF2;TLR3;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;FRMD5;PDIA6;GATAD1;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;PDE4D;APBB3;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;BRD3;PLA2R1;PDK3;G6PD;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;DLX3;FZD1;AMOTL1;NOTCH2NL;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;AREG;IFNK;ZNF107;TCF4;ANXA6;AKAP13;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;IFNE;NEURL1B;CBX7;LMO4;ZNF449;ZMAT3;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;SYNE2;HDAC11;RCBTB1;MAP3K1;FGD4;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;PLGRKT;SPRED3;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;NDRG1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;HLTF;HOXA1;MPP7;CXORF57;SEPT5;BAHCC1;METTL23;LEPR;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;IFITM2;SAMD5;MVB12B;TES;TCF25;MOSPD2;TCF12;CABLES2;HMBOX1;NFAT5;RPL13A;PODXL;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;HTR1B;IRF2BPL;STK36;RAB43;MAML2;WDR19;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;DLX2;ZNF550;OR2A4;STAT2;AMOTL2;IFT122;ZNF701;GPR161;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;USP28;ITM2A;MAPK8IP3;MSRB2;C2CD4C;CDKN2A;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;GOPC;MAGI1;BOC;PIKFYVE;TGFB1I1;RSAD2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;VPS13C;FHOD1;IFT74;SAP30L;IFITM1;ZNF12;OPHN1;LMF1;SH2B3;MYO9A;YAP1;GDNF;RALGAPB;NUB1;KLF5;TWIST2;CAPS;ATRAID;YEATS2;HOXA3;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;KCNIP3;MEF2A;MLLT6;GCSAM;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DNAJC3;NYAP1;RARA;RASSF9;COL4A1;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;FZD4;SLITRK5;ZNF883;WIPF1;ADGRA2;ZBTB1;NAT14;PPP3CA;PIK3C2B;RASA1;ARHGAP31;LIMA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;CAPN6;FOS;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;CLEC2D;FAM120B;FAM168A;SERPINB5;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;PPP2R3A;CELSR1;ZNF471;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;EDEM1;ACAA2;ABCA5;TAOK3;NFKBIE;ZNF484;DOCK1;DMPK
11102,GO:0045159,0.00358212846337909,0.999904492523215,3,4,myosin II binding,MF,GSN;TRIOBP;GCSAM
8686,GO:0034340,0.00359447812011484,0.998676405221945,15,73,response to type I interferon,BP,XAF1;STAT1;IFIT2;IFIT1;IFIT3;IFI6;OAS2;IFI35;PTPN1;EGR1;IFITM2;STAT2;SP100;RSAD2;IFITM1
17489,GO:1900748,0.00362694239238535,1,3,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,CCBE1;ROBO1;MYO1C
3650,GO:0008134,0.00365237774088682,0.997573043840088,75,502,transcription factor binding,MF,APBB2;TSC22D3;TADA3;CBX5;VDR;NR1D1;STAT1;TP53;DDIT3;MEF2D;TFDP2;SIK1;GLI2;RBFOX2;TRIB2;SMARCA1;SDR16C5;HMGA2;PER1;PIK3R1;TMEM173;BBS2;WFS1;MDFI;JARID2;TP73;AIP;APBB3;NCOA2;TLE4;KDM4C;CHD6;NFATC4;BBS4;CALR;MEIS2;TCF4;BBS1;DGKQ;LMO4;HDAC11;ARHGEF2;SOX9;ISL1;CRTC1;NCOR1;TRERF1;METTL23;TTC8;TCF12;NFAT5;NAB2;STK36;ZFPM1;RBL2;LEF1;THRA;CDKN2A;TGFB1I1;MDFIC;TACC2;YAP1;KLF5;YEATS2;PPARG;MEF2A;RARA;HES2;PBX2;TAF1;FOS;CDK5RAP3;MED12;PRDM5;RXRA
7410,GO:0031514,0.00365595730385781,0.9985652398257,17,77,motile cilium,CC,PKD2;WDR66;GLI2;SPATA6;BBS2;SEPT6;BBS4;IFT27;IFT88;SPA17;WDR19;ODF2;SCNN1A;TCTEX1D4;IFT74;TPGS1;DNAH1
3442,GO:0007254,0.00366235004603064,0.998153257068545,29,155,JNK cascade,BP,CTGF;SFRP1;GADD45B;TNIK;EGFR;MAP3K6;PAK1;PDCD4;PYCARD;ERCC6;PER1;TP73;TLR3;FZD7;IGF1R;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;NCOR1;MAP3K12;CDC42EP5;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
18209,GO:1903044,0.00366674414378775,0.999713150747373,4,8,protein localization to membrane raft,BP,FLOT1;CAV1;FLOT2;REEP2
10483,GO:0043407,0.00366982378764621,0.998707131478129,14,64,negative regulation of MAP kinase activity,BP,SFRP1;DUSP6;BMP4;PDCD4;SORL1;CAV1;DUSP5;SPRY2;TP73;SPRY4;RGS2;PTPN1;RGS14;CDK5RAP3
16147,GO:0090196,0.00369094317117995,0.999710707502607,4,8,regulation of chemokine secretion,BP,PYCARD;ALOX15B;C5;POSTN
5315,GO:0016043,0.0036967851007201,0.996920060037617,543,4593,cellular component organization,BP,SERPINE2;CPA4;ITGB6;SYT8;FLOT1;MMP2;KRT4;HTRA1;FN1;FLRT2;MMP9;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;MARVELD1;ITGA6;SFRP1;RHOBTB2;APBB2;SYNE1;F2R;TLN2;FAT4;XPC;SLITRK6;ITGB4;TENM4;ASAP3;GSN;COL5A2;ETV5;GJA5;PKD2;IRS2;NID1;SDK1;TNIK;PROM2;COL7A1;CLTCL1;NOS1;GAS6;FBN2;PDGFC;SNAI2;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;SAMD9L;AXL;DPYSL2;EGFR;HSPA2;LAMB1;FLRT3;SPTB;CEP126;DOCK5;MYLK;SYNE3;CSMD3;THBS2;RFX2;SERPINE1;DOK1;ATP10D;SERPINH1;RNF213;KRT14;TCF7L1;S100A10;STON2;RNF165;C1QTNF6;VIM;DDB2;ALS2CL;MFAP5;AMIGO2;STMN3;ADD3;TOM1L2;TIMP2;TADA3;TENM3;PLEC;PAK1;ABCA1;ANGPTL4;NSG1;VDR;PTPRM;PADI3;BMP4;NEFM;TNS1;ITM2C;SMARCA2;PTK6;AHNAK;TBC1D8;EIF2AK4;NEFL;VAV3;NR3C1;COL18A1;SORL1;NEO1;IFIT2;LGALS1;KCNMA1;ETV1;TP53;ARAP1;CEP250;KRT13;PTPRS;TTLL11;WWTR1;DDIT3;CNTRL;CUL9;PYCARD;KRT5;EFHC1;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;MAP2;MMP19;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHLDB1;HIP1;COL4A4;TFDP2;TEP1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;LIX1L;EVI5L;EMP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;DLG5;CNTN1;LPCAT2;TBC1D5;ASAP1;ERO1B;PLLP;LIMCH1;PDPN;MTHFR;SRPX;CCDC80;KRT15;NEK9;CTSV;SPG11;PLXNB1;PDE4DIP;EML2;LRP1;FYN;EMP3;IFI6;FLNC;LTBP4;ARHGAP18;CLMN;UGT8;LAMA3;CAV1;GLI2;RMI2;HLCS;RBFOX2;PLA2G6;ITGA10;SPATA6;DOCK11;SNX33;ESPN;SMARCA1;TNRC18;AHNAK2;UST;CLU;DCBLD2;NPHP4;PRKCZ;SLIT3;SDR16C5;ULK2;TP53INP1;IQSEC2;ARPIN;EHD3;HMGA2;CAMK2D;ADGRG6;GOLGB1;ITGA1;SYTL1;KANK2;HAUS4;PER1;ATP8B2;PXN;CCK;PIK3R1;SYT1;HHAT;NCAPD2;CAPRIN2;CPT1A;ACACB;PCLO;ANG;DYSF;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;ANK3;SPRY2;LAMB3;TTN;CIRBP;JARID2;HPS4;FBLN1;MLH3;TP73;CAT;SHROOM4;DLC1;PRKACB;CHEK2;METRN;ROBO1;IFT140;STOM;PRX;PHF2;FBXL7;SNCA;FLOT2;THSD4;FRMD5;GATAD1;VAMP1;FZD7;AIP;JADE2;SH3TC2;PLXNA2;SP110;COL16A1;DZIP1L;FGFR1;IGF1R;LMNA;DKK1;FSCN1;SEC24D;SEMA4A;RGS2;TGFBI;SETX;TGM2;OBSCN;SULF1;SPATA18;BRD3;G6PD;MYOF;TLE4;CCDC136;ARHGEF17;TRIOBP;KDM4C;CHD6;CDH13;NFATC4;TRAF1;RAPH1;SEPT6;TGFBR3;FZD1;AMOTL1;L3MBTL3;NAGLU;ENG;BBS4;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;TMED10;CST3;C17ORF49;AREG;TCF4;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;DGKQ;GCLC;PLXNA1;ACSS2;FHOD3;CBX7;LMO4;MSH5;TRAK1;FBXW8;SYNE2;HDAC11;RCBTB1;FGD4;PTPN1;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;COL5A3;NRK;SSH1;LYST;SOX9;ENPP1;IFT27;ISL1;BCL6;NFASC;CRTC1;NCOR1;NDRG1;PRKCA;MYBL1;TMEM175;ANXA2;RGS14;RAB13;PRIMPOL;HLTF;MPP7;SEPT5;BAHCC1;CEP68;IGFBP4;IFT88;GOLGA8B;TTC8;KCTD7;HMBOX1;RPL13A;PODXL;PAK6;DECR1;MAP3K12;CHD9;MEGF8;NLGN4Y;STK36;RAB43;WDR19;PRNP;CDH11;RET;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;OR2A4;COL12A1;STAT2;AMOTL2;IFT122;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;MSRB2;C2CD4C;CDKN2A;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;TSPYL4;MAGI2;KIAA1109;HSPA5;CELF2;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;REEP2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;CFAP54;ARHGEF19;VPS13C;FHOD1;IFT74;POLD4;SAP30L;TACC2;OPHN1;TPGS1;KCTD14;MYO9A;YAP1;CACNB1;GDNF;DNAH1;KLF5;COL17A1;GOLGA8N;SRR;YEATS2;DIXDC1;PPARG;CAPG;INF2;MEF2A;KLF7;SNX9;ICK;TBC1D16;OBSL1;ING4;OLFML2A;POSTN;UNK;LGALS3;ARL3;MIA3;NYAP1;FKBP10;COG3;ECM2;COL4A1;TMEM67;TAF1;EFNA5;FZD4;SLITRK5;WIPF1;ZBTB1;PPP3CA;PIK3C2B;SBF2;RASA1;LIMA1;PEX1;HP1BP3;COX18;CAPN6;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;MATN3;ELMO2;MYH11;NIPBL;VPS36;TTBK2;KCNRG;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;CELSR1;PSMG4;ATG16L2;TSPAN4;EPG5;MYO1C;RXRA;C2CD5;ACAA2;ABCA5;DOCK1;DMPK;LAMB2
2568,GO:0005856,0.00374511900103197,0.997080229406466,211,1560,cytoskeleton,CC,ITGB6;FLOT1;KRT4;INPP5D;MARVELD1;SYNE1;TLN2;MYH15;TNNI2;GSN;PKD2;OSBPL10;IGF2BP2;TNIK;CLTCL1;TNS4;NOS1;DNMBP;MAP6;UTRN;ROR1;DPYSL2;HSPA2;TCHH;SPTB;CEP126;SLC8A1;MYLK;ACTA2;KRT14;VIM;PSTPIP1;CTNNAL1;EVC;ADD3;TADA3;PDLIM2;PLEC;PAK1;NEFM;TNS1;SMARCA2;AHNAK;NEFL;NR3C1;CEP250;KRT13;TTLL11;CNTRL;CCDC102A;KRT5;DDX60;EFHC1;DLG4;TCP11L1;SLC7A11;MAP2;FRMD4B;MICAL1;PPL;FLG;HIP1;CCDC85B;CUL7;CHD3;TTC28;WDR66;PLEK2;GLI3;DLG5;KITLG;ASAP1;SYN1;KRT15;NEK9;PDE4DIP;EML2;KCNAB2;FYN;FLNC;GLI2;PLA2G6;TRIB2;ESPN;CLU;NPHP4;PRKCZ;PARP4;MST1R;KANK2;ULBP1;HAUS4;PTPN14;PXN;CAPRIN2;PCLO;DYSF;KIF17;PARVA;BBS2;CNTLN;ANK3;SPRY2;TTN;CASP14;SHROOM4;DAPK1;DLC1;PRKACB;IFT140;STOM;FBXL7;SNCA;FLOT2;FRMD5;DZIP1L;LMNA;ALOX15B;FSCN1;PDE4D;APBB3;MYO3B;TRIOBP;RAPH1;SEPT6;IPP;PBXIP1;BBS4;ATM;BBS1;AKAP13;SNX10;DGKQ;FHOD3;SYNE2;FGD4;VANGL2;ARHGEF2;DNAL4;KLHL12;SYNC;KRT222;SSH1;LYST;IFT27;NCOR1;NDRG1;RGS14;WDR63;SEPT5;CEP68;IFT88;TTC8;PODXL;UACA;WDR19;MAP2K5;ODF2;OR2A4;IFT122;CDC42EP5;MPRIP;SPPL2B;KLHL5;REEP2;TGFB1I1;TTC12;FLNB;UVRAG;TCTEX1D4;CCHCR1;CFAP54;FHOD1;IFT74;ZNF12;TACC2;OPHN1;TPGS1;MYO9A;DNAH1;KLHL3;YEATS2;CAPG;BEX4;ICK;OBSL1;ING4;PTPN3;ARL3;DEF6;RARA;ABCA2;TMEM67;CEP85L;WIPF1;LIMA1;KRT10;ACTR1B;CAPN6;DNM1P46;SEPT9;KLHL22;CDK5RAP3;MYH11;TTBK2;BSN;RHOBTB3;LRRCC1;MYO1C;C2CD5;SNTB1
4392,GO:0010092,0.00378116769789267,0.99940582488449,6,16,specification of animal organ identity,BP,BMP4;GLI3;FGFR1;DKK1;ISL1;GDNF
8135,GO:0032874,0.00378194280945119,0.998302318556735,22,107,positive regulation of stress-activated MAPK cascade,BP,CTGF;GADD45B;TNIK;MAP3K6;PAK1;PYCARD;XDH;ERCC6;TLR3;FZD7;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;TGFB2;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
8340,GO:0033218,0.00379550466704759,0.997977600882184,33,199,amide binding,MF,APBB2;SLC7A8;ANPEP;ITM2C;SORL1;ITGA2;PTGES;CTSV;HLCS;CLU;PIK3R1;ACACB;ANG;BACE1;MME;IGF1R;APBB3;CALR;CST3;CD1D;RNPEP;BCHE;LANCL1;PRNP;TGFB2;ITM2A;PPARG;CALCRL;FZD4;PPP3CA;OXTR;RNPEPL1;RXRA
8753,GO:0034446,0.00380844573586468,0.99855674105285,16,68,substrate adhesion-dependent cell spreading,BP,FN1;AXL;LAMB1;DOCK5;S100A10;PDPN;PARVA;LAMA5;FBLN1;FZD7;TRIOBP;CALR;POSTN;EFNA5;FZD4;DOCK1
11726,GO:0046596,0.00382376996123464,0.999375853569695,6,18,regulation of viral entry into host cell,BP,GSN;TRIM38;TRIM5;LGALS1;IFITM2;IFITM1
1307,GO:0003156,0.00384686525650311,0.999259645935102,7,21,regulation of animal organ formation,BP,BMP4;FGFR1;DKK1;SULF1;CITED2;ISL1;GDNF
6882,GO:0030424,0.00385070707838828,0.997567677923144,60,358,axon,CC,APBB2;MAP6;UTRN;ROR1;FLRT3;GJC2;STMN3;NTSR1;TIMP2;TENM3;PAK1;NEFM;SCN8A;NEFL;STAT1;SCN2A;PTPRS;DLG4;ITGA2;MICAL1;ITGA3;SYN1;SPG11;KCNAB2;PRKCZ;IL31RA;CCK;SYT1;SLC38A2;ANG;ANK3;BACE1;ROBO1;SNCA;MME;VAMP1;IGF1R;FSCN1;SETX;SEPT6;CST3;TRAK1;KCNQ3;SSH1;NFASC;SEPT5;MAP3K12;RET;TGFB2;ULK1;TH;BOC;OPHN1;TPGS1;KCNIP3;SV2A;TSHZ3;DNM1P46;BSN;ORAI2
16176,GO:0090238,0.00386879753888325,0.99989386454812,3,4,positive regulation of arachidonic acid secretion,BP,NTSR1;PLA2G6;PLA2R1
5843,GO:0017145,0.00387383818180637,0.999060562371776,9,27,stem cell division,BP,ETV5;ZFP36L2;WWTR1;FZD7;FGFR1;VANGL2;ARHGEF2;TGFB2;LEF1
19141,GO:1905207,0.00389051766629714,0.999040754601355,9,29,regulation of cardiocyte differentiation,BP,SOX6;EGFR;PAK1;BMP4;PRICKLE1;FZD7;DKK1;G6PD;TGFB2
1481,GO:0003779,0.00389234727056242,0.997612321811137,54,292,actin binding,MF,PHACTR3;SYNE1;TLN2;MYH15;TNNI2;GSN;TNS4;UTRN;EGFR;SPTB;MYLK;SYNE3;CTNNAL1;ADD3;PLEC;TNS1;KCNMA1;MICAL1;HIP1;SYN1;LIMCH1;FLNC;CLMN;ESPN;ANG;PARVA;TTN;SHROOM4;FSCN1;MYO3B;TRIOBP;IPP;FHOD3;SYNE2;FGD4;SSH1;MSRB2;MPRIP;KLHL5;FLNB;FHOD1;OPHN1;MYO9A;KLHL3;DIXDC1;CAPG;INF2;GCSAM;OBSL1;WIPF1;LIMA1;MYH11;MYO1C;SNTB1
6578,GO:0022414,0.00390437070019583,0.997188774926985,114,824,reproductive process,BP,SERPINE2;SYT8;MMP2;HTRA1;MMP9;SFRP1;ZFP36L1;SYNE1;TGFBR2;ETV5;PKD2;AXL;EGFR;HSPA2;RFX2;CRTAP;NUPR1;VDR;BMP4;SMARCA2;HSF2BP;ITGA2;MMP19;TIMP1;CUL7;BTG1;ITGA3;GLI3;PAQR8;E2F7;KITLG;MAGED2;CTSV;FUT10;GLI2;PLA2G6;SPATA6;ZNF318;SLIT3;PHC2;MST1R;CCNI;SPATA20;NCAPD2;SLC38A2;ANG;BBS2;MDFI;FBLN1;MLH3;PRKACB;TLR3;PAQR7;COL16A1;ALOX15B;RGS2;SETX;SULF1;TRO;CCDC136;SEPT6;DLX3;PBX1;BBS4;CALR;ATM;CST3;AREG;CITED2;NR2F2;ZNF449;MSH5;FBXW8;NRK;EGR1;SOX9;BCL6;PLAG1;MYBL1;RAB13;ETNK2;FNDC3A;LEPR;STOX2;ABCC2;IRF2BPL;SPA17;WDR19;TGFB2;ODF2;LEF1;THRA;HERPUD2;IGFBP2;RHBDD1;TH;GOPC;ITGB8;CFAP54;TPGS1;DNAH1;PPARG;RARA;PRKAG1;FZD4;CREBRF;FOS;AGO4;SERPINB5;ABAT;NIPBL;OXTR;RHOBTB3;RXRA
9077,GO:0035357,0.00391109625752757,0.999411542564836,6,14,peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;PDK3;CITED2;PPARG;FAM120B;RXRA
19675,GO:2000027,0.00391770195993188,0.997933691103876,32,186,regulation of organ morphogenesis,BP,SFRP1;TGFBR2;ETV5;SNAI2;MAGED1;SULF2;ROR1;VDR;BMP4;STAT1;PRICKLE1;PDGFA;FZD7;FGFR1;DKK1;PSMB9;SULF1;FZD1;ENG;CITED2;VANGL2;SOX9;ISL1;TGFB2;NPHP3;MAGI2;ARHGEF19;GDNF;FZD4;MED12;CELSR1;RXRA
6644,GO:0030001,0.0039796197715261,0.997393755038631,69,450,metal ion transport,BP,SERPINE2;CTGF;F2R;GJA5;PKD2;JPH2;NOS1;GAS6;UTRN;HSPA2;SLC8A1;ORAI3;MYLK;GJC2;SLC20A1;NTSR1;VDR;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;WNK1;SIK1;ANO6;CNTN1;MAGED2;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;PER1;SLC38A10;SLC38A2;ANK3;WFS1;KCNJ5;STOM;SNCA;PDE4D;G6PD;SLC24A1;ANXA6;KCNQ3;TMEM175;ABCC2;SLC39A11;PRNP;SCNN1A;FHL1;SLC9A4;ITPR2;CACNB1;KLHL3;CALCRL;KCNIP3;LGALS3;PTPN3;PPP3CA;STEAP2;CACNA2D3;KCNRG;TUSC3;ORAI2;DMPK
17557,GO:1901214,0.00399529458025298,0.997824794342809,35,205,regulation of neuron death,BP,NQO1;F2R;DDIT4;AXL;TRIM2;NEFL;SORL1;TP53;DDIT3;GPNMB;GPX1;LRP1;FYN;CLU;ITGA1;UNC5B;WFS1;TP73;AARS;SNCA;DKK1;G6PD;FZD1;ATM;GCLC;SSH1;EGR1;ISL1;MAP3K12;PRNP;TGFB2;SRPK2;GDNF;RASA1;FOS
7353,GO:0031406,0.00399771086931934,0.99826264431423,20,105,carboxylic acid binding,MF,NOS1;SESN3;VDR;P3H2;SESN1;CPS1;HLCS;GLDC;ACACB;AARS;GCLC;NR2F2;THNSL2;AGRN;TH;UGT1A3;SRR;PPARG;RARA;RXRA
2227,GO:0005132,0.00400609317578848,1,2,2,type I interferon receptor binding,MF,IFNK;IFNE
6454,GO:0021782,0.00403671557056312,0.998465715993856,16,66,glial cell development,BP,TENM4;GSN;ROR1;EGFR;VIM;LRP1;AHNAK2;CLU;ADGRG6;PRDM8;PRX;SH3TC2;HDAC11;NDRG1;MED12;LAMB2
8005,GO:0032649,0.00404095932479736,0.998773940172755,11,48,regulation of interferon-gamma production,BP,IL20RB;GAS6;AXL;PYCARD;TLR3;PDE4D;IL18;ISL1;PRNP;ZFPM1;RARA
2,GO:0000003,0.00405284218177813,0.997077980599142,114,825,reproduction,BP,SERPINE2;SYT8;MMP2;HTRA1;MMP9;SFRP1;ZFP36L1;SYNE1;TGFBR2;ETV5;PKD2;AXL;EGFR;HSPA2;RFX2;CRTAP;NUPR1;VDR;BMP4;SMARCA2;HSF2BP;ITGA2;MMP19;TIMP1;CUL7;BTG1;ITGA3;GLI3;PAQR8;E2F7;KITLG;MAGED2;CTSV;FUT10;GLI2;PLA2G6;SPATA6;ZNF318;SLIT3;PHC2;MST1R;CCNI;SPATA20;NCAPD2;SLC38A2;ANG;BBS2;MDFI;FBLN1;MLH3;PRKACB;TLR3;PAQR7;COL16A1;ALOX15B;RGS2;SETX;SULF1;TRO;CCDC136;SEPT6;DLX3;PBX1;BBS4;CALR;ATM;CST3;AREG;CITED2;NR2F2;ZNF449;MSH5;FBXW8;NRK;EGR1;SOX9;BCL6;PLAG1;MYBL1;RAB13;ETNK2;FNDC3A;LEPR;STOX2;ABCC2;IRF2BPL;SPA17;WDR19;TGFB2;ODF2;LEF1;THRA;HERPUD2;IGFBP2;RHBDD1;TH;GOPC;ITGB8;CFAP54;TPGS1;DNAH1;PPARG;RARA;PRKAG1;FZD4;CREBRF;FOS;AGO4;SERPINB5;ABAT;NIPBL;OXTR;RHOBTB3;RXRA
7980,GO:0032609,0.00410469670253873,0.998671362431616,12,54,interferon-gamma production,BP,IL20RB;GAS6;AXL;PYCARD;BTN3A1;TLR3;PDE4D;IL18;ISL1;PRNP;ZFPM1;RARA
10178,GO:0042802,0.00412652049166206,0.996908842308386,146,1163,identical protein binding,MF,HTRA1;FN1;MMP9;FBN1;SFRP1;NQO1;SYNE1;TENM4;PKD2;SDK1;SKP2;COL7A1;APCDD1;PDGFC;MAGED1;DPYSL2;EGFR;SDC3;FLRT3;S100A10;C1QTNF6;VIM;PSTPIP1;ALS2CL;NTSR1;TENM3;ANGPTL4;CBX5;PTPRM;PADI3;TP53I3;PCSK1;PTK6;TRIM5;NEFL;STAT1;LGALS1;TP53;WWTR1;DDIT3;PYCARD;MEF2D;PDGFA;NISCH;HIP1;IFIT3;SNX1;ANO6;E2F7;FYN;XDH;CAV1;SLC27A1;HLCS;RNF135;GLDC;SNX33;ZNF318;CAMK2D;PHC2;SYT1;TMEM173;CPT1A;ACACB;APOBEC3G;ANG;MDFI;TTN;APLP2;HPS4;FBLN1;TP73;CAT;DAPK1;CHEK2;ROBO1;STOM;TLR3;SNCA;PLXNA2;PTPRU;FGFR1;IGF1R;APOBEC3F;PRKAB2;SETX;ESYT2;G6PD;CDH13;TRAF1;AMOTL1;ENG;MKLN1;MDM2;CST3;DLK2;TCF4;ANXA6;NR2F2;ALDH4A1;KLHL12;SDC2;ENPP1;BCL6;BCHE;PRPS2;ANXA2;HOXA1;LEPR;TCF12;HMBOX1;NAB2;MAP3K12;ATXN1;PRNP;CDH11;TGFB2;SMG9;STAT2;AMOTL2;DPP9;MPRIP;SPPL2B;SP100;ULK1;GOPC;FLNB;UGT1A3;FHOD1;UGT1A6;GDNF;SRR;PPARG;TPST1;SNX9;OLFML2A;GSTZ1;FZD4;ZBTB1;DPYD;SBF2;DNPH1;ABAT;KCNRG;ADAM10;S100A11
10630,GO:0043687,0.00415728761675574,0.997508883498025,47,318,post-translational protein modification,BP,PRSS23;FN1;FBN1;CD109;SKP2;GAS6;LAMB1;NTM;CRTAP;DDB2;BMP4;LGALS1;CUL9;LTBP1;TIMP1;CUL7;DCAF16;FBXW4;WFS1;LMO7;APLP2;FBXL7;PDIA6;PSMB9;ARSD;NEGR1;FBXO17;CST3;FBXW8;NTNG1;SDC2;RAB13;IGFBP4;KCTD7;RHBDD1;KLHL5;NUB1;KLHL3;OBSL1;MIA3;DNAJC3;DCAF8;KLHL22;MATN3;FBXL4;ADAM10;LAMB2
8093,GO:0032792,0.00416808576374078,0.999882443503047,3,4,negative regulation of CREB transcription factor activity,BP,EIF2AK4;DDIT3;SIK1
15652,GO:0072207,0.00418090193346449,0.999234660328339,7,17,metanephric epithelium development,BP,FAT4;PKD2;STAT1;WWTR1;SOX9;YAP1;LAMB2
14659,GO:0070304,0.00418842521960586,0.998101425098612,22,108,positive regulation of stress-activated protein kinase signaling cascade,BP,CTGF;GADD45B;TNIK;MAP3K6;PAK1;PYCARD;XDH;ERCC6;TLR3;FZD7;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;TGFB2;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
15169,GO:0071345,0.00422911502823957,0.997031989098102,95,740,cellular response to cytokine stimulus,BP,TNFRSF6B;MMP2;FN1;FLRT2;MMP9;INPP5D;SFRP1;ZFP36L1;IL20RB;GSN;IRS2;ZFP36L2;GAS6;AXL;FLRT3;RFX2;VIM;TRIM38;XAF1;TRIM5;PDCD4;STAT1;IFIT2;TP53;PYCARD;IL32;IFIT1;TIMP1;IFIT3;FYN;IFI6;CAV1;SLC27A1;GLDC;MAP3K14;CXCR1;SLIT3;OAS2;CAMK2D;MST1R;IL31RA;PTPN14;PIK3R1;TMEM173;LAMA5;BBS2;SPRY2;JARID2;DAPK1;ROBO1;TLR3;ADAMTS7;MME;AIP;IFI35;FSCN1;CTF1;PSMB9;IL18;TLE4;IL17RE;EDA2R;TRAF1;BBS4;IFNK;SNX10;IFNE;PTPN1;ARHGEF2;EGR1;SOX9;BCL6;ANXA2;LEPR;IFITM2;RPL13A;ABCC2;RAB43;STAT2;LEF1;SPPL2B;SP100;HSPA5;RSAD2;FLNB;IFITM1;KLF5;AGPAT1;PPARG;POSTN;FZD4;CREBRF;FOS;PRDM5;MYO1C
2585,GO:0005882,0.00423426697356572,0.998423018144526,15,68,intermediate filament,CC,KRT4;KRT14;VIM;NEFM;NEFL;KRT13;KRT5;MICAL1;FLG;KRT15;CASP14;LMNA;SYNC;KRT222;KRT10
1294,GO:0003128,0.00429222220868351,0.999821971477647,3,5,heart field specification,BP,BMP4;DKK1;ISL1
3505,GO:0007416,0.0042943916518997,0.998208484616452,19,77,synapse assembly,BP,FLRT2;SLITRK6;SDK1;FLRT3;THBS2;AMIGO2;TPBG;DLG5;PCLO;SNCA;FZD1;NLGN4Y;LRRN3;AGRN;MAGI2;EFNA5;SLITRK5;BSN;OXTR
15020,GO:0070997,0.00430940611498245,0.997557552526593,39,235,neuron death,BP,NQO1;F2R;DDIT4;AXL;TRIM2;NEFL;SORL1;SCN2A;TP53;DDIT3;ADARB1;GPNMB;GPX1;LRP1;FYN;CLU;ITGA1;UNC5B;WFS1;TP73;AARS;SNCA;DKK1;G6PD;FZD1;ATM;GCLC;SSH1;EGR1;ISL1;MAP3K12;PRNP;TGFB2;HSPA5;MAGI1;SRPK2;GDNF;RASA1;FOS
9226,GO:0035637,0.00431655715725927,0.998098724826675,21,91,multicellular organismal signaling,BP,GJA5;NOS1;SLC8A1;SCN8A;SCN2A;ITGA2;CAV1;AHNAK2;EHD3;CAMK2D;ANK3;KCNJ5;PRX;PDE4D;NFASC;ITPR2;CACNB1;KCNIP3;MEF2A;CACNA2D3;DMPK
15116,GO:0071248,0.00431934163127428,0.998158125807101,19,97,cellular response to metal ion,BP,MMP9;NQO1;GSN;PKD2;EGFR;WNK1;CAMK2D;SYT1;ANK3;SNCA;NFATC4;CALR;ITPKB;PRNP;CARF;HSPA5;TH;MEF2A;FOS
5896,GO:0018108,0.0043449476960674,0.997539611305997,39,228,peptidyl-tyrosine phosphorylation,BP,GPRC5A;SFRP1;EFEMP1;GAS6;PDGFC;ROR1;AXL;EGFR;CSPG4;PTK6;TP53;CNTRL;DLG4;PDGFA;CNTN1;KITLG;FYN;CAV1;ERCC6;PRKCZ;MST1R;IL31RA;CCK;TTN;FGFR1;IGF1R;CTF1;IL18;AFAP1L2;AREG;DGKQ;PTPN1;ARHGEF2;ISL1;STK16;PRNP;RET;MAP2K5;EFNA5
10353,GO:0043195,0.0043473559754578,0.998696186831734,11,41,terminal bouton,CC,NTSR1;MICAL1;SYN1;CCK;SYT1;SNCA;VAMP1;SEPT5;TH;OPHN1;SV2A
12256,GO:0048589,0.00436094194474993,0.997159744616113,67,395,developmental growth,BP,FN1;SFRP1;ZFP36L1;TGFBR2;SLITRK6;TENM4;GSN;DUSP6;DPYSL2;FLRT3;EVC;PAK1;BMP4;EIF2AK4;PTPRS;WWTR1;SEMA5A;ADARB1;GPX1;GLI3;SPG11;PLXNB1;GLI2;ERCC6;PRKCZ;SLIT3;ULK2;TNS2;SYT1;ACACB;BBS2;SPRY2;JARID2;TP73;FZD7;PLXNA2;FGFR1;SEMA4A;PDE4D;G6PD;RAPH1;TGFBR3;BBS4;ATM;AREG;PLXNA1;VANGL2;NRK;SOX9;PLAG1;ETNK2;LEPR;MEGF8;TAF8;TGFB2;ULK1;AGRN;MAGI2;SEMA4B;YAP1;POSTN;RARA;EFNA5;MED12;NIPBL;RXRA;LAMB2
11412,GO:0045861,0.00436258730840871,0.997626480139891,34,211,negative regulation of proteolysis,BP,SERPINE2;TNFRSF6B;MMP9;CD109;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;SORL1;MICAL1;TIMP1;CRIM1;GPX1;IFI6;SERPING1;PRDX5;HERPUD1;APLP2;SNCA;GLG1;C5;MDM2;CST3;PRNP;MAP2K5;LEF1;OPHN1;DERL3;PTPN3;TAF1;SERPINB5;CAMK2N1
535,GO:0001654,0.00437925345684521,0.99750879728856,40,218,eye development,BP,COL8A1;FBN1;MYH15;TGFBR2;SLITRK6;EFEMP1;COL5A2;SDK1;FBN2;COL5A1;EGFR;VIM;TENM3;PTPRM;BMP4;SLC7A11;SMOC1;GLI3;NPHP4;IFT140;NAGLU;BBS4;CST3;MEIS2;MAF;SOX9;SALL2;WDR19;RET;TGFB2;DLX2;SMG9;IFT122;TH;RARA;COL4A1;FZD4;NIPBL;RXRA;LAMB2
16464,GO:0097191,0.00448414254006832,0.99769284197679,29,169,extrinsic apoptotic signaling pathway,BP,ITGA6;SFRP1;SNAI2;SERPINE1;BMP4;ITM2C;PYCARD;GPX1;KITLG;SRPX;FYN;IFI6;CAV1;PIK3R1;UNC5B;DAPK1;TLR3;FGFR1;LMNA;TRAF1;GCLC;ARHGEF2;RET;TGFB2;MAP2K5;SP100;YAP1;GDNF;LGALS3
10342,GO:0043177,0.00449811781796146,0.998022105396367,20,106,organic acid binding,MF,NOS1;SESN3;VDR;P3H2;SESN1;CPS1;HLCS;GLDC;ACACB;AARS;GCLC;NR2F2;THNSL2;AGRN;TH;UGT1A3;SRR;PPARG;RARA;RXRA
6667,GO:0030036,0.00451216397969741,0.996973225216659,76,470,actin cytoskeleton organization,BP,ITGB5;CTGF;SFRP1;RHOBTB2;ASAP3;GSN;TNIK;SPTB;S100A10;PAK1;ARAP1;PYCARD;SEMA5A;PDGFA;MICAL1;NISCH;HIP1;PLEK2;LIMCH1;CTSV;LRP1;ARHGAP18;ESPN;NPHP4;PRKCZ;IQSEC2;ARPIN;KANK2;PXN;PIK3R1;ANG;PARVA;TTN;SHROOM4;DLC1;FRMD5;FSCN1;OBSCN;ARHGEF17;TRIOBP;AMOTL1;BBS4;CALR;MKLN1;ARF6;AKAP13;FHOD3;FGD4;PTPN1;VANGL2;ARHGEF2;SSH1;BCL6;RAB13;PAK6;OR2A4;AMOTL2;CDC42EP5;MSRB2;FLNB;ARHGEF19;FHOD1;OPHN1;DIXDC1;CAPG;INF2;MEF2A;OBSL1;EFNA5;WIPF1;RASA1;LIMA1;MYH11;RHOBTB3;CELSR1;MYO1C
16771,GO:0098644,0.00456353418020177,0.999194394793037,7,15,complex of collagen trimers,CC,COL8A1;COL5A2;COL7A1;COL5A1;COL4A4;COL5A3;COL4A1
3291,GO:0006986,0.00458497412497482,0.997697782823386,27,158,response to unfolded protein,BP,DNAJB4;HSPA2;SERPINH1;EXTL2;DDIT3;CUL7;PIK3R1;CREB3L2;HERPUD1;WFS1;PDIA6;LMNA;TMEM129;CALR;DNAJC4;PTPN1;HERPUD2;TSPYL2;RHBDD1;HSPA5;DERL3;DNAJC3;CREBRF;CTDSP2;CDK5RAP3;UGGT2;EDEM1
9932,GO:0042311,0.00460408387915899,0.99921839383234,6,18,vasodilation,BP,NOS1;GPX1;CPS1;ITGA1;BBS2;RGS2
10479,GO:0043402,0.00460695756860859,1,3,3,glucocorticoid mediated signaling pathway,BP,NR3C1;AKAP13;CREBRF
772,GO:0002028,0.00462044666433757,0.998352906040446,14,56,regulation of sodium ion transport,BP,SERPINE2;NOS1;UTRN;SLC8A1;NETO1;WNK1;SIK1;CNTN1;CAMK2D;PER1;ANK3;STOM;PTPN3;DMPK
5318,GO:0016049,0.00462194864546535,0.997108111836315,55,346,cell growth,BP,SERPINE2;HTRA1;FN1;CTGF;SFRP1;APBB2;TGFBR2;DPYSL2;EGFR;FLRT3;PAK1;SMARCA2;EIF2AK4;TP53;PTPRS;SEMA5A;CCDC85B;CRIM1;BTG1;SPG11;PLXNB1;LTBP4;DCBLD2;PRKCZ;SLIT3;ULK2;CAMK2D;SYT1;CAPRIN2;PLXNA2;SEMA4A;G6PD;RAPH1;PLXNA1;SOX9;ENPP1;BCL6;IGFBP4;MEGF8;TGFB2;MAP2K5;LEF1;FHL1;CDKN2A;ULK1;TSPYL2;IGFBP2;KIAA1109;SEMA4B;PPARG;POSTN;EFNA5;DNPH1;ADAM10;LAMB2
13238,GO:0051954,0.00466074370492893,0.999408014942166,5,12,positive regulation of amine transport,BP,NTSR1;CCK;GDNF;ABAT;OXTR
6693,GO:0030100,0.00469131506278437,0.997587299658659,29,158,regulation of endocytosis,BP,FLOT1;PROM2;GAS6;AXL;SERPINE1;STON2;PYCARD;DLG4;ITGA2;HIP1;ANO6;TBC1D5;LRP1;CAV1;SNX33;CLU;SNCA;DKK1;CDH13;CALR;ARF6;DNAJC6;PTPN1;ANXA2;MAGI2;OPHN1;PPARG;LGALS3;PPP3CA
5378,GO:0016208,0.00472972342364654,0.999572718051804,4,9,AMP binding,MF,ACSS1;ACSS2;PRPS2;PRKAG1
2411,GO:0005588,0.00474761518938735,1,3,3,collagen type V trimer,CC,COL5A2;COL5A1;COL5A3
4348,GO:0009925,0.00477032305078966,0.998956452083724,8,21,basal plasma membrane,CC,ITGA6;PKD2;EGFR;CLCA2;MST1R;ANK3;SHROOM4;MYO1C
13596,GO:0060119,0.00477312357103229,0.998916807066739,8,24,inner ear receptor cell development,BP,FAT4;SLITRK6;FGFR1;TRIOBP;LRTOMT;NAGLU;VANGL2;IFT27
15492,GO:0071902,0.00479981716740342,0.997179896783155,43,265,positive regulation of protein serine/threonine kinase activity,BP,GADD45B;F2R;PKD2;DUSP6;TNIK;PDGFC;MAGED1;EGFR;CSPG4;MAP3K6;PAK1;BMP4;PDGFA;KITLG;SLC27A1;ERCC6;MAP3K14;ITGA1;MST1R;DUSP5;SPRY2;TP73;ROBO1;TLR3;SNCA;FGFR1;DKK1;C5;FZD8;FAM20A;AKAP13;MAP3K1;PTPN1;VANGL2;NRK;MAP3K12;MAP2K5;MAPK8IP3;MDFIC;SASH1;CCNY;FZD4;TAOK3
1337,GO:0003197,0.00481061510103764,0.998918499608971,8,23,endocardial cushion development,BP,TGFBR2;SNAI2;BMP4;ENG;MDM2;SOX9;ISL1;TGFB2
6583,GO:0022604,0.00484170220388793,0.996944726575727,57,336,regulation of cell morphogenesis,BP,FN1;RHOBTB2;TNIK;DPYSL2;DOCK5;SYNE3;S100A10;PAK1;NEFL;ARAP1;PTPRS;DLG4;SEMA5A;MAP2;CUL7;PDPN;PLXNB1;FYN;ARHGAP18;UST;ULK2;ARPIN;SYT1;CAPRIN2;PARVA;FBLN1;DLC1;METRN;ROBO1;PLXNA2;SEMA4A;TRIOBP;NFATC4;CALR;MKLN1;EFNB3;PLXNA1;TRAK1;FBXW8;FGD4;SDC2;SSH1;MEGF8;RET;CDC42EP5;SEMA4B;OBSL1;POSTN;EFNA5;FZD4;WIPF1;PPP3CA;RASA1;AGO4;TTBK2;RHOBTB3;DOCK1
19112,GO:1905114,0.00486516182370003,0.996814185877119,66,431,cell surface receptor signaling pathway involved in cell-cell signaling,BP,SFRP1;TNIK;APCDD1;SNAI2;SULF2;ROR1;RNF213;TCF7L1;NTSR1;BMP4;NETO1;GNG2;WWTR1;PRICKLE1;DDIT3;WNK1;DLG4;RBMS3;ITGA3;GLI3;CDK14;LRP1;CAV1;GLI2;NPHP4;PRKCZ;FBXW4;CAPRIN2;MDFI;SNCA;FZD7;PTPRU;DKK1;PSMB9;SULF1;TLE4;FZD8;NFATC4;FZD1;AMOTL1;FOXL1;VANGL2;KLHL12;SSH1;EGR1;SOX9;ISL1;IGFBP4;AMOTL2;LEF1;IGFBP2;NPHP3;MAGI2;TGFB1I1;ARHGEF19;MDFIC;YAP1;DIXDC1;CCNY;FZD4;PPP3CA;AGO4;MED12;ABAT;CELSR1;DMPK
5725,GO:0016877,0.00486849449485333,0.998853891869171,8,28,ligase activity, forming carbon-sulfur bonds,MF,SLC27A3;ACSL3;SLC27A1;ACSS1;ACSS2;SLC27A6;ACSF2;UBA7
15183,GO:0071360,0.00491547552586202,0.999367445562417,5,12,cellular response to exogenous dsRNA,BP,FLOT1;IFIT1;CAV1;TMEM173;TLR3
10352,GO:0043194,0.00497119083346586,0.999458451964769,5,9,axon initial segment,CC,SCN8A;CCK;ANK3;KCNQ3;NFASC
454,GO:0001228,0.00497201744800759,0.99707686271113,43,256,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ETV5;NR3C1;ETV1;TP53;DDIT3;MEF2D;TFDP2;GLI3;GLI2;HMGA2;CREB3L2;TP73;KLF13;DLX3;PBX1;MEIS2;TCF4;MAF;EGR1;SOX9;ISL1;STK16;PLAG1;SALL2;MYBL1;HLTF;HOXA1;TCF12;NFAT5;CARF;DLX2;LEF1;SSBP3;TEF;KLF5;MEIS3;MEF2A;KLF7;PBX2;CREBRF;ETV4;FOS;LITAF
12644,GO:0050878,0.00498180279856401,0.996973975393334,48,306,regulation of body fluid levels,BP,SERPINE2;F2R;GJA5;GAS6;PDGFC;PHF21A;TFPI2;AXL;DOCK9;ITPK1;SERPINE1;ANXA5;CBX5;VDR;VAV3;GNG2;WNK1;SLC7A11;ITGA2;PDGFA;MICAL1;FLG;ANO6;PDPN;FYN;XDH;CAV1;DOCK11;SERPING1;OAS2;EHD3;PIK3R1;WFS1;HPS4;FBLN1;PRKACB;DGKQ;PRCP;PRKCA;ANXA2;ZFPM1;SCNN1A;VAV2;ITPR2;SH2B3;ABAT;OXTR;DOCK1
5780,GO:0017015,0.00498677804401542,0.997923853523374,18,80,regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;FBN1;CD109;CDKN2B;TGFBR2;FBN2;PEG10;LTBP1;ITGA3;LTBP4;CAV1;GLG1;TGFBR3;ENG;MTMR4;CITED2;HSPA5;TGFB1I1
9115,GO:0035456,0.00499502646524693,0.999114291690309,6,20,response to interferon-beta,BP,XAF1;STAT1;TMEM173;TLR3;IFITM2;IFITM1
7859,GO:0032431,0.00504666391108492,1,2,2,activation of phospholipase A2 activity,BP,EGFR;ANG
14485,GO:0065007,0.00507193262794739,0.995800714065456,888,7889,biological regulation,BP,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;JPH2;PIK3C2G;IRS2;DUSP6;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;CLTCL1;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;MALL;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;TMEM204;KLF8;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;SLC8A1;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;CCNG2;THBS2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;DOK1;ATP10D;SERPINH1;RNF213;CRTAP;TCF7L1;S100A10;STON2;RNF165;ANXA5;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;ALS2CL;FAM210B;MAP3K6;AMIGO2;STMN3;TOM1L2;ASAP2;NTSR1;TIMP2;ZNF862;TADA3;TENM3;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;BMP4;TRIM38;TP53I11;ITM2C;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;ETV1;TP53;ARAP1;CEP250;EXTL2;MBNL2;PTPRS;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;PILRB;ZCCHC11;PDGFA;MAP2;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;FLG;PHLDB1;HIP1;GPNMB;TFDP2;SMOC1;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;EVI5L;ZNF18;TTC28;KLF12;IFIT3;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;KITLG;TBC1D5;P3H2;NAV2;ERMAP;ASAP1;ERO1B;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;CCDC80;SESN1;CTSV;SEC14L1;PLXNB1;PDE4DIP;EML2;KCNAB2;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;CLMN;CPS1;LAMA3;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;AHNAK2;UST;CLU;DCBLD2;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;CCNI;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DUSP5;PARVA;LAMA5;UNC5B;UHRF2;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;FBLN1;ZKSCAN1;TP73;CAT;PLCH2;CASP14;DAPK1;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;METRN;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;PAIP2B;STOM;PRX;PHF2;TLR3;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;MME;FRMD5;PDIA6;GATAD1;FZD7;AIP;GLG1;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;DZIP1L;FGFR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;FSCN1;PRKAB2;CTF1;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;ASTN2;PDE4D;APBB3;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;BRD3;PLA2R1;PDK3;G6PD;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;TGFBR3;DLX3;FZD1;AMOTL1;LRTOMT;NOTCH2NL;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;TBC1D19;DLK2;MEIS2;AREG;IFNK;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;FHOD3;IFNE;NEURL1B;CBX7;LMO4;ZNF449;ZMAT3;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;SYNE2;HDAC11;RCBTB1;RNPEP;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;ARHGEF2;DNAL4;PLGRKT;SPRED3;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;NDRG1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;CES3;HLTF;HOXA1;MPP7;CXORF57;SEPT5;BAHCC1;METTL23;LEPR;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;IFITM2;SAMD5;MVB12B;TES;KCTD7;TCF25;MOSPD2;TCF12;CABLES2;HMBOX1;NFAT5;RPL13A;PODXL;PAK6;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;HTR1B;IRF2BPL;STK36;RAB43;MAML2;WDR19;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;DLX2;ZNF550;OR2A4;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;ZNF701;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;MSRB2;C2CD4C;CDKN2A;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;RHBDD1;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;TH;CELF2;GOPC;MAGI1;SLC9A4;BOC;PIKFYVE;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;FHOD1;IFT74;POLD4;SAP30L;IFITM1;ZNF12;OPHN1;LMF1;SH2B3;MYO9A;YAP1;CACNB1;GDNF;RALGAPB;NUB1;KLF5;COL17A1;TWIST2;CAPS;KLHL3;ATRAID;YEATS2;HOXA3;UBA7;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;KCNIP3;MEF2A;MLLT6;GCSAM;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DNAJC3;NYAP1;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;FZD4;SLITRK5;ZNF883;WIPF1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;PIK3C2B;SBF2;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;CTDSP2;STEAP2;ETV4;HP1BP3;HOXA2;CAPN6;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;CLEC2D;FAM120B;FAM168A;CACNA2D3;SERPINB5;SCPEP1;CAMK2N1;ELMO2;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;PPP2R3A;CELSR1;ZNF471;LITAF;TSPAN4;S100A11;MYO1C;RXRA;C2CD5;CPT2;EDEM1;ACAA2;ABCA5;TAOK3;NFKBIE;ZNF484;DOCK1;DMPK;PINLYP
2601,GO:0005902,0.0051414544146297,0.99831061441584,12,48,microvillus,CC,PROM2;PDGFA;PDPN;CTSV;ESPN;SYTL1;BBS2;FSCN1;NFASC;PODXL;OXTR;MYO1C
12867,GO:0051235,0.00517652182013651,0.997040962888145,39,220,maintenance of location,BP,FBN1;SYNE1;F2R;TLN2;GSN;PKD2;JPH2;NOS1;FBN2;SLC8A1;SYNE3;NTSR1;ABCA1;SORL1;MEST;DDIT3;LTBP1;CAV1;CAMK2D;ACACB;ANK3;MDFI;SNCA;PDE4D;BBS4;CALR;SYNE2;ENPP1;TAF8;THRA;SP100;HSPA5;GOPC;FLNB;UVRAG;ITPR2;VPS13C;PPARG;NFKBIE
2427,GO:0005610,0.00526433941853097,1,3,3,laminin-5 complex,CC,LAMA3;LAMA5;LAMB3
7857,GO:0032429,0.00529029063228628,0.99958542454837,4,7,regulation of phospholipase A2 activity,BP,EGFR;LRP1;ANG;PLA2R1
12335,GO:0048736,0.0053146789491721,0.997371378515584,26,125,appendage development,BP,ITGA6;ITGB4;GJA5;FBN2;RNF165;BMP4;SMOC1;GLI3;GLI2;FBXW4;IFT140;PLXNA2;FGFR1;DKK1;PBX1;NR2F2;SOX9;ZNF358;MEGF8;WDR19;TGFB2;IFT122;LEF1;RARA;PBX2;NIPBL
13631,GO:0060173,0.0053146789491721,0.997371378515584,26,125,limb development,BP,ITGA6;ITGB4;GJA5;FBN2;RNF165;BMP4;SMOC1;GLI3;GLI2;FBXW4;IFT140;PLXNA2;FGFR1;DKK1;PBX1;NR2F2;SOX9;ZNF358;MEGF8;WDR19;TGFB2;IFT122;LEF1;RARA;PBX2;NIPBL
10381,GO:0043235,0.00531518638971416,0.997044320049723,36,185,receptor complex,CC,ITGB6;ITGB5;ITGA6;TGFBR2;ITGB4;ROR1;AXL;EGFR;VDR;DLG4;ITGA2;ITGA3;PLXNB1;LRP1;ITGA10;ITGA1;MST1R;CAPRIN2;AIP;PLXNA2;FGFR1;IGF1R;PLA2R1;EPHB6;TGFBR3;ENG;PLXNA1;NT5DC3;LEPR;RET;ITGB8;ITPR2;CALCRL;SHISA9;SLITRK5;RXRA
3518,GO:0007494,0.00534489329903103,0.999579866839155,4,7,midgut development,BP,EGFR;CPS1;FOXL1;RET
18948,GO:1904754,0.00535337195779549,0.999405825050745,5,9,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK5;PAK1;DOCK4;MDM2;SSH1
16087,GO:0090101,0.00542029783470765,0.997792059987832,17,74,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;FBN1;SFRP1;CD109;TGFBR2;FBN2;PEG10;LTBP1;CAV1;GLG1;DKK1;TGFBR3;FZD1;MTMR4;MAGI2;HSPA5;TGFB1I1
10049,GO:0042562,0.00542751709719573,0.998303764405143,11,44,hormone binding,MF,EGFR;VDR;NR3C1;PIK3R1;IGF1R;CDH13;CALR;UCN2;THRA;CALCRL;OXTR
12043,GO:0048015,0.00546355955123261,0.99751605838886,21,102,phosphatidylinositol-mediated signaling,BP,SERPINE2;ZFP36L1;F2R;GSN;PIK3C2G;IRS2;PDGFC;EGFR;PDGFA;PLXNB1;FYN;PIK3R1;UNC5B;CAT;FGFR1;IGF1R;IL18;SOX9;TGFB2;NYAP1;PIK3C2B
11045,GO:0045064,0.00553749608260897,0.999476189728307,4,9,T-helper 2 cell differentiation,BP,PRKCZ;IL18;BCL6;RARA
13222,GO:0051928,0.00555165558433468,0.998050021146814,13,55,positive regulation of calcium ion transport,BP,F2R;PKD2;JPH2;HSPA2;MYLK;GJC2;NTSR1;CAV1;EHD3;WFS1;SNCA;G6PD;LGALS3
8133,GO:0032872,0.00555817113077051,0.99710330687379,29,159,regulation of stress-activated MAPK cascade,BP,CTGF;SFRP1;GADD45B;TNIK;EGFR;MAP3K6;PAK1;PDCD4;PYCARD;XDH;ERCC6;PER1;TP73;TLR3;FZD7;IGF1R;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;NCOR1;TGFB2;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
13812,GO:0060441,0.00557046725372345,0.998864238760806,7,20,epithelial tube branching involved in lung morphogenesis,BP,BMP4;DLG5;SPRY2;VANGL2;SOX9;YAP1;CELSR1
8018,GO:0032673,0.00564779867001796,0.999203569423695,5,14,regulation of interleukin-4 production,BP,IL20RB;PRKCZ;ZFPM1;LEF1;RARA
11280,GO:0045621,0.00570441128439954,0.998080638049236,12,52,positive regulation of lymphocyte differentiation,BP,INPP5D;TGFBR2;GAS6;AXL;GLI3;GLI2;PRKCZ;IL18;ITPKB;BCL6;RARA;ZBTB1
11800,GO:0046718,0.00571997320718302,0.99770600999415,16,77,viral entry into host cell,BP,ITGB6;ITGB5;GSN;ANPEP;GAS6;AXL;EGFR;TRIM38;TRIM5;LGALS1;ITGA2;CAV1;EFNB3;IFITM2;UVRAG;IFITM1
8150,GO:0032892,0.00575577902294128,0.99920508641624,5,13,positive regulation of organic acid transport,BP,NTSR1;PLA2G6;CCK;PLA2R1;ABAT
5163,GO:0015718,0.00576781993298681,0.997546581915945,18,86,monocarboxylic acid transport,BP,IRS2;NTSR1;ACSL3;SLC27A1;PLA2G6;CPT1A;ACACB;PRKAB2;NCOA2;PLA2R1;SLC27A6;NCOR1;ABCC2;PPARG;SV2A;ABAT;RXRA;CPT2
2099,GO:0004867,0.00578607154792772,0.998280812185545,10,42,serine-type endopeptidase inhibitor activity,MF,SERPINE2;CD109;COL7A1;TFPI2;SERPINE1;SERPINH1;CRIM1;SERPING1;APLP2;SERPINB5
7597,GO:0031994,0.0058543569556303,0.999283908970121,5,10,insulin-like growth factor I binding,MF,ITGA6;ITGB4;IGF1R;IGFBP4;IGFBP2
1991,GO:0004714,0.00590397240589074,0.99817403061039,11,38,transmembrane receptor protein tyrosine kinase activity,MF,EFEMP1;ROR1;AXL;EGFR;CRIM1;MST1R;FGFR1;IGF1R;EPHB6;EFNB3;RET
8191,GO:0032956,0.00595259496515043,0.996510833782955,41,240,regulation of actin cytoskeleton organization,BP,CTGF;SFRP1;RHOBTB2;ASAP3;GSN;SPTB;S100A10;PAK1;ARAP1;PYCARD;SEMA5A;PDGFA;CTSV;LRP1;ARHGAP18;ARPIN;KANK2;PXN;PIK3R1;DLC1;FSCN1;TRIOBP;BBS4;ARF6;AKAP13;FHOD3;VANGL2;SSH1;OR2A4;CDC42EP5;ARHGEF19;FHOD1;DIXDC1;CAPG;EFNA5;WIPF1;RASA1;LIMA1;RHOBTB3;CELSR1;MYO1C
15679,GO:0072257,0.00599394952515472,0.999592450534011,4,6,metanephric nephron tubule epithelial cell differentiation,BP,FAT4;STAT1;WWTR1;YAP1
15703,GO:0072307,0.00599394952515472,0.999592450534011,4,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,FAT4;STAT1;WWTR1;YAP1
14657,GO:0070302,0.00601115190000635,0.996847190088771,29,160,regulation of stress-activated protein kinase signaling cascade,BP,CTGF;SFRP1;GADD45B;TNIK;EGFR;MAP3K6;PAK1;PDCD4;PYCARD;XDH;ERCC6;PER1;TP73;TLR3;FZD7;IGF1R;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;NCOR1;TGFB2;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
8358,GO:0033268,0.00602201780019145,0.999311365376517,5,9,node of Ranvier,CC,SCN8A;SCN2A;ANK3;KCNQ3;NFASC
18562,GO:1903844,0.00603052027922354,0.997433947821132,18,82,regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;FBN1;CD109;CDKN2B;TGFBR2;FBN2;PEG10;LTBP1;ITGA3;LTBP4;CAV1;GLG1;TGFBR3;ENG;MTMR4;CITED2;HSPA5;TGFB1I1
15637,GO:0072189,0.00612418430371438,0.999498686719165,4,7,ureter development,BP,BMP4;SOX9;RET;NPHP3
10412,GO:0043279,0.00618482118532804,0.997682203324357,14,64,response to alkaloid,BP,SDK1;SLC8A1;TP53;SNCA;MDM2;TMED10;BCHE;HTR1B;HSPA5;TH;SRR;PPARG;ABAT;OXTR
954,GO:0002376,0.00620598366430602,0.995063981360624,222,1851,immune system process,BP,TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;PYGB;MMP9;ITGB5;FBN1;SOX6;INPP5D;ITGA6;SFRP1;MMP28;CD109;CDKN2B;ZFP36L1;DDIT4;TGFBR2;IL20RB;SLC7A8;GSN;IRS2;ZFP36L2;HERC5;ANPEP;GAS6;AXL;TSC22D3;SDC3;SLC2A3;SERPINE1;STON2;VIM;PSTPIP1;TKFC;IFI44L;FAM210B;MFAP5;TIMP2;CXCL14;PAK1;APOBEC3C;BMP4;TRIM38;NR1D1;PTK6;XAF1;EIF2AK4;TRIM5;VAV3;STAT1;IFIT2;LGALS1;TP53;PTPRS;PYCARD;IL32;IFIT1;DDX60;MUC19;SLC7A11;ITGA2;PILRB;ADARB1;GPNMB;ITGA3;IFIT3;ANO6;GPX1;GLI3;DLG5;KITLG;ERMAP;PDPN;CTSV;SEC14L1;KCNAB2;LRP1;FYN;IFI6;FUT10;CAV1;GLI2;RNF135;RBFOX2;PLA2G6;DOCK11;MAP3K14;CLU;SERPING1;CXCR1;PRKCZ;OAS2;CAMK2D;ITGA1;MST1R;IL31RA;METTL7A;ULBP1;PIK3R1;TMEM173;APOBEC3G;JARID2;TP73;CAT;DAPK1;KLF13;BTN3A1;PRKACB;STOM;TLR3;SNCA;FLOT2;MME;FZD7;GLG1;PAG1;IGF1R;APOBEC3F;IFI35;MLEC;SEC24D;SEMA4A;C5;PDE4D;PSMB9;IL18;G6PD;FZD8;SOX13;DHTKD1;TGFBR3;L3MBTL3;PBX1;FOXL1;CALR;ATM;EFNB3;CST3;MEIS2;MANBA;IFNK;SNX10;CITED2;IFNE;LMO4;CD1D;PTMS;MAP3K1;PTPN1;CRIP2;ARHGEF2;SDC2;LYST;EGR1;SOX9;ENPP1;ITPKB;BCL6;PRCP;NFASC;NDRG1;GCNT1;PRKCA;ANXA2;LEPR;MAN2B1;IFITM2;MOSPD2;TCF12;RPL13A;ZNF160;RAB43;PRNP;RET;ZFPM1;TGFB2;DNASE1L1;STAT2;LEF1;THRA;SSBP3;ITM2A;SPPL2B;OSBPL1A;SP100;IGFBP2;VAV2;BTN3A3;RSAD2;FLNB;SRPK2;NAPRT;IFITM1;SH2B3;YAP1;NUB1;COL17A1;HOXA3;GALNT2;PPARG;GCSAM;PRR7;LGALS3;MIA3;DNAJC3;RARA;WIPF1;ZBTB1;PPP3CA;ACTR1B;FOS;AGO4;CLEC2D;ELMO2;ADAM10;S100A11;MYO1C;GBP3;CTSD;DOCK1
20052,GO:2000726,0.00621714948206731,0.999185561230225,5,11,negative regulation of cardiac muscle cell differentiation,BP,SOX6;PAK1;FZD7;DKK1;G6PD
12520,GO:0050693,0.00626060110468369,0.999794294465382,3,4,LBD domain binding,MF,CITED2;PPARG;RXRA
95,GO:0000186,0.0063020683242509,0.997891124620629,12,45,activation of MAPKK activity,BP,GADD45B;F2R;TNIK;EGFR;MAP3K6;BMP4;ERCC6;MAP3K14;MAP3K1;NRK;MAP3K12;TAOK3
3541,GO:0007566,0.00631600300344203,0.998259312260081,9,35,embryo implantation,BP,MMP2;MMP9;TGFBR2;TIMP1;FBLN1;TRO;CALR;CST3;RXRA
13908,GO:0060601,0.0063260475361517,0.999210947684206,5,10,lateral sprouting from an epithelium,BP,BMP4;GLI2;SULF1;VANGL2;CELSR1
9931,GO:0042310,0.00633596502056373,0.998126149559737,10,37,vasoconstriction,BP,F2R;GJA5;EGFR;SLC8A1;DOCK5;DOCK4;CAV1;BBS2;HTR1B;OXTR
2265,GO:0005198,0.00634182987313837,0.995740420658667,69,510,structural molecule activity,MF,KRT4;FBN1;MARVELD1;TLN2;COL5A2;CLTCL1;FBN2;MALL;COL5A1;TFPI2;LAMB1;SPTB;KRT14;VIM;MFAP5;ADD3;PLEC;NEFM;AHNAK;NEFL;COL18A1;KRT13;KRT5;MAP2;PPL;EFEMP2;FLG;HIP1;COL4A4;DLG5;PLLP;KRT15;PDE4DIP;LAMA3;CAV1;NPHP4;ANK3;LAMB3;TTN;FBLN1;FRMD5;LMNA;OBSCN;SEPT6;COPG2;AKAP13;COL5A3;SYNC;KRT222;RGS14;MPP7;SEPT5;RPL13A;ODF2;COL12A1;MAPK8IP3;AGRN;MAGI2;MAGI1;KLHL3;SASH1;OBSL1;COL4A1;KRT10;SEPT9;MATN3;MYH11;SNTB1;LAMB2
1406,GO:0003341,0.00640899179453249,0.998440201874078,8,26,cilium movement,BP,WDR66;BBS2;BBS4;STK36;SPA17;NPHP3;CFAP54;DNAH1
15198,GO:0071383,0.0064330058682049,0.99645220293643,33,189,cellular response to steroid hormone stimulus,BP,SFRP1;ZFP36L1;DDIT4;ZFP36L2;SKP2;EGFR;TADA3;PAK1;VDR;BMP4;NR1D1;NR3C1;KLF9;PAQR8;RBFOX2;KANK2;PER1;PAQR7;CALR;AKAP13;NR2F2;ISL1;ABCC2;LEF1;THRA;TGFB1I1;YAP1;PPARG;RARA;TAF1;CREBRF;MED12;RXRA
14290,GO:0061476,0.00643736042753397,0.999786242729986,3,4,response to anticoagulant,BP,SFRP1;EGR1;SOX9
15282,GO:0071503,0.00643736042753397,0.999786242729986,3,4,response to heparin,BP,SFRP1;EGR1;SOX9
15283,GO:0071504,0.00643736042753397,0.999786242729986,3,4,cellular response to heparin,BP,SFRP1;EGR1;SOX9
8768,GO:0034464,0.00647047330247099,0.999359273314384,4,9,BBSome,CC,BBS2;BBS4;BBS1;TTC8
10408,GO:0043274,0.00647566273347638,0.999142983393916,5,11,phospholipase binding,MF,NEFL;PRKCZ;SNCA;PLA2R1;DGKQ
10109,GO:0042663,0.00652286114803344,1,2,2,regulation of endodermal cell fate specification,BP,DUSP6;DKK1
13717,GO:0060318,0.00657174865472518,0.999780062648047,3,4,definitive erythrocyte differentiation,BP,RBFOX2;TGFBR3;ZFPM1
12747,GO:0051049,0.00660122560095454,0.994973397917441,149,1115,regulation of transport,BP,SERPINE2;SYT8;FLOT1;FN1;MMP9;SFRP1;F2R;ANO1;GJA5;PKD2;JPH2;IRS2;PROM2;CLTCL1;NOS1;GAS6;TCAF1;UTRN;AXL;EGFR;HSPA2;SLC8A1;MYLK;GJC2;SERPINE1;STON2;NTSR1;PAK1;ABCA1;BMP4;NR1D1;AHNAK;SCN8A;TBC1D8;NETO1;SORL1;SCN2A;KCNMA1;TP53;PYCARD;WNK1;DLG4;ITGA2;MICAL1;ACSL3;HIP1;TFDP2;SIK1;EVI5L;ANO6;GLI3;CNTN1;TBC1D5;SYN1;KCNAB2;LRP1;FYN;B3GAT3;CAV1;PLA2G6;SNX33;CLU;PRKCZ;OAS2;KCNJ15;EHD3;CAMK2D;SYTL1;PTPN14;PER1;CCK;PIK3R1;SYT1;HHAT;TMEM173;CPT1A;PCLO;ANG;ANK3;WFS1;TTN;HPS4;TP73;DAPK1;KCNJ5;STOM;SNCA;SH3TC2;FGFR1;ALOX15B;DKK1;C5;PDE4D;PLA2R1;G6PD;CDH13;LRTOMT;CALR;IDH2;MDM2;ARF6;DNAJC6;PTPN1;KCNQ3;ENPP1;ISL1;NCOR1;PRKCA;ANXA2;RAB13;SEPT5;KCTD7;HTR1B;PRNP;TGFB2;FHL1;C2CD4C;SP100;MAGI2;GOPC;REEP2;RSAD2;UVRAG;ITPR2;MDFIC;OPHN1;CACNB1;GDNF;DERL3;PPARG;KCNIP3;SHISA9;TBC1D16;POSTN;LGALS3;PTPN3;SV2A;ABCA2;EFNA5;PPP3CA;CACNA2D3;ABAT;KCNRG;OXTR;MYO1C;C2CD5;EDEM1;ACAA2;DMPK
11799,GO:0046717,0.00663391746585278,0.997733189064409,12,50,acid secretion,BP,NTSR1;PLA2G6;CCK;SYT1;SLC38A2;SNCA;PLA2R1;ABCC2;SLC9A4;SV2A;ABAT;OXTR
12356,GO:0048771,0.00663841308838395,0.996990828118969,20,97,tissue remodeling,BP,INPP5D;SFRP1;F2R;GJA5;AXL;EGFR;CSPG4;VDR;GPNMB;CAV1;TGM2;IL18;MDM2;CST3;PRKCA;LEPR;HTR1B;LIPA;HOXA3;PPP3CA
379,GO:0001012,0.00665842716018369,0.995572825963758,66,433,RNA polymerase II regulatory region DNA binding,MF,SOX6;ETV5;PHF21A;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;GLI2;HMGA2;PER1;CREB3L2;JARID2;TP73;KLF13;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;EGR1;ISL1;BCL6;PLAG1;SALL2;MYBL1;HLTF;TCF12;NFAT5;CARF;ZFPM1;RBL2;DLX2;LEF1;THRA;SSBP3;TEF;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;PRDM5;LITAF;RXRA
15485,GO:0071895,0.00671866083911643,0.999670928130929,3,5,odontoblast differentiation,BP,SERPINE1;DLX3;LEF1
2127,GO:0004930,0.00672610235477243,0.996717606630351,23,138,G-protein coupled receptor activity,MF,GPRC5A;SFRP1;F2R;LPAR5;NTSR1;CXCR1;GPR39;ADGRG6;S1PR5;FZD7;FZD8;FZD1;LANCL1;HTR1B;OR2A4;GPR161;PPARG;CALCRL;SENP7;FZD4;ADGRA2;OXTR;CELSR1
18591,GO:1903901,0.00676983710387916,0.997530197407157,13,62,negative regulation of viral life cycle,BP,GSN;APOBEC3C;EIF2AK4;TRIM5;IFIT1;OAS2;HMGA2;APOBEC3G;APOBEC3F;IFITM2;RSAD2;SRPK2;IFITM1
13882,GO:0060562,0.00677330290306296,0.99603378514312,40,223,epithelial tube morphogenesis,BP,SFRP1;FAT4;TGFBR2;ETV5;PKD2;MAGED1;PAK1;VDR;BMP4;PRICKLE1;GLI3;DLG5;GLI2;LAMA5;SPRY2;DLC1;PRKACB;NFATC4;FZD1;PBX1;ENG;BBS4;AREG;LMO4;VANGL2;SOX9;PODXL;MEGF8;RET;TGFB2;IFT122;LEF1;NPHP3;YAP1;GDNF;KLHL3;RARA;COL4A1;MED12;CELSR1
7088,GO:0030895,0.00677509372046946,1,2,2,apolipoprotein B mRNA editing enzyme complex,CC,APOBEC3G;APOBEC3F
18918,GO:1904705,0.00677878550902358,0.998309055679586,8,28,regulation of vascular smooth muscle cell proliferation,BP,MMP2;MMP9;PAK1;PDCD4;MEF2D;MDM2;HTR1B;PPARG
19625,GO:1990874,0.00677878550902358,0.998309055679586,8,28,vascular smooth muscle cell proliferation,BP,MMP2;MMP9;PAK1;PDCD4;MEF2D;MDM2;HTR1B;PPARG
1382,GO:0003283,0.00678662608108935,0.998849001938285,6,14,atrial septum development,BP,GJA5;MDM2;ISL1;ZFPM1;TGFB2;NPHP3
5534,GO:0016529,0.00679071457905205,0.997999019390816,10,34,sarcoplasmic reticulum,CC,JPH2;NOS1;P3H2;XDH;CAMK2D;ANK3;CALR;SYNE2;ITPR2;DMPK
359,GO:0000978,0.00682385533244523,0.995830000260881,46,284,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SOX6;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;MEF2D;GLI3;GLI2;HMGA2;PER1;CREB3L2;TP73;KLF13;NCOA2;NFATC4;PBX1;MEIS2;TCF4;ISL1;PLAG1;MYBL1;HLTF;TCF12;NFAT5;CARF;ZFPM1;LEF1;SSBP3;YAP1;KLF5;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;ETV4;FOS;PRDM5;LITAF;RXRA
4659,GO:0010812,0.00682591322326753,0.997691066733181,12,45,negative regulation of cell-substrate adhesion,BP,SERPINE1;LGALS1;PIK3R1;FBLN1;DLC1;FZD7;BCL6;CDKN2A;POSTN;EFNA5;FZD4;RASA1
12263,GO:0048608,0.00682960698168229,0.995781154154163,48,296,reproductive structure development,BP,SERPINE2;HTRA1;SFRP1;ZFP36L1;PKD2;AXL;EGFR;NUPR1;VDR;BMP4;MMP19;CUL7;GLI3;E2F7;KITLG;CTSV;GLI2;SLIT3;ANG;MDFI;TLR3;ALOX15B;SULF1;DLX3;ATM;CST3;CITED2;NR2F2;FBXW8;NRK;SOX9;PLAG1;RAB13;ETNK2;FNDC3A;STOX2;WDR19;TGFB2;LEF1;ITGB8;PPARG;RARA;FZD4;AGO4;SERPINB5;NIPBL;RHOBTB3;RXRA
1285,GO:0003094,0.00683320306135161,0.999045765980798,5,12,glomerular filtration,BP,F2R;GJA5;GAS6;SULF2;SULF1
13458,GO:0055024,0.0068335998302337,0.997674151905894,12,47,regulation of cardiac muscle tissue development,BP,SOX6;TGFBR2;JPH2;PAK1;BMP4;JARID2;TP73;FZD7;FGFR1;DKK1;G6PD;TGFBR3
17846,GO:1902107,0.00683711478420635,0.997108744843136,17,85,positive regulation of leukocyte differentiation,BP,INPP5D;ZFP36L1;TGFBR2;GAS6;AXL;GLI3;KITLG;GLI2;PRKCZ;IL18;ITPKB;BCL6;PRKCA;LEF1;RARA;ZBTB1;FOS
13577,GO:0060076,0.00685916078764997,0.998833964620741,6,14,excitatory synapse,CC,NETO1;DLG4;ITGA3;SYT1;NLGN4Y;BSN
3716,GO:0008238,0.0069205052291713,0.997362989295352,14,66,exopeptidase activity,MF,CPA4;ANPEP;CPVL;CTSV;BACE1;MME;RNPEP;PRCP;GGT7;DPP9;NPEPL1;PGPEP1;SCPEP1;RNPEPL1
15667,GO:0072234,0.00696446990321697,0.998812066980597,6,14,metanephric nephron tubule development,BP,FAT4;PKD2;STAT1;WWTR1;SOX9;YAP1
17994,GO:1902514,0.00699244794903777,0.999404379613714,4,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1;CAMK2D;G6PD;CACNB1
7193,GO:0031093,0.00703238407129717,0.99801949338679,9,36,platelet alpha granule lumen,CC,FN1;GAS6;SERPINE1;PDGFA;TIMP1;MAGED2;CLU;SERPING1;TGFB2
15253,GO:0071466,0.00703500490871428,0.996905752865442,18,102,cellular response to xenobiotic stimulus,BP,NQO1;DDIT4;PTGS1;EGFR;SLC8A1;NR3C1;CMBL;CES2;CHEK2;BPHL;AIP;AKR7A2;EGR1;BCHE;CES3;ABCC2;UGT1A3;UGT1A6
13789,GO:0060412,0.00703932620477452,0.998089754415881,9,29,ventricular septum morphogenesis,BP,TGFBR2;GJA5;BMP4;TGFBR3;FZD1;CITED2;VANGL2;ZFPM1;TGFB2
3432,GO:0007224,0.00708802405867076,0.996769107336905,20,96,smoothened signaling pathway,BP,SERPINE2;SFRP1;TGFBR2;EVC;BMP4;GLI3;DLG5;GLI2;HHAT;PRKACB;IFT140;IFT27;MEGF8;STK36;WDR19;IFT122;GPR161;BOC;ARL3;TTBK2
13852,GO:0060512,0.00710151375467702,0.998503946724116,7,19,prostate gland morphogenesis,BP,SFRP1;BMP4;GLI2;SULF1;SOX9;SERPINB5;RXRA
18155,GO:1902951,0.00711222829051052,1,2,2,negative regulation of dendritic spine maintenance,BP,FYN;PRNP
19310,GO:1905664,0.00711222829051052,1,2,2,regulation of calcium ion import across plasma membrane,BP,FYN;PRNP
9183,GO:0035583,0.00711231694765813,1,3,3,sequestering of TGFbeta in extracellular matrix,BP,FBN1;FBN2;LTBP1
1604,GO:0004029,0.00711902625368925,0.998963528458634,5,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH3A2;ALDH1L2;ALDH4A1;ALDH9A1;ALDH7A1
13745,GO:0060352,0.00712889810627204,0.999642990791323,3,5,cell adhesion molecule production,BP,FLOT1;CAV1;GCNT1
10532,GO:0043507,0.007142209898428,0.997310513018965,14,57,positive regulation of JUN kinase activity,BP,TNIK;MAP3K6;PAK1;ERCC6;DKK1;FZD8;PTPN1;VANGL2;NRK;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
15819,GO:0072563,0.00714602559127062,1,2,2,endothelial microparticle,CC,ANXA5;ENG
15958,GO:0080184,0.00716210960737169,1,2,2,response to phenylpropanoid,BP,EGFR;CAT
10811,GO:0044325,0.00724270937741984,0.996934050261478,17,80,ion channel binding,MF,PKD2;NOS1;TCAF1;SLC8A1;S100A10;PYCARD;PACS1;FYN;CAV1;CAMK2D;HERPUD1;ANK3;PDE4D;PRNP;FHL1;GOPC;KCNIP3
903,GO:0002286,0.0072495228381106,0.997632494756787,11,45,T cell activation involved in immune response,BP,EIF2AK4;PRKCZ;SEMA4A;IL18;IFNK;IFNE;BCL6;ZFPM1;LEF1;LGALS3;RARA
12876,GO:0051249,0.00730937809010299,0.995732449406942,38,246,regulation of lymphocyte activation,BP,INPP5D;SFRP1;ZFP36L1;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;GAS6;AXL;PAK1;BMP4;VAV3;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;PAG1;IL18;SOX13;ATM;EFNB3;CD1D;ITPKB;BCL6;PRNP;IGFBP2;LGALS3;RARA;ZBTB1
8834,GO:0034644,0.0073373053474005,0.997085268355852,15,69,cellular response to UV,BP,XPC;DDB2;EIF2AK4;TP53;TP53INP1;PIK3R1;TP73;MME;NFATC4;MDM2;USP28;RHBDD1;POLH;TAF1;ZBTB1
1305,GO:0003150,0.00737270468986261,0.999742213545479,3,4,muscular septum morphogenesis,BP,TGFBR3;FZD1;VANGL2
15141,GO:0071300,0.00742058119546414,0.997583308742293,11,43,cellular response to retinoic acid,BP,ABCA1;PTK6;KRT13;FZD7;SETX;SOX9;RET;YAP1;PPARG;RARA;FZD4
7355,GO:0031410,0.00745004918039956,0.994108251381611,200,1605,cytoplasmic vesicle,CC,SERPINE2;SYT8;FLOT1;FN1;PCDH7;PYGB;MMP9;GPRC5A;ITGB5;CD109;RHOBTB2;F2R;GSN;PKD2;TNIK;ANPEP;PROM2;COL7A1;CLTCL1;GAS6;MALL;MAP6;SAMD9L;EGFR;SLC2A3;THBS2;SERPINE1;STON2;VIM;TIMP2;ABCA1;NSG1;PCSK1;SCN8A;SORL1;ARAP1;KIAA0319L;PTPRS;DDIT3;PYCARD;DLG4;PDGFA;NISCH;TIMP1;HIP1;PACS1;GPNMB;SNX1;ANO6;TBC1D5;SYN1;PDPN;MAGED2;CTSV;SPG11;KCNAB2;LRP1;FYN;CAV1;SNX33;AHNAK2;CLU;SERPING1;CXCR1;PRKCZ;ULK2;TP53INP1;EHD3;CAMK2D;PRDX5;ITGA1;SYTL1;METTL7A;EHBP1;PDIA4;SYT1;TMEM173;ANG;DYSF;APLP2;HPS4;CAT;BACE1;WDFY2;LRIG3;STOM;TLR3;SNCA;FLOT2;MME;PDIA6;VAMP1;FZD7;SH3TC2;FGFR1;DKK1;MLEC;SEC24D;ASTN2;MYOF;CCDC136;SEPT6;AMOTL1;LAPTM4A;MTMR4;CALR;ATM;COPG2;APH1B;MDM2;ARF6;TMED10;CST3;MANBA;AREG;ANXA6;SNX10;DGKQ;HEXA;NEURL1B;NRSN2;TRAK1;CD1D;RNPEP;PTPN1;VANGL2;ARHGEF2;KLHL12;IFT27;SLC48A1;PRCP;NFASC;STK16;NDRG1;TMEM175;ANXA2;RAB13;FNDC3A;SEPT5;MAN2B1;MVB12B;MOSPD2;NMNAT2;RAB43;RET;TGFB2;VPS39;DNASE1L1;OR2A4;AMOTL2;GPR161;C2CD4C;SPPL2B;OSBPL1A;ULK1;IGFBP2;TMEM187;MAGI2;HSPA5;TH;GOPC;SNX7;PIKFYVE;EHBP1L1;FLNB;CHIC2;UVRAG;TCTEX1D4;NAPRT;ITPR2;IFT74;CAPG;CALCRL;SNX9;TBC1D16;LGALS3;DNAJC3;RASSF9;SV2A;ABCA2;TMEM67;FZD4;WIPF1;TMEM168;PIK3C2B;STEAP2;ACTR1B;DNM1P46;MYH11;VPS36;ADAM10;RHOBTB3;MPDZ;LITAF;S100A11;MYO1C;C2CD5;ABCA5;CTSD;ZNRF1
13220,GO:0051924,0.00754490027839476,0.996376310135249,22,115,regulation of calcium ion transport,BP,F2R;PKD2;JPH2;NOS1;HSPA2;SLC8A1;MYLK;GJC2;NTSR1;AHNAK;FYN;CAV1;PLA2G6;EHD3;CAMK2D;WFS1;SNCA;PDE4D;G6PD;PRNP;CACNB1;LGALS3
16089,GO:0090103,0.00757431917868655,0.998914563413019,5,12,cochlea morphogenesis,BP,GLI2;MYO3B;VANGL2;SOX9;HOXA1
6824,GO:0030296,0.00757774407503934,0.998913948948693,5,12,protein tyrosine kinase activator activity,MF,GAS6;ERCC6;AFAP1L2;DGKQ;EFNA5
11078,GO:0045111,0.0075870358779903,0.996507410813733,20,100,intermediate filament cytoskeleton,CC,KRT4;KRT14;VIM;PLEC;NEFM;SMARCA2;NEFL;KRT13;KRT5;DDX60;MICAL1;FLG;KRT15;CASP14;LMNA;SYNE2;SYNC;KRT222;ING4;KRT10
12045,GO:0048017,0.00763721375111817,0.996408620279065,21,105,inositol lipid-mediated signaling,BP,SERPINE2;ZFP36L1;F2R;GSN;PIK3C2G;IRS2;PDGFC;EGFR;PDGFA;PLXNB1;FYN;PIK3R1;UNC5B;CAT;FGFR1;IGF1R;IL18;SOX9;TGFB2;NYAP1;PIK3C2B
16368,GO:0097017,0.00771494756944465,1,2,2,renal protein absorption,BP,GSN;GAS6
14098,GO:0060993,0.00773406739563358,0.996948356522661,15,61,kidney morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;STAT1;WWTR1;GLI3;LAMA5;PBX1;VANGL2;SOX9;GCNT1;NPHP3;GDNF;KLHL3
3511,GO:0007431,0.0077432224094091,0.99783791782163,9,31,salivary gland development,BP,SNAI2;EGFR;PDGFA;LAMA5;FGFR1;TGM2;CST3;PLXNA1;TGFB2
2169,GO:0005006,0.00778646059262625,1,2,2,epidermal growth factor-activated receptor activity,MF,EFEMP1;EGFR
6659,GO:0030023,0.00778803420102105,1,3,3,extracellular matrix constituent conferring elasticity,MF,FBN1;FBN2;COL4A1
20036,GO:2000696,0.00779295971270811,0.998919283918227,5,11,regulation of epithelial cell differentiation involved in kidney development,BP,FAT4;STAT1;WWTR1;YAP1;GDNF
14912,GO:0070828,0.00784169800555739,0.998589229942194,6,15,heterochromatin organization,BP,MTHFR;TNRC18;HMGA2;BAHCC1;CDKN2A;HP1BP3
11224,GO:0045445,0.00787314468711119,0.997234022762516,12,52,myoblast differentiation,BP,ZFP36L1;CXCL14;BMP4;LGALS1;PRICKLE1;DDIT3;BTG1;FLOT2;IL18;SOX9;ISL1;BOC
12021,GO:0047844,0.00787653974152661,0.999516850579151,3,6,deoxycytidine deaminase activity,MF,APOBEC3C;APOBEC3G;APOBEC3F
16463,GO:0097190,0.00791118713379804,0.99472741737486,63,466,apoptotic signaling pathway,BP,TNFRSF6B;MMP9;PRODH;ITGA6;SFRP1;DDIT4;GSN;SNAI2;MAGED1;SERPINE1;NUPR1;BMP4;ITM2C;SCN2A;TP53;DDIT3;PYCARD;HIP1;TFDP2;GPX1;KITLG;SRPX;FYN;IFI6;CAV1;ERCC6;PLA2G6;CLU;TP53INP1;CCK;PIK3R1;UNC5B;HERPUD1;WFS1;TP73;CASP14;DAPK1;CHEK2;TLR3;FGFR1;LMNA;EDA2R;NFATC4;TRAF1;ATM;MDM2;ANXA6;GCLC;ZMAT3;PTPN1;ARHGEF2;PRKCA;UACA;RET;TGFB2;MAP2K5;USP28;SP100;YAP1;GDNF;MEIS3;LGALS3;ACAA2
14284,GO:0061458,0.00795231203374816,0.995041563922797,48,299,reproductive system development,BP,SERPINE2;HTRA1;SFRP1;ZFP36L1;PKD2;AXL;EGFR;NUPR1;VDR;BMP4;MMP19;CUL7;GLI3;E2F7;KITLG;CTSV;GLI2;SLIT3;ANG;MDFI;TLR3;ALOX15B;SULF1;DLX3;ATM;CST3;CITED2;NR2F2;FBXW8;NRK;SOX9;PLAG1;RAB13;ETNK2;FNDC3A;STOX2;WDR19;TGFB2;LEF1;ITGB8;PPARG;RARA;FZD4;AGO4;SERPINB5;NIPBL;RHOBTB3;RXRA
16686,GO:0097708,0.0079525365025118,0.993699065906335,200,1607,intracellular vesicle,CC,SERPINE2;SYT8;FLOT1;FN1;PCDH7;PYGB;MMP9;GPRC5A;ITGB5;CD109;RHOBTB2;F2R;GSN;PKD2;TNIK;ANPEP;PROM2;COL7A1;CLTCL1;GAS6;MALL;MAP6;SAMD9L;EGFR;SLC2A3;THBS2;SERPINE1;STON2;VIM;TIMP2;ABCA1;NSG1;PCSK1;SCN8A;SORL1;ARAP1;KIAA0319L;PTPRS;DDIT3;PYCARD;DLG4;PDGFA;NISCH;TIMP1;HIP1;PACS1;GPNMB;SNX1;ANO6;TBC1D5;SYN1;PDPN;MAGED2;CTSV;SPG11;KCNAB2;LRP1;FYN;CAV1;SNX33;AHNAK2;CLU;SERPING1;CXCR1;PRKCZ;ULK2;TP53INP1;EHD3;CAMK2D;PRDX5;ITGA1;SYTL1;METTL7A;EHBP1;PDIA4;SYT1;TMEM173;ANG;DYSF;APLP2;HPS4;CAT;BACE1;WDFY2;LRIG3;STOM;TLR3;SNCA;FLOT2;MME;PDIA6;VAMP1;FZD7;SH3TC2;FGFR1;DKK1;MLEC;SEC24D;ASTN2;MYOF;CCDC136;SEPT6;AMOTL1;LAPTM4A;MTMR4;CALR;ATM;COPG2;APH1B;MDM2;ARF6;TMED10;CST3;MANBA;AREG;ANXA6;SNX10;DGKQ;HEXA;NEURL1B;NRSN2;TRAK1;CD1D;RNPEP;PTPN1;VANGL2;ARHGEF2;KLHL12;IFT27;SLC48A1;PRCP;NFASC;STK16;NDRG1;TMEM175;ANXA2;RAB13;FNDC3A;SEPT5;MAN2B1;MVB12B;MOSPD2;NMNAT2;RAB43;RET;TGFB2;VPS39;DNASE1L1;OR2A4;AMOTL2;GPR161;C2CD4C;SPPL2B;OSBPL1A;ULK1;IGFBP2;TMEM187;MAGI2;HSPA5;TH;GOPC;SNX7;PIKFYVE;EHBP1L1;FLNB;CHIC2;UVRAG;TCTEX1D4;NAPRT;ITPR2;IFT74;CAPG;CALCRL;SNX9;TBC1D16;LGALS3;DNAJC3;RASSF9;SV2A;ABCA2;TMEM67;FZD4;WIPF1;TMEM168;PIK3C2B;STEAP2;ACTR1B;DNM1P46;MYH11;VPS36;ADAM10;RHOBTB3;MPDZ;LITAF;S100A11;MYO1C;C2CD5;ABCA5;CTSD;ZNRF1
12966,GO:0051409,0.00796550683063594,0.999161073607766,4,9,response to nitrosative stress,BP,DUSP6;DDIT3;ATM;GCLC
12674,GO:0050919,0.00799587590249988,0.997799967393373,9,28,negative chemotaxis,BP,FLRT2;FLRT3;SEMA5A;PDGFA;SLIT3;ROBO1;SEMA4A;SEMA4B;EFNA5
17530,GO:1901099,0.00807646175770144,0.998395190239261,6,21,negative regulation of signal transduction in absence of ligand,BP,SNAI2;FYN;IFI6;UNC5B;MAP2K5;GDNF
20247,GO:2001240,0.00807646175770144,0.998395190239261,6,21,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,SNAI2;FYN;IFI6;UNC5B;MAP2K5;GDNF
19016,GO:1904888,0.00808330999173259,0.997193438937871,12,46,cranial skeletal system development,BP,TGFBR2;BMP4;GLI3;IFT140;FOXN3;HOXA1;MEGF8;WDR19;TGFB2;DLX2;MED12;NIPBL
12523,GO:0050699,0.00811681802582531,0.998157249010885,7,23,WW domain binding,MF,TCEAL4;TCEAL3;TCEAL8;WBP1;TCEAL1;SCNN1A;LITAF
13066,GO:0051604,0.00812289803159312,0.995459671839456,32,209,protein maturation,BP,SERPINE2;CCBE1;GSN;GAS6;SERPINE1;SERPINH1;PCSK1;SORL1;PYCARD;TYSND1;GLI3;ERO1B;CTSV;CLU;SERPING1;WFS1;PRKACB;MME;AIP;GLG1;C5;MAGEF1;CALR;APH1B;MDM2;PLGRKT;TSPAN5;PRNP;SPPL2B;RHBDD1;LMF1;ADAM10
16088,GO:0090102,0.00812685876801452,0.998172732151508,7,22,cochlea development,BP,SLITRK6;GLI2;MYO3B;VANGL2;SOX9;IFT27;HOXA1
14642,GO:0070278,0.00825315343067836,1,2,2,extracellular matrix constituent secretion,BP,CTGF;ENG
12207,GO:0048488,0.00826368402458397,0.997697081200827,9,29,synaptic vesicle endocytosis,BP,SYT8;STON2;SYT1;SNCA;DNAJC6;NLGN4Y;C2CD4C;OPHN1;DNM1P46
1182,GO:0002830,0.00828396906876702,0.99907290035916,4,10,positive regulation of type 2 immune response,BP,PRKCZ;IL18;RSAD2;RARA
358,GO:0000977,0.00829332402542244,0.994441605383045,65,430,RNA polymerase II regulatory region sequence-specific DNA binding,MF,SOX6;ETV5;PHF21A;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;GLI2;HMGA2;PER1;CREB3L2;JARID2;TP73;KLF13;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;EGR1;ISL1;BCL6;PLAG1;SALL2;MYBL1;HLTF;TCF12;NFAT5;CARF;ZFPM1;DLX2;LEF1;THRA;SSBP3;TEF;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;PRDM5;LITAF;RXRA
3014,GO:0006562,0.00833179083954317,1,2,2,proline catabolic process,BP,PRODH;ALDH4A1
4397,GO:0010133,0.00833179083954317,1,2,2,proline catabolic process to glutamate,BP,PRODH;ALDH4A1
10406,GO:0043271,0.00833527907429088,0.996634235136939,15,70,negative regulation of ion transport,BP,SERPINE2;MMP9;PKD2;IRS2;NOS1;NTSR1;CAV1;CAMK2D;ANK3;SNCA;PLA2R1;HTR1B;GOPC;ABAT;KCNRG
6609,GO:0022839,0.00839957439324238,0.996005883142159,21,108,ion gated channel activity,MF,ANO1;PKD2;JPH2;GAS6;CLCA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;KCNJ15;KCNJ5;ANXA6;KCNQ3;TMEM63C;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3
1380,GO:0003279,0.00840660746946226,0.996414030944772,17,73,cardiac septum development,BP,TGFBR2;GJA5;BMP4;LTBP1;PARVA;TGFBR3;FZD1;ENG;MDM2;CITED2;LMO4;VANGL2;ISL1;ZFPM1;TGFB2;NPHP3;RARA
13448,GO:0055012,0.0084095506871673,0.999099844115341,4,9,ventricular cardiac muscle cell differentiation,BP,LMNA;MEF2A;RARA;RXRA
3396,GO:0007178,0.00843305088324264,0.995092631231901,37,212,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,HTRA1;ITGB5;FBN1;SFRP1;CD109;CDKN2B;TGFBR2;FBN2;PEG10;RNF165;VIM;BMP4;PDCD4;NEO1;WWTR1;LTBP1;ITGA3;LTBP4;CAV1;PRKCZ;PXN;GLG1;DKK1;SULF1;TGFBR3;FZD1;ENG;MTMR4;CITED2;EGR1;MEGF8;TGFB2;LEF1;MAGI2;HSPA5;TGFB1I1;FOS
8587,GO:0034112,0.00843517709636597,0.999549927169647,3,5,positive regulation of homotypic cell-cell adhesion,BP,LGALS1;PDPN;ANK3
4802,GO:0012505,0.00843608109739218,0.992969938954198,371,3159,endomembrane system,CC,SERPINE2;SYT8;SULT1E1;FLOT1;PRSS23;FN1;PCDH7;PYGB;FLRT2;MMP9;COL8A1;CTGF;ADAM19;FBN1;ST6GALNAC2;CD109;SYNE1;F2R;PTGS1;ADAMTSL1;MARCH4;GSN;COL5A2;PKD2;PITPNM3;JPH2;SCARA3;TNIK;ANPEP;COL7A1;H6PD;CLTCL1;NOS1;GAS6;DNMBP;PDGFC;MALL;MAP6;SULF2;COL5A1;SAMD9L;DOCK9;EGFR;GALNT10;SDC3;LAMB1;FLRT3;SPTB;CLCA2;SYNE3;SLC2A3;THBS2;SERPINE1;ATP10D;SERPINH1;CRTAP;S100A10;STON2;MBOAT2;FAM198B;CSPG4;MAMDC2;STMN3;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;NSG1;CBX5;BMP4;ITM2C;PCSK1;TBC1D8;HS1BP3;TRIM5;COL18A1;SORL1;NEO1;IFIT2;LGALS1;MEST;TP53;ARAP1;EXTL2;KIAA0319L;PTPRS;PRICKLE1;DDIT3;PYCARD;LTBP1;MUC19;DLG4;SLC7A11;SLC27A3;PDGFA;NISCH;TIMP1;ACSL3;HIP1;PACS1;COL4A4;DOCK4;CUL7;EVI5L;CPED1;TPBG;SNX1;ANO6;PAQR8;PTGES;LPCAT2;TBC1D5;P3H2;ERO1B;SYN1;SRPX;MAGED2;CTSV;SEC14L1;PDE4DIP;KCNAB2;LRP1;FYN;XDH;B3GAT3;FUT10;LAMA3;CAV1;SLC27A1;SEL1L;SNX33;TNRC18;OSBPL5;XYLT1;UST;CLU;FKBP9;SERPING1;CXCR1;PRKCZ;OAS2;SDR16C5;CHST3;EHD3;CAMK2D;GOLGB1;ITGA1;SYTL1;METTL7A;ULBP1;ATP8B2;EHBP1;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;ALDH3A2;ACACB;DYSF;HERPUD1;ANK3;WFS1;CES2;TMEM8B;APLP2;HPS4;CRELD2;TP73;CAT;ST6GAL2;CHEK2;BACE1;WDFY2;STOM;TLR3;MAN1A1;SNCA;FLOT2;ADAMTS7;MME;PDIA6;VAMP1;FZD7;GLG1;SH3TC2;COL16A1;LMNA;DKK1;MLEC;SEC24D;GLT8D2;TGFBI;ASTN2;PDE4D;TMEM129;TGM2;SULF1;ESYT2;MYOF;ARSD;FZD8;CCDC136;SEPT6;LRTOMT;LAPTM4A;MTMR4;CALR;COPG2;APH1B;ARF6;FAM20A;TMED10;CST3;MANBA;AREG;ANXA6;SNX10;DGKQ;HEXA;NEURL1B;AKR7A2;NRSN2;TRAK1;CD1D;FBXW8;SYNE2;RNPEP;FGD4;NEMP2;PTPN1;POGLUT1;ARHGEF2;KLHL12;SDC2;COL5A3;IFT27;BCL6;SLC48A1;PLD3;PRCP;NFASC;G6PC3;NDRG1;GCNT1;TMEM50B;PRKCA;TMEM175;BCHE;ANXA2;RAB13;CES3;FNDC3A;SEPT5;RNF24;MAN2B1;PGAP1;IGFBP4;GOLGA8B;MVB12B;MOSPD2;NMNAT2;GAL3ST4;RAB43;SLC39A11;PRNP;RET;TGFB2;VPS39;DNASE1L1;DSEL;OR2A4;COL12A1;AMOTL2;GPR161;CDC42EP5;ITM2A;MAPK8IP3;CYP4V2;C2CD4C;SPPL2B;OSBPL1A;ULK1;AGRN;TMEM187;RHBDD1;MAGI2;HSPA5;NRM;TH;GOPC;SNX7;PIKFYVE;EHBP1L1;REEP2;RSAD2;CHIC2;UVRAG;TCTEX1D4;NAPRT;ITPR2;UGT1A3;RHBDD2;LMF1;UGT1A6;ALG10;KLF5;COL17A1;GPX8;GOLGA8N;ATRAID;GALNT2;DERL3;AGPAT1;CALCRL;TPST1;KCNIP3;CERS5;SNX9;TBC1D16;OBSL1;POSTN;LGALS3;ARL3;MIA3;DNAJC3;FKBP10;COG3;RASSF9;COL4A1;SV2A;ABCA2;TMEM67;MPPE1;ZBTB1;TMEM168;PIK3C2B;PDZD2;STEAP2;ACTR1B;FOS;CDK5RAP3;AIG1;FAM169A;CLEC2D;MATN3;KLHDC2;UGGT2;CERCAM;VPS36;KCNRG;ADAM10;RHOBTB3;LITAF;S100A11;MYO1C;TUSC3;GBP3;EDEM1;ABCA5;NFKBIE;CTSD;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
16818,GO:0098758,0.00845274636687051,1,2,2,response to interleukin-8,BP,CXCR1;EGR1
16819,GO:0098759,0.00845274636687051,1,2,2,cellular response to interleukin-8,BP,CXCR1;EGR1
18393,GO:1903464,0.0084640936306456,1,2,2,negative regulation of mitotic cell cycle DNA replication,BP,CHEK2;BCL6
6910,GO:0030512,0.00848276175484296,0.996861206547964,13,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,HTRA1;FBN1;CD109;TGFBR2;FBN2;PEG10;LTBP1;CAV1;GLG1;TGFBR3;MTMR4;HSPA5;TGFB1I1
4886,GO:0014812,0.00851915783347226,0.996845983277375,13,54,muscle cell migration,BP,DOCK5;SERPINE1;PAK1;SORL1;ITGA2;PDGFA;DOCK4;LRP1;PARVA;MDM2;PLXNA1;SSH1;POSTN
627,GO:0001817,0.00856040705544005,0.994377240557641,58,411,regulation of cytokine production,BP,FLOT1;FN1;CCBE1;INPP5D;F2R;IL20RB;IGF2BP2;HERC5;GAS6;SNAI2;SULF2;AXL;SERPINE1;TKFC;PDCD4;STAT1;PTPRS;DDIT3;ZBTB20;PYCARD;DDX60;GPNMB;ERMAP;SEC14L1;POLR3GL;RNF135;TRIB2;CLU;PRKCZ;PER1;PIK3R1;TMEM173;BTN3A1;TLR3;FGFR1;ALOX15B;C5;PDE4D;IL18;SULF1;AFAP1L2;NFATC4;ARHGEF2;EGR1;ISL1;BCL6;PRNP;ZFPM1;TGFB2;MAP2K5;LEF1;BTN3A3;RSAD2;UBA7;AGPAT1;POSTN;RARA;LITAF
5115,GO:0015467,0.00860229404754855,1,2,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15;KCNJ5
9114,GO:0035455,0.00862132229725068,0.998300766627151,6,19,response to interferon-alpha,BP,GAS6;AXL;IFIT2;IFIT3;IFITM2;IFITM1
15655,GO:0072210,0.00867899586789082,0.997770113317547,8,26,metanephric nephron development,BP,PKD2;BMP4;STAT1;EGR1;SOX9;RET;GDNF;LAMB2
7955,GO:0032571,0.00870378268903543,1,2,2,response to vitamin K,BP,GAS6;POSTN
15145,GO:0071307,0.00870378268903543,1,2,2,cellular response to vitamin K,BP,GAS6;POSTN
5845,GO:0017147,0.0087050963311086,0.998037946622909,7,21,Wnt-protein binding,MF,SFRP1;APCDD1;ROR1;FZD7;FZD8;FZD1;FZD4
17726,GO:1901701,0.00870817262240074,0.993689717880435,98,708,cellular response to oxygen-containing compound,BP,MMP2;MMP9;FBN1;SFRP1;ZFP36L1;NQO1;DDIT4;ANO1;COL5A2;PKD2;IRS2;GAS6;PDGFC;SNAI2;AXL;EGFR;SLC8A1;SESN3;SERPINE1;FAM210B;PAK1;ABCA1;VDR;NR1D1;PTK6;TRIM5;PDCD4;NR3C1;STAT1;LGALS1;GNG2;TP53;KRT13;PYCARD;ITGA2;KLF9;SESN1;LRP1;FYN;CPS1;CAV1;PLA2G6;CLU;PRKCZ;TP53INP1;PRDX5;KANK2;PXN;PIK3R1;CPT1A;DAPK1;PRKACB;CHEK2;SNCA;FZD7;COL16A1;IGF1R;SETX;PDE4D;IL18;PDK3;NFATC4;MDM2;CST3;GCLC;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;ENPP1;PRKCA;PXMP2;RAB13;ABCC2;PRNP;RET;AGRN;HSPA5;CDK19;TH;ITPR2;YAP1;CACNB1;KLF5;PPARG;CALCRL;SASH1;RARA;COL4A1;TAF1;EFNA5;FZD4;PPP3CA;FOS;LITAF;MYO1C;C2CD5
14242,GO:0061343,0.00871410990884146,0.999675142540774,3,4,cell adhesion involved in heart morphogenesis,BP,FLRT2;TGFBR2;TGFB2
4469,GO:0010469,0.00874118062728041,0.995081600981076,32,215,regulation of signaling receptor activity,BP,GPRC5A;CTGF;FBN1;EFEMP1;GAS6;PDGFC;SERPINE1;CXCL14;BMP4;NETO1;IL32;DLG4;PDGFA;TIMP1;GPNMB;KITLG;CCK;DAPK1;DKK1;CTF1;PDE4D;IL18;AREG;IFNK;IFNE;THNSL2;UCN2;TGFB2;GDNF;SHISA9;TAF1;ADM2
10043,GO:0042552,0.00874913739503884,0.996137859813454,18,80,myelination,BP,MARVELD1;TENM4;MALL;SCN8A;SCN2A;PLLP;UGT8;AHNAK2;CLU;ADGRG6;PRX;SH3TC2;NFASC;NDRG1;NAB2;PIKFYVE;RARA;SBF2
8942,GO:0035023,0.00875448173113627,0.995865327683716,21,94,regulation of Rho protein signal transduction,BP,FLOT1;F2R;DNMBP;ABCA1;VAV3;ARAP1;PLEKHG3;ARHGEF1;ITGA3;ARHGEF12;DLC1;ROBO1;OBSCN;ARHGEF17;AKAP13;FGD4;ARHGEF2;BCL6;VAV2;ARHGEF19;OPHN1
17301,GO:0150034,0.00876601729733393,0.995108278235571,32,179,distal axon,CC,APBB2;UTRN;ROR1;FLRT3;STMN3;NTSR1;TIMP2;NEFL;ITGA2;MICAL1;ITGA3;SYN1;KCNAB2;CCK;SYT1;ANG;SNCA;VAMP1;FSCN1;SETX;SEPT6;TRAK1;SSH1;SEPT5;MAP3K12;TH;BOC;OPHN1;KCNIP3;SV2A;TSHZ3;ORAI2
13239,GO:0051955,0.00884449344234823,0.998640132686296,5,13,regulation of amino acid transport,BP,NTSR1;CCK;SNCA;SV2A;ABAT
3219,GO:0006869,0.0089059729420723,0.994880517285416,35,201,lipid transport,BP,PITPNM3;IRS2;OSBPL10;ATP10D;NTSR1;ABCA1;SORL1;ACSL3;ANO6;LRP1;CAV1;SLC27A1;PLA2G6;OSBPL5;CLU;ATP8B2;CPT1A;ACACB;PRKAB2;NCOA2;PLA2R1;ESYT2;SLC27A6;NCOR1;ANXA2;ABCC2;OSBPL1A;PITPNC1;PPARG;APOL6;ABCA2;FZD4;RXRA;CPT2;ABCA5
15263,GO:0071478,0.00892951475203996,0.99540582973535,25,141,cellular response to radiation,BP,SFRP1;XPC;SNAI2;DDB2;EIF2AK4;TP53;ADIRF;TP53INP1;HMGA2;PIK3R1;TP73;CHEK2;MME;NFATC4;ATM;MDM2;EGR1;USP28;RHBDD1;HSPA5;YAP1;POLH;TAF1;ZBTB1;NIPBL
875,GO:0002230,0.00894072881570687,0.998247693753832,6,18,positive regulation of defense response to virus by host,BP,EIF2AK4;STAT1;PYCARD;TMEM173;APOBEC3G;APOBEC3F
4258,GO:0009607,0.00896814184667489,0.993835596649504,71,548,response to biotic stimulus,BP,TNFRSF6B;HTRA1;TXNIP;F2R;DDIT4;HERC5;NOS1;AXL;ACTA2;SERPINE1;TKFC;IFI44L;ABCA1;VDR;APOBEC3C;NR1D1;EIF2AK4;TRIM5;PDCD4;STAT1;IFIT2;TP53;DDIT3;PYCARD;IFIT1;DDX60;RBMS3;ADARB1;IFIT3;GPX1;PTGES;SEC14L1;CPS1;CAV1;PLA2G6;MAP3K14;CLU;OAS2;HMGA2;MST1R;IL31RA;TMEM173;APOBEC3G;WFS1;TLR3;SNCA;APOBEC3F;PDE4D;IL18;IFNK;IFNE;CD1D;IFI44;LYST;PRKCA;IFITM2;ABCC2;STAT2;HSPA5;CDK19;TH;RSAD2;IFITM1;SRR;SASH1;DNAJC3;RARA;WIPF1;FOS;LITAF;GBP3
6663,GO:0030031,0.00900779192079489,0.993917966717944,66,439,cell projection assembly,BP,ITGA6;GSN;TNIK;CEP126;MYLK;RFX2;VAV3;ARAP1;CEP250;WWTR1;CNTRL;PDGFA;EVI5L;EMP1;ANO6;ASAP1;EMP3;CAV1;SPATA6;DOCK11;ESPN;NPHP4;EHD3;HAUS4;KIF17;PARVA;LAMA5;BBS2;IFT140;DZIP1L;FSCN1;CDH13;SEPT6;BBS4;ARF6;BBS1;SNX10;SYNE2;FGD4;VANGL2;SSH1;IFT27;SEPT5;IFT88;TTC8;PODXL;STK36;WDR19;ODF2;IFT122;CDC42EP5;AGRN;NPHP3;VAV2;CFAP54;IFT74;OPHN1;TPGS1;DNAH1;KLF5;ICK;ARL3;TMEM67;SEPT9;TTBK2;RHOBTB3
10478,GO:0043401,0.00900833084014656,0.995243302093841,27,147,steroid hormone mediated signaling pathway,BP,SFRP1;SKP2;TADA3;PAK1;VDR;BMP4;NR1D1;NR3C1;PAQR8;RBFOX2;KANK2;PER1;PAQR7;CALR;AKAP13;NR2F2;ISL1;LEF1;THRA;TGFB1I1;YAP1;PPARG;RARA;TAF1;CREBRF;MED12;RXRA
2176,GO:0005024,0.00905925661331728,0.999165255676745,4,7,transforming growth factor beta-activated receptor activity,MF,TGFBR2;LTBP1;LTBP4;TGFBR3
590,GO:0001755,0.00908730669753545,0.997366163443001,9,33,neural crest cell migration,BP,BMP4;KITLG;LAMA5;SEMA4A;ISL1;RET;LEF1;SEMA4B;GDNF
711,GO:0001937,0.00909490397939809,0.997932159954004,7,21,negative regulation of endothelial cell proliferation,BP,PTPRM;STAT1;XDH;CAV1;SULF1;NR2F2;PPARG
4370,GO:0009996,0.00909583643939268,1,2,2,negative regulation of cell fate specification,BP,FZD7;DKK1
2091,GO:0004857,0.00911831671166526,0.994718263122397,35,230,enzyme inhibitor activity,MF,SERPINE2;PHACTR3;FLRT2;TXNIP;CD109;CDKN2B;COL7A1;GAS6;TFPI2;FLRT3;SERPINE1;SERPINH1;ANXA5;TIMP2;ANGPTL4;WNK1;TIMP1;CRIM1;ELFN2;TRIB2;SERPING1;PRDX5;SPRY2;APLP2;SNCA;C5;CST3;ANXA2;LEF1;CDKN2A;DNAJC3;SERPINB5;CAMK2N1;TAOK3;PINLYP
19255,GO:1905477,0.00913037893241004,0.995897028318181,18,94,positive regulation of protein localization to membrane,BP,TCAF1;EGFR;PAK1;TP53;ACSL3;TFDP2;ITGA3;LRP1;FYN;PIK3R1;ANK3;TP73;STOM;ARF6;SSH1;PRNP;MYO1C;C2CD5
6607,GO:0022836,0.0091746157761802,0.995597281474314,21,109,gated channel activity,MF,ANO1;PKD2;JPH2;GAS6;CLCA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;KCNJ15;KCNJ5;ANXA6;KCNQ3;TMEM63C;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3
3402,GO:0007186,0.00921266616318341,0.993977837315981,56,382,G-protein coupled receptor signaling pathway,BP,GPRC5A;SFRP1;F2R;ANO1;NOS1;LPAR5;NTSR1;ABCA1;NSG1;VAV3;GNG2;ARHGEF1;PLXNB1;LRP1;ARHGEF12;CAV1;CXCR1;GPR39;ADGRG6;CCK;PIK3R1;APLP2;S1PR5;PRKACB;SNCA;FZD7;RGS2;C5;PDE4D;TGM2;OBSCN;FZD8;ARHGEF17;FZD1;AREG;AKAP13;DGKQ;FGD4;ARHGEF2;UCN2;PRKCA;RGS14;HTR1B;OR2A4;GPR161;AGRN;VAV2;ARHGEF19;PPARG;CALCRL;SENP7;FZD4;ADGRA2;ADM2;OXTR;CELSR1
15638,GO:0072190,0.00923989839355516,1,2,2,ureter urothelium development,BP,BMP4;SOX9
15639,GO:0072191,0.00923989839355516,1,2,2,ureter smooth muscle development,BP,BMP4;SOX9
15641,GO:0072193,0.00923989839355516,1,2,2,ureter smooth muscle cell differentiation,BP,BMP4;SOX9
15643,GO:0072197,0.00923989839355516,1,2,2,ureter morphogenesis,BP,BMP4;SOX9
19165,GO:1905276,0.00931652347138103,0.998219424318588,6,16,regulation of epithelial tube formation,BP,SFRP1;FZD1;VANGL2;NPHP3;GDNF;CELSR1
4748,GO:0010927,0.00937608266966209,0.996135091839997,16,59,cellular component assembly involved in morphogenesis,BP,TENM4;RFX2;PHLDB1;UGT8;AHNAK2;TTN;PRX;OBSCN;CCDC136;AKAP13;FHOD3;NFASC;PIKFYVE;MEF2A;OBSL1;MYH11
3756,GO:0008301,0.00941126504740843,0.998530034583692,5,13,DNA binding, bending,MF,HMGA2;FOXL1;TRERF1;LEF1;SAP30L
20059,GO:2000739,0.00944789086520497,0.999636623264599,3,4,regulation of mesenchymal stem cell differentiation,BP,SOX6;LTBP3;SOX9
10529,GO:0043502,0.00945076395689054,0.99646928185346,13,52,regulation of muscle adaptation,BP,UTRN;PAK1;CAMK2D;JARID2;LMNA;RGS2;G6PD;LMCD1;MTMR4;AKAP13;PRKCA;MEF2A;PPP3CA
1260,GO:0003015,0.00950192354280535,0.995113832941906,25,128,heart process,BP,CTGF;TNNI2;GJA5;NOS1;SLC8A1;GPX1;CAV1;EHD3;CAMK2D;TTN;KCNJ5;RGS2;PDE4D;MDM2;AKAP13;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;KCNIP3;MEF2A;CACNA2D3;DMPK
15200,GO:0071385,0.00960057076175987,0.996928739858245,10,41,cellular response to glucocorticoid stimulus,BP,ZFP36L1;DDIT4;ZFP36L2;EGFR;NR3C1;KLF9;AKAP13;ISL1;ABCC2;CREBRF
13594,GO:0060113,0.00960450650981022,0.9972048113582,9,32,inner ear receptor cell differentiation,BP,FAT4;SLITRK6;BMP4;FGFR1;TRIOBP;LRTOMT;NAGLU;VANGL2;IFT27
1092,GO:0002682,0.00961455837090459,0.99281583205908,116,924,regulation of immune system process,BP,FLOT1;MMP2;HTRA1;FBN1;INPP5D;SFRP1;MMP28;ZFP36L1;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;HERC5;GAS6;AXL;TSC22D3;SERPINE1;TKFC;FAM210B;CXCL14;PAK1;BMP4;NR1D1;EIF2AK4;TRIM5;VAV3;STAT1;LGALS1;TP53;PTPRS;PYCARD;IFIT1;DDX60;MUC19;ITGA2;PILRB;GPNMB;ANO6;GPX1;GLI3;DLG5;KITLG;ERMAP;SEC14L1;FYN;CAV1;GLI2;RNF135;RBFOX2;PLA2G6;MAP3K14;CLU;SERPING1;PRKCZ;IL31RA;ULBP1;PIK3R1;TMEM173;APOBEC3G;TP73;KLF13;BTN3A1;PRKACB;TLR3;SNCA;FLOT2;PAG1;APOBEC3F;C5;PDE4D;PSMB9;IL18;SOX13;CALR;ATM;EFNB3;MEIS2;IFNK;CD1D;MAP3K1;PTPN1;SOX9;ITPKB;BCL6;PRKCA;MOSPD2;TCF12;PRNP;ZFPM1;TGFB2;STAT2;LEF1;SPPL2B;IGFBP2;VAV2;BTN3A3;RSAD2;IFITM1;YAP1;COL17A1;PPARG;GCSAM;LGALS3;MIA3;RARA;WIPF1;ZBTB1;PPP3CA;FOS;AGO4;CLEC2D;ELMO2;ADAM10;MYO1C;DOCK1
646,GO:0001837,0.00967109327410592,0.995537547128277,19,95,epithelial to mesenchymal transition,BP,SFRP1;TGFBR2;SNAI2;BMP4;PDCD4;WWTR1;PHLDB1;CUL7;DLG5;PDPN;HMGA2;TGFBR3;ENG;KLHL12;SOX9;ISL1;TGFB2;LEF1;TGFB1I1
3271,GO:0006952,0.00967173903241592,0.992796405289932,113,911,defense response,BP,ITGB6;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;F2R;DDIT4;PTGS1;IL20RB;GSN;HERC5;AXL;EGFR;SERPINE1;VIM;NUPR1;PSTPIP1;TKFC;IFI44L;PAK1;APOBEC3C;TRIM38;NR1D1;PTK6;XAF1;EIF2AK4;TRIM5;PDCD4;STAT1;IFIT2;PTPRS;PYCARD;IL32;IFIT1;DDX60;MUC19;ITGA2;RBMS3;ADARB1;IFIT3;ANO6;GPX1;PTGES;SEC14L1;FYN;IFI6;CAV1;RNF135;PLA2G6;MAP3K14;CLU;SERPING1;PRKCZ;OAS2;PARP4;CAMK2D;PRDX5;MST1R;IL31RA;ULBP1;PER1;CCK;TMEM173;APOBEC3G;DAPK1;PRKACB;TLR3;SNCA;APOBEC3F;IFI35;C5;TGM2;PSMB9;IL18;IL17RE;AFAP1L2;NFATC4;CST3;IFNK;IFNE;CD1D;MAP3K1;PTPN1;ARHGEF2;PLGRKT;LYST;EGR1;ISL1;BCL6;PRCP;IGFBP4;IFITM2;RPL13A;RAB43;STAT2;LIPA;SP100;CDK19;RSAD2;FLNB;SRPK2;IFITM1;NUB1;PPARG;CALCRL;TPST1;LGALS3;DNAJC3;ZBTB1;FOS;MYO1C;GBP3
8132,GO:0032870,0.00968595095899837,0.993357948374896,70,473,cellular response to hormone stimulus,BP,FBN1;SFRP1;ZFP36L1;DDIT4;IRS2;ZFP36L2;SKP2;EGFR;SESN3;FAM210B;TADA3;PAK1;VDR;BMP4;NR1D1;NR3C1;STAT1;GNG2;ITGA2;SIK1;KLF9;PAQR8;FYN;CPS1;CAV1;SLC27A1;RBFOX2;PRKCZ;SLIT3;KANK2;PER1;PXN;PIK3R1;BBS2;PRKACB;CHEK2;PAQR7;IGF1R;NCOA2;BBS4;CALR;MDM2;AKAP13;GCLC;NR2F2;PTPN1;UCN2;ENPP1;ISL1;PRCP;RAB13;LEPR;ABCC2;LEF1;THRA;AGRN;IGFBP2;TGFB1I1;YAP1;PPARG;RARA;TAF1;EFNA5;CREBRF;FOS;MED12;OXTR;MYO1C;RXRA;C2CD5
15532,GO:0072009,0.00972497217422065,0.99590234048356,16,69,nephron epithelium development,BP,FAT4;PKD2;MAGED1;BMP4;STAT1;WWTR1;GLI3;LAMA5;PBX1;SOX9;PODXL;MAGI2;YAP1;GDNF;KLHL3;LAMB2
3629,GO:0008092,0.00973058709298662,0.992897879390523,101,669,cytoskeletal protein binding,MF,PHACTR3;SYNE1;TLN2;MYH15;TNNI2;GSN;PKD2;TNS4;MAP6;UTRN;AXL;DPYSL2;EGFR;SPTB;SLC8A1;MYLK;SYNE3;CTNNAL1;STMN3;ADD3;PLEC;NEFM;TNS1;KCNMA1;PYCARD;EFHC1;MAP2;MICAL1;HIP1;DLG5;SYN1;LIMCH1;EML2;FYN;FLNC;CLMN;SPATA6;ESPN;CLU;CAMK2D;PXN;ANG;KIF17;PARVA;ANK3;TTN;SHROOM4;SNCA;FRMD5;FSCN1;RGS2;MYO3B;OBSCN;TRIOBP;CDH13;IPP;BBS4;FHOD3;TRAK1;LZTS1;SYNE2;FGD4;ARHGEF2;DNAL4;SSH1;NDRG1;ANXA2;RGS14;PRNP;CDH11;MAPK8IP3;MSRB2;MPRIP;KLHL5;MAGI1;FLNB;FHOD1;IFT74;OPHN1;TPGS1;MYO9A;KLHL3;DIXDC1;PPARG;CAPG;INF2;BEX4;GCSAM;OBSL1;PTPN3;ARL3;RARA;TMEM67;WIPF1;LIMA1;CAPN6;DNM1P46;MYH11;TTBK2;MYO1C;SNTB1
455,GO:0001300,0.00977384280312989,1,2,2,chronological cell aging,BP,SERPINE1;ENG
2092,GO:0004859,0.00977934806794573,0.999284667774821,3,7,phospholipase inhibitor activity,MF,ANXA5;ANXA2;PINLYP
1987,GO:0004709,0.00979342888626872,0.99633292222611,13,51,MAP kinase kinase kinase activity,MF,ROR1;AXL;EGFR;MAP3K6;MAP3K14;MST1R;FGFR1;IGF1R;EPHB6;MAP3K1;MAP3K12;RET;TAOK3
7325,GO:0031346,0.00979807368613382,0.993961609894188,44,256,positive regulation of cell projection organization,BP,FN1;PROM2;TENM3;PAK1;PTK6;NEFL;ARAP1;DLG4;SEMA5A;ITGA2;CUL7;ITGA3;PLEK2;DLG5;CNTN1;PLXNB1;FYN;DOCK11;ESPN;SYT1;CAPRIN2;METRN;ROBO1;PLXNA2;FGFR1;FSCN1;SETX;FZD1;BBS4;NEGR1;PLXNA1;TRAK1;FBXW8;CRTC1;MEGF8;RET;CDC42EP5;AGRN;MAGI2;HSPA5;OBSL1;EFNA5;FZD4;SEPT9
1815,GO:0004467,0.00979830346925981,0.998901937437479,4,9,long-chain fatty acid-CoA ligase activity,MF,SLC27A3;ACSL3;SLC27A1;SLC27A6
10649,GO:0043901,0.00985444673081696,0.995292991949546,20,118,negative regulation of multi-organism process,BP,HTRA1;GSN;TKFC;APOBEC3C;EIF2AK4;TRIM5;STAT1;IFIT1;TIMP1;SEC14L1;OAS2;HMGA2;APOBEC3G;APOBEC3F;CALR;ANXA2;IFITM2;RSAD2;SRPK2;IFITM1
4229,GO:0009411,0.00985765444365394,0.995124825593157,22,123,response to UV,BP,XPC;SCARA3;EGFR;DDB2;EIF2AK4;TP53;GPX1;ERCC6;TP53INP1;PIK3R1;CIRBP;TP73;CAT;MME;NFATC4;MDM2;PRIMPOL;USP28;RHBDD1;POLH;TAF1;ZBTB1
15623,GO:0072170,0.00986217656951489,0.99813250966182,6,15,metanephric tubule development,BP,FAT4;PKD2;STAT1;WWTR1;SOX9;YAP1
362,GO:0000981,0.00989153216809491,0.992775583641506,100,708,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,SOX6;ZFP36L1;ETV5;TSC22D1;ZFP36L2;SNAI2;TSC22D3;KLF8;RFX2;TCF7L1;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZBTB20;MEF2D;TFDP2;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;GLI2;HMGA2;ZSCAN18;CREB3L2;JARID2;TP73;KLF13;GATAD1;SP110;TLE4;SETBP1;SOX13;NFATC4;FOXN3;DLX3;PBX1;FOXL1;MEIS2;TCF4;NR2F2;MAF;EGR1;SOX9;ISL1;BCL6;STK16;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;TSHZ1;TCF12;HMBOX1;NFAT5;ZNF160;CARF;ZFPM1;RBL2;DLX2;STAT2;LEF1;THRA;SSBP3;SP100;TEF;ZNF12;KLF5;YEATS2;HOXA3;MEIS3;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;HOXC5;PBX2;TAF1;TSHZ3;CREBRF;ETV4;HOXA2;FOS;NPAS2;PRDM5;LITAF;RXRA
740,GO:0001972,0.00993584614607112,0.998955682524888,4,8,retinoic acid binding,MF,NR2F2;UGT1A3;RARA;RXRA
11069,GO:0045091,0.00993652724675882,0.998825890347595,4,10,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C;HMGA2;APOBEC3G;APOBEC3F
7826,GO:0032391,0.00994223149306065,0.997650442476785,7,23,photoreceptor connecting cilium,CC,NPHP4;KIF17;IFT140;BBS4;WDR19;IFT122;ARL3
12227,GO:0048525,0.00996015587701458,0.996000157089396,14,72,negative regulation of viral process,BP,GSN;APOBEC3C;EIF2AK4;TRIM5;STAT1;IFIT1;OAS2;HMGA2;APOBEC3G;APOBEC3F;IFITM2;RSAD2;SRPK2;IFITM1
16966,GO:0099080,0.00999913410181574,0.992824888217654,90,598,supramolecular complex,CC,MMP2;KRT4;COL8A1;FBN1;SYNE1;MYH15;TNNI2;COL5A2;PKD2;JPH2;COL7A1;NOS1;FBN2;MAP6;COL5A1;DPYSL2;SLC8A1;KRT14;VIM;MFAP5;PLEC;PAK1;NEFM;AHNAK;SCN8A;NEFL;KRT13;TTLL11;LTBP1;KRT5;TCP11L1;MAP2;MICAL1;FLG;COL4A4;KRT15;PDE4DIP;EML2;KCNAB2;FYN;FLNC;ESPN;AHNAK2;PRKCZ;PARP4;HAUS4;KIF17;PARVA;ANK3;SPRY2;TTN;CASP14;SHROOM4;SNCA;THSD4;LMNA;FSCN1;OBSCN;PBXIP1;CST3;AKAP13;FHOD3;SYNE2;ARHGEF2;DNAL4;COL5A3;SYNC;KRT222;NCOR1;NDRG1;RGS14;ODF2;REEP2;FLNB;TPGS1;DNAH1;BEX4;ADAMTSL5;OBSL1;ARL3;COL4A1;WIPF1;PPP3CA;KRT10;CAPN6;SEPT9;KLHL22;CDK5RAP3;MYH11;MYO1C
9772,GO:0040008,0.010075755662995,0.993154814671401,66,447,regulation of growth,BP,SERPINE2;HTRA1;FN1;CTGF;SFRP1;APBB2;TGFBR2;DUSP6;GAS6;DPYSL2;EGFR;PAK1;BMP4;SMARCA2;PTK6;TP53;PTPRS;SEMA5A;CCDC85B;CRIM1;BTG1;LTBP4;DCBLD2;SLIT3;ULK2;HMGA2;CAMK2D;SYT1;CAPRIN2;ACACB;BBS2;WFS1;JARID2;TMEM8B;TP73;PLXNA2;FGFR1;ALOX15B;SEMA4A;G6PD;TGFBR3;BBS4;PLXNA1;ZMAT3;NRK;ENPP1;BCL6;IGFBP4;MEGF8;TGFB2;MAP2K5;LEF1;FHL1;CDKN2A;TSPYL2;AGRN;IGFBP2;KIAA1109;SEMA4B;YAP1;PPARG;ING4;EFNA5;DNPH1;NIPBL;ADAM10
10608,GO:0043627,0.0101706293777343,0.996476083621112,11,49,response to estrogen,BP,SFRP1;TGFBR2;CITED4;GLI3;CAV1;MDM2;CITED2;ABCC2;IGFBP2;PPARG;RARA
8871,GO:0034703,0.0101951576264182,0.995646528358885,16,75,cation channel complex,CC,NOS1;HSPA2;SCN8A;SCN2A;KCNMA1;DLG4;KCNAB2;CAMK2D;HERPUD1;KCNJ5;PDE4D;KCNQ3;SCNN1A;CACNB1;KCNIP3;SHISA9
16765,GO:0098634,0.010236070608149,0.999593886650043,3,4,cell-matrix adhesion mediator activity,MF,ITGA2;ITGA10;ITGA1
16767,GO:0098639,0.010236070608149,0.999593886650043,3,4,collagen binding involved in cell-matrix adhesion,MF,ITGA2;ITGA10;ITGA1
11913,GO:0046983,0.0102635345035171,0.992426830289757,104,852,protein dimerization activity,MF,FLOT1;SOX6;SYNE1;TENM4;ANO1;PKD2;PDGFC;AXL;EGFR;FLRT3;S100A10;NTSR1;ZNF862;TENM3;CBX5;TP53I3;TRIM5;NEFL;STAT1;LGALS1;TP53;WWTR1;DDIT3;PYCARD;MEF2D;ITGA2;PDGFA;HIP1;ITGA3;SNX1;ANO6;XDH;CAV1;SLC27A1;HLCS;GLDC;ZNF318;CAMK2D;PRDX5;PIK3R1;SYT1;TMEM173;APOBEC3G;ANG;HPS4;CAT;CHEK2;STOM;FLOT2;FGFR1;NCOA2;G6PD;CDH13;PBX1;ENG;ATM;DLK2;TCF4;ANXA6;GCLC;NR2F2;HEXA;SOX9;ENPP1;PRPS2;MPP7;TCF12;MAP3K12;TAF8;CDH11;TGFB2;SPPL2B;SP100;GOPC;CENPA;UGT1A3;UGT1A6;YAP1;GDNF;RALGAPB;TWIST2;SRR;PPARG;TPST1;MEF2A;SNX9;OLFML2A;RARA;HES2;TAF1;GSTZ1;FZD4;ZBTB1;DPYD;PPP3CA;SBF2;FOS;DNPH1;NPAS2;ABAT;ADAM10;CELSR1;S100A11;RXRA
9390,GO:0035966,0.0102853280088949,0.994401151676133,28,175,response to topologically incorrect protein,BP,DNAJB4;HSPA2;SERPINH1;EXTL2;DDIT3;CUL7;CLU;PIK3R1;CREB3L2;HERPUD1;WFS1;PDIA6;LMNA;TMEM129;CALR;DNAJC4;PTPN1;HERPUD2;TSPYL2;RHBDD1;HSPA5;DERL3;DNAJC3;CREBRF;CTDSP2;CDK5RAP3;UGGT2;EDEM1
16146,GO:0090195,0.0103534210906355,0.998761432848727,4,10,chemokine secretion,BP,PYCARD;ALOX15B;C5;POSTN
16709,GO:0097756,0.0104886371653363,0.996621238656457,10,39,negative regulation of blood vessel diameter,BP,F2R;GJA5;EGFR;SLC8A1;DOCK5;DOCK4;CAV1;BBS2;HTR1B;OXTR
4837,GO:0014048,0.0105142975989583,0.999389964911738,3,5,regulation of glutamate secretion,BP,NTSR1;CCK;SNCA
12937,GO:0051346,0.0105786830742777,0.99349273782672,42,278,negative regulation of hydrolase activity,BP,SERPINE2;PHACTR3;TNFRSF6B;MMP9;CD109;COL7A1;NOS1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;ANGPTL4;SORL1;TP53;IFIT1;WNK1;MICAL1;TIMP1;CRIM1;ELFN2;GPX1;IFI6;SERPING1;PRKCZ;PRDX5;HERPUD1;SPRY2;APLP2;SNCA;AIP;RGS2;C5;PLA2R1;BBS4;MDM2;CST3;LEPR;TGFB2;MAP2K5;LEF1;SERPINB5
18563,GO:1903845,0.0105807286017156,0.995953246388409,13,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,HTRA1;FBN1;CD109;TGFBR2;FBN2;PEG10;LTBP1;CAV1;GLG1;TGFBR3;MTMR4;HSPA5;TGFB1I1
12515,GO:0050688,0.0105913585728171,0.996108578825682,12,54,regulation of defense response to virus,BP,HTRA1;HERC5;TKFC;EIF2AK4;STAT1;PYCARD;IFIT1;DDX60;SEC14L1;TMEM173;APOBEC3G;APOBEC3F
12639,GO:0050870,0.0106113168364459,0.994901876567471,20,115,positive regulation of T cell activation,BP,TGFBR2;PAK1;LGALS1;PYCARD;GLI3;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;IL18;EFNB3;CD1D;ITPKB;BCL6;IGFBP2;RARA;ZBTB1
7313,GO:0031333,0.0107124402502313,0.995111242309444,18,92,negative regulation of protein complex assembly,BP,GSN;SPTB;SORL1;EML2;CLU;PRKCZ;KANK2;SNCA;DKK1;TRIOBP;BBS4;FHOD3;LMO4;ARHGEF2;RPL13A;THRA;ULK1;CAPG
10018,GO:0042490,0.0107479620289936,0.996796043118355,9,33,mechanoreceptor differentiation,BP,FAT4;SLITRK6;BMP4;FGFR1;TRIOBP;LRTOMT;NAGLU;VANGL2;IFT27
14031,GO:0060838,0.0107573760841599,1,2,2,lymphatic endothelial cell fate commitment,BP,PDPN;NR2F2
9283,GO:0035745,0.0107619934394823,0.999257590634028,3,6,T-helper 2 cell cytokine production,BP,PRKCZ;IL31RA;RSAD2
13456,GO:0055022,0.0107635872730489,0.998216500081601,5,14,negative regulation of cardiac muscle tissue growth,BP,TGFBR2;PAK1;JARID2;TP73;G6PD
14173,GO:0061117,0.0107635872730489,0.998216500081601,5,14,negative regulation of heart growth,BP,TGFBR2;PAK1;JARID2;TP73;G6PD
4658,GO:0010811,0.0107720920162462,0.995247245789365,17,78,positive regulation of cell-substrate adhesion,BP,FN1;COL8A1;ITGA6;SFRP1;NID1;UTRN;DOCK5;S100A10;ITGA3;CCDC80;PRKCZ;COL16A1;TRIOBP;CDH13;CALR;ECM2;DOCK1
3457,GO:0007272,0.0107864125076074,0.995119527738518,18,82,ensheathment of neurons,BP,MARVELD1;TENM4;MALL;SCN8A;SCN2A;PLLP;UGT8;AHNAK2;CLU;ADGRG6;PRX;SH3TC2;NFASC;NDRG1;NAB2;PIKFYVE;RARA;SBF2
3791,GO:0008366,0.0107864125076074,0.995119527738518,18,82,axon ensheathment,BP,MARVELD1;TENM4;MALL;SCN8A;SCN2A;PLLP;UGT8;AHNAK2;CLU;ADGRG6;PRX;SH3TC2;NFASC;NDRG1;NAB2;PIKFYVE;RARA;SBF2
10446,GO:0043330,0.0108038718817319,0.997341983525803,7,26,response to exogenous dsRNA,BP,FLOT1;IFIT1;CAV1;TMEM173;TLR3;IFNK;IFNE
19188,GO:1905330,0.0108059611482569,0.994336145671165,25,146,regulation of morphogenesis of an epithelium,BP,SFRP1;ETV5;SNAI2;MAGED1;ROR1;BMP4;STAT1;PRICKLE1;PDGFA;FZD7;FGFR1;DKK1;PSMB9;SULF1;FZD1;VANGL2;SOX9;NPHP3;MAGI2;ARHGEF19;GDNF;FZD4;MED12;CELSR1;RXRA
9017,GO:0035249,0.0108292788145367,0.996801755345422,9,31,synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;PLA2G6;SYT1;DKK1;HTR1B;OPHN1;TSHZ3;OXTR
3593,GO:0008022,0.010843149052301,0.994098337465576,28,160,protein C-terminus binding,MF,FN1;CTGF;BCAM;VIM;NEFL;TP53;CEP250;EFHC1;DLG4;EML2;PIAS3;ERCC6;SYT1;FBLN1;FOXN3;TCF4;ATXN1;GOPC;MAGI1;YAP1;PPARG;SASH1;PEX1;MED12;NIPBL;VPS36;MPDZ;MYO1C
15659,GO:0072216,0.0108856812206909,0.998677949748521,4,10,positive regulation of metanephros development,BP,PDGFA;EGR1;RET;GDNF
10114,GO:0042692,0.0109113018562075,0.99358963314621,36,203,muscle cell differentiation,BP,FLOT1;SOX6;SYNE1;NOS1;TMEM204;SPEG;SLC8A1;PAK1;BMP4;PDCD4;SIK1;GPX1;FLNC;TTN;FZD7;LMNA;DKK1;OBSCN;G6PD;MYOF;NFATC4;ENG;CALR;AKAP13;FHOD3;SOX9;LEF1;THRA;BOC;MEF2A;OBSL1;RARA;PPP3CA;MYH11;RXRA;DMPK
16175,GO:0090237,0.0109516768770158,0.999354597967664,3,5,regulation of arachidonic acid secretion,BP,NTSR1;PLA2G6;PLA2R1
7919,GO:0032507,0.0109586534213158,0.995614459962433,14,61,maintenance of protein location in cell,BP,SYNE1;TLN2;GSN;SYNE3;SORL1;CAV1;ANK3;BBS4;SYNE2;TAF8;SP100;HSPA5;FLNB;VPS13C
14332,GO:0061577,0.0109589423289298,0.998813195718751,4,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1;CAMK2D;G6PD;CACNB1
3589,GO:0008016,0.0109901259673044,0.99463594417094,21,108,regulation of heart contraction,BP,CTGF;GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;KCNJ5;RGS2;PDE4D;MDM2;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;KCNIP3;MEF2A;CACNA2D3;DMPK
5243,GO:0015874,0.0110241645343068,0.999348681505608,3,5,norepinephrine transport,BP,NISCH;SNCA;OXTR
9615,GO:0036500,0.0110243538227928,0.998655985169674,4,10,ATF6-mediated unfolded protein response,BP,DDIT3;WFS1;CALR;HSPA5
10183,GO:0042813,0.0110248987148207,0.997811778829083,6,16,Wnt-activated receptor activity,MF,SFRP1;ROR1;FZD7;FZD8;FZD1;FZD4
2284,GO:0005244,0.011161092300669,0.995494762049932,14,65,voltage-gated ion channel activity,MF,ANO1;PKD2;GAS6;SCN8A;SCN2A;KCNMA1;ANO6;KCNAB2;KCNJ15;KCNJ5;KCNQ3;CACNB1;KCNIP3;CACNA2D3
6604,GO:0022832,0.011161092300669,0.995494762049932,14,65,voltage-gated channel activity,MF,ANO1;PKD2;GAS6;SCN8A;SCN2A;KCNMA1;ANO6;KCNAB2;KCNJ15;KCNJ5;KCNQ3;CACNB1;KCNIP3;CACNA2D3
18549,GO:1903817,0.0112038110574541,0.999333952016529,3,5,negative regulation of voltage-gated potassium channel activity,BP,CAV1;ANK3;KCNRG
18170,GO:1902969,0.0112105343132095,0.998691408439516,4,9,mitotic DNA replication,BP,CHEK2;FGFR1;BCL6;LIG1
1428,GO:0003402,0.0112148896873762,0.999538934662848,3,4,planar cell polarity pathway involved in axis elongation,BP,SFRP1;VANGL2;MAGI2
10473,GO:0043395,0.0112156155093069,0.998379046148677,5,10,heparan sulfate proteoglycan binding,MF,PTPRS;SEMA5A;ITGA2;LRP1;AGRN
11756,GO:0046638,0.0112470730714935,0.997621013961665,6,20,positive regulation of alpha-beta T cell differentiation,BP,TGFBR2;GLI3;PRKCZ;IL18;ITPKB;RARA
10004,GO:0042461,0.0113127827012394,0.997663581599743,6,18,photoreceptor cell development,BP,NPHP4;IFT140;NAGLU;BBS4;TH;ARL3
3512,GO:0007435,0.0113201204848972,0.996924296621639,8,27,salivary gland morphogenesis,BP,SNAI2;EGFR;PDGFA;LAMA5;FGFR1;TGM2;PLXNA1;TGFB2
20240,GO:2001233,0.0113397421690675,0.992972339136456,42,303,regulation of apoptotic signaling pathway,BP,MMP9;ITGA6;SFRP1;GSN;SNAI2;MAGED1;SERPINE1;BMP4;ITM2C;TP53;DDIT3;PYCARD;TFDP2;GPX1;SRPX;FYN;IFI6;CAV1;PLA2G6;CLU;TP53INP1;UNC5B;HERPUD1;WFS1;TP73;DAPK1;FGFR1;LMNA;NFATC4;TRAF1;MDM2;GCLC;PTPN1;ARHGEF2;RET;MAP2K5;SP100;YAP1;GDNF;MEIS3;LGALS3;ACAA2
7454,GO:0031623,0.0113553122273515,0.995584701516987,13,60,receptor internalization,BP,FLOT1;DLG4;SNX1;TBC1D5;LRP1;CAV1;CXCR1;SNCA;DKK1;HTR1B;MAGI2;CALCRL;DNM1P46
3331,GO:0007044,0.0113941817581269,0.994843439829028,18,77,cell-substrate junction assembly,BP,FN1;ITGA6;SFRP1;ITGB4;KRT14;S100A10;PLEC;TNS1;KRT5;ITGA2;LAMC2;LAMA3;LAMA5;LAMB3;DLC1;COL16A1;COL17A1;EFNA5
3189,GO:0006816,0.0114159240708476,0.993309875679689,35,207,calcium ion transport,BP,CTGF;F2R;PKD2;JPH2;NOS1;GAS6;HSPA2;SLC8A1;ORAI3;MYLK;GJC2;NTSR1;VDR;AHNAK;DDIT3;ANO6;FYN;CAV1;PLA2G6;EHD3;CAMK2D;WFS1;SNCA;PDE4D;G6PD;SLC24A1;ANXA6;PRNP;ITPR2;CACNB1;CALCRL;LGALS3;PPP3CA;CACNA2D3;ORAI2
13442,GO:0055006,0.0114449107473587,0.995883630466916,12,42,cardiac cell development,BP,SLC8A1;PAK1;BMP4;PDCD4;TTN;LMNA;G6PD;TGFBR3;FHOD3;MEF2A;OBSL1;MYH11
12809,GO:0051146,0.0114623892439623,0.993759535788085,28,148,striated muscle cell differentiation,BP,FLOT1;SOX6;NOS1;SLC8A1;PAK1;BMP4;SIK1;GPX1;FLNC;TTN;FZD7;LMNA;DKK1;OBSCN;G6PD;MYOF;CALR;AKAP13;FHOD3;LEF1;THRA;MEF2A;OBSL1;RARA;PPP3CA;MYH11;RXRA;DMPK
12632,GO:0050863,0.0115621784314522,0.993570719526017,29,183,regulation of T cell activation,BP,TGFBR2;IL20RB;GSN;PAK1;BMP4;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;PAG1;IL18;SOX13;EFNB3;CD1D;ITPKB;BCL6;PRNP;IGFBP2;LGALS3;RARA;ZBTB1
19848,GO:2000351,0.0116133678758853,0.997196178442894,7,22,regulation of endothelial cell apoptotic process,BP,GAS6;SERPINE1;ANGPTL4;PDCD4;COL18A1;SEMA5A;ANO6
921,GO:0002317,0.011649309911965,0.999742079546009,2,3,plasma cell differentiation,BP,LGALS1;ITM2A
17542,GO:1901164,0.0116500832208182,0.999742053280517,2,3,negative regulation of trophoblast cell migration,BP,TIMP1;CALR
7995,GO:0032634,0.0116727543358985,0.998620599547469,4,9,interleukin-5 production,BP,PRKCZ;PDE4D;LEF1;RARA
8019,GO:0032674,0.0116727543358985,0.998620599547469,4,9,regulation of interleukin-5 production,BP,PRKCZ;PDE4D;LEF1;RARA
17220,GO:0120031,0.0118111418566503,0.991960909790649,64,429,plasma membrane bounded cell projection assembly,BP,ITGA6;GSN;TNIK;CEP126;MYLK;RFX2;VAV3;ARAP1;CEP250;WWTR1;CNTRL;EVI5L;EMP1;ANO6;ASAP1;EMP3;CAV1;SPATA6;DOCK11;ESPN;NPHP4;EHD3;HAUS4;KIF17;PARVA;LAMA5;BBS2;IFT140;DZIP1L;FSCN1;CDH13;SEPT6;BBS4;ARF6;BBS1;SNX10;SYNE2;FGD4;VANGL2;SSH1;IFT27;SEPT5;IFT88;TTC8;PODXL;STK36;WDR19;ODF2;IFT122;CDC42EP5;AGRN;NPHP3;VAV2;CFAP54;IFT74;OPHN1;TPGS1;DNAH1;KLF5;ICK;ARL3;TMEM67;SEPT9;TTBK2
14692,GO:0070371,0.0118179331974625,0.99335875683512,30,182,ERK1 and ERK2 cascade,BP,FN1;CTGF;ZFP36L1;F2R;DUSP6;ZFP36L2;GAS6;PDGFC;ROR1;AXL;EGFR;BMP4;PYCARD;PDGFA;GPNMB;PRKCZ;MST1R;SPRY2;FBLN1;SPRY4;FGFR1;IGF1R;EPHB6;PTPN1;SOX9;PRKCA;RGS14;RET;CAMK2N1;OXTR
10416,GO:0043292,0.0118434183785337,0.993714387368248,26,130,contractile fiber,CC,MMP2;SYNE1;MYH15;TNNI2;JPH2;NOS1;SLC8A1;PLEC;PAK1;AHNAK;SCN8A;PDE4DIP;FLNC;AHNAK2;PARVA;ANK3;TTN;OBSCN;CST3;FHOD3;SYNE2;SYNC;FLNB;OBSL1;PPP3CA;MYH11
12962,GO:0051393,0.0118607214306007,0.997995912091063,6,11,alpha-actinin binding,MF,PKD2;TTN;MAGI1;PPARG;OBSL1;RARA
6067,GO:0019221,0.0118684441830742,0.991835724497744,66,526,cytokine-mediated signaling pathway,BP,TNFRSF6B;MMP2;FN1;FLRT2;MMP9;INPP5D;IL20RB;IRS2;GAS6;AXL;FLRT3;VIM;TRIM38;XAF1;TRIM5;PDCD4;STAT1;IFIT2;TP53;PYCARD;IL32;IFIT1;TIMP1;IFIT3;FYN;IFI6;CAV1;SLC27A1;MAP3K14;CXCR1;SLIT3;OAS2;CAMK2D;MST1R;IL31RA;PIK3R1;LAMA5;BBS2;ROBO1;AIP;IFI35;FSCN1;CTF1;PSMB9;IL18;IL17RE;EDA2R;TRAF1;BBS4;IFNK;IFNE;PTPN1;EGR1;BCL6;ANXA2;LEPR;IFITM2;STAT2;SPPL2B;SP100;RSAD2;IFITM1;AGPAT1;PPARG;CREBRF;FOS
5242,GO:0015872,0.0119514364906439,0.997924149659111,5,15,dopamine transport,BP,SYT1;SNCA;HTR1B;GDNF;ABAT
4824,GO:0014033,0.0119747068432912,0.995326945215081,13,58,neural crest cell differentiation,BP,SFRP1;SNAI2;BMP4;KITLG;LAMA5;SEMA4A;KLHL12;SOX9;ISL1;RET;LEF1;SEMA4B;GDNF
365,GO:0000987,0.0120292252017494,0.992382656641787,46,291,proximal promoter sequence-specific DNA binding,MF,SOX6;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;MEF2D;GLI3;GLI2;HMGA2;PER1;CREB3L2;TP73;KLF13;NCOA2;NFATC4;PBX1;MEIS2;TCF4;ISL1;PLAG1;MYBL1;HLTF;TCF12;NFAT5;CARF;ZFPM1;LEF1;SSBP3;YAP1;KLF5;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;ETV4;FOS;PRDM5;LITAF;RXRA
16749,GO:0098590,0.0120335583898073,0.991248727275178,93,622,plasma membrane region,CC,FLOT1;FN1;ITGA6;SYNE1;F2R;TGFBR2;SLC7A8;ANO1;PKD2;CYBRD1;TNIK;PROM2;NOS1;UTRN;EGFR;ITPK1;FLRT3;SLC8A1;CLCA2;MYLK;CSPG4;PSTPIP1;EVC;PAK1;NSG1;NETO1;KCNMA1;PTPRS;DLG4;HIP1;ITGA3;PLEK2;DLG5;ASAP1;PDPN;LRP1;CAV1;PRKCZ;EHD3;MST1R;SYTL1;IL31RA;SYT1;KIF17;BBS2;ANK3;SPRY2;SHROOM4;DLC1;SPRY4;FLOT2;NIPSNAP1;FSCN1;PDE4D;MYOF;CDH13;SEPT6;AMOTL1;BBS4;ARF6;BBS1;CD1D;LZTS1;SYNE2;VANGL2;ARHGEF2;SSH1;ENPP1;ANXA2;RGS14;LEPR;TTC8;PODXL;ABCC2;NLGN4Y;OR2A4;SCNN1A;AMOTL2;GPR161;IGFBP2;GOPC;SLC9A4;SHISA9;PRR7;TMEM67;EFNA5;LIMA1;DNM1P46;CAMK2N1;OXTR;MPDZ;MYO1C;C2CD5
14797,GO:0070563,0.0120587827004258,1,2,2,negative regulation of vitamin D receptor signaling pathway,BP,SNAI2;KANK2
13794,GO:0060419,0.0121003456052239,0.995509593666145,12,50,heart growth,BP,TGFBR2;TENM4;DUSP6;PAK1;ACACB;JARID2;TP73;FGFR1;G6PD;TGFBR3;TGFB2;RXRA
20022,GO:2000669,0.012146165513683,1,2,2,negative regulation of dendritic cell apoptotic process,BP,GAS6;AXL
12519,GO:0050692,0.0123492866155793,1,2,2,DBD domain binding,MF,PPARG;RXRA
15383,GO:0071677,0.0123539387741051,0.998337128339277,4,12,positive regulation of mononuclear cell migration,BP,SERPINE1;ANO6;MOSPD2;LGALS3
3405,GO:0007189,0.012372715066261,0.995924268970195,10,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ABCA1;GNG2;ADGRG6;PDE4D;AKAP13;UCN2;PRKCA;CALCRL;ADM2
10890,GO:0044456,0.0123802580876961,0.991558512521281,64,419,synapse part,CC,SYT8;SYNE1;F2R;NOS1;UTRN;ROR1;FLRT3;SLC8A1;STON2;ADD3;NTSR1;NSG1;NR1D1;NETO1;KCNMA1;PTPRS;DLG4;ITGA2;MAP2;MICAL1;HIP1;ITGA3;DLG5;ASAP1;SYN1;KCNAB2;FYN;SYTL1;IL31RA;CCK;SYT1;PCLO;LAMA5;ANK3;SNCA;MME;VAMP1;NIPSNAP1;SEPT6;DNAJC6;LZTS1;ARHGEF2;RGS14;RAB13;SEPT5;NLGN4Y;PRNP;C2CD4C;MAGI2;TH;GOPC;OPHN1;KCNIP3;SHISA9;PRR7;SV2A;PPP3CA;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ;ZNRF1;LAMB2
8292,GO:0033139,0.0124203704766414,0.99909518915736,3,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,IFNK;IFNE;RET
16131,GO:0090179,0.0125334017644486,0.99795689385674,5,12,planar cell polarity pathway involved in neural tube closure,BP,SFRP1;FZD1;VANGL2;NPHP3;CELSR1
5140,GO:0015672,0.0125810783043159,0.992325882300737,39,252,monovalent inorganic cation transport,BP,SERPINE2;GJA5;PKD2;NOS1;UTRN;SLC8A1;SLC20A1;SCN8A;NETO1;SCN2A;KCNMA1;WNK1;SIK1;ANO6;CNTN1;MAGED2;KCNAB2;CAV1;KCNJ15;CAMK2D;PER1;SLC38A10;SLC38A2;ANK3;KCNJ5;STOM;SLC24A1;KCNQ3;NDUFA4L2;TMEM175;PRNP;SCNN1A;FHL1;SLC9A4;KLHL3;KCNIP3;PTPN3;KCNRG;DMPK
18920,GO:1904707,0.012592524251643,0.997335755372628,6,18,positive regulation of vascular smooth muscle cell proliferation,BP,MMP2;MMP9;PAK1;MEF2D;MDM2;HTR1B
12652,GO:0050890,0.0126296100676365,0.993047697741494,28,156,cognition,BP,EGFR;NTSR1;EIF2AK4;NETO1;DLG4;ITGA3;FYN;PLA2G6;PRKCZ;SHROOM4;DKK1;BBS4;MEIS2;CRTC1;BCHE;RGS14;HOXA1;METTL23;TTC8;NLGN4Y;ATXN1;PRNP;THRA;TH;FOS;NIPBL;OXTR;TUSC3
1575,GO:0003987,0.0126615514953133,1,2,2,acetate-CoA ligase activity,MF,ACSS1;ACSS2
6136,GO:0019413,0.0126615514953133,1,2,2,acetate biosynthetic process,BP,ACSS1;ACSS2
6139,GO:0019427,0.0126615514953133,1,2,2,acetyl-CoA biosynthetic process from acetate,BP,ACSS1;ACSS2
6170,GO:0019542,0.0126615514953133,1,2,2,propionate biosynthetic process,BP,ACSS1;ACSS2
4227,GO:0009409,0.0126765178328032,0.996398727117741,8,31,response to cold,BP,HSPA2;EIF2AK4;SLC27A1;CIRBP;THRA;PPARG;DNAJC3;FOS
11265,GO:0045599,0.0126794688053347,0.996094649629629,9,34,negative regulation of fat cell differentiation,BP,ZFP36L2;WWTR1;DDIT3;CCDC85B;TRIB2;ENPP1;ZFPM1;ZADH2;TGFB1I1
12320,GO:0048705,0.0126867845343916,0.993296895329802,25,131,skeletal system morphogenesis,BP,MMP2;CTGF;SFRP1;TGFBR2;FBN2;SERPINH1;BMP4;MEF2D;GLI3;MDFI;IFT140;GLG1;FGFR1;FOXN3;SOX9;HOXA1;NAB2;MEGF8;WDR19;DLX2;THRA;HOXA3;RARA;MED12;NIPBL
1389,GO:0003300,0.0127147222445437,0.995108683653355,13,48,cardiac muscle hypertrophy,BP,PAK1;CAMK2D;TTN;JARID2;LMNA;RGS2;G6PD;LMCD1;AKAP13;PRKCA;MEF2A;PPP3CA;KDM4A
12077,GO:0048104,0.0127263051355239,0.999450201018947,3,4,establishment of body hair or bristle planar orientation,BP,ASTN2;VANGL2;CELSR1
12078,GO:0048105,0.0127263051355239,0.999450201018947,3,4,establishment of body hair planar orientation,BP,ASTN2;VANGL2;CELSR1
11718,GO:0046578,0.0127729158574081,0.992487237200917,35,188,regulation of Ras protein signal transduction,BP,FLOT1;F2R;ASAP3;DNMBP;STMN3;ASAP2;TIMP2;ABCA1;VAV3;ARAP1;PLEKHG3;ARHGEF1;ITGA3;KITLG;ASAP1;ARHGEF12;IQSEC2;SPRY2;DLC1;ROBO1;SPRY4;OBSCN;ARHGEF17;ARF6;AKAP13;FGD4;ARHGEF2;ITPKB;BCL6;TGFB2;VAV2;AGAP1;ARHGEF19;OPHN1;RASA1
2782,GO:0006216,0.0127753722980713,0.998966400241759,3,7,cytidine catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F
4361,GO:0009972,0.0127753722980713,0.998966400241759,3,7,cytidine deamination,BP,APOBEC3C;APOBEC3G;APOBEC3F
11530,GO:0046087,0.0127753722980713,0.998966400241759,3,7,cytidine metabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F
4578,GO:0010668,0.0128055784212556,0.999198537296021,3,5,ectodermal cell differentiation,BP,ITGA6;FZD7;EDA2R
16967,GO:0099081,0.0128493207523456,0.990692417336909,89,597,supramolecular polymer,CC,MMP2;KRT4;COL8A1;FBN1;SYNE1;MYH15;TNNI2;COL5A2;PKD2;JPH2;NOS1;FBN2;MAP6;COL5A1;DPYSL2;SLC8A1;KRT14;VIM;MFAP5;PLEC;PAK1;NEFM;AHNAK;SCN8A;NEFL;KRT13;TTLL11;LTBP1;KRT5;TCP11L1;MAP2;MICAL1;FLG;COL4A4;KRT15;PDE4DIP;EML2;KCNAB2;FYN;FLNC;ESPN;AHNAK2;PRKCZ;PARP4;HAUS4;KIF17;PARVA;ANK3;SPRY2;TTN;CASP14;SHROOM4;SNCA;THSD4;LMNA;FSCN1;OBSCN;PBXIP1;CST3;AKAP13;FHOD3;SYNE2;ARHGEF2;DNAL4;COL5A3;SYNC;KRT222;NCOR1;NDRG1;RGS14;ODF2;REEP2;FLNB;TPGS1;DNAH1;BEX4;ADAMTSL5;OBSL1;ARL3;COL4A1;WIPF1;PPP3CA;KRT10;CAPN6;SEPT9;KLHL22;CDK5RAP3;MYH11;MYO1C
11106,GO:0045165,0.012890345896761,0.993383926290495,23,119,cell fate commitment,BP,SOX6;SFRP1;TENM4;DUSP6;BMP4;GLI3;PDPN;GLI2;PPDPF;SPRY2;FZD7;FGFR1;DKK1;NR2F2;LMO4;ARHGEF2;SOX9;ISL1;ZFPM1;DLX2;TGFB1I1;PPARG;RARA
6656,GO:0030018,0.0129032693496587,0.994257561156765,17,69,Z disc,CC,JPH2;NOS1;SLC8A1;PAK1;SCN8A;FLNC;AHNAK2;PARVA;ANK3;TTN;OBSCN;FHOD3;SYNE2;SYNC;FLNB;OBSL1;PPP3CA
20211,GO:2001181,0.0129242720955904,0.999697500346696,2,3,positive regulation of interleukin-10 secretion,BP,PYCARD;PRKCZ
707,GO:0001933,0.0129280841073889,0.991674494368263,48,326,negative regulation of protein phosphorylation,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CD109;CDKN2B;DDIT4;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;MICAL1;ADARB1;CTDSPL;XDH;CAV1;TRIB2;PRKCZ;PER1;DUSP5;SPRY2;FBLN1;TP73;SPRY4;SNCA;IGF1R;DKK1;RGS2;PDE4D;ENG;DGKQ;NR2F2;PTPN1;ENPP1;NCOR1;RGS14;PRNP;CDKN2A;DNAJC3;CTDSP2;CDK5RAP3;CAMK2N1;TAOK3
6691,GO:0030098,0.012969718257219,0.992444943353097,33,201,lymphocyte differentiation,BP,INPP5D;SFRP1;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;BMP4;LGALS1;GLI3;GLI2;DOCK11;PRKCZ;PIK3R1;FZD7;SEMA4A;IL18;FZD8;SOX13;ATM;IFNK;IFNE;CD1D;EGR1;ITPKB;BCL6;LEPR;ZFPM1;LEF1;ITM2A;RSAD2;RARA;ZBTB1
2968,GO:0006509,0.0130282403828251,0.99593480075517,9,36,membrane protein ectodomain proteolysis,BP,ADAM19;TIMP2;TIMP1;SNX33;BACE1;SPPL2B;SNX9;PTPN3;ADAM10
573,GO:0001725,0.0131276503147433,0.995337397464321,11,44,stress fiber,CC,ROR1;MYLK;MST1R;PXN;SHROOM4;FSCN1;VANGL2;FLNB;FHOD1;LIMA1;SEPT9
16619,GO:0097517,0.0131276503147433,0.995337397464321,11,44,contractile actin filament bundle,CC,ROR1;MYLK;MST1R;PXN;SHROOM4;FSCN1;VANGL2;FLNB;FHOD1;LIMA1;SEPT9
15721,GO:0072341,0.0131708584102009,0.995239010044584,11,51,modified amino acid binding,MF,JPH2;OSBPL10;GAS6;AXL;PTGES;ASAP1;MTHFR;CPS1;OSBPL5;SYT1;LANCL1
18540,GO:1903793,0.0132401870502627,0.997065304477537,6,21,positive regulation of anion transport,BP,TCAF1;NTSR1;PLA2G6;CCK;PLA2R1;ABAT
8374,GO:0033293,0.0133051701069907,0.996168070987066,8,32,monocarboxylic acid binding,MF,VDR;HLCS;ACACB;NR2F2;UGT1A3;PPARG;RARA;RXRA
13551,GO:0060047,0.013351901518998,0.993012243841164,24,126,heart contraction,BP,CTGF;TNNI2;GJA5;NOS1;SLC8A1;GPX1;CAV1;EHD3;CAMK2D;TTN;KCNJ5;RGS2;PDE4D;MDM2;TGFB2;THRA;TH;CELF2;ITPR2;CACNB1;KCNIP3;MEF2A;CACNA2D3;DMPK
11431,GO:0045907,0.0133539897264222,0.997613558817165,5,15,positive regulation of vasoconstriction,BP,F2R;GJA5;EGFR;CAV1;OXTR
19748,GO:2000182,0.0133818134491041,1,2,2,regulation of progesterone biosynthetic process,BP,DGKQ;EGR1
15745,GO:0072378,0.0133945903001606,0.998896630624946,3,7,blood coagulation, fibrin clot formation,BP,SERPING1;FBLN1;PRCP
6334,GO:0021514,0.0134165560613425,0.99940818021935,3,4,ventral spinal cord interneuron differentiation,BP,GLI3;GLI2;LMO4
6837,GO:0030315,0.0134275379312899,0.995910217186743,9,30,T-tubule,CC,NOS1;SLC8A1;AHNAK;SCN2A;AHNAK2;DYSF;ANK3;KCNJ5;PRX
1259,GO:0003014,0.0134485164768007,0.994651618942829,13,60,renal system process,BP,F2R;GSN;GJA5;GAS6;SULF2;BMP4;KCNMA1;ITGA3;MAGED2;WFS1;PRKACB;SULF1;KLHL3
9763,GO:0039692,0.0134856583889497,0.998187862916131,4,11,single stranded viral RNA replication via double stranded DNA intermediate,BP,APOBEC3C;HMGA2;APOBEC3G;APOBEC3F
1381,GO:0003281,0.0134952804830988,0.994952359341746,12,47,ventricular septum development,BP,TGFBR2;GJA5;BMP4;LTBP1;TGFBR3;FZD1;MDM2;CITED2;LMO4;VANGL2;ZFPM1;TGFB2
11233,GO:0045494,0.0135192801989025,0.997054297309298,6,19,photoreceptor cell maintenance,BP,ERCC6;NPHP4;BBS2;BBS4;BBS1;NPHP3
16808,GO:0098742,0.0135527430072243,0.993273496735465,21,102,cell-cell adhesion via plasma-membrane adhesion molecules,BP,PCDH7;FAT4;TGFBR2;TENM4;SDK1;FLRT3;AMIGO2;TENM3;PTPRM;PCDHAC2;FAT2;ROBO1;TRO;CDH13;PCDHGA11;CDH11;RET;TGFB2;MAP2K5;PCDHGB5;CELSR1
13741,GO:0060348,0.0135855999640408,0.992996154999329,23,118,bone development,BP,FBN1;FAT4;TGFBR2;PDGFC;SULF2;SERPINH1;BMP4;MEF2D;ANO6;GLI3;PLXNB1;SLC38A10;GLG1;SULF1;FOXN3;ENG;AKAP13;SOX9;ANXA2;NAB2;MEGF8;ZFPM1;RARA
9829,GO:0042092,0.0136126328441807,0.996911478100101,6,23,type 2 immune response,BP,PRKCZ;IL31RA;IL18;BCL6;RSAD2;RARA
4823,GO:0014032,0.0136242467590279,0.994814805308589,12,54,neural crest cell development,BP,SNAI2;BMP4;KITLG;LAMA5;SEMA4A;KLHL12;SOX9;ISL1;RET;LEF1;SEMA4B;GDNF
10599,GO:0043616,0.0136478048947845,0.995762889426049,9,33,keratinocyte proliferation,BP,CD109;ZFP36L1;SNAI2;VDR;KLF9;CTSV;SDR16C5;CDH13;YAP1
4941,GO:0014911,0.0136562300595126,0.996629369588335,7,21,positive regulation of smooth muscle cell migration,BP,DOCK5;PAK1;ITGA2;DOCK4;MDM2;SSH1;POSTN
7664,GO:0032104,0.0137818290789425,0.997566636600385,5,14,regulation of response to extracellular stimulus,BP,SNAI2;KANK2;CCK;BBS2;BBS4
7667,GO:0032107,0.0137818290789425,0.997566636600385,5,14,regulation of response to nutrient levels,BP,SNAI2;KANK2;CCK;BBS2;BBS4
12875,GO:0051248,0.0138233082780477,0.989555101860252,114,888,negative regulation of protein metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;INPP5D;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;DDIT4;DUSP6;ZFP36L2;IGF2BP2;COL7A1;GAS6;TFPI2;EGFR;FLRT3;SERPINE1;SERPINH1;CRTAP;TIMP2;BMP4;ITM2C;PTK6;EIF2AK4;PDCD4;SORL1;WWTR1;PYCARD;WNK1;ZCCHC11;MICAL1;ADARB1;TIMP1;CRIM1;ELFN2;GPX1;CTDSPL;FYN;IFI6;XDH;CAV1;PIAS3;TRIB2;CLU;SERPING1;PRKCZ;SDR16C5;PRDX5;PER1;CAPRIN2;ANG;DUSP5;HERPUD1;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;SPRY4;PAIP2B;SNCA;FLOT2;GLG1;IGF1R;DKK1;RGS2;C5;PDE4D;G6PD;KDM4C;ENG;CALR;MDM2;CST3;DGKQ;GCLC;NR2F2;PTPN1;ENPP1;NCOR1;ANXA2;RGS14;RPL13A;PRNP;ZFPM1;MAP2K5;LEF1;ITM2A;CDKN2A;OPHN1;ATRAID;DERL3;PPARG;BEX4;UNK;PTPN3;DNAJC3;RARA;TAF1;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;TAOK3
18206,GO:1903037,0.0138370239877728,0.992368967931581,27,169,regulation of leukocyte cell-cell adhesion,BP,TGFBR2;IL20RB;PAK1;BMP4;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;PAG1;IL18;EFNB3;CD1D;ITPKB;BCL6;PRNP;IGFBP2;LGALS3;RARA;ZBTB1
15697,GO:0072300,0.0138665957373144,1,2,2,positive regulation of metanephric glomerulus development,BP,EGR1;RET
501,GO:0001558,0.0138827877730099,0.991213123306382,44,286,regulation of cell growth,BP,SERPINE2;HTRA1;FN1;CTGF;SFRP1;APBB2;DPYSL2;EGFR;PAK1;SMARCA2;TP53;PTPRS;SEMA5A;CCDC85B;CRIM1;BTG1;LTBP4;DCBLD2;SLIT3;ULK2;CAMK2D;SYT1;CAPRIN2;PLXNA2;SEMA4A;G6PD;PLXNA1;ENPP1;BCL6;IGFBP4;MEGF8;TGFB2;MAP2K5;LEF1;FHL1;CDKN2A;TSPYL2;IGFBP2;KIAA1109;SEMA4B;PPARG;EFNA5;DNPH1;ADAM10
5132,GO:0015645,0.0139165274716121,0.998178922316791,4,10,fatty acid ligase activity,MF,SLC27A3;ACSL3;SLC27A1;SLC27A6
1093,GO:0002683,0.0139271899624481,0.991427959208946,39,266,negative regulation of immune system process,BP,HTRA1;FBN1;INPP5D;SFRP1;MMP28;ZFP36L1;IL20RB;AXL;TSC22D3;TKFC;BMP4;NR1D1;PTPRS;IFIT1;GPNMB;GPX1;GLI3;DLG5;KITLG;SEC14L1;SERPING1;IL31RA;PIK3R1;KLF13;TLR3;PAG1;C5;ATM;MEIS2;SOX9;ITPKB;BCL6;PRNP;ZFPM1;TGFB2;PPARG;GCSAM;LGALS3;RARA
11384,GO:0045807,0.0139665550713642,0.993609148831387,17,85,positive regulation of endocytosis,BP,FLOT1;GAS6;AXL;SERPINE1;PYCARD;ITGA2;HIP1;ANO6;TBC1D5;LRP1;CLU;SNCA;CALR;ANXA2;MAGI2;PPARG;PPP3CA
3449,GO:0007264,0.013986030980732,0.990241799352173,70,456,small GTPase mediated signal transduction,BP,FLOT1;RHOBTB2;F2R;ASAP3;DNMBP;ARHGAP23;DOCK9;DOCK5;DOK1;CTNNAL1;STMN3;ASAP2;TIMP2;PAK1;ABCA1;CHN2;SRGAP3;RIN2;VAV3;TP53;ARAP1;PLEKHG3;ARHGEF1;NISCH;DOCK4;ITGA3;KITLG;ASAP1;PDPN;ARHGEF12;ARHGAP18;DOCK11;IQSEC2;SPRY2;DLC1;ROBO1;SPRY4;OBSCN;ARHGEF17;CDH13;SRGAP1;ARF6;AKAP13;FGD4;VANGL2;ARHGEF2;IFT27;ITPKB;BCL6;RAB13;DEPDC7;PAK6;RAB43;TGFB2;CDC42EP5;USP28;CDKN2A;VAV2;AGAP1;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;ARL3;RASA1;ARHGAP31;RHOBTB3;CELSR1;DOCK1
15199,GO:0071384,0.0140084206118181,0.995202893421663,10,44,cellular response to corticosteroid stimulus,BP,ZFP36L1;DDIT4;ZFP36L2;EGFR;NR3C1;KLF9;AKAP13;ISL1;ABCC2;CREBRF
1097,GO:0002687,0.0140759974001882,0.994284864156952,13,71,positive regulation of leukocyte migration,BP,GAS6;SERPINE1;CXCL14;TP53;PYCARD;ITGA2;ANO6;KITLG;CALR;MOSPD2;LGALS3;MIA3;ADAM10
7986,GO:0032616,0.0141537843022199,0.998069882601989,4,11,interleukin-13 production,BP,PRKCZ;IL18;LEF1;RARA
13723,GO:0060326,0.0141983358863449,0.992560372675687,23,146,cell chemotaxis,BP,MMP28;GAS6;SERPINE1;CXCL14;VAV3;SEMA5A;DOCK4;ANO6;CXCR1;ITGA1;PARVA;FGFR1;C5;PDE4D;CALR;LYST;RAB13;MOSPD2;TGFB2;LEF1;LGALS3;ELMO2;ADAM10
4849,GO:0014066,0.014228132665287,0.994289485059153,13,61,regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2;F2R;PDGFC;EGFR;PDGFA;PLXNB1;FYN;UNC5B;CAT;FGFR1;IL18;SOX9;TGFB2
12700,GO:0050974,0.0142482029081398,0.999070574120406,3,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2;ITGA2;FYN
4709,GO:0010876,0.0142730287460402,0.991357739058357,37,225,lipid localization,BP,PITPNM3;IRS2;OSBPL10;ATP10D;NTSR1;ABCA1;SORL1;MEST;ACSL3;ANO6;LRP1;CAV1;SLC27A1;PLA2G6;OSBPL5;CLU;ATP8B2;CPT1A;ACACB;PRKAB2;NCOA2;PLA2R1;ESYT2;ENPP1;SLC27A6;NCOR1;ANXA2;ABCC2;OSBPL1A;PITPNC1;PPARG;APOL6;ABCA2;FZD4;RXRA;CPT2;ABCA5
8461,GO:0033619,0.0142739359342825,0.994521275052658,12,55,membrane protein proteolysis,BP,ADAM19;TIMP2;TIMP1;SNX33;BACE1;APH1B;RET;SPPL2B;RHBDD1;SNX9;PTPN3;ADAM10
19710,GO:2000107,0.0143112855174153,0.995822483966261,8,32,negative regulation of leukocyte apoptotic process,BP,IRS2;GAS6;AXL;TSC22D3;BMP4;KITLG;ITPKB;BCL6
5511,GO:0016480,0.0143197776979363,0.999645863122568,2,3,negative regulation of transcription by RNA polymerase III,BP,PRDX5;NAB2
6298,GO:0019933,0.014398024475311,0.994023525887099,14,62,cAMP-mediated signaling,BP,NOS1;ABCA1;GNG2;ADGRG6;PCLO;RGS2;PDE4D;AKAP13;DGKQ;SOX9;UCN2;PRKCA;CALCRL;ADM2
547,GO:0001667,0.0144741193099136,0.990831919314481,44,271,ameboidal-type cell migration,BP,MMP9;CCBE1;TGFBR2;SLC8A1;DOCK5;PAK1;PTPRM;BMP4;TNS1;SEMA5A;ITGA2;TIMP1;ITGA3;GPX1;KITLG;FAT2;PXN;LAMA5;ROBO1;FGFR1;SEMA4A;CDH13;AMOTL1;CALR;NR2F2;SYNE2;SOX9;ISL1;PRCP;PRKCA;RAB13;MEGF8;RET;TGFB2;MAP2K5;AMOTL2;LEF1;SP100;SEMA4B;GDNF;PPARG;SASH1;ADGRA2;DOCK1
425,GO:0001133,0.0145586607968514,0.997455689703564,5,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,VDR;NR1D1;THRA;PPARG;RARA
6361,GO:0021549,0.0146042461588592,0.99416815201283,13,56,cerebellum development,BP,SERPINE2;TRNP1;PAK1;PTPRS;CNTN1;GLI2;AARS;NAGLU;HSPA5;OPHN1;FZD4;ABAT;TTBK2
9767,GO:0039706,0.0146515012299573,0.99886286650112,3,6,co-receptor binding,MF,BMP4;NEO1;DKK1
11701,GO:0046530,0.0148465848523883,0.995729553355865,8,28,photoreceptor cell differentiation,BP,NPHP4;IFT140;NAGLU;BBS4;SOX9;DLX2;TH;ARL3
14701,GO:0070383,0.0148824137254177,0.998723800756028,3,7,DNA cytosine deamination,BP,APOBEC3C;APOBEC3G;APOBEC3F
12754,GO:0051056,0.0148846229821042,0.990481334827279,46,264,regulation of small GTPase mediated signal transduction,BP,FLOT1;RHOBTB2;F2R;ASAP3;DNMBP;ARHGAP23;STMN3;ASAP2;TIMP2;ABCA1;CHN2;SRGAP3;VAV3;ARAP1;PLEKHG3;ARHGEF1;ITGA3;KITLG;ASAP1;ARHGEF12;ARHGAP18;IQSEC2;SPRY2;DLC1;ROBO1;SPRY4;OBSCN;ARHGEF17;SRGAP1;ARF6;AKAP13;FGD4;ARHGEF2;ITPKB;BCL6;DEPDC7;TGFB2;VAV2;AGAP1;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;RASA1;ARHGAP31
7196,GO:0031098,0.0149334990959122,0.990980672887112,36,227,stress-activated protein kinase signaling cascade,BP,CTGF;SFRP1;GADD45B;ZFP36L1;TNIK;EGFR;MAP3K6;PAK1;PDCD4;PYCARD;XDH;ERCC6;MAP3K14;PER1;TP73;TLR3;FZD7;IGF1R;DKK1;EDA2R;FZD8;MAP3K1;PTPN1;VANGL2;NRK;NCOR1;PAK6;MAP3K12;TGFB2;MAP2K5;CDC42EP5;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
7656,GO:0032096,0.0149679918659443,0.998828697389958,3,6,negative regulation of response to food,BP,CCK;BBS2;BBS4
7659,GO:0032099,0.0149679918659443,0.998828697389958,3,6,negative regulation of appetite,BP,CCK;BBS2;BBS4
8357,GO:0033267,0.0149715298687089,0.990724048557356,40,240,axon part,CC,APBB2;UTRN;ROR1;FLRT3;GJC2;STMN3;NTSR1;TIMP2;SCN8A;NEFL;SCN2A;DLG4;ITGA2;MICAL1;ITGA3;SYN1;KCNAB2;PRKCZ;CCK;SYT1;ANG;ANK3;SNCA;VAMP1;FSCN1;SETX;SEPT6;TRAK1;KCNQ3;SSH1;NFASC;SEPT5;MAP3K12;TH;BOC;OPHN1;KCNIP3;SV2A;TSHZ3;ORAI2
13716,GO:0060317,0.0150320352631249,0.996644760432201,6,19,cardiac epithelial to mesenchymal transition,BP,TGFBR2;SNAI2;PDCD4;TGFBR3;ENG;TGFB2
2604,GO:0005911,0.0150980210133114,0.990131774818372,50,303,cell-cell junction,CC,FLOT1;FLRT2;ITGA6;GJA5;PKD2;FLRT3;SLC8A1;GJC2;ADD3;PAK1;PTPRM;AHNAK;SCN2A;FRMD4B;PPL;DLG5;FAT2;NPHP4;PRKCZ;PIK3R1;ANK3;SHROOM4;FLOT2;PTPRU;FSCN1;CDH13;AMOTL1;VANGL2;ARHGEF2;NFASC;NDRG1;ANXA2;RAB13;MPP7;PODXL;ABCC2;CDH11;AMOTL2;MAGI2;MAGI1;PIKFYVE;FHOD1;COL17A1;OBSL1;SV2A;FZD4;PDZD2;OXTR;MPDZ;S100A11
10828,GO:0044344,0.0150989189072919,0.992501375055961,20,110,cellular response to fibroblast growth factor stimulus,BP,FLRT2;CTGF;SFRP1;ZFP36L1;FAT4;DUSP6;ZFP36L2;SNAI2;SULF2;FLRT3;CPS1;RBFOX2;SPRY2;SPRY4;SNCA;FGFR1;SETX;SULF1;GCLC;POSTN
15536,GO:0072015,0.0151439510483605,0.998187533201992,4,8,glomerular visceral epithelial cell development,BP,BMP4;PODXL;MAGI2;LAMB2
15706,GO:0072310,0.0151439510483605,0.998187533201992,4,8,glomerular epithelial cell development,BP,BMP4;PODXL;MAGI2;LAMB2
19486,GO:1990393,0.0152117584639193,0.998982098753076,3,5,3M complex,CC,CUL7;FBXW8;OBSL1
4825,GO:0014034,0.0152731465889035,1,2,2,neural crest cell fate commitment,BP,SFRP1;SOX9
12341,GO:0048745,0.0152965487028857,0.997372884584727,5,12,smooth muscle tissue development,BP,PKD2;MYLK;BMP4;ENG;SOX9
6680,GO:0030056,0.0153384245529059,0.9986017013623,4,6,hemidesmosome,CC,ITGA6;ITGB4;PLEC;COL17A1
9031,GO:0035265,0.0153784685442903,0.992566589559287,19,92,organ growth,BP,TGFBR2;TENM4;DUSP6;EVC;PAK1;ACACB;SPRY2;JARID2;TP73;FGFR1;G6PD;TGFBR3;SOX9;PLAG1;LEPR;TGFB2;YAP1;RARA;RXRA
10527,GO:0043500,0.015390951841489,0.993776851017124,13,59,muscle adaptation,BP,GSN;PAK1;CAMK2D;JARID2;LMNA;RGS2;G6PD;LMCD1;AKAP13;PRKCA;MEF2A;PPP3CA;KDM4A
2593,GO:0005891,0.0154008838824598,0.997920987781394,4,10,voltage-gated calcium channel complex,CC,NOS1;HSPA2;PDE4D;CACNB1
4932,GO:0014897,0.0154090393608475,0.993897810632724,13,49,striated muscle hypertrophy,BP,PAK1;CAMK2D;TTN;JARID2;LMNA;RGS2;G6PD;LMCD1;AKAP13;PRKCA;MEF2A;PPP3CA;KDM4A
18936,GO:1904738,0.0154971553685801,0.997329261999442,5,12,vascular associated smooth muscle cell migration,BP,DOCK5;PAK1;DOCK4;MDM2;SSH1
18946,GO:1904752,0.0154971553685801,0.997329261999442,5,12,regulation of vascular associated smooth muscle cell migration,BP,DOCK5;PAK1;DOCK4;MDM2;SSH1
538,GO:0001657,0.0155032421098254,0.993502698678014,14,62,ureteric bud development,BP,SFRP1;FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;CAT;FGFR1;PBX1;SOX9;RET;GDNF;RARA
10809,GO:0044323,0.0155313979097708,1,2,2,retinoic acid-responsive element binding,MF,RARA;RXRA
568,GO:0001710,0.0155805037322026,0.998761745328681,3,6,mesodermal cell fate commitment,BP,BMP4;FGFR1;DKK1
12878,GO:0051251,0.0156672720372995,0.991480089383092,25,157,positive regulation of lymphocyte activation,BP,INPP5D;TGFBR2;IRS2;GAS6;AXL;PAK1;VAV3;LGALS1;PYCARD;GLI3;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;IL18;EFNB3;CD1D;ITPKB;BCL6;IGFBP2;RARA;ZBTB1
9116,GO:0035457,0.0156755879445586,0.997971785334393,4,9,cellular response to interferon-alpha,BP,GAS6;AXL;IFIT2;IFIT3
10871,GO:0044432,0.0157687506611312,0.987950148047571,119,956,endoplasmic reticulum part,CC,PRSS23;FN1;FLRT2;COL8A1;FBN1;PTGS1;ADAMTSL1;COL5A2;PKD2;JPH2;SCARA3;COL7A1;H6PD;NOS1;GAS6;PDGFC;COL5A1;EGFR;LAMB1;FLRT3;ATP10D;SERPINH1;CRTAP;MBOAT2;ABCA1;NSG1;BMP4;COL18A1;LGALS1;MEST;EXTL2;LTBP1;PDGFA;TIMP1;ACSL3;COL4A4;PTGES;LPCAT2;P3H2;ERO1B;CAV1;SEL1L;OSBPL5;XYLT1;SDR16C5;CAMK2D;ATP8B2;PDIA4;PIK3R1;HHAT;TMEM173;CREB3L2;ALDH3A2;HERPUD1;WFS1;CES2;APLP2;BACE1;TLR3;ADAMTS7;PDIA6;COL16A1;MLEC;SEC24D;TMEM129;ESYT2;ARSD;CALR;COPG2;TMED10;CST3;AREG;CD1D;SYNE2;PTPN1;POGLUT1;SDC2;COL5A3;PLD3;G6PC3;TMEM50B;BCHE;CES3;PGAP1;IGFBP4;COL12A1;CYP4V2;SPPL2B;ULK1;RHBDD1;HSPA5;REEP2;RSAD2;ITPR2;UGT1A3;LMF1;UGT1A6;ALG10;COL17A1;GPX8;GALNT2;DERL3;AGPAT1;CERS5;MIA3;DNAJC3;FKBP10;COL4A1;TMEM67;MPPE1;MATN3;UGGT2;CERCAM;ADAM10;TUSC3;EDEM1;DMPK;MOSPD3;LAMB2
13795,GO:0060420,0.0158513074830041,0.994904969264991,9,35,regulation of heart growth,BP,TGFBR2;DUSP6;PAK1;ACACB;JARID2;TP73;FGFR1;G6PD;TGFBR3
6748,GO:0030178,0.0158841790805897,0.991359359698492,25,154,negative regulation of Wnt signaling pathway,BP,SFRP1;APCDD1;SNAI2;RNF213;WWTR1;PRICKLE1;DDIT3;RBMS3;GLI3;LRP1;CAV1;NPHP4;MDFI;DKK1;PSMB9;NFATC4;KLHL12;EGR1;SOX9;ISL1;IGFBP4;LEF1;IGFBP2;NPHP3;MED12
4782,GO:0010976,0.0159085972390818,0.990621810815526,33,185,positive regulation of neuron projection development,BP,FN1;TENM3;PAK1;PTK6;NEFL;DLG4;SEMA5A;CUL7;ITGA3;DLG5;CNTN1;PLXNB1;FYN;SYT1;CAPRIN2;METRN;ROBO1;PLXNA2;FGFR1;SETX;FZD1;NEGR1;PLXNA1;TRAK1;FBXW8;CRTC1;MEGF8;RET;MAGI2;HSPA5;OBSL1;EFNA5;FZD4
13694,GO:0060291,0.0160560951444662,0.994445902292292,10,40,long-term synaptic potentiation,BP,SERPINE2;NSG1;EIF2AK4;PRKCZ;SNCA;SLC24A1;CRTC1;RGS14;PRNP;TSHZ3
19073,GO:1905007,0.0160747486197017,0.998900891295165,3,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2;ENG;TGFB2
1342,GO:0003206,0.0160771864237601,0.992756853586532,16,75,cardiac chamber morphogenesis,BP,TGFBR2;GJA5;BMP4;ADGRG6;PARVA;TGFBR3;FZD1;ENG;MDM2;CITED2;VANGL2;ISL1;ZFPM1;TGFB2;RARA;RXRA
3376,GO:0007156,0.0160902823255504,0.992859678330146,16,64,homophilic cell adhesion via plasma membrane adhesion molecules,BP,PCDH7;FAT4;SDK1;AMIGO2;TENM3;PTPRM;PCDHAC2;FAT2;ROBO1;TRO;CDH13;PCDHGA11;CDH11;RET;PCDHGB5;CELSR1
13809,GO:0060438,0.0161014628525672,0.996979611278556,5,15,trachea development,BP,TGFBR2;BMP4;SOX9;LEF1;RARA
19749,GO:2000191,0.0161637328393033,0.997025047337546,5,14,regulation of fatty acid transport,BP,IRS2;NTSR1;PLA2G6;PLA2R1;NCOR1
20110,GO:2000826,0.0161889697268348,0.995740728113189,7,24,regulation of heart morphogenesis,BP,TGFBR2;BMP4;DKK1;ENG;SOX9;ISL1;TGFB2
964,GO:0002407,0.0161915765874898,0.997699178608996,4,11,dendritic cell chemotaxis,BP,GAS6;ANO6;CXCR1;CALR
16135,GO:0090184,0.0161918225280614,0.99562528179412,7,28,positive regulation of kidney development,BP,MAGED1;BMP4;PDGFA;EGR1;SOX9;RET;GDNF
15265,GO:0071480,0.0162677465926954,0.995652986764437,7,26,cellular response to gamma radiation,BP,TP53;CHEK2;ATM;MDM2;EGR1;HSPA5;YAP1
6292,GO:0019911,0.0163370725780307,0.998548043215007,3,7,structural constituent of myelin sheath,MF,MARVELD1;MALL;PLLP
3246,GO:0006907,0.0163890856846114,0.996859239112677,5,16,pinocytosis,BP,PROM2;AXL;PYCARD;CAV1;SNX33
152,GO:0000308,0.0164095909511943,1,2,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,CDK14;CCNY
7683,GO:0032147,0.0164162045553996,0.989875843042309,38,239,activation of protein kinase activity,BP,GADD45B;F2R;TGFBR2;DUSP6;TNIK;GAS6;PDGFC;EGFR;CSPG4;MAP3K6;PAK1;BMP4;WNK1;PILRB;ERCC6;MAP3K14;PRKCZ;ITGA1;ANG;DUSP5;TP73;PRKACB;TLR3;C5;IL18;DGKQ;MAP3K1;PTPN1;NRK;PAK6;MAP3K12;PRNP;TGFB2;MAP2K5;MAPK8IP3;MDFIC;EFNA5;TAOK3
3379,GO:0007159,0.0164962213094741,0.990546234722412,29,187,leukocyte cell-cell adhesion,BP,TGFBR2;IL20RB;PAK1;BMP4;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;PAG1;IL18;EFNB3;CD1D;ITPKB;BCL6;GCNT1;PRNP;IGFBP2;LGALS3;RARA;ZBTB1;CERCAM
4931,GO:0014896,0.0165065758414304,0.993383864081827,13,50,muscle hypertrophy,BP,PAK1;CAMK2D;TTN;JARID2;LMNA;RGS2;G6PD;LMCD1;AKAP13;PRKCA;MEF2A;PPP3CA;KDM4A
9402,GO:0035986,0.0165921056073935,0.999555716397509,2,3,senescence-associated heterochromatin focus assembly,BP,HMGA2;CDKN2A
8819,GO:0034620,0.0166014048214208,0.99133265417582,22,132,cellular response to unfolded protein,BP,HSPA2;EXTL2;DDIT3;CUL7;PIK3R1;CREB3L2;HERPUD1;WFS1;PDIA6;LMNA;CALR;PTPN1;TSPYL2;RHBDD1;HSPA5;DERL3;DNAJC3;CREBRF;CTDSP2;CDK5RAP3;UGGT2;EDEM1
7975,GO:0032602,0.0166439344117364,0.994050343365729,10,51,chemokine production,BP,SNAI2;PYCARD;TLR3;ALOX15B;C5;IL18;EGR1;ZFPM1;MAP2K5;POSTN
18950,GO:1904761,0.0166465291968516,1,2,2,negative regulation of myofibroblast differentiation,BP,PDCD4;TP53INP1
12698,GO:0050966,0.0166542731647428,1,2,2,detection of mechanical stimulus involved in sensory perception of pain,BP,ITGA2;FYN
13816,GO:0060445,0.0166713647130986,0.996296305588839,6,17,branching involved in salivary gland morphogenesis,BP,SNAI2;PDGFA;LAMA5;FGFR1;TGM2;PLXNA1
13819,GO:0060449,0.0167303752666709,0.99863319013732,3,6,bud elongation involved in lung branching,BP,BMP4;SPRY2;YAP1
18659,GO:1904035,0.0167419414675315,0.994133041023636,10,42,regulation of epithelial cell apoptotic process,BP,ZFP36L1;GSN;GAS6;SERPINE1;ANGPTL4;PDCD4;COL18A1;SEMA5A;ANO6;WFS1
13519,GO:0060009,0.0167444795395312,0.997788560611484,4,9,Sertoli cell development,BP,CST3;SOX9;RAB13;FNDC3A
4536,GO:0010614,0.0169056886347175,0.996851622554432,5,14,negative regulation of cardiac muscle hypertrophy,BP,PAK1;JARID2;LMNA;RGS2;G6PD
1250,GO:0003002,0.0169118443713984,0.989951310221893,33,198,regionalization,BP,SFRP1;DUSP6;BMP4;DDIT3;GLI3;GLI2;MDFI;PRKACB;IFT140;PLXNA2;FGFR1;DKK1;PBX1;ATM;CITED2;NR2F2;POGLUT1;VANGL2;ISL1;PGAP1;TSHZ1;MEGF8;WDR19;DLX2;IFT122;GPR161;LEF1;SSBP3;GDNF;HOXA3;PBX2;MED12;CELSR1
13746,GO:0060353,0.0169556870092282,0.999540619064452,2,3,regulation of cell adhesion molecule production,BP,FLOT1;CAV1
13747,GO:0060355,0.0169556870092282,0.999540619064452,2,3,positive regulation of cell adhesion molecule production,BP,FLOT1;CAV1
4380,GO:0010035,0.0171384447981214,0.988752791048044,48,340,response to inorganic substance,BP,MMP9;TXNIP;NQO1;GSN;PKD2;CYBRD1;AXL;EGFR;SLC8A1;KRT14;NEFL;COL18A1;STAT1;KCNMA1;D2HGDH;TP53;WNK1;GPX1;PTGES;CPS1;CAV1;ERCC6;CAMK2D;SYT1;ANK3;TTN;CAT;SNCA;SETX;G6PD;NFATC4;CALR;MDM2;CST3;AREG;GCLC;ITPKB;NDRG1;ABCC2;PRNP;CARF;IGFBP2;HSPA5;TH;MEF2A;PPP3CA;FOS;ABAT
594,GO:0001759,0.0171411835787372,0.997521104509346,4,11,organ induction,BP,BMP4;FGFR1;DKK1;GDNF
4319,GO:0009820,0.017194878075505,0.999530587886112,2,3,alkaloid metabolic process,BP,BCHE;TH
5543,GO:0016554,0.0172202164290039,0.998438208958093,3,7,cytidine to uridine editing,BP,APOBEC3C;APOBEC3G;APOBEC3F
13629,GO:0060170,0.0172822639629233,0.993582565396868,11,45,ciliary membrane,CC,PKD2;PROM2;EVC;EHD3;BBS2;BBS4;BBS1;TTC8;SCNN1A;GPR161;TMEM67
1909,GO:0004601,0.0174530321139287,0.995706178240206,6,27,peroxidase activity,MF,PTGS1;GPX1;PRDX5;CAT;GPX8;GSTZ1
17723,GO:1901698,0.0175104200854496,0.986907825490042,99,734,response to nitrogen compound,BP,FLOT1;MMP2;CTGF;FBN1;SFRP1;ZFP36L1;NQO1;GSN;COL5A2;PKD2;IRS2;SDK1;PDGFC;EGFR;SLC8A1;SESN3;PAK1;ABCA1;BMP4;NEFL;STAT1;GNG2;TP53;IFIT1;ITGA2;ZCCHC11;MMP19;TIMP1;BTG1;MTHFR;SESN1;LRP1;FYN;CPS1;CAV1;SLC27A1;HLCS;SEL1L;GLDC;PRKCZ;PER1;PXN;PIK3R1;TMEM173;HERPUD1;WFS1;TP73;CAT;PRKACB;TLR3;SNCA;COL16A1;IGF1R;PDE4D;TMEM129;CDH13;TGFBR3;MDM2;TMED10;AREG;IFNK;DGKQ;GCLC;IFNE;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;ENPP1;NCOR1;GCNT1;BCHE;RAB13;ABCC2;HTR1B;PRNP;AGRN;RHBDD1;HSPA5;TH;ITPR2;CACNB1;KLF5;SRR;DERL3;PPARG;COL4A1;TMEM67;TAF1;PPP3CA;FOS;AGO4;ABAT;UGGT2;OXTR;MYO1C;C2CD5;EDEM1
645,GO:0001836,0.0175216532867826,0.994045930512965,9,49,release of cytochrome c from mitochondria,BP,MMP9;TP53;PYCARD;GPX1;IFI6;PLA2G6;CLU;CCK;LMNA
7125,GO:0030968,0.0176216788444109,0.991073642201076,20,117,endoplasmic reticulum unfolded protein response,BP,EXTL2;DDIT3;CUL7;PIK3R1;CREB3L2;HERPUD1;WFS1;PDIA6;LMNA;CALR;PTPN1;TSPYL2;HSPA5;DERL3;DNAJC3;CREBRF;CTDSP2;CDK5RAP3;UGGT2;EDEM1
2939,GO:0006469,0.0176339558860981,0.989636461047826,31,201,negative regulation of protein kinase activity,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CDKN2B;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;ADARB1;CAV1;TRIB2;DUSP5;SPRY2;TP73;SPRY4;IGF1R;RGS2;NR2F2;PTPN1;RGS14;CDKN2A;DNAJC3;CDK5RAP3;CAMK2N1;TAOK3
5437,GO:0016310,0.0176445571682612,0.985666185709611,203,1638,phosphorylation,BP,FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;EFEMP1;PKD2;PIK3C2G;IRS2;DUSP6;ZFP36L2;HERC5;TNIK;PROM2;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;ITPK1;HSPA2;FLRT3;SPEG;SPTB;MYLK;GJC2;CSPG4;TKFC;MAP3K6;DCAKD;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;NEFL;VAV3;PDCD4;SORL1;TP53;WWTR1;CNTRL;PYCARD;WNK1;DLG4;PILRB;PDGFA;MICAL1;ADARB1;GPNMB;SIK1;CDK14;CNTN1;KITLG;CTDSPL;NEK9;NMRK1;FYN;XDH;ALPK1;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;CLU;PRKCZ;ULK2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;CAPRIN2;ANG;DUSP5;CDK18;PHKA2;SPRY2;TTN;FBLN1;TP73;DAPK1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;MYO3B;PSMB9;IL18;OBSCN;PDK3;EPHB6;EDA2R;FZD8;DHTKD1;AFAP1L2;TGFBR3;FZD1;ENG;ATM;FAM20A;AREG;IFNK;AKAP13;DGKQ;NR2F2;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;SOX9;ENPP1;ISL1;ITPKB;STK16;NCOR1;PRKCA;PRPS2;ANXA2;RGS14;ETNK2;IGFBP4;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;CDC42EP5;MAPK8IP3;CDKN2A;EFR3A;ULK1;TSPYL2;VAV2;HSPA5;CDK19;PIKFYVE;SRPK2;UVRAG;MDFIC;GDNF;MEF2A;SNX9;ICK;SASH1;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PIK3C2B;RASA1;CTDSP2;CDK5RAP3;CAMK2N1;TTBK2;ADM2;OXTR;ADAM10;TAOK3;DMPK
4441,GO:0010359,0.0176576237708656,0.998526877868132,3,6,regulation of anion channel activity,BP,TCAF1;PRNP;GOPC
13592,GO:0060099,0.0176607478123093,0.998746979207922,3,5,regulation of phagocytosis, engulfment,BP,ITGA2;ANO6;PPARG
13593,GO:0060100,0.0176607478123093,0.998746979207922,3,5,positive regulation of phagocytosis, engulfment,BP,ITGA2;ANO6;PPARG
19124,GO:1905155,0.0176607478123093,0.998746979207922,3,5,positive regulation of membrane invagination,BP,ITGA2;ANO6;PPARG
7415,GO:0031527,0.0177005280779649,0.996959387082846,5,11,filopodium membrane,CC,UTRN;ITGA3;PDPN;ARF6;SYNE2
13198,GO:0051890,0.0177326407784089,1,2,2,regulation of cardioblast differentiation,BP,PRICKLE1;TGFB2
16894,GO:0098902,0.0177390571758957,0.998739227039186,3,5,regulation of membrane depolarization during action potential,BP,GJA5;ANK3;PTPN3
5583,GO:0016614,0.0178581135152328,0.991921383609805,15,93,oxidoreductase activity, acting on CH-OH group of donors,MF,H6PD;D2HGDH;PHGDH;KCNAB2;XDH;SDR16C5;HIBADH;ALDH3A2;CBR1;G6PD;IDH2;HSD17B11;AKR7A2;ZADH2;EHHADH
2029,GO:0004771,0.0178651956539844,0.998502762862558,3,6,sterol esterase activity,MF,CES2;CES3;LIPA
1358,GO:0003230,0.0178680926858431,0.995337023705477,7,21,cardiac atrium development,BP,GJA5;ENG;MDM2;ISL1;ZFPM1;TGFB2;NPHP3
8028,GO:0032689,0.0179050902980334,0.996394772671258,5,18,negative regulation of interferon-gamma production,BP,IL20RB;GAS6;AXL;PRNP;RARA
13071,GO:0051611,0.0179199839846861,1,2,2,regulation of serotonin uptake,BP,NOS1;SNCA
13072,GO:0051612,0.0179199839846861,1,2,2,negative regulation of serotonin uptake,BP,NOS1;SNCA
10522,GO:0043491,0.018071904203194,0.989959175059352,26,150,protein kinase B signaling,BP,ZFP36L1;IRS2;GAS6;AXL;EGFR;SESN3;DDIT3;SEMA5A;PDGFA;HIP1;GPX1;KITLG;FYN;XDH;MST1R;PIK3R1;SPRY2;FGFR1;SETX;IL18;ENG;MDM2;SOX9;MAGI2;MEIS3;PIK3C2B
1023,GO:0002526,0.0180896750684711,0.993068632894337,11,57,acute inflammatory response,BP,FN1;IL20RB;NUPR1;ANO6;PTGES;CLU;SERPING1;IL31RA;C5;PRCP;PPARG
6585,GO:0022607,0.01820851100889,0.98487008084419,265,2216,cellular component assembly,BP,FLOT1;FN1;FLRT2;ITGB5;CTGF;ITGA6;SFRP1;RHOBTB2;TLN2;XPC;SLITRK6;ITGB4;TENM4;ASAP3;GSN;GJA5;PKD2;SDK1;TNIK;COL7A1;CLTCL1;GAS6;PDGFC;SNAI2;HSPA2;FLRT3;SPTB;CEP126;MYLK;THBS2;RFX2;RNF213;KRT14;TCF7L1;S100A10;C1QTNF6;DDB2;AMIGO2;PLEC;PAK1;ABCA1;ANGPTL4;NSG1;NEFM;TNS1;AHNAK;NEFL;VAV3;SORL1;TP53;ARAP1;CEP250;WWTR1;DDIT3;CNTRL;PYCARD;KRT5;DLG4;ITGA2;PILRB;PDGFA;MAP2;ACSL3;EFEMP2;PHLDB1;HIP1;EVI5L;EMP1;TYSND1;TPBG;ANO6;LAMC2;DLG5;ASAP1;SRPX;SPG11;PDE4DIP;EML2;EMP3;FLNC;ARHGAP18;UGT8;LAMA3;CAV1;SPATA6;DOCK11;ESPN;TNRC18;AHNAK2;CLU;NPHP4;PRKCZ;ULK2;TP53INP1;ARPIN;EHD3;HMGA2;CAMK2D;KANK2;HAUS4;PXN;CCK;PIK3R1;SYT1;CPT1A;ACACB;PCLO;ANG;KIF17;PARVA;LAMA5;BBS2;ANK3;LAMB3;TTN;CIRBP;HPS4;MLH3;TP73;CAT;DLC1;PRKACB;CHEK2;IFT140;STOM;PRX;FBXL7;SNCA;FLOT2;THSD4;GATAD1;VAMP1;COL16A1;DZIP1L;IGF1R;DKK1;FSCN1;SEC24D;RGS2;SETX;TGM2;OBSCN;TLE4;CCDC136;TRIOBP;CDH13;TRAF1;SEPT6;TGFBR3;FZD1;BBS4;CALR;ATM;MDM2;ARF6;TMED10;AREG;TCF4;BBS1;ANXA6;AKAP13;SNX10;DGKQ;FHOD3;LMO4;MSH5;SYNE2;FGD4;VANGL2;ARHGEF2;KLHL12;SSH1;SOX9;IFT27;NFASC;CRTC1;NCOR1;PRKCA;TMEM175;ANXA2;RAB13;MPP7;SEPT5;BAHCC1;IFT88;GOLGA8B;TTC8;KCTD7;RPL13A;PODXL;DECR1;NLGN4Y;STK36;WDR19;PRNP;CDH11;ODF2;IFT122;LEF1;THRA;SSBP3;CDC42EP5;LRRN3;MSRB2;CDKN2A;ULK1;TSPYL2;AGRN;NPHP3;VAV2;TSPYL4;MAGI2;CELF2;GOPC;MAGI1;CENPA;PIKFYVE;SRPK2;UVRAG;CFAP54;FHOD1;IFT74;OPHN1;TPGS1;KCTD14;MYO9A;YAP1;DNAH1;KLF5;COL17A1;GOLGA8N;SRR;CAPG;MEF2A;SNX9;ICK;OBSL1;ARL3;MIA3;TMEM67;TAF1;EFNA5;SLITRK5;WIPF1;ZBTB1;SBF2;RASA1;LIMA1;HP1BP3;COX18;DNM1P46;SEPT9;AGO4;MYH11;VPS36;TTBK2;KCNRG;BSN;OXTR;RHOBTB3;PSMG4;ATG16L2;TSPAN4;MYO1C;RXRA
19665,GO:2000009,0.0182235402858267,0.99740830812457,4,10,negative regulation of protein localization to cell surface,BP,SNX33;ASTN2;ARF6;GOPC
4601,GO:0010721,0.0182801024783699,0.9889923055254,34,200,negative regulation of cell development,BP,FBN1;VIM;PAK1;ITM2C;EIF2AK4;SORL1;LGALS1;PTPRS;SEMA5A;GLI3;ASAP1;LRP1;ULK2;FBLN1;TP73;SEMA4A;G6PD;NFATC4;PBX1;CALR;EFNB3;IDH2;MDM2;ARF6;ARHGEF2;SOX9;ISL1;DLX2;SEMA4B;DIXDC1;POSTN;EFNA5;PPP3CA;KDM4A
6735,GO:0030162,0.0184038777038256,0.987019991576875,67,520,regulation of proteolysis,BP,SERPINE2;TNFRSF6B;FN1;MMP9;CCBE1;CTGF;CD109;F2R;GSN;COL7A1;GAS6;TFPI2;SERPINE1;SERPINH1;TIMP2;ABTB1;BTBD2;SORL1;PRICKLE1;PYCARD;MICAL1;TIMP1;HIP1;CRIM1;GPX1;FYN;IFI6;XDH;LTBP4;CAV1;TRIB2;SNX33;CLU;SERPING1;PRDX5;CCK;HERPUD1;APLP2;FBLN1;DAPK1;DLC1;PRKACB;ROBO1;SNCA;GLG1;C5;PSMB9;MAGEF1;MDM2;CST3;GCLC;PLGRKT;PRNP;MAP2K5;LEF1;RHBDD1;OPHN1;NUB1;DERL3;PPARG;RNF144B;SNX9;PTPN3;TAF1;SERPINB5;CAMK2N1;EDEM1
16129,GO:0090177,0.0184113023671257,0.996576972963267,5,13,establishment of planar polarity involved in neural tube closure,BP,SFRP1;FZD1;VANGL2;NPHP3;CELSR1
16130,GO:0090178,0.0184113023671257,0.996576972963267,5,13,regulation of establishment of planar polarity involved in neural tube closure,BP,SFRP1;FZD1;VANGL2;NPHP3;CELSR1
3446,GO:0007259,0.0184147554482467,0.991456990346943,16,89,JAK-STAT cascade,BP,FLRT2;PKD2;FLRT3;PTK6;STAT1;FYN;CAV1;IL31RA;CTF1;IL18;IFNK;IFNE;PTPN1;ISL1;RET;STAT2
4905,GO:0014846,0.0185562769351421,1,2,2,esophagus smooth muscle contraction,BP,SULF2;SULF1
2221,GO:0005125,0.018591569453276,0.992103167428713,13,79,cytokine activity,MF,CXCL14;BMP4;IL32;TIMP1;KITLG;CTF1;C5;IL18;AREG;IFNK;IFNE;THNSL2;TGFB2
9269,GO:0035725,0.0185961813258498,0.991473182809783,16,75,sodium ion transmembrane transport,BP,PKD2;NOS1;UTRN;SLC8A1;SLC20A1;SCN8A;NETO1;SCN2A;ANO6;CAMK2D;ANK3;STOM;SLC24A1;SCNN1A;SLC9A4;PTPN3
11478,GO:0045986,0.0186323521853929,0.997331776627807,4,10,negative regulation of smooth muscle contraction,BP,DOCK5;DOCK4;RGS2;CALCRL
10141,GO:0042744,0.0186779404037395,0.997148097033242,4,12,hydrogen peroxide catabolic process,BP,GPX1;PRDX5;CAT;SNCA
14237,GO:0061326,0.0186968640183897,0.991969087330002,14,62,renal tubule development,BP,FAT4;PKD2;MAGED1;BMP4;STAT1;WWTR1;GLI3;LAMA5;PBX1;SOX9;YAP1;GDNF;KLHL3;COL4A1
4617,GO:0010742,0.0187870122713353,0.995585795065545,6,19,macrophage derived foam cell differentiation,BP,ABCA1;STAT1;ALOX15B;IL18;PPARG;ABCA5
16068,GO:0090077,0.0187870122713353,0.995585795065545,6,19,foam cell differentiation,BP,ABCA1;STAT1;ALOX15B;IL18;PPARG;ABCA5
402,GO:0001083,0.0188162659836104,0.998631169186218,3,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,TP53;TCF4;TAF1
7567,GO:0031941,0.0188195301144513,0.994817670177228,7,26,filamentous actin,CC,PKD2;PAK1;ESPN;PRKCZ;SHROOM4;FSCN1;MYO1C
17605,GO:1901342,0.0189393729293821,0.988746678443193,32,190,regulation of vasculature development,BP,CCBE1;SFRP1;TGFBR2;THBS2;SERPINE1;ANGPTL4;PTPRM;BMP4;PDCD4;STAT1;SEMA5A;GPNMB;BTG1;XDH;HMGA2;SPRY2;TLR3;SEMA4A;C5;SULF1;ENG;EGR1;ISL1;PRKCA;TGFB2;MAP2K5;SP100;ITGB8;PPARG;SASH1;ADGRA2;ADM2
4492,GO:0010522,0.0190172182828547,0.992407641241847,12,54,regulation of calcium ion transport into cytosol,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;FYN;CAV1;CAMK2D;SNCA;PDE4D;PRNP
1020,GO:0002521,0.0190216734733206,0.987637984664265,45,297,leukocyte differentiation,BP,MMP9;FBN1;INPP5D;SFRP1;CD109;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;BMP4;LGALS1;GLI3;KITLG;GLI2;DOCK11;PRKCZ;IL31RA;PIK3R1;TLR3;FZD7;SEMA4A;IL18;FZD8;SOX13;L3MBTL3;ATM;IFNK;SNX10;IFNE;CD1D;EGR1;ITPKB;BCL6;PRKCA;ANXA2;LEPR;ZFPM1;LEF1;ITM2A;RSAD2;PPARG;RARA;ZBTB1;FOS
13638,GO:0060187,0.0190825105911059,1,2,2,cell pole,CC,ASTN2;VANGL2
12655,GO:0050893,0.0191334612164406,0.99944644139205,2,3,sensory processing,BP,BBS4;TTC8
377,GO:0001010,0.019143150558701,0.996315959272486,5,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,VDR;NR1D1;THRA;PPARG;RARA
8976,GO:0035107,0.0192101018171829,0.990106322864451,21,104,appendage morphogenesis,BP,GJA5;FBN2;RNF165;BMP4;GLI3;GLI2;FBXW4;IFT140;PLXNA2;FGFR1;DKK1;PBX1;SOX9;ZNF358;MEGF8;WDR19;TGFB2;IFT122;LEF1;PBX2;NIPBL
8977,GO:0035108,0.0192101018171829,0.990106322864451,21,104,limb morphogenesis,BP,GJA5;FBN2;RNF165;BMP4;GLI3;GLI2;FBXW4;IFT140;PLXNA2;FGFR1;DKK1;PBX1;SOX9;ZNF358;MEGF8;WDR19;TGFB2;IFT122;LEF1;PBX2;NIPBL
1295,GO:0003129,0.0192199358620093,0.999442571652077,2,3,heart induction,BP,BMP4;DKK1
7053,GO:0030851,0.0192456408736723,0.996153380424647,5,16,granulocyte differentiation,BP,INPP5D;L3MBTL3;ZFPM1;LEF1;RARA
2673,GO:0006029,0.0192600361682144,0.991996224276106,13,57,proteoglycan metabolic process,BP,SULF2;CSPG4;EXTL2;B3GAT3;XYLT1;UST;CHST3;SULF1;FOXL1;HEXA;VANGL2;GAL3ST4;DSEL
1743,GO:0004345,0.0193284431143974,1,2,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD;G6PD
3494,GO:0007389,0.0193488886323291,0.987774317916561,40,250,pattern specification process,BP,SFRP1;TGFBR2;PKD2;DUSP6;BMP4;DDIT3;GLI3;GLI2;MDFI;PRKACB;IFT140;PLXNA2;FGFR1;DKK1;PBX1;ENG;BBS4;ATM;CITED2;NR2F2;POGLUT1;VANGL2;ISL1;PGAP1;TSHZ1;TTC8;MEGF8;WDR19;DLX2;IFT122;GPR161;LEF1;SSBP3;NPHP3;IFT74;GDNF;HOXA3;PBX2;MED12;CELSR1
6269,GO:0019870,0.0194270256627352,0.998568744344183,3,5,potassium channel inhibitor activity,MF,WNK1;CAV1;RASA1
7994,GO:0032633,0.0194914256596479,0.996035730326479,5,17,interleukin-4 production,BP,IL20RB;PRKCZ;ZFPM1;LEF1;RARA
5748,GO:0016903,0.0195108451252118,0.993913836155163,8,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,BCKDHB;XDH;ALDH3A2;ALDH1L2;DHTKD1;ALDH4A1;ALDH9A1;ALDH7A1
5449,GO:0016331,0.0195306579834557,0.989708034563416,22,117,morphogenesis of embryonic epithelium,BP,SFRP1;BMP4;PRICKLE1;GLI2;LAMA5;DLC1;PRKACB;SULF1;FZD1;BBS4;LMO4;VANGL2;SOX9;RET;TGFB2;IFT122;NPHP3;TGFB1I1;GDNF;RARA;MED12;CELSR1
13953,GO:0060693,0.0195365580242528,0.998304486090191,3,6,regulation of branching involved in salivary gland morphogenesis,BP,SNAI2;PDGFA;FGFR1
4353,GO:0009953,0.0195529432156127,0.992528141833644,11,49,dorsal/ventral pattern formation,BP,SFRP1;DUSP6;BMP4;DDIT3;GLI3;GLI2;MDFI;PRKACB;WDR19;IFT122;GPR161
8990,GO:0035162,0.019574044637818,0.996210698758309,5,14,embryonic hemopoiesis,BP,TGFBR2;KITLG;PBX1;ZFPM1;SH2B3
12323,GO:0048709,0.0196783979660675,0.992049942529099,12,58,oligodendrocyte differentiation,BP,SOX6;TENM4;GSN;GLI3;CLU;PRDM8;TP73;HDAC11;SOX9;DLX2;PPARG;MED12
13498,GO:0055102,0.0196793378651992,0.99800289179506,3,8,lipase inhibitor activity,MF,ANXA5;ANXA2;PINLYP
8906,GO:0034764,0.0196999536246601,0.989975111943861,20,104,positive regulation of transmembrane transport,BP,F2R;PKD2;JPH2;IRS2;CLTCL1;NOS1;TCAF1;HSPA2;GJC2;NTSR1;PAK1;WNK1;ANO6;PRKCZ;EHD3;PIK3R1;ANK3;SNCA;G6PD;C2CD5
8597,GO:0034123,0.0197268354841657,0.996936561253307,4,12,positive regulation of toll-like receptor signaling pathway,BP,FLOT1;CAV1;TLR3;RSAD2
8581,GO:0034103,0.0197415454064771,0.992873421725464,10,43,regulation of tissue remodeling,BP,INPP5D;SFRP1;EGFR;VDR;GPNMB;IL18;CST3;PRKCA;LEPR;PPP3CA
3289,GO:0006983,0.0197740649794865,0.997115131009163,4,10,ER overload response,BP,TP53;DDIT3;WFS1;HSPA5
6547,GO:0021987,0.0197983854772019,0.990602205433551,17,81,cerebral cortex development,BP,FAT4;EGFR;LAMB1;NEFL;PTPRS;EFHC1;GLI3;LRP1;FUT10;SLC38A2;BBS2;ROBO1;BBS4;SYNE2;TH;TACC2;DIXDC1
16682,GO:0097696,0.0198107443508033,0.990720989747449,16,90,STAT cascade,BP,FLRT2;PKD2;FLRT3;PTK6;STAT1;FYN;CAV1;IL31RA;CTF1;IL18;IFNK;IFNE;PTPN1;ISL1;RET;STAT2
19709,GO:2000106,0.0198330479811712,0.99231765448785,11,55,regulation of leukocyte apoptotic process,BP,IRS2;GAS6;AXL;TSC22D3;BMP4;TP53;KITLG;ITPKB;BCL6;CDKN2A;LGALS3
12484,GO:0050651,0.0199572245866077,0.99721501579115,4,9,dermatan sulfate proteoglycan biosynthetic process,BP,CSPG4;B3GAT3;UST;DSEL
12488,GO:0050655,0.0199572245866077,0.99721501579115,4,9,dermatan sulfate proteoglycan metabolic process,BP,CSPG4;B3GAT3;UST;DSEL
1663,GO:0004126,0.0199894913694928,0.997959115151635,3,8,cytidine deaminase activity,MF,APOBEC3C;APOBEC3G;APOBEC3F
18208,GO:1903039,0.0200030722405879,0.989712005473143,20,121,positive regulation of leukocyte cell-cell adhesion,BP,TGFBR2;PAK1;LGALS1;PYCARD;GLI3;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;IL18;EFNB3;CD1D;ITPKB;BCL6;IGFBP2;RARA;ZBTB1
14041,GO:0060850,0.0200184669715939,0.998245989229323,3,6,regulation of transcription involved in cell fate commitment,BP,NR2F2;DLX2;PPARG
10302,GO:0043113,0.0200227608211469,0.993834894963008,8,30,receptor clustering,BP,GSN;ETV5;DLG4;SSH1;WDR19;IFT122;AGRN;MAGI2
15496,GO:0071910,0.0200252313218789,1,2,2,determination of liver left/right asymmetry,BP,PKD2;NPHP3
7638,GO:0032060,0.0200604388642449,0.997060129866167,4,10,bleb assembly,BP,MYLK;EMP1;ANO6;EMP3
4822,GO:0014031,0.0200746081753577,0.991892970222454,12,56,mesenchymal cell development,BP,SNAI2;BMP4;KITLG;LAMA5;SEMA4A;KLHL12;SOX9;ISL1;RET;LEF1;SEMA4B;GDNF
10008,GO:0042472,0.020125003099821,0.992329307483856,11,46,inner ear morphogenesis,BP,SLITRK6;GLI2;SPRY2;LRIG3;FGFR1;MYO3B;TRIOBP;VANGL2;SOX9;HOXA1;CELSR1
15422,GO:0071774,0.0202128100061989,0.989632568467848,20,113,response to fibroblast growth factor,BP,FLRT2;CTGF;SFRP1;ZFP36L1;FAT4;DUSP6;ZFP36L2;SNAI2;SULF2;FLRT3;CPS1;RBFOX2;SPRY2;SPRY4;SNCA;FGFR1;SETX;SULF1;GCLC;POSTN
8585,GO:0034110,0.0202331376241111,0.995059256770371,6,21,regulation of homotypic cell-cell adhesion,BP,SERPINE2;LGALS1;PDPN;ANK3;PRKCA;ABAT
13241,GO:0051957,0.0204137513112984,0.998197573688849,3,6,positive regulation of amino acid transport,BP,NTSR1;CCK;ABAT
6847,GO:0030326,0.02043161778938,0.990018057317828,18,88,embryonic limb morphogenesis,BP,GJA5;FBN2;BMP4;GLI3;GLI2;FBXW4;IFT140;FGFR1;DKK1;PBX1;ZNF358;MEGF8;WDR19;TGFB2;IFT122;LEF1;PBX2;NIPBL
8979,GO:0035113,0.02043161778938,0.990018057317828,18,88,embryonic appendage morphogenesis,BP,GJA5;FBN2;BMP4;GLI3;GLI2;FBXW4;IFT140;FGFR1;DKK1;PBX1;ZNF358;MEGF8;WDR19;TGFB2;IFT122;LEF1;PBX2;NIPBL
3307,GO:0007010,0.0204344088573957,0.983978506601415,138,982,cytoskeleton organization,BP,KRT4;ITGB5;CTGF;SFRP1;RHOBTB2;SYNE1;TLN2;ASAP3;GSN;PKD2;TNIK;MAP6;DPYSL2;SPTB;CEP126;SYNE3;KRT14;S100A10;VIM;STMN3;ADD3;PAK1;NEFM;NEFL;ARAP1;CEP250;KRT13;TTLL11;CUL9;PYCARD;KRT5;EFHC1;SEMA5A;PDGFA;MAP2;MICAL1;NISCH;PPL;PHLDB1;HIP1;CUL7;CHD3;PLEK2;LIMCH1;KRT15;CTSV;PLXNB1;EML2;LRP1;ARHGAP18;UGT8;ESPN;NPHP4;PRKCZ;IQSEC2;ARPIN;KANK2;HAUS4;PXN;PIK3R1;PCLO;ANG;PARVA;LAMA5;BBS2;CNTLN;ANK3;SPRY2;TTN;SHROOM4;DLC1;CHEK2;SNCA;FRMD5;LMNA;FSCN1;RGS2;OBSCN;ARHGEF17;TRIOBP;SEPT6;AMOTL1;BBS4;CALR;MKLN1;ARF6;AKAP13;FHOD3;SYNE2;FGD4;PTPN1;VANGL2;ARHGEF2;SSH1;SOX9;BCL6;NCOR1;RGS14;RAB13;SEPT5;CEP68;GOLGA8B;PAK6;ODF2;OR2A4;AMOTL2;CDC42EP5;MSRB2;AGRN;CENPA;FLNB;UVRAG;ARHGEF19;FHOD1;TACC2;OPHN1;TPGS1;DNAH1;GOLGA8N;DIXDC1;CAPG;INF2;MEF2A;OBSL1;TMEM67;EFNA5;WIPF1;RASA1;LIMA1;CAPN6;SEPT9;ELMO2;MYH11;TTBK2;RHOBTB3;CELSR1;MYO1C;DOCK1
15620,GO:0072163,0.0204438965048486,0.991100114904958,14,63,mesonephric epithelium development,BP,SFRP1;FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;CAT;FGFR1;PBX1;SOX9;RET;GDNF;RARA
15621,GO:0072164,0.0204438965048486,0.991100114904958,14,63,mesonephric tubule development,BP,SFRP1;FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;CAT;FGFR1;PBX1;SOX9;RET;GDNF;RARA
13251,GO:0051967,0.020586683825895,0.999380120910918,2,3,negative regulation of synaptic transmission, glutamatergic,BP,PLA2G6;HTR1B
11077,GO:0045110,0.0205973689593862,0.998174951914946,3,6,intermediate filament bundle assembly,BP,KRT14;NEFM;NEFL
8687,GO:0034341,0.0206273816851693,0.989528176840672,19,121,response to interferon-gamma,BP,GSN;VIM;TRIM38;TRIM5;STAT1;OAS2;CAMK2D;DAPK1;TLR3;SNCA;IFITM2;RPL13A;RAB43;SP100;FLNB;IFITM1;NUB1;PPARG;MYO1C
5053,GO:0015267,0.0206879358817849,0.98808265080587,28,166,channel activity,MF,ANO1;GJA5;PKD2;JPH2;GAS6;ORAI3;CLCA2;GJC2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;KCNJ15;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;TMEM63C;TMEM175;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3;ORAI2
6599,GO:0022803,0.0206879358817849,0.98808265080587,28,166,passive transmembrane transporter activity,MF,ANO1;GJA5;PKD2;JPH2;GAS6;ORAI3;CLCA2;GJC2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;KCNJ15;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;TMEM63C;TMEM175;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3;ORAI2
12393,GO:0048864,0.0207011281631377,0.991588234199716,12,57,stem cell development,BP,SNAI2;BMP4;KITLG;LAMA5;SEMA4A;KLHL12;SOX9;ISL1;RET;LEF1;SEMA4B;GDNF
12635,GO:0050866,0.0207082412395764,0.989759483392223,18,103,negative regulation of cell activation,BP,SERPINE2;INPP5D;SFRP1;IL20RB;AXL;BMP4;PDGFA;GPNMB;GLI3;DLG5;IL31RA;PAG1;ATM;GCLC;BCL6;PRNP;LGALS3;ABAT
6654,GO:0030016,0.0207100250689418,0.988730752794509,24,121,myofibril,CC,MMP2;SYNE1;MYH15;TNNI2;JPH2;NOS1;SLC8A1;PLEC;PAK1;AHNAK;SCN8A;PDE4DIP;FLNC;AHNAK2;PARVA;ANK3;TTN;OBSCN;FHOD3;SYNE2;SYNC;FLNB;OBSL1;PPP3CA
9981,GO:0042416,0.0207129271968948,0.997981991513401,3,7,dopamine biosynthetic process,BP,SNCA;TGFB2;TH
14461,GO:0061900,0.0207179589738308,0.995083973274115,6,18,glial cell activation,BP,EGFR;LRP1;CLU;TLR3;SNCA;ATM
7319,GO:0031340,0.0207623849714976,0.998154550991987,3,6,positive regulation of vesicle fusion,BP,SYT1;ANXA2;C2CD5
4628,GO:0010755,0.0207732824067048,0.99797381387518,3,7,regulation of plasminogen activation,BP,SERPINE2;SERPINE1;PLGRKT
8458,GO:0033613,0.0208255551630708,0.991574473863026,12,54,activating transcription factor binding,MF,MEF2D;SDR16C5;WFS1;DGKQ;ISL1;NCOR1;ZFPM1;RBL2;YAP1;PPARG;MEF2A;FOS
2425,GO:0005607,0.0210105333227378,1,2,2,laminin-2 complex,CC,LAMB1;LAMC2
4685,GO:0010839,0.021011236391385,0.995953188216675,5,13,negative regulation of keratinocyte proliferation,BP,CD109;SNAI2;VDR;KLF9;CTSV
13654,GO:0060216,0.021031917500666,0.995849751071447,5,14,definitive hemopoiesis,BP,ZFP36L2;MFAP5;RBFOX2;TGFBR3;ZFPM1
4267,GO:0009628,0.0211073657942483,0.983848972191772,110,863,response to abiotic stimulus,BP,SERPINE2;MMP2;TXNIP;CTGF;SFRP1;ZFP36L1;NQO1;DDIT4;TGFBR2;XPC;SLITRK6;ANO1;PKD2;SCARA3;NOS1;DNAJB4;SNAI2;EGFR;TSC22D3;HSPA2;SLC8A1;MYLK;KRT14;DDB2;NTSR1;PAK1;ANGPTL4;EIF2AK4;NETO1;COL18A1;STAT1;SCN2A;KCNMA1;ETV1;TP53;KRT13;ITGA2;PPL;SIK1;GPX1;MTHFR;FYN;ADIRF;CAV1;SLC27A1;GLI2;ERCC6;MAP3K14;NPHP4;TP53INP1;HMGA2;CAMK2D;PER1;PIK3R1;SLC38A2;ANG;TTN;CIRBP;TP73;CAT;CHEK2;TLR3;MME;LMNA;PSMB9;PDK3;MYOF;SLC24A1;NFATC4;TGFBR3;ENG;ATM;MDM2;CST3;MEIS2;CITED2;GCLC;MAP3K1;ARHGEF2;EGR1;SOX9;CRTC1;NDRG1;RGS14;PRIMPOL;HOXA1;ABCC2;HTR1B;TGFB2;THRA;USP28;IGFBP2;RHBDD1;HSPA5;TH;TGFB1I1;ITPR2;YAP1;PPARG;POSTN;DNAJC3;POLH;TAF1;ZBTB1;HP1BP3;FOS;ABAT;NIPBL;OXTR;ACAA2
11727,GO:0046597,0.0211385665958324,0.996646022797526,4,12,negative regulation of viral entry into host cell,BP,GSN;TRIM5;IFITM2;IFITM1
9303,GO:0035791,0.0211840672673891,0.996987466950313,4,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFA;HIP1;LRP1;PTPN1
11278,GO:0045619,0.021208053043692,0.989721297893919,17,97,regulation of lymphocyte differentiation,BP,INPP5D;SFRP1;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;BMP4;GLI3;GLI2;PRKCZ;IL18;SOX13;ITPKB;BCL6;RARA;ZBTB1
5860,GO:0017171,0.021353241344494,0.989859849934279,16,97,serine hydrolase activity,MF,MMP2;PRSS23;HTRA1;MMP9;PCSK1;CPVL;MMP19;TYSND1;CTSV;PLA2G6;PRCP;DPP9;RHBDD1;RHBDD2;SCPEP1;CTSD
1047,GO:0002576,0.0213611884379572,0.990261472192308,15,75,platelet degranulation,BP,FN1;PCDH7;CD109;GAS6;SERPINE1;ENDOD1;ANXA5;PDGFA;TIMP1;MAGED2;CLU;SERPING1;TTN;APLP2;TGFB2
7491,GO:0031674,0.0214415037993108,0.989803541333807,17,74,I band,CC,JPH2;NOS1;SLC8A1;PAK1;SCN8A;FLNC;AHNAK2;PARVA;ANK3;TTN;OBSCN;FHOD3;SYNE2;SYNC;FLNB;OBSL1;PPP3CA
14088,GO:0060973,0.0214505714142341,0.996789478235023,4,10,cell migration involved in heart development,BP,SNAI2;FLRT3;BMP4;ENG
5513,GO:0016485,0.021506704401191,0.988105673337807,24,153,protein processing,BP,SERPINE2;CCBE1;GSN;GAS6;SERPINE1;PCSK1;PYCARD;TYSND1;GLI3;ERO1B;CTSV;CLU;SERPING1;PRKACB;MME;GLG1;C5;APH1B;MDM2;PLGRKT;PRNP;SPPL2B;RHBDD1;ADAM10
7742,GO:0032269,0.021545083804668,0.98353783000122,108,850,negative regulation of cellular protein metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;DDIT4;DUSP6;ZFP36L2;IGF2BP2;COL7A1;GAS6;TFPI2;EGFR;FLRT3;SERPINE1;SERPINH1;CRTAP;TIMP2;BMP4;PTK6;EIF2AK4;PDCD4;SORL1;WWTR1;PYCARD;WNK1;ZCCHC11;MICAL1;ADARB1;TIMP1;CRIM1;ELFN2;GPX1;CTDSPL;FYN;IFI6;XDH;CAV1;PIAS3;TRIB2;SERPING1;PRKCZ;SDR16C5;PRDX5;PER1;CAPRIN2;ANG;DUSP5;HERPUD1;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;SPRY4;PAIP2B;SNCA;GLG1;IGF1R;DKK1;RGS2;C5;PDE4D;G6PD;KDM4C;ENG;CALR;MDM2;CST3;DGKQ;GCLC;NR2F2;PTPN1;ENPP1;NCOR1;ANXA2;RGS14;RPL13A;PRNP;MAP2K5;LEF1;CDKN2A;OPHN1;ATRAID;DERL3;PPARG;BEX4;UNK;PTPN3;DNAJC3;RARA;TAF1;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;TAOK3
7197,GO:0031099,0.0216240701923832,0.988806294217691,20,117,regeneration,BP,TGFBR2;GSN;GAS6;SULF2;AXL;EGFR;NEFL;PTPRS;GPX1;GLI3;FZD7;PTPRU;TGFBR3;ISL1;PRPS2;ULK1;PPARG;POSTN;PTPN3;LAMB2
1291,GO:0003105,0.021652387509974,0.99932976963466,2,3,negative regulation of glomerular filtration,BP,F2R;GJA5
14651,GO:0070293,0.0216937018383265,0.996529994849619,4,12,renal absorption,BP,GSN;GAS6;MAGED2;KLHL3
12965,GO:0051403,0.0217807104906003,0.986871703554099,32,204,stress-activated MAPK cascade,BP,CTGF;SFRP1;GADD45B;ZFP36L1;TNIK;EGFR;MAP3K6;PAK1;PDCD4;PYCARD;XDH;ERCC6;PER1;TP73;TLR3;FZD7;IGF1R;DKK1;EDA2R;FZD8;PTPN1;VANGL2;NRK;NCOR1;MAP3K12;TGFB2;CDC42EP5;MAPK8IP3;MDFIC;SASH1;FZD4;TAOK3
2296,GO:0005267,0.021814489288425,0.993023633027268,8,35,potassium channel activity,MF,PKD2;KCNMA1;KCNAB2;KCNJ15;KCNJ5;KCNQ3;TMEM175;KCNIP3
18808,GO:1904427,0.0218991931007356,0.992468421573581,9,38,positive regulation of calcium ion transmembrane transport,BP,F2R;PKD2;JPH2;HSPA2;GJC2;NTSR1;EHD3;SNCA;G6PD
13205,GO:0051897,0.0219468038460425,0.989397393946234,17,87,positive regulation of protein kinase B signaling,BP,IRS2;GAS6;AXL;EGFR;SEMA5A;PDGFA;HIP1;GPX1;KITLG;FYN;MST1R;PIK3R1;SPRY2;FGFR1;IL18;ENG;MEIS3
7305,GO:0031325,0.0219492321484962,0.981670357739129,265,2168,positive regulation of cellular metabolic process,BP,FLOT1;FN1;MMP9;CCBE1;CTGF;SOX6;ITGA6;SFRP1;GADD45B;CDKN2B;ZFP36L1;F2R;TGFBR2;TNNI2;GSN;ETV5;PKD2;IRS2;DUSP6;ZFP36L2;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;SESN3;RFX2;SERPINE1;VIM;NUPR1;CSPG4;MAP3K6;NTSR1;TIMP2;TADA3;PAK1;NSG1;VDR;BMP4;NR1D1;SMARCA2;PTK6;CITED4;EIF2AK4;TRIM5;VAV3;NR3C1;STAT1;ETV1;TP53;ARAP1;WWTR1;PRICKLE1;DDIT3;PYCARD;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;PDGFA;RBMS3;ACSL3;HIP1;GPNMB;TFDP2;NFIX;GLI3;E2F7;CNTN1;KITLG;TBC1D5;ABHD14B;ZFP90;SESN1;LRP1;FYN;XDH;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;SMARCA1;ZNF318;CLU;PRKCZ;SDR16C5;TP53INP1;HMGA2;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;HERPUD1;WFS1;SPRY2;CIRBP;JARID2;FBLN1;TP73;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;PHF2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;SETX;NCOA2;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;MDM2;FAM20A;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;LMO4;MAF;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;MYBL1;ANXA2;TRERF1;HLTF;HOXA1;METTL23;IGFBP4;TCF12;HMBOX1;NFAT5;PAK6;NAB2;MAP3K12;IRF2BPL;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;GPR161;LEF1;THRA;SSBP3;MAPK8IP3;SP100;ULK1;TEF;AGRN;VAV2;RHBDD1;MAGI2;HSPA5;TGFB1I1;UVRAG;MDFIC;VPS13C;FHOD1;IFT74;YAP1;GDNF;NUB1;KLF5;MEIS3;AGPAT1;PPARG;RNF144B;MEF2A;KLF7;SNX9;SASH1;DNAJC3;RARA;CCNY;PBX2;PRKAG1;TAF1;EFNA5;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;FAM168A;MED12;NPAS2;ABAT;NIPBL;LITAF;RXRA;EDEM1;TAOK3
9686,GO:0038108,0.0219910750892348,0.999313468741879,2,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2;BBS4
3201,GO:0006837,0.0220109243587235,0.997998047365157,3,6,serotonin transport,BP,NOS1;SNCA;HTR1B
12494,GO:0050661,0.0221498811661202,0.992871271849784,8,36,NADP binding,MF,H6PD;NOS1;TP53I3;MTHFR;CAT;G6PD;DECR1;DPYD
633,GO:0001823,0.0221955931294035,0.990216238083599,14,64,mesonephros development,BP,SFRP1;FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;CAT;FGFR1;PBX1;SOX9;RET;GDNF;RARA
7095,GO:0030902,0.0222178521169053,0.989268913170222,17,85,hindbrain development,BP,SERPINE2;TRNP1;PAK1;PTPRS;CNTN1;GLI2;RBFOX2;DLC1;AARS;PLXNA2;NAGLU;LEF1;HSPA5;OPHN1;FZD4;ABAT;TTBK2
15633,GO:0072182,0.0222313089164314,0.996789691060268,4,9,regulation of nephron tubule epithelial cell differentiation,BP,FAT4;STAT1;WWTR1;YAP1
15096,GO:0071216,0.0222406204127674,0.988229639756979,21,127,cellular response to biotic stimulus,BP,TXNIP;AXL;SERPINE1;ABCA1;VDR;NR1D1;TRIM5;PDCD4;TP53;DDIT3;PYCARD;WFS1;PDE4D;IL18;PRKCA;ABCC2;HSPA5;CDK19;SASH1;RARA;LITAF
7860,GO:0032432,0.0223236094287038,0.991311311844861,11,48,actin filament bundle,CC,ROR1;MYLK;MST1R;PXN;SHROOM4;FSCN1;VANGL2;FLNB;FHOD1;LIMA1;SEPT9
14867,GO:0070696,0.0223637039489433,0.996486581475685,4,11,transmembrane receptor protein serine/threonine kinase binding,MF,BMP4;PYCARD;TGFB2;MAGI2
14057,GO:0060911,0.0224082151158001,0.997748657567454,3,7,cardiac cell fate commitment,BP,TENM4;DKK1;ISL1
6540,GO:0021965,0.022464143890155,1,2,2,spinal cord ventral commissure morphogenesis,BP,ADARB1;GLI2
6304,GO:0019955,0.0225838800043599,0.990662338278143,12,60,cytokine binding,MF,CD109;TGFBR2;IL20RB;LTBP1;PDPN;LTBP4;CXCR1;IL31RA;LTBP3;TGFBR3;ENG;FZD4
8952,GO:0035050,0.0225958539124579,0.991209024415884,11,47,embryonic heart tube development,BP,TGFBR2;GJA5;PKD2;ENG;BBS4;CITED2;VANGL2;MEGF8;IFT122;NPHP3;YAP1
16462,GO:0097187,0.0227039994581442,0.999278690402837,2,3,dentinogenesis,BP,HTRA1;SERPINE1
9856,GO:0042135,0.0227590071144388,0.996404716594781,4,11,neurotransmitter catabolic process,BP,GLDC;LRTOMT;ALDH7A1;ABAT
9358,GO:0035902,0.022784070954306,0.995237811220226,5,16,response to immobilization stress,BP,SLC8A1;MDM2;TH;PPARG;FOS
3280,GO:0006970,0.0228013889024126,0.991006301787487,11,53,response to osmotic stress,BP,ZFP36L1;PKD2;EGFR;TSC22D3;MYLK;SCN2A;KCNMA1;ITGA2;TLR3;ARHGEF2;TH
13989,GO:0060740,0.0228292824680418,0.99445754065127,6,18,prostate gland epithelium morphogenesis,BP,SFRP1;BMP4;GLI2;SULF1;SOX9;RXRA
10363,GO:0043207,0.0229194733982675,0.983717037020438,65,521,response to external biotic stimulus,BP,TNFRSF6B;HTRA1;F2R;DDIT4;HERC5;NOS1;AXL;ACTA2;SERPINE1;TKFC;IFI44L;ABCA1;VDR;APOBEC3C;NR1D1;EIF2AK4;TRIM5;PDCD4;STAT1;IFIT2;PYCARD;IFIT1;DDX60;ADARB1;IFIT3;GPX1;PTGES;SEC14L1;CPS1;CAV1;PLA2G6;MAP3K14;CLU;OAS2;HMGA2;MST1R;IL31RA;TMEM173;APOBEC3G;TLR3;SNCA;APOBEC3F;PDE4D;IL18;IFNK;IFNE;CD1D;IFI44;LYST;PRKCA;IFITM2;ABCC2;STAT2;CDK19;TH;RSAD2;IFITM1;SRR;SASH1;DNAJC3;RARA;WIPF1;FOS;LITAF;GBP3
13113,GO:0051707,0.0229194733982675,0.983717037020438,65,521,response to other organism,BP,TNFRSF6B;HTRA1;F2R;DDIT4;HERC5;NOS1;AXL;ACTA2;SERPINE1;TKFC;IFI44L;ABCA1;VDR;APOBEC3C;NR1D1;EIF2AK4;TRIM5;PDCD4;STAT1;IFIT2;PYCARD;IFIT1;DDX60;ADARB1;IFIT3;GPX1;PTGES;SEC14L1;CPS1;CAV1;PLA2G6;MAP3K14;CLU;OAS2;HMGA2;MST1R;IL31RA;TMEM173;APOBEC3G;TLR3;SNCA;APOBEC3F;PDE4D;IL18;IFNK;IFNE;CD1D;IFI44;LYST;PRKCA;IFITM2;ABCC2;STAT2;CDK19;TH;RSAD2;IFITM1;SRR;SASH1;DNAJC3;RARA;WIPF1;FOS;LITAF;GBP3
8482,GO:0033673,0.0230207882386488,0.986038052595492,32,213,negative regulation of kinase activity,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CDKN2B;IRS2;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;ADARB1;CAV1;TRIB2;DUSP5;SPRY2;TP73;SPRY4;IGF1R;RGS2;NR2F2;PTPN1;RGS14;CDKN2A;DNAJC3;CDK5RAP3;CAMK2N1;TAOK3
15783,GO:0072511,0.0230312755507096,0.985434922351669,38,241,divalent inorganic cation transport,BP,CTGF;F2R;PKD2;JPH2;NOS1;GAS6;HSPA2;SLC8A1;ORAI3;MYLK;GJC2;NTSR1;VDR;AHNAK;DDIT3;ANO6;FYN;CAV1;PLA2G6;EHD3;CAMK2D;WFS1;SNCA;PDE4D;G6PD;SLC24A1;ANXA6;ABCC2;SLC39A11;PRNP;ITPR2;CACNB1;CALCRL;LGALS3;PPP3CA;CACNA2D3;TUSC3;ORAI2
1201,GO:0002862,0.0231573516304541,0.998959748154453,2,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB;GPX1
4683,GO:0010837,0.0231986724374699,0.993419642108181,7,24,regulation of keratinocyte proliferation,BP,CD109;ZFP36L1;SNAI2;VDR;KLF9;CTSV;YAP1
13665,GO:0060244,0.0232400889491143,0.999252126286069,2,3,negative regulation of cell proliferation involved in contact inhibition,BP,PAK1;SRPX
11558,GO:0046135,0.0232443440345131,0.996045689522189,4,14,pyrimidine nucleoside catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F;DPYD
16005,GO:0086064,0.0233178443496294,0.995096009981049,5,16,cell communication by electrical coupling involved in cardiac conduction,BP,GJA5;SLC8A1;CAV1;CAMK2D;PDE4D
19934,GO:2000516,0.0233392773593124,0.996095466062301,4,13,positive regulation of CD4-positive, alpha-beta T cell activation,BP,TGFBR2;PRKCZ;IL18;RARA
13639,GO:0060191,0.0233547518144489,0.991266964976792,10,46,regulation of lipase activity,BP,EGFR;ANGPTL4;LRP1;PRKCZ;ANG;SNCA;FGFR1;RGS2;PLA2R1;LMF1
17006,GO:0099512,0.0233720975405875,0.982675938045419,86,591,supramolecular fiber,CC,MMP2;KRT4;FBN1;SYNE1;MYH15;TNNI2;COL5A2;PKD2;JPH2;NOS1;FBN2;MAP6;COL5A1;DPYSL2;SLC8A1;KRT14;VIM;MFAP5;PLEC;PAK1;NEFM;AHNAK;SCN8A;NEFL;KRT13;TTLL11;LTBP1;KRT5;TCP11L1;MAP2;MICAL1;FLG;KRT15;PDE4DIP;EML2;KCNAB2;FYN;FLNC;ESPN;AHNAK2;PRKCZ;PARP4;HAUS4;KIF17;PARVA;ANK3;SPRY2;TTN;CASP14;SHROOM4;SNCA;THSD4;LMNA;FSCN1;OBSCN;PBXIP1;CST3;AKAP13;FHOD3;SYNE2;ARHGEF2;DNAL4;COL5A3;SYNC;KRT222;NCOR1;NDRG1;RGS14;ODF2;REEP2;FLNB;TPGS1;DNAH1;BEX4;ADAMTSL5;OBSL1;ARL3;WIPF1;PPP3CA;KRT10;CAPN6;SEPT9;KLHL22;CDK5RAP3;MYH11;MYO1C
2370,GO:0005501,0.0234132184973711,0.996268193977847,4,11,retinoid binding,MF,NR2F2;UGT1A3;RARA;RXRA
7170,GO:0031063,0.0234464609802029,0.994074032816968,6,21,regulation of histone deacetylation,BP,TADA3;TP53;SDR16C5;CAMK2D;BCL6;NIPBL
5379,GO:0016209,0.0236338966239422,0.991497631560738,9,52,antioxidant activity,MF,NQO1;PTGS1;GPX1;SESN1;TP53INP1;PRDX5;CAT;GPX8;GSTZ1
12518,GO:0050691,0.0237915056852052,0.993002385876314,7,29,regulation of defense response to virus by host,BP,EIF2AK4;STAT1;PYCARD;IFIT1;TMEM173;APOBEC3G;APOBEC3F
18066,GO:1902722,0.023881069278105,0.999219904738281,2,3,positive regulation of prolactin secretion,BP,EGFR;ABAT
6026,GO:0019098,0.0239965457881587,0.994843129014161,5,17,reproductive behavior,BP,SERPINE2;THRA;TH;CREBRF;OXTR
18181,GO:1902996,0.024006662195956,1,2,2,regulation of neurofibrillary tangle assembly,BP,SORL1;CLU
12605,GO:0050819,0.0240255073144577,0.992826413605741,7,32,negative regulation of coagulation,BP,SERPINE2;SERPINE1;ANXA5;PDGFA;SERPING1;ANXA2;ABAT
6459,GO:0021795,0.0241215313044754,0.992301472654234,8,30,cerebral cortex cell migration,BP,EGFR;LAMB1;EFHC1;GLI3;FUT10;ROBO1;SYNE2;DIXDC1
4618,GO:0010743,0.0241286386951225,0.994961994360961,5,15,regulation of macrophage derived foam cell differentiation,BP,ABCA1;ALOX15B;IL18;PPARG;ABCA5
7630,GO:0032051,0.024176080748304,0.998056234238075,3,5,clathrin light chain binding,MF,CLTCL1;NSG1;HIP1
7578,GO:0031957,0.0242901771405593,0.997481033251953,3,7,very long-chain fatty acid-CoA ligase activity,MF,SLC27A3;SLC27A1;SLC27A6
12776,GO:0051097,0.0243068333537521,0.999198227329721,2,3,negative regulation of helicase activity,BP,TP53;IFIT1
19071,GO:1905005,0.0243742410978713,0.997691717432519,3,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2;ENG;TGFB2
357,GO:0000976,0.0243851381538621,0.982413842126795,71,493,transcription regulatory region sequence-specific DNA binding,MF,SOX6;ETV5;PHF21A;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;GLI2;SLC2A4RG;TNRC18;HMGA2;PER1;CREB3L2;JARID2;TP73;KLF13;SETX;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;LMO4;EGR1;SOX9;ISL1;BCL6;PLAG1;SALL2;MYBL1;HLTF;BAHCC1;TCF12;NFAT5;CARF;ZFPM1;DLX2;LEF1;THRA;SSBP3;TEF;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;PRDM5;LITAF;RXRA
14017,GO:0060795,0.0243896245919288,0.994735851023546,5,17,cell fate commitment involved in formation of primary germ layer,BP,DUSP6;BMP4;FZD7;FGFR1;DKK1
9832,GO:0042095,0.0245010119947608,0.997450503534222,3,7,interferon-gamma biosynthetic process,BP,TLR3;IL18;ZFPM1
3240,GO:0006898,0.024526750540671,0.985788170175436,27,165,receptor-mediated endocytosis,BP,FLOT1;TGFBR2;SCARA3;CLTCL1;SERPINE1;SORL1;DLG4;HIP1;SNX1;TBC1D5;LRP1;CAV1;CLU;CXCR1;SNCA;DKK1;PLA2R1;CALR;ARF6;DNAJC6;ENPP1;ANXA2;HTR1B;MAGI2;CALCRL;SNX9;DNM1P46
13438,GO:0055001,0.0245470294364703,0.987771554677318,18,86,muscle cell development,BP,SLC8A1;PAK1;BMP4;GPX1;FLNC;TTN;LMNA;OBSCN;G6PD;NFATC4;ENG;AKAP13;FHOD3;LEF1;MEF2A;OBSL1;PPP3CA;MYH11
3397,GO:0007179,0.0246009980736476,0.986495325043713,23,128,transforming growth factor beta receptor signaling pathway,BP,HTRA1;ITGB5;FBN1;CD109;CDKN2B;TGFBR2;FBN2;PEG10;LTBP1;ITGA3;LTBP4;CAV1;PRKCZ;PXN;GLG1;TGFBR3;ENG;MTMR4;CITED2;TGFB2;HSPA5;TGFB1I1;FOS
3747,GO:0008289,0.0246204724864785,0.982538015549615,64,450,lipid binding,MF,SYT8;SULT1E1;PITPNM3;JPH2;PIK3C2G;OSBPL10;PROM2;GAS6;AXL;HSPA2;ANXA5;ABCA1;VDR;HS1BP3;NR3C1;ARAP1;SEC14L2;NISCH;HIP1;SNX1;PLEK2;PAQR8;ASAP1;CPS1;CAV1;SNX33;OSBPL5;SNX29;SYTL1;SYT1;PCLO;DYSF;DLC1;SNCA;FZD7;PAQR7;ALOX15B;ESYT2;MYOF;ANXA6;SNX10;NR2F2;CD1D;ANXA2;MVB12B;C2CD4C;OSBPL1A;AGAP1;SNX7;ITPR2;UGT1A3;SAP30L;OPHN1;PITPNC1;PPARG;SNX9;APOL6;RARA;MPPE1;PIK3C2B;SBF2;VPS36;RXRA;C2CD5
715,GO:0001941,0.0247219064150947,0.993673210770866,6,21,postsynaptic membrane organization,BP,ETV5;DLG4;SSH1;NLGN4Y;MAGI2;GDNF
7858,GO:0032430,0.0247324758375596,0.99917633862622,2,3,positive regulation of phospholipase A2 activity,BP,EGFR;ANG
9982,GO:0042417,0.0247467831874581,0.99463794858006,5,17,dopamine metabolic process,BP,SNCA;LRTOMT;TGFB2;TH;ABAT
11253,GO:0045582,0.0248358547411062,0.991163710595857,9,42,positive regulation of T cell differentiation,BP,TGFBR2;GLI3;GLI2;PRKCZ;IL18;ITPKB;BCL6;RARA;ZBTB1
15983,GO:0086023,0.0249694540396715,0.998584492067069,3,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1;PDE4D;AKAP13
13056,GO:0051592,0.0249959123884208,0.988029858424523,16,82,response to calcium ion,BP,TXNIP;PKD2;EGFR;KCNMA1;WNK1;PTGES;CAV1;CAMK2D;SYT1;TTN;ITPKB;CARF;HSPA5;MEF2A;PPP3CA;FOS
3287,GO:0006979,0.0250791383905951,0.983497957548909,43,320,response to oxidative stress,BP,MMP9;PRODH;TXNIP;NQO1;PTGS1;ETV5;PKD2;SCARA3;AXL;EGFR;SLC8A1;SESN3;STAT1;TP53;SLC7A11;BTG1;GPX1;SESN1;ERCC6;TP53INP1;PRDX5;PXN;CAT;DAPK1;SNCA;SETX;PLA2R1;G6PD;CHD6;FZD1;MDM2;CST3;AREG;GCLC;PXMP2;RGS14;ABCC2;PRNP;GGT7;MSRB2;NAPRT;GPX8;FOS
5343,GO:0016101,0.0250975628732256,0.990481086269133,10,47,diterpenoid metabolic process,BP,EGFR;SDC3;LRP1;SDR16C5;ALDH3A2;SDC2;CYP4V2;AGRN;UGT1A3;SCPEP1
14784,GO:0070542,0.0251349027757619,0.989951682831068,11,52,response to fatty acid,BP,CTGF;SFRP1;GNG2;CPS1;GLDC;CPT1A;CAT;PDK3;NFATC4;TGFBR3;PPARG
8231,GO:0033017,0.0251435203665792,0.993673404081275,6,19,sarcoplasmic reticulum membrane,CC,JPH2;NOS1;CAMK2D;SYNE2;ITPR2;DMPK
4874,GO:0014741,0.0251683354229603,0.994684799364054,5,15,negative regulation of muscle hypertrophy,BP,PAK1;JARID2;LMNA;RGS2;G6PD
6371,GO:0021563,0.0251729370611994,1,2,2,glossopharyngeal nerve development,BP,NAV2;HOXA3
16499,GO:0097252,0.0252064397852347,0.9991517107419,2,3,oligodendrocyte apoptotic process,BP,GAS6;TP53
1180,GO:0002828,0.0252097074578986,0.994386653444777,5,19,regulation of type 2 immune response,BP,PRKCZ;IL18;BCL6;RSAD2;RARA
13542,GO:0060038,0.0252122234372755,0.991843714443414,8,31,cardiac muscle cell proliferation,BP,TGFBR2;TENM4;JARID2;TP73;FGFR1;TGFBR3;TGFB2;RXRA
9815,GO:0042058,0.0252391227915367,0.988922025791643,13,69,regulation of epidermal growth factor receptor signaling pathway,BP,MMP9;GPRC5A;EGFR;DOK1;PTK6;ARAP1;HIP1;ITGA1;SPRY2;AFAP1L2;CDH13;MVB12B;PTPN3
19949,GO:2000553,0.0252913387545886,0.999147271103561,2,3,positive regulation of T-helper 2 cell cytokine production,BP,PRKCZ;RSAD2
7406,GO:0031507,0.02533777829395,0.99600196000885,4,10,heterochromatin assembly,BP,TNRC18;HMGA2;BAHCC1;CDKN2A
17311,GO:1900024,0.025367012872919,0.990989186245789,9,40,regulation of substrate adhesion-dependent cell spreading,BP,DOCK5;S100A10;PDPN;FBLN1;TRIOBP;CALR;POSTN;EFNA5;DOCK1
15392,GO:0071692,0.0253915426394146,0.997917708861338,3,5,protein localization to extracellular region,BP,FBN1;FBN2;LTBP1
15393,GO:0071694,0.0253915426394146,0.997917708861338,3,5,maintenance of protein location in extracellular region,BP,FBN1;FBN2;LTBP1
14239,GO:0061337,0.0256196645978174,0.988454014113597,14,66,cardiac conduction,BP,GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;KCNJ5;PDE4D;ITPR2;CACNB1;KCNIP3;MEF2A;CACNA2D3;DMPK
11763,GO:0046649,0.0256579514837102,0.982301172482192,54,390,lymphocyte activation,BP,INPP5D;SFRP1;ZFP36L1;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;GAS6;AXL;PAK1;BMP4;EIF2AK4;VAV3;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;DOCK11;MAP3K14;PRKCZ;ULBP1;PIK3R1;BTN3A1;FLOT2;FZD7;PAG1;SEMA4A;IL18;FZD8;SOX13;ATM;EFNB3;IFNK;IFNE;CD1D;EGR1;ITPKB;BCL6;LEPR;PRNP;ZFPM1;LEF1;ITM2A;IGFBP2;RSAD2;LGALS3;RARA;ZBTB1;PPP3CA
13792,GO:0060415,0.025671465024745,0.989977669390276,11,41,muscle tissue morphogenesis,BP,MYLK;ADARB1;TTN;TGFBR3;FZD1;ENG;VANGL2;ISL1;ZFPM1;TGFB2;RXRA
4495,GO:0010528,0.0257102314255075,0.995662101872711,4,12,regulation of transposition,BP,APOBEC3C;APOBEC3G;APOBEC3F;MYBL1
4496,GO:0010529,0.0257102314255075,0.995662101872711,4,12,negative regulation of transposition,BP,APOBEC3C;APOBEC3G;APOBEC3F;MYBL1
6845,GO:0030324,0.0257976166787198,0.986244626130774,21,110,lung development,BP,CCBE1;CTGF;TGFBR2;EGFR;BMP4;PDGFA;ITGA3;GLI3;DLG5;PDPN;GLI2;LAMA5;SPRY2;FGFR1;VANGL2;SOX9;LIPA;THRA;NPHP3;YAP1;CELSR1
15665,GO:0072224,0.0257977752432228,0.99750105365052,3,6,metanephric glomerulus development,BP,EGR1;RET;LAMB2
6118,GO:0019371,0.0258625195353986,0.997250755948611,3,7,cyclooxygenase pathway,BP,PTGS1;PTGES;CBR1
10877,GO:0044441,0.0259133799853351,0.983154078196832,41,269,ciliary part,CC,PTGS1;PKD2;PROM2;CEP126;EVC;CNTRL;EFHC1;WDR66;GLI3;DLG5;GLI2;SPATA6;NPHP4;EHD3;KIF17;BBS2;PRKACB;IFT140;DZIP1L;SEPT6;BBS4;BBS1;IFT27;IFT88;TTC8;SPA17;WDR19;ODF2;SCNN1A;IFT122;GPR161;NPHP3;TCTEX1D4;CFAP54;IFT74;DNAH1;ICK;ARL3;TMEM67;SEPT9;TTBK2
18499,GO:1903708,0.0259606854493101,0.986536359599455,19,112,positive regulation of hemopoiesis,BP,INPP5D;ZFP36L1;TGFBR2;GAS6;AXL;FAM210B;STAT1;GLI3;KITLG;GLI2;PRKCZ;IL18;ITPKB;BCL6;PRKCA;LEF1;RARA;ZBTB1;FOS
2396,GO:0005543,0.025966680771014,0.982773143372537,45,293,phospholipid binding,MF,SYT8;JPH2;PIK3C2G;OSBPL10;GAS6;AXL;ANXA5;ABCA1;HS1BP3;ARAP1;SEC14L2;NISCH;HIP1;SNX1;PLEK2;ASAP1;CPS1;SNX33;OSBPL5;SNX29;SYTL1;SYT1;PCLO;DYSF;SNCA;FZD7;ESYT2;MYOF;ANXA6;SNX10;ANXA2;C2CD4C;OSBPL1A;AGAP1;SNX7;ITPR2;SAP30L;OPHN1;PITPNC1;SNX9;MPPE1;PIK3C2B;SBF2;VPS36;C2CD5
15960,GO:0085029,0.0260003631778405,0.992443210782395,7,24,extracellular matrix assembly,BP,GAS6;EFEMP2;PHLDB1;LAMC2;THSD4;SOX9;MYH11
4457,GO:0010454,0.0260808177368648,0.999105579604322,2,3,negative regulation of cell fate commitment,BP,FZD7;DKK1
7198,GO:0031100,0.0260993588515132,0.989449713832524,11,55,animal organ regeneration,BP,TGFBR2;GAS6;SULF2;AXL;EGFR;GLI3;PTPRU;TGFBR3;PRPS2;PPARG;PTPN3
1326,GO:0003179,0.0261097166913207,0.992466629533116,7,23,heart valve morphogenesis,BP,TGFBR2;GJA5;BMP4;MDM2;SOX9;ZFPM1;TGFB2
539,GO:0001658,0.0261190827998369,0.990793124216827,9,36,branching involved in ureteric bud morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;PBX1;SOX9;GDNF
10366,GO:0043217,0.0261357953998452,0.994814192497462,5,12,myelin maintenance,BP,AHNAK2;CLU;PRX;SH3TC2;NDRG1
4643,GO:0010770,0.0262240474259632,0.985992742624046,21,110,positive regulation of cell morphogenesis involved in differentiation,BP,FN1;DOCK5;S100A10;PAK1;NEFL;SEMA5A;CUL7;PLXNB1;CAPRIN2;METRN;ROBO1;PLXNA2;TRIOBP;CALR;PLXNA1;TRAK1;FBXW8;MEGF8;OBSL1;EFNA5;DOCK1
8115,GO:0032816,0.026279735251366,0.995535167765263,4,12,positive regulation of natural killer cell activation,BP,GAS6;AXL;IL18;ZBTB1
2271,GO:0005216,0.0263773334721024,0.984819806836793,26,151,ion channel activity,MF,ANO1;PKD2;JPH2;GAS6;ORAI3;CLCA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;KCNJ15;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;TMEM63C;TMEM175;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3;ORAI2
3187,GO:0006813,0.0263815458027217,0.986635274188105,18,97,potassium ion transport,BP,GJA5;PKD2;NOS1;NETO1;KCNMA1;ANO6;KCNAB2;CAV1;KCNJ15;ANK3;KCNJ5;KCNQ3;TMEM175;PRNP;FHL1;SLC9A4;KCNIP3;KCNRG
679,GO:0001890,0.0264075669351992,0.986051632307286,20,114,placenta development,BP,HTRA1;ZFP36L1;PKD2;EGFR;VDR;CUL7;E2F7;CTSV;ANG;MDFI;DLX3;NR2F2;FBXW8;NRK;ETNK2;STOX2;LEF1;ITGB8;PPARG;RXRA
17358,GO:1900115,0.0264283768812987,0.995622767528646,4,11,extracellular regulation of signal transduction,BP,FBN1;FBN2;LTBP1;DKK1
17359,GO:1900116,0.0264283768812987,0.995622767528646,4,11,extracellular negative regulation of signal transduction,BP,FBN1;FBN2;LTBP1;DKK1
6072,GO:0019229,0.0265557277115738,0.992089638739009,7,27,regulation of vasoconstriction,BP,F2R;GJA5;EGFR;DOCK5;DOCK4;CAV1;OXTR
8988,GO:0035148,0.0265622868859469,0.985762075071444,21,114,tube formation,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;TGM2;FZD1;BBS4;LMO4;VANGL2;SOX9;HOXA1;PODXL;RET;TGFB2;IFT122;NPHP3;GDNF;RARA;MED12;CELSR1
13088,GO:0051651,0.0265737555693937,0.987551204245859,15,74,maintenance of location in cell,BP,SYNE1;TLN2;GSN;SYNE3;SORL1;CAV1;ANK3;BBS4;SYNE2;TAF8;SP100;HSPA5;FLNB;UVRAG;VPS13C
11753,GO:0046635,0.0265763805237916,0.992918179743695,6,24,positive regulation of alpha-beta T cell activation,BP,TGFBR2;GLI3;PRKCZ;IL18;ITPKB;RARA
5113,GO:0015459,0.0266492896488234,0.99205580741721,7,27,potassium channel regulator activity,MF,WNK1;KCNAB2;CAV1;PIAS3;PRKCZ;KCNIP3;RASA1
15436,GO:0071804,0.0266638375600477,0.987116249476401,16,83,cellular potassium ion transport,BP,PKD2;NETO1;KCNMA1;ANO6;KCNAB2;CAV1;KCNJ15;ANK3;KCNJ5;KCNQ3;TMEM175;PRNP;FHL1;SLC9A4;KCNIP3;KCNRG
15437,GO:0071805,0.0266638375600477,0.987116249476401,16,83,potassium ion transmembrane transport,BP,PKD2;NETO1;KCNMA1;ANO6;KCNAB2;CAV1;KCNJ15;ANK3;KCNJ5;KCNQ3;TMEM175;PRNP;FHL1;SLC9A4;KCNIP3;KCNRG
6338,GO:0021520,0.026672470520588,0.997381677288734,3,6,spinal cord motor neuron cell fate specification,BP,GLI3;GLI2;ISL1
9895,GO:0042249,0.0267371375365429,0.99437071267392,5,14,establishment of planar polarity of embryonic epithelium,BP,SFRP1;FZD1;VANGL2;NPHP3;CELSR1
12636,GO:0050867,0.0267926187243075,0.984288140963822,27,181,positive regulation of cell activation,BP,CTGF;INPP5D;TGFBR2;IRS2;GAS6;AXL;PAK1;VAV3;LGALS1;PYCARD;GLI3;PDPN;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;IL18;EFNB3;CD1D;ITPKB;BCL6;IGFBP2;RARA;ZBTB1
616,GO:0001786,0.0268331694110304,0.991989238287282,7,27,phosphatidylserine binding,MF,JPH2;OSBPL10;GAS6;AXL;ASAP1;OSBPL5;SYT1
16824,GO:0098772,0.0268344180526436,0.978639131382822,142,1135,molecular function regulator,MF,SERPINE2;PHACTR3;FN1;FLRT2;TXNIP;CTGF;FBN1;CD109;CDKN2B;EFEMP1;ASAP3;IRS2;COL7A1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;ARHGAP23;TFPI2;DOCK9;EGFR;FLRT3;SPTB;DOCK5;SERPINE1;SERPINH1;ANXA5;ALS2CL;ASAP2;TIMP2;CXCL14;ANGPTL4;CHN2;SRGAP3;BMP4;TBC1D8;RIN2;NEFL;VAV3;ARAP1;PYCARD;IL32;WNK1;PLEKHG3;ARHGEF1;DLG4;PDGFA;TIMP1;GPNMB;DOCK4;CRIM1;EVI5L;ELFN2;KITLG;TBC1D5;ASAP1;SEC14L1;PLXNB1;KCNAB2;FYN;ARHGEF12;B3GAT3;ARHGAP18;CAV1;PIAS3;ERCC6;TRIB2;DOCK11;SERPING1;PRKCZ;IQSEC2;CAMK2D;PRDX5;CCK;PIK3R1;SPRY2;APLP2;HPS4;FBLN1;DLC1;SNCA;FGFR1;DKK1;CTF1;SEMA4A;RGS2;C5;IL18;OBSCN;ARHGEF17;AFAP1L2;SRGAP1;FAM20A;CST3;TBC1D19;AREG;IFNK;AKAP13;DGKQ;IFNE;FGD4;ARHGEF2;THNSL2;UCN2;ANXA2;RGS14;DEPDC7;RET;TGFB2;LEF1;CDC42EP5;CDKN2A;VAV2;AGAP1;GOPC;SEMA4B;ARHGEF19;ARHGAP29;OPHN1;MYO9A;GDNF;RALGAPB;KCNIP3;TBC1D16;LGALS3;PTPN3;DNAJC3;CCNY;PRKAG1;EFNA5;SBF2;RASA1;ARHGAP31;SERPINB5;CAMK2N1;ADM2;PPP2R3A;TAOK3;DOCK1;DMPK;PINLYP
9022,GO:0035254,0.0268596076100785,0.99124563109365,8,30,glutamate receptor binding,MF,FLOT1;NETO1;DLG4;HIP1;FYN;FLOT2;PRNP;OPHN1
15491,GO:0071901,0.0269329415784956,0.985947644837888,19,116,negative regulation of protein serine/threonine kinase activity,BP,SFRP1;CDKN2B;DUSP6;BMP4;PDCD4;SORL1;PYCARD;WNK1;CAV1;DUSP5;SPRY2;TP73;SPRY4;RGS2;NR2F2;PTPN1;RGS14;CDKN2A;CDK5RAP3
3022,GO:0006570,0.0269855718085614,0.998682199677441,2,4,tyrosine metabolic process,BP,TH;GSTZ1
2193,GO:0005057,0.0270267427213641,0.985268298445364,22,118,signal transducer activity, downstream of receptor,MF,FLRT2;TGFBR2;TNIK;ROR1;AXL;EGFR;FLRT3;DOK1;MAP3K6;MAP3K14;MST1R;FGFR1;IGF1R;EPHB6;ENG;MAP3K1;NRK;RGS14;MAP3K12;RET;IFITM1;TAOK3
6300,GO:0019935,0.0270555179656978,0.987700074480584,14,67,cyclic-nucleotide-mediated signaling,BP,NOS1;ABCA1;GNG2;ADGRG6;PCLO;RGS2;PDE4D;AKAP13;DGKQ;SOX9;UCN2;PRKCA;CALCRL;ADM2
10936,GO:0044703,0.0271134396064808,0.980175400874763,74,549,multi-organism reproductive process,BP,SERPINE2;SYT8;MMP2;MMP9;SYNE1;TGFBR2;ETV5;AXL;HSPA2;RFX2;CRTAP;VDR;BMP4;SMARCA2;HSF2BP;ITGA2;MMP19;TIMP1;BTG1;ITGA3;PAQR8;MAGED2;CTSV;FUT10;PLA2G6;SPATA6;PHC2;MST1R;CCNI;SPATA20;SLC38A2;ANG;BBS2;FBLN1;MLH3;PAQR7;COL16A1;RGS2;SETX;TRO;CCDC136;SEPT6;BBS4;CALR;ATM;CST3;NR2F2;ZNF449;NRK;SOX9;BCL6;MYBL1;FNDC3A;LEPR;STOX2;ABCC2;SPA17;ODF2;THRA;HERPUD2;IGFBP2;RHBDD1;TH;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1;FOS;AGO4;ABAT;OXTR;RXRA
13909,GO:0060602,0.0271310538483911,0.994152537048569,5,15,branch elongation of an epithelium,BP,BMP4;SPRY2;AREG;SOX9;YAP1
12939,GO:0051348,0.0271471722933179,0.983025712044816,34,236,negative regulation of transferase activity,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CDKN2B;IRS2;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;TP53;WWTR1;PYCARD;WNK1;ADARB1;CAV1;TRIB2;DUSP5;SPRY2;TP73;SPRY4;IGF1R;RGS2;NR2F2;PTPN1;RGS14;CDKN2A;PPARG;DNAJC3;CDK5RAP3;CAMK2N1;TAOK3
3428,GO:0007219,0.0271985378113258,0.98510427863021,22,127,Notch signaling pathway,BP,FAT4;TGFBR2;SNAI2;EGFR;STAT1;CNTN1;SEL1L;NOTCH2NL;PBX1;APH1B;DLK2;NEURL1B;POGLUT1;SOX9;BCL6;TSPAN5;MAML2;TGFB2;DLX2;IFT74;POSTN;ADAM10
5324,GO:0016055,0.027214015556191,0.981049750833883,56,389,Wnt signaling pathway,BP,SFRP1;TNIK;APCDD1;SNAI2;SULF2;ROR1;RNF213;TCF7L1;GNG2;WWTR1;PRICKLE1;DDIT3;WNK1;RBMS3;ITGA3;GLI3;CDK14;LRP1;CAV1;NPHP4;FBXW4;CAPRIN2;MDFI;FZD7;PTPRU;DKK1;PSMB9;SULF1;TLE4;FZD8;NFATC4;FZD1;AMOTL1;FOXL1;VANGL2;KLHL12;EGR1;SOX9;ISL1;IGFBP4;AMOTL2;LEF1;IGFBP2;NPHP3;MAGI2;TGFB1I1;ARHGEF19;MDFIC;YAP1;DIXDC1;CCNY;FZD4;PPP3CA;AGO4;MED12;CELSR1
8001,GO:0032642,0.0273281910926444,0.990018857308858,9,46,regulation of chemokine production,BP,SNAI2;PYCARD;TLR3;ALOX15B;C5;EGR1;ZFPM1;MAP2K5;POSTN
7261,GO:0031252,0.027337929434002,0.981512744505912,49,300,cell leading edge,CC,FLOT1;APBB2;TLN2;ITGB4;ASAP3;GSN;PKD2;MYLK;ACTA2;VIM;CSPG4;PSTPIP1;PAK1;PTPRM;PTK6;FRMD4B;SNX1;PLEK2;KITLG;PDPN;PRKCZ;ARPIN;PXN;DYSF;SPRY2;DLC1;SPRY4;FLOT2;FSCN1;RAPH1;AMOTL1;MKLN1;ARF6;LMO4;SYNE2;FGD4;ARHGEF2;SSH1;ANXA2;RAB13;PODXL;SNX9;SHISA9;WIPF1;RASA1;ARHGAP31;S100A11;MYO1C;C2CD5
16950,GO:0099024,0.0273631632519981,0.990891279840309,8,34,plasma membrane invagination,BP,GSN;ABCA1;ITGA2;ANO6;SNX33;PPARG;SNX9;DOCK1
10883,GO:0044449,0.0273658384309794,0.984893515593982,23,117,contractile fiber part,CC,MMP2;SYNE1;TNNI2;JPH2;NOS1;SLC8A1;PLEC;PAK1;AHNAK;SCN8A;FLNC;AHNAK2;PARVA;ANK3;TTN;OBSCN;FHOD3;SYNE2;SYNC;FLNB;OBSL1;PPP3CA;MYH11
20241,GO:2001234,0.0273677635214984,0.984464051535431,24,163,negative regulation of apoptotic signaling pathway,BP,MMP9;ITGA6;SNAI2;SERPINE1;BMP4;GPX1;FYN;IFI6;CLU;UNC5B;HERPUD1;WFS1;DAPK1;LMNA;MDM2;GCLC;PTPN1;ARHGEF2;MAP2K5;YAP1;GDNF;MEIS3;LGALS3;ACAA2
9884,GO:0042220,0.0274437773185928,0.991816871462797,7,26,response to cocaine,BP,SDK1;SNCA;MDM2;HTR1B;HSPA5;ABAT;OXTR
12321,GO:0048706,0.027655750960511,0.986962873183685,15,75,embryonic skeletal system development,BP,TGFBR2;SULF2;BMP4;GLI3;MDFI;IFT140;SULF1;PBX1;HOXA1;MEGF8;WDR19;DLX2;HOXA3;MED12;NIPBL
15420,GO:0071772,0.0277044561677442,0.985651624403947,19,97,response to BMP,BP,HTRA1;FBN1;SFRP1;RNF165;BMP4;PDCD4;NEO1;ITGA3;ADAMTS7;DKK1;SULF1;TGFBR3;FZD1;ENG;EGR1;SOX9;MEGF8;TGFB2;LEF1
15421,GO:0071773,0.0277044561677442,0.985651624403947,19,97,cellular response to BMP stimulus,BP,HTRA1;FBN1;SFRP1;RNF165;BMP4;PDCD4;NEO1;ITGA3;ADAMTS7;DKK1;SULF1;TGFBR3;FZD1;ENG;EGR1;SOX9;MEGF8;TGFB2;LEF1
6564,GO:0022037,0.0277496143551997,0.987778916148368,13,61,metencephalon development,BP,SERPINE2;TRNP1;PAK1;PTPRS;CNTN1;GLI2;AARS;NAGLU;HSPA5;OPHN1;FZD4;ABAT;TTBK2
10410,GO:0043277,0.0277645678833074,0.991650444707718,7,27,apoptotic cell clearance,BP,GAS6;AXL;SPG11;LRP1;PDIA6;TGM2;RARA
10301,GO:0043112,0.0277660354531994,0.984736369265537,22,131,receptor metabolic process,BP,FLOT1;NSG1;NR1D1;ARAP1;DLG4;SNX1;TBC1D5;LRP1;CAV1;CXCR1;EHD3;SNCA;DKK1;PTPN1;ANXA2;HTR1B;MAGI2;UVRAG;PPARG;CALCRL;TBC1D16;DNM1P46
11712,GO:0046548,0.027962272595012,0.999003294702218,2,3,retinal rod cell development,BP,NAGLU;BBS4
10290,GO:0043087,0.0280483137307852,0.980475896361238,56,359,regulation of GTPase activity,BP,ITGA6;SFRP1;F2R;ASAP3;PROM2;DNMBP;ARHGAP23;DOCK9;S100A10;ALS2CL;STMN3;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;PYCARD;ARHGEF1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;ARHGEF12;ARHGAP18;DOCK11;SPRY2;DLC1;PLXNA2;RGS2;BBS4;SRGAP1;TBC1D19;PLXNA1;FGD4;BCL6;RGS14;DEPDC7;CDC42EP5;AGRN;VAV2;AGAP1;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;SNX9;TBC1D16;EFNA5;SBF2;RASA1;ARHGAP31;DOCK1
6503,GO:0021885,0.028086617767419,0.989932624482832,9,37,forebrain cell migration,BP,AXL;EGFR;LAMB1;EFHC1;GLI3;FUT10;ROBO1;SYNE2;DIXDC1
1104,GO:0002694,0.0280898945901902,0.981688923407063,40,283,regulation of leukocyte activation,BP,INPP5D;SFRP1;ZFP36L1;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;GAS6;AXL;PAK1;BMP4;VAV3;LGALS1;PYCARD;GPNMB;GLI3;DLG5;FYN;CAV1;GLI2;MAP3K14;PRKCZ;IL31RA;PIK3R1;SNCA;FLOT2;PAG1;IL18;SOX13;ATM;EFNB3;CD1D;ITPKB;BCL6;PRNP;IGFBP2;LGALS3;RARA;ZBTB1
8337,GO:0033210,0.0282263406941995,0.99689354663874,3,7,leptin-mediated signaling pathway,BP,BBS2;BBS4;LEPR
12319,GO:0048704,0.0283300148876293,0.987938724969487,12,57,embryonic skeletal system morphogenesis,BP,TGFBR2;BMP4;GLI3;MDFI;IFT140;HOXA1;MEGF8;WDR19;DLX2;HOXA3;MED12;NIPBL
1698,GO:0004180,0.0283481906579786,0.993552931745014,5,18,carboxypeptidase activity,MF,CPA4;CPVL;CTSV;PRCP;SCPEP1
13664,GO:0060242,0.0284046480085669,0.99686607851893,3,7,contact inhibition,BP,PAK1;SRPX;YAP1
8457,GO:0033612,0.0284397482650745,0.995045413404359,4,12,receptor serine/threonine kinase binding,MF,BMP4;PYCARD;TGFB2;MAGI2
6169,GO:0019541,0.0284624304274681,0.998975419263535,2,3,propionate metabolic process,BP,ACSS1;ACSS2
7662,GO:0032102,0.028538950033412,0.982843863075376,29,190,negative regulation of response to external stimulus,BP,SERPINE2;HTRA1;MMP28;CD109;IL20RB;SNAI2;SERPINE1;TKFC;PDCD4;PTPRS;IFIT1;SEMA5A;PDGFA;GPX1;SEC14L1;SERPING1;KANK2;CCK;BBS2;ROBO1;SEMA4A;C5;BBS4;ISL1;ANXA2;SEMA4B;PPARG;CALCRL;ABAT
2367,GO:0005496,0.0285487532036039,0.988313665982304,11,54,steroid binding,MF,SULT1E1;OSBPL10;PROM2;ABCA1;VDR;NR3C1;PAQR8;CAV1;OSBPL5;PAQR7;ANXA6
12255,GO:0048588,0.0286056830748041,0.983461670612132,26,142,developmental cell growth,BP,FN1;TGFBR2;DPYSL2;FLRT3;PAK1;EIF2AK4;PTPRS;SEMA5A;SPG11;PLXNB1;PRKCZ;SLIT3;ULK2;SYT1;PLXNA2;SEMA4A;G6PD;RAPH1;PLXNA1;SOX9;MEGF8;ULK1;SEMA4B;POSTN;EFNA5;LAMB2
3914,GO:0008589,0.028606422752136,0.987887240783314,12,53,regulation of smoothened signaling pathway,BP,SERPINE2;SFRP1;EVC;GLI3;DLG5;GLI2;PRKACB;IFT140;MEGF8;STK36;IFT122;GPR161
11556,GO:0046133,0.0286992454474449,0.996479025988132,3,9,pyrimidine ribonucleoside catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F
17395,GO:1900169,0.0287495700636387,1,2,2,regulation of glucocorticoid mediated signaling pathway,BP,AKAP13;CREBRF
4487,GO:0010517,0.0287719998353183,0.990365035468187,8,33,regulation of phospholipase activity,BP,EGFR;LRP1;PRKCZ;ANG;SNCA;FGFR1;RGS2;PLA2R1
12394,GO:0048865,0.0287987567737577,0.998956514851413,2,3,stem cell fate commitment,BP,SFRP1;SOX9
7932,GO:0032534,0.0288711157520388,0.997074344045181,3,6,regulation of microvillus assembly,BP,FSCN1;PODXL;KLF5
14027,GO:0060830,0.0289464879411109,0.998948170629739,2,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,WDR19;IFT122
3180,GO:0006805,0.0289580317468549,0.987956078141678,11,64,xenobiotic metabolic process,BP,NQO1;PTGS1;CMBL;CES2;BPHL;AIP;AKR7A2;BCHE;CES3;UGT1A3;UGT1A6
15900,GO:0072717,0.0289801527604911,0.998946265708734,2,3,cellular response to actinomycin D,BP,TP53;MDM2
4856,GO:0014075,0.02898375081654,0.992296610285699,6,21,response to amine,BP,ITGA2;CPS1;GLDC;TH;PPP3CA;OXTR
10849,GO:0044393,0.0289847742969356,0.998946004099621,2,3,microspike,CC,PROM2;FSCN1
19723,GO:2000134,0.0290077596860593,0.985728652929626,16,93,negative regulation of G1/S transition of mitotic cell cycle,BP,CDKN2B;PKD2;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;KANK2;TP73;CHEK2;ATM;MDM2;RBL2;FHL1;CTDSP2
1646,GO:0004095,0.0290086408579782,0.99894465271297,2,3,carnitine O-palmitoyltransferase activity,MF,CPT1A;CPT2
5476,GO:0016416,0.0290086408579782,0.99894465271297,2,3,O-palmitoyltransferase activity,MF,CPT1A;CPT2
13948,GO:0060687,0.029109994196432,0.997040338636264,3,6,regulation of branching involved in prostate gland morphogenesis,BP,SFRP1;BMP4;RXRA
17371,GO:1900133,0.0293172296847704,0.998927121806391,2,3,regulation of renin secretion into blood stream,BP,F2R;GJA5
732,GO:0001963,0.0293359445189098,0.994630665225906,4,14,synaptic transmission, dopaminergic,BP,FLOT1;SNCA;TH;GDNF
2203,GO:0005089,0.0294687206455856,0.98662340978797,14,58,Rho guanyl-nucleotide exchange factor activity,MF,DNMBP;VAV3;PLEKHG3;ARHGEF1;ARHGEF12;DOCK11;OBSCN;ARHGEF17;AKAP13;FGD4;ARHGEF2;VAV2;ARHGEF19;DOCK1
12832,GO:0051179,0.0295097731755311,0.974377313656561,496,4304,localization,BP,SERPINE2;ITGB6;SYT8;FLOT1;FN1;PCDH7;PYGB;FLRT2;MMP9;CCBE1;TXNIP;CTGF;FBN1;INPP5D;MARVELD1;ITGA6;SFRP1;MMP28;CD109;RHOBTB2;ZFP36L1;APBB2;SYNE1;F2R;TLN2;DDIT4;TGFBR2;ITGB4;ASAP3;SLC7A8;ANO1;GSN;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;OSBPL10;IGF2BP2;TNIK;ANPEP;PROM2;COL7A1;CLTCL1;TNS4;NOS1;GAS6;APCDD1;FBN2;PDGFC;SNAI2;TCAF1;MALL;MAP6;COL5A1;UTRN;SAMD9L;AXL;DPYSL2;EGFR;TSC22D3;SDC3;HSPA2;LAMB1;FLRT3;SPTB;SLC8A1;ORAI3;CLCA2;DOCK5;MYLK;SYNE3;GJC2;SLC20A1;SLC2A3;SERPINE1;ATP10D;ENDOD1;S100A10;STON2;ANXA5;CSPG4;PSTPIP1;ADD3;TOM1L2;ASAP2;NTSR1;TIMP2;CXCL14;PAK1;ABCA1;NSG1;VDR;TMC7;PTPRM;SRGAP3;BMP4;TNS1;NR1D1;PTK6;AHNAK;SCN8A;TBC1D8;RIN2;NETO1;TRIM5;MRC2;NEFL;VAV3;COL18A1;SORL1;SCN2A;KCNMA1;MEST;TP53;ARAP1;CEP250;PRICKLE1;DDIT3;CNTRL;PYCARD;LTBP1;IFIT1;WNK1;EFHC1;DLG4;SLC7A11;SEMA5A;ITGA2;PDGFA;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;HIP1;PACS1;GPNMB;TFDP2;DOCK4;BTG1;ITGA3;SIK1;EVI5L;SLC22A15;SNX1;ANO6;GPX1;LAMC2;GLI3;DLG5;CNTN1;KITLG;TBC1D5;ASAP1;PLLP;SYN1;PDPN;SRPX;MAGED2;SEC14L1;SPG11;PLXNB1;KCNAB2;LRP1;FYN;XDH;B3GAT3;LTBP4;ARHGAP18;FUT10;UGT8;LAMA3;FAT2;CAV1;SLC27A1;RBFOX2;PLA2G6;SEL1L;SNX33;SLC22A17;SLC35F3;OSBPL5;CLU;SERPING1;CXCR1;NPHP4;PRKCZ;OAS2;TP53INP1;KCNJ15;ARPIN;EHD3;CAMK2D;GOLGB1;ITGA1;SYTL1;METTL7A;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;CPT1A;SLC38A2;CALHM2;ACACB;PCLO;ANG;DYSF;KIF17;PARVA;LAMA5;BBS2;CNTLN;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;APLP2;HPS4;FBLN1;MLH3;TP73;CAT;DAPK1;DLC1;BTN3A1;ROBO1;KCNJ5;IFT140;STOM;SNCA;FLOT2;MME;FRMD5;PDIA6;VAMP1;AIP;GLG1;SH3TC2;PLXNA2;PTPRU;DZIP1L;FGFR1;IGF1R;LMNA;ALOX15B;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;C5;ASTN2;PDE4D;TMEM129;NCOA2;TGM2;PSMB9;OBSCN;SULF1;PLA2R1;ESYT2;G6PD;SLC24A1;CDH13;AKAP7;SEPT6;TGFBR3;AMOTL1;LRTOMT;ENG;BBS4;CALR;ATM;IDH2;SRGAP1;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;AREG;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;CITED2;NR2F2;PLXNA1;ELMO3;NEURL1B;LMO4;ZMAT3;TRAK1;SYNE2;PTPN1;KCNQ3;VANGL2;ARHGEF2;NDUFA4L2;KLHL12;SDC2;SLC25A35;SSH1;LYST;SOX9;ENPP1;IFT27;ISL1;SLC27A6;BCL6;SLC48A1;PRCP;NFASC;NCOR1;G6PC3;GCNT1;TMEM50B;PRKCA;TMEM63C;TMEM175;ANXA2;RGS14;TMC4;RAB13;MPP7;SEPT5;LEPR;MAN2B1;CEP68;PGAP1;IFT88;MVB12B;TTC8;KCTD7;MOSPD2;RPL13A;PODXL;PAK6;ABCC2;MEGF8;TSPAN5;NLGN4Y;ATXN1;HTR1B;RAB43;WDR19;SLC39A11;TAF8;PRNP;RET;TGFB2;MAP2K5;ODF2;VPS39;DNASE1L1;SCNN1A;AMOTL2;IFT122;LEF1;THRA;FHL1;SFXN3;MAPK8IP3;C2CD4C;EFR3A;OSBPL1A;SP100;ULK1;AGRN;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;TH;GOPC;SNX7;SLC9A4;CENPA;PIKFYVE;REEP2;RSAD2;FLNB;CHIC2;UVRAG;SEMA4B;NAPRT;CCHCR1;MON2;CFAP54;ITPR2;MDFIC;VPS13C;FHOD1;IFT74;IFITM1;OPHN1;TPGS1;LMF1;CACNB1;GDNF;DNAH1;KLHL3;DIXDC1;DERL3;PITPNC1;PPARG;BEX4;CALCRL;KCNIP3;MEF2A;GCSAM;SNX9;SHISA9;ICK;SASH1;TBC1D16;OBSL1;APOL6;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;DNAJC3;RARA;COG3;RASSF9;SV2A;ABCA2;TMEM67;PRKAG1;EFNA5;FZD4;MPPE1;WIPF1;ADGRA2;PPP3CA;PIK3C2B;ANKH;PEX1;STEAP2;ACTR1B;COX18;DNM1P46;SEPT9;CDK5RAP3;CACNA2D3;ELMO2;ABAT;NIPBL;VPS36;TTBK2;KCNRG;BSN;OXTR;ADAM10;RHOBTB3;CELSR1;ATG16L2;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;CPT2;EDEM1;ACAA2;ABCA5;NFKBIE;CTSD;DOCK1;DMPK
13049,GO:0051584,0.0295343947623239,0.998484448769168,2,4,regulation of dopamine uptake involved in synaptic transmission,BP,SNCA;GDNF
13231,GO:0051940,0.0295343947623239,0.998484448769168,2,4,regulation of catecholamine uptake involved in synaptic transmission,BP,SNCA;GDNF
3268,GO:0006942,0.0295402449551156,0.988562949862083,10,44,regulation of striated muscle contraction,BP,CTGF;GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;RGS2;PDE4D;DMPK
9553,GO:0036369,0.0295655541597075,1,2,2,transcription factor catabolic process,BP,MDM2;TAF1
4420,GO:0010243,0.0295672284756213,0.977757056360152,87,649,response to organonitrogen compound,BP,MMP2;CTGF;FBN1;SFRP1;ZFP36L1;GSN;COL5A2;PKD2;IRS2;SDK1;PDGFC;EGFR;SLC8A1;SESN3;PAK1;ABCA1;NEFL;STAT1;GNG2;TP53;ITGA2;MMP19;TIMP1;BTG1;MTHFR;SESN1;LRP1;FYN;CPS1;CAV1;SLC27A1;HLCS;SEL1L;GLDC;PRKCZ;PER1;PXN;PIK3R1;HERPUD1;WFS1;TP73;CAT;PRKACB;SNCA;COL16A1;IGF1R;PDE4D;TMEM129;CDH13;TGFBR3;MDM2;TMED10;AREG;DGKQ;GCLC;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;ENPP1;GCNT1;BCHE;RAB13;ABCC2;HTR1B;PRNP;RHBDD1;HSPA5;TH;ITPR2;CACNB1;KLF5;SRR;DERL3;PPARG;COL4A1;TMEM67;TAF1;PPP3CA;FOS;ABAT;UGGT2;OXTR;MYO1C;C2CD5;EDEM1
12085,GO:0048148,0.0295691578656593,0.99668492039983,3,7,behavioral response to cocaine,BP,SDK1;SNCA;ABAT
13449,GO:0055013,0.0296044769621979,0.988776872324481,10,37,cardiac muscle cell development,BP,SLC8A1;PAK1;BMP4;TTN;LMNA;G6PD;FHOD3;MEF2A;OBSL1;MYH11
19434,GO:1990138,0.0296324243392759,0.983742047199889,22,112,neuron projection extension,BP,FN1;DPYSL2;FLRT3;PAK1;EIF2AK4;PTPRS;SEMA5A;SPG11;PLXNB1;PRKCZ;SLIT3;ULK2;SYT1;PLXNA2;SEMA4A;RAPH1;PLXNA1;MEGF8;ULK1;SEMA4B;POSTN;LAMB2
17302,GO:0198738,0.0296717587763135,0.979224886672779,56,391,cell-cell signaling by wnt,BP,SFRP1;TNIK;APCDD1;SNAI2;SULF2;ROR1;RNF213;TCF7L1;GNG2;WWTR1;PRICKLE1;DDIT3;WNK1;RBMS3;ITGA3;GLI3;CDK14;LRP1;CAV1;NPHP4;FBXW4;CAPRIN2;MDFI;FZD7;PTPRU;DKK1;PSMB9;SULF1;TLE4;FZD8;NFATC4;FZD1;AMOTL1;FOXL1;VANGL2;KLHL12;EGR1;SOX9;ISL1;IGFBP4;AMOTL2;LEF1;IGFBP2;NPHP3;MAGI2;TGFB1I1;ARHGEF19;MDFIC;YAP1;DIXDC1;CCNY;FZD4;PPP3CA;AGO4;MED12;CELSR1
1046,GO:0002573,0.0296986138039205,0.983828159998748,21,122,myeloid leukocyte differentiation,BP,MMP9;FBN1;INPP5D;SFRP1;CD109;ZFP36L1;TGFBR2;BMP4;KITLG;IL31RA;PIK3R1;TLR3;L3MBTL3;SNX10;PRKCA;ANXA2;ZFPM1;LEF1;PPARG;RARA;FOS
6422,GO:0021695,0.0296990276930842,0.990078274672503,8,31,cerebellar cortex development,BP,SERPINE2;TRNP1;GLI2;AARS;NAGLU;HSPA5;OPHN1;TTBK2
6297,GO:0019932,0.0298245595032268,0.982428622858334,27,160,second-messenger-mediated signaling,BP,PKD2;JPH2;NOS1;EGFR;SLC8A1;ABCA1;GNG2;CAMK2D;ADGRG6;PCLO;RGS2;PDE4D;CDH13;NFATC4;LMCD1;AKAP13;DGKQ;SOX9;UCN2;PRKCA;NFAT5;PRNP;ITPR2;CALCRL;PPP3CA;ADM2;DMPK
4839,GO:0014051,0.0298372784352694,0.997387166072607,3,5,gamma-aminobutyric acid secretion,BP,NTSR1;SV2A;ABAT
4403,GO:0010159,0.0299189626984519,0.998892629874112,2,3,specification of animal organ position,BP,BMP4;HOXA3
4294,GO:0009743,0.0299605345866345,0.983122429195577,23,144,response to carbohydrate,BP,TXNIP;CTGF;ZFP36L1;TGFBR2;ANO1;IRS2;GAS6;SLC8A1;NR1D1;LGALS1;ITGA2;CTSV;PLA2G6;CAT;IGF1R;PDK3;CST3;GCLC;EGR1;TH;CALCRL;EFNA5;PPP3CA
7770,GO:0032305,0.0300236809536418,0.996405148510191,3,8,positive regulation of icosanoid secretion,BP,NTSR1;PLA2G6;PLA2R1
19751,GO:2000193,0.0300236809536418,0.996405148510191,3,8,positive regulation of fatty acid transport,BP,NTSR1;PLA2G6;PLA2R1
17502,GO:1901019,0.030091196215999,0.988312835433222,10,44,regulation of calcium ion transmembrane transporter activity,BP,PKD2;JPH2;NOS1;HSPA2;AHNAK;PLA2G6;EHD3;CAMK2D;PDE4D;CACNB1
14182,GO:0061146,0.0300928101243245,0.998882589384207,2,3,Peyer's patch morphogenesis,BP,FOXL1;RET
1095,GO:0002685,0.0301169773385962,0.985034534542576,16,102,regulation of leukocyte migration,BP,MMP28;GAS6;SERPINE1;CXCL14;TP53;PYCARD;ITGA2;ANO6;KITLG;C5;CALR;MOSPD2;GCSAM;LGALS3;MIA3;ADAM10
17757,GO:1901844,0.0302365462637891,0.996579731973848,3,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,CAV1;CAMK2D;PDE4D
4951,GO:0015020,0.0302865457451039,0.994498739002053,4,13,glucuronosyltransferase activity,MF,B3GAT3;UGT8;UGT1A3;UGT1A6
18177,GO:1902992,0.0304190622313458,0.994729767215382,4,11,negative regulation of amyloid precursor protein catabolic process,BP,SORL1;CLU;FLOT2;PRNP
18281,GO:1903225,0.0304554068662198,1,2,2,negative regulation of endodermal cell differentiation,BP,COL5A2;COL5A1
8469,GO:0033630,0.0304624585151395,0.994575229769875,4,12,positive regulation of cell adhesion mediated by integrin,BP,PODXL;RET;TGFB2;IFT74
6357,GO:0021545,0.030496451368356,0.990697428297094,7,26,cranial nerve development,BP,SLITRK6;ADARB1;GLI3;NAV2;ISL1;HOXA1;HOXA3
9939,GO:0042326,0.0305234139954225,0.979110307036053,49,350,negative regulation of phosphorylation,BP,FLRT2;GPRC5A;SFRP1;GADD45B;CD109;CDKN2B;DDIT4;IRS2;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;MICAL1;ADARB1;CTDSPL;XDH;CAV1;TRIB2;PRKCZ;PER1;DUSP5;SPRY2;FBLN1;TP73;SPRY4;SNCA;IGF1R;DKK1;RGS2;PDE4D;ENG;DGKQ;NR2F2;PTPN1;ENPP1;NCOR1;RGS14;PRNP;CDKN2A;DNAJC3;CTDSP2;CDK5RAP3;CAMK2N1;TAOK3
6948,GO:0030595,0.0306588207758723,0.98472314805972,16,103,leukocyte chemotaxis,BP,MMP28;GAS6;SERPINE1;CXCL14;VAV3;ANO6;CXCR1;ITGA1;C5;PDE4D;CALR;LYST;MOSPD2;TGFB2;LGALS3;ADAM10
4803,GO:0012506,0.0306906743062307,0.977558745805804,71,523,vesicle membrane,CC,SYT8;PCDH7;GPRC5A;CD109;PKD2;ANPEP;CLTCL1;NOS1;MAP6;EGFR;SLC2A3;NSG1;PTPRS;DLG4;HIP1;ANO6;TBC1D5;SYN1;KCNAB2;LRP1;CAV1;SNX33;AHNAK2;CXCR1;ULK2;CAMK2D;SYT1;TMEM173;DYSF;APLP2;BACE1;LRIG3;STOM;SNCA;FLOT2;MME;VAMP1;MLEC;SEC24D;MYOF;CCDC136;CALR;COPG2;MDM2;TMED10;MANBA;AREG;DGKQ;KLHL12;PRCP;NFASC;RAB13;FNDC3A;MOSPD2;RAB43;GPR161;C2CD4C;TH;SNX7;PIKFYVE;ITPR2;SNX9;LGALS3;RASSF9;SV2A;TMEM67;FZD4;ADAM10;MYO1C;C2CD5;ZNRF1
6608,GO:0022838,0.0307620289858388,0.982019436126568,26,154,substrate-specific channel activity,MF,ANO1;PKD2;JPH2;GAS6;ORAI3;CLCA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;KCNJ15;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;TMEM63C;TMEM175;SCNN1A;ITPR2;CACNB1;KCNIP3;CACNA2D3;ORAI2
6250,GO:0019840,0.0308045219235318,0.994494642776658,4,12,isoprenoid binding,MF,NR2F2;UGT1A3;RARA;RXRA
3562,GO:0007606,0.0308085790370128,0.990303281746905,7,32,sensory perception of chemical stimulus,BP,NAV2;BBS4;BBS1;OR2A4;SCNN1A;LEF1;REEP2
8120,GO:0032825,0.0308285749583969,0.996485599276545,3,7,positive regulation of natural killer cell differentiation,BP,GAS6;AXL;ZBTB1
8500,GO:0033693,0.0308956906612831,0.998835783491685,2,3,neurofilament bundle assembly,BP,NEFM;NEFL
6904,GO:0030505,0.0309061421875941,1,2,2,inorganic diphosphate transport,BP,ENPP1;ANKH
11755,GO:0046637,0.0309513221375818,0.99037187512405,7,29,regulation of alpha-beta T cell differentiation,BP,TGFBR2;GLI3;PRKCZ;IL18;ITPKB;BCL6;RARA
8872,GO:0034704,0.0310532789511822,0.991472015150677,6,23,calcium channel complex,CC,NOS1;HSPA2;CAMK2D;HERPUD1;PDE4D;CACNB1
13057,GO:0051593,0.0310713810085335,0.996228635239469,3,8,response to folic acid,BP,GSN;MTHFR;BCHE
9401,GO:0035985,0.0311792095868505,0.998351526889268,2,4,senescence-associated heterochromatin focus,CC,HMGA2;CDKN2A
7058,GO:0030856,0.0312145269653225,0.98418325270763,17,94,regulation of epithelial cell differentiation,BP,CD109;ZFP36L1;FAT4;SERPINE1;VDR;BMP4;STAT1;WWTR1;BTG1;CTSV;XDH;CAV1;ALOX15B;SOX9;KIAA1109;YAP1;GDNF
652,GO:0001843,0.0312248937076669,0.985042247694294,15,75,neural tube closure,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;FZD1;BBS4;LMO4;VANGL2;TGFB2;IFT122;NPHP3;RARA;MED12;CELSR1
13912,GO:0060606,0.0312248937076669,0.985042247694294,15,75,tube closure,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;FZD1;BBS4;LMO4;VANGL2;TGFB2;IFT122;NPHP3;RARA;MED12;CELSR1
9869,GO:0042165,0.0312454164824668,0.99262917611612,5,19,neurotransmitter binding,MF,GLDC;NIPSNAP1;BCHE;HTR1B;SRR
2829,GO:0006298,0.0312661496522925,0.990166570471193,7,31,mismatch repair,BP,XPC;MLH3;TP73;MSH5;MUTYH;LIG1;POLD4
3392,GO:0007173,0.031355556542585,0.98341959843107,19,108,epidermal growth factor receptor signaling pathway,BP,MMP9;GPRC5A;EFEMP1;EGFR;DOK1;PTK6;ARAP1;HIP1;ITGA1;PXN;PIK3R1;SPRY2;PAG1;AFAP1L2;CDH13;AREG;SOX9;MVB12B;PTPN3
16270,GO:0090403,0.0313691078245076,0.998807850445432,2,3,oxidative stress-induced premature senescence,BP,TP53;PLA2R1
3209,GO:0006853,0.0314814757290256,0.994672772437822,4,10,carnitine shuttle,BP,CPT1A;ACACB;PRKAB2;CPT2
17698,GO:1901654,0.0315202677660431,0.982696682892668,21,126,response to ketone,BP,TXNIP;SFRP1;DDIT4;EGFR;NEFL;NR3C1;GNG2;KLF9;CPS1;CAV1;SLIT3;TGFBR3;CALR;ABCC2;TGFB2;TH;YAP1;PPARG;EFNA5;FOS;OXTR
3714,GO:0008236,0.0315438560719074,0.984645410997524,15,94,serine-type peptidase activity,MF,MMP2;PRSS23;HTRA1;MMP9;PCSK1;CPVL;MMP19;TYSND1;CTSV;PRCP;DPP9;RHBDD1;RHBDD2;SCPEP1;CTSD
571,GO:0001714,0.0317447003465295,0.998304884306005,2,4,endodermal cell fate specification,BP,DUSP6;DKK1
19089,GO:1905049,0.0317746465613843,0.996653076040247,3,6,negative regulation of metallopeptidase activity,BP,TIMP2;SORL1;TIMP1
10011,GO:0042475,0.0318138944811529,0.986236652661131,12,56,odontogenesis of dentin-containing tooth,BP,HTRA1;ITGA6;ITGB4;SERPINE1;BMP4;GLI3;GLI2;LAMA5;DLX3;FAM20A;DLX2;LEF1
1332,GO:0003188,0.0319380830322241,0.996628856572808,3,6,heart valve formation,BP,GJA5;SOX9;ZFPM1
14759,GO:0070493,0.0319685456892342,0.996302194513462,3,7,thrombin-activated receptor signaling pathway,BP,F2R;SNCA;DGKQ
4425,GO:0010259,0.0319686937739188,0.991300465797476,6,21,multicellular organism aging,BP,INPP5D;RNF165;TP53;CTSV;ATM;TH
10216,GO:0042940,0.0319741895095124,0.998771790463917,2,3,D-amino acid transport,BP,NTSR1;NFKBIE
16408,GO:0097094,0.0321078811277614,0.994339310784196,4,11,craniofacial suture morphogenesis,BP,BMP4;GLI3;FOXN3;MEGF8
11750,GO:0046632,0.0321271260173767,0.986620344618065,11,53,alpha-beta T cell differentiation,BP,TGFBR2;GLI3;PRKCZ;SEMA4A;IL18;ITPKB;BCL6;ZFPM1;LEF1;RSAD2;RARA
59,GO:0000122,0.0321507153429406,0.975921242978775,82,602,negative regulation of transcription by RNA polymerase II,BP,TXNIP;SOX6;SNAI2;PHF21A;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;NR1D1;SMARCA2;NR3C1;STAT1;TP53;WWTR1;DDIT3;ZBTB20;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;SDR16C5;HMGA2;KANK2;PER1;WFS1;MDFI;JARID2;TP73;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;LMCD1;CALR;MDM2;MEIS2;CITED2;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;SALL2;TSHZ1;TCF25;HMBOX1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;SP100;KLF5;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;RARA;HES2;TAF1;TSHZ3;ZBTB1;NIPBL;PRDM5;RXRA
7134,GO:0030990,0.0322171080252428,0.989844725531684,7,30,intraciliary transport particle,CC,KIF17;IFT140;IFT27;IFT88;WDR19;IFT122;IFT74
14696,GO:0070375,0.0322308368614853,0.998756374636991,2,3,ERK5 cascade,BP,MAP2K5;MEF2A
8909,GO:0034767,0.0322822469881209,0.984892120870463,14,71,positive regulation of ion transmembrane transport,BP,F2R;PKD2;JPH2;NOS1;TCAF1;HSPA2;GJC2;NTSR1;WNK1;ANO6;EHD3;ANK3;SNCA;G6PD
10401,GO:0043266,0.0322916320599258,0.987305494039459,10,44,regulation of potassium ion transport,BP,NOS1;NETO1;ANO6;KCNAB2;CAV1;ANK3;PRNP;FHL1;KCNIP3;KCNRG
8935,GO:0035004,0.0323976262559587,0.987396153547661,10,40,phosphatidylinositol 3-kinase activity,MF,PIK3C2G;IRS2;EGFR;PDGFA;KITLG;FYN;PIK3R1;FGFR1;ATM;PIK3C2B
11283,GO:0045624,0.0325260835651422,0.995807009318847,3,9,positive regulation of T-helper cell differentiation,BP,PRKCZ;IL18;RARA
4633,GO:0010760,0.032601612693466,0.998233295077119,2,4,negative regulation of macrophage chemotaxis,BP,MMP28;C5
19262,GO:1905522,0.032601612693466,0.998233295077119,2,4,negative regulation of macrophage migration,BP,MMP28;C5
13790,GO:0060413,0.0326570917739742,0.994407484980964,4,10,atrial septum morphogenesis,BP,GJA5;ISL1;ZFPM1;TGFB2
11419,GO:0045879,0.0326667384143609,0.991149255315436,6,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;GLI3;PRKACB;MEGF8;IFT122;GPR161
10179,GO:0042803,0.0326672138848387,0.976213901822416,67,530,protein homodimerization activity,MF,SYNE1;TENM4;PKD2;PDGFC;FLRT3;S100A10;NTSR1;TENM3;CBX5;TP53I3;TRIM5;STAT1;LGALS1;WWTR1;DDIT3;PYCARD;MEF2D;PDGFA;HIP1;SNX1;ANO6;XDH;SLC27A1;HLCS;GLDC;ZNF318;CAMK2D;TMEM173;APOBEC3G;ANG;HPS4;CAT;CHEK2;STOM;FGFR1;G6PD;CDH13;ENG;DLK2;TCF4;ANXA6;NR2F2;ENPP1;PRPS2;TCF12;MAP3K12;CDH11;TGFB2;SPPL2B;SP100;GOPC;UGT1A3;UGT1A6;GDNF;SRR;TPST1;SNX9;OLFML2A;GSTZ1;FZD4;ZBTB1;DPYD;SBF2;DNPH1;ABAT;ADAM10;S100A11
5542,GO:0016553,0.0326716742870879,0.994049422419253,4,12,base conversion or substitution editing,BP,APOBEC3C;ADARB1;APOBEC3G;APOBEC3F
17844,GO:1902105,0.0327143003830441,0.980926579128394,25,158,regulation of leukocyte differentiation,BP,FBN1;INPP5D;SFRP1;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;BMP4;GLI3;KITLG;GLI2;PRKCZ;PIK3R1;TLR3;IL18;SOX13;ITPKB;BCL6;PRKCA;ZFPM1;LEF1;RARA;ZBTB1;FOS
9656,GO:0038034,0.0327680463929365,0.986855467711511,10,53,signal transduction in absence of ligand,BP,SNAI2;KITLG;SRPX;FYN;IFI6;UNC5B;FGFR1;RET;MAP2K5;GDNF
16465,GO:0097192,0.0327680463929365,0.986855467711511,10,53,extrinsic apoptotic signaling pathway in absence of ligand,BP,SNAI2;KITLG;SRPX;FYN;IFI6;UNC5B;FGFR1;RET;MAP2K5;GDNF
13907,GO:0060600,0.0327859464121237,0.994378203467049,4,10,dichotomous subdivision of an epithelial terminal unit,BP,AREG;PLXNA1;VANGL2;CELSR1
3571,GO:0007618,0.0330061200264706,0.99217679931974,5,18,mating,BP,SERPINE2;THRA;TH;ABAT;OXTR
6356,GO:0021544,0.0330289387345127,0.992365579885016,5,16,subpallium development,BP,GLI3;BBS2;BBS4;DLX2;SLITRK5
13842,GO:0060488,0.0330524086473906,1,2,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2;CELSR1
13843,GO:0060489,0.0330524086473906,1,2,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,VANGL2;CELSR1
13844,GO:0060490,0.0330524086473906,1,2,2,lateral sprouting involved in lung morphogenesis,BP,VANGL2;CELSR1
14918,GO:0070838,0.0331025503109555,0.978592564420373,37,240,divalent metal ion transport,BP,CTGF;F2R;PKD2;JPH2;NOS1;GAS6;HSPA2;SLC8A1;ORAI3;MYLK;GJC2;NTSR1;VDR;AHNAK;DDIT3;ANO6;FYN;CAV1;PLA2G6;EHD3;CAMK2D;WFS1;SNCA;PDE4D;G6PD;SLC24A1;ANXA6;SLC39A11;PRNP;ITPR2;CACNB1;CALCRL;LGALS3;PPP3CA;CACNA2D3;TUSC3;ORAI2
11111,GO:0045176,0.0331096326999518,0.99456102760107,4,9,apical protein localization,BP,DLG5;VANGL2;GOPC;CELSR1
16040,GO:0090026,0.0331204411874417,0.995699547566937,3,9,positive regulation of monocyte chemotaxis,BP,SERPINE1;ANO6;MOSPD2
9299,GO:0035787,0.0331689878843311,0.998699414665829,2,3,cell migration involved in kidney development,BP,PDGFA;VANGL2
15111,GO:0071241,0.0332307196489896,0.982233912770415,19,117,cellular response to inorganic substance,BP,MMP9;NQO1;GSN;PKD2;EGFR;WNK1;CAMK2D;SYT1;ANK3;SNCA;NFATC4;CALR;ITPKB;PRNP;CARF;HSPA5;TH;MEF2A;FOS
8063,GO:0032754,0.033298173250239,0.996084757399375,3,7,positive regulation of interleukin-5 production,BP,PRKCZ;PDE4D;RARA
19122,GO:1905153,0.033349312882638,0.99641753096194,3,6,regulation of membrane invagination,BP,ITGA2;ANO6;PPARG
11453,GO:0045933,0.0333736083856366,0.99055315911626,6,25,positive regulation of muscle contraction,BP,CTGF;F2R;ITGA2;RGS2;ABAT;OXTR
4603,GO:0010724,0.0333931514541943,0.998685663700591,2,3,regulation of definitive erythrocyte differentiation,BP,RBFOX2;ZFPM1
14846,GO:0070661,0.0334311332829897,0.980883550753688,23,157,leukocyte proliferation,BP,INPP5D;TGFBR2;IL20RB;IRS2;BMP4;VAV3;PYCARD;GPNMB;DLG5;KITLG;FYN;CLU;BTN3A1;IL18;ATM;IFNK;IFNE;CD1D;BCL6;PRNP;LEF1;IGFBP2;LGALS3
12828,GO:0051173,0.0334773924656383,0.971790850692679,252,2083,positive regulation of nitrogen compound metabolic process,BP,FLOT1;FN1;MMP9;CCBE1;CTGF;SOX6;ITGA6;SFRP1;GADD45B;CDKN2B;ZFP36L1;F2R;TGFBR2;TNNI2;GSN;ETV5;PKD2;DUSP6;ZFP36L2;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;RFX2;SERPINE1;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;VDR;BMP4;NR1D1;SMARCA2;PTK6;CITED4;EIF2AK4;TRIM5;NR3C1;STAT1;SORL1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;PYCARD;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;PDGFA;RBMS3;ACSL3;HIP1;GPNMB;TFDP2;NFIX;SNX1;GLI3;E2F7;CNTN1;KITLG;ABHD14B;ZFP90;LRP1;FYN;XDH;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;SMARCA1;ZNF318;CLU;PRKCZ;SDR16C5;TP53INP1;HMGA2;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;DUSP5;HERPUD1;WFS1;SPRY2;CIRBP;JARID2;FBLN1;TP73;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;PHF2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;SETX;NCOA2;IL18;EPHB6;EDA2R;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;MDM2;FAM20A;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;LMO4;MAF;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;MYBL1;ANXA2;TRERF1;HLTF;HOXA1;METTL23;IGFBP4;TCF12;HMBOX1;NFAT5;PAK6;NAB2;MAP3K12;IRF2BPL;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;GPR161;LEF1;THRA;SSBP3;MAPK8IP3;SP100;TEF;AGRN;RHBDD1;MAGI2;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;NUB1;KLF5;MEIS3;PPARG;RNF144B;MEF2A;KLF7;SNX9;SASH1;DNAJC3;RARA;CCNY;PBX2;PRKAG1;TAF1;EFNA5;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;FAM168A;MED12;NPAS2;ABAT;NIPBL;LITAF;RXRA;EDEM1;TAOK3
7127,GO:0030970,0.0335620095465242,0.990486965173458,6,25,retrograde protein transport, ER to cytosol,BP,SEL1L;HERPUD1;TMEM129;RHBDD1;DERL3;EDEM1
18404,GO:1903513,0.0335620095465242,0.990486965173458,6,25,endoplasmic reticulum to cytosol transport,BP,SEL1L;HERPUD1;TMEM129;RHBDD1;DERL3;EDEM1
6737,GO:0030165,0.0336059630479652,0.984782446596785,13,61,PDZ domain binding,MF,DLG4;DOCK4;CRIM1;FZD7;FZD8;TGFBR3;FZD1;SDC2;ARHGAP29;SRR;SHISA9;FZD4;SNTB1
15130,GO:0071277,0.0336647938127234,0.987410194481824,9,40,cellular response to calcium ion,BP,PKD2;WNK1;CAMK2D;SYT1;ITPKB;CARF;HSPA5;MEF2A;FOS
464,GO:0001503,0.0337180055884932,0.978050576087963,38,240,ossification,BP,MMP2;MMP9;CTGF;SFRP1;FAT4;COL5A2;FBN2;SNAI2;MN1;EGFR;SLC8A1;BMP4;MRC2;WWTR1;MEF2D;GPNMB;SMOC1;ANO6;GLI3;PLXNB1;GLI2;CAT;DKK1;FZD1;PBX1;AREG;SOX9;ENPP1;NAB2;CDH11;TGFB2;LEF1;THRA;IFITM1;TWIST2;ATRAID;ANKH;NIPBL
15617,GO:0072160,0.0337383816214814,0.994160530854924,4,10,nephron tubule epithelial cell differentiation,BP,FAT4;STAT1;WWTR1;YAP1
554,GO:0001676,0.0338067466454339,0.985656731917212,11,60,long-chain fatty acid metabolic process,BP,PTGS1;SLC27A3;ACSL3;PTGES;SLC27A1;CPT1A;CBR1;ALOX15B;SLC27A6;AIG1;ACOT1
8817,GO:0034617,0.0338458987340345,0.998657725840436,2,3,tetrahydrobiopterin binding,MF,NOS1;TH
6524,GO:0021934,0.0338469511020526,1,2,2,hindbrain tangential cell migration,BP,PLXNA2;TTBK2
6525,GO:0021935,0.0338469511020526,1,2,2,cerebellar granule cell precursor tangential migration,BP,PLXNA2;TTBK2
2823,GO:0006290,0.0338473571833176,0.995993858428013,3,7,pyrimidine dimer repair,BP,DDB2;ERCC6;POLH
12675,GO:0050920,0.0338580107776231,0.981550644361729,20,122,regulation of chemotaxis,BP,MMP28;GAS6;SERPINE1;CXCL14;SEMA5A;ITGA2;ANO6;ROBO1;PLXNA2;FGFR1;SEMA4A;C5;CDH13;CALR;PLXNA1;MOSPD2;MEGF8;SEMA4B;ADGRA2;ADAM10
15695,GO:0072298,0.0338710811643008,0.998656165441523,2,3,regulation of metanephric glomerulus development,BP,EGR1;RET
841,GO:0002155,0.0339028364059979,0.99865419679793,2,3,regulation of thyroid hormone mediated signaling pathway,BP,PRCP;THRA
12316,GO:0048701,0.0339354020448569,0.988306157587987,8,32,embryonic cranial skeleton morphogenesis,BP,TGFBR2;BMP4;IFT140;HOXA1;WDR19;DLX2;MED12;NIPBL
7756,GO:0032287,0.0339527094852679,0.994728426531338,4,8,peripheral nervous system myelin maintenance,BP,AHNAK2;PRX;SH3TC2;NDRG1
7757,GO:0032288,0.0340147156898568,0.990793571171695,6,19,myelin assembly,BP,TENM4;UGT8;AHNAK2;PRX;NFASC;PIKFYVE
13507,GO:0055119,0.0340344038581784,0.993885191419124,4,11,relaxation of cardiac muscle,BP,SLC8A1;CAMK2D;RGS2;PDE4D
1300,GO:0003139,0.0341609497747035,0.998100240959788,2,4,secondary heart field specification,BP,BMP4;ISL1
9673,GO:0038084,0.0341701636731803,0.992027418615301,5,16,vascular endothelial growth factor signaling pathway,BP,CCBE1;XDH;ROBO1;ADGRA2;MYO1C
15628,GO:0072175,0.0341747794062971,0.981798154140732,19,103,epithelial tube formation,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;FZD1;BBS4;LMO4;VANGL2;SOX9;PODXL;RET;TGFB2;IFT122;NPHP3;GDNF;RARA;MED12;CELSR1
15056,GO:0071071,0.0342949673177205,0.995669980118118,3,8,regulation of phospholipid biosynthetic process,BP,PDGFA;ACSL3;SLC27A1
3524,GO:0007501,0.0343373836165801,0.998627149000297,2,3,mesodermal cell fate specification,BP,FGFR1;DKK1
10107,GO:0042661,0.0343373836165801,0.998627149000297,2,3,regulation of mesodermal cell fate specification,BP,FGFR1;DKK1
19331,GO:1905770,0.0343373836165801,0.998627149000297,2,3,regulation of mesodermal cell differentiation,BP,FGFR1;DKK1
19369,GO:1905902,0.0343373836165801,0.998627149000297,2,3,regulation of mesoderm formation,BP,FGFR1;DKK1
12230,GO:0048534,0.034385426434894,0.974265315044106,79,616,hematopoietic or lymphoid organ development,BP,MMP9;FBN1;SOX6;INPP5D;SFRP1;CD109;CDKN2B;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;STON2;FAM210B;MFAP5;BMP4;STAT1;LGALS1;GLI3;KITLG;PDPN;KCNAB2;FUT10;GLI2;RBFOX2;DOCK11;PRKCZ;IL31RA;PIK3R1;JARID2;TP73;KLF13;TLR3;FZD7;SEMA4A;PSMB9;IL18;G6PD;FZD8;SOX13;DHTKD1;TGFBR3;L3MBTL3;PBX1;FOXL1;ATM;MEIS2;IFNK;SNX10;CITED2;IFNE;LMO4;CD1D;CRIP2;EGR1;ITPKB;BCL6;PRKCA;ANXA2;LEPR;TCF12;ZNF160;RET;ZFPM1;TGFB2;LEF1;THRA;SSBP3;ITM2A;RSAD2;SH2B3;YAP1;HOXA3;PPARG;LGALS3;RARA;ZBTB1;FOS;AGO4
6738,GO:0030166,0.0344366624168608,0.986381348472046,10,42,proteoglycan biosynthetic process,BP,CSPG4;EXTL2;B3GAT3;XYLT1;UST;CHST3;FOXL1;VANGL2;GAL3ST4;DSEL
5306,GO:0016020,0.0344492201070388,0.969861883524148,635,5729,membrane,CC,SERPINE2;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;HTRA1;FN1;PCDH7;PYGB;FLRT2;PRODH;GPRC5A;ITGB5;CTGF;ADAM19;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;CD109;RHOBTB2;APBB2;SYNE1;F2R;TLN2;FAT4;TGFBR2;XPC;SLITRK6;PTGS1;ITGB4;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;CYBRD1;SDK1;TNIK;ANPEP;PROM2;COL7A1;BCAM;CLTCL1;NOS1;DNAJB4;APCDD1;PDGFC;MAGED1;TCAF1;MALL;MAP6;SULF2;UTRN;ROR1;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TMEM204;SDC3;ITPK1;HSPA2;FLRT3;TCHH;SPTB;NYNRIN;SLC8A1;NTM;FKBP5;ORAI3;CLCA2;DOCK5;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;SERPINE1;KIAA1549L;ATP10D;SERPINH1;ENDOD1;RNF213;S100A10;STON2;MBOAT2;ANXA5;VIM;LPAR5;FAM198B;CSPG4;PSTPIP1;CTNNAL1;EVC;CNTNAP3;FAM210B;MAMDC2;AMIGO2;ADD3;ASAP2;NTSR1;DCAKD;TENM3;PLEC;PAK1;ABCA1;LOC441081;NSG1;CHN2;TMC7;PTPRM;TP53I11;ITM2C;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;NETO1;MRC2;VAV3;SORL1;NEO1;SCN2A;GNG2;KCNMA1;MEST;ARAP1;EXTL2;KIAA0319L;PTPRS;PRICKLE1;CNTRL;KRT5;IL32;WNK1;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;PDGFA;NISCH;PPL;ACSL3;FLG;HIP1;GPNMB;DOCK4;TMEM200A;CRIM1;FILIP1L;ITGA3;EMP1;KLF9;PCDHAC2;SLC22A15;ELFN2;TYSND1;TPBG;SNX1;ANO6;PLEK2;LAMC2;PAQR8;PTGES;CDK14;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;ECH1;ERMAP;ASAP1;ERO1B;PLLP;SYN1;PDPN;SRPX;MAGED2;CTSV;SPG11;PLXNB1;KCNAB2;LRP1;FYN;ARHGEF12;EMP3;IFI6;FLNC;B3GAT3;ARHGAP18;FUT10;CLMN;UGT8;CPS1;FAT2;CAV1;SLC27A1;GLI2;PLA2G6;ITGA10;SEL1L;GLDC;SNX33;SLC22A17;SLC35F3;TNRC18;OSBPL5;XYLT1;AHNAK2;UST;CLU;DCBLD2;CXCR1;PRKCZ;OAS2;SDR16C5;ULK2;PARP4;GPR39;KCNJ15;TNS2;CHST3;EHD3;CAMK2D;ADGRG6;GOLGB1;ITGA1;MST1R;SYTL1;IL31RA;METTL7A;ULBP1;ATP8B2;EHBP1;PXN;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;SLC38A2;CALHM2;ACACB;PCLO;DYSF;KIF17;PARVA;UNC5B;BBS2;HERPUD1;ANK3;WFS1;PHKA2;SPRY2;TMEM139;TMEM8B;APLP2;HPS4;CAT;PLCH2;SHROOM4;DAPK1;ST6GAL2;DLC1;S1PR5;BTN3A1;PRKACB;AARS;BACE1;ROBO1;KCNJ5;SPRY4;LRIG3;STOM;PRX;TLR3;BPHL;MAN1A1;SNCA;FLOT2;MME;FRMD5;PDIA6;VAMP1;FZD7;AIP;GLG1;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;CYYR1;PTPRU;FGFR1;PAG1;IGF1R;LMNA;ARMCX2;ALOX15B;DKK1;MLEC;FSCN1;SEC24D;SEMA4A;RGS2;C5;GLT8D2;TGFBI;ASTN2;PDE4D;TMEM129;TGM2;OBSCN;SULF1;SPATA18;PLA2R1;ESYT2;TRO;G6PD;MYOF;EPHB6;IL17RE;EDA2R;FZD8;CCDC136;TMEM263;SLC24A1;AFAP1L2;CDH13;CD99L2;ITGBL1;RAPH1;SEPT6;TGFBR3;FZD1;AMOTL1;LRTOMT;LAPTM4A;ENG;BBS4;MTMR4;CALR;NEGR1;EFNB3;IDH2;COPG2;APH1B;MDM2;ARF6;TMED10;CST3;DLK2;MANBA;TMEM14C;AREG;BBS1;ANXA6;AKAP13;SNX10;DGKQ;PLXNA1;HEXA;DNAJC4;ZMAT3;NRSN2;CYP20A1;CD1D;LZTS1;SYNE2;HDAC11;RNPEP;CSMD2;NEMP2;PTPN1;KCNQ3;VANGL2;ARHGEF2;SMIM19;DNAL4;NTNG1;PLGRKT;SPRED3;NDUFA4L2;KLHL12;SDC2;SLC25A35;SYNC;SSH1;ENPP1;ITPKB;SLC27A6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;GCNT1;TMEM50B;PRKCA;TMEM63C;PXMP2;TMEM175;BCHE;ANXA2;RGS14;TMC4;RAB13;HLTF;FNDC3A;TMEM94;MPP7;SEPT5;RNF24;METTL23;LEPR;MAN2B1;PGAP1;PLD5;LANCL1;IFITM2;GOLGA8B;MVB12B;TES;TTC8;KCTD7;MOSPD2;CNTNAP3B;NMNAT2;GAL3ST4;RPL13A;PODXL;ABCC2;MAP3K12;MEGF8;TSPAN5;NLGN4Y;XG;HTR1B;RAB43;SPA17;SLC39A11;PRNP;TMEM60;CDH11;RET;GGT7;VPS39;DSEL;OR2A4;SCNN1A;STAT2;AMOTL2;IFT122;GPR161;FHL1;CDC42EP5;LRRN3;SFXN3;ITM2A;MAPK8IP3;CYP4V2;C2CD4C;EFR3A;HERPUD2;SPPL2B;ULK1;AGRN;IGFBP2;TMEM187;TMEM164;VAV2;RHBDD1;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;NRM;TH;GOPC;SNX7;MAGI1;SLC9A4;BOC;PIKFYVE;EHBP1L1;REEP2;RSAD2;FLNB;TTPAL;CHIC2;UVRAG;SEMA4B;ITGB8;ITPR2;UGT1A3;VPS13C;RHBDD2;FHOD1;IFITM1;TACC2;LMF1;UGT1A6;MYO9A;YAP1;CACNB1;ALG10;COL17A1;GPX8;GOLGA8N;ATRAID;SRR;GALNT2;DERL3;AGPAT1;RNF144B;CALCRL;TPST1;KCNIP3;TMEM212;SLC35E2B;GCSAM;CERS5;SNX9;SHISA9;APOL6;PRR7;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DEF6;DNAJC3;COG3;RASSF9;SV2A;ABCA2;CCNY;TMEM67;PRKAG1;SENP7;TRIM16L;EFNA5;FZD4;MPPE1;SLITRK5;ADGRA2;ZBTB1;NAT14;PPP3CA;TMEM168;PIK3C2B;SBF2;RASA1;ANKH;LIMA1;PEX1;STEAP2;KRT10;ACTR1B;COX18;TMTC4;FOS;DNM1P46;CDK5RAP3;AIG1;AGO4;FAM169A;CLEC2D;CACNA2D3;CAMK2N1;ELMO2;KLHDC2;MED12;CERCAM;VPS36;PCDHGB5;OXTR;ADAM10;RHOBTB3;CELSR1;MPDZ;LITAF;ATG16L2;TSPAN4;MYO1C;TUSC3;ORAI2;C2CD5;GBP3;CPT2;SNTB1;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;CTSD;DOCK1;ZNRF1;DMPK;MOSPD3
15569,GO:0072080,0.0344951130573831,0.984319747610182,13,61,nephron tubule development,BP,FAT4;PKD2;MAGED1;BMP4;STAT1;WWTR1;GLI3;LAMA5;PBX1;SOX9;YAP1;GDNF;KLHL3
19617,GO:1990837,0.0344997075674776,0.974469299952888,74,526,sequence-specific double-stranded DNA binding,MF,SOX6;ETV5;PHF21A;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;GLI2;SLC2A4RG;TNRC18;HMGA2;PER1;CREB3L2;JARID2;MLH3;TP73;KLF13;SETX;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;LMO4;EGR1;SOX9;ISL1;BCL6;PLAG1;SALL2;MYBL1;HLTF;BAHCC1;TCF12;NFAT5;CARF;ZFPM1;DLX2;LEF1;THRA;SSBP3;TEF;TSPYL2;ORC4;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;PRDM5;LITAF;RXRA
4528,GO:0010604,0.0345999254530951,0.970717207374533,265,2207,positive regulation of macromolecule metabolic process,BP,FLOT1;FN1;MMP9;CCBE1;CTGF;SOX6;ITGA6;SFRP1;GADD45B;CDKN2B;ZFP36L1;F2R;TGFBR2;TNNI2;GSN;ETV5;PKD2;IRS2;DUSP6;ZFP36L2;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;GJC2;RFX2;ACTA2;SERPINE1;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;NSG1;VDR;BMP4;NR1D1;SMARCA2;PTK6;CITED4;EIF2AK4;TRIM5;NR3C1;STAT1;SORL1;ETV1;TP53;ARAP1;WWTR1;PRICKLE1;DDIT3;PYCARD;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;PDGFA;RBMS3;HIP1;GPNMB;TFDP2;ITGA3;NFIX;SNX1;GLI3;E2F7;CNTN1;KITLG;TBC1D5;ABHD14B;ZFP90;LRP1;FYN;XDH;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;SMARCA1;ZNF318;CLU;PRKCZ;SDR16C5;TP53INP1;HMGA2;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;DUSP5;HERPUD1;ANK3;WFS1;SPRY2;TTN;CIRBP;JARID2;FBLN1;TP73;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;PHF2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;SETX;NCOA2;IL18;EPHB6;EDA2R;FZD8;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;MDM2;FAM20A;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;LMO4;MAF;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;MYBL1;ANXA2;TRERF1;HLTF;HOXA1;METTL23;IGFBP4;TCF12;HMBOX1;NFAT5;PAK6;NAB2;MAP3K12;IRF2BPL;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;MAPK8IP3;SP100;TEF;AGRN;RHBDD1;MAGI2;HSPA5;TGFB1I1;SRPK2;ITGB8;MDFIC;FHOD1;IFT74;YAP1;GDNF;NUB1;KLF5;MEIS3;PPARG;RNF144B;MEF2A;KLF7;SNX9;SASH1;DNAJC3;RARA;CCNY;PBX2;PRKAG1;TAF1;EFNA5;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;KDM4A;CDK5RAP3;FAM168A;CAMK2N1;MED12;NPAS2;NIPBL;ADM2;LITAF;MYO1C;RXRA;EDEM1;TAOK3
4764,GO:0010954,0.0346486098251447,0.993568424343993,4,12,positive regulation of protein processing,BP,CCBE1;GSN;PLGRKT;RHBDD1
18096,GO:1902807,0.0346769516513005,0.982515642606294,16,96,negative regulation of cell cycle G1/S phase transition,BP,CDKN2B;PKD2;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;KANK2;TP73;CHEK2;ATM;MDM2;RBL2;FHL1;CTDSP2
3533,GO:0007528,0.0347764475104861,0.988129401546262,8,29,neuromuscular junction development,BP,F2R;ETV5;UTRN;ANK3;AGRN;CACNB1;COL4A1;LAMB2
13713,GO:0060314,0.034780055464403,0.991734048510135,5,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2;JPH2;NOS1;CAMK2D;PDE4D
6518,GO:0021910,0.0348347914321258,0.99619089339847,3,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,GLI3;GLI2;IFT122
13595,GO:0060117,0.0348592324270768,0.993687995313732,4,11,auditory receptor cell development,BP,SLITRK6;FGFR1;TRIOBP;LRTOMT
10588,GO:0043588,0.0349345091239693,0.97741970615246,36,244,skin development,BP,KRT4;TXNIP;ITGA6;CD109;ZFP36L1;ITGB4;COL5A2;APCDD1;COL5A1;EGFR;TCHH;KRT14;VDR;KRT13;KRT5;ITGA2;PDGFA;PPL;FLG;ITGA3;KRT15;CTSV;LAMA5;CASP14;ALOX15B;DKK1;VANGL2;COL5A3;SOX9;TGFB2;FLNB;IFT74;YAP1;SLITRK5;KRT10;CELSR1
1284,GO:0003093,0.0349784324769067,0.995548590371978,3,8,regulation of glomerular filtration,BP,F2R;GJA5;GAS6
4598,GO:0010718,0.0351119974377869,0.9868439950453,9,38,positive regulation of epithelial to mesenchymal transition,BP,TGFBR2;BMP4;WWTR1;PDPN;ENG;ISL1;TGFB2;LEF1;TGFB1I1
17810,GO:1902001,0.0352587579486159,0.991832939448184,5,15,fatty acid transmembrane transport,BP,IRS2;CPT1A;ACACB;PRKAB2;CPT2
6348,GO:0021535,0.0352727060921757,0.993805352021646,4,10,cell migration in hindbrain,BP,RBFOX2;PLXNA2;LEF1;TTBK2
6844,GO:0030323,0.0353170035235757,0.980474590491361,21,114,respiratory tube development,BP,CCBE1;CTGF;TGFBR2;EGFR;BMP4;PDGFA;ITGA3;GLI3;DLG5;PDPN;GLI2;LAMA5;SPRY2;FGFR1;VANGL2;SOX9;LIPA;THRA;NPHP3;YAP1;CELSR1
13439,GO:0055002,0.0353224980545115,0.982404387648445,16,77,striated muscle cell development,BP,SLC8A1;PAK1;BMP4;GPX1;FLNC;TTN;LMNA;OBSCN;G6PD;AKAP13;FHOD3;LEF1;MEF2A;OBSL1;PPP3CA;MYH11
15276,GO:0071496,0.0353560902485021,0.977416850169451,34,234,cellular response to external stimulus,BP,ITGA6;SFRP1;CDKN2B;SKP2;GAS6;SNAI2;AXL;EGFR;SESN3;VDR;EIF2AK4;TP53;ITGA2;SESN1;CTSV;FYN;MAP3K14;KANK2;SLC38A2;TLR3;ENG;MDM2;GCLC;MAP3K1;SSH1;SOX9;UCN2;ULK1;HSPA5;PPARG;POSTN;TAF1;PIK3C2B;FOS
11066,GO:0045087,0.0353675045743942,0.974059408683654,68,550,innate immune response,BP,FLOT1;MMP2;GSN;HERC5;AXL;VIM;PSTPIP1;TKFC;PAK1;APOBEC3C;TRIM38;NR1D1;PTK6;XAF1;TRIM5;STAT1;IFIT2;PTPRS;PYCARD;IFIT1;DDX60;MUC19;ADARB1;IFIT3;SEC14L1;FYN;IFI6;CAV1;RNF135;CLU;SERPING1;OAS2;CAMK2D;MST1R;ULBP1;TMEM173;APOBEC3G;DAPK1;PRKACB;TLR3;SNCA;APOBEC3F;IFI35;C5;PSMB9;IL18;IFNK;IFNE;CD1D;MAP3K1;PTPN1;ARHGEF2;LYST;EGR1;IFITM2;RPL13A;RAB43;STAT2;SP100;RSAD2;FLNB;SRPK2;IFITM1;NUB1;PPARG;LGALS3;ZBTB1;MYO1C
1338,GO:0003198,0.0354216159163582,0.993552608404065,4,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2;SNAI2;ENG;TGFB2
8392,GO:0033363,0.0355136509959702,0.990085651026484,6,21,secretory granule organization,BP,SERPINE2;F2R;RFX2;ABCA1;CCDC136;LYST
8298,GO:0033145,0.0355142980239006,0.993210823307836,4,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,SKP2;PAK1;YAP1;TAF1
9588,GO:0036465,0.0355201123216294,0.986705434098451,9,37,synaptic vesicle recycling,BP,SYT8;STON2;SYT1;SNCA;DNAJC6;NLGN4Y;C2CD4C;OPHN1;DNM1P46
1321,GO:0003171,0.0355489613039379,0.991746900243158,5,15,atrioventricular valve development,BP,TGFBR2;GJA5;MDM2;ZFPM1;TGFB2
11230,GO:0045472,0.0355934447033998,0.995700691191182,3,7,response to ether,BP,NFATC4;MDM2;TH
9854,GO:0042133,0.0356709693091897,0.982973562709686,14,77,neurotransmitter metabolic process,BP,NQO1;PKD2;NOS1;CPS1;CAV1;GLDC;CLU;LRTOMT;BCHE;ALDH9A1;ALDH7A1;TH;DPYD;ABAT
19930,GO:2000508,0.0356778498187199,0.997967408818373,2,4,regulation of dendritic cell chemotaxis,BP,GAS6;CALR
19931,GO:2000510,0.0356778498187199,0.997967408818373,2,4,positive regulation of dendritic cell chemotaxis,BP,GAS6;CALR
10006,GO:0042470,0.0357190273807298,0.982334868927625,15,93,melanosome,CC,FLOT1;GPNMB;SYTL1;PDIA4;HPS4;STOM;PDIA6;TMED10;ANXA6;ANXA2;HSPA5;TH;CAPG;MYH11;CTSD
12355,GO:0048770,0.0357190273807298,0.982334868927625,15,93,pigment granule,CC,FLOT1;GPNMB;SYTL1;PDIA4;HPS4;STOM;PDIA6;TMED10;ANXA6;ANXA2;HSPA5;TH;CAPG;MYH11;CTSD
6887,GO:0030431,0.0357427597458446,0.993152969370153,4,13,sleep,BP,IL18;CST3;FOS;OXTR
14233,GO:0061318,0.0359073056379402,0.993435080358027,4,11,renal filtration cell differentiation,BP,BMP4;PODXL;MAGI2;LAMB2
15594,GO:0072112,0.0359073056379402,0.993435080358027,4,11,glomerular visceral epithelial cell differentiation,BP,BMP4;PODXL;MAGI2;LAMB2
15707,GO:0072311,0.0359073056379402,0.993435080358027,4,11,glomerular epithelial cell differentiation,BP,BMP4;PODXL;MAGI2;LAMB2
9261,GO:0035710,0.0360114349225678,0.986259677626336,9,43,CD4-positive, alpha-beta T cell activation,BP,TGFBR2;PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RSAD2;RARA
3558,GO:0007601,0.0361274374694681,0.982270801683057,15,80,visual perception,BP,SLITRK6;EFEMP1;COL18A1;EML2;BBS2;WFS1;TGFBI;MYO3B;SLC24A1;BBS4;BBS1;CYP4V2;TH;MYO9A;LAMB2
12690,GO:0050953,0.0361274374694681,0.982270801683057,15,80,sensory perception of light stimulus,BP,SLITRK6;EFEMP1;COL18A1;EML2;BBS2;WFS1;TGFBI;MYO3B;SLC24A1;BBS4;BBS1;CYP4V2;TH;MYO9A;LAMB2
2705,GO:0006081,0.0361409335712774,0.98515300851154,10,58,cellular aldehyde metabolic process,BP,H6PD;TKFC;SDR16C5;ALDH3A2;G6PD;IDH2;AKR7A2;ALDH4A1;ALDH9A1;ALDH7A1
3450,GO:0007265,0.036200812026191,0.974521500304455,54,365,Ras protein signal transduction,BP,FLOT1;RHOBTB2;F2R;ASAP3;DNMBP;DOK1;CTNNAL1;STMN3;ASAP2;TIMP2;PAK1;ABCA1;VAV3;TP53;ARAP1;PLEKHG3;ARHGEF1;NISCH;ITGA3;KITLG;ASAP1;PDPN;ARHGEF12;IQSEC2;SPRY2;DLC1;ROBO1;SPRY4;OBSCN;ARHGEF17;CDH13;ARF6;AKAP13;FGD4;VANGL2;ARHGEF2;IFT27;ITPKB;BCL6;RAB13;PAK6;RAB43;TGFB2;CDC42EP5;USP28;CDKN2A;VAV2;AGAP1;ARHGEF19;ARHGAP29;OPHN1;RASA1;RHOBTB3;CELSR1
13365,GO:0052696,0.0362567210720634,0.997915845070474,2,4,flavonoid glucuronidation,BP,UGT1A3;UGT1A6
13366,GO:0052697,0.0362567210720634,0.997915845070474,2,4,xenobiotic glucuronidation,BP,UGT1A3;UGT1A6
3818,GO:0008420,0.0362838613952354,0.995313941198768,3,8,CTD phosphatase activity,MF,CTDSPL;PPM1M;CTDSP2
9804,GO:0042033,0.0363517587859736,0.995101329563748,3,9,chemokine biosynthetic process,BP,TLR3;IL18;EGR1
12557,GO:0050755,0.0363517587859736,0.995101329563748,3,9,chemokine metabolic process,BP,TLR3;IL18;EGR1
12392,GO:0048863,0.0363610307524305,0.977979403660841,27,201,stem cell differentiation,BP,SOX6;SFRP1;ZFP36L2;SNAI2;BMP4;PRICKLE1;KITLG;HMGA2;LAMA5;JARID2;TP73;SEMA4A;LTBP3;PSMB9;KDM4C;FZD1;KLHL12;SOX9;ISL1;BCHE;TCF12;RET;TGFB2;LEF1;SEMA4B;YAP1;GDNF
3404,GO:0007188,0.0364587514082491,0.982608889833528,14,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,NOS1;ABCA1;GNG2;ADGRG6;PRKACB;RGS2;PDE4D;AKAP13;UCN2;PRKCA;HTR1B;CALCRL;SENP7;ADM2
7741,GO:0032268,0.0364953297033399,0.969411245067054,224,1897,regulation of cellular protein metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;GSN;PKD2;DUSP6;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;NOS1;GAS6;PDGFC;SNAI2;MAGED1;TFPI2;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;SERPINE1;SERPINH1;CRTAP;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;BMP4;PTK6;EIF2AK4;TRIM5;PDCD4;SORL1;TP53;WWTR1;PRICKLE1;PYCARD;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;HIP1;GPNMB;CRIM1;ELFN2;GPX1;CNTN1;KITLG;CTDSPL;MTHFR;LRP1;FYN;IFI6;XDH;B3GAT3;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;CLU;SERPING1;PRKCZ;SDR16C5;CAMK2D;PRDX5;ITGA1;MST1R;IL31RA;PER1;CCK;CAPRIN2;ANG;DUSP5;HERPUD1;WFS1;SPRY2;TTN;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;TLR3;SNCA;FZD7;GLG1;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;IL18;G6PD;EPHB6;EDA2R;FZD8;KDM4C;AFAP1L2;MAGEF1;FZD1;ENG;CALR;ATM;MDM2;FAM20A;CST3;AREG;IFNK;AKAP13;DGKQ;GCLC;NR2F2;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;RPL13A;PAK6;NAB2;MAP3K12;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;MAPK8IP3;CDKN2A;TSPYL2;RHBDD1;MAGI2;HSPA5;UVRAG;MDFIC;OPHN1;NUB1;ATRAID;DERL3;PPARG;RNF144B;BEX4;SNX9;SASH1;ZYG11B;UNK;PTPN3;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;NIPBL;PPP2R3A;RXRA;EDEM1;TAOK3;DMPK
7529,GO:0031802,0.0366803445125729,0.998477865045936,2,3,type 5 metabotropic glutamate receptor binding,MF,FYN;PRNP
9764,GO:0039694,0.0368314828097917,0.989323193275113,6,25,viral RNA genome replication,BP,PIK3C2G;APOBEC3C;HMGA2;APOBEC3G;APOBEC3F;ATG16L2
15433,GO:0071801,0.0368531732554169,0.993020771928351,4,12,regulation of podosome assembly,BP,GSN;ASAP1;FSCN1;ARHGEF2
13245,GO:0051961,0.0369057408799483,0.976974245022585,31,188,negative regulation of nervous system development,BP,VIM;ITM2C;EIF2AK4;SORL1;LGALS1;PTPRS;SEMA5A;GLI3;ASAP1;LRP1;ULK2;TP73;PRKACB;SEMA4A;NFATC4;PBX1;CALR;EFNB3;IDH2;MDM2;ARF6;ARHGEF2;SOX9;ISL1;DLX2;IFT122;GPR161;SEMA4B;DIXDC1;PPP3CA;KDM4A
9265,GO:0035720,0.0370311269739668,0.998455018442484,2,3,intraciliary anterograde transport,BP,IFT122;ICK
5058,GO:0015276,0.0370331130533315,0.985943329854839,9,39,ligand-gated ion channel activity,MF,PKD2;JPH2;CLCA2;DLG4;KCNJ15;KCNJ5;ANXA6;SCNN1A;ITPR2
6605,GO:0022834,0.0370331130533315,0.985943329854839,9,39,ligand-gated channel activity,MF,PKD2;JPH2;CLCA2;DLG4;KCNJ15;KCNJ5;ANXA6;SCNN1A;ITPR2
16634,GO:0097542,0.0370806923949452,0.985844224728176,9,41,ciliary tip,CC,GLI3;GLI2;IFT140;IFT27;IFT88;WDR19;IFT122;IFT74;ICK
4232,GO:0009416,0.0371767618042051,0.976337144735383,33,223,response to light stimulus,BP,XPC;SCARA3;EGFR;DDB2;EIF2AK4;NETO1;TP53;SIK1;GPX1;ERCC6;NPHP4;TP53INP1;PER1;PIK3R1;CIRBP;TP73;CAT;MME;SLC24A1;NFATC4;MDM2;MEIS2;CRTC1;RGS14;PRIMPOL;HOXA1;USP28;RHBDD1;TH;POLH;TAF1;ZBTB1;FOS
6799,GO:0030260,0.0372057700223273,0.98110419157305,16,93,entry into host cell,BP,ITGB6;ITGB5;GSN;ANPEP;GAS6;AXL;EGFR;TRIM38;TRIM5;LGALS1;ITGA2;CAV1;EFNB3;IFITM2;UVRAG;IFITM1
10854,GO:0044409,0.0372057700223273,0.98110419157305,16,93,entry into host,BP,ITGB6;ITGB5;GSN;ANPEP;GAS6;AXL;EGFR;TRIM38;TRIM5;LGALS1;ITGA2;CAV1;EFNB3;IFITM2;UVRAG;IFITM1
13168,GO:0051806,0.0372057700223273,0.98110419157305,16,93,entry into cell of other organism involved in symbiotic interaction,BP,ITGB6;ITGB5;GSN;ANPEP;GAS6;AXL;EGFR;TRIM38;TRIM5;LGALS1;ITGA2;CAV1;EFNB3;IFITM2;UVRAG;IFITM1
13175,GO:0051828,0.0372057700223273,0.98110419157305,16,93,entry into other organism involved in symbiotic interaction,BP,ITGB6;ITGB5;GSN;ANPEP;GAS6;AXL;EGFR;TRIM38;TRIM5;LGALS1;ITGA2;CAV1;EFNB3;IFITM2;UVRAG;IFITM1
6816,GO:0030285,0.0372375706199406,0.995418957187655,3,7,integral component of synaptic vesicle membrane,CC,PTPRS;SYT1;SV2A
10180,GO:0042805,0.0372531973906414,0.990327119464332,6,15,actinin binding,MF,PKD2;TTN;MAGI1;PPARG;OBSL1;RARA
17617,GO:1901379,0.0372918426627225,0.985826705208933,9,39,regulation of potassium ion transmembrane transport,BP,NETO1;ANO6;KCNAB2;CAV1;ANK3;PRNP;FHL1;KCNIP3;KCNRG
13046,GO:0051581,0.0373377576293585,0.998434942540936,2,3,negative regulation of neurotransmitter uptake,BP,NOS1;SNCA
7132,GO:0030983,0.0375468437163912,0.992691672119668,4,13,mismatched DNA binding,MF,XPC;MLH3;MSH5;MUTYH
6753,GO:0030194,0.0375676563573749,0.992557253081529,4,14,positive regulation of blood coagulation,BP,F2R;SERPINE1;ANO6;PDPN
17329,GO:1900048,0.0375676563573749,0.992557253081529,4,14,positive regulation of hemostasis,BP,F2R;SERPINE1;ANO6;PDPN
2244,GO:0005158,0.0376215253596347,0.989690114475627,6,18,insulin receptor binding,MF,IRS2;SNX1;PIK3R1;IGF1R;PTPN1;ENPP1
11266,GO:0045600,0.0376224437012515,0.986527948496283,8,37,positive regulation of fat cell differentiation,BP,SULT1E1;SFRP1;ZFP36L1;SNAI2;ADIRF;WDFY2;KLF5;PPARG
3719,GO:0008242,0.0376723355864545,0.995060400808138,3,8,omega peptidase activity,MF,BACE1;GGT7;PGPEP1
7849,GO:0032420,0.0378352448460771,0.989027116008926,6,24,stereocilium,CC,DOCK4;ESPN;BBS2;MYO3B;TRIOBP;MYO1C
14693,GO:0070372,0.0379513571703113,0.977271372990607,26,169,regulation of ERK1 and ERK2 cascade,BP,FN1;CTGF;F2R;DUSP6;GAS6;PDGFC;ROR1;AXL;EGFR;BMP4;PYCARD;PDGFA;GPNMB;PRKCZ;MST1R;SPRY2;FBLN1;SPRY4;FGFR1;IGF1R;EPHB6;PTPN1;PRKCA;RGS14;RET;CAMK2N1
750,GO:0001991,0.03797971948509,0.995003726045737,3,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R;GJA5;MME
17004,GO:0099503,0.0380511092352974,0.971559590751912,75,609,secretory vesicle,CC,SERPINE2;SYT8;FN1;PCDH7;PYGB;MMP9;CD109;GSN;ANPEP;GAS6;SLC2A3;THBS2;SERPINE1;STON2;TIMP2;PCSK1;PTPRS;PYCARD;DLG4;PDGFA;TIMP1;ANO6;SYN1;MAGED2;CTSV;KCNAB2;CAV1;CLU;SERPING1;CXCR1;ITGA1;SYTL1;METTL7A;SYT1;TMEM173;APLP2;HPS4;CAT;STOM;SNCA;FLOT2;MME;VAMP1;MLEC;CCDC136;SEPT6;CALR;TMED10;CST3;MANBA;HEXA;RNPEP;PRCP;NFASC;ANXA2;RAB13;FNDC3A;SEPT5;MAN2B1;MOSPD2;TGFB2;DNASE1L1;C2CD4C;TH;TCTEX1D4;NAPRT;ITPR2;LGALS3;DNAJC3;SV2A;ACTR1B;ADAM10;S100A11;CTSD;ZNRF1
2216,GO:0005114,0.0380526245745434,0.995277283232044,3,7,type II transforming growth factor beta receptor binding,MF,TGFBR3;ENG;TGFB2
19510,GO:1990440,0.0380805260427194,0.994771824040225,3,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,TP53;DDIT3;HSPA5
18593,GO:1903903,0.0380824371302245,0.99838578057019,2,3,regulation of establishment of T cell polarity,BP,GSN;FLOT2
10390,GO:0043249,0.0381947687832576,0.994963959130737,3,8,erythrocyte maturation,BP,FAM210B;G6PD;L3MBTL3
20260,GO:2001258,0.038477085630514,0.990305157145074,5,20,negative regulation of cation channel activity,BP,MMP9;PKD2;CAV1;ANK3;KCNRG
1973,GO:0004691,0.0384938588816573,0.99561481316119,3,6,cAMP-dependent protein kinase activity,MF,PRKACB;AKAP13;PRKAG1
14071,GO:0060935,0.0384981799527518,0.99835808512159,2,3,cardiac fibroblast cell differentiation,BP,PDCD4;TGFBR3
14072,GO:0060936,0.0384981799527518,0.99835808512159,2,3,cardiac fibroblast cell development,BP,PDCD4;TGFBR3
14073,GO:0060938,0.0384981799527518,0.99835808512159,2,3,epicardium-derived cardiac fibroblast cell differentiation,BP,PDCD4;TGFBR3
14074,GO:0060939,0.0384981799527518,0.99835808512159,2,3,epicardium-derived cardiac fibroblast cell development,BP,PDCD4;TGFBR3
9325,GO:0035845,0.0385388430295758,0.99519214181089,3,7,photoreceptor cell outer segment organization,BP,NPHP4;IFT140;BBS4
795,GO:0002065,0.038589094714162,0.981990824359131,13,69,columnar/cuboidal epithelial cell differentiation,BP,SLITRK6;SERPINE1;BMP4;PTK6;IL31RA;FGFR1;TRIOBP;DLX3;LRTOMT;LEF1;KLF5;RARA;RXRA
10453,GO:0043367,0.0387406335067847,0.986088156744078,8,36,CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RSAD2;RARA
1359,GO:0003231,0.0387881720990033,0.980886971761946,15,74,cardiac ventricle development,BP,TGFBR2;GJA5;BMP4;LTBP1;TGFBR3;FZD1;ENG;MDM2;CITED2;LMO4;VANGL2;ISL1;ZFPM1;TGFB2;RXRA
13742,GO:0060349,0.0388200091966274,0.983355200861568,11,52,bone morphogenesis,BP,TGFBR2;SERPINH1;BMP4;MEF2D;GLI3;GLG1;FOXN3;SOX9;NAB2;MEGF8;RARA
3245,GO:0006906,0.0388448339674023,0.978519378126895,20,120,vesicle fusion,BP,SYT8;SAMD9L;TBC1D8;VAV3;EVI5L;TBC1D5;SPG11;SYTL1;SYT1;DYSF;VAMP1;CALR;TMEM175;ANXA2;RAB13;VPS39;C2CD4C;UVRAG;TBC1D16;C2CD5
7108,GO:0030934,0.0389048932596377,1,2,2,anchoring collagen complex,CC,COL7A1;COL12A1
4807,GO:0014003,0.0389167854006832,0.988503570626484,6,26,oligodendrocyte development,BP,TENM4;GSN;CLU;PRDM8;HDAC11;MED12
20051,GO:2000725,0.0390304248648794,0.988670386862163,6,23,regulation of cardiac muscle cell differentiation,BP,SOX6;PAK1;BMP4;FZD7;DKK1;G6PD
11371,GO:0045777,0.0390811409473764,0.99229325686509,4,13,positive regulation of blood pressure,BP,WNK1;PDE4D;NR2F2;OXTR
6411,GO:0021681,0.0391171585068892,0.99509026864436,3,7,cerebellar granular layer development,BP,SERPINE2;OPHN1;TTBK2
12278,GO:0048640,0.0391346225613743,0.981780308779714,13,65,negative regulation of developmental growth,BP,SFRP1;TGFBR2;PAK1;BMP4;PTPRS;SEMA5A;ULK2;BBS2;JARID2;TP73;SEMA4A;G6PD;SEMA4B
1402,GO:0003337,0.0391596315457511,0.994784362316166,3,8,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,BMP4;STAT1;GDNF
12720,GO:0051015,0.0391836705165059,0.977500611947426,23,121,actin filament binding,MF,SYNE1;TLN2;MYH15;GSN;UTRN;EGFR;SPTB;SYNE3;CTNNAL1;HIP1;FLNC;ESPN;TTN;SHROOM4;FSCN1;TRIOBP;SYNE2;CAPG;OBSL1;WIPF1;LIMA1;MYH11;MYO1C
14744,GO:0070471,0.0392607334766558,0.998306824757772,2,3,uterine smooth muscle contraction,BP,ABAT;OXTR
14745,GO:0070472,0.0392607334766558,0.998306824757772,2,3,regulation of uterine smooth muscle contraction,BP,ABAT;OXTR
14746,GO:0070474,0.0392607334766558,0.998306824757772,2,3,positive regulation of uterine smooth muscle contraction,BP,ABAT;OXTR
10998,GO:0044854,0.0392907796928434,0.997637818657837,2,4,plasma membrane raft assembly,BP,FLOT1;CAV1
11001,GO:0044857,0.0392907796928434,0.997637818657837,2,4,plasma membrane raft organization,BP,FLOT1;CAV1
14816,GO:0070588,0.0393672054665205,0.976431706739589,26,154,calcium ion transmembrane transport,BP,F2R;PKD2;JPH2;NOS1;GAS6;HSPA2;SLC8A1;ORAI3;GJC2;NTSR1;AHNAK;DDIT3;ANO6;FYN;PLA2G6;EHD3;CAMK2D;SNCA;PDE4D;G6PD;SLC24A1;PRNP;ITPR2;CACNB1;CACNA2D3;ORAI2
9181,GO:0035581,0.0393874208132092,0.995470375899667,3,6,sequestering of extracellular ligand from receptor,BP,FBN1;FBN2;LTBP1
6660,GO:0030027,0.0394417945608077,0.976171805176795,27,155,lamellipodium,CC,FLOT1;APBB2;GSN;PKD2;MYLK;ACTA2;CSPG4;PSTPIP1;PAK1;PTPRM;SNX1;PLEK2;KITLG;PDPN;ARPIN;PXN;DYSF;FLOT2;FSCN1;RAPH1;AMOTL1;SYNE2;FGD4;SSH1;RAB13;PODXL;ARHGAP31
16847,GO:0098810,0.0394670206399672,0.994726744767754,3,8,neurotransmitter reuptake,BP,NOS1;SNCA;GDNF
7658,GO:0032098,0.0395569867567237,0.994709844902973,3,8,regulation of appetite,BP,CCK;BBS2;BBS4
8646,GO:0034220,0.0396349798478234,0.970191987549997,78,580,ion transmembrane transport,BP,MMP9;F2R;SLC7A8;ANO1;GJA5;PKD2;JPH2;IRS2;NOS1;GAS6;TCAF1;UTRN;TSC22D3;HSPA2;SLC8A1;ORAI3;CLCA2;GJC2;SLC20A1;ATP10D;NTSR1;ABCA1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;WNK1;DLG4;SLC7A11;ANO6;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;ATP8B2;SLC38A10;CPT1A;SLC38A2;CALHM2;ACACB;ANK3;DAPK1;KCNJ5;STOM;SNCA;PRKAB2;PDE4D;G6PD;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;TMEM63C;TMEM175;SLC39A11;PRNP;SCNN1A;FHL1;SFXN3;GOPC;SLC9A4;ITPR2;CACNB1;KCNIP3;SHISA9;PTPN3;ANKH;STEAP2;CACNA2D3;KCNRG;TUSC3;ORAI2;CPT2
18534,GO:1903779,0.0396580842396447,0.984798097967282,9,38,regulation of cardiac conduction,BP,GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;PDE4D;ITPR2;DMPK
7222,GO:0031128,0.0398152115160308,0.990175515034841,5,17,developmental induction,BP,BMP4;FGFR1;DKK1;SOX9;GDNF
17545,GO:1901184,0.0399017741835769,0.980618500567451,14,79,regulation of ERBB signaling pathway,BP,MMP9;GPRC5A;EGFR;DOK1;PTK6;ARAP1;HIP1;ITGA1;SPRY2;SH3TC2;AFAP1L2;CDH13;MVB12B;PTPN3
13204,GO:0051896,0.0399681683379749,0.977497201132411,21,124,regulation of protein kinase B signaling,BP,IRS2;GAS6;AXL;EGFR;SESN3;DDIT3;SEMA5A;PDGFA;HIP1;GPX1;KITLG;FYN;XDH;MST1R;PIK3R1;SPRY2;FGFR1;IL18;ENG;MAGI2;MEIS3
8932,GO:0034992,0.0399690267868875,0.996048943604862,3,5,microtubule organizing center attachment site,CC,SYNE1;SYNE3;SYNE2
8933,GO:0034993,0.0399690267868875,0.996048943604862,3,5,meiotic nuclear membrane microtubule tethering complex,CC,SYNE1;SYNE3;SYNE2
16207,GO:0090286,0.0399690267868875,0.996048943604862,3,5,cytoskeletal anchoring at nuclear membrane,BP,SYNE1;SYNE3;SYNE2
17189,GO:0106083,0.0399690267868875,0.996048943604862,3,5,nuclear membrane protein complex,CC,SYNE1;SYNE3;SYNE2
17192,GO:0106094,0.0399690267868875,0.996048943604862,3,5,nuclear membrane microtubule tethering complex,CC,SYNE1;SYNE3;SYNE2
3064,GO:0006631,0.0400158441394391,0.973949829631242,35,257,fatty acid metabolic process,BP,PTGS1;IRS2;SLC27A3;ACSL3;TYSND1;GPX1;PTGES;ECH1;CAV1;SLC27A1;ACSS1;ALDH3A2;CPT1A;ACACB;CES2;SNCA;CBR1;ALOX15B;PRKAB2;PDK3;ACSS2;THNSL2;SLC27A6;DECR1;ACSF2;ZADH2;CYP4V2;TH;PPARG;PRKAG1;AIG1;ACOT1;EHHADH;CPT2;ACAA2
15573,GO:0072088,0.040031420830618,0.982811703466859,11,50,nephron epithelium morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;STAT1;GLI3;LAMA5;PBX1;SOX9;GDNF;KLHL3
10360,GO:0043202,0.040056996567175,0.98174641773755,12,69,lysosomal lumen,CC,SDC3;CSPG4;NSG1;CTSV;NAGLU;MANBA;HEXA;SDC2;MAN2B1;LIPA;AGRN;CTSD
12743,GO:0051045,0.0400690700196476,0.994921165210225,3,7,negative regulation of membrane protein ectodomain proteolysis,BP,TIMP2;TIMP1;PTPN3
12282,GO:0048644,0.0402044455294661,0.982956626152949,11,44,muscle organ morphogenesis,BP,MYLK;ADARB1;TTN;TGFBR3;FZD1;ENG;VANGL2;ISL1;ZFPM1;TGFB2;RXRA
12291,GO:0048665,0.0402141458713863,0.994895238958185,3,7,neuron fate specification,BP,GLI3;GLI2;ISL1
4833,GO:0014044,0.0402566312272486,0.987223529538671,7,23,Schwann cell development,BP,AHNAK2;ADGRG6;PRX;SH3TC2;NDRG1;MED12;LAMB2
6698,GO:0030111,0.0403120596916148,0.973318793317143,38,259,regulation of Wnt signaling pathway,BP,SFRP1;APCDD1;SNAI2;SULF2;RNF213;TCF7L1;WWTR1;PRICKLE1;DDIT3;WNK1;RBMS3;ITGA3;GLI3;CDK14;LRP1;CAV1;NPHP4;CAPRIN2;MDFI;DKK1;PSMB9;SULF1;NFATC4;FOXL1;VANGL2;KLHL12;EGR1;SOX9;ISL1;IGFBP4;LEF1;IGFBP2;NPHP3;MDFIC;YAP1;DIXDC1;CCNY;MED12
1341,GO:0003205,0.0403893678483202,0.978086388147372,19,101,cardiac chamber development,BP,TGFBR2;GJA5;BMP4;LTBP1;ADGRG6;PARVA;TGFBR3;FZD1;ENG;MDM2;CITED2;LMO4;VANGL2;ISL1;ZFPM1;TGFB2;NPHP3;RARA;RXRA
15480,GO:0071887,0.0404374057322877,0.981545989580327,12,69,leukocyte apoptotic process,BP,IRS2;GAS6;AXL;TSC22D3;BMP4;TP53;GLI3;KITLG;ITPKB;BCL6;CDKN2A;LGALS3
13683,GO:0060271,0.0404879472995911,0.97262143076963,42,287,cilium assembly,BP,GSN;CEP126;RFX2;CEP250;WWTR1;CNTRL;EVI5L;ASAP1;SPATA6;NPHP4;EHD3;HAUS4;KIF17;PARVA;LAMA5;BBS2;IFT140;DZIP1L;SEPT6;BBS4;BBS1;SNX10;SYNE2;VANGL2;IFT27;SEPT5;IFT88;TTC8;STK36;WDR19;ODF2;IFT122;NPHP3;CFAP54;IFT74;TPGS1;DNAH1;ICK;ARL3;TMEM67;SEPT9;TTBK2
7192,GO:0031092,0.0406405331489072,0.992261211118962,4,11,platelet alpha granule membrane,CC,PCDH7;CD109;APLP2;SNCA
16547,GO:0097371,0.0406698411865111,0.994813538946761,3,7,MDM2/MDM4 family protein binding,MF,TP53;TP73;CDK5RAP3
2276,GO:0005227,0.0406770511103726,0.991873027742624,4,13,calcium activated cation channel activity,MF,ANO1;KCNMA1;ANO6;TMEM63C
13452,GO:0055017,0.0407407323236457,0.983245869030601,10,46,cardiac muscle tissue growth,BP,TGFBR2;TENM4;PAK1;JARID2;TP73;FGFR1;G6PD;TGFBR3;TGFB2;RXRA
14695,GO:0070374,0.0407980690369247,0.977678979933598,19,115,positive regulation of ERK1 and ERK2 cascade,BP,CTGF;F2R;GAS6;PDGFC;ROR1;AXL;EGFR;BMP4;PYCARD;PDGFA;GPNMB;PRKCZ;MST1R;SPRY2;FGFR1;IGF1R;EPHB6;PRKCA;RET
3655,GO:0008140,0.040841537138027,0.994466757007978,3,8,cAMP response element binding protein binding,MF,DDIT3;SIK1;CRTC1
11048,GO:0045069,0.0408619268506245,0.980641482852254,13,76,regulation of viral genome replication,BP,APOBEC3C;EIF2AK4;IFIT1;ADARB1;OAS2;HMGA2;APOBEC3G;STOM;APOBEC3F;IFITM2;RSAD2;SRPK2;IFITM1
2707,GO:0006083,0.0409877997100071,0.998188536314869,2,3,acetate metabolic process,BP,ACSS1;ACSS2
1434,GO:0003413,0.0410213076242925,0.9947502536892,3,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,TGFBR2;SERPINH1;SOX9
19719,GO:2000117,0.0410567863542766,0.980535446805219,13,76,negative regulation of cysteine-type endopeptidase activity,BP,TNFRSF6B;MMP9;GAS6;MICAL1;GPX1;IFI6;PRDX5;HERPUD1;SNCA;MDM2;CST3;MAP2K5;LEF1
19947,GO:2000551,0.0411554569937367,0.997460582456277,2,4,regulation of T-helper 2 cell cytokine production,BP,PRKCZ;RSAD2
12955,GO:0051385,0.0411986084928977,0.98942112938825,5,20,response to mineralocorticoid,BP,CTGF;NEFL;HTR1B;TH;FOS
13738,GO:0060343,0.0412351904714635,0.989861320717398,5,16,trabecula formation,BP,MMP2;SFRP1;FBN2;ADGRG6;TGFBR3
15390,GO:0071688,0.0414110454763632,1,3,3,striated muscle myosin thick filament assembly,BP,TTN;OBSL1;MYH11
10545,GO:0043525,0.0414144934738361,0.984837052926159,8,38,positive regulation of neuron apoptotic process,BP,NQO1;TP53;DDIT3;ITGA1;ATM;PRNP;TGFB2;SRPK2
766,GO:0002020,0.0415177803510534,0.978666285085225,16,89,protease binding,MF,FLOT1;FN1;CCBE1;SERPINE1;TIMP2;TP53;PYCARD;TIMP1;ITGA3;TYSND1;LRP1;TTN;FLOT2;CST3;ANXA2;PRNP
3443,GO:0007256,0.0415483097246419,0.995115148832114,3,6,activation of JNKK activity,BP,TNIK;ERCC6;NRK
1377,GO:0003274,0.041689787107575,0.998139594442439,2,3,endocardial cushion fusion,BP,TGFBR2;TGFB2
3434,GO:0007227,0.041790654459132,0.998132521384866,2,3,signal transduction downstream of smoothened,BP,STK36;IFT122
9331,GO:0035860,0.0418769809676834,0.998126459864587,2,3,glial cell-derived neurotrophic factor receptor signaling pathway,BP,SULF2;SULF1
12741,GO:0051043,0.0419108187789294,0.98928113680143,5,19,regulation of membrane protein ectodomain proteolysis,BP,TIMP2;TIMP1;SNX33;SNX9;PTPN3
11912,GO:0046982,0.0419959844886092,0.971261427964262,43,348,protein heterodimerization activity,MF,FLOT1;SOX6;TENM4;AXL;EGFR;NTSR1;TENM3;NEFL;TP53;DDIT3;MEF2D;ITGA2;PDGFA;HIP1;ITGA3;SNX1;CAV1;PIK3R1;SYT1;FLOT2;PBX1;TCF4;GCLC;HEXA;SOX9;MPP7;TCF12;TAF8;TGFB2;CENPA;UGT1A3;UGT1A6;YAP1;RALGAPB;PPARG;MEF2A;RARA;TAF1;FZD4;ZBTB1;PPP3CA;FOS;RXRA
7654,GO:0032094,0.0420487305908583,0.989342883154992,5,18,response to food,BP,CPS1;CCK;BBS2;G6PD;BBS4
4416,GO:0010224,0.0421151099384361,0.991340436643859,4,14,response to UV-B,BP,XPC;TP53;ERCC6;MME
7324,GO:0031345,0.0421314623337858,0.97613886137131,21,124,negative regulation of cell projection organization,BP,VIM;ITM2C;LGALS1;PTPRS;SEMA5A;ITGA3;EVI5L;ASAP1;LRP1;FYN;ULK2;ARPIN;SPRY2;SEMA4A;NFATC4;EFNB3;MDM2;ARF6;PRNP;SEMA4B;PPP3CA
19253,GO:1905475,0.0421534795122748,0.976405995256058,20,127,regulation of protein localization to membrane,BP,GSN;TCAF1;EGFR;PAK1;TP53;ACSL3;TFDP2;ITGA3;LRP1;FYN;PIK3R1;ANK3;TP73;STOM;ARF6;SSH1;PRNP;GOPC;MYO1C;C2CD5
3573,GO:0007620,0.0422734397078088,0.994191884966466,3,8,copulation,BP,SERPINE2;ABAT;OXTR
3130,GO:0006721,0.0422855357523505,0.98230056923304,10,52,terpenoid metabolic process,BP,EGFR;SDC3;LRP1;SDR16C5;ALDH3A2;SDC2;CYP4V2;AGRN;UGT1A3;SCPEP1
5208,GO:0015812,0.042303725886262,0.994989012516349,3,6,gamma-aminobutyric acid transport,BP,NTSR1;SV2A;ABAT
17488,GO:1900747,0.0423668814993688,0.998091919619131,2,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,XDH;ADGRA2
18007,GO:1902548,0.0423668814993688,0.998091919619131,2,3,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH;ADGRA2
13535,GO:0060027,0.0423995354761931,0.994499821144939,3,7,convergent extension involved in gastrulation,BP,SFRP1;VANGL2;NPHP3
8065,GO:0032757,0.0424829238014706,0.98711428498888,6,27,positive regulation of interleukin-8 production,BP,F2R;SERPINE1;DDIT3;PYCARD;TLR3;AFAP1L2
11013,GO:0045006,0.0424954067674825,0.993558780441486,3,11,DNA deamination,BP,APOBEC3C;APOBEC3G;APOBEC3F
10220,GO:0042953,0.0426039112391704,0.994938610928982,3,6,lipoprotein transport,BP,LRP1;PPARG;MIA3
11006,GO:0044872,0.0426039112391704,0.994938610928982,3,6,lipoprotein localization,BP,LRP1;PPARG;MIA3
18647,GO:1904019,0.0426533236666835,0.980546915542053,12,61,epithelial cell apoptotic process,BP,ZFP36L1;TGFBR2;GSN;GAS6;SERPINE1;ANGPTL4;PDCD4;COL18A1;SEMA5A;ANO6;WFS1;ARF6
15744,GO:0072376,0.0426859156977641,0.988844548530083,5,21,protein activation cascade,BP,CLU;SERPING1;FBLN1;C5;PRCP
14578,GO:0070167,0.0426871960645758,0.983311577267588,9,40,regulation of biomineral tissue development,BP,GAS6;FBN2;SLC8A1;BMP4;ANO6;SOX9;ENPP1;ATRAID;ANKH
13945,GO:0060684,0.0426883459382266,0.997311316909785,2,4,epithelial-mesenchymal cell signaling,BP,BMP4;PDGFA
16864,GO:0098839,0.0427368888493371,0.994437975421932,3,7,postsynaptic density membrane,CC,NETO1;PTPRS;DLG4
17067,GO:0099634,0.0427368888493371,0.994437975421932,3,7,postsynaptic specialization membrane,CC,NETO1;PTPRS;DLG4
11079,GO:0045112,0.0428690435975808,0.998056266180569,2,3,integrin biosynthetic process,BP,COL5A1;TGFB2
14238,GO:0061333,0.0430084952363502,0.981311300477339,11,50,renal tubule morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;PBX1;SOX9;GDNF;KLHL3;COL4A1
8621,GO:0034163,0.0430205713870833,0.998045458413578,2,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS;RSAD2
6876,GO:0030395,0.0430313627257626,1,1,1,lactose binding,MF,LGALS1
8592,GO:0034117,0.0430313627257626,1,1,1,erythrocyte aggregation,BP,LGALS1
8593,GO:0034118,0.0430313627257626,1,1,1,regulation of erythrocyte aggregation,BP,LGALS1
8594,GO:0034120,0.0430313627257626,1,1,1,positive regulation of erythrocyte aggregation,BP,LGALS1
12057,GO:0048030,0.0430313627257626,1,1,1,disaccharide binding,MF,LGALS1
6148,GO:0019470,0.0430790579259644,0.997272761741754,2,4,4-hydroxyproline catabolic process,BP,PRODH;ALDH4A1
2289,GO:0005249,0.0431229806101655,0.987007822010704,6,25,voltage-gated potassium channel activity,MF,PKD2;KCNMA1;KCNAB2;KCNJ15;KCNJ5;KCNQ3
13805,GO:0060433,0.0431491999624934,0.994021772419309,3,8,bronchus development,BP,TGFBR2;BMP4;SOX9
7347,GO:0031400,0.0431650056055517,0.968556185995188,61,458,negative regulation of protein modification process,BP,PHACTR3;FLRT2;GPRC5A;SFRP1;GADD45B;CD109;CDKN2B;DDIT4;DUSP6;FLRT3;CRTAP;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;MICAL1;ADARB1;ELFN2;CTDSPL;FYN;XDH;CAV1;PIAS3;TRIB2;PRKCZ;SDR16C5;PER1;DUSP5;SPRY2;JARID2;FBLN1;TP73;SPRY4;SNCA;IGF1R;DKK1;RGS2;PDE4D;G6PD;KDM4C;ENG;DGKQ;GCLC;NR2F2;PTPN1;ENPP1;NCOR1;RGS14;PRNP;CDKN2A;BEX4;DNAJC3;TAF1;CTDSP2;KDM4A;CDK5RAP3;CAMK2N1;TAOK3
1376,GO:0003273,0.0432490061794394,0.998029122105667,2,3,cell migration involved in endocardial cushion formation,BP,SNAI2;ENG
8870,GO:0034702,0.0432584939907423,0.976688739334674,18,101,ion channel complex,CC,ANO1;NOS1;HSPA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;CAMK2D;HERPUD1;KCNJ5;PDE4D;KCNQ3;SCNN1A;CACNB1;KCNIP3;SHISA9
9250,GO:0035690,0.0433078764911707,0.971846125624427,34,238,cellular response to drug,BP,SFRP1;NQO1;DDIT4;GAS6;AXL;EGFR;SLC8A1;NR3C1;TP53;KLF9;FYN;ADIRF;TP53INP1;HMGA2;CHEK2;TLR3;SETX;MDM2;CST3;GCLC;ARHGEF2;SSH1;EGR1;SOX9;ABCC2;HTR1B;PRNP;AGRN;HSPA5;TH;ITPR2;TAF1;EFNA5;PPP3CA
6905,GO:0030506,0.0433131242500544,0.989802445432735,5,13,ankyrin binding,MF,SPTB;SLC8A1;PLEC;FLNC;OBSCN
16150,GO:0090199,0.0435099473023274,0.984932864457998,7,39,regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;PYCARD;GPX1;PLA2G6;CLU;LMNA
3592,GO:0008021,0.0435397479314331,0.977303630792817,16,103,synaptic vesicle,CC,SYT8;STON2;PTPRS;DLG4;SYN1;SYT1;SNCA;MME;VAMP1;SEPT6;RAB13;SEPT5;C2CD4C;TH;SV2A;ZNRF1
9576,GO:0036446,0.0435872764116634,0.998004835927168,2,3,myofibroblast differentiation,BP,PDCD4;TP53INP1
18949,GO:1904760,0.0435872764116634,0.998004835927168,2,3,regulation of myofibroblast differentiation,BP,PDCD4;TP53INP1
134,GO:0000281,0.0436001060594499,0.980072290636484,12,60,mitotic cytokinesis,BP,EFHC1;CUL7;SNX33;ANK3;SEPT6;BBS4;SEPT5;CENPA;SNX9;ARL3;RASA1;SEPT9
12798,GO:0051130,0.0436324241486636,0.965277125277304,118,905,positive regulation of cellular component organization,BP,FLOT1;FN1;FLRT2;MMP9;CTGF;SFRP1;SLITRK6;GSN;PROM2;NOS1;GAS6;SNAI2;AXL;FLRT3;DOCK5;THBS2;SERPINE1;S100A10;DDB2;AMIGO2;TENM3;PAK1;PTK6;NEFL;TP53;ARAP1;PYCARD;DLG4;SEMA5A;ITGA2;PHLDB1;HIP1;TFDP2;CUL7;ITGA3;TPBG;ANO6;GPX1;PLEK2;DLG5;CNTN1;TBC1D5;ASAP1;PDPN;PLXNB1;LRP1;FYN;CAV1;PLA2G6;DOCK11;ESPN;CLU;NPHP4;SDR16C5;ARPIN;PXN;CCK;SYT1;HHAT;CAPRIN2;JARID2;HPS4;TP73;METRN;ROBO1;SNCA;PLXNA2;COL16A1;FGFR1;IGF1R;FSCN1;RGS2;SETX;TRIOBP;FZD1;BBS4;CALR;NEGR1;ATM;ARF6;PLXNA1;TRAK1;FBXW8;SSH1;SOX9;ISL1;BCL6;CRTC1;ANXA2;MPP7;HMBOX1;MEGF8;RET;TGFB2;CDC42EP5;LRRN3;ULK1;AGRN;MAGI2;HSPA5;UVRAG;VPS13C;FHOD1;PPARG;SNX9;OBSL1;TAF1;EFNA5;FZD4;SLITRK5;WIPF1;PPP3CA;SEPT9;NIPBL;OXTR;MYO1C;C2CD5;DOCK1
12257,GO:0048592,0.0436651303320919,0.97705293647311,17,86,eye morphogenesis,BP,COL8A1;FBN1;EFEMP1;COL5A2;SDK1;FBN2;COL5A1;TENM3;PTPRM;BMP4;GLI3;NAGLU;BBS4;SOX9;IFT122;TH;NIPBL
4898,GO:0014832,0.0436924055677046,0.997997265072107,2,3,urinary bladder smooth muscle contraction,BP,KCNMA1;PLA2G6
4907,GO:0014848,0.0436924055677046,0.997997265072107,2,3,urinary tract smooth muscle contraction,BP,KCNMA1;PLA2G6
1320,GO:0003170,0.0436927821450132,0.985570672179417,7,26,heart valve development,BP,TGFBR2;GJA5;BMP4;MDM2;SOX9;ZFPM1;TGFB2
9695,GO:0038127,0.043739282184652,0.975113807859296,21,125,ERBB signaling pathway,BP,MMP9;GPRC5A;EFEMP1;EGFR;DOK1;PTK6;ARAP1;HIP1;ITGA1;PXN;PIK3R1;SPRY2;SH3TC2;PAG1;AFAP1L2;CDH13;AREG;SOX9;PRKCA;MVB12B;PTPN3
13869,GO:0060541,0.0437646504919351,0.974474711650583,23,130,respiratory system development,BP,CCBE1;CTGF;TGFBR2;EGFR;BMP4;PDGFA;ITGA3;GLI3;DLG5;PDPN;GLI2;LAMA5;SPRY2;FGFR1;VANGL2;SOX9;LIPA;LEF1;THRA;NPHP3;YAP1;RARA;CELSR1
6745,GO:0030175,0.0437713767020586,0.978707289955743,14,67,filopodium,CC,ITGA6;UTRN;ACTA2;ITGA3;KITLG;PDPN;FSCN1;RAPH1;ARF6;SYNE2;FGD4;PODXL;DEF6;ADGRA2
12445,GO:0050337,0.0438661119266067,1,1,1,thiosulfate-thiol sulfurtransferase activity,MF,TSTD1
15417,GO:0071733,0.0438667985069032,0.997984682090919,2,3,transcriptional activation by promoter-enhancer looping,BP,ZFPM1;NIPBL
16153,GO:0090202,0.0438667985069032,0.997984682090919,2,3,gene looping,BP,ZFPM1;NIPBL
16311,GO:0090579,0.0438667985069032,0.997984682090919,2,3,dsDNA loop formation,BP,ZFPM1;NIPBL
12322,GO:0048708,0.0438814027934303,0.982754666477358,9,40,astrocyte differentiation,BP,SERPINE2;SOX6;ROR1;EGFR;VIM;LRP1;SOX9;KDM4A;LAMB2
10358,GO:0043200,0.043969368562072,0.978328173770382,14,80,response to amino acid,BP,MMP2;CTGF;COL5A2;PDGFC;EGFR;SESN3;TP53;MTHFR;SESN1;FYN;CPS1;COL16A1;GCLC;COL4A1
10458,GO:0043372,0.0440019450214854,0.993395372141378,3,10,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;IL18;RARA
794,GO:0002064,0.0440275709724538,0.973931490437388,24,142,epithelial cell development,BP,SLITRK6;ACTA2;VIM;BMP4;COL18A1;PTPRS;GPX1;FGFR1;PDE4D;TRIOBP;LRTOMT;ENG;CST3;SOX9;RAB13;FNDC3A;PODXL;MAGI2;SLC9A4;FLNB;IFT74;KLF5;RARA;LAMB2
12567,GO:0050770,0.0441293617734788,0.974622403884479,22,120,regulation of axonogenesis,BP,FN1;DPYSL2;PAK1;NEFL;PTPRS;SEMA5A;MAP2;PLXNB1;UST;ULK2;METRN;ROBO1;PLXNA2;SEMA4A;EFNB3;PLXNA1;TRAK1;SSH1;MEGF8;RET;SEMA4B;EFNA5
1266,GO:0003044,0.044133443388447,0.988358608074601,5,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;GJA5;MME;PDE4D;OXTR
6655,GO:0030017,0.0442386345744749,0.975359775129451,20,104,sarcomere,CC,MMP2;SYNE1;TNNI2;JPH2;NOS1;SLC8A1;PAK1;SCN8A;FLNC;AHNAK2;PARVA;ANK3;TTN;OBSCN;FHOD3;SYNE2;SYNC;FLNB;OBSL1;PPP3CA
6808,GO:0030276,0.0442449957961531,0.981498766365909,10,47,clathrin binding,MF,SYT8;CLTCL1;TOM1L2;NSG1;HIP1;LRP1;SYTL1;SYT1;DNAJC6;C2CD4C
8089,GO:0032787,0.0442919671148224,0.96840771798198,53,411,monocarboxylic acid metabolic process,BP,DDIT4;PTGS1;IRS2;CSPG4;NR1D1;D2HGDH;SLC27A3;ACSL3;TYSND1;GPX1;PTGES;ECH1;CAV1;SLC27A1;HLCS;UST;ACSS1;ALDH3A2;CPT1A;ACACB;CES2;SNCA;CBR1;ALOX15B;PRKAB2;PDK3;DHTKD1;IDH2;ACSS2;ALDH4A1;THNSL2;SLC27A6;NCOR1;DECR1;ABCC2;ACSF2;DSEL;ZADH2;CYP4V2;OSBPL1A;TH;UGT1A3;UGT1A6;SRR;PPARG;PRKAG1;AIG1;ACOT1;SCPEP1;EHHADH;ABAT;CPT2;ACAA2
13660,GO:0060231,0.0443627582072202,0.990721538580568,4,14,mesenchymal to epithelial transition,BP,BMP4;STAT1;FZD7;GDNF
4287,GO:0009713,0.0443910224499531,0.993515654327798,3,9,catechol-containing compound biosynthetic process,BP,SNCA;TGFB2;TH
9986,GO:0042423,0.0443910224499531,0.993515654327798,3,9,catecholamine biosynthetic process,BP,SNCA;TGFB2;TH
15482,GO:0071889,0.0444712389808139,0.986668379127493,6,23,14-3-3 protein binding,MF,ZFP36L1;DDIT4;IRS2;SIK1;PRKCZ;SRPK2
647,GO:0001838,0.0444726889763267,0.975965837650845,18,100,embryonic epithelial tube formation,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;FZD1;BBS4;LMO4;VANGL2;SOX9;RET;TGFB2;IFT122;NPHP3;GDNF;RARA;MED12;CELSR1
2438,GO:0005641,0.0445439502196386,0.994103079349268,3,7,nuclear envelope lumen,CC,SORL1;PTGES;BCHE
10795,GO:0044304,0.044686052658237,0.982533436921947,9,37,main axon,CC,GJC2;SCN8A;SCN2A;DLG4;KCNAB2;CCK;ANK3;KCNQ3;NFASC
8564,GO:0034059,0.0447411849204538,0.997921140083104,2,3,response to anoxia,BP,CTGF;OXTR
12662,GO:0050906,0.0447493873669443,0.986189986103171,6,28,detection of stimulus involved in sensory perception,BP,SERPINE2;ANO1;NTSR1;ITGA2;FYN;OR2A4
3286,GO:0006978,0.044764783934105,0.98845331128456,5,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,TP53;TP73;CHEK2;SP100;ING4
11353,GO:0045742,0.0448678386233446,0.986348988595275,6,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,MMP9;DOK1;PTK6;ARAP1;HIP1;AFAP1L2
723,GO:0001953,0.0448705759759907,0.985006536679377,7,27,negative regulation of cell-matrix adhesion,BP,SERPINE1;PIK3R1;DLC1;BCL6;CDKN2A;POSTN;RASA1
6016,GO:0019079,0.0449209428426927,0.976535009672706,16,99,viral genome replication,BP,PIK3C2G;GAS6;APOBEC3C;EIF2AK4;IFIT1;ADARB1;OAS2;HMGA2;APOBEC3G;STOM;APOBEC3F;IFITM2;RSAD2;SRPK2;IFITM1;ATG16L2
15406,GO:0071711,0.0449794798612711,0.988841374726898,5,15,basement membrane organization,BP,FLRT2;NID1;PHLDB1;LAMC2;COL4A1
16140,GO:0090189,0.045021158329534,0.990538125013783,4,14,regulation of branching involved in ureteric bud morphogenesis,BP,MAGED1;BMP4;SOX9;GDNF
13853,GO:0060513,0.0450640010985843,0.994005581650119,3,7,prostatic bud formation,BP,BMP4;GLI2;SULF1
6772,GO:0030217,0.0451024240889363,0.973839833292631,22,136,T cell differentiation,BP,ZFP36L1;TGFBR2;ZFP36L2;BMP4;GLI3;GLI2;PRKCZ;FZD7;SEMA4A;IL18;FZD8;SOX13;CD1D;EGR1;ITPKB;BCL6;LEPR;ZFPM1;LEF1;RSAD2;RARA;ZBTB1
16728,GO:0098542,0.0452297378144134,0.970391555986284,34,266,defense response to other organism,BP,HTRA1;DDIT4;HERC5;SERPINE1;TKFC;IFI44L;APOBEC3C;EIF2AK4;TRIM5;STAT1;IFIT2;PYCARD;IFIT1;DDX60;ADARB1;IFIT3;SEC14L1;PLA2G6;MAP3K14;OAS2;IL31RA;TMEM173;APOBEC3G;TLR3;APOBEC3F;IFNK;IFNE;LYST;IFITM2;STAT2;RSAD2;IFITM1;DNAJC3;GBP3
7655,GO:0032095,0.0452704373567862,0.993603540846029,3,8,regulation of response to food,BP,CCK;BBS2;BBS4
10447,GO:0043331,0.0453239613064662,0.978249475783385,13,73,response to dsRNA,BP,FLOT1;EGFR;BMP4;IFIT1;ZCCHC11;CAV1;TMEM173;TLR3;IFNK;IFNE;NCOR1;PPP3CA;AGO4
15541,GO:0072028,0.0453709431749311,0.98006996993951,11,51,nephron morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;STAT1;GLI3;LAMA5;PBX1;SOX9;GDNF;KLHL3
3624,GO:0008083,0.0454622674871468,0.979597915441984,11,67,growth factor activity,MF,CTGF;EFEMP1;PDGFC;BMP4;PDGFA;TIMP1;KITLG;DKK1;AREG;TGFB2;GDNF
12797,GO:0051129,0.0454661241866991,0.966304373285106,67,491,negative regulation of cellular component organization,BP,GSN;PROM2;HSPA2;SPTB;VIM;TOM1L2;BMP4;ITM2C;SORL1;LGALS1;ARAP1;PTPRS;DLG4;SEMA5A;ITGA3;EVI5L;GPX1;ASAP1;EML2;LRP1;FYN;CAV1;SNX33;ESPN;CLU;PRKCZ;SDR16C5;ULK2;ARPIN;KANK2;SPRY2;JARID2;FBLN1;DLC1;PHF2;SNCA;LMNA;DKK1;SEMA4A;TRIOBP;KDM4C;NFATC4;BBS4;ATM;EFNB3;MDM2;ARF6;CST3;FHOD3;LMO4;ARHGEF2;RPL13A;PRNP;THRA;ULK1;SEMA4B;CAPG;POSTN;LGALS3;TMEM67;EFNA5;PPP3CA;LIMA1;KDM4A;KLHL22;TTBK2;ACAA2
18021,GO:1902576,0.0454906189384584,0.997030258984368,2,4,negative regulation of nuclear cell cycle DNA replication,BP,CHEK2;BCL6
2379,GO:0005516,0.0456420734758951,0.973033470313846,24,126,calmodulin binding,MF,MYH15;NOS1;MAP6;EGFR;SLC8A1;MYLK;ADD3;MAP2;PLA2G6;CAMK2D;SYT1;WFS1;PHKA2;TTN;DAPK1;RGS2;OBSCN;KCNQ3;ITPKB;SPA17;PPP3CA;MYH11;MYO1C;SNTB1
6562,GO:0022029,0.0456485465033257,0.98316323888659,8,34,telencephalon cell migration,BP,EGFR;LAMB1;EFHC1;GLI3;FUT10;ROBO1;SYNE2;DIXDC1
19048,GO:1904956,0.045661753471363,0.997012755689048,2,4,regulation of midbrain dopaminergic neuron differentiation,BP,SFRP1;DKK1
1325,GO:0003177,0.0457099741909004,0.994407950278778,3,6,pulmonary valve development,BP,GJA5;BMP4;TGFB2
1330,GO:0003184,0.0457099741909004,0.994407950278778,3,6,pulmonary valve morphogenesis,BP,GJA5;BMP4;TGFB2
7416,GO:0031528,0.0457252327909309,0.990506079308135,4,13,microvillus membrane,CC,PROM2;PDPN;SYTL1;PODXL
19718,GO:2000116,0.0458170924919082,0.971926041683262,26,190,regulation of cysteine-type endopeptidase activity,BP,TNFRSF6B;MMP9;CTGF;F2R;GSN;GAS6;PYCARD;MICAL1;HIP1;GPX1;FYN;IFI6;XDH;PRDX5;CCK;HERPUD1;DAPK1;DLC1;ROBO1;SNCA;PSMB9;MDM2;CST3;MAP2K5;LEF1;PPARG
745,GO:0001977,0.0458173594004935,0.993220525508924,3,9,renal system process involved in regulation of blood volume,BP,F2R;GJA5;GAS6
8062,GO:0032753,0.0458592111429359,0.993000263839803,3,10,positive regulation of interleukin-4 production,BP,IL20RB;PRKCZ;RARA
1153,GO:0002762,0.0459386956079493,0.98441238185074,7,29,negative regulation of myeloid leukocyte differentiation,BP,FBN1;INPP5D;SFRP1;PIK3R1;TLR3;ZFPM1;RARA
8496,GO:0033689,0.045938889860331,0.993840443878746,3,7,negative regulation of osteoblast proliferation,BP,SFRP1;PLXNB1;ATRAID
19739,GO:2000171,0.0459708482915929,0.988188278701002,5,17,negative regulation of dendrite development,BP,PTPRS;ASAP1;NFATC4;ARF6;PPP3CA
11324,GO:0045671,0.0460016674870319,0.988333692702584,5,16,negative regulation of osteoclast differentiation,BP,FBN1;INPP5D;SFRP1;PIK3R1;TLR3
16143,GO:0090192,0.0460069636747947,0.993180991396133,3,9,regulation of glomerulus development,BP,BMP4;EGR1;RET
12873,GO:0051246,0.0460110691619422,0.961010992640725,235,2011,regulation of protein metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;INPP5D;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;GSN;PKD2;DUSP6;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;NOS1;GAS6;PDGFC;SNAI2;MAGED1;TFPI2;ROR1;AXL;EGFR;HSPA2;FLRT3;GJC2;SERPINE1;SERPINH1;CRTAP;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;TADA3;PAK1;BMP4;ITM2C;PTK6;ABTB1;EIF2AK4;TRIM5;PDCD4;BTBD2;SORL1;TP53;WWTR1;PRICKLE1;PYCARD;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;HIP1;GPNMB;CRIM1;ELFN2;SNX1;GPX1;CNTN1;KITLG;CTDSPL;MTHFR;LRP1;FYN;IFI6;XDH;B3GAT3;LTBP4;CAV1;SLC27A1;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;CLU;SERPING1;PRKCZ;SDR16C5;CAMK2D;PRDX5;ITGA1;MST1R;IL31RA;PER1;CCK;CAPRIN2;ANG;DUSP5;HERPUD1;WFS1;SPRY2;TTN;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;TLR3;SNCA;FLOT2;FZD7;GLG1;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;PDE4D;PSMB9;IL18;G6PD;EPHB6;EDA2R;FZD8;KDM4C;AFAP1L2;MAGEF1;FZD1;ENG;CALR;ATM;MDM2;FAM20A;TMED10;CST3;AREG;IFNK;AKAP13;DGKQ;GCLC;NR2F2;IFNE;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;NCOR1;PRKCA;ANXA2;RGS14;IGFBP4;RPL13A;PAK6;NAB2;MAP3K12;PRNP;RET;ZFPM1;TGFB2;MAP2K5;STAT2;LEF1;ITM2A;MAPK8IP3;CDKN2A;TSPYL2;RHBDD1;MAGI2;HSPA5;UVRAG;MDFIC;OPHN1;NUB1;ATRAID;DERL3;PPARG;RNF144B;BEX4;SNX9;SASH1;ZYG11B;UNK;PTPN3;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;NIPBL;PPP2R3A;RXRA;EDEM1;TAOK3;DMPK
5319,GO:0016050,0.0460580289052721,0.968093563028772,45,318,vesicle organization,BP,SERPINE2;SYT8;F2R;COL7A1;SAMD9L;RFX2;S100A10;ALS2CL;ABCA1;TBC1D8;VAV3;DLG4;EVI5L;SNX1;TBC1D5;SRPX;SPG11;CAV1;SNX33;SYTL1;SYT1;DYSF;HPS4;VAMP1;SEC24D;CCDC136;CALR;TMED10;AREG;SNX10;KLHL12;LYST;TMEM175;ANXA2;RAB13;VPS39;C2CD4C;SNX7;UVRAG;SNX9;TBC1D16;MIA3;DNM1P46;VPS36;C2CD5
12157,GO:0048306,0.0461030465982123,0.983867489645428,7,38,calcium-dependent protein binding,MF,SYT8;SYN1;SYT1;WFS1;ANXA6;ANXA2;S100A11
1700,GO:0004185,0.0464932473103296,0.993358521817742,3,8,serine-type carboxypeptidase activity,MF,CPVL;PRCP;SCPEP1
6456,GO:0021784,0.0466665606435772,1,1,1,postganglionic parasympathetic fiber development,BP,GDNF
2103,GO:0004879,0.0466776618589218,0.984034573152373,7,30,nuclear receptor activity,MF,VDR;NR1D1;NR2F2;THRA;PPARG;RARA;RXRA
16722,GO:0098531,0.0466776618589218,0.984034573152373,7,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR;NR1D1;NR2F2;THRA;PPARG;RARA;RXRA
4827,GO:0014037,0.0467790716185918,0.982943597685445,8,30,Schwann cell differentiation,BP,AHNAK2;ADGRG6;PRX;SH3TC2;NDRG1;NAB2;MED12;LAMB2
426,GO:0001134,0.0467876305118011,0.98579531119628,6,23,transcription factor activity, transcription factor recruiting,MF,VDR;NR1D1;MYBL1;THRA;PPARG;RARA
4896,GO:0014829,0.0469849760762859,0.99036097975006,4,12,vascular smooth muscle contraction,BP,SLC8A1;DOCK5;DOCK4;BBS2
7478,GO:0031657,0.0471242636933581,0.990322863588694,4,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B;PKD2;EGFR;CDKN2A
15533,GO:0072010,0.0471481587822158,0.990316320621342,4,12,glomerular epithelium development,BP,BMP4;PODXL;MAGI2;LAMB2
1697,GO:0004177,0.0472433360975521,0.983560167535724,7,34,aminopeptidase activity,MF,ANPEP;CTSV;RNPEP;PRCP;DPP9;NPEPL1;RNPEPL1
5445,GO:0016323,0.0473734197071212,0.972483477339852,22,125,basolateral plasma membrane,CC,FLOT1;ITGA6;SLC7A8;PKD2;PROM2;EGFR;CLCA2;DLG4;ITGA3;PDPN;LRP1;MST1R;ANK3;SHROOM4;FLOT2;CD1D;VANGL2;ENPP1;ANXA2;LEPR;SLC9A4;MYO1C
629,GO:0001819,0.0474801888585007,0.968658880175151,35,253,positive regulation of cytokine production,BP,FLOT1;CCBE1;F2R;IL20RB;SULF2;SERPINE1;TKFC;STAT1;DDIT3;ZBTB20;PYCARD;DDX60;SEC14L1;POLR3GL;RNF135;CLU;PRKCZ;PIK3R1;TMEM173;TLR3;ALOX15B;C5;PDE4D;IL18;SULF1;AFAP1L2;NFATC4;ARHGEF2;EGR1;ISL1;ZFPM1;RSAD2;AGPAT1;POSTN;RARA
7286,GO:0031295,0.0475342545816318,0.983489760980293,7,33,T cell costimulation,BP,PAK1;LGALS1;FYN;CAV1;MAP3K14;PIK3R1;EFNB3
15566,GO:0072077,0.0476730093637077,0.990172306716166,4,12,renal vesicle morphogenesis,BP,BMP4;STAT1;SOX9;GDNF
15572,GO:0072087,0.0476730093637077,0.990172306716166,4,12,renal vesicle development,BP,BMP4;STAT1;SOX9;GDNF
11135,GO:0045211,0.0476930755803092,0.972712531749253,21,115,postsynaptic membrane,CC,SYNE1;F2R;UTRN;SLC8A1;NSG1;NETO1;KCNMA1;PTPRS;DLG4;HIP1;DLG5;ANK3;LZTS1;RGS14;NLGN4Y;GOPC;SHISA9;PRR7;DNM1P46;CAMK2N1;MPDZ
8949,GO:0035035,0.0477556807896857,0.985330768140138,6,24,histone acetyltransferase binding,MF,STAT1;TP53;GLI3;CITED2;EGR1;MEF2A
2313,GO:0005315,0.0477755229552294,0.997694834458459,2,3,inorganic phosphate transmembrane transporter activity,MF,SLC20A1;ANKH
16574,GO:0097435,0.0478014511386552,0.964436886753989,68,468,supramolecular fiber organization,BP,ITGB5;CTGF;SFRP1;RHOBTB2;ASAP3;GSN;COL5A2;COL5A1;SPTB;CEP126;SERPINH1;KRT14;S100A10;VIM;MFAP5;STMN3;PAK1;NEFM;NEFL;ARAP1;PYCARD;SEMA5A;MAP2;MICAL1;HIP1;GPX1;EML2;ARHGAP18;ESPN;CLU;ARPIN;KANK2;PXN;PIK3R1;ANG;TTN;SHROOM4;DLC1;SNCA;FSCN1;RGS2;OBSCN;TRIOBP;BBS4;MDM2;ARF6;CST3;AKAP13;FHOD3;ARHGEF2;COL5A3;SSH1;ANXA2;TGFB2;COL12A1;CDC42EP5;MSRB2;FHOD1;CAPG;MEF2A;OBSL1;WIPF1;RASA1;LIMA1;MYH11;TTBK2;RHOBTB3;MYO1C
15971,GO:0086010,0.0479243541332783,0.98572117168144,6,20,membrane depolarization during action potential,BP,GJA5;SLC8A1;SCN8A;SCN2A;ANK3;PTPN3
10807,GO:0044321,0.0479777142202087,0.98970292505301,4,14,response to leptin,BP,NR1D1;BBS2;BBS4;LEPR
13579,GO:0060078,0.0479855043517625,0.979564167527745,10,49,regulation of postsynaptic membrane potential,BP,SLC8A1;NTSR1;NETO1;DLG4;PRKCZ;SNCA;SSH1;PPP3CA;ABAT;DMPK
16248,GO:0090343,0.0479874170828917,0.992538991425254,3,10,positive regulation of cell aging,BP,HMGA2;LMNA;CDKN2A
14689,GO:0070365,0.0479914744550202,0.99305446505037,3,8,hepatocyte differentiation,BP,ITGA2;E2F7;CPS1
8580,GO:0034101,0.0480441707184168,0.975354964271731,15,87,erythrocyte homeostasis,BP,SOX6;INPP5D;ZFP36L1;AXL;FAM210B;BMP4;STAT1;RBFOX2;KLF13;G6PD;TGFBR3;L3MBTL3;BCL6;ZFPM1;THRA
1094,GO:0002684,0.048076036043653,0.963534985173188,76,613,positive regulation of immune system process,BP,FLOT1;MMP2;INPP5D;ZFP36L1;TGFBR2;IRS2;GAS6;AXL;SERPINE1;TKFC;FAM210B;CXCL14;PAK1;NR1D1;EIF2AK4;TRIM5;VAV3;STAT1;LGALS1;TP53;PTPRS;PYCARD;DDX60;MUC19;ITGA2;ANO6;GLI3;KITLG;ERMAP;SEC14L1;FYN;CAV1;GLI2;PLA2G6;MAP3K14;CLU;SERPING1;PRKCZ;PIK3R1;TMEM173;BTN3A1;PRKACB;TLR3;FLOT2;PAG1;C5;PDE4D;PSMB9;IL18;CALR;EFNB3;IFNK;CD1D;MAP3K1;ITPKB;BCL6;PRKCA;MOSPD2;PRNP;TGFB2;LEF1;IGFBP2;VAV2;BTN3A3;RSAD2;GCSAM;LGALS3;MIA3;RARA;WIPF1;ZBTB1;FOS;ELMO2;ADAM10;MYO1C;DOCK1
14141,GO:0061052,0.0481549621293228,0.996753384072365,2,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,PAK1;G6PD
13070,GO:0051610,0.0482107199251604,0.997661645211183,2,3,serotonin uptake,BP,NOS1;SNCA
6355,GO:0021543,0.0482269423042567,0.972750742650832,20,112,pallium development,BP,FAT4;EGFR;LAMB1;NEFL;PTPRS;EFHC1;GLI3;LRP1;FUT10;SLC38A2;BBS2;ROBO1;BBS4;SYNE2;DLX2;LEF1;TH;TACC2;DIXDC1;RARA
14130,GO:0061041,0.0482898769098887,0.97587508865761,14,80,regulation of wound healing,BP,SERPINE2;CD109;F2R;TGFBR2;MYLK;SERPINE1;PDGFA;ANO6;PDPN;CAV1;SERPING1;PRKCA;ANXA2;ABAT
1106,GO:0002696,0.0483308100804295,0.970584279505405,25,174,positive regulation of leukocyte activation,BP,INPP5D;TGFBR2;IRS2;GAS6;AXL;PAK1;VAV3;LGALS1;PYCARD;GLI3;FYN;CAV1;GLI2;MAP3K14;PRKCZ;PIK3R1;FLOT2;IL18;EFNB3;CD1D;ITPKB;BCL6;IGFBP2;RARA;ZBTB1
11366,GO:0045765,0.0483787263178667,0.969802235962835,28,174,regulation of angiogenesis,BP,CCBE1;SFRP1;TGFBR2;THBS2;SERPINE1;ANGPTL4;PTPRM;STAT1;SEMA5A;GPNMB;BTG1;HMGA2;SPRY2;TLR3;SEMA4A;C5;SULF1;ENG;ISL1;PRKCA;TGFB2;MAP2K5;SP100;ITGB8;PPARG;SASH1;ADGRA2;ADM2
18322,GO:1903319,0.0486094854520251,0.989700344233241,4,13,positive regulation of protein maturation,BP,CCBE1;GSN;PLGRKT;RHBDD1
6732,GO:0030158,0.0486400298534576,0.997628726512022,2,3,protein xylosyltransferase activity,MF,XYLT1;POGLUT1
7768,GO:0032303,0.0486698501034228,0.992618365020324,3,9,regulation of icosanoid secretion,BP,NTSR1;PLA2G6;PLA2R1
654,GO:0001845,0.0486959483509022,0.992612783199351,3,9,phagolysosome assembly,BP,SRPX;SPG11;TMEM175
15829,GO:0072577,0.0487496416238188,0.983315254970894,7,28,endothelial cell apoptotic process,BP,GAS6;SERPINE1;ANGPTL4;PDCD4;COL18A1;SEMA5A;ANO6
8023,GO:0032680,0.048785472356936,0.977091769352108,12,68,regulation of tumor necrosis factor production,BP,GAS6;AXL;ZBTB20;PYCARD;GPNMB;CLU;PIK3R1;TLR3;NFATC4;ARHGEF2;ISL1;RARA
4591,GO:0010711,0.0494134511144514,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13708,GO:0060309,0.0494134511144514,1,1,1,elastin catabolic process,BP,CST3
13709,GO:0060310,0.0494134511144514,1,1,1,regulation of elastin catabolic process,BP,CST3
13710,GO:0060311,0.0494134511144514,1,1,1,negative regulation of elastin catabolic process,BP,CST3
12238,GO:0048546,0.0494587054589114,0.983306076247862,7,25,digestive tract morphogenesis,BP,SFRP1;EGFR;BMP4;GLI3;GLI2;VANGL2;NIPBL
14700,GO:0070382,0.0494592437169483,0.97319383064017,17,112,exocytic vesicle,CC,SYT8;STON2;PTPRS;DLG4;SYN1;SYTL1;SYT1;SNCA;MME;VAMP1;SEPT6;RAB13;SEPT5;C2CD4C;TH;SV2A;ZNRF1
8301,GO:0033148,0.0494759362729256,0.992749073886999,3,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,SKP2;PAK1;YAP1
15182,GO:0071359,0.0495614107441854,0.977662207265714,11,58,cellular response to dsRNA,BP,FLOT1;EGFR;BMP4;IFIT1;ZCCHC11;CAV1;TMEM173;TLR3;NCOR1;PPP3CA;AGO4
13505,GO:0055117,0.0495819747206469,0.980001851911835,9,41,regulation of cardiac muscle contraction,BP,CTGF;GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;RGS2;PDE4D
3554,GO:0007597,0.0496211907972113,0.996081529896305,2,5,blood coagulation, intrinsic pathway,BP,SERPING1;PRCP
20153,GO:2001023,0.0496263170991082,0.980963986339159,8,42,regulation of response to drug,BP,TP53;ADIRF;HMGA2;SYT1;SNCA;HTR1B;GDNF;ABAT
5585,GO:0016616,0.0497158647019416,0.97630766805454,12,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,H6PD;PHGDH;KCNAB2;SDR16C5;HIBADH;CBR1;G6PD;IDH2;HSD17B11;AKR7A2;ZADH2;EHHADH
14839,GO:0070644,0.0497603160243954,0.997541993710253,2,3,vitamin D response element binding,MF,VDR;RXRA
3274,GO:0006955,0.0498186128702737,0.959344545078232,141,1222,immune response,BP,TNFRSF6B;FLOT1;MMP2;PYGB;MMP9;INPP5D;IL20RB;GSN;HERC5;ANPEP;GAS6;AXL;SLC2A3;VIM;PSTPIP1;TKFC;TIMP2;CXCL14;PAK1;APOBEC3C;TRIM38;NR1D1;PTK6;XAF1;EIF2AK4;TRIM5;VAV3;STAT1;IFIT2;LGALS1;PTPRS;PYCARD;IL32;IFIT1;DDX60;MUC19;PILRB;ADARB1;IFIT3;ANO6;GPX1;ERMAP;SEC14L1;KCNAB2;LRP1;FYN;IFI6;CAV1;RNF135;PLA2G6;DOCK11;MAP3K14;CLU;SERPING1;CXCR1;PRKCZ;OAS2;CAMK2D;MST1R;IL31RA;METTL7A;ULBP1;PIK3R1;TMEM173;APOBEC3G;CAT;DAPK1;BTN3A1;PRKACB;STOM;TLR3;SNCA;MME;PAG1;IGF1R;APOBEC3F;IFI35;MLEC;SEMA4A;C5;PDE4D;PSMB9;IL18;TGFBR3;CST3;MANBA;IFNK;IFNE;CD1D;MAP3K1;PTPN1;ARHGEF2;LYST;EGR1;ENPP1;BCL6;PRCP;NFASC;ANXA2;MAN2B1;IFITM2;MOSPD2;TCF12;RPL13A;RAB43;PRNP;ZFPM1;TGFB2;DNASE1L1;STAT2;LEF1;ITM2A;SPPL2B;SP100;VAV2;BTN3A3;RSAD2;FLNB;SRPK2;NAPRT;IFITM1;NUB1;COL17A1;PPARG;GCSAM;PRR7;LGALS3;DNAJC3;RARA;WIPF1;ZBTB1;PPP3CA;ACTR1B;FOS;CLEC2D;ELMO2;ADAM10;S100A11;MYO1C;CTSD;DOCK1
12297,GO:0048671,0.0498855173482462,0.997532226161595,2,3,negative regulation of collateral sprouting,BP,PTPRS;ULK2
16517,GO:0097305,0.0500142565549611,0.971997582406596,19,112,response to alcohol,BP,SFRP1;NQO1;TGFBR2;GSN;ABCA1;GNG2;TP53;FYN;TP53INP1;CAT;G6PD;TGFBR3;HTR1B;TH;ITPR2;PPARG;RARA;ABCA2;ABAT
10149,GO:0042755,0.0501370380985137,0.989081221133794,4,14,eating behavior,BP,CCK;CPT1A;TH;OXTR
3119,GO:0006701,0.0501726408836477,0.996537554234889,2,4,progesterone biosynthetic process,BP,DGKQ;EGR1
4818,GO:0014020,0.0502068352354316,0.974220446109969,15,80,primary neural tube formation,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;FZD1;BBS4;LMO4;VANGL2;TGFB2;IFT122;NPHP3;RARA;MED12;CELSR1
18198,GO:1903026,0.0502829714706058,0.995999508716383,2,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TAF1
6333,GO:0021513,0.0503059447386537,0.992995591645841,3,7,spinal cord dorsal/ventral patterning,BP,GLI3;GLI2;IFT122
5376,GO:0016202,0.0503536345443883,0.974113755747028,15,81,regulation of striated muscle tissue development,BP,FLOT1;SOX6;TGFBR2;JPH2;TSC22D3;PAK1;BMP4;JARID2;TP73;FZD7;FGFR1;DKK1;G6PD;TGFBR3;LEF1
401,GO:0001078,0.0504314726203332,0.972738648861085,17,101,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SOX6;SNAI2;KLF8;NR1D1;ZBTB20;ZFP90;TSHZ2;HMGA2;NFATC4;TSHZ1;ZFPM1;RBL2;KCNIP3;TGIF1;HES2;TSHZ3;PRDM5
9791,GO:0040037,0.0504762086559101,0.989169619464193,4,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,SULF2;SPRY2;SPRY4;SULF1
15454,GO:0071838,0.0505387045154366,0.996497834105201,2,4,cell proliferation in bone marrow,BP,HMGA2;LEF1
10161,GO:0042772,0.0505591557554103,0.986367573560664,5,19,DNA damage response, signal transduction resulting in transcription,BP,TP53;TP73;CHEK2;SP100;ING4
13744,GO:0060351,0.0506247744844188,0.98912707424329,4,13,cartilage development involved in endochondral bone morphogenesis,BP,TGFBR2;SERPINH1;SOX9;RARA
15267,GO:0071482,0.0506771097118974,0.973810261166294,15,87,cellular response to light stimulus,BP,XPC;DDB2;EIF2AK4;TP53;TP53INP1;PIK3R1;TP73;MME;NFATC4;MDM2;USP28;RHBDD1;POLH;TAF1;ZBTB1
11318,GO:0045665,0.0509007995906657,0.969386382831392,24,143,negative regulation of neuron differentiation,BP,VIM;ITM2C;EIF2AK4;LGALS1;PTPRS;SEMA5A;GLI3;ASAP1;LRP1;ULK2;TP73;SEMA4A;NFATC4;PBX1;CALR;EFNB3;MDM2;ARF6;SOX9;ISL1;DLX2;SEMA4B;DIXDC1;PPP3CA
6756,GO:0030199,0.0509020013135537,0.982497514065916,7,27,collagen fibril organization,BP,COL5A2;COL5A1;SERPINH1;COL5A3;ANXA2;TGFB2;COL12A1
15618,GO:0072161,0.0509057474955977,0.996457835212354,2,4,mesenchymal cell differentiation involved in kidney development,BP,BMP4;STAT1
20145,GO:2001012,0.0509057474955977,0.996457835212354,2,4,mesenchymal cell differentiation involved in renal system development,BP,BMP4;STAT1
10785,GO:0044291,0.0509769826615163,0.978227260442606,10,45,cell-cell contact zone,CC,FLOT1;GJA5;SLC8A1;PAK1;AHNAK;SCN2A;ANK3;FLOT2;FHOD1;OBSL1
8583,GO:0034105,0.0509934379601754,0.986216967740087,5,19,positive regulation of tissue remodeling,BP,EGFR;VDR;IL18;PRKCA;PPP3CA
13055,GO:0051591,0.0510048513989952,0.976036241675646,12,62,response to cAMP,BP,ZFP36L1;PKD2;SLC8A1;STAT1;MMP19;CPS1;PER1;AREG;DGKQ;HSPA5;ITPR2;FOS
7801,GO:0032365,0.0510097700876037,0.982277021676614,7,29,intracellular lipid transport,BP,ABCA1;CPT1A;ACACB;PRKAB2;ANXA2;ABCA2;CPT2
15108,GO:0071230,0.0510533778231178,0.977975630637395,10,50,cellular response to amino acid stimulus,BP,MMP2;COL5A2;PDGFC;EGFR;SESN3;SESN1;FYN;COL16A1;GCLC;COL4A1
9391,GO:0035967,0.0510561392025032,0.969877451828577,22,147,cellular response to topologically incorrect protein,BP,HSPA2;EXTL2;DDIT3;CUL7;PIK3R1;CREB3L2;HERPUD1;WFS1;PDIA6;LMNA;CALR;PTPN1;TSPYL2;RHBDD1;HSPA5;DERL3;DNAJC3;CREBRF;CTDSP2;CDK5RAP3;UGGT2;EDEM1
9395,GO:0035976,0.0510573318340886,0.995902724859911,2,5,transcription factor AP-1 complex,CC,DDIT3;FOS
10328,GO:0043154,0.051140430834274,0.975758671708978,12,70,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFRSF6B;MMP9;GAS6;MICAL1;GPX1;IFI6;PRDX5;HERPUD1;SNCA;MDM2;MAP2K5;LEF1
540,GO:0001659,0.0511681921607303,0.985929948758287,5,21,temperature homeostasis,BP,NTSR1;NR1D1;GPX1;SLC27A1;ABAT
14671,GO:0070325,0.0512604616579145,0.986259565570837,5,18,lipoprotein particle receptor binding,MF,LRP1;CLU;SYT1;DKK1;LANCL1
11295,GO:0045638,0.0512687212767364,0.976525821728174,11,67,negative regulation of myeloid cell differentiation,BP,FBN1;INPP5D;SFRP1;ZFP36L1;PIK3R1;KLF13;TLR3;MEIS2;ITPKB;ZFPM1;RARA
12128,GO:0048259,0.051282687507206,0.976783749267211,11,57,regulation of receptor-mediated endocytosis,BP,FLOT1;SERPINE1;DLG4;HIP1;TBC1D5;CLU;DKK1;ARF6;DNAJC6;ANXA2;MAGI2
16180,GO:0090244,0.0513165688346209,0.997419525273168,2,3,Wnt signaling pathway involved in somitogenesis,BP,SFRP1;DKK1
583,GO:0001738,0.0514143269667019,0.971008845021078,19,121,morphogenesis of a polarized epithelium,BP,SFRP1;ROR1;PRICKLE1;DLG5;LAMA5;FZD7;DKK1;ASTN2;PSMB9;FZD1;VANGL2;NPHP3;MAGI2;ARHGEF19;OPHN1;MYO9A;FZD4;MED12;CELSR1
3837,GO:0008449,0.0515581400830723,0.997400309310586,2,3,N-acetylglucosamine-6-sulfatase activity,MF,SULF2;SULF1
3403,GO:0007187,0.0515764265391436,0.974025947593294,14,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,NOS1;ABCA1;GNG2;ADGRG6;PRKACB;RGS2;PDE4D;AKAP13;UCN2;PRKCA;HTR1B;CALCRL;SENP7;ADM2
20209,GO:2001179,0.0516035564621867,0.995833931749819,2,5,regulation of interleukin-10 secretion,BP,PYCARD;PRKCZ
9266,GO:0035721,0.051618984504544,0.989071539621711,4,12,intraciliary retrograde transport,BP,IFT140;WDR19;IFT122;ICK
16738,GO:0098563,0.0516700320573821,0.988470853786659,4,15,intrinsic component of synaptic vesicle membrane,CC,PTPRS;SYN1;SYT1;SV2A
13697,GO:0060294,0.0518222930154241,0.991685396482834,3,10,cilium movement involved in cell motility,BP,BBS2;BBS4;CFAP54
7285,GO:0031294,0.051897623154041,0.981555291823459,7,34,lymphocyte costimulation,BP,PAK1;LGALS1;FYN;CAV1;MAP3K14;PIK3R1;EFNB3
15899,GO:0072716,0.0519325768687942,0.996345021065644,2,4,response to actinomycin D,BP,TP53;MDM2
13045,GO:0051580,0.0519428669488234,0.991908278704875,3,9,regulation of neurotransmitter uptake,BP,NOS1;SNCA;GDNF
18131,GO:1902904,0.051975028650632,0.972479460861058,16,89,negative regulation of supramolecular fiber organization,BP,GSN;SPTB;ARAP1;EML2;CLU;ARPIN;KANK2;DLC1;SNCA;TRIOBP;BBS4;FHOD3;ARHGEF2;CAPG;LIMA1;TTBK2
6973,GO:0030659,0.0520276743700139,0.961103633894457,67,506,cytoplasmic vesicle membrane,CC,SYT8;PCDH7;GPRC5A;CD109;PKD2;ANPEP;CLTCL1;MAP6;EGFR;SLC2A3;NSG1;PTPRS;DLG4;HIP1;ANO6;TBC1D5;SYN1;KCNAB2;LRP1;CAV1;SNX33;AHNAK2;CXCR1;ULK2;CAMK2D;SYT1;TMEM173;DYSF;APLP2;BACE1;LRIG3;STOM;SNCA;FLOT2;MME;VAMP1;MLEC;SEC24D;MYOF;CCDC136;CALR;COPG2;MDM2;TMED10;MANBA;AREG;KLHL12;PRCP;NFASC;RAB13;MOSPD2;RAB43;GPR161;C2CD4C;TH;SNX7;ITPR2;SNX9;LGALS3;RASSF9;SV2A;TMEM67;FZD4;ADAM10;MYO1C;C2CD5;ZNRF1
4337,GO:0009893,0.0520303483921876,0.955271185955668,279,2351,positive regulation of metabolic process,BP,FLOT1;FN1;MMP9;CCBE1;CTGF;SOX6;ITGA6;SFRP1;GADD45B;CDKN2B;ZFP36L1;F2R;TGFBR2;TNNI2;GSN;ETV5;PKD2;IRS2;DUSP6;ZFP36L2;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;ROR1;AXL;EGFR;HSPA2;SESN3;GJC2;RFX2;ACTA2;SERPINE1;VIM;NUPR1;CSPG4;MAP3K6;NTSR1;TIMP2;TADA3;PAK1;NSG1;VDR;BMP4;NR1D1;SMARCA2;PTK6;CITED4;EIF2AK4;TRIM5;VAV3;NR3C1;STAT1;SORL1;ETV1;TP53;ARAP1;WWTR1;PRICKLE1;DDIT3;PYCARD;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;PDGFA;RBMS3;ACSL3;HIP1;GPNMB;TFDP2;ITGA3;NFIX;SNX1;GLI3;E2F7;CNTN1;KITLG;TBC1D5;ABHD14B;ZFP90;SESN1;LRP1;FYN;XDH;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;PLA2G6;TRIB2;SNX33;MAP3K14;SMARCA1;ZNF318;CLU;PRKCZ;SDR16C5;TP53INP1;HMGA2;ITGA1;MST1R;IL31RA;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;HERPUD1;ANK3;WFS1;SPRY2;TTN;CIRBP;JARID2;FBLN1;TP73;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;PHF2;TLR3;SNCA;FZD7;FGFR1;IGF1R;DKK1;CTF1;C5;SETX;NCOA2;IL18;EPHB6;EDA2R;FZD8;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;MDM2;FAM20A;CST3;MEIS2;AREG;IFNK;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;LMO4;MAF;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;NRK;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;MYBL1;ANXA2;TRERF1;HLTF;HOXA1;METTL23;IGFBP4;TCF12;HMBOX1;NFAT5;PAK6;NAB2;MAP3K12;IRF2BPL;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;GPR161;LEF1;THRA;SSBP3;MAPK8IP3;SP100;ULK1;TEF;AGRN;VAV2;RHBDD1;MAGI2;HSPA5;TGFB1I1;SRPK2;UVRAG;ITGB8;MDFIC;VPS13C;FHOD1;IFT74;YAP1;GDNF;NUB1;KLF5;MEIS3;AGPAT1;PPARG;RNF144B;MEF2A;KLF7;SNX9;SASH1;DNAJC3;RARA;CCNY;PBX2;PRKAG1;TAF1;EFNA5;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;KDM4A;CDK5RAP3;FAM168A;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;ADM2;LITAF;MYO1C;RXRA;EDEM1;TAOK3
16769,GO:0098642,0.0521122841797127,0.99326309134076,3,6,network-forming collagen trimer,CC,COL8A1;COL4A4;COL4A1
16772,GO:0098645,0.0521122841797127,0.99326309134076,3,6,collagen network,CC,COL8A1;COL4A4;COL4A1
16776,GO:0098651,0.0521122841797127,0.99326309134076,3,6,basement membrane collagen trimer,CC,COL8A1;COL4A4;COL4A1
700,GO:0001921,0.0521515380549041,0.988687261157467,4,13,positive regulation of receptor recycling,BP,NSG1;ARAP1;SNCA;ANXA2
2267,GO:0005200,0.0521739694865724,0.973659671003028,14,79,structural constituent of cytoskeleton,MF,TLN2;SPTB;KRT14;VIM;ADD3;NEFM;NEFL;KRT5;PPL;HIP1;KRT15;ANK3;FRMD5;AGRN
4595,GO:0010715,0.0522668691172968,0.988887816797984,4,12,regulation of extracellular matrix disassembly,BP,PDPN;LRP1;FSCN1;CST3
8237,GO:0033028,0.0522919162902217,0.985532076606489,5,21,myeloid cell apoptotic process,BP,KITLG;ARF6;ITPKB;THRA;CDKN2A
12816,GO:0051153,0.0522998325680099,0.976212318177815,11,58,regulation of striated muscle cell differentiation,BP,FLOT1;SOX6;PAK1;BMP4;SIK1;FZD7;DKK1;G6PD;AKAP13;THRA;DMPK
4630,GO:0010757,0.0524608119296699,0.99628646292896,2,4,negative regulation of plasminogen activation,BP,SERPINE2;SERPINE1
17777,GO:1901897,0.052506946259424,0.997324303639997,2,3,regulation of relaxation of cardiac muscle,BP,CAMK2D;PDE4D
11235,GO:0045499,0.0525753259313195,0.985963466988192,5,17,chemorepellent activity,MF,FLRT2;FLRT3;SEMA4A;SEMA4B;EFNA5
6493,GO:0021869,0.0526159916987191,0.997315514146048,2,3,forebrain ventricular zone progenitor cell division,BP,FGFR1;DIXDC1
18218,GO:1903055,0.0526900161092284,0.988767375862172,4,12,positive regulation of extracellular matrix organization,BP,PHLDB1;PDPN;FSCN1;SOX9
1910,GO:0004602,0.0527042435881614,0.990864164829039,3,14,glutathione peroxidase activity,MF,GPX1;GPX8;GSTZ1
15456,GO:0071840,0.0527679172500456,0.953423925151765,543,4802,cellular component organization or biogenesis,BP,SERPINE2;CPA4;ITGB6;SYT8;FLOT1;MMP2;KRT4;HTRA1;FN1;FLRT2;MMP9;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;MARVELD1;ITGA6;SFRP1;RHOBTB2;APBB2;SYNE1;F2R;TLN2;FAT4;XPC;SLITRK6;ITGB4;TENM4;ASAP3;GSN;COL5A2;ETV5;GJA5;PKD2;IRS2;NID1;SDK1;TNIK;PROM2;COL7A1;CLTCL1;NOS1;GAS6;FBN2;PDGFC;SNAI2;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;SAMD9L;AXL;DPYSL2;EGFR;HSPA2;LAMB1;FLRT3;SPTB;CEP126;DOCK5;MYLK;SYNE3;CSMD3;THBS2;RFX2;SERPINE1;DOK1;ATP10D;SERPINH1;RNF213;KRT14;TCF7L1;S100A10;STON2;RNF165;C1QTNF6;VIM;DDB2;ALS2CL;MFAP5;AMIGO2;STMN3;ADD3;TOM1L2;TIMP2;TADA3;TENM3;PLEC;PAK1;ABCA1;ANGPTL4;NSG1;VDR;PTPRM;PADI3;BMP4;NEFM;TNS1;ITM2C;SMARCA2;PTK6;AHNAK;TBC1D8;EIF2AK4;NEFL;VAV3;NR3C1;COL18A1;SORL1;NEO1;IFIT2;LGALS1;KCNMA1;ETV1;TP53;ARAP1;CEP250;KRT13;PTPRS;TTLL11;WWTR1;DDIT3;CNTRL;CUL9;PYCARD;KRT5;EFHC1;DLG4;SEMA5A;ITGA2;PILRB;PDGFA;MAP2;MMP19;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHLDB1;HIP1;COL4A4;TFDP2;TEP1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;LIX1L;EVI5L;EMP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;DLG5;CNTN1;LPCAT2;TBC1D5;ASAP1;ERO1B;PLLP;LIMCH1;PDPN;MTHFR;SRPX;CCDC80;KRT15;NEK9;CTSV;SPG11;PLXNB1;PDE4DIP;EML2;LRP1;FYN;EMP3;IFI6;FLNC;LTBP4;ARHGAP18;CLMN;UGT8;LAMA3;CAV1;GLI2;RMI2;HLCS;RBFOX2;PLA2G6;ITGA10;SPATA6;DOCK11;SNX33;ESPN;SMARCA1;TNRC18;AHNAK2;UST;CLU;DCBLD2;NPHP4;PRKCZ;SLIT3;SDR16C5;ULK2;TP53INP1;IQSEC2;ARPIN;EHD3;HMGA2;CAMK2D;ADGRG6;GOLGB1;ITGA1;SYTL1;KANK2;HAUS4;PER1;ATP8B2;PXN;CCK;PIK3R1;SYT1;HHAT;NCAPD2;CAPRIN2;CPT1A;ACACB;PCLO;ANG;DYSF;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;ANK3;SPRY2;LAMB3;TTN;CIRBP;JARID2;HPS4;FBLN1;MLH3;TP73;CAT;SHROOM4;DLC1;PRKACB;CHEK2;METRN;ROBO1;IFT140;STOM;PRX;PHF2;FBXL7;SNCA;FLOT2;THSD4;FRMD5;GATAD1;VAMP1;FZD7;AIP;JADE2;SH3TC2;PLXNA2;SP110;COL16A1;DZIP1L;FGFR1;IGF1R;LMNA;DKK1;FSCN1;SEC24D;SEMA4A;RGS2;TGFBI;SETX;TGM2;OBSCN;SULF1;SPATA18;BRD3;G6PD;MYOF;TLE4;CCDC136;ARHGEF17;TRIOBP;KDM4C;CHD6;CDH13;NFATC4;TRAF1;RAPH1;SEPT6;TGFBR3;FZD1;AMOTL1;L3MBTL3;NAGLU;ENG;BBS4;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;MDM2;ARF6;TMED10;CST3;C17ORF49;AREG;TCF4;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;DGKQ;GCLC;PLXNA1;ACSS2;FHOD3;CBX7;LMO4;MSH5;TRAK1;FBXW8;SYNE2;HDAC11;RCBTB1;FGD4;PTPN1;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;COL5A3;NRK;SSH1;LYST;SOX9;ENPP1;IFT27;ISL1;BCL6;NFASC;CRTC1;NCOR1;NDRG1;PRKCA;MYBL1;TMEM175;ANXA2;RGS14;RAB13;PRIMPOL;HLTF;MPP7;SEPT5;BAHCC1;CEP68;IGFBP4;IFT88;GOLGA8B;TTC8;KCTD7;HMBOX1;RPL13A;PODXL;PAK6;DECR1;MAP3K12;CHD9;MEGF8;NLGN4Y;STK36;RAB43;WDR19;PRNP;CDH11;RET;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;OR2A4;COL12A1;STAT2;AMOTL2;IFT122;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;MSRB2;C2CD4C;CDKN2A;SP100;ULK1;TSPYL2;AGRN;IGFBP2;NPHP3;VAV2;TSPYL4;MAGI2;KIAA1109;HSPA5;CELF2;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;REEP2;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;CFAP54;ARHGEF19;VPS13C;FHOD1;IFT74;POLD4;SAP30L;TACC2;OPHN1;TPGS1;KCTD14;MYO9A;YAP1;CACNB1;GDNF;DNAH1;KLF5;COL17A1;GOLGA8N;SRR;YEATS2;DIXDC1;PPARG;CAPG;INF2;MEF2A;KLF7;SNX9;ICK;TBC1D16;OBSL1;ING4;OLFML2A;POSTN;UNK;LGALS3;ARL3;MIA3;NYAP1;FKBP10;COG3;ECM2;COL4A1;TMEM67;TAF1;EFNA5;FZD4;SLITRK5;WIPF1;ZBTB1;PPP3CA;PIK3C2B;SBF2;RASA1;LIMA1;PEX1;HP1BP3;COX18;CAPN6;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;MATN3;ELMO2;MYH11;NIPBL;VPS36;TTBK2;KCNRG;BSN;OXTR;ADAM10;PRDM5;RHOBTB3;CELSR1;PSMG4;ATG16L2;TSPAN4;EPG5;MYO1C;RXRA;C2CD5;ACAA2;ABCA5;DOCK1;DMPK;LAMB2
4437,GO:0010332,0.0527788769540554,0.977094276124275,10,50,response to gamma radiation,BP,TP53;GPX1;ERCC6;TP73;CHEK2;ATM;MDM2;EGR1;HSPA5;YAP1
17005,GO:0099504,0.052803424591072,0.972716163062807,15,79,synaptic vesicle cycle,BP,SYT8;STON2;SYN1;SYTL1;SYT1;PCLO;SNCA;DNAJC6;SEPT5;NLGN4Y;C2CD4C;MAGI2;TH;OPHN1;DNM1P46
896,GO:0002277,0.0528252931784903,1,1,1,myeloid dendritic cell activation involved in immune response,BP,PYCARD
1053,GO:0002582,0.0528252931784903,1,1,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
1056,GO:0002585,0.0528252931784903,1,1,1,positive regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1059,GO:0002588,0.0528252931784903,1,1,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
5786,GO:0017024,0.0528252931784903,1,1,1,myosin I binding,MF,PYCARD
4459,GO:0010457,0.0528269149280109,0.989017714812744,4,11,centriole-centriole cohesion,BP,CEP250;CNTLN;CEP68;ODF2
13743,GO:0060350,0.0529489334831431,0.981365392760516,7,30,endochondral bone morphogenesis,BP,TGFBR2;SERPINH1;BMP4;MEF2D;SOX9;NAB2;RARA
14472,GO:0061971,0.0529489334831431,0.981365392760516,7,30,replacement bone morphogenesis,BP,TGFBR2;SERPINH1;BMP4;MEF2D;SOX9;NAB2;RARA
18590,GO:1903900,0.0530211037689963,0.971003752472328,17,112,regulation of viral life cycle,BP,GSN;APOBEC3C;TRIM38;EIF2AK4;TRIM5;LGALS1;IFIT1;ADARB1;OAS2;HMGA2;APOBEC3G;STOM;APOBEC3F;IFITM2;RSAD2;SRPK2;IFITM1
13053,GO:0051589,0.0530612301118601,0.988422982249223,4,13,negative regulation of neurotransmitter transport,BP,NOS1;SNCA;HTR1B;ABAT
10810,GO:0044324,0.053213281064492,1,1,1,regulation of transcription involved in anterior/posterior axis specification,BP,DDIT3
19669,GO:2000016,0.053213281064492,1,1,1,negative regulation of determination of dorsal identity,BP,DDIT3
18581,GO:1903891,0.0532530949385956,0.996197970556853,2,4,regulation of ATF6-mediated unfolded protein response,BP,WFS1;HSPA5
2617,GO:0005938,0.0532728945886549,0.964441583867968,36,224,cell cortex,CC,FLOT1;CTGF;RHOBTB2;GSN;PKD2;UTRN;SPTB;ADD3;DLG4;PHLDB1;HIP1;LAMC2;CAV1;PRKCZ;PXN;PCLO;SHROOM4;DLC1;SNCA;FLOT2;ASTN2;TRIOBP;SEPT6;MKLN1;ARF6;AKAP13;CRIP2;ANXA2;SEPT5;FLNB;ITPR2;WIPF1;SEPT9;BSN;RHOBTB3;C2CD5
11003,GO:0044860,0.0533305737299683,0.996189274142891,2,4,protein localization to plasma membrane raft,BP,CAV1;FLOT2
8040,GO:0032713,0.053331351276203,0.996189186830755,2,4,negative regulation of interleukin-4 production,BP,ZFPM1;LEF1
19966,GO:2000586,0.0533326988103996,0.992390424936949,3,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFA;HIP1;LRP1
13939,GO:0060675,0.0533883317404682,0.978212209064328,9,40,ureteric bud morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;PBX1;SOX9;GDNF
15624,GO:0072171,0.0533883317404682,0.978212209064328,9,40,mesonephric tubule morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;PBX1;SOX9;GDNF
15266,GO:0071481,0.0535012831934604,0.988829520075193,4,11,cellular response to X-ray,BP,SFRP1;HMGA2;ATM;NIPBL
12123,GO:0048251,0.0535854845889729,0.992339172262225,3,7,elastic fiber assembly,BP,EFEMP2;THSD4;MYH11
13219,GO:0051923,0.0535982022832938,0.991541536138525,3,9,sulfation,BP,SULT1E1;UST;TPST1
10965,GO:0044782,0.0537137247741836,0.962858305111326,42,293,cilium organization,BP,GSN;CEP126;RFX2;CEP250;WWTR1;CNTRL;EVI5L;ASAP1;SPATA6;NPHP4;EHD3;HAUS4;KIF17;PARVA;LAMA5;BBS2;IFT140;DZIP1L;SEPT6;BBS4;BBS1;SNX10;SYNE2;VANGL2;IFT27;SEPT5;IFT88;TTC8;STK36;WDR19;ODF2;IFT122;NPHP3;CFAP54;IFT74;TPGS1;DNAH1;ICK;ARL3;TMEM67;SEPT9;TTBK2
2404,GO:0005577,0.0538249218756816,0.997217323434124,2,3,fibrinogen complex,CC,FN1;FBLN1
12589,GO:0050798,0.0538296929887157,0.982536028887391,6,29,activated T cell proliferation,BP,PYCARD;FYN;BTN3A1;IL18;PRNP;IGFBP2
4855,GO:0014074,0.0539121487405916,0.971239119950826,16,93,response to purine-containing compound,BP,ZFP36L1;PKD2;SLC8A1;STAT1;TP53;MMP19;CPS1;PER1;AREG;DGKQ;SSH1;HSPA5;ITPR2;PPARG;TAF1;FOS
6792,GO:0030246,0.053946963886329,0.969379224838931,19,123,carbohydrate binding,MF,GALNT10;SLC2A3;LGALS9C;MRC2;LGALS1;CNTN1;P3H2;MLEC;PLA2R1;G6PD;ENG;CALR;MANBA;ENPP1;PRPS2;MAN2B1;GALNT2;LGALS3;CLEC2D
12606,GO:0050820,0.0539779367814715,0.987779379558854,4,15,positive regulation of coagulation,BP,F2R;SERPINE1;ANO6;PDPN
5723,GO:0016874,0.0539955295950304,0.968808724798754,20,135,ligase activity,MF,TTLL11;SLC27A3;ACSL3;CPS1;SLC27A1;HLCS;ACSS1;ACACB;AARS;MDM2;GCLC;ACSS2;NEURL1B;SLC27A6;ACSF2;LIG1;NAPRT;TPGS1;UBA7;PPCS
606,GO:0001775,0.0540072281006983,0.957142238314595,104,858,cell activation,BP,SERPINE2;PYGB;MMP9;CTGF;INPP5D;SFRP1;ZFP36L1;F2R;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;ANPEP;GAS6;AXL;EGFR;SLC2A3;TIMP2;PAK1;BMP4;EIF2AK4;VAV3;LGALS1;GNG2;PYCARD;SLC7A11;PDGFA;TIMP1;GPNMB;ANO6;GLI3;DLG5;PDPN;KCNAB2;LRP1;FYN;CAV1;GLI2;DOCK11;MAP3K14;CLU;CXCR1;PRKCZ;IL31RA;METTL7A;ULBP1;PIK3R1;TMEM173;CAT;BTN3A1;STOM;TLR3;SNCA;FLOT2;MME;FZD7;PAG1;MLEC;SEMA4A;IL18;FZD8;SOX13;ATM;EFNB3;CST3;MANBA;IFNK;DGKQ;GCLC;IFNE;LMO4;CD1D;EGR1;ITPKB;BCL6;PRCP;NFASC;NDRG1;PRKCA;ANXA2;LEPR;MAN2B1;MOSPD2;PRNP;ZFPM1;DNASE1L1;LEF1;ITM2A;IGFBP2;VAV2;RSAD2;NAPRT;ITPR2;LGALS3;DNAJC3;RARA;ZBTB1;PPP3CA;ACTR1B;ABAT;ADAM10;S100A11;CTSD
15591,GO:0072109,0.0541514721880885,0.991417835147154,3,9,glomerular mesangium development,BP,ACTA2;BMP4;EGR1
3249,GO:0006911,0.0543310981157157,0.982658919433182,6,25,phagocytosis, engulfment,BP,GSN;ABCA1;ITGA2;ANO6;PPARG;DOCK1
10485,GO:0043409,0.054390348636084,0.968614083440324,20,129,negative regulation of MAPK cascade,BP,SFRP1;DUSP6;BMP4;PDCD4;SORL1;CAV1;PER1;DUSP5;SPRY2;FBLN1;TP73;SPRY4;IGF1R;RGS2;PTPN1;NCOR1;RGS14;CDK5RAP3;CAMK2N1;TAOK3
1413,GO:0003351,0.0544542298284793,0.991083303146927,3,10,epithelial cilium movement,BP,STK36;SPA17;NPHP3
1626,GO:0004065,0.054707034988123,0.991640937510419,3,8,arylsulfatase activity,MF,SULF2;SULF1;ARSD
12273,GO:0048634,0.0548917795900985,0.971412823459808,15,82,regulation of muscle organ development,BP,FLOT1;SOX6;TGFBR2;JPH2;TSC22D3;PAK1;BMP4;JARID2;TP73;FZD7;FGFR1;DKK1;G6PD;TGFBR3;LEF1
15493,GO:0071907,0.0549246800244837,0.997126815607313,2,3,determination of digestive tract left/right asymmetry,BP,MEGF8;NPHP3
11764,GO:0046651,0.054953097292528,0.967674619377247,21,148,lymphocyte proliferation,BP,INPP5D;TGFBR2;IL20RB;IRS2;BMP4;VAV3;PYCARD;GPNMB;DLG5;FYN;BTN3A1;IL18;ATM;IFNK;IFNE;CD1D;BCL6;PRNP;LEF1;IGFBP2;LGALS3
11720,GO:0046580,0.0549693761997789,0.977381364997369,9,41,negative regulation of Ras protein signal transduction,BP,STMN3;TIMP2;ITGA3;SPRY2;DLC1;SPRY4;BCL6;TGFB2;RASA1
15057,GO:0071072,0.055037199323369,0.995995803210619,2,4,negative regulation of phospholipid biosynthetic process,BP,PDGFA;SLC27A1
757,GO:0001999,0.0551078789498771,0.995987711900621,2,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R;GJA5
758,GO:0002001,0.0551078789498771,0.995987711900621,2,4,renin secretion into blood stream,BP,F2R;GJA5
16362,GO:0097009,0.0552255333031513,0.987787638796094,4,13,energy homeostasis,BP,ACACB;PRCP;CRTC1;LEPR
888,GO:0002262,0.0552420650401601,0.969735295696027,17,104,myeloid cell homeostasis,BP,SOX6;INPP5D;ZFP36L1;AXL;FAM210B;BMP4;STAT1;KITLG;RBFOX2;KLF13;G6PD;TGFBR3;L3MBTL3;ITPKB;BCL6;ZFPM1;THRA
12082,GO:0048145,0.0552557999229237,0.974537455530314,11,61,regulation of fibroblast proliferation,BP,FN1;SFRP1;GAS6;PDGFC;EGFR;NUPR1;TP53;PDGFA;TP53INP1;ANXA2;PPARG
11452,GO:0045932,0.0553395715199084,0.987544134166763,4,14,negative regulation of muscle contraction,BP,DOCK5;DOCK4;RGS2;CALCRL
3579,GO:0007626,0.0553724811598367,0.96923829108069,18,100,locomotory behavior,BP,SLITRK6;ETV5;NTSR1;DLG4;NAV2;SPG11;ESPN;SNCA;NCOA2;NAGLU;NEGR1;EFNB3;TH;GDNF;FZD4;ANKH;ABAT;CELSR1
16126,GO:0090174,0.0553983487546901,0.968007240207934,20,125,organelle membrane fusion,BP,SYT8;SAMD9L;TBC1D8;VAV3;EVI5L;TBC1D5;SPG11;SYTL1;SYT1;DYSF;VAMP1;CALR;TMEM175;ANXA2;RAB13;VPS39;C2CD4C;UVRAG;TBC1D16;C2CD5
10027,GO:0042501,0.0554484148586903,0.990852497805179,3,10,serine phosphorylation of STAT protein,BP,IFNK;IFNE;RET
14870,GO:0070700,0.055456637955291,0.9911238159749,3,9,BMP receptor binding,MF,BMP4;PYCARD;TGFB2
18002,GO:1902532,0.0557160350086184,0.959790206185632,52,390,negative regulation of intracellular signal transduction,BP,SERPINE2;FLRT2;MMP9;SFRP1;DDIT4;PKD2;DUSP6;SNAI2;FLRT3;SESN3;TKFC;STMN3;TIMP2;BMP4;PDCD4;STAT1;SORL1;DDIT3;PYCARD;ITGA3;GPX1;DLG5;SESN1;SEC14L1;XDH;CAV1;CLU;PER1;DUSP5;HERPUD1;WFS1;SPRY2;FBLN1;TP73;DLC1;SPRY4;IGF1R;RGS2;ATM;MDM2;PTPN1;ARHGEF2;BCL6;NCOR1;RGS14;PRNP;TGFB2;MAGI2;RASA1;CDK5RAP3;CAMK2N1;TAOK3
11594,GO:0046320,0.0557231086561603,0.985067012500763,5,16,regulation of fatty acid oxidation,BP,IRS2;TYSND1;CPT1A;ACACB;PPARG
14060,GO:0060914,0.0557271603030251,0.990568819898426,3,11,heart formation,BP,BMP4;DKK1;ISL1
6199,GO:0019695,0.055869755948429,0.99590009741935,2,4,choline metabolic process,BP,BCHE;ALDH7A1
9405,GO:0035989,0.0559483600987143,0.997041560534242,2,3,tendon development,BP,COL5A1;BMP4
8067,GO:0032760,0.0559753833309183,0.978193736819015,8,38,positive regulation of tumor necrosis factor production,BP,ZBTB20;PYCARD;CLU;PIK3R1;TLR3;NFATC4;ARHGEF2;ISL1
19461,GO:1990254,0.056139537451889,0.99586889969111,2,4,keratin filament binding,MF,KRT14;VIM
3063,GO:0006629,0.056198354265318,0.954787030448701,116,970,lipid metabolic process,BP,SULT1E1;CTGF;INPP5D;PTGS1;PITPNM3;PIK3C2G;IRS2;OSBPL10;SNAI2;EGFR;SDC3;MBOAT2;ABCA1;ANGPTL4;VDR;ISYNA1;NR1D1;VAV3;SORL1;SEC14L2;SLC27A3;PDGFA;ACSL3;SIK1;TYSND1;GPX1;PTGES;LPCAT2;KITLG;ECH1;LRP1;FYN;UGT8;CPS1;CAV1;SLC27A1;PLA2G6;SEL1L;OSBPL5;ACSS1;CLU;SDR16C5;PIK3R1;ALDH3A2;CPT1A;ACACB;ANG;CES2;CAT;PLCH2;SNCA;FGFR1;CBR1;ALOX15B;PRKAB2;NCOA2;ESYT2;PDK3;G6PD;ARSD;PBX1;BBS4;MTMR4;ATM;HSD17B11;DGKQ;NR2F2;ACSS2;HEXA;POGLUT1;SDC2;THNSL2;EGR1;SLC27A6;PLD3;NCOR1;TRERF1;ETNK2;CES3;LEPR;PGAP1;GAL3ST4;DECR1;CHD9;ACSF2;RBL2;LIPA;THRA;ZADH2;CYP4V2;EFR3A;OSBPL1A;AGRN;NPHP3;VAV2;TH;PIKFYVE;ITGB8;UGT1A3;LMF1;ALG10;AGPAT1;PPARG;CERS5;ABCA2;PRKAG1;MPPE1;PIK3C2B;AIG1;ACOT1;SCPEP1;EHHADH;NPAS2;RXRA;CPT2;ACAA2
10631,GO:0043691,0.056208101814447,0.991313969305166,3,8,reverse cholesterol transport,BP,ABCA1;CLU;ABCA5
6754,GO:0030195,0.0563553209379054,0.981435442093503,6,30,negative regulation of blood coagulation,BP,SERPINE2;SERPINE1;PDGFA;SERPING1;ANXA2;ABAT
17328,GO:1900047,0.0563553209379054,0.981435442093503,6,30,negative regulation of hemostasis,BP,SERPINE2;SERPINE1;PDGFA;SERPING1;ANXA2;ABAT
18447,GO:1903573,0.0564166612188924,0.979448071149044,7,36,negative regulation of response to endoplasmic reticulum stress,BP,CLU;HERPUD1;WFS1;PTPN1;HSPA5;DERL3;DNAJC3
1282,GO:0003085,0.0564292468253049,0.990902711311054,3,9,negative regulation of systemic arterial blood pressure,BP,NTSR1;BBS4;PRCP
8440,GO:0033591,0.0564683024482419,0.995830758799854,2,4,response to L-ascorbic acid,BP,ITGA2;CAT
17763,GO:1901861,0.0567578123792556,0.970300109886355,15,82,regulation of muscle tissue development,BP,FLOT1;SOX6;TGFBR2;JPH2;TSC22D3;PAK1;BMP4;JARID2;TP73;FZD7;FGFR1;DKK1;G6PD;TGFBR3;LEF1
12817,GO:0051154,0.0567814471122575,0.984325532985573,5,18,negative regulation of striated muscle cell differentiation,BP,SOX6;PAK1;FZD7;DKK1;G6PD
18435,GO:1903555,0.0568441180326252,0.972592503589797,12,70,regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6;AXL;ZBTB20;PYCARD;GPNMB;CLU;PIK3R1;TLR3;NFATC4;ARHGEF2;ISL1;RARA
904,GO:0002287,0.0569377324612952,0.979469124173344,7,32,alpha-beta T cell activation involved in immune response,BP,PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RARA
907,GO:0002293,0.0569377324612952,0.979469124173344,7,32,alpha-beta T cell differentiation involved in immune response,BP,PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RARA
908,GO:0002294,0.0569377324612952,0.979469124173344,7,32,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RARA
9830,GO:0042093,0.0569377324612952,0.979469124173344,7,32,T-helper cell differentiation,BP,PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RARA
1972,GO:0004690,0.0569386485449232,0.991649124274939,3,7,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB;AKAP13;PRKAG1
705,GO:0001931,0.0570939157123351,0.991119174847954,3,8,uropod,CC,FLOT1;PSTPIP1;FLOT2
7263,GO:0031254,0.0570939157123351,0.991119174847954,3,8,cell trailing edge,CC,FLOT1;PSTPIP1;FLOT2
3563,GO:0007608,0.0571986993515213,0.986981813071655,4,14,sensory perception of smell,BP,NAV2;BBS4;BBS1;OR2A4
13818,GO:0060448,0.0572316927729995,0.99693331486633,2,3,dichotomous subdivision of terminal units involved in lung branching,BP,VANGL2;CELSR1
3521,GO:0007498,0.0572382855516133,0.97161390077752,13,70,mesoderm development,BP,ZFP36L1;ITGB4;BMP4;MEST;ITGA2;ITGA3;HMGA2;FGFR1;DKK1;CITED2;POGLUT1;LEF1;YAP1
6330,GO:0021510,0.0572587465284223,0.974916538503709,10,47,spinal cord development,BP,PKD2;NEFL;PTPRS;ADARB1;GLI3;GLI2;LMO4;ISL1;IFT122;MED12
5128,GO:0015629,0.0575122927347143,0.95851721603223,52,347,actin cytoskeleton,CC,FLOT1;TLN2;MYH15;TNNI2;GSN;PKD2;UTRN;ROR1;SPTB;MYLK;PAK1;AHNAK;CCDC102A;HIP1;ASAP1;FYN;ESPN;PRKCZ;MST1R;ULBP1;PXN;PARVA;TTN;SHROOM4;DAPK1;DLC1;SNCA;FLOT2;FSCN1;APBB3;MYO3B;TRIOBP;IPP;AKAP13;FHOD3;VANGL2;ARHGEF2;MPRIP;SPPL2B;FLNB;FHOD1;OPHN1;MYO9A;CAPG;OBSL1;RARA;WIPF1;LIMA1;ACTR1B;SEPT9;MYH11;MYO1C
6773,GO:0030218,0.0575612488634207,0.970493189247489,14,80,erythrocyte differentiation,BP,SOX6;INPP5D;ZFP36L1;FAM210B;BMP4;STAT1;RBFOX2;KLF13;G6PD;TGFBR3;L3MBTL3;BCL6;ZFPM1;THRA
14271,GO:0061430,0.0575637701349763,0.987677535810037,4,11,bone trabecula morphogenesis,BP,MMP2;SFRP1;FBN2;PLXNB1
12193,GO:0048407,0.0576605396918514,0.991498114061038,3,7,platelet-derived growth factor binding,MF,COL5A1;PDGFA;COL4A1
1279,GO:0003081,0.0576835014780471,0.990326966010263,3,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R;GJA5;MME
12372,GO:0048821,0.0577464752473174,0.983687012870923,5,20,erythrocyte development,BP,SOX6;FAM210B;G6PD;L3MBTL3;BCL6
14274,GO:0061437,0.0577622716670075,0.986810026948722,4,14,renal system vasculature development,BP,PKD2;ACTA2;BMP4;EGR1
14277,GO:0061440,0.0577622716670075,0.986810026948722,4,14,kidney vasculature development,BP,PKD2;ACTA2;BMP4;EGR1
544,GO:0001664,0.0577704080522148,0.966897361942162,19,126,G-protein coupled receptor binding,MF,SFRP1;ITGB4;CXCL14;STAT1;ARAP1;ARHGEF1;DLG4;FYN;ARHGEF12;FZD7;C5;PDE4D;FZD1;BBS1;UCN2;PRNP;MAGI2;GOPC;REEP2
8185,GO:0032943,0.0578354284807419,0.965768722313747,21,149,mononuclear cell proliferation,BP,INPP5D;TGFBR2;IL20RB;IRS2;BMP4;VAV3;PYCARD;GPNMB;DLG5;FYN;BTN3A1;IL18;ATM;IFNK;IFNE;CD1D;BCL6;PRNP;LEF1;IGFBP2;LGALS3
17182,GO:0106071,0.0579558623046756,0.996871565498077,2,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;PRKCA
6074,GO:0019233,0.0580523190096075,0.977096930417242,8,40,sensory perception of pain,BP,F2R;ANO1;NTSR1;ITGA2;FYN;CCK;MME;NIPSNAP1
15473,GO:0071875,0.0580832382610069,0.987528006555064,4,11,adrenergic receptor signaling pathway,BP,NOS1;RGS2;PDE4D;AKAP13
7882,GO:0032461,0.0583142497481108,0.986288540702924,4,16,positive regulation of protein oligomerization,BP,TP53;CLU;CCK;SNX9
8049,GO:0032729,0.0585639628766751,0.98059230713555,6,29,positive regulation of interferon-gamma production,BP,PYCARD;TLR3;PDE4D;IL18;ISL1;ZFPM1
17547,GO:1901186,0.0585940334712532,0.980742897085969,6,27,positive regulation of ERBB signaling pathway,BP,MMP9;DOK1;PTK6;ARAP1;HIP1;AFAP1L2
12038,GO:0048010,0.0586530707365371,0.970721245157098,13,73,vascular endothelial growth factor receptor signaling pathway,BP,AXL;TMEM204;VAV3;FYN;PXN;PIK3R1;SULF1;MYOF;PTPN1;VAV2;FZD4;ELMO2;DOCK1
17606,GO:1901343,0.0586693992445358,0.970880552525008,13,67,negative regulation of vasculature development,BP,THBS2;SERPINE1;PTPRM;BMP4;PDCD4;STAT1;XDH;SPRY2;SEMA4A;SULF1;TGFB2;MAP2K5;PPARG
11281,GO:0045622,0.0587993144524322,0.986300573767608,4,15,regulation of T-helper cell differentiation,BP,PRKCZ;IL18;BCL6;RARA
15691,GO:0072284,0.0588897497364971,0.995545723483754,2,4,metanephric S-shaped body morphogenesis,BP,PKD2;BMP4
2378,GO:0005515,0.0589305981590018,0.948375564085912,896,8298,protein binding,MF,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;KRT4;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;SCARA3;IRS2;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;SKP2;COL7A1;BCAM;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MALL;MAP6;COL5A1;PHF21A;UTRN;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;TSC22D3;SDC3;PEG10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;CEP126;SLC8A1;NTM;FKBP5;ORAI3;DOCK5;SESN3;MYLK;SYNE3;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;KRT14;TCF7L1;S100A10;STON2;RNF165;ANXA5;C1QTNF6;VIM;NUPR1;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;ALS2CL;LGALS9C;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;TIMP2;ZNF862;TADA3;TENM3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;KIAA0040;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;FAM167A;ABTB1;RIN2;PCED1B;NETO1;FCGBP;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;GNG2;KCNMA1;ETV1;TP53;ARAP1;CEP250;KRT13;KIAA0319L;PTPRS;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;LTBP1;MEF2D;KRT5;IL32;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;DLG4;SLC7A11;ATXN7L1;SEMA5A;ITGA2;PILRB;ZCCHC11;PDGFA;MAP2;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;FLG;HIP1;PACS1;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;EVI5L;ZNF18;TTC28;KLF12;EMP1;IFIT3;NFIX;HIVEP1;TYSND1;SNX1;ANO6;GPX1;GLI3;CDK14;E2F7;DLG5;CNTN1;KITLG;TBC1D5;NAV2;ECH1;ERMAP;ASAP1;ERO1B;PLLP;SYN1;CTDSPL;LIMCH1;PDPN;ABHD14B;CCDC80;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;FLNC;TSHZ2;B3GAT3;LTBP4;ARHGAP18;CLMN;CPS1;LAMA3;POLR3GL;CAV1;SLC27A1;GLI2;IGFL1;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SPATA6;DOCK11;GLDC;SNX33;MAP3K14;ESPN;SMARCA1;ZNF318;DCAF16;AHNAK2;ACSS1;CLU;DCBLD2;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;PARP4;IQSEC2;KCNJ15;ARPIN;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;IL31RA;ULBP1;HAUS4;PTPN14;PER1;PXN;PDIA4;CCK;PIK3R1;SYT1;NCAPD2;TMEM173;CAPRIN2;CPT1A;SLC38A2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;LAMB3;TTN;TMEM139;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;APLP2;HPS4;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;CASP14;SHROOM4;DAPK1;DLC1;KLF13;BTN3A1;PRKACB;CHEK2;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;PAIP2B;STOM;PRX;PHF2;TLR3;SNCA;OARD1;FLOT2;ADAMTS7;MME;FRMD5;PDIA6;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;PLXNA2;COL16A1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;PDE4D;APBB3;WBP1;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;MYOF;TLE4;EPHB6;IL17RE;EDA2R;FZD8;TCEAL1;SETBP1;SOX13;ARHGEF17;TRIOBP;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;CD99L2;FOXN3;TRAF1;RAPH1;AKAP7;SEPT6;TGFBR3;DLX3;FZD1;DTNB;AMOTL1;IPP;NOTCH2NL;L3MBTL3;PBXIP1;PBX1;LAPTM4A;ENG;BBS4;MTMR4;LRRC20;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;SRGAP1;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;TBC1D19;DLK2;MEIS2;C17ORF49;TMEM14C;AREG;IFNK;TCF4;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;JMJD7;C20ORF194;DGKQ;CITED2;GCLC;NR2F2;ELMO3;FHOD3;HEXA;IFNE;NEURL1B;IGFL2;CBX7;DNAJC4;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;SYNE2;HDAC11;MAP3K1;FGD4;PTPN1;KCNQ3;CRIP2;VANGL2;ARHGEF2;DNAL4;NTNG1;PLGRKT;ALDH4A1;KLHL12;SDC2;COL5A3;THNSL2;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;C14ORF93;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;NDRG1;GCNT1;PRKCA;SALL2;PXMP2;BCHE;PRPS2;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;HLTF;HOXA1;MPP7;CXORF57;WDR63;SEPT5;RNF24;METTL23;LEPR;MAN2B1;CEP68;LANCL1;IGFBP4;IFT88;MVB12B;TES;TTC8;KCTD7;TCF25;TCF12;HMBOX1;C22ORF23;NFAT5;TTC23;PODXL;PAK6;ABCC2;NAB2;MAP3K12;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;HTR1B;STK36;RAB43;SPA17;WDR19;MUTYH;TAF8;PRNP;CDH11;RET;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;DLX2;ZNF550;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;USP28;ALDH7A1;ITM2A;MAPK8IP3;C11ORF68;MSRB2;TRIML2;C2CD4C;CDKN2A;MPRIP;RSRP1;HERPUD2;SPPL2B;OSBPL1A;SP100;ULK1;TEF;TSPYL2;AGRN;IGFBP2;ORC4;NPHP3;VAV2;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;KLHL5;GOPC;SNX7;MAGI1;ERICH2;BOC;CENPA;PIKFYVE;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;SEMA4B;ITGB8;NAPRT;MON2;ARHGEF19;ITPR2;ARHGAP29;MDFIC;C11ORF49;UGT1A3;FHOD1;IFT74;POLD4;SAP30L;IFITM1;TACC2;OPHN1;TPGS1;KCTD14;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;GDNF;DNAH1;RALGAPB;NUB1;KLF5;COL17A1;TWIST2;KLHL3;ATRAID;SRR;YEATS2;HOXA3;PRRC2B;UBA7;GALNT2;DIXDC1;DERL3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;OLFML2A;POSTN;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;CCNY;HES2;POLH;TMEM67;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;WIPF1;ADGRA2;ZBTB1;DPYD;PPP3CA;DCAF8;PIK3C2B;SBF2;RASA1;ARHGAP31;LIMA1;CREBRF;PEX1;CTDSP2;ACTR1B;ETV4;HP1BP3;COX18;CAPN6;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;FAM120B;FAM168A;SERPINB5;MATN3;CAMK2N1;ELMO2;EHHADH;MED12;NPAS2;ABAT;MYH11;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;ADAM10;PRDM5;RHOBTB3;PPP2R3A;CELSR1;MPDZ;LITAF;C4ORF33;ANKS6;TSPAN4;S100A11;MYO1C;RXRA;ORAI2;GBP3;SNTB1;EDEM1;ACAA2;TAOK3;NFKBIE;CTSD;DOCK1;FAM114A1;ZNRF1;DMPK;LAMB2
17987,GO:1902498,0.0589975948848247,0.996781896823133,2,3,regulation of protein autoubiquitination,BP,SASH1;TAF1
11229,GO:0045471,0.0590326966325416,0.971362008232777,12,70,response to ethanol,BP,NQO1;GSN;TP53;FYN;TP53INP1;CAT;G6PD;HTR1B;TH;ITPR2;RARA;ABAT
17550,GO:1901193,0.0590795231145846,1,1,1,regulation of formation of translation preinitiation complex,BP,RPL13A
17551,GO:1901194,0.0590795231145846,1,1,1,negative regulation of formation of translation preinitiation complex,BP,RPL13A
18910,GO:1904689,0.0590795231145846,1,1,1,negative regulation of cytoplasmic translational initiation,BP,RPL13A
12839,GO:0051187,0.0590895353213105,0.980110756708863,6,33,cofactor catabolic process,BP,GPX1;PRDX5;CAT;SNCA;ALDH1L2;GGT7
2437,GO:0005640,0.0591123572254303,0.983673483916273,5,17,nuclear outer membrane,CC,SYNE1;SYNE3;SNCA;SYNE2;DMPK
12617,GO:0050848,0.0594512507980178,0.975043140971052,9,43,regulation of calcium-mediated signaling,BP,PKD2;JPH2;NOS1;CAMK2D;PDE4D;CDH13;LMCD1;NFAT5;PRNP
9282,GO:0035744,0.0595692140835858,1,1,1,T-helper 1 cell cytokine production,BP,IL18
9890,GO:0042231,0.0595692140835858,1,1,1,interleukin-13 biosynthetic process,BP,IL18
12300,GO:0048675,0.0595950784306285,0.967350961692061,17,87,axon extension,BP,FN1;DPYSL2;PAK1;PTPRS;SEMA5A;SPG11;PLXNB1;SLIT3;ULK2;PLXNA2;SEMA4A;RAPH1;PLXNA1;MEGF8;ULK1;SEMA4B;LAMB2
884,GO:0002252,0.0596316616506929,0.95321394218902,90,750,immune effector process,BP,HTRA1;PYGB;MMP9;INPP5D;DDIT4;IL20RB;GSN;HERC5;ANPEP;SLC2A3;TKFC;IFI44L;TIMP2;PAK1;APOBEC3C;EIF2AK4;TRIM5;VAV3;STAT1;IFIT2;LGALS1;PYCARD;IFIT1;DDX60;ADARB1;IFIT3;ANO6;SEC14L1;KCNAB2;LRP1;FYN;PLA2G6;DOCK11;MAP3K14;CLU;SERPING1;CXCR1;PRKCZ;OAS2;IL31RA;METTL7A;ULBP1;PIK3R1;TMEM173;APOBEC3G;CAT;STOM;TLR3;MME;APOBEC3F;MLEC;SEMA4A;C5;IL18;CST3;MANBA;IFNK;IFNE;LYST;BCL6;PRCP;NFASC;ANXA2;MAN2B1;IFITM2;MOSPD2;ZFPM1;TGFB2;DNASE1L1;STAT2;LEF1;ITM2A;VAV2;BTN3A3;RSAD2;NAPRT;IFITM1;LGALS3;DNAJC3;RARA;WIPF1;ZBTB1;ACTR1B;ELMO2;ADAM10;S100A11;MYO1C;GBP3;CTSD;DOCK1
18544,GO:1903798,0.0596563430986687,0.98622822053093,4,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;BMP4;NCOR1;PPP3CA
9542,GO:0036336,0.0597091708263089,0.986016429281794,4,15,dendritic cell migration,BP,GAS6;ANO6;CXCR1;CALR
10975,GO:0044795,0.0598256322641386,1,1,1,trans-Golgi network to recycling endosome transport,BP,RAB13
13011,GO:0051494,0.0598770478103751,0.966965632606702,17,97,negative regulation of cytoskeleton organization,BP,GSN;SPTB;ARAP1;EML2;ESPN;ARPIN;KANK2;DLC1;SNCA;TRIOBP;BBS4;FHOD3;ARHGEF2;CAPG;TMEM67;LIMA1;TTBK2
11071,GO:0045095,0.0599835569864338,0.982424899309212,5,24,keratin filament,CC,KRT4;KRT14;KRT13;KRT5;CASP14
15101,GO:0071222,0.0600227400160775,0.96731940275794,16,104,cellular response to lipopolysaccharide,BP,AXL;SERPINE1;ABCA1;VDR;NR1D1;TRIM5;PDCD4;PYCARD;PDE4D;IL18;PRKCA;ABCC2;CDK19;SASH1;RARA;LITAF
749,GO:0001990,0.0600513437935977,0.985740217525712,4,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;GJA5;MME;OXTR
4846,GO:0014063,0.0601576074556798,1,1,1,negative regulation of serotonin secretion,BP,HTR1B
4499,GO:0010543,0.0602314838308636,0.982647420438401,5,21,regulation of platelet activation,BP,SERPINE2;PDGFA;PDPN;PRKCA;ABAT
12174,GO:0048368,0.0603027524949176,0.990402241190401,3,8,lateral mesoderm development,BP,FGFR1;CITED2;YAP1
18130,GO:1902903,0.0603658013875104,0.958933756670769,37,250,regulation of supramolecular fiber organization,BP,CTGF;SFRP1;ASAP3;GSN;SPTB;S100A10;PAK1;ARAP1;PYCARD;SEMA5A;MAP2;GPX1;EML2;ARHGAP18;CLU;ARPIN;KANK2;PXN;PIK3R1;DLC1;SNCA;RGS2;TRIOBP;BBS4;ARF6;AKAP13;FHOD3;ARHGEF2;SSH1;CDC42EP5;FHOD1;CAPG;WIPF1;RASA1;LIMA1;TTBK2;MYO1C
8467,GO:0033628,0.0604058364566939,0.979905110329565,6,28,regulation of cell adhesion mediated by integrin,BP,SNAI2;SERPINE1;PODXL;RET;TGFB2;IFT74
8118,GO:0032823,0.0604276266774712,0.989976077876802,3,9,regulation of natural killer cell differentiation,BP,GAS6;AXL;ZBTB1
16833,GO:0098793,0.0604509114507863,0.960657159256957,30,207,presynapse,CC,SYT8;ROR1;FLRT3;STON2;NTSR1;PTPRS;DLG4;ITGA2;MICAL1;HIP1;SYN1;KCNAB2;SYTL1;IL31RA;CCK;SYT1;PCLO;SNCA;MME;VAMP1;SEPT6;RAB13;SEPT5;C2CD4C;TH;OPHN1;KCNIP3;SV2A;BSN;ZNRF1
13814,GO:0060443,0.0606674175299156,0.976170011785013,8,35,mammary gland morphogenesis,BP,TGFBR2;ETV5;VDR;BMP4;GLI3;CAV1;GLI2;AREG
6762,GO:0030205,0.0607322523033281,0.990846004131899,3,7,dermatan sulfate metabolic process,BP,CSPG4;UST;DSEL
6765,GO:0030208,0.0607322523033281,0.990846004131899,3,7,dermatan sulfate biosynthetic process,BP,CSPG4;UST;DSEL
13455,GO:0055021,0.0608619300944646,0.977796083715492,7,31,regulation of cardiac muscle tissue growth,BP,TGFBR2;PAK1;JARID2;TP73;FGFR1;G6PD;TGFBR3
1460,GO:0003708,0.0609480574584929,0.995297778684512,2,4,retinoic acid receptor activity,MF,RARA;RXRA
7698,GO:0032196,0.0609867112689701,0.985614792870252,4,15,transposition,BP,APOBEC3C;APOBEC3G;APOBEC3F;MYBL1
18914,GO:1904694,0.0610820216082881,0.996599514335627,2,3,negative regulation of vascular smooth muscle contraction,BP,DOCK5;DOCK4
16805,GO:0098735,0.0610825659531181,0.996599466193018,2,3,positive regulation of the force of heart contraction,BP,NOS1;SLC8A1
1453,GO:0003690,0.0611392645487642,0.952735985738091,80,598,double-stranded DNA binding,MF,SOX6;XPC;ETV5;PHF21A;EGFR;KLF8;RFX2;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;DDX60;TFDP2;HIVEP1;GLI3;E2F7;GLI2;SLC2A4RG;TNRC18;HMGA2;PER1;CREB3L2;JARID2;MLH3;TP73;KLF13;SETX;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;LMO4;MSH5;EGR1;SOX9;ISL1;BCL6;PLAG1;SALL2;MYBL1;HLTF;BAHCC1;TCF12;HMBOX1;NFAT5;MUTYH;CARF;ZFPM1;DLX2;LEF1;THRA;SSBP3;TEF;TSPYL2;ORC4;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;PRDM5;LITAF;RXRA
2242,GO:0005154,0.061335530916649,0.979702887083842,6,26,epidermal growth factor receptor binding,MF,EFEMP1;VAV3;HIP1;SNX1;AREG;VAV2
10544,GO:0043524,0.0614158172706948,0.967303437710536,15,91,negative regulation of neuron apoptotic process,BP,F2R;AXL;NEFL;LRP1;FYN;UNC5B;WFS1;TP73;AARS;SNCA;GCLC;ISL1;MAP3K12;GDNF;RASA1
698,GO:0001919,0.0614358643447589,0.982331519038466,5,20,regulation of receptor recycling,BP,NSG1;ARAP1;SNCA;ANXA2;TBC1D16
19673,GO:2000020,0.0615057823247991,0.995229707033774,2,4,positive regulation of male gonad development,BP,CITED2;SOX9
12081,GO:0048144,0.0616100644937014,0.97104077527609,11,62,fibroblast proliferation,BP,FN1;SFRP1;GAS6;PDGFC;EGFR;NUPR1;TP53;PDGFA;TP53INP1;ANXA2;PPARG
1375,GO:0003272,0.0616315703932175,0.985854310546171,4,13,endocardial cushion formation,BP,TGFBR2;SNAI2;ENG;TGFB2
16834,GO:0098794,0.0617072764438926,0.957351476336574,40,258,postsynapse,CC,SYNE1;F2R;NOS1;UTRN;SLC8A1;ADD3;NTSR1;NSG1;NR1D1;NETO1;KCNMA1;PTPRS;DLG4;MAP2;HIP1;DLG5;ASAP1;SYN1;KCNAB2;FYN;PCLO;ANK3;SNCA;DNAJC6;LZTS1;ARHGEF2;RGS14;NLGN4Y;PRNP;MAGI2;GOPC;OPHN1;SHISA9;PRR7;PPP3CA;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ
12362,GO:0048799,0.0617572358603271,0.986104106300158,4,12,animal organ maturation,BP,FAT4;ANO6;PLXNB1;RET
9415,GO:0036004,0.0617689239878871,1,1,1,GAF domain binding,MF,AIP
15686,GO:0072273,0.0618097395319233,0.982511678418135,5,18,metanephric nephron morphogenesis,BP,PKD2;BMP4;STAT1;SOX9;GDNF
13905,GO:0060598,0.0618434978590171,1,1,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,AREG
4912,GO:0014855,0.0619441714873351,0.975413568303997,8,37,striated muscle cell proliferation,BP,TGFBR2;TENM4;JARID2;TP73;FGFR1;TGFBR3;TGFB2;RXRA
4838,GO:0014049,0.0619906387176835,0.995170223001738,2,4,positive regulation of glutamate secretion,BP,NTSR1;CCK
11923,GO:0047021,0.062017164772857,1,1,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,CBR1
12431,GO:0050221,0.062017164772857,1,1,1,prostaglandin-E2 9-reductase activity,MF,CBR1
12239,GO:0048548,0.0620551742552831,0.989590876650193,3,9,regulation of pinocytosis,BP,PROM2;AXL;CAV1
6907,GO:0030509,0.0621463567834615,0.965645042640412,17,92,BMP signaling pathway,BP,HTRA1;FBN1;SFRP1;RNF165;BMP4;PDCD4;NEO1;ITGA3;DKK1;SULF1;TGFBR3;FZD1;ENG;EGR1;MEGF8;TGFB2;LEF1
9340,GO:0035869,0.0623661454508705,0.973273993320428,9,49,ciliary transition zone,CC,NPHP4;KIF17;IFT140;BBS4;WDR19;IFT122;ARL3;TMEM67;TTBK2
16510,GO:0097283,0.0624977665139352,0.994373614462874,2,5,keratinocyte apoptotic process,BP,ZFP36L1;GSN
17863,GO:1902172,0.0624977665139352,0.994373614462874,2,5,regulation of keratinocyte apoptotic process,BP,ZFP36L1;GSN
1931,GO:0004632,0.0625230135988044,1,1,1,phosphopantothenate--cysteine ligase activity,MF,PPCS
13137,GO:0051750,0.0625844204090716,1,1,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,ECH1
7999,GO:0032640,0.0625926106538262,0.969315932919529,12,71,tumor necrosis factor production,BP,GAS6;AXL;ZBTB20;PYCARD;GPNMB;CLU;PIK3R1;TLR3;NFATC4;ARHGEF2;ISL1;RARA
8669,GO:0034284,0.0626412316137673,0.963222587735575,20,130,response to monosaccharide,BP,TXNIP;CTGF;TGFBR2;ANO1;IRS2;GAS6;SLC8A1;NR1D1;LGALS1;ITGA2;CTSV;PLA2G6;CAT;IGF1R;PDK3;GCLC;EGR1;TH;EFNA5;PPP3CA
6069,GO:0019226,0.0626932213190537,0.977378146621118,7,27,transmission of nerve impulse,BP,SCN8A;SCN2A;ITGA2;AHNAK2;ANK3;PRX;NFASC
15725,GO:0072347,0.0627587318183674,0.974889430618768,8,39,response to anesthetic,BP,SDK1;SNCA;MDM2;HTR1B;HSPA5;SRR;ABAT;OXTR
1085,GO:0002674,0.0628110822179663,0.99506892106029,2,4,negative regulation of acute inflammatory response,BP,IL20RB;PPARG
3715,GO:0008237,0.0628843983610809,0.965623894941065,16,99,metallopeptidase activity,MF,CPA4;MMP2;MMP9;ADAM19;MMP28;ANPEP;CLCA2;MMP19;ADAMTS7;MME;RNPEP;AMZ2;ADAMTS15;NPEPL1;ADAM10;RNPEPL1
18437,GO:1903557,0.062905607859523,0.97481815713901,8,39,positive regulation of tumor necrosis factor superfamily cytokine production,BP,ZBTB20;PYCARD;CLU;PIK3R1;TLR3;NFATC4;ARHGEF2;ISL1
8011,GO:0032656,0.0629892425338116,0.989043383689573,3,10,regulation of interleukin-13 production,BP,PRKCZ;LEF1;RARA
8728,GO:0034393,0.0630006976193522,0.989364997295121,3,9,positive regulation of smooth muscle cell apoptotic process,BP,PDCD4;CDKN2A;PPARG
17845,GO:1902106,0.0630269937281127,0.971654005436991,10,52,negative regulation of leukocyte differentiation,BP,FBN1;INPP5D;SFRP1;BMP4;GLI3;PIK3R1;TLR3;BCL6;ZFPM1;RARA
16397,GO:0097065,0.0630315736022714,0.995041558199118,2,4,anterior head development,BP,SOX9;SSBP3
18174,GO:1902988,0.063034184024508,0.996425147373008,2,3,neurofibrillary tangle assembly,BP,SORL1;CLU
6062,GO:0019216,0.0635236391334734,0.956546728264794,37,260,regulation of lipid metabolic process,BP,CTGF;IRS2;SNAI2;ABCA1;ANGPTL4;VDR;NR1D1;VAV3;SEC14L2;PDGFA;ACSL3;SIK1;TYSND1;CAV1;SLC27A1;PLA2G6;PIK3R1;CPT1A;ACACB;SNCA;PRKAB2;NCOA2;PDK3;BBS4;MTMR4;DGKQ;EGR1;NCOR1;CHD9;RBL2;THRA;VAV2;LMF1;PPARG;NPAS2;RXRA;CPT2
15233,GO:0071437,0.0636846787103792,0.984968361546812,4,14,invadopodium,CC,PAK1;ITGA3;PDPN;FSCN1
4271,GO:0009636,0.063710229068873,0.955418961823607,41,320,response to toxic substance,BP,TXNIP;NQO1;PTGS1;SLC7A8;GSN;AXL;SLC8A1;GJC2;NUPR1;NEFL;STAT1;KCNMA1;TP53;SLC7A11;GPX1;SESN1;FYN;ADIRF;CPS1;ERCC6;TP53INP1;PRDX5;CAT;BPHL;SETX;G6PD;MDM2;CST3;AREG;EGR1;ABCC2;HTR1B;TH;ITPR2;GPX8;RARA;GSTZ1;PPP3CA;FOS;ABAT;OXTR
7054,GO:0030852,0.0637865748599116,0.98917609244794,3,9,regulation of granulocyte differentiation,BP,INPP5D;LEF1;RARA
2699,GO:0006067,0.0638442560545207,0.988569431581773,3,11,ethanol metabolic process,BP,SULT1E1;ACSS1;ACSS2
5666,GO:0016782,0.0639457780616793,0.973944884673122,8,46,transferase activity, transferring sulfur-containing groups,MF,SULT1E1;UST;CHST3;SUGCT;TSTD1;GAL3ST4;DSEL;TPST1
7447,GO:0031594,0.0639907860993807,0.974498105271756,8,36,neuromuscular junction,CC,SERPINE2;F2R;UTRN;DLG4;ANK3;SYNC;POSTN;SV2A
12701,GO:0050982,0.0640497329607444,0.983539632474687,5,12,detection of mechanical stimulus,BP,SERPINE2;PKD2;ITGA2;FYN;TTN
5311,GO:0016034,0.0643260700039322,1,1,1,maleylacetoacetate isomerase activity,MF,GSTZ1
16080,GO:0090090,0.0643635878176861,0.962572727568445,19,130,negative regulation of canonical Wnt signaling pathway,BP,SFRP1;SNAI2;WWTR1;PRICKLE1;DDIT3;RBMS3;GLI3;CAV1;NPHP4;DKK1;PSMB9;KLHL12;EGR1;SOX9;ISL1;IGFBP4;LEF1;IGFBP2;NPHP3
12117,GO:0048243,0.0643737513174029,0.994873735087044,2,4,norepinephrine secretion,BP,NISCH;OXTR
3356,GO:0007095,0.0643922046058001,0.981383799796494,5,19,mitotic G2 DNA damage checkpoint,BP,HMGA2;FOXN3;ATM;CDK5RAP3;TAOK3
15474,GO:0071877,0.0645874978724461,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
15478,GO:0071881,0.0645874978724461,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,RGS2
16025,GO:0086096,0.0645874978724461,1,1,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17287,GO:0140193,0.0645874978724461,1,1,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
17288,GO:0140194,0.0645874978724461,1,1,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,RGS2
15264,GO:0071479,0.064837322791047,0.969252556221731,11,62,cellular response to ionizing radiation,BP,SFRP1;SNAI2;TP53;HMGA2;CHEK2;ATM;MDM2;EGR1;HSPA5;YAP1;NIPBL
6032,GO:0019118,0.0649419595756596,1,1,1,phenanthrene-epoxide hydrolase activity,MF,AKR7A2
6033,GO:0019119,0.0649419595756596,1,1,1,phenanthrene-9,10-epoxide hydrolase activity,MF,AKR7A2
14969,GO:0070920,0.0649923094624074,0.984335648398217,4,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR;BMP4;NCOR1;PPP3CA
16201,GO:0090279,0.0650362683571793,0.984538936255518,4,14,regulation of calcium ion import,BP,PKD2;FYN;PRNP;LGALS3
2600,GO:0005901,0.0651342799076184,0.969449482829056,11,53,caveola,CC,FLOT1;F2R;TGFBR2;NOS1;KCNMA1;CAV1;DLC1;FLOT2;MYOF;CDH13;EFNA5
14596,GO:0070193,0.0651544660427596,0.988505320491694,3,10,synaptonemal complex organization,BP,HSPA2;MLH3;AGO4
16939,GO:0098984,0.0652765045931019,0.958871382531041,26,152,neuron to neuron synapse,CC,NOS1;ADD3;NTSR1;NETO1;PTPRS;DLG4;MAP2;DLG5;SYN1;KCNAB2;FYN;PCLO;DNAJC6;LZTS1;ARHGEF2;RGS14;NLGN4Y;PRNP;MAGI2;GOPC;SHISA9;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ
7601,GO:0031998,0.0653842661928321,0.98537471662123,4,11,regulation of fatty acid beta-oxidation,BP,IRS2;TYSND1;CPT1A;ACACB
3330,GO:0007043,0.0654306470914912,0.965079617849622,15,81,cell-cell junction assembly,BP,TLN2;GJA5;SNAI2;DLG5;UGT8;CAV1;NPHP4;FSCN1;CDH13;NFASC;PRKCA;RAB13;MPP7;CDH11;MYO1C
2202,GO:0005088,0.0654336730809998,0.957664721640618,29,170,Ras guanyl-nucleotide exchange factor activity,MF,IRS2;DNMBP;EGFR;SPTB;ALS2CL;RIN2;NEFL;VAV3;PLEKHG3;ARHGEF1;DLG4;PDGFA;KITLG;FYN;ARHGEF12;DOCK11;CAMK2D;FGFR1;OBSCN;ARHGEF17;AKAP13;FGD4;ARHGEF2;RET;VAV2;ARHGEF19;GDNF;SBF2;DOCK1
14738,GO:0070459,0.0656122691597558,0.993926003697387,2,5,prolactin secretion,BP,EGFR;ABAT
10228,GO:0042982,0.0656300744729832,0.973256233101708,8,43,amyloid precursor protein metabolic process,BP,NSG1;ITM2C;SORL1;CLU;FLOT2;TMED10;PRNP;ITM2A
10010,GO:0042474,0.0657055911920067,0.988094290529471,3,11,middle ear morphogenesis,BP,FGFR1;NAGLU;TSHZ1
10249,GO:0043009,0.065792759070889,0.951191515852059,58,410,chordate embryonic development,BP,SOX6;SFRP1;ZFP36L1;TGFBR2;PKD2;SULF2;EGFR;ITPK1;BMP4;PRICKLE1;GLI3;E2F7;GLI2;MDFI;DLC1;PRKACB;IFT140;PLXNA2;FGFR1;DKK1;SEC24D;C5;SULF1;KDM4C;FZD1;PBX1;BBS4;ATM;NR2F2;LMO4;FBXW8;POGLUT1;VANGL2;KLHL12;NRK;SOX9;ISL1;SALL2;ZNF358;ETNK2;HOXA1;MEGF8;WDR19;TAF8;TGFB2;DLX2;IFT122;GPR161;LEF1;SSBP3;NPHP3;HOXA3;RARA;MED12;NIPBL;ADAM10;CELSR1;RXRA
6263,GO:0019863,0.0659218103805135,1,1,1,IgE binding,MF,LGALS3
4202,GO:0009314,0.0659633543333261,0.952976872261234,45,337,response to radiation,BP,SFRP1;XPC;SCARA3;SNAI2;EGFR;KRT14;DDB2;EIF2AK4;NETO1;TP53;KRT13;SIK1;GPX1;ADIRF;ERCC6;NPHP4;TP53INP1;HMGA2;PER1;PIK3R1;CIRBP;TP73;CAT;CHEK2;MME;SLC24A1;NFATC4;ATM;MDM2;MEIS2;EGR1;CRTC1;RGS14;PRIMPOL;HOXA1;USP28;RHBDD1;HSPA5;TH;YAP1;POLH;TAF1;ZBTB1;FOS;NIPBL
16395,GO:0097062,0.0660743358186237,0.984468781605673,4,13,dendritic spine maintenance,BP,ITGA3;FYN;IGF1R;PRNP
13640,GO:0060192,0.0660935688518945,0.988269431936198,3,10,negative regulation of lipase activity,BP,ANGPTL4;RGS2;PLA2R1
14652,GO:0070294,0.0661674217751354,0.99464609622073,2,4,renal sodium ion absorption,BP,MAGED2;KLHL3
18525,GO:1903763,0.066420477425065,0.99461367219538,2,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJA5;GJC2
4765,GO:0010955,0.0664233760306905,0.977563875198943,6,26,negative regulation of protein processing,BP,SERPINE2;SERPINE1;SERPING1;GLG1;MDM2;PRNP
18321,GO:1903318,0.0664233760306905,0.977563875198943,6,26,negative regulation of protein maturation,BP,SERPINE2;SERPINE1;SERPING1;GLG1;MDM2;PRNP
6613,GO:0022843,0.0665881427474015,0.972954363969884,8,40,voltage-gated cation channel activity,MF,PKD2;GAS6;KCNMA1;KCNAB2;KCNJ15;KCNJ5;KCNQ3;CACNB1
6758,GO:0030201,0.0666330749595169,0.977591395320369,6,25,heparan sulfate proteoglycan metabolic process,BP,SULF2;EXTL2;B3GAT3;XYLT1;SULF1;VANGL2
1980,GO:0004702,0.0667048329704756,0.96349171982828,16,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,TGFBR2;TNIK;ROR1;AXL;EGFR;MAP3K6;MAP3K14;MST1R;FGFR1;IGF1R;EPHB6;MAP3K1;NRK;MAP3K12;RET;TAOK3
4949,GO:0015018,0.0667238540519919,1,1,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,B3GAT3
5228,GO:0015849,0.0667427707777319,0.957636335984168,26,173,organic acid transport,BP,SLC7A8;IRS2;NTSR1;SLC7A11;ACSL3;SLC27A1;PLA2G6;CCK;SYT1;SLC38A10;CPT1A;SLC38A2;ACACB;SNCA;PRKAB2;NCOA2;PLA2R1;SLC27A6;NCOR1;ABCC2;PPARG;SV2A;ABAT;RXRA;CPT2;NFKBIE
11886,GO:0046942,0.0667427707777319,0.957636335984168,26,173,carboxylic acid transport,BP,SLC7A8;IRS2;NTSR1;SLC7A11;ACSL3;SLC27A1;PLA2G6;CCK;SYT1;SLC38A10;CPT1A;SLC38A2;ACACB;SNCA;PRKAB2;NCOA2;PLA2R1;SLC27A6;NCOR1;ABCC2;PPARG;SV2A;ABAT;RXRA;CPT2;NFKBIE
10666,GO:0043954,0.0668095799446648,0.977644969156651,6,24,cellular component maintenance,BP,F2R;ITGA3;MTHFR;FYN;IGF1R;PRNP
12565,GO:0050768,0.0668105906222562,0.956920487813182,28,176,negative regulation of neurogenesis,BP,VIM;ITM2C;EIF2AK4;SORL1;LGALS1;PTPRS;SEMA5A;GLI3;ASAP1;LRP1;ULK2;TP73;SEMA4A;NFATC4;PBX1;CALR;EFNB3;IDH2;MDM2;ARF6;ARHGEF2;SOX9;ISL1;DLX2;SEMA4B;DIXDC1;PPP3CA;KDM4A
6908,GO:0030510,0.066813901010298,0.968520688146325,11,53,regulation of BMP signaling pathway,BP,HTRA1;FBN1;SFRP1;RNF165;BMP4;NEO1;ITGA3;DKK1;SULF1;FZD1;ENG
12877,GO:0051250,0.0668744074070068,0.96578761520433,13,78,negative regulation of lymphocyte activation,BP,INPP5D;SFRP1;IL20RB;AXL;BMP4;GPNMB;GLI3;DLG5;PAG1;ATM;BCL6;PRNP;LGALS3
7371,GO:0031434,0.0669294077891653,0.971300804710977,9,42,mitogen-activated protein kinase kinase binding,MF,ROR1;AXL;EGFR;TRIB2;MST1R;FGFR1;IGF1R;EPHB6;RET
7135,GO:0030991,0.06727227611419,0.988785619935519,3,8,intraciliary transport particle A,CC,IFT140;WDR19;IFT122
18677,GO:1904064,0.0673718389604496,0.966758659214922,12,65,positive regulation of cation transmembrane transport,BP,F2R;PKD2;JPH2;NOS1;HSPA2;GJC2;NTSR1;ANO6;EHD3;ANK3;SNCA;G6PD
4494,GO:0010524,0.0674285770478257,0.977027298976636,6,27,positive regulation of calcium ion transport into cytosol,BP,F2R;PKD2;JPH2;NTSR1;CAV1;SNCA
1414,GO:0003352,0.067619167433434,0.993630656271754,2,5,regulation of cilium movement,BP,BBS2;BBS4
1415,GO:0003356,0.067619167433434,0.993630656271754,2,5,regulation of cilium beat frequency,BP,BBS2;BBS4
13698,GO:0060295,0.067619167433434,0.993630656271754,2,5,regulation of cilium movement involved in cell motility,BP,BBS2;BBS4
13699,GO:0060296,0.067619167433434,0.993630656271754,2,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2;BBS4
17816,GO:1902019,0.067619167433434,0.993630656271754,2,5,regulation of cilium-dependent cell motility,BP,BBS2;BBS4
12979,GO:0051431,0.0676462317690147,1,1,1,corticotropin-releasing hormone receptor 2 binding,MF,UCN2
9170,GO:0035567,0.0676489714738107,0.959882924944401,20,132,non-canonical Wnt signaling pathway,BP,SFRP1;ROR1;RNF213;GNG2;PRICKLE1;FZD7;DKK1;PSMB9;FZD8;FZD1;VANGL2;LEF1;NPHP3;MAGI2;ARHGEF19;FZD4;PPP3CA;AGO4;MED12;CELSR1
14135,GO:0061046,0.067755876417275,0.993610341527552,2,5,regulation of branching involved in lung morphogenesis,BP,BMP4;SOX9
15863,GO:0072659,0.0678427362119893,0.956108663818842,28,185,protein localization to plasma membrane,BP,FLOT1;TNIK;GAS6;EGFR;S100A10;NSG1;ACSL3;PACS1;ITGA3;LRP1;PRKCZ;EHD3;PIK3R1;LAMA5;BBS2;ANK3;FLOT2;ARF6;BBS1;NFASC;ANXA2;RAB13;TSPAN5;PRNP;EFR3A;GOPC;KCNIP3;C2CD5
5729,GO:0016881,0.0679479375445506,0.983175820733716,4,16,acid-amino acid ligase activity,MF,TTLL11;GCLC;TPGS1;PPCS
17906,GO:1902260,0.0680004030087332,0.99440952163906,2,4,negative regulation of delayed rectifier potassium channel activity,BP,ANK3;KCNRG
18539,GO:1903792,0.0680423822994003,0.983843698626164,4,13,negative regulation of anion transport,BP,IRS2;PLA2R1;GOPC;ABAT
7074,GO:0030879,0.0681241191068152,0.961736922615773,17,98,mammary gland development,BP,TGFBR2;ETV5;IRS2;VDR;BMP4;ITGA2;GPX1;GLI3;XDH;CAV1;GLI2;OAS2;ROBO1;AREG;SOX9;LEF1;OXTR
19849,GO:2000352,0.0683218948914574,0.98348126049977,4,14,negative regulation of endothelial cell apoptotic process,BP,GAS6;SERPINE1;ANGPTL4;SEMA5A
9883,GO:0042219,0.0683872040952916,0.982857468912427,4,17,cellular modified amino acid catabolic process,BP,PRODH;ALDH1L2;ALDH4A1;GGT7
8360,GO:0033270,0.0685686142346633,0.989114118546159,3,7,paranode region of axon,CC,GJC2;SCN2A;NFASC
7850,GO:0032421,0.0686018521868075,0.976421436573918,6,28,stereocilium bundle,CC,DOCK4;ESPN;BBS2;MYO3B;TRIOBP;MYO1C
3659,GO:0008146,0.0686086534054678,0.976418494535673,6,28,sulfotransferase activity,MF,SULT1E1;UST;CHST3;GAL3ST4;DSEL;TPST1
15567,GO:0072078,0.0686219005446774,0.968852912029794,10,48,nephron tubule morphogenesis,BP,FAT4;PKD2;MAGED1;BMP4;GLI3;LAMA5;PBX1;SOX9;GDNF;KLHL3
9523,GO:0036293,0.0686364572628514,0.953171390687056,35,262,response to decreased oxygen levels,BP,MMP2;CTGF;SFRP1;ZFP36L1;DDIT4;TGFBR2;NOS1;SLC8A1;PAK1;ANGPTL4;KCNMA1;TP53;ITGA2;MTHFR;CAV1;ANG;CAT;LMNA;PSMB9;PDK3;TGFBR3;ATM;MDM2;CST3;CITED2;EGR1;NDRG1;TGFB2;TH;ITPR2;POSTN;HP1BP3;ABAT;OXTR;ACAA2
17986,GO:1902495,0.0686569228667993,0.959980558923349,19,114,transmembrane transporter complex,CC,ANO1;NOS1;HSPA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;CAMK2D;HERPUD1;KCNJ5;PDE4D;KCNQ3;SCNN1A;CACNB1;KCNIP3;SHISA9;ABCA2
6339,GO:0021521,0.0686612189958365,0.995903526294563,2,3,ventral spinal cord interneuron specification,BP,GLI3;GLI2
6448,GO:0021775,0.0686612189958365,0.995903526294563,2,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,GLI3;GLI2
6449,GO:0021776,0.0686612189958365,0.995903526294563,2,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,GLI3;GLI2
13887,GO:0060573,0.0686612189958365,0.995903526294563,2,3,cell fate specification involved in pattern specification,BP,GLI3;GLI2
13893,GO:0060579,0.0686612189958365,0.995903526294563,2,3,ventral spinal cord interneuron fate commitment,BP,GLI3;GLI2
13894,GO:0060581,0.0686612189958365,0.995903526294563,2,3,cell fate commitment involved in pattern specification,BP,GLI3;GLI2
3575,GO:0007622,0.0687702072498949,0.97940893002969,5,21,rhythmic behavior,BP,TP53;NCOA2;NAGLU;CST3;TH
12216,GO:0048512,0.0687702072498949,0.97940893002969,5,21,circadian behavior,BP,TP53;NCOA2;NAGLU;CST3;TH
5197,GO:0015800,0.0689408600182144,0.974106483124362,7,31,acidic amino acid transport,BP,NTSR1;SLC7A11;CCK;SYT1;SLC38A2;SNCA;ABAT
7928,GO:0032527,0.0689700606051266,0.973832012902705,7,34,protein exit from endoplasmic reticulum,BP,SORL1;SEL1L;HERPUD1;TMEM129;RHBDD1;DERL3;EDEM1
1345,GO:0003209,0.0690079140076325,0.980052289017101,5,17,cardiac atrium morphogenesis,BP,GJA5;ENG;ISL1;ZFPM1;TGFB2
13883,GO:0060563,0.0690104731745816,0.973894131529641,7,33,neuroepithelial cell differentiation,BP,SLITRK6;SERPINE1;FGFR1;TRIOBP;DLX3;LRTOMT;LEF1
8149,GO:0032891,0.0690777764072949,0.988353882835551,3,8,negative regulation of organic acid transport,BP,IRS2;PLA2R1;ABAT
2618,GO:0005940,0.0690937644547629,0.98787313089111,3,9,septin ring,CC,SEPT6;SEPT5;SEPT9
7202,GO:0031105,0.0690937644547629,0.98787313089111,3,9,septin complex,CC,SEPT6;SEPT5;SEPT9
7689,GO:0032160,0.0690937644547629,0.98787313089111,3,9,septin filament array,CC,SEPT6;SEPT5;SEPT9
1435,GO:0003415,0.0692756393569715,0.994242594462349,2,4,chondrocyte hypertrophy,BP,TGFBR2;SOX9
8868,GO:0034698,0.0692818656404579,0.979363473687793,5,20,response to gonadotropin,BP,ITGA3;CTSV;TGFBR3;GCLC;EFNA5
16418,GO:0097110,0.0693404665413935,0.969867174521077,9,45,scaffold protein binding,MF,NOS1;VIM;KRT5;DLG4;KRT15;PDE4D;MDM2;NLGN4Y;ITPR2
5046,GO:0015245,0.069451138332624,0.993356363939248,2,5,fatty acid transmembrane transporter activity,MF,SLC27A1;SLC27A6
7745,GO:0032272,0.0694549782874932,0.969696831011457,9,47,negative regulation of protein polymerization,BP,GSN;SPTB;EML2;KANK2;SNCA;TRIOBP;BBS4;FHOD3;CAPG
16762,GO:0098631,0.069619591467941,0.973527544231105,7,34,cell adhesion mediator activity,MF,BCAM;ITGA2;ITGA10;ITGA1;NFASC;ANXA2;S100A11
5773,GO:0017001,0.0697844565615961,0.978355346391846,5,27,antibiotic catabolic process,BP,SULT1E1;GPX1;PRDX5;CAT;SNCA
14163,GO:0061098,0.0697972595299807,0.975903062179696,6,28,positive regulation of protein tyrosine kinase activity,BP,GAS6;DLG4;ERCC6;AFAP1L2;PTPN1;PRNP
16102,GO:0090131,0.069805068684207,1,1,1,mesenchyme migration,BP,ACTA2
19367,GO:1905897,0.0699562178396987,0.966214314863251,11,67,regulation of response to endoplasmic reticulum stress,BP,DDIT3;CAV1;CLU;PIK3R1;HERPUD1;WFS1;PTPN1;HSPA5;DERL3;DNAJC3;EDEM1
16227,GO:0090311,0.0699780421712457,0.973529666913219,7,32,regulation of protein deacetylation,BP,TADA3;TP53;SDR16C5;CAMK2D;BCL6;BEX4;NIPBL
12779,GO:0051100,0.0699952013543104,0.95953472381676,18,122,negative regulation of binding,BP,SORL1;IFIT2;DDIT3;IFIT1;ZFP90;CAV1;HMGA2;MDFI;DKK1;NFATC4;ISL1;ZFPM1;LEF1;SP100;HSPA5;TAF1;PPP3CA;TTBK2
10586,GO:0043586,0.0700102041453923,0.982930300697647,4,14,tongue development,BP,EGFR;KRT13;GLI3;LEF1
14117,GO:0061024,0.0700208647299665,0.945072223004972,84,664,membrane organization,BP,SYT8;FLOT1;MARVELD1;FAT4;GSN;ETV5;COL7A1;CLTCL1;GAS6;MALL;COL5A1;SAMD9L;EGFR;ATP10D;S100A10;STON2;ABCA1;NSG1;TBC1D8;VAV3;TP53;DLG4;ITGA2;HIP1;TFDP2;EVI5L;ANO6;LPCAT2;TBC1D5;ASAP1;PLLP;NEK9;SPG11;CAV1;SNX33;AHNAK2;CLU;SYTL1;ATP8B2;SYT1;DYSF;ANK3;TP73;PRX;SNCA;FLOT2;VAMP1;SH3TC2;LMNA;SEC24D;MYOF;CALR;TMED10;AREG;DNAJC6;SYNE2;KLHL12;SSH1;NFASC;NDRG1;PRKCA;TMEM175;ANXA2;RAB13;NLGN4Y;TGFB2;VPS39;C2CD4C;AGRN;MAGI2;REEP2;UVRAG;GDNF;PPARG;SNX9;TBC1D16;MIA3;FZD4;COX18;DNM1P46;C2CD5;ACAA2;DOCK1;DMPK
11781,GO:0046686,0.070145013574744,0.972728100512168,7,43,response to cadmium ion,BP,MMP9;GSN;EGFR;CAT;GCLC;PRNP;FOS
7954,GO:0032570,0.0701482764675691,0.975654287797043,6,29,response to progesterone,BP,TXNIP;CAV1;TGFB2;YAP1;FOS;OXTR
3029,GO:0006578,0.0701487634203925,0.993250742612941,2,5,amino-acid betaine biosynthetic process,BP,ALDH9A1;ALDH7A1
18216,GO:1903053,0.0702044994109501,0.976203283320623,6,24,regulation of extracellular matrix organization,BP,PHLDB1;PDPN;LRP1;FSCN1;CST3;SOX9
12091,GO:0048167,0.0702942320639693,0.961074819498705,16,94,regulation of synaptic plasticity,BP,SERPINE2;NSG1;EIF2AK4;NETO1;DLG4;PRKCZ;SNCA;SLC24A1;NFATC4;SSH1;CRTC1;RGS14;PRNP;SHISA9;RARA;TSHZ3
11639,GO:0046425,0.0705105267919282,0.964608003437251,12,76,regulation of JAK-STAT cascade,BP,FLRT2;FLRT3;PTK6;FYN;CAV1;IL31RA;CTF1;IL18;IFNK;IFNE;ISL1;RET
13799,GO:0060425,0.0705211941257039,0.97107011247558,8,39,lung morphogenesis,BP,TGFBR2;BMP4;DLG5;SPRY2;VANGL2;SOX9;YAP1;CELSR1
19850,GO:2000353,0.0705935614019403,0.987987395443176,3,8,positive regulation of endothelial cell apoptotic process,BP,PDCD4;COL18A1;ANO6
14795,GO:0070561,0.0707149062338014,0.987465810200618,3,9,vitamin D receptor signaling pathway,BP,SNAI2;VDR;KANK2
2388,GO:0005527,0.0707886262607863,0.986520811751936,3,12,macrolide binding,MF,FKBP5;FKBP9;FKBP10
2389,GO:0005528,0.0707886262607863,0.986520811751936,3,12,FK506 binding,MF,FKBP5;FKBP9;FKBP10
1744,GO:0004346,0.0709584466527639,1,1,1,glucose-6-phosphatase activity,MF,G6PC3
12441,GO:0050309,0.0709584466527639,1,1,1,sugar-terminal-phosphatase activity,MF,G6PC3
10696,GO:0044035,0.0709686674528528,1,1,1,multi-organism catabolic process,BP,ANXA2
10723,GO:0044115,0.0709686674528528,1,1,1,development of symbiont involved in interaction with host,BP,ANXA2
10730,GO:0044145,0.0709686674528528,1,1,1,modulation of development of symbiont involved in interaction with host,BP,ANXA2
10732,GO:0044147,0.0709686674528528,1,1,1,negative regulation of development of symbiont involved in interaction with host,BP,ANXA2
10948,GO:0044730,0.0709686674528528,1,1,1,bone sialoprotein binding,MF,ANXA2
13297,GO:0052214,0.0709686674528528,1,1,1,metabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
13298,GO:0052227,0.0709686674528528,1,1,1,catabolism of substance in other organism involved in symbiotic interaction,BP,ANXA2
13299,GO:0052229,0.0709686674528528,1,1,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
13311,GO:0052360,0.0709686674528528,1,1,1,catabolism by host of symbiont macromolecule,BP,ANXA2
13312,GO:0052361,0.0709686674528528,1,1,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,ANXA2
13313,GO:0052362,0.0709686674528528,1,1,1,catabolism by host of symbiont protein,BP,ANXA2
13314,GO:0052363,0.0709686674528528,1,1,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
13315,GO:0052364,0.0709686674528528,1,1,1,catabolism by host of substance in symbiont,BP,ANXA2
13319,GO:0052416,0.0709686674528528,1,1,1,metabolism by host of symbiont macromolecule,BP,ANXA2
13320,GO:0052417,0.0709686674528528,1,1,1,metabolism by host of symbiont protein,BP,ANXA2
13321,GO:0052418,0.0709686674528528,1,1,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,ANXA2
13322,GO:0052419,0.0709686674528528,1,1,1,metabolism by host of substance in symbiont,BP,ANXA2
19285,GO:1905581,0.0709686674528528,1,1,1,positive regulation of low-density lipoprotein particle clearance,BP,ANXA2
19290,GO:1905597,0.0709686674528528,1,1,1,positive regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
19292,GO:1905599,0.0709686674528528,1,1,1,positive regulation of low-density lipoprotein receptor activity,BP,ANXA2
1383,GO:0003284,0.0709931050131319,0.994014766267996,2,4,septum primum development,BP,GJA5;TGFB2
12489,GO:0050656,0.0710523761588481,0.994006842215134,2,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,ENPP1;GAL3ST4
1419,GO:0003365,0.0715531944142932,0.995624593784843,2,3,establishment of cell polarity involved in ameboidal cell migration,BP,AMOTL1;AMOTL2
7172,GO:0031065,0.0718159636051408,0.982089334469578,4,15,positive regulation of histone deacetylation,BP,TP53;SDR16C5;BCL6;NIPBL
12563,GO:0050766,0.0719222896060549,0.975082482717923,6,27,positive regulation of phagocytosis,BP,GAS6;PYCARD;ITGA2;ANO6;CALR;PPARG
10912,GO:0044557,0.0719528120528428,0.992974634011798,2,5,relaxation of smooth muscle,BP,SLC8A1;RGS2
9109,GO:0035438,0.0720246362479822,1,1,1,cyclic-di-GMP binding,MF,TMEM173
14298,GO:0061507,0.0720246362479822,1,1,1,cyclic-GMP-AMP binding,MF,TMEM173
7612,GO:0032020,0.0720725062021099,0.992384562739089,2,6,ISG15-protein conjugation,BP,HERC5;UBA7
12041,GO:0048013,0.0720767476421568,0.963800691316341,12,72,ephrin receptor signaling pathway,BP,MMP2;MMP9;PAK1;VAV3;FYN;EPHB6;EFNB3;APH1B;SDC2;VAV2;EFNA5;RASA1
18176,GO:1902991,0.0720910950636234,0.978113368268949,5,21,regulation of amyloid precursor protein catabolic process,BP,SORL1;CLU;FLOT2;TMED10;PRNP
12001,GO:0047658,0.0721628285638559,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
6331,GO:0021511,0.0722572068813574,0.98758096576313,3,8,spinal cord patterning,BP,GLI3;GLI2;IFT122
11728,GO:0046598,0.0722791142598966,0.992350133116442,2,6,positive regulation of viral entry into host cell,BP,TRIM38;LGALS1
4836,GO:0014047,0.0724171251739785,0.978326957593482,5,19,glutamate secretion,BP,NTSR1;CCK;SYT1;SLC38A2;SNCA
19094,GO:1905063,0.0724353069528956,0.992900064360108,2,5,regulation of vascular smooth muscle cell differentiation,BP,PDCD4;ENG
12342,GO:0048747,0.0725223807986793,0.972913323344549,7,27,muscle fiber development,BP,BMP4;GPX1;FLNC;TTN;LEF1;PPP3CA;MYH11
7839,GO:0032410,0.0726185754980259,0.969883323112908,8,41,negative regulation of transporter activity,BP,MMP9;PKD2;CAV1;CAMK2D;ANK3;SNCA;GOPC;KCNRG
17207,GO:0110053,0.0729015539658406,0.952470778018578,28,187,regulation of actin filament organization,BP,CTGF;SFRP1;ASAP3;GSN;SPTB;S100A10;PAK1;ARAP1;PYCARD;SEMA5A;ARHGAP18;ARPIN;KANK2;PXN;PIK3R1;DLC1;TRIOBP;BBS4;ARF6;FHOD3;SSH1;CDC42EP5;FHOD1;CAPG;WIPF1;RASA1;LIMA1;MYO1C
18823,GO:1904464,0.0729021485265733,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18824,GO:1904465,0.0729021485265733,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19595,GO:1990773,0.0729021485265733,1,1,1,matrix metallopeptidase secretion,BP,IDH2
13820,GO:0060452,0.0729099282214939,0.992826414458206,2,5,positive regulation of cardiac muscle contraction,BP,CTGF;RGS2
16485,GO:0097224,0.0731317685954141,1,1,1,sperm connecting piece,CC,SPATA6
2615,GO:0005929,0.0731660494680927,0.947072491782274,47,340,cilium,CC,PTGS1;PKD2;PROM2;CEP126;EVC;CEP250;TTLL11;CNTRL;EFHC1;WDR66;GLI3;DLG5;CAV1;GLI2;SPATA6;NPHP4;EHD3;KIF17;BBS2;PRKACB;IFT140;DZIP1L;SEPT6;BBS4;BBS1;DNAL4;IFT27;IFT88;TTC8;SPA17;WDR19;ODF2;SCNN1A;IFT122;GPR161;NPHP3;TCTEX1D4;CFAP54;IFT74;TPGS1;DNAH1;ICK;ARL3;TMEM67;SEPT9;TTBK2;ANKS6
2539,GO:0005801,0.0732713612514402,0.967687512105361,9,47,cis-Golgi network,CC,CTGF;B3GAT3;GOLGB1;PIK3R1;TMED10;GOLGA8B;GOLGA8N;COG3;MPPE1
10117,GO:0042698,0.0732877119294119,0.969683826791946,8,39,ovulation cycle,BP,AXL;EGFR;MMP19;SLIT3;EGR1;TGFB2;FZD4;OXTR
9926,GO:0042303,0.0734048933505954,0.960965056960678,14,80,molting cycle,BP,CD109;APCDD1;EGFR;KRT14;PDGFA;CTSV;PER1;LAMA5;DKK1;VANGL2;SOX9;TGFB2;NIPBL;CELSR1
10095,GO:0042633,0.0734048933505954,0.960965056960678,14,80,hair cycle,BP,CD109;APCDD1;EGFR;KRT14;PDGFA;CTSV;PER1;LAMA5;DKK1;VANGL2;SOX9;TGFB2;NIPBL;CELSR1
4965,GO:0015079,0.0734417054840224,0.965871356879813,10,55,potassium ion transmembrane transporter activity,MF,PKD2;KCNMA1;KCNAB2;KCNJ15;KCNJ5;SLC24A1;KCNQ3;TMEM175;SLC9A4;KCNIP3
2812,GO:0006275,0.0735859880583748,0.958900187466973,16,98,regulation of DNA replication,BP,PDGFC;EGFR;BMP4;PDGFA;E2F7;KITLG;GLI2;CHEK2;FGFR1;IGF1R;CALR;CST3;AREG;BCL6;TSPYL2;S100A11
11703,GO:0046533,0.073604341612559,0.993661793243459,2,4,negative regulation of photoreceptor cell differentiation,BP,SOX9;DLX2
14275,GO:0061438,0.0736472885951417,0.993655921852405,2,4,renal system vasculature morphogenesis,BP,PKD2;BMP4
14276,GO:0061439,0.0736472885951417,0.993655921852405,2,4,kidney vasculature morphogenesis,BP,PKD2;BMP4
4543,GO:0010628,0.0737119404442735,0.93807556877074,165,1356,positive regulation of gene expression,BP,FN1;CCBE1;CTGF;SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;GSN;ETV5;PKD2;NOS1;GAS6;MAGED1;EGFR;GJC2;RFX2;ACTA2;SERPINE1;VIM;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;EIF2AK4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;ITGA2;RBMS3;TFDP2;ITGA3;NFIX;GLI3;E2F7;CNTN1;ABHD14B;ZFP90;ADIRF;CAV1;GLI2;PIAS3;ERCC6;SMARCA1;ZNF318;CLU;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANK3;SPRY2;TTN;CIRBP;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;DKK1;SETX;NCOA2;IL18;FZD8;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;MDM2;MEIS2;TCF4;DGKQ;CITED2;NR2F2;LMO4;MAF;ARHGEF2;PLGRKT;EGR1;SOX9;ISL1;STK16;CRTC1;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;RHBDD1;HSPA5;TGFB1I1;SRPK2;ITGB8;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;DNAJC3;RARA;PBX2;PRKAG1;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;KDM4A;CDK5RAP3;CAMK2N1;MED12;NPAS2;NIPBL;ADM2;LITAF;MYO1C;RXRA
16383,GO:0097048,0.0737215973742011,0.993645757877601,2,4,dendritic cell apoptotic process,BP,GAS6;AXL
20021,GO:2000668,0.0737215973742011,0.993645757877601,2,4,regulation of dendritic cell apoptotic process,BP,GAS6;AXL
1710,GO:0004304,0.0737910441533326,1,1,1,estrone sulfotransferase activity,MF,SULT1E1
3127,GO:0006711,0.0737910441533326,1,1,1,estrogen catabolic process,BP,SULT1E1
9406,GO:0035990,0.0738096591666054,1,1,1,tendon cell differentiation,BP,BMP4
9407,GO:0035992,0.0738096591666054,1,1,1,tendon formation,BP,BMP4
12187,GO:0048389,0.0738096591666054,1,1,1,intermediate mesoderm development,BP,BMP4
12188,GO:0048390,0.0738096591666054,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
12189,GO:0048391,0.0738096591666054,1,1,1,intermediate mesoderm formation,BP,BMP4
12190,GO:0048392,0.0738096591666054,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
13453,GO:0055018,0.0738096591666054,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
13454,GO:0055020,0.0738096591666054,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
13849,GO:0060503,0.0738096591666054,1,1,1,bud dilation involved in lung branching,BP,BMP4
14183,GO:0061149,0.0738096591666054,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
14184,GO:0061150,0.0738096591666054,1,1,1,renal system segmentation,BP,BMP4
14185,GO:0061151,0.0738096591666054,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
14189,GO:0061155,0.0738096591666054,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
14211,GO:0061216,0.0738096591666054,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
14214,GO:0061227,0.0738096591666054,1,1,1,pattern specification involved in mesonephros development,BP,BMP4
15483,GO:0071893,0.0738096591666054,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
15579,GO:0072096,0.0738096591666054,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
15580,GO:0072097,0.0738096591666054,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
15581,GO:0072098,0.0738096591666054,1,1,1,anterior/posterior pattern specification involved in kidney development,BP,BMP4
15582,GO:0072099,0.0738096591666054,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
15583,GO:0072100,0.0738096591666054,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
15584,GO:0072101,0.0738096591666054,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
15640,GO:0072192,0.0738096591666054,1,1,1,ureter epithelial cell differentiation,BP,BMP4
15644,GO:0072198,0.0738096591666054,1,1,1,mesenchymal cell proliferation involved in ureter development,BP,BMP4
15645,GO:0072199,0.0738096591666054,1,1,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
15646,GO:0072200,0.0738096591666054,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
17790,GO:1901964,0.0738096591666054,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
19660,GO:2000004,0.0738096591666054,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
19661,GO:2000005,0.0738096591666054,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
19662,GO:2000006,0.0738096591666054,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
19663,GO:2000007,0.0738096591666054,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
18243,GO:1903136,0.0738560562044063,0.992678720799143,2,5,cuprous ion binding,MF,SNCA;PRNP
3474,GO:0007320,0.0739273912169987,0.993617576056401,2,4,insemination,BP,SERPINE2;OXTR
6825,GO:0030297,0.074051799760192,0.99360051559178,2,4,transmembrane receptor protein tyrosine kinase activator activity,MF,DGKQ;EFNA5
16877,GO:0098869,0.0741638413463197,0.966622669401374,9,61,cellular oxidant detoxification,BP,NQO1;PTGS1;GPX1;SESN1;TP53INP1;PRDX5;CAT;GPX8;GSTZ1
3915,GO:0008591,0.0741794816083582,1,1,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
10108,GO:0042662,0.0741794816083582,1,1,1,negative regulation of mesodermal cell fate specification,BP,DKK1
11385,GO:0045813,0.0741794816083582,1,1,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
14407,GO:0061743,0.0741794816083582,1,1,1,motor learning,BP,DKK1
16071,GO:0090081,0.0741794816083582,1,1,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,DKK1
16072,GO:0090082,0.0741794816083582,1,1,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,DKK1
16258,GO:0090381,0.0741794816083582,1,1,1,regulation of heart induction,BP,DKK1
16885,GO:0098883,0.0741794816083582,1,1,1,synapse disassembly,BP,DKK1
17077,GO:0100012,0.0741794816083582,1,1,1,regulation of heart induction by canonical Wnt signaling pathway,BP,DKK1
17583,GO:1901296,0.0741794816083582,1,1,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17596,GO:1901321,0.0741794816083582,1,1,1,positive regulation of heart induction,BP,DKK1
18917,GO:1904701,0.0741794816083582,1,1,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18922,GO:1904711,0.0741794816083582,1,1,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18932,GO:1904723,0.0741794816083582,1,1,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
19098,GO:1905067,0.0741794816083582,1,1,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
19332,GO:1905771,0.0741794816083582,1,1,1,negative regulation of mesodermal cell differentiation,BP,DKK1
19370,GO:1905903,0.0741794816083582,1,1,1,negative regulation of mesoderm formation,BP,DKK1
13052,GO:0051588,0.074270355349566,0.967102406181442,9,48,regulation of neurotransmitter transport,BP,NOS1;NTSR1;SYN1;SNCA;SEPT5;HTR1B;GDNF;SV2A;ABAT
4310,GO:0009792,0.0742988905741826,0.944270347370253,59,420,embryo development ending in birth or egg hatching,BP,SOX6;SFRP1;ZFP36L1;TGFBR2;PKD2;SULF2;EGFR;ITPK1;BMP4;PRICKLE1;GLI3;E2F7;GLI2;MDFI;DLC1;PRKACB;IFT140;PLXNA2;FGFR1;DKK1;SEC24D;C5;SULF1;KDM4C;FZD1;PBX1;BBS4;ATM;NR2F2;LMO4;FBXW8;POGLUT1;VANGL2;KLHL12;NRK;SOX9;ISL1;SALL2;ZNF358;ETNK2;HOXA1;STOX2;MEGF8;WDR19;TAF8;TGFB2;DLX2;IFT122;GPR161;LEF1;SSBP3;NPHP3;HOXA3;RARA;MED12;NIPBL;ADAM10;CELSR1;RXRA
7262,GO:0031253,0.0743722934408556,0.950059303703715,32,203,cell projection membrane,CC,PKD2;CYBRD1;PROM2;UTRN;CSPG4;EVC;PAK1;ITGA3;PLEK2;ASAP1;PDPN;EHD3;SYTL1;BBS2;SPRY2;DLC1;SPRY4;FSCN1;BBS4;ARF6;BBS1;SYNE2;ARHGEF2;TTC8;PODXL;ABCC2;SCNN1A;GPR161;SHISA9;TMEM67;MYO1C;C2CD5
10029,GO:0042531,0.0743761867893106,0.973526283535055,6,32,positive regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;FYN;IL31RA;CTF1;IL18;ISL1
7930,GO:0032530,0.0744553355239183,0.986509712665707,3,9,regulation of microvillus organization,BP,FSCN1;PODXL;KLF5
3980,GO:0008829,0.0745084059851917,1,1,1,dCTP deaminase activity,MF,APOBEC3G
147,GO:0000302,0.0746916533154038,0.953792247691616,22,164,response to reactive oxygen species,BP,MMP9;TXNIP;NQO1;PKD2;AXL;EGFR;SLC8A1;SESN3;STAT1;TP53;GPX1;SESN1;ERCC6;PRDX5;PXN;CAT;SETX;MDM2;CST3;AREG;PXMP2;FOS
19019,GO:1904892,0.074907107452227,0.961992565918389,12,77,regulation of STAT cascade,BP,FLRT2;FLRT3;PTK6;FYN;CAV1;IL31RA;CTF1;IL18;IFNK;IFNE;ISL1;RET
9125,GO:0035485,0.0749145912556211,1,1,1,adenine/guanine mispair binding,MF,MUTYH
10250,GO:0043010,0.0749176569421296,0.950360589196422,30,189,camera-type eye development,BP,COL8A1;FBN1;MYH15;TGFBR2;SLITRK6;EFEMP1;SDK1;FBN2;EGFR;VIM;TENM3;PTPRM;BMP4;SLC7A11;GLI3;NPHP4;IFT140;MAF;SOX9;WDR19;RET;TGFB2;DLX2;IFT122;TH;RARA;COL4A1;FZD4;RXRA;LAMB2
18894,GO:1904645,0.0750193123822704,0.977311286824586,5,19,response to amyloid-beta,BP,LRP1;FYN;IGF1R;PRNP;CACNB1
770,GO:0002026,0.0750534556586803,0.981254946241388,4,14,regulation of the force of heart contraction,BP,NOS1;SLC8A1;CAV1;CAMK2D
4911,GO:0014854,0.0751475724750732,0.986864528633152,3,8,response to inactivity,BP,UTRN;CAT;MTMR4
13954,GO:0060694,0.0751646659869749,1,1,1,regulation of cholesterol transporter activity,BP,PPARG
15722,GO:0072343,0.0751646659869749,1,1,1,pancreatic stellate cell proliferation,BP,PPARG
17656,GO:1901558,0.0751646659869749,1,1,1,response to metformin,BP,PPARG
19275,GO:1905563,0.0751646659869749,1,1,1,negative regulation of vascular endothelial cell proliferation,BP,PPARG
19769,GO:2000229,0.0751646659869749,1,1,1,regulation of pancreatic stellate cell proliferation,BP,PPARG
19770,GO:2000230,0.0751646659869749,1,1,1,negative regulation of pancreatic stellate cell proliferation,BP,PPARG
8328,GO:0033189,0.0751857601699651,0.985581838944227,3,11,response to vitamin A,BP,CAT;PPARG;RARA
9444,GO:0036064,0.0752088088079746,0.958740305720667,15,92,ciliary basal body,CC,PKD2;EVC;DLG5;NPHP4;KIF17;BBS2;IFT140;DZIP1L;BBS4;BBS1;IFT88;TTC8;IFT122;ICK;TTBK2
17493,GO:1900825,0.0752516743783836,0.993435058156244,2,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,GJA5;ANK3
5754,GO:0016922,0.0753236630743286,0.977405734966745,5,18,ligand-dependent nuclear receptor binding,MF,TADA3;NCOA2;ISL1;NCOR1;RXRA
3191,GO:0006820,0.075339004715539,0.945567556188447,46,334,anion transport,BP,SLC7A8;ANO1;PITPNM3;IRS2;OSBPL10;TCAF1;CLCA2;SLC20A1;SLC2A3;ATP10D;NTSR1;ABCA1;SLC7A11;ACSL3;SLC22A15;ANO6;SLC27A1;PLA2G6;SLC22A17;OSBPL5;ATP8B2;CCK;SYT1;SLC38A10;CPT1A;SLC38A2;ACACB;SNCA;FGFR1;PRKAB2;NCOA2;PLA2R1;ENPP1;SLC27A6;NCOR1;ABCC2;PRNP;GOPC;PITPNC1;PPARG;SV2A;ANKH;ABAT;RXRA;CPT2;NFKBIE
15765,GO:0072428,0.0753509354434673,1,1,1,signal transduction involved in intra-S DNA damage checkpoint,BP,CHEK2
18606,GO:1903925,0.0753509354434673,1,1,1,response to bisphenol A,BP,CHEK2
18607,GO:1903926,0.0753509354434673,1,1,1,cellular response to bisphenol A,BP,CHEK2
3940,GO:0008637,0.0754575586067636,0.959181268772805,14,104,apoptotic mitochondrial changes,BP,MMP9;IFIT2;TP53;PYCARD;TFDP2;GPX1;IFI6;PLA2G6;CLU;CCK;TP73;LMNA;GCLC;ACAA2
3126,GO:0006710,0.0754745196038962,1,1,1,androgen catabolic process,BP,HSD17B11
7393,GO:0031467,0.0755960467103641,0.992404064253821,2,5,Cul7-RING ubiquitin ligase complex,CC,CUL7;FBXW8
19460,GO:1990253,0.0756025271182289,0.98621197513748,3,9,cellular response to leucine starvation,BP,SESN3;EIF2AK4;SESN1
14111,GO:0061008,0.0756098447412409,0.956794795037533,17,104,hepaticobiliary system development,BP,PKD2;SULF2;EGFR;ITGA2;GLI3;E2F7;CPS1;JARID2;PHF2;TGFBR3;ARF6;CITED2;SOX9;NPHP3;PTPN3;RARA;NIPBL
15143,GO:0071305,0.0756774725859505,0.981044619749709,4,14,cellular response to vitamin D,BP,SFRP1;SNAI2;VDR;KANK2
17773,GO:1901890,0.0757488708039951,0.973657308131898,6,25,positive regulation of cell junction assembly,BP,FLOT1;SFRP1;S100A10;CAV1;NPHP4;COL16A1
664,GO:0001868,0.0757814625969874,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
665,GO:0001869,0.0757814625969874,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
6919,GO:0030522,0.0757837446624632,0.948882369056173,32,221,intracellular receptor signaling pathway,BP,SFRP1;SKP2;SNAI2;TKFC;TADA3;PAK1;VDR;NR1D1;NR3C1;DDX60;SEC14L1;RBFOX2;DCBLD2;KANK2;PER1;ALOX15B;NCOA2;PDK3;CALR;CITED2;NR2F2;ISL1;PRCP;THRA;TGFB1I1;YAP1;PPARG;RARA;TAF1;FAM120B;MED12;RXRA
3780,GO:0008347,0.075816060523523,0.970676311086077,7,33,glial cell migration,BP,APCDD1;LAMB1;CSPG4;GLI3;IDH2;SYNE2;TGFB2
16778,GO:0098655,0.0758531354831664,0.943547961505143,55,413,cation transmembrane transport,BP,MMP9;F2R;PKD2;JPH2;NOS1;GAS6;UTRN;HSPA2;SLC8A1;ORAI3;GJC2;SLC20A1;NTSR1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;DLG4;ANO6;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;CALHM2;ANK3;DAPK1;KCNJ5;STOM;SNCA;PDE4D;G6PD;SLC24A1;KCNQ3;NDUFA4L2;TMEM175;SLC39A11;PRNP;SCNN1A;FHL1;SLC9A4;ITPR2;CACNB1;KCNIP3;SHISA9;PTPN3;STEAP2;CACNA2D3;KCNRG;TUSC3;ORAI2
2209,GO:0005096,0.0759878133617627,0.947904396175522,35,225,GTPase activator activity,MF,ASAP3;ARHGAP23;ALS2CL;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;ARHGEF1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;ARHGEF12;ARHGAP18;DLC1;RGS2;SRGAP1;TBC1D19;RGS14;DEPDC7;CDC42EP5;AGAP1;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;TBC1D16;RASA1;ARHGAP31;DOCK1
1846,GO:0004511,0.0760163486921778,1,1,1,tyrosine 3-monooxygenase activity,MF,TH
3033,GO:0006585,0.0760163486921778,1,1,1,dopamine biosynthetic process from tyrosine,BP,TH
8259,GO:0033076,0.0760163486921778,1,1,1,isoquinoline alkaloid metabolic process,BP,TH
9010,GO:0035240,0.0760163486921778,1,1,1,dopamine binding,MF,TH
9882,GO:0042214,0.0760163486921778,1,1,1,terpene metabolic process,BP,TH
9983,GO:0042418,0.0760163486921778,1,1,1,epinephrine biosynthetic process,BP,TH
13309,GO:0052314,0.0760163486921778,1,1,1,phytoalexin metabolic process,BP,TH
565,GO:0001707,0.0761173527198713,0.968331299441047,8,38,mesoderm formation,BP,ITGB4;BMP4;ITGA2;ITGA3;HMGA2;FGFR1;DKK1;LEF1
5372,GO:0016192,0.0761556085284942,0.935699882999877,173,1437,vesicle-mediated transport,BP,SYT8;FLOT1;FN1;PCDH7;PYGB;MMP9;CD109;TGFBR2;ASAP3;GSN;SCARA3;ANPEP;PROM2;COL7A1;CLTCL1;GAS6;SAMD9L;AXL;DPYSL2;HSPA2;SPTB;SLC2A3;SERPINE1;ENDOD1;S100A10;STON2;ANXA5;PSTPIP1;ASAP2;TIMP2;PAK1;ABCA1;NSG1;TBC1D8;RIN2;MRC2;VAV3;SORL1;ARAP1;PYCARD;DLG4;ITGA2;PDGFA;MICAL1;TIMP1;ACSL3;HIP1;EVI5L;SNX1;ANO6;TBC1D5;ASAP1;SYN1;SRPX;MAGED2;SPG11;KCNAB2;LRP1;FYN;CAV1;PLA2G6;SNX33;OSBPL5;CLU;SERPING1;CXCR1;EHD3;GOLGB1;SYTL1;METTL7A;EHBP1;PIK3R1;SYT1;TMEM173;CREB3L2;PCLO;DYSF;KIF17;BBS2;ANK3;TTN;APLP2;CAT;STOM;SNCA;MME;PDIA6;VAMP1;DKK1;MLEC;SEC24D;TGM2;PLA2R1;ESYT2;CDH13;CALR;COPG2;ARF6;TMED10;CST3;MANBA;AREG;BBS1;DNAJC6;SNX10;ELMO3;NEURL1B;TRAK1;PTPN1;KLHL12;LYST;ENPP1;PRCP;NFASC;TMEM50B;TMEM175;ANXA2;RAB13;SEPT5;LEPR;MAN2B1;PGAP1;MVB12B;MOSPD2;NLGN4Y;HTR1B;RAB43;TGFB2;VPS39;DNASE1L1;MAPK8IP3;C2CD4C;OSBPL1A;VAV2;MAGI2;AGAP1;GOPC;SNX7;PIKFYVE;CHIC2;UVRAG;NAPRT;MON2;VPS13C;OPHN1;LMF1;PPARG;CALCRL;SNX9;TBC1D16;LGALS3;ARL3;MIA3;DNAJC3;RARA;COG3;RASSF9;MPPE1;WIPF1;PPP3CA;STEAP2;ACTR1B;DNM1P46;ELMO2;VPS36;ADAM10;RHOBTB3;EPG5;S100A11;MYO1C;C2CD5;CTSD;DOCK1
962,GO:0002396,0.076172056757388,1,1,1,MHC protein complex assembly,BP,CALR
963,GO:0002397,0.076172056757388,1,1,1,MHC class I protein complex assembly,BP,CALR
1011,GO:0002501,0.076172056757388,1,1,1,peptide antigen assembly with MHC protein complex,BP,CALR
1012,GO:0002502,0.076172056757388,1,1,1,peptide antigen assembly with MHC class I protein complex,BP,CALR
574,GO:0001726,0.0762344284886123,0.952566271718035,23,138,ruffle,CC,TLN2;ASAP3;GSN;PAK1;PTK6;FRMD4B;PDPN;SPRY2;DLC1;SPRY4;FSCN1;MKLN1;ARF6;FGD4;ARHGEF2;ANXA2;PODXL;SNX9;WIPF1;RASA1;S100A11;MYO1C;C2CD5
7060,GO:0030858,0.076433863463879,0.970204721010183,7,35,positive regulation of epithelial cell differentiation,BP,SERPINE1;VDR;BMP4;BTG1;ALOX15B;SOX9;GDNF
5153,GO:0015696,0.0764708494774884,0.967738598050792,8,44,ammonium transport,BP,NOS1;SEC14L1;SYT1;SLC38A2;SNCA;HTR1B;GDNF;ABAT
7636,GO:0032058,0.0765269168912273,0.993257394312996,2,4,positive regulation of translational initiation in response to stress,BP,EIF2AK4;DNAJC3
18512,GO:1903729,0.0765397021630837,0.985967192082397,3,9,regulation of plasma membrane organization,BP,GSN;ASAP1;TGFB2
1276,GO:0003071,0.0766191322476191,0.985188844033572,3,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R;GJA5;GAS6
15156,GO:0071322,0.0766234425906173,0.958747434573356,14,89,cellular response to carbohydrate stimulus,BP,ZFP36L1;ANO1;IRS2;GAS6;NR1D1;LGALS1;PLA2G6;IGF1R;PDK3;GCLC;TH;CALCRL;EFNA5;PPP3CA
18498,GO:1903707,0.076743214164648,0.958563446717036,14,94,negative regulation of hemopoiesis,BP,FBN1;INPP5D;SFRP1;ZFP36L1;BMP4;GLI3;PIK3R1;KLF13;TLR3;MEIS2;ITPKB;BCL6;ZFPM1;RARA
4571,GO:0010661,0.0767849071103126,0.980402171295403,4,15,positive regulation of muscle cell apoptotic process,BP,PDCD4;CAMK2D;CDKN2A;PPARG
16101,GO:0090130,0.0769284215493386,0.948457631383322,31,204,tissue migration,BP,MMP9;CCBE1;TGFBR2;DOCK5;ACTA2;PTPRM;BMP4;SEMA5A;ITGA2;ITGA3;GPX1;FAT2;PXN;ROBO1;FGFR1;SEMA4A;CDH13;AMOTL1;CALR;NR2F2;SOX9;PRCP;PRKCA;RAB13;TGFB2;MAP2K5;SP100;PPARG;SASH1;ADGRA2;DOCK1
13946,GO:0060685,0.0770338928038393,0.993186246116294,2,4,regulation of prostatic bud formation,BP,BMP4;SULF1
13947,GO:0060686,0.0770338928038393,0.993186246116294,2,4,negative regulation of prostatic bud formation,BP,BMP4;SULF1
4852,GO:0014069,0.0770399501892721,0.951026467311576,25,148,postsynaptic density,CC,NOS1;ADD3;NETO1;PTPRS;DLG4;MAP2;DLG5;SYN1;KCNAB2;FYN;PCLO;DNAJC6;LZTS1;ARHGEF2;RGS14;NLGN4Y;PRNP;MAGI2;GOPC;SHISA9;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ
12241,GO:0048550,0.0771178567395955,0.992160636298888,2,5,negative regulation of pinocytosis,BP,PROM2;CAV1
6128,GO:0019395,0.077248931893697,0.960601078988895,12,77,fatty acid oxidation,BP,IRS2;TYSND1;ECH1;ALDH3A2;CPT1A;ACACB;DECR1;CYP4V2;PPARG;EHHADH;CPT2;ACAA2
3832,GO:0008442,0.0772607401048259,1,1,1,3-hydroxyisobutyrate dehydrogenase activity,MF,HIBADH
11603,GO:0046329,0.0773865723304602,0.972553730603561,6,28,negative regulation of JNK cascade,BP,SFRP1;PDCD4;PER1;TP73;NCOR1;TAOK3
19703,GO:2000095,0.0774432552989932,0.985729875792415,3,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1;DKK1;NPHP3
16841,GO:0098801,0.0776240143744995,0.984911319955792,3,11,regulation of renal system process,BP,F2R;GJA5;GAS6
17520,GO:1901077,0.0776794389551915,0.993095226159782,2,4,regulation of relaxation of muscle,BP,CAMK2D;PDE4D
13048,GO:0051583,0.0777192497635386,0.991422235529416,2,6,dopamine uptake involved in synaptic transmission,BP,SNCA;GDNF
13227,GO:0051934,0.0777192497635386,0.991422235529416,2,6,catecholamine uptake involved in synaptic transmission,BP,SNCA;GDNF
16283,GO:0090493,0.0777192497635386,0.991422235529416,2,6,catecholamine uptake,BP,SNCA;GDNF
16284,GO:0090494,0.0777192497635386,0.991422235529416,2,6,dopamine uptake,BP,SNCA;GDNF
605,GO:0001774,0.0777467423434974,0.980342468167307,4,14,microglial cell activation,BP,CLU;TLR3;SNCA;ATM
15850,GO:0072608,0.0777742874961179,0.991412639346381,2,6,interleukin-10 secretion,BP,PYCARD;PRKCZ
8260,GO:0033077,0.0778772157787363,0.965173064977687,9,48,T cell differentiation in thymus,BP,ZFP36L1;ZFP36L2;BMP4;GLI3;GLI2;FZD7;FZD8;ITPKB;ZBTB1
15403,GO:0071706,0.0779066026916935,0.9602952807521,12,74,tumor necrosis factor superfamily cytokine production,BP,GAS6;AXL;ZBTB20;PYCARD;GPNMB;CLU;PIK3R1;TLR3;NFATC4;ARHGEF2;ISL1;RARA
1921,GO:0004617,0.0779597516939344,1,1,1,phosphoglycerate dehydrogenase activity,MF,PHGDH
7842,GO:0032413,0.077980692270018,0.969456947570201,7,35,negative regulation of ion transmembrane transporter activity,BP,MMP9;PKD2;CAV1;CAMK2D;ANK3;GOPC;KCNRG
4548,GO:0010634,0.078110474517328,0.95520745156112,17,102,positive regulation of epithelial cell migration,BP,MMP9;CCBE1;TGFBR2;DOCK5;BMP4;SEMA5A;ITGA2;ITGA3;FGFR1;AMOTL1;CALR;SOX9;PRKCA;TGFB2;SASH1;ADGRA2;DOCK1
10402,GO:0043267,0.0781107916307925,0.980218195368568,4,14,negative regulation of potassium ion transport,BP,NOS1;CAV1;ANK3;KCNRG
10101,GO:0042641,0.0781527266148668,0.962021517465751,11,55,actomyosin,CC,ROR1;MYLK;MST1R;PXN;SHROOM4;FSCN1;VANGL2;FLNB;FHOD1;LIMA1;SEPT9
6694,GO:0030101,0.0781924533967475,0.96905580965696,7,39,natural killer cell activation,BP,GAS6;AXL;ULBP1;IL18;IFNK;IFNE;ZBTB1
3417,GO:0007205,0.0782329030590011,0.975842925516633,5,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,F2R;LRP1;CCK;DGKQ;HTR1B
624,GO:0001808,0.0783054106695286,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1204,GO:0002865,0.0783054106695286,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1213,GO:0002884,0.0783054106695286,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
10012,GO:0042476,0.0784192300980656,0.957870945405375,14,80,odontogenesis,BP,HTRA1;ITGA6;ITGB4;LAMB1;SERPINE1;BMP4;GLI3;GLI2;LAMA5;DLX3;FAM20A;TGFB2;DLX2;LEF1
4593,GO:0010713,0.0784198047458819,0.991299779506172,2,6,negative regulation of collagen metabolic process,BP,CST3;PPARG
17199,GO:0110020,0.0784259275341739,0.960385160250545,12,63,regulation of actomyosin structure organization,BP,CTGF;SFRP1;ASAP3;S100A10;PAK1;ARAP1;PXN;PIK3R1;DLC1;BBS4;AKAP13;FHOD1
3028,GO:0006577,0.0784444745610163,0.984683506788711,3,11,amino-acid betaine metabolic process,BP,CPT1A;ALDH9A1;ALDH7A1
6284,GO:0019900,0.0784772385029646,0.938720426317106,77,581,kinase binding,MF,RHOBTB2;CDKN2B;TGFBR2;PITPNM3;IRS2;GAS6;UTRN;ROR1;AXL;EGFR;ACTA2;CSPG4;TOM1L2;PAK1;TRIM5;NR3C1;TP53;CEP250;WNK1;DLG4;MICAL1;ACSL3;DOCK4;BTG1;SIK1;TTC28;SYN1;NEK9;CAV1;PLA2G6;TRIB2;PRKCZ;TNS2;MST1R;IL31RA;PTPN14;PER1;PXN;PIK3R1;TMEM173;CNTLN;SPRY2;TTN;TP73;CHEK2;FRMD5;FGFR1;PAG1;IGF1R;EPHB6;AKAP7;AKAP13;DGKQ;MAP3K1;PTPN1;SOX9;RGS14;RAB13;CEP68;MAP3K12;RET;MAPK8IP3;CDKN2A;SP100;MEF2A;GCSAM;SASH1;DNAJC3;RARA;SV2A;CCNY;PRKAG1;CDK5RAP3;CAMK2N1;ELMO2;ADAM10;RHOBTB3
16916,GO:0098928,0.0785734912811539,1,2,2,presynaptic signal transduction,BP,PCLO;BSN
17018,GO:0099526,0.0785734912811539,1,2,2,presynapse to nucleus signaling pathway,BP,PCLO;BSN
7719,GO:0032225,0.0787596531634976,0.984595701701191,3,11,regulation of synaptic transmission, dopaminergic,BP,FLOT1;SNCA;GDNF
7575,GO:0031953,0.0787781063065515,0.984938581592983,3,10,negative regulation of protein autophosphorylation,BP,CAV1;ENG;ENPP1
16784,GO:0098662,0.0788258350678798,0.942037662897199,50,372,inorganic cation transmembrane transport,BP,F2R;PKD2;JPH2;NOS1;GAS6;UTRN;HSPA2;SLC8A1;ORAI3;GJC2;SLC20A1;NTSR1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;ANO6;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;ANK3;KCNJ5;STOM;SNCA;PDE4D;G6PD;SLC24A1;KCNQ3;NDUFA4L2;TMEM175;SLC39A11;PRNP;SCNN1A;FHL1;SLC9A4;ITPR2;CACNB1;KCNIP3;PTPN3;STEAP2;CACNA2D3;KCNRG;TUSC3;ORAI2
7917,GO:0032504,0.0788295367463309,0.94026683601705,61,465,multicellular organism reproduction,BP,SERPINE2;SFRP1;SYNE1;ETV5;AXL;EGFR;HSPA2;RFX2;CRTAP;VDR;BMP4;SMARCA2;HSF2BP;MMP19;BTG1;ITGA3;PAQR8;CTSV;PLA2G6;SPATA6;SLIT3;PHC2;CCNI;SPATA20;ANG;BBS2;MLH3;PAQR7;RGS2;SETX;CCDC136;SEPT6;BBS4;CALR;ATM;NR2F2;ZNF449;EGR1;SOX9;BCL6;MYBL1;FNDC3A;STOX2;SPA17;TGFB2;ODF2;THRA;HERPUD2;RHBDD1;TH;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1;FZD4;CREBRF;AGO4;OXTR;RXRA
10495,GO:0043425,0.0788355840818263,0.975600943253021,5,20,bHLH transcription factor binding,MF,TSC22D3;TCF4;SOX9;ISL1;TCF12
10361,GO:0043203,0.0788391162577075,0.991226163196962,2,6,axon hillock,CC,PRKCZ;CCK
10081,GO:0042610,0.0788766539713566,1,1,1,CD8 receptor binding,MF,FYN
19230,GO:1905429,0.0788766539713566,1,1,1,response to glycine,BP,FYN
19231,GO:1905430,0.0788766539713566,1,1,1,cellular response to glycine,BP,FYN
6326,GO:0021501,0.0790226770786621,1,1,1,prechordal plate formation,BP,SSBP3
6359,GO:0021547,0.0790226770786621,1,1,1,midbrain-hindbrain boundary initiation,BP,SSBP3
20062,GO:2000742,0.0790226770786621,1,1,1,regulation of anterior head development,BP,SSBP3
20063,GO:2000744,0.0790226770786621,1,1,1,positive regulation of anterior head development,BP,SSBP3
13571,GO:0060070,0.0790478545202029,0.946060348180225,33,238,canonical Wnt signaling pathway,BP,SFRP1;SNAI2;SULF2;TCF7L1;WWTR1;PRICKLE1;DDIT3;WNK1;RBMS3;GLI3;CDK14;CAV1;NPHP4;CAPRIN2;FZD7;PTPRU;DKK1;PSMB9;FZD8;FZD1;KLHL12;EGR1;SOX9;ISL1;IGFBP4;LEF1;IGFBP2;NPHP3;YAP1;DIXDC1;CCNY;FZD4;MED12
13784,GO:0060402,0.079056707989446,0.957537669974204,14,78,calcium ion transport into cytosol,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;FYN;CAV1;CAMK2D;SNCA;PDE4D;PRNP;ITPR2
1183,GO:0002831,0.0791841570929007,0.956113640002289,15,97,regulation of response to biotic stimulus,BP,HTRA1;HERC5;TKFC;EIF2AK4;TRIM5;STAT1;PYCARD;IFIT1;DDX60;SEC14L1;TMEM173;APOBEC3G;APOBEC3F;PRKCA;SASH1
9367,GO:0035921,0.0791845534303225,1,1,1,desmosome disassembly,BP,SNAI2
17457,GO:1900387,0.0791845534303225,1,1,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,SNAI2
14212,GO:0061217,0.0792031500417936,0.979120518569655,4,17,regulation of mesonephros development,BP,MAGED1;BMP4;SOX9;GDNF
4436,GO:0010324,0.0792284475135705,0.966444711371239,8,42,membrane invagination,BP,GSN;ABCA1;ITGA2;ANO6;SNX33;PPARG;SNX9;DOCK1
12087,GO:0048156,0.0792408014929727,0.984461348733083,3,11,tau protein binding,MF,FYN;CLU;SNCA
7545,GO:0031883,0.0792653528180401,1,1,1,taste receptor binding,MF,REEP2
7153,GO:0031034,0.0792956855688685,0.992529687902613,3,4,myosin filament assembly,BP,TTN;OBSL1;MYH11
16875,GO:0098862,0.0793478254185328,0.9572639507037,14,81,cluster of actin-based cell projections,CC,CYBRD1;ADD3;PLEC;DOCK4;ESPN;SLC38A2;BBS2;MME;MYO3B;TRIOBP;ABCC2;FLNB;LIMA1;MYO1C
2046,GO:0004795,0.0794911325923288,1,1,1,threonine synthase activity,MF,THNSL2
4046,GO:0009088,0.0794911325923288,1,1,1,threonine biosynthetic process,BP,THNSL2
11619,GO:0046360,0.0794911325923288,1,1,1,2-oxobutyrate biosynthetic process,BP,THNSL2
11620,GO:0046361,0.0794911325923288,1,1,1,2-oxobutyrate metabolic process,BP,THNSL2
16876,GO:0098868,0.0795623432252722,0.979720498085376,4,14,bone growth,BP,TGFBR2;EVC;LEPR;RARA
8453,GO:0033605,0.0795918459257759,0.991758544535831,2,5,positive regulation of catecholamine secretion,BP,GDNF;OXTR
10806,GO:0044320,0.0796060085163852,0.984712063669443,3,10,cellular response to leptin stimulus,BP,BBS2;BBS4;LEPR
1105,GO:0002695,0.0800641689041851,0.956626664619904,14,88,negative regulation of leukocyte activation,BP,INPP5D;SFRP1;IL20RB;AXL;BMP4;GPNMB;GLI3;DLG5;IL31RA;PAG1;ATM;BCL6;PRNP;LGALS3
10140,GO:0042743,0.0800791733234185,0.974142069845546,5,27,hydrogen peroxide metabolic process,BP,EGFR;GPX1;PRDX5;CAT;SNCA
16484,GO:0097223,0.0803075248612224,0.956402207571181,14,91,sperm part,CC,SYT8;CAV1;SPATA6;ITGA1;FLOT2;CCDC136;SEPT6;CALR;IFT27;FNDC3A;SPA17;ODF2;TCTEX1D4;DNAH1
727,GO:0001957,0.0806352348215322,0.992672412481206,2,4,intramembranous ossification,BP,MMP2;MN1
9448,GO:0036072,0.0806352348215322,0.992672412481206,2,4,direct ossification,BP,MMP2;MN1
7128,GO:0030971,0.0806595807651263,0.963860574132641,9,45,receptor tyrosine kinase binding,MF,PITPNM3;GAS6;TP53;DOCK4;PTPN14;PIK3R1;PAG1;PTPN1;ELMO2
7486,GO:0031668,0.0806849712486781,0.947628800515001,26,184,cellular response to extracellular stimulus,BP,ITGA6;SFRP1;CDKN2B;SKP2;GAS6;SNAI2;AXL;SESN3;VDR;EIF2AK4;TP53;SESN1;CTSV;FYN;KANK2;SLC38A2;MDM2;SSH1;UCN2;ULK1;HSPA5;PPARG;POSTN;TAF1;PIK3C2B;FOS
5268,GO:0015923,0.0807157082495885,0.979322556132226,4,14,mannosidase activity,MF,MAN1A1;MANBA;MAN2B1;EDEM1
7616,GO:0032026,0.0807452578926668,0.985440419541167,3,8,response to magnesium ion,BP,ANK3;SNCA;MDM2
14260,GO:0061383,0.0807783881606078,0.966235304071542,8,35,trabecula morphogenesis,BP,MMP2;SFRP1;FBN2;PLXNB1;ADGRG6;TGFBR3;ENG;TGFB2
1404,GO:0003339,0.0808979548149199,0.991543110592044,2,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1;GDNF
16470,GO:0097197,0.0810029792147098,0.991525693197975,2,5,tetraspanin-enriched microdomain,CC,PDPN;ADAM10
8021,GO:0032677,0.0810084391464511,0.967671635600652,7,39,regulation of interleukin-8 production,BP,F2R;SERPINE1;DDIT3;PYCARD;TLR3;AFAP1L2;MAP2K5
8524,GO:0033865,0.0810239310581149,0.970424149471323,6,33,nucleoside bisphosphate metabolic process,BP,SULT1E1;DCAKD;ABHD14B;ENPP1;TPST1;PPCS
8530,GO:0033875,0.0810239310581149,0.970424149471323,6,33,ribonucleoside bisphosphate metabolic process,BP,SULT1E1;DCAKD;ABHD14B;ENPP1;TPST1;PPCS
8550,GO:0034032,0.0810239310581149,0.970424149471323,6,33,purine nucleoside bisphosphate metabolic process,BP,SULT1E1;DCAKD;ABHD14B;ENPP1;TPST1;PPCS
5467,GO:0016406,0.0810506533788864,0.991517782221538,2,5,carnitine O-acyltransferase activity,MF,CPT1A;CPT2
1951,GO:0004657,0.0811537837369394,1,1,1,proline dehydrogenase activity,MF,PRODH
906,GO:0002292,0.0811781794575143,0.96798950024354,7,34,T cell differentiation involved in immune response,BP,PRKCZ;SEMA4A;IL18;BCL6;ZFPM1;LEF1;RARA
17365,GO:1900122,0.0812396497295441,0.99080010141016,2,6,positive regulation of receptor binding,BP,MMP9;ANXA2
507,GO:0001570,0.0812527818389691,0.961850321843002,10,49,vasculogenesis,BP,ZFP36L1;TGFBR2;CUL7;XDH;CAV1;TGFBR3;ENG;YAP1;FZD4;RASA1
3277,GO:0006958,0.0816069312896575,0.983795211057784,3,11,complement activation, classical pathway,BP,CLU;SERPING1;C5
1583,GO:0003996,0.0816471253905995,1,1,1,acyl-CoA ligase activity,MF,ACSF2
17967,GO:1902430,0.0817317897565805,0.984586073146523,3,9,negative regulation of amyloid-beta formation,BP,SORL1;CLU;PRNP
4231,GO:0009415,0.0817750712975081,0.984113441242319,3,10,response to water,BP,PKD2;COL18A1;TH
4105,GO:0009164,0.0817820144453737,0.977564626811563,4,21,nucleoside catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F;DPYD
5727,GO:0016879,0.0818254259823989,0.965031370390117,8,43,ligase activity, forming carbon-nitrogen bonds,MF,TTLL11;CPS1;HLCS;ACACB;GCLC;NAPRT;TPGS1;PPCS
10091,GO:0042628,0.081830186315229,1,1,1,mating plug formation,BP,SERPINE2
11173,GO:0045297,0.081830186315229,1,1,1,post-mating behavior,BP,SERPINE2
14169,GO:0061107,0.081830186315229,1,1,1,seminal vesicle development,BP,SERPINE2
14170,GO:0061108,0.081830186315229,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1847,GO:0004512,0.0818540694179567,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5722,GO:0016872,0.0818540694179567,1,1,1,intramolecular lyase activity,MF,ISYNA1
13919,GO:0060627,0.0818617605623138,0.940240992739588,47,345,regulation of vesicle-mediated transport,BP,SYT8;FLOT1;PROM2;GAS6;AXL;SERPINE1;STON2;TBC1D8;SORL1;PYCARD;DLG4;ITGA2;MICAL1;ACSL3;HIP1;EVI5L;ANO6;TBC1D5;SYN1;LRP1;CAV1;PLA2G6;SNX33;CLU;SYTL1;SYT1;PCLO;SNCA;DKK1;CDH13;CALR;ARF6;DNAJC6;PTPN1;ANXA2;RAB13;SEPT5;C2CD4C;MAGI2;GOPC;UVRAG;OPHN1;PPARG;TBC1D16;LGALS3;PPP3CA;C2CD5
1036,GO:0002548,0.0818913210478657,0.977805179592161,4,19,monocyte chemotaxis,BP,SERPINE1;ANO6;MOSPD2;LGALS3
11392,GO:0045823,0.0818917380175705,0.978160411345437,4,17,positive regulation of heart contraction,BP,CTGF;RGS2;PDE4D;TGFB2
8751,GO:0034440,0.0818993534665856,0.957785582660176,12,78,lipid oxidation,BP,IRS2;TYSND1;ECH1;ALDH3A2;CPT1A;ACACB;DECR1;CYP4V2;PPARG;EHHADH;CPT2;ACAA2
2428,GO:0005614,0.0818998467515665,0.985140767195433,3,8,interstitial matrix,CC,NAV2;CCDC80;ECM2
793,GO:0002063,0.0819272171526499,0.974795656602344,5,18,chondrocyte development,BP,TGFBR2;SULF2;SERPINH1;SULF1;SOX9
15660,GO:0072217,0.0819284455710022,0.991371607064981,2,5,negative regulation of metanephros development,BP,BMP4;STAT1
478,GO:0001523,0.0819345105724305,0.965042507821466,8,42,retinoid metabolic process,BP,SDC3;LRP1;SDR16C5;SDC2;CYP4V2;AGRN;UGT1A3;SCPEP1
3465,GO:0007288,0.0819570803850695,0.984062872268584,3,10,sperm axoneme assembly,BP,BBS2;TPGS1;DNAH1
17044,GO:0099572,0.0819600232655215,0.947523027749795,25,149,postsynaptic specialization,CC,NOS1;ADD3;NETO1;PTPRS;DLG4;MAP2;DLG5;SYN1;KCNAB2;FYN;PCLO;DNAJC6;LZTS1;ARHGEF2;RGS14;NLGN4Y;PRNP;MAGI2;GOPC;SHISA9;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ
9613,GO:0036498,0.0820492645292874,0.959237293551866,11,67,IRE1-mediated unfolded protein response,BP,EXTL2;CUL7;WFS1;PDIA6;LMNA;PTPN1;TSPYL2;HSPA5;DNAJC3;CTDSP2;EDEM1
13208,GO:0051900,0.0821373812461705,0.983345272688667,3,12,regulation of mitochondrial depolarization,BP,IFI6;CCK;GCLC
3937,GO:0008630,0.0822829540616913,0.955092608381145,14,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,DDIT4;SNAI2;NUPR1;TP53;PYCARD;ERCC6;CLU;PIK3R1;TP73;CASP14;CHEK2;NFATC4;ATM;USP28
11675,GO:0046487,0.0823715243413561,0.990596496311799,2,6,glyoxylate metabolic process,BP,IDH2;ALDH4A1
15279,GO:0071500,0.0823919878940901,0.991294021109683,2,5,cellular response to nitrosative stress,BP,DDIT3;ATM
19774,GO:2000241,0.0825207410522116,0.957499588117245,12,75,regulation of reproductive process,BP,SFRP1;NUPR1;BMP4;TIMP1;PRKACB;SULF1;CALR;CITED2;NRK;SOX9;OXTR;RXRA
6828,GO:0030301,0.0826709921070475,0.962518398162298,9,49,cholesterol transport,BP,ABCA1;LRP1;CAV1;OSBPL5;CLU;ANXA2;PPARG;ABCA2;ABCA5
806,GO:0002080,0.0827464138211133,0.983842963592163,3,10,acrosomal membrane,CC,CAV1;FLOT2;CCDC136
13548,GO:0060044,0.0828452965627681,0.98381534594934,3,10,negative regulation of cardiac muscle cell proliferation,BP,TGFBR2;JARID2;TP73
13901,GO:0060592,0.0828935721749312,0.992342706526226,2,4,mammary gland formation,BP,BMP4;GLI3
11778,GO:0046683,0.0829983705803866,0.954865602212365,14,85,response to organophosphorus,BP,ZFP36L1;PKD2;SLC8A1;STAT1;MMP19;CPS1;PER1;AREG;DGKQ;SSH1;HSPA5;ITPR2;TAF1;FOS
10028,GO:0042509,0.0830126833019798,0.966545115886125,7,41,regulation of tyrosine phosphorylation of STAT protein,BP,PTK6;FYN;CAV1;IL31RA;CTF1;IL18;ISL1
7492,GO:0031681,0.0830396329028392,0.991185165458977,2,5,G-protein beta-subunit binding,MF,F2R;GNG2
4609,GO:0010731,0.0830921773440211,1,1,1,protein glutathionylation,BP,G6PD
4610,GO:0010732,0.0830921773440211,1,1,1,regulation of protein glutathionylation,BP,G6PD
4611,GO:0010734,0.0830921773440211,1,1,1,negative regulation of protein glutathionylation,BP,G6PD
12811,GO:0051148,0.0830933026282159,0.970234790359542,6,26,negative regulation of muscle cell differentiation,BP,SOX6;PAK1;PDCD4;FZD7;DKK1;G6PD
3383,GO:0007163,0.0830950929302728,0.946165898307215,26,159,establishment or maintenance of cell polarity,BP,RHOBTB2;GSN;PAK1;DLG4;MAP2;FRMD4B;DLG5;UST;PRKCZ;PARVA;SPRY2;FLOT2;LMNA;FSCN1;AMOTL1;ARF6;SYNE2;VANGL2;ARHGEF2;MPP7;AMOTL2;NPHP3;CENPA;OPHN1;MYO9A;RHOBTB3
13154,GO:0051787,0.0833439068569818,0.973117617470959,5,24,misfolded protein binding,MF,HSPA2;CLU;HSPA5;DNAJC3;EDEM1
17356,GO:1900113,0.0836555758488097,0.991081146718193,2,5,negative regulation of histone H3-K9 trimethylation,BP,KDM4C;KDM4A
4372,GO:0010002,0.0838151326943102,0.984020150120623,3,9,cardioblast differentiation,BP,PRICKLE1;ISL1;TGFB2
14033,GO:0060840,0.0838318566440007,0.958923666170754,11,52,artery development,BP,GJA5;PKD2;MYLK;BMP4;PRICKLE1;LTBP1;GLI3;LRP1;ENG;HOXA1;TGFB2
13964,GO:0060707,0.0839785769319178,0.983497732799893,3,10,trophoblast giant cell differentiation,BP,E2F7;MDFI;NR2F2
14542,GO:0070100,0.0840999131536043,0.992164236843055,2,4,negative regulation of chemokine-mediated signaling pathway,BP,SLIT3;ROBO1
16638,GO:0097553,0.0841146348310184,0.955639083462845,13,70,calcium ion transmembrane import into cytosol,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;FYN;CAMK2D;SNCA;PDE4D;PRNP;ITPR2
4406,GO:0010165,0.0842284492486919,0.966592504373965,7,33,response to X-ray,BP,SFRP1;TP53;ERCC6;HMGA2;TP73;ATM;NIPBL
4391,GO:0010070,0.0842975128363941,1,1,1,zygote asymmetric cell division,BP,RGS14
839,GO:0002153,0.0843873836523455,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11447,GO:0045925,0.0843873836523455,1,1,1,positive regulation of female receptivity,BP,THRA
670,GO:0001881,0.0844647373925309,0.969342540436607,6,28,receptor recycling,BP,NSG1;ARAP1;EHD3;SNCA;ANXA2;TBC1D16
7093,GO:0030900,0.0844956367541038,0.941483914321385,35,227,forebrain development,BP,FAT4;AXL;EGFR;LAMB1;SLC8A1;BMP4;NEFL;PTPRS;EFHC1;SEMA5A;GLI3;LRP1;FYN;FUT10;GLI2;SLC38A2;BBS2;DLC1;ROBO1;FGFR1;DKK1;BBS4;NR2F2;SYNE2;ISL1;PGAP1;DLX2;LEF1;TH;TACC2;OPHN1;DIXDC1;RARA;SLITRK5;OXTR
18195,GO:1903019,0.0847165275495689,0.9825941455064,3,12,negative regulation of glycoprotein metabolic process,BP,ITM2C;CST3;ITM2A
3583,GO:0007634,0.0847236595481313,1,1,1,optokinetic behavior,BP,HOXA1
14048,GO:0060876,0.0847236595481313,1,1,1,semicircular canal formation,BP,HOXA1
1578,GO:0003990,0.0847730517148533,1,1,1,acetylcholinesterase activity,MF,BCHE
4817,GO:0014016,0.0847730517148533,1,1,1,neuroblast differentiation,BP,BCHE
11648,GO:0046448,0.0847730517148533,1,1,1,tropane alkaloid metabolic process,BP,BCHE
12578,GO:0050783,0.0847730517148533,1,1,1,cocaine metabolic process,BP,BCHE
18928,GO:1904719,0.0848060065966347,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,SSH1
1964,GO:0004675,0.0848960319666709,0.978650129058938,4,12,transmembrane receptor protein serine/threonine kinase activity,MF,TGFBR2;LTBP1;LTBP4;TGFBR3
13598,GO:0060122,0.0849247755864294,0.977548532663348,4,15,inner ear receptor cell stereocilium organization,BP,FAT4;TRIOBP;VANGL2;IFT27
14498,GO:0070022,0.0849619315093647,0.992035708729312,2,4,transforming growth factor beta receptor complex,CC,TGFBR2;ENG
4517,GO:0010575,0.0850097997867467,0.973087223303876,5,20,positive regulation of vascular endothelial growth factor production,BP,CCBE1;SULF2;C5;SULF1;ISL1
19932,GO:2000514,0.0850437823319475,0.972403466863487,5,24,regulation of CD4-positive, alpha-beta T cell activation,BP,TGFBR2;PRKCZ;IL18;BCL6;RARA
15247,GO:0071458,0.0850690711688333,0.990840632531851,2,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;SPPL2B
15274,GO:0071494,0.0851129929257296,0.992013099724933,2,4,cellular response to UV-C,BP,MDM2;POLH
4806,GO:0014002,0.0851302114171455,0.973256436234589,5,19,astrocyte development,BP,ROR1;EGFR;VIM;LRP1;LAMB2
12113,GO:0048232,0.0853242405249072,0.939454464462819,39,286,male gamete generation,BP,SYNE1;ETV5;AXL;HSPA2;RFX2;CRTAP;SMARCA2;HSF2BP;BTG1;CTSV;SPATA6;PHC2;CCNI;SPATA20;BBS2;MLH3;RGS2;SETX;CCDC136;SEPT6;BBS4;CALR;ATM;ZNF449;SOX9;BCL6;MYBL1;FNDC3A;SPA17;ODF2;HERPUD2;RHBDD1;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1;AGO4
3955,GO:0008721,0.0853697198220817,1,1,1,D-serine ammonia-lyase activity,MF,SRR
5712,GO:0016855,0.0853697198220817,1,1,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,SRR
5897,GO:0018114,0.0853697198220817,1,1,1,threonine racemase activity,MF,SRR
6872,GO:0030378,0.0853697198220817,1,1,1,serine racemase activity,MF,SRR
9550,GO:0036361,0.0853697198220817,1,1,1,racemase activity, acting on amino acids and derivatives,MF,SRR
11638,GO:0046416,0.0853697198220817,1,1,1,D-amino acid metabolic process,BP,SRR
11643,GO:0046437,0.0853697198220817,1,1,1,D-amino acid biosynthetic process,BP,SRR
12002,GO:0047661,0.0853697198220817,1,1,1,amino-acid racemase activity,MF,SRR
14585,GO:0070178,0.0853697198220817,1,1,1,D-serine metabolic process,BP,SRR
14586,GO:0070179,0.0853697198220817,1,1,1,D-serine biosynthetic process,BP,SRR
2122,GO:0004918,0.0853864046559647,1,1,1,interleukin-8 receptor activity,MF,CXCR1
6308,GO:0019959,0.0853864046559647,1,1,1,interleukin-8 binding,MF,CXCR1
9690,GO:0038112,0.0853864046559647,1,1,1,interleukin-8-mediated signaling pathway,BP,CXCR1
16815,GO:0098754,0.0854217864482894,0.958461063967254,10,73,detoxification,BP,NQO1;PTGS1;GPX1;SESN1;TP53INP1;PRDX5;CAT;ABCC2;GPX8;GSTZ1
13218,GO:0051920,0.0854377308870952,0.989159126759088,2,8,peroxiredoxin activity,MF,SESN1;PRDX5
12968,GO:0051412,0.085559058596028,0.983051448754529,3,10,response to corticosterone,BP,NEFL;TH;FOS
16393,GO:0097060,0.0857342744753558,0.944277803770888,26,158,synaptic membrane,CC,SYNE1;F2R;UTRN;FLRT3;SLC8A1;NSG1;NETO1;KCNMA1;PTPRS;DLG4;HIP1;ITGA3;DLG5;IL31RA;SYT1;ANK3;NIPSNAP1;LZTS1;RGS14;NLGN4Y;GOPC;SHISA9;PRR7;DNM1P46;CAMK2N1;MPDZ
4354,GO:0009954,0.0857710719783726,0.972399803700261,5,22,proximal/distal pattern formation,BP,GLI3;GLI2;PBX1;DLX2;PBX2
6037,GO:0019145,0.0858056420539532,1,1,1,aminobutyraldehyde dehydrogenase activity,MF,ALDH9A1
8503,GO:0033737,0.0858056420539532,1,1,1,1-pyrroline dehydrogenase activity,MF,ALDH9A1
11932,GO:0047105,0.0858056420539532,1,1,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,ALDH9A1
16369,GO:0097018,0.0858224991951336,1,1,1,renal albumin absorption,BP,GAS6
17376,GO:1900141,0.0858224991951336,1,1,1,regulation of oligodendrocyte apoptotic process,BP,GAS6
17377,GO:1900142,0.0858224991951336,1,1,1,negative regulation of oligodendrocyte apoptotic process,BP,GAS6
19937,GO:2000532,0.0858224991951336,1,1,1,regulation of renal albumin absorption,BP,GAS6
19938,GO:2000533,0.0858224991951336,1,1,1,negative regulation of renal albumin absorption,BP,GAS6
15461,GO:0071863,0.0858288111008308,0.990710321204103,2,5,regulation of cell proliferation in bone marrow,BP,HMGA2;LEF1
15462,GO:0071864,0.0858288111008308,0.990710321204103,2,5,positive regulation of cell proliferation in bone marrow,BP,HMGA2;LEF1
11422,GO:0045892,0.0859170648184122,0.929884868003482,109,891,negative regulation of transcription, DNA-templated,BP,TXNIP;SOX6;SFRP1;GAS6;SNAI2;MAGED1;PHF21A;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;NR1D1;SMARCA2;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;UHRF2;WFS1;MDFI;JARID2;TP73;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;CDKN2A;SP100;MDFIC;ZNF12;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;RARA;HES2;TAF1;TSHZ3;ZBTB1;KDM4A;NIPBL;PRDM5;RXRA
16219,GO:0090303,0.0859434815352044,0.968540415760352,6,29,positive regulation of wound healing,BP,F2R;TGFBR2;MYLK;SERPINE1;ANO6;PDPN
13009,GO:0051492,0.0859785206881691,0.957271222185824,11,59,regulation of stress fiber assembly,BP,CTGF;SFRP1;ASAP3;S100A10;PAK1;ARAP1;PXN;PIK3R1;DLC1;BBS4;FHOD1
10414,GO:0043281,0.0860051057896972,0.94526341679947,23,175,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFRSF6B;MMP9;CTGF;F2R;GSN;GAS6;PYCARD;MICAL1;HIP1;GPX1;IFI6;XDH;PRDX5;CCK;HERPUD1;DAPK1;DLC1;ROBO1;SNCA;MDM2;MAP2K5;LEF1;PPARG
2535,GO:0005795,0.0861867462489557,0.948866514989122,18,117,Golgi stack,CC,MARCH4;DNMBP;SULF2;ASAP2;NSG1;SORL1;ARAP1;LPCAT2;FUT10;GOLGB1;ST6GAL2;SULF1;GCNT1;GOLGA8B;GAL3ST4;GOLGA8N;GALNT2;COG3
12040,GO:0048012,0.086265095385726,0.982457718198373,3,11,hepatocyte growth factor receptor signaling pathway,BP,PAK1;MST1R;PTPN1
856,GO:0002189,0.0863401110741244,1,1,1,ribose phosphate diphosphokinase complex,CC,PRPS2
580,GO:0001733,0.0863486545850245,1,1,1,galactosylceramide sulfotransferase activity,MF,GAL3ST4
12521,GO:0050694,0.0863486545850245,1,1,1,galactose 3-O-sulfotransferase activity,MF,GAL3ST4
12522,GO:0050698,0.0863486545850245,1,1,1,proteoglycan sulfotransferase activity,MF,GAL3ST4
13237,GO:0051953,0.0864122882460838,0.990609751528782,2,5,negative regulation of amine transport,BP,SNCA;ABAT
17347,GO:1900102,0.0865316475365408,0.982380148908218,3,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,WFS1;PTPN1;HSPA5
12676,GO:0050921,0.0866084812935838,0.954960896805142,12,77,positive regulation of chemotaxis,BP,GAS6;SERPINE1;CXCL14;SEMA5A;ITGA2;ANO6;FGFR1;CDH13;CALR;MOSPD2;MEGF8;ADAM10
4624,GO:0010750,0.0867610829856191,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
8443,GO:0033594,0.0867610829856191,1,1,1,response to hydroxyisoflavone,BP,EGFR
10247,GO:0043006,0.0867610829856191,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16601,GO:0097489,0.0867610829856191,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
13493,GO:0055093,0.0868694467922888,0.976351231534151,4,17,response to hyperoxia,BP,TP53;CAV1;CAT;PPARG
16241,GO:0090330,0.0870852947848445,0.976504544278601,4,16,regulation of platelet aggregation,BP,SERPINE2;PDPN;PRKCA;ABAT
10217,GO:0042942,0.0871084407494127,1,1,1,D-serine transport,BP,NFKBIE
15515,GO:0071953,0.0871346331827511,1,1,1,elastic fiber,CC,FBLN1
397,GO:0001074,0.0872308443402252,1,1,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,TP53
403,GO:0001084,0.0872308443402252,1,1,1,transcription factor activity, TFIID-class binding,MF,TP53
8420,GO:0033552,0.0872308443402252,1,1,1,response to vitamin B3,BP,TP53
6740,GO:0030168,0.087234923397349,0.950001221337483,16,101,platelet activation,BP,SERPINE2;F2R;GAS6;AXL;VAV3;GNG2;SLC7A11;PDGFA;PDPN;FYN;PIK3R1;DGKQ;PRKCA;VAV2;ITPR2;ABAT
5265,GO:0015918,0.0872588473694562,0.958045065696349,10,56,sterol transport,BP,ABCA1;LRP1;CAV1;OSBPL5;CLU;ANXA2;OSBPL1A;PPARG;ABCA2;ABCA5
1807,GO:0004458,0.0872658978895313,1,1,1,D-lactate dehydrogenase (cytochrome) activity,MF,D2HGDH
5744,GO:0016898,0.0872658978895313,1,1,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,D2HGDH
6158,GO:0019516,0.0872658978895313,1,1,1,lactate oxidation,BP,D2HGDH
8113,GO:0032814,0.0873340194854585,0.975975908644256,4,18,regulation of natural killer cell activation,BP,GAS6;AXL;IL18;ZBTB1
12810,GO:0051147,0.0873434941772867,0.950975463559338,15,93,regulation of muscle cell differentiation,BP,FLOT1;SOX6;PAK1;BMP4;PDCD4;SIK1;FZD7;DKK1;G6PD;ENG;AKAP13;THRA;BOC;MEF2A;DMPK
4816,GO:0014015,0.0875424941043026,0.964656547828297,7,36,positive regulation of gliogenesis,BP,SERPINE2;TENM4;ETV5;GJC2;TP73;PLAG1;PPARG
3012,GO:0006560,0.0875483981540401,0.989643304263663,2,6,proline metabolic process,BP,PRODH;ALDH4A1
1328,GO:0003181,0.0875701256051823,0.977285362616085,4,13,atrioventricular valve morphogenesis,BP,TGFBR2;MDM2;ZFPM1;TGFB2
6761,GO:0030204,0.0876142595280887,0.968326949890219,6,25,chondroitin sulfate metabolic process,BP,CSPG4;B3GAT3;XYLT1;CHST3;HEXA;DSEL
9968,GO:0042391,0.0876263043751858,0.941696783754171,28,194,regulation of membrane potential,BP,GJA5;SLC8A1;NTSR1;SCN8A;NETO1;SCN2A;KCNMA1;DLG4;IFI6;CAV1;PIAS3;PRKCZ;EHD3;CAMK2D;CCK;ANK3;KCNJ5;SNCA;GCLC;KCNQ3;SSH1;CRTC1;KCTD7;FHL1;PTPN3;PPP3CA;ABAT;DMPK
2744,GO:0006145,0.0876652651931565,0.991627262359161,2,4,purine nucleobase catabolic process,BP,XDH;DPYD
16081,GO:0090091,0.0877580236254845,0.991613103290554,2,4,positive regulation of extracellular matrix disassembly,BP,PDPN;FSCN1
16737,GO:0098562,0.0877628422013667,0.945533246085315,21,139,cytoplasmic side of membrane,CC,PKD2;SPTB;NTSR1;PTK6;GNG2;DLG4;HIP1;KCNAB2;FYN;SHROOM4;RGS2;ESYT2;G6PD;PTPN1;SPPL2B;TH;SNX9;PTPN3;PPP3CA;RASA1;LITAF
13813,GO:0060442,0.087764723034622,0.982929126202844,3,9,branching involved in prostate gland morphogenesis,BP,SFRP1;BMP4;RXRA
10399,GO:0043260,0.0878189159376815,0.993921881108176,2,3,laminin-11 complex,CC,LAMA5;LAMB2
12233,GO:0048537,0.0878229942384964,0.990364840103233,2,5,mucosal-associated lymphoid tissue development,BP,FOXL1;RET
12236,GO:0048541,0.0878229942384964,0.990364840103233,2,5,Peyer's patch development,BP,FOXL1;RET
8553,GO:0034035,0.0878818513101987,0.975772324838589,4,18,purine ribonucleoside bisphosphate metabolic process,BP,SULT1E1;ABHD14B;ENPP1;TPST1
12454,GO:0050427,0.0878818513101987,0.975772324838589,4,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,SULT1E1;ABHD14B;ENPP1;TPST1
2414,GO:0005591,0.0878943455757322,1,1,1,collagen type VIII trimer,CC,COL8A1
2420,GO:0005598,0.0878943455757322,1,1,1,short-chain collagen trimer,CC,COL8A1
7109,GO:0030935,0.0878943455757322,1,1,1,sheet-forming collagen trimer,CC,COL8A1
16773,GO:0098646,0.0878943455757322,1,1,1,collagen sheet,CC,COL8A1
9567,GO:0036403,0.0879032842989898,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
10398,GO:0043259,0.0879760723445255,0.993904339027101,2,3,laminin-10 complex,CC,LAMB1;LAMA5
10658,GO:0043931,0.0880070088642799,0.983522776739297,3,8,ossification involved in bone maturation,BP,FAT4;ANO6;PLXNB1
11461,GO:0045944,0.0880382392393285,0.928646814571172,101,786,positive regulation of transcription by RNA polymerase II,BP,SOX6;ITGA6;CDKN2B;ETV5;PKD2;NOS1;EGFR;RFX2;SERPINE1;VDR;BMP4;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;TFDP2;NFIX;GLI3;E2F7;ABHD14B;ADIRF;GLI2;HMGA2;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;TP73;KLF13;TLR3;SETX;NCOA2;IL18;FZD8;CHD6;CDH13;NFATC4;DLX3;PBX1;ENG;MEIS2;TCF4;CITED2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;PLAG1;SALL2;MYBL1;HLTF;HOXA1;METTL23;TCF12;NFAT5;IRF2BPL;MAML2;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;TEF;AGRN;HSPA5;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;RARA;PBX2;TAF1;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
7501,GO:0031697,0.0881122809813551,0.991558940017812,2,4,beta-1 adrenergic receptor binding,MF,DLG4;MAGI2
2416,GO:0005593,0.088112493339313,0.991558907508164,2,4,FACIT collagen trimer,CC,COL16A1;COL12A1
16067,GO:0090075,0.0882869015272555,0.976065326204324,4,16,relaxation of muscle,BP,SLC8A1;CAMK2D;RGS2;PDE4D
3660,GO:0008150,0.0883197397213647,0.930157453620102,1184,11210,biological_process,BP,SERPINE2;PHACTR3;CPA4;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;SH3TC1;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;NCKAP5;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;TMEM204;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;NYNRIN;CEP126;SLC8A1;NTM;FKBP5;ORAI3;CLCA2;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;C1QTNF6;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;CNTNAP3;FAM210B;MFAP5;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PLEC;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;TMC7;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;LAMB4;NEFM;TNS1;TP53I11;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;CPVL;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;FRMD4B;MMP19;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;SLC22A15;WDR66;NFIX;ELFN2;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;DIP2C;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;LIMCH1;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;CCDC80;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;SLC35F3;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;CHST3;EHD3;PPDPF;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;CCNI;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;SLC38A2;CALHM2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;LAMB3;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;PRR15;TMEM8B;LMO7;APLP2;HPS4;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;METRN;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;LRIG3;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;IQCH;AIP;GLG1;JADE2;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;SP110;COL16A1;CYYR1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;GLT8D2;TGFBI;SETX;KHNYN;ASTN2;PDE4D;APBB3;TMEM129;WBP1;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;CD99L2;FOXN3;ITGBL1;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;TBC1D19;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;IFNK;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;C20ORF194;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;ACSS2;ELMO3;FHOD3;HEXA;IFNE;NEURL1B;IGFL2;CBX7;DNAJC4;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;CYP20A1;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;HSPA12A;IFI44;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;NT5DC3;CPNE8;ARHGEF2;DNAL4;NTNG1;PLGRKT;SPRED3;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;THNSL2;SYNC;ZNF546;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;TMEM63C;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;TMC4;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;STOX2;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;IFITM2;SAMD5;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;CNTNAP3B;TCF12;CABLES2;HMBOX1;C22ORF23;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;XG;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;C2CD4C;CDKN2A;EFR3A;PPM1M;HERPUD2;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;DHRS12;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;SLC9A4;BOC;CENPA;PIKFYVE;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;SEMA4B;ITGB8;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;LMF1;KCTD14;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;PGPEP1;DNAH1;ALG10;RALGAPB;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;C5ORF63;SRR;YEATS2;HOXA3;PRRC2B;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;OLFML2A;ZYG11B;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DNAJC3;NYAP1;FKBP10;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;SLITRK5;ZNF883;WIPF1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;CLEC2D;FAM120B;FAM168A;CACNA2D3;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;PSMG4;ATG16L2;TSPAN4;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;GID4;ACAA2;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;ZNRF1;DMPK;PINLYP;MOSPD3;LAMB2
8924,GO:0034976,0.0884382480424026,0.939294427913537,32,242,response to endoplasmic reticulum stress,BP,FLOT1;EIF2AK4;TP53;EXTL2;DDIT3;CUL7;SRPX;CAV1;PLA2G6;SEL1L;CLU;PDIA4;PIK3R1;CREB3L2;HERPUD1;WFS1;PDIA6;LMNA;TMEM129;CALR;PTPN1;TSPYL2;RHBDD1;HSPA5;DERL3;DNAJC3;TMEM67;CREBRF;CTDSP2;CDK5RAP3;UGGT2;EDEM1
7752,GO:0032279,0.0884483865301262,0.942864206273051,25,150,asymmetric synapse,CC,NOS1;ADD3;NETO1;PTPRS;DLG4;MAP2;DLG5;SYN1;KCNAB2;FYN;PCLO;DNAJC6;LZTS1;ARHGEF2;RGS14;NLGN4Y;PRNP;MAGI2;GOPC;SHISA9;DNM1P46;CAMK2N1;BSN;ADAM10;MPDZ
12210,GO:0048495,0.0884779999677786,0.991502878422424,2,4,Roundabout binding,MF,SLIT3;TGFB1I1
17040,GO:0099565,0.0885076715792502,0.959370103801779,9,48,chemical synaptic transmission, postsynaptic,BP,NTSR1;NETO1;DLG4;PRKCZ;SNCA;SSH1;PPP3CA;ABAT;DMPK
16733,GO:0098554,0.0886493046231757,0.981153472476878,3,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2;PTPN1;SPPL2B
14669,GO:0070320,0.0887092251404546,1,1,1,inward rectifier potassium channel inhibitor activity,MF,CAV1
17339,GO:1900085,0.0887092251404546,1,1,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,CAV1
18460,GO:1903596,0.0887092251404546,1,1,1,regulation of gap junction assembly,BP,CAV1
18461,GO:1903598,0.0887092251404546,1,1,1,positive regulation of gap junction assembly,BP,CAV1
18464,GO:1903609,0.0887092251404546,1,1,1,negative regulation of inward rectifier potassium channel activity,BP,CAV1
14362,GO:0061640,0.0887698613854128,0.953925224971641,12,69,cytoskeleton-dependent cytokinesis,BP,EFHC1;CUL7;SNX33;ANK3;SEPT6;BBS4;SEPT5;CENPA;SNX9;ARL3;RASA1;SEPT9
16384,GO:0097049,0.0887806540298202,0.990197167735309,2,5,motor neuron apoptotic process,BP,ADARB1;MAP3K12
6900,GO:0030500,0.0887903554816517,0.961687536052723,8,39,regulation of bone mineralization,BP,FBN2;SLC8A1;BMP4;ANO6;SOX9;ENPP1;ATRAID;ANKH
15098,GO:0071219,0.0888822634980102,0.948746685361295,16,109,cellular response to molecule of bacterial origin,BP,AXL;SERPINE1;ABCA1;VDR;NR1D1;TRIM5;PDCD4;PYCARD;PDE4D;IL18;PRKCA;ABCC2;CDK19;SASH1;RARA;LITAF
9820,GO:0042073,0.0889227626467047,0.959076442462015,9,49,intraciliary transport,BP,KIF17;IFT140;IFT27;IFT88;WDR19;IFT122;IFT74;ICK;ARL3
13739,GO:0060346,0.0890238593770641,0.98324805376615,3,8,bone trabecula formation,BP,MMP2;SFRP1;FBN2
546,GO:0001666,0.0891625109404517,0.938349576934547,33,254,response to hypoxia,BP,MMP2;SFRP1;ZFP36L1;DDIT4;TGFBR2;NOS1;SLC8A1;PAK1;ANGPTL4;KCNMA1;TP53;ITGA2;MTHFR;CAV1;ANG;CAT;LMNA;PSMB9;PDK3;TGFBR3;ATM;MDM2;CST3;CITED2;EGR1;NDRG1;TGFB2;TH;ITPR2;POSTN;HP1BP3;ABAT;ACAA2
12168,GO:0048339,0.0892139757300542,0.976323945130999,4,14,paraxial mesoderm development,BP,FGFR1;POGLUT1;LEF1;YAP1
6690,GO:0030097,0.0894539242844641,0.930067602394713,72,587,hemopoiesis,BP,MMP9;FBN1;SOX6;INPP5D;SFRP1;CD109;CDKN2B;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;STON2;FAM210B;MFAP5;BMP4;STAT1;LGALS1;GLI3;KITLG;KCNAB2;FUT10;GLI2;RBFOX2;DOCK11;PRKCZ;IL31RA;PIK3R1;TP73;KLF13;TLR3;FZD7;SEMA4A;PSMB9;IL18;G6PD;FZD8;SOX13;DHTKD1;TGFBR3;L3MBTL3;PBX1;ATM;MEIS2;IFNK;SNX10;IFNE;CD1D;CRIP2;EGR1;ITPKB;BCL6;PRKCA;ANXA2;LEPR;TCF12;ZNF160;ZFPM1;TGFB2;LEF1;THRA;SSBP3;ITM2A;RSAD2;SH2B3;YAP1;PPARG;LGALS3;RARA;ZBTB1;FOS;AGO4
14059,GO:0060913,0.0894618236903206,1,1,1,cardiac cell fate determination,BP,ISL1
15371,GO:0071657,0.0894618236903206,1,1,1,positive regulation of granulocyte colony-stimulating factor production,BP,ISL1
17574,GO:1901258,0.0894618236903206,1,1,1,positive regulation of macrophage colony-stimulating factor production,BP,ISL1
14448,GO:0061851,0.0896127888484387,1,1,1,leading edge of lamellipodium,CC,PDPN
18769,GO:1904328,0.0896127888484387,1,1,1,regulation of myofibroblast contraction,BP,PDPN
19592,GO:1990764,0.0896127888484387,1,1,1,myofibroblast contraction,BP,PDPN
15575,GO:0072091,0.0897558752488914,0.961088847176345,8,40,regulation of stem cell proliferation,BP,ZFP36L1;SNAI2;GLI3;KITLG;HMGA2;FBLN1;LTBP3;YAP1
10999,GO:0044855,0.0899075436819753,1,1,1,plasma membrane raft distribution,BP,GSN
11000,GO:0044856,0.0899075436819753,1,1,1,plasma membrane raft localization,BP,GSN
11002,GO:0044858,0.0899075436819753,1,1,1,plasma membrane raft polarization,BP,GSN
18595,GO:1903906,0.0899075436819753,1,1,1,regulation of plasma membrane raft polarization,BP,GSN
17159,GO:0106003,0.0899138019846522,0.982325603359697,3,9,amyloid-beta complex,CC,CLU;PRNP;FZD4
7247,GO:0031225,0.0901893910315397,0.955812227622645,10,69,anchored component of membrane,CC,CD109;NTM;CNTN1;SYN1;ULBP1;CDH13;NEGR1;NTNG1;PRNP;EFNA5
9806,GO:0042036,0.0902394801607705,0.97489066087671,4,18,negative regulation of cytokine biosynthetic process,BP,INPP5D;TRIB2;ZFPM1;MAP2K5
14565,GO:0070141,0.0902565479244815,0.989936528649135,2,5,response to UV-A,BP,EGFR;MME
4704,GO:0010871,0.0903145471929619,0.991219114498443,2,4,negative regulation of receptor biosynthetic process,BP,NR1D1;PPARG
1966,GO:0004677,0.090437612236091,0.993626890956413,2,3,DNA-dependent protein kinase activity,MF,HMGA2;ATM
942,GO:0002357,0.0904770570594566,1,1,1,defense response to tumor cell,BP,RBMS3
4897,GO:0014831,0.0904783172158677,0.989897131389634,2,5,gastro-intestinal system smooth muscle contraction,BP,SULF2;SULF1
9835,GO:0042100,0.0904787073013612,0.960325604010451,8,45,B cell proliferation,BP,INPP5D;IRS2;VAV3;ATM;IFNK;IFNE;BCL6;LEF1
14493,GO:0070008,0.0904812451769934,0.98163692416244,3,10,serine-type exopeptidase activity,MF,CPVL;PRCP;SCPEP1
2173,GO:0005010,0.0905605542484791,0.99361290157481,2,3,insulin-like growth factor-activated receptor activity,MF,CRIM1;IGF1R
13944,GO:0060683,0.0906138923908723,1,1,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,PDGFA
19488,GO:1990401,0.0906138923908723,1,1,1,embryonic lung development,BP,PDGFA
1880,GO:0004561,0.0907908068590056,1,1,1,alpha-N-acetylglucosaminidase activity,MF,NAGLU
15916,GO:0075044,0.0909686106262669,0.991117156565424,2,4,autophagy of host cells involved in interaction with symbiont,BP,ULK2;ULK1
15917,GO:0075071,0.0909686106262669,0.991117156565424,2,4,autophagy involved in symbiotic interaction,BP,ULK2;ULK1
13440,GO:0055003,0.0909875441293477,0.97999767268172,4,8,cardiac myofibril assembly,BP,TTN;FHOD3;MEF2A;OBSL1
1286,GO:0003096,0.091143275727817,0.989778636915608,2,5,renal sodium ion transport,BP,MAGED2;KLHL3
19762,GO:2000210,0.0911566592867073,0.988957824948524,2,6,positive regulation of anoikis,BP,SIK1;CHEK2
9614,GO:0036499,0.0913259837554155,0.974481349645782,4,18,PERK-mediated unfolded protein response,BP,DDIT3;HERPUD1;PTPN1;HSPA5
12264,GO:0048609,0.0914010072850416,0.930178904202253,60,460,multicellular organismal reproductive process,BP,SERPINE2;SYNE1;ETV5;AXL;EGFR;HSPA2;RFX2;CRTAP;VDR;BMP4;SMARCA2;HSF2BP;MMP19;BTG1;ITGA3;PAQR8;CTSV;PLA2G6;SPATA6;SLIT3;PHC2;CCNI;SPATA20;ANG;BBS2;MLH3;PAQR7;RGS2;SETX;CCDC136;SEPT6;BBS4;CALR;ATM;NR2F2;ZNF449;EGR1;SOX9;BCL6;MYBL1;FNDC3A;STOX2;SPA17;TGFB2;ODF2;THRA;HERPUD2;RHBDD1;TH;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1;FZD4;CREBRF;AGO4;OXTR;RXRA
5502,GO:0016459,0.0915287393986879,0.958947458589673,9,35,myosin complex,CC,MYH15;CCDC102A;TTN;SHROOM4;MYO3B;MYO9A;OBSL1;MYH11;MYO1C
17672,GO:1901585,0.0916518586060603,1,1,1,regulation of acid-sensing ion channel activity,BP,STOM
1297,GO:0003131,0.0917435053122999,1,1,1,mesodermal-endodermal cell signaling,BP,HMGA2
7158,GO:0031049,0.0917435053122999,1,1,1,programmed DNA elimination,BP,HMGA2
7160,GO:0031052,0.0917435053122999,1,1,1,chromosome breakage,BP,HMGA2
9133,GO:0035501,0.0917435053122999,1,1,1,MH1 domain binding,MF,HMGA2
9397,GO:0035978,0.0917435053122999,1,1,1,histone H2A-S139 phosphorylation,BP,HMGA2
20033,GO:2000685,0.0917435053122999,1,1,1,positive regulation of cellular response to X-ray,BP,HMGA2
16407,GO:0097091,0.0917527638541432,0.990994298952657,2,4,synaptic vesicle clustering,BP,SYN1;MAGI2
14848,GO:0070663,0.0918445692044476,0.945729120325114,17,121,regulation of leukocyte proliferation,BP,INPP5D;TGFBR2;IL20RB;IRS2;BMP4;VAV3;PYCARD;GPNMB;DLG5;KITLG;IL18;ATM;CD1D;BCL6;PRNP;IGFBP2;LGALS3
11450,GO:0045930,0.0919255301891042,0.935822192366696,34,273,negative regulation of mitotic cell cycle,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;EGFR;GJC2;TOM1L2;TIMP2;BMP4;TP53;GPNMB;TFDP2;BTG1;E2F7;CTDSPL;HMGA2;KANK2;TP73;CHEK2;FBXL7;PSMB9;FOXN3;ATM;MDM2;BCL6;RBL2;FHL1;MAGI2;PTPN3;CTDSP2;KLHL22;CDK5RAP3;TAOK3
7663,GO:0032103,0.0920974001818773,0.941595539359239,22,163,positive regulation of response to external stimulus,BP,GAS6;EGFR;SERPINE1;CXCL14;PDCD4;DDX60;SEMA5A;ITGA2;ANO6;TLR3;SNCA;FGFR1;TGM2;IL18;CDH13;CALR;PRKCA;MOSPD2;MEGF8;CDK19;SASH1;ADAM10
8704,GO:0034366,0.0921026229844648,1,1,1,spherical high-density lipoprotein particle,CC,CLU
18107,GO:1902847,0.0921026229844648,1,1,1,regulation of neuronal signal transduction,BP,CLU
18183,GO:1902998,0.0921026229844648,1,1,1,positive regulation of neurofibrillary tangle assembly,BP,CLU
19363,GO:1905891,0.0921026229844648,1,1,1,regulation of cellular response to thapsigargin,BP,CLU
19364,GO:1905892,0.0921026229844648,1,1,1,negative regulation of cellular response to thapsigargin,BP,CLU
19365,GO:1905894,0.0921026229844648,1,1,1,regulation of cellular response to tunicamycin,BP,CLU
19366,GO:1905895,0.0921026229844648,1,1,1,negative regulation of cellular response to tunicamycin,BP,CLU
1443,GO:0003433,0.0921347249288227,0.989600948025747,2,5,chondrocyte development involved in endochondral bone morphogenesis,BP,TGFBR2;SERPINH1
8291,GO:0033138,0.0922280181662589,0.954977279659343,10,60,positive regulation of peptidyl-serine phosphorylation,BP,GAS6;EGFR;PAK1;CAV1;CAPRIN2;SPRY2;SNCA;IFNK;IFNE;RET
7804,GO:0032368,0.0923744937511413,0.955148276271241,10,55,regulation of lipid transport,BP,IRS2;NTSR1;ABCA1;LRP1;PLA2G6;PLA2R1;NCOR1;ANXA2;PPARG;ABCA2
4909,GO:0014852,0.0925496038287543,1,1,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,DMPK
4910,GO:0014853,0.0925496038287543,1,1,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,DMPK
5784,GO:0017020,0.0925496038287543,1,1,1,myosin phosphatase regulator activity,MF,DMPK
6087,GO:0019276,0.0925810212925082,1,1,1,UDP-N-acetylgalactosamine metabolic process,BP,EXTL2
9016,GO:0035248,0.0925810212925082,1,1,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,EXTL2
465,GO:0001504,0.0928033687224392,0.974393891864967,4,16,neurotransmitter uptake,BP,NOS1;NTSR1;SNCA;GDNF
193,GO:0000412,0.0929815447714007,1,1,1,histone peptidyl-prolyl isomerization,BP,FKBP10
1765,GO:0004371,0.0930664641892886,1,1,1,glycerone kinase activity,MF,TKFC
1851,GO:0004516,0.0930664641892886,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
4101,GO:0009159,0.0930664641892886,1,1,1,deoxyribonucleoside monophosphate catabolic process,BP,DNPH1
5683,GO:0016807,0.0930664641892886,1,1,1,cysteine-type carboxypeptidase activity,MF,CTSV
6107,GO:0019357,0.0930664641892886,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6108,GO:0019358,0.0930664641892886,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6113,GO:0019365,0.0930664641892886,1,1,1,pyridine nucleotide salvage,BP,NAPRT
8254,GO:0033058,0.0930664641892886,1,1,1,directional locomotion,BP,ARPIN
8455,GO:0033608,0.0930664641892886,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8546,GO:0034012,0.0930664641892886,1,1,1,FAD-AMP lyase (cyclizing) activity,MF,TKFC
8696,GO:0034355,0.0930664641892886,1,1,1,NAD salvage,BP,NAPRT
9704,GO:0038161,0.0930664641892886,1,1,1,prolactin signaling pathway,BP,CREBRF
11682,GO:0046497,0.0930664641892886,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
11969,GO:0047369,0.0930664641892886,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12422,GO:0050144,0.0930664641892886,1,1,1,nucleoside deoxyribosyltransferase activity,MF,DNPH1
12434,GO:0050262,0.0930664641892886,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
12449,GO:0050354,0.0930664641892886,1,1,1,triokinase activity,MF,TKFC
14058,GO:0060912,0.0930664641892886,1,1,1,cardiac cell fate specification,BP,TENM4
14266,GO:0061400,0.0930664641892886,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,CARF
14420,GO:0061769,0.0930664641892886,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
14491,GO:0070004,0.0930664641892886,1,1,1,cysteine-type exopeptidase activity,MF,CTSV
14865,GO:0070694,0.0930664641892886,1,1,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,DNPH1
17062,GO:0099627,0.0930664641892886,1,1,1,neurotransmitter receptor cycle,BP,NSG1
17064,GO:0099630,0.0930664641892886,1,1,1,postsynaptic neurotransmitter receptor cycle,BP,NSG1
17396,GO:1900170,0.0930664641892886,1,1,1,negative regulation of glucocorticoid mediated signaling pathway,BP,CREBRF
17876,GO:1902211,0.0930664641892886,1,1,1,regulation of prolactin signaling pathway,BP,CREBRF
17877,GO:1902213,0.0930664641892886,1,1,1,positive regulation of prolactin signaling pathway,BP,CREBRF
19944,GO:2000543,0.0930664641892886,1,1,1,positive regulation of gastrulation,BP,TENM4
6285,GO:0019901,0.0930996728132191,0.927500184177105,69,522,protein kinase binding,MF,RHOBTB2;CDKN2B;TGFBR2;PITPNM3;IRS2;GAS6;UTRN;ROR1;AXL;EGFR;ACTA2;CSPG4;TOM1L2;PAK1;TRIM5;NR3C1;TP53;CEP250;WNK1;MICAL1;ACSL3;DOCK4;SIK1;SYN1;NEK9;CAV1;PLA2G6;TRIB2;PRKCZ;MST1R;IL31RA;PTPN14;PXN;PIK3R1;TMEM173;CNTLN;SPRY2;TTN;TP73;CHEK2;FRMD5;FGFR1;PAG1;IGF1R;EPHB6;AKAP7;MAP3K1;PTPN1;SOX9;RGS14;RAB13;CEP68;MAP3K12;RET;MAPK8IP3;CDKN2A;MEF2A;GCSAM;SASH1;DNAJC3;RARA;SV2A;CCNY;PRKAG1;CDK5RAP3;CAMK2N1;ELMO2;ADAM10;RHOBTB3
16022,GO:0086089,0.09313028844833,1,1,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,KCNJ5
17915,GO:1902282,0.09313028844833,1,1,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,KCNJ5
3863,GO:0008489,0.0932903501058506,1,1,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,UGT8
11953,GO:0047263,0.0932903501058506,1,1,1,N-acylsphingosine galactosyltransferase activity,MF,UGT8
7688,GO:0032156,0.0934289994918303,0.980772184680441,3,10,septin cytoskeleton,CC,SEPT6;SEPT5;SEPT9
10236,GO:0042994,0.0935701611305845,0.973629978394253,4,18,cytoplasmic sequestering of transcription factor,BP,PKD2;MDFI;THRA;NFKBIE
11749,GO:0046631,0.0937601157798321,0.952363575236292,11,65,alpha-beta T cell activation,BP,TGFBR2;GLI3;PRKCZ;SEMA4A;IL18;ITPKB;BCL6;ZFPM1;LEF1;RSAD2;RARA
14045,GO:0060872,0.0937955271841278,0.990671077544458,2,4,semicircular canal development,BP,GLI3;HOXA1
15106,GO:0071228,0.0938398047251485,1,1,1,cellular response to tumor cell,BP,TXNIP
19041,GO:1904948,0.093886941656814,0.980636673380938,3,10,midbrain dopaminergic neuron differentiation,BP,SFRP1;DKK1;FZD1
3129,GO:0006720,0.0939771285560153,0.951993242451669,11,71,isoprenoid metabolic process,BP,EGFR;SDC3;LRP1;SDR16C5;ALDH3A2;SDC2;CYP4V2;AGRN;TH;UGT1A3;SCPEP1
4279,GO:0009650,0.0940162644246546,0.979798476537468,3,12,UV protection,BP,SCARA3;GPX1;CAT
6149,GO:0019471,0.0942131461820015,0.979737838048365,3,12,4-hydroxyproline metabolic process,BP,PRODH;ERO1B;ALDH4A1
12248,GO:0048566,0.094301352302451,0.974128674994603,4,15,embryonic digestive tract development,BP,GLI3;GLI2;TGFB2;NIPBL
718,GO:0001945,0.0944425647546464,0.969375831511278,5,19,lymph vessel development,BP,CCBE1;TMEM204;PDPN;PTPN14;NR2F2
13783,GO:0060401,0.0944656757586763,0.946490774972348,15,88,cytosolic calcium ion transport,BP,CTGF;F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;FYN;CAV1;CAMK2D;SNCA;PDE4D;PRNP;ITPR2
3570,GO:0007617,0.0945828638645921,0.97998536900561,3,11,mating behavior,BP,SERPINE2;THRA;TH
6721,GO:0030141,0.0947983209606528,0.926658283366768,64,540,secretory granule,CC,SERPINE2;SYT8;FN1;PCDH7;PYGB;MMP9;CD109;GSN;ANPEP;GAS6;SLC2A3;THBS2;SERPINE1;TIMP2;PCSK1;PYCARD;PDGFA;TIMP1;ANO6;MAGED2;CTSV;KCNAB2;CAV1;CLU;SERPING1;CXCR1;ITGA1;METTL7A;SYT1;TMEM173;APLP2;HPS4;CAT;STOM;SNCA;FLOT2;MME;VAMP1;MLEC;CCDC136;CALR;TMED10;CST3;MANBA;HEXA;RNPEP;PRCP;NFASC;ANXA2;RAB13;FNDC3A;MAN2B1;MOSPD2;TGFB2;DNASE1L1;TCTEX1D4;NAPRT;ITPR2;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
6778,GO:0030224,0.0949473991893894,0.968312812540448,5,23,monocyte differentiation,BP,INPP5D;ZFP36L1;BMP4;IL31RA;PPARG
18241,GO:1903131,0.0949473991893894,0.968312812540448,5,23,mononuclear cell differentiation,BP,INPP5D;ZFP36L1;BMP4;IL31RA;PPARG
12897,GO:0051279,0.0949745507289508,0.955905154240292,9,46,regulation of release of sequestered calcium ion into cytosol,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;CAMK2D;SNCA;PDE4D
8866,GO:0034695,0.0951628443345564,0.974157048441407,4,14,response to prostaglandin E,BP,SFRP1;GNG2;TGFBR3;PPARG
3578,GO:0007625,0.0951990685873415,0.988169514656271,2,6,grooming behavior,BP,DLG4;SLITRK5
6389,GO:0021602,0.0953591844476979,0.973734216633382,4,15,cranial nerve morphogenesis,BP,ADARB1;GLI3;HOXA1;HOXA3
3789,GO:0008360,0.0953707836183705,0.941131459443959,20,122,regulation of cell shape,BP,FN1;RHOBTB2;SYNE3;ARAP1;PDPN;PLXNB1;FYN;ARHGAP18;PARVA;DLC1;PLXNA2;SEMA4A;MKLN1;PLXNA1;FGD4;CDC42EP5;WIPF1;RASA1;TTBK2;RHOBTB3
2277,GO:0005229,0.0954319366702973,0.980177178683534,3,10,intracellular calcium activated chloride channel activity,MF,ANO1;CLCA2;ANO6
14424,GO:0061778,0.0954319366702973,0.980177178683534,3,10,intracellular chloride channel activity,MF,ANO1;CLCA2;ANO6
16309,GO:0090575,0.0954338058777786,0.941598523177948,19,131,RNA polymerase II transcription factor complex,CC,TADA3;VDR;NR1D1;TP53;DDIT3;TFDP2;TLE4;PBX1;TCF4;TCF12;TAF8;LEF1;THRA;YAP1;PPARG;RARA;TAF1;FOS;RXRA
7690,GO:0032173,0.0954435806241364,1,1,1,septin collar,CC,SEPT6
11057,GO:0045078,0.0954963346465647,0.988989474186296,2,5,positive regulation of interferon-gamma biosynthetic process,BP,TLR3;ZFPM1
330,GO:0000921,0.0955102059476234,0.980153806151761,3,10,septin ring assembly,BP,SEPT6;SEPT5;SEPT9
14301,GO:0061512,0.0956278369987218,0.9638531289946,6,30,protein localization to cilium,BP,BBS2;IFT140;BBS4;BBS1;SNX10;IFT122
3368,GO:0007140,0.0956515037759275,0.968005968110234,5,23,male meiotic nuclear division,BP,HSPA2;MLH3;ATM;MYBL1;AGO4
13062,GO:0051599,0.0957031365901792,0.990365118137162,2,4,response to hydrostatic pressure,BP,PKD2;COL18A1
6779,GO:0030225,0.0957165914636594,0.967813526848469,5,24,macrophage differentiation,BP,MMP9;BMP4;IL31RA;L3MBTL3;PRKCA
1963,GO:0004674,0.0957224432578972,0.927295242406672,57,395,protein serine/threonine kinase activity,MF,TGFBR2;TNIK;ROR1;AXL;EGFR;SPEG;MYLK;MAP3K6;PAK1;EIF2AK4;LTBP1;WNK1;SIK1;CDK14;NEK9;ALPK1;LTBP4;MAP3K14;PRKCZ;ULK2;HMGA2;CAMK2D;MST1R;CDK18;PHKA2;TTN;DAPK1;PRKACB;CHEK2;FGFR1;IGF1R;PRKAB2;MYO3B;OBSCN;PDK3;EPHB6;TGFBR3;ATM;AKAP13;MAP3K1;NRK;STK16;PRKCA;PAK6;MAP3K12;STK36;RET;MAP2K5;ULK1;CDK19;SRPK2;ICK;PRKAG1;TAF1;TTBK2;TAOK3;DMPK
11299,GO:0045646,0.0957505673337979,0.960492743709888,7,36,regulation of erythrocyte differentiation,BP,INPP5D;ZFP36L1;FAM210B;STAT1;RBFOX2;KLF13;ZFPM1
1407,GO:0003342,0.0958619765407148,1,1,1,proepicardium development,BP,ZFP36L1
1408,GO:0003343,0.0958619765407148,1,1,1,septum transversum development,BP,ZFP36L1
16561,GO:0097403,0.0958619765407148,1,1,1,cellular response to raffinose,BP,ZFP36L1
17651,GO:1901545,0.0958619765407148,1,1,1,response to raffinose,BP,ZFP36L1
6810,GO:0030278,0.0960167739798414,0.941438646837425,19,118,regulation of ossification,BP,SFRP1;FBN2;SNAI2;SLC8A1;BMP4;SMOC1;ANO6;GLI3;DKK1;PBX1;AREG;SOX9;ENPP1;TGFB2;IFITM1;TWIST2;ATRAID;ANKH;NIPBL
12381,GO:0048846,0.0960426878660452,0.961399655110342,7,28,axon extension involved in axon guidance,BP,SEMA5A;SLIT3;PLXNA2;SEMA4A;PLXNA1;MEGF8;SEMA4B
17917,GO:1902284,0.0960426878660452,0.961399655110342,7,28,neuron projection extension involved in neuron projection guidance,BP,SEMA5A;SLIT3;PLXNA2;SEMA4A;PLXNA1;MEGF8;SEMA4B
10238,GO:0042996,0.0961150202655128,0.988875426934178,2,5,regulation of Golgi to plasma membrane protein transport,BP,ACSL3;GOPC
5571,GO:0016594,0.0961205551231505,0.988874404539271,2,5,glycine binding,MF,GLDC;SRR
8691,GO:0034346,0.0963181799394364,1,1,1,positive regulation of type III interferon production,BP,TLR3
466,GO:0001505,0.0964120164038387,0.937398489181954,24,164,regulation of neurotransmitter levels,BP,SYT8;NQO1;PKD2;NOS1;NTSR1;SYN1;CPS1;CAV1;GLDC;CLU;SYTL1;SYT1;PCLO;SNCA;LRTOMT;BCHE;SEPT5;ALDH9A1;ALDH7A1;C2CD4C;TH;GDNF;DPYD;ABAT
650,GO:0001841,0.0964474113445651,0.945226198471138,15,87,neural tube formation,BP,SFRP1;BMP4;PRICKLE1;DLC1;PRKACB;FZD1;BBS4;LMO4;VANGL2;TGFB2;IFT122;NPHP3;RARA;MED12;CELSR1
18660,GO:1904036,0.0965576356750061,0.967792812627726,5,22,negative regulation of epithelial cell apoptotic process,BP,GAS6;SERPINE1;ANGPTL4;SEMA5A;WFS1
3827,GO:0008431,0.0966052823404698,1,1,1,vitamin E binding,MF,SEC14L2
15170,GO:0071346,0.0967627040540883,0.944494069316975,15,107,cellular response to interferon-gamma,BP,GSN;VIM;TRIM38;TRIM5;STAT1;OAS2;CAMK2D;DAPK1;TLR3;RPL13A;RAB43;SP100;FLNB;PPARG;MYO1C
3032,GO:0006584,0.0967736430739533,0.967197908166944,5,25,catecholamine metabolic process,BP,SNCA;LRTOMT;TGFB2;TH;ABAT
4286,GO:0009712,0.0967736430739533,0.967197908166944,5,25,catechol-containing compound metabolic process,BP,SNCA;LRTOMT;TGFB2;TH;ABAT
12084,GO:0048147,0.0967867985696118,0.967343418259695,5,24,negative regulation of fibroblast proliferation,BP,SFRP1;NUPR1;TP53;TP53INP1;PPARG
9117,GO:0035458,0.0970466234449282,0.978858583008093,3,12,cellular response to interferon-beta,BP,STAT1;TMEM173;TLR3
5658,GO:0016773,0.0976293795560659,0.922547172259481,79,576,phosphotransferase activity, alcohol group as acceptor,MF,TGFBR2;EFEMP1;PIK3C2G;IRS2;TNIK;ROR1;AXL;EGFR;ITPK1;SPEG;MYLK;TKFC;MAP3K6;DCAKD;PAK1;PTK6;EIF2AK4;CNTRL;LTBP1;WNK1;PDGFA;CRIM1;SIK1;CDK14;KITLG;NEK9;NMRK1;FYN;ALPK1;LTBP4;MAP3K14;PRKCZ;ULK2;HMGA2;CAMK2D;MST1R;PIK3R1;CDK18;PHKA2;TTN;DAPK1;PRKACB;CHEK2;FGFR1;IGF1R;PRKAB2;MYO3B;OBSCN;PDK3;EPHB6;TGFBR3;ATM;EFNB3;FAM20A;AKAP13;DGKQ;MAP3K1;NRK;SOX9;ITPKB;STK16;PRKCA;ETNK2;PAK6;MAP3K12;STK36;RET;MAP2K5;ULK1;CDK19;PIKFYVE;SRPK2;ICK;PRKAG1;TAF1;PIK3C2B;TTBK2;TAOK3;DMPK
19383,GO:1905939,0.0976397664092067,0.979050250758038,3,11,regulation of gonad development,BP,NUPR1;CITED2;SOX9
19671,GO:2000018,0.0977882767971713,0.988564642501352,2,5,regulation of male gonad development,BP,CITED2;SOX9
3309,GO:0007015,0.097793924523397,0.929272409064934,41,282,actin filament organization,BP,ITGB5;CTGF;SFRP1;RHOBTB2;ASAP3;GSN;SPTB;S100A10;PAK1;ARAP1;PYCARD;SEMA5A;MICAL1;HIP1;ARHGAP18;ESPN;ARPIN;KANK2;PXN;PIK3R1;ANG;TTN;SHROOM4;DLC1;FSCN1;TRIOBP;BBS4;ARF6;FHOD3;ARHGEF2;SSH1;CDC42EP5;MSRB2;FHOD1;CAPG;OBSL1;WIPF1;RASA1;LIMA1;RHOBTB3;MYO1C
18391,GO:1903461,0.0978736765419548,1,1,1,Okazaki fragment processing involved in mitotic DNA replication,BP,LIG1
3141,GO:0006739,0.0982057226093725,0.966174545160979,5,28,NADP metabolic process,BP,H6PD;TP53I3;KCNAB2;G6PD;IDH2
1705,GO:0004252,0.0982993819261538,0.949193524748815,11,76,serine-type endopeptidase activity,MF,MMP2;PRSS23;HTRA1;MMP9;PCSK1;MMP19;TYSND1;CTSV;RHBDD1;RHBDD2;CTSD
2779,GO:0006212,0.0983454685989044,1,1,1,uracil catabolic process,BP,DPYD
2781,GO:0006214,0.0983454685989044,1,1,1,thymidine catabolic process,BP,DPYD
5827,GO:0017113,0.0983454685989044,1,1,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,DPYD
6153,GO:0019483,0.0983454685989044,1,1,1,beta-alanine biosynthetic process,BP,DPYD
11550,GO:0046127,0.0983454685989044,1,1,1,pyrimidine deoxyribonucleoside catabolic process,BP,DPYD
12487,GO:0050654,0.0984816688291369,0.963068577436283,6,26,chondroitin sulfate proteoglycan metabolic process,BP,CSPG4;B3GAT3;XYLT1;CHST3;HEXA;DSEL
9886,GO:0042222,0.0985113438922818,1,1,1,interleukin-1 biosynthetic process,BP,EGR1
11206,GO:0045360,0.0985113438922818,1,1,1,regulation of interleukin-1 biosynthetic process,BP,EGR1
11207,GO:0045362,0.0985113438922818,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,EGR1
12543,GO:0050720,0.0985113438922818,1,1,1,interleukin-1 beta biosynthetic process,BP,EGR1
12544,GO:0050722,0.0985113438922818,1,1,1,regulation of interleukin-1 beta biosynthetic process,BP,EGR1
12545,GO:0050725,0.0985113438922818,1,1,1,positive regulation of interleukin-1 beta biosynthetic process,BP,EGR1
15700,GO:0072303,0.0985113438922818,1,1,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,EGR1
13885,GO:0060571,0.0985159235572556,0.972234149892453,4,16,morphogenesis of an epithelial fold,BP,EGFR;BMP4;GLI2;SULF1
949,GO:0002369,0.098534999503837,0.971508969530769,4,19,T cell cytokine production,BP,PRKCZ;IL31RA;IL18;RSAD2
9699,GO:0038132,0.098545916181564,0.989901813955962,2,4,neuregulin binding,MF,ITGA6;ITGB4
19147,GO:1905222,0.0985944230475264,1,1,1,atrioventricular canal morphogenesis,BP,ENG
6463,GO:0021799,0.0986634012189478,0.967080342832265,5,21,cerebral cortex radially oriented cell migration,BP,LAMB1;GLI3;FUT10;SYNE2;DIXDC1
19726,GO:2000138,0.0986642820438634,0.988400577288784,2,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4;SOX9
12219,GO:0048515,0.0988004023604819,0.947583600720573,12,73,spermatid differentiation,BP,HSPA2;RFX2;SMARCA2;BBS2;CCDC136;BBS4;FNDC3A;ODF2;RHBDD1;GOPC;TPGS1;DNAH1
1708,GO:0004301,0.0988589444554814,0.986803651588283,2,7,epoxide hydrolase activity,MF,AKR7A2;RNPEP
9080,GO:0035360,0.0989381872703716,0.988349086826269,2,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;CITED2
4821,GO:0014029,0.0989591244364249,0.979114901166177,3,10,neural crest formation,BP,SFRP1;KLHL12;SOX9
15615,GO:0072148,0.0989868308248484,0.978633731972552,3,11,epithelial cell fate commitment,BP,PDPN;NR2F2;RARA
19476,GO:1990351,0.099062640929688,0.93924306000416,19,122,transporter complex,CC,ANO1;NOS1;HSPA2;SCN8A;SCN2A;KCNMA1;DLG4;ANO6;KCNAB2;CAMK2D;HERPUD1;KCNJ5;PDE4D;KCNQ3;SCNN1A;CACNB1;KCNIP3;SHISA9;ABCA2
15019,GO:0070995,0.0991665699172051,1,1,1,NADPH oxidation,BP,KCNAB2
19403,GO:1990031,0.0991665699172051,1,1,1,pinceau fiber,CC,KCNAB2
1029,GO:0002538,0.0992024678352637,1,1,1,arachidonic acid metabolite production involved in inflammatory response,BP,SERPINE1
1030,GO:0002540,0.0992024678352637,1,1,1,leukotriene production involved in inflammatory response,BP,SERPINE1
9126,GO:0035490,0.0992024678352637,1,1,1,regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
9127,GO:0035491,0.0992024678352637,1,1,1,positive regulation of leukotriene production involved in inflammatory response,BP,SERPINE1
14133,GO:0061044,0.0992024678352637,1,1,1,negative regulation of vascular wound healing,BP,SERPINE1
17599,GO:1901331,0.0992024678352637,1,1,1,positive regulation of odontoblast differentiation,BP,SERPINE1
18137,GO:1902913,0.0992024678352637,1,1,1,positive regulation of neuroepithelial cell differentiation,BP,SERPINE1
19706,GO:2000098,0.0992024678352637,1,1,1,negative regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
1335,GO:0003193,0.0992383816485508,1,1,1,pulmonary valve formation,BP,GJA5
9368,GO:0035922,0.0992383816485508,1,1,1,foramen ovale closure,BP,GJA5
15995,GO:0086044,0.0992383816485508,1,1,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,GJA5
16001,GO:0086054,0.0992383816485508,1,1,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,GJA5
16002,GO:0086055,0.0992383816485508,1,1,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,GJA5
16015,GO:0086076,0.0992383816485508,1,1,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,GJA5
16017,GO:0086078,0.0992383816485508,1,1,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,GJA5
16018,GO:0086079,0.0992383816485508,1,1,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,GJA5
16898,GO:0098906,0.0992383816485508,1,1,1,regulation of Purkinje myocyte action potential,BP,GJA5
19402,GO:1990029,0.0992383816485508,1,1,1,vasomotion,BP,GJA5
710,GO:0001936,0.0993278231898629,0.945807767182114,13,78,regulation of endothelial cell proliferation,BP,PTPRM;BMP4;STAT1;SEMA5A;XDH;CAV1;ANG;FGFR1;SULF1;CDH13;NR2F2;PRKCA;PPARG
13050,GO:0051585,0.0993582082453089,1,1,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,SNCA
13074,GO:0051620,0.0993582082453089,1,1,1,norepinephrine uptake,BP,SNCA
13075,GO:0051621,0.0993582082453089,1,1,1,regulation of norepinephrine uptake,BP,SNCA
13076,GO:0051622,0.0993582082453089,1,1,1,negative regulation of norepinephrine uptake,BP,SNCA
13234,GO:0051945,0.0993582082453089,1,1,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,SNCA
18161,GO:1902957,0.0993582082453089,1,1,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,SNCA
18300,GO:1903282,0.0993582082453089,1,1,1,regulation of glutathione peroxidase activity,BP,SNCA
18301,GO:1903284,0.0993582082453089,1,1,1,positive regulation of glutathione peroxidase activity,BP,SNCA
18302,GO:1903285,0.0993582082453089,1,1,1,positive regulation of hydrogen peroxide catabolic process,BP,SNCA
19238,GO:1905447,0.0993582082453089,1,1,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,SNCA
19804,GO:2000295,0.0993582082453089,1,1,1,regulation of hydrogen peroxide catabolic process,BP,SNCA
19915,GO:2000468,0.0993582082453089,1,1,1,regulation of peroxidase activity,BP,SNCA
19916,GO:2000470,0.0993582082453089,1,1,1,positive regulation of peroxidase activity,BP,SNCA
10562,GO:0043547,0.0994001688164783,0.927190521730156,44,299,positive regulation of GTPase activity,BP,ITGA6;SFRP1;F2R;ASAP3;DNMBP;ARHGAP23;DOCK9;S100A10;ALS2CL;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;ARHGEF1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;ARHGEF12;ARHGAP18;DOCK11;DLC1;RGS2;SRGAP1;TBC1D19;RGS14;DEPDC7;CDC42EP5;AGRN;AGAP1;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;SNX9;TBC1D16;RASA1;ARHGAP31;DOCK1
7464,GO:0031639,0.0994125976574743,0.978115064375919,3,12,plasminogen activation,BP,SERPINE2;SERPINE1;PLGRKT
18741,GO:1904262,0.0995856874466269,0.978447694483613,3,11,negative regulation of TORC1 signaling,BP,SESN3;SESN1;ATM
6665,GO:0030033,0.0996284830240057,0.972124813593798,4,15,microvillus assembly,BP,TNIK;FSCN1;PODXL;KLF5
9473,GO:0036126,0.0996768380343228,0.958182829047699,7,39,sperm flagellum,CC,SPATA6;SEPT6;IFT27;SPA17;ODF2;TCTEX1D4;DNAH1
16695,GO:0097729,0.0996768380343228,0.958182829047699,7,39,9+2 motile cilium,CC,SPATA6;SEPT6;IFT27;SPA17;ODF2;TCTEX1D4;DNAH1
3519,GO:0007495,0.0997548504871419,1,1,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,FOXL1
13141,GO:0051766,0.100036401943642,0.988141723526343,2,5,inositol trisphosphate kinase activity,MF,ITPK1;ITPKB
1959,GO:0004668,0.100044448221061,1,1,1,protein-arginine deiminase activity,MF,PADI3
5891,GO:0018101,0.100044448221061,1,1,1,protein citrullination,BP,PADI3
9569,GO:0036414,0.100044448221061,1,1,1,histone citrullination,BP,PADI3
4620,GO:0010745,0.100202655370733,0.979341922471252,3,9,negative regulation of macrophage derived foam cell differentiation,BP,ABCA1;PPARG;ABCA5
1152,GO:0002761,0.100267255845627,0.94674980796705,12,71,regulation of myeloid leukocyte differentiation,BP,FBN1;INPP5D;SFRP1;ZFP36L1;KITLG;PIK3R1;TLR3;PRKCA;ZFPM1;LEF1;RARA;FOS
10063,GO:0042583,0.100388077079055,0.988075011886069,2,5,chromaffin granule,CC,CLU;SYT1
10367,GO:0043218,0.100453882254605,0.978177040187433,3,11,compact myelin,CC,PLLP;ANXA2;MPDZ
19584,GO:1990748,0.100454901958917,0.951753201678474,9,65,cellular detoxification,BP,NQO1;PTGS1;GPX1;SESN1;TP53INP1;PRDX5;CAT;GPX8;GSTZ1
978,GO:0002433,0.100581533393065,0.950167586067875,10,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PAK1;VAV3;FYN;PLA2G6;PIK3R1;VAV2;WIPF1;ELMO2;MYO1C;DOCK1
9682,GO:0038096,0.100581533393065,0.950167586067875,10,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PAK1;VAV3;FYN;PLA2G6;PIK3R1;VAV2;WIPF1;ELMO2;MYO1C;DOCK1
18154,GO:1902950,0.100593352698391,0.987084438201132,2,6,regulation of dendritic spine maintenance,BP,FYN;PRNP
16566,GO:0097418,0.100635386160774,0.98802800852743,2,5,neurofibrillary tangle,CC,NEFM;CLU
10456,GO:0043370,0.100704369532131,0.970871186518607,4,18,regulation of CD4-positive, alpha-beta T cell differentiation,BP,PRKCZ;IL18;BCL6;RARA
19530,GO:1990523,0.100772350037259,1,1,1,bone regeneration,BP,POSTN
15552,GO:0072050,0.100810586767627,0.987039953375121,2,6,S-shaped body morphogenesis,BP,PKD2;BMP4
9357,GO:0035900,0.100944736639619,0.987012452068217,2,6,response to isolation stress,BP,LGALS1;TH
8908,GO:0034766,0.100953862137957,0.952225301986224,9,50,negative regulation of ion transmembrane transport,BP,MMP9;PKD2;IRS2;NTSR1;CAV1;CAMK2D;ANK3;GOPC;KCNRG
17684,GO:1901621,0.101094358996641,0.987940580551939,2,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;GPR161
847,GO:0002175,0.101180456271209,0.989464627931599,2,4,protein localization to paranode region of axon,BP,UGT8;NFASC
1336,GO:0003195,0.10121158938762,1,1,1,tricuspid valve formation,BP,ZFPM1
9833,GO:0042097,0.10121158938762,1,1,1,interleukin-4 biosynthetic process,BP,ZFPM1
11211,GO:0045402,0.10121158938762,1,1,1,regulation of interleukin-4 biosynthetic process,BP,ZFPM1
11212,GO:0045403,0.10121158938762,1,1,1,negative regulation of interleukin-4 biosynthetic process,BP,ZFPM1
13760,GO:0060375,0.10121158938762,1,1,1,regulation of mast cell differentiation,BP,ZFPM1
13761,GO:0060377,0.10121158938762,1,1,1,negative regulation of mast cell differentiation,BP,ZFPM1
2215,GO:0005113,0.101222926846767,0.987916044512789,2,5,patched binding,MF,CAV1;BBS1
6720,GO:0030140,0.101249133445758,0.961412057841406,6,28,trans-Golgi network transport vesicle,CC,CLTCL1;TMED10;RAB13;GOPC;RASSF9;STEAP2
8241,GO:0033032,0.101299100601535,0.970637664710913,4,18,regulation of myeloid cell apoptotic process,BP,KITLG;ITPKB;THRA;CDKN2A
1496,GO:0003842,0.101358391752746,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
6394,GO:0021615,0.101431863379742,1,1,1,glossopharyngeal nerve morphogenesis,BP,HOXA3
6453,GO:0021781,0.101446007867239,0.987873424096467,2,5,glial cell fate commitment,BP,SOX6;SOX9
11965,GO:0047325,0.101480870172018,1,1,1,inositol tetrakisphosphate 1-kinase activity,MF,ITPK1
13371,GO:0052725,0.101480870172018,1,1,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,ITPK1
13372,GO:0052726,0.101480870172018,1,1,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,ITPK1
13394,GO:0052825,0.101480870172018,1,1,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,ITPK1
13399,GO:0052830,0.101480870172018,1,1,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,ITPK1
13400,GO:0052831,0.101480870172018,1,1,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,ITPK1
13404,GO:0052835,0.101480870172018,1,1,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,ITPK1
7144,GO:0031014,0.101506910708194,0.997286707237052,1,2,troponin T binding,MF,TNNI2
9661,GO:0038044,0.101559948479504,0.989401035948345,2,4,transforming growth factor-beta secretion,BP,ITGB6;FN1
12379,GO:0048844,0.101575094059871,0.955163021150066,8,36,artery morphogenesis,BP,GJA5;PKD2;MYLK;BMP4;LRP1;ENG;HOXA1;TGFB2
3565,GO:0007611,0.101587732456506,0.935870937740299,21,134,learning or memory,BP,EGFR;NTSR1;EIF2AK4;NETO1;DLG4;ITGA3;FYN;PLA2G6;PRKCZ;DKK1;MEIS2;CRTC1;BCHE;RGS14;NLGN4Y;ATXN1;PRNP;THRA;TH;FOS;OXTR
1098,GO:0002688,0.10169817470365,0.951110440075646,9,63,regulation of leukocyte chemotaxis,BP,MMP28;GAS6;SERPINE1;CXCL14;ANO6;C5;CALR;MOSPD2;ADAM10
2946,GO:0006477,0.101747540736208,0.987815719691146,2,5,protein sulfation,BP,UST;TPST1
6350,GO:0021537,0.101763678079237,0.933616093048845,24,156,telencephalon development,BP,FAT4;EGFR;LAMB1;SLC8A1;BMP4;NEFL;PTPRS;EFHC1;GLI3;LRP1;FUT10;SLC38A2;BBS2;ROBO1;BBS4;SYNE2;DLX2;LEF1;TH;TACC2;DIXDC1;RARA;SLITRK5;OXTR
16144,GO:0090193,0.101818110047126,0.986832841184086,2,6,positive regulation of glomerulus development,BP,EGR1;RET
2262,GO:0005179,0.10195977154302,0.970159171518968,4,19,hormone activity,MF,FBN1;CCK;UCN2;ADM2
1323,GO:0003175,0.102002071858468,0.989326753072326,2,4,tricuspid valve development,BP,TGFBR2;ZFPM1
1331,GO:0003186,0.102002071858468,0.989326753072326,2,4,tricuspid valve morphogenesis,BP,TGFBR2;ZFPM1
13876,GO:0060556,0.10202693535134,0.986789750750829,2,6,regulation of vitamin D biosynthetic process,BP,SNAI2;VDR
4545,GO:0010631,0.102136246878768,0.929999578114738,30,202,epithelial cell migration,BP,MMP9;CCBE1;TGFBR2;DOCK5;PTPRM;BMP4;SEMA5A;ITGA2;ITGA3;GPX1;FAT2;PXN;ROBO1;FGFR1;SEMA4A;CDH13;AMOTL1;CALR;NR2F2;SOX9;PRCP;PRKCA;RAB13;TGFB2;MAP2K5;SP100;PPARG;SASH1;ADGRA2;DOCK1
12460,GO:0050435,0.102181988337509,0.960811793773199,6,29,amyloid-beta metabolic process,BP,SORL1;CLU;BACE1;MME;TMED10;PRNP
2314,GO:0005316,0.102267635853722,1,1,1,high-affinity inorganic phosphate:sodium symporter activity,MF,SLC20A1
7997,GO:0032637,0.102393870823131,0.956590736577323,7,41,interleukin-8 production,BP,F2R;SERPINE1;DDIT3;PYCARD;TLR3;AFAP1L2;MAP2K5
7136,GO:0030992,0.102443410647525,0.969967110313698,4,19,intraciliary transport particle B,CC,KIF17;IFT27;IFT88;IFT74
11380,GO:0045794,0.102675398774484,0.989213220501307,2,4,negative regulation of cell volume,BP,KCNMA1;ANO6
10648,GO:0043900,0.102701282902627,0.927138123698088,35,283,regulation of multi-organism process,BP,HTRA1;GSN;HERC5;TKFC;APOBEC3C;TRIM38;EIF2AK4;TRIM5;STAT1;LGALS1;PYCARD;IFIT1;DDX60;ADARB1;TIMP1;SEC14L1;CAV1;OAS2;HMGA2;TMEM173;APOBEC3G;STOM;APOBEC3F;CALR;PRKCA;ANXA2;IFITM2;MVB12B;LEF1;RSAD2;SRPK2;MDFIC;IFITM1;SASH1;OXTR
13364,GO:0052695,0.102883175073539,0.986612483637239,2,6,cellular glucuronidation,BP,UGT1A3;UGT1A6
10231,GO:0042985,0.103014631679042,0.98658518501746,2,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ITM2C;ITM2A
13520,GO:0060010,0.10304653835813,1,1,1,Sertoli cell fate commitment,BP,RARA
1884,GO:0004567,0.103108524831764,1,1,1,beta-mannosidase activity,MF,MANBA
4449,GO:0010412,0.103108524831764,1,1,1,mannan metabolic process,BP,MANBA
11616,GO:0046355,0.103108524831764,1,1,1,mannan catabolic process,BP,MANBA
10533,GO:0043508,0.103130856771939,0.976929604104051,3,12,negative regulation of JUN kinase activity,BP,SFRP1;PDCD4;TP73
7055,GO:0030853,0.103145634965908,0.987546733603958,2,5,negative regulation of granulocyte differentiation,BP,INPP5D;RARA
11595,GO:0046321,0.103271221359272,0.979243303851192,3,8,positive regulation of fatty acid oxidation,BP,IRS2;CPT1A;PPARG
6226,GO:0019782,0.103331866303031,1,1,1,ISG15 activating enzyme activity,MF,UBA7
10009,GO:0042473,0.103396848992936,0.986505687106006,2,6,outer ear morphogenesis,BP,FGFR1;HOXA1
596,GO:0001764,0.103712910783911,0.940543436425602,15,84,neuron migration,BP,FLRT2;APBB2;DDIT4;GAS6;AXL;ITGA3;FYN;CCK;FGFR1;BBS4;NR2F2;ARHGEF2;UNK;NIPBL;CELSR1
13010,GO:0051493,0.103745820662629,0.921237940007082,54,394,regulation of cytoskeleton organization,BP,CTGF;SFRP1;RHOBTB2;ASAP3;GSN;SPTB;S100A10;STMN3;PAK1;ARAP1;CEP250;PYCARD;SEMA5A;PDGFA;MAP2;PHLDB1;CTSV;PLXNB1;EML2;LRP1;ARHGAP18;ESPN;ARPIN;KANK2;PXN;PIK3R1;DLC1;SNCA;FSCN1;RGS2;TRIOBP;BBS4;ARF6;AKAP13;FHOD3;VANGL2;ARHGEF2;SSH1;OR2A4;CDC42EP5;ARHGEF19;FHOD1;DIXDC1;CAPG;TMEM67;EFNA5;WIPF1;RASA1;LIMA1;CAPN6;TTBK2;RHOBTB3;CELSR1;MYO1C
3258,GO:0006929,0.103762900275879,0.964836235118696,5,21,substrate-dependent cell migration,BP,FN1;SNAI2;ITGA2;ROBO1;OPHN1
16844,GO:0098805,0.103792521852207,0.912529117130744,141,1196,whole membrane,CC,SYT8;FLOT1;PCDH7;INPP5D;MARVELD1;CD109;SYNE1;F2R;TGFBR2;CYBRD1;ANPEP;PROM2;CLTCL1;NOS1;MALL;MAP6;EGFR;SYNE3;SLC2A3;SERPINH1;S100A10;FAM210B;NTSR1;ABCA1;NSG1;ITM2C;AHNAK;SORL1;KCNMA1;PTPRS;DLG4;ACSL3;HIP1;SNX1;ANO6;CNTN1;TBC1D5;PLLP;SYN1;PDPN;SPG11;KCNAB2;LRP1;FYN;CAV1;SLC22A17;CXCR1;PRKCZ;ULK2;EHD3;CAMK2D;ITGA1;SYT1;TMEM173;ALDH3A2;CPT1A;ACACB;UNC5B;APLP2;CAT;DLC1;BACE1;STOM;TLR3;BPHL;SNCA;FLOT2;MME;VAMP1;FZD7;PAG1;ARMCX2;DKK1;MLEC;SEC24D;SULF1;SPATA18;MYOF;CCDC136;CDH13;LAPTM4A;MTMR4;CALR;COPG2;MDM2;ARF6;TMED10;MANBA;AREG;ANXA6;SNX10;CD1D;SYNE2;KLHL12;ENPP1;SLC48A1;PRCP;NFASC;NDRG1;TMEM50B;PXMP2;TMEM175;ANXA2;RAB13;MAN2B1;MVB12B;MOSPD2;PODXL;RAB43;PRNP;RET;VPS39;GPR161;C2CD4C;SPPL2B;ULK1;TH;GOPC;PIKFYVE;RSAD2;ITPR2;VPS13C;ATRAID;LGALS3;RASSF9;SV2A;ABCA2;EFNA5;FZD4;SBF2;PEX1;STEAP2;VPS36;ADAM10;LITAF;ATG16L2;MYO1C;ABCA5;CTSD;ZNRF1;DMPK
10826,GO:0044342,0.103802516532881,0.976713269141533,3,12,type B pancreatic cell proliferation,BP,SFRP1;NR1D1;IGFBP4
4546,GO:0010632,0.103885601796168,0.932065642995945,24,156,regulation of epithelial cell migration,BP,MMP9;CCBE1;TGFBR2;DOCK5;PTPRM;BMP4;SEMA5A;ITGA2;ITGA3;FGFR1;SEMA4A;AMOTL1;CALR;NR2F2;SOX9;PRCP;PRKCA;TGFB2;MAP2K5;SP100;PPARG;SASH1;ADGRA2;DOCK1
8332,GO:0033198,0.103899674735488,0.969610240503345,4,18,response to ATP,BP,SLC8A1;DGKQ;SSH1;TAF1
12556,GO:0050750,0.103915332826679,0.969857421250691,4,17,low-density lipoprotein particle receptor binding,MF,CLU;SYT1;DKK1;LANCL1
4597,GO:0010717,0.103979876673589,0.946250747230548,11,63,regulation of epithelial to mesenchymal transition,BP,SFRP1;TGFBR2;BMP4;WWTR1;PHLDB1;PDPN;ENG;ISL1;TGFB2;LEF1;TGFB1I1
9596,GO:0036477,0.103993203692632,0.919201256378157,64,475,somatodendritic compartment,CC,NQO1;NOS1;MAP6;SLC8A1;GJC2;NTSR1;TIMP2;PAK1;NSG1;NR1D1;STAT1;PTPRS;PYCARD;EFHC1;DLG4;MAP2;ASAP1;SYN1;CTSV;SPG11;LRP1;FYN;PIAS3;CLU;PRKCZ;ITGA1;CCK;SLC38A2;ANG;KIF17;ANK3;WFS1;SNCA;MME;ASTN2;CST3;NRSN2;TRAK1;LZTS1;ARHGEF2;NFASC;CRTC1;RGS14;HTR1B;PRNP;RET;TGFB2;MAGI2;TH;GOPC;OPHN1;TPGS1;SRR;KCNIP3;SHISA9;PRR7;RARA;SV2A;FZD4;PPP3CA;DNM1P46;CAMK2N1;BSN;MPDZ
3148,GO:0006749,0.10419996153925,0.958577231226653,6,42,glutathione metabolic process,BP,GPX1;PTGES;G6PD;GCLC;GGT7;GSTZ1
5791,GO:0017046,0.104268718662862,0.970344372570518,4,15,peptide hormone binding,MF,PIK3R1;IGF1R;CALCRL;OXTR
12399,GO:0048871,0.104297402949076,0.929232775821443,28,200,multicellular organismal homeostasis,BP,CTGF;INPP5D;F2R;IL20RB;EGFR;NTSR1;NR1D1;FLG;GPX1;SLC27A1;ERCC6;NPHP4;TNS2;ACACB;BBS2;WFS1;PRKACB;BBS4;BBS1;SOX9;PRCP;CRTC1;PRKCA;LEPR;SCNN1A;LIPA;NPHP3;ABAT
12165,GO:0048332,0.104643068298887,0.953035371337871,8,40,mesoderm morphogenesis,BP,ITGB4;BMP4;ITGA2;ITGA3;HMGA2;FGFR1;DKK1;LEF1
12069,GO:0048069,0.104672246431421,0.987250335507355,2,5,eye pigmentation,BP,HPS4;LEF1
5116,GO:0015485,0.104751315733137,0.959412965566116,6,30,cholesterol binding,MF,OSBPL10;PROM2;ABCA1;CAV1;OSBPL5;ANXA6
684,GO:0001895,0.104751734247038,0.95904976375337,6,33,retina homeostasis,BP,ERCC6;NPHP4;BBS2;BBS4;BBS1;NPHP3
15239,GO:0071447,0.104987651063029,0.987188749587075,2,5,cellular response to hydroperoxide,BP,TP53INP1;DAPK1
432,GO:0001161,0.105004549549324,0.977251874612601,3,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;NCOA2;BCL6
10746,GO:0044213,0.105004549549324,0.977251874612601,3,10,intronic transcription regulatory region DNA binding,MF,ZC3H6;NCOA2;BCL6
16152,GO:0090201,0.105145305959286,0.975933551217839,3,13,negative regulation of release of cytochrome c from mitochondria,BP,GPX1;CLU;LMNA
15449,GO:0071825,0.105239295162807,0.963569450546853,5,24,protein-lipid complex subunit organization,BP,ABCA1;ACSL3;PRKACB;SNX9;ABCA5
3515,GO:0007442,0.105431312508171,0.988743458228583,2,4,hindgut morphogenesis,BP,GLI3;GLI2
3069,GO:0006638,0.10548215231576,0.945129158287458,11,67,neutral lipid metabolic process,BP,SIK1;GPX1;CPS1;CAV1;SEL1L;CPT1A;ANG;CAT;SNCA;DGKQ;LMF1
2701,GO:0006069,0.105556211644494,0.986053051782238,2,6,ethanol oxidation,BP,ACSS1;ACSS2
6777,GO:0030223,0.105647757264106,0.986033731005831,2,6,neutrophil differentiation,BP,INPP5D;LEF1
1019,GO:0002520,0.105699612654803,0.915566344165275,79,653,immune system development,BP,MMP9;FBN1;SOX6;INPP5D;SFRP1;CD109;CDKN2B;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;STON2;FAM210B;MFAP5;BMP4;STAT1;LGALS1;GLI3;KITLG;PDPN;KCNAB2;FUT10;GLI2;RBFOX2;DOCK11;PRKCZ;IL31RA;PIK3R1;JARID2;TP73;KLF13;TLR3;FZD7;SEMA4A;PSMB9;IL18;G6PD;FZD8;SOX13;DHTKD1;TGFBR3;L3MBTL3;PBX1;FOXL1;ATM;MEIS2;IFNK;SNX10;CITED2;IFNE;LMO4;CD1D;CRIP2;EGR1;ITPKB;BCL6;PRKCA;ANXA2;LEPR;TCF12;ZNF160;RET;ZFPM1;TGFB2;LEF1;THRA;SSBP3;ITM2A;RSAD2;SH2B3;YAP1;HOXA3;PPARG;LGALS3;RARA;ZBTB1;FOS;AGO4
14032,GO:0060839,0.105817357169922,0.985997908608652,2,6,endothelial cell fate commitment,BP,PDPN;NR2F2
678,GO:0001889,0.105858152769967,0.937541900157105,16,102,liver development,BP,PKD2;SULF2;EGFR;ITGA2;GLI3;E2F7;CPS1;JARID2;PHF2;TGFBR3;ARF6;CITED2;SOX9;NPHP3;PTPN3;RARA
7753,GO:0032280,0.105994079077515,0.988646530454068,2,4,symmetric synapse,CC,NTSR1;NLGN4Y
10002,GO:0042454,0.106003122020862,0.975105792685936,3,15,ribonucleoside catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F
16181,GO:0090245,0.10610916068611,0.988626667718479,2,4,axis elongation involved in somitogenesis,BP,SFRP1;MED12
14751,GO:0070482,0.106118456800075,0.924153419310344,36,282,response to oxygen levels,BP,MMP2;CTGF;SFRP1;ZFP36L1;DDIT4;TGFBR2;NOS1;SLC8A1;PAK1;ANGPTL4;KCNMA1;TP53;ITGA2;MTHFR;CAV1;ANG;CAT;LMNA;PSMB9;PDK3;TGFBR3;ATM;MDM2;CST3;CITED2;EGR1;NDRG1;TGFB2;TH;ITPR2;PPARG;POSTN;HP1BP3;ABAT;OXTR;ACAA2
16578,GO:0097443,0.106220445699215,0.986946890509628,2,5,sorting endosome,CC,CLTCL1;PTPN1
10651,GO:0043903,0.106246740247886,0.930625220675975,23,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,GSN;APOBEC3C;TRIM38;EIF2AK4;TRIM5;STAT1;LGALS1;IFIT1;ADARB1;CAV1;OAS2;HMGA2;APOBEC3G;STOM;APOBEC3F;ANXA2;IFITM2;MVB12B;LEF1;RSAD2;SRPK2;MDFIC;IFITM1
10260,GO:0043027,0.106306911625135,0.968910730088572,4,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,GAS6;PRDX5;SNCA;LEF1
725,GO:0001955,0.106308878695925,0.986929471114195,2,5,blood vessel maturation,BP,MMP2;DDIT3
5598,GO:0016645,0.106359481303259,0.968398937939795,4,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,PRODH;MTHFR;ALDH1L2;ALDH4A1
12502,GO:0050670,0.106564738241583,0.936753088424817,16,115,regulation of lymphocyte proliferation,BP,INPP5D;TGFBR2;IL20RB;IRS2;BMP4;VAV3;PYCARD;GPNMB;DLG5;IL18;ATM;CD1D;BCL6;PRNP;IGFBP2;LGALS3
14287,GO:0061469,0.106671090933572,0.985817029579327,2,6,regulation of type B pancreatic cell proliferation,BP,SFRP1;NR1D1
414,GO:0001102,0.10677861786112,0.954857874884599,7,35,RNA polymerase II activating transcription factor binding,MF,MEF2D;ISL1;NCOR1;ZFPM1;RBL2;MEF2A;FOS
9680,GO:0038094,0.106805097740765,0.946395176553487,10,59,Fc-gamma receptor signaling pathway,BP,PAK1;VAV3;FYN;PLA2G6;PIK3R1;VAV2;WIPF1;ELMO2;MYO1C;DOCK1
5161,GO:0015711,0.106817942554243,0.923730816683421,36,263,organic anion transport,BP,SLC7A8;PITPNM3;IRS2;OSBPL10;SLC2A3;ATP10D;NTSR1;ABCA1;SLC7A11;ACSL3;SLC22A15;SLC27A1;PLA2G6;SLC22A17;OSBPL5;ATP8B2;CCK;SYT1;SLC38A10;CPT1A;SLC38A2;ACACB;SNCA;PRKAB2;NCOA2;PLA2R1;SLC27A6;NCOR1;ABCC2;PITPNC1;PPARG;SV2A;ABAT;RXRA;CPT2;NFKBIE
12066,GO:0048050,0.10689636040831,0.985769147615132,2,6,post-embryonic eye morphogenesis,BP,FBN1;EFEMP1
2518,GO:0005775,0.106976491614238,0.935323286687404,17,125,vacuolar lumen,CC,PYGB;SDC3;CSPG4;NSG1;PYCARD;CTSV;NAGLU;MANBA;HEXA;SDC2;ANXA2;MAN2B1;LIPA;AGRN;NAPRT;DNAJC3;CTSD
8608,GO:0034141,0.106985213731278,0.985750243741031,2,6,positive regulation of toll-like receptor 3 signaling pathway,BP,FLOT1;CAV1
6946,GO:0030593,0.107007960586151,0.957620741098641,6,36,neutrophil chemotaxis,BP,VAV3;ITGA1;PDE4D;MOSPD2;TGFB2;LGALS3
3447,GO:0007260,0.107108875974561,0.953927839206925,7,43,tyrosine phosphorylation of STAT protein,BP,PTK6;FYN;CAV1;IL31RA;CTF1;IL18;ISL1
3707,GO:0008218,0.1071853179142,1,1,1,bioluminescence,BP,SDC2
8874,GO:0034706,0.107197966347187,0.978089632173313,3,8,sodium channel complex,CC,SCN8A;SCN2A;SCNN1A
13547,GO:0060043,0.107291952659737,0.963031227350901,5,22,regulation of cardiac muscle cell proliferation,BP,TGFBR2;JARID2;TP73;FGFR1;TGFBR3
5515,GO:0016491,0.107374436514598,0.917517403857213,56,523,oxidoreductase activity,MF,PRODH;NQO1;PTGS1;CYBRD1;H6PD;NOS1;SESN3;TP53I3;D2HGDH;MICAL1;PHGDH;BCKDHB;GPX1;P3H2;ERO1B;MTHFR;SESN1;KCNAB2;XDH;GLDC;SDR16C5;PRDX5;HIBADH;PDIA4;ALDH3A2;CAT;PHF2;SNCA;ALDH1L2;PDIA6;CBR1;ALOX15B;PYROXD2;G6PD;DHTKD1;KDM4C;IDH2;HSD17B11;AKR7A2;CYP20A1;NDUFA4L2;ALDH4A1;ALDH9A1;DECR1;ZADH2;ALDH7A1;CYP4V2;MSRB2;DHRS12;TH;GPX8;GSTZ1;DPYD;STEAP2;KDM4A;EHHADH
12856,GO:0051220,0.107436086226576,0.962571172935195,5,24,cytoplasmic sequestering of protein,BP,PKD2;MDFI;THRA;GOPC;NFKBIE
14234,GO:0061323,0.107437178177126,0.9759597235485,3,11,cell proliferation involved in heart morphogenesis,BP,BMP4;SOX9;ISL1
10909,GO:0044548,0.10757716440378,0.975914548744898,3,11,S100 protein binding,MF,AHNAK;ANXA2;S100A11
13552,GO:0060048,0.107578194018927,0.942508091698939,12,64,cardiac muscle contraction,BP,CTGF;TNNI2;GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;TTN;KCNJ5;RGS2;PDE4D
3889,GO:0008528,0.10781001557462,0.961795256821406,5,28,G-protein coupled peptide receptor activity,MF,F2R;NTSR1;CXCR1;CALCRL;OXTR
3566,GO:0007612,0.107837741034128,0.940468059325487,13,75,learning,BP,NTSR1;EIF2AK4;NETO1;DLG4;FYN;DKK1;MEIS2;BCHE;RGS14;NLGN4Y;ATXN1;TH;FOS
8618,GO:0034155,0.107889077095281,1,1,1,regulation of toll-like receptor 7 signaling pathway,BP,RSAD2
8619,GO:0034157,0.107889077095281,1,1,1,positive regulation of toll-like receptor 7 signaling pathway,BP,RSAD2
3112,GO:0006692,0.108070327111561,0.961807700028964,5,27,prostanoid metabolic process,BP,PTGS1;PTGES;CES2;CBR1;ZADH2
3113,GO:0006693,0.108070327111561,0.961807700028964,5,27,prostaglandin metabolic process,BP,PTGS1;PTGES;CES2;CBR1;ZADH2
16103,GO:0090132,0.108105864754792,0.925452972825511,30,203,epithelium migration,BP,MMP9;CCBE1;TGFBR2;DOCK5;PTPRM;BMP4;SEMA5A;ITGA2;ITGA3;GPX1;FAT2;PXN;ROBO1;FGFR1;SEMA4A;CDH13;AMOTL1;CALR;NR2F2;SOX9;PRCP;PRKCA;RAB13;TGFB2;MAP2K5;SP100;PPARG;SASH1;ADGRA2;DOCK1
1302,GO:0003143,0.108349541785613,0.950982311957312,8,40,embryonic heart tube morphogenesis,BP,TGFBR2;PKD2;ENG;BBS4;VANGL2;MEGF8;NPHP3;YAP1
19401,GO:1990026,0.108379129400912,1,1,1,hippocampal mossy fiber expansion,CC,MICAL1
9998,GO:0042447,0.108517766939013,0.985422610688899,2,6,hormone catabolic process,BP,SULT1E1;HSD17B11
3124,GO:0006706,0.108664207093913,0.974766844908705,3,13,steroid catabolic process,BP,SULT1E1;HSD17B11;TRERF1
1704,GO:0004222,0.108930049533139,0.945172323090135,10,58,metalloendopeptidase activity,MF,MMP2;MMP9;ADAM19;MMP28;CLCA2;MMP19;ADAMTS7;MME;ADAMTS15;ADAM10
2408,GO:0005583,0.108954865470748,0.977566621087699,3,8,fibrillar collagen trimer,CC,COL5A2;COL5A1;COL5A3
16770,GO:0098643,0.108954865470748,0.977566621087699,3,8,banded collagen fibril,CC,COL5A2;COL5A1;COL5A3
16039,GO:0090025,0.109044740019382,0.974639583022443,3,13,regulation of monocyte chemotaxis,BP,SERPINE1;ANO6;MOSPD2
2863,GO:0006357,0.109109403985729,0.905866253892296,191,1590,regulation of transcription by RNA polymerase II,BP,HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;ETV5;PKD2;TSC22D1;ZFP36L2;NOS1;SNAI2;MAGED1;PHF21A;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;TADA3;CBX5;VDR;BMP4;NR1D1;SMARCA2;CITED4;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;DDIT3;ZBTB20;ZC3H6;MEF2D;TFDP2;ITGA3;CHD3;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;SLC2A4RG;TCEAL3;SDR16C5;HMGA2;CAMK2D;KANK2;ZSCAN18;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;WFS1;MDFI;JARID2;TCEAL8;TP73;KLF13;TLR3;SNCA;GATAD1;SP110;FGFR1;DKK1;SETX;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;FZD8;TCEAL1;SETBP1;SOX13;KDM4C;CHD6;CDH13;NFATC4;FOXN3;LMCD1;TGFBR3;DLX3;FZD1;PBX1;ENG;FOXL1;CALR;MDM2;MEIS2;TCF4;DGKQ;CITED2;NR2F2;CBX7;LMO4;MAF;TRAK1;ARHGEF2;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;ZNF160;MEGF8;IRF2BPL;MAML2;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;STAT2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;FHOD1;IFT74;ZNF12;YAP1;GDNF;KLF5;YEATS2;HOXA3;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;KLF7;TGIF1;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;ZBTB1;PPP3CA;CREBRF;ETV4;HOXA2;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;PRDM5;LITAF;RXRA
6750,GO:0030183,0.109129079415713,0.939504629751703,13,78,B cell differentiation,BP,INPP5D;SFRP1;ZFP36L1;ZFP36L2;LGALS1;DOCK11;PIK3R1;ATM;IFNK;IFNE;BCL6;ITM2A;ZBTB1
1612,GO:0004043,0.10917020949754,1,1,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,ALDH7A1
3974,GO:0008802,0.10917020949754,1,1,1,betaine-aldehyde dehydrogenase activity,MF,ALDH7A1
6088,GO:0019285,0.10917020949754,1,1,1,glycine betaine biosynthetic process from choline,BP,ALDH7A1
7384,GO:0031455,0.10917020949754,1,1,1,glycine betaine metabolic process,BP,ALDH7A1
7385,GO:0031456,0.10917020949754,1,1,1,glycine betaine biosynthetic process,BP,ALDH7A1
9130,GO:0035497,0.109350966832209,0.975339676190347,3,11,cAMP response element binding,MF,HMGA2;CREB3L2;TCF12
4035,GO:0009071,0.109361776015871,0.98450178315902,2,7,serine family amino acid catabolic process,BP,GLDC;THNSL2
11803,GO:0046725,0.109370949092852,1,1,1,negative regulation by virus of viral protein levels in host cell,BP,STAT1
15634,GO:0072183,0.109370949092852,1,1,1,negative regulation of nephron tubule epithelial cell differentiation,BP,STAT1
15704,GO:0072308,0.109370949092852,1,1,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,STAT1
609,GO:0001778,0.109401849647113,0.988052371101087,2,4,plasma membrane repair,BP,DYSF;MYOF
7152,GO:0031033,0.109484753762896,0.983049486116809,3,5,myosin filament organization,BP,TTN;OBSL1;MYH11
8045,GO:0032722,0.109579534620312,0.956521804343296,6,34,positive regulation of chemokine production,BP,PYCARD;TLR3;ALOX15B;C5;EGR1;POSTN
11479,GO:0045987,0.109656144045484,0.967299925829734,4,18,positive regulation of smooth muscle contraction,BP,F2R;ITGA2;ABAT;OXTR
11075,GO:0045105,0.109722022605309,1,1,1,intermediate filament polymerization or depolymerization,BP,NEFL
18611,GO:1903937,0.109722022605309,1,1,1,response to acrylamide,BP,NEFL
11752,GO:0046634,0.109787232394786,0.952830605342568,7,39,regulation of alpha-beta T cell activation,BP,TGFBR2;GLI3;PRKCZ;IL18;ITPKB;BCL6;RARA
10832,GO:0044351,0.109804384128098,0.985145257231257,2,6,macropinocytosis,BP,PYCARD;SNX33
12721,GO:0051016,0.110026929591168,0.97467686314059,3,12,barbed-end actin filament capping,BP,GSN;TRIOBP;CAPG
290,GO:0000795,0.110045117714344,0.967413992841622,4,17,synaptonemal complex,CC,HSPA2;SYN1;MLH3;MSH5
16971,GO:0099086,0.110045117714344,0.967413992841622,4,17,synaptonemal structure,CC,HSPA2;SYN1;MLH3;MSH5
4858,GO:0014704,0.110133482252665,0.953485753519493,7,32,intercalated disc,CC,GJA5;SLC8A1;PAK1;SCN2A;ANK3;FHOD1;OBSL1
6669,GO:0030038,0.110161305268312,0.940604820627197,12,69,contractile actin filament bundle assembly,BP,ITGB5;CTGF;SFRP1;ASAP3;S100A10;PAK1;ARAP1;PXN;PIK3R1;DLC1;BBS4;FHOD1
10326,GO:0043149,0.110161305268312,0.940604820627197,12,69,stress fiber assembly,BP,ITGB5;CTGF;SFRP1;ASAP3;S100A10;PAK1;ARAP1;PXN;PIK3R1;DLC1;BBS4;FHOD1
8189,GO:0032947,0.110237102435158,0.939055422817276,13,72,protein-containing complex scaffold activity,MF,DLG5;PDE4DIP;CAV1;SEPT6;AKAP13;RGS14;MPP7;SEPT5;MAPK8IP3;MAGI2;MAGI1;SASH1;SEPT9
7138,GO:0031000,0.110390321164324,0.975000726912927,3,11,response to caffeine,BP,SLC8A1;TP53;PPARG
9518,GO:0036270,0.110390321164324,0.975000726912927,3,11,response to diuretic,BP,SLC8A1;TP53;PPARG
54,GO:0000111,0.110523154410357,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
11060,GO:0045081,0.110535654969209,1,1,1,negative regulation of interleukin-10 biosynthetic process,BP,TRIB2
17335,GO:1900078,0.110590135383993,0.962037048654298,5,20,positive regulation of cellular response to insulin stimulus,BP,PAK1;PRKCZ;PIK3R1;MYO1C;C2CD5
11653,GO:0046459,0.110715797663072,0.974078216012904,3,13,short-chain fatty acid metabolic process,BP,ACSS1;ACSS2;THNSL2
13811,GO:0060440,0.110769115056327,0.984935919816849,2,6,trachea formation,BP,TGFBR2;BMP4
9061,GO:0035329,0.110972185907628,0.949871659404893,8,37,hippo signaling,BP,FAT4;WWTR1;DLG5;MAP3K14;NPHP4;AMOTL1;AMOTL2;YAP1
4554,GO:0010640,0.111084222714038,0.967308727831409,4,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFA;HIP1;LRP1;SNCA
11076,GO:0045109,0.111085160316258,0.967308351696025,4,16,intermediate filament organization,BP,KRT14;VIM;NEFM;NEFL
8053,GO:0032733,0.11112451468031,0.97362727879546,3,14,positive regulation of interleukin-10 production,BP,IL20RB;PYCARD;PRKCZ
4619,GO:0010744,0.111124909433716,0.984858419439843,2,6,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B;IL18
12749,GO:0051051,0.111547283386831,0.920719250133953,34,263,negative regulation of transport,BP,SERPINE2;FN1;MMP9;SFRP1;F2R;PKD2;IRS2;PROM2;NOS1;GAS6;NTSR1;WNK1;DLG4;CAV1;SNX33;CAMK2D;ANK3;SNCA;PLA2R1;IDH2;ARF6;ENPP1;HTR1B;SP100;GOPC;RSAD2;MDFIC;DERL3;LGALS3;PPP3CA;ABAT;KCNRG;OXTR;ACAA2
17041,GO:0099568,0.111606063708079,0.916270394860477,48,338,cytoplasmic region,CC,FLOT1;CTGF;RHOBTB2;GSN;PKD2;UTRN;SPTB;ADD3;NEFL;EFHC1;DLG4;PHLDB1;HIP1;WDR66;LAMC2;GLI3;CAV1;GLI2;PRKCZ;PXN;PCLO;KIF17;SHROOM4;DLC1;IFT140;SNCA;FLOT2;ASTN2;TRIOBP;SEPT6;MKLN1;ARF6;BBS1;AKAP13;TRAK1;CRIP2;ANXA2;SEPT5;FLNB;TCTEX1D4;CFAP54;ITPR2;DNAH1;WIPF1;SEPT9;BSN;RHOBTB3;C2CD5
7484,GO:0031666,0.111710585971022,0.985847771961304,2,5,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,PRKCA;SASH1
16782,GO:0098660,0.111830418039824,0.914752059381326,53,405,inorganic ion transmembrane transport,BP,F2R;ANO1;PKD2;JPH2;NOS1;GAS6;UTRN;HSPA2;SLC8A1;ORAI3;CLCA2;GJC2;SLC20A1;NTSR1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;ANO6;KCNAB2;FYN;CAV1;PLA2G6;KCNJ15;EHD3;CAMK2D;ANK3;KCNJ5;STOM;SNCA;PDE4D;G6PD;SLC24A1;KCNQ3;NDUFA4L2;TMEM175;SLC39A11;PRNP;SCNN1A;FHL1;SLC9A4;ITPR2;CACNB1;KCNIP3;PTPN3;ANKH;STEAP2;CACNA2D3;KCNRG;TUSC3;ORAI2
8186,GO:0032944,0.111869754519456,0.933097736404042,16,116,regulation of mononuclear cell proliferation,BP,INPP5D;TGFBR2;IL20RB;IRS2;BMP4;VAV3;PYCARD;GPNMB;DLG5;IL18;ATM;CD1D;BCL6;PRNP;IGFBP2;LGALS3
9790,GO:0040036,0.112133557432003,0.960412924883097,5,24,regulation of fibroblast growth factor receptor signaling pathway,BP,DUSP6;SULF2;SPRY2;SPRY4;SULF1
15690,GO:0072283,0.112363099432165,0.974913362382476,3,10,metanephric renal vesicle morphogenesis,BP,BMP4;STAT1;GDNF
8956,GO:0035063,0.112377966694715,1,1,1,nuclear speck organization,BP,SRPK2
15211,GO:0071398,0.112663171331513,0.951726974005384,7,35,cellular response to fatty acid,BP,SFRP1;GNG2;CPS1;CPT1A;PDK3;NFATC4;PPARG
12366,GO:0048813,0.112840963470802,0.931838516059438,17,101,dendrite morphogenesis,BP,TNIK;MAP6;DLG4;MAP2;CUL7;FYN;RBFOX2;CAPRIN2;NFATC4;TRAK1;FBXW8;SDC2;MEF2A;KLF7;OBSL1;SLITRK5;PPP3CA
12806,GO:0051140,0.112985295660966,0.996617293164572,1,2,regulation of NK T cell proliferation,BP,IL18
12807,GO:0051142,0.112985295660966,0.996617293164572,1,2,positive regulation of NK T cell proliferation,BP,IL18
14224,GO:0061304,0.113074709616719,0.987398162128342,2,4,retinal blood vessel morphogenesis,BP,COL4A1;FZD4
12748,GO:0051050,0.113091930066507,0.909583342414183,77,610,positive regulation of transport,BP,FLOT1;F2R;ANO1;PKD2;JPH2;IRS2;CLTCL1;NOS1;GAS6;TCAF1;AXL;EGFR;HSPA2;MYLK;GJC2;SERPINE1;NTSR1;PAK1;ABCA1;SORL1;TP53;PYCARD;WNK1;ITGA2;ACSL3;HIP1;TFDP2;ANO6;GLI3;CNTN1;TBC1D5;LRP1;FYN;B3GAT3;CAV1;PLA2G6;CLU;PRKCZ;EHD3;CCK;PIK3R1;SYT1;HHAT;TMEM173;ANG;ANK3;WFS1;TTN;HPS4;TP73;STOM;SNCA;FGFR1;ALOX15B;C5;PLA2R1;G6PD;LRTOMT;CALR;MDM2;ISL1;ANXA2;KCTD7;PRNP;TGFB2;FHL1;MAGI2;GDNF;PPARG;POSTN;LGALS3;PPP3CA;ABAT;OXTR;MYO1C;C2CD5;EDEM1
6784,GO:0030234,0.113144297754788,0.908091032919605,89,735,enzyme regulator activity,MF,SERPINE2;PHACTR3;FN1;FLRT2;TXNIP;CD109;CDKN2B;ASAP3;COL7A1;DNAJB4;GAS6;ARHGAP23;TFPI2;EGFR;FLRT3;SERPINE1;SERPINH1;ANXA5;ALS2CL;ASAP2;TIMP2;ANGPTL4;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;PYCARD;WNK1;ARHGEF1;TIMP1;DOCK4;CRIM1;EVI5L;ELFN2;TBC1D5;ASAP1;PLXNB1;ARHGEF12;B3GAT3;ARHGAP18;CAV1;ERCC6;TRIB2;SERPING1;PRDX5;PIK3R1;SPRY2;APLP2;FBLN1;DLC1;SNCA;RGS2;C5;AFAP1L2;SRGAP1;FAM20A;CST3;TBC1D19;DGKQ;ANXA2;RGS14;DEPDC7;LEF1;CDC42EP5;CDKN2A;AGAP1;GOPC;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;TBC1D16;DNAJC3;CCNY;PRKAG1;EFNA5;SBF2;RASA1;ARHGAP31;SERPINB5;CAMK2N1;PPP2R3A;TAOK3;DOCK1;DMPK;PINLYP
16261,GO:0090385,0.113369386751419,0.984365845640745,2,6,phagosome-lysosome fusion,BP,SPG11;TMEM175
11600,GO:0046326,0.113448990755575,0.955760968898306,6,26,positive regulation of glucose import,BP,IRS2;CLTCL1;PAK1;PRKCZ;PIK3R1;C2CD5
4382,GO:0010039,0.113826535915047,0.959444447402031,5,25,response to iron ion,BP,CYBRD1;SNCA;G6PD;MDM2;ABAT
3290,GO:0006984,0.113864827373668,0.950535121293386,7,40,ER-nucleus signaling pathway,BP,TP53;DDIT3;HERPUD1;WFS1;CALR;PTPN1;HSPA5
12756,GO:0051058,0.113891845114002,0.944951958951764,9,47,negative regulation of small GTPase mediated signal transduction,BP,STMN3;TIMP2;ITGA3;SPRY2;DLC1;SPRY4;BCL6;TGFB2;RASA1
6780,GO:0030226,0.113985550654565,0.990721156575692,2,3,apolipoprotein receptor activity,MF,ABCA1;LRP1
16421,GO:0097113,0.114056252288818,0.985367264101824,2,5,AMPA glutamate receptor clustering,BP,DLG4;SSH1
16678,GO:0097688,0.114056252288818,0.985367264101824,2,5,glutamate receptor clustering,BP,DLG4;SSH1
11717,GO:0046577,0.114223870984915,1,1,1,long-chain-alcohol oxidase activity,MF,ALDH3A2
483,GO:0001534,0.114260513168281,1,1,1,radial spoke,CC,WDR66
484,GO:0001536,0.114260513168281,1,1,1,radial spoke stalk,CC,WDR66
1200,GO:0002861,0.114378733656644,0.982775566245015,2,8,regulation of inflammatory response to antigenic stimulus,BP,IL20RB;GPX1
980,GO:0002438,0.114475071272322,0.983328454215246,2,7,acute inflammatory response to antigenic stimulus,BP,IL20RB;IL31RA
13536,GO:0060028,0.114497014248294,0.985276248764345,2,5,convergent extension involved in axis elongation,BP,SFRP1;VANGL2
1057,GO:0002586,0.114517629616811,0.996521999546249,1,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
1403,GO:0003338,0.11454485336508,0.959966032426943,5,21,metanephros morphogenesis,BP,PKD2;BMP4;STAT1;SOX9;GDNF
4516,GO:0010574,0.114557485422412,0.9594891873819,5,23,regulation of vascular endothelial growth factor production,BP,CCBE1;SULF2;C5;SULF1;ISL1
4297,GO:0009749,0.114590044153538,0.929118583962305,18,124,response to glucose,BP,TXNIP;CTGF;TGFBR2;ANO1;IRS2;GAS6;SLC8A1;NR1D1;LGALS1;CTSV;PLA2G6;IGF1R;PDK3;GCLC;EGR1;TH;EFNA5;PPP3CA
7077,GO:0030882,0.114601920435631,1,1,1,lipid antigen binding,MF,CD1D
7078,GO:0030883,0.114601920435631,1,1,1,endogenous lipid antigen binding,MF,CD1D
7079,GO:0030884,0.114601920435631,1,1,1,exogenous lipid antigen binding,MF,CD1D
12034,GO:0048006,0.114601920435631,1,1,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,CD1D
8315,GO:0033173,0.114704078671983,0.959421117267603,5,23,calcineurin-NFAT signaling cascade,BP,NFATC4;LMCD1;NFAT5;PRNP;PPP3CA
16066,GO:0090074,0.114717017025028,0.985230733442274,2,5,negative regulation of protein homodimerization activity,BP,ISL1;HSPA5
10745,GO:0044212,0.114740905343318,0.907967571100798,79,605,transcription regulatory region DNA binding,MF,SOX6;ETV5;PHF21A;KLF8;RFX2;TCF7L1;VDR;NR1D1;SMARCA2;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;GLI2;SLC2A4RG;TNRC18;HMGA2;PRDX5;PER1;CREB3L2;JARID2;TP73;KLF13;SNCA;SETX;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;LMO4;EGR1;SOX9;ISL1;BCL6;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;BAHCC1;TCF12;NFAT5;CARF;ZFPM1;RBL2;DLX2;LEF1;THRA;SSBP3;TEF;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;NPAS2;PRDM5;LITAF;RXRA
12205,GO:0048486,0.114748825939212,0.973562540644142,3,11,parasympathetic nervous system development,BP,ADARB1;NAV2;GDNF
4889,GO:0014820,0.114877021255087,0.984031427205467,2,6,tonic smooth muscle contraction,BP,MYLK;BBS2
5831,GO:0017124,0.114971487595474,0.931467112206318,16,97,SH3 domain binding,MF,ADAM19;INPP5D;MICAL1;DOCK4;GPX1;ESPN;AFAP1L2;DNAJC6;ELMO3;LANCL1;UVRAG;WIPF1;ARHGAP31;ELMO2;ADAM10;DOCK1
17896,GO:1902236,0.114982666916394,0.972626364854459,3,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,HERPUD1;WFS1;PTPN1
12936,GO:0051345,0.114983411338731,0.90882003864991,71,558,positive regulation of hydrolase activity,BP,FN1;CTGF;ITGA6;SFRP1;F2R;ASAP3;GSN;DNAJB4;DNMBP;ARHGAP23;DOCK9;EGFR;HSPA2;S100A10;ALS2CL;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;PYCARD;ARHGEF1;ITGA2;HIP1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;FYN;ARHGEF12;XDH;ARHGAP18;CAV1;DOCK11;PRKCZ;ITGA1;CCK;ANG;FBLN1;DAPK1;DLC1;ROBO1;SNCA;FGFR1;RGS2;SRGAP1;TBC1D19;PTPN1;DNAL4;RGS14;DEPDC7;CDC42EP5;AGRN;MAGI2;AGAP1;HSPA5;ARHGEF19;ARHGAP29;OPHN1;LMF1;MYO9A;RALGAPB;PPARG;SNX9;TBC1D16;RASA1;ARHGAP31;DOCK1
13967,GO:0060710,0.115135417850557,0.98397382461846,2,6,chorio-allantoic fusion,BP,ZFP36L1;LEF1
17036,GO:0099552,0.115160396369155,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17037,GO:0099553,0.115160396369155,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17372,GO:1900134,0.115160396369155,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
17500,GO:1901017,0.115277530559554,0.973966030348878,3,10,negative regulation of potassium ion transmembrane transporter activity,BP,CAV1;ANK3;KCNRG
17618,GO:1901380,0.115277530559554,0.973966030348878,3,10,negative regulation of potassium ion transmembrane transport,BP,CAV1;ANK3;KCNRG
3267,GO:0006941,0.115280642089781,0.934169913657739,14,79,striated muscle contraction,BP,CTGF;TNNI2;GJA5;NOS1;SLC8A1;CAV1;EHD3;CAMK2D;TTN;KCNJ5;RGS2;PDE4D;OBSL1;DMPK
18596,GO:1903909,0.115339563054807,0.985101628670972,2,5,regulation of receptor clustering,BP,GSN;SSH1
6378,GO:0021575,0.115481468326072,0.954744261809168,6,26,hindbrain morphogenesis,BP,SERPINE2;TRNP1;GLI2;DLC1;HSPA5;OPHN1
12569,GO:0050772,0.115619343444523,0.93733947483556,12,65,positive regulation of axonogenesis,BP,FN1;PAK1;NEFL;SEMA5A;PLXNB1;METRN;ROBO1;PLXNA2;PLXNA1;TRAK1;MEGF8;EFNA5
9023,GO:0035255,0.115623155949789,0.959469810494968,5,21,ionotropic glutamate receptor binding,MF,FLOT1;NETO1;DLG4;FLOT2;OPHN1
1768,GO:0004375,0.115667519504348,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
5597,GO:0016642,0.115667519504348,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
9510,GO:0036255,0.115667519504348,1,1,1,response to methylamine,BP,GLDC
14644,GO:0070280,0.115667519504348,1,1,1,pyridoxal binding,MF,GLDC
18386,GO:1903442,0.115667519504348,1,1,1,response to lipoic acid,BP,GLDC
10267,GO:0043034,0.115677681057324,0.960798040268182,5,17,costamere,CC,PLEC;AHNAK;FLNC;AHNAK2;ANK3
3530,GO:0007519,0.11573347879996,0.933542437449388,14,87,skeletal muscle tissue development,BP,FLOT1;MYH15;TSC22D3;NUPR1;MEF2D;GPX1;CAV1;DKK1;NR2F2;EGR1;FLNB;KLF5;PPP3CA;FOS
16501,GO:0097264,0.115741670968767,0.983838348750921,2,6,self proteolysis,BP,TENM4;TENM3
9370,GO:0035925,0.115754223202948,0.973226957645691,3,11,mRNA 3'-UTR AU-rich region binding,MF,ZFP36L1;ZFP36L2;RBMS3
4489,GO:0010519,0.115804183024352,0.983824353398796,2,6,negative regulation of phospholipase activity,BP,RGS2;PLA2R1
13495,GO:0055095,0.115811896215376,1,1,1,lipoprotein particle mediated signaling,BP,CDH13
13496,GO:0055096,0.115811896215376,1,1,1,low-density lipoprotein particle mediated signaling,BP,CDH13
9442,GO:0036056,0.115872303559724,0.986890274726386,2,4,filtration diaphragm,CC,PODXL;MAGI2
9443,GO:0036057,0.115872303559724,0.986890274726386,2,4,slit diaphragm,CC,PODXL;MAGI2
15005,GO:0070977,0.115897158292276,0.974499888522618,3,9,bone maturation,BP,FAT4;ANO6;PLXNB1
11702,GO:0046532,0.115969214970254,0.984970585836019,2,5,regulation of photoreceptor cell differentiation,BP,SOX9;DLX2
15497,GO:0071914,0.115980035964126,1,1,1,prominosome,CC,PROM2
11740,GO:0046621,0.116100472068272,0.958998007370494,5,22,negative regulation of organ growth,BP,TGFBR2;PAK1;JARID2;TP73;G6PD
572,GO:0001715,0.116147846508461,1,1,1,ectodermal cell fate specification,BP,FZD7
10110,GO:0042665,0.116147846508461,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10111,GO:0042666,0.116147846508461,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
19870,GO:2000383,0.116147846508461,1,1,1,regulation of ectoderm development,BP,FZD7
19871,GO:2000384,0.116147846508461,1,1,1,negative regulation of ectoderm development,BP,FZD7
11544,GO:0046113,0.116351344759572,0.984890829624068,2,5,nucleobase catabolic process,BP,XDH;DPYD
3619,GO:0008076,0.116367545498624,0.95344035606663,6,31,voltage-gated potassium channel complex,CC,KCNMA1;DLG4;KCNAB2;KCNJ5;KCNQ3;KCNIP3
16228,GO:0090312,0.116379309887427,0.964539913954598,4,18,positive regulation of protein deacetylation,BP,TP53;SDR16C5;BCL6;NIPBL
16325,GO:0090647,0.116389541018889,0.983693065003866,2,6,modulation of age-related behavioral decline,BP,DKK1;PRNP
14484,GO:0065005,0.116716891135553,0.964399602699559,4,18,protein-lipid complex assembly,BP,ABCA1;ACSL3;PRKACB;SNX9
12495,GO:0050662,0.116732097324523,0.920108928254551,27,221,coenzyme binding,MF,PYGB;PRODH;H6PD;NOS1;TP53I3;D2HGDH;MICAL1;PHGDH;P3H2;MTHFR;XDH;HLCS;GLDC;HIBADH;ACACB;CAT;G6PD;DHTKD1;IDH2;GCLC;THNSL2;DECR1;TH;SRR;PARP15;DPYD;ABAT
1410,GO:0003345,0.116756265630255,1,1,1,proepicardium cell migration involved in pericardium morphogenesis,BP,FLRT3
17805,GO:1901991,0.116802497452502,0.921342973707802,25,202,negative regulation of mitotic cell cycle phase transition,BP,CDKN2B;ZFP36L1;PKD2;ZFP36L2;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;HMGA2;KANK2;TP73;CHEK2;FBXL7;PSMB9;FOXN3;ATM;MDM2;RBL2;FHL1;CTDSP2;KLHL22;CDK5RAP3;TAOK3
16687,GO:0097709,0.117055638590115,0.983543147138758,2,6,connective tissue replacement,BP,F2R;PPP3CA
10557,GO:0043542,0.117084668824771,0.924597334864604,21,140,endothelial cell migration,BP,CCBE1;PTPRM;BMP4;SEMA5A;GPX1;PXN;ROBO1;FGFR1;SEMA4A;CDH13;AMOTL1;CALR;NR2F2;PRCP;PRKCA;RAB13;MAP2K5;SP100;PPARG;SASH1;ADGRA2
6340,GO:0021522,0.117114482419397,0.964863360882663,4,16,spinal cord motor neuron differentiation,BP,GLI3;GLI2;LMO4;ISL1
19171,GO:1905288,0.117286282190118,0.984694970142524,2,5,vascular associated smooth muscle cell apoptotic process,BP,PDCD4;PPARG
19245,GO:1905459,0.117286282190118,0.984694970142524,2,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4;PPARG
19246,GO:1905461,0.117286282190118,0.984694970142524,2,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,PDCD4;PPARG
7530,GO:0031811,0.117348114954436,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7531,GO:0031812,0.117348114954436,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
10977,GO:0044798,0.117368102710182,0.923388362817174,22,157,nuclear transcription factor complex,CC,TADA3;VDR;NR1D1;TP53;DDIT3;TFDP2;TLE4;NFATC4;PBX1;TCF4;SOX9;TCF12;NFAT5;TAF8;LEF1;THRA;YAP1;PPARG;RARA;TAF1;FOS;RXRA
15147,GO:0071312,0.117571059156638,0.963783550162658,4,19,cellular response to alkaloid,BP,SLC8A1;MDM2;HTR1B;TH
4356,GO:0009956,0.117677429432891,1,1,1,radial pattern formation,BP,NR2F2
14040,GO:0060849,0.117677429432891,1,1,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,NR2F2
486,GO:0001539,0.117758462076732,0.964599140399414,4,16,cilium or flagellum-dependent cell motility,BP,BBS2;BBS4;CFAP54;DNAH1
13691,GO:0060285,0.117758462076732,0.964599140399414,4,16,cilium-dependent cell motility,BP,BBS2;BBS4;CFAP54;DNAH1
4826,GO:0014036,0.117970118016107,1,1,1,neural crest cell fate specification,BP,SOX9
9216,GO:0035622,0.117970118016107,1,1,1,intrahepatic bile duct development,BP,SOX9
12395,GO:0048866,0.117970118016107,1,1,1,stem cell fate specification,BP,SOX9
13526,GO:0060018,0.117970118016107,1,1,1,astrocyte fate commitment,BP,SOX9
13657,GO:0060221,0.117970118016107,1,1,1,retinal rod cell differentiation,BP,SOX9
13854,GO:0060516,0.117970118016107,1,1,1,primary prostatic bud elongation,BP,SOX9
13855,GO:0060517,0.117970118016107,1,1,1,epithelial cell proliferation involved in prostatic bud elongation,BP,SOX9
14014,GO:0060784,0.117970118016107,1,1,1,regulation of cell proliferation involved in tissue homeostasis,BP,SOX9
16515,GO:0097298,0.118086829977702,1,1,1,regulation of nucleus size,BP,HP1BP3
13008,GO:0051491,0.118180249264134,0.958029644759919,5,22,positive regulation of filopodium assembly,BP,ARAP1;DOCK11;ESPN;FSCN1;AGRN
11228,GO:0045454,0.118182480534341,0.944127646675587,8,57,cell redox homeostasis,BP,NOS1;DDIT3;GPX1;ERO1B;PRDX5;PDIA4;PDIA6;GCLC
7759,GO:0032290,0.118194777360833,0.990154417459381,2,3,peripheral nervous system myelin formation,BP,AHNAK2;PRX
6413,GO:0021683,0.118226397849672,0.984496990541704,2,5,cerebellar granular layer morphogenesis,BP,SERPINE2;OPHN1
12768,GO:0051089,0.118296377304363,1,1,1,constitutive protein ectodomain proteolysis,BP,ADAM10
506,GO:0001569,0.118329013792888,0.957728239854838,5,23,branching involved in blood vessel morphogenesis,BP,TGFBR2;NFATC4;ENG;LEF1;COL4A1
1281,GO:0003084,0.118366561248942,0.983246482792082,2,6,positive regulation of systemic arterial blood pressure,BP,WNK1;NR2F2
19911,GO:2000463,0.118425490871681,0.963984600415895,4,17,positive regulation of excitatory postsynaptic potential,BP,NETO1;DLG4;PRKCZ;SSH1
11882,GO:0046934,0.118496503957645,0.948860670322586,7,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,IRS2;EGFR;PDGFA;KITLG;FYN;PIK3R1;FGFR1
395,GO:0001067,0.118496662590433,0.904755791915504,79,606,regulatory region nucleic acid binding,MF,SOX6;ETV5;PHF21A;KLF8;RFX2;TCF7L1;VDR;NR1D1;SMARCA2;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;GLI2;SLC2A4RG;TNRC18;HMGA2;PRDX5;PER1;CREB3L2;JARID2;TP73;KLF13;SNCA;SETX;NCOA2;SOX13;NFATC4;PBX1;MEIS2;TCF4;LMO4;EGR1;SOX9;ISL1;BCL6;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;BAHCC1;TCF12;NFAT5;CARF;ZFPM1;RBL2;DLX2;LEF1;THRA;SSBP3;TEF;YAP1;KLF5;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;PBX2;TAF1;CREBRF;ETV4;FOS;MED12;NPAS2;PRDM5;LITAF;RXRA
18546,GO:1903800,0.118574009505115,0.982363292964758,2,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR;BMP4
6006,GO:0019060,0.118742425954938,0.996251962231931,1,2,intracellular transport of viral protein in host cell,BP,IFIT1
6944,GO:0030581,0.118742425954938,0.996251962231931,1,2,symbiont intracellular protein transport in host,BP,IFIT1
13114,GO:0051708,0.118742425954938,0.996251962231931,1,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,IFIT1
6379,GO:0021577,0.118989741563246,1,1,1,hindbrain structural organization,BP,HSPA5
6383,GO:0021589,0.118989741563246,1,1,1,cerebellum structural organization,BP,HSPA5
14055,GO:0060904,0.118989741563246,1,1,1,regulation of protein folding in endoplasmic reticulum,BP,HSPA5
18762,GO:1904313,0.118989741563246,1,1,1,response to methamphetamine hydrochloride,BP,HSPA5
12296,GO:0048670,0.119009891157613,0.971639087122392,3,12,regulation of collateral sprouting,BP,PTPRS;ULK2;EFNA5
10160,GO:0042771,0.119096116092269,0.947403249142523,7,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,DDIT4;NUPR1;TP53;PYCARD;TP73;CHEK2;USP28
19244,GO:1905458,0.119150353188794,1,1,1,positive regulation of lymphoid progenitor cell differentiation,BP,ZBTB1
19742,GO:2000174,0.119150353188794,1,1,1,regulation of pro-T cell differentiation,BP,ZBTB1
19743,GO:2000176,0.119150353188794,1,1,1,positive regulation of pro-T cell differentiation,BP,ZBTB1
11104,GO:0045162,0.119159721146833,0.986282921392589,2,4,clustering of voltage-gated sodium channels,BP,NFASC;AGRN
12203,GO:0048484,0.119273811666323,0.984275193978416,2,5,enteric nervous system development,BP,RET;GDNF
1268,GO:0003056,0.119293385413212,0.984271036875079,2,5,regulation of vascular smooth muscle contraction,BP,DOCK5;DOCK4
18203,GO:1903034,0.119310396356267,0.929491328659363,15,100,regulation of response to wounding,BP,SERPINE2;CD109;F2R;TGFBR2;MYLK;SERPINE1;PTPRS;PDGFA;ANO6;PDPN;CAV1;SERPING1;PRKCA;ANXA2;ABAT
15249,GO:0071460,0.119412710780059,0.996208130669064,1,2,cellular response to cell-matrix adhesion,BP,SKP2
6714,GO:0030133,0.119550131727878,0.915331168783398,32,252,transport vesicle,CC,SYT8;CLTCL1;MAP6;STON2;PCSK1;PTPRS;DLG4;SYN1;SYTL1;SYT1;SNCA;MME;VAMP1;SEC24D;SEPT6;COPG2;APH1B;TMED10;AREG;NRSN2;KLHL12;RAB13;SEPT5;C2CD4C;TMEM187;TH;GOPC;RASSF9;SV2A;TMEM168;STEAP2;ZNRF1
16850,GO:0098815,0.119574047616657,0.956929843194347,5,24,modulation of excitatory postsynaptic potential,BP,NETO1;DLG4;PRKCZ;SSH1;DMPK
11463,GO:0045947,0.119668924562504,0.963165674444548,4,18,negative regulation of translational initiation,BP,EIF2AK4;PAIP2B;RPL13A;RARA
16564,GO:0097413,0.119751016044542,0.982082127659496,2,7,Lewy body,CC,GPX1;HERPUD1
9024,GO:0035256,0.119753155620907,0.982930365138235,2,6,G-protein coupled glutamate receptor binding,MF,FYN;PRNP
8289,GO:0033135,0.119871415380741,0.932183217419774,13,85,regulation of peptidyl-serine phosphorylation,BP,DDIT4;GAS6;EGFR;PAK1;CAV1;CAPRIN2;SPRY2;SNCA;DKK1;PDE4D;IFNK;IFNE;RET
628,GO:0001818,0.120062972607343,0.922072522753206,21,161,negative regulation of cytokine production,BP,FN1;INPP5D;IL20RB;HERC5;GAS6;AXL;PDCD4;PTPRS;PYCARD;GPNMB;RNF135;TRIB2;FGFR1;BCL6;PRNP;ZFPM1;TGFB2;MAP2K5;LEF1;UBA7;RARA
5587,GO:0016620,0.120286787589662,0.956218901328095,5,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH3A2;ALDH1L2;ALDH4A1;ALDH9A1;ALDH7A1
12401,GO:0048873,0.12034389182109,0.962613943351293,4,19,homeostasis of number of cells within a tissue,BP,F2R;IL20RB;SOX9;LIPA
19388,GO:1905952,0.120360440132195,0.933806815461775,12,74,regulation of lipid localization,BP,IRS2;NTSR1;ABCA1;MEST;LRP1;PLA2G6;ACACB;PLA2R1;NCOR1;ANXA2;PPARG;ABCA2
10123,GO:0042711,0.12049144337117,0.982761074351241,2,6,maternal behavior,BP,CREBRF;OXTR
19967,GO:2000587,0.12073308173951,0.983964042310143,2,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFA;LRP1
12376,GO:0048841,0.12080861452803,0.952532775982303,6,24,regulation of axon extension involved in axon guidance,BP,SEMA5A;PLXNA2;SEMA4A;PLXNA1;MEGF8;SEMA4B
3777,GO:0008340,0.120905231910606,0.972883196841934,3,9,determination of adult lifespan,BP,INPP5D;TP53;ATM
9953,GO:0042359,0.120961831828947,0.970197422280815,3,14,vitamin D metabolic process,BP,SNAI2;VDR;FGFR1
19570,GO:1990715,0.121062392433863,1,1,1,mRNA CDS binding,MF,UNK
19091,GO:1905051,0.121110007002288,0.996095924751621,1,2,regulation of base-excision repair,BP,FAM168A
19092,GO:1905053,0.121110007002288,0.996095924751621,1,2,positive regulation of base-excision repair,BP,FAM168A
5055,GO:0015271,0.121136403119361,0.983877605149235,2,5,outward rectifier potassium channel activity,MF,PKD2;KCNMA1
12584,GO:0050792,0.121244788328991,0.921176211884945,21,163,regulation of viral process,BP,GSN;APOBEC3C;TRIM38;EIF2AK4;TRIM5;STAT1;LGALS1;IFIT1;ADARB1;OAS2;HMGA2;APOBEC3G;STOM;APOBEC3F;IFITM2;MVB12B;LEF1;RSAD2;SRPK2;MDFIC;IFITM1
14890,GO:0070765,0.121267006170783,0.98258250772926,2,6,gamma-secretase complex,CC,APH1B;TMED10
10677,GO:0043983,0.121326255365819,0.981703035707409,2,7,histone H4-K12 acetylation,BP,JADE2;ING4
7048,GO:0030837,0.121382324842997,0.946746398932119,7,37,negative regulation of actin filament polymerization,BP,GSN;SPTB;KANK2;TRIOBP;BBS4;FHOD3;CAPG
14825,GO:0070615,0.121621881394408,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
16297,GO:0090537,0.121621881394408,1,1,1,CERF complex,CC,SMARCA1
19368,GO:1905898,0.121643768093369,0.950324756312888,6,34,positive regulation of response to endoplasmic reticulum stress,BP,DDIT3;CAV1;PIK3R1;HERPUD1;PTPN1;EDEM1
12851,GO:0051208,0.121708714826544,0.933239087915369,12,68,sequestering of calcium ion,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;CAMK2D;SNCA;PDE4D;CALR;ITPR2
19552,GO:1990617,0.12191898738331,0.996041829746808,1,2,CHOP-ATF4 complex,CC,DDIT3
5060,GO:0015279,0.122043675822203,0.983682470033172,2,5,store-operated calcium channel activity,MF,ORAI3;ORAI2
4493,GO:0010523,0.122184850144834,0.970116323330981,3,13,negative regulation of calcium ion transport into cytosol,BP,PKD2;NOS1;NTSR1
19385,GO:1905941,0.122277701328737,0.982348684974154,2,6,positive regulation of gonad development,BP,CITED2;SOX9
11739,GO:0046620,0.122475737999794,0.937020645295162,10,56,regulation of organ growth,BP,TGFBR2;DUSP6;PAK1;ACACB;JARID2;TP73;FGFR1;G6PD;TGFBR3;YAP1
4842,GO:0014054,0.12258298824476,1,1,1,positive regulation of gamma-aminobutyric acid secretion,BP,NTSR1
5516,GO:0016492,0.12258298824476,1,1,1,G-protein coupled neurotensin receptor activity,MF,NTSR1
947,GO:0002367,0.122761531149616,0.941754997748895,8,52,cytokine production involved in immune response,BP,GAS6;PRKCZ;IL31RA;TLR3;IL18;BCL6;TGFB2;RSAD2
976,GO:0002431,0.122817339526406,0.936479509237462,10,61,Fc receptor mediated stimulatory signaling pathway,BP,PAK1;VAV3;FYN;PLA2G6;PIK3R1;VAV2;WIPF1;ELMO2;MYO1C;DOCK1
16141,GO:0090190,0.12310072163296,0.970217696311678,3,12,positive regulation of branching involved in ureteric bud morphogenesis,BP,MAGED1;SOX9;GDNF
534,GO:0001653,0.123102841719615,0.954401691981812,5,29,peptide receptor activity,MF,F2R;NTSR1;CXCR1;CALCRL;OXTR
6971,GO:0030656,0.123177026042646,0.981253555741089,2,7,regulation of vitamin metabolic process,BP,SNAI2;VDR
6577,GO:0022412,0.123226246588344,0.916087373259438,26,186,cellular process involved in reproduction in multicellular organism,BP,SFRP1;ETV5;HSPA2;RFX2;BMP4;SMARCA2;PAQR8;SLIT3;ANG;BBS2;MLH3;PAQR7;CCDC136;BBS4;ATM;ZNF449;MYBL1;FNDC3A;ODF2;RHBDD1;GOPC;TPGS1;DNAH1;RARA;FZD4;AGO4
15477,GO:0071880,0.123226563585681,0.973164332171439,3,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1;PDE4D;AKAP13
11834,GO:0046847,0.123289380734581,0.942406327121469,8,41,filopodium assembly,BP,ITGA6;ARAP1;DOCK11;ESPN;FSCN1;ARF6;FGD4;AGRN
11051,GO:0045072,0.123397795061208,0.982088075879604,2,6,regulation of interferon-gamma biosynthetic process,BP,TLR3;ZFPM1
9229,GO:0035640,0.123538238224518,0.970064287503118,3,12,exploration behavior,BP,DLG4;ITGA3;ABAT
13516,GO:0060005,0.123598472547049,1,1,1,vestibular reflex,BP,SLITRK6
13517,GO:0060007,0.123598472547049,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
6788,GO:0030239,0.123844965828541,0.947151798985054,7,27,myofibril assembly,BP,TTN;OBSCN;AKAP13;FHOD3;MEF2A;OBSL1;MYH11
3662,GO:0008154,0.12386242025134,0.919488784109998,21,148,actin polymerization or depolymerization,BP,GSN;SPTB;PYCARD;SEMA5A;MICAL1;ARHGAP18;ARPIN;KANK2;ANG;TRIOBP;BBS4;ARF6;FHOD3;SSH1;CDC42EP5;MSRB2;CAPG;WIPF1;RASA1;LIMA1;MYO1C
6979,GO:0030667,0.123912998264619,0.914882587024172,27,196,secretory granule membrane,CC,PCDH7;CD109;ANPEP;SLC2A3;ANO6;KCNAB2;CAV1;CXCR1;SYT1;TMEM173;APLP2;STOM;SNCA;FLOT2;MME;VAMP1;MLEC;CCDC136;TMED10;MANBA;PRCP;NFASC;RAB13;MOSPD2;ITPR2;LGALS3;ADAM10
4556,GO:0010642,0.123963134945338,0.970433928551667,3,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFA;LRP1;SNCA
9605,GO:0036488,0.123965781629564,0.99590318851117,1,2,CHOP-C/EBP complex,CC,DDIT3
15129,GO:0071276,0.123972243822153,0.960220435064822,4,23,cellular response to cadmium ion,BP,MMP9;GSN;EGFR;FOS
15434,GO:0071802,0.123973734937053,1,1,1,negative regulation of podosome assembly,BP,ARHGEF2
15486,GO:0071896,0.124085261684028,0.985351702462951,2,4,protein localization to adherens junction,BP,DLG5;MPP7
19686,GO:2000051,0.124257265955125,0.985318724993864,2,4,negative regulation of non-canonical Wnt signaling pathway,BP,SFRP1;RNF213
11383,GO:0045806,0.12452389642411,0.948696448371267,6,35,negative regulation of endocytosis,BP,PROM2;DLG4;CAV1;SNX33;ARF6;LGALS3
17312,GO:1900025,0.124755998033795,0.969635890251267,3,12,negative regulation of substrate adhesion-dependent cell spreading,BP,FBLN1;POSTN;EFNA5
13200,GO:0051892,0.125193245404808,1,1,1,negative regulation of cardioblast differentiation,BP,PRICKLE1
20034,GO:2000690,0.125193245404808,1,1,1,regulation of cardiac muscle cell myoblast differentiation,BP,PRICKLE1
20035,GO:2000691,0.125193245404808,1,1,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,PRICKLE1
16691,GO:0097720,0.125250223400762,0.95422064048084,5,24,calcineurin-mediated signaling,BP,NFATC4;LMCD1;NFAT5;PRNP;PPP3CA
9646,GO:0038021,0.125344725909242,1,1,1,leptin receptor activity,MF,LEPR
3310,GO:0007016,0.125456981657709,0.972451975083258,3,8,cytoskeletal anchoring at plasma membrane,BP,TLN2;ANK3;FLNB
12899,GO:0051281,0.125599201219403,0.95405262921759,5,24,positive regulation of release of sequestered calcium ion into cytosol,BP,F2R;PKD2;JPH2;NTSR1;SNCA
16278,GO:0090461,0.125885991689378,1,1,1,glutamate homeostasis,BP,KCTD7
13572,GO:0060071,0.125980026427817,0.926219452343959,14,99,Wnt signaling pathway, planar cell polarity pathway,BP,SFRP1;ROR1;PRICKLE1;FZD7;DKK1;PSMB9;FZD1;VANGL2;NPHP3;MAGI2;ARHGEF19;FZD4;MED12;CELSR1
9857,GO:0042136,0.126155471301313,0.937065994268604,9,54,neurotransmitter biosynthetic process,BP,NQO1;PKD2;NOS1;CAV1;CLU;ALDH9A1;TH;DPYD;ABAT
9255,GO:0035695,0.126223563370305,1,1,1,mitophagy by induced vacuole formation,BP,SPATA18
12072,GO:0048075,0.126302633789011,1,1,1,positive regulation of eye pigmentation,BP,HPS4
13193,GO:0051882,0.126304331002046,0.968276540943227,3,14,mitochondrial depolarization,BP,IFI6;CCK;GCLC
9959,GO:0042368,0.126421465397106,0.980455008206837,2,7,vitamin D biosynthetic process,BP,SNAI2;VDR
20254,GO:2001247,0.12644068078863,1,1,1,positive regulation of phosphatidylcholine biosynthetic process,BP,ACSL3
10286,GO:0043083,0.126560553846828,0.984874154515441,2,4,synaptic cleft,CC,LAMA5;LAMB2
19182,GO:1905314,0.126561031409865,0.971016715996864,3,9,semi-lunar valve development,BP,GJA5;BMP4;TGFB2
12337,GO:0048739,0.126655885107905,0.975647723311528,3,6,cardiac muscle fiber development,BP,BMP4;TTN;MYH11
4211,GO:0009374,0.126773607252705,0.982649630615565,2,5,biotin binding,MF,HLCS;ACACB
7775,GO:0032311,0.126786790434754,0.995707919482416,1,2,angiogenin-PRI complex,CC,ANG
8009,GO:0032653,0.126825194777038,0.959152104658696,4,22,regulation of interleukin-10 production,BP,IL20RB;PYCARD;TRIB2;PRKCZ
7065,GO:0030864,0.126967169554745,0.932099468179813,11,59,cortical actin cytoskeleton,CC,FLOT1;GSN;UTRN;SPTB;HIP1;SHROOM4;DLC1;FLOT2;TRIOBP;AKAP13;WIPF1
2297,GO:0005272,0.126994860941465,0.961173343849795,4,15,sodium channel activity,MF,PKD2;SCN8A;SCN2A;SCNN1A
17811,GO:1902003,0.127003291434344,0.960370915723051,4,17,regulation of amyloid-beta formation,BP,SORL1;CLU;TMED10;PRNP
15204,GO:0071391,0.127040916118423,0.969362630165251,3,11,cellular response to estrogen stimulus,BP,SFRP1;MDM2;RARA
5715,GO:0016860,0.127075158496488,0.946836961289554,6,40,intramolecular oxidoreductase activity,MF,PTGES;ECH1;ERO1B;PDIA4;PDIA6;EHHADH
11481,GO:0045989,0.127149802214255,0.980273894043237,2,7,positive regulation of striated muscle contraction,BP,CTGF;RGS2
751,GO:0001992,0.127202287330905,1,1,1,regulation of systemic arterial blood pressure by vasopressin,BP,OXTR
2158,GO:0004990,0.127202287330905,1,1,1,oxytocin receptor activity,MF,OXTR
5146,GO:0015688,0.127265599011046,0.995674293480279,1,2,iron chelate transport,BP,SLC22A17
5255,GO:0015891,0.127265599011046,0.995674293480279,1,2,siderophore transport,BP,SLC22A17
13111,GO:0051704,0.127379398771065,0.889875293249951,176,1583,multi-organism process,BP,SERPINE2;ITGB6;SYT8;TNFRSF6B;MMP2;HTRA1;FN1;MMP9;ITGB5;SYNE1;F2R;DDIT4;TGFBR2;GSN;ETV5;PIK3C2G;HERC5;ANPEP;NOS1;GAS6;AXL;EGFR;HSPA2;RFX2;ACTA2;SERPINE1;CRTAP;VIM;TKFC;IFI44L;ABCA1;CBX5;VDR;APOBEC3C;BMP4;TRIM38;NR1D1;SMARCA2;EIF2AK4;TRIM5;HSF2BP;PDCD4;STAT1;IFIT2;LGALS1;TP53;PYCARD;IFIT1;DDX60;DLG4;ITGA2;MMP19;ADARB1;TIMP1;PACS1;CUL7;BTG1;ITGA3;IFIT3;GPX1;PAQR8;PTGES;MAGED2;CTSV;SEC14L1;FYN;FUT10;CPS1;CAV1;PLA2G6;SPATA6;MAP3K14;CLU;OAS2;ULK2;HMGA2;PHC2;MST1R;IL31RA;CCNI;ULBP1;SPATA20;PIK3R1;TMEM173;SLC38A2;APOBEC3G;ANG;BBS2;FBLN1;MLH3;TP73;STOM;TLR3;SNCA;PAQR7;SP110;COL16A1;APOBEC3F;RGS2;SETX;PDE4D;PSMB9;IL18;TRO;CCDC136;CHD6;SEPT6;BBS4;CALR;ATM;EFNB3;MDM2;CST3;IFNK;NR2F2;IFNE;ZNF449;CD1D;IFI44;NRK;LYST;SOX9;BCL6;CRTC1;PRKCA;MYBL1;ANXA2;FNDC3A;LEPR;STOX2;IFITM2;MVB12B;RPL13A;ABCC2;NLGN4Y;ATXN1;RAB43;SPA17;ODF2;STAT2;LEF1;THRA;HERPUD2;SP100;ULK1;IGFBP2;RHBDD1;CDK19;TH;GOPC;CENPA;RSAD2;SRPK2;UVRAG;CFAP54;MDFIC;IFITM1;TPGS1;DNAH1;SRR;SASH1;DNAJC3;RARA;PRKAG1;TAF1;WIPF1;FOS;KDM4A;AGO4;ABAT;OXTR;MPDZ;LITAF;ATG16L2;RXRA;GBP3
19554,GO:1990622,0.127401706943436,0.995664709186053,1,2,CHOP-ATF3 complex,CC,DDIT3
12465,GO:0050482,0.127404421738396,0.96869707354301,3,12,arachidonic acid secretion,BP,NTSR1;PLA2G6;PLA2R1
18623,GO:1903963,0.127404421738396,0.96869707354301,3,12,arachidonate transport,BP,NTSR1;PLA2G6;PLA2R1
4316,GO:0009812,0.127442356066114,0.979523036270724,2,8,flavonoid metabolic process,BP,UGT1A3;UGT1A6
6671,GO:0030042,0.127470332683607,0.943643952594306,7,35,actin filament depolymerization,BP,GSN;SPTB;SEMA5A;MICAL1;TRIOBP;CAPG;LIMA1
18701,GO:1904181,0.127492586102258,0.981122174653463,2,6,positive regulation of membrane depolarization,BP,CCK;ANK3
3066,GO:0006635,0.127510909899347,0.935853512446001,9,60,fatty acid beta-oxidation,BP,IRS2;TYSND1;ECH1;CPT1A;ACACB;DECR1;EHHADH;CPT2;ACAA2
12947,GO:0051371,0.127534869555309,0.978744462933952,3,5,muscle alpha-actinin binding,MF,PKD2;TTN;OBSL1
5792,GO:0017048,0.12755499191118,0.915515680204813,23,138,Rho GTPase binding,MF,DNMBP;PAK1;SRGAP3;VAV3;PLEKHG3;ARHGEF1;DOCK4;ARHGEF12;CAV1;DOCK11;OBSCN;ARHGEF17;TRIOBP;SRGAP1;AKAP13;FGD4;ARHGEF2;PAK6;CDC42EP5;VAV2;ARHGEF19;INF2;DOCK1
12827,GO:0051172,0.127698869696558,0.888598702194185,205,1773,negative regulation of nitrogen compound metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;TXNIP;SOX6;INPP5D;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;DDIT4;DUSP6;ZFP36L2;IGF2BP2;COL7A1;GAS6;SNAI2;MAGED1;PHF21A;TFPI2;EGFR;TSC22D3;KLF8;FLRT3;ZNF608;SERPINE1;SERPINH1;CRTAP;TIMP2;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;PDCD4;NR3C1;STAT1;SORL1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;WNK1;ZCCHC11;MICAL1;ADARB1;TIMP1;TFDP2;CCDC85B;CRIM1;KLF12;NFIX;ELFN2;HIVEP1;GPX1;GLI3;E2F7;CTDSPL;ZFP90;FYN;IFI6;XDH;TSHZ2;CAV1;GLI2;PIAS3;RBFOX2;TRIB2;ZNF318;TNRC18;CLU;SERPING1;PRKCZ;SDR16C5;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ANG;DUSP5;UHRF2;HERPUD1;WFS1;MDFI;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;CHEK2;SPRY4;PAIP2B;PHF2;SNCA;FLOT2;GLG1;FGFR1;IGF1R;DKK1;RGS2;C5;PDE4D;NCOA2;G6PD;TLE4;FZD8;TCEAL1;KDM4C;NFATC4;MAGEF1;FOXN3;LMCD1;FZD1;PBXIP1;ENG;CALR;ATM;MDM2;CST3;MEIS2;DGKQ;CITED2;GCLC;NR2F2;CBX7;MAF;PTPN1;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;SALL2;ANXA2;RGS14;CXORF57;BAHCC1;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;PRNP;ZFPM1;MAP2K5;DLX2;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;OPHN1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;DERL3;PPARG;PARP15;BEX4;KCNIP3;MEF2A;TGIF1;ING4;UNK;PTPN3;DNAJC3;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;NIPBL;PRDM5;S100A11;RXRA;TAOK3
3912,GO:0008584,0.127860075709304,0.925198576897521,14,91,male gonad development,BP,SFRP1;NUPR1;KITLG;CTSV;TLR3;CST3;CITED2;SOX9;RAB13;FNDC3A;TGFB2;RARA;AGO4;RHOBTB3
3950,GO:0008670,0.127884392389316,0.995630628429951,1,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
7151,GO:0031032,0.12801788645365,0.916959348003226,21,124,actomyosin structure organization,BP,ITGB5;CTGF;SFRP1;ASAP3;S100A10;PAK1;ARAP1;LIMCH1;PXN;PIK3R1;TTN;DLC1;FRMD5;OBSCN;BBS4;AKAP13;FHOD3;FHOD1;MEF2A;OBSL1;MYH11
4296,GO:0009746,0.128178349148283,0.919384145170409,18,126,response to hexose,BP,TXNIP;CTGF;TGFBR2;ANO1;IRS2;GAS6;SLC8A1;NR1D1;LGALS1;CTSV;PLA2G6;IGF1R;PDK3;GCLC;EGR1;TH;EFNA5;PPP3CA
15592,GO:0072110,0.128229014563459,0.980004284058699,2,7,glomerular mesangial cell proliferation,BP,BMP4;EGR1
15596,GO:0072124,0.128229014563459,0.980004284058699,2,7,regulation of glomerular mesangial cell proliferation,BP,BMP4;EGR1
13974,GO:0060718,0.128394339162739,0.982289746300042,2,5,chorionic trophoblast cell differentiation,BP,HTRA1;E2F7
14882,GO:0070739,0.128400465560118,0.98090522418234,2,6,protein-glutamic acid ligase activity,MF,TTLL11;TPGS1
14883,GO:0070740,0.128400465560118,0.98090522418234,2,6,tubulin-glutamic acid ligase activity,MF,TTLL11;TPGS1
13886,GO:0060572,0.128433590169705,0.968873600505892,3,11,morphogenesis of an epithelial bud,BP,BMP4;GLI2;SULF1
559,GO:0001696,0.128454188581741,0.980892354595687,2,6,gastric acid secretion,BP,SLC9A4;OXTR
10882,GO:0044448,0.128524537810403,0.917357637781761,20,125,cell cortex part,CC,FLOT1;GSN;PKD2;UTRN;SPTB;DLG4;PHLDB1;HIP1;PRKCZ;PCLO;SHROOM4;DLC1;FLOT2;TRIOBP;SEPT6;AKAP13;SEPT5;WIPF1;SEPT9;BSN
3544,GO:0007569,0.128587975949705,0.926358913314528,13,85,cell aging,BP,SERPINE1;PDCD4;TP53;HMGA2;CHEK2;MME;LMNA;PLA2R1;ENG;CALR;ATM;BCL6;CDKN2A
4515,GO:0010573,0.128649260434016,0.952577155358717,5,24,vascular endothelial growth factor production,BP,CCBE1;SULF2;C5;SULF1;ISL1
18223,GO:1903071,0.128719130346919,0.979881352734038,2,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,CAV1;HERPUD1
2401,GO:0005548,0.128999793263859,0.938976235546963,8,42,phospholipid transporter activity,MF,PITPNM3;OSBPL10;ATP10D;ABCA1;ANO6;OSBPL5;ATP8B2;PITPNC1
5702,GO:0016838,0.129112224385812,0.995543290950406,1,2,carbon-oxygen lyase activity, acting on phosphates,MF,THNSL2
8873,GO:0034705,0.12912427203859,0.94665801616791,6,32,potassium channel complex,CC,KCNMA1;DLG4;KCNAB2;KCNJ5;KCNQ3;KCNIP3
14283,GO:0061450,0.129134515731725,0.979085300551836,2,8,trophoblast cell migration,BP,TIMP1;CALR
17541,GO:1901163,0.129134515731725,0.979085300551836,2,8,regulation of trophoblast cell migration,BP,TIMP1;CALR
10827,GO:0044343,0.129247266891086,1,1,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,SFRP1
10829,GO:0044345,0.129247266891086,1,1,1,stromal-epithelial cell signaling involved in prostate gland development,BP,SFRP1
16182,GO:0090246,0.129247266891086,1,1,1,convergent extension involved in somitogenesis,BP,SFRP1
19678,GO:2000040,0.129247266891086,1,1,1,regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19679,GO:2000041,0.129247266891086,1,1,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,SFRP1
19689,GO:2000054,0.129247266891086,1,1,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
19701,GO:2000079,0.129247266891086,1,1,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
19702,GO:2000080,0.129247266891086,1,1,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,SFRP1
956,GO:0002378,0.129339744999006,1,1,1,immunoglobulin biosynthetic process,BP,GALNT2
19775,GO:2000242,0.129340539410449,0.951341919613549,5,29,negative regulation of reproductive process,BP,BMP4;TIMP1;PRKACB;SULF1;CALR
15138,GO:0071287,0.12939703615964,0.980665914824073,2,6,cellular response to manganese ion,BP,HSPA5;TH
8330,GO:0033194,0.129410049312467,0.967524542910625,3,13,response to hydroperoxide,BP,GPX1;TP53INP1;DAPK1
11244,GO:0045545,0.129482705885692,0.982046366731516,2,5,syndecan binding,MF,SEMA5A;GPNMB
16527,GO:0097338,0.129634410573049,1,1,1,response to clozapine,BP,PRKACB
11759,GO:0046641,0.129844573778607,0.979597910821817,2,7,positive regulation of alpha-beta T cell proliferation,BP,TGFBR2;IL18
12970,GO:0051414,0.130120059561145,0.981903206252193,2,5,response to cortisol,BP,KLF9;SLIT3
8297,GO:0033144,0.130271610963228,0.951787206202119,5,24,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;KANK2;PER1;CALR;ISL1
18676,GO:1904063,0.130320200592833,0.941535293265579,7,39,negative regulation of cation transmembrane transport,BP,MMP9;PKD2;NTSR1;CAV1;CAMK2D;ANK3;KCNRG
8205,GO:0032977,0.130326636621475,1,1,1,membrane insertase activity,MF,COX18
8206,GO:0032978,0.130326636621475,1,1,1,protein insertion into membrane from inner side,BP,COX18
8207,GO:0032979,0.130326636621475,1,1,1,protein insertion into mitochondrial membrane from inner side,BP,COX18
4385,GO:0010042,0.1303781567317,0.967631371451954,3,12,response to manganese ion,BP,D2HGDH;HSPA5;TH
15409,GO:0071715,0.130498418450499,0.958237931633819,4,19,icosanoid transport,BP,NTSR1;PLA2G6;PLA2R1;ABCC2
17666,GO:1901571,0.130498418450499,0.958237931633819,4,19,fatty acid derivative transport,BP,NTSR1;PLA2G6;PLA2R1;ABCC2
11059,GO:0045080,0.130697149459137,0.979382118393697,2,7,positive regulation of chemokine biosynthetic process,BP,TLR3;EGR1
1100,GO:0002690,0.13075723716387,0.940390492735539,7,49,positive regulation of leukocyte chemotaxis,BP,GAS6;SERPINE1;CXCL14;ANO6;CALR;MOSPD2;ADAM10
1685,GO:0004157,0.130776331535915,1,1,1,dihydropyrimidinase activity,MF,DPYSL2
3464,GO:0007286,0.130816444502227,0.928991603084205,11,69,spermatid development,BP,HSPA2;RFX2;SMARCA2;BBS2;CCDC136;BBS4;FNDC3A;ODF2;GOPC;TPGS1;DNAH1
18661,GO:1904037,0.130846809110631,0.958718470824582,4,17,positive regulation of epithelial cell apoptotic process,BP,GSN;PDCD4;COL18A1;ANO6
12289,GO:0048663,0.130865972784336,0.951733100614585,5,23,neuron fate commitment,BP,BMP4;GLI3;GLI2;ISL1;DLX2
7910,GO:0032496,0.131006579983018,0.910589112618989,25,200,response to lipopolysaccharide,BP,TNFRSF6B;F2R;NOS1;AXL;SERPINE1;ABCA1;VDR;NR1D1;TRIM5;PDCD4;PYCARD;PTGES;CPS1;SNCA;PDE4D;IL18;PRKCA;ABCC2;CDK19;TH;SRR;SASH1;RARA;FOS;LITAF
498,GO:0001554,0.131071416504643,0.981688642154895,2,5,luteolysis,BP,MMP19;SLIT3
600,GO:0001768,0.131220430653478,0.98165493961448,2,5,establishment of T cell polarity,BP,GSN;FLOT2
16690,GO:0097718,0.131264863387959,0.945843649780168,6,30,disordered domain specific binding,MF,FN1;GJA5;HSPA2;TP53;FYN;MDM2
16454,GO:0097168,0.131363157990781,1,1,1,mesenchymal stem cell proliferation,BP,LTBP3
17973,GO:1902460,0.131363157990781,1,1,1,regulation of mesenchymal stem cell proliferation,BP,LTBP3
17974,GO:1902462,0.131363157990781,1,1,1,positive regulation of mesenchymal stem cell proliferation,BP,LTBP3
12638,GO:0050869,0.131380158982797,0.958487562972175,4,17,negative regulation of B cell activation,BP,INPP5D;SFRP1;ATM;BCL6
17975,GO:1902463,0.131411766774043,0.995377226292364,1,2,protein localization to cell leading edge,BP,RAB13
12025,GO:0047894,0.131533075847609,0.995368375272593,1,2,flavonol 3-sulfotransferase activity,MF,SULT1E1
10241,GO:0042999,0.131548289724054,1,1,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,GOPC
10244,GO:0043002,0.131548289724054,1,1,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,GOPC
10245,GO:0043004,0.131548289724054,1,1,1,cytoplasmic sequestering of CFTR protein,BP,GOPC
657,GO:0001849,0.131633155423903,0.995361066372115,1,2,complement component C1q binding,MF,CALR
7634,GO:0032056,0.131663851313967,0.980117045525278,2,6,positive regulation of translation in response to stress,BP,EIF2AK4;DNAJC3
15432,GO:0071800,0.13167227594765,0.958360929186211,4,17,podosome assembly,BP,GSN;ASAP1;FSCN1;ARHGEF2
4644,GO:0010771,0.131749946845897,0.928680215087569,11,64,negative regulation of cell morphogenesis involved in differentiation,BP,PTPRS;SEMA5A;ULK2;FBLN1;SEMA4A;NFATC4;EFNB3;SEMA4B;POSTN;EFNA5;PPP3CA
7096,GO:0030903,0.131787154160861,0.967685153215421,3,11,notochord development,BP,GLI2;SOX9;YAP1
8944,GO:0035025,0.131916640770171,0.967075245950234,3,12,positive regulation of Rho protein signal transduction,BP,F2R;ROBO1;AKAP13
2616,GO:0005930,0.131995115339098,0.928586813929897,11,63,axoneme,CC,EFHC1;WDR66;GLI3;GLI2;KIF17;IFT140;BBS1;TCTEX1D4;CFAP54;DNAH1;SEPT9
13006,GO:0051489,0.132227308373809,0.945333348410966,6,30,regulation of filopodium assembly,BP,ARAP1;DOCK11;ESPN;FSCN1;ARF6;AGRN
3377,GO:0007157,0.13247214278651,0.957370714055036,4,19,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,FAT4;TENM4;AMIGO2;TENM3
11854,GO:0046885,0.132548918727897,0.957638384607401,4,18,regulation of hormone biosynthetic process,BP,VDR;DGKQ;EGR1;TRERF1
4537,GO:0010615,0.132617703485911,1,1,1,positive regulation of cardiac muscle adaptation,BP,PPP3CA
18290,GO:1903244,0.132617703485911,1,1,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,PPP3CA
19139,GO:1905205,0.132617703485911,1,1,1,positive regulation of connective tissue replacement,BP,PPP3CA
10997,GO:0044853,0.13271047790958,0.928262362468335,11,61,plasma membrane raft,CC,FLOT1;F2R;TGFBR2;NOS1;KCNMA1;CAV1;DLC1;FLOT2;MYOF;CDH13;EFNA5
2288,GO:0005248,0.132759089410015,0.968922364565312,3,9,voltage-gated sodium channel activity,MF,PKD2;SCN8A;SCN2A
743,GO:0001975,0.132767524099471,0.967334839389017,3,11,response to amphetamine,BP,TH;PPP3CA;OXTR
19343,GO:1905809,0.132775926596216,0.967331831312884,3,11,negative regulation of synapse organization,BP,FYN;NFATC4;PRNP
6999,GO:0030695,0.132786878615566,0.903296541906532,36,248,GTPase regulator activity,MF,ASAP3;ARHGAP23;ALS2CL;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;ARHGEF1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;ARHGEF12;ARHGAP18;DLC1;RGS2;SRGAP1;TBC1D19;RGS14;DEPDC7;CDC42EP5;AGAP1;GOPC;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;TBC1D16;RASA1;ARHGAP31;DOCK1
1016,GO:0002514,0.132823466441885,1,1,1,B cell tolerance induction,BP,TGFBR2
1075,GO:0002649,0.132823466441885,1,1,1,regulation of tolerance induction to self antigen,BP,TGFBR2
1076,GO:0002651,0.132823466441885,1,1,1,positive regulation of tolerance induction to self antigen,BP,TGFBR2
1078,GO:0002661,0.132823466441885,1,1,1,regulation of B cell tolerance induction,BP,TGFBR2
1079,GO:0002663,0.132823466441885,1,1,1,positive regulation of B cell tolerance induction,BP,TGFBR2
2178,GO:0005026,0.132823466441885,1,1,1,transforming growth factor beta receptor activity, type II,MF,TGFBR2
19183,GO:1905317,0.132823466441885,1,1,1,inferior endocardial cushion morphogenesis,BP,TGFBR2
19724,GO:2000136,0.133067978631305,0.96722721792248,3,11,regulation of cell proliferation involved in heart morphogenesis,BP,BMP4;SOX9;ISL1
4344,GO:0009913,0.133218432146347,0.909720027390942,24,187,epidermal cell differentiation,BP,KRT4;TXNIP;CD109;ZFP36L1;SLITRK6;TCHH;KRT14;VDR;BMP4;KRT13;KRT5;PPL;FLG;KRT15;CTSV;CASP14;FGFR1;ALOX15B;TRIOBP;LRTOMT;FLNB;IFT74;YAP1;KRT10
13451,GO:0055015,0.133249521327054,0.978730583001589,2,7,ventricular cardiac muscle cell development,BP,LMNA;MEF2A
15534,GO:0072012,0.133263320385902,0.966585791707948,3,12,glomerulus vasculature development,BP,ACTA2;BMP4;EGR1
18620,GO:1903959,0.133277123907082,0.957663142918479,4,17,regulation of anion transmembrane transport,BP,IRS2;TCAF1;PRNP;GOPC
2282,GO:0005242,0.13331440959022,0.978713911609531,2,7,inward rectifier potassium channel activity,MF,KCNJ15;KCNJ5
11809,GO:0046777,0.133382367404447,0.908531993035035,26,172,protein autophosphorylation,BP,TNIK;PDGFC;EGFR;PAK1;PTK6;EIF2AK4;WNK1;PDGFA;GPNMB;SIK1;FYN;CAV1;ULK2;CAMK2D;DAPK1;CHEK2;FGFR1;IGF1R;ENG;ATM;ENPP1;STK16;MAP3K12;ULK1;TAF1;TAOK3
5374,GO:0016198,0.133423712435822,0.981153634631529,2,5,axon choice point recognition,BP,ROBO1;EFNB3
3161,GO:0006775,0.133432689820566,0.956020696006329,4,23,fat-soluble vitamin metabolic process,BP,SNAI2;VDR;FGFR1;CBR1
4453,GO:0010430,0.13355326079077,1,1,1,fatty acid omega-oxidation,BP,CYP4V2
10005,GO:0042462,0.133621390376303,0.966455233103448,3,12,eye photoreceptor cell development,BP,NAGLU;BBS4;TH
3829,GO:0008434,0.133696156321248,1,1,1,calcitriol receptor activity,MF,VDR
9713,GO:0038181,0.133696156321248,1,1,1,bile acid receptor activity,MF,VDR
9714,GO:0038183,0.133696156321248,1,1,1,bile acid signaling pathway,BP,VDR
9715,GO:0038186,0.133696156321248,1,1,1,lithocholic acid receptor activity,MF,VDR
17838,GO:1902098,0.133696156321248,1,1,1,calcitriol binding,MF,VDR
17853,GO:1902121,0.133696156321248,1,1,1,lithocholic acid binding,MF,VDR
17913,GO:1902271,0.133696156321248,1,1,1,D3 vitamins binding,MF,VDR
3823,GO:0008427,0.133744319150804,0.99520544330599,1,2,calcium-dependent protein kinase inhibitor activity,MF,CAMK2N1
4695,GO:0010858,0.133744319150804,0.99520544330599,1,2,calcium-dependent protein kinase regulator activity,MF,CAMK2N1
1391,GO:0003306,0.133774830725083,0.979600259210361,2,6,Wnt signaling pathway involved in heart development,BP,DKK1;VANGL2
19927,GO:2000501,0.133935233869264,0.995191234119674,1,2,regulation of natural killer cell chemotaxis,BP,CXCL14
19928,GO:2000503,0.133935233869264,0.995191234119674,1,2,positive regulation of natural killer cell chemotaxis,BP,CXCL14
10755,GO:0044228,0.134022308126102,1,1,1,host cell surface,CC,AXL
9575,GO:0036445,0.13417585653044,0.967539620903914,3,10,neuronal stem cell division,BP,FGFR1;ARHGEF2;LEF1
13467,GO:0055057,0.13417585653044,0.967539620903914,3,10,neuroblast division,BP,FGFR1;ARHGEF2;LEF1
17228,GO:0120043,0.134188675171349,1,1,1,stereocilium shaft,CC,TRIOBP
17229,GO:0120044,0.134188675171349,1,1,1,stereocilium base,CC,TRIOBP
244,GO:0000701,0.134414455366213,0.995155467602012,1,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,MUTYH
13630,GO:0060171,0.134420588771861,1,1,1,stereocilium membrane,CC,MYO1C
6492,GO:0021861,0.134730402605328,0.978348782037166,2,7,forebrain radial glial cell differentiation,BP,GLI3;LEF1
2174,GO:0005011,0.134799093887357,1,1,1,macrophage colony-stimulating factor receptor activity,MF,MST1R
18235,GO:1903115,0.134802295100305,0.950376078231442,5,21,regulation of actin filament-based movement,BP,GJA5;PDPN;CAV1;CAMK2D;PDE4D
7806,GO:0032370,0.134820368157216,0.943471658905794,6,33,positive regulation of lipid transport,BP,NTSR1;ABCA1;LRP1;PLA2G6;PLA2R1;ANXA2
16382,GO:0097045,0.134831862567692,1,1,1,phosphatidylserine exposure on blood platelet,BP,ANO6
17925,GO:1902304,0.134831862567692,1,1,1,positive regulation of potassium ion export,BP,ANO6
9877,GO:0042177,0.134919391208152,0.920137191594472,14,97,negative regulation of protein catabolic process,BP,SERPINE2;EGFR;TIMP2;TIMP1;FYN;SNCA;CST3;ANXA2;OPHN1;ATRAID;DERL3;PTPN3;TAF1;CDK5RAP3
13645,GO:0060200,0.135304450303604,1,1,1,clathrin-sculpted acetylcholine transport vesicle,CC,SYT1
13646,GO:0060201,0.135304450303604,1,1,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,SYT1
16811,GO:0098746,0.135304450303604,1,1,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,SYT1
12587,GO:0050795,0.13549684564753,0.949464863851427,5,23,regulation of behavior,BP,EIF2AK4;DLG4;HOXA1;LEPR;HTR1B
292,GO:0000797,0.135595412111435,1,1,1,condensin core heterodimer,CC,NCAPD2
13982,GO:0060732,0.13567801696808,0.979129683326343,2,6,positive regulation of inositol phosphate biosynthetic process,BP,NTSR1;SNCA
12406,GO:0048934,0.13604661695097,0.979038034607214,2,6,peripheral nervous system neuron differentiation,BP,ETV1;ISL1
12407,GO:0048935,0.13604661695097,0.979038034607214,2,6,peripheral nervous system neuron development,BP,ETV1;ISL1
8055,GO:0032736,0.136091969856196,0.977995297849887,2,7,positive regulation of interleukin-13 production,BP,PRKCZ;RARA
18053,GO:1902679,0.136189989736937,0.885942594220117,110,924,negative regulation of RNA biosynthetic process,BP,TXNIP;SOX6;SFRP1;GAS6;SNAI2;MAGED1;PHF21A;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;NR1D1;SMARCA2;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;UHRF2;WFS1;MDFI;JARID2;TP73;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;CDKN2A;SP100;MDFIC;ZNF12;YAP1;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;RARA;HES2;TAF1;TSHZ3;ZBTB1;KDM4A;NIPBL;PRDM5;RXRA
18400,GO:1903507,0.136189989736937,0.885942594220117,110,924,negative regulation of nucleic acid-templated transcription,BP,TXNIP;SOX6;SFRP1;GAS6;SNAI2;MAGED1;PHF21A;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;NR1D1;SMARCA2;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;UHRF2;WFS1;MDFI;JARID2;TP73;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;CDKN2A;SP100;MDFIC;ZNF12;YAP1;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;RARA;HES2;TAF1;TSHZ3;ZBTB1;KDM4A;NIPBL;PRDM5;RXRA
16498,GO:0097242,0.136340789506302,0.957738530485077,4,14,amyloid-beta clearance,BP,LRP1;CLU;MME;IGF1R
15245,GO:0071455,0.136419632205416,0.978945119810822,2,6,cellular response to hyperoxia,BP,CAV1;PPARG
7386,GO:0031460,0.136568443789129,1,1,1,glycine betaine transport,BP,SLC38A2
12328,GO:0048714,0.136588246256425,0.965366747423291,3,12,positive regulation of oligodendrocyte differentiation,BP,TENM4;TP73;PPARG
14638,GO:0070268,0.136631662622964,0.927072889291142,10,74,cornification,BP,KRT4;TCHH;KRT14;KRT13;KRT5;PPL;FLG;KRT15;CASP14;KRT10
3520,GO:0007497,0.136670978330928,1,1,1,posterior midgut development,BP,RET
6890,GO:0030449,0.13692069134952,0.964753513860016,3,13,regulation of complement activation,BP,CLU;SERPING1;C5
19784,GO:2000257,0.13692069134952,0.964753513860016,3,13,regulation of protein activation cascade,BP,CLU;SERPING1;C5
1507,GO:0003867,0.136945965992052,1,1,1,4-aminobutyrate transaminase activity,MF,ABAT
4841,GO:0014053,0.136945965992052,1,1,1,negative regulation of gamma-aminobutyric acid secretion,BP,ABAT
7681,GO:0032144,0.136945965992052,1,1,1,4-aminobutyrate transaminase complex,CC,ABAT
7682,GO:0032145,0.136945965992052,1,1,1,succinate-semialdehyde dehydrogenase binding,MF,ABAT
8450,GO:0033602,0.136945965992052,1,1,1,negative regulation of dopamine secretion,BP,ABAT
8722,GO:0034386,0.136945965992052,1,1,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,ABAT
11962,GO:0047298,0.136945965992052,1,1,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,ABAT
14308,GO:0061528,0.136945965992052,1,1,1,aspartate secretion,BP,ABAT
18818,GO:1904448,0.136945965992052,1,1,1,regulation of aspartate secretion,BP,ABAT
18819,GO:1904450,0.136945965992052,1,1,1,positive regulation of aspartate secretion,BP,ABAT
8584,GO:0034109,0.137219265949417,0.930273719846829,9,54,homotypic cell-cell adhesion,BP,SERPINE2;GAS6;LGALS1;SLC7A11;PDPN;ANK3;PTPRU;PRKCA;ABAT
6373,GO:0021566,0.137367237456361,1,1,1,hypoglossal nerve development,BP,ADARB1
6395,GO:0021618,0.137367237456361,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
6337,GO:0021517,0.13745530006571,0.955830067461383,4,17,ventral spinal cord development,BP,GLI3;GLI2;LMO4;ISL1
10497,GO:0043433,0.137490802392424,0.913862039420492,17,120,negative regulation of DNA binding transcription factor activity,BP,PKD2;GAS6;EIF2AK4;DDIT3;PYCARD;SIK1;WFS1;MDFI;CAT;PRNP;MAP2K5;THRA;CDKN2A;SP100;TAF1;CDK5RAP3;NFKBIE
19747,GO:2000181,0.137754943053069,0.924914219725777,11,62,negative regulation of blood vessel morphogenesis,BP,THBS2;SERPINE1;PTPRM;STAT1;XDH;SPRY2;SEMA4A;SULF1;TGFB2;MAP2K5;PPARG
6668,GO:0030037,0.137831171919582,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
3236,GO:0006893,0.137910035977224,0.933380851700965,8,45,Golgi to plasma membrane transport,BP,ACSL3;OSBPL5;BBS2;ANK3;BBS1;GOPC;CHIC2;STEAP2
6901,GO:0030501,0.137949296129216,0.948252126144374,5,23,positive regulation of bone mineralization,BP,FBN2;SLC8A1;BMP4;ANO6;ATRAID
14580,GO:0070169,0.137949296129216,0.948252126144374,5,23,positive regulation of biomineral tissue development,BP,FBN2;SLC8A1;BMP4;ANO6;ATRAID
9359,GO:0035904,0.138160771467504,0.937967987334534,7,33,aorta development,BP,PKD2;MYLK;PRICKLE1;LTBP1;LRP1;ENG;TGFB2
3273,GO:0006954,0.138166800427546,0.89574370145888,43,360,inflammatory response,BP,ITGB6;TNFRSF6B;FN1;F2R;PTGS1;IL20RB;AXL;EGFR;SERPINE1;NUPR1;PSTPIP1;PDCD4;PYCARD;ITGA2;ANO6;GPX1;PTGES;CLU;SERPING1;PRKCZ;PARP4;PRDX5;IL31RA;PER1;TLR3;SNCA;C5;TGM2;IL18;IL17RE;AFAP1L2;NFATC4;PLGRKT;ISL1;BCL6;PRCP;IGFBP4;LIPA;CDK19;PPARG;CALCRL;TPST1;FOS
15381,GO:0071675,0.138199753411816,0.954062762499473,4,22,regulation of mononuclear cell migration,BP,SERPINE1;ANO6;MOSPD2;LGALS3
2967,GO:0006508,0.138261517288712,0.881741981213411,142,1256,proteolysis,BP,SERPINE2;CPA4;TNFRSF6B;MMP2;PRSS23;HTRA1;FN1;MMP9;CCBE1;CTGF;ADAM19;SFRP1;MMP28;CD109;F2R;ADAMTSL1;TENM4;GSN;ANPEP;SKP2;COL7A1;GAS6;TFPI2;CLCA2;SERPINE1;SERPINH1;RNF213;RNF165;DDB2;TIMP2;TADA3;TENM3;PCSK1;NR1D1;ABTB1;BTBD2;SORL1;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;PYCARD;MMP19;MICAL1;TIMP1;HIP1;CRIM1;CUL7;TYSND1;GPX1;GLI3;ERO1B;CTSV;FYN;IFI6;XDH;LTBP4;CPS1;CAV1;RNF135;TRIB2;SEL1L;SNX33;CLU;SERPING1;FBXW4;PRDX5;CCK;HERPUD1;WFS1;APLP2;FBLN1;CASP14;DAPK1;DLC1;PRKACB;BACE1;ROBO1;FBXL7;SNCA;ADAMTS7;MME;THSD4;GLG1;C5;TMEM129;PSMB9;MAGEF1;APH1B;MDM2;CST3;GCLC;RNPEP;PLGRKT;PRCP;AMZ2;ADAMTS15;RNF24;MVB12B;ANAPC16;PRNP;RET;MAP2K5;GGT7;LEF1;DPP9;USP28;SPPL2B;NPEPL1;RHBDD1;HSPA5;TGFB1I1;RHBDD2;OPHN1;PGPEP1;NUB1;KLHL3;UBA7;DERL3;PPARG;RNF144B;SNX9;PTPN3;DNAJC3;TMEM67;TAF1;SENP7;CAPN6;SERPINB5;SCPEP1;CAMK2N1;FBXL4;UGGT2;VPS36;ADAM10;RNPEPL1;EDEM1;GID4;CTSD;ZNRF1
519,GO:0001605,0.138275630430462,1,1,1,adrenomedullin receptor activity,MF,CALCRL
2136,GO:0004948,0.138275630430462,1,1,1,calcitonin receptor activity,MF,CALCRL
15157,GO:0071324,0.138275630430462,1,1,1,cellular response to disaccharide stimulus,BP,CALCRL
15159,GO:0071329,0.138275630430462,1,1,1,cellular response to sucrose stimulus,BP,CALCRL
18247,GO:1903143,0.138275630430462,1,1,1,adrenomedullin receptor complex,CC,CALCRL
19496,GO:1990409,0.138275630430462,1,1,1,adrenomedullin binding,MF,CALCRL
2184,GO:0005042,0.138367107597482,1,1,1,netrin receptor activity,MF,UNC5B
1603,GO:0004028,0.138414972176021,0.977386814292058,2,7,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH3A2;ALDH9A1
17724,GO:1901699,0.138439807172766,0.891206721646335,59,449,cellular response to nitrogen compound,BP,FLOT1;MMP2;FBN1;SFRP1;ZFP36L1;COL5A2;PKD2;IRS2;PDGFC;EGFR;SLC8A1;SESN3;PAK1;BMP4;STAT1;GNG2;TP53;IFIT1;ZCCHC11;SESN1;LRP1;FYN;CPS1;CAV1;PRKCZ;PXN;PIK3R1;TMEM173;PRKACB;TLR3;SNCA;COL16A1;IGF1R;PDE4D;MDM2;GCLC;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;ENPP1;NCOR1;RAB13;HTR1B;PRNP;AGRN;HSPA5;TH;ITPR2;CACNB1;KLF5;PPARG;COL4A1;TAF1;PPP3CA;AGO4;MYO1C;C2CD5
11711,GO:0046546,0.138521002779333,0.917819761355782,14,92,development of primary male sexual characteristics,BP,SFRP1;NUPR1;KITLG;CTSV;TLR3;CST3;CITED2;SOX9;RAB13;FNDC3A;TGFB2;RARA;AGO4;RHOBTB3
10470,GO:0043392,0.138581214885842,0.936718686480821,7,40,negative regulation of DNA binding,BP,DDIT3;ZFP90;HMGA2;MDFI;LEF1;SP100;TAF1
5686,GO:0016812,0.138587069797175,0.979956956946383,2,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,DPYSL2;CPS1
2192,GO:0005055,0.138635772176174,0.994834242365654,1,2,laminin receptor activity,MF,BCAM
12722,GO:0051017,0.138700656152529,0.91324065933723,17,111,actin filament bundle assembly,BP,ITGB5;CTGF;SFRP1;RHOBTB2;ASAP3;S100A10;PAK1;ARAP1;ESPN;PXN;PIK3R1;DLC1;FSCN1;TRIOBP;BBS4;FHOD1;LIMA1
15078,GO:0071158,0.13873097938633,0.923424856277887,11,77,positive regulation of cell cycle arrest,BP,PKD2;TP53;TFDP2;E2F7;HMGA2;UHRF2;TP73;CHEK2;ATM;MDM2;RBL2
623,GO:0001807,0.138748624939183,0.994825502235802,1,2,regulation of type IV hypersensitivity,BP,IL20RB
14162,GO:0061097,0.138822599025905,0.929053602359757,9,57,regulation of protein tyrosine kinase activity,BP,GPRC5A;GAS6;PTK6;DLG4;CAV1;ERCC6;AFAP1L2;PTPN1;PRNP
7769,GO:0032304,0.138837188835328,1,1,1,negative regulation of icosanoid secretion,BP,PLA2R1
17375,GO:1900139,0.138837188835328,1,1,1,negative regulation of arachidonic acid secretion,BP,PLA2R1
12665,GO:0050909,0.138865001611584,0.963243818012042,3,15,sensory perception of taste,BP,SCNN1A;LEF1;REEP2
18045,GO:1902652,0.139033273857957,0.915655403194216,15,104,secondary alcohol metabolic process,BP,ABCA1;SORL1;SEC14L2;OSBPL5;ACACB;CAT;FGFR1;G6PD;DGKQ;TRERF1;LEPR;OSBPL1A;LMF1;RXRA;ACAA2
6495,GO:0021871,0.139195423978111,0.965005863941058,3,11,forebrain regionalization,BP,BMP4;GLI3;PGAP1
1293,GO:0003127,0.139198261118983,1,1,1,detection of nodal flow,BP,PKD2
12350,GO:0048763,0.139198261118983,1,1,1,calcium-induced calcium release activity,MF,PKD2
15252,GO:0071464,0.139198261118983,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15555,GO:0072055,0.139198261118983,1,1,1,renal cortex development,BP,PKD2
15556,GO:0072059,0.139198261118983,1,1,1,cortical collecting duct development,BP,PKD2
15642,GO:0072194,0.139198261118983,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15653,GO:0072208,0.139198261118983,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15657,GO:0072214,0.139198261118983,1,1,1,metanephric cortex development,BP,PKD2
15662,GO:0072219,0.139198261118983,1,1,1,metanephric cortical collecting duct development,BP,PKD2
12036,GO:0048008,0.139377627149476,0.932967681433105,8,41,platelet-derived growth factor receptor signaling pathway,BP,TXNIP;PDGFC;PDGFA;HIP1;LRP1;SNCA;PTPN1;RGS14
4987,GO:0015127,0.139392829190994,1,1,1,bilirubin transmembrane transporter activity,MF,ABCC2
5151,GO:0015694,0.139392829190994,1,1,1,mercury ion transport,BP,ABCC2
5166,GO:0015723,0.139392829190994,1,1,1,bilirubin transport,BP,ABCC2
6970,GO:0030653,0.139392829190994,1,1,1,beta-lactam antibiotic metabolic process,BP,ABCC2
9934,GO:0042316,0.139392829190994,1,1,1,penicillin metabolic process,BP,ABCC2
17522,GO:1901086,0.139392829190994,1,1,1,benzylpenicillin metabolic process,BP,ABCC2
719,GO:0001946,0.139508524214744,0.965639254762316,3,10,lymphangiogenesis,BP,CCBE1;PDPN;PTPN14
736,GO:0001968,0.139835111698665,0.954410496159661,4,18,fibronectin binding,MF,CTGF;ITGA3;CCDC80;FBLN1
15720,GO:0072338,0.139842341449917,0.979661409668218,2,5,cellular lactam metabolic process,BP,MME;ABCC2
11423,GO:0045893,0.139940313446696,0.88116655143678,129,1049,positive regulation of transcription, DNA-templated,BP,SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;ETV5;PKD2;NOS1;MAGED1;EGFR;RFX2;SERPINE1;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;TFDP2;NFIX;GLI3;E2F7;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;SMARCA1;ZNF318;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;MEIS2;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
18401,GO:1903508,0.139940313446696,0.88116655143678,129,1049,positive regulation of nucleic acid-templated transcription,BP,SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;ETV5;PKD2;NOS1;MAGED1;EGFR;RFX2;SERPINE1;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;TFDP2;NFIX;GLI3;E2F7;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;SMARCA1;ZNF318;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;MEIS2;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
19685,GO:2000050,0.140241971322976,0.955013216804919,4,16,regulation of non-canonical Wnt signaling pathway,BP,SFRP1;RNF213;DKK1;NPHP3
10664,GO:0043950,0.140529986810512,0.979498742483916,2,5,positive regulation of cAMP-mediated signaling,BP,NOS1;PRKCA
13619,GO:0060155,0.140556202992577,0.976819931140795,2,7,platelet dense granule organization,BP,F2R;ABCA1
7064,GO:0030863,0.140653576904554,0.916936319431909,14,79,cortical cytoskeleton,CC,FLOT1;GSN;UTRN;SPTB;DLG4;HIP1;PCLO;SHROOM4;DLC1;FLOT2;TRIOBP;AKAP13;WIPF1;BSN
14718,GO:0070418,0.14082344751353,1,1,1,DNA-dependent protein kinase complex,CC,UVRAG
2246,GO:0005160,0.140852981043226,0.946314859420769,5,25,transforming growth factor beta receptor binding,MF,TGFBR2;BMP4;TGFBR3;ENG;TGFB2
5572,GO:0016595,0.141053638695431,0.977776743689546,2,6,glutamate binding,MF,CPS1;GCLC
11343,GO:0045726,0.141150284799148,1,1,1,positive regulation of integrin biosynthetic process,BP,TGFB2
13199,GO:0051891,0.141150284799148,1,1,1,positive regulation of cardioblast differentiation,BP,TGFB2
18495,GO:1903701,0.141150284799148,1,1,1,substantia propria of cornea development,BP,TGFB2
15202,GO:0071387,0.141229909066819,1,1,1,cellular response to cortisol stimulus,BP,KLF9
840,GO:0002154,0.141509016123889,0.979266213416351,2,5,thyroid hormone mediated signaling pathway,BP,PRCP;THRA
16901,GO:0098909,0.141754893565943,0.979207642991397,2,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,CAV1;CAMK2D
8964,GO:0035088,0.14176721652969,0.940029106212404,6,31,establishment or maintenance of apical/basal cell polarity,BP,DLG4;DLG5;FSCN1;VANGL2;OPHN1;MYO9A
14215,GO:0061245,0.14176721652969,0.940029106212404,6,31,establishment or maintenance of bipolar cell polarity,BP,DLG4;DLG5;FSCN1;VANGL2;OPHN1;MYO9A
15563,GO:0072074,0.141879480873525,0.963395912108156,3,12,kidney mesenchyme development,BP,PKD2;BMP4;STAT1
14774,GO:0070528,0.141911328473025,0.953149856543041,4,19,protein kinase C signaling,BP,FLOT1;PLA2G6;PRKCZ;DGKQ
18054,GO:1902680,0.142048603814932,0.879280207853491,129,1050,positive regulation of RNA biosynthetic process,BP,SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;ETV5;PKD2;NOS1;MAGED1;EGFR;RFX2;SERPINE1;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;TFDP2;NFIX;GLI3;E2F7;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;SMARCA1;ZNF318;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;MEIS2;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
796,GO:0002066,0.142073350783062,0.934827385021736,7,39,columnar/cuboidal epithelial cell development,BP,SLITRK6;BMP4;FGFR1;TRIOBP;LRTOMT;KLF5;RARA
7480,GO:0031659,0.142127239900174,0.979118814938411,2,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,PKD2;EGFR
7651,GO:0032091,0.142245111781965,0.921055265964771,11,78,negative regulation of protein binding,BP,SORL1;IFIT2;IFIT1;CAV1;DKK1;NFATC4;ISL1;ZFPM1;LEF1;HSPA5;TTBK2
16366,GO:0097014,0.142353557004488,0.921759074854796,11,64,ciliary plasm,CC,EFHC1;WDR66;GLI3;GLI2;KIF17;IFT140;BBS1;TCTEX1D4;CFAP54;DNAH1;SEPT9
8582,GO:0034104,0.142375989212146,0.963209043235918,3,12,negative regulation of tissue remodeling,BP,INPP5D;SFRP1;CST3
10711,GO:0044089,0.142460177659396,0.89011968492466,50,381,positive regulation of cellular component biogenesis,BP,FLOT1;FLRT2;CTGF;SFRP1;SLITRK6;GSN;FLRT3;THBS2;S100A10;DDB2;AMIGO2;PAK1;TP53;ARAP1;PYCARD;PHLDB1;TPBG;DLG5;ASAP1;CAV1;DOCK11;ESPN;CLU;NPHP4;ARPIN;PXN;CCK;COL16A1;FSCN1;RGS2;SETX;BBS4;ATM;ARF6;SOX9;PRKCA;MPP7;CDC42EP5;LRRN3;ULK1;AGRN;FHOD1;SNX9;TAF1;EFNA5;SLITRK5;WIPF1;SEPT9;OXTR;MYO1C
19805,GO:2000297,0.142667472500263,1,1,1,negative regulation of synapse maturation,BP,NFATC4
4033,GO:0009069,0.142726063851972,0.944296013299808,5,31,serine family amino acid metabolic process,BP,PHGDH;GLDC;GCLC;THNSL2;SRR
10872,GO:0044433,0.142789011137498,0.879287054076519,119,1038,cytoplasmic vesicle part,CC,SYT8;FN1;PCDH7;PYGB;MMP9;GPRC5A;CD109;GSN;PKD2;ANPEP;CLTCL1;GAS6;MAP6;EGFR;SLC2A3;SERPINE1;TIMP2;NSG1;PCSK1;SORL1;PTPRS;PYCARD;DLG4;PDGFA;TIMP1;HIP1;SNX1;ANO6;TBC1D5;SYN1;MAGED2;KCNAB2;LRP1;CAV1;SNX33;AHNAK2;CLU;SERPING1;CXCR1;ULK2;EHD3;CAMK2D;METTL7A;SYT1;TMEM173;DYSF;APLP2;CAT;BACE1;LRIG3;STOM;TLR3;SNCA;FLOT2;MME;VAMP1;FZD7;DKK1;MLEC;SEC24D;MYOF;CCDC136;LAPTM4A;MTMR4;CALR;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;AREG;ANXA6;SNX10;CD1D;KLHL12;SLC48A1;PRCP;NFASC;NDRG1;TMEM175;ANXA2;RAB13;MAN2B1;MVB12B;MOSPD2;RAB43;RET;TGFB2;VPS39;DNASE1L1;GPR161;C2CD4C;SPPL2B;TH;GOPC;SNX7;PIKFYVE;NAPRT;ITPR2;SNX9;LGALS3;DNAJC3;RASSF9;SV2A;ABCA2;TMEM67;FZD4;STEAP2;ACTR1B;VPS36;ADAM10;LITAF;S100A11;MYO1C;C2CD5;ABCA5;CTSD;ZNRF1
10572,GO:0043560,0.142942702350761,0.964395568678265,3,10,insulin receptor substrate binding,MF,PRKCZ;PIK3R1;IGF1R
16781,GO:0098659,0.142958293928296,0.939379758472203,6,31,inorganic cation import across plasma membrane,BP,SLC8A1;FYN;KCNJ5;PRNP;SLC9A4;STEAP2
17047,GO:0099587,0.142958293928296,0.939379758472203,6,31,inorganic ion import across plasma membrane,BP,SLC8A1;FYN;KCNJ5;PRNP;SLC9A4;STEAP2
19750,GO:2000192,0.143029582530905,0.97890289262941,2,5,negative regulation of fatty acid transport,BP,IRS2;PLA2R1
7923,GO:0032511,0.143057977733371,0.97534241003891,2,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,TMEM50B;VPS36
16799,GO:0098722,0.143068833523607,0.977260535635016,2,6,asymmetric stem cell division,BP,ETV5;ARHGEF2
2254,GO:0005170,0.143097718345493,1,1,1,neurotrophin TRKC receptor binding,MF,EFNA5
1084,GO:0002673,0.143232578687441,0.944339339738202,5,29,regulation of acute inflammatory response,BP,IL20RB;CLU;SERPING1;C5;PPARG
12142,GO:0048284,0.143263293240969,0.906002657622253,20,145,organelle fusion,BP,SYT8;SAMD9L;TBC1D8;VAV3;EVI5L;TBC1D5;SPG11;SYTL1;SYT1;DYSF;VAMP1;CALR;TMEM175;ANXA2;RAB13;VPS39;C2CD4C;UVRAG;TBC1D16;C2CD5
905,GO:0002291,0.143263595102089,0.994469282848593,1,2,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
19935,GO:2000520,0.143263595102089,0.994469282848593,1,2,regulation of immunological synapse formation,BP,LGALS3
19936,GO:2000521,0.143263595102089,0.994469282848593,1,2,negative regulation of immunological synapse formation,BP,LGALS3
20218,GO:2001188,0.143263595102089,0.994469282848593,1,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
20219,GO:2001189,0.143263595102089,0.994469282848593,1,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,LGALS3
16127,GO:0090175,0.143275431478452,0.914187286059952,14,101,regulation of establishment of planar polarity,BP,SFRP1;ROR1;PRICKLE1;FZD7;DKK1;PSMB9;FZD1;VANGL2;NPHP3;MAGI2;ARHGEF19;FZD4;MED12;CELSR1
4342,GO:0009898,0.143448491005207,0.908440992811693,18,120,cytoplasmic side of plasma membrane,CC,SPTB;NTSR1;PTK6;GNG2;DLG4;HIP1;KCNAB2;FYN;SHROOM4;RGS2;ESYT2;G6PD;TH;SNX9;PTPN3;PPP3CA;RASA1;LITAF
3567,GO:0007613,0.143472221190027,0.921021823724289,11,64,memory,BP,EIF2AK4;NETO1;ITGA3;PLA2G6;PRKCZ;CRTC1;RGS14;ATXN1;PRNP;TH;OXTR
15649,GO:0072203,0.143583205668383,0.977127988983349,2,6,cell proliferation involved in metanephros development,BP,STAT1;EGR1
19788,GO:2000270,0.143589975852751,0.977126242269522,2,6,negative regulation of fibroblast apoptotic process,BP,SFRP1;GAS6
10563,GO:0043548,0.143749616508207,0.945965700580032,5,21,phosphatidylinositol 3-kinase binding,MF,IRS2;AXL;FYN;PIK3R1;IGF1R
9120,GO:0035469,0.143909017274704,1,1,1,determination of pancreatic left/right asymmetry,BP,NPHP3
15494,GO:0071908,0.143909017274704,1,1,1,determination of intestine left/right asymmetry,BP,NPHP3
15495,GO:0071909,0.143909017274704,1,1,1,determination of stomach left/right asymmetry,BP,NPHP3
19737,GO:2000167,0.143909017274704,1,1,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,NPHP3
8236,GO:0033026,0.143943796861186,1,1,1,negative regulation of mast cell apoptotic process,BP,KITLG
14796,GO:0070562,0.144030322361909,0.977012513631845,2,6,regulation of vitamin D receptor signaling pathway,BP,SNAI2;KANK2
6344,GO:0021527,0.14404804587421,1,1,1,spinal cord association neuron differentiation,BP,LMO4
9278,GO:0035735,0.144490615615308,0.933426772793453,7,39,intraciliary transport involved in cilium assembly,BP,KIF17;IFT140;IFT27;IFT88;WDR19;IFT122;IFT74
10327,GO:0043153,0.144694959484456,0.951882204787042,4,19,entrainment of circadian clock by photoperiod,BP,TP53;SIK1;PER1;CRTC1
13441,GO:0055005,0.144973707389164,1,1,1,ventricular cardiac myofibril assembly,BP,MEF2A
15121,GO:0071260,0.145027031340828,0.925088860949921,9,58,cellular response to mechanical stimulus,BP,EGFR;ITGA2;MAP3K14;SLC38A2;TLR3;ENG;GCLC;MAP3K1;SOX9
19599,GO:1990778,0.145041233231848,0.897187679031708,29,209,protein localization to cell periphery,BP,FLOT1;TNIK;GAS6;EGFR;S100A10;NSG1;ACSL3;PACS1;ITGA3;LRP1;CAV1;PRKCZ;EHD3;PIK3R1;LAMA5;BBS2;ANK3;FLOT2;ARF6;BBS1;NFASC;ANXA2;RAB13;TSPAN5;PRNP;EFR3A;GOPC;KCNIP3;C2CD5
16897,GO:0098905,0.145160432038031,0.99431580162721,1,2,regulation of bundle of His cell action potential,BP,GJA5
6573,GO:0022408,0.145219830678704,0.912923509687425,14,98,negative regulation of cell-cell adhesion,BP,SERPINE2;IL20RB;SNAI2;BMP4;GPNMB;GLI3;DLG5;PAG1;BCL6;PODXL;PRNP;MAP2K5;LGALS3;ABAT
14328,GO:0061572,0.145338534487359,0.908403851593716,17,112,actin filament bundle organization,BP,ITGB5;CTGF;SFRP1;RHOBTB2;ASAP3;S100A10;PAK1;ARAP1;ESPN;PXN;PIK3R1;DLC1;FSCN1;TRIOBP;BBS4;FHOD1;LIMA1
2406,GO:0005579,0.145371483799365,1,1,1,membrane attack complex,CC,C5
8556,GO:0034039,0.145376646803277,0.994298162491177,1,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,MUTYH
9755,GO:0039552,0.145412542125701,1,1,1,RIG-I binding,MF,SEC14L1
2520,GO:0005777,0.145418766739037,0.912557632812142,14,105,peroxisome,CC,VIM;ACSL3;TYSND1;ECH1;XDH;PRDX5;TMEM173;ALDH3A2;CAT;IDH2;PXMP2;ZADH2;PEX1;EHHADH
10060,GO:0042579,0.145418766739037,0.912557632812142,14,105,microbody,CC,VIM;ACSL3;TYSND1;ECH1;XDH;PRDX5;TMEM173;ALDH3A2;CAT;IDH2;PXMP2;ZADH2;PEX1;EHHADH
463,GO:0001502,0.145422526873169,0.962697003255469,3,11,cartilage condensation,BP,CTGF;SOX9;THRA
16809,GO:0098743,0.145422526873169,0.962697003255469,3,11,cell aggregation,BP,CTGF;SOX9;THRA
1544,GO:0003941,0.145541153142451,0.994284722004825,1,2,L-serine ammonia-lyase activity,MF,SRR
15842,GO:0072593,0.145684496382015,0.902962905909627,21,162,reactive oxygen species metabolic process,BP,CTGF;NQO1;DDIT4;TGFBR2;PKD2;NOS1;EGFR;TP53;GPX1;SESN1;XDH;CPS1;CAV1;CLU;PRDX5;CAT;SNCA;PLA2R1;PDK3;G6PD;PRCP
15256,GO:0071470,0.145717937704959,0.943625437184814,5,26,cellular response to osmotic stress,BP,ZFP36L1;PKD2;MYLK;SCN2A;ARHGEF2
13534,GO:0060026,0.145802587534789,0.962554422664922,3,11,convergent extension,BP,SFRP1;VANGL2;NPHP3
9743,GO:0039520,0.146026518144772,1,1,1,induction by virus of host autophagy,BP,EIF2AK4
8046,GO:0032725,0.146107123425487,0.975323585001963,2,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,IL18;ISL1
3174,GO:0006790,0.146175054271605,0.894095074111601,32,271,sulfur compound metabolic process,BP,SULT1E1;CSPG4;MICAL1;ACSL3;GPX1;PTGES;MTHFR;ABHD14B;B3GAT3;CPS1;HLCS;XYLT1;UST;ACSS1;CHST3;ACACB;TSTD1;SNCA;PDK3;G6PD;GCLC;ACSS2;HEXA;ENPP1;GAL3ST4;ABCC2;ACSF2;GGT7;DSEL;TPST1;GSTZ1;ACOT1
5224,GO:0015842,0.146242618000697,0.994227218770966,1,2,aminergic neurotransmitter loading into synaptic vesicle,BP,TH
16791,GO:0098700,0.146242618000697,0.994227218770966,1,2,neurotransmitter loading into synaptic vesicle,BP,TH
6982,GO:0030672,0.146247790808706,0.927777470845293,8,51,synaptic vesicle membrane,CC,SYT8;PTPRS;SYN1;SYT1;VAMP1;C2CD4C;SV2A;ZNRF1
17003,GO:0099501,0.146247790808706,0.927777470845293,8,51,exocytic vesicle membrane,CC,SYT8;PTPRS;SYN1;SYT1;VAMP1;C2CD4C;SV2A;ZNRF1
13867,GO:0060538,0.146440180061505,0.912332451215038,14,91,skeletal muscle organ development,BP,FLOT1;MYH15;TSC22D3;NUPR1;MEF2D;GPX1;CAV1;DKK1;NR2F2;EGR1;FLNB;KLF5;PPP3CA;FOS
3462,GO:0007283,0.146551990192291,0.891941476137466,36,276,spermatogenesis,BP,SYNE1;ETV5;AXL;HSPA2;RFX2;CRTAP;SMARCA2;HSF2BP;BTG1;CTSV;SPATA6;PHC2;CCNI;SPATA20;BBS2;RGS2;SETX;CCDC136;SEPT6;BBS4;CALR;ZNF449;SOX9;BCL6;MYBL1;FNDC3A;SPA17;ODF2;HERPUD2;RHBDD1;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1
9610,GO:0036494,0.146583096866189,1,1,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,DNAJC3
816,GO:0002090,0.146598821734466,0.943173930323263,5,26,regulation of receptor internalization,BP,FLOT1;DLG4;TBC1D5;DKK1;MAGI2
11801,GO:0046719,0.146858755015394,0.975118009469506,2,7,regulation by virus of viral protein levels in host cell,BP,STAT1;IFIT1
3684,GO:0008191,0.147026290746096,0.975072091463099,2,7,metalloendopeptidase inhibitor activity,MF,TIMP2;TIMP1
15889,GO:0072702,0.147184582734536,1,1,1,response to methyl methanesulfonate,BP,TP53INP1
15890,GO:0072703,0.147184582734536,1,1,1,cellular response to methyl methanesulfonate,BP,TP53INP1
13930,GO:0060665,0.147326159779648,1,1,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGFR1
16197,GO:0090272,0.147326159779648,1,1,1,negative regulation of fibroblast growth factor production,BP,FGFR1
18394,GO:1903465,0.147326159779648,1,1,1,positive regulation of mitotic cell cycle DNA replication,BP,FGFR1
20113,GO:2000830,0.147326159779648,1,1,1,positive regulation of parathyroid hormone secretion,BP,FGFR1
2419,GO:0005597,0.147433947394815,1,1,1,collagen type XVI trimer,CC,COL16A1
7133,GO:0030984,0.147514091104997,0.994122193883259,1,2,kininogen binding,MF,CTSV
12514,GO:0050687,0.147518026603437,0.950007699638852,4,21,negative regulation of defense response to virus,BP,HTRA1;TKFC;IFIT1;SEC14L1
6203,GO:0019722,0.147550370267036,0.911595003989062,14,90,calcium-mediated signaling,BP,PKD2;JPH2;NOS1;EGFR;SLC8A1;CAMK2D;PDE4D;CDH13;NFATC4;LMCD1;NFAT5;PRNP;PPP3CA;DMPK
16577,GO:0097442,0.147649325129832,1,1,1,CA3 pyramidal cell dendrite,CC,MAP2
16412,GO:0097104,0.147729689940093,0.977763188719188,2,5,postsynaptic membrane assembly,BP,NLGN4Y;MAGI2
11338,GO:0045721,0.147879075127434,0.97483781898826,2,7,negative regulation of gluconeogenesis,BP,SIK1;LEPR
11818,GO:0046813,0.148032386306213,0.994079087906832,1,2,receptor-mediated virion attachment to host cell,BP,GAS6
582,GO:0001736,0.148108755424236,0.909054391592606,15,109,establishment of planar polarity,BP,SFRP1;ROR1;PRICKLE1;FZD7;DKK1;ASTN2;PSMB9;FZD1;VANGL2;NPHP3;MAGI2;ARHGEF19;FZD4;MED12;CELSR1
3384,GO:0007164,0.148108755424236,0.909054391592606,15,109,establishment of tissue polarity,BP,SFRP1;ROR1;PRICKLE1;FZD7;DKK1;ASTN2;PSMB9;FZD1;VANGL2;NPHP3;MAGI2;ARHGEF19;FZD4;MED12;CELSR1
3261,GO:0006933,0.148221104535142,0.994063350063015,1,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,SNAI2
6883,GO:0030425,0.148485901365949,0.8854382189421,49,362,dendrite,CC,NQO1;NOS1;MAP6;SLC8A1;NTSR1;PAK1;NSG1;NR1D1;STAT1;DLG4;MAP2;ASAP1;SYN1;SPG11;LRP1;FYN;PIAS3;CLU;CCK;SLC38A2;KIF17;ANK3;WFS1;MME;TRAK1;LZTS1;ARHGEF2;NFASC;CRTC1;RGS14;HTR1B;PRNP;RET;MAGI2;TH;GOPC;OPHN1;TPGS1;KCNIP3;SHISA9;PRR7;RARA;SV2A;FZD4;PPP3CA;DNM1P46;CAMK2N1;BSN;MPDZ
16580,GO:0097447,0.148485901365949,0.8854382189421,49,362,dendritic tree,CC,NQO1;NOS1;MAP6;SLC8A1;NTSR1;PAK1;NSG1;NR1D1;STAT1;DLG4;MAP2;ASAP1;SYN1;SPG11;LRP1;FYN;PIAS3;CLU;CCK;SLC38A2;KIF17;ANK3;WFS1;MME;TRAK1;LZTS1;ARHGEF2;NFASC;CRTC1;RGS14;HTR1B;PRNP;RET;MAGI2;TH;GOPC;OPHN1;TPGS1;KCNIP3;SHISA9;PRR7;RARA;SV2A;FZD4;PPP3CA;DNM1P46;CAMK2N1;BSN;MPDZ
3973,GO:0008798,0.148542103279172,1,1,1,beta-aspartyl-peptidase activity,MF,BACE1
14973,GO:0070931,0.148542103279172,1,1,1,Golgi-associated vesicle lumen,CC,BACE1
6894,GO:0030479,0.14857194660445,0.977556297625961,2,5,actin cortical patch,CC,HIP1;WIPF1
14366,GO:0061645,0.14857194660445,0.977556297625961,2,5,endocytic patch,CC,HIP1;WIPF1
13749,GO:0060363,0.148746576415756,0.974598574028086,2,7,cranial suture morphogenesis,BP,BMP4;GLI3
2089,GO:0004855,0.148749750978637,1,1,1,xanthine oxidase activity,MF,XDH
5636,GO:0016727,0.148749750978637,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,XDH
20231,GO:2001213,0.148749750978637,1,1,1,negative regulation of vasculogenesis,BP,XDH
14711,GO:0070408,0.148830095662949,1,1,1,carbamoyl phosphate metabolic process,BP,CPS1
14712,GO:0070409,0.148830095662949,1,1,1,carbamoyl phosphate biosynthetic process,BP,CPS1
18502,GO:1903717,0.148830095662949,1,1,1,response to ammonia,BP,CPS1
18503,GO:1903718,0.148830095662949,1,1,1,cellular response to ammonia,BP,CPS1
17181,GO:0106070,0.148894276625639,0.977476907462979,2,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;PRKCA
8855,GO:0034676,0.148984040733372,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
8354,GO:0033262,0.149012875881402,0.960679544725372,3,12,regulation of nuclear cell cycle DNA replication,BP,CHEK2;FGFR1;BCL6
2947,GO:0006478,0.149174473694679,0.993983499240696,1,2,peptidyl-tyrosine sulfation,BP,TPST1
3854,GO:0008476,0.149174473694679,0.993983499240696,1,2,protein-tyrosine sulfotransferase activity,MF,TPST1
9408,GO:0035993,0.149213936207927,0.993980181535043,1,2,deltoid tuberosity development,BP,BMP4
14627,GO:0070252,0.149418931249692,0.920526195341781,10,50,actin-mediated cell contraction,BP,TNNI2;GJA5;VIM;PDPN;CAV1;CAMK2D;PARVA;TTN;KCNJ5;PDE4D
19541,GO:1990578,0.149579224253824,1,1,1,perinuclear endoplasmic reticulum membrane,CC,PIK3R1
13390,GO:0052813,0.149616785881937,0.931036475270176,7,35,phosphatidylinositol bisphosphate kinase activity,MF,IRS2;EGFR;PDGFA;KITLG;FYN;PIK3R1;FGFR1
9930,GO:0042308,0.149670747466557,0.974342669812593,2,7,negative regulation of protein import into nucleus,BP,GAS6;MDFIC
18875,GO:1904590,0.149670747466557,0.974342669812593,2,7,negative regulation of protein import,BP,GAS6;MDFIC
1803,GO:0004450,0.14982978153844,0.993928277458951,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2716,GO:0006097,0.14982978153844,0.993928277458951,1,2,glyoxylate cycle,BP,IDH2
14877,GO:0070728,0.149859798995402,0.975484911732613,2,6,leucine binding,MF,SESN3;SESN1
12301,GO:0048677,0.149899894150374,1,1,1,axon extension involved in regeneration,BP,LAMB2
15674,GO:0072244,0.149899894150374,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15675,GO:0072248,0.149899894150374,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15676,GO:0072249,0.149899894150374,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15687,GO:0072274,0.149899894150374,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15708,GO:0072312,0.149899894150374,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15709,GO:0072313,0.149899894150374,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
10817,GO:0044331,0.150068169559891,0.95971800809367,3,13,cell-cell adhesion mediated by cadherin,BP,FLOT1;CDH13;CDH11
18205,GO:1903036,0.15035096984279,0.93480440486792,6,34,positive regulation of response to wounding,BP,F2R;TGFBR2;MYLK;SERPINE1;ANO6;PDPN
14355,GO:0061626,0.150355046552497,0.975353249864115,2,6,pharyngeal arch artery morphogenesis,BP,BMP4;TGFB2
6466,GO:0021812,0.150447174551982,1,1,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,LAMB1
10397,GO:0043257,0.150447174551982,1,1,1,laminin-8 complex,CC,LAMB1
10094,GO:0042632,0.150571969700266,0.934533511733362,6,35,cholesterol homeostasis,BP,MALL;ABCA1;VDR;CAV1;IL18;ABCA2
13492,GO:0055092,0.150571969700266,0.934533511733362,6,35,sterol homeostasis,BP,MALL;ABCA1;VDR;CAV1;IL18;ABCA2
2606,GO:0005913,0.150598742935834,0.913659695533563,12,74,cell-cell adherens junction,CC,FLOT1;ITGA6;PTPRM;DLG5;FAT2;FLOT2;CDH13;NDRG1;ANXA2;CDH11;OXTR;S100A11
1961,GO:0004672,0.150653818179668,0.879768885739053,64,470,protein kinase activity,MF,TGFBR2;EFEMP1;TNIK;ROR1;AXL;EGFR;SPEG;MYLK;MAP3K6;PAK1;PTK6;EIF2AK4;CNTRL;LTBP1;WNK1;CRIM1;SIK1;CDK14;NEK9;FYN;ALPK1;LTBP4;MAP3K14;PRKCZ;ULK2;HMGA2;CAMK2D;MST1R;CDK18;PHKA2;TTN;DAPK1;PRKACB;CHEK2;FGFR1;IGF1R;PRKAB2;MYO3B;OBSCN;PDK3;EPHB6;TGFBR3;ATM;EFNB3;AKAP13;MAP3K1;NRK;SOX9;STK16;PRKCA;PAK6;MAP3K12;STK36;RET;MAP2K5;ULK1;CDK19;SRPK2;ICK;PRKAG1;TAF1;TTBK2;TAOK3;DMPK
4352,GO:0009952,0.150669685218372,0.901979251933902,19,123,anterior/posterior pattern specification,BP,SFRP1;BMP4;DDIT3;GLI3;GLI2;PLXNA2;DKK1;PBX1;ATM;NR2F2;POGLUT1;VANGL2;PGAP1;TSHZ1;LEF1;SSBP3;HOXA3;MED12;CELSR1
5323,GO:0016054,0.150846693131607,0.896923793129539,23,189,organic acid catabolic process,BP,PRODH;IRS2;NOS1;BCKDHB;TYSND1;ECH1;GLDC;HIBADH;ALDH3A2;CPT1A;ACACB;ALDH1L2;HEXA;ALDH4A1;THNSL2;DECR1;ALDH7A1;GSTZ1;AIG1;EHHADH;ABAT;CPT2;ACAA2
11633,GO:0046395,0.150846693131607,0.896923793129539,23,189,carboxylic acid catabolic process,BP,PRODH;IRS2;NOS1;BCKDHB;TYSND1;ECH1;GLDC;HIBADH;ALDH3A2;CPT1A;ACACB;ALDH1L2;HEXA;ALDH4A1;THNSL2;DECR1;ALDH7A1;GSTZ1;AIG1;EHHADH;ABAT;CPT2;ACAA2
716,GO:0001942,0.150858179674798,0.91591278918743,11,67,hair follicle development,BP,CD109;APCDD1;EGFR;PDGFA;CTSV;LAMA5;DKK1;VANGL2;SOX9;TGFB2;CELSR1
722,GO:0001952,0.15110678444837,0.90942500779874,14,83,regulation of cell-matrix adhesion,BP,SFRP1;UTRN;SERPINE1;S100A10;PRKCZ;PIK3R1;DLC1;COL16A1;CDH13;BCL6;CDKN2A;POSTN;EFNA5;RASA1
12075,GO:0048102,0.151139765805413,0.973933710788613,2,7,autophagic cell death,BP,CTSV;TP53INP1
7979,GO:0032608,0.151171701918635,0.929035005137429,7,43,interferon-beta production,BP,FLOT1;PTPRS;ZBTB20;PYCARD;RNF135;TMEM173;TLR3
6911,GO:0030513,0.151194105538187,0.941567448282642,5,23,positive regulation of BMP signaling pathway,BP,RNF165;BMP4;NEO1;SULF1;ENG
6922,GO:0030534,0.151218451117812,0.91595498137553,11,63,adult behavior,BP,SLITRK6;SDK1;NTSR1;BBS2;SNCA;BBS4;EFNB3;TPGS1;GDNF;SLITRK5;ABAT
16006,GO:0086065,0.151285404663347,0.934790673656815,6,31,cell communication involved in cardiac conduction,BP,GJA5;SLC8A1;CAV1;CAMK2D;KCNJ5;PDE4D
3810,GO:0008406,0.15131123431906,0.900024738215572,20,142,gonad development,BP,SFRP1;NUPR1;MMP19;KITLG;CTSV;SLIT3;ANG;TLR3;ATM;CST3;CITED2;SOX9;RAB13;FNDC3A;WDR19;TGFB2;RARA;FZD4;AGO4;RHOBTB3
17776,GO:1901896,0.151338372025683,0.993800109967122,1,2,positive regulation of calcium-transporting ATPase activity,BP,HSPA2
14232,GO:0061317,0.151380604636332,0.993796501039512,1,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17582,GO:1901295,0.151380604636332,0.993796501039512,1,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
19097,GO:1905066,0.151380604636332,0.993796501039512,1,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
1449,GO:0003682,0.151617695546788,0.880474396527202,57,438,chromatin binding,MF,SNAI2;PHF21A;EGFR;TCF7L1;NUPR1;CBX5;SMARCA2;STAT1;TP53;GLI3;TSHZ2;GLI2;ERCC6;SMARCA1;TNRC18;HMGA2;PER1;NCAPD2;JARID2;MLH3;TP73;SP110;NCOA2;BRD3;TLE4;KDM4C;NFATC4;DLX3;CITED2;EGR1;SOX9;ISL1;BCL6;PRIMPOL;BAHCC1;TSHZ1;NFAT5;RBL2;DLX2;LEF1;THRA;SP100;CENPA;IFT74;SAP30L;YAP1;MEIS3;PPARG;MEF2A;RARA;PBX2;TSHZ3;HP1BP3;FOS;MED12;NIPBL;RXRA
7203,GO:0031106,0.151783429346754,0.959606320290341,3,12,septin ring organization,BP,SEPT6;SEPT5;SEPT9
14081,GO:0060965,0.151918742040602,0.959553645071806,3,12,negative regulation of gene silencing by miRNA,BP,NCOR1;PPARG;PPP3CA
10132,GO:0042730,0.152213650164257,0.957994012673526,3,15,fibrinolysis,BP,SERPINE1;SERPING1;ANXA2
18770,GO:1904338,0.152308532268704,0.974831044852938,2,6,regulation of dopaminergic neuron differentiation,BP,SFRP1;DKK1
1632,GO:0004077,0.152324188087002,1,1,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,HLCS
1633,GO:0004078,0.152324188087002,1,1,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,HLCS
1634,GO:0004079,0.152324188087002,1,1,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,HLCS
1635,GO:0004080,0.152324188087002,1,1,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,HLCS
4194,GO:0009305,0.152324188087002,1,1,1,protein biotinylation,BP,HLCS
5937,GO:0018271,0.152324188087002,1,1,1,biotin-protein ligase activity,MF,HLCS
14900,GO:0070781,0.152324188087002,1,1,1,response to biotin,BP,HLCS
15068,GO:0071110,0.152324188087002,1,1,1,histone biotinylation,BP,HLCS
19521,GO:1990462,0.152523642502667,0.973546002287631,2,7,omegasome,CC,TRIM5;ULK1
17046,GO:0099580,0.152609707150875,1,1,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,SLC8A1
5317,GO:0016048,0.152658351040348,0.97350813524697,2,7,detection of temperature stimulus,BP,ANO1;NTSR1
12695,GO:0050961,0.152658351040348,0.97350813524697,2,7,detection of temperature stimulus involved in sensory perception,BP,ANO1;NTSR1
12697,GO:0050965,0.152658351040348,0.97350813524697,2,7,detection of temperature stimulus involved in sensory perception of pain,BP,ANO1;NTSR1
886,GO:0002254,0.152747866524408,0.993679047273371,1,2,kinin cascade,BP,PRCP
941,GO:0002353,0.152747866524408,0.993679047273371,1,2,plasma kallikrein-kinin cascade,BP,PRCP
12400,GO:0048872,0.15278087480799,0.89571905677171,23,170,homeostasis of number of cells,BP,SOX6;INPP5D;ZFP36L1;F2R;IL20RB;AXL;TSC22D3;FAM210B;BMP4;STAT1;KITLG;RBFOX2;DOCK11;KLF13;G6PD;TGFBR3;L3MBTL3;SOX9;ITPKB;BCL6;ZFPM1;LIPA;THRA
9751,GO:0039533,0.152800155248591,0.974698903831674,2,6,regulation of MDA-5 signaling pathway,BP,TKFC;DDX60
13559,GO:0060055,0.152820743409894,0.958634450104046,3,13,angiogenesis involved in wound healing,BP,SERPINE1;GPX1;PRCP
19761,GO:2000209,0.152894200361799,0.948088664719654,4,19,regulation of anoikis,BP,SNAI2;SIK1;CAV1;CHEK2
1647,GO:0004096,0.152993879031821,0.993657786667151,1,2,catalase activity,MF,CAT
1701,GO:0004190,0.153330905865368,0.957952907963719,3,14,aspartic-type endopeptidase activity,MF,BACE1;SPPL2B;CTSD
14489,GO:0070001,0.153330905865368,0.957952907963719,3,14,aspartic-type peptidase activity,MF,BACE1;SPPL2B;CTSD
3365,GO:0007130,0.153741483490927,0.973202844989593,2,7,synaptonemal complex assembly,BP,MLH3;AGO4
6335,GO:0021515,0.153798450685456,0.948436325488621,4,17,cell differentiation in spinal cord,BP,GLI3;GLI2;LMO4;ISL1
2602,GO:0005903,0.153910589993957,0.91682110495976,10,58,brush border,CC,CYBRD1;ADD3;PLEC;ESPN;SLC38A2;MME;ABCC2;FLNB;LIMA1;MYO1C
6650,GO:0030010,0.153928461440832,0.902410514207957,17,104,establishment of cell polarity,BP,GSN;PAK1;MAP2;FRMD4B;UST;PRKCZ;SPRY2;FLOT2;FSCN1;AMOTL1;ARF6;ARHGEF2;MPP7;AMOTL2;CENPA;OPHN1;MYO9A
12280,GO:0048642,0.154072138199412,0.973109357348047,2,7,negative regulation of skeletal muscle tissue development,BP,TSC22D3;DKK1
1674,GO:0004140,0.154284018906539,0.993545656150123,1,2,dephospho-CoA kinase activity,MF,DCAKD
8239,GO:0033030,0.154285925328118,1,1,1,negative regulation of neutrophil apoptotic process,BP,ITPKB
15647,GO:0072201,0.154828492363275,0.974150656199038,2,6,negative regulation of mesenchymal cell proliferation,BP,BMP4;LMNA
4500,GO:0010544,0.154867725241376,0.957336169810581,3,14,negative regulation of platelet activation,BP,SERPINE2;PDGFA;ABAT
15162,GO:0071333,0.154921126215031,0.910232715479191,12,83,cellular response to glucose stimulus,BP,ANO1;IRS2;GAS6;NR1D1;LGALS1;PLA2G6;IGF1R;PDK3;GCLC;TH;EFNA5;PPP3CA
14541,GO:0070099,0.154983687657247,0.974108505048574,2,6,regulation of chemokine-mediated signaling pathway,BP,SLIT3;ROBO1
8074,GO:0032769,0.155021227345014,0.972840264335997,2,7,negative regulation of monooxygenase activity,BP,CAV1;SNCA
12246,GO:0048563,0.155060735716238,0.97282903843582,2,7,post-embryonic animal organ morphogenesis,BP,FBN1;EFEMP1
12243,GO:0048560,0.155199572130659,0.993465433711283,1,2,establishment of anatomical structure orientation,BP,TTC8
4413,GO:0010193,0.155230316068875,0.993462730515898,1,2,response to ozone,BP,CAT
1487,GO:0003826,0.155259903384726,0.993460128443479,1,2,alpha-ketoacid dehydrogenase activity,MF,BCKDHB
1505,GO:0003863,0.155259903384726,0.993460128443479,1,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,BCKDHB
10221,GO:0042954,0.155345556961897,0.975863159557749,2,5,lipoprotein transporter activity,MF,LRP1;MIA3
3413,GO:0007198,0.155377164674883,0.99344981029496,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR1B
7059,GO:0030857,0.155431868218999,0.938831199311281,5,25,negative regulation of epithelial cell differentiation,BP,STAT1;XDH;CAV1;SOX9;YAP1
7650,GO:0032090,0.155471775599122,0.993441478763941,1,2,Pyrin domain binding,MF,PYCARD
15593,GO:0072111,0.155663367278621,0.957015639426914,3,14,cell proliferation involved in kidney development,BP,BMP4;STAT1;EGR1
16792,GO:0098703,0.155704395852772,0.973912382726963,2,6,calcium ion import across plasma membrane,BP,FYN;PRNP
18047,GO:1902656,0.155704395852772,0.973912382726963,2,6,calcium ion import into cytosol,BP,FYN;PRNP
13573,GO:0060072,0.155731794989738,1,1,1,large conductance calcium-activated potassium channel activity,MF,KCNMA1
8923,GO:0034975,0.156042539468457,0.956862591608116,3,14,protein folding in endoplasmic reticulum,BP,ERO1B;CALR;HSPA5
5771,GO:0016999,0.156130024983796,0.908919975506094,12,95,antibiotic metabolic process,BP,SULT1E1;EGFR;GPX1;ACSS1;PRDX5;CAT;SNCA;DHTKD1;IDH2;ACSS2;AKR7A2;ABCC2
17865,GO:1902174,0.156364901542142,0.993362545108414,1,2,positive regulation of keratinocyte apoptotic process,BP,GSN
13541,GO:0060037,0.156390077671582,0.947231729167105,4,17,pharyngeal system development,BP,BMP4;PLXNA2;ISL1;TGFB2
14026,GO:0060828,0.156614467799299,0.890076867249754,26,197,regulation of canonical Wnt signaling pathway,BP,SFRP1;SNAI2;SULF2;WWTR1;PRICKLE1;DDIT3;WNK1;RBMS3;GLI3;CDK14;CAV1;NPHP4;CAPRIN2;DKK1;PSMB9;KLHL12;EGR1;SOX9;ISL1;IGFBP4;LEF1;IGFBP2;NPHP3;YAP1;DIXDC1;CCNY
13560,GO:0060056,0.156705839436764,0.972359884173765,2,7,mammary gland involution,BP,VDR;CAV1
11052,GO:0045073,0.156721024816385,0.971427708694026,2,8,regulation of chemokine biosynthetic process,BP,TLR3;EGR1
18865,GO:1904576,0.156826132385567,0.993321580597231,1,2,response to tunicamycin,BP,CLU
18866,GO:1904577,0.156826132385567,0.993321580597231,1,2,cellular response to tunicamycin,BP,CLU
12957,GO:0051387,0.156907600552007,0.993314330686908,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
6342,GO:0021524,0.156943071553847,0.993311172758501,1,2,visceral motor neuron differentiation,BP,ISL1
9414,GO:0036003,0.156958103439951,0.945552170726245,4,21,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;DDIT3;CHD6;HSPA5
15136,GO:0071285,0.157146673544545,0.972233597462765,2,7,cellular response to lithium ion,BP,NFATC4;CALR
16268,GO:0090400,0.157210301711836,0.972215349922997,2,7,stress-induced premature senescence,BP,TP53;PLA2R1
2480,GO:0005721,0.157734159497105,0.946180826302914,4,18,pericentric heterochromatin,CC,CBX5;KDM4C;CENPA;KDM4A
14964,GO:0070905,0.1577585784314,0.993238345361799,1,2,serine binding,MF,THNSL2
14553,GO:0070123,0.157763868345292,1,1,1,transforming growth factor beta receptor activity, type III,MF,TGFBR3
6501,GO:0021882,0.157781279514661,0.993236311934502,1,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,DLX2
6509,GO:0021893,0.157781279514661,0.993236311934502,1,2,cerebral cortex GABAergic interneuron fate commitment,BP,DLX2
9349,GO:0035881,0.157781279514661,0.993236311934502,1,2,amacrine cell differentiation,BP,DLX2
14148,GO:0061074,0.157781279514661,0.993236311934502,1,2,regulation of neural retina development,BP,DLX2
14149,GO:0061075,0.157781279514661,0.993236311934502,1,2,positive regulation of neural retina development,BP,DLX2
18114,GO:1902866,0.157781279514661,0.993236311934502,1,2,regulation of retina development in camera-type eye,BP,DLX2
18115,GO:1902868,0.157781279514661,0.993236311934502,1,2,positive regulation of retina development in camera-type eye,BP,DLX2
18116,GO:1902869,0.157781279514661,0.993236311934502,1,2,regulation of amacrine cell differentiation,BP,DLX2
18117,GO:1902871,0.157781279514661,0.993236311934502,1,2,positive regulation of amacrine cell differentiation,BP,DLX2
3199,GO:0006835,0.157867004840779,0.921095885298411,8,46,dicarboxylic acid transport,BP,NTSR1;SLC7A11;CCK;SYT1;SLC38A2;SNCA;ABCC2;ABAT
5718,GO:0016863,0.157884558265534,0.96981266590873,2,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,ECH1;EHHADH
5986,GO:0018963,0.157970352857162,0.993219362931382,1,2,phthalate metabolic process,BP,TH
14307,GO:0061525,0.157978142537093,0.975191093835007,2,5,hindgut development,BP,GLI3;GLI2
7854,GO:0032426,0.157997988861595,0.971989039519723,2,7,stereocilium tip,CC,ESPN;MYO3B
12808,GO:0051145,0.158022915823168,0.930481525964983,6,34,smooth muscle cell differentiation,BP,TMEM204;BMP4;PDCD4;NFATC4;ENG;SOX9
18755,GO:1904294,0.158211850246065,0.956483190277891,3,13,positive regulation of ERAD pathway,BP,CAV1;HERPUD1;EDEM1
1099,GO:0002689,0.158242995273434,0.970976956000427,2,8,negative regulation of leukocyte chemotaxis,BP,MMP28;C5
18413,GO:1903523,0.158284626303464,0.946345655567026,4,17,negative regulation of blood circulation,BP,F2R;DOCK5;DOCK4;PDE4D
19295,GO:1905602,0.158335739893195,0.993186543219387,1,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
4814,GO:0014013,0.158478311792097,0.913422402876254,10,63,regulation of gliogenesis,BP,SERPINE2;TENM4;ETV5;GJC2;TP73;IDH2;PLAG1;DLX2;PPARG;KDM4A
16361,GO:0097006,0.158575715009027,0.920057604749636,8,52,regulation of plasma lipoprotein particle levels,BP,ABCA1;ACSL3;PRKACB;ANXA2;CES3;LIPA;LMF1;ABCA5
19633,GO:1990907,0.158594894328156,0.957645030051388,3,11,beta-catenin-TCF complex,CC,TLE4;TCF4;LEF1
9838,GO:0042104,0.15880344162182,0.954943939432627,3,16,positive regulation of activated T cell proliferation,BP,PYCARD;IL18;IGFBP2
9608,GO:0036492,0.15886319302131,0.973045475909865,2,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,EIF2AK4;DNAJC3
10984,GO:0044818,0.158933943252954,0.936747630070323,5,26,mitotic G2/M transition checkpoint,BP,HMGA2;FOXN3;ATM;CDK5RAP3;TAOK3
12852,GO:0051209,0.159065759555708,0.910608568721008,11,64,release of sequestered calcium ion into cytosol,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;CAMK2D;SNCA;PDE4D;ITPR2
12901,GO:0051283,0.159065759555708,0.910608568721008,11,64,negative regulation of sequestering of calcium ion,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;CAMK2D;SNCA;PDE4D;ITPR2
15830,GO:0072578,0.159369253676595,0.972905484703999,2,6,neurotransmitter-gated ion channel clustering,BP,DLG4;SSH1
16427,GO:0097120,0.159435468090064,0.94466367722769,4,20,receptor localization to synapse,BP,NSG1;NETO1;DLG4;KIF17
10248,GO:0043008,0.159474798275316,0.970609995779753,2,8,ATP-dependent protein binding,MF,PLA2G6;PRNP
14929,GO:0070851,0.1598295309144,0.906885396478942,12,82,growth factor receptor binding,MF,FLRT2;EFEMP1;PDGFC;FLRT3;VAV3;PYCARD;PDGFA;HIP1;SNX1;FYN;AREG;VAV2
13969,GO:0060712,0.159867719132527,0.956417091761086,3,12,spongiotrophoblast layer development,BP,ZFP36L1;FBXW8;NRK
10808,GO:0044322,0.159999609258863,0.9361834571083,5,26,endoplasmic reticulum quality control compartment,CC,SEL1L;CALR;RHBDD1;UGGT2;EDEM1
9474,GO:0036128,0.160039008822661,0.993032411664486,1,2,CatSper complex,CC,HSPA2
6704,GO:0030122,0.160039584337213,0.956348365128509,3,12,AP-2 adaptor complex,CC,EGFR;HIP1;TBC1D5
14029,GO:0060836,0.160220036386566,0.974612592491038,2,5,lymphatic endothelial cell differentiation,BP,PDPN;NR2F2
2105,GO:0004883,0.1602370593446,1,1,1,glucocorticoid receptor activity,MF,NR3C1
9664,GO:0038051,0.1602370593446,1,1,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,NR3C1
8187,GO:0032945,0.16030807186332,0.92369376828745,7,42,negative regulation of mononuclear cell proliferation,BP,INPP5D;IL20RB;BMP4;GPNMB;DLG5;ATM;PRNP
12504,GO:0050672,0.16030807186332,0.92369376828745,7,42,negative regulation of lymphocyte proliferation,BP,INPP5D;IL20RB;BMP4;GPNMB;DLG5;ATM;PRNP
902,GO:0002285,0.160575784864658,0.902066559205207,14,97,lymphocyte activation involved in immune response,BP,EIF2AK4;LGALS1;DOCK11;PRKCZ;SEMA4A;IL18;IFNK;IFNE;BCL6;ZFPM1;LEF1;ITM2A;LGALS3;RARA
7781,GO:0032332,0.160594637412741,0.956858367463385,3,11,positive regulation of chondrocyte differentiation,BP,SOX6;GLI3;SOX9
7813,GO:0032377,0.160678605876014,0.971213131749343,2,7,regulation of intracellular lipid transport,BP,ANXA2;ABCA2
7816,GO:0032380,0.160678605876014,0.971213131749343,2,7,regulation of intracellular sterol transport,BP,ANXA2;ABCA2
7819,GO:0032383,0.160678605876014,0.971213131749343,2,7,regulation of intracellular cholesterol transport,BP,ANXA2;ABCA2
8622,GO:0034164,0.160680501875761,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
16923,GO:0098948,0.160680501875761,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16957,GO:0099060,0.160680501875761,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
16958,GO:0099061,0.160680501875761,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
16986,GO:0099146,0.160680501875761,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
5963,GO:0018400,0.160693537535245,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
5433,GO:0016303,0.160707112040197,0.930724633537146,6,26,1-phosphatidylinositol-3-kinase activity,MF,PIK3C2G;IRS2;PIK3R1;FGFR1;ATM;PIK3C2B
3523,GO:0007500,0.160788741247628,0.992963970660554,1,2,mesodermal cell fate determination,BP,BMP4
4675,GO:0010828,0.160865452128956,0.929840212161035,6,29,positive regulation of glucose transmembrane transport,BP,IRS2;CLTCL1;PAK1;PRKCZ;PIK3R1;C2CD5
15651,GO:0072205,0.160921848771215,0.974430329771672,2,5,metanephric collecting duct development,BP,BMP4;DLG5
16497,GO:0097241,0.161042973967914,0.992940679536754,1,2,hematopoietic stem cell migration to bone marrow,BP,GAS6
14153,GO:0061082,0.161185274332447,0.954768025554354,3,14,myeloid leukocyte cytokine production,BP,GAS6;BCL6;TGFB2
6261,GO:0019860,0.161357264231943,0.992911828243131,1,2,uracil metabolic process,BP,DPYD
14186,GO:0061152,0.16165382631349,0.992884545436524,1,2,trachea submucosa development,BP,LEF1
14187,GO:0061153,0.16165382631349,0.992884545436524,1,2,trachea gland development,BP,LEF1
7984,GO:0032613,0.161662417888587,0.942539984189192,4,24,interleukin-10 production,BP,IL20RB;PYCARD;TRIB2;PRKCZ
9020,GO:0035252,0.161701401248162,0.972256399034827,2,6,UDP-xylosyltransferase activity,MF,XYLT1;POGLUT1
9918,GO:0042285,0.161701401248162,0.972256399034827,2,6,xylosyltransferase activity,MF,XYLT1;POGLUT1
589,GO:0001754,0.161810312057946,0.944248359296165,4,18,eye photoreceptor cell differentiation,BP,NAGLU;BBS4;SOX9;TH
12661,GO:0050905,0.161816877612139,0.91887571273474,8,44,neuromuscular process,BP,SLITRK6;NEFL;DLG4;ADARB1;KCNAB2;RBFOX2;AARS;HOXA1
19664,GO:2000008,0.161826707481954,0.934770876482963,5,28,regulation of protein localization to cell surface,BP,KCNAB2;SNX33;ASTN2;ARF6;GOPC
16269,GO:0090402,0.161883269328506,0.992863398100322,1,2,oncogene-induced cell senescence,BP,HMGA2
18869,GO:1904580,0.161902144870215,0.992861656850775,1,2,regulation of intracellular mRNA localization,BP,ZFP36L1
18870,GO:1904582,0.161902144870215,0.992861656850775,1,2,positive regulation of intracellular mRNA localization,BP,ZFP36L1
20106,GO:2000821,0.161998030242061,0.992852807939367,1,2,regulation of grooming behavior,BP,DLG4
19681,GO:2000045,0.162001825422628,0.894279705879625,18,135,regulation of G1/S transition of mitotic cell cycle,BP,CDKN2B;PKD2;EGFR;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;KANK2;TP73;CHEK2;ATM;MDM2;RBL2;FHL1;CDKN2A;CTDSP2
16842,GO:0098802,0.162181951526608,0.901261877789286,14,89,plasma membrane receptor complex,CC,ITGB6;ITGB5;ITGA6;TGFBR2;ITGB4;DLG4;ITGA2;ITGA3;ITGA10;ITGA1;ENG;ITGB8;CALCRL;SHISA9
6329,GO:0021508,0.162306967901079,1,1,1,floor plate formation,BP,GLI2
8412,GO:0033505,0.162306967901079,1,1,1,floor plate morphogenesis,BP,GLI2
13539,GO:0060032,0.162306967901079,1,1,1,notochord regression,BP,GLI2
9814,GO:0042056,0.162369976498675,0.952834039244928,3,18,chemoattractant activity,MF,BMP4;GPNMB;LGALS3
9309,GO:0035801,0.16237728845175,0.992817748885229,1,2,adrenal cortex development,BP,CITED2
9310,GO:0035802,0.16237728845175,0.992817748885229,1,2,adrenal cortex formation,BP,CITED2
7933,GO:0032535,0.162559693350836,0.878972606230355,36,264,regulation of cellular component size,BP,FN1;GSN;DPYSL2;SPTB;PAK1;NEFL;VAV3;KCNMA1;PTPRS;PYCARD;SEMA5A;ANO6;ARHGAP18;ULK2;ARPIN;KANK2;PLXNA2;SEMA4A;TRIOBP;BBS4;ARF6;PLXNA1;FHOD3;SSH1;MEGF8;RET;CDC42EP5;VAV2;SEMA4B;CAPG;EFNA5;WIPF1;RASA1;LIMA1;HP1BP3;MYO1C
12637,GO:0050868,0.162602548401321,0.913743538390146,9,59,negative regulation of T cell activation,BP,IL20RB;BMP4;GPNMB;GLI3;DLG5;PAG1;BCL6;PRNP;LGALS3
17683,GO:1901620,0.162780834267421,0.970598440185041,2,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;GPR161
14150,GO:0061077,0.162807432979384,0.913021181090011,9,68,chaperone-mediated protein folding,BP,HSPA2;FKBP5;CRTAP;CLU;FKBP9;PDIA4;CALR;HSPA5;FKBP10
13265,GO:0051990,0.163002539992656,0.99275974521767,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,D2HGDH
7929,GO:0032528,0.163076913405324,0.943643539486952,4,18,microvillus organization,BP,TNIK;FSCN1;PODXL;KLF5
14406,GO:0061741,0.16308198522573,0.992752356940463,1,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,CLU
8181,GO:0032934,0.163149174829796,0.927725261604139,6,33,sterol binding,MF,OSBPL10;PROM2;ABCA1;CAV1;OSBPL5;ANXA6
15158,GO:0071326,0.163156972781173,0.904474803141138,12,84,cellular response to monosaccharide stimulus,BP,ANO1;IRS2;GAS6;NR1D1;LGALS1;PLA2G6;IGF1R;PDK3;GCLC;TH;EFNA5;PPP3CA
15160,GO:0071331,0.163156972781173,0.904474803141138,12,84,cellular response to hexose stimulus,BP,ANO1;IRS2;GAS6;NR1D1;LGALS1;PLA2G6;IGF1R;PDK3;GCLC;TH;EFNA5;PPP3CA
4720,GO:0010887,0.163158668680934,0.971847522274364,2,6,negative regulation of cholesterol storage,BP,ABCA1;PPARG
2093,GO:0004860,0.163404534838672,0.909684167912327,10,70,protein kinase inhibitor activity,MF,FLRT2;CDKN2B;FLRT3;WNK1;TRIB2;SPRY2;CDKN2A;DNAJC3;CAMK2N1;TAOK3
14597,GO:0070194,0.163605653673629,0.992703553543501,1,2,synaptonemal complex disassembly,BP,HSPA2
9087,GO:0035374,0.163607700073473,0.971721024735197,2,6,chondroitin sulfate binding,MF,PTPRS;AGRN
15632,GO:0072179,0.163632244148097,0.992701070660897,1,2,nephric duct formation,BP,BMP4
7592,GO:0031983,0.163709608331392,0.88406131489279,26,230,vesicle lumen,CC,FN1;PYGB;GSN;GAS6;EGFR;SERPINE1;TIMP2;PCSK1;PYCARD;PDGFA;TIMP1;MAGED2;CLU;SERPING1;CAT;BACE1;CALR;ANXA2;MAN2B1;TGFB2;DNASE1L1;NAPRT;DNAJC3;ACTR1B;S100A11;CTSD
12044,GO:0048016,0.163756263166697,0.927972650997267,6,30,inositol phosphate-mediated signaling,BP,NFATC4;LMCD1;NFAT5;PRNP;ITPR2;PPP3CA
13257,GO:0051974,0.163829204615741,0.96929744559404,2,8,negative regulation of telomerase activity,BP,TP53;PPARG
8905,GO:0034763,0.163834984501348,0.909714528267189,10,65,negative regulation of transmembrane transport,BP,MMP9;PKD2;IRS2;NTSR1;CAV1;CAMK2D;ANK3;ENPP1;GOPC;KCNRG
16425,GO:0097118,0.1638627181011,1,1,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,MAGI2
7628,GO:0032049,0.164017243444163,0.969240226711261,2,8,cardiolipin biosynthetic process,BP,SLC27A1;PLA2G6
5362,GO:0016165,0.164071132857727,0.992660022732019,1,2,linoleate 13S-lipoxygenase activity,MF,ALOX15B
19088,GO:1905048,0.164107791015301,0.954086805311965,3,13,regulation of metallopeptidase activity,BP,TIMP2;SORL1;TIMP1
12129,GO:0048260,0.164289492750986,0.926897884312397,6,34,positive regulation of receptor-mediated endocytosis,BP,SERPINE1;HIP1;TBC1D5;CLU;ANXA2;MAGI2
5770,GO:0016998,0.164438678503509,0.992625550418426,1,2,cell wall macromolecule catabolic process,BP,MANBA
19923,GO:2000484,0.164506417133284,0.969091166112358,2,8,positive regulation of interleukin-8 secretion,BP,F2R;PYCARD
15216,GO:0071404,0.164603150683013,0.954509439985653,3,12,cellular response to low-density lipoprotein particle stimulus,BP,ABCA1;CDH13;PPARG
10754,GO:0044224,0.164647072959821,0.971427300901233,2,6,juxtaparanode region of axon,CC,DLG4;KCNAB2
16455,GO:0097169,0.164707435990025,0.990231675990302,1,3,AIM2 inflammasome complex,CC,PYCARD
18895,GO:1904646,0.164786581029405,0.943269760557291,4,17,cellular response to amyloid-beta,BP,LRP1;IGF1R;PRNP;CACNB1
7807,GO:0032371,0.164806599255878,0.933621079919979,5,26,regulation of sterol transport,BP,ABCA1;LRP1;ANXA2;PPARG;ABCA2
7810,GO:0032374,0.164806599255878,0.933621079919979,5,26,regulation of cholesterol transport,BP,ABCA1;LRP1;ANXA2;PPARG;ABCA2
15341,GO:0071611,0.164855904297106,0.992586311470986,1,2,granulocyte colony-stimulating factor production,BP,ISL1
15369,GO:0071655,0.164855904297106,0.992586311470986,1,2,regulation of granulocyte colony-stimulating factor production,BP,ISL1
17363,GO:1900120,0.164864935441392,0.952409167574472,3,16,regulation of receptor binding,BP,MMP9;ANXA2;LEF1
18042,GO:1902630,0.164903273762301,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18043,GO:1902631,0.164903273762301,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
5164,GO:0015721,0.165149223006254,0.953658807214185,3,13,bile acid and bile salt transport,BP,NCOA2;ABCC2;RXRA
7890,GO:0032469,0.165220250719352,0.941870738703902,4,20,endoplasmic reticulum calcium ion homeostasis,BP,CAMK2D;HERPUD1;WFS1;TGM2
1296,GO:0003130,0.165385741211268,0.992536317485336,1,2,BMP signaling pathway involved in heart induction,BP,BMP4
1298,GO:0003133,0.165385741211268,0.992536317485336,1,2,endodermal-mesodermal cell signaling,BP,BMP4
1299,GO:0003134,0.165385741211268,0.992536317485336,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4
15610,GO:0072138,0.165385741211268,0.992536317485336,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4
7497,GO:0031690,0.165436095726809,0.953540663299082,3,13,adrenergic receptor binding,MF,DLG4;PDE4D;MAGI2
6557,GO:0022011,0.165470517733871,0.935257725048523,5,20,myelination in peripheral nervous system,BP,AHNAK2;ADGRG6;PRX;SH3TC2;NDRG1
7761,GO:0032292,0.165470517733871,0.935257725048523,5,20,peripheral nervous system axon ensheathment,BP,AHNAK2;ADGRG6;PRX;SH3TC2;NDRG1
5905,GO:0018153,0.165643940804874,0.992511887808439,1,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,TGM2
5936,GO:0018262,0.165643940804874,0.992511887808439,1,2,isopeptide cross-linking,BP,TGM2
1393,GO:0003308,0.165719024115451,0.992504775563226,1,2,negative regulation of Wnt signaling pathway involved in heart development,BP,DKK1
5599,GO:0016646,0.165899957515893,0.952817247801971,3,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,MTHFR;ALDH1L2;ALDH4A1
19512,GO:1990442,0.166028009921922,0.990067771016951,1,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,DDIT3
7725,GO:0032231,0.166080546130864,0.905688287425606,11,66,regulation of actin filament bundle assembly,BP,CTGF;SFRP1;ASAP3;S100A10;PAK1;ARAP1;PXN;PIK3R1;DLC1;BBS4;FHOD1
5753,GO:0016920,0.166288976735636,1,1,1,pyroglutamyl-peptidase activity,MF,PGPEP1
1650,GO:0004104,0.166356766443959,0.992444216510074,1,2,cholinesterase activity,MF,BCHE
8356,GO:0033265,0.166356766443959,0.992444216510074,1,2,choline binding,MF,BCHE
19010,GO:1904880,0.166474325254951,0.99243302416674,1,2,response to hydrogen sulfide,BP,NQO1
14258,GO:0061371,0.166505403494459,0.920670139912237,7,37,determination of heart left/right asymmetry,BP,TGFBR2;PKD2;ENG;BBS4;VANGL2;MEGF8;NPHP3
17598,GO:1901329,0.16652072848997,0.992428603787157,1,2,regulation of odontoblast differentiation,BP,SERPINE1
13808,GO:0060437,0.166589999008432,0.992422002435664,1,2,lung growth,BP,SPRY2
19394,GO:1990000,0.16685606604916,0.952418097537355,3,14,amyloid fibril formation,BP,GSN;CLU;MDM2
7996,GO:0032635,0.166952717320299,0.907422314695616,10,68,interleukin-6 production,BP,INPP5D;F2R;GAS6;ZBTB20;PYCARD;TLR3;IL18;AFAP1L2;ARHGEF2;ISL1
2285,GO:0005245,0.167079163902928,0.952861934459878,3,13,voltage-gated calcium channel activity,MF,PKD2;GAS6;CACNB1
16912,GO:0098923,0.167137554185475,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16913,GO:0098924,0.167137554185475,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
16988,GO:0099163,0.167137554185475,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17030,GO:0099543,0.167137554185475,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17033,GO:0099548,0.167137554185475,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17289,GO:0140196,0.167137554185475,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
12548,GO:0050729,0.167159719414346,0.910406544286289,9,64,positive regulation of inflammatory response,BP,EGFR;SERPINE1;PDCD4;ITGA2;TLR3;SNCA;TGM2;IL18;CDK19
6534,GO:0021953,0.167207960431604,0.897701337186707,14,88,central nervous system neuron differentiation,BP,SFRP1;MAP2;ADARB1;GLI3;GLI2;ROBO1;DKK1;FZD1;LMO4;ISL1;CDH11;DLX2;LEF1;OPHN1
1832,GO:0004489,0.167227457767552,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
8362,GO:0033274,0.167227457767552,1,1,1,response to vitamin B2,BP,MTHFR
682,GO:0001893,0.167443333511561,0.9322034612961,5,26,maternal placenta development,BP,VDR;CTSV;NR2F2;STOX2;RXRA
5089,GO:0015368,0.167496781847421,0.970615395550183,2,6,calcium:cation antiporter activity,MF,SLC8A1;SLC24A1
7113,GO:0030947,0.167527984184567,0.941100847093501,4,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,TMEM204;MYOF;PTPN1;FZD4
8848,GO:0034663,0.167558764737697,0.968154259043412,2,8,endoplasmic reticulum chaperone complex,CC,PDIA6;HSPA5
13540,GO:0060033,0.167776536832984,0.97053517121243,2,6,anatomical structure regression,BP,GLI2;LEF1
17313,GO:1900026,0.1678562188717,0.931740776177085,5,27,positive regulation of substrate adhesion-dependent cell spreading,BP,DOCK5;S100A10;TRIOBP;CALR;DOCK1
9999,GO:0042448,0.167860027308906,0.968061152753763,2,8,progesterone metabolic process,BP,DGKQ;EGR1
15973,GO:0086012,0.167879173703764,0.953949337590746,3,11,membrane depolarization during cardiac muscle cell action potential,BP,GJA5;SLC8A1;ANK3
17873,GO:1902202,0.167890686960981,0.992297463744396,1,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,PTPN1
5934,GO:0018242,0.167958363959015,0.952497311974226,3,13,protein O-linked glycosylation via serine,BP,GALNT10;POGLUT1;GALNT2
13140,GO:0051765,0.167989133563842,0.992287992344203,1,2,inositol tetrakisphosphate kinase activity,MF,ITPK1
2100,GO:0004869,0.168287755294826,0.931080846799225,5,29,cysteine-type endopeptidase inhibitor activity,MF,GAS6;PRDX5;SNCA;CST3;LEF1
4273,GO:0009642,0.168364794733004,0.968939289597048,2,7,response to light intensity,BP,CAT;SLC24A1
17558,GO:1901215,0.168596018837253,0.889436830586662,18,130,negative regulation of neuron death,BP,F2R;AXL;NEFL;SORL1;GPNMB;LRP1;FYN;UNC5B;WFS1;TP73;AARS;SNCA;FZD1;GCLC;ISL1;MAP3K12;GDNF;RASA1
16890,GO:0098888,0.168612187806234,1,1,1,extrinsic component of presynaptic membrane,CC,HIP1
16891,GO:0098890,0.168612187806234,1,1,1,extrinsic component of postsynaptic membrane,CC,HIP1
16998,GO:0099243,0.168612187806234,1,1,1,extrinsic component of synaptic membrane,CC,HIP1
9346,GO:0035878,0.168804057782787,0.968807147545796,2,7,nail development,BP,ITGA6;ITGB4
9452,GO:0036089,0.168954490889255,0.968761838842294,2,7,cleavage furrow formation,BP,SNX33;SNX9
8725,GO:0034390,0.168955478168166,0.952082577646137,3,13,smooth muscle cell apoptotic process,BP,PDCD4;CDKN2A;PPARG
8726,GO:0034391,0.168955478168166,0.952082577646137,3,13,regulation of smooth muscle cell apoptotic process,BP,PDCD4;CDKN2A;PPARG
19714,GO:2000111,0.168973861437192,0.992192901829992,1,2,positive regulation of macrophage apoptotic process,BP,CDKN2A
11606,GO:0046332,0.169204411067176,0.906867302197897,10,56,SMAD binding,MF,TGFBR2;COL5A2;HMGA2;TGFBR3;TCF12;MAGI2;TGFB1I1;MEF2A;TGIF1;FOS
5458,GO:0016358,0.169486100342093,0.881175258689037,25,166,dendrite development,BP,SDK1;TNIK;MAP6;CSMD3;PTPRS;DLG4;MAP2;CUL7;DLG5;ASAP1;FYN;RBFOX2;CAPRIN2;NFATC4;BBS4;ARF6;TRAK1;FBXW8;SDC2;CRTC1;MEF2A;KLF7;OBSL1;SLITRK5;PPP3CA
7487,GO:0031669,0.169536661528573,0.883693036539438,22,164,cellular response to nutrient levels,BP,SFRP1;CDKN2B;GAS6;SNAI2;SESN3;VDR;EIF2AK4;TP53;SESN1;CTSV;FYN;KANK2;SLC38A2;MDM2;SSH1;UCN2;ULK1;HSPA5;PPARG;POSTN;TAF1;PIK3C2B
10137,GO:0042737,0.169537007792456,0.908477093849615,9,70,drug catabolic process,BP,SULT1E1;NOS1;GPX1;GLDC;PRDX5;CAT;SNCA;GSTZ1;DPYD
19840,GO:2000342,0.169550067744642,0.992136963770179,1,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,MAP2K5
13841,GO:0060487,0.16955583697462,0.952483292410088,3,12,lung epithelial cell differentiation,BP,SOX9;THRA;YAP1
15969,GO:0086008,0.169612586971085,0.992130881230159,1,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,KCNJ5
17825,GO:1902041,0.169621941209102,0.917790887159563,7,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1;SERPINE1;GPX1;DAPK1;ARHGEF2;SP100;LGALS3
4604,GO:0010726,0.169652086788595,0.992127036934348,1,2,positive regulation of hydrogen peroxide metabolic process,BP,SNCA
12083,GO:0048146,0.169686749518125,0.923448544369597,6,36,positive regulation of fibroblast proliferation,BP,FN1;GAS6;PDGFC;EGFR;PDGFA;ANXA2
11421,GO:0045887,0.169698920160309,1,1,1,positive regulation of synaptic growth at neuromuscular junction,BP,AGRN
12900,GO:0051282,0.169853722048832,0.903179185688677,11,65,regulation of sequestering of calcium ion,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;CAMK2D;SNCA;PDE4D;ITPR2
14373,GO:0061663,0.169941464190336,1,1,1,NEDD8 ligase activity,MF,MDM2
15142,GO:0071301,0.169941464190336,1,1,1,cellular response to vitamin B1,BP,MDM2
18798,GO:1904404,0.169941464190336,1,1,1,response to formaldehyde,BP,MDM2
2452,GO:0005667,0.170006130382722,0.874357850229267,33,259,transcription factor complex,CC,TCF7L1;TADA3;VDR;NR1D1;TP53;WWTR1;DDIT3;TFDP2;E2F7;TP73;TLE4;NFATC4;PBX1;TCF4;LMO4;SOX9;TRERF1;TCF12;NFAT5;TAF8;ZFPM1;RBL2;LEF1;THRA;YAP1;PPARG;MEF2A;RARA;PBX2;TAF1;FOS;NPAS2;RXRA
8070,GO:0032764,0.170061172853738,0.992087162274472,1,2,negative regulation of mast cell cytokine production,BP,BCL6
14221,GO:0061301,0.170069064333502,1,1,1,cerebellum vasculature morphogenesis,BP,FZD4
16825,GO:0098773,0.170375035098531,0.902524033355092,11,69,skin epidermis development,BP,CD109;APCDD1;EGFR;PDGFA;CTSV;LAMA5;DKK1;VANGL2;SOX9;TGFB2;CELSR1
2570,GO:0005859,0.170415152506321,0.958943352942552,3,7,muscle myosin complex,CC,TTN;OBSL1;MYH11
13994,GO:0060746,0.170461595189682,0.968306384966976,2,7,parental behavior,BP,CREBRF;OXTR
14736,GO:0070447,0.170473881094015,0.992046822481762,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,GJC2
19600,GO:1990782,0.170586552437757,0.909053169525901,9,53,protein tyrosine kinase binding,MF,PITPNM3;GAS6;TP53;DOCK4;PTPN14;PIK3R1;PAG1;PTPN1;ELMO2
5377,GO:0016206,0.170725234615756,0.992022198969914,1,2,catechol O-methyltransferase activity,MF,LRTOMT
17092,GO:0102084,0.170725234615756,0.992022198969914,1,2,L-dopa O-methyltransferase activity,MF,LRTOMT
17144,GO:0102938,0.170725234615756,0.992022198969914,1,2,orcinol O-methyltransferase activity,MF,LRTOMT
4313,GO:0009799,0.170814251400223,0.899543090793234,12,76,specification of symmetry,BP,TGFBR2;PKD2;BMP4;DDIT3;IFT140;ENG;BBS4;CITED2;VANGL2;MEGF8;NPHP3;IFT74
16892,GO:0098900,0.170834010190215,0.924150403948506,6,29,regulation of action potential,BP,GJA5;NTSR1;CAV1;CAMK2D;ANK3;PTPN3
3614,GO:0008064,0.170880195777374,0.887680396851646,18,131,regulation of actin polymerization or depolymerization,BP,GSN;SPTB;PYCARD;SEMA5A;ARHGAP18;ARPIN;KANK2;TRIOBP;BBS4;ARF6;FHOD3;SSH1;CDC42EP5;CAPG;WIPF1;RASA1;LIMA1;MYO1C
7723,GO:0032229,0.170915359312828,0.992003545890561,1,2,negative regulation of synaptic transmission, GABAergic,BP,HTR1B
7479,GO:0031658,0.170982495631309,0.96814831903578,2,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B;CDKN2A
11367,GO:0045766,0.171005081599722,0.892776348264075,15,100,positive regulation of angiogenesis,BP,CCBE1;TGFBR2;SERPINE1;ANGPTL4;SEMA5A;BTG1;HMGA2;TLR3;C5;ENG;ISL1;PRKCA;ITGB8;SASH1;ADM2
2776,GO:0006208,0.171035670251007,0.991991729859177,1,2,pyrimidine nucleobase catabolic process,BP,DPYD
2777,GO:0006210,0.171035670251007,0.991991729859177,1,2,thymine catabolic process,BP,DPYD
6260,GO:0019859,0.171035670251007,0.991991729859177,1,2,thymine metabolic process,BP,DPYD
17926,GO:1902305,0.171152360328914,0.917680417027006,7,38,regulation of sodium ion transmembrane transport,BP,NOS1;UTRN;NETO1;CAMK2D;ANK3;STOM;PTPN3
3549,GO:0007586,0.171244188918652,0.917040754774107,7,42,digestion,BP,VDR;WNK1;SOX9;UCN2;SLC9A4;ADM2;OXTR
819,GO:0002093,0.17134640400788,0.968037694704605,2,7,auditory receptor cell morphogenesis,BP,SLITRK6;TRIOBP
13823,GO:0060455,0.171354105913713,0.991960409261588,1,2,negative regulation of gastric acid secretion,BP,OXTR
11971,GO:0047374,0.171530228303967,0.991943057422797,1,2,methylumbelliferyl-acetate deacetylase activity,MF,CES2
16736,GO:0098560,0.171532456706122,0.991942837745661,1,2,cytoplasmic side of late endosome membrane,CC,LITAF
11248,GO:0045577,0.171563112375601,0.938759283401834,4,20,regulation of B cell differentiation,BP,INPP5D;SFRP1;ZFP36L1;ZFP36L2
11641,GO:0046427,0.171601536843258,0.92190345724921,6,39,positive regulation of JAK-STAT cascade,BP,PTK6;FYN;IL31RA;CTF1;IL18;ISL1
7794,GO:0032354,0.17163660409368,0.951622652614399,3,12,response to follicle-stimulating hormone,BP,TGFBR3;GCLC;EFNA5
11120,GO:0045186,0.171660894354639,1,1,1,zonula adherens assembly,BP,DLG5
17789,GO:1901963,0.171717361956409,0.99192459821622,1,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
4177,GO:0009258,0.172003959781696,1,1,1,10-formyltetrahydrofolate catabolic process,BP,ALDH1L2
5360,GO:0016155,0.172003959781696,1,1,1,formyltetrahydrofolate dehydrogenase activity,MF,ALDH1L2
11094,GO:0045137,0.172185457538357,0.884036525508871,20,145,development of primary sexual characteristics,BP,SFRP1;NUPR1;MMP19;KITLG;CTSV;SLIT3;ANG;TLR3;ATM;CST3;CITED2;SOX9;RAB13;FNDC3A;WDR19;TGFB2;RARA;FZD4;AGO4;RHOBTB3
14304,GO:0061517,0.172225875741863,0.991874320220877,1,2,macrophage proliferation,BP,CLU
14305,GO:0061518,0.172225875741863,0.991874320220877,1,2,microglial cell proliferation,BP,CLU
19593,GO:1990769,0.172254846814967,0.991871450616323,1,2,proximal neuron projection,CC,GJC2
8468,GO:0033629,0.172373758043316,0.967724514553976,2,7,negative regulation of cell adhesion mediated by integrin,BP,SNAI2;SERPINE1
18510,GO:1903726,0.172540220162567,0.966600097672836,2,8,negative regulation of phospholipid metabolic process,BP,PDGFA;SLC27A1
13791,GO:0060414,0.172600496894723,1,1,1,aorta smooth muscle tissue morphogenesis,BP,MYLK
2141,GO:0004955,0.172604711455514,0.991836752306267,1,2,prostaglandin receptor activity,MF,PPARG
4259,GO:0009608,0.172607218536542,0.991836503369828,1,2,response to symbiont,BP,GPX1
4260,GO:0009609,0.172607218536542,0.991836503369828,1,2,response to symbiotic bacterium,BP,GPX1
8865,GO:0034694,0.172738761104969,0.938962856021058,4,18,response to prostaglandin,BP,SFRP1;GNG2;TGFBR3;PPARG
13589,GO:0060090,0.172747700985348,0.882523366544493,21,147,molecular adaptor activity,MF,FLRT2;GAS6;FLRT3;CBX5;CHN2;TRIM5;NEFL;VAV3;HIP1;CAV1;PIK3R1;CNTLN;ANK3;PAG1;FSCN1;AFAP1L2;AKAP13;MPP7;MAPK8IP3;SH2B3;OBSL1
17621,GO:1901385,0.172773380848548,0.950482717243806,3,13,regulation of voltage-gated calcium channel activity,BP,AHNAK;EHD3;CACNB1
20079,GO:2000774,0.172790270266221,0.965705370163089,2,9,positive regulation of cellular senescence,BP,HMGA2;CDKN2A
9019,GO:0035251,0.173025433921568,0.967525186871897,2,7,UDP-glucosyltransferase activity,MF,POGLUT1;UGGT2
8692,GO:0034349,0.1730942122471,0.950347420636543,3,13,glial cell apoptotic process,BP,GAS6;TP53;PRKCA
6770,GO:0030215,0.173128328295015,0.939245056192849,4,17,semaphorin receptor binding,MF,SEMA5A;PLXNB1;SEMA4A;SEMA4B
11436,GO:0045914,0.173178637063078,0.99177965641558,1,2,negative regulation of catecholamine metabolic process,BP,SNCA
11470,GO:0045963,0.173178637063078,0.99177965641558,1,2,negative regulation of dopamine metabolic process,BP,SNCA
6119,GO:0019372,0.17327622413155,0.965548472550107,2,9,lipoxygenase pathway,BP,GPX1;ALOX15B
16696,GO:0097730,0.173382696929376,0.903511686908592,10,62,non-motile cilium,CC,PTGS1;PKD2;NPHP4;KIF17;IFT140;BBS4;WDR19;IFT122;ARL3;SEPT9
8232,GO:0033018,0.173482897249426,0.991749298896879,1,2,sarcoplasmic reticulum lumen,CC,CALR
16264,GO:0090389,0.173531724965914,1,1,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,SPG11
9822,GO:0042078,0.173662335659657,0.991731366598064,1,2,germ-line stem cell division,BP,ETV5
12079,GO:0048133,0.173662335659657,0.991731366598064,1,2,male germ-line stem cell asymmetric division,BP,ETV5
16802,GO:0098728,0.173662335659657,0.991731366598064,1,2,germline stem cell asymmetric division,BP,ETV5
17758,GO:1901856,0.173731765077974,0.99172442237574,1,2,negative regulation of cellular respiration,BP,SNCA
14303,GO:0061515,0.173739908104418,0.910847106801198,8,48,myeloid cell development,BP,FBN1;SOX6;FAM210B;G6PD;L3MBTL3;BCL6;ANXA2;ZFPM1
19264,GO:1905524,0.174050310310475,1,1,1,negative regulation of protein autoubiquitination,BP,TAF1
3190,GO:0006817,0.1740738266027,0.950607536458103,3,12,phosphate ion transport,BP,SLC20A1;FGFR1;ANKH
19288,GO:1905595,0.174233943817864,0.991674099731258,1,2,regulation of low-density lipoprotein particle receptor binding,BP,ANXA2
19562,GO:1990667,0.174233943817864,0.991674099731258,1,2,PCSK9-AnxA2 complex,CC,ANXA2
6675,GO:0030048,0.174235393664141,0.895659937623932,13,69,actin filament-based movement,BP,TNNI2;GJA5;VIM;PDPN;CAV1;CAMK2D;PARVA;TTN;KCNJ5;PDE4D;SYNE2;WIPF1;MYO1C
7223,GO:0031133,0.174252017966885,0.991672285415737,1,2,regulation of axon diameter,BP,NEFL
18933,GO:1904724,0.174261709729906,0.926673075022351,5,36,tertiary granule lumen,CC,MMP9;TIMP2;METTL7A;CST3;CTSD
6303,GO:0019953,0.174288218134365,0.861779281243221,54,439,sexual reproduction,BP,SERPINE2;SYT8;SYNE1;ETV5;AXL;HSPA2;RFX2;CRTAP;BMP4;SMARCA2;HSF2BP;MMP19;BTG1;PAQR8;CTSV;FUT10;SPATA6;PHC2;MST1R;CCNI;SPATA20;ANG;BBS2;MLH3;PAQR7;RGS2;SETX;CCDC136;SEPT6;BBS4;CALR;ATM;NR2F2;ZNF449;SOX9;BCL6;MYBL1;FNDC3A;LEPR;SPA17;ODF2;THRA;HERPUD2;RHBDD1;TH;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1;AGO4;ABAT;OXTR
7431,GO:0031572,0.174299858334479,0.921261583489501,6,33,G2 DNA damage checkpoint,BP,MAP3K14;HMGA2;FOXN3;ATM;CDK5RAP3;TAOK3
4514,GO:0010572,0.174345440736958,0.991662904002009,1,2,positive regulation of platelet activation,BP,PDPN
17735,GO:1901731,0.174345440736958,0.991662904002009,1,2,positive regulation of platelet aggregation,BP,PDPN
453,GO:0001227,0.174361443419313,0.879961798394559,22,162,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,SOX6;SNAI2;KLF8;NR1D1;ZBTB20;HIVEP1;E2F7;ZFP90;TSHZ2;HMGA2;JARID2;NFATC4;BCL6;TSHZ1;HMBOX1;ZFPM1;RBL2;KCNIP3;TGIF1;HES2;TSHZ3;PRDM5
18713,GO:1904207,0.174383866546772,0.99165904363658,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18714,GO:1904209,0.174383866546772,0.99165904363658,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
4524,GO:0010594,0.174441691663379,0.888410132223392,16,108,regulation of endothelial cell migration,BP,CCBE1;PTPRM;BMP4;SEMA5A;FGFR1;SEMA4A;AMOTL1;CALR;NR2F2;PRCP;PRKCA;MAP2K5;SP100;PPARG;SASH1;ADGRA2
18146,GO:1902938,0.174554237870583,0.991641915804011,1,2,regulation of intracellular calcium activated chloride channel activity,BP,PRNP
1990,GO:0004713,0.174692785059955,0.886794042544932,17,109,protein tyrosine kinase activity,MF,EFEMP1;ROR1;AXL;EGFR;PTK6;CNTRL;CRIM1;FYN;MST1R;TTN;FGFR1;IGF1R;EPHB6;EFNB3;STK16;RET;MAP2K5
13748,GO:0060359,0.174812779875607,0.902165958258138,10,67,response to ammonium ion,BP,SDK1;GLDC;SNCA;MDM2;HTR1B;AGRN;HSPA5;SRR;ABAT;OXTR
18395,GO:1903487,0.174849799988011,0.991612156364094,1,2,regulation of lactation,BP,OAS2
3070,GO:0006639,0.174918447919618,0.902164182745245,10,66,acylglycerol metabolic process,BP,SIK1;GPX1;CPS1;CAV1;SEL1L;CPT1A;ANG;CAT;DGKQ;LMF1
4485,GO:0010512,0.174993541054486,0.991597662375674,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFA
9300,GO:0035788,0.174993541054486,0.991597662375674,1,2,cell migration involved in metanephros development,BP,PDGFA
9301,GO:0035789,0.174993541054486,0.991597662375674,1,2,metanephric mesenchymal cell migration,BP,PDGFA
9304,GO:0035793,0.174993541054486,0.991597662375674,1,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFA
17425,GO:1900238,0.174993541054486,0.991597662375674,1,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFA
19969,GO:2000589,0.174993541054486,0.991597662375674,1,2,regulation of metanephric mesenchymal cell migration,BP,PDGFA
19970,GO:2000591,0.174993541054486,0.991597662375674,1,2,positive regulation of metanephric mesenchymal cell migration,BP,PDGFA
555,GO:0001678,0.175109639657453,0.893673343982265,13,91,cellular glucose homeostasis,BP,ANO1;IRS2;GAS6;NR1D1;LGALS1;PLA2G6;PIK3R1;IGF1R;PDK3;GCLC;TH;EFNA5;PPP3CA
7477,GO:0031652,0.175203515938827,0.965756424594288,2,8,positive regulation of heat generation,BP,SLC27A1;ABAT
16955,GO:0099054,0.175586447783849,0.949973711310691,3,12,presynapse assembly,BP,SNCA;FZD1;NLGN4Y
16944,GO:0099003,0.175615964691458,0.891510004423301,14,90,vesicle-mediated transport in synapse,BP,SYT8;STON2;SYN1;SPG11;SYTL1;SYT1;PCLO;SNCA;DNAJC6;SEPT5;NLGN4Y;C2CD4C;OPHN1;DNM1P46
7695,GO:0032185,0.175816970386444,0.949193897113179,3,13,septin cytoskeleton organization,BP,SEPT6;SEPT5;SEPT9
2629,GO:0005960,0.175955122997587,0.991500347674626,1,2,glycine cleavage complex,CC,GLDC
16896,GO:0098904,0.176022328551285,0.991493523210881,1,2,regulation of AV node cell action potential,BP,GJA5
16974,GO:0099094,0.176051613994621,0.92043267201617,6,32,ligand-gated cation channel activity,MF,PKD2;JPH2;KCNJ15;KCNJ5;SCNN1A;ITPR2
19467,GO:1990264,0.176160801573487,0.99147945229786,1,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,PTPN1
20004,GO:2000649,0.176184044954557,0.920569352656429,6,31,regulation of sodium ion transmembrane transporter activity,BP,UTRN;NETO1;CAMK2D;ANK3;STOM;PTPN3
6569,GO:0022404,0.176308508749813,0.898417594684335,11,69,molting cycle process,BP,CD109;APCDD1;EGFR;PDGFA;CTSV;LAMA5;DKK1;VANGL2;SOX9;TGFB2;CELSR1
6570,GO:0022405,0.176308508749813,0.898417594684335,11,69,hair cycle process,BP,CD109;APCDD1;EGFR;PDGFA;CTSV;LAMA5;DKK1;VANGL2;SOX9;TGFB2;CELSR1
8290,GO:0033137,0.176371278515862,0.935722947674587,4,22,negative regulation of peptidyl-serine phosphorylation,BP,DDIT4;CAV1;DKK1;PDE4D
20274,GO:2001287,0.176469371714177,0.991448050900955,1,2,negative regulation of caveolin-mediated endocytosis,BP,PROM2
4027,GO:0009063,0.176565150529561,0.900534051355928,10,74,cellular amino acid catabolic process,BP,PRODH;NOS1;BCKDHB;GLDC;HIBADH;ALDH4A1;THNSL2;ALDH7A1;GSTZ1;ABAT
8389,GO:0033343,0.176577326302682,1,1,1,positive regulation of collagen binding,BP,ITGA2
19705,GO:2000097,0.17676125466562,0.991418289073177,1,2,regulation of smooth muscle cell-matrix adhesion,BP,SERPINE1
16023,GO:0086091,0.177030745415069,0.9373322847407,4,17,regulation of heart rate by cardiac conduction,BP,GJA5;CAV1;CAMK2D;KCNJ5
11115,GO:0045180,0.177070112572246,0.970083419893287,2,5,basal cortex,CC,PKD2;PHLDB1
16526,GO:0097332,0.177268855933664,0.991366395784706,1,2,response to antipsychotic drug,BP,PRKACB
5650,GO:0016755,0.177282834084315,0.96424343451802,2,9,transferase activity, transferring amino-acyl groups,MF,TGM2;GGT7
15736,GO:0072362,0.177355736176439,1,1,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,NCOR1
6014,GO:0019075,0.177477903584296,0.991344974198017,1,2,virus maturation,BP,MVB12B
7880,GO:0032459,0.177506554647665,0.925805360473968,5,30,regulation of protein oligomerization,BP,SORL1;TP53;CLU;CCK;SNX9
9828,GO:0042091,0.177548013771226,0.991337783293837,1,2,interleukin-10 biosynthetic process,BP,TRIB2
11053,GO:0045074,0.177548013771226,0.991337783293837,1,2,regulation of interleukin-10 biosynthetic process,BP,TRIB2
16151,GO:0090200,0.177626293154584,0.933920939793065,4,27,positive regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;PYCARD;PLA2G6
4810,GO:0014009,0.177801713500466,0.927137233252186,5,24,glial cell proliferation,BP,ETV5;CLU;IDH2;AREG;PLAG1
15717,GO:0072332,0.178100738965348,0.89959723718463,10,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,DDIT4;NUPR1;TP53;PYCARD;TP73;CHEK2;EDA2R;MDM2;ZMAT3;USP28
7864,GO:0032436,0.178116849889012,0.899586185566407,10,72,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,PRICKLE1;CAV1;TRIB2;CLU;HERPUD1;MDM2;GCLC;NUB1;RNF144B;TAF1
5557,GO:0016575,0.17816852209135,0.894167860511131,12,79,histone deacetylation,BP,PHF21A;TADA3;TP53;CHD3;SDR16C5;CAMK2D;PER1;HDAC11;BCL6;SAP30L;NIPBL;PRDM5
14099,GO:0060994,0.17820859525864,0.991269868519481,1,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
11456,GO:0045936,0.1782674196796,0.858346304088283,54,440,negative regulation of phosphate metabolic process,BP,PHACTR3;FLRT2;GPRC5A;SFRP1;GADD45B;CD109;CDKN2B;DDIT4;IRS2;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;PDGFA;MICAL1;ADARB1;ELFN2;CTDSPL;XDH;CAV1;SLC27A1;TRIB2;PRKCZ;PER1;DUSP5;SPRY2;FBLN1;TP73;SPRY4;SNCA;IGF1R;DKK1;RGS2;PDE4D;ENG;DGKQ;NR2F2;PTPN1;ENPP1;NCOR1;RGS14;PRNP;TGFB2;CDKN2A;DNAJC3;CTDSP2;CDK5RAP3;CAMK2N1;TAOK3
11708,GO:0046543,0.178370826600586,0.965870593427887,2,7,development of secondary female sexual characteristics,BP,AREG;IRF2BPL
9719,GO:0038191,0.178387589108457,0.936662788738661,4,17,neuropilin binding,MF,SEMA5A;PXN;SEMA4A;SEMA4B
10844,GO:0044387,0.178465103974773,0.965841097863912,2,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,ADARB1;CDK5RAP3
2533,GO:0005793,0.178550420613889,0.88883692046299,14,102,endoplasmic reticulum-Golgi intermediate compartment,CC,FN1;ANPEP;COL7A1;SERPINH1;GOLGB1;MAN1A1;PDIA6;CALR;COPG2;TMED10;AREG;HSPA5;MPPE1;UGGT2
11080,GO:0045113,0.178599348002998,0.99122955724986,1,2,regulation of integrin biosynthetic process,BP,TGFB2
16494,GO:0097237,0.17864739330359,0.879940553323633,19,156,cellular response to toxic substance,BP,NQO1;PTGS1;AXL;TP53;GPX1;SESN1;ADIRF;CPS1;TP53INP1;PRDX5;CAT;SETX;MDM2;CST3;EGR1;TH;ITPR2;GPX8;GSTZ1
6888,GO:0030432,0.178740958277806,0.99121492299649,1,2,peristalsis,BP,GDNF
5411,GO:0016264,0.178903040818655,0.965703942939261,2,7,gap junction assembly,BP,GJA5;CAV1
20074,GO:2000766,0.178977858853915,0.967246815023596,2,6,negative regulation of cytoplasmic translation,BP,RPL13A;UNK
12905,GO:0051289,0.17913683214905,0.906581427683184,8,56,protein homotetramerization,BP,PKD2;TP53;ACACB;CAT;CRTC1;DECR1;SRR;RXRA
3694,GO:0008203,0.179390288919402,0.888299562158651,14,100,cholesterol metabolic process,BP,ABCA1;SORL1;SEC14L2;OSBPL5;ACACB;CAT;G6PD;DGKQ;TRERF1;LEPR;OSBPL1A;LMF1;RXRA;ACAA2
10869,GO:0044430,0.179418665313318,0.844357761201767,145,1188,cytoskeletal part,CC,ITGB6;FLOT1;KRT4;MYH15;TNNI2;GSN;PKD2;CLTCL1;MAP6;UTRN;ROR1;DPYSL2;HSPA2;SPTB;CEP126;SLC8A1;MYLK;KRT14;VIM;EVC;TADA3;PAK1;NEFM;NEFL;NR3C1;CEP250;KRT13;TTLL11;CNTRL;CCDC102A;KRT5;EFHC1;TCP11L1;MAP2;MICAL1;FLG;HIP1;CCDC85B;CUL7;CHD3;TTC28;WDR66;GLI3;DLG5;ASAP1;KRT15;NEK9;PDE4DIP;EML2;KCNAB2;FYN;GLI2;PLA2G6;ESPN;NPHP4;PRKCZ;PARP4;MST1R;HAUS4;PXN;CAPRIN2;DYSF;KIF17;BBS2;CNTLN;SPRY2;TTN;CASP14;SHROOM4;DLC1;PRKACB;IFT140;FBXL7;FLOT2;DZIP1L;LMNA;FSCN1;PDE4D;MYO3B;TRIOBP;SEPT6;PBXIP1;BBS4;ATM;BBS1;AKAP13;SNX10;FHOD3;VANGL2;ARHGEF2;DNAL4;KLHL12;SYNC;KRT222;IFT27;NCOR1;NDRG1;RGS14;WDR63;SEPT5;CEP68;IFT88;TTC8;PODXL;MAP2K5;ODF2;OR2A4;IFT122;SPPL2B;REEP2;TTC12;FLNB;UVRAG;TCTEX1D4;CCHCR1;CFAP54;FHOD1;IFT74;ZNF12;TACC2;TPGS1;MYO9A;DNAH1;YEATS2;CAPG;BEX4;ICK;OBSL1;ARL3;ABCA2;TMEM67;CEP85L;WIPF1;LIMA1;KRT10;ACTR1B;CAPN6;SEPT9;KLHL22;CDK5RAP3;MYH11;TTBK2;LRRCC1;MYO1C;C2CD5
5589,GO:0016624,0.179478196167129,0.96438376475799,2,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,BCKDHB;DHTKD1
15984,GO:0086024,0.1795452268688,1,1,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,PDE4D
17291,GO:0140200,0.1795452268688,1,1,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,PDE4D
17521,GO:1901078,0.1795452268688,1,1,1,negative regulation of relaxation of muscle,BP,PDE4D
17778,GO:1901898,0.1795452268688,1,1,1,negative regulation of relaxation of cardiac muscle,BP,PDE4D
7574,GO:0031952,0.179572931425674,0.917963894618805,6,34,regulation of protein autophosphorylation,BP,PDGFC;PDGFA;GPNMB;CAV1;ENG;ENPP1
7958,GO:0032580,0.179733755892127,0.898733345331823,10,68,Golgi cisterna membrane,CC,ASAP2;NSG1;ARAP1;FUT10;ST6GAL2;GOLGA8B;GAL3ST4;GOLGA8N;GALNT2;COG3
20032,GO:2000683,0.179828093441262,0.991102127871887,1,2,regulation of cellular response to X-ray,BP,HMGA2
6368,GO:0021560,0.179830867985949,0.991101838983994,1,2,abducens nerve development,BP,HOXA1
6387,GO:0021598,0.179830867985949,0.991101838983994,1,2,abducens nerve morphogenesis,BP,HOXA1
6388,GO:0021599,0.179830867985949,0.991101838983994,1,2,abducens nerve formation,BP,HOXA1
13585,GO:0060086,0.180066059458519,0.991077331827353,1,2,circadian temperature homeostasis,BP,NR1D1
4652,GO:0010801,0.180124653014498,0.946756508791444,3,14,negative regulation of peptidyl-threonine phosphorylation,BP,DDIT4;SPRY2;DGKQ
12037,GO:0048009,0.180360756761385,0.926449238628665,5,22,insulin-like growth factor receptor signaling pathway,BP,CRIM1;PIK3R1;IGF1R;IGFBP4;IGFBP2
1464,GO:0003720,0.180369069434597,0.96409482050139,2,8,telomerase activity,MF,TEP1;HMBOX1
1561,GO:0003964,0.180369069434597,0.96409482050139,2,8,RNA-directed DNA polymerase activity,MF,TEP1;HMBOX1
19437,GO:1990164,0.180410027952098,0.991041422969877,1,2,histone H2A phosphorylation,BP,HMGA2
6903,GO:0030504,0.180579744780661,1,1,1,inorganic diphosphate transmembrane transporter activity,MF,ANKH
6558,GO:0022012,0.180691770098649,1,1,1,subpallium cell proliferation in forebrain,BP,GLI3
6559,GO:0022018,0.180691770098649,1,1,1,lateral ganglionic eminence cell proliferation,BP,GLI3
13751,GO:0060366,0.180691770098649,1,1,1,lambdoid suture morphogenesis,BP,GLI3
13752,GO:0060367,0.180691770098649,1,1,1,sagittal suture morphogenesis,BP,GLI3
14046,GO:0060873,0.180691770098649,1,1,1,anterior semicircular canal development,BP,GLI3
14047,GO:0060875,0.180691770098649,1,1,1,lateral semicircular canal development,BP,GLI3
4921,GO:0014877,0.180704733847145,0.969064648852553,2,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,UTRN;MTMR4
4929,GO:0014894,0.180704733847145,0.969064648852553,2,5,response to denervation involved in regulation of muscle adaptation,BP,UTRN;MTMR4
2236,GO:0005146,0.180814708292788,0.990999074035713,1,2,leukemia inhibitory factor receptor binding,MF,CTF1
17200,GO:0110021,0.180817373459684,0.990998794765953,1,2,cardiac muscle myoblast proliferation,BP,MEIS2
17201,GO:0110022,0.180817373459684,0.990998794765953,1,2,regulation of cardiac muscle myoblast proliferation,BP,MEIS2
17202,GO:0110024,0.180817373459684,0.990998794765953,1,2,positive regulation of cardiac muscle myoblast proliferation,BP,MEIS2
4580,GO:0010675,0.180901508230288,0.889902754840505,13,83,regulation of cellular carbohydrate metabolic process,BP,DDIT4;IRS2;NTSR1;NR1D1;SIK1;ACACB;SNCA;NCOA2;PDK3;DGKQ;ENPP1;LEPR;IGFBP4
6645,GO:0030002,0.181043323591941,0.966624254543832,2,6,cellular anion homeostasis,BP,ENPP1;ABCC2
6841,GO:0030320,0.181043323591941,0.966624254543832,2,6,cellular monovalent inorganic anion homeostasis,BP,ENPP1;ABCC2
14731,GO:0070435,0.181111626074568,0.990967932032361,1,2,Shc-EGFR complex,CC,EGFR
8378,GO:0033306,0.181114918642934,0.990967586360555,1,2,phytol metabolic process,BP,ALDH3A2
18255,GO:1903173,0.181114918642934,0.990967586360555,1,2,fatty alcohol metabolic process,BP,ALDH3A2
5796,GO:0017055,0.181131789447733,0.990965815056613,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
7046,GO:0030835,0.181172455445319,0.925283030442802,5,24,negative regulation of actin filament depolymerization,BP,GSN;SPTB;TRIOBP;CAPG;LIMA1
19925,GO:2000490,0.181315050033148,0.990946561746401,1,2,negative regulation of hepatic stellate cell activation,BP,GCLC
3284,GO:0006975,0.181335072690073,0.964938010344693,2,7,DNA damage induced protein phosphorylation,BP,CHEK2;ATM
548,GO:0001669,0.18147946281955,0.905323532950685,8,53,acrosomal vesicle,CC,SYT8;CAV1;ITGA1;FLOT2;CCDC136;CALR;FNDC3A;TCTEX1D4
4508,GO:0010563,0.181681332547537,0.85539379310142,54,441,negative regulation of phosphorus metabolic process,BP,PHACTR3;FLRT2;GPRC5A;SFRP1;GADD45B;CD109;CDKN2B;DDIT4;IRS2;DUSP6;FLRT3;BMP4;PTK6;PDCD4;SORL1;WWTR1;PYCARD;WNK1;PDGFA;MICAL1;ADARB1;ELFN2;CTDSPL;XDH;CAV1;SLC27A1;TRIB2;PRKCZ;PER1;DUSP5;SPRY2;FBLN1;TP73;SPRY4;SNCA;IGF1R;DKK1;RGS2;PDE4D;ENG;DGKQ;NR2F2;PTPN1;ENPP1;NCOR1;RGS14;PRNP;TGFB2;CDKN2A;DNAJC3;CTDSP2;CDK5RAP3;CAMK2N1;TAOK3
12988,GO:0051450,0.181829248918994,0.963619087960545,2,8,myoblast proliferation,BP,GPX1;MEIS2
15688,GO:0072278,0.181921469768152,0.990882689889029,1,2,metanephric comma-shaped body morphogenesis,BP,BMP4
15205,GO:0071392,0.181968640919788,0.932876703858947,4,22,cellular response to estradiol stimulus,BP,SFRP1;EGFR;FAM210B;ITGA2
6790,GO:0030241,0.181980659195997,1,2,2,skeletal muscle myosin thick filament assembly,BP,TTN;MYH11
11372,GO:0045778,0.181997603762122,0.901390253133336,9,54,positive regulation of ossification,BP,FBN2;SLC8A1;BMP4;ANO6;GLI3;TGFB2;IFITM1;ATRAID;NIPBL
12673,GO:0050918,0.182144283703909,0.916082800967929,6,36,positive chemotaxis,BP,BMP4;SEMA5A;ITGA2;GPNMB;CDH13;LGALS3
15284,GO:0071505,0.182158735960289,0.990857631979038,1,2,response to mycophenolic acid,BP,EGR1
15285,GO:0071506,0.182158735960289,0.990857631979038,1,2,cellular response to mycophenolic acid,BP,EGR1
378,GO:0001011,0.182170217087292,1,1,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,TCF4
405,GO:0001087,0.182170217087292,1,1,1,transcription factor activity, TFIIB-class binding,MF,TCF4
18095,GO:1902806,0.182206104532392,0.877405467608178,19,146,regulation of cell cycle G1/S phase transition,BP,CDKN2B;PKD2;EGFR;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;KANK2;TP73;CHEK2;ATM;MDM2;RBL2;FHL1;CDKN2A;TAF1;CTDSP2
734,GO:0001965,0.182232263516317,0.944879741762139,3,16,G-protein alpha-subunit binding,MF,F2R;RGS2;RGS14
12197,GO:0048471,0.182292125450906,0.852392969113365,63,509,perinuclear region of cytoplasm,CC,CTGF;GSN;HERC5;NOS1;MAP6;EGFR;LAMB1;DOK1;PSTPIP1;ABCA1;PTPRM;ITM2C;STAT1;CEP250;ITGA2;ACSL3;CUL7;ITGA3;LAMC2;PTGES;CAV1;CLU;PRKCZ;OAS2;EHD3;PRDX5;PIK3R1;TMEM173;TSTD1;PRKACB;STOM;SNCA;FLOT2;CDH13;CALR;CST3;MEIS2;ANXA6;AKAP13;TRAK1;FBXW8;SYNC;STK16;NDRG1;PRKCA;ANXA2;TAF8;MAGI2;PIKFYVE;RHBDD2;ATRAID;GALNT2;PPARG;INF2;OBSL1;PRR7;DEF6;RARA;CAPN6;SEPT9;ADAM10;GBP3;NFKBIE
11840,GO:0046854,0.18262891984951,0.894323283085063,11,65,phosphatidylinositol phosphorylation,BP,PIK3C2G;IRS2;EGFR;PDGFA;KITLG;FYN;PIK3R1;FGFR1;EFR3A;PIKFYVE;PIK3C2B
4744,GO:0010919,0.182681757056851,0.96451078898068,2,7,regulation of inositol phosphate biosynthetic process,BP,NTSR1;SNCA
13275,GO:0052047,0.18286417436471,1,1,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,FN1
18729,GO:1904235,0.18286417436471,1,1,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,FN1
18730,GO:1904237,0.18286417436471,1,1,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,FN1
20225,GO:2001202,0.18286417436471,1,1,1,negative regulation of transforming growth factor-beta secretion,BP,FN1
2264,GO:0005184,0.182881935874611,0.987844852015843,1,3,neuropeptide hormone activity,MF,CCK
11251,GO:0045580,0.182912487092893,0.893281066833379,11,77,regulation of T cell differentiation,BP,TGFBR2;BMP4;GLI3;GLI2;PRKCZ;IL18;SOX13;ITPKB;BCL6;RARA;ZBTB1
5348,GO:0016125,0.182915979420378,0.88357516895721,15,110,sterol metabolic process,BP,ABCA1;SORL1;SEC14L2;OSBPL5;ACACB;CAT;G6PD;DGKQ;TRERF1;LEPR;CYP4V2;OSBPL1A;LMF1;RXRA;ACAA2
11870,GO:0046914,0.182926035305841,0.846967976133865,88,729,transition metal ion binding,MF,CPA4;MMP2;MMP9;MMP28;MARCH4;ANPEP;NOS1;UTRN;PEG10;TCHH;TRIM2;RNF165;TIMP2;VDR;APOBEC3C;TRIM38;NR1D1;XAF1;TRIM5;NR3C1;TP53;EXTL2;PRICKLE1;ZCCHC11;MMP19;TIMP1;FLG;CHD3;P3H2;XDH;GLI2;PIAS3;ZNF318;PHC2;APOBEC3G;ANG;APLP2;PHF2;SNCA;MME;GATAD1;APOBEC3F;ALOX15B;SEC24D;KDM4C;TRAF1;LMCD1;DTNB;L3MBTL3;CALR;MDM2;NR2F2;ZMAT3;CYP20A1;RNPEP;MAP3K1;PTPN1;CRIP2;ARHGEF2;EGR1;ENPP1;PRKCA;PRIMPOL;AMZ2;ADAMTS15;HLTF;RNF24;LANCL1;TES;PRNP;THRA;ZADH2;CYP4V2;MSRB2;PPM1M;NPEPL1;TH;PIKFYVE;SAP30L;GALNT2;PPARG;KLF7;RARA;MPPE1;KDM4A;RNPEPL1;LITAF;RXRA
4845,GO:0014062,0.182937785951869,0.990775088219268,1,2,regulation of serotonin secretion,BP,HTR1B
7045,GO:0030834,0.183006228658031,0.916322671909394,6,32,regulation of actin filament depolymerization,BP,GSN;SPTB;SEMA5A;TRIOBP;CAPG;LIMA1
19021,GO:1904894,0.18307266484593,0.914936209875811,6,40,positive regulation of STAT cascade,BP,PTK6;FYN;IL31RA;CTF1;IL18;ISL1
20056,GO:2000736,0.183338904836562,0.886674863796564,13,121,regulation of stem cell differentiation,BP,SOX6;ZFP36L2;BMP4;PRICKLE1;TP73;LTBP3;PSMB9;KDM4C;SOX9;TCF12;TGFB2;YAP1;GDNF
7238,GO:0031205,0.183439097844362,0.990721754935703,1,2,endoplasmic reticulum Sec complex,CC,DNAJC3
6648,GO:0030007,0.183659269082554,0.964199299111087,2,7,cellular potassium ion homeostasis,BP,KCNMA1;KCTD7
7976,GO:0032604,0.183771624267788,0.962982135760071,2,8,granulocyte macrophage colony-stimulating factor production,BP,IL18;ISL1
8002,GO:0032645,0.183771624267788,0.962982135760071,2,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,IL18;ISL1
19565,GO:1990698,0.183827082363773,0.990680361442464,1,2,palmitoleoyltransferase activity,MF,CPT1A
19839,GO:2000341,0.183993730951613,0.961308347036134,2,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MAP2K5;POSTN
15220,GO:0071417,0.184011669740093,0.855210233119174,49,375,cellular response to organonitrogen compound,BP,MMP2;FBN1;SFRP1;ZFP36L1;COL5A2;PKD2;IRS2;PDGFC;EGFR;SLC8A1;SESN3;PAK1;STAT1;GNG2;TP53;SESN1;LRP1;FYN;CPS1;CAV1;PRKCZ;PXN;PIK3R1;PRKACB;SNCA;COL16A1;IGF1R;PDE4D;MDM2;GCLC;PTPN1;ARHGEF2;SSH1;EGR1;SOX9;ENPP1;RAB13;HTR1B;PRNP;HSPA5;TH;ITPR2;CACNB1;KLF5;PPARG;COL4A1;TAF1;MYO1C;C2CD5
16666,GO:0097644,0.184064771517409,0.990654952353601,1,2,calcitonin family binding,MF,CALCRL
18383,GO:1903439,0.184064771517409,0.990654952353601,1,2,calcitonin family receptor complex,CC,CALCRL
19493,GO:1990406,0.184064771517409,0.990654952353601,1,2,CGRP receptor complex,CC,CALCRL
19495,GO:1990408,0.184064771517409,0.990654952353601,1,2,calcitonin gene-related peptide receptor signaling pathway,BP,CALCRL
12215,GO:0048511,0.184103246805818,0.868318000093679,26,187,rhythmic process,BP,MAGED1;AXL;EGFR;SERPINE1;NR1D1;TP53;MMP19;SIK1;KLF9;SLIT3;PER1;CPT1A;SETX;NCOA2;NAGLU;CST3;EGR1;CRTC1;NCOR1;TGFB2;TEF;TH;PPARG;FZD4;NPAS2;OXTR
3399,GO:0007182,0.184145673465554,0.965679699000719,2,6,common-partner SMAD protein phosphorylation,BP,TGFBR2;BMP4
9078,GO:0035358,0.184240913606178,0.964013402254816,2,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;CITED2
13396,GO:0052827,0.184262178783366,0.990633820303724,1,2,inositol pentakisphosphate phosphatase activity,MF,ITPK1
16375,GO:0097028,0.184273960449568,0.94396890117901,3,16,dendritic cell differentiation,BP,TGFBR2;GAS6;AXL
17936,GO:1902337,0.184475799164507,0.963938214698519,2,7,regulation of apoptotic process involved in morphogenesis,BP,VDR;TGFB2
18942,GO:1904748,0.184475799164507,0.963938214698519,2,7,regulation of apoptotic process involved in development,BP,VDR;TGFB2
3110,GO:0006690,0.184547059690719,0.902800620330819,8,59,icosanoid metabolic process,BP,PTGS1;GPX1;PTGES;CES2;CBR1;ALOX15B;GGT7;ZADH2
15680,GO:0072262,0.184620420914673,0.990595403697729,1,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,EGR1
15698,GO:0072301,0.184620420914673,0.990595403697729,1,2,regulation of metanephric glomerular mesangial cell proliferation,BP,EGR1
12590,GO:0050801,0.184940993002327,0.853227855779052,52,423,ion homeostasis,BP,F2R;SLC7A8;GJA5;PKD2;JPH2;CYBRD1;NOS1;EGFR;SLC8A1;NTSR1;ABCA1;VDR;NEO1;KCNMA1;TP53;DDIT3;DLG4;FYN;IFI6;CPS1;CAV1;PLA2G6;SLC22A17;CAMK2D;CCK;HERPUD1;ANK3;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;FAM20A;ANXA6;GCLC;ENPP1;TMEM175;KCTD7;ABCC2;PRNP;SCNN1A;FHL1;SFXN3;SLC9A4;ITPR2;KLHL3;PTPN3;SV2A;STEAP2;OXTR;DMPK
12439,GO:0050294,0.185053825534643,0.987540517995097,1,3,steroid sulfotransferase activity,MF,SULT1E1
9671,GO:0038066,0.185077784040919,0.921990977718847,5,28,p38MAPK cascade,BP,GADD45B;ZFP36L1;XDH;PER1;SASH1
12073,GO:0048087,0.185252955160955,0.963688965835738,2,7,positive regulation of developmental pigmentation,BP,KITLG;HPS4
2315,GO:0005319,0.185290926604279,0.889024807710116,12,80,lipid transporter activity,MF,PITPNM3;OSBPL10;ATP10D;ABCA1;ANO6;SLC27A1;OSBPL5;ATP8B2;SLC27A6;OSBPL1A;PITPNC1;ABCA5
14075,GO:0060940,0.185508650534453,0.990499777315649,1,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,PDCD4
3787,GO:0008356,0.185549289100494,0.944993299211881,3,13,asymmetric cell division,BP,ETV5;ARHGEF2;RGS14
8693,GO:0034350,0.18568493711173,0.963550102903571,2,7,regulation of glial cell apoptotic process,BP,GAS6;PRKCA
8694,GO:0034351,0.18568493711173,0.963550102903571,2,7,negative regulation of glial cell apoptotic process,BP,GAS6;PRKCA
4277,GO:0009648,0.185756484769785,0.931252955675335,4,21,photoperiodism,BP,TP53;SIK1;PER1;CRTC1
4908,GO:0014850,0.185776686555246,0.944276131096914,3,14,response to muscle activity,BP,ITGA2;TNS2;POSTN
12581,GO:0050787,0.185787269306145,0.990469670892836,1,2,detoxification of mercury ion,BP,ABCC2
17802,GO:1901988,0.185795041187168,0.867331957778067,25,215,negative regulation of cell cycle phase transition,BP,CDKN2B;ZFP36L1;PKD2;ZFP36L2;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;HMGA2;KANK2;TP73;CHEK2;FBXL7;PSMB9;FOXN3;ATM;MDM2;RBL2;FHL1;CTDSP2;KLHL22;CDK5RAP3;TAOK3
2586,GO:0005883,0.18591708907047,0.963475382544119,2,7,neurofilament,CC,NEFM;NEFL
8105,GO:0032804,0.186054014998872,0.990440797957804,1,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
19708,GO:2000105,0.18613583612022,0.944736292392537,3,13,positive regulation of DNA-dependent DNA replication,BP,BMP4;E2F7;FGFR1
10571,GO:0043559,0.186161090804725,0.967507457021342,2,5,insulin binding,MF,PIK3R1;IGF1R
10822,GO:0044338,0.186304054494887,0.990413689362874,1,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,FZD1
13476,GO:0055074,0.186505131297658,0.865345421860481,27,203,calcium ion homeostasis,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;VDR;DDIT3;DLG4;FYN;CAV1;PLA2G6;CAMK2D;HERPUD1;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;FAM20A;ANXA6;PRNP;ITPR2;SV2A;OXTR;DMPK
709,GO:0001935,0.186566239150599,0.885515210131697,13,88,endothelial cell proliferation,BP,PTPRM;BMP4;STAT1;SEMA5A;XDH;CAV1;ANG;FGFR1;SULF1;CDH13;NR2F2;PRKCA;PPARG
2252,GO:0005168,0.186583750282,0.964929423704175,2,6,neurotrophin TRKA receptor binding,MF,PIK3R1;EFNA5
14614,GO:0070228,0.186888959198672,0.912626856464733,6,40,regulation of lymphocyte apoptotic process,BP,IRS2;TSC22D3;BMP4;TP53;BCL6;LGALS3
9455,GO:0036092,0.187253174859097,0.908753186080924,7,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3C2G;IRS2;PIK3R1;FGFR1;ATM;PIKFYVE;PIK3C2B
2531,GO:0005790,0.18741321049284,0.930070766204887,4,22,smooth endoplasmic reticulum,CC,CALR;HSPA5;TH;DNAJC3
16881,GO:0098876,0.187445684122072,0.893637672775384,10,65,vesicle-mediated transport to the plasma membrane,BP,NSG1;ACSL3;OSBPL5;BBS2;ANK3;BBS1;VPS39;GOPC;CHIC2;STEAP2
3601,GO:0008038,0.187485155073904,0.922524960717812,5,22,neuron recognition,BP,NTM;SEMA5A;ROBO1;EFNB3;MEGF8
3015,GO:0006563,0.187601664133347,0.960064218647895,2,10,L-serine metabolic process,BP,PHGDH;SRR
1978,GO:0004698,0.187604457379544,1,1,1,calcium-dependent protein kinase C activity,MF,PRKCA
9096,GO:0035403,0.187604457379544,1,1,1,histone kinase activity (H3-T6 specific),MF,PRKCA
9101,GO:0035408,0.187604457379544,1,1,1,histone H3-T6 phosphorylation,BP,PRKCA
20045,GO:2000707,0.187604457379544,1,1,1,positive regulation of dense core granule biogenesis,BP,PRKCA
12276,GO:0048638,0.187669036833411,0.863072677178504,29,198,regulation of developmental growth,BP,FN1;SFRP1;TGFBR2;DUSP6;DPYSL2;PAK1;BMP4;PTPRS;SEMA5A;ULK2;SYT1;ACACB;BBS2;JARID2;TP73;PLXNA2;FGFR1;SEMA4A;G6PD;TGFBR3;BBS4;PLXNA1;NRK;MEGF8;AGRN;SEMA4B;YAP1;EFNA5;NIPBL
11225,GO:0045446,0.187776884324661,0.890542275999789,11,67,endothelial cell differentiation,BP,BMP4;COL18A1;PTPRS;BTG1;GPX1;PDPN;XDH;LAMA5;PDE4D;ENG;NR2F2
1386,GO:0003294,0.187831254116755,0.990247189981658,1,2,atrial ventricular junction remodeling,BP,GJA5
4559,GO:0010645,0.187831254116755,0.990247189981658,1,2,regulation of cell communication by chemical coupling,BP,GJA5
4565,GO:0010652,0.187831254116755,0.990247189981658,1,2,positive regulation of cell communication by chemical coupling,BP,GJA5
2698,GO:0006066,0.187874196495658,0.862397386388058,29,232,alcohol metabolic process,BP,SULT1E1;INPP5D;ITPK1;TKFC;NTSR1;ABCA1;VDR;ISYNA1;SORL1;SEC14L2;OSBPL5;ACSS1;SDR16C5;ALDH3A2;ACACB;CAT;PLCH2;SNCA;FGFR1;G6PD;DGKQ;ACSS2;ITPKB;TRERF1;LEPR;OSBPL1A;LMF1;RXRA;ACAA2
2283,GO:0005243,0.187910514263428,0.961609225455554,2,8,gap junction channel activity,MF,GJA5;GJC2
12360,GO:0048791,0.188123639805272,0.931268724356754,4,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT8;SYTL1;SYT1;C2CD4C
3292,GO:0006987,0.188314715532966,0.96147400584162,2,8,activation of signaling protein activity involved in unfolded protein response,BP,PTPN1;HSPA5
8967,GO:0035091,0.18831753453262,0.864969054533295,26,184,phosphatidylinositol binding,MF,JPH2;PIK3C2G;HS1BP3;ARAP1;NISCH;HIP1;SNX1;PLEK2;ASAP1;SNX33;OSBPL5;SNX29;SYT1;FZD7;ESYT2;SNX10;ANXA2;SNX7;ITPR2;SAP30L;PITPNC1;SNX9;MPPE1;PIK3C2B;SBF2;VPS36
2199,GO:0005085,0.188439914900947,0.85898333029852,34,228,guanyl-nucleotide exchange factor activity,MF,IRS2;DNMBP;DOCK9;EGFR;SPTB;DOCK5;ALS2CL;RIN2;NEFL;VAV3;PLEKHG3;ARHGEF1;DLG4;PDGFA;DOCK4;KITLG;FYN;ARHGEF12;DOCK11;IQSEC2;CAMK2D;HPS4;FGFR1;OBSCN;ARHGEF17;AKAP13;FGD4;ARHGEF2;RET;VAV2;ARHGEF19;GDNF;SBF2;DOCK1
19137,GO:1905203,0.188481215367305,0.990175846703884,1,2,regulation of connective tissue replacement,BP,PPP3CA
13318,GO:0052405,0.188661909823118,0.987025805198167,1,3,negative regulation by host of symbiont molecular function,BP,ANXA2
9369,GO:0035924,0.188741285576902,0.920170485465059,5,27,cellular response to vascular endothelial growth factor stimulus,BP,CCBE1;XDH;ROBO1;ADGRA2;MYO1C
14618,GO:0070232,0.188769655275712,0.928795066873177,4,24,regulation of T cell apoptotic process,BP,TSC22D3;BMP4;TP53;LGALS3
9893,GO:0042246,0.188851278483212,0.919406591044419,5,30,tissue regeneration,BP,TGFBR2;GSN;GPX1;FZD7;POSTN
992,GO:0002455,0.188950110474707,0.941457640464393,3,17,humoral immune response mediated by circulating immunoglobulin,BP,CLU;SERPING1;C5
18582,GO:1903892,0.189147845841754,0.990102373766424,1,2,negative regulation of ATF6-mediated unfolded protein response,BP,WFS1
15875,GO:0072676,0.189511450774415,0.911170626866025,6,39,lymphocyte migration,BP,GAS6;CXCL14;PYCARD;RET;GCSAM;ADAM10
10242,GO:0043000,0.189589873000015,0.990053487907822,1,2,Golgi to plasma membrane CFTR protein transport,BP,GOPC
6450,GO:0021778,0.189625824098948,1,1,1,oligodendrocyte cell fate specification,BP,SOX6
6451,GO:0021779,0.189625824098948,1,1,1,oligodendrocyte cell fate commitment,BP,SOX6
6452,GO:0021780,0.189625824098948,1,1,1,glial cell fate specification,BP,SOX6
876,GO:0002237,0.1896691495749,0.864284069630771,25,209,response to molecule of bacterial origin,BP,TNFRSF6B;F2R;NOS1;AXL;SERPINE1;ABCA1;VDR;NR1D1;TRIM5;PDCD4;PYCARD;PTGES;CPS1;SNCA;PDE4D;IL18;PRKCA;ABCC2;CDK19;TH;SRR;SASH1;RARA;FOS;LITAF
11176,GO:0045321,0.189764040104961,0.840905114568094,87,766,leukocyte activation,BP,PYGB;MMP9;INPP5D;SFRP1;ZFP36L1;TGFBR2;IL20RB;GSN;IRS2;ZFP36L2;ANPEP;GAS6;AXL;SLC2A3;TIMP2;PAK1;BMP4;EIF2AK4;VAV3;LGALS1;PYCARD;GPNMB;ANO6;GLI3;DLG5;KCNAB2;FYN;CAV1;GLI2;DOCK11;MAP3K14;CLU;CXCR1;PRKCZ;IL31RA;METTL7A;ULBP1;PIK3R1;TMEM173;CAT;BTN3A1;STOM;TLR3;SNCA;FLOT2;MME;FZD7;PAG1;MLEC;SEMA4A;IL18;FZD8;SOX13;ATM;EFNB3;CST3;MANBA;IFNK;IFNE;CD1D;EGR1;ITPKB;BCL6;PRCP;NFASC;NDRG1;ANXA2;LEPR;MAN2B1;MOSPD2;PRNP;ZFPM1;DNASE1L1;LEF1;ITM2A;IGFBP2;RSAD2;NAPRT;LGALS3;DNAJC3;RARA;ZBTB1;PPP3CA;ACTR1B;ADAM10;S100A11;CTSD
17675,GO:1901606,0.189826954135656,0.899234902041374,8,60,alpha-amino acid catabolic process,BP,PRODH;NOS1;GLDC;HIBADH;ALDH4A1;THNSL2;ALDH7A1;GSTZ1
523,GO:0001618,0.189842588586322,0.905278698632036,7,43,virus receptor activity,MF,ITGB6;ITGB5;ANPEP;AXL;EGFR;ITGA2;EFNB3
17157,GO:0104005,0.189842588586322,0.905278698632036,7,43,hijacked molecular function,MF,ITGB6;ITGB5;ANPEP;AXL;EGFR;ITGA2;EFNB3
3936,GO:0008627,0.189911263244897,0.962179547660998,2,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,SCN2A;ARHGEF2
15305,GO:0071556,0.189924639940239,0.940653873946628,3,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,PKD2;CALR;SPPL2B
16732,GO:0098553,0.189924639940239,0.940653873946628,3,18,lumenal side of endoplasmic reticulum membrane,CC,PKD2;CALR;SPPL2B
6497,GO:0021873,0.189985947998593,0.963870746144684,2,6,forebrain neuroblast division,BP,FGFR1;LEF1
14210,GO:0061213,0.190015373485085,0.941846894107324,3,15,positive regulation of mesonephros development,BP,MAGED1;SOX9;GDNF
9896,GO:0042253,0.190049705888454,0.990002490809551,1,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,IL18
18197,GO:1903025,0.190075205930801,0.960882691179536,2,8,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TAF1
18228,GO:1903078,0.190269738955176,0.905456333315929,7,40,positive regulation of protein localization to plasma membrane,BP,EGFR;ACSL3;ITGA3;LRP1;PIK3R1;ARF6;PRNP
1309,GO:0003158,0.190288738010687,0.885684597465283,12,76,endothelium development,BP,GJA5;BMP4;COL18A1;PTPRS;BTG1;GPX1;PDPN;XDH;LAMA5;PDE4D;ENG;NR2F2
7603,GO:0032000,0.190355287854679,0.966287808376922,2,5,positive regulation of fatty acid beta-oxidation,BP,IRS2;CPT1A
2253,GO:0005169,0.190716264644107,0.989928309708056,1,2,neurotrophin TRKB receptor binding,MF,EFNA5
2515,GO:0005771,0.190720341216166,0.927519402812138,4,25,multivesicular body,CC,EGFR;NSG1;BACE1;CST3
6682,GO:0030060,0.190758981750994,0.986721384169307,1,3,L-malate dehydrogenase activity,MF,PHGDH
6670,GO:0030041,0.191084792816202,0.873744462363708,17,126,actin filament polymerization,BP,GSN;SPTB;PYCARD;ARHGAP18;ARPIN;KANK2;ANG;TRIOBP;BBS4;ARF6;FHOD3;CDC42EP5;MSRB2;CAPG;WIPF1;RASA1;MYO1C
5279,GO:0015937,0.191156349265138,0.958822177584763,2,10,coenzyme A biosynthetic process,BP,DCAKD;PPCS
9607,GO:0036491,0.191164805009996,0.961768859132117,2,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,EIF2AK4;DNAJC3
7145,GO:0031016,0.191296837674457,0.904646048133122,7,41,pancreas development,BP,BMP4;PPDPF;WFS1;MEIS2;SOX9;ISL1;NPHP3
8242,GO:0033033,0.191435591422214,0.960423126536958,2,8,negative regulation of myeloid cell apoptotic process,BP,KITLG;ITPKB
10343,GO:0043178,0.191529525465303,0.899282519173253,8,48,alcohol binding,MF,OSBPL10;PROM2;ABCA1;CAV1;OSBPL5;ASTN2;ANXA6;ITPR2
14907,GO:0070820,0.191564589957243,0.87905701456652,14,106,tertiary granule,CC,MMP9;SLC2A3;TIMP2;ANO6;KCNAB2;METTL7A;STOM;VAMP1;CST3;PRCP;NFASC;LGALS3;ADAM10;CTSD
1742,GO:0004344,0.191637451023331,1,1,1,glucose dehydrogenase activity,MF,H6PD
12028,GO:0047936,0.191637451023331,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
3023,GO:0006572,0.191726466493446,0.986579630562179,1,3,tyrosine catabolic process,BP,GSTZ1
399,GO:0001076,0.191870596427488,0.867567504185256,21,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,VDR;NR1D1;SMARCA2;CITED4;NR3C1;TP53;SDR16C5;TCF4;CITED2;ISL1;MYBL1;TRERF1;THRA;YAP1;PPARG;PARP15;MEF2A;RARA;TAF1;FOS;MED12
4582,GO:0010677,0.191907187435841,0.928439717742877,4,20,negative regulation of cellular carbohydrate metabolic process,BP,DDIT4;SIK1;ENPP1;LEPR
3026,GO:0006575,0.191962915201572,0.874378341139368,16,134,cellular modified amino acid metabolic process,BP,PRODH;OSBPL10;CRTAP;GPX1;PTGES;ERO1B;MTHFR;SLC27A1;OSBPL5;ALDH1L2;G6PD;GCLC;ALDH4A1;GGT7;ALDH7A1;GSTZ1
15951,GO:0080144,0.192065774254257,0.989777189166146,1,2,amino acid homeostasis,BP,KCTD7
17895,GO:1902235,0.192270165995591,0.926699631457922,4,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3;HERPUD1;WFS1;PTPN1
13223,GO:0051930,0.192405853767338,0.94131515687733,3,14,regulation of sensory perception of pain,BP,F2R;NTSR1;CCK
13224,GO:0051931,0.192405853767338,0.94131515687733,3,14,regulation of sensory perception,BP,F2R;NTSR1;CCK
1107,GO:0002697,0.192880373626731,0.861786830171998,25,202,regulation of immune effector process,BP,HTRA1;IL20RB;HERC5;TKFC;EIF2AK4;STAT1;PYCARD;IFIT1;DDX60;SEC14L1;CLU;SERPING1;PRKCZ;TMEM173;APOBEC3G;TLR3;APOBEC3F;C5;IL18;BCL6;TGFB2;RSAD2;LGALS3;RARA;ZBTB1
4534,GO:0010612,0.1929205984057,0.962946603691773,2,6,regulation of cardiac muscle adaptation,BP,LMNA;PPP3CA
18288,GO:1903242,0.1929205984057,0.962946603691773,2,6,regulation of cardiac muscle hypertrophy in response to stress,BP,LMNA;PPP3CA
15154,GO:0071320,0.193001262043734,0.910556206576596,6,31,cellular response to cAMP,BP,ZFP36L1;PKD2;SLC8A1;CPS1;HSPA5;ITPR2
15949,GO:0080134,0.193033396709368,0.834719094645304,112,980,regulation of response to stress,BP,SERPINE2;FLOT1;MMP2;HTRA1;CTGF;SFRP1;GADD45B;CD109;F2R;TGFBR2;IL20RB;HERC5;TNIK;SNAI2;EGFR;SESN3;MYLK;SERPINE1;TKFC;MAP3K6;PAK1;NR1D1;EIF2AK4;TRIM5;PDCD4;STAT1;TP53;PTPRS;DDIT3;PYCARD;IFIT1;DDX60;MUC19;ITGA2;PDGFA;ANO6;GPX1;PDPN;SESN1;SEC14L1;FYN;XDH;CAV1;RNF135;ERCC6;CLU;SERPING1;HMGA2;CAMK2D;PER1;PIK3R1;TMEM173;APOBEC3G;HERPUD1;WFS1;TP73;PRKACB;CHEK2;TLR3;SNCA;FZD7;IGF1R;APOBEC3F;LMNA;DKK1;C5;TGM2;PSMB9;IL18;PLA2R1;EDA2R;FZD8;MAGEF1;FZD1;ATM;MDM2;IFNK;CD1D;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;ISL1;BCL6;NCOR1;PRKCA;ANXA2;CXORF57;TGFB2;GGT7;STAT2;MAPK8IP3;CDKN2A;HSPA5;CDK19;RSAD2;MDFIC;VPS13C;DERL3;PPARG;CALCRL;SASH1;DNAJC3;POLH;FZD4;PPP3CA;FAM168A;NPAS2;ABAT;EDEM1;TAOK3
8736,GO:0034405,0.193049172713616,0.917460654204746,5,28,response to fluid shear stress,BP,PKD2;TFPI2;ABCA1;CITED2;MAP2K5
514,GO:0001579,0.193071419831225,0.98966376048926,1,2,medium-chain fatty acid transport,BP,SLC27A1
19095,GO:1905064,0.193090817913097,0.989661565693391,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDCD4
13504,GO:0055114,0.193187207080914,0.840011637251841,74,712,oxidation-reduction process,BP,PYGB;PRODH;NQO1;PTGS1;IRS2;CYBRD1;H6PD;NOS1;SESN3;TP53I3;NR1D1;D2HGDH;MICAL1;PHGDH;BCKDHB;TYSND1;GPX1;PTGES;P3H2;ECH1;ERO1B;MTHFR;SESN1;KCNAB2;XDH;GLDC;ACSS1;SDR16C5;PRDX5;HIBADH;PDIA4;ALDH3A2;CPT1A;ACACB;PHKA2;TSTD1;CAT;PHF2;SNCA;ALDH1L2;PDIA6;CBR1;ALOX15B;PYROXD2;G6PD;DHTKD1;KDM4C;NFATC4;IDH2;HSD17B11;ACSS2;AKR7A2;CYP20A1;NDUFA4L2;ALDH4A1;ENPP1;LEPR;ALDH9A1;DECR1;ZADH2;ALDH7A1;CYP4V2;MSRB2;DHRS12;TH;GPX8;C5ORF63;PPARG;DPYD;STEAP2;KDM4A;EHHADH;CPT2;ACAA2
11300,GO:0045647,0.193262217310105,0.959802442295077,2,8,negative regulation of erythrocyte differentiation,BP,ZFP36L1;KLF13
5681,GO:0016803,0.193400510078503,0.958029739241427,2,10,ether hydrolase activity,MF,AKR7A2;RNPEP
7020,GO:0030804,0.193491534268011,0.94026949583118,3,15,positive regulation of cyclic nucleotide biosynthetic process,BP,NOS1;TIMP2;GPR161
9955,GO:0042362,0.193528658380639,0.958743410343688,2,9,fat-soluble vitamin biosynthetic process,BP,SNAI2;VDR
2538,GO:0005798,0.193561448339842,0.870135366505798,18,136,Golgi-associated vesicle,CC,COL7A1;CLTCL1;PACS1;BACE1;SEC24D;COPG2;TMED10;AREG;VANGL2;KLHL12;STK16;RAB13;SPPL2B;GOPC;CHIC2;RASSF9;STEAP2;ADAM10
6247,GO:0019834,0.193569986194237,0.986307228488223,1,3,phospholipase A2 inhibitor activity,MF,ANXA2
13580,GO:0060079,0.193579957361854,0.902895228916868,7,43,excitatory postsynaptic potential,BP,NETO1;DLG4;PRKCZ;SNCA;SSH1;PPP3CA;DMPK
2413,GO:0005590,0.193681629380459,1,1,1,collagen type VII trimer,CC,COL7A1
16775,GO:0098648,0.193681629380459,1,1,1,collagen anchoring fibril,CC,COL7A1
16777,GO:0098652,0.193681629380459,1,1,1,collagen type VII anchoring fibril,CC,COL7A1
7186,GO:0031086,0.193696233476035,0.959654355398878,2,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36L1;PNRC1
472,GO:0001516,0.193704074513311,0.93927433790995,3,17,prostaglandin biosynthetic process,BP,PTGS1;PTGES;CBR1
11652,GO:0046457,0.193704074513311,0.93927433790995,3,17,prostanoid biosynthetic process,BP,PTGS1;PTGES;CBR1
5253,GO:0015888,0.193734003041508,0.989588645563518,1,2,thiamine transport,BP,SLC35F3
599,GO:0001767,0.193758181795718,0.962680982426554,2,6,establishment of lymphocyte polarity,BP,GSN;FLOT2
8965,GO:0035089,0.193971387218909,0.94126134181125,3,13,establishment of apical/basal cell polarity,BP,FSCN1;OPHN1;MYO9A
742,GO:0001974,0.194426470347041,0.917523518240961,5,25,blood vessel remodeling,BP,AXL;TGM2;MDM2;CST3;HOXA3
2972,GO:0006516,0.194488726528594,0.939814164520135,3,15,glycoprotein catabolic process,BP,CST3;MANBA;EDEM1
3860,GO:0008484,0.19450205427376,0.941023204935265,3,13,sulfuric ester hydrolase activity,MF,SULF2;SULF1;ARSD
17028,GO:0099541,0.194536197430505,0.989497297823709,1,2,trans-synaptic signaling by lipid,BP,F2R
17029,GO:0099542,0.194536197430505,0.989497297823709,1,2,trans-synaptic signaling by endocannabinoid,BP,F2R
17702,GO:1901658,0.194595893505202,0.924811465178647,4,28,glycosyl compound catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F;DPYD
6265,GO:0019865,0.19468581833198,0.986140886096779,1,3,immunoglobulin binding,MF,LGALS3
2156,GO:0004984,0.194724530082098,0.986135095292903,1,3,olfactory receptor activity,MF,OR2A4
12667,GO:0050911,0.194724530082098,0.986135095292903,1,3,detection of chemical stimulus involved in sensory perception of smell,BP,OR2A4
925,GO:0002323,0.19478405651769,0.958304522281256,2,9,natural killer cell activation involved in immune response,BP,IFNK;IFNE
6435,GO:0021756,0.194805828252097,0.940886727270935,3,13,striatum development,BP,BBS2;BBS4;SLITRK5
6710,GO:0030128,0.194832921887021,0.940874549188741,3,13,clathrin coat of endocytic vesicle,CC,EGFR;HIP1;TBC1D5
6556,GO:0022010,0.194882014987611,0.959248573426754,2,8,central nervous system myelination,BP,TENM4;CLU
7760,GO:0032291,0.194882014987611,0.959248573426754,2,8,axon ensheathment in central nervous system,BP,TENM4;CLU
11014,GO:0045007,0.19496137636646,0.986099636966323,1,3,depurination,BP,MUTYH
6519,GO:0021914,0.19502502889487,0.989441415372677,1,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,IFT122
610,GO:0001779,0.19502635922907,0.940129349155196,3,14,natural killer cell differentiation,BP,GAS6;AXL;ZBTB1
12619,GO:0050850,0.195208418503783,0.925989812497658,4,22,positive regulation of calcium-mediated signaling,BP,PKD2;JPH2;CDH13;LMCD1
6741,GO:0030169,0.195214868042873,0.962217059069453,2,6,low-density lipoprotein particle binding,MF,SORL1;CDH13
11950,GO:0047237,0.195268734042423,0.989413493632277,1,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,EXTL2
14219,GO:0061299,0.195363262618825,0.962169658394323,2,6,retina vasculature morphogenesis in camera-type eye,BP,COL4A1;FZD4
9132,GO:0035500,0.195484487656869,0.989388740042218,1,2,MH2 domain binding,MF,HMGA2
16073,GO:0090083,0.195524363748939,0.939903017134991,3,14,regulation of inclusion body assembly,BP,HSPA2;SORL1;CLU
11488,GO:0046006,0.195699149817538,0.924875413662297,4,25,regulation of activated T cell proliferation,BP,PYCARD;IL18;PRNP;IGFBP2
16398,GO:0097066,0.195793889180018,0.939216307492048,3,15,response to thyroid hormone,BP,KLF9;GCLC;ANXA2
1967,GO:0004679,0.195904251974162,0.960198851677226,2,7,AMP-activated protein kinase activity,MF,PRKAB2;PRKAG1
12181,GO:0048382,0.195910748805317,0.9893397399852,1,2,mesendoderm development,BP,ZFP36L1
3221,GO:0006874,0.195916746361934,0.858579947188018,26,196,cellular calcium ion homeostasis,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;VDR;DDIT3;DLG4;FYN;CAV1;PLA2G6;CAMK2D;HERPUD1;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;ANXA6;PRNP;ITPR2;SV2A;OXTR;DMPK
19497,GO:1990410,0.195916763697794,0.989339047653694,1,2,adrenomedullin receptor signaling pathway,BP,CALCRL
5710,GO:0016853,0.19613626346341,0.875138140525235,14,121,isomerase activity,MF,ITPK1;FKBP5;ISYNA1;PTGES;ECH1;ERO1B;FKBP9;PDIA4;PDIA6;DSEL;SRR;FKBP10;GSTZ1;EHHADH
6057,GO:0019210,0.196155571120137,0.887053797008602,10,72,kinase inhibitor activity,MF,FLRT2;CDKN2B;FLRT3;WNK1;TRIB2;SPRY2;CDKN2A;DNAJC3;CAMK2N1;TAOK3
17848,GO:1902109,0.196305508475068,0.98589746073736,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2
19693,GO:2000060,0.196318189476192,0.883524118780219,11,81,positive regulation of ubiquitin-dependent protein catabolic process,BP,PRICKLE1;CAV1;TRIB2;CLU;HERPUD1;MAGEF1;MDM2;GCLC;NUB1;RNF144B;TAF1
18050,GO:1902667,0.196345073242327,0.909368903614242,6,28,regulation of axon guidance,BP,SEMA5A;PLXNA2;SEMA4A;PLXNA1;MEGF8;SEMA4B
13642,GO:0060197,0.196398504855432,0.989283516411591,1,2,cloacal septation,BP,BMP4
4588,GO:0010701,0.196476690854349,0.989274488579583,1,2,positive regulation of norepinephrine secretion,BP,OXTR
10019,GO:0042491,0.196478484086817,0.926050764211957,4,20,inner ear auditory receptor cell differentiation,BP,SLITRK6;FGFR1;TRIOBP;LRTOMT
11700,GO:0046527,0.196670178008043,0.93938108366608,3,14,glucosyltransferase activity,MF,POGLUT1;ALG10;UGGT2
6968,GO:0030644,0.196685466949613,0.989250361235916,1,2,cellular chloride ion homeostasis,BP,ABCC2
10229,GO:0042983,0.196742388110831,0.957615923835426,2,9,amyloid precursor protein biosynthetic process,BP,ITM2C;ITM2A
10230,GO:0042984,0.196742388110831,0.957615923835426,2,9,regulation of amyloid precursor protein biosynthetic process,BP,ITM2C;ITM2A
19009,GO:1904879,0.196772056536076,0.989240345580417,1,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
14096,GO:0060988,0.196820796530296,0.989234705627314,1,2,lipid tube assembly,BP,SNX9
6152,GO:0019482,0.196900092549636,0.989225526356715,1,2,beta-alanine metabolic process,BP,DPYD
2398,GO:0005545,0.196955204683519,0.940710847160272,3,12,1-phosphatidylinositol binding,MF,SYT1;SNX10;SNX9
6442,GO:0021766,0.197085861169233,0.895476573331039,8,49,hippocampus development,BP,NEFL;PTPRS;GLI3;BBS2;BBS4;DLX2;LEF1;RARA
4535,GO:0010613,0.197286499205829,0.926059618884085,4,19,positive regulation of cardiac muscle hypertrophy,BP,CAMK2D;PRKCA;MEF2A;PPP3CA
4875,GO:0014742,0.197286499205829,0.926059618884085,4,19,positive regulation of muscle hypertrophy,BP,CAMK2D;PRKCA;MEF2A;PPP3CA
5503,GO:0016460,0.197310489589946,0.930331934849813,4,13,myosin II complex,CC,TTN;SHROOM4;OBSL1;MYH11
5890,GO:0018095,0.197600036834274,0.958311868191374,2,8,protein polyglutamylation,BP,TTLL11;TPGS1
13834,GO:0060479,0.197726146345173,0.9395688033573,3,13,lung cell differentiation,BP,SOX9;THRA;YAP1
13863,GO:0060534,0.197805971024203,0.959561211775074,2,7,trachea cartilage development,BP,SOX9;RARA
11865,GO:0046903,0.197906002752582,0.830076014478469,114,996,secretion,BP,SERPINE2;ITGB6;SYT8;FN1;PCDH7;PYGB;MMP9;CTGF;SFRP1;CD109;F2R;ANO1;GSN;GJA5;IRS2;ANPEP;GAS6;AXL;EGFR;SLC2A3;SERPINE1;ENDOD1;ANXA5;NTSR1;TIMP2;PAK1;ABCA1;VDR;NR1D1;PYCARD;WNK1;PDGFA;MICAL1;NISCH;TIMP1;ACSL3;ANO6;SYN1;MAGED2;KCNAB2;XDH;LTBP4;CAV1;PLA2G6;SEL1L;CLU;SERPING1;CXCR1;PRKCZ;OAS2;SYTL1;METTL7A;PDIA4;CCK;SYT1;TMEM173;CPT1A;SLC38A2;PCLO;ANG;TTN;APLP2;CAT;BTN3A1;STOM;SNCA;MME;VAMP1;FGFR1;ALOX15B;MLEC;C5;PLA2R1;ENG;IDH2;COPG2;TMED10;CST3;MANBA;ISL1;PRCP;NFASC;PRKCA;ANXA2;RAB13;SEPT5;MAN2B1;MOSPD2;ABCC2;HTR1B;TGFB2;DNASE1L1;C2CD4C;SLC9A4;RSAD2;NAPRT;ITPR2;LMF1;GDNF;POSTN;LGALS3;MIA3;DNAJC3;SV2A;EFNA5;FZD4;PPP3CA;STEAP2;ACTR1B;ABAT;OXTR;ADAM10;S100A11;CTSD
18221,GO:1903069,0.197957932916592,0.957186078752718,2,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,CAV1;HERPUD1
8606,GO:0034139,0.197959286887847,0.958187375319009,2,8,regulation of toll-like receptor 3 signaling pathway,BP,FLOT1;CAV1
6928,GO:0030546,0.197967924165865,0.959506706585266,2,7,receptor activator activity,MF,DGKQ;EFNA5
8267,GO:0033084,0.198031777716734,0.989094046944074,1,2,regulation of immature T cell proliferation in thymus,BP,BMP4
8270,GO:0033088,0.198031777716734,0.989094046944074,1,2,negative regulation of immature T cell proliferation in thymus,BP,BMP4
2305,GO:0005294,0.198157911237664,1,1,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,SLC7A11
5080,GO:0015327,0.198157911237664,1,1,1,cystine:glutamate antiporter activity,MF,SLC7A11
5081,GO:0015328,0.198157911237664,1,1,1,cystine secondary active transmembrane transporter activity,MF,SLC7A11
17718,GO:1901680,0.198157911237664,1,1,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,SLC7A11
13718,GO:0060319,0.198358259437646,0.989055950699595,1,2,primitive erythrocyte differentiation,BP,ZFPM1
7308,GO:0031328,0.198438599621174,0.826312044420277,153,1299,positive regulation of cellular biosynthetic process,BP,SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;ETV5;PKD2;IRS2;NOS1;PDGFC;MAGED1;EGFR;RFX2;SERPINE1;VIM;NTSR1;TIMP2;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;EIF2AK4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;ITGA2;PDGFA;RBMS3;ACSL3;TFDP2;NFIX;GLI3;E2F7;KITLG;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;PLA2G6;SMARCA1;ZNF318;CLU;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CIRBP;TP73;KLF13;CHEK2;PHF2;TLR3;SNCA;FZD7;FGFR1;IGF1R;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;CST3;MEIS2;AREG;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;GPR161;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;DNAJC3;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
6363,GO:0021554,0.198811716284973,0.961060843636217,2,6,optic nerve development,BP,GLI3;NAV2
16026,GO:0086098,0.198949344056842,0.988986789854139,1,2,angiotensin-activated signaling pathway involved in heart process,BP,CAV1
16991,GO:0099173,0.199013965932908,0.88239459581112,11,69,postsynapse organization,BP,ETV5;DLG4;ITGA3;FYN;CAPRIN2;IGF1R;SSH1;NLGN4Y;PRNP;MAGI2;GDNF
6078,GO:0019239,0.199022715003215,0.923093560334671,4,25,deaminase activity,MF,APOBEC3C;ADARB1;APOBEC3G;APOBEC3F
1753,GO:0004357,0.199407477707622,0.988933017664338,1,2,glutamate-cysteine ligase activity,MF,GCLC
5823,GO:0017109,0.199407477707622,0.988933017664338,1,2,glutamate-cysteine ligase complex,CC,GCLC
16401,GO:0097069,0.199407477707622,0.988933017664338,1,2,cellular response to thyroxine stimulus,BP,GCLC
18793,GO:1904387,0.199407477707622,0.988933017664338,1,2,cellular response to L-phenylalanine derivative,BP,GCLC
12887,GO:0051260,0.199438259480295,0.855406732997311,26,215,protein homooligomerization,BP,FLOT1;PKD2;RNF213;ANGPTL4;TP53;TYSND1;CAV1;CLU;EHD3;SYT1;CPT1A;ACACB;CAT;STOM;TGM2;ANXA6;CRTC1;KCTD7;DECR1;PRNP;GOPC;KCTD14;SRR;ZBTB1;KCNRG;RXRA
5532,GO:0016525,0.199711668970382,0.885529180279847,10,60,negative regulation of angiogenesis,BP,THBS2;SERPINE1;PTPRM;STAT1;SPRY2;SEMA4A;SULF1;TGFB2;MAP2K5;PPARG
3176,GO:0006796,0.19978455890771,0.820463359935511,255,2278,phosphate-containing compound metabolic process,BP,PHACTR3;SULT1E1;FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;EFEMP1;PKD2;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;ZFP36L2;HERC5;TNIK;PROM2;H6PD;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;ITPK1;HSPA2;FLRT3;SPEG;SPTB;MYLK;GJC2;SLC20A1;MBOAT2;CSPG4;TKFC;MAP3K6;NTSR1;DCAKD;TIMP2;TADA3;PAK1;PTPRM;BMP4;ISYNA1;TP53I3;PTK6;EIF2AK4;TRIM5;NEFL;VAV3;PDCD4;SORL1;TP53;PTPRS;WWTR1;CNTRL;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;MICAL1;ADARB1;ACSL3;GPNMB;SIK1;ELFN2;GPX1;CDK14;CNTN1;LPCAT2;KITLG;CTDSPL;ABHD14B;NEK9;KCNAB2;NMRK1;FYN;XDH;ALPK1;B3GAT3;CPS1;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;OSBPL5;CLU;PRKCZ;ULK2;TNS2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;CAPRIN2;ANG;DUSP5;CDK18;PHKA2;SPRY2;TTN;FBLN1;TP73;PLCH2;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;PTPRU;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;MYO3B;PSMB9;IL18;OBSCN;PDK3;G6PD;EPHB6;EDA2R;FZD8;DHTKD1;AFAP1L2;TGFBR3;FZD1;ENG;MTMR4;ATM;IDH2;FAM20A;AREG;IFNK;AKAP13;DNAJC6;DGKQ;NR2F2;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;NT5DC3;ARHGEF2;THNSL2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;STK16;NCOR1;G6PC3;PRKCA;PRPS2;ANXA2;RGS14;ETNK2;PGAP1;IGFBP4;NMNAT2;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;GPR161;CDC42EP5;MAPK8IP3;CDKN2A;EFR3A;PPM1M;ULK1;TSPYL2;NPHP3;VAV2;MAGI2;HSPA5;CDK19;PIKFYVE;SRPK2;UVRAG;NAPRT;MDFIC;GDNF;AGPAT1;TPST1;MEF2A;SNX9;ICK;SASH1;PTPN3;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;MPPE1;PPP3CA;PIK3C2B;RASA1;CTDSP2;PPCS;DNPH1;CDK5RAP3;CAMK2N1;TTBK2;ADM2;OXTR;ADAM10;PPP2R3A;TAOK3;DMPK
9852,GO:0042129,0.199851373952791,0.880768220106276,11,85,regulation of T cell proliferation,BP,TGFBR2;IL20RB;BMP4;PYCARD;GPNMB;DLG5;IL18;CD1D;PRNP;IGFBP2;LGALS3
2410,GO:0005587,0.199973170289229,0.96341663495095,2,5,collagen type IV trimer,CC,COL4A4;COL4A1
6733,GO:0030159,0.20003000376067,0.924618211315651,4,19,receptor signaling complex scaffold activity,MF,DLG5;RGS14;MAPK8IP3;MAGI2
3018,GO:0006566,0.200130654458074,0.985313278302047,1,3,threonine metabolic process,BP,THNSL2
12317,GO:0048702,0.200142422819388,0.958771798025576,2,7,embryonic neurocranium morphogenesis,BP,HOXA1;MED12
15197,GO:0071380,0.200429489319553,0.939150796988437,3,12,cellular response to prostaglandin E stimulus,BP,SFRP1;GNG2;PPARG
16371,GO:0097021,0.200560413166807,0.988797046876347,1,2,lymphocyte migration into lymphoid organs,BP,RET
5627,GO:0016714,0.2006271966672,0.985236484599736,1,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,TH
5688,GO:0016814,0.200706984571932,0.92245229553477,4,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,APOBEC3C;ADARB1;APOBEC3G;APOBEC3F
6116,GO:0019369,0.200889979813227,0.922353710262903,4,24,arachidonic acid metabolic process,BP,PTGS1;PTGES;CBR1;ALOX15B
2418,GO:0005595,0.200899935320558,1,1,1,collagen type XII trimer,CC,COL12A1
6862,GO:0030348,0.200930153080123,0.988753245119426,1,2,syntaxin-3 binding,MF,SYT1
3793,GO:0008374,0.201097696424715,0.904360112901849,6,37,O-acyltransferase activity,MF,MBOAT2;LPCAT2;HHAT;CPT1A;AGPAT1;CPT2
1437,GO:0003417,0.201124478671731,0.957083611326081,2,8,growth plate cartilage development,BP,TGFBR2;RARA
13973,GO:0060717,0.201273586807502,0.958387233491472,2,7,chorion development,BP,HTRA1;E2F7
4017,GO:0009051,0.201306030658774,0.985131139903268,1,3,pentose-phosphate shunt, oxidative branch,BP,G6PD
7598,GO:0031995,0.201366122569575,0.958355705199546,2,7,insulin-like growth factor II binding,MF,IGFBP4;IGFBP2
1436,GO:0003416,0.201427756310146,0.937882953900132,3,13,endochondral bone growth,BP,TGFBR2;EVC;RARA
5785,GO:0017022,0.201479263067891,0.897808503897201,7,43,myosin binding,MF,GSN;AXL;PYCARD;SPATA6;TRIOBP;TRAK1;GCSAM
12120,GO:0048246,0.201496576911268,0.935246071625522,3,18,macrophage chemotaxis,BP,MMP28;C5;LGALS3
2269,GO:0005212,0.201548467145663,0.985093417074982,1,3,structural constituent of eye lens,MF,VIM
4564,GO:0010650,0.201640280429962,1,1,1,positive regulation of cell communication by electrical coupling,BP,ANK3
15862,GO:0072658,0.201640280429962,1,1,1,maintenance of protein location in membrane,BP,ANK3
15864,GO:0072660,0.201640280429962,1,1,1,maintenance of protein location in plasma membrane,BP,ANK3
17494,GO:1900827,0.201640280429962,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
2369,GO:0005499,0.201766788449625,0.98865377880405,1,2,vitamin D binding,MF,VDR
8134,GO:0032873,0.201809748401375,0.903917920726808,6,37,negative regulation of stress-activated MAPK cascade,BP,SFRP1;PDCD4;PER1;TP73;NCOR1;TAOK3
14658,GO:0070303,0.201809748401375,0.903917920726808,6,37,negative regulation of stress-activated protein kinase signaling cascade,BP,SFRP1;PDCD4;PER1;TP73;NCOR1;TAOK3
18716,GO:1904211,0.201839579054261,0.98864510165911,1,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,RHBDD1
8623,GO:0034165,0.20215202094696,0.988607814239691,1,2,positive regulation of toll-like receptor 9 signaling pathway,BP,RSAD2
7043,GO:0030832,0.202173061492411,0.863536920993178,18,132,regulation of actin filament length,BP,GSN;SPTB;PYCARD;SEMA5A;ARHGAP18;ARPIN;KANK2;TRIOBP;BBS4;ARF6;FHOD3;SSH1;CDC42EP5;CAPG;WIPF1;RASA1;LIMA1;MYO1C
14346,GO:0061614,0.202387308052027,0.904348354706464,6,33,pri-miRNA transcription by RNA polymerase II,BP,TP53;NFATC4;SOX9;TGFB2;PPARG;FOS
2352,GO:0005436,0.202436567117386,0.988573796396849,1,2,sodium:phosphate symporter activity,MF,SLC20A1
5077,GO:0015319,0.202436567117386,0.988573796396849,1,2,sodium:inorganic phosphate symporter activity,MF,SLC20A1
5078,GO:0015321,0.202436567117386,0.988573796396849,1,2,sodium-dependent phosphate transmembrane transporter activity,MF,SLC20A1
14387,GO:0061700,0.20244664637065,0.955582654847277,2,9,GATOR2 complex,CC,SESN3;SESN1
11779,GO:0046684,0.202603056519437,0.988553866046743,1,2,response to pyrethroid,BP,TH
1887,GO:0004571,0.202928223330139,0.95782190690935,2,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,MAN1A1;EDEM1
3679,GO:0008184,0.20302331768416,0.988503470288517,1,2,glycogen phosphorylase activity,MF,PYGB
17103,GO:0102250,0.20302331768416,0.988503470288517,1,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGB
17125,GO:0102499,0.20302331768416,0.988503470288517,1,2,SHG alpha-glucan phosphorylase activity,MF,PYGB
6823,GO:0030295,0.203072750890411,0.891006127862229,8,53,protein kinase activator activity,MF,GAS6;WNK1;ERCC6;SPRY2;AFAP1L2;FAM20A;DGKQ;EFNA5
3431,GO:0007223,0.203094804103046,0.904143901556628,6,32,Wnt signaling pathway, calcium modulating pathway,BP,GNG2;DKK1;LEF1;FZD4;PPP3CA;AGO4
3378,GO:0007158,0.203132805328996,0.957751778320522,2,7,neuron cell-cell adhesion,BP,NLGN4Y;RET
15451,GO:0071827,0.203269882010886,0.921691494243784,4,22,plasma lipoprotein particle organization,BP,ABCA1;ACSL3;PRKACB;ABCA5
14849,GO:0070664,0.203413155684744,0.896271624546151,7,45,negative regulation of leukocyte proliferation,BP,INPP5D;IL20RB;BMP4;GPNMB;DLG5;ATM;PRNP
11769,GO:0046658,0.203435807121345,0.920706815161275,4,25,anchored component of plasma membrane,CC,ULBP1;NTNG1;PRNP;EFNA5
7244,GO:0031214,0.203518539835635,0.879078154469655,11,70,biomineral tissue development,BP,GAS6;FBN2;SLC8A1;BMP4;GPNMB;ANO6;FAM20A;SOX9;ENPP1;ATRAID;ANKH
1405,GO:0003340,0.203522090259216,0.988443498832932,1,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,STAT1
20037,GO:2000697,0.203522090259216,0.988443498832932,1,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,STAT1
12780,GO:0051101,0.203525816641334,0.875281364713564,12,89,regulation of DNA binding,BP,MMP9;DDIT3;ITGA2;ZFP90;HMGA2;MDFI;ISL1;LEF1;SP100;PPARG;TAF1;NIPBL
3275,GO:0006956,0.203755054521365,0.935010367897449,3,16,complement activation,BP,CLU;SERPING1;C5
17828,GO:1902044,0.203772431689371,0.988413332354642,1,2,regulation of Fas signaling pathway,BP,SP100
3071,GO:0006641,0.20379878024945,0.890516461961198,8,53,triglyceride metabolic process,BP,SIK1;GPX1;CPS1;CAV1;SEL1L;CPT1A;CAT;LMF1
7185,GO:0031085,0.203879826084391,0.988400377676954,1,2,BLOC-3 complex,CC,HPS4
13615,GO:0060149,0.203884322422831,0.936057063812142,3,14,negative regulation of posttranscriptional gene silencing,BP,NCOR1;PPARG;PPP3CA
14083,GO:0060967,0.203884322422831,0.936057063812142,3,14,negative regulation of gene silencing by RNA,BP,NCOR1;PPARG;PPP3CA
10575,GO:0043565,0.203986995121134,0.827482833241341,92,748,sequence-specific DNA binding,MF,SOX6;ETV5;SNAI2;PHF21A;KLF8;RFX2;TCF7L1;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZC3H6;MEF2D;TFDP2;HIVEP1;GLI3;E2F7;ZFP90;GLI2;SLC2A4RG;TNRC18;HMGA2;GOLGB1;PER1;CREB3L2;JARID2;MLH3;TP73;KLF13;GATAD1;SETX;NCOA2;SOX13;NFATC4;FOXN3;DLX3;PBX1;FOXL1;MEIS2;TCF4;NR2F2;LMO4;MAF;EGR1;SOX9;ISL1;BCL6;PLAG1;SALL2;MYBL1;HLTF;HOXA1;BAHCC1;TCF12;HMBOX1;NFAT5;CARF;ZFPM1;DLX2;ZNF550;LEF1;THRA;SSBP3;TEF;TSPYL2;ORC4;YAP1;KLF5;HOXA3;ZNF558;MEIS3;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;HOXC5;PBX2;TAF1;CREBRF;ETV4;HOXA2;FOS;MED12;PRDM5;LITAF;RXRA
14113,GO:0061010,0.20408863523944,1,1,1,gall bladder development,BP,NIPBL
14425,GO:0061780,0.20408863523944,1,1,1,mitotic cohesin loading,BP,NIPBL
14788,GO:0070550,0.20408863523944,1,1,1,rDNA condensation,BP,NIPBL
19178,GO:1905309,0.20408863523944,1,1,1,positive regulation of cohesin loading,BP,NIPBL
19221,GO:1905405,0.20408863523944,1,1,1,regulation of mitotic cohesin loading,BP,NIPBL
19222,GO:1905406,0.20408863523944,1,1,1,positive regulation of mitotic cohesin loading,BP,NIPBL
917,GO:0002313,0.204148075982932,0.935338583671139,3,15,mature B cell differentiation involved in immune response,BP,LGALS1;DOCK11;ITM2A
12778,GO:0051099,0.204316857915778,0.861625375374721,18,140,positive regulation of binding,BP,FLOT1;MMP9;S100A10;BMP4;ITGA2;LRP1;CAV1;HMGA2;TMEM173;CAPRIN2;HERPUD1;ISL1;ANXA2;HMBOX1;PPARG;RARA;TAF1;NIPBL
16160,GO:0090210,0.204394391394399,0.988338194545325,1,2,regulation of establishment of blood-brain barrier,BP,ADGRA2
17643,GO:1901529,0.20447164003641,0.988328843269112,1,2,positive regulation of anion channel activity,BP,TCAF1
6254,GO:0019852,0.204507519460936,0.954837998591591,2,9,L-ascorbic acid metabolic process,BP,SLC2A3;GCLC
3156,GO:0006766,0.204543739794271,0.874432199433641,12,91,vitamin metabolic process,BP,SNAI2;SLC2A3;VDR;MTHFR;HLCS;ACACB;ALDH1L2;FGFR1;CBR1;GCLC;ENPP1;RXRA
1558,GO:0003960,0.204561065039997,0.984620243686206,1,3,NADPH:quinone reductase activity,MF,TP53I3
1045,GO:0002572,0.204578853243621,0.988315857691099,1,2,pro-T cell differentiation,BP,ZBTB1
13644,GO:0060199,0.204602873392143,0.988312947279761,1,2,clathrin-sculpted glutamate transport vesicle,CC,SYT1
13647,GO:0060203,0.204602873392143,0.988312947279761,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,SYT1
10337,GO:0043171,0.204682757267895,0.920600604783018,4,23,peptide catabolic process,BP,ANPEP;RNPEP;GGT7;RNPEPL1
10709,GO:0044087,0.205055157630789,0.828025507912764,83,666,regulation of cellular component biogenesis,BP,FLOT1;FLRT2;CTGF;SFRP1;SLITRK6;ASAP3;GSN;SNAI2;HSPA2;FLRT3;SPTB;THBS2;S100A10;DDB2;AMIGO2;PAK1;ABCA1;SORL1;TP53;ARAP1;PYCARD;MAP2;PHLDB1;EVI5L;TPBG;DLG5;ASAP1;EML2;ARHGAP18;CAV1;PLA2G6;DOCK11;ESPN;CLU;NPHP4;PRKCZ;ARPIN;KANK2;PXN;CCK;PIK3R1;DLC1;IFT140;SNCA;COL16A1;DKK1;FSCN1;RGS2;SETX;TRIOBP;BBS4;ATM;ARF6;AKAP13;FHOD3;LMO4;SYNE2;ARHGEF2;SSH1;SOX9;PRKCA;MPP7;IFT88;RPL13A;PODXL;THRA;CDC42EP5;LRRN3;ULK1;AGRN;PIKFYVE;FHOD1;KLF5;CAPG;SNX9;TAF1;EFNA5;SLITRK5;WIPF1;RASA1;SEPT9;OXTR;MYO1C
8936,GO:0035005,0.2051011510354,0.959002512775483,2,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3C2G;PIK3C2B
4335,GO:0009891,0.20511761301521,0.820076028503417,154,1313,positive regulation of biosynthetic process,BP,CTGF;SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;ETV5;PKD2;IRS2;NOS1;PDGFC;MAGED1;EGFR;RFX2;SERPINE1;VIM;NTSR1;TIMP2;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;EIF2AK4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;ITGA2;PDGFA;RBMS3;ACSL3;TFDP2;NFIX;GLI3;E2F7;KITLG;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;PLA2G6;SMARCA1;ZNF318;CLU;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CIRBP;TP73;KLF13;CHEK2;PHF2;TLR3;SNCA;FZD7;FGFR1;IGF1R;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;CST3;MEIS2;AREG;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;GPR161;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;DNAJC3;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
828,GO:0002116,0.205247084590528,0.939225888750799,3,10,semaphorin receptor complex,CC,PLXNB1;PLXNA2;PLXNA1
5850,GO:0017154,0.205247084590528,0.939225888750799,3,10,semaphorin receptor activity,MF,PLXNB1;PLXNA2;PLXNA1
11430,GO:0045906,0.205456374984675,0.958884871143279,2,6,negative regulation of vasoconstriction,BP,DOCK5;DOCK4
15834,GO:0072584,0.205822793726946,0.955422335979602,2,8,caveolin-mediated endocytosis,BP,PROM2;CAV1
6382,GO:0021587,0.20590470295568,0.911269093216084,5,24,cerebellum morphogenesis,BP,SERPINE2;TRNP1;GLI2;HSPA5;OPHN1
6508,GO:0021892,0.206070156303564,0.984380136807782,1,3,cerebral cortex GABAergic interneuron differentiation,BP,DLX2
3415,GO:0007202,0.206084489125798,0.953430281109364,2,10,activation of phospholipase C activity,BP,EGFR;ANG
19072,GO:1905006,0.206175246545831,0.98812154508513,1,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFB2
19390,GO:1905954,0.206208680552481,0.894446006267259,7,45,positive regulation of lipid localization,BP,NTSR1;ABCA1;LRP1;PLA2G6;ACACB;PLA2R1;ANXA2
12464,GO:0050473,0.206334259435912,0.988102091559301,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
9551,GO:0036363,0.206480912256034,0.988084134315924,1,2,transforming growth factor beta activation,BP,LTBP3
12149,GO:0048294,0.206519610262725,0.988079393313995,1,2,negative regulation of isotype switching to IgE isotypes,BP,BCL6
8041,GO:0032714,0.206629539174322,0.988065919837459,1,2,negative regulation of interleukin-5 production,BP,LEF1
1033,GO:0002543,0.20688843354363,0.988034154592942,1,2,activation of blood coagulation via clotting cascade,BP,ANO6
11486,GO:0045994,0.206892212972846,0.988033690521839,1,2,positive regulation of translational initiation by iron,BP,RXRA
15148,GO:0071313,0.207206761696341,0.987995032075357,1,2,cellular response to caffeine,BP,SLC8A1
15219,GO:0071415,0.207206761696341,0.987995032075357,1,2,cellular response to purine-containing compound,BP,SLC8A1
11719,GO:0046579,0.20722845543349,0.909499372503734,5,27,positive regulation of Ras protein signal transduction,BP,F2R;KITLG;ROBO1;AKAP13;ITPKB
17439,GO:1900271,0.207253142284923,0.920319741531584,4,20,regulation of long-term synaptic potentiation,BP,NSG1;EIF2AK4;CRTC1;PRNP
3175,GO:0006793,0.207491310165422,0.813029078501883,262,2350,phosphorus metabolic process,BP,PHACTR3;SULT1E1;FLOT1;FN1;FLRT2;MMP9;GPRC5A;CTGF;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;EFEMP1;PKD2;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;ZFP36L2;HERC5;TNIK;PROM2;H6PD;NOS1;GAS6;PDGFC;MAGED1;ROR1;AXL;EGFR;ITPK1;HSPA2;FLRT3;SPEG;SPTB;MYLK;GJC2;SLC20A1;MBOAT2;CSPG4;TKFC;MAP3K6;NTSR1;DCAKD;TIMP2;TADA3;PAK1;PTPRM;BMP4;ISYNA1;TP53I3;PTK6;EIF2AK4;TRIM5;NEFL;VAV3;PDCD4;SORL1;TP53;EXTL2;PTPRS;WWTR1;CNTRL;PYCARD;WNK1;DLG4;ITGA2;PILRB;PDGFA;MICAL1;ADARB1;ACSL3;GPNMB;SIK1;ELFN2;GPX1;CDK14;CNTN1;LPCAT2;KITLG;CTDSPL;ABHD14B;NEK9;KCNAB2;NMRK1;FYN;XDH;ALPK1;B3GAT3;CPS1;CAV1;SLC27A1;ERCC6;PLA2G6;TRIB2;MAP3K14;OSBPL5;ACSS1;CLU;PRKCZ;ULK2;TNS2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;CAPRIN2;ACACB;ANG;DUSP5;CDK18;PHKA2;SPRY2;TTN;FBLN1;TP73;PLCH2;DAPK1;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;TLR3;SNCA;FZD7;PTPRU;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;MYO3B;PSMB9;IL18;OBSCN;PDK3;G6PD;EPHB6;EDA2R;FZD8;DHTKD1;AFAP1L2;TGFBR3;FZD1;ENG;MTMR4;ATM;IDH2;FAM20A;AREG;IFNK;AKAP13;DNAJC6;DGKQ;NR2F2;ACSS2;IFNE;LMO4;MAP3K1;PTPN1;VANGL2;NT5DC3;ARHGEF2;THNSL2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;STK16;NCOR1;G6PC3;PRKCA;PRPS2;ANXA2;RGS14;ETNK2;PGAP1;IGFBP4;NMNAT2;PAK6;NAB2;MAP3K12;ACSF2;STK36;PRNP;RET;TGFB2;RBL2;MAP2K5;STAT2;GPR161;CDC42EP5;MAPK8IP3;CDKN2A;EFR3A;PPM1M;ULK1;TSPYL2;NPHP3;VAV2;MAGI2;HSPA5;CDK19;PIKFYVE;SRPK2;UVRAG;NAPRT;MDFIC;GDNF;AGPAT1;TPST1;MEF2A;SNX9;ICK;SASH1;PTPN3;DNAJC3;RARA;CCNY;PRKAG1;TAF1;EFNA5;FZD4;MPPE1;PPP3CA;PIK3C2B;RASA1;CTDSP2;PPCS;DNPH1;CDK5RAP3;ACOT1;CAMK2N1;UGGT2;TTBK2;ADM2;OXTR;ADAM10;PPP2R3A;TAOK3;DMPK
14717,GO:0070417,0.207574298797358,0.956216768748366,2,7,cellular response to cold,BP,EIF2AK4;DNAJC3
4429,GO:0010269,0.207766958468255,0.984107698623291,1,3,response to selenium ion,BP,GPX1
4784,GO:0010979,0.207819677817408,0.987919502647824,1,2,regulation of vitamin D 24-hydroxylase activity,BP,VDR
4785,GO:0010980,0.207819677817408,0.987919502647824,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
13806,GO:0060434,0.208038838673381,0.987892430932668,1,2,bronchus morphogenesis,BP,TGFBR2
14492,GO:0070006,0.208230110357812,0.933411946447946,3,15,metalloaminopeptidase activity,MF,ANPEP;RNPEP;RNPEPL1
14043,GO:0060856,0.208241523204548,0.953475194340577,2,9,establishment of blood-brain barrier,BP,ENG;ADGRA2
16600,GO:0097487,0.208281621361347,0.984024547592397,1,3,multivesicular body, internal vesicle,CC,EGFR
13527,GO:0060019,0.208548667502807,0.953362315948354,2,9,radial glial cell differentiation,BP,GLI3;LEF1
15978,GO:0086017,0.208552874804425,0.98782880129012,1,2,Purkinje myocyte action potential,BP,GJA5
15988,GO:0086029,0.208552874804425,0.98782880129012,1,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,GJA5
16009,GO:0086068,0.208552874804425,0.98782880129012,1,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,GJA5
12483,GO:0050650,0.208629742164891,0.92004121898568,4,19,chondroitin sulfate proteoglycan biosynthetic process,BP,CSPG4;B3GAT3;XYLT1;CHST3
7840,GO:0032411,0.208690789288324,0.882958541878844,9,56,positive regulation of transporter activity,BP,PKD2;JPH2;TCAF1;HSPA2;NTSR1;WNK1;EHD3;ANK3;KCTD7
11138,GO:0045216,0.208782807666586,0.848444681321593,26,176,cell-cell junction organization,BP,SFRP1;F2R;TLN2;GJA5;SDK1;SNAI2;S100A10;ITGA2;DLG5;UGT8;CAV1;NPHP4;ANG;LAMA5;DLC1;COL16A1;FSCN1;CDH13;NFASC;PRKCA;RAB13;MPP7;CDH11;TGFB2;EFNA5;MYO1C
17282,GO:0140131,0.208791488230995,0.953272993218001,2,9,positive regulation of lymphocyte chemotaxis,BP,CXCL14;ADAM10
14126,GO:0061036,0.20880726980873,0.919945799608708,4,19,positive regulation of cartilage development,BP,SOX6;BMP4;GLI3;SOX9
7030,GO:0030814,0.208813911856824,0.908283280264241,5,28,regulation of cAMP metabolic process,BP,PKD2;TIMP2;PDE4D;GPR161;NPHP3
16051,GO:0090043,0.208915045268209,0.955748698265243,2,7,regulation of tubulin deacetylation,BP,TADA3;BEX4
8995,GO:0035176,0.209030170100124,0.90071773338862,6,31,social behavior,BP,DLG4;BBS4;NLGN4Y;ATXN1;TH;OXTR
13110,GO:0051703,0.209030170100124,0.90071773338862,6,31,intraspecies interaction between organisms,BP,DLG4;BBS4;NLGN4Y;ATXN1;TH;OXTR
6692,GO:0030099,0.209122404384526,0.840315470141951,35,289,myeloid cell differentiation,BP,MMP9;FBN1;SOX6;INPP5D;SFRP1;CD109;CDKN2B;ZFP36L1;TGFBR2;FAM210B;BMP4;STAT1;KITLG;RBFOX2;IL31RA;PIK3R1;KLF13;TLR3;G6PD;TGFBR3;L3MBTL3;MEIS2;SNX10;ITPKB;BCL6;PRKCA;ANXA2;ZFPM1;LEF1;THRA;PPARG;LGALS3;RARA;FOS;AGO4
19787,GO:2000269,0.209147866506698,0.933590719092203,3,14,regulation of fibroblast apoptotic process,BP,SFRP1;GAS6;BTG1
10469,GO:0043388,0.209162695836412,0.898676197560316,6,41,positive regulation of DNA binding,BP,MMP9;ITGA2;HMGA2;ISL1;PPARG;NIPBL
19716,GO:2000113,0.209176587115121,0.818218413149726,130,1115,negative regulation of cellular macromolecule biosynthetic process,BP,TXNIP;SOX6;SFRP1;ZFP36L1;ZFP36L2;IGF2BP2;GAS6;SNAI2;MAGED1;PHF21A;EGFR;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;EIF2AK4;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;ZCCHC11;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ANG;UHRF2;WFS1;MDFI;CIRBP;JARID2;TP73;DAPK1;CHEK2;PAIP2B;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;UNK;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;AGO4;NIPBL;PRDM5;S100A11;RXRA
13581,GO:0060080,0.209451285663153,0.957551632726958,2,6,inhibitory postsynaptic potential,BP,NTSR1;ABAT
16439,GO:0097151,0.209451285663153,0.957551632726958,2,6,positive regulation of inhibitory postsynaptic potential,BP,NTSR1;ABAT
16856,GO:0098828,0.209451285663153,0.957551632726958,2,6,modulation of inhibitory postsynaptic potential,BP,NTSR1;ABAT
1878,GO:0004559,0.209522700356731,0.934136732272349,3,13,alpha-mannosidase activity,MF,MAN1A1;MAN2B1;EDEM1
17486,GO:1900745,0.209532701443584,0.932792759681328,3,15,positive regulation of p38MAPK cascade,BP,GADD45B;XDH;SASH1
19468,GO:1990266,0.209754325720421,0.898028296961858,6,43,neutrophil migration,BP,VAV3;ITGA1;PDE4D;MOSPD2;TGFB2;LGALS3
2249,GO:0005165,0.209781362166066,0.955445097881302,2,7,neurotrophin receptor binding,MF,PIK3R1;EFNA5
2251,GO:0005167,0.209781362166066,0.955445097881302,2,7,neurotrophin TRK receptor binding,MF,PIK3R1;EFNA5
9404,GO:0035988,0.209861568542642,0.955416943579057,2,7,chondrocyte proliferation,BP,CTGF;HMGA2
6252,GO:0019842,0.209897626713415,0.873525355533235,11,84,vitamin binding,MF,PYGB;VDR;SEC14L2;P3H2;HLCS;GLDC;ACACB;DHTKD1;THNSL2;SRR;ABAT
4529,GO:0010605,0.210034599725668,0.811951697208451,222,2012,negative regulation of macromolecule metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;TXNIP;CTGF;SOX6;INPP5D;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;DDIT4;DUSP6;ZFP36L2;IGF2BP2;COL7A1;GAS6;SNAI2;MAGED1;PHF21A;TFPI2;EGFR;TSC22D3;KLF8;FLRT3;ZNF608;SERPINE1;SERPINH1;CRTAP;VIM;TIMP2;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;PDCD4;NR3C1;STAT1;SORL1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;WNK1;DLG4;ZCCHC11;RBMS3;MICAL1;ADARB1;TIMP1;TFDP2;PNRC1;CCDC85B;CRIM1;KLF12;NFIX;ELFN2;HIVEP1;GPX1;GLI3;E2F7;CTDSPL;ZFP90;FYN;IFI6;XDH;TSHZ2;CAV1;GLI2;PIAS3;RBFOX2;TRIB2;ZNF318;TNRC18;CLU;SERPING1;PRKCZ;SLIT3;SDR16C5;TP53INP1;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ACACB;ANG;DUSP5;UHRF2;BBS2;HERPUD1;WFS1;MDFI;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;CHEK2;SPRY4;PAIP2B;PHF2;SNCA;FLOT2;GLG1;FGFR1;IGF1R;DKK1;RGS2;C5;PDE4D;NCOA2;PSMB9;G6PD;TLE4;FZD8;TCEAL1;KDM4C;NFATC4;MAGEF1;FOXN3;LMCD1;FZD1;PBXIP1;ENG;BBS4;CALR;ATM;MDM2;CST3;MEIS2;DGKQ;CITED2;GCLC;NR2F2;CBX7;MAF;PTPN1;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;PLAG1;PRKCA;SALL2;ANXA2;RGS14;CXORF57;BAHCC1;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;PRNP;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;SMG9;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;ITGB8;MDFIC;ZNF12;OPHN1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;DERL3;PPARG;PARP15;BEX4;KCNIP3;MEF2A;TGIF1;ING4;UNK;PTPN3;DNAJC3;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;NIPBL;PRDM5;S100A11;RXRA;TAOK3
16521,GO:0097320,0.210073463968355,0.933153439645246,3,14,plasma membrane tubulation,BP,ASAP1;SNX33;SNX9
13825,GO:0060457,0.210209381269585,0.955294763002785,2,7,negative regulation of digestive system process,BP,WNK1;OXTR
10233,GO:0042987,0.210818327425256,0.906587881451899,5,30,amyloid precursor protein catabolic process,BP,SORL1;CLU;FLOT2;TMED10;PRNP
9526,GO:0036296,0.210846797986962,0.916928661657296,4,24,response to increased oxygen levels,BP,TP53;CAV1;CAT;PPARG
18646,GO:1904018,0.211099932833418,0.860359684651816,16,112,positive regulation of vasculature development,BP,CCBE1;TGFBR2;SERPINE1;ANGPTL4;SEMA5A;BTG1;HMGA2;TLR3;C5;ENG;EGR1;ISL1;PRKCA;ITGB8;SASH1;ADM2
10841,GO:0044378,0.211182168378268,0.987500399162858,1,2,non-sequence-specific DNA binding, bending,MF,SAP30L
3538,GO:0007548,0.211240580163404,0.849365679267397,23,169,sex differentiation,BP,SFRP1;AXL;NUPR1;MMP19;KITLG;CTSV;SLIT3;ANG;TLR3;PBX1;ATM;CST3;CITED2;SOX9;RAB13;FNDC3A;WDR19;TGFB2;RARA;FZD4;AGO4;NIPBL;RHOBTB3
15075,GO:0071149,0.211429350244383,0.987469272649128,1,2,TEAD-2-YAP complex,CC,YAP1
9336,GO:0035865,0.211461950169767,0.983505367952173,1,3,cellular response to potassium ion,BP,CARF
15272,GO:0071492,0.211501141750639,0.987460224094336,1,2,cellular response to UV-A,BP,MME
6523,GO:0021932,0.211786700241443,0.954738837906878,2,7,hindbrain radial glia guided cell migration,BP,RBFOX2;LEF1
20112,GO:2000828,0.211950958089255,0.987403445790328,1,2,regulation of parathyroid hormone secretion,BP,FGFR1
12898,GO:0051280,0.211985162369007,0.951220872575044,2,10,negative regulation of release of sequestered calcium ion into cytosol,BP,PKD2;NTSR1
12902,GO:0051284,0.211985162369007,0.951220872575044,2,10,positive regulation of sequestering of calcium ion,BP,PKD2;NTSR1
10418,GO:0043295,0.21222141483536,0.950429714966118,2,11,glutathione binding,MF,PTGES;LANCL1
17490,GO:1900750,0.21222141483536,0.950429714966118,2,11,oligopeptide binding,MF,PTGES;LANCL1
2534,GO:0005794,0.212246628105495,0.814973042514164,135,1141,Golgi apparatus,CC,CTGF;ADAM19;ST6GALNAC2;SYNE1;F2R;PTGS1;MARCH4;SCARA3;COL7A1;CLTCL1;GAS6;DNMBP;PDGFC;MALL;MAP6;SULF2;EGFR;GALNT10;SDC3;SPTB;FAM198B;CSPG4;STMN3;ASAP2;NTSR1;CXCL14;ABCA1;NSG1;ITM2C;SORL1;NEO1;ARAP1;KIAA0319L;MUC19;PDGFA;ACSL3;HIP1;PACS1;DOCK4;CUL7;SNX1;PAQR8;LPCAT2;TBC1D5;P3H2;SYN1;SEC14L1;PDE4DIP;B3GAT3;FUT10;CAV1;XYLT1;UST;CLU;CHST3;GOLGB1;ATP8B2;PIK3R1;SYT1;SLC38A10;TMEM173;ANK3;CRELD2;TP73;CAT;ST6GAL2;CHEK2;BACE1;TLR3;MAN1A1;SNCA;GLG1;SEC24D;GLT8D2;TGFBI;SULF1;FZD8;LAPTM4A;CALR;COPG2;ARF6;FAM20A;TMED10;AREG;AKR7A2;FBXW8;FGD4;ARHGEF2;KLHL12;SDC2;IFT27;BCL6;GCNT1;TMEM50B;RAB13;FNDC3A;RNF24;GOLGA8B;NMNAT2;GAL3ST4;RAB43;SLC39A11;PRNP;DSEL;ITM2A;MAPK8IP3;SPPL2B;AGRN;GOPC;PIKFYVE;RSAD2;CHIC2;RHBDD2;LMF1;KLF5;GOLGA8N;GALNT2;TPST1;KCNIP3;SNX9;OBSL1;POSTN;ARL3;MIA3;COG3;MPPE1;STEAP2;ADAM10;RHOBTB3;LITAF;GBP3;EDEM1;ABCA5;NFKBIE;FAM114A1
12801,GO:0051133,0.212356548477458,0.983357662513316,1,3,regulation of NK T cell activation,BP,IL18
12802,GO:0051135,0.212356548477458,0.983357662513316,1,3,positive regulation of NK T cell activation,BP,IL18
11776,GO:0046677,0.212381437045235,0.844741464895282,26,216,response to antibiotic,BP,TXNIP;NQO1;GSN;AXL;SLC8A1;NEFL;STAT1;TP53;GPX1;FYN;CLU;TP53INP1;CAT;SETX;G6PD;MDM2;CST3;AREG;EGR1;HTR1B;HSPA5;TH;ITPR2;RARA;EFNA5;ABAT
2295,GO:0005262,0.212386648047088,0.880863986510376,9,52,calcium channel activity,MF,PKD2;JPH2;GAS6;ORAI3;SLC24A1;ITPR2;CACNB1;CACNA2D3;ORAI2
2287,GO:0005247,0.212460578990981,0.954500410382079,2,7,voltage-gated chloride channel activity,MF,ANO1;ANO6
1441,GO:0003430,0.212487336005206,0.987335552273827,1,2,growth plate cartilage chondrocyte growth,BP,TGFBR2
13786,GO:0060406,0.212552924790443,0.987327236080948,1,2,positive regulation of penile erection,BP,OXTR
17646,GO:1901534,0.212644108415407,0.987315669532457,1,2,positive regulation of hematopoietic progenitor cell differentiation,BP,ZBTB1
10961,GO:0044773,0.21274049600973,0.86560401130854,13,98,mitotic DNA damage checkpoint,BP,XPC;TP53;TFDP2;E2F7;HMGA2;TP73;CHEK2;FOXN3;ATM;MDM2;RBL2;CDK5RAP3;TAOK3
14278,GO:0061441,0.212764918683421,0.987300335715761,1,2,renal artery morphogenesis,BP,PKD2
19407,GO:1990037,0.212799825309988,0.983284202384921,1,3,Lewy body core,CC,HERPUD1
7876,GO:0032454,0.212803194253755,0.933473242058173,3,12,histone demethylase activity (H3-K9 specific),MF,PHF2;KDM4C;KDM4A
8313,GO:0033169,0.212803194253755,0.933473242058173,3,12,histone H3-K9 demethylation,BP,PHF2;KDM4C;KDM4A
14533,GO:0070087,0.212882582412263,0.956391505520742,2,6,chromo shadow domain binding,MF,SP100;NIPBL
3398,GO:0007181,0.212901984357081,0.987282926041877,1,2,transforming growth factor beta receptor complex assembly,BP,TGFBR3
19952,GO:2000563,0.212926016766114,0.987279872131675,1,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
6063,GO:0019217,0.212973250026555,0.879859245174695,9,57,regulation of fatty acid metabolic process,BP,IRS2;TYSND1;CAV1;CPT1A;ACACB;SNCA;PRKAB2;PDK3;PPARG
6813,GO:0030282,0.212978208869675,0.879965382136335,9,56,bone mineralization,BP,FBN2;SLC8A1;BMP4;GPNMB;ANO6;SOX9;ENPP1;ATRAID;ANKH
12886,GO:0051259,0.213009945912791,0.832362663516928,43,380,protein complex oligomerization,BP,FLOT1;GJA5;PKD2;RNF213;S100A10;C1QTNF6;ANGPTL4;AHNAK;SORL1;TP53;DDIT3;TYSND1;CAV1;CLU;PRKCZ;EHD3;CAMK2D;CCK;SYT1;CPT1A;ACACB;TP73;CAT;STOM;IGF1R;TGM2;TMED10;ANXA6;CRTC1;ANXA2;KCTD7;DECR1;PRNP;MAGI2;GOPC;KCTD14;SRR;SNX9;ZBTB1;SBF2;SEPT9;KCNRG;RXRA
12995,GO:0051457,0.213027939158098,0.916383635201619,4,22,maintenance of protein location in nucleus,BP,SYNE1;BBS4;TAF8;SP100
12976,GO:0051428,0.213052292421168,0.951693591053612,2,9,peptide hormone receptor binding,MF,FYN;UCN2
4957,GO:0015037,0.213303507930968,0.949432587934744,2,12,peptide disulfide oxidoreductase activity,MF,PDIA4;PDIA6
13848,GO:0060502,0.213306747948656,0.95271966879032,2,8,epithelial cell proliferation involved in lung morphogenesis,BP,BMP4;SOX9
3711,GO:0008233,0.213386174534987,0.831646307390356,44,376,peptidase activity,MF,CPA4;MMP2;PRSS23;HTRA1;MMP9;ADAM19;SFRP1;MMP28;ADAMTSL1;ANPEP;CLCA2;TADA3;PCSK1;CPVL;PYCARD;MMP19;TYSND1;CTSV;CPS1;CASP14;BACE1;ADAMTS7;MME;THSD4;PSMB9;APH1B;RNPEP;PRCP;AMZ2;ADAMTS15;GGT7;DPP9;USP28;SPPL2B;NPEPL1;RHBDD1;RHBDD2;PGPEP1;SENP7;CAPN6;SCPEP1;ADAM10;RNPEPL1;CTSD
12359,GO:0048788,0.21352088694549,0.964109357616126,2,4,cytoskeleton of presynaptic active zone,CC,PCLO;BSN
17042,GO:0099569,0.21352088694549,0.964109357616126,2,4,presynaptic cytoskeleton,CC,PCLO;BSN
18087,GO:1902769,0.213524026645675,1,1,1,regulation of choline O-acetyltransferase activity,BP,SORL1
18088,GO:1902771,0.213524026645675,1,1,1,positive regulation of choline O-acetyltransferase activity,BP,SORL1
18152,GO:1902948,0.213524026645675,1,1,1,negative regulation of tau-protein kinase activity,BP,SORL1
18159,GO:1902955,0.213524026645675,1,1,1,positive regulation of early endosome to recycling endosome transport,BP,SORL1
18182,GO:1902997,0.213524026645675,1,1,1,negative regulation of neurofibrillary tangle assembly,BP,SORL1
6137,GO:0019417,0.213614348838839,0.987192227042888,1,2,sulfur oxidation,BP,MICAL1
4945,GO:0015012,0.213653685309262,0.916849261283641,4,20,heparan sulfate proteoglycan biosynthetic process,BP,EXTL2;B3GAT3;XYLT1;VANGL2
13503,GO:0055113,0.213914550995405,1,1,1,epiboly involved in gastrulation with mouth forming second,BP,MEGF8
15619,GO:0072162,0.214008967532285,0.987141827294483,1,2,metanephric mesenchymal cell differentiation,BP,STAT1
7815,GO:0032379,0.214118217612723,0.983064652561392,1,3,positive regulation of intracellular lipid transport,BP,ANXA2
7818,GO:0032382,0.214118217612723,0.983064652561392,1,3,positive regulation of intracellular sterol transport,BP,ANXA2
7821,GO:0032385,0.214118217612723,0.983064652561392,1,3,positive regulation of intracellular cholesterol transport,BP,ANXA2
3077,GO:0006651,0.214231822542091,0.987113315455808,1,2,diacylglycerol biosynthetic process,BP,ANG
18207,GO:1903038,0.214236069956595,0.878393151265653,9,63,negative regulation of leukocyte cell-cell adhesion,BP,IL20RB;BMP4;GPNMB;GLI3;DLG5;PAG1;BCL6;PRNP;LGALS3
7050,GO:0030846,0.214316162593842,1,1,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,SETX
7427,GO:0031554,0.214316162593842,1,1,1,regulation of DNA-templated transcription, termination,BP,SETX
13884,GO:0060566,0.214316162593842,1,1,1,positive regulation of DNA-templated transcription, termination,BP,SETX
18877,GO:1904594,0.214316162593842,1,1,1,regulation of termination of RNA polymerase II transcription,BP,SETX
18878,GO:1904595,0.214316162593842,1,1,1,positive regulation of termination of RNA polymerase II transcription,BP,SETX
20095,GO:2000804,0.214316162593842,1,1,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,SETX
20096,GO:2000806,0.214316162593842,1,1,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,SETX
7329,GO:0031362,0.214401267526863,0.951188801581175,2,9,anchored component of external side of plasma membrane,CC,PRNP;EFNA5
8020,GO:0032675,0.214452536846278,0.878155425838543,9,64,regulation of interleukin-6 production,BP,INPP5D;F2R;GAS6;ZBTB20;PYCARD;TLR3;AFAP1L2;ARHGEF2;ISL1
19789,GO:2000271,0.214499409986219,0.953775692341352,2,7,positive regulation of fibroblast apoptotic process,BP,SFRP1;BTG1
1615,GO:0004046,0.214500262638045,0.983000732949795,1,3,aminoacylase activity,MF,CAT
17056,GO:0099612,0.21461366803717,0.95580096619007,2,6,protein localization to axon,BP,UGT8;NFASC
1644,GO:0004090,0.214783021598163,0.980949841057438,1,4,carbonyl reductase (NADPH) activity,MF,CBR1
2164,GO:0005000,0.215016460068694,0.987012646081171,1,2,vasopressin receptor activity,MF,OXTR
563,GO:0001705,0.215076801586318,0.987004885926812,1,2,ectoderm formation,BP,FZD7
570,GO:0001712,0.215076801586318,0.987004885926812,1,2,ectodermal cell fate commitment,BP,FZD7
19350,GO:1905843,0.215129619801623,1,1,1,regulation of cellular response to gamma radiation,BP,ATM
12677,GO:0050922,0.215304585028064,0.896044272306134,6,34,negative regulation of chemotaxis,BP,MMP28;SEMA5A;ROBO1;SEMA4A;C5;SEMA4B
8595,GO:0034121,0.215422134775827,0.895549262471762,6,36,regulation of toll-like receptor signaling pathway,BP,FLOT1;NR1D1;PTPRS;CAV1;TLR3;RSAD2
12427,GO:0050185,0.215438527202151,1,1,1,phosphatidylinositol deacylase activity,MF,PGAP1
15144,GO:0071306,0.215494304804196,0.986951121691557,1,2,cellular response to vitamin E,BP,PPARG
1695,GO:0004175,0.215546151937711,0.8410641120413,27,230,endopeptidase activity,MF,MMP2;PRSS23;HTRA1;MMP9;ADAM19;SFRP1;MMP28;CLCA2;PCSK1;PYCARD;MMP19;TYSND1;CTSV;CPS1;CASP14;BACE1;ADAMTS7;MME;PSMB9;APH1B;ADAMTS15;SPPL2B;RHBDD1;RHBDD2;CAPN6;ADAM10;CTSD
8409,GO:0033500,0.215671895233681,0.851075333905943,19,146,carbohydrate homeostasis,BP,ANO1;IRS2;GAS6;SESN3;NR1D1;LGALS1;ERO1B;PLA2G6;PIK3R1;WFS1;IGF1R;PDK3;GCLC;PRCP;LEPR;TH;PPARG;EFNA5;PPP3CA
10072,GO:0042593,0.215671895233681,0.851075333905943,19,146,glucose homeostasis,BP,ANO1;IRS2;GAS6;SESN3;NR1D1;LGALS1;ERO1B;PLA2G6;PIK3R1;WFS1;IGF1R;PDK3;GCLC;PRCP;LEPR;TH;PPARG;EFNA5;PPP3CA
6771,GO:0030216,0.216162626010777,0.850430091692171,19,156,keratinocyte differentiation,BP,KRT4;TXNIP;CD109;ZFP36L1;TCHH;KRT14;VDR;KRT13;KRT5;PPL;FLG;KRT15;CTSV;CASP14;ALOX15B;FLNB;IFT74;YAP1;KRT10
542,GO:0001661,0.216589256877836,0.986809522828146,1,2,conditioned taste aversion,BP,FOS
15607,GO:0072135,0.216667905734906,0.986799318744847,1,2,kidney mesenchymal cell proliferation,BP,STAT1
15608,GO:0072136,0.216667905734906,0.986799318744847,1,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,STAT1
13380,GO:0052746,0.216678672467977,0.986797921497243,1,2,inositol phosphorylation,BP,ITPK1
11829,GO:0046834,0.216902834519535,0.866271038209069,12,75,lipid phosphorylation,BP,PIK3C2G;IRS2;EGFR;PDGFA;KITLG;FYN;PIK3R1;FGFR1;DGKQ;EFR3A;PIKFYVE;PIK3C2B
10079,GO:0042608,0.216965312178192,0.982585078086575,1,3,T cell receptor binding,MF,FYN
6764,GO:0030207,0.217017115890449,0.952873802378937,2,7,chondroitin sulfate catabolic process,BP,CSPG4;HEXA
8376,GO:0033300,0.217089435544989,0.986744552500035,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3
14917,GO:0070837,0.217089435544989,0.986744552500035,1,2,dehydroascorbic acid transport,BP,SLC2A3
10722,GO:0044111,0.217190473844881,0.986731406302985,1,2,development involved in symbiotic interaction,BP,ANXA2
15578,GO:0072095,0.217315679046708,0.986715105506704,1,2,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
13648,GO:0060205,0.217338468482518,0.841369175561853,25,229,cytoplasmic vesicle lumen,CC,FN1;PYGB;GSN;GAS6;SERPINE1;TIMP2;PCSK1;PYCARD;PDGFA;TIMP1;MAGED2;CLU;SERPING1;CAT;BACE1;CALR;ANXA2;MAN2B1;TGFB2;DNASE1L1;NAPRT;DNAJC3;ACTR1B;S100A11;CTSD
2817,GO:0006284,0.21804177102929,0.893015615742723,6,41,base-excision repair,BP,TP53;ERCC6;HMGA2;MUTYH;LIG1;FAM168A
4982,GO:0015114,0.218096455824171,0.952484809509997,2,7,phosphate ion transmembrane transporter activity,MF,SLC20A1;ANKH
11137,GO:0045214,0.218217765031706,0.906019810867588,5,20,sarcomere organization,BP,TTN;OBSCN;AKAP13;FHOD3;OBSL1
10995,GO:0044849,0.218327961501824,0.94970642792706,2,9,estrous cycle,BP,EGR1;OXTR
17601,GO:1901338,0.218510920539536,0.982321599012916,1,3,catecholamine binding,MF,TH
4418,GO:0010226,0.218557751419437,0.92909562340209,3,14,response to lithium ion,BP,NFATC4;CALR;IGFBP2
9812,GO:0042053,0.218557996464323,0.949618987224001,2,9,regulation of dopamine metabolic process,BP,SNCA;ABAT
9819,GO:0042069,0.218557996464323,0.949618987224001,2,9,regulation of catecholamine metabolic process,BP,SNCA;ABAT
11651,GO:0046456,0.218604370259902,0.911804940959255,4,27,icosanoid biosynthetic process,BP,PTGS1;PTGES;CBR1;GGT7
16185,GO:0090251,0.218684648622823,1,1,1,protein localization involved in establishment of planar polarity,BP,CELSR1
4918,GO:0014870,0.2187308671453,0.954382266486543,2,6,response to muscle inactivity,BP,UTRN;MTMR4
19504,GO:1990425,0.219207858046175,0.98646737878652,1,2,ryanodine receptor complex,CC,NOS1
4201,GO:0009313,0.219261082398268,0.949351319301903,2,9,oligosaccharide catabolic process,BP,MANBA;MAN2B1
6742,GO:0030170,0.219300871261933,0.900825700378343,5,33,pyridoxal phosphate binding,MF,PYGB;GLDC;THNSL2;SRR;ABAT
14643,GO:0070279,0.219300871261933,0.900825700378343,5,33,vitamin B6 binding,MF,PYGB;GLDC;THNSL2;SRR;ABAT
13674,GO:0060259,0.219604911242909,0.951938798133461,2,7,regulation of feeding behavior,BP,EIF2AK4;LEPR
13740,GO:0060347,0.219751993468762,0.950336588549977,2,8,heart trabecula formation,BP,ADGRG6;TGFBR3
8782,GO:0034498,0.220018920145341,0.950236786741776,2,8,early endosome to Golgi transport,BP,SNX1;EHD3
5566,GO:0016589,0.220119491187111,0.951751906134945,2,7,NURF complex,CC,SMARCA1;C17ORF49
8879,GO:0034713,0.220146290650568,0.950189132851709,2,8,type I transforming growth factor beta receptor binding,MF,TGFBR2;ENG
17221,GO:0120032,0.220239465457649,0.851130766680538,17,123,regulation of plasma membrane bounded cell projection assembly,BP,ARAP1;EVI5L;CAV1;DOCK11;ESPN;IFT140;FSCN1;BBS4;ARF6;SYNE2;SSH1;IFT88;PODXL;CDC42EP5;AGRN;KLF5;SEPT9
8605,GO:0034138,0.220254588844242,0.926554355311773,3,17,toll-like receptor 3 signaling pathway,BP,FLOT1;CAV1;TLR3
14896,GO:0070777,0.220377496844398,0.98631295172731,1,2,D-aspartate transport,BP,NTSR1
14898,GO:0070779,0.220377496844398,0.98631295172731,1,2,D-aspartate import across plasma membrane,BP,NTSR1
14263,GO:0061387,0.220477567827127,0.863688373761003,12,74,regulation of extent of cell growth,BP,FN1;DPYSL2;PAK1;PTPRS;SEMA5A;ULK2;PLXNA2;SEMA4A;PLXNA1;MEGF8;SEMA4B;EFNA5
7594,GO:0031985,0.220530980333843,0.862754552113584,12,87,Golgi cisterna,CC,ASAP2;NSG1;SORL1;ARAP1;FUT10;ST6GAL2;GCNT1;GOLGA8B;GAL3ST4;GOLGA8N;GALNT2;COG3
19878,GO:2000393,0.220574676904951,0.986286820343511,1,2,negative regulation of lamellipodium morphogenesis,BP,ARPIN
6336,GO:0021516,0.220624014163608,0.98628027748352,1,2,dorsal spinal cord development,BP,LMO4
16977,GO:0099106,0.220887631375724,0.878725402273412,8,54,ion channel regulator activity,MF,WNK1;KCNAB2;CAV1;PIAS3;PRKCZ;CAMK2D;KCNIP3;RASA1
14494,GO:0070011,0.220899699453669,0.826102084994128,42,359,peptidase activity, acting on L-amino acid peptides,MF,CPA4;MMP2;PRSS23;HTRA1;MMP9;ADAM19;SFRP1;MMP28;ANPEP;CLCA2;TADA3;PCSK1;CPVL;PYCARD;MMP19;TYSND1;CTSV;CPS1;CASP14;BACE1;ADAMTS7;MME;PSMB9;APH1B;RNPEP;PRCP;AMZ2;ADAMTS15;GGT7;DPP9;USP28;SPPL2B;NPEPL1;RHBDD1;RHBDD2;PGPEP1;SENP7;CAPN6;SCPEP1;ADAM10;RNPEPL1;CTSD
15694,GO:0072289,0.220930734483382,0.986239562107577,1,2,metanephric nephron tubule formation,BP,SOX9
2729,GO:0006111,0.221000550381885,0.911962491450358,4,22,regulation of gluconeogenesis,BP,NR1D1;SIK1;DGKQ;LEPR
4291,GO:0009726,0.221075727534302,0.986220291310753,1,2,detection of endogenous stimulus,BP,PKD2
11202,GO:0045356,0.221077297874368,0.986220082515695,1,2,positive regulation of interferon-alpha biosynthetic process,BP,TLR3
1388,GO:0003299,0.221139366711021,0.929541993103729,3,12,muscle hypertrophy in response to stress,BP,LMNA;PPP3CA;KDM4A
4925,GO:0014887,0.221139366711021,0.929541993103729,3,12,cardiac muscle adaptation,BP,LMNA;PPP3CA;KDM4A
4933,GO:0014898,0.221139366711021,0.929541993103729,3,12,cardiac muscle hypertrophy in response to stress,BP,LMNA;PPP3CA;KDM4A
15212,GO:0071400,0.221149719329394,0.986210451289738,1,2,cellular response to oleic acid,BP,CPS1
14946,GO:0070884,0.221323798373921,0.927753418792904,3,14,regulation of calcineurin-NFAT signaling cascade,BP,LMCD1;NFAT5;PRNP
17177,GO:0106056,0.221323798373921,0.927753418792904,3,14,regulation of calcineurin-mediated signaling,BP,LMCD1;NFAT5;PRNP
8452,GO:0033604,0.221344453425236,0.986184534967995,1,2,negative regulation of catecholamine secretion,BP,ABAT
15076,GO:0071156,0.221402679285214,0.861634561447511,12,96,regulation of cell cycle arrest,BP,PKD2;TP53;TFDP2;E2F7;HMGA2;UHRF2;TP73;CHEK2;CALR;ATM;MDM2;RBL2
3461,GO:0007281,0.221431138558239,0.84829224544304,18,133,germ cell development,BP,ETV5;HSPA2;RFX2;BMP4;SMARCA2;PAQR8;ANG;BBS2;PAQR7;CCDC136;BBS4;ATM;FNDC3A;ODF2;GOPC;TPGS1;DNAH1;RARA
11546,GO:0046121,0.221536337383561,0.981799452366259,1,3,deoxyribonucleoside catabolic process,BP,DPYD
15543,GO:0072034,0.221598546807847,0.98615067730251,1,2,renal vesicle induction,BP,SOX9
6909,GO:0030511,0.221644672039654,0.912002513452941,4,21,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B;TGFBR3;CITED2;TGFB1I1
18564,GO:1903846,0.221644672039654,0.912002513452941,4,21,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B;TGFBR3;CITED2;TGFB1I1
16657,GO:0097632,0.221697205736811,0.986137518447855,1,2,extrinsic component of phagophore assembly site membrane,CC,ULK1
6008,GO:0019062,0.221710006014317,0.981769221445916,1,3,virion attachment to host cell,BP,GAS6
10932,GO:0044650,0.221710006014317,0.981769221445916,1,3,adhesion of symbiont to host cell,BP,GAS6
338,GO:0000939,0.22172029579599,0.981767429397868,1,3,condensed chromosome inner kinetochore,CC,CENPA
12306,GO:0048682,0.221960357357499,0.986102385364379,1,2,sprouting of injured axon,BP,LAMB2
17826,GO:1902042,0.222094421584036,0.910080969394798,4,26,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SERPINE1;GPX1;DAPK1;ARHGEF2
7475,GO:0031650,0.222123199066264,0.948255299522873,2,9,regulation of heat generation,BP,SLC27A1;ABAT
15132,GO:0071280,0.222187144115655,0.946545059788127,2,11,cellular response to copper ion,BP,SNCA;PRNP
622,GO:0001806,0.222278138075332,0.981670129167193,1,3,type IV hypersensitivity,BP,IL20RB
17634,GO:1901492,0.22228507053938,0.986058963765984,1,2,positive regulation of lymphangiogenesis,BP,CCBE1
9249,GO:0035686,0.22245971093646,0.981638396258692,1,3,sperm fibrous sheath,CC,SPA17
15301,GO:0071548,0.222523111823599,0.899066526695535,5,32,response to dexamethasone,BP,DDIT4;EGFR;NR3C1;CPS1;ABCC2
14142,GO:0061053,0.222654593819475,0.873793663462744,9,51,somite development,BP,SFRP1;PLXNA2;DKK1;ATM;POGLUT1;WDR19;LEF1;MED12;PPP2R3A
18772,GO:1904340,0.222822829370211,0.98157484304741,1,3,positive regulation of dopaminergic neuron differentiation,BP,DKK1
19049,GO:1904958,0.222822829370211,0.98157484304741,1,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,DKK1
13975,GO:0060720,0.222824193548992,0.985986700976146,1,2,spongiotrophoblast cell proliferation,BP,NRK
13976,GO:0060721,0.222824193548992,0.985986700976146,1,2,regulation of spongiotrophoblast cell proliferation,BP,NRK
13977,GO:0060722,0.222824193548992,0.985986700976146,1,2,cell proliferation involved in embryonic placenta development,BP,NRK
13978,GO:0060723,0.222824193548992,0.985986700976146,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,NRK
16162,GO:0090214,0.222824193548992,0.985986700976146,1,2,spongiotrophoblast layer developmental growth,BP,NRK
16635,GO:0097543,0.223122291883215,0.985946653571954,1,2,ciliary inversin compartment,CC,NPHP3
17098,GO:0102148,0.223151195046022,0.98151726642898,1,3,N-acetyl-beta-D-galactosaminidase activity,MF,HEXA
6611,GO:0022841,0.223183753685723,0.981511552019117,1,3,potassium ion leak channel activity,MF,TMEM175
19490,GO:1990403,0.223220431624565,0.94903290145234,2,8,embryonic brain development,BP,IFT140;MED12
11214,GO:0045409,0.223233129309228,0.985931746810616,1,2,negative regulation of interleukin-6 biosynthetic process,BP,INPP5D
4408,GO:0010171,0.223246009195249,0.883797357646673,7,41,body morphogenesis,BP,MMP2;PHLDB1;DKK1;IFT122;LEF1;SSBP3;NIPBL
19462,GO:1990256,0.223274589610169,1,1,1,signal clustering,BP,SEMA5A
18160,GO:1902956,0.22335883613571,0.981480806106222,1,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,SNCA
4051,GO:0009100,0.223373133846345,0.826357120872223,38,304,glycoprotein metabolic process,BP,ST6GALNAC2;ADAMTSL1;SULF2;GALNT10;CSPG4;ITM2C;EXTL2;MUC19;B3GAT3;FUT10;SEL1L;XYLT1;UST;CHST3;ST6GAL2;MAN1A1;ADAMTS7;SULF1;FOXL1;CST3;MANBA;HEXA;TRAK1;POGLUT1;VANGL2;GCNT1;MAN2B1;GAL3ST4;DSEL;ITM2A;LMF1;ALG10;GALNT2;DERL3;COG3;UGGT2;TUSC3;EDEM1
6836,GO:0030314,0.223431699054626,0.985905018318722,1,2,junctional membrane complex,CC,JPH2
14510,GO:0070051,0.223640601851615,0.985876867867328,1,2,fibrinogen binding,MF,FBLN1
1523,GO:0003896,0.22368724186054,0.981423058204451,1,3,DNA primase activity,MF,PRIMPOL
4502,GO:0010557,0.223781385696043,0.803392885019941,146,1241,positive regulation of macromolecule biosynthetic process,BP,SOX6;ITGA6;SFRP1;CDKN2B;F2R;TNNI2;ETV5;PKD2;IRS2;NOS1;PDGFC;MAGED1;EGFR;RFX2;SERPINE1;VIM;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;EIF2AK4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;ITGA2;PDGFA;RBMS3;TFDP2;NFIX;GLI3;E2F7;KITLG;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;SMARCA1;ZNF318;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CIRBP;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;FGFR1;IGF1R;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;CST3;MEIS2;AREG;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;DNAJC3;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
8296,GO:0033143,0.223833173256215,0.871775892903959,9,61,regulation of intracellular steroid hormone receptor signaling pathway,BP,SFRP1;SKP2;PAK1;KANK2;PER1;CALR;ISL1;YAP1;TAF1
4036,GO:0009072,0.223873586946938,0.945875117899962,2,11,aromatic amino acid family metabolic process,BP,TH;GSTZ1
12405,GO:0048880,0.223899116237428,0.985841987928301,1,2,sensory system development,BP,ISL1
6797,GO:0030258,0.223976917194197,0.836429957150205,25,193,lipid modification,BP,INPP5D;PIK3C2G;IRS2;EGFR;PDGFA;TYSND1;KITLG;ECH1;FYN;PIK3R1;ALDH3A2;CPT1A;ACACB;FGFR1;MTMR4;DGKQ;DECR1;CYP4V2;EFR3A;PIKFYVE;PPARG;PIK3C2B;EHHADH;CPT2;ACAA2
9834,GO:0042098,0.224013237263396,0.856736366148111,13,105,T cell proliferation,BP,TGFBR2;IL20RB;BMP4;PYCARD;GPNMB;DLG5;FYN;BTN3A1;IL18;CD1D;PRNP;IGFBP2;LGALS3
2160,GO:0004993,0.224065081626441,0.981356493068128,1,3,G-protein coupled serotonin receptor activity,MF,HTR1B
3420,GO:0007210,0.224065081626441,0.981356493068128,1,3,serotonin receptor signaling pathway,BP,HTR1B
10341,GO:0043176,0.224065081626441,0.981356493068128,1,3,amine binding,MF,HTR1B
12949,GO:0051378,0.224065081626441,0.981356493068128,1,3,serotonin binding,MF,HTR1B
16785,GO:0098664,0.224065081626441,0.981356493068128,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR1B
17048,GO:0099589,0.224065081626441,0.981356493068128,1,3,serotonin receptor activity,MF,HTR1B
12689,GO:0050951,0.224248861837098,0.948643484604926,2,8,sensory perception of temperature stimulus,BP,ANO1;NTSR1
2933,GO:0006457,0.224327142570017,0.837887063602353,23,210,protein folding,BP,DNAJB4;HSPA2;FKBP5;CRTAP;GNG2;ERO1B;LTBP4;FUT10;CLU;FKBP9;PDIA4;WFS1;PDIA6;AIP;MLEC;CALR;DNAJC4;HSPA5;PIKFYVE;TTC12;HSP90AB4P;FKBP10;UGGT2
6005,GO:0019058,0.22434643313344,0.830269787113324,31,256,viral life cycle,BP,ITGB6;ITGB5;GSN;PIK3C2G;ANPEP;GAS6;AXL;EGFR;APOBEC3C;TRIM38;EIF2AK4;TRIM5;LGALS1;IFIT1;ITGA2;ADARB1;CAV1;OAS2;HMGA2;APOBEC3G;STOM;APOBEC3F;EFNB3;IFITM2;MVB12B;RAB43;RSAD2;SRPK2;UVRAG;IFITM1;ATG16L2
7626,GO:0032045,0.224357906969246,0.948602117792062,2,8,guanyl-nucleotide exchange factor complex,CC,ULK1;DOCK1
10767,GO:0044255,0.224521265336925,0.809893456625684,85,753,cellular lipid metabolic process,BP,INPP5D;PTGS1;PITPNM3;PIK3C2G;IRS2;OSBPL10;EGFR;SDC3;MBOAT2;ISYNA1;VAV3;SLC27A3;PDGFA;ACSL3;SIK1;TYSND1;GPX1;PTGES;LPCAT2;KITLG;ECH1;LRP1;FYN;UGT8;CPS1;CAV1;SLC27A1;PLA2G6;SEL1L;OSBPL5;ACSS1;SDR16C5;PIK3R1;ALDH3A2;CPT1A;ACACB;ANG;CES2;CAT;PLCH2;SNCA;FGFR1;CBR1;ALOX15B;PRKAB2;ESYT2;PDK3;ARSD;MTMR4;ATM;DGKQ;ACSS2;HEXA;POGLUT1;SDC2;THNSL2;SLC27A6;ETNK2;PGAP1;GAL3ST4;DECR1;ACSF2;ZADH2;CYP4V2;EFR3A;AGRN;VAV2;TH;PIKFYVE;ITGB8;UGT1A3;LMF1;ALG10;AGPAT1;PPARG;CERS5;PRKAG1;MPPE1;PIK3C2B;AIG1;ACOT1;SCPEP1;EHHADH;CPT2;ACAA2
3416,GO:0007204,0.22454628749518,0.845907010357511,18,130,positive regulation of cytosolic calcium ion concentration,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;DLG4;FYN;CAV1;PLA2G6;CAMK2D;SNCA;PDE4D;TGM2;PRNP;ITPR2;OXTR
8439,GO:0033590,0.224592398236655,0.981263371138886,1,3,response to cobalamin,BP,EGFR
15574,GO:0072089,0.225032137749864,0.863280260811691,11,71,stem cell proliferation,BP,ZFP36L1;SNAI2;GLI3;KITLG;HMGA2;FBLN1;FGFR1;LTBP3;ARHGEF2;LEF1;YAP1
2106,GO:0004886,0.22504236600949,0.985687149493865,1,2,9-cis retinoic acid receptor activity,MF,RXRA
12774,GO:0051095,0.225135031137495,0.94709085364082,2,9,regulation of helicase activity,BP,TP53;IFIT1
5925,GO:0018209,0.225256863065243,0.830615508498666,30,227,peptidyl-serine modification,BP,DDIT4;TGFBR2;GAS6;EGFR;GALNT10;PAK1;CAV1;PRKCZ;HMGA2;CAMK2D;CAPRIN2;SPRY2;CHEK2;SNCA;DKK1;PDE4D;PDK3;ATM;IFNK;DGKQ;IFNE;POGLUT1;PRKCA;MAP3K12;RET;ULK1;GALNT2;TAF1;TTBK2;DMPK
15453,GO:0071837,0.225537012591371,0.94815387911209,2,8,HMG box domain binding,MF,TCF12;HOXA3
9988,GO:0042426,0.22567952318442,0.985600439443649,1,2,choline catabolic process,BP,ALDH7A1
1156,GO:0002765,0.225731758150192,0.981061276574526,1,3,immune response-inhibiting signal transduction,BP,IL20RB
4278,GO:0009649,0.225936556753586,0.908817139060067,4,23,entrainment of circadian clock,BP,TP53;SIK1;PER1;CRTC1
6637,GO:0023041,0.225947426001253,0.981022885520706,1,3,neuronal signal transduction,BP,CLU
10150,GO:0042756,0.225949754046605,0.981022470867344,1,3,drinking behavior,BP,HTR1B
10697,GO:0044036,0.225979618180102,0.981017151248389,1,3,cell wall macromolecule metabolic process,BP,MANBA
15304,GO:0071554,0.225979618180102,0.981017151248389,1,3,cell wall organization or biogenesis,BP,MANBA
8671,GO:0034308,0.226049305041463,0.896302665646976,5,35,primary alcohol metabolic process,BP,SULT1E1;ACSS1;SDR16C5;ALDH3A2;ACSS2
3534,GO:0007529,0.226169455366832,0.985533562619008,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
12121,GO:0048247,0.226249609096811,0.922711582708213,3,19,lymphocyte chemotaxis,BP,GAS6;CXCL14;ADAM10
18633,GO:1903976,0.226379676995638,0.980945809192352,1,3,negative regulation of glial cell migration,BP,IDH2
1133,GO:0002726,0.226462798769541,0.946573893971982,2,9,positive regulation of T cell cytokine production,BP,PRKCZ;RSAD2
4629,GO:0010756,0.226570330829933,0.98091175727849,1,3,positive regulation of plasminogen activation,BP,PLGRKT
6277,GO:0019887,0.226687419421638,0.843676543930009,18,147,protein kinase regulator activity,MF,FLRT2;CDKN2B;GAS6;FLRT3;WNK1;ERCC6;TRIB2;SPRY2;AFAP1L2;FAM20A;DGKQ;CDKN2A;DNAJC3;CCNY;PRKAG1;EFNA5;CAMK2N1;TAOK3
13771,GO:0060389,0.226786797308329,0.887867646887251,6,38,pathway-restricted SMAD protein phosphorylation,BP,TGFBR2;BMP4;DKK1;TGFBR3;ENG;TGFB2
11847,GO:0046875,0.226831221492572,0.908681435273833,4,22,ephrin receptor binding,MF,FYN;EFNB3;PTPN1;EFNA5
10121,GO:0042704,0.226834445450405,0.985442508078521,1,2,uterine wall breakdown,BP,TGFB2
8808,GO:0034599,0.226882466350313,0.833668966370728,25,213,cellular response to oxidative stress,BP,MMP9;PRODH;NQO1;ETV5;PKD2;AXL;EGFR;TP53;GPX1;TP53INP1;PRDX5;PXN;CAT;DAPK1;SNCA;SETX;PLA2R1;G6PD;CHD6;FZD1;MDM2;CST3;PXMP2;GPX8;FOS
14847,GO:0070662,0.226909942071558,0.985432150077899,1,2,mast cell proliferation,BP,KITLG
14851,GO:0070666,0.226909942071558,0.985432150077899,1,2,regulation of mast cell proliferation,BP,KITLG
14853,GO:0070668,0.226909942071558,0.985432150077899,1,2,positive regulation of mast cell proliferation,BP,KITLG
14220,GO:0061300,0.226914448985683,0.985431531604887,1,2,cerebellum vasculature development,BP,FZD4
5856,GO:0017162,0.227032764963907,0.947582792870058,2,8,aryl hydrocarbon receptor binding,MF,AIP;NCOA2
4423,GO:0010256,0.227159658008069,0.818967712651591,46,358,endomembrane system organization,BP,SERPINE2;FLOT1;SYNE1;F2R;FAT4;GSN;COL5A1;RFX2;ALS2CL;ABCA1;CUL7;ANO6;ASAP1;NEK9;PDE4DIP;CAV1;SNX33;AHNAK2;CLU;EHD3;GOLGB1;ATP8B2;DYSF;ANK3;PRX;SH3TC2;LMNA;MYOF;CCDC136;TMED10;SNX10;FBXW8;SYNE2;LYST;NDRG1;PRKCA;GOLGA8B;RAB43;TGFB2;REEP2;GOLGA8N;SNX9;OBSL1;COG3;VPS36;DMPK
4865,GO:0014731,0.227270829859036,0.951375946239501,2,6,spectrin-associated cytoskeleton,CC,SPTB;ANK3
12889,GO:0051262,0.227354866706981,0.853761518170115,13,116,protein tetramerization,BP,PKD2;S100A10;TP53;ACACB;TP73;CAT;IGF1R;CRTC1;ANXA2;DECR1;SRR;SBF2;RXRA
15380,GO:0071674,0.227444840433687,0.906768077771131,4,27,mononuclear cell migration,BP,SERPINE1;ANO6;MOSPD2;LGALS3
17294,GO:0150011,0.227561461910488,0.949013136725824,2,7,regulation of neuron projection arborization,BP,DLG4;FZD4
17295,GO:0150012,0.227561461910488,0.949013136725824,2,7,positive regulation of neuron projection arborization,BP,DLG4;FZD4
15277,GO:0071498,0.227564955076817,0.923412476848005,3,16,cellular response to fluid shear stress,BP,PKD2;TFPI2;MAP2K5
5653,GO:0016763,0.227737456247097,0.886899109932105,6,40,transferase activity, transferring pentosyl groups,MF,XYLT1;PARP4;POGLUT1;NAPRT;PARP15;DNPH1
15780,GO:0072507,0.228014690039304,0.82903775886327,29,227,divalent inorganic cation homeostasis,BP,F2R;PKD2;JPH2;NOS1;EGFR;SLC8A1;NTSR1;VDR;DDIT3;DLG4;FYN;CAV1;PLA2G6;CAMK2D;HERPUD1;ANK3;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;FAM20A;ANXA6;PRNP;ITPR2;SV2A;OXTR;DMPK
4783,GO:0010977,0.228020374794492,0.849407493690421,15,103,negative regulation of neuron projection development,BP,VIM;ITM2C;LGALS1;PTPRS;SEMA5A;ASAP1;LRP1;ULK2;SEMA4A;NFATC4;EFNB3;MDM2;ARF6;SEMA4B;PPP3CA
7102,GO:0030913,0.228020415919077,0.948842035197148,2,7,paranodal junction assembly,BP,UGT8;NFASC
19106,GO:1905089,0.228370674081576,1,1,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,VPS13C
19107,GO:1905090,0.228370674081576,1,1,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,VPS13C
11821,GO:0046823,0.228522594351168,0.922931250158327,3,16,negative regulation of nucleocytoplasmic transport,BP,GAS6;SP100;MDFIC
18124,GO:1902893,0.228645317916926,0.8966483476197,5,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,TP53;NFATC4;SOX9;TGFB2;FOS
6009,GO:0019064,0.228802453640009,0.980510546257766,1,3,fusion of virus membrane with host plasma membrane,BP,GAS6
9761,GO:0039663,0.228802453640009,0.980510546257766,1,3,membrane fusion involved in viral entry into host cell,BP,GAS6
10978,GO:0044800,0.228802453640009,0.980510546257766,1,3,multi-organism membrane fusion,BP,GAS6
10240,GO:0042998,0.228868661438351,0.98516195094276,1,2,positive regulation of Golgi to plasma membrane protein transport,BP,ACSL3
14134,GO:0061045,0.228963019507148,0.87913829490025,7,46,negative regulation of wound healing,BP,SERPINE2;CD109;SERPINE1;PDGFA;SERPING1;ANXA2;ABAT
781,GO:0002040,0.229008408232651,0.8603302747467,11,71,sprouting angiogenesis,BP,CCBE1;RNF213;BMP4;SEMA5A;E2F7;PARVA;ROBO1;CDH13;MAP2K5;LEF1;ADGRA2
4511,GO:0010566,0.229055273083299,0.945558154050204,2,9,regulation of ketone biosynthetic process,BP,DGKQ;EGR1
14623,GO:0070242,0.229183786846499,0.922598329615624,3,16,thymocyte apoptotic process,BP,BMP4;TP53;GLI3
16807,GO:0098739,0.22949403714418,0.87924381568728,7,43,import across plasma membrane,BP,SLC8A1;NTSR1;FYN;KCNJ5;PRNP;SLC9A4;STEAP2
13862,GO:0060532,0.229522194453302,0.985071168755113,1,2,bronchus cartilage development,BP,SOX9
14181,GO:0061145,0.229522194453302,0.985071168755113,1,2,lung smooth muscle development,BP,SOX9
12761,GO:0051082,0.229528893005941,0.855220845738806,12,102,unfolded protein binding,MF,DNAJB4;HSPA2;SERPINH1;ERO1B;AIP;CALR;DNAJC4;HSPA5;PIKFYVE;HSP90AB4P;TMEM67;UGGT2
12472,GO:0050542,0.229674496146609,0.978054818240968,1,4,icosanoid binding,MF,PPARG
12473,GO:0050543,0.229674496146609,0.978054818240968,1,4,icosatetraenoic acid binding,MF,PPARG
12474,GO:0050544,0.229674496146609,0.978054818240968,1,4,arachidonic acid binding,MF,PPARG
7210,GO:0031115,0.229695393497258,0.945306055151564,2,9,negative regulation of microtubule polymerization,BP,EML2;SNCA
304,GO:0000814,0.229794552090677,0.98033071669119,1,3,ESCRT II complex,CC,VPS36
9191,GO:0035591,0.229930419761549,0.868082717306939,9,55,signaling adaptor activity,MF,CHN2;VAV3;PIK3R1;PAG1;AFAP1L2;AKAP13;MPP7;MAPK8IP3;SH2B3
12404,GO:0048878,0.229969141369206,0.80683714222223,76,643,chemical homeostasis,BP,F2R;SLC7A8;ANO1;GJA5;PKD2;JPH2;IRS2;CYBRD1;NOS1;GAS6;MALL;EGFR;SLC8A1;SESN3;NTSR1;ABCA1;ANGPTL4;VDR;NR1D1;STAT1;NEO1;LGALS1;KCNMA1;TP53;DDIT3;IFIT1;DLG4;FLG;ERO1B;FYN;IFI6;CPS1;CAV1;PLA2G6;SLC22A17;CAMK2D;CCK;PIK3R1;HERPUD1;ANK3;WFS1;PRKACB;SNCA;IGF1R;PDE4D;TGM2;IL18;PDK3;SLC24A1;CALR;FAM20A;ANXA6;GCLC;ENPP1;PRCP;TMEM175;LEPR;KCTD7;ABCC2;PRNP;SCNN1A;FHL1;SFXN3;TH;SLC9A4;ITPR2;KLHL3;PPARG;PTPN3;SV2A;ABCA2;EFNA5;PPP3CA;STEAP2;OXTR;DMPK
20252,GO:2001245,0.230093610677499,0.984991534819687,1,2,regulation of phosphatidylcholine biosynthetic process,BP,ACSL3
5704,GO:0016841,0.230172877734884,0.980261896144465,1,3,ammonia-lyase activity,MF,SRR
19506,GO:1990428,0.230220788193233,0.984973778205582,1,2,miRNA transport,BP,TGFBR2
2040,GO:0004784,0.230471389546422,0.977893452450607,1,4,superoxide dismutase activity,MF,NQO1
5630,GO:0016721,0.230471389546422,0.977893452450607,1,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,NQO1
11838,GO:0046851,0.230697193446379,0.946172001088863,2,8,negative regulation of bone remodeling,BP,INPP5D;SFRP1
15189,GO:0071372,0.230823207354837,0.946123190768737,2,8,cellular response to follicle-stimulating hormone stimulus,BP,GCLC;EFNA5
2945,GO:0006476,0.230876255321629,0.852225725583437,13,90,protein deacetylation,BP,PHF21A;TADA3;TP53;CHD3;SDR16C5;CAMK2D;PER1;HDAC11;BCL6;SAP30L;BEX4;NIPBL;PRDM5
14868,GO:0070697,0.231087930945195,0.984852387996812,1,2,activin receptor binding,MF,MAGI2
14869,GO:0070699,0.231087930945195,0.984852387996812,1,2,type II activin receptor binding,MF,MAGI2
17716,GO:1901678,0.231133746020553,0.944737713282664,2,9,iron coordination entity transport,BP,SLC22A17;SLC48A1
4698,GO:0010863,0.231139117599652,0.922214342250322,3,15,positive regulation of phospholipase C activity,BP,EGFR;ANG;FGFR1
2213,GO:0005109,0.23116030626583,0.906219432645319,4,22,frizzled binding,MF,SFRP1;FZD7;FZD1;GOPC
1554,GO:0003955,0.231378565949941,0.98004166936033,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,NQO1
3731,GO:0008270,0.231522037643647,0.8069003209961,70,574,zinc ion binding,MF,CPA4;MMP2;MMP9;MMP28;MARCH4;ANPEP;UTRN;PEG10;TRIM2;RNF165;TIMP2;VDR;APOBEC3C;TRIM38;NR1D1;XAF1;TRIM5;NR3C1;TP53;PRICKLE1;ZCCHC11;MMP19;TIMP1;CHD3;GLI2;PIAS3;ZNF318;PHC2;APOBEC3G;PHF2;SNCA;MME;GATAD1;APOBEC3F;SEC24D;KDM4C;TRAF1;LMCD1;DTNB;L3MBTL3;CALR;MDM2;NR2F2;ZMAT3;RNPEP;MAP3K1;PTPN1;CRIP2;ARHGEF2;EGR1;ENPP1;PRKCA;AMZ2;ADAMTS15;HLTF;RNF24;LANCL1;TES;THRA;ZADH2;MSRB2;PIKFYVE;SAP30L;PPARG;KLF7;RARA;KDM4A;RNPEPL1;LITAF;RXRA
13013,GO:0051496,0.231529690825002,0.884970755245483,6,37,positive regulation of stress fiber assembly,BP,CTGF;SFRP1;S100A10;PAK1;PXN;FHOD1
17814,GO:1902017,0.231606871040967,0.884920320637941,6,37,regulation of cilium assembly,BP,EVI5L;IFT140;BBS4;SYNE2;IFT88;SEPT9
11312,GO:0045659,0.231622751416958,0.984777241364848,1,2,negative regulation of neutrophil differentiation,BP,INPP5D
7265,GO:0031258,0.231699448344525,0.906802777818426,4,20,lamellipodium membrane,CC,CSPG4;PLEK2;PDPN;SYNE2
17744,GO:1901798,0.231729554839933,0.921311448115273,3,16,positive regulation of signal transduction by p53 class mediator,BP,PLA2R1;ATM;CDK5RAP3
17346,GO:1900101,0.231750730079528,0.904837442818169,4,25,regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1;WFS1;PTPN1;HSPA5
13641,GO:0060193,0.231760513723722,0.89360255396614,5,31,positive regulation of lipase activity,BP,EGFR;PRKCZ;ANG;FGFR1;LMF1
13252,GO:0051968,0.231802926714574,0.923407617396596,3,13,positive regulation of synaptic transmission, glutamatergic,BP,EGFR;TSHZ3;OXTR
4701,GO:0010868,0.231993491144527,0.984725024885382,1,2,negative regulation of triglyceride biosynthetic process,BP,SIK1
6457,GO:0021785,0.231995610925037,0.949675754313542,2,6,branchiomotor neuron axon guidance,BP,PLXNA2;PLXNA1
15302,GO:0071549,0.232098569416481,0.904636582883563,4,25,cellular response to dexamethasone stimulus,BP,DDIT4;EGFR;NR3C1;ABCC2
11217,GO:0045415,0.232119753620219,0.979905604043864,1,3,negative regulation of interleukin-8 biosynthetic process,BP,MAP2K5
12570,GO:0050773,0.232167114387273,0.8463181672419,15,100,regulation of dendrite development,BP,SDK1;TNIK;CSMD3;PTPRS;CUL7;DLG5;ASAP1;CAPRIN2;NFATC4;ARF6;FBXW8;SDC2;CRTC1;OBSL1;PPP3CA
1378,GO:0003275,0.232310600345336,0.984680280974705,1,2,apoptotic process involved in outflow tract morphogenesis,BP,TGFB2
17903,GO:1902256,0.232310600345336,0.984680280974705,1,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,TGFB2
18377,GO:1903432,0.232436304294301,0.904758782398974,4,24,regulation of TORC1 signaling,BP,SESN3;SESN1;ATM;DGKQ
13873,GO:0060546,0.232615087161836,0.944149672576499,2,9,negative regulation of necroptotic process,BP,CAV1;ARHGEF2
417,GO:0001105,0.23266175377396,0.885145483878076,6,33,RNA polymerase II transcription coactivator activity,MF,SMARCA2;CITED4;CITED2;ISL1;MEF2A;MED12
677,GO:0001888,0.232712849379296,0.984623416394488,1,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,EXTL2
9606,GO:0036490,0.232781815271116,0.945362016427518,2,8,regulation of translation in response to endoplasmic reticulum stress,BP,EIF2AK4;DNAJC3
5504,GO:0016461,0.233170048330995,0.94690469055479,2,7,unconventional myosin complex,CC,MYO9A;MYO1C
15861,GO:0072657,0.23336026229558,0.811745303508068,49,453,protein localization to membrane,BP,FLOT1;GSN;ETV5;TNIK;GAS6;TCAF1;EGFR;SYNE3;S100A10;PAK1;NSG1;TP53;DLG4;ACSL3;PACS1;TFDP2;ITGA3;LRP1;FYN;CAV1;PRKCZ;EHD3;PIK3R1;LAMA5;BBS2;ANK3;TP73;STOM;FLOT2;ARF6;BBS1;SSH1;NFASC;ANXA2;RAB13;RPL13A;TSPAN5;WDR19;PRNP;IFT122;EFR3A;AGRN;MAGI2;GOPC;REEP2;KCNIP3;COX18;MYO1C;C2CD5
19668,GO:2000015,0.233363990006771,0.979676019654458,1,3,regulation of determination of dorsal identity,BP,DDIT3
15251,GO:0071462,0.233452571568318,0.984518530276374,1,2,cellular response to water stimulus,BP,PKD2
1269,GO:0003057,0.233468105213797,0.979656741884527,1,3,regulation of the force of heart contraction by chemical signal,BP,CAV1
16697,GO:0097731,0.233671181961976,0.870309659577972,8,50,9+0 non-motile cilium,CC,PTGS1;NPHP4;KIF17;IFT140;BBS4;WDR19;IFT122;ARL3
16699,GO:0097733,0.233671181961976,0.870309659577972,8,50,photoreceptor cell cilium,CC,PTGS1;NPHP4;KIF17;IFT140;BBS4;WDR19;IFT122;ARL3
3845,GO:0008459,0.23377769864486,0.984472301252152,1,2,chondroitin 6-sulfotransferase activity,MF,CHST3
7744,GO:0032271,0.233859936487687,0.834837336368391,20,153,regulation of protein polymerization,BP,GSN;SPTB;PAK1;PYCARD;MAP2;EML2;ARHGAP18;ARPIN;KANK2;SNCA;RGS2;TRIOBP;BBS4;ARF6;FHOD3;CDC42EP5;CAPG;WIPF1;RASA1;MYO1C
6138,GO:0019418,0.234005227416167,0.977169903427103,1,4,sulfide oxidation,BP,TSTD1
14612,GO:0070221,0.234005227416167,0.977169903427103,1,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,TSTD1
14511,GO:0070052,0.234027356653109,0.984436749535203,1,2,collagen V binding,MF,ECM2
8849,GO:0034665,0.234088480813435,0.984428038273506,1,2,integrin alpha1-beta1 complex,CC,ITGA1
8641,GO:0034205,0.23454038242236,0.904281843457656,4,22,amyloid-beta formation,BP,SORL1;CLU;TMED10;PRNP
3010,GO:0006558,0.234570942509809,0.977052863024439,1,4,L-phenylalanine metabolic process,BP,GSTZ1
3011,GO:0006559,0.234570942509809,0.977052863024439,1,4,L-phenylalanine catabolic process,BP,GSTZ1
17884,GO:1902221,0.234570942509809,0.977052863024439,1,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,GSTZ1
17885,GO:1902222,0.234570942509809,0.977052863024439,1,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,GSTZ1
1356,GO:0003228,0.234674959718352,0.97943253124227,1,3,atrial cardiac muscle tissue development,BP,ENG
13445,GO:0055009,0.234674959718352,0.97943253124227,1,3,atrial cardiac muscle tissue morphogenesis,BP,ENG
4590,GO:0010710,0.23471866116571,0.979424386354088,1,3,regulation of collagen catabolic process,BP,CST3
8862,GO:0034685,0.234839665157559,0.984320753813901,1,2,integrin alphav-beta6 complex,CC,ITGB6
8013,GO:0032660,0.23518689877123,0.941286911577832,2,11,regulation of interleukin-17 production,BP,IL18;PRNP
1392,GO:0003307,0.235292598965992,0.979317249535093,1,3,regulation of Wnt signaling pathway involved in heart development,BP,DKK1
3887,GO:0008526,0.235309806462903,0.944372545106164,2,8,phosphatidylinositol transporter activity,MF,PITPNM3;PITPNC1
7894,GO:0032474,0.235336036218055,0.984249630762578,1,2,otolith morphogenesis,BP,LRIG3
3435,GO:0007228,0.235344726906056,0.984248383868571,1,2,positive regulation of hh target transcription factor activity,BP,STK36
16990,GO:0099172,0.235373341350105,0.920790385600155,3,14,presynapse organization,BP,SNCA;FZD1;NLGN4Y
3216,GO:0006865,0.235694964184561,0.854929836661047,11,76,amino acid transport,BP,SLC7A8;NTSR1;SLC7A11;CCK;SYT1;SLC38A10;SLC38A2;SNCA;SV2A;ABAT;NFKBIE
3892,GO:0008534,0.235895924768837,0.976777426480507,1,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,MUTYH
10369,GO:0043220,0.236023082830218,0.944091933639371,2,8,Schmidt-Lanterman incisure,CC,ANXA2;MPDZ
476,GO:0001520,0.236043736631969,0.984147908706646,1,2,outer dense fiber,CC,ODF2
18925,GO:1904715,0.236054811711443,0.979174482262596,1,3,negative regulation of chaperone-mediated autophagy,BP,SNCA
9362,GO:0035909,0.236055937133752,0.905462062975725,4,18,aorta morphogenesis,BP,MYLK;LRP1;ENG;TGFB2
16960,GO:0099072,0.236058436005449,0.919104828454218,3,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,NSG1;DLG4;DNM1P46
5432,GO:0016301,0.236111430793948,0.800577315352588,80,630,kinase activity,MF,TGFBR2;EFEMP1;PIK3C2G;IRS2;TNIK;ROR1;AXL;EGFR;ITPK1;SPEG;MYLK;TKFC;MAP3K6;DCAKD;PAK1;PTK6;EIF2AK4;CNTRL;LTBP1;WNK1;DLG4;PDGFA;CRIM1;SIK1;CDK14;KITLG;NEK9;NMRK1;FYN;ALPK1;LTBP4;MAP3K14;PRKCZ;ULK2;HMGA2;CAMK2D;MST1R;PIK3R1;CDK18;PHKA2;TTN;DAPK1;PRKACB;CHEK2;FGFR1;IGF1R;PRKAB2;MYO3B;OBSCN;PDK3;EPHB6;TGFBR3;ATM;EFNB3;AKAP13;DGKQ;MAP3K1;NRK;SOX9;ITPKB;STK16;PRKCA;PRPS2;ETNK2;PAK6;MAP3K12;STK36;RET;MAP2K5;ULK1;CDK19;PIKFYVE;SRPK2;ICK;PRKAG1;TAF1;PIK3C2B;TTBK2;TAOK3;DMPK
8851,GO:0034667,0.236276317006504,0.984114396718297,1,2,integrin alpha3-beta1 complex,CC,ITGA3
12704,GO:0050994,0.236288628189979,0.891314053598487,5,29,regulation of lipid catabolic process,BP,IRS2;TYSND1;CPT1A;ACACB;THRA
2665,GO:0006015,0.236361088190899,0.979116958674296,1,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,PRPS2
11631,GO:0046391,0.236361088190899,0.979116958674296,1,3,5-phosphoribose 1-diphosphate metabolic process,BP,PRPS2
3463,GO:0007284,0.236432727550482,0.984091837095437,1,2,spermatogonial cell division,BP,ZNF449
20270,GO:2001275,0.236435010352311,0.922107798824196,3,12,positive regulation of glucose import in response to insulin stimulus,BP,PAK1;PIK3R1;C2CD5
6071,GO:0019228,0.236458570045264,0.921088735093961,3,13,neuronal action potential,BP,SCN8A;SCN2A;ANK3
7035,GO:0030819,0.236562329478853,0.942569313985329,2,9,positive regulation of cAMP biosynthetic process,BP,TIMP2;GPR161
3448,GO:0007263,0.23656316980474,0.943879037974877,2,8,nitric oxide mediated signal transduction,BP,NOS1;EGFR
14579,GO:0070168,0.236755981095695,0.943802946657722,2,8,negative regulation of biomineral tissue development,BP,GAS6;SOX9
16417,GO:0097109,0.236771356551124,0.984042932704703,1,2,neuroligin family protein binding,MF,DLG4
10120,GO:0042701,0.236795654590631,0.984039420307448,1,2,progesterone secretion,BP,FZD4
6869,GO:0030374,0.236851490481779,0.862860022231772,9,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,TADA3;VDR;NR1D1;NCOA2;TRERF1;THRA;PPARG;RARA;MED12
1490,GO:0003829,0.23698284798768,0.984012345773333,1,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,GCNT1
15815,GO:0072558,0.237085727726718,0.978980503226333,1,3,NLRP1 inflammasome complex,CC,PYCARD
9556,GO:0036374,0.237171262823207,0.978964363176285,1,3,glutathione hydrolase activity,MF,GGT7
17145,GO:0102953,0.237171262823207,0.978964363176285,1,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,GGT7
17154,GO:0103068,0.237171262823207,0.978964363176285,1,3,leukotriene C4 gamma-glutamyl transferase activity,MF,GGT7
17739,GO:1901748,0.237171262823207,0.978964363176285,1,3,leukotriene D4 metabolic process,BP,GGT7
17740,GO:1901750,0.237171262823207,0.978964363176285,1,3,leukotriene D4 biosynthetic process,BP,GGT7
433,GO:0001162,0.237276166540415,0.943597430355871,2,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6;NCOA2
3542,GO:0007567,0.237371654991129,0.94224286888514,2,9,parturition,BP,NRK;OXTR
5798,GO:0017057,0.237385111332517,0.983954075904576,1,2,6-phosphogluconolactonase activity,MF,H6PD
8233,GO:0033023,0.237431843621772,0.983947298627067,1,2,mast cell homeostasis,BP,KITLG
8234,GO:0033024,0.237431843621772,0.983947298627067,1,2,mast cell apoptotic process,BP,KITLG
8235,GO:0033025,0.237431843621772,0.983947298627067,1,2,regulation of mast cell apoptotic process,BP,KITLG
12071,GO:0048073,0.237449880870711,0.983944682364804,1,2,regulation of eye pigmentation,BP,HPS4
4235,GO:0009437,0.237639216725333,0.941101779259001,2,10,carnitine metabolic process,BP,CPT1A;ALDH9A1
19867,GO:2000380,0.237698405641759,0.945174472590353,2,7,regulation of mesoderm development,BP,FGFR1;DKK1
7253,GO:0031232,0.237716130315838,0.978861385159413,1,3,extrinsic component of external side of plasma membrane,CC,SERPINE2
17919,GO:1902287,0.237723605670463,0.922696577784609,3,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,PLXNB1;PLXNA2;PLXNA1
13986,GO:0060736,0.237970900234483,0.945069561845959,2,7,prostate gland growth,BP,SOX9;PLAG1
1852,GO:0004517,0.238040759743633,0.983858841661952,1,2,nitric-oxide synthase activity,MF,NOS1
7304,GO:0031324,0.238161803136606,0.785934122681963,213,1888,negative regulation of cellular metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;TXNIP;SOX6;INPP5D;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;DDIT4;IRS2;DUSP6;ZFP36L2;IGF2BP2;COL7A1;GAS6;SNAI2;MAGED1;PHF21A;TFPI2;EGFR;TSC22D3;KLF8;FLRT3;ZNF608;SERPINE1;SERPINH1;CRTAP;TIMP2;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;PDCD4;NR3C1;STAT1;SORL1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;WNK1;DLG4;ZCCHC11;PDGFA;MICAL1;ADARB1;TIMP1;TFDP2;CCDC85B;CRIM1;SIK1;KLF12;NFIX;ELFN2;HIVEP1;GPX1;GLI3;E2F7;CTDSPL;ZFP90;FYN;IFI6;XDH;TSHZ2;CAV1;SLC27A1;GLI2;PIAS3;RBFOX2;TRIB2;ZNF318;TNRC18;CLU;SERPING1;PRKCZ;SDR16C5;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ACACB;ANG;DUSP5;UHRF2;HERPUD1;WFS1;MDFI;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;CHEK2;SPRY4;PAIP2B;PHF2;SNCA;GLG1;FGFR1;IGF1R;DKK1;RGS2;C5;PDE4D;NCOA2;G6PD;TLE4;FZD8;TCEAL1;KDM4C;NFATC4;MAGEF1;FOXN3;LMCD1;FZD1;PBXIP1;ENG;CALR;ATM;MDM2;CST3;MEIS2;DGKQ;CITED2;GCLC;NR2F2;CBX7;MAF;LZTS1;PTPN1;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;SALL2;ANXA2;RGS14;CXORF57;BAHCC1;LEPR;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;PRNP;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;OPHN1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;DERL3;PPARG;PARP15;BEX4;KCNIP3;MEF2A;TGIF1;ING4;UNK;PTPN3;DNAJC3;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;NIPBL;PRDM5;S100A11;RXRA;TAOK3
4185,GO:0009266,0.238382635519386,0.828021954986494,22,176,response to temperature stimulus,BP,ANO1;NOS1;DNAJB4;HSPA2;NTSR1;EIF2AK4;TP53;SLC27A1;TP53INP1;CAMK2D;CIRBP;MYOF;ATM;GCLC;ABCC2;HTR1B;THRA;HSPA5;TGFB1I1;PPARG;DNAJC3;FOS
14617,GO:0070231,0.238511850971765,0.888506634773856,5,35,T cell apoptotic process,BP,TSC22D3;BMP4;TP53;GLI3;LGALS3
1478,GO:0003756,0.238606690953065,0.917247092929532,3,17,protein disulfide isomerase activity,MF,ERO1B;PDIA4;PDIA6
5719,GO:0016864,0.238606690953065,0.917247092929532,3,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,ERO1B;PDIA4;PDIA6
16735,GO:0098559,0.23862892290481,0.97868823393121,1,3,cytoplasmic side of early endosome membrane,CC,LITAF
19190,GO:1905332,0.238726025232366,0.90186393941507,4,22,positive regulation of morphogenesis of an epithelium,BP,MAGED1;BMP4;SOX9;GDNF
16242,GO:0090331,0.238771699624237,0.941676213500953,2,9,negative regulation of platelet aggregation,BP,SERPINE2;ABAT
17766,GO:1901873,0.238815071238203,0.983745955391578,1,2,regulation of post-translational protein modification,BP,CRTAP
17767,GO:1901874,0.238815071238203,0.983745955391578,1,2,negative regulation of post-translational protein modification,BP,CRTAP
7369,GO:0031432,0.238853249831659,0.944729237014619,2,7,titin binding,MF,CAMK2D;OBSCN
14003,GO:0060761,0.238976051538424,0.879175453507325,6,42,negative regulation of response to cytokine stimulus,BP,GAS6;CAV1;SLIT3;ROBO1;MAP2K5;PPARG
14934,GO:0070859,0.23909590936378,0.978599340758041,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18738,GO:1904253,0.23909590936378,0.978599340758041,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
14236,GO:0061325,0.239156495973333,0.978587792473234,1,3,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
8858,GO:0034680,0.239164981356885,0.98369479430687,1,2,integrin alpha10-beta1 complex,CC,ITGA10
14118,GO:0061025,0.239175023289381,0.827365094899697,22,176,membrane fusion,BP,SYT8;GAS6;SAMD9L;TBC1D8;VAV3;EVI5L;TBC1D5;SPG11;SYTL1;SYT1;DYSF;VAMP1;CALR;TMEM175;ANXA2;RAB13;VPS39;C2CD4C;UVRAG;TBC1D16;DNM1P46;C2CD5
14136,GO:0061047,0.239255364371318,0.978568939816951,1,3,positive regulation of branching involved in lung morphogenesis,BP,BMP4
14850,GO:0070665,0.239424043558399,0.859532170640892,9,73,positive regulation of leukocyte proliferation,BP,TGFBR2;IRS2;VAV3;PYCARD;KITLG;IL18;CD1D;BCL6;IGFBP2
9621,GO:0036507,0.239495020842286,0.901417491656517,4,22,protein demannosylation,BP,SEL1L;MAN1A1;UGGT2;EDEM1
9622,GO:0036508,0.239495020842286,0.901417491656517,4,22,protein alpha-1,2-demannosylation,BP,SEL1L;MAN1A1;UGGT2;EDEM1
15586,GO:0072103,0.239741849650643,0.983610247881116,1,2,glomerulus vasculature morphogenesis,BP,BMP4
15587,GO:0072104,0.239741849650643,0.983610247881116,1,2,glomerular capillary formation,BP,BMP4
8713,GO:0034377,0.239792952008262,0.917182619879571,3,16,plasma lipoprotein particle assembly,BP,ABCA1;ACSL3;PRKACB
2571,GO:0005861,0.239929067771376,0.978440225361073,1,3,troponin complex,CC,TNNI2
13005,GO:0051482,0.240001376847988,0.939284748772583,2,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;TGM2
3586,GO:0008009,0.240132305172706,0.937955869728236,2,13,chemokine activity,MF,CXCL14;C5
17194,GO:0106104,0.240193448765652,0.983543885988688,1,2,regulation of glutamate receptor clustering,BP,SSH1
18927,GO:1904717,0.240193448765652,0.983543885988688,1,2,regulation of AMPA glutamate receptor clustering,BP,SSH1
2140,GO:0004954,0.240426087225272,0.978344987845325,1,3,prostanoid receptor activity,MF,PPARG
15470,GO:0071872,0.24055218286139,0.942295432665479,2,8,cellular response to epinephrine stimulus,BP,SNCA;PDE4D
265,GO:0000733,0.24065063871919,0.940911863122146,2,9,DNA strand renaturation,BP,TP53;SMARCA1
10055,GO:0042573,0.240894392810015,0.939758146079668,2,10,retinoic acid metabolic process,BP,UGT1A3;SCPEP1
2390,GO:0005534,0.240895678518708,0.978254787853341,1,3,galactose binding,MF,ENG
2998,GO:0006546,0.240895927021812,0.978254740064281,1,3,glycine catabolic process,BP,GLDC
6147,GO:0019464,0.240895927021812,0.978254740064281,1,3,glycine decarboxylation via glycine cleavage system,BP,GLDC
13763,GO:0060379,0.240992413264968,0.942119457293345,2,8,cardiac muscle cell myoblast differentiation,BP,PRICKLE1;ISL1
3200,GO:0006836,0.240996397397781,0.834499119644013,17,125,neurotransmitter transport,BP,SYT8;NOS1;NTSR1;SLC7A11;SYN1;SEC14L1;SYTL1;SYT1;PCLO;SNCA;SEPT5;HTR1B;C2CD4C;TH;GDNF;SV2A;ABAT
14231,GO:0061316,0.241094273838827,0.978216577456254,1,3,canonical Wnt signaling pathway involved in heart development,BP,DKK1
3608,GO:0008050,0.241164633416235,0.983400650218169,1,2,female courtship behavior,BP,THRA
11446,GO:0045924,0.241164633416235,0.983400650218169,1,2,regulation of female receptivity,BP,THRA
14470,GO:0061951,0.241476027287718,0.878024519050356,6,39,establishment of protein localization to plasma membrane,BP,NSG1;ACSL3;BBS2;ANK3;BBS1;GOPC
13616,GO:0060151,0.241506307076346,0.983350088784342,1,2,peroxisome localization,BP,PEX1
13617,GO:0060152,0.241506307076346,0.983350088784342,1,2,microtubule-based peroxisome localization,BP,PEX1
11231,GO:0045475,0.241669669197421,0.943636603821366,2,7,locomotor rhythm,BP,NCOA2;NAGLU
12175,GO:0048369,0.241684003745495,0.983323758032902,1,2,lateral mesoderm morphogenesis,BP,FGFR1
12176,GO:0048370,0.241684003745495,0.983323758032902,1,2,lateral mesoderm formation,BP,FGFR1
12177,GO:0048371,0.241684003745495,0.983323758032902,1,2,lateral mesodermal cell differentiation,BP,FGFR1
12178,GO:0048372,0.241684003745495,0.983323758032902,1,2,lateral mesodermal cell fate commitment,BP,FGFR1
12179,GO:0048377,0.241684003745495,0.983323758032902,1,2,lateral mesodermal cell fate specification,BP,FGFR1
12180,GO:0048378,0.241684003745495,0.983323758032902,1,2,regulation of lateral mesodermal cell fate specification,BP,FGFR1
6840,GO:0030318,0.241723025615707,0.918434738982979,3,13,melanocyte differentiation,BP,GLI3;KITLG;HPS4
8393,GO:0033364,0.241859408600966,1,1,1,mast cell secretory granule organization,BP,LYST
13845,GO:0060491,0.241865839607028,0.833798688091806,17,125,regulation of cell projection assembly,BP,ARAP1;EVI5L;CAV1;DOCK11;ESPN;IFT140;FSCN1;BBS4;ARF6;SYNE2;SSH1;IFT88;PODXL;CDC42EP5;AGRN;KLF5;SEPT9
14357,GO:0061628,0.242022864593594,0.983273480044704,1,2,H3K27me3 modified histone binding,MF,TAF1
12461,GO:0050436,0.242076953145538,0.983265446688152,1,2,microfibril binding,MF,LTBP1
18242,GO:1903135,0.242088251097375,0.978024762204222,1,3,cupric ion binding,MF,PRNP
7284,GO:0031293,0.242115433985532,0.899489284085866,4,23,membrane protein intracellular domain proteolysis,BP,APH1B;SPPL2B;RHBDD1;ADAM10
7044,GO:0030833,0.242220996311314,0.83767647317288,15,115,regulation of actin filament polymerization,BP,GSN;SPTB;PYCARD;ARHGAP18;ARPIN;KANK2;TRIOBP;BBS4;ARF6;FHOD3;CDC42EP5;CAPG;WIPF1;RASA1;MYO1C
19096,GO:1905065,0.242248088725586,0.977993828271815,1,3,positive regulation of vascular smooth muscle cell differentiation,BP,ENG
11126,GO:0045197,0.242276787729876,0.887560678890273,5,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG4;DLG5;VANGL2;OPHN1;MYO9A
2222,GO:0005126,0.242404874567601,0.834773695660291,16,137,cytokine receptor binding,MF,TGFBR2;CXCL14;BMP4;STAT1;PYCARD;KITLG;PIK3R1;CTF1;C5;TRAF1;TGFBR3;ENG;IFNK;IFNE;TGFB2;EFNA5
12242,GO:0048557,0.242555712660714,0.943290867471085,2,7,embryonic digestive tract morphogenesis,BP,GLI3;NIPBL
15281,GO:0071502,0.242573115985215,0.977930848611222,1,3,cellular response to temperature stimulus,BP,HTR1B
16836,GO:0098796,0.242622953663775,0.794336044973611,80,731,membrane protein complex,CC,ITGB6;FLOT1;ITGB5;ITGA6;SYNE1;TGFBR2;ITGB4;ANO1;GJA5;PIK3C2G;CLTCL1;NOS1;UTRN;EGFR;HSPA2;SYNE3;GJC2;EVC;SCN8A;NEO1;SCN2A;GNG2;KCNMA1;DLG4;ITGA2;HIP1;ITGA3;SNX1;ANO6;TBC1D5;KCNAB2;LRP1;CAV1;ITGA10;SEL1L;CAMK2D;ITGA1;PIK3R1;SYT1;HERPUD1;KCNJ5;SNCA;FLOT2;VAMP1;IGF1R;SEC24D;C5;PDE4D;FZD8;CDH13;TGFBR3;ENG;CALR;COPG2;APH1B;TMED10;SYNE2;KCNQ3;NDUFA4L2;KLHL12;PRKCA;MPP7;MVB12B;CDH11;RET;VPS39;SCNN1A;UVRAG;ITGB8;CACNB1;DERL3;CALCRL;KCNIP3;SHISA9;DNAJC3;ABCA2;PIK3C2B;VPS36;TUSC3;SNTB1
18587,GO:1903897,0.242866078530439,0.940004930138312,2,9,regulation of PERK-mediated unfolded protein response,BP,PTPN1;HSPA5
771,GO:0002027,0.242868284622912,0.869926614554956,7,44,regulation of heart rate,BP,GJA5;SLC8A1;CAV1;CAMK2D;KCNJ5;PDE4D;MDM2
9066,GO:0035335,0.242876869428962,0.849593651956656,11,75,peptidyl-tyrosine dephosphorylation,BP,DUSP6;PTPRM;PTPRS;PTPN14;DUSP5;PTPRU;MTMR4;DNAJC6;PTPN1;SSH1;PTPN3
9482,GO:0036146,0.242925417877954,0.977862468878678,1,3,cellular response to mycotoxin,BP,EGR1
14613,GO:0070227,0.243024030176048,0.868697594509459,7,52,lymphocyte apoptotic process,BP,IRS2;TSC22D3;BMP4;TP53;GLI3;BCL6;LGALS3
1054,GO:0002583,0.243323909675238,0.975199079412729,1,4,regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
10210,GO:0042921,0.243353219678613,0.916727634457573,3,14,glucocorticoid receptor signaling pathway,BP,NR3C1;PER1;CALR
4386,GO:0010043,0.243405268323079,0.897723525034725,4,26,response to zinc ion,BP,KRT14;D2HGDH;CPS1;TH
13983,GO:0060733,0.243467143924045,0.983058211375767,1,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,EIF2AK4
15122,GO:0071262,0.243467143924045,0.983058211375767,1,2,regulation of translational initiation in response to starvation,BP,EIF2AK4
15123,GO:0071264,0.243467143924045,0.983058211375767,1,2,positive regulation of translational initiation in response to starvation,BP,EIF2AK4
10252,GO:0043014,0.243478494645176,0.898689441550383,4,23,alpha-tubulin binding,MF,EFHC1;SNCA;BBS4;BEX4
8044,GO:0032720,0.243532791132099,0.89736570527094,4,27,negative regulation of tumor necrosis factor production,BP,GAS6;AXL;GPNMB;RARA
6423,GO:0021696,0.243755683608551,0.900435512960818,4,19,cerebellar cortex morphogenesis,BP,SERPINE2;TRNP1;GLI2;OPHN1
153,GO:0000309,0.243944815059695,0.982986666501275,1,2,nicotinamide-nucleotide adenylyltransferase activity,MF,NMNAT2
6106,GO:0019355,0.243944815059695,0.982986666501275,1,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,NMNAT2
8823,GO:0034627,0.243944815059695,0.982986666501275,1,2,'de novo' NAD biosynthetic process,BP,NMNAT2
8824,GO:0034628,0.243944815059695,0.982986666501275,1,2,'de novo' NAD biosynthetic process from aspartate,BP,NMNAT2
993,GO:0002456,0.244108102936402,0.867827872748888,7,53,T cell mediated immunity,BP,IL20RB;PRKCZ;IL31RA;IL18;BTN3A3;RSAD2;ZBTB1
9155,GO:0035526,0.244128046160529,0.982959176401581,1,2,retrograde transport, plasma membrane to Golgi,BP,RAB43
7790,GO:0032350,0.244319940789629,0.897825835516862,4,24,regulation of hormone metabolic process,BP,VDR;DGKQ;EGR1;TRERF1
4026,GO:0009062,0.244399005296442,0.847560976228065,11,88,fatty acid catabolic process,BP,IRS2;TYSND1;ECH1;ALDH3A2;CPT1A;ACACB;DECR1;AIG1;EHHADH;CPT2;ACAA2
8192,GO:0032957,0.24447465791831,0.940719020354003,2,8,inositol trisphosphate metabolic process,BP,ITPK1;ITPKB
18919,GO:1904706,0.244495877291507,0.937388913344412,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,PDCD4;PPARG
18594,GO:1903905,0.24452913694812,0.982898911765565,1,2,positive regulation of establishment of T cell polarity,BP,FLOT2
10243,GO:0043001,0.244554526160744,0.8858347840834,5,30,Golgi to plasma membrane protein transport,BP,ACSL3;BBS2;ANK3;BBS1;GOPC
17686,GO:1901623,0.244621379667825,0.938203262113032,2,10,regulation of lymphocyte chemotaxis,BP,CXCL14;ADAM10
12302,GO:0048678,0.244738347165999,0.867879198661262,7,49,response to axon injury,BP,FLRT3;NEFL;LGALS1;PTPRS;CST3;ISL1;LAMB2
1920,GO:0004616,0.244808058881619,0.977495026017497,1,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,HIBADH
591,GO:0001756,0.244885402314962,0.869501870346212,7,39,somitogenesis,BP,SFRP1;PLXNA2;DKK1;ATM;POGLUT1;LEF1;MED12
8138,GO:0032877,0.245022545518437,0.982824608259322,1,2,positive regulation of DNA endoreduplication,BP,E2F7
14916,GO:0070836,0.245192769068476,0.977419518366137,1,3,caveola assembly,BP,CAV1
3536,GO:0007538,0.245372481946515,0.982771798149651,1,2,primary sex determination,BP,SOX9
3537,GO:0007542,0.245372481946515,0.982771798149651,1,2,primary sex determination, germ-line,BP,SOX9
5987,GO:0018992,0.245372481946515,0.982771798149651,1,2,germ-line sex determination,BP,SOX9
6027,GO:0019100,0.245372481946515,0.982771798149651,1,2,male germ-line sex determination,BP,SOX9
2695,GO:0006063,0.24539106947171,0.93700822589517,2,11,uronic acid metabolic process,BP,UGT1A3;UGT1A6
6179,GO:0019585,0.24539106947171,0.93700822589517,2,11,glucuronate metabolic process,BP,UGT1A3;UGT1A6
1624,GO:0004062,0.245492792445434,0.974727199326488,1,4,aryl sulfotransferase activity,MF,SULT1E1
13444,GO:0055008,0.245784759696391,0.869891072695504,7,35,cardiac muscle tissue morphogenesis,BP,TTN;TGFBR3;ENG;ISL1;ZFPM1;TGFB2;RXRA
2620,GO:0005943,0.245800209523716,0.98270712152129,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3R1
16670,GO:0097651,0.245800209523716,0.98270712152129,1,2,phosphatidylinositol 3-kinase complex, class I,CC,PIK3R1
13254,GO:0051971,0.245852312864548,0.982699233447341,1,2,positive regulation of transmission of nerve impulse,BP,ITGA2
19962,GO:2000580,0.245970537383111,0.974622583935153,1,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,DNAL4
19963,GO:2000582,0.245970537383111,0.974622583935153,1,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,DNAL4
9985,GO:0042421,0.246116612172185,0.977237608091236,1,3,norepinephrine biosynthetic process,BP,TH
9979,GO:0042414,0.246223137362551,0.982643033418407,1,2,epinephrine metabolic process,BP,TH
6514,GO:0021898,0.246259592281702,0.977209380419372,1,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,DLX2
14112,GO:0061009,0.2463041086018,0.977200587786406,1,3,common bile duct development,BP,SOX9
14209,GO:0061209,0.246333653602582,0.977194751148115,1,3,cell proliferation involved in mesonephros development,BP,BMP4
2475,GO:0005712,0.246438906803587,0.982610284323453,1,2,chiasma,CC,MLH3
12327,GO:0048713,0.246498516481557,0.896909598057132,4,23,regulation of oligodendrocyte differentiation,BP,TENM4;TP73;DLX2;PPARG
17492,GO:1900756,0.246561615124243,0.982591644013302,1,2,protein processing in phagocytic vesicle,BP,GSN
18603,GO:1903921,0.246561615124243,0.982591644013302,1,2,regulation of protein processing in phagocytic vesicle,BP,GSN
18604,GO:1903923,0.246561615124243,0.982591644013302,1,2,positive regulation of protein processing in phagocytic vesicle,BP,GSN
11093,GO:0045136,0.246572123693795,0.938474006867096,2,9,development of secondary sexual characteristics,BP,AREG;IRF2BPL
7599,GO:0031996,0.246576268720913,0.937380643857703,2,10,thioesterase binding,MF,TRAF1;ARF6
7773,GO:0032309,0.246598960343029,0.913063669334423,3,17,icosanoid secretion,BP,NTSR1;PLA2G6;PLA2R1
16086,GO:0090100,0.246667678724424,0.850793397297352,10,67,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CDKN2B;RNF165;BMP4;NEO1;SULF1;TGFBR3;ENG;CITED2;TGFB2;TGFB1I1
12430,GO:0050220,0.246767909515115,0.974447434975076,1,4,prostaglandin-E synthase activity,MF,PTGES
3495,GO:0007398,0.246806300183736,0.914183388293747,3,15,ectoderm development,BP,ITGA6;FZD7;EDA2R
1051,GO:0002580,0.246932198699006,0.977076325427371,1,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
7482,GO:0031664,0.246938101934995,0.913457099166029,3,16,regulation of lipopolysaccharide-mediated signaling pathway,BP,TRIM5;PRKCA;SASH1
9168,GO:0035562,0.246953964263548,0.939712768337094,2,8,negative regulation of chromatin binding,BP,NFATC4;PPP3CA
2391,GO:0005536,0.246992843573878,0.938299121695489,2,9,glucose binding,MF,SLC2A3;G6PD
11420,GO:0045880,0.247495128716006,0.897188170251488,4,21,positive regulation of smoothened signaling pathway,BP,SFRP1;EVC;DLG5;STK36
8387,GO:0033341,0.247506748790916,0.982447685349323,1,2,regulation of collagen binding,BP,ITGA2
18366,GO:1903416,0.247513775785366,0.976960923212867,1,3,response to glycoside,BP,CHEK2
8698,GO:0034358,0.247776559911627,0.91244062810921,3,17,plasma lipoprotein particle,CC,ABCA1;SORL1;CLU
19598,GO:1990777,0.247776559911627,0.91244062810921,3,17,lipoprotein particle,CC,ABCA1;SORL1;CLU
15077,GO:0071157,0.247812308045748,0.911916059865941,3,18,negative regulation of cell cycle arrest,BP,CHEK2;CALR;MDM2
3079,GO:0006655,0.247896273423192,0.936822441971709,2,10,phosphatidylglycerol biosynthetic process,BP,SLC27A1;PLA2G6
8702,GO:0034364,0.247935218827381,0.935920711115998,2,11,high-density lipoprotein particle,CC,ABCA1;CLU
10261,GO:0043028,0.248107936728392,0.883050888955628,5,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,GAS6;PYCARD;PRDX5;SNCA;LEF1
16931,GO:0098971,0.248239814321086,0.982335557146988,1,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,KIF17
18573,GO:1903867,0.248280045992802,0.939171434778706,2,8,extraembryonic membrane development,BP,HTRA1;E2F7
11413,GO:0045862,0.248306159144654,0.808722330003853,32,283,positive regulation of proteolysis,BP,FN1;CCBE1;CTGF;F2R;GSN;PRICKLE1;PYCARD;HIP1;FYN;XDH;CAV1;TRIB2;SNX33;CLU;CCK;HERPUD1;FBLN1;DAPK1;DLC1;ROBO1;SNCA;MAGEF1;MDM2;GCLC;PLGRKT;RHBDD1;NUB1;PPARG;RNF144B;SNX9;TAF1;EDEM1
14773,GO:0070527,0.24839213527863,0.873209811191932,6,40,platelet aggregation,BP,SERPINE2;GAS6;SLC7A11;PDPN;PRKCA;ABAT
9107,GO:0035435,0.248446778533421,0.939103216747475,2,8,phosphate ion transmembrane transport,BP,SLC20A1;ANKH
937,GO:0002347,0.248551138944298,0.936544692411219,2,10,response to tumor cell,BP,TXNIP;RBMS3
7307,GO:0031327,0.248743388274115,0.780811214059648,138,1203,negative regulation of cellular biosynthetic process,BP,TXNIP;SOX6;INPP5D;SFRP1;ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;GAS6;SNAI2;MAGED1;PHF21A;EGFR;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;EIF2AK4;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;ZCCHC11;PDGFA;TFDP2;CCDC85B;SIK1;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;SLC27A1;GLI2;RBFOX2;TRIB2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ANG;UHRF2;WFS1;MDFI;CIRBP;JARID2;TP73;DAPK1;CHEK2;PAIP2B;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;SALL2;BAHCC1;LEPR;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;YAP1;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;UNK;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;AGO4;NIPBL;PRDM5;S100A11;RXRA
18788,GO:1904381,0.248893596906792,0.982235208348628,1,2,Golgi apparatus mannose trimming,BP,MAN1A1
18867,GO:1904578,0.249013407083548,0.976661831747016,1,3,response to thapsigargin,BP,CLU
18868,GO:1904579,0.249013407083548,0.976661831747016,1,3,cellular response to thapsigargin,BP,CLU
12561,GO:0050764,0.2491025177941,0.872918210502838,6,39,regulation of phagocytosis,BP,GAS6;PYCARD;ITGA2;ANO6;CALR;PPARG
10471,GO:0043393,0.249192512048479,0.820437252072138,21,170,regulation of protein binding,BP,FLOT1;MMP9;BMP4;SORL1;IFIT2;IFIT1;LRP1;CAV1;TMEM173;CAPRIN2;HERPUD1;DKK1;NFATC4;TGFBR3;ISL1;ANXA2;ZFPM1;LEF1;HSPA5;TAF1;TTBK2
7843,GO:0032414,0.249483067085115,0.859082171515831,8,50,positive regulation of ion transmembrane transporter activity,BP,PKD2;JPH2;TCAF1;HSPA2;NTSR1;WNK1;EHD3;ANK3
3713,GO:0008235,0.249573444721113,0.882111644618008,5,32,metalloexopeptidase activity,MF,CPA4;ANPEP;RNPEP;NPEPL1;RNPEPL1
13161,GO:0051795,0.249777054116963,0.976508684311374,1,3,positive regulation of timing of catagen,BP,TGFB2
15058,GO:0071073,0.250113442186034,0.976441041763715,1,3,positive regulation of phospholipid biosynthetic process,BP,ACSL3
5745,GO:0016899,0.250124501995948,0.982045386474527,1,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,ALDH3A2
3444,GO:0007257,0.250293952497863,0.882792523622806,5,28,activation of JUN kinase activity,BP,MAP3K6;ERCC6;PTPN1;MAPK8IP3;MDFIC
17466,GO:1900449,0.250427236619971,0.895458655913277,4,21,regulation of glutamate receptor signaling pathway,BP,NETO1;DLG4;DAPK1;SHISA9
1958,GO:0004666,0.250691961177974,0.981957484251227,1,2,prostaglandin-endoperoxide synthase activity,MF,PTGS1
6889,GO:0030433,0.250863181977169,0.85150285047509,9,68,ubiquitin-dependent ERAD pathway,BP,CAV1;SEL1L;HERPUD1;WFS1;TMEM129;HSPA5;DERL3;TMEM67;EDEM1
8004,GO:0032648,0.250907185848188,0.871334074279917,6,41,regulation of interferon-beta production,BP,FLOT1;PTPRS;ZBTB20;PYCARD;RNF135;TLR3
551,GO:0001673,0.25101273669605,0.935495779011754,2,10,male germ cell nucleus,CC,HSPA2;MLH3
784,GO:0002043,0.251095748733051,0.936581956308924,2,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4;SEMA5A
9748,GO:0039530,0.251152247650872,0.93655816237499,2,9,MDA-5 signaling pathway,BP,TKFC;DDX60
8068,GO:0032762,0.251204482758825,0.976220888137682,1,3,mast cell cytokine production,BP,BCL6
8069,GO:0032763,0.251204482758825,0.976220888137682,1,3,regulation of mast cell cytokine production,BP,BCL6
6485,GO:0021847,0.251273874469561,0.981867085362395,1,2,ventricular zone neuroblast division,BP,FGFR1
9203,GO:0035607,0.251273874469561,0.981867085362395,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR1
16142,GO:0090191,0.251333647291684,0.97619474773456,1,3,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
8588,GO:0034113,0.251517605453031,0.881394340304503,5,30,heterotypic cell-cell adhesion,BP,FLOT1;PARVA;CD1D;NFASC;MAP2K5
13671,GO:0060252,0.251537143766162,0.937832557767043,2,8,positive regulation of glial cell proliferation,BP,ETV5;PLAG1
8367,GO:0033280,0.251636341382775,0.894277565078232,4,22,response to vitamin D,BP,SFRP1;SNAI2;VDR;KANK2
8861,GO:0034684,0.251894393732384,0.981770401355136,1,2,integrin alphav-beta5 complex,CC,ITGB5
19293,GO:1905600,0.251896813154806,0.976080582737042,1,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
4917,GO:0014866,0.252143160281797,0.964751663418074,2,3,skeletal myofibril assembly,BP,TTN;MYH11
8404,GO:0033484,0.252315876933459,0.975995428217821,1,3,nitric oxide homeostasis,BP,CAV1
4899,GO:0014834,0.252380996182358,0.975982180393442,1,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,FZD7
3813,GO:0008410,0.252454518347411,0.975967218079713,1,3,CoA-transferase activity,MF,SUGCT
13362,GO:0052689,0.252470517694421,0.841331304128565,11,89,carboxylic ester hydrolase activity,MF,H6PD;PLA2G6;CES2;AARS;BPHL;BCHE;CES3;PGAP1;NLGN4Y;LIPA;ACOT1
18497,GO:1903706,0.252507495155586,0.801972734832155,36,327,regulation of hemopoiesis,BP,FBN1;INPP5D;SFRP1;ZFP36L1;TGFBR2;ZFP36L2;GAS6;AXL;FAM210B;BMP4;STAT1;GLI3;KITLG;GLI2;RBFOX2;PRKCZ;PIK3R1;TP73;KLF13;TLR3;PSMB9;IL18;SOX13;MEIS2;ITPKB;BCL6;PRKCA;TCF12;ZFPM1;LEF1;YAP1;LGALS3;RARA;ZBTB1;FOS;AGO4
11269,GO:0045603,0.252530498003316,0.937421603855873,2,8,positive regulation of endothelial cell differentiation,BP,BMP4;BTG1
5434,GO:0016307,0.252547785201157,0.911949971785066,3,14,phosphatidylinositol phosphate kinase activity,MF,PIK3C2G;PIKFYVE;PIK3C2B
2610,GO:0005922,0.252827773397327,0.934717442646462,2,10,connexin complex,CC,GJA5;GJC2
12641,GO:0050872,0.252918814337299,0.935812165189431,2,9,white fat cell differentiation,BP,SNAI2;PPARG
15488,GO:0071898,0.25316482029221,0.975822392802526,1,3,regulation of estrogen receptor binding,BP,LEF1
15489,GO:0071899,0.25316482029221,0.975822392802526,1,3,negative regulation of estrogen receptor binding,BP,LEF1
10935,GO:0044691,0.253168496267085,0.981570949032311,1,2,tooth eruption,BP,FAM20A
720,GO:0001947,0.253176238690494,0.871048585744163,6,35,heart looping,BP,TGFBR2;PKD2;ENG;BBS4;VANGL2;NPHP3
14379,GO:0061684,0.253275591749055,0.934524762390677,2,10,chaperone-mediated autophagy,BP,CLU;SNCA
12109,GO:0048210,0.253341891476565,0.97578621207785,1,3,Golgi vesicle fusion to target membrane,BP,RAB13
1999,GO:0004725,0.253415433932387,0.841489499280801,11,76,protein tyrosine phosphatase activity,MF,DUSP6;PTPRM;PTPRS;PTPN14;DUSP5;PTPRU;MTMR4;DNAJC6;PTPN1;SSH1;PTPN3
7758,GO:0032289,0.253461942014535,0.975761664765435,1,3,central nervous system myelin formation,BP,TENM4
11449,GO:0045927,0.253575403556477,0.81433396342712,23,169,positive regulation of growth,BP,FN1;SFRP1;TGFBR2;EGFR;PAK1;SEMA5A;SYT1;ACACB;BBS2;WFS1;FGFR1;TGFBR3;BBS4;MEGF8;TGFB2;MAP2K5;LEF1;AGRN;YAP1;EFNA5;DNPH1;NIPBL;ADAM10
15714,GO:0072329,0.253642451942611,0.836835332795992,12,98,monocarboxylic acid catabolic process,BP,IRS2;TYSND1;ECH1;ALDH3A2;CPT1A;ACACB;DECR1;AIG1;EHHADH;ABAT;CPT2;ACAA2
17485,GO:1900744,0.253675933165292,0.89263714791374,4,23,regulation of p38MAPK cascade,BP,GADD45B;XDH;PER1;SASH1
12880,GO:0051253,0.253871842621126,0.778722957754953,113,989,negative regulation of RNA metabolic process,BP,TXNIP;SOX6;SFRP1;GAS6;SNAI2;MAGED1;PHF21A;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;NR1D1;SMARCA2;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;UHRF2;WFS1;MDFI;CIRBP;JARID2;TP73;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;CDKN2A;SP100;MDFIC;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;NIPBL;PRDM5;RXRA
3102,GO:0006682,0.253910185738253,0.975669884876608,1,3,galactosylceramide biosynthetic process,BP,UGT8
6122,GO:0019375,0.253910185738253,0.975669884876608,1,3,galactolipid biosynthetic process,BP,UGT8
6233,GO:0019797,0.254038643532533,0.975643546109483,1,3,procollagen-proline 3-dioxygenase activity,MF,P3H2
14694,GO:0070373,0.254040330900041,0.861361811710303,7,49,negative regulation of ERK1 and ERK2 cascade,BP,DUSP6;SPRY2;FBLN1;SPRY4;PTPN1;RGS14;CAMK2N1
12408,GO:0048936,0.254284485910912,0.975593093691654,1,3,peripheral nervous system neuron axonogenesis,BP,ISL1
3797,GO:0008379,0.254292832632688,0.97108486910978,1,5,thioredoxin peroxidase activity,MF,PRDX5
7684,GO:0032148,0.25429866061738,0.892263650254429,4,23,activation of protein kinase B activity,BP,GAS6;PRKCZ;ANG;IL18
12977,GO:0051429,0.254332500826197,0.975583232994602,1,3,corticotropin-releasing hormone receptor binding,MF,UCN2
1484,GO:0003810,0.254513398663006,0.975546062077489,1,3,protein-glutamine gamma-glutamyltransferase activity,MF,TGM2
17924,GO:1902302,0.254699897378203,0.98132955473534,1,2,regulation of potassium ion export,BP,ANO6
2441,GO:0005652,0.254739863532972,0.935039049810826,2,9,nuclear lamina,CC,HLCS;LMNA
16450,GO:0097164,0.254849678376198,0.827091572649404,15,128,ammonium ion metabolic process,BP,MBOAT2;ACSL3;LPCAT2;SLC27A1;PLA2G6;CPT1A;SNCA;LRTOMT;AKR7A2;BCHE;ALDH9A1;TGFB2;ALDH7A1;TH;ABAT
7282,GO:0031290,0.254943838175985,0.910688007329252,3,14,retinal ganglion cell axon guidance,BP,PTPRM;ISL1;EFNA5
2094,GO:0004861,0.254947192987239,0.932880523098024,2,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN2B;CDKN2A
5993,GO:0019005,0.25510258978487,0.860220330856695,7,52,SCF ubiquitin ligase complex,CC,SKP2;ABTB1;BTBD2;FBXW4;FBXL7;FBXO17;FBXW8
15981,GO:0086020,0.255418151897426,0.981215709349829,1,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,GJA5
15982,GO:0086021,0.255418151897426,0.981215709349829,1,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,GJA5
16000,GO:0086053,0.255418151897426,0.981215709349829,1,2,AV node cell to bundle of His cell communication by electrical coupling,BP,GJA5
16016,GO:0086077,0.255418151897426,0.981215709349829,1,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,GJA5
3899,GO:0008543,0.255425900684673,0.836075536619888,12,87,fibroblast growth factor receptor signaling pathway,BP,FLRT2;CTGF;FAT4;DUSP6;SULF2;FLRT3;RBFOX2;SPRY2;SPRY4;FGFR1;SETX;SULF1
16937,GO:0098982,0.255507302852846,0.981201550688209,1,2,GABA-ergic synapse,CC,NLGN4Y
16938,GO:0098983,0.255507302852846,0.981201550688209,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN4Y
16658,GO:0097635,0.255686872278392,0.981173013292058,1,2,extrinsic component of autophagosome membrane,CC,ULK1
3693,GO:0008202,0.255859632932136,0.811803163061709,23,196,steroid metabolic process,BP,SULT1E1;SNAI2;ABCA1;VDR;NR1D1;SORL1;SEC14L2;OSBPL5;ACACB;CAT;FGFR1;G6PD;PBX1;HSD17B11;DGKQ;EGR1;TRERF1;LEPR;CYP4V2;OSBPL1A;LMF1;RXRA;ACAA2
1457,GO:0003700,0.255878134347441,0.775185877222879,128,1083,DNA binding transcription factor activity,MF,SOX6;ZFP36L1;ETV5;TSC22D1;ZFP36L2;SNAI2;TSC22D3;KLF8;RFX2;TCF7L1;TADA3;VDR;NR1D1;NR3C1;STAT1;ETV1;TP53;DDIT3;ZBTB20;ZC3H6;MEF2D;TFDP2;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;GLI2;SLC2A4RG;ZNF678;HMGA2;GOLGB1;ZSCAN18;CREB3L2;JARID2;ZKSCAN1;TP73;KLF13;ZNF860;GATAD1;SP110;TLE4;TCEAL1;SETBP1;SOX13;NFATC4;FOXN3;DLX3;L3MBTL3;PBX1;FOXL1;ZNF699;MEIS2;TCF4;CITED2;NR2F2;LMO4;ZNF449;MAF;LZTS1;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;TRERF1;HLTF;HOXA1;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;ZNF160;ZNF302;CARF;ZFPM1;RBL2;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;SP100;ZSCAN30;TEF;ZNF12;KLF5;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;RARA;HES2;HOXC5;PBX2;TAF1;TSHZ3;ZNF883;CREBRF;ETV4;HOXA2;FOS;ZBTB25;NPAS2;PRDM5;ZNF471;LITAF;RXRA;ZNF484
9996,GO:0042445,0.255950476174258,0.828883782861165,14,117,hormone metabolic process,BP,SULT1E1;VDR;PCSK1;ERO1B;SDR16C5;MME;FGFR1;HSD17B11;DGKQ;EGR1;TRERF1;ALDH9A1;UGT1A3;SCPEP1
19884,GO:2000403,0.255993218512498,0.908045979183835,3,17,positive regulation of lymphocyte migration,BP,CXCL14;PYCARD;ADAM10
9528,GO:0036301,0.256051720899688,0.975228662881329,1,3,macrophage colony-stimulating factor production,BP,ISL1
17572,GO:1901256,0.256051720899688,0.975228662881329,1,3,regulation of macrophage colony-stimulating factor production,BP,ISL1
18509,GO:1903725,0.256140910375906,0.860328385084729,7,46,regulation of phospholipid metabolic process,BP,VAV3;PDGFA;ACSL3;SLC27A1;PIK3R1;MTMR4;VAV2
8269,GO:0033087,0.256149980183018,0.975208309819814,1,3,negative regulation of immature T cell proliferation,BP,BMP4
474,GO:0001518,0.256260126946676,0.940528453425199,2,6,voltage-gated sodium channel complex,CC,SCN8A;SCN2A
9796,GO:0042015,0.256289693755763,0.975179353636644,1,3,interleukin-20 binding,MF,IL20RB
5174,GO:0015740,0.256331533028546,0.934359896752811,2,9,C4-dicarboxylate transport,BP,NTSR1;ABAT
10356,GO:0043198,0.25649010598914,0.891375427987057,4,22,dendritic shaft,CC,SLC8A1;NTSR1;MAP2;ARHGEF2
20017,GO:2000664,0.256585576723186,0.975117967007951,1,3,positive regulation of interleukin-5 secretion,BP,PRKCZ
20020,GO:2000667,0.256585576723186,0.975117967007951,1,3,positive regulation of interleukin-13 secretion,BP,PRKCZ
13810,GO:0060439,0.256601943556566,0.93424419759889,2,9,trachea morphogenesis,BP,TGFBR2;BMP4
19581,GO:1990743,0.25680213441431,0.975072983044586,1,3,protein sialylation,BP,ST6GALNAC2
526,GO:0001635,0.256887677963007,0.975055200913868,1,3,calcitonin gene-related peptide receptor activity,MF,CALCRL
16664,GO:0097642,0.256887677963007,0.975055200913868,1,3,calcitonin family receptor activity,MF,CALCRL
5763,GO:0016964,0.25699771490379,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
14615,GO:0070229,0.257055412580321,0.889529723454649,4,26,negative regulation of lymphocyte apoptotic process,BP,IRS2;TSC22D3;BMP4;BCL6
15590,GO:0072108,0.257156841557917,0.974999202009386,1,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
19539,GO:1990573,0.257209636817828,0.974988209653606,1,3,potassium ion import across plasma membrane,BP,KCNJ5
3507,GO:0007418,0.257480542498711,0.980886582304974,1,2,ventral midline development,BP,GLI2
6527,GO:0021937,0.257480542498711,0.980886582304974,1,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,GLI2
6528,GO:0021938,0.257480542498711,0.980886582304974,1,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,GLI2
6529,GO:0021940,0.257480542498711,0.980886582304974,1,2,positive regulation of cerebellar granule cell precursor proliferation,BP,GLI2
16441,GO:0097153,0.257594954037887,0.930946223020842,2,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,PYCARD;CASP14
13898,GO:0060589,0.257913371337018,0.797096829486505,37,283,nucleoside-triphosphatase regulator activity,MF,ASAP3;DNAJB4;ARHGAP23;ALS2CL;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;ARHGEF1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;ARHGEF12;ARHGAP18;DLC1;RGS2;SRGAP1;TBC1D19;RGS14;DEPDC7;CDC42EP5;AGAP1;GOPC;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;TBC1D16;RASA1;ARHGAP31;DOCK1
15872,GO:0072673,0.257940351817419,0.908293325106293,3,15,lamellipodium morphogenesis,BP,SNX1;PDPN;ARPIN
11837,GO:0046850,0.257942072809757,0.877884860509607,5,28,regulation of bone remodeling,BP,INPP5D;SFRP1;EGFR;PRKCA;LEPR
3364,GO:0007129,0.257971436438045,0.906443286136817,3,18,synapsis,BP,MLH3;MSH5;AGO4
4246,GO:0009450,0.258244979015863,0.980763746387749,1,2,gamma-aminobutyric acid catabolic process,BP,ABAT
13874,GO:0060547,0.258275202555323,0.932356297793605,2,10,negative regulation of necrotic cell death,BP,CAV1;ARHGEF2
9962,GO:0042373,0.258443904425973,0.971804456053378,1,4,vitamin K metabolic process,BP,CBR1
3734,GO:0008273,0.258476666533554,0.980726426705567,1,2,calcium, potassium:sodium antiporter activity,MF,SLC24A1
14476,GO:0062009,0.258505059457498,0.934924037432807,2,8,secondary palate development,BP,FZD1;TSHZ1
12940,GO:0051349,0.258661268455178,0.934858141279621,2,8,positive regulation of lyase activity,BP,NOS1;TIMP2
17374,GO:1900138,0.258682894375433,0.974680352384968,1,3,negative regulation of phospholipase A2 activity,BP,PLA2R1
9092,GO:0035385,0.258886655112698,0.936747204422027,2,7,Roundabout signaling pathway,BP,SLIT3;ROBO1
9284,GO:0035747,0.259027692946742,0.974607990962264,1,3,natural killer cell chemotaxis,BP,CXCL14
6917,GO:0030520,0.259125213826027,0.858385201989483,7,45,intracellular estrogen receptor signaling pathway,BP,SKP2;TADA3;PAK1;RBFOX2;KANK2;ISL1;YAP1
12713,GO:0051005,0.259216969313038,0.974568218107865,1,3,negative regulation of lipoprotein lipase activity,BP,ANGPTL4
13479,GO:0055077,0.259269457106581,0.974557182482563,1,3,gap junction hemi-channel activity,MF,GJA5
18436,GO:1903556,0.259271460562293,0.887595581247231,4,28,negative regulation of tumor necrosis factor superfamily cytokine production,BP,GAS6;AXL;GPNMB;RARA
13583,GO:0060083,0.259372619915397,0.980581713113317,1,2,smooth muscle contraction involved in micturition,BP,KCNMA1
19616,GO:1990834,0.259399619835738,0.974529803785313,1,3,response to odorant,BP,CTSV
6723,GO:0030145,0.259483233232153,0.865675861352483,6,40,manganese ion binding,MF,EXTL2;PRIMPOL;PPM1M;NPEPL1;GALNT2;MPPE1
6912,GO:0030514,0.259540070907674,0.877210621400227,5,27,negative regulation of BMP signaling pathway,BP,HTRA1;FBN1;SFRP1;DKK1;FZD1
1212,GO:0002883,0.259554841667739,0.974497132079841,1,3,regulation of hypersensitivity,BP,IL20RB
17504,GO:1901021,0.259795584682347,0.88938347146437,4,22,positive regulation of calcium ion transmembrane transporter activity,BP,PKD2;JPH2;HSPA2;EHD3
9762,GO:0039689,0.259870698339594,0.974430575311424,1,3,negative stranded viral RNA replication,BP,ATG16L2
8451,GO:0033603,0.259978720641559,0.974407790257965,1,3,positive regulation of dopamine secretion,BP,GDNF
4326,GO:0009855,0.260118848969503,0.836420583397474,11,75,determination of bilateral symmetry,BP,TGFBR2;PKD2;DDIT3;IFT140;ENG;BBS4;CITED2;VANGL2;MEGF8;NPHP3;IFT74
5514,GO:0016486,0.260153543900794,0.905789270813281,3,17,peptide hormone processing,BP,PCSK1;ERO1B;MME
15664,GO:0072223,0.260283765662686,0.974343384647013,1,3,metanephric glomerular mesangium development,BP,EGR1
15671,GO:0072239,0.260283765662686,0.974343384647013,1,3,metanephric glomerulus vasculature development,BP,EGR1
8495,GO:0033688,0.260515157377971,0.906909667307396,3,15,regulation of osteoblast proliferation,BP,SFRP1;PLXNB1;ATRAID
16905,GO:0098914,0.260583773309744,0.980385088036173,1,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,KCNJ5
17060,GO:0099624,0.260583773309744,0.980385088036173,1,2,atrial cardiac muscle cell membrane repolarization,BP,KCNJ5
4767,GO:0010957,0.260684288371719,0.974258679640682,1,3,negative regulation of vitamin D biosynthetic process,BP,SNAI2
11560,GO:0046137,0.260684288371719,0.974258679640682,1,3,negative regulation of vitamin metabolic process,BP,SNAI2
14709,GO:0070405,0.260822796272061,0.886924663406293,4,27,ammonium ion binding,MF,ESYT2;BCHE;HTR1B;TH
10365,GO:0043209,0.260848686508466,0.819817908168845,16,138,myelin sheath,CC,GSN;HSPA2;GJC2;NEFL;CNTN1;PLLP;SYN1;PRKCZ;EHD3;FSCN1;ARF6;NFASC;NDRG1;ANXA2;HSPA5;MPDZ
15976,GO:0086015,0.260887819802153,0.980335546579912,1,2,SA node cell action potential,BP,GJA5
15979,GO:0086018,0.260887819802153,0.980335546579912,1,2,SA node cell to atrial cardiac muscle cell signaling,BP,GJA5
15822,GO:0072567,0.26094122512634,0.929446956545953,2,12,chemokine (C-X-C motif) ligand 2 production,BP,MAP2K5;POSTN
7685,GO:0032153,0.261086897743155,0.839637390893769,10,70,cell division site,CC,RHOBTB2;MYLK;PSTPIP1;SEPT6;ARF6;SSH1;SEPT5;OR2A4;LIMA1;SEPT9
12777,GO:0051098,0.26117045867507,0.796852118025586,33,281,regulation of binding,BP,FLOT1;MMP9;S100A10;BMP4;SORL1;IFIT2;DDIT3;IFIT1;ITGA2;ZFP90;LRP1;CAV1;HMGA2;TMEM173;CAPRIN2;HERPUD1;MDFI;DKK1;NFATC4;TGFBR3;ISL1;ANXA2;HMBOX1;ZFPM1;LEF1;SP100;HSPA5;PPARG;RARA;TAF1;PPP3CA;NIPBL;TTBK2
5612,GO:0016671,0.261237094282158,0.92931370019759,2,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,ERO1B;MSRB2
569,GO:0001711,0.261398461590247,0.93098552132389,2,10,endodermal cell fate commitment,BP,DUSP6;DKK1
13801,GO:0060428,0.261433854440694,0.888391547787928,4,22,lung epithelium development,BP,BMP4;SOX9;THRA;YAP1
12288,GO:0048662,0.261597605626906,0.886165766007995,4,28,negative regulation of smooth muscle cell proliferation,BP,PDCD4;TP53;ANG;PPARG
3773,GO:0008331,0.261991397132121,0.973981131303743,1,3,high voltage-gated calcium channel activity,MF,CACNB1
2218,GO:0005119,0.262057176203674,0.980144333282629,1,2,smoothened binding,MF,BBS1
5440,GO:0016314,0.262135389696452,0.980131505370373,1,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,INPP5D
8342,GO:0033227,0.262248067600112,0.97392643014427,1,3,dsRNA transport,BP,FLOT1
13607,GO:0060135,0.262448022011551,0.856205209935598,7,44,maternal process involved in female pregnancy,BP,VDR;ITGA3;CTSV;PLA2G6;NR2F2;STOX2;RXRA
3235,GO:0006892,0.26261472441455,0.82753586794404,13,89,post-Golgi vesicle-mediated transport,BP,SORL1;ACSL3;OSBPL5;EHD3;BBS2;ANK3;BBS1;GOPC;CHIC2;MON2;VPS13C;ARL3;STEAP2
19924,GO:2000489,0.262739303110477,0.973821555261176,1,3,regulation of hepatic stellate cell activation,BP,GCLC
5714,GO:0016859,0.262758274483254,0.884715407725973,4,31,cis-trans isomerase activity,MF,FKBP5;FKBP9;FKBP10;GSTZ1
12712,GO:0051004,0.262970350415019,0.930290932543745,2,10,regulation of lipoprotein lipase activity,BP,ANGPTL4;LMF1
14757,GO:0070491,0.263088147824637,0.848403587416567,8,56,repressing transcription factor binding,MF,CBX5;STAT1;BBS2;TLE4;BBS4;BBS1;TTC8;PRDM5
15597,GO:0072125,0.263204533284915,0.973722009738907,1,3,negative regulation of glomerular mesangial cell proliferation,BP,BMP4
16145,GO:0090194,0.263204533284915,0.973722009738907,1,3,negative regulation of glomerulus development,BP,BMP4
15629,GO:0072176,0.263254073806679,0.934942016553776,2,7,nephric duct development,BP,PKD2;BMP4
19801,GO:2000286,0.263329093700262,0.973695320717359,1,3,receptor internalization involved in canonical Wnt signaling pathway,BP,CAV1
10142,GO:0042745,0.263504224757513,0.930054307341912,2,10,circadian sleep/wake cycle,BP,CST3;TH
9742,GO:0039519,0.26375715918476,0.979864428513704,1,2,modulation by virus of host autophagy,BP,EIF2AK4
9530,GO:0036303,0.263810515744123,0.906932235552928,3,13,lymph vessel morphogenesis,BP,CCBE1;PDPN;PTPN14
15797,GO:0072529,0.263916136522431,0.88473442947641,4,28,pyrimidine-containing compound catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F;DPYD
4770,GO:0010960,0.264085026079379,0.934595913660335,2,7,magnesium ion homeostasis,BP,EGFR;ANK3
13979,GO:0060729,0.264462629499584,0.973451728378221,1,3,intestinal epithelial structure maintenance,BP,SOX9
17729,GO:1901722,0.264470801640991,0.928650497454826,2,11,regulation of cell proliferation involved in kidney development,BP,BMP4;EGR1
14405,GO:0061740,0.264727632034333,0.97339459452359,1,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,CLU
4936,GO:0014902,0.264744090532204,0.847578839102825,8,53,myotube differentiation,BP,FLOT1;NOS1;SIK1;GPX1;MYOF;THRA;PPP3CA;DMPK
15510,GO:0071942,0.264758368075055,0.973387963350996,1,3,XPC complex,CC,XPC
6719,GO:0030139,0.264877051037886,0.800575010518162,26,211,endocytic vesicle,CC,ITGB5;GSN;CLTCL1;EGFR;VIM;ABCA1;DLG4;HIP1;TBC1D5;LRP1;CAV1;EHD3;CAMK2D;DYSF;FLOT2;CALR;MDM2;ARF6;RAB13;RAB43;GPR161;FLNB;UVRAG;FZD4;PIK3C2B;MYO1C
728,GO:0001958,0.264978515478163,0.903772275054599,3,16,endochondral ossification,BP,BMP4;MEF2D;NAB2
9449,GO:0036075,0.264978515478163,0.903772275054599,3,16,replacement ossification,BP,BMP4;MEF2D;NAB2
14529,GO:0070081,0.265063078448888,0.973322172035784,1,3,clathrin-sculpted monoamine transport vesicle,CC,SYT1
14530,GO:0070083,0.265063078448888,0.973322172035784,1,3,clathrin-sculpted monoamine transport vesicle membrane,CC,SYT1
19815,GO:2000310,0.265160072515206,0.930534850778547,2,9,regulation of NMDA receptor activity,BP,DLG4;DAPK1
9700,GO:0038145,0.265216396377909,0.973289033237654,1,3,macrophage colony-stimulating factor signaling pathway,BP,MST1R
3276,GO:0006957,0.265248828191916,0.979616940148308,1,2,complement activation, alternative pathway,BP,C5
13105,GO:0051693,0.265323813901481,0.88651852335234,4,21,actin filament capping,BP,GSN;SPTB;TRIOBP;CAPG
14144,GO:0061055,0.26549185749616,0.979576451135914,1,2,myotome development,BP,WDR19
4919,GO:0014874,0.265517741282434,0.933997180710763,2,7,response to stimulus involved in regulation of muscle adaptation,BP,UTRN;MTMR4
4557,GO:0010643,0.265524862412202,0.973222288481492,1,3,cell communication by chemical coupling,BP,GJA5
10952,GO:0044752,0.265768558826187,0.973169490695253,1,3,response to human chorionic gonadotropin,BP,GCLC
11179,GO:0045324,0.265847749220752,0.928029283324884,2,11,late endosome to vacuole transport,BP,TMEM50B;VPS36
2088,GO:0004854,0.265908254933556,0.979506969752862,1,2,xanthine dehydrogenase activity,MF,XDH
4061,GO:0009115,0.265908254933556,0.979506969752862,1,2,xanthine catabolic process,BP,XDH
5635,GO:0016726,0.265908254933556,0.979506969752862,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,XDH
4960,GO:0015057,0.266041995710833,0.973110178398752,1,3,thrombin-activated receptor activity,MF,F2R
8505,GO:0033745,0.266046276838063,0.973109249164027,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
8716,GO:0034380,0.266243582369931,0.930058634045498,2,9,high-density lipoprotein particle assembly,BP,ABCA1;PRKACB
11598,GO:0046324,0.266324844698691,0.853633069543756,7,43,regulation of glucose import,BP,IRS2;CLTCL1;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
16567,GO:0097421,0.2664378038415,0.883459625321207,4,27,liver regeneration,BP,SULF2;EGFR;GLI3;PTPN3
4503,GO:0010558,0.266480919504337,0.764703318235551,133,1161,negative regulation of macromolecule biosynthetic process,BP,TXNIP;SOX6;INPP5D;SFRP1;ZFP36L1;ZFP36L2;IGF2BP2;GAS6;SNAI2;MAGED1;PHF21A;EGFR;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;EIF2AK4;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;ZCCHC11;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;TRIB2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ANG;UHRF2;WFS1;MDFI;CIRBP;JARID2;TP73;DAPK1;CHEK2;PAIP2B;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;YAP1;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;UNK;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;AGO4;NIPBL;PRDM5;S100A11;RXRA
6372,GO:0021564,0.266582029252275,0.979394249797581,1,2,vagus nerve development,BP,NAV2
9104,GO:0035425,0.266604864902728,0.972987847260165,1,3,autocrine signaling,BP,FZD1
1849,GO:0004514,0.266696751571518,0.972967846780462,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
13785,GO:0060405,0.266798870641019,0.97294560908765,1,3,regulation of penile erection,BP,OXTR
13109,GO:0051702,0.266935867585695,0.851907591148384,7,51,interaction with symbiont,BP,FN1;EIF2AK4;GPX1;HMGA2;STOM;ANXA2;LEF1
17696,GO:1901652,0.267014653270776,0.785726877913248,42,339,response to peptide,BP,CTGF;FBN1;ZFP36L1;IRS2;SESN3;PAK1;NEFL;STAT1;GNG2;TP53;TIMP1;BTG1;LRP1;FYN;CPS1;CAV1;SLC27A1;PRKCZ;PXN;PIK3R1;CAT;PRKACB;IGF1R;TGFBR3;MDM2;AREG;GCLC;PTPN1;ARHGEF2;EGR1;ENPP1;GCNT1;RAB13;ABCC2;PRNP;TH;CACNB1;KLF5;PPARG;OXTR;MYO1C;C2CD5
6838,GO:0030316,0.267356121563048,0.840125533098095,9,59,osteoclast differentiation,BP,FBN1;INPP5D;SFRP1;CD109;PIK3R1;TLR3;SNX10;ANXA2;FOS
9486,GO:0036151,0.267651066335297,0.901110987560648,3,18,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2;LPCAT2;PLA2G6
1492,GO:0003835,0.267737256241753,0.979200143756862,1,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,ST6GAL2
7094,GO:0030901,0.267742095524415,0.844859240547104,8,57,midbrain development,BP,SFRP1;DLG5;FGFR1;DKK1;G6PD;FZD1;HSPA5;TAF1
9475,GO:0036132,0.267935820363901,0.972697313884218,1,3,13-prostaglandin reductase activity,MF,ZADH2
11988,GO:0047522,0.267935820363901,0.972697313884218,1,3,15-oxoprostaglandin 13-oxidase activity,MF,ZADH2
8034,GO:0032696,0.267963603402283,0.972691230097068,1,3,negative regulation of interleukin-13 production,BP,LEF1
8331,GO:0033197,0.268073023029638,0.927020197457591,2,11,response to vitamin E,BP,CAT;PPARG
18204,GO:1903035,0.268081466888776,0.844608715295871,8,57,negative regulation of response to wounding,BP,SERPINE2;CD109;SERPINE1;PTPRS;PDGFA;SERPING1;ANXA2;ABAT
12857,GO:0051222,0.268086298215603,0.788567961322132,36,299,positive regulation of protein transport,BP,F2R;ANO1;IRS2;GAS6;TCAF1;EGFR;PAK1;SORL1;TP53;PYCARD;ACSL3;GLI3;LRP1;FYN;B3GAT3;PLA2G6;PRKCZ;HHAT;TMEM173;ANG;ANK3;TTN;HPS4;STOM;ALOX15B;C5;LRTOMT;MDM2;ISL1;PRNP;TGFB2;POSTN;ABAT;MYO1C;C2CD5;EDEM1
16136,GO:0090185,0.268101086689114,0.928001844250591,2,10,negative regulation of kidney development,BP,BMP4;STAT1
18545,GO:1903799,0.268226279747713,0.930765252206089,2,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,NCOR1;PPP3CA
6195,GO:0019682,0.268258413726244,0.899438496958979,3,21,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;TKFC;G6PD
19999,GO:2000644,0.268373692701982,0.92911809812366,2,9,regulation of receptor catabolic process,BP,PTPN1;ANXA2
7602,GO:0031999,0.268407249988849,0.979087081144684,1,2,negative regulation of fatty acid beta-oxidation,BP,ACACB
15609,GO:0072137,0.268617444454722,1,1,1,condensed mesenchymal cell proliferation,BP,FAT4
9103,GO:0035418,0.268806346457742,0.883889536626438,4,22,protein localization to synapse,BP,NSG1;DLG4;PCLO;BSN
8429,GO:0033564,0.268929602438388,0.978998684584136,1,2,anterior/posterior axon guidance,BP,UNC5B
6097,GO:0019322,0.269016357824547,0.969283240219932,1,4,pentose biosynthetic process,BP,G6PD
15196,GO:0071379,0.269238524912391,0.903014064184824,3,14,cellular response to prostaglandin stimulus,BP,SFRP1;GNG2;PPARG
18622,GO:1903961,0.269625753565125,0.972325841167884,1,3,positive regulation of anion transmembrane transport,BP,TCAF1
11394,GO:0045829,0.269848000665262,0.97227677285707,1,3,negative regulation of isotype switching,BP,BCL6
16442,GO:0097154,0.269904924865388,0.969065727394099,1,4,GABAergic neuron differentiation,BP,DLX2
19189,GO:1905331,0.270375507479873,0.901536154162055,3,15,negative regulation of morphogenesis of an epithelium,BP,BMP4;STAT1;SULF1
2672,GO:0006027,0.270419821540693,0.858326862803934,6,39,glycosaminoglycan catabolic process,BP,SDC3;CSPG4;NAGLU;HEXA;SDC2;AGRN
14139,GO:0061050,0.270451862101853,0.928194967910642,2,9,regulation of cell growth involved in cardiac muscle cell development,BP,PAK1;G6PD
8498,GO:0033691,0.27061370302629,0.978712201368456,1,2,sialic acid binding,MF,AGRN
16190,GO:0090261,0.270619443998889,0.968890183807529,1,4,positive regulation of inclusion body assembly,BP,CLU
3576,GO:0007623,0.270868469621416,0.808028211300811,18,133,circadian rhythm,BP,MAGED1;EGFR;SERPINE1;NR1D1;TP53;SIK1;KLF9;PER1;CPT1A;SETX;NCOA2;NAGLU;CST3;CRTC1;NCOR1;TH;PPARG;NPAS2
11938,GO:0047144,0.270915703027764,0.927988182350127,2,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2;LPCAT2
5401,GO:0016247,0.270995118990726,0.831618298971483,10,75,channel regulator activity,MF,NOS1;WNK1;KCNAB2;CAV1;PIAS3;PRKCZ;CAMK2D;KCNIP3;PTPN3;RASA1
3142,GO:0006740,0.271028532415657,0.972015292285883,1,3,NADPH regeneration,BP,G6PD
2487,GO:0005737,0.271227867277716,0.749852755909768,878,8350,cytoplasm,CC,SERPINE2;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;INPP5D;MARVELD1;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ADAMTSL1;TENM4;ASAP3;MARCH4;SLC7A8;ANO1;GSN;COL5A2;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;UTRN;ARHGAP23;SAMD9L;ROR1;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;DOCK5;SESN3;MYLK;SYNE3;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;FAM198B;CSPG4;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;LGALS9C;FAM210B;MAMDC2;STMN3;ADD3;ASAP2;NTSR1;DCAKD;TIMP2;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;PTK6;AHNAK;SCN8A;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;HS1BP3;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;MEST;D2HGDH;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;LTBP1;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SLC7A11;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;FRMD4B;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;CPED1;TTC28;KLF12;IFIT3;KLF9;WDR66;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;DLG5;LPCAT2;KITLG;TBC1D5;P3H2;ECH1;ERMAP;ASAP1;ERO1B;SYN1;PDPN;MTHFR;SRPX;ABHD14B;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;IFI6;XDH;FLNC;ALPK1;B3GAT3;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;CPS1;LAMA3;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;ZNF318;TNRC18;OSBPL5;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;PARP4;IQSEC2;CHST3;EHD3;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;JARID2;TMEM8B;LMO7;APLP2;HPS4;CRELD2;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;IFT140;SPRY4;LRIG3;PAIP2B;STOM;PRX;TLR3;BPHL;MAN1A1;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;PDIA6;VAMP1;FZD7;AIP;GLG1;NIPSNAP1;SH3TC2;COL16A1;DZIP1L;FGFR1;CBR1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;ESYT2;PDK3;G6PD;NBPF10;MYOF;EPHB6;ARSD;IL17RE;FZD8;CCDC136;SETBP1;ARHGEF17;TRIOBP;DHTKD1;AFAP1L2;CDH13;NFATC4;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;NAGLU;PBXIP1;PBX1;LAPTM4A;BBS4;MTMR4;CALR;HPS3;MKLN1;ATM;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;GCLC;NR2F2;ACSS2;ELMO3;FHOD3;HEXA;NEURL1B;CBX7;AKR7A2;NRSN2;MAF;TRAK1;CD1D;LZTS1;FBXW8;IFI44;SYNE2;RCBTB1;RNPEP;MAP3K1;FGD4;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;DNAL4;FAM117A;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;NRK;SSH1;LYST;EGR1;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;GCNT1;TMEM50B;PRKCA;PXMP2;TMEM175;BCHE;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;HLTF;FNDC3A;SEPT5;RNF24;METTL23;MAN2B1;CEP68;PGAP1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;KCTD7;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;DECR1;MAP3K12;CHD9;UACA;ATXN1;ACSF2;HTR1B;STK36;RAB43;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;GPR161;LIPA;LEF1;DPP9;THRA;FHL1;CDC42EP5;ZADH2;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;MPRIP;SPPL2B;OSBPL1A;SP100;ULK1;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;CDK19;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;IFT74;POLD4;TACC2;OPHN1;TPGS1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;UBA7;GALNT2;DIXDC1;DERL3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;NBPF15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;GCSAM;CERS5;SNX9;ICK;TBC1D16;OBSL1;ING4;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;POLH;TMEM67;PCMTD2;PRKAG1;TRIM16L;CEP85L;GSTZ1;FZD4;MPPE1;WIPF1;HCFC1R1;DPYD;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;LIMA1;PEX1;STEAP2;KRT10;ACTR1B;COX18;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;ACOT1;CLEC2D;SERPINB5;SCPEP1;MATN3;ELMO2;EHHADH;NPAS2;ABAT;MYH11;FBXL4;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;ADAM10;RNPEPL1;RHOBTB3;MPDZ;LITAF;LRRCC1;ATG16L2;ANKS6;EPG5;S100A11;MYO1C;TUSC3;C2CD5;GBP3;CPT2;SNTB1;EDEM1;ACAA2;ABCA5;TAOK3;NFKBIE;CTSD;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
1806,GO:0004457,0.271430708551687,0.96869018344378,1,4,lactate dehydrogenase activity,MF,D2HGDH
14408,GO:0061744,0.271453193747982,0.971920886405862,1,3,motor behavior,BP,ADARB1
19355,GO:1905863,0.271489220882102,0.978562368159156,1,2,invadopodium organization,BP,PDPN
16893,GO:0098901,0.271542814255404,0.883908874180299,4,19,regulation of cardiac muscle cell action potential,BP,GJA5;CAV1;CAMK2D;ANK3
3600,GO:0008037,0.271552931922472,0.836608729748789,9,62,cell recognition,BP,NTM;CNTNAP3;SEMA5A;LAMA5;ROBO1;EFNB3;MEGF8;SPA17;LGALS3
18892,GO:1904636,0.271569859064991,0.971894918610352,1,3,response to ionomycin,BP,NFATC4
18893,GO:1904637,0.271569859064991,0.971894918610352,1,3,cellular response to ionomycin,BP,NFATC4
4506,GO:0010561,0.271688110498121,0.925367312851058,2,11,negative regulation of glycoprotein biosynthetic process,BP,ITM2C;ITM2A
611,GO:0001780,0.271701192963205,0.927637381048623,2,9,neutrophil homeostasis,BP,AXL;ITPKB
14241,GO:0061341,0.271762873359733,0.978515409867613,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,VANGL2
14243,GO:0061346,0.271762873359733,0.978515409867613,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,VANGL2
16919,GO:0098936,0.271858596908682,0.978498969657491,1,2,intrinsic component of postsynaptic membrane,CC,PTPRS
16956,GO:0099055,0.271858596908682,0.978498969657491,1,2,integral component of postsynaptic membrane,CC,PTPRS
16997,GO:0099240,0.271858596908682,0.978498969657491,1,2,intrinsic component of synaptic membrane,CC,PTPRS
17074,GO:0099699,0.271858596908682,0.978498969657491,1,2,integral component of synaptic membrane,CC,PTPRS
14085,GO:0060969,0.271970900905778,0.881937970415671,4,22,negative regulation of gene silencing,BP,PHF2;NCOR1;PPARG;PPP3CA
9669,GO:0038064,0.272012324424397,0.978472552031397,1,2,collagen receptor activity,MF,ITGA2
6533,GO:0021952,0.27209892031103,0.901448675631012,3,14,central nervous system projection neuron axonogenesis,BP,ADARB1;GLI2;CDH11
14222,GO:0061302,0.272175383618797,0.971759916377665,1,3,smooth muscle cell-matrix adhesion,BP,SERPINE1
4270,GO:0009635,0.272236591290005,0.92427943815434,2,12,response to herbicide,BP,NEFL;TH
94,GO:0000185,0.272244451856352,0.899759281504442,3,16,activation of MAPKKK activity,BP,GADD45B;TNIK;NRK
11035,GO:0045053,0.272280249869424,0.938499910898636,2,5,protein retention in Golgi apparatus,BP,SORL1;VPS13C
8299,GO:0033146,0.272285776150881,0.867536380902011,5,31,regulation of intracellular estrogen receptor signaling pathway,BP,SKP2;PAK1;KANK2;ISL1;YAP1
18691,GO:1904154,0.27241475288099,0.971706445898634,1,3,positive regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
15588,GO:0072106,0.272513546597618,0.971684360280252,1,3,regulation of ureteric bud formation,BP,GDNF
15589,GO:0072107,0.272513546597618,0.971684360280252,1,3,positive regulation of ureteric bud formation,BP,GDNF
19167,GO:1905278,0.272513546597618,0.971684360280252,1,3,positive regulation of epithelial tube formation,BP,GDNF
15435,GO:0071803,0.272593471829355,0.927237940080792,2,9,positive regulation of podosome assembly,BP,ASAP1;FSCN1
11771,GO:0046661,0.27259760604937,0.816152155699687,14,103,male sex differentiation,BP,SFRP1;NUPR1;KITLG;CTSV;TLR3;CST3;CITED2;SOX9;RAB13;FNDC3A;TGFB2;RARA;AGO4;RHOBTB3
13494,GO:0055094,0.27261561697723,0.899552557273245,3,16,response to lipoprotein particle,BP,ABCA1;CDH13;PPARG
10445,GO:0043328,0.272879365890485,0.968331223636528,1,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,VPS36
7061,GO:0030859,0.272970067528437,0.900102542089114,3,15,polarized epithelial cell differentiation,BP,DLG5;OPHN1;MYO9A
15469,GO:0071871,0.273121147908892,0.927001244214083,2,9,response to epinephrine,BP,SNCA;PDE4D
9179,GO:0035579,0.273249557212857,0.841033221777863,8,55,specific granule membrane,CC,SLC2A3;ANO6;KCNAB2;STOM;VAMP1;MLEC;MOSPD2;ADAM10
19474,GO:1990316,0.273365701795415,0.928518915472614,2,8,Atg1/ULK1 kinase complex,CC,TBC1D5;ULK1
14132,GO:0061043,0.273369100270978,0.971492682867325,1,3,regulation of vascular wound healing,BP,SERPINE1
13720,GO:0060323,0.273661611277358,0.866922121465,5,30,head morphogenesis,BP,MMP2;DKK1;LEF1;SSBP3;NIPBL
3281,GO:0006971,0.273666479966069,0.928386428149665,2,8,hypotonic response,BP,MYLK;ITGA2
3605,GO:0008047,0.273758198485744,0.77605179762093,49,395,enzyme activator activity,MF,FN1;ASAP3;DNAJB4;GAS6;ARHGAP23;ALS2CL;ASAP2;CHN2;SRGAP3;TBC1D8;RIN2;VAV3;ARAP1;PYCARD;WNK1;ARHGEF1;DOCK4;EVI5L;TBC1D5;ASAP1;PLXNB1;ARHGEF12;B3GAT3;ARHGAP18;CAV1;ERCC6;SPRY2;FBLN1;DLC1;RGS2;AFAP1L2;SRGAP1;FAM20A;TBC1D19;DGKQ;RGS14;DEPDC7;CDC42EP5;AGAP1;ARHGEF19;ARHGAP29;OPHN1;MYO9A;RALGAPB;TBC1D16;EFNA5;RASA1;ARHGAP31;DOCK1
17795,GO:1901979,0.273798333413134,0.978164236361843,1,2,regulation of inward rectifier potassium channel activity,BP,CAV1
5525,GO:0016508,0.273920680118017,0.971368711706622,1,3,long-chain-enoyl-CoA hydratase activity,MF,EHHADH
12136,GO:0048268,0.274214310915469,0.899412134762884,3,15,clathrin coat assembly,BP,CLTCL1;NSG1;HIP1
1689,GO:0004165,0.274284360043592,0.971286802369798,1,3,dodecenoyl-CoA delta-isomerase activity,MF,EHHADH
7555,GO:0031914,0.274509242781823,0.971236085840333,1,3,negative regulation of synaptic plasticity,BP,RGS14
20099,GO:2000809,0.274619581536171,0.978021601731843,1,2,positive regulation of synaptic vesicle clustering,BP,MAGI2
7451,GO:0031618,0.274632099654939,0.927960324753412,2,8,nuclear pericentric heterochromatin,CC,CBX5;CENPA
14200,GO:0061187,0.274655018202814,0.978015434808794,1,2,regulation of chromatin silencing at rDNA,BP,PHF2
14201,GO:0061188,0.274655018202814,0.978015434808794,1,2,negative regulation of chromatin silencing at rDNA,BP,PHF2
1469,GO:0003726,0.274784691828366,0.977992859486116,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
11288,GO:0045629,0.274820766242296,0.97116574431685,1,3,negative regulation of T-helper 2 cell differentiation,BP,BCL6
14915,GO:0070831,0.274828715288154,0.930044703165088,2,7,basement membrane assembly,BP,PHLDB1;LAMC2
553,GO:0001675,0.27489804457129,0.927842764964811,2,8,acrosome assembly,BP,RFX2;CCDC136
10239,GO:0042997,0.274948617085841,0.971136847069556,1,3,negative regulation of Golgi to plasma membrane protein transport,BP,GOPC
4844,GO:0014061,0.275058041181062,0.971112101414169,1,3,regulation of norepinephrine secretion,BP,OXTR
9618,GO:0036503,0.275108614084512,0.823920526176672,11,86,ERAD pathway,BP,CAV1;SEL1L;HERPUD1;WFS1;TMEM129;RHBDD1;HSPA5;DERL3;TMEM67;UGGT2;EDEM1
13209,GO:0051901,0.275267060648952,0.967734465923327,1,4,positive regulation of mitochondrial depolarization,BP,CCK
14837,GO:0070640,0.275285603032545,0.971060600324384,1,3,vitamin D3 metabolic process,BP,FGFR1
3067,GO:0006636,0.275654802912675,0.877114829307809,4,29,unsaturated fatty acid biosynthetic process,BP,PTGS1;PTGES;CBR1;ALOX15B
1334,GO:0003192,0.275747739517558,0.977824773223692,1,2,mitral valve formation,BP,ZFPM1
1264,GO:0003025,0.275813761821252,0.977813222444105,1,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,NAV2
12945,GO:0051354,0.276034445064594,0.924396226987354,2,10,negative regulation of oxidoreductase activity,BP,CAV1;SNCA
18077,GO:1902742,0.276042202731036,0.879410349920115,4,22,apoptotic process involved in development,BP,VDR;SLIT3;TGFB2;LEF1
8895,GO:0034751,0.276161528539827,0.970861868717299,1,3,aryl hydrocarbon receptor complex,CC,AIP
13446,GO:0055010,0.27620879031386,0.866290869076001,5,27,ventricular cardiac muscle tissue morphogenesis,BP,TGFBR3;ENG;ISL1;TGFB2;RXRA
10538,GO:0043516,0.276382678353655,0.877915954105185,4,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;PLA2R1;ATM;MDM2
4264,GO:0009617,0.276527451937626,0.783965611941908,32,296,response to bacterium,BP,TNFRSF6B;F2R;NOS1;AXL;SERPINE1;ABCA1;VDR;NR1D1;TRIM5;PDCD4;PYCARD;GPX1;PTGES;CPS1;CAV1;PLA2G6;TLR3;SNCA;PDE4D;IL18;IFNE;CD1D;LYST;PRKCA;ABCC2;CDK19;TH;SRR;SASH1;RARA;FOS;LITAF
9609,GO:0036493,0.276580463351604,0.970766542014987,1,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,DNAJC3
16535,GO:0097350,0.276608830216227,0.970760080756864,1,3,neutrophil clearance,BP,AXL
19968,GO:2000588,0.276616046245247,0.977672578031832,1,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,HIP1
11434,GO:0045912,0.276630898489225,0.878574240230877,4,23,negative regulation of carbohydrate metabolic process,BP,DDIT4;SIK1;ENPP1;LEPR
7278,GO:0031281,0.276729685901594,0.92537313238955,2,9,positive regulation of cyclase activity,BP,NOS1;TIMP2
9923,GO:0042296,0.276877197515121,0.96732843735278,1,4,ISG15 transferase activity,MF,HERC5
9001,GO:0035196,0.27687793119582,0.854035470881423,6,38,production of miRNAs involved in gene silencing by miRNA,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPP3CA;AGO4
17417,GO:1900220,0.276984885200371,0.977607743367911,1,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,PLXNB1
13586,GO:0060087,0.277070347639181,0.967279535038497,1,4,relaxation of vascular smooth muscle,BP,RGS2
10878,GO:0044444,0.277120227146286,0.742875071300881,752,7161,cytoplasmic part,CC,SERPINE2;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;INPP5D;SFRP1;ST6GALNAC2;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;SYNE1;F2R;MYH15;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ADAMTSL1;ASAP3;MARCH4;GSN;COL5A2;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;CYBRD1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;MALL;MAP6;SULF2;COL5A1;UTRN;ARHGAP23;SAMD9L;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPTB;SLC8A1;FKBP5;CLCA2;DOCK5;MYLK;SYNE3;SLC2A3;THBS2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;ANXA5;VIM;NUPR1;FAM198B;CSPG4;PSTPIP1;CTNNAL1;TKFC;ALS2CL;LGALS9C;FAM210B;MAMDC2;STMN3;ADD3;ASAP2;NTSR1;DCAKD;TIMP2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;ITM2C;ISYNA1;TP53I3;PCSK1;PTK6;AHNAK;SCN8A;ABTB1;RIN2;XAF1;EIF2AK4;HS1BP3;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;MEST;D2HGDH;TP53;ARAP1;CEP250;KRT13;EXTL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;LTBP1;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SLC7A11;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;PNRC1;CUL7;ITGA3;CPED1;KLF12;IFIT3;KLF9;WDR66;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;LAMC2;GLI3;PAQR8;PTGES;CDK14;LPCAT2;TBC1D5;P3H2;ECH1;ASAP1;ERO1B;SYN1;PDPN;MTHFR;SRPX;ABHD14B;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;IFI6;XDH;FLNC;B3GAT3;ARHGAP18;ADIRF;FUT10;CMBL;CPS1;LAMA3;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;HLCS;RNF135;RBFOX2;PLA2G6;SEL1L;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ZNF318;TNRC18;OSBPL5;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;PARP4;CHST3;EHD3;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;HIBADH;METTL7A;ULBP1;HAUS4;PER1;ATP8B2;EHBP1;PXN;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;KIF17;PARVA;BBS2;CNTLN;HERPUD1;ANK3;WFS1;PHKA2;SPRY2;CES2;TTN;TSTD1;CIRBP;JARID2;TMEM8B;LMO7;APLP2;HPS4;CRELD2;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;PRKACB;AARS;CHEK2;BACE1;WDFY2;IFT140;SPRY4;LRIG3;STOM;TLR3;BPHL;MAN1A1;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;PDIA6;VAMP1;FZD7;AIP;GLG1;NIPSNAP1;SH3TC2;COL16A1;DZIP1L;FGFR1;CBR1;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;GLT8D2;TGFBI;ASTN2;PDE4D;APBB3;TMEM129;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;ESYT2;PDK3;G6PD;MYOF;EPHB6;ARSD;FZD8;CCDC136;SETBP1;ARHGEF17;TRIOBP;DHTKD1;AFAP1L2;CDH13;NFATC4;TRAF1;RAPH1;AKAP7;SEPT6;AMOTL1;LRTOMT;NAGLU;PBXIP1;LAPTM4A;BBS4;MTMR4;CALR;HPS3;MKLN1;ATM;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;GCLC;NR2F2;ACSS2;FHOD3;HEXA;NEURL1B;CBX7;AKR7A2;NRSN2;TRAK1;CD1D;FBXW8;SYNE2;RNPEP;MAP3K1;FGD4;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;SSH1;ENPP1;IFT27;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;GCNT1;TMEM50B;PRKCA;PXMP2;TMEM175;BCHE;ANXA2;TRERF1;RAB13;ETNK2;PRIMPOL;CES3;FNDC3A;SEPT5;RNF24;MAN2B1;CEP68;PGAP1;IGFBP4;DEPDC7;IFT88;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;KCTD7;MOSPD2;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;DECR1;MAP3K12;UACA;ATXN1;ACSF2;STK36;RAB43;SLC39A11;MUTYH;TAF8;PRNP;RET;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;STAT2;AMOTL2;IFT122;LIG1;GPR161;LIPA;DPP9;THRA;FHL1;CDC42EP5;ZADH2;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;MPRIP;SPPL2B;OSBPL1A;ULK1;AGRN;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;CDK19;TH;KLHL5;GOPC;SNX7;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;RSAD2;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;UGT1A3;VPS13C;RHBDD2;FHOD1;IFT74;POLD4;TACC2;OPHN1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;GOLGA8N;KLHL3;ATRAID;UBA7;GALNT2;DIXDC1;DERL3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;CALCRL;TPST1;KCNIP3;MEF2A;CERS5;SNX9;ICK;TBC1D16;OBSL1;ING4;POSTN;PRR7;LGALS3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;POLH;TMEM67;PRKAG1;TRIM16L;GSTZ1;FZD4;MPPE1;WIPF1;DPYD;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;LIMA1;PEX1;STEAP2;KRT10;ACTR1B;COX18;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;CDK5RAP3;AGO4;ACOT1;CLEC2D;SCPEP1;MATN3;ELMO2;EHHADH;NPAS2;ABAT;MYH11;FBXL4;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;ADAM10;RHOBTB3;MPDZ;LITAF;LRRCC1;ATG16L2;S100A11;MYO1C;TUSC3;C2CD5;GBP3;CPT2;EDEM1;ACAA2;ABCA5;NFKBIE;CTSD;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
11329,GO:0045685,0.277244889072183,0.853150642125141,6,41,regulation of glial cell differentiation,BP,SERPINE2;TENM4;TP73;DLX2;PPARG;KDM4A
8854,GO:0034673,0.277284953026271,0.977554915745617,1,2,inhibin-betaglycan-ActRII complex,CC,TGFBR3
2574,GO:0005865,0.27729138772405,0.902359856191989,3,11,striated muscle thin filament,CC,TNNI2;TTN;FHOD3
12377,GO:0048842,0.277301252337109,0.932029178499605,2,6,positive regulation of axon extension involved in axon guidance,BP,SEMA5A;MEGF8
18052,GO:1902669,0.277301252337109,0.932029178499605,2,6,positive regulation of axon guidance,BP,SEMA5A;MEGF8
15965,GO:0086004,0.277640409865899,0.879514275843123,4,20,regulation of cardiac muscle cell contraction,BP,GJA5;CAV1;CAMK2D;PDE4D
8473,GO:0033634,0.277678673147455,0.970515794294383,1,3,positive regulation of cell-cell adhesion mediated by integrin,BP,PODXL
16070,GO:0090080,0.277914059497293,0.977443922335102,1,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,FGFR1
545,GO:0001665,0.277967066008427,0.967051951554686,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2
11539,GO:0046104,0.278148261594465,0.970408197647427,1,3,thymidine metabolic process,BP,DPYD
11549,GO:0046125,0.278148261594465,0.970408197647427,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,DPYD
7670,GO:0032116,0.278173856100207,0.977397992337704,1,2,SMC loading complex,CC,NIPBL
16345,GO:0090694,0.278173856100207,0.977397992337704,1,2,Scc2-Scc4 cohesin loading complex,CC,NIPBL
3603,GO:0008045,0.278252321551476,0.898047476841659,3,14,motor neuron axon guidance,BP,RNF165;PLXNA2;PLXNA1
17034,GO:0099550,0.27825314706378,0.970384134280842,1,3,trans-synaptic signaling, modulating synaptic transmission,BP,F2R
662,GO:0001866,0.278260716660862,0.966977227442357,1,4,NK T cell proliferation,BP,IL18
14171,GO:0061110,0.278278141008893,0.977379540117161,1,2,dense core granule biogenesis,BP,PRKCA
20043,GO:2000705,0.278278141008893,0.977379540117161,1,2,regulation of dense core granule biogenesis,BP,PRKCA
14228,GO:0061311,0.278339157102473,0.896343509947208,3,16,cell surface receptor signaling pathway involved in heart development,BP,BMP4;DKK1;VANGL2
3087,GO:0006663,0.278360095022097,0.970359586069254,1,3,platelet activating factor biosynthetic process,BP,LPCAT2
14913,GO:0070829,0.278447503020436,0.977349554235407,1,2,heterochromatin maintenance,BP,MTHFR
6281,GO:0019897,0.278454154103074,0.811458328735088,14,102,extrinsic component of plasma membrane,CC,SERPINE2;S100A10;PTK6;GNG2;DLG4;HIP1;KCNAB2;FYN;SYTL1;ESYT2;CDH13;ANXA2;CDH11;SNX9
16461,GO:0097186,0.278531989959632,0.897001726802842,3,15,amelogenesis,BP,ITGA6;ITGB4;FAM20A
5576,GO:0016600,0.278554184270472,0.926217599745164,2,8,flotillin complex,CC,FLOT1;FLOT2
18164,GO:1902960,0.278639955903314,0.977315451680765,1,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19154,GO:1905246,0.278639955903314,0.977315451680765,1,2,negative regulation of aspartic-type peptidase activity,BP,SORL1
16262,GO:0090386,0.278802651104156,0.977286598607529,1,2,phagosome maturation involved in apoptotic cell clearance,BP,SPG11
16263,GO:0090387,0.278802651104156,0.977286598607529,1,2,phagolysosome assembly involved in apoptotic cell clearance,BP,SPG11
141,GO:0000293,0.278875139495396,0.970241200833827,1,3,ferric-chelate reductase activity,MF,CYBRD1
9134,GO:0035502,0.278944826831509,0.970225161906181,1,3,metanephric part of ureteric bud development,BP,PKD2
11279,GO:0045620,0.27903040962462,0.876246795030488,4,25,negative regulation of lymphocyte differentiation,BP,SFRP1;BMP4;GLI3;BCL6
16924,GO:0098953,0.279157457106554,0.970176192933918,1,3,receptor diffusion trapping,BP,DLG4
16930,GO:0098970,0.279157457106554,0.970176192933918,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17063,GO:0099628,0.279157457106554,0.970176192933918,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
1154,GO:0002763,0.279311130621008,0.862280736623519,5,33,positive regulation of myeloid leukocyte differentiation,BP,ZFP36L1;KITLG;PRKCA;LEF1;FOS
4713,GO:0010880,0.279448457906618,0.896487177465167,3,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,SLC8A1;CAMK2D;PDE4D
13561,GO:0060057,0.279482715253993,0.970101195459632,1,3,apoptotic process involved in mammary gland involution,BP,VDR
13562,GO:0060058,0.279482715253993,0.970101195459632,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
17938,GO:1902339,0.279482715253993,0.970101195459632,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
18410,GO:1903519,0.279482715253993,0.970101195459632,1,3,regulation of mammary gland involution,BP,VDR
18411,GO:1903521,0.279482715253993,0.970101195459632,1,3,positive regulation of mammary gland involution,BP,VDR
18941,GO:1904747,0.279482715253993,0.970101195459632,1,3,positive regulation of apoptotic process involved in development,BP,VDR
17918,GO:1902285,0.279521922964113,0.899641296185117,3,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,PLXNB1;PLXNA2;PLXNA1
5591,GO:0016628,0.279548478999,0.892994338742527,3,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DECR1;ZADH2;DPYD
12380,GO:0048845,0.279575350679256,0.925760693265868,2,8,venous blood vessel morphogenesis,BP,CCBE1;ENG
9965,GO:0042379,0.279778838729905,0.891829602891927,3,24,chemokine receptor binding,MF,CXCL14;STAT1;C5
3025,GO:0006574,0.279912598266725,0.966555067646067,1,4,valine catabolic process,BP,HIBADH
10071,GO:0042592,0.280081559027714,0.753002902244975,123,1094,homeostatic process,BP,CTGF;SOX6;INPP5D;ZFP36L1;F2R;IL20RB;SLC7A8;ANO1;GJA5;PKD2;JPH2;IRS2;CYBRD1;NOS1;GAS6;MALL;AXL;EGFR;TSC22D3;SLC8A1;SESN3;FAM210B;NTSR1;ABCA1;ANGPTL4;VDR;BMP4;NR1D1;STAT1;NEO1;LGALS1;KCNMA1;TP53;DDIT3;IFIT1;DLG4;FLG;TEP1;ANO6;GPX1;KITLG;ERO1B;FYN;IFI6;CPS1;CAV1;SLC27A1;ERCC6;RBFOX2;PLA2G6;DOCK11;SLC22A17;NPHP4;TNS2;CAMK2D;PRDX5;IL31RA;PDIA4;CCK;PIK3R1;ACACB;ANG;BBS2;HERPUD1;ANK3;WFS1;KLF13;PRKACB;SNCA;PDIA6;IGF1R;PDE4D;TGM2;IL18;PDK3;G6PD;SLC24A1;TGFBR3;L3MBTL3;BBS4;CALR;ATM;FAM20A;BBS1;ANXA6;GCLC;SOX9;ENPP1;ITPKB;BCL6;PRCP;CRTC1;PRKCA;TMEM175;TRERF1;LEPR;KCTD7;HMBOX1;ABCC2;PRNP;ZFPM1;SCNN1A;LIPA;THRA;FHL1;SFXN3;SP100;NPHP3;TH;SLC9A4;ITPR2;POLD4;KLHL3;PPARG;PTPN3;SV2A;ABCA2;EFNA5;PPP3CA;STEAP2;ABAT;OXTR;DMPK
20024,GO:2000671,0.280163591552638,0.969943846748237,1,3,regulation of motor neuron apoptotic process,BP,MAP3K12
20025,GO:2000672,0.280163591552638,0.969943846748237,1,3,negative regulation of motor neuron apoptotic process,BP,MAP3K12
1015,GO:0002513,0.280208341487613,0.969933488394312,1,3,tolerance induction to self antigen,BP,TGFBR2
16859,GO:0098831,0.280266722659005,0.935382967349752,2,5,presynaptic active zone cytoplasmic component,CC,PCLO;BSN
8050,GO:0032730,0.280391569359392,0.966432084091448,1,4,positive regulation of interleukin-1 alpha production,BP,ISL1
13902,GO:0060594,0.280574744830199,0.976970927437441,1,2,mammary gland specification,BP,GLI3
1322,GO:0003174,0.280632524816703,0.925286296698421,2,8,mitral valve development,BP,GJA5;ZFPM1
10962,GO:0044774,0.280769208435462,0.812110476607065,13,104,mitotic DNA integrity checkpoint,BP,XPC;TP53;TFDP2;E2F7;HMGA2;TP73;CHEK2;FOXN3;ATM;MDM2;RBL2;CDK5RAP3;TAOK3
7441,GO:0031588,0.280885773778073,0.923477507780786,2,9,nucleotide-activated protein kinase complex,CC,PRKAB2;PRKAG1
979,GO:0002437,0.280946341130979,0.892606044832336,3,20,inflammatory response to antigenic stimulus,BP,IL20RB;GPX1;IL31RA
12294,GO:0048668,0.281015169342,0.894153985382961,3,17,collateral sprouting,BP,PTPRS;ULK2;EFNA5
15742,GO:0072368,0.281386055071476,0.97682554733536,1,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,NCOR1
17184,GO:0106073,0.281422096831337,0.976819076429022,1,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,ALG10
12651,GO:0050886,0.281502375327353,0.850145035354245,6,41,endocrine process,BP,F2R;GJA5;MME;FGFR1;FZD4;OXTR
12234,GO:0048538,0.281803389712218,0.850807950302871,6,37,thymus development,BP,JARID2;PBX1;ATM;LMO4;HOXA3;ZBTB1
13558,GO:0060054,0.28192761673884,0.969533956465033,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,FZD7
17834,GO:1902074,0.282111355362508,0.919626620473099,2,12,response to salt,BP,NEFL;HSPA5
10947,GO:0044729,0.282113780834563,0.96949051130993,1,3,hemi-methylated DNA-binding,MF,EGR1
6282,GO:0019898,0.282326460911872,0.78705515808238,25,189,extrinsic component of membrane,CC,SERPINE2;PIK3C2G;S100A10;PTK6;GNG2;DLG4;HIP1;SNX1;KCNAB2;FYN;SNX33;SYTL1;PIK3R1;ALOX15B;ESYT2;CDH13;SNX10;ANXA2;PRNP;CDH11;ULK1;SNX7;VPS13C;SNX9;PIK3C2B
1994,GO:0004719,0.28250862255285,0.969398248099602,1,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2
2197,GO:0005078,0.282660824765829,0.92663732277492,2,7,MAP-kinase scaffold activity,MF,AKAP13;MAPK8IP3
11401,GO:0045838,0.282719352540712,0.921295515906168,2,10,positive regulation of membrane potential,BP,PIAS3;ANK3
3327,GO:0007040,0.28286219234638,0.840337760306329,7,51,lysosome organization,BP,ABCA1;SRPX;SPG11;HPS4;NAGLU;LYST;TMEM175
15956,GO:0080171,0.28286219234638,0.840337760306329,7,51,lytic vacuole organization,BP,ABCA1;SRPX;SPG11;HPS4;NAGLU;LYST;TMEM175
6851,GO:0030330,0.283089262610915,0.810392059917043,13,101,DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;TP53;TFDP2;E2F7;TP73;CHEK2;PLA2R1;ATM;MDM2;NDRG1;RBL2;SP100;ING4
2194,GO:0005068,0.283112981759278,0.926438297158703,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PIK3R1;PAG1
13497,GO:0055100,0.283164399918386,0.969244654288718,1,3,adiponectin binding,MF,CDH13
19725,GO:2000137,0.283212728685797,0.976496244527056,1,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
17774,GO:1901894,0.283277206865405,0.969218188042802,1,3,regulation of calcium-transporting ATPase activity,BP,HSPA2
4636,GO:0010763,0.283284616032647,0.92237338929419,2,9,positive regulation of fibroblast migration,BP,SLC8A1;PAK1
12573,GO:0050776,0.283546231582711,0.761354207010915,63,574,regulation of immune response,BP,FLOT1;MMP2;INPP5D;IL20RB;TKFC;PAK1;NR1D1;EIF2AK4;TRIM5;VAV3;STAT1;PTPRS;PYCARD;DDX60;MUC19;PILRB;GPX1;ERMAP;SEC14L1;FYN;CAV1;RNF135;PLA2G6;CLU;SERPING1;PRKCZ;ULBP1;PIK3R1;TMEM173;BTN3A1;PRKACB;TLR3;PAG1;C5;PDE4D;PSMB9;IL18;IFNK;CD1D;MAP3K1;PTPN1;BCL6;PRNP;TGFB2;STAT2;SPPL2B;VAV2;BTN3A3;RSAD2;IFITM1;COL17A1;PPARG;GCSAM;LGALS3;RARA;WIPF1;ZBTB1;PPP3CA;FOS;CLEC2D;ELMO2;MYO1C;DOCK1
8183,GO:0032940,0.283612298176601,0.752224167399626,104,932,secretion by cell,BP,SERPINE2;ITGB6;SYT8;FN1;PCDH7;PYGB;MMP9;CTGF;SFRP1;CD109;F2R;ANO1;GSN;GJA5;IRS2;ANPEP;GAS6;AXL;EGFR;SLC2A3;SERPINE1;ENDOD1;ANXA5;NTSR1;TIMP2;PAK1;ABCA1;NR1D1;PYCARD;PDGFA;MICAL1;NISCH;TIMP1;ANO6;SYN1;MAGED2;KCNAB2;LTBP4;PLA2G6;SEL1L;CLU;SERPING1;CXCR1;PRKCZ;SYTL1;METTL7A;PDIA4;CCK;SYT1;TMEM173;CPT1A;SLC38A2;PCLO;ANG;TTN;APLP2;CAT;BTN3A1;STOM;SNCA;MME;VAMP1;FGFR1;ALOX15B;MLEC;C5;ENG;IDH2;COPG2;TMED10;CST3;MANBA;ISL1;PRCP;NFASC;PRKCA;ANXA2;RAB13;SEPT5;MAN2B1;MOSPD2;HTR1B;TGFB2;DNASE1L1;C2CD4C;RSAD2;NAPRT;ITPR2;LMF1;GDNF;POSTN;LGALS3;MIA3;DNAJC3;EFNA5;FZD4;PPP3CA;STEAP2;ACTR1B;ABAT;OXTR;ADAM10;S100A11;CTSD
1096,GO:0002686,0.283848967699487,0.891399181732314,3,19,negative regulation of leukocyte migration,BP,MMP28;C5;GCSAM
2058,GO:0004813,0.283874732811277,0.969077778733439,1,3,alanine-tRNA ligase activity,MF,AARS
2906,GO:0006419,0.283874732811277,0.969077778733439,1,3,alanyl-tRNA aminoacylation,BP,AARS
16908,GO:0098917,0.283988748466854,0.969050944654022,1,3,retrograde trans-synaptic signaling,BP,NOS1
10362,GO:0043204,0.284087053148392,0.832673244042705,8,57,perikaryon,CC,GJC2;NTSR1;PTPRS;CTSV;ITGA1;CCK;ASTN2;TH
17961,GO:1902414,0.284398692531284,0.9235848542408,2,8,protein localization to cell junction,BP,DLG5;MPP7
14105,GO:0061000,0.284620238988982,0.923484210693939,2,8,negative regulation of dendritic spine development,BP,PTPRS;ASAP1
663,GO:0001867,0.28468108000627,0.965319090730434,1,4,complement activation, lectin pathway,BP,SERPING1
9750,GO:0039532,0.284703637764732,0.920364104223066,2,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,TKFC;SEC14L1
12813,GO:0051150,0.284776444384264,0.891396118892506,3,18,regulation of smooth muscle cell differentiation,BP,BMP4;PDCD4;ENG
12357,GO:0048786,0.284797557569044,0.875713472787904,4,19,presynaptic active zone,CC,SYN1;PCLO;SV2A;BSN
5391,GO:0016234,0.28487788262828,0.821496383887043,10,68,inclusion body,CC,KLF8;NEFM;GPX1;CLU;HERPUD1;SNCA;SYNE2;ATXN1;PRNP;EDEM1
13184,GO:0051864,0.28489663290118,0.923358564596869,2,8,histone demethylase activity (H3-K36 specific),MF,KDM4C;KDM4A
14785,GO:0070544,0.28489663290118,0.923358564596869,2,8,histone H3-K36 demethylation,BP,KDM4C;KDM4A
3691,GO:0008200,0.285138434761523,0.872365692245567,4,25,ion channel inhibitor activity,MF,WNK1;CAV1;CAMK2D;RASA1
6473,GO:0021823,0.285184911206688,0.976137624968945,1,2,cerebral cortex tangential migration using cell-cell interactions,BP,ROBO1
6477,GO:0021827,0.285184911206688,0.976137624968945,1,2,postnatal olfactory bulb interneuron migration,BP,ROBO1
6480,GO:0021836,0.285184911206688,0.976137624968945,1,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,ROBO1
15551,GO:0072049,0.285187762108743,0.965186241146702,1,4,comma-shaped body morphogenesis,BP,BMP4
14702,GO:0070384,0.285189704586023,0.968767472508515,1,3,Harderian gland development,BP,SOX9
17674,GO:1901605,0.285334183225501,0.797242264681561,17,149,alpha-amino acid metabolic process,BP,PRODH;NOS1;CRTAP;PHGDH;ERO1B;MTHFR;CPS1;GLDC;HIBADH;GCLC;ALDH4A1;THNSL2;NMNAT2;ALDH7A1;TH;SRR;GSTZ1
10476,GO:0043398,0.285516999886512,0.968689957553761,1,3,HLH domain binding,MF,PKD2
1458,GO:0003705,0.285657134065783,0.83189306065376,8,54,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,SNAI2;MEF2D;NFIX;HIVEP1;TLE4;SOX9;LEF1;MEF2A
16348,GO:0090722,0.285692245150025,0.976044852331032,1,2,receptor-receptor interaction,MF,FGFR1
18993,GO:1904849,0.285692245150025,0.976044852331032,1,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19946,GO:2000546,0.285692245150025,0.976044852331032,1,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
4442,GO:0010360,0.285711657037548,0.968643802954172,1,3,negative regulation of anion channel activity,BP,GOPC
17333,GO:1900076,0.28575287921086,0.83168109313033,8,55,regulation of cellular response to insulin stimulus,BP,SESN3;PAK1;PRKCZ;PIK3R1;PTPN1;ENPP1;MYO1C;C2CD5
12232,GO:0048536,0.285768548912045,0.872366134855082,4,24,spleen development,BP,CDKN2B;JARID2;PBX1;CITED2
17394,GO:1900165,0.285769610515482,0.968630054133057,1,3,negative regulation of interleukin-6 secretion,BP,GAS6
16233,GO:0090317,0.285803868023963,0.870628608329539,4,29,negative regulation of intracellular protein transport,BP,GAS6;SP100;MDFIC;DERL3
8308,GO:0033159,0.285933362133499,0.968591186928151,1,3,negative regulation of protein import into nucleus, translocation,BP,GAS6
2272,GO:0005217,0.286030735351516,0.893682315577769,3,14,intracellular ligand-gated ion channel activity,MF,PKD2;JPH2;ITPR2
5059,GO:0015278,0.286030735351516,0.893682315577769,3,14,calcium-release channel activity,MF,PKD2;JPH2;ITPR2
7363,GO:0031424,0.28641120081343,0.818587688923703,10,90,keratinization,BP,KRT4;TCHH;KRT14;KRT13;KRT5;PPL;FLG;KRT15;CASP14;KRT10
11249,GO:0045578,0.286484662971073,0.968460127297604,1,3,negative regulation of B cell differentiation,BP,SFRP1
6884,GO:0030426,0.286665663810957,0.797173603535349,17,121,growth cone,CC,APBB2;UTRN;FLRT3;STMN3;TIMP2;NEFL;ITGA3;ANG;SNCA;FSCN1;SETX;TRAK1;SSH1;MAP3K12;BOC;TSHZ3;ORAI2
19684,GO:2000049,0.286723975246481,0.968403137230183,1,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,FLOT1
13240,GO:0051956,0.286891636704036,0.968363174492514,1,3,negative regulation of amino acid transport,BP,ABAT
3569,GO:0007616,0.287179062269421,0.872399399865692,4,22,long-term memory,BP,EIF2AK4;PRKCZ;RGS14;PRNP
9853,GO:0042130,0.28726324046001,0.856379020298867,5,35,negative regulation of T cell proliferation,BP,IL20RB;BMP4;GPNMB;DLG5;PRNP
6627,GO:0023016,0.287381508067433,0.975734411436148,1,2,signal transduction by trans-phosphorylation,BP,WNK1
16050,GO:0090042,0.287439669647976,0.920443612235941,2,9,tubulin deacetylation,BP,TADA3;BEX4
16936,GO:0098978,0.287545643745103,0.975704121506592,1,2,glutamatergic synapse,CC,NLGN4Y
16940,GO:0098985,0.287545643745103,0.975704121506592,1,2,asymmetric, glutamatergic, excitatory synapse,CC,NLGN4Y
9658,GO:0038037,0.288026942069344,0.968091796181044,1,3,G-protein coupled receptor dimeric complex,CC,CALCRL
16669,GO:0097648,0.288026942069344,0.968091796181044,1,3,G-protein coupled receptor complex,CC,CALCRL
5918,GO:0018199,0.288119526796252,0.964411790170748,1,4,peptidyl-glutamine modification,BP,TGM2
2018,GO:0004749,0.288191206237361,0.964392732237276,1,4,ribose phosphate diphosphokinase activity,MF,PRPS2
5662,GO:0016778,0.288191206237361,0.964392732237276,1,4,diphosphotransferase activity,MF,PRPS2
9356,GO:0035898,0.288385745725856,0.968005748563533,1,3,parathyroid hormone secretion,BP,FGFR1
243,GO:0000700,0.288427000944605,0.964329998221636,1,4,mismatch base pair DNA N-glycosylase activity,MF,MUTYH
4718,GO:0010885,0.288617317888611,0.919892663967737,2,9,regulation of cholesterol storage,BP,ABCA1;PPARG
7754,GO:0032281,0.288839988551442,0.918406269377522,2,10,AMPA glutamate receptor complex,CC,DLG4;SHISA9
12571,GO:0050774,0.288965447009882,0.919729457384227,2,9,negative regulation of dendrite morphogenesis,BP,NFATC4;PPP3CA
9624,GO:0036510,0.289020574792762,0.967853174214135,1,3,trimming of terminal mannose on C branch,BP,EDEM1
245,GO:0000702,0.28904356871209,0.961989996287867,1,5,oxidized base lesion DNA N-glycosylase activity,MF,MUTYH
1121,GO:0002711,0.28910874654455,0.88785122997669,3,20,positive regulation of T cell mediated immunity,BP,PRKCZ;RSAD2;ZBTB1
4614,GO:0010737,0.289133681749817,0.873756150572996,4,18,protein kinase A signaling,BP,TTN;AIP;AKAP7;RAB13
8880,GO:0034714,0.28937057457691,0.967768874588001,1,3,type III transforming growth factor beta receptor binding,MF,TGFB2
12881,GO:0051254,0.289408333666033,0.743410749766573,131,1111,positive regulation of RNA metabolic process,BP,SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;F2R;TNNI2;ETV5;PKD2;ZFP36L2;NOS1;MAGED1;EGFR;RFX2;SERPINE1;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;TFDP2;NFIX;GLI3;E2F7;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;SMARCA1;ZNF318;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;MEIS2;TCF4;CITED2;NR2F2;LMO4;MAF;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;LITAF;RXRA
12194,GO:0048408,0.289411309185922,0.964067430500804,1,4,epidermal growth factor binding,MF,EGFR
4428,GO:0010266,0.289442807945477,0.967751460711146,1,3,response to vitamin B1,BP,MDM2
15769,GO:0072434,0.289798423827741,0.975286123188776,1,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,ATM
1108,GO:0002698,0.290030174761863,0.821473730088995,9,72,negative regulation of immune effector process,BP,HTRA1;IL20RB;TKFC;IFIT1;SEC14L1;SERPING1;BCL6;TGFB2;LGALS3
3687,GO:0008194,0.290176358173747,0.807828515091512,12,98,UDP-glycosyltransferase activity,MF,GALNT10;EXTL2;B3GAT3;UGT8;XYLT1;HEXA;POGLUT1;GCNT1;UGT1A3;UGT1A6;GALNT2;UGGT2
18753,GO:1904292,0.290236789704294,0.868717693584344,4,26,regulation of ERAD pathway,BP,CAV1;HERPUD1;DERL3;EDEM1
1607,GO:0004032,0.290431418377397,0.961597130103051,1,5,alditol:NADP+ 1-oxidoreductase activity,MF,AKR7A2
12016,GO:0047757,0.290568942541864,0.975142183608188,1,2,chondroitin-glucuronate 5-epimerase activity,MF,DSEL
5355,GO:0016137,0.29077116965584,0.914672251513106,2,13,glycoside metabolic process,BP,AKR7A2;TH
6010,GO:0019065,0.290783927413273,0.967427149557721,1,3,receptor-mediated endocytosis of virus by host cell,BP,CAV1
15924,GO:0075509,0.290783927413273,0.967427149557721,1,3,endocytosis involved in viral entry into host cell,BP,CAV1
13376,GO:0052742,0.290806936166979,0.845568718960393,6,33,phosphatidylinositol kinase activity,MF,PIK3C2G;IRS2;PIK3R1;FGFR1;ATM;PIK3C2B
12935,GO:0051344,0.290813471147143,0.967419983942401,1,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
10853,GO:0044406,0.29094428156628,0.963656287089961,1,4,adhesion of symbiont to host,BP,GAS6
1629,GO:0004070,0.291064833290376,0.975049284348202,1,2,aspartate carbamoyltransferase activity,MF,CPS1
1641,GO:0004087,0.291064833290376,0.975049284348202,1,2,carbamoyl-phosphate synthase (ammonia) activity,MF,CPS1
1642,GO:0004088,0.291064833290376,0.975049284348202,1,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,CPS1
1682,GO:0004151,0.291064833290376,0.975049284348202,1,2,dihydroorotase activity,MF,CPS1
5643,GO:0016743,0.291064833290376,0.975049284348202,1,2,carboxyl- or carbamoyltransferase activity,MF,CPS1
10511,GO:0043473,0.291103646386397,0.816035314454226,10,74,pigmentation,BP,SNAI2;GLI3;KITLG;BBS2;HPS4;BBS4;HPS3;LYST;LEF1;TH
11311,GO:0045658,0.29116744905471,0.967334057674112,1,3,regulation of neutrophil differentiation,BP,INPP5D
8573,GO:0034087,0.291232576941603,0.975017812971381,1,2,establishment of mitotic sister chromatid cohesion,BP,NIPBL
8064,GO:0032755,0.291332279741546,0.842574383155231,6,44,positive regulation of interleukin-6 production,BP,F2R;ZBTB20;PYCARD;TLR3;ARHGEF2;ISL1
11323,GO:0045670,0.291397139225595,0.843748973891473,6,38,regulation of osteoclast differentiation,BP,FBN1;INPP5D;SFRP1;PIK3R1;TLR3;FOS
5940,GO:0018279,0.291524208155584,0.852795144627874,5,38,protein N-linked glycosylation via asparagine,BP,ST6GALNAC2;ST6GAL2;DERL3;UGGT2;TUSC3
16400,GO:0097068,0.29153202554869,0.967245420559818,1,3,response to thyroxine,BP,GCLC
18792,GO:1904386,0.29153202554869,0.967245420559818,1,3,response to L-phenylalanine derivative,BP,GCLC
15347,GO:0071621,0.291705733274008,0.841534125246024,6,49,granulocyte chemotaxis,BP,VAV3;ITGA1;PDE4D;MOSPD2;TGFB2;LGALS3
4484,GO:0010511,0.291797811473733,0.963426197365508,1,4,regulation of phosphatidylinositol biosynthetic process,BP,PDGFA
4334,GO:0009890,0.291858880135192,0.740294837221678,138,1219,negative regulation of biosynthetic process,BP,TXNIP;SOX6;INPP5D;SFRP1;ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;GAS6;SNAI2;MAGED1;PHF21A;EGFR;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;EIF2AK4;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;ZCCHC11;PDGFA;TFDP2;CCDC85B;SIK1;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;SLC27A1;GLI2;RBFOX2;TRIB2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ANG;UHRF2;WFS1;MDFI;CIRBP;JARID2;TP73;DAPK1;CHEK2;PAIP2B;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;CALR;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;SALL2;BAHCC1;LEPR;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;YAP1;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;UNK;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;AGO4;NIPBL;PRDM5;S100A11;RXRA
10663,GO:0043949,0.291860172413956,0.888604088371288,3,16,regulation of cAMP-mediated signaling,BP,NOS1;RGS2;PRKCA
19418,GO:1990075,0.291964074711968,0.967140197689405,1,3,periciliary membrane compartment,CC,KIF17
19260,GO:1905517,0.292029238516944,0.885688766031649,3,21,macrophage migration,BP,MMP28;C5;LGALS3
4295,GO:0009744,0.292181364559186,0.967087203628071,1,3,response to sucrose,BP,CALCRL
8670,GO:0034285,0.292181364559186,0.967087203628071,1,3,response to disaccharide,BP,CALCRL
5632,GO:0016723,0.292190318293655,0.916804348345423,2,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,CYBRD1;STEAP2
8263,GO:0033080,0.292260614514463,0.967067863222681,1,3,immature T cell proliferation in thymus,BP,BMP4
8116,GO:0032817,0.292273041591066,0.963297723328304,1,4,regulation of natural killer cell proliferation,BP,IL18
8117,GO:0032819,0.292273041591066,0.963297723328304,1,4,positive regulation of natural killer cell proliferation,BP,IL18
8729,GO:0034394,0.292726077295547,0.842563381329008,6,39,protein localization to cell surface,BP,KCNAB2;SNX33;PTPRU;ASTN2;ARF6;GOPC
6462,GO:0021798,0.292921492983973,0.974699630903076,1,2,forebrain dorsal/ventral pattern formation,BP,GLI3
14087,GO:0060972,0.293001607267838,0.887940538284011,3,16,left/right pattern formation,BP,CITED2;MEGF8;IFT122
18645,GO:1904017,0.293136125722592,0.974659023801522,1,2,cellular response to Thyroglobulin triiodothyronine,BP,NCOA2
17688,GO:1901628,0.293218966588,0.9668334584502,1,3,positive regulation of postsynaptic membrane organization,BP,SSH1
17242,GO:0120103,0.293467423476166,0.917604948453106,2,9,centriolar subdistal appendage,CC,CNTRL;ODF2
6610,GO:0022840,0.293496801690843,0.962965690175304,1,4,leak channel activity,MF,TMEM175
6612,GO:0022842,0.293496801690843,0.962965690175304,1,4,narrow pore channel activity,MF,TMEM175
17699,GO:1901655,0.293594441755148,0.819606363648977,9,63,cellular response to ketone,BP,SFRP1;DDIT4;EGFR;NR3C1;GNG2;KLF9;ABCC2;PPARG;EFNA5
4199,GO:0009311,0.293598684199827,0.832120622016423,7,53,oligosaccharide metabolic process,BP,ST6GALNAC2;GALNT10;ST6GAL2;MANBA;MAN2B1;GAL3ST4;GALNT2
5782,GO:0017017,0.293646243574936,0.914031270603409,2,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5
13777,GO:0060395,0.293714708599439,0.842335726307054,6,37,SMAD protein signal transduction,BP,VIM;BMP4;WWTR1;TGFB2;MAGI2;FOS
17771,GO:1901888,0.293928041247267,0.814622195154974,10,66,regulation of cell junction assembly,BP,FLOT1;SFRP1;SNAI2;S100A10;CAV1;NPHP4;DLC1;COL16A1;EFNA5;MYO1C
15295,GO:0071542,0.294042067794363,0.887334304868635,3,16,dopaminergic neuron differentiation,BP,SFRP1;DKK1;FZD1
8718,GO:0034382,0.294237007152014,0.962764015132783,1,4,chylomicron remnant clearance,BP,LMF1
15452,GO:0071830,0.294237007152014,0.962764015132783,1,4,triglyceride-rich lipoprotein particle clearance,BP,LMF1
19215,GO:1905394,0.294296124868372,0.966568834331058,1,3,retromer complex binding,MF,TBC1D5
9826,GO:0042089,0.294373773818656,0.824395664417348,8,61,cytokine biosynthetic process,BP,INPP5D;IGF2BP2;TRIB2;TLR3;IL18;EGR1;ZFPM1;MAP2K5
2351,GO:0005432,0.294414346221173,0.966539716148971,1,3,calcium:sodium antiporter activity,MF,SLC8A1
320,GO:0000839,0.294651690865512,0.966481212872443,1,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,SEL1L
11103,GO:0045161,0.29483360394048,0.918777337256555,2,8,neuronal ion channel clustering,BP,NFASC;AGRN
7686,GO:0032154,0.294876953885524,0.831920367800775,7,48,cleavage furrow,CC,MYLK;PSTPIP1;SEPT6;ARF6;SSH1;OR2A4;LIMA1
20000,GO:2000645,0.295157447898027,0.966356348949978,1,3,negative regulation of receptor catabolic process,BP,ANXA2
10823,GO:0044339,0.295394334298811,0.966297771784147,1,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,FZD1
5262,GO:0015914,0.295395847158804,0.831886800438759,7,46,phospholipid transport,BP,PITPNM3;OSBPL10;ATP10D;ABCA1;OSBPL5;ATP8B2;PITPNC1
1379,GO:0003278,0.29550449049367,0.966270512096501,1,3,apoptotic process involved in heart morphogenesis,BP,TGFB2
13042,GO:0051573,0.295800019310951,0.916493995913831,2,9,negative regulation of histone H3-K9 methylation,BP,KDM4C;KDM4A
13183,GO:0051861,0.295855740362613,0.91293971242756,2,12,glycolipid binding,MF,HSPA2;MPPE1
12680,GO:0050925,0.295884396976902,0.974135639057699,1,2,negative regulation of negative chemotaxis,BP,ROBO1
7988,GO:0032620,0.296067056560124,0.912044433748269,2,13,interleukin-17 production,BP,IL18;PRNP
2973,GO:0006517,0.296071308458385,0.851104709385437,5,32,protein deglycosylation,BP,SEL1L;MAN1A1;MAN2B1;UGGT2;EDEM1
11576,GO:0046189,0.296175923344097,0.885364968384433,3,17,phenol-containing compound biosynthetic process,BP,SNCA;TGFB2;TH
630,GO:0001820,0.296312945622447,0.966070053715041,1,3,serotonin secretion,BP,HTR1B
15109,GO:0071233,0.29681372904062,0.917849535398798,2,8,cellular response to leucine,BP,SESN3;SESN1
7755,GO:0032286,0.296903261858706,0.965923243932055,1,3,central nervous system myelin maintenance,BP,CLU
8218,GO:0032994,0.296985901547665,0.883687713309768,3,19,protein-lipid complex,CC,ABCA1;SORL1;CLU
4245,GO:0009449,0.297237978882861,0.965839835897453,1,3,gamma-aminobutyric acid biosynthetic process,BP,ABAT
135,GO:0000285,0.297370245141545,0.965806843577192,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,PIKFYVE
9660,GO:0038042,0.297404287595689,0.961893882649316,1,4,dimeric G-protein coupled receptor signaling pathway,BP,CALCRL
16667,GO:0097646,0.297404287595689,0.961893882649316,1,4,calcitonin family receptor signaling pathway,BP,CALCRL
17769,GO:1901880,0.297412559087464,0.831209128983412,7,42,negative regulation of protein depolymerization,BP,GSN;SPTB;TRIOBP;ARHGEF2;CAPG;LIMA1;TTBK2
14760,GO:0070494,0.297581427326224,0.965754127886191,1,3,regulation of thrombin-activated receptor signaling pathway,BP,SNCA
14761,GO:0070495,0.297581427326224,0.965754127886191,1,3,negative regulation of thrombin-activated receptor signaling pathway,BP,SNCA
15153,GO:0071318,0.297773011418905,0.912941208503011,2,11,cellular response to ATP,BP,SSH1;TAF1
20224,GO:2001201,0.297773655711298,0.973772142675884,1,2,regulation of transforming growth factor-beta secretion,BP,FN1
18332,GO:1903348,0.297961253645522,0.96565919514208,1,3,positive regulation of bicellular tight junction assembly,BP,NPHP4
428,GO:0001147,0.298051175938039,0.973718492291987,1,2,transcription termination site sequence-specific DNA binding,MF,SETX
431,GO:0001160,0.298051175938039,0.973718492291987,1,2,transcription termination site DNA binding,MF,SETX
13360,GO:0052659,0.298084594684871,0.915399163074617,2,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,INPP5D;ITPK1
15564,GO:0072075,0.298151128428385,0.915367178028227,2,9,metanephric mesenchyme development,BP,PKD2;STAT1
4819,GO:0014022,0.298336803766192,0.965565179705199,1,3,neural plate elongation,BP,VANGL2
6553,GO:0022007,0.298336803766192,0.965565179705199,1,3,convergent extension involved in neural plate elongation,BP,VANGL2
3911,GO:0008582,0.298357194500674,0.973659256716569,1,2,regulation of synaptic growth at neuromuscular junction,BP,AGRN
12080,GO:0048143,0.298362171720011,0.917120540793247,2,8,astrocyte activation,BP,EGFR;LRP1
8048,GO:0032728,0.298398927280851,0.863405610655236,4,26,positive regulation of interferon-beta production,BP,FLOT1;ZBTB20;RNF135;TLR3
18842,GO:1904527,0.298521041127421,0.965519002514665,1,3,negative regulation of microtubule binding,BP,TTBK2
18109,GO:1902855,0.298583239174134,0.913707506498585,2,10,regulation of non-motile cilium assembly,BP,BBS4;SEPT9
4883,GO:0014808,0.298854527946014,0.884513125296819,3,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,SLC8A1;CAMK2D;PDE4D
18405,GO:1903514,0.298854527946014,0.884513125296819,3,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,SLC8A1;CAMK2D;PDE4D
3572,GO:0007619,0.298887169130926,0.9654271285923,1,3,courtship behavior,BP,THRA
15184,GO:0071361,0.298910760512975,0.919325316531581,2,7,cellular response to ethanol,BP,TP53INP1;ITPR2
6056,GO:0019209,0.298918739230799,0.821150711177341,8,59,kinase activator activity,MF,GAS6;WNK1;ERCC6;SPRY2;AFAP1L2;FAM20A;DGKQ;EFNA5
13756,GO:0060371,0.299109612750157,0.965371239925894,1,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,GJA5
4752,GO:0010934,0.299164218869416,0.913423454226729,2,10,macrophage cytokine production,BP,GAS6;TGFB2
10606,GO:0043625,0.299309900978092,0.961364733779186,1,4,delta DNA polymerase complex,CC,POLD4
11296,GO:0045639,0.29941436028819,0.820895265526993,8,58,positive regulation of myeloid cell differentiation,BP,INPP5D;ZFP36L1;FAM210B;STAT1;KITLG;PRKCA;LEF1;FOS
1203,GO:0002864,0.299476501115736,0.961318270784936,1,4,regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
16624,GO:0097529,0.299513848516402,0.808455175055069,10,86,myeloid leukocyte migration,BP,MMP28;SERPINE1;VAV3;ANO6;ITGA1;C5;PDE4D;MOSPD2;TGFB2;LGALS3
4596,GO:0010716,0.29954866727773,0.961298134338759,1,4,negative regulation of extracellular matrix disassembly,BP,CST3
3253,GO:0006919,0.299600901399475,0.813600800417582,9,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,F2R;PYCARD;HIP1;XDH;CCK;DLC1;ROBO1;SNCA;PPARG
7652,GO:0032092,0.299831905506528,0.809130787140096,10,74,positive regulation of protein binding,BP,FLOT1;MMP9;BMP4;LRP1;CAV1;TMEM173;CAPRIN2;HERPUD1;ANXA2;TAF1
16299,GO:0090543,0.29986934613292,0.862440583217952,4,26,Flemming body,CC,CNTRL;ARF6;OR2A4;CAPG
9307,GO:0035799,0.299894414463735,0.965173636366655,1,3,ureter maturation,BP,RET
5893,GO:0018105,0.299969734015404,0.769073479090623,27,210,peptidyl-serine phosphorylation,BP,DDIT4;TGFBR2;GAS6;EGFR;PAK1;CAV1;PRKCZ;HMGA2;CAMK2D;CAPRIN2;SPRY2;CHEK2;SNCA;DKK1;PDE4D;PDK3;ATM;IFNK;DGKQ;IFNE;PRKCA;MAP3K12;RET;ULK1;TAF1;TTBK2;DMPK
15455,GO:0071839,0.299994679280855,0.96117354888358,1,4,apoptotic process in bone marrow,BP,LEF1
14938,GO:0070863,0.300061791630635,0.91631687293686,2,8,positive regulation of protein exit from endoplasmic reticulum,BP,SORL1;EDEM1
11331,GO:0045687,0.300079172837022,0.8623026749424,4,26,positive regulation of glial cell differentiation,BP,SERPINE2;TENM4;TP73;PPARG
19172,GO:1905292,0.300251798873873,0.965083432598096,1,3,regulation of neural crest cell differentiation,BP,BMP4
19173,GO:1905294,0.300251798873873,0.965083432598096,1,3,positive regulation of neural crest cell differentiation,BP,BMP4
19179,GO:1905310,0.300251798873873,0.965083432598096,1,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,BMP4
19180,GO:1905312,0.300251798873873,0.965083432598096,1,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,BMP4
10904,GO:0044539,0.300340951046471,0.965060909257743,1,3,long-chain fatty acid import,BP,ACSL3
10825,GO:0044341,0.300399308365469,0.965046161289773,1,3,sodium-dependent phosphate transport,BP,SLC20A1
8689,GO:0034343,0.300688855595072,0.964972933332092,1,3,type III interferon production,BP,TLR3
8690,GO:0034344,0.300688855595072,0.964972933332092,1,3,regulation of type III interferon production,BP,TLR3
12850,GO:0051205,0.300703232375595,0.846007268320887,5,40,protein insertion into membrane,BP,EGFR;TP53;TFDP2;TP73;COX18
20158,GO:2001028,0.301138896552253,0.913925004317636,2,9,positive regulation of endothelial cell chemotaxis,BP,SEMA5A;FGFR1
13632,GO:0060174,0.301163663292971,0.915793892311513,2,8,limb bud formation,BP,PLXNA2;SOX9
14758,GO:0070492,0.301240460756997,0.960824327863543,1,4,oligosaccharide binding,MF,LGALS1
14766,GO:0070509,0.301247228213738,0.847509972550456,5,32,calcium ion import,BP,PKD2;SLC8A1;FYN;PRNP;LGALS3
12786,GO:0051117,0.301267950650351,0.826242426584736,7,54,ATPase binding,MF,PKD2;ABCA1;CAV1;WFS1;PDE4D;SNX10;PTPN3
754,GO:0001996,0.301448840623382,0.964780301030339,1,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,PDE4D
1396,GO:0003321,0.301448840623382,0.964780301030339,1,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,PDE4D
13911,GO:0060605,0.301506147775868,0.964765750305342,1,3,tube lumen cavitation,BP,TGM2
13928,GO:0060662,0.301506147775868,0.964765750305342,1,3,salivary gland cavitation,BP,TGM2
11376,GO:0045786,0.301506325707178,0.746261744347186,59,533,negative regulation of cell cycle,BP,CDKN2B;ZFP36L1;APBB2;XPC;PKD2;ZFP36L2;GAS6;EGFR;GJC2;NUPR1;TOM1L2;TIMP2;CBX5;BMP4;EIF2AK4;PDCD4;TP53;DDIT3;GPNMB;TFDP2;BTG1;E2F7;CTDSPL;MAP3K14;TP53INP1;HMGA2;KANK2;UHRF2;TP73;PRKACB;CHEK2;FBXL7;ALOX15B;PRKAB2;PSMB9;FOXN3;CALR;ATM;MDM2;NR2F2;BCL6;NDRG1;PRNP;TGFB2;RBL2;FHL1;USP28;CDKN2A;TSPYL2;MAGI2;ING4;PTPN3;TMEM67;PRKAG1;CTDSP2;KLHL22;CDK5RAP3;CAMK2N1;TAOK3
18784,GO:1904377,0.301528944279122,0.827309966964893,7,46,positive regulation of protein localization to cell periphery,BP,EGFR;ACSL3;ITGA3;LRP1;PIK3R1;ARF6;PRNP
12858,GO:0051223,0.301757525735605,0.747714696369583,55,477,regulation of protein transport,BP,FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;TCAF1;EGFR;PAK1;BMP4;NR1D1;SORL1;TP53;PYCARD;ACSL3;GLI3;LRP1;FYN;B3GAT3;PLA2G6;PRKCZ;PTPN14;HHAT;TMEM173;CPT1A;ANG;ANK3;TTN;HPS4;STOM;SH3TC2;ALOX15B;C5;LRTOMT;IDH2;MDM2;PTPN1;ISL1;PRKCA;PRNP;TGFB2;SP100;GOPC;RSAD2;ITPR2;MDFIC;DERL3;POSTN;EFNA5;PPP3CA;ABAT;MYO1C;C2CD5;EDEM1
4383,GO:0010040,0.301955378368437,0.960623098020459,1,4,response to iron(II) ion,BP,SNCA
20002,GO:2000647,0.301995997888636,0.912032692900848,2,10,negative regulation of stem cell proliferation,BP,SNAI2;FBLN1
10830,GO:0044346,0.302029984925687,0.881896208853416,3,17,fibroblast apoptotic process,BP,SFRP1;GAS6;BTG1
16511,GO:0097284,0.302071552170109,0.910808890302848,2,11,hepatocyte apoptotic process,BP,GSN;ARF6
10585,GO:0043585,0.302141440952437,0.972920148202833,1,2,nose morphogenesis,BP,GLI3
4488,GO:0010518,0.302151783985991,0.86133121762877,4,25,positive regulation of phospholipase activity,BP,EGFR;PRKCZ;ANG;FGFR1
10782,GO:0044282,0.302398891087918,0.76097721910743,32,301,small molecule catabolic process,BP,SULT1E1;PRODH;IRS2;NOS1;TKFC;NTSR1;APOBEC3C;BCKDHB;TYSND1;ECH1;FUT10;GLDC;HIBADH;ALDH3A2;CPT1A;ACACB;APOBEC3G;ALDH1L2;APOBEC3F;HEXA;ALDH4A1;THNSL2;TRERF1;DECR1;ALDH7A1;GSTZ1;DPYD;AIG1;EHHADH;ABAT;CPT2;ACAA2
12119,GO:0048245,0.302416893225918,0.96049287526641,1,4,eosinophil chemotaxis,BP,LGALS3
8869,GO:0034699,0.302460243576412,0.964522979025849,1,3,response to luteinizing hormone,BP,TGFBR3
10464,GO:0043380,0.302649406053113,0.960427173721799,1,4,regulation of memory T cell differentiation,BP,BCL6
6707,GO:0030125,0.302760737204681,0.861360819572519,4,24,clathrin vesicle coat,CC,CLTCL1;EGFR;HIP1;TBC1D5
4734,GO:0010906,0.302789041467658,0.807383381377291,10,68,regulation of glucose metabolic process,BP,IRS2;NR1D1;SIK1;ACACB;NCOA2;PDK3;DGKQ;ENPP1;LEPR;IGFBP4
11946,GO:0047192,0.303034058529562,0.964376498785945,1,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,LPCAT2
20245,GO:2001238,0.303161668841367,0.833644866957609,6,46,positive regulation of extrinsic apoptotic signaling pathway,BP,SFRP1;ITM2C;PYCARD;SRPX;CAV1;RET
17442,GO:1900274,0.303188178029542,0.881204979482088,3,17,regulation of phospholipase C activity,BP,EGFR;ANG;FGFR1
14358,GO:0061629,0.303245297361462,0.964322485541354,1,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,TAF1
17355,GO:1900112,0.303318261029603,0.912865813220504,2,9,regulation of histone H3-K9 trimethylation,BP,KDM4C;KDM4A
14193,GO:0061162,0.303339458235571,0.882713210666579,3,15,establishment of monopolar cell polarity,BP,FSCN1;OPHN1;MYO9A
14240,GO:0061339,0.303339458235571,0.882713210666579,3,15,establishment or maintenance of monopolar cell polarity,BP,FSCN1;OPHN1;MYO9A
12500,GO:0050667,0.303525611647533,0.910082148796768,2,11,homocysteine metabolic process,BP,MTHFR;CPS1
4583,GO:0010692,0.303680348344288,0.914593614233431,2,8,regulation of alkaline phosphatase activity,BP,ITGA2;TGFB2
17459,GO:1900402,0.303684669891993,0.914591546239018,2,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;NCOR1
9749,GO:0039531,0.303709128246103,0.881638648557402,3,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,TKFC;DDX60;SEC14L1
7364,GO:0031427,0.303753062118208,0.964192454401856,1,3,response to methotrexate,BP,ABCC2
16595,GO:0097479,0.303820231409985,0.801570717214023,11,79,synaptic vesicle localization,BP,SYT8;SYN1;SPG11;SYTL1;SYT1;PCLO;SNCA;SEPT5;C2CD4C;MAGI2;DNM1P46
11758,GO:0046640,0.303898881256658,0.909895143411732,2,11,regulation of alpha-beta T cell proliferation,BP,TGFBR2;IL18
10223,GO:0042975,0.303959887603469,0.912552813764912,2,9,peroxisome proliferator activated receptor binding,MF,NFATC4;MDM2
16399,GO:0097067,0.303978521068501,0.911052845420333,2,10,cellular response to thyroid hormone stimulus,BP,KLF9;GCLC
18166,GO:1902962,0.303996293366831,0.972553396196641,1,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
18167,GO:1902963,0.303996293366831,0.972553396196641,1,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
9057,GO:0035315,0.304048726169136,0.860080518002351,4,25,hair cell differentiation,BP,SLITRK6;FGFR1;TRIOBP;LRTOMT
4641,GO:0010768,0.304058288773895,0.972541087036029,1,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,TAF1
4388,GO:0010046,0.304064762405781,0.960025861339268,1,4,response to mycotoxin,BP,EGR1
7469,GO:0031644,0.304303752915597,0.84537381994275,5,32,regulation of neurological system process,BP,F2R;TENM4;NTSR1;ITGA2;CCK
10480,GO:0043403,0.304478329555324,0.879195145109086,3,19,skeletal muscle tissue regeneration,BP,TGFBR2;GPX1;FZD7
186,GO:0000404,0.304712134734312,0.963946090165933,1,3,heteroduplex DNA loop binding,MF,XPC
5518,GO:0016494,0.304733128030121,0.959835531060374,1,4,C-X-C chemokine receptor activity,MF,CXCR1
7809,GO:0032373,0.304827247069434,0.880972524522916,3,16,positive regulation of sterol transport,BP,ABCA1;LRP1;ANXA2
7812,GO:0032376,0.304827247069434,0.880972524522916,3,16,positive regulation of cholesterol transport,BP,ABCA1;LRP1;ANXA2
11097,GO:0045143,0.304835236545696,0.858798097925742,4,27,homologous chromosome segregation,BP,MLH3;ATM;MSH5;AGO4
15598,GO:0072126,0.30501213997483,0.959755920899442,1,4,positive regulation of glomerular mesangial cell proliferation,BP,EGR1
8912,GO:0034774,0.30503866799575,0.769084880167494,23,221,secretory granule lumen,CC,FN1;PYGB;GSN;GAS6;SERPINE1;TIMP2;PCSK1;PYCARD;PDGFA;TIMP1;MAGED2;CLU;SERPING1;CAT;ANXA2;MAN2B1;TGFB2;DNASE1L1;NAPRT;DNAJC3;ACTR1B;S100A11;CTSD
16675,GO:0097680,0.305117903103902,0.96384155793335,1,3,double-strand break repair via classical nonhomologous end joining,BP,UVRAG
4890,GO:0014821,0.305304110127883,0.959672514918992,1,4,phasic smooth muscle contraction,BP,GDNF
5273,GO:0015929,0.305360210894493,0.908171469192645,2,12,hexosaminidase activity,MF,NAGLU;HEXA
19423,GO:1990111,0.305444786982233,0.959632292343054,1,4,spermatoproteasome complex,CC,PSMB9
6545,GO:0021983,0.305555159308941,0.879787232840956,3,17,pituitary gland development,BP,BMP4;GLI2;ISL1
3487,GO:0007368,0.30558814752687,0.805043799565873,10,69,determination of left/right symmetry,BP,TGFBR2;PKD2;IFT140;ENG;BBS4;CITED2;VANGL2;MEGF8;NPHP3;IFT74
13759,GO:0060374,0.305612603921967,0.963713874174336,1,3,mast cell differentiation,BP,ZFPM1
7617,GO:0032027,0.305786998943212,0.963668799087464,1,3,myosin light chain binding,MF,SPATA6
20250,GO:2001243,0.305960472773073,0.80843963756999,9,79,negative regulation of intrinsic apoptotic signaling pathway,BP,MMP9;SNAI2;GPX1;CLU;HERPUD1;WFS1;MDM2;PTPN1;ARHGEF2
19877,GO:2000392,0.305996574092312,0.911555765113427,2,9,regulation of lamellipodium morphogenesis,BP,PDPN;ARPIN
803,GO:0002074,0.306073831979911,0.963594590948885,1,3,extraocular skeletal muscle development,BP,MYH15
6674,GO:0030047,0.306099416056196,0.963587967619267,1,3,actin modification,BP,TRIOBP
16992,GO:0099174,0.306172959572072,0.96356892436346,1,3,regulation of presynapse organization,BP,SNCA
19296,GO:1905606,0.306172959572072,0.96356892436346,1,3,regulation of presynapse assembly,BP,SNCA
15966,GO:0086005,0.306196195182756,0.88101972169578,3,15,ventricular cardiac muscle cell action potential,BP,GJA5;CAV1;KCNJ5
9840,GO:0042107,0.306238128712632,0.81515547780031,8,62,cytokine metabolic process,BP,INPP5D;IGF2BP2;TRIB2;TLR3;IL18;EGR1;ZFPM1;MAP2K5
8210,GO:0032982,0.306373736299018,0.915856852336625,2,7,myosin filament,CC,MYH15;MYH11
19688,GO:2000053,0.306395512166753,0.97207461491214,1,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
5165,GO:0015722,0.306455777398839,0.963495637234434,1,3,canalicular bile acid transport,BP,ABCC2
5904,GO:0018149,0.306575847121598,0.855715949779491,4,34,peptide cross-linking,BP,FN1;FLG;TGM2;KRT10
4584,GO:0010693,0.306608848603562,0.963455935390566,1,3,negative regulation of alkaline phosphatase activity,BP,TGFB2
12093,GO:0048169,0.306798704644468,0.879039648304502,3,17,regulation of long-term neuronal synaptic plasticity,BP,NETO1;DLG4;SNCA
11438,GO:0045916,0.306915190766772,0.963376403484366,1,3,negative regulation of complement activation,BP,SERPING1
19785,GO:2000258,0.306915190766772,0.963376403484366,1,3,negative regulation of protein activation cascade,BP,SERPING1
8650,GO:0034236,0.30696953579344,0.90834986894148,2,11,protein kinase A catalytic subunit binding,MF,SOX9;RAB13
2671,GO:0006026,0.30712491970999,0.831671939523676,6,41,aminoglycan catabolic process,BP,SDC3;CSPG4;NAGLU;HEXA;SDC2;AGRN
9259,GO:0035701,0.307214653383495,0.963298559089828,1,3,hematopoietic stem cell migration,BP,GAS6
11180,GO:0045329,0.307370759934488,0.959079259387959,1,4,carnitine biosynthetic process,BP,ALDH9A1
19882,GO:2000401,0.307399391193602,0.857091466812901,4,27,regulation of lymphocyte migration,BP,CXCL14;PYCARD;GCSAM;ADAM10
17362,GO:1900119,0.307442063091447,0.907111240393776,2,12,positive regulation of execution phase of apoptosis,BP,TP53;DLC1
20108,GO:2000823,0.307582578047943,0.959018168610774,1,4,regulation of androgen receptor activity,BP,TAF1
20109,GO:2000825,0.307582578047943,0.959018168610774,1,4,positive regulation of androgen receptor activity,BP,TAF1
13943,GO:0060681,0.307683966493223,0.963176366464391,1,3,branch elongation involved in ureteric bud branching,BP,BMP4
20263,GO:2001268,0.307816299026854,0.956477158036937,1,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9
9360,GO:0035905,0.307850724814915,0.963132890773446,1,3,ascending aorta development,BP,TGFB2
9363,GO:0035910,0.307850724814915,0.963132890773446,1,3,ascending aorta morphogenesis,BP,TGFB2
7802,GO:0032366,0.307957986924235,0.878341019893125,3,17,intracellular sterol transport,BP,ABCA1;ANXA2;ABCA2
7803,GO:0032367,0.307957986924235,0.878341019893125,3,17,intracellular cholesterol transport,BP,ABCA1;ANXA2;ABCA2
12767,GO:0051088,0.308416051226663,0.962985278819134,1,3,PMA-inducible membrane protein ectodomain proteolysis,BP,ADAM10
3552,GO:0007595,0.308440936522341,0.84246663216701,5,32,lactation,BP,VDR;XDH;CAV1;OAS2;OXTR
6054,GO:0019207,0.308444515373329,0.773484506540045,19,163,kinase regulator activity,MF,FLRT2;CDKN2B;GAS6;FLRT3;WNK1;ERCC6;TRIB2;PIK3R1;SPRY2;AFAP1L2;FAM20A;DGKQ;CDKN2A;DNAJC3;CCNY;PRKAG1;EFNA5;CAMK2N1;TAOK3
18597,GO:1903911,0.308627833094194,0.962929890980702,1,3,positive regulation of receptor clustering,BP,SSH1
8300,GO:0033147,0.308740365552353,0.910204111470034,2,9,negative regulation of intracellular estrogen receptor signaling pathway,BP,KANK2;ISL1
19520,GO:1990460,0.308966807593357,0.962841136385228,1,3,leptin receptor binding,MF,SNX1
16586,GO:0097457,0.30900712003243,0.971547788052854,1,2,hippocampal mossy fiber,CC,MICAL1
6444,GO:0021769,0.309146490272081,0.962794038774438,1,3,orbitofrontal cortex development,BP,FGFR1
2927,GO:0006447,0.309511997548293,0.962698124940683,1,3,regulation of translational initiation by iron,BP,RXRA
4967,GO:0015085,0.309994563356558,0.802115206733027,10,64,calcium ion transmembrane transporter activity,MF,PKD2;JPH2;GAS6;SLC8A1;ORAI3;SLC24A1;ITPR2;CACNB1;CACNA2D3;ORAI2
2936,GO:0006464,0.310154146864727,0.713182789237861,342,3079,cellular protein modification process,BP,PHACTR3;CPA4;FLOT1;PRSS23;FN1;FLRT2;MMP9;GPRC5A;CTGF;FBN1;SFRP1;ST6GALNAC2;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;ADAMTSL1;EFEMP1;MARCH4;PKD2;IRS2;DUSP6;ZFP36L2;HERC5;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;PHF21A;ROR1;AXL;EGFR;GALNT10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NTM;FKBP5;MYLK;GJC2;TRIM2;RNF213;CRTAP;RNF165;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;ABCA1;PTPRM;PADI3;BMP4;TRIM38;PTK6;EIF2AK4;TRIM5;NEFL;PDCD4;SORL1;LGALS1;TP53;PTPRS;TTLL11;WWTR1;PRICKLE1;CNTRL;CUL9;PYCARD;LTBP1;WNK1;MUC19;DLG4;PILRB;PDGFA;MICAL1;ADARB1;TIMP1;FLG;GPNMB;CUL7;BTG1;CHD3;SIK1;ELFN2;GPX1;CDK14;CNTN1;KITLG;P3H2;ERO1B;CTDSPL;MTHFR;NEK9;FYN;XDH;ALPK1;B3GAT3;FUT10;CAV1;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;TRIB2;SEL1L;MAP3K14;DCAF16;UST;CLU;FKBP9;PRKCZ;SDR16C5;FBXW4;ULK2;PARP4;TNS2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;CAPRIN2;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;SPRY2;TTN;JARID2;LMO7;APLP2;FBLN1;TP73;DAPK1;ST6GAL2;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PHF2;TLR3;MAN1A1;FBXL7;SNCA;ADAMTS7;PDIA6;FZD7;JADE2;PTPRU;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;IL18;OBSCN;PDK3;G6PD;EPHB6;ARSD;EDA2R;FZD8;TRIOBP;KDM4C;AFAP1L2;MAGEF1;TGFBR3;FZD1;IPP;ENG;MTMR4;NEGR1;ATM;FBXO17;MDM2;FAM20A;CST3;MANBA;AREG;IFNK;AKAP13;DNAJC6;DGKQ;GCLC;NR2F2;IFNE;NEURL1B;TRAK1;FBXW8;HDAC11;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;NCOR1;GCNT1;PRKCA;ANXA2;RGS14;RAB13;HLTF;RNF24;MAN2B1;PGAP1;IGFBP4;KCTD7;ANAPC16;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;CDC42EP5;USP28;MAPK8IP3;TRIML2;CDKN2A;PPM1M;ULK1;TSPYL2;RHBDD1;MAGI2;HSPA5;CDK19;KLHL5;SRPK2;UVRAG;MDFIC;SAP30L;TPGS1;LMF1;GDNF;ALG10;NUB1;KLHL3;YEATS2;UBA7;GALNT2;DERL3;RNF144B;PARP15;BEX4;TPST1;MEF2A;SNX9;ICK;SASH1;OBSL1;ING4;ZYG11B;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;CCNY;PCMTD2;PRKAG1;TAF1;EFNA5;FZD4;MPPE1;PPP3CA;DCAF8;RASA1;CTDSP2;KRT10;KDM4A;KLHL22;CDK5RAP3;MATN3;CAMK2N1;EHHADH;MED12;FBXL4;NIPBL;UGGT2;TTBK2;ADM2;OXTR;ADAM10;PRDM5;PPP2R3A;TUSC3;EDEM1;GID4;TAOK3;ZNRF1;DMPK;LAMB2
9499,GO:0036211,0.310154146864727,0.713182789237861,342,3079,protein modification process,BP,PHACTR3;CPA4;FLOT1;PRSS23;FN1;FLRT2;MMP9;GPRC5A;CTGF;FBN1;SFRP1;ST6GALNAC2;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;ADAMTSL1;EFEMP1;MARCH4;PKD2;IRS2;DUSP6;ZFP36L2;HERC5;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;PHF21A;ROR1;AXL;EGFR;GALNT10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NTM;FKBP5;MYLK;GJC2;TRIM2;RNF213;CRTAP;RNF165;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;ABCA1;PTPRM;PADI3;BMP4;TRIM38;PTK6;EIF2AK4;TRIM5;NEFL;PDCD4;SORL1;LGALS1;TP53;PTPRS;TTLL11;WWTR1;PRICKLE1;CNTRL;CUL9;PYCARD;LTBP1;WNK1;MUC19;DLG4;PILRB;PDGFA;MICAL1;ADARB1;TIMP1;FLG;GPNMB;CUL7;BTG1;CHD3;SIK1;ELFN2;GPX1;CDK14;CNTN1;KITLG;P3H2;ERO1B;CTDSPL;MTHFR;NEK9;FYN;XDH;ALPK1;B3GAT3;FUT10;CAV1;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;TRIB2;SEL1L;MAP3K14;DCAF16;UST;CLU;FKBP9;PRKCZ;SDR16C5;FBXW4;ULK2;PARP4;TNS2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;CAPRIN2;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;SPRY2;TTN;JARID2;LMO7;APLP2;FBLN1;TP73;DAPK1;ST6GAL2;DLC1;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PHF2;TLR3;MAN1A1;FBXL7;SNCA;ADAMTS7;PDIA6;FZD7;JADE2;PTPRU;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;IL18;OBSCN;PDK3;G6PD;EPHB6;ARSD;EDA2R;FZD8;TRIOBP;KDM4C;AFAP1L2;MAGEF1;TGFBR3;FZD1;IPP;ENG;MTMR4;NEGR1;ATM;FBXO17;MDM2;FAM20A;CST3;MANBA;AREG;IFNK;AKAP13;DNAJC6;DGKQ;GCLC;NR2F2;IFNE;NEURL1B;TRAK1;FBXW8;HDAC11;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;NCOR1;GCNT1;PRKCA;ANXA2;RGS14;RAB13;HLTF;RNF24;MAN2B1;PGAP1;IGFBP4;KCTD7;ANAPC16;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;CDC42EP5;USP28;MAPK8IP3;TRIML2;CDKN2A;PPM1M;ULK1;TSPYL2;RHBDD1;MAGI2;HSPA5;CDK19;KLHL5;SRPK2;UVRAG;MDFIC;SAP30L;TPGS1;LMF1;GDNF;ALG10;NUB1;KLHL3;YEATS2;UBA7;GALNT2;DERL3;RNF144B;PARP15;BEX4;TPST1;MEF2A;SNX9;ICK;SASH1;OBSL1;ING4;ZYG11B;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;CCNY;PCMTD2;PRKAG1;TAF1;EFNA5;FZD4;MPPE1;PPP3CA;DCAF8;RASA1;CTDSP2;KRT10;KDM4A;KLHL22;CDK5RAP3;MATN3;CAMK2N1;EHHADH;MED12;FBXL4;NIPBL;UGGT2;TTBK2;ADM2;OXTR;ADAM10;PRDM5;PPP2R3A;TUSC3;EDEM1;GID4;TAOK3;ZNRF1;DMPK;LAMB2
20003,GO:2000648,0.310163421529744,0.856949058587156,4,23,positive regulation of stem cell proliferation,BP,GLI3;KITLG;HMGA2;LTBP3
15137,GO:0071286,0.310257359329798,0.971293484993224,1,2,cellular response to magnesium ion,BP,ANK3
15074,GO:0071148,0.310259331900847,0.971293082688809,1,2,TEAD-1-YAP complex,CC,YAP1
6321,GO:0020016,0.310307280984612,0.962488928186062,1,3,ciliary pocket,CC,EHD3
6322,GO:0020018,0.310307280984612,0.962488928186062,1,3,ciliary pocket membrane,CC,EHD3
16466,GO:0097193,0.310361125227525,0.759278916888689,27,244,intrinsic apoptotic signaling pathway,BP,MMP9;PRODH;DDIT4;SNAI2;NUPR1;SCN2A;TP53;DDIT3;PYCARD;GPX1;CAV1;ERCC6;CLU;PIK3R1;HERPUD1;WFS1;TP73;CASP14;CHEK2;EDA2R;NFATC4;ATM;MDM2;ZMAT3;PTPN1;ARHGEF2;USP28
13900,GO:0060591,0.310447586086304,0.962451949639131,1,3,chondroblast differentiation,BP,RARA
10466,GO:0043383,0.310565805469014,0.962420775247892,1,3,negative T cell selection,BP,GLI3
11041,GO:0045060,0.310565805469014,0.962420775247892,1,3,negative thymic T cell selection,BP,GLI3
10039,GO:0042542,0.310805907181246,0.790657765274038,12,104,response to hydrogen peroxide,BP,TXNIP;NQO1;AXL;SLC8A1;STAT1;TP53;GPX1;CAT;SETX;MDM2;CST3;AREG
7579,GO:0031958,0.311180552777763,0.877158570356254,3,16,corticosteroid receptor signaling pathway,BP,NR3C1;PER1;CALR
10394,GO:0043254,0.311188299672603,0.747147224976277,40,335,regulation of protein complex assembly,BP,GSN;SPTB;DDB2;PAK1;ABCA1;SORL1;TP53;PYCARD;MAP2;ASAP1;EML2;ARHGAP18;CLU;PRKCZ;ARPIN;KANK2;CCK;SNCA;DKK1;FSCN1;RGS2;SETX;TRIOBP;BBS4;ATM;ARF6;FHOD3;LMO4;ARHGEF2;MPP7;RPL13A;THRA;CDC42EP5;ULK1;CAPG;SNX9;TAF1;WIPF1;RASA1;MYO1C
9559,GO:0036379,0.311314174790784,0.881626969645636,3,12,myofilament,CC,TNNI2;TTN;FHOD3
13108,GO:0051701,0.311485337730142,0.771007932862294,19,158,interaction with host,BP,ITGB6;ITGB5;GSN;ANPEP;GAS6;AXL;EGFR;TRIM38;EIF2AK4;TRIM5;LGALS1;IFIT1;ITGA2;CAV1;EFNB3;IFITM2;UVRAG;IFITM1;RXRA
13635,GO:0060180,0.311801504709975,0.962094006134129,1,3,female mating behavior,BP,THRA
16906,GO:0098915,0.311890424864806,0.962070427492382,1,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,KCNJ5
14624,GO:0070243,0.312003726796994,0.905789807433014,2,11,regulation of thymocyte apoptotic process,BP,BMP4;TP53
5402,GO:0016248,0.312447715671781,0.854085190866893,4,26,channel inhibitor activity,MF,WNK1;CAV1;CAMK2D;RASA1
7184,GO:0031084,0.312469707786266,0.961916608743626,1,3,BLOC-2 complex,CC,HPS3
15627,GO:0072174,0.312470880504128,0.961916296974692,1,3,metanephric tubule formation,BP,SOX9
18855,GO:1904562,0.312513468121087,0.970831131181569,1,2,phosphatidylinositol 5-phosphate metabolic process,BP,PIKFYVE
4961,GO:0015074,0.312518433815231,0.906773744134409,2,10,DNA integration,BP,NYNRIN;KRBA2
16798,GO:0098719,0.31251894900489,0.9083267990414,2,9,sodium ion import across plasma membrane,BP,SLC8A1;SLC9A4
2655,GO:0006001,0.312698322832305,0.957526508313952,1,4,fructose catabolic process,BP,TKFC
14354,GO:0061624,0.312698322832305,0.957526508313952,1,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,TKFC
2053,GO:0004806,0.312726498957186,0.905419529485543,2,11,triglyceride lipase activity,MF,CES2;CES3
12375,GO:0048840,0.312744470426667,0.961843521373842,1,3,otolith development,BP,LRIG3
8600,GO:0034128,0.312984175521872,0.961779691632391,1,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TLR3
12503,GO:0050671,0.31303413882813,0.809155388412627,8,69,positive regulation of lymphocyte proliferation,BP,TGFBR2;IRS2;VAV3;PYCARD;IL18;CD1D;BCL6;IGFBP2
8504,GO:0033743,0.313217843939051,0.957373276607332,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
8565,GO:0034061,0.31376680356007,0.83811037133076,5,34,DNA polymerase activity,MF,TEP1;PRIMPOL;HMBOX1;POLD4;POLH
9324,GO:0035844,0.313835287877047,0.961552543189391,1,3,cloaca development,BP,BMP4
6601,GO:0022821,0.313918078977719,0.907626989154392,2,9,potassium ion antiporter activity,MF,SLC24A1;SLC9A4
4799,GO:0010998,0.314044899822812,0.905998881758343,2,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,EIF2AK4;DNAJC3
845,GO:0002162,0.314060389702814,0.912211312481342,2,7,dystroglycan binding,MF,MAP2;AGRN
14966,GO:0070914,0.314203312850248,0.904660825264287,2,11,UV-damage excision repair,BP,XPC;DDB2
17746,GO:1901800,0.314439912577785,0.792030291418683,11,91,positive regulation of proteasomal protein catabolic process,BP,PRICKLE1;CAV1;TRIB2;CLU;HERPUD1;MDM2;GCLC;NUB1;RNF144B;TAF1;EDEM1
6673,GO:0030046,0.314469375709894,0.961382796799447,1,3,parallel actin filament bundle assembly,BP,ESPN
6531,GO:0021942,0.314469771944474,0.961382690588156,1,3,radial glia guided migration of Purkinje cell,BP,RBFOX2
13778,GO:0060396,0.314486350393971,0.87515458492015,3,16,growth hormone receptor signaling pathway,BP,PXN;PIK3R1;PTPN1
12789,GO:0051121,0.31475224678574,0.956918817063319,1,4,hepoxilin metabolic process,BP,ALOX15B
12790,GO:0051122,0.31475224678574,0.956918817063319,1,4,hepoxilin biosynthetic process,BP,ALOX15B
17147,GO:0102991,0.31486532250343,0.954294724023309,1,5,myristoyl-CoA hydrolase activity,MF,ACOT1
15964,GO:0086003,0.314912769138278,0.838936770493295,5,29,cardiac muscle cell contraction,BP,GJA5;CAV1;CAMK2D;KCNJ5;PDE4D
3083,GO:0006659,0.315062912931893,0.956826459603876,1,4,phosphatidylserine biosynthetic process,BP,SLC27A1
7254,GO:0031233,0.315075567862114,0.903174981406374,2,12,intrinsic component of external side of plasma membrane,CC,PRNP;EFNA5
7168,GO:0031061,0.31511763678259,0.874770379760457,3,16,negative regulation of histone methylation,BP,JARID2;KDM4C;KDM4A
6307,GO:0019958,0.315128233842119,0.956807025680317,1,4,C-X-C chemokine binding,MF,CXCR1
19372,GO:1905907,0.315146156724461,0.956801692463883,1,4,negative regulation of amyloid fibril formation,BP,CLU
11363,GO:0045762,0.315576575514512,0.970196248952291,1,2,positive regulation of adenylate cyclase activity,BP,TIMP2
13857,GO:0060525,0.315899773060257,0.908651038702336,2,8,prostate glandular acinus development,BP,SFRP1;RXRA
10708,GO:0044085,0.315977193217821,0.709612793641911,266,2479,cellular component biogenesis,BP,FLOT1;FN1;FLRT2;ITGB5;CTGF;ITGA6;SFRP1;RHOBTB2;TLN2;XPC;SLITRK6;ITGB4;TENM4;ASAP3;GSN;GJA5;PKD2;SDK1;TNIK;COL7A1;CLTCL1;GAS6;PDGFC;SNAI2;HSPA2;FLRT3;SPTB;CEP126;MYLK;THBS2;RFX2;RNF213;KRT14;TCF7L1;S100A10;C1QTNF6;DDB2;AMIGO2;PLEC;PAK1;ABCA1;ANGPTL4;NSG1;NEFM;TNS1;AHNAK;NEFL;VAV3;SORL1;TP53;ARAP1;CEP250;WWTR1;DDIT3;CNTRL;PYCARD;KRT5;DLG4;ITGA2;PILRB;PDGFA;MAP2;ACSL3;EFEMP2;PHLDB1;HIP1;EVI5L;EMP1;TYSND1;TPBG;ANO6;LAMC2;DLG5;ASAP1;SRPX;SPG11;PDE4DIP;EML2;EMP3;FLNC;ARHGAP18;UGT8;LAMA3;CAV1;PLA2G6;SPATA6;DOCK11;ESPN;TNRC18;AHNAK2;CLU;NPHP4;PRKCZ;ULK2;TP53INP1;ARPIN;EHD3;HMGA2;CAMK2D;KANK2;HAUS4;PXN;CCK;PIK3R1;SYT1;CPT1A;ACACB;PCLO;ANG;KIF17;PARVA;LAMA5;BBS2;ANK3;LAMB3;TTN;CIRBP;HPS4;MLH3;TP73;CAT;DLC1;PRKACB;CHEK2;IFT140;STOM;PRX;FBXL7;SNCA;FLOT2;THSD4;GATAD1;VAMP1;COL16A1;DZIP1L;IGF1R;DKK1;FSCN1;SEC24D;RGS2;SETX;TGM2;OBSCN;TLE4;CCDC136;TRIOBP;CDH13;TRAF1;SEPT6;TGFBR3;FZD1;BBS4;CALR;ATM;MDM2;ARF6;TMED10;AREG;TCF4;BBS1;ANXA6;AKAP13;SNX10;DGKQ;FHOD3;LMO4;MSH5;SYNE2;FGD4;VANGL2;ARHGEF2;KLHL12;SSH1;SOX9;IFT27;NFASC;CRTC1;NCOR1;PRKCA;TMEM175;ANXA2;RAB13;MPP7;SEPT5;BAHCC1;IFT88;GOLGA8B;TTC8;KCTD7;RPL13A;PODXL;DECR1;NLGN4Y;STK36;WDR19;PRNP;CDH11;ODF2;IFT122;LEF1;THRA;SSBP3;CDC42EP5;LRRN3;MSRB2;CDKN2A;ULK1;TSPYL2;AGRN;NPHP3;VAV2;TSPYL4;MAGI2;CELF2;GOPC;MAGI1;CENPA;PIKFYVE;SRPK2;UVRAG;CFAP54;FHOD1;IFT74;OPHN1;TPGS1;KCTD14;MYO9A;YAP1;DNAH1;KLF5;COL17A1;GOLGA8N;SRR;CAPG;MEF2A;SNX9;ICK;OBSL1;ARL3;MIA3;TMEM67;TAF1;EFNA5;SLITRK5;WIPF1;ZBTB1;SBF2;RASA1;LIMA1;HP1BP3;COX18;DNM1P46;SEPT9;AGO4;MYH11;VPS36;TTBK2;KCNRG;BSN;OXTR;RHOBTB3;PSMG4;ATG16L2;TSPAN4;MYO1C;RXRA
9221,GO:0035630,0.315981124774912,0.960976309963003,1,3,bone mineralization involved in bone maturation,BP,ANO6
12211,GO:0048496,0.316011539256731,0.960968106057193,1,3,maintenance of animal organ identity,BP,NPHP3
15848,GO:0072604,0.316034958568234,0.872131014886511,3,19,interleukin-6 secretion,BP,F2R;GAS6;PYCARD
19961,GO:2000576,0.316161001740764,0.953886789351389,1,5,positive regulation of microtubule motor activity,BP,DNAL4
9752,GO:0039534,0.316233029360545,0.95647755470781,1,4,negative regulation of MDA-5 signaling pathway,BP,TKFC
17075,GO:0099738,0.316374539016146,0.838310076960083,5,28,cell cortex region,CC,PKD2;PHLDB1;PRKCZ;PCLO;BSN
11541,GO:0046110,0.31648130398103,0.960841263273321,1,3,xanthine metabolic process,BP,XDH
7722,GO:0032228,0.316500946430425,0.874828387128632,3,15,regulation of synaptic transmission, GABAergic,BP,NISCH;HTR1B;OXTR
7194,GO:0031094,0.316917884078064,0.910837090315059,2,7,platelet dense tubular network,CC,F2R;ITPR2
17623,GO:1901387,0.316929687496919,0.960719965901329,1,3,positive regulation of voltage-gated calcium channel activity,BP,EHD3
20038,GO:2000698,0.316946292900317,0.956264064490932,1,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
13324,GO:0052428,0.316968935441497,0.956257277193583,1,4,modulation by host of symbiont molecular function,BP,ANXA2
16090,GO:0090107,0.317294708760745,0.960621055379002,1,3,regulation of high-density lipoprotein particle assembly,BP,ABCA1
6157,GO:0019511,0.317301667621675,0.903059764451256,2,11,peptidyl-proline hydroxylation,BP,CRTAP;P3H2
14673,GO:0070327,0.317357225452512,0.960604100298494,1,3,thyroid hormone transport,BP,ABCC2
1225,GO:0002903,0.317384998584671,0.901968989200503,2,12,negative regulation of B cell apoptotic process,BP,IRS2;BCL6
2426,GO:0005608,0.317508978755928,0.969791468062702,1,2,laminin-3 complex,CC,LAMB2
15232,GO:0071435,0.317565291487199,0.960547639738213,1,3,potassium ion export,BP,ANO6
18797,GO:1904398,0.317569678765715,0.96977869967406,1,2,positive regulation of neuromuscular junction development,BP,AGRN
10386,GO:0043243,0.317614965116779,0.851970032221363,4,23,positive regulation of protein complex disassembly,BP,SEMA5A;IGF1R;SETX;UVRAG
6685,GO:0030070,0.317923590941564,0.96045029947005,1,3,insulin processing,BP,ERO1B
13712,GO:0060313,0.31800215151942,0.960428937645338,1,3,negative regulation of blood vessel remodeling,BP,CST3
19687,GO:2000052,0.318016681960553,0.903968486712378,2,10,positive regulation of non-canonical Wnt signaling pathway,BP,SFRP1;DKK1
7387,GO:0031461,0.318242256988902,0.765190164987401,19,157,cullin-RING ubiquitin ligase complex,CC,SKP2;DDB2;ABTB1;BTBD2;CUL9;CUL7;DCAF16;FBXW4;FBXL7;IPP;FBXO17;FBXW8;KLHL12;ANAPC16;KLHL5;KLHL3;ZYG11B;DCAF8;KLHL22
14190,GO:0061156,0.318365018902275,0.960330179528804,1,3,pulmonary artery morphogenesis,BP,BMP4
6713,GO:0030132,0.318402702833161,0.871972597173705,3,17,clathrin coat of coated pit,CC,EGFR;HIP1;TBC1D5
7721,GO:0032227,0.31869773432285,0.960239499048707,1,3,negative regulation of synaptic transmission, dopaminergic,BP,SNCA
7159,GO:0031050,0.319134781815937,0.822787691874497,6,41,dsRNA fragmentation,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPP3CA;AGO4
14968,GO:0070918,0.319134781815937,0.822787691874497,6,41,production of small RNA involved in gene silencing by RNA,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPP3CA;AGO4
5269,GO:0015924,0.319300146366742,0.90491137819446,2,9,mannosyl-oligosaccharide mannosidase activity,MF,MAN1A1;EDEM1
6511,GO:0021895,0.319395440959936,0.903258839031853,2,10,cerebral cortex neuron differentiation,BP,DLX2;OPHN1
9685,GO:0038107,0.319537251508067,0.960010144331835,1,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,CITED2
17342,GO:1900094,0.319537251508067,0.960010144331835,1,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,CITED2
17393,GO:1900164,0.319537251508067,0.960010144331835,1,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,CITED2
7149,GO:0031022,0.319582338256722,0.969353479698816,1,2,nuclear migration along microfilament,BP,SYNE2
16380,GO:0097038,0.319594820592106,0.903156012483161,2,10,perinuclear endoplasmic reticulum,CC,PIK3R1;ADAM10
16546,GO:0097368,0.319658234244243,0.959977027390151,1,3,establishment of Sertoli cell barrier,BP,RAB13
9643,GO:0038007,0.31970454649111,0.959964345895959,1,3,netrin-activated signaling pathway,BP,UNC5B
1970,GO:0004687,0.319871940492421,0.969291998180348,1,2,myosin light chain kinase activity,MF,MYLK
12671,GO:0050916,0.319905861790259,0.959909192783858,1,3,sensory perception of sweet taste,BP,REEP2
15530,GO:0072007,0.319996200922183,0.959884428451938,1,3,mesangial cell differentiation,BP,ACTA2
15531,GO:0072008,0.319996200922183,0.959884428451938,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15613,GO:0072143,0.319996200922183,0.959884428451938,1,3,mesangial cell development,BP,ACTA2
15614,GO:0072144,0.319996200922183,0.959884428451938,1,3,glomerular mesangial cell development,BP,ACTA2
18731,GO:1904238,0.319996200922183,0.959884428451938,1,3,pericyte cell differentiation,BP,ACTA2
6965,GO:0030638,0.320039067616132,0.952653134389348,1,5,polyketide metabolic process,BP,AKR7A2
6969,GO:0030647,0.320039067616132,0.952653134389348,1,5,aminoglycoside antibiotic metabolic process,BP,AKR7A2
10918,GO:0044597,0.320039067616132,0.952653134389348,1,5,daunorubicin metabolic process,BP,AKR7A2
10919,GO:0044598,0.320039067616132,0.952653134389348,1,5,doxorubicin metabolic process,BP,AKR7A2
4219,GO:0009397,0.32026798715045,0.959809869855332,1,3,folic acid-containing compound catabolic process,BP,ALDH1L2
10048,GO:0042560,0.32026798715045,0.959809869855332,1,3,pteridine-containing compound catabolic process,BP,ALDH1L2
1711,GO:0004305,0.320440197212214,0.955209400208757,1,4,ethanolamine kinase activity,MF,ETNK2
2754,GO:0006167,0.320600752320492,0.952472875621478,1,5,AMP biosynthetic process,BP,PRPS2
8586,GO:0034111,0.320622095329696,0.901329943764771,2,11,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2;ABAT
1231,GO:0002920,0.320736277179526,0.868161372015204,3,21,regulation of humoral immune response,BP,CLU;SERPING1;C5
7463,GO:0031638,0.32080286849855,0.846771448840125,4,31,zymogen activation,BP,SERPINE2;SERPINE1;PYCARD;PLGRKT
17554,GO:1901203,0.320953573375435,0.906137366182758,2,8,positive regulation of extracellular matrix assembly,BP,PHLDB1;SOX9
1571,GO:0003980,0.321004525575199,0.96905083636368,1,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,UGGT2
16539,GO:0097359,0.321004525575199,0.96905083636368,1,2,UDP-glucosylation,BP,UGGT2
8266,GO:0033083,0.32106456953288,0.955019368906448,1,4,regulation of immature T cell proliferation,BP,BMP4
8863,GO:0034686,0.321270376439614,0.968994062687695,1,2,integrin alphav-beta8 complex,CC,ITGB8
9337,GO:0035866,0.321270376439614,0.968994062687695,1,2,alphav-beta3 integrin-PKCalpha complex,CC,PRKCA
19508,GO:1990430,0.321270376439614,0.968994062687695,1,2,extracellular matrix protein binding,MF,ITGB8
19389,GO:1905953,0.32129211978031,0.848984811655298,4,24,negative regulation of lipid localization,BP,IRS2;ABCA1;PLA2R1;PPARG
12173,GO:0048365,0.321479311370719,0.804496925084945,8,53,Rac GTPase binding,MF,PAK1;SRGAP3;VAV3;DOCK4;CAV1;SRGAP1;ARHGEF2;PAK6
3334,GO:0007050,0.321501093019323,0.752154625170594,25,215,cell cycle arrest,BP,CDKN2B;APBB2;PKD2;GAS6;EIF2AK4;TP53;DDIT3;TFDP2;E2F7;TP53INP1;HMGA2;UHRF2;TP73;CHEK2;PRKAB2;CALR;ATM;MDM2;PRNP;TGFB2;RBL2;CDKN2A;MAGI2;ING4;PRKAG1
1290,GO:0003104,0.321624134193391,0.954848659293293,1,4,positive regulation of glomerular filtration,BP,GAS6
19419,GO:1990086,0.321687093471995,0.959419230451295,1,3,lens fiber cell apoptotic process,BP,TGFBR2
6414,GO:0021684,0.322048637616397,0.959319348042082,1,3,cerebellar granular layer formation,BP,OPHN1
6429,GO:0021707,0.322048637616397,0.959319348042082,1,3,cerebellar granule cell differentiation,BP,OPHN1
3458,GO:0007274,0.322061440911881,0.903503528210156,2,9,neuromuscular synaptic transmission,BP,ETV5;ADARB1
604,GO:0001773,0.322182076251724,0.898546740851545,2,13,myeloid dendritic cell activation,BP,TGFBR2;PYCARD
12819,GO:0051156,0.322284720813742,0.866737009892919,3,22,glucose 6-phosphate metabolic process,BP,H6PD;G6PD;G6PC3
7015,GO:0030799,0.32257198946087,0.820218686901974,6,41,regulation of cyclic nucleotide metabolic process,BP,PKD2;NOS1;TIMP2;PDE4D;GPR161;NPHP3
10143,GO:0042747,0.322628737064278,0.954541222394233,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
9197,GO:0035601,0.322812736798702,0.777747384830277,13,99,protein deacylation,BP,PHF21A;TADA3;TP53;CHD3;SDR16C5;CAMK2D;PER1;HDAC11;BCL6;SAP30L;BEX4;NIPBL;PRDM5
15568,GO:0072079,0.322833669899048,0.89909575551381,2,12,nephron tubule formation,BP,SOX9;GDNF
3143,GO:0006741,0.322860287787535,0.954470186822552,1,4,NADP biosynthetic process,BP,IDH2
2514,GO:0005770,0.323052898165215,0.755280462443599,22,190,late endosome,CC,F2R;CLTCL1;EGFR;NSG1;DDIT3;DYSF;BACE1;ASTN2;LAPTM4A;CST3;ANXA6;ANXA2;MVB12B;NMNAT2;VPS39;OSBPL1A;MAGI2;PIKFYVE;UVRAG;VPS36;LITAF;ABCA5
3075,GO:0006646,0.32320439880671,0.899974624099892,2,11,phosphatidylethanolamine biosynthetic process,BP,SLC27A1;ETNK2
9908,GO:0042272,0.323211358904234,0.968577640350593,1,2,nuclear RNA export factor complex,CC,ATXN1
19817,GO:2000312,0.323303874779698,0.958971432520709,1,3,regulation of kainate selective glutamate receptor activity,BP,NETO1
20057,GO:2000737,0.323454119735083,0.86965106400191,3,16,negative regulation of stem cell differentiation,BP,ZFP36L2;PRICKLE1;YAP1
19339,GO:1905793,0.323525830069749,0.968509855112514,1,2,protein localization to pericentriolar material,BP,GOLGB1
12959,GO:0051389,0.323611196785269,0.968491438723893,1,2,inactivation of MAPKK activity,BP,IGF1R
9091,GO:0035384,0.323730528213393,0.818924232241724,6,43,thioester biosynthetic process,BP,ACSL3;ACSS1;ACACB;SNCA;PDK3;ACSS2
15344,GO:0071616,0.323730528213393,0.818924232241724,6,43,acyl-CoA biosynthetic process,BP,ACSL3;ACSS1;ACACB;SNCA;PDK3;ACSS2
5162,GO:0015712,0.323886108570621,0.954154696132616,1,4,hexose phosphate transport,BP,G6PC3
5182,GO:0015760,0.323886108570621,0.954154696132616,1,4,glucose-6-phosphate transport,BP,G6PC3
17286,GO:0140192,0.323920428907935,0.968424672431881,1,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
14213,GO:0061218,0.323951619186977,0.954134504691955,1,4,negative regulation of mesonephros development,BP,BMP4
12277,GO:0048639,0.324022800587172,0.7709391696187,15,104,positive regulation of developmental growth,BP,FN1;TGFBR2;PAK1;SEMA5A;SYT1;ACACB;BBS2;FGFR1;TGFBR3;BBS4;MEGF8;AGRN;YAP1;EFNA5;NIPBL
18656,GO:1904029,0.324253351362545,0.794155862469949,9,75,regulation of cyclin-dependent protein kinase activity,BP,CDKN2B;PKD2;HERC5;EGFR;NR2F2;CDKN2A;CCNY;CDK5RAP3;CAMK2N1
6484,GO:0021846,0.324337041861433,0.871113037962823,3,14,cell proliferation in forebrain,BP,GLI3;FGFR1;DIXDC1
19883,GO:2000402,0.324412256861258,0.958662751933315,1,3,negative regulation of lymphocyte migration,BP,GCSAM
15548,GO:0072044,0.324437200046277,0.904385532237265,2,8,collecting duct development,BP,BMP4;DLG5
6820,GO:0030291,0.324538892899,0.844486743662659,4,30,protein serine/threonine kinase inhibitor activity,MF,CDKN2B;WNK1;SPRY2;CDKN2A
12344,GO:0048752,0.324891609670411,0.958528826249684,1,3,semicircular canal morphogenesis,BP,HOXA1
4892,GO:0014824,0.325002299511336,0.953809950381679,1,4,artery smooth muscle contraction,BP,BBS2
5679,GO:0016801,0.325143919652395,0.8969589257741,2,13,hydrolase activity, acting on ether bonds,MF,AKR7A2;RNPEP
2709,GO:0006085,0.325156690344587,0.867070725203027,3,18,acetyl-CoA biosynthetic process,BP,ACSS1;PDK3;ACSS2
11195,GO:0045349,0.325204344134266,0.953747383983535,1,4,interferon-alpha biosynthetic process,BP,TLR3
11200,GO:0045354,0.325204344134266,0.953747383983535,1,4,regulation of interferon-alpha biosynthetic process,BP,TLR3
5915,GO:0018196,0.325299363089209,0.828596333779569,5,39,peptidyl-asparagine modification,BP,ST6GALNAC2;ST6GAL2;DERL3;UGGT2;TUSC3
8306,GO:0033157,0.325310439939941,0.748869773994896,25,210,regulation of intracellular protein transport,BP,GAS6;TCAF1;PAK1;BMP4;SORL1;TP53;GLI3;FYN;B3GAT3;PTPN14;HHAT;TMEM173;ANK3;HPS4;STOM;SH3TC2;MDM2;PTPN1;PRNP;SP100;MDFIC;DERL3;MYO1C;C2CD5;EDEM1
15394,GO:0071695,0.325399850553909,0.775773787935887,13,96,anatomical structure maturation,BP,MMP2;FAT4;FAM210B;DDIT3;ANO6;PLXNB1;ANG;G6PD;L3MBTL3;NFASC;RET;TGFB2;AGRN
12888,GO:0051261,0.325663139896869,0.78413133710572,11,75,protein depolymerization,BP,GSN;SPTB;STMN3;SEMA5A;MICAL1;TRIOBP;DNAJC6;ARHGEF2;CAPG;LIMA1;TTBK2
7424,GO:0031544,0.325699853680324,0.953593729540374,1,4,peptidyl-proline 3-dioxygenase activity,MF,P3H2
4510,GO:0010565,0.325820744755919,0.771032789440456,14,123,regulation of cellular ketone metabolic process,BP,NQO1;IRS2;NR1D1;TYSND1;CAV1;CPT1A;ACACB;SNCA;PRKAB2;PSMB9;PDK3;DGKQ;EGR1;PPARG
5061,GO:0015280,0.325921705701489,0.958240154177833,1,3,ligand-gated sodium channel activity,MF,SCNN1A
4891,GO:0014823,0.325985638955472,0.817655708471542,6,41,response to activity,BP,ITGA2;TNS2;CAT;GCLC;TH;POSTN
8188,GO:0032946,0.326003125635621,0.798834020744765,8,70,positive regulation of mononuclear cell proliferation,BP,TGFBR2;IRS2;VAV3;PYCARD;IL18;CD1D;BCL6;IGFBP2
5924,GO:0018208,0.326138095523343,0.827398247670575,5,42,peptidyl-proline modification,BP,FKBP5;CRTAP;P3H2;FKBP9;FKBP10
12033,GO:0048003,0.326357984894145,0.958117531666151,1,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,CD1D
12035,GO:0048007,0.326357984894145,0.958117531666151,1,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,CD1D
9064,GO:0035332,0.326390616869558,0.967888243034636,1,2,positive regulation of hippo signaling,BP,DLG5
7082,GO:0030888,0.32639365700497,0.828752756890782,5,35,regulation of B cell proliferation,BP,INPP5D;IRS2;VAV3;ATM;BCL6
12849,GO:0051204,0.326491257004532,0.842576303008102,4,32,protein insertion into mitochondrial membrane,BP,TP53;TFDP2;TP73;COX18
2247,GO:0005161,0.32651031098441,0.899557228856665,2,10,platelet-derived growth factor receptor binding,MF,PDGFC;PDGFA
12742,GO:0051044,0.326790125585746,0.896984771959006,2,12,positive regulation of membrane protein ectodomain proteolysis,BP,SNX33;SNX9
4639,GO:0010766,0.326821643598196,0.899393736284633,2,10,negative regulation of sodium ion transport,BP,SERPINE2;CAMK2D
15410,GO:0071723,0.32682738750844,0.957985359478674,1,3,lipopeptide binding,MF,CD1D
7137,GO:0030997,0.327116256481047,0.957903897423914,1,3,regulation of centriole-centriole cohesion,BP,CEP250
12731,GO:0051026,0.327410814057284,0.953060853837829,1,4,chiasma assembly,BP,MSH5
4714,GO:0010881,0.327459630139412,0.897722074040359,2,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,SLC8A1;CAMK2D
4980,GO:0015111,0.327563947870155,0.957777460549576,1,3,iodide transmembrane transporter activity,MF,ANO1
13889,GO:0060575,0.327736777011903,0.896476602458458,2,12,intestinal epithelial cell differentiation,BP,PTK6;KLF5
4034,GO:0009070,0.327762109241183,0.894767692607103,2,14,serine family amino acid biosynthetic process,BP,PHGDH;SRR
6702,GO:0030120,0.32798383306075,0.806092230401484,7,52,vesicle coat,CC,CLTCL1;EGFR;HIP1;TBC1D5;SEC24D;COPG2;KLHL12
6980,GO:0030669,0.328173671132345,0.843818363571267,4,25,clathrin-coated endocytic vesicle membrane,CC,EGFR;HIP1;TBC1D5;FZD4
15463,GO:0071865,0.32819184202581,0.952816407003793,1,4,regulation of apoptotic process in bone marrow,BP,LEF1
15464,GO:0071866,0.32819184202581,0.952816407003793,1,4,negative regulation of apoptotic process in bone marrow,BP,LEF1
65,GO:0000132,0.328229064890994,0.865138239342406,3,18,establishment of mitotic spindle orientation,BP,SPRY2;ARHGEF2;CENPA
8006,GO:0032650,0.32827188009163,0.949970697250717,1,5,regulation of interleukin-1 alpha production,BP,ISL1
1384,GO:0003289,0.328313626262047,0.957565228826892,1,3,atrial septum primum morphogenesis,BP,TGFB2
1050,GO:0002579,0.328576071177349,0.952695874772493,1,4,positive regulation of antigen processing and presentation,BP,PYCARD
16014,GO:0086075,0.328660594535011,0.957466787684196,1,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,GJA5
9971,GO:0042398,0.328684637232732,0.840796227678533,4,33,cellular modified amino acid biosynthetic process,BP,SLC27A1;GCLC;GGT7;ALDH7A1
12516,GO:0050689,0.32870493412246,0.949827190977823,1,5,negative regulation of defense response to virus by host,BP,IFIT1
15476,GO:0071879,0.328720259621086,0.957449845876945,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
16585,GO:0097454,0.328866946955426,0.957408177080239,1,3,Schwann cell microvillus,CC,NFASC
20100,GO:2000810,0.329079270849286,0.865324877926986,3,17,regulation of bicellular tight junction assembly,BP,SNAI2;NPHP4;MYO1C
1801,GO:0004448,0.329093911392096,0.949698084717485,1,5,isocitrate dehydrogenase activity,MF,IDH2
15504,GO:0071930,0.329363270896703,0.957267007618701,1,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,E2F7
1123,GO:0002713,0.32955878174241,0.952386770903918,1,4,negative regulation of B cell mediated immunity,BP,BCL6
1219,GO:0002890,0.32955878174241,0.952386770903918,1,4,negative regulation of immunoglobulin mediated immune response,BP,BCL6
9208,GO:0035612,0.329586377768386,0.901767428558608,2,8,AP-2 adaptor complex binding,MF,HIP1;TBC1D5
7432,GO:0031573,0.329655156924713,0.894518050423693,2,13,intra-S DNA damage checkpoint,BP,XPC;CHEK2
16740,GO:0098574,0.329726637024494,0.952333854086663,1,4,cytoplasmic side of lysosomal membrane,CC,LITAF
14947,GO:0070885,0.329926828350055,0.957106375891812,1,3,negative regulation of calcineurin-NFAT signaling cascade,BP,PRNP
17178,GO:0106057,0.329926828350055,0.957106375891812,1,3,negative regulation of calcineurin-mediated signaling,BP,PRNP
12714,GO:0051006,0.329967309535285,0.952257920679549,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14255,GO:0061365,0.329967309535285,0.952257920679549,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
14950,GO:0070888,0.330113416656866,0.863947276465587,3,18,E-box binding,MF,PER1;TCF4;TCF12
2720,GO:0006102,0.330244338461992,0.94931510049775,1,5,isocitrate metabolic process,BP,IDH2
8193,GO:0032958,0.330316842130076,0.864545275813791,3,17,inositol phosphate biosynthetic process,BP,NTSR1;SNCA;ITPKB
724,GO:0001954,0.330324279327984,0.815128357376367,6,38,positive regulation of cell-matrix adhesion,BP,SFRP1;UTRN;S100A10;PRKCZ;COL16A1;CDH13
2587,GO:0005884,0.330367944283486,0.784583253884305,10,73,actin filament,CC,PKD2;PAK1;FYN;ESPN;PRKCZ;SHROOM4;FSCN1;AKAP13;WIPF1;MYO1C
1240,GO:0002934,0.330396593003576,0.899193582422423,2,9,desmosome organization,BP,SNAI2;PRKCA
17908,GO:1902262,0.330430672359924,0.952111525607605,1,4,apoptotic process involved in blood vessel morphogenesis,BP,LEF1
4864,GO:0014722,0.33051663216607,0.952084338211062,1,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,DMPK
10285,GO:0043073,0.331236957716294,0.894587333584636,2,12,germ cell nucleus,CC,HSPA2;MLH3
9808,GO:0042043,0.331347199929228,0.897002788403051,2,10,neurexin family protein binding,MF,SYTL1;NLGN4Y
15214,GO:0071402,0.331348358137146,0.863164395052497,3,18,cellular response to lipoprotein particle stimulus,BP,ABCA1;CDH13;PPARG
1022,GO:0002524,0.331375958223673,0.951812047264895,1,4,hypersensitivity,BP,IL20RB
11127,GO:0045198,0.331483774197044,0.896930213754843,2,10,establishment of epithelial cell apical/basal polarity,BP,OPHN1;MYO9A
13471,GO:0055065,0.331536444097682,0.729981827805356,38,323,metal ion homeostasis,BP,F2R;SLC7A8;PKD2;JPH2;CYBRD1;NOS1;EGFR;SLC8A1;NTSR1;VDR;NEO1;KCNMA1;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;HERPUD1;ANK3;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;FAM20A;ANXA6;KCTD7;PRNP;SCNN1A;SFXN3;ITPR2;SV2A;STEAP2;OXTR;DMPK
16803,GO:0098732,0.33159292780051,0.770285598062956,13,100,macromolecule deacylation,BP,PHF21A;TADA3;TP53;CHD3;SDR16C5;CAMK2D;PER1;HDAC11;BCL6;SAP30L;BEX4;NIPBL;PRDM5
6455,GO:0021783,0.3316157866137,0.896860039854018,2,10,preganglionic parasympathetic fiber development,BP,ADARB1;NAV2
6214,GO:0019752,0.331972750358776,0.7121022022967,77,744,carboxylic acid metabolic process,BP,PRODH;NQO1;DDIT4;PTGS1;SLC7A8;IRS2;NOS1;SLC2A3;CRTAP;CSPG4;NR1D1;D2HGDH;SLC27A3;ACSL3;PHGDH;BCKDHB;TYSND1;GPX1;PTGES;ECH1;ERO1B;MTHFR;CPS1;CAV1;SLC27A1;HLCS;GLDC;UST;ACSS1;HIBADH;ALDH3A2;CPT1A;ACACB;CES2;AARS;BPHL;SNCA;ALDH1L2;CBR1;ALOX15B;PRKAB2;PSMB9;PDK3;DHTKD1;IDH2;GCLC;ACSS2;HEXA;ALDH4A1;THNSL2;SLC27A6;NCOR1;NMNAT2;DECR1;ABCC2;ACSF2;GGT7;DSEL;ZADH2;ALDH7A1;CYP4V2;OSBPL1A;TH;UGT1A3;UGT1A6;SRR;PPARG;PRKAG1;GSTZ1;DPYD;AIG1;ACOT1;SCPEP1;EHHADH;ABAT;CPT2;ACAA2
6666,GO:0030035,0.331990186060498,0.956515170632094,1,3,microspike assembly,BP,FSCN1
11843,GO:0046870,0.332156660973165,0.956467259740709,1,3,cadmium ion binding,MF,NOS1
934,GO:0002335,0.33220240652666,0.861973960479838,3,19,mature B cell differentiation,BP,LGALS1;DOCK11;ITM2A
4928,GO:0014891,0.332203348139674,0.951549010644134,1,4,striated muscle atrophy,BP,GSN
18215,GO:1903052,0.332323002333028,0.772964791944692,12,100,positive regulation of proteolysis involved in cellular protein catabolic process,BP,PRICKLE1;CAV1;TRIB2;CLU;HERPUD1;MAGEF1;MDM2;GCLC;NUB1;RNF144B;TAF1;EDEM1
14532,GO:0070086,0.332431726651879,0.951476256879206,1,4,ubiquitin-dependent endocytosis,BP,NEURL1B
12755,GO:0051057,0.332486455308969,0.825556677389236,5,31,positive regulation of small GTPase mediated signal transduction,BP,F2R;KITLG;ROBO1;AKAP13;ITPKB
10235,GO:0042989,0.332557508804251,0.946630704914893,1,6,sequestering of actin monomers,BP,GSN
6465,GO:0021801,0.33269110832762,0.863044357528768,3,17,cerebral cortex radial glia guided migration,BP,LAMB1;GLI3;SYNE2
6563,GO:0022030,0.33269110832762,0.863044357528768,3,17,telencephalon glial cell migration,BP,LAMB1;GLI3;SYNE2
15962,GO:0086001,0.332699190443224,0.813912663738202,6,36,cardiac muscle cell action potential,BP,GJA5;SLC8A1;CAV1;CAMK2D;ANK3;KCNJ5
6438,GO:0021761,0.332947011940155,0.788278162212919,9,64,limbic system development,BP,NEFL;PTPRS;GLI3;BBS2;FGFR1;BBS4;DLX2;LEF1;RARA
5651,GO:0016757,0.332982997645912,0.744714894887499,23,206,transferase activity, transferring glycosyl groups,MF,PYGB;ST6GALNAC2;GALNT10;EXTL2;B3GAT3;FUT10;UGT8;XYLT1;PARP4;ST6GAL2;GLT8D2;HEXA;POGLUT1;GCNT1;NAPRT;UGT1A3;UGT1A6;ALG10;GALNT2;PARP15;DNPH1;UGGT2;TUSC3
1119,GO:0002709,0.333222294003142,0.83787932568381,4,32,regulation of T cell mediated immunity,BP,IL20RB;PRKCZ;RSAD2;ZBTB1
8985,GO:0035136,0.333539246859934,0.840591963385424,4,24,forelimb morphogenesis,BP,RNF165;ZNF358;IFT122;NIPBL
3150,GO:0006751,0.333573373373674,0.948197187063785,1,5,glutathione catabolic process,BP,GGT7
18689,GO:1904152,0.333739283345954,0.893226670831278,2,12,regulation of retrograde protein transport, ER to cytosol,BP,DERL3;EDEM1
10151,GO:0042758,0.333952544653464,0.950990121320454,1,4,long-chain fatty acid catabolic process,BP,AIG1
20248,GO:2001241,0.334066665140267,0.893048036343244,2,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,SRPX;RET
10843,GO:0044381,0.334128519793646,0.863936717807679,3,15,glucose import in response to insulin stimulus,BP,PAK1;PIK3R1;C2CD5
20268,GO:2001273,0.334128519793646,0.863936717807679,3,15,regulation of glucose import in response to insulin stimulus,BP,PAK1;PIK3R1;C2CD5
10576,GO:0043567,0.334230886746126,0.895465187477653,2,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4;IGFBP2
10264,GO:0043031,0.334349532950862,0.950862748488114,1,4,negative regulation of macrophage activation,BP,IL31RA
3934,GO:0008625,0.334351778008173,0.792674117900534,8,65,extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1;SERPINE1;GPX1;PIK3R1;DAPK1;ARHGEF2;SP100;LGALS3
10979,GO:0044803,0.334362602217592,0.950858551902143,1,4,multi-organism membrane organization,BP,GAS6
9277,GO:0035733,0.334397260535661,0.950847421967296,1,4,hepatic stellate cell activation,BP,GCLC
11275,GO:0045616,0.334718090875795,0.82295144928834,5,34,regulation of keratinocyte differentiation,BP,CD109;ZFP36L1;VDR;CTSV;ALOX15B
8494,GO:0033687,0.335014291792513,0.860829373046117,3,18,osteoblast proliferation,BP,SFRP1;PLXNB1;ATRAID
4330,GO:0009886,0.33505572904984,0.89502335513802,2,10,post-embryonic animal morphogenesis,BP,FBN1;EFEMP1
759,GO:0002002,0.335090900504644,0.950624356095565,1,4,regulation of angiotensin levels in blood,BP,MME
760,GO:0002003,0.335090900504644,0.950624356095565,1,4,angiotensin maturation,BP,MME
10395,GO:0043255,0.335299092751703,0.79339594109545,8,54,regulation of carbohydrate biosynthetic process,BP,IRS2;NTSR1;NR1D1;SIK1;SNCA;DGKQ;ENPP1;LEPR
7317,GO:0031338,0.335445045326103,0.800962585625124,7,48,regulation of vesicle fusion,BP,TBC1D8;EVI5L;TBC1D5;SYT1;ANXA2;TBC1D16;C2CD5
15972,GO:0086011,0.335479859906649,0.893411314250538,2,11,membrane repolarization during action potential,BP,CAV1;KCNJ5
9182,GO:0035582,0.335482681561193,0.955503398912626,1,3,sequestering of BMP in extracellular matrix,BP,FBN1
6349,GO:0021536,0.335520613285556,0.822990822251507,5,32,diencephalon development,BP,BMP4;SEMA5A;GLI2;ISL1;LEF1
17679,GO:1901615,0.335568984627446,0.72693368684619,37,326,organic hydroxy compound metabolic process,BP,SULT1E1;INPP5D;SNAI2;ITPK1;TKFC;NTSR1;ABCA1;VDR;ISYNA1;NR1D1;SORL1;D2HGDH;SEC14L2;OSBPL5;ACSS1;SDR16C5;ALDH3A2;ACACB;CAT;PLCH2;SNCA;FGFR1;G6PD;LRTOMT;DGKQ;ACSS2;ITPKB;TRERF1;LEPR;TGFB2;CYP4V2;OSBPL1A;TH;LMF1;ABAT;RXRA;ACAA2
1759,GO:0004364,0.33557841448911,0.888185457171208,2,18,glutathione transferase activity,MF,PTGES;GSTZ1
2619,GO:0005942,0.335608833577165,0.862034593416957,3,16,phosphatidylinositol 3-kinase complex,CC,PIK3C2G;PIK3R1;PIK3C2B
16074,GO:0090084,0.335835134276316,0.894605034486994,2,10,negative regulation of inclusion body assembly,BP,HSPA2;SORL1
17905,GO:1902259,0.335880503449633,0.894580659285256,2,10,regulation of delayed rectifier potassium channel activity,BP,ANK3;KCNRG
12182,GO:0048384,0.335896085764849,0.858497719753266,3,21,retinoic acid receptor signaling pathway,BP,CALR;RARA;RXRA
13938,GO:0060674,0.336081483703578,0.837901031568919,4,26,placenta blood vessel development,BP,PKD2;NR2F2;FBXW8;ITGB8
9270,GO:0035726,0.336300698543602,0.950233862279801,1,4,common myeloid progenitor cell proliferation,BP,ITPKB
17499,GO:1901016,0.336306858471894,0.822763029789126,5,31,regulation of potassium ion transmembrane transporter activity,BP,NETO1;CAV1;ANK3;FHL1;KCNRG
15987,GO:0086028,0.336324603137355,0.950226128011155,1,4,bundle of His cell to Purkinje myocyte signaling,BP,GJA5
15994,GO:0086043,0.336324603137355,0.950226128011155,1,4,bundle of His cell action potential,BP,GJA5
10413,GO:0043280,0.336478222779051,0.768969263882833,12,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CTGF;F2R;GSN;PYCARD;HIP1;XDH;CCK;DAPK1;DLC1;ROBO1;SNCA;PPARG
7921,GO:0032509,0.336522347407722,0.858618833276267,3,20,endosome transport via multivesicular body sorting pathway,BP,LYST;TMEM50B;VPS36
404,GO:0001085,0.336669142708033,0.762648011529176,14,106,RNA polymerase II transcription factor binding,MF,TP53;MEF2D;BBS2;BBS4;TCF4;BBS1;ISL1;NCOR1;TTC8;ZFPM1;RBL2;MEF2A;TAF1;FOS
18283,GO:1903232,0.336672889400322,0.947143385051995,1,5,melanosome assembly,BP,HPS4
6657,GO:0030020,0.33702053082994,0.955053446865929,1,3,extracellular matrix structural constituent conferring tensile strength,MF,COL12A1
19866,GO:2000379,0.337041543797142,0.798565301677112,7,55,positive regulation of reactive oxygen species metabolic process,BP,TGFBR2;PKD2;EGFR;TP53;XDH;CLU;SNCA
8630,GO:0034188,0.337073030058427,0.965504537261076,1,2,apolipoprotein A-I receptor activity,MF,ABCA1
16301,GO:0090554,0.337073030058427,0.965504537261076,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA1
16302,GO:0090556,0.337073030058427,0.965504537261076,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA1
19237,GO:1905446,0.337123698698735,0.946989069206774,1,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,SNCA
11316,GO:0045663,0.337145490485468,0.893899930547581,2,10,positive regulation of myoblast differentiation,BP,BTG1;BOC
19044,GO:1904951,0.337178121919495,0.724724573619971,38,331,positive regulation of establishment of protein localization,BP,F2R;ANO1;IRS2;GAS6;TCAF1;EGFR;PAK1;SORL1;TP53;PYCARD;ACSL3;TFDP2;GLI3;LRP1;FYN;B3GAT3;PLA2G6;PRKCZ;HHAT;TMEM173;ANG;ANK3;TTN;HPS4;TP73;STOM;ALOX15B;C5;LRTOMT;MDM2;ISL1;PRNP;TGFB2;POSTN;ABAT;MYO1C;C2CD5;EDEM1
15521,GO:0071985,0.337197592841956,0.836335249135841,4,28,multivesicular body sorting pathway,BP,LYST;TMEM50B;UVRAG;VPS36
16443,GO:0097155,0.337238604330387,0.965466765479612,1,2,fasciculation of sensory neuron axon,BP,MEGF8
6717,GO:0030136,0.337324154009002,0.756009948206727,16,124,clathrin-coated vesicle,CC,CLTCL1;MALL;EGFR;STON2;HIP1;TBC1D5;LRP1;SYT1;ASTN2;TMED10;RAB13;GOPC;SNX9;RASSF9;FZD4;STEAP2
4926,GO:0014888,0.337340418233715,0.838485703952934,4,23,striated muscle adaptation,BP,GSN;LMNA;PPP3CA;KDM4A
3369,GO:0007141,0.337464106069687,0.891185788381806,2,12,male meiosis I,BP,HSPA2;MYBL1
2011,GO:0004740,0.337634621851577,0.954873011720366,1,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK3
16159,GO:0090209,0.337767761271476,0.949757872021281,1,4,negative regulation of triglyceride metabolic process,BP,SIK1
19680,GO:2000042,0.337909780728754,0.895230729760829,2,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1;CXORF57
2123,GO:0004920,0.337979626615075,0.949688909053656,1,4,interleukin-10 receptor activity,MF,IL20RB
16558,GO:0097396,0.33884563414367,0.949406434195391,1,4,response to interleukin-17,BP,IL17RE
16559,GO:0097398,0.33884563414367,0.949406434195391,1,4,cellular response to interleukin-17,BP,IL17RE
16560,GO:0097400,0.33884563414367,0.949406434195391,1,4,interleukin-17-mediated signaling pathway,BP,IL17RE
15847,GO:0072603,0.339065675028787,0.949334510942985,1,4,interleukin-5 secretion,BP,PRKCZ
20015,GO:2000662,0.339065675028787,0.949334510942985,1,4,regulation of interleukin-5 secretion,BP,PRKCZ
14920,GO:0070841,0.339463800672143,0.857973057923012,3,18,inclusion body assembly,BP,HSPA2;SORL1;CLU
10540,GO:0043518,0.33971904045983,0.889941264174372,2,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,SNAI2;MDM2
12804,GO:0051138,0.340224378323762,0.954107282856795,1,3,positive regulation of NK T cell differentiation,BP,TGFBR2
4029,GO:0009065,0.340293475854739,0.856175371147976,3,20,glutamine family amino acid catabolic process,BP,PRODH;NOS1;ALDH4A1
4834,GO:0014045,0.340313927129571,0.948925349834364,1,4,establishment of endothelial blood-brain barrier,BP,ENG
6555,GO:0022009,0.340313927129571,0.948925349834364,1,4,central nervous system vasculogenesis,BP,ENG
15195,GO:0071378,0.340327464942625,0.858170002939737,3,17,cellular response to growth hormone stimulus,BP,PXN;PIK3R1;PTPN1
931,GO:0002331,0.340485599748554,0.964720897729585,1,2,pre-B cell allelic exclusion,BP,ATM
14622,GO:0070236,0.340522728813779,0.948856715625723,1,4,negative regulation of activation-induced cell death of T cells,BP,TSC22D3
17050,GO:0099601,0.340544816939988,0.835223323638166,4,25,regulation of neurotransmitter receptor activity,BP,NETO1;DLG4;DAPK1;SHISA9
2536,GO:0005796,0.340694433638875,0.796656231679339,7,49,Golgi lumen,CC,GAS6;SDC3;CSPG4;MUC19;PDGFA;SDC2;AGRN
8419,GO:0033549,0.340697841937616,0.888428426463947,2,13,MAP kinase phosphatase activity,MF,DUSP6;DUSP5
8769,GO:0034465,0.340878392922127,0.94873968033558,1,4,response to carbon monoxide,BP,KCNMA1
730,GO:0001960,0.340969222818828,0.817279375957,5,38,negative regulation of cytokine-mediated signaling pathway,BP,GAS6;CAV1;SLIT3;ROBO1;PPARG
10500,GO:0043436,0.34098724115261,0.701873597061948,84,810,oxoacid metabolic process,BP,SULT1E1;PRODH;NQO1;DDIT4;PTGS1;SLC7A8;IRS2;NOS1;SLC2A3;CRTAP;CSPG4;NR1D1;D2HGDH;SLC27A3;ACSL3;PHGDH;BCKDHB;TYSND1;GPX1;PTGES;ECH1;ERO1B;MTHFR;ABHD14B;B3GAT3;CPS1;CAV1;SLC27A1;HLCS;GLDC;XYLT1;UST;ACSS1;CHST3;HIBADH;ALDH3A2;CPT1A;ACACB;CES2;AARS;BPHL;SNCA;ALDH1L2;CBR1;ALOX15B;PRKAB2;PSMB9;PDK3;DHTKD1;IDH2;GCLC;ACSS2;HEXA;ALDH4A1;THNSL2;ENPP1;SLC27A6;NCOR1;NMNAT2;DECR1;ABCC2;ACSF2;GGT7;DSEL;ZADH2;ALDH7A1;CYP4V2;OSBPL1A;TH;UGT1A3;UGT1A6;SRR;PPARG;TPST1;PRKAG1;GSTZ1;DPYD;AIG1;ACOT1;SCPEP1;EHHADH;ABAT;CPT2;ACAA2
8850,GO:0034666,0.341294877503865,0.953788491326805,1,3,integrin alpha2-beta1 complex,CC,ITGA2
18585,GO:1903895,0.341344065491072,0.948586204111256,1,4,negative regulation of IRE1-mediated unfolded protein response,BP,HSPA5
7017,GO:0030801,0.341413321845589,0.855446406032195,3,20,positive regulation of cyclic nucleotide metabolic process,BP,NOS1;TIMP2;GPR161
20261,GO:2001259,0.341455401959296,0.818973824591074,5,31,positive regulation of cation channel activity,BP,PKD2;JPH2;NTSR1;EHD3;ANK3
14540,GO:0070098,0.341494070411151,0.854374367751599,3,22,chemokine-mediated signaling pathway,BP,CXCR1;SLIT3;ROBO1
423,GO:0001129,0.341521378753689,0.953720869232396,1,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,TAF1
424,GO:0001132,0.341521378753689,0.953720869232396,1,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,TAF1
15777,GO:0072503,0.341811968876982,0.732780719609131,26,216,cellular divalent inorganic cation homeostasis,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;VDR;DDIT3;DLG4;FYN;CAV1;PLA2G6;CAMK2D;HERPUD1;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;ANXA6;PRNP;ITPR2;SV2A;OXTR;DMPK
2435,GO:0005638,0.341918274000685,0.94839657943072,1,4,lamin filament,CC,LMNA
4435,GO:0010314,0.341922716435333,0.891310018532968,2,10,phosphatidylinositol-5-phosphate binding,MF,JPH2;SAP30L
7878,GO:0032456,0.342006037726226,0.81756995838593,5,34,endocytic recycling,BP,SORL1;EHD3;ARF6;RAB13;EPG5
13488,GO:0055088,0.342110916254095,0.780230767044786,9,69,lipid homeostasis,BP,IRS2;MALL;ABCA1;ANGPTL4;VDR;CAV1;IL18;PPARG;ABCA2
12435,GO:0050265,0.342150703241868,0.953532670667847,1,3,RNA uridylyltransferase activity,MF,ZCCHC11
3082,GO:0006658,0.342173139581837,0.854413655501275,3,21,phosphatidylserine metabolic process,BP,OSBPL10;SLC27A1;OSBPL5
20242,GO:2001235,0.342226651166937,0.750730924249508,16,150,positive regulation of apoptotic signaling pathway,BP,MMP9;SFRP1;GSN;MAGED1;ITM2C;TP53;DDIT3;PYCARD;TFDP2;SRPX;CAV1;PLA2G6;TP53INP1;TP73;NFATC4;RET
66,GO:0000137,0.342329798300432,0.889661842881718,2,11,Golgi cis cisterna,CC,GOLGA8B;GOLGA8N
10498,GO:0043434,0.342500624136228,0.721626454298968,36,298,response to peptide hormone,BP,CTGF;FBN1;ZFP36L1;IRS2;SESN3;PAK1;NEFL;STAT1;GNG2;TIMP1;BTG1;FYN;CPS1;CAV1;SLC27A1;PRKCZ;PXN;PIK3R1;CAT;PRKACB;IGF1R;TGFBR3;MDM2;AREG;GCLC;PTPN1;EGR1;ENPP1;GCNT1;RAB13;ABCC2;TH;PPARG;OXTR;MYO1C;C2CD5
17680,GO:1901616,0.342581035561397,0.816078317885539,5,38,organic hydroxy compound catabolic process,BP,SULT1E1;TKFC;NTSR1;LRTOMT;TRERF1
14089,GO:0060976,0.34276629883857,0.818387139665963,5,30,coronary vasculature development,BP,BMP4;PRICKLE1;LTBP1;TGFBR3;MEGF8
6168,GO:0019538,0.342876912131266,0.679764287846923,446,4205,protein metabolic process,BP,SERPINE2;PHACTR3;CPA4;TNFRSF6B;FLOT1;MMP2;PRSS23;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;ADAM19;FBN1;INPP5D;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;ADAMTSL1;EFEMP1;TENM4;MARCH4;GSN;PKD2;IRS2;DUSP6;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;NOS1;GAS6;PDGFC;SNAI2;MAGED1;SULF2;PHF21A;TFPI2;ROR1;AXL;EGFR;GALNT10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NTM;FKBP5;CLCA2;MYLK;GJC2;TRIM2;SERPINE1;SERPINH1;RNF213;CRTAP;RNF165;VIM;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;NSG1;PTPRM;PADI3;BMP4;TRIM38;ITM2C;PCSK1;NR1D1;PTK6;ABTB1;EIF2AK4;TRIM5;NEFL;PDCD4;BTBD2;SORL1;LGALS1;D2HGDH;CPVL;TP53;EXTL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;LTBP1;WNK1;MUC19;DLG4;ITGA2;PILRB;PDGFA;MMP19;RBMS3;MICAL1;ADARB1;TIMP1;FLG;HIP1;GPNMB;CRIM1;CUL7;BTG1;CHD3;SIK1;ELFN2;TYSND1;SNX1;GPX1;GLI3;CDK14;CNTN1;KITLG;P3H2;ERO1B;CTDSPL;MTHFR;NEK9;CTSV;LRP1;FYN;IFI6;XDH;ALPK1;B3GAT3;LTBP4;FUT10;CPS1;CAV1;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;TRIB2;SEL1L;SNX33;MAP3K14;DCAF16;XYLT1;UST;CLU;FKBP9;SERPING1;PRKCZ;SDR16C5;FBXW4;ULK2;PARP4;TNS2;CHST3;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;CAPRIN2;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;SPRY2;TTN;CIRBP;JARID2;LMO7;APLP2;FBLN1;TP73;CAT;CASP14;DAPK1;ST6GAL2;DLC1;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PHF2;TLR3;MAN1A1;FBXL7;SNCA;FLOT2;ADAMTS7;MME;THSD4;PDIA6;FZD7;AIP;GLG1;JADE2;PTPRU;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;TGFBI;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;PDK3;G6PD;EPHB6;ARSD;EDA2R;FZD8;TRIOBP;KDM4C;AFAP1L2;MAGEF1;LMCD1;TGFBR3;FZD1;IPP;ENG;FOXL1;MTMR4;CALR;NEGR1;ATM;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MANBA;AREG;IFNK;AKAP13;DNAJC6;DGKQ;GCLC;NR2F2;HEXA;IFNE;NEURL1B;TRAK1;FBXW8;HDAC11;RNPEP;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;NCOR1;GCNT1;PRKCA;ANXA2;RGS14;RAB13;AMZ2;ADAMTS15;HLTF;RNF24;MAN2B1;PGAP1;IGFBP4;MVB12B;KCTD7;ANAPC16;GAL3ST4;RPL13A;PAK6;NAB2;MAP3K12;TSPAN5;STK36;PRNP;RET;ZFPM1;TGFB2;MAP2K5;GGT7;DSEL;STAT2;LEF1;DPP9;CDC42EP5;USP28;ITM2A;MAPK8IP3;MSRB2;TRIML2;CDKN2A;PPM1M;SPPL2B;ULK1;TSPYL2;NPEPL1;IGFBP2;RHBDD1;MAGI2;HSPA5;CDK19;KLHL5;TGFB1I1;SRPK2;UVRAG;MDFIC;RHBDD2;SAP30L;OPHN1;TPGS1;LMF1;GDNF;PGPEP1;ALG10;NUB1;KLHL3;ATRAID;YEATS2;UBA7;GALNT2;DERL3;PPARG;RNF144B;PARP15;BEX4;TPST1;MEF2A;SNX9;ICK;SASH1;OBSL1;ING4;ZYG11B;APOL6;UNK;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;CCNY;TMEM67;PCMTD2;PRKAG1;TAF1;SENP7;EFNA5;FZD4;MPPE1;PPP3CA;DCAF8;RASA1;CTDSP2;KRT10;CAPN6;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;TUSC3;RXRA;EDEM1;GID4;TAOK3;CTSD;ZNRF1;DMPK;LAMB2
11073,GO:0045103,0.342951225085671,0.817178904924084,5,33,intermediate filament-based process,BP,KRT14;VIM;NEFM;NEFL;SYNC
1371,GO:0003263,0.342992328359126,0.944955822261877,1,5,cardioblast proliferation,BP,ISL1
10189,GO:0042824,0.34339018434849,0.947908595099137,1,4,MHC class I peptide loading complex,CC,CALR
11151,GO:0045240,0.34340461618601,0.889067831223676,2,11,dihydrolipoyl dehydrogenase complex,CC,BCKDHB;DHTKD1
3065,GO:0006633,0.343610637925622,0.767686648528775,11,93,fatty acid biosynthetic process,BP,PTGS1;ACSL3;PTGES;ACSS1;ACACB;CBR1;ALOX15B;PRKAB2;ACSS2;THNSL2;PRKAG1
3460,GO:0007276,0.343756639972802,0.714609694106104,44,376,gamete generation,BP,SYNE1;ETV5;AXL;HSPA2;RFX2;CRTAP;BMP4;SMARCA2;HSF2BP;MMP19;BTG1;PAQR8;CTSV;SPATA6;PHC2;CCNI;SPATA20;ANG;BBS2;MLH3;PAQR7;RGS2;SETX;CCDC136;SEPT6;BBS4;CALR;ATM;ZNF449;SOX9;BCL6;MYBL1;FNDC3A;SPA17;ODF2;HERPUD2;RHBDD1;GOPC;CFAP54;TPGS1;DNAH1;RARA;PRKAG1;AGO4
3149,GO:0006750,0.343823421624238,0.885841264718295,2,14,glutathione biosynthetic process,BP,GCLC;GGT7
15735,GO:0072361,0.343863818732212,0.963934442794658,1,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,NCOR1
16786,GO:0098679,0.343863818732212,0.963934442794658,1,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,NCOR1
17418,GO:1900221,0.343904873693144,0.892015300939036,2,9,regulation of amyloid-beta clearance,BP,LRP1;CLU
10099,GO:0042637,0.344194918815071,0.947640639107773,1,4,catagen,BP,TGFB2
13160,GO:0051794,0.344194918815071,0.947640639107773,1,4,regulation of timing of catagen,BP,TGFB2
9663,GO:0038049,0.344215986456848,0.963851841293187,1,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,NR3C1
15585,GO:0072102,0.345026820258934,0.952666691900865,1,3,glomerulus morphogenesis,BP,BMP4
20175,GO:2001056,0.345190627999406,0.757680097506176,13,119,positive regulation of cysteine-type endopeptidase activity,BP,CTGF;F2R;GSN;PYCARD;HIP1;FYN;XDH;CCK;DAPK1;DLC1;ROBO1;SNCA;PPARG
1592,GO:0004012,0.345621755586764,0.859173096163154,3,13,phospholipid-translocating ATPase activity,MF,ATP10D;ABCA1;ATP8B2
9338,GO:0035867,0.345701180495212,0.963502201447967,1,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,IGF1R
13003,GO:0051480,0.345723392232339,0.743621467094087,18,141,regulation of cytosolic calcium ion concentration,BP,F2R;PKD2;JPH2;NOS1;SLC8A1;NTSR1;DDIT3;DLG4;FYN;CAV1;PLA2G6;CAMK2D;SNCA;PDE4D;TGM2;PRNP;ITPR2;OXTR
7969,GO:0032594,0.346582799151139,0.851515534623624,3,21,protein transport within lipid bilayer,BP,NSG1;HIP1;REEP2
12546,GO:0050727,0.34666082601421,0.737864390519555,20,178,regulation of inflammatory response,BP,IL20RB;EGFR;SERPINE1;PDCD4;PYCARD;ITGA2;GPX1;CLU;SERPING1;PER1;TLR3;SNCA;C5;TGM2;IL18;ISL1;BCL6;CDK19;PPARG;CALCRL
13987,GO:0060737,0.346850379905906,0.952112614329251,1,3,prostate gland morphogenetic growth,BP,SOX9
6305,GO:0019956,0.346914469007651,0.885924422773671,2,12,chemokine binding,MF,PDPN;CXCR1
14261,GO:0061384,0.347156808528933,0.831610660029878,4,23,heart trabecula morphogenesis,BP,ADGRG6;TGFBR3;ENG;TGFB2
8073,GO:0032768,0.347169587197268,0.812411941462632,5,39,regulation of monooxygenase activity,BP,EGFR;VDR;CAV1;SNCA;GDNF
8943,GO:0035024,0.347706941403515,0.853391432516125,3,17,negative regulation of Rho protein signal transduction,BP,ITGA3;DLC1;BCL6
324,GO:0000910,0.347975505613504,0.741677971446282,18,140,cytokinesis,BP,RHOBTB2;PAK1;EFHC1;CUL7;E2F7;SNX33;ANK3;SEPT6;BBS4;SEPT5;PAK6;OR2A4;CENPA;UVRAG;SNX9;ARL3;RASA1;SEPT9
7146,GO:0031017,0.348214300282748,0.946289947544808,1,4,exocrine pancreas development,BP,PPDPF
17562,GO:1901224,0.348365182478251,0.811745745828309,5,38,positive regulation of NIK/NF-kappaB signaling,BP,EGFR;PDCD4;TLR3;CALR;SASH1
18787,GO:1904380,0.348683860490365,0.851289000530889,3,19,endoplasmic reticulum mannose trimming,BP,SEL1L;UGGT2;EDEM1
10124,GO:0042713,0.348914393195057,0.951480757924565,1,3,sperm ejaculation,BP,OXTR
11256,GO:0045586,0.349208170957312,0.951390415256784,1,3,regulation of gamma-delta T cell differentiation,BP,SOX13
1608,GO:0004033,0.349237709850311,0.881386056170413,2,16,aldo-keto reductase (NADP) activity,MF,KCNAB2;AKR7A2
18431,GO:1903546,0.349358688284503,0.945901606862956,1,4,protein localization to photoreceptor outer segment,BP,BBS4
6267,GO:0019867,0.349396636002796,0.737666534411828,19,163,outer membrane,CC,SYNE1;SYNE3;FAM210B;ACSL3;TMEM173;CPT1A;ACACB;BPHL;SNCA;VAMP1;ARMCX2;SPATA18;SLC24A1;SYNE2;ULK1;RSAD2;VPS13C;ANKH;DMPK
18158,GO:1902954,0.349482073619208,0.962602697374302,1,2,regulation of early endosome to recycling endosome transport,BP,SORL1
2460,GO:0005677,0.349501946203426,0.888970424308363,2,9,chromatin silencing complex,CC,TNRC18;BAHCC1
12711,GO:0051001,0.349615767410274,0.945814137749694,1,4,negative regulation of nitric-oxide synthase activity,BP,CAV1
16294,GO:0090527,0.349790225120087,0.888812470868631,2,9,actin filament reorganization,BP,GSN;ARAP1
17052,GO:0099604,0.349871223858368,0.852865989156206,3,16,ligand-gated calcium channel activity,MF,PKD2;JPH2;ITPR2
8035,GO:0032700,0.350249984745906,0.942378224871281,1,5,negative regulation of interleukin-17 production,BP,PRNP
10490,GO:0043415,0.350366747103053,0.945558136940702,1,4,positive regulation of skeletal muscle tissue regeneration,BP,TGFBR2
10491,GO:0043416,0.350366747103053,0.945558136940702,1,4,regulation of skeletal muscle tissue regeneration,BP,TGFBR2
7165,GO:0031057,0.350389680589609,0.811967873672817,5,32,negative regulation of histone modification,BP,SDR16C5;JARID2;SNCA;KDM4C;KDM4A
467,GO:0001508,0.350582542297765,0.768434482026919,10,68,action potential,BP,GJA5;SLC8A1;NTSR1;SCN8A;SCN2A;CAV1;CAMK2D;ANK3;KCNJ5;PTPN3
11741,GO:0046622,0.350858628396224,0.827924950133319,4,25,positive regulation of organ growth,BP,ACACB;FGFR1;TGFBR3;YAP1
9805,GO:0042035,0.350929815981841,0.78754976460164,7,55,regulation of cytokine biosynthetic process,BP,INPP5D;IGF2BP2;TRIB2;TLR3;EGR1;ZFPM1;MAP2K5
10409,GO:0043276,0.351336219390095,0.826690840644543,4,27,anoikis,BP,SNAI2;SIK1;CAV1;CHEK2
13102,GO:0051684,0.351393009160092,0.950715329362122,1,3,maintenance of Golgi location,BP,UVRAG
2541,GO:0005811,0.351494393514882,0.778934867527466,8,64,lipid droplet,CC,ACSL3;LPCAT2;CAV1;SDR16C5;METTL7A;HSD17B11;ANXA2;RSAD2
11272,GO:0045606,0.351548713161858,0.8493975335093,3,19,positive regulation of epidermal cell differentiation,BP,VDR;BMP4;ALOX15B
14270,GO:0061428,0.351737449577424,0.945089009580058,1,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,CITED2
14654,GO:0070296,0.351740559425437,0.850751074561886,3,17,sarcoplasmic reticulum calcium ion transport,BP,SLC8A1;CAMK2D;PDE4D
9670,GO:0038065,0.351789386693421,0.890082883482764,2,8,collagen-activated signaling pathway,BP,ITGA2;COL4A1
5337,GO:0016080,0.351809064458221,0.950586132419795,1,3,synaptic vesicle targeting,BP,SEPT5
11445,GO:0045923,0.351830114080616,0.850692225068087,3,17,positive regulation of fatty acid metabolic process,BP,IRS2;CPT1A;PPARG
6410,GO:0021680,0.351905068292153,0.852567015013235,3,15,cerebellar Purkinje cell layer development,BP,AARS;NAGLU;HSPA5
7032,GO:0030816,0.351908008788015,0.883095819457916,2,12,positive regulation of cAMP metabolic process,BP,TIMP2;GPR161
3260,GO:0006931,0.352017194917016,0.950521424872808,1,3,substrate-dependent cell migration, cell attachment to substrate,BP,FN1
13174,GO:0051823,0.352214448750668,0.944925187464513,1,4,regulation of synapse structural plasticity,BP,DMPK
16489,GO:0097228,0.352240244099691,0.8829064292651,2,12,sperm principal piece,CC,IFT27;SPA17
11039,GO:0045058,0.352392252544836,0.826362367119307,4,26,T cell selection,BP,GLI3;CD1D;ITPKB;ZFPM1
5838,GO:0017134,0.352941768171015,0.848474127404493,3,19,fibroblast growth factor binding,MF,GLG1;FGFR1;TGFBR3
14432,GO:0061817,0.352998315414279,0.950215701823127,1,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT2
8617,GO:0034154,0.35312794349627,0.94461063443164,1,4,toll-like receptor 7 signaling pathway,BP,RSAD2
12145,GO:0048289,0.353153835730413,0.94460170298613,1,4,isotype switching to IgE isotypes,BP,BCL6
12148,GO:0048293,0.353153835730413,0.94460170298613,1,4,regulation of isotype switching to IgE isotypes,BP,BCL6
13758,GO:0060373,0.353245399204915,0.944570111501691,1,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,GJA5
832,GO:0002133,0.353367182124593,0.961664212682855,1,2,polycystin complex,CC,PKD2
15539,GO:0072021,0.353367182124593,0.961664212682855,1,2,ascending thin limb development,BP,PKD2
15630,GO:0072177,0.353367182124593,0.961664212682855,1,2,mesonephric duct development,BP,PKD2
15661,GO:0072218,0.353367182124593,0.961664212682855,1,2,metanephric ascending thin limb development,BP,PKD2
7279,GO:0031282,0.35338044749038,0.944523496988168,1,4,regulation of guanylate cyclase activity,BP,NOS1
7280,GO:0031284,0.35338044749038,0.944523496988168,1,4,positive regulation of guanylate cyclase activity,BP,NOS1
1862,GO:0004528,0.353399644602065,0.944516868821799,1,4,phosphodiesterase I activity,MF,ENPP1
321,GO:0000900,0.353779242323698,0.884750776593467,2,10,translation repressor activity, mRNA regulatory element binding,MF,PAIP2B;RARA
71,GO:0000147,0.353843434858675,0.94995143865459,1,3,actin cortical patch assembly,BP,WIPF1
10851,GO:0044396,0.353843434858675,0.94995143865459,1,3,actin cortical patch organization,BP,WIPF1
13097,GO:0051666,0.353843434858675,0.94995143865459,1,3,actin cortical patch localization,BP,WIPF1
5853,GO:0017158,0.353868138976039,0.795826508568223,6,43,regulation of calcium ion-dependent exocytosis,BP,SYT8;SYN1;SYTL1;SYT1;SEPT5;C2CD4C
7865,GO:0032437,0.353948604613338,0.949918493199554,1,3,cuticular plate,CC,TRIOBP
577,GO:0001730,0.354003276873515,0.944308210214799,1,4,2'-5'-oligoadenylate synthetase activity,MF,OAS2
4365,GO:0009987,0.354030857934677,0.67909649160639,1102,10467,cellular process,BP,SERPINE2;PHACTR3;CPA4;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;TMEM204;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;NYNRIN;CEP126;SLC8A1;NTM;FKBP5;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;C1QTNF6;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;ALS2CL;CNTNAP3;FAM210B;MFAP5;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PLEC;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;TP53I11;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;D2HGDH;CPVL;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;FRMD4B;MMP19;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;PHLDB1;HIP1;COL4A4;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;WDR66;NFIX;ELFN2;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;ECH1;ERMAP;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;LIMCH1;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;CCDC80;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;CHST3;EHD3;PPDPF;HMGA2;CAMK2D;ADGRG6;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;CCNI;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;PXN;PDIA4;SPATA20;CCK;PIK3R1;SYT1;HHAT;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;SLC38A2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;LAMB3;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;METRN;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;PAQR7;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;G6PD;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;IFNK;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;ACSS2;ELMO3;FHOD3;HEXA;IFNE;NEURL1B;CBX7;DNAJC4;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;NT5DC3;ARHGEF2;DNAL4;NTNG1;PLGRKT;SPRED3;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;THNSL2;SYNC;ZNF546;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;SLC27A6;BCL6;PCDHGA11;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;IFITM2;SAMD5;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;TCF12;CABLES2;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;USP28;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;C2CD4C;CDKN2A;EFR3A;PPM1M;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;IGFBP2;ORC4;NPHP3;VAV2;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;SLC9A4;BOC;CENPA;PIKFYVE;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;UVRAG;SEMA4B;ITGB8;NAPRT;CCHCR1;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;FHOD1;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;LMF1;KCTD14;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;DNAH1;ALG10;RALGAPB;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;PRRC2B;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;OLFML2A;ZYG11B;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DNAJC3;NYAP1;FKBP10;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;SLITRK5;ZNF883;WIPF1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;SBF2;RASA1;ARHGAP31;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;CLEC2D;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;ZNF471;LITAF;LRRCC1;PSMG4;ATG16L2;TSPAN4;EPG5;S100A11;MYO1C;TUSC3;RXRA;C2CD5;CPT2;EDEM1;GID4;ACAA2;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;ZNRF1;DMPK;LAMB2
15950,GO:0080135,0.354148762233568,0.696888061278664,60,534,regulation of cellular response to stress,BP,CTGF;SFRP1;GADD45B;TNIK;SNAI2;EGFR;MAP3K6;PAK1;EIF2AK4;PDCD4;TP53;PTPRS;DDIT3;PYCARD;GPX1;XDH;CAV1;ERCC6;CLU;HMGA2;CAMK2D;PER1;PIK3R1;HERPUD1;WFS1;TP73;CHEK2;TLR3;FZD7;IGF1R;DKK1;PLA2R1;EDA2R;FZD8;MAGEF1;FZD1;ATM;MDM2;PTPN1;VANGL2;ARHGEF2;NRK;BCL6;NCOR1;CXORF57;TGFB2;MAPK8IP3;CDKN2A;HSPA5;MDFIC;VPS13C;DERL3;SASH1;DNAJC3;POLH;FZD4;FAM168A;NPAS2;EDEM1;TAOK3
8818,GO:0034618,0.354263931606602,0.944217963471952,1,4,arginine binding,MF,NOS1
6526,GO:0021936,0.35449894640531,0.949745877961401,1,3,regulation of cerebellar granule cell precursor proliferation,BP,GLI2
15791,GO:0072523,0.354717986273193,0.8069467511138,5,38,purine-containing compound catabolic process,BP,GPX1;XDH;PDE4D;DPYD;DNPH1
6718,GO:0030137,0.354730264831926,0.84513219472121,3,23,COPI-coated vesicle,CC,PACS1;COPG2;TMED10
9330,GO:0035859,0.354828426699129,0.88039655039607,2,13,Seh1-associated complex,CC,SESN3;SESN1
1577,GO:0003989,0.354857585878021,0.961300348260322,1,2,acetyl-CoA carboxylase activity,MF,ACACB
20278,GO:2001295,0.354857585878021,0.961300348260322,1,2,malonyl-CoA biosynthetic process,BP,ACACB
19373,GO:1905908,0.35500014628036,0.943962587764408,1,4,positive regulation of amyloid fibril formation,BP,CLU
10617,GO:0043648,0.355035393558715,0.768607529644475,9,79,dicarboxylic acid metabolic process,BP,PRODH;D2HGDH;MTHFR;ALDH1L2;IDH2;GCLC;ALDH4A1;NMNAT2;TH
9235,GO:0035655,0.355254753182497,0.94055964512377,1,5,interleukin-18-mediated signaling pathway,BP,IL18
15175,GO:0071351,0.355254753182497,0.94055964512377,1,5,cellular response to interleukin-18,BP,IL18
13112,GO:0051705,0.355299044432681,0.795974091592226,6,38,multi-organism behavior,BP,DLG4;BBS4;NLGN4Y;ATXN1;TH;OXTR
18470,GO:1903626,0.355303155296034,0.943857276860094,1,4,positive regulation of DNA catabolic process,BP,ATM
1850,GO:0004515,0.355307936397638,0.949491480550438,1,3,nicotinate-nucleotide adenylyltransferase activity,MF,NMNAT2
7727,GO:0032233,0.355876507230586,0.794255484874521,6,43,positive regulation of actin filament bundle assembly,BP,CTGF;SFRP1;S100A10;PAK1;PXN;FHOD1
2963,GO:0006501,0.355903463245373,0.821674951450291,4,32,C-terminal protein lipidation,BP,CD109;NTM;NEGR1;NTNG1
14690,GO:0070369,0.355944179730942,0.949290855525246,1,3,beta-catenin-TCF7L2 complex,CC,TCF4
6325,GO:0020037,0.355952550615535,0.783521989827345,7,55,heme binding,MF,PTGS1;NOS1;NR1D1;CAT;CYP20A1;SLC48A1;CYP4V2
752,GO:0001993,0.356107068605288,0.943577298892959,1,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,PDE4D
5816,GO:0017091,0.356213032778534,0.845102815289446,3,21,AU-rich element binding,MF,ZFP36L1;ZFP36L2;RBMS3
3760,GO:0008308,0.35623646878258,0.880616680617283,2,12,voltage-gated anion channel activity,MF,ANO1;ANO6
11037,GO:0045055,0.356413771460115,0.696346486903002,56,511,regulated exocytosis,BP,SYT8;FN1;PCDH7;PYGB;MMP9;CD109;GSN;ANPEP;GAS6;SLC2A3;SERPINE1;ENDOD1;ANXA5;TIMP2;PYCARD;PDGFA;MICAL1;TIMP1;ANO6;SYN1;MAGED2;KCNAB2;CLU;SERPING1;CXCR1;SYTL1;METTL7A;SYT1;TMEM173;PCLO;TTN;APLP2;CAT;STOM;MME;MLEC;TMED10;CST3;MANBA;PRCP;NFASC;ANXA2;SEPT5;MAN2B1;MOSPD2;TGFB2;DNASE1L1;C2CD4C;NAPRT;LGALS3;DNAJC3;STEAP2;ACTR1B;ADAM10;S100A11;CTSD
9279,GO:0035739,0.356523773100582,0.94343184323638,1,4,CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
19950,GO:2000561,0.356523773100582,0.94343184323638,1,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
20162,GO:2001033,0.35675114992445,0.940009328441753,1,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
8875,GO:0034707,0.3569246051591,0.880220208997697,2,12,chloride channel complex,CC,ANO1;ANO6
13692,GO:0060287,0.357120077850791,0.943223303056416,1,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,NPHP3
5118,GO:0015491,0.357165389767887,0.846368009587511,3,18,cation:cation antiporter activity,MF,SLC8A1;SLC24A1;SLC9A4
2166,GO:0005003,0.357197147373639,0.881307577430115,2,11,ephrin receptor activity,MF,EPHB6;EFNB3
2168,GO:0005005,0.357197147373639,0.881307577430115,2,11,transmembrane-ephrin receptor activity,MF,EPHB6;EFNB3
2185,GO:0005044,0.35722581115377,0.844987983191817,3,20,scavenger receptor activity,MF,SCARA3;LRP1;ENPP1
1367,GO:0003253,0.357232928073091,0.943183784891998,1,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,BMP4
7008,GO:0030730,0.357420253245035,0.881179941428444,2,11,sequestering of triglyceride,BP,ENPP1;PPARG
7903,GO:0032487,0.357507376474613,0.948795875653131,1,3,regulation of Rap protein signal transduction,BP,TIMP2
19000,GO:1904868,0.35765584486768,0.960611393000105,1,2,telomerase catalytic core complex assembly,BP,ATM
19012,GO:1904882,0.35765584486768,0.960611393000105,1,2,regulation of telomerase catalytic core complex assembly,BP,ATM
19013,GO:1904884,0.35765584486768,0.960611393000105,1,2,positive regulation of telomerase catalytic core complex assembly,BP,ATM
4526,GO:0010596,0.357671758521171,0.806137457338552,5,33,negative regulation of endothelial cell migration,BP,PTPRM;NR2F2;MAP2K5;SP100;PPARG
4414,GO:0010212,0.357707354827016,0.737750761100022,16,134,response to ionizing radiation,BP,SFRP1;SNAI2;KRT14;TP53;GPX1;ERCC6;HMGA2;TP73;CHEK2;ATM;MDM2;EGR1;USP28;HSPA5;YAP1;NIPBL
3790,GO:0008361,0.357883004137948,0.735818692928221,17,123,regulation of cell size,BP,FN1;DPYSL2;PAK1;VAV3;KCNMA1;PTPRS;SEMA5A;ANO6;ULK2;PLXNA2;SEMA4A;PLXNA1;MEGF8;RET;VAV2;SEMA4B;EFNA5
6316,GO:0019985,0.3578889848026,0.804296049361637,5,39,translesion synthesis,BP,PRIMPOL;POLD4;UBA7;POLH;ZBTB1
7631,GO:0032052,0.357933361791534,0.939572407326029,1,5,bile acid binding,MF,VDR
9364,GO:0035912,0.358140893330598,0.942865227453404,1,4,dorsal aorta morphogenesis,BP,ENG
15287,GO:0071526,0.35819806447182,0.807289318530381,5,29,semaphorin-plexin signaling pathway,BP,PLXNB1;PLXNA2;SEMA4A;PLXNA1;SEMA4B
7981,GO:0032610,0.358206691510032,0.937251550066222,1,6,interleukin-1 alpha production,BP,ISL1
11205,GO:0045359,0.358271517909913,0.942819309663905,1,4,positive regulation of interferon-beta biosynthetic process,BP,TLR3
9434,GO:0036041,0.358408024961427,0.937174346794738,1,6,long-chain fatty acid binding,MF,PPARG
18621,GO:1903960,0.358586666587652,0.882037545172711,2,10,negative regulation of anion transmembrane transport,BP,IRS2;GOPC
4790,GO:0010986,0.358598761137668,0.942704177732969,1,4,positive regulation of lipoprotein particle clearance,BP,ANXA2
11883,GO:0046935,0.358700066814246,0.948416240213179,1,3,1-phosphatidylinositol-3-kinase regulator activity,MF,PIK3R1
294,GO:0000799,0.358750590987785,0.948400120465949,1,3,nuclear condensin complex,CC,NCAPD2
3682,GO:0008188,0.358796456019608,0.939252224635832,1,5,neuropeptide receptor activity,MF,NTSR1
9086,GO:0035373,0.359022050723172,0.960272262695838,1,2,chondroitin sulfate proteoglycan binding,MF,SEMA5A
4888,GO:0014819,0.359034642148206,0.939163685860401,1,5,regulation of skeletal muscle contraction,BP,DMPK
3535,GO:0007530,0.359108660268407,0.880211841067919,2,11,sex determination,BP,CITED2;SOX9
12800,GO:0051132,0.359128879853399,0.939128634373666,1,5,NK T cell activation,BP,IL18
9409,GO:0035994,0.35921429494902,0.850446802370455,3,13,response to muscle stretch,BP,SLC8A1;TTN;FOS
97,GO:0000188,0.35928852938626,0.842050150146681,3,23,inactivation of MAPK activity,BP,DUSP6;CAV1;DUSP5
2402,GO:0005575,0.359314357853833,0.705679102400919,1220,11676,cellular_component,CC,SERPINE2;PHACTR3;CPA4;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;SH3TC1;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;NCKAP5;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;TMEM204;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;NYNRIN;CEP126;SLC8A1;NTM;FKBP5;ORAI3;CLCA2;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;KIAA1549L;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;C1QTNF6;VIM;NUPR1;LPAR5;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;CNTNAP3;LGALS9C;FAM210B;MAMDC2;MFAP5;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;LOC441081;ANGPTL4;NSG1;CBX5;VDR;CHN2;TMC7;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;LAMB4;NEFM;TNS1;TP53I11;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;FCGBP;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;CPVL;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;ARMC9;TCP11L1;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;FRMD4B;MMP19;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;TMEM200A;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;CPED1;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;SLC22A15;WDR66;NFIX;ELFN2;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;DIP2C;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;CCDC80;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;IGFL1;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;SLC35F3;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;SNX29;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;CHST3;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;SLC38A2;CALHM2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;LAMB3;CES2;TTN;TMEM139;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;METRN;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;LRIG3;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;IQCH;AIP;GLG1;JADE2;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;SP110;COL16A1;CYYR1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;GLT8D2;TGFBI;SETX;KHNYN;ASTN2;PDE4D;APBB3;TMEM129;WBP1;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;TMEM263;KDM4C;C11ORF45;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;CD99L2;FOXN3;ITGBL1;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;IFNK;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;C20ORF194;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;ACSS2;ELMO3;FHOD3;HEXA;IFNE;NEURL1B;IGFL2;CBX7;DNAJC4;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;CYP20A1;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;HSPA12A;IFI44;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;CSMD2;FGD4;NEMP2;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;NT5DC3;CPNE8;ARHGEF2;SMIM19;DNAL4;FAM117A;NTNG1;PLGRKT;SPRED3;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;THNSL2;SYNC;ZNF546;KRT222;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;C14ORF93;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;TMEM63C;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;TMC4;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;FNDC3A;TMEM94;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;STOX2;CEP68;PGAP1;TSHZ1;PLD5;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;IFITM2;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;CNTNAP3B;TCF12;HMBOX1;C22ORF23;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;IGIP;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;XG;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;TMEM60;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;LRRN3;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;MPRIP;HERPUD2;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;TMEM164;NPHP3;VAV2;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;SLC9A4;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;TTPAL;SRPK2;CHIC2;UVRAG;TCTEX1D4;SEMA4B;ITGB8;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;NBPF15;PARP15;BEX4;CALCRL;ADAMTSL5;TPST1;KCNIP3;MEF2A;TMEM212;MLLT6;SLC35E2B;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;TBC1D16;TGIF1;OBSL1;ING4;OLFML2A;ZYG11B;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DEF6;DNAJC3;NYAP1;FKBP10;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TRIM16L;TSHZ3;EFNA5;CEP85L;GSTZ1;FZD4;MPPE1;SLITRK5;ZNF883;WIPF1;HCFC1R1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;TMTC4;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM169A;CLEC2D;FAM120B;CACNA2D3;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;ANKS6;TSPAN4;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;PINLYP;MOSPD3;LAMB2
12618,GO:0050849,0.35935098125939,0.878817114469286,2,12,negative regulation of calcium-mediated signaling,BP,PKD2;PRNP
14706,GO:0070402,0.359565313796302,0.877643496498519,2,13,NADPH binding,MF,TP53I3;DECR1
14004,GO:0060762,0.359759506870535,0.942294671356,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5
9254,GO:0035694,0.360090510967391,0.942177571454101,1,4,mitochondrial protein catabolic process,BP,SPATA18
8268,GO:0033085,0.360179513900334,0.938737032838159,1,5,negative regulation of T cell differentiation in thymus,BP,BMP4
6885,GO:0030427,0.360256488207315,0.733614807641049,17,125,site of polarized growth,CC,APBB2;UTRN;FLRT3;STMN3;TIMP2;NEFL;ITGA3;ANG;SNCA;FSCN1;SETX;TRAK1;SSH1;MAP3K12;BOC;TSHZ3;ORAI2
18874,GO:1904589,0.360410608462487,0.790268032682219,6,45,regulation of protein import,BP,GAS6;BMP4;GLI3;TMEM173;LRTOMT;MDFIC
14661,GO:0070306,0.360791387355433,0.843943001340714,3,18,lens fiber cell differentiation,BP,VIM;SLC7A11;MAF
16372,GO:0097025,0.360883185194287,0.947716906539483,1,3,MPP7-DLG1-LIN7 complex,CC,MPP7
9293,GO:0035767,0.361016600020038,0.84379184471567,3,18,endothelial cell chemotaxis,BP,SEMA5A;FGFR1;RAB13
4711,GO:0010878,0.361040556388622,0.879099389797411,2,11,cholesterol storage,BP,ABCA1;PPARG
6972,GO:0030658,0.361219201219328,0.73760608616643,15,125,transport vesicle membrane,CC,SYT8;CLTCL1;MAP6;PTPRS;SYN1;SYT1;VAMP1;SEC24D;TMED10;AREG;KLHL12;C2CD4C;RASSF9;SV2A;ZNRF1
20249,GO:2001242,0.361386693177325,0.743343040846956,13,127,regulation of intrinsic apoptotic signaling pathway,BP,MMP9;SNAI2;TP53;DDIT3;PYCARD;GPX1;CAV1;CLU;HERPUD1;WFS1;MDM2;PTPN1;ARHGEF2
407,GO:0001093,0.361504121335102,0.947516945046963,1,3,TFIIB-class transcription factor binding,MF,TCF4
8037,GO:0032703,0.361511375170927,0.877561090381831,2,12,negative regulation of interleukin-2 production,BP,IL20RB;PRNP
9306,GO:0035795,0.361730824625756,0.938156055859486,1,5,negative regulation of mitochondrial membrane permeability,BP,ACAA2
19320,GO:1905709,0.361730824625756,0.938156055859486,1,5,negative regulation of membrane permeability,BP,ACAA2
19921,GO:2000482,0.362104253115284,0.876155284868092,2,13,regulation of interleukin-8 secretion,BP,F2R;PYCARD
4877,GO:0014744,0.36210873925485,0.947321789499898,1,3,positive regulation of muscle adaptation,BP,PPP3CA
13793,GO:0060416,0.36219371691484,0.819764481203766,4,25,response to growth hormone,BP,CPS1;PXN;PIK3R1;PTPN1
12098,GO:0048185,0.362252949314152,0.878398666351064,2,11,activin binding,MF,TGFBR3;ENG
12369,GO:0048818,0.362288990577337,0.941396164969788,1,4,positive regulation of hair follicle maturation,BP,TGFB2
8563,GO:0034058,0.362307530180142,0.879916164964282,2,10,endosomal vesicle fusion,BP,SAMD9L;VPS39
3256,GO:0006925,0.362633362857561,0.875844035617042,2,13,inflammatory cell apoptotic process,BP,ITPKB;CDKN2A
5604,GO:0016653,0.362649793176459,0.876896671598257,2,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NQO1;NOS1
19619,GO:1990841,0.362653455926851,0.802349122000715,5,33,promoter-specific chromatin binding,MF,STAT1;GLI2;EGR1;ISL1;RBL2
19129,GO:1905167,0.362721491474159,0.959344815899205,1,2,positive regulation of lysosomal protein catabolic process,BP,LRP1
14668,GO:0070318,0.362783182355895,0.941219639897557,1,4,positive regulation of G0 to G1 transition,BP,CTGF
6914,GO:0030516,0.362817442806318,0.758296937322563,10,67,regulation of axon extension,BP,FN1;DPYSL2;PAK1;PTPRS;SEMA5A;PLXNA2;SEMA4A;PLXNA1;MEGF8;SEMA4B
2667,GO:0006021,0.363019727415025,0.941135032328553,1,4,inositol biosynthetic process,BP,ISYNA1
8027,GO:0032688,0.363101670799194,0.875568233662657,2,13,negative regulation of interferon-beta production,BP,PTPRS;PYCARD
7083,GO:0030889,0.363222752945314,0.879391500475629,2,10,negative regulation of B cell proliferation,BP,INPP5D;ATM
13923,GO:0060633,0.363321341174495,0.941027044029298,1,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,THRA
19728,GO:2000143,0.363321341174495,0.941027044029298,1,4,negative regulation of DNA-templated transcription, initiation,BP,THRA
7105,GO:0030916,0.363347742982518,0.946920483414008,1,3,otic vesicle formation,BP,SOX9
15333,GO:0071600,0.363347742982518,0.946920483414008,1,3,otic vesicle morphogenesis,BP,SOX9
9544,GO:0036342,0.363467946987947,0.879250746932062,2,10,post-anal tail morphogenesis,BP,VANGL2;MED12
3690,GO:0008199,0.363499659196532,0.937489589662994,1,5,ferric iron binding,MF,TH
951,GO:0002371,0.363768761848173,0.940866630840994,1,4,dendritic cell cytokine production,BP,TLR3
1137,GO:0002730,0.363768761848173,0.940866630840994,1,4,regulation of dendritic cell cytokine production,BP,TLR3
56,GO:0000118,0.363863495525252,0.770076682713499,8,55,histone deacetylase complex,CC,PHF21A;CBX5;CHD3;HDAC11;NCOR1;SALL2;TRERF1;SAP30L
18100,GO:1902816,0.363891331315599,0.940822640082835,1,4,regulation of protein localization to microtubule,BP,TTBK2
18101,GO:1902817,0.363891331315599,0.940822640082835,1,4,negative regulation of protein localization to microtubule,BP,TTBK2
7474,GO:0031649,0.364195781665289,0.874922706133151,2,13,heat generation,BP,SLC27A1;ABAT
415,GO:0001103,0.364303181448628,0.816510770261008,4,29,RNA polymerase II repressing transcription factor binding,MF,BBS2;BBS4;BBS1;TTC8
18126,GO:1902895,0.364333372895939,0.840832816107735,3,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,TP53;TGFB2;FOS
16584,GO:0097452,0.364608718508271,0.940564768699209,1,4,GAIT complex,CC,RPL13A
11042,GO:0045061,0.364725325218192,0.876963522766409,2,11,thymic T cell selection,BP,GLI3;ITPKB
8200,GO:0032966,0.364981147717313,0.936928080279216,1,5,negative regulation of collagen biosynthetic process,BP,PPARG
4813,GO:0014012,0.36511796071927,0.940381304246858,1,4,peripheral nervous system axon regeneration,BP,NEFL
12060,GO:0048037,0.36518093155384,0.700097554621224,36,351,cofactor binding,MF,PYGB;PRODH;PTGS1;H6PD;NOS1;TP53I3;NR1D1;D2HGDH;MICAL1;PHGDH;PTGES;P3H2;MTHFR;XDH;HLCS;GLDC;HIBADH;ACACB;CAT;G6PD;DHTKD1;IDH2;GCLC;CYP20A1;THNSL2;SLC48A1;LANCL1;DECR1;MUTYH;CYP4V2;TH;RSAD2;SRR;PARP15;DPYD;ABAT
17821,GO:1902035,0.365308004292241,0.940312749457368,1,4,positive regulation of hematopoietic stem cell proliferation,BP,KITLG
3285,GO:0006977,0.36531882927058,0.775386336661597,7,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
10311,GO:0043125,0.365589134068384,0.940211249313847,1,4,ErbB-3 class receptor binding,MF,PIK3R1
882,GO:0002250,0.3658396478447,0.716937395383776,22,195,adaptive immune response,BP,INPP5D;IL20RB;EIF2AK4;PYCARD;FYN;CLU;SERPING1;PRKCZ;IL31RA;BTN3A1;PAG1;SEMA4A;C5;IL18;IFNK;IFNE;BCL6;LEF1;BTN3A3;RSAD2;PRR7;ZBTB1
4640,GO:0010767,0.365984753776186,0.946060146794109,1,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,TAF1
9028,GO:0035261,0.366020450199158,0.958506431920316,1,2,external genitalia morphogenesis,BP,NIPBL
8599,GO:0034127,0.366055934320827,0.940042482842375,1,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TLR3
1131,GO:0002724,0.366205598458792,0.873732637718004,2,13,regulation of T cell cytokine production,BP,PRKCZ;RSAD2
10838,GO:0044362,0.366363032608304,0.936401594362176,1,5,negative regulation of molecular function in other organism,BP,ANXA2
13295,GO:0052204,0.366363032608304,0.936401594362176,1,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,ANXA2
18657,GO:1904030,0.366382988590191,0.815363741475516,4,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN2B;NR2F2;CDKN2A;CAMK2N1
3218,GO:0006868,0.366431502780921,0.939906490591405,1,4,glutamine transport,BP,SLC38A2
5018,GO:0015186,0.366431502780921,0.939906490591405,1,4,L-glutamine transmembrane transporter activity,MF,SLC38A2
14229,GO:0061312,0.366457624567946,0.936365459193845,1,5,BMP signaling pathway involved in heart development,BP,BMP4
13881,GO:0060561,0.366556080016844,0.840054057204518,3,18,apoptotic process involved in morphogenesis,BP,VDR;TGFB2;LEF1
13485,GO:0055085,0.366798591202692,0.67470216048588,97,872,transmembrane transport,BP,MMP9;F2R;SLC7A8;ANO1;GJA5;PKD2;JPH2;IRS2;CLTCL1;NOS1;GAS6;TCAF1;UTRN;TSC22D3;HSPA2;SLC8A1;ORAI3;CLCA2;GJC2;SLC20A1;SLC2A3;ATP10D;ADD3;NTSR1;PAK1;ABCA1;AHNAK;SCN8A;NETO1;SCN2A;KCNMA1;DDIT3;WNK1;DLG4;SLC7A11;SLC22A15;ANO6;KCNAB2;FYN;CAV1;PLA2G6;SEL1L;SLC22A17;CLU;PRKCZ;KCNJ15;EHD3;CAMK2D;ATP8B2;PIK3R1;SLC38A10;CPT1A;SLC38A2;CALHM2;ACACB;ANK3;DAPK1;KCNJ5;STOM;SNCA;PRKAB2;PDE4D;PSMB9;G6PD;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;SLC25A35;ENPP1;TMEM63C;TMEM175;ABCC2;SLC39A11;PRNP;SCNN1A;FHL1;SFXN3;GOPC;SLC9A4;ITPR2;CACNB1;KCNIP3;SHISA9;PTPN3;SV2A;ABCA2;ANKH;PEX1;STEAP2;CACNA2D3;KCNRG;TUSC3;ORAI2;C2CD5;CPT2;ABCA5
19457,GO:1990239,0.366808621195913,0.939769748874301,1,4,steroid hormone binding,MF,NR3C1
9648,GO:0038024,0.366999648533216,0.785962748300384,6,41,cargo receptor activity,MF,SCARA3;ABCA1;SORL1;HIP1;LRP1;ENPP1
6603,GO:0022829,0.367143507709113,0.872258867673745,2,14,wide pore channel activity,MF,GJA5;GJC2
1081,GO:0002666,0.367648702782366,0.939464459656626,1,4,positive regulation of T cell tolerance induction,BP,TGFBR2
10616,GO:0043647,0.367932939215818,0.774668412443269,7,50,inositol phosphate metabolic process,BP,INPP5D;ITPK1;NTSR1;ISYNA1;PLCH2;SNCA;ITPKB
16918,GO:0098935,0.367938105802055,0.945417374322279,1,3,dendritic transport,BP,KIF17
16920,GO:0098937,0.367938105802055,0.945417374322279,1,3,anterograde dendritic transport,BP,KIF17
7140,GO:0031010,0.367946487557821,0.876665500258284,2,10,ISWI-type complex,CC,SMARCA1;C17ORF49
9292,GO:0035766,0.368171133452868,0.945340381370597,1,3,cell chemotaxis to fibroblast growth factor,BP,FGFR1
9294,GO:0035768,0.368171133452868,0.945340381370597,1,3,endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
18992,GO:1904847,0.368171133452868,0.945340381370597,1,3,regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19945,GO:2000544,0.368171133452868,0.945340381370597,1,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
2780,GO:0006213,0.368195215346242,0.811372941964009,4,37,pyrimidine nucleoside metabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F;DPYD
2139,GO:0004953,0.368405585394927,0.935618562523245,1,5,icosanoid receptor activity,MF,PPARG
2107,GO:0004887,0.368474614386956,0.939163405233983,1,4,thyroid hormone receptor activity,MF,THRA
1455,GO:0003696,0.368508109993506,0.939151176537865,1,4,satellite DNA binding,MF,MLH3
8310,GO:0033162,0.36861708002766,0.933184844727461,1,6,melanosome membrane,CC,TH
11016,GO:0045009,0.36861708002766,0.933184844727461,1,6,chitosome,CC,TH
16356,GO:0090741,0.36861708002766,0.933184844727461,1,6,pigment granule membrane,CC,TH
12766,GO:0051087,0.368670845237006,0.757182508515635,9,79,chaperone binding,MF,FN1;DNAJB4;TP53;PDPN;CLU;CALR;PRNP;HSPA5;DNAJC3
5554,GO:0016572,0.368674255810991,0.813292010964588,4,29,histone phosphorylation,BP,HMGA2;ATM;PRKCA;MAP3K12
5314,GO:0016042,0.368779281681048,0.714109653511576,22,202,lipid catabolic process,BP,SULT1E1;IRS2;TYSND1;ECH1;CPS1;PLA2G6;ALDH3A2;CPT1A;ACACB;CES2;PLCH2;HSD17B11;PLD3;TRERF1;CES3;DECR1;LIPA;THRA;AIG1;EHHADH;CPT2;ACAA2
8432,GO:0033567,0.369196008884782,0.935313993489349,1,5,DNA replication, Okazaki fragment processing,BP,LIG1
7164,GO:0031056,0.369207147109572,0.73092122335736,15,118,regulation of histone modification,BP,NOS1;SNAI2;TADA3;TP53;MTHFR;SDR16C5;CAMK2D;JARID2;SNCA;KDM4C;ATM;ISL1;BCL6;KDM4A;NIPBL
2706,GO:0006082,0.369226355483483,0.674995460641159,84,817,organic acid metabolic process,BP,SULT1E1;PRODH;NQO1;DDIT4;PTGS1;SLC7A8;IRS2;NOS1;SLC2A3;CRTAP;CSPG4;NR1D1;D2HGDH;SLC27A3;ACSL3;PHGDH;BCKDHB;TYSND1;GPX1;PTGES;ECH1;ERO1B;MTHFR;ABHD14B;B3GAT3;CPS1;CAV1;SLC27A1;HLCS;GLDC;XYLT1;UST;ACSS1;CHST3;HIBADH;ALDH3A2;CPT1A;ACACB;CES2;AARS;BPHL;SNCA;ALDH1L2;CBR1;ALOX15B;PRKAB2;PSMB9;PDK3;DHTKD1;IDH2;GCLC;ACSS2;HEXA;ALDH4A1;THNSL2;ENPP1;SLC27A6;NCOR1;NMNAT2;DECR1;ABCC2;ACSF2;GGT7;DSEL;ZADH2;ALDH7A1;CYP4V2;OSBPL1A;TH;UGT1A3;UGT1A6;SRR;PPARG;TPST1;PRKAG1;GSTZ1;DPYD;AIG1;ACOT1;SCPEP1;EHHADH;ABAT;CPT2;ACAA2
4623,GO:0010749,0.369536474986873,0.944887926672645,1,3,regulation of nitric oxide mediated signal transduction,BP,EGFR
15844,GO:0072595,0.369585032038889,0.795550330201839,5,38,maintenance of protein localization in organelle,BP,SYNE1;BBS4;TAF8;SP100;HSPA5
13860,GO:0060528,0.369665320555271,0.944845110536053,1,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,RXRA
5711,GO:0016854,0.369741027387407,0.871625759579606,2,13,racemase and epimerase activity,MF,DSEL;SRR
12208,GO:0048489,0.369941392575549,0.751205236780198,10,76,synaptic vesicle transport,BP,SYT8;SYN1;SPG11;SYTL1;SYT1;PCLO;SNCA;SEPT5;C2CD4C;DNM1P46
16596,GO:0097480,0.369941392575549,0.751205236780198,10,76,establishment of synaptic vesicle localization,BP,SYT8;SYN1;SPG11;SYTL1;SYT1;PCLO;SNCA;SEPT5;C2CD4C;DNM1P46
18809,GO:1904428,0.370035836233422,0.944721871920769,1,3,negative regulation of tubulin deacetylation,BP,BEX4
10792,GO:0044300,0.370036151033114,0.944721767142055,1,3,cerebellar mossy fiber,CC,DLG4
8898,GO:0034754,0.370433576069025,0.770718252712214,7,63,cellular hormone metabolic process,BP,SULT1E1;SDR16C5;HSD17B11;DGKQ;EGR1;UGT1A3;SCPEP1
2374,GO:0005506,0.370524444380517,0.750056971138462,10,83,iron ion binding,MF,NOS1;P3H2;XDH;PHF2;SNCA;ALOX15B;CALR;CYP20A1;CYP4V2;TH
13482,GO:0055081,0.37082345355053,0.796439277447279,5,32,anion homeostasis,BP,ABCA1;CPS1;ENPP1;KCTD7;ABCC2
7098,GO:0030905,0.370840382156706,0.938296022693611,1,4,retromer, tubulation complex,CC,SNX1
10287,GO:0043084,0.370857717809886,0.938289639175186,1,4,penile erection,BP,OXTR
14336,GO:0061588,0.371004069659482,0.93823573191496,1,4,calcium activated phospholipid scrambling,BP,ANO6
14337,GO:0061589,0.371004069659482,0.93823573191496,1,4,calcium activated phosphatidylserine scrambling,BP,ANO6
14338,GO:0061590,0.371004069659482,0.93823573191496,1,4,calcium activated phosphatidylcholine scrambling,BP,ANO6
14339,GO:0061591,0.371004069659482,0.93823573191496,1,4,calcium activated galactosylceramide scrambling,BP,ANO6
4763,GO:0010952,0.371104158684763,0.72521273143577,16,152,positive regulation of peptidase activity,BP,FN1;CTGF;F2R;GSN;PYCARD;HIP1;FYN;XDH;CAV1;CCK;FBLN1;DAPK1;DLC1;ROBO1;SNCA;PPARG
13721,GO:0060324,0.371273908812828,0.782564475733288,6,41,face development,BP,MMP2;DKK1;BBS4;LEF1;RARA;NIPBL
11987,GO:0047499,0.371496261724065,0.934422705319879,1,5,calcium-independent phospholipase A2 activity,MF,PLA2G6
8980,GO:0035115,0.371540565014995,0.835252884860511,3,20,embryonic forelimb morphogenesis,BP,ZNF358;IFT122;NIPBL
11293,GO:0045636,0.371749396304467,0.944149712761082,1,3,positive regulation of melanocyte differentiation,BP,KITLG
6870,GO:0030375,0.371757617199469,0.944146959042651,1,3,thyroid hormone receptor coactivator activity,MF,NCOA2
17560,GO:1901222,0.371892763278116,0.780562663995035,6,48,regulation of NIK/NF-kappaB signaling,BP,EGFR;PDCD4;TLR3;CALR;UACA;SASH1
12746,GO:0051048,0.3720856288263,0.734760252764254,13,111,negative regulation of secretion,BP,FN1;SFRP1;F2R;GAS6;WNK1;SNCA;PLA2R1;IDH2;HTR1B;RSAD2;PPP3CA;ABAT;OXTR
14733,GO:0070444,0.372156866315434,0.937810107782863,1,4,oligodendrocyte progenitor proliferation,BP,GJC2
14734,GO:0070445,0.372156866315434,0.937810107782863,1,4,regulation of oligodendrocyte progenitor proliferation,BP,GJC2
7326,GO:0031347,0.372294255660423,0.684788585869062,49,452,regulation of defense response,BP,FLOT1;MMP2;HTRA1;IL20RB;HERC5;EGFR;SERPINE1;TKFC;PAK1;NR1D1;EIF2AK4;TRIM5;PDCD4;STAT1;PTPRS;PYCARD;IFIT1;DDX60;MUC19;ITGA2;GPX1;SEC14L1;FYN;CAV1;RNF135;CLU;SERPING1;PER1;TMEM173;APOBEC3G;PRKACB;TLR3;SNCA;APOBEC3F;C5;TGM2;PSMB9;IL18;IFNK;CD1D;MAP3K1;PTPN1;ISL1;BCL6;STAT2;CDK19;RSAD2;PPARG;CALCRL
9290,GO:0035754,0.372335748579644,0.937743902981716,1,4,B cell chemotaxis,BP,GAS6
1324,GO:0003176,0.372378305143153,0.937728146362124,1,4,aortic valve development,BP,BMP4
1327,GO:0003180,0.372378305143153,0.937728146362124,1,4,aortic valve morphogenesis,BP,BMP4
3158,GO:0006768,0.372467194729164,0.872415667171658,2,11,biotin metabolic process,BP,HLCS;ACACB
13728,GO:0060333,0.372537959381767,0.769107373936025,7,62,interferon-gamma-mediated signaling pathway,BP,TRIM38;TRIM5;STAT1;OAS2;CAMK2D;SP100;PPARG
3352,GO:0007089,0.372591257185618,0.937649264094997,1,4,traversing start control point of mitotic cell cycle,BP,MDM2
12629,GO:0050860,0.372663099523326,0.868935080842591,2,14,negative regulation of T cell receptor signaling pathway,BP,PRNP;LGALS3
8589,GO:0034114,0.37295784639428,0.868756407494456,2,14,regulation of heterotypic cell-cell adhesion,BP,FLOT1;MAP2K5
12594,GO:0050805,0.373030603512832,0.793420413910539,5,36,negative regulation of synaptic transmission,BP,PLA2G6;SNCA;SLC24A1;BCHE;HTR1B
11674,GO:0046486,0.373497391805674,0.691999682258222,37,316,glycerolipid metabolic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;OSBPL10;EGFR;MBOAT2;PDGFA;ACSL3;SIK1;GPX1;LPCAT2;KITLG;FYN;CPS1;CAV1;SLC27A1;PLA2G6;SEL1L;OSBPL5;PIK3R1;CPT1A;ANG;CAT;PLCH2;FGFR1;MTMR4;ATM;DGKQ;ETNK2;PGAP1;EFR3A;PIKFYVE;LMF1;AGPAT1;MPPE1;PIK3C2B
14254,GO:0061364,0.373536251274535,0.943549206988633,1,3,apoptotic process involved in luteolysis,BP,SLIT3
18417,GO:1903527,0.373668401500987,0.943504638002443,1,3,positive regulation of membrane tubulation,BP,ASAP1
15093,GO:0071211,0.373763851426904,0.937213817263093,1,4,protein targeting to vacuole involved in autophagy,BP,CLU
4374,GO:0010009,0.373782578066719,0.933529496989381,1,5,cytoplasmic side of endosome membrane,CC,LITAF
13004,GO:0051481,0.373878367160602,0.943433780316823,1,3,negative regulation of cytosolic calcium ion concentration,BP,SLC8A1
9652,GO:0038028,0.373993757504051,0.937128224041577,1,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,C2CD5
3585,GO:0007638,0.37406217143481,0.87770717324621,2,8,mechanosensory behavior,BP,SLITRK6;ETV1
16623,GO:0097527,0.374198819600476,0.933366093742565,1,5,necroptotic signaling pathway,BP,TLR3
6390,GO:0021603,0.37436636383658,0.936989352877421,1,4,cranial nerve formation,BP,HOXA1
20187,GO:2001137,0.374372305142036,0.943266873393932,1,3,positive regulation of endocytic recycling,BP,SORL1
13024,GO:0051541,0.374385814218779,0.936982098543056,1,4,elastin metabolic process,BP,CST3
12572,GO:0050775,0.37488230011577,0.810455972962917,4,25,positive regulation of dendrite morphogenesis,BP,CUL7;CAPRIN2;FBXW8;OBSL1
3312,GO:0007018,0.374998988634501,0.69793180762751,30,229,microtubule-based movement,BP,MYH15;NEFL;WDR66;SPG11;PRKCZ;KIF17;BBS2;IFT140;MYO3B;BBS4;COPG2;TRAK1;SYNE2;DNAL4;IFT27;WDR63;IFT88;STK36;SPA17;WDR19;IFT122;NPHP3;CFAP54;IFT74;MYO9A;DNAH1;ICK;ARL3;MYH11;MYO1C
17431,GO:1900245,0.375081251400362,0.943026781764281,1,3,positive regulation of MDA-5 signaling pathway,BP,DDX60
5446,GO:0016324,0.375092265261847,0.709179633065526,22,172,apical plasma membrane,CC,FN1;ANO1;TNIK;PROM2;EGFR;ITPK1;CSPG4;KCNMA1;PDPN;PRKCZ;SHROOM4;PDE4D;AMOTL1;VANGL2;PODXL;ABCC2;SCNN1A;AMOTL2;IGFBP2;SLC9A4;OXTR;MPDZ
1128,GO:0002718,0.375109161012339,0.790543793260828,5,41,regulation of cytokine production involved in immune response,BP,PRKCZ;TLR3;BCL6;TGFB2;RSAD2
11554,GO:0046131,0.375160289861824,0.8295395580792,3,27,pyrimidine ribonucleoside metabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F
1903,GO:0004591,0.375191966689914,0.936680982329617,1,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1
14595,GO:0070192,0.37538163864525,0.791591802321396,5,36,chromosome organization involved in meiotic cell cycle,BP,NCAPD2;MLH3;ATM;MSH5;AGO4
12708,GO:0050998,0.375440967273816,0.870646949992158,2,11,nitric-oxide synthase binding,MF,CAV1;DNM1P46
3782,GO:0008349,0.375538600668663,0.8722205731643,2,10,MAP kinase kinase kinase kinase activity,MF,TNIK;NRK
655,GO:0001846,0.375583865797067,0.932820616739179,1,5,opsonin binding,MF,CALR
10794,GO:0044302,0.375850755219273,0.942765472182178,1,3,dentate gyrus mossy fiber,CC,MICAL1
13216,GO:0051918,0.375905355786932,0.936413783899973,1,4,negative regulation of fibrinolysis,BP,SERPINE1
16488,GO:0097227,0.375955511816913,0.936394972194153,1,4,sperm annulus,CC,SEPT6
13722,GO:0060325,0.37601444688437,0.809616482383963,4,25,face morphogenesis,BP,MMP2;DKK1;LEF1;NIPBL
16453,GO:0097167,0.376046279705225,0.936360919809731,1,4,circadian regulation of translation,BP,PER1
19527,GO:1990511,0.376082436289819,0.936347352241923,1,4,piRNA biosynthetic process,BP,MYBL1
16747,GO:0098588,0.376200297646294,0.656965653042758,165,1513,bounding membrane of organelle,CC,SYT8;FLOT1;PCDH7;ST6GALNAC2;CD109;SYNE1;MARCH4;PKD2;JPH2;SCARA3;CYBRD1;ANPEP;PROM2;COL7A1;CLTCL1;NOS1;PDGFC;MALL;MAP6;EGFR;GALNT10;SYNE3;SLC2A3;FAM198B;EVC;FAM210B;ASAP2;NSG1;ITM2C;AHNAK;SORL1;ARAP1;KIAA0319L;PTPRS;DLG4;PDGFA;ACSL3;HIP1;SNX1;ANO6;LPCAT2;TBC1D5;SYN1;SPG11;KCNAB2;LRP1;B3GAT3;FUT10;CAV1;SLC22A17;XYLT1;UST;CXCR1;CHST3;EHD3;CAMK2D;GOLGB1;SYT1;TMEM173;ALDH3A2;CPT1A;ACACB;BBS2;APLP2;CAT;ST6GAL2;BACE1;STOM;TLR3;BPHL;MAN1A1;SNCA;FLOT2;MME;VAMP1;FZD7;GLG1;ARMCX2;DKK1;MLEC;SEC24D;SPATA18;CCDC136;LAPTM4A;BBS4;MTMR4;CALR;COPG2;MDM2;ARF6;TMED10;MANBA;AREG;BBS1;ANXA6;SNX10;CD1D;SYNE2;KLHL12;ENPP1;SLC48A1;PRCP;NFASC;NDRG1;GCNT1;TMEM50B;PXMP2;TMEM175;ANXA2;RAB13;FNDC3A;RNF24;MAN2B1;GOLGA8B;MVB12B;TTC8;MOSPD2;NMNAT2;GAL3ST4;RAB43;RET;VPS39;DSEL;SCNN1A;GPR161;MAPK8IP3;C2CD4C;SPPL2B;ULK1;TH;GOPC;PIKFYVE;RSAD2;ITPR2;VPS13C;RHBDD2;GOLGA8N;ATRAID;GALNT2;DERL3;TPST1;LGALS3;ARL3;MIA3;DNAJC3;COG3;RASSF9;SV2A;ABCA2;TMEM67;FZD4;MPPE1;SBF2;PEX1;STEAP2;VPS36;ADAM10;RHOBTB3;LITAF;ATG16L2;GBP3;EDEM1;ABCA5;ZNRF1;DMPK
10334,GO:0043168,0.376332960830487,0.652792706498082,229,1997,anion binding,MF,SERPINE2;SYT8;FN1;PYGB;PRODH;CTGF;FBN1;SFRP1;RHOBTB2;MYH15;TGFBR2;JPH2;PIK3C2G;OSBPL10;TNIK;NOS1;GAS6;COL5A1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;SESN3;MYLK;THBS2;ACTA2;ATP10D;ANXA5;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;VDR;BMP4;ITM2C;TP53I3;SMARCA2;PTK6;SCN8A;EIF2AK4;HS1BP3;D2HGDH;TP53;ARAP1;PTPRS;TTLL11;CUL9;SEC14L2;WNK1;DDX60;SEMA5A;ITGA2;MICAL1;NISCH;ACSL3;HIP1;GPNMB;TEP1;CHD3;SIK1;SNX1;PLEK2;LAMC2;PTGES;CDK14;P3H2;NAV2;ASAP1;SYN1;MTHFR;CCDC80;NEK9;SESN1;NMRK1;LRP1;FYN;XDH;ALPK1;CPS1;HLCS;ERCC6;GLDC;SNX33;MAP3K14;SMARCA1;OSBPL5;ACSS1;SNX29;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;SYTL1;ATP8B2;SYT1;HHAT;TMEM173;ACACB;PCLO;ANG;DYSF;KIF17;CDK18;TTN;APLP2;MLH3;DAPK1;PRKACB;AARS;CHEK2;SNCA;FZD7;FGFR1;IGF1R;SETX;ASTN2;PDE4D;MYO3B;TGM2;OBSCN;ESYT2;PDK3;MYOF;EPHB6;DHTKD1;CHD6;SEPT6;TGFBR3;ATM;ARF6;ANXA6;SNX10;DGKQ;GCLC;NR2F2;ACSS2;MSH5;HSPA12A;MAP3K1;COL5A3;THNSL2;NRK;ENPP1;IFT27;ITPKB;STK16;DDX60L;PRKCA;PRPS2;ANXA2;RAB13;ETNK2;ADAMTS15;HLTF;SEPT5;LANCL1;NMNAT2;GAL3ST4;PAK6;DECR1;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;C2CD4C;OSBPL1A;ULK1;AGRN;ORC4;AGAP1;HSPA5;CDK19;TH;SNX7;MAGI1;PIKFYVE;SRPK2;ITPR2;UGT1A3;SAP30L;OPHN1;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;PITPNC1;PPARG;PARP15;ADAMTSL5;SNX9;ICK;POSTN;ARL3;RARA;ECM2;ABCA2;PRKAG1;TAF1;MPPE1;DPYD;PIK3C2B;SBF2;PEX1;ACTR1B;SEPT9;ABAT;MYH11;VPS36;TTBK2;RHOBTB3;MYO1C;RXRA;C2CD5;GBP3;ABCA5;TAOK3;DMPK
2211,GO:0005104,0.376950371857614,0.871385341455778,2,10,fibroblast growth factor receptor binding,MF,FLRT2;FLRT3
13750,GO:0060364,0.376961899249638,0.936016793753989,1,4,frontal suture morphogenesis,BP,GLI3
8611,GO:0034144,0.377142387768284,0.935948825122153,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
11294,GO:0045637,0.377154037632936,0.710396621551713,20,181,regulation of myeloid cell differentiation,BP,FBN1;INPP5D;SFRP1;ZFP36L1;FAM210B;STAT1;KITLG;RBFOX2;PIK3R1;KLF13;TLR3;MEIS2;ITPKB;PRKCA;ZFPM1;LEF1;LGALS3;RARA;FOS;AGO4
12202,GO:0048483,0.377270190369855,0.80923308141373,4,24,autonomic nervous system development,BP,ADARB1;NAV2;RET;GDNF
2257,GO:0005173,0.377480267717233,0.942209675711016,1,3,stem cell factor receptor binding,MF,KITLG
11610,GO:0046339,0.377646000792043,0.867978720733866,2,12,diacylglycerol metabolic process,BP,ANG;DGKQ
6294,GO:0019915,0.377699966969349,0.776276777645494,6,46,lipid storage,BP,ABCA1;MEST;CAV1;ACACB;ENPP1;PPARG
7117,GO:0030951,0.37780206541779,0.935700027164302,1,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,LMNA
19682,GO:2000047,0.377819265922932,0.93193454506718,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,FLOT1
10955,GO:0044764,0.377982015619007,0.806365510257189,4,29,multi-organism cellular process,BP,GAS6;TKFC;DDX60;SEC14L1
9672,GO:0038083,0.378064256635775,0.790830853477084,5,32,peptidyl-tyrosine autophosphorylation,BP,EGFR;PTK6;FYN;CAV1;IGF1R
3921,GO:0008603,0.378077747257907,0.931831632887436,1,5,cAMP-dependent protein kinase regulator activity,MF,PRKAG1
9485,GO:0036150,0.378152482267264,0.867672123728079,2,12,phosphatidylserine acyl-chain remodeling,BP,OSBPL10;OSBPL5
1839,GO:0004497,0.378279853853149,0.788524676925374,5,39,monooxygenase activity,MF,NOS1;MICAL1;CYP20A1;CYP4V2;TH
19610,GO:1990823,0.378329930367849,0.749569734434254,9,73,response to leukemia inhibitory factor,BP,RFX2;GLDC;SPRY2;JARID2;TLE4;SNX10;KLF5;FZD4;PRDM5
19613,GO:1990830,0.378329930367849,0.749569734434254,9,73,cellular response to leukemia inhibitory factor,BP,RFX2;GLDC;SPRY2;JARID2;TLE4;SNX10;KLF5;FZD4;PRDM5
11751,GO:0046633,0.378371411858245,0.866410290384405,2,13,alpha-beta T cell proliferation,BP,TGFBR2;IL18
16120,GO:0090162,0.378995187820868,0.80739924121868,4,25,establishment of epithelial cell polarity,BP,FRMD4B;ARF6;OPHN1;MYO9A
617,GO:0001787,0.379201902012031,0.931382960653667,1,5,natural killer cell proliferation,BP,IL18
18598,GO:1903912,0.379469033792511,0.935068696060782,1,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,DNAJC3
8996,GO:0035184,0.379487445569176,0.93506170187011,1,4,histone threonine kinase activity,MF,PRKCA
9098,GO:0035405,0.379487445569176,0.93506170187011,1,4,histone-threonine phosphorylation,BP,PRKCA
1495,GO:0003841,0.379504230162561,0.830405715985436,3,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2;LPCAT2;AGPAT1
4775,GO:0010966,0.379538784286265,0.941502793427814,1,3,regulation of phosphate transport,BP,FGFR1
18584,GO:1903894,0.379560032928401,0.86568391627366,2,13,regulation of IRE1-mediated unfolded protein response,BP,PTPN1;HSPA5
12070,GO:0048070,0.379971969258448,0.866567775712352,2,12,regulation of developmental pigmentation,BP,KITLG;HPS4
12132,GO:0048263,0.38000141991311,0.931062767921904,1,5,determination of dorsal identity,BP,DDIT3
17532,GO:1901136,0.380050376926835,0.723698759650952,14,128,carbohydrate derivative catabolic process,BP,SDC3;CSPG4;APOBEC3C;APOBEC3G;APOBEC3F;PDE4D;NAGLU;CST3;MANBA;HEXA;SDC2;AGRN;DPYD;EDEM1
11357,GO:0045746,0.380071467243942,0.803766592422823,4,32,negative regulation of Notch signaling pathway,BP,EGFR;DLK2;BCL6;DLX2
9030,GO:0035264,0.38014082177936,0.725007655529438,14,103,multicellular organism growth,BP,ZFP36L1;SLITRK6;WWTR1;ADARB1;ERCC6;TNS2;BBS2;PDE4D;BBS4;ATM;PLAG1;ETNK2;RARA;NIPBL
15537,GO:0072017,0.380214758820412,0.874171110269741,2,8,distal tubule development,BP,PKD2;KLHL3
11437,GO:0045915,0.380253313150558,0.930961701286779,1,5,positive regulation of catecholamine metabolic process,BP,ABAT
11471,GO:0045964,0.380253313150558,0.930961701286779,1,5,positive regulation of dopamine metabolic process,BP,ABAT
11044,GO:0045063,0.380519280387404,0.86623468533899,2,12,T-helper 1 cell differentiation,BP,SEMA4A;LEF1
20097,GO:2000807,0.380608059252582,0.941133506496255,1,3,regulation of synaptic vesicle clustering,BP,MAGI2
16077,GO:0090087,0.38063891501596,0.67398889861781,55,491,regulation of peptide transport,BP,FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;TCAF1;EGFR;PAK1;BMP4;NR1D1;SORL1;TP53;PYCARD;ACSL3;GLI3;LRP1;FYN;B3GAT3;PLA2G6;PRKCZ;PTPN14;HHAT;TMEM173;CPT1A;ANG;ANK3;TTN;HPS4;STOM;SH3TC2;ALOX15B;C5;LRTOMT;IDH2;MDM2;PTPN1;ISL1;PRKCA;PRNP;TGFB2;SP100;GOPC;RSAD2;ITPR2;MDFIC;DERL3;POSTN;EFNA5;PPP3CA;ABAT;MYO1C;C2CD5;EDEM1
20027,GO:2000675,0.380666330355988,0.934612910485049,1,4,negative regulation of type B pancreatic cell apoptotic process,BP,WFS1
8629,GO:0034186,0.380679563522638,0.934607861976934,1,4,apolipoprotein A-I binding,MF,ABCA1
19602,GO:1990785,0.38068424405087,0.941107140129391,1,3,response to water-immersion restraint stress,BP,MDM2
19160,GO:1905268,0.380756849501967,0.775229691431359,6,40,negative regulation of chromatin organization,BP,SDR16C5;JARID2;PHF2;SNCA;KDM4C;KDM4A
17009,GO:0099515,0.381048681975727,0.871023515853563,2,9,actin filament-based transport,BP,SYNE2;MYO1C
9816,GO:0042059,0.381115035193566,0.786297188617776,5,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,GPRC5A;EGFR;ITGA1;SPRY2;PTPN3
3759,GO:0008307,0.381480637253893,0.792402736844179,5,24,structural constituent of muscle,MF,PLEC;TTN;OBSCN;OBSL1;MYH11
8444,GO:0033596,0.381495548742129,0.940825905555945,1,3,TSC1-TSC2 complex,CC,NEFL
8411,GO:0033504,0.381578173100465,0.940797217572685,1,3,floor plate development,BP,GLI2
17309,GO:1900019,0.381756647557109,0.934196148124775,1,4,regulation of protein kinase C activity,BP,EGFR
17310,GO:1900020,0.381756647557109,0.934196148124775,1,4,positive regulation of protein kinase C activity,BP,EGFR
8780,GO:0034485,0.381876715544373,0.934150154086305,1,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,INPP5D
9782,GO:0040019,0.382028549565559,0.829411242012567,3,18,positive regulation of embryonic development,BP,TENM4;PHLDB1;GDNF
7720,GO:0032226,0.382251173333971,0.930156909175049,1,5,positive regulation of synaptic transmission, dopaminergic,BP,FLOT1
656,GO:0001848,0.382489204224923,0.930060645023431,1,5,complement binding,MF,CALR
15513,GO:0071949,0.382737444950335,0.826844651798678,3,21,FAD binding,MF,PRODH;D2HGDH;MICAL1
1438,GO:0003418,0.382806158214358,0.933793448112867,1,4,growth plate cartilage chondrocyte differentiation,BP,TGFBR2
1442,GO:0003431,0.382806158214358,0.933793448112867,1,4,growth plate cartilage chondrocyte development,BP,TGFBR2
8975,GO:0035102,0.382901311846254,0.864780157075569,2,12,PRC1 complex,CC,PHC2;CBX7
19677,GO:2000036,0.382951534167246,0.828766890065312,3,18,regulation of stem cell population maintenance,BP,HMGA2;KDM4C;YAP1
13963,GO:0060706,0.383230010200807,0.826497278898456,3,21,cell differentiation involved in embryonic placenta development,BP,E2F7;MDFI;NR2F2
150,GO:0000306,0.383240766907396,0.933626245821712,1,4,extrinsic component of vacuolar membrane,CC,ULK1
16779,GO:0098656,0.383253204451945,0.707712106451388,19,151,anion transmembrane transport,BP,SLC7A8;ANO1;IRS2;TCAF1;CLCA2;SLC20A1;NTSR1;ABCA1;SLC7A11;ANO6;SLC38A10;CPT1A;SLC38A2;ACACB;PRKAB2;PRNP;GOPC;ANKH;CPT2
19621,GO:1990851,0.383512066756069,0.940123281330793,1,3,Wnt-Frizzled-LRP5/6 complex,CC,FZD8
13210,GO:0051902,0.383684469040872,0.929576035252297,1,5,negative regulation of mitochondrial depolarization,BP,IFI6
18700,GO:1904180,0.383684469040872,0.929576035252297,1,5,negative regulation of membrane depolarization,BP,IFI6
12367,GO:0048814,0.383697167819669,0.75323231475729,8,57,regulation of dendrite morphogenesis,BP,TNIK;CUL7;CAPRIN2;NFATC4;FBXW8;SDC2;OBSL1;PPP3CA
9490,GO:0036156,0.383711733881117,0.953824473213618,1,2,inner dynein arm,CC,DNAH1
11181,GO:0045332,0.383855586657496,0.832478086315815,3,14,phospholipid translocation,BP,ATP10D;ABCA1;ATP8B2
4857,GO:0014701,0.384128642519304,0.939907415158952,1,3,junctional sarcoplasmic reticulum membrane,CC,JPH2
6580,GO:0022600,0.384141820090483,0.784726912079628,5,36,digestive system process,BP,VDR;WNK1;SOX9;SLC9A4;OXTR
8649,GO:0034235,0.384417311033459,0.929277901266901,1,5,GPI anchor binding,MF,MPPE1
7904,GO:0032488,0.38451029591372,0.865177532119996,2,11,Cdc42 protein signal transduction,BP,ABCA1;RHOBTB3
9128,GO:0035493,0.384561687897651,0.862605860148336,2,13,SNARE complex assembly,BP,VAMP1;UVRAG
11784,GO:0046689,0.384750901397473,0.929141935849145,1,5,response to mercury ion,BP,ABCC2
10539,GO:0043517,0.384818415191634,0.864989717297701,2,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PLA2R1;ATM
3551,GO:0007589,0.3850741778325,0.759871778987625,7,54,body fluid secretion,BP,VDR;WNK1;XDH;CAV1;OAS2;ANXA2;OXTR
8816,GO:0034616,0.385124131102378,0.863415739683823,2,12,response to laminar fluid shear stress,BP,ABCA1;MAP2K5
4052,GO:0009101,0.385183203474319,0.688020503795284,30,253,glycoprotein biosynthetic process,BP,ST6GALNAC2;ADAMTSL1;GALNT10;CSPG4;ITM2C;EXTL2;MUC19;B3GAT3;FUT10;XYLT1;UST;CHST3;ST6GAL2;MAN1A1;ADAMTS7;FOXL1;TRAK1;POGLUT1;VANGL2;GCNT1;GAL3ST4;DSEL;ITM2A;LMF1;ALG10;GALNT2;DERL3;COG3;UGGT2;TUSC3
19150,GO:1905232,0.385276370088096,0.932839657987672,1,4,cellular response to L-glutamate,BP,FYN
12170,GO:0048341,0.38528702474066,0.932835525875133,1,4,paraxial mesoderm formation,BP,LEF1
11596,GO:0046322,0.385444968716664,0.932774253329368,1,4,negative regulation of fatty acid oxidation,BP,ACACB
9708,GO:0038166,0.385489359110366,0.928840386683742,1,5,angiotensin-activated signaling pathway,BP,CAV1
6839,GO:0030317,0.385899125344499,0.80039607818464,4,29,flagellated sperm motility,BP,NPHP4;BBS2;TPGS1;DNAH1
8104,GO:0032803,0.38622976427478,0.928537256965491,1,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,ANXA2
16259,GO:0090382,0.386270155315815,0.798762513963404,4,33,phagosome maturation,BP,SRPX;SPG11;TMEM175;RAB43
8815,GO:0034614,0.3862964986223,0.721813085027438,13,119,cellular response to reactive oxygen species,BP,MMP9;NQO1;PKD2;AXL;EGFR;TP53;PRDX5;PXN;SETX;MDM2;CST3;PXMP2;FOS
9525,GO:0036295,0.386451895326573,0.86143353842702,2,13,cellular response to increased oxygen levels,BP,CAV1;PPARG
12438,GO:0050291,0.386458729537389,0.928443356798214,1,5,sphingosine N-acyltransferase activity,MF,CERS5
5336,GO:0016079,0.386481797231163,0.759423684461296,7,50,synaptic vesicle exocytosis,BP,SYT8;SYN1;SYTL1;SYT1;PCLO;SEPT5;C2CD4C
3830,GO:0008440,0.386498423354201,0.932364698066602,1,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,ITPKB
12551,GO:0050732,0.386571169918087,0.781986705916567,5,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,GPRC5A;SFRP1;PTK6;CAV1;PRKCZ
4631,GO:0010758,0.386629899255644,0.860335976236744,2,14,regulation of macrophage chemotaxis,BP,MMP28;C5
6099,GO:0019336,0.386711188471159,0.928339734385713,1,5,phenol-containing compound catabolic process,BP,LRTOMT
6181,GO:0019614,0.386711188471159,0.928339734385713,1,5,catechol-containing compound catabolic process,BP,LRTOMT
9987,GO:0042424,0.386711188471159,0.928339734385713,1,5,catecholamine catabolic process,BP,LRTOMT
6763,GO:0030206,0.387097563694026,0.826741706634539,3,17,chondroitin sulfate biosynthetic process,BP,CSPG4;XYLT1;CHST3
6280,GO:0019896,0.387270712168244,0.863490214707957,2,11,axonal transport of mitochondrion,BP,NEFL;TRAK1
19658,GO:2000002,0.387349228346062,0.928077440717962,1,5,negative regulation of DNA damage checkpoint,BP,CHEK2
6427,GO:0021700,0.387435417204187,0.706187011483715,18,145,developmental maturation,BP,MMP2;FAT4;AXL;FAM210B;DDIT3;DLG4;ANO6;PLXNB1;ANG;FGFR1;G6PD;NFATC4;L3MBTL3;NFASC;RET;TGFB2;AGRN;PPARG
12642,GO:0050873,0.387692714193537,0.822772630693544,3,22,brown fat cell differentiation,BP,ITGA6;LAMB3;RGS2
15376,GO:0071670,0.387744592733318,0.927914615170596,1,5,smooth muscle cell chemotaxis,BP,PARVA
530,GO:0001649,0.387802745350024,0.706023158999027,18,141,osteoblast differentiation,BP,SFRP1;FBN2;SNAI2;BMP4;MRC2;WWTR1;MEF2D;GPNMB;SMOC1;GLI3;GLI2;CAT;FZD1;AREG;LEF1;IFITM1;TWIST2;ATRAID
13922,GO:0060632,0.387832868378032,0.859582607520566,2,14,regulation of microtubule-based movement,BP,BBS2;BBS4
15187,GO:0071364,0.38805137385247,0.781637063490819,5,36,cellular response to epidermal growth factor stimulus,BP,ZFP36L1;ZFP36L2;SNAI2;EGFR;SOX9
15185,GO:0071362,0.388184770479732,0.931705899872183,1,4,cellular response to ether,BP,NFATC4
11328,GO:0045684,0.388340625932433,0.797813375818747,4,31,positive regulation of epidermis development,BP,VDR;BMP4;ALOX15B;TGFB2
13039,GO:0051570,0.388530824859849,0.825735453874588,3,17,regulation of histone H3-K9 methylation,BP,JARID2;KDM4C;KDM4A
15316,GO:0071569,0.388665315118683,0.924915682259165,1,6,protein ufmylation,BP,CDK5RAP3
11252,GO:0045581,0.388902913896421,0.823101813575106,3,20,negative regulation of T cell differentiation,BP,BMP4;GLI3;BCL6
11270,GO:0045604,0.388913738054991,0.766971109192581,6,47,regulation of epidermal cell differentiation,BP,CD109;ZFP36L1;VDR;BMP4;CTSV;ALOX15B
5787,GO:0017025,0.388927575009547,0.821378675849963,3,23,TBP-class protein binding,MF,THRA;YEATS2;TAF1
16011,GO:0086070,0.389057299580208,0.938164434432645,1,3,SA node cell to atrial cardiac muscle cell communication,BP,GJA5
13253,GO:0051969,0.389085308302604,0.931352477540754,1,4,regulation of transmission of nerve impulse,BP,ITGA2
14936,GO:0070861,0.389253846547103,0.823552577637252,3,19,regulation of protein exit from endoplasmic reticulum,BP,SORL1;DERL3;EDEM1
4677,GO:0010830,0.389271785898712,0.797831346201079,4,29,regulation of myotube differentiation,BP,FLOT1;SIK1;THRA;DMPK
12650,GO:0050885,0.389541030238308,0.799472919217724,4,25,neuromuscular process controlling balance,BP,NEFL;DLG4;RBFOX2;AARS
19868,GO:2000381,0.389805348660738,0.931069082937001,1,4,negative regulation of mesoderm development,BP,DKK1
13377,GO:0052743,0.389847700849212,0.861905454024779,2,11,inositol tetrakisphosphate phosphatase activity,MF,INPP5D;ITPK1
10359,GO:0043201,0.390036219875322,0.863512905915296,2,10,response to leucine,BP,SESN3;SESN1
3531,GO:0007520,0.390062340032604,0.822276900410319,3,20,myoblast fusion,BP,FLOT1;NOS1;MYOF
15975,GO:0086014,0.390074211805501,0.863489705110787,2,10,atrial cardiac muscle cell action potential,BP,GJA5;KCNJ5
15985,GO:0086026,0.390074211805501,0.863489705110787,2,10,atrial cardiac muscle cell to AV node cell signaling,BP,GJA5;KCNJ5
16007,GO:0086066,0.390074211805501,0.863489705110787,2,10,atrial cardiac muscle cell to AV node cell communication,BP,GJA5;KCNJ5
7205,GO:0031110,0.390121994248922,0.747807640933631,8,57,regulation of microtubule polymerization or depolymerization,BP,STMN3;PAK1;MAP2;EML2;SNCA;RGS2;ARHGEF2;TTBK2
2666,GO:0006020,0.390165218311853,0.863434121357461,2,10,inositol metabolic process,BP,ITPK1;ISYNA1
15852,GO:0072611,0.390168709957827,0.926911344676214,1,5,interleukin-13 secretion,BP,PRKCZ
20018,GO:2000665,0.390168709957827,0.926911344676214,1,5,regulation of interleukin-13 secretion,BP,PRKCZ
1431,GO:0003407,0.390288478472528,0.781641980812377,5,31,neural retina development,BP,SDK1;PTPRM;SOX9;TGFB2;DLX2
9543,GO:0036337,0.390690138298256,0.930719859002614,1,4,Fas signaling pathway,BP,SP100
3016,GO:0006564,0.390742458470701,0.924025332319509,1,6,L-serine biosynthetic process,BP,PHGDH
14621,GO:0070235,0.390886494338234,0.926612644389645,1,5,regulation of activation-induced cell death of T cells,BP,TSC22D3
1357,GO:0003229,0.391024948082348,0.78105964084017,5,31,ventricular cardiac muscle tissue development,BP,TGFBR3;ENG;ISL1;TGFB2;RXRA
6893,GO:0030478,0.391081551717276,0.930565021535596,1,4,actin cap,CC,GSN
681,GO:0001892,0.391425120373599,0.738818233617984,9,69,embryonic placenta development,BP,ZFP36L1;PKD2;EGFR;E2F7;MDFI;NR2F2;FBXW8;NRK;LEF1
16232,GO:0090316,0.391620403155424,0.702039866609877,18,154,positive regulation of intracellular protein transport,BP,GAS6;TCAF1;PAK1;SORL1;TP53;GLI3;FYN;B3GAT3;HHAT;TMEM173;ANK3;HPS4;STOM;MDM2;PRNP;MYO1C;C2CD5;EDEM1
2989,GO:0006536,0.391645058446038,0.819428303315386,3,23,glutamate metabolic process,BP,PRODH;GCLC;ALDH4A1
4250,GO:0009581,0.391661011452729,0.755748567773324,7,47,detection of external stimulus,BP,SERPINE2;ANO1;PKD2;NTSR1;ITGA2;FYN;TTN
7438,GO:0031584,0.391906397643176,0.926186934827322,1,5,activation of phospholipase D activity,BP,PRKCZ
10735,GO:0044183,0.39212952562166,0.793985200601093,4,34,protein binding involved in protein folding,MF,HSPA2;CALR;HSPA5;PIKFYVE
14933,GO:0070857,0.392182091942588,0.926071600206299,1,5,regulation of bile acid biosynthetic process,BP,NR1D1
1576,GO:0003988,0.392293538605475,0.923356298005228,1,6,acetyl-CoA C-acyltransferase activity,MF,ACAA2
5278,GO:0015936,0.392465046276424,0.855797528321535,2,15,coenzyme A metabolic process,BP,DCAKD;PPCS
12885,GO:0051258,0.392577609962302,0.689271435875592,24,205,protein polymerization,BP,GSN;SPTB;PAK1;NEFL;PYCARD;MAP2;EML2;ARHGAP18;ARPIN;KANK2;ANG;SNCA;RGS2;TRIOBP;BBS4;ARF6;FHOD3;CDC42EP5;MSRB2;CAPG;WIPF1;RASA1;DNM1P46;MYO1C
9167,GO:0035561,0.392713210116942,0.819749928648102,3,21,regulation of chromatin binding,BP,NFATC4;HMBOX1;PPP3CA
15885,GO:0072687,0.392846360644455,0.929864234381035,1,4,meiotic spindle,CC,HSPA2
10833,GO:0044352,0.392885762744031,0.92984853855716,1,4,pinosome,CC,ANXA2
10834,GO:0044354,0.392885762744031,0.92984853855716,1,4,macropinosome,CC,ANXA2
12678,GO:0050923,0.39303363464948,0.936735490830896,1,3,regulation of negative chemotaxis,BP,ROBO1
12162,GO:0048318,0.393115114475512,0.925680457401318,1,5,axial mesoderm development,BP,POGLUT1
880,GO:0002248,0.393181100018901,0.925652746898726,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R
11424,GO:0045898,0.393410048335544,0.85707496354767,2,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;THRA
9351,GO:0035886,0.393497413938912,0.857019806018284,2,13,vascular smooth muscle cell differentiation,BP,PDCD4;ENG
18132,GO:1902905,0.393516330739925,0.702932024160687,17,144,positive regulation of supramolecular fiber organization,BP,CTGF;SFRP1;GSN;S100A10;PAK1;PYCARD;SEMA5A;GPX1;CLU;ARPIN;PXN;RGS2;ARF6;CDC42EP5;FHOD1;WIPF1;MYO1C
7765,GO:0032300,0.39355822619051,0.858176018899163,2,12,mismatch repair complex,CC,MLH3;MSH5
10064,GO:0042584,0.393602541240247,0.929562630586193,1,4,chromaffin granule membrane,CC,SYT1
1270,GO:0003062,0.393972691940118,0.929414703436095,1,4,regulation of heart rate by chemical signal,BP,PDE4D
5926,GO:0018210,0.394096503646541,0.71587165328014,13,102,peptidyl-threonine modification,BP,DDIT4;TGFBR2;GALNT10;WNK1;CAMK2D;SPRY2;CHEK2;DGKQ;PRKCA;MAP3K12;ULK1;GALNT2;TAF1
15849,GO:0072606,0.39411745730573,0.855613810583591,2,14,interleukin-8 secretion,BP,F2R;PYCARD
17730,GO:1901723,0.394287381529913,0.925187221162376,1,5,negative regulation of cell proliferation involved in kidney development,BP,BMP4
6496,GO:0021872,0.394337090767966,0.776949831971982,5,35,forebrain generation of neurons,BP,GLI3;ROBO1;FGFR1;DLX2;LEF1
13865,GO:0060536,0.394341642777169,0.929267064630772,1,4,cartilage morphogenesis,BP,SNAI2
9365,GO:0035914,0.394349515178952,0.776625457146672,5,36,skeletal muscle cell differentiation,BP,NUPR1;MEF2D;EGR1;KLF5;FOS
7076,GO:0030881,0.394376663125264,0.922452135125834,1,6,beta-2-microglobulin binding,MF,CD1D
20236,GO:2001225,0.39439303851114,0.925142667087673,1,5,regulation of chloride transport,BP,PRNP
17882,GO:1902219,0.394395498054423,0.929245498013243,1,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
15104,GO:0071225,0.394628569850399,0.929152116307871,1,4,cellular response to muramyl dipeptide,BP,ARHGEF2
6846,GO:0030325,0.394665863890016,0.858917586005106,2,11,adrenal gland development,BP,PBX1;CITED2
10335,GO:0043169,0.394761439678866,0.631057605312511,335,2963,cation binding,MF,CPA4;SYT8;MMP2;PCDH7;MMP9;CCBE1;ADAM19;FBN1;ITGA6;MMP28;ZFP36L1;FAT4;TGFBR2;PTGS1;EFEMP1;ASAP3;MARCH4;GSN;COL5A2;PKD2;PITPNM3;CYBRD1;NID1;ZFP36L2;ANPEP;ZNF362;NOS1;GAS6;FBN2;SNAI2;SULF2;COL5A1;PHF21A;UTRN;GALNT10;KLF8;PEG10;ITPK1;TCHH;SLC8A1;CLCA2;SESN3;MYLK;THBS2;TRIM2;ZNF608;ATP10D;ENDOD1;RNF213;S100A10;RNF165;ANXA5;TKFC;MAP3K6;ASAP2;TIMP2;ZNF862;PDLIM2;VDR;CHN2;APOBEC3C;PADI3;TRIM38;NR1D1;XAF1;TRIM5;VAV3;NR3C1;COL18A1;KCNMA1;TP53;ARAP1;EXTL2;MBNL2;PRICKLE1;CUL9;ZBTB20;LTBP1;ZC3H6;WNK1;EFHC1;ITGA2;ZCCHC11;MMP19;MICAL1;ADARB1;TIMP1;EFEMP2;FLG;SMOC1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;PCDHAC2;HIVEP1;GLI3;LPCAT2;P3H2;ASAP1;CTDSPL;LIMCH1;ZFP90;NEK9;SESN1;NMRK1;LRP1;FYN;XDH;TSHZ2;B3GAT3;LTBP4;CPS1;FAT2;GLI2;PIAS3;RNF135;ITGA10;SLC2A4RG;GLDC;ZNF318;ACSS1;FKBP9;PRKCZ;SLIT3;OAS2;ZNF678;GPR39;TNS2;EHD3;PHC2;ITGA1;SYTL1;ZSCAN18;ATP8B2;PXN;SYT1;CAPRIN2;ACACB;APOBEC3G;PCLO;ANG;DYSF;UHRF2;TTN;PRDM8;LMO7;APLP2;CRELD2;FBLN1;ZKSCAN1;TP73;CAT;PLCH2;KLF13;PRKACB;AARS;CHEK2;WDFY2;PHF2;MAN1A1;ZNF860;SNCA;ADAMTS7;MME;GATAD1;JADE2;SP110;DZIP1L;APOBEC3F;ALOX15B;SEC24D;LTBP3;ASTN2;PDE4D;TMEM129;TGM2;OBSCN;SULF1;ESYT2;ARSD;ZNF618;DHTKD1;KDM4C;SLC24A1;CDH13;TRAF1;LMCD1;DTNB;NOTCH2NL;L3MBTL3;MTMR4;ZNF699;CALR;IDH2;MDM2;DLK2;ZNF107;ANXA6;AKAP13;DGKQ;GCLC;NR2F2;ACSS2;NEURL1B;LMO4;ZNF449;ZMAT3;CYP20A1;ZBTB22;RNPEP;MAP3K1;FGD4;PTPN1;CRIP2;NT5DC3;ARHGEF2;THNSL2;ZNF546;EGR1;ENPP1;ISL1;BCL6;PCDHGA11;ZNF717;PLAG1;PRKCA;SALL2;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;PRIMPOL;AMZ2;ADAMTS15;HLTF;RNF24;MAN2B1;TSHZ1;LANCL1;TES;ZNF160;MEGF8;ZNF302;HTR1B;IRF2BPL;STK36;MUTYH;PRNP;CDH11;RET;ZFPM1;MAP2K5;ZNF550;LIG1;ZNF701;THRA;FHL1;ZADH2;CYP4V2;MSRB2;C2CD4C;PPM1M;ZSCAN30;AGRN;NPEPL1;VAV2;AGAP1;HSPA5;TH;PIKFYVE;FLYWCH1;TGFB1I1;RSAD2;SRPK2;ITPR2;ARHGAP29;YPEL4;SAP30L;ZNF12;MYO9A;KLF5;CAPS;SRR;GALNT2;ZNF558;PPARG;RNF144B;KCNIP3;MLLT6;KLF7;ICK;ING4;POSTN;UNK;ARL3;FKBP10;RARA;POLH;PRKAG1;TSHZ3;MPPE1;ZNF883;ZBTB1;DPYD;PPP3CA;LIMA1;CTDSP2;STEAP2;KDM4A;ZBTB25;CACNA2D3;MATN3;NPAS2;ABAT;BSN;PCDHGB5;ADAM10;PRDM5;RNPEPL1;PPP2R3A;CELSR1;ZNF471;LITAF;S100A11;RXRA;C2CD5;EDEM1;ZNF484;ZNRF1;DMPK
16236,GO:0090324,0.395046402608093,0.924866790469486,1,5,negative regulation of oxidative phosphorylation,BP,SNCA
19485,GO:1990391,0.395069987722024,0.776049481763356,5,36,DNA repair complex,CC,XPC;PHF21A;MLH3;ATM;MSH5
1399,GO:0003334,0.395126871159946,0.858630000765687,2,11,keratinocyte development,BP,FLNB;IFT74
9156,GO:0035529,0.395265401063009,0.924774180924934,1,5,NADH pyrophosphatase activity,MF,ENPP1
18338,GO:1903361,0.395510405052791,0.924670491101113,1,5,protein localization to basolateral plasma membrane,BP,CAV1
12240,GO:0048549,0.395780286339282,0.928689553424272,1,4,positive regulation of pinocytosis,BP,AXL
4244,GO:0009448,0.396023391959629,0.928591676670237,1,4,gamma-aminobutyric acid metabolic process,BP,ABAT
14206,GO:0061200,0.396024617416398,0.924452582119275,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,SYT1
14207,GO:0061202,0.396024617416398,0.924452582119275,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,SYT1
11455,GO:0045935,0.396165450357904,0.639658846888963,144,1268,positive regulation of nucleobase-containing compound metabolic process,BP,SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;F2R;TNNI2;ETV5;PKD2;ZFP36L2;NOS1;PDGFC;MAGED1;EGFR;RFX2;SERPINE1;TIMP2;TADA3;VDR;BMP4;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;MEF2D;SEC14L2;PDGFA;TFDP2;NFIX;GLI3;E2F7;KITLG;ABHD14B;ZFP90;ADIRF;GLI2;ERCC6;SMARCA1;ZNF318;TP53INP1;HMGA2;IL31RA;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;TP73;KLF13;CHEK2;PHF2;TLR3;FZD7;FGFR1;IGF1R;SETX;NCOA2;IL18;FZD8;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;DLX3;FZD1;PBX1;ENG;CALR;ATM;CST3;MEIS2;AREG;TCF4;CITED2;NR2F2;LMO4;MAF;PTPN1;ARHGEF2;EGR1;SOX9;ISL1;STK16;CRTC1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TCF12;HMBOX1;NFAT5;IRF2BPL;MAML2;TAF8;RET;CARF;ZFPM1;TGFB2;MAP2K5;DLX2;GPR161;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;YAP1;GDNF;KLF5;MEIS3;PPARG;MEF2A;KLF7;RARA;PBX2;TAF1;FZD4;NAT14;PPP3CA;CREBRF;ETV4;FOS;CDK5RAP3;FAM168A;MED12;NPAS2;NIPBL;LITAF;RXRA
17084,GO:0101023,0.396531959547819,0.857751640863699,2,11,vascular endothelial cell proliferation,BP,FGFR1;PPARG
19274,GO:1905562,0.396531959547819,0.857751640863699,2,11,regulation of vascular endothelial cell proliferation,BP,FGFR1;PPARG
10080,GO:0042609,0.396538659293292,0.924234358339955,1,5,CD4 receptor binding,MF,FYN
6470,GO:0021817,0.396681387790962,0.93540659926076,1,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,SYNE2
7610,GO:0032011,0.396735079968169,0.762227284926901,6,40,ARF protein signal transduction,BP,ASAP3;ASAP2;ARAP1;ASAP1;IQSEC2;AGAP1
7611,GO:0032012,0.396735079968169,0.762227284926901,6,40,regulation of ARF protein signal transduction,BP,ASAP3;ASAP2;ARAP1;ASAP1;IQSEC2;AGAP1
1982,GO:0004704,0.396846649102271,0.924103423320553,1,5,NF-kappaB-inducing kinase activity,MF,MAP3K14
1301,GO:0003140,0.39685933528735,0.928254482220627,1,4,determination of left/right asymmetry in lateral mesoderm,BP,CITED2
9065,GO:0035333,0.396924215270159,0.856057055815098,2,12,Notch receptor processing, ligand-dependent,BP,APH1B;ADAM10
4175,GO:0009256,0.397140549738583,0.928140827275933,1,4,10-formyltetrahydrofolate metabolic process,BP,ALDH1L2
9371,GO:0035926,0.397282993174621,0.923917683104509,1,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN
6399,GO:0021631,0.397374514535061,0.935152127998571,1,3,optic nerve morphogenesis,BP,GLI3
3582,GO:0007632,0.397467429749224,0.774445761246364,5,35,visual behavior,BP,NETO1;NPHP4;MEIS2;RGS14;HOXA1
1947,GO:0004653,0.397542076131878,0.855666367333977,2,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT10;GALNT2
5935,GO:0018243,0.397542076131878,0.855666367333977,2,12,protein O-linked glycosylation via threonine,BP,GALNT10;GALNT2
11898,GO:0046965,0.397675008799729,0.857035044371872,2,11,retinoid X receptor binding,MF,VDR;PPARG
2870,GO:0006366,0.397713657675816,0.633778950755471,196,1756,transcription by RNA polymerase II,BP,HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;ETV5;PKD2;TSC22D1;ZFP36L2;NOS1;SNAI2;MAGED1;PHF21A;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;TADA3;CBX5;VDR;BMP4;NR1D1;SMARCA2;CITED4;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;DDIT3;ZBTB20;ZC3H6;MEF2D;TFDP2;ITGA3;CHD3;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;ERCC6;SLC2A4RG;TCEAL3;SDR16C5;HMGA2;CAMK2D;KANK2;ZSCAN18;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;WFS1;MDFI;JARID2;TCEAL8;TP73;KLF13;TLR3;SNCA;GATAD1;SP110;FGFR1;DKK1;SETX;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;FZD8;TCEAL1;SETBP1;SOX13;KDM4C;CHD6;CDH13;NFATC4;FOXN3;LMCD1;TGFBR3;DLX3;FZD1;PBX1;ENG;FOXL1;CALR;MDM2;MEIS2;TCF4;DGKQ;CITED2;NR2F2;CBX7;LMO4;MAF;TRAK1;ARHGEF2;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;PLAG1;SALL2;MYBL1;TRERF1;HLTF;HOXA1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;ZNF160;MEGF8;IRF2BPL;MAML2;TAF8;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;STAT2;LEF1;THRA;SSBP3;SP100;TEF;AGRN;HSPA5;TGFB1I1;FHOD1;IFT74;ZNF12;YAP1;GDNF;KLF5;YEATS2;HOXA3;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;KLF7;TGIF1;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;ZBTB1;PPP3CA;CREBRF;ETV4;HOXA2;FOS;CDK5RAP3;MED12;NPAS2;NIPBL;PRDM5;LITAF;RXRA
7635,GO:0032057,0.397870871564831,0.927845140730505,1,4,negative regulation of translational initiation in response to stress,BP,EIF2AK4
6812,GO:0030280,0.398126488094872,0.855296334330889,2,12,structural constituent of epidermis,MF,FLG;KRT10
13878,GO:0060558,0.398192224586241,0.923529748763344,1,5,regulation of calcidiol 1-monooxygenase activity,BP,VDR
7971,GO:0032596,0.398404100082394,0.923439174967503,1,5,protein transport into membrane raft,BP,REEP2
14066,GO:0060923,0.398411922842428,0.923435829583323,1,5,cardiac muscle cell fate commitment,BP,DKK1
4674,GO:0010827,0.398461059090911,0.749211398250306,7,51,regulation of glucose transmembrane transport,BP,IRS2;CLTCL1;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
14885,GO:0070742,0.398503374404792,0.855057445238538,2,12,C2H2 zinc finger domain binding,MF,HMGA2;LEF1
14908,GO:0070821,0.398577868634567,0.759673845973084,6,44,tertiary granule membrane,CC,SLC2A3;ANO6;KCNAB2;STOM;VAMP1;ADAM10
11757,GO:0046639,0.39862972653402,0.856435108435737,2,11,negative regulation of alpha-beta T cell differentiation,BP,GLI3;BCL6
6543,GO:0021978,0.398715677580949,0.923305859964256,1,5,telencephalon regionalization,BP,BMP4
6061,GO:0019215,0.398716907873108,0.856380260586572,2,11,intermediate filament binding,MF,KRT14;VIM
14626,GO:0070245,0.398745860308766,0.923292938054846,1,5,positive regulation of thymocyte apoptotic process,BP,TP53
15065,GO:0071107,0.39882939903715,0.934615941700658,1,3,response to parathyroid hormone,BP,ITGA2
8338,GO:0033211,0.398864172884323,0.923242272826863,1,5,adiponectin-activated signaling pathway,BP,SLC27A1
8844,GO:0034656,0.399015292265684,0.788119004947999,4,36,nucleobase-containing small molecule catabolic process,BP,APOBEC3C;APOBEC3G;APOBEC3F;DPYD
7367,GO:0031430,0.399041076845264,0.825513364264423,3,12,M band,CC,TTN;OBSCN;OBSL1
8778,GO:0034481,0.399113270188413,0.927340396113809,1,4,chondroitin sulfotransferase activity,MF,CHST3
18135,GO:1902911,0.399172893393139,0.719986271527383,11,90,protein kinase complex,CC,TGFBR2;PYCARD;CDK14;TBC1D5;PHKA2;PRKAB2;ENG;ULK1;UVRAG;CCNY;PRKAG1
14648,GO:0070290,0.39953989655684,0.927166567982405,1,4,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
1605,GO:0004030,0.399577627690573,0.922936311484034,1,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,ALDH3A2
16935,GO:0098976,0.399608180487863,0.927138721859588,1,4,excitatory chemical synaptic transmission,BP,SSH1
18023,GO:1902581,0.399840794363478,0.92282326435839,1,5,multi-organism cellular localization,BP,IFIT1
18024,GO:1902583,0.399840794363478,0.92282326435839,1,5,multi-organism intracellular transport,BP,IFIT1
20228,GO:2001205,0.400290763815858,0.934074568323221,1,3,negative regulation of osteoclast development,BP,FBN1
11565,GO:0046164,0.400320297384829,0.788587183766476,4,31,alcohol catabolic process,BP,SULT1E1;TKFC;NTSR1;TRERF1
17348,GO:1900103,0.400330069052111,0.852672741813648,2,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PIK3R1;PTPN1
7430,GO:0031571,0.40044601895183,0.73747218100299,8,68,mitotic G1 DNA damage checkpoint,BP,TP53;TFDP2;E2F7;TP73;CHEK2;ATM;MDM2;RBL2
10985,GO:0044819,0.40044601895183,0.73747218100299,8,68,mitotic G1/S transition checkpoint,BP,TP53;TFDP2;E2F7;TP73;CHEK2;ATM;MDM2;RBL2
13670,GO:0060251,0.400519563332348,0.81721682927869,3,17,regulation of glial cell proliferation,BP,ETV5;IDH2;PLAG1
10496,GO:0043426,0.400558162843297,0.926750633410454,1,4,MRF binding,MF,TSC22D3
6581,GO:0022602,0.400558420702481,0.790519594716188,4,26,ovulation cycle process,BP,MMP19;SLIT3;TGFB2;FZD4
7577,GO:0031956,0.400672677078179,0.926703765272501,1,4,medium-chain fatty acid-CoA ligase activity,MF,ACSL3
17116,GO:0102391,0.400672677078179,0.926703765272501,1,4,decanoate-CoA ligase activity,MF,ACSL3
12706,GO:0050996,0.400674524910643,0.856937687199493,2,10,positive regulation of lipid catabolic process,BP,IRS2;CPT1A
16194,GO:0090269,0.400747326781237,0.933904854686449,1,3,fibroblast growth factor production,BP,FGFR1
16195,GO:0090270,0.400747326781237,0.933904854686449,1,3,regulation of fibroblast growth factor production,BP,FGFR1
8262,GO:0033079,0.400847489397602,0.922389879950341,1,5,immature T cell proliferation,BP,BMP4
1344,GO:0003208,0.400884449800121,0.758809380561072,6,40,cardiac ventricle morphogenesis,BP,TGFBR2;TGFBR3;ENG;ISL1;TGFB2;RXRA
6289,GO:0019905,0.401150316364613,0.737495727457058,8,63,syntaxin binding,MF,SYT8;ABCA1;SYTL1;SYT1;DAPK1;VAMP1;TMED10;C2CD4C
17441,GO:1900273,0.401315414041452,0.854740563780441,2,11,positive regulation of long-term synaptic potentiation,BP,EIF2AK4;CRTC1
5368,GO:0016185,0.401317805128684,0.926439380163493,1,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,DNM1P46
16868,GO:0098844,0.401317805128684,0.926439380163493,1,4,postsynaptic endocytic zone membrane,CC,DNM1P46
16886,GO:0098884,0.401317805128684,0.926439380163493,1,4,postsynaptic neurotransmitter receptor internalization,BP,DNM1P46
10598,GO:0043615,0.401867848351229,0.921949083987318,1,5,astrocyte cell migration,BP,APCDD1
10016,GO:0042487,0.402217280755628,0.921797774431598,1,5,regulation of odontogenesis of dentin-containing tooth,BP,BMP4
8051,GO:0032731,0.402240001120739,0.812857223386935,3,21,positive regulation of interleukin-1 beta production,BP,PYCARD;EGR1;ISL1
3125,GO:0006707,0.402241349894487,0.921787345464351,1,5,cholesterol catabolic process,BP,TRERF1
5350,GO:0016127,0.402241349894487,0.921787345464351,1,5,sterol catabolic process,BP,TRERF1
7627,GO:0032048,0.40242083231325,0.850284681242754,2,14,cardiolipin metabolic process,BP,SLC27A1;PLA2G6
18588,GO:1903898,0.402422459460373,0.921708844569861,1,5,negative regulation of PERK-mediated unfolded protein response,BP,PTPN1
11150,GO:0045239,0.402505260556953,0.851274991431436,2,13,tricarboxylic acid cycle enzyme complex,CC,BCKDHB;DHTKD1
1929,GO:0004630,0.402585390279575,0.921638181573876,1,5,phospholipase D activity,MF,PLD3
9454,GO:0036091,0.402714548624406,0.925864938337916,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,CHD6
19498,GO:1990414,0.402812134620293,0.92582469991576,1,4,replication-born double-strand break repair via sister chromatid exchange,BP,NIPBL
17768,GO:1901879,0.402946593085923,0.737226776689381,8,55,regulation of protein depolymerization,BP,GSN;SPTB;SEMA5A;TRIOBP;ARHGEF2;CAPG;LIMA1;TTBK2
16563,GO:0097411,0.403032899880995,0.925733619803991,1,4,hypoxia-inducible factor-1alpha signaling pathway,BP,PDK3
1897,GO:0004583,0.403231611615192,0.925651578668673,1,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,ALG10
9396,GO:0035977,0.403233314970352,0.925650875168604,1,4,protein deglycosylation involved in glycoprotein catabolic process,BP,EDEM1
16589,GO:0097466,0.403233314970352,0.925650875168604,1,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,EDEM1
18789,GO:1904382,0.403233314970352,0.925650875168604,1,4,mannose trimming involved in glycoprotein ERAD pathway,BP,EDEM1
18873,GO:1904587,0.403233314970352,0.925650875168604,1,4,response to glycoprotein,BP,EDEM1
10973,GO:0044793,0.403535898330916,0.925525839916847,1,4,negative regulation by host of viral process,BP,EIF2AK4
10988,GO:0044828,0.403535898330916,0.925525839916847,1,4,negative regulation by host of viral genome replication,BP,EIF2AK4
13537,GO:0060029,0.403570976263632,0.925511336341118,1,4,convergent extension involved in organogenesis,BP,VANGL2
11668,GO:0046476,0.403795909889394,0.921111945583856,1,5,glycosylceramide biosynthetic process,BP,UGT8
11330,GO:0045686,0.403911455917244,0.85160743212375,2,12,negative regulation of glial cell differentiation,BP,DLX2;KDM4A
18556,GO:1903828,0.404316512170729,0.726776206654936,9,77,negative regulation of cellular protein localization,BP,GAS6;SNX33;ASTN2;ARF6;SP100;GOPC;MDFIC;DERL3;TTBK2
7084,GO:0030890,0.404468341702865,0.810098947970161,3,23,positive regulation of B cell proliferation,BP,IRS2;VAV3;BCL6
1709,GO:0004303,0.404591522886313,0.915914967830415,1,7,estradiol 17-beta-dehydrogenase activity,MF,HSD17B11
15803,GO:0072537,0.404658908154761,0.920735453201508,1,5,fibroblast activation,BP,GCLC
5070,GO:0015298,0.404953642668903,0.811530847148434,3,20,solute:cation antiporter activity,MF,SLC8A1;SLC24A1;SLC9A4
20238,GO:2001228,0.405130309801286,0.947721940043344,1,2,regulation of response to gamma radiation,BP,ATM
16925,GO:0098957,0.405187583070333,0.924841010656157,1,4,anterograde axonal transport of mitochondrion,BP,TRAK1
6916,GO:0030518,0.405214452758352,0.70192856702647,14,113,intracellular steroid hormone receptor signaling pathway,BP,SFRP1;SKP2;TADA3;PAK1;NR3C1;RBFOX2;KANK2;PER1;CALR;ISL1;TGFB1I1;YAP1;TAF1;MED12
13545,GO:0060041,0.405265525330124,0.715851399634929,11,77,retina development in camera-type eye,BP,SDK1;PTPRM;NPHP4;IFT140;SOX9;RET;TGFB2;DLX2;COL4A1;FZD4;LAMB2
1881,GO:0004563,0.405298319016019,0.920455787648716,1,5,beta-N-acetylhexosaminidase activity,MF,HEXA
4409,GO:0010172,0.405446249141463,0.853936859183234,2,10,embryonic body morphogenesis,BP,PHLDB1;IFT122
9874,GO:0042171,0.405468569022763,0.811154225065018,3,20,lysophosphatidic acid acyltransferase activity,MF,MBOAT2;LPCAT2;AGPAT1
15345,GO:0071617,0.405468569022763,0.811154225065018,3,20,lysophospholipid acyltransferase activity,MF,MBOAT2;LPCAT2;AGPAT1
2807,GO:0006269,0.405571631138741,0.920336060331855,1,5,DNA replication, synthesis of RNA primer,BP,PRIMPOL
9825,GO:0042088,0.405738483095987,0.808672835642403,3,24,T-helper 1 type immune response,BP,SEMA4A;IL18;LEF1
441,GO:0001190,0.40574031430235,0.743915893019782,7,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SMARCA2;CITED4;CITED2;ISL1;MEF2A;FOS;MED12
11183,GO:0045334,0.405752338515444,0.767140944517736,5,37,clathrin-coated endocytic vesicle,CC,CLTCL1;EGFR;HIP1;TBC1D5;FZD4
7560,GO:0031932,0.40577418949527,0.849161784690996,2,13,TORC2 complex,CC,SESN3;SESN1
825,GO:0002102,0.405886175999164,0.785892156865261,4,27,podosome,CC,GSN;ASAP1;FSCN1;ARHGEF2
4256,GO:0009597,0.406153605891686,0.92008074842573,1,5,detection of virus,BP,TLR3
4760,GO:0010948,0.406268952616008,0.666645109477445,31,295,negative regulation of cell cycle process,BP,CDKN2B;ZFP36L1;PKD2;ZFP36L2;GJC2;TOM1L2;CBX5;BMP4;TP53;GPNMB;TFDP2;E2F7;CTDSPL;HMGA2;KANK2;TP73;CHEK2;FBXL7;PSMB9;FOXN3;CALR;ATM;MDM2;BCL6;RBL2;FHL1;TMEM67;CTDSP2;KLHL22;CDK5RAP3;TAOK3
4384,GO:0010041,0.406306256205181,0.920013697066436,1,5,response to iron(III) ion,BP,G6PD
287,GO:0000792,0.406349431551182,0.732625639128008,8,66,heterochromatin,CC,CBX5;HMGA2;PHC2;UHRF2;KDM4C;CDKN2A;CENPA;KDM4A
4525,GO:0010595,0.406580865452715,0.72544128432286,9,71,positive regulation of endothelial cell migration,BP,CCBE1;BMP4;SEMA5A;FGFR1;AMOTL1;CALR;PRKCA;SASH1;ADGRA2
12206,GO:0048487,0.406779694644723,0.783200957898221,4,32,beta-tubulin binding,MF,SNCA;RGS2;BBS4;IFT74
2499,GO:0005751,0.40679630714813,0.911281085328763,1,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2
6231,GO:0019788,0.406905874790393,0.916876109891193,1,6,NEDD8 transferase activity,MF,MDM2
20276,GO:2001293,0.406963488835086,0.931566707680189,1,3,malonyl-CoA metabolic process,BP,ACACB
11580,GO:0046209,0.40727312637368,0.752002318423877,6,46,nitric oxide metabolic process,BP,NQO1;PKD2;NOS1;CPS1;CAV1;CLU
14603,GO:0070201,0.407449255978867,0.647458953416244,57,516,regulation of establishment of protein localization,BP,FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;TCAF1;EGFR;PAK1;BMP4;NR1D1;SORL1;TP53;PYCARD;ACSL3;TFDP2;GLI3;LRP1;FYN;B3GAT3;PLA2G6;PRKCZ;PTPN14;HHAT;TMEM173;CPT1A;ANG;ANK3;TTN;HPS4;TP73;STOM;SH3TC2;ALOX15B;C5;LRTOMT;IDH2;MDM2;PTPN1;ISL1;PRKCA;PRNP;TGFB2;SP100;GOPC;RSAD2;ITPR2;MDFIC;DERL3;POSTN;EFNA5;PPP3CA;ABAT;MYO1C;C2CD5;EDEM1
2183,GO:0005041,0.407561760215587,0.854887262078894,2,9,low-density lipoprotein particle receptor activity,MF,SORL1;LRP1
7515,GO:0031730,0.407630150334047,0.919430716713619,1,5,CCR5 chemokine receptor binding,MF,STAT1
11825,GO:0046827,0.407806745478409,0.80943980973753,3,20,positive regulation of protein export from nucleus,BP,GAS6;TP53;MDM2
17066,GO:0099632,0.407895811299653,0.847782116442423,2,13,protein transport within plasma membrane,BP,NSG1;HIP1
17068,GO:0099637,0.407895811299653,0.847782116442423,2,13,neurotransmitter receptor transport,BP,NSG1;HIP1
18909,GO:1904688,0.407900126684935,0.919311509605496,1,5,regulation of cytoplasmic translational initiation,BP,RPL13A
15767,GO:0072431,0.408481062031239,0.739242382742824,7,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
17956,GO:1902400,0.408481062031239,0.739242382742824,7,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
2623,GO:0005952,0.408632156728689,0.918987734071165,1,5,cAMP-dependent protein kinase complex,CC,PRKACB
20273,GO:2001286,0.408658273375022,0.923389202520459,1,4,regulation of caveolin-mediated endocytosis,BP,PROM2
11943,GO:0047184,0.408709535854607,0.91895346240894,1,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT2
18143,GO:1902932,0.408719711149912,0.847244611843327,2,13,positive regulation of alcohol biosynthetic process,BP,NTSR1;SNCA
18125,GO:1902894,0.40908926665727,0.851624199833704,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;SOX9
12065,GO:0048048,0.40909379446051,0.786418268639831,4,22,embryonic eye morphogenesis,BP,FBN1;EFEMP1;FBN2;TH
11260,GO:0045591,0.40929587848867,0.91578532162807,1,6,positive regulation of regulatory T cell differentiation,BP,BCL6
10703,GO:0044060,0.409500076459431,0.807527123530291,3,21,regulation of endocrine process,BP,F2R;GJA5;FGFR1
10987,GO:0044827,0.409668626139728,0.847889120394809,2,12,modulation by host of viral genome replication,BP,EIF2AK4;STOM
4230,GO:0009414,0.409670470185791,0.91561356336031,1,6,response to water deprivation,BP,TH
14874,GO:0070723,0.409971491320844,0.810372026242519,3,17,response to cholesterol,BP,TGFBR2;ABCA1;ABCA2
11374,GO:0045780,0.410029159502948,0.849172352247951,2,11,positive regulation of bone resorption,BP,EGFR;PRKCA
11839,GO:0046852,0.410029159502948,0.849172352247951,2,11,positive regulation of bone remodeling,BP,EGFR;PRKCA
12744,GO:0051046,0.410048620692323,0.649646698658974,48,427,regulation of secretion,BP,SYT8;FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;EGFR;NTSR1;NR1D1;PYCARD;WNK1;MICAL1;ACSL3;SYN1;PLA2G6;PRKCZ;OAS2;SYTL1;CCK;SYT1;CPT1A;PCLO;ANG;TTN;SNCA;FGFR1;ALOX15B;C5;PLA2R1;IDH2;ISL1;PRKCA;RAB13;SEPT5;HTR1B;TGFB2;C2CD4C;RSAD2;ITPR2;GDNF;POSTN;SV2A;EFNA5;PPP3CA;ABAT;OXTR
13940,GO:0060676,0.410063636136292,0.918352253943904,1,5,ureteric bud formation,BP,GDNF
15625,GO:0072172,0.410063636136292,0.918352253943904,1,5,mesonephric tubule formation,BP,GDNF
2384,GO:0005522,0.41022234120826,0.85090106620454,2,10,profilin binding,MF,PCLO;WIPF1
1631,GO:0004075,0.410682564387685,0.930143149098533,1,3,biotin carboxylase activity,MF,ACACB
7502,GO:0031698,0.410738546756415,0.922510673697682,1,4,beta-2 adrenergic receptor binding,MF,PDE4D
11308,GO:0045655,0.410746349333189,0.845918323492826,2,13,regulation of monocyte differentiation,BP,INPP5D;ZFP36L1
13910,GO:0060603,0.410779306090614,0.783121392458495,4,25,mammary gland duct morphogenesis,BP,ETV5;VDR;GLI2;AREG
17632,GO:1901490,0.410904845924646,0.922440172310377,1,4,regulation of lymphangiogenesis,BP,CCBE1
1333,GO:0003190,0.411597614305447,0.929790039655838,1,3,atrioventricular valve formation,BP,ZFPM1
4065,GO:0009120,0.41171645338765,0.914671617212749,1,6,deoxyribonucleoside metabolic process,BP,DPYD
18541,GO:1903795,0.411776947859798,0.922069792604112,1,4,regulation of inorganic anion transmembrane transport,BP,PRNP
9118,GO:0035459,0.412232842520579,0.806175363925517,3,20,cargo loading into vesicle,BP,SEC24D;TMED10;MIA3
20084,GO:2000780,0.412737545313167,0.806552141319387,3,19,negative regulation of double-strand break repair,BP,HMGA2;MAGEF1;CXORF57
1976,GO:0004694,0.412843776179094,0.921615207612481,1,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,EIF2AK4
7106,GO:0030917,0.412986873216917,0.921554106504646,1,4,midbrain-hindbrain boundary development,BP,SSBP3
18553,GO:1903825,0.413107467867546,0.713471375244183,10,78,organic acid transmembrane transport,BP,SLC7A8;IRS2;NTSR1;SLC7A11;SLC38A10;CPT1A;SLC38A2;ACACB;PRKAB2;CPT2
19082,GO:1905039,0.413107467867546,0.713471375244183,10,78,carboxylic acid transmembrane transport,BP,SLC7A8;IRS2;NTSR1;SLC7A11;SLC38A10;CPT1A;SLC38A2;ACACB;PRKAB2;CPT2
18217,GO:1903054,0.413305620377743,0.91393551697295,1,6,negative regulation of extracellular matrix organization,BP,CST3
5687,GO:0016813,0.413399609789823,0.913891858561407,1,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,PADI3
7881,GO:0032460,0.413492407569691,0.844111841804396,2,13,negative regulation of protein oligomerization,BP,SORL1;CLU
12391,GO:0048861,0.413562171607472,0.921308157813606,1,4,leukemia inhibitory factor signaling pathway,BP,CTF1
17660,GO:1901565,0.414193282870513,0.627558784309395,104,976,organonitrogen compound catabolic process,BP,SERPINE2;PRODH;ANPEP;SKP2;NOS1;EGFR;SDC3;RNF213;RNF165;CSPG4;TIMP2;APOBEC3C;NR1D1;ABTB1;BTBD2;SORL1;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;TIMP1;BCKDHB;CUL7;SNX1;GPX1;CTSV;LRP1;FYN;XDH;CAV1;TRIB2;SEL1L;GLDC;SNX33;CLU;FBXW4;HIBADH;APOBEC3G;HERPUD1;WFS1;CHEK2;BACE1;FBXL7;SNCA;ADAMTS7;ALDH1L2;APOBEC3F;PDE4D;TMEM129;PSMB9;SPATA18;MAGEF1;LRTOMT;NAGLU;ATM;MDM2;CST3;MANBA;GCLC;HEXA;RNPEP;ALDH4A1;SDC2;THNSL2;SOX9;ANXA2;RNF24;MVB12B;ANAPC16;GGT7;USP28;ALDH7A1;AGRN;RHBDD1;HSPA5;TGFB1I1;OPHN1;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;SNX9;PTPN3;DNAJC3;TMEM67;TAF1;GSTZ1;DPYD;DNPH1;CDK5RAP3;SCPEP1;ABAT;FBXL4;UGGT2;VPS36;RNPEPL1;EDEM1;GID4;CTSD;ZNRF1
9876,GO:0042176,0.414733243414803,0.656691467386308,33,300,regulation of protein catabolic process,BP,SERPINE2;EGFR;TIMP2;SORL1;PRICKLE1;TIMP1;SNX1;GPX1;LRP1;FYN;CAV1;TRIB2;SNX33;CLU;HERPUD1;CHEK2;SNCA;MAGEF1;MDM2;CST3;GCLC;SOX9;ANXA2;OPHN1;NUB1;ATRAID;DERL3;RNF144B;SNX9;PTPN3;TAF1;CDK5RAP3;EDEM1
17061,GO:0099625,0.414735277730016,0.846120149878885,2,11,ventricular cardiac muscle cell membrane repolarization,BP,GJA5;KCNJ5
12378,GO:0048843,0.414969320113778,0.805747885147765,3,18,negative regulation of axon extension involved in axon guidance,BP,SEMA5A;SEMA4A;SEMA4B
13093,GO:0051660,0.415008014384202,0.920687889609594,1,4,establishment of centrosome localization,BP,FHOD1
13468,GO:0055059,0.415195148405037,0.920607386857849,1,4,asymmetric neuroblast division,BP,ARHGEF2
7056,GO:0030854,0.415378527095951,0.915965767719628,1,5,positive regulation of granulocyte differentiation,BP,LEF1
15151,GO:0071316,0.415390978746892,0.912963633961817,1,6,cellular response to nicotine,BP,TH
5772,GO:0017000,0.41548669650764,0.842793122057807,2,13,antibiotic biosynthetic process,BP,ACSS1;ACSS2
4251,GO:0009582,0.415914132201145,0.735016224572169,7,48,detection of abiotic stimulus,BP,SERPINE2;ANO1;PKD2;NTSR1;ITGA2;FYN;TTN
7837,GO:0032407,0.415976890677982,0.915694405588524,1,5,MutSalpha complex binding,MF,MUTYH
16654,GO:0097629,0.416005746824429,0.915681305328551,1,5,extrinsic component of omegasome membrane,CC,ULK1
2937,GO:0006465,0.416064625500692,0.839560428679629,2,16,signal peptide processing,BP,GAS6;SPPL2B
11326,GO:0045682,0.416133078592507,0.724005563763119,8,67,regulation of epidermis development,BP,CD109;ZFP36L1;VDR;BMP4;CTSV;ALOX15B;NAB2;TGFB2
7162,GO:0031054,0.416156735928565,0.842348775785238,2,13,pre-miRNA processing,BP,ZCCHC11;AGO4
4544,GO:0010629,0.416257802682585,0.619124015431711,152,1429,negative regulation of gene expression,BP,SERPINE2;TXNIP;CTGF;SOX6;SFRP1;ZFP36L1;ZFP36L2;IGF2BP2;GAS6;SNAI2;MAGED1;PHF21A;EGFR;TSC22D3;KLF8;ZNF608;SERPINE1;VIM;CBX5;VDR;BMP4;NR1D1;SMARCA2;EIF2AK4;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;ZCCHC11;RBMS3;TFDP2;PNRC1;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;FYN;XDH;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SERPING1;SLIT3;SDR16C5;TP53INP1;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ACACB;ANG;UHRF2;BBS2;WFS1;MDFI;CIRBP;JARID2;TP73;DAPK1;PAIP2B;PHF2;SNCA;FLOT2;GLG1;FGFR1;DKK1;NCOA2;PSMB9;TLE4;FZD8;TCEAL1;NFATC4;FOXN3;LMCD1;FZD1;PBXIP1;ENG;BBS4;CALR;ATM;MDM2;MEIS2;DGKQ;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;PLAG1;PRKCA;SALL2;BAHCC1;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;PRNP;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;SMG9;LEF1;THRA;CDKN2A;SP100;ITGB8;MDFIC;ZNF12;GDNF;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;UNK;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;AGO4;NIPBL;PRDM5;RXRA
13531,GO:0060023,0.416395804918259,0.92008965690124,1,4,soft palate development,BP,TSHZ1
5522,GO:0016504,0.416613481894127,0.77509364551251,4,33,peptidase activator activity,MF,FN1;PYCARD;CAV1;FBLN1
4555,GO:0010641,0.417110274894626,0.919780568149217,1,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,HIP1
10966,GO:0044783,0.417112352298938,0.722911655840587,8,69,G1 DNA damage checkpoint,BP,TP53;TFDP2;E2F7;TP73;CHEK2;ATM;MDM2;RBL2
16889,GO:0098887,0.417135625650602,0.915167358197123,1,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,NSG1
683,GO:0001894,0.417184475600879,0.690608349340466,14,121,tissue homeostasis,BP,CTGF;INPP5D;F2R;IL20RB;EGFR;ERCC6;NPHP4;BBS2;BBS4;BBS1;SOX9;PRKCA;LIPA;NPHP3
9416,GO:0036005,0.41739956062033,0.915047021327689,1,5,response to macrophage colony-stimulating factor,BP,MST1R
9417,GO:0036006,0.41739956062033,0.915047021327689,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,MST1R
10385,GO:0043242,0.417540511908114,0.733621247679745,7,48,negative regulation of protein complex disassembly,BP,GSN;SPTB;TRIOBP;ARHGEF2;CAPG;LIMA1;TTBK2
16869,GO:0098845,0.417578935015699,0.91193664981404,1,6,postsynaptic endosome,CC,NSG1
8462,GO:0033622,0.417819562184504,0.844102607535781,2,11,integrin activation,BP,FN1;COL16A1
16680,GO:0097694,0.418043943497443,0.927270254734926,1,3,establishment of RNA localization to telomere,BP,ATM
16681,GO:0097695,0.418043943497443,0.927270254734926,1,3,establishment of protein-containing complex localization to telomere,BP,ATM
9846,GO:0042117,0.418173309121223,0.91469362908899,1,5,monocyte activation,BP,ADAM10
18609,GO:1903935,0.418222201006382,0.911633289499173,1,6,response to sodium arsenite,BP,NEFL
8638,GO:0034201,0.418389796186874,0.914594589378752,1,5,response to oleic acid,BP,CPS1
1373,GO:0003266,0.41861578779979,0.914491124848725,1,5,regulation of secondary heart field cardioblast proliferation,BP,ISL1
7556,GO:0031915,0.418679803311591,0.914461802738028,1,5,positive regulation of synaptic plasticity,BP,SSH1
18157,GO:1902953,0.418719168745829,0.919081787259434,1,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
6043,GO:0019184,0.418896663746948,0.837648290561762,2,16,nonribosomal peptide biosynthetic process,BP,GCLC;GGT7
12600,GO:0050812,0.418945304350328,0.841798035879044,2,12,regulation of acyl-CoA biosynthetic process,BP,SNCA;PDK3
3118,GO:0006700,0.419009547008321,0.837571833264795,2,16,C21-steroid hormone biosynthetic process,BP,DGKQ;EGR1
7271,GO:0031267,0.419099744531675,0.636789578830989,57,443,small GTPase binding,MF,ASAP3;IRS2;DNMBP;EGFR;SPTB;ALS2CL;ASAP2;PAK1;ABCA1;SRGAP3;TBC1D8;RIN2;NEFL;VAV3;SORL1;ARAP1;PLEKHG3;ARHGEF1;DLG4;PDGFA;MICAL1;DOCK4;EVI5L;KITLG;TBC1D5;ASAP1;FYN;ARHGEF12;CAV1;DOCK11;CAMK2D;SYTL1;HPS4;FGFR1;OBSCN;ARHGEF17;TRIOBP;SRGAP1;AKAP13;FGD4;ARHGEF2;NDRG1;ANXA2;PAK6;RET;CDC42EP5;ULK1;VAV2;AGAP1;ARHGEF19;GDNF;INF2;TBC1D16;SBF2;RHOBTB3;MYO1C;DOCK1
797,GO:0002067,0.41924229036867,0.77446552520319,4,29,glandular epithelial cell differentiation,BP,BMP4;IL31RA;RARA;RXRA
14218,GO:0061298,0.419243098564632,0.847464910393809,2,9,retina vasculature development in camera-type eye,BP,COL4A1;FZD4
4190,GO:0009299,0.419311108696447,0.800902671292435,3,20,mRNA transcription,BP,TP53;DDIT3;ZBTB1
15816,GO:0072559,0.419343517603748,0.911102932561299,1,6,NLRP3 inflammasome complex,CC,PYCARD
7905,GO:0032489,0.419395569323688,0.918786869485302,1,4,regulation of Cdc42 protein signal transduction,BP,ABCA1
6370,GO:0021562,0.419782762838396,0.918617744487158,1,4,vestibulocochlear nerve development,BP,SLITRK6
13574,GO:0060073,0.420094998324888,0.918481199298315,1,4,micturition,BP,KCNMA1
744,GO:0001976,0.420290828451141,0.918395486182965,1,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,NAV2
4791,GO:0010988,0.420358258092425,0.910621281540585,1,6,regulation of low-density lipoprotein particle clearance,BP,ANXA2
3430,GO:0007221,0.420609112004065,0.803642043594141,3,16,positive regulation of transcription of Notch receptor target,BP,STAT1;PBX1;MAML2
11320,GO:0045667,0.420622729135649,0.706892655173476,10,77,regulation of osteoblast differentiation,BP,SFRP1;FBN2;SNAI2;BMP4;SMOC1;GLI3;AREG;IFITM1;TWIST2;ATRAID
8126,GO:0032839,0.420727023401693,0.798531609731682,3,22,dendrite cytoplasm,CC,DLG4;KIF17;TRAK1
1941,GO:0004645,0.420840217144851,0.913468542181276,1,5,phosphorylase activity,MF,PYGB
1799,GO:0004445,0.421077371095628,0.913359072236402,1,5,inositol-polyphosphate 5-phosphatase activity,MF,INPP5D
5584,GO:0016615,0.421289939653686,0.910177627815385,1,6,malate dehydrogenase activity,MF,PHGDH
11721,GO:0046581,0.421381741943663,0.917916962091145,1,4,intercellular canaliculus,CC,ABCC2
10073,GO:0042594,0.4217102156103,0.679860827943895,16,138,response to starvation,BP,SFRP1;GAS6;SESN3;EIF2AK4;TP53;DDIT3;TBC1D5;SESN1;CTSV;CPS1;ULK2;SLC38A2;ULK1;HSPA5;PPARG;PIK3C2B
3699,GO:0008210,0.42185114564098,0.83564109089203,2,16,estrogen metabolic process,BP,SULT1E1;HSD17B11
15944,GO:0080111,0.421881733204981,0.798971837301865,3,20,DNA demethylation,BP,APOBEC3C;APOBEC3G;APOBEC3F
7391,GO:0031465,0.421944399485564,0.912958115138194,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
7885,GO:0032464,0.421954549876045,0.909860313427551,1,6,positive regulation of protein homooligomerization,BP,CLU
8347,GO:0033239,0.422046674032437,0.917624425748182,1,4,negative regulation of cellular amine metabolic process,BP,SNCA
17820,GO:1902033,0.422060797457916,0.912904198614398,1,5,regulation of hematopoietic stem cell proliferation,BP,KITLG
13821,GO:0060453,0.422257309212912,0.912813125240622,1,5,regulation of gastric acid secretion,BP,OXTR
17731,GO:1901724,0.422319543178425,0.909685752820386,1,6,positive regulation of cell proliferation involved in kidney development,BP,EGR1
6676,GO:0030049,0.422341229312992,0.805132856674924,3,14,muscle filament sliding,BP,TNNI2;VIM;TTN
8363,GO:0033275,0.422341229312992,0.805132856674924,3,14,actin-myosin filament sliding,BP,TNNI2;VIM;TTN
14610,GO:0070212,0.422454373142114,0.91744473359402,1,4,protein poly-ADP-ribosylation,BP,PARP15
6532,GO:0021943,0.422469072258725,0.917438250373007,1,4,formation of radial glial scaffolds,BP,LEF1
11873,GO:0046920,0.422554639963703,0.912675213865854,1,5,alpha-(1->3)-fucosyltransferase activity,MF,FUT10
4805,GO:0012510,0.422676708040749,0.837991130951929,2,13,trans-Golgi network transport vesicle membrane,CC,CLTCL1;RASSF9
16794,GO:0098706,0.422719899447723,0.917327570585318,1,4,ferric iron import across plasma membrane,BP,STEAP2
12493,GO:0050660,0.423007537227877,0.72673431576797,7,60,flavin adenine dinucleotide binding,MF,PRODH;NOS1;D2HGDH;MICAL1;MTHFR;XDH;DPYD
1387,GO:0003298,0.423016061904488,0.839086060931571,2,12,physiological muscle hypertrophy,BP,PAK1;G6PD
1390,GO:0003301,0.423016061904488,0.839086060931571,2,12,physiological cardiac muscle hypertrophy,BP,PAK1;G6PD
14138,GO:0061049,0.423016061904488,0.839086060931571,2,12,cell growth involved in cardiac muscle cell development,BP,PAK1;G6PD
15374,GO:0071664,0.423126958596822,0.917147752501197,1,4,catenin-TCF7L2 complex,CC,TCF4
843,GO:0002159,0.423325049111903,0.917060156779416,1,4,desmosome assembly,BP,PRKCA
18796,GO:1904396,0.423329387684586,0.92516175469938,1,3,regulation of neuromuscular junction development,BP,AGRN
15117,GO:0071253,0.423544428106078,0.912215133890938,1,5,connexin binding,MF,GJA5
4445,GO:0010385,0.423575266110756,0.912200775199096,1,5,double-stranded methylated DNA binding,MF,EGR1
10387,GO:0043244,0.42358116475953,0.699264752094289,11,79,regulation of protein complex disassembly,BP,GSN;SPTB;SEMA5A;IGF1R;SETX;TRIOBP;ARHGEF2;UVRAG;CAPG;LIMA1;TTBK2
15938,GO:0080025,0.42361889734523,0.797662203548541,3,20,phosphatidylinositol-3,5-bisphosphate binding,MF,JPH2;HIP1;PLEK2
9361,GO:0035907,0.423630351640481,0.912175122802352,1,5,dorsal aorta development,BP,ENG
14001,GO:0060759,0.423668475533002,0.680950807665379,15,135,regulation of response to cytokine stimulus,BP,GAS6;AXL;STAT1;PYCARD;CAV1;SLIT3;ROBO1;TRAF1;PTPN1;MAP2K5;STAT2;SPPL2B;AGPAT1;PPARG;CREBRF
7440,GO:0031587,0.423966528021957,0.92490497265907,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
8109,GO:0032808,0.424152662013713,0.916693552442558,1,4,lacrimal gland development,BP,SOX9
8640,GO:0034204,0.424279443430673,0.802204953205261,3,15,lipid translocation,BP,ATP10D;ABCA1;ATP8B2
15188,GO:0071371,0.424293431248286,0.836901063721313,2,13,cellular response to gonadotropin stimulus,BP,GCLC;EFNA5
13700,GO:0060297,0.424552431904885,0.924668341888903,1,3,regulation of sarcomere organization,BP,AKAP13
15760,GO:0072413,0.424615296095248,0.725197824949188,7,61,signal transduction involved in mitotic cell cycle checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
17957,GO:1902402,0.424615296095248,0.725197824949188,7,61,signal transduction involved in mitotic DNA damage checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
17958,GO:1902403,0.424615296095248,0.725197824949188,7,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
7206,GO:0031111,0.424753741185712,0.77098379716352,4,27,negative regulation of microtubule polymerization or depolymerization,BP,EML2;SNCA;ARHGEF2;TTBK2
6689,GO:0030091,0.424834245999955,0.906261051017967,1,7,protein repair,BP,MSRB2
13490,GO:0055090,0.425085907598257,0.835236759497702,2,14,acylglycerol homeostasis,BP,ANGPTL4;IL18
14674,GO:0070328,0.425085907598257,0.835236759497702,2,14,triglyceride homeostasis,BP,ANGPTL4;IL18
2708,GO:0006084,0.425116125513813,0.7697642311363,4,29,acetyl-CoA metabolic process,BP,ACSS1;ACACB;PDK3;ACSS2
9781,GO:0040018,0.425429639789112,0.797070626746591,3,19,positive regulation of multicellular organism growth,BP,BBS2;BBS4;NIPBL
269,GO:0000768,0.425456718647624,0.769937160412367,4,28,syncytium formation by plasma membrane fusion,BP,FLOT1;CD109;NOS1;MYOF
6536,GO:0021955,0.425464726173909,0.797044127814026,3,19,central nervous system neuron axonogenesis,BP,ADARB1;GLI2;CDH11
9105,GO:0035426,0.425528573088948,0.916081804095398,1,4,extracellular matrix-cell signaling,BP,FZD4
827,GO:0002115,0.425556161568522,0.836047032287238,2,13,store-operated calcium entry,BP,ORAI3;ORAI2
9335,GO:0035864,0.425678588211476,0.908069362945678,1,6,response to potassium ion,BP,CARF
13225,GO:0051932,0.425871470966309,0.796736818197389,3,19,synaptic transmission, GABAergic,BP,NISCH;HTR1B;OXTR
18644,GO:1904016,0.426218863841373,0.915773823110823,1,4,response to Thyroglobulin triiodothyronine,BP,NCOA2
19261,GO:1905521,0.426228720808505,0.833486559424676,2,15,regulation of macrophage migration,BP,MMP28;C5
8717,GO:0034381,0.426271092982224,0.767022456454519,4,34,plasma lipoprotein particle clearance,BP,ANXA2;CES3;LIPA;LMF1
8437,GO:0033578,0.426375348648998,0.91089085926278,1,5,protein glycosylation in Golgi,BP,LMF1
10695,GO:0044033,0.426457687643708,0.907691896158625,1,6,multi-organism metabolic process,BP,ANXA2
13662,GO:0060235,0.426501213837419,0.923877838936847,1,3,lens induction in camera-type eye,BP,BMP4
19712,GO:2000109,0.426587953717634,0.907628689060398,1,6,regulation of macrophage apoptotic process,BP,CDKN2A
2622,GO:0005947,0.426594632736649,0.910787760371499,1,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,BCKDHB
14670,GO:0070324,0.427320951031819,0.910445738167495,1,5,thyroid hormone binding,MF,THRA
448,GO:0001222,0.427895973861064,0.834458392907152,2,13,transcription corepressor binding,MF,NR1D1;PER1
16377,GO:0097035,0.428487218738136,0.768512608594316,4,26,regulation of membrane lipid distribution,BP,ATP10D;ABCA1;ANO6;ATP8B2
15234,GO:0071438,0.428580059628621,0.90985087373504,1,5,invadopodium membrane,CC,ITGA3
15668,GO:0072235,0.428866416409531,0.922911281198854,1,3,metanephric distal tubule development,BP,PKD2
7208,GO:0031113,0.428869626704487,0.74840842394432,5,36,regulation of microtubule polymerization,BP,PAK1;MAP2;EML2;SNCA;RGS2
7517,GO:0031748,0.429040226689286,0.90963284948912,1,5,D1 dopamine receptor binding,MF,DLG4
6915,GO:0030517,0.429131818110902,0.767465112404022,4,27,negative regulation of axon extension,BP,PTPRS;SEMA5A;SEMA4A;SEMA4B
5256,GO:0015893,0.429195835822956,0.692496755854414,11,98,drug transport,BP,NTSR1;SLC7A11;SLC35F3;SYT1;SNCA;ABCC2;HTR1B;GDNF;FZD4;ABAT;NFKBIE
2232,GO:0005138,0.429316658597298,0.909501718297713,1,5,interleukin-6 receptor binding,MF,PYCARD
18592,GO:1903902,0.429404729209743,0.732260764803048,6,51,positive regulation of viral life cycle,BP,TRIM38;LGALS1;IFIT1;ADARB1;STOM;SRPK2
15669,GO:0072236,0.429477712379353,0.922660192747603,1,3,metanephric loop of Henle development,BP,PKD2
9837,GO:0042102,0.429539540393714,0.745125669137668,5,47,positive regulation of T cell proliferation,BP,TGFBR2;PYCARD;IL18;CD1D;IGFBP2
17175,GO:0106049,0.429676775112149,0.909330709902119,1,5,regulation of cellular response to osmotic stress,BP,ARHGEF2
17881,GO:1902218,0.429676775112149,0.909330709902119,1,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,ARHGEF2
5857,GO:0017166,0.429999305142913,0.837983397299752,2,10,vinculin binding,MF,UTRN;PXN
5657,GO:0016772,0.430032348620507,0.615201425813071,90,775,transferase activity, transferring phosphorus-containing groups,MF,TGFBR2;EFEMP1;PIK3C2G;IRS2;TNIK;ROR1;AXL;EGFR;ITPK1;SPEG;MYLK;TKFC;MAP3K6;DCAKD;PAK1;PTK6;EIF2AK4;CNTRL;LTBP1;WNK1;DLG4;ZCCHC11;PDGFA;TEP1;CRIM1;SIK1;CDK14;KITLG;NEK9;NMRK1;FYN;ALPK1;LTBP4;POLR3GL;MAP3K14;PRKCZ;OAS2;ULK2;HMGA2;CAMK2D;MST1R;PIK3R1;CDK18;PHKA2;TTN;DAPK1;PRKACB;CHEK2;FGFR1;IGF1R;PRKAB2;MYO3B;OBSCN;PDK3;EPHB6;TGFBR3;ATM;EFNB3;FAM20A;AKAP13;DGKQ;MAP3K1;NRK;SOX9;ITPKB;STK16;PRKCA;PRPS2;ETNK2;PRIMPOL;HMBOX1;NMNAT2;PAK6;MAP3K12;STK36;RET;MAP2K5;ULK1;CDK19;PIKFYVE;SRPK2;POLD4;ICK;POLH;PRKAG1;TAF1;PIK3C2B;TTBK2;TAOK3;DMPK
11662,GO:0046469,0.430114519909942,0.909122564191874,1,5,platelet activating factor metabolic process,BP,LPCAT2
7166,GO:0031058,0.430358729737101,0.70397600849322,9,75,positive regulation of histone modification,BP,NOS1;SNAI2;TP53;SDR16C5;JARID2;ATM;ISL1;BCL6;NIPBL
11164,GO:0045277,0.430528678347413,0.898531306391837,1,11,respiratory chain complex IV,CC,NDUFA4L2
661,GO:0001865,0.430610325963771,0.913797725522147,1,4,NK T cell differentiation,BP,TGFBR2
12803,GO:0051136,0.430610325963771,0.913797725522147,1,4,regulation of NK T cell differentiation,BP,TGFBR2
15989,GO:0086036,0.430627817334907,0.913789796384659,1,4,regulation of cardiac muscle cell membrane potential,BP,EHD3
1485,GO:0003823,0.430954897694025,0.789638809380419,3,24,antigen binding,MF,SLC7A8;CD1D;TSPAN4
19802,GO:2000288,0.431196104012022,0.90537528946803,1,6,positive regulation of myoblast proliferation,BP,MEIS2
11116,GO:0045182,0.431196372637033,0.74527817726508,5,40,translation regulator activity,MF,IGF2BP2;EIF2AK4;CIRBP;PAIP2B;RARA
6867,GO:0030371,0.431348850469613,0.79178732617405,3,20,translation repressor activity,MF,CIRBP;PAIP2B;RARA
2717,GO:0006098,0.431370298699383,0.82833716392322,2,17,pentose-phosphate shunt,BP,H6PD;G6PD
39,GO:0000079,0.431415639565573,0.709979581729483,8,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2B;PKD2;HERC5;EGFR;NR2F2;CDKN2A;CCNY;CDK5RAP3
12185,GO:0048387,0.43165017626003,0.908389985150123,1,5,negative regulation of retinoic acid receptor signaling pathway,BP,CALR
4716,GO:0010883,0.431922013912064,0.763845848557686,4,30,regulation of lipid storage,BP,ABCA1;MEST;ACACB;PPARG
19563,GO:1990668,0.432192677456805,0.904883479654433,1,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,CALR
10463,GO:0043379,0.432216575800669,0.908118849187768,1,5,memory T cell differentiation,BP,BCL6
16346,GO:0090713,0.432216575800669,0.908118849187768,1,5,immunological memory process,BP,BCL6
16347,GO:0090715,0.432216575800669,0.908118849187768,1,5,immunological memory formation process,BP,BCL6
6234,GO:0019798,0.432332361941218,0.904814417380678,1,6,procollagen-proline dioxygenase activity,MF,P3H2
4923,GO:0014883,0.432700791017321,0.912846792194271,1,4,transition between fast and slow fiber,BP,PPP3CA
11464,GO:0045948,0.432752734341365,0.788779211440889,3,23,positive regulation of translational initiation,BP,EIF2AK4;DNAJC3;RXRA
17507,GO:1901029,0.432835419175055,0.902264511722057,1,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,ACAA2
19727,GO:2000142,0.432958516663423,0.763002805674479,4,30,regulation of DNA-templated transcription, initiation,BP,TP53;SETX;THRA;TAF1
18079,GO:1902744,0.433232186057241,0.912604005859009,1,4,negative regulation of lamellipodium organization,BP,ARPIN
9997,GO:0042446,0.433307518083097,0.742335560264766,5,45,hormone biosynthetic process,BP,VDR;HSD17B11;DGKQ;EGR1;TRERF1
13726,GO:0060331,0.433408940053369,0.904281083154382,1,6,negative regulation of response to interferon-gamma,BP,PPARG
13731,GO:0060336,0.433408940053369,0.904281083154382,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,PPARG
11761,GO:0046643,0.433671143739772,0.912403128064162,1,4,regulation of gamma-delta T cell activation,BP,SOX13
15440,GO:0071813,0.43383221638819,0.831763265626662,2,12,lipoprotein particle binding,MF,SORL1;CDH13
15441,GO:0071814,0.43383221638819,0.831763265626662,2,12,protein-lipid complex binding,MF,SORL1;CDH13
885,GO:0002253,0.433927833521375,0.6336175666672,38,355,activation of immune response,BP,FLOT1;INPP5D;TKFC;PAK1;NR1D1;TRIM5;VAV3;PTPRS;PYCARD;DDX60;MUC19;ERMAP;SEC14L1;FYN;CAV1;PLA2G6;CLU;SERPING1;PIK3R1;TMEM173;BTN3A1;PRKACB;TLR3;PAG1;C5;PDE4D;PSMB9;MAP3K1;PRNP;VAV2;BTN3A3;RSAD2;GCSAM;LGALS3;WIPF1;ELMO2;MYO1C;DOCK1
7199,GO:0031102,0.433992063710532,0.74348377695781,5,38,neuron projection regeneration,BP,NEFL;PTPRS;ISL1;ULK1;LAMB2
6219,GO:0019774,0.434128310318805,0.897495105464898,1,10,proteasome core complex, beta-subunit complex,CC,PSMB9
16959,GO:0099068,0.434312612059965,0.83509097420085,2,10,postsynapse assembly,BP,NLGN4Y;MAGI2
9692,GO:0038114,0.434727136288524,0.911918674871649,1,4,interleukin-21-mediated signaling pathway,BP,STAT1
16816,GO:0098756,0.434727136288524,0.911918674871649,1,4,response to interleukin-21,BP,STAT1
16817,GO:0098757,0.434727136288524,0.911918674871649,1,4,cellular response to interleukin-21,BP,STAT1
1232,GO:0002921,0.434735810207633,0.906906750334739,1,5,negative regulation of humoral immune response,BP,SERPING1
2670,GO:0006024,0.434884276285741,0.693759449450343,10,80,glycosaminoglycan biosynthetic process,BP,SDC3;CSPG4;B3GAT3;XYLT1;UST;CHST3;HEXA;SDC2;DSEL;AGRN
13549,GO:0060045,0.435056746347439,0.830923449852839,2,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR1;TGFBR3
879,GO:0002246,0.435149672212857,0.903414763516362,1,6,wound healing involved in inflammatory response,BP,F2R
7130,GO:0030976,0.435502104046058,0.906536063659824,1,5,thiamine pyrophosphate binding,MF,DHTKD1
3664,GO:0008157,0.435600632968287,0.828002797447039,2,14,protein phosphatase 1 binding,MF,PHACTR3;TCTEX1D4
8525,GO:0033866,0.435617694587313,0.826120428968609,2,16,nucleoside bisphosphate biosynthetic process,BP,DCAKD;PPCS
8548,GO:0034030,0.435617694587313,0.826120428968609,2,16,ribonucleoside bisphosphate biosynthetic process,BP,DCAKD;PPCS
8551,GO:0034033,0.435617694587313,0.826120428968609,2,16,purine nucleoside bisphosphate biosynthetic process,BP,DCAKD;PPCS
13036,GO:0051567,0.435682462465303,0.762695385184257,4,26,histone H3-K9 methylation,BP,JARID2;KDM4C;KDM4A;PRDM5
14092,GO:0060979,0.435710517501347,0.920069908779126,1,3,vasculogenesis involved in coronary vascular morphogenesis,BP,TGFBR3
5371,GO:0016191,0.435769151789622,0.911438961848304,1,4,synaptic vesicle uncoating,BP,DNAJC6
9469,GO:0036122,0.435838574789087,0.911406942451469,1,4,BMP binding,MF,ENG
11765,GO:0046653,0.435953362385544,0.826754474506905,2,15,tetrahydrofolate metabolic process,BP,MTHFR;ALDH1L2
12682,GO:0050927,0.436003264104878,0.827722565884193,2,14,positive regulation of positive chemotaxis,BP,ITGA2;CDH13
11172,GO:0045296,0.436149291737261,0.636334197668565,33,297,cadherin binding,MF,GPRC5A;ITGA6;DOCK9;EGFR;CTNNAL1;PLEC;PTPRM;AHNAK;STAT1;PPL;SNX1;ASAP1;ARHGAP18;PARVA;ANK3;FSCN1;ESYT2;CDH13;PTPN1;NDRG1;ANXA2;MPP7;TES;PAK6;CDH11;MPRIP;HSPA5;FLNB;CAPG;SNX9;LIMA1;SEPT9;S100A11
4268,GO:0009629,0.436213923149488,0.9028826919401,1,6,response to gravity,BP,FOS
16849,GO:0098814,0.436443809580664,0.90607924586505,1,5,spontaneous synaptic transmission,BP,NSG1
12575,GO:0050778,0.436505407942777,0.624610199792791,47,445,positive regulation of immune response,BP,FLOT1;MMP2;INPP5D;TKFC;PAK1;NR1D1;EIF2AK4;TRIM5;VAV3;PTPRS;PYCARD;DDX60;MUC19;ERMAP;SEC14L1;FYN;CAV1;PLA2G6;CLU;SERPING1;PRKCZ;PIK3R1;TMEM173;BTN3A1;PRKACB;TLR3;PAG1;C5;PDE4D;PSMB9;IL18;IFNK;CD1D;MAP3K1;PRNP;TGFB2;VAV2;BTN3A3;RSAD2;GCSAM;LGALS3;RARA;WIPF1;ZBTB1;ELMO2;MYO1C;DOCK1
18737,GO:1904251,0.436846288464588,0.902565669484692,1,6,regulation of bile acid metabolic process,BP,NR1D1
3917,GO:0008593,0.436881492341495,0.698352086351518,9,73,regulation of Notch signaling pathway,BP,EGFR;DLK2;POGLUT1;BCL6;TSPAN5;MAML2;TGFB2;DLX2;POSTN
10702,GO:0044058,0.437193130200328,0.828066822352446,2,13,regulation of digestive system process,BP,WNK1;OXTR
13587,GO:0060088,0.437380351542482,0.905623533099615,1,5,auditory receptor cell stereocilium organization,BP,TRIOBP
13466,GO:0055056,0.437406862744921,0.905610612653124,1,5,D-glucose transmembrane transporter activity,MF,SLC2A3
2626,GO:0005955,0.437543298030324,0.910618365338082,1,4,calcineurin complex,CC,PPP3CA
18635,GO:1903978,0.437561028817749,0.91061013989564,1,4,regulation of microglial cell activation,BP,ATM
15876,GO:0072677,0.437682288069507,0.902145560188738,1,6,eosinophil migration,BP,LGALS3
6051,GO:0019203,0.437751804690903,0.905442400148141,1,5,carbohydrate phosphatase activity,MF,G6PC3
12440,GO:0050308,0.437751804690903,0.905442400148141,1,5,sugar-phosphatase activity,MF,G6PC3
18421,GO:1903533,0.43775257396009,0.689945451208688,10,94,regulation of protein targeting,BP,TCAF1;PAK1;FYN;HHAT;ANK3;HPS4;STOM;PRNP;MYO1C;C2CD5
4037,GO:0009074,0.437930434929619,0.897912511189327,1,8,aromatic amino acid family catabolic process,BP,GSTZ1
8003,GO:0032647,0.438002955905816,0.785946961285121,3,21,regulation of interferon-alpha production,BP,STAT1;PTPRS;TLR3
1129,GO:0002719,0.438018153000823,0.825307165302731,2,15,negative regulation of cytokine production involved in immune response,BP,BCL6;TGFB2
8026,GO:0032687,0.438197101725044,0.905224968190182,1,5,negative regulation of interferon-alpha production,BP,PTPRS
9487,GO:0036152,0.438234039136117,0.82515547646768,2,15,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2;PLA2G6
890,GO:0002265,0.438235853795155,0.919004647676666,1,3,astrocyte activation involved in immune response,BP,LRP1
7644,GO:0032075,0.438253014634846,0.824266116509689,2,16,positive regulation of nuclease activity,BP,PTPN1;HSPA5
20173,GO:2001054,0.438470260430427,0.905091432111573,1,5,negative regulation of mesenchymal cell apoptotic process,BP,SOX9
2424,GO:0005606,0.43856932460127,0.918863295714326,1,3,laminin-1 complex,CC,LAMB1
4815,GO:0014014,0.438818155526884,0.785314265957936,3,21,negative regulation of gliogenesis,BP,IDH2;DLX2;KDM4A
20151,GO:2001021,0.438819069711117,0.712614624688003,7,62,negative regulation of response to DNA damage stimulus,BP,SNAI2;CLU;HMGA2;CHEK2;MAGEF1;MDM2;CXORF57
10116,GO:0042695,0.438914103111014,0.904874201257292,1,5,thelarche,BP,AREG
13992,GO:0060744,0.438914103111014,0.904874201257292,1,5,mammary gland branching involved in thelarche,BP,AREG
8271,GO:0033089,0.439141604473711,0.904762732626877,1,5,positive regulation of T cell differentiation in thymus,BP,GLI2
3748,GO:0008290,0.439149831073837,0.901405328206385,1,6,F-actin capping protein complex,CC,CAPG
6815,GO:0030284,0.439248043160279,0.904710552514874,1,5,estrogen receptor activity,MF,LEF1
13653,GO:0060215,0.439302685979885,0.904683757573106,1,5,primitive hemopoiesis,BP,ZFPM1
12131,GO:0048262,0.439317034388061,0.901320767150966,1,6,determination of dorsal/ventral asymmetry,BP,DDIT3
8715,GO:0034379,0.439442146986809,0.901257463034822,1,6,very-low-density lipoprotein particle assembly,BP,ACSL3
2110,GO:0004896,0.439528854558183,0.73749071880702,5,43,cytokine receptor activity,MF,IL20RB;CXCR1;IL31RA;IL17RE;LEPR
14911,GO:0070827,0.439708238200879,0.90961044957972,1,4,chromatin maintenance,BP,MTHFR
10115,GO:0042693,0.439850298036524,0.901050769814165,1,6,muscle cell fate commitment,BP,DKK1
2650,GO:0005996,0.439884573652533,0.648216604536318,22,200,monosaccharide metabolic process,BP,IRS2;H6PD;SLC2A3;TKFC;NR1D1;NISCH;SIK1;FUT10;CPT1A;ACACB;NCOA2;PDK3;G6PD;DGKQ;GCLC;ENPP1;G6PC3;LEPR;MAN2B1;IGFBP4;UGT1A3;UGT1A6
9725,GO:0038202,0.439940335596025,0.756892723558401,4,31,TORC1 signaling,BP,SESN3;SESN1;ATM;DGKQ
12974,GO:0051425,0.44005249688254,0.90944950840953,1,4,PTB domain binding,MF,INPP5D
4280,GO:0009651,0.440131169990672,0.823819519864743,2,15,response to salt stress,BP,ZFP36L1;TH
16692,GO:0097722,0.440240853816704,0.757044154065896,4,30,sperm motility,BP,NPHP4;BBS2;TPGS1;DNAH1
503,GO:0001561,0.440358685820771,0.900792933709045,1,6,fatty acid alpha-oxidation,BP,ALDH3A2
8264,GO:0033081,0.440375556578978,0.823647035239681,2,15,regulation of T cell differentiation in thymus,BP,BMP4;GLI2
6552,GO:0021999,0.440456796095078,0.904116704238133,1,5,neural plate anterior/posterior regionalization,BP,SSBP3
1977,GO:0004697,0.440457444532975,0.827193159914656,2,12,protein kinase C activity,MF,PRKCZ;PRKCA
4615,GO:0010738,0.440561750339547,0.827120691405827,2,12,regulation of protein kinase A signaling,BP,AIP;AKAP7
6781,GO:0030228,0.440664907107197,0.830781646810407,2,10,lipoprotein particle receptor activity,MF,SORL1;LRP1
991,GO:0002449,0.440788839203009,0.668331459997386,14,132,lymphocyte mediated immunity,BP,INPP5D;IL20RB;CLU;SERPING1;PRKCZ;IL31RA;ULBP1;C5;IL18;LYST;BCL6;BTN3A3;RSAD2;ZBTB1
11649,GO:0046449,0.441132092641128,0.908943606269948,1,4,creatinine metabolic process,BP,MME
16307,GO:0090568,0.441787147286379,0.757167376908865,4,27,nuclear transcriptional repressor complex,CC,CHD3;TNRC18;SALL2;BAHCC1
17793,GO:1901977,0.441802186108329,0.900058530442134,1,6,negative regulation of cell cycle checkpoint,BP,CHEK2
13643,GO:0060198,0.441944386043649,0.899985998750711,1,6,clathrin-sculpted vesicle,CC,SYT1
12130,GO:0048261,0.442086336662544,0.8234595772394,2,14,negative regulation of receptor-mediated endocytosis,BP,DLG4;ARF6
5540,GO:0016538,0.442226149611827,0.779109674256869,3,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN2B;CDKN2A;CCNY
8839,GO:0034650,0.442458456345084,0.903128147753509,1,5,cortisol metabolic process,BP,DGKQ
8840,GO:0034651,0.442458456345084,0.903128147753509,1,5,cortisol biosynthetic process,BP,DGKQ
19694,GO:2000064,0.442458456345084,0.903128147753509,1,5,regulation of cortisol biosynthetic process,BP,DGKQ
16625,GO:0097530,0.442491007714576,0.719944554326126,6,57,granulocyte migration,BP,VAV3;ITGA1;PDE4D;MOSPD2;TGFB2;LGALS3
2980,GO:0006526,0.442539990594403,0.903087743846584,1,5,arginine biosynthetic process,BP,CPS1
47,GO:0000099,0.442579298947981,0.908262602855788,1,4,sulfur amino acid transmembrane transporter activity,MF,SLC7A11
16783,GO:0098661,0.44260572141928,0.722104061646619,6,45,inorganic anion transmembrane transport,BP,ANO1;CLCA2;SLC20A1;ANO6;PRNP;ANKH
13675,GO:0060260,0.442622013069452,0.781096767982851,3,23,regulation of transcription initiation from RNA polymerase II promoter,BP,TP53;THRA;TAF1
336,GO:0000932,0.442649345091555,0.692923961323225,9,75,P-body,CC,ZFP36L1;SYNE1;APOBEC3C;TRIM5;BTBD2;PNRC1;APOBEC3G;APOBEC3F;AGO4
15460,GO:0071855,0.442813501191441,0.89713336751943,1,7,neuropeptide receptor binding,MF,UCN2
6475,GO:0021825,0.442825031336695,0.90814664649669,1,4,substrate-dependent cerebral cortex tangential migration,BP,ROBO1
12068,GO:0048066,0.442921699626995,0.754834888482692,4,30,developmental pigmentation,BP,GLI3;KITLG;HPS4;LEF1
19531,GO:1990535,0.443263055238878,0.907939718224751,1,4,neuron projection maintenance,BP,PRNP
5180,GO:0015748,0.443300214649743,0.700101344166394,8,66,organophosphate ester transport,BP,PITPNM3;OSBPL10;ATP10D;ABCA1;OSBPL5;ATP8B2;G6PC3;PITPNC1
3656,GO:0008142,0.443321442588003,0.907912112685007,1,4,oxysterol binding,MF,OSBPL5
2375,GO:0005507,0.443787218961919,0.751794484159236,4,37,copper ion binding,MF,TP53;ANG;SNCA;PRNP
10570,GO:0043558,0.443836012933209,0.822223247421939,2,14,regulation of translational initiation in response to stress,BP,EIF2AK4;DNAJC3
11196,GO:0045350,0.443910681631868,0.898979638757419,1,6,interferon-beta biosynthetic process,BP,TLR3
11203,GO:0045357,0.443910681631868,0.898979638757419,1,6,regulation of interferon-beta biosynthetic process,BP,TLR3
10712,GO:0044090,0.443933052244564,0.824769729862885,2,12,positive regulation of vacuole organization,BP,ANXA2;ULK1
7982,GO:0032611,0.443992603531764,0.733917117591811,5,42,interleukin-1 beta production,BP,F2R;ABCA1;PYCARD;EGR1;ISL1
14192,GO:0061158,0.444123284372252,0.826335645409779,2,11,3'-UTR-mediated mRNA destabilization,BP,ZFP36L1;ZFP36L2
12627,GO:0050858,0.444134116918323,0.820090805536304,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,PRNP;LGALS3
18008,GO:1902554,0.444247346631697,0.691158889159561,9,78,serine/threonine protein kinase complex,CC,TGFBR2;PYCARD;CDK14;TBC1D5;PHKA2;ENG;ULK1;UVRAG;CCNY
2700,GO:0006068,0.444263922619915,0.896373724482245,1,7,ethanol catabolic process,BP,SULT1E1
8673,GO:0034310,0.444263922619915,0.896373724482245,1,7,primary alcohol catabolic process,BP,SULT1E1
96,GO:0000187,0.444358399538102,0.673880374344724,12,104,activation of MAPK activity,BP,DUSP6;CSPG4;MAP3K6;ERCC6;ITGA1;DUSP5;TP73;C5;PTPN1;MAP2K5;MAPK8IP3;MDFIC
16610,GO:0097501,0.444513919711005,0.896242435007064,1,7,stress response to metal ion,BP,HSPA5
17638,GO:1901522,0.444696291838787,0.781459952208765,3,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,CHD6;CARF;RXRA
3407,GO:0007191,0.444712305819708,0.898567532207888,1,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,GNG2
9696,GO:0038128,0.444917466468216,0.752781631644651,4,31,ERBB2 signaling pathway,BP,EGFR;PTK6;PIK3R1;PRKCA
10383,GO:0043237,0.445232699785974,0.907005531187216,1,4,laminin-1 binding,MF,NID1
11216,GO:0045414,0.445604648323405,0.898107537596676,1,6,regulation of interleukin-8 biosynthetic process,BP,MAP2K5
15278,GO:0071499,0.44604810074215,0.897878450940798,1,6,cellular response to laminar fluid shear stress,BP,MAP2K5
11823,GO:0046825,0.446150201752311,0.732863304129435,5,39,regulation of protein export from nucleus,BP,GAS6;TP53;PTPN14;MDM2;SP100
9042,GO:0035282,0.446264761267067,0.698332761898736,8,60,segmentation,BP,SFRP1;BMP4;PLXNA2;DKK1;ATM;POGLUT1;LEF1;MED12
9531,GO:0036309,0.446268018190502,0.934574395638129,1,2,protein localization to M-band,BP,OBSCN
13044,GO:0051575,0.446429986376793,0.901147585240743,1,5,5'-deoxyribose-5-phosphate lyase activity,MF,HMGA2
5209,GO:0015813,0.446524600327981,0.821523384295259,2,13,L-glutamate transmembrane transport,BP,NTSR1;SLC7A11
729,GO:0001959,0.446673961349691,0.663086447663974,14,127,regulation of cytokine-mediated signaling pathway,BP,GAS6;AXL;STAT1;PYCARD;CAV1;SLIT3;ROBO1;TRAF1;PTPN1;STAT2;SPPL2B;AGPAT1;PPARG;CREBRF
7576,GO:0031954,0.446964663666412,0.778943751623603,3,21,positive regulation of protein autophosphorylation,BP,PDGFC;PDGFA;GPNMB
14164,GO:0061099,0.447101013560725,0.777019460535121,3,24,negative regulation of protein tyrosine kinase activity,BP,GPRC5A;PTK6;CAV1
7887,GO:0032466,0.447112149421116,0.897327433994979,1,6,negative regulation of cytokinesis,BP,E2F7
9746,GO:0039528,0.44715490737869,0.778793940592312,3,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,TKFC;DDX60;SEC14L1
6942,GO:0030579,0.447223988630511,0.900748554825746,1,5,ubiquitin-dependent SMAD protein catabolic process,BP,TGFB1I1
4621,GO:0010746,0.447319378070582,0.906009207949377,1,4,regulation of plasma membrane long-chain fatty acid transport,BP,IRS2
4622,GO:0010748,0.447319378070582,0.906009207949377,1,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,IRS2
20101,GO:2000811,0.447437507716915,0.820876276325645,2,13,negative regulation of anoikis,BP,SNAI2;CAV1
15977,GO:0086016,0.447453859321351,0.900632840379759,1,5,AV node cell action potential,BP,GJA5
15986,GO:0086027,0.447453859321351,0.900632840379759,1,5,AV node cell to bundle of His cell signaling,BP,GJA5
2399,GO:0005546,0.447728838679982,0.730712653411624,5,42,phosphatidylinositol-4,5-bisphosphate binding,MF,JPH2;ASAP1;SYT1;FZD7;ANXA2
2180,GO:0005031,0.447793056614134,0.816677107665701,2,17,tumor necrosis factor-activated receptor activity,MF,TNFRSF6B;EDA2R
2182,GO:0005035,0.447793056614134,0.816677107665701,2,17,death receptor activity,MF,TNFRSF6B;EDA2R
2526,GO:0005785,0.447827392252401,0.894492393093219,1,7,signal recognition particle receptor complex,CC,DERL3
9845,GO:0042116,0.448323631729536,0.73129618316308,5,38,macrophage activation,BP,CLU;IL31RA;TLR3;SNCA;ATM
16608,GO:0097499,0.448406627217191,0.896654550207414,1,6,protein localization to non-motile cilium,BP,BBS4
13997,GO:0060750,0.448489146622877,0.905447685602937,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,AREG
4567,GO:0010657,0.448663330200974,0.730426904044777,5,40,muscle cell apoptotic process,BP,PDCD4;CAMK2D;CDKN2A;PPARG;DMPK
612,GO:0001781,0.448886393012876,0.8999097760382,1,5,neutrophil apoptotic process,BP,ITPKB
8238,GO:0033029,0.448886393012876,0.8999097760382,1,5,regulation of neutrophil apoptotic process,BP,ITPKB
15616,GO:0072156,0.44898431479857,0.914367385998318,1,3,distal tubule morphogenesis,BP,KLHL3
11454,GO:0045934,0.449100250884891,0.59087646102331,120,1094,negative regulation of nucleobase-containing compound metabolic process,BP,TXNIP;SOX6;SFRP1;DDIT4;GAS6;SNAI2;MAGED1;PHF21A;TSC22D3;KLF8;ZNF608;CBX5;VDR;BMP4;NR1D1;SMARCA2;PDCD4;NR3C1;STAT1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;ZC3H6;TFDP2;CCDC85B;KLF12;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;CAV1;GLI2;RBFOX2;ZNF318;TNRC18;SDR16C5;HMGA2;PRDX5;KANK2;PER1;UHRF2;WFS1;MDFI;CIRBP;JARID2;TP73;CHEK2;PHF2;SNCA;FGFR1;DKK1;NCOA2;TLE4;FZD8;TCEAL1;NFATC4;MAGEF1;FOXN3;LMCD1;FZD1;PBXIP1;CALR;ATM;MDM2;MEIS2;CITED2;GCLC;NR2F2;CBX7;MAF;EGR1;SOX9;ISL1;BCL6;NCOR1;SALL2;CXORF57;BAHCC1;TSHZ1;TCF25;HMBOX1;NAB2;ATXN1;IRF2BPL;ZFPM1;MAP2K5;DLX2;LEF1;THRA;CDKN2A;SP100;TSPYL2;MDFIC;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;PPARG;PARP15;KCNIP3;MEF2A;TGIF1;ING4;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;KDM4A;NIPBL;PRDM5;S100A11;RXRA
12338,GO:0048741,0.449335174391717,0.819527141124259,2,13,skeletal muscle fiber development,BP,GPX1;PPP3CA
11608,GO:0046337,0.449362350068576,0.818288323688361,2,14,phosphatidylethanolamine metabolic process,BP,SLC27A1;ETNK2
15273,GO:0071493,0.449387214916233,0.896142970112073,1,6,cellular response to UV-B,BP,MME
7983,GO:0032612,0.449499115687872,0.714262806238072,6,54,interleukin-1 production,BP,F2R;GAS6;ABCA1;PYCARD;EGR1;ISL1
15110,GO:0071236,0.449606846089827,0.669023420468115,12,104,cellular response to antibiotic,BP,NQO1;AXL;TP53;CLU;TP53INP1;SETX;MDM2;CST3;EGR1;HSPA5;ITPR2;EFNA5
4351,GO:0009950,0.449693522850021,0.822442551910298,2,11,dorsal/ventral axis specification,BP,SFRP1;MDFI
10603,GO:0043621,0.449861602163868,0.716283277988556,6,43,protein self-association,MF,TP53;TTN;ATXN1;RSAD2;FHOD1;PPARG
2455,GO:0005671,0.449952505888966,0.817865413658997,2,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,TADA3;YEATS2
8940,GO:0035021,0.450001496003387,0.904718514315392,1,4,negative regulation of Rac protein signal transduction,BP,STMN3
13838,GO:0060484,0.450066872430996,0.899311413961321,1,5,lung-associated mesenchyme development,BP,FGFR1
6538,GO:0021957,0.450108472495005,0.904666799200831,1,4,corticospinal tract morphogenesis,BP,CDH11
18341,GO:1903364,0.450183244655945,0.663807902245139,13,117,positive regulation of cellular protein catabolic process,BP,PRICKLE1;LRP1;CAV1;TRIB2;CLU;HERPUD1;MAGEF1;MDM2;GCLC;NUB1;RNF144B;TAF1;EDEM1
18924,GO:1904714,0.450299578820653,0.895665539844047,1,6,regulation of chaperone-mediated autophagy,BP,SNCA
16364,GO:0097011,0.45071131810007,0.895449624804874,1,6,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,ZFP36L2
16365,GO:0097012,0.45071131810007,0.895449624804874,1,6,response to granulocyte macrophage colony-stimulating factor,BP,ZFP36L2
16199,GO:0090277,0.450815425584484,0.71327273517953,6,53,positive regulation of peptide hormone secretion,BP,ANO1;IRS2;EGFR;PLA2G6;ISL1;ABAT
10582,GO:0043578,0.451149106299914,0.913412938972946,1,3,nuclear matrix organization,BP,SYNE1
16213,GO:0090292,0.451149106299914,0.913412938972946,1,3,nuclear matrix anchoring at nuclear membrane,BP,SYNE1
13796,GO:0060421,0.451165232080628,0.776370586826182,3,20,positive regulation of heart growth,BP,ACACB;FGFR1;TGFBR3
6117,GO:0019370,0.451713661244898,0.892416181815072,1,7,leukotriene biosynthetic process,BP,GGT7
5369,GO:0016188,0.452331887612764,0.898156921260091,1,5,synaptic vesicle maturation,BP,DLG4
319,GO:0000836,0.452354189853163,0.898145511719986,1,5,Hrd1p ubiquitin ligase complex,CC,SEL1L
18226,GO:1903076,0.452771748571953,0.691570832403789,8,66,regulation of protein localization to plasma membrane,BP,EGFR;ACSL3;ITGA3;LRP1;PIK3R1;ARF6;PRNP;GOPC
12794,GO:0051126,0.452842207866311,0.894327646077597,1,6,negative regulation of actin nucleation,BP,ARPIN
3979,GO:0008823,0.453032113306852,0.89779830367962,1,5,cupric reductase activity,MF,STEAP2
13416,GO:0052851,0.453032113306852,0.89779830367962,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP2
8938,GO:0035019,0.453138071557973,0.711979865279188,6,49,somatic stem cell population maintenance,BP,SFRP1;ZFP36L2;PBX1;VANGL2;SOX9;YAP1
7177,GO:0031076,0.453220571936191,0.748868235275679,4,25,embryonic camera-type eye development,BP,IFT140;WDR19;TH;RARA
11349,GO:0045738,0.45349049344983,0.773777583177819,3,21,negative regulation of DNA repair,BP,HMGA2;MAGEF1;CXORF57
11597,GO:0046323,0.453512732455131,0.701234736890847,7,52,glucose import,BP,IRS2;CLTCL1;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
4754,GO:0010936,0.453526382502414,0.897544678925009,1,5,negative regulation of macrophage cytokine production,BP,TGFB2
18051,GO:1902668,0.453565653373213,0.775305145641769,3,19,negative regulation of axon guidance,BP,SEMA5A;SEMA4A;SEMA4B
13609,GO:0060137,0.453597379532384,0.893928192276969,1,6,maternal process involved in parturition,BP,OXTR
5158,GO:0015705,0.453709506917897,0.902915369743417,1,4,iodide transport,BP,ANO1
5375,GO:0016199,0.453786721767747,0.902877588781254,1,4,axon midline choice point recognition,BP,ROBO1
8448,GO:0033600,0.453842963100982,0.902850064098538,1,4,negative regulation of mammary gland epithelial cell proliferation,BP,ROBO1
575,GO:0001727,0.453916694915853,0.897344112529803,1,5,lipid kinase activity,MF,PIK3C2B
13525,GO:0060017,0.454086992106603,0.89725652452011,1,5,parathyroid gland development,BP,HOXA3
6167,GO:0019534,0.454102786750406,0.902722840003177,1,4,toxin transmembrane transporter activity,MF,SLC7A8
18632,GO:1903975,0.454319746267322,0.893545191038431,1,6,regulation of glial cell migration,BP,IDH2
1448,GO:0003680,0.454368166447723,0.893519487005628,1,6,AT DNA binding,MF,HMGA2
5652,GO:0016758,0.454383990100501,0.648830828590592,16,151,transferase activity, transferring hexosyl groups,MF,PYGB;GALNT10;EXTL2;B3GAT3;FUT10;UGT8;XYLT1;HEXA;POGLUT1;GCNT1;UGT1A3;UGT1A6;ALG10;GALNT2;UGGT2;TUSC3
8970,GO:0035094,0.454392732218697,0.772381246573222,3,22,response to nicotine,BP,SLC7A11;TH;ABAT
8620,GO:0034162,0.454439169027633,0.814633107337173,2,14,toll-like receptor 9 signaling pathway,BP,PTPRS;RSAD2
6561,GO:0022028,0.454443295977696,0.90255594444533,1,4,tangential migration from the subventricular zone to the olfactory bulb,BP,ROBO1
8339,GO:0033216,0.454669445387657,0.896956591979037,1,5,ferric iron import,BP,STEAP2
648,GO:0001839,0.454928890758019,0.896822810604126,1,5,neural plate morphogenesis,BP,VANGL2
9286,GO:0035749,0.455005588079135,0.896783240759028,1,5,myelin sheath adaxonal region,CC,ANXA2
16823,GO:0098771,0.455636721111701,0.6089064481556,43,387,inorganic ion homeostasis,BP,F2R;SLC7A8;PKD2;JPH2;CYBRD1;NOS1;EGFR;SLC8A1;NTSR1;VDR;NEO1;KCNMA1;TP53;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;HERPUD1;ANK3;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;FAM20A;ANXA6;ENPP1;TMEM175;KCTD7;ABCC2;PRNP;SCNN1A;SFXN3;SLC9A4;ITPR2;SV2A;STEAP2;OXTR;DMPK
9384,GO:0035947,0.455823274817316,0.896360771913411,1,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1
7620,GO:0032036,0.455981281483118,0.896279007763991,1,5,myosin heavy chain binding,MF,AXL
9445,GO:0036065,0.456011470381572,0.770469979159147,3,23,fucosylation,BP,ADAMTSL1;FUT10;ADAMTS7
12092,GO:0048168,0.456106439185391,0.743845741741437,4,30,regulation of neuronal synaptic plasticity,BP,NETO1;DLG4;SNCA;SHISA9
11310,GO:0045657,0.456190201479931,0.892549370943189,1,6,positive regulation of monocyte differentiation,BP,ZFP36L1
3282,GO:0006972,0.456203141019827,0.813353991330353,2,14,hyperosmotic response,BP,TLR3;ARHGEF2
14109,GO:0061004,0.456203320160335,0.889985581263873,1,7,pattern specification involved in kidney development,BP,BMP4
15550,GO:0072048,0.456203320160335,0.889985581263873,1,7,renal system pattern specification,BP,BMP4
4520,GO:0010587,0.45653852122016,0.89599032035909,1,5,miRNA catabolic process,BP,ZCCHC11
7978,GO:0032607,0.456555558648666,0.770650387194196,3,22,interferon-alpha production,BP,STAT1;PTPRS;TLR3
20176,GO:2001057,0.457180751912328,0.708404800862677,6,49,reactive nitrogen species metabolic process,BP,NQO1;PKD2;NOS1;CPS1;CAV1;CLU
10581,GO:0043576,0.45725092284625,0.815316666472938,2,12,regulation of respiratory gaseous exchange,BP,NTSR1;TSHZ3
14381,GO:0061687,0.457382815643345,0.889341294957355,1,7,detoxification of inorganic compound,BP,ABCC2
3121,GO:0006703,0.45742046128113,0.887409278707916,1,8,estrogen biosynthetic process,BP,HSD17B11
15292,GO:0071539,0.45771848145267,0.744498648769609,4,26,protein localization to centrosome,BP,CEP250;GOLGB1;BBS4;SNX10
2549,GO:0005827,0.457893357303271,0.895286270167696,1,5,polar microtubule,CC,KLHL22
13149,GO:0051782,0.458401271747907,0.81175346393746,2,14,negative regulation of cell division,BP,TXNIP;E2F7
8243,GO:0033034,0.458462035122414,0.891331878491641,1,6,positive regulation of myeloid cell apoptotic process,BP,CDKN2A
4721,GO:0010888,0.458539784151481,0.812906368382177,2,13,negative regulation of lipid storage,BP,ABCA1;PPARG
6516,GO:0021903,0.458933582311094,0.894743633190631,1,5,rostrocaudal neural tube patterning,BP,SSBP3
14619,GO:0070233,0.458966528402859,0.810263997781551,2,15,negative regulation of T cell apoptotic process,BP,TSC22D3;BMP4
7934,GO:0032536,0.45898263756394,0.891051646807894,1,6,regulation of cell projection size,BP,NEFL
9676,GO:0038089,0.459009752421346,0.894703827778261,1,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,MYO1C
11432,GO:0045910,0.459426794308565,0.769029112101511,3,21,negative regulation of DNA recombination,BP,MAGEF1;BCL6;CXORF57
4777,GO:0010968,0.459588444799855,0.890724968744291,1,6,regulation of microtubule nucleation,BP,EML2
9657,GO:0038036,0.459678746178431,0.890676220583328,1,6,sphingosine-1-phosphate receptor activity,MF,S1PR5
1557,GO:0003958,0.459758402805707,0.894312077407132,1,5,NADPH-hemoprotein reductase activity,MF,NOS1
18775,GO:1904352,0.45978058901193,0.899915626244304,1,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1
12793,GO:0051125,0.459786610447736,0.768053077657672,3,22,regulation of actin nucleation,BP,GSN;ARPIN;WIPF1
16266,GO:0090398,0.459843167198339,0.705642090246104,6,51,cellular senescence,BP,TP53;HMGA2;PLA2R1;CALR;BCL6;CDKN2A
2165,GO:0005001,0.460035394698836,0.817271326290325,2,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRM;PTPRU
6046,GO:0019198,0.460035394698836,0.817271326290325,2,10,transmembrane receptor protein phosphatase activity,MF,PTPRM;PTPRU
3371,GO:0007144,0.460248306381357,0.890368428895264,1,6,female meiosis I,BP,MLH3
11790,GO:0046703,0.460439894744806,0.88422724625089,1,9,natural killer cell lectin-like receptor binding,MF,ULBP1
16768,GO:0098641,0.460500104429369,0.806653666458522,2,18,cadherin binding involved in cell-cell adhesion,MF,ANXA2;S100A11
13858,GO:0060526,0.460630840001778,0.899490769712569,1,4,prostate glandular acinus morphogenesis,BP,SFRP1
13859,GO:0060527,0.460630840001778,0.899490769712569,1,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,SFRP1
12568,GO:0050771,0.460767238805036,0.706394261091228,6,44,negative regulation of axonogenesis,BP,PTPRS;SEMA5A;ULK2;SEMA4A;EFNB3;SEMA4B
5809,GO:0017080,0.460947161472354,0.767116766350972,3,22,sodium channel regulator activity,MF,NOS1;CAMK2D;PTPN3
13815,GO:0060444,0.46151305088842,0.768114277328626,3,20,branching involved in mammary gland duct morphogenesis,BP,ETV5;VDR;AREG
13529,GO:0060021,0.461517933283958,0.685075336095536,8,57,roof of mouth development,BP,TGFBR2;SNAI2;GLI3;TGFBR3;FZD1;TSHZ1;TGFB2;LEF1
8057,GO:0032740,0.461861957767454,0.886872723744333,1,7,positive regulation of interleukin-17 production,BP,IL18
11114,GO:0045179,0.461991880001523,0.893137771369824,1,5,apical cortex,CC,PRKCZ
1665,GO:0004128,0.462019299284881,0.886785376140708,1,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,NQO1
6287,GO:0019903,0.462103851146998,0.657666870836402,12,100,protein phosphatase binding,MF,PHACTR3;IRS2;EGFR;STAT1;TP53;DLG4;ITGA1;PIK3R1;MTMR4;PTPN1;TCTEX1D4;PPARG
5426,GO:0016290,0.462160124870556,0.884756136851256,1,8,palmitoyl-CoA hydrolase activity,MF,ACOT1
5919,GO:0018200,0.462416604834932,0.806779917278583,2,16,peptidyl-glutamic acid modification,BP,TTLL11;TPGS1
8960,GO:0035067,0.462439117571872,0.808794268915904,2,14,negative regulation of histone acetylation,BP,SDR16C5;SNCA
12753,GO:0051055,0.462695403629293,0.736439804961604,4,35,negative regulation of lipid biosynthetic process,BP,SNAI2;PDGFA;SIK1;SLC27A1
11292,GO:0045634,0.462745875425914,0.892739446449488,1,5,regulation of melanocyte differentiation,BP,KITLG
10061,GO:0042581,0.462798024685789,0.661429829893847,11,100,specific granule,CC,SLC2A3;TIMP2;ANO6;KCNAB2;STOM;VAMP1;MLEC;MOSPD2;DNASE1L1;ADAM10;CTSD
20001,GO:2000646,0.462876150460885,0.89267052698335,1,5,positive regulation of receptor catabolic process,BP,PTPN1
3101,GO:0006681,0.462914783530479,0.888920067301145,1,6,galactosylceramide metabolic process,BP,UGT8
6121,GO:0019374,0.462914783530479,0.888920067301145,1,6,galactolipid metabolic process,BP,UGT8
2611,GO:0005923,0.463110353061207,0.657671945429003,12,89,bicellular tight junction,CC,FRMD4B;NPHP4;PRKCZ;ANK3;AMOTL1;ARHGEF2;RAB13;MPP7;AMOTL2;MAGI2;MAGI1;MPDZ
8590,GO:0034115,0.463267173280318,0.886091096177785,1,7,negative regulation of heterotypic cell-cell adhesion,BP,MAP2K5
14815,GO:0070587,0.463267173280318,0.886091096177785,1,7,regulation of cell-cell adhesion involved in gastrulation,BP,MAP2K5
2015,GO:0004745,0.463291836727708,0.886077346818753,1,7,retinol dehydrogenase activity,MF,SDR16C5
4638,GO:0010765,0.463332928606146,0.765878977234001,3,21,positive regulation of sodium ion transport,BP,NOS1;CNTN1;ANK3
14588,GO:0070181,0.463719675003235,0.883874527224014,1,8,small ribosomal subunit rRNA binding,MF,CIRBP
6985,GO:0030676,0.463764947832214,0.810595594207608,2,12,Rac guanyl-nucleotide exchange factor activity,MF,VAV3;ARHGEF2
9446,GO:0036066,0.463803767508787,0.807788549945662,2,14,protein O-linked fucosylation,BP,ADAMTSL1;ADAMTS7
19519,GO:1990459,0.463885512064885,0.888389759151134,1,6,transferrin receptor binding,MF,SNX1
10788,GO:0044295,0.464043856405122,0.766073270621171,3,20,axonal growth cone,CC,FLRT3;TRAK1;BOC
2984,GO:0006531,0.46416249677405,0.888238144873283,1,6,aspartate metabolic process,BP,NMNAT2
5835,GO:0017128,0.464317604108075,0.888153185321588,1,6,phospholipid scramblase activity,MF,ANO6
5813,GO:0017085,0.464345290372266,0.806294642323328,2,15,response to insecticide,BP,NEFL;TH
17552,GO:1901201,0.46486186881609,0.811605003042058,2,11,regulation of extracellular matrix assembly,BP,PHLDB1;SOX9
8719,GO:0034383,0.464867332986563,0.762213680039731,3,25,low-density lipoprotein particle clearance,BP,ANXA2;CES3;LIPA
12258,GO:0048593,0.465190681746127,0.673510350596899,9,66,camera-type eye morphogenesis,BP,COL8A1;SDK1;TENM3;PTPRM;BMP4;GLI3;SOX9;IFT122;TH
7070,GO:0030870,0.465338869430328,0.891362280768316,1,5,Mre11 complex,CC,SP100
11049,GO:0045070,0.465347743319696,0.73559879405097,4,31,positive regulation of viral genome replication,BP,IFIT1;ADARB1;STOM;SRPK2
3779,GO:0008344,0.465954384455012,0.716322618685571,5,37,adult locomotory behavior,BP,SLITRK6;NTSR1;SNCA;EFNB3;GDNF
5684,GO:0016810,0.465985255151534,0.653280791224578,12,111,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,PHF21A;DPYSL2;APOBEC3C;PADI3;ADARB1;CHD3;CPS1;APOBEC3G;CAT;APOBEC3F;HDAC11;SAP30L
6967,GO:0030643,0.466023168033908,0.8967689134781,1,4,cellular phosphate ion homeostasis,BP,ENPP1
15775,GO:0072501,0.466023168033908,0.8967689134781,1,4,cellular divalent inorganic anion homeostasis,BP,ENPP1
15776,GO:0072502,0.466023168033908,0.8967689134781,1,4,cellular trivalent inorganic anion homeostasis,BP,ENPP1
12347,GO:0048755,0.466037609986054,0.890989225508542,1,5,branching morphogenesis of a nerve,BP,DLX2
11267,GO:0045601,0.466265370561414,0.763500663703506,3,21,regulation of endothelial cell differentiation,BP,BMP4;BTG1;XDH
11301,GO:0045648,0.466343266374622,0.762739654172212,3,22,positive regulation of erythrocyte differentiation,BP,INPP5D;FAM210B;STAT1
12933,GO:0051342,0.466405503276561,0.88700549863538,1,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,AIP
5631,GO:0016722,0.466414198292292,0.805856784869137,2,14,oxidoreductase activity, oxidizing metal ions,MF,CYBRD1;STEAP2
2170,GO:0005007,0.466492369785489,0.89074598546894,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR1
10837,GO:0044359,0.466585647065894,0.886906122663754,1,6,modulation of molecular function in other organism,BP,ANXA2
13296,GO:0052205,0.466585647065894,0.886906122663754,1,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,ANXA2
6709,GO:0030127,0.46660513063111,0.80571508197283,2,14,COPII vesicle coat,CC,SEC24D;KLHL12
6498,GO:0021877,0.466671894160682,0.890649865464236,1,5,forebrain neuron fate commitment,BP,DLX2
12056,GO:0048029,0.466803074669302,0.713195318635926,5,46,monosaccharide binding,MF,SLC2A3;P3H2;G6PD;ENG;MANBA
3792,GO:0008373,0.466933350916889,0.805471358391648,2,14,sialyltransferase activity,MF,ST6GALNAC2;ST6GAL2
16612,GO:0097503,0.466933350916889,0.805471358391648,2,14,sialylation,BP,ST6GALNAC2;ST6GAL2
3159,GO:0006771,0.467097705753433,0.886623339040068,1,6,riboflavin metabolic process,BP,ENPP1
12769,GO:0051090,0.467241846817401,0.606257480090031,33,303,regulation of DNA binding transcription factor activity,BP,PKD2;GAS6;ROR1;TRIM38;EIF2AK4;TRIM5;DDIT3;PYCARD;SIK1;CLU;PRKCZ;WFS1;MDFI;CAT;TLR3;EDA2R;TRAF1;FZD1;ARHGEF2;CRTC1;STK36;PRNP;MAP2K5;THRA;CDKN2A;SP100;PPARG;TAF1;FZD4;PPP3CA;FOS;CDK5RAP3;NFKBIE
1017,GO:0002517,0.467310809768465,0.89030733583803,1,5,T cell tolerance induction,BP,TGFBR2
1080,GO:0002664,0.467310809768465,0.89030733583803,1,5,regulation of T cell tolerance induction,BP,TGFBR2
18090,GO:1902774,0.467367804322951,0.886473994157585,1,6,late endosome to lysosome transport,BP,VPS39
3604,GO:0008046,0.467728404979546,0.895898258386692,1,4,axon guidance receptor activity,MF,ROBO1
1968,GO:0004683,0.468007178004367,0.761382090532932,3,22,calmodulin-dependent protein kinase activity,MF,CAMK2D;PHKA2;DAPK1
14131,GO:0061042,0.468359852417747,0.885924375470962,1,6,vascular wound healing,BP,SERPINE1
14928,GO:0070849,0.468806435927349,0.713182004952467,5,39,response to epidermal growth factor,BP,ZFP36L1;ZFP36L2;SNAI2;EGFR;SOX9
15716,GO:0072331,0.469416895299849,0.612936402425476,26,245,signal transduction by p53 class mediator,BP,DDIT4;SNAI2;NUPR1;TP53;PYCARD;TFDP2;CHD3;E2F7;RMI2;TP53INP1;TP73;CHEK2;PRKAB2;PLA2R1;EDA2R;ATM;MDM2;ZMAT3;NDRG1;RBL2;USP28;SP100;ING4;PRKAG1;TAF1;CDK5RAP3
10675,GO:0043981,0.46943861597071,0.802495144793556,2,15,histone H4-K5 acetylation,BP,JADE2;ING4
10676,GO:0043982,0.46943861597071,0.802495144793556,2,15,histone H4-K8 acetylation,BP,JADE2;ING4
11866,GO:0046906,0.469551951066831,0.685182180835734,7,61,tetrapyrrole binding,MF,PTGS1;NOS1;NR1D1;CAT;CYP20A1;SLC48A1;CYP4V2
9654,GO:0038031,0.469620121055779,0.889063484489079,1,5,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
5299,GO:0016010,0.469828212054199,0.806143042042107,2,12,dystrophin-associated glycoprotein complex,CC,UTRN;SNTB1
16333,GO:0090665,0.469828212054199,0.806143042042107,2,12,glycoprotein complex,CC,UTRN;SNTB1
8054,GO:0032735,0.46988111111401,0.799611093485489,2,18,positive regulation of interleukin-12 production,BP,TLR3;ISL1
13491,GO:0055091,0.470022679570097,0.894719284062889,1,4,phospholipid homeostasis,BP,ABCA1
1349,GO:0003215,0.470031363611302,0.805992881089932,2,12,cardiac right ventricle morphogenesis,BP,ISL1;TGFB2
2080,GO:0004839,0.470069615685237,0.888820315814187,1,5,ubiquitin activating enzyme activity,MF,UBA7
18333,GO:1903349,0.470378424515964,0.884800743408158,1,6,omegasome membrane,CC,ULK1
1372,GO:0003264,0.470605450403511,0.88467392495706,1,6,regulation of cardioblast proliferation,BP,ISL1
1529,GO:0003910,0.470636172510013,0.884656756414661,1,6,DNA ligase (ATP) activity,MF,LIG1
2979,GO:0006525,0.470707877997012,0.801542098661269,2,15,arginine metabolic process,BP,NOS1;CPS1
16867,GO:0098843,0.470887999007114,0.884515965107882,1,6,postsynaptic endocytic zone,CC,DNM1P46
3269,GO:0006949,0.47098698521149,0.731194265305885,4,30,syncytium formation,BP,FLOT1;CD109;NOS1;MYOF
5895,GO:0018107,0.471031739842806,0.654524013994025,11,90,peptidyl-threonine phosphorylation,BP,DDIT4;TGFBR2;WNK1;CAMK2D;SPRY2;CHEK2;DGKQ;PRKCA;MAP3K12;ULK1;TAF1
19841,GO:2000343,0.471031821358835,0.879683566877445,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
16544,GO:0097366,0.471202719304652,0.758764456152117,3,22,response to bronchodilator,BP,TH;PPP3CA;OXTR
13993,GO:0060745,0.471289790830541,0.894064406775737,1,4,mammary gland branching involved in pregnancy,BP,VDR
5373,GO:0016197,0.471798671674538,0.622087081825431,20,176,endosomal transport,BP,CLTCL1;ABCA1;NSG1;SORL1;SNX1;TBC1D5;SNX33;EHD3;ARF6;LYST;TMEM50B;RAB13;MVB12B;VPS39;PIKFYVE;SNX9;RASSF9;VPS36;RHOBTB3;EPG5
19887,GO:2000406,0.472094343333272,0.800498208447046,2,15,positive regulation of T cell migration,BP,PYCARD;ADAM10
8348,GO:0033240,0.472139650247153,0.881075947073964,1,7,positive regulation of cellular amine metabolic process,BP,ABAT
8804,GO:0034594,0.472204102015825,0.887660864726364,1,5,phosphatidylinositol trisphosphate phosphatase activity,MF,INPP5D
11824,GO:0046826,0.472396765509605,0.880928538725627,1,7,negative regulation of protein export from nucleus,BP,SP100
7042,GO:0030828,0.472739400436269,0.883477469878894,1,6,positive regulation of cGMP biosynthetic process,BP,NOS1
2770,GO:0006195,0.47280632774652,0.728081302757154,4,34,purine nucleotide catabolic process,BP,GPX1;XDH;PDE4D;DNPH1
16048,GO:0090037,0.472929541298272,0.883370474553293,1,6,positive regulation of protein kinase C signaling,BP,PLA2G6
12795,GO:0051127,0.473019118464645,0.803777113398699,2,12,positive regulation of actin nucleation,BP,GSN;WIPF1
15501,GO:0071922,0.473057148318686,0.887195298721288,1,5,regulation of cohesin loading,BP,NIPBL
20030,GO:2000678,0.473482940523007,0.800573234518372,2,14,negative regulation of transcription regulatory region DNA binding,BP,DDIT3;TAF1
18192,GO:1903011,0.473845068730403,0.892735639908296,1,4,negative regulation of bone development,BP,FBN1
5010,GO:0015175,0.47390314873839,0.755312661895237,3,24,neutral amino acid transmembrane transporter activity,MF,SLC7A8;SLC7A11;SLC38A2
15631,GO:0072178,0.474046625193874,0.886653700335071,1,5,nephric duct morphogenesis,BP,BMP4
20156,GO:2001026,0.474077572274858,0.802988839766369,2,12,regulation of endothelial cell chemotaxis,BP,SEMA5A;FGFR1
4312,GO:0009798,0.474146085995402,0.682182128181063,7,54,axis specification,BP,SFRP1;BMP4;DDIT3;MDFI;CITED2;PGAP1;TTC8
11676,GO:0046488,0.474268382635454,0.622359823327232,19,159,phosphatidylinositol metabolic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;EGFR;PDGFA;KITLG;FYN;SLC27A1;PIK3R1;PLCH2;FGFR1;MTMR4;ATM;PGAP1;EFR3A;PIKFYVE;MPPE1;PIK3C2B
7892,GO:0032471,0.474322209742505,0.879820906866491,1,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,TGM2
16518,GO:0097306,0.474335721944868,0.695130692418893,6,41,cellular response to alcohol,BP,SFRP1;ABCA1;GNG2;TP53INP1;ITPR2;PPARG
4664,GO:0010817,0.474336982146721,0.601635998581052,31,282,regulation of hormone levels,BP,SULT1E1;SFRP1;ANO1;IRS2;EGFR;VDR;PCSK1;NR1D1;ERO1B;LTBP4;PLA2G6;SDR16C5;CPT1A;PCLO;MME;FGFR1;HSD17B11;DGKQ;EGR1;ISL1;PRKCA;TRERF1;ALDH9A1;ABCC2;ITPR2;UGT1A3;EFNA5;FZD4;PPP3CA;SCPEP1;ABAT
6684,GO:0030062,0.474403605633021,0.882538835682987,1,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,BCKDHB
10026,GO:0042500,0.474486399598853,0.882492011314568,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,SPPL2B
9388,GO:0035964,0.474524019156545,0.882470731468252,1,6,COPI-coated vesicle budding,BP,TMED10
12103,GO:0048200,0.474524019156545,0.882470731468252,1,6,Golgi transport vesicle coating,BP,TMED10
12105,GO:0048205,0.474524019156545,0.882470731468252,1,6,COPI coating of Golgi vesicle,BP,TMED10
13480,GO:0055078,0.474589207116964,0.801053965600241,2,13,sodium ion homeostasis,BP,SLC8A1;SCNN1A
194,GO:0000413,0.474848689198649,0.751880316667589,3,30,protein peptidyl-prolyl isomerization,BP,FKBP5;FKBP9;FKBP10
1477,GO:0003755,0.474848689198649,0.751880316667589,3,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP5;FKBP9;FKBP10
9928,GO:0042306,0.474972213853512,0.707154036044744,5,41,regulation of protein import into nucleus,BP,GAS6;BMP4;GLI3;TMEM173;MDFIC
16202,GO:0090280,0.475089690175965,0.886080937021856,1,5,positive regulation of calcium ion import,BP,LGALS3
11040,GO:0045059,0.475300782758753,0.882030789499291,1,6,positive thymic T cell selection,BP,ITPKB
19746,GO:2000179,0.476077581367667,0.755458531633203,3,21,positive regulation of neural precursor cell proliferation,BP,GJC2;GLI3;GLI2
4417,GO:0010225,0.476211789066718,0.799833624146276,2,13,response to UV-C,BP,MDM2;POLH
16093,GO:0090110,0.476644942607745,0.79950715873947,2,13,cargo loading into COPII-coated vesicle,BP,SEC24D;MIA3
17069,GO:0099638,0.476868884041322,0.881139398889401,1,6,endosome to plasma membrane protein transport,BP,NSG1
17070,GO:0099639,0.476868884041322,0.881139398889401,1,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,NSG1
615,GO:0001784,0.477067883549027,0.727453313826392,4,27,phosphotyrosine residue binding,MF,PIK3R1;VAV2;PTPN3;RASA1
12250,GO:0048569,0.47716030795349,0.79779403599138,2,14,post-embryonic animal organ development,BP,FBN1;EFEMP1
13215,GO:0051917,0.477404542336863,0.880833903899673,1,6,regulation of fibrinolysis,BP,SERPINE1
10824,GO:0044340,0.477432086107105,0.884787811392514,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,SFRP1
17483,GO:1900739,0.47749586566538,0.750417793314249,3,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;TFDP2;TP73
17484,GO:1900740,0.47749586566538,0.750417793314249,3,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;TFDP2;TP73
11745,GO:0046626,0.477517963613999,0.704887600811017,5,41,regulation of insulin receptor signaling pathway,BP,SESN3;PRKCZ;PIK3R1;PTPN1;ENPP1
4831,GO:0014042,0.477521287568175,0.890804791445044,1,4,positive regulation of neuron maturation,BP,RET
17659,GO:1901564,0.477950417192267,0.546230566905354,504,4895,organonitrogen compound metabolic process,BP,SERPINE2;PHACTR3;CPA4;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;CTGF;ADAM19;FBN1;INPP5D;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;F2R;DDIT4;TGFBR2;ADAMTSL1;EFEMP1;TENM4;MARCH4;SLC7A8;GSN;PKD2;IRS2;DUSP6;OSBPL10;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;SULF2;PHF21A;TFPI2;ROR1;AXL;EGFR;GALNT10;SDC3;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NTM;FKBP5;CLCA2;MYLK;GJC2;TRIM2;SERPINE1;SERPINH1;RNF213;CRTAP;MBOAT2;RNF165;VIM;NUPR1;CSPG4;DDB2;MAP3K6;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;NSG1;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;TP53I3;PCSK1;NR1D1;PTK6;ABTB1;EIF2AK4;TRIM5;NEFL;PDCD4;BTBD2;SORL1;LGALS1;D2HGDH;CPVL;TP53;EXTL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;LTBP1;WNK1;MUC19;DLG4;ITGA2;PILRB;PDGFA;MMP19;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;PHGDH;FLG;HIP1;GPNMB;BCKDHB;CRIM1;CUL7;BTG1;CHD3;SIK1;ELFN2;TYSND1;SNX1;GPX1;GLI3;PTGES;CDK14;CNTN1;LPCAT2;KITLG;P3H2;ERO1B;CTDSPL;MTHFR;ABHD14B;NEK9;CTSV;KCNAB2;NMRK1;LRP1;FYN;IFI6;XDH;ALPK1;B3GAT3;LTBP4;FUT10;UGT8;CPS1;CAV1;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;TRIB2;SEL1L;GLDC;SNX33;MAP3K14;OSBPL5;DCAF16;XYLT1;UST;CLU;FKBP9;SERPING1;PRKCZ;SDR16C5;FBXW4;ULK2;PARP4;TNS2;CHST3;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;IL31RA;HIBADH;PTPN14;PER1;CCK;PIK3R1;HHAT;CAPRIN2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;SPRY2;TTN;CIRBP;JARID2;LMO7;APLP2;FBLN1;TP73;CAT;CASP14;DAPK1;ST6GAL2;DLC1;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PHF2;TLR3;BPHL;MAN1A1;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;FZD7;AIP;GLG1;JADE2;PTPRU;FGFR1;IGF1R;APOBEC3F;DKK1;PRKAB2;CTF1;RGS2;C5;TGFBI;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;ESYT2;PDK3;G6PD;EPHB6;ARSD;EDA2R;FZD8;TRIOBP;DHTKD1;KDM4C;AFAP1L2;MAGEF1;LMCD1;TGFBR3;FZD1;IPP;LRTOMT;NAGLU;ENG;FOXL1;MTMR4;CALR;NEGR1;ATM;IDH2;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MANBA;TMEM14C;AREG;IFNK;AKAP13;DNAJC6;DGKQ;GCLC;NR2F2;HEXA;IFNE;NEURL1B;TRAK1;FBXW8;HDAC11;RNPEP;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;ALDH4A1;KLHL12;SDC2;THNSL2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;NCOR1;GCNT1;PRKCA;BCHE;PRPS2;ANXA2;RGS14;RAB13;AMZ2;ADAMTS15;HLTF;RNF24;MAN2B1;PGAP1;IGFBP4;ALDH9A1;MVB12B;KCTD7;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PAK6;ABCC2;NAB2;MAP3K12;TSPAN5;STK36;PRNP;RET;ZFPM1;TGFB2;MAP2K5;GGT7;DSEL;STAT2;GPR161;LEF1;DPP9;CDC42EP5;USP28;ALDH7A1;ITM2A;MAPK8IP3;MSRB2;TRIML2;CDKN2A;PPM1M;SPPL2B;ULK1;TSPYL2;AGRN;NPEPL1;IGFBP2;NPHP3;RHBDD1;MAGI2;HSPA5;CDK19;TH;KLHL5;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;RHBDD2;SAP30L;OPHN1;TPGS1;LMF1;GDNF;PGPEP1;ALG10;NUB1;KLHL3;ATRAID;SRR;YEATS2;UBA7;GALNT2;DERL3;PPARG;RNF144B;PARP15;BEX4;TPST1;MEF2A;CERS5;SNX9;ICK;SASH1;OBSL1;ING4;ZYG11B;APOL6;UNK;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;CCNY;TMEM67;PCMTD2;PRKAG1;TAF1;SENP7;EFNA5;GSTZ1;FZD4;MPPE1;DPYD;PPP3CA;DCAF8;RASA1;CTDSP2;KRT10;CAPN6;PPCS;DNPH1;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;ABAT;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;TUSC3;RXRA;EDEM1;GID4;TAOK3;CTSD;ZNRF1;DMPK;LAMB2
10020,GO:0042492,0.478475591197786,0.884208666319878,1,5,gamma-delta T cell differentiation,BP,SOX13
3527,GO:0007512,0.478543784475016,0.884170752901061,1,5,adult heart development,BP,MEF2D
456,GO:0001302,0.478642857566498,0.880125719766455,1,6,replicative cell aging,BP,CHEK2
12251,GO:0048570,0.478648945188205,0.884112270776132,1,5,notochord morphogenesis,BP,GLI2
38,GO:0000077,0.478770571019342,0.625811790691306,16,146,DNA damage checkpoint,BP,XPC;EIF2AK4;TP53;TFDP2;E2F7;MAP3K14;HMGA2;TP73;CHEK2;FOXN3;ATM;MDM2;RBL2;USP28;CDK5RAP3;TAOK3
5642,GO:0016742,0.47903654822673,0.879899998891293,1,6,hydroxymethyl-, formyl- and related transferase activity,MF,ALDH1L2
11112,GO:0045177,0.479310223366877,0.60397060112942,26,216,apical part of cell,CC,FN1;FAT4;ANO1;TNIK;PROM2;EGFR;ITPK1;CSPG4;KCNMA1;PDPN;CTSV;PRKCZ;SHROOM4;PDE4D;AMOTL1;LRTOMT;VANGL2;PODXL;ABCC2;SCNN1A;AMOTL2;IGFBP2;SLC9A4;SRR;OXTR;MPDZ
473,GO:0001517,0.47958817477728,0.883589087450327,1,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,CHST3
13202,GO:0051894,0.479660484090642,0.753288186341382,3,20,positive regulation of focal adhesion assembly,BP,SFRP1;S100A10;COL16A1
15351,GO:0071625,0.479722106484088,0.800646966596432,2,11,vocalization behavior,BP,DLG4;NLGN4Y
527,GO:0001637,0.479750134557624,0.876662684323027,1,7,G-protein coupled chemoattractant receptor activity,MF,CXCR1
2137,GO:0004950,0.479750134557624,0.876662684323027,1,7,chemokine receptor activity,MF,CXCR1
15710,GO:0072318,0.479896809830881,0.883416829987263,1,5,clathrin coat disassembly,BP,DNAJC6
1000,GO:0002475,0.480460798667894,0.879081101174628,1,6,antigen processing and presentation via MHC class Ib,BP,CD1D
14296,GO:0061502,0.480866498844992,0.889027978524445,1,4,early endosome to recycling endosome transport,BP,SORL1
15741,GO:0072367,0.480983658904322,0.888965404589639,1,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,NCOR1
16099,GO:0090128,0.481287214402984,0.878604276490168,1,6,regulation of synapse maturation,BP,NFATC4
8596,GO:0034122,0.481564269898939,0.750904787396383,3,21,negative regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS;TLR3
18907,GO:1904684,0.481576373737841,0.888648483724441,1,4,negative regulation of metalloendopeptidase activity,BP,SORL1
4708,GO:0010875,0.481655721670387,0.797294263075097,2,12,positive regulation of cholesterol efflux,BP,ABCA1;LRP1
5472,GO:0016411,0.481681136652161,0.74942921402943,3,23,acylglycerol O-acyltransferase activity,MF,MBOAT2;LPCAT2;AGPAT1
1074,GO:0002645,0.482158646543124,0.882149336287675,1,5,positive regulation of tolerance induction,BP,TGFBR2
814,GO:0002088,0.482287426164262,0.687050286241032,6,44,lens development in camera-type eye,BP,TGFBR2;SLITRK6;VIM;BMP4;SLC7A11;MAF
18191,GO:1903010,0.4823627083135,0.796758431356869,2,12,regulation of bone development,BP,FBN1;GLI3
9770,GO:0040001,0.482826603144194,0.749126303370707,3,22,establishment of mitotic spindle localization,BP,SPRY2;ARHGEF2;CENPA
4780,GO:0010972,0.483151159598639,0.661462311512695,8,87,negative regulation of G2/M transition of mitotic cell cycle,BP,HMGA2;FBXL7;PSMB9;FOXN3;ATM;FHL1;CDK5RAP3;TAOK3
7256,GO:0031235,0.483178975039745,0.798048735950097,2,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB;RASA1
12688,GO:0050942,0.483287153861439,0.881513573278833,1,5,positive regulation of pigment cell differentiation,BP,KITLG
11309,GO:0045656,0.483379697887227,0.881461337377121,1,5,negative regulation of monocyte differentiation,BP,INPP5D
20172,GO:2001053,0.483926762447856,0.877073104876178,1,6,regulation of mesenchymal cell apoptotic process,BP,SOX9
7675,GO:0032135,0.484127613494655,0.876956080278269,1,6,DNA insertion or deletion binding,MF,XPC
16644,GO:0097581,0.484370395353765,0.662678593711279,8,65,lamellipodium organization,BP,VAV3;SNX1;PDPN;ARPIN;FSCN1;CDH13;SSH1;VAV2
13924,GO:0060638,0.484897368550248,0.88060253638087,1,5,mesenchymal-epithelial cell signaling,BP,FGFR1
13483,GO:0055082,0.485287869464998,0.577147589253191,47,430,cellular chemical homeostasis,BP,F2R;ANO1;PKD2;JPH2;IRS2;CYBRD1;NOS1;GAS6;SLC8A1;NTSR1;VDR;NR1D1;LGALS1;KCNMA1;TP53;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;PIK3R1;HERPUD1;WFS1;SNCA;IGF1R;PDE4D;TGM2;PDK3;SLC24A1;CALR;ANXA6;GCLC;ENPP1;TMEM175;KCTD7;ABCC2;PRNP;TH;SLC9A4;ITPR2;SV2A;EFNA5;PPP3CA;OXTR;DMPK
6978,GO:0030666,0.485773737244648,0.634472991969327,12,112,endocytic vesicle membrane,CC,EGFR;DLG4;HIP1;TBC1D5;LRP1;CAV1;CAMK2D;CALR;MDM2;RAB43;GPR161;FZD4
12681,GO:0050926,0.485858444129519,0.789972949979283,2,15,regulation of positive chemotaxis,BP,ITGA2;CDH13
6079,GO:0019240,0.486052298952988,0.886235839454248,1,4,citrulline biosynthetic process,BP,CPS1
1067,GO:0002634,0.486123471140235,0.879905742765216,1,5,regulation of germinal center formation,BP,BCL6
11981,GO:0047484,0.48621693782795,0.875734428042713,1,6,regulation of response to osmotic stress,BP,ARHGEF2
8510,GO:0033762,0.486277493794816,0.717476672254804,4,31,response to glucagon,BP,GNG2;CPS1;PRKACB;ABCC2
19729,GO:2000144,0.486312693977284,0.745538009322326,3,23,positive regulation of DNA-templated transcription, initiation,BP,TP53;SETX;TAF1
17440,GO:1900272,0.486322134592193,0.875672709443376,1,6,negative regulation of long-term synaptic potentiation,BP,PRNP
4195,GO:0009306,0.486459535179188,0.583614664403013,37,334,protein secretion,BP,ITGB6;FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;EGFR;ABCA1;NR1D1;PYCARD;PLA2G6;SEL1L;PRKCZ;PDIA4;CPT1A;PCLO;ANG;TTN;BTN3A1;ALOX15B;C5;IDH2;COPG2;ISL1;PRKCA;RAB13;TGFB2;RSAD2;ITPR2;LMF1;POSTN;MIA3;EFNA5;PPP3CA;ABAT
7687,GO:0032155,0.4865721947565,0.670012988163612,7,58,cell division site part,CC,MYLK;PSTPIP1;SEPT6;ARF6;SSH1;OR2A4;LIMA1
5966,GO:0018410,0.48669496638054,0.715007658890118,4,37,C-terminal protein amino acid modification,BP,CD109;NTM;NEGR1;NTNG1
8805,GO:0034595,0.486811521163185,0.791760516178563,2,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,INPP5D;PIKFYVE
11356,GO:0045745,0.48682010036817,0.79039305418495,2,14,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;PRKCA
13711,GO:0060312,0.486867333650688,0.875352521508891,1,6,regulation of blood vessel remodeling,BP,CST3
15970,GO:0086009,0.48727516071301,0.746121333955784,3,21,membrane repolarization,BP,GJA5;CAV1;KCNJ5
8962,GO:0035082,0.487335331331576,0.744674888369758,3,23,axoneme assembly,BP,BBS2;TPGS1;DNAH1
8471,GO:0033632,0.487385241179228,0.87504786199299,1,6,regulation of cell-cell adhesion mediated by integrin,BP,PODXL
731,GO:0001961,0.48787378867425,0.715278191686461,4,33,positive regulation of cytokine-mediated signaling pathway,BP,GAS6;AXL;AGPAT1;CREBRF
14195,GO:0061178,0.488116969714079,0.714049493089528,4,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,ANO1;NR1D1;PLA2G6;EFNA5
9651,GO:0038027,0.488406157556372,0.884953219534889,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ABCA1
6283,GO:0019899,0.488435794742051,0.543798356892514,205,1820,enzyme binding,MF,PHACTR3;FLOT1;FN1;CCBE1;TXNIP;RHOBTB2;CDKN2B;SYNE1;TGFBR2;ASAP3;PKD2;PITPNM3;IRS2;GAS6;DNMBP;UTRN;ROR1;AXL;DOCK9;EGFR;HSPA2;SPTB;DOCK5;ACTA2;SERPINE1;CSPG4;ALS2CL;TOM1L2;ASAP2;TIMP2;PAK1;ABCA1;CBX5;SRGAP3;TBC1D8;ABTB1;RIN2;TRIM5;NEFL;VAV3;NR3C1;STAT1;BTBD2;SORL1;TP53;ARAP1;CEP250;CUL9;PYCARD;MEF2D;WNK1;PLEKHG3;ARHGEF1;DLG4;PDGFA;MICAL1;TIMP1;ACSL3;DOCK4;TEP1;CUL7;BTG1;ITGA3;SIK1;EVI5L;TTC28;TYSND1;GLI3;KITLG;TBC1D5;ASAP1;SYN1;NEK9;PDE4DIP;LRP1;FYN;ARHGEF12;CAV1;PIAS3;HLCS;PLA2G6;TRIB2;DOCK11;GLDC;CLU;PRKCZ;PARP4;IQSEC2;TNS2;CAMK2D;ITGA1;MST1R;SYTL1;IL31RA;PTPN14;PER1;PXN;PIK3R1;TMEM173;CNTLN;WFS1;SPRY2;TTN;HPS4;TP73;CAT;PRKACB;CHEK2;BACE1;STOM;SNCA;FLOT2;FRMD5;FGFR1;PAG1;IGF1R;MLEC;PDE4D;OBSCN;PLA2R1;EPHB6;FZD8;ARHGEF17;TRIOBP;KDM4C;TRAF1;AKAP7;MTMR4;CALR;SRGAP1;MDM2;ARF6;CST3;AKAP13;SNX10;DGKQ;CITED2;MAP3K1;FGD4;PTPN1;ARHGEF2;EGR1;SOX9;NCOR1;NDRG1;PRKCA;BCHE;ANXA2;RGS14;RAB13;HLTF;CEP68;PAK6;MAP3K12;TSPAN5;PRNP;RET;STAT2;LEF1;CDC42EP5;MAPK8IP3;CDKN2A;SP100;ULK1;VAV2;MAGI2;AGAP1;HSPA5;CDK19;TH;TCTEX1D4;ARHGEF19;GDNF;PPARG;RNF144B;INF2;BEX4;MEF2A;GCSAM;SNX9;SASH1;TBC1D16;PTPN3;DNAJC3;RARA;SV2A;CCNY;PRKAG1;FZD4;PPP3CA;SBF2;RASA1;DNM1P46;KDM4A;CDK5RAP3;CAMK2N1;ELMO2;EHHADH;ABAT;NIPBL;ADAM10;RHOBTB3;MYO1C;RXRA;DOCK1
7614,GO:0032024,0.488472121641772,0.694046101305416,5,45,positive regulation of insulin secretion,BP,ANO1;IRS2;PLA2G6;ISL1;ABAT
16312,GO:0090594,0.488686855069128,0.871346509938442,1,7,inflammatory response to wounding,BP,F2R
18451,GO:1903579,0.488737708592228,0.787733650736722,2,15,negative regulation of ATP metabolic process,BP,DDIT4;SNCA
16097,GO:0090118,0.488914168968433,0.878309812373774,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,ANXA2
12214,GO:0048505,0.489048434003274,0.874066189520328,1,6,regulation of timing of cell differentiation,BP,SERPINE2
17338,GO:1900084,0.489254566388998,0.878114195657322,1,5,regulation of peptidyl-tyrosine autophosphorylation,BP,CAV1
5634,GO:0016725,0.489258758879011,0.878111785054896,1,5,oxidoreductase activity, acting on CH or CH2 groups,MF,XDH
5196,GO:0015798,0.489519078013423,0.895307127910434,1,3,myo-inositol transport,BP,PGAP1
10135,GO:0042733,0.489805110632133,0.679406831790077,6,47,embryonic digit morphogenesis,BP,BMP4;GLI3;GLI2;FBXW4;IFT140;IFT122
8426,GO:0033559,0.490034218212835,0.676800827863038,6,60,unsaturated fatty acid metabolic process,BP,PTGS1;PTGES;CES2;CBR1;ALOX15B;ZADH2
3771,GO:0008329,0.490583526177006,0.870199389091834,1,7,signaling pattern recognition receptor activity,MF,TRIM5
9716,GO:0038187,0.490583526177006,0.870199389091834,1,7,pattern recognition receptor activity,MF,TRIM5
3114,GO:0006694,0.49062126481143,0.625044525335024,13,126,steroid biosynthetic process,BP,SNAI2;VDR;NR1D1;SEC14L2;ACACB;G6PD;PBX1;HSD17B11;DGKQ;EGR1;TRERF1;OSBPL1A;ACAA2
5473,GO:0016413,0.490910908886848,0.872960905843689,1,6,O-acetyltransferase activity,MF,LPCAT2
1971,GO:0004689,0.490934004033664,0.877146029428639,1,5,phosphorylase kinase activity,MF,PHKA2
2630,GO:0005964,0.490934004033664,0.877146029428639,1,5,phosphorylase kinase complex,CC,PHKA2
12975,GO:0051427,0.491006051750129,0.614238305016551,16,141,hormone receptor binding,MF,TADA3;VDR;STAT1;FYN;NCOA2;KDM4C;CALR;UCN2;ISL1;NCOR1;LEF1;TGFB1I1;TACC2;PPARG;MED12;RXRA
5412,GO:0016266,0.491243153024252,0.693135984402905,5,39,O-glycan processing,BP,ST6GALNAC2;GALNT10;MUC19;GCNT1;GALNT2
4797,GO:0010996,0.491248747442802,0.789956566437975,2,12,response to auditory stimulus,BP,XPC;SLITRK6
11268,GO:0045602,0.491280252323763,0.876945793407257,1,5,negative regulation of endothelial cell differentiation,BP,XDH
10096,GO:0042634,0.491287873205438,0.74132539649197,3,23,regulation of hair cycle,BP,PER1;TGFB2;NIPBL
8303,GO:0033151,0.491410726490443,0.789831420259648,2,12,V(D)J recombination,BP,ATM;LEF1
14227,GO:0061309,0.49161566541348,0.872541013580757,1,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,BMP4
8700,GO:0034362,0.491673335588247,0.87250661352407,1,6,low-density lipoprotein particle,CC,SORL1
15902,GO:0072719,0.49174057969713,0.872466494942867,1,6,cellular response to cisplatin,BP,ADIRF
1184,GO:0002832,0.491895268289994,0.710699790829194,4,36,negative regulation of response to biotic stimulus,BP,HTRA1;TKFC;IFIT1;SEC14L1
14625,GO:0070244,0.492030532236181,0.872293410986972,1,6,negative regulation of thymocyte apoptotic process,BP,BMP4
2383,GO:0005521,0.492103989557604,0.786282572174168,2,14,lamin binding,MF,SYNE1;PRNP
9184,GO:0035584,0.49218356963136,0.865309024738895,1,9,calcium-mediated signaling using intracellular calcium source,BP,PRNP
4427,GO:0010265,0.492286370835562,0.872140562788005,1,6,SCF complex assembly,BP,FBXL7
13014,GO:0051497,0.492327938935281,0.787489076275582,2,13,negative regulation of stress fiber assembly,BP,ARAP1;DLC1
8008,GO:0032652,0.492425254284782,0.690020258885073,5,47,regulation of interleukin-1 production,BP,F2R;GAS6;PYCARD;EGR1;ISL1
12048,GO:0048020,0.492530349882385,0.86509208926799,1,9,CCR chemokine receptor binding,MF,STAT1
12859,GO:0051224,0.492563997100382,0.632892968327166,11,106,negative regulation of protein transport,BP,FN1;SFRP1;F2R;GAS6;IDH2;SP100;GOPC;RSAD2;MDFIC;DERL3;PPP3CA
7896,GO:0032480,0.492714740743011,0.690429260681393,5,44,negative regulation of type I interferon production,BP,HERC5;PTPRS;PYCARD;RNF135;UBA7
4336,GO:0009892,0.492757355455899,0.538070146649126,228,2161,negative regulation of metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLRT2;MMP9;GPRC5A;TXNIP;CTGF;SOX6;INPP5D;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;DDIT4;IRS2;DUSP6;ZFP36L2;IGF2BP2;COL7A1;GAS6;SNAI2;MAGED1;PHF21A;TFPI2;EGFR;TSC22D3;KLF8;FLRT3;ZNF608;SERPINE1;SERPINH1;CRTAP;VIM;TIMP2;CBX5;VDR;BMP4;ITM2C;NR1D1;SMARCA2;PTK6;EIF2AK4;PDCD4;NR3C1;STAT1;SORL1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;WNK1;DLG4;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;TFDP2;PNRC1;CCDC85B;CRIM1;SIK1;KLF12;NFIX;ELFN2;HIVEP1;GPX1;GLI3;E2F7;CTDSPL;ZFP90;FYN;IFI6;XDH;TSHZ2;CAV1;SLC27A1;GLI2;PIAS3;RBFOX2;TRIB2;ZNF318;TNRC18;CLU;SERPING1;PRKCZ;SLIT3;SDR16C5;TP53INP1;HMGA2;PRDX5;KANK2;PER1;CAPRIN2;ACACB;ANG;DUSP5;UHRF2;BBS2;HERPUD1;WFS1;MDFI;SPRY2;CIRBP;JARID2;APLP2;FBLN1;TP73;DAPK1;CHEK2;SPRY4;PAIP2B;PHF2;SNCA;FLOT2;GLG1;FGFR1;IGF1R;DKK1;RGS2;C5;PDE4D;NCOA2;PSMB9;G6PD;TLE4;FZD8;TCEAL1;KDM4C;NFATC4;MAGEF1;FOXN3;LMCD1;FZD1;PBXIP1;ENG;BBS4;CALR;ATM;MDM2;CST3;MEIS2;DGKQ;CITED2;GCLC;NR2F2;CBX7;MAF;LZTS1;PTPN1;EGR1;SOX9;ENPP1;ISL1;BCL6;NCOR1;PLAG1;PRKCA;SALL2;ANXA2;RGS14;CXORF57;BAHCC1;LEPR;TSHZ1;TCF25;HMBOX1;RPL13A;NAB2;ATXN1;IRF2BPL;PRNP;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;SMG9;LEF1;THRA;ITM2A;CDKN2A;SP100;TSPYL2;ITGB8;MDFIC;ZNF12;OPHN1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;DERL3;PPARG;PARP15;BEX4;KCNIP3;MEF2A;TGIF1;ING4;UNK;PTPN3;DNAJC3;RARA;HES2;TAF1;TSHZ3;ZBTB1;PPP3CA;CTDSP2;KDM4A;CDK5RAP3;AGO4;SERPINB5;CAMK2N1;NIPBL;PRDM5;S100A11;RXRA;TAOK3
8329,GO:0033192,0.493030091927185,0.875930553777552,1,5,calmodulin-dependent protein phosphatase activity,MF,PPP3CA
13998,GO:0060751,0.493108633017858,0.875884855427639,1,5,branch elongation involved in mammary gland duct branching,BP,AREG
12610,GO:0050829,0.493490937938514,0.777571203985649,2,25,defense response to Gram-negative bacterium,BP,SERPINE1;PYCARD
5261,GO:0015911,0.493526208424476,0.875641706056219,1,5,plasma membrane long-chain fatty acid transport,BP,IRS2
2513,GO:0005769,0.49356948091634,0.585399931356067,29,259,early endosome,CC,FLOT1;F2R;SAMD9L;EGFR;NSG1;SORL1;NISCH;SNX1;LRP1;CAV1;DYSF;BACE1;WDFY2;TLR3;DKK1;ASTN2;MTMR4;ARF6;NEURL1B;TRAK1;PTPN1;ANXA2;MVB12B;RET;PIKFYVE;UVRAG;TBC1D16;STEAP2;LITAF
2721,GO:0006103,0.493575650998317,0.782911500676068,2,16,2-oxoglutarate metabolic process,BP,D2HGDH;IDH2
1353,GO:0003222,0.493667966865812,0.790049970522553,2,11,ventricular trabecula myocardium morphogenesis,BP,ENG;TGFB2
5152,GO:0015695,0.493833357616602,0.737984738884891,3,25,organic cation transport,BP,SLC7A8;SEC14L1;SLC38A2
6178,GO:0019563,0.49389214713536,0.875428364765568,1,5,glycerol catabolic process,BP,TKFC
17261,GO:0140058,0.494124354650804,0.78608765800962,2,13,neuron projection arborization,BP,DLG4;FZD4
11086,GO:0045124,0.494580082619852,0.73993738842799,3,21,regulation of bone resorption,BP,INPP5D;EGFR;PRKCA
9535,GO:0036314,0.495073946386135,0.741266265201458,3,19,response to sterol,BP,TGFBR2;ABCA1;ABCA2
813,GO:0002087,0.495107993550619,0.874717787041496,1,5,regulation of respiratory gaseous exchange by neurological system process,BP,TSHZ3
4019,GO:0009055,0.49545414812901,0.658504456059824,7,87,electron transfer activity,MF,NQO1;PHGDH;XDH;GLDC;AKR7A2;NDUFA4L2;ALDH4A1
15194,GO:0071377,0.495572974152529,0.737669785947733,3,23,cellular response to glucagon stimulus,BP,GNG2;CPS1;PRKACB
5456,GO:0016342,0.495628524264863,0.784910268017433,2,13,catenin complex,CC,CDH13;CDH11
7073,GO:0030878,0.495634270285815,0.782316529752106,2,15,thyroid gland development,BP,THRA;HOXA3
13530,GO:0060022,0.495646953737228,0.874401943911028,1,5,hard palate development,BP,FZD1
11277,GO:0045618,0.495657651414754,0.783493134680845,2,14,positive regulation of keratinocyte differentiation,BP,VDR;ALOX15B
4666,GO:0010819,0.495749920828185,0.867040836009325,1,7,regulation of T cell chemotaxis,BP,ADAM10
4667,GO:0010820,0.495749920828185,0.867040836009325,1,7,positive regulation of T cell chemotaxis,BP,ADAM10
9945,GO:0042340,0.495841780604524,0.866984225284236,1,7,keratan sulfate catabolic process,BP,HEXA
17928,GO:1902307,0.496182065208788,0.784476073427923,2,13,positive regulation of sodium ion transmembrane transport,BP,NOS1;ANK3
5807,GO:0017075,0.49620805868952,0.783059291226597,2,14,syntaxin-1 binding,MF,SYT1;DAPK1
14571,GO:0070160,0.496356893787961,0.625949229395906,12,91,occluding junction,CC,FRMD4B;NPHP4;PRKCZ;ANK3;AMOTL1;ARHGEF2;RAB13;MPP7;AMOTL2;MAGI2;MAGI1;MPDZ
19257,GO:1905508,0.496542371456775,0.710405309337997,4,27,protein localization to microtubule organizing center,BP,CEP250;GOLGB1;BBS4;SNX10
18326,GO:1903332,0.496788624749913,0.866399788201083,1,7,regulation of protein folding,BP,HSPA5
18511,GO:1903727,0.49679427701175,0.736006859755603,3,24,positive regulation of phospholipid metabolic process,BP,VAV3;ACSL3;VAV2
2669,GO:0006023,0.497036647048499,0.635462380877746,10,85,aminoglycan biosynthetic process,BP,SDC3;CSPG4;B3GAT3;XYLT1;UST;CHST3;HEXA;SDC2;DSEL;AGRN
16943,GO:0098993,0.49717185541291,0.863907697285239,1,8,anchored component of synaptic vesicle membrane,CC,SYN1
3913,GO:0008585,0.497213108574007,0.650196774050848,8,68,female gonad development,BP,SFRP1;NUPR1;MMP19;KITLG;SLIT3;ANG;ATM;FZD4
6076,GO:0019237,0.497342743302021,0.869094918802765,1,6,centromeric DNA binding,MF,MLH3
13714,GO:0060315,0.498089007464443,0.863331091367909,1,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2
12196,GO:0048469,0.498361549234383,0.633821378205057,10,89,cell maturation,BP,AXL;FAM210B;ANG;FGFR1;G6PD;L3MBTL3;NFASC;RET;AGRN;PPARG
8179,GO:0032930,0.498379675155656,0.863148017670416,1,8,positive regulation of superoxide anion generation,BP,EGFR
15873,GO:0072674,0.498489869502567,0.879349228285959,1,4,multinuclear osteoclast differentiation,BP,CD109
15874,GO:0072675,0.498489869502567,0.879349228285959,1,4,osteoclast fusion,BP,CD109
17914,GO:1902275,0.498590350123942,0.604182796829228,17,142,regulation of chromatin organization,BP,NOS1;SNAI2;TADA3;TP53;MTHFR;SDR16C5;CAMK2D;UHRF2;JARID2;PHF2;SNCA;KDM4C;ATM;ISL1;BCL6;KDM4A;NIPBL
3346,GO:0007076,0.498671134451477,0.741781125092145,3,16,mitotic chromosome condensation,BP,NCAPD2;TTN;NIPBL
7182,GO:0031082,0.498797350055264,0.777041723371921,2,18,BLOC complex,CC,HPS4;HPS3
6060,GO:0019213,0.4991436863617,0.669890364627437,6,51,deacetylase activity,MF,PHF21A;CHD3;CES2;OARD1;HDAC11;SAP30L
7471,GO:0031646,0.499383870934748,0.781954962295121,2,13,positive regulation of neurological system process,BP,TENM4;ITGA2
18337,GO:1903358,0.49940493209567,0.779322651994402,2,15,regulation of Golgi organization,BP,PDE4DIP;EHD3
2871,GO:0006367,0.499495230286711,0.605613938649695,16,150,transcription initiation from RNA polymerase II promoter,BP,CTGF;VDR;NR1D1;NR3C1;TP53;WWTR1;TCF4;SOX9;MAML2;THRA;YAP1;PPARG;RARA;TAF1;MED12;RXRA
13828,GO:0060462,0.499552155706328,0.872097583000604,1,5,lung lobe development,BP,TGFBR2
13829,GO:0060463,0.499552155706328,0.872097583000604,1,5,lung lobe morphogenesis,BP,TGFBR2
12718,GO:0051013,0.499777579816117,0.867611407112967,1,6,microtubule severing,BP,TTLL11
1707,GO:0004300,0.499904675323095,0.8621848796735,1,8,enoyl-CoA hydratase activity,MF,EHHADH
16571,GO:0097428,0.500034484164227,0.858941275960196,1,10,protein maturation by iron-sulfur cluster transfer,BP,MAGEF1
15167,GO:0071340,0.500163759340392,0.867375096722203,1,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5
131,GO:0000272,0.500192781500095,0.734382486879773,3,22,polysaccharide catabolic process,BP,PYGB;PHKA2;MANBA
10764,GO:0044247,0.500192781500095,0.734382486879773,3,22,cellular polysaccharide catabolic process,BP,PYGB;PHKA2;MANBA
7633,GO:0032055,0.500720249457013,0.867034079305488,1,6,negative regulation of translation in response to stress,BP,EIF2AK4
4249,GO:0009566,0.500951044016381,0.655245778846451,7,67,fertilization,BP,SYT8;FUT10;MST1R;CCDC136;NR2F2;FNDC3A;SPA17
6716,GO:0030135,0.501429331207589,0.587004389541488,23,207,coated vesicle,CC,COL7A1;CLTCL1;MALL;EGFR;STON2;HIP1;PACS1;TBC1D5;LRP1;SYT1;SEC24D;ASTN2;COPG2;TMED10;AREG;VANGL2;KLHL12;RAB13;GOPC;SNX9;RASSF9;FZD4;STEAP2
9753,GO:0039535,0.501543677397405,0.780245020094551,2,13,regulation of RIG-I signaling pathway,BP,DDX60;SEC14L1
8007,GO:0032651,0.501615501239539,0.702001836720278,4,36,regulation of interleukin-1 beta production,BP,F2R;PYCARD;EGR1;ISL1
11621,GO:0046364,0.501690893511538,0.665974746556435,6,60,monosaccharide biosynthetic process,BP,NR1D1;SIK1;G6PD;DGKQ;G6PC3;LEPR
13850,GO:0060509,0.501860076454961,0.877436188404735,1,4,Type I pneumocyte differentiation,BP,THRA
5454,GO:0016339,0.501864937664548,0.777357115876859,2,15,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH13;CDH11
9629,GO:0036515,0.502150982494067,0.877270108921692,1,4,serotonergic neuron axon guidance,BP,VANGL2
1120,GO:0002710,0.502287954260032,0.860670792671284,1,8,negative regulation of T cell mediated immunity,BP,IL20RB
14034,GO:0060841,0.502358718199203,0.783289833211559,2,11,venous blood vessel development,BP,CCBE1;ENG
14051,GO:0060897,0.502396092801102,0.866003614277594,1,6,neural plate regionalization,BP,SSBP3
3429,GO:0007220,0.502648156296157,0.776729279569559,2,15,Notch receptor processing,BP,APH1B;ADAM10
12326,GO:0048712,0.502758145676032,0.8701848975574,1,5,negative regulation of astrocyte differentiation,BP,KDM4A
3717,GO:0008239,0.502918953632748,0.862574948962768,1,7,dipeptidyl-peptidase activity,MF,PRCP
8390,GO:0033344,0.503371827186452,0.731638259280299,3,22,cholesterol efflux,BP,ABCA1;LRP1;ABCA5
11337,GO:0045719,0.503452855639329,0.869767934168728,1,5,negative regulation of glycogen biosynthetic process,BP,ENPP1
14940,GO:0070874,0.503452855639329,0.869767934168728,1,5,negative regulation of glycogen metabolic process,BP,ENPP1
6270,GO:0019871,0.503627159776773,0.869663176938937,1,5,sodium channel inhibitor activity,MF,CAMK2D
13230,GO:0051938,0.503688993256047,0.865205009799014,1,6,L-glutamate import,BP,NTSR1
16796,GO:0098712,0.503688993256047,0.865205009799014,1,6,L-glutamate import across plasma membrane,BP,NTSR1
5222,GO:0015838,0.503707760410727,0.865193394425609,1,6,amino-acid betaine transport,BP,SLC38A2
14388,GO:0061702,0.50373240493324,0.862062061592796,1,7,inflammasome complex,CC,PYCARD
7897,GO:0032481,0.503737061605166,0.65316099841252,7,63,positive regulation of type I interferon production,BP,FLOT1;STAT1;ZBTB20;POLR3GL;RNF135;TMEM173;TLR3
15466,GO:0071868,0.50384173584839,0.730543800743762,3,23,cellular response to monoamine stimulus,BP,GNG2;SNCA;PDE4D
15468,GO:0071870,0.50384173584839,0.730543800743762,3,23,cellular response to catecholamine stimulus,BP,GNG2;SNCA;PDE4D
5678,GO:0016799,0.503899352897406,0.771545352481867,2,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,MUTYH;DNPH1
7255,GO:0031234,0.503912858114299,0.643983372839976,8,67,extrinsic component of cytoplasmic side of plasma membrane,CC,PTK6;GNG2;DLG4;HIP1;KCNAB2;FYN;ESYT2;SNX9
15807,GO:0072542,0.503977546853021,0.861907250185572,1,7,protein phosphatase activator activity,MF,B3GAT3
9726,GO:0038203,0.504023386090234,0.86187828916853,1,7,TORC2 signaling,BP,SESN3
13528,GO:0060020,0.50432855237343,0.864808798868232,1,6,Bergmann glial cell differentiation,BP,VIM
9035,GO:0035270,0.504556579905171,0.643371010376666,8,67,endocrine system development,BP,BMP4;GLI2;PBX1;CITED2;SOX9;ISL1;THRA;HOXA3
12633,GO:0050864,0.50455895797173,0.642838931930259,8,71,regulation of B cell activation,BP,INPP5D;SFRP1;ZFP36L1;IRS2;ZFP36L2;VAV3;ATM;BCL6
9190,GO:0035590,0.504743675355999,0.861422686572747,1,7,purinergic nucleotide receptor signaling pathway,BP,ANO6
497,GO:0001553,0.504755798255165,0.868983498391389,1,5,luteinization,BP,FZD4
20082,GO:2000778,0.504836241111713,0.773908701552908,2,16,positive regulation of interleukin-6 secretion,BP,F2R;PYCARD
11373,GO:0045779,0.504967434696834,0.864412235616038,1,6,negative regulation of bone resorption,BP,INPP5D
17509,GO:1901031,0.505154576511394,0.72674502172262,3,28,regulation of response to reactive oxygen species,BP,SESN3;TP53;SESN1
7200,GO:0031103,0.505479907293159,0.699955180547182,4,32,axon regeneration,BP,NEFL;PTPRS;ISL1;LAMB2
8423,GO:0033555,0.505631013944704,0.699818715865041,4,32,multicellular organismal response to stress,BP,NOS1;CCK;RET;PPP3CA
2274,GO:0005220,0.505669775697759,0.886979909173997,1,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR2
602,GO:0001771,0.505928241206766,0.863814394936294,1,6,immunological synapse formation,BP,LGALS3
7571,GO:0031946,0.506027477157112,0.863752547866344,1,6,regulation of glucocorticoid biosynthetic process,BP,DGKQ
995,GO:0002460,0.506569180966966,0.605608161707642,14,134,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,INPP5D;IL20RB;CLU;SERPING1;PRKCZ;IL31RA;SEMA4A;C5;IL18;BCL6;LEF1;BTN3A3;RSAD2;ZBTB1
16403,GO:0097084,0.506921799177446,0.863194334008478,1,6,vascular smooth muscle cell development,BP,ENG
4937,GO:0014904,0.5069351039128,0.77327523172916,2,15,myotube cell development,BP,GPX1;PPP3CA
4956,GO:0015036,0.507204213496342,0.722838629841039,3,34,disulfide oxidoreductase activity,MF,ERO1B;PDIA4;PDIA6
2774,GO:0006206,0.507232414837531,0.771032155265952,2,17,pyrimidine nucleobase metabolic process,BP,CPS1;DPYD
5830,GO:0017121,0.507272970154231,0.85981496607217,1,7,phospholipid scrambling,BP,ANO6
3381,GO:0007161,0.507619567665947,0.874119710125838,1,4,calcium-independent cell-matrix adhesion,BP,FN1
1224,GO:0002902,0.507682582010812,0.770665157414685,2,17,regulation of B cell apoptotic process,BP,IRS2;BCL6
6984,GO:0030674,0.508629522422347,0.600607557067718,15,129,protein binding, bridging,MF,FLRT2;FLRT3;CBX5;CHN2;TRIM5;NEFL;VAV3;HIP1;CAV1;PIK3R1;CNTLN;ANK3;PAG1;FSCN1;OBSL1
10069,GO:0042589,0.508732601206323,0.858881569279333,1,7,zymogen granule membrane,CC,TMED10
5201,GO:0015804,0.509559300586504,0.723817835487815,3,26,neutral amino acid transport,BP,SLC7A8;SLC38A2;NFKBIE
4599,GO:0010719,0.510008678319385,0.767933193443093,2,18,negative regulation of epithelial to mesenchymal transition,BP,SFRP1;TGFB2
6866,GO:0030368,0.510158147217151,0.861161554831567,1,6,interleukin-17 receptor activity,MF,IL17RE
7805,GO:0032369,0.510474009453383,0.771644280861203,2,14,negative regulation of lipid transport,BP,IRS2;PLA2R1
5054,GO:0015269,0.51067806594594,0.85763109662849,1,7,calcium-activated potassium channel activity,MF,KCNMA1
20078,GO:2000773,0.510763800878954,0.771408977559599,2,14,negative regulation of cellular senescence,BP,HMGA2;BCL6
11139,GO:0045217,0.511066482939427,0.860587421647404,1,6,cell-cell junction maintenance,BP,F2R
14814,GO:0070586,0.511206790402882,0.854907554652985,1,8,cell-cell adhesion involved in gastrulation,BP,MAP2K5
15259,GO:0071474,0.51135469163026,0.857194467851792,1,7,cellular hyperosmotic response,BP,ARHGEF2
7372,GO:0031435,0.511408385975365,0.769639190656183,2,15,mitogen-activated protein kinase kinase kinase binding,MF,TGFBR2;SASH1
11845,GO:0046873,0.511835933786397,0.575367000063949,24,200,metal ion transmembrane transporter activity,MF,PKD2;JPH2;GAS6;SLC8A1;ORAI3;SLC20A1;SCN8A;SCN2A;KCNMA1;KCNAB2;KCNJ15;KCNJ5;SLC24A1;KCNQ3;TMEM175;SLC39A11;SCNN1A;SLC9A4;ITPR2;CACNB1;KCNIP3;CACNA2D3;TUSC3;ORAI2
289,GO:0000794,0.51208513388196,0.636475451010247,8,65,condensed nuclear chromosome,CC,HSPA2;ADD3;SYN1;NCAPD2;TTN;MLH3;MSH5;CENPA
19827,GO:2000323,0.512096499782636,0.859934460595171,1,6,negative regulation of glucocorticoid receptor signaling pathway,BP,PER1
12812,GO:0051149,0.512122418573469,0.656969902826596,6,55,positive regulation of muscle cell differentiation,BP,FLOT1;BMP4;ENG;THRA;BOC;MEF2A
19752,GO:2000194,0.512320578855834,0.856569636333927,1,7,regulation of female gonad development,BP,NUPR1
930,GO:0002329,0.512606800207519,0.871199231746029,1,4,pre-B cell differentiation,BP,ATM
653,GO:0001844,0.51263877250802,0.719345621132501,3,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;TFDP2;TP73
1528,GO:0003909,0.512728276534465,0.856305352163875,1,7,DNA ligase activity,MF,LIG1
11783,GO:0046688,0.51285044359994,0.764183444894168,2,20,response to copper ion,BP,SNCA;PRNP
2576,GO:0005869,0.513004584406846,0.853727090935901,1,8,dynactin complex,CC,ACTR1B
17697,GO:1901653,0.513170300319049,0.566153573330781,29,254,cellular response to peptide,BP,FBN1;ZFP36L1;IRS2;SESN3;PAK1;STAT1;GNG2;TP53;LRP1;FYN;CPS1;CAV1;PRKCZ;PXN;PIK3R1;PRKACB;IGF1R;MDM2;GCLC;PTPN1;ARHGEF2;ENPP1;RAB13;PRNP;CACNB1;KLF5;PPARG;MYO1C;C2CD5
3663,GO:0008156,0.513512335235484,0.692259434705599,4,33,negative regulation of DNA replication,BP,CHEK2;BCL6;TSPYL2;S100A11
6853,GO:0030332,0.513967089782333,0.721048584694377,3,24,cyclin binding,MF,CDK14;MDFIC;CDK5RAP3
12910,GO:0051294,0.513995475718983,0.721662543314164,3,23,establishment of spindle orientation,BP,SPRY2;ARHGEF2;CENPA
8959,GO:0035066,0.514302311652631,0.719138618728678,3,27,positive regulation of histone acetylation,BP,NOS1;SNAI2;ISL1
10170,GO:0042789,0.514320669649871,0.768509676448227,2,14,mRNA transcription by RNA polymerase II,BP,DDIT3;ZBTB1
10667,GO:0043966,0.514478155249155,0.654568868720578,6,56,histone H3 acetylation,BP,TADA3;PER1;JADE2;LEF1;YEATS2;ING4
3728,GO:0008266,0.514721141300767,0.765836541159801,2,16,poly(U) RNA binding,MF,RBMS3;ATXN1
18415,GO:1903525,0.514856031140351,0.862794852601561,1,5,regulation of membrane tubulation,BP,ASAP1
9431,GO:0036035,0.514857751085582,0.769536965911406,2,13,osteoclast development,BP,FBN1;ANXA2
7586,GO:0031968,0.514879777882112,0.587442029571539,17,161,organelle outer membrane,CC,SYNE1;SYNE3;FAM210B;ACSL3;TMEM173;CPT1A;ACACB;BPHL;SNCA;VAMP1;ARMCX2;SPATA18;SYNE2;ULK1;RSAD2;VPS13C;DMPK
3689,GO:0008198,0.515049942431292,0.7646119197728,2,17,ferrous iron binding,MF,SNCA;TH
7420,GO:0031532,0.515167528447186,0.624762718439772,9,78,actin cytoskeleton reorganization,BP,GSN;TNIK;PAK1;ARAP1;CTSV;PRKCZ;PARVA;MKLN1;PTPN1
12815,GO:0051152,0.515206772521391,0.852272435931188,1,8,positive regulation of smooth muscle cell differentiation,BP,ENG
13775,GO:0060393,0.515381305933239,0.6898172380482,4,35,regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP4;DKK1;ENG;TGFB2
10263,GO:0043030,0.515581253179683,0.719621281538213,3,24,regulation of macrophage activation,BP,IL31RA;SNCA;ATM
13772,GO:0060390,0.515602332352492,0.766200448477912,2,15,regulation of SMAD protein signal transduction,BP,BMP4;WWTR1
10561,GO:0043546,0.515831262876098,0.857549712044361,1,6,molybdopterin cofactor binding,MF,XDH
4724,GO:0010891,0.515937949335807,0.86212049608004,1,5,negative regulation of sequestering of triglyceride,BP,PPARG
923,GO:0002320,0.516066828088352,0.768550172452768,2,13,lymphoid progenitor cell differentiation,BP,BMP4;ZBTB1
148,GO:0000303,0.516122569220594,0.762130218036219,2,19,response to superoxide,BP,NQO1;ERCC6
11780,GO:0046685,0.516157501930925,0.716609468994629,3,29,response to arsenic-containing substance,BP,NEFL;GCLC;ABCC2
10549,GO:0043533,0.516247433108286,0.861927184667304,1,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ASTN2
2661,GO:0006011,0.516417605112655,0.857172862613372,1,6,UDP-glucose metabolic process,BP,UGGT2
6092,GO:0019317,0.516629371227971,0.857036593613671,1,6,fucose catabolic process,BP,FUT10
9949,GO:0042354,0.516629371227971,0.857036593613671,1,6,L-fucose metabolic process,BP,FUT10
9950,GO:0042355,0.516629371227971,0.857036593613671,1,6,L-fucose catabolic process,BP,FUT10
12686,GO:0050931,0.516665064081919,0.719303361261064,3,23,pigment cell differentiation,BP,GLI3;KITLG;HPS4
15481,GO:0071888,0.516670866301245,0.85130003023725,1,8,macrophage apoptotic process,BP,CDKN2A
14128,GO:0061038,0.516742430734107,0.868742733508856,1,4,uterus morphogenesis,BP,NIPBL
1155,GO:0002764,0.517046157291056,0.554018638010716,36,348,immune response-regulating signaling pathway,BP,FLOT1;INPP5D;IL20RB;TKFC;PAK1;NR1D1;TRIM5;VAV3;PTPRS;DDX60;MUC19;ERMAP;SEC14L1;FYN;CAV1;PLA2G6;PIK3R1;BTN3A1;PRKACB;TLR3;PAG1;PDE4D;PSMB9;MAP3K1;PRNP;VAV2;BTN3A3;RSAD2;GCSAM;LGALS3;WIPF1;PPP3CA;FOS;ELMO2;MYO1C;DOCK1
13915,GO:0060613,0.517504225095058,0.856472710184812,1,6,fat pad development,BP,BBS4
9889,GO:0042228,0.517687353162795,0.85306467489719,1,7,interleukin-8 biosynthetic process,BP,MAP2K5
7118,GO:0030952,0.518097918855208,0.763042298588193,2,16,establishment or maintenance of cytoskeleton polarity,BP,RHOBTB2;LMNA
12723,GO:0051018,0.518474746963701,0.6687397018296,5,37,protein kinase A binding,MF,AKAP7;AKAP13;SOX9;RAB13;RARA
16591,GO:0097470,0.518845607401995,0.860297063866642,1,5,ribbon synapse,CC,NPHP4
4057,GO:0009110,0.519023317194604,0.761310272075556,2,17,vitamin biosynthetic process,BP,SNAI2;VDR
1996,GO:0004721,0.519170719694012,0.586633414679917,16,143,phosphoprotein phosphatase activity,MF,DUSP6;PTPRM;PTPRS;CTDSPL;TNS2;PTPN14;DUSP5;PTPRU;MTMR4;DNAJC6;PTPN1;SSH1;PPM1M;PTPN3;PPP3CA;CTDSP2
3946,GO:0008652,0.519684647153619,0.649293839063796,6,58,cellular amino acid biosynthetic process,BP,PHGDH;CPS1;THNSL2;SRR;DPYD;ABAT
4761,GO:0010950,0.519787130330244,0.596264573643427,13,135,positive regulation of endopeptidase activity,BP,CTGF;F2R;GSN;PYCARD;HIP1;FYN;XDH;CCK;DAPK1;DLC1;ROBO1;SNCA;PPARG
19704,GO:2000096,0.519851042864875,0.854952698951911,1,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1
16139,GO:0090188,0.519991339642672,0.859574097813972,1,5,negative regulation of pancreatic juice secretion,BP,WNK1
17400,GO:1900181,0.520050072249169,0.762521931292136,2,15,negative regulation of protein localization to nucleus,BP,GAS6;MDFIC
14858,GO:0070673,0.520062456538567,0.849031095060715,1,8,response to interleukin-18,BP,IL18
10577,GO:0043568,0.520599851430488,0.859189092563686,1,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
10138,GO:0042738,0.52063588966804,0.851114902196442,1,7,exogenous drug catabolic process,BP,NOS1
2996,GO:0006544,0.520636146184133,0.848645035733684,1,8,glycine metabolic process,BP,GLDC
2878,GO:0006382,0.520924436647416,0.858983434976617,1,5,adenosine to inosine editing,BP,ADARB1
9678,GO:0038092,0.521177484010249,0.854088802644955,1,6,nodal signaling pathway,BP,CITED2
16413,GO:0097105,0.521376236565035,0.858696834718124,1,5,presynaptic membrane assembly,BP,NLGN4Y
19939,GO:2000535,0.52137787795056,0.853957987631713,1,6,regulation of entry of bacterium into host cell,BP,CAV1
9789,GO:0040034,0.521454634759514,0.850570435084591,1,7,regulation of development, heterochronic,BP,SERPINE2
13871,GO:0060544,0.521526182989994,0.757602477353792,2,19,regulation of necroptotic process,BP,CAV1;ARHGEF2
13481,GO:0055080,0.521610075129338,0.545324490741822,41,379,cation homeostasis,BP,F2R;SLC7A8;PKD2;JPH2;CYBRD1;NOS1;EGFR;SLC8A1;NTSR1;VDR;NEO1;KCNMA1;TP53;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;HERPUD1;ANK3;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;FAM20A;ANXA6;TMEM175;KCTD7;PRNP;SCNN1A;SFXN3;SLC9A4;ITPR2;SV2A;STEAP2;OXTR;DMPK
15711,GO:0072319,0.521811412579135,0.853674710355338,1,6,vesicle uncoating,BP,DNAJC6
18897,GO:1904659,0.521821675878024,0.626951575556472,8,66,glucose transmembrane transport,BP,IRS2;CLTCL1;SLC2A3;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
3255,GO:0006924,0.521877255713968,0.84780758791278,1,8,activation-induced cell death of T cells,BP,TSC22D3
15500,GO:0071921,0.522121717584509,0.853471725589095,1,6,cohesin loading,BP,NIPBL
4439,GO:0010340,0.522243744303477,0.850044413525182,1,7,carboxyl-O-methyltransferase activity,MF,PCMTD2
13267,GO:0051998,0.522243744303477,0.850044413525182,1,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2
14566,GO:0070142,0.522465243441239,0.853246788087788,1,6,synaptic vesicle budding,BP,DNM1P46
7777,GO:0032328,0.522550897647507,0.853190666247665,1,6,alanine transport,BP,SLC38A2
13570,GO:0060068,0.522615313077465,0.853148450819409,1,6,vagina development,BP,AXL
6232,GO:0019789,0.523129999462379,0.758843284611116,2,16,SUMO transferase activity,MF,PIAS3;MDM2
4538,GO:0010616,0.523155457747758,0.857564334247829,1,5,negative regulation of cardiac muscle adaptation,BP,LMNA
18289,GO:1903243,0.523155457747758,0.857564334247829,1,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,LMNA
11197,GO:0045351,0.523221409858455,0.84689712344928,1,8,type I interferon biosynthetic process,BP,TLR3
12588,GO:0050796,0.523241150008028,0.598437679131001,12,108,regulation of insulin secretion,BP,SFRP1;ANO1;IRS2;NR1D1;PLA2G6;CPT1A;ISL1;PRKCA;ITPR2;EFNA5;PPP3CA;ABAT
4670,GO:0010823,0.523269110245994,0.681034055994716,4,40,negative regulation of mitochondrion organization,BP,GPX1;CLU;LMNA;ACAA2
10565,GO:0043550,0.523301904628951,0.683662870180783,4,32,regulation of lipid kinase activity,BP,VAV3;PIK3R1;RBL2;VAV2
11510,GO:0046058,0.523940940451566,0.662911280043409,5,39,cAMP metabolic process,BP,PKD2;TIMP2;PDE4D;GPR161;NPHP3
17049,GO:0099590,0.524189466318537,0.852114261288226,1,6,neurotransmitter receptor internalization,BP,DNM1P46
19960,GO:2000574,0.524219209042821,0.846218911781072,1,8,regulation of microtubule motor activity,BP,DNAL4
6367,GO:0021559,0.52425824638322,0.852068962225631,1,6,trigeminal nerve development,BP,ISL1
17972,GO:1902459,0.524404335751573,0.856765728642745,1,5,positive regulation of stem cell population maintenance,BP,YAP1
9493,GO:0036159,0.524703791113849,0.856573787374786,1,5,inner dynein arm assembly,BP,DNAH1
318,GO:0000835,0.524805659558836,0.851708097396638,1,6,ER ubiquitin ligase complex,CC,SEL1L
12791,GO:0051123,0.524881406037974,0.709211929397573,3,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53;THRA;TAF1
15465,GO:0071867,0.525156059429004,0.711078734621705,3,24,response to monoamine,BP,GNG2;SNCA;PDE4D
15467,GO:0071869,0.525156059429004,0.711078734621705,3,24,response to catecholamine,BP,GNG2;SNCA;PDE4D
16240,GO:0090329,0.525330540780436,0.660155417664164,5,44,regulation of DNA-dependent DNA replication,BP,BMP4;E2F7;CHEK2;FGFR1;BCL6
6464,GO:0021800,0.525597370286521,0.855999990429795,1,5,cerebral cortex tangential migration,BP,ROBO1
7639,GO:0032069,0.525701258560594,0.70803936858622,3,29,regulation of nuclease activity,BP,OAS2;PTPN1;HSPA5
13684,GO:0060272,0.525789570209002,0.845147455134689,1,8,embryonic skeletal joint morphogenesis,BP,BMP4
13032,GO:0051560,0.525828682506722,0.754730574281362,2,18,mitochondrial calcium ion homeostasis,BP,TGM2;ANXA6
15089,GO:0071205,0.526012115237423,0.863120541445821,1,4,protein localization to juxtaparanode region of axon,BP,NFASC
1587,GO:0004000,0.526138291840106,0.850827113737616,1,6,adenosine deaminase activity,MF,ADARB1
7018,GO:0030802,0.526254073380655,0.708943452802133,3,26,regulation of cyclic nucleotide biosynthetic process,BP,NOS1;TIMP2;GPR161
6507,GO:0021891,0.526285227321789,0.855557230193482,1,5,olfactory bulb interneuron development,BP,ROBO1
17602,GO:1901339,0.526486296578038,0.850596471055737,1,6,regulation of store-operated calcium channel activity,BP,PLA2G6
303,GO:0000813,0.526709073904499,0.844517761215396,1,8,ESCRT I complex,CC,MVB12B
7778,GO:0032329,0.527047010272801,0.844285904843643,1,8,serine transport,BP,NFKBIE
3709,GO:0008227,0.527099339625246,0.844249981209367,1,8,G-protein coupled amine receptor activity,MF,HTR1B
7401,GO:0031497,0.527139634081062,0.597840627650704,11,135,chromatin assembly,BP,TP53;TNRC18;HMGA2;GATAD1;SOX9;BAHCC1;CDKN2A;TSPYL2;TSPYL4;CENPA;HP1BP3
4573,GO:0010663,0.527671974099827,0.849808841254204,1,6,positive regulation of striated muscle cell apoptotic process,BP,CAMK2D
4576,GO:0010666,0.527671974099827,0.849808841254204,1,6,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2D
18385,GO:1903441,0.527807418746181,0.846300297838175,1,7,protein localization to ciliary membrane,BP,BBS2
13715,GO:0060316,0.527813195363178,0.846296378070316,1,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2
10487,GO:0043412,0.527865982268111,0.498717827901424,348,3238,macromolecule modification,BP,PHACTR3;CPA4;FLOT1;PRSS23;FN1;FLRT2;MMP9;GPRC5A;CTGF;FBN1;SFRP1;ST6GALNAC2;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;ADAMTSL1;EFEMP1;MARCH4;PKD2;IRS2;DUSP6;ZFP36L2;HERC5;TNIK;SKP2;PROM2;NOS1;GAS6;PDGFC;SNAI2;MAGED1;PHF21A;ROR1;AXL;EGFR;GALNT10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NTM;FKBP5;MYLK;GJC2;TRIM2;RNF213;CRTAP;RNF165;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;ABCA1;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;PTK6;EIF2AK4;TRIM5;NEFL;PDCD4;SORL1;LGALS1;TP53;PTPRS;TTLL11;WWTR1;PRICKLE1;CNTRL;CUL9;PYCARD;LTBP1;WNK1;MUC19;DLG4;PILRB;PDGFA;MICAL1;ADARB1;TIMP1;FLG;GPNMB;CUL7;BTG1;CHD3;SIK1;ELFN2;GPX1;CDK14;CNTN1;KITLG;P3H2;ERO1B;CTDSPL;MTHFR;NEK9;FYN;XDH;ALPK1;B3GAT3;FUT10;CAV1;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;TRIB2;SEL1L;MAP3K14;DCAF16;UST;CLU;FKBP9;PRKCZ;SDR16C5;FBXW4;ULK2;PARP4;TNS2;HMGA2;CAMK2D;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;CAPRIN2;APOBEC3G;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;SPRY2;TTN;JARID2;LMO7;APLP2;FBLN1;TP73;DAPK1;ST6GAL2;DLC1;PRKACB;AARS;CHEK2;ROBO1;WDFY2;SPRY4;PHF2;TLR3;MAN1A1;FBXL7;SNCA;ADAMTS7;PDIA6;FZD7;JADE2;PTPRU;FGFR1;IGF1R;APOBEC3F;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;IL18;OBSCN;PDK3;G6PD;EPHB6;ARSD;EDA2R;FZD8;TRIOBP;KDM4C;AFAP1L2;MAGEF1;TGFBR3;FZD1;IPP;ENG;MTMR4;NEGR1;ATM;FBXO17;MDM2;FAM20A;CST3;MANBA;AREG;IFNK;AKAP13;DNAJC6;DGKQ;GCLC;NR2F2;IFNE;NEURL1B;TRAK1;FBXW8;HDAC11;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;NCOR1;GCNT1;PRKCA;ANXA2;RGS14;RAB13;HLTF;RNF24;MAN2B1;PGAP1;IGFBP4;KCTD7;ANAPC16;PAK6;NAB2;MAP3K12;STK36;MUTYH;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;CDC42EP5;USP28;MAPK8IP3;TRIML2;CDKN2A;PPM1M;ULK1;TSPYL2;RHBDD1;MAGI2;HSPA5;CDK19;KLHL5;SRPK2;UVRAG;MDFIC;SAP30L;TPGS1;LMF1;GDNF;ALG10;NUB1;KLHL3;YEATS2;UBA7;GALNT2;DERL3;RNF144B;PARP15;BEX4;TPST1;MEF2A;SNX9;ICK;SASH1;OBSL1;ING4;ZYG11B;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;CCNY;PCMTD2;PRKAG1;TAF1;EFNA5;FZD4;MPPE1;PPP3CA;DCAF8;RASA1;CTDSP2;KRT10;FOS;KDM4A;KLHL22;CDK5RAP3;MATN3;CAMK2N1;EHHADH;MED12;FBXL4;NIPBL;UGGT2;TTBK2;ADM2;OXTR;ADAM10;PRDM5;PPP2R3A;TUSC3;EDEM1;GID4;TAOK3;ZNRF1;DMPK;LAMB2
11074,GO:0045104,0.528203938184873,0.679111226745095,4,32,intermediate filament cytoskeleton organization,BP,KRT14;VIM;NEFM;NEFL
16795,GO:0098711,0.528347543801927,0.84935881313141,1,6,iron ion import across plasma membrane,BP,STEAP2
11355,GO:0045744,0.528742986865665,0.705715184047735,3,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,SNCA;RGS2;HTR1B
6807,GO:0030275,0.5288391866622,0.754028106380075,2,16,LRR domain binding,MF,DDIT3;ROBO1
19428,GO:1990126,0.528842837470228,0.754025009757129,2,16,retrograde transport, endosome to plasma membrane,BP,NSG1;VPS39
1894,GO:0004579,0.528977710442041,0.840990888454177,1,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,TUSC3
3068,GO:0006637,0.529013752382489,0.618469226441108,8,78,acyl-CoA metabolic process,BP,ACSL3;ACSS1;ACACB;SNCA;PDK3;ACSS2;ACSF2;ACOT1
9090,GO:0035383,0.529013752382489,0.618469226441108,8,78,thioester metabolic process,BP,ACSL3;ACSS1;ACACB;SNCA;PDK3;ACSS2;ACSF2;ACOT1
1166,GO:0002790,0.529099231808036,0.540358400755313,38,349,peptide secretion,BP,ITGB6;FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;EGFR;ABCA1;NR1D1;PYCARD;LTBP4;PLA2G6;SEL1L;PRKCZ;PDIA4;CPT1A;PCLO;ANG;TTN;BTN3A1;ALOX15B;C5;IDH2;COPG2;ISL1;PRKCA;RAB13;TGFB2;RSAD2;ITPR2;LMF1;POSTN;MIA3;EFNA5;PPP3CA;ABAT
13181,GO:0051851,0.529144784064857,0.655824374991176,5,47,modification by host of symbiont morphology or physiology,BP,EIF2AK4;HMGA2;STOM;ANXA2;LEF1
17384,GO:1900151,0.529203942154092,0.756150681581029,2,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36L2
17386,GO:1900153,0.529203942154092,0.756150681581029,2,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36L2
20091,GO:2000794,0.529237659787367,0.848764470410725,1,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,SOX9
17687,GO:1901626,0.529238457012893,0.848763937383607,1,6,regulation of postsynaptic membrane organization,BP,SSH1
10129,GO:0042726,0.529327641333547,0.845266410084853,1,7,flavin-containing compound metabolic process,BP,ENPP1
12213,GO:0048500,0.529515665107692,0.840615306901836,1,9,signal recognition particle,CC,DERL3
3183,GO:0006809,0.529744540766671,0.656226698738148,5,43,nitric oxide biosynthetic process,BP,NQO1;PKD2;NOS1;CAV1;CLU
11710,GO:0046545,0.529840590155109,0.618601812448676,8,70,development of primary female sexual characteristics,BP,SFRP1;NUPR1;MMP19;KITLG;SLIT3;ANG;ATM;FZD4
2609,GO:0005921,0.530128295019121,0.75194350613604,2,17,gap junction,CC,GJA5;GJC2
9285,GO:0035748,0.530668213367024,0.847805937736642,1,6,myelin sheath abaxonal region,CC,PRKCZ
11348,GO:0045737,0.530950868214119,0.703706289174015,3,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,PKD2;EGFR;CCNY
12535,GO:0050711,0.531123159026209,0.841470953065926,1,8,negative regulation of interleukin-1 secretion,BP,GAS6
1502,GO:0003857,0.531253014951582,0.839398285102406,1,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,EHHADH
19036,GO:1904929,0.531380208543058,0.847327335151197,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,ROR1
20262,GO:2001267,0.53167697137864,0.748268856506364,2,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9;GSN
4927,GO:0014889,0.531858994168827,0.843534456497682,1,7,muscle atrophy,BP,GSN
9653,GO:0038030,0.531957131868433,0.846938777784452,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
4349,GO:0009931,0.532002498673019,0.843435879785037,1,7,calcium-dependent protein serine/threonine kinase activity,MF,PRKCA
8285,GO:0033130,0.532033460516153,0.84688732016207,1,6,acetylcholine receptor binding,MF,DLG4
3401,GO:0007185,0.53209562125795,0.859342011986921,1,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,PTPRU
13031,GO:0051549,0.532105402705862,0.846838808927469,1,6,positive regulation of keratinocyte migration,BP,MMP9
15084,GO:0071169,0.532139907962761,0.840763497878604,1,8,establishment of protein localization to chromatin,BP,NIPBL
12833,GO:0051180,0.532532944066401,0.74988799016711,2,17,vitamin transport,BP,SLC2A3;SLC35F3
9864,GO:0042149,0.532599903387487,0.673491744999787,4,36,cellular response to glucose starvation,BP,SESN3;TP53;SESN1;HSPA5
15868,GO:0072666,0.532602665533732,0.654375902015323,5,40,establishment of protein localization to vacuole,BP,SORL1;CLU;TMEM50B;VPS13C;VPS36
7549,GO:0031902,0.532849976829675,0.599159461273497,10,104,late endosome membrane,CC,NSG1;LAPTM4A;ANXA6;ANXA2;MVB12B;VPS39;PIKFYVE;VPS36;LITAF;ABCA5
6369,GO:0021561,0.532990403937756,0.846241188682622,1,6,facial nerve development,BP,ADARB1
6392,GO:0021610,0.532990403937756,0.846241188682622,1,6,facial nerve morphogenesis,BP,ADARB1
4377,GO:0010032,0.53325041050384,0.851021343020711,1,5,meiotic chromosome condensation,BP,NCAPD2
2311,GO:0005313,0.533407758098175,0.845958809111578,1,6,L-glutamate transmembrane transporter activity,MF,SLC7A11
5007,GO:0015172,0.533407758098175,0.845958809111578,1,6,acidic amino acid transmembrane transporter activity,MF,SLC7A11
7968,GO:0032593,0.533492839515111,0.845901200162096,1,6,insulin-responsive compartment,CC,RAB13
15000,GO:0070971,0.533572591894755,0.751135357539808,2,15,endoplasmic reticulum exit site,CC,MIA3;MPPE1
7187,GO:0031087,0.533583920070715,0.842346776247026,1,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,PNRC1
4942,GO:0014912,0.5336603652334,0.749919169989122,2,16,negative regulation of smooth muscle cell migration,BP,SERPINE1;LRP1
16902,GO:0098910,0.533664558994489,0.850748607329602,1,5,regulation of atrial cardiac muscle cell action potential,BP,GJA5
7090,GO:0030897,0.533666061549587,0.752372979925467,2,14,HOPS complex,CC,VPS39;UVRAG
9230,GO:0035641,0.533705767968348,0.842262648890603,1,7,locomotory exploration behavior,BP,DLG4
13556,GO:0060052,0.533772942173181,0.842216256837635,1,7,neurofilament cytoskeleton organization,BP,NEFL
13054,GO:0051590,0.533825338062911,0.74877919842768,2,17,positive regulation of neurotransmitter transport,BP,NTSR1;SNCA
1117,GO:0002707,0.534000655423679,0.74626347756251,2,20,negative regulation of lymphocyte mediated immunity,BP,IL20RB;BCL6
15258,GO:0071472,0.534154029526794,0.841952894029419,1,7,cellular response to salt stress,BP,ZFP36L1
15388,GO:0071682,0.534306780809944,0.839248686499172,1,8,endocytic vesicle lumen,CC,CALR
3085,GO:0006661,0.534432285478739,0.578991403810202,14,119,phosphatidylinositol biosynthetic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;PDGFA;SLC27A1;PIK3R1;FGFR1;MTMR4;ATM;PGAP1;PIKFYVE;MPPE1;PIK3C2B
20154,GO:2001024,0.534742974373743,0.747107334388549,2,18,negative regulation of response to drug,BP,SNCA;ABAT
14802,GO:0070569,0.534868273057186,0.841458490009586,1,7,uridylyltransferase activity,MF,ZCCHC11
7299,GO:0031313,0.535071136790332,0.841317875299442,1,7,extrinsic component of endosome membrane,CC,SNX10
11770,GO:0046660,0.53511206956228,0.605310321079567,9,78,female sex differentiation,BP,SFRP1;AXL;NUPR1;MMP19;KITLG;SLIT3;ANG;ATM;FZD4
72,GO:0000149,0.535702090396748,0.597247198514254,10,92,SNARE binding,MF,SYT8;ABCA1;SYTL1;SYT1;DAPK1;VAMP1;SEC24D;TMED10;C2CD4C;UVRAG
8958,GO:0035065,0.535714176791899,0.649544518986985,5,47,regulation of histone acetylation,BP,NOS1;SNAI2;SDR16C5;SNCA;ISL1
8628,GO:0034185,0.53590735098356,0.753837268221934,2,12,apolipoprotein binding,MF,ABCA1;LRP1
6468,GO:0021815,0.536005593372525,0.849200475422922,1,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,SYNE2
4715,GO:0010882,0.536297090692899,0.748803850401728,2,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,SLC8A1;CAMK2D
5241,GO:0015871,0.536491498201807,0.843861397468188,1,6,choline transport,BP,SEC14L1
19803,GO:2000291,0.536810574157399,0.840108708618354,1,7,regulation of myoblast proliferation,BP,MEIS2
9844,GO:0042113,0.536858631910118,0.569039423941973,16,144,B cell activation,BP,INPP5D;SFRP1;ZFP36L1;IRS2;ZFP36L2;VAV3;LGALS1;DOCK11;PIK3R1;ATM;IFNK;IFNE;BCL6;LEF1;ITM2A;ZBTB1
16032,GO:0089717,0.537177650642069,0.848421257008351,1,5,spanning component of membrane,CC,NLGN4Y
3184,GO:0006810,0.53740154885274,0.4889748723573,355,3346,transport,BP,SERPINE2;ITGB6;SYT8;FLOT1;FN1;PCDH7;PYGB;MMP9;TXNIP;CTGF;SFRP1;CD109;ZFP36L1;F2R;TGFBR2;ASAP3;SLC7A8;ANO1;GSN;GJA5;PKD2;PITPNM3;JPH2;SCARA3;IRS2;OSBPL10;IGF2BP2;ANPEP;PROM2;COL7A1;CLTCL1;NOS1;GAS6;TCAF1;UTRN;SAMD9L;AXL;DPYSL2;EGFR;TSC22D3;HSPA2;SPTB;SLC8A1;ORAI3;CLCA2;MYLK;GJC2;SLC20A1;SLC2A3;SERPINE1;ATP10D;ENDOD1;S100A10;STON2;ANXA5;PSTPIP1;ADD3;TOM1L2;ASAP2;NTSR1;TIMP2;PAK1;ABCA1;NSG1;VDR;TMC7;BMP4;NR1D1;AHNAK;SCN8A;TBC1D8;RIN2;NETO1;MRC2;NEFL;VAV3;SORL1;SCN2A;KCNMA1;TP53;ARAP1;PRICKLE1;DDIT3;PYCARD;IFIT1;WNK1;DLG4;SLC7A11;ITGA2;PDGFA;MICAL1;NISCH;TIMP1;ACSL3;HIP1;TFDP2;SIK1;EVI5L;SLC22A15;SNX1;ANO6;GLI3;CNTN1;TBC1D5;ASAP1;PLLP;SYN1;SRPX;MAGED2;SEC14L1;SPG11;KCNAB2;LRP1;FYN;XDH;B3GAT3;LTBP4;FUT10;CAV1;SLC27A1;PLA2G6;SEL1L;SNX33;SLC22A17;SLC35F3;OSBPL5;CLU;SERPING1;CXCR1;PRKCZ;OAS2;KCNJ15;EHD3;CAMK2D;GOLGB1;SYTL1;METTL7A;PTPN14;PER1;ATP8B2;EHBP1;PDIA4;CCK;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;CPT1A;SLC38A2;CALHM2;ACACB;PCLO;ANG;DYSF;KIF17;BBS2;HERPUD1;ANK3;WFS1;TTN;APLP2;HPS4;TP73;CAT;DAPK1;BTN3A1;KCNJ5;IFT140;STOM;SNCA;MME;PDIA6;VAMP1;AIP;SH3TC2;FGFR1;ALOX15B;DKK1;MLEC;PRKAB2;SEC24D;C5;ASTN2;PDE4D;TMEM129;NCOA2;TGM2;PSMB9;PLA2R1;ESYT2;G6PD;SLC24A1;CDH13;LRTOMT;ENG;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;AREG;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;ELMO3;NEURL1B;ZMAT3;TRAK1;SYNE2;PTPN1;KCNQ3;ARHGEF2;NDUFA4L2;KLHL12;SLC25A35;LYST;ENPP1;IFT27;ISL1;SLC27A6;BCL6;SLC48A1;PRCP;NFASC;NCOR1;G6PC3;TMEM50B;PRKCA;TMEM63C;TMEM175;ANXA2;RGS14;TMC4;RAB13;SEPT5;LEPR;MAN2B1;PGAP1;IFT88;MVB12B;TTC8;KCTD7;MOSPD2;RPL13A;ABCC2;NLGN4Y;ATXN1;HTR1B;RAB43;WDR19;SLC39A11;PRNP;TGFB2;VPS39;DNASE1L1;SCNN1A;IFT122;FHL1;SFXN3;MAPK8IP3;C2CD4C;OSBPL1A;SP100;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;TH;GOPC;SNX7;SLC9A4;PIKFYVE;REEP2;RSAD2;CHIC2;UVRAG;NAPRT;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;FHOD1;IFT74;OPHN1;LMF1;CACNB1;GDNF;KLHL3;DERL3;PITPNC1;PPARG;CALCRL;KCNIP3;SNX9;SHISA9;ICK;TBC1D16;APOL6;POSTN;LGALS3;PTPN3;ARL3;MIA3;DNAJC3;RARA;COG3;RASSF9;SV2A;ABCA2;PRKAG1;EFNA5;FZD4;MPPE1;WIPF1;PPP3CA;ANKH;PEX1;STEAP2;ACTR1B;COX18;DNM1P46;CACNA2D3;ELMO2;ABAT;VPS36;KCNRG;OXTR;ADAM10;RHOBTB3;ATG16L2;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;CPT2;EDEM1;ACAA2;ABCA5;NFKBIE;CTSD;DOCK1;DMPK
9471,GO:0036124,0.537463147055568,0.749131664855393,2,14,histone H3-K9 trimethylation,BP,KDM4C;KDM4A
6132,GO:0019405,0.537538899403059,0.843144592381371,1,6,alditol catabolic process,BP,TKFC
8353,GO:0033260,0.537594753349723,0.647310205423592,5,49,nuclear DNA replication,BP,CHEK2;FGFR1;BCL6;LIG1;POLD4
11322,GO:0045669,0.53763021027488,0.649258581245031,5,41,positive regulation of osteoblast differentiation,BP,FBN2;BMP4;GLI3;IFITM1;ATRAID
9298,GO:0035774,0.537743973884289,0.743720521410253,2,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,ANO1;PLA2G6
10155,GO:0042762,0.537775180429518,0.747533670728712,2,15,regulation of sulfur metabolic process,BP,SNCA;PDK3
10331,GO:0043162,0.537809847720819,0.744453539020447,2,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B;VPS36
7047,GO:0030836,0.537992176449523,0.839283757558642,1,7,positive regulation of actin filament depolymerization,BP,SEMA5A
10355,GO:0043197,0.538123443267369,0.584249247334887,12,101,dendritic spine,CC,NOS1;SLC8A1;NTSR1;NR1D1;DLG4;ASAP1;LZTS1;RGS14;OPHN1;SHISA9;PPP3CA;DNM1P46
16524,GO:0097327,0.538346560690772,0.609889787642031,8,73,response to antineoplastic agent,BP,DDIT4;EGFR;NEFL;NR3C1;ADIRF;CPS1;EGR1;ABCC2
2385,GO:0005523,0.538891441061136,0.838653986775036,1,7,tropomyosin binding,MF,PYCARD
3697,GO:0008207,0.538900267257727,0.742005009629391,2,20,C21-steroid hormone metabolic process,BP,DGKQ;EGR1
7041,GO:0030826,0.539768260314635,0.838038318519103,1,7,regulation of cGMP biosynthetic process,BP,NOS1
17534,GO:1901142,0.539823026215277,0.841573611925871,1,6,insulin metabolic process,BP,ERO1B
8712,GO:0034375,0.539906416037694,0.835289040373748,1,8,high-density lipoprotein particle remodeling,BP,ABCA5
3632,GO:0008097,0.539918256315162,0.831608748111535,1,10,5S rRNA binding,MF,MDM2
14620,GO:0070234,0.540944920911872,0.832494102015698,1,9,positive regulation of T cell apoptotic process,BP,TP53
10641,GO:0043813,0.541060107361047,0.845820255942857,1,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,PIKFYVE
10159,GO:0042770,0.541224387593446,0.575737749375548,13,121,signal transduction in response to DNA damage,BP,SNAI2;TP53;TFDP2;E2F7;TP73;CHEK2;PLA2R1;ATM;MDM2;NDRG1;RBL2;SP100;ING4
4553,GO:0010639,0.541265015456705,0.535420128885759,31,280,negative regulation of organelle organization,BP,GSN;SPTB;TOM1L2;BMP4;ARAP1;EVI5L;GPX1;EML2;ESPN;CLU;SDR16C5;ARPIN;KANK2;JARID2;DLC1;PHF2;SNCA;LMNA;TRIOBP;KDM4C;BBS4;ATM;FHOD3;ARHGEF2;CAPG;TMEM67;LIMA1;KDM4A;KLHL22;TTBK2;ACAA2
10420,GO:0043297,0.541302952996674,0.630207746471739,6,49,apical junction assembly,BP,SNAI2;DLG5;NPHP4;RAB13;MPP7;MYO1C
7922,GO:0032510,0.541480233098604,0.840427089462235,1,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,LYST
11396,GO:0045833,0.5414914000494,0.64355090699206,5,49,negative regulation of lipid metabolic process,BP,SNAI2;PDGFA;SIK1;SLC27A1;ACACB
9429,GO:0036033,0.541494989970476,0.853362541081802,1,4,mediator complex binding,MF,NIPBL
9811,GO:0042048,0.541697686083117,0.84539019204049,1,5,olfactory behavior,BP,WFS1
6891,GO:0030473,0.542187882704352,0.845058977483742,1,5,nuclear migration along microtubule,BP,SYNE2
13144,GO:0051770,0.542285737152115,0.83986775832531,1,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,STAT1
9007,GO:0035234,0.542347530038596,0.839824794647242,1,6,ectopic germ cell programmed cell death,BP,KITLG
12719,GO:0051014,0.542367041916136,0.83981122668739,1,6,actin filament severing,BP,GSN
364,GO:0000983,0.542372509819653,0.743559078107341,2,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,STAT1;TAF1
4415,GO:0010216,0.542514895824226,0.83970838793209,1,6,maintenance of DNA methylation,BP,UHRF2
10191,GO:0042826,0.542796250623702,0.590485732977269,10,89,histone deacetylase binding,MF,CBX5;TP53;MEF2D;GLI3;NCOR1;LEF1;BEX4;MEF2A;RARA;NIPBL
398,GO:0001075,0.543117335520382,0.839288896123904,1,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,TAF1
75,GO:0000152,0.543239496776781,0.662212819843441,4,40,nuclear ubiquitin ligase complex,CC,CUL7;PHC2;CBX7;ANAPC16
16008,GO:0086067,0.543290806841367,0.839167964487702,1,6,AV node cell to bundle of His cell communication,BP,GJA5
9724,GO:0038201,0.54341728382125,0.741482621792065,2,16,TOR complex,CC,SESN3;SESN1
13477,GO:0055075,0.543435174187912,0.743983776147458,2,14,potassium ion homeostasis,BP,KCNMA1;KCTD7
2248,GO:0005164,0.543785313199961,0.737073341426098,2,21,tumor necrosis factor receptor binding,MF,STAT1;TRAF1
1048,GO:0002577,0.543883650901452,0.832436784523992,1,8,regulation of antigen processing and presentation,BP,PYCARD
10969,GO:0044786,0.543997702312586,0.625977768465094,6,57,cell cycle DNA replication,BP,E2F7;CHEK2;FGFR1;BCL6;LIG1;POLD4
5435,GO:0016308,0.544119085983445,0.838589685366999,1,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,PIKFYVE
3886,GO:0008525,0.544256587119675,0.838493548036571,1,6,phosphatidylcholine transporter activity,MF,ABCA1
7481,GO:0031663,0.544340614954309,0.661731147038273,4,38,lipopolysaccharide-mediated signaling pathway,BP,TRIM5;IL18;PRKCA;SASH1
1071,GO:0002638,0.544495991138374,0.838326068751815,1,6,negative regulation of immunoglobulin production,BP,BCL6
6800,GO:0030261,0.544569251512375,0.665718286688714,4,28,chromosome condensation,BP,HMGA2;NCAPD2;TTN;NIPBL
13676,GO:0060261,0.544586129892685,0.73943651659334,2,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,TP53;TAF1
11154,GO:0045252,0.544775332129976,0.834491797407725,1,7,oxoglutarate dehydrogenase complex,CC,DHTKD1
13085,GO:0051648,0.544966932792155,0.545746020538375,22,195,vesicle localization,BP,SYT8;COL7A1;SYN1;SPG11;PRKCZ;SYTL1;SYT1;PCLO;BBS2;SNCA;SEC24D;BBS4;TMED10;AREG;TRAK1;KLHL12;SEPT5;C2CD4C;MAGI2;TPGS1;DNM1P46;MYO1C
3117,GO:0006699,0.54499636757408,0.738171942198166,2,18,bile acid biosynthetic process,BP,NR1D1;OSBPL1A
4778,GO:0010970,0.545034829569939,0.564457838982947,15,131,transport along microtubule,BP,NEFL;SPG11;PRKCZ;KIF17;IFT140;COPG2;TRAK1;SYNE2;IFT27;IFT88;WDR19;IFT122;IFT74;ICK;ARL3
16978,GO:0099111,0.545034829569939,0.564457838982947,15,131,microtubule-based transport,BP,NEFL;SPG11;PRKCZ;KIF17;IFT140;COPG2;TRAK1;SYNE2;IFT27;IFT88;WDR19;IFT122;IFT74;ICK;ARL3
2818,GO:0006285,0.545245987437395,0.827709768545351,1,10,base-excision repair, AP site formation,BP,MUTYH
16114,GO:0090154,0.54524954528529,0.83144953542998,1,8,positive regulation of sphingolipid biosynthetic process,BP,PLA2G6
19812,GO:2000304,0.54524954528529,0.83144953542998,1,8,positive regulation of ceramide biosynthetic process,BP,PLA2G6
12598,GO:0050810,0.545264343858533,0.612650139680158,7,66,regulation of steroid biosynthetic process,BP,SNAI2;VDR;NR1D1;SEC14L2;ACACB;DGKQ;EGR1
19143,GO:1905209,0.545325752378603,0.739813295084557,2,16,positive regulation of cardiocyte differentiation,BP,BMP4;TGFB2
3909,GO:0008574,0.545448443760583,0.69321616372529,3,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,KIF17;DNAL4;WDR63
15713,GO:0072321,0.545476976996648,0.827539355166615,1,10,chaperone-mediated protein transport,BP,CLU
11754,GO:0046636,0.54549725794053,0.740836812178632,2,15,negative regulation of alpha-beta T cell activation,BP,GLI3;BCL6
19161,GO:1905269,0.545830390745567,0.594379111112479,9,81,positive regulation of chromatin organization,BP,NOS1;SNAI2;TP53;SDR16C5;JARID2;ATM;ISL1;BCL6;NIPBL
17506,GO:1901028,0.546239791380534,0.658588496030789,4,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;TFDP2;TP73;ACAA2
16330,GO:0090659,0.5463898133461,0.742999484679324,2,13,walking behavior,BP,SPG11;EFNB3
16895,GO:0098903,0.546398269960791,0.83699104227467,1,6,regulation of membrane repolarization during action potential,BP,CAV1
18557,GO:1903829,0.54672223809133,0.529824912480422,31,286,positive regulation of cellular protein localization,BP,GAS6;TCAF1;EGFR;PAK1;SORL1;TP53;CEP250;ACSL3;TFDP2;ITGA3;GLI3;LRP1;FYN;B3GAT3;SNX33;PIK3R1;HHAT;TMEM173;ANK3;HPS4;TP73;STOM;MDM2;ARF6;SSH1;PRNP;CDK5RAP3;NIPBL;MYO1C;C2CD5;EDEM1
13081,GO:0051643,0.546867944330937,0.841871963551728,1,5,endoplasmic reticulum localization,BP,ESYT2
19043,GO:1904950,0.54714917321809,0.579233772785911,11,110,negative regulation of establishment of protein localization,BP,FN1;SFRP1;F2R;GAS6;IDH2;SP100;GOPC;RSAD2;MDFIC;DERL3;PPP3CA
17432,GO:1900246,0.547398207329444,0.841508020309122,1,5,positive regulation of RIG-I signaling pathway,BP,DDX60
10778,GO:0044273,0.547620040357807,0.687861468171186,3,29,sulfur compound catabolic process,BP,CSPG4;HEXA;GGT7
7726,GO:0032232,0.547626688225078,0.740333898530587,2,14,negative regulation of actin filament bundle assembly,BP,ARAP1;DLC1
13776,GO:0060394,0.547722223757547,0.829652234235237,1,8,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,DKK1
18358,GO:1903393,0.548008016725737,0.691587693907059,3,22,positive regulation of adherens junction organization,BP,SFRP1;S100A10;COL16A1
2377,GO:0005513,0.548070943635517,0.829397713335925,1,8,detection of calcium ion,BP,SYT1
11361,GO:0045760,0.548093091980917,0.835795223236809,1,6,positive regulation of action potential,BP,ANK3
13931,GO:0060666,0.548125695570879,0.841007764943979,1,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,PLXNA1
18111,GO:1902857,0.548177171390478,0.832052176156815,1,7,positive regulation of non-motile cilium assembly,BP,SEPT9
5405,GO:0016255,0.548777268851495,0.831619272315673,1,7,attachment of GPI anchor to protein,BP,PGAP1
20070,GO:2000758,0.54885138755556,0.687158065334764,3,28,positive regulation of peptidyl-lysine acetylation,BP,NOS1;SNAI2;ISL1
8125,GO:0032838,0.548879615125492,0.564313207010584,14,123,plasma membrane bounded cell projection cytoplasm,CC,NEFL;EFHC1;DLG4;WDR66;GLI3;GLI2;KIF17;IFT140;BBS1;TRAK1;TCTEX1D4;CFAP54;DNAH1;SEPT9
12507,GO:0050679,0.548972189726373,0.568221091809494,13,117,positive regulation of epithelial cell proliferation,BP,HTRA1;SFRP1;EGFR;LAMB1;BMP4;SEMA5A;ANG;FZD7;FGFR1;CDH13;SOX9;PRKCA;MAP2K5
9628,GO:0036514,0.549083537989018,0.840347432036476,1,5,dopaminergic neuron axon guidance,BP,VANGL2
19039,GO:1904938,0.549083537989018,0.840347432036476,1,5,planar cell polarity pathway involved in axon guidance,BP,VANGL2
11767,GO:0046655,0.549154693719176,0.735409725601503,2,17,folic acid metabolic process,BP,MTHFR;ALDH1L2
4854,GO:0014072,0.549225102108234,0.735347383009716,2,17,response to isoquinoline alkaloid,BP,MDM2;SRR
10411,GO:0043278,0.549225102108234,0.735347383009716,2,17,response to morphine,BP,MDM2;SRR
13705,GO:0060304,0.54963520079322,0.839966251981592,1,5,regulation of phosphatidylinositol dephosphorylation,BP,MTMR4
13567,GO:0060065,0.549637735494334,0.740169358688655,2,13,uterus development,BP,TGFB2;NIPBL
567,GO:0001709,0.549707265372937,0.73492022294447,2,17,cell fate determination,BP,BMP4;ISL1
3391,GO:0007172,0.549715292610428,0.830941056542138,1,7,signal complex assembly,BP,PXN
5171,GO:0015732,0.54983017697738,0.828109729384286,1,8,prostaglandin transport,BP,ABCC2
8095,GO:0032794,0.549862646961271,0.738374371044808,2,14,GTPase activating protein binding,MF,PLXNB1;RGS14
8052,GO:0032732,0.549932337585872,0.686631453889899,3,27,positive regulation of interleukin-1 production,BP,PYCARD;EGR1;ISL1
16406,GO:0097090,0.550295598047914,0.834232159256725,1,6,presynaptic membrane organization,BP,NLGN4Y
19826,GO:2000322,0.550530704765645,0.830349967449648,1,7,regulation of glucocorticoid receptor signaling pathway,BP,PER1
8591,GO:0034116,0.550784934914424,0.827407944223142,1,8,positive regulation of heterotypic cell-cell adhesion,BP,FLOT1
13033,GO:0051561,0.550794101630053,0.825274699307545,1,9,positive regulation of mitochondrial calcium ion concentration,BP,TGM2
17022,GO:0099531,0.550826269731416,0.58951064688489,9,80,presynaptic process involved in chemical synaptic transmission,BP,SYT8;SYN1;SYTL1;SYT1;PCLO;SNCA;SEPT5;C2CD4C;GDNF
9412,GO:0035999,0.550985179162858,0.827260507966943,1,8,tetrahydrofolate interconversion,BP,MTHFR
8937,GO:0035014,0.551005345568381,0.833726284223704,1,6,phosphatidylinositol 3-kinase regulator activity,MF,PIK3R1
666,GO:0001871,0.551074025703833,0.833677275560049,1,6,pattern binding,MF,ENPP1
6793,GO:0030247,0.551074025703833,0.833677275560049,1,6,polysaccharide binding,MF,ENPP1
16198,GO:0090276,0.551361345135666,0.565698955580341,13,119,regulation of peptide hormone secretion,BP,SFRP1;ANO1;IRS2;EGFR;NR1D1;PLA2G6;CPT1A;ISL1;PRKCA;ITPR2;EFNA5;PPP3CA;ABAT
5781,GO:0017016,0.552218477688002,0.509011247169734,50,403,Ras GTPase binding,MF,IRS2;DNMBP;EGFR;SPTB;ALS2CL;PAK1;SRGAP3;TBC1D8;RIN2;NEFL;VAV3;PLEKHG3;ARHGEF1;DLG4;PDGFA;MICAL1;DOCK4;EVI5L;KITLG;TBC1D5;FYN;ARHGEF12;CAV1;DOCK11;CAMK2D;SYTL1;HPS4;FGFR1;OBSCN;ARHGEF17;TRIOBP;SRGAP1;AKAP13;FGD4;ARHGEF2;NDRG1;ANXA2;PAK6;RET;CDC42EP5;ULK1;VAV2;ARHGEF19;GDNF;INF2;TBC1D16;SBF2;RHOBTB3;MYO1C;DOCK1
909,GO:0002295,0.552376418871138,0.829006762639538,1,7,T-helper cell lineage commitment,BP,ZFPM1
10459,GO:0043373,0.552376418871138,0.829006762639538,1,7,CD4-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
19371,GO:1905906,0.552541262148276,0.82611184580339,1,8,regulation of amyloid fibril formation,BP,CLU
3231,GO:0006887,0.552587859013378,0.50205898073107,62,597,exocytosis,BP,SYT8;FN1;PCDH7;PYGB;MMP9;CD109;GSN;ANPEP;GAS6;SLC2A3;SERPINE1;ENDOD1;ANXA5;TIMP2;PAK1;PYCARD;PDGFA;MICAL1;TIMP1;ANO6;SYN1;MAGED2;KCNAB2;PLA2G6;CLU;SERPING1;CXCR1;SYTL1;METTL7A;SYT1;TMEM173;PCLO;TTN;APLP2;CAT;STOM;SNCA;MME;VAMP1;MLEC;TMED10;CST3;MANBA;PRCP;NFASC;ANXA2;RAB13;SEPT5;MAN2B1;MOSPD2;TGFB2;DNASE1L1;C2CD4C;NAPRT;LGALS3;MIA3;DNAJC3;STEAP2;ACTR1B;ADAM10;S100A11;CTSD
11788,GO:0046697,0.552645595576098,0.733351994102101,2,16,decidualization,BP,VDR;CTSV
9754,GO:0039536,0.553033686984869,0.828526675912521,1,7,negative regulation of RIG-I signaling pathway,BP,SEC14L1
1148,GO:0002757,0.553098525462727,0.520826439740926,33,324,immune response-activating signal transduction,BP,FLOT1;INPP5D;TKFC;PAK1;NR1D1;TRIM5;VAV3;PTPRS;DDX60;MUC19;ERMAP;SEC14L1;FYN;CAV1;PLA2G6;PIK3R1;BTN3A1;PRKACB;TLR3;PAG1;PDE4D;PSMB9;MAP3K1;PRNP;VAV2;BTN3A3;RSAD2;GCSAM;LGALS3;WIPF1;ELMO2;MYO1C;DOCK1
3678,GO:0008180,0.553424656667559,0.68285488370346,3,28,COP9 signalosome,CC,FLOT1;AMOTL1;HSPA5
4707,GO:0010874,0.553504636947515,0.735163899988902,2,14,regulation of cholesterol efflux,BP,ABCA1;LRP1
19187,GO:1905323,0.553531514777786,0.831917066959594,1,6,telomerase holoenzyme complex assembly,BP,ATM
13185,GO:0051865,0.553791785168171,0.617085173264352,6,53,protein autoubiquitination,BP,RNF213;DDB2;UHRF2;MDM2;SASH1;TAF1
3222,GO:0006875,0.553806993735172,0.523843639524589,30,280,cellular metal ion homeostasis,BP,F2R;PKD2;JPH2;CYBRD1;NOS1;SLC8A1;NTSR1;VDR;KCNMA1;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;HERPUD1;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;ANXA6;KCTD7;PRNP;ITPR2;SV2A;OXTR;DMPK
14400,GO:0061734,0.554120143513111,0.836843698389221,1,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,VPS13C
7925,GO:0032516,0.554173674370511,0.734571598101203,2,14,positive regulation of phosphoprotein phosphatase activity,BP,ITGA1;MAGI2
1044,GO:0002568,0.554269785144524,0.836738785027214,1,5,somatic diversification of T cell receptor genes,BP,LEF1
1091,GO:0002681,0.554269785144524,0.836738785027214,1,5,somatic recombination of T cell receptor gene segments,BP,LEF1
8305,GO:0033153,0.554269785144524,0.836738785027214,1,5,T cell receptor V(D)J recombination,BP,LEF1
3587,GO:0008013,0.554403554574964,0.595598055588542,8,62,beta-catenin binding,MF,TCF7L1;GLI3;DLG5;PXN;PTPRU;SOX9;LEF1;MED12
406,GO:0001091,0.554461587416774,0.731734493288111,2,16,RNA polymerase II basal transcription factor binding,MF,TP53;TCF4
4028,GO:0009064,0.554766161280263,0.63082449661803,5,48,glutamine family amino acid metabolic process,BP,PRODH;NOS1;CPS1;GCLC;ALDH4A1
11844,GO:0046872,0.554976027593129,0.472092516891071,325,2920,metal ion binding,MF,CPA4;SYT8;MMP2;PCDH7;MMP9;CCBE1;ADAM19;FBN1;ITGA6;MMP28;ZFP36L1;FAT4;TGFBR2;PTGS1;EFEMP1;ASAP3;MARCH4;GSN;COL5A2;PKD2;PITPNM3;CYBRD1;NID1;ZFP36L2;ANPEP;ZNF362;NOS1;GAS6;FBN2;SNAI2;SULF2;COL5A1;PHF21A;UTRN;GALNT10;KLF8;PEG10;ITPK1;TCHH;SLC8A1;CLCA2;MYLK;THBS2;TRIM2;ZNF608;ATP10D;ENDOD1;RNF213;S100A10;RNF165;ANXA5;TKFC;MAP3K6;ASAP2;TIMP2;ZNF862;PDLIM2;VDR;CHN2;APOBEC3C;PADI3;TRIM38;NR1D1;XAF1;TRIM5;VAV3;NR3C1;COL18A1;KCNMA1;TP53;ARAP1;EXTL2;MBNL2;PRICKLE1;CUL9;ZBTB20;LTBP1;ZC3H6;WNK1;EFHC1;ITGA2;ZCCHC11;MMP19;MICAL1;ADARB1;TIMP1;EFEMP2;FLG;SMOC1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;PCDHAC2;HIVEP1;GLI3;LPCAT2;P3H2;ASAP1;CTDSPL;LIMCH1;ZFP90;NEK9;NMRK1;LRP1;FYN;XDH;TSHZ2;B3GAT3;LTBP4;CPS1;FAT2;GLI2;PIAS3;RNF135;ITGA10;SLC2A4RG;ZNF318;FKBP9;PRKCZ;SLIT3;OAS2;ZNF678;GPR39;TNS2;EHD3;PHC2;ITGA1;SYTL1;ZSCAN18;ATP8B2;PXN;SYT1;CAPRIN2;ACACB;APOBEC3G;PCLO;ANG;DYSF;UHRF2;TTN;PRDM8;LMO7;APLP2;CRELD2;FBLN1;ZKSCAN1;TP73;CAT;PLCH2;KLF13;PRKACB;AARS;CHEK2;WDFY2;PHF2;MAN1A1;ZNF860;SNCA;ADAMTS7;MME;GATAD1;JADE2;SP110;DZIP1L;APOBEC3F;ALOX15B;SEC24D;LTBP3;ASTN2;PDE4D;TMEM129;TGM2;OBSCN;SULF1;ESYT2;ARSD;ZNF618;KDM4C;SLC24A1;CDH13;TRAF1;LMCD1;DTNB;NOTCH2NL;L3MBTL3;MTMR4;ZNF699;CALR;IDH2;MDM2;DLK2;ZNF107;ANXA6;AKAP13;DGKQ;GCLC;NR2F2;NEURL1B;LMO4;ZNF449;ZMAT3;CYP20A1;ZBTB22;RNPEP;MAP3K1;FGD4;PTPN1;CRIP2;NT5DC3;ARHGEF2;ZNF546;EGR1;ENPP1;ISL1;BCL6;PCDHGA11;ZNF717;PLAG1;PRKCA;SALL2;ZNF358;ZNF519;PRPS2;ANXA2;TRERF1;PRIMPOL;AMZ2;ADAMTS15;HLTF;RNF24;MAN2B1;TSHZ1;LANCL1;TES;ZNF160;MEGF8;ZNF302;IRF2BPL;STK36;MUTYH;PRNP;CDH11;RET;ZFPM1;MAP2K5;ZNF550;LIG1;ZNF701;THRA;FHL1;ZADH2;CYP4V2;MSRB2;C2CD4C;PPM1M;ZSCAN30;AGRN;NPEPL1;VAV2;AGAP1;HSPA5;TH;PIKFYVE;FLYWCH1;TGFB1I1;RSAD2;SRPK2;ITPR2;ARHGAP29;YPEL4;SAP30L;ZNF12;MYO9A;KLF5;CAPS;SRR;GALNT2;ZNF558;PPARG;RNF144B;KCNIP3;MLLT6;KLF7;ICK;ING4;POSTN;UNK;ARL3;FKBP10;RARA;POLH;TSHZ3;MPPE1;ZNF883;ZBTB1;DPYD;PPP3CA;LIMA1;CTDSP2;STEAP2;KDM4A;ZBTB25;CACNA2D3;MATN3;NPAS2;ABAT;BSN;PCDHGB5;ADAM10;PRDM5;RNPEPL1;PPP2R3A;CELSR1;ZNF471;LITAF;S100A11;RXRA;C2CD5;EDEM1;ZNF484;ZNRF1;DMPK
7439,GO:0031585,0.555158492237852,0.844355992116157,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
2830,GO:0006301,0.555205182494004,0.630179326081354,5,49,postreplication repair,BP,PRIMPOL;POLD4;UBA7;POLH;ZBTB1
2523,GO:0005782,0.555231137635293,0.679872319974563,3,31,peroxisomal matrix,CC,PRDX5;CAT;EHHADH
7554,GO:0031907,0.555231137635293,0.679872319974563,3,31,microbody lumen,CC,PRDX5;CAT;EHHADH
18418,GO:1903530,0.555269880123406,0.509925876583239,43,401,regulation of secretion by cell,BP,SYT8;FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;EGFR;NTSR1;NR1D1;PYCARD;MICAL1;SYN1;PLA2G6;PRKCZ;SYTL1;CCK;SYT1;CPT1A;PCLO;ANG;TTN;SNCA;FGFR1;ALOX15B;C5;IDH2;ISL1;PRKCA;RAB13;SEPT5;HTR1B;TGFB2;C2CD4C;RSAD2;ITPR2;GDNF;POSTN;EFNA5;PPP3CA;ABAT;OXTR
12956,GO:0051386,0.555337317263433,0.826836694292739,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
11746,GO:0046627,0.555462819574369,0.681419560257597,3,27,negative regulation of insulin receptor signaling pathway,BP,PRKCZ;PTPN1;ENPP1
18586,GO:1903896,0.555537247266482,0.826689481722874,1,7,positive regulation of IRE1-mediated unfolded protein response,BP,PTPN1
3157,GO:0006767,0.555847206295861,0.602158697076897,7,66,water-soluble vitamin metabolic process,BP,SLC2A3;MTHFR;HLCS;ACACB;ALDH1L2;GCLC;ENPP1
9980,GO:0042415,0.555891580230256,0.82642836645449,1,7,norepinephrine metabolic process,BP,TH
5677,GO:0016798,0.556043999715184,0.591256450415645,8,83,hydrolase activity, acting on glycosyl bonds,MF,MAN1A1;NAGLU;MANBA;HEXA;MAN2B1;MUTYH;DNPH1;EDEM1
8636,GO:0034198,0.556218212962417,0.649988440613859,4,39,cellular response to amino acid starvation,BP,SESN3;EIF2AK4;SESN1;SLC38A2
14914,GO:0070830,0.556424733546129,0.631011454169523,5,41,bicellular tight junction assembly,BP,SNAI2;NPHP4;RAB13;MPP7;MYO1C
18254,GO:1903170,0.55644867728042,0.727976809701749,2,18,negative regulation of calcium ion transmembrane transport,BP,PKD2;NTSR1
8175,GO:0032926,0.556577256039432,0.825922304935539,1,7,negative regulation of activin receptor signaling pathway,BP,MAGI2
13941,GO:0060677,0.556685169681357,0.835038817603035,1,5,ureteric bud elongation,BP,BMP4
818,GO:0002092,0.556878008441974,0.729573186483541,2,16,positive regulation of receptor internalization,BP,TBC1D5;MAGI2
5316,GO:0016045,0.556941482305719,0.825653073594894,1,7,detection of bacterium,BP,CD1D
16729,GO:0098543,0.556941482305719,0.825653073594894,1,7,detection of other organism,BP,CD1D
20069,GO:2000757,0.556985568471454,0.728422754259923,2,17,negative regulation of peptidyl-lysine acetylation,BP,SDR16C5;SNCA
5481,GO:0016421,0.557106814249898,0.829333168028492,1,6,CoA carboxylase activity,MF,ACACB
9582,GO:0036457,0.557312468602154,0.842901367823337,1,4,keratohyalin granule,CC,FLG
1891,GO:0004576,0.557348770421706,0.818625534766006,1,10,oligosaccharyl transferase activity,MF,TUSC3
18118,GO:1902882,0.557373889358807,0.612301337679578,6,60,regulation of response to oxidative stress,BP,SESN3;TP53;GPX1;SESN1;FZD1;GGT7
9520,GO:0036289,0.557500947318751,0.829046643868871,1,6,peptidyl-serine autophosphorylation,BP,ATM
6506,GO:0021889,0.557684516365099,0.828913079740737,1,6,olfactory bulb interneuron differentiation,BP,ROBO1
10182,GO:0042809,0.557706027460362,0.730037415270059,2,15,vitamin D receptor binding,MF,MED12;RXRA
6324,GO:0020027,0.557759298320831,0.822221692242815,1,8,hemoglobin metabolic process,BP,CAT
16137,GO:0090186,0.557827366767964,0.828809092032746,1,6,regulation of pancreatic juice secretion,BP,WNK1
427,GO:0001135,0.558030222877735,0.824846570949359,1,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,MYBL1
12687,GO:0050932,0.558139472941477,0.824765499679416,1,7,regulation of pigment cell differentiation,BP,KITLG
1173,GO:0002821,0.558175860368904,0.627048194202156,5,50,positive regulation of adaptive immune response,BP,EIF2AK4;PYCARD;PRKCZ;RSAD2;ZBTB1
7990,GO:0032623,0.558972635558909,0.647923780394687,4,37,interleukin-2 production,BP,IL20RB;PDE4D;IL18;PRNP
4585,GO:0010694,0.559098439467169,0.833327968290353,1,5,positive regulation of alkaline phosphatase activity,BP,ITGA2
1658,GO:0004115,0.559228022381246,0.827787150859991,1,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,PDE4D
8502,GO:0033700,0.559589989974489,0.827522362781525,1,6,phospholipid efflux,BP,ABCA1
8569,GO:0034067,0.559690798340264,0.681469268562343,3,21,protein localization to Golgi apparatus,BP,SORL1;VPS13C;OBSL1
6535,GO:0021954,0.560020183328186,0.627472903526135,5,41,central nervous system neuron development,BP,MAP2;ADARB1;GLI2;ROBO1;CDH11
10351,GO:0043190,0.560265206215353,0.827027665997303,1,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA2
10251,GO:0043011,0.560336949635929,0.820278038618285,1,8,myeloid dendritic cell differentiation,BP,TGFBR2
7066,GO:0030865,0.560377281683468,0.626819045982359,5,42,cortical cytoskeleton organization,BP,CALR;ARF6;RAB13;WIPF1;RHOBTB3
1181,GO:0002829,0.560629591314625,0.820056450606209,1,8,negative regulation of type 2 immune response,BP,BCL6
17546,GO:1901185,0.56073110089195,0.624943823656192,5,48,negative regulation of ERBB signaling pathway,BP,GPRC5A;EGFR;ITGA1;SPRY2;PTPN3
5906,GO:0018158,0.560818255565157,0.817711595137887,1,9,protein oxidation,BP,GPX1
2775,GO:0006207,0.561041981169028,0.826457336807621,1,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,CPS1
6257,GO:0019856,0.561041981169028,0.826457336807621,1,6,pyrimidine nucleobase biosynthetic process,BP,CPS1
12159,GO:0048311,0.561255629230549,0.728253324921073,2,14,mitochondrion distribution,BP,TRAK1;MEF2A
15689,GO:0072282,0.561323359953007,0.826250416884635,1,6,metanephric nephron tubule morphogenesis,BP,SOX9
9973,GO:0042402,0.56144942150784,0.81547483114606,1,10,cellular biogenic amine catabolic process,BP,ALDH7A1
6785,GO:0030235,0.561454046459541,0.822293449816901,1,7,nitric-oxide synthase regulator activity,MF,EGFR
2659,GO:0006006,0.561486524968194,0.547463184457561,15,139,glucose metabolic process,BP,IRS2;H6PD;NR1D1;NISCH;SIK1;CPT1A;ACACB;NCOA2;PDK3;G6PD;DGKQ;ENPP1;G6PC3;LEPR;IGFBP4
1993,GO:0004716,0.561646922115861,0.826012262943304,1,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR
2291,GO:0005251,0.561880999822673,0.821973271141917,1,7,delayed rectifier potassium channel activity,MF,KCNQ3
7637,GO:0032059,0.56202275670245,0.821866876860638,1,7,bleb,CC,FHOD1
1348,GO:0003214,0.562096346304205,0.825681090957361,1,6,cardiac left ventricle morphogenesis,BP,TGFBR2
16440,GO:0097152,0.562320788042308,0.821643047944479,1,7,mesenchymal cell apoptotic process,BP,SOX9
17007,GO:0099513,0.563308445966134,0.495735866423292,53,468,polymeric cytoskeletal fiber,CC,KRT4;PKD2;MAP6;DPYSL2;SLC8A1;KRT14;VIM;PAK1;NEFM;NEFL;KRT13;TTLL11;KRT5;TCP11L1;MAP2;MICAL1;FLG;KRT15;EML2;KCNAB2;FYN;ESPN;PRKCZ;PARP4;HAUS4;KIF17;SPRY2;CASP14;SHROOM4;LMNA;FSCN1;PBXIP1;AKAP13;ARHGEF2;DNAL4;SYNC;KRT222;NCOR1;NDRG1;RGS14;ODF2;REEP2;TPGS1;DNAH1;BEX4;ARL3;WIPF1;KRT10;CAPN6;SEPT9;KLHL22;CDK5RAP3;MYO1C
7568,GO:0031943,0.563524806919144,0.817853989453198,1,8,regulation of glucocorticoid metabolic process,BP,DGKQ
5043,GO:0015232,0.563850142933135,0.820491382253799,1,7,heme transporter activity,MF,SLC48A1
5251,GO:0015886,0.563850142933135,0.820491382253799,1,7,heme transport,BP,SLC48A1
7895,GO:0032479,0.563910674302339,0.562552993612215,11,107,regulation of type I interferon production,BP,FLOT1;HERC5;STAT1;PTPRS;ZBTB20;PYCARD;POLR3GL;RNF135;TMEM173;TLR3;UBA7
7155,GO:0031045,0.563913406456689,0.824337632834954,1,6,dense core granule,CC,SYT1
2743,GO:0006144,0.56399165491821,0.720297032646908,2,19,purine nucleobase metabolic process,BP,XDH;DPYD
14636,GO:0070266,0.564230452239371,0.671670061536029,3,30,necroptotic process,BP,CAV1;TLR3;ARHGEF2
12770,GO:0051091,0.564580419673152,0.532190880716381,19,182,positive regulation of DNA binding transcription factor activity,BP,ROR1;TRIM38;TRIM5;DDIT3;PYCARD;CLU;PRKCZ;CAT;TLR3;EDA2R;TRAF1;FZD1;ARHGEF2;CRTC1;STK36;PPARG;TAF1;FZD4;PPP3CA
4697,GO:0010862,0.564670384452677,0.673182656087254,3,26,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP4;ENG;TGFB2
15980,GO:0086019,0.564673433512724,0.723756271704669,2,15,cell-cell signaling involved in cardiac conduction,BP,GJA5;KCNJ5
11836,GO:0046849,0.564900228292443,0.60624632328932,6,52,bone remodeling,BP,INPP5D;SFRP1;EGFR;PRKCA;LEPR;HTR1B
9140,GO:0035510,0.565048646164549,0.672819627139517,3,26,DNA dealkylation,BP,APOBEC3C;APOBEC3G;APOBEC3F
11389,GO:0045820,0.565178305559783,0.823398144803439,1,6,negative regulation of glycolytic process,BP,DDIT4
12848,GO:0051198,0.565178305559783,0.823398144803439,1,6,negative regulation of coenzyme metabolic process,BP,DDIT4
4634,GO:0010761,0.565243672773669,0.643277481125873,4,33,fibroblast migration,BP,SLC8A1;PAK1;TNS1;SYNE2
8939,GO:0035020,0.565268982446218,0.723215353343366,2,15,regulation of Rac protein signal transduction,BP,STMN3;ARF6
13970,GO:0060713,0.565300721635208,0.719938261837707,2,18,labyrinthine layer morphogenesis,BP,ZFP36L1;LEF1
15715,GO:0072330,0.565698362376948,0.526417934144634,21,201,monocarboxylic acid biosynthetic process,BP,DDIT4;PTGS1;CSPG4;NR1D1;ACSL3;PTGES;UST;ACSS1;ACACB;CBR1;ALOX15B;PRKAB2;DHTKD1;ACSS2;THNSL2;NCOR1;DSEL;OSBPL1A;SRR;PRKAG1;ABAT
5795,GO:0017053,0.566386036055461,0.574727989384767,9,73,transcriptional repressor complex,CC,CBX5;CHD3;GLI3;TNRC18;SDR16C5;NCOR1;SALL2;BAHCC1;ZFPM1
15332,GO:0071599,0.566464916441971,0.822438916879879,1,6,otic vesicle development,BP,SOX9
4678,GO:0010831,0.566705092053035,0.71865010315421,2,18,positive regulation of myotube differentiation,BP,FLOT1;THRA
11347,GO:0045736,0.566794958464049,0.671140822690108,3,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2B;NR2F2;CDKN2A
489,GO:0001542,0.566802066362065,0.822186951824382,1,6,ovulation from ovarian follicle,BP,MMP19
2714,GO:0006094,0.566965632348348,0.617938104730314,5,52,gluconeogenesis,BP,NR1D1;SIK1;DGKQ;G6PC3;LEPR
18138,GO:1902914,0.5669839339452,0.721654151856875,2,15,regulation of protein polyubiquitination,BP,SKP2;SASH1
6787,GO:0030238,0.56702861619205,0.822017501271416,1,6,male sex determination,BP,SOX9
5605,GO:0016655,0.567585055002014,0.66370193045202,3,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,NQO1;TP53I3;CBR1
16069,GO:0090079,0.567675671606522,0.718709471274593,2,17,translation regulator activity, nucleic acid binding,MF,PAIP2B;RARA
817,GO:0002091,0.567818705965223,0.81747870841824,1,7,negative regulation of receptor internalization,BP,DLG4
11855,GO:0046886,0.567876466159685,0.814508475128352,1,8,positive regulation of hormone biosynthetic process,BP,EGR1
5577,GO:0016601,0.56809447768617,0.640066343767468,4,34,Rac protein signal transduction,BP,STMN3;NISCH;CDH13;ARF6
17307,GO:1900016,0.568265485436943,0.814207334537657,1,8,negative regulation of cytokine production involved in inflammatory response,BP,PDCD4
6244,GO:0019827,0.568762412942135,0.54437839494706,14,120,stem cell population maintenance,BP,SFRP1;ZFP36L2;ZCCHC11;FUT10;HMGA2;FZD7;KDM4C;PBX1;VANGL2;SOX9;ZNF358;YAP1;MED12;NIPBL
18960,GO:1904781,0.569571814213575,0.825757747636278,1,5,positive regulation of protein localization to centrosome,BP,CEP250
19301,GO:1905634,0.569785281512476,0.819946503235286,1,6,regulation of protein localization to chromatin,BP,NIPBL
7835,GO:0032404,0.57005543714194,0.812817334743083,1,8,mismatch repair complex binding,MF,MUTYH
2461,GO:0005680,0.570105505052618,0.713222422922455,2,21,anaphase-promoting complex,CC,CUL7;ANAPC16
9557,GO:0036376,0.5703874964988,0.81550990268099,1,7,sodium ion export across plasma membrane,BP,SLC8A1
8047,GO:0032727,0.570455062410764,0.717236232397324,2,16,positive regulation of interferon-alpha production,BP,STAT1;TLR3
1472,GO:0003730,0.570631530209378,0.600085041328761,6,54,mRNA 3'-UTR binding,MF,ZFP36L1;ZFP36L2;IGF2BP2;TP53;RBMS3;CIRBP
3414,GO:0007200,0.570819307069115,0.664893481038023,3,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R;ANO1;TGM2
1158,GO:0002768,0.570905695944575,0.513350286018905,25,250,immune response-regulating cell surface receptor signaling pathway,BP,INPP5D;PAK1;VAV3;MUC19;ERMAP;FYN;PLA2G6;PIK3R1;BTN3A1;PRKACB;PAG1;PDE4D;PSMB9;MAP3K1;PRNP;VAV2;BTN3A3;GCSAM;LGALS3;WIPF1;PPP3CA;FOS;ELMO2;MYO1C;DOCK1
18658,GO:1904031,0.571008904462914,0.665114203063952,3,30,positive regulation of cyclin-dependent protein kinase activity,BP,PKD2;EGFR;CCNY
13890,GO:0060576,0.571648584321154,0.809289630477683,1,9,intestinal epithelial cell development,BP,KLF5
7977,GO:0032606,0.572250178205277,0.554003552005877,11,108,type I interferon production,BP,FLOT1;HERC5;STAT1;PTPRS;ZBTB20;PYCARD;POLR3GL;RNF135;TMEM173;TLR3;UBA7
19711,GO:2000108,0.572251948599091,0.711910016976865,2,20,positive regulation of leukocyte apoptotic process,BP,TP53;CDKN2A
3232,GO:0006888,0.573028692190509,0.526258524882446,18,170,ER to Golgi vesicle-mediated transport,BP,COL7A1;GAS6;SPTB;SORL1;GOLGB1;CREB3L2;ANK3;SEC24D;COPG2;TMED10;AREG;KLHL12;PGAP1;GOPC;LMF1;MIA3;COG3;MPPE1
1185,GO:0002833,0.573035696153826,0.664554004318915,3,27,positive regulation of response to biotic stimulus,BP,DDX60;PRKCA;SASH1
17799,GO:1901984,0.57326442681829,0.712586466209268,2,18,negative regulation of protein acetylation,BP,SDR16C5;SNCA
17738,GO:1901741,0.573412418122252,0.807892898085043,1,9,positive regulation of myoblast fusion,BP,FLOT1
4694,GO:0010857,0.573461077057011,0.81015262596465,1,8,calcium-dependent protein kinase activity,MF,PRKCA
3122,GO:0006704,0.573541718837356,0.81008920881197,1,8,glucocorticoid biosynthetic process,BP,DGKQ
3825,GO:0008429,0.573952513052461,0.809765927493764,1,8,phosphatidylethanolamine binding,MF,ESYT2
8706,GO:0034368,0.574027249632809,0.807404356497195,1,9,protein-lipid complex remodeling,BP,ABCA5
8707,GO:0034369,0.574027249632809,0.807404356497195,1,9,plasma lipoprotein particle remodeling,BP,ABCA5
7049,GO:0030838,0.574253626684189,0.582981766496221,7,71,positive regulation of actin filament polymerization,BP,GSN;PYCARD;ARPIN;ARF6;CDC42EP5;WIPF1;MYO1C
8800,GO:0034587,0.57435519814243,0.809448653594947,1,8,piRNA metabolic process,BP,MYBL1
1175,GO:0002823,0.57438837303599,0.710681874684121,2,19,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;BCL6
8571,GO:0034085,0.574464511790556,0.812354609521213,1,7,establishment of sister chromatid cohesion,BP,NIPBL
15774,GO:0072498,0.575267345936498,0.806416343227194,1,9,embryonic skeletal joint development,BP,BMP4
9288,GO:0035751,0.575303908535328,0.803056293323137,1,11,regulation of lysosomal lumen pH,BP,TMEM175
18078,GO:1902743,0.575335052322157,0.632898443151371,4,34,regulation of lamellipodium organization,BP,PDPN;ARPIN;FSCN1;SSH1
6096,GO:0019321,0.575533287394609,0.802870610211649,1,11,pentose metabolic process,BP,G6PD
10800,GO:0044309,0.576010893109024,0.54587675984955,12,103,neuron spine,CC,NOS1;SLC8A1;NTSR1;NR1D1;DLG4;ASAP1;LZTS1;RGS14;OPHN1;SHISA9;PPP3CA;DNM1P46
11332,GO:0045713,0.576054655051769,0.811113731917035,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,PPARG
3943,GO:0008645,0.576312940218074,0.572254475409385,8,70,hexose transmembrane transport,BP,IRS2;CLTCL1;SLC2A3;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
11859,GO:0046890,0.576365824823213,0.539812840765952,13,128,regulation of lipid biosynthetic process,BP,SNAI2;VDR;NR1D1;SEC14L2;PDGFA;ACSL3;SIK1;SLC27A1;PLA2G6;ACACB;PRKAB2;DGKQ;EGR1
1522,GO:0003887,0.576437949464351,0.661786689596602,3,26,DNA-directed DNA polymerase activity,MF,PRIMPOL;POLD4;POLH
16247,GO:0090342,0.57645830536538,0.630681270061361,4,37,regulation of cell aging,BP,HMGA2;LMNA;BCL6;CDKN2A
19127,GO:1905165,0.576547014020054,0.814794624355205,1,6,regulation of lysosomal protein catabolic process,BP,LRP1
8446,GO:0033598,0.57697975855551,0.661857525099308,3,25,mammary gland epithelial cell proliferation,BP,GPX1;ROBO1;AREG
19843,GO:2000345,0.577058386972156,0.810327490492227,1,7,regulation of hepatocyte proliferation,BP,SULF2
10389,GO:0043248,0.577243552960256,0.800235270247377,1,12,proteasome assembly,BP,PSMG4
18468,GO:1903624,0.57725661085851,0.807151655869988,1,8,regulation of DNA catabolic process,BP,ATM
381,GO:0001016,0.577289297787232,0.810146287449434,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
17732,GO:1901725,0.577555539356484,0.814017361097261,1,6,regulation of histone deacetylase activity,BP,CAMK2D
17197,GO:0110011,0.577818263451754,0.819627711427861,1,5,regulation of basement membrane organization,BP,PHLDB1
18739,GO:1904259,0.577818263451754,0.819627711427861,1,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB1
18740,GO:1904261,0.577818263451754,0.819627711427861,1,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB1
20220,GO:2001197,0.577818263451754,0.819627711427861,1,5,basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB1
6832,GO:0030307,0.577921184586859,0.538846904567498,13,117,positive regulation of cell growth,BP,FN1;SFRP1;EGFR;PAK1;SEMA5A;SYT1;MEGF8;TGFB2;MAP2K5;LEF1;EFNA5;DNPH1;ADAM10
12669,GO:0050913,0.577975567086918,0.80239328105658,1,10,sensory perception of bitter taste,BP,REEP2
3370,GO:0007143,0.578310874361839,0.70786815310563,2,18,female meiotic nuclear division,BP,MLH3;ATM
9040,GO:0035280,0.578408976328914,0.809265905092013,1,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,AGO4
16801,GO:0098727,0.578497761110954,0.534360952513867,14,121,maintenance of cell number,BP,SFRP1;ZFP36L2;ZCCHC11;FUT10;HMGA2;FZD7;KDM4C;PBX1;VANGL2;SOX9;ZNF358;YAP1;MED12;NIPBL
6974,GO:0030660,0.578680195240573,0.560543825382168,9,88,Golgi-associated vesicle membrane,CC,CLTCL1;SEC24D;COPG2;TMED10;AREG;KLHL12;SPPL2B;GOPC;RASSF9
12324,GO:0048710,0.578836243767201,0.708348880859446,2,17,regulation of astrocyte differentiation,BP,SERPINE2;KDM4A
9025,GO:0035257,0.578837141815188,0.533552611885767,14,129,nuclear hormone receptor binding,MF,TADA3;VDR;STAT1;NCOA2;KDM4C;CALR;ISL1;NCOR1;LEF1;TGFB1I1;TACC2;PPARG;MED12;RXRA
3323,GO:0007033,0.578880569219186,0.529570598366499,15,142,vacuole organization,BP,ABCA1;SRPX;SPG11;ULK2;TP53INP1;HPS4;NAGLU;LYST;TMEM175;ANXA2;IFT88;ULK1;PIKFYVE;PIK3C2B;ATG16L2
8403,GO:0033483,0.579528701802031,0.805339342900149,1,8,gas homeostasis,BP,CAV1
18419,GO:1903531,0.579992056141953,0.552074222010339,10,99,negative regulation of secretion by cell,BP,FN1;SFRP1;F2R;GAS6;SNCA;IDH2;HTR1B;RSAD2;PPP3CA;ABAT
1450,GO:0003684,0.580030154992458,0.577756373405759,7,66,damaged DNA binding,MF,XPC;DDB2;TP53;TP73;MSH5;MUTYH;POLH
9747,GO:0039529,0.58004672741303,0.709587061683647,2,15,RIG-I signaling pathway,BP,DDX60;SEC14L1
8559,GO:0034045,0.580286818475667,0.708094239137682,2,16,phagophore assembly site membrane,CC,ULK2;ULK1
8157,GO:0032906,0.580483535579456,0.811747629214832,1,6,transforming growth factor beta2 production,BP,TGFB2
8160,GO:0032909,0.580483535579456,0.811747629214832,1,6,regulation of transforming growth factor beta2 production,BP,TGFB2
8307,GO:0033158,0.580598674025927,0.707801355910067,2,16,regulation of protein import into nucleus, translocation,BP,GAS6;TMEM173
13459,GO:0055025,0.580817340473775,0.658095512582387,3,25,positive regulation of cardiac muscle tissue development,BP,BMP4;FGFR1;TGFBR3
16385,GO:0097050,0.580828022595645,0.804297575944298,1,8,type B pancreatic cell apoptotic process,BP,WFS1
20026,GO:2000674,0.580828022595645,0.804297575944298,1,8,regulation of type B pancreatic cell apoptotic process,BP,WFS1
6811,GO:0030279,0.580868587674488,0.606337174085075,5,42,negative regulation of ossification,BP,SFRP1;DKK1;AREG;SOX9;TWIST2
7966,GO:0032591,0.581214277739588,0.811178108007382,1,6,dendritic spine membrane,CC,SHISA9
10779,GO:0044275,0.581215471142974,0.626265483956796,4,36,cellular carbohydrate catabolic process,BP,PYGB;TKFC;PHKA2;MANBA
15506,GO:0071933,0.581228276487841,0.807036352062404,1,7,Arp2/3 complex binding,MF,SNX9
14002,GO:0060760,0.581347577823546,0.62578635851821,4,37,positive regulation of response to cytokine stimulus,BP,GAS6;AXL;AGPAT1;CREBRF
12298,GO:0048672,0.581505408273861,0.801392418986781,1,9,positive regulation of collateral sprouting,BP,EFNA5
4570,GO:0010660,0.581742715742732,0.625389343585873,4,37,regulation of muscle cell apoptotic process,BP,PDCD4;CAMK2D;CDKN2A;PPARG
187,GO:0000405,0.581795826015679,0.806585300854175,1,7,bubble DNA binding,MF,XPC
9879,GO:0042180,0.581911177419945,0.52569814226158,15,161,cellular ketone metabolic process,BP,NQO1;IRS2;NR1D1;TYSND1;CAV1;CPT1A;ACACB;SNCA;PRKAB2;PSMB9;PDK3;DGKQ;AKR7A2;EGR1;PPARG
10419,GO:0043296,0.581957209475516,0.53563520139285,13,104,apical junction complex,CC,FRMD4B;NPHP4;PRKCZ;ANK3;SHROOM4;AMOTL1;ARHGEF2;RAB13;MPP7;AMOTL2;MAGI2;MAGI1;MPDZ
1463,GO:0003714,0.581961264827822,0.514568908499437,19,177,transcription corepressor activity,MF,NR1D1;WWTR1;DDIT3;KLF12;E2F7;RBFOX2;TLE4;LMCD1;PBXIP1;MEIS2;CITED2;NR2F2;NCOR1;NAB2;SP100;YAP1;KCNIP3;TGIF1;RARA
14845,GO:0070652,0.582028839308358,0.803331294845543,1,8,HAUS complex,CC,HAUS4
3350,GO:0007084,0.582211544079055,0.798939074714629,1,10,mitotic nuclear envelope reassembly,BP,LMNA
674,GO:0001885,0.58221576285872,0.604678951455394,5,43,endothelial cell development,BP,COL18A1;PTPRS;GPX1;PDE4D;ENG
9920,GO:0042288,0.58246685408878,0.800610043249716,1,9,MHC class I protein binding,MF,PILRB
8681,GO:0034331,0.582690002333074,0.805873150668178,1,7,cell junction maintenance,BP,F2R
8227,GO:0033010,0.583044557340655,0.809746239530293,1,6,paranodal junction,CC,NFASC
14225,GO:0061307,0.583065027965108,0.8024947826168,1,8,cardiac neural crest cell differentiation involved in heart development,BP,BMP4
14226,GO:0061308,0.583065027965108,0.8024947826168,1,8,cardiac neural crest cell development involved in heart development,BP,BMP4
5563,GO:0016581,0.583470469375172,0.706372385459405,2,15,NuRD complex,CC,CHD3;SALL2
16300,GO:0090545,0.583470469375172,0.706372385459405,2,15,CHD-type complex,CC,CHD3;SALL2
2957,GO:0006491,0.583584491826863,0.704988060730034,2,16,N-glycan processing,BP,MAN1A1;EDEM1
8042,GO:0032715,0.58383863998418,0.702646101900126,2,18,negative regulation of interleukin-6 production,BP,INPP5D;GAS6
12496,GO:0050663,0.583852914201719,0.542039677787276,11,109,cytokine secretion,BP,ITGB6;FN1;F2R;GAS6;ABCA1;PYCARD;PRKCZ;BTN3A1;ALOX15B;C5;POSTN
8662,GO:0034250,0.583969346545991,0.536400408562219,12,123,positive regulation of cellular amide metabolic process,BP,VIM;EIF2AK4;ITGA2;RBMS3;PLA2G6;CLU;CIRBP;NCOR1;PPARG;DNAJC3;PPP3CA;RXRA
446,GO:0001206,0.584284111075511,0.814714383293747,1,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,HIVEP1
19864,GO:2000377,0.584472922911133,0.541271481740501,11,111,regulation of reactive oxygen species metabolic process,BP,TGFBR2;PKD2;EGFR;TP53;XDH;CAV1;CLU;SNCA;PDK3;G6PD;PRCP
7296,GO:0031307,0.584987956747534,0.6991868574004,2,21,integral component of mitochondrial outer membrane,CC,CPT1A;DMPK
8661,GO:0034249,0.585167011577998,0.500573387487688,24,233,negative regulation of cellular amide metabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;BMP4;EIF2AK4;SORL1;ZCCHC11;CLU;CAPRIN2;ANG;CIRBP;DAPK1;PAIP2B;SNCA;CALR;NCOR1;RPL13A;PRNP;PPARG;UNK;RARA;PPP3CA;AGO4
9297,GO:0035773,0.58527247834148,0.620900616822601,4,40,insulin secretion involved in cellular response to glucose stimulus,BP,ANO1;NR1D1;PLA2G6;EFNA5
12533,GO:0050709,0.585316867041844,0.571801326022442,7,70,negative regulation of protein secretion,BP,FN1;SFRP1;F2R;GAS6;IDH2;RSAD2;PPP3CA
16763,GO:0098632,0.585422595163011,0.651864267914174,3,28,cell-cell adhesion mediator activity,MF,NFASC;ANXA2;S100A11
7724,GO:0032230,0.586206321043667,0.803054556912666,1,7,positive regulation of synaptic transmission, GABAergic,BP,OXTR
3241,GO:0006900,0.58624353232715,0.552958858093208,9,86,vesicle budding from membrane,BP,COL7A1;S100A10;SEC24D;TMED10;AREG;KLHL12;ANXA2;MIA3;DNM1P46
4068,GO:0009125,0.5863235842136,0.797449782403957,1,9,nucleoside monophosphate catabolic process,BP,DNPH1
4030,GO:0009066,0.586332937359754,0.619548875382982,4,41,aspartate family amino acid metabolic process,BP,MTHFR;THNSL2;NMNAT2;ALDH7A1
12771,GO:0051092,0.586361361077701,0.539138367458577,11,114,positive regulation of NF-kappaB transcription factor activity,BP,ROR1;TRIM38;TRIM5;PYCARD;CLU;PRKCZ;CAT;TLR3;EDA2R;TRAF1;ARHGEF2
7040,GO:0030825,0.586480825564663,0.799719381072241,1,8,positive regulation of cGMP metabolic process,BP,NOS1
11489,GO:0046007,0.586871623614772,0.799400097517482,1,8,negative regulation of activated T cell proliferation,BP,PRNP
3006,GO:0006554,0.587160840092825,0.799163573947416,1,8,lysine catabolic process,BP,ALDH7A1
300,GO:0000808,0.587245359453746,0.796689260544505,1,9,origin recognition complex,CC,ORC4
2449,GO:0005664,0.587245359453746,0.796689260544505,1,9,nuclear origin of replication recognition complex,CC,ORC4
16157,GO:0090207,0.58767972974379,0.698102350552784,2,19,regulation of triglyceride metabolic process,BP,SIK1;LMF1
10818,GO:0044332,0.588160608293985,0.811722812167356,1,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,SFRP1
2727,GO:0006109,0.58830508862513,0.520410346423847,15,131,regulation of carbohydrate metabolic process,BP,DDIT4;IRS2;NTSR1;NR1D1;SIK1;ACACB;SNCA;NCOA2;PDK3;DGKQ;ENPP1;NCOR1;LEPR;IGFBP4;PRKAG1
735,GO:0001967,0.588377444210883,0.801299750384726,1,7,suckling behavior,BP,OXTR
6575,GO:0022410,0.588449699590851,0.798107124817952,1,8,circadian sleep/wake cycle process,BP,CST3
12591,GO:0050802,0.588449699590851,0.798107124817952,1,8,circadian sleep/wake cycle, sleep,BP,CST3
14662,GO:0070307,0.58853694805964,0.798035466766538,1,8,lens fiber cell development,BP,VIM
13221,GO:0051926,0.588550584312586,0.648268640571377,3,29,negative regulation of calcium ion transport,BP,PKD2;NOS1;NTSR1
13122,GO:0051721,0.588868772802066,0.649515802549975,3,26,protein phosphatase 2A binding,MF,STAT1;TP53;PTPN1
17334,GO:1900077,0.589173600881191,0.64812802364006,3,28,negative regulation of cellular response to insulin stimulus,BP,PRKCZ;PTPN1;ENPP1
5667,GO:0016783,0.589362042255258,0.790151780622309,1,12,sulfurtransferase activity,MF,TSTD1
13469,GO:0055062,0.58940865300179,0.804706920634845,1,6,phosphate ion homeostasis,BP,ENPP1
15778,GO:0072505,0.58940865300179,0.804706920634845,1,6,divalent inorganic anion homeostasis,BP,ENPP1
15779,GO:0072506,0.58940865300179,0.804706920634845,1,6,trivalent inorganic anion homeostasis,BP,ENPP1
10056,GO:0042574,0.589467245659034,0.797270278465885,1,8,retinal metabolic process,BP,SDR16C5
18906,GO:1904683,0.589612214979405,0.804544168527312,1,6,regulation of metalloendopeptidase activity,BP,SORL1
2392,GO:0005537,0.589689299480306,0.797087330208448,1,8,mannose binding,MF,MANBA
18782,GO:1904375,0.589953510875878,0.557730349806101,8,74,regulation of protein localization to cell periphery,BP,EGFR;ACSL3;ITGA3;LRP1;PIK3R1;ARF6;PRNP;GOPC
13067,GO:0051606,0.590185538734689,0.530319262366511,12,117,detection of stimulus,BP,SERPINE2;ANO1;PKD2;NTSR1;ITGA2;FYN;HMGA2;SYT1;TTN;CD1D;OR2A4;POLD4
13656,GO:0060219,0.590367639942462,0.803939336677986,1,6,camera-type eye photoreceptor cell differentiation,BP,SOX9
10655,GO:0043922,0.590371162565921,0.794095219416384,1,9,negative regulation by host of viral transcription,BP,HMGA2
6064,GO:0019218,0.590577888823012,0.556403974948102,8,80,regulation of steroid metabolic process,BP,SNAI2;VDR;NR1D1;SEC14L2;ACACB;DGKQ;EGR1;LMF1
18555,GO:1903827,0.590631432379622,0.473084627013487,44,416,regulation of cellular protein localization,BP,GSN;GAS6;TCAF1;EGFR;PAK1;BMP4;SORL1;TP53;CEP250;ACSL3;TFDP2;ITGA3;GLI3;KCNAB2;LRP1;FYN;B3GAT3;SNX33;PTPN14;PIK3R1;HHAT;TMEM173;ANK3;HPS4;TP73;STOM;SH3TC2;LMNA;ASTN2;MDM2;ARF6;PTPN1;SSH1;PRNP;SP100;GOPC;MDFIC;DERL3;CDK5RAP3;NIPBL;TTBK2;MYO1C;C2CD5;EDEM1
4746,GO:0010922,0.590712833024481,0.649690526027317,3,23,positive regulation of phosphatase activity,BP,ITGA2;ITGA1;MAGI2
10569,GO:0043555,0.590813054478302,0.69597634589071,2,18,regulation of translation in response to stress,BP,EIF2AK4;DNAJC3
7834,GO:0032402,0.591489635647776,0.69364147058145,2,20,melanosome transport,BP,BBS2;BBS4
13212,GO:0051904,0.591489635647776,0.69364147058145,2,20,pigment granule transport,BP,BBS2;BBS4
2975,GO:0006520,0.591508918616546,0.491751244309,25,276,cellular amino acid metabolic process,BP,PRODH;NQO1;SLC7A8;NOS1;CRTAP;PHGDH;BCKDHB;ERO1B;MTHFR;CPS1;GLDC;HIBADH;AARS;BPHL;PSMB9;GCLC;ALDH4A1;THNSL2;NMNAT2;ALDH7A1;TH;SRR;GSTZ1;DPYD;ABAT
10525,GO:0043496,0.591551818839561,0.693581304875122,2,20,regulation of protein homodimerization activity,BP,ISL1;HSPA5
7429,GO:0031570,0.591612293058025,0.512860543128029,16,156,DNA integrity checkpoint,BP,XPC;EIF2AK4;TP53;TFDP2;E2F7;MAP3K14;HMGA2;TP73;CHEK2;FOXN3;ATM;MDM2;RBL2;USP28;CDK5RAP3;TAOK3
10989,GO:0044829,0.591758216347031,0.798545039389374,1,7,positive regulation by host of viral genome replication,BP,STOM
6677,GO:0030050,0.591810760522647,0.802780153569803,1,6,vesicle transport along actin filament,BP,MYO1C
17058,GO:0099622,0.592158762509642,0.696816617839992,2,16,cardiac muscle cell membrane repolarization,BP,GJA5;KCNJ5
2663,GO:0006013,0.592201506941664,0.795009340382822,1,8,mannose metabolic process,BP,MAN2B1
16042,GO:0090030,0.592681584332208,0.794610520382122,1,8,regulation of steroid hormone biosynthetic process,BP,DGKQ
6933,GO:0030551,0.592901366562632,0.696102384078488,2,16,cyclic nucleotide binding,MF,TMEM173;PDE4D
14948,GO:0070886,0.593044904800625,0.794308326987934,1,8,positive regulation of calcineurin-NFAT signaling cascade,BP,LMCD1
17179,GO:0106058,0.593044904800625,0.794308326987934,1,8,positive regulation of calcineurin-mediated signaling,BP,LMCD1
1998,GO:0004723,0.593353053128084,0.797236087699817,1,7,calcium-dependent protein serine/threonine phosphatase activity,MF,PPP3CA
17080,GO:0101003,0.593425155555085,0.613554526863923,4,37,ficolin-1-rich granule membrane,CC,SLC2A3;PRCP;NFASC;LGALS3
16789,GO:0098693,0.59345983568879,0.61506547697811,4,33,regulation of synaptic vesicle cycle,BP,SYN1;SNCA;SEPT5;MAGI2
6902,GO:0030502,0.59359155258041,0.797039817528892,1,7,negative regulation of bone mineralization,BP,SOX9
3670,GO:0008171,0.593852212822578,0.690632423792433,2,21,O-methyltransferase activity,MF,LRTOMT;PCMTD2
13146,GO:0051775,0.593952591629876,0.789142962995932,1,10,response to redox state,BP,NPAS2
18144,GO:1902936,0.594032675782101,0.563349103876846,7,66,phosphatidylinositol bisphosphate binding,MF,JPH2;HIP1;PLEK2;ASAP1;SYT1;FZD7;ANXA2
10874,GO:0044438,0.594057446666496,0.562299625455287,7,74,microbody part,CC,ACSL3;PRDX5;ALDH3A2;CAT;PXMP2;PEX1;EHHADH
10875,GO:0044439,0.594057446666496,0.562299625455287,7,74,peroxisomal part,CC,ACSL3;PRDX5;ALDH3A2;CAT;PXMP2;PEX1;EHHADH
774,GO:0002031,0.594188672773487,0.78894259553089,1,10,G-protein coupled receptor internalization,BP,HTR1B
18140,GO:1902916,0.594309037115211,0.793254402724671,1,8,positive regulation of protein polyubiquitination,BP,SKP2
9532,GO:0036310,0.594329480610822,0.793237327043236,1,8,annealing helicase activity,MF,SMARCA1
12047,GO:0048019,0.594383221253708,0.788777376130627,1,10,receptor antagonist activity,MF,DKK1
3723,GO:0008253,0.594403896774499,0.793175161504964,1,8,5'-nucleotidase activity,MF,NT5DC3
5985,GO:0018958,0.594422131560123,0.591400114664529,5,46,phenol-containing compound metabolic process,BP,SNCA;LRTOMT;TGFB2;TH;ABAT
9374,GO:0035929,0.594448664805167,0.79313775688774,1,8,steroid hormone secretion,BP,FZD4
15261,GO:0071476,0.594773547460797,0.796065094232877,1,7,cellular hypotonic response,BP,MYLK
16486,GO:0097225,0.594871878928941,0.788361980412372,1,10,sperm midpiece,CC,IFT27
1168,GO:0002792,0.595012268101788,0.561663978811632,7,71,negative regulation of peptide secretion,BP,FN1;SFRP1;F2R;GAS6;IDH2;RSAD2;PPP3CA
12814,GO:0051151,0.595331683018819,0.79560366399614,1,7,negative regulation of smooth muscle cell differentiation,BP,PDCD4
4540,GO:0010623,0.595528121078586,0.79544108319898,1,7,programmed cell death involved in cell development,BP,KITLG
17165,GO:0106018,0.595534651202434,0.696381211173096,2,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,MTMR4;PIKFYVE
4513,GO:0010571,0.595580209137263,0.799729015975339,1,6,positive regulation of nuclear cell cycle DNA replication,BP,FGFR1
10454,GO:0043368,0.595591124854756,0.692362682299173,2,17,positive T cell selection,BP,ITPKB;ZFPM1
10970,GO:0044788,0.595717992948591,0.691230860036886,2,18,modulation by host of viral process,BP,EIF2AK4;STOM
6809,GO:0030277,0.595845124696991,0.791968552383375,1,8,maintenance of gastrointestinal epithelium,BP,SOX9
8284,GO:0033129,0.59590300240525,0.791919991595556,1,8,positive regulation of histone phosphorylation,BP,ATM
7606,GO:0032007,0.595908051937263,0.611367708387245,4,36,negative regulation of TOR signaling,BP,DDIT4;SESN3;SESN1;ATM
5098,GO:0015386,0.595996207868595,0.795053298783969,1,7,potassium:proton antiporter activity,MF,SLC9A4
11977,GO:0047429,0.596156810803223,0.789231908815501,1,9,nucleoside-triphosphate diphosphatase activity,MF,ENPP1
16744,GO:0098581,0.596371485594419,0.791526623875761,1,8,detection of external biotic stimulus,BP,CD1D
17663,GO:1901568,0.596639309377351,0.541253276871155,9,97,fatty acid derivative metabolic process,BP,PTGS1;ACSL3;GPX1;PTGES;CES2;CBR1;ALOX15B;GGT7;ZADH2
5624,GO:0016709,0.596770788954341,0.689308462124633,2,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,NOS1;MICAL1
8024,GO:0032682,0.597053901576657,0.786500001953254,1,10,negative regulation of chemokine production,BP,MAP2K5
1454,GO:0003691,0.597236728258608,0.788315164668961,1,9,double-stranded telomeric DNA binding,MF,HMBOX1
16171,GO:0090232,0.597263938144192,0.790775789957156,1,8,positive regulation of spindle checkpoint,BP,NDRG1
17677,GO:1901611,0.597268046630822,0.788288535994854,1,9,phosphatidylglycerol binding,MF,PITPNC1
4702,GO:0010869,0.59766213497418,0.690349919846602,2,17,regulation of receptor biosynthetic process,BP,NR1D1;PPARG
578,GO:0001731,0.597954721582916,0.790193292560429,1,8,formation of translation preinitiation complex,BP,RPL13A
4830,GO:0014041,0.598221351327405,0.793202641074777,1,7,regulation of neuron maturation,BP,RET
10587,GO:0043587,0.598238706823161,0.789953486945054,1,8,tongue morphogenesis,BP,KRT13
10870,GO:0044431,0.598267593482056,0.450350777045267,77,717,Golgi apparatus part,CC,CTGF;ST6GALNAC2;MARCH4;SCARA3;COL7A1;CLTCL1;GAS6;DNMBP;PDGFC;MALL;SULF2;EGFR;GALNT10;SDC3;FAM198B;CSPG4;ASAP2;NSG1;SORL1;ARAP1;KIAA0319L;MUC19;PDGFA;LPCAT2;B3GAT3;FUT10;CAV1;XYLT1;UST;CHST3;GOLGB1;PIK3R1;ST6GAL2;BACE1;TLR3;MAN1A1;GLG1;SEC24D;TGFBI;SULF1;COPG2;TMED10;AREG;KLHL12;SDC2;GCNT1;TMEM50B;RAB13;FNDC3A;RNF24;GOLGA8B;NMNAT2;GAL3ST4;RAB43;DSEL;MAPK8IP3;SPPL2B;AGRN;GOPC;PIKFYVE;RHBDD2;GOLGA8N;GALNT2;TPST1;SNX9;POSTN;ARL3;MIA3;COG3;MPPE1;STEAP2;ADAM10;RHOBTB3;LITAF;GBP3;EDEM1;ABCA5
4966,GO:0015081,0.598654040912082,0.549669817745333,8,67,sodium ion transmembrane transporter activity,MF,PKD2;SLC8A1;SLC20A1;SCN8A;SCN2A;SLC24A1;SCNN1A;SLC9A4
1549,GO:0003950,0.598664113220532,0.689373179096381,2,17,NAD+ ADP-ribosyltransferase activity,MF,PARP4;PARP15
12525,GO:0050701,0.598876129553086,0.637417423014849,3,30,interleukin-1 secretion,BP,GAS6;ABCA1;PYCARD
6977,GO:0030665,0.599134199865579,0.557905577873977,7,67,clathrin-coated vesicle membrane,CC,CLTCL1;EGFR;HIP1;TBC1D5;SYT1;RASSF9;FZD4
7067,GO:0030866,0.599341372409208,0.608619579777566,4,34,cortical actin cytoskeleton organization,BP,CALR;ARF6;RAB13;WIPF1
8343,GO:0033233,0.599532811893732,0.685798508306649,2,20,regulation of protein sumoylation,BP,PIAS3;EGR1
3320,GO:0007030,0.599543476359861,0.516683048892245,13,114,Golgi organization,BP,SYNE1;CUL7;PDE4DIP;EHD3;GOLGB1;ATP8B2;TMED10;FBXW8;GOLGA8B;RAB43;GOLGA8N;OBSL1;COG3
5181,GO:0015749,0.600107618089284,0.547575440619242,8,71,monosaccharide transmembrane transport,BP,IRS2;CLTCL1;SLC2A3;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
14197,GO:0061180,0.600172920595333,0.570262692082823,6,52,mammary gland epithelium development,BP,ETV5;VDR;GPX1;GLI2;ROBO1;AREG
14008,GO:0060766,0.600310962921177,0.788197643424904,1,8,negative regulation of androgen receptor signaling pathway,BP,SFRP1
13736,GO:0060341,0.600528607876512,0.451698915284309,66,616,regulation of cellular localization,BP,ZFP36L1;F2R;ANO1;GSN;PKD2;JPH2;NOS1;GAS6;TCAF1;EGFR;SLC8A1;NTSR1;PAK1;BMP4;NR1D1;SORL1;TP53;CEP250;ACSL3;TFDP2;ITGA3;GLI3;SYN1;KCNAB2;LRP1;FYN;B3GAT3;CAV1;PLA2G6;SNX33;CAMK2D;PTPN14;PIK3R1;HHAT;TMEM173;ANK3;HPS4;TP73;STOM;SNCA;SH3TC2;LMNA;ASTN2;PDE4D;MDM2;ARF6;PTPN1;SSH1;ANXA2;SEPT5;PRNP;SP100;MAGI2;GOPC;REEP2;MDFIC;GDNF;DERL3;ABCA2;EFNA5;CDK5RAP3;NIPBL;TTBK2;MYO1C;C2CD5;EDEM1
6622,GO:0022890,0.600843574373186,0.476990872862191,29,269,inorganic cation transmembrane transporter activity,MF,ANO1;PKD2;JPH2;GAS6;SLC8A1;ORAI3;SLC20A1;SCN8A;SCN2A;KCNMA1;ANO6;KCNAB2;KCNJ15;CALHM2;KCNJ5;SLC24A1;KCNQ3;NDUFA4L2;TMEM63C;TMEM175;SLC39A11;SCNN1A;SLC9A4;ITPR2;CACNB1;KCNIP3;CACNA2D3;TUSC3;ORAI2
17223,GO:0120034,0.601313042395647,0.546183068229273,8,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ARAP1;DOCK11;ESPN;FSCN1;BBS4;CDC42EP5;AGRN;SEPT9
44,GO:0000096,0.601344353362752,0.634905321073831,3,30,sulfur amino acid metabolic process,BP,MTHFR;CPS1;GCLC
10444,GO:0043325,0.601439473942621,0.686657660467139,2,17,phosphatidylinositol-3,4-bisphosphate binding,MF,HIP1;PLEK2
1975,GO:0004693,0.601529011060623,0.634716987877632,3,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK14;CDK18;CDK19
1172,GO:0002820,0.601702734246758,0.683661484189235,2,20,negative regulation of adaptive immune response,BP,IL20RB;BCL6
4103,GO:0009162,0.601829732963652,0.780757496762979,1,11,deoxyribonucleoside monophosphate metabolic process,BP,DNPH1
17897,GO:1902237,0.601841614724914,0.782373611565297,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3
7506,GO:0031702,0.602069556744555,0.789973637711807,1,7,type 1 angiotensin receptor binding,MF,ARAP1
149,GO:0000305,0.602114959902064,0.681865063489051,2,22,response to oxygen radical,BP,NQO1;ERCC6
13959,GO:0060700,0.602212153852129,0.784054604941542,1,9,regulation of ribonuclease activity,BP,OAS2
3504,GO:0007413,0.602404443188234,0.68972819949973,2,14,axonal fasciculation,BP,SEMA5A;MEGF8
17171,GO:0106030,0.602404443188234,0.68972819949973,2,14,neuron projection fasciculation,BP,SEMA5A;MEGF8
251,GO:0000715,0.602803287666147,0.680582615949045,2,23,nucleotide-excision repair, DNA damage recognition,BP,XPC;DDB2
3634,GO:0008106,0.603285950433664,0.778129422133722,1,12,alcohol dehydrogenase (NADP+) activity,MF,AKR7A2
17529,GO:1901098,0.603422853558598,0.793271341442863,1,6,positive regulation of autophagosome maturation,BP,UVRAG
5703,GO:0016840,0.603500977683829,0.779295367699795,1,11,carbon-nitrogen lyase activity,MF,SRR
18690,GO:1904153,0.603706487237649,0.782763048705378,1,9,negative regulation of retrograde protein transport, ER to cytosol,BP,DERL3
18194,GO:1903018,0.603946155027437,0.632246673896186,3,30,regulation of glycoprotein metabolic process,BP,ITM2C;CST3;ITM2A
10710,GO:0044088,0.604349206327042,0.601980246644438,4,38,regulation of vacuole organization,BP,ANXA2;IFT88;ULK1;PIKFYVE
12574,GO:0050777,0.604432679869234,0.541576299780815,8,84,negative regulation of immune response,BP,INPP5D;IL20RB;GPX1;SERPING1;BCL6;TGFB2;PPARG;LGALS3
11346,GO:0045732,0.604697597628343,0.493330917351725,18,176,positive regulation of protein catabolic process,BP,SORL1;PRICKLE1;SNX1;LRP1;CAV1;TRIB2;SNX33;CLU;HERPUD1;MAGEF1;MDM2;GCLC;SOX9;NUB1;RNF144B;SNX9;TAF1;EDEM1
15542,GO:0072033,0.604923592794618,0.792018543988311,1,6,renal vesicle formation,BP,SOX9
3354,GO:0007093,0.605218870990752,0.501846352153378,15,152,mitotic cell cycle checkpoint,BP,CDKN2B;XPC;TP53;TFDP2;E2F7;HMGA2;TP73;CHEK2;FOXN3;ATM;MDM2;RBL2;KLHL22;CDK5RAP3;TAOK3
13080,GO:0051642,0.605276141953788,0.63582808098906,3,22,centrosome localization,BP,PLXNA2;SYNE2;FHOD1
17020,GO:0099528,0.605572341379939,0.781142590821282,1,9,G-protein coupled neurotransmitter receptor activity,MF,HTR1B
1254,GO:0003009,0.60581953807935,0.681312944659283,2,18,skeletal muscle contraction,BP,TNNI2;DMPK
20230,GO:2001212,0.605828941596321,0.786784031740355,1,7,regulation of vasculogenesis,BP,XDH
7068,GO:0030867,0.605886111024295,0.676456779694163,2,25,rough endoplasmic reticulum membrane,CC,DERL3;DNAJC3
18959,GO:1904779,0.605907222486218,0.791194415815624,1,6,regulation of protein localization to centrosome,BP,CEP250
1261,GO:0003016,0.605981845312046,0.682181136560532,2,17,respiratory system process,BP,CCBE1;TSHZ3
1398,GO:0003333,0.606195171471496,0.579185640072109,5,46,amino acid transmembrane transport,BP,SLC7A8;NTSR1;SLC7A11;SLC38A10;SLC38A2
17736,GO:1901739,0.606256446536745,0.77851826911956,1,10,regulation of myoblast fusion,BP,FLOT1
6789,GO:0030240,0.606548718776938,0.999999999999961,1,1,skeletal muscle thin filament assembly,BP,TTN
7370,GO:0031433,0.606548718776938,0.999999999999961,1,1,telethonin binding,MF,TTN
9410,GO:0035995,0.606548718776938,0.999999999999961,1,1,detection of muscle stretch,BP,TTN
10068,GO:0042588,0.606735425716394,0.780128075993501,1,9,zymogen granule,CC,TMED10
16394,GO:0097061,0.606935864442501,0.563425938016298,6,51,dendritic spine organization,BP,DLG4;ITGA3;FYN;CAPRIN2;IGF1R;PRNP
7823,GO:0032387,0.607282925157994,0.597755284322537,4,42,negative regulation of intracellular transport,BP,GAS6;SP100;MDFIC;DERL3
10042,GO:0042551,0.60735376790184,0.631444649033005,3,25,neuron maturation,BP,NFASC;RET;AGRN
13484,GO:0055083,0.607377706153829,0.683307382130042,2,15,monovalent inorganic anion homeostasis,BP,ENPP1;ABCC2
7961,GO:0032585,0.607389111083673,0.77752128825844,1,10,multivesicular body membrane,CC,NSG1
8032,GO:0032693,0.607558325959868,0.77737206692173,1,10,negative regulation of interleukin-10 production,BP,TRIB2
8447,GO:0033599,0.607617757130752,0.680559117762158,2,17,regulation of mammary gland epithelial cell proliferation,BP,GPX1;ROBO1
3720,GO:0008250,0.60781730589164,0.774113427633357,1,12,oligosaccharyltransferase complex,CC,TUSC3
8978,GO:0035112,0.607840056960557,0.789568035450556,1,6,genitalia morphogenesis,BP,NIPBL
17279,GO:0140110,0.607888829578501,0.427537392257327,153,1400,transcription regulator activity,MF,SOX6;ZFP36L1;ETV5;TSC22D1;ZFP36L2;SNAI2;MAGED1;PHF21A;TSC22D3;KLF8;RFX2;TCF7L1;TADA3;VDR;NR1D1;SMARCA2;CITED4;NR3C1;STAT1;ETV1;TP53;WWTR1;DDIT3;ZBTB20;ZC3H6;MEF2D;TFDP2;BTG1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;GLI2;RBFOX2;SLC2A4RG;SDR16C5;ZNF678;HMGA2;GOLGB1;ZSCAN18;IL31RA;PTPN14;PER1;CREB3L2;JARID2;ZKSCAN1;TP73;KLF13;PHF2;ZNF860;GATAD1;AIP;SP110;NCOA2;TLE4;TCEAL1;SETBP1;SOX13;NFATC4;FOXN3;LMCD1;DLX3;L3MBTL3;PBXIP1;PBX1;FOXL1;ZNF699;MEIS2;TCF4;CITED2;NR2F2;LMO4;ZNF449;MAF;LZTS1;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;TRERF1;HLTF;HOXA1;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;ZNF160;NAB2;ZNF302;MAML2;CARF;ZFPM1;RBL2;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;SP100;ZSCAN30;TEF;TGFB1I1;SAP30L;ZNF12;YAP1;KLF5;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;KLF7;TGIF1;ING4;RARA;HES2;HOXC5;PBX2;TAF1;TSHZ3;ZNF883;CREBRF;ETV4;HOXA2;FOS;ZBTB25;MED12;NPAS2;PRDM5;ZNF471;LITAF;RXRA;ZNF484
3627,GO:0008090,0.608037185783268,0.784894131910581,1,7,retrograde axonal transport,BP,NEFL
9187,GO:0035587,0.608073996402175,0.776916880579168,1,10,purinergic receptor signaling pathway,BP,ANO6
27,GO:0000052,0.608296283849813,0.784671588364345,1,7,citrulline metabolic process,BP,CPS1
1423,GO:0003376,0.608435262666327,0.778639268467333,1,9,sphingosine-1-phosphate signaling pathway,BP,S1PR5
16292,GO:0090520,0.608435262666327,0.778639268467333,1,9,sphingolipid mediated signaling pathway,BP,S1PR5
3499,GO:0007405,0.608478959030022,0.599597584432976,4,33,neuroblast proliferation,BP,GLI3;FGFR1;ARHGEF2;LEF1
11495,GO:0046033,0.609088045704977,0.776019814545601,1,10,AMP metabolic process,BP,PRPS2
15235,GO:0071439,0.609309609563084,0.78044990910557,1,8,clathrin complex,CC,CLTCL1
982,GO:0002440,0.6095415336965,0.51503788231093,11,113,production of molecular mediator of immune response,BP,GAS6;PRKCZ;IL31RA;TLR3;IL18;ATM;BCL6;TGFB2;ITM2A;RSAD2;GALNT2
4753,GO:0010935,0.610192868391307,0.779678525824532,1,8,regulation of macrophage cytokine production,BP,TGFB2
18168,GO:1902965,0.6106884302078,0.787154348954368,1,6,regulation of protein localization to early endosome,BP,SORL1
18169,GO:1902966,0.6106884302078,0.787154348954368,1,6,positive regulation of protein localization to early endosome,BP,SORL1
5193,GO:0015791,0.610704522071388,0.787140655282825,1,6,polyol transport,BP,PGAP1
13725,GO:0060330,0.610753914356328,0.674649447112286,2,20,regulation of response to interferon-gamma,BP,STAT1;PPARG
13729,GO:0060334,0.610753914356328,0.674649447112286,2,20,regulation of interferon-gamma-mediated signaling pathway,BP,STAT1;PPARG
7033,GO:0030817,0.610800293144664,0.675427554001511,2,19,regulation of cAMP biosynthetic process,BP,TIMP2;GPR161
6268,GO:0019869,0.610801400352764,0.779145926036863,1,8,chloride channel inhibitor activity,MF,WNK1
15974,GO:0086013,0.610821696090404,0.779128146654823,1,8,membrane repolarization during cardiac muscle cell action potential,BP,KCNJ5
9873,GO:0042169,0.610848562316385,0.628539419562343,3,24,SH2 domain binding,MF,DLC1;PAG1;AFAP1L2
16118,GO:0090160,0.611375096316036,0.778642957640501,1,8,Golgi to lysosome transport,BP,EHD3
12745,GO:0051047,0.611497242028626,0.473288740948603,24,232,positive regulation of secretion,BP,F2R;ANO1;IRS2;EGFR;NTSR1;PYCARD;ACSL3;PLA2G6;PRKCZ;CCK;SYT1;ANG;TTN;SNCA;FGFR1;ALOX15B;C5;PLA2R1;ISL1;TGFB2;GDNF;POSTN;ABAT;OXTR
19242,GO:1905456,0.612070533995561,0.781410717016536,1,7,regulation of lymphoid progenitor cell differentiation,BP,ZBTB1
9711,GO:0038179,0.612119144064679,0.62532258890964,3,27,neurotrophin signaling pathway,BP,DDIT4;SPRY2;MAGI2
5154,GO:0015697,0.612145173959148,0.777966507059725,1,8,quaternary ammonium group transport,BP,SLC38A2
1462,GO:0003713,0.6121459007004,0.466587561232988,28,260,transcription coactivator activity,MF,MAGED1;TADA3;VDR;NR1D1;SMARCA2;CITED4;WWTR1;IL31RA;PHF2;AIP;NCOA2;NFATC4;CITED2;ISL1;TRERF1;MAML2;THRA;SP100;TGFB1I1;YAP1;PPARG;MEF2A;KLF7;ING4;RARA;TAF1;MED12;RXRA
675,GO:0001886,0.612771164746393,0.780801433684132,1,7,endothelial cell morphogenesis,BP,COL18A1
15758,GO:0072401,0.612886710186783,0.542819105213053,7,72,signal transduction involved in DNA integrity checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
15762,GO:0072422,0.612886710186783,0.542819105213053,7,72,signal transduction involved in DNA damage checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
15626,GO:0072173,0.612889357569111,0.780698528120068,1,7,metanephric tubule morphogenesis,BP,SOX9
19885,GO:2000404,0.612981587698897,0.672406910578121,2,20,regulation of T cell migration,BP,PYCARD;ADAM10
20235,GO:2001224,0.613087932137472,0.679199100358527,2,14,positive regulation of neuron migration,BP,ARHGEF2;NIPBL
4042,GO:0009083,0.613114919497831,0.672272379733584,2,20,branched-chain amino acid catabolic process,BP,BCKDHB;HIBADH
7327,GO:0031348,0.613281972068751,0.51103492572464,11,114,negative regulation of defense response,BP,HTRA1;IL20RB;TKFC;PDCD4;IFIT1;GPX1;SEC14L1;SERPING1;ISL1;PPARG;CALCRL
16929,GO:0098969,0.613363781538444,0.774281334142165,1,9,neurotransmitter receptor transport to postsynaptic membrane,BP,NSG1
18424,GO:1903539,0.613363781538444,0.774281334142165,1,9,protein localization to postsynaptic membrane,BP,NSG1
18425,GO:1903540,0.613363781538444,0.774281334142165,1,9,establishment of protein localization to postsynaptic membrane,BP,NSG1
20068,GO:2000756,0.613400434349805,0.570482507335914,5,51,regulation of peptidyl-lysine acetylation,BP,NOS1;SNAI2;SDR16C5;SNCA;ISL1
5304,GO:0016018,0.613517071625585,0.772071150937861,1,10,cyclosporin A binding,MF,PPP3CA
10777,GO:0044272,0.613840195620546,0.496518895331175,14,142,sulfur compound biosynthetic process,BP,CSPG4;ACSL3;XYLT1;UST;ACSS1;CHST3;ACACB;SNCA;PDK3;GCLC;ACSS2;GGT7;DSEL;GSTZ1
974,GO:0002429,0.614029400390747,0.474041251119773,22,227,immune response-activating cell surface receptor signaling pathway,BP,INPP5D;PAK1;VAV3;MUC19;ERMAP;FYN;PLA2G6;PIK3R1;BTN3A1;PRKACB;PAG1;PDE4D;PSMB9;PRNP;VAV2;BTN3A3;GCSAM;LGALS3;WIPF1;ELMO2;MYO1C;DOCK1
10846,GO:0044389,0.614326819852722,0.463922485878185,28,283,ubiquitin-like protein ligase binding,MF,TXNIP;EGFR;ABTB1;STAT1;BTBD2;TP53;CUL9;CUL7;TRIB2;CLU;PER1;PXN;TMEM173;WFS1;PRKACB;CHEK2;FZD8;TRIOBP;TRAF1;CALR;MDM2;HLTF;STAT2;HSPA5;SNX9;FZD4;KDM4A;CDK5RAP3
18841,GO:1904526,0.614580967246707,0.773195542124545,1,9,regulation of microtubule binding,BP,TTBK2
8705,GO:0034367,0.615014843881388,0.770724488902742,1,10,protein-containing complex remodeling,BP,ABCA5
7276,GO:0031279,0.615048418036717,0.67207852661047,2,18,regulation of cyclase activity,BP,NOS1;TIMP2
12763,GO:0051084,0.615134242790816,0.619852553775001,3,32,'de novo' posttranslational protein folding,BP,HSPA2;HSPA5;UGGT2
12226,GO:0048524,0.615166012180183,0.52195327025137,9,95,positive regulation of viral process,BP,TRIM38;LGALS1;IFIT1;ADARB1;STOM;MVB12B;LEF1;SRPK2;MDFIC
588,GO:0001750,0.615189486626636,0.592148129590423,4,34,photoreceptor outer segment,CC,PTGS1;IFT140;BBS4;WDR19
11344,GO:0045727,0.615468030065206,0.514667556104561,10,105,positive regulation of translation,BP,VIM;EIF2AK4;ITGA2;RBMS3;CIRBP;NCOR1;PPARG;DNAJC3;PPP3CA;RXRA
504,GO:0001562,0.615500274469861,0.772372955803111,1,9,response to protozoan,BP,LYST
10193,GO:0042832,0.615500274469861,0.772372955803111,1,9,defense response to protozoan,BP,LYST
17010,GO:0099516,0.615516403973169,0.591013973448087,4,36,ion antiporter activity,MF,SLC8A1;SLC7A11;SLC24A1;SLC9A4
12055,GO:0048027,0.615542199384018,0.668392349406382,2,22,mRNA 5'-UTR binding,MF,IGF2BP2;RARA
10566,GO:0043551,0.615637209609485,0.62225597061847,3,26,regulation of phosphatidylinositol 3-kinase activity,BP,VAV3;PIK3R1;VAV2
7274,GO:0031272,0.615775502975584,0.772126261935113,1,9,regulation of pseudopodium assembly,BP,CDC42EP5
7275,GO:0031274,0.615775502975584,0.772126261935113,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP5
6499,GO:0021879,0.615902531742372,0.621394296487823,3,27,forebrain neuron differentiation,BP,ROBO1;DLX2;LEF1
263,GO:0000731,0.616785264999756,0.539207969895495,7,68,DNA synthesis involved in DNA repair,BP,RMI2;ATM;PRIMPOL;POLD4;UBA7;POLH;ZBTB1
6831,GO:0030306,0.617174094078117,0.78158235566877,1,6,ADP-ribosylation factor binding,MF,SORL1
252,GO:0000717,0.617232538272134,0.666671257498621,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,XPC;DDB2
8100,GO:0032799,0.617519308099591,0.668643632719548,2,19,low-density lipoprotein receptor particle metabolic process,BP,ANXA2;PPARG
11087,GO:0045125,0.61766927241334,0.768323677069494,1,10,bioactive lipid receptor activity,MF,S1PR5
4755,GO:0010939,0.617752175794276,0.664960686952483,2,24,regulation of necrotic cell death,BP,CAV1;ARHGEF2
6094,GO:0019319,0.617773668939964,0.565099701016052,5,55,hexose biosynthetic process,BP,NR1D1;SIK1;DGKQ;G6PC3;LEPR
14103,GO:0060998,0.618435540142944,0.551296051795144,6,51,regulation of dendritic spine development,BP,SDK1;PTPRS;DLG5;ASAP1;CAPRIN2;ARF6
1874,GO:0004553,0.618531571078572,0.54928207935428,6,61,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,MAN1A1;NAGLU;MANBA;HEXA;MAN2B1;EDEM1
20233,GO:2001222,0.618978540624288,0.620870354284265,3,23,regulation of neuron migration,BP,FLRT2;ARHGEF2;NIPBL
5609,GO:0016667,0.619064489450648,0.583597813084327,4,50,oxidoreductase activity, acting on a sulfur group of donors,MF,ERO1B;PDIA4;PDIA6;MSRB2
3259,GO:0006930,0.619188906650175,0.771708849221255,1,8,substrate-dependent cell migration, cell extension,BP,OPHN1
18376,GO:1903431,0.619227470193786,0.775127997550521,1,7,positive regulation of cell maturation,BP,RET
3828,GO:0008432,0.619412113872418,0.771508463279314,1,8,JUN kinase binding,MF,MAPK8IP3
10994,GO:0044848,0.61953039933565,0.771402219239001,1,8,biological phase,BP,TGFB2
10996,GO:0044851,0.61953039933565,0.771402219239001,1,8,hair cycle phase,BP,TGFB2
12370,GO:0048819,0.61953039933565,0.771402219239001,1,8,regulation of hair follicle maturation,BP,TGFB2
17815,GO:1902018,0.619566771138753,0.768708157764447,1,9,negative regulation of cilium assembly,BP,EVI5L
3481,GO:0007346,0.619619373291022,0.434738378310534,59,573,regulation of mitotic cell cycle,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;TNIK;EGFR;GJC2;TOM1L2;TIMP2;PAK1;BMP4;TP53;CEP250;CNTRL;CUL9;GPNMB;TFDP2;CUL7;BTG1;SIK1;TTC28;E2F7;CTDSPL;MAP3K14;HMGA2;KANK2;HAUS4;TMEM8B;TP73;CHEK2;FBXL7;FGFR1;PSMB9;AFAP1L2;FOXN3;PBX1;ATM;MDM2;MEIS2;MAP3K1;NRK;BCL6;PRKCA;PAK6;RBL2;MAP2K5;ODF2;FHL1;CDKN2A;MAGI2;CDK19;OBSL1;PTPN3;CTDSP2;KLHL22;CDK5RAP3;NIPBL;TAOK3
9059,GO:0035326,0.619711201518202,0.526533313148938,8,74,enhancer binding,MF,HIVEP1;SLC2A4RG;LMO4;SOX9;ISL1;TCF12;LEF1;MED12
447,GO:0001221,0.620273228607701,0.586378216151553,4,35,transcription cofactor binding,MF,NR1D1;TP53;PER1;CHD6
20005,GO:2000650,0.620494547482565,0.774001983407256,1,7,negative regulation of sodium ion transmembrane transporter activity,BP,CAMK2D
12616,GO:0050847,0.620534088512928,0.773966777540362,1,7,progesterone receptor signaling pathway,BP,YAP1
2521,GO:0005778,0.620632819582113,0.562817071237892,5,51,peroxisomal membrane,CC,ACSL3;ALDH3A2;CAT;PXMP2;PEX1
7550,GO:0031903,0.620632819582113,0.562817071237892,5,51,microbody membrane,CC,ACSL3;ALDH3A2;CAT;PXMP2;PEX1
17770,GO:1901881,0.620667176976309,0.767709078856346,1,9,positive regulation of protein depolymerization,BP,SEMA5A
12095,GO:0048172,0.620861555538247,0.773675057116194,1,7,regulation of short-term neuronal synaptic plasticity,BP,SHISA9
19993,GO:2000637,0.620872300642747,0.665224705375402,2,19,positive regulation of gene silencing by miRNA,BP,EGFR;BMP4
6093,GO:0019318,0.620914255530482,0.476313029335588,18,176,hexose metabolic process,BP,IRS2;H6PD;TKFC;NR1D1;NISCH;SIK1;FUT10;CPT1A;ACACB;NCOA2;PDK3;G6PD;DGKQ;ENPP1;G6PC3;LEPR;MAN2B1;IGFBP4
10873,GO:0044437,0.621186213713197,0.440592431921121,45,452,vacuolar part,CC,FLOT1;PYGB;CYBRD1;ANPEP;SDC3;CSPG4;NSG1;ITM2C;AHNAK;PYCARD;CTSV;SPG11;LRP1;SLC22A17;STOM;TLR3;NAGLU;LAPTM4A;MANBA;ANXA6;HEXA;CD1D;SDC2;ENPP1;SLC48A1;PRCP;TMEM50B;TMEM175;ANXA2;MAN2B1;VPS39;LIPA;SPPL2B;ULK1;AGRN;GOPC;NAPRT;ATRAID;DNAJC3;ABCA2;SBF2;LITAF;ATG16L2;ABCA5;CTSD
16993,GO:0099175,0.621657178226923,0.584911855301172,4,35,regulation of postsynapse organization,BP,FYN;CAPRIN2;SSH1;PRNP
16473,GO:0097200,0.621687394644627,0.762927238635024,1,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP14
16592,GO:0097472,0.621899551220492,0.613163918618498,3,31,cyclin-dependent protein kinase activity,MF,CDK14;CDK18;CDK19
3584,GO:0007635,0.621948321480295,0.772704926547681,1,7,chemosensory behavior,BP,WFS1
7295,GO:0031306,0.622351847928666,0.661424162724451,2,22,intrinsic component of mitochondrial outer membrane,CC,CPT1A;DMPK
14655,GO:0070300,0.622476897802699,0.664523023915505,2,18,phosphatidic acid binding,MF,JPH2;PITPNC1
14009,GO:0060767,0.6224880655098,0.76604891444375,1,9,epithelial cell proliferation involved in prostate gland development,BP,SOX9
2981,GO:0006527,0.622517240311177,0.766022244128183,1,9,arginine catabolic process,BP,NOS1
7629,GO:0032050,0.622736388211411,0.771999513773296,1,7,clathrin heavy chain binding,MF,LRP1
13463,GO:0055037,0.622988146451665,0.483478105097021,15,144,recycling endosome,CC,TNIK;NSG1;SORL1;NISCH;EHD3;FZD7;SH3TC2;ARF6;NDRG1;RAB13;OR2A4;AMOTL2;GPR161;ULK1;RASSF9
3228,GO:0006884,0.623000632013777,0.665048433069793,2,17,cell volume homeostasis,BP,KCNMA1;ANO6
2804,GO:0006266,0.623016378989927,0.660116217284741,2,23,DNA ligation,BP,LIG1;POLD4
11570,GO:0046173,0.623262204800489,0.580917931029381,4,42,polyol biosynthetic process,BP,NTSR1;ISYNA1;SNCA;ITPKB
3424,GO:0007215,0.623299441194709,0.583168160186858,4,35,glutamate receptor signaling pathway,BP,NETO1;DLG4;DAPK1;SHISA9
9097,GO:0035404,0.623421238679319,0.765194740990061,1,9,histone-serine phosphorylation,BP,HMGA2
7114,GO:0030948,0.623614535448361,0.767711490013654,1,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,PTPN1
4056,GO:0009109,0.623655352456342,0.762842299992494,1,10,coenzyme catabolic process,BP,ALDH1L2
5048,GO:0015248,0.623721198972445,0.661457676354464,2,20,sterol transporter activity,MF,ABCA1;OSBPL1A
5083,GO:0015347,0.62378953526873,0.767552372042109,1,8,sodium-independent organic anion transmembrane transporter activity,MF,SLC22A17
11856,GO:0046887,0.624057111042479,0.531066872767445,7,71,positive regulation of hormone secretion,BP,ANO1;IRS2;EGFR;PLA2G6;FGFR1;ISL1;ABAT
5834,GO:0017127,0.624066973797133,0.762461930287122,1,10,cholesterol transporter activity,MF,ABCA1
10035,GO:0042537,0.624251846636881,0.759107802582124,1,12,benzene-containing compound metabolic process,BP,TH
11397,GO:0045834,0.624334840997356,0.521129249243512,8,78,positive regulation of lipid metabolic process,BP,IRS2;NR1D1;VAV3;ACSL3;PLA2G6;CPT1A;VAV2;PPARG
360,GO:0000979,0.624357571780314,0.611476295613777,3,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,STAT1;TAF1;FOS
11879,GO:0046930,0.624471247947574,0.760346203045279,1,11,pore complex,CC,C5
16814,GO:0098751,0.624619679060236,0.613488949362807,3,25,bone cell development,BP,FBN1;ANXA2;ZFPM1
10567,GO:0043552,0.624790240797725,0.663213187696695,2,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,VAV3;VAV2
1354,GO:0003223,0.624837171334145,0.774860158719396,1,6,ventricular compact myocardium morphogenesis,BP,TGFBR3
12329,GO:0048715,0.62494771942275,0.766497266195151,1,8,negative regulation of oligodendrocyte differentiation,BP,DLX2
13464,GO:0055038,0.625021918349978,0.541906586624903,6,64,recycling endosome membrane,CC,NSG1;EHD3;FZD7;ARF6;NDRG1;RAB13
3005,GO:0006553,0.625347340601892,0.763424445508386,1,9,lysine metabolic process,BP,ALDH7A1
19045,GO:1904953,0.625454043655275,0.766034894203931,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,FZD1
8610,GO:0034143,0.625586620323745,0.763203837285562,1,9,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
18083,GO:1902750,0.625688434989741,0.517992052222559,8,97,negative regulation of cell cycle G2/M phase transition,BP,HMGA2;FBXL7;PSMB9;FOXN3;ATM;FHL1;CDK5RAP3;TAOK3
3088,GO:0006664,0.625978715796282,0.510073147799045,9,100,glycolipid metabolic process,BP,UGT8;ESYT2;ARSD;HEXA;POGLUT1;PGAP1;GAL3ST4;ITGB8;MPPE1
18402,GO:1903509,0.625978715796282,0.510073147799045,9,100,liposaccharide metabolic process,BP,UGT8;ESYT2;ARSD;HEXA;POGLUT1;PGAP1;GAL3ST4;ITGB8;MPPE1
13255,GO:0051972,0.62600806434126,0.577724675454838,4,43,regulation of telomerase activity,BP,TP53;PARP4;HMBOX1;PPARG
733,GO:0001964,0.626082809987463,0.768985958641555,1,7,startle response,BP,SLITRK6
11599,GO:0046325,0.626167218435474,0.762667914032188,1,9,negative regulation of glucose import,BP,ENPP1
6354,GO:0021542,0.626287979685169,0.765271872718567,1,8,dentate gyrus development,BP,LEF1
8560,GO:0034046,0.626509191798879,0.768599873105827,1,7,poly(G) binding,MF,ATXN1
11571,GO:0046174,0.626554643390998,0.660328352090225,2,18,polyol catabolic process,BP,TKFC;NTSR1
14810,GO:0070578,0.626724052932706,0.762153085916439,1,9,RISC-loading complex,CC,AGO4
9831,GO:0042094,0.62673773929733,0.759983047069407,1,10,interleukin-2 biosynthetic process,BP,IL18
4722,GO:0010889,0.626772143254187,0.764828035850128,1,8,regulation of sequestering of triglyceride,BP,PPARG
15963,GO:0086002,0.626872898415841,0.611813169695896,3,24,cardiac muscle cell action potential involved in contraction,BP,GJA5;CAV1;KCNJ5
11095,GO:0045141,0.627050355648524,0.764572715015566,1,8,meiotic telomere clustering,BP,ATM
16165,GO:0090220,0.627050355648524,0.764572715015566,1,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,ATM
7173,GO:0031069,0.627707708937621,0.659136097168864,2,18,hair follicle morphogenesis,BP,CTSV;TGFB2
13064,GO:0051602,0.627755434746241,0.659086690853009,2,18,response to electrical stimulus,BP,NQO1;TH
17364,GO:1900121,0.628089259238047,0.758721404511163,1,10,negative regulation of receptor binding,BP,LEF1
10705,GO:0044065,0.628106939644223,0.76360119472484,1,8,regulation of respiratory system process,BP,TSHZ3
17360,GO:1900117,0.628313063756683,0.65593999353844,2,21,regulation of execution phase of apoptosis,BP,TP53;DLC1
10813,GO:0044327,0.628373902922272,0.763355254186164,1,8,dendritic spine head,CC,DNM1P46
488,GO:0001541,0.628413689742471,0.57568830828701,4,41,ovarian follicle development,BP,MMP19;KITLG;ANG;ATM
6467,GO:0021814,0.628472104607926,0.766816265944142,1,7,cell motility involved in cerebral cortex radial glia guided migration,BP,SYNE2
8645,GO:0034219,0.628595732537533,0.517171490146091,8,73,carbohydrate transmembrane transport,BP,IRS2;CLTCL1;SLC2A3;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
7615,GO:0032025,0.629079427006614,0.75779398779872,1,10,response to cobalt ion,BP,D2HGDH
2944,GO:0006475,0.629291014516064,0.480286992787202,14,139,internal protein amino acid acetylation,BP,CPA4;NOS1;SNAI2;TADA3;SDR16C5;PER1;SNCA;JADE2;ISL1;LEF1;YEATS2;ING4;TAF1;EHHADH
16445,GO:0097157,0.630254727902887,0.761617149003164,1,8,pre-mRNA intronic binding,MF,SOX9
8177,GO:0032928,0.630359376652067,0.7548192883844,1,11,regulation of superoxide anion generation,BP,EGFR
4434,GO:0010310,0.630366824757828,0.756584248534858,1,10,regulation of hydrogen peroxide metabolic process,BP,SNCA
12866,GO:0051234,0.630425511718411,0.394699241075788,360,3430,establishment of localization,BP,SERPINE2;ITGB6;SYT8;FLOT1;FN1;PCDH7;PYGB;MMP9;TXNIP;CTGF;SFRP1;CD109;ZFP36L1;F2R;TGFBR2;ASAP3;SLC7A8;ANO1;GSN;GJA5;PKD2;PITPNM3;JPH2;SCARA3;IRS2;OSBPL10;IGF2BP2;ANPEP;PROM2;COL7A1;CLTCL1;NOS1;GAS6;TCAF1;UTRN;SAMD9L;AXL;DPYSL2;EGFR;TSC22D3;HSPA2;SPTB;SLC8A1;ORAI3;CLCA2;MYLK;SYNE3;GJC2;SLC20A1;SLC2A3;SERPINE1;ATP10D;ENDOD1;S100A10;STON2;ANXA5;PSTPIP1;ADD3;TOM1L2;ASAP2;NTSR1;TIMP2;PAK1;ABCA1;NSG1;VDR;TMC7;BMP4;NR1D1;AHNAK;SCN8A;TBC1D8;RIN2;NETO1;MRC2;NEFL;VAV3;SORL1;SCN2A;KCNMA1;TP53;ARAP1;PRICKLE1;DDIT3;PYCARD;IFIT1;WNK1;DLG4;SLC7A11;ITGA2;PDGFA;MICAL1;NISCH;TIMP1;ACSL3;HIP1;TFDP2;SIK1;EVI5L;SLC22A15;SNX1;ANO6;GLI3;CNTN1;TBC1D5;ASAP1;PLLP;SYN1;SRPX;MAGED2;SEC14L1;SPG11;KCNAB2;LRP1;FYN;XDH;B3GAT3;LTBP4;FUT10;CAV1;SLC27A1;PLA2G6;SEL1L;SNX33;SLC22A17;SLC35F3;OSBPL5;CLU;SERPING1;CXCR1;PRKCZ;OAS2;KCNJ15;EHD3;CAMK2D;GOLGB1;SYTL1;METTL7A;PTPN14;PER1;ATP8B2;EHBP1;PDIA4;CCK;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CREB3L2;CPT1A;SLC38A2;CALHM2;ACACB;PCLO;ANG;DYSF;KIF17;BBS2;HERPUD1;ANK3;WFS1;SPRY2;TTN;APLP2;HPS4;TP73;CAT;DAPK1;BTN3A1;KCNJ5;IFT140;STOM;SNCA;MME;PDIA6;VAMP1;AIP;SH3TC2;FGFR1;ALOX15B;DKK1;MLEC;PRKAB2;SEC24D;C5;ASTN2;PDE4D;TMEM129;NCOA2;TGM2;PSMB9;PLA2R1;ESYT2;G6PD;SLC24A1;CDH13;LRTOMT;ENG;BBS4;CALR;ATM;IDH2;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;AREG;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;ELMO3;NEURL1B;ZMAT3;TRAK1;SYNE2;PTPN1;KCNQ3;ARHGEF2;NDUFA4L2;KLHL12;SLC25A35;LYST;ENPP1;IFT27;ISL1;SLC27A6;BCL6;SLC48A1;PRCP;NFASC;NCOR1;G6PC3;TMEM50B;PRKCA;TMEM63C;TMEM175;ANXA2;RGS14;TMC4;RAB13;SEPT5;LEPR;MAN2B1;PGAP1;IFT88;MVB12B;TTC8;KCTD7;MOSPD2;RPL13A;ABCC2;NLGN4Y;ATXN1;HTR1B;RAB43;WDR19;SLC39A11;PRNP;TGFB2;VPS39;DNASE1L1;SCNN1A;IFT122;FHL1;SFXN3;MAPK8IP3;C2CD4C;OSBPL1A;SP100;VAV2;RHBDD1;MAGI2;AGAP1;HSPA5;TH;GOPC;SNX7;SLC9A4;CENPA;PIKFYVE;REEP2;RSAD2;CHIC2;UVRAG;NAPRT;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;FHOD1;IFT74;OPHN1;LMF1;CACNB1;GDNF;KLHL3;DERL3;PITPNC1;PPARG;CALCRL;KCNIP3;SNX9;SHISA9;ICK;TBC1D16;APOL6;POSTN;LGALS3;PTPN3;ARL3;MIA3;DNAJC3;RARA;COG3;RASSF9;SV2A;ABCA2;PRKAG1;EFNA5;FZD4;MPPE1;WIPF1;PPP3CA;ANKH;PEX1;STEAP2;ACTR1B;COX18;DNM1P46;CACNA2D3;ELMO2;ABAT;NIPBL;VPS36;KCNRG;OXTR;ADAM10;RHOBTB3;ATG16L2;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;CPT2;EDEM1;ACAA2;ABCA5;NFKBIE;CTSD;DOCK1;DMPK
798,GO:0002068,0.6305240276553,0.656212634709441,2,18,glandular epithelial cell development,BP,BMP4;RARA
2512,GO:0005768,0.63054405786206,0.418876151731851,71,679,endosome,CC,FLOT1;F2R;TNIK;CLTCL1;SAMD9L;EGFR;NSG1;SORL1;DDIT3;NISCH;SNX1;TBC1D5;LRP1;FYN;CAV1;SNX33;PRKCZ;EHD3;EHBP1;DYSF;BACE1;WDFY2;TLR3;FLOT2;FZD7;SH3TC2;DKK1;ASTN2;LAPTM4A;MTMR4;ARF6;CST3;ANXA6;SNX10;DGKQ;NEURL1B;TRAK1;CD1D;PTPN1;IFT27;SLC48A1;NDRG1;TMEM175;ANXA2;RAB13;MVB12B;NMNAT2;RAB43;RET;VPS39;OR2A4;AMOTL2;GPR161;SPPL2B;OSBPL1A;ULK1;MAGI2;SNX7;PIKFYVE;EHBP1L1;UVRAG;CALCRL;SNX9;TBC1D16;RASSF9;ABCA2;STEAP2;VPS36;LITAF;ABCA5;ZNRF1
4233,GO:0009435,0.630644949933412,0.603470358731207,3,32,NAD biosynthetic process,BP,NMRK1;NMNAT2;NAPRT
4665,GO:0010818,0.630714860897468,0.756256441910416,1,10,T cell chemotaxis,BP,ADAM10
16290,GO:0090504,0.630819559510057,0.606270173161697,3,26,epiboly,BP,COL5A1;PDPN;MEGF8
11358,GO:0045747,0.631293556883173,0.575037643670094,4,34,positive regulation of Notch signaling pathway,BP,POGLUT1;TSPAN5;MAML2;TGFB2
5733,GO:0016886,0.631505022642891,0.7555109968634,1,10,ligase activity, forming phosphoric ester bonds,MF,LIG1
9821,GO:0042074,0.631526987560891,0.768866273288091,1,6,cell migration involved in gastrulation,BP,MEGF8
17420,GO:1900223,0.631778673889678,0.768638451933909,1,6,positive regulation of amyloid-beta clearance,BP,LRP1
2454,GO:0005669,0.632034192480325,0.60089516372723,3,35,transcription factor TFIID complex,CC,TP53;TAF8;TAF1
12169,GO:0048340,0.632221611883044,0.763380750055541,1,7,paraxial mesoderm morphogenesis,BP,LEF1
17306,GO:1900015,0.632760573585835,0.652061803566292,2,20,regulation of cytokine production involved in inflammatory response,BP,PDCD4;PER1
5448,GO:0016328,0.63277469092771,0.551218774596163,5,45,lateral plasma membrane,CC,NSG1;ANK3;VANGL2;RAB13;MYO1C
367,GO:0000989,0.632827164993628,0.423000554103819,55,514,transcription factor activity, transcription factor binding,MF,MAGED1;PHF21A;TADA3;VDR;NR1D1;SMARCA2;CITED4;NR3C1;TP53;WWTR1;DDIT3;TFDP2;BTG1;KLF12;E2F7;RBFOX2;SDR16C5;HMGA2;IL31RA;PTPN14;PER1;PHF2;AIP;NCOA2;TLE4;NFATC4;LMCD1;PBXIP1;MEIS2;TCF4;CITED2;NR2F2;ISL1;NCOR1;MYBL1;TRERF1;NAB2;MAML2;THRA;SP100;TGFB1I1;SAP30L;YAP1;PPARG;PARP15;KCNIP3;MEF2A;KLF7;TGIF1;ING4;RARA;TAF1;FOS;MED12;RXRA
12318,GO:0048703,0.632974296156694,0.762686555695689,1,7,embryonic viscerocranium morphogenesis,BP,NIPBL
13077,GO:0051639,0.633066793375364,0.759000767551462,1,8,actin filament network formation,BP,FHOD3
408,GO:0001094,0.6330790445082,0.756218811924402,1,9,TFIID-class transcription factor binding,MF,TP53
7328,GO:0031349,0.633433651551422,0.442485989844648,29,297,positive regulation of defense response,BP,FLOT1;MMP2;EGFR;SERPINE1;TKFC;PAK1;NR1D1;TRIM5;PDCD4;PTPRS;PYCARD;DDX60;MUC19;ITGA2;SEC14L1;FYN;CAV1;TMEM173;PRKACB;TLR3;SNCA;TGM2;PSMB9;IL18;IFNK;CD1D;MAP3K1;CDK19;RSAD2
11213,GO:0045408,0.633521699627796,0.755801411604837,1,9,regulation of interleukin-6 biosynthetic process,BP,INPP5D
5097,GO:0015385,0.633621282878189,0.758482346386311,1,8,sodium:proton antiporter activity,MF,SLC9A4
2293,GO:0005254,0.633623131701314,0.601610752210766,3,29,chloride channel activity,MF,ANO1;CLCA2;ANO6
7797,GO:0032357,0.633690974903201,0.755641653585098,1,9,oxidized purine DNA binding,MF,MUTYH
7587,GO:0031970,0.633762359319802,0.530872503068986,6,78,organelle envelope lumen,CC,TXNIP;SORL1;PTGES;CAT;BCHE;FBXL4
7101,GO:0030911,0.633807353600982,0.75830819268046,1,8,TPR domain binding,MF,TRAK1
10403,GO:0043268,0.633928379370074,0.656375375791942,2,15,positive regulation of potassium ion transport,BP,ANO6;FHL1
7505,GO:0031701,0.634281449810474,0.757864036174375,1,8,angiotensin receptor binding,MF,ARAP1
12663,GO:0050907,0.634408271422562,0.74822793424518,1,13,detection of chemical stimulus involved in sensory perception,BP,OR2A4
3801,GO:0008385,0.634490662517144,0.754885875432627,1,9,IkappaB kinase complex,CC,PYCARD
13457,GO:0055023,0.634526004329227,0.653114482492261,2,17,positive regulation of cardiac muscle tissue growth,BP,FGFR1;TGFBR3
945,GO:0002363,0.634576032241383,0.754805090540596,1,9,alpha-beta T cell lineage commitment,BP,ZFPM1
13127,GO:0051726,0.634627981961495,0.406575854587491,104,998,regulation of cell cycle,BP,TRNP1;CTGF;SFRP1;GADD45B;CDKN2B;ZFP36L1;APBB2;XPC;PKD2;ZFP36L2;HERC5;TNIK;SKP2;GAS6;EGFR;GJC2;CCNG2;NUPR1;TOM1L2;TIMP2;PAK1;CBX5;BMP4;PTK6;EIF2AK4;PDCD4;TP53;CEP250;DDIT3;CNTRL;CUL9;ADARB1;GPNMB;TFDP2;CUL7;BTG1;SIK1;TTC28;CDK14;E2F7;CTDSPL;RMI2;MAP3K14;TP53INP1;HMGA2;KANK2;CCNI;HAUS4;UHRF2;TMEM8B;TP73;PRKACB;CHEK2;FBXL7;FGFR1;ALOX15B;PRKAB2;PSMB9;AFAP1L2;FOXN3;PBX1;BBS4;CALR;ATM;MDM2;MEIS2;CITED2;NR2F2;MAP3K1;NRK;SOX9;BCL6;NDRG1;PRKCA;CABLES2;PAK6;PRNP;TGFB2;RBL2;MAP2K5;ODF2;OR2A4;FHL1;USP28;CDKN2A;TSPYL2;MAGI2;CDK19;SRPK2;UVRAG;OBSL1;ING4;PTPN3;RARA;CCNY;TMEM67;PRKAG1;TAF1;CTDSP2;KLHL22;CDK5RAP3;CAMK2N1;NIPBL;TAOK3
17794,GO:1901978,0.634771203489425,0.754620326598052,1,9,positive regulation of cell cycle checkpoint,BP,NDRG1
6796,GO:0030252,0.634793352991524,0.761002544322442,1,7,growth hormone secretion,BP,LTBP4
16107,GO:0090140,0.63540669426292,0.651105526476083,2,18,regulation of mitochondrial fission,BP,STAT2;INF2
3311,GO:0007017,0.636164787924584,0.41396887142849,69,606,microtubule-based process,BP,MYH15;PKD2;MAP6;CEP126;STMN3;PAK1;NEFL;CEP250;TTLL11;CUL9;EFHC1;MAP2;PHLDB1;CUL7;CHD3;WDR66;SPG11;EML2;PRKCZ;HAUS4;KIF17;BBS2;CNTLN;SPRY2;CHEK2;IFT140;SNCA;LMNA;RGS2;MYO3B;BBS4;COPG2;TRAK1;SYNE2;ARHGEF2;DNAL4;IFT27;NCOR1;RGS14;WDR63;CEP68;IFT88;GOLGA8B;STK36;SPA17;WDR19;ODF2;IFT122;NPHP3;CENPA;UVRAG;CFAP54;IFT74;TACC2;TPGS1;MYO9A;DNAH1;GOLGA8N;DIXDC1;ICK;OBSL1;ARL3;TMEM67;EFNA5;PEX1;CAPN6;MYH11;TTBK2;MYO1C
17812,GO:1902004,0.636200854345572,0.753263744925674,1,9,positive regulation of amyloid-beta formation,BP,CLU
2828,GO:0006297,0.636251539265143,0.646273297019975,2,23,nucleotide-excision repair, DNA gap filling,BP,LIG1;POLD4
8101,GO:0032800,0.636610225197526,0.648872998915285,2,19,receptor biosynthetic process,BP,NR1D1;PPARG
4394,GO:0010107,0.636690339937305,0.649754671792789,2,18,potassium ion import,BP,KCNJ15;KCNJ5
2544,GO:0005815,0.636720938740662,0.414295733588372,66,612,microtubule organizing center,CC,ITGB6;FLOT1;PKD2;CEP126;EVC;NR3C1;CEP250;CNTRL;EFHC1;CCDC85B;CUL7;CHD3;TTC28;DLG5;NEK9;PDE4DIP;PLA2G6;NPHP4;PRKCZ;HAUS4;CAPRIN2;DYSF;KIF17;BBS2;CNTLN;PRKACB;IFT140;FBXL7;DZIP1L;PDE4D;TRIOBP;BBS4;BBS1;SNX10;KLHL12;IFT27;NDRG1;RGS14;CEP68;IFT88;TTC8;PODXL;ODF2;IFT122;SPPL2B;TTC12;UVRAG;TCTEX1D4;CCHCR1;IFT74;ZNF12;TACC2;TPGS1;CAPG;ICK;OBSL1;ARL3;ABCA2;TMEM67;CEP85L;ACTR1B;KLHL22;CDK5RAP3;TTBK2;LRRCC1;C2CD5
3058,GO:0006623,0.636933217011068,0.568954569231059,4,34,protein targeting to vacuole,BP,SORL1;CLU;TMEM50B;VPS13C
11663,GO:0046470,0.637024995098912,0.544423080332662,5,55,phosphatidylcholine metabolic process,BP,MBOAT2;ACSL3;LPCAT2;SLC27A1;PLA2G6
1329,GO:0003183,0.637027009448049,0.758922440348496,1,7,mitral valve morphogenesis,BP,ZFPM1
13142,GO:0051767,0.637398249148504,0.752123249860507,1,9,nitric-oxide synthase biosynthetic process,BP,STAT1
13143,GO:0051769,0.637398249148504,0.752123249860507,1,9,regulation of nitric-oxide synthase biosynthetic process,BP,STAT1
15888,GO:0072698,0.637910154771939,0.546539642183857,5,42,protein localization to microtubule cytoskeleton,BP,CEP250;GOLGB1;BBS4;SNX10;TTBK2
7862,GO:0032434,0.637964102668255,0.490559287743844,10,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,PRICKLE1;CAV1;TRIB2;CLU;HERPUD1;MDM2;GCLC;NUB1;RNF144B;TAF1
12134,GO:0048265,0.638245575930168,0.754126296152816,1,8,response to pain,BP,RET
5470,GO:0016409,0.638449060358826,0.595074326243702,3,32,palmitoyltransferase activity,MF,HHAT;CPT1A;CPT2
17927,GO:1902306,0.638572698728675,0.753815934341409,1,8,negative regulation of sodium ion transmembrane transport,BP,CAMK2D
11995,GO:0047617,0.638918490036062,0.745113511334075,1,12,acyl-CoA hydrolase activity,MF,ACOT1
12599,GO:0050811,0.639169928376209,0.750428538984594,1,9,GABA receptor binding,MF,TRAK1
14937,GO:0070862,0.639199889057647,0.748162881430933,1,10,negative regulation of protein exit from endoplasmic reticulum,BP,DERL3
6207,GO:0019731,0.639489124768922,0.739734012457845,1,17,antibacterial humoral response,BP,PLA2G6
5901,GO:0018126,0.639620575732859,0.644819146809979,2,20,protein hydroxylation,BP,CRTAP;P3H2
7833,GO:0032401,0.639647102373179,0.644010454668721,2,21,establishment of melanosome localization,BP,BBS2;BBS4
13213,GO:0051905,0.639647102373179,0.644010454668721,2,21,establishment of pigment granule localization,BP,BBS2;BBS4
26,GO:0000050,0.639664939394689,0.747713584635355,1,10,urea cycle,BP,CPS1
6183,GO:0019627,0.639664939394689,0.747713584635355,1,10,urea metabolic process,BP,CPS1
3422,GO:0007213,0.639919976956302,0.747466932505563,1,10,G-protein coupled acetylcholine receptor signaling pathway,BP,AGRN
12532,GO:0050708,0.639987582409633,0.438533038721825,27,262,regulation of protein secretion,BP,FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;EGFR;NR1D1;PYCARD;PLA2G6;PRKCZ;CPT1A;ANG;TTN;ALOX15B;C5;IDH2;ISL1;PRKCA;TGFB2;RSAD2;ITPR2;POSTN;EFNA5;PPP3CA;ABAT
17508,GO:1901030,0.640148601337097,0.592133272244058,3,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;TFDP2;TP73
11640,GO:0046426,0.640167401692692,0.593628338061806,3,31,negative regulation of JAK-STAT cascade,BP,FLRT2;FLRT3;CAV1
19020,GO:1904893,0.640167401692692,0.593628338061806,3,31,negative regulation of STAT cascade,BP,FLRT2;FLRT3;CAV1
445,GO:0001205,0.640233910011501,0.645035670052666,2,19,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D;MEF2A
13043,GO:0051574,0.640341713054803,0.755810478916623,1,7,positive regulation of histone H3-K9 methylation,BP,JARID2
6712,GO:0030131,0.64045518732737,0.594758778964479,3,28,clathrin adaptor complex,CC,EGFR;HIP1;TBC1D5
15756,GO:0072395,0.640477130240345,0.513112128191247,7,73,signal transduction involved in cell cycle checkpoint,BP,TP53;TFDP2;E2F7;CHEK2;ATM;MDM2;RBL2
3454,GO:0007269,0.640505024284131,0.504067949313086,8,75,neurotransmitter secretion,BP,SYT8;SYN1;SYTL1;SYT1;PCLO;SNCA;SEPT5;C2CD4C
17073,GO:0099643,0.640505024284131,0.504067949313086,8,75,signal release from synapse,BP,SYT8;SYN1;SYTL1;SYT1;PCLO;SNCA;SEPT5;C2CD4C
3024,GO:0006573,0.640796699324134,0.748864815782553,1,9,valine metabolic process,BP,HIBADH
20185,GO:2001135,0.640863505590374,0.75163424169654,1,8,regulation of endocytic recycling,BP,SORL1
16826,GO:0098779,0.640903293457214,0.751596220888325,1,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,VPS13C
17642,GO:1901526,0.640903293457214,0.751596220888325,1,8,positive regulation of mitophagy,BP,VPS13C
18773,GO:1904350,0.641059727919687,0.751446691482558,1,8,regulation of protein catabolic process in the vacuole,BP,LRP1
7122,GO:0030957,0.641277885086742,0.746150636308672,1,10,Tat protein binding,MF,MDFIC
17556,GO:1901213,0.641447482689561,0.748237201556611,1,9,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,BMP4
5732,GO:0016885,0.641516710503773,0.751009491737641,1,8,ligase activity, forming carbon-carbon bonds,MF,ACACB
7884,GO:0032463,0.641567298064882,0.74403961052202,1,11,negative regulation of protein homooligomerization,BP,CLU
7423,GO:0031543,0.641663161114057,0.745776234188456,1,10,peptidyl-proline dioxygenase activity,MF,P3H2
8136,GO:0032875,0.642245112588004,0.754009823081701,1,7,regulation of DNA endoreduplication,BP,E2F7
4255,GO:0009595,0.642254414060864,0.747457364136809,1,9,detection of biotic stimulus,BP,CD1D
8345,GO:0033235,0.64245082083832,0.74500951896888,1,10,positive regulation of protein sumoylation,BP,PIAS3
1421,GO:0003373,0.642706117757156,0.74986885510741,1,8,dynamin family protein polymerization involved in membrane fission,BP,DNM1P46
1422,GO:0003374,0.642706117757156,0.74986885510741,1,8,dynamin family protein polymerization involved in mitochondrial fission,BP,DNM1P46
11685,GO:0046500,0.642708348015139,0.744758464385602,1,10,S-adenosylmethionine metabolic process,BP,MTHFR
4788,GO:0010984,0.64271788010878,0.742913394272481,1,11,regulation of lipoprotein particle clearance,BP,ANXA2
12517,GO:0050690,0.642785698936833,0.640659792883512,2,21,regulation of defense response to virus by virus,BP,PACS1;FYN
16163,GO:0090218,0.642861250646837,0.643212515907828,2,18,positive regulation of lipid kinase activity,BP,VAV3;VAV2
10542,GO:0043522,0.642883550702169,0.744587559346366,1,10,leucine zipper domain binding,MF,DDIT3
14441,GO:0061842,0.643325852261558,0.594184023167541,3,24,microtubule organizing center localization,BP,PLXNA2;SYNE2;FHOD1
291,GO:0000796,0.64342533086699,0.752888266285236,1,7,condensin complex,CC,NCAPD2
13990,GO:0060742,0.643888170527382,0.748731367624914,1,8,epithelial cell differentiation involved in prostate gland development,BP,RXRA
4198,GO:0009310,0.644042913733841,0.741611837270731,1,11,amine catabolic process,BP,ALDH7A1
5621,GO:0016705,0.6446245597115,0.490761735376902,9,90,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,PTGS1;NOS1;MICAL1;P3H2;KDM4C;CYP20A1;CYP4V2;TH;KDM4A
10602,GO:0043620,0.644736459369414,0.489501600753576,9,105,regulation of DNA-templated transcription in response to stress,BP,TP53;DDIT3;PSMB9;CHD6;CITED2;EGR1;RGS14;HSPA5;TAF1
20227,GO:2001204,0.644768511334323,0.751607125886677,1,7,regulation of osteoclast development,BP,FBN1
11748,GO:0046629,0.645069761496891,0.744722313953562,1,9,gamma-delta T cell activation,BP,SOX13
5541,GO:0016540,0.645441100369422,0.742082958921796,1,10,protein autoprocessing,BP,CTSV
15858,GO:0072643,0.645609670407309,0.74419526477611,1,9,interferon-gamma secretion,BP,BTN3A1
12538,GO:0050714,0.645665913292843,0.459128070947985,15,147,positive regulation of protein secretion,BP,F2R;ANO1;IRS2;EGFR;PYCARD;PLA2G6;PRKCZ;ANG;TTN;ALOX15B;C5;ISL1;TGFB2;POSTN;ABAT
20169,GO:2001044,0.645854537607548,0.743955959542429,1,9,regulation of integrin-mediated signaling pathway,BP,TIMP1
9903,GO:0042267,0.645888264989121,0.586212860555268,3,34,natural killer cell mediated cytotoxicity,BP,ULBP1;IL18;LYST
12782,GO:0051103,0.64627684930594,0.739406319224464,1,11,DNA ligation involved in DNA repair,BP,LIG1
4085,GO:0009143,0.646302931991231,0.739380485264129,1,11,nucleoside triphosphate catabolic process,BP,ENPP1
8344,GO:0033234,0.64635851110912,0.741180060732957,1,10,negative regulation of protein sumoylation,BP,PIAS3
17721,GO:1901685,0.646377340745292,0.733586064588239,1,16,glutathione derivative metabolic process,BP,GSTZ1
17722,GO:1901687,0.646377340745292,0.733586064588239,1,16,glutathione derivative biosynthetic process,BP,GSTZ1
12915,GO:0051301,0.646774897650954,0.409348215032067,53,507,cell division,BP,TXNIP;RHOBTB2;ETV5;ZFP36L2;PDGFC;CCNG2;PAK1;NR3C1;WWTR1;CNTRL;EFHC1;PDGFA;CUL7;TTC28;CDK14;E2F7;NEK9;SNX33;HMGA2;HAUS4;NCAPD2;ANK3;CAT;CHEK2;FBXL7;FZD7;FGFR1;TRIOBP;SEPT6;BBS4;ARF6;ZNF449;VANGL2;ARHGEF2;RGS14;SEPT5;CABLES2;ANAPC16;PAK6;TGFB2;OR2A4;LIG1;LEF1;CENPA;UVRAG;DIXDC1;SNX9;ARL3;CCNY;RASA1;SEPT9;KLHL22;LRRCC1
11341,GO:0045724,0.646810640464095,0.638983304835524,2,18,positive regulation of cilium assembly,BP,BBS4;SEPT9
52,GO:0000109,0.64690567623373,0.740640420212813,1,10,nucleotide-excision repair complex,CC,XPC
18163,GO:1902959,0.646929695745312,0.745786520714603,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19153,GO:1905245,0.646929695745312,0.745786520714603,1,8,regulation of aspartic-type peptidase activity,BP,SORL1
12930,GO:0051339,0.647144767105276,0.637640741570167,2,19,regulation of lyase activity,BP,NOS1;TIMP2
509,GO:0001573,0.647590168779592,0.739964148270373,1,10,ganglioside metabolic process,BP,ITGB8
15826,GO:0072574,0.647625168096565,0.74222051317418,1,9,hepatocyte proliferation,BP,SULF2
15827,GO:0072575,0.647625168096565,0.74222051317418,1,9,epithelial cell proliferation involved in liver morphogenesis,BP,SULF2
4462,GO:0010460,0.647627780249301,0.739926950037282,1,10,positive regulation of heart rate,BP,PDE4D
17169,GO:0106027,0.647792907712691,0.519151849932703,6,53,neuron projection organization,BP,DLG4;ITGA3;FYN;CAPRIN2;IGF1R;PRNP
3681,GO:0008187,0.648238333134775,0.635580905972295,2,20,poly-pyrimidine tract binding,MF,RBMS3;ATXN1
3107,GO:0006687,0.648358639761373,0.532391039821463,5,53,glycosphingolipid metabolic process,BP,UGT8;ESYT2;ARSD;HEXA;ITGB8
12607,GO:0050821,0.648985703142304,0.463058205406968,13,133,protein stabilization,BP,FLOT1;CRTAP;HIP1;SEL1L;CLU;PIK3R1;WFS1;HPS4;CHEK2;FLOT2;CALR;COG3;TAF1
16533,GO:0097345,0.649001807947889,0.551375284368982,4,49,mitochondrial outer membrane permeabilization,BP,TP53;TFDP2;TP73;ACAA2
3227,GO:0006883,0.649085111030775,0.743683822620265,1,8,cellular sodium ion homeostasis,BP,SLC8A1
17809,GO:1901998,0.649261425974117,0.58287418135375,3,33,toxin transport,BP,SLC7A8;RAB43;HSPA5
10547,GO:0043531,0.649391329307397,0.584481895312533,3,29,ADP binding,MF,GCLC;PRPS2;PRKAG1
1526,GO:0003906,0.649437157789062,0.73340756622065,1,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,HMGA2
16516,GO:0097300,0.649660301722031,0.581718001249277,3,35,programmed necrotic cell death,BP,CAV1;TLR3;ARHGEF2
13706,GO:0060306,0.650504089900991,0.637375358042615,2,16,regulation of membrane repolarization,BP,GJA5;CAV1
17305,GO:1900006,0.650608718078825,0.516277626116641,6,52,positive regulation of dendrite development,BP,CUL7;DLG5;CAPRIN2;FBXW8;CRTC1;OBSL1
5851,GO:0017156,0.650736806920241,0.502682709450118,7,67,calcium ion regulated exocytosis,BP,SYT8;SYN1;SYTL1;SYT1;PCLO;SEPT5;C2CD4C
928,GO:0002327,0.650875550270804,0.750848361795276,1,6,immature B cell differentiation,BP,ATM
7245,GO:0031223,0.651137752263064,0.750597029650474,1,6,auditory behavior,BP,SLITRK6
16111,GO:0090150,0.651232750560529,0.435773015721411,21,265,establishment of protein localization to membrane,BP,TCAF1;EGFR;SYNE3;PAK1;NSG1;TP53;ACSL3;TFDP2;FYN;BBS2;ANK3;TP73;STOM;BBS1;RPL13A;PRNP;GOPC;REEP2;COX18;MYO1C;C2CD5
4350,GO:0009948,0.651268891037163,0.582936197532289,3,28,anterior/posterior axis specification,BP,BMP4;DDIT3;PGAP1
3550,GO:0007588,0.651271618932898,0.632291626850039,2,20,excretion,BP,KCNMA1;NFAT5
10665,GO:0043951,0.651808915322317,0.73808452802575,1,9,negative regulation of cAMP-mediated signaling,BP,RGS2
513,GO:0001578,0.651958922043643,0.530261180008588,5,45,microtubule bundle formation,BP,MAP2;BBS2;TPGS1;DNAH1;CAPN6
6687,GO:0030072,0.652047188696728,0.452418012619858,15,143,peptide hormone secretion,BP,SFRP1;ANO1;IRS2;EGFR;NR1D1;LTBP4;PLA2G6;CPT1A;PCLO;ISL1;PRKCA;ITPR2;EFNA5;PPP3CA;ABAT
16303,GO:0090557,0.652560461654347,0.744074816969293,1,7,establishment of endothelial intestinal barrier,BP,PTPRS
14887,GO:0070757,0.652621829140425,0.740204952947953,1,8,interleukin-35-mediated signaling pathway,BP,STAT1
13996,GO:0060749,0.652664227960288,0.734909423075653,1,10,mammary gland alveolus development,BP,AREG
14259,GO:0061377,0.652664227960288,0.734909423075653,1,10,mammary gland lobule development,BP,AREG
9841,GO:0042108,0.652754676907871,0.579832585543938,3,31,positive regulation of cytokine biosynthetic process,BP,TLR3;EGR1;ZFPM1
16882,GO:0098877,0.652999490896823,0.734572838811182,1,10,neurotransmitter receptor transport to plasma membrane,BP,NSG1
6242,GO:0019825,0.653217640317515,0.734353655598837,1,10,oxygen binding,MF,TH
5793,GO:0017049,0.653264765309178,0.630119491482841,2,20,GTP-Rho binding,MF,TRIOBP;CDC42EP5
1409,GO:0003344,0.653417175093199,0.748403836613357,1,6,pericardium morphogenesis,BP,FLRT3
15901,GO:0072718,0.653587786452888,0.736310780004902,1,9,response to cisplatin,BP,ADIRF
17831,GO:1902065,0.65358998770257,0.736308579446253,1,9,response to L-glutamate,BP,FYN
2636,GO:0005975,0.65360361139263,0.406658834102145,45,449,carbohydrate metabolic process,BP,PYGB;ST6GALNAC2;DDIT4;IRS2;H6PD;GALNT10;ITPK1;SLC2A3;TKFC;NTSR1;ISYNA1;NR1D1;NISCH;SIK1;B3GAT3;FUT10;CHST3;CPT1A;ACACB;PHKA2;ST6GAL2;SNCA;MLEC;GLT8D2;NCOA2;PDK3;G6PD;DHTKD1;IDH2;MANBA;DGKQ;GCLC;HEXA;AKR7A2;ENPP1;NCOR1;G6PC3;LEPR;MAN2B1;IGFBP4;GAL3ST4;UGT1A3;UGT1A6;GALNT2;PRKAG1
8579,GO:0034098,0.654007549376078,0.735890895756698,1,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,CAV1
14050,GO:0060896,0.654022667797446,0.738817107450962,1,8,neural plate pattern specification,BP,SSBP3
19015,GO:1904886,0.654410450611177,0.630750945485131,2,18,beta-catenin destruction complex disassembly,BP,CAV1;FZD1
14547,GO:0070106,0.654434378022936,0.738408139517712,1,8,interleukin-27-mediated signaling pathway,BP,STAT1
4850,GO:0014067,0.654568968281275,0.735328518260187,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2
11369,GO:0045773,0.654587695448656,0.550049779486876,4,33,positive regulation of axon extension,BP,FN1;PAK1;SEMA5A;MEGF8
6731,GO:0030157,0.654863273937105,0.737981579044595,1,8,pancreatic juice secretion,BP,WNK1
773,GO:0002029,0.655212359831814,0.728868132836597,1,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,HTR1B
6567,GO:0022401,0.655212359831814,0.728868132836597,1,12,negative adaptation of signaling pathway,BP,HTR1B
2333,GO:0005355,0.655223074594799,0.734672143696987,1,9,glucose transmembrane transporter activity,MF,SLC2A3
2516,GO:0005773,0.6552617085909,0.397062998578005,60,600,vacuole,CC,FLOT1;PYGB;CYBRD1;ANPEP;SDC3;CSPG4;NSG1;ITM2C;AHNAK;PYCARD;SNX1;TBC1D5;SRPX;CTSV;SPG11;LRP1;SLC22A17;TP53INP1;MST1R;ANK3;HPS4;CAT;STOM;TLR3;SNCA;ARSD;NAGLU;LAPTM4A;CST3;MANBA;ANXA6;HEXA;CD1D;SDC2;ENPP1;SLC48A1;PRCP;TMEM50B;TMEM175;ANXA2;MAN2B1;VPS39;LIPA;SPPL2B;ULK1;AGRN;GOPC;UVRAG;NAPRT;ATRAID;CALCRL;DNAJC3;ABCA2;SBF2;VPS36;LITAF;ATG16L2;ABCA5;CTSD;ZNRF1
3220,GO:0006873,0.655333279319617,0.412822883002756,35,342,cellular ion homeostasis,BP,F2R;PKD2;JPH2;CYBRD1;NOS1;SLC8A1;NTSR1;VDR;KCNMA1;TP53;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;HERPUD1;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;ANXA6;ENPP1;TMEM175;KCTD7;ABCC2;PRNP;SLC9A4;ITPR2;SV2A;OXTR;DMPK
2958,GO:0006493,0.655346493903175,0.479418942537278,9,86,protein O-linked glycosylation,BP,ST6GALNAC2;ADAMTSL1;GALNT10;MUC19;ADAMTS7;TRAK1;POGLUT1;GCNT1;GALNT2
7792,GO:0032352,0.655383892917709,0.732169670149935,1,10,positive regulation of hormone metabolic process,BP,EGR1
12621,GO:0050852,0.655778600106241,0.459446979331921,12,140,T cell receptor signaling pathway,BP,INPP5D;PAK1;ERMAP;FYN;PIK3R1;BTN3A1;PAG1;PDE4D;PSMB9;PRNP;BTN3A3;LGALS3
12792,GO:0051124,0.656274344856106,0.745633685754038,1,6,synaptic growth at neuromuscular junction,BP,AGRN
6205,GO:0019725,0.656387813275863,0.398151201828307,55,545,cellular homeostasis,BP,F2R;ANO1;PKD2;JPH2;IRS2;CYBRD1;NOS1;GAS6;SLC8A1;NTSR1;VDR;NR1D1;LGALS1;KCNMA1;TP53;DDIT3;DLG4;ANO6;GPX1;ERO1B;FYN;CAV1;PLA2G6;SLC22A17;TNS2;CAMK2D;PRDX5;PDIA4;PIK3R1;HERPUD1;WFS1;SNCA;PDIA6;IGF1R;PDE4D;TGM2;PDK3;SLC24A1;CALR;ANXA6;GCLC;ENPP1;TMEM175;KCTD7;ABCC2;PRNP;TH;SLC9A4;ITPR2;POLD4;SV2A;EFNA5;PPP3CA;OXTR;DMPK
614,GO:0001783,0.656512869343454,0.625034260296176,2,22,B cell apoptotic process,BP,IRS2;BCL6
7473,GO:0031648,0.656691637203047,0.545710683682088,4,38,protein destabilization,BP,GSN;SNCA;MDM2;PRNP
7314,GO:0031334,0.656693995357425,0.43320241407782,20,197,positive regulation of protein complex assembly,BP,GSN;DDB2;PAK1;TP53;PYCARD;ASAP1;CLU;ARPIN;CCK;FSCN1;RGS2;SETX;ATM;ARF6;MPP7;CDC42EP5;SNX9;TAF1;WIPF1;MYO1C
12944,GO:0051353,0.657112504870003,0.574566410725632,3,32,positive regulation of oxidoreductase activity,BP,VDR;SNCA;GDNF
7595,GO:0031987,0.65732661878212,0.735521308600846,1,8,locomotion involved in locomotory behavior,BP,FZD4
7962,GO:0032587,0.657354099165102,0.486014814639032,8,72,ruffle membrane,CC,PAK1;PDPN;SPRY2;DLC1;SPRY4;ARHGEF2;MYO1C;C2CD5
11425,GO:0045899,0.657439733370306,0.730084393008218,1,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53
6446,GO:0021772,0.657584128301202,0.629680506640534,2,16,olfactory bulb development,BP,ROBO1;DLX2
12279,GO:0048641,0.657584651889814,0.575408584408601,3,29,regulation of skeletal muscle tissue development,BP,FLOT1;TSC22D3;DKK1
7097,GO:0030904,0.657813495866866,0.625130003115031,2,20,retromer complex,CC,SNX1;TBC1D5
7468,GO:0031643,0.65796327675573,0.73488257004077,1,8,positive regulation of myelination,BP,TENM4
1666,GO:0004129,0.658011944658081,0.720257125410928,1,18,cytochrome-c oxidase activity,MF,NDUFA4L2
4944,GO:0015002,0.658011944658081,0.720257125410928,1,18,heme-copper terminal oxidase activity,MF,NDUFA4L2
5615,GO:0016676,0.658011944658081,0.720257125410928,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2
1699,GO:0004181,0.658259482079632,0.731608904529174,1,9,metallocarboxypeptidase activity,MF,CPA4
17891,GO:1902230,0.658286897628794,0.620754918261805,2,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;CLU
8248,GO:0033043,0.658365872765522,0.381181225396358,109,1012,regulation of organelle organization,BP,MMP9;CTGF;SFRP1;RHOBTB2;ASAP3;GSN;NOS1;SNAI2;SPTB;S100A10;STMN3;TOM1L2;TADA3;PAK1;BMP4;TBC1D8;TP53;ARAP1;CEP250;CUL9;PYCARD;SEMA5A;PDGFA;MAP2;PHLDB1;TFDP2;CUL7;EVI5L;GPX1;TBC1D5;ASAP1;MTHFR;CTSV;PLXNB1;PDE4DIP;EML2;LRP1;ARHGAP18;RMI2;PLA2G6;ESPN;CLU;SDR16C5;ARPIN;EHD3;CAMK2D;KANK2;PXN;PIK3R1;SYT1;HHAT;UHRF2;JARID2;HPS4;TP73;DLC1;IFT140;PHF2;SNCA;LMNA;FSCN1;RGS2;TRIOBP;KDM4C;BBS4;CALR;ATM;ARF6;AKAP13;FHOD3;SYNE2;VANGL2;ARHGEF2;SSH1;ISL1;BCL6;ANXA2;IFT88;HMBOX1;OR2A4;STAT2;CDC42EP5;ULK1;PIKFYVE;UVRAG;ARHGEF19;VPS13C;FHOD1;DIXDC1;CAPG;INF2;TBC1D16;OBSL1;TMEM67;EFNA5;WIPF1;RASA1;LIMA1;CAPN6;SEPT9;KDM4A;KLHL22;NIPBL;TTBK2;RHOBTB3;CELSR1;MYO1C;C2CD5;ACAA2
6058,GO:0019211,0.658585277189146,0.728917089243211,1,10,phosphatase activator activity,MF,B3GAT3
2474,GO:0005697,0.658686607844159,0.622634989456179,2,22,telomerase holoenzyme complex,CC,TEP1;HMBOX1
13614,GO:0060148,0.658967629754784,0.623856852514775,2,20,positive regulation of posttranscriptional gene silencing,BP,EGFR;BMP4
3941,GO:0008641,0.659161670169983,0.728328291717304,1,10,ubiquitin-like modifier activating enzyme activity,MF,UBA7
366,GO:0000988,0.659239673124389,0.395304253376929,55,519,transcription factor activity, protein binding,MF,MAGED1;PHF21A;TADA3;VDR;NR1D1;SMARCA2;CITED4;NR3C1;TP53;WWTR1;DDIT3;TFDP2;BTG1;KLF12;E2F7;RBFOX2;SDR16C5;HMGA2;IL31RA;PTPN14;PER1;PHF2;AIP;NCOA2;TLE4;NFATC4;LMCD1;PBXIP1;MEIS2;TCF4;CITED2;NR2F2;ISL1;NCOR1;MYBL1;TRERF1;NAB2;MAML2;THRA;SP100;TGFB1I1;SAP30L;YAP1;PPARG;PARP15;KCNIP3;MEF2A;KLF7;TGIF1;ING4;RARA;TAF1;FOS;MED12;RXRA
8474,GO:0033643,0.659656557479018,0.730190423106938,1,9,host cell part,CC,AXL
14616,GO:0070230,0.659771377866291,0.724186225765754,1,12,positive regulation of lymphocyte apoptotic process,BP,TP53
1706,GO:0004298,0.659918172731399,0.718262138645866,1,18,threonine-type endopeptidase activity,MF,PSMB9
14490,GO:0070003,0.659918172731399,0.718262138645866,1,18,threonine-type peptidase activity,MF,PSMB9
726,GO:0001956,0.660150077000635,0.729687969684104,1,9,positive regulation of neurotransmitter secretion,BP,SNCA
3155,GO:0006760,0.660326289981271,0.620818349354488,2,22,folic acid-containing compound metabolic process,BP,MTHFR;ALDH1L2
11379,GO:0045793,0.660390618450277,0.729442813571639,1,9,positive regulation of cell size,BP,RET
4410,GO:0010181,0.66076623821782,0.726684040409596,1,10,FMN binding,MF,NOS1
2800,GO:0006260,0.660779037817173,0.41774782069042,26,258,DNA replication,BP,PDGFC;EGFR;BMP4;PDGFA;NFIX;E2F7;KITLG;GLI2;RMI2;CHEK2;FGFR1;IGF1R;CALR;ATM;CST3;AREG;PTMS;BCL6;PRIMPOL;LIG1;TSPYL2;ORC4;POLD4;ING4;POLH;S100A11
14970,GO:0070922,0.660926835428004,0.728895694733702,1,9,small RNA loading onto RISC,BP,AGO4
13733,GO:0060338,0.661039934323237,0.571546002027311,3,29,regulation of type I interferon-mediated signaling pathway,BP,STAT1;PTPN1;STAT2
649,GO:0001840,0.661099202066691,0.731719043731567,1,8,neural plate development,BP,VANGL2
19473,GO:1990314,0.661104768794999,0.731713402250218,1,8,cellular response to insulin-like growth factor stimulus,BP,FBN1
17281,GO:0140115,0.661171217088014,0.728646062632324,1,9,export across plasma membrane,BP,SLC8A1
19707,GO:2000104,0.661173346944244,0.622314027653578,2,19,negative regulation of DNA-dependent DNA replication,BP,CHEK2;BCL6
3135,GO:0006730,0.661266029535651,0.620504805623925,2,21,one-carbon metabolic process,BP,MTHFR;ALDH1L2
2654,GO:0006000,0.661543557797908,0.723951275241026,1,11,fructose metabolic process,BP,TKFC
13087,GO:0051650,0.661691207083041,0.428038555825125,20,189,establishment of vesicle localization,BP,SYT8;COL7A1;SYN1;SPG11;PRKCZ;SYTL1;SYT1;PCLO;BBS2;SNCA;SEC24D;BBS4;TMED10;AREG;TRAK1;KLHL12;SEPT5;C2CD4C;DNM1P46;MYO1C
10097,GO:0042635,0.661767403545919,0.723719610115325,1,11,positive regulation of hair cycle,BP,TGFB2
13164,GO:0051798,0.661767403545919,0.723719610115325,1,11,positive regulation of hair follicle development,BP,TGFB2
9273,GO:0035729,0.661910805114601,0.727889507655165,1,9,cellular response to hepatocyte growth factor stimulus,BP,GCLC
7433,GO:0031577,0.662155375912079,0.568918955530365,3,32,spindle checkpoint,BP,ATM;NDRG1;KLHL22
4686,GO:0010842,0.662228285965448,0.626047230848087,2,15,retina layer formation,BP,SDK1;PTPRM
16249,GO:0090344,0.662274397349693,0.621092864238763,2,19,negative regulation of cell aging,BP,HMGA2;BCL6
9178,GO:0035578,0.662527855887745,0.500082233510917,6,70,azurophil granule lumen,CC,PYGB;PYCARD;ANXA2;MAN2B1;NAPRT;DNAJC3
7796,GO:0032356,0.662826168765359,0.724562001998171,1,10,oxidized DNA binding,MF,MUTYH
8682,GO:0034332,0.662898675012877,0.459079913609655,11,94,adherens junction organization,BP,SFRP1;S100A10;ITGA2;DLG5;ANG;LAMA5;DLC1;COL16A1;CDH13;CDH11;EFNA5
19776,GO:2000243,0.662964329595667,0.568008733596108,3,32,positive regulation of reproductive process,BP,CITED2;SOX9;OXTR
1111,GO:0002701,0.663179545852701,0.618375456152086,2,21,negative regulation of production of molecular mediator of immune response,BP,BCL6;TGFB2
11402,GO:0045839,0.663428612853221,0.536927142145771,4,42,negative regulation of mitotic nuclear division,BP,TOM1L2;BMP4;ATM;KLHL22
275,GO:0000778,0.663564382293911,0.720244326137425,1,12,condensed nuclear chromosome kinetochore,CC,CENPA
1310,GO:0003159,0.663633278972205,0.721782762606688,1,11,morphogenesis of an endothelium,BP,BMP4
14188,GO:0061154,0.663633278972205,0.721782762606688,1,11,endothelial tube morphogenesis,BP,BMP4
17980,GO:1902475,0.663802385916863,0.567950223516729,3,30,L-alpha-amino acid transmembrane transport,BP,SLC7A8;NTSR1;SLC7A11
16224,GO:0090308,0.664231404698172,0.728530254858961,1,8,regulation of methylation-dependent chromatin silencing,BP,UHRF2
9419,GO:0036010,0.664830133842245,0.61925895417854,2,18,protein localization to endosome,BP,SORL1;ARF6
17399,GO:1900180,0.665051662587193,0.476210702980011,8,83,regulation of protein localization to nucleus,BP,GAS6;BMP4;GLI3;FYN;TMEM173;LMNA;MDFIC;CDK5RAP3
8276,GO:0033116,0.665297175695397,0.513156129513266,5,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,COL7A1;CALR;TMED10;AREG;MPPE1
11982,GO:0047485,0.665441942033091,0.467474808779764,9,95,protein N-terminus binding,MF,NTSR1;TP53;PIAS3;ERCC6;SNCA;ATM;MDM2;ARF6;NIPBL
1873,GO:0004551,0.66546660268948,0.718251303777803,1,12,nucleotide diphosphatase activity,MF,ENPP1
3753,GO:0008298,0.665570552528283,0.718142079490882,1,12,intracellular mRNA localization,BP,ZFP36L1
15336,GO:0071604,0.665659057169295,0.618334374631559,2,18,transforming growth factor beta production,BP,LTBP3;TGFB2
8015,GO:0032663,0.66572167559016,0.565325654907968,3,31,regulation of interleukin-2 production,BP,IL20RB;PDE4D;PRNP
1676,GO:0004143,0.666094257600385,0.726619869888484,1,8,diacylglycerol kinase activity,MF,DGKQ
21,GO:0000038,0.666186947943818,0.612998921533454,2,24,very long-chain fatty acid metabolic process,BP,SLC27A6;ACOT1
5155,GO:0015698,0.666627113001394,0.467061721599281,9,85,inorganic anion transport,BP,ANO1;CLCA2;SLC20A1;ANO6;FGFR1;ENPP1;ABCC2;PRNP;ANKH
12649,GO:0050884,0.66667148963604,0.726025795552105,1,8,neuromuscular process controlling posture,BP,ADARB1
14707,GO:0070403,0.666770874348983,0.716878499362628,1,12,NAD+ binding,MF,PARP15
919,GO:0002315,0.667177471795948,0.725504224730279,1,8,marginal zone B cell differentiation,BP,DOCK11
8141,GO:0032880,0.66719965852492,0.380283009533987,72,693,regulation of protein localization,BP,FN1;SFRP1;F2R;ANO1;GSN;GJA5;IRS2;GAS6;TCAF1;EGFR;PAK1;BMP4;NR1D1;TRIM5;SORL1;TP53;CEP250;PYCARD;ACSL3;TFDP2;ITGA3;GLI3;KCNAB2;LRP1;FYN;B3GAT3;PLA2G6;SNX33;PRKCZ;PTPN14;PIK3R1;HHAT;TMEM173;CPT1A;ANG;ANK3;TTN;HPS4;TP73;STOM;SH3TC2;DZIP1L;LMNA;ALOX15B;C5;ASTN2;LRTOMT;IDH2;MDM2;ARF6;PTPN1;SSH1;ISL1;PRKCA;PRNP;TGFB2;SP100;GOPC;RSAD2;ITPR2;MDFIC;DERL3;POSTN;EFNA5;PPP3CA;CDK5RAP3;ABAT;NIPBL;TTBK2;MYO1C;C2CD5;EDEM1
8083,GO:0032781,0.66722290072268,0.560578237577619,3,40,positive regulation of ATPase activity,BP,DNAJB4;HSPA2;DNAL4
11019,GO:0045017,0.667391343811695,0.417596089025027,22,212,glycerolipid biosynthetic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;PDGFA;ACSL3;SIK1;LPCAT2;SLC27A1;PLA2G6;PIK3R1;ANG;FGFR1;MTMR4;ATM;DGKQ;ETNK2;PGAP1;PIKFYVE;AGPAT1;MPPE1;PIK3C2B
12061,GO:0048038,0.667427190639749,0.713647900254882,1,14,quinone binding,MF,TP53I3
9712,GO:0038180,0.667479871051909,0.725192140286049,1,8,nerve growth factor signaling pathway,BP,MAGI2
15072,GO:0071141,0.667778631370693,0.728857117095281,1,7,SMAD protein complex,CC,HMGA2
6576,GO:0022411,0.667789829241749,0.390344621538075,47,477,cellular component disassembly,BP,FLOT1;MMP2;HTRA1;FN1;MMP9;FBN1;GSN;NID1;FBN2;SNAI2;HSPA2;SPTB;STMN3;TIMP2;SEMA5A;MMP19;MICAL1;TIMP1;LIX1L;LAMC2;PDPN;NEK9;CTSV;LRP1;LAMA3;CAV1;LAMB3;IGF1R;LMNA;DKK1;FSCN1;SETX;SPATA18;TRIOBP;FZD1;CST3;DNAJC6;ARHGEF2;PRKCA;UVRAG;VPS13C;CAPG;LIMA1;CDK5RAP3;TTBK2;ADAM10;EPG5
9053,GO:0035307,0.66808419154095,0.563109726391631,3,30,positive regulation of protein dephosphorylation,BP,ITGA1;DLC1;MAGI2
7489,GO:0031672,0.668107534431564,0.573097293066103,3,18,A band,CC,TTN;OBSCN;OBSL1
14861,GO:0070679,0.668608912203816,0.733400397237631,1,6,inositol 1,4,5 trisphosphate binding,MF,ITPR2
7311,GO:0031331,0.668702229592855,0.404105323807974,30,282,positive regulation of cellular catabolic process,BP,ZFP36L1;IRS2;ZFP36L2;SESN3;EIF2AK4;PRICKLE1;SESN1;LRP1;CAV1;TRIB2;SNX33;CLU;TP53INP1;CPT1A;HERPUD1;DAPK1;SNCA;MAGEF1;ATM;MDM2;GCLC;PTPN1;ULK1;UVRAG;VPS13C;NUB1;RNF144B;SNX9;TAF1;EDEM1
1034,GO:0002544,0.668718065569906,0.714819442552573,1,12,chronic inflammatory response,BP,PTGES
12620,GO:0050851,0.6689361964414,0.436553645040305,14,161,antigen receptor-mediated signaling pathway,BP,INPP5D;PAK1;VAV3;ERMAP;FYN;PIK3R1;BTN3A1;PAG1;PDE4D;PSMB9;PRNP;BTN3A3;GCSAM;LGALS3
6705,GO:0030123,0.668936197582077,0.720621479978847,1,9,AP-3 adaptor complex,CC,VPS39
5555,GO:0016573,0.669025381773963,0.441234124244959,13,132,histone acetylation,BP,CPA4;NOS1;SNAI2;TADA3;SDR16C5;PER1;SNCA;JADE2;ISL1;LEF1;YEATS2;ING4;TAF1
3815,GO:0008417,0.669030229733059,0.718094247505939,1,10,fucosyltransferase activity,MF,FUT10
11020,GO:0045019,0.669110015371432,0.718010314395344,1,10,negative regulation of nitric oxide biosynthetic process,BP,CAV1
18799,GO:1904406,0.669110015371432,0.718010314395344,1,10,negative regulation of nitric oxide metabolic process,BP,CAV1
13029,GO:0051547,0.669193376721576,0.723418530615775,1,8,regulation of keratinocyte migration,BP,MMP9
4366,GO:0009988,0.669311662503991,0.608397410020763,2,26,cell-cell recognition,BP,SPA17;LGALS3
12987,GO:0051447,0.669316410610787,0.717793100432759,1,10,negative regulation of meiotic cell cycle,BP,PRKACB
9888,GO:0042226,0.669374587874994,0.717731850267382,1,10,interleukin-6 biosynthetic process,BP,INPP5D
10771,GO:0044262,0.669575214535624,0.41943926133892,20,191,cellular carbohydrate metabolic process,BP,PYGB;DDIT4;IRS2;ITPK1;TKFC;NTSR1;ISYNA1;NR1D1;SIK1;ACACB;PHKA2;SNCA;NCOA2;PDK3;IDH2;MANBA;DGKQ;ENPP1;LEPR;IGFBP4
15509,GO:0071941,0.66959215414371,0.715527345070556,1,11,nitrogen cycle metabolic process,BP,CPS1
1130,GO:0002720,0.669768339358896,0.60956987666096,2,23,positive regulation of cytokine production involved in immune response,BP,PRKCZ;RSAD2
5673,GO:0016791,0.669780150531871,0.416919749474775,21,206,phosphatase activity,MF,INPP5D;DUSP6;ITPK1;PTPRM;PTPRS;CTDSPL;TNS2;PTPN14;DUSP5;PTPRU;MTMR4;DNAJC6;PTPN1;NT5DC3;SSH1;G6PC3;PPM1M;PIKFYVE;PTPN3;PPP3CA;CTDSP2
4519,GO:0010586,0.669907461661271,0.610823970594079,2,21,miRNA metabolic process,BP,ZCCHC11;AGO4
20077,GO:2000772,0.669933239586607,0.560548052092949,3,31,regulation of cellular senescence,BP,HMGA2;BCL6;CDKN2A
13418,GO:0052866,0.669980733397105,0.563183121737064,3,26,phosphatidylinositol phosphate phosphatase activity,MF,INPP5D;MTMR4;PIKFYVE
11237,GO:0045504,0.670261636486909,0.716796672039044,1,10,dynein heavy chain binding,MF,WDR63
13578,GO:0060077,0.670315532167138,0.719177018818671,1,9,inhibitory synapse,CC,NLGN4Y
12039,GO:0048011,0.67058596568875,0.610875978414512,2,20,neurotrophin TRK receptor signaling pathway,BP,DDIT4;SPRY2
11304,GO:0045651,0.670726179299682,0.71874586278224,1,9,positive regulation of macrophage differentiation,BP,PRKCA
13546,GO:0060042,0.670889693316395,0.563569561604511,3,24,retina morphogenesis in camera-type eye,BP,SDK1;PTPRM;SOX9
2353,GO:0005451,0.671145391588484,0.718305182513383,1,9,monovalent cation:proton antiporter activity,MF,SLC9A4
7028,GO:0030812,0.671383611518299,0.721138476969089,1,8,negative regulation of nucleotide catabolic process,BP,DDIT4
16536,GO:0097352,0.671536899934368,0.557508591532087,3,34,autophagosome maturation,BP,LIX1L;UVRAG;EPG5
9880,GO:0042181,0.671603089502699,0.605795108756432,2,26,ketone biosynthetic process,BP,DGKQ;EGR1
8786,GO:0034504,0.671683805614668,0.414905093540178,21,204,protein localization to nucleus,BP,TXNIP;SYNE1;GAS6;BMP4;PRICKLE1;GLI3;FYN;TMEM173;LMNA;BBS4;CALR;MDM2;SYNE2;SOX9;BCL6;TAF8;SP100;PIKFYVE;MDFIC;PPP3CA;CDK5RAP3
14525,GO:0070076,0.671824306735204,0.562506968515484,3,24,histone lysine demethylation,BP,PHF2;KDM4C;KDM4A
7195,GO:0031095,0.671997410128885,0.729960017206561,1,6,platelet dense tubular network membrane,CC,ITPR2
11175,GO:0045309,0.672551067636083,0.528572636872067,4,36,protein phosphorylated amino acid binding,MF,PIK3R1;VAV2;PTPN3;RASA1
6688,GO:0030073,0.672556666771323,0.437654976198144,13,126,insulin secretion,BP,SFRP1;ANO1;IRS2;NR1D1;PLA2G6;CPT1A;PCLO;ISL1;PRKCA;ITPR2;EFNA5;PPP3CA;ABAT
9679,GO:0038093,0.672905290818174,0.43243849247634,14,154,Fc receptor signaling pathway,BP,PAK1;VAV3;FYN;PLA2G6;PIK3R1;PSMB9;MAP3K1;VAV2;WIPF1;PPP3CA;FOS;ELMO2;MYO1C;DOCK1
10493,GO:0043422,0.673235892573254,0.713643483804124,1,10,protein kinase B binding,MF,RARA
13379,GO:0052745,0.673465464215883,0.608526968120461,2,19,inositol phosphate phosphatase activity,MF,INPP5D;ITPK1
6760,GO:0030203,0.673492110789926,0.446254131963439,11,108,glycosaminoglycan metabolic process,BP,SDC3;CSPG4;B3GAT3;XYLT1;UST;CHST3;NAGLU;HEXA;SDC2;DSEL;AGRN
3278,GO:0006959,0.673796751562377,0.485855760105685,6,86,humoral immune response,BP,PLA2G6;CLU;SERPING1;C5;IFNK;IFNE
3076,GO:0006650,0.673814378803091,0.401030013623529,28,270,glycerophospholipid metabolic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;OSBPL10;EGFR;MBOAT2;PDGFA;ACSL3;LPCAT2;KITLG;FYN;SLC27A1;PLA2G6;OSBPL5;PIK3R1;PLCH2;FGFR1;MTMR4;ATM;DGKQ;ETNK2;PGAP1;EFR3A;PIKFYVE;AGPAT1;MPPE1;PIK3C2B
5713,GO:0016857,0.673962870536371,0.7128686366177,1,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,DSEL
5731,GO:0016884,0.673990473944257,0.712839183476509,1,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,CPS1
7349,GO:0031402,0.674262029170536,0.718119676319108,1,8,sodium ion binding,MF,SLC24A1
14809,GO:0070577,0.674277902532325,0.611095315532636,2,16,lysine-acetylated histone binding,MF,BRD3;TAF1
17253,GO:0140033,0.674277902532325,0.611095315532636,2,16,acetylation-dependent protein binding,MF,BRD3;TAF1
5141,GO:0015677,0.674475090626248,0.717895208856863,1,8,copper ion import,BP,STEAP2
20166,GO:2001038,0.674497156423192,0.604193071754422,2,23,regulation of cellular response to drug,BP,TP53;HMGA2
2934,GO:0006458,0.674642948629446,0.52295656216815,4,47,'de novo' protein folding,BP,HSPA2;HSPA5;PIKFYVE;UGGT2
18340,GO:1903363,0.675128160183694,0.486692875649605,6,64,negative regulation of cellular protein catabolic process,BP,ANXA2;OPHN1;ATRAID;DERL3;TAF1;CDK5RAP3
9800,GO:0042023,0.675565936914663,0.71674376335734,1,8,DNA endoreduplication,BP,E2F7
14971,GO:0070925,0.675589469982458,0.372835176587387,68,638,organelle assembly,BP,GSN;CEP126;RFX2;CEP250;WWTR1;CNTRL;EVI5L;ASAP1;SRPX;SPG11;SPATA6;NPHP4;ULK2;TP53INP1;EHD3;HAUS4;KIF17;PARVA;LAMA5;BBS2;TTN;CIRBP;HPS4;CHEK2;IFT140;DZIP1L;FSCN1;OBSCN;CCDC136;SEPT6;BBS4;BBS1;AKAP13;SNX10;FHOD3;SYNE2;VANGL2;ARHGEF2;IFT27;NCOR1;TMEM175;SEPT5;IFT88;GOLGA8B;TTC8;STK36;WDR19;ODF2;IFT122;ULK1;NPHP3;CENPA;PIKFYVE;CFAP54;IFT74;TPGS1;DNAH1;GOLGA8N;MEF2A;ICK;OBSL1;ARL3;TMEM67;SEPT9;MYH11;VPS36;TTBK2;ATG16L2
15013,GO:0070988,0.675612378569862,0.487899173796838,6,54,demethylation,BP,APOBEC3C;APOBEC3G;PHF2;APOBEC3F;KDM4C;KDM4A
12932,GO:0051341,0.675693574801547,0.501378440985454,5,55,regulation of oxidoreductase activity,BP,EGFR;VDR;CAV1;SNCA;GDNF
12331,GO:0048730,0.675747050966749,0.605012139009608,2,20,epidermis morphogenesis,BP,CTSV;TGFB2
712,GO:0001938,0.675873328174658,0.486645003841874,6,59,positive regulation of endothelial cell proliferation,BP,BMP4;SEMA5A;ANG;FGFR1;CDH13;PRKCA
12183,GO:0048385,0.675940969757996,0.708743629952404,1,11,regulation of retinoic acid receptor signaling pathway,BP,CALR
14974,GO:0070932,0.675998456303292,0.60472494597432,2,20,histone H3 deacetylation,BP,PER1;HDAC11
10891,GO:0044458,0.676008302260144,0.707007617191646,1,12,motile cilium assembly,BP,SPATA6
12705,GO:0050995,0.676226005926164,0.708436149689099,1,11,negative regulation of lipid catabolic process,BP,ACACB
13575,GO:0060074,0.676575279137624,0.712548378826537,1,9,synapse maturation,BP,NFATC4
12354,GO:0048769,0.676615038158195,0.81404277453078,1,2,sarcomerogenesis,BP,TTN
2802,GO:0006264,0.676790793818411,0.709838944286366,1,10,mitochondrial DNA replication,BP,PRIMPOL
11282,GO:0045623,0.676827917569357,0.71227830634389,1,9,negative regulation of T-helper cell differentiation,BP,BCL6
2711,GO:0006089,0.676930462534516,0.707675138444277,1,11,lactate metabolic process,BP,D2HGDH
12818,GO:0051155,0.677544612685355,0.550991645303626,3,33,positive regulation of striated muscle cell differentiation,BP,FLOT1;BMP4;THRA
4059,GO:0009112,0.677584082420755,0.55020933743202,3,35,nucleobase metabolic process,BP,XDH;CPS1;DPYD
19119,GO:1905146,0.677608855184052,0.711442218473776,1,9,lysosomal protein catabolic process,BP,LRP1
2987,GO:0006534,0.677771543627933,0.706764507023633,1,11,cysteine metabolic process,BP,GCLC
9668,GO:0038063,0.677920913772967,0.718328872647869,1,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,COL4A1
11747,GO:0046628,0.678036537051496,0.714122233928547,1,8,positive regulation of insulin receptor signaling pathway,BP,PRKCZ
6030,GO:0019104,0.678365094436128,0.700799246236076,1,15,DNA N-glycosylase activity,MF,MUTYH
9778,GO:0040015,0.678406537542606,0.710586234454098,1,9,negative regulation of multicellular organism growth,BP,BBS2
9627,GO:0036513,0.678499532098269,0.707996220007392,1,10,Derlin-1 retrotranslocation complex,CC,SEL1L
4339,GO:0009895,0.678635437555887,0.407239256721021,21,208,negative regulation of catabolic process,BP,SERPINE2;DDIT4;EGFR;TIMP2;TIMP1;FYN;ACACB;CIRBP;SNCA;CST3;LZTS1;ANXA2;LEPR;OPHN1;GDNF;ATRAID;DERL3;PTPN3;TAF1;KDM4A;CDK5RAP3
17800,GO:1901985,0.678658139528965,0.549325994894655,3,34,positive regulation of protein acetylation,BP,NOS1;SNAI2;ISL1
9108,GO:0035437,0.67868793932595,0.705769814385331,1,11,maintenance of protein localization in endoplasmic reticulum,BP,HSPA5
12547,GO:0050728,0.678813848521948,0.482087836285299,6,67,negative regulation of inflammatory response,BP,IL20RB;PDCD4;GPX1;ISL1;PPARG;CALCRL
8697,GO:0034356,0.678824715389124,0.707644502897502,1,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT
12325,GO:0048711,0.678861229164866,0.70558142268608,1,11,positive regulation of astrocyte differentiation,BP,SERPINE2
15508,GO:0071936,0.679176289017434,0.712906421113469,1,8,coreceptor activity involved in Wnt signaling pathway,MF,ROR1
17849,GO:1902110,0.679179453526623,0.516936164047575,4,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;TFDP2;TP73;ACAA2
6487,GO:0021854,0.679523276525167,0.704860810735649,1,11,hypothalamus development,BP,LEF1
10146,GO:0042752,0.679655892622517,0.470546097340135,7,66,regulation of circadian rhythm,BP,MAGED1;NR1D1;TP53;SIK1;PER1;CRTC1;PPARG
4547,GO:0010633,0.679848484056636,0.498095853608241,5,48,negative regulation of epithelial cell migration,BP,PTPRM;NR2F2;MAP2K5;SP100;PPARG
8731,GO:0034397,0.679961190446683,0.708912215118529,1,9,telomere localization,BP,ATM
159,GO:0000323,0.680075301534693,0.37504127195638,51,518,lytic vacuole,CC,FLOT1;PYGB;CYBRD1;ANPEP;SDC3;CSPG4;NSG1;ITM2C;AHNAK;PYCARD;SNX1;CTSV;SPG11;LRP1;ANK3;HPS4;CAT;STOM;TLR3;SNCA;ARSD;NAGLU;LAPTM4A;CST3;MANBA;ANXA6;HEXA;CD1D;SDC2;ENPP1;SLC48A1;PRCP;TMEM175;ANXA2;MAN2B1;VPS39;LIPA;SPPL2B;AGRN;GOPC;UVRAG;NAPRT;ATRAID;CALCRL;DNAJC3;ABCA2;VPS36;LITAF;ABCA5;CTSD;ZNRF1
2508,GO:0005764,0.680075301534693,0.37504127195638,51,518,lysosome,CC,FLOT1;PYGB;CYBRD1;ANPEP;SDC3;CSPG4;NSG1;ITM2C;AHNAK;PYCARD;SNX1;CTSV;SPG11;LRP1;ANK3;HPS4;CAT;STOM;TLR3;SNCA;ARSD;NAGLU;LAPTM4A;CST3;MANBA;ANXA6;HEXA;CD1D;SDC2;ENPP1;SLC48A1;PRCP;TMEM175;ANXA2;MAN2B1;VPS39;LIPA;SPPL2B;AGRN;GOPC;UVRAG;NAPRT;ATRAID;CALCRL;DNAJC3;ABCA2;VPS36;LITAF;ABCA5;CTSD;ZNRF1
5076,GO:0015318,0.680095876407302,0.381420448943596,41,396,inorganic molecular entity transmembrane transporter activity,MF,SLC7A8;ANO1;PKD2;JPH2;GAS6;SLC8A1;ORAI3;CLCA2;SLC20A1;SCN8A;SCN2A;KCNMA1;DLG4;SLC7A11;ANO6;KCNAB2;SLC27A1;SLC22A17;KCNJ15;SLC38A10;SLC38A2;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;SLC27A6;TMEM63C;TMEM175;ABCC2;SLC39A11;SCNN1A;SLC9A4;ITPR2;CACNB1;KCNIP3;ANKH;CACNA2D3;TUSC3;ORAI2
1073,GO:0002643,0.680483820610503,0.708347748073356,1,9,regulation of tolerance induction,BP,TGFBR2
8813,GO:0034612,0.680634755263117,0.411104926931341,18,212,response to tumor necrosis factor,BP,TNFRSF6B;SFRP1;ZFP36L1;ZFP36L2;GAS6;STAT1;PYCARD;MAP3K14;ADAMTS7;PSMB9;EDA2R;TRAF1;ARHGEF2;ABCC2;SPPL2B;NUB1;POSTN;ADAM10
14368,GO:0061647,0.681119578565966,0.518369893851817,4,37,histone H3-K9 modification,BP,JARID2;KDM4C;KDM4A;PRDM5
6736,GO:0030163,0.681126341505476,0.364655637519504,75,741,protein catabolic process,BP,SERPINE2;SKP2;EGFR;RNF213;RNF165;TIMP2;NR1D1;ABTB1;BTBD2;SORL1;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;TIMP1;CUL7;SNX1;GPX1;CTSV;LRP1;FYN;CAV1;TRIB2;SEL1L;SNX33;CLU;FBXW4;HERPUD1;WFS1;CHEK2;BACE1;FBXL7;SNCA;ADAMTS7;TMEM129;PSMB9;SPATA18;MAGEF1;ATM;MDM2;CST3;MANBA;GCLC;SOX9;ANXA2;RNF24;MVB12B;ANAPC16;USP28;RHBDD1;HSPA5;TGFB1I1;OPHN1;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;SNX9;PTPN3;DNAJC3;TMEM67;TAF1;CDK5RAP3;SCPEP1;FBXL4;UGGT2;VPS36;EDEM1;GID4;CTSD;ZNRF1
3795,GO:0008376,0.681268357477734,0.546684061774272,3,33,acetylgalactosaminyltransferase activity,MF,GALNT10;EXTL2;GALNT2
18119,GO:1902883,0.681457062430324,0.545725765329968,3,35,negative regulation of response to oxidative stress,BP,GPX1;FZD1;GGT7
3111,GO:0006691,0.681464541952182,0.70105313249711,1,12,leukotriene metabolic process,BP,GGT7
6939,GO:0030575,0.6814971602856,0.707250830589833,1,9,nuclear body organization,BP,SRPK2
7866,GO:0032438,0.681550000326495,0.596761921749941,2,22,melanosome organization,BP,HPS4;LYST
19808,GO:2000300,0.68163920199409,0.599168588729043,2,19,regulation of synaptic vesicle exocytosis,BP,SYN1;SEPT5
7746,GO:0032273,0.681720085896864,0.449362716116131,9,94,positive regulation of protein polymerization,BP,GSN;PAK1;PYCARD;ARPIN;RGS2;ARF6;CDC42EP5;WIPF1;MYO1C
18876,GO:1904591,0.681736795448438,0.547948415023652,3,29,positive regulation of protein import,BP,GLI3;TMEM173;LRTOMT
17665,GO:1901570,0.682060258597768,0.493416592915443,5,59,fatty acid derivative biosynthetic process,BP,PTGS1;ACSL3;PTGES;CBR1;GGT7
2843,GO:0006323,0.682234499692743,0.421693585338349,14,167,DNA packaging,BP,TP53;TNRC18;HMGA2;NCAPD2;TTN;GATAD1;SOX9;BAHCC1;CDKN2A;TSPYL2;TSPYL4;CENPA;HP1BP3;NIPBL
9052,GO:0035306,0.682285976959409,0.516323939717986,4,39,positive regulation of dephosphorylation,BP,ITGA2;ITGA1;DLC1;MAGI2
6471,GO:0021819,0.682498498583177,0.703647800704307,1,10,layer formation in cerebral cortex,BP,GLI3
20204,GO:2001170,0.682800649111945,0.705835045619013,1,9,negative regulation of ATP biosynthetic process,BP,DDIT4
6548,GO:0021988,0.68302024149507,0.599779687822615,2,17,olfactory lobe development,BP,ROBO1;DLX2
7832,GO:0032400,0.683111725262984,0.594266722939516,2,23,melanosome localization,BP,BBS2;BBS4
13188,GO:0051875,0.683111725262984,0.594266722939516,2,23,pigment granule localization,BP,BBS2;BBS4
16475,GO:0097202,0.683119208396408,0.699228821449395,1,12,activation of cysteine-type endopeptidase activity,BP,PYCARD
10372,GO:0043225,0.68330875293112,0.708463806929948,1,8,ATPase-coupled anion transmembrane transporter activity,MF,ABCC2
16985,GO:0099133,0.68330875293112,0.708463806929948,1,8,ATP hydrolysis coupled anion transmembrane transport,BP,ABCC2
12539,GO:0050715,0.683383902839935,0.477004939782149,6,66,positive regulation of cytokine secretion,BP,F2R;PYCARD;PRKCZ;ALOX15B;C5;POSTN
2811,GO:0006273,0.683597227695788,0.700396008457825,1,11,lagging strand elongation,BP,LIG1
11321,GO:0045668,0.683601114020444,0.546323160930679,3,28,negative regulation of osteoblast differentiation,BP,SFRP1;AREG;TWIST2
61,GO:0000124,0.68408517651794,0.69673085194296,1,13,SAGA complex,CC,TADA3
4999,GO:0015149,0.684537487298263,0.701411104707013,1,10,hexose transmembrane transporter activity,MF,SLC2A3
15934,GO:0080008,0.685095335041161,0.542637555729343,3,32,Cul4-RING E3 ubiquitin ligase complex,CC,DDB2;DCAF16;DCAF8
6642,GO:0023058,0.685175278988039,0.695516969811483,1,13,adaptation of signaling pathway,BP,HTR1B
5425,GO:0016289,0.685233347809586,0.694229547494193,1,14,CoA hydrolase activity,MF,ACOT1
3770,GO:0008328,0.685239612022705,0.596038204390326,2,18,ionotropic glutamate receptor complex,CC,DLG4;SHISA9
16883,GO:0098878,0.685239612022705,0.596038204390326,2,18,neurotransmitter receptor complex,CC,DLG4;SHISA9
10152,GO:0042759,0.685427716323224,0.702965191073096,1,9,long-chain fatty acid biosynthetic process,BP,ALOX15B
12725,GO:0051020,0.685700692887839,0.365028602645685,61,520,GTPase binding,MF,ASAP3;IRS2;DNMBP;DOCK9;EGFR;SPTB;DOCK5;ALS2CL;ASAP2;PAK1;ABCA1;SRGAP3;TBC1D8;RIN2;NEFL;VAV3;SORL1;ARAP1;PLEKHG3;ARHGEF1;DLG4;PDGFA;MICAL1;DOCK4;EVI5L;KITLG;TBC1D5;ASAP1;FYN;ARHGEF12;CAV1;DOCK11;IQSEC2;CAMK2D;SYTL1;HPS4;FGFR1;OBSCN;ARHGEF17;TRIOBP;SRGAP1;AKAP13;FGD4;ARHGEF2;NDRG1;ANXA2;PAK6;RET;CDC42EP5;ULK1;VAV2;AGAP1;ARHGEF19;GDNF;INF2;TBC1D16;SBF2;RASA1;RHOBTB3;MYO1C;DOCK1
15560,GO:0072070,0.685947113834996,0.702395172641546,1,9,loop of Henle development,BP,PKD2
2310,GO:0005310,0.686127343569477,0.593032294727456,2,20,dicarboxylic acid transmembrane transporter activity,MF,SLC7A11;ABCC2
6273,GO:0019883,0.686132307713432,0.697591034813342,1,11,antigen processing and presentation of endogenous antigen,BP,CD1D
368,GO:0000990,0.686537763406943,0.701745902347046,1,9,transcription factor activity, core RNA polymerase binding,MF,TP53
11666,GO:0046474,0.686861762964999,0.400475327725405,20,194,glycerophospholipid biosynthetic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;PDGFA;ACSL3;LPCAT2;SLC27A1;PLA2G6;PIK3R1;FGFR1;MTMR4;ATM;DGKQ;ETNK2;PGAP1;PIKFYVE;AGPAT1;MPPE1;PIK3C2B
10222,GO:0042974,0.686919041512452,0.593040671271603,2,19,retinoic acid receptor binding,MF,VDR;PPARG
7563,GO:0031936,0.687259066265105,0.70416608973984,1,8,negative regulation of chromatin silencing,BP,PHF2
5614,GO:0016675,0.68739919104462,0.687633940686394,1,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2
17797,GO:1901981,0.68755775859966,0.430612362760242,11,107,phosphatidylinositol phosphate binding,MF,JPH2;ARAP1;HIP1;PLEK2;ASAP1;OSBPL5;SYT1;FZD7;ANXA2;SAP30L;VPS36
8094,GO:0032793,0.687568854195878,0.698061168098311,1,10,positive regulation of CREB transcription factor activity,BP,CRTC1
14608,GO:0070208,0.687723163202902,0.697889849777226,1,10,protein heterotrimerization,BP,C1QTNF6
10030,GO:0042532,0.687813541012949,0.695719414966096,1,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,CAV1
11250,GO:0045579,0.688197269838373,0.697363000309785,1,10,positive regulation of B cell differentiation,BP,INPP5D
11418,GO:0045876,0.688355014884353,0.697187545048241,1,10,positive regulation of sister chromatid cohesion,BP,NIPBL
10059,GO:0042578,0.688408554996903,0.386508369222883,27,265,phosphoric ester hydrolase activity,MF,INPP5D;DUSP6;ITPK1;PTPRM;PTPRS;CTDSPL;TNS2;PTPN14;DUSP5;PLCH2;PTPRU;PDE4D;MTMR4;DNAJC6;PTPN1;NT5DC3;SSH1;ENPP1;PLD3;G6PC3;PGAP1;PPM1M;PIKFYVE;PTPN3;MPPE1;PPP3CA;CTDSP2
18420,GO:1903532,0.688577764614576,0.394346656468526,22,220,positive regulation of secretion by cell,BP,F2R;ANO1;IRS2;EGFR;NTSR1;PYCARD;PLA2G6;PRKCZ;CCK;SYT1;ANG;TTN;SNCA;FGFR1;ALOX15B;C5;ISL1;TGFB2;GDNF;POSTN;ABAT;OXTR
14479,GO:0062014,0.689445575866602,0.470324943940631,6,64,negative regulation of small molecule metabolic process,BP,DDIT4;SNAI2;SIK1;ACACB;SNCA;LEPR
8833,GO:0034643,0.689570465827445,0.589938454695921,2,19,establishment of mitochondrion localization, microtubule-mediated,BP,NEFL;TRAK1
11985,GO:0047497,0.689570465827445,0.589938454695921,2,19,mitochondrion transport along microtubule,BP,NEFL;TRAK1
10650,GO:0043902,0.689730613126813,0.417772305578976,13,143,positive regulation of multi-organism process,BP,TRIM38;LGALS1;IFIT1;DDX60;ADARB1;STOM;PRKCA;MVB12B;LEF1;SRPK2;MDFIC;SASH1;OXTR
12904,GO:0051287,0.68986664184549,0.504342557017213,4,52,NAD binding,MF,PHGDH;HIBADH;IDH2;PARP15
6664,GO:0030032,0.689951194792622,0.486207169525418,5,49,lamellipodium assembly,BP,VAV3;FSCN1;CDH13;SSH1;VAV2
12577,GO:0050780,0.690483871821385,0.694811761380313,1,10,dopamine receptor binding,MF,DLG4
8172,GO:0032922,0.690509576754889,0.486581357692985,5,45,circadian regulation of gene expression,BP,MAGED1;NR1D1;PER1;NCOA2;NPAS2
19717,GO:2000114,0.690976007298654,0.589336424139649,2,18,regulation of establishment of cell polarity,BP,GSN;FLOT2
2479,GO:0005720,0.690990895606653,0.535312382395122,3,33,nuclear heterochromatin,CC,CBX5;UHRF2;CENPA
9579,GO:0036452,0.690992307186553,0.583294979436746,2,26,ESCRT complex,CC,MVB12B;VPS36
2702,GO:0006071,0.691322311888792,0.691783761379225,1,11,glycerol metabolic process,BP,TKFC
3722,GO:0008252,0.691353459591791,0.69383705306952,1,10,nucleotidase activity,MF,NT5DC3
9267,GO:0035722,0.691740663751624,0.53216203024338,3,40,interleukin-12-mediated signaling pathway,BP,PDCD4;AIP;ANXA2
15173,GO:0071349,0.691740663751624,0.53216203024338,3,40,cellular response to interleukin-12,BP,PDCD4;AIP;ANXA2
874,GO:0002228,0.69185476507594,0.533207563349361,3,36,natural killer cell mediated immunity,BP,ULBP1;IL18;LYST
3358,GO:0007097,0.691889194211109,0.590790254584441,2,16,nuclear migration,BP,SYNE2;FHOD1
5327,GO:0016064,0.691895462357018,0.482361916089253,5,57,immunoglobulin mediated immune response,BP,INPP5D;CLU;SERPING1;C5;BCL6
6204,GO:0019724,0.691895462357018,0.482361916089253,5,57,B cell mediated immunity,BP,INPP5D;CLU;SERPING1;C5;BCL6
3628,GO:0008091,0.692088284808968,0.708825071675896,1,6,spectrin,CC,SPTB
16010,GO:0086069,0.69219582859559,0.695468908274151,1,9,bundle of His cell to Purkinje myocyte communication,BP,GJA5
2196,GO:0005072,0.692341391019387,0.698562431754488,1,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,ENG
9802,GO:0042026,0.692518358840183,0.582018965478239,2,25,protein refolding,BP,HSPA2;HSPA5
18777,GO:1904354,0.693026251454889,0.697800845323341,1,8,negative regulation of telomere capping,BP,ATM
17743,GO:1901797,0.693375020845888,0.581002083504714,2,25,negative regulation of signal transduction by p53 class mediator,BP,SNAI2;MDM2
3758,GO:0008306,0.693392613659944,0.503059819969227,4,40,associative learning,BP,NETO1;MEIS2;RGS14;FOS
76,GO:0000153,0.693454178522196,0.689372852641621,1,11,cytoplasmic ubiquitin ligase complex,CC,SEL1L
12845,GO:0051195,0.69354975286937,0.693951332234234,1,9,negative regulation of cofactor metabolic process,BP,DDIT4
12623,GO:0050854,0.693756216750938,0.531659502324888,3,34,regulation of antigen receptor-mediated signaling pathway,BP,PRNP;GCSAM;LGALS3
6142,GO:0019433,0.693904976045705,0.688861131068613,1,11,triglyceride catabolic process,BP,CPS1
18150,GO:1902946,0.694344490241391,0.696330556157005,1,8,protein localization to early endosome,BP,SORL1
18766,GO:1904321,0.694450612023506,0.696211943336283,1,8,response to forskolin,BP,EFNA5
18767,GO:1904322,0.694450612023506,0.696211943336283,1,8,cellular response to forskolin,BP,EFNA5
10013,GO:0042481,0.69448478576034,0.688201973173783,1,11,regulation of odontogenesis,BP,BMP4
889,GO:0002263,0.69493022784927,0.362524953770426,45,471,cell activation involved in immune response,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;EIF2AK4;LGALS1;PYCARD;ANO6;KCNAB2;LRP1;DOCK11;CXCR1;PRKCZ;METTL7A;TMEM173;CAT;STOM;MME;MLEC;SEMA4A;IL18;CST3;MANBA;IFNK;IFNE;BCL6;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;ZFPM1;DNASE1L1;LEF1;ITM2A;NAPRT;LGALS3;DNAJC3;RARA;ACTR1B;ADAM10;S100A11;CTSD
10601,GO:0043619,0.695083864711272,0.69222445823841,1,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,CHD6
3456,GO:0007271,0.695287513130286,0.689396321955317,1,10,synaptic transmission, cholinergic,BP,NQO1
20155,GO:2001025,0.695321158203594,0.685503398551636,1,12,positive regulation of response to drug,BP,GDNF
762,GO:0002011,0.695358728902777,0.481220022064752,5,44,morphogenesis of an epithelial sheet,BP,COL5A1;FLRT3;PDPN;VANGL2;MEGF8
3078,GO:0006654,0.695548838500885,0.531240725090803,3,30,phosphatidic acid biosynthetic process,BP,SLC27A1;DGKQ;AGPAT1
5960,GO:0018393,0.695690372004847,0.411442237248907,13,135,internal peptidyl-lysine acetylation,BP,CPA4;NOS1;SNAI2;TADA3;SDR16C5;PER1;SNCA;JADE2;ISL1;LEF1;YEATS2;ING4;TAF1
18178,GO:1902993,0.695695876823868,0.686821544258622,1,11,positive regulation of amyloid precursor protein catabolic process,BP,CLU
8961,GO:0035068,0.695816361486476,0.691397163620168,1,9,micro-ribonucleoprotein complex,CC,AGO4
4654,GO:0010804,0.695838884281334,0.682184736970845,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6
20161,GO:2001032,0.696076186759977,0.686387051961126,1,11,regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
18314,GO:1903305,0.696176903099614,0.450698306770217,7,73,regulation of regulated secretory pathway,BP,SYT8;MICAL1;SYN1;SYTL1;SYT1;SEPT5;C2CD4C
3363,GO:0007127,0.696196120825585,0.462093025586804,6,67,meiosis I,BP,HSPA2;MLH3;ATM;MSH5;MYBL1;AGO4
18365,GO:1903409,0.696246016602808,0.462603069820865,6,63,reactive oxygen species biosynthetic process,BP,NQO1;PKD2;NOS1;CAV1;CLU;SNCA
17325,GO:1900044,0.696386402259014,0.694041721810765,1,8,regulation of protein K63-linked ubiquitination,BP,SASH1
8470,GO:0033631,0.69643634306556,0.688089850155653,1,10,cell-cell adhesion mediated by integrin,BP,PODXL
3136,GO:0006732,0.696447060341312,0.377319521028769,27,293,coenzyme metabolic process,BP,DDIT4;H6PD;SLC2A3;DCAKD;TP53I3;ACSL3;MTHFR;KCNAB2;NMRK1;HLCS;ACSS1;ACACB;SNCA;ALDH1L2;PDK3;G6PD;DHTKD1;IDH2;GCLC;ACSS2;NCOR1;NMNAT2;ACSF2;NAPRT;PRKAG1;PPCS;ACOT1
10393,GO:0043252,0.696520817372045,0.687993610531183,1,10,sodium-independent organic anion transport,BP,SLC22A17
5069,GO:0015297,0.696703853469175,0.477887132083404,5,51,antiporter activity,MF,SLC7A8;SLC8A1;SLC7A11;SLC24A1;SLC9A4
20152,GO:2001022,0.696813517403034,0.461375312882242,6,67,positive regulation of response to DNA damage stimulus,BP,EGFR;HMGA2;PLA2R1;ATM;FAM168A;NPAS2
16831,GO:0098791,0.697039015482212,0.350042483941446,68,658,Golgi subcompartment,CC,ST6GALNAC2;MARCH4;SCARA3;COL7A1;CLTCL1;DNMBP;PDGFC;MALL;SULF2;EGFR;GALNT10;FAM198B;ASAP2;NSG1;SORL1;ARAP1;KIAA0319L;PDGFA;LPCAT2;B3GAT3;FUT10;CAV1;XYLT1;UST;CHST3;GOLGB1;ST6GAL2;BACE1;TLR3;MAN1A1;GLG1;SEC24D;TGFBI;SULF1;COPG2;TMED10;AREG;KLHL12;GCNT1;TMEM50B;RAB13;FNDC3A;RNF24;GOLGA8B;NMNAT2;GAL3ST4;RAB43;DSEL;MAPK8IP3;SPPL2B;GOPC;PIKFYVE;RHBDD2;GOLGA8N;GALNT2;TPST1;SNX9;POSTN;ARL3;MIA3;COG3;STEAP2;ADAM10;RHOBTB3;LITAF;GBP3;EDEM1;ABCA5
16474,GO:0097201,0.697316836480076,0.683212040085158,1,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,CITED2
8255,GO:0033059,0.697545459574584,0.496777797267321,4,45,cellular pigmentation,BP,BBS2;HPS4;BBS4;LYST
4032,GO:0009068,0.697971995490624,0.682456911545536,1,12,aspartate family amino acid catabolic process,BP,ALDH7A1
14656,GO:0070301,0.697989612888874,0.45974903337761,6,69,cellular response to hydrogen peroxide,BP,NQO1;AXL;TP53;SETX;MDM2;CST3
8346,GO:0033238,0.698946962950891,0.492544617805547,4,59,regulation of cellular amine metabolic process,BP,NQO1;SNCA;PSMB9;ABAT
7026,GO:0030810,0.699034274647144,0.526178217593367,3,32,positive regulation of nucleotide biosynthetic process,BP,NOS1;TIMP2;GPR161
17453,GO:1900373,0.699034274647144,0.526178217593367,3,32,positive regulation of purine nucleotide biosynthetic process,BP,NOS1;TIMP2;GPR161
13019,GO:0051536,0.699226411812229,0.473159002753034,5,61,iron-sulfur cluster binding,MF,XDH;MUTYH;RSAD2;DPYD;ABAT
13023,GO:0051540,0.699226411812229,0.473159002753034,5,61,metal cluster binding,MF,XDH;MUTYH;RSAD2;DPYD;ABAT
2373,GO:0005504,0.699251442141702,0.67949517553796,1,13,fatty acid binding,MF,PPARG
14007,GO:0060765,0.699271147760429,0.575875374265108,2,22,regulation of androgen receptor signaling pathway,BP,SFRP1;TAF1
10600,GO:0043618,0.699362346538162,0.435992366677345,8,100,regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;DDIT3;PSMB9;CHD6;CITED2;EGR1;HSPA5;TAF1
20029,GO:2000677,0.699528333892024,0.52558780546817,3,32,regulation of transcription regulatory region DNA binding,BP,DDIT3;HMGA2;TAF1
17681,GO:1901617,0.699664861585451,0.399317250812992,15,160,organic hydroxy compound biosynthetic process,BP,SNAI2;NTSR1;VDR;ISYNA1;NR1D1;SEC14L2;ACACB;SNCA;G6PD;DGKQ;ITPKB;TGFB2;OSBPL1A;TH;ACAA2
5779,GO:0017014,0.699694870639465,0.684360138983146,1,10,protein nitrosylation,BP,NOS1
5899,GO:0018119,0.699694870639465,0.684360138983146,1,10,peptidyl-cysteine S-nitrosylation,BP,NOS1
7310,GO:0031330,0.699744076404324,0.390814299674231,18,180,negative regulation of cellular catabolic process,BP,DDIT4;TIMP2;TIMP1;ACACB;CIRBP;SNCA;CST3;LZTS1;ANXA2;LEPR;OPHN1;GDNF;ATRAID;DERL3;PTPN3;TAF1;KDM4A;CDK5RAP3
16095,GO:0090114,0.699781529184699,0.458485954032253,6,63,COPII-coated vesicle budding,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12;MIA3
8511,GO:0033764,0.70025855945662,0.675007171696944,1,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B11
6975,GO:0030662,0.700364801643539,0.410499075490412,12,127,coated vesicle membrane,CC,CLTCL1;EGFR;HIP1;TBC1D5;SYT1;SEC24D;COPG2;TMED10;AREG;KLHL12;RASSF9;FZD4
10338,GO:0043173,0.700701998857096,0.676537437188812,1,14,nucleotide salvage,BP,NAPRT
7120,GO:0030955,0.701395423863404,0.685036991278551,1,9,potassium ion binding,MF,SLC24A1
13934,GO:0060669,0.701506377751987,0.573187120983045,2,22,embryonic placenta morphogenesis,BP,ZFP36L1;LEF1
6743,GO:0030173,0.701986008361507,0.521136432688358,3,36,integral component of Golgi membrane,CC,GALNT2;TPST1;STEAP2
9063,GO:0035331,0.702031722707276,0.687640810201537,1,8,negative regulation of hippo signaling,BP,DLG5
18092,GO:1902803,0.702035544136711,0.574175636862164,2,20,regulation of synaptic vesicle transport,BP,SYN1;SEPT5
6212,GO:0019748,0.702248846016907,0.520820564391636,3,36,secondary metabolic process,BP,AKR7A2;ABCC2;TH
18141,GO:1902930,0.702429149461767,0.470745626925157,5,53,regulation of alcohol biosynthetic process,BP,NTSR1;VDR;SEC14L2;ACACB;SNCA
3597,GO:0008028,0.702671821324638,0.569852624375921,2,25,monocarboxylic acid transmembrane transporter activity,MF,SLC27A1;SLC27A6
1025,GO:0002532,0.702958159602381,0.520310138560635,3,35,production of molecular mediator involved in inflammatory response,BP,SERPINE1;PDCD4;PER1
1026,GO:0002534,0.70309098132777,0.570571814964494,2,23,cytokine production involved in inflammatory response,BP,PDCD4;PER1
642,GO:0001833,0.703107396966637,0.680415672807541,1,10,inner cell mass cell proliferation,BP,TAF8
13612,GO:0060143,0.703190013535167,0.676391008590396,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,FLOT1
19634,GO:1990909,0.703678625981524,0.685753063260792,1,8,Wnt signalosome,CC,FZD1
6286,GO:0019902,0.703993071146096,0.395133123245841,15,143,phosphatase binding,MF,PHACTR3;IRS2;EGFR;STAT1;TP53;WNK1;DLG4;ITGA1;PIK3R1;MTMR4;PTPN1;MAGI2;TCTEX1D4;PPARG;SBF2
2641,GO:0005980,0.704363684119633,0.571364104110881,2,20,glycogen catabolic process,BP,PYGB;PHKA2
7273,GO:0031269,0.704532762109469,0.676599890428243,1,11,pseudopodium assembly,BP,CDC42EP5
15828,GO:0072576,0.704947579467611,0.678272131909311,1,10,liver morphogenesis,BP,SULF2
9180,GO:0035580,0.705021264747373,0.516851320453523,3,38,specific granule lumen,CC,TIMP2;DNASE1L1;CTSD
5469,GO:0016408,0.705155807947605,0.672577970739392,1,13,C-acyltransferase activity,MF,ACAA2
14577,GO:0070166,0.706094529403249,0.679597828349561,1,9,enamel mineralization,BP,FAM20A
13201,GO:0051893,0.706305721471113,0.468046651350005,5,45,regulation of focal adhesion assembly,BP,SFRP1;S100A10;DLC1;COL16A1;EFNA5
16092,GO:0090109,0.706305721471113,0.468046651350005,5,45,regulation of cell-substrate junction assembly,BP,SFRP1;S100A10;DLC1;COL16A1;EFNA5
3768,GO:0008324,0.706311670373568,0.362004357424543,31,306,cation transmembrane transporter activity,MF,SLC7A8;ANO1;PKD2;JPH2;GAS6;SLC8A1;ORAI3;SLC20A1;SCN8A;SCN2A;KCNMA1;ANO6;KCNAB2;KCNJ15;SLC38A2;CALHM2;KCNJ5;SLC24A1;KCNQ3;NDUFA4L2;TMEM63C;TMEM175;SLC39A11;SCNN1A;SLC9A4;ITPR2;CACNB1;KCNIP3;CACNA2D3;TUSC3;ORAI2
16037,GO:0090023,0.706393072711602,0.667749005991694,1,16,positive regulation of neutrophil chemotaxis,BP,MOSPD2
7389,GO:0031463,0.706408787979964,0.466449449148941,5,51,Cul3-RING ubiquitin ligase complex,CC,IPP;KLHL12;KLHL5;KLHL3;KLHL22
4650,GO:0010799,0.70689588712896,0.516725272037268,3,32,regulation of peptidyl-threonine phosphorylation,BP,DDIT4;SPRY2;DGKQ
40,GO:0000082,0.706975055410943,0.375754527357208,21,221,G1/S transition of mitotic cell cycle,BP,CDKN2B;PKD2;SKP2;EGFR;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;KANK2;TP73;CHEK2;ATM;MDM2;RBL2;FHL1;CDKN2A;ORC4;PPP3CA;CTDSP2
18057,GO:1902686,0.707072311670373,0.483783267398078,4,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TP53;TFDP2;TP73;ACAA2
1992,GO:0004715,0.707083518502245,0.516941619073259,3,31,non-membrane spanning protein tyrosine kinase activity,MF,PTK6;FYN;STK16
4962,GO:0015075,0.707125809044121,0.349604011654801,45,441,ion transmembrane transporter activity,MF,SLC7A8;ANO1;PKD2;JPH2;GAS6;SLC8A1;ORAI3;CLCA2;SLC20A1;SLC2A3;ABCA1;SCN8A;SCN2A;KCNMA1;DLG4;SLC7A11;SLC22A15;ANO6;KCNAB2;SLC27A1;SLC22A17;KCNJ15;SLC38A10;SLC38A2;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;SLC27A6;TMEM63C;TMEM175;ABCC2;SLC39A11;SCNN1A;SFXN3;SLC9A4;ITPR2;CACNB1;KCNIP3;ANKH;CACNA2D3;TUSC3;ORAI2
3653,GO:0008138,0.707605402108067,0.514696806904179,3,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP6;DUSP5;SSH1
13672,GO:0060253,0.707776181902609,0.677632809727547,1,9,negative regulation of glial cell proliferation,BP,IDH2
3332,GO:0007045,0.707777659314416,0.438810051869571,7,62,cell-substrate adherens junction assembly,BP,SFRP1;S100A10;ITGA2;LAMA5;DLC1;COL16A1;EFNA5
12064,GO:0048041,0.707777659314416,0.438810051869571,7,62,focal adhesion assembly,BP,SFRP1;S100A10;ITGA2;LAMA5;DLC1;COL16A1;EFNA5
14856,GO:0070671,0.707836410560794,0.512618767845511,3,41,response to interleukin-12,BP,PDCD4;AIP;ANXA2
1312,GO:0003161,0.707894688577182,0.67749396282496,1,9,cardiac conduction system development,BP,GJA5
2532,GO:0005791,0.708012999066644,0.462628902686049,5,62,rough endoplasmic reticulum,CC,SYNE3;SLC7A11;SNCA;DERL3;DNAJC3
12345,GO:0048753,0.708154213731826,0.564412569536423,2,23,pigment granule organization,BP,HPS4;LYST
11877,GO:0046928,0.708188410226685,0.515602960185778,3,31,regulation of neurotransmitter secretion,BP,SYN1;SNCA;SEPT5
10455,GO:0043369,0.708259906551344,0.674384291774921,1,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,ZFPM1
13470,GO:0055064,0.708512841356213,0.676768916624924,1,9,chloride ion homeostasis,BP,ABCC2
12659,GO:0050901,0.709208671830746,0.673263645789502,1,10,leukocyte tethering or rolling,BP,GCNT1
430,GO:0001158,0.709444129867897,0.447144910704637,6,63,enhancer sequence-specific DNA binding,MF,HIVEP1;SLC2A4RG;LMO4;SOX9;ISL1;MED12
6110,GO:0019362,0.709612066438447,0.399989296458966,12,127,pyridine nucleotide metabolic process,BP,DDIT4;H6PD;TP53I3;KCNAB2;NMRK1;G6PD;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
11681,GO:0046496,0.709612066438447,0.399989296458966,12,127,nicotinamide nucleotide metabolic process,BP,DDIT4;H6PD;TP53I3;KCNAB2;NMRK1;G6PD;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
19311,GO:1905666,0.709652133933141,0.675429109035129,1,9,regulation of protein localization to endosome,BP,SORL1
19312,GO:1905668,0.709652133933141,0.675429109035129,1,9,positive regulation of protein localization to endosome,BP,SORL1
7824,GO:0032388,0.709665723905866,0.377262046921995,19,192,positive regulation of intracellular transport,BP,GAS6;TCAF1;PAK1;SORL1;TP53;GLI3;FYN;B3GAT3;HHAT;TMEM173;ANK3;HPS4;STOM;MDM2;ANXA2;PRNP;MYO1C;C2CD5;EDEM1
2400,GO:0005547,0.709739271638893,0.514707351363607,3,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,JPH2;ARAP1;ASAP1
8043,GO:0032717,0.709804964059825,0.668567175429963,1,12,negative regulation of interleukin-8 production,BP,MAP2K5
7874,GO:0032452,0.709834800280255,0.517083975880679,3,25,histone demethylase activity,MF,PHF2;KDM4C;KDM4A
10718,GO:0044106,0.709915556960311,0.444325544605548,6,83,cellular amine metabolic process,BP,NQO1;SNCA;PSMB9;ABCC2;ALDH7A1;ABAT
2845,GO:0006333,0.709994495572696,0.398347129741872,12,157,chromatin assembly or disassembly,BP,TP53;CHD3;TNRC18;HMGA2;GATAD1;SOX9;BAHCC1;CDKN2A;TSPYL2;TSPYL4;CENPA;HP1BP3
4676,GO:0010829,0.710223054274875,0.66806756899986,1,12,negative regulation of glucose transmembrane transport,BP,ENPP1
3317,GO:0007026,0.710789915158317,0.565569578708297,2,18,negative regulation of microtubule depolymerization,BP,ARHGEF2;TTBK2
12528,GO:0050704,0.710939219294667,0.559759269841088,2,25,regulation of interleukin-1 secretion,BP,GAS6;PYCARD
10589,GO:0043589,0.710967802478257,0.673876208650167,1,9,skin morphogenesis,BP,ITGA2
10457,GO:0043371,0.711001153134133,0.671137819754451,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,BCL6
4040,GO:0009081,0.711094287872812,0.560806612835142,2,23,branched-chain amino acid metabolic process,BP,BCKDHB;HIBADH
16113,GO:0090153,0.711098925693361,0.665494254587988,1,13,regulation of sphingolipid biosynthetic process,BP,PLA2G6
19081,GO:1905038,0.711098925693361,0.665494254587988,1,13,regulation of membrane lipid metabolic process,BP,PLA2G6
19811,GO:2000303,0.711098925693361,0.665494254587988,1,13,regulation of ceramide biosynthetic process,BP,PLA2G6
16512,GO:0097286,0.711251256401816,0.668649378454801,1,11,iron ion import,BP,STEAP2
5546,GO:0016558,0.711274688568991,0.666808181492182,1,12,protein import into peroxisome matrix,BP,PEX1
9169,GO:0035563,0.711428375676904,0.666623807247668,1,12,positive regulation of chromatin binding,BP,HMBOX1
10192,GO:0042827,0.711547487790355,0.668295191410188,1,11,platelet dense granule,CC,HPS4
127,GO:0000266,0.711720640281679,0.510861763289638,3,32,mitochondrial fission,BP,STAT2;INF2;DNM1P46
7139,GO:0031005,0.711814314494914,0.670169704819399,1,10,filamin binding,MF,TMEM67
11820,GO:0046822,0.712051568743359,0.414946819711904,9,91,regulation of nucleocytoplasmic transport,BP,GAS6;BMP4;TP53;GLI3;PTPN14;TMEM173;MDM2;SP100;MDFIC
17272,GO:0140096,0.712363100131376,0.317095185903002,182,1697,catalytic activity, acting on a protein,MF,CPA4;MMP2;PRSS23;HTRA1;MMP9;ADAM19;SFRP1;MMP28;TGFBR2;ADAMTSL1;EFEMP1;MARCH4;DUSP6;HERC5;TNIK;ANPEP;SKP2;PHF21A;ROR1;AXL;EGFR;GALNT10;SPEG;FKBP5;CLCA2;MYLK;TRIM2;RNF213;RNF165;DDB2;MAP3K6;ZNF862;TADA3;PAK1;PTPRM;PCSK1;PTK6;EIF2AK4;TRIM5;CPVL;PTPRS;TTLL11;CNTRL;PYCARD;LTBP1;WNK1;MMP19;CRIM1;CHD3;SIK1;TYSND1;CDK14;P3H2;ERO1B;CTDSPL;NEK9;CTSV;FYN;ALPK1;LTBP4;CPS1;PIAS3;HLCS;RNF135;MAP3K14;XYLT1;FKBP9;PRKCZ;FBXW4;ULK2;TNS2;HMGA2;CAMK2D;MST1R;PTPN14;PDIA4;DUSP5;UHRF2;CDK18;PHKA2;TTN;LMO7;CASP14;DAPK1;PRKACB;CHEK2;BACE1;PHF2;FBXL7;ADAMTS7;MME;THSD4;PDIA6;PTPRU;FGFR1;IGF1R;PRKAB2;TMEM129;MYO3B;TGM2;PSMB9;OBSCN;PDK3;EPHB6;KDM4C;TGFBR3;IPP;MTMR4;ATM;EFNB3;FBXO17;APH1B;MDM2;AKAP13;DNAJC6;FBXW8;HDAC11;RNPEP;MAP3K1;PTPN1;POGLUT1;KLHL12;NRK;SSH1;SOX9;PRCP;STK16;GCNT1;PRKCA;AMZ2;ADAMTS15;HLTF;RNF24;PAK6;MAP3K12;STK36;RET;MAP2K5;GGT7;DPP9;USP28;PPM1M;SPPL2B;ULK1;NPEPL1;RHBDD1;CDK19;KLHL5;SRPK2;RHBDD2;SAP30L;TPGS1;PGPEP1;KLHL3;UBA7;GALNT2;RNF144B;TPST1;ICK;ZYG11B;PTPN3;FKBP10;PCMTD2;PRKAG1;TAF1;SENP7;PPP3CA;CTDSP2;CAPN6;KDM4A;KLHL22;SCPEP1;MED12;FBXL4;TTBK2;ADAM10;RNPEPL1;GID4;TAOK3;CTSD;ZNRF1;DMPK
18479,GO:1903651,0.71285835147783,0.671634060457778,1,9,positive regulation of cytoplasmic transport,BP,SORL1
1169,GO:0002793,0.713096270207863,0.384370376723015,15,155,positive regulation of peptide secretion,BP,F2R;ANO1;IRS2;EGFR;PYCARD;PLA2G6;PRKCZ;ANG;TTN;ALOX15B;C5;ISL1;TGFB2;POSTN;ABAT
8683,GO:0034333,0.713148245326101,0.42279826178817,8,71,adherens junction assembly,BP,SFRP1;S100A10;ITGA2;DLG5;LAMA5;DLC1;COL16A1;EFNA5
12625,GO:0050856,0.713756524691121,0.556874236712554,2,24,regulation of T cell receptor signaling pathway,BP,PRNP;LGALS3
4345,GO:0009914,0.71390986662593,0.375071294557797,18,177,hormone transport,BP,SFRP1;ANO1;IRS2;EGFR;NR1D1;LTBP4;PLA2G6;CPT1A;PCLO;FGFR1;ISL1;PRKCA;ABCC2;ITPR2;EFNA5;FZD4;PPP3CA;ABAT
14515,GO:0070059,0.713933959798787,0.476268804131596,4,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,DDIT3;HERPUD1;WFS1;PTPN1
18339,GO:1903362,0.71404509345281,0.372104986001821,19,202,regulation of cellular protein catabolic process,BP,PRICKLE1;GPX1;LRP1;CAV1;TRIB2;CLU;HERPUD1;MAGEF1;MDM2;GCLC;ANXA2;OPHN1;NUB1;ATRAID;DERL3;RNF144B;TAF1;CDK5RAP3;EDEM1
12231,GO:0048535,0.714110389580106,0.663392825216022,1,12,lymph node development,BP,PDPN
11391,GO:0045822,0.714122684072917,0.667408690235334,1,10,negative regulation of heart contraction,BP,PDE4D
17798,GO:1901983,0.714440018797972,0.455563442562714,5,58,regulation of protein acetylation,BP,NOS1;SNAI2;SDR16C5;SNCA;ISL1
3477,GO:0007340,0.714564014209516,0.662843825820243,1,12,acrosome reaction,BP,SYT8
2926,GO:0006446,0.714687554469028,0.439986319029416,6,70,regulation of translational initiation,BP,EIF2AK4;PAIP2B;RPL13A;DNAJC3;RARA;RXRA
16019,GO:0086080,0.714704960740701,0.672871086043953,1,8,protein binding involved in heterotypic cell-cell adhesion,MF,NFASC
1114,GO:0002704,0.714724326496728,0.554534631984168,2,26,negative regulation of leukocyte mediated immunity,BP,IL20RB;BCL6
14713,GO:0070410,0.71494775478261,0.677067102319844,1,7,co-SMAD binding,MF,TGIF1
10259,GO:0043025,0.715021253732383,0.356130904262706,28,268,neuronal cell body,CC,NQO1;GJC2;NTSR1;TIMP2;PTPRS;PYCARD;EFHC1;MAP2;CTSV;LRP1;PRKCZ;ITGA1;CCK;SLC38A2;ANG;SNCA;ASTN2;CST3;NRSN2;ARHGEF2;CRTC1;RET;TGFB2;TH;SRR;RARA;SV2A;CAMK2N1
1171,GO:0002819,0.715038758260899,0.427731862531518,7,82,regulation of adaptive immune response,BP,IL20RB;EIF2AK4;PYCARD;PRKCZ;BCL6;RSAD2;ZBTB1
1783,GO:0004407,0.715357254337626,0.476239781900258,4,42,histone deacetylase activity,MF,PHF21A;CHD3;HDAC11;SAP30L
13090,GO:0051654,0.715556494398827,0.55765675941523,2,20,establishment of mitochondrion localization,BP,NEFL;TRAK1
18571,GO:1903861,0.715574525825338,0.671836864072762,1,8,positive regulation of dendrite extension,BP,SYT1
4725,GO:0010893,0.715701038829624,0.661464513880458,1,12,positive regulation of steroid biosynthetic process,BP,NR1D1
12229,GO:0048532,0.716353716476344,0.664722107371656,1,10,anatomical structure arrangement,BP,HSPA5
3794,GO:0008375,0.716465976229795,0.473406662293131,4,48,acetylglucosaminyltransferase activity,MF,EXTL2;XYLT1;HEXA;GCNT1
15407,GO:0071712,0.716660326857783,0.662132956802369,1,11,ER-associated misfolded protein catabolic process,BP,UGGT2
7472,GO:0031647,0.716728612426318,0.366923308073574,20,211,regulation of protein stability,BP,FLOT1;GSN;CRTAP;TADA3;PYCARD;HIP1;SEL1L;CLU;PIK3R1;WFS1;HPS4;CHEK2;SNCA;FLOT2;CALR;MDM2;PRNP;USP28;COG3;TAF1
12305,GO:0048681,0.716746832415803,0.662027892040085,1,11,negative regulation of axon regeneration,BP,PTPRS
19666,GO:2000010,0.716748588675807,0.66018964540138,1,12,positive regulation of protein localization to cell surface,BP,SNX33
5619,GO:0016701,0.716802095315055,0.65726249515037,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOX15B
5620,GO:0016702,0.716802095315055,0.65726249515037,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOX15B
13155,GO:0051788,0.716957758636256,0.554262937237072,2,22,response to misfolded protein,BP,CLU;UGGT2
10881,GO:0044447,0.717081647173624,0.560423594396245,2,16,axoneme part,CC,WDR66;DNAH1
14291,GO:0061478,0.717170592313997,0.666472123345381,1,9,response to platelet aggregation inhibitor,BP,EFNA5
13148,GO:0051781,0.717231528767013,0.45291496423641,5,54,positive regulation of cell division,BP,PDGFC;PDGFA;CAT;TGFB2;OR2A4
7103,GO:0030914,0.717281476741658,0.659539607317447,1,12,STAGA complex,CC,TADA3
15727,GO:0072349,0.717409270792502,0.666184460952892,1,9,modified amino acid transmembrane transporter activity,MF,SLC7A11
442,GO:0001191,0.71752744796404,0.502932135745375,3,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,SDR16C5;CITED2;PARP15
14477,GO:0062012,0.71755982116382,0.347464435307696,33,337,regulation of small molecule metabolic process,BP,NQO1;DDIT4;PKD2;IRS2;NOS1;SNAI2;NTSR1;TIMP2;VDR;NR1D1;SEC14L2;SIK1;TYSND1;CAV1;CPT1A;ACACB;SNCA;PRKAB2;PDE4D;NCOA2;PSMB9;PDK3;DGKQ;EGR1;ENPP1;NCOR1;LEPR;IGFBP4;GPR161;NPHP3;LMF1;PPARG;PRKAG1
7740,GO:0032266,0.71760060468096,0.504575703434652,3,30,phosphatidylinositol-3-phosphate binding,MF,JPH2;HIP1;VPS36
2772,GO:0006198,0.717609307034115,0.6659432124776,1,9,cAMP catabolic process,BP,PDE4D
14635,GO:0070265,0.717944577199005,0.500502930231369,3,40,necrotic cell death,BP,CAV1;TLR3;ARHGEF2
16358,GO:0095500,0.717990086990733,0.658673631094458,1,12,acetylcholine receptor signaling pathway,BP,AGRN
18559,GO:1903831,0.717990086990733,0.658673631094458,1,12,signal transduction involved in cellular response to ammonium ion,BP,AGRN
19117,GO:1905144,0.717990086990733,0.658673631094458,1,12,response to acetylcholine,BP,AGRN
19118,GO:1905145,0.717990086990733,0.658673631094458,1,12,cellular response to acetylcholine,BP,AGRN
16903,GO:0098911,0.718247778437449,0.665172230296957,1,9,regulation of ventricular cardiac muscle cell action potential,BP,CAV1
11665,GO:0046473,0.718445316573911,0.5030556280398,3,31,phosphatidic acid metabolic process,BP,SLC27A1;DGKQ;AGPAT1
14177,GO:0061136,0.718668537274664,0.38116267321627,14,154,regulation of proteasomal protein catabolic process,BP,PRICKLE1;GPX1;CAV1;TRIB2;CLU;HERPUD1;MDM2;GCLC;OPHN1;NUB1;DERL3;RNF144B;TAF1;EDEM1
3476,GO:0007339,0.718710337727261,0.653775827903118,1,15,binding of sperm to zona pellucida,BP,SPA17
997,GO:0002467,0.719021344375194,0.661486247111589,1,10,germinal center formation,BP,BCL6
11302,GO:0045649,0.719130590654809,0.659122082744106,1,11,regulation of macrophage differentiation,BP,PRKCA
4963,GO:0015077,0.719634900173032,0.373724353525018,16,168,monovalent inorganic cation transmembrane transporter activity,MF,PKD2;SLC8A1;SLC20A1;SCN8A;SCN2A;KCNMA1;KCNAB2;KCNJ15;KCNJ5;SLC24A1;KCNQ3;NDUFA4L2;TMEM175;SCNN1A;SLC9A4;KCNIP3
14497,GO:0070016,0.719664424002364,0.660702322924318,1,10,armadillo repeat domain binding,MF,LEF1
199,GO:0000421,0.719772753524478,0.548784061873052,2,25,autophagosome membrane,CC,ULK1;ATG16L2
9433,GO:0036038,0.719791572397116,0.65490886592839,1,13,MKS complex,CC,TMEM67
17847,GO:1902108,0.719808692965025,0.46819471183181,4,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;TFDP2;TP73;ACAA2
4124,GO:0009187,0.719900107296186,0.435552917245177,6,58,cyclic nucleotide metabolic process,BP,PKD2;NOS1;TIMP2;PDE4D;GPR161;NPHP3
16555,GO:0097386,0.720155828097918,0.657865976278323,1,11,glial cell projection,CC,NFASC
14714,GO:0070411,0.720205770525127,0.662798619658766,1,9,I-SMAD binding,MF,TGFB1I1
11221,GO:0045428,0.720655960980161,0.499457028422051,3,33,regulation of nitric oxide biosynthetic process,BP,PKD2;CAV1;CLU
41,GO:0000083,0.720656749801039,0.548272795972095,2,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,TFDP2;E2F7
8282,GO:0033127,0.720732192484035,0.655305429679823,1,12,regulation of histone phosphorylation,BP,ATM
4952,GO:0015026,0.72084451137478,0.551068822006817,2,20,coreceptor activity,MF,ROR1;TGFBR3
3630,GO:0008093,0.721038329775518,0.656781677297415,1,11,cytoskeletal adaptor activity,MF,OBSL1
20073,GO:2000765,0.721106310907108,0.548361590006965,2,23,regulation of cytoplasmic translation,BP,RPL13A;UNK
946,GO:0002366,0.721148947182393,0.334771535164033,44,468,leukocyte activation involved in immune response,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;EIF2AK4;LGALS1;PYCARD;ANO6;KCNAB2;DOCK11;CXCR1;PRKCZ;METTL7A;TMEM173;CAT;STOM;MME;MLEC;SEMA4A;IL18;CST3;MANBA;IFNK;IFNE;BCL6;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;ZFPM1;DNASE1L1;LEF1;ITM2A;NAPRT;LGALS3;DNAJC3;RARA;ACTR1B;ADAM10;S100A11;CTSD
6248,GO:0019835,0.721505697165902,0.649308454969251,1,16,cytolysis,BP,C5
3696,GO:0008206,0.721557455744918,0.546542264711342,2,25,bile acid metabolic process,BP,NR1D1;OSBPL1A
7272,GO:0031268,0.72166701890705,0.654150896662878,1,12,pseudopodium organization,BP,CDC42EP5
10993,GO:0044843,0.721836026151757,0.357251415108012,22,233,cell cycle G1/S phase transition,BP,CDKN2B;PKD2;SKP2;EGFR;GJC2;TP53;GPNMB;TFDP2;E2F7;CTDSPL;KANK2;TP73;CHEK2;ATM;MDM2;RBL2;FHL1;CDKN2A;ORC4;TAF1;PPP3CA;CTDSP2
15795,GO:0072527,0.722098284022195,0.445199053685583,5,66,pyrimidine-containing compound metabolic process,BP,APOBEC3C;CPS1;APOBEC3G;APOBEC3F;DPYD
9970,GO:0042393,0.722128929560427,0.368222717347458,17,173,histone binding,MF,PHF21A;CBX5;SMARCA2;STAT1;CTSV;NCAPD2;UHRF2;PHF2;SNCA;BRD3;CD1D;LEF1;SAP30L;YEATS2;ING4;TAF1;KDM4A
3192,GO:0006821,0.722812812037529,0.466865583140138,4,43,chloride transport,BP,ANO1;CLCA2;ANO6;PRNP
4254,GO:0009593,0.722937581543513,0.543273620667833,2,28,detection of chemical stimulus,BP,SYT1;OR2A4
20251,GO:2001244,0.723087046171376,0.493151094281746,3,44,positive regulation of intrinsic apoptotic signaling pathway,BP,TP53;DDIT3;CAV1
8418,GO:0033540,0.723156827756692,0.650737626865451,1,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,EHHADH
607,GO:0001776,0.723159326756195,0.445389004836707,5,56,leukocyte homeostasis,BP,AXL;TSC22D3;KITLG;DOCK11;ITPKB
11469,GO:0045956,0.723321011789993,0.652100322724812,1,12,positive regulation of calcium ion-dependent exocytosis,BP,SYT1
14873,GO:0070717,0.723476870770157,0.546886361201719,2,21,poly-purine tract binding,MF,RBMS3;ATXN1
2096,GO:0004864,0.723706123204736,0.545087477988421,2,23,protein phosphatase inhibitor activity,MF,PHACTR3;ELFN2
3057,GO:0006622,0.724090313404331,0.546112551671983,2,21,protein targeting to lysosome,BP,SORL1;CLU
17130,GO:0102567,0.724212663209122,0.650990696480165,1,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G6
17131,GO:0102568,0.724212663209122,0.650990696480165,1,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G6
6646,GO:0030003,0.724536702807212,0.33982684271192,33,334,cellular cation homeostasis,BP,F2R;PKD2;JPH2;CYBRD1;NOS1;SLC8A1;NTSR1;VDR;KCNMA1;TP53;DDIT3;DLG4;FYN;CAV1;PLA2G6;SLC22A17;CAMK2D;HERPUD1;WFS1;SNCA;PDE4D;TGM2;SLC24A1;CALR;ANXA6;TMEM175;KCTD7;PRNP;SLC9A4;ITPR2;SV2A;OXTR;DMPK
2490,GO:0005741,0.724610306257959,0.378086387539175,13,146,mitochondrial outer membrane,CC,FAM210B;ACSL3;TMEM173;CPT1A;ACACB;BPHL;VAMP1;ARMCX2;SPATA18;ULK1;RSAD2;VPS13C;DMPK
13779,GO:0060397,0.724665180853426,0.654554565336141,1,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,PTPN1
2718,GO:0006099,0.725123458385349,0.540505285163262,2,28,tricarboxylic acid cycle,BP,DHTKD1;IDH2
696,GO:0001917,0.725300603850123,0.544582937547581,2,21,photoreceptor inner segment,CC,NOS1;BBS4
13092,GO:0051657,0.7255891266806,0.659727294771366,1,8,maintenance of organelle location,BP,UVRAG
14640,GO:0070273,0.725705454931911,0.542557474534564,2,23,phosphatidylinositol-4-phosphate binding,MF,JPH2;OSBPL5
5559,GO:0016577,0.725735076843642,0.496809125428834,3,26,histone demethylation,BP,PHF2;KDM4C;KDM4A
4170,GO:0009247,0.725886522041106,0.460906294613974,4,53,glycolipid biosynthetic process,BP,UGT8;PGAP1;GAL3ST4;MPPE1
13611,GO:0060142,0.726048599158552,0.647119986481724,1,13,regulation of syncytium formation by plasma membrane fusion,BP,FLOT1
13515,GO:0060004,0.726161491194871,0.652697056485179,1,10,reflex,BP,SLITRK6
14474,GO:0061982,0.726467922941787,0.426014187724901,6,69,meiosis I cell cycle process,BP,HSPA2;MLH3;ATM;MSH5;MYBL1;AGO4
482,GO:0001533,0.726507238216216,0.460504193143468,4,51,cornified envelope,CC,TCHH;PPL;FLG;KRT10
6701,GO:0030119,0.727060066460841,0.461638786355746,4,43,AP-type membrane coat adaptor complex,CC,EGFR;HIP1;TBC1D5;VPS39
11082,GO:0045117,0.727074602005944,0.644481535860707,1,14,azole transport,BP,SLC35F3
1,GO:0000002,0.727344222858448,0.539818178802213,2,24,mitochondrial genome maintenance,BP,PRIMPOL;MEF2A
1167,GO:0002791,0.727360482258759,0.343508449746875,27,274,regulation of peptide secretion,BP,FN1;SFRP1;F2R;ANO1;GJA5;IRS2;GAS6;EGFR;NR1D1;PYCARD;PLA2G6;PRKCZ;CPT1A;ANG;TTN;ALOX15B;C5;IDH2;ISL1;PRKCA;TGFB2;RSAD2;ITPR2;POSTN;EFNA5;PPP3CA;ABAT
7091,GO:0030898,0.727409692145786,0.657485938033072,1,8,actin-dependent ATPase activity,MF,MYO1C
74,GO:0000151,0.727439115992798,0.344734459861785,26,267,ubiquitin ligase complex,CC,SKP2;DDB2;ABTB1;BTBD2;CUL9;CUL7;SEL1L;DCAF16;FBXW4;PHC2;LMO7;FBXL7;IPP;FBXO17;CBX7;FBXW8;KLHL12;ANAPC16;KLHL5;KLHL3;RNF144B;ZYG11B;DCAF8;KLHL22;MED12;FBXL4
13084,GO:0051647,0.72787417857658,0.544272144533177,2,18,nucleus localization,BP,SYNE2;FHOD1
11067,GO:0045088,0.728261824035646,0.342330373060469,27,286,regulation of innate immune response,BP,FLOT1;MMP2;TKFC;PAK1;NR1D1;TRIM5;STAT1;PTPRS;PYCARD;DDX60;MUC19;SEC14L1;FYN;CAV1;RNF135;SERPING1;TMEM173;PRKACB;TLR3;PSMB9;IFNK;CD1D;MAP3K1;PTPN1;STAT2;RSAD2;PPARG
2205,GO:0005092,0.728342035491825,0.644228748990419,1,13,GDP-dissociation inhibitor activity,MF,RGS14
2730,GO:0006112,0.728815077784734,0.42448557393608,6,60,energy reserve metabolic process,BP,PYGB;IRS2;NR1D1;PHKA2;ENPP1;LEPR
10654,GO:0043921,0.729123833902377,0.538207155508872,2,23,modulation by host of viral transcription,BP,HMGA2;LEF1
13308,GO:0052312,0.729123833902377,0.538207155508872,2,23,modulation of transcription in other organism involved in symbiotic interaction,BP,HMGA2;LEF1
13326,GO:0052472,0.729123833902377,0.538207155508872,2,23,modulation by host of symbiont transcription,BP,HMGA2;LEF1
1283,GO:0003091,0.729164124539295,0.540554697101163,2,20,renal water homeostasis,BP,WFS1;PRKACB
15192,GO:0071375,0.729353558271926,0.347456963930014,23,224,cellular response to peptide hormone stimulus,BP,FBN1;ZFP36L1;IRS2;SESN3;PAK1;STAT1;GNG2;FYN;CPS1;CAV1;PRKCZ;PXN;PIK3R1;PRKACB;IGF1R;MDM2;GCLC;PTPN1;ENPP1;RAB13;PPARG;MYO1C;C2CD5
4804,GO:0012507,0.729498441927133,0.457862169167628,4,46,ER to Golgi transport vesicle membrane,CC,SEC24D;TMED10;AREG;KLHL12
12640,GO:0050871,0.729564265537185,0.457550015191904,4,47,positive regulation of B cell activation,BP,INPP5D;IRS2;VAV3;BCL6
4867,GO:0014733,0.730117313835165,0.65056552941527,1,9,regulation of skeletal muscle adaptation,BP,PPP3CA
3700,GO:0008211,0.730295702266975,0.641750264026351,1,13,glucocorticoid metabolic process,BP,DGKQ
8425,GO:0033558,0.730602431916073,0.457253940372899,4,43,protein deacetylase activity,MF,PHF21A;CHD3;HDAC11;SAP30L
9867,GO:0042159,0.730801384423784,0.64269938252916,1,12,lipoprotein catabolic process,BP,ATM
13501,GO:0055106,0.730840890353711,0.637504282320825,1,16,ubiquitin-protein transferase regulator activity,MF,TRIB2
4653,GO:0010803,0.731108368818009,0.454621998349483,4,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,GAS6;PYCARD;TRAF1;SPPL2B
12106,GO:0048207,0.731210526226262,0.435572422399591,5,56,vesicle targeting, rough ER to cis-Golgi,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12
12107,GO:0048208,0.731210526226262,0.435572422399591,5,56,COPII vesicle coating,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12
5829,GO:0017119,0.731284912126024,0.642084462261254,1,12,Golgi transport complex,CC,COG3
7562,GO:0031935,0.731392959634153,0.537706382269219,2,20,regulation of chromatin silencing,BP,UHRF2;PHF2
3738,GO:0008277,0.73148919319159,0.408452119370645,7,79,regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;SNCA;RGS2;DGKQ;PRKCA;RGS14;HTR1B
11830,GO:0046835,0.732240470959457,0.533552713639126,2,24,carbohydrate phosphorylation,BP,ITPK1;TKFC
6213,GO:0019751,0.732331831242789,0.398457260319004,8,86,polyol metabolic process,BP,INPP5D;ITPK1;TKFC;NTSR1;ISYNA1;PLCH2;SNCA;ITPKB
6651,GO:0030011,0.732404944828709,0.64768944990825,1,9,maintenance of cell polarity,BP,DLG5
390,GO:0001046,0.732552432148729,0.408086536684569,7,71,core promoter sequence-specific DNA binding,MF,NR1D1;STAT1;TP53;SOX9;PPARG;TAF1;FOS
9211,GO:0035615,0.732744370037362,0.642125256837983,1,11,clathrin adaptor activity,MF,HIP1
16812,GO:0098748,0.732744370037362,0.642125256837983,1,11,endocytic adaptor activity,MF,HIP1
4362,GO:0009975,0.73281031916959,0.647177706681937,1,9,cyclase activity,MF,TKFC
7116,GO:0030950,0.732882517111355,0.640046389855506,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOBTB2
68,GO:0000139,0.732965514278615,0.314723119608172,59,582,Golgi membrane,CC,ST6GALNAC2;MARCH4;SCARA3;COL7A1;PDGFC;MALL;EGFR;GALNT10;FAM198B;ASAP2;NSG1;SORL1;ARAP1;KIAA0319L;PDGFA;LPCAT2;B3GAT3;FUT10;CAV1;XYLT1;UST;CHST3;GOLGB1;ST6GAL2;TLR3;MAN1A1;GLG1;SEC24D;COPG2;TMED10;AREG;KLHL12;GCNT1;TMEM50B;FNDC3A;RNF24;GOLGA8B;NMNAT2;GAL3ST4;RAB43;DSEL;MAPK8IP3;SPPL2B;GOPC;PIKFYVE;RHBDD2;GOLGA8N;GALNT2;TPST1;ARL3;MIA3;COG3;STEAP2;ADAM10;RHOBTB3;LITAF;GBP3;EDEM1;ABCA5
6715,GO:0030134,0.733226962899306,0.417961429824489,6,68,COPII-coated ER to Golgi transport vesicle,CC,COL7A1;SEC24D;TMED10;AREG;VANGL2;KLHL12
5594,GO:0016638,0.733280968956854,0.639536561625744,1,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
11407,GO:0045844,0.733567019918554,0.454140499966785,4,41,positive regulation of striated muscle tissue development,BP,FLOT1;BMP4;FGFR1;TGFBR3
12275,GO:0048636,0.733567019918554,0.454140499966785,4,41,positive regulation of muscle organ development,BP,FLOT1;BMP4;FGFR1;TGFBR3
17765,GO:1901863,0.733567019918554,0.454140499966785,4,41,positive regulation of muscle tissue development,BP,FLOT1;BMP4;FGFR1;TGFBR3
15350,GO:0071624,0.734020933012637,0.631703205538793,1,18,positive regulation of granulocyte chemotaxis,BP,MOSPD2
844,GO:0002161,0.73442973747694,0.638063271838462,1,12,aminoacyl-tRNA editing activity,MF,AARS
17185,GO:0106074,0.73442973747694,0.638063271838462,1,12,aminoacyl-tRNA metabolism involved in translational fidelity,BP,AARS
12764,GO:0051085,0.734725748168438,0.528669855357518,2,27,chaperone cofactor-dependent protein refolding,BP,HSPA2;HSPA5
15877,GO:0072678,0.734898763908373,0.529517359834669,2,25,T cell migration,BP,PYCARD;ADAM10
8422,GO:0033554,0.735139428930558,0.294635544569224,161,1610,cellular response to stress,BP,FLOT1;MMP9;PRODH;CTGF;SFRP1;GADD45B;ZFP36L1;NQO1;DDIT4;XPC;ANO1;ETV5;PKD2;TNIK;GAS6;SNAI2;TFPI2;AXL;EGFR;HSPA2;SLC8A1;SESN3;MYLK;NUPR1;DDB2;MAP3K6;PAK1;EIF2AK4;NEFL;VAV3;PDCD4;SCN2A;TP53;EXTL2;PTPRS;DDIT3;PYCARD;TFDP2;CUL7;GPX1;E2F7;SRPX;SESN1;CTSV;XDH;CAV1;RMI2;ERCC6;PLA2G6;SEL1L;MAP3K14;CLU;TP53INP1;PARP4;HMGA2;CAMK2D;PRDX5;PER1;PXN;PDIA4;PIK3R1;CREB3L2;SLC38A2;HERPUD1;WFS1;MLH3;TP73;CAT;CASP14;DAPK1;CHEK2;TLR3;SNCA;PDIA6;FZD7;IGF1R;LMNA;DKK1;SETX;TMEM129;PSMB9;SPATA18;PLA2R1;PDK3;G6PD;MYOF;EDA2R;FZD8;CHD6;NFATC4;MAGEF1;FOXN3;FZD1;CALR;ATM;MDM2;CST3;CITED2;ZMAT3;MSH5;MAP3K1;PTPN1;VANGL2;ARHGEF2;NRK;EGR1;ISL1;BCL6;NCOR1;NDRG1;PXMP2;RGS14;PRIMPOL;CXORF57;PAK6;MAP3K12;MUTYH;TGFB2;RBL2;MAP2K5;LIG1;CDC42EP5;USP28;MAPK8IP3;CDKN2A;SP100;ULK1;TSPYL2;RHBDD1;HSPA5;UVRAG;MDFIC;VPS13C;POLD4;YAP1;GPX8;UBA7;DERL3;PPARG;SASH1;ING4;DNAJC3;POLH;TMEM67;TAF1;FZD4;ZBTB1;PIK3C2B;CREBRF;CTDSP2;HP1BP3;FOS;CDK5RAP3;FAM168A;NPAS2;NIPBL;UGGT2;EDEM1;ACAA2;TAOK3;LAMB2
11085,GO:0045123,0.735167311392975,0.53116569816633,2,22,cellular extravasation,BP,ITGA1;GCNT1
16033,GO:0089718,0.735585594213169,0.638489590399459,1,11,amino acid import across plasma membrane,BP,NTSR1
15246,GO:0071456,0.735694389127193,0.36512101191275,13,150,cellular response to hypoxia,BP,SFRP1;ZFP36L1;SLC8A1;TP53;LMNA;PSMB9;PDK3;MDM2;CITED2;EGR1;NDRG1;HP1BP3;ACAA2
9533,GO:0036312,0.735837888536562,0.643335615753587,1,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,PIK3R1
7003,GO:0030705,0.735841319069911,0.355798114924295,16,152,cytoskeleton-dependent intracellular transport,BP,NEFL;SPG11;PRKCZ;KIF17;IFT140;COPG2;TRAK1;SYNE2;IFT27;IFT88;WDR19;IFT122;IFT74;ICK;ARL3;MYO1C
5569,GO:0016592,0.735868498168649,0.479591715313684,3,35,mediator complex,CC,GLI3;CDK19;MED12
15180,GO:0071356,0.735908831914319,0.354342339761802,16,198,cellular response to tumor necrosis factor,BP,TNFRSF6B;SFRP1;ZFP36L1;ZFP36L2;GAS6;STAT1;PYCARD;MAP3K14;ADAMTS7;PSMB9;EDA2R;TRAF1;ARHGEF2;ABCC2;SPPL2B;POSTN
15867,GO:0072665,0.736117292661843,0.430298515522084,5,52,protein localization to vacuole,BP,SORL1;CLU;TMEM50B;VPS13C;VPS36
4998,GO:0015145,0.736554121059463,0.637243109184492,1,11,monosaccharide transmembrane transporter activity,MF,SLC2A3
7417,GO:0031529,0.736567667273513,0.478023428112151,3,37,ruffle organization,BP,CAV1;ARF6;LIMA1
12624,GO:0050855,0.736635034373934,0.635220708530587,1,12,regulation of B cell receptor signaling pathway,BP,GCSAM
8102,GO:0032801,0.736663001309319,0.479767597442153,3,32,receptor catabolic process,BP,PTPN1;ANXA2;UVRAG
7264,GO:0031256,0.736806391405048,0.369442221451919,12,112,leading edge membrane,CC,CSPG4;PAK1;PLEK2;PDPN;SPRY2;DLC1;SPRY4;SYNE2;ARHGEF2;SHISA9;MYO1C;C2CD5
10078,GO:0042605,0.736951310809665,0.631821589298892,1,14,peptide antigen binding,MF,SLC7A8
9305,GO:0035794,0.736994851434288,0.446762311198395,4,55,positive regulation of mitochondrial membrane permeability,BP,TP53;TFDP2;TP73;ACAA2
19321,GO:1905710,0.736994851434288,0.446762311198395,4,55,positive regulation of membrane permeability,BP,TP53;TFDP2;TP73;ACAA2
780,GO:0002039,0.737021726898924,0.41434922682568,6,61,p53 binding,MF,TP53;TEP1;TP73;MDM2;ZMAT3;TAF1
11822,GO:0046824,0.737095455461032,0.429300959230571,5,51,positive regulation of nucleocytoplasmic transport,BP,GAS6;TP53;GLI3;TMEM173;MDM2
10842,GO:0044380,0.737578514839081,0.429642914833358,5,47,protein localization to cytoskeleton,BP,CEP250;GOLGB1;BBS4;SNX10;TTBK2
1461,GO:0003712,0.737719106694862,0.315721373995668,46,454,transcription cofactor activity,MF,MAGED1;PHF21A;TADA3;VDR;NR1D1;SMARCA2;CITED4;WWTR1;DDIT3;TFDP2;BTG1;KLF12;E2F7;RBFOX2;IL31RA;PTPN14;PHF2;AIP;NCOA2;TLE4;NFATC4;LMCD1;PBXIP1;MEIS2;CITED2;NR2F2;ISL1;NCOR1;TRERF1;NAB2;MAML2;THRA;SP100;TGFB1I1;SAP30L;YAP1;PPARG;KCNIP3;MEF2A;KLF7;TGIF1;ING4;RARA;TAF1;MED12;RXRA
3223,GO:0006878,0.737941936125688,0.631909963445843,1,13,cellular copper ion homeostasis,BP,PRNP
10618,GO:0043649,0.73799025363522,0.631847062772247,1,13,dicarboxylic acid catabolic process,BP,ALDH1L2
5709,GO:0016849,0.738210288388492,0.640299983993434,1,9,phosphorus-oxygen lyase activity,MF,TKFC
985,GO:0002443,0.738269023569298,0.314826613971811,46,501,leukocyte mediated immunity,BP,PYGB;MMP9;INPP5D;IL20RB;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CLU;SERPING1;CXCR1;PRKCZ;IL31RA;METTL7A;ULBP1;TMEM173;CAT;STOM;TLR3;MME;MLEC;C5;IL18;CST3;MANBA;LYST;BCL6;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;BTN3A3;RSAD2;NAPRT;LGALS3;DNAJC3;ZBTB1;ACTR1B;ADAM10;S100A11;CTSD
10550,GO:0043534,0.738409443545289,0.391569733419564,8,82,blood vessel endothelial cell migration,BP,GPX1;ROBO1;FGFR1;AMOTL1;PRCP;PRKCA;MAP2K5;PPARG
561,GO:0001702,0.738418463565404,0.530735899790949,2,18,gastrulation with mouth forming second,BP,TENM4;MEGF8
17527,GO:1901096,0.738425808774553,0.63715179804976,1,10,regulation of autophagosome maturation,BP,UVRAG
18987,GO:1904837,0.73876039587235,0.474076277028939,3,41,beta-catenin-TCF complex assembly,BP,TCF7L1;TLE4;LEF1
4173,GO:0009251,0.738775109600409,0.527286242080331,2,21,glucan catabolic process,BP,PYGB;PHKA2
13206,GO:0051898,0.738973431164925,0.476001557722384,3,34,negative regulation of protein kinase B signaling,BP,DDIT3;XDH;MAGI2
2668,GO:0006022,0.738996225526489,0.370944252698237,11,115,aminoglycan metabolic process,BP,SDC3;CSPG4;B3GAT3;XYLT1;UST;CHST3;NAGLU;HEXA;SDC2;DSEL;AGRN
6925,GO:0030540,0.739320595711374,0.635994829357485,1,10,female genitalia development,BP,AXL
2941,GO:0006471,0.739486479758983,0.524160919522551,2,24,protein ADP-ribosylation,BP,PARP4;PARP15
10620,GO:0043651,0.74000561755934,0.627830572883471,1,14,linoleic acid metabolic process,BP,ALOX15B
9069,GO:0035338,0.740113804115215,0.629073549317883,1,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSL3
7241,GO:0031210,0.740362561508078,0.630372920080074,1,12,phosphatidylcholine binding,MF,ESYT2
12707,GO:0050997,0.740362561508078,0.630372920080074,1,12,quaternary ammonium group binding,MF,ESYT2
6769,GO:0030214,0.740432862278347,0.628655304027118,1,13,hyaluronan catabolic process,BP,HEXA
8309,GO:0033160,0.740643548754847,0.637163429243931,1,9,positive regulation of protein import into nucleus, translocation,BP,TMEM173
12909,GO:0051293,0.740895522995628,0.475291916857711,3,30,establishment of spindle localization,BP,SPRY2;ARHGEF2;CENPA
20086,GO:2000785,0.741201874080213,0.473145409935323,3,34,regulation of autophagosome assembly,BP,IFT88;ULK1;PIKFYVE
3859,GO:0008483,0.741337680757434,0.629095715270801,1,12,transaminase activity,MF,ABAT
14383,GO:0061695,0.741349820096554,0.333604390624616,23,241,transferase complex, transferring phosphorus-containing groups,CC,TGFBR2;PIK3C2G;TADA3;TP53;PYCARD;CDK14;TBC1D5;POLR3GL;PIK3R1;PHKA2;PRKAB2;CHD6;ENG;PRPS2;TAF8;ULK1;UVRAG;POLD4;CCNY;PRKAG1;TAF1;PIK3C2B;NIPBL
8139,GO:0032878,0.741439367843716,0.52469815925537,2,20,regulation of establishment or maintenance of cell polarity,BP,GSN;FLOT2
3421,GO:0007212,0.742047679003217,0.51963516741758,2,26,dopamine receptor signaling pathway,BP,NSG1;GNG2
7388,GO:0031462,0.742148452429652,0.628030899980275,1,12,Cul2-RING ubiquitin ligase complex,CC,ZYG11B
19276,GO:1905564,0.742379000039261,0.632016326832666,1,10,positive regulation of vascular endothelial cell proliferation,BP,FGFR1
17804,GO:1901990,0.742433884180959,0.319788131351195,33,356,regulation of mitotic cell cycle phase transition,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;EGFR;GJC2;TP53;CEP250;CNTRL;GPNMB;TFDP2;E2F7;CTDSPL;HMGA2;KANK2;HAUS4;TP73;CHEK2;FBXL7;PSMB9;FOXN3;PBX1;ATM;MDM2;RBL2;ODF2;FHL1;CDKN2A;CTDSP2;KLHL22;CDK5RAP3;TAOK3
5602,GO:0016651,0.742437855476215,0.418579247002922,5,83,oxidoreductase activity, acting on NAD(P)H,MF,NQO1;NOS1;TP53I3;CBR1;DECR1
18754,GO:1904293,0.742459686882819,0.625988987325983,1,13,negative regulation of ERAD pathway,BP,DERL3
17981,GO:1902476,0.74279832012585,0.471910826203228,3,32,chloride transmembrane transport,BP,ANO1;CLCA2;ANO6
20053,GO:2000727,0.742853132852749,0.627103292619278,1,12,positive regulation of cardiac muscle cell differentiation,BP,BMP4
13920,GO:0060628,0.742966146574722,0.626954342452972,1,12,regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
7398,GO:0031491,0.743165256537339,0.419324510323737,5,66,nucleosome binding,MF,SMARCA1;HMGA2;CENPA;SAP30L;HP1BP3
15177,GO:0071353,0.743519992139714,0.517697140230293,2,26,cellular response to interleukin-4,BP,LEF1;HSPA5
6711,GO:0030130,0.743867761421282,0.627711484669734,1,11,clathrin coat of trans-Golgi network vesicle,CC,CLTCL1
3366,GO:0007131,0.744147699859307,0.468630609430687,3,36,reciprocal meiotic recombination,BP,MLH3;ATM;MSH5
9321,GO:0035825,0.744147699859307,0.468630609430687,3,36,homologous recombination,BP,MLH3;ATM;MSH5
3898,GO:0008542,0.744370397415889,0.470335971343648,3,31,visual learning,BP,NETO1;MEIS2;RGS14
14120,GO:0061029,0.74438866061438,0.627024492657452,1,11,eyelid development in camera-type eye,BP,EGFR
6278,GO:0019888,0.744482544299044,0.418502847629396,5,60,protein phosphatase regulator activity,MF,PHACTR3;ELFN2;B3GAT3;PPP2R3A;DMPK
9272,GO:0035728,0.744569570580874,0.626785642585575,1,11,response to hepatocyte growth factor,BP,GCLC
6059,GO:0019212,0.744704980859275,0.517306935931307,2,24,phosphatase inhibitor activity,MF,PHACTR3;ELFN2
7456,GO:0031625,0.745293961559656,0.325923351049403,25,270,ubiquitin protein ligase binding,MF,TXNIP;EGFR;ABTB1;BTBD2;TP53;CUL9;CUL7;TRIB2;CLU;PER1;PXN;TMEM173;WFS1;PRKACB;CHEK2;FZD8;TRIOBP;TRAF1;CALR;MDM2;HLTF;HSPA5;SNX9;FZD4;KDM4A
11852,GO:0046883,0.745474518060175,0.350543818094626,14,146,regulation of hormone secretion,BP,SFRP1;ANO1;IRS2;EGFR;NR1D1;PLA2G6;CPT1A;FGFR1;ISL1;PRKCA;ITPR2;EFNA5;PPP3CA;ABAT
2942,GO:0006473,0.746039138518966,0.346305562410435,15,163,protein acetylation,BP,CPA4;NOS1;SNAI2;NUPR1;TADA3;SDR16C5;PER1;SNCA;JADE2;ISL1;LEF1;YEATS2;ING4;TAF1;EHHADH
7179,GO:0031078,0.746110664819472,0.624745623279993,1,11,histone deacetylase activity (H3-K14 specific),MF,HDAC11
7623,GO:0032041,0.746110664819472,0.624745623279993,1,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,HDAC11
4878,GO:0014745,0.746554317906309,0.626524359707174,1,10,negative regulation of muscle adaptation,BP,LMNA
4226,GO:0009408,0.746566098155896,0.352862988653529,13,139,response to heat,BP,ANO1;NOS1;DNAJB4;HSPA2;TP53;TP53INP1;CAMK2D;MYOF;ATM;GCLC;ABCC2;HSPA5;TGFB1I1
5912,GO:0018193,0.746808121045625,0.29003902555115,96,939,peptidyl-amino acid modification,BP,CPA4;GPRC5A;SFRP1;ST6GALNAC2;DDIT4;TGFBR2;EFEMP1;NOS1;GAS6;PDGFC;SNAI2;ROR1;AXL;EGFR;GALNT10;FKBP5;CRTAP;CSPG4;TADA3;PAK1;PADI3;PTK6;TP53;TTLL11;CNTRL;WNK1;DLG4;PDGFA;CNTN1;KITLG;P3H2;FYN;CAV1;PIAS3;ERCC6;FKBP9;PRKCZ;SDR16C5;HMGA2;CAMK2D;MST1R;IL31RA;PER1;CCK;CAPRIN2;SPRY2;TTN;JARID2;ST6GAL2;CHEK2;SNCA;JADE2;FGFR1;IGF1R;DKK1;CTF1;PDE4D;TGM2;IL18;PDK3;KDM4C;AFAP1L2;ATM;MDM2;AREG;IFNK;DGKQ;IFNE;PTPN1;POGLUT1;ARHGEF2;EGR1;ISL1;STK16;PRKCA;MAP3K12;PRNP;RET;MAP2K5;LEF1;ULK1;TPGS1;YEATS2;GALNT2;DERL3;TPST1;ING4;FKBP10;TAF1;EFNA5;KDM4A;UGGT2;TTBK2;PRDM5;TUSC3;DMPK
14119,GO:0061028,0.747362949218498,0.466010059250245,3,32,establishment of endothelial barrier,BP,PTPRS;PDE4D;ENG
7918,GO:0032506,0.747443626212997,0.514348995104017,2,23,cytokinetic process,BP,SNX33;SNX9
16047,GO:0090036,0.748023758761336,0.622199758164679,1,11,regulation of protein kinase C signaling,BP,PLA2G6
16632,GO:0097539,0.748513313055402,0.623923207520046,1,10,ciliary transition fiber,CC,ODF2
3623,GO:0008081,0.748558510110092,0.41405260981796,5,56,phosphoric diester hydrolase activity,MF,PLCH2;PDE4D;ENPP1;PLD3;MPPE1
32,GO:0000060,0.748666889292328,0.462772695977939,3,36,protein import into nucleus, translocation,BP,GAS6;TMEM173;BCL6
19691,GO:2000058,0.748713298956165,0.358922877972105,11,125,regulation of ubiquitin-dependent protein catabolic process,BP,PRICKLE1;CAV1;TRIB2;CLU;HERPUD1;MAGEF1;MDM2;GCLC;NUB1;RNF144B;TAF1
12757,GO:0051059,0.748988500245066,0.509925103155252,2,27,NF-kappaB binding,MF,CDKN2A;CDK5RAP3
11222,GO:0045429,0.749180416765087,0.512038247188856,2,23,positive regulation of nitric oxide biosynthetic process,BP,PKD2;CLU
18800,GO:1904407,0.749180416765087,0.512038247188856,2,23,positive regulation of nitric oxide metabolic process,BP,PKD2;CLU
19034,GO:1904925,0.749233955872464,0.620581555398609,1,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,VPS13C
4200,GO:0009312,0.749537030708295,0.50971323680357,2,26,oligosaccharide biosynthetic process,BP,GALNT10;GALNT2
2875,GO:0006376,0.749756266399799,0.509984904731432,2,25,mRNA splice site selection,BP,SETX;CELF2
13151,GO:0051784,0.749823206714849,0.432053664987875,4,47,negative regulation of nuclear division,BP,TOM1L2;BMP4;ATM;KLHL22
5961,GO:0018394,0.749937219898116,0.348819641154838,13,141,peptidyl-lysine acetylation,BP,CPA4;NOS1;SNAI2;TADA3;SDR16C5;PER1;SNCA;JADE2;ISL1;LEF1;YEATS2;ING4;TAF1
14884,GO:0070741,0.750034803801322,0.512445214482968,2,21,response to interleukin-6,BP,STAT1;ABCC2
15178,GO:0071354,0.750034803801322,0.512445214482968,2,21,cellular response to interleukin-6,BP,STAT1;ABCC2
17701,GO:1901657,0.750353699153808,0.367987439983016,9,116,glycosyl compound metabolic process,BP,APOBEC3C;DLG4;APOBEC3G;OARD1;APOBEC3F;AKR7A2;PRPS2;TH;DPYD
3326,GO:0007039,0.750564811374845,0.616821130952109,1,12,protein catabolic process in the vacuole,BP,LRP1
2940,GO:0006470,0.750760255114365,0.321492255451106,24,243,protein dephosphorylation,BP,PHACTR3;DUSP6;PTPRM;PTPRS;ELFN2;CTDSPL;B3GAT3;TNS2;ITGA1;PTPN14;DUSP5;DLC1;PTPRU;MTMR4;DNAJC6;PTPN1;SSH1;PPM1M;MAGI2;PTPN3;PPP3CA;CTDSP2;PPP2R3A;DMPK
4699,GO:0010866,0.751060840710578,0.614490455066376,1,13,regulation of triglyceride biosynthetic process,BP,SIK1
4483,GO:0010510,0.751309736495678,0.617791903863839,1,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK3
13707,GO:0060307,0.751396535249544,0.62006614036315,1,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,GJA5
19816,GO:2000311,0.75179134691872,0.619535292527707,1,10,regulation of AMPA receptor activity,BP,SHISA9
13012,GO:0051495,0.751791746908359,0.33980745097672,15,157,positive regulation of cytoskeleton organization,BP,CTGF;SFRP1;GSN;S100A10;PAK1;PYCARD;SEMA5A;ARPIN;PXN;RGS2;ARF6;CDC42EP5;FHOD1;WIPF1;MYO1C
20006,GO:2000651,0.751906542911568,0.619380282216079,1,10,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3
15764,GO:0072425,0.752436586720614,0.616270046773472,1,11,signal transduction involved in G2 DNA damage checkpoint,BP,ATM
2522,GO:0005779,0.752445648305691,0.609966826301999,1,15,integral component of peroxisomal membrane,CC,PXMP2
7252,GO:0031231,0.752445648305691,0.609966826301999,1,15,intrinsic component of peroxisomal membrane,CC,PXMP2
3475,GO:0007338,0.752461080632041,0.427662526611115,4,52,single fertilization,BP,SYT8;MST1R;CCDC136;SPA17
12526,GO:0050702,0.752690173515135,0.506669526829734,2,24,interleukin-1 beta secretion,BP,ABCA1;PYCARD
11664,GO:0046471,0.752792918149801,0.505915721770872,2,25,phosphatidylglycerol metabolic process,BP,SLC27A1;PLA2G6
4635,GO:0010762,0.752885532327347,0.506406975648243,2,24,regulation of fibroblast migration,BP,SLC8A1;PAK1
2556,GO:0005839,0.75313413608807,0.604777561066404,1,20,proteasome core complex,CC,PSMB9
91,GO:0000182,0.753179737555265,0.61766334960909,1,10,rDNA binding,MF,TSPYL2
2825,GO:0006294,0.753199734463525,0.503350007491142,2,29,nucleotide-excision repair, preincision complex assembly,BP,XPC;DDB2
6852,GO:0030331,0.753313217700394,0.457821978643714,3,33,estrogen receptor binding,MF,ISL1;LEF1;PPARG
2951,GO:0006482,0.753437374917513,0.460106326872748,3,28,protein demethylation,BP,PHF2;KDM4C;KDM4A
3703,GO:0008214,0.753437374917513,0.460106326872748,3,28,protein dealkylation,BP,PHF2;KDM4C;KDM4A
14478,GO:0062013,0.753607647031967,0.365300990781161,9,96,positive regulation of small molecule metabolic process,BP,IRS2;NOS1;NTSR1;TIMP2;NR1D1;CPT1A;SNCA;GPR161;PPARG
6129,GO:0019400,0.753666647080088,0.609524082369313,1,14,alditol metabolic process,BP,TKFC
10309,GO:0043123,0.753917799014872,0.34786408022395,12,140,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,F2R;ROR1;SLC20A1;TRIM38;TRIM5;LGALS1;FYN;MAP3K14;TGM2;EDA2R;AKAP13;LITAF
1470,GO:0003727,0.754525288896384,0.391365690066969,6,71,single-stranded RNA binding,MF,DDX60;RBMS3;ATXN1;DLX2;THRA;AGO4
12200,GO:0048477,0.755213023151895,0.425366896586076,4,46,oogenesis,BP,PAQR8;ANG;PAQR7;ATM
11492,GO:0046030,0.755264300023267,0.612427728788974,1,11,inositol trisphosphate phosphatase activity,MF,INPP5D
36,GO:0000075,0.755743523890696,0.324588692602994,19,206,cell cycle checkpoint,BP,CDKN2B;XPC;EIF2AK4;TP53;TFDP2;E2F7;MAP3K14;HMGA2;TP73;CHEK2;FOXN3;ATM;MDM2;NDRG1;RBL2;USP28;KLHL22;CDK5RAP3;TAOK3
10044,GO:0042554,0.756066426324132,0.604996230473881,1,15,superoxide anion generation,BP,EGFR
12838,GO:0051186,0.756112383041536,0.30093167195284,37,426,cofactor metabolic process,BP,DDIT4;H6PD;EGFR;SLC2A3;DCAKD;TP53I3;D2HGDH;ACSL3;GPX1;PTGES;MTHFR;KCNAB2;NMRK1;HLCS;ACSS1;PRDX5;ACACB;CAT;SNCA;ALDH1L2;PDK3;G6PD;DHTKD1;IDH2;TMEM14C;GCLC;ACSS2;AKR7A2;NCOR1;NMNAT2;ACSF2;GGT7;NAPRT;PRKAG1;GSTZ1;PPCS;ACOT1
9848,GO:0042119,0.756281309838997,0.305143089688484,32,359,neutrophil activation,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;IL18;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
11184,GO:0045335,0.756334457277006,0.361375036381217,9,105,phagocytic vesicle,CC,ITGB5;GSN;VIM;ABCA1;CALR;RAB43;FLNB;UVRAG;MYO1C
2658,GO:0006004,0.756400604969558,0.607198994229479,1,13,fucose metabolic process,BP,FUT10
10291,GO:0043090,0.756672721683649,0.608503509580352,1,12,amino acid import,BP,NTSR1
2952,GO:0006486,0.756787792508788,0.323544575934721,19,199,protein glycosylation,BP,ST6GALNAC2;ADAMTSL1;GALNT10;MUC19;B3GAT3;FUT10;ST6GAL2;MAN1A1;ADAMTS7;TRAK1;POGLUT1;GCNT1;LMF1;ALG10;GALNT2;DERL3;COG3;UGGT2;TUSC3
10488,GO:0043413,0.756787792508788,0.323544575934721,19,199,macromolecule glycosylation,BP,ST6GALNAC2;ADAMTSL1;GALNT10;MUC19;B3GAT3;FUT10;ST6GAL2;MAN1A1;ADAMTS7;TRAK1;POGLUT1;GCNT1;LMF1;ALG10;GALNT2;DERL3;COG3;UGGT2;TUSC3
869,GO:0002221,0.757049978393322,0.349130241010306,11,122,pattern recognition receptor signaling pathway,BP,FLOT1;TKFC;NR1D1;TRIM5;PTPRS;DDX60;SEC14L1;CAV1;TLR3;MAP3K1;RSAD2
15298,GO:0071545,0.757127894482873,0.607877385097312,1,12,inositol phosphate catabolic process,BP,NTSR1
6929,GO:0030547,0.757206526225182,0.603419732965244,1,15,receptor inhibitor activity,MF,DKK1
8760,GO:0034454,0.757667998628669,0.614544407911549,1,9,microtubule anchoring at centrosome,BP,BBS4
808,GO:0002082,0.757679340701596,0.604001083912692,1,14,regulation of oxidative phosphorylation,BP,SNCA
5656,GO:0016769,0.757845583826753,0.605205276408394,1,13,transferase activity, transferring nitrogenous groups,MF,ABAT
10553,GO:0043537,0.75822154625945,0.499867617132991,2,23,negative regulation of blood vessel endothelial cell migration,BP,MAP2K5;PPARG
8103,GO:0032802,0.758509278878573,0.604286566929513,1,13,low-density lipoprotein particle receptor catabolic process,BP,ANXA2
11362,GO:0045761,0.75875374891122,0.607639647470341,1,11,regulation of adenylate cyclase activity,BP,TIMP2
1657,GO:0004114,0.759020725577661,0.607271172170448,1,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE4D
3097,GO:0006677,0.759125116697974,0.601994469612621,1,14,glycosylceramide metabolic process,BP,UGT8
8130,GO:0032868,0.759698865201908,0.320350940963597,19,192,response to insulin,BP,ZFP36L1;IRS2;SESN3;PAK1;STAT1;SLC27A1;PRKCZ;PIK3R1;CAT;IGF1R;GCLC;PTPN1;EGR1;ENPP1;GCNT1;RAB13;PPARG;MYO1C;C2CD5
3108,GO:0006688,0.759926379951345,0.602318671303083,1,13,glycosphingolipid biosynthetic process,BP,UGT8
18356,GO:1903391,0.760006996826962,0.401216590820265,5,48,regulation of adherens junction organization,BP,SFRP1;S100A10;DLC1;COL16A1;EFNA5
8173,GO:0032924,0.760396441148632,0.497645589768124,2,22,activin receptor signaling pathway,BP,CITED2;MAGI2
10551,GO:0043535,0.761092597251159,0.383898605185407,6,65,regulation of blood vessel endothelial cell migration,BP,FGFR1;AMOTL1;PRCP;PRKCA;MAP2K5;PPARG
15719,GO:0072337,0.761161671323727,0.602289953426377,1,12,modified amino acid transport,BP,SLC38A2
15243,GO:0071453,0.761317749996201,0.328193381499123,15,171,cellular response to oxygen levels,BP,SFRP1;ZFP36L1;SLC8A1;TP53;CAV1;LMNA;PSMB9;PDK3;MDM2;CITED2;EGR1;NDRG1;PPARG;HP1BP3;ACAA2
6346,GO:0021533,0.761724092060507,0.608975278506725,1,9,cell differentiation in hindbrain,BP,OPHN1
15792,GO:0072524,0.76179114904565,0.338824261561015,12,132,pyridine-containing compound metabolic process,BP,DDIT4;H6PD;TP53I3;KCNAB2;NMRK1;G6PD;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
1997,GO:0004722,0.7619144916388,0.396480100276929,5,60,protein serine/threonine phosphatase activity,MF,CTDSPL;MTMR4;PPM1M;PPP3CA;CTDSP2
1703,GO:0004198,0.761988694144826,0.596746922222419,1,15,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN6
2245,GO:0005159,0.762200750312618,0.60083931134717,1,12,insulin-like growth factor receptor binding,MF,PIK3R1
2679,GO:0006044,0.762750906739402,0.598370548210955,1,13,N-acetylglucosamine metabolic process,BP,EXTL2
14191,GO:0061157,0.763069280718134,0.494803824941969,2,21,mRNA destabilization,BP,ZFP36L1;ZFP36L2
4673,GO:0010826,0.763122069981057,0.599549146753484,1,12,negative regulation of centrosome duplication,BP,TMEM67
19648,GO:1990939,0.763361175117563,0.418724839925817,4,34,ATP-dependent microtubule motor activity,MF,KIF17;DNAL4;WDR63;DNAH1
11775,GO:0046676,0.763666192423666,0.491743578598411,2,24,negative regulation of insulin secretion,BP,SFRP1;PPP3CA
16200,GO:0090278,0.763666192423666,0.491743578598411,2,24,negative regulation of peptide hormone secretion,BP,SFRP1;PPP3CA
3925,GO:0008610,0.763686385558726,0.285390114617257,49,512,lipid biosynthetic process,BP,INPP5D;PTGS1;PITPNM3;PIK3C2G;IRS2;SNAI2;MBOAT2;VDR;ISYNA1;NR1D1;SEC14L2;PDGFA;ACSL3;SIK1;PTGES;LPCAT2;UGT8;SLC27A1;PLA2G6;ACSS1;PIK3R1;ALDH3A2;ACACB;ANG;FGFR1;CBR1;ALOX15B;PRKAB2;G6PD;PBX1;MTMR4;ATM;HSD17B11;DGKQ;ACSS2;THNSL2;EGR1;TRERF1;ETNK2;PGAP1;GAL3ST4;OSBPL1A;PIKFYVE;AGPAT1;CERS5;PRKAG1;MPPE1;PIK3C2B;ACAA2
19933,GO:2000515,0.763765587063602,0.59864580465469,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,BCL6
5071,GO:0015299,0.76384227442348,0.598538033390094,1,12,solute:proton antiporter activity,MF,SLC9A4
7250,GO:0031228,0.763940918919919,0.441401562119286,3,40,intrinsic component of Golgi membrane,CC,GALNT2;TPST1;STEAP2
4196,GO:0009308,0.764202731250785,0.377646178760008,6,88,amine metabolic process,BP,NQO1;SNCA;PSMB9;ABCC2;ALDH7A1;ABAT
15311,GO:0071564,0.76442212279017,0.597722319257382,1,12,npBAF complex,CC,SMARCA2
15459,GO:0071850,0.764884336139457,0.593912015550327,1,14,mitotic cell cycle arrest,BP,MAGI2
9865,GO:0042157,0.765498058027201,0.338598215494634,11,130,lipoprotein metabolic process,BP,CD109;NTM;ABCA1;LRP1;HHAT;NEGR1;ATM;NTNG1;PGAP1;APOL6;MPPE1
1451,GO:0003688,0.76585372520871,0.592537394774226,1,14,DNA replication origin binding,MF,ORC4
3466,GO:0007289,0.766145238647207,0.597323800131964,1,11,spermatid nucleus differentiation,BP,GOPC
8637,GO:0034199,0.76628957193443,0.599581743473988,1,10,activation of protein kinase A activity,BP,PRKACB
3237,GO:0006895,0.766494992524854,0.492002357521108,2,19,Golgi to endosome transport,BP,MON2;VPS13C
11171,GO:0045295,0.76699493621444,0.601630474941109,1,9,gamma-catenin binding,MF,LEF1
8278,GO:0033120,0.767087897565779,0.486394634567649,2,25,positive regulation of RNA splicing,BP,PIK3R1;SETX
2640,GO:0005979,0.76727083871171,0.490928974401194,2,19,regulation of glycogen biosynthetic process,BP,IRS2;ENPP1
4772,GO:0010962,0.76727083871171,0.490928974401194,2,19,regulation of glucan biosynthetic process,BP,IRS2;ENPP1
12443,GO:0050321,0.767273094410444,0.593690104454787,1,12,tau-protein kinase activity,MF,TTBK2
7006,GO:0030728,0.767290751876577,0.593665018779826,1,12,ovulation,BP,MMP19
5320,GO:0016051,0.767404566552443,0.324287892221411,14,158,carbohydrate biosynthetic process,BP,IRS2;GALNT10;NTSR1;ISYNA1;NR1D1;SIK1;SNCA;GLT8D2;G6PD;DGKQ;ENPP1;G6PC3;LEPR;GALNT2
11459,GO:0045940,0.767761835693944,0.588559622680543,1,15,positive regulation of steroid metabolic process,BP,NR1D1
11848,GO:0046879,0.767845685139902,0.315472689342209,17,174,hormone secretion,BP,SFRP1;ANO1;IRS2;EGFR;NR1D1;LTBP4;PLA2G6;CPT1A;PCLO;FGFR1;ISL1;PRKCA;ITPR2;EFNA5;FZD4;PPP3CA;ABAT
20264,GO:2001269,0.76792805583634,0.588321725316191,1,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,GSN
5006,GO:0015171,0.767958640127967,0.40854366836662,4,47,amino acid transmembrane transporter activity,MF,SLC7A8;SLC7A11;SLC38A10;SLC38A2
5810,GO:0017081,0.768101967919296,0.590795366291596,1,13,chloride channel regulator activity,MF,WNK1
13968,GO:0060711,0.768207856669372,0.436560997216514,3,37,labyrinthine layer development,BP,ZFP36L1;FBXW8;LEF1
10253,GO:0043015,0.768223107568021,0.484817944041061,2,25,gamma-tubulin binding,MF,NDRG1;DIXDC1
16282,GO:0090482,0.768229049125576,0.592329996708309,1,12,vitamin transmembrane transporter activity,MF,SLC2A3
8899,GO:0034755,0.768502438366016,0.591940275324415,1,12,iron ion transmembrane transport,BP,STEAP2
5392,GO:0016235,0.768505015560288,0.437217267901978,3,34,aggresome,CC,KLF8;SYNE2;EDEM1
6565,GO:0022038,0.768528165731471,0.590186578889811,1,13,corpus callosum development,BP,PTPRS
3440,GO:0007252,0.768647922981015,0.590015369942873,1,13,I-kappaB phosphorylation,BP,TLR3
13022,GO:0051539,0.768689433739199,0.434756583829749,3,41,4 iron, 4 sulfur cluster binding,MF,MUTYH;RSAD2;DPYD
1014,GO:0002507,0.768970973534251,0.591271591829911,1,12,tolerance induction,BP,TGFBR2
11017,GO:0045010,0.768977357082414,0.43521005388133,3,38,actin nucleation,BP,GSN;ARPIN;WIPF1
6206,GO:0019730,0.769023431550328,0.477423857422424,2,44,antimicrobial humoral response,BP,PLA2G6;CLU
1775,GO:0004385,0.769204522276424,0.592983669481982,1,11,guanylate kinase activity,MF,DLG4
13082,GO:0051645,0.76945240490093,0.59058347760943,1,12,Golgi localization,BP,UVRAG
17890,GO:1902229,0.769507614155179,0.479464687013859,2,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,SNAI2;CLU
6140,GO:0019430,0.76963804588514,0.584765963296727,1,16,removal of superoxide radicals,BP,NQO1
17867,GO:1902176,0.76972143844627,0.584645767420068,1,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,GPX1
3698,GO:0008209,0.769741842485943,0.58844849630334,1,13,androgen metabolic process,BP,HSD17B11
11236,GO:0045503,0.769792907738727,0.49296767067716,2,15,dynein light chain binding,MF,WDR63;DNAH1
8950,GO:0035036,0.76986063354638,0.582618956078509,1,18,sperm-egg recognition,BP,SPA17
7291,GO:0031301,0.769976589420158,0.332778609672187,11,140,integral component of organelle membrane,CC,PTPRS;SLC22A17;SYT1;CPT1A;PXMP2;GALNT2;TPST1;SV2A;STEAP2;COX18;DMPK
6708,GO:0030126,0.769992972649929,0.585356132362865,1,15,COPI vesicle coat,CC,COPG2
5386,GO:0016229,0.770062158760019,0.581562174981238,1,19,steroid dehydrogenase activity,MF,HSD17B11
18791,GO:1904385,0.770178023315456,0.586354789422845,1,14,cellular response to angiotensin,BP,CAV1
14855,GO:0070670,0.770193940212164,0.480971166229,2,27,response to interleukin-4,BP,LEF1;HSPA5
11227,GO:0045453,0.770345282961413,0.434357363520001,3,35,bone resorption,BP,INPP5D;EGFR;PRKCA
19032,GO:1904923,0.77036060615355,0.589282539026373,1,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,VPS13C
18403,GO:1903510,0.770376995556316,0.360975014720274,7,76,mucopolysaccharide metabolic process,BP,CSPG4;B3GAT3;XYLT1;UST;CHST3;HEXA;DSEL
2510,GO:0005766,0.770382049621286,0.337727271848591,10,123,primary lysosome,CC,PYGB;PYCARD;STOM;MANBA;HEXA;PRCP;ANXA2;MAN2B1;NAPRT;DNAJC3
10062,GO:0042582,0.770382049621286,0.337727271848591,10,123,azurophil granule,CC,PYGB;PYCARD;STOM;MANBA;HEXA;PRCP;ANXA2;MAN2B1;NAPRT;DNAJC3
18569,GO:1903859,0.770641596276719,0.593412230038419,1,10,regulation of dendrite extension,BP,SYT1
17503,GO:1901020,0.770708828995948,0.58432358652023,1,15,negative regulation of calcium ion transmembrane transporter activity,BP,PKD2
5562,GO:0016580,0.770789544697718,0.590718504000404,1,11,Sin3 complex,CC,NCOR1
893,GO:0002274,0.770975867010893,0.282980349978699,39,430,myeloid leukocyte activation,BP,PYGB;MMP9;TGFBR2;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CLU;CXCR1;IL31RA;METTL7A;TMEM173;CAT;STOM;TLR3;SNCA;MME;MLEC;IL18;ATM;CST3;MANBA;PRCP;NFASC;NDRG1;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
14799,GO:0070566,0.771247048262579,0.48059853760745,2,25,adenylyltransferase activity,MF,OAS2;NMNAT2
8609,GO:0034142,0.771387971643302,0.584609923246118,1,14,toll-like receptor 4 signaling pathway,BP,NR1D1
17676,GO:1901607,0.771451099249039,0.402751478557767,4,53,alpha-amino acid biosynthetic process,BP,PHGDH;CPS1;THNSL2;SRR
10555,GO:0043539,0.771464548156342,0.479193145941373,2,27,protein serine/threonine kinase activator activity,MF,SPRY2;FAM20A
2858,GO:0006352,0.771548322958896,0.30821125870558,18,205,DNA-templated transcription, initiation,BP,CTGF;VDR;NR1D1;NR3C1;TP53;WWTR1;SETX;TCF4;SOX9;MAML2;THRA;YAP1;PPARG;RARA;TAF1;NAT14;MED12;RXRA
3080,GO:0006656,0.771826501491518,0.478197214422683,2,28,phosphatidylcholine biosynthetic process,BP,ACSL3;SLC27A1
6934,GO:0030552,0.771827743756544,0.589228635504972,1,11,cAMP binding,MF,PDE4D
12100,GO:0048193,0.771953487592539,0.288855247682615,31,308,Golgi vesicle transport,BP,COL7A1;GAS6;SPTB;SORL1;ACSL3;SNX1;OSBPL5;EHD3;GOLGB1;CREB3L2;BBS2;ANK3;SEC24D;COPG2;TMED10;AREG;BBS1;KLHL12;RAB13;PGAP1;GOPC;CHIC2;UVRAG;MON2;VPS13C;LMF1;ARL3;MIA3;COG3;MPPE1;STEAP2
4579,GO:0010669,0.772084743828333,0.58507453329985,1,13,epithelial structure maintenance,BP,SOX9
4717,GO:0010884,0.772225572885063,0.584870937117602,1,13,positive regulation of lipid storage,BP,ACACB
12834,GO:0051181,0.772350894809055,0.477007924481383,2,29,cofactor transport,BP,SLC22A17;SLC48A1
12531,GO:0050707,0.772726759390459,0.348405332113928,8,96,regulation of cytokine secretion,BP,FN1;F2R;GAS6;PYCARD;PRKCZ;ALOX15B;C5;POSTN
2953,GO:0006487,0.772765260090673,0.367600353858499,6,78,protein N-linked glycosylation,BP,ST6GALNAC2;ST6GAL2;ALG10;DERL3;UGGT2;TUSC3
2451,GO:0005666,0.772868183057913,0.579114101509277,1,17,DNA-directed RNA polymerase III complex,CC,POLR3GL
1480,GO:0003777,0.772899351321624,0.337610813095576,10,82,microtubule motor activity,MF,MYH15;KIF17;MYO3B;BBS4;DNAL4;WDR63;MYO9A;DNAH1;MYH11;MYO1C
5447,GO:0016327,0.772965113513596,0.583800305014327,1,13,apicolateral plasma membrane,CC,MPDZ
11047,GO:0045066,0.77336388570133,0.581746229896807,1,14,regulatory T cell differentiation,BP,BCL6
11258,GO:0045589,0.77336388570133,0.581746229896807,1,14,regulation of regulatory T cell differentiation,BP,BCL6
14413,GO:0061756,0.773574079161322,0.584649446422733,1,12,leukocyte adhesion to vascular endothelial cell,BP,GCNT1
5846,GO:0017148,0.773757640975336,0.301624975726043,20,217,negative regulation of translation,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;BMP4;EIF2AK4;ZCCHC11;CAPRIN2;ANG;CIRBP;DAPK1;PAIP2B;CALR;NCOR1;RPL13A;PPARG;UNK;RARA;PPP3CA;AGO4
10433,GO:0043312,0.773878285681668,0.286217174608567,31,351,neutrophil degranulation,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
4726,GO:0010894,0.774224074106416,0.579219670131561,1,15,negative regulation of steroid biosynthetic process,BP,SNAI2
11458,GO:0045939,0.774224074106416,0.579219670131561,1,15,negative regulation of steroid metabolic process,BP,SNAI2
16105,GO:0090136,0.774430016821859,0.583407427285821,1,12,epithelial cell-cell adhesion,BP,ITGB5
4127,GO:0009190,0.774841587237347,0.42824748877467,3,35,cyclic nucleotide biosynthetic process,BP,NOS1;TIMP2;GPR161
13354,GO:0052652,0.774841587237347,0.42824748877467,3,35,cyclic purine nucleotide metabolic process,BP,NOS1;TIMP2;GPR161
9507,GO:0036230,0.775084846133803,0.283883888082767,32,363,granulocyte activation,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;IL18;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
284,GO:0000788,0.775223297067044,0.568713481536666,1,31,nuclear nucleosome,CC,CENPA
13773,GO:0060391,0.775235451837231,0.582235611544624,1,12,positive regulation of SMAD protein signal transduction,BP,BMP4
10974,GO:0044794,0.775423504109973,0.580223326979951,1,13,positive regulation by host of viral process,BP,STOM
1479,GO:0003774,0.775471841756226,0.328720763340901,11,94,motor activity,MF,MYH15;CCDC102A;KIF17;MYO3B;BBS4;DNAL4;WDR63;MYO9A;DNAH1;MYH11;MYO1C
15011,GO:0070986,0.775762658956019,0.581466963188493,1,12,left/right axis specification,BP,CITED2
18371,GO:1903426,0.775874232579998,0.397638892915019,4,49,regulation of reactive oxygen species biosynthetic process,BP,PKD2;CAV1;CLU;SNCA
10046,GO:0042558,0.776044033018255,0.472253370532823,2,28,pteridine-containing compound metabolic process,BP,MTHFR;ALDH1L2
16170,GO:0090231,0.776173881740737,0.57764301627754,1,14,regulation of spindle checkpoint,BP,NDRG1
8364,GO:0033276,0.776300123054675,0.577457823774882,1,14,transcription factor TFTC complex,CC,TADA3
6700,GO:0030118,0.776340857582517,0.397916863829444,4,45,clathrin coat,CC,CLTCL1;EGFR;HIP1;TBC1D5
10668,GO:0043967,0.776404287041223,0.377908725138081,5,59,histone H4 acetylation,BP,TADA3;PER1;JADE2;LEF1;ING4
5494,GO:0016442,0.776411443349164,0.58259171991519,1,11,RISC complex,CC,AGO4
7312,GO:0031332,0.776411443349164,0.58259171991519,1,11,RNAi effector complex,CC,AGO4
20031,GO:2000679,0.776439376646408,0.575974259671482,1,15,positive regulation of transcription regulatory region DNA binding,BP,HMGA2
11091,GO:0045132,0.776499579236619,0.39680569681675,4,49,meiotic chromosome segregation,BP,MLH3;ATM;MSH5;AGO4
20087,GO:2000786,0.776845815387487,0.581957730132695,1,11,positive regulation of autophagosome assembly,BP,ULK1
14101,GO:0060996,0.777265895087263,0.352976581809002,7,70,dendritic spine development,BP,SDK1;PTPRS;DLG4;DLG5;ASAP1;CAPRIN2;ARF6
4223,GO:0009404,0.778475187667856,0.571853739211758,1,16,toxin metabolic process,BP,TH
8031,GO:0032692,0.778485583509077,0.571838338545733,1,16,negative regulation of interleukin-1 production,BP,GAS6
16648,GO:0097617,0.778670514377305,0.575456121092395,1,13,annealing activity,MF,SMARCA1
901,GO:0002283,0.779048560872755,0.280324423356853,31,352,neutrophil activation involved in immune response,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
13192,GO:0051881,0.779078491576629,0.41926013214826,3,47,regulation of mitochondrial membrane potential,BP,IFI6;CCK;GCLC
5852,GO:0017157,0.779103947975469,0.322486258235932,11,121,regulation of exocytosis,BP,SYT8;MICAL1;SYN1;PLA2G6;SYTL1;SYT1;PCLO;SNCA;RAB13;SEPT5;C2CD4C
15884,GO:0072686,0.77922249799577,0.341060124089074,8,86,mitotic spindle,CC,PKD2;TADA3;EFHC1;EML2;OR2A4;YEATS2;CAPG;KLHL22
7211,GO:0031116,0.77938905934111,0.471154387979251,2,22,positive regulation of microtubule polymerization,BP,PAK1;RGS2
16109,GO:0090148,0.779677446014426,0.575718852356299,1,12,membrane fission,BP,DNM1P46
17476,GO:1900543,0.77968647505992,0.468670424830504,2,25,negative regulation of purine nucleotide metabolic process,BP,DDIT4;SNCA
12576,GO:0050779,0.779723839005872,0.470677165595212,2,22,RNA destabilization,BP,ZFP36L1;ZFP36L2
3394,GO:0007175,0.779962553953735,0.573545474145461,1,13,negative regulation of epidermal growth factor-activated receptor activity,BP,GPRC5A
11842,GO:0046856,0.780200047739945,0.470824569171375,2,21,phosphatidylinositol dephosphorylation,BP,INPP5D;MTMR4
4512,GO:0010569,0.780248215619809,0.467868379430533,2,25,regulation of double-strand break repair via homologous recombination,BP,MAGEF1;CXORF57
2815,GO:0006282,0.780274773844927,0.347763257696941,7,83,regulation of DNA repair,BP,EGFR;HMGA2;MAGEF1;CXORF57;POLH;FAM168A;NPAS2
804,GO:0002076,0.780378368531967,0.576768881914363,1,11,osteoblast development,BP,GLI2
9425,GO:0036020,0.780492662040339,0.574512807623626,1,12,endolysosome membrane,CC,TLR3
16575,GO:0097440,0.780690057747451,0.576308219746601,1,11,apical dendrite,CC,CLU
2195,GO:0005070,0.781172849727393,0.419557072368578,3,35,SH3/SH2 adaptor activity,MF,CHN2;VAV3;PAG1
11342,GO:0045725,0.78129514069361,0.581066228616772,1,9,positive regulation of glycogen biosynthetic process,BP,IRS2
5914,GO:0018195,0.781343176158072,0.566598582982511,1,17,peptidyl-arginine modification,BP,PADI3
14094,GO:0060986,0.781558970818643,0.466619411000875,2,24,endocrine hormone secretion,BP,FGFR1;FZD4
12125,GO:0048255,0.781869158981876,0.465548271352417,2,25,mRNA stabilization,BP,CIRBP;GDNF
11692,GO:0046513,0.781872680947491,0.416752771508422,3,41,ceramide biosynthetic process,BP,UGT8;PLA2G6;CERS5
11735,GO:0046606,0.782041431837867,0.570454720944419,1,13,negative regulation of centrosome cycle,BP,TMEM67
10762,GO:0044242,0.782435731717226,0.313353076698313,12,146,cellular lipid catabolic process,BP,IRS2;TYSND1;ECH1;CPS1;ALDH3A2;CPT1A;ACACB;DECR1;AIG1;EHHADH;CPT2;ACAA2
3242,GO:0006901,0.782508039978542,0.369750655158014,5,60,vesicle coating,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12
3949,GO:0008656,0.782713892781309,0.567951088145696,1,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,PYCARD
2366,GO:0005488,0.782882682972289,0.242042327378,1056,10118,binding,MF,SERPINE2;PHACTR3;CPA4;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;PTGS1;ITGB4;EFEMP1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;NYNRIN;CEP126;SLC8A1;NTM;FKBP5;ORAI3;CLCA2;DOCK5;SESN3;MYLK;SYNE3;SLC2A3;THBS2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;RNF165;ANXA5;C1QTNF6;VIM;NUPR1;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;ALS2CL;LGALS9C;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;KIAA0040;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;FAM167A;ABTB1;RIN2;XAF1;PCED1B;EIF2AK4;NETO1;HS1BP3;FCGBP;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;GNG2;KCNMA1;D2HGDH;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;DLG4;SLC7A11;ATXN7L1;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;MMP19;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;HIP1;PACS1;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;EVI5L;ZNF18;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;NFIX;HIVEP1;TYSND1;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;LIMCH1;PDPN;MTHFR;ABHD14B;ZFP90;CCDC80;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;PABPC4L;FLNC;ALPK1;TSHZ2;B3GAT3;LTBP4;ARHGAP18;CLMN;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;IGFL1;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;AHNAK2;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;SNX29;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;HIBADH;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;NCAPD2;TMEM173;CAPRIN2;CREB3L2;CPT1A;SLC38A2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;LAMB3;TTN;TMEM139;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;DLC1;KLF13;BTN3A1;PRKACB;AARS;CHEK2;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;MAN1A1;ZNF860;SNCA;OARD1;FLOT2;ADAMTS7;MME;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;PAQR7;NIPSNAP1;PLXNA2;SP110;COL16A1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;TGFBI;SETX;KHNYN;ASTN2;PDE4D;APBB3;TMEM129;WBP1;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;CD99L2;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;DTNB;AMOTL1;IPP;NOTCH2NL;L3MBTL3;PBXIP1;PBX1;LAPTM4A;ENG;FOXL1;BBS4;MTMR4;LRRC20;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;TBC1D19;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;IFNK;ZNF107;TCF4;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;JMJD7;C20ORF194;DGKQ;CITED2;GCLC;NR2F2;ACSS2;ELMO3;FHOD3;HEXA;IFNE;NEURL1B;IGFL2;CBX7;DNAJC4;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;CYP20A1;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;HSPA12A;SYNE2;HDAC11;RNPEP;MAP3K1;FGD4;PTPN1;KCNQ3;CRIP2;VANGL2;NT5DC3;ARHGEF2;DNAL4;NTNG1;PLGRKT;ALDH4A1;KLHL12;SDC2;COL5A3;THNSL2;ZNF546;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;C14ORF93;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;DDX60L;NDRG1;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;PXMP2;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;AMZ2;ADAMTS15;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;CEP68;TSHZ1;LANCL1;IGFBP4;IFT88;MVB12B;TES;TTC8;KCTD7;TCF25;TCF12;HMBOX1;C22ORF23;NFAT5;TTC23;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;RAB43;SPA17;WDR19;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;DLX2;ZNF550;DNASE1L1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;ALDH7A1;ITM2A;MAPK8IP3;C11ORF68;CYP4V2;MSRB2;TRIML2;C2CD4C;CDKN2A;PPM1M;MPRIP;RSRP1;HERPUD2;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;NPHP3;VAV2;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;ERICH2;BOC;CENPA;PIKFYVE;FLYWCH1;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;SEMA4B;ITGB8;NAPRT;MON2;ARHGEF19;ITPR2;ARHGAP29;MDFIC;C11ORF49;UGT1A3;FHOD1;YPEL4;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;KCTD14;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;GDNF;DNAH1;RALGAPB;NUB1;KLF5;COL17A1;TWIST2;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;PRRC2B;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;ADAMTSL5;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;OLFML2A;APOL6;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;SBF2;RASA1;ARHGAP31;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;CLEC2D;FAM120B;FAM168A;CACNA2D3;SERPINB5;MATN3;CAMK2N1;ELMO2;EHHADH;MED12;NPAS2;ABAT;MYH11;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;C4ORF33;ANKS6;TSPAN4;S100A11;MYO1C;RXRA;ORAI2;C2CD5;GBP3;SNTB1;EDEM1;ACAA2;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;LAMB2
11325,GO:0045672,0.782976495375727,0.567557710598863,1,14,positive regulation of osteoclast differentiation,BP,FOS
4043,GO:0009084,0.783035010065892,0.567470011010891,1,14,glutamine family amino acid biosynthetic process,BP,CPS1
4340,GO:0009896,0.783343852004513,0.274022974670231,33,328,positive regulation of catabolic process,BP,ZFP36L1;IRS2;ZFP36L2;SESN3;EIF2AK4;SORL1;PRICKLE1;SNX1;SESN1;LRP1;CAV1;TRIB2;SNX33;CLU;TP53INP1;CPT1A;HERPUD1;DAPK1;SNCA;MAGEF1;ATM;MDM2;GCLC;PTPN1;SOX9;ULK1;UVRAG;VPS13C;NUB1;RNF144B;SNX9;TAF1;EDEM1
9392,GO:0035970,0.78346439622067,0.565531668457874,1,15,peptidyl-threonine dephosphorylation,BP,DUSP5
5130,GO:0015631,0.783563838247781,0.276933778854471,30,275,tubulin binding,MF,MYH15;MAP6;DPYSL2;STMN3;NEFM;EFHC1;MAP2;EML2;FYN;KIF17;SNCA;RGS2;MYO3B;BBS4;LZTS1;ARHGEF2;NDRG1;RGS14;PRNP;IFT74;TPGS1;MYO9A;DIXDC1;BEX4;ARL3;CAPN6;DNM1P46;MYH11;TTBK2;MYO1C
9666,GO:0038061,0.783590167003699,0.333880815340891,8,111,NIK/NF-kappaB signaling,BP,EGFR;PDCD4;MAP3K14;TLR3;PSMB9;CALR;UACA;SASH1
14792,GO:0070555,0.783636850890118,0.316112812636151,11,140,response to interleukin-1,BP,SFRP1;PYCARD;MTHFR;SNCA;ADAMTS7;PSMB9;GCLC;EGR1;SOX9;PRKCA;ABCC2
2450,GO:0005665,0.783701701716351,0.563056031594635,1,17,DNA-directed RNA polymerase II, core complex,CC,CHD6
16545,GO:0097367,0.783927697674868,0.242284571440065,171,1582,carbohydrate derivative binding,MF,SERPINE2;FN1;CTGF;FBN1;SFRP1;RHOBTB2;MYH15;TGFBR2;PIK3C2G;NID1;TNIK;NOS1;COL5A1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;THBS2;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;BMP4;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;EXTL2;PTPRS;TTLL11;CUL9;WNK1;DDX60;SEMA5A;ITGA2;ACSL3;GPNMB;TEP1;CHD3;SIK1;LAMC2;CDK14;NAV2;SYN1;CCDC80;NEK9;NMRK1;LRP1;FYN;ALPK1;LTBP4;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;HHAT;TMEM173;ACACB;ANG;KIF17;CDK18;TTN;APLP2;MLH3;DAPK1;PRKACB;AARS;CHEK2;OARD1;FGFR1;IGF1R;SETX;PDE4D;MYO3B;TGM2;OBSCN;PDK3;EPHB6;CHD6;SEPT6;TGFBR3;ENG;ATM;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;COL5A3;NRK;ENPP1;IFT27;ITPKB;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;ADAMTS15;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;PRNP;RET;MAP2K5;LIG1;ULK1;AGRN;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ADAMTSL5;ICK;POSTN;ARL3;ECM2;ABCA2;PRKAG1;TAF1;MPPE1;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
14804,GO:0070571,0.783993232672414,0.56753416410173,1,13,negative regulation of neuron projection regeneration,BP,PTPRS
6699,GO:0030117,0.784146728553619,0.334360581047258,8,92,membrane coat,CC,CLTCL1;EGFR;HIP1;TBC1D5;SEC24D;COPG2;KLHL12;VPS39
12198,GO:0048475,0.784146728553619,0.334360581047258,8,92,coated membrane,CC,CLTCL1;EGFR;HIP1;TBC1D5;SEC24D;COPG2;KLHL12;VPS39
14980,GO:0070938,0.784484249474589,0.570663285988316,1,11,contractile ring,CC,UTRN
4443,GO:0010369,0.78460428120477,0.566616070028147,1,13,chromocenter,CC,CBX5
5011,GO:0015179,0.784896017531966,0.413715451573486,3,37,L-amino acid transmembrane transporter activity,MF,SLC7A8;SLC7A11;SLC38A2
11793,GO:0046710,0.785023548039275,0.567751968363798,1,12,GDP metabolic process,BP,DLG4
10852,GO:0044403,0.785031758143163,0.255502595337295,65,714,symbiont process,BP,ITGB6;FN1;ITGB5;GSN;PIK3C2G;ANPEP;GAS6;AXL;EGFR;VIM;CBX5;APOBEC3C;TRIM38;EIF2AK4;TRIM5;STAT1;LGALS1;TP53;IFIT1;ITGA2;ADARB1;PACS1;CUL7;GPX1;FYN;CAV1;OAS2;ULK2;HMGA2;ULBP1;PIK3R1;TMEM173;APOBEC3G;FBLN1;TP73;STOM;SP110;APOBEC3F;PSMB9;CHD6;SEPT6;EFNB3;MDM2;CD1D;CRTC1;ANXA2;IFITM2;MVB12B;RPL13A;RAB43;STAT2;LEF1;SP100;ULK1;CENPA;RSAD2;SRPK2;UVRAG;MDFIC;IFITM1;TAF1;KDM4A;MPDZ;ATG16L2;RXRA
16525,GO:0097329,0.785177120271567,0.567521081484059,1,12,response to antimetabolite,BP,ABCC2
7883,GO:0032462,0.7856616931983,0.560091939475325,1,17,regulation of protein homooligomerization,BP,CLU
15942,GO:0080090,0.785671608937573,0.232696868833496,472,4496,regulation of primary metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;TSC22D3;KLF8;HSPA2;FLRT3;GJC2;RFX2;ZNF608;SERPINE1;SERPINH1;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;MAP3K6;NTSR1;TIMP2;ZNF862;TADA3;PAK1;ABCA1;ANGPTL4;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;VAV3;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;HIP1;GPNMB;TFDP2;PNRC1;CCDC85B;CRIM1;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;E2F7;CNTN1;KITLG;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;LRP1;FYN;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;UHRF2;HERPUD1;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;APLP2;FBLN1;ZKSCAN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;FLOT2;GATAD1;FZD7;AIP;GLG1;SP110;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;G6PD;TLE4;EPHB6;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;ATM;MDM2;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;LEPR;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;ITM2A;MAPK8IP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;NPHP3;VAV2;RHBDD1;MAGI2;HSPA5;TGFB1I1;SRPK2;UVRAG;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;OPHN1;LMF1;YAP1;GDNF;NUB1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;DERL3;ZNF558;MEIS3;PPARG;RNF144B;PARP15;BEX4;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;SASH1;TGIF1;ING4;ZYG11B;UNK;PTPN3;DNAJC3;RARA;ABCA2;CCNY;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;VPS36;PRDM5;PPP2R3A;ZNF471;LITAF;S100A11;RXRA;CPT2;EDEM1;TAOK3;NFKBIE;ZNF484;DMPK
7290,GO:0031300,0.785792533502465,0.308991761058524,12,154,intrinsic component of organelle membrane,CC,PTPRS;SYN1;SLC22A17;SYT1;CPT1A;PXMP2;GALNT2;TPST1;SV2A;STEAP2;COX18;DMPK
3947,GO:0008654,0.785808017109215,0.284119336760087,22,231,phospholipid biosynthetic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;MBOAT2;ISYNA1;PDGFA;ACSL3;LPCAT2;SLC27A1;PLA2G6;PIK3R1;FGFR1;MTMR4;ATM;DGKQ;ETNK2;PGAP1;PIKFYVE;AGPAT1;MPPE1;PIK3C2B
11350,GO:0045739,0.785845468886781,0.411505881639114,3,40,positive regulation of DNA repair,BP,EGFR;FAM168A;NPAS2
10504,GO:0043457,0.786063263938323,0.560477167795922,1,16,regulation of cellular respiration,BP,SNCA
10584,GO:0043584,0.786220764460292,0.570607569749061,1,10,nose development,BP,GLI3
6055,GO:0019208,0.78629826961246,0.350873241122121,6,71,phosphatase regulator activity,MF,PHACTR3;ELFN2;B3GAT3;SBF2;PPP2R3A;DMPK
2354,GO:0005452,0.786418952001229,0.565649847876717,1,12,inorganic anion exchanger activity,MF,SLC22A17
2965,GO:0006506,0.786929412099647,0.455003520401289,2,32,GPI anchor biosynthetic process,BP,PGAP1;MPPE1
7624,GO:0032042,0.787125316024569,0.561298825365538,1,14,mitochondrial DNA metabolic process,BP,PRIMPOL
6018,GO:0019081,0.787263348552657,0.561089157968911,1,14,viral translation,BP,EIF2AK4
14956,GO:0070897,0.78797713871623,0.408810823628857,3,39,DNA-templated transcriptional preinitiation complex assembly,BP,TP53;THRA;TAF1
2864,GO:0006359,0.787992620547452,0.456705601082427,2,25,regulation of transcription by RNA polymerase III,BP,PRDX5;NAB2
2581,GO:0005876,0.788423770814706,0.362561230526016,5,56,spindle microtubule,CC,PARP4;NCOR1;ARL3;CAPN6;KLHL22
11476,GO:0045980,0.788888839101036,0.454823690696803,2,26,negative regulation of nucleotide metabolic process,BP,DDIT4;SNCA
1424,GO:0003382,0.789757033601008,0.456203022618143,2,22,epithelial cell morphogenesis,BP,COL18A1;FLNB
9329,GO:0035855,0.790245537263574,0.559836257722329,1,12,megakaryocyte development,BP,ZFPM1
6643,GO:0023061,0.790334190019727,0.275913541405659,24,244,signal release,BP,SYT8;SFRP1;ANO1;IRS2;EGFR;NR1D1;SYN1;LTBP4;PLA2G6;SYTL1;SYT1;CPT1A;PCLO;SNCA;FGFR1;ISL1;PRKCA;SEPT5;C2CD4C;ITPR2;EFNA5;FZD4;PPP3CA;ABAT
7648,GO:0032088,0.790593637837813,0.358353468051551,5,65,negative regulation of NF-kappaB transcription factor activity,BP,PYCARD;CAT;MAP2K5;CDKN2A;CDK5RAP3
7249,GO:0031227,0.790652597464449,0.312570836650316,10,126,intrinsic component of endoplasmic reticulum membrane,CC,PKD2;WFS1;ESYT2;CALR;G6PC3;SPPL2B;RHBDD1;HSPA5;DERL3;EDEM1
3427,GO:0007218,0.790727847439658,0.552344357219484,1,17,neuropeptide signaling pathway,BP,NTSR1
16132,GO:0090181,0.79107383031643,0.377143813836428,4,49,regulation of cholesterol metabolic process,BP,SEC14L2;ACACB;DGKQ;LMF1
14090,GO:0060977,0.791118319643832,0.563196478681958,1,10,coronary vasculature morphogenesis,BP,TGFBR3
4186,GO:0009267,0.79142988044909,0.312177269992447,10,114,cellular response to starvation,BP,SFRP1;GAS6;SESN3;EIF2AK4;TP53;SESN1;CTSV;SLC38A2;HSPA5;PIK3C2B
17742,GO:1901796,0.791521380040333,0.295251039331874,14,160,regulation of signal transduction by p53 class mediator,BP,SNAI2;TP53;CHD3;RMI2;TP53INP1;TP73;CHEK2;PRKAB2;PLA2R1;ATM;MDM2;PRKAG1;TAF1;CDK5RAP3
7039,GO:0030823,0.791806359195903,0.555657757893093,1,13,regulation of cGMP metabolic process,BP,NOS1
4955,GO:0015035,0.792013292803154,0.547964792387844,1,20,protein disulfide oxidoreductase activity,MF,ERO1B
12985,GO:0051445,0.792019283708004,0.449711985964985,2,27,regulation of meiotic cell cycle,BP,PRKACB;CALR
12752,GO:0051054,0.792391374012323,0.288405315482302,16,181,positive regulation of DNA metabolic process,BP,PDGFC;EGFR;BMP4;PDGFA;E2F7;KITLG;GLI2;FGFR1;IGF1R;CALR;ATM;CST3;AREG;HMBOX1;FAM168A;NPAS2
12906,GO:0051290,0.792481945530579,0.44399192806109,2,43,protein heterotetramerization,BP,S100A10;ANXA2
7909,GO:0032495,0.792601368318165,0.556220955463411,1,12,response to muramyl dipeptide,BP,ARHGEF2
16036,GO:0090022,0.792821554776483,0.547421516278106,1,19,regulation of neutrophil chemotaxis,BP,MOSPD2
8757,GO:0034451,0.792876324555675,0.451633857796744,2,22,centriolar satellite,CC,FLOT1;BBS4
9919,GO:0042287,0.792917614032847,0.549961938866979,1,16,MHC protein binding,MF,PILRB
16746,GO:0098586,0.793095598681191,0.402555869682919,3,36,cellular response to virus,BP,TKFC;DDX60;SEC14L1
8758,GO:0034452,0.793144238128582,0.560095633173668,1,10,dynactin binding,MF,BBS4
1655,GO:0004112,0.793151870578002,0.555372124225871,1,12,cyclic-nucleotide phosphodiesterase activity,MF,PDE4D
18039,GO:1902624,0.793154554685335,0.546903572237044,1,19,positive regulation of neutrophil migration,BP,MOSPD2
8957,GO:0035064,0.793291167561123,0.356065427556957,5,56,methylated histone binding,MF,CBX5;PHF2;ING4;TAF1;KDM4A
17254,GO:0140034,0.793291167561123,0.356065427556957,5,56,methylation-dependent protein binding,MF,CBX5;PHF2;ING4;TAF1;KDM4A
14531,GO:0070085,0.793300828849004,0.280618970117355,19,205,glycosylation,BP,ST6GALNAC2;ADAMTSL1;GALNT10;MUC19;B3GAT3;FUT10;ST6GAL2;MAN1A1;ADAMTS7;TRAK1;POGLUT1;GCNT1;LMF1;ALG10;GALNT2;DERL3;COG3;UGGT2;TUSC3
8572,GO:0034086,0.793479997484598,0.554865449811497,1,12,maintenance of sister chromatid cohesion,BP,NIPBL
8574,GO:0034088,0.793479997484598,0.554865449811497,1,12,maintenance of mitotic sister chromatid cohesion,BP,NIPBL
15047,GO:0071044,0.793574629169677,0.556852024465225,1,11,histone mRNA catabolic process,BP,ATM
15210,GO:0071397,0.793864030687684,0.556405531197066,1,11,cellular response to cholesterol,BP,ABCA1
4976,GO:0015103,0.794092751330222,0.330690282554094,7,76,inorganic anion transmembrane transporter activity,MF,ANO1;CLCA2;SLC20A1;ANO6;SLC22A17;ABCC2;ANKH
4504,GO:0010559,0.794336292819081,0.446300972559957,2,27,regulation of glycoprotein biosynthetic process,BP,ITM2C;ITM2A
12799,GO:0051131,0.794567920096413,0.54638761099056,1,17,chaperone-mediated protein complex assembly,BP,CLU
12654,GO:0050892,0.794702791070448,0.551178032385397,1,13,intestinal absorption,BP,VDR
1702,GO:0004197,0.794714769154879,0.339634389353604,6,73,cysteine-type endopeptidase activity,MF,SFRP1;PYCARD;CTSV;CASP14;CAPN6;CTSD
14521,GO:0070069,0.795234110922503,0.54171136122636,1,22,cytochrome complex,CC,NDUFA4L2
2710,GO:0006086,0.795491172250694,0.549951340528117,1,13,acetyl-CoA biosynthetic process from pyruvate,BP,PDK3
6647,GO:0030004,0.795768608362935,0.33824574377477,6,73,cellular monovalent inorganic cation homeostasis,BP,SLC8A1;KCNMA1;TP53;TMEM175;KCTD7;SLC9A4
9862,GO:0042147,0.796669390831369,0.337629991986125,6,68,retrograde transport, endosome to Golgi,BP,CLTCL1;SNX1;TBC1D5;EHD3;PIKFYVE;RHOBTB3
14939,GO:0070873,0.797009567953351,0.446359695979873,2,21,regulation of glycogen metabolic process,BP,IRS2;ENPP1
4148,GO:0009214,0.797166065906558,0.551280735940356,1,11,cyclic nucleotide catabolic process,BP,PDE4D
17059,GO:0099623,0.797342326733074,0.551005596941215,1,11,regulation of cardiac muscle cell membrane repolarization,BP,GJA5
10781,GO:0044281,0.797426453533926,0.230123772366652,138,1497,small molecule metabolic process,BP,SULT1E1;PRODH;INPP5D;NQO1;DDIT4;PTGS1;SLC7A8;PKD2;IRS2;H6PD;NOS1;SNAI2;ITPK1;SLC2A3;CRTAP;CSPG4;TKFC;NTSR1;DCAKD;TIMP2;ABCA1;VDR;APOBEC3C;ISYNA1;TP53I3;NR1D1;SORL1;D2HGDH;EXTL2;SEC14L2;DLG4;SLC27A3;NISCH;ACSL3;PHGDH;BCKDHB;SIK1;TYSND1;GPX1;PTGES;ECH1;ERO1B;MTHFR;ABHD14B;KCNAB2;NMRK1;XDH;B3GAT3;FUT10;CPS1;CAV1;SLC27A1;HLCS;GLDC;OSBPL5;XYLT1;UST;ACSS1;SDR16C5;CHST3;HIBADH;ALDH3A2;CPT1A;ACACB;APOBEC3G;CES2;CAT;PLCH2;AARS;BPHL;SNCA;OARD1;ALDH1L2;MME;FGFR1;CBR1;APOBEC3F;ALOX15B;PRKAB2;PDE4D;NCOA2;PSMB9;PDK3;G6PD;DHTKD1;IDH2;DGKQ;GCLC;ACSS2;HEXA;AKR7A2;ALDH4A1;THNSL2;EGR1;ENPP1;ITPKB;SLC27A6;NCOR1;G6PC3;PRPS2;TRERF1;LEPR;MAN2B1;IGFBP4;NMNAT2;DECR1;ABCC2;ACSF2;GGT7;DSEL;GPR161;ZADH2;ALDH7A1;CYP4V2;OSBPL1A;NPHP3;TH;NAPRT;UGT1A3;LMF1;UGT1A6;SRR;PPARG;TPST1;PRKAG1;GSTZ1;DPYD;PPCS;DNPH1;AIG1;ACOT1;SCPEP1;EHHADH;ABAT;UGGT2;RXRA;CPT2;ACAA2
15241,GO:0071450,0.797654273123542,0.540649771998699,1,18,cellular response to oxygen radical,BP,NQO1
15242,GO:0071451,0.797654273123542,0.540649771998699,1,18,cellular response to superoxide,BP,NQO1
14646,GO:0070286,0.797819102430583,0.550260553092459,1,11,axonemal dynein complex assembly,BP,DNAH1
2638,GO:0005977,0.798253197214464,0.349567567474814,5,55,glycogen metabolic process,BP,PYGB;IRS2;NR1D1;PHKA2;ENPP1
18271,GO:1903204,0.798595154911099,0.543553386174776,1,14,negative regulation of oxidative stress-induced neuron death,BP,FZD1
3658,GO:0008144,0.798620581674935,0.229000471398445,139,1265,drug binding,MF,PYGB;SFRP1;MYH15;TGFBR2;PIK3C2G;TNIK;NOS1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;FKBP5;MYLK;ACTA2;ATP10D;TKFC;MAP3K6;DCAKD;PAK1;ABCA1;VDR;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;GLDC;MAP3K14;SMARCA1;ACSS1;FKBP9;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;FSCN1;SETX;PDE4D;MYO3B;OBSCN;PDK3;EPHB6;CHD6;ATM;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;THNSL2;NRK;ENPP1;ITPKB;STK16;DDX60L;PRKCA;PRPS2;ETNK2;HLTF;NMNAT2;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;HTR1B;STK36;RET;MAP2K5;LIG1;ULK1;ORC4;HSPA5;CDK19;TH;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;PPARG;ICK;FKBP10;RARA;ABCA2;PRKAG1;TAF1;PPP3CA;PIK3C2B;PEX1;ACTR1B;ABAT;MYH11;TTBK2;RHOBTB3;MYO1C;ABCA5;TAOK3;DMPK
3238,GO:0006896,0.799281705487061,0.542470015043486,1,14,Golgi to vacuole transport,BP,EHD3
13028,GO:0051546,0.799401704852063,0.543819560926419,1,13,keratinocyte migration,BP,MMP9
15312,GO:0071565,0.799443367163229,0.545561205968187,1,12,nBAF complex,CC,SMARCA2
4521,GO:0010591,0.799784839665719,0.439319382899613,2,25,regulation of lamellipodium assembly,BP,FSCN1;SSH1
1475,GO:0003746,0.799858137392951,0.539075179089994,1,16,translation elongation factor activity,MF,ABTB1
2343,GO:0005385,0.799941389991052,0.540099138482535,1,15,zinc ion transmembrane transporter activity,MF,SLC39A11
15318,GO:0071577,0.799941389991052,0.540099138482535,1,15,zinc ion transmembrane transport,BP,SLC39A11
12542,GO:0050718,0.800002213693337,0.541330427570817,1,14,positive regulation of interleukin-1 beta secretion,BP,PYCARD
7298,GO:0031312,0.800058285322854,0.437304242372334,2,28,extrinsic component of organelle membrane,CC,SNX10;ULK1
2964,GO:0006505,0.800207903106161,0.435081378261456,2,33,GPI anchor metabolic process,BP,PGAP1;MPPE1
3313,GO:0007019,0.8002868278605,0.393869292647462,3,32,microtubule depolymerization,BP,STMN3;ARHGEF2;TTBK2
19657,GO:2000001,0.800374192258704,0.538255847140262,1,16,regulation of DNA damage checkpoint,BP,CHEK2
7466,GO:0031641,0.801154645459297,0.437268356974947,2,25,regulation of myelination,BP,TENM4;RARA
1550,GO:0003951,0.801580309654621,0.540369024712372,1,13,NAD+ kinase activity,MF,DGKQ
16724,GO:0098533,0.801586868862571,0.54035859842705,1,13,ATPase dependent transmembrane transport complex,CC,ABCA2
11654,GO:0046460,0.801727691011275,0.435295331361915,2,27,neutral lipid biosynthetic process,BP,SIK1;ANG
11657,GO:0046463,0.801727691011275,0.435295331361915,2,27,acylglycerol biosynthetic process,BP,SIK1;ANG
10528,GO:0043501,0.802027583553947,0.541471832684337,1,12,skeletal muscle adaptation,BP,PPP3CA
391,GO:0001047,0.802097404592202,0.294264071674094,11,116,core promoter binding,MF,NR1D1;NR3C1;STAT1;TP53;E2F7;HMGA2;SOX9;PPARG;TAF1;FOS;NPAS2
5308,GO:0016024,0.802289204579951,0.539240876312683,1,13,CDP-diacylglycerol biosynthetic process,BP,AGPAT1
13203,GO:0051895,0.802402527371424,0.540875576223333,1,12,negative regulation of focal adhesion assembly,BP,DLC1
916,GO:0002312,0.802614249060741,0.361033587679588,4,50,B cell activation involved in immune response,BP,LGALS1;DOCK11;BCL6;ITM2A
6279,GO:0019894,0.803034609834606,0.389102683984158,3,34,kinesin binding,MF,SNCA;MAPK8IP3;TTBK2
4979,GO:0015108,0.803082691123511,0.388311949289665,3,36,chloride transmembrane transporter activity,MF,ANO1;CLCA2;ANO6
12653,GO:0050891,0.803194235635351,0.361310189838079,4,45,multicellular organismal water homeostasis,BP,FLG;WFS1;PRKACB;SCNN1A
17801,GO:1901987,0.803625319221389,0.249594368612139,34,378,regulation of cell cycle phase transition,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;EGFR;GJC2;TP53;CEP250;CNTRL;GPNMB;TFDP2;E2F7;CTDSPL;HMGA2;KANK2;HAUS4;TP73;CHEK2;FBXL7;PSMB9;FOXN3;PBX1;ATM;MDM2;RBL2;ODF2;FHL1;CDKN2A;TAF1;CTDSP2;KLHL22;CDK5RAP3;TAOK3
12787,GO:0051119,0.803905481474848,0.535109552965265,1,14,sugar transmembrane transporter activity,MF,SLC2A3
132,GO:0000278,0.804189780590139,0.228856237491134,90,906,mitotic cell cycle,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;TNIK;SKP2;CLTCL1;EGFR;CEP126;GJC2;TOM1L2;TIMP2;TADA3;PAK1;BMP4;TP53;CEP250;CNTRL;CUL9;EFHC1;GPNMB;TFDP2;CUL7;BTG1;SIK1;TTC28;CDK14;E2F7;CTDSPL;NEK9;SNX33;MAP3K14;HMGA2;KANK2;HAUS4;NCAPD2;ANK3;SPRY2;TTN;TMEM8B;TP73;CHEK2;FBXL7;FGFR1;LMNA;PSMB9;AFAP1L2;CDH13;FOXN3;SEPT6;PBX1;BBS4;ATM;MDM2;MEIS2;LZTS1;MAP3K1;ARHGEF2;NRK;BCL6;PRKCA;MYBL1;RGS14;SEPT5;PAK6;RBL2;MAP2K5;ODF2;LIG1;FHL1;CDKN2A;ORC4;MAGI2;CDK19;CENPA;SNX9;OBSL1;PTPN3;ARL3;CCNY;PPP3CA;RASA1;CTDSP2;SEPT9;KLHL22;CDK5RAP3;NIPBL;PRDM5;TAOK3
16056,GO:0090051,0.804444082161398,0.535795194526857,1,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,MAP2K5
4477,GO:0010499,0.805301774281233,0.525652491218294,1,22,proteasomal ubiquitin-independent protein catabolic process,BP,PSMB9
12101,GO:0048194,0.806021690960216,0.324843422911902,6,71,Golgi vesicle budding,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12;MIA3
5842,GO:0017144,0.806253602987563,0.239475041607655,45,527,drug metabolic process,BP,SULT1E1;NQO1;DDIT4;PKD2;NOS1;EGFR;CSPG4;GPX1;LPCAT2;MTHFR;CPS1;CAV1;HLCS;GLDC;UST;ACSS1;CLU;PRDX5;ALDH3A2;ACACB;CAT;SNCA;ALDH1L2;CBR1;DHTKD1;LRTOMT;IDH2;DGKQ;ACSS2;AKR7A2;EGR1;ENPP1;NCOR1;BCHE;PRPS2;ABCC2;TGFB2;GGT7;DSEL;TH;SRR;PRKAG1;GSTZ1;DPYD;ABAT
6618,GO:0022857,0.806538005069308,0.236275968376262,52,534,transmembrane transporter activity,MF,SLC7A8;ANO1;GJA5;PKD2;JPH2;GAS6;SLC8A1;ORAI3;CLCA2;GJC2;SLC20A1;SLC2A3;ABCA1;SCN8A;SCN2A;KCNMA1;DLG4;SLC7A11;SLC22A15;ANO6;KCNAB2;SLC27A1;SLC22A17;KCNJ15;SLC38A10;SLC38A2;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;SLC25A35;SLC27A6;SLC48A1;TMEM63C;TMEM175;ABCC2;SLC39A11;SCNN1A;SFXN3;SLC9A4;ITPR2;CACNB1;KCNIP3;SV2A;ABCA2;ANKH;CACNA2D3;TUSC3;ORAI2;ABCA5
3359,GO:0007098,0.806668504113668,0.293307174571892,10,108,centrosome cycle,BP,PKD2;CEP250;CHD3;HAUS4;CNTLN;BBS4;CEP68;ODF2;UVRAG;TMEM67
787,GO:0002052,0.806728142402459,0.533942336122644,1,12,positive regulation of neuroblast proliferation,BP,GLI3
15424,GO:0071786,0.806866797778181,0.528995350766506,1,15,endoplasmic reticulum tubular network organization,BP,REEP2
7147,GO:0031018,0.806971504037487,0.42790413538101,2,26,endocrine pancreas development,BP,BMP4;SOX9
12855,GO:0051219,0.806975748877644,0.324437585239911,6,64,phosphoprotein binding,MF,PKD2;PIK3R1;SNCA;VAV2;PTPN3;RASA1
14941,GO:0070875,0.807175482228985,0.538032867113187,1,10,positive regulation of glycogen metabolic process,BP,IRS2
10774,GO:0044267,0.807188683721998,0.210807029084121,396,3916,cellular protein metabolic process,BP,SERPINE2;PHACTR3;CPA4;TNFRSF6B;FLOT1;MMP2;PRSS23;FN1;FLRT2;MMP9;CCBE1;GPRC5A;CTGF;FBN1;SFRP1;ST6GALNAC2;GADD45B;CD109;CDKN2B;ZFP36L1;F2R;DDIT4;TGFBR2;ADAMTSL1;EFEMP1;MARCH4;GSN;PKD2;IRS2;DUSP6;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;NOS1;GAS6;PDGFC;SNAI2;MAGED1;PHF21A;TFPI2;ROR1;AXL;EGFR;GALNT10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NTM;FKBP5;MYLK;GJC2;TRIM2;SERPINE1;SERPINH1;RNF213;CRTAP;RNF165;VIM;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;ABCA1;PTPRM;PADI3;BMP4;TRIM38;NR1D1;PTK6;ABTB1;EIF2AK4;TRIM5;NEFL;PDCD4;BTBD2;SORL1;LGALS1;D2HGDH;CPVL;TP53;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;LTBP1;WNK1;MUC19;DLG4;ITGA2;PILRB;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;FLG;HIP1;GPNMB;CRIM1;CUL7;BTG1;CHD3;SIK1;ELFN2;GPX1;CDK14;CNTN1;KITLG;P3H2;ERO1B;CTDSPL;MTHFR;NEK9;CTSV;LRP1;FYN;IFI6;XDH;ALPK1;B3GAT3;FUT10;CAV1;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;TRIB2;SEL1L;SNX33;MAP3K14;DCAF16;UST;CLU;FKBP9;SERPING1;PRKCZ;SDR16C5;FBXW4;ULK2;PARP4;TNS2;HMGA2;CAMK2D;PRDX5;ITGA1;MST1R;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;CAPRIN2;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;SPRY2;TTN;CIRBP;JARID2;LMO7;APLP2;FBLN1;TP73;DAPK1;ST6GAL2;DLC1;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PHF2;TLR3;MAN1A1;FBXL7;SNCA;ADAMTS7;PDIA6;FZD7;GLG1;JADE2;PTPRU;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;TGFBI;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;IL18;OBSCN;SPATA18;PDK3;G6PD;EPHB6;ARSD;EDA2R;FZD8;TRIOBP;KDM4C;AFAP1L2;MAGEF1;LMCD1;TGFBR3;FZD1;IPP;ENG;MTMR4;CALR;NEGR1;ATM;FBXO17;APH1B;MDM2;FAM20A;CST3;MANBA;AREG;IFNK;AKAP13;DNAJC6;DGKQ;GCLC;NR2F2;IFNE;NEURL1B;TRAK1;FBXW8;HDAC11;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;KLHL12;SDC2;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;NCOR1;GCNT1;PRKCA;ANXA2;RGS14;RAB13;HLTF;RNF24;MAN2B1;PGAP1;IGFBP4;MVB12B;KCTD7;ANAPC16;RPL13A;PAK6;NAB2;MAP3K12;STK36;PRNP;RET;TGFB2;MAP2K5;STAT2;LEF1;CDC42EP5;USP28;MAPK8IP3;MSRB2;TRIML2;CDKN2A;PPM1M;SPPL2B;ULK1;TSPYL2;IGFBP2;RHBDD1;MAGI2;HSPA5;CDK19;KLHL5;TGFB1I1;SRPK2;UVRAG;MDFIC;SAP30L;OPHN1;TPGS1;LMF1;GDNF;ALG10;NUB1;KLHL3;ATRAID;YEATS2;UBA7;GALNT2;DERL3;PPARG;RNF144B;PARP15;BEX4;TPST1;MEF2A;SNX9;ICK;SASH1;OBSL1;ING4;ZYG11B;UNK;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;CCNY;TMEM67;PCMTD2;PRKAG1;TAF1;EFNA5;FZD4;MPPE1;PPP3CA;DCAF8;RASA1;CTDSP2;KRT10;KDM4A;KLHL22;CDK5RAP3;AGO4;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;PPP2R3A;TUSC3;RXRA;EDEM1;GID4;TAOK3;ZNRF1;DMPK;LAMB2
12534,GO:0050710,0.807227483017188,0.425602238662222,2,30,negative regulation of cytokine secretion,BP,FN1;GAS6
8992,GO:0035173,0.807396377678297,0.529477255909923,1,14,histone kinase activity,MF,PRKCA
2270,GO:0005215,0.807839951084346,0.229830836717597,67,679,transporter activity,MF,SLC7A8;ANO1;GJA5;PKD2;PITPNM3;JPH2;OSBPL10;GAS6;SLC8A1;ORAI3;CLCA2;GJC2;SLC20A1;SLC2A3;ATP10D;ABCA1;SCN8A;SCN2A;KCNMA1;DLG4;SLC7A11;SLC22A15;ANO6;SYN1;KCNAB2;LRP1;SLC27A1;SLC22A17;OSBPL5;KCNJ15;ATP8B2;SLC38A10;SLC38A2;CALHM2;KCNJ5;SLC24A1;ANXA6;KCNQ3;NDUFA4L2;SLC25A35;SLC27A6;SLC48A1;TMEM63C;TMEM175;ABCC2;SLC39A11;SCNN1A;SFXN3;OSBPL1A;SLC9A4;ITPR2;CACNB1;PITPNC1;CALCRL;KCNIP3;MIA3;COG3;RASSF9;SV2A;ABCA2;ANKH;STEAP2;COX18;CACNA2D3;TUSC3;ORAI2;ABCA5
13083,GO:0051646,0.807865502575745,0.381739737825108,3,35,mitochondrion localization,BP,NEFL;TRAK1;MEF2A
12952,GO:0051382,0.807984059698538,0.528522607461213,1,14,kinetochore assembly,BP,CENPA
136,GO:0000287,0.808159270173511,0.275070487253316,14,154,magnesium ion binding,MF,ITPK1;ATP10D;MAP3K6;WNK1;SIK1;ATP8B2;PRKACB;SNCA;IDH2;GCLC;PRPS2;SRPK2;SRR;ICK
16234,GO:0090322,0.808178438386019,0.523757442252457,1,18,regulation of superoxide metabolic process,BP,EGFR
11444,GO:0045922,0.808913050402091,0.525665423004529,1,15,negative regulation of fatty acid metabolic process,BP,ACACB
2757,GO:0006171,0.808915856071658,0.425519825491885,2,25,cAMP biosynthetic process,BP,TIMP2;GPR161
17792,GO:1901976,0.809078713244716,0.422778611259728,2,30,regulation of cell cycle checkpoint,BP,CHEK2;NDRG1
13474,GO:0055070,0.809452185500862,0.523613050708372,1,16,copper ion homeostasis,BP,PRNP
7207,GO:0031112,0.809879826275529,0.424676285491781,2,24,positive regulation of microtubule polymerization or depolymerization,BP,PAK1;RGS2
4975,GO:0015101,0.810006915904867,0.52270390865375,1,16,organic cation transmembrane transporter activity,MF,SLC7A8
13349,GO:0052629,0.810405958991069,0.530154096849935,1,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,MTMR4
9038,GO:0035278,0.810646124596428,0.527574641828811,1,12,miRNA mediated inhibition of translation,BP,AGO4
9788,GO:0040033,0.810646124596428,0.527574641828811,1,12,negative regulation of translation, ncRNA-mediated,BP,AGO4
11473,GO:0045974,0.810646124596428,0.527574641828811,1,12,regulation of translation, ncRNA-mediated,BP,AGO4
10310,GO:0043124,0.810746736014196,0.377537784312651,3,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,STAT1;PYCARD;PER1
17871,GO:1902187,0.811076776190753,0.52346757842226,1,14,negative regulation of viral release from host cell,BP,TRIM5
3137,GO:0006733,0.81114953813278,0.277992360656061,12,142,oxidoreduction coenzyme metabolic process,BP,DDIT4;H6PD;TP53I3;KCNAB2;NMRK1;G6PD;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
9875,GO:0042175,0.811232370351546,0.223954617093671,75,804,nuclear outer membrane-endoplasmic reticulum membrane network,CC,FLRT2;SYNE1;PTGS1;PKD2;JPH2;SCARA3;NOS1;EGFR;FLRT3;SYNE3;ATP10D;MBOAT2;ABCA1;NSG1;MEST;EXTL2;ACSL3;PTGES;LPCAT2;ERO1B;CAV1;SEL1L;OSBPL5;XYLT1;SDR16C5;CAMK2D;ATP8B2;PIK3R1;HHAT;TMEM173;CREB3L2;ALDH3A2;HERPUD1;WFS1;TLR3;SNCA;PDIA6;MLEC;SEC24D;TMEM129;ESYT2;CALR;COPG2;TMED10;AREG;CD1D;SYNE2;PTPN1;PLD3;G6PC3;TMEM50B;PGAP1;CYP4V2;SPPL2B;ULK1;RHBDD1;HSPA5;REEP2;RSAD2;ITPR2;UGT1A3;LMF1;UGT1A6;ALG10;GALNT2;DERL3;AGPAT1;CERS5;MIA3;DNAJC3;TMEM67;TUSC3;EDEM1;DMPK;MOSPD3
8787,GO:0034505,0.811487866598802,0.526195520674642,1,12,tooth mineralization,BP,FAM20A
2569,GO:0005858,0.811743597406511,0.538059776886842,1,8,axonemal dynein complex,CC,DNAH1
6253,GO:0019843,0.811779949531487,0.371435815111369,3,56,rRNA binding,MF,ANG;CIRBP;MDM2
10805,GO:0044319,0.812665298421078,0.419764766199888,2,25,wound healing, spreading of cells,BP,COL5A1;PDPN
16291,GO:0090505,0.812665298421078,0.419764766199888,2,25,epiboly involved in wound healing,BP,COL5A1;PDPN
3657,GO:0008143,0.812772277619477,0.520673863649268,1,14,poly(A) binding,MF,RBMS3
7204,GO:0031109,0.813476042630614,0.297086470504295,8,86,microtubule polymerization or depolymerization,BP,STMN3;PAK1;MAP2;EML2;SNCA;RGS2;ARHGEF2;TTBK2
12907,GO:0051291,0.813491730297236,0.303368446177589,7,100,protein heterooligomerization,BP,S100A10;C1QTNF6;PRKCZ;SYT1;ANXA2;MAGI2;SEPT9
9062,GO:0035330,0.813505795862243,0.525069072594739,1,11,regulation of hippo signaling,BP,DLG5
8010,GO:0032655,0.813718620654702,0.415248759405554,2,31,regulation of interleukin-12 production,BP,TLR3;ISL1
8131,GO:0032869,0.813933144357496,0.265211764281607,15,158,cellular response to insulin stimulus,BP,ZFP36L1;IRS2;SESN3;PAK1;STAT1;PRKCZ;PIK3R1;IGF1R;GCLC;PTPN1;ENPP1;RAB13;PPARG;MYO1C;C2CD5
13972,GO:0060716,0.814041025234161,0.516041420109625,1,16,labyrinthine layer blood vessel development,BP,FBXW8
944,GO:0002360,0.814041333740894,0.520142851710193,1,13,T cell lineage commitment,BP,ZFPM1
6439,GO:0021762,0.814094298434181,0.415065031471491,2,30,substantia nigra development,BP,G6PD;HSPA5
9085,GO:0035372,0.814283908802734,0.519740603948625,1,13,protein localization to microtubule,BP,TTBK2
3272,GO:0006953,0.814357253281948,0.514480000665347,1,17,acute-phase response,BP,FN1
15755,GO:0072393,0.81499475545102,0.522607208719583,1,11,microtubule anchoring at microtubule organizing center,BP,BBS4
7964,GO:0032589,0.815324569792906,0.416282057980283,2,24,neuron projection membrane,CC,SHISA9;MYO1C
2704,GO:0006073,0.815409284425539,0.325924067310089,5,56,cellular glucan metabolic process,BP,PYGB;IRS2;NR1D1;PHKA2;ENPP1
10699,GO:0044042,0.815409284425539,0.325924067310089,5,56,glucan metabolic process,BP,PYGB;IRS2;NR1D1;PHKA2;ENPP1
3625,GO:0008088,0.815473120083539,0.3433291323027,4,48,axo-dendritic transport,BP,NEFL;SPG11;KIF17;TRAK1
9783,GO:0040020,0.815591422027594,0.513456734982953,1,16,regulation of meiotic nuclear division,BP,CALR
3548,GO:0007585,0.816002386106128,0.369134809259023,3,37,respiratory gaseous exchange,BP,CCBE1;NTSR1;TSHZ3
7394,GO:0031468,0.816078168940613,0.510686386010914,1,18,nuclear envelope reassembly,BP,LMNA
2540,GO:0005802,0.816106518843242,0.262287663810239,15,166,trans-Golgi network,CC,MARCH4;CLTCL1;NSG1;SORL1;ARAP1;BACE1;TGFBI;GCNT1;RAB13;NMNAT2;RAB43;SNX9;POSTN;COG3;RHOBTB3
6976,GO:0030663,0.816191675035656,0.510496046867434,1,18,COPI-coated vesicle membrane,CC,COPG2
264,GO:0000732,0.816479076152264,0.413856564490029,2,25,strand displacement,BP,RMI2;ATM
8244,GO:0033036,0.816665468765576,0.204292490310557,232,2268,macromolecule localization,BP,ITGB6;FLOT1;FN1;TXNIP;FBN1;MARVELD1;SFRP1;ZFP36L1;SYNE1;F2R;TLN2;TGFBR2;ANO1;GSN;ETV5;GJA5;PKD2;PITPNM3;IRS2;OSBPL10;IGF2BP2;TNIK;CLTCL1;TNS4;GAS6;FBN2;TCAF1;MALL;EGFR;SYNE3;ATP10D;S100A10;TOM1L2;NTSR1;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;TRIM5;SORL1;MEST;TP53;CEP250;PRICKLE1;DDIT3;PYCARD;LTBP1;IFIT1;DLG4;ITGA2;ACSL3;HIP1;PACS1;TFDP2;ITGA3;EVI5L;SNX1;ANO6;GLI3;DLG5;TBC1D5;PLLP;KCNAB2;LRP1;FYN;B3GAT3;FUT10;UGT8;CAV1;SLC27A1;PLA2G6;SEL1L;SNX33;OSBPL5;CLU;PRKCZ;EHD3;GOLGB1;SYTL1;PTPN14;ATP8B2;EHBP1;PDIA4;PIK3R1;HHAT;TMEM173;CPT1A;ACACB;PCLO;ANG;KIF17;LAMA5;BBS2;CNTLN;HERPUD1;ANK3;MDFI;TTN;HPS4;MLH3;TP73;BTN3A1;IFT140;STOM;FLOT2;AIP;SH3TC2;PTPRU;DZIP1L;LMNA;ALOX15B;PRKAB2;SEC24D;C5;ASTN2;TMEM129;NCOA2;OBSCN;PLA2R1;ESYT2;AKAP7;SEPT6;LRTOMT;BBS4;CALR;ATM;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;SYNE2;PTPN1;VANGL2;ARHGEF2;SSH1;LYST;SOX9;ENPP1;IFT27;ISL1;SLC27A6;BCL6;NFASC;NCOR1;TMEM50B;PRKCA;ANXA2;RAB13;MPP7;SEPT5;CEP68;PGAP1;MVB12B;TTC8;RPL13A;ABCC2;TSPAN5;RAB43;WDR19;TAF8;PRNP;TGFB2;ODF2;VPS39;IFT122;THRA;EFR3A;OSBPL1A;SP100;ULK1;AGRN;RHBDD1;MAGI2;AGAP1;HSPA5;GOPC;SNX7;CENPA;PIKFYVE;REEP2;RSAD2;FLNB;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;DERL3;PITPNC1;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;OBSL1;APOL6;POSTN;ARL3;MIA3;COG3;RASSF9;ABCA2;EFNA5;FZD4;PPP3CA;PEX1;COX18;SEPT9;CDK5RAP3;ABAT;NIPBL;VPS36;TTBK2;BSN;CELSR1;ATG16L2;MYO1C;RXRA;C2CD5;CPT2;EDEM1;ABCA5;NFKBIE
5527,GO:0016514,0.816932622799216,0.515326622784214,1,13,SWI/SNF complex,CC,SMARCA2
11612,GO:0046341,0.817226700040964,0.513257195418091,1,14,CDP-diacylglycerol metabolic process,BP,AGPAT1
8112,GO:0032813,0.817387736231641,0.408832727933071,2,33,tumor necrosis factor receptor superfamily binding,MF,STAT1;TRAF1
18213,GO:1903050,0.817407648713897,0.260438030975766,15,175,regulation of proteolysis involved in cellular protein catabolic process,BP,PRICKLE1;GPX1;CAV1;TRIB2;CLU;HERPUD1;MAGEF1;MDM2;GCLC;OPHN1;NUB1;DERL3;RNF144B;TAF1;EDEM1
12622,GO:0050853,0.817667857055123,0.410395737768402,2,28,B cell receptor signaling pathway,BP,VAV3;GCSAM
7822,GO:0032386,0.817693663661027,0.23685306632223,30,317,regulation of intracellular transport,BP,GAS6;TCAF1;PAK1;BMP4;SORL1;TP53;GLI3;SYN1;FYN;B3GAT3;PTPN14;HHAT;TMEM173;ANK3;HPS4;STOM;SH3TC2;MDM2;PTPN1;ANXA2;SEPT5;PRNP;SP100;REEP2;MDFIC;DERL3;ABCA2;MYO1C;C2CD5;EDEM1
2719,GO:0006101,0.81776239212588,0.408595753433468,2,32,citrate metabolic process,BP,DHTKD1;IDH2
9524,GO:0036294,0.817855917637144,0.2658216274052,13,157,cellular response to decreased oxygen levels,BP,SFRP1;ZFP36L1;SLC8A1;TP53;LMNA;PSMB9;PDK3;MDM2;CITED2;EGR1;NDRG1;HP1BP3;ACAA2
11566,GO:0046165,0.818034630715874,0.283554180861779,9,111,alcohol biosynthetic process,BP,NTSR1;VDR;ISYNA1;SEC14L2;ACACB;SNCA;G6PD;ITPKB;ACAA2
1238,GO:0002931,0.818367297302385,0.40930303297208,2,28,response to ischemia,BP,CAV1;EGR1
15227,GO:0071425,0.818948135747648,0.510360635758895,1,14,hematopoietic stem cell proliferation,BP,KITLG
988,GO:0002446,0.819066086051818,0.234048608949596,31,361,neutrophil mediated immunity,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
8803,GO:0034593,0.819179170962328,0.410960416438405,2,23,phosphatidylinositol bisphosphate phosphatase activity,MF,MTMR4;PIKFYVE
14108,GO:0061003,0.819418809798577,0.513004158534691,1,12,positive regulation of dendritic spine morphogenesis,BP,CAPRIN2
14965,GO:0070911,0.819731216788174,0.405514802817449,2,32,global genome nucleotide-excision repair,BP,XPC;DDB2
641,GO:0001832,0.820119836506114,0.508379266542425,1,14,blastocyst growth,BP,TAF8
3580,GO:0007628,0.820373905222087,0.511391051679454,1,12,adult walking behavior,BP,EFNB3
2959,GO:0006497,0.820454287555452,0.286503805099247,8,107,protein lipidation,BP,CD109;NTM;ABCA1;HHAT;NEGR1;NTNG1;PGAP1;MPPE1
13475,GO:0055072,0.820455374576401,0.317500680518689,5,66,iron ion homeostasis,BP,CYBRD1;NEO1;SLC22A17;SFXN3;STEAP2
5266,GO:0015919,0.820943879757944,0.504428371229258,1,16,peroxisomal membrane transport,BP,PEX1
3439,GO:0007250,0.821093319433216,0.504173927123347,1,16,activation of NF-kappaB-inducing kinase activity,BP,TLR3
17619,GO:1901381,0.821118412153226,0.512347445339183,1,11,positive regulation of potassium ion transmembrane transport,BP,ANO6
19400,GO:1990023,0.821146409412732,0.508221124873556,1,13,mitotic spindle midzone,CC,OR2A4
13089,GO:0051653,0.821597326070411,0.361858442954123,3,34,spindle localization,BP,SPRY2;ARHGEF2;CENPA
18368,GO:1903421,0.821667551410748,0.507335129237374,1,13,regulation of synaptic vesicle recycling,BP,SNCA
10057,GO:0042575,0.821747336373916,0.503058826820514,1,16,DNA polymerase complex,CC,POLD4
10860,GO:0044419,0.821937527415615,0.214425256976613,65,729,interspecies interaction between organisms,BP,ITGB6;FN1;ITGB5;GSN;PIK3C2G;ANPEP;GAS6;AXL;EGFR;VIM;CBX5;APOBEC3C;TRIM38;EIF2AK4;TRIM5;STAT1;LGALS1;TP53;IFIT1;ITGA2;ADARB1;PACS1;CUL7;GPX1;FYN;CAV1;OAS2;ULK2;HMGA2;ULBP1;PIK3R1;TMEM173;APOBEC3G;FBLN1;TP73;STOM;SP110;APOBEC3F;PSMB9;CHD6;SEPT6;EFNB3;MDM2;CD1D;CRTC1;ANXA2;IFITM2;MVB12B;RPL13A;RAB43;STAT2;LEF1;SP100;ULK1;CENPA;RSAD2;SRPK2;UVRAG;MDFIC;IFITM1;TAF1;KDM4A;MPDZ;ATG16L2;RXRA
6775,GO:0030220,0.821971494425185,0.505231711677565,1,14,platelet formation,BP,ZFPM1
12281,GO:0048643,0.821990700135028,0.505198959030651,1,14,positive regulation of skeletal muscle tissue development,BP,FLOT1
12844,GO:0051194,0.822035644800569,0.506708364644415,1,13,positive regulation of cofactor metabolic process,BP,SNCA
12509,GO:0050681,0.822612181227002,0.358700885476698,3,39,androgen receptor binding,MF,KDM4C;CALR;TGFB1I1
12262,GO:0048599,0.822690690330305,0.402506645774263,2,28,oocyte development,BP,ANG;ATM
18324,GO:1903321,0.822887749102579,0.31398253591348,5,67,negative regulation of protein modification by small protein conjugation or removal,BP,FYN;CAV1;PIAS3;GCLC;TAF1
7693,GO:0032183,0.823341772189246,0.504477886542983,1,13,SUMO binding,MF,NR3C1
17515,GO:1901071,0.823406801624272,0.500218161075537,1,16,glucosamine-containing compound metabolic process,BP,EXTL2
2837,GO:0006308,0.823718925720417,0.399996166856073,2,30,DNA catabolic process,BP,ATM;DNASE1L1
2637,GO:0005976,0.824038788395747,0.290692594656177,7,80,polysaccharide metabolic process,BP,PYGB;IRS2;NR1D1;PHKA2;GLT8D2;MANBA;ENPP1
7902,GO:0032486,0.8246454030656,0.502241509431766,1,13,Rap protein signal transduction,BP,TIMP2
12709,GO:0050999,0.82492443601526,0.398083332676181,2,30,regulation of nitric-oxide synthase activity,BP,EGFR;CAV1
8460,GO:0033617,0.824959160147486,0.494000937526451,1,20,mitochondrial respiratory chain complex IV assembly,BP,COX18
5622,GO:0016706,0.825037577338125,0.355349336118344,3,38,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,P3H2;KDM4C;KDM4A
5430,GO:0016298,0.825397455903037,0.298037314350769,6,76,lipase activity,MF,PLA2G6;CES2;PLCH2;PLD3;CES3;LIPA
13472,GO:0055067,0.825505083407764,0.288208742541788,7,86,monovalent inorganic cation homeostasis,BP,SLC8A1;KCNMA1;TP53;TMEM175;KCTD7;SCNN1A;SLC9A4
12102,GO:0048199,0.825644692643357,0.310464110860923,5,64,vesicle targeting, to, from or within Golgi,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12
2292,GO:0005253,0.825651558056319,0.353859464843822,3,40,anion channel activity,MF,ANO1;CLCA2;ANO6
7414,GO:0031526,0.826171537878001,0.398586925327966,2,25,brush border membrane,CC,CYBRD1;ABCC2
17901,GO:1902254,0.826286260555558,0.493271618419474,1,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,MDM2
11655,GO:0046461,0.826347305613163,0.495144476941965,1,16,neutral lipid catabolic process,BP,CPS1
11658,GO:0046464,0.826347305613163,0.495144476941965,1,16,acylglycerol catabolic process,BP,CPS1
9681,GO:0038095,0.826474210302044,0.278417805338595,8,109,Fc-epsilon receptor signaling pathway,BP,PAK1;VAV3;PIK3R1;PSMB9;MAP3K1;VAV2;PPP3CA;FOS
2517,GO:0005774,0.826508845916197,0.225464120314345,31,343,vacuolar membrane,CC,FLOT1;CYBRD1;ANPEP;ITM2C;AHNAK;SPG11;LRP1;SLC22A17;STOM;TLR3;LAPTM4A;MANBA;ANXA6;CD1D;ENPP1;SLC48A1;PRCP;TMEM50B;TMEM175;ANXA2;MAN2B1;VPS39;SPPL2B;ULK1;GOPC;ATRAID;ABCA2;SBF2;LITAF;ATG16L2;ABCA5
1795,GO:0004435,0.826646357513787,0.497194530762081,1,14,phosphatidylinositol phospholipase C activity,MF,PLCH2
7985,GO:0032615,0.826756275343099,0.394398604069079,2,32,interleukin-12 production,BP,TLR3;ISL1
7209,GO:0031114,0.8269621974071,0.399399606869759,2,22,regulation of microtubule depolymerization,BP,ARHGEF2;TTBK2
6624,GO:0022900,0.827250861880057,0.276171967704307,8,141,electron transport chain,BP,D2HGDH;PHGDH;XDH;GLDC;SNCA;AKR7A2;NDUFA4L2;ALDH4A1
7362,GO:0031420,0.827326434124744,0.497609946344738,1,13,alkali metal ion binding,MF,SLC24A1
4522,GO:0010592,0.827521986488827,0.495674472870968,1,14,positive regulation of lamellipodium assembly,BP,FSCN1
5395,GO:0016239,0.827680799180785,0.308572773821729,5,57,positive regulation of macroautophagy,BP,SESN3;SESN1;ULK1;UVRAG;VPS13C
16458,GO:0097178,0.827977757018238,0.392816199024955,2,31,ruffle assembly,BP,CAV1;ARF6
871,GO:0002224,0.827993414173842,0.284545357691426,7,90,toll-like receptor signaling pathway,BP,FLOT1;NR1D1;PTPRS;CAV1;TLR3;MAP3K1;RSAD2
18374,GO:1903429,0.828087911851489,0.493313957454058,1,15,regulation of cell maturation,BP,RET
18357,GO:1903392,0.828088080705285,0.496286183191174,1,13,negative regulation of adherens junction organization,BP,DLC1
3355,GO:0007094,0.82831703725231,0.393094120299398,2,29,mitotic spindle assembly checkpoint,BP,ATM;KLHL22
15085,GO:0071173,0.82831703725231,0.393094120299398,2,29,spindle assembly checkpoint,BP,ATM;KLHL22
15086,GO:0071174,0.82831703725231,0.393094120299398,2,29,mitotic spindle checkpoint,BP,ATM;KLHL22
14909,GO:0070822,0.828594099185405,0.493806947464689,1,14,Sin3-type complex,CC,NCOR1
2930,GO:0006450,0.828704810654001,0.488225133825023,1,19,regulation of translational fidelity,BP,AARS
5523,GO:0016505,0.828834036118756,0.490813123312627,1,16,peptidase activator activity involved in apoptotic process,MF,PYCARD
17662,GO:1901567,0.829019649332892,0.486256219084291,1,21,fatty acid derivative binding,MF,PPARG
1010,GO:0002495,0.829086420888384,0.292945484358889,6,76,antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD;CTSV;SEC24D;OSBPL1A;ACTR1B;CTSD
12751,GO:0051053,0.82909397903673,0.264361473187921,10,109,negative regulation of DNA metabolic process,BP,TP53;HMGA2;CHEK2;MAGEF1;ATM;BCL6;CXORF57;TSPYL2;PPARG;S100A11
4062,GO:0009116,0.829223889328134,0.282250816072875,7,100,nucleoside metabolic process,BP,APOBEC3C;DLG4;APOBEC3G;OARD1;APOBEC3F;PRPS2;DPYD
7873,GO:0032451,0.829674308211963,0.349673635441385,3,34,demethylase activity,MF,PHF2;KDM4C;KDM4A
867,GO:0002218,0.829824624937821,0.238143444239626,18,209,activation of innate immune response,BP,FLOT1;TKFC;PAK1;NR1D1;TRIM5;PTPRS;PYCARD;DDX60;MUC19;SEC14L1;FYN;CAV1;TMEM173;PRKACB;TLR3;PSMB9;MAP3K1;RSAD2
7965,GO:0032590,0.829844688929023,0.490241463687323,1,15,dendrite membrane,CC,SHISA9
11880,GO:0046931,0.830218320614038,0.489585554034453,1,15,pore complex assembly,BP,ANO6
10933,GO:0044665,0.83031031334653,0.389891048196717,2,29,MLL1/2 complex,CC,C17ORF49;TAF1
15166,GO:0071339,0.83031031334653,0.389891048196717,2,29,MLL1 complex,CC,C17ORF49;TAF1
8567,GO:0034063,0.83035433127731,0.492326201909422,1,13,stress granule assembly,BP,CIRBP
9866,GO:0042158,0.830457048712388,0.273100772919949,8,109,lipoprotein biosynthetic process,BP,CD109;NTM;ABCA1;HHAT;NEGR1;NTNG1;PGAP1;MPPE1
19796,GO:2000279,0.830713120234485,0.390191295733303,2,27,negative regulation of DNA biosynthetic process,BP,TP53;PPARG
17640,GO:1901524,0.830785969227442,0.489966858484006,1,14,regulation of mitophagy,BP,VPS13C
13020,GO:0051537,0.831556571787444,0.483205731621168,1,19,2 iron, 2 sulfur cluster binding,MF,XDH
17705,GO:1901661,0.831637778802228,0.481030462400456,1,22,quinone metabolic process,BP,AKR7A2
3234,GO:0006891,0.831931219172368,0.386849717317676,2,30,intra-Golgi vesicle-mediated transport,BP,COPG2;COG3
6898,GO:0030496,0.832208159154893,0.244994188957903,14,155,midbody,CC,CEP126;CNTRL;MICAL1;TTC28;TRIOBP;SEPT6;ARF6;SSH1;ANXA2;OR2A4;HSPA5;UVRAG;CAPG;ARL3
10506,GO:0043462,0.832343769976323,0.341439557949756,3,51,regulation of ATPase activity,BP,DNAJB4;HSPA2;DNAL4
878,GO:0002244,0.832542935369899,0.253914056231056,11,158,hematopoietic progenitor cell differentiation,BP,SFRP1;STON2;BMP4;KCNAB2;TP73;PSMB9;DHTKD1;TCF12;SSBP3;YAP1;ZBTB1
6424,GO:0021697,0.832545435449913,0.490352313785513,1,12,cerebellar cortex formation,BP,OPHN1
4581,GO:0010676,0.832848044525035,0.344463568642394,3,35,positive regulation of cellular carbohydrate metabolic process,BP,IRS2;NTSR1;SNCA
11477,GO:0045981,0.833244040096874,0.342066371899537,3,41,positive regulation of nucleotide metabolic process,BP,NOS1;TIMP2;GPR161
17477,GO:1900544,0.833244040096874,0.342066371899537,3,41,positive regulation of purine nucleotide metabolic process,BP,NOS1;TIMP2;GPR161
15012,GO:0070987,0.833541775928956,0.480516118510211,1,18,error-free translesion synthesis,BP,POLH
7621,GO:0032039,0.833745760093714,0.486340099635569,1,13,integrator complex,CC,NIPBL
19597,GO:1990776,0.833745901367287,0.482145933864927,1,16,response to angiotensin,BP,CAV1
285,GO:0000790,0.833814493894284,0.221499922298958,26,303,nuclear chromatin,CC,TRNP1;SNAI2;CBX5;NR1D1;SMARCA2;STAT1;TP53;MEF2D;CHD3;POLR3GL;SMARCA1;UHRF2;KDM4C;C17ORF49;TCF4;CITED2;CBX7;NCOR1;SALL2;TCF12;CENPA;MEF2A;RARA;TAF1;NIPBL;RXRA
7360,GO:0031418,0.834052858761739,0.479605339124761,1,18,L-ascorbic acid binding,MF,P3H2
1468,GO:0003725,0.834389231856046,0.298180632725134,5,63,double-stranded RNA binding,MF,VIM;DDX60;OAS2;TLR3;AGO4
6109,GO:0019359,0.834448834735954,0.268603636355436,8,94,nicotinamide nucleotide biosynthetic process,BP,DDIT4;NMRK1;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
6111,GO:0019363,0.834448834735954,0.268603636355436,8,94,pyridine nucleotide biosynthetic process,BP,DDIT4;NMRK1;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
2603,GO:0005905,0.834463298940759,0.298921586665026,5,57,clathrin-coated pit,CC,CLTCL1;EGFR;HIP1;TBC1D5;LRP1
255,GO:0000722,0.834691787868437,0.48304947590739,1,14,telomere maintenance via recombination,BP,TEP1
7593,GO:0031984,0.834731780949562,0.191035978154363,123,1268,organelle subcompartment,CC,FLRT2;ST6GALNAC2;PTGS1;MARCH4;PKD2;JPH2;SCARA3;COL7A1;CLTCL1;NOS1;DNMBP;PDGFC;MALL;SULF2;EGFR;GALNT10;FLRT3;ATP10D;MBOAT2;FAM198B;ASAP2;ABCA1;NSG1;SORL1;MEST;ARAP1;EXTL2;KIAA0319L;PDGFA;ACSL3;PTGES;LPCAT2;ERO1B;B3GAT3;FUT10;CAV1;SEL1L;OSBPL5;XYLT1;UST;SDR16C5;CHST3;CAMK2D;GOLGB1;ATP8B2;HHAT;TMEM173;CREB3L2;ALDH3A2;HERPUD1;WFS1;ST6GAL2;BACE1;TLR3;MAN1A1;PDIA6;GLG1;MLEC;SEC24D;TGFBI;TMEM129;SULF1;ESYT2;CALR;COPG2;TMED10;AREG;CD1D;SYNE2;PTPN1;KLHL12;PLD3;G6PC3;GCNT1;TMEM50B;RAB13;FNDC3A;RNF24;PGAP1;GOLGA8B;NMNAT2;GAL3ST4;RAB43;DSEL;MAPK8IP3;CYP4V2;SPPL2B;ULK1;RHBDD1;HSPA5;GOPC;PIKFYVE;REEP2;RSAD2;ITPR2;UGT1A3;RHBDD2;LMF1;UGT1A6;ALG10;GOLGA8N;GALNT2;DERL3;AGPAT1;TPST1;CERS5;SNX9;POSTN;ARL3;MIA3;DNAJC3;COG3;TMEM67;STEAP2;ADAM10;RHOBTB3;LITAF;TUSC3;GBP3;EDEM1;ABCA5;DMPK;MOSPD3
17079,GO:0101002,0.834810512073219,0.251312025100381,11,146,ficolin-1-rich granule,CC,MMP9;GSN;SLC2A3;TIMP2;CAT;CST3;PRCP;NFASC;LGALS3;ACTR1B;CTSD
2854,GO:0006346,0.834967771476051,0.481171884214662,1,15,methylation-dependent chromatin silencing,BP,UHRF2
9546,GO:0036344,0.835213354348985,0.480732956776671,1,15,platelet morphogenesis,BP,ZFPM1
11632,GO:0046394,0.83536792196228,0.220847260801505,25,284,carboxylic acid biosynthetic process,BP,DDIT4;PTGS1;CSPG4;NR1D1;ACSL3;PHGDH;PTGES;CPS1;UST;ACSS1;ACACB;CBR1;ALOX15B;PRKAB2;DHTKD1;ACSS2;THNSL2;NCOR1;GGT7;DSEL;OSBPL1A;SRR;PRKAG1;DPYD;ABAT
4369,GO:0009994,0.8354769046235,0.381512268529972,2,29,oocyte differentiation,BP,ANG;ATM
4055,GO:0009108,0.835832664586756,0.234898655804187,16,190,coenzyme biosynthetic process,BP,DDIT4;DCAKD;ACSL3;NMRK1;ACSS1;ACACB;SNCA;PDK3;DHTKD1;IDH2;ACSS2;NCOR1;NMNAT2;NAPRT;PRKAG1;PPCS
11068,GO:0045089,0.835860689190029,0.225557011814298,21,241,positive regulation of innate immune response,BP,FLOT1;MMP2;TKFC;PAK1;NR1D1;TRIM5;PTPRS;PYCARD;DDX60;MUC19;SEC14L1;FYN;CAV1;TMEM173;PRKACB;TLR3;PSMB9;IFNK;CD1D;MAP3K1;RSAD2
10789,GO:0044297,0.836062360751695,0.215228212948012,30,312,cell body,CC,NQO1;PITPNM3;GJC2;ACTA2;NTSR1;TIMP2;PTPRS;PYCARD;EFHC1;MAP2;CTSV;LRP1;PRKCZ;ITGA1;CCK;SLC38A2;ANG;SNCA;ASTN2;CST3;NRSN2;ARHGEF2;CRTC1;RET;TGFB2;TH;SRR;RARA;SV2A;CAMK2N1
12363,GO:0048806,0.836395195567542,0.383382588742391,2,23,genitalia development,BP,AXL;NIPBL
3074,GO:0006644,0.836659875994502,0.212765622799903,32,342,phospholipid metabolic process,BP,INPP5D;PITPNM3;PIK3C2G;IRS2;OSBPL10;EGFR;MBOAT2;ISYNA1;VAV3;PDGFA;ACSL3;LPCAT2;KITLG;FYN;SLC27A1;PLA2G6;OSBPL5;PIK3R1;PLCH2;SNCA;FGFR1;MTMR4;ATM;DGKQ;ETNK2;PGAP1;EFR3A;VAV2;PIKFYVE;AGPAT1;MPPE1;PIK3C2B
3060,GO:0006625,0.836690390282923,0.47581731116913,1,17,protein targeting to peroxisome,BP,PEX1
15865,GO:0072662,0.836690390282923,0.47581731116913,1,17,protein localization to peroxisome,BP,PEX1
15866,GO:0072663,0.836690390282923,0.47581731116913,1,17,establishment of protein localization to peroxisome,BP,PEX1
13190,GO:0051879,0.836808113164648,0.37891149183863,2,30,Hsp90 protein binding,MF,NR3C1;NPAS2
12385,GO:0048854,0.837021690714509,0.382355638122594,2,23,brain morphogenesis,BP,BBS2;BBS4
10520,GO:0043489,0.837256958908773,0.378599543495426,2,29,RNA stabilization,BP,CIRBP;GDNF
8075,GO:0032770,0.837432480463284,0.473541031728696,1,18,positive regulation of monooxygenase activity,BP,GDNF
5839,GO:0017136,0.83794792298314,0.474610592131437,1,16,NAD-dependent histone deacetylase activity,MF,HDAC11
9929,GO:0042307,0.838311425190657,0.378345637690883,2,26,positive regulation of protein import into nucleus,BP,GLI3;TMEM173
11038,GO:0045056,0.838401115189743,0.475000308218236,1,15,transcytosis,BP,LRP1
12204,GO:0048485,0.838693929209179,0.47747419183619,1,13,sympathetic nervous system development,BP,GDNF
109,GO:0000226,0.838894080657388,0.203020534755918,44,427,microtubule cytoskeleton organization,BP,PKD2;MAP6;CEP126;STMN3;PAK1;NEFL;CEP250;TTLL11;CUL9;EFHC1;MAP2;PHLDB1;CUL7;CHD3;EML2;PRKCZ;HAUS4;BBS2;CNTLN;SPRY2;CHEK2;SNCA;LMNA;RGS2;BBS4;SYNE2;ARHGEF2;NCOR1;RGS14;CEP68;GOLGA8B;ODF2;CENPA;UVRAG;TACC2;TPGS1;DNAH1;GOLGA8N;DIXDC1;OBSL1;TMEM67;EFNA5;CAPN6;TTBK2
12853,GO:0051213,0.839056299601558,0.279425973296066,6,72,dioxygenase activity,MF,PTGS1;P3H2;PHF2;ALOX15B;KDM4C;KDM4A
5310,GO:0016032,0.839482065832566,0.196014159717282,60,679,viral process,BP,ITGB6;ITGB5;GSN;PIK3C2G;ANPEP;GAS6;AXL;EGFR;VIM;CBX5;APOBEC3C;TRIM38;EIF2AK4;TRIM5;STAT1;LGALS1;TP53;IFIT1;ITGA2;ADARB1;PACS1;CUL7;FYN;CAV1;OAS2;HMGA2;ULBP1;PIK3R1;TMEM173;APOBEC3G;FBLN1;TP73;STOM;SP110;APOBEC3F;PSMB9;CHD6;SEPT6;EFNB3;MDM2;CD1D;CRTC1;IFITM2;MVB12B;RPL13A;RAB43;STAT2;LEF1;SP100;CENPA;RSAD2;SRPK2;UVRAG;MDFIC;IFITM1;TAF1;KDM4A;MPDZ;ATG16L2;RXRA
5322,GO:0016053,0.839544386401444,0.215800433423219,25,285,organic acid biosynthetic process,BP,DDIT4;PTGS1;CSPG4;NR1D1;ACSL3;PHGDH;PTGES;CPS1;UST;ACSS1;ACACB;CBR1;ALOX15B;PRKAB2;DHTKD1;ACSS2;THNSL2;NCOR1;GGT7;DSEL;OSBPL1A;SRR;PRKAG1;DPYD;ABAT
14544,GO:0070102,0.839724938016008,0.475606741657058,1,13,interleukin-6-mediated signaling pathway,BP,STAT1
2639,GO:0005978,0.839982195199902,0.332790352407832,3,37,glycogen biosynthetic process,BP,IRS2;NR1D1;ENPP1
4172,GO:0009250,0.839982195199902,0.332790352407832,3,37,glucan biosynthetic process,BP,IRS2;NR1D1;ENPP1
12144,GO:0048286,0.840080729816351,0.376631062197802,2,24,lung alveolus development,BP,BMP4;PDGFA
8336,GO:0033209,0.84032289921796,0.253089012723889,9,138,tumor necrosis factor-mediated signaling pathway,BP,TNFRSF6B;GAS6;STAT1;PYCARD;MAP3K14;PSMB9;EDA2R;TRAF1;SPPL2B
7175,GO:0031072,0.840724302030861,0.259623907747465,8,102,heat shock protein binding,MF,HSPA2;FKBP5;NR3C1;SNCA;METTL23;HSPA5;NPAS2;DMPK
5590,GO:0016627,0.841284277621151,0.327991564673694,3,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,DECR1;ZADH2;DPYD
9026,GO:0035258,0.841513889548091,0.275763305614681,6,74,steroid hormone receptor binding,MF,KDM4C;CALR;ISL1;LEF1;TGFB1I1;PPARG
11813,GO:0046785,0.841643701091719,0.288281831538329,5,59,microtubule polymerization,BP,PAK1;MAP2;EML2;SNCA;RGS2
13171,GO:0051817,0.841687837508711,0.275330145426868,6,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,EIF2AK4;HMGA2;STOM;ANXA2;LEF1;RXRA
2325,GO:0005342,0.841737894871126,0.265862071970665,7,88,organic acid transmembrane transporter activity,MF,SLC7A8;SLC7A11;SLC27A1;SLC38A10;SLC38A2;SLC27A6;ABCC2
11887,GO:0046943,0.841737894871126,0.265862071970665,7,88,carboxylic acid transmembrane transporter activity,MF,SLC7A8;SLC7A11;SLC27A1;SLC38A10;SLC38A2;SLC27A6;ABCC2
7227,GO:0031146,0.841800854147931,0.301920978296606,4,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,WWTR1;FBXW4;FBXL7;PSMB9
12826,GO:0051171,0.841871148470524,0.173534118846547,456,4380,regulation of nitrogen compound metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;TSC22D3;KLF8;HSPA2;FLRT3;GJC2;RFX2;ZNF608;SERPINE1;SERPINH1;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;HIP1;GPNMB;TFDP2;PNRC1;CCDC85B;CRIM1;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;SNX1;GPX1;GLI3;E2F7;CNTN1;KITLG;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;LRP1;FYN;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;DUSP5;UHRF2;HERPUD1;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;APLP2;FBLN1;ZKSCAN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;FLOT2;GATAD1;FZD7;AIP;GLG1;SP110;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EPHB6;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;ITM2A;MAPK8IP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;NPHP3;RHBDD1;MAGI2;HSPA5;TGFB1I1;SRPK2;UVRAG;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;OPHN1;YAP1;GDNF;NUB1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;DERL3;ZNF558;MEIS3;PPARG;RNF144B;PARP15;BEX4;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;SASH1;TGIF1;ING4;ZYG11B;UNK;PTPN3;DNAJC3;RARA;ABCA2;CCNY;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;VPS36;PRDM5;PPP2R3A;ZNF471;LITAF;S100A11;RXRA;EDEM1;TAOK3;NFKBIE;ZNF484;DMPK
4159,GO:0009225,0.841876358396159,0.369447666169537,2,33,nucleotide-sugar metabolic process,BP,EXTL2;UGGT2
10054,GO:0042572,0.842104718778107,0.465035970200524,1,18,retinol metabolic process,BP,SDR16C5
1013,GO:0002504,0.842161438958488,0.274571444133487,6,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD;CTSV;SEC24D;OSBPL1A;ACTR1B;CTSD
500,GO:0001556,0.842279952850103,0.465656963595544,1,17,oocyte maturation,BP,ANG
15728,GO:0072350,0.842515901730566,0.368062211891243,2,34,tricarboxylic acid metabolic process,BP,DHTKD1;IDH2
6696,GO:0030104,0.842610821683192,0.30369568941711,4,48,water homeostasis,BP,FLG;WFS1;PRKACB;SCNN1A
12540,GO:0050716,0.842637521825483,0.465000001328688,1,17,positive regulation of interleukin-1 secretion,BP,PYCARD
17851,GO:1902116,0.843213095386707,0.368331859347212,2,30,negative regulation of organelle assembly,BP,EVI5L;ARHGEF2
18372,GO:1903427,0.843391991760088,0.462667446431745,1,18,negative regulation of reactive oxygen species biosynthetic process,BP,CAV1
1928,GO:0004629,0.843453501491773,0.46577802169965,1,15,phospholipase C activity,MF,PLCH2
11404,GO:0045841,0.843515033926803,0.367828704531837,2,30,negative regulation of mitotic metaphase/anaphase transition,BP,ATM;KLHL22
17840,GO:1902100,0.843515033926803,0.367828704531837,2,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,ATM;KLHL22
12836,GO:0051184,0.843590927682545,0.464310409571806,1,16,cofactor transmembrane transporter activity,MF,SLC48A1
1176,GO:0002824,0.843781379965081,0.324643114322522,3,46,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PRKCZ;RSAD2;ZBTB1
6192,GO:0019674,0.844365657323465,0.323727897047537,3,46,NAD metabolic process,BP,NMRK1;NMNAT2;NAPRT
3169,GO:0006783,0.844571323200169,0.460487802769008,1,18,heme biosynthetic process,BP,TMEM14C
14248,GO:0061351,0.844713533098947,0.262544609975527,7,78,neural precursor cell proliferation,BP,TRNP1;GJC2;GLI3;FGFR1;ARHGEF2;LEF1;DIXDC1
3007,GO:0006555,0.844774935067612,0.461055063414274,1,17,methionine metabolic process,BP,MTHFR
10626,GO:0043666,0.844794859871414,0.261843703157237,7,85,regulation of phosphoprotein phosphatase activity,BP,PHACTR3;ELFN2;B3GAT3;ITGA1;MAGI2;PPP2R3A;DMPK
4668,GO:0010821,0.845115638048645,0.225410624639211,15,187,regulation of mitochondrion organization,BP,MMP9;TP53;PYCARD;TFDP2;GPX1;PLA2G6;CLU;HHAT;HPS4;TP73;LMNA;STAT2;VPS13C;INF2;ACAA2
3942,GO:0008643,0.845907274145831,0.253038164919813,8,94,carbohydrate transport,BP,IRS2;CLTCL1;SLC2A3;PAK1;PRKCZ;PIK3R1;ENPP1;C2CD5
3197,GO:0006829,0.846259678541169,0.458296553604279,1,17,zinc ion transport,BP,SLC39A11
17475,GO:1900542,0.846497758567427,0.241139666769555,10,114,regulation of purine nucleotide metabolic process,BP,DDIT4;PKD2;NOS1;TIMP2;SNCA;PDE4D;NCOR1;GPR161;NPHP3;PRKAG1
5854,GO:0017160,0.846650780211348,0.461252162524639,1,14,Ral GTPase binding,MF,MYO1C
10308,GO:0043122,0.84687491613301,0.223318835383429,15,180,regulation of I-kappaB kinase/NF-kappaB signaling,BP,F2R;ROR1;SLC20A1;TRIM38;TRIM5;STAT1;LGALS1;PYCARD;FYN;MAP3K14;PER1;TGM2;EDA2R;AKAP13;LITAF
17461,GO:1900408,0.847657463042689,0.359781822124355,2,33,negative regulation of cellular response to oxidative stress,BP,GPX1;FZD1
18269,GO:1903202,0.847657463042689,0.359781822124355,2,33,negative regulation of oxidative stress-induced cell death,BP,GPX1;FZD1
9975,GO:0042405,0.847724605615145,0.462784893567778,1,12,nuclear inclusion body,CC,ATXN1
14482,GO:0065003,0.848095817760372,0.175369386848718,134,1421,protein-containing complex assembly,BP,FLOT1;FN1;XPC;GSN;GJA5;PKD2;COL7A1;CLTCL1;PDGFC;SPTB;RNF213;TCF7L1;S100A10;C1QTNF6;DDB2;PAK1;ABCA1;ANGPTL4;NSG1;AHNAK;NEFL;SORL1;TP53;DDIT3;PYCARD;DLG4;PILRB;MAP2;ACSL3;HIP1;TYSND1;ANO6;ASAP1;PDE4DIP;EML2;ARHGAP18;CAV1;CLU;PRKCZ;ARPIN;EHD3;CAMK2D;KANK2;PXN;CCK;SYT1;CPT1A;ACACB;ANG;TTN;CIRBP;TP73;CAT;PRKACB;STOM;FBXL7;SNCA;VAMP1;COL16A1;IGF1R;DKK1;FSCN1;SEC24D;RGS2;SETX;TGM2;TLE4;TRIOBP;TRAF1;SEPT6;TGFBR3;BBS4;CALR;ATM;MDM2;ARF6;TMED10;AREG;TCF4;ANXA6;DGKQ;FHOD3;LMO4;ARHGEF2;KLHL12;SOX9;CRTC1;ANXA2;MPP7;SEPT5;KCTD7;RPL13A;DECR1;PRNP;LEF1;THRA;SSBP3;CDC42EP5;MSRB2;ULK1;TSPYL2;TSPYL4;MAGI2;CELF2;GOPC;MAGI1;CENPA;SRPK2;UVRAG;KCTD14;YAP1;DNAH1;SRR;CAPG;SNX9;OBSL1;MIA3;TAF1;EFNA5;WIPF1;ZBTB1;SBF2;RASA1;HP1BP3;COX18;DNM1P46;SEPT9;AGO4;MYH11;KCNRG;PSMG4;TSPAN4;MYO1C;RXRA
4973,GO:0015095,0.848427116980128,0.455312512042382,1,16,magnesium ion transmembrane transporter activity,MF,TUSC3
5150,GO:0015693,0.848427116980128,0.455312512042382,1,16,magnesium ion transport,BP,TUSC3
18558,GO:1903830,0.848427116980128,0.455312512042382,1,16,magnesium ion transmembrane transport,BP,TUSC3
6746,GO:0030176,0.848837920125464,0.242159559975002,9,123,integral component of endoplasmic reticulum membrane,CC,PKD2;WFS1;CALR;G6PC3;SPPL2B;RHBDD1;HSPA5;DERL3;EDEM1
18373,GO:1903428,0.84940691453298,0.358349319981556,2,29,positive regulation of reactive oxygen species biosynthetic process,BP,PKD2;CLU
19345,GO:1905819,0.849424844768636,0.35750628349874,2,31,negative regulation of chromosome separation,BP,ATM;KLHL22
20103,GO:2000816,0.849424844768636,0.35750628349874,2,31,negative regulation of mitotic sister chromatid separation,BP,ATM;KLHL22
6817,GO:0030286,0.849615891124243,0.318659838039623,3,34,dynein complex,CC,DNAL4;WDR63;DNAH1
2844,GO:0006325,0.849632497564536,0.183768132770547,63,660,chromatin organization,BP,CPA4;NOS1;SNAI2;PHF21A;TCF7L1;DDB2;TADA3;PADI3;SMARCA2;NR3C1;TP53;CHD3;MTHFR;HLCS;SMARCA1;TNRC18;SDR16C5;HMGA2;CAMK2D;PER1;UHRF2;JARID2;PHF2;SNCA;GATAD1;JADE2;SP110;BRD3;KDM4C;CHD6;L3MBTL3;ATM;C17ORF49;CBX7;HDAC11;RCBTB1;SOX9;ISL1;BCL6;NCOR1;PRKCA;HLTF;BAHCC1;MAP3K12;CHD9;ZFPM1;RBL2;LEF1;CDKN2A;SP100;TSPYL2;TSPYL4;CENPA;SAP30L;YEATS2;ING4;FKBP10;TAF1;ZBTB1;HP1BP3;KDM4A;NIPBL;PRDM5
9424,GO:0036019,0.849851911354033,0.452630814004106,1,16,endolysosome,CC,TLR3
815,GO:0002089,0.849864600328831,0.456857252200174,1,13,lens morphogenesis in camera-type eye,BP,BMP4
7397,GO:0031490,0.850037122995405,0.254038345948344,7,92,chromatin DNA binding,MF,HMGA2;PER1;BCL6;THRA;CENPA;RARA;RXRA
5203,GO:0015807,0.85024522660902,0.315304462279747,3,42,L-amino acid transport,BP,SLC7A8;NTSR1;SLC7A11
3243,GO:0006903,0.850308558022172,0.262984855678675,6,77,vesicle targeting,BP,COL7A1;SEC24D;TMED10;AREG;KLHL12;SEPT5
1397,GO:0003323,0.850456999740254,0.452707947414605,1,15,type B pancreatic cell development,BP,BMP4
4020,GO:0009056,0.850519288448927,0.16935528738397,192,1981,catabolic process,BP,SERPINE2;SULT1E1;MMP2;PYGB;MMP9;PRODH;COL8A1;ZFP36L1;DDIT4;ITGB4;COL5A2;IRS2;ZFP36L2;IGF2BP2;ANPEP;SKP2;COL7A1;NOS1;COL5A1;EGFR;SDC3;SESN3;RNF213;RNF165;VIM;CSPG4;TKFC;NTSR1;TIMP2;APOBEC3C;NR1D1;ABTB1;EIF2AK4;TRIM5;MRC2;COL18A1;BTBD2;SORL1;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;PYCARD;ZCCHC11;MMP19;TIMP1;COL4A4;BCKDHB;PNRC1;CUL7;LIX1L;TYSND1;SNX1;GPX1;TBC1D5;ECH1;SRPX;SESN1;CTSV;LRP1;FYN;XDH;FUT10;CPS1;CAV1;PLA2G6;TRIB2;SEL1L;GLDC;SNX33;CLU;OAS2;FBXW4;ULK2;TP53INP1;PRDX5;HIBADH;ALDH3A2;CPT1A;ACACB;APOBEC3G;HERPUD1;WFS1;PHKA2;CES2;CIRBP;CAT;PLCH2;DAPK1;CHEK2;BACE1;FBXL7;SNCA;ADAMTS7;ALDH1L2;APOBEC3F;PRKAB2;PDE4D;TMEM129;PSMB9;SPATA18;DHTKD1;MAGEF1;LRTOMT;NAGLU;ATM;MDM2;CST3;MANBA;HSD17B11;GCLC;HEXA;LZTS1;RNPEP;PTPN1;ALDH4A1;SDC2;COL5A3;THNSL2;SOX9;ENPP1;PLD3;NCOR1;PRKCA;ANXA2;TRERF1;CES3;RNF24;LEPR;MAN2B1;IFT88;MVB12B;ANAPC16;RPL13A;DECR1;GGT7;VPS39;DNASE1L1;COL12A1;SMG9;LIPA;THRA;USP28;ALDH7A1;ULK1;AGRN;RHBDD1;HSPA5;PIKFYVE;TGFB1I1;UVRAG;VPS13C;OPHN1;GDNF;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;SNX9;PTPN3;DNAJC3;COL4A1;TMEM67;PRKAG1;TAF1;GSTZ1;DPYD;PIK3C2B;DNPH1;KDM4A;CDK5RAP3;AIG1;AGO4;SCPEP1;EHHADH;ABAT;FBXL4;UGGT2;VPS36;RNPEPL1;ATG16L2;EPG5;CPT2;EDEM1;GID4;ACAA2;CTSD;ZNRF1
2763,GO:0006182,0.850719002005125,0.453615241281064,1,14,cGMP biosynthetic process,BP,NOS1
13695,GO:0060292,0.850764181926273,0.452126841378165,1,15,long term synaptic depression,BP,SLC24A1
18227,GO:1903077,0.850764388021669,0.449834320610159,1,17,negative regulation of protein localization to plasma membrane,BP,GOPC
10139,GO:0042742,0.851135557433077,0.260440289760005,6,97,defense response to bacterium,BP,SERPINE1;PYCARD;PLA2G6;TLR3;IFNE;LYST
11899,GO:0046966,0.851188055329241,0.356263926961921,2,27,thyroid hormone receptor binding,MF,NCOR1;MED12
15248,GO:0071459,0.851324912131704,0.446219305232276,1,20,protein localization to chromosome, centromeric region,BP,CENPA
9413,GO:0036002,0.852307964568712,0.352239288484936,2,32,pre-mRNA binding,MF,SOX9;CELF2
9536,GO:0036315,0.852317655755396,0.452213246956898,1,13,cellular response to sterol,BP,ABCA1
9056,GO:0035313,0.852468251745051,0.451926733214507,1,13,wound healing, spreading of epidermal cells,BP,COL5A1
10772,GO:0044264,0.853405049501627,0.259004460885887,6,72,cellular polysaccharide metabolic process,BP,PYGB;IRS2;NR1D1;PHKA2;MANBA;ENPP1
1149,GO:0002758,0.853910634442731,0.211971135630787,16,194,innate immune response-activating signal transduction,BP,FLOT1;TKFC;PAK1;NR1D1;TRIM5;PTPRS;DDX60;MUC19;SEC14L1;FYN;CAV1;PRKACB;TLR3;PSMB9;MAP3K1;RSAD2
8925,GO:0034979,0.854003431514537,0.443661412361255,1,17,NAD-dependent protein deacetylase activity,MF,HDAC11
18037,GO:1902622,0.854057381901939,0.439696638695724,1,22,regulation of neutrophil migration,BP,MOSPD2
416,GO:0001104,0.854422868781502,0.248671026975267,7,81,RNA polymerase II transcription cofactor activity,MF,SMARCA2;CITED4;CITED2;ISL1;TRERF1;MEF2A;MED12
17827,GO:1902043,0.854792563331229,0.444443626451572,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,SFRP1
19080,GO:1905037,0.854968657462164,0.247439351338006,7,87,autophagosome organization,BP,ULK2;TP53INP1;IFT88;ULK1;PIKFYVE;PIK3C2B;ATG16L2
10580,GO:0043574,0.854972391116694,0.440849628479955,1,18,peroxisomal transport,BP,PEX1
1116,GO:0002706,0.85497314358735,0.267174691228782,5,73,regulation of lymphocyte mediated immunity,BP,IL20RB;PRKCZ;BCL6;RSAD2;ZBTB1
2543,GO:0005814,0.855324902177918,0.229392896054663,10,112,centriole,CC,CEP250;CNTLN;DZIP1L;BBS4;IFT88;ODF2;CCHCR1;CAPG;TTBK2;LRRCC1
12645,GO:0050879,0.855780983725596,0.348917936405119,2,26,multicellular organismal movement,BP,TNNI2;DMPK
12647,GO:0050881,0.855780983725596,0.348917936405119,2,26,musculoskeletal movement,BP,TNNI2;DMPK
3468,GO:0007292,0.856006825359304,0.254964282294456,6,75,female gamete generation,BP,MMP19;PAQR8;ANG;MLH3;PAQR7;ATM
7605,GO:0032006,0.856024866648252,0.254761512895211,6,77,regulation of TOR signaling,BP,DDIT4;GAS6;SESN3;SESN1;ATM;DGKQ
3333,GO:0007049,0.856387224970539,0.16493961460964,154,1541,cell cycle,BP,TRNP1;TXNIP;CTGF;MARVELD1;SFRP1;GADD45B;RHOBTB2;CDKN2B;ZFP36L1;APBB2;XPC;PKD2;ZFP36L2;HERC5;TNIK;SKP2;CLTCL1;GAS6;EGFR;HSPA2;CEP126;GJC2;CCNG2;NUPR1;TOM1L2;TIMP2;TADA3;PAK1;CBX5;BMP4;PTK6;EIF2AK4;PDCD4;NR3C1;TP53;ARAP1;CEP250;DDIT3;CNTRL;CUL9;EFHC1;ADARB1;GPNMB;TFDP2;CUL7;BTG1;CHD3;SIK1;TTC28;CDK14;E2F7;CTDSPL;NEK9;RMI2;SNX33;MAP3K14;ZNF318;TP53INP1;HMGA2;KANK2;CCNI;HAUS4;NCAPD2;UHRF2;CNTLN;ANK3;SPRY2;TTN;TMEM8B;MLH3;TP73;PRKACB;CHEK2;FBXL7;FGFR1;LMNA;ALOX15B;PRKAB2;RGS2;PSMB9;TRIOBP;AFAP1L2;CDH13;FOXN3;SEPT6;PBX1;BBS4;CALR;ATM;MDM2;ARF6;MEIS2;CITED2;NR2F2;MSH5;LZTS1;RCBTB1;MAP3K1;ARHGEF2;NRK;SOX9;BCL6;NCOR1;NDRG1;PRKCA;MYBL1;RGS14;SEPT5;CEP68;GOLGA8B;CABLES2;PAK6;PRNP;TGFB2;RBL2;MAP2K5;ODF2;OR2A4;LIG1;FHL1;USP28;CDKN2A;TSPYL2;ORC4;MAGI2;CDK19;CENPA;SRPK2;UVRAG;POLD4;GOLGA8N;DIXDC1;SNX9;OBSL1;ING4;PTPN3;ARL3;RARA;CCNY;TMEM67;PRKAG1;TAF1;PPP3CA;RASA1;CTDSP2;SEPT9;KLHL22;CDK5RAP3;AGO4;CAMK2N1;NIPBL;PRDM5;LRRCC1;TAOK3
17852,GO:1902117,0.857055927687753,0.265786947945164,5,58,positive regulation of organelle assembly,BP,ASAP1;FSCN1;BBS4;ULK1;SEPT9
9067,GO:0035336,0.857540412426204,0.435034299601038,1,19,long-chain fatty-acyl-CoA metabolic process,BP,ACSL3
14666,GO:0070316,0.857581258610521,0.303784989303915,3,41,regulation of G0 to G1 transition,BP,CTGF;CBX5;TFDP2
8973,GO:0035098,0.857683542039801,0.437631453732547,1,16,ESC/E(Z) complex,CC,JARID2
2478,GO:0005719,0.857695060832482,0.433287179735133,1,21,nuclear euchromatin,CC,TRNP1
11442,GO:0045920,0.858148799298569,0.435650418345727,1,17,negative regulation of exocytosis,BP,SNCA
853,GO:0002183,0.858195816202749,0.434606859271863,1,18,cytoplasmic translational initiation,BP,RPL13A
10552,GO:0043536,0.858204435116166,0.302776738477955,3,41,positive regulation of blood vessel endothelial cell migration,BP,FGFR1;AMOTL1;PRKCA
8174,GO:0032925,0.858245622153244,0.436537684755237,1,16,regulation of activin receptor signaling pathway,BP,MAGI2
1118,GO:0002708,0.858375617201574,0.301419109488837,3,46,positive regulation of lymphocyte mediated immunity,BP,PRKCZ;RSAD2;ZBTB1
10515,GO:0043484,0.85858421426418,0.235159415058564,8,100,regulation of RNA splicing,BP,AHNAK;MBNL2;RBFOX2;AHNAK2;PIK3R1;PRX;SETX;SRPK2
3194,GO:0006825,0.858791864155988,0.433444098062739,1,18,copper ion transport,BP,STEAP2
17850,GO:1902115,0.858946789308245,0.213567946574641,13,142,regulation of organelle assembly,BP,GSN;EVI5L;ASAP1;IFT140;FSCN1;BBS4;AKAP13;SYNE2;ARHGEF2;IFT88;ULK1;PIKFYVE;SEPT9
7344,GO:0031397,0.859347704526404,0.276591866278568,4,58,negative regulation of protein ubiquitination,BP,FYN;CAV1;GCLC;TAF1
12916,GO:0051302,0.859386477399724,0.223665175991372,10,117,regulation of cell division,BP,TXNIP;PDGFC;EFHC1;PDGFA;E2F7;CAT;BBS4;TGFB2;OR2A4;UVRAG
5700,GO:0016835,0.859535690805544,0.2983882574325,3,53,carbon-oxygen lyase activity,MF,HMGA2;THNSL2;EHHADH
5461,GO:0016363,0.859798597919382,0.233757087813896,8,95,nuclear matrix,CC,PHACTR3;TP53;TEP1;HLCS;PRKCZ;DGKQ;ATXN1;TGFB1I1
10656,GO:0043923,0.860329374588406,0.432462153405969,1,16,positive regulation by host of viral transcription,BP,LEF1
15793,GO:0072525,0.860457202756493,0.232715438239007,8,97,pyridine-containing compound biosynthetic process,BP,DDIT4;NMRK1;DHTKD1;IDH2;NCOR1;NMNAT2;NAPRT;PRKAG1
17277,GO:0140103,0.860953455864679,0.428355743741205,1,19,catalytic activity, acting on a glycoprotein,MF,GCNT1
13655,GO:0060218,0.860996473011367,0.256503071347274,5,100,hematopoietic stem cell differentiation,BP,SFRP1;TP73;PSMB9;TCF12;YAP1
5685,GO:0016811,0.861173422600236,0.258218667465635,5,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,PHF21A;CHD3;CAT;HDAC11;SAP30L
20150,GO:2001020,0.861518185827227,0.2096158115403,13,162,regulation of response to DNA damage stimulus,BP,SNAI2;EGFR;CLU;HMGA2;CHEK2;PLA2R1;MAGEF1;ATM;MDM2;CXORF57;POLH;FAM168A;NPAS2
10333,GO:0043167,0.862257578585591,0.151763707389466,467,4364,ion binding,MF,SERPINE2;CPA4;SYT8;MMP2;FN1;PCDH7;PYGB;MMP9;CCBE1;PRODH;CTGF;ADAM19;FBN1;ITGA6;SFRP1;MMP28;RHOBTB2;ZFP36L1;MYH15;FAT4;TGFBR2;PTGS1;EFEMP1;ASAP3;MARCH4;GSN;COL5A2;PKD2;PITPNM3;JPH2;PIK3C2G;OSBPL10;CYBRD1;NID1;ZFP36L2;TNIK;ANPEP;ZNF362;NOS1;GAS6;FBN2;SNAI2;SULF2;COL5A1;PHF21A;UTRN;ROR1;AXL;EGFR;GALNT10;KLF8;PEG10;ITPK1;HSPA2;TCHH;SPEG;SLC8A1;CLCA2;SESN3;MYLK;THBS2;TRIM2;ACTA2;ZNF608;ATP10D;ENDOD1;RNF213;S100A10;RNF165;ANXA5;TKFC;IFI44L;MAP3K6;ASAP2;DCAKD;TIMP2;ZNF862;PDLIM2;PAK1;ABCA1;VDR;CHN2;APOBEC3C;PADI3;BMP4;TRIM38;ITM2C;TP53I3;NR1D1;SMARCA2;PTK6;SCN8A;XAF1;EIF2AK4;HS1BP3;TRIM5;VAV3;NR3C1;COL18A1;KCNMA1;D2HGDH;TP53;ARAP1;EXTL2;MBNL2;PTPRS;TTLL11;PRICKLE1;CUL9;ZBTB20;LTBP1;ZC3H6;SEC14L2;WNK1;DDX60;EFHC1;SEMA5A;ITGA2;ZCCHC11;MMP19;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;EFEMP2;FLG;HIP1;GPNMB;SMOC1;TEP1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;PCDHAC2;HIVEP1;SNX1;PLEK2;LAMC2;GLI3;PTGES;CDK14;LPCAT2;P3H2;NAV2;ASAP1;SYN1;CTDSPL;LIMCH1;MTHFR;ZFP90;CCDC80;NEK9;SESN1;NMRK1;LRP1;FYN;XDH;ALPK1;TSHZ2;B3GAT3;LTBP4;CPS1;FAT2;GLI2;PIAS3;HLCS;RNF135;ERCC6;ITGA10;SLC2A4RG;GLDC;SNX33;MAP3K14;SMARCA1;ZNF318;OSBPL5;ACSS1;FKBP9;SNX29;PRKCZ;SLIT3;OAS2;ULK2;ZNF678;GPR39;TNS2;EHD3;CAMK2D;PHC2;ITGA1;MST1R;SYTL1;ZSCAN18;ATP8B2;PXN;SYT1;HHAT;TMEM173;CAPRIN2;ACACB;APOBEC3G;PCLO;ANG;DYSF;KIF17;UHRF2;CDK18;TTN;PRDM8;LMO7;APLP2;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;DAPK1;KLF13;PRKACB;AARS;CHEK2;WDFY2;PHF2;MAN1A1;ZNF860;SNCA;ADAMTS7;MME;GATAD1;FZD7;JADE2;SP110;DZIP1L;FGFR1;IGF1R;APOBEC3F;ALOX15B;SEC24D;LTBP3;SETX;ASTN2;PDE4D;TMEM129;MYO3B;TGM2;OBSCN;SULF1;ESYT2;PDK3;MYOF;EPHB6;ARSD;ZNF618;DHTKD1;KDM4C;SLC24A1;CHD6;CDH13;TRAF1;LMCD1;SEPT6;TGFBR3;DTNB;NOTCH2NL;L3MBTL3;MTMR4;ZNF699;CALR;ATM;IDH2;MDM2;ARF6;DLK2;ZNF107;ANXA6;AKAP13;SNX10;DGKQ;GCLC;NR2F2;ACSS2;NEURL1B;LMO4;ZNF449;ZMAT3;MSH5;CYP20A1;ZBTB22;HSPA12A;RNPEP;MAP3K1;FGD4;PTPN1;CRIP2;NT5DC3;ARHGEF2;COL5A3;THNSL2;ZNF546;NRK;EGR1;ENPP1;IFT27;ISL1;ITPKB;BCL6;PCDHGA11;STK16;DDX60L;ZNF717;PLAG1;PRKCA;SALL2;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RAB13;ETNK2;PRIMPOL;AMZ2;ADAMTS15;HLTF;SEPT5;RNF24;MAN2B1;TSHZ1;LANCL1;TES;NMNAT2;GAL3ST4;PAK6;DECR1;ZNF160;ABCC2;MAP3K12;CHD9;MEGF8;ZNF302;ACSF2;HTR1B;IRF2BPL;STK36;RAB43;MUTYH;PRNP;CDH11;RET;ZFPM1;MAP2K5;ZNF550;LIG1;ZNF701;THRA;FHL1;ZADH2;CYP4V2;MSRB2;C2CD4C;PPM1M;OSBPL1A;ZSCAN30;ULK1;AGRN;NPEPL1;ORC4;VAV2;AGAP1;HSPA5;CDK19;TH;SNX7;MAGI1;PIKFYVE;FLYWCH1;TGFB1I1;RSAD2;SRPK2;ITPR2;ARHGAP29;UGT1A3;YPEL4;SAP30L;ZNF12;OPHN1;MYO9A;HSP90AB4P;DNAH1;KLF5;CAPS;SRR;UBA7;GALNT2;ZNF558;PITPNC1;PPARG;RNF144B;PARP15;ADAMTSL5;KCNIP3;MLLT6;KLF7;SNX9;ICK;ING4;POSTN;UNK;ARL3;FKBP10;RARA;ECM2;ABCA2;POLH;PRKAG1;TAF1;TSHZ3;MPPE1;ZNF883;ZBTB1;DPYD;PPP3CA;PIK3C2B;SBF2;LIMA1;PEX1;CTDSP2;STEAP2;ACTR1B;SEPT9;KDM4A;ZBTB25;CACNA2D3;MATN3;NPAS2;ABAT;MYH11;VPS36;TTBK2;BSN;PCDHGB5;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;ZNF471;LITAF;S100A11;MYO1C;RXRA;C2CD5;GBP3;EDEM1;ABCA5;TAOK3;ZNF484;ZNRF1;DMPK
4309,GO:0009791,0.862476601648867,0.23785108652372,7,74,post-embryonic development,BP,FBN1;SOX6;EFEMP1;BMP4;ATM;ETNK2;STK36
3347,GO:0007077,0.86253314748281,0.295495923036971,3,42,mitotic nuclear envelope disassembly,BP,NEK9;LMNA;PRKCA
11864,GO:0046902,0.863028675137191,0.2699698155577,4,66,regulation of mitochondrial membrane permeability,BP,TP53;TFDP2;TP73;ACAA2
7399,GO:0031492,0.863142494286049,0.330838008561257,2,42,nucleosomal DNA binding,MF,HMGA2;CENPA
10158,GO:0042769,0.863195010310896,0.331876204905015,2,37,DNA damage response, detection of DNA damage,BP,HMGA2;POLD4
15438,GO:0071806,0.863272714518342,0.292035151703239,3,55,protein transmembrane transport,BP,CLU;PEX1;C2CD5
11858,GO:0046889,0.863600025475604,0.292913933076655,3,46,positive regulation of lipid biosynthetic process,BP,NR1D1;ACSL3;PLA2G6
16467,GO:0097194,0.863986289017851,0.253899343653686,5,71,execution phase of apoptosis,BP,TP53;CASP14;DLC1;CDK5RAP3;TAOK3
1394,GO:0003309,0.864030243712974,0.425142107745433,1,16,type B pancreatic cell differentiation,BP,BMP4
16827,GO:0098780,0.864408339233962,0.42330985126258,1,17,response to mitochondrial depolarisation,BP,VPS13C
17900,GO:1902253,0.864723209489773,0.418803853173339,1,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,MDM2
17401,GO:1900182,0.864995333146482,0.26807600978867,4,56,positive regulation of protein localization to nucleus,BP,GLI3;FYN;TMEM173;CDK5RAP3
15781,GO:0072509,0.865051893087491,0.421069673973219,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC39A11
18272,GO:1903205,0.865116393381382,0.419327852896704,1,20,regulation of hydrogen peroxide-induced cell death,BP,TP53
9050,GO:0035304,0.865367490389992,0.225652292028851,8,100,regulation of protein dephosphorylation,BP,PHACTR3;ELFN2;B3GAT3;ITGA1;DLC1;MAGI2;PPP2R3A;DMPK
9147,GO:0035518,0.866386212412202,0.419347553777559,1,17,histone H2A monoubiquitination,BP,DDB2
2809,GO:0006271,0.8666196381459,0.416309882545647,1,20,DNA strand elongation involved in DNA replication,BP,LIG1
7711,GO:0032212,0.866769761512442,0.326720499324122,2,33,positive regulation of telomere maintenance via telomerase,BP,ATM;HMBOX1
277,GO:0000780,0.867138888927719,0.415263286227178,1,20,condensed nuclear chromosome, centromeric region,CC,CENPA
11543,GO:0046112,0.867155886048692,0.415991758039789,1,19,nucleobase biosynthetic process,BP,CPS1
78,GO:0000159,0.867435634255452,0.415427018601047,1,19,protein phosphatase type 2A complex,CC,PPP2R3A
13163,GO:0051797,0.867498674032551,0.416150451464628,1,18,regulation of hair follicle development,BP,TGFB2
8143,GO:0032885,0.867577136570236,0.328785199069217,2,25,regulation of polysaccharide biosynthetic process,BP,IRS2;ENPP1
549,GO:0001671,0.867793152330803,0.412630274838429,1,22,ATPase activator activity,MF,DNAJB4
12303,GO:0048679,0.868480490996654,0.414163138812592,1,18,regulation of axon regeneration,BP,PTPRS
12371,GO:0048820,0.868730451930601,0.416920829613978,1,15,hair follicle maturation,BP,TGFB2
1927,GO:0004623,0.868858454353641,0.411782062281774,1,20,phospholipase A2 activity,MF,PLA2G6
1482,GO:0003785,0.869265884060851,0.412567831515518,1,18,actin monomer binding,MF,LIMA1
2861,GO:0006355,0.86937076015631,0.146150048688757,290,2825,regulation of transcription, DNA-templated,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
1174,GO:0002822,0.869953792204754,0.244599356003898,5,74,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL20RB;PRKCZ;BCL6;RSAD2;ZBTB1
2827,GO:0006296,0.870043190395176,0.319723105466282,2,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,DDB2;POLD4
11393,GO:0045824,0.870516955408318,0.319711302513254,2,34,negative regulation of innate immune response,BP,SERPING1;PPARG
1796,GO:0004438,0.870593705603246,0.414540363956077,1,14,phosphatidylinositol-3-phosphatase activity,MF,MTMR4
13378,GO:0052744,0.870593705603246,0.414540363956077,1,14,phosphatidylinositol monophosphate phosphatase activity,MF,MTMR4
9177,GO:0035577,0.871181606431251,0.280198192486856,3,47,azurophil granule membrane,CC,STOM;MANBA;PRCP
2530,GO:0005789,0.87157020554569,0.156765161510731,71,789,endoplasmic reticulum membrane,CC,FLRT2;PTGS1;PKD2;JPH2;SCARA3;NOS1;EGFR;FLRT3;ATP10D;MBOAT2;ABCA1;NSG1;MEST;EXTL2;ACSL3;PTGES;LPCAT2;ERO1B;CAV1;SEL1L;OSBPL5;XYLT1;SDR16C5;CAMK2D;ATP8B2;HHAT;TMEM173;CREB3L2;ALDH3A2;HERPUD1;WFS1;TLR3;PDIA6;MLEC;SEC24D;TMEM129;ESYT2;CALR;COPG2;TMED10;AREG;CD1D;SYNE2;PTPN1;PLD3;G6PC3;TMEM50B;PGAP1;CYP4V2;SPPL2B;ULK1;RHBDD1;HSPA5;REEP2;RSAD2;ITPR2;UGT1A3;LMF1;UGT1A6;ALG10;GALNT2;DERL3;AGPAT1;CERS5;MIA3;DNAJC3;TMEM67;TUSC3;EDEM1;DMPK;MOSPD3
7150,GO:0031023,0.871574621953459,0.207075288391218,10,115,microtubule organizing center organization,BP,PKD2;CEP250;CHD3;HAUS4;CNTLN;BBS4;CEP68;ODF2;UVRAG;TMEM67
2954,GO:0006488,0.871704969987311,0.405967037513305,1,20,dolichol-linked oligosaccharide biosynthetic process,BP,ALG10
17222,GO:0120033,0.871965648935382,0.406194432840133,1,19,negative regulation of plasma membrane bounded cell projection assembly,BP,EVI5L
2558,GO:0005844,0.872161817117626,0.255340917900847,4,69,polysome,CC,VIM;EIF2AK4;CALR;UNK
19532,GO:1990542,0.872290812478323,0.255318332481841,4,67,mitochondrial transmembrane transport,BP,CPT1A;ACACB;PRKAB2;CPT2
688,GO:0001909,0.872428218160771,0.277315094207355,3,52,leukocyte mediated cytotoxicity,BP,ULBP1;IL18;LYST
1110,GO:0002700,0.872838415112784,0.240278734301914,5,73,regulation of production of molecular mediator of immune response,BP,PRKCZ;TLR3;BCL6;TGFB2;RSAD2
11238,GO:0045505,0.873100897885818,0.321655655771568,2,21,dynein intermediate chain binding,MF,DNAL4;DNAH1
9350,GO:0035883,0.873150940491061,0.405557967014079,1,17,enteroendocrine cell differentiation,BP,BMP4
10136,GO:0042734,0.873213407156924,0.278806404187688,3,38,presynaptic membrane,CC,HIP1;IL31RA;SYT1
4476,GO:0010498,0.873349129779667,0.166097858556472,36,415,proteasomal protein catabolic process,BP,SKP2;RNF165;NR1D1;ABTB1;BTBD2;TP53;WWTR1;PRICKLE1;DDIT3;GPX1;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;FBXL7;TMEM129;PSMB9;MDM2;GCLC;RNF24;ANAPC16;RHBDD1;HSPA5;OPHN1;NUB1;DERL3;RNF144B;TMEM67;TAF1;UGGT2;EDEM1;GID4;ZNRF1
18976,GO:1904813,0.873520862848592,0.219672810516207,7,109,ficolin-1-rich granule lumen,CC,MMP9;GSN;TIMP2;CAT;CST3;ACTR1B;CTSD
2742,GO:0006140,0.873568863810879,0.204150517782327,10,119,regulation of nucleotide metabolic process,BP,DDIT4;PKD2;NOS1;TIMP2;SNCA;PDE4D;NCOR1;GPR161;NPHP3;PRKAG1
2554,GO:0005834,0.873837396599833,0.401567279939568,1,20,heterotrimeric G-protein complex,CC,GNG2
19203,GO:1905360,0.873837396599833,0.401567279939568,1,20,GTPase complex,CC,GNG2
18268,GO:1903201,0.874150053034825,0.275054942774716,3,48,regulation of oxidative stress-induced cell death,BP,TP53;GPX1;FZD1
3590,GO:0008017,0.874465840318756,0.176836791474601,22,212,microtubule binding,MF,MYH15;MAP6;DPYSL2;NEFM;MAP2;EML2;KIF17;SNCA;MYO3B;LZTS1;ARHGEF2;NDRG1;RGS14;PRNP;TPGS1;MYO9A;ARL3;CAPN6;DNM1P46;MYH11;TTBK2;MYO1C
3179,GO:0006801,0.874646130942371,0.311679126620981,2,36,superoxide metabolic process,BP,NQO1;EGFR
3906,GO:0008565,0.874806638381612,0.237344505837238,5,72,protein transporter activity,MF,LRP1;CALCRL;MIA3;COG3;COX18
3874,GO:0008509,0.875376108762572,0.18442409862222,16,185,anion transmembrane transporter activity,MF,SLC7A8;ANO1;CLCA2;SLC20A1;SLC2A3;ABCA1;SLC7A11;SLC22A15;ANO6;SLC27A1;SLC22A17;SLC38A10;SLC38A2;SLC27A6;ABCC2;ANKH
8981,GO:0035116,0.875530632420296,0.40061692186435,1,17,embryonic hindlimb morphogenesis,BP,BMP4
8151,GO:0032897,0.87574185713491,0.397605765444251,1,20,negative regulation of viral transcription,BP,HMGA2
16191,GO:0090263,0.875794468298783,0.210364390777835,8,110,positive regulation of canonical Wnt signaling pathway,BP,SFRP1;SULF2;WNK1;CAV1;CAPRIN2;PSMB9;YAP1;DIXDC1
7025,GO:0030809,0.876461781175603,0.398670408932307,1,17,negative regulation of nucleotide biosynthetic process,BP,DDIT4
17452,GO:1900372,0.876461781175603,0.398670408932307,1,17,negative regulation of purine nucleotide biosynthetic process,BP,DDIT4
6502,GO:0021884,0.876649492037184,0.399357465921954,1,16,forebrain neuron development,BP,ROBO1
2542,GO:0005813,0.877461136862078,0.158390642406438,42,441,centrosome,CC,ITGB6;FLOT1;CEP126;CEP250;CNTRL;EFHC1;CCDC85B;CUL7;CHD3;NEK9;PDE4DIP;NPHP4;HAUS4;CAPRIN2;CNTLN;PRKACB;IFT140;FBXL7;PDE4D;BBS4;BBS1;SNX10;IFT27;NDRG1;RGS14;CEP68;TTC8;ODF2;SPPL2B;TTC12;UVRAG;IFT74;ZNF12;TPGS1;OBSL1;ARL3;TMEM67;CEP85L;ACTR1B;KLHL22;CDK5RAP3;LRRCC1
11022,GO:0045023,0.877517512835606,0.270538053950242,3,42,G0 to G1 transition,BP,CTGF;CBX5;TFDP2
18399,GO:1903506,0.877787430208991,0.137028211821244,291,2842,regulation of nucleic acid-templated transcription,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
6385,GO:0021591,0.878208041408236,0.39499974620344,1,17,ventricular system development,BP,BBS4
11833,GO:0046839,0.878578751363882,0.306841671412865,2,29,phospholipid dephosphorylation,BP,INPP5D;MTMR4
18783,GO:1904376,0.87892146018209,0.391685893427806,1,19,negative regulation of protein localization to cell periphery,BP,GOPC
4779,GO:0010971,0.879039767278047,0.391435534932769,1,19,positive regulation of G2/M transition of mitotic cell cycle,BP,PBX1
4575,GO:0010665,0.879280009465818,0.391777845748366,1,18,regulation of cardiac muscle cell apoptotic process,BP,CAMK2D
2434,GO:0005637,0.879372204890972,0.266959559109029,3,44,nuclear inner membrane,CC,NEMP2;NRM;FAM169A
4481,GO:0010508,0.879476535012642,0.205766816941293,8,96,positive regulation of autophagy,BP,SESN3;EIF2AK4;SESN1;TP53INP1;DAPK1;ULK1;UVRAG;VPS13C
6001,GO:0019048,0.879821225478687,0.304142001408502,2,30,modulation by virus of host morphology or physiology,BP,EIF2AK4;RXRA
20190,GO:2001141,0.879907154228979,0.134731541204766,291,2844,regulation of RNA biosynthetic process,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
10757,GO:0044232,0.880082508407307,0.390074569101797,1,18,organelle membrane contact site,CC,ESYT2
189,GO:0000407,0.880289257641832,0.302544806910482,2,32,phagophore assembly site,CC,ULK2;ULK1
4432,GO:0010288,0.88095654948742,0.386599399639282,1,20,response to lead ion,BP,CAT
16855,GO:0098827,0.881057613839571,0.145848572508438,71,793,endoplasmic reticulum subcompartment,CC,FLRT2;PTGS1;PKD2;JPH2;SCARA3;NOS1;EGFR;FLRT3;ATP10D;MBOAT2;ABCA1;NSG1;MEST;EXTL2;ACSL3;PTGES;LPCAT2;ERO1B;CAV1;SEL1L;OSBPL5;XYLT1;SDR16C5;CAMK2D;ATP8B2;HHAT;TMEM173;CREB3L2;ALDH3A2;HERPUD1;WFS1;TLR3;PDIA6;MLEC;SEC24D;TMEM129;ESYT2;CALR;COPG2;TMED10;AREG;CD1D;SYNE2;PTPN1;PLD3;G6PC3;TMEM50B;PGAP1;CYP4V2;SPPL2B;ULK1;RHBDD1;HSPA5;REEP2;RSAD2;ITPR2;UGT1A3;LMF1;UGT1A6;ALG10;GALNT2;DERL3;AGPAT1;CERS5;MIA3;DNAJC3;TMEM67;TUSC3;EDEM1;DMPK;MOSPD3
3165,GO:0006779,0.881800150821766,0.384108979222821,1,21,porphyrin-containing compound biosynthetic process,BP,TMEM14C
3115,GO:0006695,0.881842779047943,0.240836595623592,4,59,cholesterol biosynthetic process,BP,SEC14L2;ACACB;G6PD;ACAA2
4997,GO:0015144,0.881900127376881,0.38534489101118,1,19,carbohydrate transmembrane transporter activity,MF,SLC2A3
18270,GO:1903203,0.882163590209244,0.385630832968132,1,18,regulation of oxidative stress-induced neuron death,BP,FZD1
2956,GO:0006490,0.882794128077471,0.3819766420479,1,21,oligosaccharide-lipid intermediate biosynthetic process,BP,ALG10
12530,GO:0050706,0.883000021160016,0.382221068050421,1,20,regulation of interleukin-1 beta secretion,BP,PYCARD
5129,GO:0015630,0.883329196831447,0.139546485673108,98,965,microtubule cytoskeleton,CC,ITGB6;FLOT1;PKD2;CLTCL1;MAP6;DPYSL2;HSPA2;CEP126;SLC8A1;EVC;TADA3;NR3C1;CEP250;TTLL11;CNTRL;EFHC1;TCP11L1;MAP2;CCDC85B;CUL7;CHD3;TTC28;DLG5;NEK9;PDE4DIP;EML2;KCNAB2;PLA2G6;NPHP4;PRKCZ;PARP4;HAUS4;PXN;CAPRIN2;DYSF;KIF17;BBS2;CNTLN;SPRY2;PRKACB;IFT140;FBXL7;DZIP1L;PDE4D;TRIOBP;SEPT6;PBXIP1;BBS4;ATM;BBS1;SNX10;ARHGEF2;DNAL4;KLHL12;LYST;IFT27;NCOR1;NDRG1;RGS14;WDR63;SEPT5;CEP68;IFT88;TTC8;PODXL;MAP2K5;ODF2;OR2A4;IFT122;SPPL2B;REEP2;TTC12;UVRAG;TCTEX1D4;CCHCR1;IFT74;ZNF12;TACC2;TPGS1;DNAH1;YEATS2;CAPG;BEX4;ICK;OBSL1;ARL3;ABCA2;TMEM67;CEP85L;ACTR1B;CAPN6;DNM1P46;SEPT9;KLHL22;CDK5RAP3;TTBK2;LRRCC1;C2CD5
18462,GO:1903599,0.883730462216057,0.383213865268325,1,17,positive regulation of autophagy of mitochondrion,BP,VPS13C
19859,GO:2000369,0.883768108412446,0.385442027257267,1,15,regulation of clathrin-dependent endocytosis,BP,DNAJC6
9593,GO:0036474,0.883772789279922,0.379245914982039,1,22,cell death in response to hydrogen peroxide,BP,TP53
8184,GO:0032941,0.883981407476238,0.380867064597636,1,19,secretion by tissue,BP,WNK1
14715,GO:0070412,0.884244792962269,0.384411298544335,1,15,R-SMAD binding,MF,FOS
8651,GO:0034237,0.884364356871493,0.384152435310781,1,15,protein kinase A regulatory subunit binding,MF,AKAP7
8142,GO:0032881,0.885297400786542,0.295231631666827,2,27,regulation of polysaccharide metabolic process,BP,IRS2;ENPP1
1004,GO:0002479,0.885411806943267,0.253731573952899,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,ITGB5;PSMB9;CALR
17772,GO:1901889,0.885769451317957,0.37987077882025,1,16,negative regulation of cell junction assembly,BP,DLC1
14286,GO:0061462,0.886030665779886,0.291825682855022,2,32,protein localization to lysosome,BP,SORL1;CLU
15061,GO:0071103,0.88613803497931,0.164961252397711,19,246,DNA conformation change,BP,XPC;DDB2;TP53;CHD3;SMARCA1;TNRC18;HMGA2;NCAPD2;TTN;GATAD1;SETX;SOX9;BAHCC1;CDKN2A;TSPYL2;TSPYL4;CENPA;HP1BP3;NIPBL
9468,GO:0036120,0.886283564038108,0.378749570142261,1,16,cellular response to platelet-derived growth factor stimulus,BP,FYN
2993,GO:0006541,0.886369957371494,0.377482475762173,1,17,glutamine metabolic process,BP,CPS1
3073,GO:0006643,0.886695096711378,0.175608251218541,13,178,membrane lipid metabolic process,BP,UGT8;PLA2G6;ALDH3A2;ESYT2;ARSD;HEXA;POGLUT1;PGAP1;GAL3ST4;TH;ITGB8;CERS5;MPPE1
8491,GO:0033683,0.88695023187859,0.288171725353713,2,39,nucleotide-excision repair, DNA incision,BP,DDB2;POLD4
3303,GO:0007006,0.887242430806064,0.207037665939597,6,99,mitochondrial membrane organization,BP,TP53;TFDP2;TP73;SNCA;COX18;ACAA2
3893,GO:0008535,0.887365954367648,0.370348248261693,1,24,respiratory chain complex IV assembly,BP,COX18
7167,GO:0031060,0.887695378102462,0.232370215924663,4,51,regulation of histone methylation,BP,MTHFR;JARID2;KDM4C;KDM4A
18046,GO:1902653,0.887795041165769,0.230991481775092,4,60,secondary alcohol biosynthetic process,BP,SEC14L2;ACACB;G6PD;ACAA2
17720,GO:1901682,0.88781649849292,0.373360516581906,1,18,sulfur compound transmembrane transporter activity,MF,SLC7A11
10330,GO:0043161,0.887961357935901,0.151249211742912,31,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,SKP2;RNF165;ABTB1;BTBD2;TP53;WWTR1;PRICKLE1;DDIT3;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;FBXL7;TMEM129;PSMB9;MDM2;GCLC;RNF24;ANAPC16;HSPA5;NUB1;DERL3;RNF144B;TMEM67;TAF1;EDEM1;GID4;ZNRF1
17644,GO:1901532,0.888005298635927,0.21499063269826,5,103,regulation of hematopoietic progenitor cell differentiation,BP,TP73;PSMB9;TCF12;YAP1;ZBTB1
4031,GO:0009067,0.888225840090397,0.37016489904945,1,21,aspartate family amino acid biosynthetic process,BP,THNSL2
1524,GO:0003899,0.888310918774898,0.285178806265097,2,41,DNA-directed 5'-3' RNA polymerase activity,MF,POLR3GL;PRIMPOL
282,GO:0000785,0.888314410340897,0.146464003282608,39,456,chromatin,CC,TRNP1;SNAI2;MAGED1;CBX5;NR1D1;SMARCA2;STAT1;TP53;MEF2D;CHD3;POLR3GL;HLCS;SMARCA1;TNRC18;SDR16C5;HMGA2;PHC2;UHRF2;TP73;KDM4C;C17ORF49;TCF4;CITED2;CBX7;MAF;NCOR1;SALL2;BAHCC1;TCF12;RBL2;CDKN2A;CENPA;MEF2A;RARA;TAF1;HP1BP3;KDM4A;NIPBL;RXRA
3050,GO:0006612,0.888478173012175,0.185935346366869,9,164,protein targeting to membrane,BP,TCAF1;PAK1;FYN;ANK3;STOM;RPL13A;PRNP;MYO1C;C2CD5
5072,GO:0015301,0.888598918573105,0.371638580465402,1,18,anion:anion antiporter activity,MF,SLC7A11
17667,GO:1901575,0.888609259861427,0.129359994968315,153,1623,organic substance catabolic process,BP,SERPINE2;SULT1E1;PYGB;PRODH;ZFP36L1;DDIT4;IRS2;ZFP36L2;IGF2BP2;ANPEP;SKP2;NOS1;EGFR;SDC3;RNF213;RNF165;VIM;CSPG4;TKFC;NTSR1;TIMP2;APOBEC3C;NR1D1;ABTB1;BTBD2;SORL1;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;ZCCHC11;TIMP1;BCKDHB;PNRC1;CUL7;TYSND1;SNX1;GPX1;ECH1;CTSV;LRP1;FYN;XDH;FUT10;CPS1;CAV1;PLA2G6;TRIB2;SEL1L;GLDC;SNX33;CLU;OAS2;FBXW4;HIBADH;ALDH3A2;CPT1A;ACACB;APOBEC3G;HERPUD1;WFS1;PHKA2;CES2;CIRBP;PLCH2;CHEK2;BACE1;FBXL7;SNCA;ADAMTS7;ALDH1L2;APOBEC3F;PDE4D;TMEM129;PSMB9;SPATA18;DHTKD1;MAGEF1;LRTOMT;NAGLU;ATM;MDM2;CST3;MANBA;HSD17B11;GCLC;HEXA;RNPEP;PTPN1;ALDH4A1;SDC2;THNSL2;SOX9;ENPP1;PLD3;NCOR1;PRKCA;ANXA2;TRERF1;CES3;RNF24;MAN2B1;MVB12B;ANAPC16;RPL13A;DECR1;GGT7;DNASE1L1;SMG9;LIPA;THRA;USP28;ALDH7A1;AGRN;RHBDD1;HSPA5;TGFB1I1;UVRAG;OPHN1;GDNF;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;SNX9;PTPN3;DNAJC3;TMEM67;PRKAG1;TAF1;GSTZ1;DPYD;DNPH1;CDK5RAP3;AIG1;AGO4;SCPEP1;EHHADH;ABAT;FBXL4;UGGT2;VPS36;RNPEPL1;CPT2;EDEM1;GID4;ACAA2;CTSD;ZNRF1
543,GO:0001662,0.888921305744843,0.370078819560831,1,19,behavioral fear response,BP,CCK
866,GO:0002209,0.888921305744843,0.370078819560831,1,19,behavioral defense response,BP,CCK
10075,GO:0042596,0.888921305744843,0.370078819560831,1,19,fear response,BP,CCK
9594,GO:0036475,0.889182956448175,0.369500973197382,1,19,neuron death in response to oxidative stress,BP,FZD1
3626,GO:0008089,0.889233215465352,0.285131383396608,2,34,anterograde axonal transport,BP,NEFL;TRAK1
42,GO:0000086,0.889530722455872,0.162121798658674,18,225,G2/M transition of mitotic cell cycle,BP,CDKN2B;SKP2;CEP250;CNTRL;CDK14;HMGA2;HAUS4;CHEK2;FBXL7;PSMB9;FOXN3;PBX1;ATM;ODF2;FHL1;CCNY;CDK5RAP3;TAOK3
11857,GO:0046888,0.889554661330782,0.284824500076265,2,33,negative regulation of hormone secretion,BP,SFRP1;PPP3CA
4373,GO:0010008,0.8898111530046,0.14840314894649,32,368,endosome membrane,CC,EGFR;NSG1;SORL1;SNX1;TBC1D5;CAV1;EHD3;BACE1;TLR3;FZD7;DKK1;LAPTM4A;MTMR4;ARF6;ANXA6;SNX10;CD1D;SLC48A1;NDRG1;TMEM175;ANXA2;RAB13;MVB12B;RET;VPS39;SPPL2B;PIKFYVE;ABCA2;STEAP2;VPS36;LITAF;ABCA5
10421,GO:0043299,0.889935647988764,0.148767748678111,31,377,leukocyte degranulation,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
7827,GO:0032392,0.890016876214229,0.203804365591419,6,81,DNA geometric change,BP,XPC;DDB2;TP53;CHD3;SMARCA1;SETX
15355,GO:0071634,0.8904995744117,0.368383117904461,1,17,regulation of transforming growth factor beta production,BP,TGFB2
18060,GO:1902692,0.890614862560616,0.369203211767916,1,16,regulation of neuroblast proliferation,BP,GLI3
17948,GO:1902373,0.890902699588146,0.282575419543445,2,32,negative regulation of mRNA catabolic process,BP,CIRBP;GDNF
19744,GO:2000177,0.891116478172191,0.247267687060153,3,41,regulation of neural precursor cell proliferation,BP,GJC2;GLI3;GLI2
6095,GO:0019320,0.891166266385653,0.280395400295201,2,38,hexose catabolic process,BP,TKFC;FUT10
9018,GO:0035250,0.89123937070211,0.362871769914788,1,22,UDP-galactosyltransferase activity,MF,UGT8
11499,GO:0046037,0.89124034625159,0.364934249115003,1,19,GMP metabolic process,BP,DLG4
8217,GO:0032993,0.891270799702995,0.181947649693461,9,163,protein-DNA complex,CC,NUPR1;DDIT3;HMGA2;LEF1;CENPA;POLD4;KCNIP3;HP1BP3;FOS
18781,GO:1904358,0.891363133454481,0.280780926945946,2,35,positive regulation of telomere maintenance via telomere lengthening,BP,ATM;HMBOX1
8059,GO:0032743,0.891522764459662,0.364304154966118,1,19,positive regulation of interleukin-2 production,BP,PDE4D
17866,GO:1902175,0.89163092069557,0.361433967057881,1,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,GPX1
174,GO:0000381,0.891665415531951,0.280790594246986,2,33,regulation of alternative mRNA splicing, via spliceosome,BP,MBNL2;RBFOX2
12715,GO:0051010,0.891859842980914,0.370703529165526,1,13,microtubule plus-end binding,MF,TTBK2
12953,GO:0051383,0.89193276090453,0.36338802981598,1,19,kinetochore organization,BP,CENPA
2879,GO:0006383,0.893264802524535,0.241683456350854,3,51,transcription by RNA polymerase III,BP,POLR3GL;PRDX5;NAB2
2824,GO:0006293,0.893426268345929,0.358594469980901,1,21,nucleotide-excision repair, preincision complex stabilization,BP,DDB2
2826,GO:0006295,0.893426268345929,0.358594469980901,1,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,DDB2
9225,GO:0035635,0.893621802036915,0.360442625368105,1,18,entry of bacterium into host cell,BP,CAV1
18477,GO:1903649,0.893893124161305,0.358984617887147,1,19,regulation of cytoplasmic transport,BP,SORL1
17244,GO:0120111,0.894409231456997,0.220133140772126,4,59,neuron projection cytoplasm,CC,NEFL;DLG4;KIF17;TRAK1
17314,GO:1900027,0.894421023782468,0.355731987575951,1,22,regulation of ruffle assembly,BP,CAV1
12840,GO:0051188,0.894749905875471,0.153810686684026,19,239,cofactor biosynthetic process,BP,DDIT4;DCAKD;ACSL3;NMRK1;ACSS1;ACACB;SNCA;PDK3;DHTKD1;IDH2;TMEM14C;GCLC;ACSS2;NCOR1;NMNAT2;GGT7;NAPRT;PRKAG1;PPCS
151,GO:0000307,0.894775184242211,0.273693558878656,2,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDK14;CCNY
9457,GO:0036094,0.896421903340443,0.119333187105305,186,1808,small molecule binding,MF,PYGB;PRODH;RHOBTB2;MYH15;TGFBR2;PIK3C2G;OSBPL10;TNIK;PROM2;H6PD;NOS1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;SESN3;MYLK;SLC2A3;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;VDR;ITM2C;TP53I3;SMARCA2;PTK6;SCN8A;EIF2AK4;D2HGDH;TP53;TTLL11;CUL9;SEC14L2;WNK1;DDX60;SLC27A3;MICAL1;ACSL3;PHGDH;TEP1;CHD3;SIK1;CDK14;P3H2;NAV2;SYN1;MTHFR;NEK9;SESN1;NMRK1;FYN;XDH;ALPK1;CPS1;CAV1;SLC27A1;HLCS;ERCC6;GLDC;MAP3K14;SMARCA1;OSBPL5;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;HIBADH;ATP8B2;HHAT;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;CAT;DAPK1;PRKACB;AARS;CHEK2;OARD1;FGFR1;IGF1R;SETX;ASTN2;PDE4D;MYO3B;TGM2;OBSCN;PDK3;G6PD;EPHB6;DHTKD1;CHD6;AKAP7;SEPT6;ENG;ATM;IDH2;ARF6;MANBA;ANXA6;DGKQ;GCLC;NR2F2;ACSS2;MSH5;HSPA12A;MAP3K1;THNSL2;NRK;ENPP1;IFT27;ITPKB;SLC27A6;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;DECR1;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;AGRN;ORC4;AGAP1;HSPA5;CDK19;TH;MAGI1;PIKFYVE;SRPK2;ITPR2;UGT1A3;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;PPARG;PARP15;ICK;ARL3;RARA;ABCA2;PRKAG1;TAF1;DPYD;PIK3C2B;PEX1;ACTR1B;SEPT9;ABAT;MYH11;TTBK2;RHOBTB3;MYO1C;RXRA;GBP3;ABCA5;TAOK3;DMPK
5789,GO:0017038,0.896443127109944,0.162494622809016,13,166,protein import,BP,TXNIP;GAS6;BMP4;PRICKLE1;GLI3;SNX33;CLU;TMEM173;LRTOMT;BCL6;MDFIC;PPP3CA;PEX1
8144,GO:0032886,0.896450436196442,0.158541230767766,15,166,regulation of microtubule-based process,BP,STMN3;PAK1;CEP250;MAP2;PHLDB1;EML2;BBS2;SNCA;RGS2;BBS4;ARHGEF2;DIXDC1;TMEM67;EFNA5;TTBK2
10992,GO:0044839,0.896890222292569,0.151001517917196,19,239,cell cycle G2/M phase transition,BP,CDKN2B;SKP2;TP53;CEP250;CNTRL;CDK14;HMGA2;HAUS4;CHEK2;FBXL7;PSMB9;FOXN3;PBX1;ATM;ODF2;FHL1;CCNY;CDK5RAP3;TAOK3
6947,GO:0030594,0.896956825103133,0.349969007738807,1,22,neurotransmitter receptor activity,MF,HTR1B
9467,GO:0036119,0.897064625153006,0.353570560666966,1,17,response to platelet-derived growth factor,BP,FYN
266,GO:0000737,0.897354931100632,0.34905829164409,1,22,DNA catabolic process, endonucleolytic,BP,DNASE1L1
2200,GO:0005086,0.897367097633967,0.355171374094225,1,15,ARF guanyl-nucleotide exchange factor activity,MF,IQSEC2
6004,GO:0019054,0.897938700770041,0.349018386216326,1,20,modulation by virus of host process,BP,EIF2AK4
19865,GO:2000378,0.89794312467569,0.267531611122731,2,37,negative regulation of reactive oxygen species metabolic process,BP,CAV1;G6PD
14775,GO:0070530,0.897959408406126,0.349726723300897,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,ZBTB1
7303,GO:0031323,0.897964528145973,0.113385982277793,476,4607,regulation of cellular metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;TSC22D3;KLF8;HSPA2;FLRT3;SESN3;GJC2;RFX2;ZNF608;SERPINE1;SERPINH1;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;MAP3K6;NTSR1;TIMP2;ZNF862;TADA3;PAK1;NSG1;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;AHNAK;CITED4;EIF2AK4;TRIM5;VAV3;PDCD4;NR3C1;STAT1;SORL1;NEO1;ETV1;TP53;ARAP1;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;HIP1;GPNMB;TFDP2;PNRC1;CCDC85B;CRIM1;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;GPX1;GLI3;E2F7;CNTN1;KITLG;TBC1D5;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;SESN1;LRP1;FYN;IFI6;XDH;TSHZ2;B3GAT3;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;OAS2;SDR16C5;ULK2;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;UHRF2;HERPUD1;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;APLP2;FBLN1;ZKSCAN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;GLG1;SP110;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;G6PD;TLE4;EPHB6;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;ATM;MDM2;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;LEPR;TSHZ1;IGFBP4;IFT88;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;ITM2A;MAPK8IP3;MSRB2;CDKN2A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPHP3;VAV2;RHBDD1;MAGI2;HSPA5;PIKFYVE;TGFB1I1;SRPK2;UVRAG;MDFIC;VPS13C;FHOD1;IFT74;SAP30L;ZNF12;OPHN1;LMF1;YAP1;GDNF;NUB1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;RNF144B;PARP15;BEX4;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;SASH1;TBC1D16;TGIF1;ING4;ZYG11B;UNK;PTPN3;DNAJC3;RARA;ABCA2;CCNY;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;VPS36;PRDM5;PPP2R3A;ZNF471;LITAF;S100A11;RXRA;EDEM1;TAOK3;NFKBIE;ZNF484;DMPK
7190,GO:0031090,0.897977049081584,0.116781788555436,210,2216,organelle membrane,CC,SYT8;SULT1E1;FLOT1;PCDH7;FLRT2;PRODH;GPRC5A;ST6GALNAC2;CD109;SYNE1;PTGS1;MARCH4;PKD2;JPH2;SCARA3;CYBRD1;ANPEP;PROM2;COL7A1;CLTCL1;NOS1;PDGFC;MALL;MAP6;EGFR;GALNT10;CLCA2;SYNE3;SLC2A3;FAM198B;EVC;FAM210B;ASAP2;PAK1;NSG1;ITM2C;AHNAK;SORL1;ARAP1;KIAA0319L;PTPRS;PRICKLE1;DLG4;SLC27A3;PDGFA;ACSL3;HIP1;SNX1;ANO6;LPCAT2;TBC1D5;SYN1;SPG11;KCNAB2;LRP1;B3GAT3;FUT10;CPS1;CAV1;SNX33;SLC22A17;TNRC18;XYLT1;AHNAK2;UST;CLU;CXCR1;ULK2;CHST3;EHD3;CAMK2D;GOLGB1;SYT1;TMEM173;ALDH3A2;CPT1A;ACACB;DYSF;BBS2;APLP2;CAT;ST6GAL2;BACE1;LRIG3;STOM;TLR3;BPHL;MAN1A1;SNCA;FLOT2;MME;VAMP1;FZD7;GLG1;NIPSNAP1;LMNA;ARMCX2;DKK1;MLEC;SEC24D;PDE4D;SPATA18;MYOF;CCDC136;LAPTM4A;BBS4;MTMR4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;TMEM14C;AREG;BBS1;ANXA6;SNX10;DGKQ;CD1D;SYNE2;NEMP2;NDUFA4L2;KLHL12;SLC25A35;ENPP1;SLC48A1;PRCP;NFASC;NDRG1;GCNT1;TMEM50B;PRKCA;PXMP2;TMEM175;ANXA2;RAB13;FNDC3A;RNF24;MAN2B1;GOLGA8B;MVB12B;TTC8;MOSPD2;NMNAT2;GAL3ST4;RAB43;PRNP;RET;VPS39;DSEL;SCNN1A;GPR161;SFXN3;MAPK8IP3;C2CD4C;SPPL2B;ULK1;NRM;TH;GOPC;SNX7;PIKFYVE;RSAD2;ITPR2;VPS13C;RHBDD2;GOLGA8N;ATRAID;GALNT2;DERL3;RNF144B;TPST1;CERS5;SNX9;LGALS3;ARL3;MIA3;DNAJC3;COG3;RASSF9;SV2A;ABCA2;TMEM67;FZD4;MPPE1;ZBTB1;SBF2;PEX1;STEAP2;COX18;DNM1P46;FAM169A;KLHDC2;VPS36;ADAM10;RHOBTB3;LITAF;ATG16L2;MYO1C;C2CD5;GBP3;CPT2;EDEM1;ACAA2;ABCA5;ZNRF1;DMPK
3745,GO:0008286,0.898015359517816,0.178349670630236,8,101,insulin receptor signaling pathway,BP,IRS2;SESN3;PRKCZ;PIK3R1;IGF1R;PTPN1;ENPP1;C2CD5
10558,GO:0043543,0.898052895223989,0.154119033415176,16,199,protein acylation,BP,CPA4;NOS1;SNAI2;NUPR1;TADA3;SDR16C5;PER1;HHAT;SNCA;JADE2;ISL1;LEF1;YEATS2;ING4;TAF1;EHHADH
116,GO:0000245,0.898144402240849,0.232743545951455,3,53,spliceosomal complex assembly,BP,SETX;CELF2;SRPK2
9592,GO:0036473,0.898274560814606,0.213117083827636,4,64,cell death in response to oxidative stress,BP,PRODH;TP53;GPX1;FZD1
3408,GO:0007193,0.898531586717363,0.26813081943389,2,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,RGS2;HTR1B
8566,GO:0034062,0.898550350020416,0.265100801151561,2,43,5'-3' RNA polymerase activity,MF,POLR3GL;PRIMPOL
16704,GO:0097747,0.898550350020416,0.265100801151561,2,43,RNA polymerase activity,MF,POLR3GL;PRIMPOL
10375,GO:0043228,0.898922085364319,0.113524153619323,328,3268,non-membrane-bounded organelle,CC,ITGB6;FLOT1;MMP2;KRT4;TRNP1;GPRC5A;INPP5D;MARVELD1;ZFP36L1;SYNE1;TLN2;MYH15;TNNI2;XPC;GSN;PKD2;JPH2;OSBPL10;IGF2BP2;TNIK;SKP2;CLTCL1;TNS4;NOS1;DNMBP;SNAI2;MAGED1;MAP6;UTRN;ROR1;DPYSL2;HSPA2;TCHH;SPTB;CEP126;SLC8A1;MYLK;ACTA2;RNF213;KRT14;STON2;VIM;PSTPIP1;CTNNAL1;EVC;ADD3;TADA3;PDLIM2;PLEC;PAK1;CBX5;APOBEC3C;NEFM;TNS1;NR1D1;SMARCA2;AHNAK;SCN8A;ABTB1;EIF2AK4;TRIM5;NEFL;NR3C1;STAT1;BTBD2;TP53;CEP250;KRT13;TTLL11;CNTRL;CCDC102A;PYCARD;MEF2D;KRT5;DDX60;EFHC1;DLG4;TCP11L1;SLC7A11;ZCCHC11;MAP2;FRMD4B;MICAL1;PPL;ADARB1;ACSL3;FLG;HIP1;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;CHD3;TTC28;WDR66;PLEK2;GLI3;DLG5;LPCAT2;KITLG;ASAP1;SYN1;ABHD14B;KRT15;MAGED2;NEK9;SESN1;CTSV;SPG11;PDE4DIP;EML2;KCNAB2;FYN;FLNC;CPS1;POLR3GL;CAV1;GLI2;HLCS;ERCC6;PLA2G6;TRIB2;MAP3K14;ESPN;SMARCA1;TNRC18;AHNAK2;CLU;NPHP4;PRKCZ;SDR16C5;PARP4;HMGA2;PHC2;MST1R;KANK2;METTL7A;ULBP1;HAUS4;PTPN14;PXN;NCAPD2;CAPRIN2;APOBEC3G;PCLO;ANG;DYSF;KIF17;PARVA;UHRF2;BBS2;CNTLN;ANK3;SPRY2;TTN;TSTD1;CIRBP;MLH3;TP73;CASP14;SHROOM4;DAPK1;DLC1;PRKACB;CHEK2;IFT140;STOM;PHF2;FBXL7;SNCA;FLOT2;FRMD5;DZIP1L;FGFR1;APOBEC3F;LMNA;ALOX15B;FSCN1;RGS2;SETX;PDE4D;APBB3;MYO3B;OBSCN;PDK3;TRIOBP;KDM4C;RAPH1;SEPT6;IPP;L3MBTL3;PBXIP1;BBS4;ATM;MDM2;CST3;C17ORF49;TCF4;BBS1;AKAP13;HSD17B11;SNX10;DGKQ;CITED2;FHOD3;CBX7;ZMAT3;MSH5;MAF;SYNE2;FGD4;VANGL2;ARHGEF2;DNAL4;KLHL12;SYNC;KRT222;SSH1;LYST;IFT27;BCL6;NCOR1;NDRG1;SALL2;ANXA2;TRERF1;RGS14;HLTF;CXORF57;WDR63;SEPT5;BAHCC1;CEP68;IFT88;TTC8;TCF12;HMBOX1;ANAPC16;RPL13A;PODXL;PAK6;UACA;ATXN1;WDR19;CARF;RBL2;MAP2K5;ODF2;OR2A4;IFT122;LIPA;CDC42EP5;CDKN2A;MPRIP;SPPL2B;SP100;TSPYL2;ORC4;KLHL5;CENPA;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;UVRAG;TCTEX1D4;CCHCR1;CFAP54;MDFIC;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;OPHN1;TPGS1;MYO9A;DNAH1;TWIST2;KLHL3;YEATS2;CAPG;BEX4;MEF2A;ICK;OBSL1;ING4;PTPN3;ARL3;DEF6;FKBP10;RARA;ABCA2;TMEM67;TAF1;CEP85L;WIPF1;PPP3CA;LIMA1;KRT10;ACTR1B;ETV4;HP1BP3;CAPN6;DNM1P46;SEPT9;KDM4A;KLHL22;CDK5RAP3;AGO4;MYH11;NIPBL;TTBK2;BSN;PRDM5;RHOBTB3;LRRCC1;MYO1C;RXRA;C2CD5;CPT2;SNTB1;NFKBIE
10379,GO:0043232,0.898922085364319,0.113524153619323,328,3268,intracellular non-membrane-bounded organelle,CC,ITGB6;FLOT1;MMP2;KRT4;TRNP1;GPRC5A;INPP5D;MARVELD1;ZFP36L1;SYNE1;TLN2;MYH15;TNNI2;XPC;GSN;PKD2;JPH2;OSBPL10;IGF2BP2;TNIK;SKP2;CLTCL1;TNS4;NOS1;DNMBP;SNAI2;MAGED1;MAP6;UTRN;ROR1;DPYSL2;HSPA2;TCHH;SPTB;CEP126;SLC8A1;MYLK;ACTA2;RNF213;KRT14;STON2;VIM;PSTPIP1;CTNNAL1;EVC;ADD3;TADA3;PDLIM2;PLEC;PAK1;CBX5;APOBEC3C;NEFM;TNS1;NR1D1;SMARCA2;AHNAK;SCN8A;ABTB1;EIF2AK4;TRIM5;NEFL;NR3C1;STAT1;BTBD2;TP53;CEP250;KRT13;TTLL11;CNTRL;CCDC102A;PYCARD;MEF2D;KRT5;DDX60;EFHC1;DLG4;TCP11L1;SLC7A11;ZCCHC11;MAP2;FRMD4B;MICAL1;PPL;ADARB1;ACSL3;FLG;HIP1;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;CHD3;TTC28;WDR66;PLEK2;GLI3;DLG5;LPCAT2;KITLG;ASAP1;SYN1;ABHD14B;KRT15;MAGED2;NEK9;SESN1;CTSV;SPG11;PDE4DIP;EML2;KCNAB2;FYN;FLNC;CPS1;POLR3GL;CAV1;GLI2;HLCS;ERCC6;PLA2G6;TRIB2;MAP3K14;ESPN;SMARCA1;TNRC18;AHNAK2;CLU;NPHP4;PRKCZ;SDR16C5;PARP4;HMGA2;PHC2;MST1R;KANK2;METTL7A;ULBP1;HAUS4;PTPN14;PXN;NCAPD2;CAPRIN2;APOBEC3G;PCLO;ANG;DYSF;KIF17;PARVA;UHRF2;BBS2;CNTLN;ANK3;SPRY2;TTN;TSTD1;CIRBP;MLH3;TP73;CASP14;SHROOM4;DAPK1;DLC1;PRKACB;CHEK2;IFT140;STOM;PHF2;FBXL7;SNCA;FLOT2;FRMD5;DZIP1L;FGFR1;APOBEC3F;LMNA;ALOX15B;FSCN1;RGS2;SETX;PDE4D;APBB3;MYO3B;OBSCN;PDK3;TRIOBP;KDM4C;RAPH1;SEPT6;IPP;L3MBTL3;PBXIP1;BBS4;ATM;MDM2;CST3;C17ORF49;TCF4;BBS1;AKAP13;HSD17B11;SNX10;DGKQ;CITED2;FHOD3;CBX7;ZMAT3;MSH5;MAF;SYNE2;FGD4;VANGL2;ARHGEF2;DNAL4;KLHL12;SYNC;KRT222;SSH1;LYST;IFT27;BCL6;NCOR1;NDRG1;SALL2;ANXA2;TRERF1;RGS14;HLTF;CXORF57;WDR63;SEPT5;BAHCC1;CEP68;IFT88;TTC8;TCF12;HMBOX1;ANAPC16;RPL13A;PODXL;PAK6;UACA;ATXN1;WDR19;CARF;RBL2;MAP2K5;ODF2;OR2A4;IFT122;LIPA;CDC42EP5;CDKN2A;MPRIP;SPPL2B;SP100;TSPYL2;ORC4;KLHL5;CENPA;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;UVRAG;TCTEX1D4;CCHCR1;CFAP54;MDFIC;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;OPHN1;TPGS1;MYO9A;DNAH1;TWIST2;KLHL3;YEATS2;CAPG;BEX4;MEF2A;ICK;OBSL1;ING4;PTPN3;ARL3;DEF6;FKBP10;RARA;ABCA2;TMEM67;TAF1;CEP85L;WIPF1;PPP3CA;LIMA1;KRT10;ACTR1B;ETV4;HP1BP3;CAPN6;DNM1P46;SEPT9;KDM4A;KLHL22;CDK5RAP3;AGO4;MYH11;NIPBL;TTBK2;BSN;PRDM5;RHOBTB3;LRRCC1;MYO1C;RXRA;C2CD5;CPT2;SNTB1;NFKBIE
10768,GO:0044257,0.899003163437734,0.127614311843673,58,633,cellular protein catabolic process,BP,SKP2;RNF213;RNF165;NR1D1;ABTB1;BTBD2;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;CUL7;GPX1;CTSV;LRP1;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;CHEK2;FBXL7;ADAMTS7;TMEM129;PSMB9;SPATA18;MAGEF1;MDM2;GCLC;ANXA2;RNF24;MVB12B;ANAPC16;USP28;RHBDD1;HSPA5;TGFB1I1;OPHN1;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;DNAJC3;TMEM67;TAF1;CDK5RAP3;SCPEP1;FBXL4;UGGT2;VPS36;EDEM1;GID4;ZNRF1
5663,GO:0016779,0.899105117407007,0.171413362186599,9,128,nucleotidyltransferase activity,MF,ZCCHC11;TEP1;POLR3GL;OAS2;PRIMPOL;HMBOX1;NMNAT2;POLD4;POLH
3210,GO:0006855,0.899192176201877,0.23191327267966,3,46,drug transmembrane transport,BP,NTSR1;SLC7A11;ABCC2
8253,GO:0033048,0.899478026254492,0.265314692062777,2,34,negative regulation of mitotic sister chromatid segregation,BP,ATM;KLHL22
8733,GO:0034399,0.899506051052146,0.167495788710737,10,120,nuclear periphery,CC,PHACTR3;TP53;MAP2;TEP1;HLCS;PRKCZ;LMNA;DGKQ;ATXN1;TGFB1I1
14601,GO:0070199,0.89951166845091,0.343534974124501,1,23,establishment of protein localization to chromosome,BP,NIPBL
14803,GO:0070570,0.899720685035631,0.344908691347687,1,20,regulation of neuron projection regeneration,BP,PTPRS
10070,GO:0042590,0.899768526884051,0.228347653791155,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,ITGB5;PSMB9;CALR
6877,GO:0030397,0.899889073408187,0.230659603852872,3,46,membrane disassembly,BP,NEK9;LMNA;PRKCA
12760,GO:0051081,0.899889073408187,0.230659603852872,3,46,nuclear envelope disassembly,BP,NEK9;LMNA;PRKCA
201,GO:0000423,0.900099451318404,0.344785240904939,1,19,mitophagy,BP,VPS13C
3938,GO:0008631,0.900143318581956,0.262756656864943,2,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PRODH;GPX1
17012,GO:0099518,0.900354317387789,0.230583100035516,3,42,vesicle cytoskeletal trafficking,BP,PRKCZ;TRAK1;MYO1C
9872,GO:0042168,0.900570063764293,0.34057033351337,1,24,heme metabolic process,BP,TMEM14C
9242,GO:0035666,0.900687570922794,0.340297373479705,1,24,TRIF-dependent toll-like receptor signaling pathway,BP,TLR3
14821,GO:0070603,0.900801231382366,0.196691469511584,5,67,SWI/SNF superfamily-type complex,CC,SMARCA2;CHD3;SMARCA1;C17ORF49;SALL2
5438,GO:0016311,0.901567310233284,0.133352951649973,33,359,dephosphorylation,BP,PHACTR3;INPP5D;DUSP6;ITPK1;PTPRM;PTPRS;WNK1;ITGA2;ELFN2;CTDSPL;B3GAT3;TNS2;ITGA1;PTPN14;DUSP5;DLC1;PTPRU;MTMR4;DNAJC6;PTPN1;NT5DC3;THNSL2;SSH1;G6PC3;TGFB2;PPM1M;MAGI2;PTPN3;PPP3CA;CTDSP2;CDK5RAP3;PPP2R3A;DMPK
7924,GO:0032515,0.901715884186596,0.260616050397517,2,35,negative regulation of phosphoprotein phosphatase activity,BP,PHACTR3;ELFN2
13543,GO:0060039,0.901923490001633,0.346004536622628,1,14,pericardium development,BP,FLRT3
6049,GO:0019201,0.902732670375927,0.337885161248544,1,20,nucleotide kinase activity,MF,DLG4
3089,GO:0006665,0.902890435501951,0.165863734876624,9,128,sphingolipid metabolic process,BP,UGT8;PLA2G6;ALDH3A2;ESYT2;ARSD;HEXA;TH;ITGB8;CERS5
4572,GO:0010662,0.903078418223192,0.337072609056763,1,20,regulation of striated muscle cell apoptotic process,BP,CAMK2D
7345,GO:0031398,0.903270155447906,0.182559788453179,6,91,positive regulation of protein ubiquitination,BP,SKP2;PRICKLE1;CAV1;WFS1;HSPA5;CDK5RAP3
3878,GO:0008514,0.903481601299931,0.16142508285782,10,130,organic anion transmembrane transporter activity,MF,SLC7A8;SLC2A3;SLC7A11;SLC22A15;SLC27A1;SLC22A17;SLC38A10;SLC38A2;SLC27A6;ABCC2
1042,GO:0002562,0.903486602893454,0.224322441787218,3,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,ATM;BCL6;LEF1
5495,GO:0016444,0.903486602893454,0.224322441787218,3,45,somatic cell DNA recombination,BP,ATM;BCL6;LEF1
6906,GO:0030507,0.903713227826605,0.33917495827367,1,16,spectrin binding,MF,ANK3
603,GO:0001772,0.903902762914388,0.335881322891814,1,19,immunological synapse,CC,LGALS3
9689,GO:0038111,0.904360138921579,0.330792801096638,1,26,interleukin-7-mediated signaling pathway,BP,IRS2
16820,GO:0098760,0.904360138921579,0.330792801096638,1,26,response to interleukin-7,BP,IRS2
16821,GO:0098761,0.904360138921579,0.330792801096638,1,26,cellular response to interleukin-7,BP,IRS2
894,GO:0002275,0.904439547532264,0.130657534991086,31,382,myeloid cell activation involved in immune response,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
6276,GO:0019886,0.904888826988867,0.189429646495964,5,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,CTSV;SEC24D;OSBPL1A;ACTR1B;CTSD
16597,GO:0097484,0.905067203029352,0.334901123569169,1,17,dendrite extension,BP,SYT1
15083,GO:0071168,0.905124584577754,0.330948141943675,1,22,protein localization to chromatin,BP,NIPBL
3096,GO:0006672,0.905224032115361,0.201111055558069,4,66,ceramide metabolic process,BP,UGT8;PLA2G6;ITGB8;CERS5
9003,GO:0035198,0.905735964672814,0.330107057028572,1,21,miRNA binding,MF,AGO4
7583,GO:0031965,0.905796441862472,0.136058796753217,22,251,nuclear membrane,CC,SULT1E1;SYNE1;EGFR;CLCA2;SYNE3;PAK1;PRICKLE1;TNRC18;SNCA;LMNA;PDE4D;MYOF;CST3;SYNE2;NEMP2;PRNP;NRM;CERS5;ZBTB1;FAM169A;KLHDC2;DMPK
15726,GO:0072348,0.905867896236639,0.329792841936118,1,21,sulfur compound transport,BP,SLC35F3
9319,GO:0035821,0.906154281680007,0.177893858498973,6,93,modification of morphology or physiology of other organism,BP,EIF2AK4;HMGA2;STOM;ANXA2;LEF1;RXRA
2976,GO:0006521,0.9069241755134,0.247325055369298,2,51,regulation of cellular amino acid metabolic process,BP,NQO1;PSMB9
3046,GO:0006606,0.907093956009834,0.160108086685161,9,114,protein import into nucleus,BP,TXNIP;GAS6;BMP4;PRICKLE1;GLI3;TMEM173;BCL6;MDFIC;PPP3CA
7412,GO:0031519,0.907216314103477,0.21715749520032,3,47,PcG protein complex,CC,PHC2;JARID2;CBX7
11377,GO:0045787,0.907588215302778,0.130161848981404,26,301,positive regulation of cell cycle,BP,CTGF;PKD2;EGFR;PTK6;TP53;TFDP2;E2F7;HMGA2;UHRF2;TP73;CHEK2;FGFR1;PBX1;CALR;ATM;MDM2;MEIS2;CITED2;PRKCA;TGFB2;RBL2;OR2A4;SRPK2;RARA;CCNY;NIPBL
19254,GO:1905476,0.907918907072123,0.324272329252605,1,22,negative regulation of protein localization to membrane,BP,GOPC
23,GO:0000045,0.908111251405934,0.17525923441476,6,84,autophagosome assembly,BP,ULK2;TP53INP1;IFT88;ULK1;PIKFYVE;ATG16L2
17822,GO:1902036,0.908234980835875,0.194221936617476,4,95,regulation of hematopoietic stem cell differentiation,BP,TP73;PSMB9;TCF12;YAP1
15348,GO:0071622,0.908265871952797,0.320718877449088,1,28,regulation of granulocyte chemotaxis,BP,MOSPD2
13243,GO:0051959,0.908622782051707,0.251723920546915,2,23,dynein light intermediate chain binding,MF,DNAL4;DNAH1
10591,GO:0043601,0.908733374646205,0.321248206256827,1,24,nuclear replisome,CC,POLD4
3296,GO:0006996,0.909200350489374,0.10249695153589,314,3091,organelle organization,BP,SERPINE2;CPA4;SYT8;KRT4;MMP9;ITGB5;CTGF;SFRP1;RHOBTB2;SYNE1;F2R;TLN2;XPC;ASAP3;GSN;PKD2;TNIK;COL7A1;NOS1;SNAI2;MAP6;PHF21A;SAMD9L;DPYSL2;HSPA2;SPTB;CEP126;SYNE3;RFX2;KRT14;TCF7L1;S100A10;VIM;DDB2;ALS2CL;STMN3;ADD3;TOM1L2;TADA3;PAK1;ABCA1;PADI3;BMP4;NEFM;SMARCA2;TBC1D8;NEFL;VAV3;NR3C1;IFIT2;TP53;ARAP1;CEP250;KRT13;TTLL11;WWTR1;CNTRL;CUL9;PYCARD;KRT5;EFHC1;DLG4;SEMA5A;PDGFA;MAP2;MICAL1;NISCH;PPL;PHLDB1;HIP1;TFDP2;TEP1;CUL7;CHD3;EVI5L;SNX1;GPX1;PLEK2;TBC1D5;ASAP1;LIMCH1;MTHFR;SRPX;KRT15;NEK9;CTSV;SPG11;PLXNB1;PDE4DIP;EML2;LRP1;IFI6;ARHGAP18;UGT8;CAV1;RMI2;HLCS;PLA2G6;SPATA6;SNX33;ESPN;SMARCA1;TNRC18;CLU;NPHP4;PRKCZ;SDR16C5;ULK2;TP53INP1;IQSEC2;ARPIN;EHD3;HMGA2;CAMK2D;ADGRG6;GOLGB1;SYTL1;KANK2;HAUS4;PER1;ATP8B2;PXN;CCK;PIK3R1;SYT1;HHAT;NCAPD2;PCLO;ANG;DYSF;KIF17;PARVA;LAMA5;UHRF2;BBS2;CNTLN;ANK3;SPRY2;TTN;CIRBP;JARID2;HPS4;MLH3;TP73;SHROOM4;DLC1;CHEK2;IFT140;PHF2;SNCA;FRMD5;GATAD1;VAMP1;AIP;JADE2;SP110;DZIP1L;LMNA;FSCN1;SEC24D;RGS2;SETX;OBSCN;SPATA18;BRD3;CCDC136;ARHGEF17;TRIOBP;KDM4C;CHD6;SEPT6;AMOTL1;L3MBTL3;NAGLU;BBS4;CALR;HPS3;MKLN1;ATM;IDH2;ARF6;TMED10;C17ORF49;AREG;BBS1;AKAP13;SNX10;GCLC;ACSS2;FHOD3;CBX7;MSH5;TRAK1;FBXW8;SYNE2;HDAC11;RCBTB1;FGD4;PTPN1;VANGL2;ARHGEF2;KLHL12;SSH1;LYST;SOX9;IFT27;ISL1;BCL6;NCOR1;PRKCA;MYBL1;TMEM175;ANXA2;RGS14;RAB13;PRIMPOL;HLTF;SEPT5;BAHCC1;CEP68;IFT88;GOLGA8B;TTC8;HMBOX1;PAK6;MAP3K12;CHD9;STK36;RAB43;WDR19;ZFPM1;RBL2;ODF2;VPS39;OR2A4;STAT2;AMOTL2;IFT122;LEF1;CDC42EP5;MSRB2;C2CD4C;CDKN2A;SP100;ULK1;TSPYL2;AGRN;NPHP3;TSPYL4;GOPC;SNX7;CENPA;PIKFYVE;REEP2;FLNB;SRPK2;UVRAG;CFAP54;ARHGEF19;VPS13C;FHOD1;IFT74;POLD4;SAP30L;TACC2;OPHN1;TPGS1;DNAH1;GOLGA8N;YEATS2;DIXDC1;CAPG;INF2;MEF2A;SNX9;ICK;TBC1D16;OBSL1;ING4;ARL3;MIA3;FKBP10;COG3;TMEM67;TAF1;EFNA5;WIPF1;ZBTB1;PIK3C2B;RASA1;LIMA1;PEX1;HP1BP3;COX18;CAPN6;DNM1P46;SEPT9;KDM4A;KLHL22;AGO4;ELMO2;MYH11;NIPBL;VPS36;TTBK2;PRDM5;RHOBTB3;CELSR1;ATG16L2;MYO1C;C2CD5;ACAA2;DOCK1;DMPK
4569,GO:0010659,0.909304729780987,0.322209409393569,1,20,cardiac muscle cell apoptotic process,BP,CAMK2D
15097,GO:0071218,0.909559105491112,0.321592645544426,1,20,cellular response to misfolded protein,BP,UGGT2
5349,GO:0016126,0.909570656049738,0.19378392555495,4,64,sterol biosynthetic process,BP,SEC14L2;ACACB;G6PD;ACAA2
14104,GO:0060999,0.909735582167703,0.246044326122517,2,30,positive regulation of dendritic spine development,BP,DLG5;CAPRIN2
7548,GO:0031901,0.910209810372288,0.159729457941233,8,107,early endosome membrane,CC,EGFR;NSG1;SNX1;CAV1;DKK1;MTMR4;PIKFYVE;LITAF
5654,GO:0016765,0.910479413921316,0.240655699796683,2,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,PTGES;GSTZ1
986,GO:0002444,0.910554668598443,0.122937718161017,31,385,myeloid leukocyte mediated immunity,BP,PYGB;MMP9;GSN;ANPEP;SLC2A3;TIMP2;PYCARD;ANO6;KCNAB2;CXCR1;METTL7A;TMEM173;CAT;STOM;MME;MLEC;CST3;MANBA;PRCP;NFASC;ANXA2;MAN2B1;MOSPD2;DNASE1L1;NAPRT;LGALS3;DNAJC3;ACTR1B;ADAM10;S100A11;CTSD
14764,GO:0070507,0.910602777661219,0.143134488277597,13,148,regulation of microtubule cytoskeleton organization,BP,STMN3;PAK1;CEP250;MAP2;PHLDB1;EML2;SNCA;RGS2;ARHGEF2;DIXDC1;TMEM67;EFNA5;TTBK2
3631,GO:0008094,0.910719078236797,0.171394126391591,6,79,DNA-dependent ATPase activity,MF,SMARCA2;CHD3;ERCC6;SMARCA1;CHD6;MSH5
418,GO:0001106,0.910831526506037,0.317825215722745,1,21,RNA polymerase II transcription corepressor activity,MF,CITED2
6918,GO:0030521,0.911120385937633,0.191688654443027,4,58,androgen receptor signaling pathway,BP,SFRP1;TGFB1I1;TAF1;MED12
13673,GO:0060255,0.911549620329789,0.0987234494990265,468,4564,regulation of macromolecule metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;TSC22D3;KLF8;HSPA2;FLRT3;GJC2;RFX2;ACTA2;ZNF608;SERPINE1;SERPINH1;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;NSG1;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;ETV1;TP53;ARAP1;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;HIP1;GPNMB;TFDP2;PNRC1;CCDC85B;CRIM1;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;SNX1;GPX1;GLI3;E2F7;CNTN1;KITLG;TBC1D5;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;LRP1;FYN;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;SLIT3;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;ANG;DUSP5;UHRF2;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;APLP2;FBLN1;ZKSCAN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;FLOT2;GATAD1;FZD7;AIP;GLG1;SP110;FGFR1;IGF1R;DKK1;CTF1;RGS2;C5;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EPHB6;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;ATM;MDM2;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;SMG9;STAT2;ZNF701;LEF1;THRA;SSBP3;ITM2A;MAPK8IP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;RHBDD1;MAGI2;HSPA5;TGFB1I1;SRPK2;UVRAG;ITGB8;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;OPHN1;YAP1;GDNF;NUB1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;DERL3;ZNF558;MEIS3;PPARG;RNF144B;PARP15;BEX4;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;ING4;ZYG11B;UNK;PTPN3;DNAJC3;RARA;ABCA2;CCNY;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;CAMK2N1;MED12;NPAS2;NIPBL;VPS36;ADM2;PRDM5;PPP2R3A;ZNF471;LITAF;S100A11;MYO1C;RXRA;EDEM1;TAOK3;NFKBIE;ZNF484;DMPK
4745,GO:0010921,0.911807088063016,0.146366634609467,11,133,regulation of phosphatase activity,BP,PHACTR3;WNK1;ITGA2;ELFN2;B3GAT3;ITGA1;TGFB2;MAGI2;CDK5RAP3;PPP2R3A;DMPK
3438,GO:0007249,0.911830772326151,0.135315326619607,16,206,I-kappaB kinase/NF-kappaB signaling,BP,F2R;ROR1;SLC20A1;TRIM38;TRIM5;STAT1;LGALS1;PYCARD;FYN;MAP3K14;PER1;TLR3;TGM2;EDA2R;AKAP13;LITAF
7343,GO:0031396,0.912072832173543,0.142885018362998,12,162,regulation of protein ubiquitination,BP,SKP2;PRICKLE1;FYN;CAV1;HERPUD1;WFS1;GCLC;HSPA5;SASH1;ZYG11B;TAF1;CDK5RAP3
15487,GO:0071897,0.912550576052896,0.137899808303892,14,179,DNA biosynthetic process,BP,CTGF;TP53;TEP1;RMI2;PARP4;ATM;PRIMPOL;HMBOX1;LIG1;POLD4;UBA7;PPARG;POLH;ZBTB1
9777,GO:0040014,0.912716802597477,0.207460249687961,3,44,regulation of multicellular organism growth,BP,BBS2;BBS4;NIPBL
16305,GO:0090559,0.912879576948858,0.187446950679701,4,71,regulation of membrane permeability,BP,TP53;TFDP2;TP73;ACAA2
2509,GO:0005765,0.913322912740799,0.123458896727393,25,299,lysosomal membrane,CC,FLOT1;CYBRD1;ANPEP;ITM2C;AHNAK;SPG11;LRP1;STOM;TLR3;LAPTM4A;MANBA;ANXA6;CD1D;ENPP1;SLC48A1;PRCP;TMEM175;ANXA2;VPS39;SPPL2B;GOPC;ATRAID;ABCA2;LITAF;ABCA5
16871,GO:0098852,0.913322912740799,0.123458896727393,25,299,lytic vacuole membrane,CC,FLOT1;CYBRD1;ANPEP;ITM2C;AHNAK;SPG11;LRP1;STOM;TLR3;LAPTM4A;MANBA;ANXA6;CD1D;ENPP1;SLC48A1;PRCP;TMEM175;ANXA2;VPS39;SPPL2B;GOPC;ATRAID;ABCA2;LITAF;ABCA5
6747,GO:0030177,0.913475975893799,0.146646537993121,10,136,positive regulation of Wnt signaling pathway,BP,SFRP1;SULF2;WNK1;CAV1;CAPRIN2;DKK1;PSMB9;SULF1;YAP1;DIXDC1
18080,GO:1902745,0.913622152706742,0.312376707535238,1,19,positive regulation of lamellipodium organization,BP,FSCN1
3908,GO:0008569,0.914560343735577,0.321181448019084,1,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH1
20083,GO:2000779,0.914859681308028,0.202631180819655,3,49,regulation of double-strand break repair,BP,HMGA2;MAGEF1;CXORF57
12846,GO:0051196,0.915974583449728,0.171444647703244,5,68,regulation of coenzyme metabolic process,BP,DDIT4;SNCA;PDK3;NCOR1;PRKAG1
16843,GO:0098803,0.916056639104183,0.22731408371153,2,66,respiratory chain complex,CC,SNCA;NDUFA4L2
2496,GO:0005747,0.916147256975828,0.298177519384752,1,42,mitochondrial respiratory chain complex I,CC,SNCA
7124,GO:0030964,0.916147256975828,0.298177519384752,1,42,NADH dehydrogenase complex,CC,SNCA
11159,GO:0045271,0.916147256975828,0.298177519384752,1,42,respiratory chain complex I,CC,SNCA
5840,GO:0017137,0.916545339140892,0.132673630685356,14,158,Rab GTPase binding,MF,ALS2CL;TBC1D8;RIN2;MICAL1;EVI5L;TBC1D5;SYTL1;HPS4;NDRG1;ANXA2;ULK1;TBC1D16;SBF2;RHOBTB3
16688,GO:0097711,0.916608939239604,0.155140556116998,7,94,ciliary basal body-plasma membrane docking,BP,CEP250;CNTRL;NPHP4;HAUS4;ODF2;TMEM67;TTBK2
3395,GO:0007176,0.916756571777425,0.302549672710295,1,22,regulation of epidermal growth factor-activated receptor activity,BP,GPRC5A
130,GO:0000271,0.916792347152925,0.181592272665887,4,59,polysaccharide biosynthetic process,BP,IRS2;NR1D1;GLT8D2;ENPP1
635,GO:0001825,0.916932663890365,0.30210699480746,1,22,blastocyst formation,BP,KDM4C
7377,GO:0031440,0.917064745977903,0.301774691554079,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
18084,GO:1902751,0.917680965086958,0.299675413006366,1,23,positive regulation of cell cycle G2/M phase transition,BP,PBX1
17460,GO:1900407,0.917726018399585,0.196573473481567,3,54,regulation of cellular response to oxidative stress,BP,TP53;GPX1;FZD1
7898,GO:0032482,0.917774940864618,0.195957220531149,3,59,Rab protein signal transduction,BP,IFT27;RAB13;RAB43
19454,GO:1990204,0.917979797121625,0.17745819791867,4,89,oxidoreductase complex,CC,BCKDHB;GLDC;SNCA;DHTKD1
10688,GO:0044003,0.918359268700005,0.226882997140658,2,34,modification by symbiont of host morphology or physiology,BP,EIF2AK4;RXRA
14520,GO:0070064,0.918742741918638,0.29952699065284,1,19,proline-rich region binding,MF,YAP1
4480,GO:0010507,0.919111222052898,0.177360957439699,4,60,negative regulation of autophagy,BP,SNCA;LZTS1;LEPR;KDM4A
8251,GO:0033046,0.919216090040138,0.224563846454263,2,36,negative regulation of sister chromatid segregation,BP,ATM;KLHL22
13262,GO:0051985,0.919216090040138,0.224563846454263,2,36,negative regulation of chromosome segregation,BP,ATM;KLHL22
92,GO:0000183,0.91947732280919,0.290293591037584,1,39,chromatin silencing at rDNA,BP,PHF2
12459,GO:0050434,0.919479185262803,0.223148747383339,2,40,positive regulation of viral transcription,BP,LEF1;MDFIC
7949,GO:0032559,0.919812161578947,0.095915884959744,124,1168,adenyl ribonucleotide binding,MF,MYH15;TGFBR2;PIK3C2G;TNIK;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;OBSCN;PDK3;EPHB6;CHD6;ATM;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;ITPKB;STK16;DDX60L;PRKCA;PRPS2;ETNK2;HLTF;NMNAT2;GAL3ST4;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RET;MAP2K5;LIG1;ULK1;ORC4;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;MYH11;TTBK2;RHOBTB3;MYO1C;ABCA5;TAOK3;DMPK
15749,GO:0072384,0.919828586271843,0.164899494135262,5,68,organelle transport along microtubule,BP,NEFL;PRKCZ;COPG2;TRAK1;SYNE2
6801,GO:0030262,0.919852115371697,0.293668905272339,1,24,apoptotic nuclear changes,BP,CDK5RAP3
10983,GO:0044815,0.919929982380744,0.189933335147901,3,91,DNA packaging complex,CC,NCAPD2;CENPA;HP1BP3
18325,GO:1903322,0.919987046968841,0.149249824575987,7,107,positive regulation of protein modification by small protein conjugation or removal,BP,SKP2;PRICKLE1;CAV1;PIAS3;WFS1;HSPA5;CDK5RAP3
7963,GO:0032588,0.920110556046616,0.175117686779732,4,65,trans-Golgi network membrane,CC,NSG1;RAB43;COG3;RHOBTB3
8229,GO:0033014,0.920171486206173,0.292853498905185,1,24,tetrapyrrole biosynthetic process,BP,TMEM14C
19042,GO:1904949,0.920248673375281,0.155766709632864,6,81,ATPase complex,CC,SMARCA2;CHD3;SMARCA1;C17ORF49;SALL2;ABCA2
14503,GO:0070034,0.920378659523687,0.293959174216972,1,21,telomerase RNA binding,MF,TEP1
19790,GO:2000272,0.920524962784619,0.293584236678555,1,21,negative regulation of signaling receptor activity,BP,GPRC5A
104,GO:0000217,0.920572893689562,0.292322449515639,1,23,DNA secondary structure binding,MF,XPC
2445,GO:0005657,0.921271305882199,0.172799492480032,4,68,replication fork,CC,TP53;BCL6;CXORF57;POLD4
955,GO:0002377,0.921376075210404,0.172849102779066,4,65,immunoglobulin production,BP,ATM;BCL6;ITM2A;GALNT2
7087,GO:0030894,0.921495792593642,0.28858627139987,1,26,replisome,CC,POLD4
7236,GO:0031201,0.921953891562597,0.217367975241771,2,43,SNARE complex,CC,SYT1;VAMP1
12259,GO:0048596,0.922100038174316,0.294854986578496,1,15,embryonic camera-type eye morphogenesis,BP,TH
70,GO:0000146,0.922629953731791,0.294833957593045,1,14,microfilament motor activity,MF,MYO1C
3775,GO:0008333,0.922658434583862,0.1879015988029,3,48,endosome to lysosome transport,BP,TRAK1;LYST;VPS39
18323,GO:1903320,0.922667818767327,0.123497306557884,14,188,regulation of protein modification by small protein conjugation or removal,BP,SKP2;PRICKLE1;FYN;CAV1;PIAS3;HERPUD1;WFS1;GCLC;EGR1;HSPA5;SASH1;ZYG11B;TAF1;CDK5RAP3
8847,GO:0034661,0.922709519740097,0.286817815175953,1,23,ncRNA catabolic process,BP,ZCCHC11
2463,GO:0005682,0.922991309382035,0.286626613537007,1,22,U5 snRNP,CC,TEP1
8088,GO:0032786,0.923468107273165,0.284356030308179,1,24,positive regulation of DNA-templated transcription, elongation,BP,ERCC6
999,GO:0002474,0.923560084877957,0.167771901458131,4,83,antigen processing and presentation of peptide antigen via MHC class I,BP,ITGB5;SEC24D;PSMB9;CALR
1145,GO:0002753,0.923602668780093,0.185799823919942,3,50,cytoplasmic pattern recognition receptor signaling pathway,BP,TKFC;DDX60;SEC14L1
12750,GO:0051052,0.923772173761932,0.107882268302206,28,324,regulation of DNA metabolic process,BP,PDGFC;EGFR;BMP4;TP53;PDGFA;E2F7;KITLG;GLI2;PARP4;HMGA2;UHRF2;CHEK2;FGFR1;IGF1R;MAGEF1;CALR;ATM;CST3;AREG;BCL6;CXORF57;HMBOX1;TSPYL2;PPARG;POLH;FAM168A;NPAS2;S100A11
10523,GO:0043492,0.923785164884383,0.150237071297339,6,76,ATPase activity, coupled to movement of substances,MF,ATP10D;ABCA1;ATP8B2;ABCC2;ABCA2;ABCA5
19777,GO:2000249,0.923814483427999,0.283454511719876,1,24,regulation of actin cytoskeleton reorganization,BP,CTSV
3633,GO:0008104,0.923833597998838,0.0883131468631659,202,2058,protein localization,BP,ITGB6;FLOT1;FN1;TXNIP;FBN1;MARVELD1;SFRP1;SYNE1;F2R;TLN2;ANO1;GSN;ETV5;GJA5;PKD2;IRS2;TNIK;CLTCL1;TNS4;GAS6;FBN2;TCAF1;MALL;EGFR;SYNE3;S100A10;TOM1L2;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;TRIM5;SORL1;TP53;CEP250;PRICKLE1;DDIT3;PYCARD;LTBP1;IFIT1;DLG4;ITGA2;ACSL3;HIP1;PACS1;TFDP2;ITGA3;EVI5L;SNX1;GLI3;DLG5;TBC1D5;PLLP;KCNAB2;LRP1;FYN;B3GAT3;FUT10;UGT8;CAV1;PLA2G6;SEL1L;SNX33;CLU;PRKCZ;EHD3;GOLGB1;SYTL1;PTPN14;EHBP1;PDIA4;PIK3R1;HHAT;TMEM173;CPT1A;PCLO;ANG;KIF17;LAMA5;BBS2;CNTLN;HERPUD1;ANK3;MDFI;TTN;HPS4;MLH3;TP73;BTN3A1;IFT140;STOM;FLOT2;AIP;SH3TC2;PTPRU;DZIP1L;LMNA;ALOX15B;SEC24D;C5;ASTN2;TMEM129;OBSCN;AKAP7;SEPT6;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;SYNE2;PTPN1;VANGL2;ARHGEF2;SSH1;LYST;SOX9;IFT27;ISL1;BCL6;NFASC;TMEM50B;PRKCA;ANXA2;RAB13;MPP7;SEPT5;CEP68;PGAP1;MVB12B;TTC8;RPL13A;TSPAN5;RAB43;WDR19;TAF8;PRNP;TGFB2;ODF2;VPS39;IFT122;THRA;EFR3A;SP100;ULK1;AGRN;RHBDD1;MAGI2;AGAP1;HSPA5;GOPC;SNX7;CENPA;PIKFYVE;REEP2;RSAD2;FLNB;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;DERL3;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;OBSL1;POSTN;ARL3;MIA3;COG3;RASSF9;EFNA5;PPP3CA;PEX1;COX18;SEPT9;CDK5RAP3;ABAT;NIPBL;VPS36;TTBK2;BSN;CELSR1;ATG16L2;MYO1C;C2CD5;EDEM1;NFKBIE
560,GO:0001701,0.924096614630966,0.111880295821122,22,247,in utero embryonic development,BP,SOX6;ZFP36L1;TGFBR2;PKD2;EGFR;GLI3;E2F7;GLI2;MDFI;FGFR1;SEC24D;C5;KDM4C;NR2F2;FBXW8;NRK;ETNK2;WDR19;TAF8;LEF1;ADAM10;RXRA
9054,GO:0035308,0.924399866241669,0.213052828515128,2,38,negative regulation of protein dephosphorylation,BP,PHACTR3;ELFN2
16438,GO:0097150,0.924521930653906,0.286320459619372,1,17,neuronal stem cell population maintenance,BP,FUT10
11124,GO:0045191,0.924923907670818,0.281046087020081,1,23,regulation of isotype switching,BP,BCL6
8663,GO:0034260,0.925077590947656,0.212032485500403,2,36,negative regulation of GTPase activity,BP,SPRY2;BBS4
2502,GO:0005758,0.925372893702514,0.180469349975958,3,71,mitochondrial intermembrane space,CC,TXNIP;CAT;FBXL4
12825,GO:0051170,0.92544328024874,0.128831516857876,10,134,import into nucleus,BP,TXNIP;GAS6;BMP4;PRICKLE1;GLI3;TMEM173;BCL6;MDFIC;PRKAG1;PPP3CA
9049,GO:0035303,0.925680495113099,0.121380323133278,13,157,regulation of dephosphorylation,BP,PHACTR3;WNK1;ITGA2;ELFN2;B3GAT3;ITGA1;DLC1;MTMR4;TGFB2;MAGI2;CDK5RAP3;PPP2R3A;DMPK
5672,GO:0016790,0.92592864440603,0.275990736408771,1,29,thiolester hydrolase activity,MF,ACOT1
17248,GO:0140013,0.926135185523501,0.139535206938363,7,103,meiotic nuclear division,BP,HSPA2;MLH3;CALR;ATM;MSH5;MYBL1;AGO4
11460,GO:0045943,0.926492314522582,0.278037974107215,1,21,positive regulation of transcription by RNA polymerase I,BP,TAF1
261,GO:0000729,0.926570303570872,0.27724397223158,1,22,DNA double-strand break processing,BP,ATM
3796,GO:0008378,0.926710642304551,0.274990312468087,1,26,galactosyltransferase activity,MF,UGT8
6274,GO:0019884,0.926817919865177,0.129483304490665,9,144,antigen processing and presentation of exogenous antigen,BP,ITGB5;CTSV;SEC24D;PSMB9;CALR;CD1D;OSBPL1A;ACTR1B;CTSD
4568,GO:0010658,0.927187753060112,0.275606547444601,1,22,striated muscle cell apoptotic process,BP,CAMK2D
3342,GO:0007063,0.927247420269347,0.276034360588781,1,21,regulation of sister chromatid cohesion,BP,NIPBL
18682,GO:1904115,0.92757267924896,0.206381603637462,2,37,axon cytoplasm,CC,NEFL;TRAK1
4024,GO:0009060,0.927703674368542,0.176125241622105,3,68,aerobic respiration,BP,CAT;DHTKD1;IDH2
17341,GO:1900087,0.927890388747488,0.273203935127148,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,MDM2
4447,GO:0010389,0.92801258939495,0.117623100244178,13,180,regulation of G2/M transition of mitotic cell cycle,BP,CEP250;CNTRL;HMGA2;HAUS4;FBXL7;PSMB9;FOXN3;PBX1;ATM;ODF2;FHL1;CDK5RAP3;TAOK3
4096,GO:0009154,0.928289269359338,0.272139586150194,1,23,purine ribonucleotide catabolic process,BP,PDE4D
2841,GO:0006312,0.928481514950112,0.272157257323906,1,22,mitotic recombination,BP,TEP1
8828,GO:0034637,0.929125391393577,0.159015599943708,4,62,cellular carbohydrate biosynthetic process,BP,IRS2;ISYNA1;NR1D1;ENPP1
286,GO:0000791,0.929136326867508,0.268155432221719,1,27,euchromatin,CC,TRNP1
1147,GO:0002756,0.929231446928643,0.268278249867897,1,26,MyD88-independent toll-like receptor signaling pathway,BP,TLR3
14919,GO:0070840,0.929275865027883,0.272766450857325,1,18,dynein complex binding,MF,SNCA
14273,GO:0061436,0.929403920017133,0.270265319771262,1,21,establishment of skin barrier,BP,FLG
7024,GO:0030808,0.929574061866664,0.140025072064624,6,85,regulation of nucleotide biosynthetic process,BP,DDIT4;NOS1;TIMP2;NCOR1;GPR161;PRKAG1
17451,GO:1900371,0.929574061866664,0.140025072064624,6,85,regulation of purine nucleotide biosynthetic process,BP,DDIT4;NOS1;TIMP2;NCOR1;GPR161;PRKAG1
613,GO:0001782,0.929584505453146,0.269196684183891,1,22,B cell homeostasis,BP,DOCK11
18012,GO:1902562,0.929816122893807,0.200680305949453,2,41,H4 histone acetyltransferase complex,CC,TADA3;YEATS2
19791,GO:2000273,0.930065549236056,0.267370738141298,1,23,positive regulation of signaling receptor activity,BP,TAF1
7967,GO:0032592,0.931047031144065,0.16975522606489,3,65,integral component of mitochondrial membrane,CC,CPT1A;COX18;DMPK
18483,GO:1903671,0.931072553116776,0.266392823668512,1,20,negative regulation of sprouting angiogenesis,BP,MAP2K5
14360,GO:0061631,0.931546636919581,0.262029408040171,1,26,ubiquitin conjugating enzyme activity,MF,TAF1
7701,GO:0032201,0.931637548481434,0.261407569265241,1,27,telomere maintenance via semi-conservative replication,BP,POLD4
2850,GO:0006338,0.931752575280625,0.116426714055721,11,155,chromatin remodeling,BP,SMARCA2;SMARCA1;TNRC18;HMGA2;SP110;SOX9;BAHCC1;CDKN2A;SP100;CENPA;ZBTB1
5321,GO:0016052,0.932090636239493,0.11869298591755,10,135,carbohydrate catabolic process,BP,PYGB;DDIT4;TKFC;FUT10;PHKA2;DHTKD1;MANBA;NCOR1;MAN2B1;PRKAG1
3254,GO:0006921,0.932212791748743,0.260216056581923,1,26,cellular component disassembly involved in execution phase of apoptosis,BP,CDK5RAP3
12388,GO:0048857,0.932655125356232,0.194566441374688,2,40,neural nucleus development,BP,G6PD;HSPA5
5697,GO:0016831,0.932670206864891,0.258247495202682,1,28,carboxy-lyase activity,MF,BCKDHB
17533,GO:1901137,0.932818517927301,0.0889493355120054,48,551,carbohydrate derivative biosynthetic process,BP,ST6GALNAC2;DDIT4;ADAMTSL1;NOS1;GALNT10;SDC3;CSPG4;DCAKD;TIMP2;ITM2C;EXTL2;MUC19;B3GAT3;FUT10;UGT8;XYLT1;UST;CHST3;ST6GAL2;MAN1A1;ADAMTS7;G6PD;DHTKD1;FOXL1;HEXA;TRAK1;POGLUT1;VANGL2;SDC2;NCOR1;GCNT1;PRPS2;PGAP1;GAL3ST4;DSEL;GPR161;ITM2A;AGRN;LMF1;ALG10;GALNT2;DERL3;COG3;PRKAG1;MPPE1;PPCS;UGGT2;TUSC3
3776,GO:0008334,0.933244493649185,0.258235958173054,1,24,histone mRNA metabolic process,BP,ATM
3027,GO:0006576,0.933349178190307,0.256388838835625,1,28,cellular biogenic amine metabolic process,BP,ALDH7A1
5826,GO:0017112,0.93340579669914,0.16660139885373,3,49,Rab guanyl-nucleotide exchange factor activity,MF,ALS2CL;RIN2;SBF2
113,GO:0000242,0.933531907266174,0.260361442033105,1,19,pericentriolar material,CC,BBS4
2386,GO:0005524,0.933625653622725,0.0801880110437381,121,1149,ATP binding,MF,MYH15;TGFBR2;PIK3C2G;TNIK;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;MYO3B;OBSCN;PDK3;EPHB6;CHD6;ATM;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;ITPKB;STK16;DDX60L;PRKCA;PRPS2;ETNK2;HLTF;NMNAT2;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RET;MAP2K5;LIG1;ULK1;ORC4;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;MYH11;TTBK2;RHOBTB3;MYO1C;ABCA5;TAOK3;DMPK
11622,GO:0046365,0.933767552487743,0.191148166332769,2,46,monosaccharide catabolic process,BP,TKFC;FUT10
6936,GO:0030554,0.933857950641567,0.0797607799798746,124,1180,adenyl nucleotide binding,MF,MYH15;TGFBR2;PIK3C2G;TNIK;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;OBSCN;PDK3;EPHB6;CHD6;ATM;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;ITPKB;STK16;DDX60L;PRKCA;PRPS2;ETNK2;HLTF;NMNAT2;GAL3ST4;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RET;MAP2K5;LIG1;ULK1;ORC4;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;MYH11;TTBK2;RHOBTB3;MYO1C;ABCA5;TAOK3;DMPK
6767,GO:0030212,0.934049149328185,0.255583317446437,1,25,hyaluronan metabolic process,BP,HEXA
1146,GO:0002755,0.934215845270023,0.255560333712112,1,24,MyD88-dependent toll-like receptor signaling pathway,BP,MAP3K1
14667,GO:0070317,0.934352637890656,0.191349232573877,2,37,negative regulation of G0 to G1 transition,BP,CBX5;TFDP2
11890,GO:0046949,0.934385283952689,0.254655290795585,1,25,fatty-acyl-CoA biosynthetic process,BP,ACSL3
4180,GO:0009261,0.935038372233712,0.253282606942118,1,24,ribonucleotide catabolic process,BP,PDE4D
18009,GO:1902555,0.93505593612093,0.251365442451882,1,29,endoribonuclease complex,CC,AGO4
19198,GO:1905348,0.93505593612093,0.251365442451882,1,29,endonuclease complex,CC,AGO4
9512,GO:0036258,0.935059033063224,0.251356866127014,1,29,multivesicular body assembly,BP,VPS36
9944,GO:0042339,0.935062588876676,0.25237875280242,1,26,keratan sulfate metabolic process,BP,HEXA
5879,GO:0018023,0.935342840351586,0.189115850830049,2,37,peptidyl-lysine trimethylation,BP,KDM4C;KDM4A
6591,GO:0022616,0.9354529965788,0.251695174540036,1,25,DNA strand elongation,BP,LIG1
18082,GO:1902749,0.935484849118998,0.104973980715443,14,195,regulation of cell cycle G2/M phase transition,BP,TP53;CEP250;CNTRL;HMGA2;HAUS4;FBXL7;PSMB9;FOXN3;PBX1;ATM;ODF2;FHL1;CDK5RAP3;TAOK3
14370,GO:0061650,0.935729155319969,0.250157205172921,1,27,ubiquitin-like protein conjugating enzyme activity,MF,TAF1
17947,GO:1902369,0.935912948749995,0.187622172346672,2,38,negative regulation of RNA catabolic process,BP,CIRBP;GDNF
18211,GO:1903046,0.936041321025955,0.118980563506919,8,116,meiotic cell cycle process,BP,HSPA2;NCAPD2;MLH3;CALR;ATM;MSH5;MYBL1;AGO4
2867,GO:0006362,0.936667486890634,0.246881206438568,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
11435,GO:0045913,0.937056789067333,0.15962476931992,3,46,positive regulation of carbohydrate metabolic process,BP,IRS2;NTSR1;SNCA
3322,GO:0007032,0.93709874806762,0.143622577120968,4,69,endosome organization,BP,ALS2CL;SNX33;SNX10;VPS36
10706,GO:0044068,0.937181781470439,0.247294115110028,1,24,modulation by symbiont of host cellular process,BP,EIF2AK4
18214,GO:1903051,0.937263744855996,0.158229256226917,3,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,OPHN1;DERL3;TAF1
2317,GO:0005326,0.937484832024017,0.246911786061782,1,23,neurotransmitter transporter activity,MF,SLC7A11
16739,GO:0098573,0.937690872279566,0.156365030431647,3,66,intrinsic component of mitochondrial membrane,CC,CPT1A;COX18;DMPK
14777,GO:0070534,0.937860486605336,0.182820531747029,2,40,protein K63-linked ubiquitination,BP,TRIM5;SASH1
2736,GO:0006120,0.93791157100323,0.240293105814142,1,45,mitochondrial electron transport, NADH to ubiquinone,BP,SNCA
5581,GO:0016605,0.938064575412092,0.125507163044686,6,86,PML body,CC,CBX5;TP53;TP53INP1;CHEK2;RGS14;SP100
3324,GO:0007034,0.938165429345366,0.112320368717751,9,119,vacuolar transport,BP,SORL1;CLU;EHD3;TRAK1;LYST;TMEM50B;VPS39;VPS13C;VPS36
13065,GO:0051603,0.938254460746771,0.0813710104627556,52,590,proteolysis involved in cellular protein catabolic process,BP,SKP2;RNF213;RNF165;NR1D1;ABTB1;BTBD2;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;CUL7;GPX1;CTSV;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;FBXL7;ADAMTS7;TMEM129;PSMB9;MAGEF1;MDM2;GCLC;RNF24;MVB12B;ANAPC16;USP28;RHBDD1;HSPA5;TGFB1I1;OPHN1;NUB1;KLHL3;UBA7;DERL3;RNF144B;DNAJC3;TMEM67;TAF1;SCPEP1;FBXL4;UGGT2;VPS36;EDEM1;GID4;ZNRF1
10946,GO:0044728,0.938419317653437,0.141637522507659,4,62,DNA methylation or demethylation,BP,APOBEC3C;APOBEC3G;APOBEC3F;FOS
11984,GO:0047496,0.938842947030149,0.181350879462298,2,36,vesicle transport along microtubule,BP,PRKCZ;TRAK1
14481,GO:0065002,0.938934660907005,0.178981862705865,2,50,intracellular protein transmembrane transport,BP,PEX1;C2CD5
5955,GO:0018345,0.939120638065242,0.240621820240426,1,27,protein palmitoylation,BP,HHAT
10783,GO:0044283,0.939182439238917,0.0818745802037314,44,541,small molecule biosynthetic process,BP,DDIT4;PTGS1;SNAI2;CSPG4;NTSR1;VDR;ISYNA1;NR1D1;SEC14L2;ACSL3;PHGDH;SIK1;GPX1;PTGES;XDH;CPS1;UST;ACSS1;ACACB;SNCA;CBR1;ALOX15B;PRKAB2;PDE4D;G6PD;DHTKD1;DGKQ;ACSS2;THNSL2;EGR1;ENPP1;ITPKB;NCOR1;G6PC3;LEPR;GGT7;DSEL;OSBPL1A;SRR;PRKAG1;DPYD;DNPH1;ABAT;ACAA2
3164,GO:0006778,0.93996904083556,0.237556949793433,1,29,porphyrin-containing compound metabolic process,BP,TMEM14C
11811,GO:0046782,0.940022066205624,0.152130096949469,3,59,regulation of viral transcription,BP,HMGA2;LEF1;MDFIC
2971,GO:0006515,0.94023790794883,0.238618624565838,1,24,protein quality control for misfolded or incompletely synthesized proteins,BP,UGGT2
8986,GO:0035137,0.940247145182959,0.240126855330625,1,21,hindlimb morphogenesis,BP,BMP4
12032,GO:0048002,0.940494398945063,0.107995689866758,9,149,antigen processing and presentation of peptide antigen,BP,ITGB5;PYCARD;CTSV;SEC24D;PSMB9;CALR;OSBPL1A;ACTR1B;CTSD
6141,GO:0019432,0.940592729184347,0.237174655219877,1,25,triglyceride biosynthetic process,BP,SIK1
9511,GO:0036257,0.940995364991592,0.234330081870066,1,30,multivesicular body organization,BP,VPS36
2833,GO:0006304,0.94106417763432,0.126803528291209,5,80,DNA modification,BP,APOBEC3C;APOBEC3G;APOBEC3F;MUTYH;FOS
11661,GO:0046467,0.941065730676406,0.114542726971755,7,117,membrane lipid biosynthetic process,BP,UGT8;PLA2G6;ALDH3A2;PGAP1;GAL3ST4;CERS5;MPPE1
686,GO:0001906,0.941236945468367,0.148927783144644,3,69,cell killing,BP,ULBP1;IL18;LYST
3298,GO:0006998,0.941466358887437,0.12607390097965,5,80,nuclear envelope organization,BP,NEK9;LMNA;SYNE2;PRKCA;DMPK
7226,GO:0031145,0.941492603723497,0.14797699575068,3,77,anaphase-promoting complex-dependent catabolic process,BP,SKP2;PSMB9;ANAPC16
4192,GO:0009303,0.941680437360949,0.233291507686758,1,27,rRNA transcription,BP,ANG
5551,GO:0016569,0.941964546537049,0.0807591001364218,36,396,covalent chromatin modification,BP,CPA4;NOS1;SNAI2;PHF21A;DDB2;TADA3;PADI3;TP53;CHD3;MTHFR;HLCS;SDR16C5;HMGA2;CAMK2D;PER1;UHRF2;JARID2;PHF2;SNCA;JADE2;KDM4C;ATM;HDAC11;ISL1;BCL6;PRKCA;MAP3K12;LEF1;SAP30L;YEATS2;ING4;FKBP10;TAF1;KDM4A;NIPBL;PRDM5
17745,GO:1901799,0.94226974837948,0.17232255312055,2,42,negative regulation of proteasomal protein catabolic process,BP,OPHN1;DERL3
18515,GO:1903749,0.942576604449442,0.1236205200652,5,90,positive regulation of establishment of protein localization to mitochondrion,BP,TP53;TFDP2;HHAT;HPS4;TP73
14740,GO:0070461,0.943086404109951,0.22957222235111,1,26,SAGA-type complex,CC,TADA3
8428,GO:0033561,0.943545984354583,0.229495649200968,1,23,regulation of water loss via skin,BP,FLG
13478,GO:0055076,0.943797894892723,0.115004423855154,6,100,transition metal ion homeostasis,BP,CYBRD1;NEO1;SLC22A17;PRNP;SFXN3;STEAP2
17531,GO:1901135,0.944104885096528,0.0707076465370199,78,907,carbohydrate derivative metabolic process,BP,SULT1E1;ST6GALNAC2;DDIT4;ADAMTSL1;PKD2;H6PD;NOS1;SULF2;GALNT10;SDC3;CSPG4;TKFC;DCAKD;TIMP2;APOBEC3C;ITM2C;EXTL2;MUC19;DLG4;ABHD14B;B3GAT3;FUT10;UGT8;SEL1L;XYLT1;UST;CHST3;APOBEC3G;ST6GAL2;MAN1A1;SNCA;OARD1;ADAMTS7;APOBEC3F;PDE4D;SULF1;ESYT2;G6PD;ARSD;DHTKD1;NAGLU;FOXL1;CST3;MANBA;HEXA;AKR7A2;TRAK1;POGLUT1;VANGL2;SDC2;ENPP1;NCOR1;G6PC3;GCNT1;PRPS2;MAN2B1;PGAP1;GAL3ST4;DSEL;GPR161;ITM2A;AGRN;NPHP3;TH;ITGB8;LMF1;ALG10;GALNT2;DERL3;TPST1;COG3;PRKAG1;MPPE1;DPYD;PPCS;UGGT2;TUSC3;EDEM1
2551,GO:0005829,0.944155195378474,0.0633475810892037,406,4102,cytosol,CC,SERPINE2;SULT1E1;KRT4;HTRA1;TXNIP;CTGF;INPP5D;SFRP1;RHOBTB2;CDKN2B;ZFP36L1;NQO1;DDIT4;TGFBR2;TNNI2;ASAP3;GSN;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;CLTCL1;TNS4;NOS1;DNAJB4;PDGFC;ARHGAP23;DPYSL2;DOCK9;TSC22D3;KLF8;PEG10;ITPK1;HSPA2;FLRT3;TCHH;SPTB;FKBP5;CLCA2;DOCK5;MYLK;ACTA2;DOK1;ENDOD1;RNF213;KRT14;TCF7L1;STON2;ANXA5;VIM;NUPR1;PSTPIP1;CTNNAL1;TKFC;ALS2CL;LGALS9C;ADD3;ASAP2;PLEC;PAK1;CHN2;SRGAP3;PADI3;TRIM38;ISYNA1;TP53I3;PTK6;AHNAK;ABTB1;RIN2;XAF1;EIF2AK4;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;STAT1;BTBD2;IFIT2;LGALS1;TP53;ARAP1;CEP250;KRT13;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;PYCARD;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;ARHGEF1;DLG4;ZCCHC11;MAP2;MICAL1;NISCH;PPL;ADARB1;PHGDH;FLG;HIP1;PACS1;DOCK4;CUL7;KLF12;IFIT3;KLF9;SNX1;ANO6;GPX1;GLI3;CDK14;TBC1D5;ASAP1;SYN1;PDPN;MTHFR;ABHD14B;KRT15;MAGED2;NEK9;SESN1;SEC14L1;SPG11;KCNAB2;NMRK1;FYN;ARHGEF12;XDH;FLNC;ARHGAP18;ADIRF;CMBL;POLR3GL;SLC27A1;GLI2;RMI2;HLCS;RNF135;RBFOX2;PLA2G6;DOCK11;GLDC;SNX33;MAP3K14;ZNF318;TNRC18;OSBPL5;AHNAK2;CLU;NPHP4;PRKCZ;OAS2;FBXW4;ULK2;TP53INP1;PARP4;EHD3;CAMK2D;PRDX5;ULBP1;HAUS4;PER1;EHBP1;PXN;PIK3R1;SYT1;NCAPD2;CAPRIN2;ACACB;APOBEC3G;KIF17;PARVA;BBS2;CNTLN;ANK3;PHKA2;SPRY2;TTN;TSTD1;LMO7;HPS4;TP73;CAT;CASP14;DLC1;PRKACB;AARS;SPRY4;MAN1A1;FBXL7;SNCA;PDIA6;VAMP1;AIP;FGFR1;CBR1;LMNA;ALOX15B;IFI35;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;PDE4D;APBB3;TGM2;PSMB9;IL18;OBSCN;G6PD;EPHB6;SETBP1;ARHGEF17;DHTKD1;AFAP1L2;NFATC4;TRAF1;RAPH1;AKAP7;AMOTL1;PBXIP1;BBS4;MTMR4;CALR;HPS3;MKLN1;IDH2;SRGAP1;COPG2;FBXO17;MDM2;ARF6;C17ORF49;BBS1;AKAP13;HSD17B11;DNAJC6;DGKQ;GCLC;NR2F2;ACSS2;CBX7;AKR7A2;FBXW8;MAP3K1;FGD4;PTPN1;ARHGEF2;KLHL12;SYNC;SSH1;ITPKB;STK16;CRTC1;NCOR1;NDRG1;PRKCA;ANXA2;TRERF1;RAB13;ETNK2;CES3;FNDC3A;CEP68;DEPDC7;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;KCTD7;HMBOX1;NFAT5;ANAPC16;RPL13A;DECR1;MAP3K12;UACA;ATXN1;STK36;PRNP;RET;RBL2;MAP2K5;ODF2;SMG9;STAT2;AMOTL2;IFT122;DPP9;THRA;FHL1;CDC42EP5;ALDH7A1;MSRB2;CDKN2A;EFR3A;MPRIP;OSBPL1A;ULK1;AGRN;ORC4;NPHP3;VAV2;AGAP1;CDK19;TH;KLHL5;CENPA;PIKFYVE;FLYWCH1;FLNB;SRPK2;NAPRT;CCHCR1;MON2;ARHGEF19;ARHGAP29;VPS13C;FHOD1;POLD4;TACC2;OPHN1;SH2B3;MYO9A;YAP1;PGPEP1;NUB1;KLHL3;UBA7;DIXDC1;PITPNC1;PPARG;RNF144B;KCNIP3;MEF2A;SNX9;ICK;TBC1D16;OBSL1;ING4;DEF6;DNAJC3;RARA;COG3;RASSF9;POLH;PRKAG1;TRIM16L;GSTZ1;WIPF1;DPYD;PPP3CA;DCAF8;PIK3C2B;SBF2;RASA1;ARHGAP31;LIMA1;PEX1;STEAP2;KRT10;ACTR1B;CAPN6;PPCS;FOS;DNPH1;KDM4A;KLHL22;CDK5RAP3;AGO4;ACOT1;SCPEP1;ELMO2;EHHADH;NPAS2;MYH11;FBXL4;VPS36;TTBK2;RHOBTB3;LITAF;MYO1C;C2CD5;NFKBIE;DOCK1;FAM114A1;ZNRF1;DMPK
10200,GO:0042866,0.944255507840939,0.121137799549214,5,77,pyruvate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;SRR;PRKAG1
16323,GO:0090630,0.944605227153076,0.120901606842246,5,70,activation of GTPase activity,BP,TBC1D8;EVI5L;TBC1D5;RALGAPB;TBC1D16
3343,GO:0007064,0.944605444712513,0.226880062643865,1,22,mitotic sister chromatid cohesion,BP,NIPBL
10292,GO:0043094,0.94464505817225,0.223219008154009,1,32,cellular metabolic compound salvage,BP,NAPRT
1115,GO:0002705,0.94474230504076,0.142345082720855,3,59,positive regulation of leukocyte mediated immunity,BP,PRKCZ;RSAD2;ZBTB1
2846,GO:0006334,0.944908059617589,0.118595568246374,5,117,nucleosome assembly,BP,SOX9;TSPYL2;TSPYL4;CENPA;HP1BP3
4669,GO:0010822,0.94496310925954,0.101032453980126,9,138,positive regulation of mitochondrion organization,BP,MMP9;TP53;PYCARD;TFDP2;PLA2G6;HHAT;HPS4;TP73;VPS13C
17580,GO:1901292,0.945042779076613,0.101059350502469,9,130,nucleoside phosphate catabolic process,BP,DDIT4;GPX1;XDH;PDE4D;DHTKD1;ENPP1;NCOR1;PRKAG1;DNPH1
783,GO:0002042,0.94562437741812,0.165108625488775,2,38,cell migration involved in sprouting angiogenesis,BP,ROBO1;MAP2K5
2676,GO:0006040,0.945652091216893,0.221677733009739,1,27,amino sugar metabolic process,BP,EXTL2
411,GO:0001098,0.945676013090174,0.16431914899183,2,42,basal transcription machinery binding,MF,TP53;TCF4
412,GO:0001099,0.945676013090174,0.16431914899183,2,42,basal RNA polymerase II transcription machinery binding,MF,TP53;TCF4
283,GO:0000786,0.945683275329521,0.161225649177139,2,84,nucleosome,CC,CENPA;HP1BP3
8570,GO:0034080,0.946329098249649,0.216733432316047,1,40,CENP-A containing nucleosome assembly,BP,CENPA
14363,GO:0061641,0.946329098249649,0.216733432316047,1,40,CENP-A containing chromatin organization,BP,CENPA
531,GO:0001650,0.946483448981241,0.101850013405779,8,118,fibrillar center,CC,SESN1;MAP3K14;PAK6;LIPA;RSAD2;ICK;KDM4A;NFKBIE
5552,GO:0016570,0.946665434509996,0.0749610600567217,35,388,histone modification,BP,CPA4;NOS1;SNAI2;PHF21A;DDB2;TADA3;PADI3;TP53;CHD3;MTHFR;HLCS;SDR16C5;HMGA2;CAMK2D;PER1;JARID2;PHF2;SNCA;JADE2;KDM4C;ATM;HDAC11;ISL1;BCL6;PRKCA;MAP3K12;LEF1;SAP30L;YEATS2;ING4;FKBP10;TAF1;KDM4A;NIPBL;PRDM5
15171,GO:0071347,0.946719672584686,0.104825597648555,7,124,cellular response to interleukin-1,BP,SFRP1;PYCARD;ADAMTS7;PSMB9;EGR1;SOX9;ABCC2
2495,GO:0005746,0.947165569349203,0.158231402950337,2,72,mitochondrial respiratory chain,CC,SNCA;NDUFA4L2
13914,GO:0060612,0.947283060605012,0.217548608193479,1,25,adipose tissue development,BP,BBS4
887,GO:0002260,0.947717838763029,0.159310804804538,2,43,lymphocyte homeostasis,BP,TSC22D3;DOCK11
8499,GO:0033692,0.947973707395369,0.136157271713793,3,52,cellular polysaccharide biosynthetic process,BP,IRS2;NR1D1;ENPP1
2519,GO:0005776,0.948593191772195,0.112841859435173,5,83,autophagosome,CC,TBC1D5;SRPX;TP53INP1;ULK1;ATG16L2
10262,GO:0043029,0.948800750830601,0.211928634482019,1,28,T cell homeostasis,BP,TSC22D3
1113,GO:0002703,0.948891570617,0.105953170083688,6,102,regulation of leukocyte mediated immunity,BP,IL20RB;PRKCZ;TLR3;BCL6;RSAD2;ZBTB1
15028,GO:0071011,0.949306292712471,0.209563794149293,1,31,precatalytic spliceosome,CC,TEP1
14102,GO:0060997,0.949540837813549,0.156094874496334,2,36,dendritic spine morphogenesis,BP,DLG4;CAPRIN2
18316,GO:1903307,0.949630258207542,0.209412324254109,1,28,positive regulation of regulated secretory pathway,BP,SYT1
12843,GO:0051193,0.949649665687009,0.111148640378233,5,77,regulation of cofactor metabolic process,BP,DDIT4;SNCA;PDK3;NCOR1;PRKAG1
15833,GO:0072583,0.949800839284903,0.155463446069107,2,36,clathrin-dependent endocytosis,BP,HIP1;DNAJC6
11241,GO:0045540,0.94985889757389,0.154446839306051,2,41,regulation of cholesterol biosynthetic process,BP,SEC14L2;ACACB
1122,GO:0002712,0.949862689531558,0.209023879081397,1,27,regulation of B cell mediated immunity,BP,BCL6
1218,GO:0002889,0.949862689531558,0.209023879081397,1,27,regulation of immunoglobulin mediated immune response,BP,BCL6
1112,GO:0002702,0.949981126012283,0.153357428646531,2,47,positive regulation of production of molecular mediator of immune response,BP,PRKCZ;RSAD2
1109,GO:0002699,0.95027489321737,0.103514466272161,6,101,positive regulation of immune effector process,BP,DDX60;PRKCZ;IL18;RSAD2;RARA;ZBTB1
10876,GO:0044440,0.951048140734726,0.070063584655041,32,395,endosomal part,CC,EGFR;NSG1;SORL1;SNX1;TBC1D5;CAV1;EHD3;BACE1;TLR3;FZD7;DKK1;LAPTM4A;MTMR4;ARF6;ANXA6;SNX10;CD1D;SLC48A1;NDRG1;TMEM175;ANXA2;RAB13;MVB12B;RET;VPS39;SPPL2B;PIKFYVE;ABCA2;STEAP2;VPS36;LITAF;ABCA5
3321,GO:0007031,0.951117547309525,0.204863707016929,1,28,peroxisome organization,BP,PEX1
2801,GO:0006261,0.951680725086036,0.0901073018593309,9,138,DNA-dependent DNA replication,BP,BMP4;E2F7;CHEK2;FGFR1;BCL6;PRIMPOL;LIG1;ORC4;POLD4
14115,GO:0061014,0.952540580698216,0.148754501360739,2,36,positive regulation of mRNA catabolic process,BP,ZFP36L1;ZFP36L2
14876,GO:0070727,0.952586580768135,0.0574144639100095,137,1467,cellular macromolecule localization,BP,FLOT1;TXNIP;ZFP36L1;SYNE1;TLN2;GSN;ETV5;TNIK;CLTCL1;GAS6;TCAF1;EGFR;SYNE3;S100A10;TOM1L2;PAK1;NSG1;BMP4;TBC1D8;SORL1;TP53;CEP250;PRICKLE1;DDIT3;IFIT1;DLG4;ACSL3;HIP1;PACS1;TFDP2;ITGA3;EVI5L;SNX1;GLI3;TBC1D5;KCNAB2;LRP1;FYN;B3GAT3;FUT10;UGT8;CAV1;SEL1L;SNX33;CLU;PRKCZ;EHD3;GOLGB1;SYTL1;PTPN14;PIK3R1;HHAT;TMEM173;LAMA5;BBS2;CNTLN;HERPUD1;ANK3;HPS4;TP73;IFT140;STOM;FLOT2;AIP;SH3TC2;PTPRU;LMNA;SEC24D;ASTN2;TMEM129;OBSCN;SEPT6;BBS4;CALR;ATM;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;TRAK1;SYNE2;PTPN1;ARHGEF2;SSH1;SOX9;IFT27;BCL6;NFASC;TMEM50B;ANXA2;RAB13;SEPT5;CEP68;RPL13A;TSPAN5;RAB43;WDR19;TAF8;PRNP;VPS39;IFT122;EFR3A;SP100;AGRN;RHBDD1;MAGI2;HSPA5;GOPC;CENPA;PIKFYVE;REEP2;FLNB;CCHCR1;MDFIC;VPS13C;DERL3;KCNIP3;SNX9;TBC1D16;OBSL1;COG3;RASSF9;PPP3CA;PEX1;COX18;SEPT9;CDK5RAP3;NIPBL;VPS36;TTBK2;CELSR1;MYO1C;C2CD5;EDEM1
8250,GO:0033045,0.952649543545092,0.113414537760802,4,69,regulation of sister chromatid segregation,BP,RMI2;ATM;KLHL22;NIPBL
6568,GO:0022402,0.952893151980277,0.0583298660679721,106,1136,cell cycle process,BP,CTGF;SFRP1;RHOBTB2;CDKN2B;ZFP36L1;APBB2;XPC;PKD2;ZFP36L2;SKP2;GAS6;EGFR;HSPA2;CEP126;GJC2;TOM1L2;PAK1;CBX5;BMP4;EIF2AK4;TP53;ARAP1;CEP250;DDIT3;CNTRL;CUL9;EFHC1;GPNMB;TFDP2;CUL7;CHD3;CDK14;E2F7;CTDSPL;NEK9;RMI2;SNX33;TP53INP1;HMGA2;KANK2;HAUS4;NCAPD2;UHRF2;CNTLN;ANK3;SPRY2;TTN;MLH3;TP73;CHEK2;FBXL7;FGFR1;LMNA;PRKAB2;PSMB9;FOXN3;SEPT6;PBX1;BBS4;CALR;ATM;MDM2;MSH5;LZTS1;ARHGEF2;SOX9;BCL6;NCOR1;PRKCA;MYBL1;RGS14;SEPT5;CEP68;GOLGA8B;PAK6;PRNP;TGFB2;RBL2;ODF2;OR2A4;LIG1;FHL1;CDKN2A;ORC4;MAGI2;CENPA;UVRAG;POLD4;GOLGA8N;SNX9;OBSL1;ING4;ARL3;CCNY;TMEM67;PRKAG1;TAF1;PPP3CA;RASA1;CTDSP2;SEPT9;KLHL22;CDK5RAP3;AGO4;NIPBL;TAOK3
19795,GO:2000278,0.953042453284567,0.104417685760981,5,85,regulation of DNA biosynthetic process,BP,TP53;PARP4;ATM;HMBOX1;PPARG
14268,GO:0061418,0.953188688960759,0.123591836866863,3,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB9;CITED2;EGR1
7557,GO:0031929,0.953243099957812,0.0983915449006357,6,94,TOR signaling,BP,DDIT4;GAS6;SESN3;SESN1;ATM;DGKQ
11516,GO:0046068,0.95351102924205,0.199756345750482,1,22,cGMP metabolic process,BP,NOS1
863,GO:0002200,0.954096114241958,0.12275098134369,3,54,somatic diversification of immune receptors,BP,ATM;BCL6;LEF1
13079,GO:0051641,0.954311444547743,0.0537155686347992,213,2179,cellular localization,BP,SYT8;FLOT1;TXNIP;MARVELD1;ZFP36L1;SYNE1;F2R;TLN2;ANO1;GSN;ETV5;PKD2;JPH2;TNIK;COL7A1;CLTCL1;NOS1;GAS6;TCAF1;MALL;MAP6;EGFR;SPTB;SLC8A1;SYNE3;S100A10;STON2;TOM1L2;NTSR1;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;NETO1;NEFL;SORL1;TP53;CEP250;PRICKLE1;DDIT3;CNTRL;IFIT1;DLG4;ACSL3;HIP1;PACS1;TFDP2;ITGA3;EVI5L;SNX1;GLI3;TBC1D5;PLLP;SYN1;SPG11;KCNAB2;LRP1;FYN;B3GAT3;FUT10;UGT8;CAV1;PLA2G6;SEL1L;SNX33;CLU;NPHP4;PRKCZ;EHD3;CAMK2D;GOLGB1;SYTL1;HAUS4;PTPN14;PIK3R1;SYT1;HHAT;TMEM173;CREB3L2;CPT1A;ACACB;PCLO;KIF17;LAMA5;BBS2;CNTLN;HERPUD1;ANK3;SPRY2;HPS4;TP73;IFT140;STOM;SNCA;FLOT2;AIP;SH3TC2;PLXNA2;PTPRU;LMNA;PRKAB2;SEC24D;ASTN2;PDE4D;TMEM129;OBSCN;ESYT2;CDH13;SEPT6;BBS4;CALR;ATM;COPG2;MDM2;ARF6;TMED10;AREG;BBS1;AKAP13;DNAJC6;SNX10;NEURL1B;TRAK1;SYNE2;PTPN1;ARHGEF2;KLHL12;SSH1;LYST;SOX9;IFT27;BCL6;NFASC;TMEM50B;ANXA2;RGS14;RAB13;SEPT5;CEP68;PGAP1;IFT88;MVB12B;RPL13A;TSPAN5;NLGN4Y;ATXN1;RAB43;WDR19;TAF8;PRNP;ODF2;VPS39;IFT122;C2CD4C;EFR3A;SP100;AGRN;RHBDD1;MAGI2;HSPA5;TH;GOPC;CENPA;PIKFYVE;REEP2;FLNB;UVRAG;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;FHOD1;IFT74;OPHN1;TPGS1;LMF1;GDNF;DERL3;KCNIP3;MEF2A;SNX9;ICK;TBC1D16;OBSL1;ARL3;MIA3;COG3;RASSF9;ABCA2;TMEM67;PRKAG1;EFNA5;MPPE1;WIPF1;PPP3CA;PEX1;COX18;DNM1P46;SEPT9;CDK5RAP3;NIPBL;VPS36;TTBK2;RHOBTB3;CELSR1;EPG5;MYO1C;C2CD5;CPT2;EDEM1
1003,GO:0002478,0.954339579222235,0.0882403969211769,8,141,antigen processing and presentation of exogenous peptide antigen,BP,ITGB5;CTSV;SEC24D;PSMB9;CALR;OSBPL1A;ACTR1B;CTSD
9927,GO:0042304,0.954415993492494,0.194599946723424,1,28,regulation of fatty acid biosynthetic process,BP,PRKAB2
7163,GO:0031055,0.954516656445581,0.191535009616936,1,42,chromatin remodeling at centromere,BP,CENPA
16917,GO:0098930,0.9546521677589,0.142674000005778,2,41,axonal transport,BP,NEFL;TRAK1
5695,GO:0016829,0.954721877543531,0.090921138278391,7,129,lyase activity,MF,TKFC;BCKDHB;GLDC;HMGA2;THNSL2;SRR;EHHADH
5568,GO:0016591,0.954992142125972,0.0949523917886833,6,103,DNA-directed RNA polymerase II, holoenzyme,CC,TADA3;TP53;CHD6;TAF8;TAF1;NIPBL
10660,GO:0043933,0.95504900504114,0.0541366410880385,150,1669,protein-containing complex subunit organization,BP,FLOT1;FN1;XPC;GSN;COL5A2;GJA5;PKD2;COL7A1;CLTCL1;PDGFC;COL5A1;SPTB;SERPINH1;RNF213;TCF7L1;S100A10;C1QTNF6;DDB2;STMN3;PAK1;ABCA1;ANGPTL4;NSG1;AHNAK;NEFL;SORL1;TP53;DDIT3;PYCARD;DLG4;SEMA5A;PILRB;MAP2;MICAL1;ACSL3;HIP1;LIX1L;TYSND1;ANO6;ASAP1;PDE4DIP;EML2;ARHGAP18;CAV1;CLU;PRKCZ;ARPIN;EHD3;CAMK2D;KANK2;PXN;CCK;SYT1;CPT1A;ACACB;ANG;TTN;CIRBP;TP73;CAT;PRKACB;STOM;FBXL7;SNCA;VAMP1;COL16A1;IGF1R;DKK1;FSCN1;SEC24D;RGS2;SETX;TGM2;TLE4;TRIOBP;TRAF1;SEPT6;TGFBR3;FZD1;BBS4;CALR;ATM;MDM2;ARF6;TMED10;AREG;TCF4;ANXA6;DNAJC6;DGKQ;FHOD3;LMO4;ARHGEF2;KLHL12;COL5A3;SOX9;CRTC1;ANXA2;MPP7;SEPT5;KCTD7;RPL13A;DECR1;PRNP;TGFB2;COL12A1;LEF1;THRA;SSBP3;CDC42EP5;MSRB2;ULK1;TSPYL2;TSPYL4;MAGI2;CELF2;GOPC;MAGI1;CENPA;SRPK2;UVRAG;KCTD14;YAP1;DNAH1;SRR;CAPG;SNX9;OBSL1;MIA3;TAF1;EFNA5;WIPF1;ZBTB1;SBF2;RASA1;LIMA1;HP1BP3;COX18;DNM1P46;SEPT9;AGO4;MYH11;TTBK2;KCNRG;PSMG4;TSPAN4;EPG5;MYO1C;RXRA;ABCA5
2728,GO:0006110,0.955374717231271,0.120221403355182,3,51,regulation of glycolytic process,BP,DDIT4;NCOR1;PRKAG1
11871,GO:0046915,0.955590845595277,0.190882950510856,1,28,transition metal ion transmembrane transporter activity,MF,SLC39A11
868,GO:0002220,0.955837769777136,0.0987998181959346,5,94,innate immune response activating cell surface receptor signaling pathway,BP,PAK1;MUC19;FYN;PRKACB;PSMB9
870,GO:0002223,0.955837769777136,0.0987998181959346,5,94,stimulatory C-type lectin receptor signaling pathway,BP,PAK1;MUC19;FYN;PRKACB;PSMB9
5063,GO:0015291,0.955873365055041,0.0834081427267623,9,125,secondary active transmembrane transporter activity,MF,SLC7A8;SLC8A1;SLC20A1;SLC7A11;SLC22A17;SLC38A2;SLC24A1;SLC9A4;ANKH
3224,GO:0006879,0.956306278510766,0.137788263174719,2,47,cellular iron ion homeostasis,BP,CYBRD1;SLC22A17
12991,GO:0051453,0.956361500198854,0.117231147852295,3,61,regulation of intracellular pH,BP,TP53;TMEM175;SLC9A4
8414,GO:0033522,0.956488198557118,0.189012605816953,1,25,histone H2A ubiquitination,BP,DDB2
7288,GO:0031297,0.956529938770325,0.188521943690972,1,26,replication fork processing,BP,PRIMPOL
18776,GO:1904353,0.956629693269017,0.188558487595222,1,25,regulation of telomere capping,BP,ATM
5776,GO:0017004,0.956666297808705,0.186011497936175,1,34,cytochrome complex assembly,BP,COX18
7888,GO:0032467,0.956756517283693,0.188151026380606,1,25,positive regulation of cytokinesis,BP,OR2A4
7293,GO:0031304,0.956862282971121,0.185015699169962,1,36,intrinsic component of mitochondrial inner membrane,CC,COX18
7294,GO:0031305,0.956862282971121,0.185015699169962,1,36,integral component of mitochondrial inner membrane,CC,COX18
672,GO:0001883,0.956892967391443,0.0676421698453805,20,282,purine nucleoside binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;DAPK1;OARD1;TGM2;SEPT6;ARF6;ANXA6;IFT27;PRPS2;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
11247,GO:0045576,0.957082550058137,0.18583315259424,1,29,mast cell activation,BP,NDRG1
6686,GO:0030071,0.957242985397515,0.13565772757126,2,45,regulation of mitotic metaphase/anaphase transition,BP,ATM;KLHL22
17839,GO:1902099,0.957242985397515,0.13565772757126,2,45,regulation of metaphase/anaphase transition of cell cycle,BP,ATM;KLHL22
13261,GO:0051984,0.957389208663976,0.185757873384909,1,26,positive regulation of chromosome segregation,BP,NIPBL
12724,GO:0051019,0.957468734849949,0.185501109534964,1,26,mitogen-activated protein kinase binding,MF,CDK5RAP3
10605,GO:0043624,0.957547982318257,0.0761334612041342,11,179,cellular protein complex disassembly,BP,GSN;SPTB;STMN3;SEMA5A;MICAL1;TRIOBP;DNAJC6;ARHGEF2;CAPG;LIMA1;TTBK2
5645,GO:0016746,0.958070920850182,0.0724470436987156,13,189,transferase activity, transferring acyl groups,MF,MBOAT2;TADA3;LPCAT2;HHAT;CPT1A;TGM2;GGT7;AGPAT1;CERS5;TAF1;NAT14;CPT2;ACAA2
9,GO:0000018,0.958165435668761,0.113436170297741,3,58,regulation of DNA recombination,BP,MAGEF1;BCL6;CXORF57
6724,GO:0030148,0.958347160323896,0.101475551994684,4,77,sphingolipid biosynthetic process,BP,UGT8;PLA2G6;ALDH3A2;CERS5
20255,GO:2001251,0.958372519307475,0.0819073427108078,8,111,negative regulation of chromosome organization,BP,SDR16C5;JARID2;PHF2;SNCA;KDM4C;ATM;KDM4A;KLHL22
2822,GO:0006289,0.958691231886135,0.0879490812749808,6,113,nucleotide-excision repair,BP,XPC;DDB2;TP53;ERCC6;LIG1;POLD4
15796,GO:0072528,0.959003287283442,0.178117770259919,1,36,pyrimidine-containing compound biosynthetic process,BP,CPS1
3746,GO:0008287,0.959131559830294,0.130865634897489,2,45,protein serine/threonine phosphatase complex,CC,PPP3CA;PPP2R3A
18306,GO:1903293,0.959131559830294,0.130865634897489,2,45,phosphatase complex,CC,PPP3CA;PPP2R3A
10960,GO:0044772,0.959182752996182,0.0573237808459009,39,483,mitotic cell cycle phase transition,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;SKP2;EGFR;GJC2;TP53;CEP250;CNTRL;GPNMB;TFDP2;CDK14;E2F7;CTDSPL;HMGA2;KANK2;HAUS4;TP73;CHEK2;FBXL7;PSMB9;FOXN3;PBX1;ATM;MDM2;LZTS1;RBL2;ODF2;FHL1;CDKN2A;ORC4;CCNY;PPP3CA;CTDSP2;KLHL22;CDK5RAP3;TAOK3
5992,GO:0019003,0.959347265412476,0.129626036838088,2,52,GDP binding,MF,PRPS2;ARL3
12879,GO:0051252,0.959361486355876,0.0470439611643,302,3019,regulation of RNA metabolic process,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;SRPK2;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
4735,GO:0010907,0.959493975170751,0.180046663097922,1,23,positive regulation of glucose metabolic process,BP,IRS2
18212,GO:1903047,0.96000814015142,0.0523289089259144,67,756,mitotic cell cycle process,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;SKP2;EGFR;CEP126;GJC2;TOM1L2;BMP4;TP53;CEP250;CNTRL;CUL9;EFHC1;GPNMB;TFDP2;CUL7;CDK14;E2F7;CTDSPL;NEK9;SNX33;HMGA2;KANK2;HAUS4;NCAPD2;ANK3;SPRY2;TTN;TP73;CHEK2;FBXL7;FGFR1;LMNA;PSMB9;FOXN3;SEPT6;PBX1;BBS4;ATM;MDM2;LZTS1;ARHGEF2;BCL6;PRKCA;SEPT5;RBL2;ODF2;LIG1;FHL1;CDKN2A;ORC4;CENPA;SNX9;OBSL1;ARL3;CCNY;PPP3CA;RASA1;CTDSP2;SEPT9;KLHL22;CDK5RAP3;NIPBL;TAOK3
7607,GO:0032008,0.960120712817659,0.175698050415959,1,30,positive regulation of TOR signaling,BP,GAS6
634,GO:0001824,0.960239254987685,0.12791801011668,2,46,blastocyst development,BP,KDM4C;TAF8
11109,GO:0045171,0.960307641776855,0.127535566669115,2,48,intercellular bridge,CC,PRKACB;SETX
3328,GO:0007041,0.960482001229375,0.0852314851679383,6,90,lysosomal transport,BP,SORL1;CLU;EHD3;TRAK1;LYST;VPS39
1924,GO:0004620,0.960679749264784,0.107652097241408,3,60,phospholipase activity,MF,PLA2G6;PLCH2;PLD3
17870,GO:1902186,0.960726135018735,0.173955855028996,1,29,regulation of viral release from host cell,BP,TRIM5
11688,GO:0046503,0.960769638939005,0.173557625194861,1,30,glycerolipid catabolic process,BP,CPS1
2547,GO:0005819,0.960941239859649,0.0597742840129055,24,297,spindle,CC,PKD2;CLTCL1;HSPA2;TADA3;NR3C1;EFHC1;TTC28;EML2;PARP4;HAUS4;SEPT6;ATM;ARHGEF2;NCOR1;RGS14;MAP2K5;ODF2;OR2A4;YEATS2;CAPG;BEX4;ARL3;CAPN6;KLHL22
15400,GO:0071702,0.961317106073308,0.046169800446181,183,1935,organic substance transport,BP,ITGB6;FLOT1;FN1;TXNIP;SFRP1;ZFP36L1;F2R;TGFBR2;SLC7A8;ANO1;GJA5;PITPNM3;IRS2;OSBPL10;IGF2BP2;CLTCL1;NOS1;GAS6;TCAF1;EGFR;SLC2A3;ATP10D;TOM1L2;NTSR1;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;SORL1;TP53;PRICKLE1;PYCARD;IFIT1;SLC7A11;NISCH;ACSL3;HIP1;EVI5L;SLC22A15;SNX1;ANO6;GLI3;TBC1D5;SEC14L1;LRP1;FYN;B3GAT3;LTBP4;FUT10;CAV1;SLC27A1;PLA2G6;SEL1L;SNX33;SLC22A17;SLC35F3;OSBPL5;CLU;PRKCZ;EHD3;SYTL1;PTPN14;ATP8B2;EHBP1;PDIA4;CCK;PIK3R1;SYT1;HHAT;SLC38A10;TMEM173;CPT1A;SLC38A2;ACACB;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;TTN;HPS4;BTN3A1;STOM;SNCA;AIP;SH3TC2;ALOX15B;PRKAB2;SEC24D;C5;ASTN2;TMEM129;NCOA2;PLA2R1;ESYT2;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;PTPN1;ARHGEF2;LYST;ENPP1;IFT27;ISL1;SLC27A6;BCL6;SLC48A1;NCOR1;G6PC3;TMEM50B;PRKCA;ANXA2;RAB13;PGAP1;MVB12B;TTC8;RPL13A;ABCC2;HTR1B;RAB43;PRNP;TGFB2;VPS39;OSBPL1A;SP100;RHBDD1;AGAP1;TH;GOPC;SNX7;REEP2;RSAD2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;GDNF;DERL3;PITPNC1;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;APOL6;POSTN;ARL3;MIA3;COG3;RASSF9;SV2A;ABCA2;EFNA5;FZD4;PPP3CA;PEX1;COX18;ABAT;VPS36;OXTR;ATG16L2;MYO1C;RXRA;C2CD5;CPT2;EDEM1;ABCA5;NFKBIE
11387,GO:0045815,0.961662509757911,0.104577334670999,3,77,positive regulation of gene expression, epigenetic,BP,ERCC6;PHF2;MYO1C
8814,GO:0034613,0.961828000867703,0.0466510807323249,135,1457,cellular protein localization,BP,FLOT1;TXNIP;SYNE1;TLN2;GSN;ETV5;TNIK;CLTCL1;GAS6;TCAF1;EGFR;SYNE3;S100A10;TOM1L2;PAK1;NSG1;BMP4;TBC1D8;SORL1;TP53;CEP250;PRICKLE1;DDIT3;IFIT1;DLG4;ACSL3;HIP1;PACS1;TFDP2;ITGA3;EVI5L;SNX1;GLI3;TBC1D5;KCNAB2;LRP1;FYN;B3GAT3;FUT10;UGT8;CAV1;SEL1L;SNX33;CLU;PRKCZ;EHD3;GOLGB1;SYTL1;PTPN14;PIK3R1;HHAT;TMEM173;LAMA5;BBS2;CNTLN;HERPUD1;ANK3;HPS4;TP73;IFT140;STOM;FLOT2;AIP;SH3TC2;PTPRU;LMNA;SEC24D;ASTN2;TMEM129;OBSCN;SEPT6;BBS4;CALR;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;TRAK1;SYNE2;PTPN1;ARHGEF2;SSH1;SOX9;IFT27;BCL6;NFASC;TMEM50B;ANXA2;RAB13;SEPT5;CEP68;RPL13A;TSPAN5;RAB43;WDR19;TAF8;PRNP;VPS39;IFT122;EFR3A;SP100;AGRN;RHBDD1;MAGI2;HSPA5;GOPC;CENPA;PIKFYVE;REEP2;FLNB;CCHCR1;MDFIC;VPS13C;DERL3;KCNIP3;SNX9;TBC1D16;OBSL1;COG3;RASSF9;PPP3CA;PEX1;COX18;SEPT9;CDK5RAP3;NIPBL;VPS36;TTBK2;CELSR1;MYO1C;C2CD5;EDEM1
7920,GO:0032508,0.961913220988498,0.0943660229474207,4,71,DNA duplex unwinding,BP,XPC;DDB2;CHD3;SETX
7951,GO:0032561,0.96212419648049,0.0600661328876654,20,284,guanyl ribonucleotide binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;TMEM173;DAPK1;TGM2;SEPT6;ARF6;ANXA6;IFT27;PRPS2;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
10951,GO:0044743,0.96217085696651,0.167377708604895,1,38,protein transmembrane import into intracellular organelle,BP,PEX1
4064,GO:0009119,0.962588046523588,0.0924370710839002,4,84,ribonucleoside metabolic process,BP,APOBEC3C;DLG4;APOBEC3G;APOBEC3F
173,GO:0000380,0.962606891011093,0.12189682255364,2,45,alternative mRNA splicing, via spliceosome,BP,MBNL2;RBFOX2
14080,GO:0060964,0.962735977072727,0.0852174197435492,5,103,regulation of gene silencing by miRNA,BP,EGFR;BMP4;NCOR1;PPARG;PPP3CA
2365,GO:0005484,0.963165097733691,0.164711533647571,1,34,SNAP receptor activity,MF,VAMP1
17251,GO:0140030,0.963300685464321,0.0732594011593585,8,114,modification-dependent protein binding,MF,CBX5;PHF2;BRD3;YEATS2;ING4;TAF1;ZBTB1;KDM4A
5398,GO:0016242,0.963518596709785,0.164607135772499,1,29,negative regulation of macroautophagy,BP,LZTS1
8759,GO:0034453,0.963539271371755,0.166496436530562,1,23,microtubule anchoring,BP,BBS4
5990,GO:0019001,0.96365445064449,0.0578298591806779,20,285,guanyl nucleotide binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;TMEM173;DAPK1;TGM2;SEPT6;ARF6;ANXA6;IFT27;PRPS2;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
6272,GO:0019882,0.963741196935823,0.0677351820509906,10,170,antigen processing and presentation,BP,ITGB5;PYCARD;CTSV;SEC24D;PSMB9;CALR;CD1D;OSBPL1A;ACTR1B;CTSD
19420,GO:1990089,0.963827463380984,0.119453584685535,2,39,response to nerve growth factor,BP,MAGI2;HSPA5
19421,GO:1990090,0.963827463380984,0.119453584685535,2,39,cellular response to nerve growth factor stimulus,BP,MAGI2;HSPA5
10089,GO:0042626,0.963828296185729,0.0905962569434455,4,66,ATPase activity, coupled to transmembrane movement of substances,MF,ABCA1;ABCC2;ABCA2;ABCA5
2857,GO:0006351,0.96392149909909,0.0419541050167912,294,2971,transcription, DNA-templated,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
8078,GO:0032774,0.964239192498894,0.0415803832691079,296,2995,RNA biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
14473,GO:0061980,0.964472639169643,0.161624276059963,1,28,regulatory RNA binding,MF,AGO4
16271,GO:0090407,0.964478368292627,0.0499466610986275,41,498,organophosphate biosynthetic process,BP,INPP5D;DDIT4;PITPNM3;PIK3C2G;IRS2;NOS1;MBOAT2;NTSR1;DCAKD;TIMP2;ISYNA1;PDGFA;ACSL3;LPCAT2;NMRK1;CPS1;SLC27A1;PLA2G6;PIK3R1;SNCA;FGFR1;G6PD;DHTKD1;MTMR4;ATM;IDH2;DGKQ;ITPKB;NCOR1;PRPS2;ETNK2;PGAP1;NMNAT2;GPR161;PIKFYVE;NAPRT;AGPAT1;PRKAG1;MPPE1;PIK3C2B;PPCS
4107,GO:0009166,0.964552411270716,0.0708534980951324,8,125,nucleotide catabolic process,BP,DDIT4;GPX1;XDH;PDE4D;DHTKD1;NCOR1;PRKAG1;DNPH1
5144,GO:0015682,0.964601380244244,0.160233840209073,1,32,ferric iron transport,BP,STEAP2
15784,GO:0072512,0.964601380244244,0.160233840209073,1,32,trivalent inorganic cation transport,BP,STEAP2
3314,GO:0007020,0.964751550828537,0.161257624866398,1,26,microtubule nucleation,BP,EML2
9587,GO:0036464,0.964883501684246,0.0644172161064207,11,161,cytoplasmic ribonucleoprotein granule,CC,ZFP36L1;SYNE1;APOBEC3C;TRIM5;BTBD2;PNRC1;APOBEC3G;TSTD1;CIRBP;APOBEC3F;AGO4
16672,GO:0097659,0.964946626680089,0.0407868255346414,295,2985,nucleic acid-templated transcription,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
20256,GO:2001252,0.964957776495832,0.0659493216165611,10,147,positive regulation of chromosome organization,BP,NOS1;SNAI2;TP53;SDR16C5;JARID2;ATM;ISL1;BCL6;HMBOX1;NIPBL
14106,GO:0061001,0.965167138910244,0.160157115593188,1,25,regulation of dendritic spine morphogenesis,BP,CAPRIN2
240,GO:0000502,0.96518360089682,0.113764224336738,2,63,proteasome complex,CC,WFS1;PSMB9
6681,GO:0030057,0.965193482031013,0.160424455961369,1,24,desmosome,CC,PPL
18097,GO:1902808,0.965394015938957,0.157956755210682,1,30,positive regulation of cell cycle G1/S phase transition,BP,MDM2
2816,GO:0006283,0.965523955130459,0.0959051803946463,3,73,transcription-coupled nucleotide-excision repair,BP,ERCC6;LIG1;POLD4
2580,GO:0005875,0.965531216729269,0.0671460184244051,9,119,microtubule associated complex,CC,MAP2;EML2;HAUS4;PXN;KIF17;DNAL4;WDR63;DNAH1;ACTR1B
18513,GO:1903747,0.965813619780384,0.0792465354775461,5,98,regulation of establishment of protein localization to mitochondrion,BP,TP53;TFDP2;HHAT;HPS4;TP73
5701,GO:0016836,0.965922442172691,0.154975723903735,1,36,hydro-lyase activity,MF,EHHADH
6966,GO:0030641,0.966323053226394,0.094465617044965,3,64,regulation of cellular pH,BP,TP53;TMEM175;SLC9A4
110,GO:0000228,0.966432967572654,0.0475283403964179,40,493,nuclear chromosome,CC,TRNP1;SNAI2;HSPA2;ADD3;CBX5;NR1D1;SMARCA2;STAT1;TP53;MEF2D;CHD3;SYN1;POLR3GL;SMARCA1;HMGA2;NCAPD2;UHRF2;TTN;MLH3;SETX;KDM4C;ATM;C17ORF49;TCF4;CITED2;CBX7;MSH5;NCOR1;SALL2;TCF12;HMBOX1;SP100;ORC4;CENPA;POLD4;MEF2A;RARA;TAF1;NIPBL;RXRA
8435,GO:0033574,0.96646424493238,0.153820952206059,1,32,response to testosterone,BP,CALR
16054,GO:0090049,0.966490366748011,0.154660378289712,1,28,regulation of cell migration involved in sprouting angiogenesis,BP,MAP2K5
16572,GO:0097431,0.966611158083229,0.154815677707446,1,26,mitotic spindle pole,CC,OR2A4
8972,GO:0035097,0.966762723437479,0.0841488019407174,4,70,histone methyltransferase complex,CC,CBX5;JARID2;C17ORF49;TAF1
14742,GO:0070469,0.966801916384725,0.108851398840523,2,78,respiratory chain,CC,SNCA;NDUFA4L2
5397,GO:0016241,0.966840957361217,0.0627419948251706,10,150,regulation of macroautophagy,BP,SESN3;SESN1;PRKAB2;LZTS1;IFT88;ULK1;PIKFYVE;UVRAG;VPS13C;PRKAG1
17273,GO:0140097,0.96688237869807,0.0597273861276767,12,178,catalytic activity, acting on DNA,MF,TEP1;CHD3;SMARCA1;HMGA2;SETX;PRIMPOL;HMBOX1;MUTYH;DNASE1L1;LIG1;POLD4;POLH
6068,GO:0019222,0.967052460693191,0.037677706477937,494,4898,regulation of metabolic process,BP,SERPINE2;PHACTR3;TNFRSF6B;FLOT1;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;GADD45B;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;TSC22D3;KLF8;HSPA2;FLRT3;SESN3;GJC2;RFX2;ACTA2;ZNF608;SERPINE1;SERPINH1;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;MAP3K6;NTSR1;TIMP2;ZNF862;TADA3;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;VAV3;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;ETV1;TP53;ARAP1;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;WNK1;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;HIP1;GPNMB;TFDP2;PNRC1;CCDC85B;CRIM1;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;E2F7;CNTN1;KITLG;TBC1D5;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;SESN1;LRP1;FYN;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;SLIT3;OAS2;SDR16C5;ULK2;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;ANG;DUSP5;UHRF2;BBS2;HERPUD1;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;APLP2;FBLN1;ZKSCAN1;TP73;CAT;DAPK1;DLC1;KLF13;PRKACB;CHEK2;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;FLOT2;GATAD1;FZD7;AIP;GLG1;SP110;FGFR1;IGF1R;DKK1;PRKAB2;CTF1;RGS2;C5;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;G6PD;TLE4;EPHB6;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;ATM;MDM2;FAM20A;TMED10;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;AKAP13;DGKQ;CITED2;GCLC;NR2F2;IFNE;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;MAP3K1;PTPN1;VANGL2;ARHGEF2;PLGRKT;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;LEPR;TSHZ1;IGFBP4;IFT88;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;SMG9;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;ITM2A;MAPK8IP3;MSRB2;CDKN2A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPHP3;VAV2;RHBDD1;MAGI2;HSPA5;PIKFYVE;TGFB1I1;SRPK2;UVRAG;ITGB8;MDFIC;VPS13C;FHOD1;IFT74;SAP30L;ZNF12;OPHN1;LMF1;YAP1;GDNF;NUB1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;RNF144B;PARP15;BEX4;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;ING4;ZYG11B;UNK;PTPN3;DNAJC3;RARA;ABCA2;CCNY;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;CTDSP2;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;CAMK2N1;MED12;NPAS2;ABAT;NIPBL;VPS36;ADM2;PRDM5;PPP2R3A;ZNF471;LITAF;S100A11;MYO1C;RXRA;CPT2;EDEM1;TAOK3;NFKBIE;ZNF484;DMPK
13899,GO:0060590,0.96721578288844,0.150653719251384,1,35,ATPase regulator activity,MF,DNAJB4
9068,GO:0035337,0.967266067948791,0.151026666925647,1,32,fatty-acyl-CoA metabolic process,BP,ACSL3
6011,GO:0019068,0.967377283399959,0.149928047433505,1,36,virion assembly,BP,RAB43
10508,GO:0043467,0.967378556093818,0.0720985456721776,6,93,regulation of generation of precursor metabolites and energy,BP,DDIT4;IRS2;SNCA;ENPP1;NCOR1;PRKAG1
19207,GO:1905369,0.967668209795975,0.107103167506302,2,64,endopeptidase complex,CC,WFS1;PSMB9
10884,GO:0044450,0.967754087553582,0.0598177583087103,11,148,microtubule organizing center part,CC,FLOT1;CEP250;CNTLN;DZIP1L;BBS4;IFT88;ODF2;CCHCR1;CAPG;TTBK2;LRRCC1
4509,GO:0010564,0.967792242425984,0.0438953891195487,53,620,regulation of cell cycle process,BP,CTGF;SFRP1;CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;EGFR;GJC2;TOM1L2;CBX5;BMP4;TP53;CEP250;CNTRL;CUL9;GPNMB;TFDP2;CUL7;E2F7;CTDSPL;RMI2;HMGA2;KANK2;HAUS4;UHRF2;TP73;CHEK2;FBXL7;FGFR1;PSMB9;FOXN3;PBX1;BBS4;CALR;ATM;MDM2;SOX9;BCL6;RBL2;ODF2;OR2A4;FHL1;CDKN2A;UVRAG;OBSL1;TMEM67;TAF1;CTDSP2;KLHL22;CDK5RAP3;NIPBL;TAOK3
7886,GO:0032465,0.967808671881372,0.0819915790553953,4,68,regulation of cytokinesis,BP,E2F7;BBS4;OR2A4;UVRAG
1471,GO:0003729,0.96781960803663,0.0581858223294833,12,180,mRNA binding,MF,ZFP36L1;ZFP36L2;IGF2BP2;TP53;RBMS3;ADARB1;RBFOX2;CIRBP;CALR;RPL13A;UNK;RARA
14084,GO:0060968,0.967845629169112,0.0674274878443903,7,127,regulation of gene silencing,BP,EGFR;BMP4;UHRF2;PHF2;NCOR1;PPARG;PPP3CA
7027,GO:0030811,0.967966333570014,0.0912290479385535,3,54,regulation of nucleotide catabolic process,BP,DDIT4;NCOR1;PRKAG1
3233,GO:0006890,0.967996221510967,0.081210942587547,4,77,retrograde vesicle-mediated transport, Golgi to ER,BP,COPG2;TMED10;UVRAG;COG3
12052,GO:0048024,0.968432212395572,0.0895671428727241,3,63,regulation of mRNA splicing, via spliceosome,BP,MBNL2;RBFOX2;SRPK2
5989,GO:0018995,0.968897282564312,0.0885743033137967,3,61,host,CC,AXL;IFIT1;MVB12B
10625,GO:0043657,0.968897282564312,0.0885743033137967,3,61,host cell,CC,AXL;IFIT1;MVB12B
10748,GO:0044215,0.968897282564312,0.0885743033137967,3,61,other organism,CC,AXL;IFIT1;MVB12B
10749,GO:0044216,0.968897282564312,0.0885743033137967,3,61,other organism cell,CC,AXL;IFIT1;MVB12B
10750,GO:0044217,0.968897282564312,0.0885743033137967,3,61,other organism part,CC,AXL;IFIT1;MVB12B
8660,GO:0034248,0.968917853064334,0.0455966426263792,33,427,regulation of cellular amide metabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;VIM;BMP4;EIF2AK4;SORL1;ITGA2;ZCCHC11;RBMS3;PLA2G6;CLU;PER1;CAPRIN2;ANG;CIRBP;DAPK1;PAIP2B;SNCA;RGS2;CALR;TMED10;NCOR1;RPL13A;PRNP;PPARG;UNK;DNAJC3;RARA;PPP3CA;AGO4;RXRA
10888,GO:0044454,0.969132355345162,0.0446493391035897,36,462,nuclear chromosome part,CC,TRNP1;SNAI2;HSPA2;CBX5;NR1D1;SMARCA2;STAT1;TP53;MEF2D;CHD3;SYN1;POLR3GL;SMARCA1;NCAPD2;UHRF2;MLH3;KDM4C;ATM;C17ORF49;TCF4;CITED2;CBX7;MSH5;NCOR1;SALL2;TCF12;HMBOX1;SP100;ORC4;CENPA;POLD4;MEF2A;RARA;TAF1;NIPBL;RXRA
5661,GO:0016776,0.96917876092309,0.144084722789194,1,33,phosphotransferase activity, phosphate group as acceptor,MF,DLG4
60,GO:0000123,0.969352671586435,0.0782073778854326,4,79,histone acetyltransferase complex,CC,TADA3;JADE2;YEATS2;ING4
2832,GO:0006303,0.969779613318322,0.0861754410448959,3,67,double-strand break repair via nonhomologous end joining,BP,HMGA2;ATM;UVRAG
4448,GO:0010390,0.969871101610449,0.142443738711717,1,29,histone monoubiquitination,BP,DDB2
8252,GO:0033047,0.969880255263373,0.0862902822972353,3,60,regulation of mitotic sister chromatid segregation,BP,ATM;KLHL22;NIPBL
3353,GO:0007091,0.970053022640156,0.101668155748678,2,48,metaphase/anaphase transition of mitotic cell cycle,BP,ATM;KLHL22
10967,GO:0044784,0.970053022640156,0.101668155748678,2,48,metaphase/anaphase transition of cell cycle,BP,ATM;KLHL22
13256,GO:0051973,0.970141235701203,0.140465454127343,1,34,positive regulation of telomerase activity,BP,HMBOX1
14606,GO:0070206,0.970153272157957,0.140422210648638,1,34,protein trimerization,BP,C1QTNF6
4021,GO:0009057,0.970177895427692,0.0378533505465169,99,1126,macromolecule catabolic process,BP,SERPINE2;PYGB;ZFP36L1;ZFP36L2;IGF2BP2;SKP2;EGFR;SDC3;RNF213;RNF165;VIM;CSPG4;TIMP2;NR1D1;ABTB1;BTBD2;SORL1;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;ZCCHC11;TIMP1;PNRC1;CUL7;SNX1;GPX1;CTSV;LRP1;FYN;CAV1;TRIB2;SEL1L;SNX33;CLU;OAS2;FBXW4;HERPUD1;WFS1;PHKA2;CIRBP;CHEK2;BACE1;FBXL7;SNCA;ADAMTS7;TMEM129;PSMB9;SPATA18;MAGEF1;NAGLU;ATM;MDM2;CST3;MANBA;GCLC;HEXA;PTPN1;SDC2;SOX9;PRKCA;ANXA2;RNF24;MVB12B;ANAPC16;RPL13A;DNASE1L1;SMG9;USP28;AGRN;RHBDD1;HSPA5;TGFB1I1;UVRAG;OPHN1;GDNF;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;SNX9;PTPN3;DNAJC3;TMEM67;TAF1;CDK5RAP3;AGO4;SCPEP1;FBXL4;UGGT2;VPS36;EDEM1;GID4;CTSD;ZNRF1
16061,GO:0090068,0.970334924735675,0.0504772001978741,16,218,positive regulation of cell cycle process,BP,CTGF;PKD2;TP53;TFDP2;E2F7;HMGA2;UHRF2;TP73;CHEK2;FGFR1;PBX1;ATM;MDM2;RBL2;OR2A4;NIPBL
13613,GO:0060147,0.970491984445904,0.0696445487832017,5,106,regulation of posttranscriptional gene silencing,BP,EGFR;BMP4;NCOR1;PPARG;PPP3CA
14082,GO:0060966,0.970491984445904,0.0696445487832017,5,106,regulation of gene silencing by RNA,BP,EGFR;BMP4;NCOR1;PPARG;PPP3CA
671,GO:0001882,0.970767255218792,0.0473129416246575,20,290,nucleoside binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;DAPK1;OARD1;TGM2;SEPT6;ARF6;ANXA6;IFT27;PRPS2;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
2488,GO:0005739,0.971214279005707,0.036128490110755,111,1423,mitochondrion,CC,MMP2;PRODH;TXNIP;DDIT4;XPC;NOS1;HSPA2;SLC8A1;FAM210B;NTSR1;DCAKD;XAF1;HS1BP3;NR3C1;D2HGDH;TP53;PYCARD;KRT5;SLC27A3;PPL;ACSL3;TFDP2;BCKDHB;IFIT3;HIVEP1;GPX1;PTGES;ECH1;FYN;IFI6;CPS1;SLC27A1;HLCS;PLA2G6;GLDC;TNRC18;ACSS1;CLU;SLIT3;OAS2;PRDX5;KANK2;HIBADH;TMEM173;CAPRIN2;ALDH3A2;SUGCT;CPT1A;ACACB;TSTD1;JARID2;TMEM8B;TP73;CAT;CASP14;AARS;STOM;BPHL;SNCA;ALDH1L2;VAMP1;NIPSNAP1;ARMCX2;RGS2;TGM2;SPATA18;PDK3;DHTKD1;IDH2;TMEM14C;ANXA6;ACSS2;TRAK1;SYNE2;PLGRKT;NDUFA4L2;ALDH4A1;SLC25A35;PRKCA;PXMP2;PRIMPOL;DECR1;ACSF2;MUTYH;LIG1;ZADH2;SFXN3;ALDH7A1;MSRB2;ULK1;RHBDD1;HSPA5;TH;PIKFYVE;RSAD2;VPS13C;POLD4;RNF144B;LGALS3;GSTZ1;PPP3CA;DCAF8;COX18;DNM1P46;EHHADH;ABAT;FBXL4;TUSC3;CPT2;ACAA2;DMPK
4774,GO:0010965,0.971282390255349,0.0981888009322879,2,49,regulation of mitotic sister chromatid separation,BP,ATM;KLHL22
25,GO:0000049,0.971520942784317,0.0971625638800961,2,54,tRNA binding,MF,EIF2AK4;AARS
7706,GO:0032206,0.971828681198066,0.0966693864558728,2,49,positive regulation of telomere maintenance,BP,ATM;HMBOX1
18450,GO:1903578,0.971887343985753,0.0728734589260293,4,73,regulation of ATP metabolic process,BP,DDIT4;SNCA;NCOR1;PRKAG1
7455,GO:0031624,0.971925817885272,0.135215593211091,1,28,ubiquitin conjugating enzyme binding,MF,RNF144B
7940,GO:0032550,0.971972668579246,0.0460055831493475,19,280,purine ribonucleoside binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;DAPK1;TGM2;SEPT6;ARF6;ANXA6;IFT27;PRPS2;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
19206,GO:1905368,0.971976008943201,0.0802979886465712,3,85,peptidase complex,CC,TADA3;WFS1;PSMB9
6774,GO:0030219,0.972018962236606,0.0803962641708676,3,78,megakaryocyte differentiation,BP,CDKN2B;ZFPM1;AGO4
5646,GO:0016747,0.972177409108143,0.0521788628911433,11,171,transferase activity, transferring acyl groups other than amino-acyl groups,MF,MBOAT2;TADA3;LPCAT2;HHAT;CPT1A;AGPAT1;CERS5;TAF1;NAT14;CPT2;ACAA2
6015,GO:0019076,0.972237672372628,0.133023271282489,1,33,viral release from host cell,BP,TRIM5
9353,GO:0035890,0.972237672372628,0.133023271282489,1,33,exit from host,BP,TRIM5
9354,GO:0035891,0.972237672372628,0.133023271282489,1,33,exit from host cell,BP,TRIM5
13282,GO:0052126,0.972237672372628,0.133023271282489,1,33,movement in host environment,BP,TRIM5
13291,GO:0052192,0.972237672372628,0.133023271282489,1,33,movement in environment of other organism involved in symbiotic interaction,BP,TRIM5
12865,GO:0051233,0.972275178396037,0.133467902041272,1,30,spindle midzone,CC,OR2A4
2862,GO:0006356,0.972820074973704,0.131454630786457,1,30,regulation of transcription by RNA polymerase I,BP,TAF1
8812,GO:0034605,0.972937516569828,0.0581413031376125,7,113,cellular response to heat,BP,ANO1;HSPA2;TP53;CAMK2D;MYOF;ATM;HSPA5
2081,GO:0004842,0.97301739252217,0.0402264835673373,32,379,ubiquitin-protein transferase activity,MF,MARCH4;HERC5;SKP2;TRIM2;RNF213;RNF165;DDB2;TRIM5;RNF135;FBXW4;UHRF2;LMO7;FBXL7;TMEM129;IPP;FBXO17;MDM2;FBXW8;KLHL12;HLTF;RNF24;KLHL5;KLHL3;UBA7;RNF144B;ZYG11B;TAF1;KLHL22;MED12;FBXL4;GID4;ZNRF1
3297,GO:0006997,0.973223298025817,0.0552988931393664,8,124,nucleus organization,BP,SYNE1;NEK9;LMNA;SYNE2;PRKCA;GOPC;SRPK2;DMPK
11305,GO:0045652,0.973264187828852,0.0917151556181371,2,65,regulation of megakaryocyte differentiation,BP,ZFPM1;AGO4
6230,GO:0019787,0.973286642258846,0.0394257461249829,34,403,ubiquitin-like protein transferase activity,MF,MARCH4;HERC5;SKP2;TRIM2;RNF213;RNF165;DDB2;ZNF862;TRIM5;PIAS3;RNF135;FBXW4;UHRF2;LMO7;FBXL7;TMEM129;IPP;FBXO17;MDM2;FBXW8;KLHL12;HLTF;RNF24;KLHL5;KLHL3;UBA7;RNF144B;ZYG11B;TAF1;KLHL22;MED12;FBXL4;GID4;ZNRF1
12927,GO:0051321,0.973499613629094,0.0513082539630016,10,153,meiotic cell cycle,BP,HSPA2;ZNF318;NCAPD2;MLH3;PRKACB;CALR;ATM;MSH5;MYBL1;AGO4
10509,GO:0043470,0.973778294327567,0.0769585348779717,3,58,regulation of carbohydrate catabolic process,BP,DDIT4;NCOR1;PRKAG1
98,GO:0000209,0.97382038149694,0.0427856402904788,20,275,protein polyubiquitination,BP,HERC5;SKP2;RNF213;RNF165;DDB2;TRIM5;FBXW4;LMO7;FBXL7;TMEM129;PSMB9;FBXO17;FBXW8;RNF24;KLHL3;RNF144B;SASH1;TAF1;FBXL4;ZNRF1
15112,GO:0071242,0.974181083685385,0.12580829725619,1,33,cellular response to ammonium ion,BP,AGRN
6926,GO:0030544,0.974236661176853,0.125278997312163,1,35,Hsp70 protein binding,MF,SNCA
10519,GO:0043488,0.974296272386509,0.053124668616118,8,141,regulation of mRNA stability,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;CIRBP;PSMB9;PRKCA;GDNF
5102,GO:0015399,0.974378952115947,0.067325735081743,4,73,primary active transmembrane transporter activity,MF,ABCA1;ABCC2;ABCA2;ABCA5
5103,GO:0015405,0.974378952115947,0.067325735081743,4,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCA1;ABCC2;ABCA2;ABCA5
20203,GO:2001169,0.974397197905751,0.0753786109621614,3,59,regulation of ATP biosynthetic process,BP,DDIT4;NCOR1;PRKAG1
3712,GO:0008234,0.974689289710539,0.0492843419793045,10,148,cysteine-type peptidase activity,MF,SFRP1;TADA3;PYCARD;CTSV;CASP14;USP28;PGPEP1;SENP7;CAPN6;CTSD
2712,GO:0006090,0.974700872576593,0.0575783245700507,6,102,pyruvate metabolic process,BP,DDIT4;PDK3;DHTKD1;NCOR1;SRR;PRKAG1
5640,GO:0016740,0.974832104856699,0.0304784593940546,181,1889,transferase activity,MF,SULT1E1;PYGB;ST6GALNAC2;TGFBR2;EFEMP1;MARCH4;PIK3C2G;IRS2;HERC5;TNIK;SKP2;ROR1;AXL;EGFR;GALNT10;ITPK1;SPEG;MYLK;TRIM2;RNF213;MBOAT2;RNF165;DDB2;TKFC;MAP3K6;DCAKD;ZNF862;TADA3;PAK1;TRIM38;PTK6;EIF2AK4;TRIM5;EXTL2;CNTRL;LTBP1;WNK1;DLG4;ZCCHC11;PDGFA;TEP1;CRIM1;SIK1;PTGES;CDK14;LPCAT2;KITLG;NEK9;NMRK1;FYN;ALPK1;B3GAT3;LTBP4;FUT10;UGT8;CPS1;POLR3GL;PIAS3;RNF135;MAP3K14;XYLT1;UST;PRKCZ;OAS2;FBXW4;ULK2;PARP4;CHST3;HMGA2;CAMK2D;MST1R;METTL7A;PIK3R1;HHAT;SUGCT;CPT1A;UHRF2;CDK18;PHKA2;TTN;TSTD1;PRDM8;LMO7;DAPK1;ST6GAL2;PRKACB;CHEK2;FBXL7;ALDH1L2;JADE2;FGFR1;IGF1R;PRKAB2;GLT8D2;TMEM129;MYO3B;TGM2;OBSCN;PDK3;EPHB6;TGFBR3;IPP;LRTOMT;ATM;EFNB3;FBXO17;MDM2;FAM20A;AKAP13;DGKQ;HEXA;NEURL1B;FBXW8;MAP3K1;POGLUT1;KLHL12;NRK;SOX9;ITPKB;STK16;GCNT1;PRKCA;PRPS2;ETNK2;PRIMPOL;HLTF;RNF24;METTL23;HMBOX1;NMNAT2;GAL3ST4;PAK6;MAP3K12;STK36;RET;MAP2K5;GGT7;DSEL;TRIML2;ULK1;CDK19;KLHL5;PIKFYVE;SRPK2;NAPRT;UGT1A3;POLD4;UGT1A6;ALG10;KLHL3;UBA7;GALNT2;AGPAT1;RNF144B;PARP15;TPST1;CERS5;ICK;ZYG11B;POLH;PCMTD2;PRKAG1;TAF1;GSTZ1;NAT14;PIK3C2B;DNPH1;KLHL22;MED12;ABAT;FBXL4;UGGT2;TTBK2;PRDM5;TUSC3;CPT2;GID4;ACAA2;TAOK3;ZNRF1;DMPK
16949,GO:0099023,0.974857344731497,0.0740417999362475,3,63,tethering complex,CC,VPS39;UVRAG;COG3
14978,GO:0070936,0.975195708764555,0.0871486751658661,2,49,protein K48-linked ubiquitination,BP,KLHL3;ZNRF1
13091,GO:0051656,0.975550415606848,0.0375671153192721,28,348,establishment of organelle localization,BP,SYT8;COL7A1;NEFL;SYN1;SPG11;PRKCZ;SYTL1;SYT1;PCLO;BBS2;SPRY2;SNCA;SEC24D;BBS4;ATM;COPG2;TMED10;AREG;TRAK1;SYNE2;ARHGEF2;KLHL12;SEPT5;C2CD4C;CENPA;FHOD1;DNM1P46;MYO1C
10958,GO:0044770,0.975646659626956,0.0351167377814054,40,510,cell cycle phase transition,BP,CDKN2B;ZFP36L1;XPC;PKD2;ZFP36L2;SKP2;EGFR;GJC2;TP53;CEP250;CNTRL;GPNMB;TFDP2;CDK14;E2F7;CTDSPL;HMGA2;KANK2;HAUS4;TP73;CHEK2;FBXL7;PSMB9;FOXN3;PBX1;ATM;MDM2;LZTS1;RBL2;ODF2;FHL1;CDKN2A;ORC4;CCNY;TAF1;PPP3CA;CTDSP2;KLHL22;CDK5RAP3;TAOK3
4338,GO:0009894,0.975733206778069,0.0325118502462255,67,768,regulation of catabolic process,BP,SERPINE2;ZFP36L1;DDIT4;IRS2;ZFP36L2;IGF2BP2;EGFR;SESN3;VIM;TIMP2;EIF2AK4;SORL1;PRICKLE1;PYCARD;TIMP1;TYSND1;SNX1;GPX1;SESN1;LRP1;FYN;CAV1;TRIB2;SNX33;CLU;ULK2;TP53INP1;CPT1A;ACACB;HERPUD1;CIRBP;DAPK1;CHEK2;SNCA;PRKAB2;PSMB9;MAGEF1;ATM;MDM2;CST3;GCLC;LZTS1;PTPN1;SOX9;NCOR1;PRKCA;ANXA2;LEPR;IFT88;THRA;ULK1;PIKFYVE;UVRAG;VPS13C;OPHN1;GDNF;NUB1;ATRAID;DERL3;RNF144B;SNX9;PTPN3;PRKAG1;TAF1;KDM4A;CDK5RAP3;EDEM1
12920,GO:0051306,0.975808779734993,0.0852428268166258,2,51,mitotic sister chromatid separation,BP,ATM;KLHL22
1776,GO:0004386,0.975980351729572,0.0471354649002066,10,137,helicase activity,MF,SMARCA2;DDX60;CHD3;NAV2;SMARCA1;SETX;CHD6;DDX60L;HLTF;CHD9
13462,GO:0055029,0.976015855640363,0.0520759746102241,7,127,nuclear DNA-directed RNA polymerase complex,CC,TADA3;TP53;POLR3GL;CHD6;TAF8;TAF1;NIPBL
3229,GO:0006885,0.976039016176334,0.0708600356342649,3,69,regulation of pH,BP,TP53;TMEM175;SLC9A4
2969,GO:0006511,0.976362375005868,0.0338963352932485,42,514,ubiquitin-dependent protein catabolic process,BP,SKP2;RNF213;RNF165;ABTB1;BTBD2;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;CUL7;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;FBXL7;TMEM129;PSMB9;MAGEF1;MDM2;GCLC;RNF24;MVB12B;ANAPC16;USP28;HSPA5;TGFB1I1;NUB1;KLHL3;UBA7;DERL3;RNF144B;TMEM67;TAF1;FBXL4;VPS36;EDEM1;GID4;ZNRF1
2715,GO:0006096,0.97645386946164,0.0625671731516266,4,75,glycolytic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
864,GO:0002204,0.976674283561465,0.116317639987023,1,33,somatic recombination of immunoglobulin genes involved in immune response,BP,BCL6
865,GO:0002208,0.976674283561465,0.116317639987023,1,33,somatic diversification of immunoglobulins involved in immune response,BP,BCL6
11123,GO:0045190,0.976674283561465,0.116317639987023,1,33,isotype switching,BP,BCL6
10956,GO:0044766,0.976745501526937,0.06913297139955,3,68,multi-organism transport,BP,IFIT1;CAV1;MVB12B
18022,GO:1902579,0.976745501526937,0.06913297139955,3,68,multi-organism localization,BP,IFIT1;CAV1;MVB12B
5512,GO:0016482,0.976822568637751,0.0470050410157461,9,131,cytosolic transport,BP,CLTCL1;SORL1;SNX1;TBC1D5;EHD3;PIKFYVE;MON2;VPS13C;RHOBTB3
5471,GO:0016410,0.977061503065555,0.0610326211961556,4,80,N-acyltransferase activity,MF,TADA3;CERS5;TAF1;NAT14
3244,GO:0006904,0.977153192620006,0.113888143730927,1,37,vesicle docking involved in exocytosis,BP,RAB13
4747,GO:0010923,0.977469366825822,0.0602786330901677,4,74,negative regulation of phosphatase activity,BP,PHACTR3;WNK1;ELFN2;TGFB2
10517,GO:0043486,0.977679802977713,0.110780185004927,1,48,histone exchange,BP,CENPA
202,GO:0000428,0.977699156781318,0.0488173510174636,7,128,DNA-directed RNA polymerase complex,CC,TADA3;TP53;POLR3GL;CHD6;TAF8;TAF1;NIPBL
1070,GO:0002637,0.977731492233736,0.111906775867873,1,35,regulation of immunoglobulin production,BP,BCL6
7939,GO:0032549,0.977842454160378,0.0370341673830033,19,284,ribonucleoside binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;DAPK1;TGM2;SEPT6;ARF6;ANXA6;IFT27;PRPS2;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
2433,GO:0005635,0.97785070993605,0.033802350355179,30,375,nuclear envelope,CC,SULT1E1;SYNE1;EGFR;CLCA2;SYNE3;PAK1;CBX5;SORL1;PRICKLE1;PTGES;TNRC18;PRKCZ;SNCA;LMNA;PDE4D;MYOF;CALR;CST3;SYNE2;NEMP2;BCHE;PRNP;NRM;ATRAID;CERS5;ZBTB1;FAM169A;KLHDC2;MYO1C;DMPK
7169,GO:0031062,0.978012746910565,0.111630954479888,1,30,positive regulation of histone methylation,BP,JARID2
3154,GO:0006757,0.978034114825848,0.0589182115988083,4,76,ATP generation from ADP,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
11012,GO:0045005,0.978049681900903,0.111123549144826,1,32,DNA-dependent DNA replication maintenance of fidelity,BP,PRIMPOL
5291,GO:0015980,0.978092824031803,0.0409143952022156,12,215,energy derivation by oxidation of organic compounds,BP,PYGB;IRS2;NR1D1;D2HGDH;PHKA2;CAT;SNCA;DHTKD1;NFATC4;IDH2;ENPP1;LEPR
1538,GO:0003924,0.978104399323118,0.039359436371921,14,227,GTPase activity,MF,RHOBTB2;SEPT6;ARF6;IFT27;RAB13;SEPT5;RAB43;AGAP1;ARL3;RASA1;DNM1P46;SEPT9;RHOBTB3;GBP3
5696,GO:0016830,0.978271688695127,0.109076677445526,1,41,carbon-carbon lyase activity,MF,BCKDHB
17260,GO:0140056,0.978538583793473,0.0424332802086173,10,155,organelle localization by membrane tethering,BP,CEP250;CNTRL;NPHP4;HAUS4;SYT1;ESYT2;RAB13;ODF2;TMEM67;TTBK2
15859,GO:0072655,0.978672278640246,0.0448600241020268,8,157,establishment of protein localization to mitochondrion,BP,TP53;DDIT3;TFDP2;HHAT;HPS4;TP73;AIP;COX18
19344,GO:1905818,0.978714399853249,0.0766888167881732,2,52,regulation of chromosome separation,BP,ATM;KLHL22
19715,GO:2000112,0.978927426620633,0.0247552865107819,317,3205,regulation of cellular macromolecule biosynthetic process,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;ZCCHC11;PDGFA;RBMS3;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;CHEK2;PAIP2B;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;SP110;FGFR1;IGF1R;DKK1;RGS2;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;ITM2A;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;NFKBIE;ZNF484
1447,GO:0003678,0.978959180397544,0.0763756732124446,2,46,DNA helicase activity,MF,CHD3;SETX
2813,GO:0006278,0.979088653170315,0.0632779475785547,3,66,RNA-dependent DNA biosynthetic process,BP,TEP1;ATM;HMBOX1
9295,GO:0035770,0.979189248810056,0.0401559301640795,11,170,ribonucleoprotein granule,CC,ZFP36L1;SYNE1;APOBEC3C;TRIM5;BTBD2;PNRC1;APOBEC3G;TSTD1;CIRBP;APOBEC3F;AGO4
3251,GO:0006914,0.979442161891836,0.0309469216721578,33,426,autophagy,BP,ITGB4;SESN3;EIF2AK4;TRIM5;TP53;PYCARD;LIX1L;TBC1D5;SRPX;SESN1;CLU;ULK2;TP53INP1;DAPK1;SNCA;PRKAB2;SPATA18;ATM;LZTS1;LEPR;IFT88;VPS39;ULK1;PIKFYVE;UVRAG;VPS13C;PRKAG1;PIK3C2B;KDM4A;VPS36;ATG16L2;EPG5;CTSD
14463,GO:0061919,0.979442161891836,0.0309469216721578,33,426,process utilizing autophagic mechanism,BP,ITGB4;SESN3;EIF2AK4;TRIM5;TP53;PYCARD;LIX1L;TBC1D5;SRPX;SESN1;CLU;ULK2;TP53INP1;DAPK1;SNCA;PRKAB2;SPATA18;ATM;LZTS1;LEPR;IFT88;VPS39;ULK1;PIKFYVE;UVRAG;VPS13C;PRKAG1;PIK3C2B;KDM4A;VPS36;ATG16L2;EPG5;CTSD
5917,GO:0018198,0.979442763021589,0.104771714689932,1,38,peptidyl-cysteine modification,BP,NOS1
361,GO:0000980,0.979451619894405,0.0746207922705166,2,50,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,HIVEP1;MED12
7075,GO:0030880,0.979546486905855,0.0451949395752749,7,130,RNA polymerase complex,CC,TADA3;TP53;POLR3GL;CHD6;TAF8;TAF1;NIPBL
11734,GO:0046605,0.979624108307854,0.0741048103880905,2,50,regulation of centrosome cycle,BP,CEP250;TMEM67
7306,GO:0031326,0.979861424760727,0.0236337589966129,331,3347,regulation of cellular biosynthetic process,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;INPP5D;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;NTSR1;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;ZCCHC11;PDGFA;RBMS3;ACSL3;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;CHEK2;PAIP2B;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;DKK1;PRKAB2;RGS2;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;LEPR;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;ITM2A;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;ABCA2;HES2;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;NFKBIE;ZNF484
7404,GO:0031503,0.980001910524095,0.035695536054105,15,217,protein-containing complex localization,BP,NSG1;NETO1;DLG4;HIP1;KIF17;IFT140;ATM;IFT27;IFT88;WDR19;IFT122;IFT74;ICK;ARL3;DNM1P46
17250,GO:0140029,0.980073551422911,0.0724161067380136,2,56,exocytic process,BP,RAB13;SEPT5
7309,GO:0031329,0.980222632339854,0.0272067564932461,59,691,regulation of cellular catabolic process,BP,ZFP36L1;DDIT4;IRS2;ZFP36L2;IGF2BP2;SESN3;VIM;TIMP2;EIF2AK4;PRICKLE1;PYCARD;TIMP1;TYSND1;GPX1;SESN1;LRP1;CAV1;TRIB2;SNX33;CLU;ULK2;TP53INP1;CPT1A;ACACB;HERPUD1;CIRBP;DAPK1;SNCA;PRKAB2;PSMB9;MAGEF1;ATM;MDM2;CST3;GCLC;LZTS1;PTPN1;NCOR1;PRKCA;ANXA2;LEPR;IFT88;ULK1;PIKFYVE;UVRAG;VPS13C;OPHN1;GDNF;NUB1;ATRAID;DERL3;RNF144B;SNX9;PTPN3;PRKAG1;TAF1;KDM4A;CDK5RAP3;EDEM1
2503,GO:0005759,0.980377386288713,0.0316508679259263,23,393,mitochondrial matrix,CC,PRODH;NR3C1;D2HGDH;TP53;BCKDHB;GPX1;CPS1;GLDC;ACSS1;PRDX5;HIBADH;ALDH1L2;PDK3;DHTKD1;IDH2;ACSS2;ALDH4A1;PRIMPOL;DECR1;ACSF2;ALDH7A1;ABAT;ACAA2
82,GO:0000166,0.980424714220741,0.0241465752663945,159,1627,nucleotide binding,MF,PRODH;RHOBTB2;MYH15;TGFBR2;PIK3C2G;TNIK;H6PD;NOS1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;TP53I3;SMARCA2;PTK6;SCN8A;EIF2AK4;D2HGDH;TP53;TTLL11;CUL9;WNK1;DDX60;SLC27A3;MICAL1;ACSL3;PHGDH;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;MTHFR;NEK9;NMRK1;FYN;XDH;ALPK1;CPS1;SLC27A1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;HIBADH;ATP8B2;HHAT;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;CAT;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;TGM2;OBSCN;PDK3;G6PD;EPHB6;CHD6;AKAP7;SEPT6;ATM;IDH2;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;IFT27;ITPKB;SLC27A6;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;DECR1;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;PARP15;ICK;ARL3;ABCA2;PRKAG1;TAF1;DPYD;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
6596,GO:0022625,0.980587191060232,0.098511585775045,1,63,cytosolic large ribosomal subunit,CC,RPL13A
17576,GO:1901265,0.980649680704027,0.0238775695191569,159,1628,nucleoside phosphate binding,MF,PRODH;RHOBTB2;MYH15;TGFBR2;PIK3C2G;TNIK;H6PD;NOS1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;TP53I3;SMARCA2;PTK6;SCN8A;EIF2AK4;D2HGDH;TP53;TTLL11;CUL9;WNK1;DDX60;SLC27A3;MICAL1;ACSL3;PHGDH;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;MTHFR;NEK9;NMRK1;FYN;XDH;ALPK1;CPS1;SLC27A1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;HIBADH;ATP8B2;HHAT;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;CAT;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;TGM2;OBSCN;PDK3;G6PD;EPHB6;CHD6;AKAP7;SEPT6;ATM;IDH2;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;IFT27;ITPKB;SLC27A6;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;DECR1;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;PARP15;ICK;ARL3;ABCA2;PRKAG1;TAF1;DPYD;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
8211,GO:0032984,0.980675901107534,0.033035022887979,18,275,protein-containing complex disassembly,BP,GSN;SPTB;STMN3;SEMA5A;MICAL1;LIX1L;CAV1;IGF1R;SETX;TRIOBP;FZD1;DNAJC6;ARHGEF2;UVRAG;CAPG;LIMA1;TTBK2;EPG5
958,GO:0002381,0.980964548361905,0.0990061050527395,1,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,BCL6
10847,GO:0044390,0.981233771928735,0.0981837051722476,1,33,ubiquitin-like protein conjugating enzyme binding,MF,RNF144B
7709,GO:0032210,0.98124024702185,0.0691632870068306,2,51,regulation of telomere maintenance via telomerase,BP,ATM;HMBOX1
19959,GO:2000573,0.981302315747954,0.0686588533078848,2,57,positive regulation of DNA biosynthetic process,BP,ATM;HMBOX1
13078,GO:0051640,0.981316086585512,0.0269483583069736,44,522,organelle localization,BP,SYT8;COL7A1;MAP6;NEFL;CEP250;CNTRL;SYN1;SPG11;NPHP4;PRKCZ;SYTL1;HAUS4;SYT1;PCLO;BBS2;SPRY2;SNCA;PLXNA2;SEC24D;ESYT2;BBS4;ATM;COPG2;TMED10;AREG;TRAK1;SYNE2;ARHGEF2;KLHL12;RAB13;SEPT5;ODF2;C2CD4C;MAGI2;CENPA;UVRAG;FHOD1;TPGS1;MEF2A;TMEM67;PEX1;DNM1P46;TTBK2;MYO1C
12140,GO:0048278,0.981325949383517,0.0686346712747751,2,56,vesicle docking,BP,SYT1;RAB13
6301,GO:0019941,0.981365433771378,0.0270656536329355,42,522,modification-dependent protein catabolic process,BP,SKP2;RNF213;RNF165;ABTB1;BTBD2;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;CUL7;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;FBXL7;TMEM129;PSMB9;MAGEF1;MDM2;GCLC;RNF24;MVB12B;ANAPC16;USP28;HSPA5;TGFB1I1;NUB1;KLHL3;UBA7;DERL3;RNF144B;TMEM67;TAF1;FBXL4;VPS36;EDEM1;GID4;ZNRF1
2387,GO:0005525,0.981696736369671,0.0314152280628781,18,277,GTP binding,MF,RHOBTB2;IFI44L;EHD3;HHAT;DAPK1;TGM2;SEPT6;ARF6;ANXA6;IFT27;RAB13;SEPT5;RAB43;AGAP1;ARL3;SEPT9;RHOBTB3;GBP3
14483,GO:0065004,0.981811856668515,0.0353359912267248,11,214,protein-DNA complex assembly,BP,XPC;DDB2;TP53;TCF4;SOX9;THRA;TSPYL2;TSPYL4;CENPA;TAF1;HP1BP3
4501,GO:0010556,0.981988361715469,0.0212270472536973,321,3253,regulation of macromolecule biosynthetic process,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;INPP5D;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;ZCCHC11;PDGFA;RBMS3;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;CHEK2;PAIP2B;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;DKK1;RGS2;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;LEF1;THRA;SSBP3;ITM2A;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;NFKBIE;ZNF484
259,GO:0000726,0.982051566675301,0.0553505237275193,3,74,non-recombinational repair,BP,HMGA2;ATM;UVRAG
17806,GO:1901992,0.982202658057202,0.0660041404268839,2,55,positive regulation of mitotic cell cycle phase transition,BP,PBX1;MDM2
2579,GO:0005874,0.982256242136986,0.0278697570963897,28,332,microtubule,CC,MAP6;DPYSL2;SLC8A1;TTLL11;TCP11L1;MAP2;EML2;KCNAB2;PARP4;HAUS4;KIF17;SPRY2;PBXIP1;ARHGEF2;DNAL4;NCOR1;NDRG1;RGS14;ODF2;REEP2;TPGS1;DNAH1;BEX4;ARL3;CAPN6;SEPT9;KLHL22;CDK5RAP3
9000,GO:0035195,0.982403055391805,0.0395047967397984,7,134,gene silencing by miRNA,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPARG;PPP3CA;AGO4
12918,GO:0051304,0.982405594281849,0.0545962505001917,3,68,chromosome separation,BP,NCAPD2;ATM;KLHL22
22,GO:0000041,0.982626249022111,0.0538394234857051,3,74,transition metal ion transport,BP,ABCC2;SLC39A11;STEAP2
19692,GO:2000059,0.982630272427535,0.0920094050472673,1,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,TAF1
14813,GO:0070585,0.982644800272322,0.0372896982415777,8,160,protein localization to mitochondrion,BP,TP53;DDIT3;TFDP2;HHAT;HPS4;TP73;AIP;COX18
5091,GO:0015370,0.982746568545983,0.09221418483956,1,31,solute:sodium symporter activity,MF,SLC20A1
6065,GO:0019219,0.982767848962183,0.0203268567883178,322,3263,regulation of nucleobase-containing compound metabolic process,BP,TRNP1;HTRA1;TXNIP;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;PDGFA;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTPN1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;NPHP3;HSPA5;TGFB1I1;SRPK2;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;FAM120B;FAM168A;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;NFKBIE;ZNF484
11493,GO:0046031,0.98295789039766,0.0472513774816305,4,80,ADP metabolic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
1589,GO:0004003,0.98314427342785,0.0902392108934316,1,33,ATP-dependent DNA helicase activity,MF,CHD3
2970,GO:0006513,0.983332538915257,0.0522372766855331,3,65,protein monoubiquitination,BP,DDB2;KLHL12;KLHL22
1782,GO:0004402,0.983404655850823,0.0624888405869814,2,51,histone acetyltransferase activity,MF,TADA3;TAF1
4468,GO:0010468,0.983545857710075,0.0193639963211477,345,3508,regulation of gene expression,BP,SERPINE2;TRNP1;HTRA1;FN1;CCBE1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;GJC2;RFX2;ACTA2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;ZCCHC11;RBMS3;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;CNTN1;KRBA2;ABHD14B;ZFP90;FYN;XDH;TSHZ2;ADIRF;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;SLIT3;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;ANG;UHRF2;BBS2;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;PRKACB;CHEK2;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;FLOT2;GATAD1;FZD7;GLG1;SP110;FGFR1;DKK1;RGS2;C5;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;ZNF699;CALR;ATM;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;PLGRKT;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;SMG9;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;RHBDD1;HSPA5;TGFB1I1;SRPK2;ITGB8;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;ICK;TGIF1;ING4;UNK;DNAJC3;RARA;ABCA2;HES2;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;CAMK2N1;MED12;NPAS2;NIPBL;VPS36;ADM2;PRDM5;ZNF471;LITAF;MYO1C;RXRA;NFKBIE;ZNF484
2808,GO:0006270,0.983577582916751,0.0875219895754094,1,41,DNA replication initiation,BP,ORC4
9868,GO:0042162,0.983806813755072,0.0871715054178619,1,35,telomeric DNA binding,MF,HMBOX1
276,GO:0000779,0.984103454841801,0.0406597226986044,5,104,condensed chromosome, centromeric region,CC,NCAPD2;PHF2;SEPT6;ANAPC16;CENPA
15402,GO:0071705,0.984116402757385,0.0197704210805013,153,1703,nitrogen compound transport,BP,ITGB6;FLOT1;FN1;TXNIP;SFRP1;ZFP36L1;F2R;TGFBR2;SLC7A8;ANO1;GJA5;IRS2;IGF2BP2;CLTCL1;NOS1;GAS6;TCAF1;EGFR;TOM1L2;NTSR1;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;SORL1;TP53;PRICKLE1;PYCARD;IFIT1;SLC7A11;NISCH;ACSL3;HIP1;EVI5L;SNX1;GLI3;TBC1D5;SEC14L1;LRP1;FYN;B3GAT3;LTBP4;FUT10;PLA2G6;SEL1L;SNX33;SLC35F3;CLU;PRKCZ;EHD3;SYTL1;PTPN14;EHBP1;PDIA4;CCK;SYT1;HHAT;SLC38A10;TMEM173;CPT1A;SLC38A2;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;TTN;HPS4;BTN3A1;STOM;SNCA;AIP;SH3TC2;ALOX15B;SEC24D;C5;ASTN2;TMEM129;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;PTPN1;ARHGEF2;LYST;IFT27;ISL1;BCL6;SLC48A1;TMEM50B;PRKCA;RAB13;PGAP1;MVB12B;TTC8;RPL13A;ABCC2;HTR1B;RAB43;PRNP;TGFB2;VPS39;SP100;RHBDD1;AGAP1;TH;GOPC;SNX7;REEP2;RSAD2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;GDNF;DERL3;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;POSTN;ARL3;MIA3;COG3;RASSF9;SV2A;EFNA5;PPP3CA;PEX1;COX18;ABAT;VPS36;OXTR;ATG16L2;MYO1C;C2CD5;EDEM1;NFKBIE
4188,GO:0009295,0.98413565881512,0.0852451661081784,1,40,nucleoid,CC,CPS1
10103,GO:0042645,0.98413565881512,0.0852451661081784,1,40,mitochondrial nucleoid,CC,CPS1
10518,GO:0043487,0.984254390559949,0.0342475119973659,8,148,regulation of RNA stability,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;CIRBP;PSMB9;PRKCA;GDNF
278,GO:0000781,0.984349690401846,0.034075137294652,8,146,chromosome, telomeric region,CC,CBX5;TEP1;CHEK2;SETX;ATM;HMBOX1;SP100;ORC4
2848,GO:0006336,0.984409894947441,0.0833562199473096,1,50,DNA replication-independent nucleosome assembly,BP,CENPA
11443,GO:0045921,0.984464202556098,0.0589161093601882,2,56,positive regulation of exocytosis,BP,PLA2G6;SYT1
6981,GO:0030670,0.984623916248863,0.0581771215826852,2,62,phagocytic vesicle membrane,CC,CALR;RAB43
1444,GO:0003674,0.984714600547534,0.0204531200133888,1161,11292,molecular_function,MF,SERPINE2;PHACTR3;CPA4;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;FBN2;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MN1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;NYNRIN;CEP126;SLC8A1;NTM;FKBP5;ORAI3;CLCA2;DOCK5;SESN3;MYLK;SYNE3;GJC2;SLC20A1;SLC2A3;THBS2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;C1QTNF6;VIM;NUPR1;LPAR5;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;ALS2CL;LGALS9C;MFAP5;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;CHN2;KIAA0040;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;FAM167A;ABTB1;RIN2;CITED4;XAF1;PCED1B;EIF2AK4;NETO1;HS1BP3;FCGBP;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;CPVL;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;PLEKHG3;DDX60;EFHC1;ARHGEF1;DLG4;SLC7A11;ATXN7L1;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;MMP19;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;SMOC1;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;SLC22A15;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;DIP2C;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;LIMCH1;PDPN;MTHFR;ABHD14B;ZFP90;CCDC80;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;PABPC4L;FLNC;ALPK1;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;IGFL1;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;SNX29;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;CHST3;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;PXN;PDIA4;SPATA20;CCK;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;SLC38A2;CALHM2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;LAMB3;CES2;TTN;TMEM139;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;IQCH;AIP;GLG1;JADE2;PAQR7;NIPSNAP1;PLXNA2;SP110;COL16A1;CYYR1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;CTF1;SEC24D;SEMA4A;LTBP3;RGS2;C5;GLT8D2;TGFBI;SETX;KHNYN;ASTN2;PDE4D;APBB3;TMEM129;WBP1;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;CD99L2;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;ENG;FOXL1;BBS4;MTMR4;LRRC20;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;TBC1D19;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;IFNK;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;JMJD7;C20ORF194;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;ACSS2;ELMO3;FHOD3;HEXA;IFNE;NEURL1B;IGFL2;CBX7;DNAJC4;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;CYP20A1;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;HSPA12A;SYNE2;HDAC11;RNPEP;MAP3K1;FGD4;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;NT5DC3;CPNE8;ARHGEF2;DNAL4;NTNG1;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;THNSL2;SYNC;ZNF546;KRT222;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;C14ORF93;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;DDX60L;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;TMEM63C;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;STOX2;CEP68;PGAP1;TSHZ1;PLD5;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;MVB12B;TES;TTC8;KCTD7;TCF25;TCF12;HMBOX1;C22ORF23;NFAT5;TTC23;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;XG;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;ODF2;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;C11ORF68;CYP4V2;MSRB2;TRIML2;C2CD4C;CDKN2A;PPM1M;MPRIP;RSRP1;HERPUD2;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;DHRS12;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;SLC9A4;ERICH2;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;SEMA4B;ITGB8;NAPRT;MON2;ARHGEF19;ITPR2;ARHGAP29;MDFIC;C11ORF49;UGT1A3;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;KCTD14;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;PGPEP1;DNAH1;ALG10;RALGAPB;NUB1;KLF5;COL17A1;GPX8;TWIST2;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;PRRC2B;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;PARP15;BEX4;CALCRL;ADAMTSL5;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;OLFML2A;ZYG11B;APOL6;POSTN;UNK;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;ECM2;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;SBF2;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;CLEC2D;FAM120B;FAM168A;CACNA2D3;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;C4ORF33;ANKS6;TSPAN4;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;GID4;ACAA2;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;PINLYP;LAMB2
2851,GO:0006342,0.984798035636872,0.0423751049141368,4,107,chromatin silencing,BP,TNRC18;UHRF2;PHF2;BAHCC1
2584,GO:0005881,0.984851565577787,0.057876179429048,2,52,cytoplasmic microtubule,CC,REEP2;ARL3
5393,GO:0016236,0.985077828561476,0.0260263895223713,18,269,macroautophagy,BP,SESN3;LIX1L;TBC1D5;SESN1;ULK2;TP53INP1;PRKAB2;LZTS1;IFT88;ULK1;PIKFYVE;UVRAG;VPS13C;PRKAG1;PIK3C2B;VPS36;ATG16L2;EPG5
11182,GO:0045333,0.985175260878662,0.0355202449200401,6,153,cellular respiration,BP,D2HGDH;CAT;SNCA;DHTKD1;NFATC4;IDH2
4077,GO:0009135,0.985271056043326,0.0381641380404043,5,94,purine nucleoside diphosphate metabolic process,BP,DDIT4;DLG4;DHTKD1;NCOR1;PRKAG1
4116,GO:0009179,0.985271056043326,0.0381641380404043,5,94,purine ribonucleoside diphosphate metabolic process,BP,DDIT4;DLG4;DHTKD1;NCOR1;PRKAG1
9051,GO:0035305,0.985512844025099,0.0410702797501607,4,79,negative regulation of dephosphorylation,BP,PHACTR3;WNK1;ELFN2;TGFB2
11816,GO:0046794,0.985563524894209,0.0554629419800481,2,55,transport of virus,BP,CAV1;MVB12B
6571,GO:0022406,0.985600310287287,0.0295504440987718,10,162,membrane docking,BP,CEP250;CNTRL;NPHP4;HAUS4;SYT1;ESYT2;RAB13;ODF2;TMEM67;TTBK2
4671,GO:0010824,0.985602185654466,0.0792032427183779,1,37,regulation of centrosome duplication,BP,TMEM67
11872,GO:0046916,0.98585638380409,0.0450825943742707,3,78,cellular transition metal ion homeostasis,BP,CYBRD1;SLC22A17;PRNP
8086,GO:0032784,0.985992486424695,0.0772110957466721,1,40,regulation of DNA-templated transcription, elongation,BP,ERCC6
7945,GO:0032555,0.985993937063082,0.017675000890125,139,1421,purine ribonucleotide binding,MF,RHOBTB2;MYH15;TGFBR2;PIK3C2G;TNIK;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;HHAT;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;TGM2;OBSCN;PDK3;EPHB6;CHD6;SEPT6;ATM;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;IFT27;ITPKB;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ARL3;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
8228,GO:0033013,0.986004026726096,0.076997693787721,1,42,tetrapyrrole metabolic process,BP,TMEM14C
274,GO:0000777,0.986019078588549,0.0395910476970316,4,92,condensed chromosome kinetochore,CC,PHF2;SEPT6;ANAPC16;CENPA
10613,GO:0043632,0.986088853259051,0.0205137080233825,42,531,modification-dependent macromolecule catabolic process,BP,SKP2;RNF213;RNF165;ABTB1;BTBD2;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;CUL7;CAV1;TRIB2;SEL1L;CLU;FBXW4;HERPUD1;WFS1;FBXL7;TMEM129;PSMB9;MAGEF1;MDM2;GCLC;RNF24;MVB12B;ANAPC16;USP28;HSPA5;TGFB1I1;NUB1;KLHL3;UBA7;DERL3;RNF144B;TMEM67;TAF1;FBXL4;VPS36;EDEM1;GID4;ZNRF1
7943,GO:0032553,0.986100650758691,0.0175323414984891,140,1432,ribonucleotide binding,MF,RHOBTB2;MYH15;TGFBR2;PIK3C2G;TNIK;NOS1;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;HHAT;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;TGM2;OBSCN;PDK3;EPHB6;CHD6;SEPT6;ATM;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;IFT27;ITPKB;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ARL3;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
7258,GO:0031248,0.986176892680184,0.039264761994079,4,88,protein acetyltransferase complex,CC,TADA3;JADE2;YEATS2;ING4
17984,GO:1902493,0.986176892680184,0.039264761994079,4,88,acetyltransferase complex,CC,TADA3;JADE2;YEATS2;ING4
14399,GO:0061733,0.986478473851394,0.0525984087510219,2,53,peptide-lysine-N-acetyltransferase activity,MF,TADA3;TAF1
8888,GO:0034724,0.986497424365984,0.0742625984816213,1,51,DNA replication-independent nucleosome organization,BP,CENPA
11386,GO:0045814,0.986534920927728,0.0349715130688091,5,121,negative regulation of gene expression, epigenetic,BP,TNRC18;UHRF2;JARID2;PHF2;BAHCC1
8789,GO:0034508,0.986553214859953,0.0740683406493414,1,50,centromere complex assembly,BP,CENPA
2057,GO:0004812,0.986665634753234,0.0739318003124889,1,44,aminoacyl-tRNA ligase activity,MF,AARS
5724,GO:0016875,0.986665634753234,0.0739318003124889,1,44,ligase activity, forming carbon-oxygen bonds,MF,AARS
4122,GO:0009185,0.986825624364116,0.0345727513963149,5,96,ribonucleoside diphosphate metabolic process,BP,DDIT4;DLG4;DHTKD1;NCOR1;PRKAG1
6052,GO:0019205,0.986845444265113,0.0732752924441304,1,42,nucleobase-containing compound kinase activity,MF,DLG4
7446,GO:0031593,0.986927879825134,0.0733331168273485,1,37,polyubiquitin modification-dependent protein binding,MF,ZBTB1
4094,GO:0009152,0.986971499810738,0.0269383285251681,10,172,purine ribonucleotide biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;DHTKD1;NCOR1;PRPS2;GPR161;PRKAG1;PPCS
3622,GO:0008080,0.987026394411046,0.0419957048753927,3,72,N-acetyltransferase activity,MF,TADA3;TAF1;NAT14
4552,GO:0010638,0.987058335247975,0.0192418258620836,41,511,positive regulation of organelle organization,BP,MMP9;CTGF;SFRP1;GSN;NOS1;SNAI2;S100A10;PAK1;TP53;PYCARD;SEMA5A;TFDP2;ASAP1;PLA2G6;SDR16C5;ARPIN;PXN;SYT1;HHAT;JARID2;HPS4;TP73;FSCN1;RGS2;BBS4;ATM;ARF6;ISL1;BCL6;ANXA2;HMBOX1;CDC42EP5;ULK1;UVRAG;VPS13C;FHOD1;WIPF1;SEPT9;NIPBL;MYO1C;C2CD5
10590,GO:0043596,0.987060806181753,0.0723894113821686,1,41,nuclear replication fork,CC,POLD4
11562,GO:0046148,0.987062799230787,0.0724605348282584,1,40,pigment biosynthetic process,BP,TMEM14C
11630,GO:0046390,0.987264410815434,0.0256383753234103,11,187,ribose phosphate biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;G6PD;DHTKD1;NCOR1;PRPS2;GPR161;PRKAG1;PPCS
288,GO:0000793,0.987381909570502,0.025475953328504,11,174,condensed chromosome,CC,HSPA2;ADD3;SYN1;NCAPD2;TTN;MLH3;PHF2;SEPT6;MSH5;ANAPC16;CENPA
8820,GO:0034622,0.987414737940103,0.0172558485936072,69,883,cellular protein-containing complex assembly,BP,XPC;GSN;CLTCL1;PDGFC;SPTB;DDB2;PAK1;NSG1;NEFL;TP53;PYCARD;PILRB;MAP2;HIP1;PDE4DIP;EML2;ARHGAP18;CLU;ARPIN;KANK2;PXN;ANG;TTN;CIRBP;SNCA;VAMP1;SEC24D;RGS2;SETX;TRIOBP;SEPT6;TGFBR3;BBS4;CALR;ATM;ARF6;TMED10;TCF4;DGKQ;FHOD3;SOX9;SEPT5;RPL13A;THRA;CDC42EP5;MSRB2;TSPYL2;TSPYL4;CELF2;CENPA;SRPK2;UVRAG;DNAH1;CAPG;SNX9;OBSL1;MIA3;TAF1;EFNA5;WIPF1;RASA1;HP1BP3;COX18;DNM1P46;SEPT9;AGO4;MYH11;PSMG4;MYO1C
5498,GO:0016447,0.987450289291941,0.0709802009595649,1,37,somatic recombination of immunoglobulin gene segments,BP,BCL6
8999,GO:0035194,0.987504197171404,0.0290632979705266,7,140,posttranscriptional gene silencing by RNA,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPARG;PPP3CA;AGO4
2713,GO:0006091,0.987516726809761,0.0207846035760427,23,365,generation of precursor metabolites and energy,BP,PYGB;DDIT4;IRS2;NR1D1;D2HGDH;PHGDH;XDH;GLDC;ACSS1;PHKA2;CAT;SNCA;DHTKD1;NFATC4;IDH2;ACSS2;AKR7A2;NDUFA4L2;ALDH4A1;ENPP1;NCOR1;LEPR;PRKAG1
4333,GO:0009889,0.98764051025515,0.0146672663031559,333,3397,regulation of biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;NTSR1;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;ZCCHC11;PDGFA;RBMS3;ACSL3;HIP1;TFDP2;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;CAV1;SLC27A1;GLI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;CHEK2;PAIP2B;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;DKK1;PRKAB2;RGS2;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;LEPR;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;ZNF701;GPR161;LEF1;THRA;SSBP3;ITM2A;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;ABCA2;HES2;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;NFKBIE;ZNF484
18619,GO:1903955,0.987668960064802,0.0483674154571652,2,62,positive regulation of protein targeting to mitochondrion,BP,HHAT;HPS4
2752,GO:0006165,0.988021723446475,0.0346737974866767,4,87,nucleoside diphosphate phosphorylation,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
5468,GO:0016407,0.988058198076754,0.0345665532808108,4,88,acetyltransferase activity,MF,TADA3;LPCAT2;TAF1;NAT14
13150,GO:0051783,0.988069102740602,0.0257351745388972,9,152,regulation of nuclear division,BP,TOM1L2;BMP4;CUL9;CUL7;CALR;ATM;OBSL1;KLHL22;NIPBL
4478,GO:0010501,0.988147426119161,0.0674714009008876,1,41,RNA secondary structure unwinding,BP,AGO4
3351,GO:0007088,0.988181135320597,0.0265141358017346,8,139,regulation of mitotic nuclear division,BP,TOM1L2;BMP4;CUL9;CUL7;ATM;OBSL1;KLHL22;NIPBL
2865,GO:0006360,0.988337275354326,0.0462488767445162,2,59,transcription by RNA polymerase I,BP,ERCC6;TAF1
137,GO:0000288,0.988355547653149,0.0382735538449711,3,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,ZFP36L1;ZFP36L2;ZCCHC11
9914,GO:0042278,0.988565160943503,0.0453378762534087,2,64,purine nucleoside metabolic process,BP,DLG4;OARD1
13486,GO:0055086,0.988612418406217,0.0172362346858958,38,545,nucleobase-containing small molecule metabolic process,BP,SULT1E1;DDIT4;PKD2;H6PD;NOS1;DCAKD;TIMP2;APOBEC3C;TP53I3;EXTL2;DLG4;GPX1;ABHD14B;KCNAB2;NMRK1;XDH;CPS1;APOBEC3G;SNCA;OARD1;APOBEC3F;PDE4D;G6PD;DHTKD1;IDH2;ENPP1;NCOR1;PRPS2;NMNAT2;GPR161;NPHP3;NAPRT;TPST1;PRKAG1;DPYD;PPCS;DNPH1;UGGT2
3195,GO:0006826,0.988706537043058,0.0648283583891413,1,42,iron ion transport,BP,STEAP2
10273,GO:0043044,0.988818696207589,0.0443641729976734,2,69,ATP-dependent chromatin remodeling,BP,SMARCA1;CENPA
8876,GO:0034708,0.988838264767022,0.0325587781587333,4,90,methyltransferase complex,CC,CBX5;JARID2;C17ORF49;TAF1
9228,GO:0035639,0.988841705640836,0.0142113448982975,136,1402,purine ribonucleoside triphosphate binding,MF,RHOBTB2;MYH15;TGFBR2;PIK3C2G;TNIK;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;HHAT;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;MYO3B;TGM2;OBSCN;PDK3;EPHB6;CHD6;SEPT6;ATM;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;IFT27;ITPKB;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ARL3;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
138,GO:0000289,0.988862690815028,0.0646851218558676,1,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,ZCCHC11
5493,GO:0016441,0.988918462435655,0.0260908370675176,7,141,posttranscriptional gene silencing,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPARG;PPP3CA;AGO4
13669,GO:0060249,0.988967370386647,0.0194052179214608,19,284,anatomical structure homeostasis,BP,CTGF;INPP5D;F2R;IL20RB;EGFR;TEP1;ERCC6;NPHP4;BBS2;BBS4;ATM;BBS1;SOX9;PRKCA;HMBOX1;LIPA;SP100;NPHP3;POLD4
4479,GO:0010506,0.989062875382969,0.0192714563293015,19,271,regulation of autophagy,BP,SESN3;EIF2AK4;PYCARD;SESN1;ULK2;TP53INP1;DAPK1;SNCA;PRKAB2;ATM;LZTS1;LEPR;IFT88;ULK1;PIKFYVE;UVRAG;VPS13C;PRKAG1;KDM4A
4106,GO:0009165,0.989253096323025,0.0204748407316629,14,232,nucleotide biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;NMRK1;DHTKD1;IDH2;NCOR1;PRPS2;NMNAT2;GPR161;NAPRT;PRKAG1;PPCS
2751,GO:0006164,0.989326420105016,0.0224571071956522,10,176,purine nucleotide biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;DHTKD1;NCOR1;PRPS2;GPR161;PRKAG1;PPCS
5808,GO:0017076,0.989477978523831,0.0133957036060136,139,1435,purine nucleotide binding,MF,RHOBTB2;MYH15;TGFBR2;PIK3C2G;TNIK;ROR1;AXL;EGFR;ITPK1;HSPA2;SPEG;MYLK;ACTA2;ATP10D;TKFC;IFI44L;MAP3K6;DCAKD;PAK1;ABCA1;ITM2C;SMARCA2;PTK6;SCN8A;EIF2AK4;TP53;TTLL11;CUL9;WNK1;DDX60;ACSL3;TEP1;CHD3;SIK1;CDK14;NAV2;SYN1;NEK9;NMRK1;FYN;ALPK1;CPS1;HLCS;ERCC6;MAP3K14;SMARCA1;ACSS1;PRKCZ;OAS2;ULK2;EHD3;CAMK2D;MST1R;ATP8B2;HHAT;TMEM173;ACACB;KIF17;CDK18;TTN;MLH3;DAPK1;PRKACB;AARS;CHEK2;FGFR1;IGF1R;SETX;PDE4D;MYO3B;TGM2;OBSCN;PDK3;EPHB6;CHD6;SEPT6;ATM;ARF6;ANXA6;DGKQ;GCLC;ACSS2;MSH5;HSPA12A;MAP3K1;NRK;ENPP1;IFT27;ITPKB;STK16;DDX60L;PRKCA;PRPS2;RAB13;ETNK2;HLTF;SEPT5;NMNAT2;GAL3ST4;PAK6;ABCC2;MAP3K12;CHD9;ACSF2;STK36;RAB43;RET;MAP2K5;LIG1;ULK1;ORC4;AGAP1;HSPA5;CDK19;MAGI1;PIKFYVE;SRPK2;MYO9A;HSP90AB4P;DNAH1;SRR;UBA7;ICK;ARL3;ABCA2;PRKAG1;TAF1;PIK3C2B;PEX1;ACTR1B;SEPT9;MYH11;TTBK2;RHOBTB3;MYO1C;GBP3;ABCA5;TAOK3;DMPK
1855,GO:0004520,0.989491193688821,0.0609843305449643,1,45,endodeoxyribonuclease activity,MF,DNASE1L1
11403,GO:0045840,0.989559787092834,0.0611408099877574,1,38,positive regulation of mitotic nuclear division,BP,NIPBL
5671,GO:0016788,0.989681087611865,0.0153784798002777,43,556,hydrolase activity, acting on ester bonds,MF,INPP5D;DUSP6;H6PD;SULF2;ITPK1;ENDOD1;PTPRM;PTPRS;CTDSPL;PLA2G6;TNS2;PTPN14;ANG;DUSP5;CES2;PLCH2;AARS;BPHL;PTPRU;PDE4D;SULF1;ARSD;MTMR4;DNAJC6;PTPN1;NT5DC3;SSH1;ENPP1;PLD3;G6PC3;BCHE;CES3;PGAP1;NLGN4Y;DNASE1L1;LIPA;PPM1M;PIKFYVE;PTPN3;MPPE1;PPP3CA;CTDSP2;ACOT1
8735,GO:0034404,0.989869542203059,0.0221288835595025,9,166,nucleobase-containing small molecule biosynthetic process,BP,DDIT4;GPX1;XDH;PDE4D;DHTKD1;ENPP1;NCOR1;PRKAG1;DNPH1
6184,GO:0019637,0.989922635816506,0.0140053535807943,67,845,organophosphate metabolic process,BP,SULT1E1;INPP5D;DDIT4;PKD2;PITPNM3;PIK3C2G;IRS2;OSBPL10;H6PD;NOS1;EGFR;ITPK1;MBOAT2;TKFC;NTSR1;DCAKD;TIMP2;ISYNA1;TP53I3;VAV3;DLG4;PDGFA;ACSL3;GPX1;LPCAT2;KITLG;ABHD14B;KCNAB2;NMRK1;FYN;XDH;CPS1;SLC27A1;PLA2G6;OSBPL5;PIK3R1;PLCH2;SNCA;FGFR1;PDE4D;G6PD;DHTKD1;MTMR4;ATM;IDH2;DGKQ;ENPP1;ITPKB;NCOR1;G6PC3;PRPS2;ETNK2;PGAP1;NMNAT2;GPR161;EFR3A;NPHP3;VAV2;PIKFYVE;NAPRT;AGPAT1;TPST1;PRKAG1;MPPE1;PIK3C2B;PPCS;DNPH1
7705,GO:0032205,0.989932035749399,0.0596357173895441,1,35,negative regulation of telomere maintenance,BP,ATM
7216,GO:0031122,0.989965435824354,0.0410273102331122,2,51,cytoplasmic microtubule organization,BP,CEP126;STMN3
3335,GO:0007051,0.989980387900313,0.0212813200181223,10,156,spindle organization,BP,CEP126;EFHC1;CHD3;HAUS4;CHEK2;NCOR1;RGS14;GOLGA8B;UVRAG;GOLGA8N
19456,GO:1990234,0.990131703608254,0.0140328116952992,58,715,transferase complex,CC,TGFBR2;PIK3C2G;SKP2;DDB2;TADA3;CBX5;ABTB1;BTBD2;TP53;CUL9;PYCARD;CUL7;CDK14;TBC1D5;POLR3GL;SEL1L;DCAF16;FBXW4;PHC2;PIK3R1;PHKA2;JARID2;LMO7;FBXL7;JADE2;PRKAB2;DHTKD1;CHD6;IPP;ENG;FBXO17;C17ORF49;CBX7;FBXW8;KLHL12;PRPS2;ANAPC16;TAF8;ULK1;KLHL5;UVRAG;POLD4;KLHL3;YEATS2;RNF144B;ING4;ZYG11B;CCNY;PRKAG1;TAF1;DCAF8;PIK3C2B;KLHL22;MED12;ABAT;FBXL4;NIPBL;TUSC3
1456,GO:0003697,0.990313396089189,0.0286906679090427,4,96,single-stranded DNA binding,MF,XPC;MLH3;CXORF57;SSBP3
18318,GO:1903312,0.99034210978277,0.0394215942506398,2,60,negative regulation of mRNA metabolic process,BP,CIRBP;GDNF
17581,GO:1901293,0.99043777384751,0.0183780842631092,14,235,nucleoside phosphate biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;NMRK1;DHTKD1;IDH2;NCOR1;PRPS2;NMNAT2;GPR161;NAPRT;PRKAG1;PPCS
2904,GO:0006417,0.990537932185007,0.0154995496231256,27,388,regulation of translation,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;VIM;BMP4;EIF2AK4;ITGA2;ZCCHC11;RBMS3;PER1;CAPRIN2;ANG;CIRBP;DAPK1;PAIP2B;RGS2;CALR;NCOR1;RPL13A;PPARG;UNK;DNAJC3;RARA;PPP3CA;AGO4;RXRA
2905,GO:0006418,0.990574521797676,0.0556391726087032,1,49,tRNA aminoacylation for protein translation,BP,AARS
11642,GO:0046434,0.990679559292263,0.0198611622831051,10,172,organophosphate catabolic process,BP,DDIT4;NTSR1;GPX1;XDH;PDE4D;DHTKD1;ENPP1;NCOR1;PRKAG1;DNPH1
281,GO:0000784,0.990899168272533,0.0247792408463689,5,114,nuclear chromosome, telomeric region,CC,CBX5;ATM;HMBOX1;SP100;ORC4
5045,GO:0015238,0.990931301430707,0.0373501914614315,2,61,drug transmembrane transporter activity,MF,SLC7A11;SLC38A2
18779,GO:1904356,0.991081859122419,0.0369068320465668,2,58,regulation of telomere maintenance via telomere lengthening,BP,ATM;HMBOX1
13086,GO:0051649,0.991416672004144,0.0109023142391303,150,1668,establishment of localization in cell,BP,SYT8;TXNIP;F2R;ANO1;PKD2;JPH2;COL7A1;CLTCL1;NOS1;GAS6;TCAF1;SPTB;SLC8A1;STON2;TOM1L2;NTSR1;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;NEFL;SORL1;TP53;PRICKLE1;DDIT3;IFIT1;HIP1;TFDP2;EVI5L;SNX1;GLI3;TBC1D5;SYN1;SPG11;FYN;B3GAT3;FUT10;CAV1;PLA2G6;SEL1L;SNX33;CLU;PRKCZ;EHD3;CAMK2D;GOLGB1;SYTL1;PTPN14;SYT1;HHAT;TMEM173;CREB3L2;CPT1A;ACACB;PCLO;KIF17;BBS2;HERPUD1;ANK3;SPRY2;HPS4;TP73;IFT140;STOM;SNCA;AIP;SH3TC2;PRKAB2;SEC24D;PDE4D;TMEM129;BBS4;CALR;ATM;COPG2;MDM2;ARF6;TMED10;AREG;AKAP13;DNAJC6;TRAK1;SYNE2;PTPN1;ARHGEF2;KLHL12;LYST;IFT27;BCL6;TMEM50B;ANXA2;RGS14;RAB13;SEPT5;PGAP1;IFT88;MVB12B;RPL13A;NLGN4Y;ATXN1;RAB43;WDR19;PRNP;VPS39;IFT122;C2CD4C;SP100;RHBDD1;MAGI2;TH;GOPC;CENPA;PIKFYVE;REEP2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;FHOD1;IFT74;OPHN1;LMF1;GDNF;DERL3;KCNIP3;SNX9;ICK;TBC1D16;ARL3;MIA3;COG3;RASSF9;ABCA2;PRKAG1;EFNA5;MPPE1;PPP3CA;PEX1;COX18;DNM1P46;VPS36;RHOBTB3;EPG5;MYO1C;C2CD5;CPT2;EDEM1
17512,GO:1901068,0.991468804881029,0.0514377149055739,1,46,guanosine-containing compound metabolic process,BP,DLG4
8249,GO:0033044,0.991506077873378,0.0150411509747059,20,279,regulation of chromosome organization,BP,NOS1;SNAI2;TADA3;TP53;MTHFR;RMI2;SDR16C5;CAMK2D;UHRF2;JARID2;PHF2;SNCA;KDM4C;ATM;ISL1;BCL6;HMBOX1;KDM4A;KLHL22;NIPBL
11451,GO:0045931,0.991633041198937,0.0215251322439342,6,114,positive regulation of mitotic cell cycle,BP,FGFR1;PBX1;MDM2;MEIS2;PRKCA;NIPBL
18319,GO:1903313,0.99169016993004,0.0348191708116221,2,56,positive regulation of mRNA metabolic process,BP,ZFP36L1;ZFP36L2
8890,GO:0034728,0.991715600580379,0.0226502278393367,5,140,nucleosome organization,BP,SOX9;TSPYL2;TSPYL4;CENPA;HP1BP3
6625,GO:0022904,0.991741739444907,0.0339751138695976,2,94,respiratory electron transport chain,BP,D2HGDH;SNCA
3302,GO:0007005,0.991755282331806,0.0131944641779621,31,484,mitochondrion organization,BP,MMP9;IFIT2;TP53;PYCARD;TFDP2;GPX1;IFI6;PLA2G6;CLU;ADGRG6;CCK;HHAT;HPS4;TP73;SNCA;AIP;LMNA;SPATA18;IDH2;GCLC;ACSS2;TRAK1;PRIMPOL;STAT2;PIKFYVE;VPS13C;INF2;MEF2A;COX18;DNM1P46;ACAA2
18277,GO:1903214,0.991842581676674,0.0340072521765724,2,67,regulation of protein targeting to mitochondrion,BP,HHAT;HPS4
13260,GO:0051983,0.991933721968945,0.0245123342942786,4,88,regulation of chromosome segregation,BP,RMI2;ATM;KLHL22;NIPBL
11884,GO:0046939,0.991975869046282,0.0243458064053518,4,93,nucleotide phosphorylation,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
10765,GO:0044248,0.992019674465029,0.0101154734544122,156,1794,cellular catabolic process,BP,SULT1E1;PYGB;PRODH;ZFP36L1;DDIT4;ITGB4;IRS2;ZFP36L2;IGF2BP2;ANPEP;SKP2;NOS1;SESN3;RNF213;RNF165;VIM;CSPG4;TKFC;TIMP2;APOBEC3C;NR1D1;ABTB1;EIF2AK4;TRIM5;BTBD2;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;PYCARD;ZCCHC11;TIMP1;BCKDHB;PNRC1;CUL7;LIX1L;TYSND1;GPX1;TBC1D5;ECH1;SRPX;SESN1;CTSV;LRP1;XDH;CPS1;CAV1;TRIB2;SEL1L;GLDC;SNX33;CLU;OAS2;FBXW4;ULK2;TP53INP1;PRDX5;HIBADH;ALDH3A2;CPT1A;ACACB;APOBEC3G;HERPUD1;WFS1;PHKA2;CIRBP;CAT;DAPK1;CHEK2;FBXL7;SNCA;ADAMTS7;ALDH1L2;APOBEC3F;PRKAB2;PDE4D;TMEM129;PSMB9;SPATA18;DHTKD1;MAGEF1;LRTOMT;ATM;MDM2;CST3;MANBA;GCLC;HEXA;LZTS1;RNPEP;PTPN1;ALDH4A1;THNSL2;ENPP1;NCOR1;PRKCA;ANXA2;RNF24;LEPR;IFT88;MVB12B;ANAPC16;RPL13A;DECR1;GGT7;VPS39;DNASE1L1;SMG9;USP28;ALDH7A1;ULK1;RHBDD1;HSPA5;PIKFYVE;TGFB1I1;UVRAG;VPS13C;OPHN1;GDNF;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;SNX9;PTPN3;DNAJC3;TMEM67;PRKAG1;TAF1;GSTZ1;DPYD;PIK3C2B;DNPH1;KDM4A;CDK5RAP3;AIG1;AGO4;SCPEP1;EHHADH;ABAT;FBXL4;UGGT2;VPS36;RNPEPL1;ATG16L2;EPG5;CPT2;EDEM1;GID4;ACAA2;CTSD;ZNRF1
16840,GO:0098800,0.992093817674808,0.0326889890814528,2,99,inner mitochondrial membrane protein complex,CC,SNCA;NDUFA4L2
3319,GO:0007029,0.99267891638683,0.0455348708624716,1,43,endoplasmic reticulum organization,BP,REEP2
851,GO:0002181,0.992687222878638,0.030718932201926,2,85,cytoplasmic translation,BP,RPL13A;UNK
9994,GO:0042440,0.992695141719839,0.0452640942290193,1,47,pigment metabolic process,BP,TMEM14C
14462,GO:0061912,0.992702971968928,0.0455205854848414,1,41,selective autophagy,BP,VPS13C
10270,GO:0043039,0.992795312506217,0.0445626940931455,1,52,tRNA aminoacylation,BP,AARS
12860,GO:0051225,0.99291606887555,0.0199301788783473,5,100,spindle assembly,BP,HAUS4;CHEK2;NCOR1;GOLGA8B;GOLGA8N
8642,GO:0034212,0.992940413673364,0.0302132589312849,2,60,peptide N-acetyltransferase activity,MF,TADA3;TAF1
16915,GO:0098927,0.993151749534966,0.043213371792195,1,41,vesicle-mediated transport between endosomal compartments,BP,SORL1
6600,GO:0022804,0.993252453811271,0.0136479412180758,13,200,active transmembrane transporter activity,MF,SLC7A8;SLC8A1;SLC20A1;ABCA1;SLC7A11;SLC22A17;SLC38A2;SLC24A1;ABCC2;SLC9A4;ABCA2;ANKH;ABCA5
4179,GO:0009260,0.993280723162551,0.0146970119975502,10,184,ribonucleotide biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;DHTKD1;NCOR1;PRPS2;GPR161;PRKAG1;PPCS
17803,GO:1901989,0.993404230466286,0.0283903607741497,2,66,positive regulation of cell cycle phase transition,BP,PBX1;MDM2
93,GO:0000184,0.99349055581113,0.0227204479093287,3,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PNRC1;RPL13A;SMG9
10269,GO:0043038,0.993585701635244,0.0404660385022456,1,53,amino acid activation,BP,AARS
6597,GO:0022626,0.993594959985946,0.0272215468322729,2,110,cytosolic ribosome,CC,EIF2AK4;RPL13A
5065,GO:0015293,0.993623533657884,0.0226812119313977,3,75,symporter activity,MF,SLC20A1;SLC38A2;SLC24A1
4327,GO:0009880,0.993631736090938,0.0410106908647493,1,36,embryonic pattern specification,BP,PGAP1
2483,GO:0005730,0.993670815682524,0.00899983265292748,65,835,nucleolus,CC,GPRC5A;SYNE1;XPC;SKP2;RNF213;STON2;CBX5;ABTB1;STAT1;TP53;PYCARD;ZCCHC11;MAP2;ADARB1;DOCK4;CHD3;ABHD14B;MAGED2;SESN1;CTSV;SPG11;CPS1;GLI2;ERCC6;MAP3K14;ANG;CIRBP;PHF2;FGFR1;RGS2;SETX;PDK3;L3MBTL3;ATM;MDM2;ZMAT3;TRERF1;HLTF;RPL13A;PODXL;PAK6;ATXN1;CARF;RBL2;LIPA;TSPYL2;ORC4;RSAD2;SRPK2;MDFIC;YPEL4;POLD4;SAP30L;TWIST2;CAPG;ICK;FKBP10;TAF1;ETV4;KDM4A;CDK5RAP3;PRDM5;MYO1C;CPT2;NFKBIE
4074,GO:0009132,0.993704996834575,0.0178723533569746,5,110,nucleoside diphosphate metabolic process,BP,DDIT4;DLG4;DHTKD1;NCOR1;PRKAG1
12982,GO:0051438,0.99376648262436,0.0396912509653638,1,48,regulation of ubiquitin-protein transferase activity,BP,ZYG11B
3301,GO:0007004,0.993859316648182,0.0267422791222422,2,64,telomere maintenance via telomerase,BP,ATM;HMBOX1
5390,GO:0016233,0.993907427741324,0.0388453526756493,1,51,telomere capping,BP,ATM
15790,GO:0072522,0.993975655149627,0.0132934166457756,10,186,purine-containing compound biosynthetic process,BP,DDIT4;NOS1;DCAKD;TIMP2;DHTKD1;NCOR1;PRPS2;GPR161;PRKAG1;PPCS
18248,GO:1903146,0.994050150805236,0.0383537620996469,1,44,regulation of autophagy of mitochondrion,BP,VPS13C
3152,GO:0006754,0.994095897498215,0.0185481317206164,4,96,ATP biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
4964,GO:0015078,0.99412680661928,0.0255730541855804,2,75,proton transmembrane transporter activity,MF,NDUFA4L2;SLC9A4
4247,GO:0009451,0.994173731149422,0.0165738672301953,5,132,RNA modification,BP,APOBEC3C;ADARB1;APOBEC3G;AARS;APOBEC3F
4475,GO:0010494,0.994186541586083,0.0378165952447102,1,40,cytoplasmic stress granule,CC,CIRBP
7847,GO:0032418,0.994194018244811,0.0374297089648795,1,48,lysosome localization,BP,MAP6
10256,GO:0043022,0.994375246967158,0.0364967777203472,1,47,ribosome binding,MF,HSPA5
14114,GO:0061013,0.994600587965673,0.0129771357977514,8,160,regulation of mRNA catabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;CIRBP;PSMB9;PRKCA;GDNF
12511,GO:0050684,0.994629873984106,0.0170336538070628,4,99,regulation of mRNA processing,BP,ZFP36L1;MBNL2;RBFOX2;SRPK2
13152,GO:0051785,0.994654452015234,0.035104938328149,1,44,positive regulation of nuclear division,BP,NIPBL
5496,GO:0016445,0.994706666022636,0.0347810987201262,1,45,somatic diversification of immunoglobulins,BP,BCL6
12912,GO:0051298,0.994824891069724,0.0231457708478687,2,61,centrosome duplication,BP,PKD2;TMEM67
4070,GO:0009127,0.994919711069289,0.0147257469150189,5,116,purine nucleoside monophosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRPS2;PRKAG1
4109,GO:0009168,0.994919711069289,0.0147257469150189,5,116,purine ribonucleoside monophosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRPS2;PRKAG1
17575,GO:1901264,0.994936104454366,0.0332200289809534,1,55,carbohydrate derivative transport,BP,G6PC3
3052,GO:0006614,0.994998732433203,0.0323467270286341,1,91,SRP-dependent cotranslational protein targeting to membrane,BP,RPL13A
10886,GO:0044452,0.995050211213267,0.0119811199981524,8,163,nucleolar part,CC,SESN1;MAP3K14;PAK6;LIPA;RSAD2;ICK;KDM4A;NFKBIE
8842,GO:0034654,0.995265772598608,0.00574774173343422,321,3378,nucleobase-containing compound biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
11118,GO:0045184,0.995470614434797,0.00591580647325249,136,1586,establishment of protein localization,BP,ITGB6;FN1;TXNIP;SFRP1;F2R;ANO1;GJA5;IRS2;CLTCL1;GAS6;TCAF1;EGFR;SYNE3;TOM1L2;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;SORL1;TP53;PRICKLE1;DDIT3;PYCARD;IFIT1;DLG4;ITGA2;ACSL3;HIP1;TFDP2;EVI5L;SNX1;GLI3;TBC1D5;LRP1;FYN;B3GAT3;FUT10;PLA2G6;SEL1L;SNX33;CLU;PRKCZ;EHD3;SYTL1;PTPN14;EHBP1;PDIA4;HHAT;TMEM173;CPT1A;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;TTN;HPS4;TP73;BTN3A1;STOM;AIP;SH3TC2;ALOX15B;SEC24D;C5;ASTN2;TMEM129;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;PTPN1;ARHGEF2;LYST;IFT27;ISL1;BCL6;TMEM50B;PRKCA;RAB13;PGAP1;MVB12B;TTC8;RPL13A;RAB43;PRNP;TGFB2;VPS39;IFT122;SP100;RHBDD1;AGAP1;GOPC;SNX7;REEP2;RSAD2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;DERL3;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;POSTN;ARL3;MIA3;COG3;RASSF9;EFNA5;PPP3CA;PEX1;COX18;ABAT;NIPBL;VPS36;ATG16L2;MYO1C;C2CD5;EDEM1
8919,GO:0034968,0.99555740230783,0.0144600583990276,4,89,histone lysine methylation,BP,JARID2;KDM4C;KDM4A;PRDM5
4954,GO:0015031,0.995596862915938,0.00579432350889072,128,1505,protein transport,BP,ITGB6;FN1;TXNIP;SFRP1;F2R;ANO1;GJA5;IRS2;CLTCL1;GAS6;TCAF1;EGFR;TOM1L2;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;SORL1;TP53;PRICKLE1;PYCARD;IFIT1;ACSL3;HIP1;EVI5L;SNX1;GLI3;TBC1D5;LRP1;FYN;B3GAT3;FUT10;PLA2G6;SEL1L;SNX33;CLU;PRKCZ;EHD3;SYTL1;PTPN14;EHBP1;PDIA4;HHAT;TMEM173;CPT1A;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;TTN;HPS4;BTN3A1;STOM;AIP;SH3TC2;ALOX15B;SEC24D;C5;ASTN2;TMEM129;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;PTPN1;ARHGEF2;LYST;IFT27;ISL1;BCL6;TMEM50B;PRKCA;RAB13;PGAP1;MVB12B;TTC8;RPL13A;RAB43;PRNP;TGFB2;VPS39;SP100;RHBDD1;AGAP1;GOPC;SNX7;REEP2;RSAD2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;DERL3;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;POSTN;ARL3;MIA3;COG3;RASSF9;EFNA5;PPP3CA;PEX1;COX18;ABAT;VPS36;ATG16L2;MYO1C;C2CD5;EDEM1
18482,GO:1903670,0.995602230444386,0.0298907351411519,1,43,regulation of sprouting angiogenesis,BP,MAP2K5
14359,GO:0061630,0.995655570905043,0.00929776512567536,12,197,ubiquitin protein ligase activity,MF,HERC5;SKP2;RNF165;UHRF2;TMEM129;MDM2;HLTF;RNF24;RNF144B;MED12;GID4;ZNRF1
18027,GO:1902600,0.995664108426147,0.019625053046699,2,82,proton transmembrane transport,BP,NDUFA4L2;SLC9A4
10164,GO:0042775,0.9956772274049,0.028741500653462,1,79,mitochondrial ATP synthesis coupled electron transport,BP,SNCA
3045,GO:0006605,0.995745759795626,0.00781939036366683,20,366,protein targeting,BP,TCAF1;PAK1;SORL1;FYN;FUT10;CLU;HHAT;ANK3;HPS4;STOM;AIP;TRAK1;TMEM50B;RPL13A;PRNP;VPS13C;RASSF9;PEX1;MYO1C;C2CD5
2834,GO:0006305,0.995783600881822,0.0288241785801829,1,44,DNA alkylation,BP,FOS
2835,GO:0006306,0.995783600881822,0.0288241785801829,1,44,DNA methylation,BP,FOS
3594,GO:0008023,0.995798243449808,0.0286733070820319,1,46,transcription elongation factor complex,CC,ERCC6
8785,GO:0034502,0.995825833632088,0.0190887555128656,2,72,protein localization to chromosome,BP,CENPA;NIPBL
7156,GO:0031047,0.995868397559337,0.0106627833518575,7,155,gene silencing by RNA,BP,EGFR;BMP4;ZCCHC11;NCOR1;PPARG;PPP3CA;AGO4
4063,GO:0009117,0.996052922177211,0.00661326318088961,30,474,nucleotide metabolic process,BP,SULT1E1;DDIT4;PKD2;H6PD;NOS1;DCAKD;TIMP2;TP53I3;DLG4;GPX1;ABHD14B;KCNAB2;NMRK1;XDH;SNCA;PDE4D;G6PD;DHTKD1;IDH2;ENPP1;NCOR1;PRPS2;NMNAT2;GPR161;NPHP3;NAPRT;TPST1;PRKAG1;PPCS;DNPH1
8394,GO:0033365,0.99607355876734,0.00586291266868595,54,729,protein localization to organelle,BP,TXNIP;SYNE1;GAS6;BMP4;SORL1;TP53;CEP250;PRICKLE1;DDIT3;TFDP2;GLI3;FYN;CLU;GOLGB1;HHAT;TMEM173;BBS2;CNTLN;HPS4;TP73;IFT140;AIP;LMNA;OBSCN;BBS4;CALR;MDM2;ARF6;BBS1;SNX10;NEURL1B;SYNE2;SOX9;BCL6;TMEM50B;CEP68;RPL13A;TAF8;IFT122;SP100;HSPA5;CENPA;PIKFYVE;MDFIC;VPS13C;OBSL1;COG3;PPP3CA;PEX1;COX18;CDK5RAP3;NIPBL;VPS36;TTBK2
10162,GO:0042773,0.996081266115174,0.0264592270925163,1,80,ATP synthesis coupled electron transport,BP,SNCA
15448,GO:0071824,0.996275563274145,0.0082319459275807,11,238,protein-DNA complex subunit organization,BP,XPC;DDB2;TP53;TCF4;SOX9;THRA;TSPYL2;TSPYL4;CENPA;TAF1;HP1BP3
4141,GO:0009206,0.996325053287399,0.0121281149249696,4,105,purine ribonucleoside triphosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
15789,GO:0072521,0.99633389832833,0.006499978782191,24,393,purine-containing compound metabolic process,BP,SULT1E1;DDIT4;PKD2;NOS1;DCAKD;TIMP2;DLG4;GPX1;ABHD14B;XDH;SNCA;OARD1;PDE4D;DHTKD1;ENPP1;NCOR1;PRPS2;GPR161;NPHP3;TPST1;PRKAG1;DPYD;PPCS;DNPH1
10868,GO:0044429,0.996339105773667,0.00546815488911017,54,850,mitochondrial part,CC,PRODH;TXNIP;FAM210B;NR3C1;D2HGDH;TP53;SLC27A3;ACSL3;BCKDHB;GPX1;CPS1;GLDC;ACSS1;CLU;PRDX5;HIBADH;TMEM173;ALDH3A2;CPT1A;ACACB;CAT;BPHL;SNCA;ALDH1L2;VAMP1;NIPSNAP1;ARMCX2;SPATA18;PDK3;DHTKD1;IDH2;TMEM14C;ACSS2;NDUFA4L2;ALDH4A1;SLC25A35;PRKCA;PRIMPOL;DECR1;ACSF2;SFXN3;ALDH7A1;ULK1;RSAD2;VPS13C;RNF144B;LGALS3;COX18;DNM1P46;ABAT;FBXL4;CPT2;ACAA2;DMPK
331,GO:0000922,0.996343563504346,0.00956959121015463,7,142,spindle pole,CC,EFHC1;TTC28;RGS14;ODF2;OR2A4;BEX4;KLHL22
18108,GO:1902850,0.99637265182863,0.0101156321743292,6,122,microtubule cytoskeleton organization involved in mitosis,BP,CEP126;EFHC1;SPRY2;CHEK2;ARHGEF2;CENPA
257,GO:0000724,0.996420528802814,0.0118650500864242,4,101,double-strand break repair via homologous recombination,BP,MAGEF1;ATM;CXORF57;NIPBL
5556,GO:0016574,0.996456623925511,0.0248943816248192,1,45,histone ubiquitination,BP,DDB2
5220,GO:0015833,0.996496820256127,0.00463561087260625,129,1523,peptide transport,BP,ITGB6;FN1;TXNIP;SFRP1;F2R;ANO1;GJA5;IRS2;CLTCL1;GAS6;TCAF1;EGFR;TOM1L2;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;SORL1;TP53;PRICKLE1;PYCARD;IFIT1;ACSL3;HIP1;EVI5L;SNX1;GLI3;TBC1D5;LRP1;FYN;B3GAT3;LTBP4;FUT10;PLA2G6;SEL1L;SNX33;CLU;PRKCZ;EHD3;SYTL1;PTPN14;EHBP1;PDIA4;HHAT;TMEM173;CPT1A;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;TTN;HPS4;BTN3A1;STOM;AIP;SH3TC2;ALOX15B;SEC24D;C5;ASTN2;TMEM129;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;PTPN1;ARHGEF2;LYST;IFT27;ISL1;BCL6;TMEM50B;PRKCA;RAB13;PGAP1;MVB12B;TTC8;RPL13A;RAB43;PRNP;TGFB2;VPS39;SP100;RHBDD1;AGAP1;GOPC;SNX7;REEP2;RSAD2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;DERL3;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;POSTN;ARL3;MIA3;COG3;RASSF9;EFNA5;PPP3CA;PEX1;COX18;ABAT;VPS36;ATG16L2;MYO1C;C2CD5;EDEM1
4087,GO:0009145,0.996549834427081,0.0114594845098734,4,106,purine nucleoside triphosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
272,GO:0000775,0.996562919088405,0.00823165800824188,9,173,chromosome, centromeric region,CC,CBX5;NCAPD2;PHF2;KDM4C;SEPT6;ANAPC16;CENPA;UVRAG;KDM4A
3151,GO:0006753,0.996673460899684,0.00562088869573854,30,479,nucleoside phosphate metabolic process,BP,SULT1E1;DDIT4;PKD2;H6PD;NOS1;DCAKD;TIMP2;TP53I3;DLG4;GPX1;ABHD14B;KCNAB2;NMRK1;XDH;SNCA;PDE4D;G6PD;DHTKD1;IDH2;ENPP1;NCOR1;PRPS2;NMNAT2;GPR161;NPHP3;NAPRT;TPST1;PRKAG1;PPCS;DNPH1
258,GO:0000725,0.996680147922453,0.0110892132072453,4,102,recombinational repair,BP,MAGEF1;ATM;CXORF57;NIPBL
3283,GO:0006974,0.996697942862171,0.0049347543308989,56,739,cellular response to DNA damage stimulus,BP,DDIT4;XPC;SNAI2;EGFR;NUPR1;DDB2;EIF2AK4;VAV3;TP53;DDIT3;PYCARD;TFDP2;E2F7;RMI2;ERCC6;MAP3K14;CLU;PARP4;HMGA2;PIK3R1;MLH3;TP73;CASP14;CHEK2;SETX;SPATA18;PLA2R1;NFATC4;MAGEF1;FOXN3;ATM;MDM2;ZMAT3;MSH5;BCL6;NDRG1;PRIMPOL;CXORF57;MUTYH;RBL2;LIG1;USP28;SP100;UVRAG;POLD4;YAP1;UBA7;ING4;POLH;TAF1;ZBTB1;CDK5RAP3;FAM168A;NPAS2;NIPBL;TAOK3
14372,GO:0061659,0.996721983105717,0.00715673962652313,12,202,ubiquitin-like protein ligase activity,MF,HERC5;SKP2;RNF165;UHRF2;TMEM129;MDM2;HLTF;RNF24;RNF144B;MED12;GID4;ZNRF1
10889,GO:0044455,0.996733892423047,0.00978536612749944,5,166,mitochondrial membrane part,CC,CPT1A;SNCA;NDUFA4L2;COX18;DMPK
10894,GO:0044464,0.996736831326329,0.00447057880403583,1135,11074,cell part,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;TMEM204;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;CEP126;SLC8A1;NTM;FKBP5;CLCA2;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;LPAR5;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;CNTNAP3;LGALS9C;FAM210B;MAMDC2;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;TCP11L1;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;FRMD4B;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;CPED1;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;SLC22A15;WDR66;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;CHST3;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;SLC38A2;CALHM2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;LRIG3;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;C5;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;CD99L2;FOXN3;ITGBL1;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;ACSS2;ELMO3;FHOD3;HEXA;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;IFI44;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;CSMD2;FGD4;NEMP2;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;ARHGEF2;DNAL4;FAM117A;NTNG1;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;ZNF546;KRT222;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;ADAMTS15;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;IFITM2;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;XG;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;MPRIP;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;SLC9A4;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;SEMA4B;ITGB8;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;NBPF15;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DEF6;DNAJC3;NYAP1;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TRIM16L;TSHZ3;EFNA5;CEP85L;GSTZ1;FZD4;MPPE1;SLITRK5;ZNF883;WIPF1;HCFC1R1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM169A;CLEC2D;FAM120B;CACNA2D3;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;ANKS6;TSPAN4;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
5755,GO:0016925,0.996831503571843,0.0122075135308935,3,85,protein sumoylation,BP,PIAS3;MDM2;EGR1
10866,GO:0044427,0.996844092366009,0.00469505013451081,58,770,chromosomal part,CC,TRNP1;SNAI2;MAGED1;HSPA2;CBX5;NR1D1;SMARCA2;STAT1;TP53;MEF2D;TEP1;CHD3;SYN1;POLR3GL;HLCS;SMARCA1;TNRC18;SDR16C5;HMGA2;PHC2;NCAPD2;UHRF2;MLH3;TP73;CHEK2;PHF2;SETX;KDM4C;SEPT6;ATM;C17ORF49;TCF4;CITED2;CBX7;MSH5;MAF;BCL6;NCOR1;SALL2;CXORF57;BAHCC1;TCF12;HMBOX1;ANAPC16;RBL2;CDKN2A;SP100;ORC4;CENPA;UVRAG;POLD4;MEF2A;RARA;TAF1;HP1BP3;KDM4A;NIPBL;RXRA
273,GO:0000776,0.996888821072179,0.009461847749804,5,121,kinetochore,CC,CBX5;PHF2;SEPT6;ANAPC16;CENPA
10773,GO:0044265,0.99694592896365,0.00436282602720187,75,960,cellular macromolecule catabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;SKP2;RNF213;RNF165;VIM;NR1D1;ABTB1;BTBD2;CPVL;TP53;WWTR1;PRICKLE1;DDIT3;CUL9;ZCCHC11;PNRC1;CUL7;GPX1;CTSV;LRP1;CAV1;TRIB2;SEL1L;CLU;OAS2;FBXW4;HERPUD1;WFS1;CIRBP;CHEK2;FBXL7;ADAMTS7;TMEM129;PSMB9;SPATA18;MAGEF1;ATM;MDM2;CST3;MANBA;GCLC;PRKCA;ANXA2;RNF24;MVB12B;ANAPC16;RPL13A;DNASE1L1;SMG9;USP28;RHBDD1;HSPA5;TGFB1I1;OPHN1;GDNF;NUB1;KLHL3;ATRAID;UBA7;DERL3;RNF144B;DNAJC3;TMEM67;TAF1;CDK5RAP3;AGO4;SCPEP1;FBXL4;UGGT2;VPS36;EDEM1;GID4;ZNRF1
17611,GO:1901361,0.996949881141687,0.00494359466917635,37,569,organic cyclic compound catabolic process,BP,SULT1E1;PRODH;ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;VIM;APOBEC3C;ZCCHC11;PNRC1;GPX1;XDH;OAS2;APOBEC3G;CIRBP;ALDH1L2;APOBEC3F;PDE4D;PSMB9;DHTKD1;LRTOMT;ATM;HSD17B11;ALDH4A1;ENPP1;NCOR1;PRKCA;TRERF1;RPL13A;DNASE1L1;SMG9;GDNF;PRKAG1;GSTZ1;DPYD;DNPH1;AGO4
2750,GO:0006163,0.99703550708004,0.00543560659512918,22,372,purine nucleotide metabolic process,BP,SULT1E1;DDIT4;PKD2;NOS1;DCAKD;TIMP2;DLG4;GPX1;ABHD14B;XDH;SNCA;PDE4D;DHTKD1;ENPP1;NCOR1;PRPS2;GPR161;NPHP3;TPST1;PRKAG1;PPCS;DNPH1
5902,GO:0018130,0.99706851424594,0.00359251431984471,323,3427,heterocycle biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;ADIRF;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;MEIS2;TMEM14C;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
6143,GO:0019438,0.99707486741503,0.00358490507013633,323,3424,aromatic compound biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;MEIS2;TMEM14C;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TH;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
3202,GO:0006839,0.997111595512623,0.00632373285609313,12,249,mitochondrial transport,BP,TP53;TFDP2;HHAT;CPT1A;ACACB;HPS4;TP73;AIP;PRKAB2;SLC25A35;CPT2;ACAA2
5878,GO:0018022,0.997139355070315,0.00973722858838494,4,95,peptidyl-lysine methylation,BP,JARID2;KDM4C;KDM4A;PRDM5
2431,GO:0005623,0.997232167017345,0.0038130135177954,1135,11079,cell,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;SLITRK6;PTGS1;ITGB4;ADAMTSL1;TENM4;ASAP3;IL20RB;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;GJA5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;APCDD1;DNMBP;PDGFC;SNAI2;MAGED1;TCAF1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;TMEM204;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;CEP126;SLC8A1;NTM;FKBP5;CLCA2;DOCK5;SESN3;MYLK;SYNE3;CSMD3;GJC2;SLC20A1;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;LPAR5;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;CNTNAP3;LGALS9C;FAM210B;MAMDC2;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;TCP11L1;SLC7A11;SEMA5A;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MAP2;FRMD4B;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;CPED1;TTC28;KLF12;EMP1;IFIT3;KLF9;PCDHAC2;SLC22A15;WDR66;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;ASAP1;ERO1B;PLLP;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;EMP3;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;ITGA10;SEL1L;SPATA6;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;DCBLD2;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;GPR39;KCNJ15;ARPIN;TNS2;CHST3;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;CCK;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;SLC38A2;CALHM2;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UNC5B;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;S1PR5;BTN3A1;PRKACB;AARS;CHEK2;BACE1;ROBO1;KCNJ5;WDFY2;IFT140;SPRY4;LRIG3;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;PAQR7;NIPSNAP1;SH3TC2;PLXNA2;SP110;COL16A1;PTPRU;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;C5;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;TRO;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;SLC24A1;AFAP1L2;CHD6;CDH13;NFATC4;CD99L2;FOXN3;ITGBL1;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;FZD1;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;NEGR1;ATM;EFNB3;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;GCLC;NR2F2;PLXNA1;ACSS2;ELMO3;FHOD3;HEXA;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;IFI44;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;CSMD2;FGD4;NEMP2;PTPN1;POGLUT1;KCNQ3;CRIP2;VANGL2;ARHGEF2;DNAL4;FAM117A;NTNG1;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;ZNF546;KRT222;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;PCDHGA11;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;ADAMTS15;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;IFITM2;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;NLGN4Y;UACA;ATXN1;ACSF2;XG;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;MPRIP;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;BTN3A3;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;SLC9A4;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;SEMA4B;ITGB8;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;IFITM1;ZNF12;TACC2;OPHN1;TPGS1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;CACNB1;GDNF;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;NBPF15;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;SHISA9;ICK;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;TSPAN18;DEF6;DNAJC3;NYAP1;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TRIM16L;TSHZ3;EFNA5;CEP85L;GSTZ1;FZD4;MPPE1;SLITRK5;ZNF883;WIPF1;HCFC1R1;ADGRA2;ZBTB1;DPYD;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;ANKH;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM169A;CLEC2D;FAM120B;CACNA2D3;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADM2;KCNRG;BSN;PCDHGB5;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;ANKS6;TSPAN4;EPG5;S100A11;MYO1C;TUSC3;RXRA;ORAI2;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
1446,GO:0003677,0.997313689515128,0.00346610814529383,175,1911,DNA binding,MF,TRNP1;SOX6;ZFP36L1;XPC;ETV5;ZFP36L2;ZNF362;SNAI2;PHF21A;EGFR;KLF8;PEG10;RFX2;TCF7L1;NUPR1;DDB2;VDR;NR1D1;SMARCA2;NR3C1;STAT1;ETV1;TP53;DDIT3;ZBTB20;ZC3H6;MEF2D;DDX60;TFDP2;CHD3;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;ZFP90;TSHZ2;GLI2;RMI2;ERCC6;SLC2A4RG;SMARCA1;TNRC18;ZNF678;PARP4;HMGA2;PHC2;GOLGB1;PRDX5;ZSCAN18;PER1;CREB3L2;ANG;UHRF2;PRDM8;JARID2;APLP2;MLH3;ZKSCAN1;TP73;KLF13;ZNF860;SNCA;GATAD1;SP110;SETX;NCOA2;SETBP1;ZNF618;SOX13;CHD6;NFATC4;FOXN3;DLX3;PBX1;FOXL1;ZNF699;CALR;ATM;MEIS2;C17ORF49;ZNF107;TCF4;NR2F2;LMO4;ZNF449;MSH5;MAF;LZTS1;ZBTB22;ZNF546;EGR1;SOX9;ISL1;BCL6;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;HLTF;HOXA1;CXORF57;BAHCC1;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;ZNF160;CHD9;ZNF302;ATXN1;MUTYH;CARF;ZFPM1;RBL2;DLX2;ZNF550;DNASE1L1;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;SP100;ZSCAN30;TEF;TSPYL2;ORC4;CENPA;FLYWCH1;SAP30L;ZNF12;YAP1;KLF5;TWIST2;HOXA3;ZNF558;MEIS3;PPARG;KCNIP3;MEF2A;CERS5;KLF7;TGIF1;RARA;HES2;POLH;HOXC5;PBX2;TAF1;TSHZ3;ZNF883;ZBTB1;NAT14;CREBRF;ETV4;HP1BP3;HOXA2;FOS;ZBTB25;MED12;NPAS2;PRDM5;ZNF471;LITAF;RXRA;ZNF484
15933,GO:0075733,0.997339568240004,0.0194103028066614,1,52,intracellular transport of virus,BP,MVB12B
3230,GO:0006886,0.997351582761536,0.00385058498279323,69,918,intracellular protein transport,BP,TXNIP;CLTCL1;GAS6;TCAF1;TOM1L2;PAK1;NSG1;BMP4;TBC1D8;SORL1;TP53;PRICKLE1;IFIT1;HIP1;EVI5L;SNX1;GLI3;TBC1D5;FYN;B3GAT3;FUT10;SEL1L;SNX33;CLU;SYTL1;PTPN14;HHAT;TMEM173;HERPUD1;ANK3;HPS4;STOM;AIP;SH3TC2;SEC24D;TMEM129;CALR;COPG2;MDM2;TMED10;TRAK1;PTPN1;ARHGEF2;IFT27;BCL6;TMEM50B;RAB13;RPL13A;RAB43;PRNP;VPS39;SP100;RHBDD1;REEP2;CCHCR1;MDFIC;VPS13C;DERL3;KCNIP3;SNX9;TBC1D16;COG3;RASSF9;PPP3CA;PEX1;VPS36;MYO1C;C2CD5;EDEM1
10255,GO:0043021,0.997366032377576,0.00898738326507915,4,110,ribonucleoprotein complex binding,MF,CBX5;RNF135;MDM2;HSPA5
10770,GO:0044260,0.997375340992633,0.00315098329949963,610,6224,cellular macromolecule metabolic process,BP,SERPINE2;PHACTR3;CPA4;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;ST6GALNAC2;GADD45B;CD109;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;ADAMTSL1;EFEMP1;MARCH4;GSN;ETV5;PKD2;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;GALNT10;TSC22D3;KLF8;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;MYLK;GJC2;RFX2;TRIM2;ZNF608;SERPINE1;SERPINH1;RNF213;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;PTK6;ABTB1;CITED4;EIF2AK4;TRIM5;NEFL;HSF2BP;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;ARAP1;EXTL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;FLG;HIP1;GPNMB;TFDP2;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;SNX1;GPX1;GLI3;CDK14;E2F7;CNTN1;KITLG;TBC1D5;P3H2;ERO1B;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;NEK9;CTSV;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;ADIRF;FUT10;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;XYLT1;UST;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;PRKCZ;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;EHD3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;APOBEC3G;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PHF2;TLR3;MAN1A1;ZNF860;FBXL7;SNCA;ADAMTS7;PDIA6;GATAD1;FZD7;GLG1;JADE2;SP110;PTPRU;FGFR1;IGF1R;APOBEC3F;DKK1;PRKAB2;CTF1;RGS2;C5;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;NEGR1;ATM;FBXO17;APH1B;MDM2;FAM20A;CST3;MEIS2;MANBA;AREG;IFNK;ZNF107;TCF4;AKAP13;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;HEXA;IFNE;NEURL1B;CBX7;LMO4;ZNF449;MSH5;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;KLHL12;SDC2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;MAN2B1;PGAP1;TSHZ1;IGFBP4;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;HTR1B;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;DSEL;SMG9;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;CDC42EP5;USP28;ITM2A;MAPK8IP3;MSRB2;TRIML2;CDKN2A;PPM1M;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;IGFBP2;ORC4;RHBDD1;MAGI2;HSPA5;CDK19;KLHL5;TGFB1I1;SRPK2;UVRAG;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;YAP1;GDNF;ALG10;NUB1;KLF5;TWIST2;KLHL3;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PPARG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;UNK;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;FZD4;MPPE1;ZNF883;ZBTB1;NAT14;PPP3CA;DCAF8;RASA1;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;FOS;DNM1P46;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;PPP2R3A;ZNF471;LITAF;S100A11;TUSC3;RXRA;EDEM1;GID4;TAOK3;NFKBIE;ZNF484;ZNRF1;DMPK;LAMB2
3051,GO:0006613,0.997387786220501,0.0186806457751064,1,96,cotranslational protein targeting to membrane,BP,RPL13A
2489,GO:0005740,0.997408564572953,0.00427217322415708,35,616,mitochondrial envelope,CC,PRODH;TXNIP;FAM210B;SLC27A3;ACSL3;CPS1;CLU;TMEM173;ALDH3A2;CPT1A;ACACB;CAT;BPHL;SNCA;VAMP1;NIPSNAP1;ARMCX2;SPATA18;IDH2;TMEM14C;NDUFA4L2;SLC25A35;PRKCA;SFXN3;ULK1;RSAD2;VPS13C;RNF144B;LGALS3;COX18;DNM1P46;FBXL4;CPT2;ACAA2;DMPK
3250,GO:0006913,0.997442547125398,0.0049319605849467,19,302,nucleocytoplasmic transport,BP,TXNIP;GAS6;BMP4;TP53;PRICKLE1;GLI3;PTPN14;TMEM173;CALR;MDM2;AKAP13;BCL6;RGS14;ATXN1;SP100;CCHCR1;MDFIC;PRKAG1;PPP3CA
5553,GO:0016571,0.997463712370059,0.00789599582603258,5,111,histone methylation,BP,MTHFR;JARID2;KDM4C;KDM4A;PRDM5
4098,GO:0009156,0.99759293435965,0.00749044352063671,5,127,ribonucleoside monophosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRPS2;PRKAG1
16621,GO:0097525,0.997599029718746,0.0176495945169807,1,62,spliceosomal snRNP complex,CC,TEP1
5550,GO:0016567,0.997606871799111,0.00364560893562623,54,709,protein ubiquitination,BP,MARCH4;HERC5;SKP2;TRIM2;RNF213;RNF165;DDB2;TRIM38;TRIM5;WWTR1;PRICKLE1;CUL9;CUL7;FYN;CAV1;RNF135;DCAF16;FBXW4;UHRF2;HERPUD1;WFS1;LMO7;FBXL7;JADE2;TMEM129;PSMB9;MAGEF1;IPP;FBXO17;MDM2;GCLC;NEURL1B;FBXW8;KLHL12;HLTF;RNF24;ANAPC16;TRIML2;HSPA5;KLHL5;NUB1;KLHL3;UBA7;RNF144B;SASH1;ZYG11B;TAF1;DCAF8;KLHL22;CDK5RAP3;MED12;FBXL4;GID4;ZNRF1
10201,GO:0042886,0.997647363343421,0.00314705112675183,129,1537,amide transport,BP,ITGB6;FN1;TXNIP;SFRP1;F2R;ANO1;GJA5;IRS2;CLTCL1;GAS6;TCAF1;EGFR;TOM1L2;PAK1;ABCA1;NSG1;BMP4;NR1D1;TBC1D8;SORL1;TP53;PRICKLE1;PYCARD;IFIT1;ACSL3;HIP1;EVI5L;SNX1;GLI3;TBC1D5;LRP1;FYN;B3GAT3;LTBP4;FUT10;PLA2G6;SEL1L;SNX33;CLU;PRKCZ;EHD3;SYTL1;PTPN14;EHBP1;PDIA4;HHAT;TMEM173;CPT1A;PCLO;ANG;KIF17;BBS2;HERPUD1;ANK3;TTN;HPS4;BTN3A1;STOM;AIP;SH3TC2;ALOX15B;SEC24D;C5;ASTN2;TMEM129;LRTOMT;BBS4;CALR;IDH2;COPG2;MDM2;ARF6;TMED10;BBS1;SNX10;NEURL1B;ZMAT3;TRAK1;PTPN1;ARHGEF2;LYST;IFT27;ISL1;BCL6;TMEM50B;PRKCA;RAB13;PGAP1;MVB12B;TTC8;RPL13A;RAB43;PRNP;TGFB2;VPS39;SP100;RHBDD1;AGAP1;GOPC;SNX7;REEP2;RSAD2;CCHCR1;MON2;ITPR2;MDFIC;VPS13C;LMF1;DERL3;PPARG;CALCRL;KCNIP3;SNX9;TBC1D16;POSTN;ARL3;MIA3;COG3;RASSF9;EFNA5;PPP3CA;PEX1;COX18;ABAT;VPS36;ATG16L2;MYO1C;C2CD5;EDEM1
2901,GO:0006413,0.997685021257537,0.00663107705496316,6,186,translational initiation,BP,EIF2AK4;PAIP2B;RPL13A;DNAJC3;RARA;RXRA
2577,GO:0005871,0.997691037762007,0.0173768118406709,1,44,kinesin complex,CC,KIF17
4136,GO:0009201,0.997745636150137,0.00781298550955007,4,111,ribonucleoside triphosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
12824,GO:0051169,0.997749290393964,0.00437185672858884,19,305,nuclear transport,BP,TXNIP;GAS6;BMP4;TP53;PRICKLE1;GLI3;PTPN14;TMEM173;CALR;MDM2;AKAP13;BCL6;RGS14;ATXN1;SP100;CCHCR1;MDFIC;PRKAG1;PPP3CA
4680,GO:0010833,0.997790257995083,0.0109648947514867,2,74,telomere maintenance via telomere lengthening,BP,ATM;HMBOX1
14519,GO:0070063,0.997866898857132,0.0160788800684792,1,53,RNA polymerase binding,MF,STOM
15843,GO:0072594,0.997872482947317,0.00376560163817123,27,460,establishment of protein localization to organelle,BP,TXNIP;GAS6;BMP4;SORL1;TP53;PRICKLE1;DDIT3;TFDP2;GLI3;CLU;HHAT;TMEM173;HPS4;TP73;AIP;NEURL1B;BCL6;TMEM50B;RPL13A;IFT122;MDFIC;VPS13C;PPP3CA;PEX1;COX18;NIPBL;VPS36
1869,GO:0004536,0.997891484257379,0.0158147047721769,1,61,deoxyribonuclease activity,MF,DNASE1L1
7584,GO:0031966,0.99794001647947,0.00350109232650355,32,576,mitochondrial membrane,CC,PRODH;FAM210B;SLC27A3;ACSL3;CPS1;CLU;TMEM173;ALDH3A2;CPT1A;ACACB;BPHL;SNCA;VAMP1;NIPSNAP1;ARMCX2;SPATA18;IDH2;TMEM14C;NDUFA4L2;SLC25A35;PRKCA;SFXN3;ULK1;RSAD2;VPS13C;RNF144B;LGALS3;COX18;DNM1P46;CPT2;ACAA2;DMPK
14762,GO:0070498,0.997961559707369,0.0101200710925503,2,93,interleukin-1-mediated signaling pathway,BP,PSMB9;EGR1
200,GO:0000422,0.998002874025091,0.0100169426250793,2,77,autophagy of mitochondrion,BP,SPATA18;VPS13C
14395,GO:0061726,0.998002874025091,0.0100169426250793,2,77,mitochondrion disassembly,BP,SPATA18;VPS13C
11033,GO:0045047,0.998065502273637,0.0144360795639519,1,101,protein targeting to ER,BP,RPL13A
17317,GO:1900034,0.998133146606415,0.00947138890411503,2,72,regulation of cellular response to heat,BP,CAMK2D;ATM
5670,GO:0016787,0.998164906849624,0.00241277802100212,159,1821,hydrolase activity,MF,CPA4;MMP2;PRSS23;HTRA1;MMP9;ADAM19;INPP5D;SFRP1;MMP28;RHOBTB2;MYH15;ADAMTSL1;DUSP6;ANPEP;H6PD;SULF2;PHF21A;DPYSL2;ITPK1;HSPA2;CLCA2;ATP10D;ENDOD1;RNF213;TADA3;ABCA1;APOBEC3C;PTPRM;PADI3;PCSK1;SMARCA2;MEST;CPVL;PTPRS;CCDC102A;PYCARD;DDX60;MMP19;ADARB1;CHD3;TYSND1;NAV2;CTDSPL;ABHD14B;CTSV;CMBL;CPS1;ERCC6;PLA2G6;SMARCA1;TNS2;PTPN14;ATP8B2;APOBEC3G;ANG;DUSP5;KIF17;CES2;MLH3;CAT;PLCH2;CASP14;AARS;BACE1;BPHL;MAN1A1;OARD1;ADAMTS7;MME;THSD4;PTPRU;APOBEC3F;SETX;PDE4D;MYO3B;PSMB9;SULF1;ARSD;CHD6;SEPT6;NAGLU;BBS4;MTMR4;APH1B;ARF6;MANBA;DNAJC6;HEXA;AKR7A2;MSH5;HDAC11;RNPEP;PTPN1;NT5DC3;DNAL4;SSH1;ENPP1;IFT27;PLD3;PRCP;DDX60L;G6PC3;BCHE;RAB13;AMZ2;CES3;ADAMTS15;HLTF;WDR63;SEPT5;MAN2B1;PGAP1;ABCC2;CHD9;NLGN4Y;RAB43;MUTYH;GGT7;DNASE1L1;LIPA;DPP9;USP28;PPM1M;SPPL2B;NPEPL1;RHBDD1;AGAP1;HSPA5;PIKFYVE;RHBDD2;SAP30L;MYO9A;PGPEP1;DNAH1;PTPN3;ARL3;ABCA2;SENP7;MPPE1;PPP3CA;RASA1;PEX1;CTDSP2;CAPN6;DNM1P46;SEPT9;DNPH1;AIG1;ACOT1;SCPEP1;MYH11;ADAM10;RNPEPL1;RHOBTB3;MYO1C;GBP3;EDEM1;ABCA5;CTSD
1486,GO:0003824,0.998213271379929,0.0021823774726058,407,4339,catalytic activity,MF,CPA4;SULT1E1;MMP2;PRSS23;HTRA1;PYGB;MMP9;PRODH;ADAM19;INPP5D;SFRP1;ST6GALNAC2;MMP28;RHOBTB2;NQO1;MYH15;TGFBR2;PTGS1;ADAMTSL1;EFEMP1;MARCH4;PIK3C2G;IRS2;DUSP6;CYBRD1;HERC5;TNIK;ANPEP;SKP2;H6PD;NOS1;SULF2;PHF21A;ROR1;AXL;DPYSL2;EGFR;GALNT10;ITPK1;HSPA2;SPEG;FKBP5;CLCA2;SESN3;MYLK;TRIM2;ATP10D;ENDOD1;RNF213;MBOAT2;RNF165;DDB2;TKFC;MAP3K6;DCAKD;ZNF862;TADA3;PAK1;ABCA1;APOBEC3C;PTPRM;PADI3;TRIM38;ISYNA1;TP53I3;PCSK1;SMARCA2;PTK6;EIF2AK4;TRIM5;MEST;D2HGDH;CPVL;EXTL2;PTPRS;TTLL11;CNTRL;CCDC102A;PYCARD;LTBP1;WNK1;DDX60;DLG4;SLC27A3;ZCCHC11;PDGFA;MMP19;MICAL1;ADARB1;ACSL3;PHGDH;BCKDHB;TEP1;CRIM1;CHD3;SIK1;TYSND1;GPX1;PTGES;CDK14;LPCAT2;KITLG;P3H2;NAV2;ECH1;DIP2C;ERO1B;CTDSPL;MTHFR;ABHD14B;NEK9;SESN1;CTSV;KCNAB2;NMRK1;FYN;XDH;ALPK1;B3GAT3;LTBP4;FUT10;CMBL;UGT8;CPS1;POLR3GL;SLC27A1;PIAS3;HLCS;RNF135;ERCC6;PLA2G6;GLDC;MAP3K14;SMARCA1;XYLT1;UST;ACSS1;FKBP9;PRKCZ;OAS2;SDR16C5;FBXW4;ULK2;PARP4;TNS2;CHST3;HMGA2;CAMK2D;PRDX5;MST1R;HIBADH;METTL7A;PTPN14;ATP8B2;PDIA4;SPATA20;PIK3R1;HHAT;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;KIF17;UHRF2;CDK18;PHKA2;CES2;TTN;TSTD1;PRDM8;LMO7;MLH3;CAT;PLCH2;CASP14;DAPK1;ST6GAL2;PRKACB;AARS;CHEK2;BACE1;PHF2;BPHL;MAN1A1;FBXL7;SNCA;OARD1;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;JADE2;PTPRU;FGFR1;CBR1;IGF1R;APOBEC3F;ALOX15B;PYROXD2;PRKAB2;GLT8D2;SETX;PDE4D;TMEM129;MYO3B;TGM2;PSMB9;OBSCN;SULF1;PDK3;G6PD;EPHB6;ARSD;DHTKD1;KDM4C;CHD6;SEPT6;TGFBR3;IPP;LRTOMT;NAGLU;BBS4;MTMR4;ATM;EFNB3;IDH2;FBXO17;APH1B;MDM2;ARF6;FAM20A;MANBA;AKAP13;HSD17B11;DNAJC6;DGKQ;GCLC;ACSS2;HEXA;NEURL1B;AKR7A2;MSH5;CYP20A1;FBXW8;HDAC11;RNPEP;MAP3K1;PTPN1;POGLUT1;NT5DC3;DNAL4;NDUFA4L2;ALDH4A1;KLHL12;THNSL2;NRK;SSH1;SOX9;ENPP1;IFT27;ITPKB;SLC27A6;PLD3;PRCP;STK16;DDX60L;G6PC3;GCNT1;PRKCA;BCHE;PRPS2;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;WDR63;SEPT5;RNF24;METTL23;MAN2B1;PGAP1;PLD5;LANCL1;ALDH9A1;HMBOX1;NMNAT2;GAL3ST4;PAK6;DECR1;ABCC2;MAP3K12;CHD9;NLGN4Y;ACSF2;STK36;RAB43;MUTYH;RET;MAP2K5;GGT7;DNASE1L1;DSEL;LIG1;LIPA;DPP9;ZADH2;USP28;ALDH7A1;CYP4V2;MSRB2;TRIML2;PPM1M;SPPL2B;ULK1;NPEPL1;DHRS12;RHBDD1;AGAP1;HSPA5;CDK19;TH;KLHL5;PIKFYVE;RSAD2;SRPK2;NAPRT;UGT1A3;RHBDD2;POLD4;SAP30L;TPGS1;UGT1A6;MYO9A;PGPEP1;DNAH1;ALG10;GPX8;KLHL3;SRR;UBA7;GALNT2;AGPAT1;RNF144B;PARP15;TPST1;CERS5;ICK;ZYG11B;PTPN3;ARL3;FKBP10;ABCA2;POLH;PCMTD2;PRKAG1;TAF1;SENP7;GSTZ1;MPPE1;DPYD;NAT14;PPP3CA;PIK3C2B;RASA1;PEX1;CTDSP2;STEAP2;CAPN6;PPCS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;AIG1;ACOT1;SCPEP1;EHHADH;MED12;ABAT;MYH11;FBXL4;UGGT2;TTBK2;ADAM10;PRDM5;RNPEPL1;RHOBTB3;MYO1C;TUSC3;GBP3;CPT2;EDEM1;GID4;ACAA2;ABCA5;TAOK3;CTSD;ZNRF1;DMPK
2948,GO:0006479,0.998239525155015,0.00489647998258766,7,149,protein methylation,BP,BTG1;MTHFR;JARID2;KDM4C;PCMTD2;KDM4A;PRDM5
3702,GO:0008213,0.998239525155015,0.00489647998258766,7,149,protein alkylation,BP,BTG1;MTHFR;JARID2;KDM4C;PCMTD2;KDM4A;PRDM5
5501,GO:0016458,0.998253554020747,0.00396430456315378,12,237,gene silencing,BP,SOX6;EGFR;BMP4;ZCCHC11;TNRC18;UHRF2;PHF2;NCOR1;BAHCC1;PPARG;PPP3CA;AGO4
17612,GO:1901362,0.998268185031394,0.00214159177543334,329,3519,organic cyclic compound biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;NUPR1;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;NR1D1;SMARCA2;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;ADIRF;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;ANG;UHRF2;WFS1;MDFI;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;CHEK2;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;MEIS2;TMEM14C;IFNK;ZNF107;TCF4;HSD17B11;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;MSRB2;CDKN2A;OSBPL1A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TH;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;ACAA2;NFKBIE;ZNF484
11551,GO:0046128,0.99829678433462,0.0131699247766887,1,62,purine ribonucleoside metabolic process,BP,DLG4
10086,GO:0042623,0.998490309547522,0.00296431638882889,20,290,ATPase activity, coupled,MF,HSPA2;ATP10D;ABCA1;SMARCA2;CHD3;ERCC6;SMARCA1;ATP8B2;KIF17;CHD6;MSH5;DNAL4;WDR63;ABCC2;HSPA5;DNAH1;ABCA2;PEX1;MYO1C;ABCA5
11867,GO:0046907,0.998508415819277,0.00203382068196892,122,1457,intracellular transport,BP,SYT8;TXNIP;COL7A1;CLTCL1;GAS6;TCAF1;SPTB;TOM1L2;PAK1;ABCA1;NSG1;BMP4;TBC1D8;NEFL;SORL1;TP53;PRICKLE1;IFIT1;HIP1;EVI5L;SNX1;GLI3;TBC1D5;SYN1;SPG11;FYN;B3GAT3;FUT10;SEL1L;SNX33;CLU;PRKCZ;EHD3;GOLGB1;SYTL1;PTPN14;SYT1;HHAT;TMEM173;CREB3L2;CPT1A;ACACB;PCLO;KIF17;BBS2;HERPUD1;ANK3;HPS4;IFT140;STOM;SNCA;AIP;SH3TC2;PRKAB2;SEC24D;TMEM129;BBS4;CALR;COPG2;MDM2;ARF6;TMED10;AREG;AKAP13;TRAK1;SYNE2;PTPN1;ARHGEF2;KLHL12;LYST;IFT27;BCL6;TMEM50B;ANXA2;RGS14;RAB13;SEPT5;PGAP1;IFT88;MVB12B;RPL13A;ATXN1;RAB43;WDR19;PRNP;VPS39;IFT122;C2CD4C;SP100;RHBDD1;GOPC;PIKFYVE;REEP2;CCHCR1;MON2;MDFIC;VPS13C;FHOD1;IFT74;LMF1;DERL3;KCNIP3;SNX9;ICK;TBC1D16;ARL3;MIA3;COG3;RASSF9;ABCA2;PRKAG1;MPPE1;PPP3CA;PEX1;DNM1P46;VPS36;RHOBTB3;EPG5;MYO1C;C2CD5;CPT2;EDEM1
5641,GO:0016741,0.998524798444941,0.00392834060196806,8,183,transferase activity, transferring one-carbon groups,MF,CPS1;METTL7A;PRDM8;ALDH1L2;LRTOMT;METTL23;PCMTD2;PRDM5
1854,GO:0004519,0.998618679600336,0.00577350438114619,3,108,endonuclease activity,MF,ENDOD1;ANG;DNASE1L1
4067,GO:0009124,0.998642059697583,0.00444277451645423,5,136,nucleoside monophosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRPS2;PRKAG1
8275,GO:0033108,0.99870475809816,0.0102625075380268,1,89,mitochondrial respiratory chain complex assembly,BP,COX18
2799,GO:0006259,0.998709155365478,0.00195418693554673,63,844,DNA metabolic process,BP,CTGF;XPC;PDGFC;EGFR;NYNRIN;DDB2;APOBEC3C;BMP4;TP53;PDGFA;TEP1;NFIX;E2F7;KITLG;KRBA2;GLI2;RMI2;ERCC6;SMARCA1;PARP4;HMGA2;APOBEC3G;UHRF2;MLH3;TP73;CHEK2;FGFR1;IGF1R;APOBEC3F;SETX;MAGEF1;CALR;ATM;CST3;AREG;MSH5;PTMS;BCL6;PRIMPOL;CXORF57;IGFBP4;HMBOX1;MUTYH;DNASE1L1;LIG1;LEF1;USP28;SP100;TSPYL2;ORC4;UVRAG;POLD4;UBA7;PPARG;ING4;POLH;ZBTB1;FOS;FAM168A;NPAS2;NIPBL;S100A11;TAOK3
4084,GO:0009142,0.998733574693442,0.00463031706702051,4,120,nucleoside triphosphate biosynthetic process,BP,DDIT4;DHTKD1;NCOR1;PRKAG1
12823,GO:0051168,0.998757475645256,0.00320814438817719,9,187,nuclear export,BP,GAS6;TP53;PTPN14;CALR;MDM2;AKAP13;ATXN1;SP100;CCHCR1
2839,GO:0006310,0.998758056053157,0.00297690955909157,11,215,DNA recombination,BP,TEP1;RMI2;MLH3;SETX;MAGEF1;ATM;MSH5;BCL6;CXORF57;LEF1;NIPBL
5066,GO:0015294,0.998763638049151,0.0100844403100197,1,53,solute:cation symporter activity,MF,SLC20A1
15845,GO:0072599,0.99877638645329,0.00972373879891401,1,104,establishment of protein localization to endoplasmic reticulum,BP,RPL13A
4191,GO:0009301,0.998828528775655,0.00951375909779527,1,67,snRNA transcription,BP,TAF8
10173,GO:0042795,0.998828528775655,0.00951375909779527,1,67,snRNA transcription by RNA polymerase II,BP,TAF8
7704,GO:0032204,0.998857027531852,0.006131579770144,2,76,regulation of telomere maintenance,BP,ATM;HMBOX1
5922,GO:0018205,0.998883723519471,0.00218920468139058,21,338,peptidyl-lysine modification,BP,CPA4;NOS1;SNAI2;TADA3;PIAS3;SDR16C5;PER1;JARID2;SNCA;JADE2;TGM2;KDM4C;MDM2;EGR1;ISL1;LEF1;YEATS2;ING4;TAF1;KDM4A;PRDM5
15001,GO:0070972,0.998916874458652,0.00573342764408004,2,125,protein localization to endoplasmic reticulum,BP,RPL13A;HSPA5
7692,GO:0032182,0.998934423201508,0.00574157004781695,2,82,ubiquitin-like protein binding,MF,NR3C1;VPS36
2873,GO:0006369,0.998943841786044,0.00868759912048139,1,69,termination of RNA polymerase II transcription,BP,SETX
10315,GO:0043130,0.998984741074464,0.00841874141817183,1,65,ubiquitin binding,MF,VPS36
3061,GO:0006626,0.999024947453928,0.00420609874922867,3,120,protein targeting to mitochondrion,BP,HHAT;HPS4;AIP
6921,GO:0030532,0.999033869503817,0.00804271148568637,1,69,small nuclear ribonucleoprotein complex,CC,TEP1
2890,GO:0006400,0.999069142061279,0.00776390261923487,1,74,tRNA modification,BP,AARS
342,GO:0000956,0.999112296377027,0.00257963699724798,7,200,nuclear-transcribed mRNA catabolic process,BP,ZFP36L1;ZFP36L2;ZCCHC11;PNRC1;ATM;RPL13A;SMG9
12917,GO:0051303,0.999175780661093,0.00702700601011332,1,65,establishment of chromosome localization,BP,ATM
6197,GO:0019693,0.999205524023578,0.00158002068745638,21,385,ribose phosphate metabolic process,BP,SULT1E1;DDIT4;PKD2;H6PD;NOS1;DCAKD;TIMP2;DLG4;ABHD14B;SNCA;PDE4D;G6PD;DHTKD1;ENPP1;NCOR1;PRPS2;GPR161;NPHP3;TPST1;PRKAG1;PPCS
2735,GO:0006119,0.999238695546958,0.00645480249661346,1,96,oxidative phosphorylation,BP,SNCA
16828,GO:0098781,0.999249561465225,0.00417949610771102,2,94,ncRNA transcription,BP,ANG;TAF8
4092,GO:0009150,0.999263220717238,0.00151542261933503,19,357,purine ribonucleotide metabolic process,BP,SULT1E1;DDIT4;PKD2;NOS1;DCAKD;TIMP2;DLG4;ABHD14B;SNCA;PDE4D;DHTKD1;ENPP1;NCOR1;PRPS2;GPR161;NPHP3;TPST1;PRKAG1;PPCS
2974,GO:0006518,0.999285121948609,0.00116131932901944,48,785,peptide metabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;ANPEP;GAS6;EGFR;VIM;BMP4;PCSK1;ABTB1;EIF2AK4;SORL1;ITGA2;RBMS3;GPX1;PTGES;ERO1B;CLU;PER1;CAPRIN2;ANG;CIRBP;DAPK1;AARS;BACE1;PAIP2B;SNCA;MME;RGS2;G6PD;CALR;TMED10;GCLC;RNPEP;NCOR1;RPL13A;PRNP;GGT7;SPPL2B;PPARG;UNK;DNAJC3;RARA;GSTZ1;PPP3CA;AGO4;RNPEPL1;RXRA
12409,GO:0050000,0.999293235799894,0.00614299021342827,1,66,chromosome localization,BP,ATM
10879,GO:0044445,0.999322229446937,0.00214266792063008,6,203,cytosolic part,CC,EIF2AK4;NEFL;PYCARD;HPS4;HPS3;RPL13A
4531,GO:0010608,0.99932662368808,0.00121482700420066,31,507,posttranscriptional regulation of gene expression,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;VIM;BMP4;EIF2AK4;ITGA2;ZCCHC11;RBMS3;CAV1;PER1;CAPRIN2;ANG;CIRBP;DAPK1;PAIP2B;RGS2;PSMB9;CALR;NCOR1;PRKCA;RPL13A;GDNF;PPARG;UNK;DNAJC3;RARA;PPP3CA;AGO4;RXRA
16223,GO:0090307,0.999355733433041,0.00569011222290277,1,61,mitotic spindle assembly,BP,CHEK2
3049,GO:0006611,0.999356371188043,0.00192666036346261,7,170,protein export from nucleus,BP,GAS6;TP53;PTPN14;CALR;MDM2;SP100;CCHCR1
17661,GO:1901566,0.999387098946155,0.000862799703767586,113,1520,organonitrogen compound biosynthetic process,BP,INPP5D;ST6GALNAC2;CD109;ZFP36L1;DDIT4;ADAMTSL1;ZFP36L2;IGF2BP2;NOS1;EGFR;GALNT10;SDC3;NTM;VIM;CSPG4;DCAKD;TIMP2;ABCA1;BMP4;ITM2C;PCSK1;ABTB1;EIF2AK4;EXTL2;MUC19;ITGA2;RBMS3;ACSL3;PHGDH;LPCAT2;NMRK1;B3GAT3;FUT10;UGT8;CPS1;SLC27A1;PLA2G6;TRIB2;XYLT1;UST;CHST3;PER1;HHAT;CAPRIN2;ALDH3A2;ANG;CIRBP;DAPK1;ST6GAL2;AARS;PAIP2B;TLR3;MAN1A1;SNCA;ADAMTS7;RGS2;IL18;DHTKD1;FOXL1;CALR;NEGR1;IDH2;TMEM14C;GCLC;HEXA;TRAK1;POGLUT1;VANGL2;NTNG1;SDC2;THNSL2;EGR1;NCOR1;GCNT1;PRPS2;PGAP1;ALDH9A1;NMNAT2;GAL3ST4;RPL13A;ZFPM1;TGFB2;MAP2K5;GGT7;DSEL;GPR161;ALDH7A1;ITM2A;AGRN;TH;NAPRT;LMF1;ALG10;SRR;GALNT2;DERL3;PPARG;CERS5;UNK;DNAJC3;RARA;COG3;PRKAG1;GSTZ1;MPPE1;DPYD;PPP3CA;PPCS;AGO4;ABAT;UGGT2;TUSC3;RXRA
10593,GO:0043603,0.99943012665031,0.000898193063107118,58,908,cellular amide metabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;ANPEP;GAS6;EGFR;VIM;BMP4;PCSK1;ABTB1;EIF2AK4;SORL1;ITGA2;RBMS3;GPX1;PTGES;ERO1B;MTHFR;UGT8;CPS1;HLCS;PLA2G6;CLU;PER1;CAPRIN2;ACACB;ANG;CIRBP;DAPK1;AARS;BACE1;PAIP2B;SNCA;ALDH1L2;MME;RGS2;G6PD;CALR;TMED10;GCLC;RNPEP;NCOR1;RPL13A;ABCC2;PRNP;GGT7;SPPL2B;ITGB8;PPARG;CERS5;UNK;DNAJC3;RARA;GSTZ1;PPP3CA;AGO4;RNPEPL1;RXRA
5276,GO:0015934,0.999438281564497,0.00491965307707271,1,115,large ribosomal subunit,CC,RPL13A
11789,GO:0046700,0.999494642404219,0.000914442137803201,32,544,heterocycle catabolic process,BP,PRODH;ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;VIM;APOBEC3C;ZCCHC11;PNRC1;GPX1;XDH;OAS2;APOBEC3G;CIRBP;ALDH1L2;APOBEC3F;PDE4D;PSMB9;DHTKD1;ATM;ALDH4A1;ENPP1;NCOR1;PRKCA;RPL13A;DNASE1L1;SMG9;GDNF;PRKAG1;DPYD;DNPH1;AGO4
10373,GO:0043226,0.999503497971474,0.000643045458231716,974,9751,organelle,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;SFRP1;ST6GALNAC2;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TNNI2;XPC;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;ASAP3;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;PKD2;JPH2;SCARA3;DUSP6;OSBPL10;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;SESN3;MYLK;SYNE3;SLC2A3;THBS2;RFX2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;FAM210B;MAMDC2;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PADI3;BMP4;NEFM;TNS1;ITM2C;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;CITED4;XAF1;EIF2AK4;NETO1;HS1BP3;FCGBP;TRIM5;NEFL;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;CPVL;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;SEC14L2;DDX60;EFHC1;MUC19;DLG4;ARMC9;TCP11L1;SLC7A11;SEMA5A;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;FRMD4B;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;SIK1;ZNF18;CPED1;TTC28;KLF12;IFIT3;KLF9;WDR66;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ASAP1;ERO1B;PLLP;SYN1;CTDSPL;PDPN;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;EML2;KCNAB2;LRP1;FYN;ARHGEF12;IFI6;XDH;FLNC;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SPATA6;SLC2A4RG;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;SNX29;PRKCZ;SLIT3;OAS2;SDR16C5;ULK2;TP53INP1;ZNF678;PARP4;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;WDFY2;IFT140;LRIG3;R3HDM2;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;SH3TC2;SP110;COL16A1;DZIP1L;FGFR1;CBR1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;LTBP3;RGS2;C5;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;G6PD;MYOF;TLE4;ARSD;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;AMOTL1;IPP;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;FOXL1;BBS4;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;COPG2;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;NR2F2;PLXNA1;ACSS2;FHOD3;HEXA;NEURL1B;CBX7;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;HSPA12A;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;FGD4;NEMP2;PTPN1;POGLUT1;VANGL2;CPNE8;ARHGEF2;DNAL4;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;ZNF546;KRT222;SSH1;LYST;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;TMC4;RAB13;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;IFT88;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;CHD9;MEGF8;ZNF302;NLGN4Y;UACA;ATXN1;ACSF2;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;MPRIP;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;ITGB8;NAPRT;CCHCR1;MON2;CFAP54;ITPR2;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;OPHN1;TPGS1;LMF1;UGT1A6;MYO9A;YAP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;SHISA9;ICK;TBC1D16;TGIF1;OBSL1;ING4;POSTN;PRR7;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;CEP85L;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;HCFC1R1;ZBTB1;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM169A;CLEC2D;FAM120B;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;PCDHGB5;ADAM10;PRDM5;RHOBTB3;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;ANKS6;TSPAN4;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
6017,GO:0019080,0.99950426421005,0.0017470657451552,5,184,viral gene expression,BP,EIF2AK4;HMGA2;RPL13A;LEF1;MDFIC
9784,GO:0040029,0.99952459178835,0.00108136753824464,15,290,regulation of gene expression, epigenetic,BP,EGFR;BMP4;ZCCHC11;GPX1;ERCC6;TNRC18;UHRF2;JARID2;PHF2;NCOR1;BAHCC1;PPARG;PPP3CA;AGO4;MYO1C
2831,GO:0006302,0.999561836534282,0.00127122801412317,8,194,double-strand break repair,BP,HMGA2;CHEK2;SETX;MAGEF1;ATM;CXORF57;UVRAG;NIPBL
1861,GO:0004527,0.999572619255194,0.00395078091486714,1,68,exonuclease activity,MF,ENPP1
5734,GO:0016887,0.999585597162808,0.000822856607985524,24,349,ATPase activity,MF,HSPA2;ATP10D;RNF213;ABCA1;SMARCA2;CHD3;ERCC6;SMARCA1;ATP8B2;KIF17;MLH3;CHD6;MSH5;DNAL4;HLTF;WDR63;ABCC2;HSPA5;DNAH1;ABCA2;PEX1;RHOBTB3;MYO1C;ABCA5
17245,GO:0120114,0.999595747240772,0.00373523227042817,1,79,Sm-like protein family complex,CC,TEP1
6020,GO:0019083,0.99960267944611,0.00159034522804009,4,170,viral transcription,BP,HMGA2;RPL13A;LEF1;MDFIC
6144,GO:0019439,0.99963647054221,0.000666456301415064,32,553,aromatic compound catabolic process,BP,ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;VIM;APOBEC3C;ZCCHC11;PNRC1;GPX1;XDH;OAS2;APOBEC3G;CIRBP;ALDH1L2;APOBEC3F;PDE4D;PSMB9;DHTKD1;LRTOMT;ATM;ENPP1;NCOR1;PRKCA;RPL13A;DNASE1L1;SMG9;GDNF;PRKAG1;GSTZ1;DPYD;DNPH1;AGO4
4178,GO:0009259,0.999643595626002,0.000759728247319374,19,371,ribonucleotide metabolic process,BP,SULT1E1;DDIT4;PKD2;NOS1;DCAKD;TIMP2;DLG4;ABHD14B;SNCA;PDE4D;DHTKD1;ENPP1;NCOR1;PRPS2;GPR161;NPHP3;TPST1;PRKAG1;PPCS
6593,GO:0022618,0.999647606207785,0.00109645751491862,7,193,ribonucleoprotein complex assembly,BP,CIRBP;SETX;ATM;RPL13A;CELF2;SRPK2;AGO4
5331,GO:0016073,0.999670768110565,0.00310871864322741,1,84,snRNA metabolic process,BP,TAF8
3737,GO:0008276,0.999671121014375,0.00312824989337767,1,72,protein methyltransferase activity,MF,PCMTD2
2814,GO:0006281,0.999680181796875,0.000605865838334663,29,483,DNA repair,BP,XPC;EGFR;DDB2;TP53;RMI2;ERCC6;PARP4;HMGA2;MLH3;TP73;CHEK2;SETX;MAGEF1;ATM;MSH5;PRIMPOL;CXORF57;MUTYH;LIG1;USP28;UVRAG;POLD4;UBA7;POLH;ZBTB1;FAM168A;NPAS2;NIPBL;TAOK3
256,GO:0000723,0.999681485647159,0.00116973798040925,5,153,telomere maintenance,BP,TEP1;ATM;HMBOX1;SP100;POLD4
18190,GO:1903008,0.999697340520861,0.00185118781734926,2,96,organelle disassembly,BP,SPATA18;VPS13C
2892,GO:0006402,0.999701977336251,0.000709056604822415,14,322,mRNA catabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;ZCCHC11;PNRC1;CIRBP;PSMB9;ATM;PRKCA;RPL13A;SMG9;GDNF;AGO4
3667,GO:0008168,0.999711443277123,0.000977114079041053,6,175,methyltransferase activity,MF,METTL7A;PRDM8;LRTOMT;METTL23;PCMTD2;PRDM5
3336,GO:0007052,0.999712756787232,0.00139875593909817,3,105,mitotic spindle organization,BP,CEP126;EFHC1;CHEK2
35,GO:0000070,0.999717192081628,0.00105176706201159,5,141,mitotic sister chromatid segregation,BP,NCAPD2;TTN;ATM;KLHL22;NIPBL
16788,GO:0098687,0.999736684041808,0.000604050513413332,16,312,chromosomal region,CC,CBX5;TEP1;NCAPD2;CHEK2;PHF2;SETX;KDM4C;SEPT6;ATM;HMBOX1;ANAPC16;SP100;ORC4;CENPA;UVRAG;KDM4A
8843,GO:0034655,0.999741731228617,0.000492683718735482,29,520,nucleobase-containing compound catabolic process,BP,ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;VIM;APOBEC3C;ZCCHC11;PNRC1;GPX1;XDH;OAS2;APOBEC3G;CIRBP;APOBEC3F;PDE4D;PSMB9;DHTKD1;ATM;ENPP1;NCOR1;PRKCA;RPL13A;DNASE1L1;SMG9;GDNF;PRKAG1;DPYD;DNPH1;AGO4
10336,GO:0043170,0.99974647376806,0.000316511203762375,662,6850,macromolecule metabolic process,BP,SERPINE2;PHACTR3;CPA4;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;GPRC5A;TXNIP;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;ADAMTSL1;EFEMP1;TENM4;MARCH4;GSN;ETV5;PKD2;IRS2;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;COL5A1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;EGFR;GALNT10;TSC22D3;KLF8;SDC3;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;CLCA2;MYLK;GJC2;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;SERPINH1;ENDOD1;RNF213;CRTAP;TCF7L1;RNF165;VIM;NUPR1;CSPG4;DDB2;MAP3K6;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;NEFL;HSF2BP;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;ARAP1;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;MMP19;RBMS3;MICAL1;ADARB1;TIMP1;FLG;HIP1;GPNMB;TFDP2;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;CDK14;E2F7;CNTN1;KITLG;TBC1D5;P3H2;ERO1B;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;NEK9;CTSV;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;LTBP4;ADIRF;FUT10;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;XYLT1;AHNAK2;UST;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;EHD3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;BBS2;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;CASP14;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;MME;THSD4;PDIA6;GATAD1;FZD7;AIP;GLG1;JADE2;SP110;PTPRU;FGFR1;IGF1R;APOBEC3F;DKK1;PRKAB2;CTF1;RGS2;C5;GLT8D2;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;NEGR1;ATM;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MEIS2;MANBA;AREG;IFNK;ZNF107;TCF4;AKAP13;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;HEXA;IFNE;NEURL1B;CBX7;LMO4;ZNF449;MSH5;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;KLHL12;SDC2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;AMZ2;ADAMTS15;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;MAN2B1;PGAP1;TSHZ1;IGFBP4;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;ATXN1;HTR1B;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DNASE1L1;DSEL;SMG9;STAT2;LIG1;ZNF701;LEF1;DPP9;THRA;SSBP3;CDC42EP5;USP28;ITM2A;MAPK8IP3;MSRB2;TRIML2;CDKN2A;PPM1M;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;RHBDD1;MAGI2;HSPA5;CDK19;CELF2;KLHL5;TGFB1I1;SRPK2;UVRAG;ITGB8;MDFIC;RHBDD2;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;YAP1;GDNF;PGPEP1;ALG10;NUB1;KLF5;TWIST2;KLHL3;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PPARG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;UNK;LGALS3;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;FZD4;MPPE1;ZNF883;ZBTB1;NAT14;PPP3CA;DCAF8;RASA1;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;CAPN6;FOS;DNM1P46;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;ZNF471;LITAF;S100A11;MYO1C;TUSC3;RXRA;EDEM1;GID4;TAOK3;NFKBIE;CTSD;ZNF484;ZNRF1;DMPK;LAMB2
7585,GO:0031967,0.999760205997146,0.000382077036199789,63,971,organelle envelope,CC,SULT1E1;PRODH;TXNIP;SYNE1;EGFR;CLCA2;SYNE3;FAM210B;PAK1;CBX5;SORL1;PRICKLE1;SLC27A3;ACSL3;PTGES;CPS1;TNRC18;CLU;PRKCZ;TMEM173;ALDH3A2;CPT1A;ACACB;CAT;BPHL;SNCA;VAMP1;NIPSNAP1;LMNA;ARMCX2;PDE4D;SPATA18;MYOF;CALR;IDH2;CST3;TMEM14C;SYNE2;NEMP2;NDUFA4L2;SLC25A35;PRKCA;BCHE;PRNP;SFXN3;ULK1;NRM;RSAD2;VPS13C;ATRAID;RNF144B;CERS5;LGALS3;ZBTB1;COX18;DNM1P46;FAM169A;KLHDC2;FBXL4;MYO1C;CPT2;ACAA2;DMPK
7589,GO:0031975,0.999760205997146,0.000382077036199789,63,971,envelope,CC,SULT1E1;PRODH;TXNIP;SYNE1;EGFR;CLCA2;SYNE3;FAM210B;PAK1;CBX5;SORL1;PRICKLE1;SLC27A3;ACSL3;PTGES;CPS1;TNRC18;CLU;PRKCZ;TMEM173;ALDH3A2;CPT1A;ACACB;CAT;BPHL;SNCA;VAMP1;NIPSNAP1;LMNA;ARMCX2;PDE4D;SPATA18;MYOF;CALR;IDH2;CST3;TMEM14C;SYNE2;NEMP2;NDUFA4L2;SLC25A35;PRKCA;BCHE;PRNP;SFXN3;ULK1;NRM;RSAD2;VPS13C;ATRAID;RNF144B;CERS5;LGALS3;ZBTB1;COX18;DNM1P46;FAM169A;KLHDC2;FBXL4;MYO1C;CPT2;ACAA2;DMPK
5825,GO:0017111,0.999767507887612,0.000394347239272276,48,647,nucleoside-triphosphatase activity,MF,RHOBTB2;MYH15;HSPA2;ATP10D;RNF213;ABCA1;SMARCA2;CCDC102A;DDX60;CHD3;NAV2;ERCC6;SMARCA1;ATP8B2;KIF17;MLH3;SETX;MYO3B;CHD6;SEPT6;BBS4;ARF6;MSH5;DNAL4;IFT27;DDX60L;RAB13;HLTF;WDR63;SEPT5;ABCC2;CHD9;RAB43;AGAP1;HSPA5;MYO9A;DNAH1;ARL3;ABCA2;RASA1;PEX1;DNM1P46;SEPT9;MYH11;RHOBTB3;MYO1C;GBP3;ABCA5
7869,GO:0032446,0.999805076068298,0.000320916679912522,56,789,protein modification by small protein conjugation,BP,MARCH4;HERC5;SKP2;TRIM2;RNF213;RNF165;DDB2;TRIM38;TRIM5;WWTR1;PRICKLE1;CUL9;CUL7;FYN;CAV1;PIAS3;RNF135;DCAF16;FBXW4;UHRF2;HERPUD1;WFS1;LMO7;FBXL7;JADE2;TMEM129;PSMB9;MAGEF1;IPP;FBXO17;MDM2;GCLC;NEURL1B;FBXW8;KLHL12;EGR1;HLTF;RNF24;ANAPC16;TRIML2;HSPA5;KLHL5;NUB1;KLHL3;UBA7;RNF144B;SASH1;ZYG11B;TAF1;DCAF8;KLHL22;CDK5RAP3;MED12;FBXL4;GID4;ZNRF1
3651,GO:0008135,0.999809116957127,0.0019212964932902,1,81,translation factor activity, RNA binding,MF,ABTB1
18317,GO:1903311,0.99981349271275,0.000500161419658348,11,250,regulation of mRNA metabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;MBNL2;RBFOX2;CIRBP;PSMB9;PRKCA;SRPK2;GDNF
7700,GO:0032200,0.999826237959753,0.000665705545409605,5,166,telomere organization,BP,TEP1;ATM;HMBOX1;SP100;POLD4
5580,GO:0016604,0.99982738356758,0.000299748205823368,45,650,nuclear body,CC,CBX5;NR1D1;PTK6;NR3C1;TP53;WWTR1;ZBTB20;HIVEP1;GLI3;E2F7;ARHGAP18;GLI2;RMI2;PIAS3;SLC2A4RG;TP53INP1;CHEK2;LMNA;SETX;NCOA2;OBSCN;SETBP1;NFATC4;RAPH1;MDM2;DGKQ;CRTC1;PLAG1;RGS14;TCF12;HMBOX1;MAML2;WDR19;USP28;SP100;FLYWCH1;ZBTB1;CREBRF;HP1BP3;AGO4;KLHDC2;FBXL4;PRDM5;MYO1C;DOCK1
2891,GO:0006401,0.999827891586407,0.000410857429575999,15,346,RNA catabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;ZCCHC11;PNRC1;OAS2;CIRBP;PSMB9;ATM;PRKCA;RPL13A;SMG9;GDNF;AGO4
15450,GO:0071826,0.999832490505301,0.000547001393267998,7,204,ribonucleoprotein complex subunit organization,BP,CIRBP;SETX;ATM;RPL13A;CELF2;SRPK2;AGO4
12143,GO:0048285,0.999841249634585,0.00034679322988862,20,352,organelle fission,BP,HSPA2;TOM1L2;BMP4;CUL9;CUL7;NCAPD2;TTN;MLH3;CHEK2;CALR;ATM;MSH5;MYBL1;STAT2;INF2;OBSL1;DNM1P46;KLHL22;AGO4;NIPBL
10775,GO:0044270,0.999854786124368,0.000280642080283428,30,544,cellular nitrogen compound catabolic process,BP,ZFP36L1;DDIT4;ZFP36L2;IGF2BP2;VIM;APOBEC3C;ZCCHC11;PNRC1;GPX1;XDH;OAS2;APOBEC3G;CIRBP;ALDH1L2;APOBEC3F;PDE4D;PSMB9;DHTKD1;ATM;ENPP1;NCOR1;PRKCA;RPL13A;DNASE1L1;SMG9;GDNF;PRKAG1;DPYD;DNPH1;AGO4
1870,GO:0004540,0.999861300704434,0.00144072544899666,1,87,ribonuclease activity,MF,ANG
9584,GO:0036459,0.999861416579608,0.00091857720783063,2,87,thiol-dependent ubiquitinyl hydrolase activity,MF,TADA3;USP28
17081,GO:0101005,0.999861416579608,0.00091857720783063,2,87,ubiquitinyl hydrolase activity,MF,TADA3;USP28
133,GO:0000280,0.999863531177908,0.000317038431339027,17,316,nuclear division,BP,HSPA2;TOM1L2;BMP4;CUL9;CUL7;NCAPD2;TTN;MLH3;CHEK2;CALR;ATM;MSH5;MYBL1;OBSL1;KLHL22;AGO4;NIPBL
2082,GO:0004843,0.999891994777002,0.00116566843008798,1,70,thiol-dependent ubiquitin-specific protease activity,MF,USP28
17249,GO:0140014,0.999903529745551,0.000268883570228511,11,238,mitotic nuclear division,BP,TOM1L2;BMP4;CUL9;CUL7;NCAPD2;TTN;CHEK2;ATM;OBSL1;KLHL22;NIPBL
1473,GO:0003735,0.999904002052638,0.00101495506889789,1,154,structural constituent of ribosome,MF,RPL13A
4023,GO:0009059,0.999907728353857,0.000118888058268277,373,4107,macromolecule biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;CD109;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;ADAMTSL1;EFEMP1;ETV5;PKD2;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;COL5A1;PHF21A;ROR1;TCEAL4;EGFR;GALNT10;TSC22D3;KLF8;SDC3;NTM;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;CSPG4;ZNF862;TADA3;ABCA1;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;MUC19;ITGA2;PDGFA;RBMS3;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;B3GAT3;ADIRF;FUT10;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;XYLT1;UST;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;ST6GAL2;KLF13;AARS;CHEK2;PAIP2B;PHF2;TLR3;MAN1A1;ZNF860;SNCA;ADAMTS7;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;DKK1;RGS2;GLT8D2;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;NEGR1;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;HEXA;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;POGLUT1;VANGL2;ARHGEF2;NTNG1;SDC2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;GCNT1;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;PGAP1;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DSEL;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;ITM2A;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;LMF1;YAP1;GDNF;ALG10;KLF5;TWIST2;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;COG3;ABCA2;HES2;POLH;HOXC5;PBX2;TAF1;TSHZ3;FZD4;MPPE1;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;TUSC3;RXRA;NFKBIE;ZNF484
7218,GO:0031124,0.99990878832751,0.000989647959026591,1,88,mRNA 3'-end processing,BP,ZFP36L1
2440,GO:0005643,0.999916562538591,0.000920751341041727,1,76,nuclear pore,CC,MYO1C
5582,GO:0016607,0.999916994855465,0.000196953141096135,17,338,nuclear speck,CC,NR3C1;GLI3;E2F7;ARHGAP18;GLI2;RMI2;PIAS3;SLC2A4RG;LMNA;NFATC4;DGKQ;PLAG1;TCF12;MAML2;HP1BP3;FBXL4;DOCK1
5505,GO:0016462,0.999917960407813,0.000143079997426856,49,685,pyrophosphatase activity,MF,RHOBTB2;MYH15;HSPA2;ATP10D;RNF213;ABCA1;SMARCA2;CCDC102A;DDX60;CHD3;NAV2;ERCC6;SMARCA1;ATP8B2;KIF17;MLH3;SETX;MYO3B;CHD6;SEPT6;BBS4;ARF6;MSH5;DNAL4;ENPP1;IFT27;DDX60L;RAB13;HLTF;WDR63;SEPT5;ABCC2;CHD9;RAB43;AGAP1;HSPA5;MYO9A;DNAH1;ARL3;ABCA2;RASA1;PEX1;DNM1P46;SEPT9;MYH11;RHOBTB3;MYO1C;GBP3;ABCA5
10760,GO:0044238,0.999919423359452,0.000102776931096832,736,7685,primary metabolic process,BP,SERPINE2;PHACTR3;CPA4;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ADAMTSL1;EFEMP1;TENM4;MARCH4;SLC7A8;GSN;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;PHF21A;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;CLCA2;MYLK;GJC2;SLC2A3;RFX2;TRIM2;ZNF608;SERPINE1;SERPINH1;ENDOD1;RNF213;CRTAP;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;DDB2;TKFC;MAP3K6;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MMP19;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;PHGDH;FLG;HIP1;GPNMB;TFDP2;BCKDHB;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;PTGES;CDK14;E2F7;CNTN1;LPCAT2;KITLG;P3H2;ECH1;ERO1B;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;NEK9;CTSV;KCNAB2;NMRK1;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;LTBP4;ADIRF;FUT10;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;PRKCZ;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;HIBADH;PTPN14;PER1;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;MME;THSD4;PDIA6;GATAD1;FZD7;AIP;GLG1;JADE2;SP110;PTPRU;FGFR1;CBR1;IGF1R;APOBEC3F;ALOX15B;DKK1;MLEC;PRKAB2;CTF1;RGS2;C5;GLT8D2;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MEIS2;MANBA;AREG;IFNK;ZNF107;TCF4;AKAP13;HSD17B11;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;ACSS2;HEXA;IFNE;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;MSH5;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;ALDH4A1;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;SLC27A6;BCL6;PLD3;PRCP;STK16;CRTC1;NCOR1;G6PC3;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;PGAP1;TSHZ1;IGFBP4;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PAK6;DECR1;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;ATXN1;ACSF2;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DNASE1L1;DSEL;SMG9;STAT2;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;CDC42EP5;ZADH2;USP28;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;CDKN2A;EFR3A;PPM1M;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;NPHP3;VAV2;RHBDD1;MAGI2;HSPA5;CDK19;TH;CELF2;KLHL5;PIKFYVE;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;UGT1A3;RHBDD2;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;UGT1A6;YAP1;GDNF;PGPEP1;ALG10;NUB1;KLF5;TWIST2;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;RNF144B;PARP15;BEX4;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;SASH1;TGIF1;OBSL1;ING4;ZYG11B;APOL6;UNK;LGALS3;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;RASA1;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;CAPN6;PPCS;FOS;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;ZNF471;LITAF;S100A11;TUSC3;RXRA;CPT2;EDEM1;GID4;ACAA2;TAOK3;NFKBIE;CTSD;ZNF484;ZNRF1;DMPK;LAMB2
5690,GO:0016817,0.999921961315624,0.000136303217626733,49,687,hydrolase activity, acting on acid anhydrides,MF,RHOBTB2;MYH15;HSPA2;ATP10D;RNF213;ABCA1;SMARCA2;CCDC102A;DDX60;CHD3;NAV2;ERCC6;SMARCA1;ATP8B2;KIF17;MLH3;SETX;MYO3B;CHD6;SEPT6;BBS4;ARF6;MSH5;DNAL4;ENPP1;IFT27;DDX60L;RAB13;HLTF;WDR63;SEPT5;ABCC2;CHD9;RAB43;AGAP1;HSPA5;MYO9A;DNAH1;ARL3;ABCA2;RASA1;PEX1;DNM1P46;SEPT9;MYH11;RHOBTB3;MYO1C;GBP3;ABCA5
5691,GO:0016818,0.999921961315624,0.000136303217626733,49,687,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RHOBTB2;MYH15;HSPA2;ATP10D;RNF213;ABCA1;SMARCA2;CCDC102A;DDX60;CHD3;NAV2;ERCC6;SMARCA1;ATP8B2;KIF17;MLH3;SETX;MYO3B;CHD6;SEPT6;BBS4;ARF6;MSH5;DNAL4;ENPP1;IFT27;DDX60L;RAB13;HLTF;WDR63;SEPT5;ABCC2;CHD9;RAB43;AGAP1;HSPA5;MYO9A;DNAH1;ARL3;ABCA2;RASA1;PEX1;DNM1P46;SEPT9;MYH11;RHOBTB3;MYO1C;GBP3;ABCA5
12868,GO:0051236,0.999927900066557,0.00026835305517112,6,176,establishment of RNA localization,BP,FLOT1;ZFP36L1;TGFBR2;IGF2BP2;ATM;MYO1C
11496,GO:0046034,0.999929010284994,0.000262751769644588,6,208,ATP metabolic process,BP,DDIT4;SNCA;DHTKD1;ENPP1;NCOR1;PRKAG1
7217,GO:0031123,0.999936429130085,0.000444655035420447,2,119,RNA 3'-end processing,BP,ZFP36L1;ZCCHC11
15401,GO:0071704,0.999936687614225,8.12032068427523e-05,757,7897,organic substance metabolic process,BP,SERPINE2;PHACTR3;CPA4;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ADAMTSL1;EFEMP1;TENM4;MARCH4;SLC7A8;GSN;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;COL5A1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;CLCA2;MYLK;GJC2;SLC2A3;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;SERPINH1;ENDOD1;RNF213;CRTAP;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;DDB2;TKFC;MAP3K6;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;ARAP1;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MMP19;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;PHGDH;FLG;HIP1;GPNMB;TFDP2;BCKDHB;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;PTGES;CDK14;E2F7;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;ECH1;ERO1B;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;NEK9;CTSV;KCNAB2;NMRK1;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;LTBP4;ADIRF;FUT10;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;EHD3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;HIBADH;PTPN14;PER1;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;BBS2;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GATAD1;FZD7;AIP;GLG1;JADE2;SP110;PTPRU;FGFR1;CBR1;IGF1R;APOBEC3F;ALOX15B;DKK1;MLEC;PRKAB2;CTF1;RGS2;C5;GLT8D2;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MEIS2;MANBA;TMEM14C;AREG;IFNK;ZNF107;TCF4;AKAP13;HSD17B11;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;ACSS2;HEXA;IFNE;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;MSH5;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;ALDH4A1;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;SLC27A6;BCL6;PLD3;PRCP;STK16;CRTC1;NCOR1;G6PC3;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;PGAP1;TSHZ1;IGFBP4;ALDH9A1;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DNASE1L1;DSEL;SMG9;STAT2;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;CDC42EP5;ZADH2;USP28;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;CDKN2A;EFR3A;PPM1M;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;NPHP3;VAV2;RHBDD1;MAGI2;HSPA5;CDK19;TH;CELF2;KLHL5;PIKFYVE;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;UGT1A3;RHBDD2;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;UGT1A6;YAP1;GDNF;PGPEP1;ALG10;NUB1;KLF5;TWIST2;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;UNK;LGALS3;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;RASA1;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;CAPN6;PPCS;FOS;DNM1P46;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;ZNF471;LITAF;S100A11;MYO1C;TUSC3;RXRA;CPT2;EDEM1;GID4;ACAA2;TAOK3;NFKBIE;CTSD;ZNF484;ZNRF1;DMPK;LAMB2
2492,GO:0005743,0.99993683125003,0.000161591996073716,14,407,mitochondrial inner membrane,CC,PRODH;CPS1;ALDH3A2;CPT1A;SNCA;NIPSNAP1;IDH2;NDUFA4L2;SLC25A35;RSAD2;LGALS3;COX18;CPT2;ACAA2
8835,GO:0034645,0.999942589742044,7.46164293963876e-05,364,4037,cellular macromolecule biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;ST6GALNAC2;CD109;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;ADAMTSL1;EFEMP1;ETV5;PKD2;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;GALNT10;TSC22D3;KLF8;NTM;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;CSPG4;ZNF862;TADA3;ABCA1;CBX5;VDR;BMP4;TRIM38;ITM2C;NR1D1;SMARCA2;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;MUC19;ITGA2;PDGFA;RBMS3;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;B3GAT3;ADIRF;FUT10;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;XYLT1;UST;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;ST6GAL2;KLF13;AARS;CHEK2;PAIP2B;PHF2;TLR3;MAN1A1;ZNF860;SNCA;ADAMTS7;GATAD1;FZD7;SP110;FGFR1;IGF1R;DKK1;RGS2;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;NEGR1;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;POGLUT1;VANGL2;ARHGEF2;NTNG1;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;GCNT1;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;PGAP1;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DSEL;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;ITM2A;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;HSPA5;TGFB1I1;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;LMF1;YAP1;GDNF;ALG10;KLF5;TWIST2;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;COG3;ABCA2;HES2;POLH;HOXC5;PBX2;TAF1;TSHZ3;FZD4;MPPE1;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;TUSC3;RXRA;NFKBIE;ZNF484
2860,GO:0006354,0.999948044087698,0.000369422785709384,2,121,DNA-templated transcription, elongation,BP,ERCC6;TAF1
15030,GO:0071013,0.999948846973417,0.000585714893503042,1,96,catalytic step 2 spliceosome,CC,TEP1
6227,GO:0019783,0.999950471426897,0.000357583262702031,2,97,ubiquitin-like protein-specific protease activity,MF,TADA3;USP28
2902,GO:0006414,0.999952046334523,0.000546453689002405,1,125,translational elongation,BP,ABTB1
7735,GO:0032259,0.999952975593319,0.000130762791424102,12,282,methylation,BP,BTG1;MTHFR;METTL7A;PRDM8;JARID2;KDM4C;LRTOMT;METTL23;PCMTD2;FOS;KDM4A;PRDM5
1853,GO:0004518,0.999953302375268,0.000195466730122192,5,177,nuclease activity,MF,ENDOD1;ANG;ENPP1;PGAP1;DNASE1L1
6266,GO:0019866,0.999954235254138,0.000110614504521629,17,450,organelle inner membrane,CC,PRODH;CPS1;ALDH3A2;CPT1A;SNCA;NIPSNAP1;IDH2;NEMP2;NDUFA4L2;SLC25A35;NRM;RSAD2;LGALS3;COX18;FAM169A;CPT2;ACAA2
2872,GO:0006368,0.999959753988124,0.000471386255052347,1,97,transcription elongation from RNA polymerase II promoter,BP,TAF1
3661,GO:0008152,0.999960273115516,5.15167834616963e-05,792,8252,metabolic process,BP,SERPINE2;PHACTR3;CPA4;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;MARCH4;SLC7A8;GSN;COL5A2;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;COL5A1;PHF21A;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;CLCA2;SESN3;MYLK;GJC2;SLC20A1;SLC2A3;RFX2;TRIM2;ACTA2;ZNF608;SERPINE1;SERPINH1;ENDOD1;RNF213;CRTAP;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;DDB2;TKFC;MAP3K6;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;ANGPTL4;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;MRC2;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;ARAP1;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;MMP19;RBMS3;MICAL1;NISCH;ADARB1;TIMP1;ACSL3;PHGDH;FLG;HIP1;COL4A4;GPNMB;TFDP2;BCKDHB;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;LIX1L;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;PTGES;CDK14;E2F7;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;ECH1;DIP2C;ERO1B;KRBA2;CTDSPL;MTHFR;SRPX;ABHD14B;ZFP90;NEK9;SESN1;CTSV;KCNAB2;NMRK1;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;LTBP4;ADIRF;FUT10;CMBL;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;EHD3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;HIBADH;METTL7A;PTPN14;PER1;PDIA4;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;BBS2;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GATAD1;FZD7;AIP;GLG1;JADE2;SP110;PTPRU;FGFR1;CBR1;IGF1R;APOBEC3F;ALOX15B;DKK1;PYROXD2;MLEC;PRKAB2;CTF1;RGS2;C5;GLT8D2;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;BBS4;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MEIS2;MANBA;TMEM14C;AREG;IFNK;ZNF107;TCF4;AKAP13;HSD17B11;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;ACSS2;HEXA;IFNE;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;MSH5;CYP20A1;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;NT5DC3;ARHGEF2;NTNG1;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;SLC27A6;BCL6;PLD3;PRCP;STK16;CRTC1;NCOR1;G6PC3;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;AMZ2;CES3;ADAMTS15;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;PGAP1;TSHZ1;IGFBP4;IFT88;ALDH9A1;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;COL12A1;SMG9;STAT2;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;CDC42EP5;ZADH2;USP28;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;CDKN2A;EFR3A;PPM1M;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;NPHP3;VAV2;DHRS12;RHBDD1;MAGI2;HSPA5;CDK19;TH;CELF2;KLHL5;PIKFYVE;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;UGT1A6;YAP1;GDNF;PGPEP1;ALG10;NUB1;KLF5;GPX8;TWIST2;KLHL3;ATRAID;C5ORF63;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;UNK;LGALS3;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;COL4A1;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;RASA1;CREBRF;CTDSP2;STEAP2;KRT10;ETV4;HP1BP3;HOXA2;CAPN6;PPCS;FOS;DNM1P46;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;ZNF471;LITAF;ATG16L2;EPG5;S100A11;MYO1C;TUSC3;RXRA;CPT2;EDEM1;GID4;ACAA2;TAOK3;NFKBIE;CTSD;ZNF484;ZNRF1;DMPK;LAMB2
4069,GO:0009126,0.999960807044989,0.000130851969740919,8,248,purine nucleoside monophosphate metabolic process,BP,DDIT4;DLG4;SNCA;DHTKD1;ENPP1;NCOR1;PRPS2;PRKAG1
4108,GO:0009167,0.999960807044989,0.000130851969740919,8,248,purine ribonucleoside monophosphate metabolic process,BP,DDIT4;DLG4;SNCA;DHTKD1;ENPP1;NCOR1;PRPS2;PRKAG1
3339,GO:0007059,0.99996223991862,9.99132117151627e-05,14,299,chromosome segregation,BP,NR3C1;RMI2;NCAPD2;TTN;MLH3;ATM;MSH5;RGS14;CENPA;UVRAG;BEX4;KLHL22;AGO4;NIPBL
12896,GO:0051276,0.999963782079049,5.86042783343914e-05,76,1046,chromosome organization,BP,CPA4;XPC;NOS1;SNAI2;PHF21A;HSPA2;TCF7L1;DDB2;TADA3;PADI3;SMARCA2;NR3C1;TP53;TEP1;CHD3;MTHFR;RMI2;HLCS;SMARCA1;TNRC18;SDR16C5;HMGA2;CAMK2D;PER1;NCAPD2;UHRF2;TTN;JARID2;MLH3;PHF2;SNCA;GATAD1;JADE2;SP110;SETX;BRD3;KDM4C;CHD6;L3MBTL3;ATM;C17ORF49;CBX7;MSH5;HDAC11;RCBTB1;SOX9;ISL1;BCL6;NCOR1;PRKCA;HLTF;BAHCC1;HMBOX1;MAP3K12;CHD9;ZFPM1;RBL2;LEF1;CDKN2A;SP100;TSPYL2;TSPYL4;CENPA;POLD4;SAP30L;YEATS2;ING4;FKBP10;TAF1;ZBTB1;HP1BP3;KDM4A;KLHL22;AGO4;NIPBL;PRDM5
2473,GO:0005694,0.999963792532449,6.15861625060186e-05,60,881,chromosome,CC,TRNP1;SNAI2;MAGED1;HSPA2;ADD3;CBX5;NR1D1;SMARCA2;STAT1;TP53;MEF2D;TEP1;CHD3;SYN1;POLR3GL;HLCS;SMARCA1;TNRC18;SDR16C5;HMGA2;PHC2;NCAPD2;UHRF2;TTN;MLH3;TP73;CHEK2;PHF2;SETX;KDM4C;SEPT6;ATM;C17ORF49;TCF4;CITED2;CBX7;MSH5;MAF;BCL6;NCOR1;SALL2;CXORF57;BAHCC1;TCF12;HMBOX1;ANAPC16;RBL2;CDKN2A;SP100;ORC4;CENPA;UVRAG;POLD4;MEF2A;RARA;TAF1;HP1BP3;KDM4A;NIPBL;RXRA
3596,GO:0008026,0.999966563430174,0.000400838865766917,1,87,ATP-dependent helicase activity,MF,CHD3
14504,GO:0070035,0.999966563430174,0.000400838865766917,1,87,purine NTP-dependent helicase activity,MF,CHD3
4066,GO:0009123,0.999969540901087,9.7597721902508e-05,9,271,nucleoside monophosphate metabolic process,BP,DDIT4;DLG4;SNCA;DHTKD1;ENPP1;NCOR1;PRPS2;PRKAG1;DNPH1
2859,GO:0006353,0.99997304685227,0.000326270573128075,1,107,DNA-templated transcription, termination,BP,SETX
12490,GO:0050657,0.999974957399618,0.000109229609389753,5,173,nucleic acid transport,BP,FLOT1;ZFP36L1;TGFBR2;IGF2BP2;MYO1C
12491,GO:0050658,0.999974957399618,0.000109229609389753,5,173,RNA transport,BP,FLOT1;ZFP36L1;TGFBR2;IGF2BP2;MYO1C
12732,GO:0051028,0.99997785325536,0.000130752678886963,3,135,mRNA transport,BP,ZFP36L1;IGF2BP2;MYO1C
16848,GO:0098813,0.999978912890543,6.60165055889283e-05,10,251,nuclear chromosome segregation,BP,RMI2;NCAPD2;TTN;MLH3;ATM;MSH5;CENPA;KLHL22;AGO4;NIPBL
4102,GO:0009161,0.999981720970069,6.35317262977899e-05,8,259,ribonucleoside monophosphate metabolic process,BP,DDIT4;DLG4;SNCA;DHTKD1;ENPP1;NCOR1;PRPS2;PRKAG1
16838,GO:0098798,0.999982872281826,0.000101045893806612,3,218,mitochondrial protein complex,CC,BCKDHB;SNCA;NDUFA4L2
3341,GO:0007062,0.999984013078427,0.000125046738464814,2,120,sister chromatid cohesion,BP,CENPA;NIPBL
3963,GO:0008757,0.99998431157763,0.000122410076346878,2,130,S-adenosylmethionine-dependent methyltransferase activity,MF,LRTOMT;PCMTD2
3598,GO:0008033,0.999984789822123,0.000192820279009975,1,120,tRNA processing,BP,AARS
10885,GO:0044451,0.999985146848945,2.50708268346556e-05,69,973,nucleoplasm part,CC,PHF21A;TADA3;CBX5;NR1D1;PTK6;NR3C1;TP53;WWTR1;ZBTB20;CHD3;HIVEP1;GLI3;E2F7;ARHGAP18;POLR3GL;GLI2;RMI2;PIAS3;ERCC6;SLC2A4RG;TNRC18;TP53INP1;JARID2;CHEK2;JADE2;LMNA;SETX;NCOA2;OBSCN;SETBP1;CHD6;NFATC4;RAPH1;MDM2;C17ORF49;DGKQ;HDAC11;CRTC1;NCOR1;PLAG1;SALL2;TRERF1;RGS14;BAHCC1;TCF12;HMBOX1;ATXN1;MAML2;WDR19;TAF8;USP28;SP100;CDK19;FLYWCH1;SAP30L;YEATS2;ING4;TAF1;ZBTB1;CREBRF;HP1BP3;AGO4;KLHDC2;MED12;FBXL4;NIPBL;PRDM5;MYO1C;DOCK1
3181,GO:0006807,0.999985240710268,1.92166547086603e-05,696,7368,nitrogen compound metabolic process,BP,SERPINE2;PHACTR3;CPA4;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;CTGF;ADAM19;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;ADAMTSL1;EFEMP1;TENM4;MARCH4;SLC7A8;GSN;ETV5;PKD2;IRS2;DUSP6;OSBPL10;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;PHF21A;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;CLCA2;MYLK;GJC2;RFX2;TRIM2;ZNF608;SERPINE1;SERPINH1;ENDOD1;RNF213;CRTAP;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;DDB2;MAP3K6;DCAKD;TIMP2;ZNF862;TADA3;TENM3;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;NEFL;HSF2BP;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;PILRB;ZCCHC11;PDGFA;MMP19;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;PHGDH;FLG;HIP1;GPNMB;TFDP2;BCKDHB;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;PTGES;CDK14;E2F7;CNTN1;LPCAT2;KITLG;P3H2;ERO1B;KRBA2;CTDSPL;MTHFR;ABHD14B;ZFP90;NEK9;CTSV;KCNAB2;NMRK1;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;LTBP4;ADIRF;FUT10;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;CLU;FKBP9;SERPING1;TCEAL3;PRKCZ;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;HIBADH;PTPN14;PER1;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;CASP14;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GATAD1;FZD7;AIP;GLG1;JADE2;SP110;PTPRU;FGFR1;IGF1R;APOBEC3F;DKK1;PRKAB2;CTF1;RGS2;C5;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MEIS2;MANBA;TMEM14C;AREG;IFNK;ZNF107;TCF4;AKAP13;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;HEXA;IFNE;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;MSH5;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;ARHGEF2;NTNG1;PLGRKT;ALDH4A1;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;PRCP;STK16;CRTC1;NCOR1;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;AMZ2;ADAMTS15;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;MAN2B1;PGAP1;TSHZ1;IGFBP4;ALDH9A1;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PAK6;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;TSPAN5;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DNASE1L1;DSEL;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;DPP9;THRA;SSBP3;CDC42EP5;USP28;ALDH7A1;ITM2A;MAPK8IP3;MSRB2;TRIML2;CDKN2A;PPM1M;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;NPHP3;RHBDD1;MAGI2;HSPA5;CDK19;TH;CELF2;KLHL5;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;RHBDD2;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;YAP1;GDNF;PGPEP1;ALG10;NUB1;KLF5;TWIST2;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PPARG;RNF144B;PARP15;BEX4;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;SASH1;TGIF1;OBSL1;ING4;ZYG11B;APOL6;UNK;LGALS3;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;RASA1;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;CAPN6;PPCS;FOS;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;ZNF471;LITAF;S100A11;TUSC3;RXRA;EDEM1;GID4;TAOK3;NFKBIE;CTSD;ZNF484;ZNRF1;DMPK;LAMB2
17275,GO:0140101,0.999986606640862,0.000171801733090638,1,118,catalytic activity, acting on a tRNA,MF,AARS
10776,GO:0044271,0.999987552631517,1.65986892869958e-05,345,3944,cellular nitrogen compound biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;PCSK1;NR1D1;SMARCA2;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;RBMS3;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;ADIRF;UGT8;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;PLA2G6;SLC2A4RG;SMARCA1;ZNF318;TNRC18;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;AARS;CHEK2;PAIP2B;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;DKK1;RGS2;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;MEIS2;TMEM14C;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;ALDH9A1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;ALDH7A1;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
2557,GO:0005840,0.999988289001271,7.08305323431175e-05,3,225,ribosome,CC,EIF2AK4;SNCA;RPL13A
4140,GO:0009205,0.999988631245404,4.67743264714851e-05,6,233,purine ribonucleoside triphosphate metabolic process,BP,DDIT4;SNCA;DHTKD1;ENPP1;NCOR1;PRKAG1
10489,GO:0043414,0.999989030860754,3.93169771493449e-05,8,234,macromolecule methylation,BP,BTG1;MTHFR;JARID2;KDM4C;PCMTD2;FOS;KDM4A;PRDM5
16221,GO:0090305,0.999989728630011,3.68496993226252e-05,8,249,nucleic acid phosphodiester bond hydrolysis,BP,ENDOD1;DDB2;PNRC1;ANG;ENPP1;PGAP1;DNASE1L1;POLD4
10374,GO:0043227,0.999990256472924,1.31646039576462e-05,894,9219,membrane-bounded organelle,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;MARVELD1;SFRP1;ST6GALNAC2;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;DDIT4;FAT4;TNNI2;XPC;PTGS1;ITGB4;ADAMTSL1;EFEMP1;TENM4;ASAP3;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;PKD2;JPH2;SCARA3;DUSP6;TSC22D1;CYBRD1;NID1;ZFP36L2;IGF2BP2;SDK1;TNIK;ANPEP;SKP2;PROM2;COL7A1;BCAM;ZNF362;H6PD;CLTCL1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;SLC8A1;FKBP5;CLCA2;SESN3;MYLK;SYNE3;SLC2A3;THBS2;RFX2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;FAM198B;CSPG4;DDB2;TKFC;EVC;FAM210B;MAMDC2;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PADI3;BMP4;ITM2C;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;CITED4;XAF1;HS1BP3;FCGBP;TRIM5;VAV3;PDCD4;NR3C1;MXRA5;COL18A1;STAT1;SORL1;NEO1;IFIT2;LGALS1;GNG2;KCNMA1;MEST;D2HGDH;CPVL;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;SEC14L2;MUC19;DLG4;ARMC9;SLC7A11;SEMA5A;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;NISCH;PPL;ADARB1;TIMP1;ACSL3;EFEMP2;PHGDH;FLG;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;FILIP1L;ITGA3;CHD3;SIK1;ZNF18;CPED1;KLF12;IFIT3;KLF9;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;GLI3;PAQR8;PTGES;CDK14;E2F7;CNTN1;LPCAT2;TBC1D5;P3H2;NAV2;ECH1;ASAP1;ERO1B;PLLP;SYN1;CTDSPL;PDPN;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;KCNAB2;LRP1;FYN;ARHGEF12;IFI6;XDH;TSHZ2;B3GAT3;LTBP4;ARHGAP18;ADIRF;FUT10;CMBL;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SLC22A17;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;SNX29;PRKCZ;SLIT3;OAS2;SDR16C5;ULK2;TP53INP1;ZNF678;PARP4;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;HIBADH;METTL7A;ULBP1;PTPN14;PER1;ATP8B2;EHBP1;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;LAMA5;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;CASP14;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;WDFY2;LRIG3;R3HDM2;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;THSD4;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;SH3TC2;SP110;COL16A1;FGFR1;CBR1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;LTBP3;RGS2;C5;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;G6PD;MYOF;TLE4;ARSD;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;AMOTL1;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;FOXL1;BBS4;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;COPG2;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;DLK2;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;DNAJC6;SNX10;DGKQ;CITED2;NR2F2;PLXNA1;ACSS2;HEXA;NEURL1B;CBX7;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;FBXW8;ZBTB22;HSPA12A;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;FGD4;NEMP2;PTPN1;POGLUT1;VANGL2;CPNE8;ARHGEF2;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;ZNF546;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;TMC4;RAB13;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;SEPT5;BAHCC1;RNF24;METTL23;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;CHD9;MEGF8;ZNF302;UACA;ATXN1;ACSF2;IRF2BPL;STK36;RAB43;MAML2;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;ITGB8;NAPRT;CCHCR1;MON2;ITPR2;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;LMF1;UGT1A6;YAP1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;TBC1D16;TGIF1;OBSL1;ING4;POSTN;PRR7;LGALS3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;HCFC1R1;ZBTB1;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;PPCS;FOS;DNM1P46;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM169A;CLEC2D;FAM120B;SERPINB5;SCPEP1;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;PCDHGB5;ADAM10;PRDM5;RHOBTB3;CELSR1;MPDZ;ZNF471;LITAF;ATG16L2;TSPAN4;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
307,GO:0000819,0.999992395724564,2.9716746554492e-05,7,215,sister chromatid segregation,BP,RMI2;NCAPD2;TTN;ATM;CENPA;KLHL22;NIPBL
2430,GO:0005622,0.999992737466684,1.06138582096839e-05,1048,10504,intracellular,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;FAT4;TGFBR2;TNNI2;XPC;PTGS1;ADAMTSL1;TENM4;ASAP3;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;DOCK5;SESN3;MYLK;SYNE3;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;LGALS9C;FAM210B;MAMDC2;MAP3K6;AMIGO2;STMN3;ADD3;TOM1L2;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;TBC1D8;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;HS1BP3;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;SCN2A;LGALS1;GNG2;MEST;D2HGDH;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;TCP11L1;SLC7A11;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;FRMD4B;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;EVI5L;ZNF18;CPED1;TTC28;KLF12;IFIT3;KLF9;WDR66;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;ASAP1;ERO1B;KRBA2;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PLXNB1;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;TNS2;CHST3;EHD3;HMGA2;CAMK2D;ADGRG6;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;IL31RA;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;IFT140;SPRY4;LRIG3;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;SH3TC2;SP110;COL16A1;DZIP1L;FGFR1;CBR1;PAG1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;PYROXD2;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;EDA2R;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;ATM;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;GCLC;NR2F2;ACSS2;ELMO3;FHOD3;HEXA;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;IFI44;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;FGD4;NEMP2;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;DNAL4;FAM117A;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;ZNF546;KRT222;NRK;SSH1;LYST;EGR1;SOX9;UCN2;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;UACA;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;MPRIP;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;OPHN1;TPGS1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;GDNF;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;NBPF15;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;ICK;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;NYAP1;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TRIM16L;TSHZ3;CEP85L;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;HCFC1R1;ZBTB1;DPYD;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;ACOT1;FAM169A;CLEC2D;FAM120B;SERPINB5;SCPEP1;MATN3;CAMK2N1;ELMO2;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADM2;KCNRG;BSN;OXTR;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;ANKS6;EPG5;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
4086,GO:0009144,0.999993050464863,2.93506833013789e-05,6,240,purine nucleoside triphosphate metabolic process,BP,DDIT4;SNCA;DHTKD1;ENPP1;NCOR1;PRKAG1
10848,GO:0044391,0.999993138500512,9.15968205069464e-05,1,182,ribosomal subunit,CC,RPL13A
4134,GO:0009199,0.999993153893438,2.89420411913977e-05,6,239,ribonucleoside triphosphate metabolic process,BP,DDIT4;SNCA;DHTKD1;ENPP1;NCOR1;PRKAG1
2893,GO:0006403,0.999993606373964,2.72777829644925e-05,6,209,RNA localization,BP,FLOT1;ZFP36L1;TGFBR2;IGF2BP2;ATM;MYO1C
10272,GO:0043043,0.999996796919224,6.94909942067673e-06,31,674,peptide biosynthetic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;VIM;BMP4;PCSK1;ABTB1;EIF2AK4;ITGA2;RBMS3;PER1;CAPRIN2;ANG;CIRBP;DAPK1;AARS;PAIP2B;RGS2;CALR;GCLC;NCOR1;RPL13A;GGT7;PPARG;UNK;DNAJC3;RARA;PPP3CA;AGO4;RXRA
5561,GO:0016579,0.999997147815976,1.09150274903862e-05,8,244,protein deubiquitination,BP,SKP2;DDB2;TADA3;TP53;RNF135;PSMB9;MDM2;USP28
8216,GO:0032991,0.999997180434198,3.85284999363924e-06,327,3844,protein-containing complex,CC,ITGB6;FLOT1;FN1;CCBE1;ITGB5;COL8A1;ITGA6;ZFP36L1;SYNE1;MYH15;TGFBR2;TNNI2;XPC;ITGB4;ANO1;GSN;COL5A2;GJA5;PKD2;JPH2;PIK3C2G;SCARA3;SKP2;COL7A1;CLTCL1;NOS1;MAGED1;COL5A1;PHF21A;UTRN;ROR1;AXL;EGFR;HSPA2;LAMB1;SPTB;SESN3;SYNE3;GJC2;CRTAP;TCF7L1;C1QTNF6;VIM;NUPR1;DDB2;EVC;TADA3;PAK1;ABCA1;CBX5;VDR;APOBEC3C;NR1D1;SMARCA2;SCN8A;ABTB1;EIF2AK4;TRIM5;NEFL;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;SCN2A;GNG2;KCNMA1;TP53;CEP250;WWTR1;DDIT3;CNTRL;CUL9;CCDC102A;PYCARD;LTBP1;DLG4;ITGA2;MAP2;HIP1;COL4A4;TFDP2;BCKDHB;TEP1;PNRC1;CUL7;ITGA3;CHD3;WDR66;SNX1;ANO6;LAMC2;GLI3;CDK14;E2F7;TBC1D5;ASAP1;SESN1;PLXNB1;EML2;KCNAB2;LRP1;LAMA3;POLR3GL;CAV1;ERCC6;ITGA10;SEL1L;GLDC;ESPN;SMARCA1;TNRC18;DCAF16;CLU;PRKCZ;SDR16C5;FBXW4;HMGA2;CAMK2D;PHC2;ITGA1;MST1R;HAUS4;PXN;PIK3R1;SYT1;NCAPD2;CAPRIN2;APOBEC3G;ANG;KIF17;LAMA5;BBS2;HERPUD1;WFS1;PHKA2;LAMB3;TTN;TSTD1;CIRBP;JARID2;LMO7;HPS4;FBLN1;MLH3;TP73;SHROOM4;PRKACB;KCNJ5;IFT140;PHF2;FBXL7;SNCA;FLOT2;PDIA6;VAMP1;AIP;JADE2;PLXNA2;COL16A1;FGFR1;IGF1R;APOBEC3F;FSCN1;PRKAB2;SEC24D;C5;PDE4D;NCOA2;MYO3B;PSMB9;PLA2R1;TLE4;EPHB6;FZD8;DHTKD1;CHD6;CDH13;NFATC4;AKAP7;SEPT6;TGFBR3;FZD1;AMOTL1;IPP;PBX1;ENG;BBS4;CALR;HPS3;ATM;COPG2;FBXO17;APH1B;MDM2;TMED10;C17ORF49;TCF4;BBS1;CITED2;GCLC;PLXNA1;CBX7;LMO4;MSH5;FBXW8;SYNE2;HDAC11;KCNQ3;NT5DC3;ARHGEF2;DNAL4;NDUFA4L2;KLHL12;COL5A3;SOX9;IFT27;NCOR1;PRKCA;SALL2;PXMP2;PRPS2;ANXA2;TRERF1;MPP7;WDR63;SEPT5;BAHCC1;METTL23;LEPR;IFT88;MVB12B;TES;TTC8;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;ATXN1;WDR19;TAF8;PRNP;CDH11;RET;ZFPM1;RBL2;ODF2;VPS39;COL12A1;SCNN1A;IFT122;LEF1;THRA;SSBP3;USP28;SP100;ULK1;ORC4;MAGI2;HSPA5;CDK19;KLHL5;CENPA;UVRAG;ITGB8;ITPR2;IFT74;POLD4;SAP30L;MYO9A;YAP1;CACNB1;DNAH1;COL17A1;KLHL3;YEATS2;DERL3;PPARG;CAPG;RNF144B;CALCRL;KCNIP3;MEF2A;SHISA9;OBSL1;ING4;ZYG11B;UNK;LGALS3;DNAJC3;RARA;COG3;COL4A1;ABCA2;CCNY;TMEM67;PBX2;PRKAG1;TAF1;FZD4;SLITRK5;PPP3CA;DCAF8;PIK3C2B;ACTR1B;HP1BP3;FOS;SEPT9;KLHL22;AGO4;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;VPS36;PPP2R3A;MYO1C;TUSC3;RXRA;SNTB1;DOCK1;LAMB2
16287,GO:0090501,0.999997220406003,4.04405119368653e-05,1,124,RNA phosphodiester bond hydrolysis,BP,ANG
10594,GO:0043604,0.999997538225597,5.18064868419127e-06,35,735,amide biosynthetic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;VIM;BMP4;PCSK1;ABTB1;EIF2AK4;ITGA2;RBMS3;UGT8;CPS1;PLA2G6;PER1;CAPRIN2;ANG;CIRBP;DAPK1;AARS;PAIP2B;RGS2;CALR;GCLC;NCOR1;RPL13A;GGT7;PPARG;CERS5;UNK;DNAJC3;RARA;PPP3CA;AGO4;RXRA
17668,GO:1901576,0.999997704490564,3.0800878031969e-06,434,4887,organic substance biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;CD109;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;PTGS1;ADAMTSL1;EFEMP1;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;COL5A1;PHF21A;ROR1;TCEAL4;EGFR;GALNT10;TSC22D3;KLF8;SDC3;NTM;RFX2;ZNF608;SERPINE1;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;ABCA1;CBX5;VDR;BMP4;TRIM38;ITM2C;ISYNA1;PCSK1;NR1D1;SMARCA2;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;MUC19;ITGA2;PDGFA;RBMS3;ACSL3;PHGDH;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;PTGES;E2F7;LPCAT2;KITLG;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;B3GAT3;ADIRF;FUT10;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;XYLT1;UST;ACSS1;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;ACACB;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;ST6GAL2;KLF13;AARS;CHEK2;PAIP2B;PHF2;TLR3;MAN1A1;ZNF860;SNCA;ADAMTS7;GATAD1;FZD7;AIP;SP110;FGFR1;CBR1;IGF1R;ALOX15B;DKK1;PRKAB2;RGS2;GLT8D2;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;MDM2;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;HSD17B11;DGKQ;CITED2;GCLC;NR2F2;ACSS2;HEXA;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;POGLUT1;VANGL2;ARHGEF2;NTNG1;SDC2;THNSL2;ZNF546;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;G6PC3;ZNF717;GCNT1;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;ETNK2;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;LEPR;PGAP1;TSHZ1;ALDH9A1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DSEL;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;ALDH7A1;ITM2A;MSRB2;CDKN2A;OSBPL1A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;HSPA5;TH;PIKFYVE;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;LMF1;YAP1;GDNF;ALG10;KLF5;TWIST2;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;COG3;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;PIK3C2B;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;TUSC3;RXRA;ACAA2;NFKBIE;ZNF484
4083,GO:0009141,0.999998054165408,8.7631948362916e-06,6,257,nucleoside triphosphate metabolic process,BP,DDIT4;SNCA;DHTKD1;ENPP1;NCOR1;PRKAG1
4022,GO:0009058,0.999998136282293,2.50609746367911e-06,437,4926,biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TNNI2;PTGS1;ADAMTSL1;EFEMP1;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;COL5A1;PHF21A;ROR1;TCEAL4;EGFR;GALNT10;TSC22D3;KLF8;SDC3;NTM;RFX2;ZNF608;SERPINE1;SERPINH1;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;ABCA1;CBX5;VDR;BMP4;TRIM38;ITM2C;ISYNA1;PCSK1;NR1D1;SMARCA2;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;MUC19;ITGA2;PDGFA;RBMS3;ACSL3;PHGDH;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;PTGES;E2F7;LPCAT2;KITLG;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;B3GAT3;ADIRF;FUT10;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;XYLT1;UST;ACSS1;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;ACACB;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;ST6GAL2;KLF13;AARS;CHEK2;PAIP2B;PHF2;TLR3;MAN1A1;ZNF860;SNCA;ADAMTS7;ALDH1L2;GATAD1;FZD7;AIP;SP110;FGFR1;CBR1;IGF1R;ALOX15B;DKK1;PRKAB2;RGS2;GLT8D2;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;MDM2;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;HSD17B11;DGKQ;CITED2;GCLC;NR2F2;ACSS2;HEXA;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;POGLUT1;VANGL2;ARHGEF2;NTNG1;SDC2;THNSL2;ZNF546;EGR1;SOX9;ENPP1;ISL1;ITPKB;BCL6;STK16;CRTC1;NCOR1;G6PC3;ZNF717;GCNT1;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;ETNK2;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;LEPR;PGAP1;TSHZ1;ALDH9A1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DSEL;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;ALDH7A1;ITM2A;MSRB2;CDKN2A;OSBPL1A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;HSPA5;TH;PIKFYVE;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;LMF1;YAP1;GDNF;ALG10;KLF5;TWIST2;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;COG3;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;PIK3C2B;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;TUSC3;RXRA;ACAA2;NFKBIE;ZNF484
17985,GO:1902494,0.999998220544247,3.02714225424501e-06,82,1232,catalytic complex,CC,TGFBR2;PIK3C2G;SKP2;PHF21A;DDB2;TADA3;CBX5;SMARCA2;ABTB1;BTBD2;GNG2;TP53;CUL9;PYCARD;BCKDHB;TEP1;CUL7;CHD3;CDK14;TBC1D5;POLR3GL;SEL1L;GLDC;SMARCA1;DCAF16;FBXW4;PHC2;PIK3R1;WFS1;PHKA2;JARID2;LMO7;FBXL7;SNCA;JADE2;PRKAB2;PSMB9;DHTKD1;CHD6;IPP;ENG;FBXO17;C17ORF49;GCLC;CBX7;FBXW8;HDAC11;DNAL4;KLHL12;NCOR1;SALL2;PRPS2;TRERF1;WDR63;ANAPC16;TAF8;ULK1;KLHL5;UVRAG;POLD4;SAP30L;DNAH1;KLHL3;YEATS2;RNF144B;ING4;ZYG11B;ABCA2;CCNY;PRKAG1;TAF1;PPP3CA;DCAF8;PIK3C2B;KLHL22;AGO4;MED12;ABAT;FBXL4;NIPBL;PPP2R3A;TUSC3
5274,GO:0015931,0.999998425467371,7.99063855533417e-06,5,207,nucleobase-containing compound transport,BP,FLOT1;ZFP36L1;TGFBR2;IGF2BP2;MYO1C
10766,GO:0044249,0.999998555341362,1.95154371450936e-06,426,4821,cellular biosynthetic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TNNI2;PTGS1;ADAMTSL1;EFEMP1;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;GALNT10;TSC22D3;KLF8;NTM;RFX2;ZNF608;SERPINE1;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;ABCA1;CBX5;VDR;BMP4;TRIM38;ITM2C;ISYNA1;PCSK1;NR1D1;SMARCA2;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;MUC19;ITGA2;PDGFA;RBMS3;ACSL3;PHGDH;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;PTGES;E2F7;LPCAT2;KITLG;KRBA2;ABHD14B;ZFP90;NMRK1;XDH;TSHZ2;B3GAT3;ADIRF;FUT10;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;PLA2G6;TRIB2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;XYLT1;UST;ACSS1;CLU;TCEAL3;PRKCZ;SDR16C5;TP53INP1;ZNF678;PARP4;CHST3;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;ACACB;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;ST6GAL2;KLF13;AARS;CHEK2;PAIP2B;PHF2;TLR3;MAN1A1;ZNF860;SNCA;ADAMTS7;GATAD1;FZD7;AIP;SP110;FGFR1;CBR1;IGF1R;ALOX15B;DKK1;PRKAB2;RGS2;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;PDK3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;MDM2;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;HSD17B11;DGKQ;CITED2;GCLC;NR2F2;ACSS2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;POGLUT1;VANGL2;ARHGEF2;NTNG1;THNSL2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;GCNT1;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;ETNK2;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;LEPR;PGAP1;TSHZ1;ALDH9A1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;GAL3ST4;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DSEL;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;ALDH7A1;ITM2A;MSRB2;CDKN2A;OSBPL1A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;HSPA5;TH;PIKFYVE;TGFB1I1;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;LMF1;YAP1;GDNF;ALG10;KLF5;TWIST2;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;TGIF1;ING4;UNK;DNAJC3;RARA;COG3;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;PIK3C2B;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;TUSC3;RXRA;NFKBIE;ZNF484
10759,GO:0044237,0.999999115422177,1.19815324585451e-06,739,7877,cellular metabolic process,BP,SERPINE2;PHACTR3;CPA4;SULT1E1;TNFRSF6B;FLOT1;MMP2;PRSS23;TRNP1;HTRA1;FN1;PYGB;FLRT2;MMP9;CCBE1;PRODH;GPRC5A;TXNIP;CTGF;FBN1;SOX6;INPP5D;ITGA6;SFRP1;ST6GALNAC2;GADD45B;CD109;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ITGB4;ADAMTSL1;EFEMP1;MARCH4;SLC7A8;GSN;ETV5;PKD2;PITPNM3;PIK3C2G;IRS2;DUSP6;OSBPL10;TSC22D1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;SULF2;PHF21A;TFPI2;ROR1;TCEAL4;AXL;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;ITPK1;HSPA2;LAMB1;FLRT3;SPEG;SPTB;NYNRIN;NTM;FKBP5;SESN3;MYLK;GJC2;SLC20A1;SLC2A3;RFX2;TRIM2;ZNF608;SERPINE1;SERPINH1;ENDOD1;RNF213;CRTAP;TCF7L1;MBOAT2;RNF165;VIM;NUPR1;CSPG4;DDB2;TKFC;MAP3K6;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PTPRM;PADI3;BMP4;TRIM38;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;STAT1;BTBD2;SORL1;NEO1;LGALS1;D2HGDH;CPVL;ETV1;TP53;ARAP1;EXTL2;MBNL2;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;SEC14L2;WNK1;MUC19;DLG4;ITGA2;SLC27A3;PILRB;ZCCHC11;PDGFA;RBMS3;MICAL1;ADARB1;TIMP1;ACSL3;PHGDH;FLG;HIP1;GPNMB;TFDP2;BCKDHB;TEP1;PNRC1;CCDC85B;CRIM1;CUL7;BTG1;ITGA3;CHD3;LIX1L;SIK1;ZNF18;KLF12;KLF9;NFIX;ELFN2;HIVEP1;TYSND1;SNX1;GPX1;GLI3;PTGES;CDK14;E2F7;CNTN1;LPCAT2;KITLG;TBC1D5;P3H2;ECH1;ERO1B;KRBA2;CTDSPL;MTHFR;SRPX;ABHD14B;ZFP90;NEK9;SESN1;CTSV;KCNAB2;NMRK1;LRP1;FYN;IFI6;XDH;ALPK1;TSHZ2;B3GAT3;ADIRF;FUT10;CMBL;UGT8;CPS1;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;PRKCZ;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;TNS2;CHST3;EHD3;HMGA2;CAMK2D;GOLGB1;PRDX5;ITGA1;MST1R;KANK2;ZSCAN18;IL31RA;HIBADH;PTPN14;PER1;CCK;PIK3R1;HHAT;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;UHRF2;HERPUD1;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;LMO7;APLP2;FBLN1;MLH3;ZKSCAN1;TP73;CAT;PLCH2;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;SPRY4;PAIP2B;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;OARD1;ADAMTS7;ALDH1L2;MME;PDIA6;GATAD1;FZD7;AIP;GLG1;JADE2;SP110;PTPRU;FGFR1;CBR1;IGF1R;APOBEC3F;ALOX15B;DKK1;PRKAB2;CTF1;RGS2;C5;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;PLA2R1;ESYT2;PDK3;G6PD;TLE4;EPHB6;ARSD;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;IPP;LRTOMT;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;MTMR4;ZNF699;CALR;NEGR1;ATM;IDH2;FBXO17;APH1B;MDM2;FAM20A;TMED10;CST3;MEIS2;MANBA;TMEM14C;AREG;IFNK;ZNF107;TCF4;AKAP13;HSD17B11;DNAJC6;DGKQ;CITED2;GCLC;NR2F2;ACSS2;HEXA;IFNE;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;MSH5;MAF;TRAK1;LZTS1;FBXW8;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;PTPN1;POGLUT1;VANGL2;NT5DC3;ARHGEF2;NTNG1;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;THNSL2;ZNF546;NRK;SSH1;EGR1;SOX9;ENPP1;ISL1;ITPKB;SLC27A6;BCL6;PRCP;STK16;CRTC1;NCOR1;G6PC3;ZNF717;GCNT1;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;HLTF;HOXA1;CXORF57;BAHCC1;RNF24;METTL23;LEPR;MAN2B1;PGAP1;TSHZ1;IGFBP4;IFT88;ALDH9A1;MVB12B;KCTD7;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PAK6;DECR1;ZNF160;ABCC2;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;CDC42EP5;ZADH2;USP28;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;TRIML2;CDKN2A;EFR3A;PPM1M;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;IGFBP2;ORC4;NPHP3;VAV2;RHBDD1;MAGI2;HSPA5;CDK19;TH;CELF2;KLHL5;PIKFYVE;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;UGT1A3;VPS13C;FHOD1;IFT74;POLD4;SAP30L;ZNF12;OPHN1;TPGS1;LMF1;UGT1A6;YAP1;GDNF;ALG10;NUB1;KLF5;TWIST2;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;AGPAT1;PPARG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;SASH1;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;UNK;LGALS3;PTPN3;MIA3;DNAJC3;FKBP10;RARA;COG3;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;TSHZ3;EFNA5;GSTZ1;FZD4;MPPE1;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;DCAF8;PIK3C2B;RASA1;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNM1P46;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AIG1;AGO4;ACOT1;FAM120B;FAM168A;SERPINB5;SCPEP1;MATN3;CAMK2N1;EHHADH;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;VPS36;TTBK2;ADM2;OXTR;ADAM10;PRDM5;RNPEPL1;PPP2R3A;ZNF471;LITAF;ATG16L2;EPG5;S100A11;TUSC3;RXRA;CPT2;EDEM1;GID4;ACAA2;TAOK3;NFKBIE;CTSD;ZNF484;ZNRF1;DMPK;LAMB2
14840,GO:0070646,0.999999163061759,3.38155497024111e-06,8,259,protein modification by small protein removal,BP,SKP2;DDB2;TADA3;TP53;RNF135;PSMB9;MDM2;USP28
2900,GO:0006412,0.999999174731698,1.92717371828283e-06,28,655,translation,BP,ZFP36L1;ZFP36L2;IGF2BP2;EGFR;VIM;BMP4;ABTB1;EIF2AK4;ITGA2;RBMS3;PER1;CAPRIN2;ANG;CIRBP;DAPK1;AARS;PAIP2B;RGS2;CALR;NCOR1;RPL13A;PPARG;UNK;DNAJC3;RARA;PPP3CA;AGO4;RXRA
10376,GO:0043229,0.99999923108734,1.07865324944259e-06,900,9280,intracellular organelle,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;ST6GALNAC2;GADD45B;CD109;RHOBTB2;CDKN2B;ZFP36L1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;TNNI2;XPC;PTGS1;ADAMTSL1;TENM4;ASAP3;MARCH4;GSN;COL5A2;ETV5;PKD2;JPH2;SCARA3;DUSP6;OSBPL10;TSC22D1;CYBRD1;ZFP36L2;IGF2BP2;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;SAMD9L;ROR1;TCEAL4;DPYSL2;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;SESN3;MYLK;SYNE3;SLC2A3;THBS2;RFX2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;VIM;NUPR1;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;EVC;FAM210B;MAMDC2;AMIGO2;STMN3;ADD3;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PADI3;BMP4;NEFM;TNS1;ITM2C;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;CITED4;XAF1;EIF2AK4;HS1BP3;TRIM5;NEFL;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;MEST;D2HGDH;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;SEC14L2;DDX60;EFHC1;MUC19;DLG4;TCP11L1;SLC7A11;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;FRMD4B;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;FLG;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;BTG1;FILIP1L;CHD3;SIK1;ZNF18;CPED1;TTC28;KLF12;IFIT3;KLF9;WDR66;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ASAP1;ERO1B;SYN1;CTDSPL;PDPN;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;EML2;KCNAB2;LRP1;FYN;IFI6;XDH;FLNC;TSHZ2;B3GAT3;ARHGAP18;ADIRF;FUT10;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;ULK2;TP53INP1;ZNF678;PARP4;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;MLH3;ZKSCAN1;TP73;CAT;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;WDFY2;IFT140;LRIG3;R3HDM2;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;SH3TC2;SP110;COL16A1;DZIP1L;FGFR1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;MYOF;TLE4;ARSD;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;CHD6;NFATC4;FOXN3;RAPH1;AKAP7;LMCD1;SEPT6;DLX3;AMOTL1;IPP;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;FOXL1;BBS4;MTMR4;ZNF699;CALR;ATM;IDH2;COPG2;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;NR2F2;ACSS2;FHOD3;HEXA;NEURL1B;CBX7;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;FBXW8;ZBTB22;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;FGD4;NEMP2;PTPN1;POGLUT1;VANGL2;ARHGEF2;DNAL4;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;ZNF546;KRT222;SSH1;LYST;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;MAN2B1;CEP68;PGAP1;TSHZ1;IGFBP4;IFT88;GOLGA8B;MVB12B;TES;TTC8;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;CHD9;MEGF8;ZNF302;UACA;ATXN1;ACSF2;IRF2BPL;STK36;RAB43;MAML2;WDR19;SLC39A11;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;PPM1M;MPRIP;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;CFAP54;ITPR2;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;OPHN1;TPGS1;LMF1;UGT1A6;MYO9A;YAP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;KLHL3;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;TBC1D16;TGIF1;OBSL1;ING4;POSTN;PRR7;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;CEP85L;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;HCFC1R1;ZBTB1;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM169A;CLEC2D;FAM120B;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;ADAM10;PRDM5;RHOBTB3;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
5328,GO:0016070,0.999999335215462,9.27107891820341e-07,321,3757,RNA metabolic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;RFX2;ZNF608;SERPINE1;TCF7L1;RNF165;VIM;NUPR1;ZNF862;TADA3;CBX5;VDR;APOBEC3C;BMP4;TRIM38;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ZCCHC11;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;KLF13;AARS;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;APOBEC3F;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;SMG9;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;HSPA5;CELF2;TGFB1I1;SRPK2;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;LGALS3;RARA;ABCA2;HES2;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;RXRA;NFKBIE;ZNF484
10864,GO:0044424,0.999999405792341,8.93080341177448e-07,1028,10385,intracellular part,CC,SERPINE2;PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;HTRA1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;ITGB5;COL8A1;CTGF;ADAM19;FBN1;SOX6;INPP5D;MARVELD1;SFRP1;ST6GALNAC2;GADD45B;MMP28;CD109;RHOBTB2;CDKN2B;ZFP36L1;NQO1;APBB2;SYNE1;F2R;TLN2;MYH15;DDIT4;TGFBR2;TNNI2;XPC;PTGS1;ADAMTSL1;TENM4;ASAP3;MARCH4;SLC7A8;ANO1;GSN;COL5A2;ETV5;PKD2;PITPNM3;JPH2;PIK3C2G;SCARA3;IRS2;DUSP6;OSBPL10;TSC22D1;CYBRD1;ZFP36L2;IGF2BP2;HERC5;TNIK;ANPEP;SKP2;PROM2;COL7A1;ZNF362;H6PD;CLTCL1;TNS4;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ARHGAP23;SAMD9L;ROR1;TCEAL4;AXL;DPYSL2;DOCK9;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;ITPK1;HSPA2;LAMB1;FLRT3;TCHH;SPEG;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;DOCK5;SESN3;MYLK;SYNE3;SLC2A3;CCNG2;THBS2;RFX2;TRIM2;ACTA2;SERPINE1;DOK1;ATP10D;SERPINH1;ENDOD1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;ANXA5;VIM;NUPR1;FAM198B;CSPG4;DDB2;PSTPIP1;CTNNAL1;TKFC;IFI44L;EVC;ALS2CL;LGALS9C;FAM210B;MAMDC2;AMIGO2;STMN3;ADD3;ASAP2;NTSR1;DCAKD;TIMP2;ZNF862;TADA3;PDLIM2;PLEC;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;CHN2;APOBEC3C;PTPRM;SRGAP3;PADI3;BMP4;TRIM38;NEFM;TNS1;ITM2C;ISYNA1;TP53I3;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;RIN2;CITED4;XAF1;EIF2AK4;HS1BP3;TRIM5;NEFL;HSF2BP;VAV3;PDCD4;NR3C1;COL18A1;STAT1;BTBD2;SORL1;NEO1;IFIT2;LGALS1;GNG2;MEST;D2HGDH;ETV1;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CUL9;CCDC102A;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;IL32;SEC14L2;IFIT1;WNK1;DDX60;EFHC1;ARHGEF1;MUC19;DLG4;TCP11L1;SLC7A11;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;FRMD4B;RBMS3;MICAL1;NISCH;PPL;ADARB1;TIMP1;ACSL3;PHGDH;FLG;PHLDB1;HIP1;PACS1;COL4A4;GPNMB;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;BTG1;FILIP1L;ITGA3;CHD3;LIX1L;SIK1;ZNF18;CPED1;TTC28;KLF12;IFIT3;KLF9;WDR66;NFIX;HIVEP1;TYSND1;TPBG;SNX1;ANO6;GPX1;PLEK2;LAMC2;GLI3;PAQR8;PTGES;CDK14;E2F7;DLG5;LPCAT2;KITLG;TBC1D5;P3H2;NAV2;ECH1;ERMAP;ASAP1;ERO1B;SYN1;CTDSPL;PDPN;MTHFR;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;EML2;KCNAB2;NMRK1;LRP1;FYN;ARHGEF12;IFI6;XDH;FLNC;ALPK1;TSHZ2;B3GAT3;ARHGAP18;ADIRF;FUT10;CMBL;CLMN;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;RNF135;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;DOCK11;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;SERPING1;TCEAL3;CXCR1;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;FBXW4;ULK2;TP53INP1;ZNF678;PARP4;IQSEC2;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;ITGA1;MST1R;SYTL1;KANK2;ZSCAN18;HIBADH;METTL7A;ULBP1;HAUS4;PTPN14;PER1;ATP8B2;EHBP1;PXN;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;PCLO;ANG;DYSF;DUSP5;KIF17;PARVA;LAMA5;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;PHKA2;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;MLH3;ZKSCAN1;TP73;CAT;PLCH2;CASP14;SHROOM4;DAPK1;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;ROBO1;WDFY2;IFT140;SPRY4;LRIG3;R3HDM2;PAIP2B;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;FRMD5;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;SH3TC2;SP110;COL16A1;DZIP1L;FGFR1;CBR1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;SEMA4A;RGS2;GLT8D2;TGFBI;SETX;ASTN2;PDE4D;APBB3;TMEM129;NCOA2;MYO3B;TGM2;PSMB9;IL18;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;NBPF10;MYOF;TLE4;EPHB6;ARSD;IL17RE;FZD8;CCDC136;TCEAL1;SETBP1;ZNF618;SOX13;ARHGEF17;TRIOBP;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;FOXN3;TRAF1;RAPH1;AKAP7;LMCD1;SEPT6;TGFBR3;DLX3;DTNB;AMOTL1;IPP;LRTOMT;NOTCH2NL;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;FOXL1;BBS4;MTMR4;ZNF699;CALR;HPS3;MKLN1;ATM;IDH2;SRGAP1;COPG2;FBXO17;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;BBS1;ANXA6;AKAP13;HSD17B11;DNAJC6;SNX10;DGKQ;CITED2;GCLC;NR2F2;ACSS2;ELMO3;FHOD3;HEXA;NEURL1B;CBX7;LMO4;AKR7A2;ZNF449;ZMAT3;MSH5;NRSN2;MAF;TRAK1;CD1D;LZTS1;FBXW8;ZBTB22;IFI44;SYNE2;HDAC11;RCBTB1;RNPEP;PTMS;MAP3K1;FGD4;NEMP2;PTPN1;POGLUT1;CRIP2;VANGL2;ARHGEF2;DNAL4;FAM117A;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;ZNF546;KRT222;NRK;SSH1;LYST;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;NFASC;STK16;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;ETNK2;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;METTL23;MAN2B1;CEP68;PGAP1;TSHZ1;LANCL1;IGFBP4;DEPDC7;IFT88;ALDH9A1;GOLGA8B;MVB12B;TES;TTC8;KCTD7;TCF25;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;MAP3K12;CHD9;MEGF8;ZNF302;UACA;ATXN1;ACSF2;HTR1B;IRF2BPL;STK36;RAB43;MAML2;SPA17;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CDH11;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;OR2A4;COL12A1;SMG9;SCNN1A;STAT2;AMOTL2;IFT122;LIG1;ZNF701;GPR161;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;CDC42EP5;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;C2CD4C;CDKN2A;EFR3A;PPM1M;MPRIP;SPPL2B;OSBPL1A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;IGFBP2;ORC4;TMEM187;NPHP3;VAV2;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;KLHL5;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;EHBP1L1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;CHIC2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;MON2;CFAP54;ARHGEF19;ITPR2;ARHGAP29;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;OPHN1;TPGS1;LMF1;SH2B3;UGT1A6;MYO9A;YAP1;HSP90AB4P;PGPEP1;DNAH1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;CAPS;KLHL3;ATRAID;SRR;YEATS2;HOXA3;UBA7;GALNT2;DIXDC1;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;INF2;NBPF15;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;GCSAM;CERS5;KLF7;SNX9;ICK;TBC1D16;TGIF1;OBSL1;ING4;ZYG11B;APOL6;POSTN;PRR7;UNK;LGALS3;PTPN3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PCMTD2;PBX2;PRKAG1;TAF1;SENP7;TRIM16L;TSHZ3;CEP85L;GSTZ1;FZD4;MPPE1;ZNF883;WIPF1;HCFC1R1;ZBTB1;DPYD;NAT14;PPP3CA;TMEM168;DCAF8;PIK3C2B;PDZD2;SBF2;RASA1;ARHGAP31;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;HOXA2;CAPN6;PPCS;FOS;DNM1P46;SEPT9;DNPH1;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;ACOT1;FAM169A;CLEC2D;FAM120B;SERPINB5;SCPEP1;MATN3;ELMO2;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;ADAM10;PRDM5;RNPEPL1;RHOBTB3;PPP2R3A;CELSR1;MPDZ;ZNF471;LITAF;LRRCC1;ATG16L2;ANKS6;EPG5;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;SNTB1;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
10863,GO:0044422,0.99999951225492,6.60918285472542e-07,659,7153,organelle part,CC,PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;COL8A1;CTGF;FBN1;SOX6;ST6GALNAC2;CD109;SYNE1;MYH15;TNNI2;XPC;PTGS1;ADAMTSL1;ASAP3;MARCH4;GSN;COL5A2;ETV5;PKD2;JPH2;SCARA3;DUSP6;CYBRD1;TNIK;ANPEP;SKP2;PROM2;COL7A1;H6PD;CLTCL1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ROR1;DPYSL2;EGFR;GALNT10;KLF8;SDC3;HSPA2;LAMB1;FLRT3;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;MYLK;SYNE3;SLC2A3;SERPINE1;ATP10D;SERPINH1;RNF213;KRT14;CRTAP;TCF7L1;STON2;MBOAT2;VIM;FAM198B;CSPG4;DDB2;EVC;FAM210B;ADD3;ASAP2;TIMP2;TADA3;PLEC;PAK1;ABCA1;NSG1;CBX5;VDR;BMP4;NEFM;ITM2C;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;CITED4;NETO1;NEFL;NR3C1;COL18A1;STAT1;SORL1;NEO1;LGALS1;MEST;D2HGDH;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CCDC102A;ZBTB20;PYCARD;LTBP1;MEF2D;KRT5;EFHC1;MUC19;DLG4;TCP11L1;SLC27A3;ZCCHC11;PDGFA;MAP2;MICAL1;ADARB1;TIMP1;ACSL3;FLG;HIP1;COL4A4;TFDP2;BCKDHB;DOCK4;TEP1;CCDC85B;CUL7;CHD3;TTC28;KLF12;KLF9;WDR66;HIVEP1;SNX1;ANO6;GPX1;GLI3;PTGES;E2F7;DLG5;LPCAT2;TBC1D5;P3H2;NAV2;ASAP1;ERO1B;SYN1;ABHD14B;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;EML2;KCNAB2;LRP1;FYN;FLNC;B3GAT3;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;SEL1L;SPATA6;SLC2A4RG;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;SERPING1;CXCR1;NPHP4;PRKCZ;OAS2;SDR16C5;ULK2;TP53INP1;PARP4;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;MST1R;HIBADH;METTL7A;HAUS4;PTPN14;PER1;ATP8B2;PXN;PDIA4;PIK3R1;SYT1;HHAT;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DYSF;DUSP5;KIF17;PARVA;UHRF2;BBS2;CNTLN;HERPUD1;ANK3;WFS1;SPRY2;CES2;TTN;CIRBP;JARID2;APLP2;MLH3;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;PRKACB;CHEK2;BACE1;IFT140;LRIG3;STOM;PHF2;TLR3;BPHL;MAN1A1;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;COL16A1;DZIP1L;FGFR1;APOBEC3F;LMNA;ARMCX2;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;RGS2;TGFBI;SETX;PDE4D;TMEM129;NCOA2;MYO3B;PSMB9;OBSCN;SULF1;SPATA18;ESYT2;PDK3;MYOF;TLE4;ARSD;CCDC136;TCEAL1;SETBP1;SOX13;TRIOBP;DHTKD1;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;SEPT6;AMOTL1;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;BBS4;MTMR4;CALR;ATM;IDH2;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;C17ORF49;TMEM14C;AREG;TCF4;BBS1;ANXA6;AKAP13;SNX10;DGKQ;CITED2;NR2F2;ACSS2;FHOD3;HEXA;CBX7;ZMAT3;MSH5;MAF;CD1D;SYNE2;HDAC11;NEMP2;PTPN1;POGLUT1;VANGL2;ARHGEF2;DNAL4;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;KRT222;EGR1;SOX9;ENPP1;IFT27;ISL1;BCL6;SLC48A1;PLD3;PRCP;NFASC;CRTC1;NCOR1;G6PC3;NDRG1;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;PXMP2;TMEM175;BCHE;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;CES3;HLTF;FNDC3A;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;MAN2B1;CEP68;PGAP1;IGFBP4;IFT88;GOLGA8B;MVB12B;TTC8;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;ACSF2;IRF2BPL;RAB43;MAML2;SPA17;WDR19;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DNASE1L1;DSEL;OR2A4;COL12A1;SCNN1A;STAT2;IFT122;LIG1;GPR161;LIPA;LEF1;THRA;USP28;SFXN3;ALDH7A1;MAPK8IP3;CYP4V2;C2CD4C;CDKN2A;SPPL2B;SP100;ULK1;TSPYL2;AGRN;ORC4;NPHP3;RHBDD1;HSPA5;CDK19;NRM;TH;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;CFAP54;ITPR2;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;TPGS1;LMF1;UGT1A6;MYO9A;YAP1;DNAH1;ALG10;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;BEX4;TPST1;MEF2A;CERS5;SNX9;ICK;TGIF1;OBSL1;ING4;POSTN;LGALS3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;POLH;TMEM67;HOXC5;PRKAG1;TAF1;TSHZ3;CEP85L;FZD4;MPPE1;WIPF1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;SBF2;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;CAPN6;FOS;DNM1P46;SEPT9;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM169A;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADAM10;PRDM5;RHOBTB3;CELSR1;LITAF;LRRCC1;ATG16L2;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;EDEM1;ACAA2;TMEM92;ABCA5;NFKBIE;CTSD;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
10880,GO:0044446,0.999999686053432,4.27328235042489e-07,647,7059,intracellular organelle part,CC,PHACTR3;ITGB6;SYT8;SULT1E1;FLOT1;PRSS23;KRT4;TRNP1;FN1;PCDH7;PYGB;FLRT2;MMP9;PRODH;GPRC5A;TXNIP;COL8A1;CTGF;FBN1;SOX6;ST6GALNAC2;CD109;SYNE1;MYH15;TNNI2;XPC;PTGS1;ADAMTSL1;ASAP3;MARCH4;GSN;COL5A2;ETV5;PKD2;JPH2;SCARA3;DUSP6;CYBRD1;TNIK;ANPEP;SKP2;COL7A1;H6PD;CLTCL1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;ROR1;DPYSL2;EGFR;GALNT10;KLF8;SDC3;HSPA2;LAMB1;FLRT3;SPTB;CEP126;SLC8A1;FKBP5;CLCA2;MYLK;SYNE3;SLC2A3;SERPINE1;ATP10D;SERPINH1;RNF213;KRT14;CRTAP;TCF7L1;STON2;MBOAT2;VIM;FAM198B;CSPG4;DDB2;EVC;FAM210B;ADD3;ASAP2;TIMP2;TADA3;PAK1;ABCA1;NSG1;CBX5;VDR;BMP4;NEFM;ITM2C;PCSK1;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;NEFL;NR3C1;COL18A1;STAT1;SORL1;NEO1;LGALS1;MEST;D2HGDH;TP53;ARAP1;CEP250;KRT13;EXTL2;MBNL2;KIAA0319L;PTPRS;TTLL11;WWTR1;PRICKLE1;DDIT3;CNTRL;CCDC102A;ZBTB20;PYCARD;LTBP1;MEF2D;KRT5;EFHC1;MUC19;DLG4;TCP11L1;SLC27A3;ZCCHC11;PDGFA;MAP2;MICAL1;ADARB1;TIMP1;ACSL3;FLG;HIP1;COL4A4;TFDP2;BCKDHB;DOCK4;TEP1;CCDC85B;CUL7;CHD3;TTC28;KLF12;KLF9;WDR66;HIVEP1;SNX1;ANO6;GPX1;GLI3;PTGES;E2F7;DLG5;LPCAT2;TBC1D5;P3H2;NAV2;ASAP1;ERO1B;SYN1;ABHD14B;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;EML2;KCNAB2;LRP1;FYN;B3GAT3;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;SEL1L;SLC2A4RG;GLDC;SNX33;MAP3K14;SLC22A17;ESPN;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;SERPING1;CXCR1;NPHP4;PRKCZ;OAS2;SDR16C5;ULK2;TP53INP1;PARP4;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;MST1R;HIBADH;METTL7A;HAUS4;PTPN14;PER1;ATP8B2;PXN;PDIA4;PIK3R1;SYT1;HHAT;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;CPT1A;ACACB;APOBEC3G;ANG;DYSF;DUSP5;KIF17;UHRF2;BBS2;CNTLN;HERPUD1;WFS1;SPRY2;CES2;TTN;CIRBP;JARID2;APLP2;MLH3;TP73;CAT;CASP14;SHROOM4;ST6GAL2;DLC1;PRKACB;CHEK2;BACE1;IFT140;LRIG3;STOM;PHF2;TLR3;BPHL;MAN1A1;FBXL7;SNCA;FLOT2;ADAMTS7;ALDH1L2;MME;PDIA6;GATAD1;VAMP1;FZD7;AIP;GLG1;JADE2;NIPSNAP1;COL16A1;DZIP1L;FGFR1;APOBEC3F;LMNA;ARMCX2;DKK1;MLEC;FSCN1;PRKAB2;SEC24D;RGS2;TGFBI;SETX;PDE4D;TMEM129;NCOA2;MYO3B;PSMB9;OBSCN;SULF1;SPATA18;ESYT2;PDK3;MYOF;TLE4;ARSD;CCDC136;TCEAL1;SETBP1;SOX13;TRIOBP;DHTKD1;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;SEPT6;AMOTL1;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;BBS4;MTMR4;CALR;ATM;IDH2;COPG2;MDM2;ARF6;TMED10;CST3;MANBA;C17ORF49;TMEM14C;AREG;TCF4;BBS1;ANXA6;AKAP13;SNX10;DGKQ;CITED2;NR2F2;ACSS2;FHOD3;HEXA;CBX7;ZMAT3;MSH5;MAF;CD1D;SYNE2;HDAC11;NEMP2;PTPN1;POGLUT1;VANGL2;ARHGEF2;DNAL4;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;SYNC;KRT222;EGR1;SOX9;ENPP1;IFT27;ISL1;BCL6;SLC48A1;PLD3;PRCP;NFASC;CRTC1;NCOR1;G6PC3;NDRG1;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;PXMP2;TMEM175;BCHE;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;CES3;HLTF;FNDC3A;MPP7;CXORF57;WDR63;SEPT5;BAHCC1;RNF24;MAN2B1;CEP68;PGAP1;IGFBP4;IFT88;GOLGA8B;MVB12B;TTC8;MOSPD2;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;ACSF2;IRF2BPL;RAB43;MAML2;WDR19;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;ODF2;VPS39;DNASE1L1;DSEL;OR2A4;COL12A1;STAT2;IFT122;LIG1;GPR161;LIPA;LEF1;THRA;USP28;SFXN3;ALDH7A1;MAPK8IP3;CYP4V2;C2CD4C;CDKN2A;SPPL2B;SP100;ULK1;TSPYL2;AGRN;ORC4;RHBDD1;HSPA5;CDK19;NRM;TH;GOPC;SNX7;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;REEP2;TGFB1I1;RSAD2;TTC12;FLNB;SRPK2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;CFAP54;ITPR2;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;TPGS1;LMF1;UGT1A6;MYO9A;YAP1;DNAH1;ALG10;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;BEX4;TPST1;MEF2A;CERS5;SNX9;ICK;TGIF1;OBSL1;ING4;POSTN;LGALS3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;RASSF9;COL4A1;SV2A;ABCA2;POLH;TMEM67;HOXC5;PRKAG1;TAF1;TSHZ3;CEP85L;FZD4;MPPE1;WIPF1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;SBF2;LIMA1;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ACTR1B;ETV4;HP1BP3;COX18;CAPN6;FOS;DNM1P46;SEPT9;KDM4A;KLHL22;ZBTB25;CDK5RAP3;AGO4;FAM169A;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;MYH11;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;ADAM10;PRDM5;RHOBTB3;CELSR1;LITAF;LRRCC1;ATG16L2;S100A11;MYO1C;TUSC3;RXRA;C2CD5;GBP3;CPT2;EDEM1;ACAA2;TMEM92;ABCA5;NFKBIE;CTSD;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
2462,GO:0005681,0.999999692694109,3.07262803723783e-06,2,181,spliceosomal complex,CC,TEP1;LGALS3
14841,GO:0070647,0.9999997007788,5.70491333975586e-07,60,950,protein modification by small protein conjugation or removal,BP,MARCH4;HERC5;SKP2;TRIM2;RNF213;RNF165;DDB2;ZNF862;TADA3;TRIM38;TRIM5;TP53;WWTR1;PRICKLE1;CUL9;CUL7;FYN;CAV1;PIAS3;RNF135;DCAF16;FBXW4;UHRF2;HERPUD1;WFS1;LMO7;FBXL7;JADE2;TMEM129;PSMB9;MAGEF1;IPP;FBXO17;MDM2;GCLC;NEURL1B;FBXW8;KLHL12;EGR1;HLTF;RNF24;ANAPC16;USP28;TRIML2;HSPA5;KLHL5;NUB1;KLHL3;UBA7;RNF144B;SASH1;ZYG11B;TAF1;DCAF8;KLHL22;CDK5RAP3;MED12;FBXL4;GID4;ZNRF1
4467,GO:0010467,0.999999719179317,3.91034967838699e-07,367,4262,gene expression,BP,SERPINE2;TRNP1;HTRA1;FN1;CCBE1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TGFBR2;TNNI2;EFEMP1;GSN;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;GJC2;RFX2;ACTA2;ZNF608;SERPINE1;SERPINH1;TCF7L1;RNF165;VIM;NUPR1;ZNF862;TADA3;CBX5;VDR;BMP4;TRIM38;PCSK1;NR1D1;SMARCA2;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;SORL1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ITGA2;ZCCHC11;RBMS3;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;TYSND1;GPX1;GLI3;E2F7;CNTN1;ERO1B;KRBA2;ABHD14B;ZFP90;CTSV;FYN;XDH;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;SERPING1;TCEAL3;PRKCZ;SLIT3;SDR16C5;TP53INP1;ZNF678;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;ANG;UHRF2;BBS2;ANK3;WFS1;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;ZKSCAN1;TP73;CAT;DAPK1;KLF13;PRKACB;AARS;CHEK2;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;FLOT2;MME;GATAD1;FZD7;AIP;GLG1;SP110;FGFR1;DKK1;RGS2;C5;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;BBS4;ZNF699;CALR;ATM;APH1B;MDM2;MEIS2;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;ARHGEF2;PLGRKT;ZNF546;EGR1;SOX9;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;HLTF;HOXA1;BAHCC1;METTL23;TSHZ1;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;TSPAN5;ATXN1;IRF2BPL;STK36;MAML2;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;SMG9;STAT2;ZNF701;LEF1;THRA;SSBP3;MSRB2;CDKN2A;SPPL2B;SP100;ZSCAN30;TEF;TSPYL2;AGRN;RHBDD1;HSPA5;CELF2;TGFB1I1;SRPK2;ITGB8;MDFIC;FHOD1;IFT74;SAP30L;ZNF12;LMF1;YAP1;GDNF;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;ICK;TGIF1;ING4;UNK;LGALS3;DNAJC3;RARA;ABCA2;HES2;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;CAMK2N1;MED12;NPAS2;NIPBL;VPS36;ADM2;ADAM10;PRDM5;ZNF471;LITAF;MYO1C;RXRA;NFKBIE;ZNF484
2889,GO:0006399,0.999999967115668,6.31217472740845e-07,1,184,tRNA metabolic process,BP,AARS
16220,GO:0090304,0.999999974320337,3.69354574940472e-08,352,4170,nucleic acid metabolic process,BP,TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;TNNI2;XPC;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;EGFR;TSC22D3;KLF8;NYNRIN;RFX2;ZNF608;SERPINE1;ENDOD1;TCF7L1;RNF165;VIM;NUPR1;DDB2;ZNF862;TADA3;CBX5;VDR;APOBEC3C;BMP4;TRIM38;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;ZCCHC11;PDGFA;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;TSHZ2;ADIRF;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;MLH3;ZKSCAN1;TP73;CAT;KLF13;AARS;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;APOBEC3F;DKK1;SETX;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MSH5;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;PGAP1;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;SMG9;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;USP28;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;HSPA5;CELF2;TGFB1I1;SRPK2;UVRAG;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;LGALS3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;MED12;NPAS2;NIPBL;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;TAOK3;NFKBIE;ZNF484
3798,GO:0008380,0.99999998232951,6.96353807988862e-08,11,391,RNA splicing,BP,AHNAK;MBNL2;TEP1;RBFOX2;AHNAK2;PIK3R1;PRX;SETX;CELF2;SRPK2;LGALS3
16447,GO:0097159,0.999999988547065,1.64737913434713e-08,401,4603,organic cyclic compound binding,MF,SULT1E1;TRNP1;PYGB;PRODH;SOX6;RHOBTB2;ZFP36L1;NQO1;SYNE1;MYH15;TGFBR2;XPC;PTGS1;ETV5;PIK3C2G;OSBPL10;ZFP36L2;IGF2BP2;HERC5;TNIK;PROM2;ZNF362;H6PD;NOS1;SNAI2;PHF21A;ROR1;AXL;EGFR;KLF8;PEG10;ITPK1;HSPA2;SPEG;NYNRIN;FKBP5;MYLK;RFX2;ACTA2;ZNF608;ATP10D;SERPINH1;ENDOD1;TCF7L1;VIM;NUPR1;DDB2;TKFC;IFI44L;MAP3K6;DCAKD;ZNF862;PLEC;PAK1;ABCA1;VDR;APOBEC3C;TNS1;ITM2C;TP53I3;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;EIF2AK4;PDCD4;NR3C1;STAT1;IFIT2;LGALS1;D2HGDH;ETV1;TP53;MBNL2;TTLL11;DDIT3;CUL9;ZBTB20;ZC3H6;MEF2D;SEC14L2;IFIT1;WNK1;DDX60;ARHGEF1;SLC27A3;ZCCHC11;RBMS3;MICAL1;ADARB1;ACSL3;PHGDH;TFDP2;TEP1;CHD3;SIK1;ZNF18;KLF12;IFIT3;KLF9;NFIX;HIVEP1;GLI3;PAQR8;CDK14;E2F7;NAV2;KRBA2;SYN1;MTHFR;ZFP90;NEK9;NMRK1;LRP1;FYN;XDH;PABPC4L;ALPK1;TSHZ2;CPS1;CAV1;SLC27A1;GLI2;RMI2;HLCS;ERCC6;RBFOX2;SLC2A4RG;GLDC;MAP3K14;SMARCA1;ZNF318;TNRC18;OSBPL5;AHNAK2;ACSS1;FKBP9;PRKCZ;OAS2;ULK2;ZNF678;PARP4;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;MST1R;ZSCAN18;HIBADH;PER1;ATP8B2;PDIA4;HHAT;TMEM173;CAPRIN2;CREB3L2;ACACB;APOBEC3G;ANG;KIF17;UHRF2;CDK18;TTN;CIRBP;PRDM8;JARID2;APLP2;MLH3;ZKSCAN1;TP73;CAT;DAPK1;KLF13;PRKACB;AARS;CHEK2;R3HDM2;PAIP2B;PRX;TLR3;ZNF860;SNCA;OARD1;GATAD1;PAQR7;SP110;DZIP1L;FGFR1;IGF1R;APOBEC3F;FSCN1;SETX;KHNYN;PDE4D;NCOA2;MYO3B;TGM2;OBSCN;PDK3;G6PD;NBPF10;EPHB6;SETBP1;ZNF618;SOX13;DHTKD1;CHD6;NFATC4;FOXN3;AKAP7;SEPT6;DLX3;PBX1;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;ARF6;MEIS2;C17ORF49;ZNF107;TCF4;ANXA6;DGKQ;GCLC;NR2F2;ACSS2;LMO4;ZNF449;ZMAT3;MSH5;CYP20A1;MAF;LZTS1;ZBTB22;HSPA12A;MAP3K1;PTPN1;THNSL2;ZNF546;NRK;EGR1;SOX9;ENPP1;IFT27;C14ORF93;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;STK16;NCOR1;DDX60L;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;ANXA2;TRERF1;RAB13;ETNK2;HLTF;FNDC3A;HOXA1;CXORF57;SEPT5;BAHCC1;TSHZ1;TES;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;GAL3ST4;RPL13A;PAK6;DECR1;ZNF160;ABCC2;MAP3K12;CHD9;ZNF302;ATXN1;ACSF2;HTR1B;STK36;RAB43;MUTYH;RET;CARF;ZFPM1;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;C11ORF68;CYP4V2;CDKN2A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;ORC4;AGAP1;HSPA5;CDK19;TH;CELF2;MAGI1;CENPA;PIKFYVE;FLYWCH1;FLNB;SRPK2;SAP30L;ZNF12;MYO9A;YAP1;HSP90AB4P;DNAH1;KLF5;TWIST2;SRR;HOXA3;PRRC2B;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;CERS5;KLF7;ICK;TGIF1;UNK;LGALS3;ARL3;FKBP10;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;ZNF883;ZBTB1;DPYD;NAT14;PIK3C2B;CREBRF;PEX1;ACTR1B;ETV4;HP1BP3;HOXA2;FOS;SEPT9;ZBTB25;AGO4;MED12;NPAS2;ABAT;MYH11;TTBK2;PRDM5;RHOBTB3;ZNF471;LITAF;MYO1C;RXRA;GBP3;ACAA2;ABCA5;TAOK3;ZNF484;DMPK
7588,GO:0031974,0.99999999553887,6.61122626380975e-09,351,4304,membrane-enclosed lumen,CC,PHACTR3;ITGB6;PRSS23;TRNP1;FN1;PYGB;MMP9;PRODH;GPRC5A;TXNIP;COL8A1;FBN1;SOX6;SYNE1;XPC;ADAMTSL1;ASAP3;GSN;COL5A2;ETV5;DUSP6;TNIK;SKP2;COL7A1;H6PD;NOS1;DNAJB4;GAS6;PDGFC;SNAI2;COL5A1;PHF21A;UTRN;EGFR;KLF8;SDC3;HSPA2;LAMB1;SLC8A1;FKBP5;SERPINE1;ATP10D;SERPINH1;RNF213;CRTAP;TCF7L1;STON2;CSPG4;DDB2;ADD3;TIMP2;TADA3;NSG1;CBX5;VDR;BMP4;PCSK1;NR1D1;SMARCA2;PTK6;ABTB1;CITED4;NR3C1;COL18A1;STAT1;SORL1;NEO1;LGALS1;D2HGDH;TP53;ARAP1;MBNL2;WWTR1;DDIT3;ZBTB20;PYCARD;LTBP1;MEF2D;MUC19;ZCCHC11;PDGFA;MAP2;ADARB1;TIMP1;COL4A4;TFDP2;BCKDHB;DOCK4;TEP1;CHD3;KLF12;KLF9;HIVEP1;GPX1;GLI3;PTGES;E2F7;P3H2;NAV2;SYN1;ABHD14B;MAGED2;SESN1;CTSV;SEC14L1;SPG11;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;GLDC;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;ACSS1;CLU;SERPING1;PRKCZ;OAS2;TP53INP1;HMGA2;CAMK2D;PHC2;PRDX5;HIBADH;METTL7A;PTPN14;PER1;PDIA4;NCAPD2;CREB3L2;ANG;DUSP5;UHRF2;CNTLN;WFS1;CES2;TTN;CIRBP;JARID2;APLP2;MLH3;TP73;CAT;PRKACB;CHEK2;BACE1;PHF2;ADAMTS7;ALDH1L2;PDIA6;GATAD1;AIP;JADE2;COL16A1;FGFR1;LMNA;PRKAB2;RGS2;SETX;NCOA2;PSMB9;OBSCN;PDK3;TLE4;ARSD;TCEAL1;SETBP1;SOX13;DHTKD1;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;L3MBTL3;NAGLU;PBX1;CALR;ATM;IDH2;MDM2;CST3;MANBA;C17ORF49;TCF4;DGKQ;CITED2;NR2F2;ACSS2;HEXA;CBX7;ZMAT3;MSH5;SYNE2;HDAC11;POGLUT1;ALDH4A1;SDC2;COL5A3;EGR1;SOX9;ISL1;BCL6;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;BCHE;ANXA2;TRERF1;RGS14;PRIMPOL;CES3;HLTF;MPP7;BAHCC1;MAN2B1;IGFBP4;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;ACSF2;IRF2BPL;MAML2;WDR19;MUTYH;TAF8;CARF;ZFPM1;TGFB2;RBL2;DNASE1L1;COL12A1;STAT2;IFT122;LIG1;LIPA;LEF1;THRA;USP28;ALDH7A1;SPPL2B;SP100;TSPYL2;AGRN;ORC4;HSPA5;CDK19;MAGI1;BOC;CENPA;FLYWCH1;TGFB1I1;RSAD2;SRPK2;NAPRT;MDFIC;RHBDD2;YPEL4;POLD4;SAP30L;ZNF12;TACC2;YAP1;KLF5;COL17A1;GPX8;TWIST2;YEATS2;HOXA3;UBA7;PITPNC1;PPARG;CAPG;MEF2A;ICK;TGIF1;ING4;MIA3;DEF6;DNAJC3;FKBP10;RARA;COL4A1;POLH;HOXC5;PRKAG1;TAF1;TSHZ3;MPPE1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;CREBRF;CTDSP2;ACTR1B;ETV4;HP1BP3;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;CERCAM;ADAM10;PRDM5;CELSR1;LITAF;ATG16L2;S100A11;MYO1C;RXRA;CPT2;ACAA2;TMEM92;NFKBIE;CTSD;DOCK1;FAM114A1;LAMB2
10380,GO:0043233,0.99999999553887,6.61122626380975e-09,351,4304,organelle lumen,CC,PHACTR3;ITGB6;PRSS23;TRNP1;FN1;PYGB;MMP9;PRODH;GPRC5A;TXNIP;COL8A1;FBN1;SOX6;SYNE1;XPC;ADAMTSL1;ASAP3;GSN;COL5A2;ETV5;DUSP6;TNIK;SKP2;COL7A1;H6PD;NOS1;DNAJB4;GAS6;PDGFC;SNAI2;COL5A1;PHF21A;UTRN;EGFR;KLF8;SDC3;HSPA2;LAMB1;SLC8A1;FKBP5;SERPINE1;ATP10D;SERPINH1;RNF213;CRTAP;TCF7L1;STON2;CSPG4;DDB2;ADD3;TIMP2;TADA3;NSG1;CBX5;VDR;BMP4;PCSK1;NR1D1;SMARCA2;PTK6;ABTB1;CITED4;NR3C1;COL18A1;STAT1;SORL1;NEO1;LGALS1;D2HGDH;TP53;ARAP1;MBNL2;WWTR1;DDIT3;ZBTB20;PYCARD;LTBP1;MEF2D;MUC19;ZCCHC11;PDGFA;MAP2;ADARB1;TIMP1;COL4A4;TFDP2;BCKDHB;DOCK4;TEP1;CHD3;KLF12;KLF9;HIVEP1;GPX1;GLI3;PTGES;E2F7;P3H2;NAV2;SYN1;ABHD14B;MAGED2;SESN1;CTSV;SEC14L1;SPG11;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;GLDC;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;ACSS1;CLU;SERPING1;PRKCZ;OAS2;TP53INP1;HMGA2;CAMK2D;PHC2;PRDX5;HIBADH;METTL7A;PTPN14;PER1;PDIA4;NCAPD2;CREB3L2;ANG;DUSP5;UHRF2;CNTLN;WFS1;CES2;TTN;CIRBP;JARID2;APLP2;MLH3;TP73;CAT;PRKACB;CHEK2;BACE1;PHF2;ADAMTS7;ALDH1L2;PDIA6;GATAD1;AIP;JADE2;COL16A1;FGFR1;LMNA;PRKAB2;RGS2;SETX;NCOA2;PSMB9;OBSCN;PDK3;TLE4;ARSD;TCEAL1;SETBP1;SOX13;DHTKD1;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;L3MBTL3;NAGLU;PBX1;CALR;ATM;IDH2;MDM2;CST3;MANBA;C17ORF49;TCF4;DGKQ;CITED2;NR2F2;ACSS2;HEXA;CBX7;ZMAT3;MSH5;SYNE2;HDAC11;POGLUT1;ALDH4A1;SDC2;COL5A3;EGR1;SOX9;ISL1;BCL6;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;BCHE;ANXA2;TRERF1;RGS14;PRIMPOL;CES3;HLTF;MPP7;BAHCC1;MAN2B1;IGFBP4;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;ACSF2;IRF2BPL;MAML2;WDR19;MUTYH;TAF8;CARF;ZFPM1;TGFB2;RBL2;DNASE1L1;COL12A1;STAT2;IFT122;LIG1;LIPA;LEF1;THRA;USP28;ALDH7A1;SPPL2B;SP100;TSPYL2;AGRN;ORC4;HSPA5;CDK19;MAGI1;BOC;CENPA;FLYWCH1;TGFB1I1;RSAD2;SRPK2;NAPRT;MDFIC;RHBDD2;YPEL4;POLD4;SAP30L;ZNF12;TACC2;YAP1;KLF5;COL17A1;GPX8;TWIST2;YEATS2;HOXA3;UBA7;PITPNC1;PPARG;CAPG;MEF2A;ICK;TGIF1;ING4;MIA3;DEF6;DNAJC3;FKBP10;RARA;COL4A1;POLH;HOXC5;PRKAG1;TAF1;TSHZ3;MPPE1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;CREBRF;CTDSP2;ACTR1B;ETV4;HP1BP3;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;CERCAM;ADAM10;PRDM5;CELSR1;LITAF;ATG16L2;S100A11;MYO1C;RXRA;CPT2;ACAA2;TMEM92;NFKBIE;CTSD;DOCK1;FAM114A1;LAMB2
14496,GO:0070013,0.99999999553887,6.61122626380975e-09,351,4304,intracellular organelle lumen,CC,PHACTR3;ITGB6;PRSS23;TRNP1;FN1;PYGB;MMP9;PRODH;GPRC5A;TXNIP;COL8A1;FBN1;SOX6;SYNE1;XPC;ADAMTSL1;ASAP3;GSN;COL5A2;ETV5;DUSP6;TNIK;SKP2;COL7A1;H6PD;NOS1;DNAJB4;GAS6;PDGFC;SNAI2;COL5A1;PHF21A;UTRN;EGFR;KLF8;SDC3;HSPA2;LAMB1;SLC8A1;FKBP5;SERPINE1;ATP10D;SERPINH1;RNF213;CRTAP;TCF7L1;STON2;CSPG4;DDB2;ADD3;TIMP2;TADA3;NSG1;CBX5;VDR;BMP4;PCSK1;NR1D1;SMARCA2;PTK6;ABTB1;CITED4;NR3C1;COL18A1;STAT1;SORL1;NEO1;LGALS1;D2HGDH;TP53;ARAP1;MBNL2;WWTR1;DDIT3;ZBTB20;PYCARD;LTBP1;MEF2D;MUC19;ZCCHC11;PDGFA;MAP2;ADARB1;TIMP1;COL4A4;TFDP2;BCKDHB;DOCK4;TEP1;CHD3;KLF12;KLF9;HIVEP1;GPX1;GLI3;PTGES;E2F7;P3H2;NAV2;SYN1;ABHD14B;MAGED2;SESN1;CTSV;SEC14L1;SPG11;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;GLDC;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;ACSS1;CLU;SERPING1;PRKCZ;OAS2;TP53INP1;HMGA2;CAMK2D;PHC2;PRDX5;HIBADH;METTL7A;PTPN14;PER1;PDIA4;NCAPD2;CREB3L2;ANG;DUSP5;UHRF2;CNTLN;WFS1;CES2;TTN;CIRBP;JARID2;APLP2;MLH3;TP73;CAT;PRKACB;CHEK2;BACE1;PHF2;ADAMTS7;ALDH1L2;PDIA6;GATAD1;AIP;JADE2;COL16A1;FGFR1;LMNA;PRKAB2;RGS2;SETX;NCOA2;PSMB9;OBSCN;PDK3;TLE4;ARSD;TCEAL1;SETBP1;SOX13;DHTKD1;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;L3MBTL3;NAGLU;PBX1;CALR;ATM;IDH2;MDM2;CST3;MANBA;C17ORF49;TCF4;DGKQ;CITED2;NR2F2;ACSS2;HEXA;CBX7;ZMAT3;MSH5;SYNE2;HDAC11;POGLUT1;ALDH4A1;SDC2;COL5A3;EGR1;SOX9;ISL1;BCL6;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;BCHE;ANXA2;TRERF1;RGS14;PRIMPOL;CES3;HLTF;MPP7;BAHCC1;MAN2B1;IGFBP4;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;ACSF2;IRF2BPL;MAML2;WDR19;MUTYH;TAF8;CARF;ZFPM1;TGFB2;RBL2;DNASE1L1;COL12A1;STAT2;IFT122;LIG1;LIPA;LEF1;THRA;USP28;ALDH7A1;SPPL2B;SP100;TSPYL2;AGRN;ORC4;HSPA5;CDK19;MAGI1;BOC;CENPA;FLYWCH1;TGFB1I1;RSAD2;SRPK2;NAPRT;MDFIC;RHBDD2;YPEL4;POLD4;SAP30L;ZNF12;TACC2;YAP1;KLF5;COL17A1;GPX8;TWIST2;YEATS2;HOXA3;UBA7;PITPNC1;PPARG;CAPG;MEF2A;ICK;TGIF1;ING4;MIA3;DEF6;DNAJC3;FKBP10;RARA;COL4A1;POLH;HOXC5;PRKAG1;TAF1;TSHZ3;MPPE1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;CREBRF;CTDSP2;ACTR1B;ETV4;HP1BP3;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;CERCAM;ADAM10;PRDM5;CELSR1;LITAF;ATG16L2;S100A11;MYO1C;RXRA;CPT2;ACAA2;TMEM92;NFKBIE;CTSD;DOCK1;FAM114A1;LAMB2
171,GO:0000377,0.999999996806351,2.110413177649e-08,5,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,MBNL2;RBFOX2;SETX;CELF2;SRPK2
183,GO:0000398,0.999999996806351,2.110413177649e-08,5,298,mRNA splicing, via spliceosome,BP,MBNL2;RBFOX2;SETX;CELF2;SRPK2
17613,GO:1901363,0.999999996856204,4.63163155740856e-09,394,4566,heterocyclic compound binding,MF,TRNP1;PYGB;PRODH;SOX6;RHOBTB2;ZFP36L1;NQO1;SYNE1;MYH15;TGFBR2;XPC;PTGS1;ETV5;PIK3C2G;ZFP36L2;IGF2BP2;HERC5;TNIK;ZNF362;H6PD;NOS1;SNAI2;PHF21A;ROR1;AXL;EGFR;KLF8;PEG10;ITPK1;HSPA2;SPEG;NYNRIN;FKBP5;MYLK;RFX2;ACTA2;ZNF608;ATP10D;SERPINH1;ENDOD1;TCF7L1;VIM;NUPR1;DDB2;TKFC;IFI44L;MAP3K6;DCAKD;ZNF862;PLEC;PAK1;ABCA1;VDR;APOBEC3C;TNS1;ITM2C;TP53I3;NR1D1;SMARCA2;PTK6;AHNAK;SCN8A;ABTB1;EIF2AK4;PDCD4;NR3C1;STAT1;IFIT2;LGALS1;D2HGDH;ETV1;TP53;MBNL2;TTLL11;DDIT3;CUL9;ZBTB20;ZC3H6;MEF2D;SEC14L2;IFIT1;WNK1;DDX60;ARHGEF1;SLC27A3;ZCCHC11;RBMS3;MICAL1;ADARB1;ACSL3;PHGDH;TFDP2;TEP1;CHD3;SIK1;ZNF18;KLF12;IFIT3;KLF9;NFIX;HIVEP1;GLI3;CDK14;E2F7;NAV2;KRBA2;SYN1;MTHFR;ZFP90;NEK9;NMRK1;LRP1;FYN;XDH;PABPC4L;ALPK1;TSHZ2;CPS1;SLC27A1;GLI2;RMI2;HLCS;ERCC6;RBFOX2;SLC2A4RG;GLDC;MAP3K14;SMARCA1;ZNF318;TNRC18;AHNAK2;ACSS1;FKBP9;PRKCZ;OAS2;ULK2;ZNF678;PARP4;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;MST1R;ZSCAN18;HIBADH;PER1;ATP8B2;PDIA4;HHAT;TMEM173;CAPRIN2;CREB3L2;ACACB;APOBEC3G;ANG;KIF17;UHRF2;CDK18;TTN;CIRBP;PRDM8;JARID2;APLP2;MLH3;ZKSCAN1;TP73;CAT;DAPK1;KLF13;PRKACB;AARS;CHEK2;R3HDM2;PAIP2B;PRX;TLR3;ZNF860;SNCA;OARD1;GATAD1;SP110;DZIP1L;FGFR1;IGF1R;APOBEC3F;FSCN1;SETX;KHNYN;PDE4D;NCOA2;MYO3B;TGM2;OBSCN;PDK3;G6PD;NBPF10;EPHB6;SETBP1;ZNF618;SOX13;DHTKD1;CHD6;NFATC4;FOXN3;AKAP7;SEPT6;DLX3;PBX1;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;ARF6;MEIS2;C17ORF49;ZNF107;TCF4;ANXA6;DGKQ;GCLC;NR2F2;ACSS2;LMO4;ZNF449;ZMAT3;MSH5;CYP20A1;MAF;LZTS1;ZBTB22;HSPA12A;MAP3K1;PTPN1;THNSL2;ZNF546;NRK;EGR1;SOX9;ENPP1;IFT27;C14ORF93;ISL1;ITPKB;SLC27A6;BCL6;SLC48A1;STK16;NCOR1;DDX60L;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;ANXA2;TRERF1;RAB13;ETNK2;HLTF;FNDC3A;HOXA1;CXORF57;SEPT5;BAHCC1;TSHZ1;TES;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;GAL3ST4;RPL13A;PAK6;DECR1;ZNF160;ABCC2;MAP3K12;CHD9;ZNF302;ATXN1;ACSF2;HTR1B;STK36;RAB43;MUTYH;RET;CARF;ZFPM1;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;C11ORF68;CYP4V2;CDKN2A;SP100;ZSCAN30;ULK1;TEF;TSPYL2;ORC4;AGAP1;HSPA5;CDK19;TH;CELF2;MAGI1;CENPA;PIKFYVE;FLYWCH1;FLNB;SRPK2;SAP30L;ZNF12;MYO9A;YAP1;HSP90AB4P;DNAH1;KLF5;TWIST2;SRR;HOXA3;PRRC2B;UBA7;ZNF558;MEIS3;PPARG;PARP15;KCNIP3;MEF2A;CERS5;KLF7;ICK;TGIF1;UNK;LGALS3;ARL3;FKBP10;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;ZNF883;ZBTB1;DPYD;NAT14;PIK3C2B;CREBRF;PEX1;ACTR1B;ETV4;HP1BP3;HOXA2;FOS;SEPT9;ZBTB25;AGO4;MED12;NPAS2;ABAT;MYH11;TTBK2;PRDM5;RHOBTB3;ZNF471;LITAF;MYO1C;RXRA;GBP3;ACAA2;ABCA5;TAOK3;ZNF484;DMPK
11672,GO:0046483,0.999999996982671,4.44612321385306e-09,394,4704,heterocycle metabolic process,BP,SULT1E1;TRNP1;HTRA1;PRODH;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;XPC;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;DPYSL2;EGFR;TSC22D3;KLF8;NYNRIN;RFX2;ZNF608;SERPINE1;ENDOD1;TCF7L1;RNF165;VIM;NUPR1;DDB2;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;APOBEC3C;BMP4;TRIM38;TP53I3;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;DLG4;ZCCHC11;PDGFA;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KITLG;KRBA2;MTHFR;ABHD14B;ZFP90;KCNAB2;NMRK1;XDH;TSHZ2;ADIRF;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;MLH3;ZKSCAN1;TP73;CAT;KLF13;AARS;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;OARD1;ALDH1L2;MME;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;APOBEC3F;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MSH5;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;PTPN1;ARHGEF2;ALDH4A1;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;PGAP1;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;RPL13A;PAK6;ZNF160;ABCC2;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;USP28;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;NPHP3;HSPA5;TH;CELF2;TGFB1I1;SRPK2;UVRAG;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;TPST1;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;LGALS3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;MED12;NPAS2;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;TAOK3;NFKBIE;ZNF484
170,GO:0000375,0.999999997449461,1.69941385990175e-08,5,301,RNA splicing, via transesterification reactions,BP,MBNL2;RBFOX2;SETX;CELF2;SRPK2
17610,GO:1901360,0.999999997700032,3.41420837559666e-09,407,4851,organic cyclic compound metabolic process,BP,SULT1E1;TRNP1;HTRA1;PRODH;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;XPC;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;DPYSL2;EGFR;TSC22D3;KLF8;NYNRIN;RFX2;ZNF608;SERPINE1;ENDOD1;TCF7L1;RNF165;VIM;NUPR1;DDB2;DCAKD;TIMP2;ZNF862;TADA3;ABCA1;CBX5;VDR;APOBEC3C;BMP4;TRIM38;TP53I3;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;SORL1;NEO1;ETV1;TP53;EXTL2;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;DLG4;ZCCHC11;PDGFA;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KITLG;KRBA2;MTHFR;ABHD14B;ZFP90;KCNAB2;NMRK1;XDH;TSHZ2;ADIRF;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;OSBPL5;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;ACACB;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;MLH3;ZKSCAN1;TP73;CAT;KLF13;AARS;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;OARD1;ALDH1L2;MME;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;APOBEC3F;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;LRTOMT;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;HSD17B11;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;AKR7A2;ZNF449;MSH5;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;PTPN1;ARHGEF2;ALDH4A1;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;LEPR;PGAP1;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;RPL13A;PAK6;ZNF160;ABCC2;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;USP28;CYP4V2;MSRB2;CDKN2A;OSBPL1A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;NPHP3;HSPA5;TH;CELF2;TGFB1I1;SRPK2;UVRAG;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;LMF1;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;TPST1;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;LGALS3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;GSTZ1;FZD4;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;ACAA2;TAOK3;NFKBIE;ZNF484
2741,GO:0006139,0.99999999854262,2.20609994720022e-09,383,4604,nucleobase-containing compound metabolic process,BP,SULT1E1;TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;XPC;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;DPYSL2;EGFR;TSC22D3;KLF8;NYNRIN;RFX2;ZNF608;SERPINE1;ENDOD1;TCF7L1;RNF165;VIM;NUPR1;DDB2;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;APOBEC3C;BMP4;TRIM38;TP53I3;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;DLG4;ZCCHC11;PDGFA;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KITLG;KRBA2;ABHD14B;ZFP90;KCNAB2;NMRK1;XDH;TSHZ2;ADIRF;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;MLH3;ZKSCAN1;TP73;CAT;KLF13;AARS;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;OARD1;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;APOBEC3F;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;CST3;MEIS2;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MSH5;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;PTPN1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;PGAP1;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;USP28;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;NPHP3;HSPA5;CELF2;TGFB1I1;SRPK2;UVRAG;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;TPST1;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;LGALS3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;FZD4;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;MED12;NPAS2;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;TAOK3;NFKBIE;ZNF484
3132,GO:0006725,0.999999999273745,1.15689867852043e-09,392,4718,cellular aromatic compound metabolic process,BP,SULT1E1;TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;APBB2;F2R;DDIT4;TNNI2;XPC;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;DPYSL2;EGFR;TSC22D3;KLF8;NYNRIN;RFX2;ZNF608;SERPINE1;ENDOD1;TCF7L1;RNF165;VIM;NUPR1;DDB2;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;APOBEC3C;BMP4;TRIM38;TP53I3;NR1D1;SMARCA2;AHNAK;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;NEO1;ETV1;TP53;EXTL2;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;DLG4;ZCCHC11;PDGFA;ADARB1;HIP1;TFDP2;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;E2F7;KITLG;KRBA2;MTHFR;ABHD14B;ZFP90;KCNAB2;NMRK1;XDH;TSHZ2;ADIRF;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;MLH3;ZKSCAN1;TP73;CAT;KLF13;AARS;CHEK2;PRX;PHF2;TLR3;ZNF860;SNCA;OARD1;ALDH1L2;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;APOBEC3F;DKK1;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;LRTOMT;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;AKR7A2;ZNF449;MSH5;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;PTMS;PTPN1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;PGAP1;TSHZ1;IGFBP4;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;RPL13A;PAK6;ZNF160;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;DLX2;ZNF550;DNASE1L1;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;USP28;MSRB2;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;NPHP3;HSPA5;TH;CELF2;TGFB1I1;SRPK2;UVRAG;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;TPST1;KCNIP3;MEF2A;MLLT6;KLF7;TGIF1;ING4;LGALS3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;GSTZ1;FZD4;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;PRDM5;ZNF471;LITAF;S100A11;RXRA;TAOK3;NFKBIE;ZNF484
2869,GO:0006364,0.999999999651151,8.3532581285042e-09,1,255,rRNA processing,BP,RPL13A
5330,GO:0016072,0.999999999665421,4.59822669000764e-09,2,284,rRNA metabolic process,BP,ANG;RPL13A
17274,GO:0140098,0.999999999855177,1.07404171073481e-09,5,332,catalytic activity, acting on RNA,MF,ZCCHC11;POLR3GL;ANG;AARS;PRIMPOL
19632,GO:1990904,0.999999999958009,1.76388526129351e-10,22,702,ribonucleoprotein complex,CC,ZFP36L1;SYNE1;VIM;CBX5;APOBEC3C;EIF2AK4;TRIM5;BTBD2;TEP1;PNRC1;APOBEC3G;TSTD1;CIRBP;SNCA;APOBEC3F;CALR;HMBOX1;RPL13A;DERL3;UNK;LGALS3;AGO4
16900,GO:0098908,0.999999999964435,0.799053813792634,0,2,regulation of neuronal action potential,BP,
1974,GO:0004692,0.999999999966141,0.88447708989985,0,1,cGMP-dependent protein kinase activity,MF,
19469,GO:1990269,0.999999999967434,0.792299865276842,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
1729,GO:0004326,0.99999999996773,0.914446395833713,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1840,GO:0004498,0.99999999996773,0.914446395833713,0,1,calcidiol 1-monooxygenase activity,MF,
3982,GO:0008841,0.99999999996773,0.914446395833713,0,1,dihydrofolate synthase activity,MF,
11863,GO:0046901,0.99999999996773,0.914446395833713,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
2025,GO:0004766,0.999999999969492,0.937170570028697,0,1,spermidine synthase activity,MF,
17458,GO:1900390,0.999999999970177,0.872216153868661,0,2,regulation of iron ion import,BP,
18813,GO:1904432,0.999999999970177,0.872216153868661,0,2,regulation of ferrous iron binding,BP,
18814,GO:1904434,0.999999999970177,0.872216153868661,0,2,positive regulation of ferrous iron binding,BP,
18815,GO:1904435,0.999999999970177,0.872216153868661,0,2,regulation of transferrin receptor binding,BP,
18816,GO:1904437,0.999999999970177,0.872216153868661,0,2,positive regulation of transferrin receptor binding,BP,
8658,GO:0034245,0.999999999970301,0.884597772431715,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
5457,GO:0016344,0.999999999970393,0.802891571971251,0,2,meiotic chromosome movement towards spindle pole,BP,
775,GO:0002032,0.999999999970922,0.851718014112741,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
17409,GO:1900208,0.99999999997143,0.866571345098177,0,2,regulation of cardiolipin metabolic process,BP,
17410,GO:1900210,0.99999999997143,0.866571345098177,0,2,positive regulation of cardiolipin metabolic process,BP,
16254,GO:0090362,0.999999999971685,0.801105596665857,0,2,positive regulation of platelet-derived growth factor production,BP,
4091,GO:0009149,0.999999999971696,0.870198102823019,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4147,GO:0009213,0.999999999971696,0.870198102823019,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7946,GO:0032556,0.999999999971696,0.870198102823019,0,2,pyrimidine deoxyribonucleotide binding,MF,
9373,GO:0035928,0.999999999971841,0.772041892903779,0,3,rRNA import into mitochondrion,BP,
1812,GO:0004464,0.999999999972013,0.906044288906517,0,2,leukotriene-C4 synthase activity,MF,
19683,GO:2000048,0.999999999972106,0.872319212418066,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
18929,GO:1904720,0.999999999972234,0.826640085022841,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
10206,GO:0042904,0.999999999972587,0.819391871572796,0,2,9-cis-retinoic acid biosynthetic process,BP,
10207,GO:0042905,0.999999999972587,0.819391871572796,0,2,9-cis-retinoic acid metabolic process,BP,
1686,GO:0004161,0.99999999997272,0.847041379346359,0,2,dimethylallyltranstransferase activity,MF,
1737,GO:0004337,0.99999999997272,0.847041379346359,0,2,geranyltranstransferase activity,MF,
8395,GO:0033383,0.99999999997272,0.847041379346359,0,2,geranyl diphosphate metabolic process,BP,
8396,GO:0033384,0.99999999997272,0.847041379346359,0,2,geranyl diphosphate biosynthetic process,BP,
16298,GO:0090541,0.999999999973166,0.79110694342646,0,2,MIT domain binding,MF,
8293,GO:0033140,0.999999999973262,0.840701756444408,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
3205,GO:0006844,0.999999999973328,0.847370237959343,0,2,acyl carnitine transport,BP,
5039,GO:0015227,0.999999999973328,0.847370237959343,0,2,acyl carnitine transmembrane transporter activity,MF,
6302,GO:0019948,0.999999999973363,0.833655368255857,0,2,SUMO activating enzyme activity,MF,
11365,GO:0045764,0.99999999997347,0.868554173120672,0,2,positive regulation of cellular amino acid metabolic process,BP,
17353,GO:1900109,0.999999999973683,0.870214344700587,0,2,regulation of histone H3-K9 dimethylation,BP,
17354,GO:1900110,0.999999999973683,0.870214344700587,0,2,negative regulation of histone H3-K9 dimethylation,BP,
17588,GO:1901301,0.9999999999737,0.790422054888635,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
13704,GO:0060302,0.99999999997376,0.858857885549977,0,2,negative regulation of cytokine activity,BP,
2022,GO:0004756,0.999999999973766,0.837870840983478,0,2,selenide, water dikinase activity,MF,
5408,GO:0016260,0.999999999973766,0.837870840983478,0,2,selenocysteine biosynthetic process,BP,
5665,GO:0016781,0.999999999973766,0.837870840983478,0,2,phosphotransferase activity, paired acceptors,MF,
14675,GO:0070329,0.999999999973766,0.837870840983478,0,2,tRNA seleno-modification,BP,
19479,GO:1990379,0.999999999973807,0.863797947433134,0,2,lipid transport across blood brain barrier,BP,
11240,GO:0045519,0.999999999973861,0.943203353210009,0,1,interleukin-23 receptor binding,MF,
14886,GO:0070743,0.999999999973861,0.943203353210009,0,1,interleukin-23 complex,CC,
5381,GO:0016212,0.999999999974028,0.840746279187479,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9477,GO:0036137,0.999999999974028,0.840746279187479,0,2,kynurenine aminotransferase activity,MF,
16387,GO:0097052,0.999999999974028,0.840746279187479,0,2,L-kynurenine metabolic process,BP,
17383,GO:1900150,0.999999999974077,0.845507989650874,0,2,regulation of defense response to fungus,BP,
8372,GO:0033291,0.999999999974302,0.962500061810201,0,1,eukaryotic 80S initiation complex,CC,
8767,GO:0034463,0.999999999974302,0.962500061810201,0,1,90S preribosome assembly,BP,
9581,GO:0036455,0.999999999974341,0.941011037104023,0,1,iron-sulfur transferase activity,MF,
1256,GO:0003011,0.999999999974537,0.766307714592919,0,2,involuntary skeletal muscle contraction,BP,
247,GO:0000706,0.999999999974729,0.787851421802423,0,2,meiotic DNA double-strand break processing,BP,
19639,GO:1990918,0.999999999974729,0.787851421802423,0,2,double-strand break repair involved in meiotic recombination,BP,
5600,GO:0016647,0.999999999974793,0.854700873578759,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11725,GO:0046592,0.999999999974793,0.854700873578759,0,2,polyamine oxidase activity,MF,
13423,GO:0052901,0.999999999974793,0.854700873578759,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
12433,GO:0050253,0.999999999975463,0.781536031243011,0,2,retinyl-palmitate esterase activity,MF,
6472,GO:0021822,0.999999999975491,0.920099166134781,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
10112,GO:0042668,0.999999999975538,0.873789337032763,0,2,auditory receptor cell fate determination,BP,
20138,GO:2000977,0.999999999975538,0.873789337032763,0,2,regulation of forebrain neuron differentiation,BP,
20139,GO:2000978,0.999999999975538,0.873789337032763,0,2,negative regulation of forebrain neuron differentiation,BP,
2312,GO:0005314,0.999999999975588,0.808273573738283,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5120,GO:0015501,0.999999999975588,0.808273573738283,0,2,glutamate:sodium symporter activity,MF,
1965,GO:0004676,0.999999999975643,0.83412305115147,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
18201,GO:1903031,0.999999999975646,0.843365556884567,0,2,regulation of microtubule plus-end binding,BP,
18202,GO:1903033,0.999999999975646,0.843365556884567,0,2,positive regulation of microtubule plus-end binding,BP,
17887,GO:1902226,0.99999999997565,0.849279677293574,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18626,GO:1903969,0.99999999997565,0.849279677293574,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18629,GO:1903972,0.99999999997565,0.849279677293574,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19065,GO:1904995,0.999999999975819,0.860285831198157,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
13532,GO:0060024,0.999999999975876,0.786272969333031,0,2,rhythmic synaptic transmission,BP,
673,GO:0001884,0.999999999975889,0.779169653240451,0,2,pyrimidine nucleoside binding,MF,
833,GO:0002134,0.999999999975889,0.779169653240451,0,2,UTP binding,MF,
7941,GO:0032551,0.999999999975889,0.779169653240451,0,2,pyrimidine ribonucleoside binding,MF,
8427,GO:0033560,0.999999999975921,0.882170211888229,0,1,folate reductase activity,MF,
13186,GO:0051870,0.999999999975921,0.882170211888229,0,1,methotrexate binding,MF,
9600,GO:0036482,0.999999999975934,0.8623306716362,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18162,GO:1902958,0.999999999975934,0.8623306716362,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18352,GO:1903383,0.999999999975934,0.8623306716362,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18353,GO:1903384,0.999999999975934,0.8623306716362,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
2457,GO:0005673,0.999999999976013,0.841584469325814,0,2,transcription factor TFIIE complex,CC,
15445,GO:0071819,0.999999999976049,0.851055838791265,0,2,DUBm complex,CC,
920,GO:0002316,0.999999999976263,0.874554561132182,0,1,follicular B cell differentiation,BP,
5947,GO:0018315,0.999999999976263,0.874554561132182,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
9807,GO:0042040,0.999999999976263,0.874554561132182,0,1,metal incorporation into metallo-molybdopterin complex,BP,
14340,GO:0061598,0.999999999976263,0.874554561132182,0,1,molybdopterin adenylyltransferase activity,MF,
14341,GO:0061599,0.999999999976263,0.874554561132182,0,1,molybdopterin molybdotransferase activity,MF,
15831,GO:0072579,0.999999999976263,0.874554561132182,0,1,glycine receptor clustering,BP,
16420,GO:0097112,0.999999999976263,0.874554561132182,0,1,gamma-aminobutyric acid receptor clustering,BP,
3721,GO:0008251,0.999999999976291,0.768638805459784,0,2,tRNA-specific adenosine deaminase activity,MF,
1532,GO:0003918,0.999999999976332,0.731070034904642,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14297,GO:0061505,0.999999999976332,0.731070034904642,0,2,DNA topoisomerase II activity,MF,
11285,GO:0045626,0.999999999976353,0.783529807997333,0,2,negative regulation of T-helper 1 cell differentiation,BP,
1515,GO:0003877,0.999999999976453,0.920581368497427,0,1,ATP adenylyltransferase activity,MF,
2069,GO:0004824,0.999999999976453,0.920581368497427,0,1,lysine-tRNA ligase activity,MF,
2917,GO:0006430,0.999999999976453,0.920581368497427,0,1,lysyl-tRNA aminoacylation,BP,
6293,GO:0019912,0.999999999976478,0.84288790234897,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
8464,GO:0033624,0.999999999976528,0.743363131408615,0,2,negative regulation of integrin activation,BP,
12416,GO:0050104,0.99999999997662,0.93193271895714,0,1,L-gulonate 3-dehydrogenase activity,MF,
17941,GO:1902359,0.999999999976689,0.839005911499415,0,2,Notch signaling pathway involved in somitogenesis,BP,
17945,GO:1902366,0.999999999976689,0.839005911499415,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17946,GO:1902367,0.999999999976689,0.839005911499415,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
2064,GO:0004819,0.999999999976792,0.790431601869656,0,2,glutamine-tRNA ligase activity,MF,
2912,GO:0006425,0.999999999976792,0.790431601869656,0,2,glutaminyl-tRNA aminoacylation,BP,
3615,GO:0008065,0.999999999976801,0.785560914414926,0,2,establishment of blood-nerve barrier,BP,
3867,GO:0008496,0.999999999976803,0.874796640506641,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
16860,GO:0098833,0.99999999997681,0.862539630996678,0,1,presynaptic endocytic zone,CC,
16861,GO:0098835,0.99999999997681,0.862539630996678,0,1,presynaptic endocytic zone membrane,CC,
10441,GO:0043321,0.999999999977053,0.764268194905712,0,2,regulation of natural killer cell degranulation,BP,
10442,GO:0043323,0.999999999977053,0.764268194905712,0,2,positive regulation of natural killer cell degranulation,BP,
14798,GO:0070564,0.999999999977116,0.841500922063817,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
4915,GO:0014858,0.999999999977175,0.739251920729022,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18068,GO:1902724,0.999999999977175,0.739251920729022,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18070,GO:1902728,0.999999999977175,0.739251920729022,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
14899,GO:0070780,0.999999999977237,0.842668726552684,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
17127,GO:0102521,0.999999999977283,0.821279360062971,0,2,tRNA-4-demethylwyosine synthase activity,MF,
14587,GO:0070180,0.999999999977646,0.95631241984852,0,1,large ribosomal subunit rRNA binding,MF,
14748,GO:0070476,0.999999999977646,0.95631241984852,0,1,rRNA (guanine-N7)-methylation,BP,
20146,GO:2001013,0.999999999977689,0.739171863729236,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
1659,GO:0004117,0.999999999977815,0.910650889350807,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2039,GO:0004782,0.999999999977815,0.910650889350807,0,1,sulfinoalanine decarboxylase activity,MF,
3841,GO:0008455,0.999999999977815,0.910650889350807,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3890,GO:0008531,0.999999999977815,0.910650889350807,0,1,riboflavin kinase activity,MF,
4162,GO:0009231,0.999999999977815,0.910650889350807,0,1,riboflavin biosynthetic process,BP,
4220,GO:0009398,0.999999999977815,0.910650889350807,0,1,FMN biosynthetic process,BP,
9978,GO:0042412,0.999999999977815,0.910650889350807,0,1,taurine biosynthetic process,BP,
11590,GO:0046305,0.999999999977815,0.910650889350807,0,1,alkanesulfonate biosynthetic process,BP,
11647,GO:0046444,0.999999999977815,0.910650889350807,0,1,FMN metabolic process,BP,
1919,GO:0004615,0.999999999977843,0.8593040809572,0,2,phosphomannomutase activity,MF,
7022,GO:0030806,0.999999999977869,0.75588723774675,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7037,GO:0030821,0.999999999977869,0.75588723774675,0,2,negative regulation of cAMP catabolic process,BP,
8280,GO:0033122,0.999999999977869,0.75588723774675,0,2,negative regulation of purine nucleotide catabolic process,BP,
826,GO:0002114,0.999999999978102,0.884754892870356,0,1,interleukin-33 receptor activity,MF,
11967,GO:0047341,0.999999999978168,0.89432118620153,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11011,GO:0045004,0.999999999978391,0.735604077411627,0,2,DNA replication proofreading,BP,
16865,GO:0098840,0.999999999978398,0.859020644213176,0,2,protein transport along microtubule,BP,
16980,GO:0099118,0.999999999978398,0.859020644213176,0,2,microtubule-based protein transport,BP,
19170,GO:1905286,0.9999999999784,0.839567349422975,0,2,serine-type peptidase complex,CC,
9123,GO:0035482,0.999999999978443,0.881584336218843,0,2,gastric motility,BP,
19191,GO:1905333,0.999999999978443,0.881584336218843,0,2,regulation of gastric motility,BP,
19540,GO:1990575,0.999999999978444,0.80629787726885,0,2,mitochondrial L-ornithine transmembrane transport,BP,
2155,GO:0004980,0.999999999978448,0.902407825967494,0,1,melanocyte-stimulating hormone receptor activity,MF,
1911,GO:0004605,0.999999999978616,0.71787101576979,0,3,phosphatidate cytidylyltransferase activity,MF,
16246,GO:0090341,0.99999999997873,0.930651649148506,0,1,negative regulation of secretion of lysosomal enzymes,BP,
8111,GO:0032810,0.999999999978999,0.802465128845222,0,2,sterol response element binding,MF,
10556,GO:0043541,0.999999999979167,0.80133374754951,0,2,UDP-N-acetylglucosamine transferase complex,CC,
167,GO:0000349,0.999999999979182,0.835483843707349,0,2,generation of catalytic spliceosome for first transesterification step,BP,
16446,GO:0097158,0.99999999997919,0.928919106261049,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
19209,GO:1905371,0.999999999979231,0.78832573106903,0,2,ceramide phosphoethanolamine metabolic process,BP,
19210,GO:1905373,0.999999999979231,0.78832573106903,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
5549,GO:0016561,0.99999999997924,0.824067423199548,0,2,protein import into peroxisome matrix, translocation,BP,
19,GO:0000035,0.999999999979427,0.910155457032714,0,2,acyl binding,MF,
20,GO:0000036,0.999999999979427,0.910155457032714,0,2,acyl carrier activity,MF,
4169,GO:0009245,0.999999999979427,0.910155457032714,0,2,lipid A biosynthetic process,BP,
10930,GO:0044620,0.999999999979427,0.910155457032714,0,2,ACP phosphopantetheine attachment site binding,MF,
11679,GO:0046493,0.999999999979427,0.910155457032714,0,2,lipid A metabolic process,BP,
12842,GO:0051192,0.999999999979427,0.910155457032714,0,2,prosthetic group binding,MF,
17577,GO:1901269,0.999999999979427,0.910155457032714,0,2,lipooligosaccharide metabolic process,BP,
17578,GO:1901271,0.999999999979427,0.910155457032714,0,2,lipooligosaccharide biosynthetic process,BP,
11609,GO:0046338,0.999999999979605,0.811576513810448,0,2,phosphatidylethanolamine catabolic process,BP,
1432,GO:0003408,0.999999999979607,0.695888882334091,0,2,optic cup formation involved in camera-type eye development,BP,
18179,GO:1902994,0.999999999979619,0.78610108470195,0,2,regulation of phospholipid efflux,BP,
18180,GO:1902995,0.999999999979619,0.78610108470195,0,2,positive regulation of phospholipid efflux,BP,
877,GO:0002238,0.999999999979724,0.861261026895671,0,1,response to molecule of fungal origin,BP,
939,GO:0002351,0.999999999979724,0.861261026895671,0,1,serotonin production involved in inflammatory response,BP,
984,GO:0002442,0.999999999979724,0.861261026895671,0,1,serotonin secretion involved in inflammatory response,BP,
1039,GO:0002554,0.999999999979724,0.861261026895671,0,1,serotonin secretion by platelet,BP,
6240,GO:0019814,0.999999999979724,0.861261026895671,0,1,immunoglobulin complex,CC,
6241,GO:0019815,0.999999999979724,0.861261026895671,0,1,B cell receptor complex,CC,
8061,GO:0032752,0.999999999979724,0.861261026895671,0,1,positive regulation of interleukin-3 production,BP,
9887,GO:0042223,0.999999999979724,0.861261026895671,0,1,interleukin-3 biosynthetic process,BP,
11209,GO:0045399,0.999999999979724,0.861261026895671,0,1,regulation of interleukin-3 biosynthetic process,BP,
11210,GO:0045401,0.999999999979724,0.861261026895671,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11219,GO:0045423,0.999999999979724,0.861261026895671,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11220,GO:0045425,0.999999999979724,0.861261026895671,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15105,GO:0071226,0.999999999979724,0.861261026895671,0,1,cellular response to molecule of fungal origin,BP,
16226,GO:0090310,0.999999999979728,0.729529560529476,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
1541,GO:0003937,0.999999999979737,0.92078311602639,0,1,IMP cyclohydrolase activity,MF,
1939,GO:0004643,0.999999999979737,0.92078311602639,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
10499,GO:0043435,0.999999999979737,0.912655098180861,0,1,response to corticotropin-releasing hormone,BP,
13384,GO:0052798,0.999999999979737,0.92078311602639,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
15193,GO:0071376,0.999999999979737,0.912655098180861,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
1915,GO:0004610,0.999999999979787,0.922388390324925,0,1,phosphoacetylglucosamine mutase activity,MF,
16745,GO:0098582,0.999999999979829,0.754220679709407,0,2,innate vocalization behavior,BP,
7358,GO:0031416,0.999999999979854,0.80120982928213,0,2,NatB complex,CC,
14280,GO:0061444,0.99999999997986,0.847782098247554,0,1,endocardial cushion cell development,BP,
4119,GO:0009182,0.9999999999799,0.797980284765427,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
11514,GO:0046066,0.9999999999799,0.797980284765427,0,3,dGDP metabolic process,BP,
11101,GO:0045155,0.99999999997992,0.802225081206594,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
1721,GO:0004315,0.999999999979965,0.764651927109949,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1214,GO:0002885,0.999999999979996,0.803363618823687,0,2,positive regulation of hypersensitivity,BP,
15670,GO:0072237,0.999999999979998,0.691204597865093,0,2,metanephric proximal tubule development,BP,
347,GO:0000961,0.999999999980002,0.761184916698096,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
12114,GO:0048237,0.999999999980037,0.856676701752948,0,2,rough endoplasmic reticulum lumen,CC,
7855,GO:0032427,0.999999999980113,0.799530374180445,0,2,GBD domain binding,MF,
12765,GO:0051086,0.999999999980157,0.922974809169335,0,1,chaperone mediated protein folding independent of cofactor,BP,
7350,GO:0031403,0.999999999980184,0.742652664859633,0,2,lithium ion binding,MF,
118,GO:0000247,0.999999999980193,0.940199968501186,0,1,C-8 sterol isomerase activity,MF,
2028,GO:0004769,0.999999999980193,0.940199968501186,0,1,steroid delta-isomerase activity,MF,
10066,GO:0042586,0.999999999980193,0.940199968501186,0,1,peptide deformylase activity,MF,
7413,GO:0031523,0.999999999980219,0.742253761016469,0,2,Myb complex,CC,
6445,GO:0021771,0.999999999980227,0.851665690601071,0,1,lateral geniculate nucleus development,BP,
9935,GO:0042320,0.999999999980227,0.851665690601071,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
13584,GO:0060084,0.999999999980227,0.851665690601071,0,1,synaptic transmission involved in micturition,BP,
7649,GO:0032089,0.99999999998023,0.77817411537355,0,2,NACHT domain binding,MF,
1757,GO:0004362,0.999999999980233,0.918034453899451,0,1,glutathione-disulfide reductase activity,MF,
5190,GO:0015786,0.999999999980233,0.918034453899451,0,1,UDP-glucose transmembrane transport,BP,
14116,GO:0061015,0.999999999980301,0.874318472682736,0,2,snRNA import into nucleus,BP,
3486,GO:0007356,0.999999999980313,0.83767305622942,0,2,thorax and anterior abdomen determination,BP,
20179,GO:2001074,0.999999999980313,0.83767305622942,0,2,regulation of metanephric ureteric bud development,BP,
20180,GO:2001076,0.999999999980313,0.83767305622942,0,2,positive regulation of metanephric ureteric bud development,BP,
5104,GO:0015410,0.999999999980386,0.705093270833532,0,3,manganese-transporting ATPase activity,MF,
9718,GO:0038190,0.999999999980559,0.815698069905454,0,2,VEGF-activated neuropilin signaling pathway,BP,
17935,GO:1902336,0.999999999980559,0.815698069905454,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
8827,GO:0034635,0.999999999980581,0.777034233153906,0,2,glutathione transport,BP,
10215,GO:0042939,0.999999999980581,0.777034233153906,0,2,tripeptide transport,BP,
8914,GO:0034776,0.999999999980589,0.742257481492718,0,2,response to histamine,BP,
15222,GO:0071420,0.999999999980589,0.742257481492718,0,2,cellular response to histamine,BP,
14005,GO:0060763,0.999999999980654,0.771323968974701,0,2,mammary duct terminal end bud growth,BP,
8832,GO:0034642,0.999999999980678,0.884549480538002,0,1,mitochondrion migration along actin filament,BP,
4207,GO:0009353,0.999999999980681,0.935960549914634,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7419,GO:0031531,0.999999999980681,0.935960549914634,0,1,thyrotropin-releasing hormone receptor binding,MF,
4706,GO:0010873,0.999999999980687,0.828010278040761,0,3,positive regulation of cholesterol esterification,BP,
7936,GO:0032542,0.999999999980697,0.815285380835336,0,2,sulfiredoxin activity,MF,
18807,GO:1904426,0.999999999980712,0.766298704534195,0,2,positive regulation of GTP binding,BP,
1617,GO:0004052,0.999999999980724,0.837758659433999,0,2,arachidonate 12-lipoxygenase activity,MF,
18457,GO:1903589,0.999999999980763,0.830254622970189,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
6351,GO:0021539,0.999999999980847,0.854435775844134,0,2,subthalamus development,BP,
218,GO:0000455,0.999999999980849,0.852628088441941,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
142,GO:0000294,0.999999999980897,0.779814500835612,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
188,GO:0000406,0.999999999980957,0.781699626379426,0,2,double-strand/single-strand DNA junction binding,MF,
7691,GO:0032181,0.999999999980957,0.781699626379426,0,2,dinucleotide repeat insertion binding,MF,
7767,GO:0032302,0.999999999980957,0.781699626379426,0,2,MutSbeta complex,CC,
2052,GO:0004803,0.999999999981021,0.765073416174773,0,2,transposase activity,MF,
6341,GO:0021523,0.999999999981045,0.852862951148674,0,2,somatic motor neuron differentiation,BP,
10427,GO:0043305,0.999999999981052,0.836167187666104,0,2,negative regulation of mast cell degranulation,BP,
1876,GO:0004557,0.999999999981098,0.82797478622927,0,2,alpha-galactosidase activity,MF,
1545,GO:0003943,0.999999999981112,0.804209701142678,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
369,GO:0000991,0.999999999981123,0.792199411244705,0,2,transcription factor activity, core RNA polymerase II binding,MF,
524,GO:0001631,0.999999999981175,0.831545840160194,0,2,cysteinyl leukotriene receptor activity,MF,
525,GO:0001632,0.999999999981175,0.831545840160194,0,2,leukotriene B4 receptor activity,MF,
2152,GO:0004974,0.999999999981175,0.831545840160194,0,2,leukotriene receptor activity,MF,
14402,GO:0061737,0.999999999981175,0.831545840160194,0,2,leukotriene signaling pathway,BP,
15498,GO:0071918,0.999999999981207,0.792509476584991,0,2,urea transmembrane transport,BP,
4687,GO:0010845,0.999999999981274,0.912025115540512,0,1,positive regulation of reciprocal meiotic recombination,BP,
5462,GO:0016401,0.999999999981325,0.766340110272935,0,2,palmitoyl-CoA oxidase activity,MF,
2190,GO:0005052,0.999999999981374,0.801523812505384,0,2,peroxisome matrix targeting signal-1 binding,MF,
5730,GO:0016882,0.999999999981384,0.846861452777888,0,2,cyclo-ligase activity,MF,
19299,GO:1905616,0.999999999981391,0.778432913327686,0,2,regulation of miRNA mediated inhibition of translation,BP,
19300,GO:1905618,0.999999999981391,0.778432913327686,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
15079,GO:0071159,0.999999999981412,0.866100578423821,0,2,NF-kappaB complex,CC,
11508,GO:0046056,0.99999999998153,0.844837865704932,0,2,dADP metabolic process,BP,
14330,GO:0061574,0.99999999998154,0.73193040526677,0,3,ASAP complex,CC,
1725,GO:0004320,0.999999999981541,0.756074406564785,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5427,GO:0016295,0.999999999981541,0.756074406564785,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5428,GO:0016296,0.999999999981541,0.756074406564785,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5429,GO:0016297,0.999999999981541,0.756074406564785,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
13658,GO:0060228,0.999999999981552,0.901866741302909,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
11204,GO:0045358,0.999999999981717,0.866594449887195,0,2,negative regulation of interferon-beta biosynthetic process,BP,
15841,GO:0072592,0.999999999981727,0.846457434651961,0,2,oxygen metabolic process,BP,
13214,GO:0051908,0.999999999981737,0.899858814904471,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
10574,GO:0043564,0.999999999981776,0.822412213677745,0,2,Ku70:Ku80 complex,CC,
2154,GO:0004979,0.999999999981782,0.924702174026204,0,1,beta-endorphin receptor activity,MF,
7462,GO:0031635,0.999999999981782,0.924702174026204,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7657,GO:0032097,0.999999999981782,0.924702174026204,0,1,positive regulation of response to food,BP,
7660,GO:0032100,0.999999999981782,0.924702174026204,0,1,positive regulation of appetite,BP,
9662,GO:0038047,0.999999999981782,0.924702174026204,0,1,morphine receptor activity,MF,
11696,GO:0046521,0.999999999981782,0.924702174026204,0,1,sphingoid catabolic process,BP,
14253,GO:0061358,0.999999999981782,0.924702174026204,0,1,negative regulation of Wnt protein secretion,BP,
12133,GO:0048264,0.999999999981789,0.904364621182527,0,1,determination of ventral identity,BP,
20257,GO:2001253,0.999999999981789,0.904364621182527,0,1,regulation of histone H3-K36 trimethylation,BP,
5406,GO:0016256,0.999999999981808,0.799790831820333,0,2,N-glycan processing to lysosome,BP,
5387,GO:0016230,0.999999999981823,0.832432581642911,0,2,sphingomyelin phosphodiesterase activator activity,MF,
1912,GO:0004607,0.999999999981837,0.935270435260825,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
9239,GO:0035663,0.99999999998187,0.786811560099887,0,2,Toll-like receptor 2 binding,MF,
17548,GO:1901187,0.999999999981892,0.772722330479888,0,2,regulation of ephrin receptor signaling pathway,BP,
3964,GO:0008761,0.999999999981909,0.857367910768947,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4214,GO:0009384,0.999999999981909,0.857367910768947,0,1,N-acylmannosamine kinase activity,MF,
911,GO:0002299,0.999999999981932,0.930619607883142,0,1,alpha-beta intraepithelial T cell differentiation,BP,
912,GO:0002300,0.999999999981932,0.930619607883142,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
913,GO:0002304,0.999999999981932,0.930619607883142,0,1,gamma-delta intraepithelial T cell differentiation,BP,
914,GO:0002305,0.999999999981932,0.930619607883142,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
14782,GO:0070539,0.999999999981978,0.892035521538525,0,1,linoleic acid binding,MF,
11709,GO:0046544,0.99999999998202,0.860175625270537,0,1,development of secondary male sexual characteristics,BP,
16402,GO:0097070,0.999999999982026,0.85094235420738,0,1,ductus arteriosus closure,BP,
16503,GO:0097272,0.999999999982026,0.85094235420738,0,1,ammonia homeostasis,BP,
16504,GO:0097273,0.999999999982026,0.85094235420738,0,1,creatinine homeostasis,BP,
16506,GO:0097275,0.999999999982026,0.85094235420738,0,1,cellular ammonia homeostasis,BP,
16507,GO:0097276,0.999999999982026,0.85094235420738,0,1,cellular creatinine homeostasis,BP,
16508,GO:0097277,0.999999999982026,0.85094235420738,0,1,cellular urea homeostasis,BP,
9223,GO:0035633,0.999999999982071,0.798930034124698,0,2,maintenance of permeability of blood-brain barrier,BP,
13803,GO:0060430,0.999999999982104,0.703729723933653,0,2,lung saccule development,BP,
4150,GO:0009216,0.999999999982143,0.835717234705238,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
2003,GO:0004729,0.999999999982144,0.926896832054277,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14906,GO:0070818,0.999999999982144,0.926896832054277,0,1,protoporphyrinogen oxidase activity,MF,
3000,GO:0006548,0.999999999982147,0.817108589069414,0,2,histidine catabolic process,BP,
13386,GO:0052805,0.999999999982147,0.817108589069414,0,2,imidazole-containing compound catabolic process,BP,
12015,GO:0047756,0.999999999982162,0.784259753947637,0,2,chondroitin 4-sulfotransferase activity,MF,
15338,GO:0071606,0.999999999982194,0.922705719535839,0,1,chemokine (C-C motif) ligand 4 production,BP,
15364,GO:0071643,0.999999999982194,0.922705719535839,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15365,GO:0071644,0.999999999982194,0.922705719535839,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15853,GO:0072615,0.999999999982194,0.922705719535839,0,1,interleukin-17 secretion,BP,
19104,GO:1905076,0.999999999982194,0.922705719535839,0,1,regulation of interleukin-17 secretion,BP,
19105,GO:1905077,0.999999999982194,0.922705719535839,0,1,negative regulation of interleukin-17 secretion,BP,
19219,GO:1905403,0.999999999982194,0.922705719535839,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
2073,GO:0004828,0.999999999982256,0.851230850807078,0,2,serine-tRNA ligase activity,MF,
2921,GO:0006434,0.999999999982256,0.851230850807078,0,2,seryl-tRNA aminoacylation,BP,
1533,GO:0003919,0.999999999982307,0.922848453356898,0,1,FMN adenylyltransferase activity,MF,
3147,GO:0006747,0.999999999982307,0.922848453356898,0,1,FAD biosynthetic process,BP,
11646,GO:0046443,0.999999999982307,0.922848453356898,0,1,FAD metabolic process,BP,
15753,GO:0072388,0.999999999982307,0.922848453356898,0,1,flavin adenine dinucleotide biosynthetic process,BP,
2070,GO:0004825,0.999999999982311,0.82143916758366,0,2,methionine-tRNA ligase activity,MF,
2918,GO:0006431,0.999999999982311,0.82143916758366,0,2,methionyl-tRNA aminoacylation,BP,
2773,GO:0006203,0.999999999982313,0.790165103654206,0,3,dGTP catabolic process,BP,
820,GO:0002094,0.999999999982346,0.833688171382052,0,2,polyprenyltransferase activity,MF,
4881,GO:0014806,0.999999999982358,0.851625937534321,0,2,smooth muscle hyperplasia,BP,
18085,GO:1902766,0.999999999982421,0.864553891344827,0,2,skeletal muscle satellite cell migration,BP,
8178,GO:0032929,0.999999999982584,0.855760673112617,0,2,negative regulation of superoxide anion generation,BP,
13971,GO:0060715,0.999999999982589,0.704919666253256,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
15250,GO:0071461,0.999999999982618,0.852996554239087,0,2,cellular response to redox state,BP,
2260,GO:0005176,0.999999999982655,0.861588282275376,0,2,ErbB-2 class receptor binding,MF,
895,GO:0002276,0.999999999982683,0.80658037174049,0,2,basophil activation involved in immune response,BP,
11246,GO:0045575,0.999999999982683,0.80658037174049,0,2,basophil activation,BP,
161,GO:0000333,0.999999999982699,0.812076844682512,0,2,telomerase catalytic core complex,CC,
4299,GO:0009753,0.999999999982809,0.871158709964977,0,2,response to jasmonic acid,BP,
5974,GO:0018636,0.999999999982809,0.871158709964977,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11924,GO:0047023,0.999999999982809,0.871158709964977,0,2,androsterone dehydrogenase activity,MF,
11931,GO:0047086,0.999999999982809,0.871158709964977,0,2,ketosteroid monooxygenase activity,MF,
11933,GO:0047115,0.999999999982809,0.871158709964977,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15208,GO:0071395,0.999999999982809,0.871158709964977,0,2,cellular response to jasmonic acid stimulus,BP,
18467,GO:1903621,0.99999999998282,0.923305234134364,0,1,protein localization to photoreceptor connecting cilium,BP,
1052,GO:0002581,0.999999999982825,0.795075780719986,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
19149,GO:1905224,0.999999999982903,0.74582651604059,0,2,clathrin-coated pit assembly,BP,
18653,GO:1904026,0.999999999982905,0.828692511908993,0,2,regulation of collagen fibril organization,BP,
4710,GO:0010877,0.999999999982998,0.862668493545431,0,2,lipid transport involved in lipid storage,BP,
7409,GO:0031510,0.999999999983015,0.777833520553733,0,3,SUMO activating enzyme complex,CC,
499,GO:0001555,0.999999999983027,0.822134214437956,0,2,oocyte growth,BP,
7443,GO:0031590,0.999999999983027,0.822134214437956,0,2,wybutosine metabolic process,BP,
7444,GO:0031591,0.999999999983027,0.822134214437956,0,2,wybutosine biosynthetic process,BP,
18388,GO:1903445,0.999999999983047,0.795896998210262,0,3,protein transport from ciliary membrane to plasma membrane,BP,
17603,GO:1901340,0.999999999983114,0.877406321390714,0,1,negative regulation of store-operated calcium channel activity,BP,
12163,GO:0048319,0.999999999983125,0.752220796702396,0,2,axial mesoderm morphogenesis,BP,
14352,GO:0061622,0.999999999983138,0.841164547450309,0,2,glycolytic process through glucose-1-phosphate,BP,
11577,GO:0046203,0.999999999983138,0.871593137641614,0,2,spermidine catabolic process,BP,
9691,GO:0038113,0.999999999983163,0.736105528722403,0,2,interleukin-9-mediated signaling pathway,BP,
15062,GO:0071104,0.999999999983163,0.736105528722403,0,2,response to interleukin-9,BP,
15179,GO:0071355,0.999999999983163,0.736105528722403,0,2,cellular response to interleukin-9,BP,
11928,GO:0047045,0.999999999983191,0.93803240586045,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
1208,GO:0002875,0.999999999983307,0.929205502435955,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2233,GO:0005141,0.999999999983307,0.929205502435955,0,1,interleukin-10 receptor binding,MF,
18672,GO:1904057,0.999999999983307,0.929205502435955,0,1,negative regulation of sensory perception of pain,BP,
14264,GO:0061394,0.999999999983315,0.854762778703049,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
4993,GO:0015140,0.999999999983328,0.856090074398315,0,2,malate transmembrane transporter activity,MF,
19436,GO:1990145,0.999999999983341,0.805582533938719,0,2,maintenance of translational fidelity,BP,
9558,GO:0036378,0.99999999998336,0.849949155624381,0,2,calcitriol biosynthetic process from calciol,BP,
2207,GO:0005094,0.999999999983396,0.867999735674734,0,2,Rho GDP-dissociation inhibitor activity,MF,
881,GO:0002249,0.999999999983439,0.709843313959164,0,2,lymphocyte anergy,BP,
1082,GO:0002667,0.999999999983439,0.709843313959164,0,2,regulation of T cell anergy,BP,
1206,GO:0002870,0.999999999983439,0.709843313959164,0,2,T cell anergy,BP,
1229,GO:0002911,0.999999999983439,0.709843313959164,0,2,regulation of lymphocyte anergy,BP,
6083,GO:0019254,0.999999999983449,0.828724334891876,0,2,carnitine metabolic process, CoA-linked,BP,
2175,GO:0005021,0.999999999983457,0.783092248918934,0,2,vascular endothelial growth factor-activated receptor activity,MF,
7580,GO:0031959,0.999999999983467,0.777527950573703,0,2,mineralocorticoid receptor signaling pathway,BP,
5783,GO:0017018,0.999999999983471,0.731590754776262,0,2,myosin phosphatase activity,MF,
11201,GO:0045355,0.999999999983484,0.866344489799201,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
235,GO:0000493,0.999999999983488,0.840952198311914,0,2,box H/ACA snoRNP assembly,BP,
2504,GO:0005760,0.999999999983504,0.75884794162924,0,2,gamma DNA polymerase complex,CC,
3869,GO:0008503,0.999999999983529,0.856828650698592,0,2,benzodiazepine receptor activity,MF,
9083,GO:0035370,0.999999999983536,0.837885291115208,0,2,UBC13-UEV1A complex,CC,
11157,GO:0045259,0.999999999983537,0.858867785509522,0,2,proton-transporting ATP synthase complex,CC,
3808,GO:0008404,0.999999999983592,0.924790885585973,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3809,GO:0008405,0.999999999983592,0.924790885585973,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15343,GO:0071614,0.999999999983592,0.924790885585973,0,1,linoleic acid epoxygenase activity,MF,
19523,GO:1990498,0.999999999983606,0.681836213225303,0,2,mitotic spindle microtubule,CC,
2771,GO:0006196,0.999999999983612,0.767365369249803,0,2,AMP catabolic process,BP,
1488,GO:0003827,0.999999999983614,0.822709914936893,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
8519,GO:0033857,0.999999999983619,0.731006152266321,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
17093,GO:0102092,0.999999999983619,0.731006152266321,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
1766,GO:0004372,0.999999999983628,0.840399662964057,0,2,glycine hydroxymethyltransferase activity,MF,
2044,GO:0004793,0.999999999983628,0.840399662964057,0,2,threonine aldolase activity,MF,
2997,GO:0006545,0.999999999983628,0.840399662964057,0,2,glycine biosynthetic process,BP,
3957,GO:0008732,0.999999999983628,0.840399662964057,0,2,L-allo-threonine aldolase activity,MF,
6086,GO:0019264,0.999999999983628,0.840399662964057,0,2,glycine biosynthetic process from serine,BP,
12788,GO:0051120,0.999999999983664,0.821924257134914,0,2,hepoxilin A3 synthase activity,MF,
10592,GO:0043602,0.999999999983682,0.914143765583063,0,1,nitrate catabolic process,BP,
11581,GO:0046210,0.999999999983682,0.914143765583063,0,1,nitric oxide catabolic process,BP,
12010,GO:0047726,0.999999999983682,0.914143765583063,0,1,iron-cytochrome-c reductase activity,MF,
16250,GO:0090345,0.999999999983682,0.914143765583063,0,1,cellular organohalogen metabolic process,BP,
16251,GO:0090346,0.999999999983682,0.914143765583063,0,1,cellular organofluorine metabolic process,BP,
217,GO:0000454,0.999999999983707,0.834507929144757,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
1350,GO:0003219,0.999999999983787,0.74777515879443,0,2,cardiac right ventricle formation,BP,
8598,GO:0034124,0.999999999983818,0.822143138897022,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
1597,GO:0004018,0.99999999998383,0.932398326535464,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14828,GO:0070626,0.99999999998383,0.932398326535464,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
3862,GO:0008488,0.999999999983833,0.90058181334546,0,1,gamma-glutamyl carboxylase activity,MF,
1157,GO:0002767,0.999999999983838,0.840058424636214,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
1824,GO:0004479,0.999999999983871,0.909833245229663,0,1,methionyl-tRNA formyltransferase activity,MF,
6317,GO:0019988,0.999999999983871,0.909833245229663,0,1,charged-tRNA amino acid modification,BP,
15514,GO:0071951,0.999999999983871,0.909833245229663,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17785,GO:1901917,0.999999999983871,0.909833245229663,0,1,regulation of exoribonuclease activity,BP,
17786,GO:1901919,0.999999999983871,0.909833245229663,0,1,positive regulation of exoribonuclease activity,BP,
19338,GO:1905779,0.999999999983871,0.909833245229663,0,1,positive regulation of exonuclease activity,BP,
11136,GO:0045213,0.999999999983876,0.851877922412429,0,2,neurotransmitter receptor metabolic process,BP,
2733,GO:0006116,0.99999999998393,0.78343206867126,0,2,NADH oxidation,BP,
13774,GO:0060392,0.999999999983933,0.862179369313256,0,2,negative regulation of SMAD protein signal transduction,BP,
9611,GO:0036496,0.999999999983945,0.854489195123619,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10924,GO:0044609,0.999999999983975,0.834528698352879,0,2,DBIRD complex,CC,
6044,GO:0019185,0.999999999983981,0.790408435846363,0,2,snRNA-activating protein complex,CC,
8479,GO:0033650,0.999999999984015,0.926754119034755,0,1,host cell mitochondrion,CC,
10736,GO:0044190,0.999999999984015,0.926754119034755,0,1,host cell mitochondrial envelope,CC,
15772,GO:0072492,0.999999999984015,0.926754119034755,0,1,host cell mitochondrial intermembrane space,CC,
18845,GO:1904530,0.999999999984021,0.902278953747546,0,1,negative regulation of actin filament binding,BP,
18887,GO:1904617,0.999999999984021,0.902278953747546,0,1,negative regulation of actin binding,BP,
3437,GO:0007231,0.999999999984027,0.83672540042528,0,2,osmosensory signaling pathway,BP,
16212,GO:0090291,0.999999999984067,0.764523588404865,0,2,negative regulation of osteoclast proliferation,BP,
9709,GO:0038171,0.999999999984098,0.727045881489325,0,3,cannabinoid signaling pathway,BP,
15502,GO:0071926,0.999999999984098,0.727045881489325,0,3,endocannabinoid signaling pathway,BP,
3864,GO:0008493,0.999999999984101,0.924728761693369,0,1,tetracycline transmembrane transporter activity,MF,
5257,GO:0015904,0.999999999984101,0.924728761693369,0,1,tetracycline transport,BP,
14410,GO:0061750,0.999999999984137,0.917140341545642,0,1,acid sphingomyelin phosphodiesterase activity,MF,
6474,GO:0021824,0.999999999984162,0.779518038455421,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6478,GO:0021828,0.999999999984162,0.779518038455421,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6489,GO:0021856,0.999999999984162,0.779518038455421,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13769,GO:0060385,0.999999999984162,0.779518038455421,0,2,axonogenesis involved in innervation,BP,
18346,GO:1903375,0.999999999984162,0.779518038455421,0,2,facioacoustic ganglion development,BP,
19984,GO:2000620,0.999999999984182,0.706968808070146,0,2,positive regulation of histone H4-K16 acetylation,BP,
18826,GO:1904468,0.999999999984185,0.720894559103296,0,3,negative regulation of tumor necrosis factor secretion,BP,
18127,GO:1902896,0.999999999984201,0.799201445504627,0,2,terminal web assembly,BP,
1756,GO:0004361,0.999999999984208,0.927543134075081,0,1,glutaryl-CoA dehydrogenase activity,MF,
2263,GO:0005183,0.999999999984208,0.927543134075081,0,1,gonadotropin hormone-releasing hormone activity,MF,
7418,GO:0031530,0.999999999984208,0.927543134075081,0,1,gonadotropin-releasing hormone receptor binding,MF,
19398,GO:1990008,0.999999999984208,0.927543134075081,0,1,neurosecretory vesicle,CC,
8740,GO:0034418,0.999999999984216,0.842305075112414,0,2,urate biosynthetic process,BP,
14752,GO:0070483,0.999999999984238,0.900245149512843,0,1,detection of hypoxia,BP,
18844,GO:1904529,0.999999999984297,0.769394461459023,0,2,regulation of actin filament binding,BP,
18886,GO:1904616,0.999999999984297,0.769394461459023,0,2,regulation of actin binding,BP,
3182,GO:0006808,0.99999999998431,0.839253169632246,0,2,regulation of nitrogen utilization,BP,
11772,GO:0046666,0.99999999998431,0.839253169632246,0,2,retinal cell programmed cell death,BP,
1640,GO:0004085,0.999999999984349,0.923724518783648,0,1,butyryl-CoA dehydrogenase activity,MF,
6180,GO:0019605,0.999999999984349,0.923724518783648,0,1,butyrate metabolic process,BP,
11618,GO:0046359,0.999999999984349,0.923724518783648,0,1,butyrate catabolic process,BP,
13419,GO:0052890,0.999999999984349,0.923724518783648,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
19987,GO:2000625,0.99999999998437,0.790549100002274,0,2,regulation of miRNA catabolic process,BP,
19988,GO:2000627,0.99999999998437,0.790549100002274,0,2,positive regulation of miRNA catabolic process,BP,
19572,GO:1990723,0.999999999984485,0.702974407659814,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
2060,GO:0004815,0.999999999984519,0.821601932531441,0,2,aspartate-tRNA ligase activity,MF,
14808,GO:0070576,0.999999999984533,0.821644968962223,0,2,vitamin D 24-hydroxylase activity,MF,
3843,GO:0008457,0.999999999984547,0.877652805995373,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
11952,GO:0047256,0.999999999984547,0.877652805995373,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
13126,GO:0051725,0.99999999998455,0.838127791955576,0,2,protein de-ADP-ribosylation,BP,
16866,GO:0098842,0.99999999998457,0.841176898125085,0,2,postsynaptic early endosome,CC,
16049,GO:0090038,0.999999999984618,0.795864236203036,0,2,negative regulation of protein kinase C signaling,BP,
7828,GO:0032393,0.999999999984633,0.874202242059551,0,2,MHC class I receptor activity,MF,
340,GO:0000941,0.999999999984714,0.91828920867816,0,1,condensed nuclear chromosome inner kinetochore,CC,
12994,GO:0051456,0.999999999984714,0.91828920867816,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
17443,GO:1900275,0.999999999984729,0.762276303482216,0,2,negative regulation of phospholipase C activity,BP,
17571,GO:1901255,0.999999999984752,0.779256665380066,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
4887,GO:0014816,0.999999999984792,0.694060214029006,0,2,skeletal muscle satellite cell differentiation,BP,
9946,GO:0042350,0.999999999984824,0.765525258797512,0,3,GDP-L-fucose biosynthetic process,BP,
125,GO:0000257,0.999999999984871,0.935058040424369,0,1,nitrilase activity,MF,
5689,GO:0016815,0.999999999984871,0.935058040424369,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
9951,GO:0042356,0.999999999984871,0.935058040424369,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12478,GO:0050577,0.999999999984871,0.935058040424369,0,1,GDP-L-fucose synthase activity,MF,
12762,GO:0051083,0.999999999984973,0.851643912903377,0,2,'de novo' cotranslational protein folding,BP,
2458,GO:0005674,0.999999999984996,0.852079035705724,0,2,transcription factor TFIIF complex,CC,
2819,GO:0006286,0.999999999985001,0.87376637065543,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
11439,GO:0045917,0.99999999998501,0.795572354473566,0,2,positive regulation of complement activation,BP,
19786,GO:2000259,0.99999999998501,0.795572354473566,0,2,positive regulation of protein activation cascade,BP,
6415,GO:0021685,0.999999999985016,0.830914428819834,0,1,cerebellar granular layer structural organization,BP,
7062,GO:0030860,0.999999999985026,0.780737419428706,0,2,regulation of polarized epithelial cell differentiation,BP,
4209,GO:0009368,0.999999999985055,0.861863548653357,0,2,endopeptidase Clp complex,CC,
1187,GO:0002835,0.999999999985068,0.819163658595827,0,2,negative regulation of response to tumor cell,BP,
1190,GO:0002838,0.999999999985068,0.819163658595827,0,2,negative regulation of immune response to tumor cell,BP,
1195,GO:0002856,0.999999999985068,0.819163658595827,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002859,0.999999999985068,0.819163658595827,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
9398,GO:0035981,0.999999999985092,0.809702452864696,0,2,tongue muscle cell differentiation,BP,
18099,GO:1902811,0.999999999985092,0.809702452864696,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20164,GO:2001035,0.999999999985092,0.809702452864696,0,2,regulation of tongue muscle cell differentiation,BP,
20165,GO:2001037,0.999999999985092,0.809702452864696,0,2,positive regulation of tongue muscle cell differentiation,BP,
9659,GO:0038039,0.999999999985114,0.872604453858924,0,1,G-protein coupled receptor heterodimeric complex,CC,
805,GO:0002079,0.999999999985161,0.73773497316218,0,2,inner acrosomal membrane,CC,
14414,GO:0061757,0.999999999985174,0.841262336329747,0,2,leukocyte adhesion to arterial endothelial cell,BP,
19067,GO:1904997,0.999999999985174,0.841262336329747,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
13918,GO:0060623,0.99999999998519,0.742615772262905,0,3,regulation of chromosome condensation,BP,
4321,GO:0009826,0.999999999985204,0.777461985934854,0,2,unidimensional cell growth,BP,
7341,GO:0031393,0.999999999985217,0.797038643130586,0,2,negative regulation of prostaglandin biosynthetic process,BP,
13634,GO:0060179,0.999999999985244,0.723924691655398,0,3,male mating behavior,BP,
16121,GO:0090164,0.999999999985285,0.753718326128586,0,2,asymmetric Golgi ribbon formation,BP,
8543,GO:0033981,0.999999999985298,0.954359266295795,0,1,D-dopachrome decarboxylase activity,MF,
1063,GO:0002605,0.999999999985319,0.85047424304993,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
4627,GO:0010754,0.999999999985319,0.85047424304993,0,1,negative regulation of cGMP-mediated signaling,BP,
1366,GO:0003252,0.999999999985326,0.773921286041377,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
2115,GO:0004906,0.999999999985335,0.845653728529573,0,2,interferon-gamma receptor activity,MF,
443,GO:0001192,0.999999999985339,0.94778732755556,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,0.999999999985339,0.94778732755556,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
13840,GO:0060486,0.999999999985355,0.751667794307523,0,2,Clara cell differentiation,BP,
7553,GO:0031906,0.999999999985448,0.837802854468441,0,2,late endosome lumen,CC,
16599,GO:0097486,0.999999999985448,0.837802854468441,0,2,multivesicular body lumen,CC,
15911,GO:0072749,0.99999999998545,0.925710473121248,0,1,cellular response to cytochalasin B,BP,
16909,GO:0098918,0.99999999998545,0.925710473121248,0,1,structural constituent of synapse,MF,
16933,GO:0098973,0.99999999998545,0.925710473121248,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16934,GO:0098974,0.99999999998545,0.925710473121248,0,1,postsynaptic actin cytoskeleton organization,BP,
16995,GO:0099186,0.99999999998545,0.925710473121248,0,1,structural constituent of postsynapse,MF,
16996,GO:0099188,0.99999999998545,0.925710473121248,0,1,postsynaptic cytoskeleton organization,BP,
17597,GO:1901328,0.99999999998545,0.925710473121248,0,1,response to cytochalasin B,BP,
17478,GO:1900623,0.999999999985472,0.774091268473061,0,2,regulation of monocyte aggregation,BP,
17479,GO:1900625,0.999999999985472,0.774091268473061,0,2,positive regulation of monocyte aggregation,BP,
5442,GO:0016320,0.999999999985473,0.768517567369442,0,2,endoplasmic reticulum membrane fusion,BP,
2186,GO:0005046,0.999999999985481,0.847094887131796,0,2,KDEL sequence binding,MF,
9710,GO:0038172,0.999999999985486,0.806672519909099,0,2,interleukin-33-mediated signaling pathway,BP,
10415,GO:0043291,0.99999999998549,0.619333570634762,0,2,RAVE complex,CC,
2051,GO:0004802,0.999999999985493,0.920589428226693,0,1,transketolase activity,MF,
1651,GO:0004105,0.999999999985532,0.794987702041057,0,2,choline-phosphate cytidylyltransferase activity,MF,
1416,GO:0003357,0.999999999985535,0.70243472231839,0,2,noradrenergic neuron differentiation,BP,
15039,GO:0071030,0.999999999985554,0.843269040573486,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15051,GO:0071048,0.999999999985554,0.843269040573486,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
123,GO:0000254,0.999999999985592,0.822522087265089,0,2,C-4 methylsterol oxidase activity,MF,
1826,GO:0004483,0.999999999985592,0.822522087265089,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2885,GO:0006393,0.999999999985592,0.822522087265089,0,2,termination of mitochondrial transcription,BP,
3207,GO:0006850,0.999999999985592,0.822522087265089,0,2,mitochondrial pyruvate transmembrane transport,BP,
4006,GO:0008988,0.999999999985592,0.822522087265089,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
5531,GO:0016524,0.999999999985592,0.822522087265089,0,2,latrotoxin receptor activity,MF,
7715,GO:0032217,0.999999999985592,0.822522087265089,0,2,riboflavin transmembrane transporter activity,MF,
7716,GO:0032218,0.999999999985592,0.822522087265089,0,2,riboflavin transport,BP,
8099,GO:0032798,0.999999999985592,0.822522087265089,0,2,Swi5-Sfr1 complex,CC,
9578,GO:0036451,0.999999999985592,0.822522087265089,0,2,cap mRNA methylation,BP,
15329,GO:0071595,0.999999999985592,0.822522087265089,0,2,Nem1-Spo7 phosphatase complex,CC,
15937,GO:0080023,0.999999999985592,0.822522087265089,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
16519,GO:0097309,0.999999999985592,0.822522087265089,0,2,cap1 mRNA methylation,BP,
19424,GO:1990112,0.999999999985592,0.822522087265089,0,2,RQC complex,CC,
19425,GO:1990116,0.999999999985592,0.822522087265089,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19627,GO:1990879,0.999999999985592,0.822522087265089,0,2,CST complex,CC,
8097,GO:0032796,0.999999999985608,0.769331835984929,0,2,uropod organization,BP,
7596,GO:0031990,0.999999999985652,0.734390558091815,0,2,mRNA export from nucleus in response to heat stress,BP,
3871,GO:0008506,0.999999999985668,0.801796107803113,0,2,sucrose:proton symporter activity,MF,
3879,GO:0008515,0.999999999985668,0.801796107803113,0,2,sucrose transmembrane transporter activity,MF,
4282,GO:0009669,0.999999999985668,0.801796107803113,0,2,sucrose:cation symporter activity,MF,
5001,GO:0015154,0.999999999985668,0.801796107803113,0,2,disaccharide transmembrane transporter activity,MF,
5002,GO:0015157,0.999999999985668,0.801796107803113,0,2,oligosaccharide transmembrane transporter activity,MF,
5184,GO:0015766,0.999999999985668,0.801796107803113,0,2,disaccharide transport,BP,
5185,GO:0015770,0.999999999985668,0.801796107803113,0,2,sucrose transport,BP,
5186,GO:0015772,0.999999999985668,0.801796107803113,0,2,oligosaccharide transport,BP,
9271,GO:0035727,0.999999999985668,0.819272454168248,0,2,lysophosphatidic acid binding,MF,
6084,GO:0019255,0.999999999985712,0.848632316555993,0,2,glucose 1-phosphate metabolic process,BP,
9315,GO:0035812,0.99999999998572,0.845320456084308,0,2,renal sodium excretion,BP,
9316,GO:0035813,0.99999999998572,0.845320456084308,0,2,regulation of renal sodium excretion,BP,
17065,GO:0099631,0.99999999998573,0.883840727435811,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
215,GO:0000451,0.999999999985742,0.795265735809424,0,2,rRNA 2'-O-methylation,BP,
216,GO:0000453,0.999999999985742,0.795265735809424,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14506,GO:0070039,0.999999999985742,0.795265735809424,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
2653,GO:0005999,0.999999999985759,0.863447622899158,0,2,xylulose biosynthetic process,BP,
5644,GO:0016744,0.999999999985759,0.863447622899158,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
9585,GO:0036461,0.999999999985787,0.877125992723439,0,2,BLOC-2 complex binding,MF,
5364,GO:0016175,0.999999999985797,0.873932324301477,0,2,superoxide-generating NADPH oxidase activity,MF,
7224,GO:0031134,0.999999999985799,0.725900670797082,0,3,sister chromatid biorientation,BP,
1574,GO:0003986,0.99999999998582,0.822955274764464,0,3,acetyl-CoA hydrolase activity,MF,
3802,GO:0008391,0.999999999985823,0.843543294670022,0,2,arachidonic acid monooxygenase activity,MF,
3803,GO:0008392,0.999999999985823,0.843543294670022,0,2,arachidonic acid epoxygenase activity,MF,
10354,GO:0043196,0.999999999985868,0.835796751966107,0,2,varicosity,CC,
19055,GO:1904975,0.999999999985875,0.757575282330442,0,2,response to bleomycin,BP,
19056,GO:1904976,0.999999999985875,0.757575282330442,0,2,cellular response to bleomycin,BP,
13851,GO:0060510,0.999999999985935,0.769721186915166,0,2,Type II pneumocyte differentiation,BP,
2746,GO:0006148,0.999999999985958,0.915718812173409,0,1,inosine catabolic process,BP,
3140,GO:0006738,0.999999999985958,0.915718812173409,0,1,nicotinamide riboside catabolic process,BP,
11680,GO:0046495,0.999999999985958,0.915718812173409,0,1,nicotinamide riboside metabolic process,BP,
14835,GO:0070637,0.999999999985958,0.915718812173409,0,1,pyridine nucleoside metabolic process,BP,
14836,GO:0070638,0.999999999985958,0.915718812173409,0,1,pyridine nucleoside catabolic process,BP,
8384,GO:0033326,0.999999999985974,0.862999221303831,0,1,cerebrospinal fluid secretion,BP,
4305,GO:0009786,0.999999999985979,0.735342071541142,0,2,regulation of asymmetric cell division,BP,
6404,GO:0021649,0.999999999986011,0.914546792669441,0,1,vestibulocochlear nerve structural organization,BP,
9674,GO:0038085,0.999999999986011,0.914546792669441,0,1,vascular endothelial growth factor binding,MF,
13703,GO:0060301,0.999999999986011,0.914546792669441,0,1,positive regulation of cytokine activity,BP,
14319,GO:0061552,0.999999999986011,0.914546792669441,0,1,ganglion morphogenesis,BP,
16549,GO:0097374,0.999999999986011,0.914546792669441,0,1,sensory neuron axon guidance,BP,
17949,GO:1902378,0.999999999986011,0.914546792669441,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
18986,GO:1904835,0.999999999986011,0.914546792669441,0,1,dorsal root ganglion morphogenesis,BP,
19083,GO:1905040,0.999999999986011,0.914546792669441,0,1,otic placode development,BP,
8302,GO:0033149,0.999999999986026,0.742189179528566,0,2,FFAT motif binding,MF,
8893,GO:0034739,0.999999999986042,0.856269613386127,0,2,histone deacetylase activity (H4-K16 specific),MF,
9545,GO:0036343,0.999999999986077,0.844578804762122,0,2,psychomotor behavior,BP,
19825,GO:2000321,0.99999999998608,0.870208769074165,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19833,GO:2000330,0.99999999998608,0.870208769074165,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
422,GO:0001128,0.999999999986084,0.935483676128833,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
5384,GO:0016222,0.999999999986089,0.828623040324043,0,2,procollagen-proline 4-dioxygenase complex,CC,
20023,GO:2000670,0.999999999986102,0.755790432865713,0,2,positive regulation of dendritic cell apoptotic process,BP,
13832,GO:0060474,0.999999999986138,0.860347061584885,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
6409,GO:0021679,0.999999999986155,0.810305211982365,0,2,cerebellar molecular layer development,BP,
6416,GO:0021687,0.999999999986155,0.810305211982365,0,2,cerebellar molecular layer morphogenesis,BP,
13417,GO:0052858,0.999999999986173,0.890528713903804,0,1,peptidyl-lysine acetyltransferase activity,MF,
3,GO:0000009,0.999999999986177,0.916335993097783,0,1,alpha-1,6-mannosyltransferase activity,MF,
13431,GO:0052917,0.999999999986177,0.916335993097783,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
11096,GO:0045142,0.999999999986183,0.765069042204495,0,2,triplex DNA binding,MF,
2206,GO:0005093,0.999999999986219,0.838424880029538,0,2,Rab GDP-dissociation inhibitor activity,MF,
8359,GO:0033269,0.999999999986238,0.806382068184793,0,2,internode region of axon,CC,
17,GO:0000032,0.999999999986263,0.926358310086101,0,1,cell wall mannoprotein biosynthetic process,BP,
1821,GO:0004476,0.999999999986263,0.926358310086101,0,1,mannose-6-phosphate isomerase activity,MF,
2689,GO:0006056,0.999999999986263,0.926358310086101,0,1,mannoprotein metabolic process,BP,
2690,GO:0006057,0.999999999986263,0.926358310086101,0,1,mannoprotein biosynthetic process,BP,
7405,GO:0031506,0.999999999986263,0.926358310086101,0,1,cell wall glycoprotein biosynthetic process,BP,
10041,GO:0042546,0.999999999986263,0.926358310086101,0,1,cell wall biogenesis,BP,
10698,GO:0044038,0.999999999986263,0.926358310086101,0,1,cell wall macromolecule biosynthetic process,BP,
14345,GO:0061611,0.999999999986263,0.926358310086101,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14817,GO:0070589,0.999999999986263,0.926358310086101,0,1,cellular component macromolecule biosynthetic process,BP,
7970,GO:0032595,0.999999999986284,0.919531401203773,0,1,B cell receptor transport within lipid bilayer,BP,
7972,GO:0032597,0.999999999986284,0.919531401203773,0,1,B cell receptor transport into membrane raft,BP,
7973,GO:0032599,0.999999999986284,0.919531401203773,0,1,protein transport out of membrane raft,BP,
7974,GO:0032600,0.999999999986284,0.919531401203773,0,1,chemokine receptor transport out of membrane raft,BP,
8164,GO:0032913,0.999999999986284,0.919531401203773,0,1,negative regulation of transforming growth factor beta3 production,BP,
8454,GO:0033606,0.999999999986284,0.919531401203773,0,1,chemokine receptor transport within lipid bilayer,BP,
15611,GO:0072139,0.999999999986284,0.919531401203773,0,1,glomerular parietal epithelial cell differentiation,BP,
20076,GO:2000768,0.999999999986284,0.919531401203773,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
7351,GO:0031404,0.999999999986302,0.715697276632966,0,3,chloride ion binding,MF,
3041,GO:0006597,0.999999999986312,0.833551377359195,0,2,spermine biosynthetic process,BP,
11177,GO:0045322,0.999999999986323,0.821024753624817,0,2,unmethylated CpG binding,MF,
6384,GO:0021590,0.999999999986366,0.725553529559389,0,2,cerebellum maturation,BP,
6418,GO:0021691,0.999999999986366,0.725553529559389,0,2,cerebellar Purkinje cell layer maturation,BP,
6426,GO:0021699,0.999999999986366,0.725553529559389,0,2,cerebellar cortex maturation,BP,
1772,GO:0004379,0.999999999986382,0.744003339973238,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5872,GO:0018008,0.999999999986382,0.744003339973238,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6031,GO:0019107,0.999999999986382,0.744003339973238,0,2,myristoyltransferase activity,MF,
5361,GO:0016160,0.999999999986388,0.77316548440034,0,2,amylase activity,MF,
1694,GO:0004174,0.999999999986399,0.823927305151086,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5601,GO:0016649,0.999999999986399,0.823927305151086,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
10477,GO:0043400,0.999999999986419,0.802179271068005,0,2,cortisol secretion,BP,
12999,GO:0051462,0.999999999986419,0.802179271068005,0,2,regulation of cortisol secretion,BP,
2005,GO:0004731,0.999999999986429,0.790249273119891,0,2,purine-nucleoside phosphorylase activity,MF,
10232,GO:0042986,0.999999999986453,0.826150715567044,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
1630,GO:0004074,0.999999999986479,0.893397946129713,0,2,biliverdin reductase activity,MF,
5351,GO:0016128,0.999999999986507,0.772174481030816,0,3,phytosteroid metabolic process,BP,
5352,GO:0016129,0.999999999986507,0.772174481030816,0,3,phytosteroid biosynthetic process,BP,
16964,GO:0099077,0.99999999998654,0.850989192312524,0,1,histone-dependent DNA binding,MF,
19315,GO:1905687,0.99999999998654,0.850989192312524,0,1,regulation of diacylglycerol kinase activity,BP,
19316,GO:1905689,0.99999999998654,0.850989192312524,0,1,positive regulation of diacylglycerol kinase activity,BP,
28,GO:0000053,0.999999999986545,0.925391804126683,0,1,argininosuccinate metabolic process,BP,
1619,GO:0004055,0.999999999986545,0.925391804126683,0,1,argininosuccinate synthase activity,MF,
11968,GO:0047349,0.999999999986577,0.855239579896769,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
19046,GO:1904954,0.999999999986597,0.833517157023403,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
2347,GO:0005412,0.999999999986612,0.794237401206898,0,2,glucose:sodium symporter activity,MF,
9539,GO:0036324,0.999999999986615,0.818745472835144,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
1664,GO:0004127,0.999999999986628,0.821325704122876,0,2,cytidylate kinase activity,MF,
18901,GO:1904672,0.999999999986651,0.674029522927619,0,3,regulation of somatic stem cell population maintenance,BP,
2560,GO:0005846,0.999999999986662,0.788332523190509,0,2,nuclear cap binding complex,CC,
13373,GO:0052735,0.99999999998667,0.689278195541984,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
7565,GO:0031938,0.999999999986698,0.858123422708219,0,2,regulation of chromatin silencing at telomere,BP,
18296,GO:1903276,0.999999999986703,0.854997361864658,0,2,regulation of sodium ion export across plasma membrane,BP,
18297,GO:1903278,0.999999999986703,0.854997361864658,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18304,GO:1903288,0.999999999986703,0.854997361864658,0,2,positive regulation of potassium ion import,BP,
12666,GO:0050910,0.999999999986708,0.758382026774306,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
528,GO:0001640,0.999999999986713,0.845978669531975,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,0.999999999986713,0.845978669531975,0,1,group III metabotropic glutamate receptor activity,MF,
3411,GO:0007196,0.999999999986713,0.845978669531975,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
9323,GO:0035841,0.999999999986713,0.845978669531975,0,1,new growing cell tip,CC,
9915,GO:0042281,0.999999999986713,0.830525654107757,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
16941,GO:0098988,0.999999999986713,0.845978669531975,0,1,G-protein coupled glutamate receptor activity,MF,
15190,GO:0071373,0.999999999986736,0.828220911188382,0,2,cellular response to luteinizing hormone stimulus,BP,
308,GO:0000820,0.999999999986767,0.699043820263882,0,2,regulation of glutamine family amino acid metabolic process,BP,
11364,GO:0045763,0.999999999986767,0.699043820263882,0,2,negative regulation of cellular amino acid metabolic process,BP,
5463,GO:0016402,0.999999999986833,0.907783632309181,0,1,pristanoyl-CoA oxidase activity,MF,
2010,GO:0004739,0.999999999986843,0.833752403548335,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2303,GO:0005290,0.999999999986846,0.826475199167371,0,2,L-histidine transmembrane transporter activity,MF,
17183,GO:0106072,0.999999999986923,0.750642870745133,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
859,GO:0002192,0.999999999986929,0.880830695370426,0,2,IRES-dependent translational initiation of linear mRNA,BP,
17198,GO:0110017,0.999999999986929,0.880830695370426,0,2,cap-independent translational initiation of linear mRNA,BP,
6826,GO:0030298,0.999999999986931,0.938430363846042,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7513,GO:0031726,0.999999999986931,0.938430363846042,0,1,CCR1 chemokine receptor binding,MF,
7514,GO:0031729,0.999999999986931,0.938430363846042,0,1,CCR4 chemokine receptor binding,MF,
11819,GO:0046817,0.999999999986931,0.938430363846042,0,1,chemokine receptor antagonist activity,MF,
5198,GO:0015801,0.999999999986942,0.839912394734975,0,2,aromatic amino acid transport,BP,
5219,GO:0015827,0.999999999986942,0.839912394734975,0,2,tryptophan transport,BP,
11286,GO:0045627,0.999999999986945,0.742399546929336,0,3,positive regulation of T-helper 1 cell differentiation,BP,
16106,GO:0090138,0.999999999986957,0.888205217275551,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
11070,GO:0045092,0.999999999986961,0.889827087409672,0,1,interleukin-18 receptor complex,CC,
2179,GO:0005030,0.999999999986964,0.834367877253856,0,1,neurotrophin receptor activity,MF,
4465,GO:0010465,0.999999999986964,0.834367877253856,0,1,nerve growth factor receptor activity,MF,
6873,GO:0030379,0.999999999986964,0.834367877253856,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6209,GO:0019740,0.999999999987034,0.732354432126589,0,3,nitrogen utilization,BP,
1888,GO:0004572,0.999999999987036,0.725601111205886,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
13864,GO:0060535,0.999999999987119,0.657759552945261,0,3,trachea cartilage morphogenesis,BP,
1900,GO:0004587,0.99999999998712,0.92268058183211,0,1,ornithine-oxo-acid transaminase activity,MF,
4395,GO:0010121,0.99999999998712,0.92268058183211,0,1,arginine catabolic process to proline via ornithine,BP,
6154,GO:0019493,0.99999999998712,0.92268058183211,0,1,arginine catabolic process to proline,BP,
6172,GO:0019544,0.99999999998712,0.92268058183211,0,1,arginine catabolic process to glutamate,BP,
11948,GO:0047223,0.99999999998715,0.755700512578569,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
16433,GO:0097135,0.999999999987157,0.835985558467466,0,2,cyclin E2-CDK2 complex,CC,
5236,GO:0015864,0.999999999987191,0.842573846246627,0,2,pyrimidine nucleoside transport,BP,
12104,GO:0048203,0.999999999987194,0.838198467133053,0,2,vesicle targeting, trans-Golgi to endosome,BP,
4053,GO:0009106,0.999999999987202,0.826383516967184,0,2,lipoate metabolic process,BP,
13345,GO:0052593,0.999999999987222,0.80252640664021,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13346,GO:0052594,0.999999999987222,0.80252640664021,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13347,GO:0052595,0.999999999987222,0.80252640664021,0,2,aliphatic-amine oxidase activity,MF,
13348,GO:0052596,0.999999999987222,0.80252640664021,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
858,GO:0002191,0.999999999987226,0.73198310415213,0,3,cap-dependent translational initiation,BP,
16360,GO:0097003,0.999999999987229,0.810744134615646,0,2,adipokinetic hormone receptor activity,MF,
1791,GO:0004422,0.999999999987231,0.862448457906708,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2762,GO:0006178,0.999999999987231,0.862448457906708,0,2,guanine salvage,BP,
7738,GO:0032263,0.999999999987231,0.862448457906708,0,2,GMP salvage,BP,
11534,GO:0046099,0.999999999987231,0.862448457906708,0,2,guanine biosynthetic process,BP,
1520,GO:0003883,0.999999999987243,0.799428301884408,0,2,CTP synthase activity,MF,
10743,GO:0044210,0.999999999987243,0.799428301884408,0,2,'de novo' CTP biosynthetic process,BP,
3388,GO:0007168,0.999999999987254,0.820556089642117,0,2,receptor guanylyl cyclase signaling pathway,BP,
15814,GO:0072557,0.999999999987288,0.881883283608346,0,2,IPAF inflammasome complex,CC,
19756,GO:2000199,0.99999999998729,0.9022906799386,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19757,GO:2000200,0.99999999998729,0.9022906799386,0,1,regulation of ribosomal subunit export from nucleus,BP,
19758,GO:2000202,0.99999999998729,0.9022906799386,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19759,GO:2000206,0.99999999998729,0.9022906799386,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19760,GO:2000208,0.99999999998729,0.9022906799386,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
7334,GO:0031372,0.999999999987311,0.850880614952771,0,2,UBC13-MMS2 complex,CC,
15017,GO:0070992,0.999999999987351,0.869259004506965,0,2,translation initiation complex,CC,
9465,GO:0036117,0.999999999987355,0.840508972850594,0,2,hyaluranon cable,CC,
854,GO:0002184,0.999999999987404,0.756117791038657,0,2,cytoplasmic translational termination,BP,
2409,GO:0005584,0.999999999987421,0.725410527833121,0,2,collagen type I trimer,CC,
2120,GO:0004915,0.999999999987423,0.789560369967526,0,2,interleukin-6 receptor activity,MF,
2596,GO:0005896,0.999999999987423,0.789560369967526,0,2,interleukin-6 receptor complex,CC,
6315,GO:0019981,0.999999999987423,0.789560369967526,0,2,interleukin-6 binding,MF,
14548,GO:0070110,0.999999999987423,0.789560369967526,0,2,ciliary neurotrophic factor receptor complex,CC,
1234,GO:0002923,0.999999999987445,0.852540315129191,0,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9476,GO:0036135,0.999999999987459,0.754502360500809,0,2,Schwann cell migration,BP,
17380,GO:1900147,0.999999999987459,0.754502360500809,0,2,regulation of Schwann cell migration,BP,
18560,GO:1903837,0.999999999987466,0.914730258134654,0,1,regulation of mRNA 3'-UTR binding,BP,
18561,GO:1903839,0.999999999987466,0.914730258134654,0,1,positive regulation of mRNA 3'-UTR binding,BP,
8947,GO:0035033,0.999999999987478,0.795363174131923,0,2,histone deacetylase regulator activity,MF,
8487,GO:0033679,0.999999999987485,0.867866060912445,0,1,3'-5' DNA/RNA helicase activity,MF,
8489,GO:0033681,0.999999999987485,0.867866060912445,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8765,GO:0034459,0.999999999987485,0.867866060912445,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9765,GO:0039695,0.999999999987485,0.867866060912445,0,1,DNA-templated viral transcription,BP,
19053,GO:1904971,0.999999999987485,0.867866060912445,0,1,regulation of viral translation,BP,
19054,GO:1904973,0.999999999987485,0.867866060912445,0,1,positive regulation of viral translation,BP,
19133,GO:1905172,0.999999999987485,0.867866060912445,0,1,RISC complex binding,MF,
19318,GO:1905698,0.999999999987485,0.867866060912445,0,1,positive regulation of polysome binding,BP,
19528,GO:1990518,0.999999999987485,0.867866060912445,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
2146,GO:0004965,0.999999999987491,0.764504334840693,0,2,G-protein coupled GABA receptor activity,MF,
119,GO:0000248,0.999999999987492,0.790451966012024,0,2,C-5 sterol desaturase activity,MF,
14871,GO:0070704,0.999999999987492,0.790451966012024,0,2,sterol desaturase activity,MF,
18570,GO:1903860,0.999999999987502,0.806563418338586,0,2,negative regulation of dendrite extension,BP,
19740,GO:2000172,0.999999999987502,0.806563418338586,0,2,regulation of branching morphogenesis of a nerve,BP,
6420,GO:0021693,0.999999999987512,0.745393099499136,0,2,cerebellar Purkinje cell layer structural organization,BP,
6425,GO:0021698,0.999999999987512,0.745393099499136,0,2,cerebellar cortex structural organization,BP,
5050,GO:0015252,0.999999999987541,0.901890829229552,0,1,proton channel activity,MF,
9113,GO:0035445,0.999999999987541,0.901890829229552,0,1,borate transmembrane transport,BP,
11796,GO:0046713,0.999999999987541,0.901890829229552,0,1,borate transport,BP,
11797,GO:0046715,0.999999999987541,0.901890829229552,0,1,active borate transmembrane transporter activity,MF,
6073,GO:0019230,0.999999999987549,0.706344090781002,0,2,proprioception,BP,
7889,GO:0032468,0.999999999987549,0.892437675864867,0,1,Golgi calcium ion homeostasis,BP,
9589,GO:0036466,0.999999999987556,0.751448597113793,0,2,synaptic vesicle recycling via endosome,BP,
8561,GO:0034056,0.999999999987558,0.679861167856951,0,3,estrogen response element binding,MF,
9947,GO:0042351,0.999999999987584,0.867948657917817,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
12186,GO:0048388,0.999999999987596,0.821106401211698,0,2,endosomal lumen acidification,BP,
13895,GO:0060584,0.99999999998767,0.801316294975936,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13896,GO:0060585,0.99999999998767,0.801316294975936,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
11122,GO:0045188,0.999999999987709,0.792999548467599,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
18532,GO:1903775,0.999999999987713,0.824140009124937,0,2,regulation of DNA double-strand break processing,BP,
7845,GO:0032416,0.99999999998772,0.92232187475804,0,1,negative regulation of sodium:proton antiporter activity,BP,
16513,GO:0097291,0.99999999998772,0.92232187475804,0,1,renal phosphate ion absorption,BP,
4893,GO:0014825,0.999999999987734,0.949419067466823,0,1,stomach fundus smooth muscle contraction,BP,
4906,GO:0014847,0.999999999987734,0.949419067466823,0,1,proximal stomach smooth muscle contraction,BP,
7534,GO:0031839,0.999999999987734,0.949419067466823,0,1,type 1 neuromedin U receptor binding,MF,
7535,GO:0031840,0.999999999987734,0.949419067466823,0,1,type 2 neuromedin U receptor binding,MF,
9124,GO:0035483,0.999999999987734,0.949419067466823,0,1,gastric emptying,BP,
10211,GO:0042922,0.999999999987734,0.949419067466823,0,1,neuromedin U receptor binding,MF,
10895,GO:0044495,0.999999999987734,0.949419067466823,0,1,modulation of blood pressure in other organism,BP,
10896,GO:0044497,0.999999999987734,0.949419067466823,0,1,positive regulation of blood pressure in other organism,BP,
17232,GO:0120060,0.999999999987734,0.949419067466823,0,1,regulation of gastric emptying,BP,
17233,GO:0120061,0.999999999987734,0.949419067466823,0,1,negative regulation of gastric emptying,BP,
17234,GO:0120063,0.999999999987734,0.949419067466823,0,1,stomach smooth muscle contraction,BP,
17235,GO:0120068,0.999999999987734,0.949419067466823,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17236,GO:0120069,0.999999999987734,0.949419067466823,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
15010,GO:0070985,0.999999999987751,0.870585047479031,0,2,TFIIK complex,CC,
9461,GO:0036112,0.999999999987754,0.848333467247748,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
3960,GO:0008747,0.999999999987765,0.930673024701157,0,1,N-acetylneuraminate lyase activity,MF,
1060,GO:0002589,0.999999999987771,0.854549349432136,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1061,GO:0002590,0.999999999987771,0.854549349432136,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
16888,GO:0098886,0.999999999987789,0.77971797179659,0,2,modification of dendritic spine,BP,
11105,GO:0045163,0.999999999987802,0.731445383748446,0,2,clustering of voltage-gated potassium channels,BP,
927,GO:0002326,0.999999999987806,0.585779053756909,0,3,B cell lineage commitment,BP,
10940,GO:0044715,0.999999999987827,0.874576236877474,0,2,8-oxo-dGDP phosphatase activity,MF,
13770,GO:0060386,0.999999999987828,0.851504804443885,0,1,synapse assembly involved in innervation,BP,
6320,GO:0020012,0.99999999998784,0.781880221765399,0,2,evasion or tolerance of host immune response,BP,
6989,GO:0030682,0.99999999998784,0.781880221765399,0,2,evasion or tolerance of host defense response,BP,
6990,GO:0030683,0.99999999998784,0.781880221765399,0,2,evasion or tolerance by virus of host immune response,BP,
13167,GO:0051805,0.99999999998784,0.781880221765399,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13169,GO:0051807,0.99999999998784,0.781880221765399,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
3170,GO:0006784,0.999999999987857,0.754282795000031,0,2,heme a biosynthetic process,BP,
11564,GO:0046160,0.999999999987857,0.754282795000031,0,2,heme a metabolic process,BP,
15519,GO:0071963,0.999999999987883,0.926887295265484,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
6987,GO:0030678,0.9999999999879,0.782457237570469,0,3,mitochondrial ribonuclease P complex,CC,
16702,GO:0097745,0.9999999999879,0.782457237570469,0,3,mitochondrial tRNA 5'-end processing,BP,
8568,GO:0034066,0.99999999998792,0.849417279209205,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
1954,GO:0004660,0.999999999987927,0.844507176019263,0,2,protein farnesyltransferase activity,MF,
2631,GO:0005965,0.999999999987927,0.844507176019263,0,2,protein farnesyltransferase complex,CC,
13285,GO:0052151,0.999999999987952,0.812773911555081,0,2,positive regulation by symbiont of host apoptotic process,BP,
13610,GO:0060139,0.999999999987952,0.812773911555081,0,2,positive regulation of apoptotic process by virus,BP,
4660,GO:0010813,0.999999999987963,0.801808101099139,0,2,neuropeptide catabolic process,BP,
18378,GO:1903433,0.999999999987969,0.802960587889866,0,2,regulation of constitutive secretory pathway,BP,
6403,GO:0021648,0.999999999987971,0.777410720096672,0,2,vestibulocochlear nerve morphogenesis,BP,
13800,GO:0060426,0.999999999987974,0.748982749259193,0,3,lung vasculature development,BP,
11862,GO:0046900,0.999999999988007,0.852379970546613,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
9921,GO:0042289,0.999999999988008,0.871001694276546,0,2,MHC class II protein binding,MF,
6021,GO:0019085,0.999999999988012,0.77989113745319,0,2,early viral transcription,BP,
1944,GO:0004649,0.999999999988031,0.811615946506617,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
19951,GO:2000562,0.999999999988034,0.817586426434825,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
85,GO:0000173,0.99999999998804,0.928766670160592,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
11704,GO:0046534,0.999999999988043,0.870789777346005,0,1,positive regulation of photoreceptor cell differentiation,BP,
4272,GO:0009637,0.999999999988046,0.787972261751075,0,2,response to blue light,BP,
4304,GO:0009785,0.999999999988046,0.787972261751075,0,2,blue light signaling pathway,BP,
4329,GO:0009882,0.999999999988046,0.787972261751075,0,2,blue light photoreceptor activity,MF,
15268,GO:0071483,0.999999999988046,0.787972261751075,0,2,cellular response to blue light,BP,
11738,GO:0046619,0.999999999988057,0.836545131298761,0,1,optic placode formation involved in camera-type eye formation,BP,
14509,GO:0070050,0.99999999998808,0.740477310103345,0,3,neuron cellular homeostasis,BP,
1787,GO:0004418,0.999999999988097,0.932644200348031,0,1,hydroxymethylbilane synthase activity,MF,
5907,GO:0018160,0.999999999988097,0.932644200348031,0,1,peptidyl-pyrromethane cofactor linkage,BP,
3800,GO:0008384,0.99999999998811,0.705844313673582,0,3,IkappaB kinase activity,MF,
13508,GO:0055120,0.999999999988117,0.943043826976725,0,1,striated muscle dense body,CC,
14252,GO:0061357,0.999999999988145,0.704761831827918,0,3,positive regulation of Wnt protein secretion,BP,
5005,GO:0015168,0.999999999988146,0.836703683458926,0,2,glycerol transmembrane transporter activity,MF,
5051,GO:0015254,0.999999999988146,0.836703683458926,0,2,glycerol channel activity,MF,
5194,GO:0015793,0.999999999988146,0.836703683458926,0,2,glycerol transport,BP,
1489,GO:0003828,0.999999999988161,0.703776131491996,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
11957,GO:0047280,0.999999999988172,0.868583869886413,0,1,nicotinamide phosphoribosyltransferase activity,MF,
16542,GO:0097362,0.999999999988173,0.811672320427807,0,2,MCM8-MCM9 complex,CC,
6512,GO:0021896,0.999999999988195,0.659689320238394,0,2,forebrain astrocyte differentiation,BP,
6513,GO:0021897,0.999999999988195,0.659689320238394,0,2,forebrain astrocyte development,BP,
9645,GO:0038018,0.999999999988201,0.730580434555295,0,2,Wnt receptor catabolic process,BP,
13487,GO:0055087,0.999999999988214,0.706743214169771,0,3,Ski complex,CC,
1627,GO:0004066,0.999999999988227,0.838947179080974,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2983,GO:0006529,0.999999999988227,0.838947179080974,0,2,asparagine biosynthetic process,BP,
18081,GO:1902746,0.999999999988233,0.915767759742053,0,1,regulation of lens fiber cell differentiation,BP,
13521,GO:0060011,0.999999999988258,0.725892294400911,0,3,Sertoli cell proliferation,BP,
3922,GO:0008607,0.999999999988272,0.753959378638512,0,3,phosphorylase kinase regulator activity,MF,
19084,GO:1905041,0.999999999988275,0.760628301939449,0,2,regulation of epithelium regeneration,BP,
19487,GO:1990399,0.999999999988275,0.760628301939449,0,2,epithelium regeneration,BP,
19199,GO:1905349,0.999999999988288,0.939069677505684,0,1,ciliary transition zone assembly,BP,
13929,GO:0060664,0.999999999988293,0.732106493584725,0,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
8921,GO:0034970,0.999999999988295,0.825334204299442,0,2,histone H3-R2 methylation,BP,
19516,GO:1990452,0.999999999988302,0.79715534352781,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
5761,GO:0016941,0.999999999988331,0.893794337010042,0,1,natriuretic peptide receptor activity,MF,
13689,GO:0060283,0.999999999988331,0.893794337010042,0,1,negative regulation of oocyte development,BP,
13830,GO:0060465,0.999999999988331,0.893794337010042,0,1,pharynx development,BP,
17404,GO:1900194,0.999999999988331,0.893794337010042,0,1,negative regulation of oocyte maturation,BP,
19360,GO:1905880,0.999999999988331,0.893794337010042,0,1,negative regulation of oogenesis,BP,
4266,GO:0009624,0.999999999988364,0.912416957309399,0,1,response to nematode,BP,
4284,GO:0009692,0.999999999988364,0.912416957309399,0,1,ethylene metabolic process,BP,
4285,GO:0009698,0.999999999988364,0.912416957309399,0,1,phenylpropanoid metabolic process,BP,
4314,GO:0009804,0.999999999988364,0.912416957309399,0,1,coumarin metabolic process,BP,
5625,GO:0016711,0.999999999988364,0.912416957309399,0,1,flavonoid 3'-monooxygenase activity,MF,
6100,GO:0019341,0.999999999988364,0.912416957309399,0,1,dibenzo-p-dioxin catabolic process,BP,
10501,GO:0043449,0.999999999988364,0.912416957309399,0,1,cellular alkene metabolic process,BP,
5414,GO:0016269,0.999999999988378,0.914412877985808,0,1,O-glycan processing, core 3,BP,
11949,GO:0047224,0.999999999988378,0.914412877985808,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1568,GO:0003977,0.999999999988387,0.821447701282749,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
2301,GO:0005287,0.999999999988395,0.758379305112177,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2302,GO:0005289,0.999999999988395,0.758379305112177,0,2,high-affinity arginine transmembrane transporter activity,MF,
2304,GO:0005292,0.999999999988395,0.758379305112177,0,2,high-affinity lysine transmembrane transporter activity,MF,
15310,GO:0071561,0.999999999988425,0.860981968531538,0,1,nucleus-vacuole junction,CC,
8465,GO:0033625,0.999999999988447,0.797220139097249,0,2,positive regulation of integrin activation,BP,
4166,GO:0009236,0.999999999988452,0.67581884896257,0,3,cobalamin biosynthetic process,BP,
15553,GO:0072053,0.999999999988461,0.789059393989128,0,2,renal inner medulla development,BP,
15554,GO:0072054,0.999999999988461,0.789059393989128,0,2,renal outer medulla development,BP,
16961,GO:0099073,0.999999999988467,0.780186810987892,0,2,mitochondrion-derived vesicle,CC,
4471,GO:0010481,0.999999999988483,0.736773598423343,0,3,epidermal cell division,BP,
4472,GO:0010482,0.999999999988483,0.736773598423343,0,3,regulation of epidermal cell division,BP,
16717,GO:0098508,0.999999999988484,0.838416307904464,0,2,endothelial to hematopoietic transition,BP,
5746,GO:0016900,0.99999999998854,0.88964176818285,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11929,GO:0047057,0.99999999998854,0.88964176818285,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
8245,GO:0033037,0.999999999988546,0.8512301611155,0,1,polysaccharide localization,BP,
6632,GO:0023025,0.999999999988547,0.827151911423172,0,2,MHC class Ib protein complex binding,MF,
6635,GO:0023030,0.999999999988547,0.827151911423172,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
9792,GO:0040038,0.999999999988555,0.76899636078766,0,2,polar body extrusion after meiotic divisions,BP,
14842,GO:0070649,0.999999999988555,0.76899636078766,0,2,formin-nucleated actin cable assembly,BP,
17196,GO:0110009,0.999999999988555,0.76899636078766,0,2,formin-nucleated actin cable organization,BP,
18287,GO:1903238,0.999999999988562,0.742601957360132,0,2,positive regulation of leukocyte tethering or rolling,BP,
3668,GO:0008169,0.999999999988571,0.743753581322282,0,3,C-methyltransferase activity,MF,
6842,GO:0030321,0.999999999988606,0.76237554541348,0,2,transepithelial chloride transport,BP,
9129,GO:0035494,0.999999999988611,0.742579181624842,0,3,SNARE complex disassembly,BP,
2553,GO:0005833,0.999999999988624,0.904859476577038,0,1,hemoglobin complex,CC,
8522,GO:0033862,0.999999999988624,0.904859476577038,0,1,UMP kinase activity,MF,
14793,GO:0070557,0.999999999988628,0.859993161564486,0,2,PCNA-p21 complex,CC,
2932,GO:0006452,0.999999999988638,0.799713937072911,0,2,translational frameshifting,BP,
11429,GO:0045905,0.999999999988638,0.799713937072911,0,2,positive regulation of translational termination,BP,
19926,GO:2000491,0.999999999988647,0.900557809932055,0,1,positive regulation of hepatic stellate cell activation,BP,
9248,GO:0035674,0.999999999988647,0.836260800447052,0,2,tricarboxylic acid transmembrane transport,BP,
9731,GO:0039019,0.999999999988647,0.758988196913205,0,2,pronephric nephron development,BP,
2453,GO:0005668,0.99999999998865,0.859910036573425,0,2,RNA polymerase transcription factor SL1 complex,CC,
7750,GO:0032277,0.999999999988662,0.919611221950501,0,1,negative regulation of gonadotropin secretion,BP,
10534,GO:0043509,0.999999999988662,0.919611221950501,0,1,activin A complex,CC,
10535,GO:0043511,0.999999999988662,0.919611221950501,0,1,inhibin complex,CC,
10536,GO:0043512,0.999999999988662,0.919611221950501,0,1,inhibin A complex,CC,
11056,GO:0045077,0.999999999988662,0.919611221950501,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11851,GO:0046882,0.999999999988662,0.919611221950501,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12097,GO:0048180,0.999999999988662,0.919611221950501,0,1,activin complex,CC,
13685,GO:0060278,0.999999999988662,0.919611221950501,0,1,regulation of ovulation,BP,
13686,GO:0060279,0.999999999988662,0.919611221950501,0,1,positive regulation of ovulation,BP,
4054,GO:0009107,0.999999999988673,0.928263580632706,0,1,lipoate biosynthetic process,BP,
5768,GO:0016992,0.999999999988673,0.928263580632706,0,1,lipoate synthase activity,MF,
14645,GO:0070283,0.999999999988673,0.928263580632706,0,1,radical SAM enzyme activity,MF,
5814,GO:0017087,0.999999999988693,0.881983171993904,0,1,mitochondrial processing peptidase complex,CC,
10652,GO:0043914,0.999999999988693,0.881983171993904,0,1,NADPH:sulfur oxidoreductase activity,MF,
3686,GO:0008193,0.999999999988699,0.821986689967633,0,2,tRNA guanylyltransferase activity,MF,
7382,GO:0031445,0.999999999988717,0.743866551160936,0,2,regulation of heterochromatin assembly,BP,
7383,GO:0031453,0.999999999988717,0.743866551160936,0,2,positive regulation of heterochromatin assembly,BP,
11382,GO:0045799,0.999999999988717,0.743866551160936,0,2,positive regulation of chromatin assembly or disassembly,BP,
11716,GO:0046573,0.999999999988727,0.929000688544503,0,1,lactonohydrolase activity,MF,
17088,GO:0102007,0.999999999988727,0.929000688544503,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
1247,GO:0002949,0.99999999998875,0.789926722966425,0,3,tRNA threonylcarbamoyladenosine modification,BP,
7112,GO:0030943,0.999999999988774,0.757340547718058,0,3,mitochondrion targeting sequence binding,MF,
9694,GO:0038124,0.9999999999888,0.760324935992662,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10022,GO:0042494,0.9999999999888,0.760324935992662,0,2,detection of bacterial lipoprotein,BP,
10024,GO:0042496,0.9999999999888,0.760324935992662,0,2,detection of diacyl bacterial lipopeptide,BP,
14681,GO:0070340,0.9999999999888,0.760324935992662,0,2,detection of bacterial lipopeptide,BP,
15411,GO:0071724,0.9999999999888,0.760324935992662,0,2,response to diacyl bacterial lipopeptide,BP,
15413,GO:0071726,0.9999999999888,0.760324935992662,0,2,cellular response to diacyl bacterial lipopeptide,BP,
7081,GO:0030886,0.99999999998882,0.852266873882796,0,2,negative regulation of myeloid dendritic cell activation,BP,
9195,GO:0035598,0.999999999988839,0.89792950710427,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
14391,GO:0061712,0.999999999988839,0.89792950710427,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
1429,GO:0003404,0.999999999988845,0.897411407444111,0,1,optic vesicle morphogenesis,BP,
1433,GO:0003409,0.999999999988845,0.897411407444111,0,1,optic cup structural organization,BP,
6396,GO:0021622,0.999999999988845,0.897411407444111,0,1,oculomotor nerve morphogenesis,BP,
6397,GO:0021623,0.999999999988845,0.897411407444111,0,1,oculomotor nerve formation,BP,
14583,GO:0070172,0.999999999988845,0.897411407444111,0,1,positive regulation of tooth mineralization,BP,
4224,GO:0009405,0.999999999988847,0.726059409545108,0,2,pathogenesis,BP,
17637,GO:1901509,0.999999999988848,0.78797383315616,0,2,regulation of endothelial tube morphogenesis,BP,
11503,GO:0046041,0.999999999988856,0.858580716864719,0,2,ITP metabolic process,BP,
7673,GO:0032129,0.999999999988858,0.821189145754137,0,2,histone deacetylase activity (H3-K9 specific),MF,
11902,GO:0046969,0.999999999988858,0.821189145754137,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19553,GO:1990619,0.999999999988858,0.821189145754137,0,2,histone H3-K9 deacetylation,BP,
2591,GO:0005889,0.99999999998887,0.792809603499156,0,2,potassium:proton exchanging ATPase complex,CC,
15940,GO:0080058,0.99999999998887,0.935152333378776,0,1,protein deglutathionylation,BP,
16639,GO:0097573,0.99999999998887,0.935152333378776,0,1,glutathione oxidoreductase activity,MF,
778,GO:0002037,0.999999999988874,0.92036405475678,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
15712,GO:0072320,0.999999999988875,0.681611113229251,0,3,volume-sensitive chloride channel activity,MF,
16215,GO:0090297,0.999999999988899,0.937121687088597,0,1,positive regulation of mitochondrial DNA replication,BP,
17762,GO:1901860,0.999999999988899,0.937121687088597,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19409,GO:1990046,0.999999999988899,0.937121687088597,0,1,stress-induced mitochondrial fusion,BP,
20222,GO:2001199,0.999999999988913,0.930205490411225,0,1,negative regulation of dendritic cell differentiation,BP,
10727,GO:0044128,0.999999999988917,0.860398414193866,0,1,positive regulation of growth of symbiont in host,BP,
10733,GO:0044148,0.999999999988917,0.860398414193866,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
14594,GO:0070191,0.999999999988955,0.837463862570133,0,2,methionine-R-sulfoxide reductase activity,MF,
5979,GO:0018879,0.999999999988963,0.838168505039151,0,2,biphenyl metabolic process,BP,
3918,GO:0008594,0.999999999988976,0.77316889254737,0,2,photoreceptor cell morphogenesis,BP,
15314,GO:0071567,0.999999999988977,0.865554473357715,0,2,UFM1 hydrolase activity,MF,
8774,GO:0034474,0.999999999988985,0.834574153341327,0,1,U2 snRNA 3'-end processing,BP,
10437,GO:0043316,0.999999999988991,0.811640888159667,0,2,cytotoxic T cell degranulation,BP,
14091,GO:0060978,0.999999999988998,0.771071929897176,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
3640,GO:0008116,0.999999999989003,0.85315978279641,0,1,prostaglandin-I synthase activity,MF,
10741,GO:0044208,0.999999999989014,0.848051175734672,0,2,'de novo' AMP biosynthetic process,BP,
6034,GO:0019135,0.99999999998903,0.924323456008819,0,1,deoxyhypusine monooxygenase activity,MF,
9041,GO:0035281,0.999999999989038,0.806785199947723,0,2,pre-miRNA export from nucleus,BP,
10051,GO:0042565,0.999999999989038,0.806785199947723,0,2,RNA nuclear export complex,CC,
17082,GO:0101006,0.99999999998904,0.791573920891603,0,3,protein histidine phosphatase activity,MF,
175,GO:0000384,0.999999999989045,0.862926870628837,0,2,first spliceosomal transesterification activity,MF,
15484,GO:0071894,0.999999999989065,0.822988646767847,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
3901,GO:0008545,0.999999999989073,0.79365155071,0,2,JUN kinase kinase activity,MF,
3002,GO:0006550,0.999999999989078,0.855140278769569,0,2,isoleucine catabolic process,BP,
9855,GO:0042134,0.999999999989096,0.870024498781885,0,2,rRNA primary transcript binding,MF,
3665,GO:0008158,0.999999999989104,0.779823997559412,0,2,hedgehog receptor activity,MF,
9514,GO:0036261,0.999999999989113,0.887485837528785,0,1,7-methylguanosine cap hypermethylation,BP,
15081,GO:0071164,0.999999999989113,0.887485837528785,0,1,RNA trimethylguanosine synthase activity,MF,
2112,GO:0004900,0.999999999989136,0.924951192630649,0,1,erythropoietin receptor activity,MF,
9705,GO:0038162,0.999999999989136,0.924951192630649,0,1,erythropoietin-mediated signaling pathway,BP,
1139,GO:0002732,0.999999999989169,0.870255583106489,0,1,positive regulation of dendritic cell cytokine production,BP,
7912,GO:0032498,0.999999999989169,0.870255583106489,0,1,detection of muramyl dipeptide,BP,
7913,GO:0032499,0.999999999989169,0.870255583106489,0,1,detection of peptidoglycan,BP,
7914,GO:0032500,0.999999999989169,0.870255583106489,0,1,muramyl dipeptide binding,MF,
10672,GO:0043972,0.999999999989169,0.866161390916098,0,1,histone H3-K23 acetylation,BP,
10683,GO:0043994,0.999999999989169,0.866161390916098,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
19855,GO:2000361,0.999999999989169,0.870255583106489,0,1,regulation of prostaglandin-E synthase activity,BP,
19856,GO:2000363,0.999999999989169,0.870255583106489,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19501,GO:1990418,0.999999999989191,0.840121139008611,0,2,response to insulin-like growth factor stimulus,BP,
1055,GO:0002584,0.999999999989199,0.798885387810696,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
2307,GO:0005298,0.999999999989233,0.872797712669173,0,1,proline:sodium symporter activity,MF,
10050,GO:0042564,0.999999999989233,0.872797712669173,0,1,NLS-dependent protein nuclear import complex,CC,
17817,GO:1902022,0.99999999998926,0.700955554105621,0,3,L-lysine transport,BP,
18361,GO:1903401,0.99999999998926,0.700955554105621,0,3,L-lysine transmembrane transport,BP,
14147,GO:0061073,0.999999999989261,0.772024077527849,0,2,ciliary body morphogenesis,BP,
51,GO:0000105,0.999999999989267,0.8186186542032,0,2,histidine biosynthetic process,BP,
7498,GO:0031691,0.999999999989276,0.849252872702246,0,2,alpha-1A adrenergic receptor binding,MF,
7499,GO:0031692,0.999999999989276,0.849252872702246,0,2,alpha-1B adrenergic receptor binding,MF,
7522,GO:0031762,0.999999999989276,0.849252872702246,0,2,follicle-stimulating hormone receptor binding,MF,
10118,GO:0042699,0.999999999989276,0.849252872702246,0,2,follicle-stimulating hormone signaling pathway,BP,
16390,GO:0097057,0.999999999989288,0.867712506688442,0,2,TRAF2-GSTP1 complex,CC,
5389,GO:0016232,0.999999999989299,0.908510353174033,0,1,HNK-1 sulfotransferase activity,MF,
6358,GO:0021546,0.999999999989309,0.833246608873641,0,2,rhombomere development,BP,
1196,GO:0002857,0.999999999989314,0.776156985480642,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1199,GO:0002860,0.999999999989314,0.776156985480642,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
9478,GO:0036138,0.999999999989333,0.835904395813274,0,1,peptidyl-histidine hydroxylation,BP,
9479,GO:0036139,0.999999999989333,0.835904395813274,0,1,peptidyl-histidine dioxygenase activity,MF,
9480,GO:0036140,0.999999999989333,0.835904395813274,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9902,GO:0042265,0.999999999989333,0.835904395813274,0,1,peptidyl-asparagine hydroxylation,BP,
17094,GO:0102113,0.999999999989333,0.835904395813274,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
16659,GO:0097636,0.999999999989365,0.796035179964953,0,2,intrinsic component of autophagosome membrane,CC,
16660,GO:0097637,0.999999999989365,0.796035179964953,0,2,integral component of autophagosome membrane,CC,
14545,GO:0070103,0.999999999989376,0.927699598663235,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14546,GO:0070104,0.999999999989376,0.927699598663235,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17874,GO:1902205,0.999999999989376,0.927699598663235,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17875,GO:1902206,0.999999999989376,0.927699598663235,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17879,GO:1902215,0.999999999989376,0.927699598663235,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17888,GO:1902227,0.999999999989376,0.927699598663235,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17894,GO:1902233,0.999999999989376,0.927699598663235,0,1,negative regulation of positive thymic T cell selection,BP,
18627,GO:1903970,0.999999999989376,0.927699598663235,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18630,GO:1903973,0.999999999989376,0.927699598663235,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
1680,GO:0004148,0.999999999989387,0.890252912626394,0,1,dihydrolipoyl dehydrogenase activity,MF,
10329,GO:0043159,0.999999999989387,0.890252912626394,0,1,acrosomal matrix,CC,
10559,GO:0043544,0.999999999989387,0.890252912626394,0,1,lipoamide binding,MF,
12759,GO:0051068,0.999999999989387,0.890252912626394,0,1,dihydrolipoamide metabolic process,BP,
15032,GO:0071020,0.999999999989419,0.859461626830746,0,2,post-spliceosomal complex,CC,
5016,GO:0015184,0.999999999989435,0.764639622518807,0,2,L-cystine transmembrane transporter activity,MF,
5207,GO:0015811,0.999999999989435,0.764639622518807,0,2,L-cystine transport,BP,
2634,GO:0005969,0.99999999998944,0.821754599250498,0,1,serine-pyruvate aminotransferase complex,CC,
5370,GO:0016189,0.99999999998944,0.821754599250498,0,1,synaptic vesicle to endosome fusion,BP,
19157,GO:1905258,0.99999999998944,0.880849951296697,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19158,GO:1905259,0.99999999998944,0.880849951296697,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
14632,GO:0070259,0.999999999989476,0.806077551248296,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15499,GO:0071920,0.99999999998948,0.839273456419665,0,2,cleavage body,CC,
1566,GO:0003975,0.999999999989502,0.920027046454525,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4002,GO:0008963,0.999999999989502,0.920027046454525,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
10,GO:0000019,0.999999999989505,0.704986070111499,0,3,regulation of mitotic recombination,BP,
9795,GO:0042008,0.999999999989532,0.891834464173354,0,1,interleukin-18 receptor activity,MF,
19551,GO:1990613,0.999999999989532,0.891834464173354,0,1,mitochondrial membrane fusion,BP,
15906,GO:0072737,0.999999999989535,0.839683144242737,0,2,response to diamide,BP,
15907,GO:0072738,0.999999999989535,0.839683144242737,0,2,cellular response to diamide,BP,
5962,GO:0018395,0.999999999989589,0.889351866499298,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6551,GO:0021998,0.999999999989589,0.889351866499298,0,1,neural plate mediolateral regionalization,BP,
8506,GO:0033746,0.999999999989589,0.889351866499298,0,1,histone demethylase activity (H3-R2 specific),MF,
8507,GO:0033749,0.999999999989589,0.889351866499298,0,1,histone demethylase activity (H4-R3 specific),MF,
12167,GO:0048338,0.999999999989589,0.889351866499298,0,1,mesoderm structural organization,BP,
12171,GO:0048352,0.999999999989589,0.889351866499298,0,1,paraxial mesoderm structural organization,BP,
14526,GO:0070077,0.999999999989589,0.889351866499298,0,1,histone arginine demethylation,BP,
14527,GO:0070078,0.999999999989589,0.889351866499298,0,1,histone H3-R2 demethylation,BP,
14528,GO:0070079,0.999999999989589,0.889351866499298,0,1,histone H4-R3 demethylation,BP,
18802,GO:1904412,0.999999999989589,0.889351866499298,0,1,regulation of cardiac ventricle development,BP,
18803,GO:1904414,0.999999999989589,0.889351866499298,0,1,positive regulation of cardiac ventricle development,BP,
19169,GO:1905285,0.999999999989589,0.889351866499298,0,1,fibrous ring of heart morphogenesis,BP,
12579,GO:0050785,0.999999999989591,0.935602507107804,0,1,advanced glycation end-product receptor activity,MF,
18879,GO:1904596,0.999999999989591,0.935602507107804,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18880,GO:1904597,0.999999999989591,0.935602507107804,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18881,GO:1904599,0.999999999989591,0.935602507107804,0,1,advanced glycation end-product binding,MF,
18882,GO:1904603,0.999999999989591,0.935602507107804,0,1,regulation of advanced glycation end-product receptor activity,BP,
18883,GO:1904604,0.999999999989591,0.935602507107804,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19138,GO:1905204,0.999999999989591,0.935602507107804,0,1,negative regulation of connective tissue replacement,BP,
8969,GO:0035093,0.999999999989633,0.711506947446058,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
17995,GO:1902523,0.999999999989649,0.771427862732895,0,2,positive regulation of protein K63-linked ubiquitination,BP,
18694,GO:1904167,0.999999999989665,0.792006962274124,0,1,regulation of thyroid hormone receptor activity,BP,
18695,GO:1904168,0.999999999989665,0.792006962274124,0,1,negative regulation of thyroid hormone receptor activity,BP,
15218,GO:0071409,0.99999999998968,0.721676019245763,0,2,cellular response to cycloheximide,BP,
3498,GO:0007403,0.999999999989682,0.894296112601168,0,1,glial cell fate determination,BP,
14011,GO:0060769,0.999999999989682,0.894296112601168,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14235,GO:0061324,0.999999999989682,0.894296112601168,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18834,GO:1904499,0.999999999989682,0.894296112601168,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18835,GO:1904501,0.999999999989682,0.894296112601168,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18966,GO:1904793,0.999999999989682,0.894296112601168,0,1,regulation of euchromatin binding,BP,
8701,GO:0034363,0.999999999989705,0.939613476693278,0,1,intermediate-density lipoprotein particle,CC,
8703,GO:0034365,0.999999999989705,0.939613476693278,0,1,discoidal high-density lipoprotein particle,CC,
8709,GO:0034371,0.999999999989705,0.939613476693278,0,1,chylomicron remodeling,BP,
11868,GO:0046911,0.999999999989705,0.939613476693278,0,1,metal chelating activity,MF,
16352,GO:0090731,0.999999999989705,0.939613476693278,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17690,GO:1901630,0.999999999989705,0.939613476693278,0,1,negative regulation of presynaptic membrane organization,BP,
18184,GO:1903000,0.999999999989705,0.939613476693278,0,1,regulation of lipid transport across blood brain barrier,BP,
18185,GO:1903002,0.999999999989705,0.939613476693278,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19351,GO:1905853,0.999999999989705,0.939613476693278,0,1,regulation of heparan sulfate binding,BP,
19352,GO:1905855,0.999999999989705,0.939613476693278,0,1,positive regulation of heparan sulfate binding,BP,
19353,GO:1905858,0.999999999989705,0.939613476693278,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19354,GO:1905860,0.999999999989705,0.939613476693278,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19362,GO:1905890,0.999999999989705,0.939613476693278,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
11125,GO:0045196,0.999999999989708,0.737987520663202,0,2,establishment or maintenance of neuroblast polarity,BP,
11129,GO:0045200,0.999999999989708,0.737987520663202,0,2,establishment of neuroblast polarity,BP,
1793,GO:0004427,0.999999999989719,0.808992681884073,0,3,inorganic diphosphatase activity,MF,
18475,GO:1903644,0.999999999989745,0.87396086690867,0,2,regulation of chaperone-mediated protein folding,BP,
2681,GO:0006046,0.999999999989772,0.784280325812519,0,3,N-acetylglucosamine catabolic process,BP,
14660,GO:0070305,0.99999999998979,0.637205601732626,0,3,response to cGMP,BP,
15155,GO:0071321,0.99999999998979,0.637205601732626,0,3,cellular response to cGMP,BP,
5668,GO:0016784,0.999999999989794,0.932521093790661,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6255,GO:0019853,0.999999999989794,0.932521093790661,0,1,L-ascorbic acid biosynthetic process,BP,
6697,GO:0030108,0.999999999989794,0.932521093790661,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7830,GO:0032397,0.999999999989794,0.932521093790661,0,1,activating MHC class I receptor activity,MF,
10196,GO:0042839,0.999999999989794,0.932521093790661,0,1,D-glucuronate metabolic process,BP,
10197,GO:0042840,0.999999999989794,0.932521093790661,0,1,D-glucuronate catabolic process,BP,
12029,GO:0047939,0.999999999989794,0.932521093790661,0,1,L-glucuronate reductase activity,MF,
581,GO:0001735,0.999999999989809,0.782145365046712,0,2,prenylcysteine oxidase activity,MF,
6849,GO:0030328,0.999999999989809,0.782145365046712,0,2,prenylcysteine catabolic process,BP,
6850,GO:0030329,0.999999999989809,0.782145365046712,0,2,prenylcysteine metabolic process,BP,
9193,GO:0035596,0.999999999989819,0.827861963471749,0,2,methylthiotransferase activity,MF,
9196,GO:0035600,0.999999999989819,0.827861963471749,0,2,tRNA methylthiolation,BP,
12466,GO:0050497,0.999999999989819,0.827861963471749,0,2,transferase activity, transferring alkylthio groups,MF,
19325,GO:1905719,0.999999999989844,0.824372796878575,0,2,protein localization to perinuclear region of cytoplasm,BP,
493,GO:0001546,0.999999999989868,0.928756532416233,0,1,preantral ovarian follicle growth,BP,
1684,GO:0004155,0.999999999989868,0.928756532416233,0,1,6,7-dihydropteridine reductase activity,MF,
12089,GO:0048162,0.999999999989868,0.928756532416233,0,1,multi-layer follicle stage,BP,
4740,GO:0010915,0.999999999989878,0.892998945435128,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4741,GO:0010916,0.999999999989878,0.892998945435128,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
8486,GO:0033678,0.999999999989897,0.911428091650658,0,1,5'-3' DNA/RNA helicase activity,MF,
8490,GO:0033682,0.999999999989897,0.911428091650658,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
2172,GO:0005009,0.999999999989897,0.809036061053858,0,1,insulin-activated receptor activity,MF,
7570,GO:0031945,0.999999999989947,0.882522325255002,0,1,positive regulation of glucocorticoid metabolic process,BP,
7573,GO:0031948,0.999999999989947,0.882522325255002,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
13995,GO:0060748,0.999999999989947,0.882522325255002,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14143,GO:0061054,0.999999999989947,0.882522325255002,0,1,dermatome development,BP,
14198,GO:0061183,0.999999999989947,0.882522325255002,0,1,regulation of dermatome development,BP,
14199,GO:0061184,0.999999999989947,0.882522325255002,0,1,positive regulation of dermatome development,BP,
14208,GO:0061205,0.999999999989947,0.882522325255002,0,1,paramesonephric duct development,BP,
14256,GO:0061369,0.999999999989947,0.882522325255002,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
19672,GO:2000019,0.999999999989947,0.882522325255002,0,1,negative regulation of male gonad development,BP,
19696,GO:2000066,0.999999999989947,0.882522325255002,0,1,positive regulation of cortisol biosynthetic process,BP,
19765,GO:2000224,0.999999999989947,0.882522325255002,0,1,regulation of testosterone biosynthetic process,BP,
19766,GO:2000225,0.999999999989947,0.882522325255002,0,1,negative regulation of testosterone biosynthetic process,BP,
11930,GO:0047066,0.999999999989969,0.945905438907778,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16685,GO:0097707,0.999999999989969,0.945905438907778,0,1,ferroptosis,BP,
17210,GO:0110075,0.999999999989969,0.945905438907778,0,1,regulation of ferroptosis,BP,
17211,GO:0110076,0.999999999989969,0.945905438907778,0,1,negative regulation of ferroptosis,BP,
7069,GO:0030868,0.999999999989975,0.721736572051453,0,3,smooth endoplasmic reticulum membrane,CC,
16569,GO:0097425,0.999999999989975,0.721736572051453,0,3,smooth endoplasmic reticulum part,CC,
7157,GO:0031048,0.999999999989978,0.788875222059912,0,2,chromatin silencing by small RNA,BP,
18523,GO:1903760,0.999999999990013,0.758790720688389,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19074,GO:1905024,0.999999999990013,0.758790720688389,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
17654,GO:1901552,0.999999999990013,0.783533198721549,0,2,positive regulation of endothelial cell development,BP,
18246,GO:1903142,0.999999999990013,0.783533198721549,0,2,positive regulation of establishment of endothelial barrier,BP,
4161,GO:0009227,0.999999999990015,0.779639055769538,0,3,nucleotide-sugar catabolic process,BP,
13051,GO:0051586,0.999999999990016,0.930930446758183,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13233,GO:0051944,0.999999999990016,0.930930446758183,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
19470,GO:1990275,0.999999999990018,0.907071425081796,0,1,preribosome binding,MF,
3826,GO:0008430,0.999999999990023,0.926621568929943,0,1,selenium binding,MF,
13041,GO:0051572,0.999999999990025,0.648685872080439,0,3,negative regulation of histone H3-K4 methylation,BP,
8190,GO:0032954,0.999999999990029,0.756517279769177,0,2,regulation of cytokinetic process,BP,
18381,GO:1903436,0.999999999990029,0.756517279769177,0,2,regulation of mitotic cytokinetic process,BP,
18382,GO:1903438,0.999999999990029,0.756517279769177,0,2,positive regulation of mitotic cytokinetic process,BP,
18397,GO:1903490,0.999999999990029,0.756517279769177,0,2,positive regulation of mitotic cytokinesis,BP,
18442,GO:1903567,0.999999999990029,0.820098518770041,0,2,regulation of protein localization to ciliary membrane,BP,
16166,GO:0090222,0.999999999990039,0.689592351226903,0,2,centrosome-templated microtubule nucleation,BP,
17167,GO:0106020,0.999999999990042,0.810013487529784,0,2,regulation of vesicle docking,BP,
16216,GO:0090298,0.999999999990049,0.702620933209117,0,3,negative regulation of mitochondrial DNA replication,BP,
17761,GO:1901859,0.999999999990049,0.702620933209117,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
5767,GO:0016979,0.999999999990049,0.933916716095217,0,1,lipoate-protein ligase activity,MF,
19700,GO:2000078,0.999999999990053,0.849120490125903,0,2,positive regulation of type B pancreatic cell development,BP,
5941,GO:0018282,0.99999999999006,0.762919956675363,0,2,metal incorporation into metallo-sulfur cluster,BP,
5942,GO:0018283,0.99999999999006,0.762919956675363,0,2,iron incorporation into metallo-sulfur cluster,BP,
13123,GO:0051722,0.999999999990067,0.914946127388332,0,1,protein C-terminal methylesterase activity,MF,
13124,GO:0051723,0.999999999990067,0.914946127388332,0,1,protein methylesterase activity,MF,
16684,GO:0097699,0.999999999990081,0.870808310843574,0,1,vascular endothelial cell response to fluid shear stress,BP,
3993,GO:0008897,0.999999999990091,0.907565336014415,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
6365,GO:0021557,0.999999999990095,0.837303755747243,0,2,oculomotor nerve development,BP,
18954,GO:1904768,0.999999999990095,0.820935159128677,0,2,all-trans-retinol binding,MF,
17922,GO:1902298,0.999999999990105,0.717744105203923,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19505,GO:1990426,0.999999999990105,0.717744105203923,0,2,mitotic recombination-dependent replication fork processing,BP,
19526,GO:1990505,0.999999999990105,0.717744105203923,0,2,mitotic DNA replication maintenance of fidelity,BP,
7342,GO:0031394,0.99999999999011,0.81277493072209,0,2,positive regulation of prostaglandin biosynthetic process,BP,
20272,GO:2001280,0.99999999999011,0.81277493072209,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
1351,GO:0003220,0.999999999990114,0.812469008495461,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1365,GO:0003251,0.999999999990114,0.812469008495461,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
6952,GO:0030616,0.999999999990114,0.812469008495461,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
9029,GO:0035262,0.999999999990114,0.812469008495461,0,1,gonad morphogenesis,BP,
14129,GO:0061040,0.999999999990114,0.812469008495461,0,1,female gonad morphogenesis,BP,
19176,GO:1905304,0.999999999990114,0.812469008495461,0,1,regulation of cardiac myofibril assembly,BP,
19177,GO:1905305,0.999999999990114,0.812469008495461,0,1,negative regulation of cardiac myofibril assembly,BP,
8377,GO:0033301,0.999999999990148,0.88691761317866,0,1,cell cycle comprising mitosis without cytokinesis,BP,
10448,GO:0043335,0.999999999990164,0.830702155136861,0,2,protein unfolding,BP,
13701,GO:0060298,0.999999999990189,0.756908337084845,0,2,positive regulation of sarcomere organization,BP,
17700,GO:1901656,0.999999999990207,0.791543585011102,0,2,glycoside transport,BP,
1679,GO:0004146,0.999999999990209,0.831313317908987,0,2,dihydrofolate reductase activity,MF,
19247,GO:1905462,0.99999999999021,0.747802038162442,0,2,regulation of DNA duplex unwinding,BP,
3478,GO:0007341,0.999999999990215,0.747301195202792,0,3,penetration of zona pellucida,BP,
9960,GO:0042369,0.999999999990216,0.823472653577186,0,2,vitamin D catabolic process,BP,
924,GO:0002322,0.999999999990228,0.74962981222873,0,2,B cell proliferation involved in immune response,BP,
4419,GO:0010232,0.99999999999023,0.901654531401037,0,1,vascular transport,BP,
13620,GO:0060156,0.99999999999023,0.901654531401037,0,1,milk ejection reflex,BP,
18343,GO:1903367,0.99999999999023,0.901654531401037,0,1,positive regulation of fear response,BP,
20144,GO:2000987,0.99999999999023,0.901654531401037,0,1,positive regulation of behavioral fear response,BP,
11532,GO:0046092,0.999999999990232,0.860989491337069,0,1,deoxycytidine metabolic process,BP,
3855,GO:0008478,0.999999999990233,0.829841637965238,0,1,pyridoxal kinase activity,MF,
4240,GO:0009443,0.999999999990233,0.829841637965238,0,1,pyridoxal 5'-phosphate salvage,BP,
9901,GO:0042264,0.99999999999024,0.743202586115882,0,2,peptidyl-aspartic acid hydroxylation,BP,
15923,GO:0075341,0.999999999990241,0.917627929301907,0,1,host cell PML body,CC,
5410,GO:0016263,0.999999999990258,0.854883208026568,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5413,GO:0016267,0.999999999990258,0.854883208026568,0,2,O-glycan processing, core 1,BP,
14653,GO:0070295,0.999999999990262,0.763834822366827,0,3,renal water absorption,BP,
17434,GO:1900248,0.999999999990264,0.725344262591256,0,2,negative regulation of cytoplasmic translational elongation,BP,
8436,GO:0033577,0.999999999990307,0.828388515182202,0,2,protein glycosylation in endoplasmic reticulum,BP,
3419,GO:0007207,0.999999999990311,0.83733256711933,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
13047,GO:0051582,0.999999999990316,0.854695996869559,0,2,positive regulation of neurotransmitter uptake,BP,
6863,GO:0030350,0.999999999990329,0.750834447541102,0,2,iron-responsive element binding,MF,
7625,GO:0032044,0.999999999990343,0.826604989017392,0,2,DSIF complex,CC,
2280,GO:0005234,0.999999999990352,0.709646558878885,0,2,extracellularly glutamate-gated ion channel activity,MF,
6923,GO:0030538,0.999999999990359,0.797371952669297,0,2,embryonic genitalia morphogenesis,BP,
16822,GO:0098770,0.999999999990371,0.690111000839819,0,2,FBXO family protein binding,MF,
14705,GO:0070401,0.999999999990387,0.852825626631176,0,2,NADP+ binding,MF,
1848,GO:0004513,0.999999999990403,0.917396348997768,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
11960,GO:0047291,0.999999999990403,0.917396348997768,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
872,GO:0002225,0.999999999990413,0.862263563703395,0,2,positive regulation of antimicrobial peptide production,BP,
1151,GO:0002760,0.999999999990413,0.862263563703395,0,2,positive regulation of antimicrobial humoral response,BP,
1170,GO:0002803,0.999999999990413,0.862263563703395,0,2,positive regulation of antibacterial peptide production,BP,
15080,GO:0071163,0.999999999990419,0.790002771203759,0,3,DNA replication preinitiation complex assembly,BP,
5295,GO:0015990,0.999999999990431,0.950158112470728,0,1,electron transport coupled proton transport,BP,
5804,GO:0017065,0.999999999990431,0.930459799422853,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
13804,GO:0060431,0.999999999990435,0.732397746573165,0,3,primary lung bud formation,BP,
4523,GO:0010593,0.999999999990459,0.727206187974945,0,2,negative regulation of lamellipodium assembly,BP,
17491,GO:1900753,0.999999999990476,0.872778349949171,0,1,doxorubicin transport,BP,
20269,GO:2001274,0.999999999990476,0.783127601762469,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
18285,GO:1903236,0.999999999990481,0.705052410320259,0,3,regulation of leukocyte tethering or rolling,BP,
7867,GO:0032440,0.99999999999049,0.937760249101754,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19302,GO:1905636,0.99999999999049,0.937760249101754,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
12390,GO:0048859,0.999999999990495,0.767317778059137,0,2,formation of anatomical boundary,BP,
532,GO:0001651,0.9999999999905,0.852393371660526,0,2,dense fibrillar component,CC,
2769,GO:0006193,0.999999999990526,0.941608856417002,0,1,ITP catabolic process,BP,
4138,GO:0009203,0.999999999990526,0.941608856417002,0,1,ribonucleoside triphosphate catabolic process,BP,
4142,GO:0009207,0.999999999990526,0.941608856417002,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9504,GO:0036220,0.999999999990526,0.941608856417002,0,1,ITP diphosphatase activity,MF,
9505,GO:0036222,0.999999999990526,0.941608856417002,0,1,XTP diphosphatase activity,MF,
5073,GO:0015307,0.999999999990549,0.835681183742358,0,2,drug:proton antiporter activity,MF,
11737,GO:0046618,0.999999999990549,0.835681183742358,0,2,drug export,BP,
1255,GO:0003010,0.999999999990558,0.78949696611311,0,2,voluntary skeletal muscle contraction,BP,
4863,GO:0014721,0.999999999990558,0.78949696611311,0,2,twitch skeletal muscle contraction,BP,
1956,GO:0004662,0.999999999990575,0.846245505600161,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2624,GO:0005953,0.999999999990575,0.846245505600161,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
15430,GO:0071798,0.999999999990588,0.770692304263147,0,2,response to prostaglandin D,BP,
15431,GO:0071799,0.999999999990588,0.770692304263147,0,2,cellular response to prostaglandin D stimulus,BP,
16532,GO:0097344,0.999999999990591,0.840366026292015,0,2,Rix1 complex,CC,
15191,GO:0071374,0.999999999990608,0.730121689144996,0,2,cellular response to parathyroid hormone stimulus,BP,
10548,GO:0043532,0.999999999990624,0.838225848955609,0,1,angiostatin binding,MF,
9943,GO:0042335,0.99999999999064,0.660791267413229,0,3,cuticle development,BP,
12042,GO:0048014,0.999999999990654,0.857865221669611,0,1,Tie signaling pathway,BP,
12683,GO:0050928,0.999999999990654,0.857865221669611,0,1,negative regulation of positive chemotaxis,BP,
4786,GO:0010982,0.999999999990704,0.804945191860051,0,2,regulation of high-density lipoprotein particle clearance,BP,
4787,GO:0010983,0.999999999990704,0.804945191860051,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
1370,GO:0003257,0.999999999990737,0.766429240141548,0,2,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
17563,GO:1901228,0.999999999990737,0.766429240141548,0,2,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
15367,GO:0071650,0.999999999990758,0.784531867092627,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16694,GO:0097726,0.999999999990788,0.941088747256848,0,1,LEM domain binding,MF,
12127,GO:0048257,0.999999999990789,0.830564253865552,0,2,3'-flap endonuclease activity,MF,
9683,GO:0038098,0.999999999990791,0.921784892740166,0,1,sequestering of BMP from receptor via BMP binding,BP,
17955,GO:1902396,0.999999999990814,0.882381261628676,0,1,protein localization to bicellular tight junction,BP,
10568,GO:0043553,0.99999999999082,0.722577401879319,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
17449,GO:1900369,0.999999999990821,0.812081179025495,0,2,negative regulation of RNA interference,BP,
14780,GO:0070537,0.999999999990829,0.748913419077324,0,3,histone H2A K63-linked deubiquitination,BP,
15134,GO:0071283,0.999999999990849,0.86994846182592,0,2,cellular response to iron(III) ion,BP,
5973,GO:0018585,0.999999999990851,0.919747016200292,0,1,fluorene oxygenase activity,MF,
5983,GO:0018917,0.999999999990851,0.919747016200292,0,1,fluorene metabolic process,BP,
18934,GO:1904732,0.999999999990858,0.783992066949746,0,2,regulation of electron transfer activity,BP,
19050,GO:1904959,0.999999999990858,0.783992066949746,0,2,regulation of cytochrome-c oxidase activity,BP,
15512,GO:0071947,0.999999999990865,0.633148685109682,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
6615,GO:0022849,0.999999999990867,0.860279481417516,0,1,glutamate-gated calcium ion channel activity,MF,
15558,GO:0072061,0.999999999990877,0.824224672422136,0,2,inner medullary collecting duct development,BP,
16607,GO:0097498,0.999999999990878,0.784823204707341,0,2,endothelial tube lumen extension,BP,
4482,GO:0010509,0.999999999990897,0.8541096250779,0,1,polyamine homeostasis,BP,
4452,GO:0010428,0.9999999999909,0.849192786465493,0,1,methyl-CpNpG binding,MF,
19451,GO:1990188,0.999999999990915,0.912123524374277,0,1,euchromatin binding,MF,
19416,GO:1990072,0.999999999990922,0.862270988367512,0,2,TRAPPIII protein complex,CC,
13405,GO:0052836,0.999999999990927,0.817917592023897,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13406,GO:0052839,0.999999999990927,0.817917592023897,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
16668,GO:0097647,0.999999999990938,0.815357077471398,0,3,amylin receptor signaling pathway,BP,
17497,GO:1901004,0.999999999990941,0.9372439689108,0,1,ubiquinone-6 metabolic process,BP,
17498,GO:1901006,0.999999999990941,0.9372439689108,0,1,ubiquinone-6 biosynthetic process,BP,
18072,GO:1902731,0.999999999990959,0.660751104440191,0,2,negative regulation of chondrocyte proliferation,BP,
14708,GO:0070404,0.999999999990968,0.804862076470115,0,3,NADH binding,MF,
18422,GO:1903537,0.999999999990968,0.832323784010826,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18423,GO:1903538,0.999999999990968,0.832323784010826,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
13030,GO:0051548,0.999999999990978,0.707155621124846,0,2,negative regulation of keratinocyte migration,BP,
11368,GO:0045769,0.99999999999099,0.787131533701886,0,1,negative regulation of asymmetric cell division,BP,
4808,GO:0014004,0.999999999990997,0.799261339379794,0,2,microglia differentiation,BP,
4809,GO:0014005,0.999999999990997,0.799261339379794,0,2,microglia development,BP,
18004,GO:1902544,0.999999999991006,0.852593108612152,0,2,regulation of DNA N-glycosylase activity,BP,
3953,GO:0008705,0.999999999991014,0.790890010633019,0,1,methionine synthase activity,MF,
9824,GO:0042084,0.999999999991014,0.790890010633019,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
15070,GO:0071139,0.999999999991025,0.76997520690895,0,2,resolution of recombination intermediates,BP,
15071,GO:0071140,0.999999999991025,0.76997520690895,0,2,resolution of mitotic recombination intermediates,BP,
19422,GO:1990108,0.999999999991038,0.738758789577212,0,2,protein linear deubiquitination,BP,
14100,GO:0060995,0.999999999991063,0.774767380135179,0,2,cell-cell signaling involved in kidney development,BP,
14216,GO:0061289,0.999999999991063,0.774767380135179,0,2,Wnt signaling pathway involved in kidney development,BP,
14217,GO:0061290,0.999999999991063,0.774767380135179,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15650,GO:0072204,0.999999999991063,0.774767380135179,0,2,cell-cell signaling involved in metanephros development,BP,
9037,GO:0035276,0.999999999991079,0.854205022983743,0,1,ethanol binding,MF,
9243,GO:0035668,0.999999999991079,0.854205022983743,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9244,GO:0035669,0.999999999991079,0.854205022983743,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20159,GO:2001029,0.999999999991079,0.854205022983743,0,1,regulation of cellular glucuronidation,BP,
20160,GO:2001031,0.999999999991079,0.854205022983743,0,1,positive regulation of cellular glucuronidation,BP,
221,GO:0000461,0.999999999991086,0.905130660422901,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
18110,GO:1902856,0.999999999991086,0.763875892097842,0,2,negative regulation of non-motile cilium assembly,BP,
7799,GO:0032361,0.999999999991097,0.922355120277508,0,1,pyridoxal phosphate catabolic process,BP,
10186,GO:0042820,0.999999999991097,0.922355120277508,0,1,vitamin B6 catabolic process,BP,
9111,GO:0035442,0.9999999999911,0.846321300325651,0,2,dipeptide transmembrane transport,BP,
10214,GO:0042938,0.9999999999911,0.846321300325651,0,2,dipeptide transport,BP,
16078,GO:0090088,0.9999999999911,0.846321300325651,0,2,regulation of oligopeptide transport,BP,
16079,GO:0090089,0.9999999999911,0.846321300325651,0,2,regulation of dipeptide transport,BP,
20132,GO:2000878,0.9999999999911,0.846321300325651,0,2,positive regulation of oligopeptide transport,BP,
20133,GO:2000880,0.9999999999911,0.846321300325651,0,2,positive regulation of dipeptide transport,BP,
20193,GO:2001148,0.9999999999911,0.846321300325651,0,2,regulation of dipeptide transmembrane transport,BP,
20194,GO:2001150,0.9999999999911,0.846321300325651,0,2,positive regulation of dipeptide transmembrane transport,BP,
1867,GO:0004534,0.999999999991117,0.57658955502954,0,3,5'-3' exoribonuclease activity,MF,
3393,GO:0007174,0.999999999991124,0.918623410372598,0,1,epidermal growth factor catabolic process,BP,
7848,GO:0032419,0.999999999991124,0.918623410372598,0,1,extrinsic component of lysosome membrane,CC,
19059,GO:1904979,0.999999999991124,0.918623410372598,0,1,negative regulation of endosome organization,BP,
19204,GO:1905365,0.999999999991124,0.918623410372598,0,1,regulation of intralumenal vesicle formation,BP,
19205,GO:1905366,0.999999999991124,0.918623410372598,0,1,negative regulation of intralumenal vesicle formation,BP,
17996,GO:1902524,0.999999999991138,0.826479231132566,0,2,positive regulation of protein K48-linked ubiquitination,BP,
18427,GO:1903542,0.99999999999116,0.822526914109908,0,2,negative regulation of exosomal secretion,BP,
16423,GO:0097116,0.999999999991189,0.86755447900949,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
12050,GO:0048022,0.999999999991209,0.711400719859398,0,2,negative regulation of melanin biosynthetic process,BP,
17455,GO:1900377,0.999999999991209,0.711400719859398,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
19270,GO:1905550,0.999999999991238,0.85827479529262,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19271,GO:1905552,0.999999999991238,0.85827479529262,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
7181,GO:0031081,0.999999999991257,0.794602568752142,0,2,nuclear pore distribution,BP,
13095,GO:0051664,0.999999999991257,0.794602568752142,0,2,nuclear pore localization,BP,
14044,GO:0060857,0.99999999999135,0.917922934083483,0,1,establishment of glial blood-brain barrier,BP,
17609,GO:1901355,0.999999999991358,0.772588984346406,0,2,response to rapamycin,BP,
17265,GO:0140066,0.999999999991362,0.727704939002147,0,2,peptidyl-lysine crotonylation,BP,
10820,GO:0044335,0.999999999991376,0.796576568453399,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
19690,GO:2000055,0.999999999991376,0.796576568453399,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
7359,GO:0031417,0.999999999991383,0.610043104152907,0,3,NatC complex,CC,
16505,GO:0097274,0.999999999991408,0.760150608922909,0,2,urea homeostasis,BP,
5528,GO:0016517,0.999999999991431,0.92261362083561,0,1,interleukin-12 receptor activity,MF,
9797,GO:0042019,0.999999999991431,0.92261362083561,0,1,interleukin-23 binding,MF,
9798,GO:0042020,0.999999999991431,0.92261362083561,0,1,interleukin-23 receptor activity,MF,
9799,GO:0042022,0.999999999991431,0.92261362083561,0,1,interleukin-12 receptor complex,CC,
15802,GO:0072536,0.999999999991431,0.92261362083561,0,1,interleukin-23 receptor complex,CC,
10346,GO:0043183,0.999999999991464,0.839407994477532,0,2,vascular endothelial growth factor receptor 1 binding,MF,
18648,GO:1904020,0.999999999991469,0.804613564584365,0,2,regulation of G-protein coupled receptor internalization,BP,
5764,GO:0016971,0.999999999991474,0.721120130645548,0,3,flavin-linked sulfhydryl oxidase activity,MF,
14697,GO:0070376,0.999999999991495,0.906848411257161,0,1,regulation of ERK5 cascade,BP,
14698,GO:0070377,0.999999999991495,0.906848411257161,0,1,negative regulation of ERK5 cascade,BP,
1585,GO:0003998,0.999999999991496,0.895740386491162,0,2,acylphosphatase activity,MF,
5213,GO:0015820,0.999999999991516,0.801334297817145,0,2,leucine transport,BP,
16367,GO:0097016,0.999999999991532,0.744462164206002,0,2,L27 domain binding,MF,
268,GO:0000741,0.999999999991547,0.926868231404504,0,1,karyogamy,BP,
3480,GO:0007344,0.999999999991547,0.926868231404504,0,1,pronuclear fusion,BP,
13131,GO:0051732,0.999999999991547,0.926868231404504,0,1,polyribonucleotide kinase activity,MF,
13134,GO:0051736,0.999999999991547,0.926868231404504,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
8488,GO:0033680,0.999999999991566,0.790989225117816,0,2,ATP-dependent DNA/RNA helicase activity,MF,
3935,GO:0008626,0.999999999991586,0.724322293236828,0,3,granzyme-mediated apoptotic signaling pathway,BP,
8737,GO:0034414,0.999999999991607,0.812567016127572,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10166,GO:0042779,0.999999999991607,0.812567016127572,0,2,tRNA 3'-trailer cleavage,BP,
10168,GO:0042781,0.999999999991607,0.812567016127572,0,2,3'-tRNA processing endoribonuclease activity,MF,
19159,GO:1905267,0.999999999991607,0.812567016127572,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
9204,GO:0035608,0.999999999991608,0.791030052012161,0,2,protein deglutamylation,BP,
8283,GO:0033128,0.999999999991623,0.842439197828142,0,2,negative regulation of histone phosphorylation,BP,
2599,GO:0005900,0.999999999991624,0.799852571590856,0,2,oncostatin-M receptor complex,CC,
14562,GO:0070138,0.999999999991629,0.687526772525939,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14564,GO:0070140,0.999999999991629,0.687526772525939,0,3,SUMO-specific isopeptidase activity,MF,
12660,GO:0050904,0.999999999991639,0.766459540052812,0,2,diapedesis,BP,
10332,GO:0043163,0.999999999991645,0.729335992158657,0,2,cell envelope organization,BP,
11147,GO:0045229,0.999999999991645,0.729335992158657,0,2,external encapsulating structure organization,BP,
9453,GO:0036090,0.999999999991676,0.850283137107329,0,2,cleavage furrow ingression,BP,
17456,GO:1900378,0.99999999999173,0.722761502607096,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
16003,GO:0086056,0.999999999991752,0.876026265063022,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16904,GO:0098912,0.999999999991752,0.876026265063022,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
4532,GO:0010609,0.999999999991774,0.834178698077054,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
8922,GO:0034971,0.999999999991796,0.905060426343517,0,1,histone H3-R17 methylation,BP,
9231,GO:0035642,0.999999999991796,0.905060426343517,0,1,histone methyltransferase activity (H3-R17 specific),MF,
1027,GO:0002536,0.999999999991797,0.871138034501601,0,2,respiratory burst involved in inflammatory response,BP,
13678,GO:0060264,0.999999999991797,0.871138034501601,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13680,GO:0060266,0.999999999991797,0.871138034501601,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
972,GO:0002424,0.999999999991801,0.820377787884579,0,2,T cell mediated immune response to tumor cell,BP,
1192,GO:0002840,0.999999999991801,0.820377787884579,0,2,regulation of T cell mediated immune response to tumor cell,BP,
2013,GO:0004742,0.999999999991876,0.8728752456879,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6920,GO:0030523,0.999999999991876,0.8728752456879,0,1,dihydrolipoamide S-acyltransferase activity,MF,
17324,GO:1900042,0.999999999991883,0.683531441405049,0,2,positive regulation of interleukin-2 secretion,BP,
14732,GO:0070436,0.999999999991904,0.784491323287463,0,2,Grb2-EGFR complex,CC,
7368,GO:0031431,0.999999999991918,0.801618363878453,0,2,Dbf4-dependent protein kinase complex,CC,
3928,GO:0008614,0.999999999991929,0.822197973572073,0,2,pyridoxine metabolic process,BP,
3929,GO:0008615,0.999999999991929,0.822197973572073,0,2,pyridoxine biosynthetic process,BP,
4924,GO:0014886,0.999999999991932,0.781744863632357,0,2,transition between slow and fast fiber,BP,
9280,GO:0035740,0.999999999991933,0.82697334104161,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
19953,GO:2000564,0.999999999991933,0.82697334104161,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
7335,GO:0031379,0.999999999991946,0.867037508708294,0,2,RNA-directed RNA polymerase complex,CC,
16116,GO:0090156,0.999999999991946,0.792871596338425,0,3,cellular sphingolipid homeostasis,BP,
7504,GO:0031700,0.999999999991959,0.933117345466985,0,1,adrenomedullin receptor binding,MF,
9160,GO:0035544,0.999999999991969,0.870531102474367,0,1,negative regulation of SNARE complex assembly,BP,
12411,GO:0050023,0.999999999991987,0.924755371435262,0,1,L-fuconate dehydratase activity,MF,
16523,GO:0097325,0.999999999991997,0.772552273605518,0,2,melanocyte proliferation,BP,
2755,GO:0006168,0.999999999992011,0.820693762935961,0,3,adenine salvage,BP,
11526,GO:0046083,0.999999999992011,0.820693762935961,0,3,adenine metabolic process,BP,
11527,GO:0046084,0.999999999992011,0.820693762935961,0,3,adenine biosynthetic process,BP,
6857,GO:0030337,0.999999999992026,0.848600285498374,0,2,DNA polymerase processivity factor activity,MF,
2649,GO:0005991,0.999999999992028,0.905525825330264,0,1,trehalose metabolic process,BP,
14716,GO:0070413,0.999999999992028,0.905525825330264,0,1,trehalose metabolism in response to stress,BP,
8604,GO:0034137,0.999999999992045,0.800764548452295,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
11090,GO:0045131,0.999999999992047,0.904948896325503,0,1,pre-mRNA branch point binding,MF,
2684,GO:0006049,0.999999999992061,0.906311821043321,0,1,UDP-N-acetylglucosamine catabolic process,BP,
1600,GO:0004021,0.999999999992082,0.882076625399849,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
2977,GO:0006522,0.999999999992082,0.882076625399849,0,1,alanine metabolic process,BP,
2978,GO:0006524,0.999999999992082,0.882076625399849,0,1,alanine catabolic process,BP,
4038,GO:0009078,0.999999999992082,0.882076625399849,0,1,pyruvate family amino acid metabolic process,BP,
4039,GO:0009080,0.999999999992082,0.882076625399849,0,1,pyruvate family amino acid catabolic process,BP,
10198,GO:0042851,0.999999999992082,0.882076625399849,0,1,L-alanine metabolic process,BP,
10199,GO:0042853,0.999999999992082,0.882076625399849,0,1,L-alanine catabolic process,BP,
12000,GO:0047635,0.999999999992082,0.882076625399849,0,1,alanine-oxo-acid transaminase activity,MF,
14006,GO:0060764,0.999999999992089,0.804538826203679,0,2,cell-cell signaling involved in mammary gland development,BP,
14480,GO:0065001,0.999999999992099,0.719780300035341,0,2,specification of axis polarity,BP,
7519,GO:0031752,0.999999999992104,0.73607515498675,0,2,D5 dopamine receptor binding,MF,
15894,GO:0072709,0.999999999992114,0.819062419499061,0,2,cellular response to sorbitol,BP,
557,GO:0001681,0.999999999992125,0.90795924369366,0,1,sialate O-acetylesterase activity,MF,
3647,GO:0008126,0.999999999992125,0.90795924369366,0,1,acetylesterase activity,MF,
3591,GO:0008020,0.999999999992136,0.823876076425673,0,2,G-protein coupled photoreceptor activity,MF,
17292,GO:0150003,0.99999999999215,0.726244423320456,0,3,regulation of spontaneous synaptic transmission,BP,
18624,GO:1903964,0.999999999992197,0.780422833902386,0,2,monounsaturated fatty acid metabolic process,BP,
18625,GO:1903966,0.999999999992197,0.780422833902386,0,2,monounsaturated fatty acid biosynthetic process,BP,
16922,GO:0098943,0.999999999992202,0.807306052501958,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
15382,GO:0071676,0.999999999992204,0.69718594693242,0,3,negative regulation of mononuclear cell migration,BP,
16041,GO:0090027,0.999999999992204,0.69718594693242,0,3,negative regulation of monocyte chemotaxis,BP,
6380,GO:0021578,0.999999999992206,0.641210115663244,0,3,hindbrain maturation,BP,
6398,GO:0021626,0.999999999992206,0.641210115663244,0,3,central nervous system maturation,BP,
18533,GO:1903778,0.999999999992217,0.769292240052715,0,2,protein localization to vacuolar membrane,BP,
13833,GO:0060478,0.999999999992224,0.862828102520825,0,2,acrosomal vesicle exocytosis,BP,
19857,GO:2000367,0.999999999992224,0.862828102520825,0,2,regulation of acrosomal vesicle exocytosis,BP,
19858,GO:2000368,0.999999999992224,0.862828102520825,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
19273,GO:1905555,0.999999999992228,0.79220086537921,0,2,positive regulation blood vessel branching,BP,
3749,GO:0008294,0.99999999999223,0.769119853878722,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
8152,GO:0032898,0.999999999992253,0.694098225147345,0,3,neurotrophin production,BP,
1764,GO:0004370,0.99999999999227,0.704811322648413,0,2,glycerol kinase activity,MF,
11568,GO:0046167,0.99999999999227,0.704811322648413,0,2,glycerol-3-phosphate biosynthetic process,BP,
9252,GO:0035692,0.999999999992276,0.807017367546959,0,2,macrophage migration inhibitory factor receptor complex,CC,
12267,GO:0048619,0.999999999992295,0.908000418791528,0,1,embryonic hindgut morphogenesis,BP,
14367,GO:0061646,0.999999999992325,0.862632762543661,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
5357,GO:0016149,0.999999999992333,0.887659197734568,0,1,translation release factor activity, codon specific,MF,
8555,GO:0034038,0.999999999992365,0.939385313438563,0,1,deoxyhypusine synthase activity,MF,
1661,GO:0004122,0.999999999992382,0.912540651281853,0,1,cystathionine beta-synthase activity,MF,
2988,GO:0006535,0.999999999992382,0.912540651281853,0,1,cysteine biosynthetic process from serine,BP,
4048,GO:0009093,0.999999999992382,0.912540651281853,0,1,cysteine catabolic process,BP,
5608,GO:0016662,0.999999999992382,0.912540651281853,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6146,GO:0019448,0.999999999992382,0.912540651281853,0,1,L-cysteine catabolic process,BP,
12453,GO:0050421,0.999999999992382,0.912540651281853,0,1,nitrite reductase (NO-forming) activity,MF,
14499,GO:0070025,0.999999999992382,0.912540651281853,0,1,carbon monoxide binding,MF,
16846,GO:0098809,0.999999999992382,0.912540651281853,0,1,nitrite reductase activity,MF,
438,GO:0001179,0.999999999992394,0.924773123571675,0,1,RNA polymerase I transcription factor binding,MF,
1136,GO:0002729,0.999999999992397,0.858510988476906,0,2,positive regulation of natural killer cell cytokine production,BP,
7714,GO:0032216,0.9999999999924,0.918321042470511,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
8734,GO:0034402,0.999999999992425,0.778286768552091,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
18913,GO:1904693,0.999999999992453,0.639168270398001,0,3,midbrain morphogenesis,BP,
2021,GO:0004753,0.999999999992457,0.849379437169049,0,1,saccharopine dehydrogenase activity,MF,
11935,GO:0047130,0.999999999992457,0.849379437169049,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11936,GO:0047131,0.999999999992457,0.849379437169049,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
1503,GO:0003858,0.999999999992458,0.811149634579986,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
6012,GO:0019072,0.999999999992459,0.743226456178489,0,2,viral genome packaging,BP,
6013,GO:0019074,0.999999999992459,0.743226456178489,0,2,viral RNA genome packaging,BP,
4901,GO:0014839,0.999999999992464,0.863984875868102,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
9516,GO:0036266,0.999999999992464,0.913437118899263,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15870,GO:0072671,0.999999999992464,0.913437118899263,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
19342,GO:1905799,0.999999999992471,0.953479547832046,0,1,regulation of intraciliary retrograde transport,BP,
8287,GO:0033132,0.999999999992474,0.833153478972471,0,2,negative regulation of glucokinase activity,BP,
18312,GO:1903300,0.999999999992474,0.833153478972471,0,2,negative regulation of hexokinase activity,BP,
2790,GO:0006231,0.99999999999249,0.784548465801627,0,3,dTMP biosynthetic process,BP,
11520,GO:0046073,0.99999999999249,0.784548465801627,0,3,dTMP metabolic process,BP,
17878,GO:1902214,0.999999999992507,0.765913742976504,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
1788,GO:0004419,0.999999999992517,0.931877622815318,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
2798,GO:0006258,0.99999999999252,0.86024317799866,0,2,UDP-glucose catabolic process,BP,
13035,GO:0051563,0.99999999999253,0.756121068173837,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
204,GO:0000430,0.999999999992549,0.860862501992015,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
206,GO:0000432,0.999999999992549,0.860862501992015,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
14537,GO:0070095,0.999999999992551,0.900497771458806,0,1,fructose-6-phosphate binding,MF,
16751,GO:0098594,0.999999999992557,0.951563121615785,0,1,mucin granule,CC,
17000,GO:0099403,0.999999999992563,0.62921809902925,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17001,GO:0099404,0.999999999992563,0.62921809902925,0,2,mitotic sister chromatid cohesion, telomeric,BP,
19026,GO:1904907,0.999999999992563,0.62921809902925,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19027,GO:1904908,0.999999999992563,0.62921809902925,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
11474,GO:0045976,0.999999999992573,0.789017426535756,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
4977,GO:0015105,0.999999999992578,0.936999653884724,0,1,arsenite transmembrane transporter activity,MF,
5156,GO:0015700,0.999999999992578,0.936999653884724,0,1,arsenite transport,BP,
18065,GO:1902715,0.999999999992583,0.735082768915079,0,2,positive regulation of interferon-gamma secretion,BP,
19544,GO:1990589,0.999999999992587,0.742492311192518,0,2,ATF4-CREB1 transcription factor complex,CC,
2149,GO:0004969,0.999999999992592,0.790420815893112,0,2,histamine receptor activity,MF,
1719,GO:0004313,0.999999999992616,0.815924136372095,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1722,GO:0004316,0.999999999992616,0.815924136372095,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1723,GO:0004317,0.999999999992616,0.815924136372095,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1724,GO:0004319,0.999999999992616,0.815924136372095,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
6042,GO:0019171,0.999999999992616,0.815924136372095,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
11934,GO:0047117,0.999999999992616,0.815924136372095,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11979,GO:0047451,0.999999999992616,0.815924136372095,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
17096,GO:0102131,0.999999999992616,0.815924136372095,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17097,GO:0102132,0.999999999992616,0.815924136372095,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
16285,GO:0090498,0.999999999992626,0.772197522873116,0,2,extrinsic component of Golgi membrane,CC,
16280,GO:0090480,0.999999999992643,0.682986935164123,0,3,purine nucleotide-sugar transmembrane transport,BP,
4539,GO:0010621,0.999999999992647,0.941648006860769,0,1,negative regulation of transcription by transcription factor localization,BP,
9494,GO:0036164,0.999999999992647,0.941648006860769,0,1,cell-abiotic substrate adhesion,BP,
11777,GO:0046680,0.999999999992663,0.920896337389405,0,1,response to DDT,BP,
20080,GO:2000775,0.999999999992663,0.920896337389405,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
6327,GO:0021502,0.999999999992671,0.774129180126883,0,2,neural fold elevation formation,BP,
10130,GO:0042727,0.999999999992671,0.840387574928299,0,2,flavin-containing compound biosynthetic process,BP,
13189,GO:0051877,0.999999999992695,0.8219791332971,0,2,pigment granule aggregation in cell center,BP,
18641,GO:1903998,0.999999999992695,0.662284763465381,0,3,regulation of eating behavior,BP,
348,GO:0000962,0.999999999992695,0.794093642475725,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11023,GO:0045025,0.999999999992695,0.794093642475725,0,2,mitochondrial degradosome,CC,
12152,GO:0048297,0.999999999992698,0.92020342870321,0,1,negative regulation of isotype switching to IgA isotypes,BP,
2625,GO:0005954,0.9999999999927,0.914680297084494,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
1889,GO:0004573,0.999999999992705,0.910187868277814,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
8155,GO:0032902,0.999999999992719,0.786197008907436,0,2,nerve growth factor production,BP,
5870,GO:0017198,0.999999999992736,0.947424895240317,0,1,N-terminal peptidyl-serine acetylation,BP,
5871,GO:0018002,0.999999999992736,0.947424895240317,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7107,GO:0030920,0.999999999992736,0.947424895240317,0,1,peptidyl-serine acetylation,BP,
14447,GO:0061850,0.999999999992736,0.947424895240317,0,1,growth cone leading edge,CC,
15517,GO:0071960,0.999999999992736,0.947424895240317,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19453,GO:1990190,0.999999999992736,0.947424895240317,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20046,GO:2000718,0.999999999992736,0.947424895240317,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20047,GO:2000719,0.999999999992736,0.947424895240317,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
9522,GO:0036292,0.999999999992736,0.828701014137039,0,2,DNA rewinding,BP,
13025,GO:0051542,0.999999999992743,0.747774007615171,0,2,elastin biosynthetic process,BP,
1083,GO:0002669,0.999999999992747,0.842616845587146,0,1,positive regulation of T cell anergy,BP,
1230,GO:0002913,0.999999999992747,0.842616845587146,0,1,positive regulation of lymphocyte anergy,BP,
6025,GO:0019089,0.999999999992747,0.842616845587146,0,1,transmission of virus,BP,
10690,GO:0044007,0.999999999992747,0.842616845587146,0,1,dissemination or transmission of symbiont from host,BP,
13173,GO:0051821,0.999999999992747,0.842616845587146,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
3019,GO:0006567,0.999999999992766,0.868951024465163,0,2,threonine catabolic process,BP,
11064,GO:0045085,0.999999999992789,0.926963680207962,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
16810,GO:0098745,0.999999999992789,0.926963680207962,0,1,Dcp1-Dcp2 complex,CC,
17749,GO:1901834,0.999999999992789,0.926963680207962,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17750,GO:1901835,0.999999999992789,0.926963680207962,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18735,GO:1904246,0.999999999992789,0.926963680207962,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
5206,GO:0015810,0.999999999992804,0.791934846789789,0,2,aspartate transmembrane transport,BP,
10521,GO:0043490,0.999999999992804,0.791934846789789,0,2,malate-aspartate shuttle,BP,
1736,GO:0004336,0.999999999992808,0.90654887977405,0,1,galactosylceramidase activity,MF,
3103,GO:0006683,0.999999999992808,0.90654887977405,0,1,galactosylceramide catabolic process,BP,
6123,GO:0019376,0.999999999992808,0.90654887977405,0,1,galactolipid catabolic process,BP,
18990,GO:1904844,0.99999999999281,0.876607500997846,0,2,response to L-glutamine,BP,
18991,GO:1904845,0.99999999999281,0.876607500997846,0,2,cellular response to L-glutamine,BP,
12424,GO:0050146,0.999999999992833,0.857021924663212,0,1,nucleoside phosphotransferase activity,MF,
18028,GO:1902603,0.999999999992843,0.763127720772989,0,3,carnitine transmembrane transport,BP,
6224,GO:0019780,0.999999999992869,0.841632912769596,0,1,FAT10 activating enzyme activity,MF,
15967,GO:0086006,0.999999999992877,0.751919996518643,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
12067,GO:0048058,0.999999999992879,0.897003033864789,0,1,compound eye corneal lens development,BP,
12343,GO:0048749,0.999999999992879,0.897003033864789,0,1,compound eye development,BP,
9427,GO:0036022,0.999999999992898,0.827560346759541,0,2,limb joint morphogenesis,BP,
9428,GO:0036023,0.999999999992898,0.827560346759541,0,2,embryonic skeletal limb joint morphogenesis,BP,
18908,GO:1904685,0.999999999992907,0.791701995694199,0,2,positive regulation of metalloendopeptidase activity,BP,
7632,GO:0032053,0.999999999992907,0.760759515061304,0,2,ciliary basal body organization,BP,
5537,GO:0016532,0.999999999992912,0.728097338134583,0,3,superoxide dismutase copper chaperone activity,MF,
1591,GO:0004008,0.999999999992914,0.687973600632236,0,2,copper-exporting ATPase activity,MF,
10628,GO:0043682,0.999999999992914,0.687973600632236,0,2,copper-transporting ATPase activity,MF,
13514,GO:0060003,0.999999999992914,0.687973600632236,0,2,copper ion export,BP,
14943,GO:0070877,0.999999999992914,0.789992838409199,0,2,microprocessor complex,CC,
18231,GO:1903095,0.999999999992914,0.789992838409199,0,2,ribonuclease III complex,CC,
17570,GO:1901254,0.999999999992922,0.87245043383471,0,1,positive regulation of intracellular transport of viral material,BP,
18074,GO:1902737,0.999999999992922,0.87245043383471,0,1,dendritic filopodium,CC,
14864,GO:0070685,0.99999999999293,0.920565251493342,0,1,macropinocytic cup,CC,
1610,GO:0004040,0.999999999992931,0.807962332956841,0,2,amidase activity,MF,
5575,GO:0016598,0.999999999992931,0.850222488130964,0,2,protein arginylation,BP,
7228,GO:0031151,0.999999999992951,0.828924216797064,0,1,histone methyltransferase activity (H3-K79 specific),MF,
20197,GO:2001160,0.999999999992961,0.820227134489274,0,2,regulation of histone H3-K79 methylation,BP,
20198,GO:2001162,0.999999999992961,0.820227134489274,0,2,positive regulation of histone H3-K79 methylation,BP,
5999,GO:0019045,0.999999999992961,0.687413611468582,0,2,latent virus replication,BP,
6000,GO:0019046,0.999999999992961,0.687413611468582,0,2,release from viral latency,BP,
1829,GO:0004486,0.99999999999297,0.893116230439534,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
10438,GO:0043317,0.99999999999297,0.893116230439534,0,1,regulation of cytotoxic T cell degranulation,BP,
10439,GO:0043318,0.99999999999297,0.893116230439534,0,1,negative regulation of cytotoxic T cell degranulation,BP,
18978,GO:1904815,0.999999999992976,0.836890880692633,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
7846,GO:0032417,0.999999999992981,0.800253346295462,0,2,positive regulation of sodium:proton antiporter activity,BP,
4626,GO:0010752,0.999999999992984,0.742394757182826,0,2,regulation of cGMP-mediated signaling,BP,
2688,GO:0006055,0.999999999992984,0.938057205735548,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11627,GO:0046381,0.999999999992984,0.938057205735548,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11978,GO:0047444,0.999999999992984,0.938057205735548,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12463,GO:0050462,0.999999999992984,0.938057205735548,0,1,N-acetylneuraminate synthase activity,MF,
3729,GO:0008267,0.999999999992988,0.821767116857583,0,1,poly-glutamine tract binding,MF,
1671,GO:0004137,0.999999999993004,0.785633750240403,0,2,deoxycytidine kinase activity,MF,
14403,GO:0061738,0.999999999993005,0.758900504263613,0,3,late endosomal microautophagy,BP,
9214,GO:0035620,0.999999999993009,0.720494009441288,0,3,ceramide transporter activity,MF,
16502,GO:0097267,0.999999999993012,0.678944895968467,0,3,omega-hydroxylase P450 pathway,BP,
552,GO:0001674,0.999999999993024,0.803005788575634,0,2,female germ cell nucleus,CC,
10065,GO:0042585,0.999999999993024,0.803005788575634,0,2,germinal vesicle,CC,
5399,GO:0016243,0.999999999993027,0.880166579610208,0,1,regulation of autophagosome size,BP,
5931,GO:0018217,0.999999999993027,0.880166579610208,0,1,peptidyl-aspartic acid phosphorylation,BP,
14121,GO:0061030,0.999999999993027,0.880166579610208,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
19111,GO:1905103,0.999999999993027,0.880166579610208,0,1,integral component of lysosomal membrane,CC,
19647,GO:1990938,0.999999999993027,0.880166579610208,0,1,peptidyl-aspartic acid autophosphorylation,BP,
14318,GO:0061551,0.999999999993028,0.658723066165631,0,3,trigeminal ganglion development,BP,
4988,GO:0015129,0.999999999993033,0.720791763056125,0,3,lactate transmembrane transporter activity,MF,
8634,GO:0034196,0.999999999993052,0.912663885570255,0,1,acylglycerol transport,BP,
8635,GO:0034197,0.999999999993052,0.912663885570255,0,1,triglyceride transport,BP,
10850,GO:0044395,0.999999999993052,0.912663885570255,0,1,protein targeting to vacuolar membrane,BP,
17472,GO:1900483,0.999999999993052,0.912663885570255,0,1,regulation of protein targeting to vacuolar membrane,BP,
15914,GO:0072755,0.999999999993072,0.885910585075608,0,1,cellular response to benomyl,BP,
17657,GO:1901561,0.999999999993072,0.885910585075608,0,1,response to benomyl,BP,
1979,GO:0004699,0.999999999993079,0.692711103514146,0,3,calcium-independent protein kinase C activity,MF,
17999,GO:1902528,0.999999999993089,0.816925385229756,0,1,regulation of protein linear polyubiquitination,BP,
18000,GO:1902530,0.999999999993089,0.816925385229756,0,1,positive regulation of protein linear polyubiquitination,BP,
20275,GO:2001288,0.999999999993089,0.816925385229756,0,1,positive regulation of caveolin-mediated endocytosis,BP,
18751,GO:1904289,0.9999999999931,0.786795956547594,0,2,regulation of mitotic DNA damage checkpoint,BP,
1395,GO:0003310,0.999999999993119,0.933026845201828,0,1,pancreatic A cell differentiation,BP,
6366,GO:0021558,0.999999999993119,0.933026845201828,0,1,trochlear nerve development,BP,
11475,GO:0045977,0.999999999993119,0.933026845201828,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13625,GO:0060164,0.999999999993119,0.933026845201828,0,1,regulation of timing of neuron differentiation,BP,
14166,GO:0061102,0.999999999993119,0.933026845201828,0,1,stomach neuroendocrine cell differentiation,BP,
14167,GO:0061105,0.999999999993119,0.933026845201828,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14168,GO:0061106,0.999999999993119,0.933026845201828,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15446,GO:0071820,0.999999999993119,0.933026845201828,0,1,N-box binding,MF,
15561,GO:0072071,0.999999999993119,0.933026845201828,0,1,kidney interstitial fibroblast differentiation,BP,
15612,GO:0072141,0.999999999993119,0.933026845201828,0,1,renal interstitial fibroblast development,BP,
19767,GO:2000226,0.999999999993119,0.933026845201828,0,1,regulation of pancreatic A cell differentiation,BP,
19768,GO:2000227,0.999999999993119,0.933026845201828,0,1,negative regulation of pancreatic A cell differentiation,BP,
7100,GO:0030910,0.999999999993128,0.756289607983321,0,2,olfactory placode formation,BP,
15397,GO:0071698,0.999999999993128,0.756289607983321,0,2,olfactory placode development,BP,
15398,GO:0071699,0.999999999993128,0.756289607983321,0,2,olfactory placode morphogenesis,BP,
17929,GO:1902308,0.999999999993137,0.732424670880822,0,3,regulation of peptidyl-serine dephosphorylation,BP,
17907,GO:1902261,0.999999999993139,0.698571078287018,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
7426,GO:0031547,0.999999999993139,0.725413388096174,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
9320,GO:0035822,0.999999999993145,0.758475314038993,0,2,gene conversion,BP,
107,GO:0000224,0.999999999993187,0.913651345414896,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
15457,GO:0071847,0.9999999999932,0.78451664640457,0,2,TNFSF11-mediated signaling pathway,BP,
5082,GO:0015333,0.9999999999932,0.700170040850991,0,3,peptide:proton symporter activity,MF,
9644,GO:0038016,0.999999999993225,0.819220838546624,0,2,insulin receptor internalization,BP,
6243,GO:0019826,0.999999999993239,0.769421396598004,0,2,oxygen sensor activity,MF,
11918,GO:0047006,0.999999999993256,0.934635807731644,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11927,GO:0047042,0.999999999993256,0.934635807731644,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12009,GO:0047718,0.999999999993256,0.934635807731644,0,1,indanol dehydrogenase activity,MF,
13766,GO:0060382,0.999999999993258,0.739303769830112,0,2,regulation of DNA strand elongation,BP,
1267,GO:0003050,0.999999999993273,0.900076330328895,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
17405,GO:1900195,0.999999999993288,0.848097528110297,0,2,positive regulation of oocyte maturation,BP,
8445,GO:0033597,0.99999999999329,0.919890949622993,0,1,mitotic checkpoint complex,CC,
19472,GO:1990298,0.99999999999329,0.919890949622993,0,1,bub1-bub3 complex,CC,
15684,GO:0072268,0.999999999993306,0.773735952972743,0,3,pattern specification involved in metanephros development,BP,
3767,GO:0008321,0.999999999993326,0.725101158963246,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
19545,GO:1990590,0.999999999993334,0.848870832154079,0,2,ATF1-ATF4 transcription factor complex,CC,
9948,GO:0042352,0.999999999993337,0.882006522800962,0,1,GDP-L-fucose salvage,BP,
12428,GO:0050201,0.999999999993337,0.882006522800962,0,1,fucokinase activity,MF,
10597,GO:0043614,0.999999999993337,0.751336841876141,0,2,multi-eIF complex,CC,
2472,GO:0005691,0.999999999993349,0.872277780974593,0,1,U6atac snRNP,CC,
6960,GO:0030624,0.999999999993349,0.872277780974593,0,1,U6atac snRNA binding,MF,
18453,GO:1903584,0.999999999993349,0.872277780974593,0,1,regulation of histone deubiquitination,BP,
18454,GO:1903586,0.999999999993349,0.872277780974593,0,1,positive regulation of histone deubiquitination,BP,
16914,GO:0098926,0.999999999993355,0.835309805893776,0,1,postsynaptic signal transduction,BP,
17019,GO:0099527,0.999999999993355,0.835309805893776,0,1,postsynapse to nucleus signaling pathway,BP,
3577,GO:0007624,0.999999999993359,0.877076101815007,0,1,ultradian rhythm,BP,
13513,GO:0060002,0.999999999993363,0.690634695883737,0,2,plus-end directed microfilament motor activity,MF,
17480,GO:1900673,0.999999999993368,0.838525328908915,0,2,olefin metabolic process,BP,
5510,GO:0016479,0.999999999993368,0.692456833244404,0,3,negative regulation of transcription by RNA polymerase I,BP,
2331,GO:0005350,0.999999999993397,0.830637816751185,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5232,GO:0015855,0.999999999993397,0.830637816751185,0,2,pyrimidine nucleobase transport,BP,
18980,GO:1904823,0.999999999993397,0.830637816751185,0,2,purine nucleobase transmembrane transport,BP,
7666,GO:0032106,0.999999999993398,0.778129032207803,0,3,positive regulation of response to extracellular stimulus,BP,
7669,GO:0032109,0.999999999993398,0.778129032207803,0,3,positive regulation of response to nutrient levels,BP,
16210,GO:0090289,0.999999999993411,0.721112185419306,0,3,regulation of osteoclast proliferation,BP,
1088,GO:0002677,0.999999999993413,0.809673182760579,0,2,negative regulation of chronic inflammatory response,BP,
5567,GO:0016590,0.999999999993414,0.848054572620078,0,1,ACF complex,CC,
4608,GO:0010730,0.999999999993425,0.692661808286253,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
11896,GO:0046963,0.999999999993438,0.849170089012281,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11897,GO:0046964,0.999999999993438,0.849170089012281,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18010,GO:1902559,0.999999999993438,0.849170089012281,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
5075,GO:0015317,0.999999999993459,0.928114173416726,0,1,phosphate:proton symporter activity,MF,
1262,GO:0003017,0.999999999993461,0.807708284981493,0,1,lymph circulation,BP,
4869,GO:0014735,0.999999999993474,0.759361587983706,0,2,regulation of muscle atrophy,BP,
4870,GO:0014736,0.999999999993474,0.759361587983706,0,2,negative regulation of muscle atrophy,BP,
2006,GO:0004733,0.999999999993477,0.893292095046717,0,1,pyridoxamine-phosphate oxidase activity,MF,
11058,GO:0045079,0.999999999993491,0.928273566155965,0,1,negative regulation of chemokine biosynthetic process,BP,
19478,GO:1990357,0.99999999999352,0.763488886149463,0,3,terminal web,CC,
6488,GO:0021855,0.999999999993524,0.716046502326359,0,3,hypothalamus cell migration,BP,
16676,GO:0097681,0.999999999993528,0.615531733312604,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
7476,GO:0031651,0.99999999999353,0.876695473643666,0,1,negative regulation of heat generation,BP,
7503,GO:0031699,0.99999999999353,0.876695473643666,0,1,beta-3 adrenergic receptor binding,MF,
14429,GO:0061798,0.99999999999353,0.876695473643666,0,1,GTP 3',8'-cyclase activity,MF,
14430,GO:0061799,0.99999999999353,0.876695473643666,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16239,GO:0090327,0.99999999999353,0.876695473643666,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
12892,GO:0051267,0.99999999999354,0.898788410612425,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13499,GO:0055103,0.99999999999354,0.898788410612425,0,1,ligase regulator activity,MF,
19991,GO:2000631,0.99999999999354,0.898788410612425,0,1,regulation of pre-miRNA processing,BP,
19992,GO:2000632,0.99999999999354,0.898788410612425,0,1,negative regulation of pre-miRNA processing,BP,
16973,GO:0099093,0.999999999993551,0.775442634967988,0,2,calcium export from the mitochondrion,BP,
5628,GO:0016715,0.999999999993569,0.801172239237088,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
7798,GO:0032358,0.999999999993576,0.948684663130264,0,1,oxidized pyrimidine DNA binding,MF,
14292,GO:0061481,0.999999999993576,0.948684663130264,0,1,response to TNF agonist,BP,
18005,GO:1902546,0.999999999993576,0.948684663130264,0,1,positive regulation of DNA N-glycosylase activity,BP,
20267,GO:2001272,0.999999999993576,0.948684663130264,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
8166,GO:0032915,0.999999999993578,0.920460569035254,0,1,positive regulation of transforming growth factor beta2 production,BP,
11134,GO:0045210,0.999999999993582,0.726198413724329,0,2,FasL biosynthetic process,BP,
2664,GO:0006014,0.999999999993591,0.815706907915762,0,3,D-ribose metabolic process,BP,
6865,GO:0030366,0.999999999993597,0.867152327332186,0,2,molybdopterin synthase activity,MF,
15835,GO:0072586,0.999999999993606,0.869963535381449,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15836,GO:0072587,0.999999999993606,0.869963535381449,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
5464,GO:0016403,0.999999999993607,0.823722131055604,0,2,dimethylargininase activity,MF,
4044,GO:0009085,0.999999999993608,0.770857691356151,0,2,lysine biosynthetic process,BP,
6271,GO:0019878,0.999999999993608,0.770857691356151,0,2,lysine biosynthetic process via aminoadipic acid,BP,
16707,GO:0097753,0.999999999993615,0.884984994076571,0,1,membrane bending,BP,
2316,GO:0005324,0.99999999999362,0.814950127791014,0,2,long-chain fatty acid transporter activity,MF,
5260,GO:0015910,0.99999999999362,0.814950127791014,0,2,peroxisomal long-chain fatty acid import,BP,
13600,GO:0060124,0.999999999993627,0.771061319970905,0,2,positive regulation of growth hormone secretion,BP,
4213,GO:0009383,0.99999999999363,0.793418405098985,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
16543,GO:0097363,0.999999999993646,0.775255841692805,0,2,protein O-GlcNAc transferase activity,MF,
4498,GO:0010536,0.999999999993647,0.885127812073819,0,2,positive regulation of activation of Janus kinase activity,BP,
13688,GO:0060282,0.99999999999365,0.709790503716283,0,3,positive regulation of oocyte development,BP,
19361,GO:1905881,0.99999999999365,0.709790503716283,0,3,positive regulation of oogenesis,BP,
5967,GO:0018423,0.999999999993661,0.849181607690696,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
14440,GO:0061833,0.999999999993661,0.802207496739394,0,2,protein localization to tricellular tight junction,BP,
18970,GO:1904799,0.999999999993668,0.881263557283631,0,1,regulation of neuron remodeling,BP,
18971,GO:1904800,0.999999999993668,0.881263557283631,0,1,negative regulation of neuron remodeling,BP,
19741,GO:2000173,0.999999999993668,0.881263557283631,0,1,negative regulation of branching morphogenesis of a nerve,BP,
13856,GO:0060523,0.999999999993691,0.740529165126152,0,2,prostate epithelial cord elongation,BP,
16650,GO:0097623,0.999999999993692,0.788809790182958,0,2,potassium ion export across plasma membrane,BP,
16482,GO:0097213,0.999999999993707,0.918527931094022,0,1,regulation of lysosomal membrane permeability,BP,
3606,GO:0008048,0.999999999993711,0.9180663083927,0,1,calcium sensitive guanylate cyclase activator activity,MF,
4691,GO:0010851,0.999999999993711,0.9180663083927,0,1,cyclase regulator activity,MF,
4692,GO:0010853,0.999999999993711,0.9180663083927,0,1,cyclase activator activity,MF,
6794,GO:0030249,0.999999999993711,0.9180663083927,0,1,guanylate cyclase regulator activity,MF,
6795,GO:0030250,0.999999999993711,0.9180663083927,0,1,guanylate cyclase activator activity,MF,
11860,GO:0046898,0.999999999993712,0.660285446042194,0,3,response to cycloheximide,BP,
5821,GO:0017102,0.99999999999372,0.823096630755525,0,2,methionyl glutamyl tRNA synthetase complex,CC,
18478,GO:1903650,0.999999999993731,0.891333516805988,0,2,negative regulation of cytoplasmic transport,BP,
19997,GO:2000642,0.999999999993731,0.891333516805988,0,2,negative regulation of early endosome to late endosome transport,BP,
3503,GO:0007412,0.999999999993737,0.830035756496456,0,2,axon target recognition,BP,
9263,GO:0035712,0.999999999993737,0.898101766457311,0,1,T-helper 2 cell activation,BP,
19957,GO:2000569,0.999999999993737,0.898101766457311,0,1,regulation of T-helper 2 cell activation,BP,
19958,GO:2000570,0.999999999993737,0.898101766457311,0,1,positive regulation of T-helper 2 cell activation,BP,
13197,GO:0051886,0.99999999999374,0.85939544957474,0,1,negative regulation of timing of anagen,BP,
20226,GO:2001203,0.99999999999374,0.85939544957474,0,1,positive regulation of transforming growth factor-beta secretion,BP,
1690,GO:0004167,0.999999999993742,0.913176110202329,0,2,dopachrome isomerase activity,MF,
5717,GO:0016862,0.999999999993742,0.913176110202329,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
12426,GO:0050178,0.999999999993742,0.913176110202329,0,2,phenylpyruvate tautomerase activity,MF,
12429,GO:0050211,0.999999999993742,0.820579998187678,0,2,procollagen galactosyltransferase activity,MF,
10371,GO:0043224,0.999999999993743,0.890946837991024,0,2,nuclear SCF ubiquitin ligase complex,CC,
3666,GO:0008160,0.999999999993755,0.912292794990032,0,1,protein tyrosine phosphatase activator activity,MF,
18674,GO:1904059,0.999999999993756,0.748672311680277,0,1,regulation of locomotor rhythm,BP,
2778,GO:0006211,0.999999999993764,0.507534640581221,0,3,5-methylcytosine catabolic process,BP,
6258,GO:0019857,0.999999999993764,0.507534640581221,0,3,5-methylcytosine metabolic process,BP,
17429,GO:1900243,0.999999999993772,0.858122443119884,0,1,negative regulation of synaptic vesicle endocytosis,BP,
19123,GO:1905154,0.999999999993772,0.858122443119884,0,1,negative regulation of membrane invagination,BP,
19125,GO:1905161,0.999999999993772,0.858122443119884,0,1,protein localization to phagocytic vesicle,BP,
19126,GO:1905162,0.999999999993772,0.858122443119884,0,1,regulation of phagosome maturation,BP,
19131,GO:1905169,0.999999999993772,0.858122443119884,0,1,regulation of protein localization to phagocytic vesicle,BP,
19132,GO:1905171,0.999999999993772,0.858122443119884,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19250,GO:1905468,0.999999999993772,0.858122443119884,0,1,regulation of clathrin-coated pit assembly,BP,
19251,GO:1905469,0.999999999993772,0.858122443119884,0,1,negative regulation of clathrin-coated pit assembly,BP,
3617,GO:0008073,0.999999999993779,0.868800153930616,0,2,ornithine decarboxylase inhibitor activity,MF,
17911,GO:1902268,0.999999999993779,0.868800153930616,0,2,negative regulation of polyamine transmembrane transport,BP,
12013,GO:0047750,0.999999999993788,0.888414291880491,0,2,cholestenol delta-isomerase activity,MF,
14495,GO:0070012,0.999999999993788,0.831543782457821,0,2,oligopeptidase activity,MF,
5800,GO:0017060,0.999999999993795,0.829757673370457,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
19240,GO:1905449,0.999999999993811,0.782279794795642,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19241,GO:1905451,0.999999999993811,0.782279794795642,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
16341,GO:0090673,0.999999999993811,0.830364929822406,0,1,endothelial cell-matrix adhesion,BP,
14822,GO:0070611,0.999999999993822,0.91191741140606,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14823,GO:0070612,0.999999999993822,0.91191741140606,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
5911,GO:0018192,0.999999999993852,0.91506195527524,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7870,GO:0032447,0.999999999993852,0.91506195527524,0,1,protein urmylation,BP,
9922,GO:0042292,0.999999999993852,0.91506195527524,0,1,URM1 activating enzyme activity,MF,
14342,GO:0061604,0.999999999993852,0.91506195527524,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14343,GO:0061605,0.999999999993852,0.91506195527524,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16853,GO:0098822,0.999999999993852,0.91506195527524,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
5647,GO:0016748,0.999999999993857,0.832360573933497,0,2,succinyltransferase activity,MF,
9347,GO:0035879,0.999999999993868,0.706449306835216,0,3,plasma membrane lactate transport,BP,
3976,GO:0008808,0.999999999993891,0.884948626273757,0,1,cardiolipin synthase activity,MF,
6937,GO:0030572,0.999999999993891,0.884948626273757,0,1,phosphatidyltransferase activity,MF,
10449,GO:0043337,0.999999999993891,0.884948626273757,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
19322,GO:1905711,0.999999999993891,0.884948626273757,0,1,response to phosphatidylethanolamine,BP,
18638,GO:1903984,0.999999999993895,0.67271515754508,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
2114,GO:0004905,0.999999999993896,0.79061574590817,0,2,type I interferon receptor activity,MF,
3726,GO:0008263,0.999999999993896,0.822090455956576,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
1948,GO:0004654,0.999999999993906,0.868284860157749,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16319,GO:0090616,0.999999999993906,0.868284860157749,0,1,mitochondrial mRNA 3'-end processing,BP,
16483,GO:0097222,0.999999999993906,0.868284860157749,0,1,mitochondrial mRNA polyadenylation,BP,
19008,GO:1904878,0.999999999993924,0.792356644891629,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
17893,GO:1902232,0.999999999993937,0.844944367057174,0,2,regulation of positive thymic T cell selection,BP,
1090,GO:0002679,0.999999999993949,0.745313301406227,0,3,respiratory burst involved in defense response,BP,
12758,GO:0051066,0.999999999993972,0.857395318231874,0,2,dihydrobiopterin metabolic process,BP,
3131,GO:0006722,0.999999999994002,0.915841105088721,0,1,triterpenoid metabolic process,BP,
6210,GO:0019742,0.999999999994002,0.915841105088721,0,1,pentacyclic triterpenoid metabolic process,BP,
19033,GO:1904924,0.999999999994002,0.915841105088721,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19208,GO:1905370,0.999999999994002,0.915841105088721,0,1,serine-type endopeptidase complex,CC,
3492,GO:0007387,0.999999999994012,0.910547585689177,0,1,anterior compartment pattern formation,BP,
3493,GO:0007388,0.999999999994012,0.910547585689177,0,1,posterior compartment specification,BP,
19561,GO:1990666,0.99999999999403,0.762390938200451,0,2,PCSK9-LDLR complex,CC,
5737,GO:0016890,0.999999999994031,0.812259989227489,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
2306,GO:0005295,0.999999999994032,0.899397973305341,0,1,neutral amino acid:sodium symporter activity,MF,
5093,GO:0015375,0.999999999994032,0.899397973305341,0,1,glycine:sodium symporter activity,MF,
7507,GO:0031704,0.999999999994032,0.899397973305341,0,1,apelin receptor binding,MF,
10474,GO:0043396,0.999999999994032,0.899397973305341,0,1,corticotropin-releasing hormone secretion,BP,
10475,GO:0043397,0.999999999994032,0.899397973305341,0,1,regulation of corticotropin-releasing hormone secretion,BP,
13002,GO:0051466,0.999999999994032,0.899397973305341,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13522,GO:0060012,0.999999999994032,0.899397973305341,0,1,synaptic transmission, glycinergic,BP,
13591,GO:0060092,0.999999999994032,0.899397973305341,0,1,regulation of synaptic transmission, glycinergic,BP,
13636,GO:0060183,0.999999999994032,0.899397973305341,0,1,apelin receptor signaling pathway,BP,
14311,GO:0061536,0.999999999994032,0.899397973305341,0,1,glycine secretion,BP,
14312,GO:0061537,0.999999999994032,0.899397973305341,0,1,glycine secretion, neurotransmission,BP,
18650,GO:1904022,0.999999999994032,0.899397973305341,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20195,GO:2001151,0.999999999994032,0.899397973305341,0,1,regulation of renal water transport,BP,
20196,GO:2001153,0.999999999994032,0.899397973305341,0,1,positive regulation of renal water transport,BP,
5613,GO:0016672,0.99999999999404,0.885766144278617,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11110,GO:0045174,0.99999999999404,0.885766144278617,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12479,GO:0050610,0.99999999999404,0.885766144278617,0,2,methylarsonate reductase activity,MF,
1516,GO:0003878,0.999999999994051,0.872749321246322,0,1,ATP citrate synthase activity,MF,
4206,GO:0009346,0.999999999994051,0.872749321246322,0,1,citrate lyase complex,CC,
1907,GO:0004597,0.999999999994062,0.889114574900721,0,1,peptide-aspartate beta-dioxygenase activity,MF,
4771,GO:0010961,0.999999999994066,0.718114530748005,0,2,cellular magnesium ion homeostasis,BP,
20016,GO:2000663,0.999999999994067,0.889077128892151,0,1,negative regulation of interleukin-5 secretion,BP,
4773,GO:0010963,0.999999999994073,0.933072073216929,0,1,regulation of L-arginine import,BP,
14987,GO:0070947,0.999999999994073,0.933072073216929,0,1,neutrophil mediated killing of fungus,BP,
14992,GO:0070953,0.999999999994073,0.933072073216929,0,1,regulation of neutrophil mediated killing of fungus,BP,
14997,GO:0070965,0.999999999994073,0.933072073216929,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19948,GO:2000552,0.999999999994073,0.933072073216929,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
311,GO:0000823,0.999999999994074,0.925986359756856,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,0.999999999994074,0.925986359756856,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,0.999999999994074,0.925986359756856,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11966,GO:0047326,0.999999999994074,0.925986359756856,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
6236,GO:0019808,0.999999999994085,0.799137870261978,0,3,polyamine binding,MF,
824,GO:0002101,0.999999999994094,0.750866159797151,0,3,tRNA wobble cytosine modification,BP,
9238,GO:0035662,0.999999999994096,0.851687030968297,0,3,Toll-like receptor 4 binding,MF,
14437,GO:0061827,0.999999999994096,0.85062689986121,0,2,sperm head,CC,
19904,GO:2000434,0.999999999994124,0.901305027168077,0,2,regulation of protein neddylation,BP,
19905,GO:2000435,0.999999999994124,0.901305027168077,0,2,negative regulation of protein neddylation,BP,
15576,GO:0072092,0.999999999994141,0.640416980678792,0,2,ureteric bud invasion,BP,
1804,GO:0004452,0.99999999999415,0.860548071909511,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12702,GO:0050992,0.99999999999415,0.860548071909511,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12703,GO:0050993,0.99999999999415,0.860548071909511,0,2,dimethylallyl diphosphate metabolic process,BP,
14500,GO:0070026,0.999999999994157,0.862699305593925,0,2,nitric oxide binding,MF,
11656,GO:0046462,0.999999999994158,0.840004789861852,0,2,monoacylglycerol metabolic process,BP,
13353,GO:0052651,0.999999999994158,0.840004789861852,0,2,monoacylglycerol catabolic process,BP,
2241,GO:0005153,0.99999999999416,0.817755527677996,0,2,interleukin-8 receptor binding,MF,
15503,GO:0071929,0.99999999999416,0.817755527677996,0,2,alpha-tubulin acetylation,BP,
6550,GO:0021997,0.999999999994174,0.695423977051085,0,2,neural plate axis specification,BP,
4550,GO:0010636,0.999999999994183,0.769582949320965,0,2,positive regulation of mitochondrial fusion,BP,
19415,GO:1990071,0.999999999994189,0.793864835777901,0,2,TRAPPII protein complex,CC,
6469,GO:0021816,0.999999999994235,0.769149505173348,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
1892,GO:0004577,0.999999999994252,0.851772883658979,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
11942,GO:0047179,0.999999999994254,0.885014545952612,0,2,platelet-activating factor acetyltransferase activity,MF,
10037,GO:0042539,0.999999999994259,0.746312229132951,0,2,hypotonic salinity response,BP,
15262,GO:0071477,0.999999999994259,0.746312229132951,0,2,cellular hypotonic salinity response,BP,
14935,GO:0070860,0.999999999994263,0.917444292607495,0,1,RNA polymerase I core factor complex,CC,
457,GO:0001306,0.999999999994269,0.943656977943517,0,1,age-dependent response to oxidative stress,BP,
458,GO:0001315,0.999999999994269,0.943656977943517,0,1,age-dependent response to reactive oxygen species,BP,
1273,GO:0003068,0.999999999994269,0.943656977943517,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1274,GO:0003069,0.999999999994269,0.943656977943517,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1275,GO:0003070,0.999999999994269,0.943656977943517,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3545,GO:0007571,0.999999999994269,0.943656977943517,0,1,age-dependent general metabolic decline,BP,
5042,GO:0015230,0.999999999994281,0.829970752204193,0,2,FAD transmembrane transporter activity,MF,
9072,GO:0035350,0.999999999994281,0.829970752204193,0,2,FAD transmembrane transport,BP,
20214,GO:2001184,0.999999999994288,0.80019347075198,0,2,positive regulation of interleukin-12 secretion,BP,
1609,GO:0004034,0.999999999994305,0.914563502890062,0,1,aldose 1-epimerase activity,MF,
9382,GO:0035945,0.999999999994305,0.914563502890062,0,1,mitochondrial ncRNA surveillance,BP,
9383,GO:0035946,0.999999999994305,0.914563502890062,0,1,mitochondrial mRNA surveillance,BP,
15035,GO:0071026,0.999999999994305,0.914563502890062,0,1,cytoplasmic RNA surveillance,BP,
20111,GO:2000827,0.999999999994305,0.914563502890062,0,1,mitochondrial RNA surveillance,BP,
15999,GO:0086048,0.999999999994311,0.776399164343127,0,2,membrane depolarization during bundle of His cell action potential,BP,
15327,GO:0071586,0.999999999994316,0.840147256776429,0,2,CAAX-box protein processing,BP,
15945,GO:0080120,0.999999999994316,0.840147256776429,0,2,CAAX-box protein maturation,BP,
2150,GO:0004970,0.999999999994317,0.619451872011951,0,3,ionotropic glutamate receptor activity,MF,
2151,GO:0004972,0.999999999994317,0.619451872011951,0,3,NMDA glutamate receptor activity,MF,
19896,GO:2000418,0.99999999999432,0.821756615396259,0,2,positive regulation of eosinophil migration,BP,
471,GO:0001515,0.999999999994328,0.9227728272151,0,1,opioid peptide activity,MF,
7260,GO:0031251,0.999999999994342,0.730778222261268,0,2,PAN complex,CC,
8058,GO:0032741,0.999999999994348,0.776728330983753,0,2,positive regulation of interleukin-18 production,BP,
8982,GO:0035120,0.9999999999944,0.784338522033077,0,1,post-embryonic appendage morphogenesis,BP,
8983,GO:0035127,0.9999999999944,0.784338522033077,0,1,post-embryonic limb morphogenesis,BP,
8984,GO:0035128,0.9999999999944,0.784338522033077,0,1,post-embryonic forelimb morphogenesis,BP,
16556,GO:0097393,0.9999999999944,0.784338522033077,0,1,telomeric repeat-containing RNA transcription,BP,
16557,GO:0097394,0.9999999999944,0.784338522033077,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17669,GO:1901580,0.9999999999944,0.784338522033077,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17670,GO:1901581,0.9999999999944,0.784338522033077,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17671,GO:1901582,0.9999999999944,0.784338522033077,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
19502,GO:1990421,0.9999999999944,0.784338522033077,0,1,subtelomeric heterochromatin,CC,
19568,GO:1990707,0.9999999999944,0.784338522033077,0,1,nuclear subtelomeric heterochromatin,CC,
15606,GO:0072134,0.999999999994422,0.714581922891288,0,2,nephrogenic mesenchyme morphogenesis,BP,
11814,GO:0046786,0.999999999994424,0.8631481413718,0,1,viral replication complex formation and maintenance,BP,
20014,GO:2000661,0.999999999994424,0.8631481413718,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
15240,GO:0071449,0.999999999994429,0.946593275067632,0,1,cellular response to lipid hydroperoxide,BP,
7712,GO:0032213,0.999999999994432,0.821557393980631,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7713,GO:0032214,0.999999999994432,0.821557393980631,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18848,GO:1904534,0.999999999994432,0.821557393980631,0,2,negative regulation of telomeric loop disassembly,BP,
19337,GO:1905778,0.999999999994432,0.821557393980631,0,2,negative regulation of exonuclease activity,BP,
19348,GO:1905838,0.999999999994432,0.821557393980631,0,2,regulation of telomeric D-loop disassembly,BP,
19349,GO:1905839,0.999999999994432,0.821557393980631,0,2,negative regulation of telomeric D-loop disassembly,BP,
18507,GO:1903723,0.99999999999445,0.94689742342986,0,1,negative regulation of centriole elongation,BP,
6412,GO:0021682,0.99999999999446,0.851893784867798,0,1,nerve maturation,BP,
2047,GO:0004797,0.999999999994461,0.800600457132502,0,2,thymidine kinase activity,MF,
1426,GO:0003400,0.999999999994477,0.919659134526112,0,1,regulation of COPII vesicle coating,BP,
2204,GO:0005090,0.999999999994477,0.919659134526112,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13927,GO:0060661,0.999999999994477,0.919659134526112,0,1,submandibular salivary gland formation,BP,
15163,GO:0071335,0.999999999994477,0.919659134526112,0,1,hair follicle cell proliferation,BP,
15164,GO:0071336,0.999999999994477,0.919659134526112,0,1,regulation of hair follicle cell proliferation,BP,
15165,GO:0071338,0.999999999994477,0.919659134526112,0,1,positive regulation of hair follicle cell proliferation,BP,
16094,GO:0090113,0.999999999994477,0.919659134526112,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
701,GO:0001922,0.99999999999448,0.653973263449854,0,3,B-1 B cell homeostasis,BP,
4025,GO:0009061,0.999999999994483,0.915995655415946,0,1,anaerobic respiration,BP,
11162,GO:0045274,0.999999999994483,0.915995655415946,0,1,plasma membrane respiratory chain complex II,CC,
11166,GO:0045282,0.999999999994483,0.915995655415946,0,1,plasma membrane succinate dehydrogenase complex,CC,
1514,GO:0003876,0.999999999994488,0.773798110222531,0,2,AMP deaminase activity,MF,
11998,GO:0047623,0.999999999994488,0.773798110222531,0,2,adenosine-phosphate deaminase activity,MF,
11875,GO:0046922,0.999999999994512,0.808748138001672,0,2,peptide-O-fucosyltransferase activity,MF,
7542,GO:0031867,0.999999999994516,0.884067970665605,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7234,GO:0031177,0.99999999999453,0.742605913814236,0,3,phosphopantetheine binding,MF,
977,GO:0002432,0.99999999999454,0.871669155035931,0,1,granuloma formation,BP,
2111,GO:0004897,0.999999999994571,0.628082819087903,0,3,ciliary neurotrophic factor receptor activity,MF,
14550,GO:0070120,0.999999999994571,0.628082819087903,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
196,GO:0000415,0.999999999994583,0.842965026261487,0,1,negative regulation of histone H3-K36 methylation,BP,
10015,GO:0042483,0.999999999994583,0.842965026261487,0,1,negative regulation of odontogenesis,BP,
14582,GO:0070171,0.999999999994583,0.842965026261487,0,1,negative regulation of tooth mineralization,BP,
9236,GO:0035658,0.999999999994585,0.750684733551248,0,3,Mon1-Ccz1 complex,CC,
17357,GO:1900114,0.999999999994598,0.73952927726113,0,2,positive regulation of histone H3-K9 trimethylation,BP,
12475,GO:0050560,0.999999999994607,0.895946607123974,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14568,GO:0070145,0.999999999994607,0.895946607123974,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
801,GO:0002071,0.999999999994609,0.817712591957266,0,2,glandular epithelial cell maturation,BP,
6070,GO:0019227,0.999999999994614,0.681700825952315,0,3,neuronal action potential propagation,BP,
16878,GO:0098870,0.999999999994614,0.681700825952315,0,3,action potential propagation,BP,
3763,GO:0008311,0.999999999994619,0.860162137714687,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
1672,GO:0004138,0.999999999994626,0.943978624225189,0,1,deoxyguanosine kinase activity,MF,
3931,GO:0008617,0.999999999994626,0.943978624225189,0,1,guanosine metabolic process,BP,
5280,GO:0015938,0.999999999994626,0.943978624225189,0,1,coenzyme A catabolic process,BP,
8527,GO:0033869,0.999999999994626,0.943978624225189,0,1,nucleoside bisphosphate catabolic process,BP,
8549,GO:0034031,0.999999999994626,0.943978624225189,0,1,ribonucleoside bisphosphate catabolic process,BP,
8552,GO:0034034,0.999999999994626,0.943978624225189,0,1,purine nucleoside bisphosphate catabolic process,BP,
12492,GO:0050659,0.999999999994628,0.737950320781407,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
8878,GO:0034711,0.999999999994637,0.730833097250822,0,3,inhibin binding,MF,
4009,GO:0009007,0.999999999994653,0.88800646657221,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8079,GO:0032775,0.999999999994653,0.88800646657221,0,1,DNA methylation on adenine,BP,
16211,GO:0090290,0.999999999994654,0.943229970288042,0,1,positive regulation of osteoclast proliferation,BP,
2685,GO:0006050,0.999999999994659,0.930290070214551,0,1,mannosamine metabolic process,BP,
2686,GO:0006051,0.999999999994659,0.930290070214551,0,1,N-acetylmannosamine metabolic process,BP,
11088,GO:0045127,0.999999999994659,0.930290070214551,0,1,N-acetylglucosamine kinase activity,MF,
10744,GO:0044211,0.999999999994661,0.798512258729085,0,3,CTP salvage,BP,
3611,GO:0008057,0.999999999994664,0.829026056297655,0,1,eye pigment granule organization,BP,
3166,GO:0006780,0.999999999994681,0.860045812872951,0,2,uroporphyrinogen III biosynthetic process,BP,
11687,GO:0046502,0.999999999994681,0.860045812872951,0,2,uroporphyrinogen III metabolic process,BP,
1771,GO:0004378,0.999999999994686,0.90663471144983,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17133,GO:0102704,0.999999999994686,0.90663471144983,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
15007,GO:0070981,0.99999999999469,0.917108300861647,0,1,L-asparagine biosynthetic process,BP,
15008,GO:0070982,0.99999999999469,0.917108300861647,0,1,L-asparagine metabolic process,BP,
5459,GO:0016361,0.999999999994694,0.838578823214405,0,2,activin receptor activity, type I,MF,
12096,GO:0048179,0.999999999994694,0.838578823214405,0,2,activin receptor complex,CC,
14584,GO:0070176,0.9999999999947,0.925894110182958,0,1,DRM complex,CC,
5953,GO:0018343,0.999999999994704,0.767673213134684,0,3,protein farnesylation,BP,
1319,GO:0003169,0.999999999994724,0.718718695896498,0,2,coronary vein morphogenesis,BP,
14077,GO:0060948,0.999999999994724,0.718718695896498,0,2,cardiac vascular smooth muscle cell development,BP,
10640,GO:0043812,0.99999999999474,0.666616371929894,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
13621,GO:0060157,0.99999999999474,0.73754095356014,0,2,urinary bladder development,BP,
4491,GO:0010521,0.999999999994749,0.754723592135227,0,3,telomerase inhibitor activity,MF,
15215,GO:0071403,0.999999999994754,0.806075500529777,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16750,GO:0098592,0.999999999994769,0.722043097403324,0,3,cytoplasmic side of apical plasma membrane,CC,
11427,GO:0045901,0.999999999994787,0.723669420796769,0,3,positive regulation of translational elongation,BP,
11108,GO:0045168,0.99999999999479,0.837003624896435,0,2,cell-cell signaling involved in cell fate commitment,BP,
11605,GO:0046331,0.99999999999479,0.837003624896435,0,2,lateral inhibition,BP,
19380,GO:1905936,0.999999999994798,0.894221934663688,0,2,regulation of germ cell proliferation,BP,
19781,GO:2000254,0.999999999994798,0.894221934663688,0,2,regulation of male germ cell proliferation,BP,
15004,GO:0070976,0.999999999994803,0.910556992035458,0,1,TIR domain binding,MF,
4693,GO:0010856,0.999999999994806,0.89780632652172,0,1,adenylate cyclase activator activity,MF,
13602,GO:0060126,0.999999999994844,0.810670647930055,0,2,somatotropin secreting cell differentiation,BP,
3092,GO:0006668,0.999999999994884,0.812416300978549,0,2,sphinganine-1-phosphate metabolic process,BP,
3467,GO:0007290,0.999999999994885,0.865340430271844,0,1,spermatid nucleus elongation,BP,
11587,GO:0046293,0.999999999994885,0.865340430271844,0,1,formaldehyde biosynthetic process,BP,
2119,GO:0004913,0.999999999994891,0.916125511137736,0,1,interleukin-4 receptor activity,MF,
19670,GO:2000017,0.999999999994894,0.809731957562617,0,2,positive regulation of determination of dorsal identity,BP,
16306,GO:0090560,0.999999999994895,0.919842953390668,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
1752,GO:0004356,0.999999999994901,0.872643040239341,0,1,glutamate-ammonia ligase activity,MF,
2994,GO:0006542,0.999999999994901,0.872643040239341,0,1,glutamine biosynthetic process,BP,
5380,GO:0016211,0.999999999994901,0.872643040239341,0,1,ammonia ligase activity,MF,
6193,GO:0019676,0.999999999994901,0.872643040239341,0,1,ammonia assimilation cycle,BP,
11062,GO:0045083,0.999999999994904,0.878030337970933,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
18962,GO:1904783,0.999999999994907,0.787216921766572,0,2,positive regulation of NMDA glutamate receptor activity,BP,
13557,GO:0060053,0.999999999994919,0.766160669465796,0,2,neurofilament cytoskeleton,CC,
1813,GO:0004465,0.999999999994922,0.734125316679699,0,3,lipoprotein lipase activity,MF,
3635,GO:0008107,0.999999999994928,0.789734575481393,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7221,GO:0031127,0.999999999994928,0.789734575481393,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
5044,GO:0015234,0.999999999994929,0.825833590204045,0,2,thiamine transmembrane transporter activity,MF,
15507,GO:0071934,0.999999999994929,0.825833590204045,0,2,thiamine transmembrane transport,BP,
9074,GO:0035354,0.999999999994933,0.894997502940998,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9693,GO:0038123,0.999999999994933,0.894997502940998,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10023,GO:0042495,0.999999999994933,0.894997502940998,0,1,detection of triacyl bacterial lipopeptide,BP,
10025,GO:0042497,0.999999999994933,0.894997502940998,0,1,triacyl lipopeptide binding,MF,
15412,GO:0071725,0.999999999994933,0.894997502940998,0,1,response to triacyl bacterial lipopeptide,BP,
15414,GO:0071727,0.999999999994933,0.894997502940998,0,1,cellular response to triacyl bacterial lipopeptide,BP,
1209,GO:0002876,0.999999999994933,0.928453839303295,0,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1236,GO:0002925,0.999999999994933,0.928453839303295,0,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
14137,GO:0061048,0.999999999994933,0.928453839303295,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15820,GO:0072564,0.999999999994933,0.928453839303295,0,1,blood microparticle formation,BP,
19022,GO:1904895,0.999999999994933,0.928453839303295,0,1,ESCRT complex assembly,BP,
19024,GO:1904902,0.999999999994933,0.928453839303295,0,1,ESCRT III complex assembly,BP,
19069,GO:1904999,0.999999999994933,0.928453839303295,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
19835,GO:2000332,0.999999999994933,0.928453839303295,0,1,regulation of blood microparticle formation,BP,
19836,GO:2000334,0.999999999994933,0.928453839303295,0,1,positive regulation of blood microparticle formation,BP,
7445,GO:0031592,0.999999999994944,0.822744624116253,0,1,centrosomal corona,CC,
18820,GO:1904454,0.999999999994944,0.822744624116253,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
14035,GO:0060842,0.999999999994953,0.662593157670348,0,3,arterial endothelial cell differentiation,BP,
2135,GO:0004947,0.999999999994961,0.820807261088124,0,2,bradykinin receptor activity,MF,
11027,GO:0045031,0.999999999994964,0.832629752581679,0,2,ATP-activated adenosine receptor activity,MF,
13034,GO:0051562,0.999999999994976,0.821165246597073,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
1734,GO:0004334,0.999999999995002,0.932936522082998,0,1,fumarylacetoacetase activity,MF,
10431,GO:0043309,0.999999999995019,0.847714789491184,0,2,regulation of eosinophil degranulation,BP,
10432,GO:0043311,0.999999999995019,0.847714789491184,0,2,positive regulation of eosinophil degranulation,BP,
18016,GO:1902566,0.999999999995019,0.847714789491184,0,2,regulation of eosinophil activation,BP,
18017,GO:1902568,0.999999999995019,0.847714789491184,0,2,positive regulation of eosinophil activation,BP,
11046,GO:0045065,0.999999999995023,0.825955639921168,0,2,cytotoxic T cell differentiation,BP,
11254,GO:0045583,0.999999999995023,0.825955639921168,0,2,regulation of cytotoxic T cell differentiation,BP,
11255,GO:0045585,0.999999999995023,0.825955639921168,0,2,positive regulation of cytotoxic T cell differentiation,BP,
14419,GO:0061768,0.999999999995034,0.863971462741197,0,1,magnesium:sodium antiporter activity,MF,
2362,GO:0005476,0.99999999999504,0.813437673305486,0,2,carnitine:acyl carnitine antiporter activity,MF,
4003,GO:0008967,0.99999999999505,0.83120311349107,0,2,phosphoglycolate phosphatase activity,MF,
8730,GO:0034395,0.999999999995051,0.93086593309381,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
19763,GO:2000211,0.999999999995054,0.861147717300833,0,1,regulation of glutamate metabolic process,BP,
19764,GO:2000212,0.999999999995054,0.861147717300833,0,1,negative regulation of glutamate metabolic process,BP,
17258,GO:0140052,0.999999999995054,0.704517000830475,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
15968,GO:0086007,0.999999999995061,0.774079159896504,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17756,GO:1901843,0.999999999995061,0.774079159896504,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
19440,GO:1990167,0.999999999995068,0.65918706653958,0,3,protein K27-linked deubiquitination,BP,
13626,GO:0060166,0.999999999995072,0.833290011903843,0,2,olfactory pit development,BP,
14423,GO:0061772,0.999999999995087,0.894496655569856,0,1,drug transport across blood-nerve barrier,BP,
18429,GO:1903544,0.999999999995087,0.894496655569856,0,1,response to butyrate,BP,
18430,GO:1903545,0.999999999995087,0.894496655569856,0,1,cellular response to butyrate,BP,
3866,GO:0008495,0.999999999995098,0.904567678142226,0,1,protoheme IX farnesyltransferase activity,MF,
12058,GO:0048033,0.999999999995098,0.904567678142226,0,1,heme o metabolic process,BP,
12059,GO:0048034,0.999999999995098,0.904567678142226,0,1,heme O biosynthetic process,BP,
6476,GO:0021826,0.999999999995099,0.821069085433362,0,2,substrate-independent telencephalic tangential migration,BP,
6479,GO:0021830,0.999999999995099,0.821069085433362,0,2,interneuron migration from the subpallium to the cortex,BP,
6483,GO:0021843,0.999999999995099,0.821069085433362,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
1749,GO:0004351,0.999999999995111,0.799711199822187,0,2,glutamate decarboxylase activity,MF,
16204,GO:0090283,0.999999999995115,0.700416655520945,0,3,regulation of protein glycosylation in Golgi,BP,
1712,GO:0004306,0.999999999995117,0.924826439355183,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
11004,GO:0044861,0.999999999995126,0.785703350437767,0,2,protein transport into plasma membrane raft,BP,
8624,GO:0034166,0.999999999995143,0.897188792509453,0,1,toll-like receptor 10 signaling pathway,BP,
19217,GO:1905397,0.999999999995155,0.85910998874464,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19218,GO:1905402,0.999999999995155,0.85910998874464,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
16173,GO:0090234,0.999999999995181,0.689457280469888,0,3,regulation of kinetochore assembly,BP,
10858,GO:0044416,0.99999999999519,0.856932252723899,0,2,induction by symbiont of host defense response,BP,
11805,GO:0046730,0.99999999999519,0.856932252723899,0,2,induction of host immune response by virus,BP,
11806,GO:0046732,0.99999999999519,0.856932252723899,0,2,active induction of host immune response by virus,BP,
13303,GO:0052251,0.99999999999519,0.856932252723899,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13330,GO:0052509,0.99999999999519,0.856932252723899,0,2,positive regulation by symbiont of host defense response,BP,
13331,GO:0052510,0.99999999999519,0.856932252723899,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
5801,GO:0017061,0.999999999995201,0.86299139590701,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
14393,GO:0061723,0.999999999995209,0.767737391417736,0,2,glycophagy,BP,
10681,GO:0043988,0.999999999995212,0.762984155966296,0,3,histone H3-S28 phosphorylation,BP,
18236,GO:1903116,0.99999999999524,0.773929812071071,0,2,positive regulation of actin filament-based movement,BP,
18535,GO:1903781,0.99999999999524,0.773929812071071,0,2,positive regulation of cardiac conduction,BP,
18616,GO:1903949,0.99999999999524,0.773929812071071,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
6105,GO:0019353,0.999999999995242,0.910594587149419,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8416,GO:0033526,0.999999999995242,0.910594587149419,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
1952,GO:0004658,0.999999999995252,0.846574386370456,0,2,propionyl-CoA carboxylase activity,MF,
4490,GO:0010520,0.99999999999527,0.821674459131437,0,2,regulation of reciprocal meiotic recombination,BP,
450,GO:0001224,0.999999999995281,0.62800519445039,0,3,RNA polymerase II transcription cofactor binding,MF,
19626,GO:1990876,0.999999999995286,0.839580292514922,0,1,cytoplasmic side of nuclear pore,CC,
6539,GO:0021960,0.999999999995287,0.635858095968785,0,3,anterior commissure morphogenesis,BP,
14598,GO:0070195,0.999999999995288,0.872662345668012,0,1,growth hormone receptor complex,CC,
19640,GO:1990923,0.999999999995296,0.801002483579708,0,2,PET complex,CC,
9631,GO:0036518,0.999999999995299,0.769956392302006,0,2,chemorepulsion of dopaminergic neuron axon,BP,
14365,GO:0061643,0.999999999995299,0.769956392302006,0,2,chemorepulsion of axon,BP,
11100,GO:0045153,0.999999999995315,0.938780593790555,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
19980,GO:2000616,0.999999999995332,0.794177652841533,0,2,negative regulation of histone H3-K9 acetylation,BP,
19381,GO:1905937,0.999999999995344,0.94640020098915,0,1,negative regulation of germ cell proliferation,BP,
19782,GO:2000255,0.999999999995344,0.94640020098915,0,1,negative regulation of male germ cell proliferation,BP,
19035,GO:1904928,0.99999999999536,0.684766387983398,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
7004,GO:0030718,0.999999999995361,0.884152046461466,0,1,germ-line stem cell population maintenance,BP,
8799,GO:0034584,0.999999999995361,0.884152046461466,0,1,piRNA binding,MF,
6229,GO:0019785,0.999999999995395,0.80982414717062,0,2,ISG15-specific protease activity,MF,
2567,GO:0005854,0.999999999995398,0.815056793009343,0,2,nascent polypeptide-associated complex,CC,
1864,GO:0004530,0.999999999995403,0.716863706356339,0,2,deoxyribonuclease I activity,MF,
9256,GO:0035697,0.999999999995436,0.854348566565922,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9257,GO:0035698,0.999999999995436,0.854348566565922,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15882,GO:0072683,0.999999999995436,0.854348566565922,0,2,T cell extravasation,BP,
19888,GO:2000407,0.999999999995436,0.854348566565922,0,2,regulation of T cell extravasation,BP,
19906,GO:2000449,0.999999999995436,0.854348566565922,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19908,GO:2000452,0.999999999995436,0.854348566565922,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19439,GO:1990166,0.999999999995439,0.753888645692398,0,3,protein localization to site of double-strand break,BP,
2647,GO:0005988,0.999999999995456,0.777877163493455,0,2,lactose metabolic process,BP,
2648,GO:0005989,0.999999999995456,0.777877163493455,0,2,lactose biosynthetic process,BP,
11615,GO:0046351,0.999999999995456,0.777877163493455,0,2,disaccharide biosynthetic process,BP,
8036,GO:0032701,0.999999999995459,0.834675554832512,0,2,negative regulation of interleukin-18 production,BP,
1160,GO:0002775,0.999999999995462,0.765898892547734,0,3,antimicrobial peptide production,BP,
1161,GO:0002778,0.999999999995462,0.765898892547734,0,3,antibacterial peptide production,BP,
1162,GO:0002784,0.999999999995462,0.765898892547734,0,3,regulation of antimicrobial peptide production,BP,
1164,GO:0002786,0.999999999995462,0.765898892547734,0,3,regulation of antibacterial peptide production,BP,
3484,GO:0007352,0.999999999995469,0.792484937766524,0,1,zygotic specification of dorsal/ventral axis,BP,
17421,GO:1900224,0.999999999995469,0.792484937766524,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
19869,GO:2000382,0.999999999995469,0.792484937766524,0,1,positive regulation of mesoderm development,BP,
809,GO:0002083,0.999999999995477,0.928959872832163,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
11961,GO:0047293,0.999999999995477,0.928959872832163,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
7518,GO:0031749,0.999999999995477,0.798784865960378,0,2,D2 dopamine receptor binding,MF,
3831,GO:0008441,0.99999999999548,0.761118127088526,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
3933,GO:0008623,0.999999999995482,0.776390259969055,0,2,CHRAC,CC,
4948,GO:0015016,0.999999999995492,0.723105121749635,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
12418,GO:0050119,0.999999999995492,0.723105121749635,0,2,N-acetylglucosamine deacetylase activity,MF,
9917,GO:0042284,0.999999999995496,0.924915498512494,0,1,sphingolipid delta-4 desaturase activity,MF,
9048,GO:0035299,0.999999999995508,0.871801597383207,0,1,inositol pentakisphosphate 2-kinase activity,MF,
1649,GO:0004103,0.99999999999551,0.846264562635276,0,2,choline kinase activity,MF,
3992,GO:0008894,0.999999999995515,0.910063770800668,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3857,GO:0008481,0.999999999995519,0.837193411410891,0,2,sphinganine kinase activity,MF,
5794,GO:0017050,0.999999999995519,0.837193411410891,0,2,D-erythro-sphingosine kinase activity,MF,
10188,GO:0042823,0.999999999995525,0.741278812281499,0,2,pyridoxal phosphate biosynthetic process,BP,
2049,GO:0004799,0.999999999995556,0.930121101021912,0,1,thymidylate synthase activity,MF,
6024,GO:0019088,0.999999999995556,0.930121101021912,0,1,immortalization of host cell by virus,BP,
6323,GO:0020021,0.999999999995556,0.930121101021912,0,1,immortalization of host cell,BP,
9823,GO:0042083,0.999999999995556,0.930121101021912,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
83,GO:0000171,0.999999999995575,0.792635859138124,0,2,ribonuclease MRP activity,MF,
1798,GO:0004441,0.999999999995575,0.92088824409942,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13398,GO:0052829,0.999999999995575,0.92088824409942,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14953,GO:0070893,0.999999999995576,0.778127917023081,0,2,transposon integration,BP,
14954,GO:0070894,0.999999999995576,0.778127917023081,0,2,regulation of transposon integration,BP,
14955,GO:0070895,0.999999999995576,0.778127917023081,0,2,negative regulation of transposon integration,BP,
1239,GO:0002933,0.999999999995579,0.846265683587904,0,2,lipid hydroxylation,BP,
17083,GO:0101020,0.999999999995579,0.846265683587904,0,2,estrogen 16-alpha-hydroxylase activity,MF,
1668,GO:0004133,0.999999999995588,0.832092446749077,0,1,glycogen debranching enzyme activity,MF,
1669,GO:0004134,0.999999999995588,0.832092446749077,0,1,4-alpha-glucanotransferase activity,MF,
1670,GO:0004135,0.999999999995588,0.832092446749077,0,1,amylo-alpha-1,6-glucosidase activity,MF,
10266,GO:0043033,0.999999999995588,0.832092446749077,0,1,isoamylase complex,CC,
17126,GO:0102500,0.999999999995588,0.832092446749077,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
4625,GO:0010751,0.99999999999559,0.690378219114007,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
9039,GO:0035279,0.999999999995599,0.807245143901486,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16835,GO:0098795,0.999999999995599,0.807245143901486,0,2,mRNA cleavage involved in gene silencing,BP,
13837,GO:0060482,0.999999999995602,0.728602796101501,0,3,lobar bronchus development,BP,
14650,GO:0070292,0.999999999995605,0.858625585236466,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
17102,GO:0102200,0.999999999995605,0.858625585236466,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
981,GO:0002439,0.999999999995648,0.791696222983584,0,3,chronic inflammatory response to antigenic stimulus,BP,
9202,GO:0035606,0.999999999995652,0.895427509288237,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
17837,GO:1902093,0.999999999995661,0.798647126884417,0,3,positive regulation of flagellated sperm motility,BP,
4749,GO:0010931,0.999999999995695,0.818972331331869,0,1,macrophage tolerance induction,BP,
4750,GO:0010932,0.999999999995695,0.818972331331869,0,1,regulation of macrophage tolerance induction,BP,
4751,GO:0010933,0.999999999995695,0.818972331331869,0,1,positive regulation of macrophage tolerance induction,BP,
10205,GO:0042903,0.999999999995722,0.81023292134334,0,2,tubulin deacetylase activity,MF,
18849,GO:1904535,0.999999999995727,0.868698721324719,0,1,positive regulation of telomeric loop disassembly,BP,
2335,GO:0005366,0.999999999995729,0.834716024792452,0,1,myo-inositol:proton symporter activity,MF,
8459,GO:0033615,0.999999999995734,0.75117879124382,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
18102,GO:1902822,0.999999999995758,0.781329653250201,0,3,regulation of late endosome to lysosome transport,BP,
19515,GO:1990450,0.999999999995777,0.920912526813829,0,1,linear polyubiquitin binding,MF,
1248,GO:0002950,0.999999999995784,0.69844736720205,0,3,ceramide phosphoethanolamine synthase activity,MF,
8327,GO:0033188,0.999999999995784,0.69844736720205,0,3,sphingomyelin synthase activity,MF,
11983,GO:0047493,0.999999999995784,0.69844736720205,0,3,ceramide cholinephosphotransferase activity,MF,
5946,GO:0018312,0.999999999995788,0.813753866598292,0,2,peptidyl-serine ADP-ribosylation,BP,
19491,GO:1990404,0.999999999995788,0.813753866598292,0,2,protein ADP-ribosylase activity,MF,
789,GO:0002054,0.999999999995791,0.791787565623174,0,3,nucleobase binding,MF,
791,GO:0002060,0.999999999995791,0.791787565623174,0,3,purine nucleobase binding,MF,
5450,GO:0016332,0.999999999995798,0.882334304732368,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
15557,GO:0072060,0.999999999995798,0.882334304732368,0,1,outer medullary collecting duct development,BP,
15932,GO:0075732,0.999999999995802,0.741399500485267,0,2,viral penetration into host nucleus,BP,
18025,GO:1902594,0.999999999995802,0.741399500485267,0,2,multi-organism nuclear import,BP,
15785,GO:0072513,0.999999999995807,0.949702772870681,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
19652,GO:1990967,0.999999999995808,0.840396168180919,0,2,multi-organism toxin transport,BP,
14790,GO:0070552,0.999999999995818,0.755649633455155,0,3,BRISC complex,CC,
144,GO:0000296,0.999999999995823,0.917715681102263,0,1,spermine transport,BP,
4376,GO:0010025,0.999999999995835,0.789674654301967,0,2,wax biosynthetic process,BP,
4407,GO:0010166,0.999999999995835,0.789674654301967,0,2,wax metabolic process,BP,
15936,GO:0080019,0.999999999995835,0.789674654301967,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17146,GO:0102965,0.999999999995835,0.789674654301967,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
1942,GO:0004647,0.99999999999584,0.848971965661568,0,2,phosphoserine phosphatase activity,MF,
15909,GO:0072740,0.999999999995848,0.924192358811148,0,1,cellular response to anisomycin,BP,
17435,GO:1900259,0.999999999995848,0.924192358811148,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17436,GO:1900260,0.999999999995848,0.924192358811148,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
11787,GO:0046696,0.999999999995849,0.827622597174983,0,2,lipopolysaccharide receptor complex,CC,
10799,GO:0044308,0.999999999995858,0.712282899334861,0,2,axonal spine,CC,
5000,GO:0015152,0.99999999999589,0.920637803990088,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7618,GO:0032028,0.99999999999589,0.920637803990088,0,1,myosin head/neck binding,MF,
19644,GO:1990930,0.999999999995893,0.930353629779738,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
16351,GO:0090725,0.999999999995894,0.836208145997425,0,2,peripheral region of growth cone,CC,
10692,GO:0044028,0.999999999995942,0.783522784783116,0,2,DNA hypomethylation,BP,
10693,GO:0044029,0.999999999995942,0.783522784783116,0,2,hypomethylation of CpG island,BP,
14581,GO:0070170,0.999999999995952,0.756475468412097,0,2,regulation of tooth mineralization,BP,
8948,GO:0035034,0.999999999995959,0.829262267051823,0,2,histone acetyltransferase regulator activity,MF,
14567,GO:0070143,0.999999999995965,0.864955698810743,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
2228,GO:0005134,0.999999999995968,0.760979570268513,0,3,interleukin-2 receptor binding,MF,
975,GO:0002430,0.999999999995972,0.917723656376459,0,1,complement receptor mediated signaling pathway,BP,
1925,GO:0004621,0.999999999995972,0.917723656376459,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2966,GO:0006507,0.999999999995972,0.917723656376459,0,1,GPI anchor release,BP,
4728,GO:0010897,0.999999999995972,0.917723656376459,0,1,negative regulation of triglyceride catabolic process,BP,
8547,GO:0034014,0.999999999995972,0.917723656376459,0,1,response to triglyceride,BP,
15213,GO:0071401,0.999999999995972,0.917723656376459,0,1,cellular response to triglyceride,BP,
5403,GO:0016250,0.999999999995974,0.909444832670577,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5694,GO:0016826,0.999999999995974,0.909444832670577,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
13565,GO:0060061,0.999999999995974,0.783393564526708,0,2,Spemann organizer formation,BP,
16431,GO:0097129,0.999999999995978,0.735660423945685,0,3,cyclin D2-CDK4 complex,CC,
2225,GO:0005130,0.99999999999599,0.931581337742378,0,1,granulocyte colony-stimulating factor receptor binding,MF,
18945,GO:1904751,0.999999999995993,0.793670536462501,0,3,positive regulation of protein localization to nucleolus,BP,
14641,GO:0070274,0.999999999995996,0.858930610439714,0,2,RES complex,CC,
3021,GO:0006569,0.999999999995997,0.793112157015848,0,3,tryptophan catabolic process,BP,
6145,GO:0019441,0.999999999995997,0.793112157015848,0,3,tryptophan catabolic process to kynurenine,BP,
9991,GO:0042436,0.999999999995997,0.793112157015848,0,3,indole-containing compound catabolic process,BP,
11582,GO:0046218,0.999999999995997,0.793112157015848,0,3,indolalkylamine catabolic process,BP,
16491,GO:0097231,0.999999999996005,0.927465207328299,0,1,cell motility in response to calcium ion,BP,
19571,GO:1990716,0.999999999996005,0.927465207328299,0,1,axonemal central apparatus,CC,
3741,GO:0008282,0.999999999996015,0.782294103672909,0,2,inward rectifying potassium channel,CC,
12417,GO:0050115,0.999999999996015,0.863558050676356,0,1,myosin-light-chain-phosphatase activity,MF,
4996,GO:0015143,0.999999999996021,0.924649064556599,0,1,urate transmembrane transporter activity,MF,
5179,GO:0015747,0.999999999996021,0.924649064556599,0,1,urate transport,BP,
17727,GO:1901702,0.999999999996021,0.924649064556599,0,1,salt transmembrane transporter activity,MF,
10093,GO:0042631,0.999999999996031,0.890516173410091,0,1,cellular response to water deprivation,BP,
5109,GO:0015433,0.999999999996033,0.784934326209866,0,2,peptide antigen-transporting ATPase activity,MF,
16437,GO:0097149,0.999999999996044,0.706248261377037,0,3,centralspindlin complex,CC,
9859,GO:0042138,0.999999999996045,0.916996082122814,0,1,meiotic DNA double-strand break formation,BP,
4276,GO:0009646,0.999999999996049,0.897609005281419,0,1,response to absence of light,BP,
6945,GO:0030586,0.999999999996049,0.897609005281419,0,1,[methionine synthase] reductase activity,MF,
7336,GO:0031380,0.999999999996049,0.897609005281419,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12462,GO:0050444,0.999999999996049,0.897609005281419,0,1,aquacobalamin reductase (NADPH) activity,MF,
15270,GO:0071485,0.999999999996049,0.897609005281419,0,1,cellular response to absence of light,BP,
18662,GO:1904041,0.999999999996049,0.897609005281419,0,1,regulation of cystathionine beta-synthase activity,BP,
18663,GO:1904042,0.999999999996049,0.897609005281419,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19549,GO:1990603,0.999999999996049,0.897609005281419,0,1,dark adaptation,BP,
4696,GO:0010859,0.999999999996056,0.872392810173208,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
18458,GO:1903593,0.999999999996056,0.793544610434197,0,3,regulation of histamine secretion by mast cell,BP,
18459,GO:1903595,0.999999999996056,0.793544610434197,0,3,positive regulation of histamine secretion by mast cell,BP,
19432,GO:1990134,0.999999999996066,0.861185460067619,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
1527,GO:0003908,0.999999999996074,0.937440134920801,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
2065,GO:0004820,0.999999999996101,0.84587911774257,0,2,glycine-tRNA ligase activity,MF,
2913,GO:0006426,0.999999999996101,0.84587911774257,0,2,glycyl-tRNA aminoacylation,BP,
14569,GO:0070150,0.999999999996101,0.84587911774257,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
952,GO:0002373,0.999999999996105,0.945960289756742,0,1,plasmacytoid dendritic cell cytokine production,BP,
1140,GO:0002736,0.999999999996105,0.945960289756742,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1141,GO:0002737,0.999999999996105,0.945960289756742,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17569,GO:1901253,0.999999999996105,0.945960289756742,0,1,negative regulation of intracellular transport of viral material,BP,
5817,GO:0017095,0.999999999996106,0.766853639837232,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
108,GO:0000225,0.99999999999611,0.940251197446582,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
1879,GO:0004560,0.999999999996127,0.847569518837893,0,2,alpha-L-fucosidase activity,MF,
5272,GO:0015928,0.999999999996127,0.847569518837893,0,2,fucosidase activity,MF,
6786,GO:0030237,0.999999999996135,0.800003850558462,0,2,female sex determination,BP,
4794,GO:0010991,0.999999999996149,0.713875526132157,0,2,negative regulation of SMAD protein complex assembly,BP,
14417,GO:0061763,0.999999999996149,0.827188839497628,0,2,multivesicular body-lysosome fusion,BP,
18258,GO:1903179,0.999999999996168,0.84917469039244,0,2,regulation of dopamine biosynthetic process,BP,
18259,GO:1903181,0.999999999996168,0.84917469039244,0,2,positive regulation of dopamine biosynthetic process,BP,
11611,GO:0046340,0.999999999996175,0.805375664221071,0,2,diacylglycerol catabolic process,BP,
1678,GO:0004145,0.999999999996185,0.889610165409069,0,2,diamine N-acetyltransferase activity,MF,
6237,GO:0019809,0.999999999996185,0.889610165409069,0,2,spermidine binding,MF,
8168,GO:0032917,0.999999999996185,0.889610165409069,0,2,polyamine acetylation,BP,
8169,GO:0032918,0.999999999996185,0.889610165409069,0,2,spermidine acetylation,BP,
10687,GO:0043998,0.999999999996206,0.896519079460273,0,1,H2A histone acetyltransferase activity,MF,
16419,GO:0097111,0.999999999996209,0.704242419989407,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16168,GO:0090226,0.999999999996217,0.9490230347291,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17078,GO:0100057,0.999999999996218,0.826810124554913,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18981,GO:1904826,0.999999999996218,0.826810124554913,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
18982,GO:1904828,0.999999999996218,0.826810124554913,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
15603,GO:0072131,0.999999999996234,0.654943383306059,0,3,kidney mesenchyme morphogenesis,BP,
15605,GO:0072133,0.999999999996234,0.654943383306059,0,3,metanephric mesenchyme morphogenesis,BP,
1905,GO:0004595,0.999999999996265,0.917588026972031,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
18094,GO:1902805,0.999999999996285,0.73237832530477,0,2,positive regulation of synaptic vesicle transport,BP,
19810,GO:2000302,0.999999999996285,0.73237832530477,0,2,positive regulation of synaptic vesicle exocytosis,BP,
2417,GO:0005594,0.999999999996293,0.829684854932344,0,2,collagen type IX trimer,CC,
1374,GO:0003270,0.999999999996294,0.805823960449161,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
14036,GO:0060843,0.999999999996294,0.805823960449161,0,1,venous endothelial cell differentiation,BP,
18342,GO:1903365,0.999999999996337,0.711897250349182,0,3,regulation of fear response,BP,
20107,GO:2000822,0.999999999996337,0.711897250349182,0,3,regulation of behavioral fear response,BP,
5465,GO:0016404,0.999999999996342,0.870595632634838,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
16617,GO:0097512,0.999999999996348,0.95301252420458,0,1,cardiac myofibril,CC,
8857,GO:0034678,0.999999999996363,0.769335519366326,0,2,integrin alpha8-beta1 complex,CC,
12558,GO:0050757,0.999999999996363,0.911872425939102,0,1,thymidylate synthase biosynthetic process,BP,
12559,GO:0050758,0.999999999996363,0.911872425939102,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12560,GO:0050760,0.999999999996363,0.911872425939102,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
8397,GO:0033385,0.999999999996377,0.908611266232212,0,1,geranylgeranyl diphosphate metabolic process,BP,
8398,GO:0033386,0.999999999996377,0.908611266232212,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
12122,GO:0048250,0.99999999999638,0.860739826316273,0,2,iron import into the mitochondrion,BP,
14428,GO:0061792,0.999999999996392,0.846786657296695,0,1,secretory granule maturation,BP,
19524,GO:1990502,0.999999999996392,0.846786657296695,0,1,dense core granule maturation,BP,
9219,GO:0035625,0.999999999996398,0.890804693529462,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
15330,GO:0071596,0.999999999996432,0.58137616022993,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
19722,GO:2000124,0.999999999996451,0.798700083740046,0,2,regulation of endocannabinoid signaling pathway,BP,
2145,GO:0004962,0.999999999996457,0.88440475637583,0,1,endothelin receptor activity,MF,
16027,GO:0086100,0.999999999996457,0.88440475637583,0,1,endothelin receptor signaling pathway,BP,
11307,GO:0045654,0.999999999996459,0.851642333324772,0,2,positive regulation of megakaryocyte differentiation,BP,
15353,GO:0071630,0.999999999996466,0.645811022295607,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
17523,GO:1901090,0.99999999999649,0.83155352864985,0,2,regulation of protein tetramerization,BP,
17524,GO:1901091,0.99999999999649,0.83155352864985,0,2,negative regulation of protein tetramerization,BP,
17525,GO:1901093,0.99999999999649,0.83155352864985,0,2,regulation of protein homotetramerization,BP,
17526,GO:1901094,0.99999999999649,0.83155352864985,0,2,negative regulation of protein homotetramerization,BP,
13605,GO:0060129,0.999999999996499,0.795260833898249,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
4243,GO:0009447,0.9999999999965,0.825407186304915,0,3,putrescine catabolic process,BP,
6629,GO:0023021,0.999999999996504,0.763555578032441,0,3,termination of signal transduction,BP,
1556,GO:0003957,0.999999999996516,0.866988729962262,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
3959,GO:0008746,0.999999999996516,0.866988729962262,0,1,NAD(P)+ transhydrogenase activity,MF,
3961,GO:0008750,0.999999999996516,0.866988729962262,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
5603,GO:0016652,0.999999999996516,0.866988729962262,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
48,GO:0000101,0.999999999996528,0.695218292187114,0,3,sulfur amino acid transport,BP,
15271,GO:0071486,0.999999999996539,0.857793950561897,0,1,cellular response to high light intensity,BP,
16593,GO:0097473,0.999999999996539,0.857793950561897,0,1,retinal rod cell apoptotic process,BP,
19399,GO:1990009,0.999999999996539,0.857793950561897,0,1,retinal cell apoptotic process,BP,
7259,GO:0031249,0.99999999999654,0.915571718627155,0,1,denatured protein binding,MF,
17951,GO:1902380,0.99999999999654,0.915571718627155,0,1,positive regulation of endoribonuclease activity,BP,
18931,GO:1904722,0.99999999999654,0.915571718627155,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
8544,GO:0033989,0.999999999996559,0.910930794425052,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9460,GO:0036111,0.999999999996559,0.910930794425052,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10915,GO:0044594,0.999999999996559,0.910930794425052,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
3778,GO:0008343,0.999999999996568,0.8220175462308,0,1,adult feeding behavior,BP,
19223,GO:1905407,0.999999999996576,0.897781676857071,0,1,regulation of creatine transmembrane transporter activity,BP,
19224,GO:1905408,0.999999999996576,0.897781676857071,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19889,GO:2000409,0.999999999996582,0.924969054894058,0,1,positive regulation of T cell extravasation,BP,
19907,GO:2000451,0.999999999996582,0.924969054894058,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19909,GO:2000454,0.999999999996582,0.924969054894058,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
3988,GO:0008889,0.999999999996592,0.697299488168217,0,3,glycerophosphodiester phosphodiesterase activity,MF,
11146,GO:0045226,0.999999999996593,0.818154487951099,0,2,extracellular polysaccharide biosynthetic process,BP,
11625,GO:0046379,0.999999999996593,0.818154487951099,0,2,extracellular polysaccharide metabolic process,BP,
5460,GO:0016362,0.999999999996627,0.605016889204874,0,2,activin receptor activity, type II,MF,
2471,GO:0005690,0.999999999996629,0.833716833882555,0,2,U4atac snRNP,CC,
15023,GO:0071005,0.999999999996629,0.833716833882555,0,2,U2-type precatalytic spliceosome,CC,
4446,GO:0010387,0.999999999996641,0.917683776477248,0,1,COP9 signalosome assembly,BP,
6156,GO:0019510,0.999999999996641,0.917683776477248,0,1,S-adenosylhomocysteine catabolic process,BP,
15127,GO:0071268,0.999999999996641,0.917683776477248,0,1,homocysteine biosynthetic process,BP,
10738,GO:0044205,0.999999999996653,0.699437162051103,0,3,'de novo' UMP biosynthetic process,BP,
2484,GO:0005731,0.999999999996655,0.927426320520891,0,1,nucleolus organizer region,CC,
3345,GO:0007072,0.999999999996655,0.927426320520891,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7071,GO:0030874,0.999999999996655,0.927426320520891,0,1,nucleolar chromatin,CC,
16548,GO:0097372,0.999999999996655,0.927426320520891,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
7380,GO:0031443,0.999999999996657,0.836286135215389,0,1,fast-twitch skeletal muscle fiber contraction,BP,
15073,GO:0071144,0.999999999996658,0.672884341904545,0,2,heteromeric SMAD protein complex,CC,
11861,GO:0046899,0.999999999996667,0.82696077141496,0,2,nucleoside triphosphate adenylate kinase activity,MF,
15054,GO:0071062,0.999999999996683,0.874454066540913,0,1,alphav-beta3 integrin-vitronectin complex,CC,
12468,GO:0050508,0.999999999996686,0.794456552491254,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12469,GO:0050509,0.999999999996686,0.794456552491254,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
5957,GO:0018352,0.99999999999669,0.849451604178052,0,2,protein-pyridoxal-5-phosphate linkage,BP,
4486,GO:0010513,0.999999999996691,0.858440922709461,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
1760,GO:0004365,0.999999999996707,0.936248646807551,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6245,GO:0019828,0.999999999996707,0.936248646807551,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9201,GO:0035605,0.999999999996707,0.936248646807551,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10647,GO:0043891,0.999999999996707,0.936248646807551,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
18520,GO:1903756,0.999999999996723,0.795709898101476,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18521,GO:1903758,0.999999999996723,0.795709898101476,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
1746,GO:0004348,0.999999999996738,0.814557322264222,0,2,glucosylceramidase activity,MF,
2697,GO:0006065,0.99999999999674,0.696942050799178,0,3,UDP-glucuronate biosynthetic process,BP,
11634,GO:0046398,0.99999999999674,0.696942050799178,0,3,UDP-glucuronate metabolic process,BP,
3288,GO:0006982,0.999999999996742,0.877130588136441,0,2,response to lipid hydroperoxide,BP,
18026,GO:1902595,0.999999999996748,0.850800160587185,0,2,regulation of DNA replication origin binding,BP,
15021,GO:0071001,0.999999999996749,0.753806316176396,0,3,U4/U6 snRNP,CC,
8764,GO:0034458,0.99999999999675,0.793710601659225,0,2,3'-5' RNA helicase activity,MF,
12269,GO:0048627,0.999999999996751,0.839789079927663,0,2,myoblast development,BP,
11335,GO:0045716,0.999999999996754,0.743421899588808,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
409,GO:0001096,0.999999999996762,0.88803129837485,0,1,TFIIF-class transcription factor binding,MF,
3017,GO:0006565,0.999999999996782,0.780016706578031,0,3,L-serine catabolic process,BP,
15092,GO:0071209,0.999999999996784,0.809557909638179,0,3,U7 snRNA binding,MF,
11494,GO:0046032,0.999999999996812,0.931200383487873,0,1,ADP catabolic process,BP,
9697,GO:0038129,0.999999999996819,0.83859113663052,0,2,ERBB3 signaling pathway,BP,
3872,GO:0008507,0.999999999996824,0.890303043838494,0,1,sodium:iodide symporter activity,MF,
11140,GO:0045218,0.999999999996824,0.702166474489862,0,3,zonula adherens maintenance,BP,
19844,GO:2000346,0.999999999996838,0.791694275157622,0,2,negative regulation of hepatocyte proliferation,BP,
17535,GO:1901143,0.999999999996843,0.766971141507668,0,2,insulin catabolic process,BP,
1439,GO:0003419,0.999999999996874,0.82734932721281,0,2,growth plate cartilage chondrocyte proliferation,BP,
1440,GO:0003420,0.999999999996874,0.82734932721281,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
6161,GO:0019520,0.999999999996875,0.837394288164119,0,2,aldonic acid metabolic process,BP,
6162,GO:0019521,0.999999999996875,0.837394288164119,0,2,D-gluconate metabolic process,BP,
10645,GO:0043874,0.999999999996877,0.922156007685469,0,1,acireductone synthase activity,MF,
8647,GO:0034224,0.999999999996877,0.918376747753213,0,1,cellular response to zinc ion starvation,BP,
7907,GO:0032493,0.999999999996913,0.704179501539526,0,3,response to bacterial lipoprotein,BP,
14680,GO:0070339,0.999999999996913,0.704179501539526,0,3,response to bacterial lipopeptide,BP,
15099,GO:0071220,0.999999999996913,0.704179501539526,0,3,cellular response to bacterial lipoprotein,BP,
15100,GO:0071221,0.999999999996913,0.704179501539526,0,3,cellular response to bacterial lipopeptide,BP,
2054,GO:0004807,0.999999999996919,0.932846376522976,0,1,triose-phosphate isomerase activity,MF,
13782,GO:0060400,0.999999999996931,0.86760626114451,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
157,GO:0000320,0.999999999996933,0.763942828614176,0,2,re-entry into mitotic cell cycle,BP,
3991,GO:0008893,0.999999999996934,0.943150144203916,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5675,GO:0016794,0.999999999996934,0.943150144203916,0,1,diphosphoric monoester hydrolase activity,MF,
4792,GO:0010989,0.999999999996935,0.733928239199792,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
11715,GO:0046570,0.999999999996935,0.937563059340787,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
16629,GO:0097534,0.999999999996949,0.752120908810047,0,2,lymphoid lineage cell migration,BP,
16630,GO:0097535,0.999999999996949,0.752120908810047,0,2,lymphoid lineage cell migration into thymus,BP,
18926,GO:1904716,0.999999999996958,0.916481349837517,0,1,positive regulation of chaperone-mediated autophagy,BP,
15738,GO:0072364,0.999999999996975,0.649178672231162,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15787,GO:0072518,0.999999999996978,0.84222300943633,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17299,GO:0150031,0.999999999996978,0.84222300943633,0,1,regulation of protein localization to lysosome,BP,
17300,GO:0150033,0.999999999996978,0.84222300943633,0,1,negative regulation of protein localization to lysosome,BP,
5991,GO:0019002,0.999999999996987,0.795933793128673,0,2,GMP binding,MF,
7201,GO:0031104,0.999999999996988,0.878247407192762,0,1,dendrite regeneration,BP,
12019,GO:0047801,0.999999999996991,0.920267645719752,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
7243,GO:0031213,0.999999999997001,0.759323090698968,0,2,RSF complex,CC,
592,GO:0001757,0.999999999997008,0.768922968313192,0,2,somite specification,BP,
19699,GO:2000077,0.99999999999702,0.766269687783942,0,2,negative regulation of type B pancreatic cell development,BP,
16618,GO:0097513,0.999999999997032,0.572449336870474,0,3,myosin II filament,CC,
8162,GO:0032911,0.99999999999704,0.688601928726227,0,3,negative regulation of transforming growth factor beta1 production,BP,
8265,GO:0033082,0.999999999997053,0.863046199874762,0,1,regulation of extrathymic T cell differentiation,BP,
19560,GO:1990654,0.999999999997053,0.863046199874762,0,1,sebum secreting cell proliferation,BP,
9735,GO:0039502,0.999999999997062,0.858640020496684,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9736,GO:0039503,0.999999999997062,0.858640020496684,0,1,suppression by virus of host innate immune response,BP,
9740,GO:0039514,0.999999999997062,0.858640020496684,0,1,suppression by virus of host JAK-STAT cascade,BP,
9756,GO:0039562,0.999999999997062,0.858640020496684,0,1,suppression by virus of host STAT activity,BP,
9757,GO:0039563,0.999999999997062,0.858640020496684,0,1,suppression by virus of host STAT1 activity,BP,
9758,GO:0039564,0.999999999997062,0.858640020496684,0,1,suppression by virus of host STAT2 activity,BP,
10856,GO:0044414,0.999999999997062,0.858640020496684,0,1,suppression of host defenses,BP,
13177,GO:0051833,0.999999999997062,0.858640020496684,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13269,GO:0052029,0.999999999997062,0.858640020496684,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13271,GO:0052037,0.999999999997062,0.858640020496684,0,1,negative regulation by symbiont of host defense response,BP,
13286,GO:0052167,0.999999999997062,0.858640020496684,0,1,modulation by symbiont of host innate immune response,BP,
13287,GO:0052170,0.999999999997062,0.858640020496684,0,1,negative regulation by symbiont of host innate immune response,BP,
13305,GO:0052261,0.999999999997062,0.858640020496684,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13306,GO:0052306,0.999999999997062,0.858640020496684,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13307,GO:0052309,0.999999999997062,0.858640020496684,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13328,GO:0052493,0.999999999997062,0.858640020496684,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13338,GO:0052561,0.999999999997062,0.858640020496684,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13339,GO:0052562,0.999999999997062,0.858640020496684,0,1,negative regulation by symbiont of host immune response,BP,
15918,GO:0075109,0.999999999997062,0.858640020496684,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15919,GO:0075111,0.999999999997062,0.858640020496684,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15920,GO:0075112,0.999999999997062,0.858640020496684,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15921,GO:0075114,0.999999999997062,0.858640020496684,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16928,GO:0098968,0.999999999997062,0.858640020496684,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
7749,GO:0032276,0.999999999997068,0.677276269773472,0,3,regulation of gonadotropin secretion,BP,
7751,GO:0032278,0.999999999997068,0.677276269773472,0,3,positive regulation of gonadotropin secretion,BP,
11849,GO:0046880,0.999999999997068,0.677276269773472,0,3,regulation of follicle-stimulating hormone secretion,BP,
11850,GO:0046881,0.999999999997068,0.677276269773472,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
19212,GO:1905384,0.999999999997072,0.840379071627843,0,2,regulation of protein localization to presynapse,BP,
19213,GO:1905386,0.999999999997072,0.840379071627843,0,2,positive regulation of protein localization to presynapse,BP,
20237,GO:2001226,0.999999999997103,0.817089431432531,0,2,negative regulation of chloride transport,BP,
10357,GO:0043199,0.999999999997104,0.692212744211134,0,3,sulfate binding,MF,
3008,GO:0006556,0.999999999997104,0.83662610495759,0,2,S-adenosylmethionine biosynthetic process,BP,
12137,GO:0048269,0.999999999997104,0.83662610495759,0,2,methionine adenosyltransferase complex,CC,
9793,GO:0042000,0.999999999997139,0.915694322928011,0,1,translocation of peptides or proteins into host,BP,
10700,GO:0044053,0.999999999997139,0.915694322928011,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13170,GO:0051808,0.999999999997139,0.915694322928011,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
18354,GO:1903385,0.999999999997145,0.765946771469068,0,2,regulation of homophilic cell adhesion,BP,
16411,GO:0097102,0.999999999997145,0.820424114884082,0,2,endothelial tip cell fate specification,BP,
8402,GO:0033477,0.999999999997148,0.922488349749516,0,1,S-methylmethionine metabolic process,BP,
11939,GO:0047150,0.999999999997148,0.922488349749516,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14356,GO:0061627,0.999999999997148,0.922488349749516,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
5298,GO:0016005,0.999999999997151,0.78712055312363,0,2,phospholipase A2 activator activity,MF,
5759,GO:0016938,0.999999999997157,0.905624904998473,0,1,kinesin I complex,CC,
961,GO:0002386,0.99999999999717,0.80759898161286,0,2,immune response in mucosal-associated lymphoid tissue,BP,
967,GO:0002415,0.99999999999717,0.80759898161286,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
18432,GO:1903547,0.999999999997179,0.884998361399714,0,2,regulation of growth hormone activity,BP,
19605,GO:1990796,0.999999999997195,0.905789518392168,0,1,photoreceptor cell terminal bouton,CC,
19397,GO:1990005,0.9999999999972,0.841214883365964,0,2,granular vesicle,CC,
19821,GO:2000317,0.9999999999972,0.723885717225906,0,3,negative regulation of T-helper 17 type immune response,BP,
19824,GO:2000320,0.9999999999972,0.723885717225906,0,3,negative regulation of T-helper 17 cell differentiation,BP,
2007,GO:0004735,0.999999999997201,0.857615283813007,0,2,pyrroline-5-carboxylate reductase activity,MF,
2019,GO:0004750,0.999999999997213,0.917572063253365,0,1,ribulose-phosphate 3-epimerase activity,MF,
16649,GO:0097621,0.999999999997213,0.917572063253365,0,1,monoamine oxidase activity,MF,
5760,GO:0016939,0.999999999997241,0.64636985418497,0,3,kinesin II complex,CC,
6868,GO:0030372,0.999999999997245,0.86492310128348,0,1,high molecular weight B cell growth factor receptor binding,MF,
17151,GO:0103053,0.99999999999725,0.863364205217399,0,2,1-ethyladenine demethylase activity,MF,
637,GO:0001827,0.999999999997274,0.739246512218492,0,2,inner cell mass cell fate commitment,BP,
638,GO:0001828,0.999999999997274,0.739246512218492,0,2,inner cell mass cellular morphogenesis,BP,
15320,GO:0071579,0.999999999997278,0.922139453396984,0,1,regulation of zinc ion transport,BP,
15321,GO:0071580,0.999999999997278,0.922139453396984,0,1,regulation of zinc ion transmembrane transport,BP,
15322,GO:0071581,0.999999999997278,0.922139453396984,0,1,regulation of zinc ion transmembrane import,BP,
15323,GO:0071582,0.999999999997278,0.922139453396984,0,1,negative regulation of zinc ion transport,BP,
15324,GO:0071583,0.999999999997278,0.922139453396984,0,1,negative regulation of zinc ion transmembrane transport,BP,
15325,GO:0071584,0.999999999997278,0.922139453396984,0,1,negative regulation of zinc ion transmembrane import,BP,
15326,GO:0071585,0.999999999997278,0.922139453396984,0,1,detoxification of cadmium ion,BP,
19443,GO:1990170,0.999999999997278,0.922139453396984,0,1,stress response to cadmium ion,BP,
14570,GO:0070159,0.999999999997281,0.916206541691208,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
13568,GO:0060066,0.999999999997286,0.829475079662803,0,2,oviduct development,BP,
5358,GO:0016150,0.999999999997288,0.929411537179191,0,1,translation release factor activity, codon nonspecific,MF,
3516,GO:0007468,0.999999999997293,0.921547149374123,0,1,regulation of rhodopsin gene expression,BP,
11416,GO:0045872,0.999999999997293,0.921547149374123,0,1,positive regulation of rhodopsin gene expression,BP,
8038,GO:0032707,0.999999999997296,0.916432928991643,0,1,negative regulation of interleukin-23 production,BP,
12012,GO:0047747,0.999999999997296,0.916432928991643,0,1,cholate-CoA ligase activity,MF,
1163,GO:0002785,0.999999999997317,0.888254938739436,0,1,negative regulation of antimicrobial peptide production,BP,
1165,GO:0002787,0.999999999997317,0.888254938739436,0,1,negative regulation of antibacterial peptide production,BP,
3781,GO:0008348,0.999999999997317,0.888254938739436,0,1,negative regulation of antimicrobial humoral response,BP,
5212,GO:0015819,0.999999999997323,0.924297195541638,0,1,lysine transport,BP,
17648,GO:1901536,0.999999999997344,0.817426160472502,0,2,negative regulation of DNA demethylation,BP,
9506,GO:0036228,0.999999999997353,0.800881814815115,0,2,protein localization to nuclear inner membrane,BP,
8533,GO:0033883,0.999999999997368,0.867978559482034,0,2,pyridoxal phosphatase activity,MF,
15883,GO:0072684,0.999999999997372,0.884525344012008,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
14433,GO:0061819,0.999999999997399,0.691834476441147,0,3,telomeric DNA-containing double minutes formation,BP,
19327,GO:1905764,0.999999999997399,0.691834476441147,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19328,GO:1905765,0.999999999997399,0.691834476441147,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19548,GO:1990599,0.999999999997399,0.691834476441147,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
2153,GO:0004977,0.999999999997419,0.834452985885506,0,2,melanocortin receptor activity,MF,
9341,GO:0035870,0.999999999997433,0.798028718508869,0,2,dITP diphosphatase activity,MF,
3816,GO:0008418,0.999999999997446,0.941257394216539,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
16257,GO:0090370,0.999999999997454,0.873559319211383,0,1,negative regulation of cholesterol efflux,BP,
18465,GO:1903613,0.999999999997462,0.856670593039939,0,1,regulation of protein tyrosine phosphatase activity,BP,
18466,GO:1903615,0.999999999997462,0.856670593039939,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
12476,GO:0050561,0.999999999997464,0.882146802857632,0,1,glutamate-tRNA(Gln) ligase activity,MF,
7931,GO:0032532,0.999999999997471,0.742628796174554,0,3,regulation of microvillus length,BP,
103,GO:0000215,0.999999999997474,0.856231483544698,0,2,tRNA 2'-phosphotransferase activity,MF,
7352,GO:0031405,0.999999999997479,0.788168821539525,0,1,lipoic acid binding,MF,
10637,GO:0043754,0.999999999997479,0.788168821539525,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
8431,GO:0033566,0.999999999997485,0.830416206814671,0,2,gamma-tubulin complex localization,BP,
8492,GO:0033684,0.999999999997485,0.73649618116006,0,2,regulation of luteinizing hormone secretion,BP,
8493,GO:0033686,0.999999999997485,0.73649618116006,0,2,positive regulation of luteinizing hormone secretion,BP,
18147,GO:1902939,0.999999999997515,0.906912273849934,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
9430,GO:0036034,0.999999999997516,0.835357147802436,0,2,mediator complex assembly,BP,
20207,GO:2001176,0.999999999997516,0.835357147802436,0,2,regulation of mediator complex assembly,BP,
20208,GO:2001178,0.999999999997516,0.835357147802436,0,2,positive regulation of mediator complex assembly,BP,
3638,GO:0008111,0.999999999997517,0.922814824601151,0,1,alpha-methylacyl-CoA racemase activity,MF,
7541,GO:0031862,0.999999999997519,0.748663621658274,0,2,prostanoid receptor binding,MF,
14724,GO:0070427,0.999999999997519,0.740050588704764,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14921,GO:0070842,0.999999999997537,0.680845289967027,0,3,aggresome assembly,BP,
15335,GO:0071603,0.999999999997538,0.769887450913474,0,2,endothelial cell-cell adhesion,BP,
16609,GO:0097500,0.999999999997546,0.699053510004005,0,3,receptor localization to non-motile cilium,BP,
9861,GO:0042144,0.999999999997546,0.789260676669754,0,2,vacuole fusion, non-autophagic,BP,
16642,GO:0097576,0.999999999997546,0.789260676669754,0,2,vacuole fusion,BP,
5108,GO:0015432,0.999999999997585,0.891419880395283,0,1,bile acid-exporting ATPase activity,MF,
8368,GO:0033283,0.999999999997585,0.891419880395283,0,1,organic acid-transporting ATPase activity,MF,
8369,GO:0033284,0.999999999997585,0.891419880395283,0,1,carboxylic acid-transporting ATPase activity,MF,
8370,GO:0033285,0.999999999997585,0.891419880395283,0,1,monocarboxylic acid-transporting ATPase activity,MF,
19329,GO:1905767,0.99999999999759,0.837809936449159,0,1,regulation of double-stranded telomeric DNA binding,BP,
19330,GO:1905768,0.99999999999759,0.837809936449159,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
1916,GO:0004611,0.9999999999976,0.922932646674085,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1917,GO:0004613,0.9999999999976,0.922932646674085,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
6171,GO:0019543,0.9999999999976,0.922932646674085,0,1,propionate catabolic process,BP,
11601,GO:0046327,0.9999999999976,0.922932646674085,0,1,glycerol biosynthetic process from pyruvate,BP,
18963,GO:1904784,0.999999999997604,0.854724383916742,0,1,NLRP1 inflammasome complex assembly,BP,
20019,GO:2000666,0.999999999997604,0.820350256720517,0,2,negative regulation of interleukin-13 secretion,BP,
15293,GO:0071540,0.999999999997605,0.857085345987891,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16430,GO:0097125,0.999999999997626,0.853545115026779,0,2,cyclin B1-CDK1 complex,CC,
9328,GO:0035853,0.999999999997642,0.870383949870425,0,1,chromosome passenger complex localization to spindle midzone,BP,
608,GO:0001777,0.999999999997661,0.949532467629379,0,1,T cell homeostatic proliferation,BP,
943,GO:0002358,0.999999999997661,0.949532467629379,0,1,B cell homeostatic proliferation,BP,
8204,GO:0032976,0.999999999997661,0.949532467629379,0,1,release of matrix enzymes from mitochondria,BP,
16435,GO:0097144,0.999999999997661,0.949532467629379,0,1,BAX complex,CC,
19426,GO:1990117,0.999999999997661,0.949532467629379,0,1,B cell receptor apoptotic signaling pathway,BP,
6589,GO:0022614,0.999999999997664,0.666068677362134,0,3,membrane to membrane docking,BP,
8167,GO:0032916,0.999999999997671,0.679772716836086,0,2,positive regulation of transforming growth factor beta3 production,BP,
15516,GO:0071955,0.999999999997673,0.721305363473667,0,2,recycling endosome to Golgi transport,BP,
2231,GO:0005137,0.999999999997675,0.919675108895764,0,1,interleukin-5 receptor binding,MF,
2595,GO:0005895,0.999999999997675,0.919675108895764,0,1,interleukin-5 receptor complex,CC,
3924,GO:0008609,0.999999999997676,0.826107728642727,0,1,alkylglycerone-phosphate synthase activity,MF,
1347,GO:0003213,0.99999999999768,0.684980408968161,0,2,cardiac right atrium morphogenesis,BP,
11588,GO:0046294,0.99999999999769,0.856294874067458,0,2,formaldehyde catabolic process,BP,
16947,GO:0099011,0.999999999997709,0.743262861919295,0,2,neuronal dense core vesicle exocytosis,BP,
17017,GO:0099525,0.999999999997709,0.743262861919295,0,2,presynaptic dense core vesicle exocytosis,BP,
491,GO:0001544,0.999999999997724,0.830607645705645,0,1,initiation of primordial ovarian follicle growth,BP,
1315,GO:0003164,0.999999999997725,0.737888156375487,0,2,His-Purkinje system development,BP,
16272,GO:0090409,0.99999999999773,0.917731631304358,0,1,malonyl-CoA synthetase activity,MF,
16273,GO:0090410,0.99999999999773,0.917731631304358,0,1,malonate catabolic process,BP,
11959,GO:0047290,0.999999999997756,0.928837720748445,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
13381,GO:0052794,0.999999999997763,0.838240752989102,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13382,GO:0052795,0.999999999997763,0.838240752989102,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13383,GO:0052796,0.999999999997763,0.838240752989102,0,2,exo-alpha-(2->8)-sialidase activity,MF,
20170,GO:2001045,0.999999999997769,0.748449397076366,0,2,negative regulation of integrin-mediated signaling pathway,BP,
7500,GO:0031694,0.999999999997777,0.94092047688541,0,1,alpha-2A adrenergic receptor binding,MF,
17090,GO:0102009,0.99999999999778,0.924174917668919,0,1,proline dipeptidase activity,MF,
5508,GO:0016476,0.999999999997785,0.706052936691442,0,3,regulation of embryonic cell shape,BP,
1950,GO:0004656,0.999999999997789,0.7610375158939,0,3,procollagen-proline 4-dioxygenase activity,MF,
63,GO:0000126,0.999999999997794,0.697941233856564,0,2,transcription factor TFIIIB complex,CC,
384,GO:0001026,0.999999999997794,0.697941233856564,0,2,TFIIIB-type transcription factor activity,MF,
5841,GO:0017143,0.999999999997801,0.831488126484357,0,2,insecticide metabolic process,BP,
5980,GO:0018894,0.999999999997801,0.831488126484357,0,2,dibenzo-p-dioxin metabolic process,BP,
2163,GO:0004999,0.999999999997802,0.908871942779626,0,1,vasoactive intestinal polypeptide receptor activity,MF,
18939,GO:1904744,0.999999999997833,0.868797592252568,0,2,positive regulation of telomeric DNA binding,BP,
14054,GO:0060903,0.999999999997835,0.806361538849182,0,2,positive regulation of meiosis I,BP,
19040,GO:1904947,0.99999999999784,0.904001578774238,0,1,folic acid import into mitochondrion,BP,
2336,GO:0005367,0.999999999997841,0.779583614922192,0,1,myo-inositol:sodium symporter activity,MF,
11972,GO:0047389,0.99999999999785,0.769673812053457,0,2,glycerophosphocholine phosphodiesterase activity,MF,
15223,GO:0071421,0.999999999997859,0.7739403310659,0,2,manganese ion transmembrane transport,BP,
15059,GO:0071074,0.99999999999788,0.923879769029173,0,1,eukaryotic initiation factor eIF2 binding,MF,
18486,GO:1903674,0.99999999999788,0.923879769029173,0,1,regulation of cap-dependent translational initiation,BP,
18487,GO:1903676,0.99999999999788,0.923879769029173,0,1,positive regulation of cap-dependent translational initiation,BP,
383,GO:0001025,0.999999999997887,0.535185160007405,0,3,RNA polymerase III transcription factor binding,MF,
429,GO:0001156,0.999999999997887,0.535185160007405,0,3,TFIIIC-class transcription factor binding,MF,
3853,GO:0008475,0.99999999999789,0.719362927149543,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11888,GO:0046946,0.99999999999789,0.719362927149543,0,3,hydroxylysine metabolic process,BP,
11889,GO:0046947,0.99999999999789,0.719362927149543,0,3,hydroxylysine biosynthetic process,BP,
6782,GO:0030229,0.999999999997896,0.668057704489884,0,3,very-low-density lipoprotein particle receptor activity,MF,
8520,GO:0033858,0.999999999997898,0.900617805568347,0,1,N-acetylgalactosamine kinase activity,MF,
15016,GO:0070991,0.999999999997898,0.741740444940074,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
4879,GO:0014802,0.999999999997905,0.863661350855944,0,2,terminal cisterna,CC,
12541,GO:0050717,0.999999999997907,0.790325433560913,0,3,positive regulation of interleukin-1 alpha secretion,BP,
3641,GO:0008117,0.999999999997908,0.850862071860351,0,1,sphinganine-1-phosphate aldolase activity,MF,
10793,GO:0044301,0.999999999997913,0.87037476871655,0,1,climbing fiber,CC,
19404,GO:1990032,0.999999999997913,0.87037476871655,0,1,parallel fiber,CC,
6101,GO:0019343,0.999999999997919,0.845843598186195,0,2,cysteine biosynthetic process via cystathionine,BP,
4001,GO:0008962,0.999999999997925,0.841932565027697,0,2,phosphatidylglycerophosphatase activity,MF,
1499,GO:0003846,0.999999999997937,0.811653230004366,0,2,2-acylglycerol O-acyltransferase activity,MF,
1677,GO:0004144,0.999999999997937,0.811653230004366,0,2,diacylglycerol O-acyltransferase activity,MF,
12432,GO:0050252,0.999999999997937,0.811653230004366,0,2,retinol O-fatty-acyltransferase activity,MF,
12510,GO:0050682,0.999999999997938,0.726809241059538,0,2,AF-2 domain binding,MF,
5028,GO:0015204,0.999999999997945,0.733450106537289,0,3,urea transmembrane transporter activity,MF,
5223,GO:0015840,0.999999999997945,0.733450106537289,0,3,urea transport,BP,
11910,GO:0046979,0.999999999997959,0.757072916595907,0,3,TAP2 binding,MF,
19061,GO:1904983,0.999999999997961,0.920331906997043,0,1,glycine import into mitochondrion,BP,
6019,GO:0019082,0.999999999997963,0.876130205251331,0,1,viral protein processing,BP,
16279,GO:0090472,0.999999999997963,0.876130205251331,0,1,dibasic protein processing,BP,
587,GO:0001743,0.999999999997964,0.748662815836449,0,2,optic placode formation,BP,
1728,GO:0004325,0.999999999997972,0.831272617284401,0,1,ferrochelatase activity,MF,
2030,GO:0004772,0.99999999999798,0.894872365311922,0,1,sterol O-acyltransferase activity,MF,
8892,GO:0034736,0.99999999999798,0.894872365311922,0,1,cholesterol O-acyltransferase activity,MF,
18440,GO:1903565,0.99999999999798,0.894872365311922,0,1,negative regulation of protein localization to cilium,BP,
18443,GO:1903568,0.99999999999798,0.894872365311922,0,1,negative regulation of protein localization to ciliary membrane,BP,
3806,GO:0008401,0.999999999997983,0.793182334274667,0,2,retinoic acid 4-hydroxylase activity,MF,
9399,GO:0035983,0.999999999997988,0.74347497065575,0,3,response to trichostatin A,BP,
9400,GO:0035984,0.999999999997988,0.74347497065575,0,3,cellular response to trichostatin A,BP,
13135,GO:0051747,0.99999999999799,0.879947013445428,0,2,cytosine C-5 DNA demethylase activity,MF,
6312,GO:0019964,0.999999999997993,0.893216728636078,0,1,interferon-gamma binding,MF,
19484,GO:1990390,0.999999999997993,0.893216728636078,0,1,protein K33-linked ubiquitination,BP,
11257,GO:0045588,0.999999999997995,0.740822820174958,0,2,positive regulation of gamma-delta T cell differentiation,BP,
8170,GO:0032919,0.999999999998022,0.945249650931013,0,1,spermine acetylation,BP,
8171,GO:0032920,0.999999999998022,0.945249650931013,0,1,putrescine acetylation,BP,
11578,GO:0046204,0.999999999998022,0.945249650931013,0,1,nor-spermidine metabolic process,BP,
12442,GO:0050313,0.999999999998022,0.945249650931013,0,1,sulfur dioxygenase activity,MF,
1616,GO:0004047,0.999999999998029,0.858405246313121,0,2,aminomethyltransferase activity,MF,
1425,GO:0003383,0.999999999998041,0.608372933062797,0,3,apical constriction,BP,
11650,GO:0046452,0.999999999998055,0.765449686549807,0,3,dihydrofolate metabolic process,BP,
19120,GO:1905150,0.999999999998056,0.739813008514291,0,2,regulation of voltage-gated sodium channel activity,BP,
1739,GO:0004340,0.99999999999806,0.654033892237961,0,3,glucokinase activity,MF,
1780,GO:0004396,0.99999999999806,0.654033892237961,0,3,hexokinase activity,MF,
3986,GO:0008865,0.99999999999806,0.654033892237961,0,3,fructokinase activity,MF,
6040,GO:0019158,0.99999999999806,0.654033892237961,0,3,mannokinase activity,MF,
16471,GO:0097198,0.999999999998077,0.738417475287667,0,2,histone H3-K36 trimethylation,BP,
17014,GO:0099522,0.999999999998079,0.921825991698533,0,1,region of cytosol,CC,
17015,GO:0099523,0.999999999998079,0.921825991698533,0,1,presynaptic cytosol,CC,
17016,GO:0099524,0.999999999998079,0.921825991698533,0,1,postsynaptic cytosol,CC,
18952,GO:1904764,0.999999999998079,0.921825991698533,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19614,GO:1990832,0.999999999998079,0.921825991698533,0,1,slow axonal transport,BP,
19615,GO:1990833,0.999999999998079,0.921825991698533,0,1,clathrin-uncoating ATPase activity,MF,
2319,GO:0005329,0.999999999998107,0.741426157001729,0,2,dopamine transmembrane transporter activity,MF,
17471,GO:1900477,0.999999999998121,0.921107104964715,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
3994,GO:0008900,0.999999999998133,0.890378253020978,0,1,potassium:proton exchanging ATPase activity,MF,
3847,GO:0008465,0.999999999998142,0.938082015307834,0,1,glycerate dehydrogenase activity,MF,
3985,GO:0008859,0.999999999998152,0.945495044826242,0,1,exoribonuclease II activity,MF,
3836,GO:0008448,0.999999999998163,0.925229214321928,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
8145,GO:0032887,0.99999999999817,0.832169385246179,0,1,regulation of spindle elongation,BP,
8146,GO:0032888,0.99999999999817,0.832169385246179,0,1,regulation of mitotic spindle elongation,BP,
13461,GO:0055028,0.99999999999817,0.832169385246179,0,1,cortical microtubule,CC,
13465,GO:0055048,0.99999999999817,0.832169385246179,0,1,anastral spindle assembly,BP,
15524,GO:0071988,0.99999999999817,0.832169385246179,0,1,protein localization to spindle pole body,BP,
17205,GO:0110028,0.99999999999817,0.832169385246179,0,1,positive regulation of mitotic spindle organization,BP,
17943,GO:1902363,0.99999999999817,0.832169385246179,0,1,regulation of protein localization to spindle pole body,BP,
17944,GO:1902365,0.99999999999817,0.832169385246179,0,1,positive regulation of protein localization to spindle pole body,BP,
18106,GO:1902846,0.99999999999817,0.832169385246179,0,1,positive regulation of mitotic spindle elongation,BP,
19326,GO:1905720,0.99999999999817,0.832169385246179,0,1,cytoplasmic microtubule bundle,CC,
12110,GO:0048211,0.999999999998171,0.803445800379366,0,2,Golgi vesicle docking,BP,
15201,GO:0071386,0.999999999998173,0.694769392189494,0,2,cellular response to corticosterone stimulus,BP,
16110,GO:0090149,0.999999999998187,0.797194847452403,0,2,mitochondrial membrane fission,BP,
8915,GO:0034777,0.999999999998195,0.918583627311879,0,1,recycling endosome lumen,CC,
2017,GO:0004748,0.999999999998233,0.695806815064129,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2635,GO:0005971,0.999999999998233,0.695806815064129,0,3,ribonucleoside-diphosphate reductase complex,CC,
5637,GO:0016728,0.999999999998233,0.695806815064129,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
14397,GO:0061731,0.999999999998233,0.695806815064129,0,3,ribonucleoside-diphosphate reductase activity,MF,
1314,GO:0003163,0.999999999998238,0.74012228167703,0,2,sinoatrial node development,BP,
14064,GO:0060921,0.999999999998238,0.74012228167703,0,2,sinoatrial node cell differentiation,BP,
14069,GO:0060931,0.999999999998238,0.74012228167703,0,2,sinoatrial node cell development,BP,
10400,GO:0043262,0.999999999998245,0.749558626450598,0,3,adenosine-diphosphatase activity,MF,
18506,GO:1903722,0.999999999998256,0.847845348365701,0,2,regulation of centriole elongation,BP,
1716,GO:0004310,0.999999999998256,0.920621675401803,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7154,GO:0031038,0.999999999998256,0.920621675401803,0,1,myosin II filament organization,BP,
10541,GO:0043519,0.999999999998256,0.920621675401803,0,1,regulation of myosin II filament organization,BP,
13266,GO:0051996,0.999999999998256,0.920621675401803,0,1,squalene synthase activity,MF,
17203,GO:0110025,0.999999999998261,0.903267924599156,0,1,DNA strand resection involved in replication fork processing,BP,
17204,GO:0110026,0.999999999998261,0.903267924599156,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
13165,GO:0051799,0.999999999998265,0.665889790721981,0,3,negative regulation of hair follicle development,BP,
2852,GO:0006343,0.999999999998266,0.883936017193307,0,1,establishment of chromatin silencing,BP,
10074,GO:0042595,0.999999999998266,0.883936017193307,0,1,behavioral response to starvation,BP,
15237,GO:0071441,0.999999999998266,0.883936017193307,0,1,negative regulation of histone H3-K14 acetylation,BP,
20008,GO:2000654,0.999999999998266,0.883936017193307,0,1,regulation of cellular response to testosterone stimulus,BP,
20009,GO:2000655,0.999999999998266,0.883936017193307,0,1,negative regulation of cellular response to testosterone stimulus,BP,
18407,GO:1903516,0.999999999998269,0.734728880203384,0,3,regulation of single strand break repair,BP,
4985,GO:0015119,0.999999999998281,0.727768160180873,0,3,hexose phosphate transmembrane transporter activity,MF,
5074,GO:0015315,0.999999999998281,0.727768160180873,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5121,GO:0015526,0.999999999998281,0.727768160180873,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
14302,GO:0061513,0.999999999998281,0.727768160180873,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
1681,GO:0004149,0.999999999998285,0.907773271285778,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5649,GO:0016751,0.999999999998285,0.907773271285778,0,1,S-succinyltransferase activity,MF,
3644,GO:0008120,0.99999999999829,0.92912343001844,0,1,ceramide glucosyltransferase activity,MF,
17139,GO:0102769,0.99999999999829,0.92912343001844,0,1,dihydroceramide glucosyltransferase activity,MF,
18683,GO:1904116,0.999999999998293,0.689603494892849,0,3,response to vasopressin,BP,
18684,GO:1904117,0.999999999998293,0.689603494892849,0,3,cellular response to vasopressin,BP,
7703,GO:0032203,0.999999999998296,0.924835334013084,0,1,telomere formation via telomerase,BP,
2002,GO:0004728,0.999999999998298,0.912734102110444,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
4007,GO:0008995,0.999999999998298,0.912734102110444,0,1,ribonuclease E activity,MF,
16183,GO:0090247,0.999999999998298,0.912734102110444,0,1,cell motility involved in somitogenic axis elongation,BP,
16184,GO:0090249,0.999999999998298,0.912734102110444,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17564,GO:1901229,0.999999999998298,0.912734102110444,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17565,GO:1901231,0.999999999998298,0.912734102110444,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17566,GO:1901232,0.999999999998298,0.912734102110444,0,1,regulation of convergent extension involved in axis elongation,BP,
17567,GO:1901233,0.999999999998298,0.912734102110444,0,1,negative regulation of convergent extension involved in axis elongation,BP,
13861,GO:0060529,0.999999999998301,0.761877374639986,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
2334,GO:0005365,0.999999999998307,0.650708762665794,0,2,myo-inositol transmembrane transporter activity,MF,
5958,GO:0018364,0.999999999998318,0.898805093354553,0,2,peptidyl-glutamine methylation,BP,
18305,GO:1903292,0.999999999998323,0.806905654717676,0,2,protein localization to Golgi membrane,BP,
14931,GO:0070853,0.99999999999833,0.68613855164648,0,2,myosin VI binding,MF,
13933,GO:0060668,0.999999999998337,0.88945184505411,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
19449,GO:1990180,0.999999999998352,0.78722377177785,0,3,mitochondrial tRNA 3'-end processing,BP,
15018,GO:0070993,0.999999999998383,0.762851165391214,0,2,translation preinitiation complex,CC,
1497,GO:0003844,0.999999999998384,0.902032223553206,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17136,GO:0102752,0.999999999998384,0.902032223553206,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
16432,GO:0097134,0.999999999998404,0.849219214266302,0,2,cyclin E1-CDK2 complex,CC,
20104,GO:2000819,0.999999999998405,0.80699814632986,0,2,regulation of nucleotide-excision repair,BP,
2348,GO:0005415,0.999999999998407,0.840402391631855,0,2,nucleoside:sodium symporter activity,MF,
5234,GO:0015860,0.999999999998407,0.840402391631855,0,2,purine nucleoside transmembrane transport,BP,
13104,GO:0051686,0.999999999998408,0.772332680740157,0,1,establishment of ER localization,BP,
16972,GO:0099089,0.999999999998408,0.772332680740157,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
2239,GO:0005151,0.999999999998427,0.793487373244122,0,2,interleukin-1, Type II receptor binding,MF,
2494,GO:0005745,0.999999999998436,0.824358757953049,0,2,m-AAA complex,CC,
19547,GO:1990597,0.999999999998443,0.70280778392637,0,3,AIP1-IRE1 complex,CC,
1683,GO:0004152,0.999999999998447,0.92125342636772,0,1,dihydroorotate dehydrogenase activity,MF,
18449,GO:1903576,0.999999999998447,0.92125342636772,0,1,response to L-arginine,BP,
1244,GO:0002945,0.99999999999845,0.767594406497837,0,2,cyclin K-CDK13 complex,CC,
18550,GO:1903818,0.999999999998452,0.556661490365518,0,3,positive regulation of voltage-gated potassium channel activity,BP,
19720,GO:2000118,0.999999999998454,0.877193015010518,0,1,regulation of sodium-dependent phosphate transport,BP,
8513,GO:0033768,0.999999999998469,0.817977838942534,0,2,SUMO-targeted ubiquitin ligase complex,CC,
5422,GO:0016282,0.999999999998478,0.870218973752073,0,1,eukaryotic 43S preinitiation complex,CC,
16335,GO:0090667,0.999999999998486,0.823718087143939,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16336,GO:0090668,0.999999999998486,0.823718087143939,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
8793,GO:0034515,0.999999999998506,0.814199457728498,0,2,proteasome storage granule,CC,
4727,GO:0010896,0.999999999998509,0.724127122923977,0,3,regulation of triglyceride catabolic process,BP,
11617,GO:0046356,0.99999999999851,0.868573100166579,0,2,acetyl-CoA catabolic process,BP,
10812,GO:0044326,0.999999999998525,0.804672968427627,0,2,dendritic spine neck,CC,
7131,GO:0030981,0.999999999998535,0.624481241868319,0,3,cortical microtubule cytoskeleton,CC,
9145,GO:0035516,0.999999999998543,0.874014465708089,0,1,oxidative DNA demethylase activity,MF,
14683,GO:0070343,0.999999999998543,0.874014465708089,0,1,white fat cell proliferation,BP,
14687,GO:0070350,0.999999999998543,0.874014465708089,0,1,regulation of white fat cell proliferation,BP,
19645,GO:1990931,0.999999999998543,0.874014465708089,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
5084,GO:0015349,0.999999999998553,0.793232277719644,0,2,thyroid hormone transmembrane transporter activity,MF,
18951,GO:1904762,0.999999999998556,0.88023449302395,0,1,positive regulation of myofibroblast differentiation,BP,
16154,GO:0090204,0.999999999998562,0.735248719471368,0,3,protein localization to nuclear pore,BP,
16318,GO:0090615,0.999999999998562,0.802063726033425,0,2,mitochondrial mRNA processing,BP,
17343,GO:1900095,0.999999999998565,0.790768031662494,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
14416,GO:0061762,0.999999999998566,0.735752291092019,0,2,CAMKK-AMPK signaling cascade,BP,
16945,GO:0099004,0.999999999998566,0.735752291092019,0,2,calmodulin dependent kinase signaling pathway,BP,
13432,GO:0052918,0.999999999998585,0.84397827823034,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13434,GO:0052926,0.999999999998585,0.84397827823034,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1844,GO:0004505,0.999999999998586,0.865145675996605,0,2,phenylalanine 4-monooxygenase activity,MF,
3646,GO:0008124,0.999999999998586,0.865145675996605,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
2238,GO:0005150,0.999999999998589,0.824159810605743,0,2,interleukin-1, Type I receptor binding,MF,
18069,GO:1902725,0.99999999999859,0.84506648230814,0,1,negative regulation of satellite cell differentiation,BP,
16492,GO:0097232,0.999999999998599,0.896419641515766,0,1,lamellar body membrane,CC,
16493,GO:0097233,0.999999999998599,0.896419641515766,0,1,alveolar lamellar body membrane,CC,
16981,GO:0099122,0.999999999998603,0.663163403863516,0,3,RNA polymerase II C-terminal domain binding,MF,
9803,GO:0042030,0.999999999998609,0.714665692763365,0,2,ATPase inhibitor activity,MF,
18828,GO:1904475,0.999999999998614,0.707276176504254,0,2,regulation of Ras GTPase binding,BP,
20181,GO:2001106,0.999999999998614,0.707276176504254,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
3967,GO:0008781,0.99999999999862,0.869523448358596,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
5758,GO:0016936,0.999999999998621,0.853551109731599,0,2,galactoside binding,MF,
19577,GO:1990737,0.999999999998629,0.705121553789831,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
8182,GO:0032937,0.999999999998646,0.726058788111893,0,3,SREBP-SCAP-Insig complex,CC,
7730,GO:0032240,0.99999999999865,0.682058119136411,0,2,negative regulation of nucleobase-containing compound transport,BP,
11827,GO:0046832,0.99999999999865,0.682058119136411,0,2,negative regulation of RNA export from nucleus,BP,
3881,GO:0008518,0.999999999998661,0.908041538204598,0,1,reduced folate carrier activity,MF,
16863,GO:0098838,0.999999999998661,0.908041538204598,0,1,reduced folate transmembrane transport,BP,
9488,GO:0036153,0.999999999998661,0.908651529630658,0,1,triglyceride acyl-chain remodeling,BP,
12890,GO:0051264,0.999999999998661,0.908651529630658,0,1,mono-olein transacylation activity,MF,
12891,GO:0051265,0.999999999998661,0.908651529630658,0,1,diolein transacylation activity,MF,
2067,GO:0004822,0.999999999998662,0.775408838454094,0,2,isoleucine-tRNA ligase activity,MF,
2915,GO:0006428,0.999999999998662,0.775408838454094,0,2,isoleucyl-tRNA aminoacylation,BP,
16043,GO:0090031,0.999999999998664,0.727772999044459,0,3,positive regulation of steroid hormone biosynthetic process,BP,
9541,GO:0036335,0.999999999998679,0.857979416648277,0,1,intestinal stem cell homeostasis,BP,
12950,GO:0051379,0.999999999998686,0.84579163568851,0,2,epinephrine binding,MF,
18542,GO:1903796,0.999999999998712,0.736815295217093,0,2,negative regulation of inorganic anion transmembrane transport,BP,
3971,GO:0008794,0.999999999998714,0.946731411659676,0,1,arsenate reductase (glutaredoxin) activity,MF,
6949,GO:0030611,0.999999999998714,0.946731411659676,0,1,arsenate reductase activity,MF,
10840,GO:0044375,0.999999999998722,0.874000394869681,0,2,regulation of peroxisome size,BP,
18389,GO:1903450,0.999999999998722,0.814199170742165,0,1,regulation of G1 to G0 transition,BP,
18390,GO:1903452,0.999999999998722,0.814199170742165,0,1,positive regulation of G1 to G0 transition,BP,
10435,GO:0043314,0.999999999998723,0.717459559787671,0,2,negative regulation of neutrophil degranulation,BP,
18014,GO:1902564,0.999999999998723,0.717459559787671,0,2,negative regulation of neutrophil activation,BP,
17689,GO:1901629,0.999999999998725,0.772288727946754,0,2,regulation of presynaptic membrane organization,BP,
2142,GO:0004957,0.999999999998739,0.894646990312502,0,1,prostaglandin E receptor activity,MF,
15881,GO:0072682,0.999999999998739,0.894646990312502,0,1,eosinophil extravasation,BP,
19895,GO:2000417,0.999999999998739,0.894646990312502,0,1,negative regulation of eosinophil migration,BP,
19897,GO:2000419,0.999999999998739,0.894646990312502,0,1,regulation of eosinophil extravasation,BP,
19898,GO:2000420,0.999999999998739,0.894646990312502,0,1,negative regulation of eosinophil extravasation,BP,
13106,GO:0051694,0.999999999998746,0.743811863940091,0,2,pointed-end actin filament capping,BP,
4078,GO:0009136,0.999999999998762,0.866894855925065,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4117,GO:0009180,0.999999999998762,0.866894855925065,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4125,GO:0009188,0.999999999998762,0.866894855925065,0,2,ribonucleoside diphosphate biosynthetic process,BP,
8576,GO:0034092,0.999999999998766,0.596124654454433,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8626,GO:0034183,0.999999999998766,0.596124654454433,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
18998,GO:1904862,0.999999999998776,0.737460207402678,0,2,inhibitory synapse assembly,BP,
15090,GO:0071207,0.999999999998781,0.804851995609726,0,2,histone pre-mRNA stem-loop binding,MF,
1777,GO:0004392,0.999999999998783,0.862874969521177,0,2,heme oxygenase (decyclizing) activity,MF,
3172,GO:0006788,0.999999999998783,0.862874969521177,0,2,heme oxidation,BP,
915,GO:0002309,0.999999999998794,0.948966569547769,0,1,T cell proliferation involved in immune response,BP,
8127,GO:0032847,0.999999999998807,0.820585431097706,0,2,regulation of cellular pH reduction,BP,
9540,GO:0036333,0.999999999998808,0.911980283374412,0,1,hepatocyte homeostasis,BP,
18955,GO:1904772,0.999999999998808,0.911980283374412,0,1,response to tetrachloromethane,BP,
5302,GO:0016013,0.999999999998815,0.760821827673509,0,2,syntrophin complex,CC,
2266,GO:0005199,0.99999999999883,0.895722159921154,0,1,structural constituent of cell wall,MF,
15375,GO:0071665,0.99999999999883,0.895722159921154,0,1,gamma-catenin-TCF7L2 complex,CC,
5478,GO:0016418,0.999999999998853,0.712184806146635,0,2,S-acetyltransferase activity,MF,
8666,GO:0034274,0.999999999998855,0.679070492671456,0,3,Atg12-Atg5-Atg16 complex,CC,
1506,GO:0003865,0.999999999998862,0.83690009443794,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
8512,GO:0033765,0.999999999998862,0.83690009443794,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9245,GO:0035671,0.999999999998862,0.83690009443794,0,2,enone reductase activity,MF,
12014,GO:0047751,0.999999999998862,0.83690009443794,0,2,cholestenone 5-alpha-reductase activity,MF,
1762,GO:0004367,0.999999999998863,0.882287380251644,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11569,GO:0046168,0.999999999998863,0.882287380251644,0,1,glycerol-3-phosphate catabolic process,BP,
7528,GO:0031798,0.999999999998865,0.826455619160375,0,1,type 1 metabotropic glutamate receptor binding,MF,
14438,GO:0061828,0.999999999998865,0.826455619160375,0,1,apical tubulobulbar complex,CC,
14439,GO:0061829,0.999999999998865,0.826455619160375,0,1,basal tubulobulbar complex,CC,
18172,GO:1902977,0.999999999998868,0.923690110476871,0,1,mitotic DNA replication preinitiation complex assembly,BP,
1031,GO:0002541,0.999999999998878,0.844693645791507,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
11005,GO:0044868,0.999999999998882,0.841881968514018,0,1,modulation by host of viral molecular function,BP,
19156,GO:1905255,0.999999999998882,0.841881968514018,0,1,regulation of RNA binding transcription factor activity,BP,
19653,GO:1990968,0.999999999998882,0.841881968514018,0,1,modulation by host of RNA binding by virus,BP,
19654,GO:1990969,0.999999999998882,0.841881968514018,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
17055,GO:0099609,0.999999999998884,0.722571136236114,0,2,microtubule lateral binding,MF,
18947,GO:1904753,0.999999999998897,0.745365853209093,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
6374,GO:0021569,0.999999999998899,0.929869079444706,0,1,rhombomere 3 development,BP,
6375,GO:0021570,0.999999999998899,0.929869079444706,0,1,rhombomere 4 development,BP,
11762,GO:0046645,0.999999999998904,0.644684287211885,0,3,positive regulation of gamma-delta T cell activation,BP,
18768,GO:1904327,0.999999999998911,0.760428960899747,0,2,protein localization to cytosolic proteasome complex,BP,
18786,GO:1904379,0.999999999998911,0.760428960899747,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
10462,GO:0043376,0.999999999998928,0.889576870717316,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
8000,GO:0032641,0.999999999998928,0.90224376260642,0,1,lymphotoxin A production,BP,
8071,GO:0032765,0.999999999998928,0.90224376260642,0,1,positive regulation of mast cell cytokine production,BP,
9842,GO:0042109,0.999999999998928,0.90224376260642,0,1,lymphotoxin A biosynthetic process,BP,
2810,GO:0006272,0.999999999998931,0.658830458345399,0,3,leading strand elongation,BP,
511,GO:0001575,0.999999999998966,0.850942447284644,0,2,globoside metabolic process,BP,
8894,GO:0034750,0.999999999998979,0.767868160339164,0,2,Scrib-APC-beta-catenin complex,CC,
49,GO:0000103,0.999999999999001,0.757430972629262,0,3,sulfate assimilation,BP,
1763,GO:0004368,0.999999999999009,0.848859675315754,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
2740,GO:0006127,0.999999999999009,0.848859675315754,0,1,glycerophosphate shuttle,BP,
5747,GO:0016901,0.999999999999009,0.848859675315754,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
13343,GO:0052590,0.999999999999009,0.848859675315754,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13344,GO:0052591,0.999999999999009,0.848859675315754,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
7287,GO:0031296,0.999999999999014,0.939372659865074,0,1,B cell costimulation,BP,
3526,GO:0007509,0.99999999999904,0.840520434430279,0,1,mesoderm migration involved in gastrulation,BP,
3620,GO:0008078,0.99999999999904,0.840520434430279,0,1,mesodermal cell migration,BP,
12608,GO:0050822,0.999999999999041,0.892337135582818,0,1,peptide stabilization,BP,
12609,GO:0050823,0.999999999999041,0.892337135582818,0,1,peptide antigen stabilization,BP,
2059,GO:0004814,0.999999999999057,0.781604658895422,0,3,arginine-tRNA ligase activity,MF,
2907,GO:0006420,0.999999999999057,0.781604658895422,0,3,arginyl-tRNA aminoacylation,BP,
5833,GO:0017126,0.999999999999075,0.856895249999678,0,1,nucleologenesis,BP,
6895,GO:0030485,0.999999999999086,0.80803832894692,0,2,smooth muscle contractile fiber,CC,
13681,GO:0060267,0.99999999999909,0.707963500565649,0,3,positive regulation of respiratory burst,BP,
17430,GO:1900244,0.999999999999111,0.800277252720263,0,2,positive regulation of synaptic vesicle endocytosis,BP,
8945,GO:0035026,0.999999999999135,0.778755401223961,0,2,leading edge cell differentiation,BP,
11031,GO:0045041,0.999999999999139,0.854545615571962,0,2,protein import into mitochondrial intermembrane space,BP,
1741,GO:0004343,0.99999999999915,0.881936495585108,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
10747,GO:0044214,0.999999999999151,0.621728885783839,0,3,spanning component of plasma membrane,CC,
17212,GO:0110095,0.999999999999152,0.810132503261967,0,3,cellular detoxification of aldehyde,BP,
16012,GO:0086072,0.999999999999154,0.914763534810525,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16020,GO:0086082,0.999999999999154,0.914763534810525,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
9601,GO:0036483,0.999999999999159,0.869009394513785,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18350,GO:1903381,0.999999999999159,0.869009394513785,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18351,GO:1903382,0.999999999999159,0.869009394513785,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
17247,GO:0140009,0.999999999999176,0.888553539051131,0,1,L-aspartate import across plasma membrane,BP,
19093,GO:1905062,0.999999999999194,0.910613366587351,0,1,positive regulation of cardioblast proliferation,BP,
2621,GO:0005945,0.9999999999992,0.810051780596182,0,2,6-phosphofructokinase complex,CC,
18508,GO:1903724,0.999999999999204,0.895397569429601,0,1,positive regulation of centriole elongation,BP,
16594,GO:0097475,0.999999999999233,0.678292882146315,0,3,motor neuron migration,BP,
18531,GO:1903774,0.999999999999234,0.779017336286535,0,3,positive regulation of viral budding via host ESCRT complex,BP,
11360,GO:0045759,0.999999999999237,0.794639045285253,0,2,negative regulation of action potential,BP,
15913,GO:0072752,0.999999999999237,0.839945664660208,0,1,cellular response to rapamycin,BP,
7844,GO:0032415,0.99999999999924,0.738080350499846,0,3,regulation of sodium:proton antiporter activity,BP,
19829,GO:2000325,0.999999999999243,0.845476073891705,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19830,GO:2000327,0.999999999999243,0.845476073891705,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19085,GO:1905042,0.999999999999255,0.918480190781375,0,1,negative regulation of epithelium regeneration,BP,
16852,GO:0098821,0.999999999999264,0.590586181979459,0,3,BMP receptor activity,MF,
460,GO:0001401,0.999999999999264,0.831401799370599,0,2,mitochondrial sorting and assembly machinery complex,CC,
15313,GO:0071566,0.999999999999266,0.905723751377219,0,1,UFM1 activating enzyme activity,MF,
860,GO:0002193,0.999999999999279,0.628995823452421,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
4894,GO:0014826,0.999999999999292,0.920791197302181,0,1,vein smooth muscle contraction,BP,
6751,GO:0030185,0.999999999999292,0.920791197302181,0,1,nitric oxide transport,BP,
7437,GO:0031583,0.999999999999292,0.920791197302181,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7508,GO:0031705,0.999999999999292,0.920791197302181,0,1,bombesin receptor binding,MF,
7509,GO:0031707,0.999999999999292,0.920791197302181,0,1,endothelin A receptor binding,MF,
7510,GO:0031708,0.999999999999292,0.920791197302181,0,1,endothelin B receptor binding,MF,
9318,GO:0035815,0.999999999999292,0.920791197302181,0,1,positive regulation of renal sodium excretion,BP,
9933,GO:0042313,0.999999999999292,0.920791197302181,0,1,protein kinase C deactivation,BP,
10344,GO:0043179,0.999999999999292,0.920791197302181,0,1,rhythmic excitation,BP,
7373,GO:0031436,0.9999999999993,0.760280540458653,0,2,BRCA1-BARD1 complex,CC,
3962,GO:0008753,0.99999999999931,0.893618596998111,0,1,NADPH dehydrogenase (quinone) activity,MF,
13015,GO:0051499,0.999999999999323,0.847988166667312,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13016,GO:0051500,0.999999999999323,0.847988166667312,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
19880,GO:2000395,0.999999999999324,0.879066611036764,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19881,GO:2000397,0.999999999999324,0.879066611036764,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
9641,GO:0038002,0.999999999999326,0.856544521758575,0,1,endocrine signaling,BP,
396,GO:0001069,0.999999999999327,0.744586265877812,0,2,regulatory region RNA binding,MF,
1601,GO:0004022,0.999999999999332,0.911773230162124,0,1,alcohol dehydrogenase (NAD) activity,MF,
5970,GO:0018467,0.999999999999332,0.911773230162124,0,1,formaldehyde dehydrogenase activity,MF,
13211,GO:0051903,0.999999999999332,0.911773230162124,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
17909,GO:1902263,0.999999999999336,0.660332598023189,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
11239,GO:0045509,0.99999999999935,0.808399162534982,0,2,interleukin-27 receptor activity,MF,
16509,GO:0097278,0.999999999999384,0.830195151516,0,2,complement-dependent cytotoxicity,BP,
13073,GO:0051615,0.999999999999386,0.85284914438785,0,1,histamine uptake,BP,
16128,GO:0090176,0.999999999999391,0.852984125802727,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
12717,GO:0051012,0.999999999999405,0.797052045549832,0,2,microtubule sliding,BP,
1024,GO:0002528,0.999999999999406,0.743966326985066,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
3903,GO:0008555,0.999999999999421,0.856299980226602,0,1,chloride-transporting ATPase activity,MF,
3851,GO:0008470,0.999999999999425,0.867857376925661,0,1,isovaleryl-CoA dehydrogenase activity,MF,
6486,GO:0021849,0.999999999999428,0.793647556817259,0,2,neuroblast division in subventricular zone,BP,
9941,GO:0042328,0.999999999999428,0.652696124157035,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
1412,GO:0003350,0.999999999999429,0.789077228917944,0,2,pulmonary myocardium development,BP,
13533,GO:0060025,0.99999999999943,0.788319520173284,0,2,regulation of synaptic activity,BP,
12861,GO:0051228,0.999999999999433,0.859169269926172,0,1,mitotic spindle disassembly,BP,
12862,GO:0051230,0.999999999999433,0.859169269926172,0,1,spindle disassembly,BP,
13159,GO:0051793,0.999999999999436,0.681152335764712,0,3,medium-chain fatty acid catabolic process,BP,
7561,GO:0031933,0.99999999999944,0.669659952003385,0,3,telomeric heterochromatin,CC,
9623,GO:0036509,0.999999999999457,0.84063902241744,0,2,trimming of terminal mannose on B branch,BP,
9625,GO:0036511,0.999999999999457,0.84063902241744,0,2,trimming of first mannose on A branch,BP,
9626,GO:0036512,0.999999999999457,0.84063902241744,0,2,trimming of second mannose on A branch,BP,
16203,GO:0090281,0.999999999999459,0.757033742983598,0,3,negative regulation of calcium ion import,BP,
1745,GO:0004347,0.999999999999467,0.920944917133049,0,1,glucose-6-phosphate isomerase activity,MF,
6080,GO:0019242,0.999999999999467,0.920944917133049,0,1,methylglyoxal biosynthetic process,BP,
2627,GO:0005956,0.999999999999471,0.8564023657641,0,2,protein kinase CK2 complex,CC,
4860,GO:0014717,0.999999999999479,0.839846217742346,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4861,GO:0014718,0.999999999999479,0.839846217742346,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4935,GO:0014901,0.999999999999479,0.839846217742346,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
3225,GO:0006880,0.99999999999948,0.820384639950667,0,3,intracellular sequestering of iron ion,BP,
16643,GO:0097577,0.99999999999948,0.820384639950667,0,3,sequestering of iron ion,BP,
18736,GO:1904247,0.999999999999494,0.902804516715498,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
6460,GO:0021796,0.999999999999502,0.720468286835284,0,3,cerebral cortex regionalization,BP,
18369,GO:1903422,0.999999999999503,0.658314138654891,0,3,negative regulation of synaptic vesicle recycling,BP,
15161,GO:0071332,0.999999999999514,0.843898688305107,0,2,cellular response to fructose stimulus,BP,
2881,GO:0006386,0.99999999999954,0.949987157977093,0,1,termination of RNA polymerase III transcription,BP,
19304,GO:1905643,0.999999999999543,0.848347169320301,0,1,positive regulation of DNA methylation,BP,
20105,GO:2000820,0.999999999999543,0.848347169320301,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
19780,GO:2000253,0.999999999999546,0.736832572003406,0,2,positive regulation of feeding behavior,BP,
15743,GO:0072369,0.999999999999568,0.722306212794862,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
18199,GO:1903027,0.99999999999957,0.82715858420571,0,1,regulation of opsonization,BP,
18200,GO:1903028,0.99999999999957,0.82715858420571,0,1,positive regulation of opsonization,BP,
1802,GO:0004449,0.999999999999578,0.789168428865883,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
16460,GO:0097180,0.999999999999579,0.882182823118085,0,2,serine protease inhibitor complex,CC,
3116,GO:0006696,0.999999999999582,0.847080558270762,0,2,ergosterol biosynthetic process,BP,
3695,GO:0008204,0.999999999999582,0.847080558270762,0,2,ergosterol metabolic process,BP,
9892,GO:0042245,0.999999999999588,0.797811509936469,0,2,RNA repair,BP,
18091,GO:1902775,0.999999999999592,0.669443553988121,0,3,mitochondrial large ribosomal subunit assembly,BP,
13294,GO:0052203,0.999999999999598,0.843083787058445,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
2126,GO:0004924,0.999999999999605,0.636271484944877,0,3,oncostatin-M receptor activity,MF,
9707,GO:0038165,0.999999999999605,0.636271484944877,0,3,oncostatin-M-mediated signaling pathway,BP,
7281,GO:0031289,0.999999999999607,0.903498245984406,0,1,actin phosphorylation,BP,
10554,GO:0043538,0.999999999999607,0.903498245984406,0,1,regulation of actin phosphorylation,BP,
3920,GO:0008597,0.999999999999619,0.849799655588844,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
9703,GO:0038158,0.999999999999627,0.82944567133655,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
16373,GO:0097026,0.999999999999631,0.820592067121573,0,1,dendritic cell dendrite assembly,BP,
1560,GO:0003963,0.999999999999633,0.833991714284264,0,2,RNA-3'-phosphate cyclase activity,MF,
7959,GO:0032581,0.999999999999638,0.925049561344266,0,1,ER-dependent peroxisome organization,BP,
17193,GO:0106101,0.999999999999638,0.925049561344266,0,1,ER-dependent peroxisome localization,BP,
17715,GO:1901676,0.999999999999646,0.8821936291588,0,1,positive regulation of histone H3-K27 acetylation,BP,
4943,GO:0014916,0.999999999999649,0.606617232579295,0,3,regulation of lung blood pressure,BP,
1845,GO:0004506,0.99999999999965,0.904725023940745,0,1,squalene monooxygenase activity,MF,
17351,GO:1900107,0.999999999999657,0.734792349471807,0,2,regulation of nodal signaling pathway,BP,
17378,GO:1900145,0.999999999999657,0.734792349471807,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17397,GO:1900175,0.999999999999657,0.734792349471807,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
15635,GO:0072185,0.999999999999665,0.916561983869724,0,1,metanephric cap development,BP,
15636,GO:0072186,0.999999999999665,0.916561983869724,0,1,metanephric cap morphogenesis,BP,
16083,GO:0090094,0.999999999999665,0.916561983869724,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16084,GO:0090095,0.999999999999665,0.916561983869724,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16085,GO:0090096,0.999999999999665,0.916561983869724,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
15824,GO:0072572,0.999999999999674,0.920107182503598,0,1,poly-ADP-D-ribose binding,MF,
14436,GO:0061825,0.999999999999697,0.881913170022322,0,1,podosome core,CC,
120,GO:0000250,0.999999999999711,0.874746103072525,0,1,lanosterol synthase activity,MF,
7428,GO:0031559,0.999999999999711,0.874746103072525,0,1,oxidosqualene cyclase activity,MF,
16582,GO:0097450,0.999999999999714,0.795039113327774,0,2,astrocyte end-foot,CC,
16583,GO:0097451,0.999999999999714,0.795039113327774,0,2,glial limiting end-foot,CC,
1809,GO:0004461,0.999999999999724,0.806475929511475,0,2,lactose synthase activity,MF,
4208,GO:0009360,0.999999999999726,0.910763170540452,0,1,DNA polymerase III complex,CC,
14891,GO:0070772,0.999999999999732,0.90207928991636,0,1,PAS complex,CC,
2321,GO:0005332,0.999999999999742,0.922421685111943,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5017,GO:0015185,0.999999999999742,0.922421685111943,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
6537,GO:0021956,0.999999999999742,0.922421685111943,0,1,central nervous system interneuron axonogenesis,BP,
11973,GO:0047391,0.999999999999746,0.834905895434056,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
11313,GO:0045660,0.999999999999747,0.922521720023177,0,1,positive regulation of neutrophil differentiation,BP,
6953,GO:0030617,0.999999999999749,0.902618151408902,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
11025,GO:0045027,0.999999999999754,0.920734647181885,0,1,DNA end binding,MF,
2583,GO:0005880,0.999999999999755,0.932880160274038,0,1,nuclear microtubule,CC,
3196,GO:0006828,0.999999999999756,0.680006173748051,0,3,manganese ion transport,BP,
2363,GO:0005477,0.999999999999757,0.891432440971332,0,1,pyruvate secondary active transmembrane transporter activity,MF,
7877,GO:0032455,0.999999999999774,0.704258108786415,0,3,nerve growth factor processing,BP,
579,GO:0001732,0.999999999999786,0.791161738941978,0,2,formation of cytoplasmic translation initiation complex,BP,
18175,GO:1902990,0.99999999999979,0.708266991224945,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
12781,GO:0051102,0.9999999999998,0.879048069807962,0,1,DNA ligation involved in DNA recombination,BP,
7007,GO:0030729,0.99999999999981,0.896568778062188,0,1,acetoacetate-CoA ligase activity,MF,
12017,GO:0047760,0.99999999999981,0.896568778062188,0,1,butyrate-CoA ligase activity,MF,
3824,GO:0008428,0.999999999999819,0.730774931492339,0,3,ribonuclease inhibitor activity,MF,
4649,GO:0010797,0.999999999999825,0.938705387031796,0,1,regulation of multivesicular body size involved in endosome transport,BP,
20007,GO:2000653,0.999999999999827,0.70108755435729,0,3,regulation of genetic imprinting,BP,
6962,GO:0030627,0.999999999999828,0.852109945145507,0,2,pre-mRNA 5'-splice site binding,MF,
10190,GO:0042825,0.999999999999847,0.710764654628333,0,3,TAP complex,CC,
9958,GO:0042365,0.999999999999857,0.757207047596062,0,3,water-soluble vitamin catabolic process,BP,
4412,GO:0010189,0.999999999999858,0.928223669812985,0,1,vitamin E biosynthetic process,BP,
8539,GO:0033961,0.999999999999858,0.926839659867235,0,1,cis-stilbene-oxide hydrolase activity,MF,
9954,GO:0042360,0.999999999999858,0.928223669812985,0,1,vitamin E metabolic process,BP,
18685,GO:1904121,0.999999999999858,0.928223669812985,0,1,phosphatidylethanolamine transporter activity,MF,
17087,GO:0102005,0.999999999999874,0.931734706641033,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
699,GO:0001920,0.999999999999876,0.718590412912176,0,3,negative regulation of receptor recycling,BP,
3522,GO:0007499,0.999999999999882,0.867649458038011,0,1,ectoderm and mesoderm interaction,BP,
12364,GO:0048807,0.999999999999882,0.867649458038011,0,1,female genitalia morphogenesis,BP,
18903,GO:1904674,0.999999999999882,0.867649458038011,0,1,positive regulation of somatic stem cell population maintenance,BP,
703,GO:0001927,0.99999999999989,0.687919238779371,0,3,exocyst assembly,BP,
17930,GO:1902309,0.999999999999892,0.799366161094713,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
2224,GO:0005128,0.999999999999901,0.898175521238044,0,1,erythropoietin receptor binding,MF,
2229,GO:0005135,0.999999999999901,0.898175521238044,0,1,interleukin-3 receptor binding,MF,
13389,GO:0052812,0.999999999999913,0.763198014898007,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
9393,GO:0035971,0.999999999999917,0.938555230922593,0,1,peptidyl-histidine dephosphorylation,BP,
9760,GO:0039656,0.999999999999951,0.836054463050283,0,2,modulation by virus of host gene expression,BP,
11810,GO:0046778,0.999999999999951,0.836054463050283,0,2,modification by virus of host mRNA processing,BP,
14737,GO:0070458,0.999999999999967,0.773008418539847,0,3,cellular detoxification of nitrogen compound,BP,
8864,GO:0034693,0.99999999999997,0.914912981912361,0,1,U11/U12 snRNP,CC,
1938,GO:0004642,0.999999999999974,0.855882528734403,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17215,GO:0120012,0.999999999999974,0.855882528734403,0,1,intermembrane sphingolipid transfer,BP,
17217,GO:0120016,0.999999999999974,0.855882528734403,0,1,intermembrane sphingolipid transfer activity,MF,
17218,GO:0120017,0.999999999999974,0.855882528734403,0,1,intermembrane ceramide transfer activity,MF,
8208,GO:0032980,0.999999999999974,0.915669823259685,0,1,keratinocyte activation,BP,
17655,GO:1901555,0.999999999999982,0.835464838275595,0,1,response to paclitaxel,BP,
19319,GO:1905705,0.999999999999982,0.835464838275595,0,1,cellular response to paclitaxel,BP,
12946,GO:0051365,0.999999999999984,0.896990642232358,0,1,cellular response to potassium ion starvation,BP,
9496,GO:0036179,1,0.909697905658428,0,1,osteoclast maturation,BP,
6,GO:0000012,1,0.413349974544365,0,8,single strand break repair,BP,
7,GO:0000014,1,0.430646102388123,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
11,GO:0000022,1,0.315171708692439,0,10,mitotic spindle elongation,BP,
14,GO:0000027,1,0.110248546940557,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.340145538965219,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.104719649542812,0,22,mannosyltransferase activity,MF,
29,GO:0000054,1,0.335156109995715,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.508059986394183,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.558037087171799,0,7,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.222031716332079,0,17,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.558843714752256,0,4,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.217671462400888,0,15,DNA replication checkpoint,BP,
45,GO:0000097,1,0.23812126058959,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.482153420762464,0,7,sulfur amino acid catabolic process,BP,
50,GO:0000104,1,0.665053558315156,0,5,succinate dehydrogenase activity,MF,
57,GO:0000120,1,0.632390151283543,0,5,RNA polymerase I transcription factor complex,CC,
62,GO:0000125,1,0.550256422802053,0,5,PCAF complex,CC,
64,GO:0000127,1,0.509251878645382,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000138,1,0.583299699947379,0,6,Golgi trans cisterna,CC,
69,GO:0000145,1,0.18352284113451,0,14,exocyst,CC,
73,GO:0000150,1,0.495435361883768,0,8,recombinase activity,MF,
77,GO:0000154,1,0.0532823659857606,0,34,rRNA modification,BP,
80,GO:0000164,1,0.293395773792359,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000172,1,0.587319112194846,0,6,ribonuclease MRP complex,CC,
86,GO:0000175,1,0.0383282057651938,0,30,3'-5'-exoribonuclease activity,MF,
87,GO:0000176,1,0.365963541574807,0,13,nuclear exosome (RNase complex),CC,
88,GO:0000177,1,0.237499627277992,0,15,cytoplasmic exosome (RNase complex),CC,
89,GO:0000178,1,0.121899274563525,0,22,exosome (RNase complex),CC,
90,GO:0000179,1,0.713728178449113,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
100,GO:0000212,1,0.247881143734093,0,10,meiotic spindle organization,BP,
101,GO:0000213,1,0.720072121967504,0,4,tRNA-intron endonuclease activity,MF,
102,GO:0000214,1,0.722977731018902,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000220,1,0.598414229664095,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
112,GO:0000235,1,0.354714895498135,0,8,astral microtubule,CC,
114,GO:0000243,1,0.52840718143988,0,8,commitment complex,CC,
115,GO:0000244,1,0.290029158644603,0,11,spliceosomal tri-snRNP complex assembly,BP,
122,GO:0000253,1,0.764076604117469,0,4,3-keto sterol reductase activity,MF,
128,GO:0000268,1,0.664647308574288,0,4,peroxisome targeting sequence binding,MF,
139,GO:0000290,1,0.347351236520061,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
140,GO:0000291,1,0.032678980957016,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
143,GO:0000295,1,0.350155904561685,0,11,adenine nucleotide transmembrane transporter activity,MF,
145,GO:0000298,1,0.68370776824984,0,4,endopolyphosphatase activity,MF,
154,GO:0000313,1,0.00363704254343029,0,84,organellar ribosome,CC,
155,GO:0000314,1,0.162246888078867,0,28,organellar small ribosomal subunit,CC,
156,GO:0000315,1,0.0314947467296894,0,51,organellar large ribosomal subunit,CC,
162,GO:0000338,1,0.436212691050883,0,10,protein deneddylation,BP,
163,GO:0000339,1,0.146472974768894,0,17,RNA cap binding,MF,
164,GO:0000340,1,0.331693282518468,0,9,RNA 7-methylguanosine cap binding,MF,
165,GO:0000346,1,0.285401234136347,0,13,transcription export complex,CC,
166,GO:0000347,1,0.585236962578931,0,6,THO complex,CC,
177,GO:0000387,1,0.0382051118487566,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.542295312405911,0,6,mRNA 3'-splice site recognition,BP,
180,GO:0000393,1,0.660760206226918,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
181,GO:0000394,1,0.237039270138406,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
182,GO:0000395,1,0.627512047687147,0,5,mRNA 5'-splice site recognition,BP,
184,GO:0000400,1,0.193931849671767,0,16,four-way junction DNA binding,MF,
185,GO:0000403,1,0.447536889049284,0,6,Y-form DNA binding,MF,
190,GO:0000408,1,0.673284212206907,0,5,EKC/KEOPS complex,CC,
195,GO:0000414,1,0.51916427193004,0,4,regulation of histone H3-K36 methylation,BP,
210,GO:0000439,1,0.412733271237918,0,9,core TFIIH complex,CC,
211,GO:0000444,1,0.602631756853456,0,4,MIS12/MIND type complex,CC,
212,GO:0000445,1,0.585236962578931,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.430313367732462,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
219,GO:0000459,1,0.559955235304582,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.0423747306328368,0,33,maturation of 5.8S rRNA,BP,
222,GO:0000462,1,0.0326995458319646,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000463,1,0.424960528964133,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.116776582228746,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.559955235304582,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.0795216999275176,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.115245097319681,0,24,maturation of LSU-rRNA,BP,
229,GO:0000478,1,0.190360084583461,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.208019356081887,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.503189172211033,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
233,GO:0000491,1,0.437796153679542,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.520643908698525,0,7,box C/D snoRNP assembly,BP,
241,GO:0000506,1,0.497796594112403,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
242,GO:0000578,1,0.0498781762059364,0,22,embryonic axis specification,BP,
248,GO:0000707,1,0.490198216482633,0,8,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.612454907406083,0,4,meiotic mismatch repair,BP,
250,GO:0000712,1,0.332447050511618,0,9,resolution of meiotic recombination intermediates,BP,
260,GO:0000727,1,0.631781292514363,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000730,1,0.405021680064092,0,10,DNA recombinase assembly,BP,
267,GO:0000738,1,0.670438727370347,0,4,DNA catabolic process, exonucleolytic,BP,
271,GO:0000774,1,0.347871950854957,0,11,adenyl-nucleotide exchange factor activity,MF,
279,GO:0000782,1,0.381577559642595,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.381577559642595,0,10,nuclear telomere cap complex,CC,
295,GO:0000800,1,0.36688527570211,0,7,lateral element,CC,
297,GO:0000803,1,0.0510627671982641,0,25,sex chromosome,CC,
298,GO:0000805,1,0.387093450220478,0,7,X chromosome,CC,
302,GO:0000812,1,0.308103765030885,0,10,Swr1 complex,CC,
305,GO:0000815,1,0.340655467521282,0,12,ESCRT III complex,CC,
314,GO:0000827,1,0.597873058565097,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
315,GO:0000828,1,0.597873058565097,0,4,inositol hexakisphosphate kinase activity,MF,
316,GO:0000829,1,0.597873058565097,0,4,inositol heptakisphosphate kinase activity,MF,
317,GO:0000832,1,0.597873058565097,0,4,inositol hexakisphosphate 5-kinase activity,MF,
325,GO:0000912,1,0.455863982259513,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.455863982259513,0,6,actomyosin contractile ring assembly,BP,
329,GO:0000920,1,0.217567007357866,0,17,cell separation after cytokinesis,BP,
332,GO:0000923,1,0.489189895636292,0,6,equatorial microtubule organizing center,CC,
334,GO:0000930,1,0.0939055942388685,0,19,gamma-tubulin complex,CC,
335,GO:0000931,1,0.357177728497392,0,8,gamma-tubulin large complex,CC,
337,GO:0000938,1,0.608106152275722,0,4,GARP complex,CC,
339,GO:0000940,1,0.217674882220706,0,13,condensed chromosome outer kinetochore,CC,
341,GO:0000942,1,0.69441939066332,0,4,condensed nuclear chromosome outer kinetochore,CC,
343,GO:0000957,1,0.532171097157114,0,5,mitochondrial RNA catabolic process,BP,
345,GO:0000959,1,0.0135899010345244,0,41,mitochondrial RNA metabolic process,BP,
346,GO:0000960,1,0.604422134518642,0,4,regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000963,1,0.220487928217705,0,16,mitochondrial RNA processing,BP,
350,GO:0000964,1,0.679376854615449,0,4,mitochondrial RNA 5'-end processing,BP,
351,GO:0000965,1,0.62510136782773,0,5,mitochondrial RNA 3'-end processing,BP,
352,GO:0000966,1,0.136754715896556,0,21,RNA 5'-end processing,BP,
354,GO:0000972,1,0.466957002809368,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.290112900846273,0,13,Prp19 complex,CC,
371,GO:0000993,1,0.0501524156654055,0,27,RNA polymerase II core binding,MF,
373,GO:0000995,1,0.52656156331015,0,4,transcription factor activity, core RNA polymerase III binding,MF,
376,GO:0001007,1,0.536470961530779,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
380,GO:0001013,1,0.377190857347052,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001030,1,0.481601780857662,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.481601780857662,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
387,GO:0001032,1,0.582882192655019,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
389,GO:0001042,1,0.461632502430474,0,6,RNA polymerase I core binding,MF,
392,GO:0001054,1,0.371756218070944,0,11,RNA polymerase I activity,MF,
393,GO:0001055,1,0.397829435760208,0,11,RNA polymerase II activity,MF,
394,GO:0001056,1,0.269229393635018,0,15,RNA polymerase III activity,MF,
434,GO:0001163,1,0.377190857347052,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.377190857347052,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
440,GO:0001188,1,0.377190857347052,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
449,GO:0001223,1,0.101733995318918,0,16,transcription coactivator binding,MF,
459,GO:0001325,1,0.176299617808424,0,15,formation of extrachromosomal circular DNA,BP,
461,GO:0001405,1,0.630069834226724,0,5,presequence translocase-associated import motor,CC,
468,GO:0001510,1,0.00271619771050776,0,61,RNA methylation,BP,
470,GO:0001514,1,0.465105226818867,0,7,selenocysteine incorporation,BP,
477,GO:0001522,1,0.231747362131866,0,18,pseudouridine synthesis,BP,
481,GO:0001530,1,0.408270463394686,0,10,lipopolysaccharide binding,MF,
494,GO:0001547,1,0.484912952848522,0,5,antral ovarian follicle growth,BP,
510,GO:0001574,1,0.685092867448072,0,4,ganglioside biosynthetic process,BP,
515,GO:0001580,1,0.566796740884618,0,8,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
520,GO:0001608,1,0.621032820429962,0,5,G-protein coupled nucleotide receptor activity,MF,
522,GO:0001614,1,0.572476206501971,0,6,purinergic nucleotide receptor activity,MF,
533,GO:0001652,1,0.679695399542532,0,4,granular component,CC,
541,GO:0001660,1,0.499713392405849,0,7,fever generation,BP,
550,GO:0001672,1,0.372083014533813,0,7,regulation of chromatin assembly or disassembly,BP,
558,GO:0001682,1,0.375844356771632,0,12,tRNA 5'-leader removal,BP,
584,GO:0001739,1,0.556836417565462,0,6,sex chromatin,CC,
586,GO:0001741,1,0.309493199050027,0,11,XY body,CC,
631,GO:0001821,1,0.564403580273439,0,7,histamine secretion,BP,
636,GO:0001826,1,0.472345019971841,0,5,inner cell mass cell differentiation,BP,
639,GO:0001829,1,0.325725316532752,0,10,trophectodermal cell differentiation,BP,
651,GO:0001842,1,0.551583028900226,0,5,neural fold formation,BP,
676,GO:0001887,1,0.678310286014165,0,4,selenium compound metabolic process,BP,
680,GO:0001891,1,0.170501472769225,0,16,phagocytic cup,CC,
689,GO:0001910,1,0.059915304914412,0,29,regulation of leukocyte mediated cytotoxicity,BP,
690,GO:0001911,1,0.408723348877172,0,10,negative regulation of leukocyte mediated cytotoxicity,BP,
691,GO:0001912,1,0.174798508038412,0,17,positive regulation of leukocyte mediated cytotoxicity,BP,
692,GO:0001913,1,0.15501300427185,0,20,T cell mediated cytotoxicity,BP,
693,GO:0001914,1,0.310636338304979,0,13,regulation of T cell mediated cytotoxicity,BP,
695,GO:0001916,1,0.482688253178679,0,8,positive regulation of T cell mediated cytotoxicity,BP,
713,GO:0001939,1,0.49906456457994,0,6,female pronucleus,CC,
714,GO:0001940,1,0.495606094430775,0,5,male pronucleus,CC,
741,GO:0001973,1,0.658975370540333,0,5,adenosine receptor signaling pathway,BP,
767,GO:0002021,1,0.351277045636954,0,10,response to dietary excess,BP,
768,GO:0002024,1,0.573999692017185,0,5,diet induced thermogenesis,BP,
777,GO:0002036,1,0.636660970340411,0,4,regulation of L-glutamate import across plasma membrane,BP,
786,GO:0002051,1,0.532083211181936,0,4,osteoblast fate commitment,BP,
799,GO:0002069,1,0.575778257780512,0,6,columnar/cuboidal epithelial cell maturation,BP,
800,GO:0002070,1,0.325082309408226,0,11,epithelial cell maturation,BP,
802,GO:0002072,1,0.382917081121547,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
810,GO:0002084,1,0.425723186933642,0,9,protein depalmitoylation,BP,
821,GO:0002097,1,0.215968592512643,0,16,tRNA wobble base modification,BP,
822,GO:0002098,1,0.340719594014053,0,12,tRNA wobble uridine modification,BP,
835,GO:0002138,1,0.617491790100065,0,5,retinoic acid biosynthetic process,BP,
836,GO:0002143,1,0.721341322018172,0,4,tRNA wobble position uridine thiolation,BP,
838,GO:0002151,1,0.471565674713587,0,6,G-quadruplex RNA binding,MF,
842,GO:0002158,1,0.660143625302064,0,4,osteoclast proliferation,BP,
850,GO:0002178,1,0.336410452611271,0,11,palmitoyltransferase complex,CC,
852,GO:0002182,1,0.303485146941404,0,11,cytoplasmic translational elongation,BP,
857,GO:0002190,1,0.682261320943129,0,5,cap-independent translational initiation,BP,
862,GO:0002199,1,0.545675068024364,0,7,zona pellucida receptor complex,CC,
873,GO:0002227,1,0.632010284222713,0,10,innate immune response in mucosa,BP,
883,GO:0002251,1,0.341990686306288,0,15,organ or tissue specific immune response,BP,
897,GO:0002278,1,0.711660041264575,0,4,eosinophil activation involved in immune response,BP,
898,GO:0002279,1,0.0570910786804239,0,26,mast cell activation involved in immune response,BP,
899,GO:0002281,1,0.484732956605112,0,6,macrophage activation involved in immune response,BP,
929,GO:0002328,1,0.25337526602963,0,9,pro-B cell differentiation,BP,
938,GO:0002349,1,0.658333772693186,0,5,histamine production involved in inflammatory response,BP,
953,GO:0002374,1,0.274488970591771,0,12,cytokine secretion involved in immune response,BP,
960,GO:0002385,1,0.389842422631642,0,14,mucosal immune response,BP,
969,GO:0002418,1,0.441981492543598,0,8,immune response to tumor cell,BP,
970,GO:0002420,1,0.635773978388593,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
971,GO:0002423,1,0.635773978388593,0,4,natural killer cell mediated immune response to tumor cell,BP,
983,GO:0002441,1,0.658333772693186,0,5,histamine secretion involved in inflammatory response,BP,
989,GO:0002447,1,0.711660041264575,0,4,eosinophil mediated immunity,BP,
990,GO:0002448,1,0.0500595405649258,0,27,mast cell mediated immunity,BP,
998,GO:0002468,1,0.602859001912844,0,4,dendritic cell antigen processing and presentation,BP,
1005,GO:0002480,1,0.497706924826601,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1007,GO:0002483,1,0.421353853926782,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1021,GO:0002523,1,0.65967151400909,0,5,leukocyte migration involved in inflammatory response,BP,
1037,GO:0002551,1,0.452885919759199,0,8,mast cell chemotaxis,BP,
1038,GO:0002553,1,0.658333772693186,0,5,histamine secretion by mast cell,BP,
1043,GO:0002566,1,0.195611506118077,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1049,GO:0002578,1,0.679411560890491,0,4,negative regulation of antigen processing and presentation,BP,
1062,GO:0002604,1,0.602859001912844,0,4,regulation of dendritic cell antigen processing and presentation,BP,
1072,GO:0002639,1,0.101453270537173,0,22,positive regulation of immunoglobulin production,BP,
1086,GO:0002675,1,0.342511630366668,0,11,positive regulation of acute inflammatory response,BP,
1087,GO:0002676,1,0.606691406389047,0,6,regulation of chronic inflammatory response,BP,
1101,GO:0002691,1,0.249449231428305,0,12,regulation of cellular extravasation,BP,
1102,GO:0002692,1,0.609395330462072,0,4,negative regulation of cellular extravasation,BP,
1103,GO:0002693,1,0.443351386463227,0,7,positive regulation of cellular extravasation,BP,
1124,GO:0002714,1,0.119601802121759,0,19,positive regulation of B cell mediated immunity,BP,
1125,GO:0002715,1,0.146245335041739,0,18,regulation of natural killer cell mediated immunity,BP,
1126,GO:0002716,1,0.426694210704031,0,9,negative regulation of natural killer cell mediated immunity,BP,
1127,GO:0002717,1,0.318341571923447,0,10,positive regulation of natural killer cell mediated immunity,BP,
1142,GO:0002739,1,0.352493904801488,0,10,regulation of cytokine secretion involved in immune response,BP,
1144,GO:0002741,1,0.454674116959642,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1150,GO:0002759,1,0.708544101025574,0,4,regulation of antimicrobial humoral response,BP,
1177,GO:0002825,1,0.350503607439657,0,11,regulation of T-helper 1 type immune response,BP,
1178,GO:0002826,1,0.655211951057972,0,4,negative regulation of T-helper 1 type immune response,BP,
1179,GO:0002827,1,0.535061535035405,0,7,positive regulation of T-helper 1 type immune response,BP,
1186,GO:0002834,1,0.52153734034675,0,6,regulation of response to tumor cell,BP,
1189,GO:0002837,1,0.52153734034675,0,6,regulation of immune response to tumor cell,BP,
1194,GO:0002855,1,0.635773978388593,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1197,GO:0002858,1,0.635773978388593,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1202,GO:0002863,1,0.705661854520106,0,4,positive regulation of inflammatory response to antigenic stimulus,BP,
1215,GO:0002886,1,0.0517244877134071,0,27,regulation of myeloid leukocyte mediated immunity,BP,
1216,GO:0002887,1,0.599887852441392,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
1217,GO:0002888,1,0.257705800847801,0,13,positive regulation of myeloid leukocyte mediated immunity,BP,
1220,GO:0002891,1,0.119601802121759,0,19,positive regulation of immunoglobulin mediated immune response,BP,
1223,GO:0002901,1,0.752604289511319,0,4,mature B cell apoptotic process,BP,
1227,GO:0002905,1,0.752604289511319,0,4,regulation of mature B cell apoptotic process,BP,
1228,GO:0002906,1,0.752604289511319,0,4,negative regulation of mature B cell apoptotic process,BP,
1233,GO:0002922,1,0.595102495171861,0,6,positive regulation of humoral immune response,BP,
1242,GO:0002943,1,0.713618497342041,0,4,tRNA dihydrouridine synthesis,BP,
1287,GO:0003097,1,0.686975602618558,0,4,renal water transport,BP,
1289,GO:0003100,1,0.669080985598268,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
1308,GO:0003157,1,0.354863146647384,0,8,endocardium development,BP,
1343,GO:0003207,1,0.525221623628972,0,4,cardiac chamber formation,BP,
1346,GO:0003211,1,0.525221623628972,0,4,cardiac ventricle formation,BP,
1369,GO:0003256,1,0.566066030246925,0,4,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1411,GO:0003348,1,0.543103242080231,0,4,cardiac endothelial cell differentiation,BP,
1452,GO:0003689,1,0.477177598061809,0,8,DNA clamp loader activity,MF,
1467,GO:0003724,1,0.000969907320125272,0,60,RNA helicase activity,MF,
1474,GO:0003743,1,0.00749893485706255,0,49,translation initiation factor activity,MF,
1476,GO:0003747,1,0.507403253590429,0,6,translation release factor activity,MF,
1491,GO:0003831,1,0.411360445548408,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1493,GO:0003836,1,0.523980776952359,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1494,GO:0003839,1,0.744803091461668,0,4,gamma-glutamylcyclotransferase activity,MF,
1500,GO:0003847,1,0.72951379104349,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1530,GO:0003916,1,0.47356028432625,0,6,DNA topoisomerase activity,MF,
1531,GO:0003917,1,0.647832487924942,0,4,DNA topoisomerase type I activity,MF,
1537,GO:0003923,1,0.616297425221167,0,5,GPI-anchor transamidase activity,MF,
1547,GO:0003945,1,0.683140222201549,0,4,N-acetyllactosamine synthase activity,MF,
1553,GO:0003954,1,0.093607847408711,0,40,NADH dehydrogenase activity,MF,
1580,GO:0003993,1,0.615439506185972,0,6,acid phosphatase activity,MF,
1582,GO:0003995,1,0.244960318832478,0,13,acyl-CoA dehydrogenase activity,MF,
1590,GO:0004004,1,0.00107418206465698,0,59,ATP-dependent RNA helicase activity,MF,
1595,GO:0004016,1,0.35333650130297,0,6,adenylate cyclase activity,MF,
1596,GO:0004017,1,0.588986104605768,0,5,adenylate kinase activity,MF,
1614,GO:0004045,1,0.76023703305641,0,4,aminoacyl-tRNA hydrolase activity,MF,
1643,GO:0004089,1,0.55549119849456,0,5,carbonate dehydratase activity,MF,
1654,GO:0004111,1,0.666762148987148,0,4,creatine kinase activity,MF,
1692,GO:0004169,1,0.65621722307981,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1696,GO:0004176,1,0.63582050271555,0,4,ATP-dependent peptidase activity,MF,
1714,GO:0004308,1,0.703684776249283,0,4,exo-alpha-sialidase activity,MF,
1715,GO:0004309,1,0.554776269049781,0,4,exopolyphosphatase activity,MF,
1718,GO:0004312,1,0.395500975991801,0,9,fatty acid synthase activity,MF,
1731,GO:0004331,1,0.605209872386156,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1761,GO:0004366,1,0.573328438961435,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1769,GO:0004376,1,0.697810334169854,0,4,glycolipid mannosyltransferase activity,MF,
1774,GO:0004383,1,0.35333650130297,0,6,guanylate cyclase activity,MF,
1785,GO:0004415,1,0.610461183613482,0,5,hyalurononglucosaminidase activity,MF,
1794,GO:0004430,1,0.505365199108291,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1797,GO:0004439,1,0.352765416464181,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1814,GO:0004466,1,0.701468500116348,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1816,GO:0004468,1,0.57047522016411,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1817,GO:0004470,1,0.670292975419145,0,4,malic enzyme activity,MF,
1822,GO:0004477,1,0.668809260983139,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1831,GO:0004488,1,0.668809260983139,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1856,GO:0004521,1,0.012250285145901,0,47,endoribonuclease activity,MF,
1858,GO:0004523,1,0.626199801370447,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1859,GO:0004525,1,0.581767111366194,0,4,ribonuclease III activity,MF,
1860,GO:0004526,1,0.404635366593859,0,11,ribonuclease P activity,MF,
1863,GO:0004529,1,0.173108189894144,0,17,exodeoxyribonuclease activity,MF,
1866,GO:0004532,1,0.020966173589006,0,34,exoribonuclease activity,MF,
1868,GO:0004535,1,0.209184959797093,0,12,poly(A)-specific ribonuclease activity,MF,
1871,GO:0004549,1,0.257626256767416,0,16,tRNA-specific ribonuclease activity,MF,
1872,GO:0004550,1,0.394409288898934,0,12,nucleoside diphosphate kinase activity,MF,
1882,GO:0004565,1,0.683450954603231,0,4,beta-galactosidase activity,MF,
1904,GO:0004594,1,0.68909714565322,0,4,pantothenate kinase activity,MF,
1906,GO:0004596,1,0.344272960592942,0,10,peptide alpha-N-acetyltransferase activity,MF,
1918,GO:0004614,1,0.618511625941219,0,4,phosphoglucomutase activity,MF,
1926,GO:0004622,1,0.191596339206649,0,16,lysophospholipase activity,MF,
1946,GO:0004652,1,0.352230560658578,0,8,polynucleotide adenylyltransferase activity,MF,
1953,GO:0004659,1,0.208317687103798,0,15,prenyltransferase activity,MF,
1955,GO:0004661,1,0.637094017184806,0,5,protein geranylgeranyltransferase activity,MF,
1957,GO:0004663,1,0.69997065096977,0,4,Rab geranylgeranyltransferase activity,MF,
1985,GO:0004707,1,0.285553648084918,0,12,MAP kinase activity,MF,
1986,GO:0004708,1,0.279997688092203,0,12,MAP kinase kinase activity,MF,
1988,GO:0004711,1,0.370610448872249,0,7,ribosomal protein S6 kinase activity,MF,
1989,GO:0004712,1,0.0161791309523513,0,36,protein serine/threonine/tyrosine kinase activity,MF,
1995,GO:0004720,1,0.584905390964139,0,5,protein-lysine 6-oxidase activity,MF,
2000,GO:0004726,1,0.419791526450853,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2009,GO:0004738,1,0.590458801681483,0,5,pyruvate dehydrogenase activity,MF,
2024,GO:0004758,1,0.558837253109958,0,5,serine C-palmitoyltransferase activity,MF,
2026,GO:0004767,1,0.586020208770895,0,5,sphingomyelin phosphodiesterase activity,MF,
2042,GO:0004791,1,0.600219856952465,0,6,thioredoxin-disulfide reductase activity,MF,
2071,GO:0004826,1,0.647342097040853,0,5,phenylalanine-tRNA ligase activity,MF,
2083,GO:0004844,1,0.670573002177609,0,5,uracil DNA N-glycosylase activity,MF,
2084,GO:0004849,1,0.662144996595706,0,5,uridine kinase activity,MF,
2095,GO:0004862,1,0.534110545703086,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2097,GO:0004865,1,0.625917985250374,0,6,protein serine/threonine phosphatase inhibitor activity,MF,
2113,GO:0004904,1,0.607595117647547,0,5,interferon receptor activity,MF,
2116,GO:0004908,1,0.586690903006476,0,5,interleukin-1 receptor activity,MF,
2187,GO:0005047,1,0.61853573034892,0,5,signal recognition particle binding,MF,
2188,GO:0005048,1,0.0088711508298585,0,40,signal sequence binding,MF,
2189,GO:0005049,1,0.307524093475752,0,8,nuclear export signal receptor activity,MF,
2198,GO:0005080,1,0.0160071664442373,0,35,protein kinase C binding,MF,
2201,GO:0005087,1,0.728118107622009,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2208,GO:0005095,1,0.288568040915246,0,11,GTPase inhibitor activity,MF,
2214,GO:0005112,1,0.103727954329053,0,15,Notch binding,MF,
2219,GO:0005123,1,0.230492801822229,0,14,death receptor binding,MF,
2226,GO:0005131,1,0.593029752894648,0,4,growth hormone receptor binding,MF,
2237,GO:0005149,1,0.39802098362197,0,9,interleukin-1 receptor binding,MF,
2256,GO:0005172,1,0.385853769583553,0,9,vascular endothelial growth factor receptor binding,MF,
2275,GO:0005225,1,0.321782359190702,0,8,volume-sensitive anion channel activity,MF,
2278,GO:0005230,1,0.296114630162841,0,10,extracellular ligand-gated ion channel activity,MF,
2279,GO:0005231,1,0.376579149519987,0,8,excitatory extracellular ligand-gated ion channel activity,MF,
2286,GO:0005246,1,0.156416134375231,0,18,calcium channel regulator activity,MF,
2300,GO:0005283,1,0.426653550801294,0,7,amino acid:sodium symporter activity,MF,
2318,GO:0005328,1,0.28379780385494,0,10,neurotransmitter:sodium symporter activity,MF,
2323,GO:0005337,1,0.638759740217478,0,5,nucleoside transmembrane transporter activity,MF,
2324,GO:0005338,1,0.327015601872515,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2326,GO:0005343,1,0.203947557256118,0,13,organic acid:sodium symporter activity,MF,
2328,GO:0005345,1,0.631397266464262,0,5,purine nucleobase transmembrane transporter activity,MF,
2329,GO:0005346,1,0.350155904561685,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2330,GO:0005347,1,0.451469318137596,0,8,ATP transmembrane transporter activity,MF,
2332,GO:0005351,1,0.398800671217425,0,8,carbohydrate:proton symporter activity,MF,
2339,GO:0005372,1,0.711847665668703,0,4,water transmembrane transporter activity,MF,
2340,GO:0005375,1,0.463502722806414,0,6,copper ion transmembrane transporter activity,MF,
2341,GO:0005381,1,0.517222582130775,0,6,iron ion transmembrane transporter activity,MF,
2342,GO:0005384,1,0.617996238308515,0,4,manganese ion transmembrane transporter activity,MF,
2344,GO:0005388,1,0.286419009529823,0,8,calcium-transporting ATPase activity,MF,
2345,GO:0005391,1,0.583692426136901,0,5,sodium:potassium-exchanging ATPase activity,MF,
2346,GO:0005402,1,0.264470347107898,0,11,carbohydrate:cation symporter activity,MF,
2349,GO:0005416,1,0.324590366936123,0,9,amino acid:cation symporter activity,MF,
2394,GO:0005540,1,0.424067864205242,0,8,hyaluronic acid binding,MF,
2395,GO:0005542,1,0.563403539446642,0,6,folic acid binding,MF,
2436,GO:0005639,1,0.399546688124563,0,8,integral component of nuclear inner membrane,CC,
2439,GO:0005642,1,0.4821408785827,0,5,annulate lamellae,CC,
2443,GO:0005655,1,0.540171565127369,0,8,nucleolar ribonuclease P complex,CC,
2446,GO:0005658,1,0.540449619529315,0,6,alpha DNA polymerase:primase complex,CC,
2447,GO:0005662,1,0.238300293864333,0,14,DNA replication factor A complex,CC,
2448,GO:0005663,1,0.594590315304817,0,6,DNA replication factor C complex,CC,
2456,GO:0005672,1,0.7504190760382,0,4,transcription factor TFIIA complex,CC,
2459,GO:0005675,1,0.315626859374783,0,13,holo TFIIH complex,CC,
2464,GO:0005683,1,0.645154847569961,0,7,U7 snRNP,CC,
2465,GO:0005684,1,0.00416757215313274,0,58,U2-type spliceosomal complex,CC,
2466,GO:0005685,1,0.165857031258674,0,20,U1 snRNP,CC,
2467,GO:0005686,1,0.178690668031421,0,20,U2 snRNP,CC,
2468,GO:0005687,1,0.391751643957799,0,11,U4 snRNP,CC,
2469,GO:0005688,1,0.58341098004445,0,8,U6 snRNP,CC,
2470,GO:0005689,1,0.125572645270895,0,26,U12-type spliceosomal complex,CC,
2482,GO:0005726,1,0.573113733367388,0,4,perichromatin fibrils,CC,
2485,GO:0005732,1,0.185351930443924,0,24,small nucleolar ribonucleoprotein complex,CC,
2486,GO:0005736,1,0.324062482133094,0,12,DNA-directed RNA polymerase I complex,CC,
2491,GO:0005742,1,0.55217065526927,0,8,mitochondrial outer membrane translocase complex,CC,
2493,GO:0005744,1,0.346261830077454,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2497,GO:0005749,1,0.665053558315156,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2498,GO:0005750,1,0.415496923539368,0,11,mitochondrial respiratory chain complex III,CC,
2501,GO:0005757,1,0.735850480860475,0,4,mitochondrial permeability transition pore complex,CC,
2505,GO:0005761,1,0.00363704254343029,0,84,mitochondrial ribosome,CC,
2506,GO:0005762,1,0.0314947467296894,0,51,mitochondrial large ribosomal subunit,CC,
2507,GO:0005763,1,0.162246888078867,0,28,mitochondrial small ribosomal subunit,CC,
2511,GO:0005767,1,0.406402947411107,0,10,secondary lysosome,CC,
2525,GO:0005784,1,0.780888294069398,0,4,Sec61 translocon complex,CC,
2527,GO:0005786,1,0.614824461911355,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2528,GO:0005787,1,0.661713035957328,0,5,signal peptidase complex,CC,
2537,GO:0005797,1,0.504242035138546,0,7,Golgi medial cisterna,CC,
2545,GO:0005816,1,0.44363791259337,0,7,spindle pole body,CC,
2546,GO:0005818,1,0.354714895498135,0,8,aster,CC,
2548,GO:0005826,1,0.508472793033081,0,5,actomyosin contractile ring,CC,
2550,GO:0005828,1,0.34445983554413,0,7,kinetochore microtubule,CC,
2552,GO:0005832,1,0.364989886358705,0,10,chaperonin-containing T-complex,CC,
2555,GO:0005838,1,0.196318304552509,0,21,proteasome regulatory particle,CC,
2559,GO:0005845,1,0.282168101071645,0,11,mRNA cap binding complex,CC,
2561,GO:0005847,1,0.167037260017254,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2562,GO:0005849,1,0.131388016302514,0,18,mRNA cleavage factor complex,CC,
2563,GO:0005850,1,0.630907222938332,0,4,eukaryotic translation initiation factor 2 complex,CC,
2564,GO:0005851,1,0.586965677458038,0,6,eukaryotic translation initiation factor 2B complex,CC,
2565,GO:0005852,1,0.218931991238893,0,17,eukaryotic translation initiation factor 3 complex,CC,
2572,GO:0005862,1,0.689592326501009,0,4,muscle thin filament tropomyosin,CC,
2575,GO:0005868,1,0.093618696671515,0,20,cytoplasmic dynein complex,CC,
2582,GO:0005879,1,0.526909457052618,0,5,axonemal microtubule,CC,
2588,GO:0005885,1,0.458994732149996,0,10,Arp2/3 protein complex,CC,
2592,GO:0005890,1,0.655581219326702,0,4,sodium:potassium-exchanging ATPase complex,CC,
2594,GO:0005892,1,0.553008268978545,0,5,acetylcholine-gated channel complex,CC,
2607,GO:0005915,1,0.401206968913152,0,7,zonula adherens,CC,
2608,GO:0005916,1,0.444683324081361,0,6,fascia adherens,CC,
2633,GO:0005968,1,0.627888946147874,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2642,GO:0005981,1,0.627437118479328,0,4,regulation of glycogen catabolic process,BP,
2645,GO:0005984,1,0.457551782470581,0,6,disaccharide metabolic process,BP,
2651,GO:0005997,1,0.727170314930741,0,4,xylulose metabolic process,BP,
2656,GO:0006002,1,0.522403812980783,0,6,fructose 6-phosphate metabolic process,BP,
2657,GO:0006003,1,0.605209872386156,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2660,GO:0006007,1,0.116672364695784,0,21,glucose catabolic process,BP,
2662,GO:0006012,1,0.333400652711168,0,11,galactose metabolic process,BP,
2677,GO:0006041,1,0.689544203511442,0,4,glucosamine metabolic process,BP,
2682,GO:0006047,1,0.260816863434855,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2683,GO:0006048,1,0.396734754332926,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2687,GO:0006054,1,0.349167413296393,0,10,N-acetylneuraminate metabolic process,BP,
2696,GO:0006064,1,0.668783099174664,0,5,glucuronate catabolic process,BP,
2703,GO:0006072,1,0.367857945270896,0,7,glycerol-3-phosphate metabolic process,BP,
2722,GO:0006104,1,0.579538381902393,0,6,succinyl-CoA metabolic process,BP,
2723,GO:0006105,1,0.317190768808493,0,11,succinate metabolic process,BP,
2725,GO:0006107,1,0.36578036672011,0,10,oxaloacetate metabolic process,BP,
2726,GO:0006108,1,0.581210902335803,0,6,malate metabolic process,BP,
2737,GO:0006121,1,0.732128269053255,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2738,GO:0006122,1,0.302813247076984,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2739,GO:0006123,1,0.387817204752285,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2747,GO:0006152,1,0.621460175833551,0,6,purine nucleoside catabolic process,BP,
2753,GO:0006166,1,0.65261027100157,0,5,purine ribonucleoside salvage,BP,
2761,GO:0006177,1,0.66918869392382,0,5,GMP biosynthetic process,BP,
2764,GO:0006183,1,0.539438273846972,0,9,GTP biosynthetic process,BP,
2767,GO:0006188,1,0.348033241116158,0,10,IMP biosynthetic process,BP,
2768,GO:0006189,1,0.521633057727743,0,6,'de novo' IMP biosynthetic process,BP,
2784,GO:0006220,1,0.0356904341307075,0,41,pyrimidine nucleotide metabolic process,BP,
2785,GO:0006221,1,0.102120402898052,0,28,pyrimidine nucleotide biosynthetic process,BP,
2786,GO:0006222,1,0.42863412653333,0,9,UMP biosynthetic process,BP,
2789,GO:0006228,1,0.529748526556488,0,8,UTP biosynthetic process,BP,
2792,GO:0006235,1,0.741101523470802,0,4,dTTP biosynthetic process,BP,
2794,GO:0006241,1,0.405945836541469,0,12,CTP biosynthetic process,BP,
2795,GO:0006244,1,0.389164988542716,0,12,pyrimidine nucleotide catabolic process,BP,
2803,GO:0006265,1,0.359250388130508,0,9,DNA topological change,BP,
2806,GO:0006268,1,0.496149910149423,0,7,DNA unwinding involved in DNA replication,BP,
2820,GO:0006287,1,0.54797054755092,0,5,base-excision repair, gap-filling,BP,
2836,GO:0006307,1,0.396202637516321,0,10,DNA dealkylation involved in DNA repair,BP,
2838,GO:0006309,1,0.16500565982024,0,17,apoptotic DNA fragmentation,BP,
2847,GO:0006335,1,0.163292034700609,0,32,DNA replication-dependent nucleosome assembly,BP,
2849,GO:0006337,1,0.140787238631911,0,16,nucleosome disassembly,BP,
2853,GO:0006344,1,0.55385939764844,0,4,maintenance of chromatin silencing,BP,
2855,GO:0006348,1,0.450264652217544,0,8,chromatin silencing at telomere,BP,
2856,GO:0006349,1,0.167169646032326,0,13,regulation of gene expression by genetic imprinting,BP,
2866,GO:0006361,1,0.0330146274465759,0,35,transcription initiation from RNA polymerase I promoter,BP,
2868,GO:0006363,1,0.0602320708617121,0,30,termination of RNA polymerase I transcription,BP,
2874,GO:0006370,1,0.0499964956605736,0,32,7-methylguanosine mRNA capping,BP,
2876,GO:0006378,1,0.0112592503479922,0,39,mRNA polyadenylation,BP,
2877,GO:0006379,1,0.062535048743177,0,27,mRNA cleavage,BP,
2880,GO:0006384,1,0.387646508985209,0,7,transcription initiation from RNA polymerase III promoter,BP,
2882,GO:0006388,1,0.326034142575856,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2883,GO:0006390,1,0.23099136488806,0,13,mitochondrial transcription,BP,
2886,GO:0006396,1,0,22,876,RNA processing,BP,ZFP36L1;EGFR;BMP4;AHNAK;MBNL2;ZCCHC11;ADARB1;TEP1;RBFOX2;AHNAK2;PIK3R1;AARS;PRX;SETX;NCOR1;RPL13A;ATXN1;CELF2;SRPK2;LGALS3;PPP3CA;AGO4
2888,GO:0006398,1,0.581703223550408,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2895,GO:0006405,1,3.79572047223606e-07,0,133,RNA export from nucleus,BP,
2896,GO:0006406,1,8.67617548380067e-06,0,103,mRNA export from nucleus,BP,
2899,GO:0006409,1,0.0194740901827199,0,32,tRNA export from nucleus,BP,
2903,GO:0006415,1,0.00057478269818927,0,100,translational termination,BP,
2919,GO:0006432,1,0.647342097040853,0,5,phenylalanyl-tRNA aminoacylation,BP,
2928,GO:0006448,1,0.17287300930492,0,17,regulation of translational elongation,BP,
2929,GO:0006449,1,0.459120491725824,0,7,regulation of translational termination,BP,
2931,GO:0006451,1,0.465105226818867,0,7,translational readthrough,BP,
2943,GO:0006474,1,0.16604995015413,0,14,N-terminal protein amino acid acetylation,BP,
2955,GO:0006489,1,0.509839352074055,0,7,dolichyl diphosphate biosynthetic process,BP,
2960,GO:0006498,1,0.512789830027675,0,5,N-terminal protein lipidation,BP,
2961,GO:0006499,1,0.557298196446508,0,4,N-terminal protein myristoylation,BP,
2990,GO:0006537,1,0.631501046171189,0,4,glutamate biosynthetic process,BP,
2991,GO:0006538,1,0.516724302933793,0,6,glutamate catabolic process,BP,
2999,GO:0006547,1,0.668878526466339,0,4,histidine metabolic process,BP,
3001,GO:0006549,1,0.560749555425906,0,5,isoleucine metabolic process,BP,
3003,GO:0006551,1,0.464063301628008,0,7,leucine metabolic process,BP,
3004,GO:0006552,1,0.609964575130003,0,5,leucine catabolic process,BP,
3013,GO:0006561,1,0.706724684053345,0,4,proline biosynthetic process,BP,
3020,GO:0006568,1,0.600101640821467,0,5,tryptophan metabolic process,BP,
3031,GO:0006582,1,0.282369198128705,0,9,melanin metabolic process,BP,
3034,GO:0006586,1,0.600101640821467,0,5,indolalkylamine metabolic process,BP,
3036,GO:0006590,1,0.313666569533133,0,9,thyroid hormone generation,BP,
3037,GO:0006591,1,0.518094967194119,0,7,ornithine metabolic process,BP,
3039,GO:0006595,1,0.325337724112793,0,14,polyamine metabolic process,BP,
3040,GO:0006596,1,0.36642867596369,0,12,polyamine biosynthetic process,BP,
3042,GO:0006598,1,0.714240487593825,0,5,polyamine catabolic process,BP,
3043,GO:0006600,1,0.441809083895762,0,8,creatine metabolic process,BP,
3047,GO:0006607,1,0.0550279279972515,0,20,NLS-bearing protein import into nucleus,BP,
3048,GO:0006610,1,0.344075875310034,0,8,ribosomal protein import into nucleus,BP,
3053,GO:0006616,1,0.640904322406737,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3055,GO:0006620,1,0.45228749951128,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3056,GO:0006621,1,0.461393870974429,0,8,protein retention in ER lumen,BP,
3062,GO:0006627,1,0.610824925638029,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3081,GO:0006657,1,0.49977187542918,0,7,CDP-choline pathway,BP,
3086,GO:0006662,1,0.416180475028212,0,9,glycerol ether metabolic process,BP,
3094,GO:0006670,1,0.37535850242614,0,10,sphingosine metabolic process,BP,
3098,GO:0006678,1,0.469842706706826,0,7,glucosylceramide metabolic process,BP,
3104,GO:0006684,1,0.249510009853139,0,13,sphingomyelin metabolic process,BP,
3105,GO:0006685,1,0.573972899616303,0,5,sphingomyelin catabolic process,BP,
3106,GO:0006686,1,0.507139971091966,0,6,sphingomyelin biosynthetic process,BP,
3109,GO:0006689,1,0.689604914952756,0,4,ganglioside catabolic process,BP,
3120,GO:0006702,1,0.551787450588189,0,5,androgen biosynthetic process,BP,
3123,GO:0006705,1,0.57987063703513,0,5,mineralocorticoid biosynthetic process,BP,
3134,GO:0006729,1,0.577508046634912,0,7,tetrahydrobiopterin biosynthetic process,BP,
3138,GO:0006734,1,0.0702003689597518,0,26,NADH metabolic process,BP,
3139,GO:0006735,1,0.185489348956892,0,17,NADH regeneration,BP,
3145,GO:0006743,1,0.283753432878489,0,15,ubiquinone metabolic process,BP,
3146,GO:0006744,1,0.326255788477142,0,14,ubiquinone biosynthetic process,BP,
3163,GO:0006777,1,0.546181131221943,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3168,GO:0006782,1,0.567748773233281,0,7,protoporphyrinogen IX biosynthetic process,BP,
3171,GO:0006787,1,0.706396257959951,0,5,porphyrin-containing compound catabolic process,BP,
3177,GO:0006797,1,0.503645705848175,0,5,polyphosphate metabolic process,BP,
3178,GO:0006798,1,0.554776269049781,0,4,polyphosphate catabolic process,BP,
3198,GO:0006833,1,0.566150967392382,0,6,water transport,BP,
3203,GO:0006842,1,0.644540905780246,0,4,tricarboxylic acid transport,BP,
3208,GO:0006851,1,0.134226233615058,0,20,mitochondrial calcium ion transmembrane transport,BP,
3211,GO:0006857,1,0.410411051339164,0,8,oligopeptide transport,BP,
3213,GO:0006862,1,0.214368073958286,0,16,nucleotide transport,BP,
3214,GO:0006863,1,0.589345871873905,0,6,purine nucleobase transport,BP,
3226,GO:0006882,1,0.122676070373621,0,21,cellular zinc ion homeostasis,BP,
3248,GO:0006910,1,0.499473467083847,0,6,phagocytosis, recognition,BP,
3279,GO:0006968,1,0.123608665706586,0,19,cellular defense response,BP,
3294,GO:0006991,1,0.372213266349917,0,9,response to sterol depletion,BP,
3295,GO:0006995,1,0.435873988956502,0,10,cellular response to nitrogen starvation,BP,
3299,GO:0006999,1,0.144569051648352,0,15,nuclear pore organization,BP,
3300,GO:0007000,1,0.456747862820506,0,7,nucleolus organization,BP,
3304,GO:0007007,1,0.152880171046288,0,22,inner mitochondrial membrane organization,BP,
3315,GO:0007021,1,0.590772467392052,0,7,tubulin complex assembly,BP,
3316,GO:0007023,1,0.711909426626989,0,4,post-chaperonin tubulin folding pathway,BP,
3318,GO:0007028,1,0.29498941963194,0,8,cytoplasm organization,BP,
3325,GO:0007035,1,0.137676903156692,0,19,vacuolar acidification,BP,
3329,GO:0007042,1,0.54450699464297,0,8,lysosomal lumen acidification,BP,
3349,GO:0007080,1,0.0144013850242184,0,43,mitotic metaphase plate congression,BP,
3357,GO:0007096,1,0.215707455081753,0,15,regulation of exit from mitosis,BP,
3360,GO:0007099,1,0.0291538794603393,0,29,centriole replication,BP,
3361,GO:0007100,1,0.203696090924434,0,13,mitotic centrosome separation,BP,
3367,GO:0007135,1,0.559307066115175,0,6,meiosis II,BP,
3400,GO:0007183,1,0.216667006575424,0,11,SMAD protein complex assembly,BP,
3406,GO:0007190,1,0.165275526916496,0,14,activation of adenylate cyclase activity,BP,
3409,GO:0007194,1,0.429061247737212,0,7,negative regulation of adenylate cyclase activity,BP,
3423,GO:0007214,1,0.492864282490307,0,6,gamma-aminobutyric acid signaling pathway,BP,
3425,GO:0007216,1,0.579711445452864,0,5,G-protein coupled glutamate receptor signaling pathway,BP,
3441,GO:0007253,1,0.558244315693175,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3445,GO:0007258,1,0.648845041750045,0,4,JUN phosphorylation,BP,
3455,GO:0007270,1,0.395202860716035,0,6,neuron-neuron synaptic transmission,BP,
3469,GO:0007296,1,0.532878934887709,0,4,vitellogenesis,BP,
3479,GO:0007342,1,0.753994515734163,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3482,GO:0007350,1,0.228048648332356,0,12,blastoderm segmentation,BP,
3483,GO:0007351,1,0.328191333243499,0,9,tripartite regional subdivision,BP,
3490,GO:0007379,1,0.315812750504796,0,11,segment specification,BP,
3491,GO:0007386,1,0.556193093812222,0,5,compartment pattern specification,BP,
3500,GO:0007406,1,0.566378182706027,0,4,negative regulation of neuroblast proliferation,BP,
3514,GO:0007440,1,0.31851920277725,0,6,foregut morphogenesis,BP,
3539,GO:0007549,1,0.17637811748395,0,12,dosage compensation,BP,
3559,GO:0007602,1,0.0871078172693788,0,23,phototransduction,BP,
3560,GO:0007603,1,0.181063688245106,0,16,phototransduction, visible light,BP,
3568,GO:0007614,1,0.58599952284886,0,6,short-term memory,BP,
3595,GO:0008024,1,0.362918556373393,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3599,GO:0008035,1,0.667414406046671,0,4,high-density lipoprotein particle binding,MF,
3610,GO:0008053,1,0.151070345979368,0,20,mitochondrial fusion,BP,
3613,GO:0008063,1,0.662917193678797,0,4,Toll signaling pathway,BP,
3616,GO:0008066,1,0.524010735463566,0,4,glutamate receptor activity,MF,
3618,GO:0008074,1,0.35333650130297,0,6,guanylate cyclase complex, soluble,CC,
3621,GO:0008079,1,0.507403253590429,0,6,translation termination factor activity,MF,
3645,GO:0008121,1,0.59956416221942,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3652,GO:0008137,1,0.109589409366666,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3654,GO:0008139,1,0.0433205856871823,0,23,nuclear localization sequence binding,MF,
3669,GO:0008170,1,0.000288692213819876,0,74,N-methyltransferase activity,MF,
3671,GO:0008172,1,0.561307977483763,0,5,S-methyltransferase activity,MF,
3672,GO:0008173,1,0.00438973488718533,0,55,RNA methyltransferase activity,MF,
3673,GO:0008174,1,0.403924543363831,0,9,mRNA methyltransferase activity,MF,
3674,GO:0008175,1,0.0539962033221683,0,28,tRNA methyltransferase activity,MF,
3676,GO:0008177,1,0.665053558315156,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
3677,GO:0008179,1,0.27925547185592,0,10,adenylate cyclase binding,MF,
3680,GO:0008186,1,0.000946313797698411,0,60,RNA-dependent ATPase activity,MF,
3683,GO:0008190,1,0.367449202318129,0,8,eukaryotic initiation factor 4E binding,MF,
3688,GO:0008195,1,0.351056899186518,0,9,phosphatidate phosphatase activity,MF,
3701,GO:0008212,1,0.57987063703513,0,5,mineralocorticoid metabolic process,BP,
3704,GO:0008215,1,0.633754992881327,0,6,spermine metabolic process,BP,
3705,GO:0008216,1,0.599959586386957,0,7,spermidine metabolic process,BP,
3732,GO:0008271,1,0.524046267093156,0,5,secondary active sulfate transmembrane transporter activity,MF,
3733,GO:0008272,1,0.434285613984869,0,7,sulfate transport,BP,
3735,GO:0008274,1,0.357177728497392,0,8,gamma-tubulin ring complex,CC,
3736,GO:0008275,1,0.618452555744787,0,4,gamma-tubulin small complex,CC,
3739,GO:0008278,1,0.343496718975651,0,8,cohesin complex,CC,
3750,GO:0008295,1,0.71796483947677,0,4,spermidine biosynthetic process,BP,
3751,GO:0008296,1,0.45754978884697,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3752,GO:0008297,1,0.523326240464085,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3754,GO:0008299,1,0.119456729474738,0,22,isoprenoid biosynthetic process,BP,
3761,GO:0008309,1,0.710891817181846,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3762,GO:0008310,1,0.641294788348799,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3764,GO:0008312,1,0.565115567089413,0,7,7S RNA binding,MF,
3765,GO:0008318,1,0.461223730979864,0,7,protein prenyltransferase activity,MF,
3766,GO:0008320,1,0.354983490888571,0,14,protein transmembrane transporter activity,MF,
3769,GO:0008327,1,0.1625969238034,0,16,methyl-CpG binding,MF,
3772,GO:0008330,1,0.712002052494143,0,4,protein tyrosine/threonine phosphatase activity,MF,
3784,GO:0008353,1,0.212426432839947,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3785,GO:0008354,1,0.461607047090122,0,7,germ cell migration,BP,
3804,GO:0008395,1,0.574393783436134,0,6,steroid hydroxylase activity,MF,
3811,GO:0008408,1,0.00681923258264081,0,45,3'-5' exonuclease activity,MF,
3812,GO:0008409,1,0.137154756760704,0,16,5'-3' exonuclease activity,MF,
3833,GO:0008443,1,0.492953753739683,0,6,phosphofructokinase activity,MF,
3850,GO:0008469,1,0.491347449754605,0,8,histone-arginine N-methyltransferase activity,MF,
3852,GO:0008474,1,0.394479224690736,0,10,palmitoyl-(protein) hydrolase activity,MF,
3856,GO:0008479,1,0.747161558278607,0,4,queuine tRNA-ribosyltransferase activity,MF,
3861,GO:0008486,1,0.68370776824984,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3865,GO:0008494,1,0.521990031178001,0,7,translation activator activity,MF,
3868,GO:0008499,1,0.38635753491026,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3870,GO:0008504,1,0.621268677808466,0,4,monoamine transmembrane transporter activity,MF,
3875,GO:0008510,1,0.473884158771319,0,5,sodium:bicarbonate symporter activity,MF,
3880,GO:0008517,1,0.614044969322225,0,4,folic acid transmembrane transporter activity,MF,
3882,GO:0008519,1,0.15916484760687,0,17,ammonium transmembrane transporter activity,MF,
3888,GO:0008527,1,0.631537246499078,0,7,taste receptor activity,MF,
3891,GO:0008532,1,0.439066253714314,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
3894,GO:0008536,1,0.0138532561530078,0,32,Ran GTPase binding,MF,
3896,GO:0008540,1,0.381551945325553,0,12,proteasome regulatory particle, base subcomplex,CC,
3897,GO:0008541,1,0.592168614581205,0,7,proteasome regulatory particle, lid subcomplex,CC,
3902,GO:0008553,1,0.373668919657873,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3904,GO:0008556,1,0.583692426136901,0,5,potassium-transporting ATPase activity,MF,
3905,GO:0008559,1,0.586840828683395,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
3907,GO:0008568,1,0.316337358805659,0,10,microtubule-severing ATPase activity,MF,
3919,GO:0008595,1,0.328191333243499,0,9,anterior/posterior axis specification, embryo,BP,
3923,GO:0008608,1,0.0503396992173099,0,28,attachment of spindle microtubules to kinetochore,BP,
3926,GO:0008611,1,0.562408796068154,0,5,ether lipid biosynthetic process,BP,
3927,GO:0008612,1,0.694367408454579,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3932,GO:0008622,1,0.611146492916437,0,5,epsilon DNA polymerase complex,CC,
3939,GO:0008635,1,0.402555475602546,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3944,GO:0008649,1,0.23358304772187,0,16,rRNA methyltransferase activity,MF,
3948,GO:0008655,1,0.364959933040258,0,12,pyrimidine-containing compound salvage,BP,
3978,GO:0008821,1,0.426846278855041,0,9,crossover junction endodeoxyribonuclease activity,MF,
3997,GO:0008934,1,0.625206360179963,0,4,inositol monophosphate 1-phosphatase activity,MF,
4000,GO:0008948,1,0.663787279644035,0,4,oxaloacetate decarboxylase activity,MF,
4004,GO:0008970,1,0.483746406613275,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
4010,GO:0009008,1,0.548827550854153,0,5,DNA-methyltransferase activity,MF,
4012,GO:0009019,1,0.639773394309259,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4016,GO:0009048,1,0.207721122091355,0,10,dosage compensation by inactivation of X chromosome,BP,
4018,GO:0009052,1,0.647963124557668,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4045,GO:0009086,1,0.310338134844001,0,11,methionine biosynthetic process,BP,
4047,GO:0009092,1,0.704438332460335,0,4,homoserine metabolic process,BP,
4058,GO:0009111,1,0.510387414360263,0,7,vitamin catabolic process,BP,
4060,GO:0009113,1,0.302872979034518,0,13,purine nucleobase biosynthetic process,BP,
4071,GO:0009128,1,0.456154797617652,0,8,purine nucleoside monophosphate catabolic process,BP,
4072,GO:0009129,1,0.288897811012924,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4073,GO:0009130,1,0.288897811012924,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4075,GO:0009133,1,0.737854495794954,0,4,nucleoside diphosphate biosynthetic process,BP,
4076,GO:0009134,1,0.523567827547559,0,7,nucleoside diphosphate catabolic process,BP,
4079,GO:0009137,1,0.677253568213733,0,4,purine nucleoside diphosphate catabolic process,BP,
4088,GO:0009146,1,0.587101938045444,0,6,purine nucleoside triphosphate catabolic process,BP,
4089,GO:0009147,1,0.198692439096762,0,20,pyrimidine nucleoside triphosphate metabolic process,BP,
4090,GO:0009148,1,0.250478811295354,0,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4093,GO:0009151,1,0.432732162183288,0,10,purine deoxyribonucleotide metabolic process,BP,
4097,GO:0009155,1,0.580820179275534,0,6,purine deoxyribonucleotide catabolic process,BP,
4099,GO:0009157,1,0.464853125030477,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4100,GO:0009158,1,0.456154797617652,0,8,ribonucleoside monophosphate catabolic process,BP,
4104,GO:0009163,1,0.0323673599653225,0,40,nucleoside biosynthetic process,BP,
4110,GO:0009169,1,0.456154797617652,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4112,GO:0009173,1,0.42863412653333,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4113,GO:0009174,1,0.42863412653333,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4114,GO:0009176,1,0.674181577553939,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4115,GO:0009177,1,0.674181577553939,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4118,GO:0009181,1,0.677253568213733,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4123,GO:0009186,1,0.679190592187849,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4128,GO:0009191,1,0.576088056563493,0,6,ribonucleoside diphosphate catabolic process,BP,
4135,GO:0009200,1,0.258452832136363,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4137,GO:0009202,1,0.619323730627933,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4139,GO:0009204,1,0.5425600376158,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4143,GO:0009208,1,0.308239110936787,0,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4144,GO:0009209,1,0.33807323877686,0,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4145,GO:0009211,1,0.644882474862882,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4146,GO:0009212,1,0.741101523470802,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4149,GO:0009215,1,0.464556444285295,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4151,GO:0009217,1,0.623524269081531,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4152,GO:0009218,1,0.179925382622497,0,20,pyrimidine ribonucleotide metabolic process,BP,
4153,GO:0009219,1,0.249460794224464,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4154,GO:0009220,1,0.217832719048119,0,18,pyrimidine ribonucleotide biosynthetic process,BP,
4155,GO:0009221,1,0.537141387701403,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4157,GO:0009223,1,0.429536621521393,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4160,GO:0009226,1,0.135156801672825,0,21,nucleotide-sugar biosynthetic process,BP,
4165,GO:0009235,1,0.233913987902554,0,13,cobalamin metabolic process,BP,
4168,GO:0009240,1,0.687423612958341,0,5,isopentenyl diphosphate biosynthetic process,BP,
4171,GO:0009249,1,0.64636107922449,0,7,protein lipoylation,BP,
4181,GO:0009262,1,0.0695236684466378,0,32,deoxyribonucleotide metabolic process,BP,
4182,GO:0009263,1,0.325203806257316,0,13,deoxyribonucleotide biosynthetic process,BP,
4183,GO:0009264,1,0.231226104843203,0,18,deoxyribonucleotide catabolic process,BP,
4184,GO:0009265,1,0.467481507294576,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4187,GO:0009268,1,0.10809692765903,0,22,response to pH,BP,
4189,GO:0009298,1,0.740047124855265,0,4,GDP-mannose biosynthetic process,BP,
4193,GO:0009304,1,0.452843796581424,0,7,tRNA transcription,BP,
4197,GO:0009309,1,0.331056998959264,0,13,amine biosynthetic process,BP,
4203,GO:0009328,1,0.699773968091891,0,4,phenylalanine-tRNA ligase complex,CC,
4212,GO:0009378,1,0.515184635504144,0,5,four-way junction helicase activity,MF,
4216,GO:0009394,1,0.107845432471963,0,28,2'-deoxyribonucleotide metabolic process,BP,
4217,GO:0009395,1,0.0486888602475137,0,28,phospholipid catabolic process,BP,
4218,GO:0009396,1,0.434623583040868,0,9,folic acid-containing compound biosynthetic process,BP,
4222,GO:0009403,1,0.652130700429222,0,4,toxin biosynthetic process,BP,
4225,GO:0009407,1,0.745934628110952,0,4,toxin catabolic process,BP,
4236,GO:0009438,1,0.676087096454963,0,5,methylglyoxal metabolic process,BP,
4241,GO:0009445,1,0.554150582180947,0,7,putrescine metabolic process,BP,
4242,GO:0009446,1,0.62294303590528,0,5,putrescine biosynthetic process,BP,
4248,GO:0009452,1,0.0443584351077598,0,33,7-methylguanosine RNA capping,BP,
4252,GO:0009583,1,0.045776500077928,0,28,detection of light stimulus,BP,
4253,GO:0009584,1,0.0867997930879598,0,22,detection of visible light,BP,
4265,GO:0009620,1,0.176505445703173,0,20,response to fungus,BP,
4298,GO:0009750,1,0.672364561326387,0,4,response to fructose,BP,
4301,GO:0009756,1,0.573695744293296,0,6,carbohydrate mediated signaling,BP,
4302,GO:0009757,1,0.626630671729826,0,5,hexose mediated signaling,BP,
4311,GO:0009794,1,0.672036016078619,0,4,regulation of mitotic cell cycle, embryonic,BP,
4322,GO:0009838,1,0.664199205700844,0,5,abscission,BP,
4328,GO:0009881,1,0.649167492073228,0,4,photoreceptor activity,MF,
4343,GO:0009912,1,0.555762076242852,0,5,auditory receptor cell fate commitment,BP,
4347,GO:0009922,1,0.604691418187653,0,5,fatty acid elongase activity,MF,
4363,GO:0009982,1,0.312770502432659,0,13,pseudouridine synthase activity,MF,
4387,GO:0010044,1,0.693482663815454,0,4,response to aluminum ion,BP,
4398,GO:0010138,1,0.739151194551673,0,4,pyrimidine ribonucleotide salvage,BP,
4401,GO:0010155,1,0.442116301301108,0,9,regulation of proton transport,BP,
4411,GO:0010182,1,0.626630671729826,0,5,sugar mediated signaling pathway,BP,
4421,GO:0010248,1,0.588706232113599,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4422,GO:0010255,1,0.626630671729826,0,5,glucose mediated signaling pathway,BP,
4424,GO:0010257,1,0.0273250013523178,0,55,NADH dehydrogenase complex assembly,BP,
4430,GO:0010273,1,0.683797242433706,0,5,detoxification of copper ion,BP,
4431,GO:0010286,1,0.678383264501779,0,5,heat acclimation,BP,
4451,GO:0010421,1,0.321439432587313,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4454,GO:0010447,1,0.314584988928056,0,11,response to acidic pH,BP,
4455,GO:0010452,1,0.258470058719104,0,9,histone H3-K36 methylation,BP,
4458,GO:0010455,1,0.66819854539338,0,4,positive regulation of cell fate commitment,BP,
4460,GO:0010458,1,0.0625244885022544,0,26,exit from mitosis,BP,
4461,GO:0010459,1,0.735347761280334,0,4,negative regulation of heart rate,BP,
4473,GO:0010484,1,0.548747272004139,0,4,H3 histone acetyltransferase activity,MF,
4474,GO:0010485,1,0.110793435238265,0,18,H4 histone acetyltransferase activity,MF,
4505,GO:0010560,1,0.212049507515905,0,13,positive regulation of glycoprotein biosynthetic process,BP,
4527,GO:0010603,1,0.337489371935252,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4530,GO:0010606,1,0.440362703391102,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4541,GO:0010624,1,0.542289969046619,0,4,regulation of Schwann cell proliferation,BP,
4542,GO:0010626,1,0.542289969046619,0,4,negative regulation of Schwann cell proliferation,BP,
4549,GO:0010635,1,0.43605691770158,0,8,regulation of mitochondrial fusion,BP,
4551,GO:0010637,1,0.622407526398087,0,5,negative regulation of mitochondrial fusion,BP,
4566,GO:0010656,1,0.0819839555613588,0,22,negative regulation of muscle cell apoptotic process,BP,
4574,GO:0010664,1,0.178627144269392,0,15,negative regulation of striated muscle cell apoptotic process,BP,
4577,GO:0010667,1,0.255792261615802,0,12,negative regulation of cardiac muscle cell apoptotic process,BP,
4605,GO:0010727,1,0.607834146089519,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4606,GO:0010728,1,0.638589489989509,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4616,GO:0010739,1,0.600767306824253,0,5,positive regulation of protein kinase A signaling,BP,
4632,GO:0010759,1,0.489263967008539,0,7,positive regulation of macrophage chemotaxis,BP,
4637,GO:0010764,1,0.538393927287614,0,6,negative regulation of fibroblast migration,BP,
4645,GO:0010792,1,0.549020888658557,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4646,GO:0010793,1,0.518058420103184,0,5,regulation of mRNA export from nucleus,BP,
4651,GO:0010800,1,0.0831084321978706,0,21,positive regulation of peptidyl-threonine phosphorylation,BP,
4655,GO:0010807,1,0.485825268736437,0,6,regulation of synaptic vesicle priming,BP,
4662,GO:0010815,1,0.629729401138662,0,4,bradykinin catabolic process,BP,
4672,GO:0010825,1,0.476577677770962,0,6,positive regulation of centrosome duplication,BP,
4679,GO:0010832,1,0.477631879223871,0,5,negative regulation of myotube differentiation,BP,
4681,GO:0010835,1,0.487730632726476,0,7,regulation of protein ADP-ribosylation,BP,
4684,GO:0010838,1,0.52452083885631,0,5,positive regulation of keratinocyte proliferation,BP,
4688,GO:0010847,1,0.564820741686975,0,4,regulation of chromatin assembly,BP,
4700,GO:0010867,1,0.398905830315551,0,9,positive regulation of triglyceride biosynthetic process,BP,
4703,GO:0010870,1,0.355756607829279,0,10,positive regulation of receptor biosynthetic process,BP,
4705,GO:0010872,1,0.679503145379365,0,5,regulation of cholesterol esterification,BP,
4738,GO:0010911,1,0.409214780798115,0,7,regulation of isomerase activity,BP,
4739,GO:0010912,1,0.409214780798115,0,7,positive regulation of isomerase activity,BP,
4742,GO:0010917,1,0.478938290019977,0,8,negative regulation of mitochondrial membrane potential,BP,
4743,GO:0010918,1,0.488003826256469,0,7,positive regulation of mitochondrial membrane potential,BP,
4756,GO:0010940,1,0.677051414978871,0,5,positive regulation of necrotic cell death,BP,
4759,GO:0010944,1,0.533112026634959,0,6,negative regulation of transcription by competitive promoter binding,BP,
4768,GO:0010958,1,0.636660970340411,0,4,regulation of amino acid import across plasma membrane,BP,
4789,GO:0010985,1,0.655377826356268,0,5,negative regulation of lipoprotein particle clearance,BP,
4795,GO:0010992,1,0.464807834970864,0,7,ubiquitin recycling,BP,
4796,GO:0010994,1,0.627710059887089,0,5,free ubiquitin chain polymerization,BP,
4798,GO:0010997,1,0.567902822181254,0,5,anaphase-promoting complex binding,MF,
4811,GO:0014010,1,0.460104646283479,0,5,Schwann cell proliferation,BP,
4880,GO:0014805,1,0.756392609311286,0,4,smooth muscle adaptation,BP,
4882,GO:0014807,1,0.513826237964604,0,6,regulation of somitogenesis,BP,
4902,GO:0014841,1,0.414624073017975,0,7,skeletal muscle satellite cell proliferation,BP,
4903,GO:0014842,1,0.414624073017975,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4913,GO:0014856,1,0.414624073017975,0,7,skeletal muscle cell proliferation,BP,
4914,GO:0014857,1,0.414624073017975,0,7,regulation of skeletal muscle cell proliferation,BP,
4934,GO:0014900,1,0.698498471908995,0,4,muscle hyperplasia,BP,
4946,GO:0015014,1,0.572135675055271,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4947,GO:0015015,1,0.619703656871637,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4953,GO:0015030,1,0.00609746212592277,0,51,Cajal body,CC,
4958,GO:0015038,1,0.719900732870859,0,5,glutathione disulfide oxidoreductase activity,MF,
4978,GO:0015106,1,0.223863153724156,0,11,bicarbonate transmembrane transporter activity,MF,
4983,GO:0015116,1,0.484336217574832,0,6,sulfate transmembrane transporter activity,MF,
4986,GO:0015125,1,0.685694895518691,0,4,bile acid transmembrane transporter activity,MF,
4992,GO:0015137,1,0.644540905780246,0,4,citrate transmembrane transporter activity,MF,
4995,GO:0015142,1,0.644540905780246,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5003,GO:0015165,1,0.400870669288636,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5004,GO:0015166,1,0.544417574057986,0,4,polyol transmembrane transporter activity,MF,
5009,GO:0015174,1,0.44074530908693,0,7,basic amino acid transmembrane transporter activity,MF,
5012,GO:0015180,1,0.553004676984237,0,5,L-alanine transmembrane transporter activity,MF,
5013,GO:0015181,1,0.533334263020881,0,5,arginine transmembrane transporter activity,MF,
5019,GO:0015187,1,0.580919242211073,0,5,glycine transmembrane transporter activity,MF,
5020,GO:0015189,1,0.533334263020881,0,5,L-lysine transmembrane transporter activity,MF,
5023,GO:0015193,1,0.520767029337323,0,5,L-proline transmembrane transporter activity,MF,
5024,GO:0015194,1,0.518107632560311,0,7,L-serine transmembrane transporter activity,MF,
5029,GO:0015205,1,0.52733705836089,0,6,nucleobase transmembrane transporter activity,MF,
5032,GO:0015215,1,0.237778241044025,0,15,nucleotide transmembrane transporter activity,MF,
5033,GO:0015216,1,0.350155904561685,0,11,purine nucleotide transmembrane transporter activity,MF,
5034,GO:0015217,1,0.412399612959831,0,9,ADP transmembrane transporter activity,MF,
5036,GO:0015220,1,0.640667358514141,0,4,choline transmembrane transporter activity,MF,
5038,GO:0015226,1,0.671368492391168,0,4,carnitine transmembrane transporter activity,MF,
5049,GO:0015250,1,0.711847665668703,0,4,water channel activity,MF,
5062,GO:0015288,1,0.615214491542373,0,6,porin activity,MF,
5067,GO:0015295,1,0.133578374455765,0,18,solute:proton symporter activity,MF,
5068,GO:0015296,1,0.366701765428644,0,7,anion:cation symporter activity,MF,
5086,GO:0015355,1,0.708208928626698,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5094,GO:0015377,1,0.411917541912566,0,6,cation:chloride symporter activity,MF,
5096,GO:0015379,1,0.411917541912566,0,6,potassium:chloride symporter activity,MF,
5111,GO:0015440,1,0.633650346241753,0,4,peptide-transporting ATPase activity,MF,
5112,GO:0015450,1,0.614062402038786,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5114,GO:0015464,1,0.482188888130921,0,7,acetylcholine receptor activity,MF,
5123,GO:0015556,1,0.487200477129272,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5124,GO:0015562,1,0.604485306438579,0,4,efflux transmembrane transporter activity,MF,
5126,GO:0015605,1,0.111425100779618,0,21,organophosphate ester transmembrane transporter activity,MF,
5127,GO:0015616,1,0.513626268029526,0,4,DNA translocase activity,MF,
5131,GO:0015643,1,0.485628484362061,0,7,toxic substance binding,MF,
5133,GO:0015651,1,0.524708339635598,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5136,GO:0015662,1,0.0570903635264654,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5157,GO:0015701,1,0.0974194970471331,0,19,bicarbonate transport,BP,
5168,GO:0015727,1,0.629731851416094,0,4,lactate transport,BP,
5178,GO:0015746,1,0.644540905780246,0,4,citrate transport,BP,
5187,GO:0015780,1,0.300188215034731,0,12,nucleotide-sugar transmembrane transport,BP,
5199,GO:0015802,1,0.456039041522254,0,7,basic amino acid transport,BP,
5204,GO:0015808,1,0.553004676984237,0,5,L-alanine transport,BP,
5205,GO:0015809,1,0.501724362077351,0,6,arginine transport,BP,
5210,GO:0015816,1,0.497375753017096,0,6,glycine transport,BP,
5215,GO:0015822,1,0.553937217261481,0,4,ornithine transport,BP,
5216,GO:0015824,1,0.454492662217093,0,6,proline transport,BP,
5217,GO:0015825,1,0.518107632560311,0,7,L-serine transport,BP,
5226,GO:0015846,1,0.556381738024631,0,6,polyamine transport,BP,
5230,GO:0015851,1,0.492211197053719,0,7,nucleobase transport,BP,
5231,GO:0015853,1,0.709547022364568,0,4,adenine transport,BP,
5233,GO:0015858,1,0.638759740217478,0,5,nucleoside transport,BP,
5237,GO:0015865,1,0.315691948545288,0,12,purine nucleotide transport,BP,
5238,GO:0015866,1,0.412399612959831,0,9,ADP transport,BP,
5239,GO:0015867,1,0.407042351586544,0,9,ATP transport,BP,
5240,GO:0015868,1,0.315691948545288,0,12,purine ribonucleotide transport,BP,
5246,GO:0015879,1,0.671368492391168,0,4,carnitine transport,BP,
5250,GO:0015884,1,0.582436038037941,0,5,folic acid transport,BP,
5264,GO:0015917,1,0.535178383074326,0,4,aminophospholipid transport,BP,
5270,GO:0015925,1,0.565847134127148,0,6,galactosidase activity,MF,
5271,GO:0015926,1,0.326903387830648,0,8,glucosidase activity,MF,
5275,GO:0015932,1,0.0436794547851416,0,32,nucleobase-containing compound transmembrane transporter activity,MF,
5277,GO:0015935,1,0.0115822668913226,0,68,small ribosomal subunit,CC,
5281,GO:0015939,1,0.577353817533129,0,5,pantothenate metabolic process,BP,
5283,GO:0015949,1,0.0969507669820191,0,28,nucleobase-containing small molecule interconversion,BP,
5286,GO:0015959,1,0.507916749150552,0,7,diadenosine polyphosphate metabolic process,BP,
5288,GO:0015961,1,0.68370776824984,0,4,diadenosine polyphosphate catabolic process,BP,
5292,GO:0015985,1,0.480730601255475,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5293,GO:0015986,1,0.480730601255475,0,8,ATP synthesis coupled proton transport,BP,
5294,GO:0015988,1,0.143521474877606,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5296,GO:0015991,1,0.151062587531701,0,20,ATP hydrolysis coupled proton transport,BP,
5297,GO:0016004,1,0.42131232456395,0,8,phospholipase activator activity,MF,
5325,GO:0016056,1,0.2329780279385,0,13,rhodopsin mediated signaling pathway,BP,
5332,GO:0016074,1,0.407858053578887,0,12,snoRNA metabolic process,BP,
5333,GO:0016075,1,0.236066638919993,0,15,rRNA catabolic process,BP,
5335,GO:0016078,1,0.611470705152522,0,6,tRNA catabolic process,BP,
5338,GO:0016081,1,0.477311750713084,0,6,synaptic vesicle docking,BP,
5339,GO:0016082,1,0.252451846657697,0,11,synaptic vesicle priming,BP,
5340,GO:0016093,1,0.57131386829972,0,6,polyprenol metabolic process,BP,
5344,GO:0016102,1,0.617491790100065,0,5,diterpenoid biosynthetic process,BP,
5346,GO:0016114,1,0.466920548447647,0,8,terpenoid biosynthetic process,BP,
5356,GO:0016139,1,0.521160779549729,0,7,glycoside catabolic process,BP,
5363,GO:0016174,1,0.60678554563511,0,4,NAD(P)H oxidase activity,MF,
5365,GO:0016176,1,0.505251302982355,0,5,superoxide-generating NADPH oxidase activator activity,MF,
5366,GO:0016180,1,0.113279946219601,0,22,snRNA processing,BP,
5385,GO:0016226,1,0.189747712938323,0,20,iron-sulfur cluster assembly,BP,
5396,GO:0016240,1,0.631026401641079,0,4,autophagosome membrane docking,BP,
5400,GO:0016246,1,0.187330238685971,0,15,RNA interference,BP,
5404,GO:0016254,1,0.223196104793922,0,17,preassembly of GPI anchor in ER membrane,BP,
5407,GO:0016259,1,0.660071610893377,0,4,selenocysteine metabolic process,BP,
5415,GO:0016272,1,0.662796442249428,0,7,prefoldin complex,CC,
5416,GO:0016273,1,0.372490608211451,0,11,arginine N-methyltransferase activity,MF,
5417,GO:0016274,1,0.372490608211451,0,11,protein-arginine N-methyltransferase activity,MF,
5419,GO:0016278,1,0.00332637385621873,0,48,lysine N-methyltransferase activity,MF,
5420,GO:0016279,1,0.00366932727810468,0,47,protein-lysine N-methyltransferase activity,MF,
5421,GO:0016281,1,0.362601831007575,0,9,eukaryotic translation initiation factor 4F complex,CC,
5439,GO:0016312,1,0.609942310754463,0,4,inositol bisphosphate phosphatase activity,MF,
5444,GO:0016322,1,0.477467065626855,0,6,neuron remodeling,BP,
5453,GO:0016338,1,0.496891959696091,0,8,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5477,GO:0016417,1,0.0552422211614938,0,27,S-acyltransferase activity,MF,
5483,GO:0016423,1,0.274858582374021,0,13,tRNA (guanine) methyltransferase activity,MF,
5484,GO:0016426,1,0.684003077914347,0,4,tRNA (adenine) methyltransferase activity,MF,
5485,GO:0016427,1,0.408385493137173,0,8,tRNA (cytosine) methyltransferase activity,MF,
5486,GO:0016428,1,0.641974928888427,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5489,GO:0016433,1,0.598784410358407,0,6,rRNA (adenine) methyltransferase activity,MF,
5491,GO:0016435,1,0.677301101972653,0,4,rRNA (guanine) methyltransferase activity,MF,
5497,GO:0016446,1,0.232718593399113,0,14,somatic hypermutation of immunoglobulin genes,BP,
5499,GO:0016453,1,0.719649459296542,0,4,C-acetyltransferase activity,MF,
5500,GO:0016454,1,0.558837253109958,0,5,C-palmitoyltransferase activity,MF,
5506,GO:0016469,1,0.12297657075847,0,24,proton-transporting two-sector ATPase complex,CC,
5507,GO:0016471,1,0.338597787716395,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5519,GO:0016500,1,0.419706094866379,0,6,protein-hormone receptor activity,MF,
5520,GO:0016502,1,0.572476206501971,0,6,nucleotide receptor activity,MF,
5535,GO:0016530,1,0.558677375456914,0,6,metallochaperone activity,MF,
5536,GO:0016531,1,0.671017212994542,0,5,copper chaperone activity,MF,
5544,GO:0016556,1,0.262098006026452,0,15,mRNA modification,BP,
5547,GO:0016559,1,0.557443144947388,0,7,peroxisome fission,BP,
5548,GO:0016560,1,0.643928067667178,0,4,protein import into peroxisome matrix, docking,BP,
5560,GO:0016578,1,0.0831935226419909,0,21,histone deubiquitination,BP,
5564,GO:0016584,1,0.531789672105577,0,7,nucleosome positioning,BP,
5570,GO:0016593,1,0.370459575617184,0,8,Cdc73/Paf1 complex,CC,
5578,GO:0016602,1,0.654310722868342,0,4,CCAAT-binding factor complex,CC,
5592,GO:0016634,1,0.536751276212218,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5593,GO:0016635,1,0.612665895287909,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5596,GO:0016641,1,0.337876775311628,0,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5607,GO:0016661,1,0.617367726663822,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5610,GO:0016668,1,0.384876195407743,0,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5611,GO:0016670,1,0.447669493806172,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5616,GO:0016679,1,0.547031248821125,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5617,GO:0016681,1,0.59956416221942,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5626,GO:0016712,1,0.454033433832893,0,8,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5629,GO:0016717,1,0.55573065331806,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5660,GO:0016775,1,0.63462860091183,0,5,phosphotransferase activity, nitrogenous group as acceptor,MF,
5664,GO:0016780,1,0.156570940608782,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
5676,GO:0016796,1,0.00450156901698479,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5682,GO:0016805,1,0.455658493554954,0,7,dipeptidase activity,MF,
5698,GO:0016832,1,0.519934299055225,0,7,aldehyde-lyase activity,MF,
5699,GO:0016833,1,0.645949689668012,0,5,oxo-acid-lyase activity,MF,
5705,GO:0016842,1,0.568008995619031,0,7,amidine-lyase activity,MF,
5708,GO:0016846,1,0.610831898681439,0,7,carbon-sulfur lyase activity,MF,
5716,GO:0016861,1,0.529974601775967,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5720,GO:0016866,1,0.0962376983778753,0,25,intramolecular transferase activity,MF,
5721,GO:0016868,1,0.422432278490422,0,9,intramolecular transferase activity, phosphotransferases,MF,
5735,GO:0016888,1,0.286437897887918,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5736,GO:0016889,1,0.17556907480102,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5738,GO:0016891,1,0.0792051400771655,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5739,GO:0016892,1,0.628362168143814,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5740,GO:0016893,1,0.0342306922809588,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5741,GO:0016894,1,0.110247096535352,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5742,GO:0016895,1,0.173108189894144,0,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5743,GO:0016896,1,0.0247088338839277,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
5752,GO:0016918,1,0.659244484541161,0,5,retinal binding,MF,
5756,GO:0016926,1,0.413244513853276,0,7,protein desumoylation,BP,
5757,GO:0016929,1,0.445206687148922,0,6,SUMO-specific protease activity,MF,
5765,GO:0016972,1,0.624247039815981,0,4,thiol oxidase activity,MF,
5766,GO:0016973,1,0.352493805469482,0,10,poly(A)+ mRNA export from nucleus,BP,
5769,GO:0016997,1,0.703684776249283,0,4,alpha-sialidase activity,MF,
5774,GO:0017002,1,0.435299795211655,0,5,activin-activated receptor activity,MF,
5788,GO:0017034,1,0.465875583560635,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
5790,GO:0017040,1,0.69022794747288,0,4,N-acylsphingosine amidohydrolase activity,MF,
5797,GO:0017056,1,0.0427646983959284,0,25,structural constituent of nuclear pore,MF,
5799,GO:0017059,1,0.443037457320044,0,8,serine C-palmitoyltransferase complex,CC,
5802,GO:0017062,1,0.410067277741973,0,9,respiratory chain complex III assembly,BP,
5805,GO:0017069,1,0.0297405478690513,0,38,snRNA binding,MF,
5806,GO:0017070,1,0.360518125635792,0,11,U6 snRNA binding,MF,
5819,GO:0017099,1,0.701468500116348,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5820,GO:0017101,1,0.306225079607515,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5822,GO:0017108,1,0.541402732763585,0,6,5'-flap endonuclease activity,MF,
5824,GO:0017110,1,0.250205520625946,0,13,nucleoside-diphosphatase activity,MF,
5844,GO:0017146,1,0.543931616046601,0,4,NMDA selective glutamate receptor complex,CC,
5847,GO:0017150,1,0.713618497342041,0,4,tRNA dihydrouridine synthase activity,MF,
5848,GO:0017151,1,0.436193072537248,0,7,DEAD/H-box RNA helicase binding,MF,
5849,GO:0017153,1,0.638898770833589,0,4,sodium:dicarboxylate symporter activity,MF,
5859,GO:0017169,1,0.544317263355027,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5861,GO:0017176,1,0.589622313336771,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5864,GO:0017182,1,0.41849410433972,0,9,peptidyl-diphthamide metabolic process,BP,
5865,GO:0017183,1,0.41849410433972,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5866,GO:0017185,1,0.434948796638408,0,8,peptidyl-lysine hydroxylation,BP,
5868,GO:0017187,1,0.713203852126284,0,4,peptidyl-glutamic acid carboxylation,BP,
5869,GO:0017196,1,0.49960155887586,0,6,N-terminal peptidyl-methionine acetylation,BP,
5880,GO:0018024,1,0.00718454343617839,0,40,histone-lysine N-methyltransferase activity,MF,
5882,GO:0018026,1,0.352080961105122,0,9,peptidyl-lysine monomethylation,BP,
5883,GO:0018027,1,0.181523370935884,0,14,peptidyl-lysine dimethylation,BP,
5887,GO:0018065,1,0.480722710233827,0,11,protein-cofactor linkage,BP,
5888,GO:0018076,1,0.482614140659329,0,4,N-terminal peptidyl-lysine acetylation,BP,
5892,GO:0018103,1,0.458556480991337,0,6,protein C-linked glycosylation,BP,
5903,GO:0018146,1,0.106727973001726,0,21,keratan sulfate biosynthetic process,BP,
5909,GO:0018171,1,0.709985025593964,0,4,peptidyl-cysteine oxidation,BP,
5921,GO:0018202,1,0.33291199119911,0,11,peptidyl-histidine modification,BP,
5923,GO:0018206,1,0.345551314525612,0,10,peptidyl-methionine modification,BP,
5927,GO:0018211,1,0.458556480991337,0,6,peptidyl-tryptophan modification,BP,
5929,GO:0018214,1,0.713203852126284,0,4,protein carboxylation,BP,
5930,GO:0018216,1,0.295906699321121,0,13,peptidyl-arginine methylation,BP,
5932,GO:0018230,1,0.160076794062286,0,18,peptidyl-L-cysteine S-palmitoylation,BP,
5933,GO:0018231,1,0.160076794062286,0,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
5948,GO:0018317,1,0.458556480991337,0,6,protein C-linked glycosylation via tryptophan,BP,
5951,GO:0018335,1,0.636672944782569,0,4,protein succinylation,BP,
5952,GO:0018342,1,0.349612930702169,0,9,protein prenylation,BP,
5954,GO:0018344,1,0.531314768907244,0,6,protein geranylgeranylation,BP,
5959,GO:0018377,1,0.557298196446508,0,4,protein myristoylation,BP,
5964,GO:0018401,1,0.578744654837566,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5965,GO:0018406,1,0.458556480991337,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5977,GO:0018812,1,0.676521685353154,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5981,GO:0018904,1,0.300777480828215,0,13,ether metabolic process,BP,
5982,GO:0018916,1,0.722597454675674,0,4,nitrobenzene metabolic process,BP,
5997,GO:0019042,1,0.303807907656708,0,11,viral latency,BP,
5998,GO:0019043,1,0.442064785446285,0,9,establishment of viral latency,BP,
6002,GO:0019049,1,0.610175564620951,0,4,evasion or tolerance of host defenses by virus,BP,
6022,GO:0019086,1,0.671358691560905,0,4,late viral transcription,BP,
6029,GO:0019103,1,0.590027898545348,0,6,pyrimidine nucleotide binding,MF,
6035,GO:0019136,1,0.689590509506108,0,4,deoxynucleoside kinase activity,MF,
6048,GO:0019200,1,0.127086464212456,0,19,carbohydrate kinase activity,MF,
6053,GO:0019206,1,0.381503939162329,0,11,nucleoside kinase activity,MF,
6077,GO:0019238,1,0.568480287576402,0,6,cyclohydrolase activity,MF,
6085,GO:0019262,1,0.679003806337126,0,5,N-acetylneuraminate catabolic process,BP,
6098,GO:0019323,1,0.717962657767667,0,4,pentose catabolic process,BP,
6103,GO:0019346,1,0.704438332460335,0,4,transsulfuration,BP,
6104,GO:0019348,1,0.636623107703086,0,5,dolichol metabolic process,BP,
6114,GO:0019367,1,0.604691418187653,0,5,fatty acid elongation, saturated fatty acid,BP,
6115,GO:0019368,1,0.604691418187653,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6120,GO:0019373,1,0.607931033041869,0,5,epoxygenase P450 pathway,BP,
6124,GO:0019377,1,0.352663580787831,0,11,glycolipid catabolic process,BP,
6125,GO:0019388,1,0.45585015083255,0,8,galactose catabolic process,BP,
6130,GO:0019401,1,0.715228670973145,0,4,alditol biosynthetic process,BP,
6155,GO:0019509,1,0.624781004174174,0,5,L-methionine salvage from methylthioadenosine,BP,
6164,GO:0019530,1,0.597163090491902,0,4,taurine metabolic process,BP,
6165,GO:0019531,1,0.524046267093156,0,5,oxalate transmembrane transporter activity,MF,
6166,GO:0019532,1,0.524046267093156,0,5,oxalate transport,BP,
6182,GO:0019626,1,0.525578884402289,0,7,short-chain fatty acid catabolic process,BP,
6185,GO:0019640,1,0.668783099174664,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6186,GO:0019646,1,0.387817204752285,0,14,aerobic electron transport chain,BP,
6191,GO:0019673,1,0.606667511679306,0,7,GDP-mannose metabolic process,BP,
6196,GO:0019692,1,0.0898431741966845,0,30,deoxyribose phosphate metabolic process,BP,
6198,GO:0019694,1,0.597163090491902,0,4,alkanesulfonate metabolic process,BP,
6200,GO:0019706,1,0.0926461482341011,0,23,protein-cysteine S-palmitoyltransferase activity,MF,
6201,GO:0019707,1,0.0926461482341011,0,23,protein-cysteine S-acyltransferase activity,MF,
6202,GO:0019720,1,0.546181131221943,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6215,GO:0019755,1,0.680932234662032,0,4,one-carbon compound transport,BP,
6218,GO:0019773,1,0.65584879906632,0,7,proteasome core complex, alpha-subunit complex,CC,
6228,GO:0019784,1,0.564699046114776,0,7,NEDD8-specific protease activity,MF,
6246,GO:0019829,1,0.0203964132595639,0,34,cation-transporting ATPase activity,MF,
6251,GO:0019841,1,0.73410223397265,0,4,retinol binding,MF,
6256,GO:0019855,1,0.454341226519498,0,8,calcium channel inhibitor activity,MF,
6275,GO:0019885,1,0.453972165999126,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6290,GO:0019907,1,0.493682484956217,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6291,GO:0019908,1,0.167079855129539,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6295,GO:0019918,1,0.689502734880999,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6296,GO:0019919,1,0.53683935665943,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6299,GO:0019934,1,0.540320813879587,0,5,cGMP-mediated signaling,BP,
6313,GO:0019966,1,0.483458308879397,0,7,interleukin-1 binding,MF,
6318,GO:0019992,1,0.370268323934327,0,8,diacylglycerol binding,MF,
6347,GO:0021534,1,0.486280189986907,0,5,cell proliferation in hindbrain,BP,
6352,GO:0021540,1,0.67445082841821,0,4,corpus callosum morphogenesis,BP,
6360,GO:0021548,1,0.541542571283182,0,5,pons development,BP,
6391,GO:0021604,1,0.541415502922951,0,5,cranial nerve structural organization,BP,
6393,GO:0021612,1,0.541415502922951,0,5,facial nerve structural organization,BP,
6400,GO:0021636,1,0.582267777131436,0,4,trigeminal nerve morphogenesis,BP,
6401,GO:0021637,1,0.582267777131436,0,4,trigeminal nerve structural organization,BP,
6406,GO:0021670,1,0.359956156542031,0,8,lateral ventricle development,BP,
6419,GO:0021692,1,0.233363133275025,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6421,GO:0021694,1,0.380393678304141,0,5,cerebellar Purkinje cell layer formation,BP,
6428,GO:0021702,1,0.380393678304141,0,5,cerebellar Purkinje cell differentiation,BP,
6458,GO:0021794,1,0.358349378925282,0,7,thalamus development,BP,
6490,GO:0021859,1,0.487671739322408,0,5,pyramidal neuron differentiation,BP,
6491,GO:0021860,1,0.487671739322408,0,5,pyramidal neuron development,BP,
6521,GO:0021924,1,0.486280189986907,0,5,cell proliferation in external granule layer,BP,
6522,GO:0021930,1,0.486280189986907,0,5,cerebellar granule cell precursor proliferation,BP,
6544,GO:0021979,1,0.650454229002716,0,4,hypothalamus cell differentiation,BP,
6546,GO:0021984,1,0.574497964502354,0,5,adenohypophysis development,BP,
6560,GO:0022027,1,0.438975342215691,0,4,interkinetic nuclear migration,BP,
6566,GO:0022400,1,0.28307631555563,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6584,GO:0022605,1,0.65301046192372,0,4,mammalian oogenesis stage,BP,
6590,GO:0022615,1,0.725460774376071,0,4,protein to membrane docking,BP,
6595,GO:0022624,1,0.157864903663926,0,24,proteasome accessory complex,CC,
6598,GO:0022627,1,0.0586722701704292,0,43,cytosolic small ribosomal subunit,CC,
6602,GO:0022824,1,0.366229845852546,0,8,transmitter-gated ion channel activity,MF,
6606,GO:0022835,1,0.366229845852546,0,8,transmitter-gated channel activity,MF,
6614,GO:0022848,1,0.656356228235222,0,4,acetylcholine-gated cation-selective channel activity,MF,
6617,GO:0022853,1,0.0177494730168137,0,35,active ion transmembrane transporter activity,MF,
6619,GO:0022858,1,0.553004676984237,0,5,alanine transmembrane transporter activity,MF,
6620,GO:0022884,1,0.312940494618439,0,15,macromolecule transmembrane transporter activity,MF,
6621,GO:0022889,1,0.518107632560311,0,7,serine transmembrane transporter activity,MF,
6628,GO:0023019,1,0.334915134770013,0,9,signal transduction involved in regulation of gene expression,BP,
6630,GO:0023023,1,0.357852422212633,0,12,MHC protein complex binding,MF,
6633,GO:0023026,1,0.43268837430983,0,10,MHC class II protein complex binding,MF,
6634,GO:0023029,1,0.65883401808842,0,4,MHC class Ib protein binding,MF,
6636,GO:0023035,1,0.508246065926923,0,6,CD40 signaling pathway,BP,
6649,GO:0030008,1,0.319268553799723,0,13,TRAPP complex,CC,
6652,GO:0030014,1,0.159212154445842,0,15,CCR4-NOT complex,CC,
6653,GO:0030015,1,0.572861172145119,0,5,CCR4-NOT core complex,CC,
6672,GO:0030043,1,0.710960842684803,0,4,actin filament fragmentation,BP,
6683,GO:0030061,1,0.584169615777976,0,5,mitochondrial crista,CC,
6703,GO:0030121,1,0.466089037432036,0,6,AP-1 adaptor complex,CC,
6706,GO:0030124,1,0.66082800968998,0,4,AP-4 adaptor complex,CC,
6725,GO:0030149,1,0.154480930310729,0,19,sphingolipid catabolic process,BP,
6726,GO:0030150,1,0.230244686728278,0,18,protein import into mitochondrial matrix,BP,
6727,GO:0030151,1,0.686417303709436,0,4,molybdenum ion binding,MF,
6744,GO:0030174,1,0.559177656277091,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6759,GO:0030202,1,0.554540666260527,0,4,heparin metabolic process,BP,
6766,GO:0030210,1,0.554540666260527,0,4,heparin biosynthetic process,BP,
6768,GO:0030213,1,0.299550797055823,0,11,hyaluronan biosynthetic process,BP,
6791,GO:0030242,1,0.522263853067006,0,5,autophagy of peroxisome,BP,
6798,GO:0030259,1,0.670482285400058,0,4,lipid glycosylation,BP,
6802,GO:0030263,1,0.603449097322455,0,4,apoptotic chromosome condensation,BP,
6806,GO:0030274,1,0.624821172989286,0,4,LIM domain binding,MF,
6818,GO:0030289,1,0.697692587409944,0,4,protein phosphatase 4 complex,CC,
6834,GO:0030309,1,0.484149648283752,0,8,poly-N-acetyllactosamine metabolic process,BP,
6835,GO:0030311,1,0.484149648283752,0,8,poly-N-acetyllactosamine biosynthetic process,BP,
6861,GO:0030346,1,0.475889965249698,0,6,protein phosphatase 2B binding,MF,
6874,GO:0030388,1,0.706209283640288,0,4,fructose 1,6-bisphosphate metabolic process,BP,
6880,GO:0030422,1,0.412064220210814,0,9,production of siRNA involved in RNA interference,BP,
6881,GO:0030423,1,0.596328464087955,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6886,GO:0030430,1,0.649353549096186,0,4,host cell cytoplasm,CC,
6896,GO:0030488,1,0.0422449210413618,0,32,tRNA methylation,BP,
6897,GO:0030490,1,0.00693566427184454,0,53,maturation of SSU-rRNA,BP,
6899,GO:0030497,1,0.384387845299767,0,10,fatty acid elongation,BP,
6913,GO:0030515,1,0.0594340028095365,0,30,snoRNA binding,MF,
6924,GO:0030539,1,0.319565093909802,0,9,male genitalia development,BP,
6930,GO:0030548,1,0.592655078970133,0,6,acetylcholine receptor regulator activity,MF,
6941,GO:0030578,1,0.538244231637176,0,4,PML body organization,BP,
6954,GO:0030618,1,0.508391521953389,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
6955,GO:0030619,1,0.48961164196374,0,7,U1 snRNA binding,MF,
6956,GO:0030620,1,0.597214063001974,0,6,U2 snRNA binding,MF,
6957,GO:0030621,1,0.513437847455323,0,6,U4 snRNA binding,MF,
6963,GO:0030628,1,0.609938701018827,0,6,pre-mRNA 3'-splice site binding,MF,
6983,GO:0030673,1,0.262042779396347,0,9,axolemma,CC,
6986,GO:0030677,1,0.346978695581156,0,13,ribonuclease P complex,CC,
6988,GO:0030681,1,0.443520787782869,0,10,multimeric ribonuclease P complex,CC,
6991,GO:0030684,1,0.000508976052207411,0,74,preribosome,CC,
6992,GO:0030686,1,0.0332083656839942,0,32,90S preribosome,CC,
6993,GO:0030687,1,0.0874114536050974,0,24,preribosome, large subunit precursor,CC,
6994,GO:0030688,1,0.270567843875153,0,12,preribosome, small subunit precursor,CC,
7011,GO:0030742,1,0.102893665590981,0,20,GTP-dependent protein binding,MF,
7016,GO:0030800,1,0.294582674770775,0,10,negative regulation of cyclic nucleotide metabolic process,BP,
7019,GO:0030803,1,0.389798585127292,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7029,GO:0030813,1,0.199711786478918,0,11,positive regulation of nucleotide catabolic process,BP,
7031,GO:0030815,1,0.294582674770775,0,10,negative regulation of cAMP metabolic process,BP,
7034,GO:0030818,1,0.389798585127292,0,8,negative regulation of cAMP biosynthetic process,BP,
7072,GO:0030877,1,0.26107852151457,0,10,beta-catenin destruction complex,CC,
7085,GO:0030891,1,0.688032886792611,0,4,VCB complex,CC,
7089,GO:0030896,1,0.671820284904205,0,4,checkpoint clamp complex,CC,
7099,GO:0030906,1,0.684749603537669,0,4,retromer, cargo-selective complex,CC,
7104,GO:0030915,1,0.509277495965818,0,7,Smc5-Smc6 complex,CC,
7115,GO:0030949,1,0.430221030317613,0,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7119,GO:0030953,1,0.369510901769004,0,7,astral microtubule organization,BP,
7141,GO:0031011,1,0.26359351512662,0,15,Ino80 complex,CC,
7161,GO:0031053,1,0.282744803679237,0,10,primary miRNA processing,BP,
7178,GO:0031077,1,0.458500182611618,0,7,post-embryonic camera-type eye development,BP,
7180,GO:0031080,1,0.305020231844112,0,10,nuclear pore outer ring,CC,
7183,GO:0031083,1,0.325981187379557,0,13,BLOC-1 complex,CC,
7188,GO:0031088,1,0.537689329608661,0,5,platelet dense granule membrane,CC,
7189,GO:0031089,1,0.614240151773894,0,5,platelet dense granule lumen,CC,
7213,GO:0031118,1,0.576888350037895,0,8,rRNA pseudouridine synthesis,BP,
7214,GO:0031119,1,0.563985331112676,0,7,tRNA pseudouridine synthesis,BP,
7215,GO:0031120,1,0.776506823788193,0,4,snRNA pseudouridine synthesis,BP,
7219,GO:0031125,1,0.420654782703286,0,12,rRNA 3'-end processing,BP,
7220,GO:0031126,1,0.615700457421154,0,7,snoRNA 3'-end processing,BP,
7225,GO:0031143,1,0.279356881965098,0,12,pseudopodium,CC,
7230,GO:0031163,1,0.189747712938323,0,20,metallo-sulfur cluster assembly,BP,
7232,GO:0031167,1,0.156119293320344,0,21,rRNA methylation,BP,
7240,GO:0031209,1,0.344417850841111,0,8,SCAR complex,CC,
7242,GO:0031211,1,0.443037457320044,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7251,GO:0031229,1,0.399546688124563,0,8,intrinsic component of nuclear inner membrane,CC,
7267,GO:0031261,1,0.624536618027836,0,5,DNA replication preinitiation complex,CC,
7268,GO:0031262,1,0.757885240355169,0,4,Ndc80 complex,CC,
7269,GO:0031264,1,0.413730277759466,0,9,death-inducing signaling complex,CC,
7270,GO:0031265,1,0.550437893405319,0,6,CD95 death-inducing signaling complex,CC,
7277,GO:0031280,1,0.429061247737212,0,7,negative regulation of cyclase activity,BP,
7289,GO:0031298,1,0.380950595533719,0,9,replication fork protection complex,CC,
7300,GO:0031314,1,0.570187400656308,0,5,extrinsic component of mitochondrial inner membrane,CC,
7320,GO:0031341,1,0.0361671285325326,0,35,regulation of cell killing,BP,
7321,GO:0031342,1,0.373356959782531,0,11,negative regulation of cell killing,BP,
7322,GO:0031343,1,0.115571898787223,0,22,positive regulation of cell killing,BP,
7330,GO:0031365,1,0.0533225296065333,0,24,N-terminal protein amino acid modification,BP,
7331,GO:0031369,1,0.0547810229423243,0,28,translation initiation factor binding,MF,
7333,GO:0031371,1,0.472503353083398,0,8,ubiquitin conjugating enzyme complex,CC,
7337,GO:0031386,1,0.413605368359401,0,12,protein tag,MF,
7339,GO:0031390,1,0.487409186921594,0,8,Ctf18 RFC-like complex,CC,
7340,GO:0031392,1,0.647788665326799,0,4,regulation of prostaglandin biosynthetic process,BP,
7356,GO:0031414,1,0.325622547479349,0,9,N-terminal protein acetyltransferase complex,CC,
7357,GO:0031415,1,0.666415268750791,0,4,NatA complex,CC,
7361,GO:0031419,1,0.491298636617361,0,6,cobalamin binding,MF,
7365,GO:0031428,1,0.674932335215344,0,5,box C/D snoRNP complex,CC,
7366,GO:0031429,1,0.730410947474543,0,5,box H/ACA snoRNP complex,CC,
7378,GO:0031441,1,0.363656666057369,0,9,negative regulation of mRNA 3'-end processing,BP,
7379,GO:0031442,1,0.355270278459652,0,9,positive regulation of mRNA 3'-end processing,BP,
7390,GO:0031464,1,0.298977822939893,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7392,GO:0031466,1,0.659650567586108,0,4,Cul5-RING ubiquitin ligase complex,CC,
7396,GO:0031489,1,0.273799684647375,0,13,myosin V binding,MF,
7402,GO:0031498,1,0.126402733719719,0,17,chromatin disassembly,BP,
7403,GO:0031501,1,0.772585367642128,0,4,mannosyltransferase complex,CC,
7422,GO:0031536,1,0.744391660214152,0,4,positive regulation of exit from mitosis,BP,
7425,GO:0031545,1,0.531527017527525,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7448,GO:0031595,1,0.541265037195442,0,8,nuclear proteasome complex,CC,
7449,GO:0031597,1,0.351330750218234,0,12,cytosolic proteasome complex,CC,
7450,GO:0031616,1,0.427679124329259,0,9,spindle pole centrosome,CC,
7452,GO:0031620,1,0.678801738024316,0,4,regulation of fever generation,BP,
7453,GO:0031622,1,0.678801738024316,0,4,positive regulation of fever generation,BP,
7459,GO:0031628,1,0.597019731046302,0,4,opioid receptor binding,MF,
7460,GO:0031629,1,0.371440726308187,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7465,GO:0031640,1,0.287432911430588,0,19,killing of cells of other organism,BP,
7467,GO:0031642,1,0.488271212402728,0,6,negative regulation of myelination,BP,
7470,GO:0031645,1,0.453684797024097,0,7,negative regulation of neurological system process,BP,
7483,GO:0031665,1,0.429288303476534,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7494,GO:0031683,1,0.275602237635285,0,12,G-protein beta/gamma-subunit complex binding,MF,
7516,GO:0031731,1,0.856738126052784,0,4,CCR6 chemokine receptor binding,MF,
7532,GO:0031821,1,0.531095526701712,0,6,G-protein coupled serotonin receptor binding,MF,
7536,GO:0031848,1,0.330704062794098,0,10,protection from non-homologous end joining at telomere,BP,
7538,GO:0031852,1,0.597019731046302,0,4,mu-type opioid receptor binding,MF,
7551,GO:0031904,1,0.192654435947669,0,17,endosome lumen,CC,
7559,GO:0031931,1,0.398768825163517,0,7,TORC1 complex,CC,
7564,GO:0031937,1,0.35125935588716,0,8,positive regulation of chromatin silencing,BP,
7569,GO:0031944,1,0.645363185638385,0,4,negative regulation of glucocorticoid metabolic process,BP,
7572,GO:0031947,1,0.645363185638385,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7608,GO:0032009,1,0.399669697475263,0,7,early phagosome,CC,
7613,GO:0032021,1,0.676521685353154,0,4,NELF complex,CC,
7622,GO:0032040,1,0.0351890928595842,0,33,small-subunit processome,CC,
7640,GO:0032070,1,0.434353019117878,0,9,regulation of deoxyribonuclease activity,BP,
7641,GO:0032071,1,0.50988627788403,0,7,regulation of endodeoxyribonuclease activity,BP,
7643,GO:0032074,1,0.54661272771159,0,6,negative regulation of nuclease activity,BP,
7646,GO:0032077,1,0.645507205266809,0,5,positive regulation of deoxyribonuclease activity,BP,
7647,GO:0032079,1,0.689890206859696,0,4,positive regulation of endodeoxyribonuclease activity,BP,
7671,GO:0032119,1,0.443104994435801,0,8,sequestering of zinc ion,BP,
7674,GO:0032133,1,0.721016079769798,0,4,chromosome passenger complex,CC,
7677,GO:0032138,1,0.619884822825416,0,4,single base insertion or deletion binding,MF,
7694,GO:0032184,1,0.588048249638293,0,4,SUMO polymer binding,MF,
7702,GO:0032202,1,0.690009841359599,0,4,telomere assembly,BP,
7710,GO:0032211,1,0.0940987566411601,0,19,negative regulation of telomere maintenance via telomerase,BP,
7728,GO:0032237,1,0.599035623705926,0,4,activation of store-operated calcium channel activity,BP,
7729,GO:0032239,1,0.111124916156386,0,16,regulation of nucleobase-containing compound transport,BP,
7731,GO:0032241,1,0.412228981966911,0,7,positive regulation of nucleobase-containing compound transport,BP,
7736,GO:0032261,1,0.544826465995028,0,7,purine nucleotide salvage,BP,
7737,GO:0032262,1,0.687008757591475,0,5,pyrimidine nucleotide salvage,BP,
7739,GO:0032264,1,0.667340392164226,0,4,IMP salvage,BP,
7747,GO:0032274,1,0.397606761331748,0,7,gonadotropin secretion,BP,
7748,GO:0032275,1,0.489447967340602,0,5,luteinizing hormone secretion,BP,
7762,GO:0032296,1,0.581767111366194,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7771,GO:0032306,1,0.682403427045187,0,5,regulation of prostaglandin secretion,BP,
7772,GO:0032308,1,0.682403427045187,0,5,positive regulation of prostaglandin secretion,BP,
7774,GO:0032310,1,0.594072009212466,0,6,prostaglandin secretion,BP,
7776,GO:0032324,1,0.50725616153214,0,7,molybdopterin cofactor biosynthetic process,BP,
7782,GO:0032341,1,0.57987063703513,0,5,aldosterone metabolic process,BP,
7783,GO:0032342,1,0.57987063703513,0,5,aldosterone biosynthetic process,BP,
7784,GO:0032344,1,0.57987063703513,0,5,regulation of aldosterone metabolic process,BP,
7787,GO:0032347,1,0.57987063703513,0,5,regulation of aldosterone biosynthetic process,BP,
7791,GO:0032351,1,0.457227081530323,0,7,negative regulation of hormone metabolic process,BP,
7793,GO:0032353,1,0.457227081530323,0,7,negative regulation of hormone biosynthetic process,BP,
7800,GO:0032364,1,0.562440413042411,0,5,oxygen homeostasis,BP,
7808,GO:0032372,1,0.654339615638855,0,4,negative regulation of sterol transport,BP,
7811,GO:0032375,1,0.654339615638855,0,4,negative regulation of cholesterol transport,BP,
7825,GO:0032389,1,0.471623527692332,0,7,MutLalpha complex,CC,
7836,GO:0032405,1,0.559614109232821,0,5,MutLalpha complex binding,MF,
7861,GO:0032433,1,0.171191469183558,0,12,filopodium tip,CC,
7863,GO:0032435,1,0.0594818236799365,0,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7871,GO:0032449,1,0.561773615215157,0,5,CBM complex,CC,
7875,GO:0032453,1,0.379834714314683,0,6,histone demethylase activity (H3-K4 specific),MF,
7899,GO:0032483,1,0.582602931106019,0,4,regulation of Rab protein signal transduction,BP,
7906,GO:0032490,1,0.602791388306642,0,4,detection of molecule of bacterial origin,BP,
7908,GO:0032494,1,0.539263685274144,0,5,response to peptidoglycan,BP,
7926,GO:0032525,1,0.45151659436966,0,6,somite rostral/caudal axis specification,BP,
7935,GO:0032541,1,0.611774861553751,0,5,cortical endoplasmic reticulum,CC,
7937,GO:0032543,1,4.81268168782225e-05,0,129,mitochondrial translation,BP,
7942,GO:0032552,1,0.611774917497038,0,6,deoxyribonucleotide binding,MF,
7944,GO:0032554,1,0.703058206404085,0,4,purine deoxyribonucleotide binding,MF,
7989,GO:0032621,1,0.512936283971606,0,6,interleukin-18 production,BP,
7992,GO:0032627,1,0.68601548468449,0,4,interleukin-23 production,BP,
8014,GO:0032661,1,0.582751205784656,0,5,regulation of interleukin-18 production,BP,
8016,GO:0032667,1,0.68601548468449,0,4,regulation of interleukin-23 production,BP,
8030,GO:0032691,1,0.348108936122303,0,11,negative regulation of interleukin-1 beta production,BP,
8033,GO:0032695,1,0.291875138274778,0,11,negative regulation of interleukin-12 production,BP,
8081,GO:0032777,1,0.68634397578499,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8082,GO:0032780,1,0.502750454159386,0,7,negative regulation of ATPase activity,BP,
8085,GO:0032783,1,0.530951137345516,0,4,ELL-EAF complex,CC,
8087,GO:0032785,1,0.301990344302673,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8092,GO:0032790,1,0.427363285702628,0,8,ribosome disassembly,BP,
8098,GO:0032797,1,0.333267576877571,0,11,SMN complex,CC,
8107,GO:0032806,1,0.0705060001825931,0,25,carboxy-terminal domain protein kinase complex,CC,
8108,GO:0032807,1,0.672717580922213,0,4,DNA ligase IV complex,CC,
8110,GO:0032809,1,0.380515775852248,0,7,neuronal cell body membrane,CC,
8114,GO:0032815,1,0.67351118370502,0,5,negative regulation of natural killer cell activation,BP,
8137,GO:0032876,1,0.526752128794713,0,4,negative regulation of DNA endoreduplication,BP,
8156,GO:0032905,1,0.496919885782964,0,6,transforming growth factor beta1 production,BP,
8159,GO:0032908,1,0.496919885782964,0,6,regulation of transforming growth factor beta1 production,BP,
8176,GO:0032927,1,0.415829580683874,0,6,positive regulation of activin receptor signaling pathway,BP,
8180,GO:0032933,1,0.412182992540971,0,8,SREBP signaling pathway,BP,
8194,GO:0032959,1,0.478089784834927,0,6,inositol trisphosphate biosynthetic process,BP,
8195,GO:0032960,1,0.62328518458419,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8202,GO:0032968,1,0.186474600336745,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8209,GO:0032981,1,0.0273250013523178,0,55,mitochondrial respiratory chain complex I assembly,BP,
8212,GO:0032986,1,0.12337610388223,0,18,protein-DNA complex disassembly,BP,
8213,GO:0032988,1,0.259417643538555,0,13,ribonucleoprotein complex disassembly,BP,
8221,GO:0033003,1,0.11242303155576,0,21,regulation of mast cell activation,BP,
8223,GO:0033005,1,0.394109943603245,0,9,positive regulation of mast cell activation,BP,
8224,GO:0033006,1,0.134196028137039,0,19,regulation of mast cell activation involved in immune response,BP,
8226,GO:0033008,1,0.43220427649508,0,8,positive regulation of mast cell activation involved in immune response,BP,
8230,GO:0033015,1,0.706396257959951,0,5,tetrapyrrole catabolic process,BP,
8240,GO:0033031,1,0.651691463111631,0,4,positive regulation of neutrophil apoptotic process,BP,
8246,GO:0033038,1,0.691515866844403,0,6,bitter taste receptor activity,MF,
8256,GO:0033061,1,0.44455199733051,0,9,DNA recombinase mediator complex,CC,
8257,GO:0033063,1,0.540527172418095,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8273,GO:0033093,1,0.627134090001999,0,4,Weibel-Palade body,CC,
8277,GO:0033119,1,0.123433619051148,0,22,negative regulation of RNA splicing,BP,
8286,GO:0033131,1,0.49054148230124,0,6,regulation of glucokinase activity,BP,
8288,GO:0033133,1,0.588822391938387,0,4,positive regulation of glucokinase activity,BP,
8304,GO:0033152,1,0.546081348128557,0,4,immunoglobulin V(D)J recombination,BP,
8314,GO:0033170,1,0.477177598061809,0,8,protein-DNA loading ATPase activity,MF,
8316,GO:0033176,1,0.165920760352318,0,20,proton-transporting V-type ATPase complex,CC,
8317,GO:0033177,1,0.448369453436449,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8318,GO:0033178,1,0.399366323004244,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8319,GO:0033179,1,0.479889871556132,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8320,GO:0033180,1,0.462610167832023,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8322,GO:0033182,1,0.289708226368679,0,10,regulation of histone ubiquitination,BP,
8324,GO:0033184,1,0.555995988786935,0,5,positive regulation of histone ubiquitination,BP,
8333,GO:0033202,1,0.26359351512662,0,15,DNA helicase complex,CC,
8335,GO:0033206,1,0.617392517584289,0,4,meiotic cytokinesis,BP,
8341,GO:0033220,1,0.633650346241753,0,4,amide-transporting ATPase activity,MF,
8351,GO:0033256,1,0.521726473186938,0,7,I-kappaB/NF-kappaB complex,CC,
8355,GO:0033263,1,0.59380691899933,0,4,CORVET complex,CC,
8366,GO:0033278,1,0.601681897027603,0,4,cell proliferation in midbrain,BP,
8375,GO:0033299,1,0.614836359668255,0,5,secretion of lysosomal enzymes,BP,
8379,GO:0033313,1,0.595803292854654,0,5,meiotic cell cycle checkpoint,BP,
8380,GO:0033314,1,0.443723660543071,0,8,mitotic DNA replication checkpoint,BP,
8385,GO:0033327,1,0.4723601872387,0,6,Leydig cell differentiation,BP,
8391,GO:0033353,1,0.623631499877112,0,4,S-adenosylmethionine cycle,BP,
8401,GO:0033391,1,0.472925076359754,0,6,chromatoid body,CC,
8406,GO:0033489,1,0.679423684919392,0,4,cholesterol biosynthetic process via desmosterol,BP,
8407,GO:0033490,1,0.679423684919392,0,4,cholesterol biosynthetic process via lathosterol,BP,
8410,GO:0033503,1,0.651233666197552,0,4,HULC complex,CC,
8415,GO:0033523,1,0.246919480976291,0,12,histone H2B ubiquitination,BP,
8417,GO:0033539,1,0.296071800530557,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8421,GO:0033553,1,0.605126617043216,0,4,rDNA heterochromatin,CC,
8434,GO:0033572,1,0.0513359603658717,0,29,transferrin transport,BP,
8438,GO:0033588,1,0.62903735129288,0,5,Elongator holoenzyme complex,CC,
8441,GO:0033592,1,0.545825882510911,0,5,RNA strand annealing activity,MF,
8449,GO:0033601,1,0.321610392110478,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8463,GO:0033623,1,0.474027670299931,0,6,regulation of integrin activation,BP,
8476,GO:0033646,1,0.448645782700413,0,7,host intracellular part,CC,
8477,GO:0033647,1,0.572426089238601,0,5,host intracellular organelle,CC,
8478,GO:0033648,1,0.572426089238601,0,5,host intracellular membrane-bounded organelle,CC,
8480,GO:0033655,1,0.649353549096186,0,4,host cell cytoplasm part,CC,
8481,GO:0033668,1,0.687420852935059,0,4,negative regulation by symbiont of host apoptotic process,BP,
8497,GO:0033690,1,0.469190077978895,0,6,positive regulation of osteoblast proliferation,BP,
8508,GO:0033750,1,0.335156109995715,0,13,ribosome localization,BP,
8540,GO:0033962,1,0.0724066318214624,0,18,cytoplasmic mRNA processing body assembly,BP,
8554,GO:0034036,1,0.503685143195164,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8575,GO:0034091,1,0.360460370364955,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8577,GO:0034093,1,0.60479661631344,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8601,GO:0034134,1,0.36109446798778,0,10,toll-like receptor 2 signaling pathway,BP,
8602,GO:0034135,1,0.53527080972892,0,6,regulation of toll-like receptor 2 signaling pathway,BP,
8612,GO:0034145,1,0.601237667119542,0,5,positive regulation of toll-like receptor 4 signaling pathway,BP,
8625,GO:0034182,1,0.360460370364955,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8627,GO:0034184,1,0.60479661631344,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8632,GO:0034190,1,0.613081980625735,0,4,apolipoprotein receptor binding,MF,
8644,GO:0034214,1,0.394057949221238,0,8,protein hexamerization,BP,
8648,GO:0034227,1,0.671497704714421,0,5,tRNA thio-modification,BP,
8656,GO:0034243,1,0.0592343710998003,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8657,GO:0034244,1,0.340600304269069,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8674,GO:0034311,1,0.216676782250727,0,17,diol metabolic process,BP,
8675,GO:0034312,1,0.257180668438411,0,15,diol biosynthetic process,BP,
8676,GO:0034314,1,0.0500275552335079,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8677,GO:0034315,1,0.206144030971558,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8678,GO:0034316,1,0.649255310742367,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
8684,GO:0034334,1,0.599333455796157,0,4,adherens junction maintenance,BP,
8699,GO:0034361,1,0.53989159869283,0,7,very-low-density lipoprotein particle,CC,
8720,GO:0034384,1,0.539684542340485,0,6,high-density lipoprotein particle clearance,BP,
8721,GO:0034385,1,0.53989159869283,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8723,GO:0034388,1,0.516990726096968,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8724,GO:0034389,1,0.211351506730204,0,15,lipid particle organization,BP,
8732,GO:0034398,1,0.539598234540085,0,5,telomere tethering at nuclear periphery,BP,
8743,GO:0034427,1,0.457619205223268,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8744,GO:0034431,1,0.68370776824984,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8745,GO:0034432,1,0.68370776824984,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8746,GO:0034433,1,0.568672741103182,0,7,steroid esterification,BP,
8747,GO:0034434,1,0.568672741103182,0,7,sterol esterification,BP,
8748,GO:0034435,1,0.568672741103182,0,7,cholesterol esterification,BP,
8754,GO:0034447,1,0.74653978379008,0,4,very-low-density lipoprotein particle clearance,BP,
8755,GO:0034448,1,0.737995612514983,0,4,EGO complex,CC,
8756,GO:0034450,1,0.241265218206466,0,12,ubiquitin-ubiquitin ligase activity,MF,
8770,GO:0034470,1,1.81602287551986e-11,4,396,ncRNA processing,BP,ZCCHC11;AARS;RPL13A;AGO4
8771,GO:0034471,1,0.178204079442078,0,19,ncRNA 5'-end processing,BP,
8772,GO:0034472,1,0.256412305449162,0,14,snRNA 3'-end processing,BP,
8775,GO:0034475,1,0.585650556902141,0,8,U4 snRNA 3'-end processing,BP,
8779,GO:0034483,1,0.381804012054974,0,8,heparan sulfate sulfotransferase activity,MF,
8781,GO:0034497,1,0.243466466011874,0,12,protein localization to phagophore assembly site,BP,
8784,GO:0034501,1,0.224675436315956,0,16,protein localization to kinetochore,BP,
8790,GO:0034511,1,0.513375815633637,0,6,U3 snoRNA binding,MF,
8792,GO:0034513,1,0.730410947474543,0,5,box H/ACA snoRNA binding,MF,
8794,GO:0034518,1,0.255882340164748,0,12,RNA cap binding complex,CC,
8796,GO:0034551,1,0.410067277741973,0,9,mitochondrial respiratory chain complex III assembly,BP,
8797,GO:0034552,1,0.72660851081118,0,4,respiratory chain complex II assembly,BP,
8798,GO:0034553,1,0.72660851081118,0,4,mitochondrial respiratory chain complex II assembly,BP,
8806,GO:0034596,1,0.318471358429243,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8810,GO:0034603,1,0.590458801681483,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8811,GO:0034604,1,0.590458801681483,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8821,GO:0034625,1,0.604691418187653,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8822,GO:0034626,1,0.604691418187653,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8825,GO:0034629,1,0.115989141543996,0,20,cellular protein-containing complex localization,BP,
8829,GO:0034638,1,0.573108422959096,0,6,phosphatidylcholine catabolic process,BP,
8837,GO:0034648,1,0.528452432792865,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8845,GO:0034657,1,0.647595072062789,0,4,GID complex,CC,
8877,GO:0034709,1,0.456857777235546,0,12,methylosome,CC,
8881,GO:0034715,1,0.682295671891661,0,6,pICln-Sm protein complex,CC,
8883,GO:0034719,1,0.2769436132083,0,16,SMN-Sm protein complex,CC,
8884,GO:0034720,1,0.379834714314683,0,6,histone H3-K4 demethylation,BP,
8887,GO:0034723,1,0.163292034700609,0,32,DNA replication-dependent nucleosome organization,BP,
8910,GO:0034770,1,0.267912640324867,0,9,histone H4-K20 methylation,BP,
8911,GO:0034773,1,0.461835319321998,0,6,histone H4-K20 trimethylation,BP,
8920,GO:0034969,1,0.390346646156602,0,10,histone arginine methylation,BP,
8926,GO:0034982,1,0.421788602036701,0,10,mitochondrial protein processing,BP,
8927,GO:0034983,1,0.460813103452029,0,6,peptidyl-lysine deacetylation,BP,
8941,GO:0035022,1,0.59769267249016,0,4,positive regulation of Rac protein signal transduction,BP,
8946,GO:0035032,1,0.540491468571836,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8955,GO:0035061,1,0.554291650997178,0,4,interchromatin granule,CC,
8963,GO:0035087,1,0.623180245915867,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8966,GO:0035090,1,0.563320945346896,0,5,maintenance of apical/basal cell polarity,BP,
8971,GO:0035095,1,0.56915823241062,0,4,behavioral response to nicotine,BP,
8987,GO:0035145,1,0.112089612031637,0,21,exon-exon junction complex,CC,
8993,GO:0035174,1,0.506649791439473,0,6,histone serine kinase activity,MF,
9002,GO:0035197,1,0.298702687803845,0,9,siRNA binding,MF,
9008,GO:0035235,1,0.288757642398985,0,9,ionotropic glutamate receptor signaling pathway,BP,
9012,GO:0035242,1,0.53683935665943,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9013,GO:0035243,1,0.689502734880999,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9014,GO:0035246,1,0.372490608211451,0,11,peptidyl-arginine N-methylation,BP,
9015,GO:0035247,1,0.44559429402604,0,9,peptidyl-arginine omega-N-methylation,BP,
9021,GO:0035253,1,0.318097452464924,0,9,ciliary rootlet,CC,
9027,GO:0035259,1,0.257556188730368,0,11,glucocorticoid receptor binding,MF,
9032,GO:0035267,1,0.13874251628461,0,19,NuA4 histone acetyltransferase complex,CC,
9033,GO:0035268,1,0.126185108121784,0,18,protein mannosylation,BP,
9034,GO:0035269,1,0.305808549238961,0,12,protein O-linked mannosylation,BP,
9055,GO:0035312,1,0.515905126585071,0,6,5'-3' exodeoxyribonuclease activity,MF,
9058,GO:0035325,1,0.455103077169043,0,8,Toll-like receptor binding,MF,
9060,GO:0035327,1,0.117776134791751,0,20,transcriptionally active chromatin,CC,
9070,GO:0035339,1,0.732956055053486,0,4,SPOTS complex,CC,
9076,GO:0035356,1,0.640988406200052,0,5,cellular triglyceride homeostasis,BP,
9081,GO:0035363,1,0.672527824539148,0,4,histone locus body,CC,
9082,GO:0035368,1,0.636988672298639,0,4,selenocysteine insertion sequence binding,MF,
9084,GO:0035371,1,0.0626404535753592,0,18,microtubule plus-end,CC,
9088,GO:0035376,1,0.609222002231697,0,5,sterol import,BP,
9106,GO:0035434,1,0.463502722806414,0,6,copper ion transmembrane transport,BP,
9119,GO:0035461,1,0.389383159810452,0,8,vitamin transmembrane transport,BP,
9137,GO:0035507,1,0.413102165867259,0,6,regulation of myosin-light-chain-phosphatase activity,BP,
9139,GO:0035509,1,0.578498802701178,0,4,negative regulation of myosin-light-chain-phosphatase activity,BP,
9141,GO:0035511,1,0.630892173589116,0,5,oxidative DNA demethylation,BP,
9142,GO:0035513,1,0.663687381257641,0,4,oxidative RNA demethylation,BP,
9144,GO:0035515,1,0.663687381257641,0,4,oxidative RNA demethylase activity,MF,
9148,GO:0035519,1,0.700020104624244,0,4,protein K29-linked ubiquitination,BP,
9149,GO:0035520,1,0.295724977227642,0,9,monoubiquitinated protein deubiquitination,BP,
9150,GO:0035521,1,0.646031329248442,0,4,monoubiquitinated histone deubiquitination,BP,
9151,GO:0035522,1,0.646031329248442,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9152,GO:0035523,1,0.556147443191913,0,4,protein K29-linked deubiquitination,BP,
9153,GO:0035524,1,0.520767029337323,0,5,proline transmembrane transport,BP,
9159,GO:0035542,1,0.480985959792964,0,6,regulation of SNARE complex assembly,BP,
9161,GO:0035546,1,0.522090796030619,0,4,interferon-beta secretion,BP,
9162,GO:0035547,1,0.522090796030619,0,4,regulation of interferon-beta secretion,BP,
9163,GO:0035549,1,0.522090796030619,0,4,positive regulation of interferon-beta secretion,BP,
9186,GO:0035586,1,0.52917924836002,0,7,purinergic receptor activity,MF,
9188,GO:0035588,1,0.491481686857981,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9189,GO:0035589,1,0.621032820429962,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9209,GO:0035613,1,0.15992958481597,0,15,RNA stem-loop binding,MF,
9220,GO:0035627,1,0.491461894161334,0,6,ceramide transport,BP,
9222,GO:0035631,1,0.328230488630444,0,11,CD40 receptor complex,CC,
9232,GO:0035646,1,0.358380158688266,0,10,endosome to melanosome transport,BP,
9233,GO:0035650,1,0.701834739771866,0,4,AP-1 adaptor complex binding,MF,
9246,GO:0035672,1,0.489579882830333,0,6,oligopeptide transmembrane transport,BP,
9247,GO:0035673,1,0.578522385159644,0,4,oligopeptide transmembrane transporter activity,MF,
9268,GO:0035723,1,0.330554394316351,0,9,interleukin-15-mediated signaling pathway,BP,
9296,GO:0035771,1,0.528325197351165,0,5,interleukin-4-mediated signaling pathway,BP,
9312,GO:0035809,1,0.428174276375083,0,8,regulation of urine volume,BP,
9313,GO:0035810,1,0.581578738627128,0,5,positive regulation of urine volume,BP,
9332,GO:0035861,1,0.0226931621017106,0,32,site of double-strand break,CC,
9342,GO:0035871,1,0.25491913658129,0,9,protein K11-linked deubiquitination,BP,
9343,GO:0035872,1,0.0284662341723754,0,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9344,GO:0035873,1,0.629731851416094,0,4,lactate transmembrane transport,BP,
9345,GO:0035877,1,0.669036205648412,0,4,death effector domain binding,MF,
9355,GO:0035897,1,0.6173732864995,0,5,proteolysis in other organism,BP,
9372,GO:0035927,1,0.691249133915067,0,4,RNA import into mitochondrion,BP,
9375,GO:0035930,1,0.591841584648785,0,5,corticosteroid hormone secretion,BP,
9389,GO:0035965,1,0.599983585895867,0,5,cardiolipin acyl-chain remodeling,BP,
9394,GO:0035973,1,0.393101412743287,0,7,aggrephagy,BP,
9422,GO:0036017,1,0.795101759789843,0,4,response to erythropoietin,BP,
9423,GO:0036018,1,0.795101759789843,0,4,cellular response to erythropoietin,BP,
9426,GO:0036021,1,0.684337979980311,0,4,endolysosome lumen,CC,
9432,GO:0036037,1,0.484350338854413,0,7,CD8-positive, alpha-beta T cell activation,BP,
9435,GO:0036042,1,0.751893791820589,0,4,long-chain fatty acyl-CoA binding,MF,
9459,GO:0036109,1,0.318896114029193,0,11,alpha-linolenic acid metabolic process,BP,
9470,GO:0036123,1,0.618803837123272,0,5,histone H3-K9 dimethylation,BP,
9483,GO:0036148,1,0.268614405803918,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9484,GO:0036149,1,0.477404590783378,0,7,phosphatidylinositol acyl-chain remodeling,BP,
9489,GO:0036155,1,0.592295226792228,0,5,acylglycerol acyl-chain remodeling,BP,
9492,GO:0036158,1,0.451137651093806,0,6,outer dynein arm assembly,BP,
9513,GO:0036260,1,0.0443584351077598,0,33,RNA capping,BP,
9515,GO:0036265,1,0.702015081301858,0,4,RNA (guanine-N7)-methylation,BP,
9527,GO:0036297,1,0.00564758770705648,0,48,interstrand cross-link repair,BP,
9529,GO:0036302,1,0.447086285040264,0,5,atrioventricular canal development,BP,
9549,GO:0036353,1,0.393547968268309,0,8,histone H2A-K119 monoubiquitination,BP,
9566,GO:0036402,1,0.654952888566821,0,6,proteasome-activating ATPase activity,MF,
9571,GO:0036438,1,0.648265555274323,0,4,maintenance of lens transparency,BP,
9573,GO:0036442,1,0.116377730291651,0,22,proton-exporting ATPase activity,MF,
9574,GO:0036444,1,0.418058109388989,0,8,calcium import into the mitochondrion,BP,
9577,GO:0036449,1,0.309218463846887,0,7,microtubule minus-end,CC,
9586,GO:0036462,1,0.496187556653877,0,7,TRAIL-activated apoptotic signaling pathway,BP,
9598,GO:0036480,1,0.472143515268179,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9599,GO:0036481,1,0.605440961595657,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9642,GO:0038003,1,0.691929449257405,0,4,opioid receptor signaling pathway,BP,
9688,GO:0038110,1,0.345841099533763,0,8,interleukin-2-mediated signaling pathway,BP,
9702,GO:0038155,1,0.513525412520824,0,6,interleukin-23-mediated signaling pathway,BP,
9717,GO:0038189,1,0.639658795922613,0,4,neuropilin signaling pathway,BP,
9766,GO:0039702,1,0.163127558435769,0,20,viral budding via host ESCRT complex,BP,
9773,GO:0040009,1,0.491327762417518,0,4,regulation of growth rate,BP,
9779,GO:0040016,1,0.444826415813571,0,7,embryonic cleavage,BP,
9786,GO:0040031,1,0.640764459292462,0,6,snRNA modification,BP,
9809,GO:0042044,1,0.299929602905162,0,11,fluid transport,BP,
9810,GO:0042045,1,0.587594222208044,0,4,epithelial fluid transport,BP,
9813,GO:0042054,1,0.00299834611122905,0,50,histone methyltransferase activity,MF,
9827,GO:0042090,1,0.555349926967314,0,5,interleukin-12 biosynthetic process,BP,
9836,GO:0042101,1,0.450811680672419,0,7,T cell receptor complex,CC,
9847,GO:0042118,1,0.411183585998305,0,7,endothelial cell activation,BP,
9849,GO:0042126,1,0.689480816822048,0,4,nitrate metabolic process,BP,
9863,GO:0042148,1,0.459892184467729,0,8,strand invasion,BP,
9870,GO:0042166,1,0.597231361230678,0,5,acetylcholine binding,MF,
9871,GO:0042167,1,0.706396257959951,0,5,heme catabolic process,BP,
9878,GO:0042178,1,0.471191628418413,0,9,xenobiotic catabolic process,BP,
9881,GO:0042182,1,0.705974882312141,0,4,ketone catabolic process,BP,
9897,GO:0042254,1,2.06332763872587e-11,1,317,ribosome biogenesis,BP,RPL13A
9898,GO:0042255,1,0.0138947282497513,0,54,ribosome assembly,BP,
9899,GO:0042256,1,0.613828403046017,0,5,mature ribosome assembly,BP,
9900,GO:0042262,1,0.713978393262313,0,5,DNA protection,BP,
9904,GO:0042268,1,0.697965259716852,0,5,regulation of cytolysis,BP,
9905,GO:0042269,1,0.178452267162978,0,16,regulation of natural killer cell mediated cytotoxicity,BP,
9909,GO:0042273,1,0.00359883918696364,0,67,ribosomal large subunit biogenesis,BP,
9910,GO:0042274,1,0.00224782361808391,0,70,ribosomal small subunit biogenesis,BP,
9912,GO:0042276,1,0.146627585487849,0,19,error-prone translesion synthesis,BP,
9924,GO:0042297,1,0.448064018941213,0,4,vocal learning,BP,
9925,GO:0042301,1,0.559866107569607,0,6,phosphate ion binding,MF,
9957,GO:0042364,1,0.391473342380843,0,8,water-soluble vitamin biosynthetic process,BP,
9966,GO:0042382,1,0.504480040986372,0,6,paraspeckles,CC,
9969,GO:0042392,1,0.628572558814672,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9972,GO:0042401,1,0.331056998959264,0,13,cellular biogenic amine biosynthetic process,BP,
9974,GO:0042403,1,0.280442668495224,0,10,thyroid hormone metabolic process,BP,
9976,GO:0042406,1,0.705523624574948,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
9977,GO:0042407,1,0.271798427964647,0,15,cristae formation,BP,
9984,GO:0042420,1,0.678953556987118,0,4,dopamine catabolic process,BP,
9989,GO:0042428,1,0.548318940789467,0,4,serotonin metabolic process,BP,
9990,GO:0042430,1,0.403302658227718,0,8,indole-containing compound metabolic process,BP,
9992,GO:0042438,1,0.319506558309112,0,8,melanin biosynthetic process,BP,
9993,GO:0042439,1,0.592902230506226,0,5,ethanolamine-containing compound metabolic process,BP,
10001,GO:0042451,1,0.20406107597222,0,20,purine nucleoside biosynthetic process,BP,
10003,GO:0042455,1,0.0557226854871548,0,34,ribonucleoside biosynthetic process,BP,
10014,GO:0042482,1,0.626519151533631,0,5,positive regulation of odontogenesis,BP,
10031,GO:0042533,1,0.408507337843825,0,8,tumor necrosis factor biosynthetic process,BP,
10032,GO:0042534,1,0.408507337843825,0,8,regulation of tumor necrosis factor biosynthetic process,BP,
10033,GO:0042535,1,0.604119699455615,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
10036,GO:0042538,1,0.619061749071785,0,5,hyperosmotic salinity response,BP,
10038,GO:0042541,1,0.547837930889189,0,6,hemoglobin biosynthetic process,BP,
10045,GO:0042555,1,0.319829129395358,0,11,MCM complex,CC,
10047,GO:0042559,1,0.308150510694806,0,14,pteridine-containing compound biosynthetic process,BP,
10058,GO:0042577,1,0.5070903509568,0,7,lipid phosphatase activity,MF,
10067,GO:0042587,1,0.539993057299938,0,5,glycogen granule,CC,
10076,GO:0042599,1,0.313030495452729,0,12,lamellar body,CC,
10082,GO:0042611,1,0.439295283910156,0,12,MHC protein complex,CC,
10083,GO:0042612,1,0.534859556888181,0,9,MHC class I protein complex,CC,
10085,GO:0042622,1,0.436464351322893,0,6,photoreceptor outer segment membrane,CC,
10088,GO:0042625,1,0.0177494730168137,0,35,ATPase coupled ion transmembrane transporter activity,MF,
10092,GO:0042629,1,0.335632854390328,0,10,mast cell granule,CC,
10098,GO:0042636,1,0.595364356473706,0,4,negative regulation of hair cycle,BP,
10100,GO:0042640,1,0.580262085891584,0,4,anagen,BP,
10125,GO:0042719,1,0.710864540623945,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10127,GO:0042721,1,0.68527725183143,0,5,mitochondrial inner membrane protein insertion complex,CC,
10133,GO:0042731,1,0.64140403959996,0,4,PH domain binding,MF,
10145,GO:0042749,1,0.636160949904638,0,4,regulation of circadian sleep/wake cycle,BP,
10147,GO:0042753,1,0.423574893459761,0,6,positive regulation of circadian rhythm,BP,
10148,GO:0042754,1,0.349009572745989,0,9,negative regulation of circadian rhythm,BP,
10153,GO:0042760,1,0.618403686826189,0,5,very long-chain fatty acid catabolic process,BP,
10154,GO:0042761,1,0.384387845299767,0,10,very long-chain fatty acid biosynthetic process,BP,
10156,GO:0042765,1,0.616297425221167,0,5,GPI-anchor transamidase complex,CC,
10165,GO:0042776,1,0.787897982316361,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10167,GO:0042780,1,0.53639210614291,0,7,tRNA 3'-end processing,BP,
10169,GO:0042788,1,0.12200411476055,0,29,polysomal ribosome,CC,
10171,GO:0042790,1,0.274292152177757,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10172,GO:0042791,1,0.509251878645382,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10174,GO:0042796,1,0.531531968887759,0,6,snRNA transcription by RNA polymerase III,BP,
10175,GO:0042797,1,0.509251878645382,0,6,tRNA transcription by RNA polymerase III,BP,
10176,GO:0042799,1,0.572904694623033,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10177,GO:0042800,1,0.159951413532072,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10184,GO:0042816,1,0.542655469409799,0,5,vitamin B6 metabolic process,BP,
10194,GO:0042834,1,0.485518251316836,0,7,peptidoglycan binding,MF,
10202,GO:0042887,1,0.0541866182656257,0,30,amide transmembrane transporter activity,MF,
10203,GO:0042891,1,0.474140861311593,0,7,antibiotic transport,BP,
10204,GO:0042895,1,0.543290409463333,0,6,antibiotic transmembrane transporter activity,MF,
10208,GO:0042908,1,0.438295392374656,0,6,xenobiotic transport,BP,
10209,GO:0042910,1,0.438295392374656,0,6,xenobiotic transmembrane transporter activity,MF,
10224,GO:0042976,1,0.489225772242169,0,7,activation of Janus kinase activity,BP,
10226,GO:0042979,1,0.688860970498452,0,4,ornithine decarboxylase regulator activity,MF,
10257,GO:0043023,1,0.332307084521639,0,11,ribosomal large subunit binding,MF,
10258,GO:0043024,1,0.220865408736641,0,14,ribosomal small subunit binding,MF,
10265,GO:0043032,1,0.28528034301197,0,12,positive regulation of macrophage activation,BP,
10274,GO:0043045,1,0.456797604919075,0,6,DNA methylation involved in embryo development,BP,
10275,GO:0043046,1,0.481510636541659,0,7,DNA methylation involved in gamete generation,BP,
10276,GO:0043047,1,0.308370583616434,0,11,single-stranded telomeric DNA binding,MF,
10294,GO:0043096,1,0.697739636536297,0,5,purine nucleobase salvage,BP,
10295,GO:0043097,1,0.392674654125011,0,11,pyrimidine nucleoside salvage,BP,
10296,GO:0043101,1,0.312918555008853,0,13,purine-containing compound salvage,BP,
10297,GO:0043102,1,0.576335232761397,0,6,amino acid salvage,BP,
10303,GO:0043114,1,0.100704206300825,0,18,regulation of vascular permeability,BP,
10304,GO:0043116,1,0.4290238305913,0,7,negative regulation of vascular permeability,BP,
10305,GO:0043117,1,0.662309264692372,0,4,positive regulation of vascular permeability,BP,
10307,GO:0043121,1,0.518184383785947,0,5,neurotrophin binding,MF,
10314,GO:0043129,1,0.51271142805399,0,5,surfactant homeostasis,BP,
10319,GO:0043137,1,0.699262187915628,0,4,DNA replication, removal of RNA primer,BP,
10320,GO:0043138,1,0.239033194609522,0,12,3'-5' DNA helicase activity,MF,
10321,GO:0043139,1,0.497585441046228,0,7,5'-3' DNA helicase activity,MF,
10322,GO:0043140,1,0.381743212344424,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10323,GO:0043141,1,0.620916270554525,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10324,GO:0043142,1,0.238808408203705,0,13,single-stranded DNA-dependent ATPase activity,MF,
10325,GO:0043144,1,0.576775635520304,0,8,snoRNA processing,BP,
10339,GO:0043174,1,0.256179298799727,0,16,nucleoside salvage,BP,
10340,GO:0043175,1,0.0194033919152758,0,35,RNA polymerase core enzyme binding,MF,
10347,GO:0043184,1,0.528108102916288,0,6,vascular endothelial growth factor receptor 2 binding,MF,
10349,GO:0043186,1,0.484417405822341,0,7,P granule,CC,
10350,GO:0043189,1,0.13874251628461,0,19,H4/H2A histone acetyltransferase complex,CC,
10364,GO:0043208,1,0.678819298735241,0,4,glycosphingolipid binding,MF,
10368,GO:0043219,1,0.636494246070721,0,4,lateral loop,CC,
10384,GO:0043240,1,0.301280769741009,0,11,Fanconi anaemia nuclear complex,CC,
10388,GO:0043247,1,0.218680702063963,0,13,telomere maintenance in response to DNA damage,BP,
10422,GO:0043300,1,0.0487742273872472,0,27,regulation of leukocyte degranulation,BP,
10423,GO:0043301,1,0.53574508870647,0,5,negative regulation of leukocyte degranulation,BP,
10424,GO:0043302,1,0.245510171362464,0,13,positive regulation of leukocyte degranulation,BP,
10425,GO:0043303,1,0.0570910786804239,0,26,mast cell degranulation,BP,
10426,GO:0043304,1,0.134196028137039,0,19,regulation of mast cell degranulation,BP,
10428,GO:0043306,1,0.43220427649508,0,8,positive regulation of mast cell degranulation,BP,
10429,GO:0043307,1,0.711660041264575,0,4,eosinophil activation,BP,
10430,GO:0043308,1,0.711660041264575,0,4,eosinophil degranulation,BP,
10434,GO:0043313,1,0.541974554096138,0,4,regulation of neutrophil degranulation,BP,
10440,GO:0043320,1,0.513405914552778,0,6,natural killer cell degranulation,BP,
10450,GO:0043353,1,0.419436203086798,0,6,enucleate erythrocyte differentiation,BP,
10460,GO:0043374,1,0.565214110628884,0,5,CD8-positive, alpha-beta T cell differentiation,BP,
10502,GO:0043455,1,0.37059882892617,0,8,regulation of secondary metabolic process,BP,
10503,GO:0043456,1,0.720953381969224,0,4,regulation of pentose-phosphate shunt,BP,
10505,GO:0043461,1,0.699154269584688,0,4,proton-transporting ATP synthase complex assembly,BP,
10510,GO:0043471,1,0.415813685181878,0,9,regulation of cellular carbohydrate catabolic process,BP,
10513,GO:0043476,1,0.233387928958553,0,12,pigment accumulation,BP,
10514,GO:0043482,1,0.233387928958553,0,12,cellular pigment accumulation,BP,
10516,GO:0043485,1,0.358380158688266,0,10,endosome to pigment granule transport,BP,
10524,GO:0043495,1,0.388733634703089,0,7,protein membrane anchor,MF,
10526,GO:0043497,1,0.39509313474592,0,9,regulation of protein heterodimerization activity,BP,
10537,GO:0043515,1,0.516632675448984,0,5,kinetochore binding,MF,
10546,GO:0043527,1,0.662608000243412,0,5,tRNA methyltransferase complex,CC,
10560,GO:0043545,1,0.50725616153214,0,7,molybdopterin cofactor metabolic process,BP,
10573,GO:0043562,1,0.435873988956502,0,10,cellular response to nitrogen levels,BP,
10578,GO:0043569,1,0.56827465659639,0,4,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10579,GO:0043570,1,0.601223874621405,0,4,maintenance of DNA repeat elements,BP,
10604,GO:0043622,1,0.596636946670461,0,4,cortical microtubule organization,BP,
10609,GO:0043628,1,0.0846496253426906,0,27,ncRNA 3'-end processing,BP,
10612,GO:0043631,1,0.00829321351212343,0,41,RNA polyadenylation,BP,
10614,GO:0043633,1,0.457434187570951,0,8,polyadenylation-dependent RNA catabolic process,BP,
10615,GO:0043634,1,0.526863052978842,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10619,GO:0043650,1,0.422388109642351,0,8,dicarboxylic acid biosynthetic process,BP,
10621,GO:0043652,1,0.454085906826802,0,8,engulfment of apoptotic cell,BP,
10622,GO:0043653,1,0.514822035059814,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10624,GO:0043656,1,0.448645782700413,0,7,intracellular region of host,CC,
10632,GO:0043696,1,0.49378601111789,0,5,dedifferentiation,BP,
10633,GO:0043697,1,0.49378601111789,0,5,cell dedifferentiation,BP,
10635,GO:0043734,1,0.702015057744537,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10657,GO:0043928,1,0.0386319021135766,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10669,GO:0043968,1,0.181517552952104,0,16,histone H2A acetylation,BP,
10671,GO:0043970,1,0.222313699677038,0,13,histone H3-K9 acetylation,BP,
10678,GO:0043984,1,0.102561977916759,0,19,histone H4-K16 acetylation,BP,
10679,GO:0043985,1,0.567035259198617,0,6,histone H4-R3 methylation,BP,
10680,GO:0043987,1,0.694750411611066,0,4,histone H3-S10 phosphorylation,BP,
10684,GO:0043995,1,0.303197289113456,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10685,GO:0043996,1,0.303197289113456,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10691,GO:0044020,1,0.713704312289919,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10694,GO:0044030,1,0.172889769035398,0,14,regulation of DNA methylation,BP,
10719,GO:0044107,1,0.71995932858144,0,4,cellular alcohol metabolic process,BP,
10720,GO:0044108,1,0.71995932858144,0,4,cellular alcohol biosynthetic process,BP,
10721,GO:0044110,1,0.585691899955189,0,6,growth involved in symbiotic interaction,BP,
10724,GO:0044116,1,0.585691899955189,0,6,growth of symbiont involved in interaction with host,BP,
10725,GO:0044117,1,0.585691899955189,0,6,growth of symbiont in host,BP,
10726,GO:0044126,1,0.623297609682607,0,5,regulation of growth of symbiont in host,BP,
10728,GO:0044130,1,0.724457233026123,0,4,negative regulation of growth of symbiont in host,BP,
10729,GO:0044144,1,0.623297609682607,0,5,modulation of growth of symbiont involved in interaction with host,BP,
10731,GO:0044146,1,0.724457233026123,0,4,negative regulation of growth of symbiont involved in interaction with host,BP,
10734,GO:0044154,1,0.447876073062048,0,8,histone H3-K14 acetylation,BP,
10739,GO:0044206,1,0.739151194551673,0,4,UMP salvage,BP,
10758,GO:0044233,1,0.255353488657698,0,12,ER-mitochondrion membrane contact site,CC,
10786,GO:0044292,1,0.314429139068727,0,10,dendrite terminus,CC,
10787,GO:0044294,1,0.398568376404737,0,7,dendritic growth cone,CC,
10790,GO:0044298,1,0.380515775852248,0,7,cell body membrane,CC,
10802,GO:0044314,1,0.743418121193824,0,4,protein K27-linked ubiquitination,BP,
10839,GO:0044364,1,0.287432911430588,0,19,disruption of cells of other organism,BP,
10845,GO:0044388,1,0.69102003424314,0,5,small protein activating enzyme binding,MF,
10855,GO:0044413,1,0.610175564620951,0,4,avoidance of host defenses,BP,
10857,GO:0044415,1,0.610175564620951,0,4,evasion or tolerance of host defenses,BP,
10859,GO:0044417,1,0.440727307193361,0,9,translocation of molecules into host,BP,
10887,GO:0044453,1,0.399546688124563,0,8,nuclear membrane part,CC,
10899,GO:0044528,1,0.673629626875299,0,4,regulation of mitochondrial mRNA stability,BP,
10901,GO:0044531,1,0.55540854170317,0,6,modulation of programmed cell death in other organism,BP,
10902,GO:0044532,1,0.55540854170317,0,6,modulation of apoptotic process in other organism,BP,
10906,GO:0044545,1,0.625703679336429,0,5,NSL complex,CC,
10907,GO:0044546,1,0.341520119648898,0,9,NLRP3 inflammasome complex assembly,BP,
10908,GO:0044547,1,0.57941946636511,0,5,DNA topoisomerase binding,MF,
10911,GO:0044550,1,0.188729643070594,0,13,secondary metabolite biosynthetic process,BP,
10914,GO:0044571,1,0.765791223381147,0,4,[2Fe-2S] cluster assembly,BP,
10927,GO:0044613,1,0.268426004915655,0,12,nuclear pore central transport channel,CC,
10928,GO:0044614,1,0.548170317887374,0,4,nuclear pore cytoplasmic filaments,CC,
10929,GO:0044615,1,0.231824101031537,0,9,nuclear pore nuclear basket,CC,
10934,GO:0044666,1,0.282093739162346,0,11,MLL3/4 complex,CC,
10954,GO:0044754,1,0.491898043085748,0,8,autolysosome,CC,
10957,GO:0044769,1,0.191546499498807,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
10971,GO:0044789,1,0.522008398724664,0,5,modulation by host of viral release from host cell,BP,
10972,GO:0044791,1,0.522008398724664,0,5,positive regulation by host of viral release from host cell,BP,
10980,GO:0044804,1,0.135155168194497,0,18,autophagy of nucleus,BP,
10982,GO:0044806,1,0.398877632315502,0,7,G-quadruplex DNA unwinding,BP,
10986,GO:0044821,1,0.628768859873375,0,4,meiotic telomere tethering at nuclear periphery,BP,
10991,GO:0044837,1,0.419122618756318,0,7,actomyosin contractile ring organization,BP,
11008,GO:0044878,1,0.732375397860169,0,4,mitotic cytokinesis checkpoint,BP,
11009,GO:0045002,1,0.50718583244359,0,7,double-strand break repair via single-strand annealing,BP,
11010,GO:0045003,1,0.405021680064092,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11015,GO:0045008,1,0.521895596231508,0,8,depyrimidination,BP,
11021,GO:0045022,1,0.010928893036708,0,38,early endosome to late endosome transport,BP,
11024,GO:0045026,1,0.230787240817326,0,16,plasma membrane fusion,BP,
11026,GO:0045028,1,0.621032820429962,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11029,GO:0045039,1,0.667787133066022,0,6,protein import into mitochondrial inner membrane,BP,
11030,GO:0045040,1,0.627835296428657,0,6,protein import into mitochondrial outer membrane,BP,
11032,GO:0045046,1,0.530725765325632,0,6,protein import into peroxisome membrane,BP,
11034,GO:0045048,1,0.59531977560874,0,5,protein insertion into ER membrane,BP,
11054,GO:0045075,1,0.555349926967314,0,5,regulation of interleukin-12 biosynthetic process,BP,
11055,GO:0045076,1,0.486001986281251,0,7,regulation of interleukin-2 biosynthetic process,BP,
11065,GO:0045086,1,0.524315552236372,0,6,positive regulation of interleukin-2 biosynthetic process,BP,
11081,GO:0045116,1,0.282231480653889,0,14,protein neddylation,BP,
11083,GO:0045120,1,0.2205371853539,0,12,pronucleus,CC,
11092,GO:0045134,1,0.678455526412087,0,4,uridine-diphosphatase activity,MF,
11098,GO:0045144,1,0.629044098629863,0,5,meiotic sister chromatid segregation,BP,
11121,GO:0045187,1,0.636160949904638,0,4,regulation of circadian sleep/wake cycle, sleep,BP,
11128,GO:0045199,1,0.563320945346896,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11149,GO:0045236,1,0.486827720840146,0,8,CXCR chemokine receptor binding,MF,
11155,GO:0045254,1,0.470619859309602,0,7,pyruvate dehydrogenase complex,CC,
11156,GO:0045257,1,0.665053558315156,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11161,GO:0045273,1,0.665053558315156,0,5,respiratory chain complex II,CC,
11163,GO:0045275,1,0.415496923539368,0,11,respiratory chain complex III,CC,
11165,GO:0045281,1,0.665053558315156,0,5,succinate dehydrogenase complex,CC,
11167,GO:0045283,1,0.665053558315156,0,5,fumarate reductase complex,CC,
11168,GO:0045292,1,0.20436439337121,0,16,mRNA cis splicing, via spliceosome,BP,
11170,GO:0045294,1,0.40399961943574,0,8,alpha-catenin binding,MF,
11174,GO:0045298,1,0.637967720681024,0,4,tubulin complex,CC,
11186,GO:0045338,1,0.696197218216065,0,4,farnesyl diphosphate metabolic process,BP,
11188,GO:0045341,1,0.605011965841501,0,4,MHC class I biosynthetic process,BP,
11189,GO:0045342,1,0.568597482277257,0,5,MHC class II biosynthetic process,BP,
11190,GO:0045343,1,0.605011965841501,0,4,regulation of MHC class I biosynthetic process,BP,
11191,GO:0045345,1,0.605011965841501,0,4,positive regulation of MHC class I biosynthetic process,BP,
11192,GO:0045346,1,0.568597482277257,0,5,regulation of MHC class II biosynthetic process,BP,
11215,GO:0045410,1,0.510001008856672,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11226,GO:0045448,1,0.672036016078619,0,4,mitotic cell cycle, embryonic,BP,
11234,GO:0045495,1,0.484417405822341,0,7,pole plasm,CC,
11242,GO:0045541,1,0.645544182485026,0,5,negative regulation of cholesterol biosynthetic process,BP,
11243,GO:0045542,1,0.542611487778688,0,5,positive regulation of cholesterol biosynthetic process,BP,
11245,GO:0045569,1,0.678473206052514,0,4,TRAIL binding,MF,
11271,GO:0045605,1,0.321537034944717,0,10,negative regulation of epidermal cell differentiation,BP,
11273,GO:0045607,1,0.572821468070871,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11276,GO:0045617,1,0.522892749800223,0,6,negative regulation of keratinocyte differentiation,BP,
11284,GO:0045625,1,0.581658410238047,0,5,regulation of T-helper 1 cell differentiation,BP,
11290,GO:0045631,1,0.572821468070871,0,5,regulation of mechanoreceptor differentiation,BP,
11291,GO:0045632,1,0.631625213852126,0,4,negative regulation of mechanoreceptor differentiation,BP,
11306,GO:0045653,1,0.444075449679821,0,17,negative regulation of megakaryocyte differentiation,BP,
11327,GO:0045683,1,0.214030271107261,0,13,negative regulation of epidermis development,BP,
11333,GO:0045714,1,0.458423510141703,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11336,GO:0045717,1,0.285562975894103,0,12,negative regulation of fatty acid biosynthetic process,BP,
11339,GO:0045722,1,0.315667542217552,0,9,positive regulation of gluconeogenesis,BP,
11340,GO:0045723,1,0.385933439171162,0,9,positive regulation of fatty acid biosynthetic process,BP,
11345,GO:0045730,1,0.252810342386571,0,14,respiratory burst,BP,
11352,GO:0045741,1,0.515589866062192,0,6,positive regulation of epidermal growth factor-activated receptor activity,BP,
11354,GO:0045743,1,0.521342506298194,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11378,GO:0045792,1,0.379871869660999,0,7,negative regulation of cell size,BP,
11390,GO:0045821,1,0.235594763800411,0,10,positive regulation of glycolytic process,BP,
11395,GO:0045830,1,0.164384678805365,0,16,positive regulation of isotype switching,BP,
11398,GO:0045835,1,0.5096824660785,0,6,negative regulation of meiotic nuclear division,BP,
11399,GO:0045836,1,0.513256717853868,0,6,positive regulation of meiotic nuclear division,BP,
11400,GO:0045837,1,0.478938290019977,0,8,negative regulation of membrane potential,BP,
11405,GO:0045842,1,0.407025051189813,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11408,GO:0045851,1,0.0247061925267494,0,38,pH reduction,BP,
11417,GO:0045875,1,0.453732636456543,0,5,negative regulation of sister chromatid cohesion,BP,
11426,GO:0045900,1,0.62583283261336,0,4,negative regulation of translational elongation,BP,
11433,GO:0045911,1,0.11311222538842,0,19,positive regulation of DNA recombination,BP,
11441,GO:0045919,1,0.741135582603264,0,4,positive regulation of cytolysis,BP,
11462,GO:0045945,1,0.265342099157294,0,10,positive regulation of transcription by RNA polymerase III,BP,
11466,GO:0045953,1,0.490073034727302,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11467,GO:0045954,1,0.364344736214303,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11468,GO:0045955,1,0.433531352847582,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11482,GO:0045990,1,0.628620759254511,0,4,carbon catabolite regulation of transcription,BP,
11483,GO:0045991,1,0.628620759254511,0,4,carbon catabolite activation of transcription,BP,
11490,GO:0046015,1,0.698050752829161,0,4,regulation of transcription by glucose,BP,
11498,GO:0046036,1,0.405945836541469,0,12,CTP metabolic process,BP,
11501,GO:0046039,1,0.0759962870038726,0,27,GTP metabolic process,BP,
11502,GO:0046040,1,0.271231268256176,0,12,IMP metabolic process,BP,
11505,GO:0046049,1,0.42863412653333,0,9,UMP metabolic process,BP,
11506,GO:0046051,1,0.483015885186812,0,9,UTP metabolic process,BP,
11511,GO:0046060,1,0.694487414417945,0,5,dATP metabolic process,BP,
11518,GO:0046070,1,0.74589031103183,0,4,dGTP metabolic process,BP,
11521,GO:0046075,1,0.741101523470802,0,4,dTTP metabolic process,BP,
11523,GO:0046078,1,0.736843723948814,0,4,dUMP metabolic process,BP,
11528,GO:0046085,1,0.535172011598428,0,6,adenosine metabolic process,BP,
11533,GO:0046098,1,0.665891289566769,0,4,guanine metabolic process,BP,
11535,GO:0046100,1,0.674448828824125,0,5,hypoxanthine metabolic process,BP,
11536,GO:0046101,1,0.730278050981992,0,4,hypoxanthine biosynthetic process,BP,
11552,GO:0046129,1,0.20406107597222,0,20,purine ribonucleoside biosynthetic process,BP,
11553,GO:0046130,1,0.621460175833551,0,6,purine ribonucleoside catabolic process,BP,
11555,GO:0046132,1,0.217832719048119,0,18,pyrimidine ribonucleoside biosynthetic process,BP,
11557,GO:0046134,1,0.126608287433194,0,24,pyrimidine nucleoside biosynthetic process,BP,
11561,GO:0046146,1,0.577508046634912,0,7,tetrahydrobiopterin metabolic process,BP,
11563,GO:0046149,1,0.706396257959951,0,5,pigment catabolic process,BP,
11574,GO:0046184,1,0.294051671750792,0,11,aldehyde biosynthetic process,BP,
11575,GO:0046185,1,0.470438465549232,0,9,aldehyde catabolic process,BP,
11613,GO:0046348,1,0.496717270052293,0,8,amino sugar catabolic process,BP,
11614,GO:0046349,1,0.301009778334779,0,11,amino sugar biosynthetic process,BP,
11623,GO:0046368,1,0.687182997043187,0,4,GDP-L-fucose metabolic process,BP,
11628,GO:0046385,1,0.467481507294576,0,10,deoxyribose phosphate biosynthetic process,BP,
11629,GO:0046386,1,0.207785546872281,0,19,deoxyribose phosphate catabolic process,BP,
11637,GO:0046415,1,0.597427470863189,0,5,urate metabolic process,BP,
11644,GO:0046439,1,0.569069317188918,0,5,L-cysteine metabolic process,BP,
11659,GO:0046465,1,0.509839352074055,0,7,dolichyl diphosphate metabolic process,BP,
11660,GO:0046466,1,0.116040259959456,0,22,membrane lipid catabolic process,BP,
11667,GO:0046475,1,0.209659292665434,0,15,glycerophospholipid catabolic process,BP,
11669,GO:0046477,1,0.555725509405751,0,6,glycosylceramide catabolic process,BP,
11671,GO:0046479,1,0.383163123361659,0,10,glycosphingolipid catabolic process,BP,
11673,GO:0046485,1,0.464107431147248,0,7,ether lipid metabolic process,BP,
11677,GO:0046490,1,0.687423612958341,0,5,isopentenyl diphosphate metabolic process,BP,
11683,GO:0046498,1,0.556053038493421,0,6,S-adenosylhomocysteine metabolic process,BP,
11686,GO:0046501,1,0.410830214465027,0,9,protoporphyrinogen IX metabolic process,BP,
11689,GO:0046504,1,0.562408796068154,0,5,glycerol ether biosynthetic process,BP,
11691,GO:0046512,1,0.445490403541677,0,8,sphingosine biosynthetic process,BP,
11693,GO:0046514,1,0.365796607916486,0,11,ceramide catabolic process,BP,
11694,GO:0046519,1,0.28480759807334,0,12,sphingoid metabolic process,BP,
11695,GO:0046520,1,0.393662963385577,0,9,sphingoid biosynthetic process,BP,
11706,GO:0046540,1,0.100381870465637,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11729,GO:0046599,1,0.130919276045886,0,17,regulation of centriole replication,BP,
11730,GO:0046600,1,0.356578618877266,0,8,negative regulation of centriole replication,BP,
11732,GO:0046602,1,0.358185419200793,0,8,regulation of mitotic centrosome separation,BP,
11736,GO:0046607,1,0.314238810777455,0,9,positive regulation of centrosome cycle,BP,
11743,GO:0046624,1,0.488066253834728,0,6,sphingolipid transporter activity,MF,
11744,GO:0046625,1,0.343619738418935,0,11,sphingolipid binding,MF,
11766,GO:0046654,1,0.501659733239042,0,7,tetrahydrofolate biosynthetic process,BP,
11798,GO:0046716,1,0.253610173975662,0,12,muscle cell cellular homeostasis,BP,
11804,GO:0046726,1,0.614724263099219,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11808,GO:0046755,1,0.123051829787933,0,23,viral budding,BP,
11812,GO:0046784,1,0.481329319481261,0,8,viral mRNA export from host cell nucleus,BP,
11826,GO:0046831,1,0.125821314863941,0,15,regulation of RNA export from nucleus,BP,
11828,GO:0046833,1,0.412228981966911,0,7,positive regulation of RNA export from nucleus,BP,
11831,GO:0046836,1,0.625733931468478,0,5,glycolipid transport,BP,
11832,GO:0046838,1,0.295974999474844,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11841,GO:0046855,1,0.295974999474844,0,10,inositol phosphate dephosphorylation,BP,
11853,GO:0046884,1,0.586272249188992,0,4,follicle-stimulating hormone secretion,BP,
11876,GO:0046923,1,0.658581582757515,0,5,ER retention sequence binding,MF,
11878,GO:0046929,1,0.365256504857093,0,8,negative regulation of neurotransmitter secretion,BP,
11885,GO:0046940,1,0.636896832546137,0,5,nucleoside monophosphate phosphorylation,BP,
11891,GO:0046950,1,0.50893107438993,0,7,cellular ketone body metabolic process,BP,
11892,GO:0046951,1,0.571410255069493,0,6,ketone body biosynthetic process,BP,
11895,GO:0046961,1,0.191546499498807,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11904,GO:0046972,1,0.303197289113456,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11905,GO:0046974,1,0.543215171090623,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11906,GO:0046975,1,0.382463927994576,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11907,GO:0046976,1,0.568073155834516,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11908,GO:0046977,1,0.665939350616995,0,4,TAP binding,MF,
11909,GO:0046978,1,0.665939350616995,0,4,TAP1 binding,MF,
11914,GO:0046984,1,0.676886075088744,0,4,regulation of hemoglobin biosynthetic process,BP,
11937,GO:0047134,1,0.68326331691962,0,5,protein-disulfide reductase activity,MF,
11951,GO:0047238,1,0.622643910097147,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11970,GO:0047372,1,0.384484122346356,0,9,acylglycerol lipase activity,MF,
11986,GO:0047498,1,0.513454101999518,0,6,calcium-dependent phospholipase A2 activity,MF,
11991,GO:0047555,1,0.558924257436256,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
11999,GO:0047631,1,0.707570647164017,0,5,ADP-ribose diphosphatase activity,MF,
12053,GO:0048025,1,0.185055266698696,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12054,GO:0048026,1,0.293767227364989,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12062,GO:0048039,1,0.638197365985342,0,6,ubiquinone binding,MF,
12074,GO:0048096,1,0.38594445005041,0,8,chromatin-mediated maintenance of transcription,BP,
12086,GO:0048149,1,0.560161562493416,0,4,behavioral response to ethanol,BP,
12094,GO:0048170,1,0.598684794599158,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
12099,GO:0048188,1,0.214144328645656,0,12,Set1C/COMPASS complex,CC,
12112,GO:0048227,1,0.431439459655199,0,8,plasma membrane to endosome transport,BP,
12116,GO:0048240,1,0.4834015913653,0,7,sperm capacitation,BP,
12124,GO:0048254,1,0.688108272907956,0,4,snoRNA localization,BP,
12126,GO:0048256,1,0.446119001326745,0,8,flap endonuclease activity,MF,
12135,GO:0048266,1,0.494515543255043,0,5,behavioral response to pain,BP,
12139,GO:0048273,1,0.488821927907734,0,6,mitogen-activated protein kinase p38 binding,MF,
12141,GO:0048280,1,0.390783108646155,0,10,vesicle fusion with Golgi apparatus,BP,
12146,GO:0048290,1,0.573986990162816,0,6,isotype switching to IgA isotypes,BP,
12147,GO:0048291,1,0.420826630297853,0,8,isotype switching to IgG isotypes,BP,
12151,GO:0048296,1,0.640380261351035,0,5,regulation of isotype switching to IgA isotypes,BP,
12153,GO:0048298,1,0.69592885750916,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12154,GO:0048302,1,0.458791414676781,0,7,regulation of isotype switching to IgG isotypes,BP,
12155,GO:0048304,1,0.573951216806683,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12156,GO:0048305,1,0.349467480795091,0,12,immunoglobulin secretion,BP,
12158,GO:0048308,1,0.215997327485324,0,15,organelle inheritance,BP,
12160,GO:0048312,1,0.425152590033916,0,6,intracellular distribution of mitochondria,BP,
12161,GO:0048313,1,0.238189195488226,0,14,Golgi inheritance,BP,
12184,GO:0048386,1,0.65563038420214,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
12192,GO:0048406,1,0.586958169344731,0,4,nerve growth factor binding,MF,
12199,GO:0048476,1,0.67410655561765,0,5,Holliday junction resolvase complex,CC,
12201,GO:0048478,1,0.414381569789065,0,7,replication fork protection,BP,
12209,GO:0048490,1,0.219749121703038,0,15,anterograde synaptic vesicle transport,BP,
12222,GO:0048520,1,0.596274563565491,0,4,positive regulation of behavior,BP,
12223,GO:0048521,1,0.665422764772963,0,4,negative regulation of behavior,BP,
12228,GO:0048531,1,0.330250051657512,0,12,beta-1,3-galactosyltransferase activity,MF,
12235,GO:0048539,1,0.637120329624015,0,4,bone marrow development,BP,
12266,GO:0048617,1,0.395331631792178,0,5,embryonic foregut morphogenesis,BP,
12304,GO:0048680,1,0.717560310172401,0,4,positive regulation of axon regeneration,BP,
12334,GO:0048733,1,0.477117404897715,0,5,sebaceous gland development,BP,
12339,GO:0048742,1,0.507434143751136,0,5,regulation of skeletal muscle fiber development,BP,
12348,GO:0048757,1,0.358380158688266,0,10,pigment granule maturation,BP,
12358,GO:0048787,1,0.605737457107747,0,4,presynaptic active zone membrane,CC,
12361,GO:0048793,1,0.551048093584684,0,4,pronephros development,BP,
12384,GO:0048853,1,0.356261367969586,0,7,forebrain morphogenesis,BP,
12403,GO:0048875,1,0.414914771777207,0,7,chemical homeostasis within a tissue,BP,
12414,GO:0050072,1,0.437734662441143,0,7,m7G(5')pppN diphosphatase activity,MF,
12421,GO:0050136,1,0.109589409366666,0,38,NADH dehydrogenase (quinone) activity,MF,
12423,GO:0050145,1,0.636896832546137,0,5,nucleoside phosphate kinase activity,MF,
12455,GO:0050428,1,0.503685143195164,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12470,GO:0050510,1,0.618531117361366,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12497,GO:0050664,1,0.53026020969492,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12498,GO:0050665,1,0.377369175011841,0,9,hydrogen peroxide biosynthetic process,BP,
12512,GO:0050685,1,0.111524112085039,0,21,positive regulation of mRNA processing,BP,
12513,GO:0050686,1,0.0606636774085536,0,27,negative regulation of mRNA processing,BP,
12524,GO:0050700,1,0.278233509837083,0,11,CARD domain binding,MF,
12527,GO:0050703,1,0.704869689058595,0,5,interleukin-1 alpha secretion,BP,
12529,GO:0050705,1,0.737743807837051,0,4,regulation of interleukin-1 alpha secretion,BP,
12537,GO:0050713,1,0.611292099944698,0,5,negative regulation of interleukin-1 beta secretion,BP,
12552,GO:0050733,1,0.626795699307583,0,4,RS domain binding,MF,
12553,GO:0050746,1,0.388092683442811,0,8,regulation of lipoprotein metabolic process,BP,
12554,GO:0050747,1,0.578875852301791,0,5,positive regulation of lipoprotein metabolic process,BP,
12562,GO:0050765,1,0.387977338938083,0,9,negative regulation of phagocytosis,BP,
12580,GO:0050786,1,0.646013797536623,0,8,RAGE receptor binding,MF,
12601,GO:0050815,1,0.526751063800962,0,6,phosphoserine residue binding,MF,
12611,GO:0050830,1,0.0814207806572829,0,36,defense response to Gram-positive bacterium,BP,
12612,GO:0050832,1,0.348125807476522,0,14,defense response to fungus,BP,
12626,GO:0050857,1,0.310317752961803,0,11,positive regulation of antigen receptor-mediated signaling pathway,BP,
12630,GO:0050861,1,0.636142788111859,0,4,positive regulation of B cell receptor signaling pathway,BP,
12631,GO:0050862,1,0.487938256054603,0,7,positive regulation of T cell receptor signaling pathway,BP,
12648,GO:0050882,1,0.345047116764907,0,6,voluntary musculoskeletal movement,BP,
12664,GO:0050908,1,0.582499293185768,0,4,detection of light stimulus involved in visual perception,BP,
12668,GO:0050912,1,0.517628046834368,0,9,detection of chemical stimulus involved in sensory perception of taste,BP,
12685,GO:0050930,1,0.462411815181401,0,8,induction of positive chemotaxis,BP,
12696,GO:0050962,1,0.582499293185768,0,4,detection of light stimulus involved in sensory perception,BP,
12710,GO:0051000,1,0.260821335647321,0,12,positive regulation of nitric-oxide synthase activity,BP,
12716,GO:0051011,1,0.215742694257553,0,10,microtubule minus-end binding,MF,
12726,GO:0051021,1,0.656737708783703,0,4,GDP-dissociation inhibitor binding,MF,
12727,GO:0051022,1,0.656737708783703,0,4,Rho GDP-dissociation inhibitor binding,MF,
12728,GO:0051023,1,0.440747895497734,0,10,regulation of immunoglobulin secretion,BP,
12729,GO:0051024,1,0.674170402354322,0,5,positive regulation of immunoglobulin secretion,BP,
12733,GO:0051029,1,0.553107970181376,0,6,rRNA transport,BP,
12734,GO:0051030,1,0.746215266574838,0,4,snRNA transport,BP,
12735,GO:0051031,1,0.0174305352003882,0,33,tRNA transport,BP,
12738,GO:0051036,1,0.628007371575066,0,5,regulation of endosome size,BP,
12775,GO:0051096,1,0.519097067951303,0,6,positive regulation of helicase activity,BP,
12783,GO:0051105,1,0.555342541759755,0,6,regulation of DNA ligation,BP,
12784,GO:0051106,1,0.612439961890468,0,5,positive regulation of DNA ligation,BP,
12822,GO:0051167,1,0.668783099174664,0,5,xylulose 5-phosphate metabolic process,BP,
12831,GO:0051177,1,0.685035481322591,0,4,meiotic sister chromatid cohesion,BP,
12835,GO:0051182,1,0.474420684956241,0,7,coenzyme transport,BP,
12837,GO:0051185,1,0.528734826214153,0,6,coenzyme transmembrane transporter activity,MF,
12841,GO:0051189,1,0.50725616153214,0,7,prosthetic group metabolic process,BP,
12847,GO:0051197,1,0.235594763800411,0,10,positive regulation of coenzyme metabolic process,BP,
12863,GO:0051231,1,0.288784745412318,0,11,spindle elongation,BP,
12869,GO:0051238,1,0.349108684750664,0,12,sequestering of metal ion,BP,
12882,GO:0051255,1,0.34343249572822,0,10,spindle midzone assembly,BP,
12883,GO:0051256,1,0.419565462562679,0,8,mitotic spindle midzone assembly,BP,
12903,GO:0051286,1,0.502045388254985,0,5,cell tip,CC,
12908,GO:0051292,1,0.26587818039237,0,10,nuclear pore complex assembly,BP,
12913,GO:0051299,1,0.180483959300102,0,14,centrosome separation,BP,
12919,GO:0051305,1,0.516857256149387,0,5,chromosome movement towards spindle pole,BP,
12921,GO:0051307,1,0.228654734472947,0,12,meiotic chromosome separation,BP,
12923,GO:0051310,1,0.00344014799514966,0,53,metaphase plate congression,BP,
12925,GO:0051315,1,0.253633776857836,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12931,GO:0051340,1,0.515161261872514,0,8,regulation of ligase activity,BP,
12941,GO:0051350,1,0.361420697543851,0,9,negative regulation of lyase activity,BP,
12942,GO:0051351,1,0.568131155753032,0,7,positive regulation of ligase activity,BP,
12958,GO:0051388,1,0.608552552868024,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12963,GO:0051400,1,0.440539343431378,0,8,BH domain binding,MF,
12967,GO:0051410,1,0.635790400900824,0,5,detoxification of nitrogen compound,BP,
12971,GO:0051415,1,0.489189895636292,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
12973,GO:0051418,1,0.337271902720715,0,8,microtubule nucleation by microtubule organizing center,BP,
12981,GO:0051434,1,0.678233750833634,0,4,BH3 domain binding,MF,
12983,GO:0051443,1,0.0423276964219916,0,30,positive regulation of ubiquitin-protein transferase activity,BP,
12984,GO:0051444,1,0.292628264310544,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
12986,GO:0051446,1,0.345451006841928,0,9,positive regulation of meiotic cell cycle,BP,
12989,GO:0051451,1,0.41845643386159,0,8,myoblast migration,BP,
12990,GO:0051452,1,0.0268411149387565,0,37,intracellular pH reduction,BP,
13017,GO:0051503,1,0.315691948545288,0,12,adenine nucleotide transport,BP,
13037,GO:0051568,1,0.00356343135988793,0,45,histone H3-K4 methylation,BP,
13038,GO:0051569,1,0.0773026290558893,0,21,regulation of histone H3-K4 methylation,BP,
13040,GO:0051571,1,0.165100888519216,0,14,positive regulation of histone H3-K4 methylation,BP,
13060,GO:0051597,1,0.457721230754453,0,6,response to methylmercury,BP,
13063,GO:0051601,1,0.562823593974166,0,5,exocyst localization,BP,
13069,GO:0051608,1,0.481316048188954,0,8,histamine transport,BP,
13094,GO:0051661,1,0.423223816859557,0,5,maintenance of centrosome location,BP,
13101,GO:0051683,1,0.498993831547078,0,7,establishment of Golgi localization,BP,
13107,GO:0051697,1,0.71359325383004,0,4,protein delipidation,BP,
13115,GO:0051709,1,0.559970695639617,0,7,regulation of killing of cells of other organism,BP,
13117,GO:0051712,1,0.559970695639617,0,7,positive regulation of killing of cells of other organism,BP,
13130,GO:0051731,1,0.603154717880337,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13139,GO:0051764,1,0.246493786846856,0,11,actin crosslink formation,BP,
13157,GO:0051791,1,0.487572308766424,0,7,medium-chain fatty acid metabolic process,BP,
13158,GO:0051792,1,0.651611660136777,0,4,medium-chain fatty acid biosynthetic process,BP,
13172,GO:0051818,1,0.597829463870959,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13176,GO:0051832,1,0.610175564620951,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13178,GO:0051834,1,0.610175564620951,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
13180,GO:0051836,1,0.440727307193361,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13182,GO:0051852,1,0.735580526214814,0,4,disruption by host of symbiont cells,BP,
13187,GO:0051873,1,0.735580526214814,0,4,killing by host of symbiont cells,BP,
13191,GO:0051880,1,0.354005877782526,0,7,G-quadruplex DNA binding,MF,
13194,GO:0051883,1,0.597829463870959,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
13195,GO:0051884,1,0.580262085891584,0,4,regulation of timing of anagen,BP,
13248,GO:0051964,1,0.56238726552023,0,4,negative regulation of synapse assembly,BP,
13263,GO:0051987,1,0.575864240177914,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13264,GO:0051988,1,0.243388264039549,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13272,GO:0052040,1,0.55540854170317,0,6,modulation by symbiont of host programmed cell death,BP,
13273,GO:0052041,1,0.687420852935059,0,4,negative regulation by symbiont of host programmed cell death,BP,
13284,GO:0052150,1,0.593244532205875,0,5,modulation by symbiont of host apoptotic process,BP,
13288,GO:0052173,1,0.527991907517561,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13293,GO:0052200,1,0.527991907517561,0,6,response to host defenses,BP,
13301,GO:0052248,1,0.55540854170317,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13325,GO:0052433,1,0.55540854170317,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13327,GO:0052490,1,0.687420852935059,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13340,GO:0052564,1,0.621859073802555,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13342,GO:0052572,1,0.621859073802555,0,5,response to host immune response,BP,
13351,GO:0052646,1,0.340481816184504,0,8,alditol phosphate metabolic process,BP,
13352,GO:0052650,1,0.559185426982374,0,7,NADP-retinol dehydrogenase activity,MF,
13359,GO:0052658,1,0.466562146418431,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13369,GO:0052723,1,0.597873058565097,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13370,GO:0052724,1,0.597873058565097,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13385,GO:0052803,1,0.668878526466339,0,4,imidazole-containing compound metabolic process,BP,
13388,GO:0052811,1,0.574435403400394,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13401,GO:0052832,1,0.625206360179963,0,4,inositol monophosphate 3-phosphatase activity,MF,
13402,GO:0052833,1,0.625206360179963,0,4,inositol monophosphate 4-phosphatase activity,MF,
13403,GO:0052834,1,0.625206360179963,0,4,inositol monophosphate phosphatase activity,MF,
13407,GO:0052840,1,0.68370776824984,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13408,GO:0052841,1,0.68370776824984,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13409,GO:0052842,1,0.68370776824984,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13410,GO:0052843,1,0.68370776824984,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13411,GO:0052844,1,0.68370776824984,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13412,GO:0052845,1,0.68370776824984,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13413,GO:0052846,1,0.68370776824984,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13414,GO:0052847,1,0.68370776824984,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13415,GO:0052848,1,0.68370776824984,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13473,GO:0055069,1,0.122676070373621,0,21,zinc ion homeostasis,BP,
13489,GO:0055089,1,0.268936573013737,0,11,fatty acid homeostasis,BP,
13500,GO:0055105,1,0.695340112198861,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13510,GO:0055129,1,0.706724684053345,0,4,L-proline biosynthetic process,BP,
13511,GO:0055131,1,0.654595823365549,0,5,C3HC4-type RING finger domain binding,MF,
13523,GO:0060013,1,0.500722963566862,0,5,righting reflex,BP,
13550,GO:0060046,1,0.605980720893863,0,5,regulation of acrosome reaction,BP,
13553,GO:0060049,1,0.251100395293158,0,11,regulation of protein glycosylation,BP,
13554,GO:0060050,1,0.359536140722262,0,8,positive regulation of protein glycosylation,BP,
13563,GO:0060059,1,0.405049739309238,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13590,GO:0060091,1,0.623759815825261,0,5,kinocilium,CC,
13597,GO:0060120,1,0.555762076242852,0,5,inner ear receptor cell fate commitment,BP,
13599,GO:0060123,1,0.515474789856144,0,4,regulation of growth hormone secretion,BP,
13608,GO:0060136,1,0.616662357306769,0,4,embryonic process involved in female pregnancy,BP,
13622,GO:0060158,1,0.725816620095294,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13623,GO:0060159,1,0.689848769200096,0,4,regulation of dopamine receptor signaling pathway,BP,
13649,GO:0060211,1,0.227667624612324,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13651,GO:0060213,1,0.227667624612324,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13659,GO:0060229,1,0.42131232456395,0,8,lipase activator activity,MF,
13661,GO:0060232,1,0.690022372768055,0,4,delamination,BP,
13663,GO:0060236,1,0.0113360668267267,0,35,regulation of mitotic spindle organization,BP,
13677,GO:0060263,1,0.437018413147852,0,8,regulation of respiratory burst,BP,
13687,GO:0060281,1,0.527980110244187,0,6,regulation of oocyte development,BP,
13696,GO:0060293,1,0.484417405822341,0,7,germ plasm,CC,
13734,GO:0060339,1,0.426508042420132,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13735,GO:0060340,1,0.299758997316076,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13753,GO:0060368,1,0.541331782381125,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13754,GO:0060369,1,0.64421523667435,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13847,GO:0060501,1,0.650924971145588,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13868,GO:0060539,1,0.578401109706042,0,5,diaphragm development,BP,
13888,GO:0060574,1,0.704173228252778,0,4,intestinal epithelial cell maturation,BP,
13897,GO:0060586,1,0.545766549110109,0,5,multicellular organismal iron ion homeostasis,BP,
13925,GO:0060644,1,0.297280745073458,0,11,mammary gland epithelial cell differentiation,BP,
13935,GO:0060670,1,0.342120291892442,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13955,GO:0060696,1,0.625204415214149,0,5,regulation of phospholipid catabolic process,BP,
13958,GO:0060699,1,0.6769341213651,0,4,regulation of endoribonuclease activity,BP,
13999,GO:0060753,1,0.577670147819641,0,6,regulation of mast cell chemotaxis,BP,
14000,GO:0060754,1,0.619391903029076,0,5,positive regulation of mast cell chemotaxis,BP,
14010,GO:0060768,1,0.428039803118472,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14012,GO:0060770,1,0.594059225967601,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14015,GO:0060788,1,0.30209333345027,0,10,ectodermal placode formation,BP,
14016,GO:0060789,1,0.551789178569171,0,6,hair follicle placode formation,BP,
14030,GO:0060837,1,0.479194120356462,0,6,blood vessel endothelial cell differentiation,BP,
14052,GO:0060900,1,0.320285241694117,0,7,embryonic camera-type eye formation,BP,
14062,GO:0060916,1,0.569161164392211,0,4,mesenchymal cell proliferation involved in lung development,BP,
14076,GO:0060947,1,0.569359196554428,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14078,GO:0060956,1,0.543103242080231,0,4,endocardial cell differentiation,BP,
14093,GO:0060982,1,0.365477077664304,0,7,coronary artery morphogenesis,BP,
14097,GO:0060992,1,0.275120226540828,0,10,response to fungicide,BP,
14140,GO:0061051,1,0.508108254376046,0,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14146,GO:0061072,1,0.459769117398824,0,5,iris morphogenesis,BP,
14152,GO:0061081,1,0.615883994937628,0,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14154,GO:0061083,1,0.653616101070934,0,4,regulation of protein refolding,BP,
14155,GO:0061084,1,0.653616101070934,0,4,negative regulation of protein refolding,BP,
14156,GO:0061085,1,0.35707529510905,0,9,regulation of histone H3-K27 methylation,BP,
14157,GO:0061086,1,0.633377368273353,0,4,negative regulation of histone H3-K27 methylation,BP,
14158,GO:0061087,1,0.50426040739872,0,6,positive regulation of histone H3-K27 methylation,BP,
14159,GO:0061088,1,0.481879703413443,0,6,regulation of sequestering of zinc ion,BP,
14165,GO:0061101,1,0.692385544517861,0,4,neuroendocrine cell differentiation,BP,
14174,GO:0061133,1,0.696733889950368,0,5,endopeptidase activator activity,MF,
14196,GO:0061179,1,0.530535577816307,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14203,GO:0061196,1,0.583972240561682,0,4,fungiform papilla development,BP,
14204,GO:0061197,1,0.583972240561682,0,4,fungiform papilla morphogenesis,BP,
14230,GO:0061314,1,0.445032165493653,0,5,Notch signaling involved in heart development,BP,
14250,GO:0061355,1,0.65168027882807,0,4,Wnt protein secretion,BP,
14251,GO:0061356,1,0.65168027882807,0,4,regulation of Wnt protein secretion,BP,
14269,GO:0061419,1,0.527618573151382,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14288,GO:0061470,1,0.57401871166289,0,4,T follicular helper cell differentiation,BP,
14300,GO:0061511,1,0.614553467450955,0,4,centriole elongation,BP,
14315,GO:0061548,1,0.362323126314468,0,8,ganglion development,BP,
14316,GO:0061549,1,0.469544224423878,0,6,sympathetic ganglion development,BP,
14317,GO:0061550,1,0.589071808679968,0,4,cranial ganglion development,BP,
14331,GO:0061575,1,0.779600453408039,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14333,GO:0061578,1,0.24768314656669,0,11,Lys63-specific deubiquitinase activity,MF,
14344,GO:0061608,1,0.367823123305585,0,9,nuclear import signal receptor activity,MF,
14347,GO:0061615,1,0.173431375324591,0,18,glycolytic process through fructose-6-phosphate,BP,
14348,GO:0061617,1,0.521238323840741,0,8,MICOS complex,CC,
14350,GO:0061620,1,0.173431375324591,0,18,glycolytic process through glucose-6-phosphate,BP,
14351,GO:0061621,1,0.185489348956892,0,17,canonical glycolysis,BP,
14361,GO:0061635,1,0.531738901307084,0,7,regulation of protein complex stability,BP,
14374,GO:0061665,1,0.60986914537556,0,5,SUMO ligase activity,MF,
14375,GO:0061668,1,0.514927840484526,0,6,mitochondrial ribosome assembly,BP,
14377,GO:0061673,1,0.564274829796054,0,5,mitotic spindle astral microtubule,CC,
14378,GO:0061676,1,0.491491767140125,0,6,importin-alpha family protein binding,MF,
14392,GO:0061718,1,0.185489348956892,0,17,glucose catabolic process to pyruvate,BP,
14394,GO:0061724,1,0.440474759054798,0,6,lipophagy,BP,
14398,GO:0061732,1,0.556386411135886,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14434,GO:0061820,1,0.351870832881786,0,9,telomeric D-loop disassembly,BP,
14435,GO:0061821,1,0.574305585227698,0,4,telomeric D-loop binding,MF,
14442,GO:0061844,1,0.220178162028863,0,26,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
14475,GO:0061983,1,0.559307066115175,0,6,meiosis II cell cycle process,BP,
14508,GO:0070044,1,0.691798616762869,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
14522,GO:0070070,1,0.296378685117715,0,8,proton-transporting V-type ATPase complex assembly,BP,
14523,GO:0070071,1,0.207142582270168,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14524,GO:0070072,1,0.296378685117715,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14552,GO:0070122,1,0.630105542591166,0,4,isopeptidase activity,MF,
14555,GO:0070125,1,0.00279358647409567,0,86,mitochondrial translational elongation,BP,
14556,GO:0070126,1,0.00232925709372132,0,88,mitochondrial translational termination,BP,
14557,GO:0070127,1,0.442599414666209,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14558,GO:0070129,1,0.185123194814719,0,18,regulation of mitochondrial translation,BP,
14560,GO:0070131,1,0.367362398337521,0,11,positive regulation of mitochondrial translation,BP,
14561,GO:0070137,1,0.551781652919991,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14563,GO:0070139,1,0.551781652919991,0,4,SUMO-specific endopeptidase activity,MF,
14573,GO:0070162,1,0.54690569097478,0,5,adiponectin secretion,BP,
14574,GO:0070163,1,0.54690569097478,0,5,regulation of adiponectin secretion,BP,
14575,GO:0070164,1,0.603051093498423,0,4,negative regulation of adiponectin secretion,BP,
14589,GO:0070182,1,0.154540779445861,0,18,DNA polymerase binding,MF,
14592,GO:0070187,1,0.564206251247115,0,6,shelterin complex,CC,
14593,GO:0070189,1,0.725760624781005,0,4,kynurenine metabolic process,BP,
14599,GO:0070197,1,0.628768859873375,0,4,meiotic attachment of telomere to nuclear envelope,BP,
14600,GO:0070198,1,0.0474969468590374,0,26,protein localization to chromosome, telomeric region,BP,
14602,GO:0070200,1,0.237073887592699,0,14,establishment of protein localization to telomere,BP,
14604,GO:0070202,1,0.375111565302699,0,11,regulation of establishment of protein localization to chromosome,BP,
14605,GO:0070203,1,0.413633306734648,0,10,regulation of establishment of protein localization to telomere,BP,
14607,GO:0070207,1,0.183371783288073,0,17,protein homotrimerization,BP,
14611,GO:0070213,1,0.551716738490588,0,4,protein auto-ADP-ribosylation,BP,
14628,GO:0070254,1,0.475305504747504,0,8,mucus secretion,BP,
14629,GO:0070255,1,0.499514439942814,0,7,regulation of mucus secretion,BP,
14631,GO:0070257,1,0.536483226995682,0,6,positive regulation of mucus secretion,BP,
14634,GO:0070262,1,0.285438521374833,0,13,peptidyl-serine dephosphorylation,BP,
14639,GO:0070269,1,0.499014747436276,0,8,pyroptosis,BP,
14664,GO:0070314,1,0.549476673711641,0,5,G1 to G0 transition,BP,
14676,GO:0070330,1,0.488505570422549,0,7,aromatase activity,MF,
14682,GO:0070341,1,0.480985554493584,0,6,fat cell proliferation,BP,
14684,GO:0070344,1,0.480985554493584,0,6,regulation of fat cell proliferation,BP,
14685,GO:0070345,1,0.60447329738766,0,4,negative regulation of fat cell proliferation,BP,
14688,GO:0070358,1,0.57129756641754,0,5,actin polymerization-dependent cell motility,BP,
14691,GO:0070370,1,0.678383264501779,0,5,cellular heat acclimation,BP,
14704,GO:0070391,1,0.603338983894325,0,5,response to lipoteichoic acid,BP,
14719,GO:0070419,1,0.41509407471978,0,7,nonhomologous end joining complex,CC,
14720,GO:0070423,1,0.0308926240182702,0,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,
14721,GO:0070424,1,0.465324450165476,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14727,GO:0070431,1,0.446154891239864,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14743,GO:0070470,1,0.736305555034107,0,4,plasma membrane respiratory chain,CC,
14747,GO:0070475,1,0.48212406487752,0,9,rRNA base methylation,BP,
14753,GO:0070486,1,0.353107065598457,0,10,leukocyte aggregation,BP,
14754,GO:0070487,1,0.634483507587057,0,4,monocyte aggregation,BP,
14765,GO:0070508,1,0.609222002231697,0,5,cholesterol import,BP,
14769,GO:0070513,1,0.481116994263131,0,8,death domain binding,MF,
14770,GO:0070522,1,0.627429838597744,0,4,ERCC4-ERCC1 complex,CC,
14772,GO:0070525,1,0.316422110261173,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14776,GO:0070531,1,0.570611546864137,0,5,BRCA1-A complex,CC,
14778,GO:0070535,1,0.48583842563247,0,5,histone H2A K63-linked ubiquitination,BP,
14779,GO:0070536,1,0.0399456455448179,0,25,protein K63-linked deubiquitination,BP,
14786,GO:0070545,1,0.669941972544924,0,4,PeBoW complex,CC,
14800,GO:0070567,1,0.392392287227652,0,9,cytidylyltransferase activity,MF,
14801,GO:0070568,1,0.594949446487254,0,5,guanylyltransferase activity,MF,
14805,GO:0070572,1,0.717560310172401,0,4,positive regulation of neuron projection regeneration,BP,
14811,GO:0070579,1,0.463266113520739,0,4,methylcytosine dioxygenase activity,MF,
14812,GO:0070584,1,0.12141202060686,0,21,mitochondrion morphogenesis,BP,
14819,GO:0070601,1,0.44739425863835,0,8,centromeric sister chromatid cohesion,BP,
14830,GO:0070628,1,0.151959864782893,0,18,proteasome binding,MF,
14833,GO:0070633,1,0.294136178528436,0,10,transepithelial transport,BP,
14854,GO:0070669,1,0.312732080707694,0,9,response to interleukin-2,BP,
14857,GO:0070672,1,0.283892719677303,0,10,response to interleukin-15,BP,
14866,GO:0070695,1,0.475814857620715,0,5,FHF complex,CC,
14879,GO:0070734,1,0.138004583378705,0,18,histone H3-K27 methylation,BP,
14888,GO:0070761,1,0.565668522841033,0,6,pre-snoRNP complex,CC,
14894,GO:0070775,1,0.414025231016471,0,7,H3 histone acetyltransferase complex,CC,
14895,GO:0070776,1,0.414025231016471,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14897,GO:0070778,1,0.639771869605514,0,4,L-aspartate transmembrane transport,BP,
14902,GO:0070813,1,0.616413841891992,0,5,hydrogen sulfide metabolic process,BP,
14903,GO:0070814,1,0.652130700429222,0,4,hydrogen sulfide biosynthetic process,BP,
14904,GO:0070815,1,0.639747097281739,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14905,GO:0070816,1,0.20031123959953,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14926,GO:0070847,1,0.488972253367113,0,8,core mediator complex,CC,
14942,GO:0070876,1,0.6489245393914,0,4,SOSS complex,CC,
14944,GO:0070878,1,0.339487514431983,0,8,primary miRNA binding,MF,
14945,GO:0070883,1,0.553446567334934,0,5,pre-miRNA binding,MF,
14959,GO:0070900,1,0.447316634488846,0,9,mitochondrial tRNA modification,BP,
14960,GO:0070901,1,0.680430523956329,0,4,mitochondrial tRNA methylation,BP,
14967,GO:0070915,1,0.707721407869631,0,4,lysophosphatidic acid receptor activity,MF,
14975,GO:0070933,1,0.305912370480487,0,9,histone H4 deacetylation,BP,
14976,GO:0070934,1,0.566408362400222,0,4,CRD-mediated mRNA stabilization,BP,
14977,GO:0070935,1,0.290845869475477,0,11,3'-UTR-mediated mRNA stabilization,BP,
14979,GO:0070937,1,0.496947447950073,0,5,CRD-mediated mRNA stability complex,CC,
14982,GO:0070940,1,0.579301521590013,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
14983,GO:0070942,1,0.708859101469637,0,4,neutrophil mediated cytotoxicity,BP,
14999,GO:0070970,1,0.338929825412353,0,8,interleukin-2 secretion,BP,
15002,GO:0070973,1,0.53876334374276,0,4,protein localization to endoplasmic reticulum exit site,BP,
15006,GO:0070979,1,0.0924265074462585,0,27,protein K11-linked ubiquitination,BP,
15014,GO:0070989,1,0.265452081903057,0,10,oxidative demethylation,BP,
15015,GO:0070990,1,0.643557060724743,0,6,snRNP binding,MF,
15022,GO:0071004,1,0.175752842141707,0,17,U2-type prespliceosome,CC,
15025,GO:0071007,1,0.0672568516280544,0,29,U2-type catalytic step 2 spliceosome,CC,
15026,GO:0071008,1,0.698179996911892,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15027,GO:0071010,1,0.113875875330639,0,22,prespliceosome,CC,
15029,GO:0071012,1,0.555187601369178,0,6,catalytic step 1 spliceosome,CC,
15031,GO:0071014,1,0.438525551440924,0,9,post-mRNA release spliceosomal complex,CC,
15034,GO:0071025,1,0.274156333481479,0,15,RNA surveillance,BP,
15036,GO:0071027,1,0.330774438212237,0,13,nuclear RNA surveillance,BP,
15037,GO:0071028,1,0.330774438212237,0,13,nuclear mRNA surveillance,BP,
15038,GO:0071029,1,0.641398836060504,0,6,nuclear ncRNA surveillance,BP,
15041,GO:0071033,1,0.676128117146535,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15042,GO:0071034,1,0.649866470850073,0,4,CUT catabolic process,BP,
15043,GO:0071035,1,0.641398836060504,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15044,GO:0071038,1,0.705558402036375,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15045,GO:0071042,1,0.708664137373549,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15046,GO:0071043,1,0.649866470850073,0,4,CUT metabolic process,BP,
15049,GO:0071046,1,0.641398836060504,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15050,GO:0071047,1,0.708664137373549,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15053,GO:0071051,1,0.717587989991528,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15066,GO:0071108,1,0.0237610393769666,0,25,protein K48-linked deubiquitination,BP,
15082,GO:0071166,1,1.46227051761459e-06,0,122,ribonucleoprotein complex localization,BP,
15087,GO:0071203,1,0.47011059255728,0,6,WASH complex,CC,
15088,GO:0071204,1,0.539923956613257,0,6,histone pre-mRNA 3'end processing complex,CC,
15091,GO:0071208,1,0.774329585546065,0,4,histone pre-mRNA DCP binding,MF,
15102,GO:0071223,1,0.603338983894325,0,5,cellular response to lipoteichoic acid,BP,
15113,GO:0071243,1,0.248845848657126,0,16,cellular response to arsenic-containing substance,BP,
15118,GO:0071256,1,0.780888294069398,0,4,translocon complex,CC,
15119,GO:0071257,1,0.54356165930689,0,5,cellular response to electrical stimulus,BP,
15124,GO:0071265,1,0.534195838234898,0,7,L-methionine biosynthetic process,BP,
15126,GO:0071267,1,0.576335232761397,0,6,L-methionine salvage,BP,
15131,GO:0071279,1,0.641388583968526,0,4,cellular response to cobalt ion,BP,
15133,GO:0071281,1,0.493735295096384,0,7,cellular response to iron ion,BP,
15135,GO:0071284,1,0.571530508928815,0,4,cellular response to lead ion,BP,
15139,GO:0071294,1,0.459668347135402,0,8,cellular response to zinc ion,BP,
15174,GO:0071350,1,0.330554394316351,0,9,cellular response to interleukin-15,BP,
15176,GO:0071352,1,0.312732080707694,0,9,cellular response to interleukin-2,BP,
15203,GO:0071389,1,0.502403418499458,0,6,cellular response to mineralocorticoid stimulus,BP,
15207,GO:0071394,1,0.460172219894495,0,7,cellular response to testosterone stimulus,BP,
15228,GO:0071426,1,1.59213521451663e-06,0,121,ribonucleoprotein complex export from nucleus,BP,
15229,GO:0071427,1,8.67617548380067e-06,0,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
15230,GO:0071428,1,0.256764224434957,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15231,GO:0071431,1,0.0194740901827199,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15236,GO:0071440,1,0.539991643093837,0,6,regulation of histone H3-K14 acetylation,BP,
15238,GO:0071442,1,0.673636161124915,0,4,positive regulation of histone H3-K14 acetylation,BP,
15254,GO:0071467,1,0.267379837675532,0,13,cellular response to pH,BP,
15255,GO:0071468,1,0.496712258355874,0,6,cellular response to acidic pH,BP,
15280,GO:0071501,1,0.412182992540971,0,8,cellular response to sterol depletion,BP,
15286,GO:0071514,1,0.100046685113978,0,18,genetic imprinting,BP,
15289,GO:0071532,1,0.587802781187342,0,4,ankyrin repeat binding,MF,
15290,GO:0071535,1,0.667938908036192,0,4,RING-like zinc finger domain binding,MF,
15294,GO:0071541,1,0.549398483431736,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15296,GO:0071543,1,0.68370776824984,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15303,GO:0071550,1,0.460873771088902,0,9,death-inducing signaling complex assembly,BP,
15306,GO:0071557,1,0.472503404074547,0,5,histone H3-K27 demethylation,BP,
15307,GO:0071558,1,0.472503404074547,0,5,histone demethylase activity (H3-K27 specific),MF,
15319,GO:0071578,1,0.515338665763558,0,6,zinc ion import across plasma membrane,BP,
15331,GO:0071598,1,0.614865843506202,0,5,neuronal ribonucleoprotein granule,CC,
15337,GO:0071605,1,0.529301134759258,0,7,monocyte chemotactic protein-1 production,BP,
15339,GO:0071608,1,0.670073288663618,0,4,macrophage inflammatory protein-1 alpha production,BP,
15340,GO:0071609,1,0.394246501394477,0,8,chemokine (C-C motif) ligand 5 production,BP,
15356,GO:0071635,1,0.505598088135402,0,6,negative regulation of transforming growth factor beta production,BP,
15357,GO:0071636,1,0.353082480786907,0,8,positive regulation of transforming growth factor beta production,BP,
15358,GO:0071637,1,0.529301134759258,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15360,GO:0071639,1,0.642990168482936,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
15361,GO:0071640,1,0.670073288663618,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
15366,GO:0071649,1,0.424777103083864,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
15368,GO:0071651,1,0.541504844035263,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15377,GO:0071671,1,0.678843941735595,0,4,regulation of smooth muscle cell chemotaxis,BP,
15385,GO:0071679,1,0.324026866914331,0,8,commissural neuron axon guidance,BP,
15386,GO:0071680,1,0.510900645376549,0,5,response to indole-3-methanol,BP,
15387,GO:0071681,1,0.510900645376549,0,5,cellular response to indole-3-methanol,BP,
15395,GO:0071696,1,0.276254705075593,0,11,ectodermal placode development,BP,
15396,GO:0071697,1,0.30209333345027,0,10,ectodermal placode morphogenesis,BP,
15415,GO:0071731,1,0.2734637272089,0,11,response to nitric oxide,BP,
15416,GO:0071732,1,0.328125627674862,0,10,cellular response to nitric oxide,BP,
15418,GO:0071763,1,0.527102327560274,0,6,nuclear membrane organization,BP,
15423,GO:0071782,1,0.153562598404046,0,18,endoplasmic reticulum tubular network,CC,
15425,GO:0071787,1,0.695816825128738,0,4,endoplasmic reticulum tubular network formation,BP,
15429,GO:0071797,1,0.680941521802134,0,4,LUBAC complex,CC,
15442,GO:0071816,1,0.713841284244727,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15443,GO:0071817,1,0.638251365973136,0,5,MMXD complex,CC,
15520,GO:0071971,1,0.542065204432376,0,6,extracellular exosome assembly,BP,
15522,GO:0071986,1,0.5604796610138,0,6,Ragulator complex,CC,
15523,GO:0071987,1,0.593854228852802,0,4,WD40-repeat domain binding,MF,
15535,GO:0072014,1,0.578665306689984,0,4,proximal tubule development,BP,
15549,GO:0072047,1,0.724037935969956,0,4,proximal/distal pattern formation involved in nephron development,BP,
15570,GO:0072081,1,0.724037935969956,0,4,specification of nephron tubule identity,BP,
15571,GO:0072086,1,0.724037935969956,0,4,specification of loop of Henle identity,BP,
15723,GO:0072344,1,0.687827998315678,0,4,rescue of stalled ribosome,BP,
15724,GO:0072345,1,0.557733732404719,0,5,NAADP-sensitive calcium-release channel activity,MF,
15732,GO:0072357,1,0.415192743731962,0,7,PTW/PP1 phosphatase complex,CC,
15748,GO:0072383,1,0.339514744136684,0,7,plus-end-directed vesicle transport along microtubule,BP,
15750,GO:0072385,1,0.511620026376198,0,4,minus-end-directed organelle transport along microtubule,BP,
15751,GO:0072386,1,0.288884475175775,0,8,plus-end-directed organelle transport along microtubule,BP,
15757,GO:0072396,1,0.461104695725648,0,6,response to cell cycle checkpoint signaling,BP,
15759,GO:0072402,1,0.461104695725648,0,6,response to DNA integrity checkpoint signaling,BP,
15763,GO:0072423,1,0.461104695725648,0,6,response to DNA damage checkpoint signaling,BP,
15770,GO:0072487,1,0.583196451945428,0,5,MSL complex,CC,
15771,GO:0072488,1,0.49641328441596,0,7,ammonium transmembrane transport,BP,
15788,GO:0072520,1,0.282735036425918,0,10,seminiferous tubule development,BP,
15794,GO:0072526,1,0.701880777579227,0,4,pyridine-containing compound catabolic process,BP,
15798,GO:0072530,1,0.487706419723231,0,8,purine-containing compound transmembrane transport,BP,
15799,GO:0072531,1,0.5548753996529,0,6,pyrimidine-containing compound transmembrane transport,BP,
15804,GO:0072538,1,0.353985521973317,0,9,T-helper 17 type immune response,BP,
15805,GO:0072539,1,0.427501664660183,0,7,T-helper 17 cell differentiation,BP,
15806,GO:0072540,1,0.676479603581853,0,4,T-helper 17 cell lineage commitment,BP,
15809,GO:0072546,1,0.368810524404041,0,10,ER membrane protein complex,CC,
15810,GO:0072553,1,0.617674859231832,0,4,terminal button organization,BP,
15837,GO:0072588,1,0.658509351825273,0,8,box H/ACA RNP complex,CC,
15838,GO:0072589,1,0.781131142148676,0,4,box H/ACA scaRNP complex,CC,
15846,GO:0072602,1,0.590089053548944,0,4,interleukin-4 secretion,BP,
15851,GO:0072610,1,0.658860359990952,0,4,interleukin-12 secretion,BP,
15856,GO:0072641,1,0.414033458797749,0,6,type I interferon secretion,BP,
15857,GO:0072642,1,0.414033458797749,0,6,interferon-alpha secretion,BP,
15860,GO:0072656,1,0.579737070076001,0,5,maintenance of protein location in mitochondrion,BP,
15869,GO:0072669,1,0.594367519928649,0,7,tRNA-splicing ligase complex,CC,
15871,GO:0072672,1,0.602937630620094,0,4,neutrophil extravasation,BP,
15887,GO:0072697,1,0.262059609251462,0,11,protein localization to cell cortex,BP,
15893,GO:0072708,1,0.676810526473205,0,4,response to sorbitol,BP,
15895,GO:0072710,1,0.308647612134056,0,9,response to hydroxyurea,BP,
15896,GO:0072711,1,0.340348517785808,0,8,cellular response to hydroxyurea,BP,
15915,GO:0072757,1,0.642655319227439,0,4,cellular response to camptothecin,BP,
15922,GO:0075136,1,0.527991907517561,0,6,response to host,BP,
15927,GO:0075522,1,0.330661639792739,0,10,IRES-dependent viral translational initiation,BP,
15928,GO:0075525,1,0.620620694843511,0,5,viral translational termination-reinitiation,BP,
15931,GO:0075713,1,0.479084653172103,0,8,establishment of integrated proviral latency,BP,
15935,GO:0080009,1,0.406534620526778,0,10,mRNA methylation,BP,
15941,GO:0080084,1,0.481601780857662,0,5,5S rDNA binding,MF,
15954,GO:0080154,1,0.52179884826266,0,6,regulation of fertilization,BP,
15957,GO:0080182,1,0.133238229116725,0,16,histone H3-K4 trimethylation,BP,
15959,GO:0085020,1,0.51187604545196,0,7,protein K6-linked ubiquitination,BP,
15993,GO:0086042,1,0.424338018038185,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16013,GO:0086073,1,0.463902557415488,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16021,GO:0086083,1,0.463902557415488,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16030,GO:0089701,1,0.684826243508875,0,5,U2AF,CC,
16034,GO:0089720,1,0.596834044945403,0,6,caspase binding,MF,
16035,GO:0090009,1,0.525244260393392,0,4,primitive streak formation,BP,
16044,GO:0090032,1,0.645363185638385,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16053,GO:0090045,1,0.531196605726837,0,6,positive regulation of deacetylase activity,BP,
16055,GO:0090050,1,0.171746026232743,0,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,
16057,GO:0090063,1,0.620209871914528,0,4,positive regulation of microtubule nucleation,BP,
16062,GO:0090069,1,0.222276622638661,0,13,regulation of ribosome biogenesis,BP,
16063,GO:0090070,1,0.434979843162035,0,8,positive regulation of ribosome biogenesis,BP,
16064,GO:0090071,1,0.595782086418216,0,4,negative regulation of ribosome biogenesis,BP,
16065,GO:0090073,1,0.45060466566145,0,8,positive regulation of protein homodimerization activity,BP,
16075,GO:0090085,1,0.300279954965984,0,11,regulation of protein deubiquitination,BP,
16100,GO:0090129,1,0.605068011275552,0,5,positive regulation of synapse maturation,BP,
16108,GO:0090141,1,0.256287479740569,0,12,positive regulation of mitochondrial fission,BP,
16112,GO:0090151,1,0.419193834860605,0,12,establishment of protein localization to mitochondrial membrane,BP,
16115,GO:0090155,1,0.681942638928889,0,4,negative regulation of sphingolipid biosynthetic process,BP,
16117,GO:0090158,1,0.638933798002759,0,5,endoplasmic reticulum membrane organization,BP,
16119,GO:0090161,1,0.228641561214864,0,11,Golgi ribbon formation,BP,
16122,GO:0090166,1,0.537299826685149,0,6,Golgi disassembly,BP,
16123,GO:0090168,1,0.639021719268687,0,4,Golgi reassembly,BP,
16124,GO:0090169,1,0.0402304699542367,0,25,regulation of spindle assembly,BP,
16125,GO:0090170,1,0.694102473546865,0,4,regulation of Golgi inheritance,BP,
16155,GO:0090205,1,0.491562965857485,0,6,positive regulation of cholesterol metabolic process,BP,
16156,GO:0090206,1,0.645544182485026,0,5,negative regulation of cholesterol metabolic process,BP,
16158,GO:0090208,1,0.31470588405498,0,11,positive regulation of triglyceride metabolic process,BP,
16164,GO:0090219,1,0.651343431378121,0,4,negative regulation of lipid kinase activity,BP,
16167,GO:0090224,1,0.00761068583309672,0,38,regulation of spindle organization,BP,
16169,GO:0090230,1,0.596403612682084,0,4,regulation of centromere complex assembly,BP,
16174,GO:0090235,1,0.331885634421286,0,7,regulation of metaphase plate congression,BP,
16177,GO:0090239,1,0.318698274320138,0,11,regulation of histone H4 acetylation,BP,
16178,GO:0090240,1,0.484327532103309,0,7,positive regulation of histone H4 acetylation,BP,
16179,GO:0090241,1,0.682529304018463,0,4,negative regulation of histone H4 acetylation,BP,
16192,GO:0090266,1,0.249370948863152,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16193,GO:0090267,1,0.448676622242739,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16214,GO:0090296,1,0.658428856660633,0,4,regulation of mitochondrial DNA replication,BP,
16222,GO:0090306,1,0.581297981748426,0,4,spindle assembly involved in meiosis,BP,
16225,GO:0090309,1,0.588080137713341,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16231,GO:0090315,1,0.690035929072319,0,4,negative regulation of protein targeting to membrane,BP,
16243,GO:0090335,1,0.369360139889876,0,8,regulation of brown fat cell differentiation,BP,
16260,GO:0090383,1,0.150897968692039,0,21,phagosome acidification,BP,
16265,GO:0090394,1,0.610323545545256,0,4,negative regulation of excitatory postsynaptic potential,BP,
16277,GO:0090435,1,0.492010569784554,0,7,protein localization to nuclear envelope,BP,
16281,GO:0090481,1,0.367989653928387,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16288,GO:0090502,1,0.00309443400440473,0,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
16289,GO:0090503,1,0.0195754268117983,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
16293,GO:0090521,1,0.607792464072587,0,4,glomerular visceral epithelial cell migration,BP,
16296,GO:0090533,1,0.451443550868315,0,7,cation-transporting ATPase complex,CC,
16310,GO:0090576,1,0.35536053534543,0,8,RNA polymerase III transcription factor complex,CC,
16314,GO:0090599,1,0.476978191516951,0,5,alpha-glucosidase activity,MF,
16317,GO:0090611,1,0.603345883999915,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16324,GO:0090646,1,0.331298879041394,0,12,mitochondrial tRNA processing,BP,
16326,GO:0090649,1,0.471493268780977,0,5,response to oxygen-glucose deprivation,BP,
16327,GO:0090650,1,0.471493268780977,0,5,cellular response to oxygen-glucose deprivation,BP,
16328,GO:0090656,1,0.176299617808424,0,15,t-circle formation,BP,
16329,GO:0090657,1,0.278857857881676,0,11,telomeric loop disassembly,BP,
16331,GO:0090661,1,0.750054315293667,0,5,box H/ACA telomerase RNP complex,CC,
16332,GO:0090662,1,0.131486974361989,0,21,ATP hydrolysis coupled transmembrane transport,BP,
16334,GO:0090666,1,0.716645098632539,0,4,scaRNA localization to Cajal body,BP,
16337,GO:0090669,1,0.679729748978127,0,4,telomerase RNA stabilization,BP,
16338,GO:0090670,1,0.184593140487749,0,19,RNA localization to Cajal body,BP,
16339,GO:0090671,1,0.184593140487749,0,19,telomerase RNA localization to Cajal body,BP,
16340,GO:0090672,1,0.184593140487749,0,19,telomerase RNA localization,BP,
16344,GO:0090685,1,0.184593140487749,0,19,RNA localization to nucleus,BP,
16349,GO:0090723,1,0.305382111959815,0,11,growth cone part,CC,
16350,GO:0090724,1,0.638034028954724,0,4,central region of growth cone,CC,
16353,GO:0090734,1,0.0160730665179039,0,35,site of DNA damage,CC,
16354,GO:0090735,1,0.405021680064092,0,10,DNA repair complex assembly,BP,
16355,GO:0090737,1,0.176299617808424,0,15,telomere maintenance via telomere trimming,BP,
16359,GO:0097001,1,0.458921156490669,0,8,ceramide binding,MF,
16374,GO:0097027,1,0.535044526526167,0,7,ubiquitin-protein transferase activator activity,MF,
16381,GO:0097039,1,0.522462896423721,0,5,protein linear polyubiquitination,BP,
16389,GO:0097056,1,0.673218561104875,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16396,GO:0097064,1,0.0118895894202185,0,37,ncRNA export from nucleus,BP,
16409,GO:0097100,1,0.627925599499782,0,5,supercoiled DNA binding,MF,
16414,GO:0097106,1,0.352041565001277,0,7,postsynaptic density organization,BP,
16415,GO:0097107,1,0.494525224774235,0,4,postsynaptic density assembly,BP,
16426,GO:0097119,1,0.617684765562975,0,4,postsynaptic density protein 95 clustering,BP,
16434,GO:0097136,1,0.542324980666416,0,6,Bcl-2 family protein complex,CC,
16451,GO:0097165,1,0.565844609350083,0,5,nuclear stress granule,CC,
16456,GO:0097176,1,0.722877777132644,0,4,epoxide metabolic process,BP,
16459,GO:0097179,1,0.791410017126117,0,4,protease inhibitor complex,CC,
16472,GO:0097199,1,0.629944838939684,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16477,GO:0097208,1,0.630224202329382,0,5,alveolar lamellar body,CC,
16478,GO:0097209,1,0.623562575318812,0,4,epidermal lamellar body,CC,
16496,GO:0097240,1,0.628768859873375,0,4,chromosome attachment to the nuclear envelope,BP,
16500,GO:0097255,1,0.6625914444192,0,5,R2TP complex,CC,
16514,GO:0097296,1,0.302695930015662,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16522,GO:0097322,1,0.515386591193163,0,6,7SK snRNA binding,MF,
16528,GO:0097340,1,0.222540481546471,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16529,GO:0097341,1,0.222540481546471,0,11,zymogen inhibition,BP,
16530,GO:0097342,1,0.531555254937207,0,6,ripoptosome,CC,
16534,GO:0097346,1,0.0939733959217842,0,23,INO80-type complex,CC,
16537,GO:0097354,1,0.349612930702169,0,9,prenylation,BP,
16541,GO:0097361,1,0.683128691625231,0,4,CIA complex,CC,
16551,GO:0097381,1,0.490408332824452,0,5,photoreceptor disc membrane,CC,
16554,GO:0097384,1,0.476368672937076,0,7,cellular lipid biosynthetic process,BP,
16568,GO:0097422,1,0.592815691401649,0,5,tubular endosome,CC,
16570,GO:0097427,1,0.504402995480314,0,5,microtubule bundle,CC,
16573,GO:0097433,1,0.611440516090335,0,5,dense body,CC,
16581,GO:0097449,1,0.534886341501076,0,6,astrocyte projection,CC,
16590,GO:0097468,1,0.321439432587313,0,11,programmed cell death in response to reactive oxygen species,BP,
16602,GO:0097490,1,0.595157671364636,0,4,sympathetic neuron projection extension,BP,
16603,GO:0097491,1,0.595157671364636,0,4,sympathetic neuron projection guidance,BP,
16605,GO:0097494,1,0.619194231910929,0,4,regulation of vesicle size,BP,
16611,GO:0097502,1,0.0471555411157718,0,28,mannosylation,BP,
16613,GO:0097504,1,0.31955356812796,0,11,Gemini of coiled bodies,CC,
16615,GO:0097506,1,0.670573002177609,0,5,deaminated base DNA N-glycosylase activity,MF,
16620,GO:0097524,1,0.601824927170003,0,4,sperm plasma membrane,CC,
16622,GO:0097526,1,0.0751262167505425,0,29,spliceosomal tri-snRNP complex,CC,
16626,GO:0097531,1,0.389524634003943,0,9,mast cell migration,BP,
16637,GO:0097550,1,0.569701857302526,0,6,transcriptional preinitiation complex,CC,
16646,GO:0097602,1,0.171099955915092,0,17,cullin family protein binding,MF,
16674,GO:0097677,1,0.509524725747022,0,6,STAT family protein binding,MF,
16698,GO:0097732,1,0.623759815825261,0,5,9+2 non-motile cilium,CC,
16700,GO:0097734,1,0.193312010749966,0,17,extracellular exosome biogenesis,BP,
16710,GO:0098501,1,0.655192708318851,0,5,polynucleotide dephosphorylation,BP,
16714,GO:0098505,1,0.362887407870155,0,10,G-rich strand telomeric DNA binding,MF,
16719,GO:0098519,1,0.593657186965074,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16720,GO:0098528,1,0.620666345219909,0,4,skeletal muscle fiber differentiation,BP,
16723,GO:0098532,1,0.573718395567971,0,6,histone H3-K27 trimethylation,BP,
16725,GO:0098534,1,0.0268352277973432,0,30,centriole assembly,BP,
16734,GO:0098556,1,0.782284928772833,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16742,GO:0098576,1,0.695863447917081,0,4,lumenal side of membrane,CC,
16752,GO:0098596,1,0.448064018941213,0,4,imitative learning,BP,
16753,GO:0098597,1,0.345043846168765,0,5,observational learning,BP,
16754,GO:0098598,1,0.448064018941213,0,4,learned vocalization behavior or vocal learning,BP,
16755,GO:0098599,1,0.394479224690736,0,10,palmitoyl hydrolase activity,MF,
16790,GO:0098698,1,0.494525224774235,0,4,postsynaptic specialization assembly,BP,
16804,GO:0098734,1,0.394479224690736,0,10,macromolecule depalmitoylation,BP,
16829,GO:0098787,1,0.202102778470983,0,14,mRNA cleavage involved in mRNA processing,BP,
16830,GO:0098789,1,0.277990398492566,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16832,GO:0098792,1,0.338561889924613,0,10,xenophagy,BP,
16839,GO:0098799,1,0.373892999398385,0,12,outer mitochondrial membrane protein complex,CC,
16854,GO:0098826,1,0.694695600338781,0,4,endoplasmic reticulum tubular network membrane,CC,
16870,GO:0098847,1,0.262871654283294,0,13,sequence-specific single stranded DNA binding,MF,
16926,GO:0098960,1,0.591333092121373,0,5,postsynaptic neurotransmitter receptor activity,MF,
16965,GO:0099078,1,0.510702014094112,0,8,BORC complex,CC,
16970,GO:0099084,1,0.352041565001277,0,7,postsynaptic specialization organization,BP,
16979,GO:0099116,1,0.264867491802364,0,16,tRNA 5'-end processing,BP,
16983,GO:0099131,1,0.131486974361989,0,21,ATP hydrolysis coupled ion transmembrane transport,BP,
16984,GO:0099132,1,0.0296836701078713,0,30,ATP hydrolysis coupled cation transmembrane transport,BP,
17002,GO:0099500,1,0.371440726308187,0,10,vesicle fusion to plasma membrane,BP,
17008,GO:0099514,1,0.219749121703038,0,15,synaptic vesicle cytoskeletal transport,BP,
17011,GO:0099517,1,0.219749121703038,0,15,synaptic vesicle transport along microtubule,BP,
17021,GO:0099529,1,0.591333092121373,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17039,GO:0099563,1,0.225971324130957,0,12,modification of synaptic structure,BP,
17051,GO:0099602,1,0.592655078970133,0,6,neurotransmitter receptor regulator activity,MF,
17086,GO:0101031,1,0.338796840469741,0,11,chaperone complex,CC,
17099,GO:0102158,1,0.676521685353154,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17104,GO:0102336,1,0.604691418187653,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17105,GO:0102337,1,0.604691418187653,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17106,GO:0102338,1,0.604691418187653,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17111,GO:0102343,1,0.676521685353154,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17112,GO:0102344,1,0.676521685353154,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17113,GO:0102345,1,0.676521685353154,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17117,GO:0102420,1,0.629396506004828,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17137,GO:0102756,1,0.604691418187653,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17166,GO:0106019,1,0.259735274978531,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17180,GO:0106068,1,0.509277495965818,0,7,SUMO ligase complex,CC,
17187,GO:0106077,1,0.636672944782569,0,4,histone succinylation,BP,
17213,GO:0110096,1,0.695441678910622,0,5,cellular response to aldehyde,BP,
17214,GO:0120009,1,0.595386106297786,0,5,intermembrane lipid transfer,BP,
17216,GO:0120013,1,0.595386106297786,0,5,intermembrane lipid transfer activity,MF,
17246,GO:0140007,1,0.703831340899727,0,4,KICSTOR complex,CC,
17255,GO:0140035,1,0.476359737421708,0,6,ubiquitination-like modification-dependent protein binding,MF,
17256,GO:0140036,1,0.476359737421708,0,6,ubiquitin-dependent protein binding,MF,
17259,GO:0140053,1,3.69330043073541e-06,0,153,mitochondrial gene expression,BP,
17262,GO:0140059,1,0.560329408572876,0,5,dendrite arborization,BP,
17270,GO:0140078,1,0.446299387783932,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17271,GO:0140080,1,0.446299387783932,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17276,GO:0140102,1,0.23358304772187,0,16,catalytic activity, acting on a rRNA,MF,
17278,GO:0140104,1,0.0499168619565283,0,27,molecular carrier activity,MF,
17280,GO:0140112,1,0.157903406730696,0,19,extracellular vesicle biogenesis,BP,
17284,GO:0140142,1,0.106486691856267,0,18,nucleocytoplasmic carrier activity,MF,
17293,GO:0150005,1,0.370696172002202,0,10,enzyme activator complex,CC,
17308,GO:1900017,1,0.379281258206871,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17315,GO:1900028,1,0.676206327895029,0,4,negative regulation of ruffle assembly,BP,
17316,GO:1900029,1,0.32209647211592,0,11,positive regulation of ruffle assembly,BP,
17319,GO:1900037,1,0.383893371446063,0,10,regulation of cellular response to hypoxia,BP,
17320,GO:1900038,1,0.544469940724197,0,6,negative regulation of cellular response to hypoxia,BP,
17322,GO:1900040,1,0.503702333274836,0,5,regulation of interleukin-2 secretion,BP,
17326,GO:1900045,1,0.476882014762081,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17330,GO:1900060,1,0.681942638928889,0,4,negative regulation of ceramide biosynthetic process,BP,
17340,GO:1900086,1,0.560487732464607,0,4,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
17361,GO:1900118,1,0.4726344407386,0,7,negative regulation of execution phase of apoptosis,BP,
17366,GO:1900125,1,0.478163554114535,0,6,regulation of hyaluronan biosynthetic process,BP,
17403,GO:1900193,1,0.630886415459442,0,5,regulation of oocyte maturation,BP,
17422,GO:1900225,1,0.341520119648898,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17423,GO:1900226,1,0.629437898570261,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
17424,GO:1900227,1,0.595996279928173,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17428,GO:1900242,1,0.428886276324597,0,6,regulation of synaptic vesicle endocytosis,BP,
17433,GO:1900247,1,0.303485146941404,0,11,regulation of cytoplasmic translational elongation,BP,
17437,GO:1900262,1,0.609616538841498,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17438,GO:1900264,1,0.609616538841498,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17445,GO:1900363,1,0.252430367741657,0,12,regulation of mRNA polyadenylation,BP,
17446,GO:1900364,1,0.398521718104773,0,8,negative regulation of mRNA polyadenylation,BP,
17454,GO:1900376,1,0.51412932237739,0,4,regulation of secondary metabolite biosynthetic process,BP,
17462,GO:1900409,1,0.278638658750505,0,12,positive regulation of cellular response to oxidative stress,BP,
17463,GO:1900424,1,0.255321403067422,0,13,regulation of defense response to bacterium,BP,
17464,GO:1900425,1,0.576978823005222,0,5,negative regulation of defense response to bacterium,BP,
17465,GO:1900426,1,0.531192477366136,0,7,positive regulation of defense response to bacterium,BP,
17468,GO:1900451,1,0.547307676808229,0,5,positive regulation of glutamate receptor signaling pathway,BP,
17469,GO:1900452,1,0.578369577794101,0,4,regulation of long term synaptic depression,BP,
17495,GO:1900864,1,0.447316634488846,0,9,mitochondrial RNA modification,BP,
17501,GO:1901018,1,0.25367891756681,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17510,GO:1901032,1,0.291705704376164,0,13,negative regulation of response to reactive oxygen species,BP,
17511,GO:1901033,1,0.491042627148743,0,7,positive regulation of response to reactive oxygen species,BP,
17514,GO:1901070,1,0.401961869557762,0,13,guanosine-containing compound biosynthetic process,BP,
17516,GO:1901072,1,0.633085992371454,0,5,glucosamine-containing compound catabolic process,BP,
17528,GO:1901097,1,0.623470218490547,0,4,negative regulation of autophagosome maturation,BP,
17538,GO:1901159,1,0.668783099174664,0,5,xylulose 5-phosphate biosynthetic process,BP,
17539,GO:1901160,1,0.416291770224547,0,7,primary amino compound metabolic process,BP,
17543,GO:1901165,1,0.626397707112054,0,5,positive regulation of trophoblast cell migration,BP,
17561,GO:1901223,1,0.450877448832518,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17585,GO:1901298,1,0.372989091399878,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17586,GO:1901299,1,0.589459309158171,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17587,GO:1901300,1,0.632886989033314,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
17594,GO:1901317,1,0.724306755298746,0,4,regulation of flagellated sperm motility,BP,
17604,GO:1901341,1,0.599035623705926,0,4,positive regulation of store-operated calcium channel activity,BP,
17622,GO:1901386,1,0.666815967569972,0,4,negative regulation of voltage-gated calcium channel activity,BP,
17626,GO:1901407,1,0.414334875621309,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17627,GO:1901409,1,0.524987717575272,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17630,GO:1901474,1,0.68251078192024,0,4,azole transmembrane transporter activity,MF,
17635,GO:1901503,1,0.562408796068154,0,5,ether biosynthetic process,BP,
17636,GO:1901505,1,0.0431766128619478,0,32,carbohydrate derivative transmembrane transporter activity,MF,
17641,GO:1901525,1,0.471507151809687,0,6,negative regulation of mitophagy,BP,
17645,GO:1901533,1,0.529986812201804,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17647,GO:1901535,1,0.448950078532005,0,5,regulation of DNA demethylation,BP,
17650,GO:1901538,1,0.456797604919075,0,6,changes to DNA methylation involved in embryo development,BP,
17652,GO:1901550,1,0.339939776340683,0,9,regulation of endothelial cell development,BP,
17658,GO:1901563,1,0.552729389903601,0,5,response to camptothecin,BP,
17664,GO:1901569,1,0.619533477526754,0,5,fatty acid derivative catabolic process,BP,
17678,GO:1901612,1,0.529812970372951,0,6,cardiolipin binding,MF,
17682,GO:1901618,1,0.166641317385687,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17695,GO:1901642,1,0.638759740217478,0,5,nucleoside transmembrane transport,BP,
17703,GO:1901659,1,0.0265957093779883,0,42,glycosyl compound biosynthetic process,BP,
17704,GO:1901660,1,0.44168943149629,0,6,calcium ion export,BP,
17707,GO:1901663,1,0.326255788477142,0,14,quinone biosynthetic process,BP,
17712,GO:1901673,1,0.106487515381917,0,19,regulation of mitotic spindle assembly,BP,
17717,GO:1901679,1,0.469421819567501,0,8,nucleotide transmembrane transport,BP,
17734,GO:1901727,1,0.611899225546569,0,4,positive regulation of histone deacetylase activity,BP,
17751,GO:1901836,1,0.298999391568806,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17753,GO:1901838,1,0.352108946785307,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17754,GO:1901841,1,0.665797465866514,0,4,regulation of high voltage-gated calcium channel activity,BP,
17759,GO:1901857,1,0.691342726117374,0,5,positive regulation of cellular respiration,BP,
17760,GO:1901858,1,0.658428856660633,0,4,regulation of mitochondrial DNA metabolic process,BP,
17779,GO:1901906,1,0.68370776824984,0,4,diadenosine pentaphosphate metabolic process,BP,
17780,GO:1901907,1,0.68370776824984,0,4,diadenosine pentaphosphate catabolic process,BP,
17781,GO:1901908,1,0.68370776824984,0,4,diadenosine hexaphosphate metabolic process,BP,
17782,GO:1901909,1,0.68370776824984,0,4,diadenosine hexaphosphate catabolic process,BP,
17783,GO:1901910,1,0.68370776824984,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17784,GO:1901911,1,0.68370776824984,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17791,GO:1901970,1,0.407025051189813,0,8,positive regulation of mitotic sister chromatid separation,BP,
17818,GO:1902023,1,0.587501164358792,0,4,L-arginine transport,BP,
17819,GO:1902031,1,0.561386832821682,0,6,regulation of NADP metabolic process,BP,
17830,GO:1902047,1,0.60628932181797,0,5,polyamine transmembrane transport,BP,
17835,GO:1902075,1,0.596702364815743,0,6,cellular response to salt,BP,
17836,GO:1902083,1,0.459470990657255,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17841,GO:1902101,1,0.407025051189813,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17859,GO:1902165,1,0.297418520030452,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17860,GO:1902166,1,0.343516236805434,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17862,GO:1902170,1,0.247968861194162,0,12,cellular response to reactive nitrogen species,BP,
17868,GO:1902177,1,0.632162813478415,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17872,GO:1902188,1,0.21372245280868,0,15,positive regulation of viral release from host cell,BP,
17886,GO:1902224,1,0.50893107438993,0,7,ketone body metabolic process,BP,
17892,GO:1902231,1,0.63843605388691,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17910,GO:1902267,1,0.688860970498452,0,4,regulation of polyamine transmembrane transport,BP,
17940,GO:1902358,1,0.484336217574832,0,6,sulfate transmembrane transport,BP,
17959,GO:1902410,1,0.528530791307209,0,6,mitotic cytokinetic process,BP,
17962,GO:1902415,1,0.417672144015491,0,9,regulation of mRNA binding,BP,
17963,GO:1902416,1,0.497878379146923,0,7,positive regulation of mRNA binding,BP,
17971,GO:1902455,1,0.625259463211307,0,4,negative regulation of stem cell population maintenance,BP,
17978,GO:1902473,1,0.420814374095218,0,7,regulation of protein localization to synapse,BP,
17979,GO:1902474,1,0.464024697141022,0,6,positive regulation of protein localization to synapse,BP,
17990,GO:1902510,1,0.538678955669921,0,7,regulation of apoptotic DNA fragmentation,BP,
17993,GO:1902513,1,0.512904898448577,0,6,regulation of organelle transport along microtubule,BP,
17997,GO:1902525,1,0.650098381036883,0,5,regulation of protein monoubiquitination,BP,
17998,GO:1902527,1,0.732641169779369,0,4,positive regulation of protein monoubiquitination,BP,
18013,GO:1902563,1,0.541974554096138,0,4,regulation of neutrophil activation,BP,
18018,GO:1902570,1,0.408565470062017,0,9,protein localization to nucleolus,BP,
18035,GO:1902617,1,0.592521288364006,0,4,response to fluoride,BP,
18063,GO:1902713,1,0.606959052522528,0,4,regulation of interferon-gamma secretion,BP,
18075,GO:1902739,1,0.414033458797749,0,6,regulation of interferon-alpha secretion,BP,
18076,GO:1902741,1,0.414033458797749,0,6,positive regulation of interferon-alpha secretion,BP,
18120,GO:1902884,1,0.278638658750505,0,12,positive regulation of response to oxidative stress,BP,
18129,GO:1902902,1,0.356073405268397,0,11,negative regulation of autophagosome assembly,BP,
18139,GO:1902915,1,0.416374448254057,0,6,negative regulation of protein polyubiquitination,BP,
18142,GO:1902931,1,0.518269814648659,0,7,negative regulation of alcohol biosynthetic process,BP,
18165,GO:1902961,1,0.489540099779744,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18186,GO:1903003,1,0.522362363733592,0,6,positive regulation of protein deubiquitination,BP,
18193,GO:1903012,1,0.658807419571641,0,4,positive regulation of bone development,BP,
18196,GO:1903020,1,0.178846742824985,0,15,positive regulation of glycoprotein metabolic process,BP,
18219,GO:1903059,1,0.612929431781794,0,4,regulation of protein lipidation,BP,
18220,GO:1903061,1,0.612929431781794,0,4,positive regulation of protein lipidation,BP,
18238,GO:1903121,1,0.636442509309257,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18244,GO:1903140,1,0.339939776340683,0,9,regulation of establishment of endothelial barrier,BP,
18249,GO:1903147,1,0.408673324212453,0,8,negative regulation of autophagy of mitochondrion,BP,
18273,GO:1903206,1,0.291705704376164,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18276,GO:1903209,1,0.300132384820197,0,11,positive regulation of oxidative stress-induced cell death,BP,
18293,GO:1903251,1,0.560332587097495,0,5,multi-ciliated epithelial cell differentiation,BP,
18295,GO:1903265,1,0.492921523521391,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18309,GO:1903297,1,0.618589252308046,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18310,GO:1903298,1,0.618589252308046,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18311,GO:1903299,1,0.444863734566654,0,7,regulation of hexokinase activity,BP,
18313,GO:1903301,1,0.534000765515409,0,5,positive regulation of hexokinase activity,BP,
18315,GO:1903306,1,0.2321665780513,0,12,negative regulation of regulated secretory pathway,BP,
18327,GO:1903333,1,0.625401865909757,0,5,negative regulation of protein folding,BP,
18328,GO:1903335,1,0.713078144522985,0,4,regulation of vacuolar transport,BP,
18331,GO:1903347,1,0.578498802701178,0,4,negative regulation of bicellular tight junction assembly,BP,
18334,GO:1903350,1,0.271187224861371,0,11,response to dopamine,BP,
18335,GO:1903351,1,0.271187224861371,0,11,cellular response to dopamine,BP,
18336,GO:1903352,1,0.553937217261481,0,4,L-ornithine transmembrane transport,BP,
18344,GO:1903371,1,0.542796652336754,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18347,GO:1903376,1,0.472143515268179,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18348,GO:1903377,1,0.685144595941207,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18362,GO:1903405,1,0.460453984329657,0,9,protein localization to nuclear body,BP,
18370,GO:1903423,1,0.512502507021725,0,5,positive regulation of synaptic vesicle recycling,BP,
18375,GO:1903430,1,0.693059662508854,0,4,negative regulation of cell maturation,BP,
18398,GO:1903504,1,0.249370948863152,0,13,regulation of mitotic spindle checkpoint,BP,
18426,GO:1903541,1,0.249167574038073,0,14,regulation of exosomal secretion,BP,
18428,GO:1903543,1,0.249167574038073,0,14,positive regulation of exosomal secretion,BP,
18433,GO:1903551,1,0.542065204432376,0,6,regulation of extracellular exosome assembly,BP,
18434,GO:1903553,1,0.643210508284986,0,4,positive regulation of extracellular exosome assembly,BP,
18439,GO:1903564,1,0.550372083033453,0,4,regulation of protein localization to cilium,BP,
18452,GO:1903580,1,0.0823399041313075,0,21,positive regulation of ATP metabolic process,BP,
18455,GO:1903587,1,0.591914042069271,0,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18463,GO:1903608,1,0.429912462832067,0,7,protein localization to cytoplasmic stress granule,BP,
18484,GO:1903672,1,0.0651081178491616,0,23,positive regulation of sprouting angiogenesis,BP,
18490,GO:1903689,1,0.32784949006109,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18491,GO:1903690,1,0.495148028018402,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18501,GO:1903715,1,0.652163714437245,0,4,regulation of aerobic respiration,BP,
18514,GO:1903748,1,0.64683413717228,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18516,GO:1903750,1,0.702482524353666,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18517,GO:1903751,1,0.702482524353666,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18518,GO:1903753,1,0.633243770917225,0,4,negative regulation of p38MAPK cascade,BP,
18530,GO:1903772,1,0.663185769103175,0,5,regulation of viral budding via host ESCRT complex,BP,
18538,GO:1903789,1,0.571560341589888,0,5,regulation of amino acid transmembrane transport,BP,
18554,GO:1903826,1,0.581974244719919,0,4,arginine transmembrane transport,BP,
18572,GO:1903862,1,0.650094480589419,0,5,positive regulation of oxidative phosphorylation,BP,
18610,GO:1903936,1,0.653504946346724,0,5,cellular response to sodium arsenite,BP,
18678,GO:1904090,1,0.791410017126117,0,4,peptidase inhibitor complex,CC,
18721,GO:1904220,1,0.696302083340414,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18742,GO:1904263,1,0.440427458796225,0,8,positive regulation of TORC1 signaling,BP,
18750,GO:1904288,1,0.593096618101992,0,4,BAT3 complex binding,MF,
18763,GO:1904315,1,0.591333092121373,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18778,GO:1904355,1,0.165492865062282,0,16,positive regulation of telomere capping,BP,
18780,GO:1904357,1,0.0349759005638545,0,26,negative regulation of telomere maintenance via telomere lengthening,BP,
18804,GO:1904415,1,0.533164058837002,0,6,regulation of xenophagy,BP,
18805,GO:1904417,1,0.533164058837002,0,6,positive regulation of xenophagy,BP,
18806,GO:1904424,1,0.311450022173964,0,9,regulation of GTP binding,BP,
18810,GO:1904429,1,0.471100287440654,0,7,regulation of t-circle formation,BP,
18812,GO:1904431,1,0.669177142377347,0,4,positive regulation of t-circle formation,BP,
18825,GO:1904467,1,0.246518703100071,0,10,regulation of tumor necrosis factor secretion,BP,
18827,GO:1904469,1,0.342056702463355,0,7,positive regulation of tumor necrosis factor secretion,BP,
18832,GO:1904491,1,0.732637276932196,0,4,protein localization to ciliary transition zone,BP,
18836,GO:1904502,1,0.479518319159945,0,5,regulation of lipophagy,BP,
18837,GO:1904504,1,0.479518319159945,0,5,positive regulation of lipophagy,BP,
18838,GO:1904505,1,0.600971276018291,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18839,GO:1904506,1,0.600971276018291,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18843,GO:1904528,1,0.557491733837019,0,6,positive regulation of microtubule binding,BP,
18898,GO:1904666,1,0.225016028049492,0,18,regulation of ubiquitin protein ligase activity,BP,
18899,GO:1904667,1,0.720284024166655,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18900,GO:1904668,1,0.312500172794496,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18904,GO:1904680,1,0.132543823798541,0,22,peptide transmembrane transporter activity,MF,
18911,GO:1904690,1,0.629292000398131,0,4,positive regulation of cytoplasmic translational initiation,BP,
18937,GO:1904742,1,0.583911336906834,0,4,regulation of telomeric DNA binding,BP,
18943,GO:1904749,1,0.665987070141955,0,4,regulation of protein localization to nucleolus,BP,
18956,GO:1904776,1,0.464526647821513,0,6,regulation of protein localization to cell cortex,BP,
18958,GO:1904778,1,0.512221461210831,0,5,positive regulation of protein localization to cell cortex,BP,
18967,GO:1904796,1,0.569589443418138,0,5,regulation of core promoter binding,BP,
18969,GO:1904798,1,0.672756821222265,0,4,positive regulation of core promoter binding,BP,
18977,GO:1904814,1,0.294599608819044,0,13,regulation of protein localization to chromosome, telomeric region,BP,
18979,GO:1904816,1,0.352070128059798,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
18995,GO:1904851,1,0.45656817951467,0,9,positive regulation of establishment of protein localization to telomere,BP,
18997,GO:1904861,1,0.357836109628422,0,7,excitatory synapse assembly,BP,
18999,GO:1904867,1,0.460453984329657,0,9,protein localization to Cajal body,BP,
19001,GO:1904869,1,0.497899168900216,0,8,regulation of protein localization to Cajal body,BP,
19002,GO:1904871,1,0.497899168900216,0,8,positive regulation of protein localization to Cajal body,BP,
19003,GO:1904872,1,0.199616450362811,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19004,GO:1904874,1,0.300092875512682,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19014,GO:1904885,1,0.480646489982536,0,5,beta-catenin destruction complex assembly,BP,
19023,GO:1904896,1,0.399866029833234,0,10,ESCRT complex disassembly,BP,
19025,GO:1904903,1,0.399866029833234,0,10,ESCRT III complex disassembly,BP,
19064,GO:1904994,1,0.50978424141469,0,6,regulation of leukocyte adhesion to vascular endothelial cell,BP,
19066,GO:1904996,1,0.59261328939568,0,4,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
19090,GO:1905050,1,0.505891817590111,0,7,positive regulation of metallopeptidase activity,BP,
19108,GO:1905097,1,0.443870436438211,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19109,GO:1905098,1,0.627656256325831,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
19140,GO:1905206,1,0.559051155435989,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
19144,GO:1905214,1,0.300934036701969,0,11,regulation of RNA binding,BP,
19146,GO:1905216,1,0.42616497108288,0,8,positive regulation of RNA binding,BP,
19152,GO:1905244,1,0.357190748845637,0,8,regulation of modification of synaptic structure,BP,
19155,GO:1905247,1,0.489540099779744,0,6,positive regulation of aspartic-type peptidase activity,BP,
19194,GO:1905340,1,0.704395780969137,0,4,regulation of protein localization to kinetochore,BP,
19196,GO:1905342,1,0.704395780969137,0,4,positive regulation of protein localization to kinetochore,BP,
19200,GO:1905354,1,0.121899274563525,0,22,exoribonuclease complex,CC,
19239,GO:1905448,1,0.736023699419529,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19259,GO:1905516,1,0.595731801210389,0,5,positive regulation of fertilization,BP,
19263,GO:1905523,1,0.43609251533172,0,8,positive regulation of macrophage migration,BP,
19346,GO:1905820,1,0.338670137413124,0,9,positive regulation of chromosome separation,BP,
19347,GO:1905832,1,0.497873702887398,0,4,positive regulation of spindle assembly,BP,
19359,GO:1905879,1,0.527980110244187,0,6,regulation of oogenesis,BP,
19393,GO:1905961,1,0.443037457320044,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19395,GO:1990001,1,0.312314939975872,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19412,GO:1990050,1,0.619930526570341,0,6,phosphatidic acid transporter activity,MF,
19427,GO:1990124,1,0.384053389433738,0,7,messenger ribonucleoprotein complex,CC,
19430,GO:1990130,1,0.597188190604348,0,5,GATOR1 complex,CC,
19435,GO:1990144,1,0.576007514989247,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19442,GO:1990169,1,0.683797242433706,0,5,stress response to copper ion,BP,
19445,GO:1990173,1,0.396109561765621,0,10,protein localization to nucleoplasm,BP,
19450,GO:1990182,1,0.193312010749966,0,17,exosomal secretion,BP,
19455,GO:1990226,1,0.626079260283631,0,5,histone methyltransferase binding,MF,
19458,GO:1990246,1,0.676521685353154,0,4,uniplex complex,CC,
19459,GO:1990247,1,0.39902340607715,0,7,N6-methyladenosine-containing RNA binding,MF,
19480,GO:1990380,1,0.230783605539738,0,9,Lys48-specific deubiquitinase activity,MF,
19481,GO:1990381,1,0.207089117775922,0,13,ubiquitin-specific protease binding,MF,
19492,GO:1990405,1,0.538467808745042,0,4,protein antigen binding,MF,
19500,GO:1990416,1,0.443352948936679,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19511,GO:1990441,1,0.686494505383782,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
19513,GO:1990446,1,0.746189276505813,0,4,U1 snRNP binding,MF,
19522,GO:1990481,1,0.701448732561922,0,4,mRNA pseudouridine synthesis,BP,
19534,GO:1990564,1,0.661472782538277,0,5,protein polyufmylation,BP,
19546,GO:1990592,1,0.661472782538277,0,5,protein K69-linked ufmylation,BP,
19556,GO:1990635,1,0.616346375158102,0,4,proximal dendrite,CC,
19569,GO:1990712,1,0.569057605248698,0,5,HFE-transferrin receptor complex,CC,
19573,GO:1990726,1,0.751378315756917,0,5,Lsm1-7-Pat1 complex,CC,
19583,GO:1990745,1,0.626410862012117,0,4,EARP complex,CC,
19586,GO:1990752,1,0.0185775035566592,0,25,microtubule end,CC,
19591,GO:1990763,1,0.532628481334979,0,5,arrestin family protein binding,MF,
19596,GO:1990774,1,0.220445887056037,0,11,tumor necrosis factor secretion,BP,
19606,GO:1990809,1,0.694683549263168,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19609,GO:1990822,1,0.581974244719919,0,4,basic amino acid transmembrane transport,BP,
19611,GO:1990825,1,0.357760562147638,0,10,sequence-specific mRNA binding,MF,
19620,GO:1990845,1,0.484736829900587,0,6,adaptive thermogenesis,BP,
19623,GO:1990868,1,0.532311795510445,0,5,response to chemokine,BP,
19624,GO:1990869,1,0.532311795510445,0,5,cellular response to chemokine,BP,
19649,GO:1990948,1,0.754456542771767,0,5,ubiquitin ligase inhibitor activity,MF,
19651,GO:1990966,1,0.639990138568062,0,4,ATP generation from poly-ADP-D-ribose,BP,
19676,GO:2000035,1,0.647763965018723,0,4,regulation of stem cell division,BP,
19698,GO:2000074,1,0.462979569583388,0,7,regulation of type B pancreatic cell development,BP,
19721,GO:2000121,1,0.519216875764514,0,7,regulation of removal of superoxide radicals,BP,
19733,GO:2000152,1,0.731684166612939,0,4,regulation of ubiquitin-specific protease activity,BP,
19738,GO:2000169,1,0.459470990657255,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19745,GO:2000178,1,0.200526487811023,0,13,negative regulation of neural precursor cell proliferation,BP,
19755,GO:2000197,1,0.467414173695864,0,6,regulation of ribonucleoprotein complex localization,BP,
19771,GO:2000232,1,0.287089002660362,0,11,regulation of rRNA processing,BP,
19773,GO:2000234,1,0.434979843162035,0,8,positive regulation of rRNA processing,BP,
19778,GO:2000251,1,0.363140103564356,0,11,positive regulation of actin cytoskeleton reorganization,BP,
19820,GO:2000316,1,0.521614986961245,0,7,regulation of T-helper 17 type immune response,BP,
19822,GO:2000318,1,0.720638538785827,0,4,positive regulation of T-helper 17 type immune response,BP,
19823,GO:2000319,1,0.629908370944031,0,5,regulation of T-helper 17 cell differentiation,BP,
19842,GO:2000344,1,0.691830598623214,0,4,positive regulation of acrosome reaction,BP,
19845,GO:2000347,1,0.610615432333173,0,4,positive regulation of hepatocyte proliferation,BP,
19846,GO:2000348,1,0.616785117163829,0,4,regulation of CD40 signaling pathway,BP,
19851,GO:2000354,1,0.703479384723286,0,4,regulation of ovarian follicle development,BP,
19860,GO:2000370,1,0.592316093124477,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19861,GO:2000371,1,0.470262339133852,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19862,GO:2000373,1,0.470262339133852,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19879,GO:2000394,1,0.501282293904502,0,5,positive regulation of lamellipodium morphogenesis,BP,
19912,GO:2000465,1,0.444998175109546,0,6,regulation of glycogen (starch) synthase activity,BP,
19918,GO:2000479,1,0.268408487869655,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19919,GO:2000480,1,0.523900422227201,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19920,GO:2000481,1,0.553497008320427,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
19922,GO:2000483,1,0.579475393012911,0,5,negative regulation of interleukin-8 secretion,BP,
19973,GO:2000601,1,0.459353764098819,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
19979,GO:2000615,1,0.281862641730056,0,11,regulation of histone H3-K9 acetylation,BP,
19981,GO:2000617,1,0.429682521179665,0,7,positive regulation of histone H3-K9 acetylation,BP,
19982,GO:2000618,1,0.526681988120077,0,5,regulation of histone H4-K16 acetylation,BP,
19985,GO:2000622,1,0.586985897159768,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19986,GO:2000623,1,0.586985897159768,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19989,GO:2000628,1,0.485401422052666,0,7,regulation of miRNA metabolic process,BP,
19990,GO:2000630,1,0.595829451655499,0,5,positive regulation of miRNA metabolic process,BP,
19996,GO:2000641,1,0.148836509499157,0,17,regulation of early endosome to late endosome transport,BP,
19998,GO:2000643,1,0.365167088217166,0,8,positive regulation of early endosome to late endosome transport,BP,
20012,GO:2000659,1,0.527696020041752,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20013,GO:2000660,1,0.66247437806978,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
20028,GO:2000676,1,0.676912542998872,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20075,GO:2000767,1,0.404510105388811,0,8,positive regulation of cytoplasmic translation,BP,
20085,GO:2000781,1,0.184737236654639,0,14,positive regulation of double-strand break repair,BP,
20114,GO:2000831,1,0.531451694865705,0,6,regulation of steroid hormone secretion,BP,
20116,GO:2000833,1,0.701027952609225,0,4,positive regulation of steroid hormone secretion,BP,
20121,GO:2000846,1,0.591841584648785,0,5,regulation of corticosteroid hormone secretion,BP,
20136,GO:2000973,1,0.440439664699064,0,6,regulation of pro-B cell differentiation,BP,
20140,GO:2000980,1,0.572821468070871,0,5,regulation of inner ear receptor cell differentiation,BP,
20141,GO:2000981,1,0.631625213852126,0,4,negative regulation of inner ear receptor cell differentiation,BP,
20147,GO:2001014,1,0.271810513352796,0,11,regulation of skeletal muscle cell differentiation,BP,
20149,GO:2001016,1,0.653105259401162,0,4,positive regulation of skeletal muscle cell differentiation,BP,
20163,GO:2001034,1,0.520337632488405,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20167,GO:2001039,1,0.291705704376164,0,13,negative regulation of cellular response to drug,BP,
20168,GO:2001040,1,0.506999155201757,0,6,positive regulation of cellular response to drug,BP,
20171,GO:2001046,1,0.540526508332712,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20188,GO:2001138,1,0.543097362887755,0,6,regulation of phospholipid transport,BP,
20189,GO:2001140,1,0.543097362887755,0,6,positive regulation of phospholipid transport,BP,
20201,GO:2001166,1,0.566856724345068,0,5,regulation of histone H2B ubiquitination,BP,
20202,GO:2001168,1,0.616021716357681,0,4,positive regulation of histone H2B ubiquitination,BP,
20205,GO:2001171,1,0.121585711751436,0,17,positive regulation of ATP biosynthetic process,BP,
20212,GO:2001182,1,0.658860359990952,0,4,regulation of interleukin-12 secretion,BP,
20215,GO:2001185,1,0.679203377328337,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
20232,GO:2001214,1,0.539083018467024,0,5,positive regulation of vasculogenesis,BP,
20234,GO:2001223,1,0.56360755149757,0,5,negative regulation of neuron migration,BP,
20258,GO:2001256,1,0.418937537471928,0,8,regulation of store-operated calcium entry,BP,
20265,GO:2001270,1,0.649025328591263,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20271,GO:2001279,1,0.647788665326799,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
2442,GO:0005654,1,0,209,3041,nucleoplasm,CC,PHACTR3;ITGB6;SOX6;SYNE1;XPC;ASAP3;ETV5;DUSP6;TNIK;SKP2;NOS1;DNAJB4;SNAI2;PHF21A;UTRN;KLF8;SLC8A1;FKBP5;ATP10D;TCF7L1;DDB2;ADD3;TADA3;CBX5;VDR;NR1D1;SMARCA2;PTK6;CITED4;NR3C1;STAT1;NEO1;TP53;ARAP1;MBNL2;WWTR1;DDIT3;ZBTB20;MEF2D;ADARB1;TFDP2;CHD3;KLF12;KLF9;HIVEP1;GLI3;E2F7;NAV2;SEC14L1;ARHGAP18;ADIRF;FUT10;POLR3GL;GLI2;RMI2;PIAS3;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;DCAF16;OAS2;TP53INP1;HMGA2;CAMK2D;PHC2;PTPN14;PER1;NCAPD2;CREB3L2;DUSP5;UHRF2;CNTLN;CIRBP;JARID2;TP73;PRKACB;CHEK2;PHF2;GATAD1;AIP;JADE2;LMNA;PRKAB2;SETX;NCOA2;PSMB9;OBSCN;TLE4;TCEAL1;SETBP1;SOX13;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;PBX1;ATM;MDM2;C17ORF49;DGKQ;CITED2;NR2F2;ACSS2;CBX7;ZMAT3;SYNE2;HDAC11;EGR1;SOX9;ISL1;BCL6;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;TRERF1;RGS14;HLTF;MPP7;BAHCC1;TCF12;HMBOX1;NFAT5;ANAPC16;VWA5A;DECR1;CHD9;ATXN1;IRF2BPL;MAML2;WDR19;MUTYH;TAF8;CARF;ZFPM1;RBL2;STAT2;IFT122;LIG1;LEF1;THRA;USP28;SPPL2B;SP100;TSPYL2;ORC4;CDK19;MAGI1;BOC;CENPA;FLYWCH1;SRPK2;RHBDD2;POLD4;SAP30L;ZNF12;TACC2;YAP1;KLF5;YEATS2;HOXA3;UBA7;PITPNC1;PPARG;CAPG;MEF2A;TGIF1;ING4;DEF6;RARA;POLH;HOXC5;PRKAG1;TAF1;TSHZ3;MPPE1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;CREBRF;CTDSP2;ETV4;HP1BP3;FOS;KDM4A;ZBTB25;AGO4;KLHDC2;MED12;NPAS2;FBXL4;NIPBL;PRDM5;CELSR1;LITAF;ATG16L2;MYO1C;RXRA;CPT2;TMEM92;DOCK1;FAM114A1
7590,GO:0031981,1,0,252,3516,nuclear lumen,CC,PHACTR3;ITGB6;TRNP1;GPRC5A;SOX6;SYNE1;XPC;ASAP3;ETV5;DUSP6;TNIK;SKP2;NOS1;DNAJB4;SNAI2;PHF21A;UTRN;KLF8;HSPA2;SLC8A1;FKBP5;ATP10D;RNF213;TCF7L1;STON2;DDB2;ADD3;TADA3;CBX5;VDR;NR1D1;SMARCA2;PTK6;ABTB1;CITED4;NR3C1;STAT1;NEO1;TP53;ARAP1;MBNL2;WWTR1;DDIT3;ZBTB20;PYCARD;MEF2D;ZCCHC11;MAP2;ADARB1;TFDP2;DOCK4;TEP1;CHD3;KLF12;KLF9;HIVEP1;GLI3;E2F7;NAV2;SYN1;ABHD14B;MAGED2;SESN1;CTSV;SEC14L1;SPG11;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;PRKCZ;OAS2;TP53INP1;HMGA2;CAMK2D;PHC2;PTPN14;PER1;NCAPD2;CREB3L2;ANG;DUSP5;UHRF2;CNTLN;TTN;CIRBP;JARID2;MLH3;TP73;PRKACB;CHEK2;PHF2;GATAD1;AIP;JADE2;FGFR1;LMNA;PRKAB2;RGS2;SETX;NCOA2;PSMB9;OBSCN;PDK3;TLE4;TCEAL1;SETBP1;SOX13;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;L3MBTL3;PBX1;ATM;MDM2;C17ORF49;TCF4;DGKQ;CITED2;NR2F2;ACSS2;CBX7;ZMAT3;MSH5;SYNE2;HDAC11;EGR1;SOX9;ISL1;BCL6;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;TRERF1;RGS14;HLTF;MPP7;BAHCC1;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;IRF2BPL;MAML2;WDR19;MUTYH;TAF8;CARF;ZFPM1;RBL2;STAT2;IFT122;LIG1;LIPA;LEF1;THRA;USP28;SPPL2B;SP100;TSPYL2;ORC4;CDK19;MAGI1;BOC;CENPA;FLYWCH1;TGFB1I1;RSAD2;SRPK2;MDFIC;RHBDD2;YPEL4;POLD4;SAP30L;ZNF12;TACC2;YAP1;KLF5;TWIST2;YEATS2;HOXA3;UBA7;PITPNC1;PPARG;CAPG;MEF2A;ICK;TGIF1;ING4;DEF6;FKBP10;RARA;POLH;HOXC5;PRKAG1;TAF1;TSHZ3;MPPE1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;CREBRF;CTDSP2;ETV4;HP1BP3;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;KLHDC2;MED12;NPAS2;FBXL4;NIPBL;PRDM5;CELSR1;LITAF;ATG16L2;MYO1C;RXRA;CPT2;TMEM92;NFKBIE;DOCK1;FAM114A1
13767,GO:0060383,1.00000000000001,0.878171321832886,0,1,positive regulation of DNA strand elongation,BP,
19249,GO:1905464,1.00000000000001,0.878171321832886,0,1,positive regulation of DNA duplex unwinding,BP,
19334,GO:1905774,1.00000000000001,0.878171321832886,0,1,regulation of DNA helicase activity,BP,
19335,GO:1905776,1.00000000000001,0.878171321832886,0,1,positive regulation of DNA helicase activity,BP,
19650,GO:1990955,1.00000000000001,0.878171321832886,0,1,G-rich single-stranded DNA binding,MF,
10867,GO:0044428,1.00000000000001,0,281,3795,nuclear part,CC,PHACTR3;ITGB6;SULT1E1;FLOT1;TRNP1;GPRC5A;SOX6;SYNE1;XPC;ASAP3;ETV5;DUSP6;TNIK;SKP2;NOS1;DNAJB4;SNAI2;PHF21A;UTRN;EGFR;KLF8;HSPA2;SLC8A1;FKBP5;CLCA2;SYNE3;ATP10D;RNF213;TCF7L1;STON2;DDB2;ADD3;TADA3;PAK1;CBX5;VDR;NR1D1;SMARCA2;PTK6;ABTB1;CITED4;NR3C1;STAT1;SORL1;NEO1;TP53;ARAP1;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;MEF2D;ZCCHC11;MAP2;ADARB1;TFDP2;DOCK4;TEP1;CUL7;CHD3;KLF12;KLF9;HIVEP1;GLI3;PTGES;E2F7;NAV2;SYN1;ABHD14B;MAGED2;SESN1;CTSV;SEC14L1;SPG11;ARHGAP18;ADIRF;FUT10;CPS1;POLR3GL;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;SLC2A4RG;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;PRKCZ;OAS2;TP53INP1;HMGA2;CAMK2D;PHC2;PTPN14;PER1;NCAPD2;CREB3L2;APOBEC3G;ANG;DUSP5;UHRF2;CNTLN;TTN;CIRBP;JARID2;MLH3;TP73;PRKACB;CHEK2;PHF2;SNCA;GATAD1;AIP;JADE2;FGFR1;APOBEC3F;LMNA;PRKAB2;RGS2;SETX;PDE4D;NCOA2;PSMB9;OBSCN;PDK3;MYOF;TLE4;TCEAL1;SETBP1;SOX13;KDM4C;CHD6;NFATC4;RAPH1;LMCD1;AMOTL1;L3MBTL3;PBX1;CALR;ATM;MDM2;CST3;C17ORF49;TCF4;DGKQ;CITED2;NR2F2;ACSS2;CBX7;ZMAT3;MSH5;SYNE2;HDAC11;NEMP2;EGR1;SOX9;ISL1;BCL6;CRTC1;NCOR1;PLAG1;PRKCA;SALL2;BCHE;TRERF1;RGS14;HLTF;MPP7;BAHCC1;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;PODXL;PAK6;VWA5A;DECR1;CHD9;ATXN1;IRF2BPL;MAML2;WDR19;MUTYH;TAF8;PRNP;CARF;ZFPM1;RBL2;STAT2;IFT122;LIG1;LIPA;LEF1;THRA;USP28;SPPL2B;SP100;TSPYL2;ORC4;HSPA5;CDK19;NRM;MAGI1;BOC;CENPA;FLYWCH1;TGFB1I1;RSAD2;SRPK2;UVRAG;MDFIC;RHBDD2;YPEL4;POLD4;SAP30L;ZNF12;TACC2;YAP1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;UBA7;PITPNC1;PPARG;CAPG;MEF2A;CERS5;ICK;TGIF1;ING4;LGALS3;DEF6;FKBP10;RARA;POLH;HOXC5;PRKAG1;TAF1;TSHZ3;MPPE1;HCFC1R1;ZBTB1;PPP3CA;DCAF8;PIK3C2B;CREBRF;CTDSP2;ETV4;HP1BP3;FOS;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM169A;KLHDC2;MED12;NPAS2;FBXL4;NIPBL;PRDM5;CELSR1;LITAF;ATG16L2;MYO1C;RXRA;CPT2;TMEM92;NFKBIE;DOCK1;FAM114A1;DMPK
8846,GO:0034660,1.00000000000001,0,7,546,ncRNA metabolic process,BP,ZCCHC11;ANG;AARS;MYBL1;RPL13A;TAF8;AGO4
19792,GO:2000275,1.00000000000003,0.869661207395503,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
17752,GO:1901837,1.00000000000003,0.849284758801173,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
1143,GO:0002740,1.00000000000003,0.862720463884834,0,2,negative regulation of cytokine secretion involved in immune response,BP,
1207,GO:0002874,1.00000000000003,0.862720463884834,0,2,regulation of chronic inflammatory response to antigenic stimulus,BP,
4612,GO:0010735,1.00000000000004,0.670345368820948,0,3,positive regulation of transcription via serum response element binding,BP,
9157,GO:0035538,1.00000000000004,0.898457842710211,0,1,carbohydrate response element binding,MF,
782,GO:0002041,1.00000000000007,0.917699729501946,0,1,intussusceptive angiogenesis,BP,
10134,GO:0042732,1.00000000000007,0.842188397664973,0,2,D-xylose metabolic process,BP,
1790,GO:0004421,1.00000000000011,0.892814682085862,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
4275,GO:0009645,1.00000000000011,0.892814682085862,0,1,response to low light intensity stimulus,BP,
4400,GO:0010142,1.00000000000011,0.892814682085862,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
11785,GO:0046690,1.00000000000011,0.892814682085862,0,1,response to tellurium ion,BP,
18086,GO:1902767,1.00000000000011,0.892814682085862,0,1,isoprenoid biosynthetic process via mevalonate,BP,
7829,GO:0032395,1.00000000000011,0.81616526121499,0,3,MHC class II receptor activity,MF,
14771,GO:0070524,1.00000000000011,0.933974324463412,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
4729,GO:0010898,1.00000000000012,0.78905998591453,0,2,positive regulation of triglyceride catabolic process,BP,
7376,GO:0031439,1.00000000000012,0.798206508246093,0,2,positive regulation of mRNA cleavage,BP,
20210,GO:2001180,1.00000000000013,0.821796452782146,0,2,negative regulation of interleukin-10 secretion,BP,
8084,GO:0032782,1.00000000000015,0.850903574082866,0,2,bile acid secretion,BP,
4204,GO:0009330,1.00000000000015,0.754706123060524,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
8631,GO:0034189,1.00000000000016,0.790838606918027,0,2,very-low-density lipoprotein particle binding,MF,
10819,GO:0044334,1.00000000000016,0.787547489379772,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
5692,GO:0016822,1.00000000000017,0.86592350381979,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5693,GO:0016823,1.00000000000017,0.86592350381979,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
13,GO:0000026,1.00000000000017,0.702337215006418,0,3,alpha-1,2-mannosyltransferase activity,MF,
7490,GO:0031673,1.00000000000017,0.715776055120783,0,1,H zone,CC,
2748,GO:0006154,1.00000000000018,0.850205667292027,0,2,adenosine catabolic process,BP,
11538,GO:0046103,1.00000000000018,0.850205667292027,0,2,inosine biosynthetic process,BP,
14095,GO:0060987,1.00000000000019,0.917220402949989,0,1,lipid tube,CC,
1040,GO:0002560,1.0000000000002,0.876171845650858,0,1,basophil mediated immunity,BP,
1041,GO:0002561,1.0000000000002,0.876171845650858,0,1,basophil degranulation,BP,
8475,GO:0033644,1.0000000000002,0.876171845650858,0,1,host cell membrane,CC,
10751,GO:0044218,1.0000000000002,0.876171845650858,0,1,other organism cell membrane,CC,
10753,GO:0044221,1.0000000000002,0.876171845650858,0,1,host cell synapse,CC,
10756,GO:0044231,1.0000000000002,0.876171845650858,0,1,host cell presynaptic membrane,CC,
10780,GO:0044279,1.0000000000002,0.876171845650858,0,1,other organism membrane,CC,
15813,GO:0072556,1.0000000000002,0.876171845650858,0,1,other organism presynaptic membrane,CC,
2982,GO:0006528,1.00000000000021,0.786249608040207,0,3,asparagine metabolic process,BP,
14536,GO:0070094,1.00000000000023,0.912856631553573,0,1,positive regulation of glucagon secretion,BP,
11963,GO:0047322,1.00000000000023,0.692753534954771,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12452,GO:0050405,1.00000000000023,0.692753534954771,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
10467,GO:0043385,1.00000000000024,0.910025478734685,0,1,mycotoxin metabolic process,BP,
10468,GO:0043387,1.00000000000024,0.910025478734685,0,1,mycotoxin catabolic process,BP,
11583,GO:0046222,1.00000000000024,0.910025478734685,0,1,aflatoxin metabolic process,BP,
11584,GO:0046223,1.00000000000024,0.910025478734685,0,1,aflatoxin catabolic process,BP,
17615,GO:1901376,1.00000000000024,0.910025478734685,0,1,organic heteropentacyclic compound metabolic process,BP,
17616,GO:1901377,1.00000000000024,0.910025478734685,0,1,organic heteropentacyclic compound catabolic process,BP,
18536,GO:1903786,1.00000000000024,0.910025478734685,0,1,regulation of glutathione biosynthetic process,BP,
18537,GO:1903788,1.00000000000024,0.910025478734685,0,1,positive regulation of glutathione biosynthetic process,BP,
6402,GO:0021644,1.00000000000024,0.931146250709868,0,1,vagus nerve morphogenesis,BP,
10897,GO:0044501,1.00000000000024,0.77100939458998,0,2,modulation of signal transduction in other organism,BP,
13268,GO:0052027,1.00000000000024,0.77100939458998,0,2,modulation by symbiont of host signal transduction pathway,BP,
13302,GO:0052250,1.00000000000024,0.77100939458998,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
8334,GO:0033204,1.00000000000024,0.914571855604373,0,1,ribonuclease P RNA binding,MF,
3340,GO:0007060,1.00000000000024,0.829669082422142,0,2,male meiosis chromosome segregation,BP,
18444,GO:1903569,1.00000000000025,0.916449072702598,0,1,positive regulation of protein localization to ciliary membrane,BP,
950,GO:0002370,1.00000000000026,0.747530080878556,0,3,natural killer cell cytokine production,BP,
1134,GO:0002727,1.00000000000026,0.747530080878556,0,3,regulation of natural killer cell cytokine production,BP,
5862,GO:0017177,1.00000000000026,0.882451757411912,0,1,glucosidase II complex,CC,
8537,GO:0033919,1.00000000000026,0.882451757411912,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16315,GO:0090600,1.00000000000026,0.882451757411912,0,1,alpha-1,3-glucosidase activity,MF,
7717,GO:0032222,1.00000000000027,0.800787124621581,0,1,regulation of synaptic transmission, cholinergic,BP,
7718,GO:0032224,1.00000000000027,0.800787124621581,0,1,positive regulation of synaptic transmission, cholinergic,BP,
16404,GO:0097086,1.00000000000028,0.888404181668878,0,1,amniotic stem cell differentiation,BP,
20044,GO:2000706,1.00000000000028,0.888404181668878,0,1,negative regulation of dense core granule biogenesis,BP,
20060,GO:2000740,1.00000000000028,0.888404181668878,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20093,GO:2000797,1.00000000000028,0.888404181668878,0,1,regulation of amniotic stem cell differentiation,BP,
20094,GO:2000798,1.00000000000028,0.888404181668878,0,1,negative regulation of amniotic stem cell differentiation,BP,
5526,GO:0016509,1.00000000000028,0.758617628952566,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
6730,GO:0030156,1.00000000000028,0.951620798434724,0,1,benzodiazepine receptor binding,MF,
5669,GO:0016785,1.00000000000028,0.85256605260519,0,1,transferase activity, transferring selenium-containing groups,MF,
16758,GO:0098621,1.00000000000028,0.85256605260519,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
14371,GO:0061656,1.00000000000028,0.939031899979907,0,1,SUMO conjugating enzyme activity,MF,
18260,GO:1903182,1.00000000000028,0.939031899979907,0,1,regulation of SUMO transferase activity,BP,
18519,GO:1903755,1.00000000000028,0.939031899979907,0,1,positive regulation of SUMO transferase activity,BP,
19477,GO:1990356,1.00000000000028,0.939031899979907,0,1,sumoylated E2 ligase complex,CC,
8882,GO:0034718,1.00000000000028,0.855605404253589,0,1,SMN-Gemin2 complex,CC,
4868,GO:0014734,1.00000000000029,0.686304204928378,0,2,skeletal muscle hypertrophy,BP,
18710,GO:1904204,1.00000000000029,0.686304204928378,0,2,regulation of skeletal muscle hypertrophy,BP,
7171,GO:0031064,1.0000000000003,0.670477762825358,0,2,negative regulation of histone deacetylation,BP,
20115,GO:2000832,1.0000000000003,0.758163065654683,0,2,negative regulation of steroid hormone secretion,BP,
20122,GO:2000847,1.0000000000003,0.758163065654683,0,2,negative regulation of corticosteroid hormone secretion,BP,
20125,GO:2000850,1.0000000000003,0.758163065654683,0,2,negative regulation of glucocorticoid secretion,BP,
5254,GO:0015889,1.0000000000003,0.736457761437502,0,3,cobalamin transport,BP,
18409,GO:1903518,1.00000000000031,0.810270929506044,0,2,positive regulation of single strand break repair,BP,
8219,GO:0032996,1.00000000000032,0.924666757986557,0,1,Bcl3-Bcl10 complex,CC,
11061,GO:0045082,1.00000000000032,0.924666757986557,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
7407,GO:0031508,1.00000000000032,0.847790898310552,0,2,pericentric heterochromatin assembly,BP,
18379,GO:1903434,1.00000000000033,0.883565263515866,0,1,negative regulation of constitutive secretory pathway,BP,
10926,GO:0044611,1.00000000000035,0.627933183065555,0,3,nuclear pore inner ring,CC,
14985,GO:0070944,1.00000000000037,0.84204241680347,0,2,neutrophil mediated killing of bacterium,BP,
14986,GO:0070945,1.00000000000037,0.84204241680347,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
7148,GO:0031021,1.00000000000037,0.765459002237892,0,3,interphase microtubule organizing center,CC,
11185,GO:0045337,1.00000000000038,0.756239435704886,0,3,farnesyl diphosphate biosynthetic process,BP,
3999,GO:0008941,1.00000000000038,0.843958801528899,0,2,nitric oxide dioxygenase activity,MF,
5623,GO:0016708,1.00000000000038,0.843958801528899,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
8222,GO:0033004,1.00000000000038,0.757012275158076,0,3,negative regulation of mast cell activation,BP,
8225,GO:0033007,1.00000000000038,0.757012275158076,0,3,negative regulation of mast cell activation involved in immune response,BP,
17823,GO:1902037,1.00000000000039,0.75277131505315,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
10742,GO:0044209,1.00000000000039,0.876871539752331,0,2,AMP salvage,BP,
14037,GO:0060844,1.00000000000039,0.82228265191859,0,2,arterial endothelial cell fate commitment,BP,
16188,GO:0090259,1.00000000000039,0.703164837750874,0,3,regulation of retinal ganglion cell axon guidance,BP,
2050,GO:0004801,1.0000000000004,0.937933303460211,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
1466,GO:0003723,1.00000000000041,0,76,1482,RNA binding,MF,ZFP36L1;NQO1;SYNE1;ZFP36L2;IGF2BP2;HERC5;PEG10;SERPINH1;VIM;PLEC;APOBEC3C;TNS1;AHNAK;ABTB1;EIF2AK4;PDCD4;NR3C1;IFIT2;LGALS1;TP53;MBNL2;IFIT1;DDX60;ARHGEF1;ZCCHC11;RBMS3;ADARB1;TEP1;CHD3;IFIT3;LRP1;PABPC4L;RBFOX2;AHNAK2;OAS2;GOLGB1;PDIA4;CAPRIN2;APOBEC3G;ANG;CIRBP;AARS;R3HDM2;PRX;TLR3;APOBEC3F;FSCN1;KHNYN;NBPF10;CALR;MDM2;ZMAT3;PTPN1;SOX9;C14ORF93;DDX60L;ANXA2;HLTF;FNDC3A;CXORF57;TES;RPL13A;ATXN1;DLX2;THRA;C11ORF68;CDKN2A;CELF2;FLNB;SRPK2;PRRC2B;UNK;LGALS3;RARA;AGO4;ACAA2
11980,GO:0047464,1.00000000000041,0.861132627754162,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12451,GO:0050379,1.00000000000041,0.861132627754162,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12115,GO:0048239,1.00000000000042,0.834712185474485,0,2,negative regulation of DNA recombination at telomere,BP,
15886,GO:0072695,1.00000000000042,0.834712185474485,0,2,regulation of DNA recombination at telomere,BP,
4719,GO:0010886,1.00000000000042,0.711098491284484,0,3,positive regulation of cholesterol storage,BP,
6216,GO:0019763,1.00000000000042,0.810128544578207,0,2,immunoglobulin receptor activity,MF,
2162,GO:0004998,1.00000000000043,0.859300493845428,0,1,transferrin receptor activity,MF,
4970,GO:0015091,1.00000000000043,0.859300493845428,0,1,ferric iron transmembrane transporter activity,MF,
8433,GO:0033570,1.00000000000043,0.859300493845428,0,1,transferrin transmembrane transporter activity,MF,
15782,GO:0072510,1.00000000000043,0.859300493845428,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
2048,GO:0004798,1.00000000000046,0.85116287476995,0,2,thymidylate kinase activity,MF,
2788,GO:0006227,1.00000000000046,0.85116287476995,0,2,dUDP biosynthetic process,BP,
2791,GO:0006233,1.00000000000046,0.85116287476995,0,2,dTDP biosynthetic process,BP,
4081,GO:0009139,1.00000000000046,0.85116287476995,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4132,GO:0009196,1.00000000000046,0.85116287476995,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4133,GO:0009197,1.00000000000046,0.85116287476995,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11519,GO:0046072,1.00000000000046,0.85116287476995,0,2,dTDP metabolic process,BP,
11522,GO:0046077,1.00000000000046,0.85116287476995,0,2,dUDP metabolic process,BP,
2259,GO:0005175,1.00000000000046,0.95353803257463,0,1,CD27 receptor binding,MF,
2894,GO:0006404,1.00000000000048,0.700058520480177,0,3,RNA import into nucleus,BP,
3885,GO:0008523,1.00000000000049,0.89732487413316,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
5245,GO:0015878,1.00000000000049,0.89732487413316,0,1,biotin transport,BP,
5252,GO:0015887,1.00000000000049,0.89732487413316,0,1,pantothenate transmembrane transport,BP,
9308,GO:0035800,1.0000000000005,0.825559509751108,0,2,deubiquitinase activator activity,MF,
19736,GO:2000158,1.0000000000005,0.825559509751108,0,2,positive regulation of ubiquitin-specific protease activity,BP,
14951,GO:0070889,1.00000000000051,0.835829009405182,0,2,platelet alpha granule organization,BP,
410,GO:0001097,1.00000000000051,0.704420728537505,0,3,TFIIH-class transcription factor binding,MF,
176,GO:0000386,1.00000000000053,0.686156999035431,0,3,second spliceosomal transesterification activity,MF,
5409,GO:0016262,1.00000000000054,0.716786897757979,0,3,protein N-acetylglucosaminyltransferase activity,MF,
1639,GO:0004084,1.00000000000055,0.760885402025849,0,2,branched-chain-amino-acid transaminase activity,MF,
4041,GO:0009082,1.00000000000055,0.760885402025849,0,2,branched-chain amino acid biosynthetic process,BP,
4049,GO:0009098,1.00000000000055,0.760885402025849,0,2,leucine biosynthetic process,BP,
4050,GO:0009099,1.00000000000055,0.760885402025849,0,2,valine biosynthetic process,BP,
13355,GO:0052654,1.00000000000055,0.760885402025849,0,2,L-leucine transaminase activity,MF,
13356,GO:0052655,1.00000000000055,0.760885402025849,0,2,L-valine transaminase activity,MF,
13357,GO:0052656,1.00000000000055,0.760885402025849,0,2,L-isoleucine transaminase activity,MF,
16238,GO:0090326,1.00000000000056,0.897559631337219,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18103,GO:1902823,1.00000000000056,0.897559631337219,0,1,negative regulation of late endosome to lysosome transport,BP,
18329,GO:1903336,1.00000000000056,0.897559631337219,0,1,negative regulation of vacuolar transport,BP,
19834,GO:2000331,1.00000000000056,0.897559631337219,0,1,regulation of terminal button organization,BP,
9302,GO:0035790,1.00000000000056,0.883900065377429,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
19964,GO:2000583,1.00000000000056,0.883900065377429,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19965,GO:2000584,1.00000000000056,0.883900065377429,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
14279,GO:0061443,1.00000000000057,0.767613188469422,0,2,endocardial cushion cell differentiation,BP,
13780,GO:0060398,1.00000000000059,0.630405422187755,0,3,regulation of growth hormone receptor signaling pathway,BP,
13966,GO:0060709,1.00000000000062,0.907502691829445,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
17076,GO:0100002,1.00000000000062,0.907502691829445,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
8517,GO:0033829,1.00000000000063,0.783809109538404,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
19286,GO:1905590,1.00000000000065,0.901559792000798,0,1,fibronectin fibril organization,BP,
19832,GO:2000329,1.00000000000065,0.901559792000798,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
16133,GO:0090182,1.00000000000065,0.857331505947194,0,2,regulation of secretion of lysosomal enzymes,BP,
831,GO:0002127,1.00000000000067,0.93338990501348,0,1,tRNA wobble base cytosine methylation,BP,
1245,GO:0002946,1.00000000000067,0.93338990501348,0,1,tRNA C5-cytosine methylation,BP,
1241,GO:0002940,1.0000000000007,0.833774666791917,0,2,tRNA N2-guanine methylation,BP,
12996,GO:0051458,1.0000000000007,0.776815467746739,0,2,corticotropin secretion,BP,
12997,GO:0051459,1.0000000000007,0.776815467746739,0,2,regulation of corticotropin secretion,BP,
12998,GO:0051461,1.0000000000007,0.776815467746739,0,2,positive regulation of corticotropin secretion,BP,
14637,GO:0070267,1.0000000000007,0.890227849553637,0,1,oncosis,BP,
19643,GO:1990928,1.00000000000071,0.741575405334114,0,2,response to amino acid starvation,BP,
2117,GO:0004909,1.00000000000072,0.796583686229159,0,2,interleukin-1, Type I, activating receptor activity,MF,
58,GO:0000121,1.00000000000073,0.901488656107719,0,1,glycerol-1-phosphatase activity,MF,
10318,GO:0043136,1.00000000000073,0.901488656107719,0,1,glycerol-3-phosphatase activity,MF,
11178,GO:0045323,1.00000000000076,0.736183836038142,0,3,interleukin-1 receptor complex,CC,
19267,GO:1905538,1.00000000000078,0.787088182324458,0,2,polysome binding,MF,
9491,GO:0036157,1.0000000000008,0.588043717250546,0,3,outer dynein arm,CC,
16255,GO:0090365,1.00000000000081,0.919435667640083,0,1,regulation of mRNA modification,BP,
16256,GO:0090367,1.00000000000081,0.919435667640083,0,1,negative regulation of mRNA modification,BP,
18278,GO:1903215,1.00000000000081,0.919435667640083,0,1,negative regulation of protein targeting to mitochondrion,BP,
20191,GO:2001144,1.00000000000081,0.919435667640083,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20192,GO:2001145,1.00000000000081,0.919435667640083,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
7696,GO:0032190,1.00000000000081,0.872159025699745,0,2,acrosin binding,MF,
9311,GO:0035803,1.00000000000081,0.872159025699745,0,2,egg coat formation,BP,
2358,GO:0005461,1.00000000000085,0.841724653801903,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
5191,GO:0015787,1.00000000000085,0.841724653801903,0,1,UDP-glucuronic acid transmembrane transport,BP,
3755,GO:0008300,1.00000000000086,0.792617716849428,0,2,isoprenoid catabolic process,BP,
18044,GO:1902636,1.00000000000087,0.86235200292608,0,2,kinociliary basal body,CC,
18492,GO:1903691,1.00000000000088,0.662270427582351,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
11194,GO:0045348,1.00000000000088,0.760362417790355,0,3,positive regulation of MHC class II biosynthetic process,BP,
11472,GO:0045967,1.00000000000091,0.629275821945098,0,2,negative regulation of growth rate,BP,
4274,GO:0009644,1.00000000000091,0.790000789678513,0,2,response to high light intensity,BP,
13985,GO:0060735,1.00000000000091,0.935010956940061,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18041,GO:1902629,1.00000000000091,0.935010956940061,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
8528,GO:0033871,1.00000000000092,0.923279716359004,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11903,GO:0046970,1.00000000000092,0.923279716359004,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14272,GO:0061433,1.00000000000092,0.923279716359004,0,1,cellular response to caloric restriction,BP,
14735,GO:0070446,1.00000000000092,0.923279716359004,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
3916,GO:0008592,1.00000000000093,0.898935021364375,0,1,regulation of Toll signaling pathway,BP,
9891,GO:0042241,1.00000000000093,0.898935021364375,0,1,interleukin-18 biosynthetic process,BP,
11208,GO:0045381,1.00000000000093,0.898935021364375,0,1,regulation of interleukin-18 biosynthetic process,BP,
11359,GO:0045751,1.00000000000093,0.898935021364375,0,1,negative regulation of Toll signaling pathway,BP,
2476,GO:0005713,1.00000000000093,0.914813404298827,0,1,recombination nodule,CC,
2477,GO:0005715,1.00000000000093,0.914813404298827,0,1,late recombination nodule,CC,
5008,GO:0015173,1.00000000000093,0.914813404298827,0,1,aromatic amino acid transmembrane transporter activity,MF,
5026,GO:0015196,1.00000000000093,0.914813404298827,0,1,L-tryptophan transmembrane transporter activity,MF,
10278,GO:0043060,1.00000000000093,0.914813404298827,0,1,meiotic metaphase I plate congression,BP,
12884,GO:0051257,1.00000000000093,0.914813404298827,0,1,meiotic spindle midzone assembly,BP,
12924,GO:0051311,1.00000000000093,0.914813404298827,0,1,meiotic metaphase plate congression,BP,
18746,GO:1904271,1.00000000000093,0.914813404298827,0,1,L-proline import across plasma membrane,BP,
18853,GO:1904555,1.00000000000093,0.914813404298827,0,1,L-proline transmembrane transport,BP,
18854,GO:1904556,1.00000000000093,0.914813404298827,0,1,L-tryptophan transmembrane transport,BP,
19305,GO:1905647,1.00000000000093,0.914813404298827,0,1,proline import across plasma membrane,BP,
2573,GO:0005863,1.00000000000093,0.887077974270447,0,1,striated muscle myosin thick filament,CC,
3308,GO:0007014,1.00000000000093,0.887077974270447,0,1,actin ubiquitination,BP,
9562,GO:0036392,1.00000000000093,0.887077974270447,0,1,chemokine (C-C motif) ligand 20 production,BP,
18575,GO:1903881,1.00000000000093,0.887077974270447,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18576,GO:1903883,1.00000000000093,0.887077974270447,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18577,GO:1903884,1.00000000000093,0.887077974270447,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18578,GO:1903886,1.00000000000093,0.887077974270447,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18303,GO:1903286,1.00000000000093,0.736536976769007,0,3,regulation of potassium ion import,BP,
8652,GO:0034238,1.00000000000094,0.880552587878301,0,1,macrophage fusion,BP,
8653,GO:0034239,1.00000000000094,0.880552587878301,0,1,regulation of macrophage fusion,BP,
8654,GO:0034241,1.00000000000094,0.880552587878301,0,1,positive regulation of macrophage fusion,BP,
11148,GO:0045234,1.00000000000095,0.926134567503142,0,1,protein palmitoleylation,BP,
7176,GO:0031074,1.00000000000096,0.704144004135139,0,3,nucleocytoplasmic transport complex,CC,
9640,GO:0038001,1.00000000000096,0.840337154567393,0,2,paracrine signaling,BP,
15766,GO:0072429,1.00000000000096,0.761567498595771,0,3,response to intra-S DNA damage checkpoint signaling,BP,
9963,GO:0042374,1.00000000000096,0.941413401017455,0,1,phylloquinone metabolic process,BP,
9964,GO:0042376,1.00000000000096,0.941413401017455,0,1,phylloquinone catabolic process,BP,
17252,GO:0140031,1.00000000000096,0.829253004221594,0,2,phosphorylation-dependent protein binding,MF,
17706,GO:1901662,1.00000000000096,0.941413401017455,0,1,quinone catabolic process,BP,
576,GO:0001729,1.00000000000097,0.78910004166322,0,2,ceramide kinase activity,MF,
16942,GO:0098989,1.00000000000099,0.775201939853947,0,2,NMDA selective glutamate receptor signaling pathway,BP,
7237,GO:0031204,1.00000000000099,0.699348142535891,0,3,posttranslational protein targeting to membrane, translocation,BP,
12018,GO:0047800,1.00000000000101,0.886966935626248,0,1,cysteamine dioxygenase activity,MF,
17208,GO:0110057,1.00000000000102,0.854779206844705,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17209,GO:0110059,1.00000000000102,0.854779206844705,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
2177,GO:0005025,1.00000000000102,0.651766899279658,0,3,transforming growth factor beta receptor activity, type I,MF,
19831,GO:2000328,1.00000000000104,0.78453590020174,0,3,regulation of T-helper 17 cell lineage commitment,BP,
966,GO:0002414,1.00000000000107,0.748290542271741,0,3,immunoglobulin transcytosis in epithelial cells,BP,
19317,GO:1905696,1.00000000000108,0.744897064464886,0,2,regulation of polysome binding,BP,
10752,GO:0044220,1.00000000000108,0.864291917179589,0,1,host cell perinuclear region of cytoplasm,CC,
3348,GO:0007079,1.00000000000109,0.64379380545812,0,3,mitotic chromosome movement towards spindle pole,BP,
16862,GO:0098837,1.0000000000011,0.76349498566896,0,3,postsynaptic recycling endosome,CC,
11072,GO:0045098,1.0000000000011,0.928473931965249,0,1,type III intermediate filament,CC,
12118,GO:0048244,1.0000000000011,0.928473931965249,0,1,phytanoyl-CoA dioxygenase activity,MF,
16405,GO:0097089,1.0000000000011,0.928473931965249,0,1,methyl-branched fatty acid metabolic process,BP,
11722,GO:0046586,1.00000000000111,0.856265067294513,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
7063,GO:0030862,1.00000000000111,0.85388507453623,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9728,GO:0039007,1.00000000000111,0.85388507453623,0,1,pronephric nephron morphogenesis,BP,
9729,GO:0039008,1.00000000000111,0.85388507453623,0,1,pronephric nephron tubule morphogenesis,BP,
9732,GO:0039020,1.00000000000111,0.85388507453623,0,1,pronephric nephron tubule development,BP,
9733,GO:0039022,1.00000000000111,0.85388507453623,0,1,pronephric duct development,BP,
9734,GO:0039023,1.00000000000111,0.85388507453623,0,1,pronephric duct morphogenesis,BP,
14551,GO:0070121,1.00000000000111,0.85388507453623,0,1,Kupffer's vesicle development,BP,
15595,GO:0072114,1.00000000000111,0.85388507453623,0,1,pronephros morphogenesis,BP,
7527,GO:0031775,1.00000000000111,0.819022077299849,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7891,GO:0032470,1.00000000000111,0.819022077299849,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
15991,GO:0086039,1.00000000000111,0.819022077299849,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
18406,GO:1903515,1.00000000000111,0.819022077299849,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19406,GO:1990036,1.00000000000111,0.819022077299849,0,1,calcium ion import into sarcoplasmic reticulum,BP,
508,GO:0001572,1.00000000000112,0.864663131945548,0,1,lactosylceramide biosynthetic process,BP,
11670,GO:0046478,1.00000000000112,0.864663131945548,0,1,lactosylceramide metabolic process,BP,
1430,GO:0003406,1.00000000000112,0.675434930927624,0,3,retinal pigment epithelium development,BP,
18040,GO:1902626,1.00000000000112,0.840598692256923,0,3,assembly of large subunit precursor of preribosome,BP,
11760,GO:0046642,1.00000000000112,0.688893398905936,0,3,negative regulation of alpha-beta T cell proliferation,BP,
12150,GO:0048295,1.00000000000114,0.81523198790467,0,2,positive regulation of isotype switching to IgE isotypes,BP,
2566,GO:0005853,1.00000000000115,0.789132512954209,0,3,eukaryotic translation elongation factor 1 complex,CC,
6131,GO:0019402,1.00000000000118,0.935081597924395,0,1,galactitol metabolic process,BP,
14353,GO:0061623,1.00000000000118,0.935081597924395,0,1,glycolytic process from galactose,BP,
7642,GO:0032072,1.00000000000119,0.894346258205833,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7852,GO:0032423,1.00000000000119,0.894346258205833,0,1,regulation of mismatch repair,BP,
7853,GO:0032425,1.00000000000119,0.894346258205833,0,1,positive regulation of mismatch repair,BP,
9262,GO:0035711,1.00000000000119,0.894346258205833,0,1,T-helper 1 cell activation,BP,
19902,GO:2000426,1.00000000000119,0.894346258205833,0,1,negative regulation of apoptotic cell clearance,BP,
11815,GO:0046790,1.00000000000121,0.633101013070176,0,3,virion binding,MF,
5976,GO:0018773,1.00000000000122,0.928173851713543,0,1,acetylpyruvate hydrolase activity,MF,
8795,GO:0034545,1.00000000000122,0.928173851713543,0,1,fumarylpyruvate hydrolase activity,MF,
11997,GO:0047621,1.00000000000122,0.928173851713543,0,1,acylpyruvate hydrolase activity,MF,
13335,GO:0052550,1.00000000000122,0.928173851713543,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13341,GO:0052567,1.00000000000122,0.928173851713543,0,1,response to defense-related host reactive oxygen species production,BP,
2125,GO:0004923,1.00000000000124,0.715916930687932,0,2,leukemia inhibitory factor receptor activity,MF,
20123,GO:2000848,1.00000000000125,0.780668734366456,0,3,positive regulation of corticosteroid hormone secretion,BP,
14306,GO:0061519,1.00000000000125,0.890077507851793,0,1,macrophage homeostasis,BP,
14456,GO:0061890,1.00000000000127,0.835526066636294,0,2,positive regulation of astrocyte activation,BP,
18637,GO:1903980,1.00000000000127,0.835526066636294,0,2,positive regulation of microglial cell activation,BP,
9376,GO:0035931,1.00000000000128,0.821380061254286,0,2,mineralocorticoid secretion,BP,
9377,GO:0035932,1.00000000000128,0.821380061254286,0,2,aldosterone secretion,BP,
20127,GO:2000855,1.00000000000128,0.821380061254286,0,2,regulation of mineralocorticoid secretion,BP,
20128,GO:2000857,1.00000000000128,0.821380061254286,0,2,positive regulation of mineralocorticoid secretion,BP,
20129,GO:2000858,1.00000000000128,0.821380061254286,0,2,regulation of aldosterone secretion,BP,
20130,GO:2000860,1.00000000000128,0.821380061254286,0,2,positive regulation of aldosterone secretion,BP,
17869,GO:1902178,1.00000000000129,0.873915137463187,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
16813,GO:0098749,1.00000000000129,0.86791819976381,0,1,cerebellar neuron development,BP,
16479,GO:0097210,1.0000000000013,0.777485005611214,0,2,response to gonadotropin-releasing hormone,BP,
16480,GO:0097211,1.0000000000013,0.777485005611214,0,2,cellular response to gonadotropin-releasing hormone,BP,
2614,GO:0005927,1.0000000000013,0.93090893051211,0,1,muscle tendon junction,CC,
8643,GO:0034213,1.0000000000013,0.93090893051211,0,1,quinolinate catabolic process,BP,
11846,GO:0046874,1.0000000000013,0.93090893051211,0,1,quinolinate metabolic process,BP,
1636,GO:0004081,1.00000000000131,0.859240288266092,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3972,GO:0008796,1.00000000000131,0.859240288266092,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
2167,GO:0005004,1.00000000000131,0.84314250675201,0,1,GPI-linked ephrin receptor activity,MF,
13226,GO:0051933,1.00000000000131,0.84314250675201,0,1,amino acid neurotransmitter reuptake,BP,
13228,GO:0051935,1.00000000000131,0.84314250675201,0,1,glutamate reuptake,BP,
13232,GO:0051941,1.00000000000131,0.84314250675201,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13235,GO:0051946,1.00000000000131,0.84314250675201,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
16444,GO:0097156,1.00000000000131,0.84314250675201,0,1,fasciculation of motor neuron axon,BP,
16448,GO:0097161,1.00000000000131,0.84314250675201,0,1,DH domain binding,MF,
18829,GO:1904477,1.00000000000131,0.84314250675201,0,1,positive regulation of Ras GTPase binding,BP,
19110,GO:1905099,1.00000000000131,0.84314250675201,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20182,GO:2001108,1.00000000000131,0.84314250675201,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
16540,GO:0097360,1.00000000000132,0.767043858944015,0,2,chorionic trophoblast cell proliferation,BP,
17620,GO:1901382,1.00000000000132,0.767043858944015,0,2,regulation of chorionic trophoblast cell proliferation,BP,
6343,GO:0021526,1.00000000000132,0.924596042305019,0,1,medial motor column neuron differentiation,BP,
18034,GO:1902616,1.00000000000132,0.924596042305019,0,1,acyl carnitine transmembrane transport,BP,
4602,GO:0010722,1.00000000000133,0.832631302743546,0,1,regulation of ferrochelatase activity,BP,
8928,GO:0034986,1.00000000000133,0.832631302743546,0,1,iron chaperone activity,MF,
18725,GO:1904229,1.00000000000133,0.832631302743546,0,1,regulation of succinate dehydrogenase activity,BP,
18726,GO:1904231,1.00000000000133,0.832631302743546,0,1,positive regulation of succinate dehydrogenase activity,BP,
18727,GO:1904232,1.00000000000133,0.832631302743546,0,1,regulation of aconitate hydratase activity,BP,
18728,GO:1904234,1.00000000000133,0.832631302743546,0,1,positive regulation of aconitate hydratase activity,BP,
13061,GO:0051598,1.00000000000134,0.868276095580584,0,1,meiotic recombination checkpoint,BP,
13965,GO:0060708,1.00000000000134,0.752429566999692,0,3,spongiotrophoblast differentiation,BP,
7375,GO:0031438,1.00000000000135,0.902874258053218,0,1,negative regulation of mRNA cleavage,BP,
18930,GO:1904721,1.00000000000135,0.902874258053218,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
2337,GO:0005368,1.00000000000135,0.841135222571981,0,1,taurine transmembrane transporter activity,MF,
2338,GO:0005369,1.00000000000135,0.841135222571981,0,1,taurine:sodium symporter activity,MF,
5172,GO:0015734,1.00000000000135,0.841135222571981,0,1,taurine transport,BP,
14512,GO:0070053,1.00000000000135,0.782033848792438,0,2,thrombospondin receptor activity,MF,
17857,GO:1902162,1.00000000000135,0.876761239990369,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17858,GO:1902164,1.00000000000135,0.876761239990369,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
20010,GO:2000656,1.00000000000138,0.924455070551691,0,1,regulation of apolipoprotein binding,BP,
20011,GO:2000657,1.00000000000138,0.924455070551691,0,1,negative regulation of apolipoprotein binding,BP,
3091,GO:0006667,1.00000000000139,0.768872287499285,0,2,sphinganine metabolic process,BP,
11690,GO:0046511,1.00000000000139,0.768872287499285,0,2,sphinganine biosynthetic process,BP,
5443,GO:0016321,1.00000000000139,0.760332045448581,0,3,female meiosis chromosome segregation,BP,
7318,GO:0031339,1.0000000000014,0.681842592185169,0,3,negative regulation of vesicle fusion,BP,
2371,GO:0005502,1.0000000000014,0.866801695689935,0,1,11-cis retinal binding,MF,
2372,GO:0005503,1.0000000000014,0.866801695689935,0,1,all-trans retinal binding,MF,
14457,GO:0061896,1.0000000000014,0.866801695689935,0,1,all-trans retinol 3,4-desaturase activity,MF,
14458,GO:0061897,1.0000000000014,0.866801695689935,0,1,all-trans retinal 3,4-desaturase activity,MF,
14459,GO:0061898,1.0000000000014,0.866801695689935,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14460,GO:0061899,1.0000000000014,0.866801695689935,0,1,11-cis-retinal 3,4-desaturase activity,MF,
2273,GO:0005219,1.00000000000141,0.945072818428253,0,1,ryanodine-sensitive calcium-release channel activity,MF,
11964,GO:0047323,1.00000000000143,0.920235531783731,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13317,GO:0052381,1.00000000000143,0.920235531783731,0,1,tRNA dimethylallyltransferase activity,MF,
13957,GO:0060698,1.00000000000144,0.790773995144904,0,2,endoribonuclease inhibitor activity,MF,
13960,GO:0060701,1.00000000000144,0.790773995144904,0,2,negative regulation of ribonuclease activity,BP,
13961,GO:0060702,1.00000000000144,0.790773995144904,0,2,negative regulation of endoribonuclease activity,BP,
309,GO:0000821,1.00000000000145,0.811777714910455,0,1,regulation of arginine metabolic process,BP,
8349,GO:0033241,1.00000000000145,0.811777714910455,0,1,regulation of cellular amine catabolic process,BP,
8350,GO:0033242,1.00000000000145,0.811777714910455,0,1,negative regulation of cellular amine catabolic process,BP,
9604,GO:0036487,1.00000000000145,0.811777714910455,0,1,nitric-oxide synthase inhibitor activity,MF,
15475,GO:0071878,1.00000000000145,0.811777714910455,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16806,GO:0098736,1.00000000000145,0.811777714910455,0,1,negative regulation of the force of heart contraction,BP,
17290,GO:0140199,1.00000000000145,0.811777714910455,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17336,GO:1900081,1.00000000000145,0.811777714910455,0,1,regulation of arginine catabolic process,BP,
17337,GO:1900082,1.00000000000145,0.811777714910455,0,1,negative regulation of arginine catabolic process,BP,
18291,GO:1903248,1.00000000000145,0.811777714910455,0,1,regulation of citrulline biosynthetic process,BP,
18292,GO:1903249,1.00000000000145,0.811777714910455,0,1,negative regulation of citrulline biosynthetic process,BP,
19799,GO:2000283,1.00000000000145,0.811777714910455,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
16921,GO:0098939,1.00000000000145,0.840808100844598,0,1,dendritic transport of mitochondrion,BP,
16932,GO:0098972,1.00000000000145,0.840808100844598,0,1,anterograde dendritic transport of mitochondrion,BP,
16342,GO:0090677,1.00000000000146,0.838966786100754,0,2,reversible differentiation,BP,
16343,GO:0090678,1.00000000000146,0.838966786100754,0,2,cell dedifferentiation involved in phenotypic switching,BP,
19134,GO:1905174,1.00000000000146,0.838966786100754,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19646,GO:1990936,1.00000000000146,0.838966786100754,0,2,vascular smooth muscle cell dedifferentiation,BP,
2364,GO:0005483,1.00000000000147,0.724588370963095,0,3,soluble NSF attachment protein activity,MF,
10530,GO:0043504,1.00000000000148,0.695616385471775,0,3,mitochondrial DNA repair,BP,
13950,GO:0060689,1.00000000000148,0.683370826610673,0,3,cell differentiation involved in salivary gland development,BP,
16706,GO:0097752,1.00000000000149,0.747621519329726,0,3,regulation of DNA stability,BP,
7338,GO:0031389,1.00000000000151,0.906805772485333,0,1,Rad17 RFC-like complex,CC,
12785,GO:0051107,1.00000000000151,0.906805772485333,0,1,negative regulation of DNA ligation,BP,
12943,GO:0051352,1.00000000000151,0.906805772485333,0,1,negative regulation of ligase activity,BP,
19006,GO:1904876,1.00000000000151,0.906805772485333,0,1,negative regulation of DNA ligase activity,BP,
9011,GO:0035241,1.00000000000153,0.757462810074849,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
17419,GO:1900222,1.00000000000153,0.812712849578878,0,2,negative regulation of amyloid-beta clearance,BP,
8639,GO:0034203,1.00000000000153,0.860220111175634,0,1,glycolipid translocation,BP,
5326,GO:0016062,1.00000000000154,0.91316971975597,0,1,adaptation of rhodopsin mediated signaling,BP,
9552,GO:0036367,1.00000000000154,0.91316971975597,0,1,light adaption,BP,
2066,GO:0004821,1.00000000000157,0.843820652854206,0,2,histidine-tRNA ligase activity,MF,
2914,GO:0006427,1.00000000000157,0.843820652854206,0,2,histidyl-tRNA aminoacylation,BP,
2821,GO:0006288,1.0000000000016,0.772338363785048,0,3,base-excision repair, DNA ligation,BP,
344,GO:0000958,1.00000000000161,0.699188816795201,0,3,mitochondrial mRNA catabolic process,BP,
936,GO:0002339,1.00000000000162,0.872864213305745,0,2,B cell selection,BP,
940,GO:0002352,1.00000000000162,0.872864213305745,0,2,B cell negative selection,BP,
7174,GO:0031071,1.00000000000163,0.916287476660019,0,1,cysteine desulfurase activity,MF,
4828,GO:0014038,1.00000000000163,0.672312643719402,0,3,regulation of Schwann cell differentiation,BP,
13921,GO:0060631,1.00000000000163,0.726471118494587,0,3,regulation of meiosis I,BP,
19655,GO:1990983,1.00000000000164,0.912821668151731,0,1,tRNA demethylation,BP,
19656,GO:1990984,1.00000000000164,0.912821668151731,0,1,tRNA demethylase activity,MF,
7680,GO:0032143,1.00000000000165,0.786892625996789,0,2,single thymine insertion binding,MF,
7766,GO:0032301,1.00000000000165,0.786892625996789,0,2,MutSalpha complex,CC,
15114,GO:0071245,1.00000000000167,0.888865049000607,0,1,cellular response to carbon monoxide,BP,
18363,GO:1903406,1.00000000000167,0.888865049000607,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18364,GO:1903408,1.00000000000167,0.888865049000607,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
2632,GO:0005967,1.00000000000169,0.695766836274912,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
7987,GO:0032618,1.00000000000169,0.859644273616789,0,2,interleukin-15 production,BP,
19976,GO:2000609,1.00000000000171,0.737292891749824,0,3,regulation of thyroid hormone generation,BP,
17902,GO:1902255,1.00000000000172,0.860242926386482,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
3883,GO:0008520,1.00000000000173,0.835245225314558,0,1,L-ascorbate:sodium symporter activity,MF,
5041,GO:0015229,1.00000000000173,0.835245225314558,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5249,GO:0015882,1.00000000000173,0.835245225314558,0,1,L-ascorbic acid transmembrane transport,BP,
14952,GO:0070890,1.00000000000173,0.835245225314558,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14963,GO:0070904,1.00000000000173,0.835245225314558,0,1,transepithelial L-ascorbic acid transport,BP,
232,GO:0000481,1.00000000000173,0.889551861027748,0,1,maturation of 5S rRNA,BP,
11697,GO:0046523,1.00000000000173,0.902114568158881,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
10686,GO:0043997,1.00000000000173,0.901678196742911,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17186,GO:0106075,1.00000000000173,0.901678196742911,0,1,peptide N-succinyltransferase activity,MF,
17188,GO:0106078,1.00000000000173,0.901678196742911,0,1,histone succinyltransferase activity,MF,
18664,GO:1904044,1.00000000000174,0.770913645532108,0,3,response to aldosterone,BP,
5057,GO:0015275,1.00000000000175,0.792734859954345,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
17283,GO:0140135,1.00000000000175,0.792734859954345,0,2,mechanosensitive cation channel activity,MF,
12049,GO:0048021,1.00000000000175,0.621865818725005,0,3,regulation of melanin biosynthetic process,BP,
8371,GO:0033290,1.00000000000177,0.876632331335033,0,1,eukaryotic 48S preinitiation complex,CC,
10740,GO:0044207,1.00000000000177,0.876632331335033,0,1,translation initiation ternary complex,CC,
19499,GO:1990415,1.00000000000177,0.732003272738002,0,3,Pex17p-Pex14p docking complex,CC,
19507,GO:1990429,1.00000000000177,0.732003272738002,0,3,peroxisomal importomer complex,CC,
18488,GO:1903677,1.00000000000178,0.774586939508836,0,3,regulation of cap-independent translational initiation,BP,
18489,GO:1903679,1.00000000000178,0.774586939508836,0,3,positive regulation of cap-independent translational initiation,BP,
5815,GO:0017089,1.00000000000178,0.845800769997034,0,2,glycolipid transporter activity,MF,
1598,GO:0004019,1.00000000000178,0.909542436778714,0,1,adenylosuccinate synthase activity,MF,
1786,GO:0004416,1.0000000000018,0.841954540701996,0,2,hydroxyacylglutathione hydrolase activity,MF,
6081,GO:0019243,1.0000000000018,0.841954540701996,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
13059,GO:0051596,1.0000000000018,0.841954540701996,0,2,methylglyoxal catabolic process,BP,
14396,GO:0061727,1.0000000000018,0.841954540701996,0,2,methylglyoxal catabolic process to lactate,BP,
14723,GO:0070426,1.00000000000181,0.836834938602765,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14730,GO:0070434,1.00000000000181,0.836834938602765,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
9616,GO:0036501,1.00000000000182,0.872143946399471,0,1,UFD1-NPL4 complex,CC,
1755,GO:0004360,1.00000000000182,0.813953323339011,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
14787,GO:0070548,1.00000000000182,0.813953323339011,0,1,L-glutamine aminotransferase activity,MF,
2357,GO:0005459,1.00000000000183,0.871027493095172,0,2,UDP-galactose transmembrane transporter activity,MF,
15718,GO:0072334,1.00000000000183,0.871027493095172,0,2,UDP-galactose transmembrane transport,BP,
14025,GO:0060825,1.00000000000183,0.858218838936941,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19818,GO:2000313,1.00000000000183,0.858218838936941,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
2368,GO:0005497,1.00000000000183,0.875599959948457,0,2,androgen binding,MF,
1842,GO:0004500,1.00000000000184,0.903544196933802,0,1,dopamine beta-monooxygenase activity,MF,
3035,GO:0006589,1.00000000000184,0.903544196933802,0,1,octopamine biosynthetic process,BP,
11607,GO:0046333,1.00000000000184,0.903544196933802,0,1,octopamine metabolic process,BP,
14501,GO:0070032,1.00000000000185,0.846859455756049,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
14502,GO:0070033,1.00000000000185,0.846859455756049,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
19431,GO:1990131,1.00000000000185,0.797373975183277,0,3,Gtr1-Gtr2 GTPase complex,CC,
13350,GO:0052642,1.00000000000187,0.925637335378771,0,1,lysophosphatidic acid phosphatase activity,MF,
20285,GO:2001311,1.00000000000187,0.925637335378771,0,1,lysobisphosphatidic acid metabolic process,BP,
16481,GO:0097212,1.00000000000187,0.847572408723334,0,2,lysosomal membrane organization,BP,
3977,GO:0008817,1.00000000000187,0.877203657717375,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
17685,GO:1901622,1.00000000000188,0.912874099852552,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
11388,GO:0045819,1.00000000000188,0.881796669399721,0,1,positive regulation of glycogen catabolic process,BP,
3337,GO:0007056,1.00000000000188,0.844727537944832,0,2,spindle assembly involved in female meiosis,BP,
3338,GO:0007057,1.00000000000188,0.844727537944832,0,2,spindle assembly involved in female meiosis I,BP,
15752,GO:0072387,1.00000000000189,0.815126448924123,0,2,flavin adenine dinucleotide metabolic process,BP,
4871,GO:0014738,1.0000000000019,0.750387723218465,0,3,regulation of muscle hyperplasia,BP,
2884,GO:0006391,1.0000000000019,0.756557360544403,0,3,transcription initiation from mitochondrial promoter,BP,
17128,GO:0102522,1.00000000000192,0.918941726982089,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
15908,GO:0072739,1.00000000000193,0.838175745890778,0,2,response to anisomycin,BP,
14309,GO:0061534,1.00000000000193,0.77019886405158,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
9198,GO:0035602,1.00000000000193,0.878106201135615,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9199,GO:0035603,1.00000000000193,0.878106201135615,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9200,GO:0035604,1.00000000000193,0.878106201135615,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
13903,GO:0060595,1.00000000000193,0.878106201135615,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13916,GO:0060615,1.00000000000193,0.878106201135615,0,1,mammary gland bud formation,BP,
13926,GO:0060648,1.00000000000193,0.878106201135615,0,1,mammary gland bud morphogenesis,BP,
13932,GO:0060667,1.00000000000193,0.878106201135615,0,1,branch elongation involved in salivary gland morphogenesis,BP,
14061,GO:0060915,1.00000000000193,0.878106201135615,0,1,mesenchymal cell differentiation involved in lung development,BP,
439,GO:0001181,1.00000000000194,0.823538278235453,0,2,transcription factor activity, core RNA polymerase I binding,MF,
2061,GO:0004816,1.00000000000194,0.832831471746175,0,2,asparagine-tRNA ligase activity,MF,
17331,GO:1900062,1.00000000000195,0.8870409517502,0,1,regulation of replicative cell aging,BP,
14672,GO:0070326,1.00000000000195,0.777015358873353,0,3,very-low-density lipoprotein particle receptor binding,MF,
9314,GO:0035811,1.00000000000197,0.844749638438834,0,1,negative regulation of urine volume,BP,
18711,GO:1904205,1.00000000000197,0.844749638438834,0,1,negative regulation of skeletal muscle hypertrophy,BP,
1621,GO:0004057,1.00000000000197,0.918909887952805,0,1,arginyltransferase activity,MF,
8616,GO:0034150,1.00000000000198,0.849539485502093,0,1,toll-like receptor 6 signaling pathway,BP,
9075,GO:0035355,1.00000000000198,0.849539485502093,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
19444,GO:1990172,1.00000000000198,0.849539485502093,0,1,G-protein coupled receptor catabolic process,BP,
2680,GO:0006045,1.00000000000199,0.758871431158211,0,2,N-acetylglucosamine biosynthetic process,BP,
17517,GO:1901073,1.00000000000199,0.758871431158211,0,2,glucosamine-containing compound biosynthetic process,BP,
1732,GO:0004332,1.00000000000199,0.864747739850767,0,2,fructose-bisphosphate aldolase activity,MF,
10643,GO:0043849,1.00000000000205,0.906365828647854,0,1,Ras palmitoyltransferase activity,MF,
16677,GO:0097682,1.00000000000206,0.920653935947164,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
5200,GO:0015803,1.00000000000207,0.728583948909788,0,3,branched-chain amino acid transport,BP,
2421,GO:0005600,1.00000000000208,0.903198646101151,0,1,collagen type XIII trimer,CC,
7110,GO:0030936,1.00000000000208,0.903198646101151,0,1,transmembrane collagen trimer,CC,
19772,GO:2000233,1.00000000000209,0.769349062720459,0,2,negative regulation of rRNA processing,BP,
1581,GO:0003994,1.0000000000021,0.810476288607271,0,2,aconitate hydratase activity,MF,
846,GO:0002169,1.0000000000021,0.811048389628282,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1828,GO:0004485,1.0000000000021,0.811048389628282,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
12299,GO:0048674,1.0000000000021,0.915243417669269,0,1,collateral sprouting of injured axon,BP,
12307,GO:0048686,1.0000000000021,0.915243417669269,0,1,regulation of sprouting of injured axon,BP,
12308,GO:0048687,1.0000000000021,0.915243417669269,0,1,positive regulation of sprouting of injured axon,BP,
12309,GO:0048688,1.0000000000021,0.915243417669269,0,1,negative regulation of sprouting of injured axon,BP,
12310,GO:0048689,1.0000000000021,0.915243417669269,0,1,formation of growth cone in injured axon,BP,
12311,GO:0048693,1.0000000000021,0.915243417669269,0,1,regulation of collateral sprouting of injured axon,BP,
12312,GO:0048694,1.0000000000021,0.915243417669269,0,1,positive regulation of collateral sprouting of injured axon,BP,
19136,GO:1905202,1.0000000000021,0.811048389628282,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
19283,GO:1905578,1.0000000000021,0.915243417669269,0,1,regulation of ERBB3 signaling pathway,BP,
19284,GO:1905580,1.0000000000021,0.915243417669269,0,1,positive regulation of ERBB3 signaling pathway,BP,
19386,GO:1905942,1.0000000000021,0.915243417669269,0,1,regulation of formation of growth cone in injured axon,BP,
19387,GO:1905943,1.0000000000021,0.915243417669269,0,1,negative regulation of formation of growth cone in injured axon,BP,
18589,GO:1903899,1.00000000000212,0.698954288407314,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
7552,GO:0031905,1.00000000000213,0.757002144412583,0,3,early endosome lumen,CC,
5031,GO:0015211,1.00000000000213,0.914696956940198,0,1,purine nucleoside transmembrane transporter activity,MF,
7893,GO:0032472,1.00000000000213,0.823676329209497,0,2,Golgi calcium ion transport,BP,
3574,GO:0007621,1.00000000000213,0.828784226706907,0,1,negative regulation of female receptivity,BP,
16887,GO:0098885,1.00000000000214,0.831938610658508,0,1,modification of postsynaptic actin cytoskeleton,BP,
16987,GO:0099159,1.00000000000214,0.831938610658508,0,1,regulation of modification of postsynaptic structure,BP,
17382,GO:1900149,1.00000000000214,0.831938610658508,0,1,positive regulation of Schwann cell migration,BP,
18744,GO:1904266,1.00000000000214,0.831938610658508,0,1,regulation of Schwann cell chemotaxis,BP,
18745,GO:1904268,1.00000000000214,0.831938610658508,0,1,positive regulation of Schwann cell chemotaxis,BP,
19164,GO:1905274,1.00000000000214,0.831938610658508,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19585,GO:1990751,1.00000000000214,0.831938610658508,0,1,Schwann cell chemotaxis,BP,
16187,GO:0090258,1.00000000000216,0.775637331668319,0,2,negative regulation of mitochondrial fission,BP,
3054,GO:0006617,1.00000000000217,0.870164962806045,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
8430,GO:0033565,1.00000000000218,0.698642992307323,0,3,ESCRT-0 complex,CC,
16217,GO:0090299,1.00000000000219,0.928514154599955,0,1,regulation of neural crest formation,BP,
16218,GO:0090301,1.00000000000219,0.928514154599955,0,1,negative regulation of neural crest formation,BP,
19819,GO:2000314,1.00000000000219,0.928514154599955,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
1138,GO:0002731,1.0000000000022,0.809049450565657,0,2,negative regulation of dendritic cell cytokine production,BP,
14450,GO:0061880,1.00000000000221,0.927738841823222,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14451,GO:0061881,1.00000000000221,0.927738841823222,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
5994,GO:0019008,1.00000000000222,0.818532999452682,0,2,molybdopterin synthase complex,CC,
2086,GO:0004852,1.00000000000222,0.935199542745317,0,1,uroporphyrinogen-III synthase activity,MF,
15221,GO:0071418,1.00000000000222,0.935199542745317,0,1,cellular response to amine stimulus,BP,
15363,GO:0071642,1.00000000000222,0.813855665094209,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
19216,GO:1905395,1.00000000000224,0.827183520326119,0,2,response to flavonoid,BP,
5455,GO:0016340,1.00000000000225,0.708074464270702,0,2,calcium-dependent cell-matrix adhesion,BP,
8991,GO:0035166,1.00000000000225,0.703886064597309,0,3,post-embryonic hemopoiesis,BP,
4723,GO:0010890,1.00000000000226,0.771149362448917,0,3,positive regulation of sequestering of triglyceride,BP,
6958,GO:0030622,1.00000000000226,0.713316551830363,0,3,U4atac snRNA binding,MF,
18692,GO:1904155,1.00000000000227,0.896357465692008,0,1,DN2 thymocyte differentiation,BP,
18693,GO:1904156,1.00000000000227,0.896357465692008,0,1,DN3 thymocyte differentiation,BP,
3675,GO:0008176,1.00000000000227,0.868658157316198,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17160,GO:0106004,1.00000000000227,0.868658157316198,0,2,tRNA (guanine-N7)-methylation,BP,
11835,GO:0046848,1.0000000000023,0.934682553251231,0,1,hydroxyapatite binding,MF,
5300,GO:0016011,1.00000000000231,0.690801978163101,0,3,dystroglycan complex,CC,
6221,GO:0019777,1.00000000000232,0.859677490455022,0,2,Atg12 transferase activity,MF,
8196,GO:0032962,1.00000000000232,0.714038029764141,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
7212,GO:0031117,1.00000000000235,0.821153192389615,0,2,positive regulation of microtubule depolymerization,BP,
3095,GO:0006671,1.00000000000236,0.872105780112032,0,1,phytosphingosine metabolic process,BP,
14893,GO:0070774,1.00000000000236,0.872105780112032,0,1,phytoceramidase activity,MF,
15334,GO:0071602,1.00000000000236,0.872105780112032,0,1,phytosphingosine biosynthetic process,BP,
8783,GO:0034499,1.00000000000239,0.72236110199074,0,2,late endosome to Golgi transport,BP,
4661,GO:0010814,1.00000000000241,0.859835739923344,0,1,substance P catabolic process,BP,
4663,GO:0010816,1.00000000000241,0.859835739923344,0,1,calcitonin catabolic process,BP,
7292,GO:0031302,1.00000000000241,0.859835739923344,0,1,intrinsic component of endosome membrane,CC,
8916,GO:0034959,1.00000000000241,0.859835739923344,0,1,endothelin maturation,BP,
10682,GO:0043990,1.00000000000242,0.902384413680967,0,1,histone H2A-S1 phosphorylation,BP,
1914,GO:0004609,1.00000000000242,0.838431208631577,0,2,phosphatidylserine decarboxylase activity,MF,
3799,GO:0008381,1.00000000000242,0.718944755039395,0,3,mechanosensitive ion channel activity,MF,
1740,GO:0004342,1.00000000000243,0.847669614139648,0,2,glucosamine-6-phosphate deaminase activity,MF,
2678,GO:0006043,1.00000000000243,0.847669614139648,0,2,glucosamine catabolic process,BP,
388,GO:0001034,1.00000000000243,0.925792968718361,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
1535,GO:0003921,1.00000000000243,0.914879813041687,0,1,GMP synthase activity,MF,
1536,GO:0003922,1.00000000000243,0.914879813041687,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
3983,GO:0008852,1.00000000000245,0.908164560605417,0,1,exodeoxyribonuclease I activity,MF,
5920,GO:0018201,1.00000000000245,0.674746127593044,0,3,peptidyl-glycine modification,BP,
306,GO:0000818,1.00000000000246,0.839628587345589,0,2,nuclear MIS12/MIND complex,CC,
19243,GO:1905457,1.00000000000246,0.704103887247552,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20137,GO:2000974,1.00000000000246,0.704103887247552,0,3,negative regulation of pro-B cell differentiation,BP,
19060,GO:1904980,1.00000000000247,0.833582344478548,0,1,positive regulation of endosome organization,BP,
517,GO:0001588,1.00000000000247,0.879567182225544,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2138,GO:0004952,1.00000000000247,0.879567182225544,0,2,dopamine neurotransmitter receptor activity,MF,
5988,GO:0018993,1.00000000000248,0.906505889249037,0,1,somatic sex determination,BP,
6028,GO:0019101,1.00000000000248,0.906505889249037,0,1,female somatic sex determination,BP,
13524,GO:0060014,1.00000000000248,0.906505889249037,0,1,granulosa cell differentiation,BP,
6443,GO:0021768,1.00000000000249,0.89241254084041,0,1,nucleus accumbens development,BP,
18240,GO:1903126,1.0000000000025,0.920219478899554,0,1,negative regulation of centriole-centriole cohesion,BP,
20206,GO:2001173,1.0000000000025,0.920219478899554,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
9327,GO:0035851,1.0000000000025,0.905216106860946,0,1,Krueppel-associated box domain binding,MF,
6007,GO:0019061,1.0000000000025,0.917954801807721,0,1,uncoating of virus,BP,
11428,GO:0045903,1.00000000000251,0.823773860609103,0,3,positive regulation of translational fidelity,BP,
11099,GO:0045145,1.00000000000252,0.81610536023696,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14665,GO:0070315,1.00000000000252,0.809317305629997,0,2,G1 to G0 transition involved in cell differentiation,BP,
6332,GO:0021512,1.00000000000252,0.87477641893363,0,1,spinal cord anterior/posterior patterning,BP,
16378,GO:0097036,1.00000000000254,0.933344368436752,0,1,regulation of plasma membrane sterol distribution,BP,
8853,GO:0034670,1.00000000000254,0.800596685742857,0,1,chemotaxis to arachidonic acid,BP,
3090,GO:0006666,1.00000000000254,0.85878456031408,0,1,3-keto-sphinganine metabolic process,BP,
11992,GO:0047560,1.00000000000254,0.85878456031408,0,1,3-dehydrosphinganine reductase activity,MF,
15354,GO:0071633,1.00000000000256,0.907752538978688,0,1,dihydroceramidase activity,MF,
14958,GO:0070899,1.00000000000257,0.904454972756867,0,1,mitochondrial tRNA wobble uridine modification,BP,
807,GO:0002081,1.00000000000257,0.820779357657897,0,1,outer acrosomal membrane,CC,
2432,GO:0005634,1.00000000000257,0,485,5702,nucleus,CC,PHACTR3;ITGB6;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;GPRC5A;TXNIP;SOX6;MARVELD1;GADD45B;CDKN2B;ZFP36L1;APBB2;SYNE1;TNNI2;XPC;TENM4;ASAP3;GSN;ETV5;DUSP6;TSC22D1;ZFP36L2;IGF2BP2;TNIK;SKP2;ZNF362;NOS1;DNAJB4;PDGFC;SNAI2;MAGED1;PHF21A;UTRN;TCEAL4;EGFR;TSC22D3;KLF8;PEG10;HSPA2;SPEG;SLC8A1;FKBP5;CLCA2;SESN3;SYNE3;RFX2;DOK1;ATP10D;RNF213;KRT14;TCF7L1;STON2;RNF165;NUPR1;DDB2;TKFC;AMIGO2;ADD3;ZNF862;TADA3;PDLIM2;PAK1;NSG1;CBX5;VDR;APOBEC3C;PADI3;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;XAF1;TRIM5;PDCD4;NR3C1;STAT1;SORL1;NEO1;LGALS1;ETV1;TP53;ARAP1;KRT13;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;KRT5;SEC14L2;ITGA2;ZCCHC11;MAP2;PPL;ADARB1;FLG;HIP1;TFDP2;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;BTG1;FILIP1L;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GLI3;PTGES;CDK14;E2F7;NAV2;SYN1;CTDSPL;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;LRP1;FYN;TSHZ2;ARHGAP18;ADIRF;FUT10;CPS1;FAT2;POLR3GL;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;TRIB2;SLC2A4RG;GLDC;MAP3K14;SMARCA1;ZNF318;TNRC18;DCAF16;AHNAK2;CLU;TCEAL3;NPHP4;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;EHD3;HMGA2;CAMK2D;PHC2;PRDX5;ZSCAN18;PTPN14;PER1;PIK3R1;NCAPD2;CAPRIN2;CREB3L2;ACACB;APOBEC3G;ANG;DUSP5;LAMA5;UHRF2;CNTLN;CDK18;MDFI;SPRY2;TTN;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;MLH3;ZKSCAN1;TP73;CASP14;DLC1;KLF13;PRKACB;CHEK2;R3HDM2;PRX;PHF2;ZNF860;SNCA;ALDH1L2;GATAD1;AIP;JADE2;SP110;FGFR1;APOBEC3F;LMNA;ALOX15B;IFI35;PRKAB2;SEMA4A;RGS2;SETX;PDE4D;APBB3;NCOA2;PSMB9;OBSCN;BRD3;PDK3;G6PD;MYOF;TLE4;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;KDM4C;CHD6;NFATC4;FOXN3;RAPH1;AKAP7;LMCD1;DLX3;AMOTL1;L3MBTL3;PBXIP1;PBX1;FOXL1;BBS4;ZNF699;CALR;ATM;MDM2;CST3;MEIS2;C17ORF49;AREG;ZNF107;TCF4;AKAP13;SNX10;DGKQ;CITED2;NR2F2;ACSS2;CBX7;ZNF449;ZMAT3;MSH5;MAF;TRAK1;ZBTB22;SYNE2;HDAC11;RCBTB1;PTMS;NEMP2;ZNF546;EGR1;SOX9;ISL1;ITPKB;BCL6;CRTC1;NCOR1;NDRG1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;MPP7;BAHCC1;METTL23;CEP68;TSHZ1;MVB12B;TES;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;CHD9;MEGF8;ZNF302;UACA;ATXN1;IRF2BPL;STK36;MAML2;WDR19;SLC39A11;MUTYH;TAF8;PRNP;CARF;ZFPM1;RBL2;MAP2K5;ODF2;DLX2;ZNF550;DNASE1L1;STAT2;IFT122;LIG1;ZNF701;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;USP28;ALDH7A1;CDKN2A;PPM1M;SPPL2B;SP100;ZSCAN30;TEF;TSPYL2;NPEPL1;ORC4;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;MAGI1;BOC;CENPA;FLYWCH1;TGFB1I1;RSAD2;SRPK2;UVRAG;TCTEX1D4;CCHCR1;ITPR2;MDFIC;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;YAP1;NUB1;KLF5;TWIST2;ATRAID;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PITPNC1;PPARG;CAPG;PARP15;BEX4;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;ICK;TGIF1;ING4;PRR7;LGALS3;ARL3;DEF6;FKBP10;RARA;CCNY;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;MPPE1;ZNF883;HCFC1R1;ZBTB1;NAT14;PPP3CA;DCAF8;PIK3C2B;PDZD2;CREBRF;CTDSP2;KRT10;ETV4;HP1BP3;HOXA2;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM169A;FAM120B;KLHDC2;MED12;NPAS2;FBXL4;NIPBL;VPS36;TTBK2;BSN;ADAM10;PRDM5;CELSR1;ZNF471;LITAF;ATG16L2;S100A11;MYO1C;RXRA;CPT2;DGCR6;TMEM92;TAOK3;NFKBIE;ZNF484;DOCK1;FAM114A1;DMPK
4968,GO:0015086,1.00000000000258,0.876506298725962,0,1,cadmium ion transmembrane transporter activity,MF,
4969,GO:0015087,1.00000000000258,0.876506298725962,0,1,cobalt ion transmembrane transporter activity,MF,
4972,GO:0015094,1.00000000000258,0.876506298725962,0,1,lead ion transmembrane transporter activity,MF,
5149,GO:0015692,1.00000000000258,0.876506298725962,0,1,lead ion transport,BP,
14829,GO:0070627,1.00000000000258,0.876506298725962,0,1,ferrous iron import,BP,
14910,GO:0070826,1.00000000000258,0.876506298725962,0,1,paraferritin complex,CC,
20178,GO:2001070,1.00000000000258,0.782413675915671,0,2,starch binding,MF,
18567,GO:1903850,1.00000000000259,0.911464605064162,0,1,regulation of cristae formation,BP,
18568,GO:1903852,1.00000000000259,0.911464605064162,0,1,positive regulation of cristae formation,BP,
18850,GO:1904542,1.00000000000259,0.911464605064162,0,1,regulation of free ubiquitin chain polymerization,BP,
18851,GO:1904544,1.00000000000259,0.911464605064162,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19011,GO:1904881,1.00000000000259,0.911464605064162,0,1,cellular response to hydrogen sulfide,BP,
16252,GO:0090360,1.0000000000026,0.738049507589386,0,3,platelet-derived growth factor production,BP,
16253,GO:0090361,1.0000000000026,0.738049507589386,0,3,regulation of platelet-derived growth factor production,BP,
6306,GO:0019957,1.0000000000026,0.830885175671022,0,2,C-C chemokine binding,MF,
19509,GO:1990439,1.00000000000263,0.905734719822599,0,1,MAP kinase serine/threonine phosphatase activity,MF,
3084,GO:0006660,1.00000000000263,0.926208955846751,0,1,phosphatidylserine catabolic process,BP,
11198,GO:0045352,1.00000000000263,0.926208955846751,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11199,GO:0045353,1.00000000000263,0.926208955846751,0,1,interleukin-1 Type II receptor antagonist activity,MF,
9213,GO:0035617,1.00000000000264,0.713105849683614,0,3,stress granule disassembly,BP,
16962,GO:0099074,1.00000000000265,0.818087219552875,0,2,mitochondrion to lysosome transport,BP,
16963,GO:0099075,1.00000000000265,0.818087219552875,0,2,mitochondrion-derived vesicle mediated transport,BP,
8603,GO:0034136,1.00000000000267,0.668498228772418,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
8272,GO:0033091,1.00000000000267,0.912751633424108,0,1,positive regulation of immature T cell proliferation,BP,
1738,GO:0004339,1.00000000000269,0.840952004500235,0,1,glucan 1,4-alpha-glucosidase activity,MF,
2643,GO:0005982,1.00000000000269,0.840952004500235,0,1,starch metabolic process,BP,
2644,GO:0005983,1.00000000000269,0.840952004500235,0,1,starch catabolic process,BP,
10763,GO:0044245,1.00000000000269,0.840952004500235,0,1,polysaccharide digestion,BP,
1834,GO:0004491,1.00000000000269,0.91938782021441,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4732,GO:0010904,1.00000000000269,0.91938782021441,0,1,regulation of UDP-glucose catabolic process,BP,
4733,GO:0010905,1.00000000000269,0.91938782021441,0,1,negative regulation of UDP-glucose catabolic process,BP,
5971,GO:0018478,1.00000000000269,0.91938782021441,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18723,GO:1904226,1.00000000000269,0.91938782021441,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18724,GO:1904227,1.00000000000269,0.91938782021441,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
14289,GO:0061474,1.0000000000027,0.913548671058759,0,1,phagolysosome membrane,CC,
13179,GO:0051835,1.0000000000027,0.713871046006829,0,3,positive regulation of synapse structural plasticity,BP,
3995,GO:0008903,1.00000000000271,0.941387377768245,0,1,hydroxypyruvate isomerase activity,MF,
99,GO:0000210,1.00000000000271,0.892714152393944,0,1,NAD+ diphosphatase activity,MF,
3144,GO:0006742,1.00000000000271,0.892714152393944,0,1,NADP catabolic process,BP,
6112,GO:0019364,1.00000000000271,0.892714152393944,0,1,pyridine nucleotide catabolic process,BP,
6194,GO:0019677,1.00000000000271,0.892714152393944,0,1,NAD catabolic process,BP,
17813,GO:1902010,1.00000000000271,0.892714152393944,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
13166,GO:0051800,1.00000000000271,0.853919069477438,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20098,GO:2000808,1.00000000000271,0.853919069477438,0,1,negative regulation of synaptic vesicle clustering,BP,
7679,GO:0032142,1.00000000000272,0.682735525260829,0,3,single guanine insertion binding,MF,
7734,GO:0032258,1.00000000000272,0.834325199067851,0,2,protein localization by the Cvt pathway,BP,
13428,GO:0052906,1.00000000000273,0.857680076026133,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14892,GO:0070773,1.00000000000273,0.935412502127646,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15297,GO:0071544,1.00000000000273,0.935412502127646,0,1,diphosphoinositol polyphosphate catabolic process,BP,
1339,GO:0003199,1.00000000000275,0.931287146722915,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4820,GO:0014028,1.00000000000275,0.931287146722915,0,1,notochord formation,BP,
9462,GO:0036114,1.00000000000275,0.931287146722915,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9463,GO:0036115,1.00000000000275,0.931287146722915,0,1,fatty-acyl-CoA catabolic process,BP,
9464,GO:0036116,1.00000000000275,0.931287146722915,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
17473,GO:1900533,1.00000000000275,0.931287146722915,0,1,palmitic acid metabolic process,BP,
17474,GO:1900535,1.00000000000275,0.931287146722915,0,1,palmitic acid biosynthetic process,BP,
13007,GO:0051490,1.00000000000276,0.764639742131554,0,3,negative regulation of filopodium assembly,BP,
12672,GO:0050917,1.00000000000276,0.738657712943364,0,2,sensory perception of umami taste,BP,
14335,GO:0061582,1.00000000000277,0.740663592347246,0,2,intestinal epithelial cell migration,BP,
837,GO:0002144,1.00000000000277,0.920686210072613,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
1773,GO:0004382,1.00000000000278,0.822816014757241,0,2,guanosine-diphosphatase activity,MF,
10704,GO:0044062,1.00000000000279,0.779648785020037,0,3,regulation of excretion,BP,
13387,GO:0052810,1.00000000000281,0.886548263366982,0,1,1-phosphatidylinositol-5-kinase activity,MF,
5137,GO:0015669,1.00000000000282,0.78560765398031,0,3,gas transport,BP,
13058,GO:0051595,1.00000000000283,0.741263977898921,0,3,response to methylglyoxal,BP,
13145,GO:0051771,1.00000000000283,0.792317849590381,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
9210,GO:0035614,1.00000000000283,0.789108277447561,0,3,snRNA stem-loop binding,MF,
19558,GO:1990641,1.00000000000283,0.803845021070305,0,2,response to iron ion starvation,BP,
1770,GO:0004377,1.00000000000284,0.913702577492046,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
5492,GO:0016436,1.00000000000284,0.804876230949048,0,2,rRNA (uridine) methyltransferase activity,MF,
11131,GO:0045204,1.00000000000286,0.666375815979246,0,3,MAPK export from nucleus,BP,
16196,GO:0090271,1.00000000000286,0.702822724362112,0,2,positive regulation of fibroblast growth factor production,BP,
9143,GO:0035514,1.00000000000287,0.769075538539974,0,3,DNA demethylase activity,MF,
5090,GO:0015369,1.00000000000287,0.855026292610776,0,1,calcium:proton antiporter activity,MF,
12805,GO:0051139,1.00000000000287,0.855026292610776,0,1,metal ion:proton antiporter activity,MF,
2745,GO:0006147,1.00000000000289,0.855453368400657,0,1,guanine catabolic process,BP,
3990,GO:0008892,1.00000000000289,0.855453368400657,0,1,guanine deaminase activity,MF,
3193,GO:0006824,1.00000000000289,0.806620314375733,0,2,cobalt ion transport,BP,
10077,GO:0042602,1.0000000000029,0.948235080231221,0,1,riboflavin reductase (NADPH) activity,MF,
7493,GO:0031682,1.0000000000029,0.90369327300226,0,1,G-protein gamma-subunit binding,MF,
18089,GO:1902773,1.0000000000029,0.90369327300226,0,1,GTPase activator complex,CC,
9175,GO:0035574,1.0000000000029,0.768077607255267,0,2,histone H4-K20 demethylation,BP,
9176,GO:0035575,1.0000000000029,0.768077607255267,0,2,histone demethylase activity (H4-K20 specific),MF,
12467,GO:0050501,1.00000000000291,0.754830490205335,0,3,hyaluronan synthase activity,MF,
7111,GO:0030942,1.00000000000292,0.789758715874655,0,3,endoplasmic reticulum signal peptide binding,MF,
117,GO:0000246,1.00000000000292,0.874114008310712,0,1,delta24(24-1) sterol reductase activity,MF,
12481,GO:0050614,1.00000000000292,0.874114008310712,0,1,delta24-sterol reductase activity,MF,
6135,GO:0019408,1.00000000000294,0.788310531531963,0,2,dolichol biosynthetic process,BP,
301,GO:0000811,1.00000000000295,0.745550900943656,0,3,GINS complex,CC,
8536,GO:0033906,1.00000000000296,0.848595578437429,0,2,hyaluronoglucuronidase activity,MF,
2692,GO:0006060,1.00000000000298,0.853624178839214,0,2,sorbitol metabolic process,BP,
11624,GO:0046370,1.00000000000298,0.853624178839214,0,2,fructose biosynthetic process,BP,
764,GO:0002017,1.00000000000299,0.92443749165048,0,1,regulation of blood volume by renal aldosterone,BP,
6931,GO:0030549,1.000000000003,0.940340935918422,0,1,acetylcholine receptor activator activity,MF,
1362,GO:0003247,1.000000000003,0.929021114812771,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1555,GO:0003956,1.000000000003,0.929021114812771,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2481,GO:0005724,1.000000000003,0.929021114812771,0,1,nuclear telomeric heterochromatin,CC,
7408,GO:0031509,1.000000000003,0.929021114812771,0,1,telomeric heterochromatin assembly,BP,
7566,GO:0031940,1.000000000003,0.929021114812771,0,1,positive regulation of chromatin silencing at telomere,BP,
18073,GO:1902732,1.000000000003,0.929021114812771,0,1,positive regulation of chondrocyte proliferation,BP,
19268,GO:1905547,1.000000000003,0.929021114812771,0,1,regulation of telomeric heterochromatin assembly,BP,
19269,GO:1905549,1.000000000003,0.929021114812771,0,1,positive regulation of telomeric heterochromatin assembly,BP,
328,GO:0000917,1.000000000003,0.924986927329481,0,1,division septum assembly,BP,
16295,GO:0090529,1.000000000003,0.924986927329481,0,1,cell septum assembly,BP,
11559,GO:0046136,1.00000000000301,0.865273174296693,0,2,positive regulation of vitamin metabolic process,BP,
13877,GO:0060557,1.00000000000301,0.865273174296693,0,2,positive regulation of vitamin D biosynthetic process,BP,
13879,GO:0060559,1.00000000000301,0.865273174296693,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
15685,GO:0072272,1.00000000000302,0.842711179404391,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
10659,GO:0043932,1.00000000000302,0.827438897563454,0,2,ossification involved in bone remodeling,BP,
17937,GO:1902338,1.00000000000303,0.694402463163617,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18940,GO:1904746,1.00000000000303,0.694402463163617,0,3,negative regulation of apoptotic process involved in development,BP,
1226,GO:0002904,1.00000000000304,0.741290647494749,0,3,positive regulation of B cell apoptotic process,BP,
3133,GO:0006726,1.00000000000305,0.864501376343082,0,1,eye pigment biosynthetic process,BP,
5367,GO:0016182,1.00000000000305,0.864501376343082,0,1,synaptic vesicle budding from endosome,BP,
9995,GO:0042441,1.00000000000305,0.864501376343082,0,1,eye pigment metabolic process,BP,
10443,GO:0043324,1.00000000000305,0.864501376343082,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10512,GO:0043474,1.00000000000305,0.864501376343082,0,1,pigment metabolic process involved in pigmentation,BP,
16858,GO:0098830,1.00000000000305,0.864501376343082,0,1,presynaptic endosome,CC,
370,GO:0000992,1.00000000000305,0.762512812213979,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
374,GO:0001002,1.00000000000305,0.762512812213979,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,1.00000000000305,0.762512812213979,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
11900,GO:0046967,1.00000000000306,0.79653673151966,0,2,cytosol to ER transport,BP,
8613,GO:0034146,1.00000000000306,0.871367873047223,0,1,toll-like receptor 5 signaling pathway,BP,
8614,GO:0034147,1.00000000000306,0.871367873047223,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8615,GO:0034148,1.00000000000306,0.871367873047223,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
14722,GO:0070425,1.00000000000306,0.871367873047223,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14725,GO:0070428,1.00000000000306,0.871367873047223,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14726,GO:0070429,1.00000000000306,0.871367873047223,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14729,GO:0070433,1.00000000000306,0.871367873047223,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15825,GO:0072573,1.00000000000306,0.871367873047223,0,1,tolerance induction to lipopolysaccharide,BP,
19847,GO:2000349,1.00000000000306,0.871367873047223,0,1,negative regulation of CD40 signaling pathway,BP,
19007,GO:1904877,1.00000000000306,0.920524973148432,0,1,positive regulation of DNA ligase activity,BP,
9794,GO:0042007,1.00000000000307,0.933778732113657,0,1,interleukin-18 binding,MF,
11529,GO:0046086,1.00000000000307,0.809938407690908,0,2,adenosine biosynthetic process,BP,
10803,GO:0044316,1.00000000000307,0.886942272225811,0,1,cone cell pedicle,CC,
5579,GO:0016603,1.00000000000308,0.853229653468416,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5867,GO:0017186,1.00000000000308,0.853229653468416,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
17447,GO:1900365,1.00000000000309,0.681554674656962,0,3,positive regulation of mRNA polyadenylation,BP,
5303,GO:0016015,1.00000000000309,0.749886083940765,0,3,morphogen activity,MF,
16982,GO:0099130,1.0000000000031,0.918766636446231,0,1,estrogen binding,MF,
18605,GO:1903924,1.0000000000031,0.918766636446231,0,1,estradiol binding,MF,
18743,GO:1904265,1.00000000000312,0.844419833137461,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
19358,GO:1905878,1.00000000000313,0.800233906458887,0,1,invadopodium disassembly,BP,
19378,GO:1905927,1.00000000000313,0.800233906458887,0,1,regulation of invadopodium disassembly,BP,
19379,GO:1905929,1.00000000000313,0.800233906458887,0,1,positive regulation of invadopodium disassembly,BP,
20088,GO:2000790,1.00000000000314,0.724833476134182,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20089,GO:2000791,1.00000000000314,0.724833476134182,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
7461,GO:0031630,1.00000000000315,0.882158506341717,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
17168,GO:0106022,1.00000000000315,0.882158506341717,0,1,positive regulation of vesicle docking,BP,
14267,GO:0061408,1.00000000000315,0.838101162061442,0,2,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
18032,GO:1902612,1.00000000000316,0.909871795685107,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18033,GO:1902613,1.00000000000316,0.909871795685107,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19466,GO:1990262,1.00000000000316,0.909871795685107,0,1,anti-Mullerian hormone signaling pathway,BP,
14649,GO:0070291,1.00000000000316,0.720451854702311,0,3,N-acylethanolamine metabolic process,BP,
2597,GO:0005898,1.00000000000316,0.880031021235141,0,1,interleukin-13 receptor complex,CC,
1754,GO:0004359,1.00000000000317,0.728553562334866,0,3,glutaminase activity,MF,
1713,GO:0004307,1.00000000000319,0.865404195932094,0,2,ethanolaminephosphotransferase activity,MF,
7546,GO:0031893,1.0000000000032,0.919108926108533,0,1,vasopressin receptor binding,MF,
7547,GO:0031896,1.0000000000032,0.919108926108533,0,1,V2 vasopressin receptor binding,MF,
1311,GO:0003160,1.00000000000321,0.687482645330917,0,3,endocardium morphogenesis,BP,
12730,GO:0051025,1.00000000000321,0.82319397180884,0,2,negative regulation of immunoglobulin secretion,BP,
14834,GO:0070634,1.00000000000321,0.71419536183192,0,3,transepithelial ammonium transport,BP,
5267,GO:0015920,1.00000000000322,0.9110605168789,0,1,lipopolysaccharide transport,BP,
7911,GO:0032497,1.00000000000322,0.9110605168789,0,1,detection of lipopolysaccharide,BP,
14763,GO:0070506,1.00000000000322,0.9110605168789,0,1,high-density lipoprotein particle receptor activity,MF,
9497,GO:0036194,1.00000000000323,0.806901165045467,0,3,muscle cell projection,CC,
9498,GO:0036195,1.00000000000323,0.806901165045467,0,3,muscle cell projection membrane,CC,
14454,GO:0061888,1.00000000000324,0.716645885714769,0,3,regulation of astrocyte activation,BP,
669,GO:0001880,1.00000000000324,0.742252233022907,0,2,Mullerian duct regression,BP,
1805,GO:0004454,1.00000000000325,0.915653484314348,0,1,ketohexokinase activity,MF,
5978,GO:0018872,1.00000000000325,0.914796787172043,0,1,arsonoacetate metabolic process,BP,
7013,GO:0030791,1.00000000000325,0.914796787172043,0,1,arsenite methyltransferase activity,MF,
7014,GO:0030792,1.00000000000325,0.914796787172043,0,1,methylarsonite methyltransferase activity,MF,
1064,GO:0002606,1.00000000000326,0.708881316588093,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
8685,GO:0034338,1.00000000000326,0.67788963826191,0,3,short-chain carboxylesterase activity,MF,
13984,GO:0060734,1.00000000000327,0.867313605525142,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
16205,GO:0090284,1.00000000000329,0.831631102009065,0,1,positive regulation of protein glycosylation in Golgi,BP,
14179,GO:0061140,1.00000000000329,0.720363161442368,0,3,lung secretory cell differentiation,BP,
6310,GO:0019961,1.0000000000033,0.756175287602215,0,2,interferon binding,MF,
16701,GO:0097742,1.0000000000033,0.651945049939574,0,3,de novo centriole assembly,BP,
16726,GO:0098535,1.0000000000033,0.651945049939574,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
1265,GO:0003032,1.00000000000331,0.826650724692019,0,2,detection of oxygen,BP,
4766,GO:0010956,1.00000000000331,0.802904190943943,0,2,negative regulation of calcidiol 1-monooxygenase activity,BP,
12602,GO:0050816,1.00000000000331,0.705373640708529,0,3,phosphothreonine residue binding,MF,
5482,GO:0016422,1.00000000000333,0.770646812610041,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
8158,GO:0032907,1.00000000000337,0.625056302562688,0,3,transforming growth factor beta3 production,BP,
8161,GO:0032910,1.00000000000337,0.625056302562688,0,3,regulation of transforming growth factor beta3 production,BP,
8974,GO:0035101,1.00000000000338,0.712711180782719,0,3,FACT complex,CC,
16495,GO:0097238,1.00000000000339,0.883791821036226,0,2,cellular response to methylglyoxal,BP,
769,GO:0002025,1.00000000000339,0.921776676877946,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2132,GO:0004939,1.00000000000339,0.921776676877946,0,1,beta-adrenergic receptor activity,MF,
2133,GO:0004941,1.00000000000339,0.921776676877946,0,1,beta2-adrenergic receptor activity,MF,
12951,GO:0051380,1.00000000000339,0.921776676877946,0,1,norepinephrine binding,MF,
14452,GO:0061884,1.00000000000339,0.921776676877946,0,1,regulation of mini excitatory postsynaptic potential,BP,
14453,GO:0061885,1.00000000000339,0.921776676877946,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16851,GO:0098816,1.00000000000339,0.921776676877946,0,1,mini excitatory postsynaptic potential,BP,
11723,GO:0046587,1.00000000000339,0.90434200745777,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18858,GO:1904567,1.00000000000339,0.90434200745777,0,1,response to wortmannin,BP,
18859,GO:1904568,1.00000000000339,0.90434200745777,0,1,cellular response to wortmannin,BP,
19559,GO:1990646,1.00000000000339,0.90434200745777,0,1,cellular response to prolactin,BP,
17387,GO:1900154,1.00000000000339,0.877395633416477,0,1,regulation of bone trabecula formation,BP,
17388,GO:1900155,1.00000000000339,0.877395633416477,0,1,negative regulation of bone trabecula formation,BP,
17389,GO:1900157,1.00000000000339,0.877395633416477,0,1,regulation of bone mineralization involved in bone maturation,BP,
17390,GO:1900158,1.00000000000339,0.877395633416477,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
3945,GO:0008650,1.00000000000339,0.890603964515974,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
19580,GO:1990742,1.0000000000034,0.831122852450321,0,2,microvesicle,CC,
16237,GO:0090325,1.0000000000034,0.786877602455231,0,2,regulation of locomotion involved in locomotory behavior,BP,
5586,GO:0016618,1.00000000000341,0.768099737665191,0,3,hydroxypyruvate reductase activity,MF,
6804,GO:0030267,1.00000000000341,0.768099737665191,0,3,glyoxylate reductase (NADP) activity,MF,
13138,GO:0051754,1.00000000000343,0.724138290527695,0,3,meiotic sister chromatid cohesion, centromeric,BP,
1363,GO:0003249,1.00000000000343,0.628761841525217,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1364,GO:0003250,1.00000000000343,0.628761841525217,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
20090,GO:2000793,1.00000000000343,0.628761841525217,0,2,cell proliferation involved in heart valve development,BP,
4938,GO:0014908,1.00000000000344,0.844195705536026,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
14755,GO:0070488,1.00000000000345,0.919583111127016,0,2,neutrophil aggregation,BP,
19076,GO:1905031,1.00000000000349,0.61866285285526,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
17737,GO:1901740,1.00000000000349,0.923059267903108,0,1,negative regulation of myoblast fusion,BP,
18613,GO:1903943,1.00000000000349,0.923059267903108,0,1,regulation of hepatocyte apoptotic process,BP,
18614,GO:1903944,1.00000000000349,0.923059267903108,0,1,negative regulation of hepatocyte apoptotic process,BP,
19574,GO:1990729,1.00000000000349,0.923059267903108,0,1,primary miRNA modification,BP,
19582,GO:1990744,1.00000000000349,0.923059267903108,0,1,primary miRNA methylation,BP,
9218,GO:0035624,1.00000000000349,0.732238609369329,0,2,receptor transactivation,BP,
16640,GO:0097574,1.00000000000349,0.751948130151399,0,2,lateral part of cell,CC,
16641,GO:0097575,1.00000000000349,0.751948130151399,0,2,lateral cell cortex,CC,
9045,GO:0035290,1.0000000000035,0.69508739913285,0,3,trunk segmentation,BP,
9602,GO:0036484,1.0000000000035,0.69508739913285,0,3,trunk neural crest cell migration,BP,
9603,GO:0036486,1.0000000000035,0.69508739913285,0,3,ventral trunk neural crest cell migration,BP,
17544,GO:1901166,1.0000000000035,0.69508739913285,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
5345,GO:0016103,1.00000000000351,0.869583065553548,0,1,diterpenoid catabolic process,BP,
5347,GO:0016115,1.00000000000351,0.869583065553548,0,1,terpenoid catabolic process,BP,
8841,GO:0034653,1.00000000000351,0.869583065553548,0,1,retinoic acid catabolic process,BP,
16422,GO:0097114,1.00000000000352,0.782404646864757,0,2,NMDA glutamate receptor clustering,BP,
6102,GO:0019344,1.00000000000353,0.775211036876318,0,3,cysteine biosynthetic process,BP,
18790,GO:1904383,1.00000000000353,0.919818962316083,0,1,response to sodium phosphate,BP,
18871,GO:1904585,1.00000000000353,0.919818962316083,0,1,response to putrescine,BP,
18872,GO:1904586,1.00000000000353,0.919818962316083,0,1,cellular response to putrescine,BP,
19612,GO:1990828,1.00000000000353,0.919818962316083,0,1,hepatocyte dedifferentiation,BP,
8526,GO:0033867,1.00000000000354,0.928878388882834,0,1,Fas-activated serine/threonine kinase activity,MF,
18064,GO:1902714,1.00000000000354,0.82574021133551,0,2,negative regulation of interferon-gamma secretion,BP,
11517,GO:0046069,1.00000000000355,0.733012268536757,0,2,cGMP catabolic process,BP,
13781,GO:0060399,1.00000000000356,0.726628674775137,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
1945,GO:0004651,1.00000000000357,0.80871539147389,0,2,polynucleotide 5'-phosphatase activity,MF,
16716,GO:0098507,1.00000000000357,0.80871539147389,0,2,polynucleotide 5' dephosphorylation,BP,
14349,GO:0061618,1.00000000000357,0.780708945757633,0,1,sublamina densa,CC,
7993,GO:0032632,1.00000000000357,0.789944254905525,0,2,interleukin-3 production,BP,
8017,GO:0032672,1.00000000000357,0.789944254905525,0,2,regulation of interleukin-3 production,BP,
4121,GO:0009184,1.00000000000357,0.931537621370623,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4129,GO:0009192,1.00000000000357,0.931537621370623,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10941,GO:0044716,1.00000000000357,0.931537621370623,0,1,8-oxo-GDP phosphatase activity,MF,
10942,GO:0044717,1.00000000000357,0.931537621370623,0,1,8-hydroxy-dADP phosphatase activity,MF,
11509,GO:0046057,1.00000000000357,0.931537621370623,0,1,dADP catabolic process,BP,
11515,GO:0046067,1.00000000000357,0.931537621370623,0,1,dGDP catabolic process,BP,
11795,GO:0046712,1.00000000000357,0.931537621370623,0,1,GDP catabolic process,BP,
2055,GO:0004809,1.00000000000359,0.769656538645012,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
18821,GO:1904455,1.00000000000359,0.727862645430824,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
11303,GO:0045650,1.00000000000359,0.853118498428822,0,2,negative regulation of macrophage differentiation,BP,
18698,GO:1904177,1.00000000000359,0.640572289916779,0,3,regulation of adipose tissue development,BP,
18699,GO:1904179,1.00000000000359,0.640572289916779,0,3,positive regulation of adipose tissue development,BP,
4832,GO:0014043,1.0000000000036,0.815869246683221,0,2,negative regulation of neuron maturation,BP,
785,GO:0002046,1.00000000000361,0.944950591796596,0,1,opsin binding,MF,
9555,GO:0036372,1.00000000000361,0.944950591796596,0,1,opsin transport,BP,
9378,GO:0035933,1.00000000000362,0.720582697640419,0,3,glucocorticoid secretion,BP,
20124,GO:2000849,1.00000000000362,0.720582697640419,0,3,regulation of glucocorticoid secretion,BP,
10195,GO:0042835,1.00000000000363,0.866446739209258,0,1,BRE binding,MF,
15408,GO:0071713,1.00000000000363,0.866446739209258,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
2161,GO:0004996,1.00000000000364,0.883279394524329,0,1,thyroid-stimulating hormone receptor activity,MF,
9722,GO:0038194,1.00000000000364,0.883279394524329,0,1,thyroid-stimulating hormone signaling pathway,BP,
9727,GO:0039003,1.00000000000364,0.883279394524329,0,1,pronephric field specification,BP,
9730,GO:0039017,1.00000000000364,0.883279394524329,0,1,pattern specification involved in pronephros development,BP,
10131,GO:0042728,1.00000000000364,0.883279394524329,0,1,flavin-containing compound catabolic process,BP,
14739,GO:0070460,1.00000000000364,0.883279394524329,0,1,thyroid-stimulating hormone secretion,BP,
15527,GO:0072003,1.00000000000364,0.883279394524329,0,1,kidney rudiment formation,BP,
15528,GO:0072004,1.00000000000364,0.883279394524329,0,1,kidney field specification,BP,
15540,GO:0072025,1.00000000000364,0.883279394524329,0,1,distal convoluted tubule development,BP,
15559,GO:0072069,1.00000000000364,0.883279394524329,0,1,DCT cell differentiation,BP,
15663,GO:0072221,1.00000000000364,0.883279394524329,0,1,metanephric distal convoluted tubule development,BP,
15672,GO:0072240,1.00000000000364,0.883279394524329,0,1,metanephric DCT cell differentiation,BP,
15701,GO:0072304,1.00000000000364,0.883279394524329,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15702,GO:0072305,1.00000000000364,0.883279394524329,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15705,GO:0072309,1.00000000000364,0.883279394524329,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15754,GO:0072389,1.00000000000364,0.883279394524329,0,1,flavin adenine dinucleotide catabolic process,BP,
17406,GO:1900200,1.00000000000364,0.883279394524329,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17407,GO:1900204,1.00000000000364,0.883279394524329,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17408,GO:1900205,1.00000000000364,0.883279394524329,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17411,GO:1900211,1.00000000000364,0.883279394524329,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17412,GO:1900212,1.00000000000364,0.883279394524329,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17413,GO:1900214,1.00000000000364,0.883279394524329,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17414,GO:1900215,1.00000000000364,0.883279394524329,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17415,GO:1900217,1.00000000000364,0.883279394524329,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17416,GO:1900218,1.00000000000364,0.883279394524329,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17537,GO:1901147,1.00000000000364,0.883279394524329,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18187,GO:1903004,1.00000000000364,0.883279394524329,0,1,regulation of protein K63-linked deubiquitination,BP,
18188,GO:1903006,1.00000000000364,0.883279394524329,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18189,GO:1903007,1.00000000000364,0.883279394524329,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19971,GO:2000592,1.00000000000364,0.883279394524329,0,1,regulation of metanephric DCT cell differentiation,BP,
19972,GO:2000594,1.00000000000364,0.883279394524329,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19978,GO:2000612,1.00000000000364,0.883279394524329,0,1,regulation of thyroid-stimulating hormone secretion,BP,
14390,GO:0061711,1.00000000000364,0.853780324566534,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
4292,GO:0009737,1.00000000000367,0.872836462738912,0,1,response to abscisic acid,BP,
4293,GO:0009738,1.00000000000367,0.872836462738912,0,1,abscisic acid-activated signaling pathway,BP,
4306,GO:0009787,1.00000000000367,0.872836462738912,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4307,GO:0009789,1.00000000000367,0.872836462738912,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15095,GO:0071215,1.00000000000367,0.872836462738912,0,1,cellular response to abscisic acid stimulus,BP,
17628,GO:1901419,1.00000000000367,0.872836462738912,0,1,regulation of response to alcohol,BP,
17629,GO:1901421,1.00000000000367,0.872836462738912,0,1,positive regulation of response to alcohol,BP,
19391,GO:1905957,1.00000000000367,0.872836462738912,0,1,regulation of cellular response to alcohol,BP,
19392,GO:1905959,1.00000000000367,0.872836462738912,0,1,positive regulation of cellular response to alcohol,BP,
9737,GO:0039506,1.00000000000368,0.781010735392416,0,2,modulation by virus of host molecular function,BP,
9738,GO:0039507,1.00000000000368,0.781010735392416,0,2,suppression by virus of host molecular function,BP,
13277,GO:0052055,1.00000000000368,0.781010735392416,0,2,modulation by symbiont of host molecular function,BP,
13278,GO:0052056,1.00000000000368,0.781010735392416,0,2,negative regulation by symbiont of host molecular function,BP,
8900,GO:0034756,1.00000000000369,0.711538601376787,0,3,regulation of iron ion transport,BP,
18774,GO:1904351,1.0000000000037,0.725619206937801,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19128,GO:1905166,1.0000000000037,0.725619206937801,0,3,negative regulation of lysosomal protein catabolic process,BP,
18360,GO:1903400,1.0000000000037,0.629658154571777,0,3,L-arginine transmembrane transport,BP,
17303,GO:1900003,1.00000000000371,0.78028242093736,0,3,regulation of serine-type endopeptidase activity,BP,
17304,GO:1900004,1.00000000000371,0.78028242093736,0,3,negative regulation of serine-type endopeptidase activity,BP,
18019,GO:1902571,1.00000000000371,0.78028242093736,0,3,regulation of serine-type peptidase activity,BP,
18020,GO:1902572,1.00000000000371,0.78028242093736,0,3,negative regulation of serine-type peptidase activity,BP,
16091,GO:0090108,1.00000000000372,0.921220880610406,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16138,GO:0090187,1.00000000000372,0.921220880610406,0,1,positive regulation of pancreatic juice secretion,BP,
16245,GO:0090340,1.00000000000372,0.921220880610406,0,1,positive regulation of secretion of lysosomal enzymes,BP,
3412,GO:0007197,1.00000000000374,0.794069866098519,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5749,GO:0016907,1.00000000000374,0.794069866098519,0,2,G-protein coupled acetylcholine receptor activity,MF,
10225,GO:0042978,1.00000000000374,0.792908947038756,0,2,ornithine decarboxylase activator activity,MF,
17912,GO:1902269,1.00000000000374,0.792908947038756,0,2,positive regulation of polyamine transmembrane transport,BP,
1498,GO:0003845,1.00000000000375,0.863396981106506,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
2732,GO:0006114,1.00000000000375,0.765660125898622,0,3,glycerol biosynthetic process,BP,
3817,GO:0008419,1.00000000000376,0.911646522575049,0,1,RNA lariat debranching enzyme activity,MF,
9534,GO:0036313,1.00000000000376,0.824547090822897,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
4904,GO:0014843,1.00000000000378,0.837744985739064,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
10106,GO:0042660,1.00000000000378,0.837744985739064,0,1,positive regulation of cell fate specification,BP,
9785,GO:0040030,1.00000000000378,0.885154885938352,0,1,regulation of molecular function, epigenetic,BP,
10268,GO:0043035,1.00000000000378,0.885154885938352,0,1,chromatin insulator sequence binding,MF,
10185,GO:0042819,1.00000000000378,0.682274530003115,0,3,vitamin B6 biosynthetic process,BP,
12111,GO:0048213,1.00000000000378,0.908123609284441,0,1,Golgi vesicle prefusion complex stabilization,BP,
12980,GO:0051433,1.00000000000381,0.869241570576848,0,1,BH2 domain binding,MF,
9348,GO:0035880,1.00000000000381,0.814085630476287,0,2,embryonic nail plate morphogenesis,BP,
16797,GO:0098713,1.00000000000381,0.918130007645394,0,1,leucine import across plasma membrane,BP,
18547,GO:1903801,1.00000000000381,0.918130007645394,0,1,L-leucine import across plasma membrane,BP,
5139,GO:0015671,1.00000000000381,0.84619149470115,0,2,oxygen transport,BP,
4444,GO:0010370,1.00000000000382,0.815319538887823,0,2,perinucleolar chromocenter,CC,
3030,GO:0006580,1.00000000000383,0.910865720209743,0,1,ethanolamine metabolic process,BP,
18250,GO:1903165,1.00000000000383,0.910865720209743,0,1,response to polycyclic arene,BP,
18905,GO:1904681,1.00000000000383,0.910865720209743,0,1,response to 3-methylcholanthrene,BP,
14998,GO:0070966,1.00000000000383,0.672386891382028,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
6353,GO:0021541,1.00000000000384,0.875417656922174,0,1,ammon gyrus development,BP,
19807,GO:2000299,1.00000000000386,0.895896749971345,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
502,GO:0001560,1.00000000000386,0.736529230858968,0,2,regulation of cell growth by extracellular stimulus,BP,
1983,GO:0004705,1.00000000000386,0.71833168690665,0,3,JUN kinase activity,MF,
5750,GO:0016909,1.00000000000386,0.71833168690665,0,3,SAP kinase activity,MF,
14018,GO:0060800,1.00000000000389,0.766035383650103,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
10953,GO:0044753,1.00000000000389,0.906698953826666,0,1,amphisome,CC,
18681,GO:1904106,1.00000000000389,0.906698953826666,0,1,protein localization to microvillus,BP,
19052,GO:1904970,1.00000000000389,0.906698953826666,0,1,brush border assembly,BP,
14728,GO:0070432,1.00000000000392,0.729176776437829,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
7948,GO:0032558,1.00000000000393,0.781293915903054,0,3,adenyl deoxyribonucleotide binding,MF,
7952,GO:0032564,1.00000000000393,0.781293915903054,0,3,dATP binding,MF,
14421,GO:0061770,1.00000000000394,0.91980297081446,0,1,translation elongation factor binding,MF,
14591,GO:0070184,1.00000000000394,0.91980297081446,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15808,GO:0072545,1.00000000000394,0.91980297081446,0,1,tyrosine binding,MF,
18145,GO:1902937,1.00000000000394,0.91980297081446,0,1,inward rectifier potassium channel complex,CC,
18988,GO:1904842,1.00000000000394,0.91980297081446,0,1,response to nitroglycerin,BP,
18989,GO:1904843,1.00000000000394,0.91980297081446,0,1,cellular response to nitroglycerin,BP,
13679,GO:0060265,1.00000000000395,0.948459644632812,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
2299,GO:0005280,1.00000000000395,0.692164683701319,0,3,amino acid:proton symporter activity,MF,
12212,GO:0048499,1.00000000000395,0.750625003123128,0,3,synaptic vesicle membrane organization,BP,
19101,GO:1905071,1.00000000000395,0.759012429868324,0,2,occluding junction disassembly,BP,
19102,GO:1905073,1.00000000000395,0.759012429868324,0,2,regulation of occluding junction disassembly,BP,
19103,GO:1905075,1.00000000000395,0.759012429868324,0,2,positive regulation of occluding junction disassembly,BP,
10293,GO:0043095,1.00000000000397,0.952372884962215,0,1,regulation of GTP cyclohydrolase I activity,BP,
10299,GO:0043105,1.00000000000397,0.952372884962215,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10910,GO:0044549,1.00000000000397,0.952372884962215,0,1,GTP cyclohydrolase binding,MF,
2355,GO:0005456,1.00000000000398,0.925619078918429,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5188,GO:0015782,1.00000000000398,0.925619078918429,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5015,GO:0015183,1.00000000000398,0.720037225209948,0,3,L-aspartate transmembrane transporter activity,MF,
15040,GO:0071031,1.00000000000398,0.8644810190674,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15052,GO:0071049,1.00000000000398,0.8644810190674,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
13956,GO:0060697,1.000000000004,0.909021231416241,0,1,positive regulation of phospholipid catabolic process,BP,
17391,GO:1900161,1.000000000004,0.909021231416241,0,1,regulation of phospholipid scramblase activity,BP,
17392,GO:1900163,1.000000000004,0.909021231416241,0,1,positive regulation of phospholipid scramblase activity,BP,
20064,GO:2000752,1.000000000004,0.909021231416241,0,1,regulation of glucosylceramide catabolic process,BP,
20065,GO:2000753,1.000000000004,0.909021231416241,0,1,positive regulation of glucosylceramide catabolic process,BP,
20066,GO:2000754,1.000000000004,0.909021231416241,0,1,regulation of sphingomyelin catabolic process,BP,
20067,GO:2000755,1.000000000004,0.909021231416241,0,1,positive regulation of sphingomyelin catabolic process,BP,
11218,GO:0045416,1.000000000004,0.722031828249377,0,3,positive regulation of interleukin-8 biosynthetic process,BP,
5943,GO:0018293,1.00000000000402,0.938906128450617,0,1,protein-FAD linkage,BP,
3639,GO:0008113,1.00000000000402,0.872421505660407,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
19607,GO:1990812,1.00000000000403,0.710448936740352,0,3,growth cone filopodium,CC,
996,GO:0002461,1.00000000000403,0.917204395172199,0,1,tolerance induction dependent upon immune response,BP,
1018,GO:0002519,1.00000000000403,0.917204395172199,0,1,natural killer cell tolerance induction,BP,
1077,GO:0002652,1.00000000000403,0.917204395172199,0,1,regulation of tolerance induction dependent upon immune response,BP,
8039,GO:0032712,1.00000000000403,0.917204395172199,0,1,negative regulation of interleukin-3 production,BP,
15370,GO:0071656,1.00000000000403,0.917204395172199,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17573,GO:1901257,1.00000000000403,0.917204395172199,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
12830,GO:0051176,1.00000000000404,0.690728686697967,0,3,positive regulation of sulfur metabolic process,BP,
8998,GO:0035189,1.00000000000404,0.724251857751469,0,3,Rb-E2F complex,CC,
1032,GO:0002542,1.00000000000406,0.921432745868029,0,1,Factor XII activation,BP,
13217,GO:0051919,1.00000000000406,0.921432745868029,0,1,positive regulation of fibrinolysis,BP,
16490,GO:0097229,1.00000000000406,0.93586484527966,0,1,sperm end piece,CC,
9451,GO:0036085,1.00000000000407,0.899616538558795,0,1,GDP-fucose import into Golgi lumen,BP,
13652,GO:0060214,1.0000000000041,0.930780078732375,0,1,endocardium formation,BP,
19116,GO:1905143,1.0000000000041,0.930780078732375,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
14404,GO:0061739,1.00000000000411,0.700976983247712,0,3,protein lipidation involved in autophagosome assembly,BP,
9251,GO:0035691,1.00000000000412,0.936272721199384,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9253,GO:0035693,1.00000000000412,0.936272721199384,0,1,NOS2-CD74 complex,CC,
10104,GO:0042658,1.00000000000412,0.936272721199384,0,1,MHC class II protein binding, via antigen binding groove,MF,
11869,GO:0046912,1.00000000000412,0.705134066737896,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
13099,GO:0051673,1.00000000000413,0.859093229075848,0,2,membrane disruption in other organism,BP,
5956,GO:0018350,1.00000000000413,0.916109293274054,0,1,protein esterification,BP,
10769,GO:0044258,1.00000000000413,0.916109293274054,0,1,intestinal lipid catabolic process,BP,
8766,GO:0034462,1.00000000000413,0.918352874609437,0,1,small-subunit processome assembly,BP,
16730,GO:0098547,1.00000000000413,0.918352874609437,0,1,lumenal side of Golgi membrane,CC,
18811,GO:1904430,1.00000000000413,0.704078759303649,0,3,negative regulation of t-circle formation,BP,
4303,GO:0009758,1.00000000000414,0.812456763288552,0,1,carbohydrate utilization,BP,
10596,GO:0043610,1.00000000000414,0.812456763288552,0,1,regulation of carbohydrate utilization,BP,
17983,GO:1902488,1.00000000000414,0.812456763288552,0,1,cholangiocyte apoptotic process,BP,
18643,GO:1904000,1.00000000000414,0.812456763288552,0,1,positive regulation of eating behavior,BP,
18670,GO:1904054,1.00000000000414,0.812456763288552,0,1,regulation of cholangiocyte proliferation,BP,
18671,GO:1904056,1.00000000000414,0.812456763288552,0,1,positive regulation of cholangiocyte proliferation,BP,
18702,GO:1904192,1.00000000000414,0.812456763288552,0,1,regulation of cholangiocyte apoptotic process,BP,
18703,GO:1904193,1.00000000000414,0.812456763288552,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18704,GO:1904195,1.00000000000414,0.812456763288552,0,1,regulation of granulosa cell proliferation,BP,
18705,GO:1904197,1.00000000000414,0.812456763288552,0,1,positive regulation of granulosa cell proliferation,BP,
18707,GO:1904200,1.00000000000414,0.812456763288552,0,1,iodide transmembrane transport,BP,
18708,GO:1904201,1.00000000000414,0.812456763288552,0,1,regulation of iodide transport,BP,
18709,GO:1904202,1.00000000000414,0.812456763288552,0,1,negative regulation of iodide transport,BP,
18712,GO:1904206,1.00000000000414,0.812456763288552,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18717,GO:1904212,1.00000000000414,0.812456763288552,0,1,regulation of iodide transmembrane transport,BP,
18718,GO:1904213,1.00000000000414,0.812456763288552,0,1,negative regulation of iodide transmembrane transport,BP,
19567,GO:1990705,1.00000000000414,0.812456763288552,0,1,cholangiocyte proliferation,BP,
19579,GO:1990739,1.00000000000414,0.812456763288552,0,1,granulosa cell proliferation,BP,
16031,GO:0089709,1.00000000000414,0.833285689617669,0,2,L-histidine transmembrane transport,BP,
14376,GO:0061669,1.00000000000414,0.743766018154062,0,2,spontaneous neurotransmitter secretion,BP,
16989,GO:0099170,1.00000000000417,0.717737742836033,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17032,GO:0099547,1.00000000000417,0.717737742836033,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17045,GO:0099578,1.00000000000417,0.717737742836033,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
4320,GO:0009822,1.00000000000417,0.927504145196777,0,1,alkaloid catabolic process,BP,
660,GO:0001855,1.00000000000417,0.930131639268305,0,1,complement component C4b binding,MF,
3532,GO:0007525,1.00000000000418,0.586319150152084,0,2,somatic muscle development,BP,
20221,GO:2001198,1.00000000000418,0.778338747792564,0,3,regulation of dendritic cell differentiation,BP,
5803,GO:0017064,1.00000000000421,0.92067007129917,0,1,fatty acid amide hydrolase activity,MF,
17091,GO:0102077,1.00000000000421,0.92067007129917,0,1,oleamide hydrolase activity,MF,
17155,GO:0103073,1.00000000000421,0.92067007129917,0,1,anandamide amidohydrolase activity,MF,
10040,GO:0042543,1.00000000000422,0.957237802934679,0,1,protein N-linked glycosylation via arginine,BP,
15739,GO:0072365,1.00000000000422,0.813922602523246,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
14663,GO:0070309,1.00000000000422,0.710876475897485,0,3,lens fiber cell morphogenesis,BP,
14678,GO:0070336,1.00000000000424,0.771689999557006,0,2,flap-structured DNA binding,MF,
1518,GO:0003881,1.00000000000427,0.924543106550613,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
19901,GO:2000425,1.00000000000429,0.643262340464233,0,3,regulation of apoptotic cell clearance,BP,
2797,GO:0006256,1.00000000000429,0.906073286483394,0,1,UDP catabolic process,BP,
4082,GO:0009140,1.00000000000429,0.906073286483394,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4130,GO:0009193,1.00000000000429,0.906073286483394,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4131,GO:0009195,1.00000000000429,0.906073286483394,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4156,GO:0009222,1.00000000000429,0.906073286483394,0,1,pyrimidine ribonucleotide catabolic process,BP,
11504,GO:0046048,1.00000000000429,0.906073286483394,0,1,UDP metabolic process,BP,
19566,GO:1990700,1.0000000000043,0.881564311872544,0,1,nucleolar chromatin organization,BP,
20071,GO:2000759,1.0000000000043,0.863780215671332,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20072,GO:2000761,1.0000000000043,0.863780215671332,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
121,GO:0000252,1.00000000000431,0.929806343696137,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
8655,GO:0034242,1.00000000000431,0.782606178681057,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
11919,GO:0047012,1.00000000000431,0.929806343696137,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17152,GO:0103066,1.00000000000431,0.929806343696137,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17153,GO:0103067,1.00000000000431,0.929806343696137,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
9519,GO:0036284,1.00000000000431,0.770156272053614,0,2,tubulobulbar complex,CC,
452,GO:0001226,1.00000000000432,0.89768303373218,0,1,RNA polymerase II transcription corepressor binding,MF,
3820,GO:0008424,1.00000000000432,0.89768303373218,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9447,GO:0036071,1.00000000000432,0.89768303373218,0,1,N-glycan fucosylation,BP,
11874,GO:0046921,1.00000000000432,0.89768303373218,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
16457,GO:0097177,1.00000000000432,0.792425618153824,0,3,mitochondrial ribosome binding,MF,
14469,GO:0061945,1.00000000000433,0.721655809354676,0,3,regulation of protein K48-linked ubiquitination,BP,
24,GO:0000048,1.00000000000433,0.916505548788958,0,1,peptidyltransferase activity,MF,
1249,GO:0002951,1.00000000000433,0.916505548788958,0,1,leukotriene-C(4) hydrolase,MF,
14411,GO:0061752,1.00000000000433,0.83485874518861,0,2,telomeric repeat-containing RNA binding,MF,
5235,GO:0015862,1.00000000000434,0.917060221916468,0,1,uridine transport,BP,
14590,GO:0070183,1.00000000000436,0.908439498753704,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
7732,GO:0032252,1.00000000000439,0.603787333530787,0,3,secretory granule localization,BP,
18093,GO:1902804,1.00000000000439,0.730569356602604,0,3,negative regulation of synaptic vesicle transport,BP,
19809,GO:2000301,1.00000000000439,0.730569356602604,0,3,negative regulation of synaptic vesicle exocytosis,BP,
12004,GO:0047685,1.00000000000439,0.931811601530344,0,1,amine sulfotransferase activity,MF,
451,GO:0001225,1.0000000000044,0.699605678005245,0,2,RNA polymerase II transcription coactivator binding,MF,
17239,GO:0120092,1.00000000000441,0.895821942603711,0,1,crotonyl-CoA hydratase activity,MF,
17240,GO:0120093,1.00000000000441,0.895821942603711,0,1,regulation of peptidyl-lysine crotonylation,BP,
17241,GO:0120094,1.00000000000441,0.895821942603711,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
8901,GO:0034757,1.00000000000442,0.81580069001181,0,1,negative regulation of iron ion transport,BP,
8902,GO:0034759,1.00000000000442,0.81580069001181,0,1,regulation of iron ion transmembrane transport,BP,
8903,GO:0034760,1.00000000000442,0.81580069001181,0,1,negative regulation of iron ion transmembrane transport,BP,
19414,GO:1990070,1.00000000000443,0.950758339661631,0,1,TRAPPI protein complex,CC,
8750,GO:0034437,1.00000000000445,0.805111538681942,0,2,glycoprotein transporter activity,MF,
518,GO:0001595,1.00000000000446,0.939511977604989,0,1,angiotensin receptor activity,MF,
2134,GO:0004945,1.00000000000446,0.939511977604989,0,1,angiotensin type II receptor activity,MF,
6998,GO:0030692,1.00000000000448,0.84170240637597,0,2,Noc4p-Nop14p complex,CC,
15103,GO:0071224,1.00000000000448,0.725163494046946,0,3,cellular response to peptidoglycan,BP,
20266,GO:2001271,1.00000000000449,0.684143267639061,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
5945,GO:0018307,1.00000000000449,0.865734251749316,0,2,enzyme active site formation,BP,
43,GO:0000095,1.0000000000045,0.918702978400233,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5202,GO:0015805,1.0000000000045,0.918702978400233,0,1,S-adenosyl-L-methionine transport,BP,
17788,GO:1901962,1.0000000000045,0.918702978400233,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
2628,GO:0005958,1.00000000000451,0.618687979991223,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2962,GO:0006500,1.00000000000452,0.920171336269321,0,1,N-terminal protein palmitoylation,BP,
5873,GO:0018009,1.00000000000452,0.920171336269321,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
15565,GO:0072076,1.00000000000453,0.656086878853231,0,3,nephrogenic mesenchyme development,BP,
15821,GO:0072566,1.00000000000456,0.834387442667163,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19837,GO:2000338,1.00000000000456,0.834387442667163,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19838,GO:2000340,1.00000000000456,0.834387442667163,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
14455,GO:0061889,1.00000000000456,0.857736988925984,0,1,negative regulation of astrocyte activation,BP,
18636,GO:1903979,1.00000000000456,0.857736988925984,0,1,negative regulation of microglial cell activation,BP,
16679,GO:0097692,1.00000000000457,0.844551725835684,0,1,histone H3-K4 monomethylation,BP,
17775,GO:1901895,1.00000000000457,0.844551725835684,0,1,negative regulation of calcium-transporting ATPase activity,BP,
1825,GO:0004482,1.00000000000457,0.845106103697491,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
7421,GO:0031533,1.00000000000457,0.845106103697491,0,1,mRNA cap methyltransferase complex,CC,
17161,GO:0106005,1.00000000000457,0.845106103697491,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
9620,GO:0036506,1.00000000000458,0.687113881298511,0,3,maintenance of unfolded protein,BP,
18785,GO:1904378,1.00000000000458,0.687113881298511,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
436,GO:0001165,1.00000000000459,0.868566226286771,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
15747,GO:0072382,1.0000000000046,0.748760866787325,0,1,minus-end-directed vesicle transport along microtubule,BP,
1932,GO:0004633,1.0000000000046,0.918846216263056,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
5105,GO:0015420,1.00000000000461,0.842485527872765,0,1,cobalamin-transporting ATPase activity,MF,
5107,GO:0015431,1.00000000000461,0.842485527872765,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
8826,GO:0034634,1.00000000000461,0.842485527872765,0,1,glutathione transmembrane transporter activity,MF,
8913,GO:0034775,1.00000000000461,0.842485527872765,0,1,glutathione transmembrane transport,BP,
9112,GO:0035443,1.00000000000461,0.842485527872765,0,1,tripeptide transmembrane transport,BP,
10213,GO:0042937,1.00000000000461,0.842485527872765,0,1,tripeptide transmembrane transporter activity,MF,
11742,GO:0046623,1.00000000000461,0.842485527872765,0,1,sphingolipid-translocating ATPase activity,MF,
15525,GO:0071997,1.00000000000461,0.842485527872765,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16951,GO:0099039,1.00000000000461,0.842485527872765,0,1,sphingolipid translocation,BP,
6830,GO:0030305,1.00000000000462,0.926527268499438,0,1,heparanase activity,MF,
17932,GO:1902311,1.00000000000462,0.926395770225762,0,1,regulation of copper ion transmembrane transport,BP,
9004,GO:0035226,1.00000000000465,0.902827772719248,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9005,GO:0035227,1.00000000000465,0.902827772719248,0,1,regulation of glutamate-cysteine ligase activity,BP,
9006,GO:0035229,1.00000000000465,0.902827772719248,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
5916,GO:0018197,1.00000000000466,0.654122717683678,0,3,peptidyl-aspartic acid modification,BP,
2243,GO:0005157,1.00000000000467,0.915473440305475,0,1,macrophage colony-stimulating factor receptor binding,MF,
10017,GO:0042488,1.00000000000467,0.915473440305475,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13913,GO:0060611,1.00000000000467,0.915473440305475,0,1,mammary gland fat development,BP,
17889,GO:1902228,1.00000000000467,0.915473440305475,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18628,GO:1903971,1.00000000000467,0.915473440305475,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18631,GO:1903974,1.00000000000467,0.915473440305475,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18686,GO:1904124,1.00000000000467,0.915473440305475,0,1,microglial cell migration,BP,
18687,GO:1904139,1.00000000000467,0.915473440305475,0,1,regulation of microglial cell migration,BP,
18688,GO:1904141,1.00000000000467,0.915473440305475,0,1,positive regulation of microglial cell migration,BP,
19564,GO:1990682,1.00000000000467,0.915473440305475,0,1,CSF1-CSF1R complex,CC,
3373,GO:0007147,1.00000000000467,0.889176997928148,0,1,female meiosis II,BP,
8323,GO:0033183,1.00000000000467,0.620110843973535,0,3,negative regulation of histone ubiquitination,BP,
17592,GO:1901314,1.00000000000467,0.620110843973535,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17593,GO:1901315,1.00000000000467,0.620110843973535,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
495,GO:0001550,1.00000000000469,0.740938682228918,0,2,ovarian cumulus expansion,BP,
12090,GO:0048165,1.00000000000469,0.740938682228918,0,2,fused antrum stage,BP,
16614,GO:0097505,1.00000000000469,0.851290428408725,0,1,Rad6-Rad18 complex,CC,
16388,GO:0097055,1.0000000000047,0.833630115256431,0,2,agmatine biosynthetic process,BP,
17540,GO:1901162,1.0000000000047,0.833630115256431,0,2,primary amino compound biosynthetic process,BP,
18666,GO:1904046,1.0000000000047,0.87548414659866,0,2,negative regulation of vascular endothelial growth factor production,BP,
9698,GO:0038131,1.0000000000047,0.829314385918388,0,2,neuregulin receptor activity,MF,
14063,GO:0060920,1.0000000000047,0.630273496680135,0,3,cardiac pacemaker cell differentiation,BP,
14067,GO:0060926,1.0000000000047,0.630273496680135,0,3,cardiac pacemaker cell development,BP,
16948,GO:0099022,1.00000000000472,0.843824957632614,0,2,vesicle tethering,BP,
16952,GO:0099044,1.00000000000472,0.843824957632614,0,2,vesicle tethering to endoplasmic reticulum,BP,
8072,GO:0032767,1.00000000000472,0.693427350554375,0,3,copper-dependent protein binding,MF,
13121,GO:0051717,1.00000000000473,0.77524388843811,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
17162,GO:0106014,1.00000000000474,0.846959318764114,0,2,regulation of inflammatory response to wounding,BP,
17163,GO:0106015,1.00000000000474,0.846959318764114,0,2,negative regulation of inflammatory response to wounding,BP,
18349,GO:1903378,1.00000000000474,0.782984262337163,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
2898,GO:0006408,1.00000000000474,0.853497515380665,0,2,snRNA export from nucleus,BP,
4981,GO:0015112,1.00000000000475,0.911628379126058,0,1,nitrate transmembrane transporter activity,MF,
5159,GO:0015706,1.00000000000475,0.911628379126058,0,1,nitrate transport,BP,
19806,GO:2000298,1.00000000000475,0.820660233366978,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
1841,GO:0004499,1.00000000000475,0.920059093569417,0,1,N,N-dimethylaniline monooxygenase activity,MF,
10963,GO:0044778,1.00000000000476,0.840767917181741,0,2,meiotic DNA integrity checkpoint,BP,
3876,GO:0008511,1.00000000000477,0.836331448459111,0,1,sodium:potassium:chloride symporter activity,MF,
4283,GO:0009674,1.00000000000477,0.836331448459111,0,1,potassium:sodium symporter activity,MF,
5095,GO:0015378,1.00000000000477,0.836331448459111,0,1,sodium:chloride symporter activity,MF,
11381,GO:0045795,1.00000000000477,0.836331448459111,0,1,positive regulation of cell volume,BP,
124,GO:0000255,1.00000000000477,0.655774768570386,0,3,allantoin metabolic process,BP,
16004,GO:0086057,1.00000000000479,0.883636891612023,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19446,GO:1990174,1.00000000000479,0.883636891612023,0,1,phosphodiesterase decapping endonuclease activity,MF,
1625,GO:0004064,1.00000000000481,0.782214498346954,0,3,arylesterase activity,MF,
5885,GO:0018057,1.00000000000481,0.723216243286226,0,3,peptidyl-lysine oxidation,BP,
668,GO:0001878,1.00000000000483,0.91742831327677,0,1,response to yeast,BP,
4215,GO:0009386,1.00000000000483,0.91742831327677,0,1,translational attenuation,BP,
14445,GO:0061847,1.00000000000483,0.91742831327677,0,1,response to cholecystokinin,BP,
15291,GO:0071538,1.00000000000483,0.91742831327677,0,1,SH2 domain-mediated complex assembly,BP,
19618,GO:1990839,1.00000000000483,0.91742831327677,0,1,response to endothelin,BP,
19622,GO:1990859,1.00000000000483,0.91742831327677,0,1,cellular response to endothelin,BP,
19913,GO:2000466,1.00000000000485,0.689165987367457,0,3,negative regulation of glycogen (starch) synthase activity,BP,
5558,GO:0016576,1.00000000000485,0.729586515003064,0,3,histone dephosphorylation,BP,
382,GO:0001018,1.00000000000487,0.832692954715408,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
15654,GO:0072209,1.00000000000487,0.907219308642269,0,1,metanephric mesangial cell differentiation,BP,
15677,GO:0072254,1.00000000000487,0.907219308642269,0,1,metanephric glomerular mesangial cell differentiation,BP,
15678,GO:0072255,1.00000000000487,0.907219308642269,0,1,metanephric glomerular mesangial cell development,BP,
17427,GO:1900241,1.00000000000487,0.907219308642269,0,1,positive regulation of phenotypic switching,BP,
19135,GO:1905176,1.00000000000487,0.907219308642269,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
13682,GO:0060268,1.00000000000488,0.728585112053537,0,3,negative regulation of respiratory burst,BP,
19503,GO:1990423,1.00000000000489,0.680330137079273,0,3,RZZ complex,CC,
6515,GO:0021902,1.0000000000049,0.707629977745007,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
8076,GO:0032771,1.00000000000491,0.874173837072212,0,1,regulation of monophenol monooxygenase activity,BP,
8077,GO:0032773,1.00000000000491,0.874173837072212,0,1,positive regulation of monophenol monooxygenase activity,BP,
8163,GO:0032912,1.00000000000491,0.874173837072212,0,1,negative regulation of transforming growth factor beta2 production,BP,
12051,GO:0048023,1.00000000000491,0.874173837072212,0,1,positive regulation of melanin biosynthetic process,BP,
13162,GO:0051796,1.00000000000491,0.874173837072212,0,1,negative regulation of timing of catagen,BP,
14053,GO:0060901,1.00000000000491,0.874173837072212,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18133,GO:1902908,1.00000000000491,0.874173837072212,0,1,regulation of melanosome transport,BP,
18134,GO:1902910,1.00000000000491,0.874173837072212,0,1,positive regulation of melanosome transport,BP,
17023,GO:0099532,1.00000000000491,0.710392369250355,0,2,synaptic vesicle endosomal processing,BP,
7851,GO:0032422,1.00000000000491,0.678992793897832,0,3,purine-rich negative regulatory element binding,MF,
9146,GO:0035517,1.00000000000491,0.65129072239817,0,3,PR-DUB complex,CC,
9706,GO:0038163,1.00000000000493,0.944869196758259,0,1,thrombopoietin-mediated signaling pathway,BP,
19382,GO:1905938,1.00000000000493,0.944869196758259,0,1,positive regulation of germ cell proliferation,BP,
19783,GO:2000256,1.00000000000493,0.944869196758259,0,1,positive regulation of male germ cell proliferation,BP,
15854,GO:0072616,1.00000000000496,0.880245820572633,0,1,interleukin-18 secretion,BP,
8773,GO:0034473,1.00000000000496,0.816184588241747,0,3,U1 snRNA 3'-end processing,BP,
8776,GO:0034476,1.00000000000496,0.816184588241747,0,3,U5 snRNA 3'-end processing,BP,
18830,GO:1904481,1.00000000000498,0.914979249674375,0,1,response to tetrahydrofolate,BP,
18831,GO:1904482,1.00000000000498,0.914979249674375,0,1,cellular response to tetrahydrofolate,BP,
19642,GO:1990927,1.00000000000499,0.746134462719819,0,2,calcium ion regulated lysosome exocytosis,BP,
1008,GO:0002488,1.00000000000499,0.87964891408724,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1009,GO:0002489,1.00000000000499,0.87964891408724,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
8788,GO:0034506,1.00000000000499,0.87964891408724,0,1,chromosome, centromeric core domain,CC,
11901,GO:0046968,1.00000000000499,0.87964891408724,0,1,peptide antigen transport,BP,
11911,GO:0046980,1.00000000000499,0.87964891408724,0,1,tapasin binding,MF,
15731,GO:0072356,1.00000000000499,0.87964891408724,0,1,chromosome passenger complex localization to kinetochore,BP,
2020,GO:0004751,1.000000000005,0.925202199709104,0,1,ribose-5-phosphate isomerase activity,MF,
1188,GO:0002836,1.00000000000501,0.711956592056054,0,3,positive regulation of response to tumor cell,BP,
1191,GO:0002839,1.00000000000501,0.711956592056054,0,3,positive regulation of immune response to tumor cell,BP,
2016,GO:0004747,1.00000000000502,0.939082274731553,0,1,ribokinase activity,MF,
6262,GO:0019862,1.00000000000502,0.930481068848872,0,1,IgA binding,MF,
16244,GO:0090336,1.00000000000502,0.711369390465932,0,3,positive regulation of brown fat cell differentiation,BP,
790,GO:0002055,1.00000000000503,0.951591956851709,0,1,adenine binding,MF,
1586,GO:0003999,1.00000000000503,0.951591956851709,0,1,adenine phosphoribosyltransferase activity,MF,
8515,GO:0033814,1.00000000000505,0.933732824254431,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12482,GO:0050632,1.00000000000505,0.933732824254431,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14781,GO:0070538,1.00000000000505,0.933732824254431,0,1,oleic acid binding,MF,
17614,GO:1901373,1.00000000000505,0.933732824254431,0,1,lipid hydroperoxide transport,BP,
15300,GO:0071547,1.00000000000506,0.909522942940568,0,1,piP-body,CC,
2033,GO:0004775,1.00000000000507,0.857860909549695,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
1521,GO:0003886,1.00000000000507,0.659333980516793,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
8080,GO:0032776,1.00000000000507,0.659333980516793,0,3,DNA methylation on cytosine,BP,
16096,GO:0090116,1.00000000000507,0.659333980516793,0,3,C-5 methylation of cytosine,BP,
1564,GO:0003973,1.00000000000507,0.846587835732016,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
6311,GO:0019962,1.00000000000507,0.846587835732016,0,1,type I interferon binding,MF,
11990,GO:0047545,1.00000000000507,0.846587835732016,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
2023,GO:0004757,1.00000000000507,0.932913969030721,0,1,sepiapterin reductase activity,MF,
5944,GO:0018298,1.00000000000509,0.718651942228879,0,3,protein-chromophore linkage,BP,
9787,GO:0040032,1.00000000000509,0.924218537402982,0,1,post-embryonic body morphogenesis,BP,
2090,GO:0004856,1.00000000000509,0.887510591682161,0,1,xylulokinase activity,MF,
2652,GO:0005998,1.00000000000509,0.887510591682161,0,1,xylulose catabolic process,BP,
19336,GO:1905777,1.0000000000051,0.747468977205965,0,3,regulation of exonuclease activity,BP,
5975,GO:0018738,1.0000000000051,0.939157907559788,0,1,S-formylglutathione hydrolase activity,MF,
3807,GO:0008403,1.00000000000512,0.900521791967534,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
6858,GO:0030342,1.00000000000512,0.900521791967534,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
10821,GO:0044336,1.00000000000512,0.705171594687818,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
4736,GO:0010908,1.00000000000513,0.714239891777716,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4737,GO:0010909,1.00000000000513,0.714239891777716,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
18071,GO:1902730,1.00000000000513,0.714239891777716,0,3,positive regulation of proteoglycan biosynthetic process,BP,
1418,GO:0003363,1.00000000000513,0.848087812587328,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1235,GO:0002924,1.00000000000513,0.918241454434714,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9839,GO:0042105,1.00000000000513,0.918241454434714,0,1,alpha-beta T cell receptor complex,CC,
19192,GO:1905335,1.00000000000514,0.758012409479984,0,1,regulation of aggrephagy,BP,
19193,GO:1905337,1.00000000000514,0.758012409479984,0,1,positive regulation of aggrephagy,BP,
8311,GO:0033167,1.00000000000515,0.794549040341792,0,1,ARC complex,CC,
8312,GO:0033168,1.00000000000515,0.794549040341792,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
9568,GO:0036404,1.00000000000515,0.794549040341792,0,1,conversion of ds siRNA to ss siRNA,BP,
3954,GO:0008709,1.00000000000516,0.945617979453352,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6814,GO:0030283,1.00000000000516,0.945617979453352,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11920,GO:0047015,1.00000000000516,0.945617979453352,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
3840,GO:0008454,1.00000000000516,0.771712838756797,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
2062,GO:0004817,1.00000000000517,0.842900401142349,0,2,cysteine-tRNA ligase activity,MF,
2910,GO:0006423,1.00000000000517,0.842900401142349,0,2,cysteinyl-tRNA aminoacylation,BP,
16045,GO:0090034,1.00000000000517,0.815906022455674,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16046,GO:0090035,1.00000000000517,0.815906022455674,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
3884,GO:0008521,1.00000000000519,0.911501074905708,0,1,acetyl-CoA transmembrane transporter activity,MF,
5244,GO:0015876,1.00000000000519,0.911501074905708,0,1,acetyl-CoA transport,BP,
5263,GO:0015916,1.00000000000519,0.911501074905708,0,1,fatty-acyl-CoA transport,BP,
5342,GO:0016095,1.00000000000519,0.911501074905708,0,1,polyprenol catabolic process,BP,
17114,GO:0102389,1.00000000000519,0.911501074905708,0,1,polyprenol reductase activity,MF,
17600,GO:1901337,1.00000000000519,0.911501074905708,0,1,thioester transport,BP,
2598,GO:0005899,1.00000000000519,0.557810532062539,0,3,insulin receptor complex,CC,
18029,GO:1902605,1.0000000000052,0.909967944424912,0,1,heterotrimeric G-protein complex assembly,BP,
19410,GO:1990047,1.0000000000052,0.917875124469833,0,1,spindle matrix,CC,
1620,GO:0004056,1.00000000000521,0.922505031701532,0,1,argininosuccinate lyase activity,MF,
10000,GO:0042450,1.00000000000521,0.922505031701532,0,1,arginine biosynthetic process via ornithine,BP,
19162,GO:1905271,1.00000000000522,0.954860059890516,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19163,GO:1905273,1.00000000000522,0.954860059890516,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
7763,GO:0032298,1.00000000000523,0.918472233946829,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16428,GO:0097123,1.00000000000523,0.918472233946829,0,1,cyclin A1-CDK2 complex,CC,
6023,GO:0019087,1.00000000000525,0.691537147401139,0,3,transformation of host cell by virus,BP,
19734,GO:2000156,1.00000000000526,0.801477120385069,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19977,GO:2000611,1.00000000000527,0.797615406871077,0,2,positive regulation of thyroid hormone generation,BP,
10900,GO:0044530,1.00000000000528,0.663338936448361,0,3,supraspliceosomal complex,CC,
3895,GO:0008537,1.00000000000529,0.80436650345061,0,3,proteasome activator complex,CC,
18056,GO:1902685,1.00000000000529,0.874413929680731,0,1,positive regulation of receptor localization to synapse,BP,
8258,GO:0033065,1.0000000000053,0.863206761378748,0,2,Rad51C-XRCC3 complex,CC,
1818,GO:0004471,1.00000000000532,0.715168660909279,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1819,GO:0004473,1.00000000000532,0.715168660909279,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
9801,GO:0042025,1.00000000000532,0.690999053330955,0,3,host cell nucleus,CC,
10716,GO:0044094,1.00000000000532,0.690999053330955,0,3,host cell nuclear part,CC,
12022,GO:0047860,1.00000000000533,0.937268455037786,0,1,diiodophenylpyruvate reductase activity,MF,
1656,GO:0004113,1.00000000000533,0.858510224456172,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
4689,GO:0010848,1.00000000000535,0.897978747336512,0,1,regulation of chromatin disassembly,BP,
19894,GO:2000416,1.00000000000535,0.735169180580455,0,3,regulation of eosinophil migration,BP,
4167,GO:0009237,1.00000000000536,0.906246911322624,0,1,siderophore metabolic process,BP,
6090,GO:0019290,1.00000000000536,0.906246911322624,0,1,siderophore biosynthetic process,BP,
14988,GO:0070948,1.00000000000536,0.763726428663252,0,3,regulation of neutrophil mediated cytotoxicity,BP,
1767,GO:0004373,1.00000000000537,0.893819438226212,0,1,glycogen (starch) synthase activity,MF,
14314,GO:0061547,1.00000000000537,0.893819438226212,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
4682,GO:0010836,1.00000000000537,0.787101695440933,0,3,negative regulation of protein ADP-ribosylation,BP,
4731,GO:0010900,1.00000000000537,0.959829594932118,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
1830,GO:0004487,1.00000000000538,0.751933215240179,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
7374,GO:0031437,1.00000000000538,0.720666821928886,0,3,regulation of mRNA cleavage,BP,
19211,GO:1905383,1.00000000000539,0.795979385436931,0,3,protein localization to presynapse,BP,
19604,GO:1990791,1.0000000000054,0.817869049849745,0,2,dorsal root ganglion development,BP,
834,GO:0002135,1.0000000000054,0.913531531121258,0,1,CTP binding,MF,
5818,GO:0017098,1.0000000000054,0.913531531121258,0,1,sulfonylurea receptor binding,MF,
17624,GO:1901388,1.0000000000054,0.913531531121258,0,1,regulation of transforming growth factor beta activation,BP,
17625,GO:1901389,1.0000000000054,0.913531531121258,0,1,negative regulation of transforming growth factor beta activation,BP,
18480,GO:1903659,1.0000000000054,0.913531531121258,0,1,regulation of complement-dependent cytotoxicity,BP,
18481,GO:1903660,1.0000000000054,0.913531531121258,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19637,GO:1990913,1.0000000000054,0.913531531121258,0,1,sperm head plasma membrane,CC,
19638,GO:1990917,1.0000000000054,0.913531531121258,0,1,ooplasm,CC,
11636,GO:0046404,1.0000000000054,0.719392837002178,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13132,GO:0051733,1.0000000000054,0.719392837002178,0,3,polydeoxyribonucleotide kinase activity,MF,
13133,GO:0051734,1.0000000000054,0.719392837002178,0,3,ATP-dependent polynucleotide kinase activity,MF,
2223,GO:0005127,1.00000000000541,0.662869384175916,0,3,ciliary neurotrophic factor receptor binding,MF,
18896,GO:1904647,1.00000000000541,0.807920202213434,0,1,response to rotenone,BP,
2444,GO:0005656,1.00000000000542,0.779689138128758,0,3,nuclear pre-replicative complex,CC,
2805,GO:0006267,1.00000000000542,0.779689138128758,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9560,GO:0036387,1.00000000000542,0.779689138128758,0,3,pre-replicative complex,CC,
9561,GO:0036388,1.00000000000542,0.779689138128758,0,3,pre-replicative complex assembly,BP,
17923,GO:1902299,1.00000000000542,0.779689138128758,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
9215,GO:0035621,1.00000000000542,0.789705434098174,0,2,ER to Golgi ceramide transport,BP,
19265,GO:1905535,1.00000000000544,0.858323217687169,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19266,GO:1905537,1.00000000000544,0.858323217687169,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19297,GO:1905610,1.00000000000544,0.858323217687169,0,1,regulation of mRNA cap binding,BP,
19298,GO:1905612,1.00000000000544,0.858323217687169,0,1,positive regulation of mRNA cap binding,BP,
15404,GO:0071707,1.00000000000544,0.937366498537496,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
9234,GO:0035651,1.00000000000544,0.768502174254656,0,3,AP-3 adaptor complex binding,MF,
17708,GO:1901664,1.00000000000545,0.732602006470183,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17709,GO:1901666,1.00000000000545,0.732602006470183,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
253,GO:0000718,1.00000000000545,0.927251963138499,0,1,nucleotide-excision repair, DNA damage removal,BP,
1673,GO:0004139,1.00000000000545,0.927251963138499,0,1,deoxyribose-phosphate aldolase activity,MF,
10831,GO:0044349,1.00000000000545,0.927251963138499,0,1,DNA excision,BP,
11635,GO:0046403,1.00000000000545,0.927251963138499,0,1,polynucleotide 3'-phosphatase activity,MF,
16712,GO:0098503,1.00000000000545,0.927251963138499,0,1,DNA 3' dephosphorylation,BP,
16713,GO:0098504,1.00000000000545,0.927251963138499,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16715,GO:0098506,1.00000000000545,0.927251963138499,0,1,polynucleotide 3' dephosphorylation,BP,
3529,GO:0007518,1.00000000000546,0.916441001278319,0,1,myoblast fate determination,BP,
17861,GO:1902167,1.00000000000548,0.956193377632147,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
18972,GO:1904803,1.00000000000548,0.956193377632147,0,1,regulation of translation involved in cellular response to UV,BP,
15961,GO:0085032,1.00000000000548,0.897954129527079,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
7354,GO:0031407,1.00000000000549,0.916497483312997,0,1,oxylipin metabolic process,BP,
12030,GO:0047977,1.00000000000549,0.916497483312997,0,1,hepoxilin-epoxide hydrolase activity,MF,
17741,GO:1901751,1.00000000000549,0.916497483312997,0,1,leukotriene A4 metabolic process,BP,
20279,GO:2001300,1.00000000000549,0.916497483312997,0,1,lipoxin metabolic process,BP,
20280,GO:2001301,1.00000000000549,0.916497483312997,0,1,lipoxin biosynthetic process,BP,
20281,GO:2001302,1.00000000000549,0.916497483312997,0,1,lipoxin A4 metabolic process,BP,
20282,GO:2001303,1.00000000000549,0.916497483312997,0,1,lipoxin A4 biosynthetic process,BP,
20283,GO:2001304,1.00000000000549,0.916497483312997,0,1,lipoxin B4 metabolic process,BP,
20284,GO:2001306,1.00000000000549,0.916497483312997,0,1,lipoxin B4 biosynthetic process,BP,
9095,GO:0035402,1.00000000000549,0.823483700979652,0,2,histone kinase activity (H3-T11 specific),MF,
9100,GO:0035407,1.00000000000549,0.823483700979652,0,2,histone H3-T11 phosphorylation,BP,
18715,GO:1904210,1.0000000000055,0.934542444179672,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18732,GO:1904239,1.0000000000055,0.934542444179672,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18733,GO:1904240,1.0000000000055,0.934542444179672,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
17898,GO:1902238,1.00000000000554,0.876047034746266,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17899,GO:1902239,1.00000000000554,0.876047034746266,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19429,GO:1990127,1.00000000000554,0.876047034746266,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
13872,GO:0060545,1.00000000000555,0.815927477738511,0,2,positive regulation of necroptotic process,BP,
9675,GO:0038086,1.00000000000556,0.89192242405437,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9677,GO:0038091,1.00000000000556,0.89192242405437,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
16627,GO:0097532,1.00000000000556,0.89192242405437,0,1,stress response to acid chemical,BP,
16628,GO:0097533,1.00000000000556,0.89192242405437,0,1,cellular stress response to acid chemical,BP,
18445,GO:1903570,1.00000000000556,0.89192242405437,0,1,regulation of protein kinase D signaling,BP,
18446,GO:1903572,1.00000000000556,0.89192242405437,0,1,positive regulation of protein kinase D signaling,BP,
2290,GO:0005250,1.00000000000557,0.793186511559868,0,2,A-type (transient outward) potassium channel activity,MF,
6434,GO:0021747,1.00000000000558,0.658810441060153,0,3,cochlear nucleus development,BP,
17470,GO:1900453,1.00000000000558,0.816260748239671,0,2,negative regulation of long term synaptic depression,BP,
10378,GO:0043231,1.00000000000558,0,751,8286,intracellular membrane-bounded organelle,CC,PHACTR3;ITGB6;SULT1E1;FLOT1;MMP2;PRSS23;KRT4;TRNP1;FN1;PYGB;FLRT2;PRODH;GPRC5A;TXNIP;COL8A1;CTGF;ADAM19;FBN1;SOX6;MARVELD1;ST6GALNAC2;GADD45B;RHOBTB2;CDKN2B;ZFP36L1;APBB2;SYNE1;F2R;DDIT4;TNNI2;XPC;PTGS1;ADAMTSL1;TENM4;ASAP3;MARCH4;GSN;COL5A2;ETV5;PKD2;JPH2;SCARA3;DUSP6;TSC22D1;CYBRD1;ZFP36L2;IGF2BP2;TNIK;ANPEP;SKP2;COL7A1;ZNF362;H6PD;CLTCL1;NOS1;DNAJB4;GAS6;DNMBP;PDGFC;SNAI2;MAGED1;MALL;MAP6;SULF2;COL5A1;PHF21A;UTRN;TCEAL4;EGFR;GALNT10;TSC22D3;KLF8;SDC3;PEG10;HSPA2;LAMB1;FLRT3;SPEG;SPTB;SLC8A1;FKBP5;CLCA2;SESN3;SYNE3;RFX2;DOK1;ATP10D;SERPINH1;RNF213;KRT14;CRTAP;TCF7L1;S100A10;STON2;MBOAT2;RNF165;VIM;NUPR1;FAM198B;CSPG4;DDB2;TKFC;FAM210B;MAMDC2;AMIGO2;STMN3;ADD3;ASAP2;NTSR1;DCAKD;ZNF862;TADA3;PDLIM2;CXCL14;PAK1;ABCA1;NSG1;CBX5;VDR;APOBEC3C;PADI3;BMP4;ITM2C;NR1D1;SMARCA2;PTK6;AHNAK;ABTB1;CITED4;XAF1;HS1BP3;TRIM5;PDCD4;NR3C1;COL18A1;STAT1;SORL1;NEO1;IFIT2;LGALS1;MEST;D2HGDH;ETV1;TP53;ARAP1;KRT13;EXTL2;MBNL2;KIAA0319L;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;LTBP1;ZC3H6;MEF2D;KRT5;SEC14L2;MUC19;DLG4;SLC7A11;ITGA2;SLC27A3;ZCCHC11;PDGFA;MAP2;PPL;ADARB1;TIMP1;ACSL3;FLG;HIP1;PACS1;COL4A4;TFDP2;BCKDHB;DOCK4;TEP1;PNRC1;CCDC85B;CUL7;BTG1;FILIP1L;CHD3;SIK1;ZNF18;CPED1;KLF12;IFIT3;KLF9;NFIX;HIVEP1;TYSND1;TPBG;SNX1;GPX1;GLI3;PAQR8;PTGES;CDK14;E2F7;LPCAT2;TBC1D5;P3H2;NAV2;ECH1;ASAP1;ERO1B;SYN1;CTDSPL;SRPX;ABHD14B;ZFP90;KRT15;MAGED2;NEK9;SESN1;CTSV;SEC14L1;SPG11;PDE4DIP;LRP1;FYN;IFI6;XDH;TSHZ2;B3GAT3;ARHGAP18;ADIRF;FUT10;UGT8;CPS1;LAMA3;FAT2;POLR3GL;CAV1;SLC27A1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;TRIB2;SEL1L;SLC2A4RG;GLDC;MAP3K14;SLC22A17;SMARCA1;ZNF318;TNRC18;OSBPL5;DCAF16;XYLT1;AHNAK2;UST;ACSS1;CLU;FKBP9;TCEAL3;NPHP4;PRKCZ;SLIT3;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;CHST3;EHD3;HMGA2;CAMK2D;PHC2;GOLGB1;PRDX5;MST1R;KANK2;ZSCAN18;HIBADH;METTL7A;ULBP1;PTPN14;PER1;ATP8B2;PDIA4;PIK3R1;SYT1;HHAT;SLC38A10;NCAPD2;TMEM173;CAPRIN2;CREB3L2;ALDH3A2;SUGCT;CPT1A;ACACB;APOBEC3G;ANG;DUSP5;LAMA5;UHRF2;CNTLN;HERPUD1;ANK3;WFS1;CDK18;MDFI;SPRY2;CES2;TTN;TSTD1;CIRBP;PRDM8;JARID2;TCEAL8;TMEM8B;LMO7;APLP2;HPS4;CRELD2;MLH3;ZKSCAN1;TP73;CAT;CASP14;ST6GAL2;DLC1;KLF13;PRKACB;AARS;CHEK2;BACE1;R3HDM2;STOM;PRX;PHF2;TLR3;BPHL;MAN1A1;ZNF860;SNCA;ADAMTS7;ALDH1L2;PDIA6;GATAD1;VAMP1;AIP;GLG1;JADE2;NIPSNAP1;SP110;COL16A1;FGFR1;IGF1R;APOBEC3F;LMNA;ARMCX2;ALOX15B;IFI35;MLEC;PRKAB2;SEC24D;SEMA4A;RGS2;GLT8D2;TGFBI;SETX;PDE4D;APBB3;TMEM129;NCOA2;TGM2;PSMB9;OBSCN;SULF1;SPATA18;BRD3;ESYT2;PDK3;G6PD;MYOF;TLE4;ARSD;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;TRIOBP;DHTKD1;KDM4C;CHD6;NFATC4;FOXN3;RAPH1;AKAP7;LMCD1;DLX3;AMOTL1;LRTOMT;L3MBTL3;NAGLU;PBXIP1;PBX1;LAPTM4A;FOXL1;BBS4;ZNF699;CALR;ATM;IDH2;COPG2;APH1B;MDM2;ARF6;FAM20A;TMED10;CST3;MEIS2;MANBA;C17ORF49;TMEM14C;AREG;ZNF107;TCF4;ANXA6;AKAP13;DNAJC6;SNX10;DGKQ;CITED2;NR2F2;ACSS2;HEXA;CBX7;AKR7A2;ZNF449;ZMAT3;MSH5;MAF;TRAK1;CD1D;FBXW8;ZBTB22;SYNE2;HDAC11;RCBTB1;PTMS;FGD4;NEMP2;PTPN1;POGLUT1;ARHGEF2;PLGRKT;NDUFA4L2;ALDH4A1;KLHL12;SDC2;COL5A3;SLC25A35;ZNF546;EGR1;SOX9;ENPP1;IFT27;ISL1;ITPKB;BCL6;SLC48A1;PLD3;PRCP;CRTC1;NCOR1;G6PC3;NDRG1;ZNF717;GCNT1;PLAG1;TMEM50B;PRKCA;SALL2;MYBL1;PXMP2;TMEM175;ZNF358;BCHE;ZNF519;ANXA2;TRERF1;RGS14;RAB13;PRIMPOL;CES3;HLTF;FNDC3A;HOXA1;MPP7;BAHCC1;RNF24;METTL23;MAN2B1;CEP68;PGAP1;TSHZ1;IGFBP4;GOLGA8B;MVB12B;TES;TCF25;TCF12;HMBOX1;NFAT5;ANAPC16;NMNAT2;GAL3ST4;RPL13A;PODXL;PAK6;VWA5A;DECR1;ZNF160;NAB2;CHD9;MEGF8;ZNF302;UACA;ATXN1;ACSF2;IRF2BPL;STK36;RAB43;MAML2;WDR19;SLC39A11;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;RBL2;MAP2K5;ODF2;VPS39;DLX2;ZNF550;DNASE1L1;DSEL;COL12A1;STAT2;IFT122;LIG1;ZNF701;LIPA;LEF1;DPP9;THRA;SSBP3;FHL1;ZADH2;USP28;SFXN3;ALDH7A1;ITM2A;MAPK8IP3;CYP4V2;MSRB2;CDKN2A;PPM1M;SPPL2B;SP100;ZSCAN30;ULK1;TEF;TSPYL2;AGRN;NPEPL1;ORC4;RHBDD1;TSPYL4;MAGI2;KIAA1109;AGAP1;HSPA5;CDK19;NRM;TH;CELF2;GOPC;MAGI1;BOC;CENPA;PIKFYVE;FLYWCH1;REEP2;TGFB1I1;RSAD2;SRPK2;CHIC2;UVRAG;TCTEX1D4;NAPRT;CCHCR1;ITPR2;MDFIC;UGT1A3;VPS13C;RHBDD2;FHOD1;YPEL4;IFT74;POLD4;SAP30L;ZNF12;TACC2;LMF1;UGT1A6;YAP1;ALG10;NUB1;KLF5;COL17A1;GPX8;TWIST2;GOLGA8N;ATRAID;YEATS2;HOXA3;UBA7;GALNT2;DERL3;ZNF558;MEIS3;PITPNC1;AGPAT1;PPARG;CAPG;RNF144B;PARP15;BEX4;CALCRL;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;SNX9;ICK;TGIF1;OBSL1;ING4;POSTN;PRR7;LGALS3;ARL3;MIA3;DEF6;DNAJC3;FKBP10;RARA;COG3;COL4A1;SV2A;ABCA2;CCNY;HES2;POLH;TMEM67;HOXC5;PBX2;PRKAG1;TAF1;SENP7;TSHZ3;GSTZ1;MPPE1;ZNF883;HCFC1R1;ZBTB1;NAT14;PPP3CA;DCAF8;PIK3C2B;PDZD2;SBF2;CREBRF;PEX1;CTDSP2;STEAP2;KRT10;ETV4;HP1BP3;COX18;HOXA2;FOS;DNM1P46;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM169A;CLEC2D;FAM120B;MATN3;EHHADH;KLHDC2;MED12;NPAS2;ABAT;FBXL4;NIPBL;UGGT2;CERCAM;VPS36;TTBK2;KCNRG;BSN;ADAM10;PRDM5;RHOBTB3;CELSR1;ZNF471;LITAF;ATG16L2;S100A11;MYO1C;TUSC3;RXRA;GBP3;CPT2;DGCR6;EDEM1;ACAA2;TMEM92;ABCA5;TAOK3;NFKBIE;CTSD;ZNF484;DOCK1;FAM114A1;ZNRF1;DMPK;MOSPD3;LAMB2
5312,GO:0016035,1.00000000000559,0.742372443738632,0,2,zeta DNA polymerase complex,CC,
13576,GO:0060075,1.00000000000559,0.710032094596313,0,3,regulation of resting membrane potential,BP,
1584,GO:0003997,1.00000000000559,0.695656736926777,0,3,acyl-CoA oxidase activity,MF,
16286,GO:0090500,1.00000000000559,0.836362460967704,0,2,endocardial cushion to mesenchymal transition,BP,
3410,GO:0007195,1.00000000000559,0.746291716597233,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
9649,GO:0038025,1.0000000000056,0.778884112645342,0,2,reelin receptor activity,MF,
14957,GO:0070898,1.00000000000561,0.784847489946768,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
1837,GO:0004494,1.00000000000562,0.905393359588586,0,1,methylmalonyl-CoA mutase activity,MF,
11586,GO:0046292,1.00000000000562,0.740973173406814,0,3,formaldehyde metabolic process,BP,
7764,GO:0032299,1.00000000000562,0.795472209682937,0,3,ribonuclease H2 complex,CC,
2693,GO:0006061,1.00000000000562,0.934147554309721,0,1,sorbitol biosynthetic process,BP,
5984,GO:0018931,1.00000000000562,0.934147554309721,0,1,naphthalene metabolic process,BP,
6133,GO:0019406,1.00000000000562,0.934147554309721,0,1,hexitol biosynthetic process,BP,
10639,GO:0043795,1.00000000000562,0.934147554309721,0,1,glyceraldehyde oxidoreductase activity,MF,
16274,GO:0090420,1.00000000000562,0.934147554309721,0,1,naphthalene-containing compound metabolic process,BP,
7533,GO:0031826,1.00000000000564,0.790205761855635,0,3,type 2A serotonin receptor binding,MF,
8165,GO:0032914,1.00000000000564,0.721705642658574,0,3,positive regulation of transforming growth factor beta1 production,BP,
1667,GO:0004132,1.00000000000567,0.921883585852521,0,1,dCMP deaminase activity,MF,
2359,GO:0005462,1.00000000000567,0.770083839849213,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
19536,GO:1990569,1.00000000000567,0.770083839849213,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
1726,GO:0004322,1.00000000000568,0.662819999516571,0,3,ferroxidase activity,MF,
5633,GO:0016724,1.00000000000568,0.662819999516571,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
11512,GO:0046061,1.00000000000569,0.797936814002633,0,3,dATP catabolic process,BP,
3873,GO:0008508,1.00000000000569,0.861305436811159,0,2,bile acid:sodium symporter activity,MF,
10452,GO:0043366,1.0000000000057,0.795590017589528,0,2,beta selection,BP,
19308,GO:1905661,1.00000000000573,0.816513380829406,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19309,GO:1905663,1.00000000000573,0.816513380829406,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
293,GO:0000798,1.00000000000577,0.713290747663245,0,3,nuclear cohesin complex,CC,
1883,GO:0004566,1.00000000000578,0.850091727268736,0,2,beta-glucuronidase activity,MF,
9164,GO:0035552,1.00000000000578,0.742236912055492,0,3,oxidative single-stranded DNA demethylation,BP,
4984,GO:0015117,1.00000000000578,0.924262213620289,0,1,thiosulfate transmembrane transporter activity,MF,
4990,GO:0015131,1.00000000000578,0.924262213620289,0,1,oxaloacetate transmembrane transporter activity,MF,
5160,GO:0015709,1.00000000000578,0.924262213620289,0,1,thiosulfate transport,BP,
5170,GO:0015729,1.00000000000578,0.924262213620289,0,1,oxaloacetate transport,BP,
5176,GO:0015743,1.00000000000578,0.924262213620289,0,1,malate transport,BP,
15225,GO:0071423,1.00000000000578,0.924262213620289,0,1,malate transmembrane transport,BP,
17939,GO:1902356,1.00000000000578,0.924262213620289,0,1,oxaloacetate(2-) transmembrane transport,BP,
8261,GO:0033078,1.00000000000578,0.800555978825929,0,2,extrathymic T cell differentiation,BP,
19636,GO:1990911,1.0000000000058,0.847848151541979,0,2,response to psychosocial stress,BP,
17982,GO:1902480,1.0000000000058,0.915522601523561,0,1,protein localization to mitotic spindle,BP,
18345,GO:1903373,1.0000000000058,0.657486096253562,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
8607,GO:0034140,1.00000000000582,0.693576513438509,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
11698,GO:0046525,1.00000000000583,0.92727128492392,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
1789,GO:0004420,1.00000000000583,0.86983635572523,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9916,GO:0042282,1.00000000000583,0.86983635572523,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
14294,GO:0061485,1.00000000000584,0.8284535214804,0,1,memory T cell proliferation,BP,
14962,GO:0070903,1.00000000000585,0.922907370337392,0,1,mitochondrial tRNA thio-modification,BP,
8742,GO:0034423,1.00000000000585,0.911971309321835,0,1,autophagosome lumen,CC,
19899,GO:2000422,1.00000000000585,0.911971309321835,0,1,regulation of eosinophil chemotaxis,BP,
19900,GO:2000424,1.00000000000585,0.911971309321835,0,1,positive regulation of eosinophil chemotaxis,BP,
1570,GO:0003979,1.00000000000588,0.899979720229371,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6631,GO:0023024,1.00000000000588,0.899979720229371,0,1,MHC class I protein complex binding,MF,
1313,GO:0003162,1.00000000000588,0.686231223201125,0,2,atrioventricular node development,BP,
2157,GO:0004985,1.00000000000589,0.787095114276366,0,3,opioid receptor activity,MF,
19875,GO:2000389,1.00000000000589,0.704744148303106,0,3,regulation of neutrophil extravasation,BP,
19876,GO:2000391,1.00000000000589,0.704744148303106,0,3,positive regulation of neutrophil extravasation,BP,
8365,GO:0033277,1.0000000000059,0.774997165775553,0,2,abortive mitotic cell cycle,BP,
11731,GO:0046601,1.0000000000059,0.710308937320067,0,3,positive regulation of centriole replication,BP,
16538,GO:0097356,1.0000000000059,0.82814848003314,0,1,perinucleolar compartment,CC,
14783,GO:0070541,1.00000000000591,0.699759071967701,0,3,response to platinum ion,BP,
9650,GO:0038026,1.00000000000591,0.677902634353188,0,3,reelin-mediated signaling pathway,BP,
6036,GO:0019144,1.00000000000594,0.87425960459256,0,2,ADP-sugar diphosphatase activity,MF,
6996,GO:0030690,1.00000000000594,0.908570944567444,0,1,Noc1p-Noc2p complex,CC,
6997,GO:0030691,1.00000000000594,0.908570944567444,0,1,Noc2p-Noc3p complex,CC,
8891,GO:0034729,1.00000000000594,0.679886282685909,0,3,histone H3-K79 methylation,BP,
254,GO:0000720,1.00000000000595,0.742687015726163,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
4015,GO:0009041,1.00000000000596,0.772582364497066,0,3,uridylate kinase activity,MF,
11947,GO:0047220,1.00000000000597,0.909110423237646,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
7868,GO:0032444,1.00000000000597,0.643845958268121,0,2,activin responsive factor complex,CC,
299,GO:0000806,1.00000000000598,0.789538032510537,0,2,Y chromosome,CC,
10835,GO:0044355,1.00000000000598,0.933208022465726,0,1,clearance of foreign intracellular DNA,BP,
10836,GO:0044356,1.00000000000598,0.933208022465726,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16953,GO:0099046,1.00000000000598,0.933208022465726,0,1,clearance of foreign intracellular nucleic acids,BP,
18889,GO:1904627,1.00000000000598,0.933208022465726,0,1,response to phorbol 13-acetate 12-myristate,BP,
18890,GO:1904628,1.00000000000598,0.933208022465726,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
7021,GO:0030805,1.00000000000599,0.640854954419096,0,3,regulation of cyclic nucleotide catabolic process,BP,
7036,GO:0030820,1.00000000000599,0.640854954419096,0,3,regulation of cAMP catabolic process,BP,
8279,GO:0033121,1.00000000000599,0.640854954419096,0,3,regulation of purine nucleotide catabolic process,BP,
935,GO:0002337,1.00000000000599,0.823329480244146,0,2,B-1a B cell differentiation,BP,
15346,GO:0071619,1.00000000000599,0.917978699938795,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20199,GO:2001163,1.00000000000599,0.917978699938795,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20200,GO:2001165,1.00000000000599,0.917978699938795,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
3984,GO:0008853,1.000000000006,0.742133266986909,0,3,exodeoxyribonuclease III activity,MF,
14981,GO:0070939,1.000000000006,0.681580392836726,0,3,Dsl1/NZR complex,CC,
8153,GO:0032899,1.00000000000603,0.882876226974931,0,1,regulation of neurotrophin production,BP,
8154,GO:0032901,1.00000000000603,0.882876226974931,0,1,positive regulation of neurotrophin production,BP,
8838,GO:0034649,1.00000000000603,0.882876226974931,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12191,GO:0048403,1.00000000000603,0.882876226974931,0,1,brain-derived neurotrophic factor binding,MF,
601,GO:0001770,1.00000000000604,0.833608077192229,0,1,establishment of natural killer cell polarity,BP,
13618,GO:0060154,1.00000000000604,0.743639959730777,0,3,cellular process regulating host cell cycle in response to virus,BP,
1735,GO:0004335,1.00000000000605,0.842146237611164,0,2,galactokinase activity,MF,
246,GO:0000703,1.00000000000605,0.876919327083532,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
11954,GO:0047273,1.00000000000608,0.897040203032059,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
13153,GO:0051786,1.00000000000608,0.897040203032059,0,1,all-trans-retinol 13,14-reductase activity,MF,
1159,GO:0002774,1.00000000000609,0.903094572876973,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14852,GO:0070667,1.00000000000609,0.903094572876973,0,1,negative regulation of mast cell proliferation,BP,
1969,GO:0004686,1.00000000000609,0.829357200667123,0,1,elongation factor-2 kinase activity,MF,
15244,GO:0071454,1.00000000000609,0.829357200667123,0,1,cellular response to anoxia,BP,
19798,GO:2000282,1.00000000000609,0.768013628196171,0,2,regulation of cellular amino acid biosynthetic process,BP,
18210,GO:1903045,1.0000000000061,0.852364128567289,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
1508,GO:0003868,1.0000000000061,0.925949425094459,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
14543,GO:0070101,1.00000000000612,0.810442752082525,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
6805,GO:0030272,1.00000000000612,0.94750842383148,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7400,GO:0031493,1.00000000000613,0.740665823430076,0,3,nucleosomal histone binding,MF,
20239,GO:2001229,1.00000000000615,0.757959013170468,0,1,negative regulation of response to gamma radiation,BP,
17653,GO:1901551,1.00000000000615,0.875901839220359,0,1,negative regulation of endothelial cell development,BP,
18245,GO:1903141,1.00000000000615,0.875901839220359,0,1,negative regulation of establishment of endothelial barrier,BP,
968,GO:0002416,1.00000000000616,0.926574379584045,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
6217,GO:0019770,1.00000000000616,0.926574379584045,0,1,IgG receptor activity,MF,
6264,GO:0019864,1.00000000000616,0.926574379584045,0,1,IgG binding,MF,
11193,GO:0045347,1.00000000000616,0.694890074125095,0,3,negative regulation of MHC class II biosynthetic process,BP,
19517,GO:1990454,1.00000000000616,0.704902361937831,0,3,L-type voltage-gated calcium channel complex,CC,
19575,GO:1990730,1.00000000000618,0.787108777425308,0,2,VCP-NSFL1C complex,CC,
14023,GO:0060821,1.00000000000619,0.813228910637719,0,1,inactivation of X chromosome by DNA methylation,BP,
16452,GO:0097166,1.00000000000619,0.813228910637719,0,1,lens epithelial cell proliferation,BP,
20183,GO:2001109,1.00000000000619,0.813228910637719,0,1,regulation of lens epithelial cell proliferation,BP,
20184,GO:2001111,1.00000000000619,0.813228910637719,0,1,positive regulation of lens epithelial cell proliferation,BP,
4095,GO:0009153,1.00000000000622,0.870376900739977,0,2,purine deoxyribonucleotide biosynthetic process,BP,
1981,GO:0004703,1.00000000000622,0.826821052466389,0,2,G-protein coupled receptor kinase activity,MF,
12006,GO:0047696,1.00000000000622,0.826821052466389,0,2,beta-adrenergic receptor kinase activity,MF,
8968,GO:0035092,1.00000000000623,0.620786966418395,0,3,sperm chromatin condensation,BP,
9521,GO:0036290,1.00000000000623,0.879783439190441,0,1,protein trans-autophosphorylation,BP,
17916,GO:1902283,1.00000000000623,0.879783439190441,0,1,negative regulation of primary amine oxidase activity,BP,
19475,GO:1990332,1.00000000000623,0.879783439190441,0,1,Ire1 complex,CC,
19542,GO:1990579,1.00000000000623,0.879783439190441,0,1,peptidyl-serine trans-autophosphorylation,BP,
19555,GO:1990630,1.00000000000623,0.879783439190441,0,1,IRE1-RACK1-PP2A complex,CC,
1934,GO:0004637,1.00000000000624,0.893781785963556,0,1,phosphoribosylamine-glycine ligase activity,MF,
1937,GO:0004641,1.00000000000624,0.893781785963556,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1940,GO:0004644,1.00000000000624,0.893781785963556,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
10122,GO:0042709,1.00000000000625,0.916658637501574,0,1,succinate-CoA ligase complex,CC,
11152,GO:0045244,1.00000000000625,0.916658637501574,0,1,succinate-CoA ligase complex (GDP-forming),CC,
17829,GO:1902045,1.00000000000625,0.916658637501574,0,1,negative regulation of Fas signaling pathway,BP,
19929,GO:2000504,1.00000000000625,0.916658637501574,0,1,positive regulation of blood vessel remodeling,BP,
9138,GO:0035508,1.00000000000625,0.853213873919903,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
16793,GO:0098705,1.00000000000627,0.865315778005829,0,1,copper ion import across plasma membrane,BP,
15299,GO:0071546,1.00000000000628,0.804149053746505,0,2,pi-body,CC,
1316,GO:0003165,1.00000000000629,0.852404495461094,0,1,Purkinje myocyte development,BP,
19405,GO:1990034,1.0000000000063,0.701784464641205,0,3,calcium ion export across plasma membrane,BP,
3212,GO:0006858,1.0000000000063,0.768852166411359,0,3,extracellular transport,BP,
9667,GO:0038062,1.00000000000633,0.884116004012514,0,1,protein tyrosine kinase collagen receptor activity,MF,
9495,GO:0036166,1.00000000000633,0.693647908782442,0,3,phenotypic switching,BP,
17426,GO:1900239,1.00000000000633,0.693647908782442,0,3,regulation of phenotypic switching,BP,
8128,GO:0032848,1.00000000000634,0.883864128898315,0,1,negative regulation of cellular pH reduction,BP,
10461,GO:0043375,1.00000000000634,0.883864128898315,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11773,GO:0046668,1.00000000000634,0.883864128898315,0,1,regulation of retinal cell programmed cell death,BP,
11774,GO:0046671,1.00000000000634,0.883864128898315,0,1,negative regulation of retinal cell programmed cell death,BP,
3044,GO:0006601,1.00000000000635,0.944112992174694,0,1,creatine biosynthetic process,BP,
7009,GO:0030731,1.00000000000635,0.944112992174694,0,1,guanidinoacetate N-methyltransferase activity,MF,
18847,GO:1904533,1.00000000000636,0.713670178549885,0,3,regulation of telomeric loop disassembly,BP,
14409,GO:0061749,1.00000000000636,0.739691229567922,0,2,forked DNA-dependent helicase activity,MF,
14446,GO:0061849,1.00000000000636,0.739691229567922,0,2,telomeric G-quadruplex DNA binding,MF,
9739,GO:0039513,1.00000000000636,0.909600837740255,0,1,suppression by virus of host catalytic activity,BP,
9741,GO:0039516,1.00000000000636,0.909600837740255,0,1,modulation by virus of host catalytic activity,BP,
9759,GO:0039650,1.00000000000636,0.909600837740255,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13276,GO:0052053,1.00000000000636,0.909600837740255,0,1,negative regulation by symbiont of host catalytic activity,BP,
13283,GO:0052148,1.00000000000636,0.909600837740255,0,1,modulation by symbiont of host catalytic activity,BP,
13292,GO:0052199,1.00000000000636,0.909600837740255,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
15946,GO:0080121,1.00000000000637,0.827619889225427,0,2,AMP transport,BP,
3470,GO:0007308,1.00000000000642,0.913065669250776,0,1,oocyte construction,BP,
3471,GO:0007309,1.00000000000642,0.913065669250776,0,1,oocyte axis specification,BP,
3472,GO:0007314,1.00000000000642,0.913065669250776,0,1,oocyte anterior/posterior axis specification,BP,
3473,GO:0007315,1.00000000000642,0.913065669250776,0,1,pole plasm assembly,BP,
3788,GO:0008358,1.00000000000642,0.913065669250776,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7005,GO:0030719,1.00000000000642,0.913065669250776,0,1,P granule organization,BP,
9291,GO:0035755,1.00000000000642,0.913065669250776,0,1,cardiolipin hydrolase activity,MF,
10052,GO:0042567,1.00000000000642,0.770649557534941,0,2,insulin-like growth factor ternary complex,CC,
5047,GO:0015247,1.00000000000645,0.644530554218553,0,3,aminophospholipid transmembrane transporter activity,MF,
17368,GO:1900127,1.00000000000645,0.715356628282053,0,3,positive regulation of hyaluronan biosynthetic process,BP,
19277,GO:1905572,1.00000000000645,0.908103112536698,0,1,ganglioside GM1 transport to membrane,BP,
19279,GO:1905574,1.00000000000645,0.908103112536698,0,1,ganglioside GM2 binding,MF,
19280,GO:1905575,1.00000000000645,0.908103112536698,0,1,ganglioside GM3 binding,MF,
19282,GO:1905577,1.00000000000645,0.908103112536698,0,1,ganglioside GP1c binding,MF,
15399,GO:0071701,1.00000000000646,0.864051374851589,0,1,regulation of MAPK export from nucleus,BP,
6959,GO:0030623,1.00000000000646,0.83053098387971,0,1,U5 snRNA binding,MF,
14699,GO:0070381,1.00000000000646,0.791917929039181,0,2,endosome to plasma membrane transport vesicle,CC,
10126,GO:0042720,1.00000000000647,0.884845679566127,0,2,mitochondrial inner membrane peptidase complex,CC,
8060,GO:0032747,1.00000000000648,0.814460510767865,0,2,positive regulation of interleukin-23 production,BP,
18416,GO:1903526,1.0000000000065,0.774652249247967,0,2,negative regulation of membrane tubulation,BP,
15761,GO:0072414,1.0000000000065,0.833813993689161,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15768,GO:0072432,1.0000000000065,0.833813993689161,0,1,response to G1 DNA damage checkpoint signaling,BP,
4866,GO:0014732,1.00000000000653,0.733785202698863,0,3,skeletal muscle atrophy,BP,
1519,GO:0003882,1.00000000000655,0.915111511008721,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
16386,GO:0097051,1.00000000000656,0.634005728315784,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
1717,GO:0004311,1.00000000000656,0.75664338718568,0,3,farnesyltranstransferase activity,MF,
13836,GO:0060481,1.00000000000656,0.825783098501428,0,2,lobar bronchus epithelium development,BP,
18284,GO:1903233,1.00000000000656,0.706499270037152,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
15545,GO:0072038,1.00000000000657,0.77686724475846,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15546,GO:0072039,1.00000000000657,0.77686724475846,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15547,GO:0072040,1.00000000000657,0.77686724475846,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17536,GO:1901145,1.00000000000657,0.77686724475846,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18902,GO:1904673,1.00000000000657,0.77686724475846,0,2,negative regulation of somatic stem cell population maintenance,BP,
3930,GO:0008616,1.00000000000658,0.798537820195648,0,3,queuosine biosynthetic process,BP,
11545,GO:0046116,1.00000000000658,0.798537820195648,0,3,queuosine metabolic process,BP,
1593,GO:0004013,1.00000000000659,0.694791386758177,0,3,adenosylhomocysteinase activity,MF,
5680,GO:0016802,1.00000000000659,0.694791386758177,0,3,trialkylsulfonium hydrolase activity,MF,
11547,GO:0046122,1.00000000000659,0.87895862335385,0,2,purine deoxyribonucleoside metabolic process,BP,
9956,GO:0042363,1.00000000000659,0.716062425612318,0,3,fat-soluble vitamin catabolic process,BP,
17970,GO:1902445,1.0000000000066,0.821654810161643,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
1572,GO:0003983,1.00000000000663,0.920043068811949,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
2068,GO:0004823,1.00000000000663,0.756198792617368,0,2,leucine-tRNA ligase activity,MF,
2916,GO:0006429,1.00000000000663,0.756198792617368,0,2,leucyl-tRNA aminoacylation,BP,
13136,GO:0051748,1.00000000000663,0.920043068811949,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
18642,GO:1903999,1.00000000000665,0.81519012031223,0,2,negative regulation of eating behavior,BP,
19779,GO:2000252,1.00000000000665,0.81519012031223,0,2,negative regulation of feeding behavior,BP,
19441,GO:1990168,1.00000000000665,0.67600597419139,0,3,protein K33-linked deubiquitination,BP,
9684,GO:0038101,1.00000000000667,0.927213358080907,0,1,sequestering of nodal from receptor via nodal binding,BP,
17352,GO:1900108,1.00000000000667,0.927213358080907,0,1,negative regulation of nodal signaling pathway,BP,
17379,GO:1900146,1.00000000000667,0.927213358080907,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17398,GO:1900176,1.00000000000667,0.927213358080907,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
6734,GO:0030160,1.00000000000667,0.617089661176662,0,3,GKAP/Homer scaffold activity,MF,
6848,GO:0030327,1.00000000000667,0.704615073128497,0,3,prenylated protein catabolic process,BP,
7000,GO:0030696,1.00000000000668,0.90078556265619,0,1,tRNA (m5U54) methyltransferase activity,MF,
7001,GO:0030697,1.00000000000668,0.90078556265619,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
9205,GO:0035609,1.00000000000669,0.871236688953566,0,1,C-terminal protein deglutamylation,BP,
9206,GO:0035610,1.00000000000669,0.871236688953566,0,1,protein side chain deglutamylation,BP,
13755,GO:0060370,1.00000000000669,0.851136432716521,0,1,susceptibility to T cell mediated cytotoxicity,BP,
11925,GO:0047025,1.00000000000669,0.84398542891048,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
8867,GO:0034696,1.0000000000067,0.840416172630764,0,2,response to prostaglandin F,BP,
16616,GO:0097510,1.00000000000671,0.921538969937264,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
12373,GO:0048822,1.00000000000671,0.648625217258595,0,3,enucleate erythrocyte development,BP,
3602,GO:0008043,1.00000000000673,0.889484765551245,0,2,intracellular ferritin complex,CC,
14647,GO:0070288,1.00000000000673,0.889484765551245,0,2,ferritin complex,CC,
17140,GO:0102773,1.00000000000674,0.870994064438273,0,1,dihydroceramide kinase activity,MF,
4357,GO:0009957,1.00000000000674,0.755434483356231,0,2,epidermal cell fate specification,BP,
1810,GO:0004462,1.00000000000675,0.921645397934851,0,1,lactoylglutathione lyase activity,MF,
2908,GO:0006421,1.00000000000676,0.7461604271313,0,3,asparaginyl-tRNA aminoacylation,BP,
512,GO:0001576,1.00000000000676,0.920928720052926,0,1,globoside biosynthetic process,BP,
1548,GO:0003948,1.00000000000676,0.920928720052926,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12471,GO:0050512,1.00000000000676,0.920928720052926,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
1784,GO:0004408,1.00000000000677,0.917747580133872,0,1,holocytochrome-c synthase activity,MF,
5775,GO:0017003,1.00000000000677,0.917747580133872,0,1,protein-heme linkage,BP,
5778,GO:0017006,1.00000000000677,0.917747580133872,0,1,protein-tetrapyrrole linkage,BP,
5886,GO:0018063,1.00000000000677,0.917747580133872,0,1,cytochrome c-heme linkage,BP,
8749,GO:0034436,1.00000000000678,0.760455653084866,0,3,glycoprotein transport,BP,
13433,GO:0052925,1.00000000000678,0.931548546151938,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
8373,GO:0033292,1.00000000000678,0.67203218398139,0,2,T-tubule organization,BP,
1675,GO:0004142,1.00000000000679,0.742950795102456,0,3,diacylglycerol cholinephosphotransferase activity,MF,
4920,GO:0014876,1.00000000000681,0.934659175184971,0,1,response to injury involved in regulation of muscle adaptation,BP,
5659,GO:0016774,1.00000000000682,0.753217797866365,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
15362,GO:0071641,1.00000000000682,0.823358447386681,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
3849,GO:0008467,1.00000000000683,0.785661833519054,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
17323,GO:1900041,1.00000000000683,0.736978797694438,0,3,negative regulation of interleukin-2 secretion,BP,
191,GO:0000409,1.00000000000684,0.835982010720667,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,1.00000000000684,0.835982010720667,0,1,positive regulation of transcription by galactose,BP,
205,GO:0000431,1.00000000000684,0.835982010720667,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
207,GO:0000435,1.00000000000684,0.835982010720667,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
4,GO:0000010,1.00000000000684,0.828078171711475,0,2,trans-hexaprenyltranstransferase activity,MF,
12447,GO:0050347,1.00000000000684,0.828078171711475,0,2,trans-octaprenyltranstransferase activity,MF,
9570,GO:0036435,1.00000000000685,0.742984014344821,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
9503,GO:0036219,1.00000000000686,0.95231488272853,0,1,GTP diphosphatase activity,MF,
10938,GO:0044713,1.00000000000686,0.95231488272853,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10939,GO:0044714,1.00000000000686,0.95231488272853,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12005,GO:0047693,1.00000000000686,0.95231488272853,0,1,ATP diphosphatase activity,MF,
11491,GO:0046016,1.00000000000686,0.751985167687258,0,3,positive regulation of transcription by glucose,BP,
18916,GO:1904700,1.00000000000687,0.912593521759335,0,1,granulosa cell apoptotic process,BP,
18921,GO:1904708,1.00000000000687,0.912593521759335,0,1,regulation of granulosa cell apoptotic process,BP,
17880,GO:1902216,1.00000000000688,0.825614839391784,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
5995,GO:0019034,1.00000000000688,0.753042188731561,0,2,viral replication complex,CC,
6259,GO:0019858,1.00000000000689,0.838850693755774,0,2,cytosine metabolic process,BP,
10674,GO:0043974,1.00000000000691,0.671046217499784,0,3,histone H3-K27 acetylation,BP,
17713,GO:1901674,1.00000000000691,0.671046217499784,0,3,regulation of histone H3-K27 acetylation,BP,
16562,GO:0097409,1.00000000000691,0.923084640683984,0,1,glial cytoplasmic inclusion,CC,
16565,GO:0097414,1.00000000000691,0.923084640683984,0,1,classical Lewy body,CC,
16588,GO:0097462,1.00000000000691,0.923084640683984,0,1,Lewy neurite,CC,
19408,GO:1990038,1.00000000000691,0.923084640683984,0,1,Lewy body corona,CC,
17733,GO:1901726,1.00000000000691,0.78716606667764,0,1,negative regulation of histone deacetylase activity,BP,
3293,GO:0006990,1.00000000000692,0.69553400237881,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
7707,GO:0032207,1.00000000000692,0.906784434051045,0,1,regulation of telomere maintenance via recombination,BP,
7708,GO:0032208,1.00000000000692,0.906784434051045,0,1,negative regulation of telomere maintenance via recombination,BP,
18408,GO:1903517,1.00000000000692,0.906784434051045,0,1,negative regulation of single strand break repair,BP,
18529,GO:1903770,1.00000000000692,0.906784434051045,0,1,negative regulation of beta-galactosidase activity,BP,
18551,GO:1903823,1.00000000000692,0.906784434051045,0,1,telomere single strand break repair,BP,
18552,GO:1903824,1.00000000000692,0.906784434051045,0,1,negative regulation of telomere single strand break repair,BP,
8382,GO:0033319,1.00000000000693,0.92086396987974,0,1,UDP-D-xylose metabolic process,BP,
8383,GO:0033320,1.00000000000693,0.92086396987974,0,1,UDP-D-xylose biosynthetic process,BP,
12063,GO:0048040,1.00000000000693,0.92086396987974,0,1,UDP-glucuronate decarboxylase activity,MF,
2063,GO:0004818,1.00000000000693,0.759647574675943,0,2,glutamate-tRNA ligase activity,MF,
2911,GO:0006424,1.00000000000693,0.759647574675943,0,2,glutamyl-tRNA aminoacylation,BP,
16468,GO:0097195,1.00000000000694,0.798511429499163,0,2,pilomotor reflex,BP,
10212,GO:0042923,1.00000000000695,0.848313659796509,0,2,neuropeptide binding,MF,
20186,GO:2001136,1.00000000000695,0.896195713581707,0,1,negative regulation of endocytic recycling,BP,
6328,GO:0021503,1.00000000000695,0.81643682518955,0,1,neural fold bending,BP,
4895,GO:0014827,1.00000000000697,0.918687064478856,0,1,intestine smooth muscle contraction,BP,
15439,GO:0071812,1.00000000000698,0.901583488513463,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15458,GO:0071848,1.00000000000698,0.901583488513463,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
3160,GO:0006772,1.00000000000699,0.92596788660222,0,1,thiamine metabolic process,BP,
9952,GO:0042357,1.00000000000699,0.92596788660222,0,1,thiamine diphosphate metabolic process,BP,
12444,GO:0050333,1.00000000000699,0.92596788660222,0,1,thiamin-triphosphatase activity,MF,
1811,GO:0004463,1.00000000000699,0.921172094262193,0,1,leukotriene-A4 hydrolase activity,MF,
9339,GO:0035868,1.00000000000699,0.747206253659256,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
18298,GO:1903279,1.000000000007,0.803066321417632,0,2,regulation of calcium:sodium antiporter activity,BP,
18299,GO:1903281,1.000000000007,0.803066321417632,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18128,GO:1902897,1.00000000000701,0.802384857986157,0,2,regulation of postsynaptic density protein 95 clustering,BP,
19357,GO:1905874,1.00000000000701,0.802384857986157,0,2,regulation of postsynaptic density organization,BP,
16098,GO:0090119,1.00000000000701,0.869510957030594,0,1,vesicle-mediated cholesterol transport,BP,
18752,GO:1904290,1.00000000000701,0.869510957030594,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
19641,GO:1990926,1.00000000000701,0.869510957030594,0,1,short-term synaptic potentiation,BP,
1645,GO:0004092,1.00000000000702,0.908368468104053,0,1,carnitine O-acetyltransferase activity,MF,
5211,GO:0015817,1.00000000000703,0.90899143747198,0,1,histidine transport,BP,
7520,GO:0031753,1.00000000000703,0.90899143747198,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7521,GO:0031755,1.00000000000703,0.90899143747198,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
3128,GO:0006713,1.00000000000704,0.926078901171972,0,1,glucocorticoid catabolic process,BP,
16946,GO:0099010,1.00000000000706,0.64865443881827,0,3,modification of postsynaptic structure,BP,
11956,GO:0047277,1.00000000000706,0.923245719201514,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
2887,GO:0006397,1.00000000000708,0,8,439,mRNA processing,BP,ZFP36L1;MBNL2;ADARB1;RBFOX2;SETX;CELF2;SRPK2;LGALS3
10300,GO:0043111,1.00000000000709,0.805219364897755,0,2,replication fork arrest,BP,
79,GO:0000160,1.00000000000709,0.887189098861629,0,1,phosphorelay signal transduction system,BP,
19130,GO:1905168,1.00000000000709,0.887189098861629,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
7699,GO:0032197,1.00000000000709,0.881866544276625,0,1,transposition, RNA-mediated,BP,
19447,GO:1990175,1.00000000000709,0.881866544276625,0,1,EH domain binding,MF,
6089,GO:0019287,1.00000000000711,0.79884329616803,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
17095,GO:0102121,1.00000000000711,0.829020386685891,0,2,ceramidase activity,MF,
19005,GO:1904875,1.00000000000711,0.834731829157571,0,2,regulation of DNA ligase activity,BP,
15693,GO:0072287,1.00000000000711,0.751222789918088,0,1,metanephric distal tubule morphogenesis,BP,
12383,GO:0048852,1.00000000000712,0.658991162441384,0,3,diencephalon morphogenesis,BP,
7676,GO:0032137,1.00000000000713,0.71984755742361,0,3,guanine/thymine mispair binding,MF,
13544,GO:0060040,1.00000000000715,0.810716521892054,0,2,retinal bipolar neuron differentiation,BP,
3099,GO:0006679,1.00000000000715,0.799147114869896,0,2,glucosylceramide biosynthetic process,BP,
1385,GO:0003292,1.00000000000716,0.8516120512926,0,1,cardiac septum cell differentiation,BP,
14065,GO:0060922,1.00000000000716,0.8516120512926,0,1,atrioventricular node cell differentiation,BP,
14068,GO:0060928,1.00000000000716,0.8516120512926,0,1,atrioventricular node cell development,BP,
19306,GO:1905651,1.00000000000716,0.641697957399489,0,3,regulation of artery morphogenesis,BP,
19307,GO:1905653,1.00000000000716,0.641697957399489,0,3,positive regulation of artery morphogenesis,BP,
17089,GO:0102008,1.00000000000716,0.861571997572659,0,1,cytosolic dipeptidase activity,MF,
17150,GO:0103046,1.00000000000716,0.861571997572659,0,1,alanylglutamate dipeptidase activity,MF,
14038,GO:0060846,1.00000000000717,0.752005267155477,0,3,blood vessel endothelial cell fate commitment,BP,
14039,GO:0060847,1.00000000000717,0.752005267155477,0,3,endothelial cell fate specification,BP,
16410,GO:0097101,1.00000000000717,0.752005267155477,0,3,blood vessel endothelial cell fate specification,BP,
9906,GO:0042270,1.00000000000719,0.754985652113246,0,3,protection from natural killer cell mediated cytotoxicity,BP,
15317,GO:0071573,1.0000000000072,0.906018871222238,0,1,shelterin complex assembly,BP,
18964,GO:1904790,1.0000000000072,0.906018871222238,0,1,regulation of shelterin complex assembly,BP,
18965,GO:1904792,1.0000000000072,0.906018871222238,0,1,positive regulation of shelterin complex assembly,BP,
18994,GO:1904850,1.0000000000072,0.906018871222238,0,1,negative regulation of establishment of protein localization to telomere,BP,
19028,GO:1904910,1.0000000000072,0.906018871222238,0,1,regulation of establishment of RNA localization to telomere,BP,
19029,GO:1904911,1.0000000000072,0.906018871222238,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19030,GO:1904913,1.0000000000072,0.906018871222238,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19031,GO:1904914,1.0000000000072,0.906018871222238,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
17118,GO:0102485,1.00000000000721,0.698209237664205,0,2,dATP phosphohydrolase activity,MF,
17119,GO:0102486,1.00000000000721,0.698209237664205,0,2,dCTP phosphohydrolase activity,MF,
17120,GO:0102487,1.00000000000721,0.698209237664205,0,2,dUTP phosphohydrolase activity,MF,
17121,GO:0102488,1.00000000000721,0.698209237664205,0,2,dTTP phosphohydrolase activity,MF,
17122,GO:0102489,1.00000000000721,0.698209237664205,0,2,GTP phosphohydrolase activity,MF,
17123,GO:0102490,1.00000000000721,0.698209237664205,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17124,GO:0102491,1.00000000000721,0.698209237664205,0,2,dGTP phosphohydrolase activity,MF,
7092,GO:0030899,1.00000000000722,0.94405922048295,0,1,calcium-dependent ATPase activity,MF,
7381,GO:0031444,1.00000000000722,0.94405922048295,0,1,slow-twitch skeletal muscle fiber contraction,BP,
13702,GO:0060300,1.00000000000722,0.785456890758693,0,3,regulation of cytokine activity,BP,
10465,GO:0043382,1.00000000000723,0.782166537419117,0,3,positive regulation of memory T cell differentiation,BP,
5087,GO:0015362,1.00000000000724,0.878849417622931,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
9289,GO:0035752,1.00000000000725,0.924009670465031,0,1,lysosomal lumen pH elevation,BP,
7121,GO:0030956,1.00000000000725,0.765164158001372,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12477,GO:0050567,1.00000000000725,0.765164158001372,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14862,GO:0070681,1.00000000000725,0.765164158001372,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
2578,GO:0005873,1.00000000000728,0.663225020991827,0,3,plus-end kinesin complex,CC,
3822,GO:0008426,1.00000000000728,0.786057503635105,0,3,protein kinase C inhibitor activity,MF,
2159,GO:0004992,1.00000000000728,0.877171736720939,0,1,platelet activating factor receptor activity,MF,
4989,GO:0015130,1.00000000000728,0.877171736720939,0,1,mevalonate transmembrane transporter activity,MF,
5169,GO:0015728,1.00000000000728,0.877171736720939,0,1,mevalonate transport,BP,
10436,GO:0043315,1.00000000000728,0.877171736720939,0,1,positive regulation of neutrophil degranulation,BP,
13147,GO:0051780,1.00000000000728,0.877171736720939,0,1,behavioral response to nutrient,BP,
15120,GO:0071258,1.00000000000728,0.877171736720939,0,1,cellular response to gravity,BP,
18015,GO:1902565,1.00000000000728,0.877171736720939,0,1,positive regulation of neutrophil activation,BP,
18148,GO:1902941,1.00000000000728,0.877171736720939,0,1,regulation of voltage-gated chloride channel activity,BP,
18149,GO:1902943,1.00000000000728,0.877171736720939,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18543,GO:1903797,1.00000000000728,0.877171736720939,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18756,GO:1904298,1.00000000000728,0.877171736720939,0,1,regulation of transcytosis,BP,
18757,GO:1904300,1.00000000000728,0.877171736720939,0,1,positive regulation of transcytosis,BP,
18758,GO:1904301,1.00000000000728,0.877171736720939,0,1,regulation of maternal process involved in parturition,BP,
18759,GO:1904303,1.00000000000728,0.877171736720939,0,1,positive regulation of maternal process involved in parturition,BP,
18764,GO:1904316,1.00000000000728,0.877171736720939,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18765,GO:1904317,1.00000000000728,0.877171736720939,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
17960,GO:1902412,1.00000000000728,0.628227922598425,0,3,regulation of mitotic cytokinesis,BP,
14554,GO:0070124,1.00000000000729,0.857857802442617,0,2,mitochondrial translational initiation,BP,
19220,GO:1905404,1.00000000000729,0.931081387237746,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
7283,GO:0031291,1.00000000000729,0.750830316122719,0,3,Ran protein signal transduction,BP,
12692,GO:0050955,1.0000000000073,0.877256906901867,0,1,thermoception,BP,
12694,GO:0050960,1.0000000000073,0.877256906901867,0,1,detection of temperature stimulus involved in thermoception,BP,
12699,GO:0050968,1.0000000000073,0.877256906901867,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
13822,GO:0060454,1.0000000000073,0.877256906901867,0,1,positive regulation of gastric acid secretion,BP,
16161,GO:0090212,1.0000000000073,0.877256906901867,0,1,negative regulation of establishment of blood-brain barrier,BP,
16647,GO:0097603,1.0000000000073,0.877256906901867,0,1,temperature-gated ion channel activity,MF,
17673,GO:1901594,1.0000000000073,0.877256906901867,0,1,response to capsazepine,BP,
12485,GO:0050652,1.0000000000073,0.886843662356275,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12486,GO:0050653,1.0000000000073,0.886843662356275,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
1984,GO:0004706,1.00000000000731,0.679141105064142,0,3,JUN kinase kinase kinase activity,MF,
5751,GO:0016917,1.00000000000732,0.68877629089235,0,3,GABA receptor activity,MF,
2220,GO:0005124,1.00000000000733,0.915881813841268,0,1,scavenger receptor binding,MF,
3998,GO:0008940,1.00000000000733,0.719325446656866,0,3,nitrate reductase activity,MF,
5418,GO:0016277,1.00000000000733,0.915881813841268,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17747,GO:1901804,1.00000000000733,0.915881813841268,0,1,beta-glucoside metabolic process,BP,
17748,GO:1901805,1.00000000000733,0.915881813841268,0,1,beta-glucoside catabolic process,BP,
18822,GO:1904457,1.00000000000733,0.915881813841268,0,1,positive regulation of neuronal action potential,BP,
2171,GO:0005008,1.00000000000733,0.839150064699203,0,1,hepatocyte growth factor-activated receptor activity,MF,
18944,GO:1904750,1.00000000000733,0.839150064699203,0,1,negative regulation of protein localization to nucleolus,BP,
3173,GO:0006789,1.00000000000734,0.916368319258553,0,1,bilirubin conjugation,BP,
6461,GO:0021797,1.00000000000734,0.894959967179934,0,1,forebrain anterior/posterior pattern specification,BP,
6500,GO:0021881,1.00000000000734,0.894959967179934,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12164,GO:0048320,1.00000000000734,0.894959967179934,0,1,axial mesoderm formation,BP,
14024,GO:0060823,1.00000000000734,0.894959967179934,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
17796,GO:1901980,1.00000000000736,0.796906630324355,0,1,positive regulation of inward rectifier potassium channel activity,BP,
15737,GO:0072363,1.00000000000736,0.797620714214939,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15740,GO:0072366,1.00000000000736,0.797620714214939,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
6504,GO:0021886,1.00000000000737,0.736766867487536,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6505,GO:0021888,1.00000000000737,0.736766867487536,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
13119,GO:0051715,1.00000000000737,0.83453999603353,0,3,cytolysis in other organism,BP,
1504,GO:0003860,1.00000000000738,0.923578509608088,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
7604,GO:0032002,1.00000000000739,0.837502576678249,0,2,interleukin-28 receptor complex,CC,
18673,GO:1904058,1.00000000000739,0.67659280059901,0,3,positive regulation of sensory perception of pain,BP,
702,GO:0001923,1.00000000000739,0.709216237151798,0,3,B-1 B cell differentiation,BP,
6739,GO:0030167,1.0000000000074,0.747989202396503,0,3,proteoglycan catabolic process,BP,
6757,GO:0030200,1.0000000000074,0.747989202396503,0,3,heparan sulfate proteoglycan catabolic process,BP,
1517,GO:0003880,1.0000000000074,0.734297098460348,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2950,GO:0006481,1.0000000000074,0.734297098460348,0,3,C-terminal protein methylation,BP,
5394,GO:0016237,1.0000000000074,0.862153437079096,0,1,lysosomal microautophagy,BP,
6222,GO:0019778,1.0000000000074,0.862153437079096,0,1,Atg12 activating enzyme activity,MF,
6223,GO:0019779,1.0000000000074,0.862153437079096,0,1,Atg8 activating enzyme activity,MF,
8889,GO:0034727,1.0000000000074,0.862153437079096,0,1,piecemeal microautophagy of the nucleus,BP,
9744,GO:0039521,1.0000000000074,0.862153437079096,0,1,suppression by virus of host autophagy,BP,
14415,GO:0061760,1.0000000000074,0.906160195274862,0,1,antifungal innate immune response,BP,
19078,GO:1905034,1.0000000000074,0.906160195274862,0,1,regulation of antifungal innate immune response,BP,
19079,GO:1905035,1.0000000000074,0.906160195274862,0,1,negative regulation of antifungal innate immune response,BP,
19635,GO:1990910,1.0000000000074,0.760835978581343,0,3,response to hypobaric hypoxia,BP,
13727,GO:0060332,1.0000000000074,0.616626866197458,0,3,positive regulation of response to interferon-gamma,BP,
13730,GO:0060335,1.0000000000074,0.616626866197458,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
2298,GO:0005275,1.00000000000741,0.904069846267851,0,1,amine transmembrane transporter activity,MF,
5052,GO:0015265,1.00000000000741,0.904069846267851,0,1,urea channel activity,MF,
15009,GO:0070984,1.00000000000741,0.876569273083353,0,1,SET domain binding,MF,
2992,GO:0006540,1.00000000000742,0.787637020577912,0,2,glutamate decarboxylation to succinate,BP,
5451,GO:0016333,1.00000000000742,0.905887971610127,0,1,morphogenesis of follicular epithelium,BP,
5452,GO:0016334,1.00000000000742,0.905887971610127,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9894,GO:0042247,1.00000000000742,0.905887971610127,0,1,establishment of planar polarity of follicular epithelium,BP,
10102,GO:0042643,1.00000000000742,0.905887971610127,0,1,actomyosin, actin portion,CC,
12386,GO:0048855,1.00000000000742,0.842945310601335,0,1,adenohypophysis morphogenesis,BP,
10492,GO:0043418,1.00000000000743,0.749918969169521,0,3,homocysteine catabolic process,BP,
3989,GO:0008890,1.00000000000744,0.930142180495411,0,1,glycine C-acetyltransferase activity,MF,
6159,GO:0019518,1.00000000000744,0.930142180495411,0,1,L-threonine catabolic process to glycine,BP,
6417,GO:0021688,1.00000000000745,0.897089748455366,0,1,cerebellar molecular layer formation,BP,
14042,GO:0060853,1.00000000000745,0.897089748455366,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
922,GO:0002318,1.00000000000745,0.738593699968216,0,3,myeloid progenitor cell differentiation,BP,
15998,GO:0086047,1.00000000000745,0.878651572616827,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18706,GO:1904199,1.00000000000745,0.878651572616827,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19576,GO:1990736,1.00000000000745,0.878651572616827,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
11018,GO:0045016,1.00000000000745,0.896270385230417,0,1,mitochondrial magnesium ion transmembrane transport,BP,
14989,GO:0070949,1.00000000000746,0.846486429811823,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
14993,GO:0070960,1.00000000000746,0.846486429811823,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
14994,GO:0070961,1.00000000000746,0.846486429811823,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
8521,GO:0033860,1.00000000000747,0.821098184633908,0,3,regulation of NAD(P)H oxidase activity,BP,
8523,GO:0033864,1.00000000000747,0.821098184633908,0,3,positive regulation of NAD(P)H oxidase activity,BP,
19384,GO:1905940,1.00000000000749,0.737054429709032,0,3,negative regulation of gonad development,BP,
11915,GO:0046985,1.00000000000749,0.77748646806321,0,3,positive regulation of hemoglobin biosynthetic process,BP,
18307,GO:1903294,1.0000000000075,0.760967803478865,0,2,regulation of glutamate secretion, neurotransmission,BP,
18308,GO:1903296,1.0000000000075,0.760967803478865,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
2235,GO:0005143,1.0000000000075,0.79097227730093,0,2,interleukin-12 receptor binding,MF,
829,GO:0002118,1.00000000000751,0.894170721378409,0,1,aggressive behavior,BP,
830,GO:0002121,1.00000000000751,0.894170721378409,0,1,inter-male aggressive behavior,BP,
14262,GO:0061386,1.00000000000752,0.687246464399332,0,2,closure of optic fissure,BP,
485,GO:0001537,1.00000000000752,0.782507181691393,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
3724,GO:0008254,1.00000000000752,0.831912976611257,0,1,3'-nucleotidase activity,MF,
3072,GO:0006642,1.00000000000753,0.69372789944894,0,3,triglyceride mobilization,BP,
10128,GO:0042723,1.00000000000754,0.764686117706516,0,3,thiamine-containing compound metabolic process,BP,
8025,GO:0032685,1.00000000000755,0.898273793637963,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8763,GO:0034457,1.0000000000076,0.808913089854881,0,3,Mpp10 complex,CC,
490,GO:0001543,1.00000000000761,0.827691322288125,0,1,ovarian follicle rupture,BP,
1509,GO:0003870,1.00000000000762,0.916931901348621,0,1,5-aminolevulinate synthase activity,MF,
5648,GO:0016749,1.00000000000762,0.916931901348621,0,1,N-succinyltransferase activity,MF,
11768,GO:0046657,1.00000000000762,0.820960297756557,0,2,folic acid catabolic process,BP,
9224,GO:0035634,1.00000000000763,0.892881258940115,0,2,response to stilbenoid,BP,
2043,GO:0004792,1.00000000000763,0.802934568898931,0,3,thiosulfate sulfurtransferase activity,MF,
2041,GO:0004790,1.00000000000764,0.913325225475921,0,1,thioether S-methyltransferase activity,MF,
7012,GO:0030748,1.00000000000764,0.913325225475921,0,1,amine N-methyltransferase activity,MF,
17134,GO:0102707,1.00000000000764,0.913325225475921,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
6225,GO:0019781,1.00000000000765,0.851900495306418,0,2,NEDD8 activating enzyme activity,MF,
14022,GO:0060819,1.00000000000766,0.710049413283439,0,2,inactivation of X chromosome by genetic imprinting,BP,
4205,GO:0009331,1.00000000000767,0.748926207454091,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
13555,GO:0060051,1.00000000000768,0.842241515071249,0,2,negative regulation of protein glycosylation,BP,
16206,GO:0090285,1.00000000000768,0.842241515071249,0,2,negative regulation of protein glycosylation in Golgi,BP,
5085,GO:0015350,1.00000000000769,0.764061051521577,0,2,methotrexate transmembrane transporter activity,MF,
13242,GO:0051958,1.00000000000769,0.764061051521577,0,2,methotrexate transport,BP,
2129,GO:0004935,1.00000000000772,0.847502208722413,0,2,adrenergic receptor activity,MF,
1648,GO:0004098,1.00000000000774,0.924018347871953,0,1,cerebroside-sulfatase activity,MF,
11894,GO:0046958,1.00000000000775,0.898200096591235,0,1,nonassociative learning,BP,
12268,GO:0048625,1.00000000000775,0.693357940379791,0,3,myoblast fate commitment,BP,
18938,GO:1904743,1.00000000000776,0.672121515977009,0,2,negative regulation of telomeric DNA binding,BP,
17608,GO:1901350,1.00000000000778,0.833962056354102,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
19062,GO:1904990,1.00000000000778,0.915301018652178,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19063,GO:1904992,1.00000000000778,0.915301018652178,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
1820,GO:0004475,1.00000000000778,0.929702024654864,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
3996,GO:0008905,1.00000000000778,0.929702024654864,0,1,mannose-phosphate guanylyltransferase activity,MF,
2765,GO:0006185,1.0000000000078,0.944544335569017,0,1,dGDP biosynthetic process,BP,
4111,GO:0009170,1.0000000000078,0.944544335569017,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4120,GO:0009183,1.0000000000078,0.944544335569017,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11507,GO:0046054,1.0000000000078,0.944544335569017,0,1,dGMP metabolic process,BP,
11794,GO:0046711,1.0000000000078,0.944544335569017,0,1,GDP biosynthetic process,BP,
7086,GO:0030893,1.0000000000078,0.644676484043633,0,3,meiotic cohesin complex,CC,
14389,GO:0061709,1.0000000000078,0.838935108618324,0,1,reticulophagy,BP,
3636,GO:0008108,1.00000000000781,0.935673929996158,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
17085,GO:0101030,1.00000000000781,0.935673929996158,0,1,tRNA-guanine transglycosylation,BP,
19514,GO:1990448,1.00000000000781,0.839723795382986,0,1,exon-exon junction complex binding,MF,
12437,GO:0050290,1.00000000000782,0.865794721005381,0,1,sphingomyelin phosphodiesterase D activity,MF,
5025,GO:0015195,1.00000000000782,0.873825924705735,0,1,L-threonine transmembrane transporter activity,MF,
5218,GO:0015826,1.00000000000782,0.873825924705735,0,1,threonine transport,BP,
8801,GO:0034589,1.00000000000782,0.873825924705735,0,1,hydroxyproline transport,BP,
8802,GO:0034590,1.00000000000782,0.873825924705735,0,1,L-hydroxyproline transmembrane transporter activity,MF,
3344,GO:0007066,1.00000000000783,0.946015171409821,0,1,female meiosis sister chromatid cohesion,BP,
18229,GO:1903093,1.00000000000784,0.738955510074537,0,3,regulation of protein K48-linked deubiquitination,BP,
18649,GO:1904021,1.00000000000784,0.894621939058806,0,1,negative regulation of G-protein coupled receptor internalization,BP,
5517,GO:0016493,1.00000000000787,0.825142240051599,0,2,C-C chemokine receptor activity,MF,
9110,GO:0035441,1.00000000000787,0.816517182298039,0,1,cell migration involved in vasculogenesis,BP,
14310,GO:0061535,1.00000000000789,0.586064555035145,0,3,glutamate secretion, neurotransmission,BP,
16576,GO:0097441,1.00000000000789,0.658142879139635,0,3,basal dendrite,CC,
19550,GO:1990604,1.0000000000079,0.693249170978445,0,3,IRE1-TRAF2-ASK1 complex,CC,
1511,GO:0003873,1.0000000000079,0.66733545563405,0,3,6-phosphofructo-2-kinase activity,MF,
1069,GO:0002636,1.00000000000791,0.931124617925364,0,1,positive regulation of germinal center formation,BP,
2749,GO:0006157,1.00000000000791,0.931124617925364,0,1,deoxyadenosine catabolic process,BP,
9936,GO:0042321,1.00000000000791,0.931124617925364,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9937,GO:0042323,1.00000000000791,0.931124617925364,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11531,GO:0046090,1.00000000000791,0.931124617925364,0,1,deoxyadenosine metabolic process,BP,
11542,GO:0046111,1.00000000000791,0.931124617925364,0,1,xanthine biosynthetic process,BP,
11548,GO:0046124,1.00000000000791,0.931124617925364,0,1,purine deoxyribonucleoside catabolic process,BP,
13627,GO:0060167,1.00000000000791,0.931124617925364,0,1,regulation of adenosine receptor signaling pathway,BP,
13628,GO:0060169,1.00000000000791,0.931124617925364,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13787,GO:0060407,1.00000000000791,0.931124617925364,0,1,negative regulation of penile erection,BP,
14630,GO:0070256,1.00000000000791,0.931124617925364,0,1,negative regulation of mucus secretion,BP,
12108,GO:0048209,1.00000000000794,0.789568465491219,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
3637,GO:0008109,1.00000000000795,0.777691596150486,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
2212,GO:0005105,1.00000000000796,0.917930901404597,0,1,type 1 fibroblast growth factor receptor binding,MF,
5545,GO:0016557,1.00000000000796,0.790802967457712,0,3,peroxisome membrane biogenesis,BP,
14426,GO:0061783,1.00000000000796,0.809963275617386,0,3,peptidoglycan muralytic activity,MF,
10944,GO:0044725,1.00000000000801,0.786280663430542,0,1,chromatin reprogramming in the zygote,BP,
10945,GO:0044727,1.00000000000801,0.786280663430542,0,1,DNA demethylation of male pronucleus,BP,
9655,GO:0038033,1.00000000000802,0.758831545715852,0,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
1510,GO:0003872,1.00000000000802,0.738761457394717,0,3,6-phosphofructokinase activity,MF,
7537,GO:0031849,1.00000000000804,0.886008469997426,0,1,olfactory receptor binding,MF,
7900,GO:0032484,1.00000000000804,0.643771126167487,0,3,Ral protein signal transduction,BP,
7901,GO:0032485,1.00000000000804,0.643771126167487,0,3,regulation of Ral protein signal transduction,BP,
15811,GO:0072554,1.00000000000805,0.916618379048869,0,1,blood vessel lumenization,BP,
17549,GO:1901189,1.00000000000805,0.916618379048869,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17584,GO:1901297,1.00000000000805,0.916618379048869,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19099,GO:1905068,1.00000000000805,0.916618379048869,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
721,GO:0001951,1.00000000000805,0.689679798160426,0,3,intestinal D-glucose absorption,BP,
17158,GO:0106001,1.00000000000805,0.689679798160426,0,3,intestinal hexose absorption,BP,
10034,GO:0042536,1.00000000000806,0.774672421496746,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
6364,GO:0021555,1.00000000000806,0.800205090588908,0,2,midbrain-hindbrain boundary morphogenesis,BP,
14984,GO:0070943,1.00000000000806,0.785678443833741,0,3,neutrophil mediated killing of symbiont cell,BP,
17332,GO:1900063,1.00000000000808,0.623145685681278,0,3,regulation of peroxisome organization,BP,
1835,GO:0004492,1.0000000000081,0.92049276482595,0,1,methylmalonyl-CoA decarboxylase activity,MF,
10670,GO:0043969,1.0000000000081,0.812346572525184,0,1,histone H2B acetylation,BP,
14464,GO:0061920,1.0000000000081,0.812346572525184,0,1,protein propionyltransferase activity,MF,
14465,GO:0061921,1.0000000000081,0.812346572525184,0,1,peptidyl-lysine propionylation,BP,
17263,GO:0140064,1.0000000000081,0.812346572525184,0,1,peptide crotonyltransferase activity,MF,
17264,GO:0140065,1.0000000000081,0.812346572525184,0,1,peptide butyryltransferase activity,MF,
17266,GO:0140067,1.0000000000081,0.812346572525184,0,1,peptidyl-lysine butyrylation,BP,
17267,GO:0140068,1.0000000000081,0.812346572525184,0,1,histone crotonyltransferase activity,MF,
17268,GO:0140069,1.0000000000081,0.812346572525184,0,1,histone butyryltransferase activity,MF,
15128,GO:0071275,1.00000000000813,0.919946969752727,0,1,cellular response to aluminum ion,BP,
19314,GO:1905672,1.00000000000813,0.919946969752727,0,1,negative regulation of lysosome organization,BP,
1730,GO:0004329,1.00000000000816,0.794397850995358,0,2,formate-tetrahydrofolate ligase activity,MF,
4176,GO:0009257,1.00000000000816,0.794397850995358,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
1628,GO:0004069,1.00000000000817,0.842127212477934,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2985,GO:0006532,1.00000000000817,0.842127212477934,0,2,aspartate biosynthetic process,BP,
2986,GO:0006533,1.00000000000817,0.842127212477934,0,2,aspartate catabolic process,BP,
6174,GO:0019550,1.00000000000817,0.842127212477934,0,2,glutamate catabolic process to aspartate,BP,
6175,GO:0019551,1.00000000000817,0.842127212477934,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
3774,GO:0008332,1.00000000000819,0.923484344137015,0,1,low voltage-gated calcium channel activity,MF,
6481,GO:0021840,1.00000000000819,0.916255113936888,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6482,GO:0021842,1.00000000000819,0.916255113936888,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
2412,GO:0005589,1.0000000000082,0.710532182556743,0,2,collagen type VI trimer,CC,
16774,GO:0098647,1.0000000000082,0.710532182556743,0,2,collagen beaded filament,CC,
8714,GO:0034378,1.0000000000082,0.731209436704101,0,3,chylomicron assembly,BP,
11465,GO:0045950,1.0000000000082,0.829532673804759,0,2,negative regulation of mitotic recombination,BP,
6208,GO:0019732,1.00000000000821,0.821820672118422,0,2,antifungal humoral response,BP,
13737,GO:0060342,1.00000000000823,0.924419922119709,0,1,photoreceptor inner segment membrane,CC,
19903,GO:2000427,1.00000000000823,0.719274975513095,0,2,positive regulation of apoptotic cell clearance,BP,
8836,GO:0034647,1.00000000000824,0.663207042680989,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8885,GO:0034721,1.00000000000824,0.663207042680989,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
2935,GO:0006463,1.00000000000825,0.886351702236898,0,1,steroid hormone receptor complex assembly,BP,
18912,GO:1904691,1.00000000000827,0.920283706824159,0,1,negative regulation of type B pancreatic cell proliferation,BP,
1271,GO:0003064,1.00000000000828,0.925094377052251,0,1,regulation of heart rate by hormone,BP,
19374,GO:1905912,1.00000000000828,0.925094377052251,0,1,regulation of calcium ion export across plasma membrane,BP,
19375,GO:1905913,1.00000000000828,0.925094377052251,0,1,negative regulation of calcium ion export across plasma membrane,BP,
1808,GO:0004459,1.00000000000829,0.798240884772126,0,3,L-lactate dehydrogenase activity,MF,
17710,GO:1901668,1.00000000000831,0.796646351239061,0,3,regulation of superoxide dismutase activity,BP,
7239,GO:0031208,1.00000000000832,0.764706381898937,0,2,POZ domain binding,MF,
14990,GO:0070950,1.00000000000832,0.907208766749913,0,1,regulation of neutrophil mediated killing of bacterium,BP,
14991,GO:0070951,1.00000000000832,0.907208766749913,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14995,GO:0070962,1.00000000000832,0.907208766749913,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
14996,GO:0070963,1.00000000000832,0.907208766749913,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16149,GO:0090198,1.00000000000832,0.907208766749913,0,1,negative regulation of chemokine secretion,BP,
16376,GO:0097029,1.00000000000832,0.907208766749913,0,1,mature conventional dendritic cell differentiation,BP,
17373,GO:1900135,1.00000000000832,0.907208766749913,0,1,positive regulation of renin secretion into blood stream,BP,
19057,GO:1904977,1.00000000000832,0.907208766749913,0,1,lymphatic endothelial cell migration,BP,
14516,GO:0070060,1.00000000000834,0.808120108905835,0,1,'de novo' actin filament nucleation,BP,
6932,GO:0030550,1.00000000000834,0.728691909341739,0,3,acetylcholine receptor inhibitor activity,MF,
17992,GO:1902512,1.00000000000834,0.821436942426124,0,3,positive regulation of apoptotic DNA fragmentation,BP,
1002,GO:0002477,1.00000000000836,0.944679554210097,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1006,GO:0002481,1.00000000000836,0.944679554210097,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
7023,GO:0030807,1.00000000000837,0.847848540069611,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7038,GO:0030822,1.00000000000837,0.847848540069611,0,1,positive regulation of cAMP catabolic process,BP,
8281,GO:0033123,1.00000000000837,0.847848540069611,0,1,positive regulation of purine nucleotide catabolic process,BP,
1205,GO:0002866,1.00000000000837,0.760052598278725,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
55,GO:0000117,1.00000000000837,0.85271427833201,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
1899,GO:0004586,1.00000000000838,0.730458812052696,0,3,ornithine decarboxylase activity,MF,
8399,GO:0033387,1.00000000000838,0.730458812052696,0,3,putrescine biosynthetic process from ornithine,BP,
3718,GO:0008240,1.00000000000839,0.772003169778127,0,2,tripeptidyl-peptidase activity,MF,
11160,GO:0045272,1.0000000000084,0.803843640212962,0,3,plasma membrane respiratory chain complex I,CC,
18448,GO:1903575,1.00000000000841,0.834847589143314,0,2,cornified envelope assembly,BP,
17920,GO:1902292,1.00000000000842,0.939588087967681,0,1,cell cycle DNA replication initiation,BP,
17933,GO:1902315,1.00000000000842,0.939588087967681,0,1,nuclear cell cycle DNA replication initiation,BP,
18171,GO:1902975,1.00000000000842,0.939588087967681,0,1,mitotic DNA replication initiation,BP,
17164,GO:0106017,1.00000000000842,0.62885913569575,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
4916,GO:0014859,1.00000000000842,0.89674261339795,0,1,negative regulation of skeletal muscle cell proliferation,BP,
18067,GO:1902723,1.00000000000842,0.89674261339795,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
10417,GO:0043293,1.00000000000843,0.772558533595176,0,2,apoptosome,CC,
667,GO:0001875,1.00000000000844,0.715221945027117,0,3,lipopolysaccharide receptor activity,MF,
19631,GO:1990889,1.00000000000845,0.924737629150097,0,1,H4K20me3 modified histone binding,MF,
9612,GO:0036497,1.00000000000845,0.916271297158724,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17931,GO:1902310,1.00000000000845,0.916271297158724,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18599,GO:1903916,1.00000000000845,0.916271297158724,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18600,GO:1903917,1.00000000000845,0.916271297158724,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
2008,GO:0004736,1.00000000000846,0.879805895785229,0,1,pyruvate carboxylase activity,MF,
19278,GO:1905573,1.00000000000846,0.838941450731708,0,2,ganglioside GM1 binding,MF,
19281,GO:1905576,1.00000000000846,0.838941450731708,0,2,ganglioside GT1b binding,MF,
8562,GO:0034057,1.00000000000848,0.80380792311436,0,2,RNA strand-exchange activity,MF,
556,GO:0001680,1.0000000000085,0.917938868463625,0,1,tRNA 3'-terminal CCA addition,BP,
2056,GO:0004810,1.0000000000085,0.917938868463625,0,1,tRNA adenylyltransferase activity,MF,
13435,GO:0052927,1.0000000000085,0.917938868463625,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13436,GO:0052928,1.0000000000085,0.917938868463625,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13437,GO:0052929,1.0000000000085,0.917938868463625,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19608,GO:1990817,1.0000000000085,0.917938868463625,0,1,RNA adenylyltransferase activity,MF,
469,GO:0001512,1.00000000000851,0.940559335961607,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18801,GO:1904408,1.00000000000851,0.940559335961607,0,1,melatonin binding,MF,
19287,GO:1905594,1.00000000000851,0.940559335961607,0,1,resveratrol binding,MF,
17402,GO:1900186,1.00000000000851,0.715149994710043,0,3,negative regulation of clathrin-dependent endocytosis,BP,
7301,GO:0031315,1.00000000000852,0.83474182456199,0,1,extrinsic component of mitochondrial outer membrane,CC,
18493,GO:1903697,1.00000000000852,0.8961210136736,0,1,negative regulation of microvillus assembly,BP,
12926,GO:0051316,1.00000000000853,0.832821618352149,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
2104,GO:0004882,1.00000000000855,0.898003360512046,0,1,androgen receptor activity,MF,
9379,GO:0035935,1.00000000000855,0.898003360512046,0,1,androgen secretion,BP,
16449,GO:0097162,1.00000000000855,0.898003360512046,0,1,MADS box domain binding,MF,
20117,GO:2000834,1.00000000000855,0.898003360512046,0,1,regulation of androgen secretion,BP,
20118,GO:2000836,1.00000000000855,0.898003360512046,0,1,positive regulation of androgen secretion,BP,
1823,GO:0004478,1.00000000000856,0.908409078571633,0,1,methionine adenosyltransferase activity,MF,
19235,GO:1905443,1.00000000000857,0.870109323297454,0,1,regulation of clathrin coat assembly,BP,
19236,GO:1905445,1.00000000000857,0.870109323297454,0,1,positive regulation of clathrin coat assembly,BP,
2258,GO:0005174,1.00000000000858,0.917843245740076,0,1,CD40 receptor binding,MF,
3305,GO:0007008,1.00000000000859,0.895372582996043,0,1,outer mitochondrial membrane organization,BP,
5309,GO:0016031,1.00000000000859,0.895372582996043,0,1,tRNA import into mitochondrion,BP,
14538,GO:0070096,1.00000000000859,0.895372582996043,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19151,GO:1905242,1.00000000000859,0.895372582996043,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
1551,GO:0003952,1.0000000000086,0.915226948285125,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
11707,GO:0046541,1.0000000000086,0.909948740565796,0,1,saliva secretion,BP,
17031,GO:0099545,1.0000000000086,0.863692814468926,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17038,GO:0099557,1.0000000000086,0.863692814468926,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17170,GO:0106028,1.0000000000086,0.863692814468926,0,1,neuron projection retraction,BP,
17467,GO:1900450,1.0000000000086,0.863692814468926,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18961,GO:1904782,1.0000000000086,0.863692814468926,0,1,negative regulation of NMDA glutamate receptor activity,BP,
18441,GO:1903566,1.00000000000862,0.615054621464979,0,3,positive regulation of protein localization to cilium,BP,
8741,GO:0034421,1.00000000000862,0.715497935425854,0,3,post-translational protein acetylation,BP,
9595,GO:0036476,1.00000000000863,0.801275079113638,0,3,neuron death in response to hydrogen peroxide,BP,
17711,GO:1901671,1.00000000000863,0.87840479148149,0,2,positive regulation of superoxide dismutase activity,BP,
18274,GO:1903207,1.00000000000863,0.801275079113638,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18275,GO:1903208,1.00000000000863,0.801275079113638,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
18985,GO:1904833,1.00000000000863,0.87840479148149,0,2,positive regulation of removal of superoxide radicals,BP,
12244,GO:0048561,1.00000000000867,0.918814383186325,0,1,establishment of animal organ orientation,BP,
2075,GO:0004830,1.00000000000868,0.827511054984755,0,2,tryptophan-tRNA ligase activity,MF,
2923,GO:0006436,1.00000000000868,0.827511054984755,0,2,tryptophanyl-tRNA aminoacylation,BP,
6376,GO:0021571,1.00000000000869,0.896096107520764,0,1,rhombomere 5 development,BP,
6377,GO:0021572,1.00000000000869,0.896096107520764,0,1,rhombomere 6 development,BP,
9043,GO:0035283,1.00000000000869,0.896096107520764,0,1,central nervous system segmentation,BP,
9044,GO:0035284,1.00000000000869,0.896096107520764,0,1,brain segmentation,BP,
10661,GO:0043946,1.00000000000869,0.926877761715908,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10662,GO:0043947,1.00000000000869,0.926877761715908,0,1,positive regulation by host of symbiont catalytic activity,BP,
13323,GO:0052422,1.00000000000869,0.926877761715908,0,1,modulation by host of symbiont catalytic activity,BP,
4873,GO:0014740,1.0000000000087,0.828962137493062,0,2,negative regulation of muscle hyperplasia,BP,
585,GO:0001740,1.0000000000087,0.690644418613762,0,3,Barr body,CC,
6722,GO:0030144,1.00000000000871,0.734216230605275,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
6309,GO:0019960,1.00000000000871,0.626542006425821,0,3,C-X3-C chemokine binding,MF,
15910,GO:0072741,1.00000000000874,0.667464283921028,0,3,protein localization to cell division site,BP,
18237,GO:1903119,1.00000000000874,0.667464283921028,0,3,protein localization to actin cytoskeleton,BP,
18833,GO:1904498,1.00000000000874,0.667464283921028,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19448,GO:1990179,1.00000000000874,0.667464283921028,0,3,protein localization to actomyosin contractile ring,BP,
2381,GO:0005519,1.00000000000875,0.880780953037471,0,1,cytoskeletal regulatory protein binding,MF,
8096,GO:0032795,1.00000000000875,0.942198175205842,0,1,heterotrimeric G-protein binding,MF,
1962,GO:0004673,1.00000000000876,0.951822866657419,0,1,protein histidine kinase activity,MF,
5894,GO:0018106,1.00000000000876,0.951822866657419,0,1,peptidyl-histidine phosphorylation,BP,
14107,GO:0061002,1.00000000000877,0.657205433609269,0,3,negative regulation of dendritic spine morphogenesis,BP,
3649,GO:0008131,1.0000000000088,0.704967043130682,0,3,primary amine oxidase activity,MF,
1930,GO:0004631,1.00000000000882,0.936635054119995,0,1,phosphomevalonate kinase activity,MF,
1836,GO:0004493,1.00000000000884,0.947899092628196,0,1,methylmalonyl-CoA epimerase activity,MF,
11678,GO:0046491,1.00000000000884,0.947899092628196,0,1,L-methylmalonyl-CoA metabolic process,BP,
8951,GO:0035037,1.00000000000885,0.869727628841972,0,1,sperm entry,BP,
20229,GO:2001206,1.00000000000886,0.758692630611576,0,3,positive regulation of osteoclast development,BP,
2012,GO:0004741,1.00000000000886,0.636195883355539,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
10234,GO:0042988,1.00000000000887,0.858965719750446,0,1,X11-like protein binding,MF,
372,GO:0000994,1.00000000000887,0.926283536133269,0,1,RNA polymerase III core binding,MF,
2500,GO:0005753,1.00000000000889,0.919212476670811,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4690,GO:0010849,1.00000000000889,0.919212476670811,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19793,GO:2000276,1.00000000000889,0.919212476670811,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
18222,GO:1903070,1.0000000000089,0.752370797937203,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
17921,GO:1902296,1.00000000000892,0.897658361938408,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17934,GO:1902319,1.00000000000892,0.897658361938408,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18173,GO:1902983,1.00000000000892,0.897658361938408,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
14369,GO:0061649,1.00000000000892,0.674477909910641,0,3,ubiquitin modification-dependent histone binding,MF,
7678,GO:0032139,1.00000000000892,0.731415431189914,0,3,dinucleotide insertion or deletion binding,MF,
15823,GO:0072570,1.00000000000894,0.898873957126968,0,1,ADP-D-ribose binding,MF,
15912,GO:0072750,1.00000000000894,0.936950910398701,0,1,cellular response to leptomycin B,BP,
17607,GO:1901344,1.00000000000894,0.936950910398701,0,1,response to leptomycin B,BP,
17728,GO:1901707,1.00000000000894,0.936950910398701,0,1,leptomycin B binding,MF,
437,GO:0001172,1.00000000000896,0.811323918459831,0,2,transcription, RNA-templated,BP,
1562,GO:0003968,1.00000000000896,0.811323918459831,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
7582,GO:0031962,1.00000000000897,0.849106153685636,0,1,mineralocorticoid receptor binding,MF,
13693,GO:0060290,1.00000000000897,0.849106153685636,0,1,transdifferentiation,BP,
14418,GO:0061767,1.00000000000897,0.849106153685636,0,1,negative regulation of lung blood pressure,BP,
16910,GO:0098920,1.00000000000899,0.910301946844651,0,1,retrograde trans-synaptic signaling by lipid,BP,
16911,GO:0098921,1.00000000000899,0.910301946844651,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
14820,GO:0070602,1.00000000000899,0.74995655027357,0,3,regulation of centromeric sister chromatid cohesion,BP,
8518,GO:0033842,1.00000000000901,0.798209459248069,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
1539,GO:0003933,1.00000000000901,0.923169335474087,0,1,GTP cyclohydrolase activity,MF,
1540,GO:0003934,1.00000000000901,0.923169335474087,0,1,GTP cyclohydrolase I activity,MF,
9411,GO:0035998,1.00000000000901,0.923169335474087,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
4237,GO:0009439,1.00000000000904,0.87747323701256,0,2,cyanate metabolic process,BP,
4238,GO:0009440,1.00000000000904,0.87747323701256,0,2,cyanate catabolic process,BP,
8386,GO:0033328,1.00000000000904,0.889514350734018,0,1,peroxisome membrane targeting sequence binding,MF,
9458,GO:0036105,1.00000000000904,0.889514350734018,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17369,GO:1900130,1.00000000000904,0.889514350734018,0,1,regulation of lipid binding,BP,
17370,GO:1900131,1.00000000000904,0.889514350734018,0,1,negative regulation of lipid binding,BP,
849,GO:0002177,1.00000000000906,0.786846050721816,0,3,manchette,CC,
5762,GO:0016942,1.00000000000907,0.72842634107473,0,3,insulin-like growth factor binding protein complex,CC,
9580,GO:0036454,1.00000000000907,0.72842634107473,0,3,growth factor complex,CC,
823,GO:0002100,1.00000000000908,0.844538534800989,0,1,tRNA wobble adenosine to inosine editing,BP,
2148,GO:0004968,1.00000000000908,0.844538534800989,0,1,gonadotropin-releasing hormone receptor activity,MF,
8896,GO:0034752,1.00000000000908,0.844538534800989,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8897,GO:0034753,1.00000000000908,0.844538534800989,0,1,nuclear aryl hydrocarbon receptor complex,CC,
13367,GO:0052717,1.00000000000908,0.844538534800989,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13368,GO:0052718,1.00000000000908,0.844538534800989,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
7458,GO:0031627,1.0000000000091,0.730127447698527,0,3,telomeric loop formation,BP,
18760,GO:1904304,1.0000000000091,0.832798816108096,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18761,GO:1904306,1.0000000000091,0.832798816108096,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
10053,GO:0042568,1.00000000000911,0.945222424228422,0,1,insulin-like growth factor binary complex,CC,
1637,GO:0004082,1.00000000000912,0.794949848906938,0,3,bisphosphoglycerate mutase activity,MF,
1923,GO:0004619,1.00000000000912,0.794949848906938,0,3,phosphoglycerate mutase activity,MF,
11705,GO:0046538,1.00000000000912,0.794949848906938,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
19113,GO:1905123,1.00000000000912,0.761930453470836,0,2,regulation of glucosylceramidase activity,BP,
687,GO:0001907,1.00000000000914,0.760949851788063,0,3,killing by symbiont of host cells,BP,
10689,GO:0044004,1.00000000000914,0.760949851788063,0,3,disruption by symbiont of host cell,BP,
10903,GO:0044533,1.00000000000914,0.760949851788063,0,3,positive regulation of apoptotic process in other organism,BP,
13274,GO:0052042,1.00000000000914,0.760949851788063,0,3,positive regulation by symbiont of host programmed cell death,BP,
13310,GO:0052330,1.00000000000914,0.760949851788063,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13329,GO:0052501,1.00000000000914,0.760949851788063,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
1896,GO:0004582,1.00000000000916,0.842942151658631,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8325,GO:0033185,1.00000000000916,0.842942151658631,0,3,dolichol-phosphate-mannose synthase complex,CC,
957,GO:0002380,1.00000000000916,0.870127579906188,0,1,immunoglobulin secretion involved in immune response,BP,
18,GO:0000033,1.0000000000092,0.783333333323102,0,3,alpha-1,3-mannosyltransferase activity,MF,
1720,GO:0004314,1.0000000000092,0.753295672597877,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5479,GO:0016419,1.0000000000092,0.753295672597877,0,2,S-malonyltransferase activity,MF,
5480,GO:0016420,1.0000000000092,0.753295672597877,0,2,malonyltransferase activity,MF,
3206,GO:0006848,1.00000000000921,0.733209669325271,0,3,pyruvate transport,BP,
12613,GO:0050833,1.00000000000921,0.733209669325271,0,3,pyruvate transmembrane transporter activity,MF,
17631,GO:1901475,1.00000000000921,0.733209669325271,0,3,pyruvate transmembrane transport,BP,
8708,GO:0034370,1.00000000000923,0.878789558841332,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8710,GO:0034372,1.00000000000923,0.878789558841332,0,2,very-low-density lipoprotein particle remodeling,BP,
10348,GO:0043185,1.00000000000924,0.921058406446935,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14827,GO:0070625,1.00000000000924,0.921058406446935,0,1,zymogen granule exocytosis,BP,
12003,GO:0047676,1.00000000000926,0.858951206953838,0,1,arachidonate-CoA ligase activity,MF,
1857,GO:0004522,1.00000000000928,0.93054494800639,0,1,ribonuclease A activity,MF,
3969,GO:0008785,1.00000000000928,0.93054494800639,0,1,alkyl hydroperoxide reductase activity,MF,
9366,GO:0035915,1.00000000000928,0.921669987965578,0,1,pore formation in membrane of other organism,BP,
19863,GO:2000374,1.00000000000928,0.921669987965578,0,1,regulation of oxygen metabolic process,BP,
5037,GO:0015222,1.00000000000929,0.803288887491451,0,2,serotonin transmembrane transporter activity,MF,
13502,GO:0055108,1.00000000000929,0.922756040171816,0,1,Golgi to transport vesicle transport,BP,
19483,GO:1990386,1.00000000000929,0.922756040171816,0,1,mitotic cleavage furrow ingression,BP,
19543,GO:1990583,1.00000000000929,0.922756040171816,0,1,phospholipase D activator activity,MF,
4991,GO:0015136,1.00000000000931,0.89696585611837,0,1,sialic acid transmembrane transporter activity,MF,
5122,GO:0015538,1.00000000000931,0.89696585611837,0,1,sialic acid:proton symporter activity,MF,
5173,GO:0015739,1.00000000000931,0.89696585611837,0,1,sialic acid transport,BP,
5538,GO:0016533,1.00000000000934,0.831049602931319,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
20157,GO:2001027,1.00000000000934,0.685314229104125,0,2,negative regulation of endothelial cell chemotaxis,BP,
2250,GO:0005166,1.00000000000935,0.944436305489715,0,1,neurotrophin p75 receptor binding,MF,
3497,GO:0007402,1.00000000000935,0.944436305489715,0,1,ganglion mother cell fate determination,BP,
3609,GO:0008052,1.00000000000935,0.944436305489715,0,1,sensory organ boundary specification,BP,
4404,GO:0010160,1.00000000000935,0.944436305489715,0,1,formation of animal organ boundary,BP,
12396,GO:0048867,1.00000000000935,0.944436305489715,0,1,stem cell fate determination,BP,
14202,GO:0061193,1.00000000000935,0.944436305489715,0,1,taste bud development,BP,
16968,GO:0099082,1.00000000000935,0.944436305489715,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16969,GO:0099083,1.00000000000935,0.944436305489715,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17026,GO:0099538,1.00000000000935,0.944436305489715,0,1,synaptic signaling via neuropeptide,BP,
17027,GO:0099540,1.00000000000935,0.944436305489715,0,1,trans-synaptic signaling by neuropeptide,BP,
17035,GO:0099551,1.00000000000935,0.944436305489715,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
11974,GO:0047395,1.00000000000936,0.905986186323522,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11996,GO:0047620,1.00000000000936,0.905986186323522,0,1,acylglycerol kinase activity,MF,
14972,GO:0070926,1.00000000000936,0.883374568660998,0,1,regulation of ATP:ADP antiporter activity,BP,
20048,GO:2000721,1.00000000000937,0.868495720607457,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
1653,GO:0004109,1.00000000000941,0.832500744751819,0,2,coproporphyrinogen oxidase activity,MF,
2995,GO:0006543,1.00000000000941,0.705466253715563,0,3,glutamine catabolic process,BP,
19452,GO:1990189,1.00000000000943,0.849380269469091,0,2,peptide-serine-N-acetyltransferase activity,MF,
10913,GO:0044565,1.00000000000943,0.844125433074423,0,2,dendritic cell proliferation,BP,
8274,GO:0033106,1.00000000000944,0.85560974901345,0,2,cis-Golgi network membrane,CC,
7831,GO:0032398,1.00000000000944,0.9281937695578,0,1,MHC class Ib protein complex,CC,
7998,GO:0032639,1.00000000000944,0.9281937695578,0,1,TRAIL production,BP,
8022,GO:0032679,1.00000000000944,0.9281937695578,0,1,regulation of TRAIL production,BP,
8066,GO:0032759,1.00000000000944,0.9281937695578,0,1,positive regulation of TRAIL production,BP,
19954,GO:2000566,1.00000000000944,0.9281937695578,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20217,GO:2001187,1.00000000000944,0.9281937695578,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
15444,GO:0071818,1.00000000000948,0.766280373776707,0,3,BAT3 complex,CC,
15746,GO:0072379,1.00000000000948,0.766280373776707,0,3,ER membrane insertion complex,CC,
7495,GO:0031685,1.00000000000948,0.792867670144095,0,2,adenosine receptor binding,MF,
18156,GO:1902952,1.00000000000949,0.816127223631759,0,2,positive regulation of dendritic spine maintenance,BP,
3362,GO:0007113,1.00000000000949,0.797184715316161,0,3,endomitotic cell cycle,BP,
8485,GO:0033677,1.00000000000949,0.720003761651441,0,3,DNA/RNA helicase activity,MF,
4014,GO:0009032,1.0000000000095,0.928554426939404,0,1,thymidine phosphorylase activity,MF,
5359,GO:0016154,1.0000000000095,0.928554426939404,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
994,GO:0002457,1.00000000000951,0.713530645572058,0,3,T cell antigen processing and presentation,BP,
739,GO:0001971,1.00000000000951,0.826253175861145,0,1,negative regulation of activation of membrane attack complex,BP,
2078,GO:0004833,1.00000000000954,0.930396062113935,0,1,tryptophan 2,3-dioxygenase activity,MF,
8509,GO:0033754,1.00000000000954,0.930396062113935,0,1,indoleamine 2,3-dioxygenase activity,MF,
8667,GO:0034275,1.00000000000954,0.930396062113935,0,1,kynurenic acid metabolic process,BP,
8668,GO:0034276,1.00000000000954,0.930396062113935,0,1,kynurenic acid biosynthetic process,BP,
9517,GO:0036269,1.00000000000954,0.930396062113935,0,1,swimming behavior,BP,
8532,GO:0033882,1.00000000000955,0.940123193652289,0,1,choloyl-CoA hydrolase activity,MF,
11143,GO:0045222,1.00000000000955,0.940123193652289,0,1,CD4 biosynthetic process,BP,
11144,GO:0045223,1.00000000000955,0.940123193652289,0,1,regulation of CD4 biosynthetic process,BP,
11145,GO:0045225,1.00000000000955,0.940123193652289,0,1,negative regulation of CD4 biosynthetic process,BP,
13391,GO:0052815,1.00000000000955,0.940123193652289,0,1,medium-chain acyl-CoA hydrolase activity,MF,
1445,GO:0003676,1.00000000000959,0,244,3229,nucleic acid binding,MF,TRNP1;SOX6;ZFP36L1;NQO1;SYNE1;XPC;ETV5;ZFP36L2;IGF2BP2;HERC5;ZNF362;SNAI2;PHF21A;EGFR;KLF8;PEG10;NYNRIN;RFX2;ZNF608;SERPINH1;ENDOD1;TCF7L1;VIM;NUPR1;DDB2;ZNF862;PLEC;VDR;APOBEC3C;TNS1;NR1D1;SMARCA2;AHNAK;ABTB1;EIF2AK4;PDCD4;NR3C1;STAT1;IFIT2;LGALS1;ETV1;TP53;MBNL2;DDIT3;ZBTB20;ZC3H6;MEF2D;IFIT1;DDX60;ARHGEF1;ZCCHC11;RBMS3;ADARB1;TFDP2;TEP1;CHD3;ZNF18;KLF12;IFIT3;KLF9;NFIX;HIVEP1;GLI3;E2F7;KRBA2;ZFP90;LRP1;PABPC4L;TSHZ2;GLI2;RMI2;ERCC6;RBFOX2;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;OAS2;ZNF678;PARP4;EHD3;HMGA2;PHC2;GOLGB1;PRDX5;ZSCAN18;PER1;PDIA4;CAPRIN2;CREB3L2;APOBEC3G;ANG;UHRF2;CIRBP;PRDM8;JARID2;APLP2;MLH3;ZKSCAN1;TP73;KLF13;AARS;R3HDM2;PAIP2B;PRX;TLR3;ZNF860;SNCA;GATAD1;SP110;DZIP1L;APOBEC3F;FSCN1;SETX;KHNYN;NCOA2;NBPF10;SETBP1;ZNF618;SOX13;CHD6;NFATC4;FOXN3;DLX3;PBX1;FOXL1;ZNF699;CALR;ATM;MDM2;MEIS2;C17ORF49;ZNF107;TCF4;NR2F2;LMO4;ZNF449;ZMAT3;MSH5;MAF;LZTS1;ZBTB22;PTPN1;ZNF546;EGR1;SOX9;ENPP1;C14ORF93;ISL1;BCL6;NCOR1;DDX60L;ZNF717;PLAG1;SALL2;MYBL1;ZNF358;ZNF519;ANXA2;TRERF1;HLTF;FNDC3A;HOXA1;CXORF57;BAHCC1;TSHZ1;TES;TCF25;TCF12;HMBOX1;NFAT5;RPL13A;ZNF160;CHD9;ZNF302;ATXN1;MUTYH;CARF;ZFPM1;RBL2;DLX2;ZNF550;DNASE1L1;STAT2;LIG1;ZNF701;LEF1;THRA;SSBP3;C11ORF68;CDKN2A;SP100;ZSCAN30;TEF;TSPYL2;ORC4;CELF2;CENPA;FLYWCH1;FLNB;SRPK2;SAP30L;ZNF12;YAP1;KLF5;TWIST2;HOXA3;PRRC2B;ZNF558;MEIS3;PPARG;KCNIP3;MEF2A;CERS5;KLF7;TGIF1;UNK;LGALS3;RARA;HES2;POLH;HOXC5;PBX2;TAF1;TSHZ3;ZNF883;ZBTB1;NAT14;CREBRF;ETV4;HP1BP3;HOXA2;FOS;ZBTB25;AGO4;MED12;NPAS2;PRDM5;ZNF471;LITAF;RXRA;ACAA2;ZNF484
7960,GO:0032584,1.00000000000959,0.711362142435779,0,3,growth cone membrane,CC,
5282,GO:0015942,1.0000000000096,0.759306301913916,0,3,formate metabolic process,BP,
17195,GO:0110008,1.00000000000962,0.903371685433263,0,1,ncRNA deadenylation,BP,
198,GO:0000417,1.00000000000962,0.87953709000463,0,1,HIR complex,CC,
5858,GO:0017168,1.00000000000962,0.87953709000463,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
7002,GO:0030702,1.00000000000962,0.87953709000463,0,1,chromatin silencing at centromere,BP,
19100,GO:1905069,1.00000000000962,0.87953709000463,0,1,allantois development,BP,
2191,GO:0005053,1.00000000000962,0.932264786851886,0,1,peroxisome matrix targeting signal-2 binding,MF,
7558,GO:0031930,1.00000000000963,0.932801370456324,0,1,mitochondria-nucleus signaling pathway,BP,
6961,GO:0030626,1.00000000000963,0.817235584734466,0,2,U12 snRNA binding,MF,
5968,GO:0018444,1.00000000000965,0.671157340033668,0,3,translation release factor complex,CC,
17968,GO:1902442,1.00000000000965,0.886449944804096,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17969,GO:1902443,1.00000000000965,0.886449944804096,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
1272,GO:0003065,1.00000000000968,0.926060369380291,0,1,positive regulation of heart rate by epinephrine,BP,
2118,GO:0004910,1.00000000000969,0.933481109737184,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8029,GO:0032690,1.00000000000969,0.933481109737184,0,1,negative regulation of interleukin-1 alpha production,BP,
12536,GO:0050712,1.00000000000969,0.933481109737184,0,1,negative regulation of interleukin-1 alpha secretion,BP,
11993,GO:0047578,1.0000000000097,0.915094998006734,0,1,4-hydroxyglutamate transaminase activity,MF,
5996,GO:0019035,1.0000000000097,0.85155842268558,0,1,viral integration complex,CC,
11415,GO:0045870,1.0000000000097,0.85155842268558,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19248,GO:1905463,1.0000000000097,0.85155842268558,0,1,negative regulation of DNA duplex unwinding,BP,
619,GO:0001794,1.00000000000971,0.859747410485339,0,1,type IIa hypersensitivity,BP,
620,GO:0001796,1.00000000000971,0.859747410485339,0,1,regulation of type IIa hypersensitivity,BP,
621,GO:0001798,1.00000000000971,0.859747410485339,0,1,positive regulation of type IIa hypersensitivity,BP,
738,GO:0001970,1.00000000000971,0.859747410485339,0,1,positive regulation of activation of membrane attack complex,BP,
987,GO:0002445,1.00000000000971,0.859747410485339,0,1,type II hypersensitivity,BP,
1221,GO:0002892,1.00000000000971,0.859747410485339,0,1,regulation of type II hypersensitivity,BP,
1222,GO:0002894,1.00000000000971,0.859747410485339,0,1,positive regulation of type II hypersensitivity,BP,
7511,GO:0031714,1.00000000000971,0.859747410485339,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7512,GO:0031715,1.00000000000971,0.859747410485339,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
14750,GO:0070481,1.00000000000971,0.906419759685881,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14844,GO:0070651,1.00000000000971,0.906419759685881,0,1,nonfunctional rRNA decay,BP,
1089,GO:0002678,1.00000000000972,0.798515011922157,0,3,positive regulation of chronic inflammatory response,BP,
15800,GO:0072534,1.00000000000972,0.819806346679827,0,1,perineuronal net,CC,
2035,GO:0004777,1.00000000000973,0.859468597898499,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4011,GO:0009013,1.00000000000973,0.859468597898499,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10316,GO:0043131,1.00000000000973,0.859468597898499,0,1,erythrocyte enucleation,BP,
10451,GO:0043354,1.00000000000973,0.859468597898499,0,1,enucleate erythrocyte maturation,BP,
14466,GO:0061930,1.00000000000973,0.859468597898499,0,1,regulation of erythrocyte enucleation,BP,
14467,GO:0061931,1.00000000000973,0.859468597898499,0,1,positive regulation of erythrocyte enucleation,BP,
16316,GO:0090601,1.00000000000973,0.859468597898499,0,1,enucleation,BP,
18105,GO:1902838,1.00000000000973,0.859468597898499,0,1,regulation of nuclear migration along microtubule,BP,
2356,GO:0005457,1.00000000000974,0.75308932016588,0,2,GDP-fucose transmembrane transporter activity,MF,
5189,GO:0015783,1.00000000000974,0.75308932016588,0,2,GDP-fucose transmembrane transport,BP,
9450,GO:0036080,1.00000000000974,0.75308932016588,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
5436,GO:0016309,1.00000000000974,0.678716725677462,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
2793,GO:0006238,1.00000000000977,0.937908552167842,0,1,CMP salvage,BP,
4158,GO:0009224,1.00000000000977,0.937908552167842,0,1,CMP biosynthetic process,BP,
11497,GO:0046035,1.00000000000977,0.937908552167842,0,1,CMP metabolic process,BP,
15538,GO:0072019,1.00000000000978,0.920123217122546,0,1,proximal convoluted tubule development,BP,
15666,GO:0072229,1.00000000000978,0.920123217122546,0,1,metanephric proximal convoluted tubule development,BP,
18112,GO:1902858,1.00000000000978,0.920123217122546,0,1,propionyl-CoA metabolic process,BP,
18113,GO:1902860,1.00000000000978,0.920123217122546,0,1,propionyl-CoA biosynthetic process,BP,
9264,GO:0035718,1.00000000000979,0.872788280557401,0,2,macrophage migration inhibitory factor binding,MF,
12948,GO:0051377,1.0000000000098,0.697634620697035,0,3,mannose-ethanolamine phosphotransferase activity,MF,
7257,GO:0031247,1.0000000000098,0.838389264014461,0,2,actin rod assembly,BP,
9380,GO:0035936,1.00000000000981,0.836227882229628,0,1,testosterone secretion,BP,
20119,GO:2000843,1.00000000000981,0.836227882229628,0,1,regulation of testosterone secretion,BP,
20120,GO:2000845,1.00000000000981,0.836227882229628,0,1,positive regulation of testosterone secretion,BP,
18565,GO:1903847,1.00000000000982,0.703935101666754,0,2,regulation of aorta morphogenesis,BP,
18566,GO:1903849,1.00000000000982,0.703935101666754,0,2,positive regulation of aorta morphogenesis,BP,
5329,GO:0016071,1.00000000000983,0,24,737,mRNA metabolic process,BP,ZFP36L1;ZFP36L2;IGF2BP2;VIM;TP53;MBNL2;DDIT3;ZCCHC11;ADARB1;PNRC1;RBFOX2;CIRBP;SETX;PSMB9;ATM;PRKCA;RPL13A;SMG9;CELF2;SRPK2;GDNF;LGALS3;ZBTB1;AGO4
15996,GO:0086045,1.00000000000984,0.769711514578976,0,2,membrane depolarization during AV node cell action potential,BP,
10981,GO:0044805,1.00000000000985,0.763875062080702,0,2,late nucleophagy,BP,
918,GO:0002314,1.0000000000099,0.853338897130136,0,2,germinal center B cell differentiation,BP,
17053,GO:0099606,1.0000000000099,0.813941034743263,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17054,GO:0099607,1.0000000000099,0.813941034743263,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18504,GO:1903719,1.00000000000991,0.781089922012879,0,3,regulation of I-kappaB phosphorylation,BP,
18505,GO:1903721,1.00000000000991,0.781089922012879,0,3,positive regulation of I-kappaB phosphorylation,BP,
4587,GO:0010700,1.00000000000991,0.902220291399329,0,1,negative regulation of norepinephrine secretion,BP,
7496,GO:0031686,1.00000000000991,0.902220291399329,0,1,A1 adenosine receptor binding,MF,
11028,GO:0045032,1.00000000000991,0.902220291399329,0,1,ADP-activated adenosine receptor activity,MF,
13870,GO:0060542,1.00000000000991,0.850888831044978,0,1,regulation of strand invasion,BP,
14679,GO:0070337,1.00000000000991,0.850888831044978,0,1,3'-flap-structured DNA binding,MF,
16721,GO:0098530,1.00000000000991,0.850888831044978,0,1,positive regulation of strand invasion,BP,
17976,GO:1902464,1.00000000000992,0.871744789076796,0,1,regulation of histone H3-K27 trimethylation,BP,
17977,GO:1902466,1.00000000000992,0.871744789076796,0,1,positive regulation of histone H3-K27 trimethylation,BP,
3100,GO:0006680,1.00000000000992,0.740438193982314,0,3,glucosylceramide catabolic process,BP,
14756,GO:0070489,1.00000000000993,0.880803841585372,0,1,T cell aggregation,BP,
4862,GO:0014719,1.00000000000994,0.778968730741966,0,3,skeletal muscle satellite cell activation,BP,
18230,GO:1903094,1.00000000000995,0.886306051178313,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19735,GO:2000157,1.00000000000995,0.886306051178313,0,2,negative regulation of ubiquitin-specific protease activity,BP,
5092,GO:0015373,1.00000000000995,0.744576381214808,0,2,anion:sodium symporter activity,MF,
15067,GO:0071109,1.00000000000996,0.665770358469369,0,2,superior temporal gyrus development,BP,
12027,GO:0047933,1.00000000000998,0.815738980382672,0,1,glucose-1,6-bisphosphate synthase activity,MF,
9911,GO:0042275,1.00000000001003,0.931493951010404,0,1,error-free postreplication DNA repair,BP,
6843,GO:0030322,1.00000000001003,0.838613162868175,0,2,stabilization of membrane potential,BP,
14539,GO:0070097,1.00000000001006,0.738613704724149,0,2,delta-catenin binding,MF,
14293,GO:0061484,1.00000000001007,0.67981851667094,0,3,hematopoietic stem cell homeostasis,BP,
1361,GO:0003245,1.0000000000101,0.839363785272458,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
14160,GO:0061091,1.00000000001012,0.861223229903912,0,1,regulation of phospholipid translocation,BP,
14161,GO:0061092,1.00000000001012,0.861223229903912,0,1,positive regulation of phospholipid translocation,BP,
14223,GO:0061303,1.00000000001012,0.662639167971764,0,3,cornea development in camera-type eye,BP,
5889,GO:0018094,1.00000000001013,0.894722132815292,0,1,protein polyglycylation,BP,
14880,GO:0070735,1.00000000001013,0.894722132815292,0,1,protein-glycine ligase activity,MF,
14881,GO:0070736,1.00000000001013,0.894722132815292,0,1,protein-glycine ligase activity, initiating,MF,
16469,GO:0097196,1.00000000001013,0.837448389308053,0,2,Shu complex,CC,
7991,GO:0032625,1.00000000001018,0.890817241860737,0,1,interleukin-21 production,BP,
15855,GO:0072619,1.00000000001018,0.890817241860737,0,1,interleukin-21 secretion,BP,
8147,GO:0032889,1.00000000001022,0.913855861551915,0,1,regulation of vacuole fusion, non-autophagic,BP,
6494,GO:0021870,1.00000000001024,0.846693862850948,0,1,Cajal-Retzius cell differentiation,BP,
18968,GO:1904797,1.00000000001024,0.846693862850948,0,1,negative regulation of core promoter binding,BP,
516,GO:0001582,1.00000000001024,0.913290726995372,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8247,GO:0033041,1.00000000001024,0.913290726995372,0,1,sweet taste receptor activity,MF,
10642,GO:0043843,1.00000000001024,0.913290726995372,0,1,ADP-specific glucokinase activity,MF,
18527,GO:1903767,1.00000000001024,0.913290726995372,0,1,sweet taste receptor complex,CC,
18528,GO:1903768,1.00000000001024,0.913290726995372,0,1,taste receptor complex,CC,
3858,GO:0008482,1.00000000001026,0.917012120848635,0,1,sulfite oxidase activity,MF,
9851,GO:0042128,1.00000000001026,0.917012120848635,0,1,nitrate assimilation,BP,
16076,GO:0090086,1.00000000001027,0.8185437586966,0,3,negative regulation of protein deubiquitination,BP,
310,GO:0000822,1.00000000001028,0.600419970870558,0,3,inositol hexakisphosphate binding,MF,
5832,GO:0017125,1.00000000001028,0.865769826435917,0,1,deoxycytidyl transferase activity,MF,
1606,GO:0004031,1.00000000001029,0.862384796770259,0,1,aldehyde oxidase activity,MF,
5588,GO:0016623,1.00000000001029,0.862384796770259,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
17141,GO:0102797,1.00000000001029,0.862384796770259,0,1,geranial:oxygen oxidoreductase activity,MF,
17142,GO:0102798,1.00000000001029,0.862384796770259,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17824,GO:1902038,1.00000000001029,0.893869637079234,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17904,GO:1902257,1.00000000001029,0.893869637079234,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
4126,GO:0009189,1.0000000000103,0.803954759392186,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
9192,GO:0035594,1.00000000001031,0.751676831624912,0,3,ganglioside binding,MF,
7672,GO:0032127,1.00000000001032,0.901084264467215,0,1,dense core granule membrane,CC,
15055,GO:0071065,1.00000000001032,0.901084264467215,0,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
15069,GO:0071133,1.00000000001032,0.901084264467215,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
15801,GO:0072535,1.00000000001032,0.901084264467215,0,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,
15879,GO:0072680,1.00000000001032,0.901084264467215,0,1,extracellular matrix-dependent thymocyte migration,BP,
15880,GO:0072681,1.00000000001032,0.901084264467215,0,1,fibronectin-dependent thymocyte migration,BP,
19813,GO:2000307,1.00000000001032,0.901084264467215,0,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19814,GO:2000309,1.00000000001032,0.901084264467215,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
19890,GO:2000410,1.00000000001032,0.901084264467215,0,1,regulation of thymocyte migration,BP,
19891,GO:2000412,1.00000000001032,0.901084264467215,0,1,positive regulation of thymocyte migration,BP,
19892,GO:2000413,1.00000000001032,0.901084264467215,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
19893,GO:2000415,1.00000000001032,0.901084264467215,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
4346,GO:0009918,1.00000000001033,0.911582973781342,0,1,sterol delta7 reductase activity,MF,
5119,GO:0015499,1.00000000001033,0.911582973781342,0,1,formate transmembrane transporter activity,MF,
5135,GO:0015660,1.00000000001033,0.911582973781342,0,1,formate efflux transmembrane transporter activity,MF,
5167,GO:0015724,1.00000000001033,0.911582973781342,0,1,formate transport,BP,
5195,GO:0015797,1.00000000001033,0.911582973781342,0,1,mannitol transport,BP,
5353,GO:0016131,1.00000000001033,0.911582973781342,0,1,brassinosteroid metabolic process,BP,
5354,GO:0016132,1.00000000001033,0.911582973781342,0,1,brassinosteroid biosynthetic process,BP,
11802,GO:0046724,1.00000000001033,0.911582973781342,0,1,oxalic acid secretion,BP,
11994,GO:0047598,1.00000000001033,0.911582973781342,0,1,7-dehydrocholesterol reductase activity,MF,
18494,GO:1903699,1.00000000001036,0.777061912619473,0,1,tarsal gland development,BP,
18500,GO:1903709,1.00000000001036,0.777061912619473,0,1,uterine gland development,BP,
9093,GO:0035400,1.00000000001039,0.85732545301757,0,1,histone tyrosine kinase activity,MF,
9094,GO:0035401,1.00000000001039,0.85732545301757,0,1,histone kinase activity (H3-Y41 specific),MF,
9099,GO:0035406,1.00000000001039,0.85732545301757,0,1,histone-tyrosine phosphorylation,BP,
9102,GO:0035409,1.00000000001039,0.85732545301757,0,1,histone H3-Y41 phosphorylation,BP,
1618,GO:0004053,1.00000000001039,0.860946911304145,0,2,arginase activity,MF,
6173,GO:0019547,1.00000000001039,0.860946911304145,0,2,arginine catabolic process to ornithine,BP,
6440,GO:0021763,1.00000000001043,0.918591583903539,0,1,subthalamic nucleus development,BP,
13603,GO:0060127,1.00000000001043,0.918591583903539,0,1,prolactin secreting cell differentiation,BP,
13826,GO:0060459,1.00000000001043,0.918591583903539,0,1,left lung development,BP,
13827,GO:0060460,1.00000000001043,0.918591583903539,0,1,left lung morphogenesis,BP,
13891,GO:0060577,1.00000000001043,0.918591583903539,0,1,pulmonary vein morphogenesis,BP,
13892,GO:0060578,1.00000000001043,0.918591583903539,0,1,superior vena cava morphogenesis,BP,
14122,GO:0061031,1.00000000001043,0.918591583903539,0,1,endodermal digestive tract morphogenesis,BP,
14505,GO:0070037,1.00000000001043,0.942937644483494,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
1886,GO:0004569,1.00000000001043,0.868778405052515,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1758,GO:0004363,1.00000000001044,0.923966316055741,0,1,glutathione synthase activity,MF,
19228,GO:1905424,1.00000000001045,0.839456267963686,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19229,GO:1905426,1.00000000001045,0.839456267963686,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
1875,GO:0004556,1.00000000001046,0.919403767991993,0,1,alpha-amylase activity,MF,
17148,GO:0103025,1.00000000001046,0.919403767991993,0,1,alpha-amylase activity (releasing maltohexaose),MF,
16845,GO:0098808,1.00000000001046,0.837178725210661,0,2,mRNA cap binding,MF,
14932,GO:0070856,1.00000000001049,0.846773399763348,0,1,myosin VI light chain binding,MF,
19601,GO:1990784,1.00000000001051,0.879403236159938,0,1,response to dsDNA,BP,
19603,GO:1990786,1.00000000001051,0.879403236159938,0,1,cellular response to dsDNA,BP,
19313,GO:1905671,1.00000000001051,0.731477342327111,0,3,regulation of lysosome organization,BP,
5056,GO:0015272,1.00000000001051,0.902781251848976,0,1,ATP-activated inward rectifier potassium channel activity,MF,
812,GO:0002086,1.00000000001053,0.889802056240277,0,1,diaphragm contraction,BP,
1890,GO:0004574,1.00000000001053,0.889802056240277,0,1,oligo-1,6-glucosidase activity,MF,
2646,GO:0005985,1.00000000001053,0.889802056240277,0,1,sucrose metabolic process,BP,
10345,GO:0043181,1.00000000001053,0.889802056240277,0,1,vacuolar sequestering,BP,
10623,GO:0043654,1.00000000001056,0.699703297922689,0,3,recognition of apoptotic cell,BP,
11063,GO:0045084,1.00000000001057,0.743257446470849,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
18667,GO:1904047,1.00000000001059,0.760482252765667,0,3,S-adenosyl-L-methionine binding,MF,
15063,GO:0071105,1.00000000001059,0.865209101876586,0,1,response to interleukin-11,BP,
15172,GO:0071348,1.00000000001059,0.865209101876586,0,1,cellular response to interleukin-11,BP,
8860,GO:0034683,1.00000000001061,0.835490682359022,0,1,integrin alphav-beta3 complex,CC,
11334,GO:0045715,1.00000000001061,0.835490682359022,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12555,GO:0050748,1.00000000001061,0.835490682359022,0,1,negative regulation of lipoprotein metabolic process,BP,
13279,GO:0052066,1.00000000001061,0.835490682359022,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13289,GO:0052190,1.00000000001061,0.835490682359022,0,1,modulation by symbiont of host phagocytosis,BP,
13290,GO:0052191,1.00000000001061,0.835490682359022,0,1,positive regulation by symbiont of host phagocytosis,BP,
13300,GO:0052231,1.00000000001061,0.835490682359022,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13316,GO:0052370,1.00000000001061,0.835490682359022,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13332,GO:0052522,1.00000000001061,0.835490682359022,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
19940,GO:2000536,1.00000000001061,0.835490682359022,0,1,negative regulation of entry of bacterium into host cell,BP,
19753,GO:2000195,1.00000000001062,0.835183117179121,0,2,negative regulation of female gonad development,BP,
19588,GO:1990756,1.00000000001063,0.750031559470642,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
18456,GO:1903588,1.00000000001064,0.712966869302289,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
12270,GO:0048630,1.00000000001067,0.687179816044365,0,3,skeletal muscle tissue growth,BP,
12271,GO:0048631,1.00000000001067,0.687179816044365,0,3,regulation of skeletal muscle tissue growth,BP,
12272,GO:0048633,1.00000000001067,0.687179816044365,0,3,positive regulation of skeletal muscle tissue growth,BP,
2796,GO:0006253,1.00000000001068,0.941205462843059,0,1,dCTP catabolic process,BP,
11513,GO:0046065,1.00000000001068,0.941205462843059,0,1,dCTP metabolic process,BP,
12020,GO:0047840,1.00000000001068,0.941205462843059,0,1,dCTP diphosphatase activity,MF,
891,GO:0002266,1.00000000001068,0.835023952707471,0,2,follicular dendritic cell activation,BP,
892,GO:0002268,1.00000000001068,0.835023952707471,0,2,follicular dendritic cell differentiation,BP,
8352,GO:0033257,1.00000000001068,0.835023952707471,0,2,Bcl3/NF-kappaB2 complex,CC,
6041,GO:0019166,1.00000000001068,0.787922958030945,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
1602,GO:0004027,1.00000000001069,0.938380484162685,0,1,alcohol sulfotransferase activity,MF,
19333,GO:1905773,1.0000000000107,0.649555774635176,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
14123,GO:0061032,1.00000000001071,0.904488811784806,0,1,visceral serous pericardium development,BP,
15622,GO:0072166,1.00000000001071,0.904488811784806,0,1,posterior mesonephric tubule development,BP,
15696,GO:0072299,1.00000000001071,0.904488811784806,0,1,negative regulation of metanephric glomerulus development,BP,
15699,GO:0072302,1.00000000001071,0.904488811784806,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
5088,GO:0015367,1.00000000001071,0.92624622188938,0,1,oxoglutarate:malate antiporter activity,MF,
5175,GO:0015742,1.00000000001071,0.92624622188938,0,1,alpha-ketoglutarate transport,BP,
8752,GO:0034441,1.00000000001076,0.925884901147478,0,1,plasma lipoprotein particle oxidation,BP,
9907,GO:0042271,1.00000000001077,0.744344192099386,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
8738,GO:0034416,1.00000000001078,0.823377556099923,0,2,bisphosphoglycerate phosphatase activity,MF,
13258,GO:0051977,1.0000000000108,0.919316071290978,0,1,lysophospholipid transport,BP,
13259,GO:0051978,1.0000000000108,0.919316071290978,0,1,lysophospholipid transporter activity,MF,
18719,GO:1904217,1.0000000000108,0.76777040080324,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18720,GO:1904219,1.0000000000108,0.76777040080324,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18722,GO:1904222,1.0000000000108,0.76777040080324,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18696,GO:1904170,1.0000000000108,0.865151761707384,0,1,regulation of bleb assembly,BP,
18697,GO:1904172,1.0000000000108,0.865151761707384,0,1,positive regulation of bleb assembly,BP,
6995,GO:0030689,1.00000000001082,0.764736031994772,0,3,Noc complex,CC,
848,GO:0002176,1.00000000001082,0.81613269886856,0,3,male germ cell proliferation,BP,
9456,GO:0036093,1.00000000001082,0.81613269886856,0,3,germ cell proliferation,BP,
2079,GO:0004835,1.00000000001082,0.859380830943938,0,1,tubulin-tyrosine ligase activity,MF,
5908,GO:0018166,1.00000000001082,0.859380830943938,0,1,C-terminal protein-tyrosinylation,BP,
5949,GO:0018322,1.00000000001082,0.859380830943938,0,1,protein tyrosinylation,BP,
3819,GO:0008422,1.00000000001085,0.753171745580942,0,2,beta-glucosidase activity,MF,
8501,GO:0033699,1.00000000001085,0.922040248306057,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17243,GO:0120108,1.00000000001085,0.922040248306057,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19438,GO:1990165,1.00000000001085,0.922040248306057,0,1,single-strand break-containing DNA binding,MF,
18098,GO:1902809,1.00000000001087,0.734488605610146,0,3,regulation of skeletal muscle fiber differentiation,BP,
1594,GO:0004014,1.0000000000109,0.898310625712639,0,1,adenosylmethionine decarboxylase activity,MF,
3009,GO:0006557,1.0000000000109,0.898310625712639,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6238,GO:0019810,1.0000000000109,0.898310625712639,0,1,putrescine binding,MF,
11684,GO:0046499,1.0000000000109,0.898310625712639,0,1,S-adenosylmethioninamine metabolic process,BP,
14677,GO:0070335,1.0000000000109,0.832913827640838,0,1,aspartate binding,MF,
14749,GO:0070478,1.00000000001093,0.876088601632459,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
4438,GO:0010335,1.00000000001097,0.870164115266739,0,1,response to non-ionic osmotic stress,BP,
8538,GO:0033925,1.00000000001097,0.870164115266739,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15257,GO:0071471,1.00000000001097,0.870164115266739,0,1,cellular response to non-ionic osmotic stress,BP,
13564,GO:0060060,1.00000000001098,0.833029458960926,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14818,GO:0070593,1.00000000001098,0.833029458960926,0,1,dendrite self-avoidance,BP,
4269,GO:0009631,1.00000000001098,0.86011636615099,0,1,cold acclimation,BP,
11592,GO:0046317,1.00000000001098,0.86011636615099,0,1,regulation of glucosylceramide biosynthetic process,BP,
11593,GO:0046318,1.00000000001098,0.86011636615099,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18233,GO:1903108,1.00000000001098,0.86011636615099,0,1,regulation of mitochondrial transcription,BP,
18234,GO:1903109,1.00000000001098,0.86011636615099,0,1,positive regulation of mitochondrial transcription,BP,
9563,GO:0036396,1.00000000001099,0.787930559288593,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11169,GO:0045293,1.00000000001099,0.787930559288593,0,3,mRNA editing complex,CC,
20135,GO:2000969,1.00000000001099,0.695291609813801,0,3,positive regulation of AMPA receptor activity,BP,
4289,GO:0009720,1.00000000001101,0.904893029271338,0,1,detection of hormone stimulus,BP,
8558,GO:0034041,1.00000000001101,0.904893029271338,0,1,sterol-transporting ATPase activity,MF,
5423,GO:0016286,1.00000000001101,0.914152202013964,0,1,small conductance calcium-activated potassium channel activity,MF,
5287,GO:0015960,1.00000000001101,0.742953720992353,0,3,diadenosine polyphosphate biosynthetic process,BP,
5289,GO:0015965,1.00000000001101,0.742953720992353,0,3,diadenosine tetraphosphate metabolic process,BP,
5290,GO:0015966,1.00000000001101,0.742953720992353,0,3,diadenosine tetraphosphate biosynthetic process,BP,
16370,GO:0097020,1.00000000001101,0.895797001126583,0,1,COPII adaptor activity,MF,
11500,GO:0046038,1.00000000001103,0.933824683408106,0,1,GMP catabolic process,BP,
13358,GO:0052657,1.00000000001103,0.933824683408106,0,1,guanine phosphoribosyltransferase activity,MF,
4730,GO:0010899,1.00000000001104,0.750044048578838,0,3,regulation of phosphatidylcholine catabolic process,BP,
14859,GO:0070676,1.00000000001105,0.794430394763926,0,3,intralumenal vesicle formation,BP,
5441,GO:0016316,1.00000000001106,0.736466308566703,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5855,GO:0017161,1.00000000001106,0.736466308566703,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
8807,GO:0034597,1.00000000001106,0.736466308566703,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
13397,GO:0052828,1.00000000001106,0.736466308566703,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
5828,GO:0017116,1.00000000001106,0.708393298520469,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
14265,GO:0061395,1.00000000001108,0.927436037432928,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14334,GO:0061580,1.00000000001108,0.877566928239443,0,1,colon epithelial cell migration,BP,
14922,GO:0070843,1.00000000001108,0.877566928239443,0,1,misfolded protein transport,BP,
14923,GO:0070844,1.00000000001108,0.877566928239443,0,1,polyubiquitinated protein transport,BP,
14924,GO:0070845,1.00000000001108,0.877566928239443,0,1,polyubiquitinated misfolded protein transport,BP,
14925,GO:0070846,1.00000000001108,0.877566928239443,0,1,Hsp90 deacetylation,BP,
8557,GO:0034040,1.00000000001109,0.656731712878571,0,3,lipid-transporting ATPase activity,MF,
640,GO:0001831,1.00000000001111,0.837446336375516,0,1,trophectodermal cellular morphogenesis,BP,
3215,GO:0006864,1.00000000001112,0.808968812993565,0,2,pyrimidine nucleotide transport,BP,
5035,GO:0015218,1.00000000001112,0.808968812993565,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19529,GO:1990519,1.00000000001112,0.808968812993565,0,2,pyrimidine nucleotide import into mitochondrion,BP,
746,GO:0001978,1.00000000001112,0.919427692208328,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
747,GO:0001983,1.00000000001112,0.919427692208328,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
748,GO:0001985,1.00000000001112,0.919427692208328,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
753,GO:0001994,1.00000000001112,0.919427692208328,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
755,GO:0001997,1.00000000001112,0.919427692208328,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1288,GO:0003099,1.00000000001112,0.919427692208328,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2130,GO:0004936,1.00000000001112,0.919427692208328,0,1,alpha-adrenergic receptor activity,MF,
2131,GO:0004937,1.00000000001112,0.919427692208328,0,1,alpha1-adrenergic receptor activity,MF,
18639,GO:1903995,1.00000000001112,0.919427692208328,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18640,GO:1903997,1.00000000001112,0.919427692208328,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
5,GO:0000011,1.00000000001114,0.906933535810631,0,1,vacuole inheritance,BP,
333,GO:0000928,1.00000000001114,0.906933535810631,0,1,gamma-tubulin small complex, spindle pole body,CC,
643,GO:0001834,1.00000000001114,0.906933535810631,0,1,trophectodermal cell proliferation,BP,
1563,GO:0003972,1.00000000001114,0.906933535810631,0,1,RNA ligase (ATP) activity,MF,
1638,GO:0004083,1.00000000001114,0.906933535810631,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
2014,GO:0004743,1.00000000001114,0.906933535810631,0,1,pyruvate kinase activity,MF,
2731,GO:0006113,1.00000000001114,0.906933535810631,0,1,fermentation,BP,
2759,GO:0006174,1.00000000001114,0.906933535810631,0,1,dADP phosphorylation,BP,
2766,GO:0006186,1.00000000001114,0.906933535810631,0,1,dGDP phosphorylation,BP,
2949,GO:0006480,1.00000000001114,0.906933535810631,0,1,N-terminal protein amino acid methylation,BP,
3153,GO:0006756,1.00000000001114,0.906933535810631,0,1,AMP phosphorylation,BP,
3372,GO:0007146,1.00000000001114,0.906933535810631,0,1,meiotic recombination nodule assembly,BP,
3838,GO:0008452,1.00000000001114,0.906933535810631,0,1,RNA ligase activity,MF,
3839,GO:0008453,1.00000000001114,0.906933535810631,0,1,alanine-glyoxylate transaminase activity,MF,
3952,GO:0008700,1.00000000001114,0.906933535810631,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3970,GO:0008792,1.00000000001114,0.906933535810631,0,1,arginine decarboxylase activity,MF,
4234,GO:0009436,1.00000000001114,0.906933535810631,0,1,glyoxylate catabolic process,BP,
4426,GO:0010260,1.00000000001114,0.906933535810631,0,1,animal organ senescence,BP,
4440,GO:0010348,1.00000000001114,0.906933535810631,0,1,lithium:proton antiporter activity,MF,
4812,GO:0014011,1.00000000001114,0.906933535810631,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5027,GO:0015203,1.00000000001114,0.906933535810631,0,1,polyamine transmembrane transporter activity,MF,
5064,GO:0015292,1.00000000001114,0.906933535810631,0,1,uniporter activity,MF,
5117,GO:0015489,1.00000000001114,0.906933535810631,0,1,putrescine transmembrane transporter activity,MF,
5227,GO:0015847,1.00000000001114,0.906933535810631,0,1,putrescine transport,BP,
5488,GO:0016430,1.00000000001114,0.906933535810631,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5573,GO:0016596,1.00000000001114,0.906933535810631,0,1,thienylcyclohexylpiperidine binding,MF,
5706,GO:0016843,1.00000000001114,0.906933535810631,0,1,amine-lyase activity,MF,
5707,GO:0016844,1.00000000001114,0.906933535810631,0,1,strictosidine synthase activity,MF,
5811,GO:0017082,1.00000000001114,0.906933535810631,0,1,mineralocorticoid receptor activity,MF,
5863,GO:0017178,1.00000000001114,0.906933535810631,0,1,diphthine-ammonia ligase activity,MF,
5874,GO:0018011,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-alanine methylation,BP,
5875,GO:0018012,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5876,GO:0018013,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-glycine methylation,BP,
5877,GO:0018016,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-proline dimethylation,BP,
5881,GO:0018025,1.00000000001114,0.906933535810631,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5913,GO:0018194,1.00000000001114,0.906933535810631,0,1,peptidyl-alanine modification,BP,
6187,GO:0019659,1.00000000001114,0.906933535810631,0,1,glucose catabolic process to lactate,BP,
6188,GO:0019660,1.00000000001114,0.906933535810631,0,1,glycolytic fermentation,BP,
6189,GO:0019661,1.00000000001114,0.906933535810631,0,1,glucose catabolic process to lactate via pyruvate,BP,
6190,GO:0019666,1.00000000001114,0.906933535810631,0,1,nitrogenous compound fermentation,BP,
6235,GO:0019799,1.00000000001114,0.906933535810631,0,1,tubulin N-acetyltransferase activity,MF,
6319,GO:0020003,1.00000000001114,0.906933535810631,0,1,symbiont-containing vacuole,CC,
6803,GO:0030264,1.00000000001114,0.906933535810631,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6892,GO:0030474,1.00000000001114,0.906933535810631,0,1,spindle pole body duplication,BP,
6964,GO:0030629,1.00000000001114,0.906933535810631,0,1,U6 snRNA 3'-end binding,MF,
7010,GO:0030735,1.00000000001114,0.906933535810631,0,1,carnosine N-methyltransferase activity,MF,
7123,GO:0030961,1.00000000001114,0.906933535810631,0,1,peptidyl-arginine hydroxylation,BP,
7653,GO:0032093,1.00000000001114,0.906933535810631,0,1,SAM domain binding,MF,
7733,GO:0032253,1.00000000001114,0.906933535810631,0,1,dense core granule localization,BP,
8456,GO:0033609,1.00000000001114,0.906933535810631,0,1,oxalate metabolic process,BP,
8695,GO:0034353,1.00000000001114,0.906933535810631,0,1,RNA pyrophosphohydrolase activity,MF,
8777,GO:0034477,1.00000000001114,0.906933535810631,0,1,U6 snRNA 3'-end processing,BP,
8791,GO:0034512,1.00000000001114,0.906933535810631,0,1,box C/D snoRNA binding,MF,
8934,GO:0034998,1.00000000001114,0.906933535810631,0,1,oligosaccharyltransferase I complex,CC,
9131,GO:0035498,1.00000000001114,0.906933535810631,0,1,carnosine metabolic process,BP,
9171,GO:0035568,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-proline methylation,BP,
9172,GO:0035570,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-serine methylation,BP,
9173,GO:0035572,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-serine dimethylation,BP,
9174,GO:0035573,1.00000000001114,0.906933535810631,0,1,N-terminal peptidyl-serine trimethylation,BP,
9185,GO:0035585,1.00000000001114,0.906933535810631,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9538,GO:0036317,1.00000000001114,0.906933535810631,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9860,GO:0042140,1.00000000001114,0.906933535810631,0,1,late meiotic recombination nodule assembly,BP,
10163,GO:0042774,1.00000000001114,0.906933535810631,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10181,GO:0042806,1.00000000001114,0.906933535810631,0,1,fucose binding,MF,
10218,GO:0042946,1.00000000001114,0.906933535810631,0,1,glucoside transport,BP,
10219,GO:0042947,1.00000000001114,0.906933535810631,0,1,glucoside transmembrane transporter activity,MF,
10507,GO:0043465,1.00000000001114,0.906933535810631,0,1,regulation of fermentation,BP,
10814,GO:0044328,1.00000000001114,0.906933535810631,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10815,GO:0044329,1.00000000001114,0.906933535810631,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10816,GO:0044330,1.00000000001114,0.906933535810631,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10920,GO:0044599,1.00000000001114,0.906933535810631,0,1,AP-5 adaptor complex,CC,
10931,GO:0044648,1.00000000001114,0.906933535810631,0,1,histone H3-K4 dimethylation,BP,
10949,GO:0044732,1.00000000001114,0.906933535810631,0,1,mitotic spindle pole body,CC,
10950,GO:0044736,1.00000000001114,0.906933535810631,0,1,acid-sensing ion channel activity,MF,
11117,GO:0045183,1.00000000001114,0.906933535810631,0,1,translation factor activity, non-nucleic acid binding,MF,
11572,GO:0046176,1.00000000001114,0.906933535810631,0,1,aldonic acid catabolic process,BP,
11573,GO:0046177,1.00000000001114,0.906933535810631,0,1,D-gluconate catabolic process,BP,
11591,GO:0046316,1.00000000001114,0.906933535810631,0,1,gluconokinase activity,MF,
11807,GO:0046745,1.00000000001114,0.906933535810631,0,1,viral capsid secondary envelopment,BP,
11917,GO:0046996,1.00000000001114,0.906933535810631,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11922,GO:0047017,1.00000000001114,0.906933535810631,0,1,prostaglandin-F synthase activity,MF,
12011,GO:0047734,1.00000000001114,0.906933535810631,0,1,CDP-glycerol diphosphatase activity,MF,
12413,GO:0050046,1.00000000001114,0.906933535810631,0,1,lathosterol oxidase activity,MF,
12446,GO:0050346,1.00000000001114,0.906933535810631,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12670,GO:0050915,1.00000000001114,0.906933535810631,0,1,sensory perception of sour taste,BP,
12914,GO:0051300,1.00000000001114,0.906933535810631,0,1,spindle pole body organization,BP,
12922,GO:0051308,1.00000000001114,0.906933535810631,0,1,male meiosis chromosome separation,BP,
12972,GO:0051417,1.00000000001114,0.906933535810631,0,1,microtubule nucleation by spindle pole body,BP,
12993,GO:0051455,1.00000000001114,0.906933535810631,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13103,GO:0051685,1.00000000001114,0.906933535810631,0,1,maintenance of ER location,BP,
13429,GO:0052907,1.00000000001114,0.906933535810631,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13430,GO:0052909,1.00000000001114,0.906933535810631,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13724,GO:0060327,1.00000000001114,0.906933535810631,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13917,GO:0060620,1.00000000001114,0.906933535810631,0,1,regulation of cholesterol import,BP,
14049,GO:0060887,1.00000000001114,0.906933535810631,0,1,limb epidermis development,BP,
14194,GO:0061163,1.00000000001114,0.906933535810631,0,1,endoplasmic reticulum polarization,BP,
14295,GO:0061495,1.00000000001114,0.906933535810631,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14299,GO:0061508,1.00000000001114,0.906933535810631,0,1,CDP phosphorylation,BP,
14321,GO:0061565,1.00000000001114,0.906933535810631,0,1,dAMP phosphorylation,BP,
14322,GO:0061566,1.00000000001114,0.906933535810631,0,1,CMP phosphorylation,BP,
14323,GO:0061567,1.00000000001114,0.906933535810631,0,1,dCMP phosphorylation,BP,
14324,GO:0061568,1.00000000001114,0.906933535810631,0,1,GDP phosphorylation,BP,
14325,GO:0061569,1.00000000001114,0.906933535810631,0,1,UDP phosphorylation,BP,
14326,GO:0061570,1.00000000001114,0.906933535810631,0,1,dCDP phosphorylation,BP,
14327,GO:0061571,1.00000000001114,0.906933535810631,0,1,TDP phosphorylation,BP,
14329,GO:0061573,1.00000000001114,0.906933535810631,0,1,actin filament bundle retrograde transport,BP,
14380,GO:0061685,1.00000000001114,0.906933535810631,0,1,diphthine methylesterase activity,MF,
14488,GO:0065010,1.00000000001114,0.906933535810631,0,1,extracellular membrane-bounded organelle,CC,
14559,GO:0070130,1.00000000001114,0.906933535810631,0,1,negative regulation of mitochondrial translation,BP,
14576,GO:0070165,1.00000000001114,0.906933535810631,0,1,positive regulation of adiponectin secretion,BP,
14633,GO:0070260,1.00000000001114,0.906933535810631,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14789,GO:0070551,1.00000000001114,0.906933535810631,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14791,GO:0070553,1.00000000001114,0.906933535810631,0,1,nicotinic acid receptor activity,MF,
14794,GO:0070560,1.00000000001114,0.906933535810631,0,1,protein secretion by platelet,BP,
14806,GO:0070573,1.00000000001114,0.906933535810631,0,1,metallodipeptidase activity,MF,
14831,GO:0070631,1.00000000001114,0.906933535810631,0,1,spindle pole body localization,BP,
14832,GO:0070632,1.00000000001114,0.906933535810631,0,1,establishment of spindle pole body localization,BP,
14843,GO:0070650,1.00000000001114,0.906933535810631,0,1,actin filament bundle distribution,BP,
14889,GO:0070762,1.00000000001114,0.906933535810631,0,1,nuclear pore transmembrane ring,CC,
15226,GO:0071424,1.00000000001114,0.906933535810631,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15426,GO:0071789,1.00000000001114,0.906933535810631,0,1,spindle pole body localization to nuclear envelope,BP,
15427,GO:0071790,1.00000000001114,0.906933535810631,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15479,GO:0071885,1.00000000001114,0.906933535810631,0,1,N-terminal protein N-methyltransferase activity,MF,
15505,GO:0071931,1.00000000001114,0.906933535810631,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15903,GO:0072720,1.00000000001114,0.906933535810631,0,1,response to dithiothreitol,BP,
15939,GO:0080048,1.00000000001114,0.906933535810631,0,1,GDP-D-glucose phosphorylase activity,MF,
15990,GO:0086038,1.00000000001114,0.906933535810631,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16320,GO:0090624,1.00000000001114,0.906933535810631,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16321,GO:0090625,1.00000000001114,0.906933535810631,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16520,GO:0097310,1.00000000001114,0.906933535810631,0,1,cap2 mRNA methylation,BP,
16633,GO:0097541,1.00000000001114,0.906933535810631,0,1,axonemal basal plate,CC,
16655,GO:0097630,1.00000000001114,0.906933535810631,0,1,intrinsic component of omegasome membrane,CC,
16656,GO:0097631,1.00000000001114,0.906933535810631,0,1,integral component of omegasome membrane,CC,
16671,GO:0097655,1.00000000001114,0.906933535810631,0,1,serpin family protein binding,MF,
16689,GO:0097712,1.00000000001114,0.906933535810631,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16761,GO:0098629,1.00000000001114,0.906933535810631,0,1,trans-Golgi network membrane organization,BP,
16800,GO:0098725,1.00000000001114,0.906933535810631,0,1,symmetric cell division,BP,
17013,GO:0099519,1.00000000001114,0.906933535810631,0,1,dense core granule cytoskeletal transport,BP,
17129,GO:0102524,1.00000000001114,0.906933535810631,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17230,GO:0120048,1.00000000001114,0.906933535810631,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17231,GO:0120049,1.00000000001114,0.906933535810631,0,1,snRNA (adenine-N6)-methylation,BP,
17381,GO:1900148,1.00000000001114,0.906933535810631,0,1,negative regulation of Schwann cell migration,BP,
17496,GO:1901003,1.00000000001114,0.906933535810631,0,1,negative regulation of fermentation,BP,
17595,GO:1901318,1.00000000001114,0.906933535810631,0,1,negative regulation of flagellated sperm motility,BP,
17639,GO:1901523,1.00000000001114,0.906933535810631,0,1,icosanoid catabolic process,BP,
17787,GO:1901950,1.00000000001114,0.906933535810631,0,1,dense core granule transport,BP,
17854,GO:1902145,1.00000000001114,0.906933535810631,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17855,GO:1902151,1.00000000001114,0.906933535810631,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17856,GO:1902153,1.00000000001114,0.906933535810631,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17952,GO:1902387,1.00000000001114,0.906933535810631,0,1,ceramide 1-phosphate binding,MF,
17953,GO:1902388,1.00000000001114,0.906933535810631,0,1,ceramide 1-phosphate transporter activity,MF,
17954,GO:1902389,1.00000000001114,0.906933535810631,0,1,ceramide 1-phosphate transport,BP,
18058,GO:1902688,1.00000000001114,0.906933535810631,0,1,regulation of NAD metabolic process,BP,
18059,GO:1902689,1.00000000001114,0.906933535810631,0,1,negative regulation of NAD metabolic process,BP,
18136,GO:1902912,1.00000000001114,0.906933535810631,0,1,pyruvate kinase complex,CC,
18294,GO:1903259,1.00000000001114,0.906933535810631,0,1,exon-exon junction complex disassembly,BP,
18651,GO:1904023,1.00000000001114,0.906933535810631,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18652,GO:1904024,1.00000000001114,0.906933535810631,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18655,GO:1904028,1.00000000001114,0.906933535810631,0,1,positive regulation of collagen fibril organization,BP,
18923,GO:1904713,1.00000000001114,0.906933535810631,0,1,beta-catenin destruction complex binding,MF,
18957,GO:1904777,1.00000000001114,0.906933535810631,0,1,negative regulation of protein localization to cell cortex,BP,
18973,GO:1904806,1.00000000001114,0.906933535810631,0,1,regulation of protein oxidation,BP,
18974,GO:1904808,1.00000000001114,0.906933535810631,0,1,positive regulation of protein oxidation,BP,
19086,GO:1905044,1.00000000001114,0.906933535810631,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19087,GO:1905045,1.00000000001114,0.906933535810631,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19168,GO:1905279,1.00000000001114,0.906933535810631,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19184,GO:1905319,1.00000000001114,0.906933535810631,0,1,mesenchymal stem cell migration,BP,
19185,GO:1905320,1.00000000001114,0.906933535810631,0,1,regulation of mesenchymal stem cell migration,BP,
19186,GO:1905322,1.00000000001114,0.906933535810631,0,1,positive regulation of mesenchymal stem cell migration,BP,
19197,GO:1905344,1.00000000001114,0.906933535810631,0,1,prostaglandin catabolic process,BP,
19232,GO:1905435,1.00000000001114,0.906933535810631,0,1,regulation of histone H3-K4 trimethylation,BP,
19233,GO:1905437,1.00000000001114,0.906933535810631,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19303,GO:1905642,1.00000000001114,0.906933535810631,0,1,negative regulation of DNA methylation,BP,
19411,GO:1990048,1.00000000001114,0.906933535810631,0,1,anterograde neuronal dense core vesicle transport,BP,
19465,GO:1990261,1.00000000001114,0.906933535810631,0,1,pre-mRNA catabolic process,BP,
19537,GO:1990570,1.00000000001114,0.906933535810631,0,1,GDP-mannose transmembrane transport,BP,
19578,GO:1990738,1.00000000001114,0.906933535810631,0,1,pseudouridine 5'-phosphatase activity,MF,
19587,GO:1990755,1.00000000001114,0.906933535810631,0,1,mitotic spindle microtubule depolymerization,BP,
19659,GO:2000003,1.00000000001114,0.906933535810631,0,1,positive regulation of DNA damage checkpoint,BP,
20049,GO:2000722,1.00000000001114,0.906933535810631,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20050,GO:2000724,1.00000000001114,0.906933535810631,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20134,GO:2000909,1.00000000001114,0.906933535810631,0,1,regulation of sterol import,BP,
9322,GO:0035838,1.00000000001115,0.741209968593452,0,2,growing cell tip,CC,
16531,GO:0097343,1.00000000001115,0.637839106091184,0,3,ripoptosome assembly,BP,
17505,GO:1901026,1.00000000001115,0.637839106091184,0,3,ripoptosome assembly involved in necroptotic process,BP,
11944,GO:0047186,1.00000000001116,0.882828939113741,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
20177,GO:2001069,1.00000000001117,0.829022500557846,0,2,glycogen binding,MF,
4613,GO:0010736,1.00000000001121,0.873539632011157,0,1,serum response element binding,MF,
4900,GO:0014835,1.00000000001121,0.873539632011157,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
2032,GO:0004774,1.00000000001121,0.786356921357755,0,3,succinate-CoA ligase activity,MF,
3848,GO:0008466,1.00000000001121,0.925747109508963,0,1,glycogenin glucosyltransferase activity,MF,
17135,GO:0102751,1.00000000001121,0.925747109508963,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
3740,GO:0008281,1.00000000001121,0.866547875111357,0,1,sulfonylurea receptor activity,MF,
14930,GO:0070852,1.00000000001122,0.610164998949608,0,3,cell body fiber,CC,
1800,GO:0004446,1.00000000001125,0.907876727134205,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6864,GO:0030351,1.00000000001125,0.907876727134205,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8514,GO:0033787,1.00000000001125,0.907876727134205,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8739,GO:0034417,1.00000000001125,0.907876727134205,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13395,GO:0052826,1.00000000001125,0.907876727134205,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
17988,GO:1902499,1.00000000001125,0.907876727134205,0,1,positive regulation of protein autoubiquitination,BP,
1660,GO:0004118,1.00000000001126,0.8758397496231,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1546,GO:0003944,1.00000000001128,0.919037259305729,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
12415,GO:0050080,1.00000000001129,0.919260283664672,0,1,malonyl-CoA decarboxylase activity,MF,
16436,GO:0097145,1.00000000001129,0.919260283664672,0,1,BAK complex,CC,
20277,GO:2001294,1.00000000001129,0.919260283664672,0,1,malonyl-CoA catabolic process,BP,
2085,GO:0004850,1.0000000000113,0.925673881816073,0,1,uridine phosphorylase activity,MF,
2783,GO:0006218,1.0000000000113,0.925673881816073,0,1,uridine catabolic process,BP,
11540,GO:0046108,1.0000000000113,0.925673881816073,0,1,uridine metabolic process,BP,
16631,GO:0097536,1.00000000001131,0.910800502570439,0,1,thymus epithelium morphogenesis,BP,
1599,GO:0004020,1.00000000001133,0.807177429408324,0,2,adenylylsulfate kinase activity,MF,
2037,GO:0004779,1.00000000001133,0.807177429408324,0,2,sulfate adenylyltransferase activity,MF,
2038,GO:0004781,1.00000000001133,0.807177429408324,0,2,sulfate adenylyltransferase (ATP) activity,MF,
11817,GO:0046811,1.00000000001134,0.851786419914343,0,1,histone deacetylase inhibitor activity,MF,
15269,GO:0071484,1.00000000001135,0.769953535218128,0,2,cellular response to light intensity,BP,
4589,GO:0010705,1.00000000001137,0.868707568142068,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
15992,GO:0086040,1.00000000001137,0.868707568142068,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16024,GO:0086092,1.00000000001137,0.868707568142068,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
1865,GO:0004531,1.00000000001142,0.922238866882684,0,1,deoxyribonuclease II activity,MF,
214,GO:0000448,1.00000000001143,0.76819311697296,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
2240,GO:0005152,1.00000000001144,0.702973069834598,0,3,interleukin-1 receptor antagonist activity,MF,
13363,GO:0052692,1.00000000001144,0.933755772751498,0,1,raffinose alpha-galactosidase activity,MF,
16550,GO:0097376,1.00000000001144,0.933755772751498,0,1,interneuron axon guidance,BP,
9381,GO:0035938,1.00000000001145,0.842551181853816,0,1,estradiol secretion,BP,
20131,GO:2000864,1.00000000001145,0.842551181853816,0,1,regulation of estradiol secretion,BP,
11036,GO:0045054,1.00000000001147,0.746155075705861,0,3,constitutive secretory pathway,BP,
948,GO:0002368,1.00000000001148,0.917300409357702,0,1,B cell cytokine production,BP,
1193,GO:0002842,1.00000000001148,0.917300409357702,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9547,GO:0036351,1.00000000001148,0.917300409357702,0,1,histone H2A-K13 ubiquitination,BP,
9548,GO:0036352,1.00000000001148,0.917300409357702,0,1,histone H2A-K15 ubiquitination,BP,
10113,GO:0042670,1.00000000001148,0.706890284381553,0,3,retinal cone cell differentiation,BP,
11713,GO:0046549,1.00000000001148,0.706890284381553,0,3,retinal cone cell development,BP,
10791,GO:0044299,1.0000000000115,0.841017430785909,0,1,C-fiber,CC,
6510,GO:0021894,1.00000000001151,0.942672780495362,0,1,cerebral cortex GABAergic interneuron development,BP,
1058,GO:0002587,1.00000000001152,0.93486995908014,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
10804,GO:0044317,1.00000000001152,0.93486995908014,0,1,rod spherule,CC,
8,GO:0000015,1.00000000001153,0.925527963127323,0,1,phosphopyruvate hydratase complex,CC,
1933,GO:0004634,1.00000000001153,0.925527963127323,0,1,phosphopyruvate hydratase activity,MF,
19256,GO:1905502,1.00000000001156,0.939284150371903,0,1,acetyl-CoA binding,MF,
12911,GO:0051295,1.00000000001159,0.636613621283045,0,3,establishment of meiotic spindle localization,BP,
15878,GO:0072679,1.0000000000116,0.807686235083383,0,2,thymocyte migration,BP,
6827,GO:0030299,1.0000000000116,0.734401192844601,0,3,intestinal cholesterol absorption,BP,
10761,GO:0044241,1.0000000000116,0.734401192844601,0,3,lipid digestion,BP,
16872,GO:0098856,1.0000000000116,0.734401192844601,0,3,intestinal lipid absorption,BP,
17755,GO:1901842,1.00000000001162,0.932588200828075,0,1,negative regulation of high voltage-gated calcium channel activity,BP,
1567,GO:0003976,1.00000000001163,0.735818078238132,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
3710,GO:0008228,1.00000000001163,0.708964573250087,0,2,opsonization,BP,
521,GO:0001609,1.00000000001164,0.76967577615897,0,3,G-protein coupled adenosine receptor activity,MF,
7947,GO:0032557,1.00000000001165,0.716857608742841,0,3,pyrimidine ribonucleotide binding,MF,
19272,GO:1905553,1.00000000001165,0.741232235920242,0,3,regulation of blood vessel branching,BP,
5565,GO:0016586,1.00000000001166,0.720349076048003,0,2,RSC-type complex,CC,
15891,GO:0072706,1.00000000001167,0.913109061036785,0,1,response to sodium dodecyl sulfate,BP,
15892,GO:0072707,1.00000000001167,0.913109061036785,0,1,cellular response to sodium dodecyl sulfate,BP,
10119,GO:0042700,1.00000000001167,0.867831334931176,0,1,luteinizing hormone signaling pathway,BP,
12088,GO:0048160,1.00000000001167,0.867831334931176,0,1,primary follicle stage,BP,
16357,GO:0093001,1.00000000001167,0.899568010205309,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
12693,GO:0050957,1.00000000001169,0.880918424684988,0,1,equilibrioception,BP,
697,GO:0001918,1.00000000001169,0.909031155677051,0,1,farnesylated protein binding,MF,
13807,GO:0060435,1.00000000001172,0.935888756030447,0,1,bronchiole development,BP,
13835,GO:0060480,1.00000000001172,0.935888756030447,0,1,lung goblet cell differentiation,BP,
9165,GO:0035553,1.00000000001173,0.727089429358138,0,3,oxidative single-stranded RNA demethylation,BP,
13018,GO:0051525,1.00000000001173,0.696736941585937,0,2,NFAT protein binding,MF,
12295,GO:0048669,1.00000000001174,0.713423465061601,0,3,collateral sprouting in absence of injury,BP,
5142,GO:0015679,1.00000000001175,0.7059092373353,0,2,plasma membrane copper ion transport,BP,
2787,GO:0006226,1.00000000001176,0.792213132119053,0,3,dUMP biosynthetic process,BP,
4800,GO:0010999,1.00000000001177,0.870632548394873,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11485,GO:0045993,1.00000000001177,0.870632548394873,0,1,negative regulation of translational initiation by iron,BP,
11916,GO:0046986,1.00000000001177,0.870632548394873,0,1,negative regulation of hemoglobin biosynthetic process,BP,
14767,GO:0070510,1.00000000001178,0.833125841892587,0,1,regulation of histone H4-K20 methylation,BP,
14768,GO:0070512,1.00000000001178,0.833125841892587,0,1,positive regulation of histone H4-K20 methylation,BP,
12,GO:0000023,1.00000000001179,0.649663713654186,0,3,maltose metabolic process,BP,
1877,GO:0004558,1.00000000001179,0.649663713654186,0,3,alpha-1,4-glucosidase activity,MF,
7872,GO:0032450,1.00000000001179,0.649663713654186,0,3,maltose alpha-glucosidase activity,MF,
327,GO:0000916,1.00000000001181,0.919451619562586,0,1,actomyosin contractile ring contraction,BP,
9500,GO:0036213,1.00000000001181,0.919451619562586,0,1,contractile ring contraction,BP,
16104,GO:0090135,1.00000000001184,0.724497096050246,0,3,actin filament branching,BP,
10370,GO:0043221,1.00000000001184,0.883398380360278,0,1,SMC family protein binding,MF,
12864,GO:0051232,1.00000000001186,0.916352157974054,0,1,meiotic spindle elongation,BP,
2308,GO:0005308,1.00000000001186,0.89135708040401,0,1,creatine transmembrane transporter activity,MF,
2309,GO:0005309,1.00000000001186,0.89135708040401,0,1,creatine:sodium symporter activity,MF,
5248,GO:0015881,1.00000000001186,0.89135708040401,0,1,creatine transmembrane transport,BP,
1552,GO:0003953,1.00000000001187,0.932087366455845,0,1,NAD+ nucleosidase activity,MF,
12420,GO:0050135,1.00000000001187,0.932087366455845,0,1,NAD(P)+ nucleosidase activity,MF,
14431,GO:0061809,1.00000000001187,0.932087366455845,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
11158,GO:0045263,1.00000000001187,0.934356228474382,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11975,GO:0047408,1.00000000001192,0.825286901058768,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11976,GO:0047409,1.00000000001192,0.825286901058768,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
1922,GO:0004618,1.00000000001195,0.915506219386707,0,1,phosphoglycerate kinase activity,MF,
6940,GO:0030576,1.00000000001195,0.736920149995066,0,3,Cajal body organization,BP,
12313,GO:0048696,1.00000000001195,0.932043124649186,0,1,regulation of collateral sprouting in absence of injury,BP,
12314,GO:0048697,1.00000000001195,0.932043124649186,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13566,GO:0060064,1.00000000001195,0.932043124649186,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
19252,GO:1905474,1.00000000001195,0.932043124649186,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
15948,GO:0080129,1.00000000001196,0.941830969524329,0,1,proteasome core complex assembly,BP,
5148,GO:0015691,1.00000000001199,0.726643473279831,0,3,cadmium ion transport,BP,
14807,GO:0070574,1.00000000001199,0.726643473279831,0,3,cadmium ion transmembrane transport,BP,
855,GO:0002188,1.00000000001201,0.620287293748661,0,3,translation reinitiation,BP,
18634,GO:1903977,1.00000000001205,0.761607905575103,0,2,positive regulation of glial cell migration,BP,
9122,GO:0035473,1.00000000001205,0.809182930582068,0,2,lipase binding,MF,
11579,GO:0046208,1.00000000001209,0.804387174938873,0,3,spermine catabolic process,BP,
3546,GO:0007576,1.00000000001209,0.913514383246168,0,1,nucleolar fragmentation,BP,
13942,GO:0060678,1.00000000001211,0.918161852819881,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15599,GO:0072127,1.00000000001211,0.918161852819881,0,1,renal capsule development,BP,
15600,GO:0072128,1.00000000001211,0.918161852819881,0,1,renal capsule morphogenesis,BP,
15601,GO:0072129,1.00000000001211,0.918161852819881,0,1,renal capsule formation,BP,
15602,GO:0072130,1.00000000001211,0.918161852819881,0,1,renal capsule specification,BP,
15656,GO:0072213,1.00000000001211,0.918161852819881,0,1,metanephric capsule development,BP,
15681,GO:0072265,1.00000000001211,0.918161852819881,0,1,metanephric capsule morphogenesis,BP,
15682,GO:0072266,1.00000000001211,0.918161852819881,0,1,metanephric capsule formation,BP,
15683,GO:0072267,1.00000000001211,0.918161852819881,0,1,metanephric capsule specification,BP,
704,GO:0001928,1.00000000001212,0.918225535301825,0,1,regulation of exocyst assembly,BP,
13633,GO:0060178,1.00000000001212,0.918225535301825,0,1,regulation of exocyst localization,BP,
18471,GO:1903630,1.00000000001213,0.93863026601695,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18472,GO:1903632,1.00000000001213,0.93863026601695,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
5301,GO:0016012,1.00000000001215,0.810922974755121,0,2,sarcoglycan complex,CC,
16424,GO:0097117,1.00000000001218,0.832695496819823,0,1,guanylate kinase-associated protein clustering,BP,
2143,GO:0004960,1.00000000001218,0.918042417844782,0,1,thromboxane receptor activity,MF,
2144,GO:0004961,1.00000000001218,0.918042417844782,0,1,thromboxane A2 receptor activity,MF,
5313,GO:0016036,1.00000000001218,0.918042417844782,0,1,cellular response to phosphate starvation,BP,
7315,GO:0031335,1.00000000001218,0.918042417844782,0,1,regulation of sulfur amino acid metabolic process,BP,
7316,GO:0031337,1.00000000001218,0.918042417844782,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9317,GO:0035814,1.00000000001218,0.918042417844782,0,1,negative regulation of renal sodium excretion,BP,
9721,GO:0038193,1.00000000001218,0.918042417844782,0,1,thromboxane A2 signaling pathway,BP,
12499,GO:0050666,1.00000000001218,0.918042417844782,0,1,regulation of homocysteine metabolic process,BP,
12501,GO:0050668,1.00000000001218,0.918042417844782,0,1,positive regulation of homocysteine metabolic process,BP,
13991,GO:0060743,1.0000000000122,0.9133596909879,0,1,epithelial cell maturation involved in prostate gland development,BP,
12290,GO:0048664,1.00000000001225,0.803580727463583,0,3,neuron fate determination,BP,
10737,GO:0044194,1.00000000001225,0.770677188869929,0,3,cytolytic granule,CC,
53,GO:0000110,1.00000000001227,0.699048134855841,0,3,nucleotide-excision repair factor 1 complex,CC,
6441,GO:0021764,1.00000000001227,0.648202598132601,0,2,amygdala development,BP,
9079,GO:0035359,1.00000000001229,0.879025957343578,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
13447,GO:0055011,1.00000000001229,0.927797801614903,0,1,atrial cardiac muscle cell differentiation,BP,
13450,GO:0055014,1.00000000001229,0.927797801614903,0,1,atrial cardiac muscle cell development,BP,
2077,GO:0004832,1.00000000001233,0.670908500432757,0,3,valine-tRNA ligase activity,MF,
2925,GO:0006438,1.00000000001233,0.670908500432757,0,3,valyl-tRNA aminoacylation,BP,
618,GO:0001792,1.00000000001234,0.87433376022948,0,1,polymeric immunoglobulin receptor activity,MF,
4008,GO:0009000,1.00000000001237,0.914863219769417,0,1,selenocysteine lyase activity,MF,
1778,GO:0004394,1.00000000001238,0.876611302586155,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1693,GO:0004170,1.00000000001238,0.924560742235668,0,1,dUTP diphosphatase activity,MF,
11524,GO:0046080,1.00000000001238,0.924560742235668,0,1,dUTP metabolic process,BP,
11525,GO:0046081,1.00000000001238,0.924560742235668,0,1,dUTP catabolic process,BP,
1827,GO:0004484,1.00000000001238,0.870586408401061,0,1,mRNA guanylyltransferase activity,MF,
12450,GO:0050355,1.00000000001238,0.870586408401061,0,1,triphosphatase activity,MF,
11786,GO:0046695,1.0000000000124,0.78888174036777,0,3,SLIK (SAGA-like) complex,CC,
5898,GO:0018117,1.0000000000124,0.928797101909147,0,1,protein adenylylation,BP,
5910,GO:0018175,1.0000000000124,0.928797101909147,0,1,protein nucleotidylation,BP,
10921,GO:0044601,1.0000000000124,0.928797101909147,0,1,protein denucleotidylation,BP,
10922,GO:0044602,1.0000000000124,0.928797101909147,0,1,protein deadenylylation,BP,
10923,GO:0044603,1.0000000000124,0.928797101909147,0,1,protein adenylylhydrolase activity,MF,
14878,GO:0070733,1.0000000000124,0.928797101909147,0,1,protein adenylyltransferase activity,MF,
8633,GO:0034191,1.00000000001243,0.68976926985959,0,3,apolipoprotein A-I receptor binding,MF,
10629,GO:0043686,1.00000000001244,0.78110445452967,0,3,co-translational protein modification,BP,
17107,GO:0102339,1.00000000001244,0.913582927222275,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17108,GO:0102340,1.00000000001244,0.913582927222275,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17109,GO:0102341,1.00000000001244,0.913582927222275,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17110,GO:0102342,1.00000000001244,0.913582927222275,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
17138,GO:0102758,1.00000000001245,0.939816920433141,0,1,very-long-chain enoyl-CoA reductase activity,MF,
3204,GO:0006843,1.00000000001248,0.929743716152015,0,1,mitochondrial citrate transmembrane transport,BP,
16052,GO:0090044,1.00000000001248,0.929743716152015,0,1,positive regulation of tubulin deacetylation,BP,
19533,GO:1990546,1.00000000001248,0.929743716152015,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
9420,GO:0036015,1.00000000001249,0.736507575179521,0,3,response to interleukin-3,BP,
9421,GO:0036016,1.00000000001249,0.736507575179521,0,3,cellular response to interleukin-3,BP,
1687,GO:0004163,1.00000000001249,0.925875694993414,0,1,diphosphomevalonate decarboxylase activity,MF,
17071,GO:0099640,1.0000000000125,0.947174706821566,0,1,axo-dendritic protein transport,BP,
17072,GO:0099641,1.0000000000125,0.947174706821566,0,1,anterograde axonal protein transport,BP,
2036,GO:0004778,1.0000000000125,0.929226051077573,0,1,succinyl-CoA hydrolase activity,MF,
8090,GO:0032788,1.0000000000125,0.929226051077573,0,1,saturated monocarboxylic acid metabolic process,BP,
8091,GO:0032789,1.0000000000125,0.929226051077573,0,1,unsaturated monocarboxylic acid metabolic process,BP,
1352,GO:0003221,1.00000000001251,0.792170109802772,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1355,GO:0003226,1.00000000001251,0.792170109802772,0,1,right ventricular compact myocardium morphogenesis,BP,
6362,GO:0021553,1.00000000001251,0.792170109802772,0,1,olfactory nerve development,BP,
13824,GO:0060456,1.00000000001251,0.725619863043137,0,3,positive regulation of digestive system process,BP,
8326,GO:0033186,1.00000000001253,0.676661568829551,0,3,CAF-1 complex,CC,
6819,GO:0030290,1.00000000001253,0.890428400483967,0,1,sphingolipid activator protein activity,MF,
7856,GO:0032428,1.00000000001253,0.890428400483967,0,1,beta-N-acetylgalactosaminidase activity,MF,
20148,GO:2001015,1.00000000001256,0.759525253964224,0,2,negative regulation of skeletal muscle cell differentiation,BP,
7600,GO:0031997,1.00000000001258,0.752462711387361,0,3,N-terminal myristoylation domain binding,MF,
12934,GO:0051343,1.00000000001258,0.752462711387361,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
17450,GO:1900370,1.00000000001258,0.856118817260685,0,1,positive regulation of RNA interference,BP,
7457,GO:0031626,1.00000000001259,0.858770090933132,0,1,beta-endorphin binding,MF,
15839,GO:0072590,1.00000000001259,0.850126819574801,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15840,GO:0072591,1.00000000001259,0.850126819574801,0,1,citrate-L-glutamate ligase activity,MF,
8664,GO:0034271,1.00000000001259,0.71490491083573,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8665,GO:0034272,1.00000000001259,0.71490491083573,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
1781,GO:0004397,1.00000000001259,0.900964918640415,0,1,histidine ammonia-lyase activity,MF,
2109,GO:0004890,1.00000000001259,0.900964918640415,0,1,GABA-A receptor activity,MF,
2281,GO:0005237,1.00000000001259,0.900964918640415,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6176,GO:0019556,1.00000000001259,0.900964918640415,0,1,histidine catabolic process to glutamate and formamide,BP,
6177,GO:0019557,1.00000000001259,0.900964918640415,0,1,histidine catabolic process to glutamate and formate,BP,
6616,GO:0022851,1.00000000001259,0.900964918640415,0,1,GABA-gated chloride ion channel activity,MF,
10595,GO:0043606,1.00000000001259,0.900964918640415,0,1,formamide metabolic process,BP,
16975,GO:0099095,1.00000000001259,0.900964918640415,0,1,ligand-gated anion channel activity,MF,
18061,GO:1902710,1.00000000001259,0.900964918640415,0,1,GABA receptor complex,CC,
18062,GO:1902711,1.00000000001259,0.900964918640415,0,1,GABA-A receptor complex,CC,
13606,GO:0060134,1.0000000000126,0.638204509874961,0,3,prepulse inhibition,BP,
20142,GO:2000983,1.00000000001261,0.894698867910254,0,2,regulation of ATP citrate synthase activity,BP,
20143,GO:2000984,1.00000000001261,0.894698867910254,0,2,negative regulation of ATP citrate synthase activity,BP,
10990,GO:0044830,1.00000000001266,0.791004130110707,0,2,modulation by host of viral RNA genome replication,BP,
17285,GO:0140161,1.00000000001268,0.794478820561333,0,3,monocarboxylate:sodium symporter activity,MF,
2691,GO:0006059,1.00000000001268,0.798201116263005,0,3,hexitol metabolic process,BP,
106,GO:0000221,1.0000000000127,0.706172136994036,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
1935,GO:0004638,1.00000000001271,0.896345028061134,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1936,GO:0004639,1.00000000001271,0.896345028061134,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
3877,GO:0008513,1.00000000001272,0.919228411258014,0,1,secondary active organic cation transmembrane transporter activity,MF,
8535,GO:0033897,1.00000000001273,0.937809644425583,0,1,ribonuclease T2 activity,MF,
19994,GO:2000638,1.00000000001274,0.807105810170903,0,2,regulation of SREBP signaling pathway,BP,
19995,GO:2000639,1.00000000001274,0.807105810170903,0,2,negative regulation of SREBP signaling pathway,BP,
15518,GO:0071962,1.0000000000128,0.780634442734544,0,3,mitotic sister chromatid cohesion, centromeric,BP,
1779,GO:0004395,1.00000000001284,0.937415579590994,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3821,GO:0008425,1.00000000001284,0.937415579590994,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3951,GO:0008689,1.00000000001284,0.937415579590994,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4450,GO:0010420,1.00000000001284,0.937415579590994,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4647,GO:0010795,1.00000000001284,0.937415579590994,0,1,regulation of ubiquinone biosynthetic process,BP,
6943,GO:0030580,1.00000000001284,0.937415579590994,0,1,quinone cofactor methyltransferase activity,MF,
10916,GO:0044595,1.00000000001284,0.937415579590994,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10917,GO:0044596,1.00000000001284,0.937415579590994,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
14313,GO:0061542,1.00000000001284,0.937415579590994,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
685,GO:0001905,1.00000000001284,0.710353285920962,0,2,activation of membrane attack complex,BP,
737,GO:0001969,1.00000000001284,0.710353285920962,0,2,regulation of activation of membrane attack complex,BP,
16954,GO:0099053,1.00000000001285,0.71551274435007,0,3,activating signal cointegrator 1 complex,CC,
14468,GO:0061944,1.00000000001286,0.873186698582194,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14079,GO:0060957,1.00000000001286,0.905448603330332,0,1,endocardial cell fate commitment,BP,
14281,GO:0061445,1.00000000001286,0.905448603330332,0,1,endocardial cushion cell fate commitment,BP,
4922,GO:0014878,1.00000000001287,0.857014881324976,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
13936,GO:0060671,1.00000000001289,0.714077904864158,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13937,GO:0060672,1.00000000001289,0.714077904864158,0,3,epithelial cell morphogenesis involved in placental branching,BP,
8531,GO:0033878,1.0000000000129,0.884742797433665,0,1,hormone-sensitive lipase activity,MF,
17633,GO:1901491,1.0000000000129,0.757510711368933,0,2,negative regulation of lymphangiogenesis,BP,
19518,GO:1990456,1.00000000001293,0.884091984009172,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
4433,GO:0010309,1.00000000001294,0.928293546579087,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19535,GO:1990565,1.00000000001294,0.928293546579087,0,1,HSP90-CDC37 chaperone complex,CC,
17057,GO:0099617,1.00000000001296,0.895072559879236,0,1,matrix side of mitochondrial inner membrane,CC,
228,GO:0000472,1.00000000001298,0.67308979306442,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
353,GO:0000967,1.00000000001298,0.67308979306442,0,3,rRNA 5'-end processing,BP,
13797,GO:0060423,1.00000000001303,0.82137982501034,0,2,foregut regionalization,BP,
13798,GO:0060424,1.00000000001303,0.82137982501034,0,2,lung field specification,BP,
13846,GO:0060492,1.00000000001303,0.82137982501034,0,2,lung induction,BP,
18771,GO:1904339,1.00000000001305,0.833466566093639,0,1,negative regulation of dopaminergic neuron differentiation,BP,
8484,GO:0033676,1.00000000001307,0.934055089597088,0,1,double-stranded DNA-dependent ATPase activity,MF,
18668,GO:1904048,1.00000000001309,0.869223668464019,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18669,GO:1904050,1.00000000001309,0.869223668464019,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19174,GO:1905301,1.00000000001309,0.869223668464019,0,1,regulation of macropinocytosis,BP,
19175,GO:1905302,1.00000000001309,0.869223668464019,0,1,negative regulation of macropinocytosis,BP,
419,GO:0001112,1.00000000001311,0.903841940015326,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,1.00000000001311,0.903841940015326,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,1.00000000001311,0.903841940015326,0,1,protein-DNA complex remodeling,BP,
4210,GO:0009372,1.00000000001315,0.897904880089181,0,1,quorum sensing,BP,
9564,GO:0036398,1.00000000001315,0.897904880089181,0,1,TCR signalosome,CC,
9565,GO:0036399,1.00000000001315,0.897904880089181,0,1,TCR signalosome assembly,BP,
12402,GO:0048874,1.00000000001315,0.897904880089181,0,1,homeostasis of number of cells in a free-living population,BP,
13280,GO:0052097,1.00000000001315,0.897904880089181,0,1,interspecies quorum sensing,BP,
13281,GO:0052106,1.00000000001315,0.897904880089181,0,1,quorum sensing involved in interaction with host,BP,
13980,GO:0060730,1.00000000001315,0.897904880089181,0,1,regulation of intestinal epithelial structure maintenance,BP,
13981,GO:0060731,1.00000000001315,0.897904880089181,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14872,GO:0070715,1.00000000001315,0.897904880089181,0,1,sodium-dependent organic cation transport,BP,
3966,GO:0008775,1.00000000001318,0.925418986959353,0,1,acetate CoA-transferase activity,MF,
4324,GO:0009850,1.00000000001318,0.925418986959353,0,1,auxin metabolic process,BP,
4325,GO:0009852,1.00000000001318,0.925418986959353,0,1,auxin catabolic process,BP,
4396,GO:0010124,1.00000000001318,0.925418986959353,0,1,phenylacetate catabolic process,BP,
6822,GO:0030294,1.00000000001318,0.919013373892018,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
10090,GO:0042627,1.0000000000132,0.828613192327145,0,3,chylomicron,CC,
8472,GO:0033633,1.00000000001321,0.864099386329209,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
7879,GO:0032458,1.00000000001321,0.883184337580884,0,1,slow endocytic recycling,BP,
169,GO:0000354,1.00000000001321,0.746752466511459,0,2,cis assembly of pre-catalytic spliceosome,BP,
14534,GO:0070091,1.00000000001323,0.689997343310122,0,3,glucagon secretion,BP,
14535,GO:0070092,1.00000000001323,0.689997343310122,0,3,regulation of glucagon secretion,BP,
7619,GO:0032029,1.00000000001328,0.777185369134571,0,1,myosin tail binding,MF,
3834,GO:0008444,1.0000000000133,0.919244346913915,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
9583,GO:0036458,1.0000000000133,0.919244346913915,0,1,hepatocyte growth factor binding,MF,
3987,GO:0008887,1.0000000000134,0.898959437543688,0,1,glycerate kinase activity,MF,
19713,GO:2000110,1.00000000001341,0.753589323513731,0,3,negative regulation of macrophage apoptotic process,BP,
16857,GO:0098829,1.00000000001342,0.841449487896649,0,1,intestinal folate absorption,BP,
18817,GO:1904447,1.00000000001342,0.841449487896649,0,1,folic acid import across plasma membrane,BP,
1885,GO:0004568,1.00000000001343,0.807253244817873,0,2,chitinase activity,MF,
2674,GO:0006030,1.00000000001343,0.807253244817873,0,2,chitin metabolic process,BP,
2675,GO:0006032,1.00000000001343,0.807253244817873,0,2,chitin catabolic process,BP,
3612,GO:0008061,1.00000000001343,0.807253244817873,0,2,chitin binding,MF,
13512,GO:0060001,1.00000000001343,0.813498884530369,0,1,minus-end directed microfilament motor activity,MF,
4080,GO:0009138,1.00000000001345,0.771205903284819,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
6783,GO:0030233,1.00000000001347,0.928898741419691,0,1,deoxynucleotide transmembrane transporter activity,MF,
6829,GO:0030302,1.00000000001347,0.928898741419691,0,1,deoxynucleotide transport,BP,
7129,GO:0030974,1.00000000001347,0.928898741419691,0,1,thiamine pyrophosphate transmembrane transport,BP,
15048,GO:0071045,1.00000000001347,0.928898741419691,0,1,nuclear histone mRNA catabolic process,BP,
15352,GO:0071629,1.00000000001347,0.928898741419691,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16275,GO:0090422,1.00000000001347,0.928898741419691,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
12260,GO:0048597,1.00000000001349,0.817527854953983,0,3,post-embryonic camera-type eye morphogenesis,BP,
158,GO:0000322,1.0000000000135,0.735715082293779,0,3,storage vacuole,CC,
1898,GO:0004584,1.00000000001351,0.916545863680952,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
5939,GO:0018277,1.00000000001351,0.916545863680952,0,1,protein deamination,BP,
9287,GO:0035750,1.00000000001351,0.856453600984664,0,1,protein localization to myelin sheath abaxonal region,BP,
19754,GO:2000196,1.00000000001352,0.821389140348174,0,2,positive regulation of female gonad development,BP,
19872,GO:2000386,1.00000000001352,0.821389140348174,0,2,positive regulation of ovarian follicle development,BP,
5125,GO:0015578,1.00000000001353,0.915045425494375,0,1,mannose transmembrane transporter activity,MF,
5183,GO:0015761,1.00000000001353,0.915045425494375,0,1,mannose transmembrane transport,BP,
3814,GO:0008413,1.00000000001353,0.878085362980655,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9158,GO:0035539,1.00000000001353,0.878085362980655,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
3981,GO:0008832,1.00000000001354,0.899883008542046,0,1,dGTPase activity,MF,
5674,GO:0016793,1.00000000001354,0.899883008542046,0,1,triphosphoric monoester hydrolase activity,MF,
7950,GO:0032560,1.00000000001354,0.899883008542046,0,1,guanyl deoxyribonucleotide binding,MF,
7953,GO:0032567,1.00000000001354,0.899883008542046,0,1,dGTP binding,MF,
13026,GO:0051543,1.00000000001355,0.916626432310119,0,1,regulation of elastin biosynthetic process,BP,
13027,GO:0051545,1.00000000001355,0.916626432310119,0,1,negative regulation of elastin biosynthetic process,BP,
7785,GO:0032345,1.00000000001357,0.72839603546794,0,3,negative regulation of aldosterone metabolic process,BP,
7788,GO:0032348,1.00000000001357,0.72839603546794,0,3,negative regulation of aldosterone biosynthetic process,BP,
19695,GO:2000065,1.00000000001357,0.72839603546794,0,3,negative regulation of cortisol biosynthetic process,BP,
15577,GO:0072093,1.00000000001358,0.567642558419154,0,3,metanephric renal vesicle formation,BP,
7786,GO:0032346,1.00000000001358,0.796138462380676,0,2,positive regulation of aldosterone metabolic process,BP,
7789,GO:0032349,1.00000000001358,0.796138462380676,0,2,positive regulation of aldosterone biosynthetic process,BP,
4950,GO:0015019,1.00000000001359,0.858438232653227,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
12340,GO:0048743,1.00000000001359,0.780868431936147,0,2,positive regulation of skeletal muscle fiber development,BP,
7609,GO:0032010,1.00000000001359,0.754840668931179,0,3,phagolysosome,CC,
3975,GO:0008803,1.00000000001364,0.944598398926639,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4518,GO:0010585,1.00000000001364,0.923621392356886,0,1,glutamine secretion,BP,
18548,GO:1903803,1.00000000001364,0.923621392356886,0,1,L-glutamine import across plasma membrane,BP,
2121,GO:0004917,1.00000000001365,0.925783791194126,0,1,interleukin-7 receptor activity,MF,
10084,GO:0042613,1.00000000001365,0.821414521678584,0,3,MHC class II protein complex,CC,
15391,GO:0071691,1.00000000001367,0.835568223787916,0,1,cardiac muscle thin filament assembly,BP,
10717,GO:0044105,1.00000000001369,0.948938347413868,0,1,L-xylulose reductase (NAD+) activity,MF,
12412,GO:0050038,1.00000000001369,0.948938347413868,0,1,L-xylulose reductase (NADP+) activity,MF,
9554,GO:0036371,1.0000000000137,0.820554618909455,0,1,protein localization to T-tubule,BP,
15997,GO:0086046,1.0000000000137,0.820554618909455,0,1,membrane depolarization during SA node cell action potential,BP,
16899,GO:0098907,1.0000000000137,0.820554618909455,0,1,regulation of SA node cell action potential,BP,
7411,GO:0031515,1.00000000001377,0.762819081098809,0,3,tRNA (m1A) methyltransferase complex,CC,
6871,GO:0030377,1.00000000001379,0.933321616617182,0,1,urokinase plasminogen activator receptor activity,MF,
9723,GO:0038195,1.00000000001379,0.933321616617182,0,1,urokinase plasminogen activator signaling pathway,BP,
15359,GO:0071638,1.00000000001383,0.823244587327466,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
6039,GO:0019153,1.00000000001384,0.929848155516594,0,1,protein-disulfide reductase (glutathione) activity,MF,
15812,GO:0072555,1.00000000001384,0.929848155516594,0,1,17-beta-ketosteroid reductase activity,MF,
15832,GO:0072582,1.00000000001384,0.929848155516594,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
10959,GO:0044771,1.00000000001385,0.817792888359697,0,2,meiotic cell cycle phase transition,BP,
17807,GO:1901993,1.00000000001385,0.817792888359697,0,2,regulation of meiotic cell cycle phase transition,BP,
17808,GO:1901994,1.00000000001385,0.817792888359697,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17190,GO:0106088,1.00000000001385,0.836435039222457,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17191,GO:0106089,1.00000000001385,0.836435039222457,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17237,GO:0120077,1.00000000001385,0.836435039222457,0,1,angiogenic sprout fusion,BP,
17238,GO:0120078,1.00000000001385,0.836435039222457,0,1,cell adhesion involved in sprouting angiogenesis,BP,
7645,GO:0032076,1.00000000001385,0.910500508395446,0,1,negative regulation of deoxyribonuclease activity,BP,
9537,GO:0036316,1.00000000001385,0.910500508395446,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
13962,GO:0060703,1.00000000001385,0.910500508395446,0,1,deoxyribonuclease inhibitor activity,MF,
14686,GO:0070346,1.00000000001385,0.910500508395446,0,1,positive regulation of fat cell proliferation,BP,
17589,GO:1901303,1.00000000001385,0.910500508395446,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17991,GO:1902511,1.00000000001385,0.910500508395446,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18469,GO:1903625,1.00000000001385,0.910500508395446,0,1,negative regulation of DNA catabolic process,BP,
1001,GO:0002476,1.00000000001387,0.816478301126814,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
11232,GO:0045485,1.00000000001391,0.871574789335017,0,1,omega-6 fatty acid desaturase activity,MF,
9508,GO:0036245,1.00000000001392,0.805764636646106,0,2,cellular response to menadione,BP,
6220,GO:0019776,1.00000000001392,0.734300682334128,0,3,Atg8 ligase activity,MF,
15817,GO:0072560,1.00000000001393,0.901630858234866,0,1,type B pancreatic cell maturation,BP,
6935,GO:0030553,1.00000000001393,0.648313244044555,0,3,cGMP binding,MF,
17568,GO:1901252,1.00000000001394,0.825298259112267,0,2,regulation of intracellular transport of viral material,BP,
209,GO:0000438,1.00000000001399,0.797461843762833,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
10798,GO:0044307,1.00000000001401,0.769295813267678,0,1,dendritic branch,CC,
19340,GO:1905794,1.00000000001403,0.796482314194275,0,1,response to puromycin,BP,
19341,GO:1905795,1.00000000001403,0.796482314194275,0,1,cellular response to puromycin,BP,
11141,GO:0045219,1.00000000001405,0.855274027491084,0,1,regulation of FasL biosynthetic process,BP,
11142,GO:0045221,1.00000000001405,0.855274027491084,0,1,negative regulation of FasL biosynthetic process,BP,
10306,GO:0043120,1.00000000001407,0.781940266451656,0,3,tumor necrosis factor binding,MF,
16058,GO:0090065,1.00000000001407,0.965944415271552,0,1,regulation of production of siRNA involved in RNA interference,BP,
16787,GO:0098680,1.00000000001407,0.965944415271552,0,1,template-free RNA nucleotidyltransferase,MF,
18496,GO:1903704,1.00000000001407,0.965944415271552,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19538,GO:1990572,1.00000000001407,0.965944415271552,0,1,TERT-RMRP complex,CC,
2128,GO:0004931,1.00000000001408,0.92184244051208,0,1,extracellularly ATP-gated cation channel activity,MF,
5529,GO:0016519,1.00000000001408,0.92184244051208,0,1,gastric inhibitory peptide receptor activity,MF,
9089,GO:0035381,1.00000000001408,0.92184244051208,0,1,ATP-gated ion channel activity,MF,
9720,GO:0038192,1.00000000001408,0.92184244051208,0,1,gastric inhibitory peptide signaling pathway,BP,
2076,GO:0004831,1.00000000001411,0.829360438755484,0,2,tyrosine-tRNA ligase activity,MF,
2924,GO:0006437,1.00000000001411,0.829360438755484,0,2,tyrosyl-tRNA aminoacylation,BP,
10801,GO:0044313,1.00000000001411,0.613263146955651,0,3,protein K6-linked deubiquitination,BP,
5424,GO:0016287,1.00000000001411,0.91094936086505,0,1,glycerone-phosphate O-acyltransferase activity,MF,
3162,GO:0006776,1.00000000001412,0.758694888708993,0,3,vitamin A metabolic process,BP,
2320,GO:0005330,1.00000000001414,0.86936708438032,0,1,dopamine:sodium symporter activity,MF,
2322,GO:0005335,1.00000000001414,0.86936708438032,0,1,serotonin:sodium symporter activity,MF,
4847,GO:0014064,1.00000000001414,0.86936708438032,0,1,positive regulation of serotonin secretion,BP,
6239,GO:0019811,1.00000000001414,0.86936708438032,0,1,cocaine binding,MF,
6530,GO:0021941,1.00000000001414,0.86936708438032,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
16060,GO:0090067,1.00000000001414,0.86936708438032,0,1,regulation of thalamus size,BP,
13000,GO:0051463,1.00000000001416,0.844011214906124,0,1,negative regulation of cortisol secretion,BP,
13601,GO:0060125,1.00000000001416,0.844011214906124,0,1,negative regulation of growth hormone secretion,BP,
5110,GO:0015439,1.00000000001416,0.904881847739681,0,1,heme-transporting ATPase activity,MF,
17989,GO:1902504,1.00000000001416,0.904881847739681,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
11733,GO:0046604,1.00000000001416,0.659525041461567,0,3,positive regulation of mitotic centrosome separation,BP,
1622,GO:0004060,1.00000000001416,0.922106362159853,0,1,arylamine N-acetyltransferase activity,MF,
7543,GO:0031870,1.0000000000142,0.846852950884703,0,1,thromboxane A2 receptor binding,MF,
9466,GO:0036118,1.00000000001422,0.73924556647147,0,3,hyaluranon cable assembly,BP,
17349,GO:1900104,1.00000000001422,0.73924556647147,0,3,regulation of hyaluranon cable assembly,BP,
17350,GO:1900106,1.00000000001422,0.73924556647147,0,3,positive regulation of hyaluranon cable assembly,BP,
1501,GO:0003854,1.00000000001422,0.777350645823898,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
9619,GO:0036505,1.00000000001423,0.905613907631225,0,1,prosaposin receptor activity,MF,
19525,GO:1990504,1.00000000001426,0.629410361013168,0,3,dense core granule exocytosis,BP,
10494,GO:0043423,1.00000000001427,0.872933481862582,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19941,GO:2000537,1.00000000001427,0.872933481862582,0,1,regulation of B cell chemotaxis,BP,
19942,GO:2000538,1.00000000001427,0.872933481862582,0,1,positive regulation of B cell chemotaxis,BP,
203,GO:0000429,1.00000000001427,0.719650076204431,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000436,1.00000000001427,0.719650076204431,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
2147,GO:0004966,1.00000000001428,0.790331049069569,0,3,galanin receptor activity,MF,
2897,GO:0006407,1.00000000001433,0.716472274942908,0,3,rRNA export from nucleus,BP,
1573,GO:0003985,1.00000000001434,0.773710313033275,0,3,acetyl-CoA C-acetyltransferase activity,MF,
8727,GO:0034392,1.00000000001435,0.677713506404341,0,3,negative regulation of smooth muscle cell apoptotic process,BP,
7938,GO:0032545,1.00000000001435,0.745995436075028,0,3,CURI complex,CC,
8762,GO:0034456,1.00000000001435,0.745995436075028,0,3,UTP-C complex,CC,
13762,GO:0060378,1.00000000001436,0.824807220590898,0,1,regulation of brood size,BP,
2361,GO:0005471,1.00000000001438,0.760166998997649,0,3,ATP:ADP antiporter activity,MF,
5030,GO:0015207,1.00000000001438,0.760166998997649,0,3,adenine transmembrane transporter activity,MF,
4221,GO:0009400,1.00000000001438,0.907897377015485,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
17321,GO:1900039,1.00000000001438,0.939664282011529,0,1,positive regulation of cellular response to hypoxia,BP,
17832,GO:1902071,1.00000000001438,0.939664282011529,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17833,GO:1902073,1.00000000001438,0.939664282011529,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
1750,GO:0004352,1.00000000001439,0.892839813634992,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1751,GO:0004353,1.00000000001439,0.892839813634992,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
5595,GO:0016639,1.00000000001439,0.892839813634992,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5728,GO:0016880,1.00000000001439,0.791420860276795,0,2,acid-ammonia (or amide) ligase activity,MF,
19417,GO:1990074,1.00000000001439,0.892010388243472,0,1,polyuridylation-dependent mRNA catabolic process,BP,
16645,GO:0097598,1.00000000001443,0.855951954125852,0,1,sperm cytoplasmic droplet,CC,
19376,GO:1905918,1.00000000001444,0.919786981320772,0,1,regulation of CoA-transferase activity,BP,
19377,GO:1905920,1.00000000001444,0.919786981320772,0,1,positive regulation of CoA-transferase activity,BP,
16727,GO:0098536,1.00000000001448,0.671176499646278,0,3,deuterosome,CC,
1360,GO:0003241,1.00000000001449,0.676359293430524,0,3,growth involved in heart morphogenesis,BP,
18601,GO:1903918,1.00000000001451,0.827881745735405,0,1,regulation of actin filament severing,BP,
18602,GO:1903919,1.00000000001451,0.827881745735405,0,1,negative regulation of actin filament severing,BP,
8688,GO:0034342,1.00000000001452,0.834674335185198,0,2,response to type III interferon,BP,
10673,GO:0043973,1.00000000001454,0.919077072153636,0,1,histone H3-K4 acetylation,BP,
10610,GO:0043629,1.00000000001454,0.821485559609128,0,1,ncRNA polyadenylation,BP,
10611,GO:0043630,1.00000000001454,0.821485559609128,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
4586,GO:0010698,1.00000000001455,0.851402560716284,0,2,acetyltransferase activator activity,MF,
3968,GO:0008783,1.0000000000146,0.919180610598966,0,1,agmatinase activity,MF,
8400,GO:0033388,1.0000000000146,0.919180610598966,0,1,putrescine biosynthetic process from arginine,BP,
7126,GO:0030969,1.00000000001461,0.727250088281491,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
14513,GO:0070054,1.00000000001461,0.727250088281491,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14514,GO:0070055,1.00000000001461,0.727250088281491,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
16741,GO:0098575,1.00000000001463,0.846586045544562,0,2,lumenal side of lysosomal membrane,CC,
19148,GO:1905223,1.00000000001464,0.843129357607336,0,1,epicardium morphogenesis,BP,
14021,GO:0060816,1.00000000001467,0.708373167734616,0,2,random inactivation of X chromosome,BP,
14056,GO:0060907,1.00000000001468,0.713429255764014,0,3,positive regulation of macrophage cytokine production,BP,
1237,GO:0002930,1.00000000001469,0.859527183089116,0,1,trabecular meshwork development,BP,
1588,GO:0004001,1.00000000001469,0.921481747481823,0,1,adenosine kinase activity,MF,
2001,GO:0004727,1.00000000001469,0.921481747481823,0,1,prenylated protein tyrosine phosphatase activity,MF,
2756,GO:0006169,1.00000000001469,0.921481747481823,0,1,adenosine salvage,BP,
2760,GO:0006175,1.00000000001469,0.921481747481823,0,1,dATP biosynthetic process,BP,
18279,GO:1903223,1.0000000000147,0.665155349982659,0,3,positive regulation of oxidative stress-induced neuron death,BP,
2034,GO:0004776,1.00000000001475,0.855076736679906,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
9385,GO:0035948,1.00000000001476,0.702824443376514,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
16879,GO:0098871,1.00000000001479,0.927896320979827,0,1,postsynaptic actin cytoskeleton,CC,
17043,GO:0099571,1.00000000001479,0.927896320979827,0,1,postsynaptic cytoskeleton,CC,
3607,GO:0008049,1.0000000000148,0.923948989454664,0,1,male courtship behavior,BP,
3846,GO:0008460,1.0000000000148,0.923948989454664,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
18953,GO:1904766,1.00000000001482,0.835994947878896,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
2415,GO:0005592,1.00000000001482,0.8310295285358,0,1,collagen type XI trimer,CC,
14449,GO:0061857,1.00000000001483,0.801067945747384,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14863,GO:0070682,1.00000000001485,0.764816822732932,0,3,proteasome regulatory particle assembly,BP,
6075,GO:0019236,1.00000000001486,0.825942513088374,0,2,response to pheromone,BP,
2234,GO:0005142,1.00000000001489,0.916690830282233,0,1,interleukin-11 receptor binding,MF,
5837,GO:0017133,1.00000000001489,0.916690830282233,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10638,GO:0043783,1.00000000001489,0.916690830282233,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11153,GO:0045251,1.00000000001489,0.916690830282233,0,1,electron transfer flavoprotein complex,CC,
8408,GO:0033499,1.00000000001493,0.855728976720562,0,2,galactose catabolic process via UDP-galactose,BP,
11480,GO:0045988,1.00000000001494,0.70280497464702,0,3,negative regulation of striated muscle contraction,BP,
13506,GO:0055118,1.00000000001494,0.70280497464702,0,3,negative regulation of cardiac muscle contraction,BP,
16029,GO:0089700,1.00000000001495,0.680203168262011,0,3,protein kinase D signaling,BP,
9258,GO:0035700,1.00000000001497,0.92622758285642,0,1,astrocyte chemotaxis,BP,
9481,GO:0036145,1.00000000001497,0.92622758285642,0,1,dendritic cell homeostasis,BP,
19910,GO:2000458,1.00000000001497,0.92622758285642,0,1,regulation of astrocyte chemotaxis,BP,
9121,GO:0035470,1.00000000001498,0.925756275675282,0,1,positive regulation of vascular wound healing,BP,
13951,GO:0060690,1.00000000001498,0.925756275675282,0,1,epithelial cell differentiation involved in salivary gland development,BP,
13952,GO:0060691,1.00000000001498,0.925756275675282,0,1,epithelial cell maturation involved in salivary gland development,BP,
17344,GO:1900098,1.00000000001498,0.925756275675282,0,1,regulation of plasma cell differentiation,BP,
17345,GO:1900100,1.00000000001498,0.925756275675282,0,1,positive regulation of plasma cell differentiation,BP,
18396,GO:1903489,1.00000000001498,0.925756275675282,0,1,positive regulation of lactation,BP,
17691,GO:1901631,1.00000000001499,0.821929879213662,0,1,positive regulation of presynaptic membrane organization,BP,
18794,GO:1904393,1.00000000001499,0.821929879213662,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18795,GO:1904395,1.00000000001499,0.821929879213662,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
19886,GO:2000405,1.000000000015,0.854765498264978,0,1,negative regulation of T cell migration,BP,
16308,GO:0090571,1.00000000001502,0.766198073253886,0,3,RNA polymerase II transcription repressor complex,CC,
2072,GO:0004827,1.00000000001502,0.742846983113663,0,3,proline-tRNA ligase activity,MF,
2920,GO:0006433,1.00000000001502,0.742846983113663,0,3,prolyl-tRNA aminoacylation,BP,
19557,GO:1990637,1.00000000001503,0.695655838742508,0,3,response to prolactin,BP,
17964,GO:1902423,1.00000000001503,0.770021153537141,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17965,GO:1902425,1.00000000001503,0.770021153537141,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
18665,GO:1904045,1.00000000001504,0.918973568411919,0,1,cellular response to aldosterone,BP,
17296,GO:0150018,1.00000000001512,0.674478216533214,0,3,basal dendrite development,BP,
17297,GO:0150019,1.00000000001512,0.674478216533214,0,3,basal dendrite morphogenesis,BP,
17298,GO:0150020,1.00000000001512,0.674478216533214,0,3,basal dendrite arborization,BP,
6447,GO:0021773,1.00000000001512,0.632322392471334,0,3,striatal medium spiny neuron differentiation,BP,
9665,GO:0038052,1.00000000001514,0.771643102524346,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
14507,GO:0070042,1.00000000001515,0.903750501351245,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
17649,GO:1901537,1.00000000001515,0.549275966309798,0,3,positive regulation of DNA demethylation,BP,
16673,GO:0097676,1.0000000000152,0.583606280273695,0,3,histone H3-K36 dimethylation,BP,
959,GO:0002384,1.00000000001522,0.87734222936923,0,1,hepatic immune response,BP,
14549,GO:0070119,1.00000000001522,0.87734222936923,0,1,ciliary neurotrophic factor binding,MF,
4793,GO:0010990,1.00000000001524,0.628356855926573,0,3,regulation of SMAD protein complex assembly,BP,
129,GO:0000270,1.00000000001524,0.86941632741919,0,2,peptidoglycan metabolic process,BP,
3958,GO:0008745,1.00000000001524,0.86941632741919,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4174,GO:0009253,1.00000000001524,0.86941632741919,0,2,peptidoglycan catabolic process,BP,
5305,GO:0016019,1.00000000001524,0.86941632741919,0,2,peptidoglycan receptor activity,MF,
13116,GO:0051710,1.00000000001524,0.86941632741919,0,2,regulation of cytolysis in other organism,BP,
13118,GO:0051714,1.00000000001524,0.86941632741919,0,2,positive regulation of cytolysis in other organism,BP,
4829,GO:0014040,1.00000000001525,0.725373686493681,0,2,positive regulation of Schwann cell differentiation,BP,
8761,GO:0034455,1.00000000001539,0.694422841326698,0,3,t-UTP complex,CC,
15288,GO:0071528,1.00000000001539,0.882947216139535,0,1,tRNA re-export from nucleus,BP,
15328,GO:0071593,1.0000000000154,0.696154192401095,0,3,lymphocyte aggregation,BP,
9768,GO:0039713,1.00000000001541,0.893932378723122,0,1,viral factory,CC,
9769,GO:0039714,1.00000000001541,0.893932378723122,0,1,cytoplasmic viral factory,CC,
15786,GO:0072517,1.00000000001541,0.893932378723122,0,1,host cell viral assembly compartment,CC,
17444,GO:1900276,1.00000000001541,0.893932378723122,0,1,regulation of proteinase activated receptor activity,BP,
17481,GO:1900736,1.00000000001541,0.893932378723122,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17482,GO:1900737,1.00000000001541,0.893932378723122,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
593,GO:0001758,1.00000000001542,0.737863428719042,0,3,retinal dehydrogenase activity,MF,
644,GO:0001835,1.00000000001543,0.898641608247319,0,1,blastocyst hatching,BP,
8997,GO:0035188,1.00000000001543,0.898641608247319,0,1,hatching,BP,
15389,GO:0071684,1.00000000001543,0.898641608247319,0,1,organism emergence from protective structure,BP,
5777,GO:0017005,1.00000000001545,0.888802710642106,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6436,GO:0021757,1.00000000001545,0.888802710642106,0,1,caudate nucleus development,BP,
6437,GO:0021758,1.00000000001545,0.888802710642106,0,1,putamen development,BP,
5836,GO:0017130,1.00000000001549,0.837037646649724,0,1,poly(C) RNA binding,MF,
16743,GO:0098577,1.00000000001549,0.837037646649724,0,1,inactive sex chromosome,CC,
18121,GO:1902889,1.00000000001549,0.837037646649724,0,1,protein localization to spindle microtubule,BP,
19471,GO:1990280,1.00000000001549,0.837037646649724,0,1,RNA localization to chromatin,BP,
160,GO:0000332,1.00000000001551,0.960224327899431,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
238,GO:0000496,1.00000000001551,0.960224327899431,0,1,base pairing,MF,
239,GO:0000497,1.00000000001551,0.960224327899431,0,1,base pairing with DNA,MF,
1465,GO:0003721,1.00000000001551,0.960224327899431,0,1,telomerase RNA reverse transcriptase activity,MF,
5099,GO:0015389,1.00000000001551,0.918782551677623,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5100,GO:0015390,1.00000000001551,0.918782551677623,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5101,GO:0015391,1.00000000001551,0.918782551677623,0,1,nucleobase:cation symporter activity,MF,
18747,GO:1904274,1.00000000001551,0.918782551677623,0,1,tricellular tight junction assembly,BP,
1246,GO:0002947,1.00000000001555,0.877502620804371,0,1,tumor necrosis factor receptor superfamily complex,CC,
12480,GO:0050613,1.00000000001557,0.823236048706057,0,2,delta14-sterol reductase activity,MF,
5655,GO:0016768,1.00000000001557,0.927916062752182,0,1,spermine synthase activity,MF,
10187,GO:0042822,1.00000000001558,0.683709031661786,0,3,pyridoxal phosphate metabolic process,BP,
6003,GO:0019050,1.00000000001562,0.783765429212183,0,3,suppression by virus of host apoptotic process,BP,
9745,GO:0039526,1.00000000001562,0.783765429212183,0,3,modulation by virus of host apoptotic process,BP,
12382,GO:0048850,1.00000000001563,0.71653882737621,0,2,hypophysis morphogenesis,BP,
3418,GO:0007206,1.00000000001567,0.875592209614326,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
15419,GO:0071765,1.00000000001567,0.875592209614326,0,1,nuclear inner membrane organization,BP,
8931,GO:0034991,1.00000000001568,0.805077663998844,0,2,nuclear meiotic cohesin complex,CC,
6082,GO:0019249,1.0000000000157,0.723437935578251,0,3,lactate biosynthetic process,BP,
16718,GO:0098518,1.00000000001575,0.749873079441819,0,3,polynucleotide phosphatase activity,MF,
3730,GO:0008269,1.00000000001576,0.919021335512953,0,1,JAK pathway signal transduction adaptor activity,MF,
4315,GO:0009810,1.00000000001576,0.919021335512953,0,1,stilbene metabolic process,BP,
8534,GO:0033885,1.00000000001576,0.919021335512953,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11585,GO:0046272,1.00000000001576,0.919021335512953,0,1,stilbene catabolic process,BP,
625,GO:0001809,1.00000000001576,0.934425979312308,0,1,positive regulation of type IV hypersensitivity,BP,
13831,GO:0060467,1.00000000001576,0.934425979312308,0,1,negative regulation of fertilization,BP,
19853,GO:2000359,1.00000000001576,0.934425979312308,0,1,regulation of binding of sperm to zona pellucida,BP,
19854,GO:2000360,1.00000000001576,0.934425979312308,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19873,GO:2000387,1.00000000001576,0.934425979312308,0,1,regulation of antral ovarian follicle growth,BP,
19874,GO:2000388,1.00000000001576,0.934425979312308,0,1,positive regulation of antral ovarian follicle growth,BP,
8295,GO:0033142,1.00000000001577,0.919292160555036,0,1,progesterone receptor binding,MF,
8321,GO:0033181,1.00000000001577,0.928313539498696,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
14382,GO:0061689,1.00000000001586,0.694725949457219,0,3,tricellular tight junction,CC,
1895,GO:0004581,1.00000000001589,0.939804187841726,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1035,GO:0002545,1.00000000001591,0.924402361933135,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1210,GO:0002880,1.00000000001591,0.924402361933135,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1211,GO:0002882,1.00000000001591,0.924402361933135,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1534,GO:0003920,1.00000000001591,0.924402361933135,0,1,GMP reductase activity,MF,
5284,GO:0015950,1.00000000001591,0.924402361933135,0,1,purine nucleotide interconversion,BP,
5285,GO:0015951,1.00000000001591,0.924402361933135,0,1,purine ribonucleotide interconversion,BP,
5606,GO:0016657,1.00000000001591,0.924402361933135,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18011,GO:1902560,1.00000000001591,0.924402361933135,0,1,GMP reductase complex,CC,
8954,GO:0035054,1.00000000001594,0.901131951722792,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
12739,GO:0051040,1.00000000001594,0.901131951722792,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12740,GO:0051042,1.00000000001594,0.901131951722792,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13604,GO:0060128,1.00000000001594,0.901131951722792,0,1,corticotropin hormone secreting cell differentiation,BP,
14019,GO:0060804,1.00000000001594,0.901131951722792,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14875,GO:0070724,1.00000000001594,0.901131951722792,0,1,BMP receptor complex,CC,
2027,GO:0004768,1.00000000001596,0.703100478577897,0,3,stearoyl-CoA 9-desaturase activity,MF,
5383,GO:0016215,1.00000000001596,0.703100478577897,0,3,acyl-CoA desaturase activity,MF,
1833,GO:0004490,1.00000000001597,0.929994874863093,0,1,methylglutaconyl-CoA hydratase activity,MF,
12410,GO:0050011,1.00000000001597,0.929994874863093,0,1,itaconyl-CoA hydratase activity,MF,
2217,GO:0005115,1.00000000001597,0.850060038249208,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
6405,GO:0021650,1.00000000001597,0.850060038249208,0,1,vestibulocochlear nerve formation,BP,
9630,GO:0036517,1.00000000001597,0.850060038249208,0,1,chemoattraction of serotonergic neuron axon,BP,
13196,GO:0051885,1.00000000001597,0.850060038249208,0,1,positive regulation of timing of anagen,BP,
13538,GO:0060031,1.00000000001597,0.850060038249208,0,1,mediolateral intercalation,BP,
13569,GO:0060067,1.00000000001597,0.850060038249208,0,1,cervix development,BP,
13906,GO:0060599,1.00000000001597,0.850060038249208,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14013,GO:0060775,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14020,GO:0060809,1.00000000001597,0.850060038249208,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14244,GO:0061347,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14245,GO:0061348,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14246,GO:0061349,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14247,GO:0061350,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14249,GO:0061354,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14364,GO:0061642,1.00000000001597,0.850060038249208,0,1,chemoattraction of axon,BP,
17950,GO:1902379,1.00000000001597,0.850060038249208,0,1,chemoattractant activity involved in axon guidance,MF,
19037,GO:1904933,1.00000000001597,0.850060038249208,0,1,regulation of cell proliferation in midbrain,BP,
19038,GO:1904934,1.00000000001597,0.850060038249208,0,1,negative regulation of cell proliferation in midbrain,BP,
19047,GO:1904955,1.00000000001597,0.850060038249208,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19234,GO:1905438,1.00000000001597,0.850060038249208,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
2124,GO:0004921,1.00000000001598,0.899955551778936,0,1,interleukin-11 receptor activity,MF,
6314,GO:0019970,1.00000000001598,0.899955551778936,0,1,interleukin-11 binding,MF,
9701,GO:0038154,1.00000000001598,0.899955551778936,0,1,interleukin-11-mediated signaling pathway,BP,
4648,GO:0010796,1.00000000001598,0.796300357088607,0,3,regulation of multivesicular body size,BP,
1652,GO:0004108,1.00000000001601,0.904971224148683,0,1,citrate (Si)-synthase activity,MF,
9572,GO:0036440,1.00000000001601,0.904971224148683,0,1,citrate synthase activity,MF,
2004,GO:0004730,1.00000000001602,0.928433759086749,0,1,pseudouridylate synthase activity,MF,
14961,GO:0070902,1.00000000001602,0.928433759086749,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
6211,GO:0019747,1.00000000001606,0.947119190683495,0,1,regulation of isoprenoid metabolic process,BP,
6879,GO:0030421,1.00000000001606,0.947119190683495,0,1,defecation,BP,
12960,GO:0051391,1.00000000001606,0.881298182950248,0,1,tRNA acetylation,BP,
12961,GO:0051392,1.00000000001606,0.881298182950248,0,1,tRNA N-acetyltransferase activity,MF,
18975,GO:1904812,1.00000000001606,0.881298182950248,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19628,GO:1990882,1.00000000001606,0.881298182950248,0,1,rRNA acetylation,BP,
19629,GO:1990883,1.00000000001606,0.881298182950248,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19630,GO:1990884,1.00000000001606,0.881298182950248,0,1,RNA acetylation,BP,
16884,GO:0098881,1.00000000001609,0.721556566535696,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16927,GO:0098967,1.00000000001609,0.721556566535696,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
5431,GO:0016300,1.00000000001609,0.717795873479203,0,3,tRNA (uracil) methyltransferase activity,MF,
1317,GO:0003166,1.0000000000161,0.865670381782827,0,1,bundle of His development,BP,
1318,GO:0003167,1.0000000000161,0.865670381782827,0,1,atrioventricular bundle cell differentiation,BP,
13904,GO:0060596,1.0000000000161,0.865670381782827,0,1,mammary placode formation,BP,
14070,GO:0060932,1.0000000000161,0.865670381782827,0,1,His-Purkinje system cell differentiation,BP,
14710,GO:0070407,1.00000000001611,0.901725503868597,0,1,oxidation-dependent protein catabolic process,BP,
3786,GO:0008355,1.00000000001612,0.871782653386056,0,1,olfactory learning,BP,
16683,GO:0097698,1.00000000001614,0.932153814215509,0,1,telomere maintenance via base-excision repair,BP,
18608,GO:1903929,1.00000000001615,0.900713708664172,0,1,primary palate development,BP,
18104,GO:1902824,1.00000000001616,0.870515204691391,0,2,positive regulation of late endosome to lysosome transport,BP,
18330,GO:1903337,1.00000000001616,0.870515204691391,0,2,positive regulation of vacuolar transport,BP,
12969,GO:0051413,1.00000000001617,0.914110002272436,0,1,response to cortisone,BP,
16693,GO:0097724,1.00000000001621,0.925337511278766,0,1,sperm flagellum movement,BP,
19225,GO:1905419,1.00000000001621,0.925337511278766,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
2758,GO:0006172,1.00000000001625,0.917795418646941,0,1,ADP biosynthetic process,BP,
16487,GO:0097226,1.00000000001625,0.917795418646941,0,1,sperm mitochondrial sheath,CC,
16391,GO:0097058,1.00000000001625,0.925921754611659,0,1,CRLF-CLCF1 complex,CC,
16392,GO:0097059,1.00000000001625,0.925921754611659,0,1,CNTFR-CLCF1 complex,CC,
16363,GO:0097010,1.00000000001626,0.689908895633722,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17513,GO:1901069,1.00000000001628,0.869889241965533,0,2,guanosine-containing compound catabolic process,BP,
19983,GO:2000619,1.00000000001628,0.745046084030089,0,3,negative regulation of histone H4-K16 acetylation,BP,
15904,GO:0072733,1.00000000001629,0.775352211543573,0,3,response to staurosporine,BP,
15905,GO:0072734,1.00000000001629,0.775352211543573,0,3,cellular response to staurosporine,BP,
4013,GO:0009020,1.00000000001629,0.923076181274022,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13361,GO:0052666,1.00000000001629,0.923076181274022,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17176,GO:0106050,1.00000000001629,0.923076181274022,0,1,tRNA 2'-O-methyltransferase activity,MF,
1579,GO:0003991,1.0000000000163,0.921188352108422,0,1,acetylglutamate kinase activity,MF,
1611,GO:0004042,1.0000000000163,0.921188352108422,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
17149,GO:0103045,1.0000000000163,0.921188352108422,0,1,methione N-acyltransferase activity,MF,
5334,GO:0016077,1.0000000000163,0.847523069671125,0,1,snoRNA catabolic process,BP,
9333,GO:0035862,1.0000000000163,0.847523069671125,0,1,dITP metabolic process,BP,
9334,GO:0035863,1.0000000000163,0.847523069671125,0,1,dITP catabolic process,BP,
12657,GO:0050897,1.0000000000163,0.847523069671125,0,1,cobalt ion binding,MF,
16552,GO:0097382,1.0000000000163,0.847523069671125,0,1,deoxynucleoside-diphosphatase activity,MF,
16553,GO:0097383,1.0000000000163,0.847523069671125,0,1,dIDP diphosphatase activity,MF,
17692,GO:1901639,1.0000000000163,0.847523069671125,0,1,XDP catabolic process,BP,
17693,GO:1901640,1.0000000000163,0.847523069671125,0,1,XTP binding,MF,
17694,GO:1901641,1.0000000000163,0.847523069671125,0,1,ITP binding,MF,
19396,GO:1990003,1.0000000000163,0.847523069671125,0,1,IDP phosphatase activity,MF,
7231,GO:0031166,1.00000000001644,0.700627427446906,0,3,integral component of vacuolar membrane,CC,
7297,GO:0031310,1.00000000001644,0.700627427446906,0,3,intrinsic component of vacuolar membrane,CC,
15378,GO:0071672,1.00000000001649,0.752914723181731,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
13650,GO:0060212,1.00000000001652,0.925491594014771,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17385,GO:1900152,1.00000000001652,0.925491594014771,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
11955,GO:0047275,1.00000000001653,0.891331961802992,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
10391,GO:0043250,1.00000000001654,0.93188863634514,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10392,GO:0043251,1.00000000001654,0.93188863634514,0,1,sodium-dependent organic anion transport,BP,
4379,GO:0010034,1.00000000001656,0.891457562680847,0,1,response to acetate,BP,
1513,GO:0003875,1.00000000001659,0.893995112376952,0,1,ADP-ribosylarginine hydrolase activity,MF,
15024,GO:0071006,1.00000000001659,0.754336419548138,0,3,U2-type catalytic step 1 spliceosome,CC,
16661,GO:0097638,1.00000000001664,0.687056507396198,0,2,L-arginine import across plasma membrane,BP,
19058,GO:1904978,1.00000000001664,0.662863871806014,0,3,regulation of endosome organization,BP,
10636,GO:0043739,1.00000000001666,0.898715033099406,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
19433,GO:1990136,1.00000000001667,0.914093110020096,0,1,linoleate 9S-lipoxygenase activity,MF,
5138,GO:0015670,1.00000000001675,0.928413691321894,0,1,carbon dioxide transport,BP,
8129,GO:0032849,1.00000000001675,0.928413691321894,0,1,positive regulation of cellular pH reduction,BP,
17864,GO:1902173,1.00000000001677,0.900317402305983,0,1,negative regulation of keratinocyte apoptotic process,BP,
11941,GO:0047166,1.00000000001678,0.923810684892278,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
4994,GO:0015141,1.0000000000168,0.730599985416298,0,3,succinate transmembrane transporter activity,MF,
5177,GO:0015744,1.0000000000168,0.730599985416298,0,3,succinate transport,BP,
15224,GO:0071422,1.0000000000168,0.730599985416298,0,3,succinate transmembrane transport,BP,
270,GO:0000773,1.00000000001685,0.944463300913534,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1913,GO:0004608,1.00000000001685,0.944463300913534,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11926,GO:0047035,1.00000000001685,0.944463300913534,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15943,GO:0080101,1.00000000001685,0.944463300913534,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
18734,GO:1904245,1.00000000001686,0.836861669616056,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
3433,GO:0007225,1.00000000001687,0.865827934613381,0,1,patched ligand maturation,BP,
9227,GO:0035638,1.00000000001687,0.865827934613381,0,1,signal maturation,BP,
19121,GO:1905152,1.00000000001689,0.849112817149735,0,1,positive regulation of voltage-gated sodium channel activity,BP,
1542,GO:0003938,1.0000000000169,0.848145195141028,0,2,IMP dehydrogenase activity,MF,
18286,GO:1903237,1.00000000001691,0.949447407227004,0,1,negative regulation of leukocyte tethering or rolling,BP,
19589,GO:1990758,1.00000000001694,0.925256252694859,0,1,mitotic sister chromatid biorientation,BP,
1960,GO:0004671,1.00000000001698,0.86472798976214,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
15379,GO:0071673,1.00000000001699,0.901642695794683,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
18856,GO:1904565,1.00000000001699,0.901642695794683,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18857,GO:1904566,1.00000000001699,0.901642695794683,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
9194,GO:0035597,1.00000000001702,0.921974224538781,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
5143,GO:0015680,1.00000000001702,0.762948277273783,0,3,intracellular copper ion transport,BP,
9135,GO:0035504,1.00000000001703,0.931954777346978,0,1,regulation of myosin light chain kinase activity,BP,
9136,GO:0035505,1.00000000001703,0.931954777346978,0,1,positive regulation of myosin light chain kinase activity,BP,
10312,GO:0043126,1.00000000001703,0.931954777346978,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10313,GO:0043128,1.00000000001703,0.931954777346978,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
5530,GO:0016520,1.00000000001704,0.868372599355611,0,1,growth hormone-releasing hormone receptor activity,MF,
18048,GO:1902659,1.00000000001709,0.745492341355068,0,3,regulation of glucose mediated signaling pathway,BP,
18049,GO:1902661,1.00000000001709,0.745492341355068,0,3,positive regulation of glucose mediated signaling pathway,BP,
3426,GO:0007217,1.00000000001713,0.913135070405887,0,1,tachykinin receptor signaling pathway,BP,
18679,GO:1904098,1.00000000001713,0.722790284321706,0,3,regulation of protein O-linked glycosylation,BP,
18680,GO:1904100,1.00000000001713,0.722790284321706,0,3,positive regulation of protein O-linked glycosylation,BP,
6588,GO:0022613,1.00000000001718,0,7,447,ribonucleoprotein complex biogenesis,BP,CIRBP;SETX;ATM;RPL13A;CELF2;SRPK2;AGO4
2102,GO:0004874,1.00000000001718,0.730529701927605,0,2,aryl hydrocarbon receptor activity,MF,
12978,GO:0051430,1.0000000000172,0.799779125622943,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
7544,GO:0031871,1.00000000001722,0.70556129750605,0,3,proteinase activated receptor binding,MF,
1943,GO:0004648,1.00000000001723,0.920420341599909,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2360,GO:0005464,1.00000000001726,0.837134919141188,0,1,UDP-xylose transmembrane transporter activity,MF,
5192,GO:0015790,1.00000000001726,0.837134919141188,0,1,UDP-xylose transmembrane transport,BP,
14443,GO:0061845,1.00000000001726,0.898519129828073,0,1,neuron projection branch point,CC,
14444,GO:0061846,1.00000000001726,0.898519129828073,0,1,dendritic spine cytoplasm,CC,
1068,GO:0002635,1.00000000001729,0.786005094337551,0,1,negative regulation of germinal center formation,BP,
15471,GO:0071873,1.00000000001729,0.893040850269657,0,1,response to norepinephrine,BP,
15472,GO:0071874,1.00000000001729,0.893040850269657,0,1,cellular response to norepinephrine stimulus,BP,
694,GO:0001915,1.00000000001732,0.744929878570513,0,3,negative regulation of T cell mediated cytotoxicity,BP,
8106,GO:0032805,1.00000000001734,0.835172785254597,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
17518,GO:1901074,1.00000000001734,0.83662933805575,0,1,regulation of engulfment of apoptotic cell,BP,
17519,GO:1901076,1.00000000001734,0.83662933805575,0,1,positive regulation of engulfment of apoptotic cell,BP,
3059,GO:0006624,1.00000000001741,0.874894922002968,0,2,vacuolar protein processing,BP,
2031,GO:0004773,1.00000000001745,0.842866456746541,0,1,steryl-sulfatase activity,MF,
16705,GO:0097749,1.00000000001745,0.842866456746541,0,1,membrane tubulation,BP,
9274,GO:0035730,1.00000000001746,0.945385902435032,0,1,S-nitrosoglutathione binding,MF,
9275,GO:0035731,1.00000000001746,0.945385902435032,0,1,dinitrosyl-iron complex binding,MF,
9276,GO:0035732,1.00000000001746,0.945385902435032,0,1,nitric oxide storage,BP,
11724,GO:0046588,1.00000000001746,0.946842056210218,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
8856,GO:0034677,1.00000000001753,0.885837225754045,0,1,integrin alpha7-beta1 complex,CC,
8859,GO:0034681,1.00000000001753,0.885837225754045,0,1,integrin alpha11-beta1 complex,CC,
6386,GO:0021592,1.00000000001753,0.857651637744134,0,1,fourth ventricle development,BP,
6549,GO:0021993,1.00000000001753,0.857651637744134,0,1,initiation of neural tube closure,BP,
926,GO:0002325,1.00000000001754,0.939689698591156,0,1,natural killer cell differentiation involved in immune response,BP,
8119,GO:0032824,1.00000000001754,0.939689698591156,0,1,negative regulation of natural killer cell differentiation,BP,
8121,GO:0032826,1.00000000001754,0.939689698591156,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8122,GO:0032827,1.00000000001754,0.939689698591156,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
900,GO:0002282,1.00000000001756,0.911755160676224,0,1,microglial cell activation involved in immune response,BP,
2842,GO:0006313,1.0000000000176,0.879425519802416,0,1,transposition, DNA-mediated,BP,
6432,GO:0021730,1.00000000001762,0.820055624375308,0,1,trigeminal sensory nucleus development,BP,
6433,GO:0021740,1.00000000001762,0.820055624375308,0,1,principal sensory nucleus of trigeminal nerve development,BP,
14180,GO:0061141,1.00000000001762,0.820055624375308,0,1,lung ciliated cell differentiation,BP,
20092,GO:2000795,1.00000000001762,0.820055624375308,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
1949,GO:0004655,1.00000000001765,0.900148720427707,0,1,porphobilinogen synthase activity,MF,
18996,GO:1904854,1.00000000001765,0.900148720427707,0,1,proteasome core complex binding,MF,
3725,GO:0008260,1.00000000001768,0.890704318360243,0,1,3-oxoacid CoA-transferase activity,MF,
10271,GO:0043041,1.00000000001768,0.890704318360243,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
14609,GO:0070209,1.00000000001773,0.896369902504311,0,1,ASTRA complex,CC,
18612,GO:1903939,1.00000000001773,0.896369902504311,0,1,regulation of TORC2 signaling,BP,
18840,GO:1904515,1.00000000001773,0.896369902504311,0,1,positive regulation of TORC2 signaling,BP,
1135,GO:0002728,1.00000000001781,0.870743476786654,0,1,negative regulation of natural killer cell cytokine production,BP,
19917,GO:2000474,1.00000000001784,0.879114467347184,0,1,regulation of opioid receptor signaling pathway,BP,
9212,GO:0035616,1.00000000001788,0.668442809989152,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
6950,GO:0030613,1.00000000001789,0.838577749797948,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6951,GO:0030614,1.00000000001789,0.838577749797948,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
4497,GO:0010533,1.00000000001792,0.830890882722269,0,3,regulation of activation of Janus kinase activity,BP,
8809,GO:0034602,1.00000000001792,0.873776436629645,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
14124,GO:0061034,1.00000000001792,0.873776436629645,0,1,olfactory bulb mitral cell layer development,BP,
3485,GO:0007354,1.00000000001799,0.751684269286015,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
6091,GO:0019303,1.00000000001799,0.881659905279549,0,2,D-ribose catabolic process,BP,
973,GO:0002428,1.000000000018,0.771302862332753,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
7266,GO:0031260,1.00000000001802,0.942066835139978,0,1,pseudopodium membrane,CC,
4163,GO:0009233,1.00000000001806,0.888678087853004,0,1,menaquinone metabolic process,BP,
4164,GO:0009234,1.00000000001806,0.888678087853004,0,1,menaquinone biosynthetic process,BP,
7697,GO:0032194,1.00000000001806,0.888678087853004,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9961,GO:0042371,1.00000000001806,0.888678087853004,0,1,vitamin K biosynthetic process,BP,
779,GO:0002038,1.0000000000181,0.918114083984266,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4712,GO:0010879,1.0000000000181,0.918114083984266,0,1,cholesterol transport involved in cholesterol storage,BP,
9073,GO:0035352,1.0000000000181,0.918114083984266,0,1,NAD transmembrane transport,BP,
10317,GO:0043132,1.0000000000181,0.918114083984266,0,1,NAD transport,BP,
10925,GO:0044610,1.0000000000181,0.918114083984266,0,1,FMN transmembrane transporter activity,MF,
13125,GO:0051724,1.0000000000181,0.918114083984266,0,1,NAD transmembrane transporter activity,MF,
3783,GO:0008352,1.00000000001811,0.911482845418799,0,1,katanin complex,CC,
1543,GO:0003939,1.00000000001813,0.913804834874159,0,1,L-iditol 2-dehydrogenase activity,MF,
2694,GO:0006062,1.00000000001813,0.913804834874159,0,1,sorbitol catabolic process,BP,
6134,GO:0019407,1.00000000001813,0.913804834874159,0,1,hexitol catabolic process,BP,
6160,GO:0019519,1.00000000001813,0.913804834874159,0,1,pentitol metabolic process,BP,
6163,GO:0019527,1.00000000001813,0.913804834874159,0,1,pentitol catabolic process,BP,
7302,GO:0031320,1.00000000001813,0.913804834874159,0,1,hexitol dehydrogenase activity,MF,
11699,GO:0046526,1.00000000001813,0.913804834874159,0,1,D-xylulose reductase activity,MF,
12820,GO:0051160,1.00000000001813,0.913804834874159,0,1,L-xylitol catabolic process,BP,
12821,GO:0051164,1.00000000001813,0.913804834874159,0,1,L-xylitol metabolic process,BP,
1483,GO:0003796,1.00000000001813,0.931625100073995,0,1,lysozyme activity,MF,
1747,GO:0004349,1.00000000001815,0.893141355961399,0,1,glutamate 5-kinase activity,MF,
1748,GO:0004350,1.00000000001815,0.893141355961399,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3038,GO:0006592,1.00000000001815,0.893141355961399,0,1,ornithine biosynthetic process,BP,
5812,GO:0017084,1.00000000001815,0.893141355961399,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6050,GO:0019202,1.00000000001815,0.893141355961399,0,1,amino acid kinase activity,MF,
6821,GO:0030292,1.00000000001815,0.722853503928254,0,3,protein tyrosine kinase inhibitor activity,MF,
13021,GO:0051538,1.00000000001817,0.762188645092963,0,3,3 iron, 4 sulfur cluster binding,MF,
4656,GO:0010808,1.00000000001817,0.842564313820169,0,1,positive regulation of synaptic vesicle priming,BP,
10796,GO:0044305,1.00000000001817,0.842564313820169,0,1,calyx of Held,CC,
14427,GO:0061789,1.00000000001817,0.842564313820169,0,1,dense core granule priming,BP,
4368,GO:0009992,1.00000000001826,0.919475550142892,0,1,cellular water homeostasis,BP,
4971,GO:0015093,1.00000000001828,0.759656816337255,0,2,ferrous iron transmembrane transporter activity,MF,
5145,GO:0015684,1.00000000001828,0.759656816337255,0,2,ferrous iron transport,BP,
18574,GO:1903874,1.00000000001828,0.759656816337255,0,2,ferrous iron transmembrane transport,BP,
168,GO:0000350,1.0000000000183,0.790898845649706,0,3,generation of catalytic spliceosome for second transesterification step,BP,
15260,GO:0071475,1.00000000001831,0.76824586343863,0,3,cellular hyperosmotic salinity response,BP,
5900,GO:0018125,1.00000000001835,0.770109147078711,0,3,peptidyl-cysteine methylation,BP,
1792,GO:0004423,1.00000000001839,0.850394044486434,0,1,iduronate-2-sulfatase activity,MF,
1132,GO:0002725,1.00000000001839,0.777594321691636,0,3,negative regulation of T cell cytokine production,BP,
2074,GO:0004829,1.0000000000184,0.74607252465741,0,3,threonine-tRNA ligase activity,MF,
2922,GO:0006435,1.0000000000184,0.74607252465741,0,3,threonyl-tRNA aminoacylation,BP,
13817,GO:0060447,1.00000000001841,0.826854458289432,0,1,bud outgrowth involved in lung branching,BP,
13988,GO:0060739,1.00000000001841,0.826854458289432,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
18583,GO:1903893,1.00000000001843,0.914328967165855,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
16880,GO:0098875,1.00000000001845,0.865911073156731,0,1,epididymosome,CC,
8381,GO:0033316,1.00000000001846,0.903853358828316,0,1,meiotic spindle assembly checkpoint,BP,
10964,GO:0044779,1.00000000001846,0.903853358828316,0,1,meiotic spindle checkpoint,BP,
10968,GO:0044785,1.00000000001846,0.903853358828316,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17842,GO:1902102,1.00000000001846,0.903853358828316,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17843,GO:1902103,1.00000000001846,0.903853358828316,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18232,GO:1903096,1.00000000001846,0.903853358828316,0,1,protein localization to meiotic spindle midzone,BP,
19114,GO:1905132,1.00000000001846,0.903853358828316,0,1,regulation of meiotic chromosome separation,BP,
19115,GO:1905133,1.00000000001846,0.903853358828316,0,1,negative regulation of meiotic chromosome separation,BP,
19202,GO:1905359,1.00000000001846,0.903853358828316,0,1,protein localization to meiotic spindle,BP,
7080,GO:0030885,1.00000000001847,0.803877255348008,0,3,regulation of myeloid dendritic cell activation,BP,
12023,GO:0047874,1.0000000000185,0.920541082074606,0,1,dolichyldiphosphatase activity,MF,
12138,GO:0048270,1.00000000001851,0.920985426809963,0,1,methionine adenosyltransferase regulator activity,MF,
10254,GO:0043020,1.00000000001854,0.821777274262442,0,3,NADPH oxidase complex,CC,
4399,GO:0010139,1.00000000001854,0.929473584710898,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4405,GO:0010164,1.00000000001854,0.929473584710898,0,1,response to cesium ion,BP,
6859,GO:0030343,1.00000000001854,0.929473584710898,0,1,vitamin D3 25-hydroxylase activity,MF,
14838,GO:0070643,1.00000000001854,0.929473584710898,0,1,vitamin D 25-hydroxylase activity,MF,
8831,GO:0034641,1.0000000000186,0,421,5133,cellular nitrogen compound metabolic process,BP,SULT1E1;TRNP1;HTRA1;TXNIP;CTGF;FBN1;SOX6;ITGA6;SFRP1;CDKN2B;ZFP36L1;NQO1;APBB2;F2R;DDIT4;TNNI2;XPC;EFEMP1;ETV5;PKD2;TSC22D1;ZFP36L2;IGF2BP2;ANPEP;ZNF362;H6PD;NOS1;GAS6;PDGFC;SNAI2;MAGED1;MN1;PHF21A;ROR1;TCEAL4;DPYSL2;EGFR;TSC22D3;KLF8;NYNRIN;RFX2;ZNF608;SERPINE1;ENDOD1;TCF7L1;RNF165;VIM;NUPR1;DDB2;DCAKD;TIMP2;ZNF862;TADA3;CBX5;VDR;APOBEC3C;BMP4;TRIM38;TP53I3;PCSK1;NR1D1;SMARCA2;AHNAK;ABTB1;CITED4;EIF2AK4;TRIM5;HSF2BP;PDCD4;NR3C1;STAT1;SORL1;NEO1;ETV1;TP53;EXTL2;MBNL2;WWTR1;PRICKLE1;DDIT3;ZBTB20;PYCARD;ZC3H6;MEF2D;SEC14L2;DLG4;ITGA2;ZCCHC11;PDGFA;RBMS3;ADARB1;HIP1;TFDP2;BCKDHB;TEP1;PNRC1;CCDC85B;BTG1;ITGA3;CHD3;SIK1;ZNF18;KLF12;KLF9;NFIX;HIVEP1;GPX1;GLI3;PTGES;E2F7;KITLG;ERO1B;KRBA2;MTHFR;ABHD14B;ZFP90;KCNAB2;NMRK1;XDH;TSHZ2;ADIRF;UGT8;CPS1;POLR3GL;CAV1;GLI2;RMI2;PIAS3;HLCS;ERCC6;RBFOX2;PLA2G6;SLC2A4RG;SMARCA1;ZNF318;TNRC18;AHNAK2;CLU;TCEAL3;PRKCZ;OAS2;SDR16C5;TP53INP1;ZNF678;PARP4;HMGA2;CAMK2D;GOLGB1;PRDX5;KANK2;ZSCAN18;IL31RA;PTPN14;PER1;PIK3R1;TMEM173;CAPRIN2;CREB3L2;CPT1A;ACACB;APOBEC3G;ANG;UHRF2;WFS1;MDFI;CIRBP;PRDM8;JARID2;TCEAL8;MLH3;ZKSCAN1;TP73;CAT;DAPK1;KLF13;AARS;CHEK2;BACE1;PAIP2B;PRX;PHF2;TLR3;ZNF860;SNCA;OARD1;ALDH1L2;MME;GATAD1;FZD7;AIP;SP110;FGFR1;IGF1R;APOBEC3F;DKK1;RGS2;SETX;PDE4D;APBB3;NCOA2;PSMB9;IL18;SULF1;BRD3;G6PD;TLE4;EDA2R;FZD8;TCEAL1;SETBP1;ZNF618;SOX13;DHTKD1;KDM4C;AFAP1L2;CHD6;CDH13;NFATC4;MAGEF1;FOXN3;TRAF1;LMCD1;TGFBR3;DLX3;FZD1;L3MBTL3;PBXIP1;PBX1;ENG;FOXL1;ZNF699;CALR;ATM;IDH2;MDM2;TMED10;CST3;MEIS2;TMEM14C;AREG;IFNK;ZNF107;TCF4;DGKQ;CITED2;GCLC;NR2F2;CBX7;LMO4;ZNF449;MSH5;MAF;TRAK1;LZTS1;ZBTB22;HDAC11;RCBTB1;RNPEP;PTMS;PTPN1;ARHGEF2;ZNF546;EGR1;SOX9;ENPP1;ISL1;BCL6;STK16;CRTC1;NCOR1;ZNF717;PLAG1;PRKCA;SALL2;MYBL1;ZNF358;ZNF519;PRPS2;TRERF1;RGS14;PRIMPOL;HLTF;HOXA1;CXORF57;BAHCC1;METTL23;PGAP1;TSHZ1;IGFBP4;ALDH9A1;TCF25;TCF12;HMBOX1;NFAT5;NMNAT2;RPL13A;PAK6;ZNF160;ABCC2;NAB2;CHD9;MEGF8;ZNF302;ATXN1;IRF2BPL;STK36;MAML2;MUTYH;TAF8;PRNP;RET;CARF;ZFPM1;TGFB2;RBL2;MAP2K5;GGT7;DLX2;ZNF550;DNASE1L1;SMG9;STAT2;LIG1;ZNF701;GPR161;LEF1;THRA;SSBP3;USP28;ALDH7A1;MSRB2;CDKN2A;SPPL2B;SP100;ZSCAN30;TEF;TSPYL2;AGRN;ORC4;NPHP3;HSPA5;TH;CELF2;TGFB1I1;SRPK2;UVRAG;ITGB8;NAPRT;MDFIC;FHOD1;IFT74;POLD4;SAP30L;ZNF12;YAP1;GDNF;KLF5;TWIST2;YEATS2;HOXA3;UBA7;ZNF558;MEIS3;PPARG;PARP15;TPST1;KCNIP3;MEF2A;MLLT6;CERS5;KLF7;TGIF1;ING4;UNK;LGALS3;DNAJC3;RARA;ABCA2;HES2;POLH;HOXC5;PBX2;PRKAG1;TAF1;TSHZ3;GSTZ1;FZD4;ZNF883;ZBTB1;DPYD;NAT14;PPP3CA;RASA1;CREBRF;ETV4;HP1BP3;HOXA2;PPCS;FOS;DNPH1;KDM4A;ZBTB25;CDK5RAP3;AGO4;FAM120B;FAM168A;MED12;NPAS2;ABAT;NIPBL;UGGT2;VPS36;PRDM5;RNPEPL1;ZNF471;LITAF;S100A11;RXRA;TAOK3;NFKBIE;ZNF484
11626,GO:0046380,1.00000000001863,0.885130598127566,0,1,N-acetylneuraminate biosynthetic process,BP,
12419,GO:0050124,1.00000000001863,0.885130598127566,0,1,N-acylneuraminate-9-phosphatase activity,MF,
19356,GO:1905867,1.00000000001864,0.774899553947416,0,3,epididymis development,BP,
19166,GO:1905277,1.00000000001867,0.903025087913174,0,1,negative regulation of epithelial tube formation,BP,
19974,GO:2000606,1.00000000001867,0.903025087913174,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19975,GO:2000607,1.00000000001867,0.903025087913174,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20039,GO:2000699,1.00000000001867,0.903025087913174,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20040,GO:2000701,1.00000000001867,0.903025087913174,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20041,GO:2000702,1.00000000001867,0.903025087913174,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20042,GO:2000703,1.00000000001867,0.903025087913174,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20054,GO:2000733,1.00000000001867,0.903025087913174,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20055,GO:2000734,1.00000000001867,0.903025087913174,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
14151,GO:0061078,1.00000000001874,0.956849139905074,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16235,GO:0090323,1.00000000001874,0.956849139905074,0,1,prostaglandin secretion involved in immune response,BP,
18473,GO:1903636,1.00000000001874,0.956849139905074,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18474,GO:1903638,1.00000000001874,0.956849139905074,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18476,GO:1903645,1.00000000001874,0.956849139905074,0,1,negative regulation of chaperone-mediated protein folding,BP,
5487,GO:0016429,1.00000000001876,0.754210026571875,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14471,GO:0061953,1.00000000001876,0.754210026571875,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15925,GO:0075519,1.00000000001877,0.952837785540543,0,1,microtubule-dependent intracellular transport of viral material,BP,
15926,GO:0075521,1.00000000001877,0.952837785540543,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15930,GO:0075606,1.00000000001877,0.952837785540543,0,1,transport of viral material towards nucleus,BP,
12448,GO:0050353,1.0000000000188,0.907648672944802,0,1,trimethyllysine dioxygenase activity,MF,
2840,GO:0006311,1.00000000001883,0.900941027754318,0,1,meiotic gene conversion,BP,
5382,GO:0016213,1.00000000001883,0.900941027754318,0,1,linoleoyl-CoA desaturase activity,MF,
11089,GO:0045128,1.00000000001883,0.900941027754318,0,1,negative regulation of reciprocal meiotic recombination,BP,
17206,GO:0110029,1.00000000001883,0.900941027754318,0,1,negative regulation of meiosis I,BP,
3555,GO:0007598,1.00000000001884,0.916723010858117,0,1,blood coagulation, extrinsic pathway,BP,
17553,GO:1901202,1.00000000001884,0.916723010858117,0,1,negative regulation of extracellular matrix assembly,BP,
18359,GO:1903394,1.00000000001884,0.916723010858117,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
8711,GO:0034374,1.00000000001885,0.787221067526943,0,3,low-density lipoprotein particle remodeling,BP,
910,GO:0002296,1.00000000001886,0.736321848672926,0,2,T-helper 1 cell lineage commitment,BP,
3727,GO:0008265,1.00000000001887,0.910082897666179,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17143,GO:0102867,1.00000000001887,0.910082897666179,0,1,molybdenum cofactor sulfurtransferase activity,MF,
355,GO:0000973,1.00000000001887,0.717344423231274,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
2327,GO:0005344,1.00000000001893,0.923228731938697,0,1,oxygen carrier activity,MF,
12024,GO:0047888,1.00000000001893,0.923228731938697,0,1,fatty acid peroxidase activity,MF,
4885,GO:0014810,1.00000000001895,0.950329307741117,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
1417,GO:0003360,1.000000000019,0.668618844736191,0,3,brainstem development,BP,
15150,GO:0071315,1.00000000001901,0.700838231110628,0,3,cellular response to morphine,BP,
15152,GO:0071317,1.00000000001901,0.700838231110628,0,3,cellular response to isoquinoline alkaloid,BP,
19590,GO:1990761,1.00000000001903,0.814332481851859,0,2,growth cone lamellipodium,CC,
7814,GO:0032378,1.00000000001905,0.888852579914227,0,1,negative regulation of intracellular lipid transport,BP,
7817,GO:0032381,1.00000000001905,0.888852579914227,0,1,negative regulation of intracellular sterol transport,BP,
7820,GO:0032384,1.00000000001905,0.888852579914227,0,1,negative regulation of intracellular cholesterol transport,BP,
19289,GO:1905596,1.00000000001905,0.888852579914227,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19291,GO:1905598,1.00000000001905,0.888852579914227,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19294,GO:1905601,1.00000000001905,0.888852579914227,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
111,GO:0000229,1.00000000001906,0.929910963305292,0,1,cytoplasmic chromosome,CC,
126,GO:0000262,1.00000000001906,0.929910963305292,0,1,mitochondrial chromosome,CC,
1028,GO:0002537,1.00000000001906,0.827500982998239,0,1,nitric oxide production involved in inflammatory response,BP,
14285,GO:0061459,1.00000000001906,0.827500982998239,0,1,L-arginine transmembrane transporter activity,MF,
16651,GO:0097625,1.00000000001906,0.827500982998239,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16652,GO:0097626,1.00000000001906,0.827500982998239,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16653,GO:0097627,1.00000000001906,0.827500982998239,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16662,GO:0097639,1.00000000001906,0.827500982998239,0,1,L-lysine import across plasma membrane,BP,
16663,GO:0097640,1.00000000001906,0.827500982998239,0,1,L-ornithine import across plasma membrane,BP,
8929,GO:0034987,1.00000000001907,0.81536274716847,0,1,immunoglobulin receptor binding,MF,
8930,GO:0034988,1.00000000001907,0.81536274716847,0,1,Fc-gamma receptor I complex binding,MF,
13757,GO:0060372,1.00000000001907,0.81536274716847,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
19070,GO:1905000,1.00000000001907,0.81536274716847,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
13270,GO:0052031,1.00000000001913,0.735782395405684,0,3,modulation by symbiont of host defense response,BP,
13304,GO:0052255,1.00000000001913,0.735782395405684,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13336,GO:0052552,1.00000000001913,0.735782395405684,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13337,GO:0052553,1.00000000001913,0.735782395405684,0,3,modulation by symbiont of host immune response,BP,
15929,GO:0075528,1.00000000001913,0.735782395405684,0,3,modulation by virus of host immune response,BP,
17579,GO:1901291,1.00000000001913,0.923836575580389,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
11791,GO:0046707,1.00000000001914,0.789206294371813,0,2,IDP metabolic process,BP,
11792,GO:0046709,1.00000000001914,0.789206294371813,0,2,IDP catabolic process,BP,
3685,GO:0008192,1.00000000001915,0.71559498964017,0,3,RNA guanylyltransferase activity,MF,
20213,GO:2001183,1.00000000001915,0.924332214091977,0,1,negative regulation of interleukin-12 secretion,BP,
15168,GO:0071344,1.00000000001916,0.87083739072801,0,2,diphosphate metabolic process,BP,
475,GO:0001519,1.00000000001918,0.886708189850461,0,1,peptide amidation,BP,
1843,GO:0004504,1.00000000001918,0.886708189850461,0,1,peptidylglycine monooxygenase activity,MF,
1908,GO:0004598,1.00000000001918,0.886708189850461,0,1,peptidylamidoglycolate lyase activity,MF,
5884,GO:0018032,1.00000000001918,0.886708189850461,0,1,protein amidation,BP,
7235,GO:0031179,1.00000000001918,0.886708189850461,0,1,peptide modification,BP,
17269,GO:0140074,1.0000000000192,0.859016542214854,0,1,cardiac endothelial to mesenchymal transition,BP,
16172,GO:0090233,1.00000000001925,0.911152831922802,0,1,negative regulation of spindle checkpoint,BP,
17966,GO:1902426,1.00000000001925,0.911152831922802,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19195,GO:1905341,1.00000000001925,0.911152831922802,0,1,negative regulation of protein localization to kinetochore,BP,
5490,GO:0016434,1.00000000001929,0.719564719870952,0,3,rRNA (cytosine) methyltransferase activity,MF,
14422,GO:0061771,1.0000000000193,0.744092918235301,0,3,response to caloric restriction,BP,
4317,GO:0009814,1.00000000001931,0.919132818856203,0,1,defense response, incompatible interaction,BP,
4318,GO:0009817,1.00000000001931,0.919132818856203,0,1,defense response to fungus, incompatible interaction,BP,
19181,GO:1905313,1.00000000001931,0.919132818856203,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19489,GO:1990402,1.00000000001931,0.919132818856203,0,1,embryonic liver development,BP,
19914,GO:2000467,1.00000000001935,0.655405947221448,0,3,positive regulation of glycogen (starch) synthase activity,BP,
18526,GO:1903764,1.00000000001939,0.861465603566394,0,1,regulation of potassium ion export across plasma membrane,BP,
1559,GO:0003962,1.00000000001942,0.926915915346341,0,1,cystathionine gamma-synthase activity,MF,
1662,GO:0004123,1.00000000001942,0.926915915346341,0,1,cystathionine gamma-lyase activity,MF,
5938,GO:0018272,1.00000000001942,0.926915915346341,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9352,GO:0035887,1.00000000001942,0.926915915346341,0,1,aortic smooth muscle cell differentiation,BP,
10898,GO:0044524,1.00000000001942,0.926915915346341,0,1,protein sulfhydration,BP,
10905,GO:0044540,1.00000000001942,0.926915915346341,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12031,GO:0047982,1.00000000001942,0.926915915346341,0,1,homocysteine desulfhydrase activity,MF,
15125,GO:0071266,1.00000000001942,0.926915915346341,0,1,'de novo' L-methionine biosynthetic process,BP,
15952,GO:0080146,1.00000000001942,0.926915915346341,0,1,L-cysteine desulfhydrase activity,MF,
18983,GO:1904829,1.00000000001942,0.926915915346341,0,1,regulation of aortic smooth muscle cell differentiation,BP,
18984,GO:1904831,1.00000000001942,0.926915915346341,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
146,GO:0000301,1.00000000001942,0.745947419297298,0,3,retrograde transport, vesicle recycling within Golgi,BP,
8442,GO:0033593,1.00000000001948,0.781440148260139,0,1,BRCA2-MAGE-D1 complex,CC,
8830,GO:0034640,1.00000000001951,0.899227649962732,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
16976,GO:0099098,1.00000000001951,0.899227649962732,0,1,microtubule polymerization based movement,BP,
17367,GO:1900126,1.00000000001958,0.668498062018817,0,3,negative regulation of hyaluronan biosynthetic process,BP,
7539,GO:0031859,1.00000000001962,0.92400099523776,0,1,platelet activating factor receptor binding,MF,
9858,GO:0042137,1.00000000001962,0.92400099523776,0,1,sequestering of neurotransmitter,BP,
6776,GO:0030222,1.00000000001962,0.88922694788158,0,1,eosinophil differentiation,BP,
11297,GO:0045643,1.00000000001962,0.88922694788158,0,1,regulation of eosinophil differentiation,BP,
11298,GO:0045645,1.00000000001962,0.88922694788158,0,1,positive regulation of eosinophil differentiation,BP,
5539,GO:0016534,1.00000000001966,0.883780337127826,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
6381,GO:0021586,1.00000000001966,0.883780337127826,0,1,pons maturation,BP,
6430,GO:0021718,1.00000000001966,0.883780337127826,0,1,superior olivary nucleus development,BP,
6431,GO:0021722,1.00000000001966,0.883780337127826,0,1,superior olivary nucleus maturation,BP,
2087,GO:0004853,1.00000000001967,0.934495826250931,0,1,uroporphyrinogen decarboxylase activity,MF,
14517,GO:0070061,1.00000000001968,0.754267342847438,0,3,fructose binding,MF,
14257,GO:0061370,1.00000000001971,0.804243165581237,0,2,testosterone biosynthetic process,BP,
3842,GO:0008456,1.00000000001981,0.88672049990514,0,1,alpha-N-acetylgalactosaminidase activity,MF,
1623,GO:0004061,1.00000000001984,0.927837171436216,0,1,arylformamidase activity,MF,
4776,GO:0010967,1.00000000001984,0.927837171436216,0,1,regulation of polyamine biosynthetic process,BP,
7143,GO:0031013,1.00000000001984,0.927837171436216,0,1,troponin I binding,MF,
13422,GO:0052899,1.00000000001984,0.927837171436216,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13424,GO:0052902,1.00000000001984,0.927837171436216,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13425,GO:0052903,1.00000000001984,0.927837171436216,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13426,GO:0052904,1.00000000001984,0.927837171436216,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17590,GO:1901304,1.00000000001984,0.927837171436216,0,1,regulation of spermidine biosynthetic process,BP,
17591,GO:1901307,1.00000000001984,0.927837171436216,0,1,positive regulation of spermidine biosynthetic process,BP,
5388,GO:0016231,1.00000000001986,0.859791558022609,0,1,beta-N-acetylglucosaminidase activity,MF,
17100,GO:0102166,1.00000000001986,0.859791558022609,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17101,GO:0102167,1.00000000001986,0.859791558022609,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17132,GO:0102571,1.00000000001986,0.859791558022609,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
763,GO:0002016,1.00000000001993,0.95304166839311,0,1,regulation of blood volume by renin-angiotensin,BP,
765,GO:0002019,1.00000000001993,0.95304166839311,0,1,regulation of renal output by angiotensin,BP,
1280,GO:0003083,1.00000000001993,0.95304166839311,0,1,negative regulation of renal output by angiotensin,BP,
1292,GO:0003106,1.00000000001993,0.95304166839311,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4930,GO:0014895,1.00000000001993,0.95304166839311,0,1,smooth muscle hypertrophy,BP,
10087,GO:0042624,1.00000000001993,0.95304166839311,0,1,ATPase activity, uncoupled,MF,
1525,GO:0003905,1.00000000002004,0.941988135037585,0,1,alkylbase DNA N-glycosylase activity,MF,
3956,GO:0008725,1.00000000002004,0.941988135037585,0,1,DNA-3-methyladenine glycosylase activity,MF,
10634,GO:0043733,1.00000000002004,0.941988135037585,0,1,DNA-3-methylbase glycosylase activity,MF,
10653,GO:0043916,1.00000000002004,0.941988135037585,0,1,DNA-7-methylguanine glycosylase activity,MF,
13392,GO:0052821,1.00000000002004,0.941988135037585,0,1,DNA-7-methyladenine glycosylase activity,MF,
13393,GO:0052822,1.00000000002004,0.941988135037585,0,1,DNA-3-methylguanine glycosylase activity,MF,
7540,GO:0031860,1.00000000002011,0.655400770276801,0,3,telomeric 3' overhang formation,BP,
17714,GO:1901675,1.00000000002012,0.838746294612669,0,1,negative regulation of histone H3-K27 acetylation,BP,
12007,GO:0047708,1.00000000002013,0.921351169273663,0,1,biotinidase activity,MF,
13764,GO:0060380,1.00000000002013,0.921351169273663,0,1,regulation of single-stranded telomeric DNA binding,BP,
13765,GO:0060381,1.00000000002013,0.921351169273663,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
10784,GO:0044284,1.00000000002018,0.947035972135813,0,1,mitochondrial crista junction,CC,
18884,GO:1904612,1.0000000000202,0.739667561968922,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18885,GO:1904613,1.0000000000202,0.739667561968922,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
3513,GO:0007439,1.00000000002023,0.905349113750011,0,1,ectodermal digestive tract development,BP,
9501,GO:0036215,1.00000000002023,0.905349113750011,0,1,response to stem cell factor,BP,
9502,GO:0036216,1.00000000002023,0.905349113750011,0,1,cellular response to stem cell factor stimulus,BP,
9687,GO:0038109,1.00000000002023,0.905349113750011,0,1,Kit signaling pathway,BP,
12265,GO:0048611,1.00000000002023,0.905349113750011,0,1,embryonic ectodermal digestive tract development,BP,
4607,GO:0010729,1.00000000002023,0.921957732475221,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
14826,GO:0070618,1.00000000002025,0.910986458983903,0,1,Grb2-Sos complex,CC,
15897,GO:0072714,1.00000000002025,0.92700195029376,0,1,response to selenite ion,BP,
15898,GO:0072715,1.00000000002025,0.92700195029376,0,1,cellular response to selenite ion,BP,
18860,GO:1904569,1.00000000002025,0.92700195029376,0,1,regulation of selenocysteine incorporation,BP,
18861,GO:1904570,1.00000000002025,0.92700195029376,0,1,negative regulation of selenocysteine incorporation,BP,
18862,GO:1904572,1.00000000002025,0.92700195029376,0,1,negative regulation of mRNA binding,BP,
18863,GO:1904573,1.00000000002025,0.92700195029376,0,1,regulation of selenocysteine insertion sequence binding,BP,
18864,GO:1904574,1.00000000002025,0.92700195029376,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19145,GO:1905215,1.00000000002025,0.92700195029376,0,1,negative regulation of RNA binding,BP,
3805,GO:0008398,1.0000000000203,0.902851019838927,0,1,sterol 14-demethylase activity,MF,
8405,GO:0033488,1.0000000000203,0.902851019838927,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
11881,GO:0046933,1.00000000002033,0.82474269086286,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
16665,GO:0097643,1.00000000002038,0.946869736080242,0,1,amylin receptor activity,MF,
18384,GO:1903440,1.00000000002038,0.946869736080242,0,1,amylin receptor complex,CC,
19494,GO:1990407,1.00000000002038,0.946869736080242,0,1,calcitonin gene-related peptide binding,MF,
11440,GO:0045918,1.00000000002056,0.941765576518324,0,1,negative regulation of cytolysis,BP,
11782,GO:0046687,1.00000000002056,0.941765576518324,0,1,response to chromate,BP,
15115,GO:0071247,1.00000000002056,0.941765576518324,0,1,cellular response to chromate,BP,
17883,GO:1902220,1.00000000002056,0.941765576518324,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
20081,GO:2000777,1.00000000002056,0.846163776011388,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
11043,GO:0045062,1.00000000002058,0.927601712923926,0,1,extrathymic T cell selection,BP,
15033,GO:0071021,1.00000000002058,0.927601712923926,0,1,U2-type post-spliceosomal complex,CC,
8994,GO:0035175,1.00000000002063,0.927582173911993,0,1,histone kinase activity (H3-S10 specific),MF,
15729,GO:0072354,1.00000000002063,0.927582173911993,0,1,histone kinase activity (H3-T3 specific),MF,
15730,GO:0072355,1.00000000002063,0.927582173911993,0,1,histone H3-T3 phosphorylation,BP,
4872,GO:0014739,1.00000000002072,0.905227206127651,0,1,positive regulation of muscle hyperplasia,BP,
18282,GO:1903231,1.00000000002072,0.905227206127651,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
15315,GO:0071568,1.00000000002072,0.853465448857469,0,2,UFM1 transferase activity,MF,
18367,GO:1903420,1.00000000002073,0.842459269010635,0,1,protein localization to endoplasmic reticulum tubular network,BP,
3217,GO:0006867,1.00000000002076,0.909228905430005,0,1,asparagine transport,BP,
5014,GO:0015182,1.00000000002076,0.909228905430005,0,1,L-asparagine transmembrane transporter activity,MF,
5021,GO:0015190,1.00000000002076,0.909228905430005,0,1,L-leucine transmembrane transporter activity,MF,
5022,GO:0015191,1.00000000002076,0.909228905430005,0,1,L-methionine transmembrane transporter activity,MF,
5134,GO:0015658,1.00000000002076,0.909228905430005,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5214,GO:0015821,1.00000000002076,0.909228905430005,0,1,methionine transport,BP,
10644,GO:0043865,1.00000000002076,0.909228905430005,0,1,methionine transmembrane transporter activity,MF,
18036,GO:1902618,1.00000000002078,0.848274002163813,0,1,cellular response to fluoride,BP,
1893,GO:0004578,1.00000000002088,0.881657151035022,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6045,GO:0019187,1.00000000002088,0.881657151035022,0,1,beta-1,4-mannosyltransferase activity,MF,
12736,GO:0051032,1.00000000002088,0.881657151035022,0,1,nucleic acid transmembrane transporter activity,MF,
12737,GO:0051033,1.00000000002088,0.881657151035022,0,1,RNA transmembrane transporter activity,MF,
658,GO:0001850,1.0000000000209,0.925364645596676,0,1,complement component C3a binding,MF,
659,GO:0001851,1.0000000000209,0.925364645596676,0,1,complement component C3b binding,MF,
7956,GO:0032574,1.00000000002092,0.881102239534548,0,1,5'-3' RNA helicase activity,MF,
7957,GO:0032575,1.00000000002092,0.881102239534548,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7332,GO:0031370,1.00000000002092,0.865744945247914,0,1,eukaryotic initiation factor 4G binding,MF,
20223,GO:2001200,1.00000000002093,0.836747465717424,0,2,positive regulation of dendritic cell differentiation,BP,
1565,GO:0003974,1.00000000002096,0.929535741369574,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1569,GO:0003978,1.00000000002096,0.929535741369574,0,1,UDP-glucose 4-epimerase activity,MF,
3642,GO:0008118,1.00000000002103,0.918758678949898,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
11989,GO:0047536,1.00000000002103,0.918758678949898,0,1,2-aminoadipate transaminase activity,MF,
3093,GO:0006669,1.00000000002112,0.90537124230634,0,1,sphinganine-1-phosphate biosynthetic process,BP,
16429,GO:0097124,1.00000000002117,0.834731407547393,0,2,cyclin A2-CDK2 complex,CC,
10646,GO:0043890,1.00000000002122,0.916416781817543,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
9386,GO:0035962,1.00000000002123,0.884019964035863,0,1,response to interleukin-13,BP,
9387,GO:0035963,1.00000000002123,0.884019964035863,0,1,cellular response to interleukin-13,BP,
12436,GO:0050277,1.00000000002123,0.884019964035863,0,1,sedoheptulokinase activity,MF,
11409,GO:0045852,1.00000000002124,0.744471711907479,0,3,pH elevation,BP,
12992,GO:0051454,1.00000000002124,0.744471711907479,0,3,intracellular pH elevation,BP,
16579,GO:0097444,1.00000000002137,0.859740055893043,0,1,spine apparatus,CC,
19201,GO:1905355,1.00000000002137,0.859740055893043,0,1,spine apparatus assembly,BP,
17318,GO:1900036,1.00000000002139,0.916980040835749,0,1,positive regulation of cellular response to heat,BP,
5040,GO:0015228,1.00000000002143,0.756032131790319,0,3,coenzyme A transmembrane transporter activity,MF,
5247,GO:0015880,1.00000000002143,0.756032131790319,0,3,coenzyme A transport,BP,
9071,GO:0035349,1.00000000002143,0.756032131790319,0,3,coenzyme A transmembrane transport,BP,
15060,GO:0071077,1.00000000002143,0.756032131790319,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15064,GO:0071106,1.00000000002143,0.756032131790319,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15947,GO:0080122,1.00000000002143,0.756032131790319,0,3,AMP transmembrane transporter activity,MF,
3167,GO:0006781,1.00000000002146,0.91964316192936,0,1,succinyl-CoA pathway,BP,
1065,GO:0002625,1.00000000002152,0.923296726306781,0,1,regulation of T cell antigen processing and presentation,BP,
1066,GO:0002626,1.00000000002152,0.923296726306781,0,1,negative regulation of T cell antigen processing and presentation,BP,
4393,GO:0010106,1.00000000002152,0.923296726306781,0,1,cellular response to iron ion starvation,BP,
18748,GO:1904282,1.00000000002152,0.923296726306781,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18749,GO:1904283,1.00000000002152,0.923296726306781,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20216,GO:2001186,1.00000000002152,0.923296726306781,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
1727,GO:0004324,1.00000000002154,0.924122647959524,0,1,ferredoxin-NADP+ reductase activity,MF,
4959,GO:0015039,1.00000000002154,0.924122647959524,0,1,NADPH-adrenodoxin reductase activity,MF,
5638,GO:0016730,1.00000000002154,0.924122647959524,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5639,GO:0016731,1.00000000002154,0.924122647959524,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
19068,GO:1904998,1.00000000002159,0.906095031675794,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
6038,GO:0019150,1.0000000000216,0.92140826081816,0,1,D-ribulokinase activity,MF,
16711,GO:0098502,1.0000000000216,0.81019460379798,0,3,DNA dephosphorylation,BP,
14205,GO:0061198,1.00000000002173,0.691070521094686,0,3,fungiform papilla formation,BP,
9436,GO:0036046,1.00000000002183,0.901060409852516,0,1,protein demalonylation,BP,
9437,GO:0036047,1.00000000002183,0.901060409852516,0,1,peptidyl-lysine demalonylation,BP,
9438,GO:0036048,1.00000000002183,0.901060409852516,0,1,protein desuccinylation,BP,
9439,GO:0036049,1.00000000002183,0.901060409852516,0,1,peptidyl-lysine desuccinylation,BP,
9440,GO:0036054,1.00000000002183,0.901060409852516,0,1,protein-malonyllysine demalonylase activity,MF,
9441,GO:0036055,1.00000000002183,0.901060409852516,0,1,protein-succinyllysine desuccinylase activity,MF,
14384,GO:0061697,1.00000000002183,0.901060409852516,0,1,protein-glutaryllysine deglutarylase activity,MF,
14385,GO:0061698,1.00000000002183,0.901060409852516,0,1,protein deglutarylation,BP,
14386,GO:0061699,1.00000000002183,0.901060409852516,0,1,peptidyl-lysine deglutarylation,BP,
237,GO:0000495,1.00000000002189,0.91295259741468,0,1,box H/ACA snoRNA 3'-end processing,BP,
2734,GO:0006117,1.00000000002189,0.91295259741468,0,1,acetaldehyde metabolic process,BP,
8542,GO:0033979,1.00000000002189,0.91295259741468,0,1,box H/ACA snoRNA metabolic process,BP,
8918,GO:0034964,1.00000000002189,0.91295259741468,0,1,box H/ACA snoRNA processing,BP,
9154,GO:0035525,1.00000000002189,0.91295259741468,0,1,NF-kappaB p50/p65 complex,CC,
16379,GO:0097037,1.00000000002194,0.894045293332309,0,1,heme export,BP,
16759,GO:0098625,1.00000000002207,0.884936506651081,0,1,methylselenol reductase activity,MF,
16760,GO:0098626,1.00000000002207,0.884936506651081,0,1,methylseleninic acid reductase activity,MF,
1243,GO:0002944,1.00000000002218,0.751383919121173,0,2,cyclin K-CDK12 complex,CC,
932,GO:0002332,1.00000000002228,0.852734501094055,0,1,transitional stage B cell differentiation,BP,
933,GO:0002333,1.00000000002228,0.852734501094055,0,1,transitional one stage B cell differentiation,BP,
18846,GO:1904531,1.00000000002228,0.852734501094055,0,1,positive regulation of actin filament binding,BP,
18888,GO:1904618,1.00000000002228,0.852734501094055,0,1,positive regulation of actin binding,BP,
19413,GO:1990051,1.00000000002228,0.852734501094055,0,1,activation of protein kinase C activity,BP,
14901,GO:0070782,1.00000000002232,0.919850951447884,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15384,GO:0071678,1.00000000002238,0.825791708886941,0,1,olfactory bulb axon guidance,BP,
756,GO:0001998,1.00000000002245,0.92375896020506,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
776,GO:0002034,1.00000000002245,0.92375896020506,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1277,GO:0003072,1.00000000002245,0.92375896020506,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18485,GO:1903673,1.00000000002245,0.92375896020506,0,1,mitotic cleavage furrow formation,BP,
18915,GO:1904695,1.00000000002245,0.92375896020506,0,1,positive regulation of vascular smooth muscle contraction,BP,
2181,GO:0005034,1.00000000002249,0.900905177948723,0,1,osmosensor activity,MF,
6695,GO:0030103,1.00000000002249,0.900905177948723,0,1,vasopressin secretion,BP,
16606,GO:0097497,1.00000000002249,0.900905177948723,0,1,blood vessel endothelial cell delamination,BP,
18387,GO:1903444,1.00000000002249,0.900905177948723,0,1,negative regulation of brown fat cell differentiation,BP,
18522,GO:1903759,1.00000000002249,0.900905177948723,0,1,signal transduction involved in regulation of aerobic respiration,BP,
15003,GO:0070975,1.00000000002251,0.829956452683112,0,1,FHA domain binding,MF,
8424,GO:0033557,1.00000000002257,0.745961344019471,0,3,Slx1-Slx4 complex,CC,
13427,GO:0052905,1.00000000002257,0.745961344019471,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
11132,GO:0045208,1.00000000002257,0.890729410203794,0,1,MAPK phosphatase export from nucleus,BP,
11133,GO:0045209,1.00000000002257,0.890729410203794,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11537,GO:0046102,1.00000000002265,0.778540153534205,0,3,inosine metabolic process,BP,
16757,GO:0098619,1.00000000002272,0.924070458266813,0,1,selenocysteine-tRNA ligase activity,MF,
3489,GO:0007371,1.00000000002288,0.886400813941848,0,1,ventral midline determination,BP,
13666,GO:0060245,1.00000000002288,0.886400813941848,0,1,detection of cell density,BP,
13667,GO:0060246,1.00000000002288,0.886400813941848,0,1,detection of cell density by contact stimulus,BP,
13668,GO:0060248,1.00000000002288,0.886400813941848,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14172,GO:0061113,1.00000000002288,0.886400813941848,0,1,pancreas morphogenesis,BP,
15544,GO:0072036,1.00000000002288,0.886400813941848,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15692,GO:0072285,1.00000000002288,0.886400813941848,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
9207,GO:0035611,1.00000000002289,0.90794894123864,0,1,protein branching point deglutamylation,BP,
1420,GO:0003366,1.00000000002292,0.846601087740999,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
8852,GO:0034669,1.00000000002292,0.846601087740999,0,1,integrin alpha4-beta7 complex,CC,
19594,GO:1990771,1.00000000002292,0.846601087740999,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
5106,GO:0015421,1.00000000002294,0.891532932088301,0,1,oligopeptide-transporting ATPase activity,MF,
12628,GO:0050859,1.00000000002307,0.746131070269061,0,3,negative regulation of B cell receptor signaling pathway,BP,
10144,GO:0042748,1.00000000002308,0.645099753847354,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
7051,GO:0030849,1.00000000002313,0.859629850596978,0,1,autosome,CC,
14401,GO:0061736,1.00000000002321,0.851739462741428,0,1,engulfment of target by autophagosome,BP,
14412,GO:0061753,1.00000000002321,0.851739462741428,0,1,substrate localization to autophagosome,BP,
3844,GO:0008458,1.0000000000233,0.898617122874293,0,1,carnitine O-octanoyltransferase activity,MF,
5474,GO:0016414,1.0000000000233,0.898617122874293,0,1,O-octanoyltransferase activity,MF,
5475,GO:0016415,1.0000000000233,0.898617122874293,0,1,octanoyltransferase activity,MF,
3648,GO:0008127,1.00000000002339,0.936610827825118,0,1,quercetin 2,3-dioxygenase activity,MF,
811,GO:0002085,1.00000000002351,0.674457175288772,0,3,inhibition of neuroepithelial cell differentiation,BP,
11274,GO:0045608,1.00000000002351,0.674457175288772,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
11940,GO:0047159,1.00000000002353,0.881355937198773,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11945,GO:0047191,1.00000000002353,0.881355937198773,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
20253,GO:2001246,1.00000000002353,0.881355937198773,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
18380,GO:1903435,1.0000000000236,0.908781984558933,0,1,positive regulation of constitutive secretory pathway,BP,
4005,GO:0008973,1.00000000002369,0.898739497558137,0,1,phosphopentomutase activity,MF,
5521,GO:0016503,1.00000000002388,0.936417380941978,0,1,pheromone receptor activity,MF,
11714,GO:0046554,1.00000000002388,0.936417380941978,0,1,malate dehydrogenase (NADP+) activity,MF,
11567,GO:0046166,1.0000000000239,0.858764375352478,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
13374,GO:0052739,1.00000000002391,0.921269705782806,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13375,GO:0052740,1.00000000002391,0.921269705782806,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18852,GO:1904550,1.00000000002391,0.921269705782806,0,1,response to arachidonic acid,BP,
19828,GO:2000324,1.00000000002391,0.921269705782806,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
3835,GO:0008446,1.00000000002394,0.928233642825381,0,1,GDP-mannose 4,6-dehydratase activity,MF,
15955,GO:0080163,1.00000000002395,0.916052499258862,0,1,regulation of protein serine/threonine phosphatase activity,BP,
9509,GO:0036250,1.00000000002407,0.923604233191274,0,1,peroxisome transport along microtubule,BP,
10943,GO:0044721,1.00000000002407,0.923604233191274,0,1,protein import into peroxisome matrix, substrate release,BP,
4884,GO:0014809,1.00000000002409,0.737780626099565,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
6408,GO:0021678,1.0000000000241,0.779935576178951,0,3,third ventricle development,BP,
1613,GO:0004044,1.00000000002414,0.886229007826107,0,1,amidophosphoribosyltransferase activity,MF,
1838,GO:0004496,1.00000000002428,0.921180222654231,0,1,mevalonate kinase activity,MF,
13420,GO:0052894,1.00000000002428,0.921180222654231,0,1,norspermine:oxygen oxidoreductase activity,MF,
13421,GO:0052895,1.00000000002428,0.921180222654231,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
10157,GO:0042766,1.00000000002437,0.818655337926202,0,1,nucleosome mobilization,BP,
20102,GO:2000812,1.00000000002446,0.883041974635687,0,1,regulation of barbed-end actin filament capping,BP,
10407,GO:0043273,1.00000000002447,0.855896409120856,0,1,CTPase activity,MF,
12368,GO:0048817,1.00000000002452,0.751249097493892,0,2,negative regulation of hair follicle maturation,BP,
6150,GO:0019474,1.00000000002453,0.708381922078215,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6151,GO:0019477,1.00000000002453,0.708381922078215,0,3,L-lysine catabolic process,BP,
8413,GO:0033512,1.00000000002453,0.708381922078215,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11645,GO:0046440,1.00000000002453,0.708381922078215,0,3,L-lysine metabolic process,BP,
17448,GO:1900368,1.00000000002454,0.69522025819186,0,3,regulation of RNA interference,BP,
492,GO:0001545,1.00000000002457,0.879037012323674,0,1,primary ovarian follicle growth,BP,
15206,GO:0071393,1.00000000002457,0.879037012323674,0,1,cellular response to progesterone stimulus,BP,
1688,GO:0004164,1.00000000002468,0.926023341113798,0,1,diphthine synthase activity,MF,
1733,GO:0004333,1.00000000002468,0.926023341113798,0,1,fumarate hydratase activity,MF,
4323,GO:0009841,1.00000000002476,0.916610324995838,0,1,mitochondrial endopeptidase Clp complex,CC,
8659,GO:0034247,1.00000000002479,0.93680491991591,0,1,snoRNA splicing,BP,
15428,GO:0071796,1.00000000002479,0.93680491991591,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
965,GO:0002408,1.0000000000248,0.854642205999862,0,1,myeloid dendritic cell chemotaxis,BP,
2909,GO:0006422,1.00000000002482,0.917028157038941,0,1,aspartyl-tRNA aminoacylation,BP,
8388,GO:0033342,1.00000000002496,0.913872855500936,0,1,negative regulation of collagen binding,BP,
18891,GO:1904631,1.000000000025,0.918504061066823,0,1,response to glucoside,BP,
2724,GO:0006106,1.000000000025,0.779820918052449,0,3,fumarate metabolic process,BP,
8529,GO:0033872,1.00000000002503,0.921908289170026,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
2350,GO:0005427,1.00000000002503,0.901251040696486,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
5079,GO:0015322,1.00000000002503,0.901251040696486,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
1512,GO:0003874,1.00000000002506,0.946097551529508,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4239,GO:0009441,1.00000000002506,0.946097551529508,0,1,glycolate metabolic process,BP,
5950,GO:0018323,1.00000000002506,0.946097551529508,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8672,GO:0034309,1.00000000002506,0.946097551529508,0,1,primary alcohol biosynthetic process,BP,
9590,GO:0036470,1.00000000002506,0.946097551529508,0,1,tyrosine 3-monooxygenase activator activity,MF,
9591,GO:0036471,1.00000000002506,0.946097551529508,0,1,cellular response to glyoxal,BP,
9597,GO:0036478,1.00000000002506,0.946097551529508,0,1,L-dopa decarboxylase activator activity,MF,
9632,GO:0036524,1.00000000002506,0.946097551529508,0,1,protein deglycase activity,MF,
9633,GO:0036525,1.00000000002506,0.946097551529508,0,1,protein deglycation,BP,
9634,GO:0036526,1.00000000002506,0.946097551529508,0,1,peptidyl-cysteine deglycation,BP,
9635,GO:0036527,1.00000000002506,0.946097551529508,0,1,peptidyl-arginine deglycation,BP,
9636,GO:0036528,1.00000000002506,0.946097551529508,0,1,peptidyl-lysine deglycation,BP,
9637,GO:0036529,1.00000000002506,0.946097551529508,0,1,protein deglycation, glyoxal removal,BP,
9638,GO:0036530,1.00000000002506,0.946097551529508,0,1,protein deglycation, methylglyoxal removal,BP,
9639,GO:0036531,1.00000000002506,0.946097551529508,0,1,glutathione deglycation,BP,
11187,GO:0045340,1.00000000002506,0.946097551529508,0,1,mercury ion binding,MF,
11589,GO:0046295,1.00000000002506,0.946097551529508,0,1,glycolate biosynthetic process,BP,
17172,GO:0106044,1.00000000002506,0.946097551529508,0,1,guanine deglycation,BP,
17173,GO:0106045,1.00000000002506,0.946097551529508,0,1,guanine deglycation, methylglyoxal removal,BP,
17174,GO:0106046,1.00000000002506,0.946097551529508,0,1,guanine deglycation, glyoxal removal,BP,
17257,GO:0140041,1.00000000002506,0.946097551529508,0,1,cellular detoxification of methylglyoxal,BP,
18224,GO:1903072,1.00000000002506,0.946097551529508,0,1,regulation of death-inducing signaling complex assembly,BP,
18225,GO:1903073,1.00000000002506,0.946097551529508,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18239,GO:1903122,1.00000000002506,0.946097551529508,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18251,GO:1903167,1.00000000002506,0.946097551529508,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18252,GO:1903168,1.00000000002506,0.946097551529508,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18256,GO:1903176,1.00000000002506,0.946097551529508,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18257,GO:1903178,1.00000000002506,0.946097551529508,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18261,GO:1903184,1.00000000002506,0.946097551529508,0,1,L-dopa metabolic process,BP,
18262,GO:1903185,1.00000000002506,0.946097551529508,0,1,L-dopa biosynthetic process,BP,
18263,GO:1903189,1.00000000002506,0.946097551529508,0,1,glyoxal metabolic process,BP,
18264,GO:1903195,1.00000000002506,0.946097551529508,0,1,regulation of L-dopa biosynthetic process,BP,
18265,GO:1903197,1.00000000002506,0.946097551529508,0,1,positive regulation of L-dopa biosynthetic process,BP,
18266,GO:1903198,1.00000000002506,0.946097551529508,0,1,regulation of L-dopa decarboxylase activity,BP,
18267,GO:1903200,1.00000000002506,0.946097551529508,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19794,GO:2000277,1.00000000002506,0.946097551529508,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19800,GO:2000284,1.00000000002506,0.946097551529508,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
6658,GO:0030021,1.00000000002514,0.902734695612705,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6860,GO:0030345,1.00000000002514,0.902734695612705,0,1,structural constituent of tooth enamel,MF,
4402,GO:0010157,1.00000000002526,0.824164737312823,0,1,response to chlorate,BP,
16416,GO:0097108,1.00000000002526,0.824164737312823,0,1,hedgehog family protein binding,MF,
236,GO:0000494,1.00000000002538,0.939867873887797,0,1,box C/D snoRNA 3'-end processing,BP,
8541,GO:0033967,1.00000000002538,0.939867873887797,0,1,box C/D snoRNA metabolic process,BP,
8917,GO:0034963,1.00000000002538,0.939867873887797,0,1,box C/D snoRNA processing,BP,
9418,GO:0036009,1.00000000002538,0.939867873887797,0,1,protein-glutamine N-methyltransferase activity,MF,
19463,GO:1990258,1.00000000002538,0.939867873887797,0,1,histone glutamine methylation,BP,
19464,GO:1990259,1.00000000002538,0.939867873887797,0,1,histone-glutamine methyltransferase activity,MF,
5969,GO:0018455,1.00000000002546,0.937097260532144,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
19482,GO:1990384,1.00000000002546,0.937097260532144,0,1,hyaloid vascular plexus regression,BP,
2045,GO:0004794,1.00000000002547,0.934217015798466,0,1,L-threonine ammonia-lyase activity,MF,
11921,GO:0047016,1.0000000000255,0.919355928621465,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
5972,GO:0018479,1.00000000002575,0.920702352293266,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
14741,GO:0070463,1.00000000002581,0.8930659775733,0,1,tubulin-dependent ATPase activity,MF,
8516,GO:0033823,1.00000000002588,0.904792298486391,0,1,procollagen glucosyltransferase activity,MF,
13128,GO:0051728,1.00000000002588,0.904792298486391,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13129,GO:0051729,1.00000000002588,0.904792298486391,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13637,GO:0060184,1.00000000002588,0.904792298486391,0,1,cell cycle switching,BP,
7229,GO:0031161,1.0000000000259,0.901179609539186,0,1,phosphatidylinositol catabolic process,BP,
14860,GO:0070678,1.00000000002604,0.911115940039821,0,1,preprotein binding,MF,
3965,GO:0008768,1.00000000002609,0.948010973386289,0,1,UDP-sugar diphosphatase activity,MF,
6875,GO:0030389,1.00000000002611,0.953216659365106,0,1,fructosamine metabolic process,BP,
10607,GO:0043626,1.00000000002621,0.935685842858304,0,1,PCNA complex,CC,
10976,GO:0044796,1.00000000002621,0.935685842858304,0,1,DNA polymerase processivity factor complex,CC,
9617,GO:0036502,1.00000000002624,0.901464928762138,0,1,Derlin-1-VIMP complex,CC,
10298,GO:0043103,1.00000000002641,0.793935630420239,0,3,hypoxanthine salvage,BP,
3643,GO:0008119,1.00000000002649,0.898666088423035,0,1,thiopurine S-methyltransferase activity,MF,
172,GO:0000379,1.0000000000266,0.780034369698137,0,3,tRNA-type intron splice site recognition and cleavage,BP,
5341,GO:0016094,1.00000000002706,0.707453596087105,0,3,polyprenol biosynthetic process,BP,
8886,GO:0034722,1.00000000002714,0.932131653630891,0,1,gamma-glutamyl-peptidase activity,MF,
15342,GO:0071612,1.00000000002717,0.777454863688197,0,1,IP-10 production,BP,
15372,GO:0071658,1.00000000002717,0.777454863688197,0,1,regulation of IP-10 production,BP,
15373,GO:0071660,1.00000000002717,0.777454863688197,0,1,positive regulation of IP-10 production,BP,
197,GO:0000416,1.00000000002718,0.886769751428723,0,1,positive regulation of histone H3-K36 methylation,BP,
12026,GO:0047915,1.0000000000273,0.928134053636737,0,1,ganglioside galactosyltransferase activity,MF,
3910,GO:0008579,1.00000000002752,0.857594797299258,0,1,JUN kinase phosphatase activity,MF,
9237,GO:0035659,1.00000000002795,0.927523633262807,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
11107,GO:0045167,1.00000000002795,0.927523633262807,0,1,asymmetric protein localization involved in cell fate determination,BP,
14703,GO:0070390,1.00000000002795,0.927523633262807,0,1,transcription export complex 2,CC,
19017,GO:1904889,1.00000000002795,0.927523633262807,0,1,regulation of excitatory synapse assembly,BP,
19018,GO:1904891,1.00000000002795,0.927523633262807,0,1,positive regulation of excitatory synapse assembly,BP,
179,GO:0000390,1.00000000002797,0.851560850535353,0,2,spliceosomal complex disassembly,BP,
12425,GO:0050152,1.00000000002798,0.937195026399779,0,1,omega-amidase activity,MF,
9217,GO:0035623,1.00000000002798,0.898886172682794,0,1,renal glucose absorption,BP,
2255,GO:0005171,1.0000000000281,0.92166179003374,0,1,hepatocyte growth factor receptor binding,MF,
17555,GO:1901207,1.00000000002845,0.880826739516501,0,1,regulation of heart looping,BP,
18524,GO:1903762,1.00000000002845,0.880826739516501,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18615,GO:1903947,1.00000000002845,0.880826739516501,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18617,GO:1903952,1.00000000002845,0.880826739516501,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18618,GO:1903954,1.00000000002845,0.880826739516501,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19075,GO:1905026,1.00000000002845,0.880826739516501,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19077,GO:1905033,1.00000000002845,0.880826739516501,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
18355,GO:1903387,1.00000000002848,0.857623211516173,0,1,positive regulation of homophilic cell adhesion,BP,
18055,GO:1902683,1.00000000002893,0.802644161576845,0,2,regulation of receptor localization to synapse,BP,
12008,GO:0047710,1.00000000002904,0.941948814289379,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
1901,GO:0004588,1.00000000002911,0.911555698410778,0,1,orotate phosphoribosyltransferase activity,MF,
1902,GO:0004590,1.00000000002911,0.911555698410778,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
13624,GO:0060161,1.0000000000292,0.739199739885951,0,3,positive regulation of dopamine receptor signaling pathway,BP,
296,GO:0000801,1.0000000000294,0.876917136023987,0,1,central element,CC,
6541,GO:0021966,1.00000000002944,0.862061189191162,0,1,corticospinal neuron axon guidance,BP,
6542,GO:0021972,1.00000000002944,0.862061189191162,0,1,corticospinal neuron axon guidance through spinal cord,BP,
12679,GO:0050924,1.00000000002944,0.862061189191162,0,1,positive regulation of negative chemotaxis,BP,
12684,GO:0050929,1.00000000002944,0.862061189191162,0,1,induction of negative chemotaxis,BP,
15349,GO:0071623,1.00000000002944,0.862061189191162,0,1,negative regulation of granulocyte chemotaxis,BP,
16038,GO:0090024,1.00000000002944,0.862061189191162,0,1,negative regulation of neutrophil chemotaxis,BP,
16189,GO:0090260,1.00000000002944,0.862061189191162,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18038,GO:1902623,1.00000000002944,0.862061189191162,0,1,negative regulation of neutrophil migration,BP,
15149,GO:0071314,1.00000000002965,0.90883199719603,0,1,cellular response to cocaine,BP,
17942,GO:1902362,1.00000000002965,0.90883199719603,0,1,melanocyte apoptotic process,BP,
5524,GO:0016507,1.00000000002966,0.903406230247245,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9472,GO:0036125,1.00000000002966,0.903406230247245,0,1,fatty acid beta-oxidation multienzyme complex,CC,
2230,GO:0005136,1.00000000002981,0.901701854239108,0,1,interleukin-4 receptor binding,MF,
496,GO:0001552,1.00000000003009,0.923381890795733,0,1,ovarian follicle atresia,BP,
19852,GO:2000355,1.00000000003009,0.923381890795733,0,1,negative regulation of ovarian follicle development,BP,
1400,GO:0003335,1.00000000003135,0.913565803083996,0,1,corneocyte development,BP,
1401,GO:0003336,1.00000000003135,0.913565803083996,0,1,corneocyte desquamation,BP,
19323,GO:1905715,1.00000000003135,0.913565803083996,0,1,regulation of cornification,BP,
19324,GO:1905716,1.00000000003135,0.913565803083996,0,1,negative regulation of cornification,BP,
11958,GO:0047288,1.00000000003252,0.80728987870173,0,2,monosialoganglioside sialyltransferase activity,MF,
8012,GO:0032658,1.00000000003304,0.926171737789564,0,1,regulation of interleukin-15 production,BP,
8056,GO:0032738,1.00000000003304,0.926171737789564,0,1,positive regulation of interleukin-15 production,BP,
9240,GO:0035664,1.00000000003304,0.926171737789564,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9241,GO:0035665,1.00000000003304,0.926171737789564,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
11259,GO:0045590,1.00000000003315,0.890955293442403,0,1,negative regulation of regulatory T cell differentiation,BP,
6126,GO:0019389,1.0000000000333,0.911827375927942,0,1,glucuronoside metabolic process,BP,
6127,GO:0019391,1.0000000000333,0.911827375927942,0,1,glucuronoside catabolic process,BP,
17115,GO:0102390,1.0000000000333,0.911827375927942,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
4355,GO:0009955,1.0000000000338,0.91908503532618,0,1,adaxial/abaxial pattern specification,BP,
9260,GO:0035709,1.0000000000338,0.91908503532618,0,1,memory T cell activation,BP,
16276,GO:0090427,1.0000000000338,0.91908503532618,0,1,activation of meiosis,BP,
19667,GO:2000011,1.0000000000338,0.91908503532618,0,1,regulation of adaxial/abaxial pattern formation,BP,
19955,GO:2000567,1.0000000000338,0.91908503532618,0,1,regulation of memory T cell activation,BP,
19956,GO:2000568,1.0000000000338,0.91908503532618,0,1,positive regulation of memory T cell activation,BP,
20174,GO:2001055,1.0000000000338,0.91908503532618,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
11893,GO:0046952,1.00000000003572,0.733544917271691,0,3,ketone body catabolic process,BP,
7395,GO:0031475,1.00000000003594,0.931515780435878,0,1,myosin V complex,CC,
1691,GO:0004168,1.00000000003605,0.919164679062199,0,1,dolichol kinase activity,MF,
10277,GO:0043048,1.00000000003605,0.919164679062199,0,1,dolichyl monophosphate biosynthetic process,BP,
4375,GO:0010015,1.00000000003734,0.950443570959773,0,1,root morphogenesis,BP,
4389,GO:0010053,1.00000000003734,0.950443570959773,0,1,root epidermal cell differentiation,BP,
4390,GO:0010054,1.00000000003734,0.950443570959773,0,1,trichoblast differentiation,BP,
6594,GO:0022622,1.00000000003734,0.950443570959773,0,1,root system development,BP,
7523,GO:0031763,1.00000000003734,0.950443570959773,0,1,galanin receptor binding,MF,
7524,GO:0031764,1.00000000003734,0.950443570959773,0,1,type 1 galanin receptor binding,MF,
7525,GO:0031765,1.00000000003734,0.950443570959773,0,1,type 2 galanin receptor binding,MF,
7526,GO:0031766,1.00000000003734,0.950443570959773,0,1,type 3 galanin receptor binding,MF,
12172,GO:0048364,1.00000000003734,0.950443570959773,0,1,root development,BP,
12351,GO:0048764,1.00000000003734,0.950443570959773,0,1,trichoblast maturation,BP,
12352,GO:0048765,1.00000000003734,0.950443570959773,0,1,root hair cell differentiation,BP,
12353,GO:0048767,1.00000000003734,0.950443570959773,0,1,root hair elongation,BP,
13001,GO:0051464,1.00000000003734,0.950443570959773,0,1,positive regulation of cortisol secretion,BP,
15953,GO:0080147,1.00000000003734,0.950443570959773,0,1,root hair cell development,BP,
16304,GO:0090558,1.00000000003734,0.950443570959773,0,1,plant epidermis development,BP,
16322,GO:0090627,1.00000000003734,0.950443570959773,0,1,plant epidermal cell differentiation,BP,
16999,GO:0099402,1.00000000003734,0.950443570959773,0,1,plant organ development,BP,
18030,GO:1902606,1.00000000003734,0.950443570959773,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18031,GO:1902608,1.00000000003734,0.950443570959773,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18122,GO:1902890,1.00000000003734,0.950443570959773,0,1,regulation of root hair elongation,BP,
18123,GO:1902891,1.00000000003734,0.950443570959773,0,1,negative regulation of root hair elongation,BP,
18579,GO:1903888,1.00000000003734,0.950443570959773,0,1,regulation of plant epidermal cell differentiation,BP,
18580,GO:1903889,1.00000000003734,0.950443570959773,0,1,negative regulation of plant epidermal cell differentiation,BP,
19214,GO:1905392,1.00000000003734,0.950443570959773,0,1,plant organ morphogenesis,BP,
19226,GO:1905421,1.00000000003734,0.950443570959773,0,1,regulation of plant organ morphogenesis,BP,
19227,GO:1905422,1.00000000003734,0.950443570959773,0,1,negative regulation of plant organ morphogenesis,BP,
19697,GO:2000067,1.00000000003734,0.950443570959773,0,1,regulation of root morphogenesis,BP,
19797,GO:2000280,1.00000000003734,0.950443570959773,0,1,regulation of root development,BP,
20126,GO:2000851,1.00000000003734,0.950443570959773,0,1,positive regulation of glucocorticoid secretion,BP,
861,GO:0002196,1.00000000003804,0.924113944140119,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4974,GO:0015098,1.00000000003804,0.924113944140119,0,1,molybdate ion transmembrane transporter activity,MF,
5147,GO:0015689,1.00000000003804,0.924113944140119,0,1,molybdate ion transport,BP,
16764,GO:0098633,1.00000000003862,0.913736693749523,0,1,collagen fibril binding,MF,
18654,GO:1904027,1.00000000003862,0.913736693749523,0,1,negative regulation of collagen fibril organization,BP,
15447,GO:0071821,1.00000000004356,0.832926674046406,0,1,FANCM-MHF complex,CC,
18935,GO:1904734,1.00000000004772,0.961015969172602,0,1,positive regulation of electron transfer activity,BP,
19051,GO:1904960,1.00000000004772,0.961015969172602,0,1,positive regulation of cytochrome-c oxidase activity,BP,
